ENK_UV_RESPONSE_EPIDERMIS_UP carbohydrate metabolic disorder DOID_2978 9.933E-08 5.652E-05 9.933E-08 5.652E-05 ENK_UV_RESPONSE_EPIDERMIS_UP oral cavity cancer DOID_8618 1.487E-07 4.231E-05 1.487E-07 4.231E-05 ENK_UV_RESPONSE_EPIDERMIS_UP adenoid cystic carcinoma DOID_4866 7.236E-07 1.372E-04 7.236E-07 1.372E-04 ENK_UV_RESPONSE_EPIDERMIS_UP salivary gland cancer DOID_8850 9.127E-07 1.298E-04 9.127E-07 1.298E-04 ENK_UV_RESPONSE_EPIDERMIS_UP biliary tract cancer DOID_4607 1.085E-06 1.234E-04 1.085E-06 1.234E-04 ENK_UV_RESPONSE_EPIDERMIS_UP gallbladder cancer DOID_3121 1.139E-06 1.08E-04 1.139E-06 1.08E-04 ENK_UV_RESPONSE_EPIDERMIS_UP reproductive organ benign neoplasm DOID_0050622 3.286E-06 2.671E-04 3.286E-06 2.671E-04 ENK_UV_RESPONSE_EPIDERMIS_UP arrhythmogenic right ventricular dysplasia DOID_0050431 4.814E-06 3.424E-04 4.814E-06 3.424E-04 ENK_UV_RESPONSE_EPIDERMIS_UP female reproductive organ benign neoplasm DOID_0060086 7.365E-06 4.656E-04 7.365E-06 4.656E-04 ENK_UV_RESPONSE_EPIDERMIS_UP uterine benign neoplasm DOID_0060095 7.365E-06 4.656E-04 7.365E-06 4.656E-04 ENK_UV_RESPONSE_EPIDERMIS_UP uterine fibroid DOID_13223 7.365E-06 4.656E-04 7.365E-06 4.656E-04 ENK_UV_RESPONSE_EPIDERMIS_UP leiomyoma DOID_127 1.063E-05 6.047E-04 1.063E-05 6.047E-04 ENK_UV_RESPONSE_EPIDERMIS_UP bone resorption disease DOID_0080011 1.513E-05 7.828E-04 1.513E-05 7.828E-04 ENK_UV_RESPONSE_EPIDERMIS_UP osteoporosis DOID_11476 1.513E-05 7.828E-04 1.513E-05 7.828E-04 ENK_UV_RESPONSE_EPIDERMIS_UP transitional cell carcinoma DOID_2671 2.851E-05 1.352E-03 4.391E-04 0.01388079 ENK_UV_RESPONSE_EPIDERMIS_UP lymphoblastic leukemia DOID_1037 3.7E-05 1.62E-03 3.7E-05 1.755E-03 ENK_UV_RESPONSE_EPIDERMIS_UP pre-malignant neoplasm DOID_0060071 1.332E-04 5.412E-03 1.332E-04 5.829E-03 ENK_UV_RESPONSE_EPIDERMIS_UP in situ carcinoma DOID_8719 1.332E-04 5.412E-03 1.332E-04 5.829E-03 ENK_UV_RESPONSE_EPIDERMIS_UP myositis DOID_633 1.592E-04 6.039E-03 4.984E-03 0.0746251 ENK_UV_RESPONSE_EPIDERMIS_UP allergic contact dermatitis DOID_3042 1.674E-04 5.952E-03 0.03074925 0.20828957 ENK_UV_RESPONSE_EPIDERMIS_UP brain infarction DOID_3454 1.768E-04 5.919E-03 0.031561 0.21127303 ENK_UV_RESPONSE_EPIDERMIS_UP astrocytoma DOID_3069 1.867E-04 5.901E-03 0.03238117 0.21424283 ENK_UV_RESPONSE_EPIDERMIS_UP pancreatic ductal carcinoma DOID_3587 1.969E-04 5.896E-03 1.969E-04 8.002E-03 ENK_UV_RESPONSE_EPIDERMIS_UP pancreatic carcinoma DOID_4905 2.3E-04 6.543E-03 2.3E-04 8.724E-03 ENK_UV_RESPONSE_EPIDERMIS_UP pancreatitis DOID_4989 2.801E-04 7.59E-03 3.845E-03 0.06434716 ENK_UV_RESPONSE_EPIDERMIS_UP mixed glioma DOID_5076 2.801E-04 7.245E-03 3.845E-03 0.06250867 ENK_UV_RESPONSE_EPIDERMIS_UP contact dermatitis DOID_2773 3.079E-04 7.618E-03 0.04102918 0.23114458 ENK_UV_RESPONSE_EPIDERMIS_UP pneumoconiosis DOID_10316 4.11E-04 9.743E-03 4.11E-04 0.01461447 ENK_UV_RESPONSE_EPIDERMIS_UP primary bacterial infectious disease DOID_0050338 4.209E-04 9.579E-03 4.209E-04 0.0140865 ENK_UV_RESPONSE_EPIDERMIS_UP lymphoid leukemia DOID_10747 4.449E-04 9.737E-03 4.449E-04 0.0133237 ENK_UV_RESPONSE_EPIDERMIS_UP conjunctival disease DOID_4251 6.673E-04 0.01406366 6.673E-04 0.01898594 ENK_UV_RESPONSE_EPIDERMIS_UP conjunctivitis DOID_6195 6.673E-04 0.01406366 6.673E-04 0.01898594 ENK_UV_RESPONSE_EPIDERMIS_UP cervix uteri carcinoma in situ DOID_8991 6.866E-04 0.01395293 6.866E-04 0.01860391 ENK_UV_RESPONSE_EPIDERMIS_UP Huntington's disease DOID_12858 7.825E-04 0.01535327 7.825E-04 0.0202384 ENK_UV_RESPONSE_EPIDERMIS_UP sickle cell anemia DOID_10923 8.136E-04 0.01543041 0.04211965 0.23268042 ENK_UV_RESPONSE_EPIDERMIS_UP cerebral infarction DOID_3526 8.865E-04 0.01627176 0.01518317 0.13934233 ENK_UV_RESPONSE_EPIDERMIS_UP proteinuria DOID_576 9.416E-04 0.01674351 0.01578919 0.1403758 ENK_UV_RESPONSE_EPIDERMIS_UP common cold DOID_10459 9.738E-04 0.01679007 9.738E-04 0.0240901 ENK_UV_RESPONSE_EPIDERMIS_UP osteopetrosis DOID_13533 9.738E-04 0.01629624 9.738E-04 0.02308634 ENK_UV_RESPONSE_EPIDERMIS_UP movement disease DOID_480 1.184E-03 0.01924391 1.184E-03 0.02694147 ENK_UV_RESPONSE_EPIDERMIS_UP eyelid disease DOID_530 1.336E-03 0.02111229 1.336E-03 0.02923241 ENK_UV_RESPONSE_EPIDERMIS_UP giant cell tumor DOID_200 1.389E-03 0.02135723 0.02031318 0.16279151 ENK_UV_RESPONSE_EPIDERMIS_UP malignant giant cell tumor DOID_2705 1.389E-03 0.02135723 0.02031318 0.16279151 ENK_UV_RESPONSE_EPIDERMIS_UP giant cell glioblastoma DOID_3074 1.389E-03 0.02135723 0.02031318 0.16279151 ENK_UV_RESPONSE_EPIDERMIS_UP bile duct adenocarcinoma DOID_4896 1.462E-03 0.0218881 1.462E-03 0.03080547 ENK_UV_RESPONSE_EPIDERMIS_UP cholangiocarcinoma DOID_4947 1.462E-03 0.0218881 1.462E-03 0.03080547 ENK_UV_RESPONSE_EPIDERMIS_UP vasculitis DOID_865 1.462E-03 0.02132686 0.02099868 0.16367465 ENK_UV_RESPONSE_EPIDERMIS_UP hypertrophic cardiomyopathy DOID_11984 1.778E-03 0.02528697 0.02383537 0.17167499 ENK_UV_RESPONSE_EPIDERMIS_UP glioblastoma DOID_3068 1.778E-03 0.02467021 0.02383537 0.1674361 ENK_UV_RESPONSE_EPIDERMIS_UP bile duct cancer DOID_4606 1.778E-03 0.02408283 1.778E-03 0.03612424 ENK_UV_RESPONSE_EPIDERMIS_UP bile duct carcinoma DOID_4897 1.778E-03 0.02408283 1.778E-03 0.03612424 ENK_UV_RESPONSE_EPIDERMIS_UP osteosclerosis DOID_4254 2.223E-03 0.0294152 2.223E-03 0.04361564 ENK_UV_RESPONSE_EPIDERMIS_UP endocrine organ benign neoplasm DOID_0060089 2.744E-03 0.03548431 2.744E-03 0.05204365 ENK_UV_RESPONSE_EPIDERMIS_UP tuberculosis DOID_399 2.744E-03 0.03469577 2.744E-03 0.05036482 ENK_UV_RESPONSE_EPIDERMIS_UP nephrosis DOID_2527 3.086E-03 0.03816938 0.03404645 0.22267162 ENK_UV_RESPONSE_EPIDERMIS_UP glycogen metabolism disorder DOID_0050728 3.629E-03 0.0439359 3.629E-03 0.06453085 ENK_UV_RESPONSE_EPIDERMIS_UP glycogen storage disease DOID_2747 3.629E-03 0.0439359 3.629E-03 0.06453085 ENK_UV_RESPONSE_EPIDERMIS_UP lingual-facial-buccal dyskinesia DOID_9854 3.629E-03 0.04302056 3.629E-03 0.06257537 ENK_UV_RESPONSE_EPIDERMIS_UP aneurysm disease DOID_2403 3.711E-03 0.04309669 0.26606077 0.57562197 ENK_UV_RESPONSE_EPIDERMIS_UP bacterial pneumonia DOID_874 3.845E-03 0.04375607 3.845E-03 0.06077232 ENK_UV_RESPONSE_EPIDERMIS_UP spinal muscular atrophy DOID_12377 4.984E-03 0.05560301 4.984E-03 0.07664199 ENK_UV_RESPONSE_EPIDERMIS_UP seminoma DOID_4440 5.353E-03 0.05857898 5.353E-03 0.07810531 ENK_UV_RESPONSE_EPIDERMIS_UP hypotrichosis DOID_4535 5.353E-03 0.05747372 5.353E-03 0.07615268 ENK_UV_RESPONSE_EPIDERMIS_UP fragments of torsion dystonia DOID_531 5.353E-03 0.05640939 5.353E-03 0.0742953 ENK_UV_RESPONSE_EPIDERMIS_UP amino acid metabolic disorder DOID_9252 5.511E-03 0.05701409 5.511E-03 0.07466131 ENK_UV_RESPONSE_EPIDERMIS_UP lymphoma DOID_0060058 6.029E-03 0.0612629 6.029E-03 0.07978424 ENK_UV_RESPONSE_EPIDERMIS_UP invasive ductal carcinoma DOID_3008 6.129E-03 0.06118611 6.129E-03 0.07926382 ENK_UV_RESPONSE_EPIDERMIS_UP autoimmune disease of the nervous system DOID_438 6.129E-03 0.06013117 0.11076221 0.329967 ENK_UV_RESPONSE_EPIDERMIS_UP central nervous system hereditary degenerative disease DOID_481 6.129E-03 0.059112 6.129E-03 0.0775024 ENK_UV_RESPONSE_EPIDERMIS_UP Crohn's disease DOID_8778 6.391E-03 0.06060431 6.391E-03 0.0790491 ENK_UV_RESPONSE_EPIDERMIS_UP toxic encephalopathy DOID_3602 6.535E-03 0.06096135 6.535E-03 0.07912005 ENK_UV_RESPONSE_EPIDERMIS_UP dystonic disease DOID_544 6.535E-03 0.0599781 6.535E-03 0.07747171 ENK_UV_RESPONSE_EPIDERMIS_UP hypersensitivity reaction type I disease DOID_1205 6.576E-03 0.05939242 6.576E-03 0.07636168 ENK_UV_RESPONSE_EPIDERMIS_UP dilated cardiomyopathy DOID_12930 6.576E-03 0.05846441 0.0554041 0.24249947 ENK_UV_RESPONSE_EPIDERMIS_UP congenital disorder of glycosylation DOID_5212 6.953E-03 0.06086857 6.953E-03 0.07912915 ENK_UV_RESPONSE_EPIDERMIS_UP ulcerative colitis DOID_8577 7.151E-03 0.06165133 7.151E-03 0.07978407 ENK_UV_RESPONSE_EPIDERMIS_UP gonadal disease DOID_2277 7.383E-03 0.06270146 7.383E-03 0.08078842 ENK_UV_RESPONSE_EPIDERMIS_UP germinoma DOID_3304 7.825E-03 0.06547365 7.825E-03 0.08400392 ENK_UV_RESPONSE_EPIDERMIS_UP hair disease DOID_421 8.742E-03 0.07209302 8.742E-03 0.09211885 ENK_UV_RESPONSE_EPIDERMIS_UP nephroblastoma DOID_2154 9.218E-03 0.07493298 9.218E-03 0.09536925 ENK_UV_RESPONSE_EPIDERMIS_UP periodontal disease DOID_3388 9.218E-03 0.07387759 0.13480048 0.37415353 ENK_UV_RESPONSE_EPIDERMIS_UP adenoma DOID_657 0.01020455 0.08064432 0.01020455 0.10368555 ENK_UV_RESPONSE_EPIDERMIS_UP pulmonary sarcoidosis DOID_13406 0.01071437 0.08351335 0.01071437 0.1069557 ENK_UV_RESPONSE_EPIDERMIS_UP multiple myeloma DOID_9538 0.01071437 0.08238479 0.01071437 0.10511163 ENK_UV_RESPONSE_EPIDERMIS_UP benign mesothelioma DOID_2645 0.01286326 0.09758926 0.01286326 0.12405414 ENK_UV_RESPONSE_EPIDERMIS_UP pulmonary emphysema DOID_9675 0.01286326 0.09630519 0.01286326 0.12198657 ENK_UV_RESPONSE_EPIDERMIS_UP endometriosis of uterus DOID_288 0.01342743 0.09922349 0.16148334 0.41019653 OSADA_ASCL1_TARGETS_UP diabetic retinopathy DOID_8947 2.943E-07 1.675E-04 2.446E-05 6.96E-03 OSADA_ASCL1_TARGETS_UP retinal vascular disease DOID_2462 5.078E-07 1.445E-04 3.668E-05 5.218E-03 OSADA_ASCL1_TARGETS_UP temporal lobe epilepsy DOID_3328 1.83E-05 3.47E-03 1.83E-05 0.01041003 OSADA_ASCL1_TARGETS_UP focal epilepsy DOID_2234 3.422E-05 4.867E-03 3.422E-05 6.49E-03 OSADA_ASCL1_TARGETS_UP Hirschsprung's disease DOID_10487 4.082E-05 4.646E-03 4.082E-05 4.646E-03 OSADA_ASCL1_TARGETS_UP megacolon DOID_11372 4.761E-05 4.515E-03 4.761E-05 4.515E-03 OSADA_ASCL1_TARGETS_UP neuroendocrine tumor DOID_169 7.989E-05 6.494E-03 7.989E-05 6.494E-03 OSADA_ASCL1_TARGETS_UP colonic disease DOID_5353 9.912E-05 7.05E-03 9.912E-05 7.05E-03 OSADA_ASCL1_TARGETS_UP uremia DOID_4676 1.318E-04 8.333E-03 0.01685471 0.30936544 OSADA_ASCL1_TARGETS_UP portal hypertension DOID_10762 1.691E-04 9.621E-03 0.01903285 0.30082473 OSADA_ASCL1_TARGETS_UP Sciatic Neuropathy DOID_11446 2.109E-04 0.0109116 2.109E-04 0.01333639 OSADA_ASCL1_TARGETS_UP lesion of sciatic nerve DOID_12528 2.109E-04 0.0109116 2.109E-04 0.01333639 OSADA_ASCL1_TARGETS_UP mononeuritis of lower limb DOID_9473 2.109E-04 0.0109116 2.109E-04 0.01333639 OSADA_ASCL1_TARGETS_UP pleurisy DOID_10247 2.259E-04 0.01071185 2.259E-04 0.01285422 OSADA_ASCL1_TARGETS_UP mononeuritis DOID_1802 2.259E-04 9.888E-03 2.259E-04 0.01168565 OSADA_ASCL1_TARGETS_UP hepatic vascular disease DOID_272 2.259E-04 9.182E-03 0.0219298 0.30434279 OSADA_ASCL1_TARGETS_UP mononeuropathy DOID_1188 2.414E-04 9.156E-03 2.414E-04 0.01144537 OSADA_ASCL1_TARGETS_UP dysostosis DOID_1934 2.574E-04 9.152E-03 2.574E-04 0.01126414 OSADA_ASCL1_TARGETS_UP pleural disease DOID_1532 3.083E-04 0.01031888 3.083E-04 0.01253007 OSADA_ASCL1_TARGETS_UP neuritis DOID_1803 6.304E-04 0.01992752 6.304E-04 0.02391302 OSADA_ASCL1_TARGETS_UP oral cavity cancer DOID_8618 9.37E-04 0.02806123 9.37E-04 0.03332271 OSADA_ASCL1_TARGETS_UP neuroectodermal tumor DOID_171 1.031E-03 0.02932751 1.031E-03 0.03450296 OSADA_ASCL1_TARGETS_UP pancreatitis DOID_4989 1.604E-03 0.04346232 1.604E-03 0.05070604 OSADA_ASCL1_TARGETS_UP mixed glioma DOID_5076 1.604E-03 0.04148676 0.0574528 0.43014002 OSADA_ASCL1_TARGETS_UP bone development disease DOID_0080006 1.85E-03 0.04577376 1.85E-03 0.05541034 OSADA_ASCL1_TARGETS_UP transitional cell carcinoma DOID_2671 2.024E-03 0.04797958 0.06440654 0.45243608 OSADA_ASCL1_TARGETS_UP nervous system cancer DOID_3093 2.113E-03 0.04809816 2.113E-03 0.06012269 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP medullomyoblastoma DOID_3861 5.441E-06 3.096E-03 5.441E-06 3.096E-03 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP adult medulloblastoma DOID_3864 5.441E-06 3.096E-03 5.441E-06 3.096E-03 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP childhood medulloblastoma DOID_3869 5.441E-06 3.096E-03 5.441E-06 3.096E-03 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP medulloblastoma DOID_3858 6.365E-06 1.811E-03 6.365E-06 1.811E-03 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP primitive neuroectodermal tumor DOID_168 9.743E-06 1.848E-03 9.743E-06 1.848E-03 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP neuroectodermal tumor DOID_171 2.645E-05 3.762E-03 2.645E-05 3.762E-03 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP ulcerative colitis DOID_8577 1.004E-04 0.01142651 1.004E-04 0.01142651 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP endometrial carcinoma DOID_2871 3.807E-04 0.03610671 0.02831483 0.41310605 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP endometrial cancer DOID_1380 4.301E-04 0.03496504 0.03005843 0.4275811 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP calcinosis DOID_182 5.961E-04 0.04239451 0.03527102 0.4459825 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP hepatitis DOID_2237 6.572E-04 0.04155064 0.03700251 0.43863388 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP cervix uteri carcinoma in situ DOID_8991 7.213E-04 0.04104122 7.213E-04 0.06840203 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP uterine cancer DOID_363 8.228E-04 0.04256281 0.04131803 0.45211458 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP proteinuria DOID_576 8.941E-04 0.04239704 0.04303898 0.45350328 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP brain cancer DOID_1319 9.309E-04 0.0407435 0.04389832 0.44603834 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP heart valve disease DOID_4079 9.309E-04 0.03783325 0.04389832 0.4382131 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP central nervous system cancer DOID_3620 9.683E-04 0.03673167 0.04475692 0.43908087 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP calcium metabolism disease DOID_10575 1.045E-03 0.03717605 0.04647188 0.44817797 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP atrophic muscular disease DOID_913 1.166E-03 0.03903682 1.166E-03 0.0948037 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP muscular dystrophy DOID_9884 1.166E-03 0.03903682 1.166E-03 0.0948037 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP hypertrophic cardiomyopathy DOID_11984 1.382E-03 0.04368802 1.382E-03 0.09829804 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP pre-malignant neoplasm DOID_0060071 1.615E-03 0.048377 1.615E-03 0.10212921 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP congenital heart defect DOID_1682 1.615E-03 0.04595815 1.615E-03 0.09191629 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP in situ carcinoma DOID_8719 1.615E-03 0.048377 1.615E-03 0.10212921 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP mineral metabolism disease DOID_0050032 1.664E-03 0.04509112 0.05839317 0.49590621 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP cholestasis DOID_13580 1.714E-03 0.04432093 0.05923914 0.48850825 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP tooth disease DOID_1091 1.815E-03 0.04489313 1.815E-03 0.09386746 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP bile duct disease DOID_4138 2.025E-03 0.04800976 0.06429945 0.50118336 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP biliary tract disease DOID_9741 2.079E-03 0.04732554 0.06514026 0.50087578 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP mixed glioma DOID_5076 2.361E-03 0.0516736 0.06933333 0.49937553 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP lipid metabolism disorder DOID_3146 2.479E-03 0.05223638 2.479E-03 0.11753187 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP nervous system cancer DOID_3093 3.107E-03 0.06313571 0.07932237 0.5309933 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP lymphoblastic leukemia DOID_1037 3.308E-03 0.06491236 3.308E-03 0.14480449 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP encephalomyelitis DOID_640 3.308E-03 0.06274861 0.08180333 0.53501257 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.377E-03 0.06198174 0.08262887 0.53427076 FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP mouth disease DOID_403 3.377E-03 0.06004481 3.377E-03 0.13724528 LAU_APOPTOSIS_CDKN2A_UP transitional cell carcinoma DOID_2671 3.924E-10 2.233E-07 3.706E-03 0.14058846 LAU_APOPTOSIS_CDKN2A_UP reproductive organ benign neoplasm DOID_0050622 3.392E-09 9.651E-07 1.561E-03 0.0683174 LAU_APOPTOSIS_CDKN2A_UP lymphoma DOID_0060058 3.959E-08 7.509E-06 2.452E-06 1.395E-03 LAU_APOPTOSIS_CDKN2A_UP multiple myeloma DOID_9538 7.639E-08 1.087E-05 8.947E-06 2.545E-03 LAU_APOPTOSIS_CDKN2A_UP breast benign neoplasm DOID_0060082 1.524E-07 1.735E-05 5.35E-05 4.349E-03 LAU_APOPTOSIS_CDKN2A_UP thoracic benign neoplasm DOID_0060097 1.524E-07 1.735E-05 5.35E-05 4.349E-03 LAU_APOPTOSIS_CDKN2A_UP benign breast phyllodes tumor DOID_1631 1.524E-07 1.735E-05 5.35E-05 4.349E-03 LAU_APOPTOSIS_CDKN2A_UP myeloma DOID_0070004 1.911E-07 1.813E-05 1.763E-05 3.343E-03 LAU_APOPTOSIS_CDKN2A_UP bone marrow cancer DOID_4960 3.262E-07 2.651E-05 2.619E-05 3.725E-03 LAU_APOPTOSIS_CDKN2A_UP pustulosis of palm and sole DOID_4398 3.501E-07 2.49E-05 2.76E-05 3.14E-03 LAU_APOPTOSIS_CDKN2A_UP nervous system cancer DOID_3093 2.25E-06 1.423E-04 1.097E-04 6.935E-03 LAU_APOPTOSIS_CDKN2A_UP papilloma DOID_2615 6.483E-06 3.689E-04 0.03547478 0.43880755 LAU_APOPTOSIS_CDKN2A_UP nephroblastoma DOID_2154 7.051E-06 3.647E-04 0.03644248 0.44118667 LAU_APOPTOSIS_CDKN2A_UP adenoma DOID_657 8.281E-06 3.927E-04 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP peripheral nervous system neoplasm DOID_1192 9.646E-06 4.222E-04 7.826E-04 0.04453261 LAU_APOPTOSIS_CDKN2A_UP glaucoma DOID_1686 1.985E-05 8.066E-04 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP pre-malignant neoplasm DOID_0060071 4.07E-05 1.544E-03 2.015E-03 0.08190466 LAU_APOPTOSIS_CDKN2A_UP in situ carcinoma DOID_8719 4.07E-05 1.544E-03 2.015E-03 0.08190466 LAU_APOPTOSIS_CDKN2A_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 4.38E-05 1.558E-03 4.38E-05 4.154E-03 LAU_APOPTOSIS_CDKN2A_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 4.38E-05 1.558E-03 4.38E-05 4.154E-03 LAU_APOPTOSIS_CDKN2A_UP Hodgkin's granuloma DOID_8651 4.38E-05 1.558E-03 4.38E-05 4.154E-03 LAU_APOPTOSIS_CDKN2A_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 4.38E-05 1.558E-03 4.38E-05 4.154E-03 LAU_APOPTOSIS_CDKN2A_UP endocrine organ benign neoplasm DOID_0060089 5.066E-05 1.696E-03 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP retinal detachment DOID_5327 6.416E-05 2.028E-03 0.01196381 0.32416223 LAU_APOPTOSIS_CDKN2A_UP Hodgkin's lymphoma DOID_8567 6.416E-05 1.921E-03 6.416E-05 4.563E-03 LAU_APOPTOSIS_CDKN2A_UP ocular hypertension DOID_9282 6.416E-05 1.825E-03 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP borderline glaucoma DOID_9283 6.416E-05 1.825E-03 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP angiosarcoma DOID_0001816 1.164E-04 3.153E-03 0.01592069 0.39386393 LAU_APOPTOSIS_CDKN2A_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.245E-04 3.219E-03 0.09189432 0.58097629 LAU_APOPTOSIS_CDKN2A_UP male reproductive organ benign neoplasm DOID_0060087 1.482E-04 3.666E-03 0.01789333 0.40725229 LAU_APOPTOSIS_CDKN2A_UP testicular cancer DOID_2998 1.655E-04 3.924E-03 0.01887821 0.39784089 LAU_APOPTOSIS_CDKN2A_UP papillary adenoma DOID_3172 3.38E-04 7.693E-03 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP microcystic adenoma DOID_5403 3.38E-04 7.693E-03 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP follicular adenoma DOID_6204 3.38E-04 7.693E-03 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP seminoma DOID_4440 3.638E-04 7.961E-03 0.02769897 0.45030605 LAU_APOPTOSIS_CDKN2A_UP sarcoma DOID_1115 4.181E-04 8.811E-03 0.02964862 0.4439491 LAU_APOPTOSIS_CDKN2A_UP female reproductive organ benign neoplasm DOID_0060086 4.761E-04 9.675E-03 0.03159447 0.42802985 LAU_APOPTOSIS_CDKN2A_UP uterine benign neoplasm DOID_0060095 4.761E-04 9.675E-03 0.03159447 0.42802985 LAU_APOPTOSIS_CDKN2A_UP uterine fibroid DOID_13223 4.761E-04 9.675E-03 0.03159447 0.42802985 LAU_APOPTOSIS_CDKN2A_UP germinoma DOID_3304 5.378E-04 0.01055238 0.03353652 0.44377394 LAU_APOPTOSIS_CDKN2A_UP leiomyoma DOID_127 5.701E-04 0.01081202 0.03450612 0.44622688 LAU_APOPTOSIS_CDKN2A_UP autonomic nervous system neoplasm DOID_2621 5.701E-04 0.01046324 0.03450612 0.43631073 LAU_APOPTOSIS_CDKN2A_UP neuroblastoma DOID_769 5.701E-04 0.01046324 0.03450612 0.43631073 LAU_APOPTOSIS_CDKN2A_UP thyroid carcinoma DOID_3963 6.373E-04 0.01133147 0.03644248 0.43199528 LAU_APOPTOSIS_CDKN2A_UP spindle cell carcinoma DOID_4015 6.373E-04 0.01098809 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP thyroid cancer DOID_1781 7.081E-04 0.01185093 0.03837507 0.43670825 LAU_APOPTOSIS_CDKN2A_UP benign mesothelioma DOID_2645 9.012E-04 0.0146509 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP cervix uteri carcinoma in situ DOID_8991 9.012E-04 0.01424393 0.04319002 0.45509488 LAU_APOPTOSIS_CDKN2A_UP Huntington's disease DOID_12858 9.847E-04 0.01514367 9.847E-04 0.05093779 LAU_APOPTOSIS_CDKN2A_UP uterine cancer DOID_363 1.028E-03 0.01539077 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP brain cancer DOID_1319 1.163E-03 0.0169616 0.04893699 0.47195166 LAU_APOPTOSIS_CDKN2A_UP thyroid adenoma DOID_2891 1.163E-03 0.01653756 1.000 1.000 LAU_APOPTOSIS_CDKN2A_UP central nervous system cancer DOID_3620 1.209E-03 0.01678214 0.04989155 0.47313816 LAU_APOPTOSIS_CDKN2A_UP integumentary system benign neoplasm DOID_0060121 1.257E-03 0.01702712 0.05084517 0.47427706 LAU_APOPTOSIS_CDKN2A_UP skin benign neoplasm DOID_3165 1.257E-03 0.01702712 0.05084517 0.47427706 LAU_APOPTOSIS_CDKN2A_UP lung small cell carcinoma DOID_5409 1.257E-03 0.01663114 0.05084517 0.46662743 LAU_APOPTOSIS_CDKN2A_UP B-cell lymphocytic neoplasm DOID_707 1.355E-03 0.01751803 1.355E-03 0.06423279 LAU_APOPTOSIS_CDKN2A_UP bile duct adenocarcinoma DOID_4896 1.508E-03 0.01906761 0.05559931 0.47933349 LAU_APOPTOSIS_CDKN2A_UP cholangiocarcinoma DOID_4947 1.508E-03 0.01906761 0.05559931 0.47933349 LAU_APOPTOSIS_CDKN2A_UP integumentary system cancer DOID_0060122 1.561E-03 0.01930709 0.05654736 0.48023055 LAU_APOPTOSIS_CDKN2A_UP skin cancer DOID_4159 1.561E-03 0.01930709 0.05654736 0.48023055 LAU_APOPTOSIS_CDKN2A_UP hypertrophic cardiomyopathy DOID_11984 1.725E-03 0.02088011 0.05938593 0.48971876 LAU_APOPTOSIS_CDKN2A_UP hypersensitivity reaction type IV disease DOID_2916 1.725E-03 0.02044511 0.05938593 0.48272278 LAU_APOPTOSIS_CDKN2A_UP bile duct cancer DOID_4606 1.725E-03 0.02002786 0.05938593 0.46931382 LAU_APOPTOSIS_CDKN2A_UP bile duct carcinoma DOID_4897 1.725E-03 0.02002786 0.05938593 0.46931382 LAU_APOPTOSIS_CDKN2A_UP astrocytoma DOID_3069 2.392E-03 0.02722429 0.06972306 0.51522626 LAU_APOPTOSIS_CDKN2A_UP biliary tract cancer DOID_4607 3.314E-03 0.03697469 0.08179711 0.54755947 LAU_APOPTOSIS_CDKN2A_UP Human immunodeficiency virus infectious disease DOID_526 3.869E-03 0.04233379 3.869E-03 0.13758481 LAU_APOPTOSIS_CDKN2A_UP lymphoblastic leukemia DOID_1037 4.119E-03 0.04421975 0.09098087 0.58827407 LAU_APOPTOSIS_CDKN2A_UP transient cerebral ischemia DOID_224 9.98E-03 0.09962056 9.98E-03 0.29886169 WOO_LIVER_CANCER_RECURRENCE_DN amino acid metabolic disorder DOID_9252 1.217E-14 6.922E-12 1.217E-14 6.922E-12 WOO_LIVER_CANCER_RECURRENCE_DN lipid metabolism disorder DOID_3146 2.531E-09 7.201E-07 1.465E-07 2.779E-05 WOO_LIVER_CANCER_RECURRENCE_DN familial hyperlipidemia DOID_1168 2.759E-08 5.233E-06 1.829E-06 2.601E-04 WOO_LIVER_CANCER_RECURRENCE_DN familial hypercholesterolemia DOID_13810 3.061E-08 4.354E-06 3.061E-08 8.708E-06 WOO_LIVER_CANCER_RECURRENCE_DN hypoglycemia DOID_9993 3.701E-08 4.212E-06 5.294E-06 5.021E-04 WOO_LIVER_CANCER_RECURRENCE_DN endocrine pancreas disease DOID_1428 5.275E-08 5.002E-06 3.053E-06 3.474E-04 WOO_LIVER_CANCER_RECURRENCE_DN chronic kidney failure DOID_784 1.756E-07 1.427E-05 2.767E-04 0.01431332 WOO_LIVER_CANCER_RECURRENCE_DN peroxisomal disease DOID_906 2.046E-06 1.455E-04 2.873E-04 0.01362438 WOO_LIVER_CANCER_RECURRENCE_DN metabolic syndrome X DOID_14221 6.853E-06 4.333E-04 6.853E-06 5.57E-04 WOO_LIVER_CANCER_RECURRENCE_DN alcohol abuse DOID_1574 7.907E-06 4.499E-04 2.767E-04 0.01574466 WOO_LIVER_CANCER_RECURRENCE_DN carbohydrate metabolic disorder DOID_2978 1.23E-05 6.361E-04 1.23E-05 8.746E-04 WOO_LIVER_CANCER_RECURRENCE_DN pneumoconiosis DOID_10316 2.289E-05 1.085E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_DN hyperinsulinism DOID_2018 4.43E-05 1.939E-03 4.43E-05 2.801E-03 WOO_LIVER_CANCER_RECURRENCE_DN cholestasis DOID_13580 1.429E-04 5.809E-03 4.586E-03 0.17396496 WOO_LIVER_CANCER_RECURRENCE_DN bile duct disease DOID_4138 1.837E-04 6.969E-03 5.407E-03 0.14650279 WOO_LIVER_CANCER_RECURRENCE_DN biliary tract disease DOID_9741 1.912E-04 6.798E-03 5.55E-03 0.14353945 WOO_LIVER_CANCER_RECURRENCE_DN bacterial pneumonia DOID_874 2.314E-04 7.744E-03 6.29E-03 0.15561183 WOO_LIVER_CANCER_RECURRENCE_DN lymphatic system cancer DOID_0060073 2.873E-04 9.083E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_DN reticulosarcoma DOID_8538 2.873E-04 9.083E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_DN lymphosarcoma DOID_8675 2.873E-04 9.083E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_DN glycogen metabolism disorder DOID_0050728 5.315E-04 0.01591675 5.315E-04 0.02326295 WOO_LIVER_CANCER_RECURRENCE_DN glycogen storage disease DOID_2747 5.315E-04 0.01591675 5.315E-04 0.02326295 WOO_LIVER_CANCER_RECURRENCE_DN extrinsic allergic alveolitis DOID_841 7.903E-04 0.0224849 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_DN hepatitis C DOID_1883 1.381E-03 0.03740947 0.05325049 0.4887021 WOO_LIVER_CANCER_RECURRENCE_DN hepatitis DOID_2237 1.776E-03 0.04594642 0.06022945 0.52723934 WOO_LIVER_CANCER_RECURRENCE_DN peptic ulcer DOID_750 1.776E-03 0.04394875 0.06022945 0.51925086 WOO_LIVER_CANCER_RECURRENCE_DN benign mesothelioma DOID_2645 1.948E-03 0.046188 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_DN cerebral infarction DOID_3526 2.314E-03 0.05267142 2.314E-03 0.09405611 WOO_LIVER_CANCER_RECURRENCE_DN cerebral degeneration DOID_1443 4.586E-03 0.0966472 0.09571349 0.68937946 WOO_LIVER_CANCER_RECURRENCE_DN temporal lobe epilepsy DOID_3328 4.719E-03 0.09588693 4.719E-03 0.15793141 WOO_LIVER_CANCER_RECURRENCE_DN hyperglycemia DOID_4195 4.719E-03 0.09258048 4.719E-03 0.14915745 WOO_LIVER_CANCER_RECURRENCE_DN brain infarction DOID_3454 4.989E-03 0.09461825 4.989E-03 0.14939724 WOO_LIVER_CANCER_RECURRENCE_DN nephrosis DOID_2527 5.407E-03 0.09924382 5.407E-03 0.15382793 WONG_ENDMETRIUM_CANCER_DN facioscapulohumeral muscular dystrophy DOID_11727 4.616E-05 0.02626594 4.616E-05 0.02626594 WONG_ENDMETRIUM_CANCER_DN Ehlers-Danlos syndrome DOID_13359 1.074E-04 0.0305441 1.074E-04 0.0305441 WONG_ENDMETRIUM_CANCER_DN corneal dystrophy DOID_2566 1.074E-04 0.02036273 1.074E-04 0.02036273 WONG_ENDMETRIUM_CANCER_DN spinal cord disease DOID_319 3.832E-04 0.05451666 0.0284178 0.29399507 WONG_ENDMETRIUM_CANCER_DN toxic encephalopathy DOID_3602 4.705E-04 0.05354683 4.705E-04 0.06693354 WONG_ENDMETRIUM_CANCER_DN corneal disease DOID_10124 5.016E-04 0.04756627 5.016E-04 0.05707952 WONG_ENDMETRIUM_CANCER_DN medullomyoblastoma DOID_3861 7.081E-04 0.05756166 0.03837507 0.32110901 WONG_ENDMETRIUM_CANCER_DN adult medulloblastoma DOID_3864 7.081E-04 0.05756166 0.03837507 0.32110901 WONG_ENDMETRIUM_CANCER_DN childhood medulloblastoma DOID_3869 7.081E-04 0.05756166 0.03837507 0.32110901 WONG_ENDMETRIUM_CANCER_DN refractive error DOID_9835 7.459E-04 0.05305449 0.03936531 0.31547689 WONG_ENDMETRIUM_CANCER_DN medulloblastoma DOID_3858 7.847E-04 0.04960941 0.04035455 0.31891307 WONG_ENDMETRIUM_CANCER_DN congenital diaphragmatic hernia DOID_3827 8.65E-04 0.04922107 8.65E-04 0.08203512 WONG_ENDMETRIUM_CANCER_DN adenoid cystic carcinoma DOID_4866 9.067E-04 0.04689872 9.067E-04 0.07369799 WONG_ENDMETRIUM_CANCER_DN salivary gland cancer DOID_8850 9.927E-04 0.04707128 9.927E-04 0.07060692 WONG_ENDMETRIUM_CANCER_DN primitive neuroectodermal tumor DOID_168 1.037E-03 0.04539595 0.04626922 0.34641036 WONG_ENDMETRIUM_CANCER_DN diabetic autonomic neuropathy DOID_11503 1.083E-03 0.0439983 1.083E-03 0.06844179 WONG_ENDMETRIUM_CANCER_DN autonomic neuropathy DOID_11504 1.083E-03 0.0439983 1.083E-03 0.06844179 WONG_ENDMETRIUM_CANCER_DN diabetic polyneuropathy DOID_12785 1.083E-03 0.0439983 1.083E-03 0.06844179 WONG_ENDMETRIUM_CANCER_DN diabetic neuropathy DOID_9743 1.083E-03 0.0439983 1.083E-03 0.06844179 WONG_ENDMETRIUM_CANCER_DN autonomic nervous system disease DOID_11465 1.224E-03 0.04644483 1.224E-03 0.06966725 WONG_ENDMETRIUM_CANCER_DN heart valve disease DOID_4079 1.224E-03 0.04354203 1.224E-03 0.06333386 WONG_ENDMETRIUM_CANCER_DN atrophic muscular disease DOID_913 1.533E-03 0.05131846 1.533E-03 0.07270115 WONG_ENDMETRIUM_CANCER_DN muscular dystrophy DOID_9884 1.533E-03 0.05131846 1.533E-03 0.07270115 WONG_ENDMETRIUM_CANCER_DN bile duct adenocarcinoma DOID_4896 1.588E-03 0.05019731 1.588E-03 0.06950397 WONG_ENDMETRIUM_CANCER_DN cholangiocarcinoma DOID_4947 1.588E-03 0.05019731 1.588E-03 0.06950397 WONG_ENDMETRIUM_CANCER_DN reproductive organ benign neoplasm DOID_0050622 1.644E-03 0.04922182 0.05799219 0.40240925 WONG_ENDMETRIUM_CANCER_DN bile duct cancer DOID_4606 1.816E-03 0.05166714 1.816E-03 0.0738102 WONG_ENDMETRIUM_CANCER_DN bile duct carcinoma DOID_4897 1.816E-03 0.05166714 1.816E-03 0.0738102 WONG_ENDMETRIUM_CANCER_DN oral cavity cancer DOID_8618 1.816E-03 0.0492068 1.816E-03 0.06888952 WONG_ENDMETRIUM_CANCER_DN neuroectodermal tumor DOID_171 1.997E-03 0.05164358 0.06380091 0.41727261 WONG_ENDMETRIUM_CANCER_DN carotid artery disease DOID_3407 1.997E-03 0.0493982 1.997E-03 0.07100992 WONG_ENDMETRIUM_CANCER_DN collagen disease DOID_854 1.997E-03 0.04733995 1.997E-03 0.06683286 WONG_ENDMETRIUM_CANCER_DN pre-malignant neoplasm DOID_0060071 2.122E-03 0.04829171 0.06572938 0.4250002 WONG_ENDMETRIUM_CANCER_DN in situ carcinoma DOID_8719 2.122E-03 0.04829171 0.06572938 0.4250002 WONG_ENDMETRIUM_CANCER_DN nephrosis DOID_2527 2.658E-03 0.05816806 2.658E-03 0.08402054 WONG_ENDMETRIUM_CANCER_DN diabetic retinopathy DOID_8947 2.801E-03 0.05902713 2.801E-03 0.08388066 WONG_ENDMETRIUM_CANCER_DN chromosomal disease DOID_0080014 3.329E-03 0.06765583 3.329E-03 0.09471816 WONG_ENDMETRIUM_CANCER_DN female reproductive system disease DOID_229 3.329E-03 0.06532287 0.08196587 0.48081009 WONG_ENDMETRIUM_CANCER_DN biliary tract cancer DOID_4607 3.488E-03 0.06615852 3.488E-03 0.09451217 WONG_ENDMETRIUM_CANCER_DN retinal vascular disease DOID_2462 3.65E-03 0.06700426 3.65E-03 0.09441509 HOQUE_METHYLATED_IN_CANCER pre-malignant neoplasm DOID_0060071 8.339E-21 4.745E-18 3.735E-10 2.125E-07 HOQUE_METHYLATED_IN_CANCER in situ carcinoma DOID_8719 8.339E-21 4.745E-18 3.735E-10 2.125E-07 HOQUE_METHYLATED_IN_CANCER granulosa cell tumor DOID_2999 1.17E-13 3.328E-11 2.99E-04 0.02126568 HOQUE_METHYLATED_IN_CANCER sex cord-gonadal stromal tumor DOID_192 1.67E-13 3.167E-11 3.319E-04 0.01888656 HOQUE_METHYLATED_IN_CANCER cervix uteri carcinoma in situ DOID_8991 1.914E-13 2.723E-11 3.789E-07 7.186E-05 HOQUE_METHYLATED_IN_CANCER mixed glioma DOID_5076 1.53E-11 1.741E-09 5.243E-03 0.15702313 HOQUE_METHYLATED_IN_CANCER benign mesothelioma DOID_2645 2.967E-11 2.814E-09 1.000 1.000 HOQUE_METHYLATED_IN_CANCER transitional cell carcinoma DOID_2671 3.562E-11 2.895E-09 2.481E-04 0.02352703 HOQUE_METHYLATED_IN_CANCER invasive ductal carcinoma DOID_3008 5.003E-10 3.558E-08 7.534E-04 0.03062133 HOQUE_METHYLATED_IN_CANCER astrocytoma DOID_3069 6.383E-10 4.035E-08 0.09245722 0.55966127 HOQUE_METHYLATED_IN_CANCER vulva cancer DOID_1245 2.058E-09 1.171E-07 1.371E-04 0.01560061 HOQUE_METHYLATED_IN_CANCER embryonal cancer DOID_688 2.287E-09 1.183E-07 1.339E-03 0.05080809 HOQUE_METHYLATED_IN_CANCER gallbladder cancer DOID_3121 5.293E-09 2.51E-07 1.000 1.000 HOQUE_METHYLATED_IN_CANCER giant cell tumor DOID_200 1.306E-08 5.717E-07 0.07266447 0.51044548 HOQUE_METHYLATED_IN_CANCER malignant giant cell tumor DOID_2705 1.306E-08 5.717E-07 0.07266447 0.51044548 HOQUE_METHYLATED_IN_CANCER giant cell glioblastoma DOID_3074 1.306E-08 5.717E-07 0.07266447 0.51044548 HOQUE_METHYLATED_IN_CANCER bile duct adenocarcinoma DOID_4896 1.43E-08 5.813E-07 1.000 1.000 HOQUE_METHYLATED_IN_CANCER cholangiocarcinoma DOID_4947 1.43E-08 5.813E-07 1.000 1.000 HOQUE_METHYLATED_IN_CANCER glioblastoma DOID_3068 2.024E-08 7.678E-07 0.07889474 0.52813064 HOQUE_METHYLATED_IN_CANCER bile duct cancer DOID_4606 2.024E-08 7.198E-07 1.000 1.000 HOQUE_METHYLATED_IN_CANCER bile duct carcinoma DOID_4897 2.024E-08 7.198E-07 1.000 1.000 HOQUE_METHYLATED_IN_CANCER biliary tract cancer DOID_4607 1.089E-07 3.646E-06 1.000 1.000 HOQUE_METHYLATED_IN_CANCER lymphoma DOID_0060058 1.806E-07 5.71E-06 7.166E-03 0.16990168 HOQUE_METHYLATED_IN_CANCER nephroblastoma DOID_2154 1.856E-07 5.559E-06 0.04861043 0.44611833 HOQUE_METHYLATED_IN_CANCER lymphoblastic leukemia DOID_1037 1.905E-07 5.419E-06 2.909E-04 0.02364745 HOQUE_METHYLATED_IN_CANCER lymphoid leukemia DOID_10747 2.072E-07 5.615E-06 1.871E-05 2.662E-03 HOQUE_METHYLATED_IN_CANCER congenital diaphragmatic hernia DOID_3827 3.13E-07 8.096E-06 3.13E-07 8.905E-05 HOQUE_METHYLATED_IN_CANCER glaucoma DOID_1686 7.496E-07 1.854E-05 0.06765053 0.49350193 HOQUE_METHYLATED_IN_CANCER oral cavity cancer DOID_8618 1.432E-06 3.395E-05 0.07889474 0.52198958 HOQUE_METHYLATED_IN_CANCER neuroectodermal tumor DOID_171 1.738E-06 3.957E-05 0.08261318 0.52816739 HOQUE_METHYLATED_IN_CANCER testicular cancer DOID_2998 2.189E-06 4.79E-05 1.000 1.000 HOQUE_METHYLATED_IN_CANCER pancreatic ductal carcinoma DOID_3587 2.952E-06 6.22E-05 0.09368042 0.56109642 HOQUE_METHYLATED_IN_CANCER pancreatic carcinoma DOID_4905 3.469E-06 7.049E-05 0.09734033 0.57099639 HOQUE_METHYLATED_IN_CANCER portal hypertension DOID_10762 5.834E-06 1.145E-04 5.648E-04 0.02921781 HOQUE_METHYLATED_IN_CANCER nervous system cancer DOID_3093 7.436E-06 1.41E-04 1.000 1.000 HOQUE_METHYLATED_IN_CANCER alcohol-related neurodevelopmental disorder DOID_0050667 8.806E-06 1.616E-04 3E-04 0.01896781 HOQUE_METHYLATED_IN_CANCER hepatic vascular disease DOID_272 9.075E-06 1.614E-04 7.534E-04 0.03297681 HOQUE_METHYLATED_IN_CANCER germinoma DOID_3304 1.333E-05 2.298E-04 1.000 1.000 HOQUE_METHYLATED_IN_CANCER allergic rhinitis DOID_4481 1.333E-05 2.23E-04 1.000 1.000 HOQUE_METHYLATED_IN_CANCER spindle cell carcinoma DOID_4015 1.725E-05 2.805E-04 1.000 1.000 HOQUE_METHYLATED_IN_CANCER medullomyoblastoma DOID_3861 1.871E-05 2.958E-04 0.04989155 0.43674292 HOQUE_METHYLATED_IN_CANCER adult medulloblastoma DOID_3864 1.871E-05 2.958E-04 0.04989155 0.43674292 HOQUE_METHYLATED_IN_CANCER childhood medulloblastoma DOID_3869 1.871E-05 2.958E-04 0.04989155 0.43674292 HOQUE_METHYLATED_IN_CANCER medulloblastoma DOID_3858 2.188E-05 3.364E-04 0.0524487 0.44542254 HOQUE_METHYLATED_IN_CANCER primitive neuroectodermal tumor DOID_168 3.342E-05 5.004E-04 0.06007974 0.4682928 HOQUE_METHYLATED_IN_CANCER brain cancer DOID_1319 4.299E-05 6.272E-04 1.000 1.000 HOQUE_METHYLATED_IN_CANCER neuritis DOID_1803 4.299E-05 6.115E-04 0.0651336 0.48764498 HOQUE_METHYLATED_IN_CANCER central nervous system cancer DOID_3620 4.563E-05 6.333E-04 1.000 1.000 HOQUE_METHYLATED_IN_CANCER familial adenomatous polyposis DOID_0050424 9.683E-05 1.312E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER invasive lobular carcinoma DOID_3457 9.683E-05 1.281E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER larynx cancer DOID_2596 1.371E-04 1.773E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER laryngeal benign neoplasm DOID_2598 1.371E-04 1.773E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Lynch syndrome DOID_3883 1.371E-04 1.733E-03 0.01735059 0.30851515 HOQUE_METHYLATED_IN_CANCER nephrosis DOID_2527 1.39E-04 1.719E-03 4.505E-03 0.16020138 HOQUE_METHYLATED_IN_CANCER aneurysm disease DOID_2403 1.687E-04 2.043E-03 5.117E-03 0.16174139 HOQUE_METHYLATED_IN_CANCER mental depression DOID_1596 2.096E-04 2.484E-03 5.898E-03 0.1525517 HOQUE_METHYLATED_IN_CANCER tongue cancer DOID_8649 2.104E-04 2.443E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Barrett's esophagus DOID_9206 2.104E-04 2.394E-03 0.02131246 0.3368553 HOQUE_METHYLATED_IN_CANCER drug-induced mental disorder DOID_1203 2.382E-04 2.658E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER drug psychosis DOID_1742 2.382E-04 2.658E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER substance-induced psychosis DOID_8646 2.382E-04 2.658E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Human immunodeficiency virus infectious disease DOID_526 2.647E-04 2.896E-03 6.875E-03 0.17007569 HOQUE_METHYLATED_IN_CANCER encephalomyelitis DOID_640 2.909E-04 3.123E-03 0.12018558 0.67044698 HOQUE_METHYLATED_IN_CANCER mouth disease DOID_403 3E-04 3.161E-03 0.12137212 0.67049261 HOQUE_METHYLATED_IN_CANCER Crohn's disease DOID_8778 3E-04 3.104E-03 0.12137212 0.66404556 HOQUE_METHYLATED_IN_CANCER muscle cancer DOID_4045 4.408E-04 4.479E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER intracranial aneurysm DOID_10941 6.558E-04 6.547E-03 6.558E-04 0.03109713 HOQUE_METHYLATED_IN_CANCER myopia DOID_11830 6.558E-04 6.434E-03 0.03700395 0.42969888 HOQUE_METHYLATED_IN_CANCER seminoma DOID_4440 6.558E-04 6.325E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER lung adenocarcinoma DOID_3910 7.038E-04 6.674E-03 0.03830038 0.41118709 HOQUE_METHYLATED_IN_CANCER pleurisy DOID_10247 7.534E-04 7.028E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER toxic encephalopathy DOID_3602 8.047E-04 7.385E-03 0.04088812 0.40816382 HOQUE_METHYLATED_IN_CANCER female reproductive organ benign neoplasm DOID_0060086 8.576E-04 7.746E-03 0.04217942 0.41379468 HOQUE_METHYLATED_IN_CANCER uterine benign neoplasm DOID_0060095 8.576E-04 7.746E-03 0.04217942 0.41379468 HOQUE_METHYLATED_IN_CANCER uterine fibroid DOID_13223 8.576E-04 7.746E-03 0.04217942 0.41379468 HOQUE_METHYLATED_IN_CANCER leiomyoma DOID_127 1.026E-03 9.123E-03 0.04604312 0.4366423 HOQUE_METHYLATED_IN_CANCER pleural disease DOID_1532 1.026E-03 8.983E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER autonomic nervous system neoplasm DOID_2621 1.026E-03 8.846E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER neuroblastoma DOID_769 1.026E-03 8.846E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER papilloma DOID_2615 1.086E-03 9.219E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER myocarditis DOID_820 1.086E-03 9.084E-03 1.000 1.000 HOQUE_METHYLATED_IN_CANCER esophageal disease DOID_6050 1.147E-03 9.455E-03 0.04861043 0.43903709 HOQUE_METHYLATED_IN_CANCER refractive error DOID_9835 1.274E-03 0.01035197 0.05117097 0.44115577 HOQUE_METHYLATED_IN_CANCER multiple myeloma DOID_9538 1.339E-03 0.0107341 1.000 1.000 HOQUE_METHYLATED_IN_CANCER peripheral nervous system neoplasm DOID_1192 1.407E-03 0.01111828 1.000 1.000 HOQUE_METHYLATED_IN_CANCER adenoid cystic carcinoma DOID_4866 1.547E-03 0.01205522 0.05627178 0.46403834 HOQUE_METHYLATED_IN_CANCER pulmonary emphysema DOID_9675 1.619E-03 0.01244792 1.000 1.000 HOQUE_METHYLATED_IN_CANCER endometriosis of uterus DOID_288 1.693E-03 0.01284216 1.000 1.000 HOQUE_METHYLATED_IN_CANCER salivary gland cancer DOID_8850 1.693E-03 0.01267319 0.0588121 0.47805837 HOQUE_METHYLATED_IN_CANCER nephrotic syndrome DOID_1184 1.768E-03 0.01306595 0.06007974 0.48148415 HOQUE_METHYLATED_IN_CANCER Huntington's disease DOID_12858 1.768E-03 0.01289843 0.06007974 0.47479687 HOQUE_METHYLATED_IN_CANCER endometriosis DOID_289 1.768E-03 0.01273516 1.000 1.000 HOQUE_METHYLATED_IN_CANCER influenza DOID_8469 1.845E-03 0.01312363 1.000 1.000 HOQUE_METHYLATED_IN_CANCER myeloma DOID_0070004 2.086E-03 0.01465044 1.000 1.000 HOQUE_METHYLATED_IN_CANCER autonomic nervous system disease DOID_11465 2.086E-03 0.01447178 0.0651336 0.49414692 HOQUE_METHYLATED_IN_CANCER thyroid adenoma DOID_2891 2.086E-03 0.01429742 1.000 1.000 HOQUE_METHYLATED_IN_CANCER movement disease DOID_480 2.34E-03 0.0158508 0.0689065 0.49009748 HOQUE_METHYLATED_IN_CANCER B-cell lymphocytic neoplasm DOID_707 2.428E-03 0.01625284 1.000 1.000 HOQUE_METHYLATED_IN_CANCER orofacial cleft DOID_0050567 2.517E-03 0.01665574 1.000 1.000 HOQUE_METHYLATED_IN_CANCER bone marrow cancer DOID_4960 2.701E-03 0.01766462 1.000 1.000 HOQUE_METHYLATED_IN_CANCER reproductive organ benign neoplasm DOID_0050622 2.795E-03 0.01807209 0.07516152 0.5152639 HOQUE_METHYLATED_IN_CANCER hypertrophic cardiomyopathy DOID_11984 3.086E-03 0.01973158 0.07889474 0.53441791 HOQUE_METHYLATED_IN_CANCER melancholia DOID_2848 3.186E-03 0.02014546 0.08013585 0.52410691 HOQUE_METHYLATED_IN_CANCER neurotic disorder DOID_4964 3.288E-03 0.0205597 0.08137533 0.52616551 HOQUE_METHYLATED_IN_CANCER uterine disease DOID_345 3.819E-03 0.02361893 1.000 1.000 HOQUE_METHYLATED_IN_CANCER endocrine organ benign neoplasm DOID_0060089 4.155E-03 0.02542268 1.000 1.000 HOQUE_METHYLATED_IN_CANCER male reproductive system disease DOID_48 4.505E-03 0.02726832 0.09490201 0.5624921 HOQUE_METHYLATED_IN_CANCER cystic fibrosis DOID_1485 4.991E-03 0.02989548 1.000 1.000 HOQUE_METHYLATED_IN_CANCER endogenous depression DOID_1595 4.991E-03 0.02958407 0.09977222 0.57928973 HOQUE_METHYLATED_IN_CANCER bone resorption disease DOID_0080011 5.117E-03 0.03001387 5.117E-03 0.17125559 HOQUE_METHYLATED_IN_CANCER osteoporosis DOID_11476 5.117E-03 0.03001387 5.117E-03 0.17125559 HOQUE_METHYLATED_IN_CANCER chromosomal disease DOID_0080014 5.632E-03 0.03270023 5.632E-03 0.16023111 HOQUE_METHYLATED_IN_CANCER female reproductive system disease DOID_229 5.632E-03 0.03236992 1.000 1.000 HOQUE_METHYLATED_IN_CANCER alcohol abuse DOID_1574 5.898E-03 0.03356137 5.898E-03 0.15981607 HOQUE_METHYLATED_IN_CANCER hypersensitivity reaction type I disease DOID_1205 7.614E-03 0.04289492 1.000 1.000 HOQUE_METHYLATED_IN_CANCER ulcerative colitis DOID_8577 8.074E-03 0.04504076 1.000 1.000 HOQUE_METHYLATED_IN_CANCER brachydactyly DOID_0050581 0.01337299 0.07387604 0.01337299 0.3043693 HOQUE_METHYLATED_IN_CANCER hyperparathyroidism DOID_13543 0.01337299 0.0731657 1.000 1.000 HOQUE_METHYLATED_IN_CANCER ventricular septal defect DOID_1657 0.01337299 0.07246888 0.01337299 0.29266279 HOQUE_METHYLATED_IN_CANCER rectal neoplasm DOID_1984 0.01337299 0.07178521 1.000 1.000 HOQUE_METHYLATED_IN_CANCER rectum cancer DOID_1993 0.01337299 0.07178521 1.000 1.000 HOQUE_METHYLATED_IN_CANCER labyrinthine disease DOID_4539 0.01337299 0.07111432 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01337299 0.07045586 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01337299 0.07045586 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Hodgkin's granuloma DOID_8651 0.01337299 0.07045586 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01337299 0.07045586 1.000 1.000 HOQUE_METHYLATED_IN_CANCER craniosynostosis DOID_2340 0.01470061 0.07673987 0.01470061 0.30980171 HOQUE_METHYLATED_IN_CANCER hemochromatosis DOID_2352 0.01470061 0.07604224 0.01470061 0.29873736 HOQUE_METHYLATED_IN_CANCER inner ear disease DOID_2952 0.01470061 0.07535717 1.000 1.000 HOQUE_METHYLATED_IN_CANCER islet cell tumor DOID_1799 0.01602647 0.08142021 1.000 1.000 HOQUE_METHYLATED_IN_CANCER tic disorder DOID_2769 0.01602647 0.08069967 0.01602647 0.31445045 HOQUE_METHYLATED_IN_CANCER stomach disease DOID_76 0.01602647 0.07999178 1.000 1.000 HOQUE_METHYLATED_IN_CANCER peritonitis DOID_8283 0.01602647 0.0792962 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Hodgkin's lymphoma DOID_8567 0.01602647 0.07861261 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Hirschsprung's disease DOID_10487 0.01735059 0.08438021 0.01735059 0.32908282 HOQUE_METHYLATED_IN_CANCER parathyroid gland disease DOID_11201 0.01735059 0.08366512 1.000 1.000 HOQUE_METHYLATED_IN_CANCER impotence DOID_1875 0.01735059 0.08296206 0.01735059 0.31846725 HOQUE_METHYLATED_IN_CANCER Leydig cell tumor DOID_2696 0.01735059 0.08227071 1.000 1.000 HOQUE_METHYLATED_IN_CANCER sex cord-stromal neoplasm DOID_4757 0.01735059 0.08227071 1.000 1.000 HOQUE_METHYLATED_IN_CANCER alcohol dependence DOID_0050741 0.01867296 0.08780919 1.000 1.000 HOQUE_METHYLATED_IN_CANCER open-angle glaucoma DOID_1067 0.01867296 0.08708945 1.000 1.000 HOQUE_METHYLATED_IN_CANCER megacolon DOID_11372 0.01867296 0.0863814 0.01867296 0.32196704 HOQUE_METHYLATED_IN_CANCER hypercalcemia DOID_12678 0.01867296 0.08568478 0.01867296 0.31249742 HOQUE_METHYLATED_IN_CANCER polycystic kidney disease DOID_898 0.01867296 0.0849993 1.000 1.000 HOQUE_METHYLATED_IN_CANCER idiopathic pulmonary fibrosis DOID_0050156 0.01999358 0.09028847 1.000 1.000 HOQUE_METHYLATED_IN_CANCER skeletal system cancer DOID_0060124 0.01999358 0.08957754 1.000 1.000 HOQUE_METHYLATED_IN_CANCER bone cancer DOID_184 0.01999358 0.08957754 1.000 1.000 HOQUE_METHYLATED_IN_CANCER mesenchymal cell neoplasm DOID_3350 0.01999358 0.08887771 1.000 1.000 HOQUE_METHYLATED_IN_CANCER spindle cell sarcoma DOID_4235 0.01999358 0.08887771 1.000 1.000 HOQUE_METHYLATED_IN_CANCER lung oat cell carcinoma DOID_5411 0.01999358 0.08818874 1.000 1.000 HOQUE_METHYLATED_IN_CANCER oral submucous fibrosis DOID_5773 0.01999358 0.08751036 1.000 1.000 HOQUE_METHYLATED_IN_CANCER epithelioid sarcoma DOID_6193 0.01999358 0.08887771 1.000 1.000 HOQUE_METHYLATED_IN_CANCER silicosis DOID_10325 0.02131246 0.09257092 1.000 1.000 HOQUE_METHYLATED_IN_CANCER Fanconi's anemia DOID_13636 0.02131246 0.09186963 0.02131246 0.34647974 HOQUE_METHYLATED_IN_CANCER thyroiditis DOID_7166 0.02131246 0.09117888 1.000 1.000 HOQUE_METHYLATED_IN_CANCER autoimmune thyroiditis DOID_7188 0.02131246 0.09117888 1.000 1.000 HOQUE_METHYLATED_IN_CANCER chronic myeloid leukemia DOID_8552 0.02131246 0.09049844 1.000 1.000 HOQUE_METHYLATED_IN_CANCER penile disease DOID_1529 0.0226296 0.09537959 0.0226296 0.3480066 HOQUE_METHYLATED_IN_CANCER urinary system benign neoplasm DOID_731 0.0226296 0.09467827 1.000 1.000 HOQUE_METHYLATED_IN_CANCER neuroendocrine tumor DOID_169 0.02394501 0.09945043 1.000 1.000 HOQUE_METHYLATED_IN_CANCER sexual dysfunction DOID_1876 0.02394501 0.09872977 0.02394501 0.35854496 HOQUE_METHYLATED_IN_CANCER prion disease DOID_649 0.02394501 0.09801949 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP nervous system cancer DOID_3093 5.867E-13 3.338E-10 0.0680601 0.73068292 HOFMANN_CELL_LYMPHOMA_UP transitional cell carcinoma DOID_2671 7.649E-09 2.176E-06 0.06662927 0.72907792 HOFMANN_CELL_LYMPHOMA_UP lymphoma DOID_0060058 9.533E-09 1.808E-06 0.06948881 0.73220616 HOFMANN_CELL_LYMPHOMA_UP cervix uteri carcinoma in situ DOID_8991 3.668E-08 5.218E-06 0.03312859 0.62833899 HOFMANN_CELL_LYMPHOMA_UP pre-malignant neoplasm DOID_0060071 1.925E-07 2.191E-05 0.04929299 0.65227235 HOFMANN_CELL_LYMPHOMA_UP in situ carcinoma DOID_8719 1.925E-07 2.191E-05 0.04929299 0.65227235 HOFMANN_CELL_LYMPHOMA_UP sarcoma DOID_1115 1.611E-06 1.528E-04 0.02270434 0.71770949 HOFMANN_CELL_LYMPHOMA_UP allergic rhinitis DOID_4481 2.37E-06 1.926E-04 0.02569372 0.63564032 HOFMANN_CELL_LYMPHOMA_UP medullomyoblastoma DOID_3861 3.334E-06 2.371E-04 3.905E-04 0.11108473 HOFMANN_CELL_LYMPHOMA_UP adult medulloblastoma DOID_3864 3.334E-06 2.371E-04 3.905E-04 0.11108473 HOFMANN_CELL_LYMPHOMA_UP childhood medulloblastoma DOID_3869 3.334E-06 2.371E-04 3.905E-04 0.11108473 HOFMANN_CELL_LYMPHOMA_UP medulloblastoma DOID_3858 3.901E-06 2.466E-04 4.328E-04 0.08209004 HOFMANN_CELL_LYMPHOMA_UP peripheral nervous system neoplasm DOID_1192 4.207E-06 2.394E-04 0.0309039 0.60635589 HOFMANN_CELL_LYMPHOMA_UP primitive neuroectodermal tumor DOID_168 5.975E-06 3.091E-04 5.727E-04 0.06517062 HOFMANN_CELL_LYMPHOMA_UP brain cancer DOID_1319 7.699E-06 3.65E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP vascular skin disease DOID_9540 7.699E-06 3.37E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP central nervous system cancer DOID_3620 8.176E-06 3.323E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP B-cell lymphocytic neoplasm DOID_707 9.723E-06 3.688E-04 0.04050867 0.6229577 HOFMANN_CELL_LYMPHOMA_UP bone marrow cancer DOID_4960 1.145E-05 4.073E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP reproductive organ benign neoplasm DOID_0050622 1.207E-05 4.04E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP parasitic protozoa infectious disease DOID_2789 1.207E-05 3.816E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP pustulosis of palm and sole DOID_4398 1.207E-05 3.615E-04 0.04344545 0.61801153 HOFMANN_CELL_LYMPHOMA_UP neuroectodermal tumor DOID_171 1.625E-05 4.622E-04 1.106E-03 0.08990195 HOFMANN_CELL_LYMPHOMA_UP parasitic infectious disease DOID_1398 1.95E-05 5.285E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP peripheral vascular disease DOID_341 2.618E-05 6.772E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP cystic fibrosis DOID_1485 2.945E-05 7.287E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP pancreatitis DOID_4989 3.178E-05 7.534E-04 0.05944324 0.6902694 HOFMANN_CELL_LYMPHOMA_UP Hodgkin's lymphoma DOID_8567 3.711E-05 8.447E-04 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP hypersensitivity reaction type I disease DOID_1205 5.653E-05 1.237E-03 0.07162791 0.71502252 HOFMANN_CELL_LYMPHOMA_UP angiosarcoma DOID_0001816 6.735E-05 1.419E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP male reproductive organ benign neoplasm DOID_0060087 8.579E-05 1.743E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP leishmaniasis DOID_9065 9.584E-05 1.88E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP pulmonary edema DOID_11396 1.064E-04 2.019E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP esophagitis DOID_11963 1.064E-04 1.954E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP colon carcinoma DOID_1520 1.064E-04 1.893E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Kawasaki disease DOID_13378 1.176E-04 2.027E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP lymphadenitis DOID_1602 1.176E-04 2.027E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP autoimmune hepatitis DOID_2048 1.176E-04 1.968E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP lymph node disease DOID_9942 1.176E-04 2.027E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP polyarteritis nodosa DOID_9810 1.415E-04 2.301E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP thrombocytopenia DOID_1588 2.425E-04 3.833E-03 2.425E-04 0.13799594 HOFMANN_CELL_LYMPHOMA_UP bronchiolitis obliterans DOID_2799 2.94E-04 4.521E-03 0.02494721 0.67595046 HOFMANN_CELL_LYMPHOMA_UP esophageal disease DOID_6050 3.701E-04 5.541E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP embryonal cancer DOID_688 4.328E-04 6.315E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP multiple myeloma DOID_9538 4.328E-04 6.157E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP blood platelet disease DOID_2218 4.548E-04 6.312E-03 4.548E-04 0.06469415 HOFMANN_CELL_LYMPHOMA_UP respiratory syncytial virus infectious disease DOID_1273 4.773E-04 6.466E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP peptic ulcer DOID_750 4.773E-04 6.316E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP lymphatic system disease DOID_75 5.004E-04 6.47E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP pulmonary emphysema DOID_9675 5.239E-04 6.625E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP influenza DOID_8469 5.978E-04 7.395E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP myeloma DOID_0070004 6.765E-04 8.19E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP autoimmune disease of gastrointestinal tract DOID_0060031 7.316E-04 8.673E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP pulmonary tuberculosis DOID_2957 7.316E-04 8.496E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP hemorrhagic disease DOID_2213 7.888E-04 8.976E-03 7.888E-04 0.07480368 HOFMANN_CELL_LYMPHOMA_UP giant cell tumor DOID_200 8.481E-04 9.462E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP malignant giant cell tumor DOID_2705 8.481E-04 9.462E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP giant cell glioblastoma DOID_3074 8.481E-04 9.462E-03 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP hypersensitivity reaction type IV disease DOID_2916 1.005E-03 0.01100124 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP glioblastoma DOID_3068 1.005E-03 0.01079367 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP respiratory failure DOID_11162 1.141E-03 0.01201823 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP tuberculosis DOID_399 1.359E-03 0.01405725 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP astrocytoma DOID_3069 1.397E-03 0.01419396 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP blood coagulation disease DOID_1247 1.436E-03 0.01433097 1.436E-03 0.10210818 HOFMANN_CELL_LYMPHOMA_UP bacterial pneumonia DOID_874 1.721E-03 0.01687892 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP primary bacterial infectious disease DOID_0050338 2.123E-03 0.0204751 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Human immunodeficiency virus infectious disease DOID_526 2.266E-03 0.0214915 2.266E-03 0.14327666 HOFMANN_CELL_LYMPHOMA_UP lymphoblastic leukemia DOID_1037 2.414E-03 0.02251613 0.07020237 0.72627546 HOFMANN_CELL_LYMPHOMA_UP encephalomyelitis DOID_640 2.414E-03 0.02215297 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.464E-03 0.02225466 0.07091541 0.7205512 HOFMANN_CELL_LYMPHOMA_UP dilated cardiomyopathy DOID_12930 2.515E-03 0.02235755 2.515E-03 0.14308833 HOFMANN_CELL_LYMPHOMA_UP hyperparathyroidism DOID_13543 7.624E-03 0.06674036 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP childhood type dermatomyositis DOID_14203 7.624E-03 0.06572915 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP rectal neoplasm DOID_1984 7.624E-03 0.06474811 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP rectum cancer DOID_1993 7.624E-03 0.06474811 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Noonan syndrome DOID_3490 7.624E-03 0.06379593 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.624E-03 0.06287136 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.624E-03 0.06287136 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Hodgkin's granuloma DOID_8651 7.624E-03 0.06287136 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 7.624E-03 0.06287136 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP cutaneous leishmaniasis DOID_9111 7.624E-03 0.06197319 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP maturity-onset diabetes of the young DOID_0050524 8.383E-03 0.06718557 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP breast benign neoplasm DOID_0060082 8.383E-03 0.06625244 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP thoracic benign neoplasm DOID_0060097 8.383E-03 0.06625244 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP nervous system benign neoplasm DOID_0060115 8.383E-03 0.06534487 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP dermatomyositis DOID_10223 8.383E-03 0.06446183 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP benign breast phyllodes tumor DOID_1631 8.383E-03 0.06625244 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP prostatic adenoma DOID_2883 8.383E-03 0.06360234 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP invasive lobular carcinoma DOID_3457 8.383E-03 0.06276547 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP parathyroid gland disease DOID_11201 9.9E-03 0.07316002 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Leydig cell tumor DOID_2696 9.9E-03 0.07222207 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP sex cord-stromal neoplasm DOID_4757 9.9E-03 0.07222207 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP monocytic leukemia DOID_8527 9.9E-03 0.07130787 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Legionnaires' disease DOID_10457 0.01065803 0.07580521 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP legionellosis DOID_10458 0.01065803 0.07580521 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP polycystic kidney disease DOID_898 0.01065803 0.07486934 0.01065803 0.55131059 HOFMANN_CELL_LYMPHOMA_UP skeletal system cancer DOID_0060124 0.0114151 0.07920967 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP bone cancer DOID_184 0.0114151 0.07920967 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP hemangioma DOID_255 0.0114151 0.07825533 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP mesenchymal cell neoplasm DOID_3350 0.0114151 0.07732372 0.0114151 0.54126607 HOFMANN_CELL_LYMPHOMA_UP spindle cell sarcoma DOID_4235 0.0114151 0.07732372 0.0114151 0.54126607 HOFMANN_CELL_LYMPHOMA_UP epithelioid sarcoma DOID_6193 0.0114151 0.07732372 0.0114151 0.54126607 HOFMANN_CELL_LYMPHOMA_UP intermediate coronary syndrome DOID_8805 0.0114151 0.07641403 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP silicosis DOID_10325 0.01217162 0.08053082 0.01217162 0.53274238 HOFMANN_CELL_LYMPHOMA_UP spastic diplegia DOID_10965 0.01217162 0.07960518 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Barrett's esophagus DOID_9206 0.01217162 0.07870058 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Graves' disease DOID_12361 0.01292758 0.08264934 0.01292758 0.52541364 HOFMANN_CELL_LYMPHOMA_UP bronchitis DOID_6132 0.01292758 0.08173101 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP urinary system benign neoplasm DOID_731 0.01292758 0.08083287 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP Down syndrome DOID_14250 0.01443782 0.08929476 1.000 1.000 HOFMANN_CELL_LYMPHOMA_UP psoriasis DOID_8893 0.01443782 0.0883346 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_DN nervous system cancer DOID_3093 4.677E-08 2.661E-05 1.102E-06 6.271E-04 MULLIGHAN_MLL_SIGNATURE_2_DN myeloma DOID_0070004 1.065E-06 3.029E-04 3.303E-05 2.685E-03 MULLIGHAN_MLL_SIGNATURE_2_DN lung small cell carcinoma DOID_5409 1.298E-06 2.463E-04 3.862E-05 2.441E-03 MULLIGHAN_MLL_SIGNATURE_2_DN aortic aneurysm DOID_3627 1.429E-06 2.033E-04 4.165E-05 2.37E-03 MULLIGHAN_MLL_SIGNATURE_2_DN giant cell tumor DOID_200 1.886E-06 2.147E-04 0.01757651 0.09434938 MULLIGHAN_MLL_SIGNATURE_2_DN malignant giant cell tumor DOID_2705 1.886E-06 2.147E-04 0.01757651 0.09434938 MULLIGHAN_MLL_SIGNATURE_2_DN giant cell glioblastoma DOID_3074 1.886E-06 2.147E-04 0.01757651 0.09434938 MULLIGHAN_MLL_SIGNATURE_2_DN bile duct adenocarcinoma DOID_4896 2.062E-06 1.955E-04 5.556E-05 2.874E-03 MULLIGHAN_MLL_SIGNATURE_2_DN cholangiocarcinoma DOID_4947 2.062E-06 1.955E-04 5.556E-05 2.874E-03 MULLIGHAN_MLL_SIGNATURE_2_DN bone marrow cancer DOID_4960 2.062E-06 1.676E-04 5.556E-05 2.635E-03 MULLIGHAN_MLL_SIGNATURE_2_DN glioblastoma DOID_3068 2.896E-06 2.059E-04 0.0206435 0.10876065 MULLIGHAN_MLL_SIGNATURE_2_DN bile duct cancer DOID_4606 2.896E-06 1.831E-04 7.259E-05 2.95E-03 MULLIGHAN_MLL_SIGNATURE_2_DN bile duct carcinoma DOID_4897 2.896E-06 1.831E-04 7.259E-05 2.95E-03 MULLIGHAN_MLL_SIGNATURE_2_DN astrocytoma DOID_3069 6.597E-06 3.753E-04 0.02810242 0.1402656 MULLIGHAN_MLL_SIGNATURE_2_DN celiac disease DOID_10608 6.957E-06 3.599E-04 6.957E-06 1.979E-03 MULLIGHAN_MLL_SIGNATURE_2_DN autonomic nervous system neoplasm DOID_2621 7.833E-06 3.714E-04 7.833E-06 1.486E-03 MULLIGHAN_MLL_SIGNATURE_2_DN neuroblastoma DOID_769 7.833E-06 3.714E-04 7.833E-06 1.486E-03 MULLIGHAN_MLL_SIGNATURE_2_DN thyroid carcinoma DOID_3963 9.825E-06 4.3E-04 7.948E-03 0.05583208 MULLIGHAN_MLL_SIGNATURE_2_DN aneurysm disease DOID_2403 1.041E-05 4.232E-04 1.987E-04 6.283E-03 MULLIGHAN_MLL_SIGNATURE_2_DN thyroid cancer DOID_1781 1.217E-05 4.615E-04 8.801E-03 0.05891825 MULLIGHAN_MLL_SIGNATURE_2_DN multiple myeloma DOID_9538 1.348E-05 4.794E-04 4.136E-04 0.0106965 MULLIGHAN_MLL_SIGNATURE_2_DN biliary tract cancer DOID_4607 1.489E-05 4.985E-04 2.634E-04 7.888E-03 MULLIGHAN_MLL_SIGNATURE_2_DN peripheral nervous system neoplasm DOID_1192 1.49E-05 4.709E-04 1.49E-05 2.119E-03 MULLIGHAN_MLL_SIGNATURE_2_DN bacterial meningitis DOID_9470 1.632E-05 4.888E-04 1.147E-03 0.01918875 MULLIGHAN_MLL_SIGNATURE_2_DN pulmonary emphysema DOID_9675 1.98E-05 5.634E-04 0.01110516 0.06868297 MULLIGHAN_MLL_SIGNATURE_2_DN skeletal system cancer DOID_0060124 2.035E-05 5.513E-04 1.32E-03 0.02086134 MULLIGHAN_MLL_SIGNATURE_2_DN thoracic aortic aneurysm DOID_14004 2.035E-05 5.263E-04 1.32E-03 0.02029752 MULLIGHAN_MLL_SIGNATURE_2_DN bone cancer DOID_184 2.035E-05 5.513E-04 1.32E-03 0.02086134 MULLIGHAN_MLL_SIGNATURE_2_DN membranoproliferative glomerulonephritis DOID_2920 2.035E-05 5.034E-04 2.035E-05 2.316E-03 MULLIGHAN_MLL_SIGNATURE_2_DN amino acid metabolic disorder DOID_9252 2.075E-05 4.92E-04 2.075E-05 1.968E-03 MULLIGHAN_MLL_SIGNATURE_2_DN endometriosis of uterus DOID_288 2.167E-05 4.933E-04 5.862E-04 0.01282885 MULLIGHAN_MLL_SIGNATURE_2_DN endometriosis DOID_289 2.367E-05 5.18E-04 6.255E-04 0.01318079 MULLIGHAN_MLL_SIGNATURE_2_DN gallbladder cancer DOID_3121 2.58E-05 5.437E-04 6.663E-04 0.0135409 MULLIGHAN_MLL_SIGNATURE_2_DN pre-eclampsia DOID_10591 3.303E-05 6.713E-04 0.01417926 0.08149493 MULLIGHAN_MLL_SIGNATURE_2_DN autoimmune disease of gastrointestinal tract DOID_0060031 3.862E-05 7.577E-04 3.862E-05 2.747E-03 MULLIGHAN_MLL_SIGNATURE_2_DN smallpox DOID_8736 5.951E-05 1.129E-03 5.951E-05 2.605E-03 MULLIGHAN_MLL_SIGNATURE_2_DN carotid artery disease DOID_3407 8.764E-05 1.609E-03 1.637E-03 0.0211719 MULLIGHAN_MLL_SIGNATURE_2_DN meningitis DOID_9471 8.838E-05 1.572E-03 3.396E-03 0.02884319 MULLIGHAN_MLL_SIGNATURE_2_DN uterine disease DOID_345 1.111E-04 1.915E-03 1.949E-03 0.02174164 MULLIGHAN_MLL_SIGNATURE_2_DN morbid obesity DOID_11981 1.267E-04 2.121E-03 4.289E-03 0.03342845 MULLIGHAN_MLL_SIGNATURE_2_DN blood coagulation disease DOID_1247 1.464E-04 2.38E-03 1.464E-04 5.554E-03 MULLIGHAN_MLL_SIGNATURE_2_DN pancreatic ductal carcinoma DOID_3587 1.464E-04 2.314E-03 2.387E-03 0.02301939 MULLIGHAN_MLL_SIGNATURE_2_DN pancreatic carcinoma DOID_4905 1.711E-04 2.632E-03 2.677E-03 0.02417569 MULLIGHAN_MLL_SIGNATURE_2_DN diabetic retinopathy DOID_8947 1.711E-04 2.563E-03 2.677E-03 0.02379795 MULLIGHAN_MLL_SIGNATURE_2_DN invasive ductal carcinoma DOID_3008 1.745E-04 2.546E-03 5.278E-03 0.0395124 MULLIGHAN_MLL_SIGNATURE_2_DN coronary stenosis DOID_4248 1.745E-04 2.482E-03 1.745E-04 6.206E-03 MULLIGHAN_MLL_SIGNATURE_2_DN toxic encephalopathy DOID_3602 1.927E-04 2.674E-03 1.927E-04 6.449E-03 MULLIGHAN_MLL_SIGNATURE_2_DN female reproductive system disease DOID_229 2.404E-04 3.257E-03 3.435E-03 0.02874149 MULLIGHAN_MLL_SIGNATURE_2_DN retinal vascular disease DOID_2462 2.879E-04 3.81E-03 3.921E-03 0.03142451 MULLIGHAN_MLL_SIGNATURE_2_DN transitional cell carcinoma DOID_2671 3.278E-04 4.239E-03 4.312E-03 0.03315602 MULLIGHAN_MLL_SIGNATURE_2_DN spindle cell carcinoma DOID_4015 3.278E-04 4.145E-03 7.948E-03 0.0551512 MULLIGHAN_MLL_SIGNATURE_2_DN Human immunodeficiency virus infectious disease DOID_526 3.564E-04 4.409E-03 3.564E-04 0.0101408 MULLIGHAN_MLL_SIGNATURE_2_DN lymphoma DOID_0060058 3.869E-04 4.683E-03 3.869E-04 0.01048193 MULLIGHAN_MLL_SIGNATURE_2_DN Crohn's disease DOID_8778 4.191E-04 4.968E-03 4.191E-04 0.01036761 MULLIGHAN_MLL_SIGNATURE_2_DN blood platelet disease DOID_2218 4.45E-04 5.168E-03 4.45E-04 0.01055133 MULLIGHAN_MLL_SIGNATURE_2_DN respiratory syncytial virus infectious disease DOID_1273 4.78E-04 5.44E-03 0.01015495 0.06718797 MULLIGHAN_MLL_SIGNATURE_2_DN systemic scleroderma DOID_418 4.78E-04 5.333E-03 0.01015495 0.06566097 MULLIGHAN_MLL_SIGNATURE_2_DN cervix uteri carcinoma in situ DOID_8991 5.486E-04 6.003E-03 0.01110516 0.06943773 MULLIGHAN_MLL_SIGNATURE_2_DN chondrosarcoma DOID_3371 5.724E-04 6.145E-03 0.03555939 0.16721731 MULLIGHAN_MLL_SIGNATURE_2_DN cutaneous leishmaniasis DOID_9111 5.724E-04 6.031E-03 0.03555939 0.16449833 MULLIGHAN_MLL_SIGNATURE_2_DN cannabis abuse DOID_9505 5.724E-04 5.922E-03 5.724E-04 0.01302792 MULLIGHAN_MLL_SIGNATURE_2_DN rheumatic disease DOID_1575 6.255E-04 6.355E-03 0.012093 0.07243069 MULLIGHAN_MLL_SIGNATURE_2_DN scleroderma DOID_419 6.255E-04 6.355E-03 0.012093 0.07243069 MULLIGHAN_MLL_SIGNATURE_2_DN diabetic autonomic neuropathy DOID_11503 6.663E-04 6.652E-03 0.01260085 0.07391632 MULLIGHAN_MLL_SIGNATURE_2_DN autonomic neuropathy DOID_11504 6.663E-04 6.652E-03 0.01260085 0.07391632 MULLIGHAN_MLL_SIGNATURE_2_DN diabetic polyneuropathy DOID_12785 6.663E-04 6.652E-03 0.01260085 0.07391632 MULLIGHAN_MLL_SIGNATURE_2_DN diabetic neuropathy DOID_9743 6.663E-04 6.652E-03 0.01260085 0.07391632 MULLIGHAN_MLL_SIGNATURE_2_DN chronic monocytic leukemia DOID_8593 6.979E-04 6.847E-03 6.979E-04 0.01369422 MULLIGHAN_MLL_SIGNATURE_2_DN autonomic nervous system disease DOID_11465 7.991E-04 7.707E-03 0.01417926 0.08067998 MULLIGHAN_MLL_SIGNATURE_2_DN brain cancer DOID_1319 7.991E-04 7.578E-03 0.01417926 0.07988116 MULLIGHAN_MLL_SIGNATURE_2_DN thyroid adenoma DOID_2891 7.991E-04 7.454E-03 0.16567386 0.37557143 MULLIGHAN_MLL_SIGNATURE_2_DN central nervous system cancer DOID_3620 8.468E-04 7.771E-03 0.01472344 0.08133628 MULLIGHAN_MLL_SIGNATURE_2_DN glaucoma DOID_1686 8.963E-04 8.095E-03 0.01527653 0.08358022 MULLIGHAN_MLL_SIGNATURE_2_DN infancy electroclinical syndrome DOID_0050703 9.851E-04 8.758E-03 9.851E-04 0.01868473 MULLIGHAN_MLL_SIGNATURE_2_DN cannabis dependence DOID_1849 9.851E-04 8.624E-03 9.851E-04 0.01808199 MULLIGHAN_MLL_SIGNATURE_2_DN monocytic leukemia DOID_8527 9.851E-04 8.493E-03 9.851E-04 0.01751693 MULLIGHAN_MLL_SIGNATURE_2_DN hallucinogen dependence DOID_9977 9.851E-04 8.624E-03 9.851E-04 0.01808199 MULLIGHAN_MLL_SIGNATURE_2_DN hemorrhagic disease DOID_2213 1.001E-03 8.498E-03 1.001E-03 0.01725386 MULLIGHAN_MLL_SIGNATURE_2_DN parasitic protozoa infectious disease DOID_2789 1.232E-03 0.01030709 0.01877812 0.09985746 MULLIGHAN_MLL_SIGNATURE_2_DN idiopathic pulmonary fibrosis DOID_0050156 1.32E-03 0.01088418 1.32E-03 0.02145738 MULLIGHAN_MLL_SIGNATURE_2_DN melancholia DOID_2848 1.494E-03 0.01214392 1.494E-03 0.02237038 MULLIGHAN_MLL_SIGNATURE_2_DN spastic diplegia DOID_10965 1.505E-03 0.01206007 1.505E-03 0.02195551 MULLIGHAN_MLL_SIGNATURE_2_DN chronic myeloid leukemia DOID_8552 1.505E-03 0.01189257 1.505E-03 0.02140662 MULLIGHAN_MLL_SIGNATURE_2_DN Barrett's esophagus DOID_9206 1.505E-03 0.01172966 1.505E-03 0.02088451 MULLIGHAN_MLL_SIGNATURE_2_DN neurotic disorder DOID_4964 1.565E-03 0.01203019 1.565E-03 0.02119605 MULLIGHAN_MLL_SIGNATURE_2_DN neuroectodermal tumor DOID_171 1.637E-03 0.01242085 1.637E-03 0.02166427 MULLIGHAN_MLL_SIGNATURE_2_DN collagen disease DOID_854 1.637E-03 0.01225741 0.02258283 0.11576245 MULLIGHAN_MLL_SIGNATURE_2_DN lymphatic system cancer DOID_0060073 1.701E-03 0.01257323 1.701E-03 0.02151419 MULLIGHAN_MLL_SIGNATURE_2_DN methylmalonic acidemia DOID_14749 1.701E-03 0.01241203 1.701E-03 0.02104649 MULLIGHAN_MLL_SIGNATURE_2_DN penile disease DOID_1529 1.701E-03 0.01225492 1.701E-03 0.02059869 MULLIGHAN_MLL_SIGNATURE_2_DN reticulosarcoma DOID_8538 1.701E-03 0.01257323 1.701E-03 0.02151419 MULLIGHAN_MLL_SIGNATURE_2_DN lymphosarcoma DOID_8675 1.701E-03 0.01257323 1.701E-03 0.02151419 MULLIGHAN_MLL_SIGNATURE_2_DN hypothyroidism DOID_1459 1.712E-03 0.01217594 1.712E-03 0.02029323 MULLIGHAN_MLL_SIGNATURE_2_DN pre-malignant neoplasm DOID_0060071 1.789E-03 0.0125652 0.02391592 0.12150144 MULLIGHAN_MLL_SIGNATURE_2_DN in situ carcinoma DOID_8719 1.789E-03 0.0125652 0.02391592 0.12150144 MULLIGHAN_MLL_SIGNATURE_2_DN neuroendocrine tumor DOID_169 1.91E-03 0.01325099 1.91E-03 0.02217512 MULLIGHAN_MLL_SIGNATURE_2_DN cholestasis DOID_13580 1.949E-03 0.01335932 1.949E-03 0.02217647 MULLIGHAN_MLL_SIGNATURE_2_DN parasitic infectious disease DOID_1398 1.949E-03 0.01320028 0.02528056 0.1272977 MULLIGHAN_MLL_SIGNATURE_2_DN temporal lobe epilepsy DOID_3328 2.032E-03 0.01360216 2.032E-03 0.02223429 MULLIGHAN_MLL_SIGNATURE_2_DN allergic contact dermatitis DOID_3042 2.117E-03 0.01400912 2.117E-03 0.02273177 MULLIGHAN_MLL_SIGNATURE_2_DN dissociative disorder DOID_10935 2.129E-03 0.01392579 2.129E-03 0.022436 MULLIGHAN_MLL_SIGNATURE_2_DN dissociative amnesia DOID_11037 2.129E-03 0.01392579 2.129E-03 0.022436 MULLIGHAN_MLL_SIGNATURE_2_DN infertility DOID_5223 2.129E-03 0.01376754 2.129E-03 0.02202807 MULLIGHAN_MLL_SIGNATURE_2_DN leishmaniasis DOID_9065 2.129E-03 0.01361285 0.06648807 0.22385628 MULLIGHAN_MLL_SIGNATURE_2_DN endocrine organ benign neoplasm DOID_0060089 2.205E-03 0.01394041 0.22684625 0.48524631 MULLIGHAN_MLL_SIGNATURE_2_DN brain infarction DOID_3454 2.205E-03 0.01378722 2.205E-03 0.02240423 MULLIGHAN_MLL_SIGNATURE_2_DN amnestic disorder DOID_10914 2.36E-03 0.0145976 2.36E-03 0.02356103 MULLIGHAN_MLL_SIGNATURE_2_DN alopecia DOID_987 2.36E-03 0.01444063 2.36E-03 0.02315481 MULLIGHAN_MLL_SIGNATURE_2_DN bile duct disease DOID_4138 2.481E-03 0.01501936 2.481E-03 0.02353033 MULLIGHAN_MLL_SIGNATURE_2_DN male reproductive system disease DOID_48 2.481E-03 0.01486126 2.481E-03 0.02314459 MULLIGHAN_MLL_SIGNATURE_2_DN biliary tract disease DOID_9741 2.578E-03 0.01527907 2.578E-03 0.02365792 MULLIGHAN_MLL_SIGNATURE_2_DN endogenous depression DOID_1595 2.882E-03 0.01690291 2.882E-03 0.02522434 MULLIGHAN_MLL_SIGNATURE_2_DN mixed glioma DOID_5076 3.096E-03 0.01797389 0.03410233 0.16444261 MULLIGHAN_MLL_SIGNATURE_2_DN bacterial pneumonia DOID_874 3.096E-03 0.01779234 0.03410233 0.16306074 MULLIGHAN_MLL_SIGNATURE_2_DN pulmonary embolism DOID_9477 3.121E-03 0.01775643 0.07991615 0.24447468 MULLIGHAN_MLL_SIGNATURE_2_DN contact dermatitis DOID_2773 3.319E-03 0.01870023 3.319E-03 0.02861702 MULLIGHAN_MLL_SIGNATURE_2_DN mental depression DOID_1596 3.673E-03 0.02048998 3.673E-03 0.03028953 MULLIGHAN_MLL_SIGNATURE_2_DN focal epilepsy DOID_2234 3.673E-03 0.02029104 3.673E-03 0.02985682 MULLIGHAN_MLL_SIGNATURE_2_DN organic acidemia DOID_0060159 3.98E-03 0.02177747 3.98E-03 0.03145634 MULLIGHAN_MLL_SIGNATURE_2_DN hypotrichosis DOID_4535 4.608E-03 0.02496948 4.608E-03 0.03495727 MULLIGHAN_MLL_SIGNATURE_2_DN encephalomyelitis DOID_640 5.014E-03 0.02691695 0.04653817 0.18262219 MULLIGHAN_MLL_SIGNATURE_2_DN dilated cardiomyopathy DOID_12930 5.313E-03 0.02825588 0.04830492 0.18697619 MULLIGHAN_MLL_SIGNATURE_2_DN supratentorial cancer DOID_1659 5.628E-03 0.0296526 0.10619974 0.27846843 MULLIGHAN_MLL_SIGNATURE_2_DN cerebrum cancer DOID_368 5.628E-03 0.0296526 0.10619974 0.27846843 MULLIGHAN_MLL_SIGNATURE_2_DN ulcerative colitis DOID_8577 5.782E-03 0.03018251 5.782E-03 0.0427259 MULLIGHAN_MLL_SIGNATURE_2_DN female reproductive organ benign neoplasm DOID_0060086 5.989E-03 0.03098123 0.10943233 0.28562842 MULLIGHAN_MLL_SIGNATURE_2_DN uterine benign neoplasm DOID_0060095 5.989E-03 0.03098123 0.10943233 0.28562842 MULLIGHAN_MLL_SIGNATURE_2_DN uterine fibroid DOID_13223 5.989E-03 0.03098123 0.10943233 0.28562842 MULLIGHAN_MLL_SIGNATURE_2_DN spastic cerebral palsy DOID_0050669 6.361E-03 0.03260596 6.361E-03 0.04640079 MULLIGHAN_MLL_SIGNATURE_2_DN abdominal aortic aneurysm DOID_7693 6.361E-03 0.03231484 0.11265332 0.28744277 MULLIGHAN_MLL_SIGNATURE_2_DN leiomyoma DOID_127 7.134E-03 0.03592347 0.11906064 0.29975886 MULLIGHAN_MLL_SIGNATURE_2_DN hair disease DOID_421 7.536E-03 0.03761428 7.536E-03 0.05427883 MULLIGHAN_MLL_SIGNATURE_2_DN pneumoconiosis DOID_10316 7.948E-03 0.0393252 7.948E-03 0.05652998 MULLIGHAN_MLL_SIGNATURE_2_DN nephroblastoma DOID_2154 7.948E-03 0.03898619 0.12542203 0.31300497 MULLIGHAN_MLL_SIGNATURE_2_DN esophageal disease DOID_6050 7.948E-03 0.03865298 7.948E-03 0.05448673 MULLIGHAN_MLL_SIGNATURE_2_DN leukopenia DOID_615 7.948E-03 0.03832541 7.948E-03 0.05383807 MULLIGHAN_MLL_SIGNATURE_2_DN hepatitis DOID_2237 0.01015495 0.04855601 0.01015495 0.06641569 MULLIGHAN_MLL_SIGNATURE_2_DN intracranial arterial disease DOID_13089 0.01062531 0.05038168 0.14423387 0.34482804 MULLIGHAN_MLL_SIGNATURE_2_DN cerebral arterial disease DOID_3527 0.01062531 0.05038168 0.14423387 0.34482804 MULLIGHAN_MLL_SIGNATURE_2_DN adenoid cystic carcinoma DOID_4866 0.01062531 0.0499653 0.01062531 0.06793035 MULLIGHAN_MLL_SIGNATURE_2_DN lymphatic system disease DOID_75 0.01062531 0.04955575 0.01062531 0.06717557 MULLIGHAN_MLL_SIGNATURE_2_DN autoimmune disease of urogenital tract DOID_0060049 0.01159441 0.05363592 0.01159441 0.07093783 MULLIGHAN_MLL_SIGNATURE_2_DN primary biliary cirrhosis DOID_12236 0.01159441 0.05363592 0.01159441 0.07093783 MULLIGHAN_MLL_SIGNATURE_2_DN salivary gland cancer DOID_8850 0.01159441 0.05320338 0.01159441 0.07018318 MULLIGHAN_MLL_SIGNATURE_2_DN uveal disease DOID_3480 0.012093 0.05504733 0.012093 0.07167621 MULLIGHAN_MLL_SIGNATURE_2_DN learning disability DOID_8927 0.01311789 0.05923873 0.01311789 0.07616408 MULLIGHAN_MLL_SIGNATURE_2_DN neuritis DOID_1803 0.01417926 0.06352754 0.01417926 0.07909802 MULLIGHAN_MLL_SIGNATURE_2_DN calcium metabolism disease DOID_10575 0.01583845 0.07040684 0.17469839 0.39445788 MULLIGHAN_MLL_SIGNATURE_2_DN B-cell lymphocytic neoplasm DOID_707 0.01640913 0.07237825 0.01640913 0.08892186 MULLIGHAN_MLL_SIGNATURE_2_DN vasculitis DOID_865 0.01817307 0.07954213 0.18658053 0.41796977 MULLIGHAN_MLL_SIGNATURE_2_DN reproductive organ benign neoplasm DOID_0050622 0.01877812 0.08156296 0.18952443 0.42289962 MULLIGHAN_MLL_SIGNATURE_2_DN oral cavity cancer DOID_8618 0.0206435 0.08898599 0.0206435 0.10776285 MULLIGHAN_MLL_SIGNATURE_2_DN leukocyte disease DOID_9500 0.02128182 0.09104777 0.02128182 0.11008503 GALLUZZI_PERMEABILIZE_MITOCHONDRIA alcohol-related neurodevelopmental disorder DOID_0050667 4.469E-16 2.543E-13 4.402E-08 2.505E-05 GALLUZZI_PERMEABILIZE_MITOCHONDRIA lymphoma DOID_0060058 5.438E-12 1.547E-09 2.452E-06 4.651E-04 GALLUZZI_PERMEABILIZE_MITOCHONDRIA multiple myeloma DOID_9538 4.935E-10 9.361E-08 7.449E-04 0.06055294 GALLUZZI_PERMEABILIZE_MITOCHONDRIA myeloma DOID_0070004 1.578E-09 2.244E-07 1.163E-03 0.06615024 GALLUZZI_PERMEABILIZE_MITOCHONDRIA bone marrow cancer DOID_4960 3.102E-09 3.53E-07 1.508E-03 0.07150355 GALLUZZI_PERMEABILIZE_MITOCHONDRIA reproductive organ benign neoplasm DOID_0050622 3.392E-09 3.217E-07 1.561E-03 0.0683174 GALLUZZI_PERMEABILIZE_MITOCHONDRIA mitochondrial myopathy DOID_699 5.071E-09 4.122E-07 1.22E-06 3.472E-04 GALLUZZI_PERMEABILIZE_MITOCHONDRIA papilloma DOID_2615 4.938E-08 3.512E-06 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA spindle cell carcinoma DOID_4015 5.532E-08 3.498E-06 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA thyroid adenoma DOID_2891 1.911E-07 1.088E-05 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA B-cell lymphocytic neoplasm DOID_707 2.617E-07 1.354E-05 1.355E-03 0.07007214 GALLUZZI_PERMEABILIZE_MITOCHONDRIA mitochondrial metabolism disease DOID_700 3.753E-07 1.779E-05 2.905E-05 4.133E-03 GALLUZZI_PERMEABILIZE_MITOCHONDRIA endocrine organ benign neoplasm DOID_0060089 7.943E-07 3.477E-05 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA transitional cell carcinoma DOID_2671 2.061E-06 8.375E-05 0.08640023 0.59953329 GALLUZZI_PERMEABILIZE_MITOCHONDRIA lymphoblastic leukemia DOID_1037 2.558E-06 9.704E-05 1.207E-04 0.01373115 GALLUZZI_PERMEABILIZE_MITOCHONDRIA papillary adenoma DOID_3172 2.673E-06 9.504E-05 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA microcystic adenoma DOID_5403 2.673E-06 9.504E-05 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA follicular adenoma DOID_6204 2.673E-06 9.504E-05 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA female reproductive organ benign neoplasm DOID_0060086 4.516E-06 1.512E-04 0.03159447 0.36688273 GALLUZZI_PERMEABILIZE_MITOCHONDRIA uterine benign neoplasm DOID_0060095 4.516E-06 1.512E-04 0.03159447 0.36688273 GALLUZZI_PERMEABILIZE_MITOCHONDRIA uterine fibroid DOID_13223 4.516E-06 1.512E-04 0.03159447 0.36688273 GALLUZZI_PERMEABILIZE_MITOCHONDRIA leiomyoma DOID_127 5.947E-06 1.88E-04 0.03450612 0.36359228 GALLUZZI_PERMEABILIZE_MITOCHONDRIA adenoma DOID_657 8.281E-06 2.48E-04 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA hepatitis DOID_2237 1.038E-05 2.953E-04 8.213E-04 0.05841213 GALLUZZI_PERMEABILIZE_MITOCHONDRIA hypertrophic cardiomyopathy DOID_11984 3.212E-05 8.703E-04 1.725E-03 0.07009751 GALLUZZI_PERMEABILIZE_MITOCHONDRIA endocrine pancreas disease DOID_1428 4.258E-05 1.101E-03 2.076E-03 0.07874679 GALLUZZI_PERMEABILIZE_MITOCHONDRIA transient cerebral ischemia DOID_224 4.38E-05 1.084E-03 9.98E-03 0.28391861 GALLUZZI_PERMEABILIZE_MITOCHONDRIA mesenchymal cell neoplasm DOID_3350 1.019E-04 2.415E-03 0.01493292 0.28322763 GALLUZZI_PERMEABILIZE_MITOCHONDRIA spindle cell sarcoma DOID_4235 1.019E-04 2.415E-03 0.01493292 0.28322763 GALLUZZI_PERMEABILIZE_MITOCHONDRIA epithelioid sarcoma DOID_6193 1.019E-04 2.415E-03 0.01493292 0.28322763 GALLUZZI_PERMEABILIZE_MITOCHONDRIA restrictive cardiomyopathy DOID_397 1.164E-04 2.648E-03 0.01592069 0.29222162 GALLUZZI_PERMEABILIZE_MITOCHONDRIA tongue cancer DOID_8649 1.164E-04 2.546E-03 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA male reproductive organ benign neoplasm DOID_0060087 1.482E-04 3.123E-03 0.01789333 0.29089449 GALLUZZI_PERMEABILIZE_MITOCHONDRIA hypoglycemia DOID_9993 2.442E-04 4.963E-03 0.02280813 0.33276471 GALLUZZI_PERMEABILIZE_MITOCHONDRIA diffuse large B-cell lymphoma DOID_0050745 3.905E-04 7.661E-03 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA sarcoma DOID_1115 4.181E-04 7.93E-03 0.02964862 0.37489035 GALLUZZI_PERMEABILIZE_MITOCHONDRIA abdominal aortic aneurysm DOID_7693 5.065E-04 9.297E-03 0.03256597 0.36333405 GALLUZZI_PERMEABILIZE_MITOCHONDRIA chronic leukemia DOID_1036 5.701E-04 0.01013627 0.03450612 0.37045251 GALLUZZI_PERMEABILIZE_MITOCHONDRIA chronic lymphocytic leukemia DOID_1040 5.701E-04 0.01013627 0.03450612 0.37045251 GALLUZZI_PERMEABILIZE_MITOCHONDRIA thyroid carcinoma DOID_3963 6.373E-04 0.01098809 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA esophageal disease DOID_6050 6.373E-04 0.01066491 0.03644248 0.37701407 GALLUZZI_PERMEABILIZE_MITOCHONDRIA lymphoid leukemia DOID_10747 6.722E-04 0.01092886 6.722E-04 0.06375168 GALLUZZI_PERMEABILIZE_MITOCHONDRIA thyroid cancer DOID_1781 7.081E-04 0.01119254 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA benign mesothelioma DOID_2645 9.012E-04 0.01385896 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA hyperinsulinism DOID_2018 9.847E-04 0.01474515 9.847E-04 0.0622573 GALLUZZI_PERMEABILIZE_MITOCHONDRIA brain cancer DOID_1319 1.163E-03 0.0169616 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA central nervous system cancer DOID_3620 1.209E-03 0.0172017 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA integumentary system benign neoplasm DOID_0060121 1.257E-03 0.01744241 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA glaucoma DOID_1686 1.257E-03 0.01702712 0.05084517 0.46662743 GALLUZZI_PERMEABILIZE_MITOCHONDRIA skin benign neoplasm DOID_3165 1.257E-03 0.01744241 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA aortic aneurysm DOID_3627 1.305E-03 0.01727243 0.05179786 0.46051533 GALLUZZI_PERMEABILIZE_MITOCHONDRIA integumentary system cancer DOID_0060122 1.561E-03 0.02018469 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA skin cancer DOID_4159 1.561E-03 0.02018469 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA oral cavity cancer DOID_8618 1.725E-03 0.02180811 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA carotid artery disease DOID_3407 1.896E-03 0.02345795 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA hyperglycemia DOID_4195 2.2E-03 0.02663285 2.2E-03 0.07823399 GALLUZZI_PERMEABILIZE_MITOCHONDRIA aneurysm disease DOID_2403 2.871E-03 0.03403293 0.07624355 0.57082344 GALLUZZI_PERMEABILIZE_MITOCHONDRIA mixed glioma DOID_5076 2.943E-03 0.03417166 0.07717141 0.56295555 GALLUZZI_PERMEABILIZE_MITOCHONDRIA lipid metabolism disorder DOID_3146 3.089E-03 0.0351501 3.089E-03 0.10338264 GALLUZZI_PERMEABILIZE_MITOCHONDRIA biliary tract cancer DOID_4607 3.314E-03 0.03697469 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA amino acid metabolic disorder DOID_9252 3.787E-03 0.04143958 0.08731815 0.59860275 GALLUZZI_PERMEABILIZE_MITOCHONDRIA nervous system cancer DOID_3093 3.869E-03 0.04153504 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA teratoma DOID_3307 9.98E-03 0.09962056 9.98E-03 0.27039867 GALLUZZI_PERMEABILIZE_MITOCHONDRIA chondrosarcoma DOID_3371 9.98E-03 0.09790297 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA malignant teratoma DOID_5563 9.98E-03 0.09962056 9.98E-03 0.27039867 GALLUZZI_PERMEABILIZE_MITOCHONDRIA mature teratoma DOID_5566 9.98E-03 0.09962056 9.98E-03 0.27039867 GALLUZZI_PERMEABILIZE_MITOCHONDRIA acute T cell leukemia DOID_5603 9.98E-03 0.0962436 9.98E-03 0.25810783 GALLUZZI_PERMEABILIZE_MITOCHONDRIA adrenoleukodystrophy DOID_10588 0.01097217 0.09909786 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA neuronal ceroid lipofuscinosis DOID_14503 0.01097217 0.09754946 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA prostatic adenoma DOID_2883 0.01097217 0.0960487 0.01097217 0.26013188 GALLUZZI_PERMEABILIZE_MITOCHONDRIA mitochondrial encephalomyopathy DOID_890 0.01196381 0.09865807 0.01196381 0.25212618 GALLUZZI_PERMEABILIZE_MITOCHONDRIA ocular hypertension DOID_9282 0.01196381 0.09724867 1.000 1.000 GALLUZZI_PERMEABILIZE_MITOCHONDRIA borderline glaucoma DOID_9283 0.01196381 0.09724867 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN hypersensitivity reaction type I disease DOID_1205 1.883E-08 1.072E-05 7.631E-05 0.04341987 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN systemic scleroderma DOID_418 4.573E-08 1.301E-05 5.819E-04 0.05518203 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN rheumatic disease DOID_1575 6.652E-08 1.262E-05 6.98E-04 0.04964565 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN scleroderma DOID_419 6.652E-08 1.262E-05 6.98E-04 0.04964565 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN collagen disease DOID_854 2.563E-07 3.645E-05 1.347E-03 0.07663128 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN nephrosis DOID_2527 4.613E-07 5.25E-05 0.06063271 0.46000015 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN bacterial pneumonia DOID_874 6.319E-07 5.992E-05 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN nephrotic syndrome DOID_1184 8.09E-06 6.576E-04 0.03812162 0.41713848 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN respiratory failure DOID_11162 2.303E-05 1.638E-03 0.05345325 0.45395369 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 3.093E-05 1.955E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 3.093E-05 1.955E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN Hodgkin's granuloma DOID_8651 3.093E-05 1.955E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 3.093E-05 1.955E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN Hodgkin's lymphoma DOID_8567 4.532E-05 2.578E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN viral pneumonia DOID_10533 6.241E-05 3.229E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN aspergillosis DOID_13564 6.241E-05 2.959E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN Human immunodeficiency virus infectious disease DOID_526 6.518E-05 2.853E-03 0.07483371 0.50094565 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN angiosarcoma DOID_0001816 8.222E-05 3.342E-03 8.222E-05 0.02339099 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN acquired immunodeficiency syndrome DOID_635 1.578E-04 5.985E-03 0.0184112 0.32737422 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN myasthenia gravis DOID_437 1.727E-04 6.142E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN neuromuscular junction disease DOID_439 2.391E-04 8.003E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN lung adenocarcinoma DOID_3910 2.763E-04 8.733E-03 2.763E-04 0.05239929 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN sarcoma DOID_1115 2.958E-04 8.86E-03 2.958E-04 0.04208439 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN autoimmune disease of the nervous system DOID_438 2.958E-04 8.417E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN opportunistic mycosis DOID_2473 3.585E-04 9.714E-03 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN bronchiolitis obliterans DOID_2799 3.585E-04 9.273E-03 0.02749324 0.37246788 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN systemic mycosis DOID_0050136 4.271E-04 0.0105665 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN fungal infectious disease DOID_1564 4.271E-04 0.0105665 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN male infertility DOID_12336 4.513E-04 0.01069924 4.513E-04 0.05135633 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN periodontal disease DOID_3388 4.513E-04 0.01027127 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN pulmonary sarcoidosis DOID_13406 5.277E-04 0.01154847 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN adult respiratory distress syndrome DOID_11394 6.099E-04 0.01285408 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN lymphatic system disease DOID_75 6.099E-04 0.01239501 6.099E-04 0.04958003 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN myeloma DOID_0070004 8.244E-04 0.01617537 0.04136919 0.42798308 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN pre-eclampsia DOID_10591 8.244E-04 0.01563619 0.04136919 0.42034053 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN glaucoma DOID_1686 8.914E-04 0.01636216 8.914E-04 0.05635854 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN pulmonary tuberculosis DOID_2957 8.914E-04 0.01585084 0.04298899 0.40767893 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN aortic aneurysm DOID_3627 9.259E-04 0.01596487 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN sarcoidosis DOID_11335 1.033E-03 0.01728964 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN bone marrow cancer DOID_4960 1.07E-03 0.01739724 0.0470269 0.42473501 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN hypersensitivity reaction type IV disease DOID_2916 1.224E-03 0.01935307 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN melancholia DOID_2848 1.265E-03 0.01944744 0.0510483 0.45385131 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN neurotic disorder DOID_4964 1.305E-03 0.01954622 0.05185061 0.45389224 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN tooth disease DOID_1091 1.608E-03 0.02346373 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN brain infarction DOID_3454 1.654E-03 0.02352787 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN tuberculosis DOID_399 1.654E-03 0.02295402 0.05824544 0.45399525 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN pancreatic ductal carcinoma DOID_3587 1.747E-03 0.02367202 0.0598376 0.46010265 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN male reproductive system disease DOID_48 1.795E-03 0.02375128 1.795E-03 0.0928459 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN biliary tract disease DOID_9741 1.843E-03 0.02383487 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN pancreatic carcinoma DOID_4905 1.892E-03 0.02392249 0.06222097 0.45978869 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN cystic fibrosis DOID_1485 1.991E-03 0.02463285 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN endogenous depression DOID_1595 1.991E-03 0.02410875 0.06380662 0.46546112 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN aneurysm disease DOID_2403 2.042E-03 0.02420691 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN pancreatitis DOID_4989 2.093E-03 0.02430813 0.06538968 0.47097123 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN mixed glioma DOID_5076 2.093E-03 0.02382196 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN mental depression DOID_1596 2.359E-03 0.02631582 0.06933599 0.4811241 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN primary bacterial infectious disease DOID_0050338 2.582E-03 0.02825173 0.07248141 0.4968906 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN primary immunodeficiency disease DOID_612 2.697E-03 0.02895525 2.697E-03 0.12788567 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN lymphoma DOID_0060058 2.874E-03 0.03028668 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.995E-03 0.0309892 0.07796113 0.51581256 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN mouth disease DOID_403 2.995E-03 0.03043582 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN brachydactyly DOID_0050581 8.41E-03 0.08395073 8.41E-03 0.36809166 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN phagocyte bactericidal dysfunction DOID_3262 8.41E-03 0.0825033 8.41E-03 0.3417994 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN keratitis DOID_4677 8.41E-03 0.08110494 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN visceral leishmaniasis DOID_9146 8.41E-03 0.07975319 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN prediabetes syndrome DOID_11716 9.247E-03 0.0862551 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN familial atrial fibrillation DOID_0050650 0.01008355 0.09254098 0.01008355 0.38250271 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN parathyroid gland disease DOID_11201 0.01091939 0.09862113 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN newborn respiratory distress syndrome DOID_12716 0.01091939 0.09708017 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN epilepsy with generalized tonic-clonic seizures DOID_7725 0.01091939 0.09558663 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN psoriatic arthritis DOID_9008 0.01091939 0.09413835 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN open-angle glaucoma DOID_1067 0.01175454 0.09982586 0.01175454 0.41802077 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN hypercalcemia DOID_12678 0.01175454 0.09835783 0.01175454 0.39343131 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN narcolepsy DOID_8986 0.01175454 0.09693235 0.01175454 0.37157402 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN oral submucous fibrosis DOID_5773 0.01258901 0.09948812 1.000 1.000 ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN panic disorder DOID_594 0.01258901 0.09812527 0.01258901 0.37700763 PEREZ_TP63_TARGETS congenital heart defect DOID_1682 1.014E-08 5.767E-06 1.014E-08 5.767E-06 PEREZ_TP63_TARGETS astrocytoma DOID_3069 1.879E-08 5.345E-06 5.102E-07 5.806E-05 PEREZ_TP63_TARGETS aortic valve disease DOID_62 4.138E-08 7.848E-06 4.138E-08 1.177E-05 PEREZ_TP63_TARGETS heart valve disease DOID_4079 5.585E-08 7.945E-06 5.585E-08 1.059E-05 PEREZ_TP63_TARGETS giant cell tumor DOID_200 1.119E-07 1.273E-05 3.349E-06 3.176E-04 PEREZ_TP63_TARGETS malignant giant cell tumor DOID_2705 1.119E-07 1.273E-05 3.349E-06 3.176E-04 PEREZ_TP63_TARGETS giant cell glioblastoma DOID_3074 1.119E-07 1.273E-05 3.349E-06 3.176E-04 PEREZ_TP63_TARGETS glioblastoma DOID_3068 1.881E-07 1.784E-05 5.131E-06 4.171E-04 PEREZ_TP63_TARGETS oral cavity cancer DOID_8618 1.881E-07 1.529E-05 1.881E-07 2.676E-05 PEREZ_TP63_TARGETS temporal lobe epilepsy DOID_3328 3.954E-07 2.812E-05 9.444E-06 6.717E-04 PEREZ_TP63_TARGETS pancreatic ductal carcinoma DOID_3587 5.54E-07 3.503E-05 1.246E-05 7.876E-04 PEREZ_TP63_TARGETS pancreatic carcinoma DOID_4905 7.044E-07 4.008E-05 1.517E-05 7.849E-04 PEREZ_TP63_TARGETS ureteral obstruction DOID_5199 7.665E-07 3.965E-05 5.129E-05 2.085E-03 PEREZ_TP63_TARGETS focal epilepsy DOID_2234 1.367E-06 6.484E-05 2.616E-05 1.24E-03 PEREZ_TP63_TARGETS urinary tract obstruction DOID_5200 2.183E-06 9.556E-05 1.097E-04 3.9E-03 PEREZ_TP63_TARGETS lung small cell carcinoma DOID_5409 2.309E-06 9.383E-05 6.09E-05 2.31E-03 PEREZ_TP63_TARGETS ureteral disease DOID_1426 2.612E-06 9.907E-05 1.25E-04 4.182E-03 PEREZ_TP63_TARGETS Charcot-Marie-Tooth disease DOID_10595 1.104E-05 3.927E-04 3.586E-04 9.275E-03 PEREZ_TP63_TARGETS nephrosis DOID_2527 1.332E-05 4.457E-04 2.415E-04 7.233E-03 PEREZ_TP63_TARGETS aortic valve stenosis DOID_1712 1.408E-05 4.45E-04 1.408E-05 8.01E-04 PEREZ_TP63_TARGETS syndrome DOID_225 1.723E-05 5.159E-04 2.957E-04 8.011E-03 PEREZ_TP63_TARGETS systemic scleroderma DOID_418 2.599E-05 7.394E-04 6.718E-04 0.01365175 PEREZ_TP63_TARGETS pulmonary emphysema DOID_9675 3.132E-05 8.486E-04 7.704E-04 0.01369914 PEREZ_TP63_TARGETS tongue cancer DOID_8649 3.541E-05 9.158E-04 3.541E-05 1.55E-03 PEREZ_TP63_TARGETS rheumatic disease DOID_1575 3.741E-05 9.256E-04 8.778E-04 0.01469055 PEREZ_TP63_TARGETS scleroderma DOID_419 3.741E-05 9.256E-04 8.778E-04 0.01469055 PEREZ_TP63_TARGETS nervous system cancer DOID_3093 3.834E-05 9.089E-04 5.543E-04 0.01261495 PEREZ_TP63_TARGETS encephalomyelitis DOID_640 4.473E-05 1.018E-03 6.925E-03 0.05472823 PEREZ_TP63_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 4.703E-05 1.029E-03 6.507E-04 0.0137137 PEREZ_TP63_TARGETS pre-eclampsia DOID_10591 5.214E-05 1.099E-03 1.12E-03 0.01770285 PEREZ_TP63_TARGETS brain cancer DOID_1319 5.214E-05 1.06E-03 1.12E-03 0.0172244 PEREZ_TP63_TARGETS central nervous system cancer DOID_3620 5.64E-05 1.107E-03 1.187E-03 0.01776654 PEREZ_TP63_TARGETS subependymal glioma DOID_4843 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS pilocytic astrocytoma DOID_4851 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS subependymal giant cell astrocytoma DOID_5077 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS fibrillary astrocytoma DOID_6726 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS juvenile pilocytic astrocytoma DOID_6811 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS childhood pilocytic astrocytoma DOID_6812 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS gemistocytic astrocytoma DOID_7005 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS childhood cerebral astrocytoma DOID_7007 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS protoplasmic astrocytoma DOID_7008 7.123E-05 1.351E-03 2.969E-03 0.03447427 PEREZ_TP63_TARGETS alopecia DOID_987 7.123E-05 1.307E-03 2.969E-03 0.03378479 PEREZ_TP63_TARGETS benign glioma DOID_0060101 9.565E-05 1.701E-03 3.59E-03 0.04005605 PEREZ_TP63_TARGETS benign ependymoma DOID_4844 9.565E-05 1.701E-03 3.59E-03 0.04005605 PEREZ_TP63_TARGETS Goodpasture syndrome DOID_9808 1.25E-04 2.155E-03 4.267E-03 0.04185985 PEREZ_TP63_TARGETS collagen disease DOID_854 1.376E-04 2.303E-03 2.284E-03 0.02888183 PEREZ_TP63_TARGETS hypotrichosis DOID_4535 1.999E-04 3.249E-03 5.782E-03 0.04910419 PEREZ_TP63_TARGETS endocrine organ benign neoplasm DOID_0060089 2.059E-04 3.254E-03 2.059E-04 6.508E-03 PEREZ_TP63_TARGETS polycystic ovary syndrome DOID_11612 2.718E-04 4.18E-03 7.056E-03 0.05500146 PEREZ_TP63_TARGETS supratentorial cancer DOID_1659 2.718E-04 4.07E-03 7.056E-03 0.0542582 PEREZ_TP63_TARGETS toxic encephalopathy DOID_3602 2.718E-04 3.965E-03 2.718E-04 7.732E-03 PEREZ_TP63_TARGETS cerebrum cancer DOID_368 2.718E-04 4.07E-03 7.056E-03 0.0542582 PEREZ_TP63_TARGETS pancreatitis DOID_4989 3.258E-04 4.634E-03 0.04215307 0.21039558 PEREZ_TP63_TARGETS chromosomal disease DOID_0080014 3.75E-04 5.204E-03 3.75E-04 9.276E-03 PEREZ_TP63_TARGETS mental depression DOID_1596 4.106E-04 5.562E-03 5.089E-03 0.04747242 PEREZ_TP63_TARGETS chronic kidney failure DOID_784 4.106E-04 5.433E-03 5.089E-03 0.04670674 PEREZ_TP63_TARGETS hair disease DOID_421 4.253E-04 5.5E-03 9.434E-03 0.06710268 PEREZ_TP63_TARGETS transitional cell carcinoma DOID_2671 5.1E-04 6.449E-03 5.1E-04 0.01209243 PEREZ_TP63_TARGETS pulmonary sarcoidosis DOID_13406 5.816E-04 7.194E-03 0.15032446 0.38015385 PEREZ_TP63_TARGETS uveitis DOID_13141 6.257E-04 7.575E-03 6.257E-04 0.01369237 PEREZ_TP63_TARGETS adenoid cystic carcinoma DOID_4866 7.2E-04 8.535E-03 7.2E-04 0.01412754 PEREZ_TP63_TARGETS brachydactyly DOID_0050581 7.221E-04 8.386E-03 7.221E-04 0.01369643 PEREZ_TP63_TARGETS ventricular septal defect DOID_1657 7.221E-04 8.218E-03 7.221E-04 0.01325461 PEREZ_TP63_TARGETS ulcerative colitis DOID_8577 7.586E-04 8.463E-03 7.972E-03 0.05891105 PEREZ_TP63_TARGETS salivary gland cancer DOID_8850 8.23E-04 9.006E-03 8.23E-04 0.01419067 PEREZ_TP63_TARGETS nephrotic syndrome DOID_1184 8.778E-04 9.424E-03 0.0150951 0.09987338 PEREZ_TP63_TARGETS uveal disease DOID_3480 8.778E-04 9.25E-03 8.778E-04 0.01427082 PEREZ_TP63_TARGETS Charcot-Marie-Tooth disease type 4 DOID_0050541 8.803E-04 9.107E-03 0.04379267 0.21481062 PEREZ_TP63_TARGETS diabetic autonomic neuropathy DOID_11503 9.349E-04 9.499E-03 0.01572444 0.1016728 PEREZ_TP63_TARGETS autonomic neuropathy DOID_11504 9.349E-04 9.499E-03 0.01572444 0.1016728 PEREZ_TP63_TARGETS diabetic polyneuropathy DOID_12785 9.349E-04 9.499E-03 0.01572444 0.1016728 PEREZ_TP63_TARGETS influenza DOID_8469 9.349E-04 9.332E-03 0.01572444 0.0994134 PEREZ_TP63_TARGETS diabetic neuropathy DOID_9743 9.349E-04 9.499E-03 0.01572444 0.1016728 PEREZ_TP63_TARGETS common cold DOID_10459 1.053E-03 0.01033507 0.04767806 0.21703051 PEREZ_TP63_TARGETS autonomic nervous system disease DOID_11465 1.12E-03 0.01080174 0.01767867 0.10701238 PEREZ_TP63_TARGETS Charcot-Marie-Tooth disease type 2 DOID_0050539 1.242E-03 0.01177557 1.242E-03 0.01811626 PEREZ_TP63_TARGETS Hirschsprung's disease DOID_10487 1.242E-03 0.01158253 0.05154775 0.22389824 PEREZ_TP63_TARGETS megacolon DOID_11372 1.445E-03 0.01325959 0.05540182 0.22843215 PEREZ_TP63_TARGETS eating disorder DOID_8670 1.445E-03 0.01304912 1.445E-03 0.02055236 PEREZ_TP63_TARGETS atopic dermatitis DOID_3310 1.477E-03 0.01313264 0.20071119 0.45681867 PEREZ_TP63_TARGETS sarcoidosis DOID_11335 1.556E-03 0.01362209 0.20396274 0.46236971 PEREZ_TP63_TARGETS bone marrow cancer DOID_4960 1.638E-03 0.01411911 1.638E-03 0.02272833 PEREZ_TP63_TARGETS corneal dystrophy DOID_2566 1.663E-03 0.01412006 1.663E-03 0.02252487 PEREZ_TP63_TARGETS osteochondrodysplasia DOID_2256 1.722E-03 0.01440858 1.722E-03 0.02278566 PEREZ_TP63_TARGETS silicosis DOID_10325 1.895E-03 0.01562776 0.06306335 0.23763607 PEREZ_TP63_TARGETS hemolytic-uremic syndrome DOID_12554 1.895E-03 0.0154045 0.06306335 0.23452972 PEREZ_TP63_TARGETS hypertrophic cardiomyopathy DOID_11984 1.991E-03 0.01595349 1.991E-03 0.02574313 PEREZ_TP63_TARGETS hypersensitivity reaction type IV disease DOID_2916 1.991E-03 0.01573192 0.22002438 0.48524757 PEREZ_TP63_TARGETS inherited blood coagulation disease DOID_2214 2.403E-03 0.0187335 2.403E-03 0.02972925 PEREZ_TP63_TARGETS heart septal defect DOID_1681 2.679E-03 0.02059957 2.679E-03 0.03243337 PEREZ_TP63_TARGETS cerebral degeneration DOID_1443 2.715E-03 0.02059935 2.715E-03 0.03218648 PEREZ_TP63_TARGETS colonic disease DOID_5353 2.969E-03 0.02222683 0.07820168 0.2632944 PEREZ_TP63_TARGETS male reproductive system disease DOID_48 3.45E-03 0.0254967 0.03659936 0.19105536 PEREZ_TP63_TARGETS gastric ulcer DOID_10808 3.59E-03 0.0261905 3.59E-03 0.03928574 PEREZ_TP63_TARGETS muscular atrophy DOID_767 3.59E-03 0.02585897 3.59E-03 0.0385445 PEREZ_TP63_TARGETS diabetic retinopathy DOID_8947 3.72E-03 0.02645694 3.72E-03 0.03919547 PEREZ_TP63_TARGETS myasthenia gravis DOID_437 3.922E-03 0.02754906 0.08939572 0.2906638 PEREZ_TP63_TARGETS uremia DOID_4676 3.922E-03 0.0272131 3.922E-03 0.04057225 PEREZ_TP63_TARGETS endogenous depression DOID_1595 4.002E-03 0.02743344 0.04026844 0.20276764 PEREZ_TP63_TARGETS bone resorption disease DOID_0080011 4.147E-03 0.02809385 4.147E-03 0.04214077 PEREZ_TP63_TARGETS osteoporosis DOID_11476 4.147E-03 0.02809385 4.147E-03 0.04214077 PEREZ_TP63_TARGETS Lewy body dementia DOID_12217 4.267E-03 0.02856319 4.267E-03 0.04259423 PEREZ_TP63_TARGETS mixed glioma DOID_5076 4.296E-03 0.02842564 0.04215307 0.20856606 PEREZ_TP63_TARGETS bacterial pneumonia DOID_874 4.296E-03 0.0280989 0.27817599 0.58191963 PEREZ_TP63_TARGETS hypogonadism DOID_1924 4.998E-03 0.03231536 4.998E-03 0.04819918 PEREZ_TP63_TARGETS bronchiolitis DOID_2942 4.998E-03 0.03195227 0.1004547 0.31754846 PEREZ_TP63_TARGETS osteosarcoma DOID_3347 4.998E-03 0.03159724 4.998E-03 0.04739586 PEREZ_TP63_TARGETS bone development disease DOID_0080006 5.258E-03 0.03287536 5.258E-03 0.04748663 PEREZ_TP63_TARGETS cystitis DOID_1679 5.383E-03 0.03329462 0.10411129 0.32549079 PEREZ_TP63_TARGETS neuromuscular junction disease DOID_439 5.383E-03 0.03293661 0.10411129 0.32021256 PEREZ_TP63_TARGETS myositis DOID_633 5.383E-03 0.03258622 0.10411129 0.31849098 PEREZ_TP63_TARGETS ankylosing spondylitis DOID_7147 5.383E-03 0.03224321 5.383E-03 0.04786101 PEREZ_TP63_TARGETS retinal vascular disease DOID_2462 5.43E-03 0.03218113 5.43E-03 0.04752905 PEREZ_TP63_TARGETS seminoma DOID_4440 5.782E-03 0.03391732 5.782E-03 0.04984819 PEREZ_TP63_TARGETS primary bacterial infectious disease DOID_0050338 5.783E-03 0.03357713 0.05102708 0.22683131 PEREZ_TP63_TARGETS lung adenocarcinoma DOID_3910 6.194E-03 0.03559914 6.194E-03 0.05182816 PEREZ_TP63_TARGETS periodontitis DOID_824 6.194E-03 0.03524315 0.11138023 0.33007995 PEREZ_TP63_TARGETS Human immunodeficiency virus infectious disease DOID_526 6.339E-03 0.03571025 6.339E-03 0.05227152 PEREZ_TP63_TARGETS invasive ductal carcinoma DOID_3008 6.619E-03 0.03692201 6.619E-03 0.05380064 PEREZ_TP63_TARGETS autoimmune disease of the nervous system DOID_438 6.619E-03 0.03656354 0.11499269 0.33383083 PEREZ_TP63_TARGETS lymphoblastic leukemia DOID_1037 6.925E-03 0.03788878 6.925E-03 0.05549905 PEREZ_TP63_TARGETS hypersensitivity reaction type I disease DOID_1205 7.333E-03 0.03974044 0.05942166 0.22845219 PEREZ_TP63_TARGETS dilated cardiomyopathy DOID_12930 7.333E-03 0.03936553 0.05942166 0.22691895 PEREZ_TP63_TARGETS corneal disease DOID_10124 7.507E-03 0.03991998 7.507E-03 0.05695251 PEREZ_TP63_TARGETS gonadal disease DOID_2277 7.97E-03 0.04199052 7.97E-03 0.05967074 PEREZ_TP63_TARGETS bronchiolitis obliterans DOID_2799 7.97E-03 0.04160529 1.000 1.000 PEREZ_TP63_TARGETS endometrial cancer DOID_1380 8.446E-03 0.04368781 8.446E-03 0.06161102 PEREZ_TP63_TARGETS germinoma DOID_3304 8.446E-03 0.04329423 8.446E-03 0.06083113 PEREZ_TP63_TARGETS bladder disease DOID_365 8.934E-03 0.04538773 0.13283733 0.36164805 PEREZ_TP63_TARGETS myocarditis DOID_820 9.434E-03 0.04750632 0.13636313 0.36772806 PEREZ_TP63_TARGETS metal metabolism disorder DOID_896 9.434E-03 0.0470896 9.434E-03 0.06627425 PEREZ_TP63_TARGETS pneumoconiosis DOID_10316 9.947E-03 0.04921708 0.13987468 0.37541837 PEREZ_TP63_TARGETS male infertility DOID_12336 9.947E-03 0.0487928 9.947E-03 0.06902396 PEREZ_TP63_TARGETS periodontal disease DOID_3388 9.947E-03 0.04837576 0.13987468 0.37365584 PEREZ_TP63_TARGETS calcinosis DOID_182 0.01155778 0.05573202 0.01155778 0.07923348 PEREZ_TP63_TARGETS respiratory syncytial virus infectious disease DOID_1273 0.01269074 0.06068091 1.000 1.000 PEREZ_TP63_TARGETS congenital diaphragmatic hernia DOID_3827 0.01269074 0.06017524 0.01269074 0.08596463 PEREZ_TP63_TARGETS peptic ulcer DOID_750 0.01269074 0.05967792 0.01269074 0.08495328 PEREZ_TP63_TARGETS adult respiratory distress syndrome DOID_11394 0.01327467 0.0619122 0.16064809 0.39570893 PEREZ_TP63_TARGETS hyperinsulinism DOID_2018 0.0150951 0.06983016 0.0150951 0.09872541 PEREZ_TP63_TARGETS uterine cancer DOID_363 0.01572444 0.07215489 0.01572444 0.10053041 PEREZ_TP63_TARGETS cataract DOID_83 0.01636488 0.07449294 0.01636488 0.10232547 PEREZ_TP63_TARGETS leukodystrophy DOID_10579 0.01701633 0.07684357 0.01701633 0.10524227 PEREZ_TP63_TARGETS proteinuria DOID_576 0.01701633 0.0762385 0.18092296 0.42893819 PEREZ_TP63_TARGETS lens disease DOID_110 0.01767867 0.07858722 0.01767867 0.10816305 PEREZ_TP63_TARGETS neuritis DOID_1803 0.01767867 0.07797801 0.18425448 0.43322644 PEREZ_TP63_TARGETS thyroid adenoma DOID_2891 0.01767867 0.07737818 0.01767867 0.10588593 PEREZ_TP63_TARGETS hemolytic anemia DOID_583 0.01835182 0.07971134 0.18757253 0.43741299 PEREZ_TP63_TARGETS normocytic anemia DOID_720 0.01835182 0.07971134 0.18757253 0.43741299 PEREZ_TP63_TARGETS integumentary system benign neoplasm DOID_0060121 0.01903568 0.0820553 0.01903568 0.11282603 PEREZ_TP63_TARGETS pulmonary tuberculosis DOID_2957 0.01903568 0.08143834 0.19087717 0.44150046 PEREZ_TP63_TARGETS skin benign neoplasm DOID_3165 0.01903568 0.0820553 0.01903568 0.11282603 PEREZ_TP63_TARGETS calcium metabolism disease DOID_10575 0.01973014 0.08377948 0.01973014 0.1157366 PEREZ_TP63_TARGETS hemorrhagic disease DOID_2213 0.02043512 0.08613024 0.02043512 0.1186488 PEREZ_TP63_TARGETS atrophic muscular disease DOID_913 0.02187623 0.0915263 0.02187623 0.12573309 PEREZ_TP63_TARGETS muscular dystrophy DOID_9884 0.02187623 0.0915263 0.02187623 0.12573309 PEREZ_TP63_TARGETS integumentary system cancer DOID_0060122 0.02335826 0.0970135 0.02335826 0.13290849 PEREZ_TP63_TARGETS skin cancer DOID_4159 0.02335826 0.0970135 0.02335826 0.13290849 HADDAD_B_LYMPHOCYTE_PROGENITOR primary immunodeficiency disease DOID_612 2.424E-14 1.379E-11 2.424E-14 1.379E-11 HADDAD_B_LYMPHOCYTE_PROGENITOR agammaglobulinemia DOID_2583 2.712E-13 7.715E-11 2.712E-13 7.715E-11 HADDAD_B_LYMPHOCYTE_PROGENITOR blood protein disease DOID_620 4.16E-13 7.89E-11 4.16E-13 7.89E-11 HADDAD_B_LYMPHOCYTE_PROGENITOR B cell deficiency DOID_2115 6.208E-12 8.831E-10 6.208E-12 8.831E-10 HADDAD_B_LYMPHOCYTE_PROGENITOR pre-malignant neoplasm DOID_0060071 1.272E-07 1.448E-05 3.708E-06 2.345E-04 HADDAD_B_LYMPHOCYTE_PROGENITOR in situ carcinoma DOID_8719 1.272E-07 1.448E-05 3.708E-06 2.345E-04 HADDAD_B_LYMPHOCYTE_PROGENITOR MHC class II deficiency DOID_5812 5.386E-07 5.108E-05 5.386E-07 6.13E-05 HADDAD_B_LYMPHOCYTE_PROGENITOR lymphoblastic leukemia DOID_1037 1.12E-06 9.102E-05 1.12E-06 1.062E-04 HADDAD_B_LYMPHOCYTE_PROGENITOR severe combined immunodeficiency DOID_627 1.729E-06 1.23E-04 1.729E-06 1.406E-04 HADDAD_B_LYMPHOCYTE_PROGENITOR combined T cell and B cell immunodeficiency DOID_628 2.038E-06 1.289E-04 2.038E-06 1.45E-04 HADDAD_B_LYMPHOCYTE_PROGENITOR endocrine organ benign neoplasm DOID_0060089 5.327E-06 3.031E-04 2.027E-03 0.02957154 HADDAD_B_LYMPHOCYTE_PROGENITOR embryonal cancer DOID_688 1.199E-05 6.205E-04 1.199E-05 6.825E-04 HADDAD_B_LYMPHOCYTE_PROGENITOR cervix uteri carcinoma in situ DOID_8991 1.762E-05 8.357E-04 1.762E-05 9.117E-04 HADDAD_B_LYMPHOCYTE_PROGENITOR testicular cancer DOID_2998 3.925E-05 1.718E-03 3.925E-05 1.861E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR B-cell lymphocytic neoplasm DOID_707 3.996E-05 1.624E-03 9.186E-04 0.01742309 HADDAD_B_LYMPHOCYTE_PROGENITOR reproductive organ benign neoplasm DOID_0050622 5.303E-05 2.012E-03 5.303E-05 2.321E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR mitochondrial myopathy DOID_699 5.36E-05 1.906E-03 0.07116261 0.33464069 HADDAD_B_LYMPHOCYTE_PROGENITOR muscular atrophy DOID_767 6.191E-05 2.072E-03 6.191E-05 2.516E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR osteosarcoma DOID_3347 1.034E-04 3.27E-03 1.034E-04 3.924E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR tooth disease DOID_1091 1.109E-04 3.322E-03 1.946E-03 0.02992914 HADDAD_B_LYMPHOCYTE_PROGENITOR tuberculosis DOID_399 1.172E-04 3.335E-03 0.02592739 0.21075267 HADDAD_B_LYMPHOCYTE_PROGENITOR seminoma DOID_4440 1.297E-04 3.514E-03 1.297E-04 4.612E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR diffuse large B-cell lymphoma DOID_0050745 1.443E-04 3.731E-03 4.661E-03 0.05412512 HADDAD_B_LYMPHOCYTE_PROGENITOR invasive ductal carcinoma DOID_3008 1.599E-04 3.956E-03 1.599E-04 5.352E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR aneurysm disease DOID_2403 1.774E-04 4.206E-03 0.0315697 0.24948834 HADDAD_B_LYMPHOCYTE_PROGENITOR mixed glioma DOID_5076 1.862E-04 4.239E-03 1.862E-04 5.887E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR germinoma DOID_3304 2.333E-04 5.105E-03 2.333E-04 6.985E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR focal epilepsy DOID_2234 2.352E-04 4.957E-03 3.38E-03 0.04273855 HADDAD_B_LYMPHOCYTE_PROGENITOR chronic leukemia DOID_1036 2.545E-04 5.171E-03 2.545E-04 7.24E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR chronic lymphocytic leukemia DOID_1040 2.545E-04 5.171E-03 2.545E-04 7.24E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR primary bacterial infectious disease DOID_0050338 2.806E-04 5.506E-03 0.03923103 0.25956345 HADDAD_B_LYMPHOCYTE_PROGENITOR transitional cell carcinoma DOID_2671 2.929E-04 5.555E-03 2.929E-04 7.935E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR nephroblastoma DOID_2154 3.006E-04 5.517E-03 3.006E-04 7.773E-03 HADDAD_B_LYMPHOCYTE_PROGENITOR nervous system cancer DOID_3093 3.185E-04 5.664E-03 4.222E-03 0.05222091 HADDAD_B_LYMPHOCYTE_PROGENITOR lymphoma DOID_0060058 3.458E-04 5.962E-03 4.483E-03 0.05314743 HADDAD_B_LYMPHOCYTE_PROGENITOR mouth disease DOID_403 3.746E-04 6.269E-03 4.755E-03 0.05410939 HADDAD_B_LYMPHOCYTE_PROGENITOR multiple myeloma DOID_9538 3.792E-04 6.165E-03 8.732E-03 0.08872643 HADDAD_B_LYMPHOCYTE_PROGENITOR benign mesothelioma DOID_2645 5.032E-04 7.953E-03 0.0104945 0.10120966 HADDAD_B_LYMPHOCYTE_PROGENITOR gonadal dysgenesis DOID_14447 5.397E-04 8.299E-03 5.397E-04 0.01335051 HADDAD_B_LYMPHOCYTE_PROGENITOR breast benign neoplasm DOID_0060082 6.581E-04 9.854E-03 6.581E-04 0.01560145 HADDAD_B_LYMPHOCYTE_PROGENITOR thoracic benign neoplasm DOID_0060097 6.581E-04 9.854E-03 6.581E-04 0.01560145 HADDAD_B_LYMPHOCYTE_PROGENITOR common variable immunodeficiency DOID_12177 6.581E-04 9.601E-03 6.581E-04 0.01497739 HADDAD_B_LYMPHOCYTE_PROGENITOR benign breast phyllodes tumor DOID_1631 6.581E-04 9.854E-03 6.581E-04 0.01560145 HADDAD_B_LYMPHOCYTE_PROGENITOR chronic monocytic leukemia DOID_8593 6.581E-04 9.361E-03 6.581E-04 0.01440134 HADDAD_B_LYMPHOCYTE_PROGENITOR myeloma DOID_0070004 7.333E-04 0.01017741 0.01340509 0.12712489 HADDAD_B_LYMPHOCYTE_PROGENITOR thyroid adenoma DOID_2891 7.333E-04 9.935E-03 0.16124204 0.47292124 HADDAD_B_LYMPHOCYTE_PROGENITOR bone marrow disease DOID_4961 7.333E-04 9.704E-03 0.01340509 0.12504088 HADDAD_B_LYMPHOCYTE_PROGENITOR common cold DOID_10459 7.879E-04 0.01018839 1.000 1.000 HADDAD_B_LYMPHOCYTE_PROGENITOR pituitary cancer DOID_1785 7.879E-04 9.962E-03 7.879E-04 0.0166033 HADDAD_B_LYMPHOCYTE_PROGENITOR pituitary carcinoma DOID_4916 7.879E-04 9.962E-03 7.879E-04 0.0166033 HADDAD_B_LYMPHOCYTE_PROGENITOR integumentary system benign neoplasm DOID_0060121 8.227E-04 0.01017605 0.16712463 0.47785886 HADDAD_B_LYMPHOCYTE_PROGENITOR glaucoma DOID_1686 8.227E-04 9.96E-03 8.227E-04 0.01671779 HADDAD_B_LYMPHOCYTE_PROGENITOR pulmonary tuberculosis DOID_2957 8.227E-04 9.752E-03 0.16712463 0.47546957 HADDAD_B_LYMPHOCYTE_PROGENITOR skin benign neoplasm DOID_3165 8.227E-04 0.01017605 0.16712463 0.47785886 HADDAD_B_LYMPHOCYTE_PROGENITOR aortic aneurysm DOID_3627 8.698E-04 0.01010036 0.17005055 0.48138687 HADDAD_B_LYMPHOCYTE_PROGENITOR movement disease DOID_480 8.698E-04 9.898E-03 8.698E-04 0.01706612 HADDAD_B_LYMPHOCYTE_PROGENITOR monocytic leukemia DOID_8527 9.29E-04 0.0103643 9.29E-04 0.01705094 HADDAD_B_LYMPHOCYTE_PROGENITOR bone marrow cancer DOID_4960 1.075E-03 0.01176704 0.01718907 0.15282158 HADDAD_B_LYMPHOCYTE_PROGENITOR narcolepsy DOID_8986 1.081E-03 0.01160866 1.081E-03 0.01922685 HADDAD_B_LYMPHOCYTE_PROGENITOR mitochondrial metabolism disease DOID_700 1.189E-03 0.0125253 0.18739306 0.51760511 HADDAD_B_LYMPHOCYTE_PROGENITOR congenital nervous system abnormality DOID_2490 1.248E-03 0.0129118 1.248E-03 0.02151966 HADDAD_B_LYMPHOCYTE_PROGENITOR pituitary adenoma DOID_3829 1.419E-03 0.0144216 1.419E-03 0.02375322 HADDAD_B_LYMPHOCYTE_PROGENITOR juvenile rheumatoid arthritis DOID_676 1.605E-03 0.01602088 1.605E-03 0.02609114 HADDAD_B_LYMPHOCYTE_PROGENITOR dental caries DOID_216 1.801E-03 0.0176721 1.801E-03 0.02847171 HADDAD_B_LYMPHOCYTE_PROGENITOR temporal lobe epilepsy DOID_3328 1.868E-03 0.01801058 0.0245882 0.20276354 HADDAD_B_LYMPHOCYTE_PROGENITOR granulosa cell tumor DOID_2999 2.009E-03 0.019049 2.009E-03 0.03007737 HADDAD_B_LYMPHOCYTE_PROGENITOR sex cord-gonadal stromal tumor DOID_192 2.227E-03 0.02077084 2.227E-03 0.03167553 HADDAD_B_LYMPHOCYTE_PROGENITOR funisitis DOID_0050698 2.695E-03 0.02473188 2.695E-03 0.03739943 HADDAD_B_LYMPHOCYTE_PROGENITOR sleep disorder DOID_535 2.945E-03 0.02659626 2.945E-03 0.0398944 HADDAD_B_LYMPHOCYTE_PROGENITOR metabolic syndrome X DOID_14221 3.054E-03 0.02715054 3.054E-03 0.0404101 HADDAD_B_LYMPHOCYTE_PROGENITOR chromosomal disease DOID_0080014 3.16E-03 0.02766486 3.16E-03 0.04086854 HADDAD_B_LYMPHOCYTE_PROGENITOR Lewy body dementia DOID_12217 3.205E-03 0.02763184 0.08090968 0.36250083 HADDAD_B_LYMPHOCYTE_PROGENITOR sphingolipidosis DOID_1927 3.476E-03 0.02951858 0.08413609 0.3740112 HADDAD_B_LYMPHOCYTE_PROGENITOR myositis DOID_633 4.048E-03 0.03387323 1.000 1.000 HADDAD_B_LYMPHOCYTE_PROGENITOR teeth hard tissue disease DOID_214 4.35E-03 0.03586793 4.35E-03 0.05265717 HADDAD_B_LYMPHOCYTE_PROGENITOR extrinsic allergic alveolitis DOID_841 4.35E-03 0.03535553 1.000 1.000 HADDAD_B_LYMPHOCYTE_PROGENITOR dilated cardiomyopathy DOID_12930 4.894E-03 0.03922166 0.04581281 0.27153637 HADDAD_B_LYMPHOCYTE_PROGENITOR ulcerative colitis DOID_8577 5.327E-03 0.04209603 5.327E-03 0.05942968 HADDAD_B_LYMPHOCYTE_PROGENITOR female reproductive organ benign neoplasm DOID_0060086 5.655E-03 0.04408041 5.655E-03 0.06188211 HADDAD_B_LYMPHOCYTE_PROGENITOR uterine benign neoplasm DOID_0060095 5.655E-03 0.04408041 5.655E-03 0.06188211 HADDAD_B_LYMPHOCYTE_PROGENITOR uterine fibroid DOID_13223 5.655E-03 0.04408041 5.655E-03 0.06188211 HADDAD_B_LYMPHOCYTE_PROGENITOR leiomyoma DOID_127 6.738E-03 0.05180746 6.738E-03 0.07233495 HADDAD_B_LYMPHOCYTE_PROGENITOR papilloma DOID_2615 7.118E-03 0.05399999 1.000 1.000 HADDAD_B_LYMPHOCYTE_PROGENITOR myocarditis DOID_820 7.118E-03 0.05328946 7.118E-03 0.07499999 HADDAD_B_LYMPHOCYTE_PROGENITOR thyroid carcinoma DOID_3963 7.507E-03 0.05547605 0.12198722 0.43112252 HADDAD_B_LYMPHOCYTE_PROGENITOR spindle cell carcinoma DOID_4015 7.507E-03 0.05476481 0.12198722 0.42846127 HADDAD_B_LYMPHOCYTE_PROGENITOR hyperthyroidism DOID_7998 7.507E-03 0.05407159 0.12198722 0.42323614 HADDAD_B_LYMPHOCYTE_PROGENITOR lymphoid leukemia DOID_10747 7.906E-03 0.05623351 7.906E-03 0.0817942 HADDAD_B_LYMPHOCYTE_PROGENITOR aplastic anemia DOID_12449 7.906E-03 0.05553927 0.12507049 0.43130367 HADDAD_B_LYMPHOCYTE_PROGENITOR thyroid cancer DOID_1781 8.315E-03 0.05769555 0.12814301 0.43660701 HADDAD_B_LYMPHOCYTE_PROGENITOR adenoma DOID_657 8.315E-03 0.05700043 0.12814301 0.43400816 HADDAD_B_LYMPHOCYTE_PROGENITOR microcephaly DOID_10907 9.159E-03 0.06204255 9.159E-03 0.09143113 HADDAD_B_LYMPHOCYTE_PROGENITOR lymphatic system disease DOID_75 0.01004035 0.06721128 0.01004035 0.09849928 HADDAD_B_LYMPHOCYTE_PROGENITOR nephrotic syndrome DOID_1184 0.01142959 0.07562138 0.14935287 0.47475858 HADDAD_B_LYMPHOCYTE_PROGENITOR cerebral infarction DOID_3526 0.01239997 0.08109863 0.15531822 0.47514014 HADDAD_B_LYMPHOCYTE_PROGENITOR leukodystrophy DOID_10579 0.01289822 0.08339869 0.1582853 0.47906562 HADDAD_B_LYMPHOCYTE_PROGENITOR brain cancer DOID_1319 0.01340509 0.08570217 0.16124204 0.4778475 HADDAD_B_LYMPHOCYTE_PROGENITOR vascular skin disease DOID_9540 0.01340509 0.08474993 0.16124204 0.470496 HADDAD_B_LYMPHOCYTE_PROGENITOR central nervous system cancer DOID_3620 0.01392051 0.08704143 0.16418847 0.47664918 HADDAD_B_LYMPHOCYTE_PROGENITOR lung small cell carcinoma DOID_5409 0.01444442 0.08933562 0.01444442 0.13256253 HADDAD_B_LYMPHOCYTE_PROGENITOR orofacial cleft DOID_0050567 0.01606645 0.09829905 0.01606645 0.14510812 PENG_RAPAMYCIN_RESPONSE_UP lymphoma DOID_0060058 1.755E-12 9.983E-10 3.387E-09 1.927E-06 PENG_RAPAMYCIN_RESPONSE_UP B-cell lymphocytic neoplasm DOID_707 4.07E-09 1.158E-06 2.17E-07 6.175E-05 PENG_RAPAMYCIN_RESPONSE_UP myasthenia gravis DOID_437 2.775E-07 5.264E-05 2.364E-05 1.223E-03 PENG_RAPAMYCIN_RESPONSE_UP neuroectodermal tumor DOID_171 5.134E-07 7.303E-05 5.134E-07 9.737E-05 PENG_RAPAMYCIN_RESPONSE_UP neuromuscular junction disease DOID_439 5.46E-07 6.213E-05 3.878E-05 1.697E-03 PENG_RAPAMYCIN_RESPONSE_UP diffuse large B-cell lymphoma DOID_0050745 7.362E-07 6.981E-05 7.362E-07 1.047E-04 PENG_RAPAMYCIN_RESPONSE_UP autoimmune disease of the nervous system DOID_438 8.479E-07 6.892E-05 5.354E-05 1.904E-03 PENG_RAPAMYCIN_RESPONSE_UP chronic leukemia DOID_1036 1.605E-06 1.142E-04 3.29E-03 0.03284191 PENG_RAPAMYCIN_RESPONSE_UP chronic lymphocytic leukemia DOID_1040 1.605E-06 1.142E-04 3.29E-03 0.03284191 PENG_RAPAMYCIN_RESPONSE_UP medullomyoblastoma DOID_3861 2.25E-06 1.423E-04 2.25E-06 2.561E-04 PENG_RAPAMYCIN_RESPONSE_UP adult medulloblastoma DOID_3864 2.25E-06 1.423E-04 2.25E-06 2.561E-04 PENG_RAPAMYCIN_RESPONSE_UP childhood medulloblastoma DOID_3869 2.25E-06 1.423E-04 2.25E-06 2.561E-04 PENG_RAPAMYCIN_RESPONSE_UP primary bacterial infectious disease DOID_0050338 2.664E-06 1.516E-04 2.664E-06 2.527E-04 PENG_RAPAMYCIN_RESPONSE_UP medulloblastoma DOID_3858 2.775E-06 1.436E-04 2.775E-06 2.256E-04 PENG_RAPAMYCIN_RESPONSE_UP primary immunodeficiency disease DOID_612 2.974E-06 1.41E-04 2.974E-06 2.115E-04 PENG_RAPAMYCIN_RESPONSE_UP lymphoblastic leukemia DOID_1037 3.677E-06 1.609E-04 1.629E-03 0.02206759 PENG_RAPAMYCIN_RESPONSE_UP primitive neuroectodermal tumor DOID_168 4.901E-06 1.992E-04 4.901E-06 3.098E-04 PENG_RAPAMYCIN_RESPONSE_UP neurotic disorder DOID_4964 1.733E-05 6.576E-04 1.733E-05 9.863E-04 PENG_RAPAMYCIN_RESPONSE_UP carotid artery disease DOID_3407 1.846E-05 6.563E-04 5.176E-04 0.01015625 PENG_RAPAMYCIN_RESPONSE_UP tuberculosis DOID_399 2.786E-05 9.325E-04 2.786E-05 1.321E-03 PENG_RAPAMYCIN_RESPONSE_UP astrocytoma DOID_3069 2.944E-05 9.308E-04 7.307E-04 0.0122277 PENG_RAPAMYCIN_RESPONSE_UP pancreatic carcinoma DOID_4905 3.645E-05 1.092E-03 8.552E-04 0.01351756 PENG_RAPAMYCIN_RESPONSE_UP B cell deficiency DOID_2115 4.336E-05 1.233E-03 4.336E-05 1.762E-03 PENG_RAPAMYCIN_RESPONSE_UP bacterial pneumonia DOID_874 4.46E-05 1.208E-03 4.46E-05 1.692E-03 PENG_RAPAMYCIN_RESPONSE_UP amino acid metabolic disorder DOID_9252 7.385E-05 1.91E-03 7.385E-05 2.472E-03 PENG_RAPAMYCIN_RESPONSE_UP autonomic nervous system neoplasm DOID_2621 8.556E-05 2.117E-03 3.29E-03 0.03172862 PENG_RAPAMYCIN_RESPONSE_UP neuroblastoma DOID_769 8.556E-05 2.117E-03 3.29E-03 0.03172862 PENG_RAPAMYCIN_RESPONSE_UP encephalomyelitis DOID_640 8.732E-05 2.07E-03 1.629E-03 0.02155439 PENG_RAPAMYCIN_RESPONSE_UP hypersensitivity reaction type I disease DOID_1205 9.468E-05 2.155E-03 1.729E-03 0.02093253 PENG_RAPAMYCIN_RESPONSE_UP pneumoconiosis DOID_10316 1.012E-04 2.215E-03 1.012E-04 3.2E-03 PENG_RAPAMYCIN_RESPONSE_UP peripheral nervous system neoplasm DOID_1192 1.379E-04 2.906E-03 4.491E-03 0.03993181 PENG_RAPAMYCIN_RESPONSE_UP uveitis DOID_13141 1.379E-04 2.802E-03 4.491E-03 0.03931748 PENG_RAPAMYCIN_RESPONSE_UP cervix uteri carcinoma in situ DOID_8991 1.704E-04 3.344E-03 1.704E-04 5.103E-03 PENG_RAPAMYCIN_RESPONSE_UP uveal disease DOID_3480 1.946E-04 3.692E-03 5.625E-03 0.04507679 PENG_RAPAMYCIN_RESPONSE_UP neuritis DOID_1803 2.496E-04 4.581E-03 2.496E-04 7.1E-03 PENG_RAPAMYCIN_RESPONSE_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.588E-04 4.602E-03 2.588E-04 7.013E-03 PENG_RAPAMYCIN_RESPONSE_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.588E-04 4.602E-03 2.588E-04 7.013E-03 PENG_RAPAMYCIN_RESPONSE_UP Hodgkin's granuloma DOID_8651 2.588E-04 4.602E-03 2.588E-04 7.013E-03 PENG_RAPAMYCIN_RESPONSE_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 2.588E-04 4.602E-03 2.588E-04 7.013E-03 PENG_RAPAMYCIN_RESPONSE_UP integumentary system benign neoplasm DOID_0060121 2.804E-04 4.835E-03 7.139E-03 0.05275102 PENG_RAPAMYCIN_RESPONSE_UP pulmonary tuberculosis DOID_2957 2.804E-04 4.693E-03 2.804E-04 7.252E-03 PENG_RAPAMYCIN_RESPONSE_UP skin benign neoplasm DOID_3165 2.804E-04 4.835E-03 7.139E-03 0.05275102 PENG_RAPAMYCIN_RESPONSE_UP sarcoidosis DOID_11335 3.493E-04 5.678E-03 3.493E-04 8.64E-03 PENG_RAPAMYCIN_RESPONSE_UP giant cell tumor DOID_200 3.493E-04 5.52E-03 3.493E-04 8.28E-03 PENG_RAPAMYCIN_RESPONSE_UP malignant giant cell tumor DOID_2705 3.493E-04 5.52E-03 3.493E-04 8.28E-03 PENG_RAPAMYCIN_RESPONSE_UP giant cell glioblastoma DOID_3074 3.493E-04 5.52E-03 3.493E-04 8.28E-03 PENG_RAPAMYCIN_RESPONSE_UP Hodgkin's lymphoma DOID_8567 3.784E-04 5.82E-03 3.784E-04 8.613E-03 PENG_RAPAMYCIN_RESPONSE_UP reproductive organ benign neoplasm DOID_0050622 3.874E-04 5.801E-03 8.816E-03 0.0634944 PENG_RAPAMYCIN_RESPONSE_UP pustulosis of palm and sole DOID_4398 3.874E-04 5.652E-03 0.13153495 0.40238381 PENG_RAPAMYCIN_RESPONSE_UP hypersensitivity reaction type IV disease DOID_2916 4.495E-04 6.394E-03 4.495E-04 9.837E-03 PENG_RAPAMYCIN_RESPONSE_UP glioblastoma DOID_3068 4.495E-04 6.238E-03 4.495E-04 9.473E-03 PENG_RAPAMYCIN_RESPONSE_UP melancholia DOID_2848 4.715E-04 6.388E-03 4.715E-04 9.582E-03 PENG_RAPAMYCIN_RESPONSE_UP Legionnaires' disease DOID_10457 5.201E-04 6.883E-03 5.201E-04 9.865E-03 PENG_RAPAMYCIN_RESPONSE_UP legionellosis DOID_10458 5.201E-04 6.883E-03 5.201E-04 9.865E-03 PENG_RAPAMYCIN_RESPONSE_UP respiratory failure DOID_11162 5.417E-04 7.006E-03 5.417E-04 9.943E-03 PENG_RAPAMYCIN_RESPONSE_UP pre-malignant neoplasm DOID_0060071 5.665E-04 7.163E-03 5.665E-04 0.0100736 PENG_RAPAMYCIN_RESPONSE_UP in situ carcinoma DOID_8719 5.665E-04 7.163E-03 5.665E-04 0.0100736 PENG_RAPAMYCIN_RESPONSE_UP hyperglycemia DOID_4195 6.453E-04 7.982E-03 0.01229764 0.08533363 PENG_RAPAMYCIN_RESPONSE_UP angiosarcoma DOID_0001816 6.837E-04 8.277E-03 0.03813644 0.19203218 PENG_RAPAMYCIN_RESPONSE_UP silicosis DOID_10325 6.837E-04 8.105E-03 6.837E-04 0.01178881 PENG_RAPAMYCIN_RESPONSE_UP brain infarction DOID_3454 7.014E-04 8.145E-03 0.01298558 0.0890216 PENG_RAPAMYCIN_RESPONSE_UP pancreatic ductal carcinoma DOID_3587 7.606E-04 8.656E-03 7.606E-04 0.01236574 PENG_RAPAMYCIN_RESPONSE_UP male reproductive organ benign neoplasm DOID_0060087 8.69E-04 9.695E-03 0.04280119 0.20994719 PENG_RAPAMYCIN_RESPONSE_UP endogenous depression DOID_1595 9.223E-04 0.01009184 9.223E-04 0.01418312 PENG_RAPAMYCIN_RESPONSE_UP syndrome DOID_225 9.223E-04 9.901E-03 0.01552164 0.1026955 PENG_RAPAMYCIN_RESPONSE_UP agammaglobulinemia DOID_2583 9.697E-04 0.01021755 9.697E-04 0.01451968 PENG_RAPAMYCIN_RESPONSE_UP mixed glioma DOID_5076 9.926E-04 0.01026844 0.01628218 0.10527911 PENG_RAPAMYCIN_RESPONSE_UP blood protein disease DOID_620 1.076E-03 0.0109301 1.076E-03 0.01569451 PENG_RAPAMYCIN_RESPONSE_UP mental depression DOID_1596 1.183E-03 0.01180755 1.183E-03 0.01682575 PENG_RAPAMYCIN_RESPONSE_UP muscular atrophy DOID_767 1.304E-03 0.01279003 1.304E-03 0.01809321 PENG_RAPAMYCIN_RESPONSE_UP nervous system cancer DOID_3093 1.486E-03 0.01432733 0.02116874 0.1323628 PENG_RAPAMYCIN_RESPONSE_UP Human immunodeficiency virus infectious disease DOID_526 1.486E-03 0.01408854 0.02116874 0.13092407 PENG_RAPAMYCIN_RESPONSE_UP Crohn's disease DOID_8778 1.679E-03 0.01565684 1.679E-03 0.02170608 PENG_RAPAMYCIN_RESPONSE_UP spastic quadriplegia DOID_10970 1.685E-03 0.0154654 1.685E-03 0.02130788 PENG_RAPAMYCIN_RESPONSE_UP severe combined immunodeficiency DOID_627 1.685E-03 0.01521991 1.685E-03 0.02084467 PENG_RAPAMYCIN_RESPONSE_UP bronchiolitis DOID_2942 1.823E-03 0.01620503 1.823E-03 0.02160671 PENG_RAPAMYCIN_RESPONSE_UP combined T cell and B cell immunodeficiency DOID_628 1.823E-03 0.01595572 1.823E-03 0.02116575 PENG_RAPAMYCIN_RESPONSE_UP spinal cord disease DOID_319 2.113E-03 0.018219 2.113E-03 0.02404908 PENG_RAPAMYCIN_RESPONSE_UP Sciatic Neuropathy DOID_11446 2.266E-03 0.01924612 2.266E-03 0.02528412 PENG_RAPAMYCIN_RESPONSE_UP lesion of sciatic nerve DOID_12528 2.266E-03 0.01924612 2.266E-03 0.02528412 PENG_RAPAMYCIN_RESPONSE_UP perinatal necrotizing enterocolitis DOID_8677 2.266E-03 0.01896309 2.266E-03 0.02479788 PENG_RAPAMYCIN_RESPONSE_UP mononeuritis of lower limb DOID_9473 2.266E-03 0.01924612 2.266E-03 0.02528412 PENG_RAPAMYCIN_RESPONSE_UP sarcoma DOID_1115 2.424E-03 0.0199916 0.0703234 0.2778751 PENG_RAPAMYCIN_RESPONSE_UP mononeuritis DOID_1802 2.424E-03 0.019706 2.424E-03 0.0260268 PENG_RAPAMYCIN_RESPONSE_UP mononeuropathy DOID_1188 2.587E-03 0.02073564 2.587E-03 0.02726353 PENG_RAPAMYCIN_RESPONSE_UP spastic cerebral palsy DOID_0050669 2.929E-03 0.02314492 2.929E-03 0.03029881 PENG_RAPAMYCIN_RESPONSE_UP opportunistic mycosis DOID_2473 2.929E-03 0.02282787 2.929E-03 0.02975776 PENG_RAPAMYCIN_RESPONSE_UP celiac disease DOID_10608 3.107E-03 0.02388919 0.07932237 0.3008962 PENG_RAPAMYCIN_RESPONSE_UP hereditary spastic paraplegia DOID_2476 3.29E-03 0.02495985 3.29E-03 0.03227567 PENG_RAPAMYCIN_RESPONSE_UP systemic mycosis DOID_0050136 3.478E-03 0.02603931 3.478E-03 0.03298312 PENG_RAPAMYCIN_RESPONSE_UP fungal infectious disease DOID_1564 3.478E-03 0.02603931 3.478E-03 0.03298312 PENG_RAPAMYCIN_RESPONSE_UP spindle cell carcinoma DOID_4015 3.671E-03 0.02712703 0.08601501 0.31173593 PENG_RAPAMYCIN_RESPONSE_UP esophageal disease DOID_6050 3.671E-03 0.02677925 0.08601501 0.30781472 PENG_RAPAMYCIN_RESPONSE_UP paraplegia DOID_607 3.671E-03 0.02644027 3.671E-03 0.03424232 PENG_RAPAMYCIN_RESPONSE_UP adenoma DOID_657 4.072E-03 0.02895876 0.09045001 0.3176917 PENG_RAPAMYCIN_RESPONSE_UP pulmonary sarcoidosis DOID_13406 4.279E-03 0.03005924 4.279E-03 0.03927094 PENG_RAPAMYCIN_RESPONSE_UP multiple myeloma DOID_9538 4.279E-03 0.02969266 4.279E-03 0.03864759 PENG_RAPAMYCIN_RESPONSE_UP hepatitis DOID_2237 4.709E-03 0.03227952 4.709E-03 0.04059395 PENG_RAPAMYCIN_RESPONSE_UP adult respiratory distress syndrome DOID_11394 4.931E-03 0.03339855 4.931E-03 0.0418728 PENG_RAPAMYCIN_RESPONSE_UP endometriosis of uterus DOID_288 5.389E-03 0.03607197 5.389E-03 0.04508996 PENG_RAPAMYCIN_RESPONSE_UP hyperinsulinism DOID_2018 5.625E-03 0.03721456 5.625E-03 0.04638336 PENG_RAPAMYCIN_RESPONSE_UP endometriosis DOID_289 5.625E-03 0.0367868 5.625E-03 0.04572074 PENG_RAPAMYCIN_RESPONSE_UP diabetic autonomic neuropathy DOID_11503 5.865E-03 0.03792552 5.865E-03 0.04635341 PENG_RAPAMYCIN_RESPONSE_UP autonomic neuropathy DOID_11504 5.865E-03 0.03792552 5.865E-03 0.04635341 PENG_RAPAMYCIN_RESPONSE_UP diabetic polyneuropathy DOID_12785 5.865E-03 0.03792552 5.865E-03 0.04635341 PENG_RAPAMYCIN_RESPONSE_UP influenza DOID_8469 5.865E-03 0.03749939 5.865E-03 0.04571843 PENG_RAPAMYCIN_RESPONSE_UP diabetic neuropathy DOID_9743 5.865E-03 0.03792552 5.865E-03 0.04635341 PENG_RAPAMYCIN_RESPONSE_UP myeloma DOID_0070004 6.616E-03 0.04182495 6.616E-03 0.05086818 PENG_RAPAMYCIN_RESPONSE_UP autonomic nervous system disease DOID_11465 6.616E-03 0.04136534 6.616E-03 0.05018994 PENG_RAPAMYCIN_RESPONSE_UP vascular skin disease DOID_9540 6.616E-03 0.04091571 6.616E-03 0.04952955 PENG_RAPAMYCIN_RESPONSE_UP autoimmune disease of gastrointestinal tract DOID_0060031 7.139E-03 0.04367557 0.11876312 0.38178653 PENG_RAPAMYCIN_RESPONSE_UP hemorrhagic disease DOID_2213 7.68E-03 0.04648647 0.12304091 0.38679711 PENG_RAPAMYCIN_RESPONSE_UP bile duct adenocarcinoma DOID_4896 8.525E-03 0.05105991 0.1294191 0.40240147 PENG_RAPAMYCIN_RESPONSE_UP cholangiocarcinoma DOID_4947 8.525E-03 0.05105991 0.1294191 0.40240147 PENG_RAPAMYCIN_RESPONSE_UP bone marrow cancer DOID_4960 8.525E-03 0.05052804 8.525E-03 0.06218835 PENG_RAPAMYCIN_RESPONSE_UP integumentary system cancer DOID_0060122 8.816E-03 0.05171194 0.13153495 0.40675755 PENG_RAPAMYCIN_RESPONSE_UP skin cancer DOID_4159 8.816E-03 0.05171194 0.13153495 0.40675755 PENG_RAPAMYCIN_RESPONSE_UP hypertrophic cardiomyopathy DOID_11984 9.714E-03 0.0563991 0.13785204 0.41283058 PENG_RAPAMYCIN_RESPONSE_UP bile duct cancer DOID_4606 9.714E-03 0.05582942 0.13785204 0.41066916 PENG_RAPAMYCIN_RESPONSE_UP bile duct carcinoma DOID_4897 9.714E-03 0.05582942 0.13785204 0.41066916 PENG_RAPAMYCIN_RESPONSE_UP oral cavity cancer DOID_8618 9.714E-03 0.05527112 0.13785204 0.40853026 PENG_RAPAMYCIN_RESPONSE_UP leukocyte disease DOID_9500 0.0100218 0.05645947 0.13994761 0.41259167 PENG_RAPAMYCIN_RESPONSE_UP endocrine pancreas disease DOID_1428 0.01162631 0.0648566 0.01162631 0.08269216 PENG_RAPAMYCIN_RESPONSE_UP uterine disease DOID_345 0.01195989 0.06606969 0.01195989 0.08401455 PENG_RAPAMYCIN_RESPONSE_UP blood coagulation disease DOID_1247 0.01368994 0.07489979 0.16266906 0.46746815 PENG_RAPAMYCIN_RESPONSE_UP peripheral vascular disease DOID_341 0.01441057 0.07809159 0.01441057 0.09761449 PENG_RAPAMYCIN_RESPONSE_UP cystic fibrosis DOID_1485 0.01552164 0.08331899 0.01552164 0.10390368 PENG_RAPAMYCIN_RESPONSE_UP aneurysm disease DOID_2403 0.01589994 0.08455203 0.17481125 0.48998819 PENG_RAPAMYCIN_RESPONSE_UP pancreatitis DOID_4989 0.01628218 0.08578298 0.01628218 0.10648922 PENG_RAPAMYCIN_RESPONSE_UP lipid metabolism disorder DOID_3146 0.0170584 0.08904796 0.0170584 0.10905873 PENG_RAPAMYCIN_RESPONSE_UP female reproductive system disease DOID_229 0.01745233 0.09027613 0.01745233 0.11033749 PENG_RAPAMYCIN_RESPONSE_UP biliary tract cancer DOID_4607 0.01825173 0.09356069 0.18677926 0.51341739 HOSHIDA_LIVER_CANCER_SURVIVAL_DN thrombophilia DOID_2452 8.052E-08 4.581E-05 8.052E-08 4.581E-05 HOSHIDA_LIVER_CANCER_SURVIVAL_DN blood coagulation disease DOID_1247 2.716E-07 7.727E-05 2.716E-07 7.727E-05 HOSHIDA_LIVER_CANCER_SURVIVAL_DN chronic kidney failure DOID_784 5.829E-07 1.105E-04 0.01116809 0.28884729 HOSHIDA_LIVER_CANCER_SURVIVAL_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.294E-05 4.685E-03 0.01407808 0.32041718 HOSHIDA_LIVER_CANCER_SURVIVAL_DN Crohn's disease DOID_8778 3.294E-05 3.748E-03 7.938E-04 0.06452523 HOSHIDA_LIVER_CANCER_SURVIVAL_DN Charcot-Marie-Tooth disease DOID_10595 3.613E-05 3.426E-03 1.866E-03 0.13273437 HOSHIDA_LIVER_CANCER_SURVIVAL_DN hyperinsulinism DOID_2018 9.018E-05 7.33E-03 3.393E-03 0.17553433 HOSHIDA_LIVER_CANCER_SURVIVAL_DN diabetic autonomic neuropathy DOID_11503 9.62E-05 6.842E-03 3.54E-03 0.16785514 HOSHIDA_LIVER_CANCER_SURVIVAL_DN autonomic neuropathy DOID_11504 9.62E-05 6.842E-03 3.54E-03 0.16785514 HOSHIDA_LIVER_CANCER_SURVIVAL_DN diabetic polyneuropathy DOID_12785 9.62E-05 6.842E-03 3.54E-03 0.16785514 HOSHIDA_LIVER_CANCER_SURVIVAL_DN diabetic neuropathy DOID_9743 9.62E-05 6.842E-03 3.54E-03 0.16785514 HOSHIDA_LIVER_CANCER_SURVIVAL_DN autonomic nervous system disease DOID_11465 1.158E-04 7.322E-03 3.997E-03 0.1749487 HOSHIDA_LIVER_CANCER_SURVIVAL_DN intracranial arteriosclerosis DOID_13097 2.255E-04 0.01282991 1.000 1.000 HOSHIDA_LIVER_CANCER_SURVIVAL_DN porphyria DOID_13268 2.255E-04 0.01166356 2.255E-04 0.04276637 HOSHIDA_LIVER_CANCER_SURVIVAL_DN osteopetrosis DOID_13533 2.255E-04 0.01069159 2.255E-04 0.03207478 HOSHIDA_LIVER_CANCER_SURVIVAL_DN vascular dementia DOID_8725 2.255E-04 0.01282991 1.000 1.000 HOSHIDA_LIVER_CANCER_SURVIVAL_DN carotid artery disease DOID_3407 2.416E-04 0.01057506 1.000 1.000 HOSHIDA_LIVER_CANCER_SURVIVAL_DN endocrine pancreas disease DOID_1428 2.767E-04 0.01124532 7.068E-03 0.25135618 HOSHIDA_LIVER_CANCER_SURVIVAL_DN cholestasis DOID_13580 2.891E-04 0.01096534 7.273E-03 0.24344613 HOSHIDA_LIVER_CANCER_SURVIVAL_DN bile duct disease DOID_4138 3.709E-04 0.0131905 8.562E-03 0.25640957 HOSHIDA_LIVER_CANCER_SURVIVAL_DN biliary tract disease DOID_9741 3.858E-04 0.01291455 8.786E-03 0.24996202 HOSHIDA_LIVER_CANCER_SURVIVAL_DN lipid metabolism disorder DOID_3146 5.013E-04 0.01584738 0.01042663 0.28251211 HOSHIDA_LIVER_CANCER_SURVIVAL_DN inherited blood coagulation disease DOID_2214 5.189E-04 0.01554028 5.189E-04 0.05905308 HOSHIDA_LIVER_CANCER_SURVIVAL_DN osteosclerosis DOID_4254 5.189E-04 0.01476327 5.189E-04 0.0492109 HOSHIDA_LIVER_CANCER_SURVIVAL_DN testicular cancer DOID_2998 5.793E-04 0.01569538 0.03499806 0.43291079 HOSHIDA_LIVER_CANCER_SURVIVAL_DN primary immunodeficiency disease DOID_612 6.795E-04 0.01757361 0.01271853 0.31464535 HOSHIDA_LIVER_CANCER_SURVIVAL_DN familial hypercholesterolemia DOID_13810 7.797E-04 0.01928861 0.04041255 0.43386306 HOSHIDA_LIVER_CANCER_SURVIVAL_DN muscular atrophy DOID_767 7.797E-04 0.01848492 0.04041255 0.42582856 HOSHIDA_LIVER_CANCER_SURVIVAL_DN opiate dependence DOID_2559 8.529E-04 0.01941205 0.04221072 0.42136664 HOSHIDA_LIVER_CANCER_SURVIVAL_DN ulcerative colitis DOID_8577 8.936E-04 0.01955553 0.01520904 0.33284397 HOSHIDA_LIVER_CANCER_SURVIVAL_DN meningitis DOID_9471 9.293E-04 0.0195844 0.04400556 0.41731941 HOSHIDA_LIVER_CANCER_SURVIVAL_DN papillary adenoma DOID_3172 1.178E-03 0.02392969 0.04937022 0.43893212 HOSHIDA_LIVER_CANCER_SURVIVAL_DN microcystic adenoma DOID_5403 1.178E-03 0.02392969 0.04937022 0.43893212 HOSHIDA_LIVER_CANCER_SURVIVAL_DN follicular adenoma DOID_6204 1.178E-03 0.02392969 0.04937022 0.43893212 HOSHIDA_LIVER_CANCER_SURVIVAL_DN spinal cord disease DOID_319 1.267E-03 0.0248517 0.05115184 0.4477753 HOSHIDA_LIVER_CANCER_SURVIVAL_DN celiac disease DOID_10608 1.866E-03 0.03539583 1.866E-03 0.1179861 HOSHIDA_LIVER_CANCER_SURVIVAL_DN papilloma DOID_2615 2.091E-03 0.0383742 0.06528675 0.48879156 HOSHIDA_LIVER_CANCER_SURVIVAL_DN medullomyoblastoma DOID_3861 2.327E-03 0.04138243 0.06878791 0.48321385 HOSHIDA_LIVER_CANCER_SURVIVAL_DN adult medulloblastoma DOID_3864 2.327E-03 0.04138243 0.06878791 0.48321385 HOSHIDA_LIVER_CANCER_SURVIVAL_DN childhood medulloblastoma DOID_3869 2.327E-03 0.04138243 0.06878791 0.48321385 HOSHIDA_LIVER_CANCER_SURVIVAL_DN adenoma DOID_657 2.45E-03 0.04224644 0.07053364 0.48943466 HOSHIDA_LIVER_CANCER_SURVIVAL_DN medulloblastoma DOID_3858 2.576E-03 0.04310989 0.07227615 0.48958485 HOSHIDA_LIVER_CANCER_SURVIVAL_DN hepatitis DOID_2237 2.837E-03 0.04611552 0.0757515 0.50119305 HOSHIDA_LIVER_CANCER_SURVIVAL_DN intracranial arterial disease DOID_13089 2.971E-03 0.04696483 1.000 1.000 HOSHIDA_LIVER_CANCER_SURVIVAL_DN cerebral arterial disease DOID_3527 2.971E-03 0.04696483 1.000 1.000 HOSHIDA_LIVER_CANCER_SURVIVAL_DN Huntington's disease DOID_12858 3.393E-03 0.05218588 3.393E-03 0.19308777 HOSHIDA_LIVER_CANCER_SURVIVAL_DN primitive neuroectodermal tumor DOID_168 3.393E-03 0.05081257 0.08266374 0.53449622 HOSHIDA_LIVER_CANCER_SURVIVAL_DN thyroid adenoma DOID_2891 3.997E-03 0.05831623 0.08952501 0.53620767 HOSHIDA_LIVER_CANCER_SURVIVAL_DN autoimmune disease of gastrointestinal tract DOID_0060031 4.316E-03 0.06139793 4.316E-03 0.17542265 HOSHIDA_LIVER_CANCER_SURVIVAL_DN glaucoma DOID_1686 4.316E-03 0.05990042 4.316E-03 0.16372781 HOSHIDA_LIVER_CANCER_SURVIVAL_DN movement disease DOID_480 4.48E-03 0.06069408 0.09463773 0.54947825 HOSHIDA_LIVER_CANCER_SURVIVAL_DN familial hyperlipidemia DOID_1168 5.523E-03 0.07307801 0.10477841 0.57882441 HOSHIDA_LIVER_CANCER_SURVIVAL_DN neuroectodermal tumor DOID_171 6.468E-03 0.08364255 0.11314336 0.60734504 HOSHIDA_LIVER_CANCER_SURVIVAL_DN hyperglycemia DOID_4195 7.482E-03 0.09459995 7.482E-03 0.23649989 HOSHIDA_LIVER_CANCER_SURVIVAL_DN endocrine organ benign neoplasm DOID_0060089 7.906E-03 0.097791 0.12472498 0.64516831 HOSHIDA_LIVER_CANCER_SURVIVAL_DN astrocytoma DOID_3069 8.122E-03 0.09832657 0.12636728 0.6477746 ZHANG_PROLIFERATING_VS_QUIESCENT alcohol-related neurodevelopmental disorder DOID_0050667 1.38E-13 7.85E-11 4.013E-06 1.142E-03 ZHANG_PROLIFERATING_VS_QUIESCENT sarcoma DOID_1115 1.821E-10 5.18E-08 5.027E-06 9.535E-04 ZHANG_PROLIFERATING_VS_QUIESCENT Human immunodeficiency virus infectious disease DOID_526 8.461E-10 1.605E-07 5.974E-08 3.399E-05 ZHANG_PROLIFERATING_VS_QUIESCENT transitional cell carcinoma DOID_2671 5.347E-08 7.607E-06 1.389E-04 8.781E-03 ZHANG_PROLIFERATING_VS_QUIESCENT nervous system cancer DOID_3093 5.974E-08 6.798E-06 0.09706263 0.37827832 ZHANG_PROLIFERATING_VS_QUIESCENT brain cancer DOID_1319 2.887E-07 2.738E-05 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT central nervous system cancer DOID_3620 3.13E-07 2.544E-05 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT angiosarcoma DOID_0001816 7.009E-07 4.985E-05 1.424E-04 8.101E-03 ZHANG_PROLIFERATING_VS_QUIESCENT Down syndrome DOID_14250 1.21E-06 7.65E-05 0.02084563 0.1976861 ZHANG_PROLIFERATING_VS_QUIESCENT testicular cancer DOID_2998 1.21E-06 6.885E-05 0.02084563 0.19444535 ZHANG_PROLIFERATING_VS_QUIESCENT pancreatitis DOID_4989 1.935E-06 1.001E-04 3.584E-03 0.07553973 ZHANG_PROLIFERATING_VS_QUIESCENT mixed glioma DOID_5076 1.935E-06 9.177E-05 0.0849443 0.34772161 ZHANG_PROLIFERATING_VS_QUIESCENT meningitis DOID_9471 2.518E-06 1.102E-04 0.02626044 0.20753044 ZHANG_PROLIFERATING_VS_QUIESCENT acute pancreatitis DOID_2913 2.859E-06 1.162E-04 0.02733989 0.21022159 ZHANG_PROLIFERATING_VS_QUIESCENT primary bacterial infectious disease DOID_0050338 2.966E-06 1.125E-04 4.414E-03 0.08102111 ZHANG_PROLIFERATING_VS_QUIESCENT lymphoma DOID_0060058 3.69E-06 1.312E-04 0.09906706 0.38346366 ZHANG_PROLIFERATING_VS_QUIESCENT spindle cell carcinoma DOID_4015 9.569E-06 3.203E-04 9.569E-06 1.361E-03 ZHANG_PROLIFERATING_VS_QUIESCENT calcinosis DOID_182 1.214E-05 3.837E-04 1.214E-05 1.381E-03 ZHANG_PROLIFERATING_VS_QUIESCENT embryonal cancer DOID_688 1.214E-05 3.635E-04 1.214E-05 1.151E-03 ZHANG_PROLIFERATING_VS_QUIESCENT multiple myeloma DOID_9538 1.214E-05 3.454E-04 9.099E-04 0.04706846 ZHANG_PROLIFERATING_VS_QUIESCENT pulmonary emphysema DOID_9675 1.622E-05 4.395E-04 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT myeloma DOID_0070004 2.39E-05 6.181E-04 1.419E-03 0.06728771 ZHANG_PROLIFERATING_VS_QUIESCENT pulmonary tuberculosis DOID_2957 2.69E-05 6.656E-04 1.534E-03 0.06234293 ZHANG_PROLIFERATING_VS_QUIESCENT calcium metabolism disease DOID_10575 2.85E-05 6.756E-04 2.85E-05 2.316E-03 ZHANG_PROLIFERATING_VS_QUIESCENT bile duct adenocarcinoma DOID_4896 3.548E-05 8.076E-04 1.84E-03 0.06157906 ZHANG_PROLIFERATING_VS_QUIESCENT cholangiocarcinoma DOID_4947 3.548E-05 8.076E-04 1.84E-03 0.06157906 ZHANG_PROLIFERATING_VS_QUIESCENT bone marrow cancer DOID_4960 3.548E-05 7.765E-04 1.84E-03 0.05815801 ZHANG_PROLIFERATING_VS_QUIESCENT bile duct cancer DOID_4606 4.351E-05 9.169E-04 2.104E-03 0.0598484 ZHANG_PROLIFERATING_VS_QUIESCENT bile duct carcinoma DOID_4897 4.351E-05 9.169E-04 2.104E-03 0.0598484 ZHANG_PROLIFERATING_VS_QUIESCENT oral cavity cancer DOID_8618 4.351E-05 8.842E-04 2.104E-03 0.05699848 ZHANG_PROLIFERATING_VS_QUIESCENT teratoma DOID_3307 5.361E-05 1.052E-03 0.01102481 0.1742533 ZHANG_PROLIFERATING_VS_QUIESCENT malignant teratoma DOID_5563 5.361E-05 1.052E-03 0.01102481 0.1742533 ZHANG_PROLIFERATING_VS_QUIESCENT mature teratoma DOID_5566 5.361E-05 1.052E-03 0.01102481 0.1742533 ZHANG_PROLIFERATING_VS_QUIESCENT pre-malignant neoplasm DOID_0060071 5.511E-05 1.045E-03 0.0706055 0.32139622 ZHANG_PROLIFERATING_VS_QUIESCENT in situ carcinoma DOID_8719 5.511E-05 1.045E-03 0.0706055 0.32139622 ZHANG_PROLIFERATING_VS_QUIESCENT mineral metabolism disease DOID_0050032 5.765E-05 1.058E-03 5.765E-05 4.1E-03 ZHANG_PROLIFERATING_VS_QUIESCENT cholestasis DOID_13580 6.026E-05 1.072E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT invasive lobular carcinoma DOID_3457 6.548E-05 1.129E-03 0.01212075 0.17683858 ZHANG_PROLIFERATING_VS_QUIESCENT tuberculosis DOID_399 6.857E-05 1.147E-03 2.837E-03 0.0672518 ZHANG_PROLIFERATING_VS_QUIESCENT astrocytoma DOID_3069 7.149E-05 1.162E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT bile duct disease DOID_4138 7.759E-05 1.226E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT peritonitis DOID_8283 7.852E-05 1.208E-03 0.01321549 0.17090036 ZHANG_PROLIFERATING_VS_QUIESCENT peripheral vascular disease DOID_341 8.076E-05 1.209E-03 0.07984826 0.33905717 ZHANG_PROLIFERATING_VS_QUIESCENT biliary tract disease DOID_9741 8.076E-05 1.178E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT diabetic retinopathy DOID_8947 8.401E-05 1.195E-03 0.08086968 0.33834447 ZHANG_PROLIFERATING_VS_QUIESCENT larynx cancer DOID_2596 9.274E-05 1.287E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT laryngeal benign neoplasm DOID_2598 9.274E-05 1.287E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT chromosomal disease DOID_0080014 1.092E-04 1.48E-03 0.08798868 0.35507488 ZHANG_PROLIFERATING_VS_QUIESCENT biliary tract cancer DOID_4607 1.172E-04 1.551E-03 4.035E-03 0.07917767 ZHANG_PROLIFERATING_VS_QUIESCENT chronic kidney failure DOID_784 1.172E-04 1.516E-03 4.035E-03 0.07653842 ZHANG_PROLIFERATING_VS_QUIESCENT mesenchymal cell neoplasm DOID_3350 1.247E-04 1.576E-03 0.01649264 0.18046749 ZHANG_PROLIFERATING_VS_QUIESCENT spindle cell sarcoma DOID_4235 1.247E-04 1.576E-03 0.01649264 0.18046749 ZHANG_PROLIFERATING_VS_QUIESCENT epithelioid sarcoma DOID_6193 1.247E-04 1.576E-03 0.01649264 0.18046749 ZHANG_PROLIFERATING_VS_QUIESCENT retinal vascular disease DOID_2462 1.256E-04 1.554E-03 0.09203248 0.36114815 ZHANG_PROLIFERATING_VS_QUIESCENT Barrett's esophagus DOID_9206 1.424E-04 1.724E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT urinary system benign neoplasm DOID_731 1.612E-04 1.911E-03 0.01867149 0.18638734 ZHANG_PROLIFERATING_VS_QUIESCENT dilated cardiomyopathy DOID_12930 1.734E-04 2.013E-03 5.219E-03 0.08998843 ZHANG_PROLIFERATING_VS_QUIESCENT prion disease DOID_649 1.813E-04 2.063E-03 0.01975915 0.19055859 ZHANG_PROLIFERATING_VS_QUIESCENT ulcerative colitis DOID_8577 1.897E-04 2.116E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT subependymal glioma DOID_4843 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT pilocytic astrocytoma DOID_4851 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT subependymal giant cell astrocytoma DOID_5077 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT fibrillary astrocytoma DOID_6726 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT juvenile pilocytic astrocytoma DOID_6811 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT childhood pilocytic astrocytoma DOID_6812 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT gemistocytic astrocytoma DOID_7005 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT childhood cerebral astrocytoma DOID_7007 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT protoplasmic astrocytoma DOID_7008 2.248E-04 2.46E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT benign glioma DOID_0060101 2.729E-04 2.93E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT hepatitis B DOID_2043 2.729E-04 2.876E-03 0.02409804 0.20775428 ZHANG_PROLIFERATING_VS_QUIESCENT benign ependymoma DOID_4844 2.729E-04 2.93E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT lingual-facial-buccal dyskinesia DOID_9854 2.987E-04 3.09E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT diabetic angiopathy DOID_11713 3.256E-04 3.308E-03 0.02626044 0.2165535 ZHANG_PROLIFERATING_VS_QUIESCENT osteosarcoma DOID_3347 3.829E-04 3.822E-03 0.02841817 0.20999921 ZHANG_PROLIFERATING_VS_QUIESCENT fragments of torsion dystonia DOID_531 4.447E-04 4.363E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT lung adenocarcinoma DOID_3910 4.773E-04 4.603E-03 0.03164602 0.22230349 ZHANG_PROLIFERATING_VS_QUIESCENT central nervous system hereditary degenerative disease DOID_481 5.11E-04 4.846E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT supratentorial cancer DOID_1659 5.459E-04 5.092E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT toxic encephalopathy DOID_3602 5.459E-04 5.01E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT cerebrum cancer DOID_368 5.459E-04 5.092E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT focal glomerulosclerosis DOID_3945 5.459E-04 4.93E-03 0.03379209 0.22357792 ZHANG_PROLIFERATING_VS_QUIESCENT dystonic disease DOID_544 5.459E-04 4.853E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT corneal disease DOID_10124 5.819E-04 5.094E-03 0.03486339 0.22801458 ZHANG_PROLIFERATING_VS_QUIESCENT papilloma DOID_2615 7.37E-04 6.354E-03 0.03913699 0.23690372 ZHANG_PROLIFERATING_VS_QUIESCENT esophageal disease DOID_6050 7.786E-04 6.612E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT hyperthyroidism DOID_7998 7.786E-04 6.515E-03 0.04020251 0.23342067 ZHANG_PROLIFERATING_VS_QUIESCENT peptic ulcer DOID_750 1.003E-03 8.271E-03 0.04551279 0.251425 ZHANG_PROLIFERATING_VS_QUIESCENT adenoid cystic carcinoma DOID_4866 1.051E-03 8.545E-03 0.04657139 0.25479927 ZHANG_PROLIFERATING_VS_QUIESCENT benign mesothelioma DOID_2645 1.1E-03 8.819E-03 0.04762886 0.25810305 ZHANG_PROLIFERATING_VS_QUIESCENT cervix uteri carcinoma in situ DOID_8991 1.1E-03 8.697E-03 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT salivary gland cancer DOID_8850 1.151E-03 8.97E-03 0.04868518 0.26133835 ZHANG_PROLIFERATING_VS_QUIESCENT cerebral infarction DOID_3526 1.309E-03 0.01006161 0.05184727 0.27065227 ZHANG_PROLIFERATING_VS_QUIESCENT proteinuria DOID_576 1.363E-03 0.01034264 0.05289902 0.27363221 ZHANG_PROLIFERATING_VS_QUIESCENT heart valve disease DOID_4079 1.419E-03 0.01062437 0.05394963 0.2669334 ZHANG_PROLIFERATING_VS_QUIESCENT hemolytic anemia DOID_583 1.476E-03 0.01090676 1.476E-03 0.06460158 ZHANG_PROLIFERATING_VS_QUIESCENT normocytic anemia DOID_720 1.476E-03 0.01090676 1.476E-03 0.06460158 ZHANG_PROLIFERATING_VS_QUIESCENT glaucoma DOID_1686 1.534E-03 0.01118976 0.05604744 0.27026267 ZHANG_PROLIFERATING_VS_QUIESCENT aortic aneurysm DOID_3627 1.593E-03 0.01147332 1.593E-03 0.06042617 ZHANG_PROLIFERATING_VS_QUIESCENT movement disease DOID_480 1.593E-03 0.01132991 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT hemorrhagic disease DOID_2213 1.653E-03 0.01161227 1.653E-03 0.05878713 ZHANG_PROLIFERATING_VS_QUIESCENT atopic dermatitis DOID_3310 1.714E-03 0.01189517 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT hypertrophic cardiomyopathy DOID_11984 2.104E-03 0.0144213 2.104E-03 0.06299832 ZHANG_PROLIFERATING_VS_QUIESCENT melancholia DOID_2848 2.172E-03 0.01471429 0.06646857 0.31256707 ZHANG_PROLIFERATING_VS_QUIESCENT neurotic disorder DOID_4964 2.242E-03 0.01500742 0.06750448 0.31483648 ZHANG_PROLIFERATING_VS_QUIESCENT carotid artery disease DOID_3407 2.313E-03 0.01530067 0.06853927 0.3170638 ZHANG_PROLIFERATING_VS_QUIESCENT parasitic infectious disease DOID_1398 2.606E-03 0.0170426 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT hyperglycemia DOID_4195 2.682E-03 0.01733973 2.682E-03 0.06935894 ZHANG_PROLIFERATING_VS_QUIESCENT endocrine organ benign neoplasm DOID_0060089 2.837E-03 0.01813532 2.837E-03 0.07017579 ZHANG_PROLIFERATING_VS_QUIESCENT brain infarction DOID_3454 2.837E-03 0.01793381 0.0757515 0.33155848 ZHANG_PROLIFERATING_VS_QUIESCENT blood coagulation disease DOID_1247 2.996E-03 0.01873115 2.996E-03 0.06818138 ZHANG_PROLIFERATING_VS_QUIESCENT pancreatic ductal carcinoma DOID_3587 2.996E-03 0.01852755 0.0778021 0.33793431 ZHANG_PROLIFERATING_VS_QUIESCENT nephrosis DOID_2527 3.077E-03 0.01882426 0.07882574 0.33978669 ZHANG_PROLIFERATING_VS_QUIESCENT male reproductive system disease DOID_48 3.077E-03 0.018624 0.07882574 0.33723191 ZHANG_PROLIFERATING_VS_QUIESCENT pancreatic carcinoma DOID_4905 3.242E-03 0.01941733 0.08086968 0.34085072 ZHANG_PROLIFERATING_VS_QUIESCENT cystic fibrosis DOID_1485 3.411E-03 0.02021828 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT endogenous depression DOID_1595 3.411E-03 0.02000984 0.0829092 0.34434549 ZHANG_PROLIFERATING_VS_QUIESCENT aneurysm disease DOID_2403 3.497E-03 0.02030588 3.497E-03 0.07653753 ZHANG_PROLIFERATING_VS_QUIESCENT metabolic syndrome X DOID_14221 3.762E-03 0.02162111 3.762E-03 0.07644605 ZHANG_PROLIFERATING_VS_QUIESCENT mental depression DOID_1596 4.035E-03 0.02296153 0.09001277 0.36068499 ZHANG_PROLIFERATING_VS_QUIESCENT lymphoblastic leukemia DOID_1037 5.012E-03 0.02823547 0.10006765 0.38471953 ZHANG_PROLIFERATING_VS_QUIESCENT encephalomyelitis DOID_640 5.012E-03 0.02795865 5.012E-03 0.0891182 ZHANG_PROLIFERATING_VS_QUIESCENT hypersensitivity reaction type I disease DOID_1205 5.219E-03 0.02883125 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT brachydactyly DOID_0050581 0.01102481 0.06031845 0.01102481 0.18450349 ZHANG_PROLIFERATING_VS_QUIESCENT interstitial nephritis DOID_1063 0.01102481 0.05974399 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT Diamond-Blackfan anemia DOID_1339 0.01102481 0.05918036 0.01102481 0.17923196 ZHANG_PROLIFERATING_VS_QUIESCENT hyperparathyroidism DOID_13543 0.01102481 0.05862728 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT transient cerebral ischemia DOID_224 0.01102481 0.05808443 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT lateral sclerosis DOID_230 0.01102481 0.05755155 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT acute kidney failure DOID_3021 0.01102481 0.05702835 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT labyrinthine disease DOID_4539 0.01102481 0.05651458 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT keratitis DOID_4677 0.01102481 0.05600999 0.01102481 0.16954375 ZHANG_PROLIFERATING_VS_QUIESCENT acute T cell leukemia DOID_5603 0.01102481 0.05551432 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01102481 0.05502736 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01102481 0.05502736 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT Hodgkin's granuloma DOID_8651 0.01102481 0.05502736 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01102481 0.05502736 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT cutaneous leishmaniasis DOID_9111 0.01102481 0.05454886 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT craniosynostosis DOID_2340 0.01212075 0.05945435 0.01212075 0.18149222 ZHANG_PROLIFERATING_VS_QUIESCENT inner ear disease DOID_2952 0.01212075 0.05894619 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT chronic monocytic leukemia DOID_8593 0.01212075 0.05844665 0.01212075 0.17241761 ZHANG_PROLIFERATING_VS_QUIESCENT pituitary cancer DOID_1785 0.01321549 0.06319005 0.01321549 0.18340526 ZHANG_PROLIFERATING_VS_QUIESCENT epidermolysis bullosa DOID_2730 0.01321549 0.06266347 0.01321549 0.17903847 ZHANG_PROLIFERATING_VS_QUIESCENT pituitary carcinoma DOID_4916 0.01321549 0.06319005 0.01321549 0.18340526 ZHANG_PROLIFERATING_VS_QUIESCENT retinal detachment DOID_5327 0.01321549 0.06214559 0.01321549 0.17487479 ZHANG_PROLIFERATING_VS_QUIESCENT aortic valve insufficiency DOID_57 0.01321549 0.0616362 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT Hodgkin's lymphoma DOID_8567 0.01321549 0.06113509 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT ocular hypertension DOID_9282 0.01321549 0.06064206 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT borderline glaucoma DOID_9283 0.01321549 0.06064206 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT encephalitis DOID_9588 0.01321549 0.06015693 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT Charcot-Marie-Tooth disease type 2 DOID_0050539 0.01430906 0.06461788 0.01430906 0.18093007 ZHANG_PROLIFERATING_VS_QUIESCENT parathyroid gland disease DOID_11201 0.01430906 0.06410908 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT obstructive hydrocephalus DOID_14159 0.01430906 0.06360823 0.01430906 0.17699681 ZHANG_PROLIFERATING_VS_QUIESCENT communicating hydrocephalus DOID_1573 0.01430906 0.06360823 0.01430906 0.17699681 ZHANG_PROLIFERATING_VS_QUIESCENT vesiculobullous skin disease DOID_2731 0.01430906 0.06311514 0.01430906 0.17323092 ZHANG_PROLIFERATING_VS_QUIESCENT intracranial thrombosis DOID_4193 0.01430906 0.06262964 0.01430906 0.16962194 ZHANG_PROLIFERATING_VS_QUIESCENT monocytic leukemia DOID_8527 0.01430906 0.06215155 0.01430906 0.16616027 ZHANG_PROLIFERATING_VS_QUIESCENT Legionnaires' disease DOID_10457 0.01540144 0.06638953 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT legionellosis DOID_10458 0.01540144 0.06638953 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT viral pneumonia DOID_10533 0.01540144 0.06589036 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT hydrocephalus DOID_10908 0.01540144 0.06539864 0.01540144 0.17526835 ZHANG_PROLIFERATING_VS_QUIESCENT rhabdomyosarcoma DOID_3247 0.01540144 0.0649142 0.01540144 0.17183172 ZHANG_PROLIFERATING_VS_QUIESCENT T-cell leukemia DOID_715 0.01540144 0.06443689 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT parasitic helminthiasis infectious disease DOID_883 0.01540144 0.06396655 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT bacterial meningitis DOID_9470 0.01540144 0.06350303 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT renovascular hypertension DOID_1591 0.01649264 0.06751302 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT hemangioma DOID_255 0.01649264 0.06703078 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT membranoproliferative glomerulonephritis DOID_2920 0.01649264 0.06655539 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT skeletal muscle cancer DOID_4043 0.01649264 0.06608669 0.01649264 0.17706244 ZHANG_PROLIFERATING_VS_QUIESCENT nutritional deficiency disease DOID_5113 0.01649264 0.06562454 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT intermediate coronary syndrome DOID_8805 0.01649264 0.06516881 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT intracranial hypertension DOID_9428 0.01649264 0.06471937 0.01649264 0.17378351 ZHANG_PROLIFERATING_VS_QUIESCENT spastic diplegia DOID_10965 0.01758265 0.06852417 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT pituitary adenoma DOID_3829 0.01758265 0.06805802 0.01758265 0.18190053 ZHANG_PROLIFERATING_VS_QUIESCENT restrictive cardiomyopathy DOID_397 0.01758265 0.06759817 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT chronic myeloid leukemia DOID_8552 0.01758265 0.06714449 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT tongue cancer DOID_8649 0.01758265 0.06669686 0.01758265 0.17865231 ZHANG_PROLIFERATING_VS_QUIESCENT drug-induced mental disorder DOID_1203 0.01867149 0.07035814 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT drug psychosis DOID_1742 0.01867149 0.07035814 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT bronchitis DOID_6132 0.01867149 0.06989525 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT substance-induced psychosis DOID_8646 0.01867149 0.07035814 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT male reproductive organ benign neoplasm DOID_0060087 0.01975915 0.07348338 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT inherited blood coagulation disease DOID_2214 0.01975915 0.07300621 0.01975915 0.19384409 ZHANG_PROLIFERATING_VS_QUIESCENT ureteral obstruction DOID_5199 0.01975915 0.07253521 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT granulosa cell tumor DOID_2999 0.02084563 0.07603312 0.02084563 0.19130913 ZHANG_PROLIFERATING_VS_QUIESCENT leishmaniasis DOID_9065 0.02084563 0.07554883 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT membranous glomerulonephritis DOID_10976 0.02193094 0.07897915 0.02193094 0.1980747 ZHANG_PROLIFERATING_VS_QUIESCENT esophagitis DOID_11963 0.02193094 0.07848243 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT colon carcinoma DOID_1520 0.02193094 0.07799191 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT sex cord-gonadal stromal tumor DOID_192 0.02193094 0.07750749 0.02193094 0.19497979 ZHANG_PROLIFERATING_VS_QUIESCENT gastric ulcer DOID_10808 0.02409804 0.08464063 0.02409804 0.2109505 ZHANG_PROLIFERATING_VS_QUIESCENT sinusitis DOID_0050127 0.02517982 0.08789767 0.02517982 0.2138406 ZHANG_PROLIFERATING_VS_QUIESCENT paranasal sinus disease DOID_1352 0.02517982 0.08789767 0.02517982 0.2138406 ZHANG_PROLIFERATING_VS_QUIESCENT optic nerve disease DOID_1891 0.02517982 0.08736171 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT muscle cancer DOID_4045 0.02517982 0.08683224 0.02517982 0.21069589 ZHANG_PROLIFERATING_VS_QUIESCENT urinary tract obstruction DOID_5200 0.02517982 0.08630916 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT pulmonary embolism DOID_9477 0.02517982 0.08579234 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT synostosis DOID_11971 0.02626044 0.08894162 0.02626044 0.21345988 ZHANG_PROLIFERATING_VS_QUIESCENT ureteral disease DOID_1426 0.02626044 0.08841534 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT congenital hemolytic anemia DOID_589 0.02626044 0.08789525 0.02626044 0.21045341 ZHANG_PROLIFERATING_VS_QUIESCENT aortic valve disease DOID_62 0.02626044 0.08738124 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT toxic shock syndrome DOID_14115 0.02733989 0.09044417 0.02733989 0.21310134 ZHANG_PROLIFERATING_VS_QUIESCENT commensal bacterial infectious disease DOID_0050339 0.02841817 0.09346786 0.02841817 0.21559919 ZHANG_PROLIFERATING_VS_QUIESCENT portal hypertension DOID_10762 0.02841817 0.09293069 0.02841817 0.21276236 ZHANG_PROLIFERATING_VS_QUIESCENT urticaria DOID_1555 0.02841817 0.09239965 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT spinal muscular atrophy DOID_12377 0.02949528 0.09535691 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT papillary adenoma DOID_3172 0.02949528 0.09481817 0.02949528 0.21516432 ZHANG_PROLIFERATING_VS_QUIESCENT microcystic adenoma DOID_5403 0.02949528 0.09481817 0.02949528 0.21516432 ZHANG_PROLIFERATING_VS_QUIESCENT follicular adenoma DOID_6204 0.02949528 0.09481817 0.02949528 0.21516432 ZHANG_PROLIFERATING_VS_QUIESCENT myositis DOID_633 0.02949528 0.09428549 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT congenital hypoplastic anemia DOID_1342 0.03057123 0.09717894 0.03057123 0.22019027 ZHANG_PROLIFERATING_VS_QUIESCENT middle cerebral artery infarction DOID_3525 0.03057123 0.09663906 1.000 1.000 ZHANG_PROLIFERATING_VS_QUIESCENT seminoma DOID_4440 0.03057123 0.09610514 0.03057123 0.21743789 ZHANG_PROLIFERATING_VS_QUIESCENT perinatal necrotizing enterocolitis DOID_8677 0.03164602 0.09893727 0.03164602 0.21959247 ZHANG_PROLIFERATING_VS_QUIESCENT hepatic vascular disease DOID_272 0.03271963 0.09955868 0.03271963 0.22163657 ZHANG_PROLIFERATING_VS_QUIESCENT coronary stenosis DOID_4248 0.03271963 0.09902911 0.03271963 0.21902909 ZHU_CMV_ALL_DN aneurysm disease DOID_2403 1.41E-14 8.024E-12 1.253E-03 0.03752507 ZHU_CMV_ALL_DN uterine disease DOID_345 1.239E-11 3.526E-09 8.111E-04 0.03550149 ZHU_CMV_ALL_DN female reproductive system disease DOID_229 6.399E-11 1.214E-08 1.445E-03 0.0411024 ZHU_CMV_ALL_DN aortic aneurysm DOID_3627 1.075E-10 1.529E-08 8.864E-03 0.14010672 ZHU_CMV_ALL_DN Ehlers-Danlos syndrome DOID_13359 3.57E-10 4.062E-08 0.03923241 0.31004504 ZHU_CMV_ALL_DN collagen disease DOID_854 4.23E-10 4.011E-08 0.15707251 0.55169295 ZHU_CMV_ALL_DN dilated cardiomyopathy DOID_12930 8.142E-09 6.618E-07 1.359E-04 0.01933779 ZHU_CMV_ALL_DN abdominal aortic aneurysm DOID_7693 2.716E-08 1.932E-06 1.000 1.000 ZHU_CMV_ALL_DN diabetic retinopathy DOID_8947 5.783E-08 3.656E-06 1.12E-03 0.03749973 ZHU_CMV_ALL_DN oral submucous fibrosis DOID_5773 6.332E-08 3.603E-06 1.000 1.000 ZHU_CMV_ALL_DN bone resorption disease DOID_0080011 7.306E-08 3.779E-06 1.253E-03 0.03960979 ZHU_CMV_ALL_DN osteoporosis DOID_11476 7.306E-08 3.779E-06 1.253E-03 0.03960979 ZHU_CMV_ALL_DN retinal vascular disease DOID_2462 1.305E-07 6.186E-06 1.654E-03 0.04277532 ZHU_CMV_ALL_DN endometriosis of uterus DOID_288 1.363E-07 5.967E-06 2.401E-04 0.02276761 ZHU_CMV_ALL_DN endometriosis DOID_289 1.526E-07 6.203E-06 2.563E-04 0.01823178 ZHU_CMV_ALL_DN heart valve disease DOID_4079 2.339E-07 8.873E-06 1.000 1.000 ZHU_CMV_ALL_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.349E-07 8.355E-06 0.02724562 0.2719782 ZHU_CMV_ALL_DN mouth disease DOID_403 2.349E-07 7.863E-06 0.02724562 0.26728892 ZHU_CMV_ALL_DN hypersensitivity reaction type I disease DOID_1205 2.499E-07 7.899E-06 6.444E-06 3.667E-03 ZHU_CMV_ALL_DN atrophic muscular disease DOID_913 4.164E-07 1.247E-05 4.591E-04 0.02902775 ZHU_CMV_ALL_DN muscular dystrophy DOID_9884 4.164E-07 1.247E-05 4.591E-04 0.02902775 ZHU_CMV_ALL_DN aortic valve disease DOID_62 4.839E-07 1.377E-05 1.000 1.000 ZHU_CMV_ALL_DN reproductive organ benign neoplasm DOID_0050622 4.974E-07 1.348E-05 0.14345 0.52322467 ZHU_CMV_ALL_DN osteochondrodysplasia DOID_2256 4.974E-07 1.287E-05 0.01054215 0.15785486 ZHU_CMV_ALL_DN mineral metabolism disease DOID_0050032 1.029E-06 2.545E-05 0.01388406 0.17954613 ZHU_CMV_ALL_DN endocrine organ benign neoplasm DOID_0060089 1.375E-06 3.26E-05 0.01549771 0.19595996 ZHU_CMV_ALL_DN blood coagulation disease DOID_1247 1.58E-06 3.596E-05 9.97E-04 0.03545463 ZHU_CMV_ALL_DN chronic kidney failure DOID_784 3.364E-06 7.362E-05 0.20308363 0.63144581 ZHU_CMV_ALL_DN bone development disease DOID_0080006 3.564E-06 7.511E-05 0.02221525 0.24308614 ZHU_CMV_ALL_DN adenoma DOID_657 3.633E-06 7.382E-05 4.883E-03 0.09262146 ZHU_CMV_ALL_DN aortic valve insufficiency DOID_57 3.968E-06 7.785E-05 1.000 1.000 ZHU_CMV_ALL_DN transitional cell carcinoma DOID_2671 4.46E-06 8.459E-05 1.823E-03 0.04508811 ZHU_CMV_ALL_DN osteogenesis imperfecta DOID_12347 5.148E-06 9.449E-05 0.03409082 0.28951752 ZHU_CMV_ALL_DN adult respiratory distress syndrome DOID_11394 5.406E-06 9.613E-05 0.10843267 0.46741054 ZHU_CMV_ALL_DN adenoid cystic carcinoma DOID_4866 5.406E-06 9.321E-05 2.096E-04 0.0238531 ZHU_CMV_ALL_DN salivary gland cancer DOID_8850 6.5E-06 1.088E-04 2.401E-04 0.01951509 ZHU_CMV_ALL_DN nephrotic syndrome DOID_1184 7.105E-06 1.155E-04 0.11554771 0.48343122 ZHU_CMV_ALL_DN glaucoma DOID_1686 1.164E-05 1.84E-04 8.545E-03 0.13891109 ZHU_CMV_ALL_DN hemorrhagic disease DOID_2213 1.355E-05 2.083E-04 9.189E-03 0.14131919 ZHU_CMV_ALL_DN congenital nervous system abnormality DOID_2490 2.063E-05 3.089E-04 5.624E-04 0.03200305 ZHU_CMV_ALL_DN hypertrophic cardiomyopathy DOID_11984 2.203E-05 3.215E-04 0.01161083 0.16939902 ZHU_CMV_ALL_DN oral cavity cancer DOID_8618 2.203E-05 3.134E-04 5.904E-04 0.02799461 ZHU_CMV_ALL_DN placenta disease DOID_780 2.724E-05 3.78E-04 1.000 1.000 ZHU_CMV_ALL_DN respiratory failure DOID_11162 2.835E-05 3.841E-04 0.15932198 0.55616078 ZHU_CMV_ALL_DN pre-malignant neoplasm DOID_0060071 3.012E-05 3.986E-04 0.16156551 0.56055349 ZHU_CMV_ALL_DN in situ carcinoma DOID_8719 3.012E-05 3.986E-04 0.16156551 0.56055349 ZHU_CMV_ALL_DN endocrine pancreas disease DOID_1428 3.197E-05 4.134E-04 0.1638031 0.56487252 ZHU_CMV_ALL_DN brain infarction DOID_3454 4.02E-05 5.083E-04 0.01549771 0.19169996 ZHU_CMV_ALL_DN spastic quadriplegia DOID_10970 4.045E-05 5.003E-04 1.000 1.000 ZHU_CMV_ALL_DN toxic shock syndrome DOID_14115 4.045E-05 4.897E-04 1.000 1.000 ZHU_CMV_ALL_DN commensal bacterial infectious disease DOID_0050339 4.564E-05 5.41E-04 1.000 1.000 ZHU_CMV_ALL_DN nephrosis DOID_2527 4.731E-05 5.494E-04 0.1793016 0.5931547 ZHU_CMV_ALL_DN peripheral vascular disease DOID_341 4.988E-05 5.676E-04 4.988E-05 0.01418945 ZHU_CMV_ALL_DN gestational diabetes DOID_11714 6.376E-05 7.114E-04 0.07447267 0.43239745 ZHU_CMV_ALL_DN lung adenocarcinoma DOID_3910 6.376E-05 6.977E-04 2.722E-03 0.0573716 ZHU_CMV_ALL_DN metabolic syndrome X DOID_14221 7.075E-05 7.596E-04 0.19666614 0.63222052 ZHU_CMV_ALL_DN focal glomerulosclerosis DOID_3945 7.814E-05 8.233E-04 3.107E-03 0.06096554 ZHU_CMV_ALL_DN female reproductive organ benign neoplasm DOID_0060086 8.605E-05 8.903E-04 0.081856 0.42341874 ZHU_CMV_ALL_DN uterine benign neoplasm DOID_0060095 8.605E-05 8.903E-04 0.081856 0.42341874 ZHU_CMV_ALL_DN uterine fibroid DOID_13223 8.605E-05 8.903E-04 0.081856 0.42341874 ZHU_CMV_ALL_DN endometrial carcinoma DOID_2871 8.605E-05 8.744E-04 0.081856 0.41960416 ZHU_CMV_ALL_DN spastic cerebral palsy DOID_0050669 9.448E-05 9.431E-04 1.000 1.000 ZHU_CMV_ALL_DN endometrial cancer DOID_1380 1.034E-04 1.015E-03 0.08674578 0.42920305 ZHU_CMV_ALL_DN Human immunodeficiency virus infectious disease DOID_526 1.108E-04 1.068E-03 0.02518268 0.27035749 ZHU_CMV_ALL_DN leiomyoma DOID_127 1.129E-04 1.071E-03 0.089181 0.43744818 ZHU_CMV_ALL_DN papilloma DOID_2615 1.229E-04 1.147E-03 0.09160979 0.44174549 ZHU_CMV_ALL_DN encephalomyelitis DOID_640 1.254E-04 1.151E-03 0.02672365 0.27153139 ZHU_CMV_ALL_DN hyperthyroidism DOID_7998 1.335E-04 1.206E-03 1.335E-04 0.02532219 ZHU_CMV_ALL_DN ulcerative colitis DOID_8577 1.529E-04 1.359E-03 0.02937437 0.2740003 ZHU_CMV_ALL_DN calcinosis DOID_182 1.688E-04 1.477E-03 0.10126097 0.45013667 ZHU_CMV_ALL_DN multiple myeloma DOID_9538 1.688E-04 1.455E-03 0.10126097 0.44321149 ZHU_CMV_ALL_DN blood platelet disease DOID_2218 1.818E-04 1.544E-03 5.385E-03 0.09884726 ZHU_CMV_ALL_DN congenital diaphragmatic hernia DOID_3827 1.954E-04 1.635E-03 0.10604843 0.46062255 ZHU_CMV_ALL_DN cervix uteri carcinoma in situ DOID_8991 2.245E-04 1.851E-03 0.11081063 0.46704627 ZHU_CMV_ALL_DN autoimmune disease of urogenital tract DOID_0060049 2.401E-04 1.952E-03 1.000 1.000 ZHU_CMV_ALL_DN primary biliary cirrhosis DOID_12236 2.401E-04 1.952E-03 1.000 1.000 ZHU_CMV_ALL_DN rheumatic disease DOID_1575 2.563E-04 2.054E-03 1.000 1.000 ZHU_CMV_ALL_DN scleroderma DOID_419 2.563E-04 2.054E-03 1.000 1.000 ZHU_CMV_ALL_DN diabetic autonomic neuropathy DOID_11503 2.733E-04 2.16E-03 0.11790687 0.48615224 ZHU_CMV_ALL_DN autonomic neuropathy DOID_11504 2.733E-04 2.16E-03 0.11790687 0.48615224 ZHU_CMV_ALL_DN diabetic polyneuropathy DOID_12785 2.733E-04 2.16E-03 0.11790687 0.48615224 ZHU_CMV_ALL_DN gallbladder cancer DOID_3121 2.733E-04 2.13E-03 0.11790687 0.48265474 ZHU_CMV_ALL_DN uterine cancer DOID_363 2.733E-04 2.101E-03 0.11790687 0.47920721 ZHU_CMV_ALL_DN diabetic neuropathy DOID_9743 2.733E-04 2.16E-03 0.11790687 0.48615224 ZHU_CMV_ALL_DN proteinuria DOID_576 3.093E-04 2.347E-03 0.12260652 0.48446604 ZHU_CMV_ALL_DN chondrosarcoma DOID_3371 3.119E-04 2.335E-03 1.000 1.000 ZHU_CMV_ALL_DN insulinoma DOID_3892 3.119E-04 2.305E-03 0.0263273 0.27741171 ZHU_CMV_ALL_DN myeloma DOID_0070004 3.284E-04 2.396E-03 0.12494704 0.49030941 ZHU_CMV_ALL_DN autonomic nervous system disease DOID_11465 3.284E-04 2.365E-03 0.12494704 0.48363854 ZHU_CMV_ALL_DN neuritis DOID_1803 3.284E-04 2.336E-03 7.921E-03 0.1408466 ZHU_CMV_ALL_DN thyroid adenoma DOID_2891 3.284E-04 2.307E-03 0.12494704 0.48037071 ZHU_CMV_ALL_DN hemolytic anemia DOID_583 3.483E-04 2.417E-03 8.23E-03 0.13773428 ZHU_CMV_ALL_DN normocytic anemia DOID_720 3.483E-04 2.417E-03 8.23E-03 0.13773428 ZHU_CMV_ALL_DN calcium metabolism disease DOID_10575 3.903E-04 2.675E-03 0.13193157 0.50046042 ZHU_CMV_ALL_DN orofacial cleft DOID_0050567 4.354E-04 2.949E-03 0.13655723 0.51119121 ZHU_CMV_ALL_DN islet cell tumor DOID_1799 4.558E-04 3.051E-03 0.03150981 0.28458861 ZHU_CMV_ALL_DN ocular hypertension DOID_9282 4.558E-04 3.016E-03 1.000 1.000 ZHU_CMV_ALL_DN borderline glaucoma DOID_9283 4.558E-04 3.016E-03 1.000 1.000 ZHU_CMV_ALL_DN bone marrow cancer DOID_4960 4.837E-04 3.164E-03 0.14115848 0.51818824 ZHU_CMV_ALL_DN familial hyperlipidemia DOID_1168 5.354E-04 3.462E-03 0.14573546 0.51827173 ZHU_CMV_ALL_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 5.378E-04 3.438E-03 0.03409082 0.29842576 ZHU_CMV_ALL_DN carotid stenosis DOID_13001 5.378E-04 3.4E-03 1.000 1.000 ZHU_CMV_ALL_DN nonsyndromic deafness DOID_0050563 5.904E-04 3.692E-03 5.904E-04 0.03053958 ZHU_CMV_ALL_DN melancholia DOID_2848 6.192E-04 3.83E-03 0.01197722 0.1703759 ZHU_CMV_ALL_DN aspergillosis DOID_13564 6.263E-04 3.832E-03 1.000 1.000 ZHU_CMV_ALL_DN neurotic disorder DOID_4964 6.489E-04 3.928E-03 0.01234864 0.17137496 ZHU_CMV_ALL_DN hypothyroidism DOID_1459 7.11E-04 4.259E-03 0.01310646 0.17756126 ZHU_CMV_ALL_DN thoracic aortic aneurysm DOID_14004 7.214E-04 4.276E-03 0.03923241 0.30579784 ZHU_CMV_ALL_DN intermediate coronary syndrome DOID_8805 7.214E-04 4.232E-03 1.000 1.000 ZHU_CMV_ALL_DN congenital heart defect DOID_1682 7.435E-04 4.317E-03 0.0134928 0.17854424 ZHU_CMV_ALL_DN cholestasis DOID_13580 8.111E-04 4.662E-03 0.16603479 0.56911924 ZHU_CMV_ALL_DN silicosis DOID_10325 8.23E-04 4.683E-03 0.04179304 0.31289789 ZHU_CMV_ALL_DN spastic diplegia DOID_10965 8.23E-04 4.637E-03 1.000 1.000 ZHU_CMV_ALL_DN hemolytic-uremic syndrome DOID_12554 8.23E-04 4.591E-03 0.04179304 0.30883428 ZHU_CMV_ALL_DN pituitary adenoma DOID_3829 8.23E-04 4.547E-03 0.04179304 0.30487486 ZHU_CMV_ALL_DN restrictive cardiomyopathy DOID_397 8.23E-04 4.503E-03 0.04179304 0.30101569 ZHU_CMV_ALL_DN chronic myeloid leukemia DOID_8552 8.23E-04 4.46E-03 8.23E-04 0.03344928 ZHU_CMV_ALL_DN temporal lobe epilepsy DOID_3328 8.463E-04 4.543E-03 0.16826058 0.56651046 ZHU_CMV_ALL_DN familial hypertrophic cardiomyopathy DOID_11986 9.311E-04 4.951E-03 9.311E-04 0.03532047 ZHU_CMV_ALL_DN urinary system benign neoplasm DOID_731 9.311E-04 4.906E-03 0.04434691 0.31152335 ZHU_CMV_ALL_DN bile duct disease DOID_4138 1.037E-03 5.414E-03 0.1793016 0.58972606 ZHU_CMV_ALL_DN congenital muscular dystrophy DOID_0050557 1.046E-03 5.409E-03 0.04689404 0.32539889 ZHU_CMV_ALL_DN male reproductive organ benign neoplasm DOID_0060087 1.046E-03 5.36E-03 0.04689404 0.32147842 ZHU_CMV_ALL_DN ureteral obstruction DOID_5199 1.046E-03 5.312E-03 1.000 1.000 ZHU_CMV_ALL_DN biliary tract disease DOID_9741 1.078E-03 5.429E-03 0.18149232 0.59010932 ZHU_CMV_ALL_DN endogenous depression DOID_1595 1.208E-03 6.028E-03 0.01850445 0.21487817 ZHU_CMV_ALL_DN limb-girdle muscular dystrophy DOID_11724 1.294E-03 6.403E-03 0.05196815 0.3438358 ZHU_CMV_ALL_DN bacterial pneumonia DOID_874 1.299E-03 6.374E-03 1.000 1.000 ZHU_CMV_ALL_DN lipid metabolism disorder DOID_3146 1.395E-03 6.785E-03 0.19666614 0.62866871 ZHU_CMV_ALL_DN coronary restenosis DOID_4247 1.428E-03 6.885E-03 1.000 1.000 ZHU_CMV_ALL_DN auditory system disease DOID_2742 1.495E-03 7.15E-03 1.495E-03 0.04051695 ZHU_CMV_ALL_DN mental depression DOID_1596 1.547E-03 7.336E-03 0.02173583 0.24250364 ZHU_CMV_ALL_DN focal epilepsy DOID_2234 1.547E-03 7.275E-03 0.20308363 0.63842311 ZHU_CMV_ALL_DN biliary tract cancer DOID_4607 1.547E-03 7.215E-03 0.20308363 0.63491529 ZHU_CMV_ALL_DN familial hypercholesterolemia DOID_13810 1.568E-03 7.253E-03 0.05701552 0.36865716 ZHU_CMV_ALL_DN thrombophilia DOID_2452 1.568E-03 7.194E-03 0.05701552 0.36451494 ZHU_CMV_ALL_DN acquired immunodeficiency syndrome DOID_635 1.568E-03 7.137E-03 0.05701552 0.36046478 ZHU_CMV_ALL_DN muscular atrophy DOID_767 1.568E-03 7.08E-03 1.000 1.000 ZHU_CMV_ALL_DN urinary tract obstruction DOID_5200 1.714E-03 7.68E-03 1.000 1.000 ZHU_CMV_ALL_DN hypoglycemia DOID_9993 1.714E-03 7.62E-03 1.000 1.000 ZHU_CMV_ALL_DN diabetic angiopathy DOID_11713 1.867E-03 8.234E-03 1.867E-03 0.04425866 ZHU_CMV_ALL_DN Lewy body dementia DOID_12217 1.867E-03 8.171E-03 0.06203628 0.38368088 ZHU_CMV_ALL_DN ureteral disease DOID_1426 1.867E-03 8.108E-03 1.000 1.000 ZHU_CMV_ALL_DN primary immunodeficiency disease DOID_612 1.881E-03 8.108E-03 0.21576672 0.66723512 ZHU_CMV_ALL_DN urticaria DOID_1555 2.191E-03 9.372E-03 2.191E-03 0.04985825 ZHU_CMV_ALL_DN autosomal dominant nonsyndromic deafness DOID_0050564 2.362E-03 0.01002866 2.362E-03 0.05168617 ZHU_CMV_ALL_DN papillary adenoma DOID_3172 2.362E-03 9.954E-03 0.06951783 0.42080472 ZHU_CMV_ALL_DN microcystic adenoma DOID_5403 2.362E-03 9.954E-03 0.06951783 0.42080472 ZHU_CMV_ALL_DN follicular adenoma DOID_6204 2.362E-03 9.954E-03 0.06951783 0.42080472 ZHU_CMV_ALL_DN intracranial aneurysm DOID_10941 2.539E-03 0.01062284 0.07199852 0.42674124 ZHU_CMV_ALL_DN spinal cord disease DOID_319 2.539E-03 0.0105453 1.000 1.000 ZHU_CMV_ALL_DN Sciatic Neuropathy DOID_11446 2.722E-03 0.01122488 0.07447267 0.43685515 ZHU_CMV_ALL_DN lesion of sciatic nerve DOID_12528 2.722E-03 0.01122488 0.07447267 0.43685515 ZHU_CMV_ALL_DN periodontitis DOID_824 2.722E-03 0.01114412 0.07447267 0.4237495 ZHU_CMV_ALL_DN mononeuritis of lower limb DOID_9473 2.722E-03 0.01122488 0.07447267 0.43685515 ZHU_CMV_ALL_DN autoimmune disease of cardiovascular system DOID_0060051 2.912E-03 0.01183432 1.000 1.000 ZHU_CMV_ALL_DN renal hypertension DOID_1073 2.912E-03 0.01175039 0.07694029 0.42920611 ZHU_CMV_ALL_DN secondary hypertension DOID_11130 2.912E-03 0.01175039 0.07694029 0.42920611 ZHU_CMV_ALL_DN sarcoma DOID_1115 2.912E-03 0.01166764 1.000 1.000 ZHU_CMV_ALL_DN Behcet's disease DOID_13241 2.912E-03 0.01183432 1.000 1.000 ZHU_CMV_ALL_DN thrombocytopenia DOID_1588 2.912E-03 0.01158605 0.07694029 0.42503906 ZHU_CMV_ALL_DN mononeuritis DOID_1802 2.912E-03 0.01150559 0.07694029 0.42095215 ZHU_CMV_ALL_DN hepatic vascular disease DOID_272 2.912E-03 0.01142624 1.000 1.000 ZHU_CMV_ALL_DN coronary stenosis DOID_4248 2.912E-03 0.01134798 1.000 1.000 ZHU_CMV_ALL_DN polycystic ovary syndrome DOID_11612 3.107E-03 0.01202722 0.07940139 0.42622067 ZHU_CMV_ALL_DN mononeuropathy DOID_1188 3.107E-03 0.01194595 0.07940139 0.4222373 ZHU_CMV_ALL_DN multiple epiphyseal dysplasia DOID_12721 3.107E-03 0.01186578 0.07940139 0.4183277 ZHU_CMV_ALL_DN toxic encephalopathy DOID_3602 3.107E-03 0.01178667 3.107E-03 0.06314288 ZHU_CMV_ALL_DN age related macular degeneration DOID_10871 3.516E-03 0.01324896 0.08430412 0.42829505 ZHU_CMV_ALL_DN degeneration of macula and posterior pole DOID_2007 3.516E-03 0.01324896 0.08430412 0.42829505 ZHU_CMV_ALL_DN gonadal disease DOID_2277 3.516E-03 0.0131618 0.08430412 0.42450482 ZHU_CMV_ALL_DN opportunistic mycosis DOID_2473 3.516E-03 0.01307577 1.000 1.000 ZHU_CMV_ALL_DN Charcot-Marie-Tooth disease DOID_10595 3.729E-03 0.01377891 0.08674578 0.43296799 ZHU_CMV_ALL_DN systemic mycosis DOID_0050136 4.173E-03 0.01532068 1.000 1.000 ZHU_CMV_ALL_DN fungal infectious disease DOID_1564 4.173E-03 0.01532068 1.000 1.000 ZHU_CMV_ALL_DN hair disease DOID_421 4.173E-03 0.01522247 1.000 1.000 ZHU_CMV_ALL_DN metal metabolism disorder DOID_896 4.173E-03 0.01512551 1.000 1.000 ZHU_CMV_ALL_DN pneumoconiosis DOID_10316 4.404E-03 0.01586115 0.09403216 0.44961596 ZHU_CMV_ALL_DN male infertility DOID_12336 4.404E-03 0.01576139 0.09403216 0.44586916 ZHU_CMV_ALL_DN hepatitis C DOID_1883 4.404E-03 0.01566288 0.09403216 0.44218429 ZHU_CMV_ALL_DN periodontal disease DOID_3388 4.404E-03 0.0155656 0.09403216 0.43855983 ZHU_CMV_ALL_DN spindle cell carcinoma DOID_4015 4.404E-03 0.01546951 0.09403216 0.4349943 ZHU_CMV_ALL_DN macular degeneration DOID_4448 4.404E-03 0.01537461 0.09403216 0.43148628 ZHU_CMV_ALL_DN refractive error DOID_9835 4.883E-03 0.01694295 0.09885774 0.4429138 ZHU_CMV_ALL_DN cleft palate DOID_674 5.132E-03 0.01769596 0.10126097 0.44664724 ZHU_CMV_ALL_DN uveitis DOID_13141 5.385E-03 0.01845943 1.000 1.000 ZHU_CMV_ALL_DN intracranial arterial disease DOID_13089 5.91E-03 0.02013642 0.10843267 0.46389618 ZHU_CMV_ALL_DN cerebral arterial disease DOID_3527 5.91E-03 0.02013642 0.10843267 0.46389618 ZHU_CMV_ALL_DN lymphatic system disease DOID_75 5.91E-03 0.02001656 0.10843267 0.46043426 ZHU_CMV_ALL_DN hyperinsulinism DOID_2018 6.739E-03 0.0226889 0.11554771 0.47990252 ZHU_CMV_ALL_DN uveal disease DOID_3480 6.739E-03 0.02255543 1.000 1.000 ZHU_CMV_ALL_DN cerebral infarction DOID_3526 7.319E-03 0.02435413 0.1202598 0.48530374 ZHU_CMV_ALL_DN cataract DOID_83 7.319E-03 0.02421254 0.1202598 0.48188611 ZHU_CMV_ALL_DN leukodystrophy DOID_10579 7.617E-03 0.02505366 0.12260652 0.48785391 ZHU_CMV_ALL_DN lens disease DOID_110 7.921E-03 0.02590282 0.12494704 0.48695113 ZHU_CMV_ALL_DN brain cancer DOID_1319 7.921E-03 0.02575481 1.000 1.000 ZHU_CMV_ALL_DN vascular skin disease DOID_9540 7.921E-03 0.02560847 7.921E-03 0.13657852 ZHU_CMV_ALL_DN central nervous system cancer DOID_3620 8.23E-03 0.02645743 1.000 1.000 ZHU_CMV_ALL_DN vasculitis DOID_865 0.01019619 0.03259342 1.000 1.000 ZHU_CMV_ALL_DN smallpox DOID_8736 0.01054215 0.03351109 0.14345 0.51335251 ZHU_CMV_ALL_DN bile duct cancer DOID_4606 0.01161083 0.03670312 0.15028828 0.53114306 ZHU_CMV_ALL_DN bile duct carcinoma DOID_4897 0.01161083 0.03670312 0.15028828 0.53114306 ZHU_CMV_ALL_DN neuroectodermal tumor DOID_171 0.01272506 0.04000308 1.000 1.000 ZHU_CMV_ALL_DN carotid artery disease DOID_3407 0.01272506 0.03978328 1.000 1.000 ZHU_CMV_ALL_DN parasitic infectious disease DOID_1398 0.01428021 0.04440131 0.16603479 0.56571135 ZHU_CMV_ALL_DN cerebral degeneration DOID_1443 0.01428021 0.04416 0.16603479 0.56234402 ZHU_CMV_ALL_DN hyperglycemia DOID_4195 0.01468122 0.04515467 0.16826058 0.56317805 ZHU_CMV_ALL_DN tooth disease DOID_1091 0.01508706 0.04615344 0.17048048 0.56727131 ZHU_CMV_ALL_DN pancreatic ductal carcinoma DOID_3587 0.01633331 0.04969868 0.01633331 0.19773732 ZHU_CMV_ALL_DN male reproductive system disease DOID_48 0.01675821 0.05072032 0.1793016 0.58633683 ZHU_CMV_ALL_DN pancreatic carcinoma DOID_4905 0.01762205 0.05305262 0.01762205 0.20889471 ZHU_CMV_ALL_DN cystic fibrosis DOID_1485 0.01850445 0.05541595 1.000 1.000 ZHU_CMV_ALL_DN syndrome DOID_225 0.01850445 0.05512581 0.18802982 0.60789187 ZHU_CMV_ALL_DN mixed glioma DOID_5076 0.01940518 0.05750806 0.01940518 0.22083096 ZHU_CMV_ALL_DN chromosomal disease DOID_0080014 0.02079019 0.06129336 0.19881096 0.63197452 ZHU_CMV_ALL_DN primary bacterial infectious disease DOID_0050338 0.02367965 0.06945218 1.000 1.000 ZHU_CMV_ALL_DN nervous system cancer DOID_3093 0.02518268 0.07348178 1.000 1.000 ZHU_CMV_ALL_DN gallbladder disease DOID_0000000 0.0263273 0.07642976 1.000 1.000 ZHU_CMV_ALL_DN facioscapulohumeral muscular dystrophy DOID_11727 0.0263273 0.07604179 1.000 1.000 ZHU_CMV_ALL_DN hyperparathyroidism DOID_13543 0.0263273 0.07565774 1.000 1.000 ZHU_CMV_ALL_DN familial combined hyperlipidemia DOID_13809 0.0263273 0.07527755 1.000 1.000 ZHU_CMV_ALL_DN ventricular septal defect DOID_1657 0.0263273 0.07490116 1.000 1.000 ZHU_CMV_ALL_DN bilirubin metabolic disorder DOID_2741 0.0263273 0.07452852 1.000 1.000 ZHU_CMV_ALL_DN progressive muscular atrophy DOID_318 0.0263273 0.07415957 1.000 1.000 ZHU_CMV_ALL_DN hypokalemia DOID_4500 0.0263273 0.07379425 1.000 1.000 ZHU_CMV_ALL_DN holoprosencephaly DOID_4621 0.0263273 0.07343251 0.0263273 0.27236786 ZHU_CMV_ALL_DN nervous system benign neoplasm DOID_0060115 0.02892198 0.08027612 1.000 1.000 ZHU_CMV_ALL_DN common variable immunodeficiency DOID_12177 0.02892198 0.07988643 1.000 1.000 ZHU_CMV_ALL_DN migraine without aura DOID_12783 0.02892198 0.07950051 0.02892198 0.27892551 ZHU_CMV_ALL_DN prostatic adenoma DOID_2883 0.02892198 0.07911829 0.02892198 0.27427675 ZHU_CMV_ALL_DN invasive lobular carcinoma DOID_3457 0.02892198 0.07873974 1.000 1.000 ZHU_CMV_ALL_DN chronic monocytic leukemia DOID_8593 0.02892198 0.07836479 1.000 1.000 ZHU_CMV_ALL_DN bronchiectasis DOID_9563 0.02892198 0.07799339 1.000 1.000 ZHU_CMV_ALL_DN beta thalassemia DOID_12241 0.03150981 0.08457114 1.000 1.000 ZHU_CMV_ALL_DN porphyria DOID_13268 0.03150981 0.08417409 1.000 1.000 ZHU_CMV_ALL_DN aortic valve stenosis DOID_1712 0.03150981 0.08378076 1.000 1.000 ZHU_CMV_ALL_DN pituitary cancer DOID_1785 0.03150981 0.08339108 0.03150981 0.28917875 ZHU_CMV_ALL_DN relapsing-remitting multiple sclerosis DOID_2378 0.03150981 0.08300501 1.000 1.000 ZHU_CMV_ALL_DN epidermolysis bullosa DOID_2730 0.03150981 0.0826225 1.000 1.000 ZHU_CMV_ALL_DN pituitary carcinoma DOID_4916 0.03150981 0.08339108 0.03150981 0.28917875 ZHU_CMV_ALL_DN stomach disease DOID_76 0.03150981 0.0822435 0.03150981 0.28014191 ZHU_CMV_ALL_DN lipodystrophy DOID_811 0.03150981 0.08186796 1.000 1.000 ZHU_CMV_ALL_DN essential hypertension DOID_10825 0.03409082 0.08817125 0.03409082 0.29390415 ZHU_CMV_ALL_DN parathyroid gland disease DOID_11201 0.03409082 0.08777228 1.000 1.000 ZHU_CMV_ALL_DN vulva cancer DOID_1245 0.03409082 0.08737691 0.03409082 0.28525991 ZHU_CMV_ALL_DN newborn respiratory distress syndrome DOID_12716 0.03409082 0.08698509 1.000 1.000 ZHU_CMV_ALL_DN polyneuropathy DOID_1389 0.03409082 0.08659676 1.000 1.000 ZHU_CMV_ALL_DN larynx cancer DOID_2596 0.03409082 0.08621188 0.03409082 0.28112571 ZHU_CMV_ALL_DN laryngeal benign neoplasm DOID_2598 0.03409082 0.08621188 0.03409082 0.28112571 ZHU_CMV_ALL_DN Leydig cell tumor DOID_2696 0.03409082 0.08583042 1.000 1.000 ZHU_CMV_ALL_DN vesiculobullous skin disease DOID_2731 0.03409082 0.08545231 1.000 1.000 ZHU_CMV_ALL_DN sex cord-stromal neoplasm DOID_4757 0.03409082 0.08583042 1.000 1.000 ZHU_CMV_ALL_DN monocytic leukemia DOID_8527 0.03409082 0.08507752 1.000 1.000 ZHU_CMV_ALL_DN alcohol dependence DOID_0050741 0.03666501 0.09110214 0.03666501 0.29803415 ZHU_CMV_ALL_DN Legionnaires' disease DOID_10457 0.03666501 0.09070605 1.000 1.000 ZHU_CMV_ALL_DN legionellosis DOID_10458 0.03666501 0.09070605 1.000 1.000 ZHU_CMV_ALL_DN tethered spinal cord syndrome DOID_1089 0.03666501 0.09031338 1.000 1.000 ZHU_CMV_ALL_DN rhabdomyosarcoma DOID_3247 0.03666501 0.0899241 1.000 1.000 ZHU_CMV_ALL_DN congenital structural myopathy DOID_422 0.03666501 0.08953816 0.03666501 0.29383649 ZHU_CMV_ALL_DN parasitic helminthiasis infectious disease DOID_883 0.03666501 0.08915552 1.000 1.000 ZHU_CMV_ALL_DN skeletal system cancer DOID_0060124 0.03923241 0.09499252 1.000 1.000 ZHU_CMV_ALL_DN thalassemia DOID_10241 0.03923241 0.09459001 1.000 1.000 ZHU_CMV_ALL_DN renovascular hypertension DOID_1591 0.03923241 0.0941909 1.000 1.000 ZHU_CMV_ALL_DN bone cancer DOID_184 0.03923241 0.09499252 1.000 1.000 ZHU_CMV_ALL_DN hemangioma DOID_255 0.03923241 0.09379514 1.000 1.000 ZHU_CMV_ALL_DN arthropathy DOID_381 0.03923241 0.09340269 0.03923241 0.30166544 ZHU_CMV_ALL_DN skeletal muscle cancer DOID_4043 0.03923241 0.09301351 1.000 1.000 ZHU_CMV_ALL_DN panic disorder DOID_594 0.03923241 0.09262756 0.03923241 0.29764323 ZHU_CMV_ALL_DN varicose veins DOID_799 0.03923241 0.0922448 1.000 1.000 ZHU_CMV_ALL_DN angiosarcoma DOID_0001816 0.04179304 0.09786107 1.000 1.000 ZHU_CMV_ALL_DN vein disease DOID_866 0.04179304 0.09746 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE transitional cell carcinoma DOID_2671 2.766E-08 1.574E-05 9.481E-05 8.992E-03 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE multiple myeloma DOID_9538 6.84E-08 1.946E-05 8.246E-06 4.692E-03 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE myeloma DOID_0070004 1.712E-07 3.247E-05 1.625E-05 4.623E-03 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE bone marrow cancer DOID_4960 2.922E-07 4.156E-05 2.414E-05 4.579E-03 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE astrocytoma DOID_3069 7.53E-07 8.57E-05 0.0679512 0.44958409 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE brain cancer DOID_1319 1.625E-05 1.541E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE central nervous system cancer DOID_3620 1.725E-05 1.402E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE giant cell tumor DOID_200 2.289E-05 1.628E-03 0.05325049 0.41506206 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE malignant giant cell tumor DOID_2705 2.289E-05 1.628E-03 0.05325049 0.41506206 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE giant cell glioblastoma DOID_3074 2.289E-05 1.628E-03 0.05325049 0.41506206 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE reproductive organ benign neoplasm DOID_0050622 2.544E-05 1.609E-03 1.48E-03 0.08422091 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE hypertrophic cardiomyopathy DOID_11984 2.962E-05 1.685E-03 2.962E-05 4.213E-03 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE glioblastoma DOID_3068 2.962E-05 1.532E-03 0.05786853 0.4276259 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE pancreatic carcinoma DOID_4905 5.727E-05 2.716E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE diabetic retinopathy DOID_8947 5.727E-05 2.507E-03 2.524E-03 0.1104723 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE lipodystrophy DOID_811 6.079E-05 2.471E-03 6.079E-05 6.918E-03 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE retinal vascular disease DOID_2462 8.572E-05 3.252E-03 3.291E-03 0.11702852 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE nervous system cancer DOID_3093 1.012E-04 3.599E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE angiosarcoma DOID_0001816 1.103E-04 3.691E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE subependymal glioma DOID_4843 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE pilocytic astrocytoma DOID_4851 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE subependymal giant cell astrocytoma DOID_5077 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE fibrillary astrocytoma DOID_6726 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE juvenile pilocytic astrocytoma DOID_6811 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE childhood pilocytic astrocytoma DOID_6812 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE gemistocytic astrocytoma DOID_7005 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE childhood cerebral astrocytoma DOID_7007 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE protoplasmic astrocytoma DOID_7008 1.742E-04 5.505E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE benign glioma DOID_0060101 2.115E-04 6.333E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE benign ependymoma DOID_4844 2.115E-04 6.333E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE muscle cancer DOID_4045 2.315E-04 6.585E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE portal hypertension DOID_10762 2.968E-04 8.042E-03 0.02507622 0.37548347 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE seminoma DOID_4440 3.448E-04 8.917E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE lung adenocarcinoma DOID_3910 3.701E-04 9.155E-03 0.02792996 0.35315882 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE sarcoma DOID_1115 3.963E-04 9.395E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE hepatic vascular disease DOID_272 3.963E-04 9.019E-03 0.0288794 0.34234118 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE supratentorial cancer DOID_1659 4.233E-04 9.265E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE cerebrum cancer DOID_368 4.233E-04 9.265E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE female reproductive organ benign neoplasm DOID_0060086 4.513E-04 9.51E-03 4.513E-04 0.03668309 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE uterine benign neoplasm DOID_0060095 4.513E-04 9.51E-03 4.513E-04 0.03668309 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE uterine fibroid DOID_13223 4.513E-04 9.51E-03 4.513E-04 0.03668309 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Charcot-Marie-Tooth disease DOID_10595 5.098E-04 0.01035985 0.03266813 0.36447387 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE germinoma DOID_3304 5.098E-04 0.01000261 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE leiomyoma DOID_127 5.404E-04 0.0102489 5.404E-04 0.03843338 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE thyroid carcinoma DOID_3963 6.041E-04 0.01108818 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE thyroid cancer DOID_1781 6.713E-04 0.01193665 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE systemic scleroderma DOID_418 7.786E-04 0.01342465 0.04020251 0.38771569 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE intracranial arterial disease DOID_13089 8.161E-04 0.01365701 8.161E-04 0.05159316 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE cerebral arterial disease DOID_3527 8.161E-04 0.01365701 8.161E-04 0.05159316 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE cervix uteri carcinoma in situ DOID_8991 8.544E-04 0.01389003 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE rheumatic disease DOID_1575 9.336E-04 0.01475654 0.04394825 0.40994352 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE scleroderma DOID_419 9.336E-04 0.01475654 0.04394825 0.40994352 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE uterine cancer DOID_363 9.745E-04 0.01498663 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE thyroid adenoma DOID_2891 1.102E-03 0.01650564 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE vascular skin disease DOID_9540 1.102E-03 0.01608242 0.04767977 0.39896749 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE pustulosis of palm and sole DOID_4398 1.48E-03 0.02105523 0.05510034 0.41252758 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE familial hyperlipidemia DOID_1168 1.531E-03 0.0212494 1.531E-03 0.07920231 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE collagen disease DOID_854 1.799E-03 0.02436629 0.06062883 0.43122252 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE pre-malignant neoplasm DOID_0060071 1.911E-03 0.02529147 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE in situ carcinoma DOID_8719 1.911E-03 0.02529147 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE allergic contact dermatitis DOID_3042 2.147E-03 0.02775966 2.147E-03 0.10178543 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE endocrine organ benign neoplasm DOID_0060089 2.207E-03 0.0279124 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE pancreatic ductal carcinoma DOID_3587 2.332E-03 0.02884153 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE peripheral vascular disease DOID_341 2.459E-03 0.0297703 0.07068275 0.45702821 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE mixed glioma DOID_5076 2.792E-03 0.03309275 0.07521803 0.4703193 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE contact dermatitis DOID_2773 2.93E-03 0.03402729 2.93E-03 0.11909553 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE lipid metabolism disorder DOID_3146 2.93E-03 0.03334675 2.93E-03 0.11115583 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Human immunodeficiency virus infectious disease DOID_526 3.671E-03 0.0409565 3.671E-03 0.12286949 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE lymphoma DOID_0060058 3.829E-03 0.04189278 0.08780254 0.5372005 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE lymphoblastic leukemia DOID_1037 3.908E-03 0.04196057 3.908E-03 0.12355057 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE encephalomyelitis DOID_640 3.908E-03 0.04118352 0.08869503 0.53123657 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE ulcerative colitis DOID_8577 4.32E-03 0.04468983 0.09314476 0.54080986 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE angioedema DOID_1558 9.718E-03 0.09874281 9.718E-03 0.29103143 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE retinal vascular occlusion DOID_1729 9.718E-03 0.09701048 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE teratoma DOID_3307 9.718E-03 0.09533788 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Noonan syndrome DOID_3490 9.718E-03 0.09372199 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE keratitis DOID_4677 9.718E-03 0.09215995 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE malignant teratoma DOID_5563 9.718E-03 0.09533788 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE mature teratoma DOID_5566 9.718E-03 0.09533788 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE acute T cell leukemia DOID_5603 9.718E-03 0.09064913 9.718E-03 0.27647986 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 9.718E-03 0.08918705 9.718E-03 0.26331415 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Hodgkin's lymphoma, lymphocytic depletion DOID_8628 9.718E-03 0.08918705 9.718E-03 0.26331415 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Hodgkin's granuloma DOID_8651 9.718E-03 0.08918705 9.718E-03 0.26331415 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Hodgkin's lymphoma, mixed cellularity DOID_8654 9.718E-03 0.08918705 9.718E-03 0.26331415 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Charcot-Marie-Tooth disease type 4 DOID_0050541 0.01068484 0.09650274 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE migraine without aura DOID_12783 0.01068484 0.09499488 0.01068484 0.27634875 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE hemochromatosis DOID_2352 0.01068484 0.09353342 0.01068484 0.26433359 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE retinal detachment DOID_5327 0.01165066 0.09894366 0.01165066 0.26516901 SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE Hodgkin's lymphoma DOID_8567 0.01165066 0.09748861 0.01165066 0.2549702 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP aortic valve insufficiency DOID_57 1.196E-07 6.802E-05 1.196E-07 6.802E-05 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP aortic valve disease DOID_62 1.092E-06 3.108E-04 1.092E-06 3.108E-04 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP hyperthyroidism DOID_7998 4.162E-06 7.894E-04 4.162E-06 7.894E-04 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP heart valve disease DOID_4079 1.042E-05 1.482E-03 1.042E-05 1.482E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP glaucoma DOID_1686 1.174E-05 1.336E-03 8.914E-04 0.01749058 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP B-cell lymphocytic neoplasm DOID_707 1.316E-05 1.248E-03 1.316E-05 1.497E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP brain infarction DOID_3454 3.003E-05 2.441E-03 3.003E-05 2.847E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Sjogren's syndrome DOID_12894 3.093E-05 2.2E-03 3.093E-05 2.514E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP transient cerebral ischemia DOID_224 3.093E-05 1.955E-03 3.093E-05 2.2E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP lateral sclerosis DOID_230 3.093E-05 1.76E-03 3.093E-05 1.955E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP diabetic retinopathy DOID_8947 3.683E-05 1.905E-03 3.683E-05 2.095E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP retinal vascular disease DOID_2462 5.517E-05 2.616E-03 5.517E-05 2.854E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP lymphoma DOID_0060058 6.95E-05 3.042E-03 6.95E-05 3.295E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP encephalomyelitis DOID_640 7.172E-05 2.915E-03 2.935E-03 0.03552712 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP restrictive cardiomyopathy DOID_397 8.222E-05 3.119E-03 8.222E-05 3.599E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP glucose intolerance DOID_10603 1.047E-04 3.724E-03 1.047E-04 4.256E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP ureteral obstruction DOID_5199 1.047E-04 3.505E-03 1.047E-04 3.972E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP urinary tract obstruction DOID_5200 1.727E-04 5.459E-03 1.727E-04 6.142E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP diabetic angiopathy DOID_11713 1.883E-04 5.639E-03 1.883E-04 6.303E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP ureteral disease DOID_1426 1.883E-04 5.357E-03 1.883E-04 5.953E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP spinal muscular atrophy DOID_12377 2.391E-04 6.478E-03 2.391E-04 7.16E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP myositis DOID_633 2.391E-04 6.184E-03 2.391E-04 6.802E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP autoimmune disease of cardiovascular system DOID_0060051 2.958E-04 7.319E-03 2.958E-04 8.016E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP pleurisy DOID_10247 2.958E-04 7.014E-03 2.958E-04 7.652E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Behcet's disease DOID_13241 2.958E-04 7.319E-03 2.958E-04 8.016E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP focal glomerulosclerosis DOID_3945 3.161E-04 7.194E-03 3.161E-04 7.82E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP pleural disease DOID_1532 4.036E-04 8.833E-03 4.036E-04 9.569E-03 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP esophageal disease DOID_6050 4.513E-04 9.51E-03 4.513E-04 0.01027127 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP respiratory syncytial virus infectious disease DOID_1273 5.819E-04 0.01182472 0.03486339 0.17401113 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP diabetic autonomic neuropathy DOID_11503 7.286E-04 0.0142965 0.03893451 0.18308873 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP autonomic neuropathy DOID_11504 7.286E-04 0.0142965 0.03893451 0.18308873 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP diabetic polyneuropathy DOID_12785 7.286E-04 0.0142965 0.03893451 0.18308873 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP diabetic neuropathy DOID_9743 7.286E-04 0.0142965 0.03893451 0.18308873 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP cataract DOID_83 7.599E-04 0.01441323 7.599E-04 0.01663065 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP proteinuria DOID_576 7.918E-04 0.01453417 7.918E-04 0.01668738 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP lens disease DOID_110 8.244E-04 0.01465893 8.244E-04 0.01675306 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP autonomic nervous system disease DOID_11465 8.244E-04 0.01421472 0.04136919 0.18681801 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP hemorrhagic disease DOID_2213 9.61E-04 0.01608282 9.61E-04 0.01822719 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP giant cell tumor DOID_200 1.033E-03 0.01679565 1.033E-03 0.01896283 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP malignant giant cell tumor DOID_2705 1.033E-03 0.01679565 1.033E-03 0.01896283 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP giant cell glioblastoma DOID_3074 1.033E-03 0.01679565 1.033E-03 0.01896283 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP atrophic muscular disease DOID_913 1.033E-03 0.0163291 1.033E-03 0.01837024 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP muscular dystrophy DOID_9884 1.033E-03 0.0163291 1.033E-03 0.01837024 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP bile duct adenocarcinoma DOID_4896 1.07E-03 0.01645685 1.07E-03 0.01845162 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP cholangiocarcinoma DOID_4947 1.07E-03 0.01645685 1.07E-03 0.01845162 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP vasculitis DOID_865 1.07E-03 0.01602377 1.07E-03 0.01790892 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP glioblastoma DOID_3068 1.224E-03 0.01786437 1.224E-03 0.01990601 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP bile duct cancer DOID_4606 1.224E-03 0.01741776 1.224E-03 0.01935307 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP bile duct carcinoma DOID_4897 1.224E-03 0.01741776 1.224E-03 0.01935307 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP melancholia DOID_2848 1.265E-03 0.01755013 0.0510483 0.21201813 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP neurotic disorder DOID_4964 1.305E-03 0.01768467 0.05185061 0.21225177 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP collagen disease DOID_854 1.347E-03 0.01782123 0.05265226 0.21097981 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP hypothyroidism DOID_1459 1.389E-03 0.01795964 0.05345325 0.21269159 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP parasitic infectious disease DOID_1398 1.519E-03 0.01920184 1.519E-03 0.02335358 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP hyperglycemia DOID_4195 1.563E-03 0.01933496 1.563E-03 0.02340548 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP astrocytoma DOID_3069 1.7E-03 0.02058499 1.7E-03 0.02480755 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP blood coagulation disease DOID_1247 1.747E-03 0.02071302 1.747E-03 0.02485562 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP nephrosis DOID_2527 1.795E-03 0.02084296 1.795E-03 0.02490988 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP peripheral vascular disease DOID_341 1.843E-03 0.02097468 1.843E-03 0.02496986 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP endogenous depression DOID_1595 1.991E-03 0.02221787 0.06380662 0.2372939 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP pancreatitis DOID_4989 2.093E-03 0.02290573 0.06538968 0.23850466 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP mental depression DOID_1596 2.359E-03 0.02532277 0.06933599 0.24203789 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP biliary tract cancer DOID_4607 2.359E-03 0.02485383 2.359E-03 0.03121179 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP transitional cell carcinoma DOID_2671 2.639E-03 0.02730344 2.639E-03 0.0341293 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP amino acid metabolic disorder DOID_9252 2.697E-03 0.02740407 0.07405025 0.25382285 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP nervous system cancer DOID_3093 2.756E-03 0.02750714 2.756E-03 0.03484237 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Human immunodeficiency virus infectious disease DOID_526 2.756E-03 0.02703287 2.756E-03 0.03408493 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.995E-03 0.02888824 0.07796113 0.26404691 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP dilated cardiomyopathy DOID_12930 3.057E-03 0.02898957 3.057E-03 0.03623696 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP interstitial nephritis DOID_1063 8.41E-03 0.07844576 1.000 1.000 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP facioscapulohumeral muscular dystrophy DOID_11727 8.41E-03 0.07718051 8.41E-03 0.09765697 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP acute kidney failure DOID_3021 8.41E-03 0.07595542 8.41E-03 0.09570383 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP conjunctival disease DOID_4251 8.41E-03 0.07476862 8.41E-03 0.09382729 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP conjunctivitis DOID_6195 8.41E-03 0.07476862 8.41E-03 0.09382729 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 9.247E-03 0.08094709 9.247E-03 0.10118386 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP trypanosomiasis DOID_10113 9.247E-03 0.07972062 9.247E-03 0.09927474 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP dermatomyositis DOID_10223 9.247E-03 0.07853076 9.247E-03 0.09743631 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP heroin dependence DOID_9976 9.247E-03 0.0773759 1.000 1.000 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP stomach disease DOID_76 0.01008355 0.08315276 0.01008355 0.10431892 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP ocular hypertension DOID_9282 0.01008355 0.08196487 0.01008355 0.10245608 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP borderline glaucoma DOID_9283 0.01008355 0.08196487 0.01008355 0.10245608 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.01091939 0.08750889 1.000 1.000 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Legionnaires' disease DOID_10457 0.01175454 0.0928935 0.01175454 0.11733916 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP legionellosis DOID_10458 0.01175454 0.0928935 0.01175454 0.11733916 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP viral pneumonia DOID_10533 0.01175454 0.09162099 0.01175454 0.11531607 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP open-angle glaucoma DOID_1067 0.01175454 0.09038287 0.01175454 0.11336156 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP eyelid disease DOID_530 0.01175454 0.08917776 0.01175454 0.11147221 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP parasitic helminthiasis infectious disease DOID_883 0.01175454 0.08800437 0.01175454 0.10964479 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP narcolepsy DOID_8986 0.01175454 0.08686146 0.01175454 0.10787633 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP bacterial meningitis DOID_9470 0.01175454 0.08574785 0.01175454 0.10616401 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP peripheral neuropathy DOID_0060053 0.01258901 0.09067272 1.000 1.000 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Ehlers-Danlos syndrome DOID_13359 0.01258901 0.08953931 0.01258901 0.11192414 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP hemangioma DOID_255 0.01258901 0.08843389 0.01258901 0.11020223 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP membranoproliferative glomerulonephritis DOID_2920 0.01258901 0.08735543 0.01258901 0.1085325 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP nutritional deficiency disease DOID_5113 0.01258901 0.08630295 0.01258901 0.10691261 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP hyperhomocysteinemia DOID_9279 0.01258901 0.08527553 1.000 1.000 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP thyroiditis DOID_7166 0.01342279 0.08985375 0.01342279 0.11231719 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP autoimmune thyroiditis DOID_7188 0.01342279 0.08985375 0.01342279 0.11231719 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Barrett's esophagus DOID_9206 0.01342279 0.08880894 0.01342279 0.11068941 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP methylmalonic acidemia DOID_14749 0.0142559 0.09323684 0.0142559 0.11588007 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP juvenile rheumatoid arthritis DOID_676 0.0142559 0.09217733 0.0142559 0.11424796 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP neuroendocrine tumor DOID_169 0.01508832 0.09646352 0.01508832 0.11923963 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP prion disease DOID_649 0.01508832 0.09539171 0.01508832 0.11760621 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP eosinophilia DOID_999 0.01508832 0.09434345 0.01508832 0.11601694 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP dissociative disorder DOID_10935 0.01592006 0.09846211 1.000 1.000 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP dissociative amnesia DOID_11037 0.01592006 0.09846211 1.000 1.000 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP Down syndrome DOID_14250 0.01592006 0.09740338 0.01592006 0.12078019 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP limb-girdle muscular dystrophy DOID_11724 0.01675112 0.09928529 0.01675112 0.12378426 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP subependymal glioma DOID_4843 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP pilocytic astrocytoma DOID_4851 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP subependymal giant cell astrocytoma DOID_5077 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP fibrillary astrocytoma DOID_6726 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP juvenile pilocytic astrocytoma DOID_6811 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP childhood pilocytic astrocytoma DOID_6812 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP gemistocytic astrocytoma DOID_7005 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP childhood cerebral astrocytoma DOID_7007 0.01675112 0.09826173 0.01675112 0.12219728 KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP protoplasmic astrocytoma DOID_7008 0.01675112 0.09826173 0.01675112 0.12219728 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP sarcoidosis DOID_11335 5.019E-16 2.856E-13 2.289E-05 4.341E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hypersensitivity reaction type IV disease DOID_2916 1.037E-15 2.95E-13 2.962E-05 4.213E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pleurisy DOID_10247 3.293E-13 6.246E-11 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pleural disease DOID_1532 8.971E-13 1.276E-10 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary sarcoidosis DOID_13406 2.114E-12 2.406E-10 8.246E-06 2.346E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP primary bacterial infectious disease DOID_0050338 3.003E-12 2.848E-10 3.441E-03 0.1631373 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP male reproductive system disease DOID_48 9.962E-11 8.098E-09 0.0697731 0.66168153 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bacterial pneumonia DOID_874 1.609E-10 1.145E-08 0.07521803 0.6793501 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP influenza DOID_8469 9.95E-10 6.291E-08 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary tuberculosis DOID_2957 1.68E-09 9.559E-08 1.192E-03 0.08476179 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP esophagitis DOID_11963 3.677E-09 1.902E-07 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP tuberculosis DOID_399 8.304E-09 3.937E-07 2.207E-03 0.12560582 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cystitis DOID_1679 1.325E-08 5.802E-07 0.02602837 0.51069465 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cystic fibrosis DOID_1485 1.34E-08 5.445E-07 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP extrinsic allergic alveolitis DOID_841 1.545E-08 5.862E-07 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP chronic kidney failure DOID_784 2.072E-08 7.367E-07 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bronchiolitis obliterans DOID_2799 3.078E-08 1.03E-06 0.0317223 0.530882 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bladder disease DOID_365 3.933E-08 1.243E-06 0.03361307 0.53127319 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hypersensitivity reaction type I disease DOID_1205 4.036E-08 1.209E-06 2.492E-06 1.418E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP ulcerative colitis DOID_8577 4.705E-08 1.339E-06 0.09314476 0.7571338 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP esophageal disease DOID_6050 4.954E-08 1.342E-06 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP systemic scleroderma DOID_418 8.366E-08 2.164E-06 0.04020251 0.58654425 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP peptic ulcer DOID_750 8.366E-08 2.07E-06 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP adult respiratory distress syndrome DOID_11394 9.217E-08 2.185E-06 0.04114028 0.58522046 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary emphysema DOID_9675 1.013E-07 2.306E-06 0.04207716 0.58394887 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP rheumatic disease DOID_1575 1.216E-07 2.662E-06 0.04394825 0.58154778 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP scleroderma DOID_419 1.216E-07 2.662E-06 0.04394825 0.58154778 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP proteinuria DOID_576 1.576E-07 3.321E-06 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP common cold DOID_10459 1.871E-07 3.802E-06 0.01165066 0.41432658 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP aortic aneurysm DOID_3627 2.172E-07 4.261E-06 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP parasitic protozoa infectious disease DOID_2789 3.136E-07 5.948E-06 0.05510034 0.61474698 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP collagen disease DOID_854 4.677E-07 8.584E-06 0.06062883 0.63884818 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP respiratory failure DOID_11162 4.98E-07 8.855E-06 0.06154717 0.63673349 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP parasitic infectious disease DOID_1398 5.978E-07 1.031E-05 0.06429698 0.65330325 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperglycemia DOID_4195 6.341E-07 1.061E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP aneurysm disease DOID_2403 1.094E-06 1.779E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pancreatitis DOID_4989 1.151E-06 1.82E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bronchiolitis DOID_2942 2.191E-06 3.369E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mouth disease DOID_403 2.391E-06 3.581E-05 0.08958667 0.73876547 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP myositis DOID_633 2.463E-06 3.593E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP abdominal aortic aneurysm DOID_7693 4.575E-06 6.508E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP papilloma DOID_2615 5.975E-06 8.293E-05 0.0345571 0.53143221 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP uveitis DOID_13141 8.891E-06 1.205E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP respiratory syncytial virus infectious disease DOID_1273 9.569E-06 1.266E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hepatitis DOID_2237 9.569E-06 1.237E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP intracranial arterial disease DOID_13089 1.028E-05 1.3E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cerebral arterial disease DOID_3527 1.028E-05 1.3E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP endometriosis of uterus DOID_288 1.18E-05 1.46E-04 0.04301315 0.58272577 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP endometriosis DOID_289 1.262E-05 1.528E-04 0.04394825 0.56833078 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP uveal disease DOID_3480 1.262E-05 1.496E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP gallbladder cancer DOID_3121 1.347E-05 1.564E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pre-eclampsia DOID_10591 1.625E-05 1.849E-04 0.04767977 0.58977802 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP thyroid adenoma DOID_2891 1.625E-05 1.813E-04 0.04767977 0.57722955 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hemolytic anemia DOID_583 1.725E-05 1.888E-04 1.147E-03 0.09320203 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP normocytic anemia DOID_720 1.725E-05 1.888E-04 1.147E-03 0.09320203 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP atopic dermatitis DOID_3310 2.168E-05 2.327E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP giant cell tumor DOID_200 2.289E-05 2.412E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP malignant giant cell tumor DOID_2705 2.289E-05 2.412E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP giant cell glioblastoma DOID_3074 2.289E-05 2.412E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP glioblastoma DOID_3068 2.962E-05 3.064E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP melancholia DOID_2848 3.11E-05 3.16E-04 0.0587895 0.64329285 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP neurotic disorder DOID_4964 3.264E-05 3.258E-04 0.0597096 0.64103328 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cholestasis DOID_13580 4.105E-05 4.027E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP uterine disease DOID_345 4.105E-05 3.959E-04 0.06429698 0.64184179 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cutaneous leishmaniasis DOID_9111 4.15E-05 3.936E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP temporal lobe epilepsy DOID_3328 4.289E-05 4E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP allergic contact dermatitis DOID_3042 4.478E-05 4.109E-04 2.147E-03 0.1357139 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP endocrine organ benign neoplasm DOID_0060089 4.672E-05 4.22E-04 0.06703895 0.6576752 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP astrocytoma DOID_3069 4.872E-05 4.331E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP familial adenomatous polyposis DOID_0050424 5.069E-05 4.438E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bile duct disease DOID_4138 5.288E-05 4.559E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP biliary tract disease DOID_9741 5.505E-05 4.675E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP diabetic retinopathy DOID_8947 5.727E-05 4.792E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP stomach disease DOID_76 6.079E-05 5.013E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP encephalitis DOID_9588 6.079E-05 4.942E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP endogenous depression DOID_1595 6.19E-05 4.96E-04 0.0734065 0.67368227 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP contact dermatitis DOID_2773 7.186E-05 5.679E-04 2.93E-03 0.15157613 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP female reproductive system disease DOID_229 7.45E-05 5.807E-04 0.07792885 0.69283616 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mental depression DOID_1596 7.998E-05 6.15E-04 0.07973177 0.69795962 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP focal epilepsy DOID_2234 7.998E-05 6.068E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP biliary tract cancer DOID_4607 7.998E-05 5.988E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Legionnaires' disease DOID_10457 8.372E-05 6.186E-04 0.01357955 0.40667186 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP legionellosis DOID_10458 8.372E-05 6.186E-04 0.01357955 0.40667186 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP viral pneumonia DOID_10533 8.372E-05 6.107E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP retinal vascular disease DOID_2462 8.572E-05 6.174E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP idiopathic pulmonary fibrosis DOID_0050156 9.654E-05 6.866E-04 0.01454262 0.41373768 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP tongue cancer DOID_8649 1.103E-04 7.746E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Barrett's esophagus DOID_9206 1.103E-04 7.651E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP dilated cardiomyopathy DOID_12930 1.184E-04 8.119E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP granulosa cell tumor DOID_2999 1.568E-04 1.062E-03 0.01838577 0.41846022 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP leishmaniasis DOID_9065 1.568E-04 1.05E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP sex cord-gonadal stromal tumor DOID_192 1.742E-04 1.152E-03 0.01934428 0.42334215 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mitochondrial myopathy DOID_699 1.924E-04 1.258E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP sinusitis DOID_0050127 2.315E-04 1.497E-03 0.02221434 0.46814664 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP paranasal sinus disease DOID_1352 2.315E-04 1.497E-03 0.02221434 0.46814664 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP IgA glomerulonephritis DOID_2986 2.315E-04 1.48E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP urinary tract obstruction DOID_5200 2.315E-04 1.463E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hypoglycemia DOID_9993 2.315E-04 1.447E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Goodpasture syndrome DOID_9808 2.524E-04 1.561E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP acute pancreatitis DOID_2913 2.741E-04 1.677E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP portal hypertension DOID_10762 2.968E-04 1.797E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP osteosarcoma DOID_3347 2.968E-04 1.778E-03 2.968E-04 0.03377517 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP middle cerebral artery infarction DOID_3525 3.448E-04 2.043E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP gestational diabetes DOID_11714 3.701E-04 2.171E-03 3.701E-04 0.03509603 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP periodontitis DOID_824 3.701E-04 2.149E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hepatic vascular disease DOID_272 3.963E-04 2.278E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP spastic cerebral palsy DOID_0050669 4.801E-04 2.732E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP myocarditis DOID_820 5.718E-04 3.221E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pneumoconiosis DOID_10316 6.041E-04 3.37E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP periodontal disease DOID_3388 6.041E-04 3.337E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP thyroid carcinoma DOID_3963 6.041E-04 3.305E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP spindle cell carcinoma DOID_4015 6.041E-04 3.274E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP thyroid cancer DOID_1781 6.713E-04 3.604E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphatic system disease DOID_75 8.161E-04 4.34E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune disease of urogenital tract DOID_0060049 8.936E-04 4.708E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP primary biliary cirrhosis DOID_12236 8.936E-04 4.708E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP nephrotic syndrome DOID_1184 9.336E-04 4.874E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP diabetic autonomic neuropathy DOID_11503 9.745E-04 5.041E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP autonomic neuropathy DOID_11504 9.745E-04 5.041E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP diabetic polyneuropathy DOID_12785 9.745E-04 5.041E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP diabetic neuropathy DOID_9743 9.745E-04 5.041E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cerebral infarction DOID_3526 1.016E-03 5.21E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP autonomic nervous system disease DOID_11465 1.102E-03 5.6E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP neuritis DOID_1803 1.102E-03 5.551E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bone marrow disease DOID_4961 1.102E-03 5.502E-03 0.04767977 0.56520394 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP integumentary system benign neoplasm DOID_0060121 1.192E-03 5.896E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP glaucoma DOID_1686 1.192E-03 5.846E-03 0.04954021 0.57527307 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP skin benign neoplasm DOID_3165 1.192E-03 5.896E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP B-cell lymphocytic neoplasm DOID_707 1.285E-03 6.247E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP integumentary system cancer DOID_0060122 1.48E-03 7.137E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP skin cancer DOID_4159 1.48E-03 7.137E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mitochondrial metabolism disease DOID_700 1.531E-03 7.321E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bile duct cancer DOID_4606 1.636E-03 7.756E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bile duct carcinoma DOID_4897 1.636E-03 7.756E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP oral cavity cancer DOID_8618 1.636E-03 7.692E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP carotid artery disease DOID_3407 1.799E-03 8.388E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP endocrine pancreas disease DOID_1428 1.969E-03 9.108E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP tooth disease DOID_1091 2.147E-03 9.85E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP brain infarction DOID_3454 2.207E-03 0.01004847 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pancreatic ductal carcinoma DOID_3587 2.332E-03 0.01052945 0.06886258 0.6641154 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP nephrosis DOID_2527 2.395E-03 0.01073014 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pancreatic carcinoma DOID_4905 2.524E-03 0.01121984 0.07159153 0.6677964 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bone resorption disease DOID_0080011 2.724E-03 0.0120131 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP osteoporosis DOID_11476 2.724E-03 0.0120131 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP metabolic syndrome X DOID_14221 2.93E-03 0.01282567 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lipid metabolism disorder DOID_3146 2.93E-03 0.01272777 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP transitional cell carcinoma DOID_2671 3.517E-03 0.01515844 0.08422407 0.72611357 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP amino acid metabolic disorder DOID_9252 3.593E-03 0.01537312 0.08511997 0.72288449 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphoma DOID_0060058 3.829E-03 0.0162569 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphoblastic leukemia DOID_1037 3.908E-03 0.01647341 0.08869503 0.74216873 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP encephalomyelitis DOID_640 3.908E-03 0.01635228 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.989E-03 0.01656815 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP leber hereditary optic neuropathy DOID_705 8.75E-03 0.0360797 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP gallbladder disease DOID_0000000 9.718E-03 0.03978127 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperparathyroidism DOID_13543 9.718E-03 0.03949712 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP familial combined hyperlipidemia DOID_13809 9.718E-03 0.039217 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hypolipoproteinemia DOID_1387 9.718E-03 0.03894083 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP childhood type dermatomyositis DOID_14203 9.718E-03 0.03866851 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP retinal vascular occlusion DOID_1729 9.718E-03 0.03839998 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP transient cerebral ischemia DOID_224 9.718E-03 0.03813515 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP acute kidney failure DOID_3021 9.718E-03 0.03787395 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Hermansky-Pudlak syndrome DOID_3753 9.718E-03 0.03761631 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP conjunctival disease DOID_4251 9.718E-03 0.03736214 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP conjunctivitis DOID_6195 9.718E-03 0.03736214 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP polycythemia DOID_8432 9.718E-03 0.03711139 9.718E-03 0.42535363 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP alopecia areata DOID_986 9.718E-03 0.03686398 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP trypanosomiasis DOID_10113 0.01068484 0.04026273 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP dermatomyositis DOID_10223 0.01068484 0.03999785 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP adrenoleukodystrophy DOID_10588 0.01068484 0.03973642 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP sickle cell anemia DOID_10923 0.01068484 0.03947839 0.01068484 0.43426232 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP neuronal ceroid lipofuscinosis DOID_14503 0.01068484 0.03922369 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP chronic monocytic leukemia DOID_8593 0.01068484 0.03897226 0.01068484 0.4053115 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bronchiectasis DOID_9563 0.01068484 0.03872403 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP beta thalassemia DOID_12241 0.01165066 0.04195712 0.01165066 0.38995443 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP intracranial arteriosclerosis DOID_13097 0.01165066 0.04169324 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP diarrhea DOID_13250 0.01165066 0.04143266 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP relapsing-remitting multiple sclerosis DOID_2378 0.01165066 0.04117531 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP vascular dementia DOID_8725 0.01165066 0.04169324 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mitochondrial encephalomyopathy DOID_890 0.01165066 0.04092114 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP parathyroid gland disease DOID_11201 0.01261556 0.04403838 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP carotid stenosis DOID_13001 0.01261556 0.04376985 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP polyneuropathy DOID_1389 0.01261556 0.04350458 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP larynx cancer DOID_2596 0.01261556 0.04324251 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP laryngeal benign neoplasm DOID_2598 0.01261556 0.04324251 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP monocytic leukemia DOID_8527 0.01261556 0.04298357 0.01261556 0.39879201 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP open-angle glaucoma DOID_1067 0.01357955 0.04599265 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP eyelid disease DOID_530 0.01357955 0.04572051 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP polycystic kidney disease DOID_898 0.01357955 0.04545156 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bacterial meningitis DOID_9470 0.01357955 0.04518576 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP skeletal system cancer DOID_0060124 0.01454262 0.04810903 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP thalassemia DOID_10241 0.01454262 0.04783095 0.01454262 0.39403589 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP thoracic aortic aneurysm DOID_14004 0.01454262 0.04755606 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP renovascular hypertension DOID_1591 0.01454262 0.04728431 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP bone cancer DOID_184 0.01454262 0.04810903 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP oral submucous fibrosis DOID_5773 0.01454262 0.04701565 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP varicose veins DOID_799 0.01454262 0.04675002 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP intermediate coronary syndrome DOID_8805 0.01454262 0.04648738 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperhomocysteinemia DOID_9279 0.01454262 0.04622767 0.01454262 0.37612516 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP angiosarcoma DOID_0001816 0.01550478 0.04901234 0.01550478 0.38357484 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP silicosis DOID_10325 0.01550478 0.04874155 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP spastic diplegia DOID_10965 0.01550478 0.04847374 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hemolytic-uremic syndrome DOID_12554 0.01550478 0.04820886 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP restrictive cardiomyopathy DOID_397 0.01550478 0.04794685 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP vein disease DOID_866 0.01550478 0.04768768 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphatic system cancer DOID_0060073 0.01646603 0.05037188 0.01646603 0.39038203 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP drug-induced mental disorder DOID_1203 0.01646603 0.05010251 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP methylmalonic acidemia DOID_14749 0.01646603 0.049836 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP drug psychosis DOID_1742 0.01646603 0.05010251 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP urinary system benign neoplasm DOID_731 0.01646603 0.04957232 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP reticulosarcoma DOID_8538 0.01646603 0.05037188 0.01646603 0.39038203 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP substance-induced psychosis DOID_8646 0.01646603 0.05010251 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphosarcoma DOID_8675 0.01646603 0.05037188 0.01646603 0.39038203 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP glucose intolerance DOID_10603 0.01742636 0.05218735 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP ureteral obstruction DOID_5199 0.01742636 0.05191412 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP prion disease DOID_649 0.01742636 0.05164373 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Down syndrome DOID_14250 0.01838577 0.05420469 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP amnestic disorder DOID_10914 0.01934428 0.05673658 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP membranous glomerulonephritis DOID_10976 0.01934428 0.05644562 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary edema DOID_11396 0.01934428 0.05615763 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP amyloidosis DOID_9120 0.01934428 0.05587257 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP alopecia DOID_987 0.01934428 0.05559038 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Kawasaki disease DOID_13378 0.02030188 0.05804908 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphadenitis DOID_1602 0.02030188 0.05804908 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune hepatitis DOID_2048 0.02030188 0.05775884 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP coronary restenosis DOID_4247 0.02030188 0.05747148 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lymph node disease DOID_9942 0.02030188 0.05804908 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP funisitis DOID_0050698 0.02125856 0.05988179 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP gastric ulcer DOID_10808 0.02125856 0.05958681 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP neutropenia DOID_1227 0.02125856 0.05929472 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP familial hypercholesterolemia DOID_13810 0.02125856 0.05900547 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP agranulocytosis DOID_12987 0.02221434 0.06135903 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP optic nerve disease DOID_1891 0.02221434 0.0610626 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP muscle cancer DOID_4045 0.02221434 0.06076903 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP myasthenia gravis DOID_437 0.02221434 0.06047827 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP sleep disorder DOID_535 0.02221434 0.06019028 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP polyarteritis nodosa DOID_9810 0.02221434 0.05990502 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Lewy body dementia DOID_12217 0.02316921 0.06218528 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP ureteral disease DOID_1426 0.02316921 0.06189333 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP congenital hemolytic anemia DOID_589 0.02316921 0.06160411 0.02316921 0.47083141 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP meningitis DOID_9471 0.02316921 0.06131758 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP spastic quadriplegia DOID_10970 0.02412317 0.06354668 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP sphingolipidosis DOID_1927 0.02412317 0.06325384 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP organic acidemia DOID_0060159 0.02507622 0.06545125 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP urticaria DOID_1555 0.02507622 0.06515238 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP morbid obesity DOID_11981 0.02602837 0.06731884 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP papillary adenoma DOID_3172 0.02602837 0.06701423 0.02602837 0.4936715 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP neuromuscular junction disease DOID_439 0.02602837 0.06671236 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP microcystic adenoma DOID_5403 0.02602837 0.06701423 0.02602837 0.4936715 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP follicular adenoma DOID_6204 0.02602837 0.06701423 0.02602837 0.4936715 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hypotrichosis DOID_4535 0.02697962 0.06884037 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP diffuse large B-cell lymphoma DOID_0050745 0.02792996 0.07094708 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Sciatic Neuropathy DOID_11446 0.02792996 0.07063176 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lesion of sciatic nerve DOID_12528 0.02792996 0.07063176 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP lung adenocarcinoma DOID_3910 0.02792996 0.07031923 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP perinatal necrotizing enterocolitis DOID_8677 0.02792996 0.07000946 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mononeuritis of lower limb DOID_9473 0.02792996 0.07063176 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP renal hypertension DOID_1073 0.0288794 0.07207183 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP secondary hypertension DOID_11130 0.0288794 0.07207183 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP sarcoma DOID_1115 0.0288794 0.0717571 0.0288794 0.53007667 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP malaria DOID_12365 0.0288794 0.07144512 0.0288794 0.51351178 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mononeuritis DOID_1802 0.0288794 0.07113583 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP coronary stenosis DOID_4248 0.0288794 0.07082921 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune disease of the nervous system DOID_438 0.0288794 0.07052522 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP mononeuropathy DOID_1188 0.02982793 0.07253031 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cranial nerve disease DOID_5656 0.02982793 0.07222167 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP endometrial carcinoma DOID_2871 0.03077557 0.07420041 0.03077557 0.53064536 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP age related macular degeneration DOID_10871 0.0317223 0.07616029 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP degeneration of macula and posterior pole DOID_2007 0.0317223 0.07616029 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP endometrial cancer DOID_1380 0.03266813 0.07810154 0.03266813 0.53109049 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP allergic rhinitis DOID_4481 0.03266813 0.07777476 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP chronic leukemia DOID_1036 0.03361307 0.07969098 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP chronic lymphocytic leukemia DOID_1040 0.03361307 0.07969098 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hair disease DOID_421 0.0345571 0.08158918 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP metal metabolism disorder DOID_896 0.0345571 0.08125203 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP nephroblastoma DOID_2154 0.03550024 0.08312608 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP macular degeneration DOID_4448 0.03550024 0.0827854 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP leukopenia DOID_615 0.03550024 0.0824475 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperthyroidism DOID_7998 0.03550024 0.08211235 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP aplastic anemia DOID_12449 0.03644248 0.0839505 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP adenoma DOID_657 0.03738383 0.08577177 0.03738383 0.55977368 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP calcinosis DOID_182 0.03832428 0.08757637 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP multiple myeloma DOID_9538 0.03832428 0.08722607 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP microcephaly DOID_10907 0.03926384 0.08900847 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP benign mesothelioma DOID_2645 0.04207716 0.09500755 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP cervix uteri carcinoma in situ DOID_8991 0.04207716 0.09463203 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP Huntington's disease DOID_12858 0.04394825 0.098451 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP idiopathic generalized epilepsy DOID_1827 0.04394825 0.09806492 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP uterine cancer DOID_363 0.04488246 0.09975828 0.04488246 0.56751379 LEI_MYB_TARGETS myeloma DOID_0070004 4.938E-19 2.81E-16 2.619E-07 4.967E-05 LEI_MYB_TARGETS bone marrow cancer DOID_4960 3.299E-18 9.387E-16 5.8E-07 8.251E-05 LEI_MYB_TARGETS multiple myeloma DOID_9538 1.35E-16 2.56E-14 5.92E-05 2.807E-03 LEI_MYB_TARGETS epidermolysis bullosa DOID_2730 7.925E-14 1.127E-11 1.799E-11 1.024E-08 LEI_MYB_TARGETS vesiculobullous skin disease DOID_2731 1.71E-13 1.945E-11 3.327E-11 9.465E-09 LEI_MYB_TARGETS transitional cell carcinoma DOID_2671 5.281E-11 5.008E-09 1.187E-04 3.974E-03 LEI_MYB_TARGETS aneurysm disease DOID_2403 3.953E-10 3.213E-08 8.524E-03 0.12125373 LEI_MYB_TARGETS intracranial arterial disease DOID_13089 2.808E-09 1.997E-07 0.02170036 0.20927971 LEI_MYB_TARGETS cerebral arterial disease DOID_3527 2.808E-09 1.997E-07 0.02170036 0.20927971 LEI_MYB_TARGETS pancreatic ductal carcinoma DOID_3587 5.225E-09 3.303E-07 4.363E-05 2.483E-03 LEI_MYB_TARGETS pancreatic carcinoma DOID_4905 7.231E-09 4.114E-07 5.298E-05 2.741E-03 LEI_MYB_TARGETS varicose veins DOID_799 1.118E-08 5.783E-07 1.000 1.000 LEI_MYB_TARGETS vein disease DOID_866 1.619E-08 7.678E-07 1.000 1.000 LEI_MYB_TARGETS pleural disease DOID_1532 2.857E-08 1.251E-06 0.16907441 0.56259262 LEI_MYB_TARGETS nervous system cancer DOID_3093 3.321E-08 1.35E-06 0.08519614 0.39411875 LEI_MYB_TARGETS hypertrophic cardiomyopathy DOID_11984 3.509E-08 1.331E-06 4.157E-03 0.07630228 LEI_MYB_TARGETS oral cavity cancer DOID_8618 3.509E-08 1.248E-06 1.819E-05 1.479E-03 LEI_MYB_TARGETS carotid artery disease DOID_3407 4.93E-08 1.65E-06 0.28738142 0.79765868 LEI_MYB_TARGETS brain infarction DOID_3454 1.023E-07 3.234E-06 0.05428457 0.35099911 LEI_MYB_TARGETS adult respiratory distress syndrome DOID_11394 1.036E-07 3.103E-06 1.000 1.000 LEI_MYB_TARGETS astrocytoma DOID_3069 1.128E-07 3.21E-06 6.604E-03 0.09887966 LEI_MYB_TARGETS cystic fibrosis DOID_1485 1.97E-07 5.338E-06 1.000 1.000 LEI_MYB_TARGETS brain cancer DOID_1319 2.619E-07 6.774E-06 0.0287415 0.24049877 LEI_MYB_TARGETS heart valve disease DOID_4079 2.619E-07 6.479E-06 0.0287415 0.23362738 LEI_MYB_TARGETS central nervous system cancer DOID_3620 2.955E-07 7.006E-06 0.02981259 0.23560227 LEI_MYB_TARGETS middle cerebral artery infarction DOID_3525 3.461E-07 7.876E-06 0.1377054 0.51548928 LEI_MYB_TARGETS lung adenocarcinoma DOID_3910 4.164E-07 9.112E-06 1.61E-05 1.527E-03 LEI_MYB_TARGETS invasive ductal carcinoma DOID_3008 4.975E-07 1.048E-05 5.286E-04 0.01503998 LEI_MYB_TARGETS atrophic muscular disease DOID_913 5.212E-07 1.059E-05 0.03539978 0.26159058 LEI_MYB_TARGETS muscular dystrophy DOID_9884 5.212E-07 1.059E-05 0.03539978 0.26159058 LEI_MYB_TARGETS parasitic protozoa infectious disease DOID_2789 6.441E-07 1.264E-05 1.000 1.000 LEI_MYB_TARGETS lymphoma DOID_0060058 7.108E-07 1.348E-05 0.01364326 0.15526033 LEI_MYB_TARGETS glioblastoma DOID_3068 8.721E-07 1.601E-05 4.157E-03 0.07391783 LEI_MYB_TARGETS dilated cardiomyopathy DOID_12930 8.803E-07 1.565E-05 1.69E-04 5.343E-03 LEI_MYB_TARGETS ulcerative colitis DOID_8577 1.082E-06 1.866E-05 0.41118399 1.000 LEI_MYB_TARGETS collagen disease DOID_854 1.162E-06 1.945E-05 0.28738142 0.79378655 LEI_MYB_TARGETS respiratory failure DOID_11162 1.275E-06 2.072E-05 1.000 1.000 LEI_MYB_TARGETS papilloma DOID_2615 1.283E-06 2.027E-05 0.01550806 0.16649216 LEI_MYB_TARGETS myocarditis DOID_820 1.283E-06 1.973E-05 9.083E-04 0.02461088 LEI_MYB_TARGETS pre-malignant neoplasm DOID_0060071 1.396E-06 2.091E-05 5.185E-03 0.08429103 LEI_MYB_TARGETS in situ carcinoma DOID_8719 1.396E-06 2.091E-05 5.185E-03 0.08429103 LEI_MYB_TARGETS mineral metabolism disease DOID_0050032 1.527E-06 2.228E-05 0.0489582 0.33972215 LEI_MYB_TARGETS parasitic infectious disease DOID_1398 1.667E-06 2.372E-05 1.000 1.000 LEI_MYB_TARGETS basal cell carcinoma DOID_2513 1.695E-06 2.353E-05 9.313E-05 3.533E-03 LEI_MYB_TARGETS endocrine organ benign neoplasm DOID_0060089 2.153E-06 2.917E-05 3.815E-05 2.412E-03 LEI_MYB_TARGETS skin carcinoma DOID_3451 2.171E-06 2.872E-05 1.113E-04 3.959E-03 LEI_MYB_TARGETS embryonal cancer DOID_688 2.201E-06 2.846E-05 0.01893839 0.18905168 LEI_MYB_TARGETS leishmaniasis DOID_9065 2.738E-06 3.462E-05 1.000 1.000 LEI_MYB_TARGETS nephrosis DOID_2527 2.749E-06 3.4E-05 0.32416056 0.88252324 LEI_MYB_TARGETS benign mesothelioma DOID_2645 3.571E-06 4.323E-05 1.633E-03 0.0387266 LEI_MYB_TARGETS rheumatic disease DOID_1575 4.469E-06 5.297E-05 0.21608988 0.66462239 LEI_MYB_TARGETS scleroderma DOID_419 4.469E-06 5.297E-05 0.21608988 0.66462239 LEI_MYB_TARGETS contact dermatitis DOID_2773 5.017E-06 5.826E-05 5.017E-06 5.709E-04 LEI_MYB_TARGETS cerebral infarction DOID_3526 5.535E-06 6.298E-05 0.22434923 0.66834926 LEI_MYB_TARGETS bone development disease DOID_0080006 6.619E-06 7.385E-05 0.01073964 0.13001817 LEI_MYB_TARGETS calcium metabolism disease DOID_10575 9.079E-06 9.935E-05 0.03200169 0.24943781 LEI_MYB_TARGETS aortic aneurysm DOID_3627 9.079E-06 9.747E-05 0.03200169 0.24606703 LEI_MYB_TARGETS bronchiolitis DOID_2942 1.026E-05 1.081E-04 1.000 1.000 LEI_MYB_TARGETS giant cell tumor DOID_200 1.193E-05 1.234E-04 0.03539978 0.26503256 LEI_MYB_TARGETS malignant giant cell tumor DOID_2705 1.193E-05 1.234E-04 0.03539978 0.26503256 LEI_MYB_TARGETS giant cell glioblastoma DOID_3074 1.193E-05 1.234E-04 0.03539978 0.26503256 LEI_MYB_TARGETS myositis DOID_633 1.199E-05 1.219E-04 8.912E-03 0.11525247 LEI_MYB_TARGETS mouth disease DOID_403 1.249E-05 1.247E-04 0.39856025 1.000 LEI_MYB_TARGETS reproductive organ benign neoplasm DOID_0050622 1.419E-05 1.392E-04 0.26436501 0.74467174 LEI_MYB_TARGETS integumentary system cancer DOID_0060122 1.419E-05 1.369E-04 3.605E-03 0.07326837 LEI_MYB_TARGETS skin cancer DOID_4159 1.419E-05 1.369E-04 3.605E-03 0.07326837 LEI_MYB_TARGETS pustulosis of palm and sole DOID_4398 1.419E-05 1.346E-04 0.03773927 0.27181825 LEI_MYB_TARGETS facioscapulohumeral muscular dystrophy DOID_11727 1.689E-05 1.575E-04 1.000 1.000 LEI_MYB_TARGETS Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.689E-05 1.55E-04 1.000 1.000 LEI_MYB_TARGETS Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.689E-05 1.55E-04 1.000 1.000 LEI_MYB_TARGETS Hodgkin's granuloma DOID_8651 1.689E-05 1.55E-04 1.000 1.000 LEI_MYB_TARGETS Hodgkin's lymphoma, mixed cellularity DOID_8654 1.689E-05 1.55E-04 1.000 1.000 LEI_MYB_TARGETS cutaneous leishmaniasis DOID_9111 1.689E-05 1.525E-04 1.000 1.000 LEI_MYB_TARGETS pleurisy DOID_10247 1.85E-05 1.645E-04 0.1467863 0.53198347 LEI_MYB_TARGETS sarcoma DOID_1115 1.85E-05 1.619E-04 0.1467863 0.52529186 LEI_MYB_TARGETS focal glomerulosclerosis DOID_3945 2.115E-05 1.824E-04 0.01164514 0.13522625 LEI_MYB_TARGETS invasive lobular carcinoma DOID_3457 2.313E-05 1.964E-04 1.000 1.000 LEI_MYB_TARGETS spastic cerebral palsy DOID_0050669 2.728E-05 2.283E-04 1.000 1.000 LEI_MYB_TARGETS bronchiolitis obliterans DOID_2799 2.728E-05 2.25E-04 1.000 1.000 LEI_MYB_TARGETS Hodgkin's lymphoma DOID_8567 3.072E-05 2.497E-04 1.000 1.000 LEI_MYB_TARGETS allergic contact dermatitis DOID_3042 3.561E-05 2.854E-04 3.561E-05 2.533E-03 LEI_MYB_TARGETS parathyroid gland disease DOID_11201 3.978E-05 3.144E-04 1.000 1.000 LEI_MYB_TARGETS osteogenesis imperfecta DOID_12347 3.978E-05 3.101E-04 0.06646249 0.35676562 LEI_MYB_TARGETS pneumoconiosis DOID_10316 4.331E-05 3.33E-04 1.000 1.000 LEI_MYB_TARGETS nephroblastoma DOID_2154 4.331E-05 3.286E-04 0.17782658 0.58487469 LEI_MYB_TARGETS hyperthyroidism DOID_7998 4.331E-05 3.243E-04 9.846E-04 0.02546621 LEI_MYB_TARGETS peripheral vascular disease DOID_341 4.971E-05 3.673E-04 0.05980493 0.37394512 LEI_MYB_TARGETS bone resorption disease DOID_0080011 6.381E-05 4.655E-04 0.06550891 0.36905517 LEI_MYB_TARGETS osteoporosis DOID_11476 6.381E-05 4.655E-04 0.06550891 0.36905517 LEI_MYB_TARGETS bacterial pneumonia DOID_874 6.778E-05 4.882E-04 1.000 1.000 LEI_MYB_TARGETS systemic scleroderma DOID_418 7.19E-05 5.114E-04 0.19930776 0.62311053 LEI_MYB_TARGETS peptic ulcer DOID_750 7.19E-05 5.051E-04 0.19930776 0.61970555 LEI_MYB_TARGETS spastic diplegia DOID_10965 7.699E-05 5.343E-04 1.000 1.000 LEI_MYB_TARGETS tongue cancer DOID_8649 7.699E-05 5.278E-04 7.699E-05 3.37E-03 LEI_MYB_TARGETS adenoid cystic carcinoma DOID_4866 7.895E-05 5.348E-04 0.02170036 0.20579172 LEI_MYB_TARGETS pulmonary emphysema DOID_9675 8.649E-05 5.79E-04 1.000 1.000 LEI_MYB_TARGETS biliary tract cancer DOID_4607 9.053E-05 5.99E-04 0.36243932 0.96820645 LEI_MYB_TARGETS familial hypertrophic cardiomyopathy DOID_11986 9.313E-05 6.091E-04 9.313E-05 3.785E-03 LEI_MYB_TARGETS salivary gland cancer DOID_8850 9.454E-05 6.113E-04 0.0236286 0.21340751 LEI_MYB_TARGETS learning disability DOID_8927 1.219E-04 7.796E-04 0.02664724 0.22973154 LEI_MYB_TARGETS testicular cancer DOID_2998 1.317E-04 8.325E-04 1.000 1.000 LEI_MYB_TARGETS neuritis DOID_1803 1.432E-04 8.951E-04 0.0287415 0.23701328 LEI_MYB_TARGETS thyroid adenoma DOID_2891 1.432E-04 8.854E-04 2.362E-03 0.04977674 LEI_MYB_TARGETS hemolytic anemia DOID_583 1.547E-04 9.465E-04 0.23657617 0.69031712 LEI_MYB_TARGETS normocytic anemia DOID_720 1.547E-04 9.465E-04 0.23657617 0.69031712 LEI_MYB_TARGETS Crohn's disease DOID_8778 1.61E-04 9.745E-04 0.01443206 0.15792008 LEI_MYB_TARGETS glaucoma DOID_1686 1.669E-04 9.996E-04 0.24060904 0.69495709 LEI_MYB_TARGETS pulmonary tuberculosis DOID_2957 1.669E-04 9.892E-04 1.000 1.000 LEI_MYB_TARGETS hypersensitivity reaction type I disease DOID_1205 1.69E-04 9.914E-04 0.40174121 1.000 LEI_MYB_TARGETS funisitis DOID_0050698 2.068E-04 1.201E-03 5.968E-03 0.09177199 LEI_MYB_TARGETS atopic dermatitis DOID_3310 2.077E-04 1.194E-03 0.25258093 0.71859275 LEI_MYB_TARGETS bile duct adenocarcinoma DOID_4896 2.386E-04 1.357E-03 0.26045767 0.7373155 LEI_MYB_TARGETS cholangiocarcinoma DOID_4947 2.386E-04 1.357E-03 0.26045767 0.7373155 LEI_MYB_TARGETS osteochondrodysplasia DOID_2256 2.552E-04 1.438E-03 0.03773927 0.2753031 LEI_MYB_TARGETS diabetic angiopathy DOID_11713 2.698E-04 1.505E-03 0.11925409 0.49529619 LEI_MYB_TARGETS mitochondrial metabolism disease DOID_700 2.726E-04 1.506E-03 0.03893068 0.27689444 LEI_MYB_TARGETS spastic quadriplegia DOID_10970 3.053E-04 1.671E-03 1.000 1.000 LEI_MYB_TARGETS sphingolipidosis DOID_1927 3.053E-04 1.655E-03 3.053E-04 9.144E-03 LEI_MYB_TARGETS bile duct cancer DOID_4606 3.1E-04 1.664E-03 0.27596421 0.76972371 LEI_MYB_TARGETS bile duct carcinoma DOID_4897 3.1E-04 1.664E-03 0.27596421 0.76972371 LEI_MYB_TARGETS neuroectodermal tumor DOID_171 3.729E-04 1.983E-03 4.757E-03 0.08202584 LEI_MYB_TARGETS spinal muscular atrophy DOID_12377 3.853E-04 2.03E-03 8.912E-03 0.12074068 LEI_MYB_TARGETS papillary adenoma DOID_3172 3.853E-04 2.011E-03 8.912E-03 0.11793276 LEI_MYB_TARGETS microcystic adenoma DOID_5403 3.853E-04 2.011E-03 8.912E-03 0.11793276 LEI_MYB_TARGETS follicular adenoma DOID_6204 3.853E-04 2.011E-03 8.912E-03 0.11793276 LEI_MYB_TARGETS intracranial aneurysm DOID_10941 4.299E-04 2.224E-03 0.1377054 0.52586826 LEI_MYB_TARGETS seminoma DOID_4440 4.299E-04 2.204E-03 0.1377054 0.51212007 LEI_MYB_TARGETS endocrine pancreas disease DOID_1428 4.443E-04 2.257E-03 0.29861948 0.81689656 LEI_MYB_TARGETS cerebral degeneration DOID_1443 4.701E-04 2.367E-03 0.05027103 0.34462909 LEI_MYB_TARGETS periodontitis DOID_824 4.776E-04 2.384E-03 1.000 1.000 LEI_MYB_TARGETS hyperglycemia DOID_4195 4.97E-04 2.459E-03 1.000 1.000 LEI_MYB_TARGETS renal hypertension DOID_1073 5.286E-04 2.593E-03 0.1467863 0.52861649 LEI_MYB_TARGETS secondary hypertension DOID_11130 5.286E-04 2.593E-03 0.1467863 0.52861649 LEI_MYB_TARGETS tuberculosis DOID_399 5.54E-04 2.694E-03 1.000 1.000 LEI_MYB_TARGETS toxic encephalopathy DOID_3602 5.83E-04 2.811E-03 0.01164514 0.13804346 LEI_MYB_TARGETS female reproductive organ benign neoplasm DOID_0060086 6.408E-04 3.064E-03 0.15577205 0.54045301 LEI_MYB_TARGETS uterine benign neoplasm DOID_0060095 6.408E-04 3.064E-03 0.15577205 0.54045301 LEI_MYB_TARGETS uterine fibroid DOID_13223 6.408E-04 3.064E-03 0.15577205 0.54045301 LEI_MYB_TARGETS male reproductive system disease DOID_48 6.481E-04 3.073E-03 1.000 1.000 LEI_MYB_TARGETS abdominal aortic aneurysm DOID_7693 7.022E-04 3.302E-03 1.000 1.000 LEI_MYB_TARGETS germinoma DOID_3304 7.672E-04 3.578E-03 0.16466362 0.55440002 LEI_MYB_TARGETS leiomyoma DOID_127 8.359E-04 3.867E-03 0.16907441 0.56590199 LEI_MYB_TARGETS pancreatitis DOID_4989 8.692E-04 3.988E-03 8.822E-03 0.12243531 LEI_MYB_TARGETS periodontal disease DOID_3388 9.846E-04 4.482E-03 1.000 1.000 LEI_MYB_TARGETS esophageal disease DOID_6050 9.846E-04 4.446E-03 0.01633797 0.17215377 LEI_MYB_TARGETS female reproductive system disease DOID_229 9.975E-04 4.469E-03 9.753E-03 0.12332596 LEI_MYB_TARGETS chronic kidney failure DOID_784 1.09E-03 4.846E-03 1.000 1.000 LEI_MYB_TARGETS adenoma DOID_657 1.149E-03 5.069E-03 0.01805335 0.18343495 LEI_MYB_TARGETS hyperparathyroidism DOID_13543 1.212E-03 5.304E-03 1.000 1.000 LEI_MYB_TARGETS retinal vascular occlusion DOID_1729 1.212E-03 5.264E-03 1.000 1.000 LEI_MYB_TARGETS lateral sclerosis DOID_230 1.212E-03 5.224E-03 0.05152617 0.33699299 LEI_MYB_TARGETS polycythemia DOID_8432 1.212E-03 5.185E-03 1.212E-03 0.02998195 LEI_MYB_TARGETS pulmonary sarcoidosis DOID_13406 1.238E-03 5.255E-03 1.000 1.000 LEI_MYB_TARGETS calcinosis DOID_182 1.238E-03 5.216E-03 0.19078313 0.60986293 LEI_MYB_TARGETS primary bacterial infectious disease DOID_0050338 1.293E-03 5.411E-03 1.000 1.000 LEI_MYB_TARGETS hepatitis DOID_2237 1.427E-03 5.926E-03 0.02076211 0.20368343 LEI_MYB_TARGETS breast benign neoplasm DOID_0060082 1.476E-03 6.086E-03 1.000 1.000 LEI_MYB_TARGETS thoracic benign neoplasm DOID_0060097 1.476E-03 6.086E-03 1.000 1.000 LEI_MYB_TARGETS trypanosomiasis DOID_10113 1.476E-03 6.042E-03 1.000 1.000 LEI_MYB_TARGETS pneumocystosis DOID_11339 1.476E-03 5.999E-03 1.000 1.000 LEI_MYB_TARGETS benign breast phyllodes tumor DOID_1631 1.476E-03 6.086E-03 1.000 1.000 LEI_MYB_TARGETS lymphatic system disease DOID_75 1.528E-03 6.166E-03 0.20353651 0.62941453 LEI_MYB_TARGETS cervix uteri carcinoma in situ DOID_8991 1.633E-03 6.545E-03 1.000 1.000 LEI_MYB_TARGETS lymphoblastic leukemia DOID_1037 1.645E-03 6.547E-03 0.08996561 0.39992527 LEI_MYB_TARGETS carbohydrate metabolic disorder DOID_2978 1.645E-03 6.502E-03 0.08996561 0.39682507 LEI_MYB_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 1.71E-03 6.71E-03 0.39856025 1.000 LEI_MYB_TARGETS otitis media DOID_10754 1.765E-03 6.879E-03 0.0615099 0.38042538 LEI_MYB_TARGETS middle ear disease DOID_5100 1.765E-03 6.879E-03 0.0615099 0.38042538 LEI_MYB_TARGETS stomach disease DOID_76 1.765E-03 6.833E-03 0.0615099 0.35352662 LEI_MYB_TARGETS lipodystrophy DOID_811 1.765E-03 6.786E-03 1.000 1.000 LEI_MYB_TARGETS nephrotic syndrome DOID_1184 1.858E-03 7.095E-03 1.000 1.000 LEI_MYB_TARGETS hyperinsulinism DOID_2018 1.858E-03 7.047E-03 0.21608988 0.65401672 LEI_MYB_TARGETS gallbladder cancer DOID_3121 1.977E-03 7.449E-03 1.000 1.000 LEI_MYB_TARGETS influenza DOID_8469 1.977E-03 7.4E-03 1.000 1.000 LEI_MYB_TARGETS berylliosis DOID_10322 2.079E-03 7.731E-03 1.000 1.000 LEI_MYB_TARGETS vulva cancer DOID_1245 2.079E-03 7.681E-03 2.079E-03 0.04731538 LEI_MYB_TARGETS newborn respiratory distress syndrome DOID_12716 2.079E-03 7.632E-03 1.000 1.000 LEI_MYB_TARGETS Lynch syndrome DOID_3883 2.079E-03 7.583E-03 2.079E-03 0.04549556 LEI_MYB_TARGETS cataract DOID_83 2.1E-03 7.613E-03 0.02664724 0.23326588 LEI_MYB_TARGETS leukodystrophy DOID_10579 2.229E-03 8.027E-03 0.22844637 0.67701033 LEI_MYB_TARGETS pre-eclampsia DOID_10591 2.362E-03 8.453E-03 0.23252198 0.68551817 LEI_MYB_TARGETS lens disease DOID_110 2.362E-03 8.4E-03 0.0287415 0.2440883 LEI_MYB_TARGETS vascular skin disease DOID_9540 2.362E-03 8.348E-03 0.23252198 0.68198457 LEI_MYB_TARGETS tethered spinal cord syndrome DOID_1089 2.417E-03 8.489E-03 0.07138907 0.37611462 LEI_MYB_TARGETS hypercalcemia DOID_12678 2.417E-03 8.437E-03 0.07138907 0.37266403 LEI_MYB_TARGETS autoimmune disease of gastrointestinal tract DOID_0060031 2.643E-03 9.169E-03 0.24060904 0.69850279 LEI_MYB_TARGETS thoracic aortic aneurysm DOID_14004 2.779E-03 9.584E-03 0.07628978 0.38414941 LEI_MYB_TARGETS mesenchymal cell neoplasm DOID_3350 2.779E-03 9.526E-03 0.07628978 0.37101609 LEI_MYB_TARGETS spindle cell sarcoma DOID_4235 2.779E-03 9.526E-03 0.07628978 0.37101609 LEI_MYB_TARGETS oral submucous fibrosis DOID_5773 2.779E-03 9.469E-03 1.000 1.000 LEI_MYB_TARGETS epithelioid sarcoma DOID_6193 2.779E-03 9.526E-03 0.07628978 0.37101609 LEI_MYB_TARGETS intermediate coronary syndrome DOID_8805 2.779E-03 9.413E-03 1.000 1.000 LEI_MYB_TARGETS B-cell lymphocytic neoplasm DOID_707 2.943E-03 9.91E-03 0.03311932 0.25126521 LEI_MYB_TARGETS angiosarcoma DOID_0001816 3.165E-03 0.01059396 1.000 1.000 LEI_MYB_TARGETS silicosis DOID_10325 3.165E-03 0.01053201 1.000 1.000 LEI_MYB_TARGETS hemolytic-uremic syndrome DOID_12554 3.165E-03 0.01047077 1.000 1.000 LEI_MYB_TARGETS Barrett's esophagus DOID_9206 3.165E-03 0.01041025 0.08116475 0.38167557 LEI_MYB_TARGETS sarcoidosis DOID_11335 3.264E-03 0.01067397 1.000 1.000 LEI_MYB_TARGETS vasculitis DOID_865 3.432E-03 0.0111595 1.000 1.000 LEI_MYB_TARGETS urinary system benign neoplasm DOID_731 3.575E-03 0.01155703 0.08601413 0.38537038 LEI_MYB_TARGETS keratosis DOID_161 4.008E-03 0.01288347 4.008E-03 0.0786336 LEI_MYB_TARGETS neuroendocrine tumor DOID_169 4.008E-03 0.01281109 4.008E-03 0.07601248 LEI_MYB_TARGETS ureteral obstruction DOID_5199 4.008E-03 0.01273952 1.000 1.000 LEI_MYB_TARGETS hypersensitivity reaction type IV disease DOID_2916 4.157E-03 0.01314095 1.000 1.000 LEI_MYB_TARGETS esophagitis DOID_11963 4.943E-03 0.0155375 0.10040998 0.42957354 LEI_MYB_TARGETS colon carcinoma DOID_1520 4.943E-03 0.01545213 0.10040998 0.42636776 LEI_MYB_TARGETS brain edema DOID_4724 4.943E-03 0.01536769 4.943E-03 0.08271432 LEI_MYB_TARGETS Kawasaki disease DOID_13378 5.444E-03 0.01683465 1.000 1.000 LEI_MYB_TARGETS lymphadenitis DOID_1602 5.444E-03 0.01683465 1.000 1.000 LEI_MYB_TARGETS autoimmune hepatitis DOID_2048 5.444E-03 0.01674365 1.000 1.000 LEI_MYB_TARGETS Leigh disease DOID_3652 5.444E-03 0.01665363 5.444E-03 0.08604377 LEI_MYB_TARGETS mitochondrial myopathy DOID_699 5.444E-03 0.01656458 1.000 1.000 LEI_MYB_TARGETS lymph node disease DOID_9942 5.444E-03 0.01683465 1.000 1.000 LEI_MYB_TARGETS cholestasis DOID_13580 5.635E-03 0.01705467 1.000 1.000 LEI_MYB_TARGETS uterine disease DOID_345 5.635E-03 0.01696444 0.05027103 0.34052636 LEI_MYB_TARGETS muscular atrophy DOID_767 5.968E-03 0.01787139 0.10988165 0.45972545 LEI_MYB_TARGETS tooth disease DOID_1091 6.108E-03 0.01819531 1.000 1.000 LEI_MYB_TARGETS IgA glomerulonephritis DOID_2986 6.513E-03 0.01930266 1.000 1.000 LEI_MYB_TARGETS urinary tract obstruction DOID_5200 6.513E-03 0.01920264 1.000 1.000 LEI_MYB_TARGETS polyarteritis nodosa DOID_9810 6.513E-03 0.01910366 1.000 1.000 LEI_MYB_TARGETS synostosis DOID_11971 7.081E-03 0.02066193 0.11925409 0.49170709 LEI_MYB_TARGETS ureteral disease DOID_1426 7.081E-03 0.02055651 1.000 1.000 LEI_MYB_TARGETS aortic valve disease DOID_62 7.081E-03 0.02045216 0.11925409 0.48124523 LEI_MYB_TARGETS meningitis DOID_9471 7.081E-03 0.02034887 1.000 1.000 LEI_MYB_TARGETS Goodpasture syndrome DOID_9808 7.081E-03 0.02024661 1.000 1.000 LEI_MYB_TARGETS bile duct disease DOID_4138 7.123E-03 0.02026401 1.000 1.000 LEI_MYB_TARGETS biliary tract disease DOID_9741 7.391E-03 0.02092291 1.000 1.000 LEI_MYB_TARGETS diabetic retinopathy DOID_8947 7.665E-03 0.02159195 0.33128651 0.8976287 LEI_MYB_TARGETS toxic shock syndrome DOID_14115 7.67E-03 0.02149912 1.000 1.000 LEI_MYB_TARGETS acute pancreatitis DOID_2913 7.67E-03 0.02139373 0.12390342 0.49648625 LEI_MYB_TARGETS commensal bacterial infectious disease DOID_0050339 8.281E-03 0.02298396 1.000 1.000 LEI_MYB_TARGETS organic acidemia DOID_0060159 8.281E-03 0.02287239 8.281E-03 0.12081312 LEI_MYB_TARGETS portal hypertension DOID_10762 8.281E-03 0.02276189 1.000 1.000 LEI_MYB_TARGETS urticaria DOID_1555 8.281E-03 0.02265246 0.12852833 0.50786542 LEI_MYB_TARGETS osteosarcoma DOID_3347 8.281E-03 0.02254407 0.12852833 0.5043629 LEI_MYB_TARGETS mixed glioma DOID_5076 8.822E-03 0.02390404 0.34531492 0.93120469 LEI_MYB_TARGETS morbid obesity DOID_11981 8.912E-03 0.02403369 0.13312895 0.51530865 LEI_MYB_TARGETS cleft lip DOID_9296 8.912E-03 0.02392032 0.13312895 0.51182683 LEI_MYB_TARGETS spinal cord disease DOID_319 9.565E-03 0.02555107 0.1377054 0.51890312 LEI_MYB_TARGETS auditory system disease DOID_2742 0.01007597 0.02679079 0.35905047 0.96367793 LEI_MYB_TARGETS diffuse large B-cell lymphoma DOID_0050745 0.01023794 0.02709482 0.01023794 0.12663883 LEI_MYB_TARGETS Sciatic Neuropathy DOID_11446 0.01023794 0.02696938 1.000 1.000 LEI_MYB_TARGETS lesion of sciatic nerve DOID_12528 0.01023794 0.02696938 1.000 1.000 LEI_MYB_TARGETS mononeuritis of lower limb DOID_9473 0.01023794 0.02696938 1.000 1.000 LEI_MYB_TARGETS autoimmune disease of cardiovascular system DOID_0060051 0.01093146 0.02866359 1.000 1.000 LEI_MYB_TARGETS Behcet's disease DOID_13241 0.01093146 0.02866359 1.000 1.000 LEI_MYB_TARGETS mononeuritis DOID_1802 0.01093146 0.02853211 1.000 1.000 LEI_MYB_TARGETS hepatic vascular disease DOID_272 0.01093146 0.02840182 1.000 1.000 LEI_MYB_TARGETS coronary stenosis DOID_4248 0.01093146 0.02827272 0.1467863 0.52200878 LEI_MYB_TARGETS retinal vascular disease DOID_2462 0.01108074 0.02852915 0.36916362 0.98156122 LEI_MYB_TARGETS autoimmune disease of endocrine system DOID_0060005 0.01164514 0.02984724 0.15129101 0.53468685 LEI_MYB_TARGETS mononeuropathy DOID_1188 0.01164514 0.02971339 1.000 1.000 LEI_MYB_TARGETS supratentorial cancer DOID_1659 0.01164514 0.02958074 0.15129101 0.53138631 LEI_MYB_TARGETS cerebrum cancer DOID_368 0.01164514 0.02958074 0.15129101 0.53138631 LEI_MYB_TARGETS cranial nerve disease DOID_5656 0.01164514 0.02944927 0.15129101 0.52812627 LEI_MYB_TARGETS dysostosis DOID_1934 0.01237876 0.031166 0.15577205 0.53394153 LEI_MYB_TARGETS Human immunodeficiency virus infectious disease DOID_526 0.01287974 0.03228445 0.38566724 1.000 LEI_MYB_TARGETS opportunistic mycosis DOID_2473 0.01313209 0.03277263 1.000 1.000 LEI_MYB_TARGETS Charcot-Marie-Tooth disease DOID_10595 0.0139049 0.03454972 0.0139049 0.15513503 LEI_MYB_TARGETS celiac disease DOID_10608 0.0139049 0.03439951 0.16466362 0.55770002 LEI_MYB_TARGETS allergic rhinitis DOID_4481 0.0139049 0.03425059 1.000 1.000 LEI_MYB_TARGETS encephalomyelitis DOID_640 0.0140345 0.03442081 0.08996561 0.39377257 LEI_MYB_TARGETS autonomic nervous system neoplasm DOID_2621 0.01469696 0.03589086 1.000 1.000 LEI_MYB_TARGETS neuroblastoma DOID_769 0.01469696 0.03589086 1.000 1.000 LEI_MYB_TARGETS systemic mycosis DOID_0050136 0.01550806 0.03770976 1.000 1.000 LEI_MYB_TARGETS fungal infectious disease DOID_1564 0.01550806 0.03770976 1.000 1.000 LEI_MYB_TARGETS hair disease DOID_421 0.01550806 0.0375493 0.17346202 0.57383656 LEI_MYB_TARGETS lymphoid leukemia DOID_10747 0.01718647 0.04143687 0.01718647 0.17780186 LEI_MYB_TARGETS medullomyoblastoma DOID_3861 0.01718647 0.04126203 0.1821682 0.59230689 LEI_MYB_TARGETS adult medulloblastoma DOID_3864 0.01718647 0.04126203 0.1821682 0.59230689 LEI_MYB_TARGETS childhood medulloblastoma DOID_3869 0.01718647 0.04126203 0.1821682 0.59230689 LEI_MYB_TARGETS medulloblastoma DOID_3858 0.01893839 0.04527708 0.19078313 0.60645587 LEI_MYB_TARGETS peripheral nervous system neoplasm DOID_1192 0.01984138 0.04723743 1.000 1.000 LEI_MYB_TARGETS congenital diaphragmatic hernia DOID_3827 0.02076211 0.0492235 1.000 1.000 LEI_MYB_TARGETS autoimmune disease of urogenital tract DOID_0060049 0.0236286 0.05578703 0.0236286 0.22040448 LEI_MYB_TARGETS primary biliary cirrhosis DOID_12236 0.0236286 0.05578703 0.0236286 0.22040448 LEI_MYB_TARGETS endometriosis of uterus DOID_288 0.0236286 0.0555565 0.0236286 0.21684957 LEI_MYB_TARGETS primitive neuroectodermal tumor DOID_168 0.02461818 0.05764504 0.21608988 0.66104915 LEI_MYB_TARGETS endometriosis DOID_289 0.02461818 0.05740879 0.02461818 0.21887101 LEI_MYB_TARGETS uterine cancer DOID_363 0.02562446 0.05951151 0.22023043 0.6595322 LEI_MYB_TARGETS proteinuria DOID_576 0.02768632 0.06403869 1.000 1.000 LEI_MYB_TARGETS bone marrow disease DOID_4961 0.0287415 0.06621019 0.0287415 0.23033685 LEI_MYB_TARGETS movement disease DOID_480 0.03200169 0.07342323 0.24462072 0.70297572 LEI_MYB_TARGETS orofacial cleft DOID_0050567 0.03425208 0.07827081 0.25258093 0.72220377 LEI_MYB_TARGETS melancholia DOID_2848 0.0425894 0.09693348 1.000 1.000 LEI_MYB_TARGETS leukocyte disease DOID_9500 0.0425894 0.09654729 1.000 1.000 LEI_MYB_TARGETS neurotic disorder DOID_4964 0.04383654 0.09898012 1.000 1.000 ROY_WOUND_BLOOD_VESSEL_DN epidermolysis bullosa DOID_2730 8.34E-06 4.746E-03 8.34E-06 4.746E-03 ROY_WOUND_BLOOD_VESSEL_DN vesiculobullous skin disease DOID_2731 9.855E-06 2.804E-03 9.855E-06 2.804E-03 ROY_WOUND_BLOOD_VESSEL_DN uterine cancer DOID_363 1.356E-04 0.02571846 1.000 1.000 ROY_WOUND_BLOOD_VESSEL_DN oral cavity cancer DOID_8618 2.289E-04 0.03255734 2.289E-04 0.04340978 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 newborn respiratory distress syndrome DOID_12716 1.461E-10 8.31E-08 3.199E-08 1.82E-05 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 respiratory failure DOID_11162 2.107E-08 5.995E-06 2.727E-05 3.879E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 diabetic angiopathy DOID_11713 4.649E-07 8.819E-05 1.831E-03 0.043399 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 peripheral vascular disease DOID_341 1.721E-06 2.448E-04 1.048E-03 0.03725819 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 congenital diaphragmatic hernia DOID_3827 4.722E-06 5.374E-04 5.537E-03 0.07001154 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 hemolytic anemia DOID_583 1.035E-05 9.818E-04 1.035E-05 2.945E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 normocytic anemia DOID_720 1.035E-05 9.818E-04 1.035E-05 2.945E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 neurotic disorder DOID_4964 2.409E-05 1.958E-03 2.409E-05 4.568E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 hyperglycemia DOID_4195 3.454E-05 2.456E-03 0.01440726 0.1122977 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 portal hypertension DOID_10762 4.43E-05 2.801E-03 2.148E-03 0.04526993 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 endogenous depression DOID_1595 5.596E-05 3.184E-03 5.596E-05 6.368E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 metabolic syndrome X DOID_14221 6.806E-05 3.521E-03 1.356E-03 0.04285983 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 malaria DOID_12365 6.865E-05 3.255E-03 2.856E-03 0.05077479 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 hepatic vascular disease DOID_272 6.865E-05 3.005E-03 2.856E-03 0.04923616 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 mental depression DOID_1596 7.832E-05 3.183E-03 7.832E-05 7.427E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 amino acid metabolic disorder DOID_9252 1.021E-04 3.874E-03 1.828E-03 0.04523143 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 respiratory syncytial virus infectious disease DOID_1273 1.897E-04 6.746E-03 5.537E-03 0.07160271 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 adult respiratory distress syndrome DOID_11394 2.035E-04 6.813E-03 5.797E-03 0.07170769 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 spinocerebellar ataxia DOID_1441 2.331E-04 7.37E-03 2.331E-04 0.01895113 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 spinocerebellar degeneration DOID_2478 3.004E-04 8.996E-03 3.004E-04 0.02136601 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 proteinuria DOID_576 3.004E-04 8.546E-03 3.004E-04 0.01899201 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 3.057E-04 8.284E-03 3.057E-04 0.01739611 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 Hodgkin's lymphoma, lymphocytic depletion DOID_8628 3.057E-04 8.284E-03 3.057E-04 0.01739611 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 Hodgkin's granuloma DOID_8651 3.057E-04 8.284E-03 3.057E-04 0.01739611 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 Hodgkin's lymphoma, mixed cellularity DOID_8654 3.057E-04 8.284E-03 3.057E-04 0.01739611 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 pre-eclampsia DOID_10591 3.19E-04 8.25E-03 7.771E-03 0.08039168 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 pneumocystosis DOID_11339 3.73E-04 9.228E-03 3.73E-04 0.01929575 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 Hodgkin's lymphoma DOID_8567 4.469E-04 0.0105944 4.469E-04 0.02118881 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 parasitic protozoa infectious disease DOID_2789 4.945E-04 0.01125542 0.01034348 0.09341967 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 familial hyperlipidemia DOID_1168 5.2E-04 0.01138054 0.01068816 0.09356251 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 melancholia DOID_2848 6.015E-04 0.01267661 6.015E-04 0.02632835 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 hyperhomocysteinemia DOID_9279 7.073E-04 0.01437251 0.03885111 0.19057142 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 cholestasis DOID_13580 7.88E-04 0.01546151 0.01401349 0.11390969 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 parasitic infectious disease DOID_1398 7.88E-04 0.01494613 0.01401349 0.11230533 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 tuberculosis DOID_399 8.936E-04 0.01640142 8.936E-04 0.03631742 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 bile duct disease DOID_4138 1.008E-03 0.01791805 0.0164469 0.12477713 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 glucose intolerance DOID_10603 1.025E-03 0.01767819 1.025E-03 0.03889201 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 biliary tract disease DOID_9741 1.048E-03 0.01753327 0.01686879 0.12465381 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 cystic fibrosis DOID_1485 1.174E-03 0.01907981 0.01816194 0.13248901 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 mixed glioma DOID_5076 1.263E-03 0.01995711 0.01904665 0.1371841 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 bacterial pneumonia DOID_874 1.263E-03 0.01941773 0.01904665 0.1354693 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 brain edema DOID_4724 1.269E-03 0.01899927 0.05146643 0.21854028 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 amyloidosis DOID_9120 1.269E-03 0.01851211 1.269E-03 0.04246895 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 lipid metabolism disorder DOID_3146 1.356E-03 0.01928692 0.01994921 0.14013703 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 chronic kidney failure DOID_784 1.504E-03 0.02086631 0.2012881 0.51130773 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 familial hypercholesterolemia DOID_13810 1.537E-03 0.02082748 1.537E-03 0.04603969 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 muscular atrophy DOID_767 1.537E-03 0.02034312 1.537E-03 0.04373771 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 retinal vascular disease DOID_2462 1.607E-03 0.02078662 0.02228231 0.15093615 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 sinusitis DOID_0050127 1.681E-03 0.02125377 1.681E-03 0.04554378 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 paranasal sinus disease DOID_1352 1.681E-03 0.02125377 1.681E-03 0.04554378 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 uremia DOID_4676 1.681E-03 0.02079173 1.000 1.000 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 primary bacterial infectious disease DOID_0050338 1.716E-03 0.02077021 1.716E-03 0.04437273 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 congenital hemolytic anemia DOID_589 1.831E-03 0.0216995 1.831E-03 0.04166304 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 lymphoma DOID_0060058 2.006E-03 0.02329263 2.006E-03 0.04389765 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 Crohn's disease DOID_8778 2.13E-03 0.02423913 0.02674949 0.16366087 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 osteosarcoma DOID_3347 2.148E-03 0.02396644 2.148E-03 0.04365315 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 cleft lip DOID_9296 2.316E-03 0.02534244 0.06885291 0.2665123 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 ulcerative colitis DOID_8577 2.392E-03 0.0256831 0.02884143 0.16918324 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 fragments of torsion dystonia DOID_531 2.49E-03 0.02623598 2.49E-03 0.04885321 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 dystonia DOID_543 2.49E-03 0.02575896 2.49E-03 0.04722477 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 gestational diabetes DOID_11714 2.67E-03 0.02712639 0.07376227 0.27795187 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 migraine DOID_6364 2.67E-03 0.02665049 2.67E-03 0.04900251 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 pleurisy DOID_10247 2.856E-03 0.02801368 0.07620733 0.28527613 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 central nervous system hereditary degenerative disease DOID_481 2.856E-03 0.02753887 2.856E-03 0.04778804 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 toxic encephalopathy DOID_3602 3.047E-03 0.02889785 3.047E-03 0.04953918 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 dystonic disease DOID_544 3.047E-03 0.02842412 3.047E-03 0.04816309 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 female reproductive organ benign neoplasm DOID_0060086 3.245E-03 0.02977893 0.0810783 0.29014813 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 uterine benign neoplasm DOID_0060095 3.245E-03 0.02977893 0.0810783 0.29014813 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 uterine fibroid DOID_13223 3.245E-03 0.02977893 0.0810783 0.29014813 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 endometrial carcinoma DOID_2871 3.245E-03 0.02930625 3.245E-03 0.04989982 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 opportunistic mycosis DOID_2473 3.448E-03 0.03065691 3.448E-03 0.05163268 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 bronchiolitis obliterans DOID_2799 3.448E-03 0.03018526 0.08350424 0.29511746 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 celiac disease DOID_10608 3.657E-03 0.0315318 3.657E-03 0.05336151 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 endometrial cancer DOID_1380 3.657E-03 0.03106118 3.657E-03 0.05202747 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 allergic rhinitis DOID_4481 3.657E-03 0.0306044 0.08592384 0.29994272 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 leiomyoma DOID_127 3.872E-03 0.031934 0.08833711 0.30648669 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 pleural disease DOID_1532 3.872E-03 0.0314778 0.08833711 0.3046292 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 systemic mycosis DOID_0050136 4.093E-03 0.03280375 4.093E-03 0.05680649 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 fungal infectious disease DOID_1564 4.093E-03 0.03280375 4.093E-03 0.05680649 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 multiple myeloma DOID_9538 5.033E-03 0.03977662 5.033E-03 0.0681885 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 uveitis DOID_13141 5.282E-03 0.04117308 5.282E-03 0.06989848 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 intracranial arterial disease DOID_13089 5.797E-03 0.04457505 0.1074176 0.34145594 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 cerebral arterial disease DOID_3527 5.797E-03 0.04457505 0.1074176 0.34145594 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 lymphatic system disease DOID_75 5.797E-03 0.04398071 5.797E-03 0.07018199 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 benign mesothelioma DOID_2645 6.063E-03 0.04539106 6.063E-03 0.07186917 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 pulmonary emphysema DOID_9675 6.063E-03 0.04480156 0.10977469 0.34700998 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 autoimmune disease of urogenital tract DOID_0060049 6.334E-03 0.04620516 6.334E-03 0.07355107 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 primary biliary cirrhosis DOID_12236 6.334E-03 0.04620516 6.334E-03 0.07355107 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 primitive neuroectodermal tumor DOID_168 6.611E-03 0.04761243 6.611E-03 0.07522765 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 hyperinsulinism DOID_2018 6.611E-03 0.04701728 0.11447039 0.35398725 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 uveal disease DOID_3480 6.611E-03 0.04643682 6.611E-03 0.0737526 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 uterine cancer DOID_363 6.893E-03 0.04782736 6.893E-03 0.07542006 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 cataract DOID_83 7.18E-03 0.0492213 7.18E-03 0.07708242 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 myeloma DOID_0070004 7.771E-03 0.05263741 7.771E-03 0.08188041 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 lens disease DOID_110 7.771E-03 0.05201814 7.771E-03 0.07895611 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 vascular skin disease DOID_9540 7.771E-03 0.05141328 0.12378837 0.36877267 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 autoimmune disease of gastrointestinal tract DOID_0060031 8.383E-03 0.05482494 8.383E-03 0.08368017 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 pulmonary tuberculosis DOID_2957 8.383E-03 0.05420193 8.383E-03 0.0822374 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 movement disease DOID_480 8.697E-03 0.05559956 8.697E-03 0.08387053 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 orofacial cleft DOID_0050567 9.34E-03 0.05904909 0.13529943 0.38686119 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 sarcoidosis DOID_11335 9.669E-03 0.06045989 9.669E-03 0.0916975 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 atrophic muscular disease DOID_913 9.669E-03 0.05980272 9.669E-03 0.09019426 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 muscular dystrophy DOID_9884 9.669E-03 0.05980272 9.669E-03 0.09019426 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 bone marrow cancer DOID_4960 0.01000386 0.06120641 0.01000386 0.09180961 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 reproductive organ benign neoplasm DOID_0050622 0.01034348 0.06261105 0.14213408 0.40235966 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 pustulosis of palm and sole DOID_4398 0.01034348 0.06195199 0.01034348 0.09195999 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 hypersensitivity reaction type IV disease DOID_2916 0.0113926 0.0675249 0.0113926 0.09821804 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 leukocyte disease DOID_9500 0.01175231 0.06893878 1.000 1.000 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 neuroectodermal tumor DOID_171 0.01248653 0.07249834 0.01248653 0.10604234 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 congenital heart defect DOID_1682 0.01324034 0.0760985 0.01324034 0.11079046 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 mineral metabolism disease DOID_0050032 0.01362451 0.07752346 0.01362451 0.11235284 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 endocrine pancreas disease DOID_1428 0.01362451 0.0767559 0.16231876 0.43772214 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 uterine disease DOID_345 0.01401349 0.07817332 0.16453227 0.43952517 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 temporal lobe epilepsy DOID_3328 0.01440726 0.07958963 0.01440726 0.11385739 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 blood coagulation disease DOID_1247 0.01602962 0.08770052 0.01602962 0.12325479 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 male reproductive system disease DOID_48 0.0164469 0.08912652 0.0164469 0.12313532 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 diabetic retinopathy DOID_8947 0.01729528 0.09283978 0.18203315 0.47731273 KOYAMA_SEMA3B_TARGETS_DN mixed glioma DOID_5076 1.89E-09 1.076E-06 2.342E-05 1.11E-03 KOYAMA_SEMA3B_TARGETS_DN congenital heart defect DOID_1682 1.321E-08 3.757E-06 1.321E-08 7.514E-06 KOYAMA_SEMA3B_TARGETS_DN astrocytoma DOID_3069 2.446E-08 4.639E-06 1.401E-05 1.138E-03 KOYAMA_SEMA3B_TARGETS_DN peripheral vascular disease DOID_341 3.261E-08 4.638E-06 2.941E-04 8.368E-03 KOYAMA_SEMA3B_TARGETS_DN vascular skin disease DOID_9540 7.009E-08 7.976E-06 1.25E-03 0.01778262 KOYAMA_SEMA3B_TARGETS_DN giant cell tumor DOID_200 1.403E-07 1.33E-05 4.037E-06 5.743E-04 KOYAMA_SEMA3B_TARGETS_DN malignant giant cell tumor DOID_2705 1.403E-07 1.33E-05 4.037E-06 5.743E-04 KOYAMA_SEMA3B_TARGETS_DN giant cell glioblastoma DOID_3074 1.403E-07 1.33E-05 4.037E-06 5.743E-04 KOYAMA_SEMA3B_TARGETS_DN bone marrow cancer DOID_4960 1.562E-07 1.27E-05 1.562E-07 4.444E-05 KOYAMA_SEMA3B_TARGETS_DN glioblastoma DOID_3068 2.357E-07 1.677E-05 6.182E-06 7.035E-04 KOYAMA_SEMA3B_TARGETS_DN thyroid carcinoma DOID_3963 4.915E-07 3.107E-05 1.81E-05 1.145E-03 KOYAMA_SEMA3B_TARGETS_DN thyroid cancer DOID_1781 6.447E-07 3.669E-05 2.24E-05 1.159E-03 KOYAMA_SEMA3B_TARGETS_DN pancreatic ductal carcinoma DOID_3587 6.931E-07 3.585E-05 1.498E-05 1.066E-03 KOYAMA_SEMA3B_TARGETS_DN pancreatic carcinoma DOID_4905 8.809E-07 4.177E-05 1.824E-05 1.038E-03 KOYAMA_SEMA3B_TARGETS_DN lymphatic system disease DOID_75 1.063E-06 4.654E-05 3.317E-05 1.348E-03 KOYAMA_SEMA3B_TARGETS_DN testicular cancer DOID_2998 1.127E-06 4.581E-05 2.887E-03 0.03221422 KOYAMA_SEMA3B_TARGETS_DN glaucoma DOID_1686 2.784E-06 1.056E-04 2.784E-06 5.281E-04 KOYAMA_SEMA3B_TARGETS_DN lymphoma DOID_0060058 3.082E-06 1.096E-04 5.099E-05 1.934E-03 KOYAMA_SEMA3B_TARGETS_DN lymphoblastic leukemia DOID_1037 3.278E-06 1.097E-04 5.364E-05 1.908E-03 KOYAMA_SEMA3B_TARGETS_DN ulcerative colitis DOID_8577 4.419E-06 1.397E-04 8.746E-04 0.01715967 KOYAMA_SEMA3B_TARGETS_DN Noonan syndrome DOID_3490 8.662E-06 2.594E-04 8.662E-06 8.215E-04 KOYAMA_SEMA3B_TARGETS_DN open-angle glaucoma DOID_1067 2.595E-05 7.383E-04 2.595E-05 1.136E-03 KOYAMA_SEMA3B_TARGETS_DN pulmonary emphysema DOID_9675 3.636E-05 9.853E-04 8.605E-04 0.0174864 KOYAMA_SEMA3B_TARGETS_DN transitional cell carcinoma DOID_2671 4.139E-05 1.07E-03 6.627E-03 0.05985091 KOYAMA_SEMA3B_TARGETS_DN Huntington's disease DOID_12858 4.343E-05 1.074E-03 9.802E-04 0.01742931 KOYAMA_SEMA3B_TARGETS_DN primary immunodeficiency disease DOID_612 4.364E-05 1.035E-03 6.139E-04 0.01455348 KOYAMA_SEMA3B_TARGETS_DN Leigh disease DOID_3652 9.279E-05 2.112E-03 9.279E-05 3.106E-03 KOYAMA_SEMA3B_TARGETS_DN benign glioma DOID_0060101 1.071E-04 2.344E-03 0.08887152 0.30647209 KOYAMA_SEMA3B_TARGETS_DN benign ependymoma DOID_4844 1.071E-04 2.344E-03 0.08887152 0.30647209 KOYAMA_SEMA3B_TARGETS_DN pustulosis of palm and sole DOID_4398 1.085E-04 2.288E-03 1.92E-03 0.02427852 KOYAMA_SEMA3B_TARGETS_DN polyarteritis nodosa DOID_9810 1.228E-04 2.495E-03 0.09271909 0.2997566 KOYAMA_SEMA3B_TARGETS_DN aortic valve disease DOID_62 1.399E-04 2.745E-03 1.399E-04 4.422E-03 KOYAMA_SEMA3B_TARGETS_DN neuroectodermal tumor DOID_171 1.594E-04 3.023E-03 2.545E-03 0.0295558 KOYAMA_SEMA3B_TARGETS_DN vitiligo DOID_12306 2.236E-04 4.105E-03 2.236E-04 6.698E-03 KOYAMA_SEMA3B_TARGETS_DN supratentorial cancer DOID_1659 3.04E-04 5.406E-03 7.596E-03 0.06548443 KOYAMA_SEMA3B_TARGETS_DN toxic encephalopathy DOID_3602 3.04E-04 5.242E-03 7.596E-03 0.06450705 KOYAMA_SEMA3B_TARGETS_DN cerebrum cancer DOID_368 3.04E-04 5.406E-03 7.596E-03 0.06548443 KOYAMA_SEMA3B_TARGETS_DN celiac disease DOID_10608 4.01E-04 6.711E-03 4.01E-04 0.01086504 KOYAMA_SEMA3B_TARGETS_DN female reproductive system disease DOID_229 4.332E-04 7.043E-03 4.332E-04 0.01120493 KOYAMA_SEMA3B_TARGETS_DN chronic leukemia DOID_1036 4.372E-04 6.911E-03 9.613E-03 0.07492703 KOYAMA_SEMA3B_TARGETS_DN chronic lymphocytic leukemia DOID_1040 4.372E-04 6.911E-03 9.613E-03 0.07492703 KOYAMA_SEMA3B_TARGETS_DN nephroblastoma DOID_2154 5.159E-04 7.933E-03 0.01070081 0.08228053 KOYAMA_SEMA3B_TARGETS_DN lymphoid leukemia DOID_10747 5.584E-04 8.361E-03 5.584E-04 0.01381328 KOYAMA_SEMA3B_TARGETS_DN nervous system cancer DOID_3093 6.397E-04 9.333E-03 7.04E-03 0.06259383 KOYAMA_SEMA3B_TARGETS_DN multiple myeloma DOID_9538 6.499E-04 9.245E-03 6.499E-04 0.0147918 KOYAMA_SEMA3B_TARGETS_DN Crohn's disease DOID_8778 7.506E-04 0.0104174 7.913E-03 0.06525353 KOYAMA_SEMA3B_TARGETS_DN rectal neoplasm DOID_1984 7.79E-04 0.01055401 7.79E-04 0.01704879 KOYAMA_SEMA3B_TARGETS_DN rectum cancer DOID_1993 7.79E-04 0.01055401 7.79E-04 0.01704879 KOYAMA_SEMA3B_TARGETS_DN insulinoma DOID_3892 7.79E-04 0.01030857 0.04141635 0.22443719 KOYAMA_SEMA3B_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 7.804E-04 0.01009167 8.141E-03 0.0661717 KOYAMA_SEMA3B_TARGETS_DN adenoid cystic carcinoma DOID_4866 8.043E-04 0.01016993 8.043E-04 0.01694988 KOYAMA_SEMA3B_TARGETS_DN salivary gland cancer DOID_8850 9.191E-04 0.01136902 9.191E-04 0.0174325 KOYAMA_SEMA3B_TARGETS_DN nervous system benign neoplasm DOID_0060115 9.495E-04 0.01149513 9.495E-04 0.0174281 KOYAMA_SEMA3B_TARGETS_DN primitive neuroectodermal tumor DOID_168 9.802E-04 0.01161954 0.01622364 0.11834939 KOYAMA_SEMA3B_TARGETS_DN cataract DOID_83 1.11E-03 0.01288926 1.11E-03 0.0191386 KOYAMA_SEMA3B_TARGETS_DN ovarian disease DOID_1100 1.136E-03 0.01293058 1.136E-03 0.01901557 KOYAMA_SEMA3B_TARGETS_DN islet cell tumor DOID_1799 1.136E-03 0.01267704 0.04949275 0.2346781 KOYAMA_SEMA3B_TARGETS_DN aortic valve insufficiency DOID_57 1.136E-03 0.01243325 1.136E-03 0.01847226 KOYAMA_SEMA3B_TARGETS_DN Hodgkin's lymphoma DOID_8567 1.136E-03 0.01219867 1.136E-03 0.01795915 KOYAMA_SEMA3B_TARGETS_DN myeloma DOID_0070004 1.25E-03 0.01317231 1.25E-03 0.01922446 KOYAMA_SEMA3B_TARGETS_DN lens disease DOID_110 1.25E-03 0.01293282 1.25E-03 0.01871855 KOYAMA_SEMA3B_TARGETS_DN brain cancer DOID_1319 1.25E-03 0.01270187 0.01899258 0.13178997 KOYAMA_SEMA3B_TARGETS_DN neuritis DOID_1803 1.25E-03 0.01247903 0.19071503 0.44292592 KOYAMA_SEMA3B_TARGETS_DN heart valve disease DOID_4079 1.25E-03 0.01226388 1.25E-03 0.01823859 KOYAMA_SEMA3B_TARGETS_DN central nervous system cancer DOID_3620 1.324E-03 0.01277008 0.01971374 0.135146 KOYAMA_SEMA3B_TARGETS_DN parathyroid gland disease DOID_11201 1.339E-03 0.0126994 1.339E-03 0.01858449 KOYAMA_SEMA3B_TARGETS_DN larynx cancer DOID_2596 1.339E-03 0.01249121 0.05350555 0.24162425 KOYAMA_SEMA3B_TARGETS_DN laryngeal benign neoplasm DOID_2598 1.339E-03 0.01249121 0.05350555 0.24162425 KOYAMA_SEMA3B_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.401E-03 0.01285649 1.401E-03 0.01897864 KOYAMA_SEMA3B_TARGETS_DN aortic aneurysm DOID_3627 1.48E-03 0.0133703 1.48E-03 0.01958904 KOYAMA_SEMA3B_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 1.563E-03 0.01389271 0.02194491 0.14865066 KOYAMA_SEMA3B_TARGETS_DN skeletal system cancer DOID_0060124 1.793E-03 0.01569308 1.793E-03 0.02318296 KOYAMA_SEMA3B_TARGETS_DN bone cancer DOID_184 1.793E-03 0.01569308 1.793E-03 0.02318296 KOYAMA_SEMA3B_TARGETS_DN mitochondrial metabolism disease DOID_700 2.017E-03 0.01738673 2.017E-03 0.02494618 KOYAMA_SEMA3B_TARGETS_DN oral cavity cancer DOID_8618 2.219E-03 0.01884483 2.219E-03 0.02686391 KOYAMA_SEMA3B_TARGETS_DN familial hypertrophic cardiomyopathy DOID_11986 2.309E-03 0.01932218 2.309E-03 0.02737309 KOYAMA_SEMA3B_TARGETS_DN basal cell carcinoma DOID_2513 2.309E-03 0.01904215 0.0693891 0.26677295 KOYAMA_SEMA3B_TARGETS_DN skin carcinoma DOID_3451 2.591E-03 0.021058 0.07331842 0.27627934 KOYAMA_SEMA3B_TARGETS_DN ureteral obstruction DOID_5199 2.591E-03 0.02076141 2.591E-03 0.0294812 KOYAMA_SEMA3B_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 3.417E-03 0.02700587 0.03638241 0.22022966 KOYAMA_SEMA3B_TARGETS_DN Kawasaki disease DOID_13378 3.526E-03 0.02748624 0.08500774 0.29857655 KOYAMA_SEMA3B_TARGETS_DN lymphadenitis DOID_1602 3.526E-03 0.02748624 0.08500774 0.29857655 KOYAMA_SEMA3B_TARGETS_DN lymph node disease DOID_9942 3.526E-03 0.02748624 0.08500774 0.29857655 KOYAMA_SEMA3B_TARGETS_DN diabetic retinopathy DOID_8947 4.139E-03 0.03182699 4.139E-03 0.04529225 KOYAMA_SEMA3B_TARGETS_DN optic nerve disease DOID_1891 4.225E-03 0.03205361 0.09271909 0.30320208 KOYAMA_SEMA3B_TARGETS_DN muscle cancer DOID_4045 4.225E-03 0.03163185 0.09271909 0.3014695 KOYAMA_SEMA3B_TARGETS_DN urinary tract obstruction DOID_5200 4.225E-03 0.03122105 4.225E-03 0.04535889 KOYAMA_SEMA3B_TARGETS_DN ureteral disease DOID_1426 4.596E-03 0.0335299 4.596E-03 0.04843207 KOYAMA_SEMA3B_TARGETS_DN aneurysm disease DOID_2403 4.613E-03 0.03322849 4.613E-03 0.04772819 KOYAMA_SEMA3B_TARGETS_DN toxic shock syndrome DOID_14115 4.982E-03 0.03543638 4.982E-03 0.05062341 KOYAMA_SEMA3B_TARGETS_DN severe combined immunodeficiency DOID_627 4.982E-03 0.0349989 4.982E-03 0.04973528 KOYAMA_SEMA3B_TARGETS_DN chromosomal disease DOID_0080014 5.295E-03 0.03674218 0.04822701 0.2345399 KOYAMA_SEMA3B_TARGETS_DN commensal bacterial infectious disease DOID_0050339 5.383E-03 0.03689982 5.383E-03 0.05280491 KOYAMA_SEMA3B_TARGETS_DN urticaria DOID_1555 5.383E-03 0.03646053 0.10416519 0.32211952 KOYAMA_SEMA3B_TARGETS_DN combined T cell and B cell immunodeficiency DOID_628 5.383E-03 0.03603159 5.383E-03 0.05190991 KOYAMA_SEMA3B_TARGETS_DN ankylosing spondylitis DOID_7147 5.797E-03 0.0383556 5.797E-03 0.05497637 KOYAMA_SEMA3B_TARGETS_DN retinal vascular disease DOID_2462 6.034E-03 0.0394639 6.034E-03 0.05628458 KOYAMA_SEMA3B_TARGETS_DN myopia DOID_11830 6.226E-03 0.04025603 6.226E-03 0.05713759 KOYAMA_SEMA3B_TARGETS_DN diffuse large B-cell lymphoma DOID_0050745 6.669E-03 0.04263437 0.11546777 0.33692904 KOYAMA_SEMA3B_TARGETS_DN Sciatic Neuropathy DOID_11446 6.669E-03 0.04216065 0.11546777 0.33521002 KOYAMA_SEMA3B_TARGETS_DN lesion of sciatic nerve DOID_12528 6.669E-03 0.04216065 0.11546777 0.33521002 KOYAMA_SEMA3B_TARGETS_DN mononeuritis of lower limb DOID_9473 6.669E-03 0.04216065 0.11546777 0.33521002 KOYAMA_SEMA3B_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 7.04E-03 0.04402203 0.05789815 0.25148126 KOYAMA_SEMA3B_TARGETS_DN mononeuritis DOID_1802 7.125E-03 0.04406844 0.11920372 0.34256019 KOYAMA_SEMA3B_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 7.596E-03 0.04647282 7.596E-03 0.06649189 KOYAMA_SEMA3B_TARGETS_DN mononeuropathy DOID_1188 7.596E-03 0.04597843 0.12292399 0.34625618 KOYAMA_SEMA3B_TARGETS_DN cranial nerve disease DOID_5656 7.596E-03 0.04549445 0.12292399 0.34118902 KOYAMA_SEMA3B_TARGETS_DN encephalomyelitis DOID_640 7.689E-03 0.04557435 7.689E-03 0.06434026 KOYAMA_SEMA3B_TARGETS_DN dilated cardiomyopathy DOID_12930 8.141E-03 0.04775277 8.141E-03 0.0652397 KOYAMA_SEMA3B_TARGETS_DN abdominal aortic aneurysm DOID_7693 8.577E-03 0.04980166 8.577E-03 0.06778559 KOYAMA_SEMA3B_TARGETS_DN pneumoconiosis DOID_10316 0.01070081 0.06150262 0.14491992 0.38175665 KOYAMA_SEMA3B_TARGETS_DN aplastic anemia DOID_12449 0.01126428 0.06409373 0.14853224 0.3806975 KOYAMA_SEMA3B_TARGETS_DN medullomyoblastoma DOID_3861 0.01126428 0.06345914 0.14853224 0.37899033 KOYAMA_SEMA3B_TARGETS_DN adult medulloblastoma DOID_3864 0.01126428 0.06345914 0.14853224 0.37899033 KOYAMA_SEMA3B_TARGETS_DN childhood medulloblastoma DOID_3869 0.01126428 0.06345914 0.14853224 0.37899033 KOYAMA_SEMA3B_TARGETS_DN adenoma DOID_657 0.01184056 0.06605175 0.15212939 0.38643581 KOYAMA_SEMA3B_TARGETS_DN refractive error DOID_9835 0.01184056 0.06541047 0.01184056 0.08983038 KOYAMA_SEMA3B_TARGETS_DN medulloblastoma DOID_3858 0.01242954 0.06800394 0.15571144 0.39203455 KOYAMA_SEMA3B_TARGETS_DN embryonal cancer DOID_688 0.01242954 0.06735628 0.01242954 0.09305802 KOYAMA_SEMA3B_TARGETS_DN congenital diaphragmatic hernia DOID_3827 0.01364514 0.07324606 0.01364514 0.10083224 KOYAMA_SEMA3B_TARGETS_DN benign mesothelioma DOID_2645 0.01491014 0.07928849 0.16988986 0.41135034 KOYAMA_SEMA3B_TARGETS_DN diabetic autonomic neuropathy DOID_11503 0.0168983 0.08902901 0.0168983 0.12171055 KOYAMA_SEMA3B_TARGETS_DN autonomic neuropathy DOID_11504 0.0168983 0.08902901 0.0168983 0.12171055 KOYAMA_SEMA3B_TARGETS_DN diabetic polyneuropathy DOID_12785 0.0168983 0.08902901 0.0168983 0.12171055 KOYAMA_SEMA3B_TARGETS_DN uterine cancer DOID_363 0.0168983 0.08821223 0.18036817 0.4258485 KOYAMA_SEMA3B_TARGETS_DN diabetic neuropathy DOID_9743 0.0168983 0.08902901 0.0168983 0.12171055 KOYAMA_SEMA3B_TARGETS_DN leukodystrophy DOID_10579 0.01828288 0.09457235 0.01828288 0.13003698 KOYAMA_SEMA3B_TARGETS_DN autonomic nervous system disease DOID_11465 0.01899258 0.09735835 0.01899258 0.133417 KOYAMA_SEMA3B_TARGETS_DN thyroid adenoma DOID_2891 0.01899258 0.09648908 0.19071503 0.44112541 KOYAMA_SEMA3B_TARGETS_DN bone marrow disease DOID_4961 0.01899258 0.0956352 0.19071503 0.43933948 LEE_LIVER_CANCER_MYC_TGFA_UP diabetic autonomic neuropathy DOID_11503 2.469E-07 1.405E-04 2.128E-05 0.0121102 LEE_LIVER_CANCER_MYC_TGFA_UP autonomic neuropathy DOID_11504 2.469E-07 1.405E-04 2.128E-05 0.0121102 LEE_LIVER_CANCER_MYC_TGFA_UP diabetic polyneuropathy DOID_12785 2.469E-07 1.405E-04 2.128E-05 0.0121102 LEE_LIVER_CANCER_MYC_TGFA_UP diabetic neuropathy DOID_9743 2.469E-07 1.405E-04 2.128E-05 0.0121102 LEE_LIVER_CANCER_MYC_TGFA_UP autonomic nervous system disease DOID_11465 3.18E-07 9.047E-05 2.567E-05 7.302E-03 LEE_LIVER_CANCER_MYC_TGFA_UP brain cancer DOID_1319 3.18E-07 6.031E-05 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP central nervous system cancer DOID_3620 3.448E-07 4.904E-05 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP peripheral vascular disease DOID_341 1.644E-06 1.871E-04 0.08167063 0.68339103 LEE_LIVER_CANCER_MYC_TGFA_UP benign glioma DOID_0060101 2.062E-06 1.955E-04 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP benign ependymoma DOID_4844 2.062E-06 1.955E-04 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP diabetic angiopathy DOID_11713 2.705E-06 2.199E-04 0.02687756 0.49333334 LEE_LIVER_CANCER_MYC_TGFA_UP urticaria DOID_1555 3.47E-06 2.468E-04 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP nervous system cancer DOID_3093 3.727E-06 2.356E-04 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP vascular skin disease DOID_9540 2.567E-05 1.46E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP mineral metabolism disease DOID_0050032 6.189E-05 3.202E-03 2.651E-03 0.18857958 LEE_LIVER_CANCER_MYC_TGFA_UP brain infarction DOID_3454 7.361E-05 3.49E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP astrocytoma DOID_3069 7.675E-05 3.359E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP pancreatic ductal carcinoma DOID_3587 7.998E-05 3.25E-03 0.07957982 0.67583459 LEE_LIVER_CANCER_MYC_TGFA_UP beta thalassemia DOID_12241 8.234E-05 3.123E-03 0.01352819 0.40513362 LEE_LIVER_CANCER_MYC_TGFA_UP pancreatic carcinoma DOID_4905 9.018E-05 3.207E-03 0.0827143 0.68209328 LEE_LIVER_CANCER_MYC_TGFA_UP pancreatitis DOID_4989 1.051E-04 3.517E-03 3.754E-03 0.21361479 LEE_LIVER_CANCER_MYC_TGFA_UP mixed glioma DOID_5076 1.051E-04 3.321E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP metabolic syndrome X DOID_14221 1.131E-04 3.386E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP contact dermatitis DOID_2773 1.131E-04 3.217E-03 0.08895201 0.69333829 LEE_LIVER_CANCER_MYC_TGFA_UP chromosomal disease DOID_0080014 1.172E-04 3.176E-03 4.034E-03 0.20867914 LEE_LIVER_CANCER_MYC_TGFA_UP thalassemia DOID_10241 1.307E-04 3.381E-03 0.0168822 0.38423898 LEE_LIVER_CANCER_MYC_TGFA_UP hemangioma DOID_255 1.307E-04 3.234E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP transitional cell carcinoma DOID_2671 1.491E-04 3.534E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP schizophreniform disorder DOID_11328 1.691E-04 3.848E-03 1.691E-04 0.03206507 LEE_LIVER_CANCER_MYC_TGFA_UP schizoaffective disorder DOID_5418 1.691E-04 3.848E-03 1.691E-04 0.03206507 LEE_LIVER_CANCER_MYC_TGFA_UP bronchitis DOID_6132 1.691E-04 3.7E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.804E-04 3.802E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP ulcerative colitis DOID_8577 2.035E-04 4.136E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP testicular cancer DOID_2998 2.123E-04 4.165E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP brain edema DOID_4724 2.357E-04 4.47E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP subependymal glioma DOID_4843 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP pilocytic astrocytoma DOID_4851 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP subependymal giant cell astrocytoma DOID_5077 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP fibrillary astrocytoma DOID_6726 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP juvenile pilocytic astrocytoma DOID_6811 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP childhood pilocytic astrocytoma DOID_6812 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP gemistocytic astrocytoma DOID_7005 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP childhood cerebral astrocytoma DOID_7007 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP protoplasmic astrocytoma DOID_7008 2.357E-04 4.326E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP acute pancreatitis DOID_2913 3.708E-04 6.593E-03 0.02798201 0.49755516 LEE_LIVER_CANCER_MYC_TGFA_UP spinal cord disease DOID_319 4.662E-04 8.038E-03 4.662E-04 0.06631404 LEE_LIVER_CANCER_MYC_TGFA_UP middle cerebral artery infarction DOID_3525 4.662E-04 7.802E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP gestational diabetes DOID_11714 5.004E-04 8.134E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP supratentorial cancer DOID_1659 5.722E-04 9.045E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP toxic encephalopathy DOID_3602 5.722E-04 8.8E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP cerebrum cancer DOID_368 5.722E-04 9.045E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP myocarditis DOID_820 7.725E-04 0.01156724 7.725E-04 0.08791105 LEE_LIVER_CANCER_MYC_TGFA_UP hepatitis DOID_2237 1.051E-03 0.01533687 1.051E-03 0.09968967 LEE_LIVER_CANCER_MYC_TGFA_UP congenital diaphragmatic hernia DOID_3827 1.051E-03 0.01495345 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP intracranial arterial disease DOID_13089 1.102E-03 0.01528938 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP cerebral arterial disease DOID_3527 1.102E-03 0.01528938 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP pulmonary emphysema DOID_9675 1.153E-03 0.01562483 0.04873542 0.60283593 LEE_LIVER_CANCER_MYC_TGFA_UP cerebral infarction DOID_3526 1.371E-03 0.01814534 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP pulmonary tuberculosis DOID_2957 1.607E-03 0.02078579 0.05734364 0.60423202 LEE_LIVER_CANCER_MYC_TGFA_UP giant cell tumor DOID_200 1.861E-03 0.02353615 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP malignant giant cell tumor DOID_2705 1.861E-03 0.02353615 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP giant cell glioblastoma DOID_3074 1.861E-03 0.02353615 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP bile duct adenocarcinoma DOID_4896 1.928E-03 0.02384461 0.06268509 0.62575111 LEE_LIVER_CANCER_MYC_TGFA_UP cholangiocarcinoma DOID_4947 1.928E-03 0.02384461 0.06268509 0.62575111 LEE_LIVER_CANCER_MYC_TGFA_UP vasculitis DOID_865 1.928E-03 0.02333728 0.06268509 0.6149623 LEE_LIVER_CANCER_MYC_TGFA_UP reproductive organ benign neoplasm DOID_0050622 1.995E-03 0.0236502 0.06374982 0.6148076 LEE_LIVER_CANCER_MYC_TGFA_UP glioblastoma DOID_3068 2.204E-03 0.02559306 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP bile duct cancer DOID_4606 2.204E-03 0.0250812 0.06693695 0.61430845 LEE_LIVER_CANCER_MYC_TGFA_UP bile duct carcinoma DOID_4897 2.204E-03 0.0250812 0.06693695 0.61430845 LEE_LIVER_CANCER_MYC_TGFA_UP neuroectodermal tumor DOID_171 2.423E-03 0.02703036 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP carotid artery disease DOID_3407 2.423E-03 0.02651054 2.423E-03 0.19693547 LEE_LIVER_CANCER_MYC_TGFA_UP pre-malignant neoplasm DOID_0060071 2.574E-03 0.02763498 0.07222529 0.6523205 LEE_LIVER_CANCER_MYC_TGFA_UP in situ carcinoma DOID_8719 2.574E-03 0.02763498 0.07222529 0.6523205 LEE_LIVER_CANCER_MYC_TGFA_UP parasitic infectious disease DOID_1398 2.73E-03 0.02876365 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP hyperglycemia DOID_4195 2.809E-03 0.02906281 0.07538423 0.67021296 LEE_LIVER_CANCER_MYC_TGFA_UP allergic contact dermatitis DOID_3042 2.89E-03 0.02936227 0.07643488 0.66909917 LEE_LIVER_CANCER_MYC_TGFA_UP tuberculosis DOID_399 2.971E-03 0.029662 0.07748436 0.66800907 LEE_LIVER_CANCER_MYC_TGFA_UP diabetic retinopathy DOID_8947 3.396E-03 0.03331251 0.0827143 0.67234909 LEE_LIVER_CANCER_MYC_TGFA_UP bone resorption disease DOID_0080011 3.663E-03 0.03532608 3.663E-03 0.23158208 LEE_LIVER_CANCER_MYC_TGFA_UP osteoporosis DOID_11476 3.663E-03 0.03532608 3.663E-03 0.23158208 LEE_LIVER_CANCER_MYC_TGFA_UP biliary tract cancer DOID_4607 4.226E-03 0.0400778 0.09205531 0.68025289 LEE_LIVER_CANCER_MYC_TGFA_UP retinal vascular disease DOID_2462 4.422E-03 0.04124982 0.09411844 0.68658196 LEE_LIVER_CANCER_MYC_TGFA_UP primary bacterial infectious disease DOID_0050338 4.622E-03 0.04242213 0.09617699 0.69271781 LEE_LIVER_CANCER_MYC_TGFA_UP amino acid metabolic disorder DOID_9252 4.827E-03 0.04359455 0.09823097 0.69004224 LEE_LIVER_CANCER_MYC_TGFA_UP Human immunodeficiency virus infectious disease DOID_526 4.931E-03 0.04383559 0.09925625 0.68874153 LEE_LIVER_CANCER_MYC_TGFA_UP hypersensitivity reaction type I disease DOID_1205 5.465E-03 0.0478356 0.10436559 0.69863555 LEE_LIVER_CANCER_MYC_TGFA_UP DiGeorge syndrome DOID_11198 0.010163 0.08761734 0.010163 0.48189536 LEE_LIVER_CANCER_MYC_TGFA_UP velocardiofacial syndrome DOID_12583 0.010163 0.08761734 0.010163 0.48189536 LEE_LIVER_CANCER_MYC_TGFA_UP T cell deficiency DOID_11200 0.01128597 0.09584652 0.01128597 0.49397823 LEE_LIVER_CANCER_MYC_TGFA_UP Diamond-Blackfan anemia DOID_1339 0.01128597 0.09443701 0.01128597 0.45869407 LEE_LIVER_CANCER_MYC_TGFA_UP hyperparathyroidism DOID_13543 0.01128597 0.09306836 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP familial combined hyperlipidemia DOID_13809 0.01128597 0.09173881 0.01128597 0.42811446 LEE_LIVER_CANCER_MYC_TGFA_UP angioedema DOID_1558 0.01128597 0.09044672 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP lateral sclerosis DOID_230 0.01128597 0.08919051 0.01128597 0.40135731 LEE_LIVER_CANCER_MYC_TGFA_UP hypokalemia DOID_4500 0.01128597 0.08796873 0.01128597 0.37774806 LEE_LIVER_CANCER_MYC_TGFA_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.0124077 0.09540516 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP breast benign neoplasm DOID_0060082 0.0124077 0.09413309 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP thoracic benign neoplasm DOID_0060097 0.0124077 0.09413309 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP temporal arteritis DOID_13375 0.0124077 0.09289449 0.0124077 0.3922212 LEE_LIVER_CANCER_MYC_TGFA_UP benign breast phyllodes tumor DOID_1631 0.0124077 0.09413309 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP invasive lobular carcinoma DOID_3457 0.0124077 0.09168807 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP central nervous system vasculitis DOID_525 0.0124077 0.09289449 0.0124077 0.3922212 LEE_LIVER_CANCER_MYC_TGFA_UP bronchiectasis DOID_9563 0.0124077 0.09051258 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP islet cell tumor DOID_1799 0.01352819 0.0974372 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP peritonitis DOID_8283 0.01352819 0.09621924 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP progressive myoclonus epilepsy DOID_891 0.01352819 0.09503134 0.01352819 0.38487694 LEE_LIVER_CANCER_MYC_TGFA_UP parathyroid gland disease DOID_11201 0.01464743 0.09921892 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP newborn respiratory distress syndrome DOID_12716 0.01464743 0.09805164 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP carotid stenosis DOID_13001 0.01464743 0.09691151 0.01464743 0.36236476 LEE_LIVER_CANCER_MYC_TGFA_UP larynx cancer DOID_2596 0.01464743 0.09579758 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP laryngeal benign neoplasm DOID_2598 0.01464743 0.09579758 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP intracranial thrombosis DOID_4193 0.01464743 0.09470897 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP rhabdomyosarcoma DOID_3247 0.01576544 0.09967261 1.000 1.000 LEE_LIVER_CANCER_MYC_TGFA_UP parasitic helminthiasis infectious disease DOID_883 0.01576544 0.0985773 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN oral cavity cancer DOID_8618 9.09E-13 5.172E-10 9.09E-13 5.172E-10 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN adenoid cystic carcinoma DOID_4866 2.424E-12 6.897E-10 2.424E-12 6.897E-10 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN salivary gland cancer DOID_8850 3.583E-12 6.795E-10 3.583E-12 6.795E-10 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN multiple myeloma DOID_9538 5.791E-09 8.237E-07 2.937E-07 4.178E-05 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN myeloma DOID_0070004 2.329E-08 2.651E-06 9.196E-07 1.047E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN encephalomyelitis DOID_640 4.767E-08 4.521E-06 2.216E-05 9.701E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bone marrow cancer DOID_4960 5.214E-08 4.238E-06 1.782E-06 1.448E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bronchiolitis obliterans DOID_2799 1.081E-07 7.685E-06 6.006E-03 0.06102941 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN uveal disease DOID_3480 6.017E-07 3.804E-05 2.107E-05 1.09E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN Human immunodeficiency virus infectious disease DOID_526 9.266E-07 5.273E-05 9.266E-07 8.788E-05 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN lymphoblastic leukemia DOID_1037 1.12E-06 5.792E-05 2.216E-05 1.051E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN hypersensitivity reaction type I disease DOID_1205 1.266E-06 6.002E-05 2.451E-05 9.964E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN Goodpasture syndrome DOID_9808 1.457E-06 6.376E-05 3.205E-03 0.04342147 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN opportunistic mycosis DOID_2473 5.474E-06 2.225E-04 6.006E-03 0.06213904 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN celiac disease DOID_10608 6.187E-06 2.347E-04 6.187E-06 4.4E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN diabetic retinopathy DOID_8947 7.454E-06 2.651E-04 7.454E-06 4.713E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN systemic mycosis DOID_0050136 7.816E-06 2.616E-04 7.118E-03 0.06864406 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN fungal infectious disease DOID_1564 7.816E-06 2.616E-04 7.118E-03 0.06864406 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN uveitis DOID_13141 1.326E-05 4.19E-04 4.081E-04 0.01009708 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN retinal vascular disease DOID_2462 1.446E-05 4.329E-04 1.446E-05 8.225E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN aspergillosis DOID_13564 1.494E-05 4.249E-04 1.081E-03 0.02050864 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN influenza DOID_8469 2.297E-05 6.224E-04 0.0119104 0.10589093 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN autoimmune disease of gastrointestinal tract DOID_0060031 3.439E-05 8.895E-04 3.439E-05 1.305E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN smallpox DOID_8736 5.303E-05 1.312E-03 5.303E-05 1.886E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN acute pancreatitis DOID_2913 9.175E-05 2.175E-03 3.476E-03 0.04494875 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN tuberculosis DOID_399 1.172E-04 2.668E-03 2.027E-03 0.03203584 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN intracranial aneurysm DOID_10941 1.297E-04 2.838E-03 4.35E-03 0.05156014 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN pancreatic ductal carcinoma DOID_3587 1.306E-04 2.753E-03 1.306E-04 4.372E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN pancreatic carcinoma DOID_4905 1.527E-04 3.104E-03 1.527E-04 4.828E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN pancreatitis DOID_4989 1.862E-04 3.654E-03 2.848E-03 0.03951912 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bacterial pneumonia DOID_874 1.862E-04 3.532E-03 0.03230617 0.21883582 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN lipid metabolism disorder DOID_3146 2.049E-04 3.76E-03 2.049E-04 6.135E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN allergic rhinitis DOID_4481 2.333E-04 4.148E-03 6.367E-03 0.06246474 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN chronic leukemia DOID_1036 2.545E-04 4.388E-03 2.545E-04 7.24E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN chronic lymphocytic leukemia DOID_1040 2.545E-04 4.388E-03 2.545E-04 7.24E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN myocarditis DOID_820 2.769E-04 4.634E-03 2.769E-04 7.503E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN primary bacterial infectious disease DOID_0050338 2.806E-04 4.562E-03 3.847E-03 0.04864293 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN lymphoma DOID_0060058 3.458E-04 5.465E-03 3.458E-04 8.942E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN chondrosarcoma DOID_3371 5.397E-04 8.299E-03 5.397E-04 0.01279423 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN acute T cell leukemia DOID_5603 5.397E-04 8.081E-03 0.03453751 0.21835381 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN temporal arteritis DOID_13375 6.581E-04 9.601E-03 6.581E-04 0.01497739 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN central nervous system vasculitis DOID_525 6.581E-04 9.601E-03 6.581E-04 0.01497739 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN eosinophilic pneumonia DOID_5870 6.581E-04 9.361E-03 0.03792545 0.22715351 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN pulmonary eosinophilia DOID_9498 6.581E-04 9.361E-03 0.03792545 0.22715351 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN Loeffler syndrome DOID_9503 6.581E-04 9.361E-03 0.03792545 0.22715351 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN neuritis DOID_1803 7.333E-04 0.01017741 7.333E-04 0.016049 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN pulmonary tuberculosis DOID_2957 8.227E-04 0.01114519 0.01444442 0.12086583 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN movement disease DOID_480 8.698E-04 0.01150971 8.698E-04 0.01833028 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN atopic dermatitis DOID_3310 9.691E-04 0.01253267 0.01606645 0.13059731 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN sarcoidosis DOID_11335 1.021E-03 0.01291476 0.01662368 0.13322355 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN atrophic muscular disease DOID_913 1.021E-03 0.012634 1.021E-03 0.02075587 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN muscular dystrophy DOID_9884 1.021E-03 0.012634 1.021E-03 0.02075587 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bile duct adenocarcinoma DOID_4896 1.075E-03 0.01301885 1.075E-03 0.02109952 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN cholangiocarcinoma DOID_4947 1.075E-03 0.01301885 1.075E-03 0.02109952 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN T-cell leukemia DOID_715 1.081E-03 0.0128179 0.04801866 0.24614968 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN congenital nervous system abnormality DOID_2490 1.248E-03 0.01449283 1.248E-03 0.02290803 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN hypertrophic cardiomyopathy DOID_11984 1.309E-03 0.01489953 1.309E-03 0.02328052 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN hypersensitivity reaction type IV disease DOID_2916 1.309E-03 0.01460738 0.01953106 0.14817566 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bile duct cancer DOID_4606 1.309E-03 0.01432647 1.309E-03 0.02257505 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bile duct carcinoma DOID_4897 1.309E-03 0.01432647 1.309E-03 0.02257505 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN leukocyte disease DOID_9500 1.372E-03 0.01473323 0.02013635 0.1487998 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN congenital heart defect DOID_1682 1.644E-03 0.01731859 1.644E-03 0.027506 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN eosinophilia DOID_999 1.801E-03 0.01863603 0.06131295 0.27688151 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN agammaglobulinemia DOID_2583 2.009E-03 0.02040964 2.009E-03 0.03265543 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN limb-girdle muscular dystrophy DOID_11724 2.227E-03 0.02222844 2.227E-03 0.03424381 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN blood protein disease DOID_620 2.227E-03 0.02184519 2.227E-03 0.03334266 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN funisitis DOID_0050698 2.695E-03 0.02598944 2.695E-03 0.03931735 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bone resorption disease DOID_0080011 2.748E-03 0.02605829 2.748E-03 0.03908743 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN osteoporosis DOID_11476 2.748E-03 0.02605829 2.748E-03 0.03908743 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN aneurysm disease DOID_2403 2.748E-03 0.0256311 0.0315697 0.21906293 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN biliary tract cancer DOID_4607 3.38E-03 0.03101991 3.38E-03 0.04472638 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN bronchiolitis DOID_2942 3.757E-03 0.03393098 0.08735126 0.34043058 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN transitional cell carcinoma DOID_2671 3.97E-03 0.03529166 3.97E-03 0.04910144 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN ankylosing spondylitis DOID_7147 4.048E-03 0.03543661 4.048E-03 0.04900808 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN vitiligo DOID_12306 4.35E-03 0.03749829 4.35E-03 0.0505079 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN B cell deficiency DOID_2115 4.35E-03 0.03693861 4.35E-03 0.04949774 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN migraine DOID_6364 4.661E-03 0.03900193 4.661E-03 0.05200257 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN alcohol-related neurodevelopmental disorder DOID_0050667 4.755E-03 0.03920971 4.755E-03 0.05202826 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN dilated cardiomyopathy DOID_12930 4.894E-03 0.03978197 4.894E-03 0.05254223 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN corneal disease DOID_10124 5.655E-03 0.04532211 0.10640837 0.36918515 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN spastic cerebral palsy DOID_0050669 6.006E-03 0.04746732 6.006E-03 0.06328976 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN abdominal aortic aneurysm DOID_7693 6.006E-03 0.04681708 0.10954593 0.37324333 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN Charcot-Marie-Tooth disease DOID_10595 6.367E-03 0.04895885 6.367E-03 0.06356061 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN periodontal disease DOID_3388 7.507E-03 0.05695541 0.12198722 0.39663272 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN lymphoid leukemia DOID_10747 7.906E-03 0.05919317 0.12507049 0.39980397 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN pulmonary sarcoidosis DOID_13406 8.732E-03 0.06452831 8.732E-03 0.08281133 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN microcephaly DOID_10907 9.159E-03 0.06681506 9.159E-03 0.08543565 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN autoimmune disease of urogenital tract DOID_0060049 0.0109576 0.07892248 0.0109576 0.10056252 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN primary biliary cirrhosis DOID_12236 0.0109576 0.07892248 0.0109576 0.10056252 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN gallbladder cancer DOID_3121 0.0119104 0.08471275 0.0119104 0.10757174 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN heart valve disease DOID_4079 0.01340509 0.09416659 0.01340509 0.11734605 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN vascular skin disease DOID_9540 0.01340509 0.09301821 0.01340509 0.11556808 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN glaucoma DOID_1686 0.01444442 0.09902261 0.01444442 0.1226698 MUELLER_PLURINET embryonal cancer DOID_688 4.029E-16 2.292E-13 4.029E-16 2.292E-13 MUELLER_PLURINET pre-malignant neoplasm DOID_0060071 4.459E-12 1.268E-09 1.896E-10 3.596E-08 MUELLER_PLURINET in situ carcinoma DOID_8719 4.459E-12 1.268E-09 1.896E-10 3.596E-08 MUELLER_PLURINET uterine cancer DOID_363 1.104E-11 2.094E-09 1.104E-11 3.141E-09 MUELLER_PLURINET transitional cell carcinoma DOID_2671 7.868E-11 1.119E-08 6.218E-08 5.896E-06 MUELLER_PLURINET cervix uteri carcinoma in situ DOID_8991 3.696E-10 4.206E-08 1.841E-08 2.095E-06 MUELLER_PLURINET reproductive organ benign neoplasm DOID_0050622 2.773E-09 2.629E-07 3.074E-06 1.346E-04 MUELLER_PLURINET lymphoma DOID_0060058 3.356E-09 2.728E-07 1.813E-06 8.595E-05 MUELLER_PLURINET endometrial cancer DOID_1380 3.62E-09 2.574E-07 3.62E-09 5.149E-07 MUELLER_PLURINET breast benign neoplasm DOID_0060082 6.821E-08 4.312E-06 9.025E-06 3.21E-04 MUELLER_PLURINET thoracic benign neoplasm DOID_0060097 6.821E-08 4.312E-06 9.025E-06 3.21E-04 MUELLER_PLURINET benign breast phyllodes tumor DOID_1631 6.821E-08 4.312E-06 9.025E-06 3.21E-04 MUELLER_PLURINET seminoma DOID_4440 7.236E-08 4.117E-06 7.236E-08 5.881E-06 MUELLER_PLURINET nervous system cancer DOID_3093 7.244E-08 3.747E-06 1.597E-06 9.09E-05 MUELLER_PLURINET endometrial carcinoma DOID_2871 1.464E-07 6.943E-06 1.464E-07 1.041E-05 MUELLER_PLURINET vulva cancer DOID_1245 1.469E-07 6.429E-06 1.556E-05 5.207E-04 MUELLER_PLURINET germinoma DOID_3304 2.011E-07 8.173E-06 2.011E-07 1.271E-05 MUELLER_PLURINET papilloma DOID_2615 2.708E-07 1.027E-05 3.639E-04 6.903E-03 MUELLER_PLURINET endocrine organ benign neoplasm DOID_0060089 3.429E-07 1.219E-05 1.678E-04 3.673E-03 MUELLER_PLURINET colon carcinoma DOID_1520 9.747E-07 3.262E-05 6.079E-05 1.572E-03 MUELLER_PLURINET biliary tract cancer DOID_4607 1.002E-06 3.166E-05 4.388E-03 0.0438016 MUELLER_PLURINET brain cancer DOID_1319 1.457E-06 4.364E-05 4.235E-05 1.205E-03 MUELLER_PLURINET thyroid adenoma DOID_2891 1.457E-06 4.145E-05 9.604E-04 0.01401267 MUELLER_PLURINET central nervous system cancer DOID_3620 1.611E-06 4.364E-05 4.582E-05 1.242E-03 MUELLER_PLURINET muscle cancer DOID_4045 1.766E-06 4.566E-05 1.766E-06 9.133E-05 MUELLER_PLURINET papillary adenoma DOID_3172 3.457E-06 8.553E-05 4.854E-03 0.04680996 MUELLER_PLURINET microcystic adenoma DOID_5403 3.457E-06 8.553E-05 4.854E-03 0.04680996 MUELLER_PLURINET follicular adenoma DOID_6204 3.457E-06 8.553E-05 4.854E-03 0.04680996 MUELLER_PLURINET congenital nervous system abnormality DOID_2490 3.642E-06 8.634E-05 8.704E-05 2.153E-03 MUELLER_PLURINET hypertrophic cardiomyopathy DOID_11984 3.954E-06 9E-05 9.288E-05 2.202E-03 MUELLER_PLURINET neuroectodermal tumor DOID_171 5.021E-06 1.099E-04 5.021E-06 2.041E-04 MUELLER_PLURINET sarcoma DOID_1115 5.351E-06 1.128E-04 2.105E-04 4.277E-03 MUELLER_PLURINET invasive ductal carcinoma DOID_3008 5.351E-06 1.087E-04 5.351E-06 2.03E-04 MUELLER_PLURINET spindle cell carcinoma DOID_4015 1.263E-05 2.478E-04 8.981E-03 0.07300374 MUELLER_PLURINET adenoma DOID_657 1.563E-05 2.965E-04 9.943E-03 0.07968011 MUELLER_PLURINET multiple myeloma DOID_9538 1.732E-05 3.179E-04 4.98E-04 8.586E-03 MUELLER_PLURINET peripheral nervous system neoplasm DOID_1192 1.913E-05 3.402E-04 5.358E-04 8.966E-03 MUELLER_PLURINET intracranial arterial disease DOID_13089 2.318E-05 3.996E-04 0.01199532 0.0922343 MUELLER_PLURINET cerebral arterial disease DOID_3527 2.318E-05 3.996E-04 0.01199532 0.0922343 MUELLER_PLURINET angiosarcoma DOID_0001816 3.02E-05 5.054E-04 1.706E-03 0.02065431 MUELLER_PLURINET primitive neuroectodermal tumor DOID_168 3.037E-05 4.938E-04 3.037E-05 9.601E-04 MUELLER_PLURINET gallbladder cancer DOID_3121 3.31E-05 5.231E-04 0.01421679 0.10643887 MUELLER_PLURINET urinary system benign neoplasm DOID_731 3.657E-05 5.624E-04 3.657E-05 1.095E-03 MUELLER_PLURINET dilated cardiomyopathy DOID_12930 3.833E-05 5.739E-04 5.54E-04 9.006E-03 MUELLER_PLURINET myeloma DOID_0070004 4.235E-05 6.179E-04 9.604E-04 0.01438143 MUELLER_PLURINET male reproductive organ benign neoplasm DOID_0060087 4.376E-05 6.225E-04 2.164E-03 0.02414659 MUELLER_PLURINET B-cell lymphocytic neoplasm DOID_707 5.747E-05 7.976E-04 1.202E-03 0.01667963 MUELLER_PLURINET bone marrow cancer DOID_4960 7.114E-05 9.638E-04 1.406E-03 0.01818075 MUELLER_PLURINET reading disorder DOID_13365 1.363E-04 1.804E-03 1.363E-04 3.103E-03 MUELLER_PLURINET osteosarcoma DOID_3347 1.363E-04 1.763E-03 4.506E-03 0.04420097 MUELLER_PLURINET dyslexia DOID_4428 1.363E-04 1.804E-03 1.363E-04 3.103E-03 MUELLER_PLURINET spinal cord disease DOID_319 1.708E-04 2.16E-03 1.708E-04 3.599E-03 MUELLER_PLURINET middle cerebral artery infarction DOID_3525 1.708E-04 2.113E-03 5.214E-03 0.04863537 MUELLER_PLURINET supratentorial cancer DOID_1659 2.324E-04 2.813E-03 6.366E-03 0.05572538 MUELLER_PLURINET cerebrum cancer DOID_368 2.324E-04 2.813E-03 6.366E-03 0.05572538 MUELLER_PLURINET bone resorption disease DOID_0080011 2.534E-04 3.004E-03 2.534E-04 4.973E-03 MUELLER_PLURINET osteoporosis DOID_11476 2.534E-04 3.004E-03 2.534E-04 4.973E-03 MUELLER_PLURINET female reproductive organ benign neoplasm DOID_0060086 2.557E-04 2.969E-03 6.773E-03 0.05839284 MUELLER_PLURINET uterine benign neoplasm DOID_0060095 2.557E-04 2.969E-03 6.773E-03 0.05839284 MUELLER_PLURINET uterine fibroid DOID_13223 2.557E-04 2.969E-03 6.773E-03 0.05839284 MUELLER_PLURINET leiomyoma DOID_127 3.345E-04 3.807E-03 8.064E-03 0.06848434 MUELLER_PLURINET autonomic nervous system neoplasm DOID_2621 3.345E-04 3.733E-03 8.064E-03 0.06747721 MUELLER_PLURINET neuroblastoma DOID_769 3.345E-04 3.733E-03 8.064E-03 0.06747721 MUELLER_PLURINET medullomyoblastoma DOID_3861 4.276E-04 4.679E-03 4.276E-04 7.848E-03 MUELLER_PLURINET adult medulloblastoma DOID_3864 4.276E-04 4.679E-03 4.276E-04 7.848E-03 MUELLER_PLURINET childhood medulloblastoma DOID_3869 4.276E-04 4.679E-03 4.276E-04 7.848E-03 MUELLER_PLURINET medulloblastoma DOID_3858 4.98E-04 5.346E-03 4.98E-04 8.854E-03 MUELLER_PLURINET alcohol-related neurodevelopmental disorder DOID_0050667 5.327E-04 5.613E-03 0.30987844 0.83962301 MUELLER_PLURINET microcephaly DOID_10907 5.358E-04 5.543E-03 0.01094748 0.08533036 MUELLER_PLURINET lymphatic system disease DOID_75 6.168E-04 6.267E-03 0.01199532 0.09100451 MUELLER_PLURINET holoprosencephaly DOID_4621 6.496E-04 6.484E-03 6.496E-04 0.01026653 MUELLER_PLURINET cerebral infarction DOID_3526 8.523E-04 8.362E-03 0.01479786 0.10935039 MUELLER_PLURINET learning disability DOID_8927 8.523E-04 8.22E-03 8.523E-04 0.01310736 MUELLER_PLURINET relapsing-remitting multiple sclerosis DOID_2378 9.479E-04 8.989E-03 0.04525353 0.25749257 MUELLER_PLURINET integumentary system benign neoplasm DOID_0060121 1.077E-03 0.01004503 0.01722232 0.12404431 MUELLER_PLURINET skin benign neoplasm DOID_3165 1.077E-03 0.01004503 0.01722232 0.12404431 MUELLER_PLURINET lung small cell carcinoma DOID_5409 1.077E-03 9.883E-03 0.01722232 0.12249376 MUELLER_PLURINET Lynch syndrome DOID_3883 1.117E-03 0.0100919 1.117E-03 0.01589475 MUELLER_PLURINET tethered spinal cord syndrome DOID_1089 1.3E-03 0.01156067 1.3E-03 0.01761625 MUELLER_PLURINET rhabdomyosarcoma DOID_3247 1.3E-03 0.01138281 1.3E-03 0.01720657 MUELLER_PLURINET pustulosis of palm and sole DOID_4398 1.478E-03 0.01274579 0.20065705 0.6273289 MUELLER_PLURINET mesenchymal cell neoplasm DOID_3350 1.497E-03 0.0127098 0.0562454 0.27353533 MUELLER_PLURINET skeletal muscle cancer DOID_4043 1.497E-03 0.01252289 1.497E-03 0.01892348 MUELLER_PLURINET spindle cell sarcoma DOID_4235 1.497E-03 0.0127098 0.0562454 0.27353533 MUELLER_PLURINET lung oat cell carcinoma DOID_5411 1.497E-03 0.0123414 0.0562454 0.27121723 MUELLER_PLURINET epithelioid sarcoma DOID_6193 1.497E-03 0.0127098 0.0562454 0.27353533 MUELLER_PLURINET varicose veins DOID_799 1.497E-03 0.01216509 1.497E-03 0.0185121 MUELLER_PLURINET restrictive cardiomyopathy DOID_397 1.706E-03 0.01367257 1.706E-03 0.02022401 MUELLER_PLURINET chronic myeloid leukemia DOID_8552 1.706E-03 0.01348268 1.706E-03 0.01981128 MUELLER_PLURINET vein disease DOID_866 1.706E-03 0.01329798 1.706E-03 0.01941505 MUELLER_PLURINET bile duct cancer DOID_4606 1.71E-03 0.01314818 0.20987092 0.63519444 MUELLER_PLURINET bile duct carcinoma DOID_4897 1.71E-03 0.01314818 0.20987092 0.63519444 MUELLER_PLURINET carotid artery disease DOID_3407 1.963E-03 0.01489228 0.21897931 0.65235197 MUELLER_PLURINET testicular cancer DOID_2998 2.413E-03 0.0180643 2.413E-03 0.02640167 MUELLER_PLURINET infertility DOID_5223 2.413E-03 0.0178297 0.07070596 0.31929914 MUELLER_PLURINET hyperglycemia DOID_4195 2.434E-03 0.01775674 2.434E-03 0.02613256 MUELLER_PLURINET brain infarction DOID_3454 2.64E-03 0.01901826 0.0307841 0.21103799 MUELLER_PLURINET subependymal glioma DOID_4843 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET pilocytic astrocytoma DOID_4851 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET subependymal giant cell astrocytoma DOID_5077 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET fibrillary astrocytoma DOID_6726 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET juvenile pilocytic astrocytoma DOID_6811 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET childhood pilocytic astrocytoma DOID_6812 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET gemistocytic astrocytoma DOID_7005 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET childhood cerebral astrocytoma DOID_7007 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET protoplasmic astrocytoma DOID_7008 2.674E-03 0.01901983 0.07428658 0.32514665 MUELLER_PLURINET astrocytoma DOID_3069 2.748E-03 0.01930102 0.03158514 0.21395174 MUELLER_PLURINET male reproductive system disease DOID_48 2.97E-03 0.02060717 2.97E-03 0.03129236 MUELLER_PLURINET pancreatic carcinoma DOID_4905 3.203E-03 0.02195549 0.03487049 0.23071287 MUELLER_PLURINET benign glioma DOID_0060101 3.235E-03 0.02191218 0.08140677 0.34827408 MUELLER_PLURINET benign ependymoma DOID_4844 3.235E-03 0.02191218 0.08140677 0.34827408 MUELLER_PLURINET muscular atrophy DOID_767 3.235E-03 0.02165439 3.235E-03 0.03346587 MUELLER_PLURINET chromosomal disease DOID_0080014 4.105E-03 0.02715773 4.105E-03 0.04170652 MUELLER_PLURINET cleft lip DOID_9296 4.854E-03 0.03174469 4.854E-03 0.04602979 MUELLER_PLURINET primary immunodeficiency disease DOID_612 5.307E-03 0.03431671 5.307E-03 0.04870759 MUELLER_PLURINET Human immunodeficiency virus infectious disease DOID_526 5.471E-03 0.03497716 5.471E-03 0.04941218 MUELLER_PLURINET diffuse large B-cell lymphoma DOID_0050745 5.586E-03 0.03531679 0.10590179 0.41272683 MUELLER_PLURINET lung adenocarcinoma DOID_3910 5.586E-03 0.03492869 5.586E-03 0.04966423 MUELLER_PLURINET lymphoblastic leukemia DOID_1037 5.98E-03 0.03698418 0.05212459 0.27718592 MUELLER_PLURINET age related macular degeneration DOID_10871 7.192E-03 0.04400293 0.11960653 0.44773759 MUELLER_PLURINET degeneration of macula and posterior pole DOID_2007 7.192E-03 0.04400293 0.11960653 0.44773759 MUELLER_PLURINET chronic leukemia DOID_1036 8.064E-03 0.0488133 0.12638046 0.47000313 MUELLER_PLURINET chronic lymphocytic leukemia DOID_1040 8.064E-03 0.0488133 0.12638046 0.47000313 MUELLER_PLURINET metal metabolism disorder DOID_896 8.517E-03 0.0510124 0.12974798 0.47023313 MUELLER_PLURINET nephroblastoma DOID_2154 8.981E-03 0.05323189 8.981E-03 0.07406176 MUELLER_PLURINET thyroid carcinoma DOID_3963 8.981E-03 0.05268311 0.13310262 0.4763232 MUELLER_PLURINET macular degeneration DOID_4448 8.981E-03 0.05214553 0.13310262 0.47334618 MUELLER_PLURINET thyroid cancer DOID_1781 9.943E-03 0.05714432 0.13977341 0.49093252 MUELLER_PLURINET cleft palate DOID_674 0.01043959 0.05940128 0.01043959 0.08250177 MUELLER_PLURINET proteinuria DOID_576 0.01538903 0.08669659 0.1723703 0.56044973 MUELLER_PLURINET heart valve disease DOID_4079 0.01599022 0.08920032 0.01599022 0.11664658 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN endometrial carcinoma DOID_2871 2.533E-07 1.441E-04 8.373E-03 0.10137228 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN endometrial cancer DOID_1380 3.475E-07 9.887E-05 9.418E-03 0.10717438 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN cerebral degeneration DOID_1443 5.057E-07 9.592E-05 5.057E-07 2.877E-04 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN uterine cancer DOID_363 1.831E-06 2.605E-04 0.01749889 0.16876044 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN lymphoma DOID_0060058 3.431E-06 3.904E-04 7.434E-04 0.05287397 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN B-cell lymphocytic neoplasm DOID_707 3.685E-06 3.495E-04 1.648E-03 0.04261803 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN neuroectodermal tumor DOID_171 8.582E-06 6.976E-04 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN pre-malignant neoplasm DOID_0060071 9.99E-06 7.105E-04 2.928E-03 0.05552878 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN in situ carcinoma DOID_8719 9.99E-06 7.105E-04 2.928E-03 0.05552878 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN leiomyoma DOID_127 1.554E-05 9.825E-04 4.616E-04 0.04377302 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN beta thalassemia DOID_12241 1.668E-05 9.493E-04 0.0503989 0.34550572 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN medullomyoblastoma DOID_3861 2.169E-05 1.122E-03 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN adult medulloblastoma DOID_3864 2.169E-05 1.122E-03 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN childhood medulloblastoma DOID_3869 2.169E-05 1.122E-03 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN medulloblastoma DOID_3858 2.668E-05 1.265E-03 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN thalassemia DOID_10241 3.418E-05 1.496E-03 0.06259903 0.38716141 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN bone development disease DOID_0080006 3.633E-05 1.476E-03 3.633E-05 0.01033495 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN transitional cell carcinoma DOID_2671 4.521E-05 1.715E-03 6.973E-03 0.09017855 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN primitive neuroectodermal tumor DOID_168 4.669E-05 1.66E-03 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN osteochondrodysplasia DOID_2256 1.166E-04 3.903E-03 1.166E-04 0.02211639 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN glioblastoma DOID_3068 1.42E-04 4.489E-03 0.02849047 0.23839822 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN sphingolipidosis DOID_1927 1.674E-04 5.013E-03 1.674E-04 0.02381305 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN endocrine pancreas disease DOID_1428 2.044E-04 5.816E-03 3.055E-03 0.05432808 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN astrocytoma DOID_3069 2.698E-04 7.312E-03 0.03859771 0.30932527 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN multiple epiphyseal dysplasia DOID_12721 3.21E-04 8.303E-03 3.21E-04 0.03653291 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN female reproductive organ benign neoplasm DOID_0060086 3.531E-04 8.736E-03 8.373E-03 0.10357603 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN uterine benign neoplasm DOID_0060095 3.531E-04 8.736E-03 8.373E-03 0.10357603 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN uterine fibroid DOID_13223 3.531E-04 8.736E-03 8.373E-03 0.10357603 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN biliary tract cancer DOID_4607 5.086E-04 0.01205787 0.05200914 0.34015176 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN amino acid metabolic disorder DOID_9252 6.581E-04 0.01497753 6.581E-04 0.05349116 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN carbohydrate metabolic disorder DOID_2978 7.735E-04 0.01692767 7.735E-04 0.04890217 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN dilated cardiomyopathy DOID_12930 8.363E-04 0.01762352 8.563E-03 0.10150783 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN adenoid cystic carcinoma DOID_4866 8.487E-04 0.01724648 8.487E-04 0.04829015 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN autoimmune disease of urogenital tract DOID_0060049 9.697E-04 0.01902656 0.01611559 0.16374589 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN primary biliary cirrhosis DOID_12236 9.697E-04 0.01902656 0.01611559 0.16374589 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN spinocerebellar ataxia DOID_1441 9.697E-04 0.01839234 9.697E-04 0.05016094 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN salivary gland cancer DOID_8850 9.697E-04 0.01779904 9.697E-04 0.04598086 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN adrenoleukodystrophy DOID_10588 9.851E-04 0.01751625 9.851E-04 0.04311691 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN migraine without aura DOID_12783 9.851E-04 0.01698545 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN nephrotic syndrome DOID_1184 1.034E-03 0.01730625 1.034E-03 0.04202947 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN hyperinsulinism DOID_2018 1.034E-03 0.01681179 1.034E-03 0.03922751 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN learning disability DOID_8927 1.171E-03 0.01850643 1.171E-03 0.04163948 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN mucopolysaccharidosis DOID_12798 1.179E-03 0.01812771 1.179E-03 0.03945442 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN epidermolysis bullosa DOID_2730 1.179E-03 0.01765066 1.179E-03 0.03726251 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN leukodystrophy DOID_10579 1.243E-03 0.01813986 1.243E-03 0.03723446 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN spinocerebellar degeneration DOID_2478 1.243E-03 0.01768637 1.243E-03 0.03537273 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN vesiculobullous skin disease DOID_2731 1.389E-03 0.01927899 1.389E-03 0.03763993 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN giant cell tumor DOID_200 1.83E-03 0.02479202 0.21452694 0.77256855 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN malignant giant cell tumor DOID_2705 1.83E-03 0.02479202 0.21452694 0.77256855 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN giant cell glioblastoma DOID_3074 1.83E-03 0.02479202 0.21452694 0.77256855 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN atrophic muscular disease DOID_913 1.83E-03 0.02421547 1.83E-03 0.04527239 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN muscular dystrophy DOID_9884 1.83E-03 0.02421547 1.83E-03 0.04527239 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN hemangioma DOID_255 1.86E-03 0.02404678 1.86E-03 0.04408576 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN bile duct adenocarcinoma DOID_4896 1.926E-03 0.02434822 0.21790912 0.77981312 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN cholangiocarcinoma DOID_4947 1.926E-03 0.02434822 0.21790912 0.77981312 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN reproductive organ benign neoplasm DOID_0050622 2.024E-03 0.02503945 0.02595037 0.22372363 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN congenital nervous system abnormality DOID_2490 2.231E-03 0.02700853 2.231E-03 0.05077605 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN bile duct cancer DOID_4606 2.339E-03 0.02772668 0.23129367 0.80247622 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN bile duct carcinoma DOID_4897 2.339E-03 0.02772668 0.23129367 0.80247622 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN oral cavity cancer DOID_8618 2.339E-03 0.02716083 2.339E-03 0.05118772 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN lymphatic system cancer DOID_0060073 2.395E-03 0.02725446 0.07064578 0.40197449 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN hyperostosis DOID_205 2.395E-03 0.02672006 2.395E-03 0.05047122 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN urinary system benign neoplasm DOID_731 2.395E-03 0.02620621 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN reticulosarcoma DOID_8538 2.395E-03 0.02725446 0.07064578 0.40197449 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN lymphosarcoma DOID_8675 2.395E-03 0.02725446 0.07064578 0.40197449 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN congenital muscular dystrophy DOID_0050557 2.687E-03 0.02884424 2.687E-03 0.05459803 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN hypothyroidism DOID_1459 2.803E-03 0.02953946 2.803E-03 0.0550045 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN testicular cancer DOID_2998 2.994E-03 0.03097792 2.994E-03 0.05496082 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN colon carcinoma DOID_1520 3.318E-03 0.0337101 3.318E-03 0.05720502 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN mitochondrial myopathy DOID_699 3.657E-03 0.03650186 3.657E-03 0.0611943 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN pancreatic ductal carcinoma DOID_3587 3.893E-03 0.03819215 0.0395753 0.31275481 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN nephrosis DOID_2527 4.045E-03 0.03900906 4.045E-03 0.06575813 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN pancreatic carcinoma DOID_4905 4.359E-03 0.04134001 0.04256386 0.31453035 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN glycogen metabolism disorder DOID_0050728 4.381E-03 0.04086154 4.381E-03 0.06923761 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN glycogen storage disease DOID_2747 4.381E-03 0.04086154 4.381E-03 0.06923761 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN congenital hemolytic anemia DOID_589 4.765E-03 0.04373396 0.09827255 0.48204381 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN aneurysm disease DOID_2403 4.858E-03 0.04387494 4.858E-03 0.07470598 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN mixed glioma DOID_5076 5.031E-03 0.04473218 0.29182603 0.95982087 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN spastic quadriplegia DOID_10970 5.165E-03 0.04521547 5.165E-03 0.07734226 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN lipid metabolism disorder DOID_3146 5.39E-03 0.04646452 0.04878332 0.34697136 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN reading disorder DOID_13365 5.58E-03 0.04738773 5.58E-03 0.0814097 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN dyslexia DOID_4428 5.58E-03 0.04738773 5.58E-03 0.0814097 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN morbid obesity DOID_11981 6.009E-03 0.05028451 6.009E-03 0.08548366 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN myopia DOID_11830 6.453E-03 0.0532179 6.453E-03 0.08956184 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN congenital hypoplastic anemia DOID_1342 6.453E-03 0.05245765 0.11369119 0.5259373 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN seminoma DOID_4440 6.453E-03 0.05171881 6.453E-03 0.08742941 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN diffuse large B-cell lymphoma DOID_0050745 6.912E-03 0.05462457 0.11750473 0.53063645 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN lung adenocarcinoma DOID_3910 6.912E-03 0.05387629 6.912E-03 0.0914644 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN migraine DOID_6364 6.912E-03 0.05314823 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN primary immunodeficiency disease DOID_612 7.189E-03 0.05453812 0.05868069 0.36691554 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN sarcoma DOID_1115 7.385E-03 0.05529044 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN nervous system cancer DOID_3093 7.408E-03 0.05474136 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN lymphoblastic leukemia DOID_1037 8.089E-03 0.05900887 0.33624799 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN alcohol-related neurodevelopmental disorder DOID_0050667 8.324E-03 0.05995444 8.324E-03 0.10525334 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN spastic cerebral palsy DOID_0050669 8.889E-03 0.06322087 8.889E-03 0.10321775 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN germinoma DOID_3304 9.418E-03 0.06615702 9.418E-03 0.10507292 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN esophageal disease DOID_6050 0.01108683 0.07693177 0.14743174 0.60351553 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN aplastic anemia DOID_12449 0.01167002 0.08000292 0.15110097 0.5970587 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN refractive error DOID_9835 0.01226643 0.08309047 0.01226643 0.13422306 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN cleft palate DOID_674 0.01287593 0.08619301 0.01287593 0.13823407 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN embryonal cancer DOID_688 0.01287593 0.08519077 0.15839242 0.62155372 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN multiple myeloma DOID_9538 0.01287593 0.08421156 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN microcephaly DOID_10907 0.01349841 0.08727947 0.01349841 0.1422332 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN hepatitis DOID_2237 0.01413373 0.09036058 0.01413373 0.14621984 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN cervix uteri carcinoma in situ DOID_8991 0.01544244 0.09763053 0.17278912 0.6643041 MAHAJAN_RESPONSE_TO_IL1A_UP influenza DOID_8469 3.468E-15 1.973E-12 0.06599827 0.42673879 MAHAJAN_RESPONSE_TO_IL1A_UP hypersensitivity reaction type I disease DOID_1205 1.853E-14 5.272E-12 6.283E-09 3.575E-06 MAHAJAN_RESPONSE_TO_IL1A_UP bacterial pneumonia DOID_874 2.664E-11 5.052E-09 0.10976236 0.50366761 MAHAJAN_RESPONSE_TO_IL1A_UP periodontitis DOID_824 6.167E-10 8.773E-08 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pleurisy DOID_10247 7.392E-10 8.413E-08 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hyperglycemia DOID_4195 7.863E-10 7.456E-08 4.555E-03 0.1993831 MAHAJAN_RESPONSE_TO_IL1A_UP male reproductive system disease DOID_48 1.208E-09 9.822E-08 0.10195787 0.49584641 MAHAJAN_RESPONSE_TO_IL1A_UP diabetic retinopathy DOID_8947 1.423E-09 1.012E-07 0.1045668 0.49998749 MAHAJAN_RESPONSE_TO_IL1A_UP cystic fibrosis DOID_1485 1.668E-09 1.054E-07 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pleural disease DOID_1532 1.675E-09 9.53E-08 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP periodontal disease DOID_3388 2.244E-09 1.161E-07 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP chronic kidney failure DOID_784 2.818E-09 1.336E-07 0.1162152 0.51661289 MAHAJAN_RESPONSE_TO_IL1A_UP retinal vascular disease DOID_2462 3.247E-09 1.421E-07 0.11878346 0.52393635 MAHAJAN_RESPONSE_TO_IL1A_UP primary bacterial infectious disease DOID_0050338 3.728E-09 1.515E-07 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pulmonary tuberculosis DOID_2957 1.316E-08 4.992E-07 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP mitochondrial myopathy DOID_699 2.329E-08 8.282E-07 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP Goodpasture syndrome DOID_9808 4.122E-08 1.38E-06 0.03425384 0.45326592 MAHAJAN_RESPONSE_TO_IL1A_UP uterine disease DOID_345 5.186E-08 1.639E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP bronchiolitis DOID_2942 5.786E-08 1.733E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP tooth disease DOID_1091 6.008E-08 1.709E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP tuberculosis DOID_399 6.456E-08 1.749E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP extrinsic allergic alveolitis DOID_841 7.908E-08 2.045E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP sarcoma DOID_1115 1.056E-07 2.613E-06 0.04263568 0.44108547 MAHAJAN_RESPONSE_TO_IL1A_UP bone resorption disease DOID_0080011 1.108E-07 2.626E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP osteoporosis DOID_11476 1.108E-07 2.626E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pancreatitis DOID_4989 1.18E-07 2.687E-06 0.10976236 0.51192446 MAHAJAN_RESPONSE_TO_IL1A_UP female reproductive system disease DOID_229 1.421E-07 3.11E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP bronchiolitis obliterans DOID_2799 1.572E-07 3.313E-06 0.04679977 0.41607922 MAHAJAN_RESPONSE_TO_IL1A_UP spindle cell carcinoma DOID_4015 2.526E-07 5.133E-06 1.332E-03 0.18950174 MAHAJAN_RESPONSE_TO_IL1A_UP encephalomyelitis DOID_640 2.798E-07 5.491E-06 0.12898342 0.54769825 MAHAJAN_RESPONSE_TO_IL1A_UP mouth disease DOID_403 2.949E-07 5.593E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP multiple myeloma DOID_9538 3.484E-07 6.395E-06 0.05644696 0.39652247 MAHAJAN_RESPONSE_TO_IL1A_UP ulcerative colitis DOID_8577 3.616E-07 6.43E-06 9.34E-03 0.33215113 MAHAJAN_RESPONSE_TO_IL1A_UP hepatitis DOID_2237 4.258E-07 7.342E-06 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP proteinuria DOID_576 8E-07 1.339E-05 0.06870973 0.42962459 MAHAJAN_RESPONSE_TO_IL1A_UP myeloma DOID_0070004 8.686E-07 1.412E-05 0.07006257 0.43332173 MAHAJAN_RESPONSE_TO_IL1A_UP atopic dermatitis DOID_3310 1.279E-06 2.022E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP bone marrow cancer DOID_4960 1.479E-06 2.274E-05 0.07947852 0.44336548 MAHAJAN_RESPONSE_TO_IL1A_UP reproductive organ benign neoplasm DOID_0050622 1.587E-06 2.376E-05 0.08081599 0.44215673 MAHAJAN_RESPONSE_TO_IL1A_UP integumentary system cancer DOID_0060122 1.587E-06 2.315E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP parasitic protozoa infectious disease DOID_2789 1.587E-06 2.257E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP skin cancer DOID_4159 1.587E-06 2.315E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP angiosarcoma DOID_0001816 1.596E-06 2.216E-05 0.02296589 0.4506066 MAHAJAN_RESPONSE_TO_IL1A_UP mitochondrial metabolism disease DOID_700 1.7E-06 2.303E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP respiratory failure DOID_11162 2.513E-06 3.325E-05 4.054E-03 0.19221862 MAHAJAN_RESPONSE_TO_IL1A_UP dissociative disorder DOID_10935 2.754E-06 3.561E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP dissociative amnesia DOID_11037 2.754E-06 3.561E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP leishmaniasis DOID_9065 2.754E-06 3.482E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP endocrine pancreas disease DOID_1428 2.839E-06 3.511E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP cholestasis DOID_13580 3.013E-06 3.647E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP parasitic infectious disease DOID_1398 3.013E-06 3.571E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP temporal lobe epilepsy DOID_3328 3.195E-06 3.71E-05 0.09540285 0.48468054 MAHAJAN_RESPONSE_TO_IL1A_UP amnestic disorder DOID_10914 3.237E-06 3.683E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP bile duct disease DOID_4138 4.229E-06 4.719E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP placenta disease DOID_780 4.363E-06 4.774E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP biliary tract disease DOID_9741 4.463E-06 4.791E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hypoglycemia DOID_9993 5.012E-06 5.282E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP meningitis DOID_9471 5.723E-06 5.92E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP lipid metabolism disorder DOID_3146 6.374E-06 6.476E-05 0.11234903 0.51141279 MAHAJAN_RESPONSE_TO_IL1A_UP focal epilepsy DOID_2234 7.355E-06 7.342E-05 0.1162152 0.5248131 MAHAJAN_RESPONSE_TO_IL1A_UP biliary tract cancer DOID_4607 7.355E-06 7.215E-05 0.1162152 0.52068071 MAHAJAN_RESPONSE_TO_IL1A_UP myositis DOID_633 8.245E-06 7.951E-05 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP nervous system cancer DOID_3093 1.007E-05 9.553E-05 3.311E-04 0.09420458 MAHAJAN_RESPONSE_TO_IL1A_UP Sciatic Neuropathy DOID_11446 1.028E-05 9.588E-05 0.04124368 0.4601501 MAHAJAN_RESPONSE_TO_IL1A_UP lesion of sciatic nerve DOID_12528 1.028E-05 9.588E-05 0.04124368 0.4601501 MAHAJAN_RESPONSE_TO_IL1A_UP mononeuritis of lower limb DOID_9473 1.028E-05 9.588E-05 0.04124368 0.4601501 MAHAJAN_RESPONSE_TO_IL1A_UP mononeuritis DOID_1802 1.141E-05 1.047E-04 0.04263568 0.43320895 MAHAJAN_RESPONSE_TO_IL1A_UP carbohydrate metabolic disorder DOID_2978 1.144E-05 1.033E-04 8.464E-03 0.32106035 MAHAJAN_RESPONSE_TO_IL1A_UP mononeuropathy DOID_1188 1.262E-05 1.122E-04 0.04402569 0.4319072 MAHAJAN_RESPONSE_TO_IL1A_UP age related macular degeneration DOID_10871 1.528E-05 1.338E-04 0.04679977 0.43654214 MAHAJAN_RESPONSE_TO_IL1A_UP degeneration of macula and posterior pole DOID_2007 1.528E-05 1.338E-04 0.04679977 0.43654214 MAHAJAN_RESPONSE_TO_IL1A_UP gonadal disease DOID_2277 1.528E-05 1.318E-04 0.04679977 0.42950113 MAHAJAN_RESPONSE_TO_IL1A_UP pneumoconiosis DOID_10316 2.168E-05 1.841E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP macular degeneration DOID_4448 2.168E-05 1.814E-04 0.05232425 0.40233103 MAHAJAN_RESPONSE_TO_IL1A_UP uveitis DOID_13141 2.962E-05 2.442E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP respiratory syncytial virus infectious disease DOID_1273 3.186E-05 2.59E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP systemic scleroderma DOID_418 3.186E-05 2.554E-04 1.714E-03 0.16256734 MAHAJAN_RESPONSE_TO_IL1A_UP adult respiratory distress syndrome DOID_11394 3.422E-05 2.704E-04 0.06055206 0.42017224 MAHAJAN_RESPONSE_TO_IL1A_UP intracranial arterial disease DOID_13089 3.422E-05 2.667E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP cerebral arterial disease DOID_3527 3.422E-05 2.667E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP autoimmune disease of urogenital tract DOID_0060049 3.926E-05 3.019E-04 1.966E-03 0.15977487 MAHAJAN_RESPONSE_TO_IL1A_UP primary biliary cirrhosis DOID_12236 3.926E-05 3.019E-04 1.966E-03 0.15977487 MAHAJAN_RESPONSE_TO_IL1A_UP rheumatic disease DOID_1575 4.196E-05 3.183E-04 2.053E-03 0.14602204 MAHAJAN_RESPONSE_TO_IL1A_UP uveal disease DOID_3480 4.196E-05 3.142E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP scleroderma DOID_419 4.196E-05 3.183E-04 2.053E-03 0.14602204 MAHAJAN_RESPONSE_TO_IL1A_UP uterine cancer DOID_363 4.478E-05 3.309E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP cerebral infarction DOID_3526 4.771E-05 3.48E-04 0.06735497 0.43061771 MAHAJAN_RESPONSE_TO_IL1A_UP neuritis DOID_1803 5.396E-05 3.886E-04 0.07006257 0.42866236 MAHAJAN_RESPONSE_TO_IL1A_UP vascular skin disease DOID_9540 5.396E-05 3.838E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP autoimmune disease of gastrointestinal tract DOID_0060031 6.071E-05 4.265E-04 0.07276245 0.44044502 MAHAJAN_RESPONSE_TO_IL1A_UP integumentary system benign neoplasm DOID_0060121 6.071E-05 4.213E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP skin benign neoplasm DOID_3165 6.071E-05 4.213E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP leber hereditary optic neuropathy DOID_705 7.391E-05 5.067E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP sarcoidosis DOID_11335 7.584E-05 5.137E-04 0.07813914 0.44910272 MAHAJAN_RESPONSE_TO_IL1A_UP bile duct adenocarcinoma DOID_4896 7.997E-05 5.353E-04 0.07947852 0.44775523 MAHAJAN_RESPONSE_TO_IL1A_UP cholangiocarcinoma DOID_4947 7.997E-05 5.353E-04 0.07947852 0.44775523 MAHAJAN_RESPONSE_TO_IL1A_UP familial hyperlipidemia DOID_1168 8.867E-05 5.867E-04 0.08215156 0.44518321 MAHAJAN_RESPONSE_TO_IL1A_UP childhood type dermatomyositis DOID_14203 9.23E-05 6.037E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP retinal vascular occlusion DOID_1729 9.23E-05 5.968E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP acute kidney failure DOID_3021 9.23E-05 5.901E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP chondrosarcoma DOID_3371 9.23E-05 5.836E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP visceral leishmaniasis DOID_9146 9.23E-05 5.771E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hypersensitivity reaction type IV disease DOID_2916 9.796E-05 6.059E-04 0.08481697 0.45103606 MAHAJAN_RESPONSE_TO_IL1A_UP bile duct cancer DOID_4606 9.796E-05 5.994E-04 0.08481697 0.44276017 MAHAJAN_RESPONSE_TO_IL1A_UP bile duct carcinoma DOID_4897 9.796E-05 5.994E-04 0.08481697 0.44276017 MAHAJAN_RESPONSE_TO_IL1A_UP melancholia DOID_2848 1.028E-04 6.225E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP leukocyte disease DOID_9500 1.028E-04 6.159E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP neurotic disorder DOID_4964 1.079E-04 6.394E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP dermatomyositis DOID_10223 1.127E-04 6.611E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP neuroectodermal tumor DOID_171 1.131E-04 6.564E-04 3.933E-03 0.22377234 MAHAJAN_RESPONSE_TO_IL1A_UP collagen disease DOID_854 1.131E-04 6.498E-04 3.933E-03 0.2034294 MAHAJAN_RESPONSE_TO_IL1A_UP common cold DOID_10459 1.351E-04 7.689E-04 0.01727344 0.51729405 MAHAJAN_RESPONSE_TO_IL1A_UP mitochondrial encephalomyopathy DOID_890 1.351E-04 7.612E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP cerebral degeneration DOID_1443 1.354E-04 7.555E-04 0.09408622 0.48229782 MAHAJAN_RESPONSE_TO_IL1A_UP brain infarction DOID_3454 1.54E-04 8.506E-04 0.09803048 0.48929246 MAHAJAN_RESPONSE_TO_IL1A_UP polyneuropathy DOID_1389 1.595E-04 8.729E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP Leydig cell tumor DOID_2696 1.595E-04 8.646E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP sex cord-stromal neoplasm DOID_4757 1.595E-04 8.646E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP peripheral vascular disease DOID_341 1.812E-04 9.725E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP Legionnaires' disease DOID_10457 1.86E-04 9.889E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP legionellosis DOID_10458 1.86E-04 9.889E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP viral pneumonia DOID_10533 1.86E-04 9.797E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP eyelid disease DOID_530 1.86E-04 9.708E-04 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP endogenous depression DOID_1595 2.035E-04 1.053E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP aneurysm disease DOID_2403 2.113E-04 1.083E-03 0.10846625 0.51431082 MAHAJAN_RESPONSE_TO_IL1A_UP mesenchymal cell neoplasm DOID_3350 2.144E-04 1.089E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP spindle cell sarcoma DOID_4235 2.144E-04 1.089E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP epithelioid sarcoma DOID_6193 2.144E-04 1.089E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP varicose veins DOID_799 2.144E-04 1.079E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hemolytic-uremic syndrome DOID_12554 2.448E-04 1.222E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP vein disease DOID_866 2.448E-04 1.211E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP mental depression DOID_1596 2.623E-04 1.287E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP drug-induced mental disorder DOID_1203 2.771E-04 1.348E-03 0.02438394 0.44756322 MAHAJAN_RESPONSE_TO_IL1A_UP drug psychosis DOID_1742 2.771E-04 1.348E-03 0.02438394 0.44756322 MAHAJAN_RESPONSE_TO_IL1A_UP substance-induced psychosis DOID_8646 2.771E-04 1.348E-03 0.02438394 0.44756322 MAHAJAN_RESPONSE_TO_IL1A_UP glucose intolerance DOID_10603 3.115E-04 1.502E-03 0.02579996 0.4448539 MAHAJAN_RESPONSE_TO_IL1A_UP lymphoma DOID_0060058 3.527E-04 1.687E-03 0.12771479 0.54638884 MAHAJAN_RESPONSE_TO_IL1A_UP lymphoblastic leukemia DOID_1037 3.638E-04 1.725E-03 8.464E-03 0.34399323 MAHAJAN_RESPONSE_TO_IL1A_UP Crohn's disease DOID_8778 3.752E-04 1.764E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pulmonary edema DOID_11396 3.861E-04 1.801E-03 0.02862596 0.42863613 MAHAJAN_RESPONSE_TO_IL1A_UP esophagitis DOID_11963 3.861E-04 1.786E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP Kawasaki disease DOID_13378 4.264E-04 1.956E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP lymphadenitis DOID_1602 4.264E-04 1.956E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP autoimmune hepatitis DOID_2048 4.264E-04 1.941E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP lymph node disease DOID_9942 4.264E-04 1.956E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP neutropenia DOID_1227 4.686E-04 2.116E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP sinusitis DOID_0050127 5.127E-04 2.297E-03 0.03284988 0.47927131 MAHAJAN_RESPONSE_TO_IL1A_UP agranulocytosis DOID_12987 5.127E-04 2.279E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP paranasal sinus disease DOID_1352 5.127E-04 2.297E-03 0.03284988 0.47927131 MAHAJAN_RESPONSE_TO_IL1A_UP optic nerve disease DOID_1891 5.127E-04 2.261E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP IgA glomerulonephritis DOID_2986 5.127E-04 2.244E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP uremia DOID_4676 5.127E-04 2.227E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP polyarteritis nodosa DOID_9810 5.127E-04 2.21E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP Lewy body dementia DOID_12217 5.588E-04 2.391E-03 0.03425384 0.46405797 MAHAJAN_RESPONSE_TO_IL1A_UP acute pancreatitis DOID_2913 6.068E-04 2.577E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP portal hypertension DOID_10762 6.568E-04 2.768E-03 0.03705576 0.4685495 MAHAJAN_RESPONSE_TO_IL1A_UP urticaria DOID_1555 6.568E-04 2.748E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP cystitis DOID_1679 7.087E-04 2.943E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP intracranial aneurysm DOID_10941 7.625E-04 3.144E-03 0.0398497 0.47238498 MAHAJAN_RESPONSE_TO_IL1A_UP spinal cord disease DOID_319 7.625E-04 3.121E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP middle cerebral artery infarction DOID_3525 7.625E-04 3.099E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP seminoma DOID_4440 7.625E-04 3.077E-03 0.0398497 0.45348958 MAHAJAN_RESPONSE_TO_IL1A_UP gestational diabetes DOID_11714 8.182E-04 3.278E-03 0.04124368 0.45130106 MAHAJAN_RESPONSE_TO_IL1A_UP lung adenocarcinoma DOID_3910 8.182E-04 3.256E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP perinatal necrotizing enterocolitis DOID_8677 8.182E-04 3.233E-03 0.04124368 0.44278595 MAHAJAN_RESPONSE_TO_IL1A_UP thrombocytopenia DOID_1588 8.758E-04 3.437E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hepatic vascular disease DOID_272 8.758E-04 3.413E-03 0.04263568 0.42560879 MAHAJAN_RESPONSE_TO_IL1A_UP invasive ductal carcinoma DOID_3008 8.758E-04 3.39E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP multiple epiphyseal dysplasia DOID_12721 9.353E-04 3.596E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP cranial nerve disease DOID_5656 9.353E-04 3.572E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP female reproductive organ benign neoplasm DOID_0060086 9.968E-04 3.781E-03 0.04541372 0.437973 MAHAJAN_RESPONSE_TO_IL1A_UP uterine benign neoplasm DOID_0060095 9.968E-04 3.781E-03 0.04541372 0.437973 MAHAJAN_RESPONSE_TO_IL1A_UP uterine fibroid DOID_13223 9.968E-04 3.781E-03 0.04541372 0.437973 MAHAJAN_RESPONSE_TO_IL1A_UP endometrial carcinoma DOID_2871 9.968E-04 3.756E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP opportunistic mycosis DOID_2473 1.06E-03 3.968E-03 0.04679977 0.42268366 MAHAJAN_RESPONSE_TO_IL1A_UP abdominal aortic aneurysm DOID_7693 1.06E-03 3.942E-03 0.04679977 0.40967801 MAHAJAN_RESPONSE_TO_IL1A_UP celiac disease DOID_10608 1.125E-03 4.158E-03 0.04818385 0.41540317 MAHAJAN_RESPONSE_TO_IL1A_UP endometrial cancer DOID_1380 1.125E-03 4.131E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP germinoma DOID_3304 1.125E-03 4.104E-03 0.04818385 0.40920312 MAHAJAN_RESPONSE_TO_IL1A_UP allergic rhinitis DOID_4481 1.125E-03 4.078E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP chronic leukemia DOID_1036 1.192E-03 4.294E-03 0.04956595 0.41475038 MAHAJAN_RESPONSE_TO_IL1A_UP chronic lymphocytic leukemia DOID_1040 1.192E-03 4.294E-03 0.04956595 0.41475038 MAHAJAN_RESPONSE_TO_IL1A_UP leiomyoma DOID_127 1.192E-03 4.267E-03 0.04956595 0.4087395 MAHAJAN_RESPONSE_TO_IL1A_UP autonomic nervous system neoplasm DOID_2621 1.192E-03 4.24E-03 1.192E-03 0.22615281 MAHAJAN_RESPONSE_TO_IL1A_UP bladder disease DOID_365 1.192E-03 4.214E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP neuroblastoma DOID_769 1.192E-03 4.24E-03 1.192E-03 0.22615281 MAHAJAN_RESPONSE_TO_IL1A_UP systemic mycosis DOID_0050136 1.261E-03 4.43E-03 0.05094608 0.41411886 MAHAJAN_RESPONSE_TO_IL1A_UP fungal infectious disease DOID_1564 1.261E-03 4.43E-03 0.05094608 0.41411886 MAHAJAN_RESPONSE_TO_IL1A_UP hepatitis C DOID_1883 1.332E-03 4.65E-03 0.05232425 0.41350689 MAHAJAN_RESPONSE_TO_IL1A_UP nephroblastoma DOID_2154 1.332E-03 4.622E-03 0.05232425 0.40784241 MAHAJAN_RESPONSE_TO_IL1A_UP esophageal disease DOID_6050 1.332E-03 4.594E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP leukopenia DOID_615 1.332E-03 4.566E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP aplastic anemia DOID_12449 1.405E-03 4.787E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP medullomyoblastoma DOID_3861 1.405E-03 4.758E-03 0.05370044 0.40740738 MAHAJAN_RESPONSE_TO_IL1A_UP adult medulloblastoma DOID_3864 1.405E-03 4.758E-03 0.05370044 0.40740738 MAHAJAN_RESPONSE_TO_IL1A_UP childhood medulloblastoma DOID_3869 1.405E-03 4.758E-03 0.05370044 0.40740738 MAHAJAN_RESPONSE_TO_IL1A_UP refractive error DOID_9835 1.479E-03 4.981E-03 0.05507468 0.41233545 MAHAJAN_RESPONSE_TO_IL1A_UP pulmonary sarcoidosis DOID_13406 1.556E-03 5.208E-03 0.05644696 0.41177333 MAHAJAN_RESPONSE_TO_IL1A_UP medulloblastoma DOID_3858 1.556E-03 5.177E-03 0.05644696 0.40656101 MAHAJAN_RESPONSE_TO_IL1A_UP embryonal cancer DOID_688 1.556E-03 5.147E-03 0.05644696 0.401479 MAHAJAN_RESPONSE_TO_IL1A_UP peripheral nervous system neoplasm DOID_1192 1.634E-03 5.375E-03 1.634E-03 0.18596391 MAHAJAN_RESPONSE_TO_IL1A_UP blood platelet disease DOID_2218 1.634E-03 5.344E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP peptic ulcer DOID_750 1.714E-03 5.574E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP lymphatic system disease DOID_75 1.796E-03 5.807E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pulmonary emphysema DOID_9675 1.88E-03 6.044E-03 0.06191653 0.41941078 MAHAJAN_RESPONSE_TO_IL1A_UP endometriosis of uterus DOID_288 1.966E-03 6.283E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP primitive neuroectodermal tumor DOID_168 2.053E-03 6.526E-03 0.06463963 0.42767382 MAHAJAN_RESPONSE_TO_IL1A_UP endometriosis DOID_289 2.053E-03 6.49E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP gallbladder cancer DOID_3121 2.142E-03 6.735E-03 0.06599827 0.43164384 MAHAJAN_RESPONSE_TO_IL1A_UP leukodystrophy DOID_10579 2.326E-03 7.273E-03 0.06870973 0.43439819 MAHAJAN_RESPONSE_TO_IL1A_UP pre-eclampsia DOID_10591 2.421E-03 7.527E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP bone marrow disease DOID_4961 2.421E-03 7.486E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hemolytic anemia DOID_583 2.517E-03 7.743E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP normocytic anemia DOID_720 2.517E-03 7.743E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP lung small cell carcinoma DOID_5409 2.616E-03 8.002E-03 0.07276245 0.43580875 MAHAJAN_RESPONSE_TO_IL1A_UP calcium metabolism disease DOID_10575 2.716E-03 8.263E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP aortic aneurysm DOID_3627 2.716E-03 8.219E-03 0.0741095 0.43925317 MAHAJAN_RESPONSE_TO_IL1A_UP hemorrhagic disease DOID_2213 2.818E-03 8.482E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP B-cell lymphocytic neoplasm DOID_707 2.818E-03 8.438E-03 0.07545463 0.43809882 MAHAJAN_RESPONSE_TO_IL1A_UP giant cell tumor DOID_200 3.027E-03 9.016E-03 0.07813914 0.4446117 MAHAJAN_RESPONSE_TO_IL1A_UP malignant giant cell tumor DOID_2705 3.027E-03 9.016E-03 0.07813914 0.4446117 MAHAJAN_RESPONSE_TO_IL1A_UP giant cell glioblastoma DOID_3074 3.027E-03 9.016E-03 0.07813914 0.4446117 MAHAJAN_RESPONSE_TO_IL1A_UP osteochondrodysplasia DOID_2256 3.243E-03 9.61E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pustulosis of palm and sole DOID_4398 3.243E-03 9.56E-03 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP retinitis pigmentosa DOID_10584 3.58E-03 0.01049961 3.58E-03 0.22632486 MAHAJAN_RESPONSE_TO_IL1A_UP glioblastoma DOID_3068 3.58E-03 0.01044576 0.08481697 0.4468598 MAHAJAN_RESPONSE_TO_IL1A_UP pre-malignant neoplasm DOID_0060071 4.177E-03 0.01212501 0.09144731 0.47303199 MAHAJAN_RESPONSE_TO_IL1A_UP in situ carcinoma DOID_8719 4.177E-03 0.01212501 0.09144731 0.47303199 MAHAJAN_RESPONSE_TO_IL1A_UP mineral metabolism disease DOID_0050032 4.301E-03 0.01242313 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP endocrine organ benign neoplasm DOID_0060089 4.816E-03 0.01384077 0.09803048 0.49362249 MAHAJAN_RESPONSE_TO_IL1A_UP astrocytoma DOID_3069 4.949E-03 0.01415157 0.09934148 0.49152436 MAHAJAN_RESPONSE_TO_IL1A_UP blood coagulation disease DOID_1247 5.084E-03 0.01446405 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pancreatic ductal carcinoma DOID_3587 5.084E-03 0.01439209 0.10065061 0.49370859 MAHAJAN_RESPONSE_TO_IL1A_UP pancreatic carcinoma DOID_4905 5.498E-03 0.01548752 0.1045668 0.50422467 MAHAJAN_RESPONSE_TO_IL1A_UP mixed glioma DOID_5076 6.074E-03 0.01702439 0.10976236 0.50776247 MAHAJAN_RESPONSE_TO_IL1A_UP metabolic syndrome X DOID_14221 6.371E-03 0.01777114 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP contact dermatitis DOID_2773 6.371E-03 0.01768446 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP bone development disease DOID_0080006 6.986E-03 0.019297 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP amino acid metabolic disorder DOID_9252 7.791E-03 0.02141635 0.12389801 0.53815244 MAHAJAN_RESPONSE_TO_IL1A_UP Human immunodeficiency virus infectious disease DOID_526 7.957E-03 0.02176689 0.12517209 0.53956758 MAHAJAN_RESPONSE_TO_IL1A_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.636E-03 0.02351114 0.13025023 0.54898062 MAHAJAN_RESPONSE_TO_IL1A_UP dilated cardiomyopathy DOID_12930 8.81E-03 0.02386974 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP congenital disorder of glycosylation type II DOID_0050571 0.01441502 0.03887272 0.01441502 0.48247905 MAHAJAN_RESPONSE_TO_IL1A_UP interstitial nephritis DOID_1063 0.01441502 0.03868936 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hyperparathyroidism DOID_13543 0.01441502 0.03850772 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hypolipoproteinemia DOID_1387 0.01441502 0.03832778 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP angioedema DOID_1558 0.01441502 0.03814951 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP transient cerebral ischemia DOID_224 0.01441502 0.03797289 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP progressive muscular atrophy DOID_318 0.01441502 0.0377979 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP Hermansky-Pudlak syndrome DOID_3753 0.01441502 0.03762451 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP conjunctival disease DOID_4251 0.01441502 0.03745271 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP conjunctivitis DOID_6195 0.01441502 0.03745271 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP cutaneous leishmaniasis DOID_9111 0.01441502 0.03728247 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP familial adenomatous polyposis DOID_0050424 0.01584525 0.04079613 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP breast benign neoplasm DOID_0060082 0.01584525 0.04061237 0.01584525 0.50088584 MAHAJAN_RESPONSE_TO_IL1A_UP thoracic benign neoplasm DOID_0060097 0.01584525 0.04061237 0.01584525 0.50088584 MAHAJAN_RESPONSE_TO_IL1A_UP trypanosomiasis DOID_10113 0.01584525 0.04043025 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP adrenoleukodystrophy DOID_10588 0.01584525 0.04024976 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pneumocystosis DOID_11339 0.01584525 0.04007087 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP prediabetes syndrome DOID_11716 0.01584525 0.03989356 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP neuronal ceroid lipofuscinosis DOID_14503 0.01584525 0.03971782 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP benign breast phyllodes tumor DOID_1631 0.01584525 0.04061237 0.01584525 0.50088584 MAHAJAN_RESPONSE_TO_IL1A_UP bronchiectasis DOID_9563 0.01584525 0.03954362 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP otitis media DOID_10754 0.01727344 0.04291959 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP intracranial arteriosclerosis DOID_13097 0.01727344 0.04273299 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pituitary cancer DOID_1785 0.01727344 0.042548 0.01727344 0.49142935 MAHAJAN_RESPONSE_TO_IL1A_UP epidermolysis bullosa DOID_2730 0.01727344 0.0423646 0.01727344 0.46802795 MAHAJAN_RESPONSE_TO_IL1A_UP pituitary carcinoma DOID_4916 0.01727344 0.042548 0.01727344 0.49142935 MAHAJAN_RESPONSE_TO_IL1A_UP middle ear disease DOID_5100 0.01727344 0.04291959 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP stomach disease DOID_76 0.01727344 0.04218278 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP vascular dementia DOID_8725 0.01727344 0.04273299 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP encephalitis DOID_9588 0.01727344 0.04200251 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP berylliosis DOID_10322 0.0186996 0.0452769 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP parathyroid gland disease DOID_11201 0.0186996 0.04508505 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP obstructive hydrocephalus DOID_14159 0.0186996 0.04489481 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP communicating hydrocephalus DOID_1573 0.0186996 0.04489481 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP impotence DOID_1875 0.0186996 0.04470618 0.0186996 0.48363958 MAHAJAN_RESPONSE_TO_IL1A_UP vesiculobullous skin disease DOID_2731 0.0186996 0.04451912 0.0186996 0.46261177 MAHAJAN_RESPONSE_TO_IL1A_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.0186996 0.04433363 0.0186996 0.44333628 MAHAJAN_RESPONSE_TO_IL1A_UP tethered spinal cord syndrome DOID_1089 0.02012372 0.04751203 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hydrocephalus DOID_10908 0.02012372 0.0473157 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hypercalcemia DOID_12678 0.02012372 0.04712098 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP bacterial meningitis DOID_9470 0.02012372 0.04692786 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP idiopathic pulmonary fibrosis DOID_0050156 0.02154582 0.05003907 0.02154582 0.49038286 MAHAJAN_RESPONSE_TO_IL1A_UP hemangioma DOID_255 0.02154582 0.04983566 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP membranoproliferative glomerulonephritis DOID_2920 0.02154582 0.04963389 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP nutritional deficiency disease DOID_5113 0.02154582 0.04943376 0.02154582 0.47152198 MAHAJAN_RESPONSE_TO_IL1A_UP lung oat cell carcinoma DOID_5411 0.02154582 0.04923523 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP panic disorder DOID_594 0.02154582 0.04903829 0.02154582 0.4540582 MAHAJAN_RESPONSE_TO_IL1A_UP hyperhomocysteinemia DOID_9279 0.02154582 0.04884291 0.02154582 0.43784184 MAHAJAN_RESPONSE_TO_IL1A_UP intracranial hypertension DOID_9428 0.02154582 0.04864909 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pituitary adenoma DOID_3829 0.02296589 0.05165056 0.02296589 0.43558638 MAHAJAN_RESPONSE_TO_IL1A_UP restrictive cardiomyopathy DOID_397 0.02296589 0.05144721 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP thyroiditis DOID_7166 0.02296589 0.05124546 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP autoimmune thyroiditis DOID_7188 0.02296589 0.05124546 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP tongue cancer DOID_8649 0.02296589 0.05104528 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP lymphatic system cancer DOID_0060073 0.02438394 0.05398623 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP methylmalonic acidemia DOID_14749 0.02438394 0.05377698 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP penile disease DOID_1529 0.02438394 0.05356934 0.02438394 0.43357687 MAHAJAN_RESPONSE_TO_IL1A_UP basal cell carcinoma DOID_2513 0.02438394 0.05336331 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP reticulosarcoma DOID_8538 0.02438394 0.05398623 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP lymphosarcoma DOID_8675 0.02438394 0.05398623 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP neuroendocrine tumor DOID_169 0.02579996 0.05624589 0.02579996 0.43176996 MAHAJAN_RESPONSE_TO_IL1A_UP sexual dysfunction DOID_1876 0.02579996 0.05603122 0.02579996 0.41943367 MAHAJAN_RESPONSE_TO_IL1A_UP skin carcinoma DOID_3451 0.02579996 0.05581817 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP prion disease DOID_649 0.02579996 0.05560674 0.02579996 0.40778274 MAHAJAN_RESPONSE_TO_IL1A_UP eosinophilia DOID_999 0.02579996 0.0553969 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP conduct disorder DOID_12995 0.02721397 0.05821334 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP MHC class II deficiency DOID_5812 0.02721397 0.05799531 0.02721397 0.41850673 MAHAJAN_RESPONSE_TO_IL1A_UP membranous glomerulonephritis DOID_10976 0.02862596 0.06077676 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP brain edema DOID_4724 0.02862596 0.06055083 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP alopecia DOID_987 0.02862596 0.06032657 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP sexual disorder DOID_0060043 0.03284988 0.06897262 0.03284988 0.46728953 MAHAJAN_RESPONSE_TO_IL1A_UP muscle cancer DOID_4045 0.03284988 0.06871905 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP sleep disorder DOID_535 0.03284988 0.06846733 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP pulmonary embolism DOID_9477 0.03284988 0.06821745 0.03284988 0.45589222 MAHAJAN_RESPONSE_TO_IL1A_UP spastic quadriplegia DOID_10970 0.0356558 0.07377509 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP sphingolipidosis DOID_1927 0.0356558 0.07350779 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP severe combined immunodeficiency DOID_627 0.0356558 0.07324242 0.0356558 0.46109431 MAHAJAN_RESPONSE_TO_IL1A_UP commensal bacterial infectious disease DOID_0050339 0.03705576 0.07584434 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP organic acidemia DOID_0060159 0.03705576 0.0755725 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hypogonadism DOID_1924 0.03705576 0.0753026 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP osteosarcoma DOID_3347 0.03705576 0.07503462 0.03705576 0.45836364 MAHAJAN_RESPONSE_TO_IL1A_UP combined T cell and B cell immunodeficiency DOID_628 0.03705576 0.07476854 0.03705576 0.44861123 MAHAJAN_RESPONSE_TO_IL1A_UP spinal muscular atrophy DOID_12377 0.03845373 0.07731509 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP myopia DOID_11830 0.0398497 0.07983971 0.0398497 0.46274447 MAHAJAN_RESPONSE_TO_IL1A_UP hypotrichosis DOID_4535 0.0398497 0.07955957 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP diffuse large B-cell lymphoma DOID_0050745 0.04124368 0.08205474 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP autoimmune disease of cardiovascular system DOID_0060051 0.04263568 0.08452858 0.04263568 0.44925372 MAHAJAN_RESPONSE_TO_IL1A_UP Behcet's disease DOID_13241 0.04263568 0.08452858 0.04263568 0.44925372 MAHAJAN_RESPONSE_TO_IL1A_UP autoimmune disease of endocrine system DOID_0060005 0.04402569 0.08698131 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP polycystic ovary syndrome DOID_11612 0.04402569 0.08668034 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP congenital disorder of glycosylation DOID_5212 0.04541372 0.08910485 0.04541372 0.43067345 MAHAJAN_RESPONSE_TO_IL1A_UP spastic cerebral palsy DOID_0050669 0.04679977 0.09150883 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP papilloma DOID_2615 0.05094608 0.09927507 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP hair disease DOID_421 0.05094608 0.09893625 1.000 1.000 MAHAJAN_RESPONSE_TO_IL1A_UP myocarditis DOID_820 0.05094608 0.09859973 0.05094608 0.4082862 KORKOLA_EMBRYONAL_CARCINOMA_UP embryonal cancer DOID_688 3.526E-19 2.006E-16 2.023E-16 1.151E-13 KORKOLA_EMBRYONAL_CARCINOMA_UP transitional cell carcinoma DOID_2671 2.214E-05 6.298E-03 0.05321417 0.81834765 KORKOLA_EMBRYONAL_CARCINOMA_UP aspergillosis DOID_13564 3.19E-05 6.05E-03 8.462E-03 0.96293115 KORKOLA_EMBRYONAL_CARCINOMA_UP seminoma DOID_4440 1.318E-04 0.01875021 1.000 1.000 KORKOLA_EMBRYONAL_CARCINOMA_UP endometrial carcinoma DOID_2871 1.727E-04 0.01965372 0.01924023 0.68423055 KORKOLA_EMBRYONAL_CARCINOMA_UP opportunistic mycosis DOID_2473 1.838E-04 0.01742832 0.01983574 0.6639139 KORKOLA_EMBRYONAL_CARCINOMA_UP endometrial cancer DOID_1380 1.952E-04 0.01586636 0.02043091 0.64584372 KORKOLA_EMBRYONAL_CARCINOMA_UP germinoma DOID_3304 1.952E-04 0.01388307 1.000 1.000 KORKOLA_EMBRYONAL_CARCINOMA_UP systemic mycosis DOID_0050136 2.19E-04 0.01384809 0.02162021 0.61509491 KORKOLA_EMBRYONAL_CARCINOMA_UP fungal infectious disease DOID_1564 2.19E-04 0.01384809 0.02162021 0.61509491 KORKOLA_EMBRYONAL_CARCINOMA_UP multiple myeloma DOID_9538 2.708E-04 0.01540797 1.000 1.000 KORKOLA_EMBRYONAL_CARCINOMA_UP uterine cancer DOID_363 3.743E-04 0.01936253 0.02813671 0.6670744 KORKOLA_EMBRYONAL_CARCINOMA_UP myeloma DOID_0070004 4.237E-04 0.02009108 1.000 1.000 KORKOLA_EMBRYONAL_CARCINOMA_UP bone marrow cancer DOID_4960 5.506E-04 0.02409998 1.000 1.000 KORKOLA_EMBRYONAL_CARCINOMA_UP reproductive organ benign neoplasm DOID_0050622 5.701E-04 0.02316924 0.03461168 0.63529173 KORKOLA_EMBRYONAL_CARCINOMA_UP bone resorption disease DOID_0080011 1.054E-03 0.0399949 1.054E-03 0.29996172 KORKOLA_EMBRYONAL_CARCINOMA_UP osteoporosis DOID_11476 1.054E-03 0.0399949 1.054E-03 0.29996172 KORKOLA_EMBRYONAL_CARCINOMA_UP nervous system cancer DOID_3093 1.426E-03 0.05069937 0.05436537 0.81404987 GOUYER_TATI_TARGETS_DN nephroblastoma DOID_2154 2.431E-07 1.383E-04 7.18E-05 0.0408556 GOUYER_TATI_TARGETS_DN leukodystrophy DOID_10579 5.75E-07 1.636E-04 1.265E-04 0.03598708 GOUYER_TATI_TARGETS_DN cerebral degeneration DOID_1443 1.558E-06 2.956E-04 2.441E-04 0.04630264 GOUYER_TATI_TARGETS_DN Lewy body dementia DOID_12217 2.983E-05 4.243E-03 8.2E-03 0.51841634 GOUYER_TATI_TARGETS_DN metabolic syndrome X DOID_14221 3.549E-04 0.04039208 0.02776079 0.42691591 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN aneurysm disease DOID_2403 9.677E-06 5.506E-03 7.95E-04 0.07539422 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN Kawasaki disease DOID_13378 5.519E-05 0.01570197 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN lymphadenitis DOID_1602 5.519E-05 0.01570197 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN lymph node disease DOID_9942 5.519E-05 0.01570197 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN polyarteritis nodosa DOID_9810 6.645E-05 0.01260344 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN intracranial aneurysm DOID_10941 9.912E-05 0.0141005 9.912E-05 0.05640201 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN hepatitis DOID_2237 2.248E-04 0.02558069 0.02193094 0.44566808 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN adult respiratory distress syndrome DOID_11394 2.357E-04 0.02235004 0.0224475 0.41202018 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN adenoid cystic carcinoma DOID_4866 2.357E-04 0.01915717 2.357E-04 0.06705011 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN lymphatic system disease DOID_75 2.357E-04 0.01676253 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN salivary gland cancer DOID_8850 2.582E-04 0.01632524 2.582E-04 0.04897573 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN heart valve disease DOID_4079 3.19E-04 0.01815165 0.02605612 0.42359813 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN vascular skin disease DOID_9540 3.19E-04 0.0165015 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN oral cavity cancer DOID_8618 4.749E-04 0.02251848 4.749E-04 0.06755544 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN leukocyte disease DOID_9500 4.906E-04 0.02147237 0.03221292 0.44705244 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN collagen disease DOID_854 5.227E-04 0.02124319 5.227E-04 0.05948093 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN respiratory failure DOID_11162 5.391E-04 0.02044994 0.03374633 0.44655026 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN mineral metabolism disease DOID_0050032 5.727E-04 0.02036639 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN peripheral vascular disease DOID_341 7.17E-04 0.02399722 1.000 1.000 DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN dilated cardiomyopathy DOID_12930 1.195E-03 0.03776308 0.04995974 0.51685626 INGA_TP53_TARGETS pre-malignant neoplasm DOID_0060071 1.127E-08 6.412E-06 2.259E-06 1.285E-03 INGA_TP53_TARGETS in situ carcinoma DOID_8719 1.127E-08 6.412E-06 2.259E-06 1.285E-03 INGA_TP53_TARGETS transitional cell carcinoma DOID_2671 3.973E-08 1.13E-05 5.735E-04 0.04079342 INGA_TP53_TARGETS Human immunodeficiency virus infectious disease DOID_526 4.342E-08 8.236E-06 5.992E-04 0.03788226 INGA_TP53_TARGETS female reproductive organ benign neoplasm DOID_0060086 2.468E-07 3.511E-05 0.01258901 0.42136147 INGA_TP53_TARGETS uterine benign neoplasm DOID_0060095 2.468E-07 3.511E-05 0.01258901 0.42136147 INGA_TP53_TARGETS uterine fibroid DOID_13223 2.468E-07 3.511E-05 0.01258901 0.42136147 INGA_TP53_TARGETS leiomyoma DOID_127 3.255E-07 3.704E-05 0.01376161 0.39151784 INGA_TP53_TARGETS cervix uteri carcinoma in situ DOID_8991 6.572E-07 6.232E-05 1.369E-04 0.03894968 INGA_TP53_TARGETS bile duct adenocarcinoma DOID_4896 1.447E-06 1.177E-04 2.303E-04 0.04367813 INGA_TP53_TARGETS cholangiocarcinoma DOID_4947 1.447E-06 1.177E-04 2.303E-04 0.04367813 INGA_TP53_TARGETS reproductive organ benign neoplasm DOID_0050622 1.526E-06 1.085E-04 0.02270849 0.47856046 INGA_TP53_TARGETS bile duct cancer DOID_4606 1.779E-06 1.125E-04 2.638E-04 0.03752723 INGA_TP53_TARGETS bile duct carcinoma DOID_4897 1.779E-06 1.125E-04 2.638E-04 0.03752723 INGA_TP53_TARGETS pancreatic ductal carcinoma DOID_3587 3.065E-06 1.744E-04 3.778E-04 0.04299519 INGA_TP53_TARGETS pancreatic carcinoma DOID_4905 3.462E-06 1.791E-04 4.094E-04 0.03882938 INGA_TP53_TARGETS biliary tract cancer DOID_4607 4.854E-06 2.301E-04 5.118E-04 0.04160485 INGA_TP53_TARGETS breast benign neoplasm DOID_0060082 8.02E-06 3.51E-04 1.000 1.000 INGA_TP53_TARGETS thoracic benign neoplasm DOID_0060097 8.02E-06 3.51E-04 1.000 1.000 INGA_TP53_TARGETS benign breast phyllodes tumor DOID_1631 8.02E-06 3.51E-04 1.000 1.000 INGA_TP53_TARGETS seminoma DOID_4440 5.49E-05 2.231E-03 1.000 1.000 INGA_TP53_TARGETS germinoma DOID_3304 8.137E-05 3.087E-03 1.000 1.000 INGA_TP53_TARGETS gallbladder cancer DOID_3121 1.563E-04 5.56E-03 0.01843904 0.47690071 INGA_TP53_TARGETS lymphoma DOID_0060058 6.254E-04 0.02093209 0.03656036 0.6303893 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN Diamond-Blackfan anemia DOID_1339 8.611E-08 4.9E-05 8.611E-08 4.9E-05 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN Ehlers-Danlos syndrome DOID_13359 3.255E-07 9.26E-05 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN congenital hypoplastic anemia DOID_1342 2.324E-06 4.408E-04 2.324E-06 6.612E-04 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN aplastic anemia DOID_12449 5.947E-06 8.46E-04 5.947E-06 1.128E-03 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN medullomyoblastoma DOID_3861 5.947E-06 6.768E-04 5.701E-04 0.0648721 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN adult medulloblastoma DOID_3864 5.947E-06 6.768E-04 5.701E-04 0.0648721 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN childhood medulloblastoma DOID_3869 5.947E-06 6.768E-04 5.701E-04 0.0648721 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN medulloblastoma DOID_3858 6.956E-06 6.597E-04 6.318E-04 0.05991185 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN primitive neuroectodermal tumor DOID_168 1.065E-05 8.655E-04 8.354E-04 0.06790509 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN heart valve disease DOID_4079 1.371E-05 9.753E-04 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN bone marrow disease DOID_4961 1.371E-05 8.67E-04 1.371E-05 1.951E-03 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN osteochondrodysplasia DOID_2256 2.148E-05 1.222E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN neuroectodermal tumor DOID_171 2.889E-05 1.495E-03 1.61E-03 0.11453421 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN collagen disease DOID_854 2.889E-05 1.37E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN aortic valve insufficiency DOID_57 5.433E-05 2.378E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN osteogenesis imperfecta DOID_12347 6.417E-05 2.608E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN bone development disease DOID_0080006 6.999E-05 2.655E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN rhabdomyosarcoma DOID_3247 7.482E-05 2.661E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN skeletal muscle cancer DOID_4043 8.629E-05 2.888E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN oral submucous fibrosis DOID_5773 8.629E-05 2.728E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN ureteral obstruction DOID_5199 1.255E-04 3.759E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN muscle cancer DOID_4045 2.069E-04 5.888E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN urinary tract obstruction DOID_5200 2.069E-04 5.607E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN ureteral disease DOID_1426 2.256E-04 5.836E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN aortic valve disease DOID_62 2.256E-04 5.582E-03 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN intracranial aneurysm DOID_10941 3.083E-04 7.309E-03 0.02553938 0.51899676 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN calcinosis DOID_182 6.318E-04 0.01437884 0.03628983 0.52945925 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN multiple myeloma DOID_9538 6.318E-04 0.01382581 0.03628983 0.51622277 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN cervix uteri carcinoma in situ DOID_8991 7.644E-04 0.01610981 0.03984764 0.50385122 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN gallbladder cancer DOID_3121 8.72E-04 0.01772051 0.04250762 0.51461349 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN myeloma DOID_0070004 9.865E-04 0.01935495 0.04516044 0.53533937 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN calcium metabolism disease DOID_10575 1.108E-03 0.02101007 0.04780612 0.52310927 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN bone marrow cancer DOID_4960 1.28E-03 0.02349445 0.05132262 0.5509919 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN congenital nervous system abnormality DOID_2490 1.417E-03 0.02519783 0.05395171 0.5684912 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN pre-malignant neoplasm DOID_0060071 1.711E-03 0.02950839 0.05918868 0.59084842 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN in situ carcinoma DOID_8719 1.711E-03 0.02950839 0.05918868 0.59084842 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN mineral metabolism disease DOID_0050032 1.763E-03 0.02950467 0.06005877 0.57921082 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN bone resorption disease DOID_0080011 2.44E-03 0.03966346 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN osteoporosis DOID_11476 2.44E-03 0.03966346 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN aneurysm disease DOID_2403 2.44E-03 0.0385617 0.07043902 0.59820599 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN biliary tract cancer DOID_4607 2.817E-03 0.04332386 0.0755873 0.62332134 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.576E-03 0.05354042 0.08495396 0.6532271 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN mouth disease DOID_403 3.576E-03 0.05216759 1.000 1.000 POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN ulcerative colitis DOID_8577 3.872E-03 0.05508615 0.08833711 0.66136602 MARZEC_IL2_SIGNALING_DN reproductive organ benign neoplasm DOID_0050622 5.126E-06 2.917E-03 5.21E-04 0.14822734 MARZEC_IL2_SIGNALING_DN pre-malignant neoplasm DOID_0060071 7.579E-06 2.156E-03 6.742E-04 0.1278707 MARZEC_IL2_SIGNALING_DN in situ carcinoma DOID_8719 7.579E-06 2.156E-03 6.742E-04 0.1278707 MARZEC_IL2_SIGNALING_DN transitional cell carcinoma DOID_2671 1.928E-05 3.657E-03 0.05095986 0.4202342 MARZEC_IL2_SIGNALING_DN chronic leukemia DOID_1036 1.891E-04 0.02689382 1.891E-04 0.10757529 MARZEC_IL2_SIGNALING_DN chronic lymphocytic leukemia DOID_1040 1.891E-04 0.02689382 1.891E-04 0.10757529 MARZEC_IL2_SIGNALING_DN benign mesothelioma DOID_2645 2.996E-04 0.0340991 0.02523162 0.38802144 MARZEC_IL2_SIGNALING_DN cervix uteri carcinoma in situ DOID_8991 2.996E-04 0.02841592 0.02523162 0.37781035 MARZEC_IL2_SIGNALING_DN cataract DOID_83 3.568E-04 0.02900163 0.02749503 0.34010151 MARZEC_IL2_SIGNALING_DN lens disease DOID_110 3.872E-04 0.02753926 0.02862485 0.33932368 MARZEC_IL2_SIGNALING_DN glaucoma DOID_1686 4.188E-04 0.02647902 1.000 1.000 MARZEC_IL2_SIGNALING_DN nephrosis DOID_2527 8.466E-04 0.0481692 0.04208532 0.38010395 MARZEC_IL2_SIGNALING_DN lymphoblastic leukemia DOID_1037 1.389E-03 0.07185743 1.389E-03 0.19760795 WILENSKY_RESPONSE_TO_DARAPLADIB bacterial pneumonia DOID_874 1.616E-14 9.197E-12 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB aneurysm disease DOID_2403 3.57E-12 1.016E-09 1.127E-05 3.207E-03 WILENSKY_RESPONSE_TO_DARAPLADIB bronchiolitis obliterans DOID_2799 7.33E-12 1.39E-09 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pulmonary tuberculosis DOID_2957 7.973E-11 1.134E-08 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB aortic aneurysm DOID_3627 8.801E-11 1.002E-08 3.959E-04 0.04505302 WILENSKY_RESPONSE_TO_DARAPLADIB sarcoidosis DOID_11335 1.17E-10 1.11E-08 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hypersensitivity reaction type IV disease DOID_2916 1.819E-10 1.479E-08 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB carotid artery disease DOID_3407 2.329E-10 1.657E-08 5.971E-06 3.398E-03 WILENSKY_RESPONSE_TO_DARAPLADIB tuberculosis DOID_399 3.968E-10 2.508E-08 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB contact dermatitis DOID_2773 8.283E-10 4.713E-08 0.04446452 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB chronic kidney failure DOID_784 9.947E-10 5.145E-08 0.04605501 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB primary bacterial infectious disease DOID_0050338 1.257E-09 5.96E-08 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB encephalomyelitis DOID_640 1.751E-09 7.663E-08 0.05133848 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB abdominal aortic aneurysm DOID_7693 2.816E-09 1.145E-07 1.527E-04 0.02172295 WILENSKY_RESPONSE_TO_DARAPLADIB allergic rhinitis DOID_4481 3.191E-09 1.21E-07 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pulmonary sarcoidosis DOID_13406 6.274E-09 2.231E-07 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pulmonary emphysema DOID_9675 9.307E-09 3.115E-07 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pre-eclampsia DOID_10591 1.575E-08 4.98E-07 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB allergic contact dermatitis DOID_3042 6.228E-08 1.865E-06 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB brain infarction DOID_3454 6.597E-08 1.877E-06 0.03861106 0.955204 WILENSKY_RESPONSE_TO_DARAPLADIB varicose veins DOID_799 6.636E-08 1.798E-06 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB vein disease DOID_866 8.164E-08 2.112E-06 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB cystic fibrosis DOID_1485 9.66E-08 2.39E-06 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB prion disease DOID_649 1.189E-07 2.818E-06 9.926E-03 0.56479671 WILENSKY_RESPONSE_TO_DARAPLADIB meningitis DOID_9471 2.942E-07 6.697E-06 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB intracranial aneurysm DOID_10941 4.756E-07 1.041E-05 1.095E-04 0.02077019 WILENSKY_RESPONSE_TO_DARAPLADIB extrinsic allergic alveolitis DOID_841 4.756E-07 1.002E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB renal hypertension DOID_1073 5.89E-07 1.197E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB secondary hypertension DOID_11130 5.89E-07 1.197E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB respiratory syncytial virus infectious disease DOID_1273 1.658E-06 3.254E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hepatitis DOID_2237 1.658E-06 3.145E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB systemic scleroderma DOID_418 1.658E-06 3.044E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB peptic ulcer DOID_750 1.658E-06 2.949E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB rheumatic disease DOID_1575 2.19E-06 3.775E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB scleroderma DOID_419 2.19E-06 3.775E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB diabetic autonomic neuropathy DOID_11503 2.338E-06 3.913E-05 0.02572112 0.97568775 WILENSKY_RESPONSE_TO_DARAPLADIB autonomic neuropathy DOID_11504 2.338E-06 3.913E-05 0.02572112 0.97568775 WILENSKY_RESPONSE_TO_DARAPLADIB diabetic polyneuropathy DOID_12785 2.338E-06 3.913E-05 0.02572112 0.97568775 WILENSKY_RESPONSE_TO_DARAPLADIB influenza DOID_8469 2.338E-06 3.801E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB diabetic neuropathy DOID_9743 2.338E-06 3.913E-05 0.02572112 0.97568775 WILENSKY_RESPONSE_TO_DARAPLADIB cerebral infarction DOID_3526 2.493E-06 3.94E-05 0.02626147 0.9339235 WILENSKY_RESPONSE_TO_DARAPLADIB autonomic nervous system disease DOID_11465 2.823E-06 4.341E-05 0.02734132 0.91512991 WILENSKY_RESPONSE_TO_DARAPLADIB vasculitis DOID_865 4.204E-06 6.295E-05 0.0311118 0.93171662 WILENSKY_RESPONSE_TO_DARAPLADIB parasitic protozoa infectious disease DOID_2789 4.432E-06 6.466E-05 0.03164931 0.90042276 WILENSKY_RESPONSE_TO_DARAPLADIB collagen disease DOID_854 5.971E-06 8.494E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB parasitic infectious disease DOID_1398 7.172E-06 9.954E-05 0.03700874 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB cerebral degeneration DOID_1443 7.172E-06 9.717E-05 0.03700874 0.95718069 WILENSKY_RESPONSE_TO_DARAPLADIB uterine disease DOID_345 7.172E-06 9.491E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hyperglycemia DOID_4195 7.496E-06 9.693E-05 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB male reproductive system disease DOID_48 9.258E-06 1.171E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB diabetic retinopathy DOID_8947 1.003E-05 1.241E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB female reproductive system disease DOID_229 1.308E-05 1.583E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB phagocyte bactericidal dysfunction DOID_3262 1.312E-05 1.555E-04 5.526E-03 0.44919757 WILENSKY_RESPONSE_TO_DARAPLADIB chondrosarcoma DOID_3371 1.312E-05 1.523E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB retinal vascular disease DOID_2462 1.507E-05 1.715E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB temporal arteritis DOID_13375 1.602E-05 1.788E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB central nervous system vasculitis DOID_525 1.602E-05 1.788E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB encephalitis DOID_9588 1.922E-05 2.103E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mouth disease DOID_403 2.025E-05 2.174E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hypersensitivity reaction type I disease DOID_1205 2.088E-05 2.201E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB viral pneumonia DOID_10533 2.649E-05 2.74E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB aspergillosis DOID_13564 2.649E-05 2.691E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bacterial meningitis DOID_9470 2.649E-05 2.644E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB thoracic aortic aneurysm DOID_14004 3.055E-05 2.997E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB coronary restenosis DOID_4247 6.098E-05 5.881E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB sinusitis DOID_0050127 7.342E-05 6.962E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB paranasal sinus disease DOID_1352 7.342E-05 6.962E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB toxic shock syndrome DOID_14115 8.7E-05 8.115E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB sphingolipidosis DOID_1927 8.7E-05 7.984E-04 0.01376089 0.6524955 WILENSKY_RESPONSE_TO_DARAPLADIB commensal bacterial infectious disease DOID_0050339 9.422E-05 8.509E-04 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB periodontitis DOID_824 1.176E-04 1.045E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB coronary stenosis DOID_4248 1.259E-04 1.102E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB opportunistic mycosis DOID_2473 1.527E-04 1.317E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pleural disease DOID_1532 1.72E-04 1.46E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB systemic mycosis DOID_0050136 1.82E-04 1.523E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB fungal infectious disease DOID_1564 1.82E-04 1.523E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB myocarditis DOID_820 1.82E-04 1.501E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pneumoconiosis DOID_10316 1.924E-04 1.564E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB periodontal disease DOID_3388 1.924E-04 1.542E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB uveitis DOID_13141 2.365E-04 1.869E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB adult respiratory distress syndrome DOID_11394 2.603E-04 2.029E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB endometriosis of uterus DOID_288 2.852E-04 2.193E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB endometriosis DOID_289 2.98E-04 2.261E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB uveal disease DOID_3480 2.98E-04 2.231E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB leukodystrophy DOID_10579 3.383E-04 2.5E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB neuritis DOID_1803 3.523E-04 2.57E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB integumentary system benign neoplasm DOID_0060121 3.811E-04 2.745E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB skin benign neoplasm DOID_3165 3.811E-04 2.745E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB atopic dermatitis DOID_3310 4.264E-04 3.032E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB giant cell tumor DOID_200 4.42E-04 3.105E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB malignant giant cell tumor DOID_2705 4.42E-04 3.105E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB giant cell glioblastoma DOID_3074 4.42E-04 3.105E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB integumentary system cancer DOID_0060122 4.741E-04 3.29E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB skin cancer DOID_4159 4.741E-04 3.29E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB glioblastoma DOID_3068 5.244E-04 3.595E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB respiratory failure DOID_11162 5.952E-04 4.032E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mineral metabolism disease DOID_0050032 6.323E-04 4.232E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB tooth disease DOID_1091 6.899E-04 4.565E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB endocrine organ benign neoplasm DOID_0060089 7.097E-04 4.641E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB astrocytoma DOID_3069 7.297E-04 4.718E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bone resorption disease DOID_0080011 8.775E-04 5.61E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB osteoporosis DOID_11476 8.775E-04 5.61E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mixed glioma DOID_5076 8.997E-04 5.688E-03 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB metabolic syndrome X DOID_14221 9.449E-04 5.908E-03 0.04446452 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB chromosomal disease DOID_0080014 9.679E-04 5.986E-03 9.679E-04 0.09179258 WILENSKY_RESPONSE_TO_DARAPLADIB primary immunodeficiency disease DOID_612 1.162E-03 7.107E-03 0.04922845 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB leber hereditary optic neuropathy DOID_705 4.975E-03 0.03011373 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB childhood type dermatomyositis DOID_14203 5.526E-03 0.03309877 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB acute kidney failure DOID_3021 5.526E-03 0.03275399 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB Hermansky-Pudlak syndrome DOID_3753 5.526E-03 0.03241632 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB adrenal gland hyperfunction DOID_3947 5.526E-03 0.03208554 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB conjunctival disease DOID_4251 5.526E-03 0.03176144 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB conjunctivitis DOID_6195 5.526E-03 0.03176144 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB cutaneous leishmaniasis DOID_9111 5.526E-03 0.03144383 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB trypanosomiasis DOID_10113 6.077E-03 0.03423673 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB dermatomyositis DOID_10223 6.077E-03 0.03390107 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB adrenoleukodystrophy DOID_10588 6.077E-03 0.03357194 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB prediabetes syndrome DOID_11716 6.077E-03 0.03324913 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bronchiectasis DOID_9563 6.077E-03 0.03293247 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB common cold DOID_10459 6.628E-03 0.03557802 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB otitis media DOID_10754 6.628E-03 0.03524552 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB middle ear disease DOID_5100 6.628E-03 0.03524552 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB peritonitis DOID_8283 6.628E-03 0.03491917 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mitochondrial encephalomyopathy DOID_890 6.628E-03 0.03459881 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB ocular hypertension DOID_9282 6.628E-03 0.03428428 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB borderline glaucoma DOID_9283 6.628E-03 0.03428428 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB berylliosis DOID_10322 7.178E-03 0.03679699 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB newborn respiratory distress syndrome DOID_12716 7.178E-03 0.03646845 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB carotid stenosis DOID_13001 7.178E-03 0.03614572 7.178E-03 0.51055828 WILENSKY_RESPONSE_TO_DARAPLADIB polyneuropathy DOID_1389 7.178E-03 0.03582865 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB larynx cancer DOID_2596 7.178E-03 0.0355171 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB laryngeal benign neoplasm DOID_2598 7.178E-03 0.0355171 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB eyelid disease DOID_530 7.728E-03 0.03790945 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB skeletal system cancer DOID_0060124 8.278E-03 0.0402595 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB renovascular hypertension DOID_1591 8.278E-03 0.03991832 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bone cancer DOID_184 8.278E-03 0.0402595 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB Williams-Beuren syndrome DOID_1928 8.278E-03 0.03958287 8.278E-03 0.52337354 WILENSKY_RESPONSE_TO_DARAPLADIB adrenal cortex disease DOID_3952 8.278E-03 0.03925302 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB lung oat cell carcinoma DOID_5411 8.278E-03 0.03892861 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB oral submucous fibrosis DOID_5773 8.278E-03 0.03860952 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB silicosis DOID_10325 8.828E-03 0.0408379 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB adrenal gland disease DOID_9553 9.377E-03 0.04302901 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB glucose intolerance DOID_10603 9.926E-03 0.04518374 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB dissociative disorder DOID_10935 0.01047482 0.04730295 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB dissociative amnesia DOID_11037 0.01047482 0.04730295 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB Down syndrome DOID_14250 0.01047482 0.04693049 0.01047482 0.54183385 WILENSKY_RESPONSE_TO_DARAPLADIB leishmaniasis DOID_9065 0.01047482 0.04656385 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB amnestic disorder DOID_10914 0.01102322 0.0486218 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB esophagitis DOID_11963 0.01102322 0.04824779 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB brain edema DOID_4724 0.01102322 0.04787949 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB subependymal glioma DOID_4843 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pilocytic astrocytoma DOID_4851 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB subependymal giant cell astrocytoma DOID_5077 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB fibrillary astrocytoma DOID_6726 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB juvenile pilocytic astrocytoma DOID_6811 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB childhood pilocytic astrocytoma DOID_6812 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB gemistocytic astrocytoma DOID_7005 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB childhood cerebral astrocytoma DOID_7007 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB protoplasmic astrocytoma DOID_7008 0.01102322 0.04751676 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB amyloidosis DOID_9120 0.01102322 0.04715949 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB Kawasaki disease DOID_13378 0.01157133 0.04913499 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB lymphadenitis DOID_1602 0.01157133 0.04913499 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB autoimmune hepatitis DOID_2048 0.01157133 0.04877103 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mitochondrial myopathy DOID_699 0.01157133 0.04841242 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB lymph node disease DOID_9942 0.01157133 0.04913499 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB benign glioma DOID_0060101 0.01211916 0.0503343 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB gastric ulcer DOID_10808 0.01211916 0.04996956 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB familial hypercholesterolemia DOID_13810 0.01211916 0.04961007 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hepatitis B DOID_2043 0.01211916 0.04925571 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB benign ependymoma DOID_4844 0.01211916 0.0503343 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB placenta disease DOID_780 0.01211916 0.04890638 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB optic nerve disease DOID_1891 0.01266669 0.05075596 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB opiate dependence DOID_2559 0.01266669 0.05040102 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB IgA glomerulonephritis DOID_2986 0.01266669 0.05005102 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB myasthenia gravis DOID_437 0.01266669 0.04970584 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB pulmonary embolism DOID_9477 0.01266669 0.04936538 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB polyarteritis nodosa DOID_9810 0.01266669 0.04902957 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB diabetic angiopathy DOID_11713 0.01321393 0.05080222 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB Lewy body dementia DOID_12217 0.01321393 0.05046126 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB Goodpasture syndrome DOID_9808 0.01321393 0.05012486 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB portal hypertension DOID_10762 0.01430756 0.0539139 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bronchiolitis DOID_2942 0.01430756 0.05355921 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB neuromuscular junction disease DOID_439 0.01485393 0.0552411 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB myositis DOID_633 0.01485393 0.05488239 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB middle cerebral artery infarction DOID_3525 0.01540002 0.05653299 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB Sciatic Neuropathy DOID_11446 0.01594583 0.05816138 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB lesion of sciatic nerve DOID_12528 0.01594583 0.05816138 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB perinatal necrotizing enterocolitis DOID_8677 0.01594583 0.05779092 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mononeuritis of lower limb DOID_9473 0.01594583 0.05816138 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB autoimmune disease of cardiovascular system DOID_0060051 0.01649134 0.0593897 0.01649134 0.72181323 WILENSKY_RESPONSE_TO_DARAPLADIB pleurisy DOID_10247 0.01649134 0.05901618 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB malaria DOID_12365 0.01649134 0.05864733 0.01649134 0.67025515 WILENSKY_RESPONSE_TO_DARAPLADIB Behcet's disease DOID_13241 0.01649134 0.0593897 0.01649134 0.72181323 WILENSKY_RESPONSE_TO_DARAPLADIB mononeuritis DOID_1802 0.01649134 0.05828306 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hepatic vascular disease DOID_272 0.01649134 0.05792328 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB autoimmune disease of the nervous system DOID_438 0.01649134 0.05756793 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mononeuropathy DOID_1188 0.01703656 0.05910857 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB supratentorial cancer DOID_1659 0.01703656 0.05875034 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB cerebrum cancer DOID_368 0.01703656 0.05875034 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB focal glomerulosclerosis DOID_3945 0.01703656 0.05839642 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB cranial nerve disease DOID_5656 0.01703656 0.05804674 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB thyroid carcinoma DOID_3963 0.02030188 0.06876052 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB spindle cell carcinoma DOID_4015 0.02030188 0.06835366 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB esophageal disease DOID_6050 0.02030188 0.06795158 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB thyroid cancer DOID_1781 0.02138802 0.07116831 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB calcinosis DOID_182 0.02193066 0.07254967 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB multiple myeloma DOID_9538 0.02193066 0.07213031 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB intracranial arterial disease DOID_13089 0.02355686 0.07703363 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB cerebral arterial disease DOID_3527 0.02355686 0.07703363 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB lymphatic system disease DOID_75 0.02355686 0.07659344 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB autoimmune disease of urogenital tract DOID_0060049 0.02463956 0.07965857 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB primary biliary cirrhosis DOID_12236 0.02463956 0.07965857 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hyperinsulinism DOID_2018 0.02518048 0.08094742 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB learning disability DOID_8927 0.02626147 0.08394818 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB myeloma DOID_0070004 0.02734132 0.08691178 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB brain cancer DOID_1319 0.02734132 0.08642894 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB thyroid adenoma DOID_2891 0.02734132 0.08595143 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB vascular skin disease DOID_9540 0.02734132 0.08547917 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB central nervous system cancer DOID_3620 0.02788081 0.08668952 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hemolytic anemia DOID_583 0.02788081 0.08621838 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB normocytic anemia DOID_720 0.02788081 0.08621838 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB autoimmune disease of gastrointestinal tract DOID_0060031 0.02842002 0.08741077 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB glaucoma DOID_1686 0.02842002 0.08694082 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB lung small cell carcinoma DOID_5409 0.02842002 0.08647589 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB calcium metabolism disease DOID_10575 0.02895895 0.08764702 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB withdrawal disorder DOID_0060001 0.02949759 0.08880491 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB atrophic muscular disease DOID_913 0.03057402 0.09156113 0.03057402 0.9664786 WILENSKY_RESPONSE_TO_DARAPLADIB muscular dystrophy DOID_9884 0.03057402 0.09156113 0.03057402 0.9664786 WILENSKY_RESPONSE_TO_DARAPLADIB bile duct adenocarcinoma DOID_4896 0.0311118 0.09268385 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB cholangiocarcinoma DOID_4947 0.0311118 0.09268385 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bone marrow cancer DOID_4960 0.0311118 0.09220112 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB familial hyperlipidemia DOID_1168 0.03218653 0.09489188 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB mitochondrial metabolism disease DOID_700 0.03218653 0.09440275 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB hypertrophic cardiomyopathy DOID_11984 0.03326011 0.0970513 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bile duct cancer DOID_4606 0.03326011 0.09655614 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB bile duct carcinoma DOID_4897 0.03326011 0.09655614 1.000 1.000 WILENSKY_RESPONSE_TO_DARAPLADIB leukocyte disease DOID_9500 0.03379648 0.09761522 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS pulmonary tuberculosis DOID_2957 2.457E-07 1.398E-04 1.033E-05 5.879E-03 OKUMURA_INFLAMMATORY_RESPONSE_LPS ulcerative colitis DOID_8577 2.503E-07 7.122E-05 0.02778745 0.26798403 OKUMURA_INFLAMMATORY_RESPONSE_LPS tuberculosis DOID_399 1.184E-06 2.246E-04 3.571E-05 0.01016067 OKUMURA_INFLAMMATORY_RESPONSE_LPS primary bacterial infectious disease DOID_0050338 3.639E-06 5.177E-04 8.661E-05 0.01642695 OKUMURA_INFLAMMATORY_RESPONSE_LPS systemic scleroderma DOID_418 4.357E-06 4.959E-04 5.324E-03 0.10819168 OKUMURA_INFLAMMATORY_RESPONSE_LPS peptic ulcer DOID_750 4.357E-06 4.132E-04 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS rheumatic disease DOID_1575 6.302E-06 5.123E-04 6.357E-03 0.11303877 OKUMURA_INFLAMMATORY_RESPONSE_LPS scleroderma DOID_419 6.302E-06 5.123E-04 6.357E-03 0.11303877 OKUMURA_INFLAMMATORY_RESPONSE_LPS aortic aneurysm DOID_3627 1.115E-05 7.933E-04 3.572E-04 0.02258546 OKUMURA_INFLAMMATORY_RESPONSE_LPS parasitic protozoa infectious disease DOID_2789 1.6E-05 1.012E-03 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS pustulosis of palm and sole DOID_4398 1.6E-05 9.105E-04 4.662E-04 0.02040361 OKUMURA_INFLAMMATORY_RESPONSE_LPS esophagitis DOID_11963 1.849E-05 9.567E-04 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS collagen disease DOID_854 2.368E-05 1.123E-03 0.01201548 0.18477862 OKUMURA_INFLAMMATORY_RESPONSE_LPS parasitic infectious disease DOID_1398 3.011E-05 1.318E-03 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS uterine disease DOID_345 3.011E-05 1.224E-03 0.01348669 0.20194543 OKUMURA_INFLAMMATORY_RESPONSE_LPS diabetic retinopathy DOID_8947 4.669E-05 1.771E-03 0.01664966 0.22031764 OKUMURA_INFLAMMATORY_RESPONSE_LPS aneurysm disease DOID_2403 5.436E-05 1.933E-03 1.149E-03 0.03844889 OKUMURA_INFLAMMATORY_RESPONSE_LPS bacterial pneumonia DOID_874 5.711E-05 1.911E-03 0.01833816 0.23187579 OKUMURA_INFLAMMATORY_RESPONSE_LPS female reproductive system disease DOID_229 6.596E-05 2.085E-03 0.01965002 0.23293462 OKUMURA_INFLAMMATORY_RESPONSE_LPS chronic kidney failure DOID_784 7.239E-05 2.168E-03 1.419E-03 0.04248954 OKUMURA_INFLAMMATORY_RESPONSE_LPS retinal vascular disease DOID_2462 7.927E-05 2.255E-03 0.02145857 0.24419856 OKUMURA_INFLAMMATORY_RESPONSE_LPS lymphoma DOID_0060058 1.071E-04 2.902E-03 1.071E-04 0.0152363 OKUMURA_INFLAMMATORY_RESPONSE_LPS metal metabolism disorder DOID_896 1.124E-04 2.907E-03 1.124E-04 0.01279178 OKUMURA_INFLAMMATORY_RESPONSE_LPS Crohn's disease DOID_8778 1.162E-04 2.875E-03 0.02576847 0.25723263 OKUMURA_INFLAMMATORY_RESPONSE_LPS esophageal disease DOID_6050 1.221E-04 2.895E-03 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS blood platelet disease DOID_2218 1.663E-04 3.784E-03 0.10073579 0.45491002 OKUMURA_INFLAMMATORY_RESPONSE_LPS respiratory syncytial virus infectious disease DOID_1273 1.787E-04 3.911E-03 5.324E-03 0.11651411 OKUMURA_INFLAMMATORY_RESPONSE_LPS congenital diaphragmatic hernia DOID_3827 1.787E-04 3.766E-03 5.324E-03 0.11219877 OKUMURA_INFLAMMATORY_RESPONSE_LPS spinocerebellar ataxia DOID_1441 2.197E-04 4.464E-03 2.197E-04 0.02083096 OKUMURA_INFLAMMATORY_RESPONSE_LPS endometriosis of uterus DOID_288 2.197E-04 4.31E-03 6.091E-03 0.11552572 OKUMURA_INFLAMMATORY_RESPONSE_LPS endometriosis DOID_289 2.345E-04 4.449E-03 6.357E-03 0.10961335 OKUMURA_INFLAMMATORY_RESPONSE_LPS spinocerebellar degeneration DOID_2478 2.831E-04 5.196E-03 2.831E-04 0.0230097 OKUMURA_INFLAMMATORY_RESPONSE_LPS Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.936E-04 5.221E-03 2.936E-04 0.0208856 OKUMURA_INFLAMMATORY_RESPONSE_LPS Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.936E-04 5.221E-03 2.936E-04 0.0208856 OKUMURA_INFLAMMATORY_RESPONSE_LPS Hodgkin's granuloma DOID_8651 2.936E-04 5.221E-03 2.936E-04 0.0208856 OKUMURA_INFLAMMATORY_RESPONSE_LPS Hodgkin's lymphoma, mixed cellularity DOID_8654 2.936E-04 5.221E-03 2.936E-04 0.0208856 OKUMURA_INFLAMMATORY_RESPONSE_LPS hemochromatosis DOID_2352 3.583E-04 6.178E-03 3.583E-04 0.02038705 OKUMURA_INFLAMMATORY_RESPONSE_LPS eosinophilic pneumonia DOID_5870 3.583E-04 5.996E-03 0.02807399 0.25764675 OKUMURA_INFLAMMATORY_RESPONSE_LPS pulmonary eosinophilia DOID_9498 3.583E-04 5.996E-03 0.02807399 0.25764675 OKUMURA_INFLAMMATORY_RESPONSE_LPS Loeffler syndrome DOID_9503 3.583E-04 5.996E-03 0.02807399 0.25764675 OKUMURA_INFLAMMATORY_RESPONSE_LPS hemorrhagic disease DOID_2213 3.775E-04 6.138E-03 0.13052765 0.53431822 OKUMURA_INFLAMMATORY_RESPONSE_LPS atopic dermatitis DOID_3310 3.986E-04 6.3E-03 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS Hodgkin's lymphoma DOID_8567 4.292E-04 6.601E-03 4.292E-04 0.02220294 OKUMURA_INFLAMMATORY_RESPONSE_LPS bile duct adenocarcinoma DOID_4896 4.429E-04 6.632E-03 4.429E-04 0.02099984 OKUMURA_INFLAMMATORY_RESPONSE_LPS cholangiocarcinoma DOID_4947 4.429E-04 6.632E-03 4.429E-04 0.02099984 OKUMURA_INFLAMMATORY_RESPONSE_LPS bile duct cancer DOID_4606 5.407E-04 7.888E-03 5.407E-04 0.02197495 OKUMURA_INFLAMMATORY_RESPONSE_LPS bile duct carcinoma DOID_4897 5.407E-04 7.888E-03 5.407E-04 0.02197495 OKUMURA_INFLAMMATORY_RESPONSE_LPS aspergillosis DOID_13564 5.898E-04 8.39E-03 5.898E-04 0.02237405 OKUMURA_INFLAMMATORY_RESPONSE_LPS intermediate coronary syndrome DOID_8805 6.794E-04 9.429E-03 0.0380881 0.26429423 OKUMURA_INFLAMMATORY_RESPONSE_LPS congenital heart defect DOID_1682 6.811E-04 9.227E-03 6.811E-04 0.02422038 OKUMURA_INFLAMMATORY_RESPONSE_LPS allergic contact dermatitis DOID_3042 8.087E-04 0.01070054 0.16585639 0.61280706 OKUMURA_INFLAMMATORY_RESPONSE_LPS blood coagulation disease DOID_1247 9.137E-04 0.01181533 0.17232055 0.62852815 OKUMURA_INFLAMMATORY_RESPONSE_LPS nephrosis DOID_2527 9.505E-04 0.01201844 0.17446423 0.63229392 OKUMURA_INFLAMMATORY_RESPONSE_LPS bile duct disease DOID_4138 9.505E-04 0.01175717 0.01583186 0.22520828 OKUMURA_INFLAMMATORY_RESPONSE_LPS eosinophilia DOID_999 9.85E-04 0.01192506 0.0455316 0.29109525 OKUMURA_INFLAMMATORY_RESPONSE_LPS biliary tract disease DOID_9741 9.882E-04 0.01171487 0.01623854 0.22535924 OKUMURA_INFLAMMATORY_RESPONSE_LPS contact dermatitis DOID_2773 1.279E-03 0.01485533 0.191417 0.67649859 OKUMURA_INFLAMMATORY_RESPONSE_LPS chromosomal disease DOID_0080014 1.325E-03 0.015076 0.01965002 0.23789068 OKUMURA_INFLAMMATORY_RESPONSE_LPS autoimmune hepatitis DOID_2048 1.345E-03 0.01500796 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS biliary tract cancer DOID_4607 1.419E-03 0.01552502 1.419E-03 0.04485007 OKUMURA_INFLAMMATORY_RESPONSE_LPS uremia DOID_4676 1.615E-03 0.01734024 1.615E-03 0.04595164 OKUMURA_INFLAMMATORY_RESPONSE_LPS urinary tract obstruction DOID_5200 1.615E-03 0.01701913 0.05781094 0.34625708 OKUMURA_INFLAMMATORY_RESPONSE_LPS ureteral disease DOID_1426 1.759E-03 0.0181981 1.759E-03 0.04766169 OKUMURA_INFLAMMATORY_RESPONSE_LPS Goodpasture syndrome DOID_9808 1.759E-03 0.01787313 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS Human immunodeficiency virus infectious disease DOID_526 1.781E-03 0.01777416 1.781E-03 0.04605122 OKUMURA_INFLAMMATORY_RESPONSE_LPS encephalomyelitis DOID_640 1.952E-03 0.01914569 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS bronchiolitis DOID_2942 2.064E-03 0.01990901 0.06510335 0.37043807 OKUMURA_INFLAMMATORY_RESPONSE_LPS ankylosing spondylitis DOID_7147 2.226E-03 0.02110784 0.06752172 0.36942171 OKUMURA_INFLAMMATORY_RESPONSE_LPS extrinsic allergic alveolitis DOID_841 2.393E-03 0.02232131 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS Sciatic Neuropathy DOID_11446 2.566E-03 0.02354843 0.07233989 0.38112407 OKUMURA_INFLAMMATORY_RESPONSE_LPS lesion of sciatic nerve DOID_12528 2.566E-03 0.02354843 0.07233989 0.38112407 OKUMURA_INFLAMMATORY_RESPONSE_LPS mononeuritis of lower limb DOID_9473 2.566E-03 0.02354843 0.07233989 0.38112407 OKUMURA_INFLAMMATORY_RESPONSE_LPS mononeuritis DOID_1802 2.745E-03 0.02478827 0.07473973 0.38660826 OKUMURA_INFLAMMATORY_RESPONSE_LPS mononeuropathy DOID_1188 2.929E-03 0.02603998 0.07713343 0.39186535 OKUMURA_INFLAMMATORY_RESPONSE_LPS focal glomerulosclerosis DOID_3945 2.929E-03 0.02563937 0.07713343 0.38839752 OKUMURA_INFLAMMATORY_RESPONSE_LPS opportunistic mycosis DOID_2473 3.315E-03 0.0285758 3.315E-03 0.08200012 OKUMURA_INFLAMMATORY_RESPONSE_LPS systemic mycosis DOID_0050136 3.935E-03 0.03341845 3.935E-03 0.09329317 OKUMURA_INFLAMMATORY_RESPONSE_LPS fungal infectious disease DOID_1564 3.935E-03 0.03341845 3.935E-03 0.09329317 OKUMURA_INFLAMMATORY_RESPONSE_LPS myocarditis DOID_820 3.935E-03 0.032927 3.935E-03 0.08956145 OKUMURA_INFLAMMATORY_RESPONSE_LPS pulmonary sarcoidosis DOID_13406 4.839E-03 0.03990717 0.09840269 0.45521246 OKUMURA_INFLAMMATORY_RESPONSE_LPS hepatitis DOID_2237 5.324E-03 0.04327667 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS adenoid cystic carcinoma DOID_4866 5.574E-03 0.0446735 5.574E-03 0.10937305 OKUMURA_INFLAMMATORY_RESPONSE_LPS salivary gland cancer DOID_8850 6.091E-03 0.04813572 6.091E-03 0.11179908 OKUMURA_INFLAMMATORY_RESPONSE_LPS nephrotic syndrome DOID_1184 6.357E-03 0.04955124 0.11231191 0.49926154 OKUMURA_INFLAMMATORY_RESPONSE_LPS hyperinsulinism DOID_2018 6.357E-03 0.04888163 0.11231191 0.48782807 OKUMURA_INFLAMMATORY_RESPONSE_LPS uveal disease DOID_3480 6.357E-03 0.04822987 0.11231191 0.4841324 OKUMURA_INFLAMMATORY_RESPONSE_LPS gallbladder cancer DOID_3121 6.629E-03 0.04962741 6.629E-03 0.11093185 OKUMURA_INFLAMMATORY_RESPONSE_LPS proteinuria DOID_576 7.187E-03 0.0531094 0.11918666 0.50990382 OKUMURA_INFLAMMATORY_RESPONSE_LPS myeloma DOID_0070004 7.474E-03 0.05452167 0.12146651 0.51577942 OKUMURA_INFLAMMATORY_RESPONSE_LPS pre-eclampsia DOID_10591 7.474E-03 0.05383152 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS neuritis DOID_1803 7.474E-03 0.05315863 0.12146651 0.51195884 OKUMURA_INFLAMMATORY_RESPONSE_LPS heart valve disease DOID_4079 7.474E-03 0.05250235 0.12146651 0.50819443 OKUMURA_INFLAMMATORY_RESPONSE_LPS autoimmune disease of gastrointestinal tract DOID_0060031 8.063E-03 0.05595044 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS glaucoma DOID_1686 8.063E-03 0.05527634 8.063E-03 0.13108388 OKUMURA_INFLAMMATORY_RESPONSE_LPS sarcoidosis DOID_11335 9.302E-03 0.06300997 0.13502347 0.54877395 OKUMURA_INFLAMMATORY_RESPONSE_LPS giant cell tumor DOID_200 9.302E-03 0.06226868 0.13502347 0.54488194 OKUMURA_INFLAMMATORY_RESPONSE_LPS malignant giant cell tumor DOID_2705 9.302E-03 0.06226868 0.13502347 0.54488194 OKUMURA_INFLAMMATORY_RESPONSE_LPS giant cell glioblastoma DOID_3074 9.302E-03 0.06226868 0.13502347 0.54488194 OKUMURA_INFLAMMATORY_RESPONSE_LPS bone marrow cancer DOID_4960 9.624E-03 0.06367606 0.13726274 0.55001761 OKUMURA_INFLAMMATORY_RESPONSE_LPS hypersensitivity reaction type IV disease DOID_2916 0.01096169 0.07169197 0.1461626 0.5696337 OKUMURA_INFLAMMATORY_RESPONSE_LPS glioblastoma DOID_3068 0.01096169 0.07087729 0.1461626 0.56575864 OKUMURA_INFLAMMATORY_RESPONSE_LPS oral cavity cancer DOID_8618 0.01096169 0.07008092 0.01096169 0.1732556 OKUMURA_INFLAMMATORY_RESPONSE_LPS leukocyte disease DOID_9500 0.01130818 0.0714928 0.14837333 0.5704353 OKUMURA_INFLAMMATORY_RESPONSE_LPS mineral metabolism disease DOID_0050032 0.01311188 0.08198526 1.000 1.000 OKUMURA_INFLAMMATORY_RESPONSE_LPS endocrine pancreas disease DOID_1428 0.01311188 0.08109412 0.15934227 0.60443835 OKUMURA_INFLAMMATORY_RESPONSE_LPS cholestasis DOID_13580 0.01348669 0.08251534 0.16151922 0.60863865 OKUMURA_INFLAMMATORY_RESPONSE_LPS astrocytoma DOID_3069 0.01503197 0.09099137 0.17017136 0.62469357 OKUMURA_INFLAMMATORY_RESPONSE_LPS pancreatic ductal carcinoma DOID_3587 0.01542967 0.09241558 0.01542967 0.22511486 OKUMURA_INFLAMMATORY_RESPONSE_LPS peripheral vascular disease DOID_341 0.01623854 0.09624717 0.17660241 0.63599224 OKUMURA_INFLAMMATORY_RESPONSE_LPS pancreatic carcinoma DOID_4905 0.01664966 0.09766658 0.01664966 0.2255633 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN Crohn's disease DOID_8778 4.161E-10 2.368E-07 1.375E-08 7.824E-06 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hemolytic anemia DOID_583 8.418E-09 2.395E-06 3.963E-07 1.127E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN normocytic anemia DOID_720 8.418E-09 2.395E-06 3.963E-07 1.127E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN parasitic protozoa infectious disease DOID_2789 1.861E-08 3.53E-06 2.523E-05 1.595E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN parasitic infectious disease DOID_1398 4.916E-08 6.993E-06 4.735E-05 2.694E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN pulmonary tuberculosis DOID_2957 4.374E-07 4.978E-05 4.736E-04 9.624E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN ulcerative colitis DOID_8577 4.966E-07 4.709E-05 1.134E-05 1.076E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN congenital hemolytic anemia DOID_589 6.817E-07 5.541E-05 6.817E-07 1.293E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN vasculitis DOID_865 6.966E-07 4.955E-05 2.354E-05 1.674E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN tuberculosis DOID_399 2.097E-06 1.326E-04 1.177E-03 0.01762123 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN bacterial pneumonia DOID_874 3.793E-06 2.158E-04 8.954E-05 3.639E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN blood platelet disease DOID_2218 6.254E-06 3.235E-04 6.254E-06 8.897E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN primary bacterial infectious disease DOID_0050338 6.415E-06 3.042E-04 2.252E-03 0.0261457 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN primary immunodeficiency disease DOID_612 7.154E-06 3.131E-04 7.154E-06 8.142E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN encephalomyelitis DOID_640 8.832E-06 3.59E-04 1.743E-04 4.312E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hemorrhagic disease DOID_2213 1.897E-05 7.197E-04 1.897E-05 1.542E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN leishmaniasis DOID_9065 2.226E-05 7.917E-04 0.05372531 0.17982177 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN funisitis DOID_0050698 3.516E-05 1.177E-03 1.855E-03 0.02199403 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN carotid artery disease DOID_3407 3.728E-05 1.178E-03 0.01496049 0.09055869 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN allergic contact dermatitis DOID_3042 5.308E-05 1.59E-03 5.308E-05 2.746E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN brain infarction DOID_3454 5.612E-05 1.597E-03 1.177E-03 0.01809748 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN blood coagulation disease DOID_1247 6.259E-05 1.696E-03 6.259E-05 2.968E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN Sciatic Neuropathy DOID_11446 8.22E-05 2.126E-03 8.22E-05 3.598E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN lesion of sciatic nerve DOID_12528 8.22E-05 2.126E-03 8.22E-05 3.598E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN mononeuritis of lower limb DOID_9473 8.22E-05 2.126E-03 8.22E-05 3.598E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN malaria DOID_12365 9.114E-05 2.255E-03 9.114E-05 3.457E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN thrombocytopenia DOID_1588 9.114E-05 2.161E-03 9.114E-05 3.241E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN mononeuritis DOID_1802 9.114E-05 2.074E-03 9.114E-05 3.05E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN metabolic syndrome X DOID_14221 9.858E-05 2.157E-03 1.782E-03 0.02204005 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN contact dermatitis DOID_2773 9.858E-05 2.077E-03 9.858E-05 3.116E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN mononeuropathy DOID_1188 1.007E-04 2.046E-03 1.007E-04 3.015E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN opportunistic mycosis DOID_2473 1.217E-04 2.388E-03 4.154E-03 0.04074815 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN autonomic nervous system neoplasm DOID_2621 1.454E-04 2.757E-03 1.454E-04 4.136E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN neuroblastoma DOID_769 1.454E-04 2.757E-03 1.454E-04 4.136E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN nervous system cancer DOID_3093 1.54E-04 2.827E-03 1.54E-04 4.173E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN systemic mycosis DOID_0050136 1.583E-04 2.814E-03 4.928E-03 0.04752598 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN fungal infectious disease DOID_1564 1.583E-04 2.814E-03 4.928E-03 0.04752598 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN lymphoma DOID_0060058 1.673E-04 2.885E-03 1.673E-04 4.328E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.815E-04 3.037E-03 1.815E-04 4.303E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN dilated cardiomyopathy DOID_12930 1.889E-04 3.071E-03 2.875E-03 0.03207153 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN pulmonary sarcoidosis DOID_13406 2.171E-04 3.432E-03 6.055E-03 0.05383695 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN multiple myeloma DOID_9538 2.171E-04 3.339E-03 6.055E-03 0.05220553 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN peripheral nervous system neoplasm DOID_1192 2.338E-04 3.501E-03 2.338E-04 5.321E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN systemic scleroderma DOID_418 2.513E-04 3.666E-03 6.659E-03 0.05655317 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN pulmonary emphysema DOID_9675 2.886E-04 4.106E-03 0.12008122 0.30367207 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN endometriosis of uterus DOID_288 3.086E-04 4.283E-03 7.614E-03 0.06101701 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN rheumatic disease DOID_1575 3.294E-04 4.463E-03 7.945E-03 0.06192611 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN endometriosis DOID_289 3.294E-04 4.359E-03 7.945E-03 0.06027474 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN scleroderma DOID_419 3.294E-04 4.463E-03 7.945E-03 0.06192611 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN gallbladder cancer DOID_3121 3.512E-04 4.541E-03 8.282E-03 0.06200843 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN cutaneous leishmaniasis DOID_9111 3.698E-04 4.675E-03 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN alopecia areata DOID_986 3.698E-04 4.574E-03 0.02864275 0.1381163 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN proteinuria DOID_576 3.973E-04 4.81E-03 8.976E-03 0.06548121 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN myeloma DOID_0070004 4.218E-04 5E-03 9.333E-03 0.0672196 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN neuritis DOID_1803 4.218E-04 4.898E-03 4.218E-04 9.231E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN sickle cell anemia DOID_10923 4.511E-04 5.133E-03 4.511E-04 9.506E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN temporal arteritis DOID_13375 4.511E-04 5.032E-03 0.03146192 0.14321464 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN central nervous system vasculitis DOID_525 4.511E-04 5.032E-03 0.03146192 0.14321464 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN common cold DOID_10459 5.403E-04 5.912E-03 0.03427298 0.15001018 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN beta thalassemia DOID_12241 5.403E-04 5.8E-03 5.403E-04 0.0106001 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN relapsing-remitting multiple sclerosis DOID_2378 5.403E-04 5.693E-03 5.403E-04 0.01024677 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN sarcoidosis DOID_11335 5.89E-04 6.094E-03 0.01160104 0.07765872 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN bile duct adenocarcinoma DOID_4896 6.205E-04 6.304E-03 0.01200033 0.07939755 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN cholangiocarcinoma DOID_4947 6.205E-04 6.304E-03 0.01200033 0.07939755 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN bone marrow cancer DOID_4960 6.205E-04 6.194E-03 0.01200033 0.07848493 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN larynx cancer DOID_2596 6.373E-04 6.252E-03 0.03707595 0.15177134 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN laryngeal benign neoplasm DOID_2598 6.373E-04 6.252E-03 0.03707595 0.15177134 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN psoriatic arthritis DOID_9008 6.373E-04 6.146E-03 6.373E-04 0.01169697 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hypertrophic cardiomyopathy DOID_11984 7.568E-04 7.177E-03 0.01365684 0.08731171 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hypersensitivity reaction type IV disease DOID_2916 7.568E-04 7.059E-03 0.01365684 0.08634158 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN bile duct cancer DOID_4606 7.568E-04 6.945E-03 0.01365684 0.08539278 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN bile duct carcinoma DOID_4897 7.568E-04 6.945E-03 0.01365684 0.08539278 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN oral cavity cancer DOID_8618 7.568E-04 6.835E-03 7.568E-04 0.01345644 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN thalassemia DOID_10241 8.546E-04 7.598E-03 8.546E-04 0.01473563 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN adrenal cortex disease DOID_3952 8.546E-04 7.481E-03 8.546E-04 0.01430223 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN collagen disease DOID_854 8.706E-04 7.505E-03 0.01496049 0.08960544 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hypothyroidism DOID_1459 9.108E-04 7.735E-03 9.108E-04 0.01480671 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN pre-malignant neoplasm DOID_0060071 9.521E-04 7.967E-03 0.01585821 0.09399292 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN in situ carcinoma DOID_8719 9.521E-04 7.967E-03 0.01585821 0.09399292 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hemolytic-uremic syndrome DOID_12554 9.749E-04 8.039E-03 0.0454366 0.17008832 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN uterine disease DOID_345 1.038E-03 8.441E-03 0.01677849 0.09643395 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN adrenal gland disease DOID_9553 1.103E-03 8.837E-03 1.103E-03 0.01742943 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN nephrosis DOID_2527 1.326E-03 0.01048169 0.01967185 0.11082461 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN bile duct disease DOID_4138 1.326E-03 0.0103381 1.326E-03 0.01935081 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN peripheral vascular disease DOID_341 1.379E-03 0.01060104 1.379E-03 0.01961193 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN biliary tract disease DOID_9741 1.379E-03 0.01045969 1.379E-03 0.01913359 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN conduct disorder DOID_12995 1.381E-03 0.01034151 1.381E-03 0.0187132 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN Down syndrome DOID_14250 1.381E-03 0.0102072 1.381E-03 0.01827801 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN agammaglobulinemia DOID_2583 1.381E-03 0.01007634 1.381E-03 0.0178626 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN blood protein disease DOID_620 1.532E-03 0.01103329 1.532E-03 0.01936956 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN alopecia DOID_987 1.532E-03 0.01089538 0.05647233 0.18467102 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN cystic fibrosis DOID_1485 1.544E-03 0.01084282 0.20298305 0.45832283 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN pancreatitis DOID_4989 1.66E-03 0.01151867 0.0227581 0.12572195 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN chromosomal disease DOID_0080014 1.845E-03 0.01264646 1.845E-03 0.02233311 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN female reproductive system disease DOID_229 1.845E-03 0.01249591 0.02437124 0.1320689 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN biliary tract cancer DOID_4607 1.975E-03 0.0132192 0.02547197 0.13673163 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN chronic kidney failure DOID_784 1.975E-03 0.01306549 0.21906487 0.48313145 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN IgA glomerulonephritis DOID_2986 2.028E-03 0.01326519 0.06466608 0.20441667 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN transitional cell carcinoma DOID_2671 2.324E-03 0.01502887 0.02831046 0.15054815 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN Human immunodeficiency virus infectious disease DOID_526 2.474E-03 0.01581812 0.02947983 0.14095818 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN lymphoblastic leukemia DOID_1037 2.71E-03 0.01713305 2.71E-03 0.03083949 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN myositis DOID_633 2.793E-03 0.0174619 0.07548149 0.21912739 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN vitiligo DOID_12306 3.002E-03 0.01856559 3.002E-03 0.03284681 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN B cell deficiency DOID_2115 3.002E-03 0.01836596 3.002E-03 0.03222706 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hypotrichosis DOID_4535 3.002E-03 0.01817058 0.07816592 0.22462834 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN periodontitis DOID_824 3.218E-03 0.01927464 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN invasive ductal carcinoma DOID_3008 3.441E-03 0.0203977 3.441E-03 0.03626257 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN autoimmune disease of the nervous system DOID_438 3.441E-03 0.02018741 3.441E-03 0.03560325 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN toxic encephalopathy DOID_3602 3.672E-03 0.02131913 3.672E-03 0.03730848 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN corneal disease DOID_10124 3.909E-03 0.02246822 3.909E-03 0.03902375 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN bronchiolitis obliterans DOID_2799 4.154E-03 0.02363393 0.09147267 0.24550919 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN allergic rhinitis DOID_4481 4.405E-03 0.02481553 0.09411109 0.24906608 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN pleural disease DOID_1532 4.663E-03 0.02601231 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN papilloma DOID_2615 4.928E-03 0.02722362 4.928E-03 0.04673388 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hair disease DOID_421 4.928E-03 0.02696185 0.09936517 0.26054737 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN myocarditis DOID_820 4.928E-03 0.02670508 0.09936517 0.2593522 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN periodontal disease DOID_3388 5.2E-03 0.02791203 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN leukopenia DOID_615 5.2E-03 0.02765117 5.2E-03 0.04850288 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hyperthyroidism DOID_7998 5.2E-03 0.02739514 5.2E-03 0.04772057 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN medullomyoblastoma DOID_3861 5.478E-03 0.0285978 5.478E-03 0.04947874 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN adult medulloblastoma DOID_3864 5.478E-03 0.0285978 5.478E-03 0.04947874 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN childhood medulloblastoma DOID_3869 5.478E-03 0.0285978 5.478E-03 0.04947874 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN calcinosis DOID_182 6.055E-03 0.03132332 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN medulloblastoma DOID_3858 6.055E-03 0.03104113 6.055E-03 0.05300869 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN intracranial arterial disease DOID_13089 6.971E-03 0.03541441 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN cerebral arterial disease DOID_3527 6.971E-03 0.03541441 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN adenoid cystic carcinoma DOID_4866 6.971E-03 0.035101 6.971E-03 0.05832961 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN lymphatic system disease DOID_75 6.971E-03 0.0347931 6.971E-03 0.05748425 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN cervix uteri carcinoma in situ DOID_8991 7.289E-03 0.03606495 0.12008122 0.30502775 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN spinocerebellar ataxia DOID_1441 7.614E-03 0.03734662 7.614E-03 0.06188868 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN salivary gland cancer DOID_8850 7.614E-03 0.03702742 7.614E-03 0.06016955 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN nephrotic syndrome DOID_1184 7.945E-03 0.03831022 0.12518602 0.31379228 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN primitive neuroectodermal tumor DOID_168 7.945E-03 0.03798828 7.945E-03 0.06108927 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN influenza DOID_8469 8.282E-03 0.03927201 0.12772741 0.3146186 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN cerebral infarction DOID_3526 8.626E-03 0.04056439 0.13026148 0.31947751 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN spinocerebellar degeneration DOID_2478 8.976E-03 0.04186504 8.976E-03 0.06633162 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN pre-eclampsia DOID_10591 9.333E-03 0.04317356 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN vascular skin disease DOID_9540 9.333E-03 0.04282539 9.333E-03 0.06637935 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN autoimmune disease of gastrointestinal tract DOID_0060031 0.01006432 0.0458128 0.14032501 0.33268721 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN integumentary system benign neoplasm DOID_0060121 0.01006432 0.04544921 0.01006432 0.07069877 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN glaucoma DOID_1686 0.01006432 0.04509134 0.14032501 0.33130677 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN skin benign neoplasm DOID_3165 0.01006432 0.04544921 0.01006432 0.07069877 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN calcium metabolism disease DOID_10575 0.01043936 0.04640621 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN movement disease DOID_480 0.01043936 0.04604647 0.01043936 0.07243896 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN B-cell lymphocytic neoplasm DOID_707 0.01082051 0.04736056 0.01082051 0.07417919 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN atopic dermatitis DOID_3310 0.01120775 0.04868101 0.01120775 0.07591919 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN giant cell tumor DOID_200 0.01160104 0.05000751 0.15027315 0.35332819 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN malignant giant cell tumor DOID_2705 0.01160104 0.05000751 0.15027315 0.35332819 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN giant cell glioblastoma DOID_3074 0.01160104 0.05000751 0.15027315 0.35332819 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN reproductive organ benign neoplasm DOID_0050622 0.0124056 0.05307357 0.15520435 0.36342089 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN integumentary system cancer DOID_0060122 0.0124056 0.0526775 0.0124056 0.08021346 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN skin cancer DOID_4159 0.0124056 0.0526775 0.0124056 0.08021346 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN glioblastoma DOID_3068 0.01365684 0.05756106 0.16254804 0.37597493 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN leukocyte disease DOID_9500 0.01408562 0.05893173 0.01408562 0.08711647 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN neuroectodermal tumor DOID_171 0.01496049 0.06213516 0.01496049 0.09153244 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN mineral metabolism disease DOID_0050032 0.01631555 0.06727207 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN endocrine pancreas disease DOID_1428 0.01631555 0.0667881 0.01631555 0.09570666 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN cholestasis DOID_13580 0.01677849 0.06819258 0.01677849 0.09741797 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN hyperglycemia DOID_4195 0.017247 0.06959961 0.18182338 0.41549199 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN tooth disease DOID_1091 0.01772105 0.07100899 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN endocrine organ benign neoplasm DOID_0060089 0.01820059 0.07242054 0.01820059 0.10356137 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN astrocytoma DOID_3069 0.0186856 0.07383406 0.18893773 0.43002228 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN male reproductive system disease DOID_48 0.01967185 0.07719507 0.19364655 0.4389836 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN syndrome DOID_225 0.02170838 0.08460322 0.02170838 0.12109873 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN mixed glioma DOID_5076 0.0227581 0.08809089 0.0227581 0.12451309 SMID_BREAST_CANCER_BASAL_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.757E-14 9.995E-12 1.752E-09 4.984E-07 SMID_BREAST_CANCER_BASAL_DN endocrine organ benign neoplasm DOID_0060089 6.26E-11 1.781E-08 3.406E-07 1.938E-05 SMID_BREAST_CANCER_BASAL_DN metabolic syndrome X DOID_14221 3.124E-10 5.926E-08 1.216E-05 2.768E-04 SMID_BREAST_CANCER_BASAL_DN focal epilepsy DOID_2234 4.643E-10 6.605E-08 4.643E-10 2.642E-07 SMID_BREAST_CANCER_BASAL_DN diabetic autonomic neuropathy DOID_11503 4.862E-10 5.533E-08 2.662E-07 1.893E-05 SMID_BREAST_CANCER_BASAL_DN autonomic neuropathy DOID_11504 4.862E-10 5.533E-08 2.662E-07 1.893E-05 SMID_BREAST_CANCER_BASAL_DN diabetic polyneuropathy DOID_12785 4.862E-10 5.533E-08 2.662E-07 1.893E-05 SMID_BREAST_CANCER_BASAL_DN diabetic neuropathy DOID_9743 4.862E-10 5.533E-08 2.662E-07 1.893E-05 SMID_BREAST_CANCER_BASAL_DN autonomic nervous system disease DOID_11465 8.722E-10 8.271E-08 4.127E-07 2.135E-05 SMID_BREAST_CANCER_BASAL_DN nervous system cancer DOID_3093 1.104E-09 8.972E-08 1.624E-08 3.081E-06 SMID_BREAST_CANCER_BASAL_DN gestational diabetes DOID_11714 7.631E-09 5.427E-07 6.816E-06 1.939E-04 SMID_BREAST_CANCER_BASAL_DN peripheral vascular disease DOID_341 3.562E-08 2.252E-06 7.439E-05 1.114E-03 SMID_BREAST_CANCER_BASAL_DN peripheral nervous system neoplasm DOID_1192 9.983E-08 5.68E-06 9.983E-08 1.42E-05 SMID_BREAST_CANCER_BASAL_DN chronic kidney failure DOID_784 1.076E-07 5.565E-06 1.542E-05 3.249E-04 SMID_BREAST_CANCER_BASAL_DN bone development disease DOID_0080006 1.192E-07 5.651E-06 1.504E-06 5.349E-05 SMID_BREAST_CANCER_BASAL_DN morbid obesity DOID_11981 1.594E-07 6.976E-06 1.594E-07 1.814E-05 SMID_BREAST_CANCER_BASAL_DN transitional cell carcinoma DOID_2671 1.772E-07 7.2E-06 2.243E-05 4.254E-04 SMID_BREAST_CANCER_BASAL_DN amino acid metabolic disorder DOID_9252 1.95E-07 7.397E-06 1.95E-07 1.849E-05 SMID_BREAST_CANCER_BASAL_DN myopia DOID_11830 2.013E-07 7.158E-06 2.013E-07 1.636E-05 SMID_BREAST_CANCER_BASAL_DN temporal lobe epilepsy DOID_3328 2.72E-07 9.105E-06 2.72E-07 1.72E-05 SMID_BREAST_CANCER_BASAL_DN thyroid adenoma DOID_2891 4.127E-07 1.305E-05 1.036E-04 1.437E-03 SMID_BREAST_CANCER_BASAL_DN vascular skin disease DOID_9540 4.127E-07 1.236E-05 1.227E-03 8.95E-03 SMID_BREAST_CANCER_BASAL_DN endometrial carcinoma DOID_2871 4.691E-07 1.335E-05 4.691E-07 2.224E-05 SMID_BREAST_CANCER_BASAL_DN endometrial cancer DOID_1380 6.853E-07 1.857E-05 6.853E-07 3E-05 SMID_BREAST_CANCER_BASAL_DN endogenous depression DOID_1595 7.091E-07 1.834E-05 8.727E-06 2.257E-04 SMID_BREAST_CANCER_BASAL_DN leiomyoma DOID_127 8.207E-07 2.03E-05 1.78E-05 3.492E-04 SMID_BREAST_CANCER_BASAL_DN autonomic nervous system neoplasm DOID_2621 8.207E-07 1.946E-05 8.207E-07 3.335E-05 SMID_BREAST_CANCER_BASAL_DN neuroblastoma DOID_769 8.207E-07 1.946E-05 8.207E-07 3.335E-05 SMID_BREAST_CANCER_BASAL_DN electroclinical syndrome DOID_0050701 8.626E-07 1.963E-05 8.626E-07 3.272E-05 SMID_BREAST_CANCER_BASAL_DN bile duct adenocarcinoma DOID_4896 1.033E-06 2.26E-05 1.544E-05 3.137E-04 SMID_BREAST_CANCER_BASAL_DN cholangiocarcinoma DOID_4947 1.033E-06 2.26E-05 1.544E-05 3.137E-04 SMID_BREAST_CANCER_BASAL_DN bone marrow cancer DOID_4960 1.033E-06 2.177E-05 1.94E-04 2.3E-03 SMID_BREAST_CANCER_BASAL_DN contact dermatitis DOID_2773 1.044E-06 2.121E-05 1.046E-03 8.38E-03 SMID_BREAST_CANCER_BASAL_DN female reproductive system disease DOID_229 1.146E-06 2.248E-05 1.104E-03 8.607E-03 SMID_BREAST_CANCER_BASAL_DN mental depression DOID_1596 1.375E-06 2.608E-05 1.542E-05 3.374E-04 SMID_BREAST_CANCER_BASAL_DN biliary tract cancer DOID_4607 1.375E-06 2.524E-05 1.494E-04 1.848E-03 SMID_BREAST_CANCER_BASAL_DN refractive error DOID_9835 1.598E-06 2.842E-05 1.598E-06 5.35E-05 SMID_BREAST_CANCER_BASAL_DN hypertrophic cardiomyopathy DOID_11984 1.651E-06 2.846E-05 2.674E-04 2.983E-03 SMID_BREAST_CANCER_BASAL_DN bile duct cancer DOID_4606 1.651E-06 2.762E-05 2.289E-05 4.201E-04 SMID_BREAST_CANCER_BASAL_DN bile duct carcinoma DOID_4897 1.651E-06 2.762E-05 2.289E-05 4.201E-04 SMID_BREAST_CANCER_BASAL_DN melancholia DOID_2848 1.846E-06 3.001E-05 2.514E-05 4.471E-04 SMID_BREAST_CANCER_BASAL_DN multiple myeloma DOID_9538 1.866E-06 2.949E-05 5.239E-04 4.808E-03 SMID_BREAST_CANCER_BASAL_DN neurotic disorder DOID_4964 2.06E-06 3.168E-05 2.757E-05 4.615E-04 SMID_BREAST_CANCER_BASAL_DN congenital diaphragmatic hernia DOID_3827 2.51E-06 3.759E-05 6.323E-04 5.621E-03 SMID_BREAST_CANCER_BASAL_DN congenital heart defect DOID_1682 2.831E-06 4.131E-05 3.602E-05 5.855E-04 SMID_BREAST_CANCER_BASAL_DN uterine disease DOID_345 3.468E-06 4.934E-05 3.805E-03 0.02101943 SMID_BREAST_CANCER_BASAL_DN urticaria DOID_1555 3.863E-06 5.362E-05 1.79E-03 0.01212281 SMID_BREAST_CANCER_BASAL_DN endometriosis DOID_289 4.344E-06 5.884E-05 8.952E-04 7.49E-03 SMID_BREAST_CANCER_BASAL_DN brain infarction DOID_3454 4.645E-06 6.147E-05 4.442E-03 0.02384288 SMID_BREAST_CANCER_BASAL_DN uterine cancer DOID_363 4.94E-06 6.389E-05 4.94E-06 1.562E-04 SMID_BREAST_CANCER_BASAL_DN larynx cancer DOID_2596 5E-06 6.323E-05 5E-06 1.497E-04 SMID_BREAST_CANCER_BASAL_DN laryngeal benign neoplasm DOID_2598 5E-06 6.323E-05 5E-06 1.497E-04 SMID_BREAST_CANCER_BASAL_DN migraine DOID_6364 6.816E-06 8.431E-05 6.816E-06 1.847E-04 SMID_BREAST_CANCER_BASAL_DN myeloma DOID_0070004 7.141E-06 8.645E-05 1.227E-03 9.186E-03 SMID_BREAST_CANCER_BASAL_DN syndrome DOID_225 8.727E-06 1.035E-04 8.727E-06 2.159E-04 SMID_BREAST_CANCER_BASAL_DN lung small cell carcinoma DOID_5409 9.006E-06 1.046E-04 9.006E-06 2.135E-04 SMID_BREAST_CANCER_BASAL_DN hemolytic-uremic syndrome DOID_12554 1.245E-05 1.417E-04 9.569E-03 0.03678951 SMID_BREAST_CANCER_BASAL_DN pituitary adenoma DOID_3829 1.245E-05 1.389E-04 9.569E-03 0.0365426 SMID_BREAST_CANCER_BASAL_DN alcohol abuse DOID_1574 1.542E-05 1.687E-04 1.494E-04 1.89E-03 SMID_BREAST_CANCER_BASAL_DN papilloma DOID_2615 2.051E-05 2.202E-04 0.04447111 0.11147164 SMID_BREAST_CANCER_BASAL_DN childhood electroclinical syndrome DOID_0050704 2.689E-05 2.834E-04 2.689E-05 4.637E-04 SMID_BREAST_CANCER_BASAL_DN adenoma DOID_657 3.061E-05 3.167E-04 5.753E-03 0.02661222 SMID_BREAST_CANCER_BASAL_DN hypersensitivity reaction type I disease DOID_1205 3.647E-05 3.706E-04 3.075E-04 3.24E-03 SMID_BREAST_CANCER_BASAL_DN dilated cardiomyopathy DOID_12930 3.647E-05 3.641E-04 2.205E-03 0.01458827 SMID_BREAST_CANCER_BASAL_DN cholestasis DOID_13580 4.271E-05 4.19E-04 3.805E-03 0.0212255 SMID_BREAST_CANCER_BASAL_DN allergic contact dermatitis DOID_3042 5.037E-05 4.858E-04 0.02790569 0.07633817 SMID_BREAST_CANCER_BASAL_DN benign mesothelioma DOID_2645 5.557E-05 5.27E-04 5.557E-05 8.784E-04 SMID_BREAST_CANCER_BASAL_DN opiate dependence DOID_2559 5.752E-05 5.365E-04 1.245E-03 8.964E-03 SMID_BREAST_CANCER_BASAL_DN pulmonary embolism DOID_9477 5.752E-05 5.279E-04 1.245E-03 8.852E-03 SMID_BREAST_CANCER_BASAL_DN endometriosis of uterus DOID_288 6.204E-05 5.604E-04 8.573E-03 0.03364075 SMID_BREAST_CANCER_BASAL_DN blood coagulation disease DOID_1247 6.388E-05 5.68E-04 0.03107155 0.08300335 SMID_BREAST_CANCER_BASAL_DN pancreatic ductal carcinoma DOID_3587 6.388E-05 5.592E-04 0.03107155 0.08261548 SMID_BREAST_CANCER_BASAL_DN synostosis DOID_11971 6.852E-05 5.907E-04 6.852E-05 1.054E-03 SMID_BREAST_CANCER_BASAL_DN bile duct disease DOID_4138 6.898E-05 5.858E-04 5.147E-03 0.02502949 SMID_BREAST_CANCER_BASAL_DN Huntington's disease DOID_12858 6.908E-05 5.78E-04 8.952E-04 7.602E-03 SMID_BREAST_CANCER_BASAL_DN hyperinsulinism DOID_2018 6.908E-05 5.697E-04 9.108E-03 0.03525641 SMID_BREAST_CANCER_BASAL_DN biliary tract disease DOID_9741 7.439E-05 6.047E-04 5.397E-03 0.02559229 SMID_BREAST_CANCER_BASAL_DN pancreatic carcinoma DOID_4905 8.014E-05 6.422E-04 0.0344177 0.0886139 SMID_BREAST_CANCER_BASAL_DN diabetic retinopathy DOID_8947 8.014E-05 6.333E-04 5.656E-03 0.02659725 SMID_BREAST_CANCER_BASAL_DN cerebral infarction DOID_3526 8.499E-05 6.624E-04 0.01023732 0.03832258 SMID_BREAST_CANCER_BASAL_DN learning disability DOID_8927 8.499E-05 6.535E-04 8.499E-05 1.24E-03 SMID_BREAST_CANCER_BASAL_DN proteinuria DOID_576 9.392E-05 7.126E-04 0.01083081 0.03925307 SMID_BREAST_CANCER_BASAL_DN pre-eclampsia DOID_10591 1.036E-04 7.754E-04 1.036E-04 1.473E-03 SMID_BREAST_CANCER_BASAL_DN neuritis DOID_1803 1.036E-04 7.653E-04 1.227E-03 9.066E-03 SMID_BREAST_CANCER_BASAL_DN pancreatitis DOID_4989 1.068E-04 7.788E-04 9.354E-04 7.713E-03 SMID_BREAST_CANCER_BASAL_DN mixed glioma DOID_5076 1.068E-04 7.69E-04 1.068E-04 1.446E-03 SMID_BREAST_CANCER_BASAL_DN papillary adenoma DOID_3172 1.107E-04 7.873E-04 0.02616794 0.07227939 SMID_BREAST_CANCER_BASAL_DN microcystic adenoma DOID_5403 1.107E-04 7.873E-04 0.02616794 0.07227939 SMID_BREAST_CANCER_BASAL_DN follicular adenoma DOID_6204 1.107E-04 7.873E-04 0.02616794 0.07227939 SMID_BREAST_CANCER_BASAL_DN hemolytic anemia DOID_583 1.14E-04 8.005E-04 0.01207647 0.0421565 SMID_BREAST_CANCER_BASAL_DN normocytic anemia DOID_720 1.14E-04 8.005E-04 0.01207647 0.0421565 SMID_BREAST_CANCER_BASAL_DN lipid metabolism disorder DOID_3146 1.225E-04 8.499E-04 1.046E-03 8.264E-03 SMID_BREAST_CANCER_BASAL_DN invasive lobular carcinoma DOID_3457 1.26E-04 8.638E-04 0.0980629 0.21135526 SMID_BREAST_CANCER_BASAL_DN juvenile myoclonic epilepsy DOID_4890 1.282E-04 8.683E-04 1.282E-04 1.696E-03 SMID_BREAST_CANCER_BASAL_DN movement disease DOID_480 1.371E-04 9.178E-04 1.371E-04 1.773E-03 SMID_BREAST_CANCER_BASAL_DN Sciatic Neuropathy DOID_11446 1.476E-04 9.766E-04 2.464E-03 0.01592997 SMID_BREAST_CANCER_BASAL_DN lesion of sciatic nerve DOID_12528 1.476E-04 9.766E-04 2.464E-03 0.01592997 SMID_BREAST_CANCER_BASAL_DN mononeuritis of lower limb DOID_9473 1.476E-04 9.766E-04 2.464E-03 0.01592997 SMID_BREAST_CANCER_BASAL_DN withdrawal disorder DOID_0060001 1.499E-04 9.806E-04 1.499E-04 1.815E-03 SMID_BREAST_CANCER_BASAL_DN hemorrhagic disease DOID_2213 1.499E-04 9.695E-04 0.01409303 0.04689434 SMID_BREAST_CANCER_BASAL_DN pituitary cancer DOID_1785 1.668E-04 1.067E-03 0.10648732 0.22033195 SMID_BREAST_CANCER_BASAL_DN pituitary carcinoma DOID_4916 1.668E-04 1.067E-03 0.10648732 0.22033195 SMID_BREAST_CANCER_BASAL_DN mononeuritis DOID_1802 1.691E-04 1.069E-03 2.719E-03 0.01718787 SMID_BREAST_CANCER_BASAL_DN retinal vascular disease DOID_2462 1.699E-04 1.062E-03 9.062E-03 0.03531691 SMID_BREAST_CANCER_BASAL_DN mononeuropathy DOID_1188 1.927E-04 1.192E-03 2.989E-03 0.01848806 SMID_BREAST_CANCER_BASAL_DN multiple epiphyseal dysplasia DOID_12721 1.927E-04 1.179E-03 2.989E-03 0.01828926 SMID_BREAST_CANCER_BASAL_DN toxic encephalopathy DOID_3602 1.927E-04 1.166E-03 2.989E-03 0.01790423 SMID_BREAST_CANCER_BASAL_DN reproductive organ benign neoplasm DOID_0050622 2.107E-04 1.262E-03 0.01706133 0.05453875 SMID_BREAST_CANCER_BASAL_DN osteochondrodysplasia DOID_2256 2.107E-04 1.249E-03 2.132E-03 0.01427171 SMID_BREAST_CANCER_BASAL_DN essential hypertension DOID_10825 2.154E-04 1.263E-03 6.336E-03 0.02816469 SMID_BREAST_CANCER_BASAL_DN female reproductive organ benign neoplasm DOID_0060086 2.186E-04 1.269E-03 3.276E-03 0.01941656 SMID_BREAST_CANCER_BASAL_DN uterine benign neoplasm DOID_0060095 2.186E-04 1.269E-03 3.276E-03 0.01941656 SMID_BREAST_CANCER_BASAL_DN corneal disease DOID_10124 2.186E-04 1.256E-03 0.03587089 0.09193937 SMID_BREAST_CANCER_BASAL_DN uterine fibroid DOID_13223 2.186E-04 1.269E-03 3.276E-03 0.01941656 SMID_BREAST_CANCER_BASAL_DN dysostosis DOID_1934 2.186E-04 1.244E-03 2.186E-04 2.538E-03 SMID_BREAST_CANCER_BASAL_DN Human immunodeficiency virus infectious disease DOID_526 2.307E-04 1.3E-03 1.747E-03 0.01212436 SMID_BREAST_CANCER_BASAL_DN gonadal disease DOID_2277 2.469E-04 1.378E-03 2.469E-04 2.81E-03 SMID_BREAST_CANCER_BASAL_DN carbohydrate metabolic disorder DOID_2978 2.747E-04 1.517E-03 2.747E-04 3.006E-03 SMID_BREAST_CANCER_BASAL_DN mouth disease DOID_403 2.907E-04 1.591E-03 2.907E-04 3.121E-03 SMID_BREAST_CANCER_BASAL_DN Crohn's disease DOID_8778 2.907E-04 1.575E-03 0.01267426 0.043707 SMID_BREAST_CANCER_BASAL_DN childhood absence epilepsy DOID_1825 3.114E-04 1.671E-03 3.114E-04 3.221E-03 SMID_BREAST_CANCER_BASAL_DN neuroectodermal tumor DOID_171 3.35E-04 1.781E-03 3.35E-04 3.404E-03 SMID_BREAST_CANCER_BASAL_DN carotid artery disease DOID_3407 3.35E-04 1.765E-03 0.02211896 0.06487469 SMID_BREAST_CANCER_BASAL_DN lung oat cell carcinoma DOID_5411 3.379E-04 1.764E-03 3.379E-04 3.373E-03 SMID_BREAST_CANCER_BASAL_DN ulcerative colitis DOID_8577 3.624E-04 1.874E-03 2.518E-03 0.01609928 SMID_BREAST_CANCER_BASAL_DN nephroblastoma DOID_2154 3.87E-04 1.984E-03 3.87E-04 3.797E-03 SMID_BREAST_CANCER_BASAL_DN spindle cell carcinoma DOID_4015 3.87E-04 1.966E-03 4.959E-03 0.02474917 SMID_BREAST_CANCER_BASAL_DN macular degeneration DOID_4448 3.87E-04 1.949E-03 4.959E-03 0.02453396 SMID_BREAST_CANCER_BASAL_DN endocrine pancreas disease DOID_1428 4.147E-04 2.07E-03 0.02492126 0.06985319 SMID_BREAST_CANCER_BASAL_DN cerebral degeneration DOID_1443 4.443E-04 2.198E-03 4.443E-04 4.285E-03 SMID_BREAST_CANCER_BASAL_DN drug-induced mental disorder DOID_1203 4.981E-04 2.443E-03 4.981E-04 4.724E-03 SMID_BREAST_CANCER_BASAL_DN drug psychosis DOID_1742 4.981E-04 2.443E-03 4.981E-04 4.724E-03 SMID_BREAST_CANCER_BASAL_DN urinary system benign neoplasm DOID_731 4.981E-04 2.422E-03 0.01077863 0.03956799 SMID_BREAST_CANCER_BASAL_DN substance-induced psychosis DOID_8646 4.981E-04 2.443E-03 4.981E-04 4.724E-03 SMID_BREAST_CANCER_BASAL_DN adolescence-adult electroclinical syndrome DOID_0050705 5.239E-04 2.526E-03 5.239E-04 4.887E-03 SMID_BREAST_CANCER_BASAL_DN neuroendocrine tumor DOID_169 5.936E-04 2.838E-03 5.936E-04 5.361E-03 SMID_BREAST_CANCER_BASAL_DN hepatitis DOID_2237 6.323E-04 2.998E-03 7.079E-03 0.03051623 SMID_BREAST_CANCER_BASAL_DN peptic ulcer DOID_750 6.323E-04 2.973E-03 6.323E-04 5.535E-03 SMID_BREAST_CANCER_BASAL_DN nephrosis DOID_2527 6.56E-04 3.059E-03 0.03216697 0.08357537 SMID_BREAST_CANCER_BASAL_DN intracranial arterial disease DOID_13089 6.92E-04 3.201E-03 0.06110719 0.14427382 SMID_BREAST_CANCER_BASAL_DN cerebral arterial disease DOID_3527 6.92E-04 3.201E-03 0.06110719 0.14427382 SMID_BREAST_CANCER_BASAL_DN infertility DOID_5223 7E-04 3.212E-03 7E-04 6.035E-03 SMID_BREAST_CANCER_BASAL_DN pulmonary emphysema DOID_9675 7.557E-04 3.44E-03 8.056E-03 0.03321701 SMID_BREAST_CANCER_BASAL_DN aneurysm disease DOID_2403 8.836E-04 3.99E-03 6.481E-03 0.02815176 SMID_BREAST_CANCER_BASAL_DN juvenile absence epilepsy DOID_0060172 9.476E-04 4.246E-03 9.476E-04 7.703E-03 SMID_BREAST_CANCER_BASAL_DN gallbladder cancer DOID_3121 9.713E-04 4.318E-03 9.663E-03 0.03641308 SMID_BREAST_CANCER_BASAL_DN thrombophilia DOID_2452 1.09E-03 4.807E-03 0.01775534 0.05550984 SMID_BREAST_CANCER_BASAL_DN leukodystrophy DOID_10579 1.137E-03 4.977E-03 1.137E-03 8.743E-03 SMID_BREAST_CANCER_BASAL_DN auditory system disease DOID_2742 1.165E-03 5.062E-03 1.165E-03 8.841E-03 SMID_BREAST_CANCER_BASAL_DN brain cancer DOID_1319 1.227E-03 5.289E-03 0.01144383 0.04121227 SMID_BREAST_CANCER_BASAL_DN central nervous system cancer DOID_3620 1.322E-03 5.654E-03 0.01207647 0.04241673 SMID_BREAST_CANCER_BASAL_DN Lewy body dementia DOID_12217 1.413E-03 5.998E-03 1.413E-03 9.923E-03 SMID_BREAST_CANCER_BASAL_DN meningitis DOID_9471 1.413E-03 5.954E-03 0.02095646 0.06178356 SMID_BREAST_CANCER_BASAL_DN reading disorder DOID_13365 1.79E-03 7.488E-03 1.79E-03 0.01226887 SMID_BREAST_CANCER_BASAL_DN dyslexia DOID_4428 1.79E-03 7.488E-03 1.79E-03 0.01226887 SMID_BREAST_CANCER_BASAL_DN spinal cord disease DOID_319 2.224E-03 9.237E-03 2.224E-03 0.01454607 SMID_BREAST_CANCER_BASAL_DN familial hyperlipidemia DOID_1168 2.27E-03 9.361E-03 0.0178537 0.05521063 SMID_BREAST_CANCER_BASAL_DN oral cavity cancer DOID_8618 2.566E-03 0.01050243 0.01949906 0.05778628 SMID_BREAST_CANCER_BASAL_DN sarcoma DOID_1115 2.719E-03 0.01104935 0.03184375 0.08427484 SMID_BREAST_CANCER_BASAL_DN polycystic ovary syndrome DOID_11612 2.989E-03 0.01206313 2.989E-03 0.01869123 SMID_BREAST_CANCER_BASAL_DN supratentorial cancer DOID_1659 2.989E-03 0.01197818 2.989E-03 0.0180947 SMID_BREAST_CANCER_BASAL_DN cerebrum cancer DOID_368 2.989E-03 0.01197818 2.989E-03 0.0180947 SMID_BREAST_CANCER_BASAL_DN congenital disorder of glycosylation DOID_5212 3.276E-03 0.01303489 3.276E-03 0.01921639 SMID_BREAST_CANCER_BASAL_DN pre-malignant neoplasm DOID_0060071 3.417E-03 0.01350048 0.12657408 0.24006884 SMID_BREAST_CANCER_BASAL_DN in situ carcinoma DOID_8719 3.417E-03 0.01350048 0.12657408 0.24006884 SMID_BREAST_CANCER_BASAL_DN age related macular degeneration DOID_10871 3.579E-03 0.01404371 0.03795426 0.09641059 SMID_BREAST_CANCER_BASAL_DN degeneration of macula and posterior pole DOID_2007 3.579E-03 0.01404371 0.03795426 0.09641059 SMID_BREAST_CANCER_BASAL_DN brachydactyly DOID_0050581 3.724E-03 0.01451157 3.724E-03 0.02161928 SMID_BREAST_CANCER_BASAL_DN facioscapulohumeral muscular dystrophy DOID_11727 3.724E-03 0.01441285 3.724E-03 0.02140091 SMID_BREAST_CANCER_BASAL_DN angioedema DOID_1558 3.724E-03 0.01431547 1.000 1.000 SMID_BREAST_CANCER_BASAL_DN bilirubin metabolic disorder DOID_2741 3.724E-03 0.01421939 3.724E-03 0.0211869 SMID_BREAST_CANCER_BASAL_DN cannabis abuse DOID_9505 3.724E-03 0.0141246 3.724E-03 0.02097713 SMID_BREAST_CANCER_BASAL_DN Charcot-Marie-Tooth disease DOID_10595 3.898E-03 0.01468944 3.898E-03 0.02132794 SMID_BREAST_CANCER_BASAL_DN hyperglycemia DOID_4195 4.01E-03 0.01501045 0.13601039 0.24646468 SMID_BREAST_CANCER_BASAL_DN tooth disease DOID_1091 4.222E-03 0.01570161 4.222E-03 0.02287949 SMID_BREAST_CANCER_BASAL_DN breast benign neoplasm DOID_0060082 4.523E-03 0.01671154 4.523E-03 0.02405213 SMID_BREAST_CANCER_BASAL_DN thoracic benign neoplasm DOID_0060097 4.523E-03 0.01671154 4.523E-03 0.02405213 SMID_BREAST_CANCER_BASAL_DN nervous system benign neoplasm DOID_0060115 4.523E-03 0.01660373 4.523E-03 0.02382942 SMID_BREAST_CANCER_BASAL_DN obsessive-compulsive disorder DOID_10933 4.523E-03 0.01649729 4.523E-03 0.0236108 SMID_BREAST_CANCER_BASAL_DN benign breast phyllodes tumor DOID_1631 4.523E-03 0.01671154 4.523E-03 0.02405213 SMID_BREAST_CANCER_BASAL_DN craniosynostosis DOID_2340 4.523E-03 0.01639221 4.523E-03 0.02339616 SMID_BREAST_CANCER_BASAL_DN heroin dependence DOID_9976 4.523E-03 0.01628847 0.0980629 0.2082007 SMID_BREAST_CANCER_BASAL_DN astrocytoma DOID_3069 4.669E-03 0.0167085 4.669E-03 0.02393379 SMID_BREAST_CANCER_BASAL_DN male infertility DOID_12336 4.959E-03 0.01763378 4.959E-03 0.02519112 SMID_BREAST_CANCER_BASAL_DN thyroid carcinoma DOID_3963 4.959E-03 0.01752426 4.959E-03 0.02496819 SMID_BREAST_CANCER_BASAL_DN esophageal disease DOID_6050 4.959E-03 0.01741608 4.959E-03 0.02432246 SMID_BREAST_CANCER_BASAL_DN hyperthyroidism DOID_7998 4.959E-03 0.01730924 0.04672897 0.11460684 SMID_BREAST_CANCER_BASAL_DN male reproductive system disease DOID_48 5.147E-03 0.01785641 5.147E-03 0.02481738 SMID_BREAST_CANCER_BASAL_DN esophageal carcinoma DOID_1107 5.394E-03 0.01860186 5.394E-03 0.0257925 SMID_BREAST_CANCER_BASAL_DN intracranial arteriosclerosis DOID_13097 5.394E-03 0.0184898 0.10648732 0.2219461 SMID_BREAST_CANCER_BASAL_DN esophagus squamous cell carcinoma DOID_3748 5.394E-03 0.01860186 5.394E-03 0.0257925 SMID_BREAST_CANCER_BASAL_DN vascular dementia DOID_8725 5.394E-03 0.0184898 0.10648732 0.2219461 SMID_BREAST_CANCER_BASAL_DN thyroid cancer DOID_1781 5.753E-03 0.01960062 5.753E-03 0.02683036 SMID_BREAST_CANCER_BASAL_DN cystic fibrosis DOID_1485 6.198E-03 0.02099172 6.198E-03 0.02844039 SMID_BREAST_CANCER_BASAL_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 6.336E-03 0.02133183 6.336E-03 0.02884064 SMID_BREAST_CANCER_BASAL_DN variable age at onset electroclinical syndrome DOID_0050706 6.336E-03 0.02120635 6.336E-03 0.02861175 SMID_BREAST_CANCER_BASAL_DN Hirschsprung's disease DOID_10487 6.336E-03 0.02108234 6.336E-03 0.02838646 SMID_BREAST_CANCER_BASAL_DN parathyroid gland disease DOID_11201 6.336E-03 0.02095977 0.11483328 0.22926364 SMID_BREAST_CANCER_BASAL_DN polyneuropathy DOID_1389 6.336E-03 0.02083861 6.336E-03 0.02794636 SMID_BREAST_CANCER_BASAL_DN cannabis dependence DOID_1849 6.336E-03 0.02071885 6.336E-03 0.02773138 SMID_BREAST_CANCER_BASAL_DN hallucinogen dependence DOID_9977 6.336E-03 0.02071885 6.336E-03 0.02773138 SMID_BREAST_CANCER_BASAL_DN blood platelet disease DOID_2218 6.619E-03 0.02152066 0.31944503 0.45784439 SMID_BREAST_CANCER_BASAL_DN alcohol dependence DOID_0050741 7.346E-03 0.02375062 7.346E-03 0.0314294 SMID_BREAST_CANCER_BASAL_DN megacolon DOID_11372 7.346E-03 0.02361644 7.346E-03 0.03119485 SMID_BREAST_CANCER_BASAL_DN rhabdomyosarcoma DOID_3247 7.346E-03 0.02348376 7.346E-03 0.03096378 SMID_BREAST_CANCER_BASAL_DN bacterial meningitis DOID_9470 7.346E-03 0.02335257 7.346E-03 0.0307361 SMID_BREAST_CANCER_BASAL_DN primary ciliary dyskinesia DOID_9562 7.346E-03 0.02322283 7.346E-03 0.03051175 SMID_BREAST_CANCER_BASAL_DN adenoid cystic carcinoma DOID_4866 7.558E-03 0.02376089 0.06110719 0.14367765 SMID_BREAST_CANCER_BASAL_DN lymphatic system disease DOID_75 7.558E-03 0.02363034 0.06110719 0.14308638 SMID_BREAST_CANCER_BASAL_DN peripheral neuropathy DOID_0060053 8.425E-03 0.02619465 8.425E-03 0.03448648 SMID_BREAST_CANCER_BASAL_DN skeletal system cancer DOID_0060124 8.425E-03 0.02605229 8.425E-03 0.03424015 SMID_BREAST_CANCER_BASAL_DN congenital ichthyosiform erythroderma DOID_1699 8.425E-03 0.02591146 8.425E-03 0.03399731 SMID_BREAST_CANCER_BASAL_DN bone cancer DOID_184 8.425E-03 0.02605229 8.425E-03 0.03424015 SMID_BREAST_CANCER_BASAL_DN communication disorder DOID_2033 8.425E-03 0.02577215 0.1312927 0.24574194 SMID_BREAST_CANCER_BASAL_DN skeletal muscle cancer DOID_4043 8.425E-03 0.02563433 8.425E-03 0.03375789 SMID_BREAST_CANCER_BASAL_DN panic disorder DOID_594 8.425E-03 0.02549798 8.425E-03 0.03352182 SMID_BREAST_CANCER_BASAL_DN spinocerebellar ataxia DOID_1441 8.573E-03 0.02580904 8.573E-03 0.03387437 SMID_BREAST_CANCER_BASAL_DN salivary gland cancer DOID_8850 8.573E-03 0.02567321 0.06619439 0.15436315 SMID_BREAST_CANCER_BASAL_DN angiosarcoma DOID_0001816 9.569E-03 0.02850706 0.13940761 0.25181882 SMID_BREAST_CANCER_BASAL_DN Barrett's esophagus DOID_9206 9.569E-03 0.02835858 9.569E-03 0.03629899 SMID_BREAST_CANCER_BASAL_DN congenital disorder of glycosylation type I DOID_0050570 0.01077863 0.0317774 0.01077863 0.04008521 SMID_BREAST_CANCER_BASAL_DN lymphatic system cancer DOID_0060073 0.01077863 0.0316136 0.14744692 0.2613623 SMID_BREAST_CANCER_BASAL_DN schizophreniform disorder DOID_11328 0.01077863 0.03145148 0.01077863 0.03982492 SMID_BREAST_CANCER_BASAL_DN Graves' disease DOID_12361 0.01077863 0.03129101 0.14744692 0.26055061 SMID_BREAST_CANCER_BASAL_DN schizoaffective disorder DOID_5418 0.01077863 0.03145148 0.01077863 0.03982492 SMID_BREAST_CANCER_BASAL_DN reticulosarcoma DOID_8538 0.01077863 0.0316136 0.14744692 0.2613623 SMID_BREAST_CANCER_BASAL_DN lymphosarcoma DOID_8675 0.01077863 0.0316136 0.14744692 0.2613623 SMID_BREAST_CANCER_BASAL_DN spinocerebellar degeneration DOID_2478 0.01083081 0.03128291 0.01083081 0.03950469 SMID_BREAST_CANCER_BASAL_DN glucose intolerance DOID_10603 0.01205175 0.03463357 1.000 1.000 SMID_BREAST_CANCER_BASAL_DN sexual dysfunction DOID_1876 0.01205175 0.03445954 0.01205175 0.0431286 SMID_BREAST_CANCER_BASAL_DN dental caries DOID_216 0.01205175 0.03428724 0.01205175 0.04285905 SMID_BREAST_CANCER_BASAL_DN inherited blood coagulation disease DOID_2214 0.01205175 0.03411665 0.01205175 0.04259284 SMID_BREAST_CANCER_BASAL_DN lymphoblastic leukemia DOID_1037 0.01223396 0.03446102 0.01223396 0.04244589 SMID_BREAST_CANCER_BASAL_DN integumentary system benign neoplasm DOID_0060121 0.01272882 0.03567833 0.01272882 0.04363072 SMID_BREAST_CANCER_BASAL_DN skin benign neoplasm DOID_3165 0.01272882 0.03567833 0.01272882 0.04363072 SMID_BREAST_CANCER_BASAL_DN conduct disorder DOID_12995 0.01338725 0.03733992 0.01338725 0.04561284 SMID_BREAST_CANCER_BASAL_DN heart septal defect DOID_1681 0.01338725 0.03715778 0.01338725 0.04534134 SMID_BREAST_CANCER_BASAL_DN testicular cancer DOID_2998 0.01338725 0.0369774 0.01338725 0.04507305 SMID_BREAST_CANCER_BASAL_DN calcium metabolism disease DOID_10575 0.01340098 0.03683652 0.01340098 0.04485388 SMID_BREAST_CANCER_BASAL_DN aortic aneurysm DOID_3627 0.01340098 0.03665942 0.08783098 0.20070613 SMID_BREAST_CANCER_BASAL_DN colon carcinoma DOID_1520 0.01478384 0.04024884 0.17111829 0.29064569 SMID_BREAST_CANCER_BASAL_DN brain edema DOID_4724 0.01478384 0.04005718 0.17111829 0.28892079 SMID_BREAST_CANCER_BASAL_DN colonic disease DOID_5353 0.01478384 0.03986733 0.01478384 0.04890702 SMID_BREAST_CANCER_BASAL_DN amyloidosis DOID_9120 0.01478384 0.03967928 0.01478384 0.04862432 SMID_BREAST_CANCER_BASAL_DN orofacial cleft DOID_0050567 0.01480502 0.03954957 0.01480502 0.04841412 SMID_BREAST_CANCER_BASAL_DN atopic dermatitis DOID_3310 0.01480502 0.03936476 0.01480502 0.04813747 SMID_BREAST_CANCER_BASAL_DN giant cell tumor DOID_200 0.01553704 0.04111895 0.01553704 0.05023053 SMID_BREAST_CANCER_BASAL_DN malignant giant cell tumor DOID_2705 0.01553704 0.04111895 0.01553704 0.05023053 SMID_BREAST_CANCER_BASAL_DN giant cell glioblastoma DOID_3074 0.01553704 0.04111895 0.01553704 0.05023053 SMID_BREAST_CANCER_BASAL_DN atrophic muscular disease DOID_913 0.01553704 0.04092858 0.01553704 0.04994674 SMID_BREAST_CANCER_BASAL_DN muscular dystrophy DOID_9884 0.01553704 0.04092858 0.01553704 0.04994674 SMID_BREAST_CANCER_BASAL_DN autoimmune hepatitis DOID_2048 0.01624029 0.04258397 0.17886219 0.29845333 SMID_BREAST_CANCER_BASAL_DN integumentary system cancer DOID_0060122 0.01706133 0.04453164 0.01706133 0.05423406 SMID_BREAST_CANCER_BASAL_DN skin cancer DOID_4159 0.01706133 0.04453164 0.01706133 0.05423406 SMID_BREAST_CANCER_BASAL_DN smallpox DOID_8736 0.01706133 0.0443283 0.01706133 0.05393276 SMID_BREAST_CANCER_BASAL_DN gastric ulcer DOID_10808 0.01775534 0.04592177 0.01775534 0.05581652 SMID_BREAST_CANCER_BASAL_DN acquired immunodeficiency syndrome DOID_635 0.01775534 0.04571398 0.01775534 0.0552065 SMID_BREAST_CANCER_BASAL_DN placenta disease DOID_780 0.01775534 0.04550806 0.18653395 0.30499372 SMID_BREAST_CANCER_BASAL_DN sinusitis DOID_0050127 0.0193278 0.04931623 0.0193278 0.05944605 SMID_BREAST_CANCER_BASAL_DN sexual disorder DOID_0060043 0.0193278 0.04909607 0.0193278 0.05912644 SMID_BREAST_CANCER_BASAL_DN paranasal sinus disease DOID_1352 0.0193278 0.04931623 0.0193278 0.05944605 SMID_BREAST_CANCER_BASAL_DN IgA glomerulonephritis DOID_2986 0.0193278 0.04887786 0.19413423 0.31381356 SMID_BREAST_CANCER_BASAL_DN muscle cancer DOID_4045 0.0193278 0.04866159 0.0193278 0.05881026 SMID_BREAST_CANCER_BASAL_DN polyarteritis nodosa DOID_9810 0.0193278 0.04844722 0.19413423 0.30941842 SMID_BREAST_CANCER_BASAL_DN lingual-facial-buccal dyskinesia DOID_9854 0.0193278 0.04823473 0.0193278 0.05849744 SMID_BREAST_CANCER_BASAL_DN nonsyndromic deafness DOID_0050563 0.01949906 0.04844963 0.01949906 0.05870352 SMID_BREAST_CANCER_BASAL_DN retinitis pigmentosa DOID_10584 0.01949906 0.04823898 0.01949906 0.05839456 SMID_BREAST_CANCER_BASAL_DN glioblastoma DOID_3068 0.01949906 0.04803015 0.01949906 0.05808883 SMID_BREAST_CANCER_BASAL_DN diabetic angiopathy DOID_11713 0.02095646 0.05139753 0.20166369 0.31962853 SMID_BREAST_CANCER_BASAL_DN ureteral disease DOID_1426 0.02095646 0.05117694 0.20166369 0.31874067 SMID_BREAST_CANCER_BASAL_DN Goodpasture syndrome DOID_9808 0.02095646 0.05095823 0.20166369 0.31697967 SMID_BREAST_CANCER_BASAL_DN collagen disease DOID_854 0.02211896 0.05355613 0.02211896 0.064542 SMID_BREAST_CANCER_BASAL_DN sphingolipidosis DOID_1927 0.02264014 0.05458577 0.02264014 0.06572572 SMID_BREAST_CANCER_BASAL_DN respiratory failure DOID_11162 0.0230328 0.05529816 0.12346477 0.2349547 SMID_BREAST_CANCER_BASAL_DN hypothyroidism DOID_1459 0.0230328 0.05506581 0.0230328 0.06652621 SMID_BREAST_CANCER_BASAL_DN organic acidemia DOID_0060159 0.02437768 0.05803725 0.02437768 0.07005506 SMID_BREAST_CANCER_BASAL_DN hypogonadism DOID_1924 0.02437768 0.05779542 0.02437768 0.06970302 SMID_BREAST_CANCER_BASAL_DN bronchiolitis DOID_2942 0.02437768 0.05755561 0.02437768 0.06935451 SMID_BREAST_CANCER_BASAL_DN osteosarcoma DOID_3347 0.02437768 0.05731778 0.02437768 0.06900946 SMID_BREAST_CANCER_BASAL_DN mineral metabolism disease DOID_0050032 0.02492126 0.05835472 0.02492126 0.070199 SMID_BREAST_CANCER_BASAL_DN parasitic infectious disease DOID_1398 0.02589586 0.0603883 0.1328475 0.24150232 SMID_BREAST_CANCER_BASAL_DN autosomal dominant nonsyndromic deafness DOID_0050564 0.02616794 0.06077369 0.02616794 0.07298802 SMID_BREAST_CANCER_BASAL_DN spinal muscular atrophy DOID_12377 0.02616794 0.06052665 0.02616794 0.07263198 SMID_BREAST_CANCER_BASAL_DN cleft lip DOID_9296 0.02616794 0.0602816 0.02616794 0.07193022 SMID_BREAST_CANCER_BASAL_DN teeth hard tissue disease DOID_214 0.02800977 0.06426435 0.02800977 0.07625626 SMID_BREAST_CANCER_BASAL_DN middle cerebral artery infarction DOID_3525 0.02800977 0.06400626 0.23108652 0.35346298 SMID_BREAST_CANCER_BASAL_DN seminoma DOID_4440 0.02800977 0.06375023 0.02800977 0.07589314 SMID_BREAST_CANCER_BASAL_DN fragments of torsion dystonia DOID_531 0.02800977 0.06349625 0.02800977 0.07553345 SMID_BREAST_CANCER_BASAL_DN lung adenocarcinoma DOID_3910 0.02990207 0.06751698 0.23827168 0.36153756 SMID_BREAST_CANCER_BASAL_DN periodontitis DOID_824 0.02990207 0.06725011 0.02990207 0.08025603 SMID_BREAST_CANCER_BASAL_DN renal hypertension DOID_1073 0.03184375 0.071335 0.24538988 0.36938318 SMID_BREAST_CANCER_BASAL_DN secondary hypertension DOID_11130 0.03184375 0.071335 0.24538988 0.36938318 SMID_BREAST_CANCER_BASAL_DN malaria DOID_12365 0.03184375 0.07105526 0.24538988 0.36840856 SMID_BREAST_CANCER_BASAL_DN thrombocytopenia DOID_1588 0.03184375 0.0707777 0.24538988 0.36743906 SMID_BREAST_CANCER_BASAL_DN invasive ductal carcinoma DOID_3008 0.03184375 0.0705023 0.03184375 0.08388468 SMID_BREAST_CANCER_BASAL_DN autoimmune disease of the nervous system DOID_438 0.03184375 0.07022903 0.03184375 0.08349811 SMID_BREAST_CANCER_BASAL_DN central nervous system hereditary degenerative disease DOID_481 0.03184375 0.06995788 0.03184375 0.0831151 SMID_BREAST_CANCER_BASAL_DN autoimmune disease of endocrine system DOID_0060005 0.03383371 0.07404377 0.25244176 0.37503749 SMID_BREAST_CANCER_BASAL_DN dystonic disease DOID_544 0.03383371 0.07376008 0.03383371 0.08750627 SMID_BREAST_CANCER_BASAL_DN bone resorption disease DOID_0080011 0.03794263 0.08240213 0.03794263 0.09681326 SMID_BREAST_CANCER_BASAL_DN osteoporosis DOID_11476 0.03794263 0.08240213 0.03794263 0.09681326 SMID_BREAST_CANCER_BASAL_DN abdominal aortic aneurysm DOID_7693 0.03795426 0.08211396 0.26634896 0.39262321 SMID_BREAST_CANCER_BASAL_DN germinoma DOID_3304 0.04008276 0.08639049 0.04008276 0.10136484 SMID_BREAST_CANCER_BASAL_DN hereditary spastic paraplegia DOID_2476 0.04225538 0.09072947 0.04225538 0.10638632 SMID_BREAST_CANCER_BASAL_DN myocarditis DOID_820 0.04447111 0.09512806 0.28672751 0.41725819 SMID_BREAST_CANCER_BASAL_DN metal metabolism disorder DOID_896 0.04447111 0.09477177 0.04447111 0.11098273 SMID_BREAST_CANCER_BASAL_DN periodontal disease DOID_3388 0.04672897 0.09921189 0.04672897 0.11610824 SMID_BREAST_CANCER_BASAL_DN paraplegia DOID_607 0.04672897 0.09884307 0.04672897 0.11560342 SMID_BREAST_CANCER_BASAL_DN leukopenia DOID_615 0.04672897 0.09847698 0.04672897 0.11510297 MCCABE_HOXC6_TARGETS_DN tethered spinal cord syndrome DOID_1089 5.689E-06 3.237E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN spinal cord disease DOID_319 2.358E-05 6.71E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN endometrial carcinoma DOID_2871 3.093E-05 5.866E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN endometrial cancer DOID_1380 3.497E-05 4.975E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN germinoma DOID_3304 3.497E-05 3.98E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN refractive error DOID_9835 4.616E-05 4.378E-03 0.01024097 0.44823937 MCCABE_HOXC6_TARGETS_DN cleft palate DOID_674 4.858E-05 3.949E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN uterine cancer DOID_363 6.727E-05 4.784E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN orofacial cleft DOID_0050567 9.23E-05 5.836E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN uterine disease DOID_345 1.413E-04 8.042E-03 1.000 1.000 MCCABE_HOXC6_TARGETS_DN female reproductive system disease DOID_229 2.107E-04 0.01089821 1.000 1.000 MCCABE_HOXC6_TARGETS_DN transitional cell carcinoma DOID_2671 2.477E-04 0.01174571 0.02349056 0.39312141 SENESE_HDAC2_TARGETS_DN familial hypertrophic cardiomyopathy DOID_11986 1.304E-10 7.419E-08 1.304E-10 7.419E-08 SENESE_HDAC2_TARGETS_DN heart valve disease DOID_4079 5.64E-10 1.605E-07 4.252E-08 6.049E-06 SENESE_HDAC2_TARGETS_DN aortic valve insufficiency DOID_57 5.85E-09 1.11E-06 5.85E-09 1.664E-06 SENESE_HDAC2_TARGETS_DN Ehlers-Danlos syndrome DOID_13359 1.606E-08 2.285E-06 1.606E-08 3.047E-06 SENESE_HDAC2_TARGETS_DN aortic valve disease DOID_62 1.234E-07 1.405E-05 1.234E-07 1.405E-05 SENESE_HDAC2_TARGETS_DN collagen disease DOID_854 1.499E-07 1.422E-05 6.969E-06 4.406E-04 SENESE_HDAC2_TARGETS_DN dilated cardiomyopathy DOID_12930 1.207E-06 9.811E-05 1.207E-06 1.145E-04 SENESE_HDAC2_TARGETS_DN ureteral obstruction DOID_5199 5.251E-06 3.735E-04 5.251E-06 4.268E-04 SENESE_HDAC2_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 5.749E-06 3.635E-04 2.184E-04 7.767E-03 SENESE_HDAC2_TARGETS_DN oral cavity cancer DOID_8618 5.749E-06 3.271E-04 5.749E-06 4.089E-04 SENESE_HDAC2_TARGETS_DN mineral metabolism disease DOID_0050032 8.371E-06 4.33E-04 2.884E-04 9.115E-03 SENESE_HDAC2_TARGETS_DN urinary tract obstruction DOID_5200 1.132E-05 5.367E-04 1.132E-05 6.44E-04 SENESE_HDAC2_TARGETS_DN ureteral disease DOID_1426 1.292E-05 5.654E-04 1.292E-05 6.682E-04 SENESE_HDAC2_TARGETS_DN encephalomyelitis DOID_640 3.34E-05 1.358E-03 8.021E-04 0.01629896 SENESE_HDAC2_TARGETS_DN calcinosis DOID_182 6.17E-05 2.34E-03 2.648E-03 0.0470816 SENESE_HDAC2_TARGETS_DN cleft palate DOID_674 6.17E-05 2.194E-03 6.17E-05 2.925E-03 SENESE_HDAC2_TARGETS_DN arrhythmogenic right ventricular dysplasia DOID_0050431 1.269E-04 4.249E-03 1.269E-04 5.556E-03 SENESE_HDAC2_TARGETS_DN calcium metabolism disease DOID_10575 1.437E-04 4.543E-03 4.604E-03 0.06389385 SENESE_HDAC2_TARGETS_DN facioscapulohumeral muscular dystrophy DOID_11727 1.585E-04 4.746E-03 1.585E-04 6.442E-03 SENESE_HDAC2_TARGETS_DN orofacial cleft DOID_0050567 1.605E-04 4.567E-03 1.605E-04 6.089E-03 SENESE_HDAC2_TARGETS_DN glioblastoma DOID_3068 2.184E-04 5.918E-03 2.184E-04 7.31E-03 SENESE_HDAC2_TARGETS_DN congenital heart defect DOID_1682 2.758E-04 7.134E-03 7.054E-03 0.08190763 SENESE_HDAC2_TARGETS_DN astrocytoma DOID_3069 3.566E-04 8.821E-03 3.566E-04 0.01067791 SENESE_HDAC2_TARGETS_DN oral submucous fibrosis DOID_5773 3.675E-04 8.714E-03 3.675E-04 0.0104567 SENESE_HDAC2_TARGETS_DN pancreatic ductal carcinoma DOID_3587 3.713E-04 8.452E-03 3.713E-04 0.01006132 SENESE_HDAC2_TARGETS_DN nephrosis DOID_2527 3.865E-04 8.458E-03 8.796E-03 0.10009385 SENESE_HDAC2_TARGETS_DN pancreatic carcinoma DOID_4905 4.18E-04 8.809E-03 4.18E-04 0.01081119 SENESE_HDAC2_TARGETS_DN restrictive cardiomyopathy DOID_397 4.195E-04 8.526E-03 4.195E-04 0.01037898 SENESE_HDAC2_TARGETS_DN tongue cancer DOID_8649 4.195E-04 8.232E-03 4.195E-04 9.947E-03 SENESE_HDAC2_TARGETS_DN aneurysm disease DOID_2403 4.683E-04 8.882E-03 9.972E-03 0.11125679 SENESE_HDAC2_TARGETS_DN basal cell carcinoma DOID_2513 4.749E-04 8.717E-03 4.749E-04 0.01080852 SENESE_HDAC2_TARGETS_DN skin carcinoma DOID_3451 5.336E-04 9.488E-03 5.336E-04 0.01167755 SENESE_HDAC2_TARGETS_DN brain edema DOID_4724 6.61E-04 0.0113974 6.61E-04 0.01393015 SENESE_HDAC2_TARGETS_DN coronary restenosis DOID_4247 7.297E-04 0.0122116 0.0391446 0.27841596 SENESE_HDAC2_TARGETS_DN coronary stenosis DOID_4248 1.495E-03 0.02430266 0.05545464 0.33928697 SENESE_HDAC2_TARGETS_DN focal glomerulosclerosis DOID_3945 1.596E-03 0.0252261 1.000 1.000 SENESE_HDAC2_TARGETS_DN hair disease DOID_421 2.149E-03 0.03305027 2.149E-03 0.04216758 SENESE_HDAC2_TARGETS_DN hepatitis C DOID_1883 2.269E-03 0.03397772 0.0679512 0.37538089 SENESE_HDAC2_TARGETS_DN spindle cell carcinoma DOID_4015 2.269E-03 0.0331065 2.269E-03 0.04303845 SENESE_HDAC2_TARGETS_DN medullomyoblastoma DOID_3861 2.392E-03 0.03403036 2.392E-03 0.04391014 SENESE_HDAC2_TARGETS_DN adult medulloblastoma DOID_3864 2.392E-03 0.03403036 2.392E-03 0.04391014 SENESE_HDAC2_TARGETS_DN childhood medulloblastoma DOID_3869 2.392E-03 0.03403036 2.392E-03 0.04391014 SENESE_HDAC2_TARGETS_DN medulloblastoma DOID_3858 2.648E-03 0.03674662 2.648E-03 0.04565489 SENESE_HDAC2_TARGETS_DN hepatitis DOID_2237 2.916E-03 0.03949991 0.07677735 0.3935704 SENESE_HDAC2_TARGETS_DN systemic scleroderma DOID_418 2.916E-03 0.03858131 0.07677735 0.39005638 SENESE_HDAC2_TARGETS_DN peptic ulcer DOID_750 2.916E-03 0.03770446 0.07677735 0.38660456 SENESE_HDAC2_TARGETS_DN adenoid cystic carcinoma DOID_4866 3.054E-03 0.03861762 3.054E-03 0.05111155 SENESE_HDAC2_TARGETS_DN benign mesothelioma DOID_2645 3.196E-03 0.03952861 0.08028469 0.3972347 SENESE_HDAC2_TARGETS_DN salivary gland cancer DOID_8850 3.34E-03 0.04043744 3.34E-03 0.05430171 SENESE_HDAC2_TARGETS_DN nephrotic syndrome DOID_1184 3.488E-03 0.04134411 3.488E-03 0.05512547 SENESE_HDAC2_TARGETS_DN rheumatic disease DOID_1575 3.488E-03 0.04050035 0.08377889 0.40058983 SENESE_HDAC2_TARGETS_DN primitive neuroectodermal tumor DOID_168 3.488E-03 0.03969034 3.488E-03 0.0536356 SENESE_HDAC2_TARGETS_DN uveal disease DOID_3480 3.488E-03 0.0389121 3.488E-03 0.05222413 SENESE_HDAC2_TARGETS_DN scleroderma DOID_419 3.488E-03 0.04050035 0.08377889 0.40058983 SENESE_HDAC2_TARGETS_DN pre-eclampsia DOID_10591 4.108E-03 0.04494906 4.108E-03 0.05993208 SENESE_HDAC2_TARGETS_DN glaucoma DOID_1686 4.436E-03 0.04762036 4.436E-03 0.06309697 SENESE_HDAC2_TARGETS_DN aortic aneurysm DOID_3627 4.604E-03 0.04851199 4.604E-03 0.06237256 SENESE_HDAC2_TARGETS_DN giant cell tumor DOID_200 5.126E-03 0.05303446 5.126E-03 0.06783478 SENESE_HDAC2_TARGETS_DN malignant giant cell tumor DOID_2705 5.126E-03 0.05303446 5.126E-03 0.06783478 SENESE_HDAC2_TARGETS_DN giant cell glioblastoma DOID_3074 5.126E-03 0.05303446 5.126E-03 0.06783478 SENESE_HDAC2_TARGETS_DN atrophic muscular disease DOID_913 5.126E-03 0.05208742 5.126E-03 0.06629308 SENESE_HDAC2_TARGETS_DN muscular dystrophy DOID_9884 5.126E-03 0.05208742 5.126E-03 0.06629308 SENESE_HDAC2_TARGETS_DN integumentary system cancer DOID_0060122 5.489E-03 0.0547944 5.489E-03 0.06940624 SENESE_HDAC2_TARGETS_DN osteochondrodysplasia DOID_2256 5.489E-03 0.05384967 5.489E-03 0.0678974 SENESE_HDAC2_TARGETS_DN skin cancer DOID_4159 5.489E-03 0.0547944 5.489E-03 0.06940624 SENESE_HDAC2_TARGETS_DN neuroectodermal tumor DOID_171 6.646E-03 0.06409032 6.646E-03 0.08045381 SENESE_HDAC2_TARGETS_DN respiratory failure DOID_11162 6.848E-03 0.06494348 0.11632763 0.5052704 SENESE_HDAC2_TARGETS_DN pre-malignant neoplasm DOID_0060071 7.054E-03 0.06579465 7.054E-03 0.08361403 SENESE_HDAC2_TARGETS_DN in situ carcinoma DOID_8719 7.054E-03 0.06579465 7.054E-03 0.08361403 SENESE_HDAC2_TARGETS_DN cerebral degeneration DOID_1443 7.473E-03 0.06857955 0.1213616 0.52314203 SENESE_HDAC2_TARGETS_DN pancreatitis DOID_4989 0.01021528 0.09226186 0.01021528 0.11177879 MACLACHLAN_BRCA1_TARGETS_UP transitional cell carcinoma DOID_2671 3.973E-08 2.261E-05 0.03503037 0.68731994 MACLACHLAN_BRCA1_TARGETS_UP nephroblastoma DOID_2154 3.862E-07 1.099E-04 0.01454262 0.75225033 MACLACHLAN_BRCA1_TARGETS_UP embryonal cancer DOID_688 4.907E-07 9.308E-05 0.01571306 0.7450611 MACLACHLAN_BRCA1_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 1.526E-06 2.171E-04 0.02270849 0.6800596 MACLACHLAN_BRCA1_TARGETS_UP nervous system cancer DOID_3093 6.161E-06 7.011E-04 1.000 1.000 MACLACHLAN_BRCA1_TARGETS_UP breast benign neoplasm DOID_0060082 8.02E-06 7.606E-04 1.000 1.000 MACLACHLAN_BRCA1_TARGETS_UP thoracic benign neoplasm DOID_0060097 8.02E-06 7.606E-04 1.000 1.000 MACLACHLAN_BRCA1_TARGETS_UP benign breast phyllodes tumor DOID_1631 8.02E-06 7.606E-04 1.000 1.000 MACLACHLAN_BRCA1_TARGETS_UP intracranial aneurysm DOID_10941 5.49E-05 4.463E-03 0.01102351 0.78404718 MACLACHLAN_BRCA1_TARGETS_UP adenoid cystic carcinoma DOID_4866 1.307E-04 9.297E-03 1.307E-04 0.07437548 MACLACHLAN_BRCA1_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 1.369E-04 8.655E-03 0.01727163 0.7019684 MACLACHLAN_BRCA1_TARGETS_UP salivary gland cancer DOID_8850 1.432E-04 8.15E-03 1.432E-04 0.04075198 MACLACHLAN_BRCA1_TARGETS_UP brain cancer DOID_1319 1.77E-04 9.158E-03 1.000 1.000 MACLACHLAN_BRCA1_TARGETS_UP central nervous system cancer DOID_3620 1.842E-04 8.735E-03 1.000 1.000 MACLACHLAN_BRCA1_TARGETS_UP atrophic muscular disease DOID_913 2.223E-04 9.728E-03 0.02193352 0.69334296 MACLACHLAN_BRCA1_TARGETS_UP muscular dystrophy DOID_9884 2.223E-04 9.728E-03 0.02193352 0.69334296 MACLACHLAN_BRCA1_TARGETS_UP oral cavity cancer DOID_8618 2.638E-04 0.01072207 2.638E-04 0.05003631 MACLACHLAN_BRCA1_TARGETS_UP pre-malignant neoplasm DOID_0060071 3.089E-04 0.01171643 0.02580265 0.66735045 MACLACHLAN_BRCA1_TARGETS_UP in situ carcinoma DOID_8719 3.089E-04 0.01171643 0.02580265 0.66735045 MACLACHLAN_BRCA1_TARGETS_UP aneurysm disease DOID_2403 4.423E-04 0.01573044 0.03081117 0.70126226 MACLACHLAN_BRCA1_TARGETS_UP mixed glioma DOID_5076 4.536E-04 0.01518127 0.03119544 0.68270031 MACLACHLAN_BRCA1_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 5.992E-04 0.01894113 0.03579565 0.67892412 MACLACHLAN_BRCA1_TARGETS_UP mouth disease DOID_403 6.521E-04 0.01952961 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 heart valve disease DOID_4079 4.961E-11 2.823E-08 3.19E-04 0.09075826 VERRECCHIA_RESPONSE_TO_TGFB1_C2 aneurysm disease DOID_2403 5.227E-10 1.487E-07 0.04087178 0.62854169 VERRECCHIA_RESPONSE_TO_TGFB1_C2 aortic valve insufficiency DOID_57 2.754E-08 5.223E-06 6.313E-03 0.32656428 VERRECCHIA_RESPONSE_TO_TGFB1_C2 diabetic angiopathy DOID_11713 2.523E-07 3.589E-05 0.01258851 0.51163307 VERRECCHIA_RESPONSE_TO_TGFB1_C2 aortic valve disease DOID_62 2.523E-07 2.871E-05 0.01258851 0.4775242 VERRECCHIA_RESPONSE_TO_TGFB1_C2 intracranial aneurysm DOID_10941 4.078E-07 3.868E-05 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 abdominal aortic aneurysm DOID_7693 6.781E-07 5.512E-05 0.01727027 0.44667208 VERRECCHIA_RESPONSE_TO_TGFB1_C2 aortic aneurysm DOID_3627 2.892E-06 2.057E-04 0.0275988 0.56084707 VERRECCHIA_RESPONSE_TO_TGFB1_C2 atrophic muscular disease DOID_913 3.419E-06 2.161E-04 4.003E-04 0.07591986 VERRECCHIA_RESPONSE_TO_TGFB1_C2 muscular dystrophy DOID_9884 3.419E-06 2.161E-04 4.003E-04 0.07591986 VERRECCHIA_RESPONSE_TO_TGFB1_C2 peripheral vascular disease DOID_341 8.274E-06 4.708E-04 0.03884105 0.61390432 VERRECCHIA_RESPONSE_TO_TGFB1_C2 transitional cell carcinoma DOID_2671 1.432E-05 7.409E-04 0.0464353 0.66054214 VERRECCHIA_RESPONSE_TO_TGFB1_C2 mouth disease DOID_403 1.739E-05 8.243E-04 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 carotid stenosis DOID_13001 2.055E-05 8.995E-04 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 Ehlers-Danlos syndrome DOID_13359 2.765E-05 1.124E-03 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 oral submucous fibrosis DOID_5773 2.765E-05 1.049E-03 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 congenital muscular dystrophy DOID_0050557 4.025E-05 1.431E-03 4.025E-05 0.02290175 VERRECCHIA_RESPONSE_TO_TGFB1_C2 coronary restenosis DOID_4247 5.519E-05 1.847E-03 0.01102322 0.4824779 VERRECCHIA_RESPONSE_TO_TGFB1_C2 coronary stenosis DOID_4248 1.14E-04 3.604E-03 0.01571203 0.47053408 VERRECCHIA_RESPONSE_TO_TGFB1_C2 calcinosis DOID_182 2.038E-04 6.102E-03 0.02089706 0.47561701 VERRECCHIA_RESPONSE_TO_TGFB1_C2 calcium metabolism disease DOID_10575 3.585E-04 0.0101997 0.0275988 0.58161918 VERRECCHIA_RESPONSE_TO_TGFB1_C2 leukocyte disease DOID_9500 4.906E-04 0.01329242 0.03221292 0.57278594 VERRECCHIA_RESPONSE_TO_TGFB1_C2 carotid artery disease DOID_3407 5.227E-04 0.01351839 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 collagen disease DOID_854 5.227E-04 0.01293064 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 mineral metabolism disease DOID_0050032 5.727E-04 0.01357759 0.03476732 0.59947289 VERRECCHIA_RESPONSE_TO_TGFB1_C2 cholestasis DOID_13580 5.899E-04 0.01342523 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 astrocytoma DOID_3069 6.61E-04 0.01446592 0.03731532 0.62448281 VERRECCHIA_RESPONSE_TO_TGFB1_C2 nephrosis DOID_2527 6.981E-04 0.01471109 0.03833273 0.6231806 VERRECCHIA_RESPONSE_TO_TGFB1_C2 bile duct disease DOID_4138 6.981E-04 0.0141857 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 biliary tract disease DOID_9741 7.17E-04 0.01406733 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 pancreatitis DOID_4989 8.151E-04 0.01546059 0.04137883 0.61959347 VERRECCHIA_RESPONSE_TO_TGFB1_C2 contact dermatitis DOID_2773 8.561E-04 0.01571422 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 primary immunodeficiency disease DOID_612 1.053E-03 0.01871778 1.053E-03 0.14974223 VERRECCHIA_RESPONSE_TO_TGFB1_C2 Crohn's disease DOID_8778 1.17E-03 0.02017972 0.04945701 0.67002474 VERRECCHIA_RESPONSE_TO_TGFB1_C2 arrhythmogenic right ventricular dysplasia DOID_0050431 4.738E-03 0.07929943 4.738E-03 0.53923611 VERRECCHIA_RESPONSE_TO_TGFB1_C2 DiGeorge syndrome DOID_11198 4.738E-03 0.07703373 4.738E-03 0.44936343 VERRECCHIA_RESPONSE_TO_TGFB1_C2 velocardiofacial syndrome DOID_12583 4.738E-03 0.07703373 4.738E-03 0.44936343 VERRECCHIA_RESPONSE_TO_TGFB1_C2 T cell deficiency DOID_11200 5.264E-03 0.08319461 5.264E-03 0.42785798 VERRECCHIA_RESPONSE_TO_TGFB1_C2 facioscapulohumeral muscular dystrophy DOID_11727 5.264E-03 0.0809461 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 phagocyte bactericidal dysfunction DOID_3262 5.264E-03 0.07881594 5.264E-03 0.37437573 VERRECCHIA_RESPONSE_TO_TGFB1_C2 teratoma DOID_3307 5.264E-03 0.07679502 5.264E-03 0.33277843 VERRECCHIA_RESPONSE_TO_TGFB1_C2 malignant teratoma DOID_5563 5.264E-03 0.07679502 5.264E-03 0.33277843 VERRECCHIA_RESPONSE_TO_TGFB1_C2 mature teratoma DOID_5566 5.264E-03 0.07679502 5.264E-03 0.33277843 VERRECCHIA_RESPONSE_TO_TGFB1_C2 migraine without aura DOID_12783 5.789E-03 0.08234203 5.789E-03 0.32936813 VERRECCHIA_RESPONSE_TO_TGFB1_C2 bronchiectasis DOID_9563 5.789E-03 0.08033369 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 osteogenesis imperfecta DOID_12347 6.838E-03 0.09263293 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 newborn respiratory distress syndrome DOID_12716 6.838E-03 0.09047868 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 arthropathy DOID_381 7.886E-03 0.09970859 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 varicose veins DOID_799 7.886E-03 0.09754102 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 hyperhomocysteinemia DOID_9279 7.886E-03 0.09546567 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 spastic diplegia DOID_10965 8.409E-03 0.09968363 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 restrictive cardiomyopathy DOID_397 8.409E-03 0.09764927 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 vein disease DOID_866 8.409E-03 0.09569629 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C2 bronchitis DOID_6132 8.932E-03 0.09965868 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH alcohol-related neurodevelopmental disorder DOID_0050667 2.241E-11 1.275E-08 1.057E-07 6.012E-05 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH Huntington's disease DOID_12858 2.724E-07 7.751E-05 2.724E-07 7.751E-05 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH adult respiratory distress syndrome DOID_11394 1.865E-05 3.538E-03 1.206E-03 0.17156806 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH integumentary system benign neoplasm DOID_0060121 3.316E-05 4.717E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH glaucoma DOID_1686 3.316E-05 3.773E-03 1.759E-03 0.16682232 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH skin benign neoplasm DOID_3165 3.316E-05 4.717E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH integumentary system cancer DOID_0060122 4.607E-05 4.369E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH skin cancer DOID_4159 4.607E-05 4.369E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH respiratory failure DOID_11162 6.483E-05 5.27E-03 2.732E-03 0.22211314 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH endocrine organ benign neoplasm DOID_0060089 8.441E-05 6.004E-03 3.25E-03 0.23114468 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH mixed glioma DOID_5076 1.204E-04 7.614E-03 4.105E-03 0.23355764 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH transitional cell carcinoma DOID_2671 1.708E-04 9.718E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH Graves' disease DOID_12361 1.853E-04 9.583E-03 0.01999253 0.43752894 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH lymphoma DOID_0060058 1.942E-04 9.21E-03 5.618E-03 0.29061971 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH hypersensitivity reaction type I disease DOID_1205 2.131E-04 9.328E-03 5.971E-03 0.28313269 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH morbid obesity DOID_11981 4.745E-04 0.01928553 4.745E-04 0.08999912 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH Sciatic Neuropathy DOID_11446 5.48E-04 0.02078889 0.03386906 0.48178739 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH lesion of sciatic nerve DOID_12528 5.48E-04 0.02078889 0.03386906 0.48178739 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH mononeuritis of lower limb DOID_9473 5.48E-04 0.02078889 0.03386906 0.48178739 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH mononeuritis DOID_1802 5.867E-04 0.02086594 0.03501673 0.46336088 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH autoimmune disease of endocrine system DOID_0060005 6.267E-04 0.02097707 0.03616306 0.45726181 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH mononeuropathy DOID_1188 6.267E-04 0.01981168 0.03616306 0.44732133 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH toxic encephalopathy DOID_3602 6.267E-04 0.01876896 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH hyperthyroidism DOID_7998 8.936E-04 0.02542252 0.04301315 0.44499059 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH embryonal cancer DOID_688 1.044E-03 0.0282922 0.04642032 0.45539935 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH uterine cancer DOID_363 1.44E-03 0.03723075 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH neuritis DOID_1803 1.628E-03 0.04026473 0.05769211 0.48274724 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH thyroid adenoma DOID_2891 1.628E-03 0.03858703 0.05769211 0.47575091 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH autoimmune disease of gastrointestinal tract DOID_0060031 1.759E-03 0.04003736 1.759E-03 0.20018678 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH reproductive organ benign neoplasm DOID_0050622 2.183E-03 0.0477747 0.06661565 0.50539075 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH pustulosis of palm and sole DOID_4398 2.183E-03 0.04600527 0.06661565 0.49226372 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH hypertrophic cardiomyopathy DOID_11984 2.411E-03 0.04900159 0.06994063 0.51020795 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH male reproductive system disease DOID_48 3.524E-03 0.06915024 3.524E-03 0.22281744 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH cystic fibrosis DOID_1485 3.907E-03 0.07409593 0.08856457 0.57923262 VANTVEER_BREAST_CANCER_ESR1_DN phagocyte bactericidal dysfunction DOID_3262 1.606E-08 9.137E-06 1.606E-08 9.137E-06 VANTVEER_BREAST_CANCER_ESR1_DN sarcoidosis DOID_11335 1.859E-08 5.289E-06 6.536E-04 0.01690384 VANTVEER_BREAST_CANCER_ESR1_DN hypersensitivity reaction type IV disease DOID_2916 3.141E-08 5.957E-06 8.394E-04 0.0183689 VANTVEER_BREAST_CANCER_ESR1_DN endocrine organ benign neoplasm DOID_0060089 7.906E-08 1.125E-05 2.501E-06 3.558E-04 VANTVEER_BREAST_CANCER_ESR1_DN pulmonary sarcoidosis DOID_13406 1.361E-07 1.549E-05 2.412E-04 0.0105589 VANTVEER_BREAST_CANCER_ESR1_DN uveal disease DOID_3480 2.796E-07 2.651E-05 3.658E-04 0.01300939 VANTVEER_BREAST_CANCER_ESR1_DN nervous system cancer DOID_3093 3.74E-07 3.04E-05 8.985E-06 8.52E-04 VANTVEER_BREAST_CANCER_ESR1_DN brain cancer DOID_1319 4.28E-07 3.044E-05 1.605E-05 1.305E-03 VANTVEER_BREAST_CANCER_ESR1_DN central nervous system cancer DOID_3620 4.734E-07 2.993E-05 1.738E-05 1.236E-03 VANTVEER_BREAST_CANCER_ESR1_DN giant cell tumor DOID_200 7.606E-07 4.328E-05 7.606E-07 2.164E-04 VANTVEER_BREAST_CANCER_ESR1_DN malignant giant cell tumor DOID_2705 7.606E-07 4.328E-05 7.606E-07 2.164E-04 VANTVEER_BREAST_CANCER_ESR1_DN giant cell glioblastoma DOID_3074 7.606E-07 4.328E-05 7.606E-07 2.164E-04 VANTVEER_BREAST_CANCER_ESR1_DN glioblastoma DOID_3068 1.171E-06 6.055E-05 1.171E-06 2.22E-04 VANTVEER_BREAST_CANCER_ESR1_DN allergic contact dermatitis DOID_3042 2.331E-06 1.105E-04 1.252E-03 0.02297697 VANTVEER_BREAST_CANCER_ESR1_DN astrocytoma DOID_3069 2.681E-06 1.174E-04 2.681E-06 3.051E-04 VANTVEER_BREAST_CANCER_ESR1_DN bone resorption disease DOID_0080011 4.248E-06 1.726E-04 1.773E-03 0.02727059 VANTVEER_BREAST_CANCER_ESR1_DN osteoporosis DOID_11476 4.248E-06 1.726E-04 1.773E-03 0.02727059 VANTVEER_BREAST_CANCER_ESR1_DN contact dermatitis DOID_2773 5.106E-06 1.937E-04 1.973E-03 0.0295429 VANTVEER_BREAST_CANCER_ESR1_DN uveitis DOID_13141 7.206E-06 2.563E-04 6.808E-03 0.07309137 VANTVEER_BREAST_CANCER_ESR1_DN amino acid metabolic disorder DOID_9252 8.517E-06 2.851E-04 2.654E-03 0.03595601 VANTVEER_BREAST_CANCER_ESR1_DN thyroid adenoma DOID_2891 1.605E-05 5.074E-04 4.682E-04 0.014022 VANTVEER_BREAST_CANCER_ESR1_DN pustulosis of palm and sole DOID_4398 2.903E-05 8.692E-04 7.243E-04 0.0164861 VANTVEER_BREAST_CANCER_ESR1_DN esophagitis DOID_11963 2.908E-05 8.274E-04 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN oral cavity cancer DOID_8618 3.545E-05 9.606E-04 8.394E-04 0.01768857 VANTVEER_BREAST_CANCER_ESR1_DN nephrosis DOID_2527 7.586E-05 1.962E-03 7.586E-05 4.796E-03 VANTVEER_BREAST_CANCER_ESR1_DN extrinsic allergic alveolitis DOID_841 8.212E-05 2.032E-03 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN perinatal necrotizing enterocolitis DOID_8677 9.14E-05 2.167E-03 0.08366012 0.33288537 VANTVEER_BREAST_CANCER_ESR1_DN bacterial pneumonia DOID_874 1.028E-04 2.34E-03 0.02431959 0.1921923 VANTVEER_BREAST_CANCER_ESR1_DN supratentorial cancer DOID_1659 1.119E-04 2.45E-03 1.119E-04 6.369E-03 VANTVEER_BREAST_CANCER_ESR1_DN cerebrum cancer DOID_368 1.119E-04 2.45E-03 1.119E-04 6.369E-03 VANTVEER_BREAST_CANCER_ESR1_DN chronic kidney failure DOID_784 1.301E-04 2.743E-03 2.186E-03 0.0303393 VANTVEER_BREAST_CANCER_ESR1_DN Charcot-Marie-Tooth disease DOID_10595 1.48E-04 3.008E-03 1.48E-04 7.658E-03 VANTVEER_BREAST_CANCER_ESR1_DN primary bacterial infectious disease DOID_0050338 1.555E-04 3.051E-03 0.02961776 0.2188637 VANTVEER_BREAST_CANCER_ESR1_DN primary immunodeficiency disease DOID_612 1.694E-04 3.213E-03 1.694E-04 8.033E-03 VANTVEER_BREAST_CANCER_ESR1_DN thyroid carcinoma DOID_3963 1.91E-04 3.505E-03 5.573E-03 0.06342035 VANTVEER_BREAST_CANCER_ESR1_DN esophageal disease DOID_6050 1.91E-04 3.396E-03 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN carbohydrate metabolic disorder DOID_2978 1.999E-04 3.448E-03 2.998E-03 0.03876624 VANTVEER_BREAST_CANCER_ESR1_DN thyroid cancer DOID_1781 2.236E-04 3.743E-03 6.176E-03 0.06890868 VANTVEER_BREAST_CANCER_ESR1_DN hepatitis DOID_2237 2.791E-04 4.537E-03 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN peptic ulcer DOID_750 2.791E-04 4.411E-03 0.11887398 0.4002325 VANTVEER_BREAST_CANCER_ESR1_DN adenoid cystic carcinoma DOID_4866 2.994E-04 4.604E-03 2.994E-04 0.01216681 VANTVEER_BREAST_CANCER_ESR1_DN salivary gland cancer DOID_8850 3.427E-04 5.132E-03 3.427E-04 0.01300008 VANTVEER_BREAST_CANCER_ESR1_DN rheumatic disease DOID_1575 3.658E-04 5.337E-03 8.51E-03 0.08206832 VANTVEER_BREAST_CANCER_ESR1_DN scleroderma DOID_419 3.658E-04 5.337E-03 8.51E-03 0.08206832 VANTVEER_BREAST_CANCER_ESR1_DN uterine cancer DOID_363 3.899E-04 5.546E-03 3.899E-04 0.01305039 VANTVEER_BREAST_CANCER_ESR1_DN influenza DOID_8469 3.899E-04 5.411E-03 0.13205767 0.42452437 VANTVEER_BREAST_CANCER_ESR1_DN acute kidney failure DOID_3021 3.97E-04 5.379E-03 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN spinocerebellar degeneration DOID_2478 4.411E-04 5.837E-03 4.411E-04 0.01394338 VANTVEER_BREAST_CANCER_ESR1_DN pre-eclampsia DOID_10591 4.682E-04 6.055E-03 0.13987383 0.43971388 VANTVEER_BREAST_CANCER_ESR1_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 4.843E-04 6.124E-03 4.843E-04 0.01377876 VANTVEER_BREAST_CANCER_ESR1_DN integumentary system benign neoplasm DOID_0060121 5.256E-04 6.502E-03 0.01077546 0.1021873 VANTVEER_BREAST_CANCER_ESR1_DN pulmonary tuberculosis DOID_2957 5.256E-04 6.364E-03 0.14504581 0.43899502 VANTVEER_BREAST_CANCER_ESR1_DN skin benign neoplasm DOID_3165 5.256E-04 6.502E-03 0.01077546 0.1021873 VANTVEER_BREAST_CANCER_ESR1_DN lung small cell carcinoma DOID_5409 5.256E-04 6.231E-03 0.01077546 0.1005121 VANTVEER_BREAST_CANCER_ESR1_DN otitis media DOID_10754 5.8E-04 6.736E-03 0.03549873 0.21719115 VANTVEER_BREAST_CANCER_ESR1_DN middle ear disease DOID_5100 5.8E-04 6.736E-03 0.03549873 0.21719115 VANTVEER_BREAST_CANCER_ESR1_DN progressive myoclonus epilepsy DOID_891 5.8E-04 6.601E-03 5.8E-04 0.0157162 VANTVEER_BREAST_CANCER_ESR1_DN variable age at onset electroclinical syndrome DOID_0050706 6.841E-04 7.633E-03 6.841E-04 0.01692526 VANTVEER_BREAST_CANCER_ESR1_DN impotence DOID_1875 6.841E-04 7.486E-03 6.841E-04 0.01622004 VANTVEER_BREAST_CANCER_ESR1_DN integumentary system cancer DOID_0060122 7.243E-04 7.776E-03 0.01327669 0.11991171 VANTVEER_BREAST_CANCER_ESR1_DN skin cancer DOID_4159 7.243E-04 7.776E-03 0.01327669 0.11991171 VANTVEER_BREAST_CANCER_ESR1_DN hemangioma DOID_255 9.174E-04 9.666E-03 9.174E-04 0.01864197 VANTVEER_BREAST_CANCER_ESR1_DN lung oat cell carcinoma DOID_5411 9.174E-04 9.49E-03 0.04417645 0.23491961 VANTVEER_BREAST_CANCER_ESR1_DN panic disorder DOID_594 9.174E-04 9.321E-03 9.174E-04 0.01799915 VANTVEER_BREAST_CANCER_ESR1_DN collagen disease DOID_854 9.653E-04 9.636E-03 0.0160044 0.13797733 VANTVEER_BREAST_CANCER_ESR1_DN endocrine pancreas disease DOID_1428 1.103E-03 0.0108179 0.18286544 0.50756311 VANTVEER_BREAST_CANCER_ESR1_DN uterine disease DOID_345 1.151E-03 0.01110114 0.18532695 0.5094253 VANTVEER_BREAST_CANCER_ESR1_DN penile disease DOID_1529 1.184E-03 0.01122383 1.184E-03 0.02244766 VANTVEER_BREAST_CANCER_ESR1_DN tuberculosis DOID_399 1.304E-03 0.01216543 0.19266747 0.52453487 VANTVEER_BREAST_CANCER_ESR1_DN keratosis DOID_161 1.329E-03 0.01219551 1.329E-03 0.02362879 VANTVEER_BREAST_CANCER_ESR1_DN sexual dysfunction DOID_1876 1.329E-03 0.01200193 1.329E-03 0.02291277 VANTVEER_BREAST_CANCER_ESR1_DN pancreatic ductal carcinoma DOID_3587 1.413E-03 0.01256299 1.413E-03 0.02364797 VANTVEER_BREAST_CANCER_ESR1_DN male reproductive system disease DOID_48 1.47E-03 0.01286431 0.02103016 0.17597296 VANTVEER_BREAST_CANCER_ESR1_DN pancreatic carcinoma DOID_4905 1.587E-03 0.01367992 1.587E-03 0.02579642 VANTVEER_BREAST_CANCER_ESR1_DN diabetic retinopathy DOID_8947 1.587E-03 0.01347574 0.02210442 0.18228136 VANTVEER_BREAST_CANCER_ESR1_DN subependymal glioma DOID_4843 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN pilocytic astrocytoma DOID_4851 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN subependymal giant cell astrocytoma DOID_5077 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN fibrillary astrocytoma DOID_6726 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN juvenile pilocytic astrocytoma DOID_6811 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN childhood pilocytic astrocytoma DOID_6812 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN gemistocytic astrocytoma DOID_7005 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN childhood cerebral astrocytoma DOID_7007 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN protoplasmic astrocytoma DOID_7008 1.644E-03 0.01375431 1.644E-03 0.02598036 VANTVEER_BREAST_CANCER_ESR1_DN coronary restenosis DOID_4247 1.813E-03 0.01495242 0.06130038 0.29066598 VANTVEER_BREAST_CANCER_ESR1_DN mitochondrial myopathy DOID_699 1.813E-03 0.01473881 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN pancreatitis DOID_4989 1.838E-03 0.01473302 0.02431959 0.19489924 VANTVEER_BREAST_CANCER_ESR1_DN benign glioma DOID_0060101 1.991E-03 0.01573143 1.991E-03 0.02904264 VANTVEER_BREAST_CANCER_ESR1_DN gastric ulcer DOID_10808 1.991E-03 0.01551593 0.06412466 0.2990732 VANTVEER_BREAST_CANCER_ESR1_DN benign ependymoma DOID_4844 1.991E-03 0.01573143 1.991E-03 0.02904264 VANTVEER_BREAST_CANCER_ESR1_DN female reproductive system disease DOID_229 2.043E-03 0.01570537 0.22137964 0.58048394 VANTVEER_BREAST_CANCER_ESR1_DN auditory system disease DOID_2742 2.114E-03 0.01603496 0.02662163 0.20750285 VANTVEER_BREAST_CANCER_ESR1_DN sexual disorder DOID_0060043 2.176E-03 0.01629084 2.176E-03 0.03095259 VANTVEER_BREAST_CANCER_ESR1_DN hypoglycemia DOID_9993 2.176E-03 0.01607927 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN retinal vascular disease DOID_2462 2.336E-03 0.01703985 0.02840375 0.21265441 VANTVEER_BREAST_CANCER_ESR1_DN Goodpasture syndrome DOID_9808 2.369E-03 0.01706343 0.06974796 0.30528146 VANTVEER_BREAST_CANCER_ESR1_DN bronchiolitis DOID_2942 2.779E-03 0.01976396 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN morbid obesity DOID_11981 2.995E-03 0.02104026 2.995E-03 0.03963398 VANTVEER_BREAST_CANCER_ESR1_DN cystitis DOID_1679 2.995E-03 0.02078367 0.07812018 0.33171927 VANTVEER_BREAST_CANCER_ESR1_DN myositis DOID_633 2.995E-03 0.02053327 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN encephalomyelitis DOID_640 2.998E-03 0.02030613 0.03338108 0.21341386 VANTVEER_BREAST_CANCER_ESR1_DN mouth disease DOID_403 3.088E-03 0.02066961 0.03402562 0.21511752 VANTVEER_BREAST_CANCER_ESR1_DN hypersensitivity reaction type I disease DOID_1205 3.179E-03 0.02103553 0.03467501 0.21681409 VANTVEER_BREAST_CANCER_ESR1_DN lung adenocarcinoma DOID_3910 3.451E-03 0.02257009 0.08366012 0.33760715 VANTVEER_BREAST_CANCER_ESR1_DN ulcerative colitis DOID_8577 3.464E-03 0.02239932 0.03665199 0.21723938 VANTVEER_BREAST_CANCER_ESR1_DN pleurisy DOID_10247 3.69E-03 0.02359255 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN renal hypertension DOID_1073 3.69E-03 0.02333041 3.69E-03 0.04666082 VANTVEER_BREAST_CANCER_ESR1_DN secondary hypertension DOID_11130 3.69E-03 0.02333041 3.69E-03 0.04666082 VANTVEER_BREAST_CANCER_ESR1_DN coronary stenosis DOID_4248 3.69E-03 0.02307403 0.0864177 0.33679228 VANTVEER_BREAST_CANCER_ESR1_DN endometrial carcinoma DOID_2871 4.191E-03 0.02592198 4.191E-03 0.05184396 VANTVEER_BREAST_CANCER_ESR1_DN congenital disorder of glycosylation DOID_5212 4.191E-03 0.02564325 4.191E-03 0.05074089 VANTVEER_BREAST_CANCER_ESR1_DN abdominal aortic aneurysm DOID_7693 4.453E-03 0.02695442 0.09464119 0.35900559 VANTVEER_BREAST_CANCER_ESR1_DN endometrial cancer DOID_1380 4.722E-03 0.02828219 4.722E-03 0.05597516 VANTVEER_BREAST_CANCER_ESR1_DN pleural disease DOID_1532 4.998E-03 0.02962576 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN bladder disease DOID_365 4.998E-03 0.02932034 0.10008271 0.36978612 VANTVEER_BREAST_CANCER_ESR1_DN papilloma DOID_2615 5.282E-03 0.03066821 0.1027913 0.37734356 VANTVEER_BREAST_CANCER_ESR1_DN myocarditis DOID_820 5.282E-03 0.03035843 0.1027913 0.37253663 VANTVEER_BREAST_CANCER_ESR1_DN nephroblastoma DOID_2154 5.573E-03 0.03171018 5.573E-03 0.06471465 VANTVEER_BREAST_CANCER_ESR1_DN spindle cell carcinoma DOID_4015 5.573E-03 0.03139622 0.10549181 0.37751472 VANTVEER_BREAST_CANCER_ESR1_DN hyperthyroidism DOID_7998 5.573E-03 0.03108841 0.10549181 0.37515526 VANTVEER_BREAST_CANCER_ESR1_DN aplastic anemia DOID_12449 5.871E-03 0.03243345 0.10818426 0.38234066 VANTVEER_BREAST_CANCER_ESR1_DN adenoma DOID_657 6.176E-03 0.03379176 6.176E-03 0.06758351 VANTVEER_BREAST_CANCER_ESR1_DN multiple myeloma DOID_9538 6.489E-03 0.0351627 0.11354509 0.38919974 VANTVEER_BREAST_CANCER_ESR1_DN respiratory syncytial virus infectious disease DOID_1273 7.135E-03 0.03829807 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN systemic scleroderma DOID_418 7.135E-03 0.03794014 7.135E-03 0.07517768 VANTVEER_BREAST_CANCER_ESR1_DN benign mesothelioma DOID_2645 7.808E-03 0.04113868 0.12417111 0.415608 VANTVEER_BREAST_CANCER_ESR1_DN pulmonary emphysema DOID_9675 7.808E-03 0.04076126 7.808E-03 0.08078141 VANTVEER_BREAST_CANCER_ESR1_DN autoimmune disease of urogenital tract DOID_0060049 8.156E-03 0.04218689 0.12680782 0.42195117 VANTVEER_BREAST_CANCER_ESR1_DN primary biliary cirrhosis DOID_12236 8.156E-03 0.04218689 0.12680782 0.42195117 VANTVEER_BREAST_CANCER_ESR1_DN spinocerebellar ataxia DOID_1441 8.156E-03 0.04180683 8.156E-03 0.0828671 VANTVEER_BREAST_CANCER_ESR1_DN endometriosis of uterus DOID_288 8.156E-03 0.04143355 0.12680782 0.41949797 VANTVEER_BREAST_CANCER_ESR1_DN nephrotic syndrome DOID_1184 8.51E-03 0.04284983 8.51E-03 0.08494791 VANTVEER_BREAST_CANCER_ESR1_DN Huntington's disease DOID_12858 8.51E-03 0.04247396 8.51E-03 0.08348329 VANTVEER_BREAST_CANCER_ESR1_DN endometriosis DOID_289 8.51E-03 0.04210462 0.12943667 0.42085408 VANTVEER_BREAST_CANCER_ESR1_DN myeloma DOID_0070004 9.994E-03 0.04902032 0.13987383 0.44215673 VANTVEER_BREAST_CANCER_ESR1_DN neuritis DOID_1803 9.994E-03 0.04860134 0.13987383 0.43490826 VANTVEER_BREAST_CANCER_ESR1_DN bone marrow disease DOID_4961 9.994E-03 0.04818947 0.13987383 0.43020655 VANTVEER_BREAST_CANCER_ESR1_DN hemolytic anemia DOID_583 0.01038124 0.04963802 0.14246369 0.43581633 VANTVEER_BREAST_CANCER_ESR1_DN normocytic anemia DOID_720 0.01038124 0.04963802 0.14246369 0.43581633 VANTVEER_BREAST_CANCER_ESR1_DN calcium metabolism disease DOID_10575 0.01117623 0.05299394 0.14762022 0.44442279 VANTVEER_BREAST_CANCER_ESR1_DN aortic aneurysm DOID_3627 0.01117623 0.05255598 0.14762022 0.44208372 VANTVEER_BREAST_CANCER_ESR1_DN bile duct adenocarcinoma DOID_4896 0.01284385 0.05990289 0.01284385 0.11787342 VANTVEER_BREAST_CANCER_ESR1_DN cholangiocarcinoma DOID_4947 0.01284385 0.05990289 0.01284385 0.11787342 VANTVEER_BREAST_CANCER_ESR1_DN bone marrow cancer DOID_4960 0.01284385 0.05941587 0.15784127 0.4653455 VANTVEER_BREAST_CANCER_ESR1_DN parasitic protozoa infectious disease DOID_2789 0.01327669 0.06092289 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN smallpox DOID_8736 0.01327669 0.0604355 0.01327669 0.11803809 VANTVEER_BREAST_CANCER_ESR1_DN mitochondrial metabolism disease DOID_700 0.01371582 0.06193891 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN bile duct cancer DOID_4606 0.01461279 0.0654699 0.01461279 0.12791811 VANTVEER_BREAST_CANCER_ESR1_DN bile duct carcinoma DOID_4897 0.01461279 0.0654699 0.01461279 0.12791811 VANTVEER_BREAST_CANCER_ESR1_DN leukocyte disease DOID_9500 0.01507055 0.06699329 0.17044688 0.48492138 VANTVEER_BREAST_CANCER_ESR1_DN carotid artery disease DOID_3407 0.0160044 0.07059305 0.1754366 0.49417537 VANTVEER_BREAST_CANCER_ESR1_DN mineral metabolism disease DOID_0050032 0.01745043 0.07637921 0.18286544 0.51005117 VANTVEER_BREAST_CANCER_ESR1_DN cholestasis DOID_13580 0.01794435 0.07794151 0.18532695 0.51189823 VANTVEER_BREAST_CANCER_ESR1_DN parasitic infectious disease DOID_1398 0.01794435 0.07735104 1.000 1.000 VANTVEER_BREAST_CANCER_ESR1_DN tooth disease DOID_1091 0.01894982 0.08107103 0.01894982 0.16093204 VANTVEER_BREAST_CANCER_ESR1_DN brain infarction DOID_3454 0.01946129 0.08263785 0.19266747 0.52705667 VANTVEER_BREAST_CANCER_ESR1_DN bile duct disease DOID_4138 0.02103016 0.08863823 0.19994241 0.54174873 VANTVEER_BREAST_CANCER_ESR1_DN biliary tract disease DOID_9741 0.02156448 0.09022198 0.20235293 0.54568158 VANTVEER_BREAST_CANCER_ESR1_DN aneurysm disease DOID_2403 0.02375756 0.0986719 0.2119232 0.56879386 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP adult respiratory distress syndrome DOID_11394 5.401E-09 3.073E-06 5.046E-07 2.871E-04 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP respiratory failure DOID_11162 4.521E-08 1.286E-05 2.703E-06 7.689E-04 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP bacterial pneumonia DOID_874 1.294E-07 2.454E-05 6.21E-06 8.834E-04 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP uremia DOID_4676 5.294E-06 7.531E-04 5.294E-06 1.004E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP primary bacterial infectious disease DOID_0050338 9.493E-06 1.08E-03 3.168E-04 0.01386726 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pulmonary sarcoidosis DOID_13406 2.901E-05 2.751E-03 0.05744395 0.25535631 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pulmonary emphysema DOID_9675 3.873E-05 3.148E-03 1.948E-03 0.02995978 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP diabetic autonomic neuropathy DOID_11503 4.727E-05 3.362E-03 2.22E-03 0.03323983 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP autonomic neuropathy DOID_11504 4.727E-05 3.362E-03 2.22E-03 0.03323983 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP diabetic polyneuropathy DOID_12785 4.727E-05 3.362E-03 2.22E-03 0.03323983 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP diabetic neuropathy DOID_9743 4.727E-05 3.362E-03 2.22E-03 0.03323983 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP autonomic nervous system disease DOID_11465 5.696E-05 3.601E-03 2.508E-03 0.03243904 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP aortic aneurysm DOID_3627 6.786E-05 3.861E-03 2.814E-03 0.03406466 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP sarcoidosis DOID_11335 8.005E-05 4.141E-03 0.07950284 0.3119801 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP parasitic protozoa infectious disease DOID_2789 8.892E-05 4.216E-03 8.892E-05 0.01011902 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP lateral sclerosis DOID_230 9.571E-05 4.189E-03 9.571E-05 9.076E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP hypersensitivity reaction type IV disease DOID_2916 1.034E-04 4.202E-03 0.08629167 0.33175649 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP trypanosomiasis DOID_10113 1.169E-04 4.433E-03 1.169E-04 9.499E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP common cold DOID_10459 1.401E-04 4.982E-03 0.01758495 0.12994596 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP parasitic infectious disease DOID_1398 1.429E-04 4.784E-03 1.429E-04 0.01016511 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP uterine disease DOID_345 1.429E-04 4.518E-03 1.429E-04 9.036E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP brain infarction DOID_3454 1.625E-04 4.866E-03 1.625E-04 9.245E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP tuberculosis DOID_399 1.625E-04 4.623E-03 1.625E-04 8.405E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP thoracic aortic aneurysm DOID_14004 2.223E-04 6.022E-03 0.02193352 0.14182015 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP renovascular hypertension DOID_1591 2.223E-04 5.748E-03 0.02193352 0.14022667 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP hyperhomocysteinemia DOID_9279 2.223E-04 5.499E-03 0.02193352 0.13419541 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP aneurysm disease DOID_2403 2.229E-04 5.285E-03 6.139E-03 0.05726044 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pancreatitis DOID_4989 2.314E-04 5.266E-03 6.29E-03 0.05772697 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP female reproductive system disease DOID_229 2.579E-04 5.645E-03 2.579E-04 0.01223095 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP ureteral obstruction DOID_5199 3.229E-04 6.806E-03 3.229E-04 0.01312533 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.957E-04 8.041E-03 8.941E-03 0.07708308 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP mouth disease DOID_403 3.957E-04 7.764E-03 3.957E-04 0.0150106 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP hepatitis B DOID_2043 4.857E-04 9.213E-03 4.857E-04 0.01727394 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP muscular atrophy DOID_767 4.857E-04 8.916E-03 4.857E-04 0.01625782 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP placenta disease DOID_780 4.857E-04 8.637E-03 4.857E-04 0.01535461 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP urinary tract obstruction DOID_5200 5.315E-04 9.164E-03 5.315E-04 0.01591675 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pulmonary embolism DOID_9477 5.315E-04 8.895E-03 5.315E-04 0.01512091 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP Lewy body dementia DOID_12217 5.793E-04 9.417E-03 0.0348661 0.18540947 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP ureteral disease DOID_1426 5.793E-04 9.156E-03 5.793E-04 0.01569515 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP toxic shock syndrome DOID_14115 6.29E-04 9.673E-03 6.29E-04 0.01626907 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP commensal bacterial infectious disease DOID_0050339 6.808E-04 0.01019418 6.808E-04 0.01684255 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP cystitis DOID_1679 7.346E-04 0.01071725 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP middle cerebral artery infarction DOID_3525 7.903E-04 0.01124245 7.903E-04 0.01873742 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP extrinsic allergic alveolitis DOID_841 7.903E-04 0.01096824 0.04055987 0.20244356 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP Sciatic Neuropathy DOID_11446 8.481E-04 0.01148932 8.481E-04 0.01930206 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP lesion of sciatic nerve DOID_12528 8.481E-04 0.01148932 8.481E-04 0.01930206 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP periodontitis DOID_824 8.481E-04 0.01122213 8.481E-04 0.01855967 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP mononeuritis of lower limb DOID_9473 8.481E-04 0.01148932 8.481E-04 0.01930206 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP autoimmune disease of cardiovascular system DOID_0060051 9.078E-04 0.01173931 9.078E-04 0.01913073 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pleurisy DOID_10247 9.078E-04 0.01147844 0.04339437 0.21285685 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP renal hypertension DOID_1073 9.078E-04 0.01122891 0.04339437 0.21103756 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP secondary hypertension DOID_11130 9.078E-04 0.01122891 0.04339437 0.21103756 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP Behcet's disease DOID_13241 9.078E-04 0.01173931 9.078E-04 0.01913073 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP mononeuritis DOID_1802 9.078E-04 0.01098999 9.078E-04 0.01844749 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP invasive ductal carcinoma DOID_3008 9.078E-04 0.01076104 9.078E-04 0.01781137 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP mononeuropathy DOID_1188 9.695E-04 0.01125775 9.695E-04 0.01838765 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP toxic encephalopathy DOID_3602 9.695E-04 0.01103259 9.695E-04 0.0177945 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP focal glomerulosclerosis DOID_3945 9.695E-04 0.01081627 9.695E-04 0.01723843 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP female reproductive organ benign neoplasm DOID_0060086 1.033E-03 0.01130476 1.033E-03 0.01781357 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP uterine benign neoplasm DOID_0060095 1.033E-03 0.01130476 1.033E-03 0.01781357 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP uterine fibroid DOID_13223 1.033E-03 0.01130476 1.033E-03 0.01781357 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP leiomyoma DOID_127 1.236E-03 0.01326753 1.236E-03 0.02068175 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pleural disease DOID_1532 1.236E-03 0.01302184 0.05044468 0.23335791 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP bladder disease DOID_365 1.236E-03 0.01278508 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP periodontal disease DOID_3388 1.381E-03 0.01402855 1.381E-03 0.02244568 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP respiratory syncytial virus infectious disease DOID_1273 1.776E-03 0.0177337 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP systemic scleroderma DOID_418 1.776E-03 0.01742795 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP intracranial arterial disease DOID_13089 1.861E-03 0.0179513 1.861E-03 0.02942019 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP cerebral arterial disease DOID_3527 1.861E-03 0.0179513 1.861E-03 0.02942019 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP autoimmune disease of urogenital tract DOID_0060049 2.037E-03 0.01931623 0.06439255 0.27342805 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP primary biliary cirrhosis DOID_12236 2.037E-03 0.01931623 0.06439255 0.27342805 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP rheumatic disease DOID_1575 2.127E-03 0.0198444 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP scleroderma DOID_419 2.127E-03 0.0198444 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP cerebral infarction DOID_3526 2.314E-03 0.02123848 2.314E-03 0.03376373 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP cataract DOID_83 2.314E-03 0.02090136 2.314E-03 0.03291964 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP leukodystrophy DOID_10579 2.41E-03 0.02143002 0.06991517 0.28619953 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP proteinuria DOID_576 2.41E-03 0.02110033 0.06991517 0.28415524 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP myeloma DOID_0070004 2.508E-03 0.02162602 2.508E-03 0.03481262 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pre-eclampsia DOID_10591 2.508E-03 0.02130325 2.508E-03 0.03398375 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP lens disease DOID_110 2.508E-03 0.02098996 2.508E-03 0.03319343 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP neuritis DOID_1803 2.508E-03 0.02068576 2.508E-03 0.03171817 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP integumentary system benign neoplasm DOID_0060121 2.71E-03 0.02202971 2.71E-03 0.03352347 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP skin benign neoplasm DOID_3165 2.71E-03 0.02202971 2.71E-03 0.03352347 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP atrophic muscular disease DOID_913 3.136E-03 0.02512949 3.136E-03 0.0371707 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP muscular dystrophy DOID_9884 3.136E-03 0.02512949 3.136E-03 0.0371707 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP bone marrow cancer DOID_4960 3.247E-03 0.02565732 3.247E-03 0.03770055 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP vasculitis DOID_865 3.247E-03 0.02530585 3.247E-03 0.03694654 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP reproductive organ benign neoplasm DOID_0050622 3.359E-03 0.02583103 3.359E-03 0.03748031 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP integumentary system cancer DOID_0060122 3.359E-03 0.02548661 3.359E-03 0.03675954 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP osteochondrodysplasia DOID_2256 3.359E-03 0.02515126 3.359E-03 0.03606596 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP skin cancer DOID_4159 3.359E-03 0.02548661 3.359E-03 0.03675954 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP oral cavity cancer DOID_8618 3.709E-03 0.02740502 3.709E-03 0.03907753 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP collagen disease DOID_854 4.074E-03 0.02971907 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP cerebral degeneration DOID_1443 4.586E-03 0.03303132 0.09571349 0.36066873 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP tooth disease DOID_1091 4.853E-03 0.03451491 4.853E-03 0.0502035 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pancreatic ductal carcinoma DOID_3587 5.266E-03 0.03699054 5.266E-03 0.05350417 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP nephrosis DOID_2527 5.407E-03 0.03751901 5.407E-03 0.05397471 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP pancreatic carcinoma DOID_4905 5.694E-03 0.03903805 5.694E-03 0.0558648 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP diabetic retinopathy DOID_8947 5.694E-03 0.03857331 0.10636448 0.38548656 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP cystic fibrosis DOID_1485 5.989E-03 0.04009024 5.989E-03 0.05775713 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP bone resorption disease DOID_0080011 6.139E-03 0.04061496 6.139E-03 0.05821478 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP osteoporosis DOID_11476 6.139E-03 0.04061496 6.139E-03 0.05821478 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP alcohol abuse DOID_1574 7.073E-03 0.04625789 7.073E-03 0.06387994 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP bone development disease DOID_0080006 7.234E-03 0.046777 7.234E-03 0.06431838 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP retinal vascular disease DOID_2462 7.398E-03 0.04729511 0.12080866 0.4269573 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP amino acid metabolic disorder DOID_9252 8.067E-03 0.05100277 0.12600403 0.4425697 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP lymphoma DOID_0060058 8.587E-03 0.05369022 8.587E-03 0.0751663 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP encephalomyelitis DOID_640 8.763E-03 0.05419766 0.13116924 0.45509329 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP hypersensitivity reaction type I disease DOID_1205 9.121E-03 0.05580325 9.121E-03 0.07745824 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP gallbladder disease DOID_0000000 0.01467537 0.0888328 0.01467537 0.12279829 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP interstitial nephritis DOID_1063 0.01467537 0.08789772 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP facioscapulohumeral muscular dystrophy DOID_11727 0.01467537 0.08698212 0.01467537 0.1210186 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP Sjogren's syndrome DOID_12894 0.01467537 0.0860854 0.01467537 0.11928977 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP angioedema DOID_1558 0.01467537 0.08520698 0.01467537 0.11760963 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP rectal neoplasm DOID_1984 0.01467537 0.0843463 0.01467537 0.11597616 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP rectum cancer DOID_1993 0.01467537 0.0843463 0.01467537 0.11597616 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP transient cerebral ischemia DOID_224 0.01467537 0.08350284 0.01467537 0.11438745 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP bilirubin metabolic disorder DOID_2741 0.01467537 0.08267608 0.01467537 0.11284167 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP holoprosencephaly DOID_4621 0.01467537 0.08186553 0.01467537 0.11133712 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP hemochromatosis DOID_2352 0.01613122 0.08911323 0.01613122 0.12077187 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP heroin dependence DOID_9976 0.01613122 0.08825637 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP porphyria DOID_13268 0.01758495 0.09529371 0.01758495 0.12827999 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP epidermolysis bullosa DOID_2730 0.01758495 0.09439471 0.01758495 0.12665619 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP retinal detachment DOID_5327 0.01758495 0.09351251 0.01758495 0.12507299 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP aortic valve insufficiency DOID_57 0.01758495 0.09264666 0.01758495 0.12352888 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP peritonitis DOID_8283 0.01758495 0.09179669 0.01758495 0.12202243 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP encephalitis DOID_9588 0.01758495 0.09096217 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP newborn respiratory distress syndrome DOID_12716 0.01903658 0.09758392 0.01903658 0.1305038 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP Leydig cell tumor DOID_2696 0.01903658 0.09671264 0.01903658 0.12895018 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP vesiculobullous skin disease DOID_2731 0.01903658 0.09585677 0.01903658 0.12743312 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP intracranial thrombosis DOID_4193 0.01903658 0.09501592 0.01903658 0.12595134 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP sex cord-stromal neoplasm DOID_4757 0.01903658 0.09671264 0.01903658 0.12895018 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.01903658 0.0941897 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP viral pneumonia DOID_10533 0.0204861 0.099629 1.000 1.000 LAIHO_COLORECTAL_CANCER_SERRATED_UP polyneuropathy DOID_1389 9.613E-07 5.47E-04 1.775E-04 0.1009918 LAIHO_COLORECTAL_CANCER_SERRATED_UP peripheral vascular disease DOID_341 5.527E-06 1.572E-03 2.122E-04 0.02414654 LAIHO_COLORECTAL_CANCER_SERRATED_UP thyroid carcinoma DOID_3963 2.544E-05 4.826E-03 1.48E-03 0.04432679 LAIHO_COLORECTAL_CANCER_SERRATED_UP thyroid cancer DOID_1781 2.986E-05 4.248E-03 1.644E-03 0.04676073 LAIHO_COLORECTAL_CANCER_SERRATED_UP proteinuria DOID_576 5.955E-05 6.777E-03 2.583E-03 0.06390163 LAIHO_COLORECTAL_CANCER_SERRATED_UP vascular skin disease DOID_9540 6.328E-05 6.001E-03 2.688E-03 0.05882601 LAIHO_COLORECTAL_CANCER_SERRATED_UP angioedema DOID_1558 1.027E-04 8.348E-03 0.01519588 0.21088921 LAIHO_COLORECTAL_CANCER_SERRATED_UP hypothyroidism DOID_1459 1.388E-04 9.869E-03 4.498E-03 0.08530351 LAIHO_COLORECTAL_CANCER_SERRATED_UP pancreatic ductal carcinoma DOID_3587 1.959E-04 0.0123829 1.959E-04 0.05572306 LAIHO_COLORECTAL_CANCER_SERRATED_UP open-angle glaucoma DOID_1067 2.069E-04 0.01177079 2.069E-04 0.03923596 LAIHO_COLORECTAL_CANCER_SERRATED_UP polycystic kidney disease DOID_898 2.069E-04 0.01070072 2.069E-04 0.02942697 LAIHO_COLORECTAL_CANCER_SERRATED_UP pancreatic carcinoma DOID_4905 2.207E-04 0.01046317 2.207E-04 0.02092634 LAIHO_COLORECTAL_CANCER_SERRATED_UP membranoproliferative glomerulonephritis DOID_2920 2.385E-04 0.01043717 2.385E-04 0.01938331 LAIHO_COLORECTAL_CANCER_SERRATED_UP adrenal cortex disease DOID_3952 2.385E-04 9.692E-03 0.02270849 0.21182184 LAIHO_COLORECTAL_CANCER_SERRATED_UP aneurysm disease DOID_2403 2.474E-04 9.385E-03 6.571E-03 0.10997411 LAIHO_COLORECTAL_CANCER_SERRATED_UP thyroiditis DOID_7166 2.723E-04 9.682E-03 0.02420424 0.21188021 LAIHO_COLORECTAL_CANCER_SERRATED_UP autoimmune thyroiditis DOID_7188 2.723E-04 9.682E-03 0.02420424 0.21188021 LAIHO_COLORECTAL_CANCER_SERRATED_UP adrenal gland disease DOID_9553 3.083E-04 0.01031744 0.02569774 0.21823903 LAIHO_COLORECTAL_CANCER_SERRATED_UP ureteral obstruction DOID_5199 3.464E-04 0.0109515 3.464E-04 0.02464088 LAIHO_COLORECTAL_CANCER_SERRATED_UP transitional cell carcinoma DOID_2671 3.632E-04 0.01087696 3.632E-04 0.02296247 LAIHO_COLORECTAL_CANCER_SERRATED_UP membranous glomerulonephritis DOID_10976 4.294E-04 0.01221586 0.03016477 0.24875009 LAIHO_COLORECTAL_CANCER_SERRATED_UP hypersensitivity reaction type I disease DOID_1205 4.524E-04 0.01225742 9.758E-03 0.13880254 LAIHO_COLORECTAL_CANCER_SERRATED_UP autoimmune hepatitis DOID_2048 4.741E-04 0.01226225 0.03164931 0.25011743 LAIHO_COLORECTAL_CANCER_SERRATED_UP ulcerative colitis DOID_8577 4.945E-04 0.01223415 4.945E-04 0.02813854 LAIHO_COLORECTAL_CANCER_SERRATED_UP urinary tract obstruction DOID_5200 5.701E-04 0.01351539 5.701E-04 0.02948812 LAIHO_COLORECTAL_CANCER_SERRATED_UP ureteral disease DOID_1426 6.213E-04 0.01414039 6.213E-04 0.02945915 LAIHO_COLORECTAL_CANCER_SERRATED_UP urticaria DOID_1555 7.301E-04 0.01597896 0.03903854 0.25828987 LAIHO_COLORECTAL_CANCER_SERRATED_UP myositis DOID_633 7.878E-04 0.01660179 0.04050972 0.26494289 LAIHO_COLORECTAL_CANCER_SERRATED_UP Sciatic Neuropathy DOID_11446 9.094E-04 0.01848103 9.094E-04 0.03980529 LAIHO_COLORECTAL_CANCER_SERRATED_UP lesion of sciatic nerve DOID_12528 9.094E-04 0.01848103 9.094E-04 0.03980529 LAIHO_COLORECTAL_CANCER_SERRATED_UP mononeuritis of lower limb DOID_9473 9.094E-04 0.01848103 9.094E-04 0.03980529 LAIHO_COLORECTAL_CANCER_SERRATED_UP mononeuritis DOID_1802 9.734E-04 0.01909953 9.734E-04 0.03956331 LAIHO_COLORECTAL_CANCER_SERRATED_UP autoimmune disease of the nervous system DOID_438 9.734E-04 0.01846288 9.734E-04 0.03692576 LAIHO_COLORECTAL_CANCER_SERRATED_UP autoimmune disease of endocrine system DOID_0060005 1.04E-03 0.01908077 0.04637235 0.28371901 LAIHO_COLORECTAL_CANCER_SERRATED_UP mononeuropathy DOID_1188 1.04E-03 0.0184845 1.04E-03 0.036969 LAIHO_COLORECTAL_CANCER_SERRATED_UP myocarditis DOID_820 1.402E-03 0.02416566 1.402E-03 0.04690981 LAIHO_COLORECTAL_CANCER_SERRATED_UP metal metabolism disorder DOID_896 1.402E-03 0.02345491 1.402E-03 0.04430371 LAIHO_COLORECTAL_CANCER_SERRATED_UP peptic ulcer DOID_750 1.904E-03 0.03095633 0.06231367 0.31377412 LAIHO_COLORECTAL_CANCER_SERRATED_UP nephrotic syndrome DOID_1184 2.28E-03 0.03603695 0.06804533 0.32535962 LAIHO_COLORECTAL_CANCER_SERRATED_UP Huntington's disease DOID_12858 2.28E-03 0.03506297 2.28E-03 0.06177762 LAIHO_COLORECTAL_CANCER_SERRATED_UP cataract DOID_83 2.48E-03 0.03713503 2.48E-03 0.06414233 LAIHO_COLORECTAL_CANCER_SERRATED_UP lens disease DOID_110 2.688E-03 0.03921734 2.688E-03 0.06372817 LAIHO_COLORECTAL_CANCER_SERRATED_UP neuritis DOID_1803 2.688E-03 0.0382369 2.688E-03 0.06117905 LAIHO_COLORECTAL_CANCER_SERRATED_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.904E-03 0.0403009 0.07657833 0.34309505 LAIHO_COLORECTAL_CANCER_SERRATED_UP glaucoma DOID_1686 2.904E-03 0.03934136 2.904E-03 0.06119767 LAIHO_COLORECTAL_CANCER_SERRATED_UP aortic aneurysm DOID_3627 3.015E-03 0.03989424 0.07799302 0.34670333 LAIHO_COLORECTAL_CANCER_SERRATED_UP B-cell lymphocytic neoplasm DOID_707 3.128E-03 0.04044742 3.128E-03 0.06356022 LAIHO_COLORECTAL_CANCER_SERRATED_UP giant cell tumor DOID_200 3.359E-03 0.04247769 0.0822243 0.35988942 LAIHO_COLORECTAL_CANCER_SERRATED_UP malignant giant cell tumor DOID_2705 3.359E-03 0.04247769 0.0822243 0.35988942 LAIHO_COLORECTAL_CANCER_SERRATED_UP giant cell glioblastoma DOID_3074 3.359E-03 0.04247769 0.0822243 0.35988942 LAIHO_COLORECTAL_CANCER_SERRATED_UP atrophic muscular disease DOID_913 3.359E-03 0.04155426 3.359E-03 0.06591366 LAIHO_COLORECTAL_CANCER_SERRATED_UP muscular dystrophy DOID_9884 3.359E-03 0.04155426 3.359E-03 0.06591366 LAIHO_COLORECTAL_CANCER_SERRATED_UP glioblastoma DOID_3068 3.973E-03 0.04809267 0.08923406 0.37061445 LAIHO_COLORECTAL_CANCER_SERRATED_UP leukocyte disease DOID_9500 4.101E-03 0.0486128 0.09062968 0.3709949 LAIHO_COLORECTAL_CANCER_SERRATED_UP parasitic infectious disease DOID_1398 4.911E-03 0.05703052 0.09895941 0.39376156 LAIHO_COLORECTAL_CANCER_SERRATED_UP hyperglycemia DOID_4195 5.053E-03 0.05750197 5.053E-03 0.09274512 LAIHO_COLORECTAL_CANCER_SERRATED_UP endocrine organ benign neoplasm DOID_0060089 5.342E-03 0.05959793 0.10309611 0.40456334 LAIHO_COLORECTAL_CANCER_SERRATED_UP astrocytoma DOID_3069 5.489E-03 0.06006309 0.10447085 0.40438037 LAIHO_COLORECTAL_CANCER_SERRATED_UP nephrosis DOID_2527 5.789E-03 0.06215118 0.10721414 0.40942848 LAIHO_COLORECTAL_CANCER_SERRATED_UP bile duct disease DOID_4138 5.789E-03 0.06100023 5.789E-03 0.10293789 LAIHO_COLORECTAL_CANCER_SERRATED_UP biliary tract disease DOID_9741 5.942E-03 0.06147185 5.942E-03 0.10245308 LAIHO_COLORECTAL_CANCER_SERRATED_UP electroclinical syndrome DOID_0050701 6.733E-03 0.06841515 6.733E-03 0.10946424 LAIHO_COLORECTAL_CANCER_SERRATED_UP mixed glioma DOID_5076 6.733E-03 0.06721488 6.733E-03 0.10642357 LAIHO_COLORECTAL_CANCER_SERRATED_UP biliary tract cancer DOID_4607 7.57E-03 0.07426289 7.57E-03 0.1164121 LAIHO_COLORECTAL_CANCER_SERRATED_UP bone development disease DOID_0080006 7.743E-03 0.07466943 7.743E-03 0.11593411 LAIHO_COLORECTAL_CANCER_SERRATED_UP lymphoma DOID_0060058 9.187E-03 0.08712548 9.187E-03 0.1340392 LAIHO_COLORECTAL_CANCER_SERRATED_UP encephalomyelitis DOID_640 9.376E-03 0.08745476 0.13552462 0.48806019 LINDSTEDT_DENDRITIC_CELL_MATURATION_C opportunistic mycosis DOID_2473 4.251E-08 2.419E-05 0.03425117 0.4146578 LINDSTEDT_DENDRITIC_CELL_MATURATION_C chronic leukemia DOID_1036 5.431E-08 1.545E-05 6.318E-04 0.05991185 LINDSTEDT_DENDRITIC_CELL_MATURATION_C chronic lymphocytic leukemia DOID_1040 5.431E-08 1.545E-05 6.318E-04 0.05991185 LINDSTEDT_DENDRITIC_CELL_MATURATION_C lymphoblastic leukemia DOID_1037 5.453E-08 1.034E-05 4.555E-03 0.16199417 LINDSTEDT_DENDRITIC_CELL_MATURATION_C systemic mycosis DOID_0050136 6.105E-08 8.685E-06 0.03730758 0.44225025 LINDSTEDT_DENDRITIC_CELL_MATURATION_C fungal infectious disease DOID_1564 6.105E-08 8.685E-06 0.03730758 0.44225025 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bone resorption disease DOID_0080011 1.507E-06 1.715E-04 1.507E-06 8.576E-04 LINDSTEDT_DENDRITIC_CELL_MATURATION_C osteoporosis DOID_11476 1.507E-06 1.715E-04 1.507E-06 8.576E-04 LINDSTEDT_DENDRITIC_CELL_MATURATION_C primary bacterial infectious disease DOID_0050338 2.431E-06 2.305E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bronchiolitis DOID_2942 2.782E-06 2.261E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C encephalomyelitis DOID_640 3.155E-06 2.244E-04 0.09553555 0.6969196 LINDSTEDT_DENDRITIC_CELL_MATURATION_C myocarditis DOID_820 7.583E-06 4.794E-04 6.685E-04 0.05433752 LINDSTEDT_DENDRITIC_CELL_MATURATION_C systemic scleroderma DOID_418 1.214E-05 6.907E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C rheumatic disease DOID_1575 1.6E-05 8.279E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C scleroderma DOID_419 1.6E-05 8.279E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C sarcoidosis DOID_11335 2.901E-05 1.376E-03 0.05744395 0.52718723 LINDSTEDT_DENDRITIC_CELL_MATURATION_C hypersensitivity reaction type IV disease DOID_2916 3.753E-05 1.643E-03 0.06241352 0.55489523 LINDSTEDT_DENDRITIC_CELL_MATURATION_C collagen disease DOID_854 4.335E-05 1.762E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C Paget's disease of bone DOID_5408 4.858E-05 1.843E-03 4.858E-05 0.01382224 LINDSTEDT_DENDRITIC_CELL_MATURATION_C mineral metabolism disease DOID_0050032 4.974E-05 1.769E-03 2.298E-03 0.10896655 LINDSTEDT_DENDRITIC_CELL_MATURATION_C brain infarction DOID_3454 5.917E-05 1.98E-03 2.576E-03 0.10469544 LINDSTEDT_DENDRITIC_CELL_MATURATION_C tuberculosis DOID_399 5.917E-05 1.87E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C invasive lobular carcinoma DOID_3457 5.934E-05 1.777E-03 5.934E-05 0.01125504 LINDSTEDT_DENDRITIC_CELL_MATURATION_C pancreatic ductal carcinoma DOID_3587 6.429E-05 1.829E-03 0.0742365 0.6211848 LINDSTEDT_DENDRITIC_CELL_MATURATION_C pancreatic carcinoma DOID_4905 7.251E-05 1.965E-03 0.07716945 0.63636838 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bacterial pneumonia DOID_874 8.45E-05 2.185E-03 0.08106597 0.62333157 LINDSTEDT_DENDRITIC_CELL_MATURATION_C contact dermatitis DOID_2773 9.095E-05 2.25E-03 9.095E-05 0.01293717 LINDSTEDT_DENDRITIC_CELL_MATURATION_C transitional cell carcinoma DOID_2671 1.199E-04 2.844E-03 4.1E-03 0.15550785 LINDSTEDT_DENDRITIC_CELL_MATURATION_C hyperostosis DOID_205 1.461E-04 3.326E-03 1.461E-04 0.01663159 LINDSTEDT_DENDRITIC_CELL_MATURATION_C prion disease DOID_649 1.643E-04 3.596E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C myasthenia gravis DOID_437 2.708E-04 5.707E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C neuromuscular junction disease DOID_439 3.747E-04 7.614E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C middle cerebral artery infarction DOID_3525 4.032E-04 7.912E-03 0.02913612 0.42508857 LINDSTEDT_DENDRITIC_CELL_MATURATION_C autoimmune disease of the nervous system DOID_438 4.634E-04 8.789E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C corneal disease DOID_10124 5.277E-04 9.686E-03 0.03323027 0.41104397 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bronchiolitis obliterans DOID_2799 5.614E-04 9.982E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C pulmonary sarcoidosis DOID_13406 8.254E-04 0.01423244 0.04136812 0.47076921 LINDSTEDT_DENDRITIC_CELL_MATURATION_C multiple myeloma DOID_9538 8.254E-04 0.01381384 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C intracranial arterial disease DOID_13089 9.537E-04 0.01550421 0.04440256 0.47669922 LINDSTEDT_DENDRITIC_CELL_MATURATION_C cerebral arterial disease DOID_3527 9.537E-04 0.01550421 0.04440256 0.47669922 LINDSTEDT_DENDRITIC_CELL_MATURATION_C cervix uteri carcinoma in situ DOID_8991 9.984E-04 0.0157808 0.04541196 0.47850752 LINDSTEDT_DENDRITIC_CELL_MATURATION_C diabetic autonomic neuropathy DOID_11503 1.139E-03 0.01751039 1.139E-03 0.08098554 LINDSTEDT_DENDRITIC_CELL_MATURATION_C autonomic neuropathy DOID_11504 1.139E-03 0.01751039 1.139E-03 0.08098554 LINDSTEDT_DENDRITIC_CELL_MATURATION_C diabetic polyneuropathy DOID_12785 1.139E-03 0.01751039 1.139E-03 0.08098554 LINDSTEDT_DENDRITIC_CELL_MATURATION_C gallbladder cancer DOID_3121 1.139E-03 0.01704959 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C diabetic neuropathy DOID_9743 1.139E-03 0.01751039 1.139E-03 0.08098554 LINDSTEDT_DENDRITIC_CELL_MATURATION_C cerebral infarction DOID_3526 1.187E-03 0.01732315 0.04943917 0.51147068 LINDSTEDT_DENDRITIC_CELL_MATURATION_C myeloma DOID_0070004 1.288E-03 0.01831806 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C autonomic nervous system disease DOID_11465 1.288E-03 0.01787128 1.288E-03 0.0814136 LINDSTEDT_DENDRITIC_CELL_MATURATION_C pulmonary tuberculosis DOID_2957 1.392E-03 0.01885901 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C calcium metabolism disease DOID_10575 1.446E-03 0.01913004 1.446E-03 0.08225918 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bile duct adenocarcinoma DOID_4896 1.67E-03 0.02159524 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C cholangiocarcinoma DOID_4947 1.67E-03 0.02159524 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bone marrow cancer DOID_4960 1.67E-03 0.02111534 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C hypertrophic cardiomyopathy DOID_11984 1.91E-03 0.02362186 1.91E-03 0.0987823 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bile duct cancer DOID_4606 1.91E-03 0.02311926 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C bile duct carcinoma DOID_4897 1.91E-03 0.02311926 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C pre-malignant neoplasm DOID_0060071 2.231E-03 0.02644605 0.06735755 0.58070369 LINDSTEDT_DENDRITIC_CELL_MATURATION_C in situ carcinoma DOID_8719 2.231E-03 0.02644605 0.06735755 0.58070369 LINDSTEDT_DENDRITIC_CELL_MATURATION_C allergic contact dermatitis DOID_3042 2.505E-03 0.02908972 2.505E-03 0.10964586 LINDSTEDT_DENDRITIC_CELL_MATURATION_C mixed glioma DOID_5076 3.256E-03 0.03705492 0.08106597 0.63187036 LINDSTEDT_DENDRITIC_CELL_MATURATION_C biliary tract cancer DOID_4607 3.666E-03 0.0409056 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C alcohol-related neurodevelopmental disorder DOID_0050667 4.649E-03 0.05087106 4.649E-03 0.15560561 LINDSTEDT_DENDRITIC_CELL_MATURATION_C hypersensitivity reaction type I disease DOID_1205 4.744E-03 0.05092815 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_C ulcerative colitis DOID_8577 5.033E-03 0.0530355 0.1003092 0.72248016 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN myeloma DOID_0070004 4.578E-07 2.605E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN bone marrow cancer DOID_4960 7.803E-07 2.22E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN neuroectodermal tumor DOID_171 1.247E-06 2.365E-04 0.07638414 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN biliary tract cancer DOID_4607 3.899E-06 5.547E-04 5.03E-03 0.71550608 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN cleft lip DOID_9296 5.115E-06 5.821E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN sarcoma DOID_1115 7.082E-06 6.716E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN female reproductive organ benign neoplasm DOID_0060086 8.636E-06 7.02E-04 0.03893451 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN uterine benign neoplasm DOID_0060095 8.636E-06 7.02E-04 0.03893451 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN uterine fibroid DOID_13223 8.636E-06 7.02E-04 0.03893451 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN leiomyoma DOID_127 1.137E-05 8.084E-04 0.04250762 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN autonomic nervous system neoplasm DOID_2621 1.137E-05 7.186E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN neuroblastoma DOID_769 1.137E-05 7.186E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN cleft palate DOID_674 1.708E-05 9.721E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN peripheral nervous system neoplasm DOID_1192 1.842E-05 9.526E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN benign mesothelioma DOID_2645 2.282E-05 1.082E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN diabetic autonomic neuropathy DOID_11503 2.787E-05 1.22E-03 0.05667048 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN autonomic neuropathy DOID_11504 2.787E-05 1.22E-03 0.05667048 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN diabetic polyneuropathy DOID_12785 2.787E-05 1.22E-03 0.05667048 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN gallbladder cancer DOID_3121 2.787E-05 1.133E-03 0.05667048 0.97713648 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN diabetic neuropathy DOID_9743 2.787E-05 1.22E-03 0.05667048 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN autonomic nervous system disease DOID_11465 3.36E-05 1.274E-03 0.06017904 0.97833919 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN orofacial cleft DOID_0050567 4.478E-05 1.592E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN bile duct adenocarcinoma DOID_4896 4.985E-05 1.669E-03 0.06831607 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN cholangiocarcinoma DOID_4947 4.985E-05 1.669E-03 0.06831607 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN reproductive organ benign neoplasm DOID_0050622 5.252E-05 1.66E-03 0.06947286 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN bile duct cancer DOID_4606 6.11E-05 1.83E-03 0.07293481 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN bile duct carcinoma DOID_4897 6.11E-05 1.83E-03 0.07293481 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN pancreatic ductal carcinoma DOID_3587 1.045E-04 2.973E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN pancreatic carcinoma DOID_4905 1.178E-04 3.192E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN mixed glioma DOID_5076 1.372E-04 3.549E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN mesenchymal cell neoplasm DOID_3350 1.563E-04 3.868E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN spindle cell sarcoma DOID_4235 1.563E-04 3.868E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN oral submucous fibrosis DOID_5773 1.563E-04 3.706E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN epithelioid sarcoma DOID_6193 1.563E-04 3.868E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN chronic myeloid leukemia DOID_8552 1.785E-04 4.063E-03 0.01965641 0.74563318 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN nervous system cancer DOID_3093 2.075E-04 4.542E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN lymphoma DOID_0060058 2.212E-04 4.661E-03 0.11019394 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN neuroendocrine tumor DOID_169 2.273E-04 4.618E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN mouth disease DOID_403 2.353E-04 4.617E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN periodontitis DOID_824 5.978E-04 0.01133914 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN periodontal disease DOID_3388 9.745E-04 0.01788726 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN spindle cell carcinoma DOID_4015 9.745E-04 0.01732829 0.04488246 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN medullomyoblastoma DOID_3861 1.028E-03 0.0177227 0.04606772 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN adult medulloblastoma DOID_3864 1.028E-03 0.0177227 0.04606772 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN childhood medulloblastoma DOID_3869 1.028E-03 0.0177227 0.04606772 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN medulloblastoma DOID_3858 1.139E-03 0.01905542 0.04843392 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN multiple myeloma DOID_9538 1.139E-03 0.01851098 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN hepatitis DOID_2237 1.255E-03 0.01983435 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN primitive neuroectodermal tumor DOID_168 1.504E-03 0.02312519 0.05549812 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN cataract DOID_83 1.636E-03 0.02450117 1.636E-03 0.93104462 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN lens disease DOID_110 1.774E-03 0.02588498 1.774E-03 0.50475705 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN lung small cell carcinoma DOID_5409 1.917E-03 0.02727563 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN giant cell tumor DOID_200 2.22E-03 0.03080765 0.06715787 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN malignant giant cell tumor DOID_2705 2.22E-03 0.03080765 0.06715787 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN giant cell glioblastoma DOID_3074 2.22E-03 0.03080765 0.06715787 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN hypertrophic cardiomyopathy DOID_11984 2.628E-03 0.03559689 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN glioblastoma DOID_3068 2.628E-03 0.03476906 0.07293481 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN melancholia DOID_2848 2.713E-03 0.03508382 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN neurotic disorder DOID_4964 2.8E-03 0.03540101 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN pre-malignant neoplasm DOID_0060071 3.068E-03 0.03794626 3.068E-03 0.58184268 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN in situ carcinoma DOID_8719 3.068E-03 0.03794626 3.068E-03 0.58184268 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN tooth disease DOID_1091 3.443E-03 0.04168221 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN allergic contact dermatitis DOID_3042 3.443E-03 0.04081383 0.08324517 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN brain infarction DOID_3454 3.54E-03 0.04110738 0.08438382 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN astrocytoma DOID_3069 3.638E-03 0.04140363 0.08552108 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN nephrosis DOID_2527 3.839E-03 0.04282706 0.08779146 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN biliary tract disease DOID_9741 3.941E-03 0.04312028 0.08892458 0.99211928 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN endogenous depression DOID_1595 4.254E-03 0.04567474 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN pancreatitis DOID_4989 4.47E-03 0.04709844 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN contact dermatitis DOID_2773 4.69E-03 0.04852171 0.09681792 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN mental depression DOID_1596 5.03E-03 0.05110758 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN transitional cell carcinoma DOID_2671 5.621E-03 0.05610808 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN lymphoblastic leukemia DOID_1037 6.242E-03 0.06123285 0.11129981 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN integumentary system cancer DOID_0060122 3.506E-09 1.995E-06 3.625E-06 6.876E-04 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN skin cancer DOID_4159 3.506E-09 1.995E-06 3.625E-06 6.876E-04 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN allergic contact dermatitis DOID_3042 1.343E-08 3.822E-06 3.839E-07 2.185E-04 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN contact dermatitis DOID_2773 4.093E-08 7.764E-06 9.859E-07 2.805E-04 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN epidermolysis bullosa DOID_2730 1.168E-07 1.661E-05 1.327E-05 1.888E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN vesiculobullous skin disease DOID_2731 1.681E-07 1.914E-05 1.72E-05 1.958E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN integumentary system benign neoplasm DOID_0060121 2.096E-06 1.988E-04 1.186E-03 0.0293516 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN skin benign neoplasm DOID_3165 2.096E-06 1.988E-04 1.186E-03 0.0293516 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN hypertrophic cardiomyopathy DOID_11984 4.662E-06 3.789E-04 1.882E-03 0.03570053 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN invasive ductal carcinoma DOID_3008 6.114E-06 4.348E-04 2.324E-04 8.264E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN nephrosis DOID_2527 1.211E-05 7.655E-04 3.265E-03 0.04531066 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN relapsing-remitting multiple sclerosis DOID_2378 1.327E-05 7.552E-04 1.013E-03 0.02620618 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN nephroblastoma DOID_2154 1.442E-05 7.458E-04 4.358E-04 0.01377462 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN congenital ichthyosiform erythroderma DOID_1699 2.721E-05 1.29E-03 2.721E-05 2.58E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN transitional cell carcinoma DOID_2671 3.139E-05 1.374E-03 3.139E-05 2.551E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN keratosis DOID_161 4.837E-05 1.966E-03 4.837E-05 3.441E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN giant cell tumor DOID_200 7.561E-05 2.868E-03 1.471E-03 0.03099907 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN malignant giant cell tumor DOID_2705 7.561E-05 2.868E-03 1.471E-03 0.03099907 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN giant cell glioblastoma DOID_3074 7.561E-05 2.868E-03 1.471E-03 0.03099907 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN glioblastoma DOID_3068 1.058E-04 3.762E-03 1.882E-03 0.0345489 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN toxic shock syndrome DOID_14115 1.336E-04 4.471E-03 1.336E-04 8.445E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN hypothyroidism DOID_1459 1.355E-04 4.285E-03 1.355E-04 7.713E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN pre-malignant neoplasm DOID_0060071 1.438E-04 4.308E-03 1.438E-04 7.441E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN in situ carcinoma DOID_8719 1.438E-04 4.308E-03 1.438E-04 7.441E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN commensal bacterial infectious disease DOID_0050339 1.506E-04 4.284E-03 1.506E-04 7.139E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN autosomal dominant nonsyndromic deafness DOID_0050564 1.689E-04 4.576E-03 1.689E-04 7.392E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN hyperglycemia DOID_4195 1.71E-04 4.422E-03 0.03106859 0.24216477 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN vitiligo DOID_12306 1.886E-04 4.666E-03 1.886E-04 7.666E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN astrocytoma DOID_3069 2.016E-04 4.779E-03 3.021E-03 0.04297751 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN renal hypertension DOID_1073 2.324E-04 5.289E-03 2.324E-04 8.815E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN secondary hypertension DOID_11130 2.324E-04 5.289E-03 2.324E-04 8.815E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN auditory system disease DOID_2742 3.643E-04 7.973E-03 4.662E-03 0.05895138 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN leiomyoma DOID_127 3.692E-04 7.781E-03 3.692E-04 0.01235732 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN chronic kidney failure DOID_784 3.811E-04 7.745E-03 4.819E-03 0.05960722 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN thyroid cancer DOID_1781 5.095E-04 9.998E-03 0.01060335 0.10969644 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN Human immunodeficiency virus infectious disease DOID_526 5.148E-04 9.763E-03 5.148E-04 0.01541546 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN arrhythmogenic right ventricular dysplasia DOID_0050431 5.57E-04 0.01022429 5.57E-04 0.01584765 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN childhood type dermatomyositis DOID_14203 6.945E-04 0.01234861 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN keratitis DOID_4677 6.945E-04 0.01197441 0.03912832 0.27830019 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN dermatomyositis DOID_10223 8.466E-04 0.01416781 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN cerebral infarction DOID_3526 9.394E-04 0.01527204 0.01576922 0.1470932 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN osteopetrosis DOID_13533 1.013E-03 0.01601489 1.013E-03 0.0274541 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN impotence DOID_1875 1.194E-03 0.01836705 1.194E-03 0.02831587 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN withdrawal disorder DOID_0060001 1.324E-03 0.01982353 1.324E-03 0.03013176 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN atopic dermatitis DOID_3310 1.396E-03 0.02037029 1.396E-03 0.03055544 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN renovascular hypertension DOID_1591 1.599E-03 0.02275124 1.599E-03 0.03250177 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN varicose veins DOID_799 1.599E-03 0.02219633 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN vein disease DOID_866 1.823E-03 0.02469863 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN nonsyndromic deafness DOID_0050563 1.882E-03 0.02490735 1.882E-03 0.03693159 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN oral cavity cancer DOID_8618 1.882E-03 0.02434127 1.882E-03 0.03346925 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN penile disease DOID_1529 2.061E-03 0.0260575 2.061E-03 0.03553295 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN basal cell carcinoma DOID_2513 2.061E-03 0.02549103 2.061E-03 0.03448787 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN urinary system benign neoplasm DOID_731 2.061E-03 0.02494867 0.06560944 0.3274717 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN sexual dysfunction DOID_1876 2.312E-03 0.02741084 2.312E-03 0.03759201 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN skin carcinoma DOID_3451 2.312E-03 0.02685144 2.312E-03 0.03654779 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN osteosclerosis DOID_4254 2.312E-03 0.02631441 2.312E-03 0.03556001 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN prion disease DOID_649 2.312E-03 0.02579844 2.312E-03 0.03462422 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN eosinophilia DOID_999 2.312E-03 0.02530231 2.312E-03 0.03373642 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN uterine disease DOID_345 2.568E-03 0.02757385 0.23786096 0.66344552 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN dissociative disorder DOID_10935 2.578E-03 0.02716068 0.07304142 0.35828078 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN dissociative amnesia DOID_11037 2.578E-03 0.02716068 0.07304142 0.35828078 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN amnestic disorder DOID_10914 2.857E-03 0.02955261 0.07673536 0.36385351 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN brain infarction DOID_3454 2.904E-03 0.02950447 0.03274082 0.25175036 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN tuberculosis DOID_399 2.904E-03 0.02898685 0.03274082 0.24839368 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN male reproductive system disease DOID_48 3.265E-03 0.03202995 0.03531384 0.26438911 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN funisitis DOID_0050698 3.455E-03 0.03331954 3.455E-03 0.04680602 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN gastric ulcer DOID_10808 3.455E-03 0.03276421 3.455E-03 0.04571751 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN placenta disease DOID_780 3.455E-03 0.0322271 0.08407943 0.38272956 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN sexual disorder DOID_0060043 3.774E-03 0.03463662 3.774E-03 0.04880614 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN bone resorption disease DOID_0080011 3.926E-03 0.03545562 0.0397693 0.27596015 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN osteoporosis DOID_11476 3.926E-03 0.03545562 0.0397693 0.27596015 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN sphingolipidosis DOID_1927 4.452E-03 0.03958077 0.09498686 0.41575017 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN female reproductive system disease DOID_229 4.509E-03 0.03946881 0.28223257 0.74693177 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN myositis DOID_633 5.182E-03 0.04467287 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN cleft lip DOID_9296 5.182E-03 0.04400611 5.182E-03 0.06273211 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN primary bacterial infectious disease DOID_0050338 5.477E-03 0.04582962 0.04927182 0.30473547 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN seminoma DOID_4440 5.566E-03 0.04589789 5.566E-03 0.06597822 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN lung adenocarcinoma DOID_3910 5.963E-03 0.04846718 5.963E-03 0.06923883 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN perinatal necrotizing enterocolitis DOID_8677 5.963E-03 0.04778455 5.963E-03 0.06785405 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN malaria DOID_12365 6.372E-03 0.05035547 0.11287989 0.45877612 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN Crohn's disease DOID_8778 6.753E-03 0.05263714 6.753E-03 0.07534336 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN dilated cardiomyopathy DOID_12930 6.949E-03 0.05342879 0.32132688 0.82358106 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN female reproductive organ benign neoplasm DOID_0060086 7.228E-03 0.05483421 7.228E-03 0.0790878 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN uterine benign neoplasm DOID_0060095 7.228E-03 0.05483421 7.228E-03 0.0790878 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN corneal disease DOID_10124 7.228E-03 0.05411271 0.1199383 0.46425099 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN uterine fibroid DOID_13223 7.228E-03 0.05483421 7.228E-03 0.0790878 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN age related macular degeneration DOID_10871 7.674E-03 0.05670816 0.12344656 0.47141674 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN degeneration of macula and posterior pole DOID_2007 7.674E-03 0.05670816 0.12344656 0.47141674 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN abdominal aortic aneurysm DOID_7693 7.674E-03 0.05598113 0.12344656 0.46517281 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN germinoma DOID_3304 8.133E-03 0.05857465 8.133E-03 0.08730938 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN allergic rhinitis DOID_4481 8.133E-03 0.05784246 0.12694093 0.4720875 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN thyroid carcinoma DOID_3963 9.58E-03 0.06729455 0.13734121 0.49149151 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN spindle cell carcinoma DOID_4015 9.58E-03 0.06647389 0.13734121 0.48841968 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN macular degeneration DOID_4448 9.58E-03 0.065673 0.13734121 0.48538602 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.01060335 0.07182505 0.01060335 0.11172785 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN embryonal cancer DOID_688 0.01113251 0.07452232 0.01113251 0.11311424 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN peptic ulcer DOID_750 0.01222503 0.08088424 0.01222503 0.12203587 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN adenoid cystic carcinoma DOID_4866 0.0127882 0.08363778 0.0127882 0.12545667 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN salivary gland cancer DOID_8850 0.01394786 0.09018559 0.01394786 0.1345141 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN nephrotic syndrome DOID_1184 0.01454416 0.09298456 0.16780934 0.54875583 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN uterine cancer DOID_363 0.01515131 0.09578994 0.01515131 0.14368492 DOANE_BREAST_CANCER_ESR1_DN oral cavity cancer DOID_8618 1.443E-11 8.209E-09 2.091E-09 1.19E-06 DOANE_BREAST_CANCER_ESR1_DN adenoid cystic carcinoma DOID_4866 5.73E-08 1.63E-05 5.73E-08 1.63E-05 DOANE_BREAST_CANCER_ESR1_DN salivary gland cancer DOID_8850 6.909E-08 1.31E-05 6.909E-08 1.31E-05 DOANE_BREAST_CANCER_ESR1_DN benign mesothelioma DOID_2645 7.766E-06 1.105E-03 6.794E-04 0.07731103 DOANE_BREAST_CANCER_ESR1_DN uveal disease DOID_3480 8.891E-06 1.012E-03 7.425E-04 0.07041039 DOANE_BREAST_CANCER_ESR1_DN amino acid metabolic disorder DOID_9252 6.928E-05 6.57E-03 2.867E-03 0.11650665 DOANE_BREAST_CANCER_ESR1_DN tongue cancer DOID_8649 8.75E-05 7.113E-03 0.01383952 0.26248958 DOANE_BREAST_CANCER_ESR1_DN esophagitis DOID_11963 1.382E-04 9.832E-03 0.01727027 0.2655888 DOANE_BREAST_CANCER_ESR1_DN lung adenocarcinoma DOID_3910 2.94E-04 0.01858448 0.02494721 0.33011534 DOANE_BREAST_CANCER_ESR1_DN multiple epiphyseal dysplasia DOID_12721 3.363E-04 0.01913581 3.363E-04 0.04783952 DOANE_BREAST_CANCER_ESR1_DN spindle cell carcinoma DOID_4015 4.801E-04 0.02483457 0.0317223 0.32232122 DOANE_BREAST_CANCER_ESR1_DN esophageal disease DOID_6050 4.801E-04 0.02276502 0.0317223 0.31666646 DOANE_BREAST_CANCER_ESR1_DN uveitis DOID_13141 5.898E-04 0.02581665 0.03509271 0.33279582 DOANE_BREAST_CANCER_ESR1_DN giant cell tumor DOID_200 1.099E-03 0.04465578 1.099E-03 0.08931156 DOANE_BREAST_CANCER_ESR1_DN malignant giant cell tumor DOID_2705 1.099E-03 0.04465578 1.099E-03 0.08931156 DOANE_BREAST_CANCER_ESR1_DN giant cell glioblastoma DOID_3074 1.099E-03 0.04465578 1.099E-03 0.08931156 DOANE_BREAST_CANCER_ESR1_DN integumentary system cancer DOID_0060122 1.178E-03 0.04468834 0.04929045 0.36902981 DOANE_BREAST_CANCER_ESR1_DN osteochondrodysplasia DOID_2256 1.178E-03 0.04189532 1.178E-03 0.08379063 DOANE_BREAST_CANCER_ESR1_DN skin cancer DOID_4159 1.178E-03 0.04468834 0.04929045 0.36902981 DOANE_BREAST_CANCER_ESR1_DN glioblastoma DOID_3068 1.302E-03 0.04358191 1.302E-03 0.08232139 DOANE_BREAST_CANCER_ESR1_DN bile duct cancer DOID_4606 1.302E-03 0.04116069 1.302E-03 0.07408925 DOANE_BREAST_CANCER_ESR1_DN bile duct carcinoma DOID_4897 1.302E-03 0.04116069 1.302E-03 0.07408925 DOANE_BREAST_CANCER_ESR1_DN astrocytoma DOID_3069 1.808E-03 0.05413952 1.808E-03 0.09351371 DOANE_BREAST_CANCER_ESR1_DN biliary tract cancer DOID_4607 2.507E-03 0.07133096 2.507E-03 0.11888493 DOANE_BREAST_CANCER_ESR1_DN bone development disease DOID_0080006 2.566E-03 0.06951397 2.566E-03 0.11229179 DOANE_BREAST_CANCER_ESR1_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.183E-03 0.08233569 0.08029793 0.45689521 DOANE_BREAST_CANCER_ESR1_DN dilated cardiomyopathy DOID_12930 3.249E-03 0.08037026 0.08110052 0.45689305 ONDER_CDH1_TARGETS_1_UP uterine disease DOID_345 1.526E-07 8.685E-05 7.069E-06 1.341E-03 ONDER_CDH1_TARGETS_1_UP female reproductive system disease DOID_229 4.164E-07 1.185E-04 1.563E-05 1.779E-03 ONDER_CDH1_TARGETS_1_UP endometriosis of uterus DOID_288 1.334E-06 2.53E-04 1.334E-06 7.591E-04 ONDER_CDH1_TARGETS_1_UP endometriosis DOID_289 1.459E-06 2.076E-04 1.459E-06 4.151E-04 ONDER_CDH1_TARGETS_1_UP glaucoma DOID_1686 2.401E-06 2.733E-04 1.145E-04 7.241E-03 ONDER_CDH1_TARGETS_1_UP bile duct cancer DOID_4606 4.573E-06 4.336E-04 0.10380677 0.42801486 ONDER_CDH1_TARGETS_1_UP bile duct carcinoma DOID_4897 4.573E-06 4.336E-04 0.10380677 0.42801486 ONDER_CDH1_TARGETS_1_UP brain infarction DOID_3454 8.4E-06 6.828E-04 2.891E-04 0.01495274 ONDER_CDH1_TARGETS_1_UP pancreatitis DOID_4989 1.351E-05 9.607E-04 1.351E-05 1.921E-03 ONDER_CDH1_TARGETS_1_UP morbid obesity DOID_11981 1.565E-05 9.896E-04 1.565E-05 1.484E-03 ONDER_CDH1_TARGETS_1_UP biliary tract cancer DOID_4607 1.718E-05 9.774E-04 0.14167177 0.49153195 ONDER_CDH1_TARGETS_1_UP chronic kidney failure DOID_784 1.718E-05 8.885E-04 0.01028225 0.21668886 ONDER_CDH1_TARGETS_1_UP amino acid metabolic disorder DOID_9252 2.249E-05 1.066E-03 2.249E-05 1.828E-03 ONDER_CDH1_TARGETS_1_UP dilated cardiomyopathy DOID_12930 2.892E-05 1.266E-03 0.01322662 0.22805894 ONDER_CDH1_TARGETS_1_UP adenoma DOID_657 4.816E-05 1.957E-03 0.06765398 0.36662015 ONDER_CDH1_TARGETS_1_UP benign mesothelioma DOID_2645 6.934E-05 2.63E-03 0.07599465 0.37930665 ONDER_CDH1_TARGETS_1_UP pulmonary emphysema DOID_9675 6.934E-05 2.466E-03 2.856E-03 0.10835481 ONDER_CDH1_TARGETS_1_UP hyperinsulinism DOID_2018 7.928E-05 2.653E-03 7.928E-05 5.638E-03 ONDER_CDH1_TARGETS_1_UP cerebral infarction DOID_3526 9.009E-05 2.848E-03 3.39E-03 0.12056773 ONDER_CDH1_TARGETS_1_UP proteinuria DOID_576 9.585E-05 2.87E-03 0.0842618 0.39954137 ONDER_CDH1_TARGETS_1_UP rectal neoplasm DOID_1984 1.413E-04 4.021E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_UP rectum cancer DOID_1993 1.413E-04 4.021E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_UP bile duct adenocarcinoma DOID_4896 1.507E-04 4.082E-03 0.09733789 0.42934309 ONDER_CDH1_TARGETS_1_UP cholangiocarcinoma DOID_4947 1.507E-04 4.082E-03 0.09733789 0.42934309 ONDER_CDH1_TARGETS_1_UP familial hyperlipidemia DOID_1168 1.67E-04 4.318E-03 0.10057806 0.43355239 ONDER_CDH1_TARGETS_1_UP pituitary cancer DOID_1785 2.068E-04 5.116E-03 0.02131608 0.28206631 ONDER_CDH1_TARGETS_1_UP pituitary carcinoma DOID_4916 2.068E-04 5.116E-03 0.02131608 0.28206631 ONDER_CDH1_TARGETS_1_UP aortic valve insufficiency DOID_57 2.068E-04 4.903E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_UP endocrine pancreas disease DOID_1428 2.435E-04 5.543E-03 2.435E-04 0.01385689 ONDER_CDH1_TARGETS_1_UP endocrine organ benign neoplasm DOID_0060089 2.891E-04 6.326E-03 7.273E-03 0.18811747 ONDER_CDH1_TARGETS_1_UP bile duct disease DOID_4138 3.266E-04 6.883E-03 7.878E-03 0.1949048 ONDER_CDH1_TARGETS_1_UP biliary tract disease DOID_9741 3.398E-04 6.905E-03 8.085E-03 0.19168043 ONDER_CDH1_TARGETS_1_UP pituitary adenoma DOID_3829 3.743E-04 7.344E-03 0.02832146 0.30990217 ONDER_CDH1_TARGETS_1_UP chronic myeloid leukemia DOID_8552 3.743E-04 7.099E-03 3.743E-04 0.01774686 ONDER_CDH1_TARGETS_1_UP bone resorption disease DOID_0080011 3.959E-04 7.266E-03 8.935E-03 0.20336648 ONDER_CDH1_TARGETS_1_UP osteoporosis DOID_11476 3.959E-04 7.266E-03 8.935E-03 0.20336648 ONDER_CDH1_TARGETS_1_UP lipid metabolism disorder DOID_3146 4.416E-04 7.853E-03 0.13702626 0.48128361 ONDER_CDH1_TARGETS_1_UP osteosclerosis DOID_4254 4.761E-04 8.209E-03 0.0318056 0.31202393 ONDER_CDH1_TARGETS_1_UP retinal vascular disease DOID_2462 5.252E-04 8.79E-03 0.01075003 0.21845591 ONDER_CDH1_TARGETS_1_UP testicular cancer DOID_2998 5.315E-04 8.641E-03 0.03354305 0.29821871 ONDER_CDH1_TARGETS_1_UP transitional cell carcinoma DOID_2671 5.799E-04 9.165E-03 0.1493596 0.50889587 ONDER_CDH1_TARGETS_1_UP lymphoma DOID_0060058 6.583E-04 0.0101232 6.583E-04 0.02881219 ONDER_CDH1_TARGETS_1_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.999E-04 0.01047971 0.01296877 0.23803977 ONDER_CDH1_TARGETS_1_UP mouth disease DOID_403 6.999E-04 0.010211 0.01296877 0.23060103 ONDER_CDH1_TARGETS_1_UP aortic valve disease DOID_62 8.529E-04 0.01213234 1.000 1.000 ONDER_CDH1_TARGETS_1_UP spastic quadriplegia DOID_10970 9.26E-04 0.01285079 1.000 1.000 ONDER_CDH1_TARGETS_1_UP middle cerebral artery infarction DOID_3525 1.163E-03 0.01575167 0.0490425 0.34881481 ONDER_CDH1_TARGETS_1_UP diffuse large B-cell lymphoma DOID_0050745 1.247E-03 0.01650589 1.247E-03 0.05069666 ONDER_CDH1_TARGETS_1_UP endometrial carcinoma DOID_2871 1.519E-03 0.01963824 1.000 1.000 ONDER_CDH1_TARGETS_1_UP spastic cerebral palsy DOID_0050669 1.615E-03 0.02041703 1.000 1.000 ONDER_CDH1_TARGETS_1_UP endometrial cancer DOID_1380 1.714E-03 0.02119697 1.000 1.000 ONDER_CDH1_TARGETS_1_UP papilloma DOID_2615 1.92E-03 0.02324378 0.06261402 0.36354465 ONDER_CDH1_TARGETS_1_UP pneumoconiosis DOID_10316 2.027E-03 0.02403228 0.06429698 0.36954528 ONDER_CDH1_TARGETS_1_UP nephroblastoma DOID_2154 2.027E-03 0.02354182 0.06429698 0.36584982 ONDER_CDH1_TARGETS_1_UP spindle cell carcinoma DOID_4015 2.027E-03 0.02307099 1.000 1.000 ONDER_CDH1_TARGETS_1_UP pulmonary sarcoidosis DOID_13406 2.366E-03 0.02639855 0.06932803 0.37214763 ONDER_CDH1_TARGETS_1_UP microcephaly DOID_10907 2.485E-03 0.02718719 0.07099912 0.37406015 ONDER_CDH1_TARGETS_1_UP congenital diaphragmatic hernia DOID_3827 2.606E-03 0.02797559 0.07266724 0.37588784 ONDER_CDH1_TARGETS_1_UP intracranial arterial disease DOID_13089 2.73E-03 0.02876365 0.07433242 0.37763526 ONDER_CDH1_TARGETS_1_UP cerebral arterial disease DOID_3527 2.73E-03 0.02876365 0.07433242 0.37763526 ONDER_CDH1_TARGETS_1_UP nephrotic syndrome DOID_1184 3.118E-03 0.0322569 0.0793103 0.38570565 ONDER_CDH1_TARGETS_1_UP gallbladder cancer DOID_3121 3.253E-03 0.03305074 1.000 1.000 ONDER_CDH1_TARGETS_1_UP uterine cancer DOID_363 3.253E-03 0.0324709 1.000 1.000 ONDER_CDH1_TARGETS_1_UP cataract DOID_83 3.39E-03 0.03326006 3.39E-03 0.11347551 ONDER_CDH1_TARGETS_1_UP myeloma DOID_0070004 3.673E-03 0.03542609 0.08590646 0.40397336 ONDER_CDH1_TARGETS_1_UP pre-eclampsia DOID_10591 3.673E-03 0.03483566 3.673E-03 0.11611886 ONDER_CDH1_TARGETS_1_UP lens disease DOID_110 3.673E-03 0.03426458 3.673E-03 0.11000734 ONDER_CDH1_TARGETS_1_UP heart valve disease DOID_4079 3.673E-03 0.03371193 1.000 1.000 ONDER_CDH1_TARGETS_1_UP withdrawal disorder DOID_0060001 4.271E-03 0.03857744 4.271E-03 0.12151894 ONDER_CDH1_TARGETS_1_UP B-cell lymphocytic neoplasm DOID_707 4.271E-03 0.03797467 4.271E-03 0.11573233 ONDER_CDH1_TARGETS_1_UP sarcoidosis DOID_11335 4.586E-03 0.04014576 0.09571349 0.42882659 ONDER_CDH1_TARGETS_1_UP giant cell tumor DOID_200 4.586E-03 0.03953749 0.09571349 0.42547639 ONDER_CDH1_TARGETS_1_UP malignant giant cell tumor DOID_2705 4.586E-03 0.03953749 0.09571349 0.42547639 ONDER_CDH1_TARGETS_1_UP giant cell glioblastoma DOID_3074 4.586E-03 0.03953749 0.09571349 0.42547639 ONDER_CDH1_TARGETS_1_UP bone marrow cancer DOID_4960 4.747E-03 0.04031712 0.09733789 0.42604045 ONDER_CDH1_TARGETS_1_UP osteochondrodysplasia DOID_2256 4.911E-03 0.04109552 0.09895941 0.42983132 ONDER_CDH1_TARGETS_1_UP congenital nervous system abnormality DOID_2490 5.247E-03 0.04326665 0.10219384 0.43394251 ONDER_CDH1_TARGETS_1_UP hypersensitivity reaction type IV disease DOID_2916 5.418E-03 0.04404346 0.10380677 0.4343092 ONDER_CDH1_TARGETS_1_UP glioblastoma DOID_3068 5.418E-03 0.04342313 0.10380677 0.43113906 ONDER_CDH1_TARGETS_1_UP carotid artery disease DOID_3407 5.948E-03 0.04700942 1.000 1.000 ONDER_CDH1_TARGETS_1_UP cholestasis DOID_13580 6.691E-03 0.05215026 0.11501758 0.44520409 ONDER_CDH1_TARGETS_1_UP astrocytoma DOID_3069 7.473E-03 0.05745854 0.1213616 0.45430755 ONDER_CDH1_TARGETS_1_UP pancreatic ductal carcinoma DOID_3587 7.674E-03 0.05822234 0.12294059 0.45721041 ONDER_CDH1_TARGETS_1_UP nephrosis DOID_2527 7.878E-03 0.05898435 0.12451678 0.46006525 ONDER_CDH1_TARGETS_1_UP pancreatic carcinoma DOID_4905 8.294E-03 0.06128871 0.1276608 0.46863868 ONDER_CDH1_TARGETS_1_UP diabetic retinopathy DOID_8947 8.294E-03 0.06050296 0.1276608 0.46563459 ONDER_CDH1_TARGETS_1_UP cystic fibrosis DOID_1485 8.719E-03 0.06279939 0.1307937 0.47402301 ONDER_CDH1_TARGETS_1_UP bacterial pneumonia DOID_874 9.154E-03 0.06510665 9.154E-03 0.20032816 ONDER_CDH1_TARGETS_1_UP metabolic syndrome X DOID_14221 9.598E-03 0.06742384 0.13702626 0.48729965 ONDER_CDH1_TARGETS_1_UP bone development disease DOID_0080006 0.01051497 0.07296366 0.1432148 0.49387405 ONDER_CDH1_TARGETS_1_UP primary immunodeficiency disease DOID_612 0.01171333 0.08029985 0.01171333 0.22982371 ONDER_CDH1_TARGETS_1_UP Human immunodeficiency virus infectious disease DOID_526 0.01195989 0.08101403 0.01195989 0.22683927 ONDER_CDH1_TARGETS_1_UP encephalomyelitis DOID_640 0.01271317 0.08510347 0.15697956 0.52234721 ONDER_CDH1_TARGETS_1_UP hypersensitivity reaction type I disease DOID_1205 0.01322662 0.08751099 0.16000868 0.52627134 ONDER_CDH1_TARGETS_1_UP ulcerative colitis DOID_8577 0.01401349 0.09165148 0.01401349 0.23451995 BROWNE_HCMV_INFECTION_4HR_DN germinoma DOID_3304 3.126E-06 1.779E-03 3.126E-06 1.779E-03 BROWNE_HCMV_INFECTION_4HR_DN Human immunodeficiency virus infectious disease DOID_526 8.242E-06 2.345E-03 1.651E-04 0.01341865 BROWNE_HCMV_INFECTION_4HR_DN carbohydrate metabolic disorder DOID_2978 9.643E-06 1.829E-03 9.643E-06 2.743E-03 BROWNE_HCMV_INFECTION_4HR_DN osteosarcoma DOID_3347 6.21E-05 8.834E-03 6.21E-05 0.01177882 BROWNE_HCMV_INFECTION_4HR_DN male reproductive system disease DOID_48 7.081E-05 8.058E-03 1.397E-03 0.07947735 BROWNE_HCMV_INFECTION_4HR_DN seminoma DOID_4440 7.791E-05 7.389E-03 7.791E-05 0.01108316 BROWNE_HCMV_INFECTION_4HR_DN pancreatitis DOID_4989 9.602E-05 7.805E-03 0.21096148 0.60320142 BROWNE_HCMV_INFECTION_4HR_DN sarcoma DOID_1115 9.614E-05 6.838E-03 3.565E-03 0.10675661 BROWNE_HCMV_INFECTION_4HR_DN invasive ductal carcinoma DOID_3008 9.614E-05 6.078E-03 9.614E-05 0.01094124 BROWNE_HCMV_INFECTION_4HR_DN gonadal disease DOID_2277 1.284E-04 7.304E-03 1.284E-04 0.01217393 BROWNE_HCMV_INFECTION_4HR_DN leukodystrophy DOID_10579 4.188E-04 0.02166545 9.292E-03 0.1652234 BROWNE_HCMV_INFECTION_4HR_DN angiosarcoma DOID_0001816 1.01E-03 0.04790471 1.01E-03 0.07185706 BROWNE_HCMV_INFECTION_4HR_DN cerebral degeneration DOID_1443 1.094E-03 0.04787605 0.01735721 0.22968033 BROWNE_HCMV_INFECTION_4HR_DN allergic contact dermatitis DOID_3042 1.19E-03 0.04835064 1.19E-03 0.07521211 BROWNE_HCMV_INFECTION_4HR_DN pancreatic ductal carcinoma DOID_3587 1.343E-03 0.05094576 0.19441605 0.57022026 BROWNE_HCMV_INFECTION_4HR_DN pancreatic carcinoma DOID_4905 1.508E-03 0.05363949 0.20154864 0.58510803 BROWNE_HCMV_INFECTION_4HR_DN aneurysm disease DOID_2403 1.686E-03 0.05642545 1.686E-03 0.08720297 BROWNE_HCMV_INFECTION_4HR_DN mitochondrial myopathy DOID_699 1.751E-03 0.05535226 1.751E-03 0.08302839 BROWNE_HCMV_INFECTION_4HR_DN contact dermatitis DOID_2773 1.876E-03 0.05617737 1.876E-03 0.08210539 BROWNE_HCMV_INFECTION_4HR_DN sinusitis DOID_0050127 2.101E-03 0.05978669 0.06580396 0.36708286 BROWNE_HCMV_INFECTION_4HR_DN paranasal sinus disease DOID_1352 2.101E-03 0.05978669 0.06580396 0.36708286 BROWNE_HCMV_INFECTION_4HR_DN Lewy body dementia DOID_12217 2.288E-03 0.06199645 0.06856552 0.36123869 BROWNE_HCMV_INFECTION_4HR_DN portal hypertension DOID_10762 2.684E-03 0.06941676 2.684E-03 0.10908347 BROWNE_HCMV_INFECTION_4HR_DN hypogonadism DOID_1924 2.684E-03 0.06639864 2.684E-03 0.10181124 BROWNE_HCMV_INFECTION_4HR_DN lymphoblastic leukemia DOID_1037 2.852E-03 0.06760704 2.852E-03 0.10141056 BROWNE_HCMV_INFECTION_4HR_DN cleft lip DOID_9296 2.893E-03 0.06584675 2.893E-03 0.09683345 BROWNE_HCMV_INFECTION_4HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.937E-03 0.06428231 0.03294354 0.28401325 BROWNE_HCMV_INFECTION_4HR_DN Sciatic Neuropathy DOID_11446 3.334E-03 0.07025176 3.334E-03 0.10537764 BROWNE_HCMV_INFECTION_4HR_DN lesion of sciatic nerve DOID_12528 3.334E-03 0.07025176 3.334E-03 0.10537764 BROWNE_HCMV_INFECTION_4HR_DN mononeuritis of lower limb DOID_9473 3.334E-03 0.07025176 3.334E-03 0.10537764 BROWNE_HCMV_INFECTION_4HR_DN mononeuritis DOID_1802 3.565E-03 0.07244198 3.565E-03 0.10141878 BROWNE_HCMV_INFECTION_4HR_DN hepatic vascular disease DOID_272 3.565E-03 0.06994398 3.565E-03 0.09658931 BROWNE_HCMV_INFECTION_4HR_DN mononeuropathy DOID_1188 3.803E-03 0.07213651 3.803E-03 0.09836797 BROWNE_HCMV_INFECTION_4HR_DN congenital disorder of glycosylation DOID_5212 4.049E-03 0.07432039 4.049E-03 0.10017096 BROWNE_HCMV_INFECTION_4HR_DN age related macular degeneration DOID_10871 4.302E-03 0.07649563 4.302E-03 0.10199418 BROWNE_HCMV_INFECTION_4HR_DN degeneration of macula and posterior pole DOID_2007 4.302E-03 0.07649563 4.302E-03 0.10199418 BROWNE_HCMV_INFECTION_4HR_DN autonomic nervous system neoplasm DOID_2621 4.829E-03 0.08326946 0.09841381 0.42422319 BROWNE_HCMV_INFECTION_4HR_DN neuroblastoma DOID_769 4.829E-03 0.08326946 0.09841381 0.42422319 BROWNE_HCMV_INFECTION_4HR_DN pneumoconiosis DOID_10316 5.385E-03 0.09011743 0.10373801 0.4438115 BROWNE_HCMV_INFECTION_4HR_DN male infertility DOID_12336 5.385E-03 0.08754265 5.385E-03 0.12255971 BROWNE_HCMV_INFECTION_4HR_DN macular degeneration DOID_4448 5.385E-03 0.08511091 5.385E-03 0.11784587 BROWNE_HCMV_INFECTION_4HR_DN pulmonary sarcoidosis DOID_13406 6.27E-03 0.09642818 0.11166594 0.44745014 BROWNE_HCMV_INFECTION_4HR_DN embryonal cancer DOID_688 6.27E-03 0.0938906 6.27E-03 0.13214232 BROWNE_HCMV_INFECTION_4HR_DN multiple myeloma DOID_9538 6.27E-03 0.09148315 0.11166594 0.43819255 BROWNE_HCMV_INFECTION_4HR_DN microcephaly DOID_10907 6.579E-03 0.09359038 6.579E-03 0.13370054 BROWNE_HCMV_INFECTION_4HR_DN peripheral nervous system neoplasm DOID_1192 6.579E-03 0.09130769 0.11429311 0.44542998 BROWNE_HCMV_INFECTION_4HR_DN congenital diaphragmatic hernia DOID_3827 6.895E-03 0.09341092 6.895E-03 0.13528478 BROWNE_HCMV_INFECTION_4HR_DN systemic scleroderma DOID_418 6.895E-03 0.09123857 0.11691257 0.44948144 BROWNE_HCMV_INFECTION_4HR_DN pulmonary emphysema DOID_9675 7.547E-03 0.09759233 0.12212849 0.45419028 BROWNE_HCMV_INFECTION_4HR_DN salivary gland cancer DOID_8850 7.883E-03 0.09967057 7.883E-03 0.14950585 BROWNE_HCMV_INFECTION_4HR_DN uterine cancer DOID_363 8.574E-03 0.0995654 8.574E-03 0.15737758 PARENT_MTOR_SIGNALING_UP amino acid metabolic disorder DOID_9252 2.143E-12 1.219E-09 4.756E-11 2.706E-08 PARENT_MTOR_SIGNALING_UP carbohydrate metabolic disorder DOID_2978 1.461E-09 4.158E-07 1.461E-09 4.158E-07 PARENT_MTOR_SIGNALING_UP encephalomyelitis DOID_640 1.461E-09 2.772E-07 5.051E-06 4.106E-04 PARENT_MTOR_SIGNALING_UP atrophic muscular disease DOID_913 5.613E-09 7.984E-07 1.338E-07 2.538E-05 PARENT_MTOR_SIGNALING_UP muscular dystrophy DOID_9884 5.613E-09 7.984E-07 1.338E-07 2.538E-05 PARENT_MTOR_SIGNALING_UP primary bacterial infectious disease DOID_0050338 1.403E-08 1.596E-06 0.02492776 0.14774891 PARENT_MTOR_SIGNALING_UP mitochondrial metabolism disease DOID_700 1.933E-07 1.833E-05 1.933E-07 2.75E-05 PARENT_MTOR_SIGNALING_UP mouth disease DOID_403 4.114E-07 3.344E-05 6.165E-05 3.189E-03 PARENT_MTOR_SIGNALING_UP Crohn's disease DOID_8778 4.114E-07 2.926E-05 4.751E-03 0.04914891 PARENT_MTOR_SIGNALING_UP parasitic infectious disease DOID_1398 5.206E-07 3.291E-05 1.357E-03 0.02756877 PARENT_MTOR_SIGNALING_UP trypanosomiasis DOID_10113 7.523E-07 4.28E-05 0.07453879 0.29453174 PARENT_MTOR_SIGNALING_UP bone resorption disease DOID_0080011 1.458E-06 7.54E-05 1.458E-06 1.659E-04 PARENT_MTOR_SIGNALING_UP osteoporosis DOID_11476 1.458E-06 7.54E-05 1.458E-06 1.659E-04 PARENT_MTOR_SIGNALING_UP nutritional deficiency disease DOID_5113 3.043E-06 1.443E-04 3.043E-06 2.886E-04 PARENT_MTOR_SIGNALING_UP metal metabolism disorder DOID_896 5.168E-06 2.262E-04 5.168E-06 3.676E-04 PARENT_MTOR_SIGNALING_UP carotid artery disease DOID_3407 6.012E-06 2.443E-04 6.012E-06 3.801E-04 PARENT_MTOR_SIGNALING_UP cerebral degeneration DOID_1443 8.574E-06 3.252E-04 1.19E-04 4.837E-03 PARENT_MTOR_SIGNALING_UP tooth disease DOID_1091 1.015E-05 3.61E-04 1.511E-03 0.02865473 PARENT_MTOR_SIGNALING_UP tuberculosis DOID_399 1.102E-05 3.689E-04 0.08896612 0.29431235 PARENT_MTOR_SIGNALING_UP blood coagulation disease DOID_1247 1.295E-05 4.093E-04 1.667E-04 5.927E-03 PARENT_MTOR_SIGNALING_UP male reproductive system disease DOID_48 1.401E-05 4.196E-04 1.855E-03 0.03298325 PARENT_MTOR_SIGNALING_UP peripheral vascular disease DOID_341 1.514E-05 4.307E-04 0.09759114 0.30849645 PARENT_MTOR_SIGNALING_UP Huntington's disease DOID_12858 1.774E-05 4.808E-04 4.15E-03 0.04722189 PARENT_MTOR_SIGNALING_UP metabolic syndrome X DOID_14221 2.527E-05 6.536E-04 2.699E-03 0.03839754 PARENT_MTOR_SIGNALING_UP spinal muscular atrophy DOID_12377 3.662E-05 9.059E-04 0.01533684 0.1064227 PARENT_MTOR_SIGNALING_UP hemorrhagic disease DOID_2213 3.911E-05 9.272E-04 5.688E-04 0.01407165 PARENT_MTOR_SIGNALING_UP facioscapulohumeral muscular dystrophy DOID_11727 3.952E-05 8.995E-04 3.952E-05 2.249E-03 PARENT_MTOR_SIGNALING_UP giant cell tumor DOID_200 4.67E-05 1.022E-03 0.05897361 0.28198306 PARENT_MTOR_SIGNALING_UP malignant giant cell tumor DOID_2705 4.67E-05 1.022E-03 0.05897361 0.28198306 PARENT_MTOR_SIGNALING_UP giant cell glioblastoma DOID_3074 4.67E-05 1.022E-03 0.05897361 0.28198306 PARENT_MTOR_SIGNALING_UP parasitic protozoa infectious disease DOID_2789 5.539E-05 1.167E-03 0.06273294 0.29258232 PARENT_MTOR_SIGNALING_UP hypertrophic cardiomyopathy DOID_11984 7.069E-05 1.436E-03 9.033E-04 0.01976771 PARENT_MTOR_SIGNALING_UP glioblastoma DOID_3068 7.069E-05 1.387E-03 0.06851909 0.28048464 PARENT_MTOR_SIGNALING_UP collagen disease DOID_854 8.906E-05 1.689E-03 0.07447314 0.29633018 PARENT_MTOR_SIGNALING_UP allergic rhinitis DOID_4481 9.31E-05 1.709E-03 0.02373949 0.14218707 PARENT_MTOR_SIGNALING_UP respiratory failure DOID_11162 9.593E-05 1.706E-03 0.01083239 0.08443332 PARENT_MTOR_SIGNALING_UP hypothyroidism DOID_1459 9.593E-05 1.654E-03 0.01083239 0.08329233 PARENT_MTOR_SIGNALING_UP autonomic nervous system neoplasm DOID_2621 1.045E-04 1.75E-03 0.0250635 0.14702196 PARENT_MTOR_SIGNALING_UP neuroblastoma DOID_769 1.045E-04 1.75E-03 0.0250635 0.14702196 PARENT_MTOR_SIGNALING_UP mineral metabolism disease DOID_0050032 1.109E-04 1.803E-03 1.109E-04 5.258E-03 PARENT_MTOR_SIGNALING_UP systemic mycosis DOID_0050136 1.17E-04 1.849E-03 0.2239974 0.47735775 PARENT_MTOR_SIGNALING_UP fungal infectious disease DOID_1564 1.17E-04 1.849E-03 0.2239974 0.47735775 PARENT_MTOR_SIGNALING_UP primary ciliary dyskinesia DOID_9562 1.174E-04 1.806E-03 1.174E-04 5.139E-03 PARENT_MTOR_SIGNALING_UP hepatitis C DOID_1883 1.304E-04 1.953E-03 0.02779935 0.15977608 PARENT_MTOR_SIGNALING_UP lung oat cell carcinoma DOID_5411 1.46E-04 2.13E-03 1.46E-04 5.538E-03 PARENT_MTOR_SIGNALING_UP endocrine organ benign neoplasm DOID_0060089 1.461E-04 2.079E-03 0.01374682 0.09777425 PARENT_MTOR_SIGNALING_UP astrocytoma DOID_3069 1.561E-04 2.167E-03 0.09110025 0.29963031 PARENT_MTOR_SIGNALING_UP nephrosis DOID_2527 1.777E-04 2.408E-03 1.855E-03 0.03404723 PARENT_MTOR_SIGNALING_UP peripheral nervous system neoplasm DOID_1192 1.956E-04 2.589E-03 0.03360934 0.17707144 PARENT_MTOR_SIGNALING_UP hepatitis DOID_2237 2.15E-04 2.781E-03 3.203E-03 0.0387815 PARENT_MTOR_SIGNALING_UP cystic fibrosis DOID_1485 2.277E-04 2.879E-03 0.01765725 0.1168253 PARENT_MTOR_SIGNALING_UP adult respiratory distress syndrome DOID_11394 2.358E-04 2.917E-03 3.426E-03 0.04061195 PARENT_MTOR_SIGNALING_UP bacterial pneumonia DOID_874 2.563E-04 3.103E-03 0.4310046 0.78855826 PARENT_MTOR_SIGNALING_UP female reproductive system disease DOID_229 3.043E-04 3.608E-03 2.821E-03 0.03821191 PARENT_MTOR_SIGNALING_UP influenza DOID_8469 3.334E-04 3.871E-03 1.000 1.000 PARENT_MTOR_SIGNALING_UP alcohol abuse DOID_1574 3.399E-04 3.869E-03 3.074E-03 0.04067915 PARENT_MTOR_SIGNALING_UP leukodystrophy DOID_10579 3.917E-04 4.37E-03 3.917E-04 0.01310965 PARENT_MTOR_SIGNALING_UP Leigh disease DOID_3652 4.137E-04 4.527E-03 4.137E-04 0.01307656 PARENT_MTOR_SIGNALING_UP heart valve disease DOID_4079 4.234E-04 4.546E-03 4.234E-04 0.01267985 PARENT_MTOR_SIGNALING_UP bone marrow disease DOID_4961 4.234E-04 4.461E-03 4.234E-04 0.01204585 PARENT_MTOR_SIGNALING_UP integumentary system benign neoplasm DOID_0060121 4.923E-04 5.093E-03 5.858E-03 0.05555174 PARENT_MTOR_SIGNALING_UP skin benign neoplasm DOID_3165 4.923E-04 5.093E-03 5.858E-03 0.05555174 PARENT_MTOR_SIGNALING_UP calcium metabolism disease DOID_10575 5.296E-04 5.381E-03 5.296E-04 0.01434869 PARENT_MTOR_SIGNALING_UP glycogen metabolism disorder DOID_0050728 5.452E-04 5.442E-03 5.452E-04 0.0140996 PARENT_MTOR_SIGNALING_UP glycogen storage disease DOID_2747 5.452E-04 5.442E-03 5.452E-04 0.0140996 PARENT_MTOR_SIGNALING_UP lymphoblastic leukemia DOID_1037 5.673E-04 5.566E-03 0.02947474 0.1628265 PARENT_MTOR_SIGNALING_UP diabetic angiopathy DOID_11713 6.198E-04 5.977E-03 0.01222704 0.09035303 PARENT_MTOR_SIGNALING_UP bone marrow cancer DOID_4960 6.989E-04 6.628E-03 0.06084322 0.28849826 PARENT_MTOR_SIGNALING_UP toxic shock syndrome DOID_14115 7.007E-04 6.536E-03 0.16145333 0.39769241 PARENT_MTOR_SIGNALING_UP ulcerative colitis DOID_8577 7.166E-04 6.576E-03 0.03357532 0.18022977 PARENT_MTOR_SIGNALING_UP commensal bacterial infectious disease DOID_0050339 7.88E-04 7.117E-03 0.16734082 0.40865634 PARENT_MTOR_SIGNALING_UP organic acidemia DOID_0060159 7.88E-04 7.006E-03 7.88E-04 0.018682 PARENT_MTOR_SIGNALING_UP infantile epileptic encephalopathy DOID_2481 8.819E-04 7.72E-03 8.819E-04 0.02007238 PARENT_MTOR_SIGNALING_UP leukocyte disease DOID_9500 9.603E-04 8.279E-03 0.0704856 0.28444187 PARENT_MTOR_SIGNALING_UP spinal cord disease DOID_319 9.826E-04 8.345E-03 0.17899254 0.41912245 PARENT_MTOR_SIGNALING_UP lung adenocarcinoma DOID_3910 1.09E-03 9.124E-03 1.09E-03 0.02297859 PARENT_MTOR_SIGNALING_UP periodontitis DOID_824 1.09E-03 8.992E-03 0.18475734 0.42561509 PARENT_MTOR_SIGNALING_UP coronary stenosis DOID_4248 1.205E-03 9.797E-03 0.19048182 0.42839586 PARENT_MTOR_SIGNALING_UP central nervous system hereditary degenerative disease DOID_481 1.205E-03 9.659E-03 0.19048182 0.4250359 PARENT_MTOR_SIGNALING_UP polycystic ovary syndrome DOID_11612 1.328E-03 0.01049118 0.01994896 0.12898817 PARENT_MTOR_SIGNALING_UP toxic encephalopathy DOID_3602 1.328E-03 0.01034747 0.19616625 0.43601013 PARENT_MTOR_SIGNALING_UP uterine disease DOID_345 1.357E-03 0.01043143 0.01223961 0.0881562 PARENT_MTOR_SIGNALING_UP corneal disease DOID_10124 1.457E-03 0.01105613 0.20181091 0.44681092 PARENT_MTOR_SIGNALING_UP dysostosis DOID_1934 1.457E-03 0.01091066 1.457E-03 0.02859345 PARENT_MTOR_SIGNALING_UP opportunistic mycosis DOID_2473 1.595E-03 0.01178481 0.20741608 0.45218294 PARENT_MTOR_SIGNALING_UP abdominal aortic aneurysm DOID_7693 1.595E-03 0.01163373 0.20741608 0.44874429 PARENT_MTOR_SIGNALING_UP celiac disease DOID_10608 1.74E-03 0.01253316 0.02373949 0.1436997 PARENT_MTOR_SIGNALING_UP leiomyoma DOID_127 1.893E-03 0.01346709 1.893E-03 0.03264748 PARENT_MTOR_SIGNALING_UP gallbladder disease DOID_0000000 2.127E-03 0.01493868 2.127E-03 0.03558922 PARENT_MTOR_SIGNALING_UP Sjogren's syndrome DOID_12894 2.127E-03 0.0147565 0.06799773 0.30227117 PARENT_MTOR_SIGNALING_UP transient cerebral ischemia DOID_224 2.127E-03 0.01457872 0.06799773 0.29762084 PARENT_MTOR_SIGNALING_UP lateral sclerosis DOID_230 2.127E-03 0.01440516 0.06799773 0.29534892 PARENT_MTOR_SIGNALING_UP progressive muscular atrophy DOID_318 2.127E-03 0.01423569 0.06799773 0.29311143 PARENT_MTOR_SIGNALING_UP Hermansky-Pudlak syndrome DOID_3753 2.127E-03 0.01407016 2.127E-03 0.03457238 PARENT_MTOR_SIGNALING_UP insulinoma DOID_3892 2.127E-03 0.01390843 1.000 1.000 PARENT_MTOR_SIGNALING_UP pneumoconiosis DOID_10316 2.225E-03 0.01438502 1.000 1.000 PARENT_MTOR_SIGNALING_UP nephroblastoma DOID_2154 2.225E-03 0.01422339 0.02779935 0.15817832 PARENT_MTOR_SIGNALING_UP periodontal disease DOID_3388 2.225E-03 0.01406535 0.22944734 0.48533657 PARENT_MTOR_SIGNALING_UP thyroid carcinoma DOID_3963 2.225E-03 0.01391078 2.225E-03 0.03516337 PARENT_MTOR_SIGNALING_UP aneurysm disease DOID_2403 2.357E-03 0.01457766 0.10644073 0.31544153 PARENT_MTOR_SIGNALING_UP medullomyoblastoma DOID_3861 2.403E-03 0.01470232 0.02921026 0.16294744 PARENT_MTOR_SIGNALING_UP adult medulloblastoma DOID_3864 2.403E-03 0.01470232 0.02921026 0.16294744 PARENT_MTOR_SIGNALING_UP childhood medulloblastoma DOID_3869 2.403E-03 0.01470232 0.02921026 0.16294744 PARENT_MTOR_SIGNALING_UP adrenoleukodystrophy DOID_10588 2.587E-03 0.01566058 2.587E-03 0.03978634 PARENT_MTOR_SIGNALING_UP hemochromatosis DOID_2352 2.587E-03 0.01549573 2.587E-03 0.03873933 PARENT_MTOR_SIGNALING_UP invasive lobular carcinoma DOID_3457 2.587E-03 0.01533432 0.07453879 0.28657142 PARENT_MTOR_SIGNALING_UP thyroid cancer DOID_1781 2.59E-03 0.01519218 2.59E-03 0.03778567 PARENT_MTOR_SIGNALING_UP adenoma DOID_657 2.59E-03 0.01503716 1.000 1.000 PARENT_MTOR_SIGNALING_UP lipid metabolism disorder DOID_3146 2.699E-03 0.01551416 0.11321381 0.31120125 PARENT_MTOR_SIGNALING_UP calcinosis DOID_182 2.785E-03 0.01584936 2.785E-03 0.03865698 PARENT_MTOR_SIGNALING_UP medulloblastoma DOID_3858 2.785E-03 0.01569244 0.03211571 0.17403657 PARENT_MTOR_SIGNALING_UP blood platelet disease DOID_2218 2.99E-03 0.01667917 0.03360934 0.17544693 PARENT_MTOR_SIGNALING_UP mental depression DOID_1596 3.074E-03 0.01698256 0.02212422 0.13833718 PARENT_MTOR_SIGNALING_UP chronic kidney failure DOID_784 3.074E-03 0.01681927 0.4507301 0.82200457 PARENT_MTOR_SIGNALING_UP esophageal carcinoma DOID_1107 3.09E-03 0.01674623 3.09E-03 0.03996259 PARENT_MTOR_SIGNALING_UP porphyria DOID_13268 3.09E-03 0.01658824 3.09E-03 0.03907453 PARENT_MTOR_SIGNALING_UP pituitary cancer DOID_1785 3.09E-03 0.01643321 0.08103411 0.29556672 PARENT_MTOR_SIGNALING_UP islet cell tumor DOID_1799 3.09E-03 0.01628105 1.000 1.000 PARENT_MTOR_SIGNALING_UP esophagus squamous cell carcinoma DOID_3748 3.09E-03 0.01674623 3.09E-03 0.03996259 PARENT_MTOR_SIGNALING_UP pituitary carcinoma DOID_4916 3.09E-03 0.01643321 0.08103411 0.29556672 PARENT_MTOR_SIGNALING_UP retinal detachment DOID_5327 3.09E-03 0.01613169 3.09E-03 0.03822508 PARENT_MTOR_SIGNALING_UP intracranial arterial disease DOID_13089 3.426E-03 0.01772158 0.03667616 0.18971577 PARENT_MTOR_SIGNALING_UP cerebral arterial disease DOID_3527 3.426E-03 0.01772158 0.03667616 0.18971577 PARENT_MTOR_SIGNALING_UP obstructive hydrocephalus DOID_14159 3.635E-03 0.01863479 0.08748401 0.29807428 PARENT_MTOR_SIGNALING_UP communicating hydrocephalus DOID_1573 3.635E-03 0.01863479 0.08748401 0.29807428 PARENT_MTOR_SIGNALING_UP spinocerebellar ataxia DOID_1441 3.899E-03 0.01980795 3.899E-03 0.04527532 PARENT_MTOR_SIGNALING_UP primary immunodeficiency disease DOID_612 3.927E-03 0.01977649 0.4735034 0.85531249 PARENT_MTOR_SIGNALING_UP nervous system cancer DOID_3093 4.084E-03 0.02038294 0.13652887 0.35472569 PARENT_MTOR_SIGNALING_UP Human immunodeficiency virus infectious disease DOID_526 4.084E-03 0.0202057 0.13652887 0.3531133 PARENT_MTOR_SIGNALING_UP nephrotic syndrome DOID_1184 4.15E-03 0.02035426 0.04146869 0.21067574 PARENT_MTOR_SIGNALING_UP primitive neuroectodermal tumor DOID_168 4.15E-03 0.02018029 0.04146869 0.20881136 PARENT_MTOR_SIGNALING_UP idiopathic generalized epilepsy DOID_1827 4.15E-03 0.02000927 4.15E-03 0.04629597 PARENT_MTOR_SIGNALING_UP Legionnaires' disease DOID_10457 4.222E-03 0.02018547 1.000 1.000 PARENT_MTOR_SIGNALING_UP legionellosis DOID_10458 4.222E-03 0.02018547 1.000 1.000 PARENT_MTOR_SIGNALING_UP hydrocephalus DOID_10908 4.222E-03 0.02001726 0.09388882 0.30527279 PARENT_MTOR_SIGNALING_UP parasitic helminthiasis infectious disease DOID_883 4.222E-03 0.01985182 4.222E-03 0.04619367 PARENT_MTOR_SIGNALING_UP Zellweger syndrome DOID_905 4.222E-03 0.01968911 4.222E-03 0.04532209 PARENT_MTOR_SIGNALING_UP cataract DOID_83 4.68E-03 0.02164798 4.68E-03 0.04930928 PARENT_MTOR_SIGNALING_UP renovascular hypertension DOID_1591 4.849E-03 0.02224871 0.10024884 0.31170266 PARENT_MTOR_SIGNALING_UP adrenal cortex disease DOID_3952 4.849E-03 0.02207072 0.10024884 0.3066752 PARENT_MTOR_SIGNALING_UP intracranial hypertension DOID_9428 4.849E-03 0.02189555 0.10024884 0.30180734 PARENT_MTOR_SIGNALING_UP hypersensitivity reaction type I disease DOID_1205 4.928E-03 0.02208022 0.49533589 0.88910449 PARENT_MTOR_SIGNALING_UP dilated cardiomyopathy DOID_12930 4.928E-03 0.02190772 4.928E-03 0.05007478 PARENT_MTOR_SIGNALING_UP spinocerebellar degeneration DOID_2478 4.959E-03 0.02187458 4.959E-03 0.04950564 PARENT_MTOR_SIGNALING_UP proteinuria DOID_576 4.959E-03 0.02170632 0.29194706 0.56695522 PARENT_MTOR_SIGNALING_UP myeloma DOID_0070004 5.249E-03 0.02279817 0.2969215 0.57465419 PARENT_MTOR_SIGNALING_UP lens disease DOID_110 5.249E-03 0.02262545 5.249E-03 0.05149241 PARENT_MTOR_SIGNALING_UP thyroid adenoma DOID_2891 5.249E-03 0.02245534 0.04819972 0.23848382 PARENT_MTOR_SIGNALING_UP pituitary adenoma DOID_3829 5.516E-03 0.02342112 0.10656438 0.31094939 PARENT_MTOR_SIGNALING_UP restrictive cardiomyopathy DOID_397 5.516E-03 0.02324763 5.516E-03 0.05319372 PARENT_MTOR_SIGNALING_UP autoimmune disease of gastrointestinal tract DOID_0060031 5.858E-03 0.02450812 0.0517039 0.2514489 PARENT_MTOR_SIGNALING_UP pulmonary tuberculosis DOID_2957 5.858E-03 0.02432923 1.000 1.000 PARENT_MTOR_SIGNALING_UP lung small cell carcinoma DOID_5409 5.858E-03 0.02415293 5.858E-03 0.05464106 PARENT_MTOR_SIGNALING_UP aortic aneurysm DOID_3627 6.178E-03 0.02528785 0.31163687 0.59704168 PARENT_MTOR_SIGNALING_UP familial hypertrophic cardiomyopathy DOID_11986 6.222E-03 0.02528932 6.222E-03 0.05710491 PARENT_MTOR_SIGNALING_UP Bardet-Biedl syndrome DOID_1935 6.222E-03 0.02510996 6.222E-03 0.05619848 PARENT_MTOR_SIGNALING_UP juvenile rheumatoid arthritis DOID_676 6.222E-03 0.02493313 1.000 1.000 PARENT_MTOR_SIGNALING_UP peroxisomal disease DOID_906 6.222E-03 0.02475877 6.222E-03 0.05532038 PARENT_MTOR_SIGNALING_UP adrenal gland disease DOID_9553 6.222E-03 0.02458684 0.11283576 0.31318803 PARENT_MTOR_SIGNALING_UP withdrawal disorder DOID_0060001 6.507E-03 0.02553613 0.05529624 0.26664037 PARENT_MTOR_SIGNALING_UP B-cell lymphocytic neoplasm DOID_707 6.507E-03 0.02536122 0.31647349 0.6042732 PARENT_MTOR_SIGNALING_UP atopic dermatitis DOID_3310 6.848E-03 0.02650566 1.000 1.000 PARENT_MTOR_SIGNALING_UP congenital muscular dystrophy DOID_0050557 6.968E-03 0.02678873 6.968E-03 0.06099589 PARENT_MTOR_SIGNALING_UP dental caries DOID_216 6.968E-03 0.02660894 6.968E-03 0.06007171 PARENT_MTOR_SIGNALING_UP prion disease DOID_649 6.968E-03 0.02643155 6.968E-03 0.05917511 PARENT_MTOR_SIGNALING_UP eosinophilia DOID_999 6.968E-03 0.02625651 0.11906328 0.32260478 PARENT_MTOR_SIGNALING_UP infertility DOID_5223 7.752E-03 0.02901833 7.752E-03 0.0648645 PARENT_MTOR_SIGNALING_UP integumentary system cancer DOID_0060122 7.931E-03 0.029495 7.931E-03 0.06540196 PARENT_MTOR_SIGNALING_UP skin cancer DOID_4159 7.931E-03 0.029495 7.931E-03 0.06540196 PARENT_MTOR_SIGNALING_UP pustulosis of palm and sole DOID_4398 7.931E-03 0.02930348 0.06273294 0.2902036 PARENT_MTOR_SIGNALING_UP colon carcinoma DOID_1520 8.574E-03 0.03147316 0.13138797 0.344515 PARENT_MTOR_SIGNALING_UP hypersensitivity reaction type IV disease DOID_2916 9.11E-03 0.03322692 0.34939492 0.65829706 PARENT_MTOR_SIGNALING_UP mitochondrial myopathy DOID_699 9.432E-03 0.03418518 9.432E-03 0.07667247 PARENT_MTOR_SIGNALING_UP thrombophilia DOID_2452 0.01032806 0.03719409 0.01032806 0.08276995 PARENT_MTOR_SIGNALING_UP muscular atrophy DOID_767 0.01032806 0.03696017 0.14354087 0.36625451 PARENT_MTOR_SIGNALING_UP placenta disease DOID_780 0.01032806 0.03672917 0.01032806 0.08162037 PARENT_MTOR_SIGNALING_UP neuroectodermal tumor DOID_171 0.01038535 0.03670352 0.07447314 0.29841701 PARENT_MTOR_SIGNALING_UP heart conduction disease DOID_10273 0.01125977 0.03954819 0.01125977 0.08542409 PARENT_MTOR_SIGNALING_UP uremia DOID_4676 0.01125977 0.03930556 0.01125977 0.08430009 PARENT_MTOR_SIGNALING_UP hypoglycemia DOID_9993 0.01125977 0.0390659 0.14955365 0.37487236 PARENT_MTOR_SIGNALING_UP pre-malignant neoplasm DOID_0060071 0.01129042 0.03893485 0.37193844 0.69161102 PARENT_MTOR_SIGNALING_UP in situ carcinoma DOID_8719 0.01129042 0.03893485 0.37193844 0.69161102 PARENT_MTOR_SIGNALING_UP endocrine pancreas disease DOID_1428 0.01175948 0.0403081 0.37635288 0.69754002 PARENT_MTOR_SIGNALING_UP synostosis DOID_11971 0.01222704 0.04165978 0.01222704 0.08919465 PARENT_MTOR_SIGNALING_UP Goodpasture syndrome DOID_9808 0.01222704 0.0414118 1.000 1.000 PARENT_MTOR_SIGNALING_UP hyperglycemia DOID_4195 0.01273086 0.04286306 0.08474401 0.29765027 PARENT_MTOR_SIGNALING_UP bronchiolitis DOID_2942 0.0142661 0.04774949 1.000 1.000 PARENT_MTOR_SIGNALING_UP osteosarcoma DOID_3347 0.0142661 0.04747025 0.0142661 0.10021498 PARENT_MTOR_SIGNALING_UP ankylosing spondylitis DOID_7147 0.01533684 0.0507364 0.17318713 0.41404822 PARENT_MTOR_SIGNALING_UP bile duct disease DOID_4138 0.01535493 0.05050263 0.01535493 0.10526452 PARENT_MTOR_SIGNALING_UP biliary tract disease DOID_9741 0.01591352 0.05203904 0.01591352 0.10779515 PARENT_MTOR_SIGNALING_UP vitiligo DOID_12306 0.01644101 0.05345676 0.17899254 0.42260064 PARENT_MTOR_SIGNALING_UP B cell deficiency DOID_2115 0.01644101 0.05315303 1.000 1.000 PARENT_MTOR_SIGNALING_UP teeth hard tissue disease DOID_214 0.01644101 0.05285273 0.01644101 0.11005804 PARENT_MTOR_SIGNALING_UP middle cerebral artery infarction DOID_3525 0.01644101 0.0525558 0.17899254 0.41740474 PARENT_MTOR_SIGNALING_UP fragments of torsion dystonia DOID_531 0.01644101 0.0522622 1.000 1.000 PARENT_MTOR_SIGNALING_UP dystonia DOID_543 0.01644101 0.05197185 1.000 1.000 PARENT_MTOR_SIGNALING_UP extrinsic allergic alveolitis DOID_841 0.01644101 0.05168471 1.000 1.000 PARENT_MTOR_SIGNALING_UP migraine DOID_6364 0.01757809 0.05495568 0.18475734 0.42734523 PARENT_MTOR_SIGNALING_UP perinatal necrotizing enterocolitis DOID_8677 0.01757809 0.05465538 0.18475734 0.4238989 PARENT_MTOR_SIGNALING_UP endogenous depression DOID_1595 0.01765725 0.05460313 0.10420833 0.31207653 PARENT_MTOR_SIGNALING_UP syndrome DOID_225 0.01765725 0.05430798 0.10420833 0.31044263 PARENT_MTOR_SIGNALING_UP renal hypertension DOID_1073 0.01874758 0.05735146 0.19048182 0.43527773 PARENT_MTOR_SIGNALING_UP secondary hypertension DOID_11130 0.01874758 0.05735146 0.19048182 0.43527773 PARENT_MTOR_SIGNALING_UP sarcoma DOID_1115 0.01874758 0.05704477 1.000 1.000 PARENT_MTOR_SIGNALING_UP thrombocytopenia DOID_1588 0.01874758 0.05674134 0.19048182 0.43180938 PARENT_MTOR_SIGNALING_UP hepatic vascular disease DOID_272 0.01874758 0.05644112 0.19048182 0.43009585 PARENT_MTOR_SIGNALING_UP invasive ductal carcinoma DOID_3008 0.01874758 0.05614406 0.01874758 0.12261347 PARENT_MTOR_SIGNALING_UP electroclinical syndrome DOID_0050701 0.01887654 0.05623431 0.10868596 0.31233491 PARENT_MTOR_SIGNALING_UP focal glomerulosclerosis DOID_3945 0.01994896 0.05911958 0.01994896 0.12753886 PARENT_MTOR_SIGNALING_UP dystonic disease DOID_544 0.01994896 0.05881326 1.000 1.000 PARENT_MTOR_SIGNALING_UP female reproductive organ benign neoplasm DOID_0060086 0.02118174 0.06212582 0.02118174 0.13391565 PARENT_MTOR_SIGNALING_UP uterine benign neoplasm DOID_0060095 0.02118174 0.06212582 0.02118174 0.13391565 PARENT_MTOR_SIGNALING_UP uterine fibroid DOID_13223 0.02118174 0.06212582 0.02118174 0.13391565 PARENT_MTOR_SIGNALING_UP spastic cerebral palsy DOID_0050669 0.02244541 0.06549456 0.02244541 0.13882 PARENT_MTOR_SIGNALING_UP bronchiolitis obliterans DOID_2799 0.02244541 0.06516041 0.20741608 0.45045706 PARENT_MTOR_SIGNALING_UP bone development disease DOID_0080006 0.02280799 0.06587689 0.02280799 0.13954567 PARENT_MTOR_SIGNALING_UP chronic leukemia DOID_1036 0.0250635 0.07202591 0.21850905 0.47095322 PARENT_MTOR_SIGNALING_UP chronic lymphocytic leukemia DOID_1040 0.0250635 0.07202591 0.21850905 0.47095322 PARENT_MTOR_SIGNALING_UP transitional cell carcinoma DOID_2671 0.02565715 0.07336141 0.46977425 0.85127882 PARENT_MTOR_SIGNALING_UP male infertility DOID_12336 0.02779935 0.07908916 0.02779935 0.16140645 PARENT_MTOR_SIGNALING_UP leukopenia DOID_615 0.02779935 0.07869568 0.22944734 0.4799836 PARENT_MTOR_SIGNALING_UP lymphoma DOID_0060058 0.02868852 0.08081073 0.48453479 0.87246929 PARENT_MTOR_SIGNALING_UP lymphoid leukemia DOID_10747 0.02921026 0.08187507 0.23485916 0.48594494 PARENT_MTOR_SIGNALING_UP aplastic anemia DOID_12449 0.02921026 0.08147372 0.02921026 0.16456078 PARENT_MTOR_SIGNALING_UP autosomal recessive nonsyndromic deafness DOID_0050565 0.0306492 0.08507022 0.0306492 0.16768649 PARENT_MTOR_SIGNALING_UP embryonal cancer DOID_688 0.03211571 0.08870796 0.24556945 0.50443688 PARENT_MTOR_SIGNALING_UP multiple myeloma DOID_9538 0.03211571 0.08827942 1.000 1.000 PARENT_MTOR_SIGNALING_UP microcephaly DOID_10907 0.03360934 0.09194094 0.03360934 0.17872631 PARENT_MTOR_SIGNALING_UP systemic scleroderma DOID_418 0.03512964 0.09564002 0.25613037 0.52423806 PARENT_MTOR_SIGNALING_UP peptic ulcer DOID_750 0.03512964 0.09518459 1.000 1.000 PARENT_MTOR_SIGNALING_UP lymphatic system disease DOID_75 0.03667616 0.09890396 0.26135547 0.53111165 THUM_SYSTOLIC_HEART_FAILURE_UP encephalomyelitis DOID_640 2.036E-14 1.159E-11 2.404E-05 2.28E-03 THUM_SYSTOLIC_HEART_FAILURE_UP contact dermatitis DOID_2773 9.081E-14 2.584E-11 7.129E-11 4.056E-08 THUM_SYSTOLIC_HEART_FAILURE_UP retinal vascular disease DOID_2462 1.894E-13 3.592E-11 1.889E-03 0.03583354 THUM_SYSTOLIC_HEART_FAILURE_UP hypersensitivity reaction type I disease DOID_1205 7.222E-13 1.027E-10 2.045E-06 2.91E-04 THUM_SYSTOLIC_HEART_FAILURE_UP diabetic retinopathy DOID_8947 1.132E-12 1.288E-10 0.01080526 0.09176407 THUM_SYSTOLIC_HEART_FAILURE_UP peripheral vascular disease DOID_341 2.865E-11 2.717E-09 0.01042398 0.09267567 THUM_SYSTOLIC_HEART_FAILURE_UP pancreatitis DOID_4989 5.544E-11 4.507E-09 1.387E-03 0.02922577 THUM_SYSTOLIC_HEART_FAILURE_UP systemic scleroderma DOID_418 1.446E-10 1.029E-08 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP primary immunodeficiency disease DOID_612 2.044E-10 1.292E-08 4.321E-09 1.229E-06 THUM_SYSTOLIC_HEART_FAILURE_UP rheumatic disease DOID_1575 3.132E-10 1.782E-08 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP scleroderma DOID_419 3.132E-10 1.782E-08 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP allergic contact dermatitis DOID_3042 3.997E-10 2.068E-08 1.002E-08 1.9E-06 THUM_SYSTOLIC_HEART_FAILURE_UP vascular skin disease DOID_9540 6.314E-10 2.994E-08 0.03622794 0.20409603 THUM_SYSTOLIC_HEART_FAILURE_UP prion disease DOID_649 7.54E-10 3.3E-08 1.618E-04 7.67E-03 THUM_SYSTOLIC_HEART_FAILURE_UP Human immunodeficiency virus infectious disease DOID_526 4.765E-09 1.937E-07 0.01800758 0.12054489 THUM_SYSTOLIC_HEART_FAILURE_UP collagen disease DOID_854 4.844E-09 1.837E-07 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP brain infarction DOID_3454 1.123E-08 3.994E-07 8.978E-03 0.08374662 THUM_SYSTOLIC_HEART_FAILURE_UP membranoproliferative glomerulonephritis DOID_2920 2.106E-08 7.049E-07 3.56E-03 0.05331061 THUM_SYSTOLIC_HEART_FAILURE_UP pustulosis of palm and sole DOID_4398 5.834E-08 1.844E-06 5.13E-03 0.06210459 THUM_SYSTOLIC_HEART_FAILURE_UP transitional cell carcinoma DOID_2671 7.423E-08 2.223E-06 2.14E-04 9.367E-03 THUM_SYSTOLIC_HEART_FAILURE_UP ulcerative colitis DOID_8577 1.693E-07 4.816E-06 0.02239901 0.14161153 THUM_SYSTOLIC_HEART_FAILURE_UP peptic ulcer DOID_750 1.89E-07 5.12E-06 0.22304789 0.52228087 THUM_SYSTOLIC_HEART_FAILURE_UP acute pancreatitis DOID_2913 3.549E-07 9.178E-06 0.13945584 0.41328319 THUM_SYSTOLIC_HEART_FAILURE_UP urticaria DOID_1555 4.372E-07 1.082E-05 0.01055366 0.09238508 THUM_SYSTOLIC_HEART_FAILURE_UP bone resorption disease DOID_0080011 5.056E-07 1.199E-05 8.326E-06 9.475E-04 THUM_SYSTOLIC_HEART_FAILURE_UP osteoporosis DOID_11476 5.056E-07 1.199E-05 8.326E-06 9.475E-04 THUM_SYSTOLIC_HEART_FAILURE_UP aneurysm disease DOID_2403 5.056E-07 1.151E-05 1.324E-03 0.0289668 THUM_SYSTOLIC_HEART_FAILURE_UP neuritis DOID_1803 5.5E-07 1.204E-05 3.375E-03 0.05333911 THUM_SYSTOLIC_HEART_FAILURE_UP bacterial pneumonia DOID_874 5.513E-07 1.162E-05 0.08327697 0.32455204 THUM_SYSTOLIC_HEART_FAILURE_UP hepatic vascular disease DOID_272 9.289E-07 1.888E-05 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP autoimmune disease of the nervous system DOID_438 9.289E-07 1.822E-05 0.01390613 0.104113 THUM_SYSTOLIC_HEART_FAILURE_UP giant cell tumor DOID_200 1.091E-06 2.069E-05 0.04449918 0.24582558 THUM_SYSTOLIC_HEART_FAILURE_UP malignant giant cell tumor DOID_2705 1.091E-06 2.069E-05 0.04449918 0.24582558 THUM_SYSTOLIC_HEART_FAILURE_UP giant cell glioblastoma DOID_3074 1.091E-06 2.069E-05 0.04449918 0.24582558 THUM_SYSTOLIC_HEART_FAILURE_UP glioblastoma DOID_3068 1.819E-06 3.339E-05 0.05186916 0.27842973 THUM_SYSTOLIC_HEART_FAILURE_UP dilated cardiomyopathy DOID_12930 2.045E-06 3.637E-05 0.11503431 0.37617543 THUM_SYSTOLIC_HEART_FAILURE_UP carotid artery disease DOID_3407 2.42E-06 4.173E-05 6.002E-04 0.02134638 THUM_SYSTOLIC_HEART_FAILURE_UP respiratory failure DOID_11162 2.653E-06 4.44E-05 0.05805484 0.30586301 THUM_SYSTOLIC_HEART_FAILURE_UP pre-malignant neoplasm DOID_0060071 2.904E-06 4.721E-05 4.889E-05 3.974E-03 THUM_SYSTOLIC_HEART_FAILURE_UP in situ carcinoma DOID_8719 2.904E-06 4.721E-05 4.889E-05 3.974E-03 THUM_SYSTOLIC_HEART_FAILURE_UP mineral metabolism disease DOID_0050032 3.173E-06 5.016E-05 7.657E-03 0.07780485 THUM_SYSTOLIC_HEART_FAILURE_UP parasitic infectious disease DOID_1398 3.463E-06 5.326E-05 0.06285295 0.30566949 THUM_SYSTOLIC_HEART_FAILURE_UP astrocytoma DOID_3069 4.846E-06 7.256E-05 0.0694503 0.31613778 THUM_SYSTOLIC_HEART_FAILURE_UP hepatitis DOID_2237 5.23E-06 7.63E-05 0.02626599 0.15899304 THUM_SYSTOLIC_HEART_FAILURE_UP blood coagulation disease DOID_1247 5.254E-06 7.473E-05 9.86E-04 0.0280518 THUM_SYSTOLIC_HEART_FAILURE_UP pancreatic ductal carcinoma DOID_3587 5.254E-06 7.291E-05 9.86E-04 0.026716 THUM_SYSTOLIC_HEART_FAILURE_UP brain edema DOID_4724 5.625E-06 7.621E-05 0.11320756 0.3745064 THUM_SYSTOLIC_HEART_FAILURE_UP nephrosis DOID_2527 5.689E-06 7.528E-05 0.35908087 0.72710681 THUM_SYSTOLIC_HEART_FAILURE_UP cervix uteri carcinoma in situ DOID_8991 6.612E-06 8.55E-05 1.408E-04 7.284E-03 THUM_SYSTOLIC_HEART_FAILURE_UP pancreatic carcinoma DOID_4905 6.647E-06 8.405E-05 1.146E-03 0.02835393 THUM_SYSTOLIC_HEART_FAILURE_UP syndrome DOID_225 7.732E-06 9.564E-05 0.01159181 0.09289775 THUM_SYSTOLIC_HEART_FAILURE_UP funisitis DOID_0050698 8.413E-06 1.019E-04 0.12380118 0.39798234 THUM_SYSTOLIC_HEART_FAILURE_UP gastric ulcer DOID_10808 8.413E-06 9.973E-05 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP acquired immunodeficiency syndrome DOID_635 8.413E-06 9.77E-05 7.62E-03 0.08029085 THUM_SYSTOLIC_HEART_FAILURE_UP myasthenia gravis DOID_437 1.014E-05 1.154E-04 8.313E-03 0.08016985 THUM_SYSTOLIC_HEART_FAILURE_UP uremia DOID_4676 1.014E-05 1.131E-04 8.313E-03 0.07883369 THUM_SYSTOLIC_HEART_FAILURE_UP pulmonary embolism DOID_9477 1.014E-05 1.109E-04 0.12905065 0.39691796 THUM_SYSTOLIC_HEART_FAILURE_UP pre-eclampsia DOID_10591 1.253E-05 1.345E-04 0.03622794 0.20821918 THUM_SYSTOLIC_HEART_FAILURE_UP heart valve disease DOID_4079 1.253E-05 1.32E-04 0.03622794 0.20613699 THUM_SYSTOLIC_HEART_FAILURE_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.522E-05 1.574E-04 2.705E-04 0.01026116 THUM_SYSTOLIC_HEART_FAILURE_UP lung small cell carcinoma DOID_5409 1.522E-05 1.546E-04 3.772E-03 0.05365603 THUM_SYSTOLIC_HEART_FAILURE_UP portal hypertension DOID_10762 1.687E-05 1.684E-04 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP bronchiolitis DOID_2942 1.687E-05 1.655E-04 0.14461193 0.41981728 THUM_SYSTOLIC_HEART_FAILURE_UP neuromuscular junction disease DOID_439 1.972E-05 1.901E-04 0.01135337 0.09362417 THUM_SYSTOLIC_HEART_FAILURE_UP nervous system cancer DOID_3093 2.002E-05 1.899E-04 0.10539726 0.35910803 THUM_SYSTOLIC_HEART_FAILURE_UP B cell deficiency DOID_2115 2.289E-05 2.136E-04 6.213E-04 0.02079695 THUM_SYSTOLIC_HEART_FAILURE_UP middle cerebral artery infarction DOID_3525 2.289E-05 2.101E-04 0.15483201 0.43398726 THUM_SYSTOLIC_HEART_FAILURE_UP vasculitis DOID_865 2.393E-05 2.161E-04 4.886E-03 0.06318339 THUM_SYSTOLIC_HEART_FAILURE_UP angioedema DOID_1558 2.465E-05 2.191E-04 0.05829594 0.29883234 THUM_SYSTOLIC_HEART_FAILURE_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.552E-05 2.234E-04 2.704E-03 0.04525643 THUM_SYSTOLIC_HEART_FAILURE_UP autoimmune disease of cardiovascular system DOID_0060051 3.036E-05 2.617E-04 0.01390613 0.10692687 THUM_SYSTOLIC_HEART_FAILURE_UP Behcet's disease DOID_13241 3.036E-05 2.617E-04 0.01390613 0.10692687 THUM_SYSTOLIC_HEART_FAILURE_UP autoimmune disease of endocrine system DOID_0060005 3.469E-05 2.946E-04 0.01480715 0.10664897 THUM_SYSTOLIC_HEART_FAILURE_UP congenital heart defect DOID_1682 4.889E-05 4.091E-04 0.32747624 0.67268584 THUM_SYSTOLIC_HEART_FAILURE_UP celiac disease DOID_10608 5.042E-05 4.157E-04 1.105E-03 0.02858835 THUM_SYSTOLIC_HEART_FAILURE_UP uterine disease DOID_345 5.647E-05 4.59E-04 7.976E-03 0.07824717 THUM_SYSTOLIC_HEART_FAILURE_UP hyperglycemia DOID_4195 6.059E-05 4.856E-04 6.059E-05 4.309E-03 THUM_SYSTOLIC_HEART_FAILURE_UP spindle cell carcinoma DOID_4015 7.079E-05 5.595E-04 0.02071664 0.13395191 THUM_SYSTOLIC_HEART_FAILURE_UP macular degeneration DOID_4448 7.079E-05 5.518E-04 0.1993385 0.49314612 THUM_SYSTOLIC_HEART_FAILURE_UP esophageal disease DOID_6050 7.079E-05 5.443E-04 1.416E-03 0.02779126 THUM_SYSTOLIC_HEART_FAILURE_UP parasitic helminthiasis infectious disease DOID_883 7.345E-05 5.572E-04 0.08065549 0.32548208 THUM_SYSTOLIC_HEART_FAILURE_UP polycystic kidney disease DOID_898 7.345E-05 5.499E-04 0.08065549 0.32318995 THUM_SYSTOLIC_HEART_FAILURE_UP bacterial meningitis DOID_9470 7.345E-05 5.427E-04 0.08065549 0.31650326 THUM_SYSTOLIC_HEART_FAILURE_UP male reproductive system disease DOID_48 8.476E-05 6.183E-04 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP cystic fibrosis DOID_1485 1.09E-04 7.847E-04 0.37432418 0.7499664 THUM_SYSTOLIC_HEART_FAILURE_UP hemolytic-uremic syndrome DOID_12554 1.12E-04 7.966E-04 1.12E-04 7.081E-03 THUM_SYSTOLIC_HEART_FAILURE_UP thyroiditis DOID_7166 1.12E-04 7.867E-04 0.09163625 0.33423734 THUM_SYSTOLIC_HEART_FAILURE_UP autoimmune thyroiditis DOID_7188 1.12E-04 7.867E-04 0.09163625 0.33423734 THUM_SYSTOLIC_HEART_FAILURE_UP Barrett's esophagus DOID_9206 1.12E-04 7.772E-04 1.12E-04 6.373E-03 THUM_SYSTOLIC_HEART_FAILURE_UP respiratory syncytial virus infectious disease DOID_1273 1.172E-04 8.034E-04 0.22304789 0.52661515 THUM_SYSTOLIC_HEART_FAILURE_UP congenital diaphragmatic hernia DOID_3827 1.172E-04 7.939E-04 0.22304789 0.52443906 THUM_SYSTOLIC_HEART_FAILURE_UP intracranial arterial disease DOID_13089 1.286E-04 8.61E-04 0.22770522 0.5310011 THUM_SYSTOLIC_HEART_FAILURE_UP cerebral arterial disease DOID_3527 1.286E-04 8.61E-04 0.22770522 0.5310011 THUM_SYSTOLIC_HEART_FAILURE_UP lymphatic system disease DOID_75 1.286E-04 8.51E-04 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP juvenile rheumatoid arthritis DOID_676 1.354E-04 8.855E-04 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP metabolic syndrome X DOID_14221 1.381E-04 8.93E-04 0.08685536 0.32513618 THUM_SYSTOLIC_HEART_FAILURE_UP benign mesothelioma DOID_2645 1.408E-04 9.003E-04 2.341E-03 0.04297154 THUM_SYSTOLIC_HEART_FAILURE_UP female reproductive system disease DOID_229 1.463E-04 9.247E-04 0.01369931 0.10677959 THUM_SYSTOLIC_HEART_FAILURE_UP endometriosis of uterus DOID_288 1.538E-04 9.619E-04 2.497E-03 0.04440678 THUM_SYSTOLIC_HEART_FAILURE_UP endometriosis DOID_289 1.677E-04 1.037E-03 2.66E-03 0.04586365 THUM_SYSTOLIC_HEART_FAILURE_UP uveal disease DOID_3480 1.677E-04 1.026E-03 0.24151107 0.55188674 THUM_SYSTOLIC_HEART_FAILURE_UP diabetic autonomic neuropathy DOID_11503 1.824E-04 1.104E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP autonomic neuropathy DOID_11504 1.824E-04 1.104E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP diabetic polyneuropathy DOID_12785 1.824E-04 1.104E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP influenza DOID_8469 1.824E-04 1.093E-03 0.0323432 0.18778857 THUM_SYSTOLIC_HEART_FAILURE_UP diabetic neuropathy DOID_9743 1.824E-04 1.104E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP agammaglobulinemia DOID_2583 1.912E-04 1.133E-03 5.708E-03 0.06627788 THUM_SYSTOLIC_HEART_FAILURE_UP cerebral infarction DOID_3526 1.981E-04 1.162E-03 0.25057818 0.56804377 THUM_SYSTOLIC_HEART_FAILURE_UP primary bacterial infectious disease DOID_0050338 2.031E-04 1.179E-03 0.41440746 0.81590949 THUM_SYSTOLIC_HEART_FAILURE_UP proteinuria DOID_576 2.147E-04 1.234E-03 0.25507119 0.57139964 THUM_SYSTOLIC_HEART_FAILURE_UP pulmonary edema DOID_11396 2.24E-04 1.275E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP blood protein disease DOID_620 2.24E-04 1.262E-03 6.317E-03 0.06912117 THUM_SYSTOLIC_HEART_FAILURE_UP autonomic nervous system disease DOID_11465 2.323E-04 1.296E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP hemolytic anemia DOID_583 2.509E-04 1.386E-03 2.509E-04 0.01019598 THUM_SYSTOLIC_HEART_FAILURE_UP normocytic anemia DOID_720 2.509E-04 1.386E-03 2.509E-04 0.01019598 THUM_SYSTOLIC_HEART_FAILURE_UP Kawasaki disease DOID_13378 2.602E-04 1.423E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP lymphadenitis DOID_1602 2.602E-04 1.423E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP lymph node disease DOID_9942 2.602E-04 1.423E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP glaucoma DOID_1686 2.705E-04 1.466E-03 3.772E-03 0.05503182 THUM_SYSTOLIC_HEART_FAILURE_UP pulmonary tuberculosis DOID_2957 2.705E-04 1.452E-03 0.26838994 0.59191424 THUM_SYSTOLIC_HEART_FAILURE_UP mouth disease DOID_403 2.891E-04 1.537E-03 2.704E-03 0.04396339 THUM_SYSTOLIC_HEART_FAILURE_UP Crohn's disease DOID_8778 2.891E-04 1.523E-03 0.43857303 0.85461662 THUM_SYSTOLIC_HEART_FAILURE_UP calcium metabolism disease DOID_10575 2.912E-04 1.52E-03 3.981E-03 0.05524569 THUM_SYSTOLIC_HEART_FAILURE_UP hemorrhagic disease DOID_2213 3.131E-04 1.619E-03 4.197E-03 0.05685321 THUM_SYSTOLIC_HEART_FAILURE_UP atopic dermatitis DOID_3310 3.36E-04 1.723E-03 0.04307596 0.2402963 THUM_SYSTOLIC_HEART_FAILURE_UP sexual disorder DOID_0060043 3.434E-04 1.745E-03 0.12905065 0.40568962 THUM_SYSTOLIC_HEART_FAILURE_UP polyarteritis nodosa DOID_9810 3.434E-04 1.729E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP diabetic angiopathy DOID_11713 3.907E-04 1.95E-03 0.13426881 0.41074706 THUM_SYSTOLIC_HEART_FAILURE_UP meningitis DOID_9471 3.907E-04 1.933E-03 0.13426881 0.40209975 THUM_SYSTOLIC_HEART_FAILURE_UP parasitic protozoa infectious disease DOID_2789 4.122E-04 2.022E-03 0.29432034 0.62722199 THUM_SYSTOLIC_HEART_FAILURE_UP spastic quadriplegia DOID_10970 4.42E-04 2.15E-03 9.78E-03 0.08975614 THUM_SYSTOLIC_HEART_FAILURE_UP hypersensitivity reaction type IV disease DOID_2916 5E-04 2.411E-03 0.30694032 0.64209207 THUM_SYSTOLIC_HEART_FAILURE_UP myositis DOID_633 5.572E-04 2.664E-03 0.01135337 0.09228668 THUM_SYSTOLIC_HEART_FAILURE_UP ankylosing spondylitis DOID_7147 5.572E-04 2.642E-03 0.14973726 0.42600249 THUM_SYSTOLIC_HEART_FAILURE_UP intracranial aneurysm DOID_10941 6.213E-04 2.922E-03 0.01217891 0.09624722 THUM_SYSTOLIC_HEART_FAILURE_UP periodontitis DOID_824 6.9E-04 3.218E-03 6.9E-04 0.02181148 THUM_SYSTOLIC_HEART_FAILURE_UP cholestasis DOID_13580 7.551E-04 3.493E-03 0.33551994 0.68426827 THUM_SYSTOLIC_HEART_FAILURE_UP cerebral degeneration DOID_1443 7.551E-04 3.465E-03 7.976E-03 0.07961993 THUM_SYSTOLIC_HEART_FAILURE_UP pleurisy DOID_10247 7.633E-04 3.474E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP sarcoma DOID_1115 7.633E-04 3.447E-03 0.16493051 0.44688316 THUM_SYSTOLIC_HEART_FAILURE_UP coronary stenosis DOID_4248 7.633E-04 3.42E-03 0.01390613 0.10550118 THUM_SYSTOLIC_HEART_FAILURE_UP toxic encephalopathy DOID_3602 8.414E-04 3.74E-03 0.16993463 0.44973397 THUM_SYSTOLIC_HEART_FAILURE_UP tooth disease DOID_1091 8.423E-04 3.715E-03 8.423E-04 0.02522476 THUM_SYSTOLIC_HEART_FAILURE_UP tuberculosis DOID_399 8.884E-04 3.889E-03 0.34740626 0.70597915 THUM_SYSTOLIC_HEART_FAILURE_UP spastic cerebral palsy DOID_0050669 1.012E-03 4.397E-03 0.01668238 0.11436473 THUM_SYSTOLIC_HEART_FAILURE_UP age related macular degeneration DOID_10871 1.012E-03 4.363E-03 0.17985346 0.4672905 THUM_SYSTOLIC_HEART_FAILURE_UP degeneration of macula and posterior pole DOID_2007 1.012E-03 4.363E-03 0.17985346 0.4672905 THUM_SYSTOLIC_HEART_FAILURE_UP bile duct disease DOID_4138 1.038E-03 4.439E-03 0.35908087 0.72452842 THUM_SYSTOLIC_HEART_FAILURE_UP biliary tract disease DOID_9741 1.091E-03 4.632E-03 0.36292601 0.72969929 THUM_SYSTOLIC_HEART_FAILURE_UP leiomyoma DOID_127 1.204E-03 5.073E-03 1.204E-03 0.02853687 THUM_SYSTOLIC_HEART_FAILURE_UP pleural disease DOID_1532 1.204E-03 5.036E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP arrhythmogenic right ventricular dysplasia DOID_0050431 1.25E-03 5.191E-03 1.25E-03 0.02844818 THUM_SYSTOLIC_HEART_FAILURE_UP myocarditis DOID_820 1.307E-03 5.39E-03 0.01967339 0.12866846 THUM_SYSTOLIC_HEART_FAILURE_UP mixed glioma DOID_5076 1.387E-03 5.677E-03 0.38180993 0.75961485 THUM_SYSTOLIC_HEART_FAILURE_UP periodontal disease DOID_3388 1.416E-03 5.757E-03 1.416E-03 0.02878381 THUM_SYSTOLIC_HEART_FAILURE_UP Sjogren's syndrome DOID_12894 1.556E-03 6.28E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP acute kidney failure DOID_3021 1.556E-03 6.236E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP insulinoma DOID_3892 1.556E-03 6.192E-03 0.05829594 0.28843817 THUM_SYSTOLIC_HEART_FAILURE_UP visceral leishmaniasis DOID_9146 1.556E-03 6.149E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP auditory system disease DOID_2742 1.661E-03 6.517E-03 0.01414519 0.10452743 THUM_SYSTOLIC_HEART_FAILURE_UP focal epilepsy DOID_2234 1.735E-03 6.76E-03 0.01459923 0.10649953 THUM_SYSTOLIC_HEART_FAILURE_UP chronic kidney failure DOID_784 1.735E-03 6.714E-03 0.09230759 0.32826886 THUM_SYSTOLIC_HEART_FAILURE_UP calcinosis DOID_182 1.777E-03 6.834E-03 0.02398084 0.14831629 THUM_SYSTOLIC_HEART_FAILURE_UP sickle cell anemia DOID_10923 1.895E-03 7.235E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP peripheral nervous system neoplasm DOID_1192 1.909E-03 7.243E-03 0.21836261 0.51770135 THUM_SYSTOLIC_HEART_FAILURE_UP uveitis DOID_13141 1.909E-03 7.195E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP blood platelet disease DOID_2218 1.909E-03 7.148E-03 0.02511271 0.15364659 THUM_SYSTOLIC_HEART_FAILURE_UP adult respiratory distress syndrome DOID_11394 2.191E-03 8.149E-03 0.02744037 0.16435336 THUM_SYSTOLIC_HEART_FAILURE_UP esophageal carcinoma DOID_1107 2.265E-03 8.367E-03 0.06954258 0.31404546 THUM_SYSTOLIC_HEART_FAILURE_UP islet cell tumor DOID_1799 2.265E-03 8.313E-03 0.06954258 0.3091385 THUM_SYSTOLIC_HEART_FAILURE_UP esophagus squamous cell carcinoma DOID_3748 2.265E-03 8.367E-03 0.06954258 0.31404546 THUM_SYSTOLIC_HEART_FAILURE_UP aortic valve insufficiency DOID_57 2.265E-03 8.26E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP ocular hypertension DOID_9282 2.265E-03 8.207E-03 0.06954258 0.30205899 THUM_SYSTOLIC_HEART_FAILURE_UP borderline glaucoma DOID_9283 2.265E-03 8.207E-03 0.06954258 0.30205899 THUM_SYSTOLIC_HEART_FAILURE_UP impotence DOID_1875 2.666E-03 9.6E-03 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP psoriatic arthritis DOID_9008 2.666E-03 9.54E-03 0.07511565 0.31197668 THUM_SYSTOLIC_HEART_FAILURE_UP viral pneumonia DOID_10533 3.098E-03 0.01101644 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP rhabdomyosarcoma DOID_3247 3.098E-03 0.01094801 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP narcolepsy DOID_8986 3.098E-03 0.01088043 0.08065549 0.32092988 THUM_SYSTOLIC_HEART_FAILURE_UP brain cancer DOID_1319 3.375E-03 0.01178042 0.25953738 0.57912459 THUM_SYSTOLIC_HEART_FAILURE_UP peripheral neuropathy DOID_0060053 3.56E-03 0.01235246 3.56E-03 0.05475144 THUM_SYSTOLIC_HEART_FAILURE_UP thoracic aortic aneurysm DOID_14004 3.56E-03 0.01227759 0.08616229 0.33351253 THUM_SYSTOLIC_HEART_FAILURE_UP skeletal muscle cancer DOID_4043 3.56E-03 0.01220363 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP lung oat cell carcinoma DOID_5411 3.56E-03 0.01213056 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP varicose veins DOID_799 3.56E-03 0.01205835 0.08616229 0.32684228 THUM_SYSTOLIC_HEART_FAILURE_UP central nervous system cancer DOID_3620 3.57E-03 0.01201952 0.26397691 0.58672993 THUM_SYSTOLIC_HEART_FAILURE_UP aortic aneurysm DOID_3627 3.981E-03 0.01332396 0.27277662 0.59926602 THUM_SYSTOLIC_HEART_FAILURE_UP angiosarcoma DOID_0001816 4.053E-03 0.01348596 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP spastic diplegia DOID_10965 4.053E-03 0.01340756 0.09163625 0.33857808 THUM_SYSTOLIC_HEART_FAILURE_UP vein disease DOID_866 4.053E-03 0.01333006 0.09163625 0.33000649 THUM_SYSTOLIC_HEART_FAILURE_UP penile disease DOID_1529 4.575E-03 0.01496154 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP hyperostosis DOID_205 4.575E-03 0.01487604 4.575E-03 0.06054204 THUM_SYSTOLIC_HEART_FAILURE_UP bronchitis DOID_6132 4.575E-03 0.01479152 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP peroxisomal disease DOID_906 4.575E-03 0.01470795 0.09707756 0.33887811 THUM_SYSTOLIC_HEART_FAILURE_UP sarcoidosis DOID_11335 4.649E-03 0.01486122 0.28578017 0.61828486 THUM_SYSTOLIC_HEART_FAILURE_UP bone marrow cancer DOID_4960 4.886E-03 0.01553111 0.29006304 0.6228146 THUM_SYSTOLIC_HEART_FAILURE_UP keratosis DOID_161 5.127E-03 0.01620676 0.10248642 0.35342288 THUM_SYSTOLIC_HEART_FAILURE_UP sexual dysfunction DOID_1876 5.127E-03 0.01611722 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP inherited blood coagulation disease DOID_2214 5.127E-03 0.01602866 5.127E-03 0.06482702 THUM_SYSTOLIC_HEART_FAILURE_UP reproductive organ benign neoplasm DOID_0050622 5.13E-03 0.01595036 5.13E-03 0.06345469 THUM_SYSTOLIC_HEART_FAILURE_UP Down syndrome DOID_14250 5.708E-03 0.01765009 5.708E-03 0.06765867 THUM_SYSTOLIC_HEART_FAILURE_UP MHC class II deficiency DOID_5812 5.708E-03 0.01755468 5.708E-03 0.06495232 THUM_SYSTOLIC_HEART_FAILURE_UP leishmaniasis DOID_9065 5.708E-03 0.0174603 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP nonsyndromic deafness DOID_0050563 5.906E-03 0.01796916 5.906E-03 0.06588691 THUM_SYSTOLIC_HEART_FAILURE_UP hypertrophic cardiomyopathy DOID_11984 5.906E-03 0.01787358 0.30694032 0.64446141 THUM_SYSTOLIC_HEART_FAILURE_UP amyloidosis DOID_9120 6.317E-03 0.01901746 6.317E-03 0.067817 THUM_SYSTOLIC_HEART_FAILURE_UP autoimmune hepatitis DOID_2048 6.954E-03 0.02082666 0.11852022 0.38536002 THUM_SYSTOLIC_HEART_FAILURE_UP hepatitis B DOID_2043 7.62E-03 0.02270003 0.12380118 0.39353561 THUM_SYSTOLIC_HEART_FAILURE_UP thrombophilia DOID_2452 7.62E-03 0.0225818 0.12380118 0.3913493 THUM_SYSTOLIC_HEART_FAILURE_UP muscular atrophy DOID_767 7.62E-03 0.0224648 7.62E-03 0.07883101 THUM_SYSTOLIC_HEART_FAILURE_UP temporal lobe epilepsy DOID_3328 8.302E-03 0.02435045 0.06448133 0.29588612 THUM_SYSTOLIC_HEART_FAILURE_UP muscle cancer DOID_4045 8.313E-03 0.02425652 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP sleep disorder DOID_535 8.313E-03 0.02413276 0.12905065 0.39907512 THUM_SYSTOLIC_HEART_FAILURE_UP Lewy body dementia DOID_12217 9.033E-03 0.02609042 0.13426881 0.40637741 THUM_SYSTOLIC_HEART_FAILURE_UP aortic valve disease DOID_62 9.033E-03 0.02595865 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP Goodpasture syndrome DOID_9808 9.033E-03 0.0258282 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP toxic shock syndrome DOID_14115 9.78E-03 0.0278244 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP severe combined immunodeficiency DOID_627 9.78E-03 0.02768597 9.78E-03 0.08833143 THUM_SYSTOLIC_HEART_FAILURE_UP commensal bacterial infectious disease DOID_0050339 0.01055366 0.02972787 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP hypogonadism DOID_1924 0.01055366 0.02958143 0.14461193 0.42197019 THUM_SYSTOLIC_HEART_FAILURE_UP combined T cell and B cell immunodeficiency DOID_628 0.01055366 0.02943642 0.01055366 0.09098531 THUM_SYSTOLIC_HEART_FAILURE_UP morbid obesity DOID_11981 0.01135337 0.03151253 0.14973726 0.43030555 THUM_SYSTOLIC_HEART_FAILURE_UP infantile epileptic encephalopathy DOID_2481 0.01135337 0.03135955 0.01135337 0.095001 THUM_SYSTOLIC_HEART_FAILURE_UP seminoma DOID_4440 0.01217891 0.03347729 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP extrinsic allergic alveolitis DOID_841 0.01217891 0.03331635 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP Sciatic Neuropathy DOID_11446 0.01302994 0.03547386 0.15989637 0.4416555 THUM_SYSTOLIC_HEART_FAILURE_UP gestational diabetes DOID_11714 0.01302994 0.03530494 0.15989637 0.4395219 THUM_SYSTOLIC_HEART_FAILURE_UP lesion of sciatic nerve DOID_12528 0.01302994 0.03547386 0.15989637 0.4416555 THUM_SYSTOLIC_HEART_FAILURE_UP migraine DOID_6364 0.01302994 0.03513761 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP perinatal necrotizing enterocolitis DOID_8677 0.01302994 0.03497187 0.15989637 0.43531595 THUM_SYSTOLIC_HEART_FAILURE_UP mononeuritis of lower limb DOID_9473 0.01302994 0.03547386 0.15989637 0.4416555 THUM_SYSTOLIC_HEART_FAILURE_UP renal hypertension DOID_1073 0.01390613 0.0371483 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP secondary hypertension DOID_11130 0.01390613 0.0371483 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP malaria DOID_12365 0.01390613 0.03697471 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP mononeuritis DOID_1802 0.01390613 0.03680274 0.16493051 0.44266728 THUM_SYSTOLIC_HEART_FAILURE_UP biliary tract cancer DOID_4607 0.01459923 0.03845816 0.09230759 0.33033345 THUM_SYSTOLIC_HEART_FAILURE_UP mononeuropathy DOID_1188 0.01480715 0.03882612 0.16993463 0.45183553 THUM_SYSTOLIC_HEART_FAILURE_UP focal glomerulosclerosis DOID_3945 0.01480715 0.03864802 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP bone development disease DOID_0080006 0.01506146 0.0391323 0.01506146 0.10712467 THUM_SYSTOLIC_HEART_FAILURE_UP female reproductive organ benign neoplasm DOID_0060086 0.01573267 0.04069041 0.01573267 0.11051717 THUM_SYSTOLIC_HEART_FAILURE_UP uterine benign neoplasm DOID_0060095 0.01573267 0.04069041 0.01573267 0.11051717 THUM_SYSTOLIC_HEART_FAILURE_UP corneal disease DOID_10124 0.01573267 0.04050629 0.17490888 0.45863205 THUM_SYSTOLIC_HEART_FAILURE_UP uterine fibroid DOID_13223 0.01573267 0.04069041 0.01573267 0.11051717 THUM_SYSTOLIC_HEART_FAILURE_UP dysostosis DOID_1934 0.01573267 0.04032383 0.01573267 0.1091694 THUM_SYSTOLIC_HEART_FAILURE_UP gonadal disease DOID_2277 0.01668238 0.04256624 0.17985346 0.46516645 THUM_SYSTOLIC_HEART_FAILURE_UP opportunistic mycosis DOID_2473 0.01668238 0.04237622 0.17985346 0.46306163 THUM_SYSTOLIC_HEART_FAILURE_UP Charcot-Marie-Tooth disease DOID_10595 0.01765594 0.04464991 0.01765594 0.11959798 THUM_SYSTOLIC_HEART_FAILURE_UP germinoma DOID_3304 0.01765594 0.04445235 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP allergic rhinitis DOID_4481 0.01765594 0.04425652 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP autonomic nervous system neoplasm DOID_2621 0.01865305 0.04655081 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP neuroblastoma DOID_769 0.01865305 0.04655081 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP lymphoma DOID_0060058 0.01905569 0.04734799 0.43177173 0.84716591 THUM_SYSTOLIC_HEART_FAILURE_UP lymphoblastic leukemia DOID_1037 0.01959217 0.04846934 0.01959217 0.1296273 THUM_SYSTOLIC_HEART_FAILURE_UP systemic mycosis DOID_0050136 0.01967339 0.04845955 0.19451089 0.49409238 THUM_SYSTOLIC_HEART_FAILURE_UP fungal infectious disease DOID_1564 0.01967339 0.04845955 0.19451089 0.49409238 THUM_SYSTOLIC_HEART_FAILURE_UP metal metabolism disorder DOID_896 0.01967339 0.04825067 0.19451089 0.48756253 THUM_SYSTOLIC_HEART_FAILURE_UP hepatitis C DOID_1883 0.02071664 0.05059128 0.1993385 0.49747197 THUM_SYSTOLIC_HEART_FAILURE_UP hyperthyroidism DOID_7998 0.02071664 0.05037508 0.1993385 0.48889486 THUM_SYSTOLIC_HEART_FAILURE_UP lymphoid leukemia DOID_10747 0.0217825 0.05274147 0.0217825 0.13926118 THUM_SYSTOLIC_HEART_FAILURE_UP adenoma DOID_657 0.02287067 0.05514158 0.20890749 0.50582281 THUM_SYSTOLIC_HEART_FAILURE_UP refractive error DOID_9835 0.02287067 0.05490891 0.02287067 0.14300453 THUM_SYSTOLIC_HEART_FAILURE_UP pulmonary emphysema DOID_9675 0.02863557 0.06846067 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP primitive neuroectodermal tumor DOID_168 0.03108727 0.07401111 0.24151107 0.55635546 THUM_SYSTOLIC_HEART_FAILURE_UP idiopathic generalized epilepsy DOID_1827 0.03108727 0.07370273 0.03108727 0.18425683 THUM_SYSTOLIC_HEART_FAILURE_UP hyperinsulinism DOID_2018 0.03108727 0.07339691 0.24151107 0.55411209 THUM_SYSTOLIC_HEART_FAILURE_UP gallbladder cancer DOID_3121 0.0323432 0.07604661 0.0323432 0.18972454 THUM_SYSTOLIC_HEART_FAILURE_UP learning disability DOID_8927 0.03361881 0.07872058 0.25057818 0.56578963 THUM_SYSTOLIC_HEART_FAILURE_UP leukodystrophy DOID_10579 0.03491381 0.08141786 0.25507119 0.57365813 THUM_SYSTOLIC_HEART_FAILURE_UP myeloma DOID_0070004 0.03622794 0.08413755 1.000 1.000 THUM_SYSTOLIC_HEART_FAILURE_UP integumentary system benign neoplasm DOID_0060121 0.03891248 0.09000488 0.26838994 0.59421741 THUM_SYSTOLIC_HEART_FAILURE_UP skin benign neoplasm DOID_3165 0.03891248 0.09000488 0.26838994 0.59421741 THUM_SYSTOLIC_HEART_FAILURE_UP B-cell lymphocytic neoplasm DOID_707 0.04167027 0.09599344 1.000 1.000 GOZGIT_ESR1_TARGETS_UP middle cerebral artery infarction DOID_3525 2.509E-09 1.428E-06 2.509E-09 1.428E-06 GOZGIT_ESR1_TARGETS_UP intracranial arterial disease DOID_13089 2.402E-08 6.833E-06 2.402E-08 6.833E-06 GOZGIT_ESR1_TARGETS_UP cerebral arterial disease DOID_3527 2.402E-08 6.833E-06 2.402E-08 6.833E-06 GOZGIT_ESR1_TARGETS_UP cerebral infarction DOID_3526 4.24E-08 8.041E-06 4.24E-08 8.041E-06 GOZGIT_ESR1_TARGETS_UP brain infarction DOID_3454 3.112E-07 4.426E-05 3.112E-07 4.426E-05 GOZGIT_ESR1_TARGETS_UP bacterial pneumonia DOID_874 1.994E-05 2.269E-03 5.476E-04 0.01832922 GOZGIT_ESR1_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.088E-05 3.877E-03 4.088E-05 4.653E-03 GOZGIT_ESR1_TARGETS_UP ulcerative colitis DOID_8577 4.797E-05 3.899E-03 4.797E-05 4.549E-03 GOZGIT_ESR1_TARGETS_UP aortic aneurysm DOID_3627 1.622E-04 0.01153923 1.622E-04 0.01318769 GOZGIT_ESR1_TARGETS_UP withdrawal disorder DOID_0060001 1.715E-04 0.01084504 1.715E-04 0.01220067 GOZGIT_ESR1_TARGETS_UP vasculitis DOID_865 2.015E-04 0.01146506 5.744E-03 0.09079251 GOZGIT_ESR1_TARGETS_UP oral cavity cancer DOID_8618 2.464E-04 0.0127475 2.464E-04 0.01558028 GOZGIT_ESR1_TARGETS_UP epidermolysis bullosa DOID_2730 2.516E-04 0.01193091 2.516E-04 0.01431709 GOZGIT_ESR1_TARGETS_UP vesiculobullous skin disease DOID_2731 2.97E-04 0.01299885 2.97E-04 0.01536228 GOZGIT_ESR1_TARGETS_UP respiratory failure DOID_11162 2.974E-04 0.01208718 7.41E-03 0.10284263 GOZGIT_ESR1_TARGETS_UP pre-malignant neoplasm DOID_0060071 3.111E-04 0.01180182 3.111E-04 0.01475228 GOZGIT_ESR1_TARGETS_UP in situ carcinoma DOID_8719 3.111E-04 0.01180182 3.111E-04 0.01475228 GOZGIT_ESR1_TARGETS_UP nephrosis DOID_2527 4.358E-04 0.01549681 4.358E-04 0.01907299 GOZGIT_ESR1_TARGETS_UP peripheral vascular disease DOID_341 4.533E-04 0.01517142 0.13814313 0.49127151 GOZGIT_ESR1_TARGETS_UP tongue cancer DOID_8649 4.551E-04 0.01438771 4.551E-04 0.01849848 GOZGIT_ESR1_TARGETS_UP diabetic retinopathy DOID_8947 4.712E-04 0.01411226 0.01001265 0.13249298 GOZGIT_ESR1_TARGETS_UP adrenal gland disease DOID_9553 5.152E-04 0.01465666 5.152E-04 0.01954221 GOZGIT_ESR1_TARGETS_UP aneurysm disease DOID_2403 5.278E-04 0.01430177 5.278E-04 0.01877108 GOZGIT_ESR1_TARGETS_UP metabolic syndrome X DOID_14221 5.886E-04 0.01522357 0.01157877 0.14973452 GOZGIT_ESR1_TARGETS_UP agammaglobulinemia DOID_2583 6.461E-04 0.01598384 0.03693484 0.29599895 GOZGIT_ESR1_TARGETS_UP chronic kidney failure DOID_784 6.537E-04 0.01549777 6.537E-04 0.0206637 GOZGIT_ESR1_TARGETS_UP retinal vascular disease DOID_2462 6.995E-04 0.015921 0.01296058 0.15690575 GOZGIT_ESR1_TARGETS_UP pulmonary edema DOID_11396 7.17E-04 0.01569049 0.03884105 0.29865616 GOZGIT_ESR1_TARGETS_UP blood protein disease DOID_620 7.17E-04 0.01510936 0.03884105 0.29079678 GOZGIT_ESR1_TARGETS_UP lymphoma DOID_0060058 8.759E-04 0.01779956 8.759E-04 0.02623093 GOZGIT_ESR1_TARGETS_UP carbohydrate metabolic disorder DOID_2978 9.032E-04 0.01772108 9.032E-04 0.02569557 GOZGIT_ESR1_TARGETS_UP Crohn's disease DOID_8778 9.31E-04 0.01765796 9.31E-04 0.02522566 GOZGIT_ESR1_TARGETS_UP portal hypertension DOID_10762 1.217E-03 0.02233779 1.217E-03 0.03147598 GOZGIT_ESR1_TARGETS_UP urticaria DOID_1555 1.217E-03 0.02163973 0.05020034 0.32459086 GOZGIT_ESR1_TARGETS_UP cystitis DOID_1679 1.313E-03 0.02263371 0.05208064 0.32926537 GOZGIT_ESR1_TARGETS_UP B cell deficiency DOID_2115 1.412E-03 0.02362759 0.05395726 0.33012561 GOZGIT_ESR1_TARGETS_UP spinal cord disease DOID_319 1.412E-03 0.02295252 0.05395726 0.32661363 GOZGIT_ESR1_TARGETS_UP dystonia DOID_543 1.412E-03 0.02231495 1.412E-03 0.03492775 GOZGIT_ESR1_TARGETS_UP Sciatic Neuropathy DOID_11446 1.514E-03 0.0232903 1.514E-03 0.03590588 GOZGIT_ESR1_TARGETS_UP lesion of sciatic nerve DOID_12528 1.514E-03 0.0232903 1.514E-03 0.03590588 GOZGIT_ESR1_TARGETS_UP mononeuritis of lower limb DOID_9473 1.514E-03 0.0232903 1.514E-03 0.03590588 GOZGIT_ESR1_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 1.621E-03 0.02426614 0.05769952 0.33501045 GOZGIT_ESR1_TARGETS_UP Behcet's disease DOID_13241 1.621E-03 0.02426614 0.05769952 0.33501045 GOZGIT_ESR1_TARGETS_UP thrombocytopenia DOID_1588 1.621E-03 0.02364393 0.05769952 0.32831024 GOZGIT_ESR1_TARGETS_UP mononeuritis DOID_1802 1.621E-03 0.02305283 1.621E-03 0.03688453 GOZGIT_ESR1_TARGETS_UP hepatic vascular disease DOID_272 1.621E-03 0.02249057 1.621E-03 0.03546589 GOZGIT_ESR1_TARGETS_UP polycystic ovary syndrome DOID_11612 1.73E-03 0.02343921 0.05956516 0.33557007 GOZGIT_ESR1_TARGETS_UP mononeuropathy DOID_1188 1.73E-03 0.02289411 1.73E-03 0.03646099 GOZGIT_ESR1_TARGETS_UP toxic encephalopathy DOID_3602 1.73E-03 0.02237379 1.73E-03 0.03515882 GOZGIT_ESR1_TARGETS_UP bladder disease DOID_365 2.203E-03 0.02784978 0.06699137 0.34340621 GOZGIT_ESR1_TARGETS_UP esophageal disease DOID_6050 2.459E-03 0.03041748 0.07068275 0.34972593 GOZGIT_ESR1_TARGETS_UP blood platelet disease DOID_2218 3.012E-03 0.03646724 0.07802232 0.35802179 GOZGIT_ESR1_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 3.462E-03 0.04103672 3.462E-03 0.06792284 GOZGIT_ESR1_TARGETS_UP nephrotic syndrome DOID_1184 3.778E-03 0.04386902 3.778E-03 0.07165273 GOZGIT_ESR1_TARGETS_UP pre-eclampsia DOID_10591 4.449E-03 0.05062472 4.449E-03 0.08165277 GOZGIT_ESR1_TARGETS_UP neuritis DOID_1803 4.449E-03 0.04963208 4.449E-03 0.07910112 GOZGIT_ESR1_TARGETS_UP thyroid adenoma DOID_2891 4.449E-03 0.04867761 4.449E-03 0.07670412 GOZGIT_ESR1_TARGETS_UP vascular skin disease DOID_9540 4.449E-03 0.04775917 0.0943279 0.39177063 GOZGIT_ESR1_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 4.803E-03 0.05061022 0.09791254 0.40371186 GOZGIT_ESR1_TARGETS_UP integumentary system benign neoplasm DOID_0060121 4.803E-03 0.04969003 4.803E-03 0.08038093 GOZGIT_ESR1_TARGETS_UP pulmonary tuberculosis DOID_2957 4.803E-03 0.04880271 0.09791254 0.40080746 GOZGIT_ESR1_TARGETS_UP skin benign neoplasm DOID_3165 4.803E-03 0.04969003 4.803E-03 0.08038093 GOZGIT_ESR1_TARGETS_UP hemorrhagic disease DOID_2213 5.17E-03 0.05161138 0.10148318 0.40953143 GOZGIT_ESR1_TARGETS_UP bile duct adenocarcinoma DOID_4896 5.744E-03 0.05635397 5.744E-03 0.09338658 GOZGIT_ESR1_TARGETS_UP cholangiocarcinoma DOID_4947 5.744E-03 0.05635397 5.744E-03 0.09338658 GOZGIT_ESR1_TARGETS_UP integumentary system cancer DOID_0060122 5.942E-03 0.05730426 5.942E-03 0.09137707 GOZGIT_ESR1_TARGETS_UP skin cancer DOID_4159 5.942E-03 0.05730426 5.942E-03 0.09137707 GOZGIT_ESR1_TARGETS_UP congenital nervous system abnormality DOID_2490 6.346E-03 0.06018404 6.346E-03 0.09502743 GOZGIT_ESR1_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 6.553E-03 0.06112618 6.553E-03 0.09560762 GOZGIT_ESR1_TARGETS_UP bile duct cancer DOID_4606 6.553E-03 0.06014028 6.553E-03 0.09321743 GOZGIT_ESR1_TARGETS_UP bile duct carcinoma DOID_4897 6.553E-03 0.06014028 6.553E-03 0.09321743 GOZGIT_ESR1_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 8.786E-03 0.07935302 8.786E-03 0.11902953 GOZGIT_ESR1_TARGETS_UP tuberculosis DOID_399 8.786E-03 0.07811313 0.13127596 0.47882066 GOZGIT_ESR1_TARGETS_UP blood coagulation disease DOID_1247 9.268E-03 0.08113064 0.13471627 0.48823922 GOZGIT_ESR1_TARGETS_UP syndrome DOID_225 0.01052339 0.09072437 0.14325833 0.50008584 GOZGIT_ESR1_TARGETS_UP pancreatitis DOID_4989 0.01104546 0.09380398 0.14665181 0.50268001 GOZGIT_ESR1_TARGETS_UP lipid metabolism disorder DOID_3146 0.01157877 0.09688704 0.01157877 0.14640708 CHANDRAN_METASTASIS_DN oral cavity cancer DOID_8618 1.678E-09 9.547E-07 6.575E-08 3.741E-05 CHANDRAN_METASTASIS_DN mouth disease DOID_403 4.154E-08 1.182E-05 9.961E-07 1.417E-04 CHANDRAN_METASTASIS_DN adenoid cystic carcinoma DOID_4866 3.661E-07 6.944E-05 3.661E-07 1.042E-04 CHANDRAN_METASTASIS_DN salivary gland cancer DOID_8850 4.622E-07 6.574E-05 4.622E-07 8.766E-05 CHANDRAN_METASTASIS_DN tooth disease DOID_1091 4.277E-06 4.867E-04 4.277E-06 4.867E-04 CHANDRAN_METASTASIS_DN nephroblastoma DOID_2154 7.745E-06 7.345E-04 7.078E-03 0.11507046 CHANDRAN_METASTASIS_DN aneurysm disease DOID_2403 7.772E-06 6.318E-04 1.578E-04 0.01122189 CHANDRAN_METASTASIS_DN skeletal system cancer DOID_0060124 1.7E-05 1.209E-03 1.172E-03 0.04445157 CHANDRAN_METASTASIS_DN bone cancer DOID_184 1.7E-05 1.209E-03 1.172E-03 0.04445157 CHANDRAN_METASTASIS_DN uterine cancer DOID_363 2.037E-05 1.288E-03 5.594E-04 0.02893569 CHANDRAN_METASTASIS_DN proteinuria DOID_576 2.407E-05 1.37E-03 6.325E-04 0.02768193 CHANDRAN_METASTASIS_DN lung small cell carcinoma DOID_5409 3.052E-05 1.579E-03 3.052E-05 2.894E-03 CHANDRAN_METASTASIS_DN bile duct adenocarcinoma DOID_4896 4.395E-05 2.084E-03 0.01622876 0.18845228 CHANDRAN_METASTASIS_DN cholangiocarcinoma DOID_4947 4.395E-05 2.084E-03 0.01622876 0.18845228 CHANDRAN_METASTASIS_DN bile duct cancer DOID_4606 5.745E-05 2.515E-03 0.01844494 0.20183022 CHANDRAN_METASTASIS_DN bile duct carcinoma DOID_4897 5.745E-05 2.515E-03 0.01844494 0.20183022 CHANDRAN_METASTASIS_DN urinary tract obstruction DOID_5200 6.485E-05 2.636E-03 0.07542259 0.38317367 CHANDRAN_METASTASIS_DN ureteral disease DOID_1426 7.393E-05 2.804E-03 3.019E-03 0.07469126 CHANDRAN_METASTASIS_DN teeth hard tissue disease DOID_214 1.185E-04 4.213E-03 1.185E-04 9.63E-03 CHANDRAN_METASTASIS_DN mixed glioma DOID_5076 1.656E-04 5.544E-03 2.612E-03 0.07077806 CHANDRAN_METASTASIS_DN dysostosis DOID_1934 1.776E-04 5.614E-03 1.776E-04 0.01122851 CHANDRAN_METASTASIS_DN endometrial carcinoma DOID_2871 1.776E-04 5.319E-03 5.33E-03 0.09783451 CHANDRAN_METASTASIS_DN biliary tract cancer DOID_4607 2.093E-04 5.955E-03 0.03413702 0.31328972 CHANDRAN_METASTASIS_DN endometrial cancer DOID_1380 2.132E-04 5.777E-03 6.002E-03 0.10348907 CHANDRAN_METASTASIS_DN transitional cell carcinoma DOID_2671 2.607E-04 6.742E-03 0.03788041 0.3079136 CHANDRAN_METASTASIS_DN rectal neoplasm DOID_1984 5.078E-04 0.01256366 5.078E-04 0.02889643 CHANDRAN_METASTASIS_DN rectum cancer DOID_1993 5.078E-04 0.01256366 5.078E-04 0.02889643 CHANDRAN_METASTASIS_DN familial adenomatous polyposis DOID_0050424 6.193E-04 0.01468298 0.03680419 0.33240606 CHANDRAN_METASTASIS_DN nervous system benign neoplasm DOID_0060115 6.193E-04 0.01409566 6.193E-04 0.02936595 CHANDRAN_METASTASIS_DN pre-eclampsia DOID_10591 6.712E-04 0.01468798 0.01265011 0.1755588 CHANDRAN_METASTASIS_DN heart valve disease DOID_4079 6.712E-04 0.01414398 0.01265011 0.16739327 CHANDRAN_METASTASIS_DN glaucoma DOID_1686 7.53E-04 0.01530244 0.01363278 0.17237891 CHANDRAN_METASTASIS_DN aortic aneurysm DOID_3627 7.962E-04 0.0156225 0.01413617 0.17485831 CHANDRAN_METASTASIS_DN withdrawal disorder DOID_0060001 8.41E-04 0.01595052 0.01464753 0.17732857 CHANDRAN_METASTASIS_DN monocytic leukemia DOID_8527 8.744E-04 0.01604938 8.744E-04 0.03553791 CHANDRAN_METASTASIS_DN open-angle glaucoma DOID_1067 1.018E-03 0.01809875 0.04660628 0.31570204 CHANDRAN_METASTASIS_DN arthropathy DOID_381 1.172E-03 0.02020526 1.172E-03 0.04167335 CHANDRAN_METASTASIS_DN lung oat cell carcinoma DOID_5411 1.172E-03 0.01961099 1.172E-03 0.03922198 CHANDRAN_METASTASIS_DN oral submucous fibrosis DOID_5773 1.172E-03 0.01905067 0.04985159 0.31871412 CHANDRAN_METASTASIS_DN tongue cancer DOID_8649 1.336E-03 0.0211203 0.05308595 0.32133942 CHANDRAN_METASTASIS_DN urinary system benign neoplasm DOID_731 1.511E-03 0.02323759 1.000 1.000 CHANDRAN_METASTASIS_DN dental caries DOID_216 1.696E-03 0.0253977 1.696E-03 0.05361737 CHANDRAN_METASTASIS_DN osteosclerosis DOID_4254 1.696E-03 0.02474648 1.696E-03 0.05079541 CHANDRAN_METASTASIS_DN ureteral obstruction DOID_5199 1.696E-03 0.02412782 0.05952192 0.33203896 CHANDRAN_METASTASIS_DN granulosa cell tumor DOID_2999 1.891E-03 0.02625015 0.06272361 0.34317054 CHANDRAN_METASTASIS_DN microphthalmia DOID_10629 2.097E-03 0.02840908 2.097E-03 0.05965907 CHANDRAN_METASTASIS_DN sex cord-gonadal stromal tumor DOID_192 2.097E-03 0.02774841 0.06591449 0.35051724 CHANDRAN_METASTASIS_DN pancreatitis DOID_4989 2.612E-03 0.03378044 0.03054895 0.30495354 CHANDRAN_METASTASIS_DN synostosis DOID_11971 3.019E-03 0.03817553 3.019E-03 0.07808631 CHANDRAN_METASTASIS_DN aortic valve disease DOID_62 3.019E-03 0.03734563 0.07857056 0.38875347 CHANDRAN_METASTASIS_DN Goodpasture syndrome DOID_9808 3.019E-03 0.03655104 3.019E-03 0.07157912 CHANDRAN_METASTASIS_DN bone development disease DOID_0080006 3.206E-03 0.03800453 3.206E-03 0.07296869 CHANDRAN_METASTASIS_DN portal hypertension DOID_10762 3.539E-03 0.04110032 0.08483464 0.40907551 CHANDRAN_METASTASIS_DN myositis DOID_633 3.814E-03 0.04340403 0.08795082 0.41019684 CHANDRAN_METASTASIS_DN spinal cord disease DOID_319 4.098E-03 0.0457246 4.098E-03 0.08969055 CHANDRAN_METASTASIS_DN middle cerebral artery infarction DOID_3525 4.098E-03 0.04484528 4.098E-03 0.08636868 CHANDRAN_METASTASIS_DN lymphoblastic leukemia DOID_1037 4.241E-03 0.04553131 0.04177294 0.30868571 CHANDRAN_METASTASIS_DN dilated cardiomyopathy DOID_12930 4.495E-03 0.04736818 0.04337035 0.29732203 CHANDRAN_METASTASIS_DN hepatic vascular disease DOID_272 4.695E-03 0.0485765 0.09723631 0.41599596 CHANDRAN_METASTASIS_DN supratentorial cancer DOID_1659 5.008E-03 0.05088628 5.008E-03 0.10177255 CHANDRAN_METASTASIS_DN toxic encephalopathy DOID_3602 5.008E-03 0.04999354 5.008E-03 0.09826316 CHANDRAN_METASTASIS_DN cerebrum cancer DOID_368 5.008E-03 0.05088628 5.008E-03 0.10177255 CHANDRAN_METASTASIS_DN female reproductive organ benign neoplasm DOID_0060086 5.33E-03 0.05229086 5.33E-03 0.10109566 CHANDRAN_METASTASIS_DN uterine benign neoplasm DOID_0060095 5.33E-03 0.05229086 5.33E-03 0.10109566 CHANDRAN_METASTASIS_DN uterine fibroid DOID_13223 5.33E-03 0.05229086 5.33E-03 0.10109566 CHANDRAN_METASTASIS_DN Charcot-Marie-Tooth disease DOID_10595 6.002E-03 0.05788372 6.002E-03 0.1067231 CHANDRAN_METASTASIS_DN allergic rhinitis DOID_4481 6.002E-03 0.05691899 0.10947121 0.44492229 CHANDRAN_METASTASIS_DN leiomyoma DOID_127 6.352E-03 0.05924747 6.352E-03 0.10629693 CHANDRAN_METASTASIS_DN bladder disease DOID_365 6.352E-03 0.05829186 0.11250414 0.45400607 CHANDRAN_METASTASIS_DN periodontal disease DOID_3388 7.078E-03 0.06392803 7.078E-03 0.11187406 CHANDRAN_METASTASIS_DN calcinosis DOID_182 8.235E-03 0.07321275 0.12751572 0.49024626 CHANDRAN_METASTASIS_DN systemic scleroderma DOID_418 9.05E-03 0.07922085 0.13344956 0.49955791 CHANDRAN_METASTASIS_DN adult respiratory distress syndrome DOID_11394 9.47E-03 0.08164558 9.47E-03 0.14563806 CHANDRAN_METASTASIS_DN intracranial arterial disease DOID_13089 9.47E-03 0.08042699 9.47E-03 0.14180548 CHANDRAN_METASTASIS_DN cerebral arterial disease DOID_3527 9.47E-03 0.08042699 9.47E-03 0.14180548 CHANDRAN_METASTASIS_DN benign mesothelioma DOID_2645 9.899E-03 0.08283436 9.899E-03 0.14442914 CHANDRAN_METASTASIS_DN autoimmune disease of urogenital tract DOID_0060049 0.01033691 0.08524209 0.14227533 0.52567961 CHANDRAN_METASTASIS_DN primary biliary cirrhosis DOID_12236 0.01033691 0.08524209 0.14227533 0.52567961 CHANDRAN_METASTASIS_DN endometriosis of uterus DOID_288 0.01033691 0.08402435 0.14227533 0.52228813 CHANDRAN_METASTASIS_DN rheumatic disease DOID_1575 0.01078291 0.08641516 0.14519738 0.52959813 CHANDRAN_METASTASIS_DN endometriosis DOID_289 0.01078291 0.08521495 0.14519738 0.52289436 CHANDRAN_METASTASIS_DN scleroderma DOID_419 0.01078291 0.08641516 0.14519738 0.52959813 CHANDRAN_METASTASIS_DN influenza DOID_8469 0.01123729 0.08758929 0.14810955 0.53002727 CHANDRAN_METASTASIS_DN cerebral infarction DOID_3526 0.01169999 0.08996343 0.01169999 0.16643235 CHANDRAN_METASTASIS_DN brain cancer DOID_1319 0.01265011 0.09597214 0.01265011 0.17137883 CHANDRAN_METASTASIS_DN central nervous system cancer DOID_3620 0.0131374 0.09835767 0.0131374 0.16989051 WOOD_EBV_EBNA1_TARGETS_UP lymphoblastic leukemia DOID_1037 2.649E-08 1.508E-05 1.015E-06 5.774E-04 WOOD_EBV_EBNA1_TARGETS_UP middle cerebral artery infarction DOID_3525 2.235E-07 6.357E-05 0.05115184 0.38296572 WOOD_EBV_EBNA1_TARGETS_UP intracranial arterial disease DOID_13089 1.319E-06 2.501E-04 0.07748436 0.40822777 WOOD_EBV_EBNA1_TARGETS_UP cerebral arterial disease DOID_3527 1.319E-06 2.501E-04 0.07748436 0.40822777 WOOD_EBV_EBNA1_TARGETS_UP cerebral infarction DOID_3526 2.064E-06 2.937E-04 0.08610072 0.43742241 WOOD_EBV_EBNA1_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 5.436E-06 6.186E-04 5.892E-03 0.10160049 WOOD_EBV_EBNA1_TARGETS_UP brain infarction DOID_3454 9.979E-06 9.464E-04 0.12472498 0.49977827 WOOD_EBV_EBNA1_TARGETS_UP pancreatic ductal carcinoma DOID_3587 1.115E-05 9.061E-04 1.115E-05 3.171E-03 WOOD_EBV_EBNA1_TARGETS_UP pancreatic carcinoma DOID_4905 1.308E-05 9.306E-04 1.308E-05 2.482E-03 WOOD_EBV_EBNA1_TARGETS_UP pleurisy DOID_10247 2.464E-05 1.558E-03 0.0547052 0.37960069 WOOD_EBV_EBNA1_TARGETS_UP toxic encephalopathy DOID_3602 2.725E-05 1.55E-03 1.552E-03 0.05521017 WOOD_EBV_EBNA1_TARGETS_UP pleural disease DOID_1532 3.946E-05 2.041E-03 0.0635313 0.38456713 WOOD_EBV_EBNA1_TARGETS_UP pneumoconiosis DOID_10316 4.672E-05 2.215E-03 2.207E-03 0.05981229 WOOD_EBV_EBNA1_TARGETS_UP medullomyoblastoma DOID_3861 5.066E-05 2.217E-03 5.066E-05 7.206E-03 WOOD_EBV_EBNA1_TARGETS_UP adult medulloblastoma DOID_3864 5.066E-05 2.217E-03 5.066E-05 7.206E-03 WOOD_EBV_EBNA1_TARGETS_UP childhood medulloblastoma DOID_3869 5.066E-05 2.217E-03 5.066E-05 7.206E-03 WOOD_EBV_EBNA1_TARGETS_UP medulloblastoma DOID_3858 5.917E-05 2.405E-03 5.917E-05 6.733E-03 WOOD_EBV_EBNA1_TARGETS_UP multiple myeloma DOID_9538 5.917E-05 2.244E-03 2.576E-03 0.06372766 WOOD_EBV_EBNA1_TARGETS_UP pulmonary emphysema DOID_9675 7.889E-05 2.806E-03 3.109E-03 0.06804259 WOOD_EBV_EBNA1_TARGETS_UP endometriosis of uterus DOID_288 8.441E-05 2.825E-03 8.441E-05 8.005E-03 WOOD_EBV_EBNA1_TARGETS_UP primitive neuroectodermal tumor DOID_168 9.018E-05 2.851E-03 9.018E-05 7.33E-03 WOOD_EBV_EBNA1_TARGETS_UP endometriosis DOID_289 9.018E-05 2.701E-03 9.018E-05 6.414E-03 WOOD_EBV_EBNA1_TARGETS_UP myeloma DOID_0070004 1.158E-04 3.295E-03 3.997E-03 0.08423456 WOOD_EBV_EBNA1_TARGETS_UP bone marrow cancer DOID_4960 1.713E-04 4.641E-03 5.164E-03 0.0947814 WOOD_EBV_EBNA1_TARGETS_UP neuroectodermal tumor DOID_171 2.416E-04 6.249E-03 2.416E-04 0.01527509 WOOD_EBV_EBNA1_TARGETS_UP cholestasis DOID_13580 2.891E-04 7.151E-03 0.1197798 0.50113756 WOOD_EBV_EBNA1_TARGETS_UP uterine disease DOID_345 2.891E-04 6.853E-03 2.891E-04 0.01644801 WOOD_EBV_EBNA1_TARGETS_UP hyperglycemia DOID_4195 3.018E-04 6.869E-03 0.12143125 0.49708188 WOOD_EBV_EBNA1_TARGETS_UP bile duct disease DOID_4138 3.709E-04 8.117E-03 0.12964276 0.50873608 WOOD_EBV_EBNA1_TARGETS_UP biliary tract disease DOID_9741 3.858E-04 8.131E-03 0.13127596 0.50813621 WOOD_EBV_EBNA1_TARGETS_UP hemolytic-uremic syndrome DOID_12554 4.08E-04 8.291E-03 1.000 1.000 WOOD_EBV_EBNA1_TARGETS_UP metabolic syndrome X DOID_14221 5.013E-04 9.836E-03 0.14262406 0.53743769 WOOD_EBV_EBNA1_TARGETS_UP keratosis DOID_161 5.189E-04 9.842E-03 5.189E-04 0.02684231 WOOD_EBV_EBNA1_TARGETS_UP female reproductive system disease DOID_229 5.194E-04 9.534E-03 5.194E-04 0.02462949 WOOD_EBV_EBNA1_TARGETS_UP chronic kidney failure DOID_784 5.569E-04 9.902E-03 0.01116809 0.17651779 WOOD_EBV_EBNA1_TARGETS_UP transitional cell carcinoma DOID_2671 6.58E-04 0.01134468 6.58E-04 0.02879802 WOOD_EBV_EBNA1_TARGETS_UP lymphoma DOID_0060058 7.467E-04 0.01249644 7.467E-04 0.03034851 WOOD_EBV_EBNA1_TARGETS_UP encephalomyelitis DOID_640 7.7E-04 0.0125185 7.7E-04 0.02920982 WOOD_EBV_EBNA1_TARGETS_UP urticaria DOID_1555 1.092E-03 0.01725418 0.04758531 0.38680057 WOOD_EBV_EBNA1_TARGETS_UP cranial nerve disease DOID_5656 1.552E-03 0.02387467 1.552E-03 0.05196251 WOOD_EBV_EBNA1_TARGETS_UP opportunistic mycosis DOID_2473 1.759E-03 0.02633213 0.06001065 0.37523143 WOOD_EBV_EBNA1_TARGETS_UP chronic leukemia DOID_1036 1.977E-03 0.02884283 1.977E-03 0.06249279 WOOD_EBV_EBNA1_TARGETS_UP chronic lymphocytic leukemia DOID_1040 1.977E-03 0.02884283 1.977E-03 0.06249279 WOOD_EBV_EBNA1_TARGETS_UP leiomyoma DOID_127 1.977E-03 0.02812176 1.977E-03 0.05920369 WOOD_EBV_EBNA1_TARGETS_UP autonomic nervous system neoplasm DOID_2621 1.977E-03 0.02743586 1.977E-03 0.05624351 WOOD_EBV_EBNA1_TARGETS_UP neuroblastoma DOID_769 1.977E-03 0.02743586 1.977E-03 0.05624351 WOOD_EBV_EBNA1_TARGETS_UP systemic mycosis DOID_0050136 2.091E-03 0.02832381 0.06528675 0.39103325 WOOD_EBV_EBNA1_TARGETS_UP fungal infectious disease DOID_1564 2.091E-03 0.02832381 0.06528675 0.39103325 WOOD_EBV_EBNA1_TARGETS_UP nephroblastoma DOID_2154 2.207E-03 0.02921066 2.207E-03 0.05709355 WOOD_EBV_EBNA1_TARGETS_UP lymphoid leukemia DOID_10747 2.327E-03 0.03009632 0.06878791 0.38752794 WOOD_EBV_EBNA1_TARGETS_UP peripheral nervous system neoplasm DOID_1192 2.705E-03 0.03420093 2.705E-03 0.06412674 WOOD_EBV_EBNA1_TARGETS_UP uveitis DOID_13141 2.705E-03 0.03345743 0.07401543 0.39359607 WOOD_EBV_EBNA1_TARGETS_UP adult respiratory distress syndrome DOID_11394 2.971E-03 0.03597306 1.000 1.000 WOOD_EBV_EBNA1_TARGETS_UP benign mesothelioma DOID_2645 3.109E-03 0.0368564 3.109E-03 0.07076429 WOOD_EBV_EBNA1_TARGETS_UP uveal disease DOID_3480 3.393E-03 0.03940567 0.08266374 0.42759697 WOOD_EBV_EBNA1_TARGETS_UP leukodystrophy DOID_10579 3.842E-03 0.04371991 0.08781445 0.43830194 WOOD_EBV_EBNA1_TARGETS_UP pre-eclampsia DOID_10591 3.997E-03 0.04459477 3.997E-03 0.08122618 WOOD_EBV_EBNA1_TARGETS_UP vascular skin disease DOID_9540 3.997E-03 0.04373717 0.08952501 0.43169262 WOOD_EBV_EBNA1_TARGETS_UP hemolytic anemia DOID_583 4.155E-03 0.0446096 1.000 1.000 WOOD_EBV_EBNA1_TARGETS_UP normocytic anemia DOID_720 4.155E-03 0.0446096 1.000 1.000 WOOD_EBV_EBNA1_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 4.647E-03 0.04896306 4.647E-03 0.09117259 WOOD_EBV_EBNA1_TARGETS_UP atrophic muscular disease DOID_913 4.989E-03 0.05160996 4.989E-03 0.09461825 WOOD_EBV_EBNA1_TARGETS_UP muscular dystrophy DOID_9884 4.989E-03 0.05160996 4.989E-03 0.09461825 WOOD_EBV_EBNA1_TARGETS_UP osteochondrodysplasia DOID_2256 5.342E-03 0.05427669 5.342E-03 0.0949842 WOOD_EBV_EBNA1_TARGETS_UP leukocyte disease DOID_9500 6.082E-03 0.06070887 0.10980667 0.46626862 WOOD_EBV_EBNA1_TARGETS_UP carotid artery disease DOID_3407 6.468E-03 0.06345297 0.11314336 0.47687833 WOOD_EBV_EBNA1_TARGETS_UP respiratory failure DOID_11162 6.665E-03 0.06428028 1.000 1.000 WOOD_EBV_EBNA1_TARGETS_UP pre-malignant neoplasm DOID_0060071 6.865E-03 0.06510579 6.865E-03 0.11489258 WOOD_EBV_EBNA1_TARGETS_UP in situ carcinoma DOID_8719 6.865E-03 0.06510579 6.865E-03 0.11489258 WOOD_EBV_EBNA1_TARGETS_UP cerebral degeneration DOID_1443 7.273E-03 0.06784564 0.1197798 0.49747963 WOOD_EBV_EBNA1_TARGETS_UP temporal lobe epilepsy DOID_3328 7.482E-03 0.06866126 0.12143125 0.50068392 WOOD_EBV_EBNA1_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 7.906E-03 0.07140296 7.906E-03 0.12852532 WOOD_EBV_EBNA1_TARGETS_UP peripheral vascular disease DOID_341 8.786E-03 0.07811313 0.13127596 0.51161659 WOOD_EBV_EBNA1_TARGETS_UP bacterial pneumonia DOID_874 9.945E-03 0.08705721 1.000 1.000 WOOD_EBV_EBNA1_TARGETS_UP contact dermatitis DOID_2773 0.01042663 0.08989022 0.14262406 0.53390192 WOOD_EBV_EBNA1_TARGETS_UP focal epilepsy DOID_2234 0.01116809 0.09484538 0.14744268 0.54125731 WOOD_EBV_EBNA1_TARGETS_UP bone development disease DOID_0080006 0.01142027 0.0955608 0.01142027 0.17562526 JAEGER_METASTASIS_DN vesiculobullous skin disease DOID_2731 2.938E-22 1.672E-19 2.938E-22 1.672E-19 JAEGER_METASTASIS_DN epidermolysis bullosa DOID_2730 5.827E-20 1.658E-17 5.827E-20 1.658E-17 JAEGER_METASTASIS_DN integumentary system cancer DOID_0060122 4.577E-14 8.681E-12 4.577E-14 8.681E-12 JAEGER_METASTASIS_DN skin cancer DOID_4159 4.577E-14 8.681E-12 4.577E-14 8.681E-12 JAEGER_METASTASIS_DN oral cavity cancer DOID_8618 3.87E-12 5.505E-10 3.87E-12 5.505E-10 JAEGER_METASTASIS_DN adenoid cystic carcinoma DOID_4866 4.964E-10 5.649E-08 4.964E-10 5.649E-08 JAEGER_METASTASIS_DN salivary gland cancer DOID_8850 6.942E-10 6.584E-08 6.942E-10 6.584E-08 JAEGER_METASTASIS_DN uterine cancer DOID_363 9.555E-10 7.767E-08 1.476E-06 6.998E-05 JAEGER_METASTASIS_DN cleft lip DOID_9296 1.215E-09 8.638E-08 1.215E-09 9.872E-08 JAEGER_METASTASIS_DN integumentary system benign neoplasm DOID_0060121 1.998E-09 1.263E-07 1.998E-09 1.421E-07 JAEGER_METASTASIS_DN skin benign neoplasm DOID_3165 1.998E-09 1.263E-07 1.998E-09 1.421E-07 JAEGER_METASTASIS_DN endometrial cancer DOID_1380 5.389E-09 3.066E-07 1.162E-05 3.673E-04 JAEGER_METASTASIS_DN ulcerative colitis DOID_8577 9.266E-09 4.793E-07 3.819E-06 1.552E-04 JAEGER_METASTASIS_DN transitional cell carcinoma DOID_2671 9.791E-08 4.643E-06 3.668E-05 9.486E-04 JAEGER_METASTASIS_DN orofacial cleft DOID_0050567 1.082E-07 4.734E-06 1.082E-07 6.839E-06 JAEGER_METASTASIS_DN endometrial carcinoma DOID_2871 2.036E-07 8.276E-06 9.067E-06 3.035E-04 JAEGER_METASTASIS_DN germinoma DOID_3304 2.795E-07 1.06E-05 1.162E-05 3.48E-04 JAEGER_METASTASIS_DN cleft palate DOID_674 6.48E-07 2.304E-05 6.48E-07 3.687E-05 JAEGER_METASTASIS_DN keratosis DOID_161 8.07E-07 2.701E-05 8.07E-07 4.174E-05 JAEGER_METASTASIS_DN synostosis DOID_11971 2.749E-06 8.69E-05 2.749E-06 1.203E-04 JAEGER_METASTASIS_DN arrhythmogenic right ventricular dysplasia DOID_0050431 5.638E-06 1.688E-04 5.638E-06 2.139E-04 JAEGER_METASTASIS_DN invasive ductal carcinoma DOID_3008 6.955E-06 1.979E-04 2.557E-04 5.018E-03 JAEGER_METASTASIS_DN dysostosis DOID_1934 9.067E-06 2.457E-04 9.067E-06 3.225E-04 JAEGER_METASTASIS_DN bone development disease DOID_0080006 2.945E-05 7.617E-04 2.945E-05 8.379E-04 JAEGER_METASTASIS_DN endometriosis of uterus DOID_288 3.604E-05 8.916E-04 3.604E-05 9.765E-04 JAEGER_METASTASIS_DN endometriosis DOID_289 3.934E-05 9.328E-04 3.934E-05 9.734E-04 JAEGER_METASTASIS_DN basal cell carcinoma DOID_2513 4.455E-05 1.014E-03 4.455E-05 1.056E-03 JAEGER_METASTASIS_DN skin carcinoma DOID_3451 5.329E-05 1.166E-03 5.329E-05 1.213E-03 JAEGER_METASTASIS_DN testicular cancer DOID_2998 6.31E-05 1.33E-03 2.748E-03 0.03635855 JAEGER_METASTASIS_DN atopic dermatitis DOID_3310 7.99E-05 1.624E-03 1.533E-03 0.02357024 JAEGER_METASTASIS_DN giant cell tumor DOID_200 8.577E-05 1.683E-03 0.02240806 0.16346391 JAEGER_METASTASIS_DN malignant giant cell tumor DOID_2705 8.577E-05 1.683E-03 0.02240806 0.16346391 JAEGER_METASTASIS_DN giant cell glioblastoma DOID_3074 8.577E-05 1.683E-03 0.02240806 0.16346391 JAEGER_METASTASIS_DN glioblastoma DOID_3068 1.199E-04 2.275E-03 0.02627564 0.18457823 JAEGER_METASTASIS_DN congenital heart defect DOID_1682 1.63E-04 2.992E-03 1.63E-04 3.568E-03 JAEGER_METASTASIS_DN uterine disease DOID_345 1.83E-04 3.255E-03 1.83E-04 3.857E-03 JAEGER_METASTASIS_DN autosomal dominant nonsyndromic deafness DOID_0050564 1.859E-04 3.206E-03 1.859E-04 3.778E-03 JAEGER_METASTASIS_DN seminoma DOID_4440 2.076E-04 3.474E-03 5.928E-03 0.06133097 JAEGER_METASTASIS_DN astrocytoma DOID_3069 2.283E-04 3.711E-03 0.03564335 0.23311569 JAEGER_METASTASIS_DN lung adenocarcinoma DOID_3910 2.309E-04 3.649E-03 6.35E-03 0.06339194 JAEGER_METASTASIS_DN female reproductive system disease DOID_229 3.937E-04 6.055E-03 3.937E-04 7.468E-03 JAEGER_METASTASIS_DN chronic kidney failure DOID_784 4.311E-04 6.455E-03 0.04810128 0.26572452 JAEGER_METASTASIS_DN papilloma DOID_2615 4.417E-04 6.444E-03 4.417E-04 8.107E-03 JAEGER_METASTASIS_DN myocarditis DOID_820 4.417E-04 6.283E-03 4.417E-04 7.853E-03 JAEGER_METASTASIS_DN spindle cell carcinoma DOID_4015 4.792E-04 6.65E-03 0.14155964 0.46559211 JAEGER_METASTASIS_DN embryonal cancer DOID_688 6.038E-04 8.181E-03 0.01184524 0.09628487 JAEGER_METASTASIS_DN hypersensitivity reaction type I disease DOID_1205 7.1E-04 9.396E-03 7.597E-03 0.06972061 JAEGER_METASTASIS_DN dilated cardiomyopathy DOID_12930 7.1E-04 9.182E-03 7.597E-03 0.06861393 JAEGER_METASTASIS_DN benign mesothelioma DOID_2645 7.997E-04 0.01011232 0.01421313 0.11232318 JAEGER_METASTASIS_DN breast benign neoplasm DOID_0060082 9.031E-04 0.01117038 1.000 1.000 JAEGER_METASTASIS_DN thoracic benign neoplasm DOID_0060097 9.031E-04 0.01117038 1.000 1.000 JAEGER_METASTASIS_DN benign breast phyllodes tumor DOID_1631 9.031E-04 0.01117038 1.000 1.000 JAEGER_METASTASIS_DN craniosynostosis DOID_2340 9.031E-04 0.01093272 9.031E-04 0.01557084 JAEGER_METASTASIS_DN diarrhea DOID_13250 1.081E-03 0.01281125 1.081E-03 0.01808647 JAEGER_METASTASIS_DN leukodystrophy DOID_10579 1.096E-03 0.01272628 1.096E-03 0.01781679 JAEGER_METASTASIS_DN hemolytic anemia DOID_583 1.231E-03 0.01401257 0.01880117 0.13893329 JAEGER_METASTASIS_DN normocytic anemia DOID_720 1.231E-03 0.01401257 0.01880117 0.13893329 JAEGER_METASTASIS_DN glaucoma DOID_1686 1.303E-03 0.01453517 1.303E-03 0.02059149 JAEGER_METASTASIS_DN lung small cell carcinoma DOID_5409 1.303E-03 0.01425565 0.19310436 0.55493123 JAEGER_METASTASIS_DN idiopathic pulmonary fibrosis DOID_0050156 1.705E-03 0.01830971 0.05998768 0.27750399 JAEGER_METASTASIS_DN congenital ichthyosiform erythroderma DOID_1699 1.705E-03 0.01797064 1.705E-03 0.02553723 JAEGER_METASTASIS_DN arthropathy DOID_381 1.705E-03 0.0176439 1.705E-03 0.02488243 JAEGER_METASTASIS_DN hemolytic-uremic syndrome DOID_12554 1.944E-03 0.01975097 0.06385727 0.27526354 JAEGER_METASTASIS_DN tongue cancer DOID_8649 1.944E-03 0.01940446 1.944E-03 0.02765136 JAEGER_METASTASIS_DN nonsyndromic deafness DOID_0050563 2.065E-03 0.02025904 2.065E-03 0.02865913 JAEGER_METASTASIS_DN juvenile rheumatoid arthritis DOID_676 2.197E-03 0.02118896 1.000 1.000 JAEGER_METASTASIS_DN pre-malignant neoplasm DOID_0060071 2.587E-03 0.02452958 2.587E-03 0.03504226 JAEGER_METASTASIS_DN in situ carcinoma DOID_8719 2.587E-03 0.02452958 2.587E-03 0.03504226 JAEGER_METASTASIS_DN granulosa cell tumor DOID_2999 2.748E-03 0.0256298 0.07537133 0.30201609 JAEGER_METASTASIS_DN cerebral degeneration DOID_1443 2.816E-03 0.02584271 2.816E-03 0.03641472 JAEGER_METASTASIS_DN sex cord-gonadal stromal tumor DOID_192 3.045E-03 0.02749924 0.07917799 0.30857724 JAEGER_METASTASIS_DN endocrine organ benign neoplasm DOID_0060089 3.183E-03 0.02829608 0.03474523 0.22988415 JAEGER_METASTASIS_DN bile duct disease DOID_4138 3.577E-03 0.03131667 3.577E-03 0.04523519 JAEGER_METASTASIS_DN funisitis DOID_0050698 3.682E-03 0.03174199 3.682E-03 0.04554285 JAEGER_METASTASIS_DN peripheral vascular disease DOID_341 3.715E-03 0.03155323 0.03839101 0.24544362 JAEGER_METASTASIS_DN biliary tract disease DOID_9741 3.715E-03 0.03108921 3.715E-03 0.04498013 JAEGER_METASTASIS_DN muscle cancer DOID_4045 4.022E-03 0.03316403 0.0905048 0.34331488 JAEGER_METASTASIS_DN syndrome DOID_225 4.149E-03 0.03372157 4.149E-03 0.04917728 JAEGER_METASTASIS_DN contact dermatitis DOID_2773 4.772E-03 0.03824251 4.772E-03 0.05541262 JAEGER_METASTASIS_DN auditory system disease DOID_2742 5.104E-03 0.04033301 5.104E-03 0.05807954 JAEGER_METASTASIS_DN mental depression DOID_1596 5.275E-03 0.04111296 5.275E-03 0.05884797 JAEGER_METASTASIS_DN morbid obesity DOID_11981 5.52E-03 0.04244186 5.52E-03 0.06039803 JAEGER_METASTASIS_DN spinal muscular atrophy DOID_12377 5.52E-03 0.04187597 0.10539215 0.38196262 JAEGER_METASTASIS_DN papillary adenoma DOID_3172 5.52E-03 0.04132497 5.52E-03 0.05925844 JAEGER_METASTASIS_DN microcystic adenoma DOID_5403 5.52E-03 0.04132497 5.52E-03 0.05925844 JAEGER_METASTASIS_DN follicular adenoma DOID_6204 5.52E-03 0.04132497 5.52E-03 0.05925844 JAEGER_METASTASIS_DN ankylosing spondylitis DOID_7147 5.52E-03 0.04078828 0.10539215 0.37954513 JAEGER_METASTASIS_DN spinal cord disease DOID_319 5.928E-03 0.0432462 5.928E-03 0.06246673 JAEGER_METASTASIS_DN hypotrichosis DOID_4535 5.928E-03 0.04269878 5.928E-03 0.06023578 JAEGER_METASTASIS_DN perinatal necrotizing enterocolitis DOID_8677 6.35E-03 0.04516676 6.35E-03 0.06229897 JAEGER_METASTASIS_DN lymphoma DOID_0060058 6.969E-03 0.04895321 6.969E-03 0.06720695 JAEGER_METASTASIS_DN polycystic ovary syndrome DOID_11612 7.234E-03 0.05019811 7.234E-03 0.06860408 JAEGER_METASTASIS_DN alcohol-related neurodevelopmental disorder DOID_0050667 7.384E-03 0.05062026 7.384E-03 0.06887675 JAEGER_METASTASIS_DN allergic rhinitis DOID_4481 8.658E-03 0.05864524 8.658E-03 0.07697188 JAEGER_METASTASIS_DN autonomic nervous system neoplasm DOID_2621 9.158E-03 0.06130299 9.158E-03 0.08016545 JAEGER_METASTASIS_DN neuroblastoma DOID_769 9.158E-03 0.06130299 9.158E-03 0.08016545 JAEGER_METASTASIS_DN hair disease DOID_421 9.67E-03 0.0639824 9.67E-03 0.083371 JAEGER_METASTASIS_DN nephroblastoma DOID_2154 0.01019567 0.06668199 0.01019567 0.08658707 JAEGER_METASTASIS_DN medullomyoblastoma DOID_3861 0.01073327 0.06940038 0.14509549 0.46908712 JAEGER_METASTASIS_DN adult medulloblastoma DOID_3864 0.01073327 0.06940038 0.14509549 0.46908712 JAEGER_METASTASIS_DN childhood medulloblastoma DOID_3869 0.01073327 0.06940038 0.14509549 0.46908712 JAEGER_METASTASIS_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.01128317 0.07213621 0.01128317 0.09441357 JAEGER_METASTASIS_DN adenoma DOID_657 0.01128317 0.0713347 0.01128317 0.09304526 JAEGER_METASTASIS_DN medulloblastoma DOID_3858 0.01184524 0.07406528 0.15212383 0.48088033 JAEGER_METASTASIS_DN multiple myeloma DOID_9538 0.01184524 0.07326023 0.15212383 0.47822353 JAEGER_METASTASIS_DN peripheral nervous system neoplasm DOID_1192 0.01241938 0.07598522 0.01241938 0.09952994 JAEGER_METASTASIS_DN cervix uteri carcinoma in situ DOID_8991 0.01421313 0.08603477 0.01421313 0.1107845 JAEGER_METASTASIS_DN primitive neuroectodermal tumor DOID_168 0.01546735 0.09264126 0.17286623 0.52599404 WALLACE_PROSTATE_CANCER_RACE_UP contact dermatitis DOID_2773 8.243E-28 4.691E-25 1.69E-20 9.617E-18 WALLACE_PROSTATE_CANCER_RACE_UP allergic contact dermatitis DOID_3042 2.223E-25 6.324E-23 5.156E-18 1.467E-15 WALLACE_PROSTATE_CANCER_RACE_UP primary immunodeficiency disease DOID_612 1.709E-21 3.242E-19 7.765E-15 1.473E-12 WALLACE_PROSTATE_CANCER_RACE_UP tuberculosis DOID_399 1.056E-19 1.502E-17 3.789E-03 0.0431136 WALLACE_PROSTATE_CANCER_RACE_UP primary bacterial infectious disease DOID_0050338 3.13E-18 3.562E-16 7.109E-03 0.06631009 WALLACE_PROSTATE_CANCER_RACE_UP Human immunodeficiency virus infectious disease DOID_526 5.109E-18 4.845E-16 1.742E-07 1.239E-05 WALLACE_PROSTATE_CANCER_RACE_UP ankylosing spondylitis DOID_7147 1.557E-17 1.266E-15 1.765E-09 1.674E-07 WALLACE_PROSTATE_CANCER_RACE_UP encephalomyelitis DOID_640 3.451E-16 2.455E-14 2.173E-07 1.374E-05 WALLACE_PROSTATE_CANCER_RACE_UP pulmonary tuberculosis DOID_2957 4.193E-16 2.651E-14 0.02189931 0.14489196 WALLACE_PROSTATE_CANCER_RACE_UP hypersensitivity reaction type I disease DOID_1205 4.575E-16 2.603E-14 2.508E-07 1.427E-05 WALLACE_PROSTATE_CANCER_RACE_UP systemic scleroderma DOID_418 1.872E-13 9.685E-12 0.01462984 0.10672284 WALLACE_PROSTATE_CANCER_RACE_UP collagen disease DOID_854 2.434E-13 1.154E-11 0.03218226 0.19480539 WALLACE_PROSTATE_CANCER_RACE_UP rheumatic disease DOID_1575 4.558E-13 1.995E-11 0.01738728 0.1221403 WALLACE_PROSTATE_CANCER_RACE_UP scleroderma DOID_419 4.558E-13 1.995E-11 0.01738728 0.1221403 WALLACE_PROSTATE_CANCER_RACE_UP influenza DOID_8469 5.616E-13 2.282E-11 5.459E-05 2.071E-03 WALLACE_PROSTATE_CANCER_RACE_UP sarcoidosis DOID_11335 3.019E-12 1.145E-10 1.928E-03 0.02550612 WALLACE_PROSTATE_CANCER_RACE_UP myasthenia gravis DOID_437 6.279E-12 2.233E-10 0.09603086 0.36186461 WALLACE_PROSTATE_CANCER_RACE_UP hypersensitivity reaction type IV disease DOID_2916 6.783E-12 2.27E-10 2.463E-03 0.03046538 WALLACE_PROSTATE_CANCER_RACE_UP respiratory syncytial virus infectious disease DOID_1273 1.185E-11 3.747E-10 3.485E-05 1.416E-03 WALLACE_PROSTATE_CANCER_RACE_UP severe combined immunodeficiency DOID_627 1.222E-11 3.66E-10 1.064E-09 1.513E-07 WALLACE_PROSTATE_CANCER_RACE_UP combined T cell and B cell immunodeficiency DOID_628 1.666E-11 4.74E-10 1.378E-09 1.568E-07 WALLACE_PROSTATE_CANCER_RACE_UP neuromuscular junction disease DOID_439 2.241E-11 6.072E-10 0.11177003 0.39016653 WALLACE_PROSTATE_CANCER_RACE_UP B cell deficiency DOID_2115 2.977E-11 7.7E-10 6.687E-06 3.171E-04 WALLACE_PROSTATE_CANCER_RACE_UP autoimmune disease of the nervous system DOID_438 5.081E-11 1.257E-09 0.12339537 0.40121125 WALLACE_PROSTATE_CANCER_RACE_UP autoimmune disease of gastrointestinal tract DOID_0060031 7.283E-11 1.727E-09 1.557E-03 0.02214149 WALLACE_PROSTATE_CANCER_RACE_UP juvenile rheumatoid arthritis DOID_676 7.653E-11 1.742E-09 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP bacterial pneumonia DOID_874 8.45E-11 1.849E-09 0.04822056 0.24067979 WALLACE_PROSTATE_CANCER_RACE_UP bronchiolitis obliterans DOID_2799 1.055E-10 2.223E-09 9.205E-03 0.07590773 WALLACE_PROSTATE_CANCER_RACE_UP pustulosis of palm and sole DOID_4398 1.814E-10 3.687E-09 5.755E-06 2.977E-04 WALLACE_PROSTATE_CANCER_RACE_UP systemic mycosis DOID_0050136 2.038E-10 3.999E-09 5.293E-04 9.716E-03 WALLACE_PROSTATE_CANCER_RACE_UP fungal infectious disease DOID_1564 2.038E-10 3.999E-09 5.293E-04 9.716E-03 WALLACE_PROSTATE_CANCER_RACE_UP pulmonary sarcoidosis DOID_13406 4.486E-10 8.508E-09 7.231E-04 0.01246836 WALLACE_PROSTATE_CANCER_RACE_UP myositis DOID_633 1.765E-09 3.24E-08 2.232E-04 5.292E-03 WALLACE_PROSTATE_CANCER_RACE_UP syndrome DOID_225 2.061E-09 3.664E-08 3.929E-04 8.599E-03 WALLACE_PROSTATE_CANCER_RACE_UP aneurysm disease DOID_2403 2.284E-09 3.939E-08 4.125E-04 8.693E-03 WALLACE_PROSTATE_CANCER_RACE_UP thyroiditis DOID_7166 6.365E-09 1.065E-07 2.197E-03 0.0277736 WALLACE_PROSTATE_CANCER_RACE_UP autoimmune thyroiditis DOID_7188 6.365E-09 1.065E-07 2.197E-03 0.0277736 WALLACE_PROSTATE_CANCER_RACE_UP celiac disease DOID_10608 7.82E-09 1.271E-07 4.465E-04 9.073E-03 WALLACE_PROSTATE_CANCER_RACE_UP allergic rhinitis DOID_4481 7.82E-09 1.236E-07 4.465E-04 8.76E-03 WALLACE_PROSTATE_CANCER_RACE_UP Crohn's disease DOID_8778 1.09E-08 1.677E-07 6.715E-05 2.388E-03 WALLACE_PROSTATE_CANCER_RACE_UP ulcerative colitis DOID_8577 1.507E-08 2.257E-07 8.155E-05 2.442E-03 WALLACE_PROSTATE_CANCER_RACE_UP agammaglobulinemia DOID_2583 1.676E-08 2.446E-07 7.587E-05 2.54E-03 WALLACE_PROSTATE_CANCER_RACE_UP MHC class II deficiency DOID_5812 1.676E-08 2.385E-07 1.676E-08 1.363E-06 WALLACE_PROSTATE_CANCER_RACE_UP blood protein disease DOID_620 2.227E-08 3.091E-07 8.898E-05 2.531E-03 WALLACE_PROSTATE_CANCER_RACE_UP funisitis DOID_0050698 3.756E-08 5.089E-07 4.156E-03 0.04636837 WALLACE_PROSTATE_CANCER_RACE_UP pancreatitis DOID_4989 6.6E-08 8.733E-07 5.292E-03 0.05475015 WALLACE_PROSTATE_CANCER_RACE_UP aortic aneurysm DOID_3627 1.246E-07 1.612E-06 0.02269361 0.14673484 WALLACE_PROSTATE_CANCER_RACE_UP nervous system cancer DOID_3093 1.742E-07 2.202E-06 7.787E-03 0.06816188 WALLACE_PROSTATE_CANCER_RACE_UP vasculitis DOID_865 1.941E-07 2.402E-06 0.02598733 0.16429767 WALLACE_PROSTATE_CANCER_RACE_UP pleurisy DOID_10247 1.976E-07 2.392E-06 0.12339537 0.41545543 WALLACE_PROSTATE_CANCER_RACE_UP lymphoma DOID_0060058 2.02E-07 2.395E-06 7.957E-04 0.01331604 WALLACE_PROSTATE_CANCER_RACE_UP parasitic protozoa infectious disease DOID_2789 2.158E-07 2.506E-06 2.132E-03 0.02756963 WALLACE_PROSTATE_CANCER_RACE_UP autoimmune disease of endocrine system DOID_0060005 2.348E-07 2.672E-06 8.153E-03 0.07028996 WALLACE_PROSTATE_CANCER_RACE_UP psoriatic arthritis DOID_9008 2.458E-07 2.742E-06 0.05545961 0.24847653 WALLACE_PROSTATE_CANCER_RACE_UP leukocyte disease DOID_9500 3.23E-07 3.534E-06 8.014E-06 3.507E-04 WALLACE_PROSTATE_CANCER_RACE_UP opportunistic mycosis DOID_2473 3.256E-07 3.496E-06 9.205E-03 0.07702402 WALLACE_PROSTATE_CANCER_RACE_UP eyelid disease DOID_530 3.429E-07 3.613E-06 1.675E-03 0.02324978 WALLACE_PROSTATE_CANCER_RACE_UP carotid artery disease DOID_3407 3.911E-07 4.046E-06 2.824E-03 0.03347677 WALLACE_PROSTATE_CANCER_RACE_UP chronic leukemia DOID_1036 4.423E-07 4.494E-06 4.868E-04 9.233E-03 WALLACE_PROSTATE_CANCER_RACE_UP chronic lymphocytic leukemia DOID_1040 4.423E-07 4.494E-06 4.868E-04 9.233E-03 WALLACE_PROSTATE_CANCER_RACE_UP pleural disease DOID_1532 4.423E-07 4.415E-06 0.14243581 0.44530756 WALLACE_PROSTATE_CANCER_RACE_UP parasitic infectious disease DOID_1398 5.628E-07 5.521E-06 3.354E-03 0.03894602 WALLACE_PROSTATE_CANCER_RACE_UP brain infarction DOID_3454 7.285E-07 7.025E-06 0.267914 0.68978763 WALLACE_PROSTATE_CANCER_RACE_UP peripheral vascular disease DOID_341 1.009E-06 9.573E-06 0.04294521 0.23272216 WALLACE_PROSTATE_CANCER_RACE_UP pulmonary emphysema DOID_9675 1.433E-06 1.337E-05 0.01598285 0.11511698 WALLACE_PROSTATE_CANCER_RACE_UP endometriosis of uterus DOID_288 1.607E-06 1.474E-05 0.17929211 0.52049596 WALLACE_PROSTATE_CANCER_RACE_UP endometriosis DOID_289 1.796E-06 1.622E-05 0.18288999 0.5255778 WALLACE_PROSTATE_CANCER_RACE_UP uveal disease DOID_3480 1.796E-06 1.597E-05 0.18288999 0.52293671 WALLACE_PROSTATE_CANCER_RACE_UP biliary tract cancer DOID_4607 2.115E-06 1.851E-05 6.262E-03 0.06143026 WALLACE_PROSTATE_CANCER_RACE_UP hepatitis B DOID_2043 2.438E-06 2.102E-05 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP proteinuria DOID_576 2.472E-06 2.1E-05 0.0195882 0.13268673 WALLACE_PROSTATE_CANCER_RACE_UP lymphoblastic leukemia DOID_1037 4.054E-06 3.392E-05 8.501E-03 0.07219567 WALLACE_PROSTATE_CANCER_RACE_UP mouth disease DOID_403 4.308E-06 3.553E-05 0.34413861 0.81589528 WALLACE_PROSTATE_CANCER_RACE_UP atopic dermatitis DOID_3310 4.416E-06 3.589E-05 0.21457353 0.57863667 WALLACE_PROSTATE_CANCER_RACE_UP vitiligo DOID_12306 6.687E-06 5.359E-05 6.685E-03 0.06339468 WALLACE_PROSTATE_CANCER_RACE_UP extrinsic allergic alveolitis DOID_841 6.687E-06 5.284E-05 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP autoimmune disease of cardiovascular system DOID_0060051 8.889E-06 6.928E-05 7.649E-03 0.06908364 WALLACE_PROSTATE_CANCER_RACE_UP sarcoma DOID_1115 8.889E-06 6.835E-05 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP Behcet's disease DOID_13241 8.889E-06 6.928E-05 7.649E-03 0.06908364 WALLACE_PROSTATE_CANCER_RACE_UP Sjogren's syndrome DOID_12894 9.673E-06 7.338E-05 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP teratoma DOID_3307 9.673E-06 7.242E-05 8.38E-04 0.01362407 WALLACE_PROSTATE_CANCER_RACE_UP conjunctival disease DOID_4251 9.673E-06 7.148E-05 8.38E-04 0.01324563 WALLACE_PROSTATE_CANCER_RACE_UP malignant teratoma DOID_5563 9.673E-06 7.242E-05 8.38E-04 0.01362407 WALLACE_PROSTATE_CANCER_RACE_UP mature teratoma DOID_5566 9.673E-06 7.242E-05 8.38E-04 0.01362407 WALLACE_PROSTATE_CANCER_RACE_UP conjunctivitis DOID_6195 9.673E-06 7.148E-05 8.38E-04 0.01324563 WALLACE_PROSTATE_CANCER_RACE_UP visceral leishmaniasis DOID_9146 9.673E-06 7.056E-05 0.04293898 0.23492578 WALLACE_PROSTATE_CANCER_RACE_UP respiratory failure DOID_11162 1.012E-05 7.29E-05 0.03311023 0.19831285 WALLACE_PROSTATE_CANCER_RACE_UP uterine disease DOID_345 1.264E-05 8.989E-05 0.25819462 0.67391164 WALLACE_PROSTATE_CANCER_RACE_UP abdominal aortic aneurysm DOID_7693 1.314E-05 9.229E-05 0.13486947 0.42871916 WALLACE_PROSTATE_CANCER_RACE_UP dermatomyositis DOID_10223 1.326E-05 9.199E-05 0.04713075 0.24603115 WALLACE_PROSTATE_CANCER_RACE_UP common variable immunodeficiency DOID_12177 1.326E-05 9.088E-05 0.04713075 0.24159816 WALLACE_PROSTATE_CANCER_RACE_UP male reproductive system disease DOID_48 1.912E-05 1.295E-04 0.04191786 0.2433802 WALLACE_PROSTATE_CANCER_RACE_UP hepatitis C DOID_1883 2.092E-05 1.4E-04 0.01147895 0.09199327 WALLACE_PROSTATE_CANCER_RACE_UP periodontal disease DOID_3388 2.092E-05 1.384E-04 0.14993637 0.45867631 WALLACE_PROSTATE_CANCER_RACE_UP esophageal disease DOID_6050 2.092E-05 1.368E-04 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP berylliosis DOID_10322 2.283E-05 1.476E-04 0.05545961 0.25448806 WALLACE_PROSTATE_CANCER_RACE_UP larynx cancer DOID_2596 2.283E-05 1.46E-04 1.44E-03 0.02101072 WALLACE_PROSTATE_CANCER_RACE_UP laryngeal benign neoplasm DOID_2598 2.283E-05 1.46E-04 1.44E-03 0.02101072 WALLACE_PROSTATE_CANCER_RACE_UP cystic fibrosis DOID_1485 2.471E-05 1.562E-04 0.04608311 0.24737065 WALLACE_PROSTATE_CANCER_RACE_UP viral pneumonia DOID_10533 2.896E-05 1.811E-04 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP uveitis DOID_13141 3.164E-05 1.957E-04 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP female reproductive system disease DOID_229 3.339E-05 2.043E-04 0.30554193 0.74615174 WALLACE_PROSTATE_CANCER_RACE_UP thoracic aortic aneurysm DOID_14004 3.609E-05 2.185E-04 0.06371611 0.27258997 WALLACE_PROSTATE_CANCER_RACE_UP adult respiratory distress syndrome DOID_11394 3.829E-05 2.294E-04 0.17204903 0.50723263 WALLACE_PROSTATE_CANCER_RACE_UP autoimmune disease of urogenital tract DOID_0060049 4.592E-05 2.722E-04 0.0166787 0.11862726 WALLACE_PROSTATE_CANCER_RACE_UP primary biliary cirrhosis DOID_12236 4.592E-05 2.722E-04 0.0166787 0.11862726 WALLACE_PROSTATE_CANCER_RACE_UP diabetic autonomic neuropathy DOID_11503 5.459E-05 3.203E-04 0.1864722 0.5305134 WALLACE_PROSTATE_CANCER_RACE_UP autonomic neuropathy DOID_11504 5.459E-05 3.203E-04 0.1864722 0.5305134 WALLACE_PROSTATE_CANCER_RACE_UP diabetic polyneuropathy DOID_12785 5.459E-05 3.203E-04 0.1864722 0.5305134 WALLACE_PROSTATE_CANCER_RACE_UP gallbladder cancer DOID_3121 5.459E-05 3.17E-04 0.01810848 0.12414124 WALLACE_PROSTATE_CANCER_RACE_UP diabetic neuropathy DOID_9743 5.459E-05 3.203E-04 0.1864722 0.5305134 WALLACE_PROSTATE_CANCER_RACE_UP prion disease DOID_649 6.41E-05 3.684E-04 2.784E-03 0.03371016 WALLACE_PROSTATE_CANCER_RACE_UP autonomic nervous system disease DOID_11465 6.977E-05 3.97E-04 0.19712543 0.54982533 WALLACE_PROSTATE_CANCER_RACE_UP brain cancer DOID_1319 6.977E-05 3.931E-04 0.19712543 0.54714326 WALLACE_PROSTATE_CANCER_RACE_UP vascular skin disease DOID_9540 6.977E-05 3.892E-04 0.19712543 0.53925177 WALLACE_PROSTATE_CANCER_RACE_UP central nervous system cancer DOID_3620 7.546E-05 4.168E-04 0.2006456 0.54625524 WALLACE_PROSTATE_CANCER_RACE_UP psoriasis DOID_8893 7.587E-05 4.151E-04 7.587E-05 2.398E-03 WALLACE_PROSTATE_CANCER_RACE_UP leishmaniasis DOID_9065 7.587E-05 4.112E-04 0.0800145 0.31398793 WALLACE_PROSTATE_CANCER_RACE_UP glaucoma DOID_1686 8.147E-05 4.373E-04 0.02189931 0.14659657 WALLACE_PROSTATE_CANCER_RACE_UP hemorrhagic disease DOID_2213 9.452E-05 5.026E-04 0.21111433 0.57201929 WALLACE_PROSTATE_CANCER_RACE_UP autoimmune hepatitis DOID_2048 1.035E-04 5.451E-04 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP giant cell tumor DOID_200 1.09E-04 5.692E-04 0.21801765 0.58515115 WALLACE_PROSTATE_CANCER_RACE_UP malignant giant cell tumor DOID_2705 1.09E-04 5.692E-04 0.21801765 0.58515115 WALLACE_PROSTATE_CANCER_RACE_UP giant cell glioblastoma DOID_3074 1.09E-04 5.692E-04 0.21801765 0.58515115 WALLACE_PROSTATE_CANCER_RACE_UP acquired immunodeficiency syndrome DOID_635 1.194E-04 6.177E-04 0.09205294 0.34918749 WALLACE_PROSTATE_CANCER_RACE_UP IgA glomerulonephritis DOID_2986 1.369E-04 7.017E-04 1.369E-04 3.709E-03 WALLACE_PROSTATE_CANCER_RACE_UP glioblastoma DOID_3068 1.523E-04 7.737E-04 0.23501439 0.6278084 WALLACE_PROSTATE_CANCER_RACE_UP bile duct cancer DOID_4606 1.523E-04 7.669E-04 0.02946194 0.18221569 WALLACE_PROSTATE_CANCER_RACE_UP bile duct carcinoma DOID_4897 1.523E-04 7.669E-04 0.02946194 0.18221569 WALLACE_PROSTATE_CANCER_RACE_UP ureteral disease DOID_1426 1.559E-04 7.784E-04 4.937E-03 0.05202407 WALLACE_PROSTATE_CANCER_RACE_UP toxic shock syndrome DOID_14115 1.766E-04 8.74E-04 1.766E-04 4.569E-03 WALLACE_PROSTATE_CANCER_RACE_UP commensal bacterial infectious disease DOID_0050339 1.99E-04 9.764E-04 1.99E-04 4.924E-03 WALLACE_PROSTATE_CANCER_RACE_UP urticaria DOID_1555 1.99E-04 9.68E-04 0.10786096 0.38358053 WALLACE_PROSTATE_CANCER_RACE_UP intracranial aneurysm DOID_10941 2.492E-04 1.202E-03 6.685E-03 0.06446917 WALLACE_PROSTATE_CANCER_RACE_UP middle cerebral artery infarction DOID_3525 2.492E-04 1.192E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP tooth disease DOID_1091 2.595E-04 1.231E-03 0.26468835 0.68458033 WALLACE_PROSTATE_CANCER_RACE_UP astrocytoma DOID_3069 2.892E-04 1.36E-03 0.27112558 0.69491197 WALLACE_PROSTATE_CANCER_RACE_UP blood coagulation disease DOID_1247 3.05E-04 1.422E-03 0.27432316 0.69995461 WALLACE_PROSTATE_CANCER_RACE_UP malaria DOID_12365 3.068E-04 1.419E-03 7.649E-03 0.06800421 WALLACE_PROSTATE_CANCER_RACE_UP supratentorial cancer DOID_1659 3.386E-04 1.554E-03 0.12723678 0.41135073 WALLACE_PROSTATE_CANCER_RACE_UP toxic encephalopathy DOID_3602 3.386E-04 1.541E-03 3.386E-04 7.707E-03 WALLACE_PROSTATE_CANCER_RACE_UP cerebrum cancer DOID_368 3.386E-04 1.554E-03 0.12723678 0.41135073 WALLACE_PROSTATE_CANCER_RACE_UP mixed glioma DOID_5076 4.327E-04 1.954E-03 5.292E-03 0.05377247 WALLACE_PROSTATE_CANCER_RACE_UP lipid metabolism disorder DOID_3146 4.753E-04 2.13E-03 0.3024811 0.74507248 WALLACE_PROSTATE_CANCER_RACE_UP chronic kidney failure DOID_784 5.447E-04 2.421E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP pneumoconiosis DOID_10316 5.742E-04 2.533E-03 0.14993637 0.46115564 WALLACE_PROSTATE_CANCER_RACE_UP nephroblastoma DOID_2154 5.742E-04 2.513E-03 0.01147895 0.09071559 WALLACE_PROSTATE_CANCER_RACE_UP leukopenia DOID_615 5.742E-04 2.494E-03 5.742E-04 0.01020979 WALLACE_PROSTATE_CANCER_RACE_UP calcinosis DOID_182 7.231E-04 3.117E-03 0.01332927 0.10112473 WALLACE_PROSTATE_CANCER_RACE_UP peripheral nervous system neoplasm DOID_1192 7.777E-04 3.327E-03 0.01397294 0.10325458 WALLACE_PROSTATE_CANCER_RACE_UP familial combined hyperlipidemia DOID_13809 8.38E-04 3.559E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP childhood type dermatomyositis DOID_14203 8.38E-04 3.532E-03 0.04293898 0.24679071 WALLACE_PROSTATE_CANCER_RACE_UP angioedema DOID_1558 8.38E-04 3.506E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP phagocyte bactericidal dysfunction DOID_3262 8.38E-04 3.481E-03 0.04293898 0.24432281 WALLACE_PROSTATE_CANCER_RACE_UP intracranial arterial disease DOID_13089 8.946E-04 3.689E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP cerebral arterial disease DOID_3527 8.946E-04 3.689E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP lymphatic system disease DOID_75 8.946E-04 3.662E-03 0.17204903 0.50461803 WALLACE_PROSTATE_CANCER_RACE_UP nervous system benign neoplasm DOID_0060115 1.021E-03 4.151E-03 0.04713075 0.25062987 WALLACE_PROSTATE_CANCER_RACE_UP trypanosomiasis DOID_10113 1.021E-03 4.121E-03 0.04713075 0.24830922 WALLACE_PROSTATE_CANCER_RACE_UP prediabetes syndrome DOID_11716 1.021E-03 4.092E-03 0.04713075 0.24379451 WALLACE_PROSTATE_CANCER_RACE_UP invasive lobular carcinoma DOID_3457 1.021E-03 4.064E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP bronchiectasis DOID_9563 1.021E-03 4.036E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP Huntington's disease DOID_12858 1.09E-03 4.277E-03 1.09E-03 0.01676044 WALLACE_PROSTATE_CANCER_RACE_UP relapsing-remitting multiple sclerosis DOID_2378 1.222E-03 4.763E-03 0.05130427 0.24950536 WALLACE_PROSTATE_CANCER_RACE_UP ocular hypertension DOID_9282 1.222E-03 4.73E-03 0.05130427 0.24326772 WALLACE_PROSTATE_CANCER_RACE_UP borderline glaucoma DOID_9283 1.222E-03 4.73E-03 0.05130427 0.24326772 WALLACE_PROSTATE_CANCER_RACE_UP encephalitis DOID_9588 1.222E-03 4.698E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP cerebral infarction DOID_3526 1.234E-03 4.712E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP pre-eclampsia DOID_10591 1.389E-03 5.27E-03 0.19712543 0.55253383 WALLACE_PROSTATE_CANCER_RACE_UP heart valve disease DOID_4079 1.389E-03 5.235E-03 1.389E-03 0.02080301 WALLACE_PROSTATE_CANCER_RACE_UP calcium metabolism disease DOID_10575 1.645E-03 6.157E-03 0.02269361 0.14842144 WALLACE_PROSTATE_CANCER_RACE_UP open-angle glaucoma DOID_1067 1.675E-03 6.23E-03 0.05959687 0.2649267 WALLACE_PROSTATE_CANCER_RACE_UP aspergillosis DOID_13564 1.675E-03 6.19E-03 0.05959687 0.262873 WALLACE_PROSTATE_CANCER_RACE_UP narcolepsy DOID_8986 1.675E-03 6.15E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP B-cell lymphocytic neoplasm DOID_707 1.736E-03 6.331E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP idiopathic pulmonary fibrosis DOID_0050156 1.927E-03 6.986E-03 0.06371611 0.27675165 WALLACE_PROSTATE_CANCER_RACE_UP skeletal system cancer DOID_0060124 1.927E-03 6.941E-03 0.06371611 0.27465505 WALLACE_PROSTATE_CANCER_RACE_UP bone cancer DOID_184 1.927E-03 6.941E-03 0.06371611 0.27465505 WALLACE_PROSTATE_CANCER_RACE_UP membranoproliferative glomerulonephritis DOID_2920 1.927E-03 6.898E-03 1.927E-03 0.02611273 WALLACE_PROSTATE_CANCER_RACE_UP mesenchymal cell neoplasm DOID_3350 1.927E-03 6.855E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP adrenal cortex disease DOID_3952 1.927E-03 6.812E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP spindle cell sarcoma DOID_4235 1.927E-03 6.855E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP oral submucous fibrosis DOID_5773 1.927E-03 6.77E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP epithelioid sarcoma DOID_6193 1.927E-03 6.855E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP bile duct adenocarcinoma DOID_4896 2.028E-03 7.08E-03 0.02598733 0.16614371 WALLACE_PROSTATE_CANCER_RACE_UP cholangiocarcinoma DOID_4947 2.028E-03 7.08E-03 0.02598733 0.16614371 WALLACE_PROSTATE_CANCER_RACE_UP angiosarcoma DOID_0001816 2.197E-03 7.621E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP familial hyperlipidemia DOID_1168 2.239E-03 7.721E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP bronchitis DOID_6132 2.482E-03 8.508E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP adrenal gland disease DOID_9553 2.482E-03 8.457E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP glucose intolerance DOID_10603 2.784E-03 9.431E-03 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP ureteral obstruction DOID_5199 2.784E-03 9.375E-03 0.07596653 0.30440111 WALLACE_PROSTATE_CANCER_RACE_UP eosinophilia DOID_999 2.784E-03 9.32E-03 0.07596653 0.30227243 WALLACE_PROSTATE_CANCER_RACE_UP hypothyroidism DOID_1459 2.951E-03 9.82E-03 0.24834698 0.66032445 WALLACE_PROSTATE_CANCER_RACE_UP pre-malignant neoplasm DOID_0060071 3.082E-03 0.01019554 0.25164388 0.66597846 WALLACE_PROSTATE_CANCER_RACE_UP in situ carcinoma DOID_8719 3.082E-03 0.01019554 0.25164388 0.66597846 WALLACE_PROSTATE_CANCER_RACE_UP mineral metabolism disease DOID_0050032 3.216E-03 0.01057797 0.0349973 0.20743194 WALLACE_PROSTATE_CANCER_RACE_UP membranous glomerulonephritis DOID_10976 3.438E-03 0.01124287 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP esophagitis DOID_11963 3.438E-03 0.01117862 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP colon carcinoma DOID_1520 3.438E-03 0.01111511 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP subependymal glioma DOID_4843 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP pilocytic astrocytoma DOID_4851 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP subependymal giant cell astrocytoma DOID_5077 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP fibrillary astrocytoma DOID_6726 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP juvenile pilocytic astrocytoma DOID_6811 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP childhood pilocytic astrocytoma DOID_6812 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP gemistocytic astrocytoma DOID_7005 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP childhood cerebral astrocytoma DOID_7007 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP protoplasmic astrocytoma DOID_7008 3.438E-03 0.01105231 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP amyloidosis DOID_9120 3.438E-03 0.01099022 0.08404484 0.32754461 WALLACE_PROSTATE_CANCER_RACE_UP hyperglycemia DOID_4195 3.495E-03 0.01111033 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP benign glioma DOID_0060101 4.156E-03 0.01313771 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP neutropenia DOID_1227 4.156E-03 0.01306512 4.156E-03 0.04547667 WALLACE_PROSTATE_CANCER_RACE_UP familial hypercholesterolemia DOID_13810 4.156E-03 0.01299333 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP benign ependymoma DOID_4844 4.156E-03 0.01313771 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP sinusitis DOID_0050127 4.539E-03 0.01411249 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP agranulocytosis DOID_12987 4.539E-03 0.01403579 4.539E-03 0.04872804 WALLACE_PROSTATE_CANCER_RACE_UP paranasal sinus disease DOID_1352 4.539E-03 0.01411249 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP urinary tract obstruction DOID_5200 4.539E-03 0.01395993 0.09603086 0.35948392 WALLACE_PROSTATE_CANCER_RACE_UP sleep disorder DOID_535 4.539E-03 0.01388487 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP pulmonary embolism DOID_9477 4.539E-03 0.01381062 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP diabetic retinopathy DOID_8947 4.586E-03 0.01388072 0.28383247 0.70833631 WALLACE_PROSTATE_CANCER_RACE_UP diabetic angiopathy DOID_11713 4.937E-03 0.01486402 0.09999145 0.37186361 WALLACE_PROSTATE_CANCER_RACE_UP Goodpasture syndrome DOID_9808 4.937E-03 0.01478579 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP spastic quadriplegia DOID_10970 5.351E-03 0.01594161 0.10393479 0.38154126 WALLACE_PROSTATE_CANCER_RACE_UP acute pancreatitis DOID_2913 5.351E-03 0.01585858 0.10393479 0.37909548 WALLACE_PROSTATE_CANCER_RACE_UP metabolic syndrome X DOID_14221 5.668E-03 0.01671114 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP bronchiolitis DOID_2942 5.781E-03 0.01695436 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP osteosarcoma DOID_3347 5.781E-03 0.01686742 5.781E-03 0.05770432 WALLACE_PROSTATE_CANCER_RACE_UP cystitis DOID_1679 6.225E-03 0.01807203 0.11177003 0.39257497 WALLACE_PROSTATE_CANCER_RACE_UP retinal vascular disease DOID_2462 6.677E-03 0.01928615 0.31765231 0.76263362 WALLACE_PROSTATE_CANCER_RACE_UP periodontitis DOID_824 7.16E-03 0.02057454 0.11953716 0.40486098 WALLACE_PROSTATE_CANCER_RACE_UP transitional cell carcinoma DOID_2671 7.331E-03 0.02096048 0.32659714 0.78081416 WALLACE_PROSTATE_CANCER_RACE_UP amino acid metabolic disorder DOID_9252 7.557E-03 0.02149834 7.557E-03 0.06934948 WALLACE_PROSTATE_CANCER_RACE_UP renal hypertension DOID_1073 7.649E-03 0.02165308 0.12339537 0.41301158 WALLACE_PROSTATE_CANCER_RACE_UP secondary hypertension DOID_11130 7.649E-03 0.02165308 0.12339537 0.41301158 WALLACE_PROSTATE_CANCER_RACE_UP thrombocytopenia DOID_1588 7.649E-03 0.02154589 0.12339537 0.41059631 WALLACE_PROSTATE_CANCER_RACE_UP coronary stenosis DOID_4248 7.649E-03 0.02143975 0.12339537 0.40351706 WALLACE_PROSTATE_CANCER_RACE_UP corneal disease DOID_10124 8.672E-03 0.02418767 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP spastic cerebral palsy DOID_0050669 9.205E-03 0.02554943 0.13486947 0.4311277 WALLACE_PROSTATE_CANCER_RACE_UP autonomic nervous system neoplasm DOID_2621 0.01031394 0.0284885 0.14243581 0.44287419 WALLACE_PROSTATE_CANCER_RACE_UP bladder disease DOID_365 0.01031394 0.02835087 0.14243581 0.44046726 WALLACE_PROSTATE_CANCER_RACE_UP neuroblastoma DOID_769 0.01031394 0.0284885 0.14243581 0.44287419 WALLACE_PROSTATE_CANCER_RACE_UP papilloma DOID_2615 0.0108895 0.02978907 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP myocarditis DOID_820 0.0108895 0.02964654 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP male infertility DOID_12336 0.01147895 0.03110249 0.01147895 0.09330746 WALLACE_PROSTATE_CANCER_RACE_UP spindle cell carcinoma DOID_4015 0.01147895 0.03095508 0.01147895 0.08947291 WALLACE_PROSTATE_CANCER_RACE_UP aplastic anemia DOID_12449 0.01208215 0.03242802 0.15366216 0.46507323 WALLACE_PROSTATE_CANCER_RACE_UP medullomyoblastoma DOID_3861 0.01208215 0.03227578 0.01208215 0.09290191 WALLACE_PROSTATE_CANCER_RACE_UP adult medulloblastoma DOID_3864 0.01208215 0.03227578 0.01208215 0.09290191 WALLACE_PROSTATE_CANCER_RACE_UP childhood medulloblastoma DOID_3869 0.01208215 0.03227578 0.01208215 0.09290191 WALLACE_PROSTATE_CANCER_RACE_UP medulloblastoma DOID_3858 0.01332927 0.03544091 0.01332927 0.09979414 WALLACE_PROSTATE_CANCER_RACE_UP multiple myeloma DOID_9538 0.01332927 0.03527607 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP blood platelet disease DOID_2218 0.01397294 0.03680835 0.16474242 0.49077715 WALLACE_PROSTATE_CANCER_RACE_UP hepatitis DOID_2237 0.01462984 0.0383612 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP peptic ulcer DOID_750 0.01462984 0.03818524 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP primitive neuroectodermal tumor DOID_168 0.01738728 0.04517518 0.01738728 0.12065079 WALLACE_PROSTATE_CANCER_RACE_UP uterine cancer DOID_363 0.01810848 0.0468351 0.1864722 0.52787403 WALLACE_PROSTATE_CANCER_RACE_UP myeloma DOID_0070004 0.02034649 0.0523853 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP neuritis DOID_1803 0.02034649 0.05214933 0.19712543 0.54448722 WALLACE_PROSTATE_CANCER_RACE_UP bone marrow disease DOID_4961 0.02034649 0.05191547 0.19712543 0.54185685 WALLACE_PROSTATE_CANCER_RACE_UP integumentary system benign neoplasm DOID_0060121 0.02189931 0.05562816 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP skin benign neoplasm DOID_3165 0.02189931 0.05562816 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP bone marrow cancer DOID_4960 0.02598733 0.06571907 1.000 1.000 WALLACE_PROSTATE_CANCER_RACE_UP mitochondrial metabolism disease DOID_700 0.02770248 0.06974651 0.02770248 0.1732166 WALLACE_PROSTATE_CANCER_RACE_UP neuroectodermal tumor DOID_171 0.03218226 0.08066831 0.03218226 0.19690008 WALLACE_PROSTATE_CANCER_RACE_UP cholestasis DOID_13580 0.0359562 0.08973279 0.25819462 0.67701722 WALLACE_PROSTATE_CANCER_RACE_UP temporal lobe epilepsy DOID_3328 0.03692518 0.0917486 0.26144858 0.67928877 WALLACE_PROSTATE_CANCER_RACE_UP biliary tract disease DOID_9741 0.04294521 0.09973807 0.28067655 0.70665909 DIRMEIER_LMP1_RESPONSE_EARLY pancreatitis DOID_4989 5.877E-08 3.344E-05 1.461E-04 8.315E-03 DIRMEIER_LMP1_RESPONSE_EARLY bacterial pneumonia DOID_874 5.877E-08 1.672E-05 4.658E-03 0.10193382 DIRMEIER_LMP1_RESPONSE_EARLY sarcoma DOID_1115 6.049E-08 1.147E-05 7.55E-06 2.148E-03 DIRMEIER_LMP1_RESPONSE_EARLY lymphoma DOID_0060058 1.324E-07 1.884E-05 6.343E-06 3.609E-03 DIRMEIER_LMP1_RESPONSE_EARLY pulmonary sarcoidosis DOID_13406 1.998E-07 2.274E-05 0.04943917 0.37014326 DIRMEIER_LMP1_RESPONSE_EARLY adult respiratory distress syndrome DOID_11394 2.691E-07 2.552E-05 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY rheumatic disease DOID_1575 3.549E-07 2.885E-05 2.783E-05 3.167E-03 DIRMEIER_LMP1_RESPONSE_EARLY scleroderma DOID_419 3.549E-07 2.885E-05 2.783E-05 3.167E-03 DIRMEIER_LMP1_RESPONSE_EARLY cerebral infarction DOID_3526 4.223E-07 3.004E-05 0.05903579 0.41470821 DIRMEIER_LMP1_RESPONSE_EARLY vascular skin disease DOID_9540 4.99E-07 3.154E-05 0.06142008 0.41115327 DIRMEIER_LMP1_RESPONSE_EARLY psoriatic arthritis DOID_9008 5.399E-07 3.072E-05 0.01633771 0.2324039 DIRMEIER_LMP1_RESPONSE_EARLY B-cell lymphocytic neoplasm DOID_707 6.826E-07 3.531E-05 4.515E-05 3.67E-03 DIRMEIER_LMP1_RESPONSE_EARLY sarcoidosis DOID_11335 7.913E-07 3.752E-05 0.06853753 0.44315741 DIRMEIER_LMP1_RESPONSE_EARLY bone marrow cancer DOID_4960 8.503E-07 3.722E-05 5.312E-05 3.778E-03 DIRMEIER_LMP1_RESPONSE_EARLY pustulosis of palm and sole DOID_4398 9.124E-07 3.708E-05 2.48E-03 0.07055656 DIRMEIER_LMP1_RESPONSE_EARLY hypersensitivity reaction type IV disease DOID_2916 1.119E-06 4.245E-05 0.07442833 0.45052896 DIRMEIER_LMP1_RESPONSE_EARLY collagen disease DOID_854 1.359E-06 4.832E-05 7.517E-05 4.752E-03 DIRMEIER_LMP1_RESPONSE_EARLY respiratory failure DOID_11162 1.447E-06 4.842E-05 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY brain infarction DOID_3454 2.064E-06 6.526E-05 0.08610072 0.4899131 DIRMEIER_LMP1_RESPONSE_EARLY Kawasaki disease DOID_13378 2.493E-06 7.466E-05 0.02626147 0.29885552 DIRMEIER_LMP1_RESPONSE_EARLY lymphadenitis DOID_1602 2.493E-06 7.466E-05 0.02626147 0.29885552 DIRMEIER_LMP1_RESPONSE_EARLY lymph node disease DOID_9942 2.493E-06 7.466E-05 0.02626147 0.29885552 DIRMEIER_LMP1_RESPONSE_EARLY peripheral vascular disease DOID_341 2.573E-06 7.32E-05 0.09072921 0.50121281 DIRMEIER_LMP1_RESPONSE_EARLY polyarteritis nodosa DOID_9810 3.314E-06 8.979E-05 0.02872705 0.30269801 DIRMEIER_LMP1_RESPONSE_EARLY acute pancreatitis DOID_2913 4.296E-06 1.111E-04 4.622E-04 0.0175342 DIRMEIER_LMP1_RESPONSE_EARLY Human immunodeficiency virus infectious disease DOID_526 5.822E-06 1.44E-04 2.21E-04 0.01047896 DIRMEIER_LMP1_RESPONSE_EARLY diffuse large B-cell lymphoma DOID_0050745 6.801E-06 1.612E-04 6.235E-04 0.02217476 DIRMEIER_LMP1_RESPONSE_EARLY malaria DOID_12365 7.55E-06 1.718E-04 0.03730855 0.33169629 DIRMEIER_LMP1_RESPONSE_EARLY allergic rhinitis DOID_4481 1.109E-05 2.427E-04 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY multiple myeloma DOID_9538 1.821E-05 3.837E-04 1.821E-05 3.454E-03 DIRMEIER_LMP1_RESPONSE_EARLY systemic scleroderma DOID_418 2.112E-05 4.292E-04 2.112E-05 3.004E-03 DIRMEIER_LMP1_RESPONSE_EARLY lymphatic system disease DOID_75 2.268E-05 4.451E-04 0.05304908 0.37731159 DIRMEIER_LMP1_RESPONSE_EARLY influenza DOID_8469 2.97E-05 5.633E-04 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY myeloma DOID_0070004 3.58E-05 6.572E-04 3.58E-05 3.395E-03 DIRMEIER_LMP1_RESPONSE_EARLY pulmonary tuberculosis DOID_2957 4.03E-05 7.166E-04 0.06379846 0.41725661 DIRMEIER_LMP1_RESPONSE_EARLY parasitic protozoa infectious disease DOID_2789 5.597E-05 9.65E-04 0.07089824 0.44330878 DIRMEIER_LMP1_RESPONSE_EARLY visceral leishmaniasis DOID_9146 7.018E-05 1.175E-03 0.01259082 0.21071114 DIRMEIER_LMP1_RESPONSE_EARLY sickle cell anemia DOID_10923 8.571E-05 1.393E-03 0.01384134 0.21877 DIRMEIER_LMP1_RESPONSE_EARLY bronchiectasis DOID_9563 8.571E-05 1.355E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY cholestasis DOID_13580 9.009E-05 1.386E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY parasitic infectious disease DOID_1398 9.009E-05 1.349E-03 0.08261422 0.47966829 DIRMEIER_LMP1_RESPONSE_EARLY tuberculosis DOID_399 1.025E-04 1.495E-03 0.08610072 0.48506248 DIRMEIER_LMP1_RESPONSE_EARLY encephalitis DOID_9588 1.028E-04 1.462E-03 0.0150903 0.22016355 DIRMEIER_LMP1_RESPONSE_EARLY bile duct disease DOID_4138 1.159E-04 1.609E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY biliary tract disease DOID_9741 1.206E-04 1.634E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY hepatic coma DOID_12550 1.214E-04 1.606E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY hepatic encephalopathy DOID_13413 1.214E-04 1.606E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY cystic fibrosis DOID_1485 1.356E-04 1.753E-03 0.0941855 0.51530339 DIRMEIER_LMP1_RESPONSE_EARLY syndrome DOID_225 1.356E-04 1.714E-03 0.0941855 0.51039574 DIRMEIER_LMP1_RESPONSE_EARLY mesenchymal cell neoplasm DOID_3350 1.631E-04 2.017E-03 0.01882789 0.24347889 DIRMEIER_LMP1_RESPONSE_EARLY spindle cell sarcoma DOID_4235 1.631E-04 2.017E-03 0.01882789 0.24347889 DIRMEIER_LMP1_RESPONSE_EARLY epithelioid sarcoma DOID_6193 1.631E-04 2.017E-03 0.01882789 0.24347889 DIRMEIER_LMP1_RESPONSE_EARLY hyperhomocysteinemia DOID_9279 1.631E-04 1.974E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY angiosarcoma DOID_0001816 1.862E-04 2.208E-03 1.862E-04 9.634E-03 DIRMEIER_LMP1_RESPONSE_EARLY silicosis DOID_10325 1.862E-04 2.163E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY primary bacterial infectious disease DOID_0050338 2.004E-04 2.28E-03 0.10674888 0.54232241 DIRMEIER_LMP1_RESPONSE_EARLY bronchitis DOID_6132 2.109E-04 2.353E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY Crohn's disease DOID_8778 2.506E-04 2.742E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY hypersensitivity reaction type I disease DOID_1205 2.583E-04 2.773E-03 6.77E-03 0.13757103 DIRMEIER_LMP1_RESPONSE_EARLY leishmaniasis DOID_9065 2.648E-04 2.79E-03 0.02378976 0.2762525 DIRMEIER_LMP1_RESPONSE_EARLY ulcerative colitis DOID_8577 2.825E-04 2.923E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY acquired immunodeficiency syndrome DOID_635 3.568E-04 3.625E-03 3.568E-04 0.01561626 DIRMEIER_LMP1_RESPONSE_EARLY sinusitis DOID_0050127 3.905E-04 3.898E-03 0.02872705 0.31434024 DIRMEIER_LMP1_RESPONSE_EARLY paranasal sinus disease DOID_1352 3.905E-04 3.898E-03 0.02872705 0.31434024 DIRMEIER_LMP1_RESPONSE_EARLY diabetic angiopathy DOID_11713 4.256E-04 4.175E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY aortic valve disease DOID_62 4.256E-04 4.105E-03 0.02995755 0.30992447 DIRMEIER_LMP1_RESPONSE_EARLY Goodpasture syndrome DOID_9808 4.256E-04 4.036E-03 4.256E-04 0.01729768 DIRMEIER_LMP1_RESPONSE_EARLY spastic quadriplegia DOID_10970 4.622E-04 4.312E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY urticaria DOID_1555 5.004E-04 4.592E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY bronchiolitis DOID_2942 5.004E-04 4.519E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY osteosarcoma DOID_3347 5.004E-04 4.448E-03 0.03241397 0.32934906 DIRMEIER_LMP1_RESPONSE_EARLY cystitis DOID_1679 5.399E-04 4.727E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY middle cerebral artery infarction DOID_3525 5.81E-04 5.009E-03 0.03486429 0.33062973 DIRMEIER_LMP1_RESPONSE_EARLY migraine DOID_6364 6.235E-04 5.295E-03 0.03608718 0.32593023 DIRMEIER_LMP1_RESPONSE_EARLY perinatal necrotizing enterocolitis DOID_8677 6.235E-04 5.218E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY pleurisy DOID_10247 6.675E-04 5.505E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY spastic cerebral palsy DOID_0050669 8.083E-04 6.57E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY pleural disease DOID_1532 9.094E-04 7.288E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY bladder disease DOID_365 9.094E-04 7.187E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY pneumoconiosis DOID_10316 1.016E-03 7.921E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY spindle cell carcinoma DOID_4015 1.016E-03 7.814E-03 0.04581578 0.35711208 DIRMEIER_LMP1_RESPONSE_EARLY esophageal disease DOID_6050 1.016E-03 7.71E-03 0.04581578 0.35228624 DIRMEIER_LMP1_RESPONSE_EARLY medullomyoblastoma DOID_3861 1.072E-03 8.025E-03 1.072E-03 0.035876 DIRMEIER_LMP1_RESPONSE_EARLY adult medulloblastoma DOID_3864 1.072E-03 8.025E-03 1.072E-03 0.035876 DIRMEIER_LMP1_RESPONSE_EARLY childhood medulloblastoma DOID_3869 1.072E-03 8.025E-03 1.072E-03 0.035876 DIRMEIER_LMP1_RESPONSE_EARLY medulloblastoma DOID_3858 1.187E-03 8.774E-03 1.187E-03 0.03753349 DIRMEIER_LMP1_RESPONSE_EARLY respiratory syncytial virus infectious disease DOID_1273 1.309E-03 9.546E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY hepatitis DOID_2237 1.309E-03 9.425E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY congenital diaphragmatic hernia DOID_3827 1.309E-03 9.307E-03 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY intracranial arterial disease DOID_13089 1.371E-03 9.633E-03 0.05304908 0.38208768 DIRMEIER_LMP1_RESPONSE_EARLY cerebral arterial disease DOID_3527 1.371E-03 9.633E-03 0.05304908 0.38208768 DIRMEIER_LMP1_RESPONSE_EARLY primitive neuroectodermal tumor DOID_168 1.568E-03 0.01087981 1.568E-03 0.04695499 DIRMEIER_LMP1_RESPONSE_EARLY pre-eclampsia DOID_10591 1.85E-03 0.01268097 0.06142008 0.42619546 DIRMEIER_LMP1_RESPONSE_EARLY heart valve disease DOID_4079 1.85E-03 0.01253 0.06142008 0.42106058 DIRMEIER_LMP1_RESPONSE_EARLY hypertrophic cardiomyopathy DOID_11984 2.739E-03 0.01833484 0.07442833 0.45537336 DIRMEIER_LMP1_RESPONSE_EARLY melancholia DOID_2848 2.828E-03 0.01871063 2.828E-03 0.07662448 DIRMEIER_LMP1_RESPONSE_EARLY leukocyte disease DOID_9500 2.828E-03 0.01849556 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY neurotic disorder DOID_4964 2.918E-03 0.01886971 2.918E-03 0.07547883 DIRMEIER_LMP1_RESPONSE_EARLY neuroectodermal tumor DOID_171 3.01E-03 0.01924405 3.01E-03 0.07446609 DIRMEIER_LMP1_RESPONSE_EARLY congenital heart defect DOID_1682 3.198E-03 0.02021535 3.198E-03 0.07580757 DIRMEIER_LMP1_RESPONSE_EARLY mineral metabolism disease DOID_0050032 3.293E-03 0.0205918 0.08144916 0.47777912 DIRMEIER_LMP1_RESPONSE_EARLY endocrine pancreas disease DOID_1428 3.293E-03 0.02036797 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY endogenous depression DOID_1595 4.433E-03 0.02712536 4.433E-03 0.10090633 DIRMEIER_LMP1_RESPONSE_EARLY bone resorption disease DOID_0080011 4.545E-03 0.02751171 0.09533474 0.5117497 DIRMEIER_LMP1_RESPONSE_EARLY osteoporosis DOID_11476 4.545E-03 0.02751171 0.09533474 0.5117497 DIRMEIER_LMP1_RESPONSE_EARLY mixed glioma DOID_5076 4.658E-03 0.02789768 0.09648255 0.51307077 DIRMEIER_LMP1_RESPONSE_EARLY contact dermatitis DOID_2773 4.887E-03 0.02896702 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY mental depression DOID_1596 5.241E-03 0.03074364 5.241E-03 0.11044938 DIRMEIER_LMP1_RESPONSE_EARLY primary immunodeficiency disease DOID_612 5.983E-03 0.03473703 0.10901472 0.54893254 DIRMEIER_LMP1_RESPONSE_EARLY amino acid metabolic disorder DOID_9252 5.983E-03 0.03438616 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY lymphoblastic leukemia DOID_1037 6.502E-03 0.03699909 0.11352954 0.56172443 DIRMEIER_LMP1_RESPONSE_EARLY encephalomyelitis DOID_640 6.502E-03 0.03663276 0.11352954 0.55688198 DIRMEIER_LMP1_RESPONSE_EARLY arrhythmogenic right ventricular dysplasia DOID_0050431 0.01133876 0.06325249 0.01133876 0.22247428 DIRMEIER_LMP1_RESPONSE_EARLY T cell deficiency DOID_11200 0.01259082 0.06955513 0.01259082 0.23880596 DIRMEIER_LMP1_RESPONSE_EARLY Diamond-Blackfan anemia DOID_1339 0.01259082 0.06888633 0.01259082 0.23110254 DIRMEIER_LMP1_RESPONSE_EARLY childhood type dermatomyositis DOID_14203 0.01259082 0.06823027 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY bilirubin metabolic disorder DOID_2741 0.01259082 0.06758659 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY acute kidney failure DOID_3021 0.01259082 0.06695494 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY insulinoma DOID_3892 0.01259082 0.06633499 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY hypokalemia DOID_4500 0.01259082 0.06572641 0.01259082 0.22388059 DIRMEIER_LMP1_RESPONSE_EARLY Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01259082 0.0651289 0.01259082 0.21709633 DIRMEIER_LMP1_RESPONSE_EARLY Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01259082 0.0651289 0.01259082 0.21709633 DIRMEIER_LMP1_RESPONSE_EARLY Hodgkin's granuloma DOID_8651 0.01259082 0.0651289 0.01259082 0.21709633 DIRMEIER_LMP1_RESPONSE_EARLY Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01259082 0.0651289 0.01259082 0.21709633 DIRMEIER_LMP1_RESPONSE_EARLY cutaneous leishmaniasis DOID_9111 0.01259082 0.06454215 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY Charcot-Marie-Tooth disease type 4 DOID_0050541 0.01384134 0.07031893 0.01384134 0.22502057 DIRMEIER_LMP1_RESPONSE_EARLY dermatomyositis DOID_10223 0.01384134 0.06969664 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY migraine without aura DOID_12783 0.01384134 0.06908526 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY hemochromatosis DOID_2352 0.01384134 0.06848452 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY otitis media DOID_10754 0.0150903 0.07402051 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY aortic valve stenosis DOID_1712 0.0150903 0.07338785 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY islet cell tumor DOID_1799 0.0150903 0.07276592 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY middle ear disease DOID_5100 0.0150903 0.07402051 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY aortic valve insufficiency DOID_57 0.0150903 0.07215444 0.0150903 0.23206429 DIRMEIER_LMP1_RESPONSE_EARLY peritonitis DOID_8283 0.0150903 0.07155316 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY Hodgkin's lymphoma DOID_8567 0.0150903 0.07096181 0.0150903 0.22595733 DIRMEIER_LMP1_RESPONSE_EARLY leprosy DOID_1024 0.01633771 0.076198 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY berylliosis DOID_10322 0.01633771 0.0755785 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY newborn respiratory distress syndrome DOID_12716 0.01633771 0.074969 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY viral pneumonia DOID_10533 0.01758357 0.08004043 0.01758357 0.24402569 DIRMEIER_LMP1_RESPONSE_EARLY hypercalcemia DOID_12678 0.01758357 0.07940518 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY aspergillosis DOID_13564 0.01758357 0.07877995 0.01758357 0.23821555 DIRMEIER_LMP1_RESPONSE_EARLY peripheral neuropathy DOID_0060053 0.01882789 0.08369587 0.01882789 0.24914119 DIRMEIER_LMP1_RESPONSE_EARLY lung oat cell carcinoma DOID_5411 0.01882789 0.08304706 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY oral submucous fibrosis DOID_5773 0.01882789 0.08240824 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY hemolytic-uremic syndrome DOID_12554 0.02007067 0.08717718 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY thyroiditis DOID_7166 0.02007067 0.08651675 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY autoimmune thyroiditis DOID_7188 0.02007067 0.08651675 1.000 1.000 DIRMEIER_LMP1_RESPONSE_EARLY tongue cancer DOID_8649 0.02007067 0.08586625 0.02007067 0.25378247 DIRMEIER_LMP1_RESPONSE_EARLY Barrett's esophagus DOID_9206 0.02007067 0.08522546 0.02007067 0.24826546 DIRMEIER_LMP1_RESPONSE_EARLY keratosis DOID_161 0.0225516 0.09505082 0.0225516 0.27301831 DIRMEIER_LMP1_RESPONSE_EARLY psoriasis DOID_8893 0.02378976 0.09953215 0.02378976 0.28200776 DANG_MYC_TARGETS_DN nephroblastoma DOID_2154 1.708E-06 9.716E-04 0.02316921 0.50704921 DANG_MYC_TARGETS_DN spindle cell carcinoma DOID_4015 1.708E-06 4.858E-04 2.524E-04 0.14359106 DANG_MYC_TARGETS_DN adenoma DOID_657 2.007E-06 3.806E-04 0.02440683 0.49598163 DANG_MYC_TARGETS_DN myeloma DOID_0070004 4.284E-06 6.094E-04 0.03118693 0.4929267 DANG_MYC_TARGETS_DN bone marrow cancer DOID_4960 6.377E-06 7.257E-04 0.035478 0.44859957 DANG_MYC_TARGETS_DN mineral metabolism disease DOID_0050032 1.04E-05 9.86E-04 0.04157652 0.46386349 DANG_MYC_TARGETS_DN pancreatic ductal carcinoma DOID_3587 1.347E-05 1.095E-03 0.04521787 0.46779943 DANG_MYC_TARGETS_DN pancreatic carcinoma DOID_4905 1.52E-05 1.081E-03 0.04703357 0.4778947 DANG_MYC_TARGETS_DN transitional cell carcinoma DOID_2671 2.526E-05 1.597E-03 0.05546319 0.54411298 DANG_MYC_TARGETS_DN berylliosis DOID_10322 2.983E-05 1.697E-03 1.000 1.000 DANG_MYC_TARGETS_DN newborn respiratory distress syndrome DOID_12716 2.983E-05 1.543E-03 1.000 1.000 DANG_MYC_TARGETS_DN Leydig cell tumor DOID_2696 2.983E-05 1.414E-03 1.000 1.000 DANG_MYC_TARGETS_DN sex cord-stromal neoplasm DOID_4757 2.983E-05 1.414E-03 1.000 1.000 DANG_MYC_TARGETS_DN hemangioma DOID_255 4.013E-05 1.756E-03 9.456E-03 0.59781022 DANG_MYC_TARGETS_DN placenta disease DOID_780 8.804E-05 3.578E-03 1.000 1.000 DANG_MYC_TARGETS_DN toxic shock syndrome DOID_14115 1.142E-04 4.332E-03 1.000 1.000 DANG_MYC_TARGETS_DN commensal bacterial infectious disease DOID_0050339 1.237E-04 4.398E-03 1.000 1.000 DANG_MYC_TARGETS_DN autoimmune disease of cardiovascular system DOID_0060051 1.653E-04 5.532E-03 1.000 1.000 DANG_MYC_TARGETS_DN Behcet's disease DOID_13241 1.653E-04 5.532E-03 1.000 1.000 DANG_MYC_TARGETS_DN focal glomerulosclerosis DOID_3945 1.766E-04 5.583E-03 1.000 1.000 DANG_MYC_TARGETS_DN endometrial carcinoma DOID_2871 1.883E-04 5.639E-03 1.000 1.000 DANG_MYC_TARGETS_DN abdominal aortic aneurysm DOID_7693 2.004E-04 5.701E-03 1.000 1.000 DANG_MYC_TARGETS_DN endometrial cancer DOID_1380 2.128E-04 5.766E-03 1.000 1.000 DANG_MYC_TARGETS_DN papilloma DOID_2615 2.388E-04 6.176E-03 0.02254983 0.51323422 DANG_MYC_TARGETS_DN pneumoconiosis DOID_10316 2.524E-04 6.243E-03 1.000 1.000 DANG_MYC_TARGETS_DN medullomyoblastoma DOID_3861 2.663E-04 6.313E-03 0.02378821 0.50131443 DANG_MYC_TARGETS_DN adult medulloblastoma DOID_3864 2.663E-04 6.313E-03 0.02378821 0.50131443 DANG_MYC_TARGETS_DN childhood medulloblastoma DOID_3869 2.663E-04 6.313E-03 0.02378821 0.50131443 DANG_MYC_TARGETS_DN pulmonary sarcoidosis DOID_13406 2.952E-04 6.719E-03 1.000 1.000 DANG_MYC_TARGETS_DN calcinosis DOID_182 2.952E-04 6.461E-03 0.02502508 0.49100924 DANG_MYC_TARGETS_DN medulloblastoma DOID_3858 2.952E-04 6.221E-03 0.02502508 0.47464226 DANG_MYC_TARGETS_DN peptic ulcer DOID_750 3.256E-04 6.617E-03 1.000 1.000 DANG_MYC_TARGETS_DN adult respiratory distress syndrome DOID_11394 3.414E-04 6.698E-03 1.000 1.000 DANG_MYC_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 3.575E-04 6.78E-03 0.02749431 0.47406855 DANG_MYC_TARGETS_DN pulmonary emphysema DOID_9675 3.575E-04 6.562E-03 1.000 1.000 DANG_MYC_TARGETS_DN nephrotic syndrome DOID_1184 3.908E-04 6.949E-03 1.000 1.000 DANG_MYC_TARGETS_DN primitive neuroectodermal tumor DOID_168 3.908E-04 6.739E-03 0.02872668 0.4807494 DANG_MYC_TARGETS_DN uterine cancer DOID_363 4.08E-04 6.828E-03 1.000 1.000 DANG_MYC_TARGETS_DN learning disability DOID_8927 4.256E-04 6.919E-03 0.02995755 0.48702416 DANG_MYC_TARGETS_DN pre-eclampsia DOID_10591 4.618E-04 7.3E-03 1.000 1.000 DANG_MYC_TARGETS_DN vascular skin disease DOID_9540 4.618E-04 7.102E-03 1.000 1.000 DANG_MYC_TARGETS_DN integumentary system benign neoplasm DOID_0060121 4.995E-04 7.48E-03 0.03241481 0.46110067 DANG_MYC_TARGETS_DN glaucoma DOID_1686 4.995E-04 7.288E-03 0.03241481 0.44985432 DANG_MYC_TARGETS_DN skin benign neoplasm DOID_3165 4.995E-04 7.48E-03 0.03241481 0.46110067 DANG_MYC_TARGETS_DN calcium metabolism disease DOID_10575 5.189E-04 7.382E-03 0.03302819 0.44745337 DANG_MYC_TARGETS_DN aortic aneurysm DOID_3627 5.189E-04 7.202E-03 1.000 1.000 DANG_MYC_TARGETS_DN sarcoidosis DOID_11335 5.793E-04 7.848E-03 1.000 1.000 DANG_MYC_TARGETS_DN giant cell tumor DOID_200 5.793E-04 7.665E-03 0.0348661 0.45088213 DANG_MYC_TARGETS_DN malignant giant cell tumor DOID_2705 5.793E-04 7.665E-03 0.0348661 0.45088213 DANG_MYC_TARGETS_DN giant cell glioblastoma DOID_3074 5.793E-04 7.665E-03 0.0348661 0.45088213 DANG_MYC_TARGETS_DN bile duct adenocarcinoma DOID_4896 6.001E-04 7.76E-03 1.000 1.000 DANG_MYC_TARGETS_DN cholangiocarcinoma DOID_4947 6.001E-04 7.76E-03 1.000 1.000 DANG_MYC_TARGETS_DN vasculitis DOID_865 6.001E-04 7.588E-03 1.000 1.000 DANG_MYC_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 6.213E-04 7.685E-03 1.000 1.000 DANG_MYC_TARGETS_DN integumentary system cancer DOID_0060122 6.213E-04 7.521E-03 0.03608952 0.44641166 DANG_MYC_TARGETS_DN skin cancer DOID_4159 6.213E-04 7.521E-03 0.03608952 0.44641166 DANG_MYC_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 6.87E-04 8.144E-03 1.000 1.000 DANG_MYC_TARGETS_DN glioblastoma DOID_3068 6.87E-04 7.978E-03 0.03792185 0.44953198 DANG_MYC_TARGETS_DN bile duct cancer DOID_4606 6.87E-04 7.818E-03 1.000 1.000 DANG_MYC_TARGETS_DN bile duct carcinoma DOID_4897 6.87E-04 7.818E-03 1.000 1.000 DANG_MYC_TARGETS_DN neuroectodermal tumor DOID_171 7.56E-04 8.434E-03 0.03975085 0.46159662 DANG_MYC_TARGETS_DN carotid artery disease DOID_3407 7.56E-04 8.272E-03 1.000 1.000 DANG_MYC_TARGETS_DN respiratory failure DOID_11162 7.797E-04 8.37E-03 1.000 1.000 DANG_MYC_TARGETS_DN pre-malignant neoplasm DOID_0060071 8.037E-04 8.469E-03 0.04096833 0.46621961 DANG_MYC_TARGETS_DN in situ carcinoma DOID_8719 8.037E-04 8.469E-03 0.04096833 0.46621961 DANG_MYC_TARGETS_DN cerebral degeneration DOID_1443 8.529E-04 8.824E-03 0.04218433 0.46159394 DANG_MYC_TARGETS_DN uterine disease DOID_345 8.529E-04 8.666E-03 1.000 1.000 DANG_MYC_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 9.293E-04 9.277E-03 0.04400556 0.47243707 DANG_MYC_TARGETS_DN astrocytoma DOID_3069 9.555E-04 9.374E-03 0.0446119 0.47007725 DANG_MYC_TARGETS_DN blood coagulation disease DOID_1247 9.82E-04 9.471E-03 1.000 1.000 DANG_MYC_TARGETS_DN nephrosis DOID_2527 1.009E-03 9.568E-03 1.000 1.000 DANG_MYC_TARGETS_DN male reproductive system disease DOID_48 1.009E-03 9.411E-03 1.000 1.000 DANG_MYC_TARGETS_DN peripheral vascular disease DOID_341 1.036E-03 9.509E-03 1.000 1.000 DANG_MYC_TARGETS_DN cystic fibrosis DOID_1485 1.12E-03 0.01011553 1.000 1.000 DANG_MYC_TARGETS_DN aneurysm disease DOID_2403 1.149E-03 0.01021216 1.000 1.000 DANG_MYC_TARGETS_DN bacterial pneumonia DOID_874 1.178E-03 0.01030889 1.000 1.000 DANG_MYC_TARGETS_DN female reproductive system disease DOID_229 1.267E-03 0.01092077 1.000 1.000 DANG_MYC_TARGETS_DN biliary tract cancer DOID_4607 1.328E-03 0.011277 1.000 1.000 DANG_MYC_TARGETS_DN chronic kidney failure DOID_784 1.328E-03 0.01111116 1.000 1.000 DANG_MYC_TARGETS_DN nervous system cancer DOID_3093 1.553E-03 0.01280491 0.05666157 0.546448 DANG_MYC_TARGETS_DN lymphoma DOID_0060058 1.62E-03 0.01316965 1.62E-03 0.4609376 DANG_MYC_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.689E-03 0.01353514 0.05905396 0.5508476 DANG_MYC_TARGETS_DN dilated cardiomyopathy DOID_12930 1.724E-03 0.01362288 0.05965115 0.54744362 DANG_MYC_TARGETS_DN hyperparathyroidism DOID_13543 6.313E-03 0.04920961 6.313E-03 1.000 DANG_MYC_TARGETS_DN rectal neoplasm DOID_1984 6.313E-03 0.04854462 1.000 1.000 DANG_MYC_TARGETS_DN rectum cancer DOID_1993 6.313E-03 0.04854462 1.000 1.000 DANG_MYC_TARGETS_DN transient cerebral ischemia DOID_224 6.313E-03 0.04789736 6.313E-03 0.89807541 DANG_MYC_TARGETS_DN acute kidney failure DOID_3021 6.313E-03 0.04726713 1.000 1.000 DANG_MYC_TARGETS_DN insulinoma DOID_3892 6.313E-03 0.04665327 1.000 1.000 DANG_MYC_TARGETS_DN polycythemia DOID_8432 6.313E-03 0.04605515 6.313E-03 0.71846033 DANG_MYC_TARGETS_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 6.943E-03 0.05000423 1.000 1.000 DANG_MYC_TARGETS_DN adrenoleukodystrophy DOID_10588 6.943E-03 0.04937917 1.000 1.000 DANG_MYC_TARGETS_DN invasive lobular carcinoma DOID_3457 6.943E-03 0.04876956 1.000 1.000 DANG_MYC_TARGETS_DN pituitary cancer DOID_1785 7.571E-03 0.0525384 1.000 1.000 DANG_MYC_TARGETS_DN islet cell tumor DOID_1799 7.571E-03 0.05190541 1.000 1.000 DANG_MYC_TARGETS_DN pituitary carcinoma DOID_4916 7.571E-03 0.0525384 1.000 1.000 DANG_MYC_TARGETS_DN aortic valve insufficiency DOID_57 7.571E-03 0.05128749 1.000 1.000 DANG_MYC_TARGETS_DN parathyroid gland disease DOID_11201 8.2E-03 0.05489114 8.2E-03 0.77762451 DANG_MYC_TARGETS_DN obstructive hydrocephalus DOID_14159 8.2E-03 0.05425287 8.2E-03 0.66653529 DANG_MYC_TARGETS_DN communicating hydrocephalus DOID_1573 8.2E-03 0.05425287 8.2E-03 0.66653529 DANG_MYC_TARGETS_DN viral pneumonia DOID_10533 8.828E-03 0.0577371 1.000 1.000 DANG_MYC_TARGETS_DN hydrocephalus DOID_10908 8.828E-03 0.057081 8.828E-03 0.62789099 DANG_MYC_TARGETS_DN membranoproliferative glomerulonephritis DOID_2920 9.456E-03 0.06045272 1.000 1.000 DANG_MYC_TARGETS_DN oral submucous fibrosis DOID_5773 9.456E-03 0.05978102 1.000 1.000 DANG_MYC_TARGETS_DN varicose veins DOID_799 9.456E-03 0.05912409 1.000 1.000 DANG_MYC_TARGETS_DN intracranial hypertension DOID_9428 9.456E-03 0.05848143 9.456E-03 0.5380292 DANG_MYC_TARGETS_DN angiosarcoma DOID_0001816 0.01008302 0.06169074 0.01008302 0.5215672 DANG_MYC_TARGETS_DN silicosis DOID_10325 0.01008302 0.06103446 1.000 1.000 DANG_MYC_TARGETS_DN spastic diplegia DOID_10965 0.01008302 0.06039199 1.000 1.000 DANG_MYC_TARGETS_DN pituitary adenoma DOID_3829 0.01008302 0.05976291 1.000 1.000 DANG_MYC_TARGETS_DN vein disease DOID_866 0.01008302 0.0591468 1.000 1.000 DANG_MYC_TARGETS_DN penile disease DOID_1529 0.01070996 0.06218337 1.000 1.000 DANG_MYC_TARGETS_DN urinary system benign neoplasm DOID_731 0.01070996 0.06155525 1.000 1.000 DANG_MYC_TARGETS_DN osteosclerosis DOID_4254 0.01133653 0.06450484 1.000 1.000 DANG_MYC_TARGETS_DN ureteral obstruction DOID_5199 0.01133653 0.06386618 1.000 1.000 DANG_MYC_TARGETS_DN dissociative disorder DOID_10935 0.01196271 0.06673315 0.01196271 0.5672318 DANG_MYC_TARGETS_DN dissociative amnesia DOID_11037 0.01196271 0.06673315 0.01196271 0.5672318 DANG_MYC_TARGETS_DN testicular cancer DOID_2998 0.01196271 0.06608526 1.000 1.000 DANG_MYC_TARGETS_DN granulosa cell tumor DOID_2999 0.01196271 0.06544982 0.01196271 0.52359858 DANG_MYC_TARGETS_DN amnestic disorder DOID_10914 0.01258851 0.06821774 0.01258851 0.51163307 DANG_MYC_TARGETS_DN sex cord-gonadal stromal tumor DOID_192 0.01258851 0.06757418 0.01258851 0.4775242 DANG_MYC_TARGETS_DN subependymal glioma DOID_4843 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN pilocytic astrocytoma DOID_4851 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN subependymal giant cell astrocytoma DOID_5077 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN fibrillary astrocytoma DOID_6726 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN juvenile pilocytic astrocytoma DOID_6811 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN childhood pilocytic astrocytoma DOID_6812 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN gemistocytic astrocytoma DOID_7005 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN childhood cerebral astrocytoma DOID_7007 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN protoplasmic astrocytoma DOID_7008 0.01258851 0.06694265 1.000 1.000 DANG_MYC_TARGETS_DN amyloidosis DOID_9120 0.01258851 0.06632281 0.01258851 0.44767894 DANG_MYC_TARGETS_DN Kawasaki disease DOID_13378 0.01321393 0.06897916 1.000 1.000 DANG_MYC_TARGETS_DN lymphadenitis DOID_1602 0.01321393 0.06897916 1.000 1.000 DANG_MYC_TARGETS_DN autoimmune hepatitis DOID_2048 0.01321393 0.06835208 1.000 1.000 DANG_MYC_TARGETS_DN coronary restenosis DOID_4247 0.01321393 0.06773629 1.000 1.000 DANG_MYC_TARGETS_DN lymph node disease DOID_9942 0.01321393 0.06897916 1.000 1.000 DANG_MYC_TARGETS_DN benign glioma DOID_0060101 0.01383898 0.07030694 1.000 1.000 DANG_MYC_TARGETS_DN benign ependymoma DOID_4844 0.01383898 0.07030694 1.000 1.000 DANG_MYC_TARGETS_DN muscular atrophy DOID_767 0.01383898 0.06968476 1.000 1.000 DANG_MYC_TARGETS_DN sinusitis DOID_0050127 0.01446364 0.07219132 1.000 1.000 DANG_MYC_TARGETS_DN paranasal sinus disease DOID_1352 0.01446364 0.07219132 1.000 1.000 DANG_MYC_TARGETS_DN IgA glomerulonephritis DOID_2986 0.01446364 0.07156357 1.000 1.000 DANG_MYC_TARGETS_DN uremia DOID_4676 0.01446364 0.07094665 1.000 1.000 DANG_MYC_TARGETS_DN urinary tract obstruction DOID_5200 0.01446364 0.07034026 1.000 1.000 DANG_MYC_TARGETS_DN polyarteritis nodosa DOID_9810 0.01446364 0.06974416 1.000 1.000 DANG_MYC_TARGETS_DN diabetic angiopathy DOID_11713 0.01508792 0.0721431 1.000 1.000 DANG_MYC_TARGETS_DN ureteral disease DOID_1426 0.01508792 0.0715419 1.000 1.000 DANG_MYC_TARGETS_DN aortic valve disease DOID_62 0.01508792 0.07095065 1.000 1.000 DANG_MYC_TARGETS_DN spastic quadriplegia DOID_10970 0.01571183 0.07327894 1.000 1.000 DANG_MYC_TARGETS_DN X-linked disease DOID_0050735 0.01633535 0.07556762 0.01633535 0.54675394 DANG_MYC_TARGETS_DN portal hypertension DOID_10762 0.01633535 0.0749582 1.000 1.000 DANG_MYC_TARGETS_DN urticaria DOID_1555 0.01633535 0.07435854 1.000 1.000 DANG_MYC_TARGETS_DN papillary adenoma DOID_3172 0.0169585 0.07658244 0.0169585 0.53607711 DANG_MYC_TARGETS_DN microcystic adenoma DOID_5403 0.0169585 0.07658244 0.0169585 0.53607711 DANG_MYC_TARGETS_DN follicular adenoma DOID_6204 0.0169585 0.07658244 0.0169585 0.53607711 DANG_MYC_TARGETS_DN spinal cord disease DOID_319 0.01758127 0.07876964 0.01758127 0.52651283 DANG_MYC_TARGETS_DN Sciatic Neuropathy DOID_11446 0.01820366 0.08092097 0.01820366 0.51789422 DANG_MYC_TARGETS_DN lesion of sciatic nerve DOID_12528 0.01820366 0.08092097 0.01820366 0.51789422 DANG_MYC_TARGETS_DN mononeuritis of lower limb DOID_9473 0.01820366 0.08092097 0.01820366 0.51789422 DANG_MYC_TARGETS_DN renal hypertension DOID_1073 0.01882568 0.08303729 1.000 1.000 DANG_MYC_TARGETS_DN secondary hypertension DOID_11130 0.01882568 0.08303729 1.000 1.000 DANG_MYC_TARGETS_DN sarcoma DOID_1115 0.01882568 0.08239854 0.01882568 0.51008619 DANG_MYC_TARGETS_DN thrombocytopenia DOID_1588 0.01882568 0.08176954 1.000 1.000 DANG_MYC_TARGETS_DN mononeuritis DOID_1802 0.01882568 0.08115008 0.01882568 0.48690046 DANG_MYC_TARGETS_DN hepatic vascular disease DOID_272 0.01882568 0.08053993 1.000 1.000 DANG_MYC_TARGETS_DN coronary stenosis DOID_4248 0.01882568 0.07993888 1.000 1.000 DANG_MYC_TARGETS_DN mononeuropathy DOID_1188 0.01944731 0.08196682 0.01944731 0.4811096 DANG_MYC_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 0.01944731 0.08136412 1.000 1.000 DANG_MYC_TARGETS_DN supratentorial cancer DOID_1659 0.01944731 0.08077022 1.000 1.000 DANG_MYC_TARGETS_DN cerebrum cancer DOID_368 0.01944731 0.08077022 1.000 1.000 DANG_MYC_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 0.02006857 0.0827465 1.000 1.000 DANG_MYC_TARGETS_DN uterine benign neoplasm DOID_0060095 0.02006857 0.0827465 1.000 1.000 DANG_MYC_TARGETS_DN uterine fibroid DOID_13223 0.02006857 0.0827465 1.000 1.000 DANG_MYC_TARGETS_DN spastic cerebral palsy DOID_0050669 0.02068945 0.08469279 1.000 1.000 DANG_MYC_TARGETS_DN bronchiolitis obliterans DOID_2799 0.02068945 0.08408784 1.000 1.000 DANG_MYC_TARGETS_DN Charcot-Marie-Tooth disease DOID_10595 0.02130996 0.0859955 1.000 1.000 DANG_MYC_TARGETS_DN allergic rhinitis DOID_4481 0.02130996 0.08538989 1.000 1.000 DANG_MYC_TARGETS_DN leiomyoma DOID_127 0.02193008 0.08726026 1.000 1.000 DANG_MYC_TARGETS_DN pleural disease DOID_1532 0.02193008 0.08665429 1.000 1.000 DANG_MYC_TARGETS_DN autonomic nervous system neoplasm DOID_2621 0.02193008 0.08605667 0.02193008 0.51992572 DANG_MYC_TARGETS_DN neuroblastoma DOID_769 0.02193008 0.08605667 0.02193008 0.51992572 DANG_MYC_TARGETS_DN multiple myeloma DOID_9538 0.02502508 0.09752923 0.02502508 0.45933122 DANG_MYC_TARGETS_DN peripheral nervous system neoplasm DOID_1192 0.02564295 0.09925739 0.02564295 0.45596364 DANG_MYC_TARGETS_DN blood platelet disease DOID_2218 0.02564295 0.09858673 1.000 1.000 DANG_MYC_TARGETS_DN congenital diaphragmatic hernia DOID_3827 0.02626044 0.09961461 1.000 1.000 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP mixed glioma DOID_5076 1.935E-06 1.101E-03 1.935E-06 1.101E-03 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP endogenous depression DOID_1595 9.077E-05 0.02582545 9.077E-05 0.02582545 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP major depressive disorder DOID_1470 9.274E-05 0.01758892 9.274E-05 0.01758892 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP mental depression DOID_1596 1.172E-04 0.01667455 1.172E-04 0.01667455 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP Ehlers-Danlos syndrome DOID_13359 1.247E-04 0.01418647 0.01649264 0.29325967 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP dilated cardiomyopathy DOID_12930 1.734E-04 0.0164415 1.734E-04 0.0197298 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP coronary stenosis DOID_4248 5.11E-04 0.04154019 0.03271963 0.3384995 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP polycystic ovary syndrome DOID_11612 5.459E-04 0.03882713 5.459E-04 0.0517695 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP female reproductive organ benign neoplasm DOID_0060086 5.819E-04 0.03678802 5.819E-04 0.04729889 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP uterine benign neoplasm DOID_0060095 5.819E-04 0.03678802 5.819E-04 0.04729889 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP uterine fibroid DOID_13223 5.819E-04 0.03678802 5.819E-04 0.04729889 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP leiomyoma DOID_127 6.966E-04 0.03963413 6.966E-04 0.04954267 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP endometriosis of uterus DOID_288 1.151E-03 0.05953148 1.151E-03 0.0727607 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP endometriosis DOID_289 1.202E-03 0.05701099 1.202E-03 0.06841319 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP lung small cell carcinoma DOID_5409 1.534E-03 0.06713854 1.534E-03 0.07934554 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP giant cell tumor DOID_200 1.776E-03 0.07220151 1.776E-03 0.0842351 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP malignant giant cell tumor DOID_2705 1.776E-03 0.07220151 1.776E-03 0.0842351 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP giant cell glioblastoma DOID_3074 1.776E-03 0.07220151 1.776E-03 0.0842351 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP reproductive organ benign neoplasm DOID_0050622 1.904E-03 0.07223144 1.904E-03 0.08334397 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP glioblastoma DOID_3068 2.104E-03 0.0748105 2.104E-03 0.08549771 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP collagen disease DOID_854 2.313E-03 0.0774034 0.06853927 0.49998522 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP uterine disease DOID_345 2.606E-03 0.08237256 2.606E-03 0.09884707 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP astrocytoma DOID_3069 2.916E-03 0.0873156 2.916E-03 0.10368727 HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP syndrome DOID_225 3.411E-03 0.09704774 3.411E-03 0.11417382 BROWNE_HCMV_INFECTION_30MIN_UP atrophic muscular disease DOID_913 1.768E-05 0.01006173 1.768E-05 0.01006173 BROWNE_HCMV_INFECTION_30MIN_UP muscular dystrophy DOID_9884 1.768E-05 0.01006173 1.768E-05 0.01006173 BROWNE_HCMV_INFECTION_30MIN_UP Human immunodeficiency virus infectious disease DOID_526 7.836E-05 0.02229418 3.107E-03 0.10398823 BROWNE_HCMV_INFECTION_30MIN_UP tongue cancer DOID_8649 9.295E-05 0.01762888 9.295E-05 0.02644332 BROWNE_HCMV_INFECTION_30MIN_UP congenital muscular dystrophy DOID_0050557 1.184E-04 0.01683866 1.184E-04 0.02245155 BROWNE_HCMV_INFECTION_30MIN_UP Goodpasture syndrome DOID_9808 2.128E-04 0.02421864 2.128E-04 0.0302733 BROWNE_HCMV_INFECTION_30MIN_UP myopia DOID_11830 2.908E-04 0.02757874 2.908E-04 0.03309449 BROWNE_HCMV_INFECTION_30MIN_UP middle cerebral artery infarction DOID_3525 2.908E-04 0.02363892 2.908E-04 0.02757874 BROWNE_HCMV_INFECTION_30MIN_UP refractive error DOID_9835 5.666E-04 0.04029742 5.666E-04 0.0460542 BROWNE_HCMV_INFECTION_30MIN_UP cleft palate DOID_674 5.961E-04 0.03768401 5.961E-04 0.04239451 BROWNE_HCMV_INFECTION_30MIN_UP uveitis DOID_13141 6.263E-04 0.03563485 0.03613714 0.33164571 BROWNE_HCMV_INFECTION_30MIN_UP intracranial arterial disease DOID_13089 6.889E-04 0.03563429 6.889E-04 0.04355302 BROWNE_HCMV_INFECTION_30MIN_UP cerebral arterial disease DOID_3527 6.889E-04 0.03563429 6.889E-04 0.04355302 BROWNE_HCMV_INFECTION_30MIN_UP nephrotic syndrome DOID_1184 7.883E-04 0.03737665 0.04045643 0.34878345 BROWNE_HCMV_INFECTION_30MIN_UP uveal disease DOID_3480 7.883E-04 0.03450152 0.04045643 0.33852511 BROWNE_HCMV_INFECTION_30MIN_UP cerebral infarction DOID_3526 8.581E-04 0.03487663 8.581E-04 0.04882728 BROWNE_HCMV_INFECTION_30MIN_UP orofacial cleft DOID_0050567 1.125E-03 0.04268562 1.125E-03 0.05820766 BROWNE_HCMV_INFECTION_30MIN_UP bile duct adenocarcinoma DOID_4896 1.208E-03 0.04296073 0.04989283 0.35486276 BROWNE_HCMV_INFECTION_30MIN_UP cholangiocarcinoma DOID_4947 1.208E-03 0.04296073 0.04989283 0.35486276 BROWNE_HCMV_INFECTION_30MIN_UP bile duct cancer DOID_4606 1.382E-03 0.0462579 0.05330187 0.35266004 BROWNE_HCMV_INFECTION_30MIN_UP bile duct carcinoma DOID_4897 1.382E-03 0.0462579 0.05330187 0.35266004 BROWNE_HCMV_INFECTION_30MIN_UP oral cavity cancer DOID_8618 1.382E-03 0.04368802 1.382E-03 0.06553202 BROWNE_HCMV_INFECTION_30MIN_UP brain infarction DOID_3454 1.866E-03 0.05588815 1.866E-03 0.08168269 BROWNE_HCMV_INFECTION_30MIN_UP pancreatic ductal carcinoma DOID_3587 1.971E-03 0.05608609 0.0634579 0.38007943 BROWNE_HCMV_INFECTION_30MIN_UP nephrosis DOID_2527 2.025E-03 0.0548683 0.06429945 0.38110818 BROWNE_HCMV_INFECTION_30MIN_UP pancreatic carcinoma DOID_4905 2.134E-03 0.05520155 0.06598034 0.37922033 BROWNE_HCMV_INFECTION_30MIN_UP diabetic retinopathy DOID_8947 2.134E-03 0.05280148 2.134E-03 0.08674529 BROWNE_HCMV_INFECTION_30MIN_UP pancreatitis DOID_4989 2.361E-03 0.05597973 0.06933333 0.39060066 BROWNE_HCMV_INFECTION_30MIN_UP alcohol abuse DOID_1574 2.66E-03 0.06054327 2.66E-03 0.10090544 BROWNE_HCMV_INFECTION_30MIN_UP biliary tract cancer DOID_4607 2.66E-03 0.05821468 0.07350815 0.39458621 BROWNE_HCMV_INFECTION_30MIN_UP retinal vascular disease DOID_2462 2.784E-03 0.05867792 2.784E-03 0.09901899 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE transitional cell carcinoma DOID_2671 2.208E-09 1.256E-06 6.34E-03 0.22547018 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE astrocytoma DOID_3069 4.252E-08 1.21E-05 0.09072807 0.49165971 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE multiple myeloma DOID_9538 2.362E-07 4.479E-05 0.05144656 0.41229706 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE myeloma DOID_0070004 5.894E-07 8.384E-05 0.06389736 0.44885927 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE giant cell tumor DOID_200 9.345E-07 1.064E-04 0.07129082 0.45071642 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE malignant giant cell tumor DOID_2705 9.345E-07 1.064E-04 0.07129082 0.45071642 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE giant cell glioblastoma DOID_3074 9.345E-07 1.064E-04 0.07129082 0.45071642 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE bone marrow cancer DOID_4960 1.004E-06 9.522E-05 0.07251749 0.44368226 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE angiosarcoma DOID_0001816 1.194E-06 9.707E-05 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE glioblastoma DOID_3068 1.321E-06 9.398E-05 0.0774083 0.45407546 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE amino acid metabolic disorder DOID_9252 6.573E-06 4.156E-04 6.573E-06 3.74E-03 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE nervous system cancer DOID_3093 6.866E-06 3.906E-04 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE seminoma DOID_4440 6.909E-06 3.574E-04 0.03629124 0.38240211 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE lymphoma DOID_0060058 7.478E-06 3.546E-04 0.11680469 0.56323616 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE sarcoma DOID_1115 8.546E-06 3.741E-04 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Charcot-Marie-Tooth disease DOID_10595 1.255E-05 5.1E-04 9.309E-04 0.10593311 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE germinoma DOID_3304 1.255E-05 4.76E-04 0.04389832 0.40947782 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE spindle cell carcinoma DOID_4015 1.625E-05 5.779E-04 0.04767977 0.41738137 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE cervix uteri carcinoma in situ DOID_8991 2.752E-05 9.21E-04 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE uterine cancer DOID_363 3.36E-05 1.062E-03 0.06017904 0.4280234 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE brain cancer DOID_1319 4.05E-05 1.213E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE thyroid adenoma DOID_2891 4.05E-05 1.152E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE central nervous system cancer DOID_3620 4.299E-05 1.165E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE reproductive organ benign neoplasm DOID_0050622 6.328E-05 1.637E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE hypertrophic cardiomyopathy DOID_11984 7.361E-05 1.821E-03 2.968E-03 0.16889862 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE pre-malignant neoplasm DOID_0060071 9.316E-05 2.209E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE in situ carcinoma DOID_8719 9.316E-05 2.209E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE endocrine organ benign neoplasm DOID_0060089 1.158E-04 2.636E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE pancreatic carcinoma DOID_4905 1.418E-04 3.103E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE diabetic retinopathy DOID_8947 1.418E-04 2.988E-03 4.565E-03 0.23613338 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE mixed glioma DOID_5076 1.651E-04 3.355E-03 0.10029662 0.51413311 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE hemangioma DOID_255 1.77E-04 3.474E-03 0.01960516 0.32809815 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE nutritional deficiency disease DOID_5113 1.77E-04 3.358E-03 1.77E-04 0.05036783 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE chromosomal disease DOID_0080014 1.841E-04 3.38E-03 5.419E-03 0.22023635 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE biliary tract cancer DOID_4607 1.976E-04 3.513E-03 0.10622678 0.53020208 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE retinal vascular disease DOID_2462 2.116E-04 3.649E-03 5.937E-03 0.22521383 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE methylmalonic acidemia DOID_14749 2.289E-04 3.831E-03 2.289E-04 0.04341892 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE lymphoblastic leukemia DOID_1037 2.743E-04 4.459E-03 7.039E-03 0.23559155 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE encephalomyelitis DOID_640 2.743E-04 4.335E-03 7.039E-03 0.22250313 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE subependymal glioma DOID_4843 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE pilocytic astrocytoma DOID_4851 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE subependymal giant cell astrocytoma DOID_5077 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE fibrillary astrocytoma DOID_6726 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE juvenile pilocytic astrocytoma DOID_6811 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE childhood pilocytic astrocytoma DOID_6812 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE gemistocytic astrocytoma DOID_7005 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE childhood cerebral astrocytoma DOID_7007 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE protoplasmic astrocytoma DOID_7008 3.19E-04 4.906E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE benign glioma DOID_0060101 3.872E-04 5.798E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE benign ependymoma DOID_4844 3.872E-04 5.798E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE muscle cancer DOID_4045 4.237E-04 6.182E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE organic acidemia DOID_0060159 5.429E-04 7.723E-03 5.429E-04 0.07723058 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE portal hypertension DOID_10762 5.429E-04 7.535E-03 0.03374238 0.39182484 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE papillary adenoma DOID_3172 5.859E-04 7.937E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE microcystic adenoma DOID_5403 5.859E-04 7.937E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE follicular adenoma DOID_6204 5.859E-04 7.937E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE hepatic vascular disease DOID_272 7.242E-04 9.583E-03 0.0388335 0.38097003 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE supratentorial cancer DOID_1659 7.735E-04 0.01000314 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE cerebrum cancer DOID_368 7.735E-04 0.01000314 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE female reproductive organ benign neoplasm DOID_0060086 8.244E-04 0.01042412 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE uterine benign neoplasm DOID_0060095 8.244E-04 0.01042412 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE uterine fibroid DOID_13223 8.244E-04 0.01042412 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE leiomyoma DOID_127 9.865E-04 0.01220203 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE papilloma DOID_2615 1.044E-03 0.01263427 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE metal metabolism disorder DOID_896 1.044E-03 0.01237105 1.044E-03 0.09896843 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE thyroid carcinoma DOID_3963 1.102E-03 0.01280029 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE thyroid cancer DOID_1781 1.224E-03 0.01393345 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE adenoma DOID_657 1.224E-03 0.01366025 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE systemic scleroderma DOID_418 1.419E-03 0.01552793 0.05394963 0.40929788 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE endometriosis of uterus DOID_288 1.628E-03 0.01747337 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Huntington's disease DOID_12858 1.7E-03 0.01791425 1.7E-03 0.13819565 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE rheumatic disease DOID_1575 1.7E-03 0.01758854 0.05893638 0.43551689 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE endometriosis DOID_289 1.7E-03 0.01727446 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE scleroderma DOID_419 1.7E-03 0.01758854 0.05893638 0.43551689 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE cataract DOID_83 1.85E-03 0.01846527 1.85E-03 0.13156503 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE lens disease DOID_110 2.005E-03 0.01967428 2.005E-03 0.12678982 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE neuritis DOID_1803 2.005E-03 0.01934082 0.06389736 0.43804338 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE B-cell lymphocytic neoplasm DOID_707 2.335E-03 0.02214208 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE bile duct adenocarcinoma DOID_4896 2.597E-03 0.02422914 0.07251749 0.4485049 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE cholangiocarcinoma DOID_4947 2.597E-03 0.02422914 0.07251749 0.4485049 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE bile duct cancer DOID_4606 2.968E-03 0.02724171 0.0774083 0.44944204 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE bile duct carcinoma DOID_4897 2.968E-03 0.02724171 0.0774083 0.44944204 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE collagen disease DOID_854 3.262E-03 0.02945984 0.08105981 0.46588919 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE uterine disease DOID_345 3.673E-03 0.03265843 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE allergic contact dermatitis DOID_3042 3.888E-03 0.03403267 0.08832039 0.48321443 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE pancreatic ductal carcinoma DOID_3587 4.22E-03 0.03638145 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE syndrome DOID_225 4.802E-03 0.04078092 0.09791377 0.52068165 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE bone resorption disease DOID_0080011 4.923E-03 0.04119029 4.923E-03 0.23341167 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE osteoporosis DOID_11476 4.923E-03 0.04119029 4.923E-03 0.23341167 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE contact dermatitis DOID_2773 5.293E-03 0.04364546 0.10267329 0.51700093 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE lipid metabolism disorder DOID_3146 5.293E-03 0.04302195 5.293E-03 0.23165668 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE female reproductive system disease DOID_229 5.419E-03 0.04342689 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE chronic kidney failure DOID_784 5.675E-03 0.04485001 0.10622678 0.52559162 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE alcohol-related neurodevelopmental disorder DOID_0050667 7.183E-03 0.05598419 0.11913862 0.56491562 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE retinal vascular occlusion DOID_1729 0.01311233 0.09947889 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE transient cerebral ischemia DOID_224 0.01311233 0.09816995 0.01311233 0.37304583 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE bilirubin metabolic disorder DOID_2741 0.01311233 0.09689502 0.01311233 0.35528174 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE teratoma DOID_3307 0.01311233 0.09565278 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE chondrosarcoma DOID_3371 0.01311233 0.09444198 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Noonan syndrome DOID_3490 0.01311233 0.09326146 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE keratitis DOID_4677 0.01311233 0.09211008 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE malignant teratoma DOID_5563 0.01311233 0.09565278 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE mature teratoma DOID_5566 0.01311233 0.09565278 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE acute T cell leukemia DOID_5603 0.01311233 0.09098679 0.01311233 0.33913257 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01311233 0.08989056 0.01311233 0.32438768 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01311233 0.08989056 0.01311233 0.32438768 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Hodgkin's granuloma DOID_8651 0.01311233 0.08989056 0.01311233 0.32438768 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01311233 0.08989056 0.01311233 0.32438768 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE cannabis abuse DOID_9505 0.01311233 0.08882044 0.01311233 0.31087152 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Charcot-Marie-Tooth disease type 4 DOID_0050541 0.01441426 0.09649075 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE migraine without aura DOID_12783 0.01441426 0.09536876 0.01441426 0.32806855 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE hemochromatosis DOID_2352 0.01441426 0.09427257 0.01441426 0.31545053 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE retinal detachment DOID_5327 0.0157145 0.09935059 0.0157145 0.31934118 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE lipodystrophy DOID_811 0.0157145 0.09825883 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE Hodgkin's lymphoma DOID_8567 0.0157145 0.0971908 0.0157145 0.30832942 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hypersensitivity reaction type I disease DOID_1205 4.342E-12 2.471E-09 8.244E-10 4.691E-07 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP cystic fibrosis DOID_1485 2.715E-10 7.725E-08 0.03640151 0.49315385 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bacterial pneumonia DOID_874 3.09E-10 5.861E-08 6.582E-04 0.02496797 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP primary bacterial infectious disease DOID_0050338 5.322E-10 7.57E-08 8.136E-04 0.0257193 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pulmonary tuberculosis DOID_2957 9.491E-09 1.08E-06 2.784E-04 0.02262828 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP Legionnaires' disease DOID_10457 3.26E-08 3.092E-06 6.628E-03 0.18856105 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP legionellosis DOID_10458 3.26E-08 3.092E-06 6.628E-03 0.18856105 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP tuberculosis DOID_399 3.387E-08 2.753E-06 5.189E-04 0.02271272 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pleurisy DOID_10247 3.619E-07 2.574E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pleural disease DOID_1532 5.826E-07 3.683E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hepatitis DOID_2237 1.02E-06 5.802E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pulmonary emphysema DOID_9675 1.176E-06 6.082E-05 1.99E-04 0.01887657 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP influenza DOID_8469 1.438E-06 6.82E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP sarcoidosis DOID_11335 2.452E-06 1.073E-04 3.229E-04 0.02296933 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hypersensitivity reaction type IV disease DOID_2916 3.179E-06 1.292E-04 3.832E-04 0.02422789 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP melancholia DOID_2848 3.34E-06 1.267E-04 3.959E-04 0.02252561 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP neurotic disorder DOID_4964 3.506E-06 1.247E-04 4.087E-04 0.02114328 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP cholestasis DOID_13580 4.418E-06 1.479E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP tooth disease DOID_1091 4.822E-06 1.524E-04 0.03272644 0.49003535 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bile duct disease DOID_4138 5.704E-06 1.708E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP male reproductive system disease DOID_48 5.704E-06 1.623E-04 0.03456563 0.49169605 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP biliary tract disease DOID_9741 5.94E-06 1.609E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP endogenous depression DOID_1595 6.686E-06 1.729E-04 6.259E-04 0.02543659 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP mental depression DOID_1596 8.662E-06 2.143E-04 7.426E-04 0.02485401 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP cutaneous leishmaniasis DOID_9111 9.56E-06 2.266E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP amino acid metabolic disorder DOID_9252 1.064E-05 2.421E-04 8.503E-04 0.02546508 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP mouth disease DOID_403 1.249E-05 2.733E-04 0.04462228 0.57704717 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP common cold DOID_10459 1.401E-05 2.953E-04 1.401E-05 3.987E-03 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP ulcerative colitis DOID_8577 1.412E-05 2.869E-04 0.0464401 0.58720921 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP viral pneumonia DOID_10533 1.931E-05 3.789E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hyperhomocysteinemia DOID_9279 2.227E-05 4.225E-04 2.227E-05 4.225E-03 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP leishmaniasis DOID_9065 3.623E-05 6.651E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP esophagitis DOID_11963 4.025E-05 7.157E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP mitochondrial myopathy DOID_699 4.447E-05 7.668E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP sinusitis DOID_0050127 5.355E-05 8.962E-04 0.01086661 0.24732393 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP paranasal sinus disease DOID_1352 5.355E-05 8.962E-04 0.01086661 0.24732393 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hypoglycemia DOID_9993 5.355E-05 8.706E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP acute pancreatitis DOID_2913 6.346E-05 1.003E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP osteosarcoma DOID_3347 6.873E-05 1.057E-03 6.873E-05 9.777E-03 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP myositis DOID_633 7.421E-05 1.111E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP extrinsic allergic alveolitis DOID_841 7.989E-05 1.166E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP lung adenocarcinoma DOID_3910 8.579E-05 1.22E-03 0.01368298 0.28835604 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP periodontitis DOID_824 8.579E-05 1.191E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP periodontal disease DOID_3388 1.404E-04 1.902E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP esophageal disease DOID_6050 1.404E-04 1.858E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pulmonary sarcoidosis DOID_13406 1.643E-04 2.125E-03 1.643E-04 0.01869805 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP systemic scleroderma DOID_418 1.813E-04 2.292E-03 0.01975915 0.37476524 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP peptic ulcer DOID_750 1.813E-04 2.242E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP adult respiratory distress syndrome DOID_11394 1.901E-04 2.301E-03 0.02022508 0.37122812 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP intracranial arterial disease DOID_13089 1.901E-04 2.253E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP cerebral arterial disease DOID_3527 1.901E-04 2.253E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP rheumatic disease DOID_1575 2.177E-04 2.527E-03 0.02162162 0.38445943 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP scleroderma DOID_419 2.177E-04 2.527E-03 0.02162162 0.38445943 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP giant cell tumor DOID_200 3.229E-04 3.675E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP malignant giant cell tumor DOID_2705 3.229E-04 3.675E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP giant cell glioblastoma DOID_3074 3.229E-04 3.675E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP parasitic protozoa infectious disease DOID_2789 3.464E-04 3.865E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP mitochondrial metabolism disease DOID_700 3.585E-04 3.923E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP glioblastoma DOID_3068 3.832E-04 4.114E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP collagen disease DOID_854 4.218E-04 4.445E-03 0.02996145 0.48708753 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP respiratory failure DOID_11162 4.351E-04 4.501E-03 0.0304228 0.48084921 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP endocrine pancreas disease DOID_1428 4.622E-04 4.697E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP parasitic infectious disease DOID_1398 4.761E-04 4.753E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP temporal lobe epilepsy DOID_3328 4.902E-04 4.809E-03 0.03226612 0.49620066 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP allergic contact dermatitis DOID_3042 5.044E-04 4.865E-03 5.044E-04 0.02391906 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP astrocytoma DOID_3069 5.336E-04 5.06E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bone resorption disease DOID_0080011 6.419E-04 5.988E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP osteoporosis DOID_11476 6.419E-04 5.988E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pancreatitis DOID_4989 6.582E-04 6.041E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP contact dermatitis DOID_2773 6.914E-04 6.244E-03 6.914E-04 0.02458624 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP focal epilepsy DOID_2234 7.426E-04 6.602E-03 0.03960638 0.52409378 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP dilated cardiomyopathy DOID_12930 9.652E-04 8.449E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP leber hereditary optic neuropathy DOID_705 4.266E-03 0.03677386 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hypolipoproteinemia DOID_1387 4.738E-03 0.04024097 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP childhood type dermatomyositis DOID_14203 4.738E-03 0.03964919 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP retinal vascular occlusion DOID_1729 4.738E-03 0.03907457 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP transient cerebral ischemia DOID_224 4.738E-03 0.03851636 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP acute kidney failure DOID_3021 4.738E-03 0.03797387 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP familial adenomatous polyposis DOID_0050424 5.211E-03 0.04118187 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP dermatomyositis DOID_10223 5.211E-03 0.04061774 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP adrenoleukodystrophy DOID_10588 5.211E-03 0.04006885 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP neuronal ceroid lipofuscinosis DOID_14503 5.211E-03 0.0395346 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bronchiectasis DOID_9563 5.211E-03 0.03901441 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP intracranial arteriosclerosis DOID_13097 5.684E-03 0.04199902 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP stomach disease DOID_76 5.684E-03 0.04146057 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP vascular dementia DOID_8725 5.684E-03 0.04199902 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP mitochondrial encephalomyopathy DOID_890 5.684E-03 0.04093575 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP encephalitis DOID_9588 5.684E-03 0.04042405 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bacterial meningitis DOID_9470 6.628E-03 0.04655828 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP idiopathic pulmonary fibrosis DOID_0050156 7.1E-03 0.0492645 7.1E-03 0.19236612 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP varicose veins DOID_799 7.1E-03 0.04867095 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP intermediate coronary syndrome DOID_8805 7.1E-03 0.04809153 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP angiosarcoma DOID_0001816 7.571E-03 0.05068277 7.571E-03 0.19581981 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP spastic diplegia DOID_10965 7.571E-03 0.05009344 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP restrictive cardiomyopathy DOID_397 7.571E-03 0.04951765 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP tongue cancer DOID_8649 7.571E-03 0.04895495 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP vein disease DOID_866 7.571E-03 0.0484049 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP Barrett's esophagus DOID_9206 7.571E-03 0.04786706 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP drug-induced mental disorder DOID_1203 8.043E-03 0.0502886 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP methylmalonic acidemia DOID_14749 8.043E-03 0.04974198 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP drug psychosis DOID_1742 8.043E-03 0.0502886 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP substance-induced psychosis DOID_8646 8.043E-03 0.0502886 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP dental caries DOID_216 8.514E-03 0.05208999 8.514E-03 0.21062474 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP Down syndrome DOID_14250 8.985E-03 0.05438676 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pulmonary edema DOID_11396 9.456E-03 0.05663391 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP brain edema DOID_4724 9.456E-03 0.05604397 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP Kawasaki disease DOID_13378 9.926E-03 0.05822646 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP lymphadenitis DOID_1602 9.926E-03 0.05822646 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP autoimmune hepatitis DOID_2048 9.926E-03 0.05763232 9.926E-03 0.23533196 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP lymph node disease DOID_9942 9.926E-03 0.05822646 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP neutropenia DOID_1227 0.01039647 0.05975346 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP agranulocytosis DOID_12987 0.01086661 0.06183098 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP optic nerve disease DOID_1891 0.01086661 0.0612188 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP IgA glomerulonephritis DOID_2986 0.01086661 0.06061861 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP sleep disorder DOID_535 0.01086661 0.06003008 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP polyarteritis nodosa DOID_9810 0.01086661 0.05945287 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP Lewy body dementia DOID_12217 0.01133653 0.06143318 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP meningitis DOID_9471 0.01133653 0.06085362 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP commensal bacterial infectious disease DOID_0050339 0.01227574 0.06527939 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP organic acidemia DOID_0060159 0.01227574 0.06467496 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP portal hypertension DOID_10762 0.01227574 0.06408161 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP urticaria DOID_1555 0.01227574 0.06349905 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bronchiolitis DOID_2942 0.01227574 0.06292698 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP cystitis DOID_1679 0.01274503 0.06474929 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP teeth hard tissue disease DOID_214 0.01321411 0.06653829 0.01321411 0.28918565 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP middle cerebral artery infarction DOID_3525 0.01321411 0.06595462 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP diffuse large B-cell lymphoma DOID_0050745 0.01368298 0.06770098 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP perinatal necrotizing enterocolitis DOID_8677 0.01368298 0.06711735 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP sarcoma DOID_1115 0.01415163 0.0688229 0.01415163 0.28758141 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hepatic vascular disease DOID_272 0.01415163 0.06823966 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP cranial nerve disease DOID_5656 0.01462008 0.0699061 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP spastic cerebral palsy DOID_0050669 0.01555635 0.07376301 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP abdominal aortic aneurysm DOID_7693 0.01555635 0.0731534 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bladder disease DOID_365 0.01649177 0.07691654 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP papilloma DOID_2615 0.01695917 0.07845339 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP metal metabolism disorder DOID_896 0.01695917 0.0778207 0.01695917 0.33275059 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pneumoconiosis DOID_10316 0.01742636 0.07932477 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP thyroid carcinoma DOID_3963 0.01742636 0.07869521 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP spindle cell carcinoma DOID_4015 0.01742636 0.07807557 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP leukopenia DOID_615 0.01742636 0.0774656 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP hyperthyroidism DOID_7998 0.01742636 0.07686509 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP aplastic anemia DOID_12449 0.01789333 0.07831775 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP thyroid cancer DOID_1781 0.0183601 0.07974732 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP calcinosis DOID_182 0.01882666 0.08115432 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP multiple myeloma DOID_9538 0.01882666 0.08054414 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP uveitis DOID_13141 0.01929301 0.08192331 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP respiratory syncytial virus infectious disease DOID_1273 0.01975915 0.08328116 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP lymphatic system disease DOID_75 0.02022508 0.08461817 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP benign mesothelioma DOID_2645 0.0206908 0.0859348 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP uveal disease DOID_3480 0.02162162 0.08915001 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP gallbladder cancer DOID_3121 0.02208671 0.09041252 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP cerebral infarction DOID_3526 0.0225516 0.09165615 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP learning disability DOID_8927 0.0225516 0.0910061 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP leukodystrophy DOID_10579 0.02301628 0.0922272 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP myeloma DOID_0070004 0.02348075 0.09343038 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP pre-eclampsia DOID_10591 0.02348075 0.09278156 0.02348075 0.40486499 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP brain cancer DOID_1319 0.02348075 0.09214169 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP thyroid adenoma DOID_2891 0.02348075 0.09151058 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP heart valve disease DOID_4079 0.02348075 0.09088806 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bone marrow disease DOID_4961 0.02348075 0.09027395 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP vascular skin disease DOID_9540 0.02348075 0.08966808 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP central nervous system cancer DOID_3620 0.02394501 0.09083139 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.02440906 0.0919785 0.02440906 0.40849276 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP integumentary system benign neoplasm DOID_0060121 0.02440906 0.09137338 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP skin benign neoplasm DOID_3165 0.02440906 0.09137338 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP calcium metabolism disease DOID_10575 0.0248729 0.09250118 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP aortic aneurysm DOID_3627 0.0248729 0.09190052 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP B-cell lymphocytic neoplasm DOID_707 0.02533654 0.09300961 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP atopic dermatitis DOID_3310 0.02579996 0.09410371 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP bone marrow cancer DOID_4960 0.02672619 0.09686116 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP integumentary system cancer DOID_0060122 0.02718899 0.09791479 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP skin cancer DOID_4159 0.02718899 0.09791479 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP aneurysm disease DOID_2403 2.083E-10 1.186E-07 3.022E-03 0.24565191 LEE_LIVER_CANCER_MYC_E2F1_UP diabetic angiopathy DOID_11713 1.001E-08 2.847E-06 0.02440683 0.60380372 LEE_LIVER_CANCER_MYC_E2F1_UP heart valve disease DOID_4079 2.128E-07 4.035E-05 0.05019259 0.54922273 LEE_LIVER_CANCER_MYC_E2F1_UP osteogenesis imperfecta DOID_12347 2.858E-07 4.065E-05 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP peripheral vascular disease DOID_341 1.102E-06 1.254E-04 0.07435971 0.6131982 LEE_LIVER_CANCER_MYC_E2F1_UP bone resorption disease DOID_0080011 1.359E-06 1.288E-04 3.022E-03 0.2865939 LEE_LIVER_CANCER_MYC_E2F1_UP osteoporosis DOID_11476 1.359E-06 1.288E-04 3.022E-03 0.2865939 LEE_LIVER_CANCER_MYC_E2F1_UP uremia DOID_4676 1.757E-06 1.428E-04 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP intracranial aneurysm DOID_10941 3.239E-06 2.304E-04 3.832E-04 0.10903333 LEE_LIVER_CANCER_MYC_E2F1_UP malaria DOID_12365 4.008E-06 2.534E-04 0.03041726 0.59680757 LEE_LIVER_CANCER_MYC_E2F1_UP calcinosis DOID_182 9.685E-06 5.511E-04 0.04035455 0.62058759 LEE_LIVER_CANCER_MYC_E2F1_UP hepatitis DOID_2237 1.124E-05 5.813E-04 0.04233007 0.61758486 LEE_LIVER_CANCER_MYC_E2F1_UP calcium metabolism disease DOID_10575 2.275E-05 1.079E-03 0.05312478 0.57033967 LEE_LIVER_CANCER_MYC_E2F1_UP aortic aneurysm DOID_3627 2.275E-05 9.958E-04 0.05312478 0.55977783 LEE_LIVER_CANCER_MYC_E2F1_UP osteochondrodysplasia DOID_2256 2.986E-05 1.214E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP parasitic protozoa infectious disease DOID_2789 2.986E-05 1.133E-03 0.05799219 0.56892342 LEE_LIVER_CANCER_MYC_E2F1_UP carotid artery disease DOID_3407 4.015E-05 1.428E-03 4.015E-05 0.02284553 LEE_LIVER_CANCER_MYC_E2F1_UP collagen disease DOID_854 4.015E-05 1.344E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP mineral metabolism disease DOID_0050032 4.607E-05 1.456E-03 0.06669216 0.6023467 LEE_LIVER_CANCER_MYC_E2F1_UP parasitic infectious disease DOID_1398 4.816E-05 1.442E-03 0.06765398 0.60148618 LEE_LIVER_CANCER_MYC_E2F1_UP brain infarction DOID_3454 5.48E-05 1.559E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP tuberculosis DOID_399 5.48E-05 1.485E-03 0.07053364 0.59020062 LEE_LIVER_CANCER_MYC_E2F1_UP pancreatitis DOID_4989 7.828E-05 2.025E-03 3.098E-03 0.22031408 LEE_LIVER_CANCER_MYC_E2F1_UP metabolic syndrome X DOID_14221 8.426E-05 2.084E-03 0.08101844 0.64928862 LEE_LIVER_CANCER_MYC_E2F1_UP contact dermatitis DOID_2773 8.426E-05 1.998E-03 0.08101844 0.64027072 LEE_LIVER_CANCER_MYC_E2F1_UP bone development disease DOID_0080006 9.709E-05 2.21E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP Ehlers-Danlos syndrome DOID_13359 1.074E-04 2.35E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP oral submucous fibrosis DOID_5773 1.074E-04 2.263E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP primary bacterial infectious disease DOID_0050338 1.075E-04 2.185E-03 0.08763049 0.64755516 LEE_LIVER_CANCER_MYC_E2F1_UP spastic diplegia DOID_10965 1.226E-04 2.406E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP encephalomyelitis DOID_640 1.305E-04 2.475E-03 0.09326104 0.66331917 LEE_LIVER_CANCER_MYC_E2F1_UP hypersensitivity reaction type I disease DOID_1205 1.388E-04 2.547E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP prion disease DOID_649 1.561E-04 2.776E-03 0.0183601 0.52234493 LEE_LIVER_CANCER_MYC_E2F1_UP membranous glomerulonephritis DOID_10976 1.936E-04 3.339E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP brain edema DOID_4724 1.936E-04 3.241E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP myasthenia gravis DOID_437 2.573E-04 4.184E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP spastic quadriplegia DOID_10970 3.048E-04 4.817E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP urticaria DOID_1555 3.299E-04 5.074E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP neuromuscular junction disease DOID_439 3.561E-04 5.332E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP middle cerebral artery infarction DOID_3525 3.832E-04 5.591E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP gestational diabetes DOID_11714 4.114E-04 5.852E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP pleurisy DOID_10247 4.405E-04 6.113E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP autoimmune disease of the nervous system DOID_438 4.405E-04 5.967E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP spastic cerebral palsy DOID_0050669 5.336E-04 7.061E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP abdominal aortic aneurysm DOID_7693 5.336E-04 6.9E-03 0.03340893 0.63365597 LEE_LIVER_CANCER_MYC_E2F1_UP pleural disease DOID_1532 6.005E-04 7.593E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP myocarditis DOID_820 6.354E-04 7.86E-03 6.354E-04 0.12052009 LEE_LIVER_CANCER_MYC_E2F1_UP hepatitis C DOID_1883 6.713E-04 8.127E-03 0.03738383 0.66473125 LEE_LIVER_CANCER_MYC_E2F1_UP thyroid carcinoma DOID_3963 6.713E-04 7.958E-03 0.03738383 0.62562941 LEE_LIVER_CANCER_MYC_E2F1_UP thyroid cancer DOID_1781 7.459E-04 8.662E-03 0.03936531 0.63996741 LEE_LIVER_CANCER_MYC_E2F1_UP pulmonary sarcoidosis DOID_13406 7.847E-04 8.93E-03 0.04035455 0.63782613 LEE_LIVER_CANCER_MYC_E2F1_UP multiple myeloma DOID_9538 7.847E-04 8.755E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP respiratory syncytial virus infectious disease DOID_1273 8.65E-04 9.466E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP systemic scleroderma DOID_418 8.65E-04 9.287E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP intracranial arterial disease DOID_13089 9.067E-04 9.553E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP cerebral arterial disease DOID_3527 9.067E-04 9.553E-03 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP benign mesothelioma DOID_2645 9.492E-04 9.82E-03 0.04430162 0.6301906 LEE_LIVER_CANCER_MYC_E2F1_UP pulmonary emphysema DOID_9675 9.492E-04 9.645E-03 0.04430162 0.6148201 LEE_LIVER_CANCER_MYC_E2F1_UP autoimmune disease of urogenital tract DOID_0060049 9.927E-04 9.91E-03 0.04528592 0.61351635 LEE_LIVER_CANCER_MYC_E2F1_UP primary biliary cirrhosis DOID_12236 9.927E-04 9.91E-03 0.04528592 0.61351635 LEE_LIVER_CANCER_MYC_E2F1_UP rheumatic disease DOID_1575 1.037E-03 0.01017495 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP scleroderma DOID_419 1.037E-03 0.01017495 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP diabetic autonomic neuropathy DOID_11503 1.083E-03 0.01044027 0.04725154 0.58448102 LEE_LIVER_CANCER_MYC_E2F1_UP autonomic neuropathy DOID_11504 1.083E-03 0.01044027 0.04725154 0.58448102 LEE_LIVER_CANCER_MYC_E2F1_UP diabetic polyneuropathy DOID_12785 1.083E-03 0.01044027 0.04725154 0.58448102 LEE_LIVER_CANCER_MYC_E2F1_UP diabetic neuropathy DOID_9743 1.083E-03 0.01044027 0.04725154 0.58448102 LEE_LIVER_CANCER_MYC_E2F1_UP cerebral infarction DOID_3526 1.129E-03 0.01070568 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP proteinuria DOID_576 1.176E-03 0.01097114 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP myeloma DOID_0070004 1.224E-03 0.01123665 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP autonomic nervous system disease DOID_11465 1.224E-03 0.01105829 0.05019259 0.57119163 LEE_LIVER_CANCER_MYC_E2F1_UP thyroid adenoma DOID_2891 1.224E-03 0.01088551 0.05019259 0.5599918 LEE_LIVER_CANCER_MYC_E2F1_UP vascular skin disease DOID_9540 1.224E-03 0.01071804 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP B-cell lymphocytic neoplasm DOID_707 1.427E-03 0.01229875 0.05410022 0.5596914 LEE_LIVER_CANCER_MYC_E2F1_UP sarcoidosis DOID_11335 1.533E-03 0.0130211 0.05604816 0.56948937 LEE_LIVER_CANCER_MYC_E2F1_UP bone marrow cancer DOID_4960 1.588E-03 0.01328752 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP hypersensitivity reaction type IV disease DOID_2916 1.816E-03 0.01497598 0.06090093 0.56807586 LEE_LIVER_CANCER_MYC_E2F1_UP leukocyte disease DOID_9500 1.875E-03 0.01524422 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP cholestasis DOID_13580 2.25E-03 0.01803506 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP hyperglycemia DOID_4195 2.316E-03 0.01830359 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP allergic contact dermatitis DOID_3042 2.383E-03 0.01857178 0.06957472 0.59981842 LEE_LIVER_CANCER_MYC_E2F1_UP endocrine organ benign neoplasm DOID_0060089 2.45E-03 0.01883963 0.07053364 0.59900959 LEE_LIVER_CANCER_MYC_E2F1_UP blood coagulation disease DOID_1247 2.588E-03 0.01963265 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP pancreatic ductal carcinoma DOID_3587 2.588E-03 0.01937432 2.588E-03 0.36811217 LEE_LIVER_CANCER_MYC_E2F1_UP nephrosis DOID_2527 2.658E-03 0.01964116 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP bile duct disease DOID_4138 2.658E-03 0.01938935 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP biliary tract disease DOID_9741 2.729E-03 0.01965567 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP pancreatic carcinoma DOID_4905 2.801E-03 0.01992166 2.801E-03 0.3187465 LEE_LIVER_CANCER_MYC_E2F1_UP bacterial pneumonia DOID_874 3.098E-03 0.02175942 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP chromosomal disease DOID_0080014 3.329E-03 0.02310199 3.329E-03 0.2104848 LEE_LIVER_CANCER_MYC_E2F1_UP biliary tract cancer DOID_4607 3.488E-03 0.02391272 3.488E-03 0.19847556 LEE_LIVER_CANCER_MYC_E2F1_UP transitional cell carcinoma DOID_2671 3.901E-03 0.02642142 3.901E-03 0.20176357 LEE_LIVER_CANCER_MYC_E2F1_UP lymphoma DOID_0060058 4.246E-03 0.02842303 0.09232497 0.66497355 LEE_LIVER_CANCER_MYC_E2F1_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.424E-03 0.02926933 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP mouth disease DOID_403 4.424E-03 0.0289329 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP ulcerative colitis DOID_8577 4.79E-03 0.03097027 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP DiGeorge syndrome DOID_11198 9.221E-03 0.05895536 9.221E-03 0.43725227 LEE_LIVER_CANCER_MYC_E2F1_UP velocardiofacial syndrome DOID_12583 9.221E-03 0.05895536 9.221E-03 0.43725227 LEE_LIVER_CANCER_MYC_E2F1_UP T cell deficiency DOID_11200 0.01024097 0.06474569 0.01024097 0.44823937 LEE_LIVER_CANCER_MYC_E2F1_UP Sjogren's syndrome DOID_12894 0.01024097 0.0640342 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP familial combined hyperlipidemia DOID_13809 0.01024097 0.06333817 0.01024097 0.41622227 LEE_LIVER_CANCER_MYC_E2F1_UP angioedema DOID_1558 0.01024097 0.06265712 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP familial adenomatous polyposis DOID_0050424 0.01125943 0.06815548 0.01125943 0.42710765 LEE_LIVER_CANCER_MYC_E2F1_UP dermatomyositis DOID_10223 0.01125943 0.06743805 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP bronchiectasis DOID_9563 0.01125943 0.06673557 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP beta thalassemia DOID_12241 0.01227687 0.07201584 0.01227687 0.43659605 LEE_LIVER_CANCER_MYC_E2F1_UP aortic valve insufficiency DOID_57 0.01227687 0.07128099 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP peritonitis DOID_8283 0.01227687 0.07056098 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP progressive myoclonus epilepsy DOID_891 0.01227687 0.06985537 0.01227687 0.41091393 LEE_LIVER_CANCER_MYC_E2F1_UP variable age at onset electroclinical syndrome DOID_0050706 0.01329328 0.07488988 0.01329328 0.42021546 LEE_LIVER_CANCER_MYC_E2F1_UP newborn respiratory distress syndrome DOID_12716 0.01329328 0.07415567 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP larynx cancer DOID_2596 0.01329328 0.07343571 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP laryngeal benign neoplasm DOID_2598 0.01329328 0.07343571 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP intracranial thrombosis DOID_4193 0.01329328 0.0727296 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP viral pneumonia DOID_10533 0.01430868 0.07753943 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP narcolepsy DOID_8986 0.01430868 0.07680792 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP thalassemia DOID_10241 0.01532306 0.08148432 0.01532306 0.45888537 LEE_LIVER_CANCER_MYC_E2F1_UP thoracic aortic aneurysm DOID_14004 0.01532306 0.08072983 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP communication disorder DOID_2033 0.01532306 0.07998919 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP membranoproliferative glomerulonephritis DOID_2920 0.01532306 0.07926202 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP hyperhomocysteinemia DOID_9279 0.01532306 0.07854795 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP thyroiditis DOID_7166 0.01633642 0.08299487 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP autoimmune thyroiditis DOID_7188 0.01633642 0.08299487 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP bronchitis DOID_6132 0.01734877 0.08735797 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP juvenile rheumatoid arthritis DOID_676 0.01734877 0.08659167 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP glucose intolerance DOID_10603 0.0183601 0.0908426 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP ureteral obstruction DOID_5199 0.0183601 0.09005947 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP eosinophilia DOID_999 0.0183601 0.08928973 1.000 1.000 LEE_LIVER_CANCER_MYC_E2F1_UP Down syndrome DOID_14250 0.01937042 0.09340482 0.01937042 0.52484615 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP lymphoma DOID_0060058 4.857E-09 2.764E-06 2.379E-06 1.354E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP mixed glioma DOID_5076 3.77E-08 1.073E-05 1.889E-05 2.149E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP transitional cell carcinoma DOID_2671 8.573E-08 1.626E-05 4.977E-04 0.0123126 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP bone marrow cancer DOID_4960 1.199E-07 1.705E-05 3.544E-06 1.008E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP neuroectodermal tumor DOID_171 2.42E-07 2.754E-05 1.342E-04 5.875E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP multiple myeloma DOID_9538 5.886E-07 5.582E-05 2.081E-05 1.974E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP biliary tract cancer DOID_4607 1.317E-06 1.07E-04 4.998E-03 0.05469147 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP myeloma DOID_0070004 1.835E-06 1.305E-04 5.083E-05 3.214E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP brain cancer DOID_1319 1.835E-06 1.16E-04 1.099E-03 0.02017631 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP central nervous system cancer DOID_3620 2.028E-06 1.154E-04 1.165E-03 0.02070631 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP bile duct adenocarcinoma DOID_4896 3.544E-06 1.833E-04 0.02233978 0.14123707 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cholangiocarcinoma DOID_4947 3.544E-06 1.833E-04 0.02233978 0.14123707 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP reproductive organ benign neoplasm DOID_0050622 3.866E-06 1.833E-04 9.133E-05 4.724E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP bile duct cancer DOID_4606 4.971E-06 2.176E-04 0.02534902 0.15677821 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP bile duct carcinoma DOID_4897 4.971E-06 2.176E-04 0.02534902 0.15677821 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP invasive ductal carcinoma DOID_3008 6.441E-06 2.618E-04 6.441E-06 1.222E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP porphyria DOID_13268 1.381E-05 5.237E-04 1.381E-05 1.964E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP chromosomal disease DOID_0080014 2.259E-05 8.033E-04 2.259E-05 1.836E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP intracranial arterial disease DOID_13089 2.784E-05 9.32E-04 7.066E-04 0.01546285 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cerebral arterial disease DOID_3527 2.784E-05 9.32E-04 7.066E-04 0.01546285 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP tongue cancer DOID_8649 3.473E-05 1.098E-03 1.871E-03 0.02877224 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP primitive neuroectodermal tumor DOID_168 3.647E-05 1.092E-03 0.01491046 0.10474136 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP nervous system cancer DOID_3093 3.716E-05 1.057E-03 6.226E-03 0.0580757 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP gallbladder cancer DOID_3121 3.974E-05 1.077E-03 9.175E-04 0.01800143 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP lymphatic system cancer DOID_0060073 4.204E-05 1.087E-03 4.204E-05 2.99E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP reticulosarcoma DOID_8538 4.204E-05 1.087E-03 4.204E-05 2.99E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP lymphosarcoma DOID_8675 4.204E-05 1.087E-03 4.204E-05 2.99E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.559E-05 1.128E-03 6.351E-04 0.0144539 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP testicular cancer DOID_2998 5.956E-05 1.412E-03 2.645E-03 0.0367078 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP psoriasis DOID_8893 5.956E-05 1.356E-03 5.956E-05 3.389E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pustulosis of palm and sole DOID_4398 9.133E-05 1.999E-03 0.02307727 0.14429632 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP mitochondrial metabolism disease DOID_700 9.767E-05 2.058E-03 9.767E-05 4.631E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP hypertrophic cardiomyopathy DOID_11984 1.113E-04 2.261E-03 1.954E-03 0.02926046 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP carotid artery disease DOID_3407 1.342E-04 2.634E-03 0.02770784 0.1659554 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP acute pancreatitis DOID_2913 1.389E-04 2.634E-03 1.389E-04 5.644E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pre-malignant neoplasm DOID_0060071 1.513E-04 2.777E-03 1.513E-04 5.74E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP congenital heart defect DOID_1682 1.513E-04 2.69E-03 1.513E-04 5.381E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP in situ carcinoma DOID_8719 1.513E-04 2.777E-03 1.513E-04 5.74E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP osteosarcoma DOID_3347 1.565E-04 2.699E-03 0.09983485 0.30872841 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP middle cerebral artery infarction DOID_3525 1.961E-04 3.281E-03 1.961E-04 6.562E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP brain infarction DOID_3454 2.008E-04 3.265E-03 2.008E-04 6.348E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP astrocytoma DOID_3069 2.12E-04 3.35E-03 0.25281074 0.53675116 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP lung adenocarcinoma DOID_3910 2.18E-04 3.353E-03 6.116E-03 0.05800312 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pancreatic carcinoma DOID_4905 2.611E-04 3.909E-03 0.03796637 0.2117928 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP supratentorial cancer DOID_1659 2.666E-04 3.89E-03 0.11786632 0.33701476 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cerebrum cancer DOID_368 2.666E-04 3.89E-03 0.11786632 0.33701476 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP female reproductive organ benign neoplasm DOID_0060086 2.934E-04 4.173E-03 2.934E-04 8.785E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP uterine benign neoplasm DOID_0060095 2.934E-04 4.173E-03 2.934E-04 8.785E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP uterine fibroid DOID_13223 2.934E-04 4.173E-03 2.934E-04 8.785E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP endometrial carcinoma DOID_2871 2.934E-04 4.071E-03 7.413E-03 0.06489499 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP contact dermatitis DOID_2773 3.493E-04 4.732E-03 3.493E-04 9.937E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP endometrial cancer DOID_1380 3.518E-04 4.656E-03 8.341E-03 0.07190755 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP leiomyoma DOID_127 3.837E-04 4.962E-03 3.837E-04 0.01039592 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP bone development disease DOID_0080006 4.188E-04 5.296E-03 4.188E-04 0.01083215 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP medullomyoblastoma DOID_3861 4.902E-04 6.063E-03 0.14250906 0.37026327 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP adult medulloblastoma DOID_3864 4.902E-04 6.063E-03 0.14250906 0.37026327 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP childhood medulloblastoma DOID_3869 4.902E-04 6.063E-03 0.14250906 0.37026327 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP adenoma DOID_657 5.295E-04 6.41E-03 0.01087301 0.08474989 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP medulloblastoma DOID_3858 5.707E-04 6.765E-03 0.14942337 0.38126412 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP lymphoblastic leukemia DOID_1037 6.105E-04 7.089E-03 6.802E-03 0.06242912 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP carbohydrate metabolic disorder DOID_2978 6.105E-04 6.947E-03 6.105E-04 0.01447385 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP Crohn's disease DOID_8778 6.351E-04 7.085E-03 7.001E-03 0.06224698 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cervix uteri carcinoma in situ DOID_8991 7.56E-04 8.273E-03 7.56E-04 0.01593259 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pulmonary emphysema DOID_9675 7.56E-04 8.117E-03 0.01369999 0.09867459 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP Huntington's disease DOID_12858 8.614E-04 9.077E-03 8.614E-04 0.01750583 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP breast benign neoplasm DOID_0060082 8.69E-04 8.99E-03 0.04351402 0.21344378 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP thoracic benign neoplasm DOID_0060097 8.69E-04 8.99E-03 0.04351402 0.21344378 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP benign breast phyllodes tumor DOID_1631 8.69E-04 8.99E-03 0.04351402 0.21344378 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP uterine cancer DOID_363 9.175E-04 9.322E-03 0.01553237 0.1052133 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cerebral infarction DOID_3526 9.758E-04 9.74E-03 9.758E-04 0.01850683 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP peritonitis DOID_8283 1.04E-03 0.01020264 0.0473753 0.210598 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pre-eclampsia DOID_10591 1.099E-03 0.01060111 0.01746362 0.11690355 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP thyroid adenoma DOID_2891 1.099E-03 0.01042443 0.01746362 0.11421611 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP larynx cancer DOID_2596 1.226E-03 0.01143432 0.05122109 0.2158874 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP laryngeal benign neoplasm DOID_2598 1.226E-03 0.01143432 0.05122109 0.2158874 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP glaucoma DOID_1686 1.232E-03 0.01130807 1.232E-03 0.02124547 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pulmonary tuberculosis DOID_2957 1.232E-03 0.01112858 0.01880476 0.12158989 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP Williams-Beuren syndrome DOID_1928 1.641E-03 0.0145933 1.641E-03 0.02746974 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP mesenchymal cell neoplasm DOID_3350 1.641E-03 0.01436879 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP spindle cell sarcoma DOID_4235 1.641E-03 0.01436879 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP epithelioid sarcoma DOID_6193 1.641E-03 0.01436879 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP osteochondrodysplasia DOID_2256 1.69E-03 0.01457174 1.69E-03 0.02747814 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP congenital nervous system abnormality DOID_2490 1.863E-03 0.01582579 1.863E-03 0.02945356 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP chronic myeloid leukemia DOID_8552 1.871E-03 0.01565548 0.06266615 0.23930901 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP oral cavity cancer DOID_8618 1.954E-03 0.01611445 0.02534902 0.15509242 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP hyperostosis DOID_205 2.115E-03 0.01719037 2.115E-03 0.03085452 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP urinary system benign neoplasm DOID_731 2.115E-03 0.01694826 0.06645061 0.24712679 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP male reproductive organ benign neoplasm DOID_0060087 2.373E-03 0.01875228 0.07021989 0.25944882 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP neuroendocrine tumor DOID_169 2.373E-03 0.0184954 2.373E-03 0.0337541 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP temporal lobe epilepsy DOID_3328 2.779E-03 0.02136595 2.779E-03 0.03764477 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP allergic contact dermatitis DOID_3042 2.895E-03 0.02196042 2.895E-03 0.03830306 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP colon carcinoma DOID_1520 2.931E-03 0.0219451 0.07771315 0.26637821 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP subependymal glioma DOID_4843 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pilocytic astrocytoma DOID_4851 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP subependymal giant cell astrocytoma DOID_5077 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP fibrillary astrocytoma DOID_6726 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP juvenile pilocytic astrocytoma DOID_6811 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP childhood pilocytic astrocytoma DOID_6812 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP gemistocytic astrocytoma DOID_7005 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP childhood cerebral astrocytoma DOID_7007 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP protoplasmic astrocytoma DOID_7008 2.931E-03 0.0216601 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP endocrine organ benign neoplasm DOID_0060089 3.013E-03 0.02198274 0.03353692 0.19471946 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP tuberculosis DOID_399 3.013E-03 0.02170447 0.03353692 0.1927526 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP Leigh disease DOID_3652 3.231E-03 0.02298151 3.231E-03 0.04178457 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP mitochondrial myopathy DOID_699 3.231E-03 0.02269779 3.231E-03 0.04085602 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pancreatic ductal carcinoma DOID_3587 3.26E-03 0.0226215 0.03528288 0.20075957 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP benign glioma DOID_0060101 3.545E-03 0.02430162 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP benign ependymoma DOID_4844 3.545E-03 0.02430162 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP diabetic retinopathy DOID_8947 3.653E-03 0.02474155 3.653E-03 0.04518022 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP optic nerve disease DOID_1891 3.872E-03 0.02592122 0.08884069 0.29051928 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP electroclinical syndrome DOID_0050701 4.219E-03 0.02791388 4.219E-03 0.05107646 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pancreatitis DOID_4989 4.219E-03 0.02759303 4.219E-03 0.05001237 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP bacterial pneumonia DOID_874 4.219E-03 0.02727947 4.219E-03 0.04899171 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP auditory system disease DOID_2742 4.836E-03 0.03091715 0.04548553 0.21214153 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP combined T cell and B cell immunodeficiency DOID_628 4.935E-03 0.03119999 4.935E-03 0.05615998 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP focal epilepsy DOID_2234 4.998E-03 0.03125227 4.998E-03 0.05576385 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP chronic kidney failure DOID_784 4.998E-03 0.03091257 0.04646113 0.21492994 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP spinal muscular atrophy DOID_12377 5.316E-03 0.03252308 0.1034702 0.3165298 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP papillary adenoma DOID_3172 5.316E-03 0.03217709 0.1034702 0.31483713 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP microcystic adenoma DOID_5403 5.316E-03 0.03217709 0.1034702 0.31483713 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP follicular adenoma DOID_6204 5.316E-03 0.03217709 0.1034702 0.31483713 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cleft lip DOID_9296 5.316E-03 0.03183839 5.316E-03 0.0570688 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP retinal vascular disease DOID_2462 5.332E-03 0.03160601 5.332E-03 0.05618846 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP primary bacterial infectious disease DOID_0050338 5.68E-03 0.03331831 0.05043949 0.21908452 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP spinal cord disease DOID_319 5.71E-03 0.03315031 5.71E-03 0.05906782 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP seminoma DOID_4440 5.71E-03 0.03281546 5.71E-03 0.05801304 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP juvenile myoclonic epilepsy DOID_4890 5.71E-03 0.0324873 5.71E-03 0.05699527 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP fragments of torsion dystonia DOID_531 5.71E-03 0.03216565 0.10709096 0.31903014 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP dystonia DOID_543 5.71E-03 0.0318503 5.71E-03 0.05601259 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP amino acid metabolic disorder DOID_9252 6.041E-03 0.03337022 6.041E-03 0.05825649 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP sarcoma DOID_1115 6.536E-03 0.03575918 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP thrombocytopenia DOID_1588 6.536E-03 0.03541861 0.11428897 0.33520836 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP coronary stenosis DOID_4248 6.536E-03 0.03508448 0.11428897 0.33348934 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP central nervous system hereditary degenerative disease DOID_481 6.536E-03 0.03475658 0.11428897 0.33010367 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP encephalomyelitis DOID_640 6.802E-03 0.03583894 6.802E-03 0.06143818 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP toxic encephalopathy DOID_3602 6.968E-03 0.03637588 0.11786632 0.33532969 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP dystonic disease DOID_544 6.968E-03 0.03604519 0.11786632 0.33200959 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cranial nerve disease DOID_5656 6.968E-03 0.03572046 0.11786632 0.33037408 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP hypersensitivity reaction type I disease DOID_1205 7.204E-03 0.03659785 0.32480927 0.66242465 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP germinoma DOID_3304 8.341E-03 0.0419991 8.341E-03 0.0708343 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP allergic rhinitis DOID_4481 8.341E-03 0.04163069 0.12851249 0.35325413 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP chronic leukemia DOID_1036 8.823E-03 0.04365476 0.13203277 0.36118579 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP chronic lymphocytic leukemia DOID_1040 8.823E-03 0.04365476 0.13203277 0.36118579 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP childhood absence epilepsy DOID_1825 8.823E-03 0.04327842 8.823E-03 0.0738279 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP papilloma DOID_2615 9.317E-03 0.04531317 0.13553892 0.36550542 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP metal metabolism disorder DOID_896 9.317E-03 0.04492916 9.317E-03 0.07683537 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP pneumoconiosis DOID_10316 9.824E-03 0.04697369 0.139031 0.37315395 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP nephroblastoma DOID_2154 9.824E-03 0.04658224 0.139031 0.36966653 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP thyroid carcinoma DOID_3963 9.824E-03 0.04619726 0.139031 0.36794715 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP spindle cell carcinoma DOID_4015 9.824E-03 0.0458186 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP leukopenia DOID_615 9.824E-03 0.04544609 9.824E-03 0.07985527 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP childhood electroclinical syndrome DOID_0050704 0.01034257 0.04745905 0.01034257 0.08288623 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP lymphoid leukemia DOID_10747 0.01034257 0.04707938 0.01034257 0.08173503 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP thyroid cancer DOID_1781 0.01087301 0.04910113 0.14597317 0.3775397 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP adolescence-adult electroclinical syndrome DOID_0050705 0.01141524 0.05114385 0.01141524 0.08777391 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP calcinosis DOID_182 0.01141524 0.05074429 0.14942337 0.38298153 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP cleft palate DOID_674 0.01141524 0.05035092 0.01141524 0.08660359 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP embryonal cancer DOID_688 0.01141524 0.04996361 0.01141524 0.08546407 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP peripheral nervous system neoplasm DOID_1192 0.01196915 0.05198813 0.15285973 0.38656527 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP blood platelet disease DOID_2218 0.01196915 0.05159428 0.15285973 0.38315941 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP respiratory syncytial virus infectious disease DOID_1273 0.01253465 0.05362566 0.01253465 0.09262615 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP lymphatic system disease DOID_75 0.01311163 0.05567548 0.01311163 0.09564762 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP benign mesothelioma DOID_2645 0.01369999 0.05774291 0.16308626 0.40522307 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP autoimmune disease of urogenital tract DOID_0060049 0.01429963 0.05982713 0.01429963 0.10170612 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP primary biliary cirrhosis DOID_12236 0.01429963 0.05982713 0.01429963 0.10170612 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP hyperinsulinism DOID_2018 0.01491046 0.06192737 0.01491046 0.10346403 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP diabetic autonomic neuropathy DOID_11503 0.01553237 0.06404288 0.01553237 0.10648093 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP autonomic neuropathy DOID_11504 0.01553237 0.06404288 0.01553237 0.10648093 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP diabetic polyneuropathy DOID_12785 0.01553237 0.06404288 0.01553237 0.10648093 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP diabetic neuropathy DOID_9743 0.01553237 0.06404288 0.01553237 0.10648093 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP autonomic nervous system disease DOID_11465 0.01746362 0.07148778 0.01746362 0.11554421 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP integumentary system benign neoplasm DOID_0060121 0.01880476 0.07642793 0.18976132 0.44433824 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP skin benign neoplasm DOID_3165 0.01880476 0.07642793 0.18976132 0.44433824 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP calcium metabolism disease DOID_10575 0.01949114 0.07865572 0.19303575 0.45015303 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP movement disease DOID_480 0.01949114 0.07810181 0.19303575 0.44831568 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP hemorrhagic disease DOID_2213 0.02018792 0.08032815 0.19629703 0.45219842 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP orofacial cleft DOID_0050567 0.02089502 0.08256433 0.02089502 0.13358724 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP atopic dermatitis DOID_3310 0.02089502 0.08199492 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP giant cell tumor DOID_200 0.02161233 0.08422889 0.20278036 0.46152809 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP malignant giant cell tumor DOID_2705 0.02161233 0.08422889 0.20278036 0.46152809 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP giant cell glioblastoma DOID_3074 0.02161233 0.08422889 0.20278036 0.46152809 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP integumentary system cancer DOID_0060122 0.02307727 0.08932629 0.20921172 0.47238679 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP skin cancer DOID_4159 0.02307727 0.08932629 0.20921172 0.47238679 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP glioblastoma DOID_3068 0.02534902 0.09745672 0.21876225 0.48623329 DACOSTA_UV_RESPONSE_VIA_ERCC3_UP leukocyte disease DOID_9500 0.02612574 0.09976878 0.02612574 0.15814413 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP transitional cell carcinoma DOID_2671 2.763E-09 1.572E-06 2.526E-05 3.593E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cervix uteri carcinoma in situ DOID_8991 1.648E-08 4.689E-06 2.902E-06 1.651E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pre-malignant neoplasm DOID_0060071 8.669E-08 1.644E-05 9.936E-06 2.827E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP in situ carcinoma DOID_8719 8.669E-08 1.644E-05 9.936E-06 2.827E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP diabetic angiopathy DOID_11713 4.472E-07 6.362E-05 0.01508792 0.13627029 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP endometrial carcinoma DOID_2871 1.092E-06 1.243E-04 1.883E-04 9.741E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP abdominal aortic aneurysm DOID_7693 1.201E-06 1.139E-04 0.02068945 0.14533701 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP endometrial cancer DOID_1380 1.317E-06 1.07E-04 2.128E-04 0.0100911 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pneumoconiosis DOID_10316 1.708E-06 1.215E-04 2.524E-04 0.01104547 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP adenoma DOID_657 2.007E-06 1.269E-04 2.806E-04 0.0114027 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP lymphatic system disease DOID_75 2.705E-06 1.539E-04 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP uterine cancer DOID_363 3.549E-06 1.836E-04 4.08E-04 0.01451043 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hemolytic anemia DOID_583 4.55E-06 2.158E-04 0.03180105 0.17233143 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP normocytic anemia DOID_720 4.55E-06 2.158E-04 0.03180105 0.17233143 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP aortic aneurysm DOID_3627 5.114E-06 2.238E-04 0.03302819 0.1756359 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP reproductive organ benign neoplasm DOID_0050622 6.722E-06 2.732E-04 6.213E-04 0.01860578 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cholestasis DOID_13580 1.087E-05 4.124E-04 8.529E-04 0.0220588 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP nephrosis DOID_2527 1.403E-05 4.989E-04 0.04582347 0.21027062 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP bile duct disease DOID_4138 1.403E-05 4.696E-04 1.009E-03 0.02495981 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP male reproductive system disease DOID_48 1.403E-05 4.435E-04 0.04582347 0.20858845 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP peripheral vascular disease DOID_341 1.461E-05 4.375E-04 0.04642871 0.20966615 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP biliary tract disease DOID_9741 1.461E-05 4.156E-04 1.036E-03 0.02456567 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP aneurysm disease DOID_2403 1.708E-05 4.627E-04 0.04884597 0.21379504 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP invasive lobular carcinoma DOID_3457 2.105E-05 5.445E-04 2.105E-05 3.993E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP relapsing-remitting multiple sclerosis DOID_2378 2.525E-05 6.247E-04 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP Leydig cell tumor DOID_2696 2.983E-05 7.072E-04 8.2E-03 0.10850574 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP sex cord-stromal neoplasm DOID_4757 2.983E-05 7.072E-04 8.2E-03 0.10850574 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.064E-05 6.974E-04 1.689E-03 0.03099983 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP dilated cardiomyopathy DOID_12930 3.161E-05 6.917E-04 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP varicose veins DOID_799 4.013E-05 8.456E-04 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP angiosarcoma DOID_0001816 4.584E-05 9.315E-04 4.584E-05 5.217E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP silicosis DOID_10325 4.584E-05 8.994E-04 0.01008302 0.11474478 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP vein disease DOID_866 4.584E-05 8.694E-04 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP amyloidosis DOID_9120 7.247E-05 1.33E-03 0.01258851 0.12349764 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP osteosarcoma DOID_3347 1.237E-04 2.199E-03 1.237E-04 0.01172823 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP myositis DOID_633 1.335E-04 2.302E-03 0.0169585 0.14402072 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP seminoma DOID_4440 1.437E-04 2.405E-03 0.01758127 0.1408978 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP Sciatic Neuropathy DOID_11446 1.543E-04 2.509E-03 1.543E-04 0.01254367 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP lesion of sciatic nerve DOID_12528 1.543E-04 2.509E-03 1.543E-04 0.01254367 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP mononeuritis of lower limb DOID_9473 1.543E-04 2.509E-03 1.543E-04 0.01254367 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP sarcoma DOID_1115 1.653E-04 2.612E-03 1.653E-04 0.01175514 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP malaria DOID_12365 1.653E-04 2.542E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP mononeuritis DOID_1802 1.653E-04 2.475E-03 1.653E-04 0.01044901 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP mononeuropathy DOID_1188 1.766E-04 2.577E-03 1.766E-04 0.01004879 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP corneal disease DOID_10124 1.883E-04 2.679E-03 0.02006857 0.14829892 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP age related macular degeneration DOID_10871 2.004E-04 2.781E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP degeneration of macula and posterior pole DOID_2007 2.004E-04 2.781E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP germinoma DOID_3304 2.128E-04 2.883E-03 0.02130996 0.1478703 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP nephroblastoma DOID_2154 2.524E-04 3.339E-03 0.02316921 0.15329395 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP macular degeneration DOID_4448 2.524E-04 3.263E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP adult respiratory distress syndrome DOID_11394 3.414E-04 4.316E-03 0.02687756 0.16623189 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pulmonary emphysema DOID_9675 3.575E-04 4.422E-03 0.02749431 0.16642832 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP autoimmune disease of urogenital tract DOID_0060049 3.74E-04 4.527E-03 3.74E-04 0.01418581 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP primary biliary cirrhosis DOID_12236 3.74E-04 4.527E-03 3.74E-04 0.01418581 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cerebral infarction DOID_3526 4.256E-04 5.045E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP learning disability DOID_8927 4.256E-04 4.942E-03 0.02995755 0.17218026 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP proteinuria DOID_576 4.435E-04 5.047E-03 0.03057242 0.1739571 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP neuritis DOID_1803 4.618E-04 5.153E-03 4.618E-04 0.01545817 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP glaucoma DOID_1686 4.995E-04 5.466E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP lung small cell carcinoma DOID_5409 4.995E-04 5.363E-03 4.995E-04 0.01579088 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP vasculitis DOID_865 6.001E-04 6.323E-03 0.035478 0.1802409 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP parasitic protozoa infectious disease DOID_2789 6.213E-04 6.427E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hypersensitivity reaction type IV disease DOID_2916 6.87E-04 6.981E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP melancholia DOID_2848 7.096E-04 7.084E-03 7.096E-04 0.02018919 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP leukocyte disease DOID_9500 7.096E-04 6.962E-03 0.03853189 0.19064909 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP neurotic disorder DOID_4964 7.326E-04 7.065E-03 7.326E-04 0.01985055 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP carotid artery disease DOID_3407 7.56E-04 7.169E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP respiratory failure DOID_11162 7.797E-04 7.273E-03 0.04035978 0.1962796 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP endocrine pancreas disease DOID_1428 8.281E-04 7.6E-03 0.04157652 0.20048337 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP parasitic infectious disease DOID_1398 8.529E-04 7.703E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP uterine disease DOID_345 8.529E-04 7.583E-03 0.04218433 0.20170491 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP endocrine organ benign neoplasm DOID_0060089 9.293E-04 8.135E-03 0.04400556 0.20693525 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP brain infarction DOID_3454 9.293E-04 8.012E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP blood coagulation disease DOID_1247 9.82E-04 8.34E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cystic fibrosis DOID_1485 1.12E-03 9.372E-03 0.0482422 0.21278925 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP endogenous depression DOID_1595 1.12E-03 9.236E-03 1.12E-03 0.02549113 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP bacterial pneumonia DOID_874 1.178E-03 9.573E-03 0.04944936 0.21155404 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP metabolic syndrome X DOID_14221 1.237E-03 9.911E-03 0.05065506 0.21509497 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP female reproductive system disease DOID_229 1.267E-03 0.01001071 0.05125735 0.21604025 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP mental depression DOID_1596 1.328E-03 0.01035012 1.328E-03 0.02905995 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP chronic kidney failure DOID_784 1.328E-03 0.01021025 0.05246085 0.21948693 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP bone development disease DOID_0080006 1.359E-03 0.01031 1.359E-03 0.02863888 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP primary bacterial infectious disease DOID_0050338 1.454E-03 0.01088826 1.454E-03 0.02955385 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP nervous system cancer DOID_3093 1.553E-03 0.01147453 1.553E-03 0.03046687 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP Human immunodeficiency virus infectious disease DOID_526 1.553E-03 0.01132742 1.553E-03 0.0294513 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP gallbladder disease DOID_0000000 6.313E-03 0.04547217 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP facioscapulohumeral muscular dystrophy DOID_11727 6.313E-03 0.04490377 6.313E-03 0.11225943 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hyperparathyroidism DOID_13543 6.313E-03 0.0443494 6.313E-03 0.10885763 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP familial combined hyperlipidemia DOID_13809 6.313E-03 0.04380856 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP childhood type dermatomyositis DOID_14203 6.313E-03 0.04328074 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP rectal neoplasm DOID_1984 6.313E-03 0.0427655 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP rectum cancer DOID_1993 6.313E-03 0.0427655 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP acute kidney failure DOID_3021 6.313E-03 0.04226237 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP insulinoma DOID_3892 6.313E-03 0.04177095 6.313E-03 0.10565593 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP adrenal gland hyperfunction DOID_3947 6.313E-03 0.04129082 6.313E-03 0.10263719 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP keratitis DOID_4677 6.313E-03 0.04082161 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP breast benign neoplasm DOID_0060082 6.943E-03 0.04438578 6.943E-03 0.1097315 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP thoracic benign neoplasm DOID_0060097 6.943E-03 0.04438578 6.943E-03 0.1097315 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP dermatomyositis DOID_10223 6.943E-03 0.0438926 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP adrenoleukodystrophy DOID_10588 6.943E-03 0.04341026 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP sickle cell anemia DOID_10923 6.943E-03 0.04293841 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP benign breast phyllodes tumor DOID_1631 6.943E-03 0.04438578 6.943E-03 0.1097315 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP eosinophilic pneumonia DOID_5870 6.943E-03 0.04247671 6.943E-03 0.10676578 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pulmonary eosinophilia DOID_9498 6.943E-03 0.04247671 6.943E-03 0.10676578 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP Loeffler syndrome DOID_9503 6.943E-03 0.04247671 6.943E-03 0.10676578 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP bronchiectasis DOID_9563 6.943E-03 0.04202483 6.943E-03 0.10395616 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pituitary cancer DOID_1785 7.571E-03 0.04534894 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP islet cell tumor DOID_1799 7.571E-03 0.04487655 7.571E-03 0.11046536 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pituitary carcinoma DOID_4916 7.571E-03 0.04534894 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP retinal detachment DOID_5327 7.571E-03 0.04441391 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP peritonitis DOID_8283 7.571E-03 0.0439607 7.571E-03 0.10770373 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP ocular hypertension DOID_9282 7.571E-03 0.04351666 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP borderline glaucoma DOID_9283 7.571E-03 0.04351666 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP berylliosis DOID_10322 8.2E-03 0.04665747 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP parathyroid gland disease DOID_11201 8.2E-03 0.04619552 8.2E-03 0.11379871 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP vulva cancer DOID_1245 8.2E-03 0.04574262 8.2E-03 0.11108922 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP newborn respiratory distress syndrome DOID_12716 8.2E-03 0.04529851 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP carotid stenosis DOID_13001 8.2E-03 0.04486295 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP Legionnaires' disease DOID_10457 8.828E-03 0.04783931 8.828E-03 0.114162 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP legionellosis DOID_10458 8.828E-03 0.04783931 8.828E-03 0.114162 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP viral pneumonia DOID_10533 8.828E-03 0.047388 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP aspergillosis DOID_13564 8.828E-03 0.04694512 8.828E-03 0.11162507 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP parasitic helminthiasis infectious disease DOID_883 8.828E-03 0.04651044 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP Ehlers-Danlos syndrome DOID_13359 9.456E-03 0.04936048 9.456E-03 0.11696287 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hemangioma DOID_255 9.456E-03 0.04891175 9.456E-03 0.1144743 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP corneal dystrophy DOID_2566 9.456E-03 0.0484711 9.456E-03 0.11208942 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP membranoproliferative glomerulonephritis DOID_2920 9.456E-03 0.04803832 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP adrenal cortex disease DOID_3952 9.456E-03 0.0476132 9.456E-03 0.10980188 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hemolytic-uremic syndrome DOID_12554 0.01008302 0.05032666 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pituitary adenoma DOID_3829 0.01008302 0.04988904 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP urinary system benign neoplasm DOID_731 0.01070996 0.05253422 0.01070996 0.1194896 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP adrenal gland disease DOID_9553 0.01070996 0.05208521 0.01070996 0.11719173 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP male reproductive organ benign neoplasm DOID_0060087 0.01133653 0.05466512 0.01133653 0.12170724 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP glucose intolerance DOID_10603 0.01133653 0.05420575 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP eosinophilia DOID_999 0.01133653 0.05375403 0.01133653 0.11945341 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP dissociative disorder DOID_10935 0.01196271 0.05625439 0.01196271 0.12375967 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP dissociative amnesia DOID_11037 0.01196271 0.05625439 0.01196271 0.12375967 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP testicular cancer DOID_2998 0.01196271 0.05579329 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP amnestic disorder DOID_10914 0.01258851 0.05823466 0.01258851 0.12790827 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP membranous glomerulonephritis DOID_10976 0.01258851 0.05776502 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP colon carcinoma DOID_1520 0.01258851 0.0573029 0.01258851 0.12566426 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP Kawasaki disease DOID_13378 0.01321393 0.05967245 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP lymphadenitis DOID_1602 0.01321393 0.05967245 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP coronary restenosis DOID_4247 0.01321393 0.05920259 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP lymph node disease DOID_9942 0.01321393 0.05967245 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP familial hypercholesterolemia DOID_13810 0.01383898 0.06151857 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP acquired immunodeficiency syndrome DOID_635 0.01383898 0.06104169 0.01383898 0.13346403 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP placenta disease DOID_780 0.01383898 0.06057214 0.01383898 0.13123963 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP myasthenia gravis DOID_437 0.01446364 0.06282298 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP uremia DOID_4676 0.01446364 0.06234705 0.01446364 0.13491493 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP polyarteritis nodosa DOID_9810 0.01446364 0.06187828 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hypoglycemia DOID_9993 0.01446364 0.0614165 0.01446364 0.13273889 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP synostosis DOID_11971 0.01508792 0.0635928 0.01508792 0.13414107 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP spastic quadriplegia DOID_10970 0.01571183 0.06573552 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP toxic shock syndrome DOID_14115 0.01571183 0.0652557 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP sphingolipidosis DOID_1927 0.01571183 0.06478283 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP commensal bacterial infectious disease DOID_0050339 0.01633535 0.06686919 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP X-linked disease DOID_0050735 0.01633535 0.06639155 0.01633535 0.14299718 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP portal hypertension DOID_10762 0.01633535 0.06592069 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hypogonadism DOID_1924 0.01633535 0.06545646 0.01633535 0.14083056 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP neuromuscular junction disease DOID_439 0.0169585 0.06747824 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cleft lip DOID_9296 0.0169585 0.06700964 0.0169585 0.14190276 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP vitiligo DOID_12306 0.01758127 0.06899134 0.01758127 0.14498179 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP spinal cord disease DOID_319 0.01758127 0.06851879 0.01758127 0.14291063 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP middle cerebral artery infarction DOID_3525 0.01758127 0.06805268 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP extrinsic allergic alveolitis DOID_841 0.01758127 0.06759286 0.01758127 0.13894089 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP diffuse large B-cell lymphoma DOID_0050745 0.01820366 0.069516 0.01820366 0.14188883 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP gestational diabetes DOID_11714 0.01820366 0.06905256 0.01820366 0.13997141 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP periodontitis DOID_824 0.01820366 0.06859526 0.01820366 0.13810513 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP renal hypertension DOID_1073 0.01882568 0.07047243 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP secondary hypertension DOID_11130 0.01882568 0.07047243 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hepatic vascular disease DOID_272 0.01882568 0.07001183 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP invasive ductal carcinoma DOID_3008 0.01882568 0.06955721 0.01882568 0.14094487 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP coronary stenosis DOID_4248 0.01882568 0.06910845 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP autoimmune disease of the nervous system DOID_438 0.01882568 0.06866545 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP dysostosis DOID_1934 0.02006857 0.07273259 0.02006857 0.14639765 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP spastic cerebral palsy DOID_0050669 0.02068945 0.07450822 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP gonadal disease DOID_2277 0.02068945 0.07403961 0.02068945 0.14901643 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP opportunistic mycosis DOID_2473 0.02068945 0.07357686 0.02068945 0.14715373 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP bronchiolitis obliterans DOID_2799 0.02068945 0.07311986 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP allergic rhinitis DOID_4481 0.02130996 0.07484793 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP leiomyoma DOID_127 0.02193008 0.07655348 0.02193008 0.15033997 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pleural disease DOID_1532 0.02193008 0.07608669 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP systemic mycosis DOID_0050136 0.02254983 0.07776276 0.02254983 0.15274828 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP fungal infectious disease DOID_1564 0.02254983 0.07776276 0.02254983 0.15274828 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP papilloma DOID_2615 0.02254983 0.07729431 0.02254983 0.15095124 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP metal metabolism disorder DOID_896 0.02254983 0.07683147 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP periodontal disease DOID_3388 0.02316921 0.0784719 0.02316921 0.15153195 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pulmonary sarcoidosis DOID_13406 0.02502508 0.08425602 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cleft palate DOID_674 0.02502508 0.0837604 0.02502508 0.16180986 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP embryonal cancer DOID_688 0.02502508 0.08327057 0.02502508 0.15999177 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP multiple myeloma DOID_9538 0.02502508 0.08278644 0.02502508 0.15821409 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP microcephaly DOID_10907 0.02564295 0.0843401 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP uveitis DOID_13141 0.02564295 0.08385538 0.02564295 0.16033886 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP blood platelet disease DOID_2218 0.02564295 0.08337621 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hepatitis DOID_2237 0.02626044 0.08489882 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP peptic ulcer DOID_750 0.02626044 0.08441916 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP intracranial arterial disease DOID_13089 0.02687756 0.0859176 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cerebral arterial disease DOID_3527 0.02687756 0.0859176 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP adenoid cystic carcinoma DOID_4866 0.02687756 0.08543762 0.02687756 0.16444445 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP benign mesothelioma DOID_2645 0.02749431 0.08691257 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP endometriosis of uterus DOID_288 0.02811068 0.08837004 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP salivary gland cancer DOID_8850 0.02811068 0.08788449 0.02811068 0.16836818 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP nephrotic syndrome DOID_1184 0.02872668 0.08931956 0.02872668 0.17026541 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP idiopathic generalized epilepsy DOID_1827 0.02872668 0.08883413 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hyperinsulinism DOID_2018 0.02872668 0.08835394 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP endometriosis DOID_289 0.02872668 0.08787892 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP uveal disease DOID_3480 0.02872668 0.08740898 0.02872668 0.1685101 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP gallbladder cancer DOID_3121 0.0293423 0.08880728 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP influenza DOID_8469 0.0293423 0.0883374 0.0293423 0.17036499 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP cataract DOID_83 0.02995755 0.08971498 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP leukodystrophy DOID_10579 0.03057242 0.09107701 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP myeloma DOID_0070004 0.03118693 0.09242376 0.03118693 0.17569664 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pre-eclampsia DOID_10591 0.03118693 0.09194488 0.03118693 0.17397413 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP lens disease DOID_110 0.03118693 0.09147093 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP brain cancer DOID_1319 0.03118693 0.09100185 0.03118693 0.17228506 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP vascular skin disease DOID_9540 0.03118693 0.09053756 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP central nervous system cancer DOID_3620 0.03180105 0.09185178 0.03180105 0.17398846 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pulmonary tuberculosis DOID_2957 0.03241481 0.09315165 0.03241481 0.17400025 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP hemorrhagic disease DOID_2213 0.0336412 0.09619017 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP B-cell lymphocytic neoplasm DOID_707 0.0336412 0.09570922 0.0336412 0.1772393 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP orofacial cleft DOID_0050567 0.03425384 0.09696734 0.03425384 0.17881133 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP sarcoidosis DOID_11335 0.0348661 0.09821195 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP atrophic muscular disease DOID_913 0.0348661 0.09772815 0.0348661 0.18035285 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP muscular dystrophy DOID_9884 0.0348661 0.09772815 0.0348661 0.18035285 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP bone marrow cancer DOID_4960 0.035478 0.09895579 0.035478 0.18186469 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP pustulosis of palm and sole DOID_4398 0.03608952 0.09968416 1.000 1.000 VALK_AML_CLUSTER_5 pulmonary tuberculosis DOID_2957 1.346E-06 7.658E-04 2.187E-04 0.0622261 VALK_AML_CLUSTER_5 tuberculosis DOID_399 3.464E-06 9.854E-04 4.08E-04 0.05803566 VALK_AML_CLUSTER_5 primary bacterial infectious disease DOID_0050338 6.85E-06 1.299E-03 6.401E-04 0.07284135 VALK_AML_CLUSTER_5 bronchiolitis DOID_2942 5.395E-05 7.675E-03 5.395E-05 0.03069882 VALK_AML_CLUSTER_5 opportunistic mycosis DOID_2473 8.75E-05 9.958E-03 0.01383952 0.24608398 VALK_AML_CLUSTER_5 bronchiolitis obliterans DOID_2799 8.75E-05 8.298E-03 0.01383952 0.23862689 VALK_AML_CLUSTER_5 systemic mycosis DOID_0050136 1.043E-04 8.48E-03 0.01508871 0.23203996 VALK_AML_CLUSTER_5 fungal infectious disease DOID_1564 1.043E-04 8.48E-03 0.01508871 0.23203996 VALK_AML_CLUSTER_5 uveitis DOID_13141 1.356E-04 9.646E-03 1.000 1.000 VALK_AML_CLUSTER_5 uveal disease DOID_3480 1.71E-04 0.01080931 1.000 1.000 VALK_AML_CLUSTER_5 leukodystrophy DOID_10579 1.941E-04 0.01104554 0.02048476 0.2241506 VALK_AML_CLUSTER_5 cerebral degeneration DOID_1443 3.743E-04 0.01936021 0.02832146 0.25579226 VALK_AML_CLUSTER_5 brain infarction DOID_3454 4.08E-04 0.01934522 4.08E-04 0.07738088 VALK_AML_CLUSTER_5 bacterial pneumonia DOID_874 5.177E-04 0.02265743 0.03324063 0.26269332 VALK_AML_CLUSTER_5 transitional cell carcinoma DOID_2671 6.545E-04 0.02659947 6.545E-04 0.06206543 VALK_AML_CLUSTER_5 lymphoblastic leukemia DOID_1037 7.287E-04 0.0276436 7.287E-04 0.05923628 VALK_AML_CLUSTER_5 encephalomyelitis DOID_640 7.287E-04 0.02591587 0.03935676 0.28710252 VALK_AML_CLUSTER_5 Crohn's disease DOID_8778 7.441E-04 0.02490425 0.03976321 0.28639577 VALK_AML_CLUSTER_5 hypersensitivity reaction type I disease DOID_1205 7.595E-04 0.02400994 0.0401695 0.28570555 VALK_AML_CLUSTER_5 ulcerative colitis DOID_8577 8.069E-04 0.02416472 0.0413874 0.29073368 VALK_AML_CLUSTER_5 aspergillosis DOID_13564 5.893E-03 0.09862781 1.000 1.000 VALK_AML_CLUSTER_5 T-cell leukemia DOID_715 5.893E-03 0.09580987 5.893E-03 0.23952468 HAHTOLA_CTCL_PATHOGENESIS bronchiolitis obliterans DOID_2799 3.355E-08 1.909E-05 2.051E-05 0.01166795 HAHTOLA_CTCL_PATHOGENESIS respiratory syncytial virus infectious disease DOID_1273 3.341E-05 9.504E-03 8.829E-03 0.16206194 HAHTOLA_CTCL_PATHOGENESIS hepatitis DOID_2237 3.341E-05 6.336E-03 3.341E-05 9.504E-03 HAHTOLA_CTCL_PATHOGENESIS peptic ulcer DOID_750 3.341E-05 4.752E-03 8.829E-03 0.15699751 HAHTOLA_CTCL_PATHOGENESIS autoimmune disease of urogenital tract DOID_0060049 3.84E-05 4.37E-03 3.84E-05 7.283E-03 HAHTOLA_CTCL_PATHOGENESIS primary biliary cirrhosis DOID_12236 3.84E-05 4.37E-03 3.84E-05 7.283E-03 HAHTOLA_CTCL_PATHOGENESIS endometriosis of uterus DOID_288 3.84E-05 3.642E-03 9.457E-03 0.16306914 HAHTOLA_CTCL_PATHOGENESIS endometriosis DOID_289 4.014E-05 3.263E-03 9.667E-03 0.16177524 HAHTOLA_CTCL_PATHOGENESIS diabetic autonomic neuropathy DOID_11503 4.192E-05 2.982E-03 9.876E-03 0.1560948 HAHTOLA_CTCL_PATHOGENESIS autonomic neuropathy DOID_11504 4.192E-05 2.982E-03 9.876E-03 0.1560948 HAHTOLA_CTCL_PATHOGENESIS diabetic polyneuropathy DOID_12785 4.192E-05 2.982E-03 9.876E-03 0.1560948 HAHTOLA_CTCL_PATHOGENESIS influenza DOID_8469 4.192E-05 2.65E-03 9.876E-03 0.15187602 HAHTOLA_CTCL_PATHOGENESIS diabetic neuropathy DOID_9743 4.192E-05 2.982E-03 9.876E-03 0.1560948 HAHTOLA_CTCL_PATHOGENESIS pre-eclampsia DOID_10591 4.749E-05 2.702E-03 0.01050342 0.15727484 HAHTOLA_CTCL_PATHOGENESIS autonomic nervous system disease DOID_11465 4.749E-05 2.457E-03 0.01050342 0.15324215 HAHTOLA_CTCL_PATHOGENESIS pulmonary tuberculosis DOID_2957 5.139E-05 2.437E-03 0.01092154 0.14796083 HAHTOLA_CTCL_PATHOGENESIS uterine disease DOID_345 8.814E-05 3.858E-03 0.01426094 0.16560158 HAHTOLA_CTCL_PATHOGENESIS hyperglycemia DOID_4195 9.077E-05 3.689E-03 0.01446933 0.16466097 HAHTOLA_CTCL_PATHOGENESIS allergic contact dermatitis DOID_3042 9.343E-05 3.544E-03 0.01467768 0.16375682 HAHTOLA_CTCL_PATHOGENESIS tuberculosis DOID_399 9.612E-05 3.418E-03 0.01488598 0.16288702 HAHTOLA_CTCL_PATHOGENESIS diabetic retinopathy DOID_8947 1.102E-04 3.688E-03 0.01592695 0.16782281 HAHTOLA_CTCL_PATHOGENESIS bacterial pneumonia DOID_874 1.221E-04 3.86E-03 0.01675902 0.17028363 HAHTOLA_CTCL_PATHOGENESIS contact dermatitis DOID_2773 1.283E-04 3.843E-03 0.01717483 0.16849099 HAHTOLA_CTCL_PATHOGENESIS female reproductive system disease DOID_229 1.315E-04 3.74E-03 0.01738267 0.16763969 HAHTOLA_CTCL_PATHOGENESIS retinal vascular disease DOID_2462 1.445E-04 3.914E-03 0.01821367 0.16989476 HAHTOLA_CTCL_PATHOGENESIS primary bacterial infectious disease DOID_0050338 1.512E-04 3.91E-03 0.01862894 0.17096561 HAHTOLA_CTCL_PATHOGENESIS hypersensitivity reaction type I disease DOID_1205 1.796E-04 4.443E-03 1.796E-04 0.02554932 HAHTOLA_CTCL_PATHOGENESIS ulcerative colitis DOID_8577 1.909E-04 4.526E-03 0.02091017 0.18027105 HAHTOLA_CTCL_PATHOGENESIS Hermansky-Pudlak syndrome DOID_3753 2.108E-03 0.04798839 2.108E-03 0.23994193 HAHTOLA_CTCL_PATHOGENESIS conjunctival disease DOID_4251 2.108E-03 0.04614268 2.108E-03 0.19995161 HAHTOLA_CTCL_PATHOGENESIS conjunctivitis DOID_6195 2.108E-03 0.04614268 2.108E-03 0.19995161 HAHTOLA_CTCL_PATHOGENESIS trypanosomiasis DOID_10113 2.319E-03 0.04887255 2.319E-03 0.1885084 HAHTOLA_CTCL_PATHOGENESIS temporal arteritis DOID_13375 2.319E-03 0.0471271 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS central nervous system vasculitis DOID_525 2.319E-03 0.0471271 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS bronchiectasis DOID_9563 2.319E-03 0.04550203 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS ocular hypertension DOID_9282 2.53E-03 0.04797953 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS borderline glaucoma DOID_9283 2.53E-03 0.04797953 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS encephalitis DOID_9588 2.53E-03 0.0464318 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS polyneuropathy DOID_1389 2.74E-03 0.04872471 2.74E-03 0.19489883 HAHTOLA_CTCL_PATHOGENESIS larynx cancer DOID_2596 2.74E-03 0.0472482 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS laryngeal benign neoplasm DOID_2598 2.74E-03 0.0472482 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS eyelid disease DOID_530 2.951E-03 0.04938157 2.951E-03 0.1865526 HAHTOLA_CTCL_PATHOGENESIS bacterial meningitis DOID_9470 2.951E-03 0.04797067 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS skeletal system cancer DOID_0060124 3.161E-03 0.04996483 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS thoracic aortic aneurysm DOID_14004 3.161E-03 0.04861443 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS bone cancer DOID_184 3.161E-03 0.04996483 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS oral submucous fibrosis DOID_5773 3.161E-03 0.04733511 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS varicose veins DOID_799 3.161E-03 0.04612139 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS vein disease DOID_866 3.372E-03 0.04796181 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS glucose intolerance DOID_10603 3.792E-03 0.0526313 3.792E-03 0.21578832 HAHTOLA_CTCL_PATHOGENESIS MHC class II deficiency DOID_5812 4.003E-03 0.05422751 4.003E-03 0.20705049 HAHTOLA_CTCL_PATHOGENESIS esophagitis DOID_11963 4.213E-03 0.05574896 4.213E-03 0.19976712 HAHTOLA_CTCL_PATHOGENESIS brain edema DOID_4724 4.213E-03 0.05448194 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS subependymal glioma DOID_4843 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS pilocytic astrocytoma DOID_4851 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS subependymal giant cell astrocytoma DOID_5077 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS fibrillary astrocytoma DOID_6726 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS juvenile pilocytic astrocytoma DOID_6811 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS childhood pilocytic astrocytoma DOID_6812 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS gemistocytic astrocytoma DOID_7005 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS childhood cerebral astrocytoma DOID_7007 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS protoplasmic astrocytoma DOID_7008 4.213E-03 0.05327123 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS autoimmune hepatitis DOID_2048 4.423E-03 0.05471377 4.423E-03 0.19360256 HAHTOLA_CTCL_PATHOGENESIS benign glioma DOID_0060101 4.633E-03 0.05609445 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS gastric ulcer DOID_10808 4.633E-03 0.05492582 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS familial hypercholesterolemia DOID_13810 4.633E-03 0.05380488 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS benign ependymoma DOID_4844 4.633E-03 0.05609445 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS sinusitis DOID_0050127 4.844E-03 0.05512046 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS paranasal sinus disease DOID_1352 4.844E-03 0.05512046 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS opiate dependence DOID_2559 4.844E-03 0.05403966 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS myasthenia gravis DOID_437 4.844E-03 0.05300044 4.844E-03 0.19685878 HAHTOLA_CTCL_PATHOGENESIS pulmonary embolism DOID_9477 4.844E-03 0.05200043 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS meningitis DOID_9471 5.054E-03 0.05325157 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS Goodpasture syndrome DOID_9808 5.054E-03 0.05228336 5.054E-03 0.19170564 HAHTOLA_CTCL_PATHOGENESIS severe combined immunodeficiency DOID_627 5.264E-03 0.05348436 5.264E-03 0.18719526 HAHTOLA_CTCL_PATHOGENESIS bronchiolitis DOID_2942 5.474E-03 0.05464284 5.474E-03 0.18321421 HAHTOLA_CTCL_PATHOGENESIS combined T cell and B cell immunodeficiency DOID_628 5.474E-03 0.05370072 5.474E-03 0.17303564 HAHTOLA_CTCL_PATHOGENESIS neuromuscular junction disease DOID_439 5.684E-03 0.05481588 5.684E-03 0.17021774 HAHTOLA_CTCL_PATHOGENESIS intracranial aneurysm DOID_10941 5.894E-03 0.0558935 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS vitiligo DOID_12306 5.894E-03 0.05497722 5.894E-03 0.16768051 HAHTOLA_CTCL_PATHOGENESIS middle cerebral artery infarction DOID_3525 5.894E-03 0.05409049 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS extrinsic allergic alveolitis DOID_841 5.894E-03 0.05323191 5.894E-03 0.15969573 HAHTOLA_CTCL_PATHOGENESIS Sciatic Neuropathy DOID_11446 6.104E-03 0.05426659 6.104E-03 0.15786643 HAHTOLA_CTCL_PATHOGENESIS lesion of sciatic nerve DOID_12528 6.104E-03 0.05426659 6.104E-03 0.15786643 HAHTOLA_CTCL_PATHOGENESIS mononeuritis of lower limb DOID_9473 6.104E-03 0.05426659 6.104E-03 0.15786643 HAHTOLA_CTCL_PATHOGENESIS pleurisy DOID_10247 6.314E-03 0.05526909 6.314E-03 0.15619525 HAHTOLA_CTCL_PATHOGENESIS renal hypertension DOID_1073 6.314E-03 0.05443168 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS secondary hypertension DOID_11130 6.314E-03 0.05443168 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS mononeuritis DOID_1802 6.314E-03 0.05361926 6.314E-03 0.14968711 HAHTOLA_CTCL_PATHOGENESIS autoimmune disease of the nervous system DOID_438 6.314E-03 0.05283075 6.314E-03 0.14369963 HAHTOLA_CTCL_PATHOGENESIS mononeuropathy DOID_1188 6.524E-03 0.05379562 6.524E-03 0.1427653 HAHTOLA_CTCL_PATHOGENESIS supratentorial cancer DOID_1659 6.524E-03 0.05302711 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS cerebrum cancer DOID_368 6.524E-03 0.05302711 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS focal glomerulosclerosis DOID_3945 6.524E-03 0.05228025 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS abdominal aortic aneurysm DOID_7693 6.943E-03 0.05487008 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS allergic rhinitis DOID_4481 7.153E-03 0.05575324 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS pleural disease DOID_1532 7.363E-03 0.05661224 7.363E-03 0.15515946 HAHTOLA_CTCL_PATHOGENESIS myocarditis DOID_820 7.572E-03 0.05744803 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS esophageal disease DOID_6050 7.782E-03 0.05826154 7.782E-03 0.15813847 HAHTOLA_CTCL_PATHOGENESIS pulmonary sarcoidosis DOID_13406 8.41E-03 0.06215025 8.41E-03 0.16501962 HAHTOLA_CTCL_PATHOGENESIS calcinosis DOID_182 8.41E-03 0.06135345 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS uveitis DOID_13141 8.62E-03 0.06208551 8.62E-03 0.16349186 HAHTOLA_CTCL_PATHOGENESIS systemic scleroderma DOID_418 8.829E-03 0.062799 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS adult respiratory distress syndrome DOID_11394 9.039E-03 0.0634946 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS intracranial arterial disease DOID_13089 9.039E-03 0.06272028 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS cerebral arterial disease DOID_3527 9.039E-03 0.06272028 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS pulmonary emphysema DOID_9675 9.248E-03 0.0633998 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS rheumatic disease DOID_1575 9.667E-03 0.06548046 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS uveal disease DOID_3480 9.667E-03 0.0647101 9.667E-03 0.15715309 HAHTOLA_CTCL_PATHOGENESIS scleroderma DOID_419 9.667E-03 0.06548046 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS cerebral infarction DOID_3526 0.01008514 0.06672611 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS brain cancer DOID_1319 0.01050342 0.06869476 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS neuritis DOID_1803 0.01050342 0.06791414 0.01050342 0.1494111 HAHTOLA_CTCL_PATHOGENESIS central nervous system cancer DOID_3620 0.0107125 0.06848776 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS autoimmune disease of gastrointestinal tract DOID_0060031 0.01092154 0.06904839 0.01092154 0.15156963 HAHTOLA_CTCL_PATHOGENESIS integumentary system benign neoplasm DOID_0060121 0.01092154 0.06828961 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS glaucoma DOID_1686 0.01092154 0.06754734 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS skin benign neoplasm DOID_3165 0.01092154 0.06828961 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS calcium metabolism disease DOID_10575 0.01113054 0.06809976 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS aortic aneurysm DOID_3627 0.01113054 0.06737529 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS withdrawal disorder DOID_0060001 0.0113395 0.06791766 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS atopic dermatitis DOID_3310 0.01154843 0.0684485 0.01154843 0.15281526 HAHTOLA_CTCL_PATHOGENESIS sarcoidosis DOID_11335 0.01175732 0.06896817 0.01175732 0.15204347 HAHTOLA_CTCL_PATHOGENESIS giant cell tumor DOID_200 0.01175732 0.06826442 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS malignant giant cell tumor DOID_2705 0.01175732 0.06826442 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS giant cell glioblastoma DOID_3074 0.01175732 0.06826442 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS bile duct adenocarcinoma DOID_4896 0.01196616 0.06877523 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS cholangiocarcinoma DOID_4947 0.01196616 0.06877523 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS vasculitis DOID_865 0.01196616 0.06808747 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS integumentary system cancer DOID_0060122 0.01217497 0.0685897 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS parasitic protozoa infectious disease DOID_2789 0.01217497 0.06791725 0.01217497 0.15394578 HAHTOLA_CTCL_PATHOGENESIS skin cancer DOID_4159 0.01217497 0.0685897 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS familial hyperlipidemia DOID_1168 0.01238374 0.06841117 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS hypertrophic cardiomyopathy DOID_11984 0.01280117 0.07003717 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS hypersensitivity reaction type IV disease DOID_2916 0.01280117 0.06937015 0.01280117 0.15834491 HAHTOLA_CTCL_PATHOGENESIS glioblastoma DOID_3068 0.01280117 0.06871571 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS bile duct cancer DOID_4606 0.01280117 0.06807351 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS bile duct carcinoma DOID_4897 0.01280117 0.06807351 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS carotid artery disease DOID_3407 0.01342702 0.0707405 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS collagen disease DOID_854 0.01342702 0.0700915 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS respiratory failure DOID_11162 0.01363556 0.07053302 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS hypothyroidism DOID_1459 0.01363556 0.06989759 0.01363556 0.16507729 HAHTOLA_CTCL_PATHOGENESIS mineral metabolism disease DOID_0050032 0.01405252 0.07139183 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS parasitic infectious disease DOID_1398 0.01426094 0.07180954 0.01426094 0.16905161 HAHTOLA_CTCL_PATHOGENESIS brain infarction DOID_3454 0.01488598 0.07429934 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS astrocytoma DOID_3069 0.01509425 0.07468374 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS pancreatic ductal carcinoma DOID_3587 0.01530248 0.07506132 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS male reproductive system disease DOID_48 0.01551068 0.07543226 0.01551068 0.16652028 HAHTOLA_CTCL_PATHOGENESIS pancreatic carcinoma DOID_4905 0.01592695 0.07680027 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS cystic fibrosis DOID_1485 0.01634306 0.07814455 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS bone resorption disease DOID_0080011 0.01655106 0.07847961 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS osteoporosis DOID_11476 0.01655106 0.07847961 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS aneurysm disease DOID_2403 0.01655106 0.07783102 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS pancreatitis DOID_4989 0.01675902 0.07816298 0.01675902 0.17337969 HAHTOLA_CTCL_PATHOGENESIS metabolic syndrome X DOID_14221 0.01717483 0.07945104 0.01717483 0.17144697 HAHTOLA_CTCL_PATHOGENESIS lipid metabolism disorder DOID_3146 0.01717483 0.0788103 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS biliary tract cancer DOID_4607 0.01779825 0.08101764 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS chronic kidney failure DOID_784 0.01779825 0.08037464 0.01779825 0.16878675 HAHTOLA_CTCL_PATHOGENESIS primary immunodeficiency disease DOID_612 0.01904406 0.08532337 0.01904406 0.17200109 HAHTOLA_CTCL_PATHOGENESIS nervous system cancer DOID_3093 0.01925156 0.08557919 1.000 1.000 HAHTOLA_CTCL_PATHOGENESIS carbohydrate metabolic disorder DOID_2978 0.01987383 0.08766052 0.01987383 0.17669074 HAHTOLA_CTCL_PATHOGENESIS encephalomyelitis DOID_640 0.01987383 0.08698621 0.01987383 0.17397242 HAHTOLA_CTCL_PATHOGENESIS mouth disease DOID_403 0.02008117 0.0872228 1.000 1.000 FUNG_IL2_SIGNALING_2 autoimmune hepatitis DOID_2048 1.228E-08 6.986E-06 4.975E-03 0.25733554 FUNG_IL2_SIGNALING_2 autoimmune disease of gastrointestinal tract DOID_0060031 2.033E-07 5.783E-05 0.01227848 0.22536947 FUNG_IL2_SIGNALING_2 hypersensitivity reaction type I disease DOID_1205 1.349E-06 2.558E-04 2.305E-04 0.02623544 FUNG_IL2_SIGNALING_2 ulcerative colitis DOID_8577 1.479E-06 2.103E-04 2.45E-04 0.0232348 FUNG_IL2_SIGNALING_2 esophagitis DOID_11963 9.497E-06 1.081E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 extrinsic allergic alveolitis DOID_841 1.888E-05 1.79E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 allergic rhinitis DOID_4481 2.799E-05 2.276E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 esophageal disease DOID_6050 3.322E-05 2.363E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 multiple myeloma DOID_9538 3.889E-05 2.459E-03 3.889E-05 0.02213036 FUNG_IL2_SIGNALING_2 respiratory syncytial virus infectious disease DOID_1273 4.292E-05 2.442E-03 9.928E-03 0.21726375 FUNG_IL2_SIGNALING_2 systemic scleroderma DOID_418 4.292E-05 2.22E-03 9.928E-03 0.20921694 FUNG_IL2_SIGNALING_2 peptic ulcer DOID_750 4.292E-05 2.035E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 rheumatic disease DOID_1575 5.157E-05 2.257E-03 0.0108686 0.21324949 FUNG_IL2_SIGNALING_2 scleroderma DOID_419 5.157E-05 2.257E-03 0.0108686 0.21324949 FUNG_IL2_SIGNALING_2 myeloma DOID_0070004 6.101E-05 2.48E-03 6.101E-05 0.01735662 FUNG_IL2_SIGNALING_2 atopic dermatitis DOID_3310 7.391E-05 2.804E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 bone marrow cancer DOID_4960 7.942E-05 2.824E-03 7.942E-05 0.01506248 FUNG_IL2_SIGNALING_2 parasitic protozoa infectious disease DOID_2789 8.224E-05 2.753E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 collagen disease DOID_854 1.002E-04 3.168E-03 0.01509287 0.21469605 FUNG_IL2_SIGNALING_2 respiratory failure DOID_11162 1.034E-04 3.096E-03 0.01532708 0.21270994 FUNG_IL2_SIGNALING_2 parasitic infectious disease DOID_1398 1.132E-04 3.22E-03 1.000 1.000 FUNG_IL2_SIGNALING_2 cystic fibrosis DOID_1485 1.49E-04 4.038E-03 0.01836731 0.23752275 FUNG_IL2_SIGNALING_2 lymphoma DOID_0060058 2.165E-04 5.6E-03 0.02209768 0.26194962 FUNG_IL2_SIGNALING_2 lymphoblastic leukemia DOID_1037 2.211E-04 5.471E-03 2.211E-04 0.03145675 FUNG_IL2_SIGNALING_2 Paget's disease of bone DOID_5408 2.372E-03 0.05622972 2.372E-03 0.1927876 FUNG_IL2_SIGNALING_2 prostatic adenoma DOID_2883 2.609E-03 0.05937232 1.000 1.000 FUNG_IL2_SIGNALING_2 eosinophilic pneumonia DOID_5870 2.609E-03 0.05708876 1.000 1.000 FUNG_IL2_SIGNALING_2 pulmonary eosinophilia DOID_9498 2.609E-03 0.05708876 1.000 1.000 FUNG_IL2_SIGNALING_2 Loeffler syndrome DOID_9503 2.609E-03 0.05708876 1.000 1.000 FUNG_IL2_SIGNALING_2 Hodgkin's lymphoma DOID_8567 2.845E-03 0.05996571 1.000 1.000 FUNG_IL2_SIGNALING_2 hypercalcemia DOID_12678 3.319E-03 0.06744719 3.319E-03 0.23606517 FUNG_IL2_SIGNALING_2 angiosarcoma DOID_0001816 3.792E-03 0.07440878 3.792E-03 0.23976164 FUNG_IL2_SIGNALING_2 hyperostosis DOID_205 4.029E-03 0.07641596 4.029E-03 0.22924788 FUNG_IL2_SIGNALING_2 bronchitis DOID_6132 4.029E-03 0.07395093 1.000 1.000 FUNG_IL2_SIGNALING_2 male reproductive organ benign neoplasm DOID_0060087 4.266E-03 0.07584608 1.000 1.000 FUNG_IL2_SIGNALING_2 eosinophilia DOID_999 4.266E-03 0.07354771 1.000 1.000 FUNG_IL2_SIGNALING_2 psoriasis DOID_8893 4.502E-03 0.0753424 1.000 1.000 FUNG_IL2_SIGNALING_2 pulmonary edema DOID_11396 4.738E-03 0.07703373 1.000 1.000 FUNG_IL2_SIGNALING_2 Kawasaki disease DOID_13378 4.975E-03 0.0786303 1.000 1.000 FUNG_IL2_SIGNALING_2 lymphadenitis DOID_1602 4.975E-03 0.0786303 1.000 1.000 FUNG_IL2_SIGNALING_2 lymph node disease DOID_9942 4.975E-03 0.0786303 1.000 1.000 FUNG_IL2_SIGNALING_2 funisitis DOID_0050698 5.211E-03 0.08013981 5.211E-03 0.24709775 FUNG_IL2_SIGNALING_2 acquired immunodeficiency syndrome DOID_635 5.211E-03 0.07803087 5.211E-03 0.22809023 FUNG_IL2_SIGNALING_2 sinusitis DOID_0050127 5.447E-03 0.07947761 1.000 1.000 FUNG_IL2_SIGNALING_2 paranasal sinus disease DOID_1352 5.447E-03 0.07947761 1.000 1.000 FUNG_IL2_SIGNALING_2 uremia DOID_4676 5.447E-03 0.07749067 5.447E-03 0.2214019 FUNG_IL2_SIGNALING_2 polyarteritis nodosa DOID_9810 5.447E-03 0.07560065 1.000 1.000 FUNG_IL2_SIGNALING_2 bronchiolitis DOID_2942 6.156E-03 0.08340041 6.156E-03 0.23352115 FUNG_IL2_SIGNALING_2 ankylosing spondylitis DOID_7147 6.392E-03 0.08458505 6.392E-03 0.22732233 FUNG_IL2_SIGNALING_2 vitiligo DOID_12306 6.628E-03 0.0857152 6.628E-03 0.22185112 FUNG_IL2_SIGNALING_2 sarcoma DOID_1115 7.1E-03 0.08977794 7.1E-03 0.22444485 FUNG_IL2_SIGNALING_2 malaria DOID_12365 7.1E-03 0.08782625 1.000 1.000 FUNG_IL2_SIGNALING_2 coronary stenosis DOID_4248 7.1E-03 0.0859576 7.1E-03 0.21263197 FUNG_IL2_SIGNALING_2 bronchiolitis obliterans DOID_2799 7.808E-03 0.09255421 1.000 1.000 FUNG_IL2_SIGNALING_2 chronic leukemia DOID_1036 8.279E-03 0.09613994 8.279E-03 0.23554286 FUNG_IL2_SIGNALING_2 chronic lymphocytic leukemia DOID_1040 8.279E-03 0.09613994 8.279E-03 0.23554286 FUNG_IL2_SIGNALING_2 autonomic nervous system neoplasm DOID_2621 8.279E-03 0.09421714 8.279E-03 0.22432654 FUNG_IL2_SIGNALING_2 neuroblastoma DOID_769 8.279E-03 0.09421714 8.279E-03 0.22432654 FUNG_IL2_SIGNALING_2 myocarditis DOID_820 8.515E-03 0.09499887 8.515E-03 0.22022465 FUNG_IL2_SIGNALING_2 medullomyoblastoma DOID_3861 8.986E-03 0.09832745 8.986E-03 0.22230553 FUNG_IL2_SIGNALING_2 adult medulloblastoma DOID_3864 8.986E-03 0.09832745 8.986E-03 0.22230553 FUNG_IL2_SIGNALING_2 childhood medulloblastoma DOID_3869 8.986E-03 0.09832745 8.986E-03 0.22230553 FUNG_IL2_SIGNALING_2 lymphatic system disease DOID_75 0.010163 0.09970249 1.000 1.000 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 reproductive organ benign neoplasm DOID_0050622 1.564E-08 8.897E-06 2.795E-03 0.22719198 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 female reproductive organ benign neoplasm DOID_0060086 1.016E-07 2.889E-05 8.576E-04 0.12199374 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 uterine benign neoplasm DOID_0060095 1.016E-07 2.889E-05 8.576E-04 0.12199374 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 uterine fibroid DOID_13223 1.016E-07 2.889E-05 8.576E-04 0.12199374 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 leiomyoma DOID_127 1.474E-07 2.797E-05 1.026E-03 0.11677307 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 myeloma DOID_0070004 6.389E-07 9.089E-05 0.0651336 0.52198618 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 bone marrow cancer DOID_4960 1.088E-06 1.239E-04 0.07391382 0.53919184 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 cleft lip DOID_9296 6.557E-06 6.218E-04 0.0357058 0.47247905 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 transitional cell carcinoma DOID_2671 6.814E-06 5.538E-04 0.11422923 0.67704614 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 mouth disease DOID_403 8.806E-06 6.263E-04 3E-04 0.08535512 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 cleft palate DOID_674 2.188E-05 1.383E-03 0.0524487 0.47370334 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 multiple myeloma DOID_9538 2.188E-05 1.245E-03 0.0524487 0.46630172 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 cervix uteri carcinoma in situ DOID_8991 2.921E-05 1.511E-03 0.05754278 0.48868422 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 orofacial cleft DOID_0050567 5.727E-05 2.716E-03 0.07141347 0.52771771 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 hyperparathyroidism DOID_13543 7.929E-05 3.471E-03 0.01337299 0.42273514 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 invasive lobular carcinoma DOID_3457 9.683E-05 3.935E-03 0.01470061 0.36368026 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 pre-malignant neoplasm DOID_0060071 9.886E-05 3.75E-03 0.08508396 0.56293921 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 in situ carcinoma DOID_8719 9.886E-05 3.75E-03 0.08508396 0.56293921 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 tooth disease DOID_1091 1.178E-04 4.19E-03 4.042E-03 0.20906167 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 parathyroid gland disease DOID_11201 1.371E-04 4.588E-03 0.01735059 0.39489939 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 bone development disease DOID_0080006 2.169E-04 6.858E-03 6.034E-03 0.24522189 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 nervous system cancer DOID_3093 2.647E-04 7.927E-03 6.875E-03 0.26078272 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 male reproductive organ benign neoplasm DOID_0060087 2.677E-04 7.617E-03 0.02394501 0.43950673 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 dental caries DOID_216 2.677E-04 7.255E-03 2.677E-04 0.15234859 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 alcohol-related neurodevelopmental disorder DOID_0050667 3E-04 7.76E-03 0.12137212 0.69060739 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 teeth hard tissue disease DOID_214 6.558E-04 0.01622459 6.558E-04 0.12438853 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 multiple epiphyseal dysplasia DOID_12721 8.047E-04 0.01907792 0.04088812 0.47480281 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 papilloma DOID_2615 1.086E-03 0.02470717 1.000 1.000 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 medullomyoblastoma DOID_3861 1.209E-03 0.02646415 0.04989155 0.47313816 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 adult medulloblastoma DOID_3864 1.209E-03 0.02646415 0.04989155 0.47313816 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 childhood medulloblastoma DOID_3869 1.209E-03 0.02646415 0.04989155 0.47313816 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 medulloblastoma DOID_3858 1.339E-03 0.02822672 0.0524487 0.48134372 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 embryonal cancer DOID_688 1.339E-03 0.02721862 1.339E-03 0.12702023 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 primitive neuroectodermal tumor DOID_168 1.768E-03 0.03469234 0.06007974 0.49544021 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 gallbladder cancer DOID_3121 1.845E-03 0.03499635 1.000 1.000 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 brain cancer DOID_1319 2.086E-03 0.03828019 0.0651336 0.51473637 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 central nervous system cancer DOID_3620 2.169E-03 0.03856444 0.0663929 0.51750079 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 osteochondrodysplasia DOID_2256 2.795E-03 0.04819224 0.07516152 0.5345863 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 congenital nervous system abnormality DOID_2490 2.988E-03 0.04999971 0.07765197 0.53882894 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 neuroectodermal tumor DOID_171 3.391E-03 0.05513228 0.08261318 0.56634816 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 carotid artery disease DOID_3407 3.391E-03 0.05360083 3.391E-03 0.24120372 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 congenital heart defect DOID_1682 3.602E-03 0.05539421 3.602E-03 0.22773177 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 temporal lobe epilepsy DOID_3328 3.93E-03 0.05883917 3.93E-03 0.22358885 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 hyperglycemia DOID_4195 3.93E-03 0.05733047 0.0887779 0.57402984 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 allergic contact dermatitis DOID_3042 4.042E-03 0.05749196 0.09000596 0.57543138 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 pancreatitis DOID_4989 5.243E-03 0.07276682 5.243E-03 0.24861996 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 contact dermatitis DOID_2773 5.501E-03 0.07452572 0.10461674 0.64007446 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 focal epilepsy DOID_2234 5.898E-03 0.07804971 5.898E-03 0.25816442 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 biliary tract cancer DOID_4607 5.898E-03 0.07627585 1.000 1.000 BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 Human immunodeficiency virus infectious disease DOID_526 6.875E-03 0.08692757 0.11661649 0.67708965 VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP aortic valve insufficiency DOID_57 2.569E-06 1.462E-03 2.53E-03 0.47979527 VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP aortic valve disease DOID_62 1.073E-05 3.052E-03 5.054E-03 0.35944807 VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP heart valve disease DOID_4079 4.749E-05 9.007E-03 0.01050342 0.2490185 NAKAJIMA_EOSINOPHIL Human immunodeficiency virus infectious disease DOID_526 1.883E-07 1.071E-04 1.187E-03 0.09649267 NAKAJIMA_EOSINOPHIL allergic contact dermatitis DOID_3042 7.829E-06 2.227E-03 6.899E-04 0.19627623 NAKAJIMA_EOSINOPHIL contact dermatitis DOID_2773 1.261E-05 2.392E-03 9.449E-04 0.1344159 NAKAJIMA_EOSINOPHIL visceral leishmaniasis DOID_9146 1.312E-05 1.866E-03 1.000 1.000 NAKAJIMA_EOSINOPHIL peritonitis DOID_8283 1.922E-05 2.188E-03 1.922E-05 0.01093793 NAKAJIMA_EOSINOPHIL hypersensitivity reaction type I disease DOID_1205 2.088E-05 1.981E-03 1.318E-03 0.09375446 NAKAJIMA_EOSINOPHIL leishmaniasis DOID_9065 4.969E-05 4.039E-03 1.000 1.000 NAKAJIMA_EOSINOPHIL hepatitis B DOID_2043 6.706E-05 4.769E-03 0.01211916 0.45971997 NAKAJIMA_EOSINOPHIL acquired immunodeficiency syndrome DOID_635 6.706E-05 4.239E-03 0.01211916 0.43098748 NAKAJIMA_EOSINOPHIL sinusitis DOID_0050127 7.342E-05 4.177E-03 0.01266669 0.42396154 NAKAJIMA_EOSINOPHIL paranasal sinus disease DOID_1352 7.342E-05 4.177E-03 0.01266669 0.42396154 NAKAJIMA_EOSINOPHIL meningitis DOID_9471 8.007E-05 4.142E-03 0.01321393 0.41770713 NAKAJIMA_EOSINOPHIL urticaria DOID_1555 9.422E-05 4.467E-03 0.01430756 0.38766664 NAKAJIMA_EOSINOPHIL systemic scleroderma DOID_418 2.483E-04 0.01086674 0.02301508 0.42243801 NAKAJIMA_EOSINOPHIL rheumatic disease DOID_1575 2.98E-04 0.01211356 0.02518048 0.42140276 NAKAJIMA_EOSINOPHIL scleroderma DOID_419 2.98E-04 0.01211356 0.02518048 0.42140276 NAKAJIMA_EOSINOPHIL vascular skin disease DOID_9540 3.523E-04 0.01336363 0.02734132 0.37040973 NAKAJIMA_EOSINOPHIL parasitic protozoa infectious disease DOID_2789 4.741E-04 0.01686059 1.000 1.000 NAKAJIMA_EOSINOPHIL collagen disease DOID_854 5.771E-04 0.01931487 0.03486837 0.38154041 NAKAJIMA_EOSINOPHIL parasitic infectious disease DOID_1398 6.512E-04 0.02058504 1.000 1.000 NAKAJIMA_EOSINOPHIL peripheral vascular disease DOID_341 7.914E-04 0.02370093 0.04074353 0.40672048 NAKAJIMA_EOSINOPHIL cystic fibrosis DOID_1485 8.556E-04 0.02434146 1.000 1.000 NAKAJIMA_EOSINOPHIL endogenous depression DOID_1595 8.556E-04 0.02318234 8.556E-04 0.16227641 NAKAJIMA_EOSINOPHIL mental depression DOID_1596 1.015E-03 0.02624537 1.015E-03 0.11547962 NAKAJIMA_EOSINOPHIL chronic kidney failure DOID_784 1.015E-03 0.02510427 1.015E-03 0.09623302 NAKAJIMA_EOSINOPHIL encephalomyelitis DOID_640 1.265E-03 0.02998947 0.05133848 0.44940915 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 lymphoblastic leukemia DOID_1037 5.438E-06 3.094E-03 5.438E-06 3.094E-03 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 hyperparathyroidism DOID_13543 5.689E-06 1.619E-03 3.687E-03 0.69933245 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 parathyroid gland disease DOID_11201 9.855E-06 1.869E-03 4.791E-03 0.30288827 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 papilloma DOID_2615 7.921E-05 0.01126754 0.0132148 0.37596107 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 bone marrow cancer DOID_4960 1.998E-04 0.02273459 0.02084836 0.35947625 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 neuroectodermal tumor DOID_171 2.52E-04 0.02389583 2.52E-04 0.0716875 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 transitional cell carcinoma DOID_2671 4.978E-04 0.04046741 0.03273324 0.43314456 MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 nervous system cancer DOID_3093 5.201E-04 0.03699363 0.03344922 0.4325592 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP oral cavity cancer DOID_8618 2.024E-08 1.152E-05 1.432E-06 2.716E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP adenoid cystic carcinoma DOID_4866 3.448E-07 9.809E-05 2.725E-05 3.876E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP salivary gland cancer DOID_8850 4.154E-07 7.879E-05 3.127E-05 3.559E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP epidermolysis bullosa DOID_2730 5.002E-07 7.116E-05 5.002E-07 2.846E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP vesiculobullous skin disease DOID_2731 6.497E-07 7.394E-05 6.497E-07 1.848E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP endometrial carcinoma DOID_2871 1.107E-05 1.049E-03 0.04217942 0.58536808 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP endometrial cancer DOID_1380 1.333E-05 1.083E-03 0.04475692 0.60634977 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP benign mesothelioma DOID_2645 2.921E-05 2.078E-03 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP uterine cancer DOID_363 3.567E-05 2.255E-03 0.06134571 0.67126368 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP aortic aneurysm DOID_3627 5.123E-05 2.915E-03 5.123E-05 4.859E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP vasculitis DOID_865 6.375E-05 3.298E-03 0.07391382 0.70094939 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP pre-malignant neoplasm DOID_0060071 9.886E-05 4.687E-03 3.602E-03 0.12809912 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP in situ carcinoma DOID_8719 9.886E-05 4.687E-03 3.602E-03 0.12809912 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP aneurysm disease DOID_2403 1.687E-04 7.386E-03 1.687E-04 0.01371641 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP thoracic aortic aneurysm DOID_14004 1.842E-04 7.487E-03 1.842E-04 0.01310292 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP female reproductive system disease DOID_229 1.953E-04 7.409E-03 0.10582387 0.79228661 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP basal cell carcinoma DOID_2513 2.382E-04 8.471E-03 2.382E-04 0.01505973 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP skin carcinoma DOID_3451 2.677E-04 8.962E-03 2.677E-04 0.01523486 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP dilated cardiomyopathy DOID_12930 3.093E-04 9.777E-03 0.1225571 0.84018063 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP sinusitis DOID_0050127 4.408E-04 0.01320216 4.408E-04 0.02280373 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP paranasal sinus disease DOID_1352 4.408E-04 0.01320216 4.408E-04 0.02280373 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP myositis DOID_633 6.095E-04 0.01734046 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP female reproductive organ benign neoplasm DOID_0060086 8.576E-04 0.0232369 0.04217942 0.60000228 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP uterine benign neoplasm DOID_0060095 8.576E-04 0.0232369 0.04217942 0.60000228 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP uterine fibroid DOID_13223 8.576E-04 0.0232369 0.04217942 0.60000228 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP leiomyoma DOID_127 1.026E-03 0.02653933 0.04604312 0.60926833 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP spindle cell carcinoma DOID_4015 1.147E-03 0.02836583 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP lymphoid leukemia DOID_10747 1.209E-03 0.02866949 1.209E-03 0.05733899 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP blood platelet disease DOID_2218 1.407E-03 0.03202066 0.05372475 0.66455174 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP adult respiratory distress syndrome DOID_11394 1.547E-03 0.03384735 1.547E-03 0.06769469 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP cervix uteri carcinoma in situ DOID_8991 1.619E-03 0.03411651 0.05754278 0.65483686 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP endometriosis of uterus DOID_288 1.693E-03 0.03439865 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP endometriosis DOID_289 1.768E-03 0.03469234 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP glaucoma DOID_1686 2.254E-03 0.04274412 0.06765053 0.72628586 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP lung small cell carcinoma DOID_5409 2.254E-03 0.04136528 0.06765053 0.71283612 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP hemorrhagic disease DOID_2213 2.428E-03 0.04317162 0.07016081 0.70037723 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP bile duct adenocarcinoma DOID_4896 2.701E-03 0.04657037 0.07391382 0.71282988 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP cholangiocarcinoma DOID_4947 2.701E-03 0.04657037 0.07391382 0.71282988 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP reproductive organ benign neoplasm DOID_0050622 2.795E-03 0.04677482 0.07516152 0.70109678 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP integumentary system cancer DOID_0060122 2.795E-03 0.0454384 2.795E-03 0.11359599 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP skin cancer DOID_4159 2.795E-03 0.0454384 2.795E-03 0.11359599 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP hypertrophic cardiomyopathy DOID_11984 3.086E-03 0.04878084 0.07889474 0.71255721 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP bile duct cancer DOID_4606 3.086E-03 0.04746244 0.07889474 0.7014235 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP bile duct carcinoma DOID_4897 3.086E-03 0.04746244 0.07889474 0.7014235 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP respiratory failure DOID_11162 3.496E-03 0.05234689 3.496E-03 0.13261212 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP uterine disease DOID_345 3.819E-03 0.05571645 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP blood coagulation disease DOID_1247 4.387E-03 0.06240208 0.09368042 0.77252406 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP bile duct disease DOID_4138 4.505E-03 0.06251761 0.09490201 0.77141773 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP biliary tract disease DOID_9741 4.624E-03 0.06264744 0.09612198 0.77032964 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP diabetic retinopathy DOID_8947 4.745E-03 0.06279052 0.09734033 0.76925902 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP mixed glioma DOID_5076 5.243E-03 0.06780544 0.10219768 0.78581733 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP biliary tract cancer DOID_4607 5.898E-03 0.07458083 0.10823335 0.79980227 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP retinal vascular disease DOID_2462 6.17E-03 0.07632348 0.11063646 0.80707878 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP nervous system cancer DOID_3093 6.875E-03 0.08322853 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP Human immunodeficiency virus infectious disease DOID_526 6.875E-03 0.0814946 0.11661649 0.83993399 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP lymphoblastic leukemia DOID_1037 7.314E-03 0.08493412 7.314E-03 0.2448101 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP alcohol-related neurodevelopmental disorder DOID_0050667 7.463E-03 0.08493376 0.12137212 0.86325923 CHASSOT_SKIN_WOUND tongue cancer DOID_8649 4.669E-06 2.657E-03 3.372E-03 0.63949085 CHASSOT_SKIN_WOUND osteosarcoma DOID_3347 1.263E-05 3.594E-03 1.000 1.000 CHASSOT_SKIN_WOUND middle cerebral artery infarction DOID_3525 1.469E-05 2.786E-03 5.894E-03 0.67072206 CHASSOT_SKIN_WOUND intracranial arterial disease DOID_13089 3.503E-05 4.983E-03 9.039E-03 0.51430628 CHASSOT_SKIN_WOUND cerebral arterial disease DOID_3527 3.503E-05 4.983E-03 9.039E-03 0.51430628 CHASSOT_SKIN_WOUND cerebral infarction DOID_3526 4.374E-05 4.978E-03 0.01008514 0.52167683 CHASSOT_SKIN_WOUND oral cavity cancer DOID_8618 7.086E-05 6.72E-03 0.01280117 0.56029736 CHASSOT_SKIN_WOUND brain infarction DOID_3454 9.612E-05 7.814E-03 0.01488598 0.60500891 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN allergic contact dermatitis DOID_3042 1.859E-24 1.058E-21 1.212E-20 6.897E-18 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN contact dermatitis DOID_2773 3.01E-23 8.564E-21 1.327E-19 3.774E-17 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN parasitic infectious disease DOID_1398 3.734E-17 7.083E-15 2.216E-15 4.203E-13 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN parasitic protozoa infectious disease DOID_2789 3.4E-16 4.837E-14 2.181E-14 3.102E-12 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN primary immunodeficiency disease DOID_612 2.413E-12 2.747E-10 2.413E-12 2.747E-10 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN systemic scleroderma DOID_418 3.984E-12 3.778E-10 2.495E-10 1.775E-08 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN rheumatic disease DOID_1575 8.694E-12 7.067E-10 4.888E-10 3.09E-08 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN scleroderma DOID_419 8.694E-12 7.067E-10 4.888E-10 3.09E-08 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN malaria DOID_12365 1.956E-11 1.392E-09 1.956E-11 1.855E-09 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bacterial pneumonia DOID_874 2.509E-11 1.586E-09 6.716E-07 2.011E-05 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN encephalomyelitis DOID_640 1.211E-10 6.89E-09 3.46E-09 1.969E-07 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN collagen disease DOID_854 1.392E-10 7.2E-09 5.357E-09 2.54E-07 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hypersensitivity reaction type I disease DOID_1205 1.463E-10 6.939E-09 1.463E-10 1.189E-08 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pancreatitis DOID_4989 8.658E-10 3.79E-08 6.716E-07 2.123E-05 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hemolytic anemia DOID_583 1.041E-09 4.229E-08 4.409E-08 1.93E-06 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN normocytic anemia DOID_720 1.041E-09 4.229E-08 4.409E-08 1.93E-06 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN vasculitis DOID_865 2.331E-09 8.843E-08 8.718E-08 3.307E-06 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bronchiolitis obliterans DOID_2799 2.869E-09 1.02E-07 2.749E-04 3.328E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN systemic mycosis DOID_0050136 4.998E-09 1.673E-07 4.998E-09 2.586E-07 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN fungal infectious disease DOID_1564 4.998E-09 1.673E-07 4.998E-09 2.586E-07 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN brain infarction DOID_3454 1.122E-08 3.545E-07 3.293E-07 1.102E-05 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN influenza DOID_8469 2.662E-08 7.971E-07 7.855E-04 7.327E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pre-eclampsia DOID_10591 3.902E-08 1.11E-06 9.416E-04 8.504E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN temporal arteritis DOID_13375 6.635E-08 1.798E-06 8.841E-06 1.797E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN central nervous system vasculitis DOID_525 6.635E-08 1.798E-06 8.841E-06 1.797E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN Human immunodeficiency virus infectious disease DOID_526 6.91E-08 1.787E-06 6.91E-08 2.808E-06 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN opportunistic mycosis DOID_2473 1.663E-07 4.113E-06 1.663E-07 5.912E-06 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN uveitis DOID_13141 5.122E-07 1.214E-05 1.862E-05 3.532E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN leishmaniasis DOID_9065 7.609E-07 1.732E-05 7.609E-07 2.165E-05 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN uveal disease DOID_3480 9.226E-07 2.019E-05 2.957E-05 5.257E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN cerebral infarction DOID_3526 1.145E-06 2.414E-05 3.505E-05 6.043E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN leukodystrophy DOID_10579 1.272E-06 2.584E-05 1.272E-06 3.446E-05 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN funisitis DOID_0050698 1.423E-06 2.793E-05 8.001E-05 1.198E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.717E-06 3.257E-05 4.819E-05 8.064E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN integumentary system benign neoplasm DOID_0060121 1.717E-06 3.152E-05 4.819E-05 7.834E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pulmonary tuberculosis DOID_2957 1.717E-06 3.054E-05 0.01700115 0.07994756 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN skin benign neoplasm DOID_3165 1.717E-06 3.152E-05 4.819E-05 7.834E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN congenital hemolytic anemia DOID_589 2.055E-06 3.544E-05 2.055E-06 5.316E-05 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN Goodpasture syndrome DOID_9808 2.055E-06 3.44E-05 3.794E-03 0.02372513 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN acute pancreatitis DOID_2913 2.44E-06 3.966E-05 1.185E-04 1.644E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN sarcoidosis DOID_11335 2.493E-06 3.941E-05 1.31E-03 0.01095795 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN ulcerative colitis DOID_8577 2.502E-06 3.848E-05 6.056E-04 6.265E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bronchiolitis DOID_2942 2.874E-06 4.304E-05 4.446E-03 0.02749565 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN combined T cell and B cell immunodeficiency DOID_628 2.874E-06 4.194E-05 2.874E-06 7.111E-05 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hypersensitivity reaction type IV disease DOID_2916 3.824E-06 5.439E-05 1.677E-03 0.0130693 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN phagocyte bactericidal dysfunction DOID_3262 6.448E-06 8.949E-05 6.448E-06 1.529E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN cerebral degeneration DOID_1443 6.557E-06 8.884E-05 6.557E-06 1.492E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN endocrine organ benign neoplasm DOID_0060089 8.115E-06 1.074E-04 8.115E-06 1.776E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN tuberculosis DOID_399 8.115E-06 1.049E-04 0.03039857 0.13203654 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN celiac disease DOID_10608 8.707E-06 1.101E-04 8.707E-06 1.835E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN blood coagulation disease DOID_1247 9.305E-06 1.151E-04 9.305E-06 1.826E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN nephrosis DOID_2527 9.949E-06 1.204E-04 1.919E-04 2.539E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN myocarditis DOID_820 1.099E-05 1.303E-04 3.567E-04 4.228E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN diarrhea DOID_13250 1.176E-05 1.365E-04 9.35E-04 8.581E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pneumoconiosis DOID_10316 1.229E-05 1.399E-04 3.871E-04 4.495E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pulmonary sarcoidosis DOID_13406 1.686E-05 1.881E-04 0.0103034 0.05428368 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN aspergillosis DOID_13564 1.934E-05 2.116E-04 1.934E-05 3.55E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN respiratory syncytial virus infectious disease DOID_1273 2.052E-05 2.203E-04 0.0113169 0.05853923 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN intracranial arterial disease DOID_13089 2.256E-05 2.377E-04 6.046E-04 6.491E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN cerebral arterial disease DOID_3527 2.256E-05 2.377E-04 6.046E-04 6.491E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN primary bacterial infectious disease DOID_0050338 2.448E-05 2.533E-04 0.04582978 0.15709123 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN endometriosis of uterus DOID_288 2.708E-05 2.751E-04 0.01291574 0.06446538 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN endometriosis DOID_289 2.957E-05 2.951E-04 0.01346929 0.06664373 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN neuritis DOID_1803 4.123E-05 4.045E-04 9.416E-04 8.371E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN MHC class II deficiency DOID_5812 5.077E-05 4.896E-04 5.077E-05 8.024E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hemorrhagic disease DOID_2213 5.596E-05 5.306E-04 5.596E-05 8.605E-04 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN atopic dermatitis DOID_3310 6.017E-05 5.612E-04 1.243E-03 0.01087987 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN giant cell tumor DOID_200 6.46E-05 5.929E-04 1.31E-03 0.01079914 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN malignant giant cell tumor DOID_2705 6.46E-05 5.929E-04 1.31E-03 0.01079914 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN giant cell glioblastoma DOID_3074 6.46E-05 5.929E-04 1.31E-03 0.01079914 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN integumentary system cancer DOID_0060122 7.418E-05 6.7E-04 1.45E-03 0.01178325 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN skin cancer DOID_4159 7.418E-05 6.7E-04 1.45E-03 0.01178325 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN glioblastoma DOID_3068 9.044E-05 8.041E-04 1.677E-03 0.01289268 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pulmonary embolism DOID_9477 9.175E-05 8.032E-04 3.487E-03 0.02229247 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN Lewy body dementia DOID_12217 1.046E-04 9.015E-04 1.046E-04 1.526E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN carotid artery disease DOID_3407 1.091E-04 9.269E-04 1.925E-03 0.01441159 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN sphingolipidosis DOID_1927 1.185E-04 9.915E-04 1.185E-04 1.686E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN severe combined immunodeficiency DOID_627 1.185E-04 9.772E-04 1.185E-04 1.605E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN uterine disease DOID_345 1.382E-04 1.124E-03 0.02807338 0.12287504 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hyperglycemia DOID_4195 1.463E-04 1.173E-03 0.23252658 0.48822001 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN myositis DOID_633 1.499E-04 1.184E-03 4.789E-03 0.02899093 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN intracranial aneurysm DOID_10941 1.674E-04 1.305E-03 5.145E-03 0.03081524 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN middle cerebral artery infarction DOID_3525 1.674E-04 1.287E-03 5.145E-03 0.03017988 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN astrocytoma DOID_3069 1.726E-04 1.309E-03 2.695E-03 0.01825393 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN male reproductive system disease DOID_48 1.919E-04 1.437E-03 0.03279745 0.14031392 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN toxic encephalopathy DOID_3602 2.277E-04 1.683E-03 2.277E-04 2.945E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN cystic fibrosis DOID_1485 2.351E-04 1.715E-03 0.03610721 0.15106621 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN syndrome DOID_225 2.351E-04 1.693E-03 2.351E-04 2.972E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN aneurysm disease DOID_2403 2.469E-04 1.756E-03 3.504E-03 0.02215489 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN corneal disease DOID_10124 2.506E-04 1.76E-03 2.506E-04 3.099E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN female reproductive system disease DOID_229 2.984E-04 2.071E-03 0.04041681 0.15538626 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN chronic kidney failure DOID_784 3.268E-04 2.241E-03 0.0421925 0.15389445 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN retinal vascular disease DOID_2462 3.572E-04 2.42E-03 0.043997 0.15945411 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN lymphoma DOID_0060058 4.794E-04 3.209E-03 4.794E-04 5.455E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN mouth disease DOID_403 5.191E-04 3.435E-03 0.05245955 0.16769372 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN blood platelet disease DOID_2218 5.251E-04 3.435E-03 5.251E-04 5.859E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN dilated cardiomyopathy DOID_12930 5.398E-04 3.491E-03 5.398E-04 5.907E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hepatitis DOID_2237 5.64E-04 3.606E-03 0.0113169 0.05801185 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN lymphatic system disease DOID_75 6.046E-04 3.822E-03 6.046E-04 6.37E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN ventricular septal defect DOID_1657 6.407E-04 4.006E-03 6.407E-04 6.51E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN adrenal gland hyperfunction DOID_3947 6.407E-04 3.963E-03 6.407E-04 6.396E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN conjunctival disease DOID_4251 6.407E-04 3.92E-03 0.03760024 0.15066575 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN conjunctivitis DOID_6195 6.407E-04 3.92E-03 0.03760024 0.15066575 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN visceral leishmaniasis DOID_9146 6.407E-04 3.879E-03 6.407E-04 6.286E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pulmonary emphysema DOID_9675 6.47E-04 3.875E-03 0.01237243 0.06285634 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN autoimmune disease of urogenital tract DOID_0060049 6.913E-04 4.097E-03 0.01291574 0.06503587 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN primary biliary cirrhosis DOID_12236 6.913E-04 4.097E-03 0.01291574 0.06503587 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN trypanosomiasis DOID_10113 7.812E-04 4.582E-03 0.04128215 0.15659694 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN sickle cell anemia DOID_10923 7.812E-04 4.536E-03 7.812E-04 7.534E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN common variable immunodeficiency DOID_12177 7.812E-04 4.49E-03 7.812E-04 7.408E-03 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bronchiectasis DOID_9563 7.812E-04 4.445E-03 0.04128215 0.15352641 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN diabetic autonomic neuropathy DOID_11503 7.855E-04 4.425E-03 0.16491132 0.37684554 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN autonomic neuropathy DOID_11504 7.855E-04 4.425E-03 0.16491132 0.37684554 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN diabetic polyneuropathy DOID_12785 7.855E-04 4.425E-03 0.16491132 0.37684554 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN diabetic neuropathy DOID_9743 7.855E-04 4.425E-03 0.16491132 0.37684554 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN proteinuria DOID_576 8.876E-04 4.951E-03 0.01519062 0.07451261 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN encephalitis DOID_9588 9.35E-04 5.165E-03 0.04495006 0.15500962 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN autonomic nervous system disease DOID_11465 9.416E-04 5.152E-03 0.17446878 0.39083754 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN glaucoma DOID_1686 1.056E-03 5.721E-03 0.01700115 0.08061379 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN polyneuropathy DOID_1389 1.102E-03 5.917E-03 0.04860405 0.16364321 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN viral pneumonia DOID_10533 1.283E-03 6.822E-03 1.283E-03 0.01105911 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN eyelid disease DOID_530 1.283E-03 6.758E-03 0.05224414 0.17183189 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN polycystic kidney disease DOID_898 1.283E-03 6.696E-03 1.283E-03 0.01089405 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bacterial meningitis DOID_9470 1.283E-03 6.635E-03 0.05224414 0.16890294 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pustulosis of palm and sole DOID_4398 1.45E-03 7.431E-03 1.45E-03 0.01161729 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN adrenal cortex disease DOID_3952 1.476E-03 7.501E-03 1.476E-03 0.01166782 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hypertrophic cardiomyopathy DOID_11984 1.677E-03 8.443E-03 0.02294583 0.10444944 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN silicosis DOID_10325 1.683E-03 8.401E-03 0.0594829 0.18394439 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hemolytic-uremic syndrome DOID_12554 1.683E-03 8.328E-03 0.0594829 0.18196649 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN adrenal gland disease DOID_9553 1.903E-03 9.333E-03 1.903E-03 0.01443552 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN congenital heart defect DOID_1682 2.102E-03 0.01022461 2.102E-03 0.0155361 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN glucose intolerance DOID_10603 2.135E-03 0.01029617 0.06666674 0.19860405 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN inherited blood coagulation disease DOID_2214 2.135E-03 0.01020964 2.135E-03 0.01557625 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN ureteral obstruction DOID_5199 2.135E-03 0.01012456 0.06666674 0.19654598 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN prion disease DOID_649 2.135E-03 0.01004089 2.135E-03 0.01537908 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN heart septal defect DOID_1681 2.38E-03 0.01110233 2.38E-03 0.01693105 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN agammaglobulinemia DOID_2583 2.38E-03 0.01101206 2.38E-03 0.01672202 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN blood protein disease DOID_620 2.638E-03 0.01210658 2.638E-03 0.01830752 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN amyloidosis DOID_9120 2.638E-03 0.01200973 2.638E-03 0.01808695 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pancreatic ductal carcinoma DOID_3587 2.802E-03 0.01265559 0.03198976 0.13789525 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bile duct disease DOID_4138 2.913E-03 0.01305015 2.913E-03 0.01949846 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN biliary tract disease DOID_9741 3.026E-03 0.01345027 3.026E-03 0.02001901 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pancreatic carcinoma DOID_4905 3.141E-03 0.01385592 0.03443668 0.14514423 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN diabetic retinopathy DOID_8947 3.141E-03 0.01374934 0.25287826 0.52706128 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN familial hypercholesterolemia DOID_13810 3.192E-03 0.01386294 0.08087135 0.23123516 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN thrombophilia DOID_2452 3.192E-03 0.01375792 3.192E-03 0.02087408 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN acquired immunodeficiency syndrome DOID_635 3.192E-03 0.01365448 3.192E-03 0.02063688 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN sinusitis DOID_0050127 3.487E-03 0.01480619 0.08438882 0.23889174 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN paranasal sinus disease DOID_1352 3.487E-03 0.01480619 0.08438882 0.23889174 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN urinary tract obstruction DOID_5200 3.487E-03 0.01469652 0.08438882 0.23537863 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bone resorption disease DOID_0080011 3.504E-03 0.01466132 0.03695404 0.15348066 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN osteoporosis DOID_11476 3.504E-03 0.01466132 0.03695404 0.15348066 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN ureteral disease DOID_1426 3.794E-03 0.01575903 0.08789293 0.23928745 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN meningitis DOID_9471 3.794E-03 0.01564483 0.08789293 0.23814799 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN osteosarcoma DOID_3347 4.446E-03 0.01819856 4.446E-03 0.0272 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN B cell deficiency DOID_2115 5.145E-03 0.02091034 5.145E-03 0.03049425 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN extrinsic allergic alveolitis DOID_841 5.145E-03 0.02076204 0.10177668 0.2632315 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN diffuse large B-cell lymphoma DOID_0050745 5.512E-03 0.02208768 5.512E-03 0.03200459 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN periodontitis DOID_824 5.512E-03 0.02193322 0.1052147 0.27089213 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN perinatal necrotizing enterocolitis DOID_8677 5.512E-03 0.0217809 5.512E-03 0.03168131 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN lymphoblastic leukemia DOID_1037 5.868E-03 0.02302494 5.868E-03 0.03338616 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pleurisy DOID_10247 5.891E-03 0.02295958 1.000 1.000 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN renal hypertension DOID_1073 5.891E-03 0.0228034 0.10863964 0.2772016 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN secondary hypertension DOID_11130 5.891E-03 0.0228034 0.10863964 0.2772016 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN thrombocytopenia DOID_1588 5.891E-03 0.02264932 5.891E-03 0.0331891 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN autoimmune disease of the nervous system DOID_438 5.891E-03 0.02249731 5.891E-03 0.03286372 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN renal tubular transport disease DOID_447 5.891E-03 0.02234733 5.891E-03 0.03254465 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN Crohn's disease DOID_8778 6.04E-03 0.02276017 6.04E-03 0.03304601 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN spastic cerebral palsy DOID_0050669 7.097E-03 0.02656842 7.097E-03 0.03846095 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN abdominal aortic aneurysm DOID_7693 7.097E-03 0.02639477 0.11883657 0.29527513 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN allergic rhinitis DOID_4481 7.522E-03 0.02779292 0.12220973 0.30233624 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN pleural disease DOID_1532 7.958E-03 0.02921421 1.000 1.000 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN hair disease DOID_421 8.405E-03 0.03065788 0.12891763 0.3134792 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN periodontal disease DOID_3388 8.864E-03 0.03212316 0.13225247 0.32021981 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN macular degeneration DOID_4448 8.864E-03 0.03191985 8.864E-03 0.04757865 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN lymphoid leukemia DOID_10747 9.333E-03 0.03339795 9.333E-03 0.04962873 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN calcinosis DOID_182 0.0103034 0.03664148 0.1421811 0.33568898 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN multiple myeloma DOID_9538 0.0103034 0.0364139 0.0103034 0.05378566 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN peptic ulcer DOID_750 0.0113169 0.03974886 1.000 1.000 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN adult respiratory distress syndrome DOID_11394 0.01183945 0.04132913 1.000 1.000 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN nephrotic syndrome DOID_1184 0.01346929 0.04673188 0.16170114 0.37401605 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN myeloma DOID_0070004 0.01578433 0.05443202 0.01578433 0.0767631 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN thyroid adenoma DOID_2891 0.01578433 0.05410412 0.01578433 0.07611257 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bone marrow disease DOID_4961 0.01578433 0.05378014 0.01578433 0.07547297 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN calcium metabolism disease DOID_10575 0.0176241 0.05969114 0.1839176 0.40561673 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN aortic aneurysm DOID_3627 0.0176241 0.05933794 0.1839176 0.40405064 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN movement disease DOID_480 0.0176241 0.05898889 0.0176241 0.08219764 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN B-cell lymphocytic neoplasm DOID_707 0.01825663 0.06074866 0.01825663 0.08445545 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bile duct adenocarcinoma DOID_4896 0.02021089 0.06686044 0.19634916 0.42805622 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN cholangiocarcinoma DOID_4947 0.02021089 0.06686044 0.19634916 0.42805622 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bone marrow cancer DOID_4960 0.02021089 0.06647397 0.02021089 0.09274191 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN familial hyperlipidemia DOID_1168 0.02156016 0.0705042 0.20249423 0.43809588 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bile duct cancer DOID_4606 0.02294583 0.07460674 0.20859263 0.4478838 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN bile duct carcinoma DOID_4897 0.02294583 0.07460674 0.20859263 0.4478838 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN oral cavity cancer DOID_8618 0.02294583 0.07418284 0.02294583 0.10362047 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN leukocyte disease DOID_9500 0.02365213 0.07603424 0.02365213 0.10596897 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN respiratory failure DOID_11162 0.02582389 0.0825494 1.000 1.000 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN mineral metabolism disease DOID_0050032 0.02731504 0.08682826 0.22661135 0.47756244 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN endocrine pancreas disease DOID_1428 0.02731504 0.08634588 0.02731504 0.1214239 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN cholestasis DOID_13580 0.02807338 0.08825279 0.02807338 0.12382756 JAATINEN_HEMATOPOIETIC_STEM_CELL_DN tooth disease DOID_1091 0.02961522 0.09258825 0.23546732 0.49257687 YAGI_AML_FAB_MARKERS inherited blood coagulation disease DOID_2214 2.379E-07 1.354E-04 2.379E-07 1.354E-04 YAGI_AML_FAB_MARKERS blood coagulation disease DOID_1247 2.998E-06 8.529E-04 2.998E-06 8.529E-04 YAGI_AML_FAB_MARKERS blood platelet disease DOID_2218 7.46E-06 1.415E-03 7.46E-06 1.415E-03 YAGI_AML_FAB_MARKERS intracranial thrombosis DOID_4193 7.606E-06 1.082E-03 7.606E-06 1.082E-03 YAGI_AML_FAB_MARKERS hemorrhagic disease DOID_2213 2.26E-05 2.572E-03 2.26E-05 2.572E-03 YAGI_AML_FAB_MARKERS spastic quadriplegia DOID_10970 5.956E-05 5.649E-03 5.956E-05 5.649E-03 YAGI_AML_FAB_MARKERS tooth disease DOID_1091 6.312E-05 5.131E-03 1.284E-03 0.0456502 YAGI_AML_FAB_MARKERS seminoma DOID_4440 8.428E-05 5.994E-03 3.275E-03 0.07166676 YAGI_AML_FAB_MARKERS thrombocytopenia DOID_1588 1.04E-04 6.574E-03 1.04E-04 8.453E-03 YAGI_AML_FAB_MARKERS focal glomerulosclerosis DOID_3945 1.149E-04 6.536E-03 4.005E-03 0.07857398 YAGI_AML_FAB_MARKERS spastic cerebral palsy DOID_0050669 1.388E-04 7.181E-03 1.388E-04 9.873E-03 YAGI_AML_FAB_MARKERS germinoma DOID_3304 1.519E-04 7.203E-03 4.803E-03 0.08815587 YAGI_AML_FAB_MARKERS transitional cell carcinoma DOID_2671 1.679E-04 7.348E-03 1.679E-04 0.01061433 YAGI_AML_FAB_MARKERS mouth disease DOID_403 2.152E-04 8.748E-03 3.165E-03 0.07502903 YAGI_AML_FAB_MARKERS pre-eclampsia DOID_10591 4.803E-04 0.01822007 0.01016197 0.15627469 YAGI_AML_FAB_MARKERS neuritis DOID_1803 4.803E-04 0.01708131 0.01016197 0.1521622 YAGI_AML_FAB_MARKERS glaucoma DOID_1686 5.392E-04 0.01804735 0.01095664 0.14843632 YAGI_AML_FAB_MARKERS retinal detachment DOID_5327 5.902E-04 0.01865681 1.000 1.000 YAGI_AML_FAB_MARKERS vasculitis DOID_865 7.061E-04 0.0211449 7.061E-04 0.04017531 YAGI_AML_FAB_MARKERS reproductive organ benign neoplasm DOID_0050622 7.429E-04 0.02113673 0.01349853 0.17456052 YAGI_AML_FAB_MARKERS osteochondrodysplasia DOID_2256 7.429E-04 0.02013022 7.429E-04 0.03843042 YAGI_AML_FAB_MARKERS pustulosis of palm and sole DOID_4398 7.429E-04 0.01921521 0.01349853 0.17068139 YAGI_AML_FAB_MARKERS open-angle glaucoma DOID_1067 8.105E-04 0.02005191 8.105E-04 0.03843284 YAGI_AML_FAB_MARKERS hypertrophic cardiomyopathy DOID_11984 8.609E-04 0.02040937 8.609E-04 0.03767883 YAGI_AML_FAB_MARKERS spastic diplegia DOID_10965 1.065E-03 0.02423041 1.065E-03 0.04326858 YAGI_AML_FAB_MARKERS cerebral degeneration DOID_1443 1.18E-03 0.0258328 0.01824106 0.21181967 YAGI_AML_FAB_MARKERS familial hypertrophic cardiomyopathy DOID_11986 1.204E-03 0.0253766 1.204E-03 0.04567789 YAGI_AML_FAB_MARKERS dental caries DOID_216 1.352E-03 0.02747457 1.352E-03 0.04525223 YAGI_AML_FAB_MARKERS testicular cancer DOID_2998 1.508E-03 0.02958931 0.05610119 0.33251641 YAGI_AML_FAB_MARKERS brain edema DOID_4724 1.672E-03 0.0317182 1.672E-03 0.05286367 YAGI_AML_FAB_MARKERS hepatitis B DOID_2043 2.025E-03 0.03717116 2.025E-03 0.06064768 YAGI_AML_FAB_MARKERS bone development disease DOID_0080006 2.317E-03 0.04119916 2.317E-03 0.06591866 YAGI_AML_FAB_MARKERS Lewy body dementia DOID_12217 2.41E-03 0.04155577 0.07033864 0.36718063 YAGI_AML_FAB_MARKERS amino acid metabolic disorder DOID_9252 2.72E-03 0.04552743 2.72E-03 0.07371108 YAGI_AML_FAB_MARKERS nervous system cancer DOID_3093 2.806E-03 0.0456173 0.24409178 0.65205738 YAGI_AML_FAB_MARKERS Human immunodeficiency virus infectious disease DOID_526 2.806E-03 0.04435015 2.806E-03 0.07257297 YAGI_AML_FAB_MARKERS papillary adenoma DOID_3172 3.047E-03 0.04685583 3.047E-03 0.07537677 YAGI_AML_FAB_MARKERS microcystic adenoma DOID_5403 3.047E-03 0.04685583 3.047E-03 0.07537677 YAGI_AML_FAB_MARKERS follicular adenoma DOID_6204 3.047E-03 0.04685583 3.047E-03 0.07537677 YAGI_AML_FAB_MARKERS encephalomyelitis DOID_640 3.072E-03 0.04600664 0.03391751 0.27570094 YAGI_AML_FAB_MARKERS alcohol-related neurodevelopmental disorder DOID_0050667 3.165E-03 0.04617171 0.03457183 0.27706157 YAGI_AML_FAB_MARKERS hypersensitivity reaction type I disease DOID_1205 3.259E-03 0.04635246 0.03523106 0.27842322 YAGI_AML_FAB_MARKERS teeth hard tissue disease DOID_214 3.275E-03 0.04544721 3.275E-03 0.07453343 YAGI_AML_FAB_MARKERS dystonia DOID_543 3.275E-03 0.04436514 3.275E-03 0.06901244 YAGI_AML_FAB_MARKERS Sciatic Neuropathy DOID_11446 3.51E-03 0.04645133 0.08436319 0.39026548 YAGI_AML_FAB_MARKERS lesion of sciatic nerve DOID_12528 3.51E-03 0.04645133 0.08436319 0.39026548 YAGI_AML_FAB_MARKERS lung adenocarcinoma DOID_3910 3.51E-03 0.04539562 3.51E-03 0.07133598 YAGI_AML_FAB_MARKERS periodontitis DOID_824 3.51E-03 0.04438683 0.08436319 0.38711818 YAGI_AML_FAB_MARKERS mononeuritis of lower limb DOID_9473 3.51E-03 0.04645133 0.08436319 0.39026548 YAGI_AML_FAB_MARKERS malaria DOID_12365 3.754E-03 0.04643159 0.08714283 0.38437417 YAGI_AML_FAB_MARKERS mononeuritis DOID_1802 3.754E-03 0.04544368 0.08714283 0.38141744 YAGI_AML_FAB_MARKERS mononeuropathy DOID_1188 4.005E-03 0.04747178 0.0899141 0.37897127 YAGI_AML_FAB_MARKERS female reproductive organ benign neoplasm DOID_0060086 4.263E-03 0.04950525 0.09267703 0.37666593 YAGI_AML_FAB_MARKERS uterine benign neoplasm DOID_0060095 4.263E-03 0.04950525 0.09267703 0.37666593 YAGI_AML_FAB_MARKERS uterine fibroid DOID_13223 4.263E-03 0.04950525 0.09267703 0.37666593 YAGI_AML_FAB_MARKERS celiac disease DOID_10608 4.803E-03 0.05465664 4.803E-03 0.0910944 YAGI_AML_FAB_MARKERS leiomyoma DOID_127 5.084E-03 0.05672041 0.10091604 0.40154702 YAGI_AML_FAB_MARKERS papilloma DOID_2615 5.372E-03 0.05878581 5.372E-03 0.09552694 YAGI_AML_FAB_MARKERS periodontal disease DOID_3388 5.668E-03 0.06085224 0.10636746 0.40619519 YAGI_AML_FAB_MARKERS lymphoid leukemia DOID_10747 5.971E-03 0.06291915 5.971E-03 0.10295861 YAGI_AML_FAB_MARKERS adenoma DOID_657 6.282E-03 0.06498605 6.282E-03 0.10512448 YAGI_AML_FAB_MARKERS pulmonary sarcoidosis DOID_13406 6.599E-03 0.06705245 1.000 1.000 YAGI_AML_FAB_MARKERS intracranial arterial disease DOID_13089 7.595E-03 0.07581458 7.595E-03 0.12346945 YAGI_AML_FAB_MARKERS cerebral arterial disease DOID_3527 7.595E-03 0.07581458 7.595E-03 0.12346945 YAGI_AML_FAB_MARKERS endometriosis of uterus DOID_288 8.294E-03 0.08136467 1.000 1.000 YAGI_AML_FAB_MARKERS endometriosis DOID_289 8.654E-03 0.0834568 1.000 1.000 YAGI_AML_FAB_MARKERS gallbladder cancer DOID_3121 9.021E-03 0.08554463 9.021E-03 0.14257438 YAGI_AML_FAB_MARKERS leukodystrophy DOID_10579 9.775E-03 0.0911772 0.13839466 0.45518245 YAGI_AML_FAB_MARKERS brain cancer DOID_1319 0.01016197 0.0932607 0.14101166 0.45848933 YAGI_AML_FAB_MARKERS thyroid adenoma DOID_2891 0.01016197 0.09178037 0.01016197 0.1482606 YAGI_AML_FAB_MARKERS central nervous system cancer DOID_3620 0.01055596 0.09384912 0.14362077 0.45653753 YAGI_AML_FAB_MARKERS hemolytic anemia DOID_583 0.01055596 0.09240529 0.01055596 0.1501586 YAGI_AML_FAB_MARKERS normocytic anemia DOID_720 0.01055596 0.09240529 0.01055596 0.1501586 YAGI_AML_FAB_MARKERS autoimmune disease of gastrointestinal tract DOID_0060031 0.01095664 0.09445948 0.01095664 0.15205672 LI_PROSTATE_CANCER_EPIGENETIC transitional cell carcinoma DOID_2671 6.545E-20 3.724E-17 4.521E-05 8.574E-03 LI_PROSTATE_CANCER_EPIGENETIC mixed glioma DOID_5076 3.332E-11 9.48E-09 0.05944324 0.62635557 LI_PROSTATE_CANCER_EPIGENETIC benign mesothelioma DOID_2645 1.936E-10 3.673E-08 0.03312859 0.47125424 LI_PROSTATE_CANCER_EPIGENETIC pre-malignant neoplasm DOID_0060071 1.575E-09 2.241E-07 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC in situ carcinoma DOID_8719 1.575E-09 2.241E-07 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC invasive ductal carcinoma DOID_3008 7.461E-09 8.49E-07 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC nervous system cancer DOID_3093 8.549E-09 8.108E-07 2.266E-03 0.12894899 LI_PROSTATE_CANCER_EPIGENETIC leiomyoma DOID_127 1.422E-08 1.156E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC nephroblastoma DOID_2154 1.791E-08 1.274E-06 0.02792996 0.46741609 LI_PROSTATE_CANCER_EPIGENETIC endometriosis of uterus DOID_288 4.024E-08 2.544E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC endometriosis DOID_289 4.405E-08 2.506E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC gallbladder cancer DOID_3121 4.812E-08 2.489E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC brain cancer DOID_1319 6.204E-08 2.942E-06 0.03756319 0.49705711 LI_PROSTATE_CANCER_EPIGENETIC neuritis DOID_1803 6.204E-08 2.715E-06 0.03756319 0.48576036 LI_PROSTATE_CANCER_EPIGENETIC invasive lobular carcinoma DOID_3457 6.612E-08 2.687E-06 8.383E-03 0.39751461 LI_PROSTATE_CANCER_EPIGENETIC central nervous system cancer DOID_3620 6.728E-08 2.552E-06 0.03830038 0.48428702 LI_PROSTATE_CANCER_EPIGENETIC glaucoma DOID_1686 7.285E-08 2.591E-06 0.03903702 0.48287099 LI_PROSTATE_CANCER_EPIGENETIC epidermolysis bullosa DOID_2730 8.812E-08 2.949E-06 8.812E-08 5.014E-05 LI_PROSTATE_CANCER_EPIGENETIC bile duct adenocarcinoma DOID_4896 1.06E-07 3.351E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC cholangiocarcinoma DOID_4947 1.06E-07 3.351E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC vesiculobullous skin disease DOID_2731 1.145E-07 3.429E-06 1.145E-07 3.257E-05 LI_PROSTATE_CANCER_EPIGENETIC bile duct cancer DOID_4606 1.398E-07 3.976E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC bile duct carcinoma DOID_4897 1.398E-07 3.976E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC oral cavity cancer DOID_8618 1.398E-07 3.787E-06 0.04564234 0.49943248 LI_PROSTATE_CANCER_EPIGENETIC neuroectodermal tumor DOID_171 1.699E-07 4.394E-06 1.106E-03 0.0786642 LI_PROSTATE_CANCER_EPIGENETIC uterine disease DOID_345 2.173E-07 5.376E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC astrocytoma DOID_3069 2.739E-07 6.494E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC testicular cancer DOID_2998 3.867E-07 8.802E-06 0.01443782 0.48324222 LI_PROSTATE_CANCER_EPIGENETIC granulosa cell tumor DOID_2999 3.867E-07 8.463E-06 0.01443782 0.45639543 LI_PROSTATE_CANCER_EPIGENETIC sex cord-gonadal stromal tumor DOID_192 4.547E-07 9.583E-06 0.0151921 0.45496341 LI_PROSTATE_CANCER_EPIGENETIC female reproductive system disease DOID_229 4.865E-07 9.886E-06 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC biliary tract cancer DOID_4607 5.354E-07 1.051E-05 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Sciatic Neuropathy DOID_11446 1.451E-06 2.752E-05 0.02195562 0.48049019 LI_PROSTATE_CANCER_EPIGENETIC lesion of sciatic nerve DOID_12528 1.451E-06 2.752E-05 0.02195562 0.48049019 LI_PROSTATE_CANCER_EPIGENETIC mononeuritis of lower limb DOID_9473 1.451E-06 2.752E-05 0.02195562 0.48049019 LI_PROSTATE_CANCER_EPIGENETIC mononeuritis DOID_1802 1.611E-06 2.957E-05 0.02270434 0.47847299 LI_PROSTATE_CANCER_EPIGENETIC mononeuropathy DOID_1188 1.783E-06 3.17E-05 0.02345252 0.44481606 LI_PROSTATE_CANCER_EPIGENETIC female reproductive organ benign neoplasm DOID_0060086 1.966E-06 3.39E-05 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC uterine benign neoplasm DOID_0060095 1.966E-06 3.39E-05 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC uterine fibroid DOID_13223 1.966E-06 3.39E-05 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC pleural disease DOID_1532 2.591E-06 4.336E-05 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC medullomyoblastoma DOID_3861 3.334E-06 5.42E-05 3.905E-04 0.05554236 LI_PROSTATE_CANCER_EPIGENETIC adult medulloblastoma DOID_3864 3.334E-06 5.42E-05 3.905E-04 0.05554236 LI_PROSTATE_CANCER_EPIGENETIC childhood medulloblastoma DOID_3869 3.334E-06 5.42E-05 3.905E-04 0.05554236 LI_PROSTATE_CANCER_EPIGENETIC medulloblastoma DOID_3858 3.901E-06 6.165E-05 4.328E-04 0.04925402 LI_PROSTATE_CANCER_EPIGENETIC embryonal cancer DOID_688 3.901E-06 5.999E-05 4.328E-04 0.04104502 LI_PROSTATE_CANCER_EPIGENETIC cervix uteri carcinoma in situ DOID_8991 5.218E-06 7.814E-05 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC primitive neuroectodermal tumor DOID_168 5.975E-06 8.717E-05 5.727E-04 0.04655045 LI_PROSTATE_CANCER_EPIGENETIC heart valve disease DOID_4079 7.699E-06 1.095E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC giant cell tumor DOID_200 1.085E-05 1.506E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC malignant giant cell tumor DOID_2705 1.085E-05 1.506E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC giant cell glioblastoma DOID_3074 1.085E-05 1.506E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC reproductive organ benign neoplasm DOID_0050622 1.207E-05 1.635E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC glioblastoma DOID_3068 1.406E-05 1.86E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC pancreatic ductal carcinoma DOID_3587 2.414E-05 3.122E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC nephrosis DOID_2527 2.515E-05 3.18E-04 1.475E-03 0.09323985 LI_PROSTATE_CANCER_EPIGENETIC pancreatic carcinoma DOID_4905 2.725E-05 3.37E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC bone resorption disease DOID_0080011 3.06E-05 3.705E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC osteoporosis DOID_11476 3.06E-05 3.705E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC aneurysm disease DOID_2403 3.06E-05 3.628E-04 0.0587217 0.63042732 LI_PROSTATE_CANCER_EPIGENETIC familial adenomatous polyposis DOID_0050424 3.094E-05 3.593E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC aortic valve stenosis DOID_1712 3.711E-05 4.223E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC peritonitis DOID_8283 3.711E-05 4.141E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC larynx cancer DOID_2596 4.384E-05 4.797E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC laryngeal benign neoplasm DOID_2598 4.384E-05 4.797E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC open-angle glaucoma DOID_1067 5.112E-05 5.488E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC lymphoma DOID_0060058 5.147E-05 5.424E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC lymphoblastic leukemia DOID_1037 5.312E-05 5.496E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC idiopathic pulmonary fibrosis DOID_0050156 5.896E-05 5.991E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC skeletal system cancer DOID_0060124 5.896E-05 5.885E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC bone cancer DOID_184 5.896E-05 5.885E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC tongue cancer DOID_8649 6.735E-05 6.607E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Barrett's esophagus DOID_9206 6.735E-05 6.495E-04 0.01217162 0.43285318 LI_PROSTATE_CANCER_EPIGENETIC drug-induced mental disorder DOID_1203 7.629E-05 7.235E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC drug psychosis DOID_1742 7.629E-05 7.235E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC substance-induced psychosis DOID_8646 7.629E-05 7.235E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC prion disease DOID_649 8.579E-05 8.002E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC alopecia DOID_987 1.064E-04 9.768E-04 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC muscle cancer DOID_4045 1.415E-04 1.278E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC pulmonary embolism DOID_9477 1.415E-04 1.258E-03 0.01745161 0.45136202 LI_PROSTATE_CANCER_EPIGENETIC aortic valve disease DOID_62 1.543E-04 1.351E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC meningitis DOID_9471 1.543E-04 1.33E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC portal hypertension DOID_10762 1.815E-04 1.542E-03 0.01970611 0.48751199 LI_PROSTATE_CANCER_EPIGENETIC cystitis DOID_1679 1.96E-04 1.64E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC hypotrichosis DOID_4535 2.109E-04 1.74E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC pleurisy DOID_10247 2.425E-04 1.971E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC hepatic vascular disease DOID_272 2.425E-04 1.944E-03 0.02270434 0.46138467 LI_PROSTATE_CANCER_EPIGENETIC abdominal aortic aneurysm DOID_7693 2.94E-04 2.323E-03 0.02494721 0.45790193 LI_PROSTATE_CANCER_EPIGENETIC germinoma DOID_3304 3.122E-04 2.433E-03 0.02569372 0.45686648 LI_PROSTATE_CANCER_EPIGENETIC allergic rhinitis DOID_4481 3.122E-04 2.4E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC chronic leukemia DOID_1036 3.309E-04 2.511E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC chronic lymphocytic leukemia DOID_1040 3.309E-04 2.511E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC autonomic nervous system neoplasm DOID_2621 3.309E-04 2.478E-03 0.02643969 0.45588427 LI_PROSTATE_CANCER_EPIGENETIC bladder disease DOID_365 3.309E-04 2.446E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC neuroblastoma DOID_769 3.309E-04 2.478E-03 0.02643969 0.45588427 LI_PROSTATE_CANCER_EPIGENETIC papilloma DOID_2615 3.502E-04 2.555E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC hair disease DOID_421 3.502E-04 2.523E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC myocarditis DOID_820 3.502E-04 2.491E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC spindle cell carcinoma DOID_4015 3.701E-04 2.6E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC esophageal disease DOID_6050 3.701E-04 2.568E-03 0.02792996 0.45406134 LI_PROSTATE_CANCER_EPIGENETIC multiple myeloma DOID_9538 4.328E-04 2.967E-03 0.03016124 0.47671518 LI_PROSTATE_CANCER_EPIGENETIC peripheral nervous system neoplasm DOID_1192 4.548E-04 3.081E-03 0.0309039 0.47525191 LI_PROSTATE_CANCER_EPIGENETIC adenoid cystic carcinoma DOID_4866 5.004E-04 3.349E-03 0.03238758 0.47252647 LI_PROSTATE_CANCER_EPIGENETIC pulmonary emphysema DOID_9675 5.239E-04 3.466E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC salivary gland cancer DOID_8850 5.48E-04 3.584E-03 0.03386906 0.47003648 LI_PROSTATE_CANCER_EPIGENETIC myeloma DOID_0070004 6.765E-04 4.374E-03 0.03756319 0.50889181 LI_PROSTATE_CANCER_EPIGENETIC thyroid adenoma DOID_2891 6.765E-04 4.325E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC aortic aneurysm DOID_3627 7.599E-04 4.804E-03 0.03977312 0.47147719 LI_PROSTATE_CANCER_EPIGENETIC B-cell lymphocytic neoplasm DOID_707 7.888E-04 4.932E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC bone marrow cancer DOID_4960 8.785E-04 5.433E-03 0.04271207 0.49598302 LI_PROSTATE_CANCER_EPIGENETIC carotid artery disease DOID_3407 1.106E-03 6.767E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC endocrine organ benign neoplasm DOID_0060089 1.359E-03 8.225E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC male reproductive system disease DOID_48 1.475E-03 8.833E-03 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC metabolic syndrome X DOID_14221 1.806E-03 0.0107071 0.0608847 0.62987991 LI_PROSTATE_CANCER_EPIGENETIC mental depression DOID_1596 1.939E-03 0.01137507 0.0630429 0.64056091 LI_PROSTATE_CANCER_EPIGENETIC chronic kidney failure DOID_784 1.939E-03 0.011259 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Human immunodeficiency virus infectious disease DOID_526 2.266E-03 0.01302515 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC encephalomyelitis DOID_640 2.414E-03 0.01373484 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC alcohol-related neurodevelopmental disorder DOID_0050667 2.464E-03 0.01388162 2.464E-03 0.12745852 LI_PROSTATE_CANCER_EPIGENETIC ulcerative colitis DOID_8577 2.67E-03 0.01489292 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC hyperparathyroidism DOID_13543 7.624E-03 0.0421177 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC rectal neoplasm DOID_1984 7.624E-03 0.04171273 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC rectum cancer DOID_1993 7.624E-03 0.04171273 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC progressive muscular atrophy DOID_318 7.624E-03 0.04131546 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC labyrinthine disease DOID_4539 7.624E-03 0.04092569 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.624E-03 0.04054321 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.624E-03 0.04054321 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Hodgkin's granuloma DOID_8651 7.624E-03 0.04054321 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Hodgkin's lymphoma, mixed cellularity DOID_8654 7.624E-03 0.04054321 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC inner ear disease DOID_2952 8.383E-03 0.04416829 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC eosinophilic pneumonia DOID_5870 8.383E-03 0.04376308 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC pulmonary eosinophilia DOID_9498 8.383E-03 0.04376308 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Loeffler syndrome DOID_9503 8.383E-03 0.04376308 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC familial atrial fibrillation DOID_0050650 9.142E-03 0.04729007 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC islet cell tumor DOID_1799 9.142E-03 0.04686404 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC stomach disease DOID_76 9.142E-03 0.04644561 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC lipodystrophy DOID_811 9.142E-03 0.04603458 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Hodgkin's lymphoma DOID_8567 9.142E-03 0.04563077 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Hirschsprung's disease DOID_10487 9.9E-03 0.0489854 9.9E-03 0.43333243 LI_PROSTATE_CANCER_EPIGENETIC parathyroid gland disease DOID_11201 9.9E-03 0.04856312 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC vulva cancer DOID_1245 9.9E-03 0.04814805 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Leydig cell tumor DOID_2696 9.9E-03 0.04774001 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC Lynch syndrome DOID_3883 9.9E-03 0.04733884 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC intracranial thrombosis DOID_4193 9.9E-03 0.04694435 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC sex cord-stromal neoplasm DOID_4757 9.9E-03 0.04774001 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC alcohol dependence DOID_0050741 0.01065803 0.05011914 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC megacolon DOID_11372 0.01065803 0.04970833 0.01065803 0.4331726 LI_PROSTATE_CANCER_EPIGENETIC polycystic kidney disease DOID_898 0.01065803 0.0493042 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC mesenchymal cell neoplasm DOID_3350 0.0114151 0.05238059 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC spindle cell sarcoma DOID_4235 0.0114151 0.05238059 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC lung oat cell carcinoma DOID_5411 0.0114151 0.05196154 0.0114151 0.43301285 LI_PROSTATE_CANCER_EPIGENETIC oral submucous fibrosis DOID_5773 0.0114151 0.05154915 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC epithelioid sarcoma DOID_6193 0.0114151 0.05238059 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC intermediate coronary syndrome DOID_8805 0.0114151 0.05114325 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC chronic myeloid leukemia DOID_8552 0.01217162 0.05410665 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC urinary system benign neoplasm DOID_731 0.01292758 0.05702163 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC neuroendocrine tumor DOID_169 0.01368298 0.05988933 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC eosinophilia DOID_999 0.01368298 0.05943216 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC conduct disorder DOID_12995 0.01443782 0.06223574 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC amnestic disorder DOID_10914 0.0151921 0.06499477 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC esophagitis DOID_11963 0.0151921 0.06450974 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC colon carcinoma DOID_1520 0.0151921 0.06403189 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC brain edema DOID_4724 0.0151921 0.06356107 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC subependymal glioma DOID_4843 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC pilocytic astrocytoma DOID_4851 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC subependymal giant cell astrocytoma DOID_5077 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC colonic disease DOID_5353 0.0151921 0.06263989 0.0151921 0.43221524 LI_PROSTATE_CANCER_EPIGENETIC fibrillary astrocytoma DOID_6726 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC juvenile pilocytic astrocytoma DOID_6811 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC childhood pilocytic astrocytoma DOID_6812 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC gemistocytic astrocytoma DOID_7005 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC childhood cerebral astrocytoma DOID_7007 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC protoplasmic astrocytoma DOID_7008 0.0151921 0.06309712 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC coronary restenosis DOID_4247 0.01594583 0.06527464 0.01594583 0.43205595 LI_PROSTATE_CANCER_EPIGENETIC benign glioma DOID_0060101 0.01669899 0.06786949 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC gastric ulcer DOID_10808 0.01669899 0.06738814 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC hepatitis B DOID_2043 0.01669899 0.06691358 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC benign ependymoma DOID_4844 0.01669899 0.06786949 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC sinusitis DOID_0050127 0.01745161 0.06944031 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC heart conduction disease DOID_10273 0.01745161 0.06895809 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC paranasal sinus disease DOID_1352 0.01745161 0.06944031 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC IgA glomerulonephritis DOID_2986 0.01745161 0.06848251 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC myasthenia gravis DOID_437 0.01745161 0.06801346 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC uremia DOID_4676 0.01745161 0.06755078 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC urinary tract obstruction DOID_5200 0.01745161 0.06709435 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC lingual-facial-buccal dyskinesia DOID_9854 0.01745161 0.06664406 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC bronchiolitis DOID_2942 0.01970611 0.07475184 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC osteosarcoma DOID_3347 0.01970611 0.07425679 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC morbid obesity DOID_11981 0.0204565 0.07657729 0.0204565 0.48498949 LI_PROSTATE_CANCER_EPIGENETIC spinal muscular atrophy DOID_12377 0.0204565 0.07607678 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC papillary adenoma DOID_3172 0.0204565 0.07558278 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC neuromuscular junction disease DOID_439 0.0204565 0.07509515 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC microcystic adenoma DOID_5403 0.0204565 0.07558278 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC follicular adenoma DOID_6204 0.0204565 0.07558278 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC cleft lip DOID_9296 0.0204565 0.07461377 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC intracranial aneurysm DOID_10941 0.02120633 0.07685608 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC vitiligo DOID_12306 0.02120633 0.07636965 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC spinal cord disease DOID_319 0.02120633 0.07588933 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC middle cerebral artery infarction DOID_3525 0.02120633 0.07541502 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC seminoma DOID_4440 0.02120633 0.07494661 0.02120633 0.48265616 LI_PROSTATE_CANCER_EPIGENETIC fragments of torsion dystonia DOID_531 0.02120633 0.07448398 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC diffuse large B-cell lymphoma DOID_0050745 0.02195562 0.07664261 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC gestational diabetes DOID_11714 0.02195562 0.07617527 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC lung adenocarcinoma DOID_3910 0.02195562 0.07571361 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC migraine DOID_6364 0.02195562 0.0752575 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC sarcoma DOID_1115 0.02270434 0.07735791 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC coronary stenosis DOID_4248 0.02270434 0.07689745 0.02270434 0.44547485 LI_PROSTATE_CANCER_EPIGENETIC autoimmune disease of the nervous system DOID_438 0.02270434 0.07644243 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC central nervous system hereditary degenerative disease DOID_481 0.02270434 0.07599277 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC polycystic ovary syndrome DOID_11612 0.02345252 0.0780379 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC supratentorial cancer DOID_1659 0.02345252 0.0775842 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC toxic encephalopathy DOID_3602 0.02345252 0.07713573 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC cerebrum cancer DOID_368 0.02345252 0.0775842 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC dystonic disease DOID_544 0.02345252 0.07669242 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC endometrial carcinoma DOID_2871 0.02420014 0.07868502 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC gonadal disease DOID_2277 0.02494721 0.08065318 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC endometrial cancer DOID_1380 0.02569372 0.08259733 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC metal metabolism disorder DOID_896 0.0271851 0.08690068 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC male infertility DOID_12336 0.02792996 0.08878294 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC thyroid carcinoma DOID_3963 0.02792996 0.08828971 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC lymphoid leukemia DOID_10747 0.02867427 0.09014177 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC thyroid cancer DOID_1781 0.02941803 0.09197176 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC adenoma DOID_657 0.02941803 0.09146918 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC congenital diaphragmatic hernia DOID_3827 0.03164602 0.09786186 0.03164602 0.47385744 LI_PROSTATE_CANCER_EPIGENETIC systemic scleroderma DOID_418 0.03164602 0.09733288 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC peptic ulcer DOID_750 0.03164602 0.09680958 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC adult respiratory distress syndrome DOID_11394 0.03238758 0.0985483 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC intracranial arterial disease DOID_13089 0.03238758 0.09802411 1.000 1.000 LI_PROSTATE_CANCER_EPIGENETIC cerebral arterial disease DOID_3527 0.03238758 0.09802411 1.000 1.000 CHANG_POU5F1_TARGETS_UP aortic valve insufficiency DOID_57 4.127E-06 2.348E-03 3.161E-03 0.44967759 CHANG_POU5F1_TARGETS_UP Ehlers-Danlos syndrome DOID_13359 6.563E-06 1.867E-03 3.95E-03 0.37459793 CHANG_POU5F1_TARGETS_UP aortic valve disease DOID_62 1.723E-05 3.268E-03 6.313E-03 0.39914463 CHANG_POU5F1_TARGETS_UP heart valve disease DOID_4079 7.619E-05 0.01083874 0.01311233 0.35528174 CHANG_POU5F1_TARGETS_UP aortic aneurysm DOID_3627 8.568E-05 9.75E-03 8.568E-05 0.04874931 CHANG_POU5F1_TARGETS_UP collagen disease DOID_854 1.251E-04 0.01186824 0.01675595 0.36669748 CHANG_POU5F1_TARGETS_UP aneurysm disease DOID_2403 1.909E-04 0.01551401 1.909E-04 0.05429903 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN glaucoma DOID_1686 1.1E-07 6.257E-05 8.914E-04 0.10144536 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN temporal lobe epilepsy DOID_3328 2.756E-05 7.84E-03 1.563E-03 0.11117601 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN bacterial pneumonia DOID_874 4.294E-05 8.144E-03 0.06538968 0.43263636 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN focal epilepsy DOID_2234 5.147E-05 7.322E-03 2.359E-03 0.10323898 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN open-angle glaucoma DOID_1067 6.241E-05 7.103E-03 0.01175454 0.29079706 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN membranous glomerulonephritis DOID_10976 1.299E-04 0.01231923 0.01675112 0.28882994 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN middle cerebral artery infarction DOID_3525 2.574E-04 0.02091912 2.574E-04 0.14643381 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN Sciatic Neuropathy DOID_11446 2.763E-04 0.01964973 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN lesion of sciatic nerve DOID_12528 2.763E-04 0.01964973 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN mononeuritis of lower limb DOID_9473 2.763E-04 0.01964973 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN pleurisy DOID_10247 2.958E-04 0.01870417 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN mononeuritis DOID_1802 2.958E-04 0.01683375 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN mononeuropathy DOID_1188 3.161E-04 0.0163502 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN pleural disease DOID_1532 4.036E-04 0.01913741 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN pulmonary sarcoidosis DOID_13406 5.277E-04 0.02309695 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN respiratory syncytial virus infectious disease DOID_1273 5.819E-04 0.02364944 0.03486339 0.34802226 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN intracranial arterial disease DOID_13089 6.099E-04 0.02313735 6.099E-04 0.17353009 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN cerebral arterial disease DOID_3527 6.099E-04 0.02313735 6.099E-04 0.17353009 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN autoimmune disease of urogenital tract DOID_0060049 6.68E-04 0.02375608 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN primary biliary cirrhosis DOID_12236 6.68E-04 0.02375608 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN nephrotic syndrome DOID_1184 6.98E-04 0.02336266 6.98E-04 0.1323884 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN cerebral infarction DOID_3526 7.599E-04 0.02402205 7.599E-04 0.10809921 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN neuritis DOID_1803 8.244E-04 0.02468872 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN hemolytic anemia DOID_583 8.576E-04 0.02439875 0.04217942 0.37500143 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN normocytic anemia DOID_720 8.576E-04 0.02439875 0.04217942 0.37500143 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN sarcoidosis DOID_11335 1.033E-03 0.02799275 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN hypersensitivity reaction type IV disease DOID_2916 1.224E-03 0.03166865 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN melancholia DOID_2848 1.265E-03 0.03128501 1.265E-03 0.11992588 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN neurotic disorder DOID_4964 1.305E-03 0.03094818 1.305E-03 0.10610804 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN brain infarction DOID_3454 1.654E-03 0.03764459 1.654E-03 0.10456829 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN tuberculosis DOID_399 1.654E-03 0.03619672 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN nephrosis DOID_2527 1.795E-03 0.03782611 1.795E-03 0.10213049 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN cystic fibrosis DOID_1485 1.991E-03 0.04046826 0.06380662 0.4322139 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN endogenous depression DOID_1595 1.991E-03 0.0390728 1.991E-03 0.10301012 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN mental depression DOID_1596 2.359E-03 0.04473689 2.359E-03 0.11184223 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN retinal vascular disease DOID_2462 2.469E-03 0.04531983 0.07090999 0.44338222 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN primary bacterial infectious disease DOID_0050338 2.582E-03 0.04590906 1.000 1.000 WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN primary immunodeficiency disease DOID_612 2.697E-03 0.04650388 0.07405025 0.4579847 SUNG_METASTASIS_STROMA_UP Ehlers-Danlos syndrome DOID_13359 7.635E-09 4.344E-06 7.635E-09 4.344E-06 SUNG_METASTASIS_STROMA_UP collagen disease DOID_854 5.943E-08 1.691E-05 3.354E-06 9.542E-04 SUNG_METASTASIS_STROMA_UP aneurysm disease DOID_2403 7.792E-06 1.478E-03 7.018E-03 0.1815015 SUNG_METASTASIS_STROMA_UP pleural disease DOID_1532 2.379E-05 3.384E-03 0.05395171 0.4263684 SUNG_METASTASIS_STROMA_UP aortic aneurysm DOID_3627 8.344E-05 9.496E-03 0.08057314 0.48259073 SUNG_METASTASIS_STROMA_UP giant cell tumor DOID_200 9.841E-05 9.332E-03 3.59E-03 0.12768305 SUNG_METASTASIS_STROMA_UP malignant giant cell tumor DOID_2705 9.841E-05 9.332E-03 3.59E-03 0.12768305 SUNG_METASTASIS_STROMA_UP giant cell glioblastoma DOID_3074 9.841E-05 9.332E-03 3.59E-03 0.12768305 SUNG_METASTASIS_STROMA_UP osteochondrodysplasia DOID_2256 1.093E-04 8.884E-03 1.093E-04 0.02072946 SUNG_METASTASIS_STROMA_UP hypertrophic cardiomyopathy DOID_11984 1.27E-04 9.036E-03 1.27E-04 0.01807282 SUNG_METASTASIS_STROMA_UP glioblastoma DOID_3068 1.27E-04 8.032E-03 4.245E-03 0.13418644 SUNG_METASTASIS_STROMA_UP oral cavity cancer DOID_8618 1.27E-04 7.229E-03 4.245E-03 0.12712399 SUNG_METASTASIS_STROMA_UP pre-malignant neoplasm DOID_0060071 1.606E-04 8.309E-03 0.09934023 0.55416267 SUNG_METASTASIS_STROMA_UP in situ carcinoma DOID_8719 1.606E-04 8.309E-03 0.09934023 0.55416267 SUNG_METASTASIS_STROMA_UP osteogenesis imperfecta DOID_12347 1.9E-04 9.008E-03 1.9E-04 0.02161964 SUNG_METASTASIS_STROMA_UP astrocytoma DOID_3069 2.079E-04 9.102E-03 5.863E-03 0.1588658 SUNG_METASTASIS_STROMA_UP nephrosis DOID_2527 2.255E-04 9.166E-03 0.11070144 0.57788183 SUNG_METASTASIS_STROMA_UP skeletal system cancer DOID_0060124 2.552E-04 9.681E-03 0.02348289 0.3611288 SUNG_METASTASIS_STROMA_UP bone cancer DOID_184 2.552E-04 9.681E-03 0.02348289 0.3611288 SUNG_METASTASIS_STROMA_UP pancreatitis DOID_4989 2.839E-04 0.01009643 7.19E-03 0.17788158 SUNG_METASTASIS_STROMA_UP spastic diplegia DOID_10965 2.914E-04 9.753E-03 2.914E-04 0.02763287 SUNG_METASTASIS_STROMA_UP tongue cancer DOID_8649 2.914E-04 9.211E-03 0.02502899 0.32367038 SUNG_METASTASIS_STROMA_UP vein disease DOID_866 2.914E-04 8.726E-03 2.914E-04 0.02368532 SUNG_METASTASIS_STROMA_UP bone development disease DOID_0080006 3.513E-04 9.993E-03 3.513E-04 0.02498363 SUNG_METASTASIS_STROMA_UP membranous glomerulonephritis DOID_10976 4.595E-04 0.01244975 4.595E-04 0.02904941 SUNG_METASTASIS_STROMA_UP blood protein disease DOID_620 4.595E-04 0.01188385 4.595E-04 0.02614447 SUNG_METASTASIS_STROMA_UP urinary tract obstruction DOID_5200 6.1E-04 0.0150901 0.0357845 0.36359609 SUNG_METASTASIS_STROMA_UP spastic quadriplegia DOID_10970 7.218E-04 0.01711296 7.218E-04 0.03733736 SUNG_METASTASIS_STROMA_UP acute pancreatitis DOID_2913 7.218E-04 0.01642844 7.218E-04 0.03422591 SUNG_METASTASIS_STROMA_UP portal hypertension DOID_10762 7.812E-04 0.01709554 1.000 1.000 SUNG_METASTASIS_STROMA_UP middle cerebral artery infarction DOID_3525 9.067E-04 0.01910807 0.04339549 0.36853781 SUNG_METASTASIS_STROMA_UP pleurisy DOID_10247 1.041E-03 0.021161 1.000 1.000 SUNG_METASTASIS_STROMA_UP hepatic vascular disease DOID_272 1.041E-03 0.02043131 1.000 1.000 SUNG_METASTASIS_STROMA_UP spastic cerebral palsy DOID_0050669 1.26E-03 0.02389969 1.26E-03 0.05515313 SUNG_METASTASIS_STROMA_UP papilloma DOID_2615 1.499E-03 0.02751272 1.000 1.000 SUNG_METASTASIS_STROMA_UP spindle cell carcinoma DOID_4015 1.583E-03 0.02814734 0.05694668 0.4263508 SUNG_METASTASIS_STROMA_UP uveitis DOID_13141 1.941E-03 0.03346934 1.941E-03 0.07889202 SUNG_METASTASIS_STROMA_UP intracranial arterial disease DOID_13089 2.133E-03 0.03570043 0.06587575 0.46854129 SUNG_METASTASIS_STROMA_UP cerebral arterial disease DOID_3527 2.133E-03 0.03570043 0.06587575 0.46854129 SUNG_METASTASIS_STROMA_UP cervix uteri carcinoma in situ DOID_8991 2.233E-03 0.03629498 0.06735583 0.46175259 SUNG_METASTASIS_STROMA_UP endometriosis of uterus DOID_288 2.334E-03 0.03689054 0.06883359 0.46626566 SUNG_METASTASIS_STROMA_UP nephrotic syndrome DOID_1184 2.438E-03 0.03748692 1.000 1.000 SUNG_METASTASIS_STROMA_UP endometriosis DOID_289 2.438E-03 0.03650042 0.07030906 0.46518436 SUNG_METASTASIS_STROMA_UP uveal disease DOID_3480 2.438E-03 0.03556451 2.438E-03 0.09246774 SUNG_METASTASIS_STROMA_UP cerebral infarction DOID_3526 2.651E-03 0.03771448 0.0732531 0.4790921 SUNG_METASTASIS_STROMA_UP proteinuria DOID_576 2.761E-03 0.03832141 0.07472168 0.48314357 SUNG_METASTASIS_STROMA_UP neuritis DOID_1803 2.873E-03 0.03892816 0.07618797 0.47638411 SUNG_METASTASIS_STROMA_UP thyroid adenoma DOID_2891 2.873E-03 0.03802286 1.000 1.000 SUNG_METASTASIS_STROMA_UP withdrawal disorder DOID_0060001 3.343E-03 0.04323155 0.08203032 0.48620052 SUNG_METASTASIS_STROMA_UP sarcoidosis DOID_11335 3.59E-03 0.04539842 0.08493785 0.49824368 SUNG_METASTASIS_STROMA_UP atrophic muscular disease DOID_913 3.59E-03 0.0444115 3.59E-03 0.12017229 SUNG_METASTASIS_STROMA_UP muscular dystrophy DOID_9884 3.59E-03 0.0444115 3.59E-03 0.12017229 SUNG_METASTASIS_STROMA_UP bile duct adenocarcinoma DOID_4896 3.717E-03 0.0450015 1.000 1.000 SUNG_METASTASIS_STROMA_UP cholangiocarcinoma DOID_4947 3.717E-03 0.0450015 1.000 1.000 SUNG_METASTASIS_STROMA_UP hypersensitivity reaction type IV disease DOID_2916 4.245E-03 0.05031991 0.09216713 0.52443095 SUNG_METASTASIS_STROMA_UP bile duct cancer DOID_4606 4.245E-03 0.04929298 1.000 1.000 SUNG_METASTASIS_STROMA_UP bile duct carcinoma DOID_4897 4.245E-03 0.04929298 1.000 1.000 SUNG_METASTASIS_STROMA_UP hypothyroidism DOID_1459 4.805E-03 0.05468425 4.805E-03 0.13671062 SUNG_METASTASIS_STROMA_UP uterine disease DOID_345 5.247E-03 0.05853723 0.10219384 0.56454657 SUNG_METASTASIS_STROMA_UP hyperglycemia DOID_4195 5.398E-03 0.05906542 0.10361731 0.56690626 SUNG_METASTASIS_STROMA_UP endocrine organ benign neoplasm DOID_0060089 5.706E-03 0.06126032 1.000 1.000 SUNG_METASTASIS_STROMA_UP brain infarction DOID_3454 5.706E-03 0.06012587 0.1064576 0.57689879 SUNG_METASTASIS_STROMA_UP tuberculosis DOID_399 5.706E-03 0.05903267 0.1064576 0.57145635 SUNG_METASTASIS_STROMA_UP pancreatic ductal carcinoma DOID_3587 6.022E-03 0.06119084 0.10928903 0.57579129 SUNG_METASTASIS_STROMA_UP male reproductive system disease DOID_48 6.183E-03 0.0617247 0.11070144 0.57262836 SUNG_METASTASIS_STROMA_UP peripheral vascular disease DOID_341 6.346E-03 0.06225935 0.11211164 0.57469843 SUNG_METASTASIS_STROMA_UP pancreatic carcinoma DOID_4905 6.511E-03 0.06279467 0.11351965 0.57672037 SUNG_METASTASIS_STROMA_UP mixed glioma DOID_5076 7.19E-03 0.06818794 0.11912975 0.59460375 SUNG_METASTASIS_STROMA_UP chromosomal disease DOID_0080014 7.72E-03 0.07200883 7.72E-03 0.18302243 SUNG_METASTASIS_STROMA_UP female reproductive system disease DOID_229 7.72E-03 0.07084739 0.1233144 0.60487839 SUNG_METASTASIS_STROMA_UP biliary tract cancer DOID_4607 8.082E-03 0.07299663 1.000 1.000 SUNG_METASTASIS_STROMA_UP primary bacterial infectious disease DOID_0050338 8.83E-03 0.07850213 0.13162514 0.63470089 SUNG_METASTASIS_STROMA_UP primary immunodeficiency disease DOID_612 9.215E-03 0.0806643 9.215E-03 0.20972718 SUNG_METASTASIS_STROMA_UP amino acid metabolic disorder DOID_9252 9.215E-03 0.07944211 9.215E-03 0.20166075 SUNG_METASTASIS_STROMA_UP carbohydrate metabolic disorder DOID_2978 0.01000679 0.08498304 0.01000679 0.21088383 SUNG_METASTASIS_STROMA_UP encephalomyelitis DOID_640 0.01000679 0.08373329 0.1398584 0.6631619 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 aneurysm disease DOID_2403 5.533E-12 3.148E-09 4.005E-03 0.16277859 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 transitional cell carcinoma DOID_2671 1.412E-11 4.018E-09 4.107E-06 2.337E-03 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 diabetic angiopathy DOID_11713 7.828E-11 1.485E-08 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 heart valve disease DOID_4079 3.814E-09 5.425E-07 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 peripheral vascular disease DOID_341 3.039E-08 3.458E-06 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 intracranial aneurysm DOID_10941 3.472E-08 3.293E-06 0.03272006 0.66491836 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 abdominal aortic aneurysm DOID_7693 6.909E-08 5.616E-06 0.03845173 0.60775101 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 teratoma DOID_3307 1.864E-07 1.326E-05 0.0118081 0.35362145 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 malignant teratoma DOID_5563 1.864E-07 1.326E-05 0.0118081 0.35362145 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 mature teratoma DOID_5566 1.864E-07 1.326E-05 0.0118081 0.35362145 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 aortic valve insufficiency DOID_57 3.412E-07 2.157E-05 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 aortic aneurysm DOID_3627 4.859E-07 2.765E-05 0.06104817 0.8078235 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 cholestasis DOID_13580 1.334E-06 6.901E-05 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 astrocytoma DOID_3069 1.679E-06 7.963E-05 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 nephrosis DOID_2527 1.875E-06 8.207E-05 0.08421555 0.95837291 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 bile duct disease DOID_4138 1.875E-06 7.621E-05 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 biliary tract disease DOID_9741 1.979E-06 7.507E-05 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 aortic valve disease DOID_62 3.108E-06 1.105E-04 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 alcohol-related neurodevelopmental disorder DOID_0050667 5.312E-06 1.778E-04 5.852E-03 0.20812744 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 gestational diabetes DOID_11714 5.588E-06 1.766E-04 0.03386906 0.64238319 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 nephroblastoma DOID_2154 1.18E-05 3.535E-04 8.936E-04 0.10169007 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 embryonal cancer DOID_688 1.497E-05 4.26E-04 1.044E-03 0.0990227 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 neuritis DOID_1803 2.946E-05 7.981E-04 1.628E-03 0.08418989 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 giant cell tumor DOID_200 4.145E-05 1.072E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 malignant giant cell tumor DOID_2705 4.145E-05 1.072E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 giant cell glioblastoma DOID_3074 4.145E-05 1.072E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 atrophic muscular disease DOID_913 4.145E-05 1.025E-03 2.037E-03 0.09658114 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 muscular dystrophy DOID_9884 4.145E-05 1.025E-03 2.037E-03 0.09658114 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 osteochondrodysplasia DOID_2256 4.607E-05 1.092E-03 0.06661565 0.86146151 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 arrhythmogenic right ventricular dysplasia DOID_0050431 4.933E-05 1.123E-03 4.933E-05 0.01403562 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 glioblastoma DOID_3068 5.36E-05 1.173E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 leukocyte disease DOID_9500 5.627E-05 1.186E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 carotid artery disease DOID_3407 6.189E-05 1.258E-03 0.07325403 0.92625652 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 pre-malignant neoplasm DOID_0060071 6.786E-05 1.332E-03 6.786E-05 0.01287149 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 in situ carcinoma DOID_8719 6.786E-05 1.332E-03 6.786E-05 0.01287149 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 osteogenesis imperfecta DOID_12347 1.066E-04 2.021E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 newborn respiratory distress syndrome DOID_12716 1.066E-04 1.956E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 carotid stenosis DOID_13001 1.066E-04 1.895E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 pancreatitis DOID_4989 1.204E-04 2.077E-03 0.0907315 0.97407965 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 metabolic syndrome X DOID_14221 1.296E-04 2.169E-03 0.09289339 0.97882108 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 contact dermatitis DOID_2773 1.296E-04 2.107E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 Ehlers-Danlos syndrome DOID_13359 1.432E-04 2.264E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 oral submucous fibrosis DOID_5773 1.432E-04 2.203E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 bone development disease DOID_0080006 1.493E-04 2.235E-03 0.09720211 0.98764285 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 spastic diplegia DOID_10965 1.636E-04 2.387E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 nervous system cancer DOID_3093 1.823E-04 2.593E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 mouth disease DOID_403 2.067E-04 2.868E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 congenital muscular dystrophy DOID_0050557 2.082E-04 2.821E-03 2.082E-04 0.02962349 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 membranous glomerulonephritis DOID_10976 2.582E-04 3.417E-03 0.02347983 0.53440086 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 brain edema DOID_4724 2.582E-04 3.339E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 subependymal glioma DOID_4843 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 pilocytic astrocytoma DOID_4851 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 subependymal giant cell astrocytoma DOID_5077 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 fibrillary astrocytoma DOID_6726 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 juvenile pilocytic astrocytoma DOID_6811 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 childhood pilocytic astrocytoma DOID_6812 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 gemistocytic astrocytoma DOID_7005 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 childhood cerebral astrocytoma DOID_7007 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 protoplasmic astrocytoma DOID_7008 2.582E-04 3.265E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 coronary restenosis DOID_4247 2.852E-04 3.528E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 benign glioma DOID_0060101 3.135E-04 3.795E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 benign ependymoma DOID_4844 3.135E-04 3.795E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 uremia DOID_4676 3.431E-04 4.067E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 spastic quadriplegia DOID_10970 4.062E-04 4.717E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 acute pancreatitis DOID_2913 4.062E-04 4.622E-03 0.02926504 0.61673352 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 urticaria DOID_1555 4.397E-04 4.906E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 middle cerebral artery infarction DOID_3525 5.106E-04 5.587E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 autoimmune disease of cardiovascular system DOID_0060051 5.867E-04 6.299E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 Behcet's disease DOID_13241 5.867E-04 6.299E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 invasive ductal carcinoma DOID_3008 5.867E-04 6.183E-03 0.03501673 0.62264118 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 coronary stenosis DOID_4248 5.867E-04 6.07E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 supratentorial cancer DOID_1659 6.267E-04 6.368E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 toxic encephalopathy DOID_3602 6.267E-04 6.256E-03 0.03616306 0.60519945 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 cerebrum cancer DOID_368 6.267E-04 6.368E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 focal glomerulosclerosis DOID_3945 6.267E-04 6.148E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 spastic cerebral palsy DOID_0050669 7.106E-04 6.853E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 calcinosis DOID_182 1.044E-03 9.902E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 multiple myeloma DOID_9538 1.044E-03 9.74E-03 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 adult respiratory distress syndrome DOID_11394 1.206E-03 0.01106891 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 intracranial arterial disease DOID_13089 1.206E-03 0.01089321 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 cerebral arterial disease DOID_3527 1.206E-03 0.01089321 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 adenoid cystic carcinoma DOID_4866 1.206E-03 0.010723 1.206E-03 0.09803889 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 benign mesothelioma DOID_2645 1.263E-03 0.01105246 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 cervix uteri carcinoma in situ DOID_8991 1.263E-03 0.010885 1.263E-03 0.08980124 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 salivary gland cancer DOID_8850 1.32E-03 0.0112128 1.32E-03 0.08347306 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 primitive neuroectodermal tumor DOID_168 1.379E-03 0.01154138 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 cerebral infarction DOID_3526 1.501E-03 0.01237745 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 proteinuria DOID_576 1.564E-03 0.01271022 1.564E-03 0.08897157 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 myeloma DOID_0070004 1.628E-03 0.0130435 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 pre-eclampsia DOID_10591 1.628E-03 0.01286234 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 brain cancer DOID_1319 1.628E-03 0.01268615 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 vascular skin disease DOID_9540 1.628E-03 0.01251471 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 central nervous system cancer DOID_3620 1.693E-03 0.01284216 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 calcium metabolism disease DOID_10575 1.827E-03 0.01367635 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 bone marrow cancer DOID_4960 2.109E-03 0.01558719 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 vasculitis DOID_865 2.109E-03 0.01538735 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 hypertrophic cardiomyopathy DOID_11984 2.411E-03 0.01736765 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 oral cavity cancer DOID_8618 2.411E-03 0.01715056 2.411E-03 0.10554188 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 neuroectodermal tumor DOID_171 2.65E-03 0.01861836 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 collagen disease DOID_854 2.65E-03 0.01839131 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 respiratory failure DOID_11162 2.732E-03 0.01873243 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 mineral metabolism disease DOID_0050032 2.9E-03 0.01964556 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 hyperglycemia DOID_4195 3.073E-03 0.02056886 0.07875073 0.93352426 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 allergic contact dermatitis DOID_3042 3.161E-03 0.02091188 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 brain infarction DOID_3454 3.25E-03 0.02125468 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 pancreatic ductal carcinoma DOID_3587 3.432E-03 0.02218894 0.08312512 0.9652693 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 pancreatic carcinoma DOID_4905 3.713E-03 0.02373933 0.08639259 0.96387022 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 diabetic retinopathy DOID_8947 3.713E-03 0.02347556 0.08639259 0.94533426 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 bacterial pneumonia DOID_874 4.105E-03 0.02566568 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 chronic kidney failure DOID_784 4.62E-03 0.02857292 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 retinal vascular disease DOID_2462 4.834E-03 0.02957509 0.09827616 0.98103743 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 primary immunodeficiency disease DOID_612 5.275E-03 0.03193316 0.10255987 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 encephalomyelitis DOID_640 5.735E-03 0.03434856 5.735E-03 0.21754089 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 Crohn's disease DOID_8778 5.852E-03 0.03468791 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 DiGeorge syndrome DOID_11198 0.01063345 0.0623756 0.01063345 0.35590783 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 velocardiofacial syndrome DOID_12583 0.01063345 0.0623756 0.01063345 0.35590783 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 T cell deficiency DOID_11200 0.0118081 0.06855926 0.0118081 0.37326709 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 facioscapulohumeral muscular dystrophy DOID_11727 0.0118081 0.06786674 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 angioedema DOID_1558 0.0118081 0.06718808 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 rectal neoplasm DOID_1984 0.0118081 0.06652285 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 rectum cancer DOID_1993 0.0118081 0.06652285 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 phagocyte bactericidal dysfunction DOID_3262 0.0118081 0.06587066 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 familial adenomatous polyposis DOID_0050424 0.01298138 0.07171268 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 migraine without aura DOID_12783 0.01298138 0.07102314 0.01298138 0.36932031 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 invasive lobular carcinoma DOID_3457 0.01298138 0.07034673 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 eosinophilic pneumonia DOID_5870 0.01298138 0.06968308 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 pulmonary eosinophilia DOID_9498 0.01298138 0.06968308 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 Loeffler syndrome DOID_9503 0.01298138 0.06968308 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 bronchiectasis DOID_9563 0.01298138 0.06903183 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 relapsing-remitting multiple sclerosis DOID_2378 0.0141533 0.07456694 0.0141533 0.38348713 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 peritonitis DOID_8283 0.0141533 0.07388284 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 cone-rod dystrophy DOID_0050572 0.01532386 0.07926617 0.01532386 0.39633087 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 Lynch syndrome DOID_3883 0.01532386 0.07855206 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 intracranial thrombosis DOID_4193 0.01532386 0.07785071 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 thoracic aortic aneurysm DOID_14004 0.01766091 0.08892972 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 communication disorder DOID_2033 0.01766091 0.08814964 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 membranoproliferative glomerulonephritis DOID_2920 0.01766091 0.08738312 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 arthropathy DOID_381 0.01766091 0.08662982 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 varicose veins DOID_799 0.01766091 0.08588939 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 hyperhomocysteinemia DOID_9279 0.01766091 0.08516152 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 restrictive cardiomyopathy DOID_397 0.0188274 0.09002345 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 vein disease DOID_866 0.0188274 0.08927326 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 bronchitis DOID_6132 0.01999253 0.09401448 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 urinary system benign neoplasm DOID_731 0.01999253 0.09324387 0.01999253 0.49459793 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 keratosis DOID_161 0.02115632 0.09786946 0.02115632 0.501581 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 ureteral obstruction DOID_5199 0.02115632 0.09708019 1.000 1.000 VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 eosinophilia DOID_999 0.02115632 0.09630355 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_MF_UP spindle cell carcinoma DOID_4015 2.191E-06 1.246E-03 2.191E-06 1.246E-03 ZHAN_MULTIPLE_MYELOMA_MF_UP Human immunodeficiency virus infectious disease DOID_526 3.453E-05 9.824E-03 3.453E-05 9.824E-03 ZHAN_MULTIPLE_MYELOMA_MF_UP encephalomyelitis DOID_640 3.801E-05 7.209E-03 1.942E-03 0.06499123 ZHAN_MULTIPLE_MYELOMA_MF_UP prion disease DOID_649 6.873E-05 9.777E-03 0.01227574 0.23282984 ZHAN_MULTIPLE_MYELOMA_MF_UP acquired immunodeficiency syndrome DOID_635 1.036E-04 0.01178916 1.036E-04 0.0196486 ZHAN_MULTIPLE_MYELOMA_MF_UP Goodpasture syndrome DOID_9808 1.237E-04 0.01172823 0.01633535 0.25121127 ZHAN_MULTIPLE_MYELOMA_MF_UP bronchiolitis DOID_2942 1.455E-04 0.01182751 1.455E-04 0.02069815 ZHAN_MULTIPLE_MYELOMA_MF_UP endometrial carcinoma DOID_2871 2.215E-04 0.01575436 0.02172323 0.25751075 ZHAN_MULTIPLE_MYELOMA_MF_UP endometrial cancer DOID_1380 2.503E-04 0.01582571 0.02306575 0.25734146 ZHAN_MULTIPLE_MYELOMA_MF_UP macular degeneration DOID_4448 2.968E-04 0.01688759 2.968E-04 0.03377517 ZHAN_MULTIPLE_MYELOMA_MF_UP uveitis DOID_13141 3.648E-04 0.01887044 3.648E-04 0.03459581 ZHAN_MULTIPLE_MYELOMA_MF_UP respiratory syncytial virus infectious disease DOID_1273 3.829E-04 0.01815514 3.829E-04 0.0311231 ZHAN_MULTIPLE_MYELOMA_MF_UP adenoid cystic carcinoma DOID_4866 4.014E-04 0.01756868 4.014E-04 0.0285491 ZHAN_MULTIPLE_MYELOMA_MF_UP benign mesothelioma DOID_2645 4.203E-04 0.01708342 0.02975186 0.27304532 ZHAN_MULTIPLE_MYELOMA_MF_UP salivary gland cancer DOID_8850 4.397E-04 0.01667909 4.397E-04 0.02779849 ZHAN_MULTIPLE_MYELOMA_MF_UP uveal disease DOID_3480 4.595E-04 0.01634052 4.595E-04 0.02614483 ZHAN_MULTIPLE_MYELOMA_MF_UP uterine cancer DOID_363 4.797E-04 0.01605607 0.0317491 0.26181505 ZHAN_MULTIPLE_MYELOMA_MF_UP neuritis DOID_1803 5.429E-04 0.01716235 5.429E-04 0.02808385 ZHAN_MULTIPLE_MYELOMA_MF_UP oral cavity cancer DOID_8618 8.073E-04 0.02417673 8.073E-04 0.03827982 ZHAN_MULTIPLE_MYELOMA_MF_UP tuberculosis DOID_399 1.092E-03 0.03105753 0.04758531 0.29430478 ZHAN_MULTIPLE_MYELOMA_MF_UP diabetic retinopathy DOID_8947 1.249E-03 0.03385178 1.249E-03 0.05468365 ZHAN_MULTIPLE_MYELOMA_MF_UP cystic fibrosis DOID_1485 1.315E-03 0.0340191 1.315E-03 0.05345859 ZHAN_MULTIPLE_MYELOMA_MF_UP bacterial pneumonia DOID_874 1.383E-03 0.03421242 1.383E-03 0.05245904 ZHAN_MULTIPLE_MYELOMA_MF_UP retinal vascular disease DOID_2462 1.632E-03 0.0387009 1.632E-03 0.05805135 ZHAN_MULTIPLE_MYELOMA_MF_UP primary bacterial infectious disease DOID_0050338 1.707E-03 0.03885811 0.05929871 0.32134256 ZHAN_MULTIPLE_MYELOMA_MF_UP nervous system cancer DOID_3093 1.823E-03 0.0398893 0.06123743 0.32564579 ZHAN_MULTIPLE_MYELOMA_MF_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.982E-03 0.04177347 0.06381642 0.3331334 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pleural disease DOID_1532 2.72E-14 1.548E-11 0.21194019 0.55318333 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN primary bacterial infectious disease DOID_0050338 4.19E-14 1.192E-11 0.02281131 0.15451944 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN transitional cell carcinoma DOID_2671 4.868E-14 9.233E-12 3.34E-03 0.04751826 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN encephalomyelitis DOID_640 1.003E-13 1.427E-11 4.805E-05 4.557E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bacterial pneumonia DOID_874 2.916E-13 3.318E-11 0.42000691 0.90182615 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pleurisy DOID_10247 3.32E-13 3.148E-11 0.18465331 0.50757359 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN biliary tract cancer DOID_4607 6.18E-13 5.024E-11 2.718E-03 0.03964884 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN influenza DOID_8469 7.144E-13 5.081E-11 0.27377419 0.64637973 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN vesiculobullous skin disease DOID_2731 1.005E-12 6.352E-11 1.005E-12 5.717E-10 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bile duct adenocarcinoma DOID_4896 5.614E-12 3.195E-10 0.05727125 0.29357965 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cholangiocarcinoma DOID_4947 5.614E-12 3.195E-10 0.05727125 0.29357965 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pancreatitis DOID_4989 7.777E-12 4.023E-10 0.42000691 0.90524216 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bile duct cancer DOID_4606 1.145E-11 5.429E-10 0.0645348 0.3221079 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bile duct carcinoma DOID_4897 1.145E-11 5.429E-10 0.0645348 0.3221079 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN respiratory failure DOID_11162 2.219E-11 9.714E-10 0.07208805 0.33621393 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN tuberculosis DOID_399 5.525E-11 2.245E-09 0.38331583 0.83565788 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN allergic rhinitis DOID_4481 6.235E-11 2.365E-09 0.02226832 0.1526587 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autoimmune disease of gastrointestinal tract DOID_0060031 7.498E-11 2.666E-09 1.435E-06 2.722E-04 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pulmonary tuberculosis DOID_2957 7.498E-11 2.51E-09 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN epidermolysis bullosa DOID_2730 8.175E-11 2.584E-09 8.175E-11 2.326E-08 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN metabolic syndrome X DOID_14221 2.398E-10 7.181E-09 2.385E-03 0.03991164 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hypersensitivity reaction type IV disease DOID_2916 3.352E-10 9.535E-09 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN gallbladder cancer DOID_3121 1.001E-09 2.712E-08 4.006E-03 0.05065995 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cataract DOID_83 1.194E-09 3.088E-08 1.858E-05 2.643E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lens disease DOID_110 1.679E-09 4.154E-08 2.274E-05 2.588E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN neuritis DOID_1803 1.679E-09 3.981E-08 0.04532257 0.25037419 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pancreatic ductal carcinoma DOID_3587 1.748E-09 3.979E-08 0.08798195 0.34288854 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN nephrosis DOID_2527 1.978E-09 4.33E-08 1.515E-04 6.63E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN peripheral vascular disease DOID_341 2.235E-09 4.71E-08 0.01452801 0.11809196 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pancreatic carcinoma DOID_4905 2.52E-09 5.122E-08 0.09418784 0.35491976 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN diabetic retinopathy DOID_8947 2.52E-09 4.945E-08 0.01505085 0.12061878 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN sarcoidosis DOID_11335 4.289E-09 8.135E-08 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN periodontal disease DOID_3388 5.247E-09 9.631E-08 0.02608855 0.16868617 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN integumentary system cancer DOID_0060122 5.721E-09 1.017E-07 6.566E-04 0.01624489 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN skin cancer DOID_4159 5.721E-09 1.017E-07 6.566E-04 0.01624489 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN retinal vascular disease DOID_2462 8.505E-09 1.466E-07 0.02150044 0.15103397 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN diabetic angiopathy DOID_11713 1.112E-08 1.861E-07 0.15066409 0.45358661 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN carotid artery disease DOID_3407 1.275E-08 2.074E-07 9.527E-04 0.02258588 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pre-malignant neoplasm DOID_0060071 1.636E-08 2.586E-07 8.782E-05 4.543E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN in situ carcinoma DOID_8719 1.636E-08 2.586E-07 8.782E-05 4.543E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pulmonary emphysema DOID_9675 1.876E-08 2.885E-07 0.2587843 0.61869019 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mouth disease DOID_403 2.039E-08 3.053E-07 0.1383321 0.43486722 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN dilated cardiomyopathy DOID_12930 2.234E-08 3.26E-07 0.14064477 0.43492867 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hyperglycemia DOID_4195 2.34E-08 3.329E-07 0.01161058 0.10009724 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN brain infarction DOID_3454 2.943E-08 4.084E-07 0.08391619 0.34852781 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN diabetic autonomic neuropathy DOID_11503 3.026E-08 4.099E-07 2.926E-04 8.325E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autonomic neuropathy DOID_11504 3.026E-08 4.099E-07 2.926E-04 8.325E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN diabetic polyneuropathy DOID_12785 3.026E-08 4.099E-07 2.926E-04 8.325E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN diabetic neuropathy DOID_9743 3.026E-08 4.099E-07 2.926E-04 8.325E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN periodontitis DOID_824 3.816E-08 5.049E-07 0.01647608 0.12335383 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autonomic nervous system disease DOID_11465 4.723E-08 6.107E-07 3.719E-04 0.01007592 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cystic fibrosis DOID_1485 6.226E-08 7.873E-07 0.41204597 0.8948632 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN contact dermatitis DOID_2773 9.246E-08 1.144E-06 2.455E-04 8.732E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN celiac disease DOID_10608 1.05E-07 1.271E-06 8.153E-05 4.639E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN leiomyoma DOID_127 1.26E-07 1.494E-06 1.717E-03 0.03256007 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN spindle cell carcinoma DOID_4015 1.784E-07 2.072E-06 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN oral cavity cancer DOID_8618 1.936E-07 2.203E-06 6.009E-05 3.799E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN brain edema DOID_4724 1.964E-07 2.192E-06 0.12722419 0.40441656 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pulmonary sarcoidosis DOID_13406 2.897E-07 3.17E-06 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mineral metabolism disease DOID_0050032 3.728E-07 4.002E-06 0.07596682 0.33507846 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN adult respiratory distress syndrome DOID_11394 4.523E-07 4.766E-06 0.25371949 0.61695038 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN tooth disease DOID_1091 5.051E-07 5.225E-06 0.08190563 0.3426787 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN allergic contact dermatitis DOID_3042 5.051E-07 5.132E-06 1.163E-04 5.517E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN acute pancreatitis DOID_2913 6.548E-07 6.536E-06 0.15642542 0.45644135 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN nephrotic syndrome DOID_1184 6.832E-07 6.702E-06 2.691E-04 8.508E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cerebral infarction DOID_3526 8.85E-07 8.535E-06 0.0421008 0.23955352 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN peritonitis DOID_8283 9.785E-07 9.28E-06 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN aneurysm disease DOID_2403 1.16E-06 1.082E-05 0.41603995 0.90010165 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN middle cerebral artery infarction DOID_3525 1.191E-06 1.093E-05 0.17347686 0.48150407 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN gestational diabetes DOID_11714 1.432E-06 1.293E-05 0.01647608 0.12499855 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lung adenocarcinoma DOID_3910 1.432E-06 1.273E-05 9.876E-04 0.02247671 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN integumentary system benign neoplasm DOID_0060121 1.435E-06 1.256E-05 0.04863217 0.26354002 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN glaucoma DOID_1686 1.435E-06 1.237E-05 0.29808926 0.6922971 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN skin benign neoplasm DOID_3165 1.435E-06 1.256E-05 0.04863217 0.26354002 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN aortic aneurysm DOID_3627 1.609E-06 1.367E-05 0.30285407 0.69485471 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Legionnaires' disease DOID_10457 1.958E-06 1.638E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN legionellosis DOID_10458 1.958E-06 1.638E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN polycystic ovary syndrome DOID_11612 2.026E-06 1.67E-05 5.62E-05 3.998E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN female reproductive organ benign neoplasm DOID_0060086 2.387E-06 1.941E-05 1.321E-03 0.02783013 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN uterine benign neoplasm DOID_0060095 2.387E-06 1.941E-05 1.321E-03 0.02783013 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN uterine fibroid DOID_13223 2.387E-06 1.941E-05 1.321E-03 0.02783013 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN vasculitis DOID_865 2.487E-06 1.993E-05 0.05727125 0.29095841 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN reproductive organ benign neoplasm DOID_0050622 2.758E-06 2.18E-05 6.566E-04 0.01698329 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN tongue cancer DOID_8649 3.522E-06 2.745E-05 1.615E-04 6.565E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lymphoma DOID_0060058 3.756E-06 2.888E-05 0.02627477 0.16798141 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Crohn's disease DOID_8778 4.324E-06 3.28E-05 0.02773456 0.17153222 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN nephroblastoma DOID_2154 5.027E-06 3.764E-05 0.22259849 0.57311556 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN ulcerative colitis DOID_8577 5.675E-06 4.194E-05 4.864E-03 0.05766069 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN prion disease DOID_649 5.858E-06 4.274E-05 0.11526372 0.39272488 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN uterine disease DOID_345 7.048E-06 5.076E-05 1.196E-03 0.0261634 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pulmonary edema DOID_11396 9.177E-06 6.527E-05 0.12722419 0.40898624 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN astrocytoma DOID_3069 9.836E-06 6.909E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN intracranial arterial disease DOID_13089 1.074E-05 7.452E-05 0.25371949 0.61432506 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cerebral arterial disease DOID_3527 1.074E-05 7.452E-05 0.25371949 0.61432506 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN biliary tract disease DOID_9741 1.246E-05 8.544E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autoimmune disease of urogenital tract DOID_0060049 1.348E-05 9.131E-05 3.541E-03 0.04797433 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN primary biliary cirrhosis DOID_12236 1.348E-05 9.131E-05 3.541E-03 0.04797433 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN endometriosis of uterus DOID_288 1.348E-05 9.024E-05 2.471E-04 8.269E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hepatitis B DOID_2043 1.371E-05 9.07E-05 9.67E-03 0.08733778 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN endometriosis DOID_289 1.504E-05 9.837E-05 2.691E-04 8.06E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN syndrome DOID_225 1.563E-05 1.011E-04 1.942E-04 7.366E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN IgA glomerulonephritis DOID_2986 1.651E-05 1.055E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mixed glioma DOID_5076 1.808E-05 1.143E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN female reproductive system disease DOID_229 2.233E-05 1.396E-04 2.492E-03 0.04052052 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN heart valve disease DOID_4079 2.274E-05 1.406E-04 0.2884621 0.67268416 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN vascular skin disease DOID_9540 2.274E-05 1.391E-04 0.04532257 0.24796674 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hemolytic anemia DOID_583 2.507E-05 1.518E-04 5.044E-03 0.05857699 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN normocytic anemia DOID_720 2.507E-05 1.518E-04 5.044E-03 0.05857699 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN urticaria DOID_1555 2.743E-05 1.643E-04 0.16214781 0.46597023 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hypokalemia DOID_4500 3.567E-05 2.114E-04 0.06576688 0.31446515 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN primary immunodeficiency disease DOID_612 3.769E-05 2.211E-04 0.12690156 0.41738142 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN giant cell tumor DOID_200 3.966E-05 2.303E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN malignant giant cell tumor DOID_2705 3.966E-05 2.303E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN giant cell glioblastoma DOID_3074 3.966E-05 2.303E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Sciatic Neuropathy DOID_11446 4.288E-05 2.465E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lesion of sciatic nerve DOID_12528 4.288E-05 2.465E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mononeuritis of lower limb DOID_9473 4.288E-05 2.465E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lymphoblastic leukemia DOID_1037 4.805E-05 2.734E-04 4.054E-03 0.05014698 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autoimmune disease of cardiovascular system DOID_0060051 4.921E-05 2.773E-04 0.18465331 0.51003754 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Behcet's disease DOID_13241 4.921E-05 2.773E-04 0.18465331 0.51003754 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mononeuritis DOID_1802 4.921E-05 2.745E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hypersensitivity reaction type I disease DOID_1205 5.402E-05 2.984E-04 0.02848036 0.17425079 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN congenital nervous system abnormality DOID_2490 5.547E-05 3.035E-04 5.547E-05 4.509E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mononeuropathy DOID_1188 5.62E-05 3.046E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN toxic encephalopathy DOID_3602 5.62E-05 3.017E-04 0.19018495 0.51044923 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN glioblastoma DOID_3068 6.009E-05 3.196E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN aortic valve insufficiency DOID_57 6.475E-05 3.411E-04 0.07839383 0.33538412 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN ocular hypertension DOID_9282 6.475E-05 3.38E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN borderline glaucoma DOID_9283 6.475E-05 3.38E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN age related macular degeneration DOID_10871 7.232E-05 3.741E-04 1.445E-03 0.02937286 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN degeneration of macula and posterior pole DOID_2007 7.232E-05 3.741E-04 1.445E-03 0.02937286 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN abdominal aortic aneurysm DOID_7693 7.232E-05 3.707E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN neuroectodermal tumor DOID_171 7.575E-05 3.849E-04 9.463E-03 0.08684937 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN larynx cancer DOID_2596 8.375E-05 4.217E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN laryngeal benign neoplasm DOID_2598 8.375E-05 4.217E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN intracranial thrombosis DOID_4193 8.375E-05 4.18E-04 0.08464341 0.33445901 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cholestasis DOID_13580 1.013E-04 5.013E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN viral pneumonia DOID_10533 1.061E-04 5.202E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN open-angle glaucoma DOID_1067 1.061E-04 5.158E-04 0.09085077 0.35166046 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN macular degeneration DOID_4448 1.143E-04 5.51E-04 2.018E-03 0.0358788 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN medullomyoblastoma DOID_3861 1.27E-04 6.074E-04 2.18E-03 0.03758596 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN adult medulloblastoma DOID_3864 1.27E-04 6.074E-04 2.18E-03 0.03758596 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN childhood medulloblastoma DOID_3869 1.27E-04 6.074E-04 2.18E-03 0.03758596 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN idiopathic pulmonary fibrosis DOID_0050156 1.319E-04 6.254E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN skeletal system cancer DOID_0060124 1.319E-04 6.203E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bone cancer DOID_184 1.319E-04 6.203E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN oral submucous fibrosis DOID_5773 1.319E-04 6.152E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bile duct disease DOID_4138 1.515E-04 7.007E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN male reproductive system disease DOID_48 1.515E-04 6.951E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN calcinosis DOID_182 1.556E-04 7.084E-04 0.2383173 0.60001125 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN medulloblastoma DOID_3858 1.556E-04 7.027E-04 2.528E-03 0.03995138 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hemolytic-uremic syndrome DOID_12554 1.615E-04 7.237E-04 5.159E-03 0.05871479 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN respiratory syncytial virus infectious disease DOID_1273 1.886E-04 8.383E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN urinary system benign neoplasm DOID_731 1.952E-04 8.608E-04 0.10922239 0.38600958 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN keratosis DOID_161 2.33E-04 1.02E-03 6.52E-03 0.06999693 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN primitive neuroectodermal tumor DOID_168 2.691E-04 1.169E-03 3.769E-03 0.04987938 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN testicular cancer DOID_2998 2.753E-04 1.187E-03 7.255E-03 0.07241856 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN uterine cancer DOID_363 2.926E-04 1.252E-03 0.04052378 0.2329094 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN amnestic disorder DOID_10914 3.223E-04 1.369E-03 0.12722419 0.41366037 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autoimmune hepatitis DOID_2048 3.741E-04 1.577E-03 8.83E-03 0.08373949 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN coronary restenosis DOID_4247 3.741E-04 1.565E-03 8.83E-03 0.08236671 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN amino acid metabolic disorder DOID_9252 3.983E-04 1.654E-03 3.476E-03 0.04823659 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN calcium metabolism disease DOID_10575 4.654E-04 1.919E-03 0.30285407 0.69766789 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN sinusitis DOID_0050127 4.932E-04 2.019E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN paranasal sinus disease DOID_1352 4.932E-04 2.019E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN myasthenia gravis DOID_437 4.932E-04 2.005E-03 0.14486357 0.44315793 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lingual-facial-buccal dyskinesia DOID_9854 4.932E-04 1.99E-03 0.01054408 0.09230121 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.094E-04 2.041E-03 0.02773456 0.17341719 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN aortic valve disease DOID_62 5.609E-04 2.232E-03 0.15066409 0.44649932 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN meningitis DOID_9471 5.609E-04 2.216E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN severe combined immunodeficiency DOID_627 6.342E-04 2.489E-03 0.15642542 0.45411257 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN parasitic protozoa infectious disease DOID_2789 6.566E-04 2.559E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pustulosis of palm and sole DOID_4398 6.566E-04 2.542E-03 0.32619916 0.74242928 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN commensal bacterial infectious disease DOID_0050339 7.133E-04 2.742E-03 0.16214781 0.46833557 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bronchiolitis DOID_2942 7.133E-04 2.724E-03 0.16214781 0.46362867 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN combined T cell and B cell immunodeficiency DOID_628 7.133E-04 2.706E-03 0.16214781 0.46131053 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN neuromuscular junction disease DOID_439 7.985E-04 3.009E-03 0.16783154 0.47042437 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN ankylosing spondylitis DOID_7147 7.985E-04 2.989E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cleft lip DOID_9296 7.985E-04 2.969E-03 0.0143709 0.11850788 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN leukocyte disease DOID_9500 8.453E-04 3.123E-03 0.34431322 0.76829107 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN fragments of torsion dystonia DOID_531 8.898E-04 3.267E-03 0.01540791 0.12009726 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN collagen disease DOID_854 9.527E-04 3.475E-03 0.35318752 0.78501445 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN congenital heart defect DOID_1682 1.069E-03 3.875E-03 0.01029162 0.09149893 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN invasive ductal carcinoma DOID_3008 1.092E-03 3.932E-03 0.18465331 0.50513333 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN coronary stenosis DOID_4248 1.092E-03 3.907E-03 0.01757496 0.1298721 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autoimmune disease of the nervous system DOID_438 1.092E-03 3.883E-03 0.18465331 0.50271643 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN central nervous system hereditary degenerative disease DOID_481 1.092E-03 3.859E-03 0.01757496 0.12820707 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN parasitic infectious disease DOID_1398 1.196E-03 4.199E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN dystonic disease DOID_544 1.203E-03 4.199E-03 0.01870408 0.13471669 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN temporal lobe epilepsy DOID_3328 1.262E-03 4.38E-03 0.37485331 0.82351944 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN opportunistic mycosis DOID_2473 1.445E-03 4.984E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN arrhythmogenic right ventricular dysplasia DOID_0050431 1.597E-03 5.474E-03 1.597E-03 0.03133499 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bladder disease DOID_365 1.717E-03 5.849E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN systemic mycosis DOID_0050136 1.863E-03 6.311E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN fungal infectious disease DOID_1564 1.863E-03 6.311E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN papilloma DOID_2615 1.863E-03 6.274E-03 0.02478742 0.16592993 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hair disease DOID_421 1.863E-03 6.237E-03 0.02478742 0.16400051 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN myocarditis DOID_820 1.863E-03 6.201E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN metal metabolism disorder DOID_896 1.863E-03 6.165E-03 0.02478742 0.16211545 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN childhood type dermatomyositis DOID_14203 1.987E-03 6.537E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN angioedema DOID_1558 1.987E-03 6.499E-03 0.06576688 0.32540306 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN chondrosarcoma DOID_3371 1.987E-03 6.462E-03 0.06576688 0.31984062 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN insulinoma DOID_3892 1.987E-03 6.425E-03 0.06576688 0.3171301 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN labyrinthine disease DOID_4539 1.987E-03 6.389E-03 0.06576688 0.3118446 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN holoprosencephaly DOID_4621 1.987E-03 6.353E-03 1.987E-03 0.03647804 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.987E-03 6.317E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.987E-03 6.317E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Hodgkin's granuloma DOID_8651 1.987E-03 6.317E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 1.987E-03 6.317E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN thyroid carcinoma DOID_3963 2.018E-03 6.378E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bone resorption disease DOID_0080011 2.081E-03 6.543E-03 0.10051566 0.36662443 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN osteoporosis DOID_11476 2.081E-03 6.543E-03 0.10051566 0.36662443 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN thyroid cancer DOID_1781 2.35E-03 7.346E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN adenoma DOID_657 2.35E-03 7.306E-03 0.02877178 0.1741611 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN familial adenomatous polyposis DOID_0050424 2.418E-03 7.478E-03 0.07210175 0.33354385 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN dermatomyositis DOID_10223 2.418E-03 7.438E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pneumocystosis DOID_11339 2.418E-03 7.398E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN temporal arteritis DOID_13375 2.418E-03 7.358E-03 0.07210175 0.32560233 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN inner ear disease DOID_2952 2.418E-03 7.319E-03 0.07210175 0.32051479 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN central nervous system vasculitis DOID_525 2.418E-03 7.358E-03 0.07210175 0.32560233 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cleft palate DOID_674 2.528E-03 7.61E-03 0.03015305 0.17871964 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN auditory system disease DOID_2742 2.603E-03 7.796E-03 0.11131293 0.38857091 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN microcephaly DOID_10907 2.714E-03 8.084E-03 2.714E-03 0.04173218 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN uveitis DOID_13141 2.714E-03 8.042E-03 0.24348622 0.60499416 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN alcohol abuse DOID_1574 2.718E-03 8.012E-03 2.718E-03 0.04069223 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mental depression DOID_1596 2.718E-03 7.971E-03 0.4394426 0.93649005 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN focal epilepsy DOID_2234 2.718E-03 7.93E-03 0.4394426 0.93299568 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN chronic kidney failure DOID_784 2.718E-03 7.889E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN common cold DOID_10459 2.889E-03 8.344E-03 0.07839383 0.34312375 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN esophageal carcinoma DOID_1107 2.889E-03 8.302E-03 0.07839383 0.34050448 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN islet cell tumor DOID_1799 2.889E-03 8.26E-03 0.07839383 0.3379249 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN esophagus squamous cell carcinoma DOID_3748 2.889E-03 8.302E-03 0.07839383 0.34050448 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN stomach disease DOID_76 2.889E-03 8.219E-03 0.07839383 0.33288125 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lipodystrophy DOID_811 2.889E-03 8.178E-03 0.07839383 0.33041546 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Hodgkin's lymphoma DOID_8567 2.889E-03 8.137E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hepatitis DOID_2237 2.908E-03 8.151E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN congenital diaphragmatic hernia DOID_3827 2.908E-03 8.111E-03 0.24862021 0.61240216 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN systemic scleroderma DOID_418 2.908E-03 8.071E-03 0.24862021 0.6097625 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN peptic ulcer DOID_750 2.908E-03 8.032E-03 0.24862021 0.60714549 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN adenoid cystic carcinoma DOID_4866 3.111E-03 8.55E-03 0.03445048 0.20208582 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN benign mesothelioma DOID_2645 3.322E-03 9.086E-03 0.2587843 0.62393332 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cervix uteri carcinoma in situ DOID_8991 3.322E-03 9.043E-03 0.2587843 0.62130069 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN leprosy DOID_1024 3.399E-03 9.209E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN carotid stenosis DOID_13001 3.399E-03 9.166E-03 0.08464341 0.34157516 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Lynch syndrome DOID_3883 3.399E-03 9.122E-03 0.08464341 0.33679789 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN salivary gland cancer DOID_8850 3.541E-03 9.46E-03 0.0374394 0.21737774 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN nervous system cancer DOID_3093 3.615E-03 9.611E-03 0.46556738 0.98478751 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN rheumatic disease DOID_1575 3.769E-03 9.976E-03 0.26881142 0.63997363 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN uveal disease DOID_3480 3.769E-03 9.93E-03 0.26881142 0.63730707 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN scleroderma DOID_419 3.769E-03 9.976E-03 0.26881142 0.63997363 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN aspergillosis DOID_13564 3.948E-03 0.0103513 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN congenital structural myopathy DOID_422 3.948E-03 0.01030382 3.948E-03 0.05105075 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN polycystic kidney disease DOID_898 3.948E-03 0.01025677 0.09085077 0.34694018 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN proteinuria DOID_576 4.507E-03 0.0116576 0.04370052 0.24378034 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN thoracic aortic aneurysm DOID_14004 4.535E-03 0.01167539 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hemangioma DOID_255 4.535E-03 0.0116228 0.0970162 0.36317248 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN membranoproliferative glomerulonephritis DOID_2920 4.535E-03 0.01157068 0.0970162 0.35845596 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN mesenchymal cell neoplasm DOID_3350 4.535E-03 0.01151902 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN arthropathy DOID_381 4.535E-03 0.01146783 4.535E-03 0.05489917 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN spindle cell sarcoma DOID_4235 4.535E-03 0.01151902 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN epithelioid sarcoma DOID_6193 4.535E-03 0.01151902 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN varicose veins DOID_799 4.535E-03 0.01141708 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hyperhomocysteinemia DOID_9279 4.535E-03 0.01136679 0.0970162 0.35614334 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN thyroid adenoma DOID_2891 4.771E-03 0.01190731 0.2884621 0.6754524 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN thyroiditis DOID_7166 5.159E-03 0.01281982 0.10313998 0.37380032 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autoimmune thyroiditis DOID_7188 5.159E-03 0.01281982 0.10313998 0.37380032 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN vein disease DOID_866 5.159E-03 0.01276409 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Barrett's esophagus DOID_9206 5.159E-03 0.01270883 0.10313998 0.37143449 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN movement disease DOID_480 5.618E-03 0.01377976 0.05031898 0.27010848 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN schizophreniform disorder DOID_11328 5.821E-03 0.01421616 0.10922239 0.39086505 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN methylmalonic acidemia DOID_14749 5.821E-03 0.01415541 5.821E-03 0.06494834 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN basal cell carcinoma DOID_2513 5.821E-03 0.01409517 5.821E-03 0.06369933 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN schizoaffective disorder DOID_5418 5.821E-03 0.01421616 0.10922239 0.39086505 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN bronchitis DOID_6132 5.821E-03 0.01403545 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN withdrawal disorder DOID_0060001 5.92E-03 0.01421191 0.05202665 0.27666507 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN B-cell lymphocytic neoplasm DOID_707 5.92E-03 0.0141522 0.05202665 0.27158865 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN orofacial cleft DOID_0050567 6.23E-03 0.01483238 0.05375482 0.27805902 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN skin carcinoma DOID_3451 6.52E-03 0.01545766 6.52E-03 0.06870069 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN atrophic muscular disease DOID_913 6.55E-03 0.01546511 6.55E-03 0.06776531 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN muscular dystrophy DOID_9884 6.55E-03 0.01546511 6.55E-03 0.06776531 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN dissociative disorder DOID_10935 7.255E-03 0.01705726 0.12126422 0.40828014 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN dissociative amnesia DOID_11037 7.255E-03 0.01705726 0.12126422 0.40828014 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN conduct disorder DOID_12995 7.255E-03 0.01698707 7.255E-03 0.07371175 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN granulosa cell tumor DOID_2999 7.255E-03 0.01691745 0.12126422 0.40350493 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN psoriasis DOID_8893 7.255E-03 0.0168484 7.255E-03 0.07116997 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN membranous glomerulonephritis DOID_10976 8.025E-03 0.01856151 0.12722419 0.41131003 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN sex cord-gonadal stromal tumor DOID_192 8.025E-03 0.01848637 0.12722419 0.40668857 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN subependymal glioma DOID_4843 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pilocytic astrocytoma DOID_4851 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN subependymal giant cell astrocytoma DOID_5077 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN fibrillary astrocytoma DOID_6726 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN juvenile pilocytic astrocytoma DOID_6811 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN childhood pilocytic astrocytoma DOID_6812 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN gemistocytic astrocytoma DOID_7005 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN childhood cerebral astrocytoma DOID_7007 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN protoplasmic astrocytoma DOID_7008 8.025E-03 0.01841183 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN amyloidosis DOID_9120 8.025E-03 0.01833788 8.025E-03 0.07739208 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hypertrophic cardiomyopathy DOID_11984 8.297E-03 0.01888322 0.3398307 0.76127428 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN melancholia DOID_2848 8.676E-03 0.01966689 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN neurotic disorder DOID_4964 9.064E-03 0.02046692 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN benign glioma DOID_0060101 9.67E-03 0.02174814 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN gastric ulcer DOID_10808 9.67E-03 0.02166252 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN thrombophilia DOID_2452 9.67E-03 0.02157757 0.1390236 0.43226463 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN benign ependymoma DOID_4844 9.67E-03 0.02174814 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN uremia DOID_4676 0.01054408 0.02343585 0.14486357 0.4407881 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN urinary tract obstruction DOID_5200 0.01054408 0.02334466 0.14486357 0.43844348 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pulmonary embolism DOID_9477 0.01054408 0.02325418 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Goodpasture syndrome DOID_9808 0.01145164 0.02515823 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN spastic quadriplegia DOID_10970 0.01239229 0.02712005 0.01239229 0.10524198 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN toxic shock syndrome DOID_14115 0.01239229 0.02701614 0.15642542 0.46117131 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN sphingolipidosis DOID_1927 0.01239229 0.02691302 0.15642542 0.45879414 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN endocrine organ benign neoplasm DOID_0060089 0.01254141 0.02713333 0.38331583 0.83887194 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN organic acidemia DOID_0060159 0.01336554 0.02880678 0.01336554 0.1118381 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN portal hypertension DOID_10762 0.01336554 0.02869808 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN blood coagulation disease DOID_1247 0.01351381 0.02890736 0.08798195 0.34525329 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cystitis DOID_1679 0.0143709 0.03062563 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN myositis DOID_633 0.0143709 0.03051136 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN intracranial aneurysm DOID_10941 0.01540791 0.03259145 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN vitiligo DOID_12306 0.01540791 0.03247074 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hypotrichosis DOID_4535 0.01540791 0.03235092 0.01540791 0.12176527 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN endogenous depression DOID_1595 0.01612813 0.03373863 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN diffuse large B-cell lymphoma DOID_0050745 0.01647608 0.03434026 0.01647608 0.12668772 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN perinatal necrotizing enterocolitis DOID_8677 0.01647608 0.03421493 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN sarcoma DOID_1115 0.01757496 0.03636419 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN malaria DOID_12365 0.01757496 0.03623243 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hepatic vascular disease DOID_272 0.01757496 0.03610163 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autoimmune disease of endocrine system DOID_0060005 0.01870408 0.0382828 0.19018495 0.51531065 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN supratentorial cancer DOID_1659 0.01870408 0.03814559 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cerebrum cancer DOID_368 0.01870408 0.03814559 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN cranial nerve disease DOID_5656 0.01870408 0.03800935 0.19018495 0.50567868 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN corneal disease DOID_10124 0.01986297 0.04022076 0.19567921 0.5178673 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN endometrial carcinoma DOID_2871 0.01986297 0.04007813 0.19567921 0.51546977 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN spastic cerebral palsy DOID_0050669 0.0210512 0.04232557 0.0210512 0.14972669 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Charcot-Marie-Tooth disease DOID_10595 0.02226832 0.04461504 0.02226832 0.15452039 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN endometrial cancer DOID_1380 0.02226832 0.0444585 0.20655658 0.54161609 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN chronic leukemia DOID_1036 0.02351387 0.04678109 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN chronic lymphocytic leukemia DOID_1040 0.02351387 0.04678109 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN autonomic nervous system neoplasm DOID_2621 0.02351387 0.04661809 0.21194019 0.55065738 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN neuroblastoma DOID_769 0.02351387 0.04661809 0.21194019 0.55065738 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Human immunodeficiency virus infectious disease DOID_526 0.02485747 0.04911076 0.46556738 0.98114015 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN pneumoconiosis DOID_10316 0.02608855 0.05136465 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hepatitis C DOID_1883 0.02608855 0.05118753 0.22259849 0.57572063 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN esophageal disease DOID_6050 0.02608855 0.05101162 0.22259849 0.57053396 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN leukopenia DOID_615 0.02608855 0.05083693 0.22259849 0.56797551 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hyperthyroidism DOID_7998 0.02608855 0.05066342 0.22259849 0.56543991 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lymphoid leukemia DOID_10747 0.02741681 0.05306178 0.02741681 0.17333514 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN refractive error DOID_9835 0.02877178 0.0554954 0.02877178 0.17232783 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN peripheral nervous system neoplasm DOID_1192 0.0315602 0.06066808 0.24348622 0.60764764 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN Huntington's disease DOID_12858 0.03896985 0.07465942 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hyperinsulinism DOID_2018 0.03896985 0.07440888 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN learning disability DOID_8927 0.0421008 0.08011824 0.0421008 0.23718171 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN myeloma DOID_0070004 0.04532257 0.0859618 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN brain cancer DOID_1319 0.04532257 0.08567622 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN central nervous system cancer DOID_3620 0.04696657 0.08849 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN lung small cell carcinoma DOID_5409 0.04863217 0.09132575 0.29808926 0.68948288 CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN hemorrhagic disease DOID_2213 0.05202665 0.09737883 0.05202665 0.27410336 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP lymphoma DOID_0060058 4.224E-09 2.403E-06 1.85E-05 3.508E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP transitional cell carcinoma DOID_2671 5.631E-08 1.602E-05 9.703E-07 5.521E-04 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP carbohydrate metabolic disorder DOID_2978 1.4E-06 2.656E-04 1.4E-06 3.984E-04 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP B-cell lymphocytic neoplasm DOID_707 1.543E-05 2.196E-03 2.732E-04 0.01036423 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP diffuse large B-cell lymphoma DOID_0050745 2.297E-05 2.614E-03 6.218E-04 0.01608277 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP perinatal necrotizing enterocolitis DOID_8677 2.297E-05 2.179E-03 2.297E-05 3.268E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP mitochondrial metabolism disease DOID_700 2.387E-05 1.94E-03 2.387E-05 2.716E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP congenital nervous system abnormality DOID_2490 2.592E-05 1.843E-03 2.592E-05 2.458E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP oral cavity cancer DOID_8618 2.81E-05 1.776E-03 4.369E-04 0.01462175 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP Zellweger syndrome DOID_905 6.603E-05 3.757E-03 6.603E-05 5.368E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP nutritional deficiency disease DOID_5113 8.219E-05 4.252E-03 8.219E-05 5.846E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP microcephaly DOID_10907 9.278E-05 4.399E-03 9.278E-05 5.866E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP bone resorption disease DOID_0080011 9.784E-05 4.283E-03 9.784E-05 5.567E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP osteoporosis DOID_11476 9.784E-05 4.283E-03 9.784E-05 5.567E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP aneurysm disease DOID_2403 9.784E-05 3.977E-03 9.784E-05 5.061E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP mixed glioma DOID_5076 1.039E-04 3.941E-03 0.01127278 0.09432665 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP lymphatic system disease DOID_75 1.12E-04 3.985E-03 1.12E-04 5.313E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP peroxisomal disease DOID_906 1.218E-04 4.076E-03 1.218E-04 5.331E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP hyperinsulinism DOID_2018 1.462E-04 4.62E-03 2.404E-03 0.03598945 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP colon carcinoma DOID_1520 2.016E-04 6.037E-03 5.893E-03 0.06706652 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP myeloma DOID_0070004 2.026E-04 5.764E-03 2.026E-04 8.234E-03 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP bone marrow cancer DOID_4960 3.367E-04 9.122E-03 3.367E-04 0.01197324 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP reading disorder DOID_13365 4.481E-04 0.01159069 4.481E-04 0.0141664 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP osteosarcoma DOID_3347 4.481E-04 0.01108675 9.854E-03 0.08626287 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP dyslexia DOID_4428 4.481E-04 0.01159069 4.481E-04 0.0141664 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP carotid artery disease DOID_3407 5.247E-04 0.01244092 0.05301397 0.29573479 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP intracranial aneurysm DOID_10941 5.599E-04 0.01274284 5.599E-04 0.01676689 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP seminoma DOID_4440 5.599E-04 0.01225273 5.599E-04 0.01592855 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP pre-malignant neoplasm DOID_0060071 5.899E-04 0.01243161 5.899E-04 0.0159835 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP in situ carcinoma DOID_8719 5.899E-04 0.01243161 5.899E-04 0.0159835 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP lung adenocarcinoma DOID_3910 6.218E-04 0.01263646 6.218E-04 0.01538352 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP endocrine pancreas disease DOID_1428 6.245E-04 0.01225389 6.942E-03 0.07181463 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP invasive ductal carcinoma DOID_3008 6.88E-04 0.01304887 6.88E-04 0.01631108 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP tuberculosis DOID_399 7.776E-04 0.01427254 0.06367366 0.28304932 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP congenital disorder of glycosylation DOID_5212 8.334E-04 0.01481861 8.334E-04 0.01896782 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP spastic cerebral palsy DOID_0050669 9.128E-04 0.01573949 0.01559186 0.11988879 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP age related macular degeneration DOID_10871 9.128E-04 0.01527657 9.128E-04 0.01997705 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP degeneration of macula and posterior pole DOID_2007 9.128E-04 0.01527657 9.128E-04 0.01997705 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP germinoma DOID_3304 9.969E-04 0.01620724 9.969E-04 0.02100938 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP pancreatic carcinoma DOID_4905 1.004E-03 0.01586791 9.809E-03 0.08858986 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP hereditary spastic paraplegia DOID_2476 1.086E-03 0.01669741 1.086E-03 0.02206443 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP male infertility DOID_12336 1.278E-03 0.01913777 1.278E-03 0.02507708 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP macular degeneration DOID_4448 1.278E-03 0.01864706 1.278E-03 0.02424118 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP paraplegia DOID_607 1.278E-03 0.01818088 1.278E-03 0.0234592 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP lipid metabolism disorder DOID_3146 1.332E-03 0.01848971 1.332E-03 0.02368994 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP lymphoid leukemia DOID_10747 1.382E-03 0.01871968 0.02037252 0.15054497 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP bone development disease DOID_0080006 1.589E-03 0.02102398 1.589E-03 0.02739488 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP multiple myeloma DOID_9538 1.605E-03 0.02075063 1.605E-03 0.02685376 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP common variable immunodeficiency DOID_12177 1.765E-03 0.02232169 0.06174756 0.29036662 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP primary bacterial infectious disease DOID_0050338 1.802E-03 0.02229477 0.09390479 0.31246681 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP primary immunodeficiency disease DOID_612 1.955E-03 0.02367222 0.09748023 0.32247822 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP amino acid metabolic disorder DOID_9252 1.955E-03 0.02317905 1.955E-03 0.03178841 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP intracranial arterial disease DOID_13089 1.979E-03 0.02298047 0.0256816 0.18040531 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP cerebral arterial disease DOID_3527 1.979E-03 0.02298047 0.0256816 0.18040531 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP Human immunodeficiency virus infectious disease DOID_526 2.035E-03 0.0231594 0.09928232 0.32097523 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP cervix uteri carcinoma in situ DOID_8991 2.115E-03 0.02359467 2.115E-03 0.03342579 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP salivary gland cancer DOID_8850 2.256E-03 0.02468907 2.256E-03 0.03469816 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP lymphoblastic leukemia DOID_1037 2.288E-03 0.02456125 0.104744 0.32746889 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP encephalomyelitis DOID_640 2.288E-03 0.02410641 0.104744 0.32567945 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.377E-03 0.02458691 0.10658249 0.32959477 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP dilated cardiomyopathy DOID_12930 2.468E-03 0.02507406 2.468E-03 0.03600378 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP vulva cancer DOID_1245 2.485E-03 0.0248022 0.0725595 0.28871578 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP hepatic coma DOID_12550 2.485E-03 0.02437457 0.0725595 0.28671081 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP hepatic encephalopathy DOID_13413 2.485E-03 0.02437457 0.0725595 0.28671081 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP learning disability DOID_8927 2.715E-03 0.02618815 2.715E-03 0.03862752 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP T-cell leukemia DOID_715 2.888E-03 0.02738473 0.07791887 0.29361483 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP polycystic kidney disease DOID_898 2.888E-03 0.0269358 2.888E-03 0.04007522 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP heart valve disease DOID_4079 3.051E-03 0.02800282 3.051E-03 0.0413375 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP hemolytic anemia DOID_583 3.228E-03 0.0291572 3.228E-03 0.04271868 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP normocytic anemia DOID_720 3.228E-03 0.0291572 3.228E-03 0.04271868 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP thoracic aortic aneurysm DOID_14004 3.319E-03 0.02951049 3.319E-03 0.04292434 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP congenital ichthyosiform erythroderma DOID_1699 3.319E-03 0.02905648 3.319E-03 0.04197047 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP integumentary system benign neoplasm DOID_0060121 3.412E-03 0.02941129 0.03646268 0.23052517 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP pulmonary tuberculosis DOID_2957 3.412E-03 0.02897231 0.26026417 0.55883136 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP skin benign neoplasm DOID_3165 3.412E-03 0.02941129 0.03646268 0.23052517 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP lung small cell carcinoma DOID_5409 3.412E-03 0.02854625 0.03646268 0.22799193 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP tongue cancer DOID_8649 3.779E-03 0.03116368 0.0885453 0.29811999 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP orofacial cleft DOID_0050567 3.999E-03 0.03250462 3.999E-03 0.04946356 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP congenital disorder of glycosylation type I DOID_0050570 4.267E-03 0.0341938 4.267E-03 0.05165446 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP urinary system benign neoplasm DOID_731 4.267E-03 0.03371888 4.267E-03 0.05057832 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP reproductive organ benign neoplasm DOID_0050622 4.644E-03 0.03619761 0.04444889 0.26622544 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP male reproductive organ benign neoplasm DOID_0060087 4.782E-03 0.03676863 0.09904983 0.3257766 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP conduct disorder DOID_12995 5.324E-03 0.04039284 5.324E-03 0.06182578 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP agammaglobulinemia DOID_2583 5.324E-03 0.03986136 0.10425681 0.33140851 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP hypertrophic cardiomyopathy DOID_11984 5.349E-03 0.03952393 0.04866216 0.27968455 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP blood protein disease DOID_620 5.893E-03 0.04299136 0.10943383 0.33298315 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP amyloidosis DOID_9120 5.893E-03 0.04244716 5.893E-03 0.06575149 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP respiratory failure DOID_11162 6.383E-03 0.04539869 0.31401022 0.65688168 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP Leigh disease DOID_3652 6.489E-03 0.04558372 6.489E-03 0.07100541 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP mitochondrial myopathy DOID_699 6.489E-03 0.04502782 6.489E-03 0.06966569 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP congenital heart defect DOID_1682 6.659E-03 0.04564891 6.659E-03 0.07016406 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP funisitis DOID_0050698 7.111E-03 0.04816841 7.111E-03 0.07225262 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP hepatitis B DOID_2043 7.111E-03 0.04760172 7.111E-03 0.07098503 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP muscular atrophy DOID_767 7.111E-03 0.04704822 7.111E-03 0.06976115 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP glycogen metabolism disorder DOID_0050728 7.759E-03 0.05074413 7.759E-03 0.07482609 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP glycogen storage disease DOID_2747 7.759E-03 0.05074413 7.759E-03 0.07482609 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP endocrine organ benign neoplasm DOID_0060089 8.144E-03 0.05265757 0.06367366 0.28527806 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP synostosis DOID_11971 8.432E-03 0.05390875 8.432E-03 0.07996465 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP astrocytoma DOID_3069 8.462E-03 0.05350068 0.06525113 0.28781312 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP pancreatic ductal carcinoma DOID_3587 8.788E-03 0.05494911 8.788E-03 0.08197327 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP male reproductive system disease DOID_48 9.121E-03 0.05641098 9.121E-03 0.08370661 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP spastic quadriplegia DOID_10970 9.131E-03 0.05586438 0.13487556 0.38372098 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP organic acidemia DOID_0060159 9.854E-03 0.05964985 9.854E-03 0.08761072 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP syndrome DOID_225 0.01052593 0.06304477 0.07498286 0.28827869 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP autosomal dominant nonsyndromic deafness DOID_0050564 0.01060246 0.06284168 0.01060246 0.09140608 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP spinal muscular atrophy DOID_12377 0.01060246 0.06219383 0.01060246 0.09004181 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP papillary adenoma DOID_3172 0.01060246 0.0615592 0.14484849 0.40401368 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP microcystic adenoma DOID_5403 0.01060246 0.0615592 0.14484849 0.40401368 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP follicular adenoma DOID_6204 0.01060246 0.0615592 0.14484849 0.40401368 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP congenital hypoplastic anemia DOID_1342 0.01137497 0.06537735 0.01137497 0.09380228 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP B cell deficiency DOID_2115 0.01137497 0.06472357 0.14979195 0.41174697 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP spinal cord disease DOID_319 0.01137497 0.06408275 0.14979195 0.40976741 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP chromosomal disease DOID_0080014 0.01244908 0.06944634 0.01244908 0.10119323 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP auditory system disease DOID_2742 0.01285621 0.07102119 0.01285621 0.10303073 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP supratentorial cancer DOID_1659 0.01383542 0.07569573 0.16445231 0.42340889 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP cerebrum cancer DOID_368 0.01383542 0.07569573 0.16445231 0.42340889 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP cranial nerve disease DOID_5656 0.01383542 0.07497481 0.01383542 0.10933827 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP dysostosis DOID_1934 0.01470223 0.07892044 0.01470223 0.1145968 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP mouth disease DOID_403 0.01833509 0.09750154 0.01833509 0.1391022 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP papilloma DOID_2615 0.0183949 0.09691388 0.18832913 0.46590988 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP adenoma DOID_657 2.574E-06 1.465E-03 3.299E-04 0.06257834 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP diabetic retinopathy DOID_8947 1.947E-05 5.54E-03 0.05085302 0.5358402 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP retinal vascular disease DOID_2462 2.921E-05 5.54E-03 0.0580041 0.57902336 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP mouth disease DOID_403 3.922E-05 5.578E-03 1.000 1.000 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP diabetic angiopathy DOID_11713 1.237E-04 0.01407387 0.01633535 0.54675394 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP papillary adenoma DOID_3172 1.571E-04 0.01489638 1.571E-04 0.0893783 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP microcystic adenoma DOID_5403 1.571E-04 0.01489638 1.571E-04 0.0893783 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP follicular adenoma DOID_6204 1.571E-04 0.01489638 1.571E-04 0.0893783 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP intracranial aneurysm DOID_10941 1.691E-04 0.01374471 0.01903285 0.54148452 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP papilloma DOID_2615 2.809E-04 0.01997685 2.809E-04 0.07990741 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP Huntington's disease DOID_12858 4.595E-04 0.02904981 0.03108379 0.50533369 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP thyroid adenoma DOID_2891 5.429E-04 0.03089223 5.429E-04 0.07723058 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP pustulosis of palm and sole DOID_4398 7.301E-04 0.03776845 0.03903854 0.51657973 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP endocrine organ benign neoplasm DOID_0060089 1.092E-03 0.05176255 1.092E-03 0.12423012 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP peripheral vascular disease DOID_341 1.217E-03 0.05326704 0.05020034 0.53894332 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP bone resorption disease DOID_0080011 1.349E-03 0.05482404 0.05280848 0.54632769 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP osteoporosis DOID_11476 1.349E-03 0.05482404 0.05280848 0.54632769 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP aneurysm disease DOID_2403 1.349E-03 0.0511691 0.05280848 0.53657184 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP transitional cell carcinoma DOID_2671 1.745E-03 0.06206956 1.745E-03 0.16551883 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP Human immunodeficiency virus infectious disease DOID_526 1.823E-03 0.06100717 0.06123743 0.59057796 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.982E-03 0.0626602 0.06381642 0.59527116 ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP dilated cardiomyopathy DOID_12930 2.023E-03 0.06058653 0.0644601 0.57309054 KIM_LRRC3B_TARGETS autoimmune disease of gastrointestinal tract DOID_0060031 4.899E-13 2.787E-10 4.583E-04 0.08692614 KIM_LRRC3B_TARGETS tuberculosis DOID_399 3.421E-12 9.733E-10 1.000 1.000 KIM_LRRC3B_TARGETS myositis DOID_633 4.128E-12 7.829E-10 0.01625746 0.38543732 KIM_LRRC3B_TARGETS primary bacterial infectious disease DOID_0050338 1.378E-11 1.961E-09 1.000 1.000 KIM_LRRC3B_TARGETS sarcoidosis DOID_11335 1.931E-10 2.197E-08 1.000 1.000 KIM_LRRC3B_TARGETS hypersensitivity reaction type IV disease DOID_2916 3.001E-10 2.846E-08 1.000 1.000 KIM_LRRC3B_TARGETS autoimmune hepatitis DOID_2048 6.117E-10 4.972E-08 0.01266669 0.51481044 KIM_LRRC3B_TARGETS myasthenia gravis DOID_437 9.042E-10 6.431E-08 1.000 1.000 KIM_LRRC3B_TARGETS neuromuscular junction disease DOID_439 1.789E-09 1.131E-07 1.000 1.000 KIM_LRRC3B_TARGETS ankylosing spondylitis DOID_7147 1.789E-09 1.018E-07 1.000 1.000 KIM_LRRC3B_TARGETS Human immunodeficiency virus infectious disease DOID_526 2.45E-09 1.268E-07 0.05436537 0.54269991 KIM_LRRC3B_TARGETS autoimmune disease of the nervous system DOID_438 2.791E-09 1.323E-07 1.000 1.000 KIM_LRRC3B_TARGETS hypersensitivity reaction type I disease DOID_1205 3.205E-09 1.403E-07 0.05723751 0.54280239 KIM_LRRC3B_TARGETS celiac disease DOID_10608 4.715E-09 1.916E-07 0.02043091 0.43056248 KIM_LRRC3B_TARGETS proteinuria DOID_576 2.141E-08 8.122E-07 0.02931705 0.49062953 KIM_LRRC3B_TARGETS angioedema DOID_1558 2.334E-08 8.3E-07 1.000 1.000 KIM_LRRC3B_TARGETS pulmonary tuberculosis DOID_2957 2.733E-08 9.146E-07 1.000 1.000 KIM_LRRC3B_TARGETS collagen disease DOID_854 6.382E-08 2.018E-06 1.000 1.000 KIM_LRRC3B_TARGETS adrenal cortex disease DOID_3952 8.832E-08 2.645E-06 1.000 1.000 KIM_LRRC3B_TARGETS adrenal gland disease DOID_9553 1.319E-07 3.752E-06 1.000 1.000 KIM_LRRC3B_TARGETS pancreatitis DOID_4989 1.579E-07 4.277E-06 0.04743804 0.51908164 KIM_LRRC3B_TARGETS mixed glioma DOID_5076 1.579E-07 4.083E-06 1.554E-05 4.422E-03 KIM_LRRC3B_TARGETS psoriasis DOID_8893 1.878E-07 4.646E-06 1.878E-07 1.069E-04 KIM_LRRC3B_TARGETS primary immunodeficiency disease DOID_612 2.656E-07 6.296E-06 1.395E-03 0.19846196 KIM_LRRC3B_TARGETS hepatitis B DOID_2043 2.981E-07 6.785E-06 1.000 1.000 KIM_LRRC3B_TARGETS encephalomyelitis DOID_640 3.158E-07 6.912E-06 0.05608966 0.54093245 KIM_LRRC3B_TARGETS urticaria DOID_1555 5.025E-07 1.059E-05 1.000 1.000 KIM_LRRC3B_TARGETS extrinsic allergic alveolitis DOID_841 6.326E-07 1.286E-05 1.000 1.000 KIM_LRRC3B_TARGETS pneumoconiosis DOID_10316 1.495E-06 2.934E-05 1.000 1.000 KIM_LRRC3B_TARGETS uveitis DOID_13141 2.048E-06 3.884E-05 0.02458742 0.48242207 KIM_LRRC3B_TARGETS systemic scleroderma DOID_418 2.205E-06 4.047E-05 1.000 1.000 KIM_LRRC3B_TARGETS pulmonary emphysema DOID_9675 2.541E-06 4.519E-05 0.02636361 0.48389978 KIM_LRRC3B_TARGETS endometriosis of uterus DOID_288 2.722E-06 4.693E-05 1.000 1.000 KIM_LRRC3B_TARGETS rheumatic disease DOID_1575 2.911E-06 4.871E-05 1.000 1.000 KIM_LRRC3B_TARGETS endometriosis DOID_289 2.911E-06 4.732E-05 1.000 1.000 KIM_LRRC3B_TARGETS uveal disease DOID_3480 2.911E-06 4.6E-05 0.02754602 0.48980261 KIM_LRRC3B_TARGETS scleroderma DOID_419 2.911E-06 4.871E-05 1.000 1.000 KIM_LRRC3B_TARGETS vascular skin disease DOID_9540 3.752E-06 5.77E-05 1.000 1.000 KIM_LRRC3B_TARGETS vasculitis DOID_865 5.586E-06 8.364E-05 1.000 1.000 KIM_LRRC3B_TARGETS uterine disease DOID_345 9.526E-06 1.39E-04 1.000 1.000 KIM_LRRC3B_TARGETS peripheral vascular disease DOID_341 1.28E-05 1.821E-04 1.000 1.000 KIM_LRRC3B_TARGETS bacterial pneumonia DOID_874 1.554E-05 2.157E-04 0.04743804 0.50928765 KIM_LRRC3B_TARGETS Sjogren's syndrome DOID_12894 1.58E-05 2.14E-04 1.000 1.000 KIM_LRRC3B_TARGETS childhood type dermatomyositis DOID_14203 1.58E-05 2.09E-04 6.051E-03 0.68860618 KIM_LRRC3B_TARGETS female reproductive system disease DOID_229 1.736E-05 2.245E-04 1.000 1.000 KIM_LRRC3B_TARGETS trypanosomiasis DOID_10113 1.93E-05 2.44E-04 1.000 1.000 KIM_LRRC3B_TARGETS dermatomyositis DOID_10223 1.93E-05 2.387E-04 6.654E-03 0.6310393 KIM_LRRC3B_TARGETS bronchiectasis DOID_9563 1.93E-05 2.336E-04 1.000 1.000 KIM_LRRC3B_TARGETS stomach disease DOID_76 2.315E-05 2.744E-04 1.000 1.000 KIM_LRRC3B_TARGETS encephalitis DOID_9588 2.315E-05 2.688E-04 1.000 1.000 KIM_LRRC3B_TARGETS berylliosis DOID_10322 2.735E-05 3.112E-04 1.000 1.000 KIM_LRRC3B_TARGETS polyneuropathy DOID_1389 2.735E-05 3.051E-04 1.000 1.000 KIM_LRRC3B_TARGETS narcolepsy DOID_8986 3.19E-05 3.49E-04 1.000 1.000 KIM_LRRC3B_TARGETS thyroiditis DOID_7166 4.203E-05 4.512E-04 1.000 1.000 KIM_LRRC3B_TARGETS autoimmune thyroiditis DOID_7188 4.203E-05 4.512E-04 1.000 1.000 KIM_LRRC3B_TARGETS juvenile rheumatoid arthritis DOID_676 4.762E-05 5.017E-04 1.000 1.000 KIM_LRRC3B_TARGETS funisitis DOID_0050698 8.073E-05 8.352E-04 1.000 1.000 KIM_LRRC3B_TARGETS sleep disorder DOID_535 8.839E-05 8.981E-04 1.000 1.000 KIM_LRRC3B_TARGETS Goodpasture syndrome DOID_9808 9.639E-05 9.622E-04 1.000 1.000 KIM_LRRC3B_TARGETS severe combined immunodeficiency DOID_627 1.047E-04 1.027E-03 0.01506193 0.38955622 KIM_LRRC3B_TARGETS combined T cell and B cell immunodeficiency DOID_628 1.134E-04 1.094E-03 0.01565987 0.38741152 KIM_LRRC3B_TARGETS vitiligo DOID_12306 1.318E-04 1.25E-03 1.000 1.000 KIM_LRRC3B_TARGETS pleurisy DOID_10247 1.516E-04 1.414E-03 1.000 1.000 KIM_LRRC3B_TARGETS autoimmune disease of endocrine system DOID_0060005 1.62E-04 1.486E-03 1.000 1.000 KIM_LRRC3B_TARGETS bronchiolitis obliterans DOID_2799 1.838E-04 1.66E-03 1.000 1.000 KIM_LRRC3B_TARGETS pleural disease DOID_1532 2.069E-04 1.84E-03 1.000 1.000 KIM_LRRC3B_TARGETS systemic mycosis DOID_0050136 2.19E-04 1.917E-03 1.000 1.000 KIM_LRRC3B_TARGETS fungal infectious disease DOID_1564 2.19E-04 1.917E-03 1.000 1.000 KIM_LRRC3B_TARGETS esophageal disease DOID_6050 2.315E-04 1.996E-03 1.000 1.000 KIM_LRRC3B_TARGETS pulmonary sarcoidosis DOID_13406 2.708E-04 2.3E-03 1.000 1.000 KIM_LRRC3B_TARGETS respiratory syncytial virus infectious disease DOID_1273 2.987E-04 2.499E-03 1.000 1.000 KIM_LRRC3B_TARGETS peptic ulcer DOID_750 2.987E-04 2.463E-03 1.000 1.000 KIM_LRRC3B_TARGETS autoimmune disease of urogenital tract DOID_0060049 3.431E-04 2.789E-03 1.000 1.000 KIM_LRRC3B_TARGETS primary biliary cirrhosis DOID_12236 3.431E-04 2.789E-03 1.000 1.000 KIM_LRRC3B_TARGETS influenza DOID_8469 3.743E-04 3E-03 1.000 1.000 KIM_LRRC3B_TARGETS pre-eclampsia DOID_10591 4.237E-04 3.349E-03 1.000 1.000 KIM_LRRC3B_TARGETS neuritis DOID_1803 4.237E-04 3.303E-03 0.02990671 0.45991677 KIM_LRRC3B_TARGETS aortic aneurysm DOID_3627 4.761E-04 3.661E-03 1.000 1.000 KIM_LRRC3B_TARGETS B-cell lymphocytic neoplasm DOID_707 4.942E-04 3.75E-03 0.03226193 0.47069329 KIM_LRRC3B_TARGETS parasitic protozoa infectious disease DOID_2789 5.701E-04 4.268E-03 1.000 1.000 KIM_LRRC3B_TARGETS pustulosis of palm and sole DOID_4398 5.701E-04 4.213E-03 0.03461168 0.48034253 KIM_LRRC3B_TARGETS hypothyroidism DOID_1459 7.155E-04 5.219E-03 1.000 1.000 KIM_LRRC3B_TARGETS parasitic infectious disease DOID_1398 7.827E-04 5.638E-03 1.000 1.000 KIM_LRRC3B_TARGETS nephrosis DOID_2527 9.26E-04 6.586E-03 0.0439562 0.5321506 KIM_LRRC3B_TARGETS male reproductive system disease DOID_48 9.26E-04 6.505E-03 1.000 1.000 KIM_LRRC3B_TARGETS diabetic retinopathy DOID_8947 9.764E-04 6.775E-03 0.04511816 0.53483824 KIM_LRRC3B_TARGETS cystic fibrosis DOID_1485 1.028E-03 7.048E-03 0.04627878 0.5374005 KIM_LRRC3B_TARGETS aneurysm disease DOID_2403 1.054E-03 7.142E-03 1.000 1.000 KIM_LRRC3B_TARGETS retinal vascular disease DOID_2462 1.276E-03 8.545E-03 0.05148486 0.53263426 KIM_LRRC3B_TARGETS lymphoma DOID_0060058 1.488E-03 9.842E-03 0.05551523 0.54462353 KIM_LRRC3B_TARGETS Hermansky-Pudlak syndrome DOID_3753 6.051E-03 0.03957507 1.000 1.000 KIM_LRRC3B_TARGETS adrenal gland hyperfunction DOID_3947 6.051E-03 0.03912535 1.000 1.000 KIM_LRRC3B_TARGETS conjunctival disease DOID_4251 6.051E-03 0.03868574 1.000 1.000 KIM_LRRC3B_TARGETS conjunctivitis DOID_6195 6.051E-03 0.03868574 1.000 1.000 KIM_LRRC3B_TARGETS pneumocystosis DOID_11339 6.654E-03 0.04206929 1.000 1.000 KIM_LRRC3B_TARGETS common variable immunodeficiency DOID_12177 6.654E-03 0.04160699 1.000 1.000 KIM_LRRC3B_TARGETS temporal arteritis DOID_13375 6.654E-03 0.04115474 1.000 1.000 KIM_LRRC3B_TARGETS central nervous system vasculitis DOID_525 6.654E-03 0.04115474 1.000 1.000 KIM_LRRC3B_TARGETS common cold DOID_10459 7.257E-03 0.04440045 7.257E-03 0.58989165 KIM_LRRC3B_TARGETS leprosy DOID_1024 7.859E-03 0.04757498 1.000 1.000 KIM_LRRC3B_TARGETS psoriatic arthritis DOID_9008 7.859E-03 0.04707419 7.859E-03 0.55900602 KIM_LRRC3B_TARGETS viral pneumonia DOID_10533 8.462E-03 0.05015266 1.000 1.000 KIM_LRRC3B_TARGETS open-angle glaucoma DOID_1067 8.462E-03 0.04963563 1.000 1.000 KIM_LRRC3B_TARGETS eyelid disease DOID_530 8.462E-03 0.04912914 1.000 1.000 KIM_LRRC3B_TARGETS bacterial meningitis DOID_9470 8.462E-03 0.04863289 8.462E-03 0.53496175 KIM_LRRC3B_TARGETS idiopathic pulmonary fibrosis DOID_0050156 9.063E-03 0.05157064 1.000 1.000 KIM_LRRC3B_TARGETS thoracic aortic aneurysm DOID_14004 9.063E-03 0.05106004 1.000 1.000 KIM_LRRC3B_TARGETS arthropathy DOID_381 9.063E-03 0.05055946 1.000 1.000 KIM_LRRC3B_TARGETS hyperhomocysteinemia DOID_9279 9.063E-03 0.05006859 9.063E-03 0.51570645 KIM_LRRC3B_TARGETS lymphatic system cancer DOID_0060073 0.01026588 0.05616621 1.000 1.000 KIM_LRRC3B_TARGETS reticulosarcoma DOID_8538 0.01026588 0.05616621 1.000 1.000 KIM_LRRC3B_TARGETS lymphosarcoma DOID_8675 0.01026588 0.05616621 1.000 1.000 KIM_LRRC3B_TARGETS glucose intolerance DOID_10603 0.01086661 0.05888665 1.000 1.000 KIM_LRRC3B_TARGETS ureteral obstruction DOID_5199 0.01086661 0.05833112 0.01086661 0.56209985 KIM_LRRC3B_TARGETS prion disease DOID_649 0.01086661 0.05778597 1.000 1.000 KIM_LRRC3B_TARGETS eosinophilia DOID_999 0.01086661 0.05725091 1.000 1.000 KIM_LRRC3B_TARGETS agammaglobulinemia DOID_2583 0.01146698 0.05985975 1.000 1.000 KIM_LRRC3B_TARGETS MHC class II deficiency DOID_5812 0.01146698 0.05931557 0.01146698 0.54372605 KIM_LRRC3B_TARGETS membranous glomerulonephritis DOID_10976 0.01206701 0.06185701 1.000 1.000 KIM_LRRC3B_TARGETS esophagitis DOID_11963 0.01206701 0.06130472 1.000 1.000 KIM_LRRC3B_TARGETS blood protein disease DOID_620 0.01206701 0.0607622 1.000 1.000 KIM_LRRC3B_TARGETS amyloidosis DOID_9120 0.01206701 0.0602292 0.01206701 0.52816373 KIM_LRRC3B_TARGETS juvenile absence epilepsy DOID_0060172 0.01266669 0.06267258 1.000 1.000 KIM_LRRC3B_TARGETS acquired immunodeficiency syndrome DOID_635 0.01326602 0.06507212 0.01326602 0.50322438 KIM_LRRC3B_TARGETS opiate dependence DOID_2559 0.013865 0.06742895 0.013865 0.49307421 KIM_LRRC3B_TARGETS urinary tract obstruction DOID_5200 0.013865 0.06685752 0.013865 0.46406984 KIM_LRRC3B_TARGETS hypoglycemia DOID_9993 0.013865 0.06629569 1.000 1.000 KIM_LRRC3B_TARGETS ureteral disease DOID_1426 0.01446364 0.06858176 0.01446364 0.45721172 KIM_LRRC3B_TARGETS meningitis DOID_9471 0.01446364 0.06801497 0.01446364 0.43314794 KIM_LRRC3B_TARGETS toxic shock syndrome DOID_14115 0.01506193 0.07024784 1.000 1.000 KIM_LRRC3B_TARGETS sphingolipidosis DOID_1927 0.01506193 0.06967672 0.01506193 0.42851184 KIM_LRRC3B_TARGETS acute pancreatitis DOID_2913 0.01506193 0.06911481 0.01506193 0.40810651 KIM_LRRC3B_TARGETS commensal bacterial infectious disease DOID_0050339 0.01565987 0.07128372 1.000 1.000 KIM_LRRC3B_TARGETS bronchiolitis DOID_2942 0.01565987 0.07071798 1.000 1.000 KIM_LRRC3B_TARGETS cystitis DOID_1679 0.01625746 0.07283855 1.000 1.000 KIM_LRRC3B_TARGETS B cell deficiency DOID_2115 0.01685471 0.07492444 1.000 1.000 KIM_LRRC3B_TARGETS juvenile myoclonic epilepsy DOID_4890 0.01685471 0.07434363 1.000 1.000 KIM_LRRC3B_TARGETS diffuse large B-cell lymphoma DOID_0050745 0.01745161 0.07638434 0.01745161 0.39719858 KIM_LRRC3B_TARGETS Sciatic Neuropathy DOID_11446 0.01745161 0.07580126 1.000 1.000 KIM_LRRC3B_TARGETS lesion of sciatic nerve DOID_12528 0.01745161 0.07580126 1.000 1.000 KIM_LRRC3B_TARGETS mononeuritis of lower limb DOID_9473 0.01745161 0.07580126 1.000 1.000 KIM_LRRC3B_TARGETS autoimmune disease of cardiovascular system DOID_0060051 0.01804816 0.07779851 1.000 1.000 KIM_LRRC3B_TARGETS Behcet's disease DOID_13241 0.01804816 0.07779851 1.000 1.000 KIM_LRRC3B_TARGETS thrombocytopenia DOID_1588 0.01804816 0.07721356 0.01804816 0.39497704 KIM_LRRC3B_TARGETS mononeuritis DOID_1802 0.01804816 0.07663734 1.000 1.000 KIM_LRRC3B_TARGETS mononeuropathy DOID_1188 0.01864437 0.07858255 1.000 1.000 KIM_LRRC3B_TARGETS opportunistic mycosis DOID_2473 0.01983574 0.08298924 1.000 1.000 KIM_LRRC3B_TARGETS abdominal aortic aneurysm DOID_7693 0.01983574 0.08238348 1.000 1.000 KIM_LRRC3B_TARGETS bladder disease DOID_365 0.02102573 0.08669305 1.000 1.000 KIM_LRRC3B_TARGETS myocarditis DOID_820 0.02162021 0.08850287 1.000 1.000 KIM_LRRC3B_TARGETS hepatitis C DOID_1883 0.02221434 0.09028542 1.000 1.000 KIM_LRRC3B_TARGETS adolescence-adult electroclinical syndrome DOID_0050705 0.02399466 0.09682953 1.000 1.000 KIM_LRRC3B_TARGETS embryonal cancer DOID_688 0.02399466 0.09614763 1.000 1.000 KIM_LRRC3B_TARGETS multiple myeloma DOID_9538 0.02399466 0.09547527 0.02399466 0.48760586 KIM_LRRC3B_TARGETS blood platelet disease DOID_2218 0.02458742 0.09715445 0.02458742 0.46634134 KIM_LRRC3B_TARGETS hepatitis DOID_2237 0.02517982 0.09880911 1.000 1.000 MANN_RESPONSE_TO_AMIFOSTINE_UP lung adenocarcinoma DOID_3910 6.735E-05 0.0383216 6.735E-05 0.0383216 MANN_RESPONSE_TO_AMIFOSTINE_UP sarcoma DOID_1115 7.214E-05 0.02052437 7.214E-05 0.02052437 MANN_RESPONSE_TO_AMIFOSTINE_UP medullomyoblastoma DOID_3861 1.164E-04 0.02206935 1.164E-04 0.02206935 MANN_RESPONSE_TO_AMIFOSTINE_UP adult medulloblastoma DOID_3864 1.164E-04 0.02206935 1.164E-04 0.02206935 MANN_RESPONSE_TO_AMIFOSTINE_UP childhood medulloblastoma DOID_3869 1.164E-04 0.02206935 1.164E-04 0.02206935 MANN_RESPONSE_TO_AMIFOSTINE_UP medulloblastoma DOID_3858 1.29E-04 0.01835593 1.29E-04 0.01835593 MANN_RESPONSE_TO_AMIFOSTINE_UP primitive neuroectodermal tumor DOID_168 1.71E-04 0.01945677 1.71E-04 0.01945677 MANN_RESPONSE_TO_AMIFOSTINE_UP B-cell lymphocytic neoplasm DOID_707 2.359E-04 0.02237349 0.02255278 0.42775103 MANN_RESPONSE_TO_AMIFOSTINE_UP neuroectodermal tumor DOID_171 3.316E-04 0.02695064 3.316E-04 0.03144241 MANN_RESPONSE_TO_AMIFOSTINE_UP Human immunodeficiency virus infectious disease DOID_526 6.837E-04 0.04862886 6.837E-04 0.05557584 MANN_RESPONSE_TO_AMIFOSTINE_UP lymphoma DOID_0060058 7.136E-04 0.0451138 0.03895015 0.46172156 MANN_RESPONSE_TO_AMIFOSTINE_UP alcohol-related neurodevelopmental disorder DOID_0050667 7.441E-04 0.04233722 0.03976321 0.45250532 MANN_RESPONSE_TO_AMIFOSTINE_UP mouth disease DOID_403 7.441E-04 0.03848838 0.03976321 0.44363267 URS_ADIPOCYTE_DIFFERENTIATION_DN facioscapulohumeral muscular dystrophy DOID_11727 1.503E-08 8.552E-06 1.503E-08 8.552E-06 URS_ADIPOCYTE_DIFFERENTIATION_DN atrophic muscular disease DOID_913 2.032E-08 5.781E-06 2.032E-08 5.781E-06 URS_ADIPOCYTE_DIFFERENTIATION_DN muscular dystrophy DOID_9884 2.032E-08 5.781E-06 2.032E-08 5.781E-06 URS_ADIPOCYTE_DIFFERENTIATION_DN aortic valve insufficiency DOID_57 2.754E-08 5.223E-06 1.74E-05 3.299E-03 URS_ADIPOCYTE_DIFFERENTIATION_DN collagen disease DOID_854 3.505E-08 4.986E-06 5.227E-04 0.02287728 URS_ADIPOCYTE_DIFFERENTIATION_DN Ehlers-Danlos syndrome DOID_13359 5.689E-08 6.474E-06 2.765E-05 3.933E-03 URS_ADIPOCYTE_DIFFERENTIATION_DN aortic valve disease DOID_62 2.523E-07 2.393E-05 7.247E-05 5.154E-03 URS_ADIPOCYTE_DIFFERENTIATION_DN heart valve disease DOID_4079 2.422E-06 1.969E-04 3.19E-04 0.0201685 URS_ADIPOCYTE_DIFFERENTIATION_DN integumentary system benign neoplasm DOID_0060121 2.729E-06 1.941E-04 3.451E-04 0.01963581 URS_ADIPOCYTE_DIFFERENTIATION_DN skin benign neoplasm DOID_3165 2.729E-06 1.941E-04 3.451E-04 0.01963581 URS_ADIPOCYTE_DIFFERENTIATION_DN integumentary system cancer DOID_0060122 3.803E-06 2.404E-04 4.294E-04 0.02221066 URS_ADIPOCYTE_DIFFERENTIATION_DN skin cancer DOID_4159 3.803E-06 2.404E-04 4.294E-04 0.02221066 URS_ADIPOCYTE_DIFFERENTIATION_DN carotid artery disease DOID_3407 5.124E-06 2.916E-04 5.227E-04 0.02478372 URS_ADIPOCYTE_DIFFERENTIATION_DN oral submucous fibrosis DOID_5773 2.765E-05 1.43E-03 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN varicose veins DOID_799 2.765E-05 1.311E-03 7.886E-03 0.28043042 URS_ADIPOCYTE_DIFFERENTIATION_DN vein disease DOID_866 3.159E-05 1.383E-03 8.409E-03 0.26582301 URS_ADIPOCYTE_DIFFERENTIATION_DN ureteral obstruction DOID_5199 4.025E-05 1.636E-03 4.025E-05 4.58E-03 URS_ADIPOCYTE_DIFFERENTIATION_DN urinary tract obstruction DOID_5200 6.645E-05 2.521E-03 6.645E-05 6.302E-03 URS_ADIPOCYTE_DIFFERENTIATION_DN diabetic angiopathy DOID_11713 7.247E-05 2.577E-03 0.01258851 0.32558468 URS_ADIPOCYTE_DIFFERENTIATION_DN ureteral disease DOID_1426 7.247E-05 2.426E-03 7.247E-05 5.891E-03 URS_ADIPOCYTE_DIFFERENTIATION_DN renal hypertension DOID_1073 1.14E-04 3.604E-03 0.01571203 0.37250615 URS_ADIPOCYTE_DIFFERENTIATION_DN secondary hypertension DOID_11130 1.14E-04 3.604E-03 0.01571203 0.37250615 URS_ADIPOCYTE_DIFFERENTIATION_DN focal glomerulosclerosis DOID_3945 1.218E-04 3.648E-03 0.01623171 0.36943368 URS_ADIPOCYTE_DIFFERENTIATION_DN abdominal aortic aneurysm DOID_7693 1.382E-04 3.933E-03 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN cerebral infarction DOID_3526 2.939E-04 7.964E-03 0.02502638 0.47466702 URS_ADIPOCYTE_DIFFERENTIATION_DN glaucoma DOID_1686 3.451E-04 8.925E-03 0.02708483 0.49713775 URS_ADIPOCYTE_DIFFERENTIATION_DN aortic aneurysm DOID_3627 3.585E-04 8.869E-03 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN withdrawal disorder DOID_0060001 3.722E-04 8.824E-03 0.02811251 0.48472784 URS_ADIPOCYTE_DIFFERENTIATION_DN giant cell tumor DOID_200 4.003E-04 9.11E-03 0.02913916 0.48765237 URS_ADIPOCYTE_DIFFERENTIATION_DN malignant giant cell tumor DOID_2705 4.003E-04 9.11E-03 0.02913916 0.48765237 URS_ADIPOCYTE_DIFFERENTIATION_DN giant cell glioblastoma DOID_3074 4.003E-04 9.11E-03 0.02913916 0.48765237 URS_ADIPOCYTE_DIFFERENTIATION_DN glioblastoma DOID_3068 4.749E-04 0.01039314 0.03170127 0.51537203 URS_ADIPOCYTE_DIFFERENTIATION_DN allergic contact dermatitis DOID_3042 6.249E-04 0.01317003 0.03629689 0.57369245 URS_ADIPOCYTE_DIFFERENTIATION_DN brain infarction DOID_3454 6.429E-04 0.01306364 0.03680623 0.56602013 URS_ADIPOCYTE_DIFFERENTIATION_DN astrocytoma DOID_3069 6.61E-04 0.01296945 0.03731532 0.55874778 URS_ADIPOCYTE_DIFFERENTIATION_DN peripheral vascular disease DOID_341 7.17E-04 0.01359842 0.03884105 0.55251389 URS_ADIPOCYTE_DIFFERENTIATION_DN bone resorption disease DOID_0080011 7.95E-04 0.01459243 0.04087178 0.56722055 URS_ADIPOCYTE_DIFFERENTIATION_DN osteoporosis DOID_11476 7.95E-04 0.01459243 0.04087178 0.56722055 URS_ADIPOCYTE_DIFFERENTIATION_DN aneurysm disease DOID_2403 7.95E-04 0.01413642 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN contact dermatitis DOID_2773 8.561E-04 0.01476185 0.04239215 0.56095664 URS_ADIPOCYTE_DIFFERENTIATION_DN biliary tract cancer DOID_4607 9.195E-04 0.01538733 0.04391024 0.56783922 URS_ADIPOCYTE_DIFFERENTIATION_DN retinal vascular disease DOID_2462 9.629E-04 0.01565377 0.04492102 0.5680014 URS_ADIPOCYTE_DIFFERENTIATION_DN mouth disease DOID_403 1.17E-03 0.01849807 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN temporal arteritis DOID_13375 5.789E-03 0.08901841 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN central nervous system vasculitis DOID_525 5.789E-03 0.08901841 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN bronchiectasis DOID_9563 5.789E-03 0.08667582 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN osteopetrosis DOID_13533 6.313E-03 0.09210787 6.313E-03 0.25658622 URS_ADIPOCYTE_DIFFERENTIATION_DN ocular hypertension DOID_9282 6.313E-03 0.08980518 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN borderline glaucoma DOID_9283 6.313E-03 0.08980518 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN encephalitis DOID_9588 6.313E-03 0.08761481 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN osteogenesis imperfecta DOID_12347 6.838E-03 0.09263293 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN larynx cancer DOID_2596 6.838E-03 0.09047868 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN laryngeal benign neoplasm DOID_2598 6.838E-03 0.09047868 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN bacterial meningitis DOID_9470 7.362E-03 0.09520022 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN skeletal system cancer DOID_0060124 7.886E-03 0.09970859 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN thoracic aortic aneurysm DOID_14004 7.886E-03 0.09754102 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN bone cancer DOID_184 7.886E-03 0.09970859 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN corneal dystrophy DOID_2566 7.886E-03 0.09546567 7.886E-03 0.29912578 URS_ADIPOCYTE_DIFFERENTIATION_DN membranoproliferative glomerulonephritis DOID_2920 7.886E-03 0.09347681 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN spastic diplegia DOID_10965 8.409E-03 0.09764927 1.000 1.000 URS_ADIPOCYTE_DIFFERENTIATION_DN restrictive cardiomyopathy DOID_397 8.409E-03 0.09569629 8.409E-03 0.28145966 URS_ADIPOCYTE_DIFFERENTIATION_DN hyperostosis DOID_205 8.932E-03 0.09965868 8.932E-03 0.26750486 RAMASWAMY_METASTASIS_DN leukodystrophy DOID_10579 1.29E-05 7.339E-03 9.475E-04 0.10783079 RAMASWAMY_METASTASIS_DN aortic aneurysm DOID_3627 1.636E-05 4.654E-03 1.108E-03 0.10505037 RAMASWAMY_METASTASIS_DN cerebral degeneration DOID_1443 3.467E-05 6.575E-03 1.815E-03 0.12911996 RAMASWAMY_METASTASIS_DN blood coagulation disease DOID_1247 4.289E-05 6.101E-03 4.289E-05 0.02440256 RAMASWAMY_METASTASIS_DN aneurysm disease DOID_2403 5.432E-05 6.182E-03 2.44E-03 0.15424679 RAMASWAMY_METASTASIS_DN inherited blood coagulation disease DOID_2214 1.255E-04 0.01190277 1.255E-04 0.03570832 RAMASWAMY_METASTASIS_DN brain edema DOID_4724 1.557E-04 0.01265493 0.0183078 0.43404737 RAMASWAMY_METASTASIS_DN spinal muscular atrophy DOID_12377 2.864E-04 0.02037317 2.864E-04 0.05432845 RAMASWAMY_METASTASIS_DN pneumoconiosis DOID_10316 5.404E-04 0.034163 1.000 1.000 RAMASWAMY_METASTASIS_DN paraplegia DOID_607 5.404E-04 0.0307467 0.03361307 0.53127319 RAMASWAMY_METASTASIS_DN blood platelet disease DOID_2218 6.638E-04 0.03433515 6.638E-04 0.09442167 RAMASWAMY_METASTASIS_DN endometriosis of uterus DOID_288 7.995E-04 0.03791102 0.04073509 0.55186352 RAMASWAMY_METASTASIS_DN endometriosis DOID_289 8.354E-04 0.03656428 0.04162175 0.55076226 RAMASWAMY_METASTASIS_DN neuritis DOID_1803 9.865E-04 0.0400924 0.04516044 0.55861499 RAMASWAMY_METASTASIS_DN pulmonary tuberculosis DOID_2957 1.067E-03 0.0404579 1.000 1.000 RAMASWAMY_METASTASIS_DN withdrawal disorder DOID_0060001 1.15E-03 0.04088536 0.04868643 0.56535875 RAMASWAMY_METASTASIS_DN hemorrhagic disease DOID_2213 1.15E-03 0.03848034 1.15E-03 0.09345226 RAMASWAMY_METASTASIS_DN sarcoidosis DOID_11335 1.236E-03 0.03906552 1.000 1.000 RAMASWAMY_METASTASIS_DN pustulosis of palm and sole DOID_4398 1.325E-03 0.03967911 0.05219977 0.58238569 RAMASWAMY_METASTASIS_DN hypersensitivity reaction type IV disease DOID_2916 1.464E-03 0.04165908 1.000 1.000 RAMASWAMY_METASTASIS_DN respiratory failure DOID_11162 1.66E-03 0.04499119 0.05831781 0.60332429 RAMASWAMY_METASTASIS_DN hypothyroidism DOID_1459 1.66E-03 0.04294613 0.05831781 0.59255064 RAMASWAMY_METASTASIS_DN cholestasis DOID_13580 1.815E-03 0.04491129 0.06092807 0.59772539 RAMASWAMY_METASTASIS_DN uterine disease DOID_345 1.815E-03 0.04303999 0.06092807 0.58759445 RAMASWAMY_METASTASIS_DN tuberculosis DOID_399 1.977E-03 0.04499481 1.000 1.000 RAMASWAMY_METASTASIS_DN bile duct disease DOID_4138 2.145E-03 0.04694331 0.06612752 0.60687997 RAMASWAMY_METASTASIS_DN peripheral vascular disease DOID_341 2.203E-03 0.04641631 1.000 1.000 RAMASWAMY_METASTASIS_DN biliary tract disease DOID_9741 2.203E-03 0.04475858 0.06699137 0.59559514 RAMASWAMY_METASTASIS_DN female reproductive system disease DOID_229 2.689E-03 0.05275051 0.07387429 0.62738016 RAMASWAMY_METASTASIS_DN primary bacterial infectious disease DOID_0050338 3.083E-03 0.05847608 1.000 1.000 RAMASWAMY_METASTASIS_DN encephalomyelitis DOID_640 3.503E-03 0.06430003 0.08410627 0.65556808 NGUYEN_NOTCH1_TARGETS_UP brain edema DOID_4724 7.247E-05 0.04123458 7.247E-05 0.04123458 NGUYEN_NOTCH1_TARGETS_UP coronary stenosis DOID_4248 1.653E-04 0.04702056 1.653E-04 0.04702056 NGUYEN_NOTCH1_TARGETS_UP multiple myeloma DOID_9538 2.952E-04 0.0559916 0.02502508 0.418802 NGUYEN_NOTCH1_TARGETS_UP hepatitis DOID_2237 3.256E-04 0.04631876 3.256E-04 0.06175835 NGUYEN_NOTCH1_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 3.575E-04 0.04068171 3.575E-04 0.05085214 NGUYEN_NOTCH1_TARGETS_UP myeloma DOID_0070004 4.618E-04 0.04379816 0.03118693 0.4225086 NGUYEN_NOTCH1_TARGETS_UP calcium metabolism disease DOID_10575 5.189E-04 0.04218118 5.189E-04 0.05905365 NGUYEN_NOTCH1_TARGETS_UP atrophic muscular disease DOID_913 5.793E-04 0.04119978 5.793E-04 0.05493304 NGUYEN_NOTCH1_TARGETS_UP muscular dystrophy DOID_9884 5.793E-04 0.04119978 5.793E-04 0.05493304 NGUYEN_NOTCH1_TARGETS_UP bone marrow cancer DOID_4960 6.001E-04 0.03793907 0.035478 0.4205621 NGUYEN_NOTCH1_TARGETS_UP pre-malignant neoplasm DOID_0060071 8.037E-04 0.04573132 8.037E-04 0.06533045 NGUYEN_NOTCH1_TARGETS_UP in situ carcinoma DOID_8719 8.037E-04 0.04573132 8.037E-04 0.06533045 NGUYEN_NOTCH1_TARGETS_UP mineral metabolism disease DOID_0050032 8.281E-04 0.04283657 8.281E-04 0.05890029 NGUYEN_NOTCH1_TARGETS_UP metabolic syndrome X DOID_14221 1.237E-03 0.05863955 1.237E-03 0.07818607 ACEVEDO_LIVER_CANCER_DN metabolic syndrome X DOID_14221 1.726E-17 9.823E-15 4.976E-13 9.437E-11 ACEVEDO_LIVER_CANCER_DN carbohydrate metabolic disorder DOID_2978 1.765E-16 5.022E-14 1.765E-16 1.004E-13 ACEVEDO_LIVER_CANCER_DN lipid metabolism disorder DOID_3146 5.785E-16 1.097E-13 1.776E-14 5.054E-12 ACEVEDO_LIVER_CANCER_DN retinal vascular disease DOID_2462 3.952E-14 5.622E-12 5.248E-10 5.972E-08 ACEVEDO_LIVER_CANCER_DN familial hyperlipidemia DOID_1168 2.905E-13 3.306E-11 9.763E-12 1.389E-09 ACEVEDO_LIVER_CANCER_DN diabetic retinopathy DOID_8947 5.361E-12 5.084E-10 5.876E-08 4.776E-06 ACEVEDO_LIVER_CANCER_DN familial hypercholesterolemia DOID_13810 1.085E-10 8.817E-09 6.996E-09 6.635E-07 ACEVEDO_LIVER_CANCER_DN adult respiratory distress syndrome DOID_11394 5.501E-10 3.912E-08 5.062E-07 2.4E-05 ACEVEDO_LIVER_CANCER_DN respiratory failure DOID_11162 7.148E-10 4.519E-08 3.437E-07 2.445E-05 ACEVEDO_LIVER_CANCER_DN parasitic infectious disease DOID_1398 1.082E-09 6.158E-08 7.866E-06 2.034E-04 ACEVEDO_LIVER_CANCER_DN bacterial pneumonia DOID_874 4.739E-09 2.451E-07 2.015E-05 4.247E-04 ACEVEDO_LIVER_CANCER_DN silicosis DOID_10325 6.228E-08 2.953E-06 1.71E-04 2.56E-03 ACEVEDO_LIVER_CANCER_DN auditory system disease DOID_2742 1.295E-07 5.67E-06 2E-06 7.587E-05 ACEVEDO_LIVER_CANCER_DN chronic kidney failure DOID_784 1.421E-07 5.777E-06 2.167E-06 7.706E-05 ACEVEDO_LIVER_CANCER_DN pneumoconiosis DOID_10316 1.998E-07 7.581E-06 1.23E-04 1.892E-03 ACEVEDO_LIVER_CANCER_DN primary immunodeficiency disease DOID_612 2.422E-07 8.614E-06 3.43E-06 1.148E-04 ACEVEDO_LIVER_CANCER_DN amino acid metabolic disorder DOID_9252 2.422E-07 8.107E-06 3.43E-06 1.084E-04 ACEVEDO_LIVER_CANCER_DN thrombophilia DOID_2452 3.63E-07 1.147E-05 3.63E-07 2.295E-05 ACEVEDO_LIVER_CANCER_DN hypolipoproteinemia DOID_1387 4.531E-07 1.357E-05 4.531E-07 2.578E-05 ACEVEDO_LIVER_CANCER_DN glycogen metabolism disorder DOID_0050728 4.612E-07 1.312E-05 4.612E-07 2.385E-05 ACEVEDO_LIVER_CANCER_DN glycogen storage disease DOID_2747 4.612E-07 1.312E-05 4.612E-07 2.385E-05 ACEVEDO_LIVER_CANCER_DN meningitis DOID_9471 5.792E-07 1.569E-05 5.931E-04 6.25E-03 ACEVEDO_LIVER_CANCER_DN brain infarction DOID_3454 6.338E-07 1.639E-05 6.338E-07 2.774E-05 ACEVEDO_LIVER_CANCER_DN uveal disease DOID_3480 7.643E-07 1.891E-05 1.65E-05 3.611E-04 ACEVEDO_LIVER_CANCER_DN pre-eclampsia DOID_10591 1.267E-06 3.004E-05 2.494E-05 4.893E-04 ACEVEDO_LIVER_CANCER_DN pancreatitis DOID_4989 1.436E-06 3.269E-05 1.436E-06 5.837E-05 ACEVEDO_LIVER_CANCER_DN parasitic helminthiasis infectious disease DOID_883 2.113E-06 4.625E-05 1.123E-04 1.825E-03 ACEVEDO_LIVER_CANCER_DN toxic encephalopathy DOID_3602 2.226E-06 4.691E-05 1.271E-03 0.01130106 ACEVEDO_LIVER_CANCER_DN nutritional deficiency disease DOID_5113 2.866E-06 5.824E-05 4.708E-03 0.02790396 ACEVEDO_LIVER_CANCER_DN pre-malignant neoplasm DOID_0060071 6.605E-06 1.296E-04 6.605E-06 1.978E-04 ACEVEDO_LIVER_CANCER_DN in situ carcinoma DOID_8719 6.605E-06 1.296E-04 6.605E-06 1.978E-04 ACEVEDO_LIVER_CANCER_DN endocrine pancreas disease DOID_1428 7.213E-06 1.368E-04 7.213E-06 2.052E-04 ACEVEDO_LIVER_CANCER_DN cholestasis DOID_13580 7.866E-06 1.444E-04 7.866E-06 2.131E-04 ACEVEDO_LIVER_CANCER_DN pulmonary sarcoidosis DOID_13406 8.193E-06 1.457E-04 0.03123727 0.10579765 ACEVEDO_LIVER_CANCER_DN temporal lobe epilepsy DOID_3328 8.565E-06 1.477E-04 1.189E-04 1.879E-03 ACEVEDO_LIVER_CANCER_DN uveitis DOID_13141 9.278E-06 1.553E-04 1.846E-04 2.694E-03 ACEVEDO_LIVER_CANCER_DN blood coagulation disease DOID_1247 1.189E-05 1.932E-04 1.189E-05 2.94E-04 ACEVEDO_LIVER_CANCER_DN bile duct disease DOID_4138 1.286E-05 2.033E-04 1.286E-05 3.049E-04 ACEVEDO_LIVER_CANCER_DN biliary tract disease DOID_9741 1.39E-05 2.137E-04 1.39E-05 3.163E-04 ACEVEDO_LIVER_CANCER_DN bone resorption disease DOID_0080011 1.875E-05 2.807E-04 2.254E-04 3.206E-03 ACEVEDO_LIVER_CANCER_DN osteoporosis DOID_11476 1.875E-05 2.807E-04 2.254E-04 3.206E-03 ACEVEDO_LIVER_CANCER_DN contact dermatitis DOID_2773 2.321E-05 3.387E-04 2.321E-05 4.717E-04 ACEVEDO_LIVER_CANCER_DN neuritis DOID_1803 2.494E-05 3.547E-04 5.033E-03 0.02835511 ACEVEDO_LIVER_CANCER_DN acute pancreatitis DOID_2913 2.515E-05 3.491E-04 2.515E-05 4.771E-04 ACEVEDO_LIVER_CANCER_DN hemolytic anemia DOID_583 2.749E-05 3.724E-04 4.316E-04 5.012E-03 ACEVEDO_LIVER_CANCER_DN normocytic anemia DOID_720 2.749E-05 3.724E-04 4.316E-04 5.012E-03 ACEVEDO_LIVER_CANCER_DN alcohol abuse DOID_1574 2.85E-05 3.771E-04 2.85E-05 5.23E-04 ACEVEDO_LIVER_CANCER_DN focal epilepsy DOID_2234 2.85E-05 3.685E-04 3.172E-04 4.102E-03 ACEVEDO_LIVER_CANCER_DN primary bacterial infectious disease DOID_0050338 3.7E-05 4.679E-04 0.02397444 0.08688825 ACEVEDO_LIVER_CANCER_DN hyperparathyroidism DOID_13543 3.778E-05 4.673E-04 2.064E-03 0.01608916 ACEVEDO_LIVER_CANCER_DN angioedema DOID_1558 3.778E-05 4.573E-04 3.778E-05 6.717E-04 ACEVEDO_LIVER_CANCER_DN conjunctival disease DOID_4251 3.778E-05 4.478E-04 3.778E-05 6.514E-04 ACEVEDO_LIVER_CANCER_DN labyrinthine disease DOID_4539 3.778E-05 4.387E-04 2.064E-03 0.01525336 ACEVEDO_LIVER_CANCER_DN conjunctivitis DOID_6195 3.778E-05 4.478E-04 3.778E-05 6.514E-04 ACEVEDO_LIVER_CANCER_DN sarcoidosis DOID_11335 4.346E-05 4.946E-04 0.05742194 0.17287347 ACEVEDO_LIVER_CANCER_DN Sciatic Neuropathy DOID_11446 4.621E-05 5.156E-04 0.0170845 0.06894382 ACEVEDO_LIVER_CANCER_DN lesion of sciatic nerve DOID_12528 4.621E-05 5.156E-04 0.0170845 0.06894382 ACEVEDO_LIVER_CANCER_DN lung adenocarcinoma DOID_3910 4.621E-05 5.057E-04 1.044E-03 9.899E-03 ACEVEDO_LIVER_CANCER_DN mononeuritis of lower limb DOID_9473 4.621E-05 5.156E-04 0.0170845 0.06894382 ACEVEDO_LIVER_CANCER_DN vasculitis DOID_865 4.737E-05 5.086E-04 6.605E-04 6.833E-03 ACEVEDO_LIVER_CANCER_DN parasitic protozoa infectious disease DOID_2789 5.155E-05 5.432E-04 7.61E-03 0.03765218 ACEVEDO_LIVER_CANCER_DN pustulosis of palm and sole DOID_4398 5.155E-05 5.333E-04 7.61E-03 0.03732759 ACEVEDO_LIVER_CANCER_DN inner ear disease DOID_2952 5.168E-05 5.251E-04 2.511E-03 0.01742654 ACEVEDO_LIVER_CANCER_DN autoimmune disease of cardiovascular system DOID_0060051 5.304E-05 5.294E-04 1.154E-03 0.01042236 ACEVEDO_LIVER_CANCER_DN Behcet's disease DOID_13241 5.304E-05 5.294E-04 1.154E-03 0.01042236 ACEVEDO_LIVER_CANCER_DN mononeuritis DOID_1802 5.304E-05 5.203E-04 0.01822239 0.07101741 ACEVEDO_LIVER_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.67E-05 5.468E-04 5.558E-04 6.081E-03 ACEVEDO_LIVER_CANCER_DN Crohn's disease DOID_8778 5.67E-05 5.377E-04 0.02912974 0.10106598 ACEVEDO_LIVER_CANCER_DN mononeuropathy DOID_1188 6.056E-05 5.649E-04 0.01939145 0.07355822 ACEVEDO_LIVER_CANCER_DN hypersensitivity reaction type IV disease DOID_2916 6.581E-05 6.04E-04 0.06673828 0.19778169 ACEVEDO_LIVER_CANCER_DN aortic valve stenosis DOID_1712 6.855E-05 6.191E-04 6.855E-05 1.147E-03 ACEVEDO_LIVER_CANCER_DN melancholia DOID_2848 7.119E-05 6.329E-04 0.06865819 0.19339856 ACEVEDO_LIVER_CANCER_DN neurotic disorder DOID_4964 7.689E-05 6.731E-04 0.07059616 0.19690792 ACEVEDO_LIVER_CANCER_DN parathyroid gland disease DOID_11201 8.866E-05 7.644E-04 3.529E-03 0.02231284 ACEVEDO_LIVER_CANCER_DN uterine disease DOID_345 1.109E-04 9.416E-04 1.283E-03 0.01106329 ACEVEDO_LIVER_CANCER_DN hepatitis C DOID_1883 1.23E-04 1.03E-03 2.131E-03 0.01535009 ACEVEDO_LIVER_CANCER_DN tuberculosis DOID_399 1.362E-04 1.123E-03 0.08671051 0.2081784 ACEVEDO_LIVER_CANCER_DN nephrosis DOID_2527 1.657E-04 1.347E-03 1.755E-03 0.01426963 ACEVEDO_LIVER_CANCER_DN hemolytic-uremic syndrome DOID_12554 1.71E-04 1.37E-03 5.356E-03 0.02958802 ACEVEDO_LIVER_CANCER_DN peripheral vascular disease DOID_341 1.765E-04 1.395E-03 0.01528886 0.06492062 ACEVEDO_LIVER_CANCER_DN endogenous depression DOID_1595 2.123E-04 1.655E-03 0.10161219 0.22323295 ACEVEDO_LIVER_CANCER_DN aneurysm disease DOID_2403 2.254E-04 1.733E-03 2.254E-04 3.128E-03 ACEVEDO_LIVER_CANCER_DN mixed glioma DOID_5076 2.391E-04 1.814E-03 0.01814241 0.07168772 ACEVEDO_LIVER_CANCER_DN female reproductive system disease DOID_229 2.839E-04 2.126E-03 2.671E-03 0.01831291 ACEVEDO_LIVER_CANCER_DN Huntington's disease DOID_12858 2.896E-04 2.14E-03 2.896E-04 3.923E-03 ACEVEDO_LIVER_CANCER_DN hyperinsulinism DOID_2018 2.896E-04 2.112E-03 2.896E-04 3.832E-03 ACEVEDO_LIVER_CANCER_DN influenza DOID_8469 3.148E-04 2.267E-03 0.04195618 0.13336908 ACEVEDO_LIVER_CANCER_DN mental depression DOID_1596 3.172E-04 2.256E-03 0.1171553 0.24328966 ACEVEDO_LIVER_CANCER_DN membranous glomerulonephritis DOID_10976 3.41E-04 2.395E-03 8.328E-03 0.04015608 ACEVEDO_LIVER_CANCER_DN amyloidosis DOID_9120 3.41E-04 2.366E-03 3.41E-04 4.311E-03 ACEVEDO_LIVER_CANCER_DN cerebral infarction DOID_3526 3.416E-04 2.342E-03 3.416E-04 4.225E-03 ACEVEDO_LIVER_CANCER_DN proteinuria DOID_576 3.699E-04 2.506E-03 4.755E-03 0.02733018 ACEVEDO_LIVER_CANCER_DN heart valve disease DOID_4079 3.999E-04 2.677E-03 3.999E-04 4.841E-03 ACEVEDO_LIVER_CANCER_DN transitional cell carcinoma DOID_2671 4.132E-04 2.734E-03 4.132E-04 4.899E-03 ACEVEDO_LIVER_CANCER_DN pulmonary tuberculosis DOID_2957 4.651E-04 3.042E-03 0.05033015 0.15479922 ACEVEDO_LIVER_CANCER_DN urinary tract obstruction DOID_5200 5.217E-04 3.373E-03 5.217E-04 5.936E-03 ACEVEDO_LIVER_CANCER_DN hypoglycemia DOID_9993 5.217E-04 3.335E-03 5.217E-04 5.82E-03 ACEVEDO_LIVER_CANCER_DN hypersensitivity reaction type I disease DOID_1205 5.827E-04 3.684E-03 0.02991028 0.10252378 ACEVEDO_LIVER_CANCER_DN aortic valve disease DOID_62 5.931E-04 3.709E-03 5.931E-04 6.368E-03 ACEVEDO_LIVER_CANCER_DN urticaria DOID_1555 7.542E-04 4.665E-03 7.542E-04 7.663E-03 ACEVEDO_LIVER_CANCER_DN autosomal dominant nonsyndromic deafness DOID_0050564 8.442E-04 5.165E-03 8.442E-04 8.427E-03 ACEVEDO_LIVER_CANCER_DN nonsyndromic deafness DOID_0050563 8.539E-04 5.169E-03 8.539E-04 8.377E-03 ACEVEDO_LIVER_CANCER_DN bile duct cancer DOID_4606 8.539E-04 5.115E-03 8.743E-03 0.04111279 ACEVEDO_LIVER_CANCER_DN bile duct carcinoma DOID_4897 8.539E-04 5.115E-03 8.743E-03 0.04111279 ACEVEDO_LIVER_CANCER_DN extrinsic allergic alveolitis DOID_841 9.407E-04 5.575E-03 0.01597825 0.06588133 ACEVEDO_LIVER_CANCER_DN collagen disease DOID_854 1.023E-03 6.001E-03 1.023E-03 9.866E-03 ACEVEDO_LIVER_CANCER_DN perinatal necrotizing enterocolitis DOID_8677 1.044E-03 6.061E-03 1.044E-03 9.737E-03 ACEVEDO_LIVER_CANCER_DN hypothyroidism DOID_1459 1.084E-03 6.232E-03 1.084E-03 9.95E-03 ACEVEDO_LIVER_CANCER_DN renal hypertension DOID_1073 1.154E-03 6.566E-03 0.01822239 0.07150718 ACEVEDO_LIVER_CANCER_DN secondary hypertension DOID_11130 1.154E-03 6.566E-03 0.01822239 0.07150718 ACEVEDO_LIVER_CANCER_DN malaria DOID_12365 1.154E-03 6.501E-03 0.18789636 0.33202804 ACEVEDO_LIVER_CANCER_DN cerebral degeneration DOID_1443 1.283E-03 7.159E-03 1.283E-03 0.0112335 ACEVEDO_LIVER_CANCER_DN hyperglycemia DOID_4195 1.355E-03 7.485E-03 0.01222558 0.05310195 ACEVEDO_LIVER_CANCER_DN corneal disease DOID_10124 1.395E-03 7.635E-03 0.02059118 0.07657764 ACEVEDO_LIVER_CANCER_DN allergic contact dermatitis DOID_3042 1.429E-03 7.746E-03 1.429E-03 0.01213856 ACEVEDO_LIVER_CANCER_DN age related macular degeneration DOID_10871 1.527E-03 8.198E-03 0.20463101 0.35283347 ACEVEDO_LIVER_CANCER_DN degeneration of macula and posterior pole DOID_2007 1.527E-03 8.198E-03 0.20463101 0.35283347 ACEVEDO_LIVER_CANCER_DN abdominal aortic aneurysm DOID_7693 1.527E-03 8.122E-03 1.527E-03 0.01277952 ACEVEDO_LIVER_CANCER_DN Charcot-Marie-Tooth disease DOID_10595 1.667E-03 8.78E-03 1.667E-03 0.01374302 ACEVEDO_LIVER_CANCER_DN childhood absence epilepsy DOID_1825 1.814E-03 9.467E-03 1.814E-03 0.01453392 ACEVEDO_LIVER_CANCER_DN metal metabolism disorder DOID_896 1.968E-03 0.01018191 1.968E-03 0.0155557 ACEVEDO_LIVER_CANCER_DN familial combined hyperlipidemia DOID_13809 2.064E-03 0.01058116 2.064E-03 0.01587174 ACEVEDO_LIVER_CANCER_DN retinal vascular occlusion DOID_1729 2.064E-03 0.01048668 2.064E-03 0.01566011 ACEVEDO_LIVER_CANCER_DN insulinoma DOID_3892 2.064E-03 0.01039388 2.064E-03 0.01545406 ACEVEDO_LIVER_CANCER_DN keratitis DOID_4677 2.064E-03 0.01030271 2.064E-03 0.0150578 ACEVEDO_LIVER_CANCER_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.064E-03 0.01021312 0.06700683 0.19063444 ACEVEDO_LIVER_CANCER_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.064E-03 0.01021312 0.06700683 0.19063444 ACEVEDO_LIVER_CANCER_DN Hodgkin's granuloma DOID_8651 2.064E-03 0.01021312 0.06700683 0.19063444 ACEVEDO_LIVER_CANCER_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 2.064E-03 0.01021312 0.06700683 0.19063444 ACEVEDO_LIVER_CANCER_DN syndrome DOID_225 2.13E-03 0.01044793 0.01696799 0.06896274 ACEVEDO_LIVER_CANCER_DN macular degeneration DOID_4448 2.131E-03 0.01036459 0.22641069 0.37668912 ACEVEDO_LIVER_CANCER_DN hyperthyroidism DOID_7998 2.131E-03 0.01027676 0.22641069 0.3755909 ACEVEDO_LIVER_CANCER_DN childhood electroclinical syndrome DOID_0050704 2.302E-03 0.0110078 2.302E-03 0.0163741 ACEVEDO_LIVER_CANCER_DN adenoma DOID_657 2.481E-03 0.01176584 2.481E-03 0.01743088 ACEVEDO_LIVER_CANCER_DN biliary tract cancer DOID_4607 2.912E-03 0.01369346 0.02127176 0.07808794 ACEVEDO_LIVER_CANCER_DN osteopetrosis DOID_13533 3E-03 0.01399156 3E-03 0.02032107 ACEVEDO_LIVER_CANCER_DN islet cell tumor DOID_1799 3E-03 0.0138778 3E-03 0.020082 ACEVEDO_LIVER_CANCER_DN peritonitis DOID_8283 3E-03 0.01376589 0.07986151 0.20561628 ACEVEDO_LIVER_CANCER_DN Hodgkin's lymphoma DOID_8567 3E-03 0.01365576 0.07986151 0.20469008 ACEVEDO_LIVER_CANCER_DN ocular hypertension DOID_9282 3E-03 0.01354738 1.000 1.000 ACEVEDO_LIVER_CANCER_DN borderline glaucoma DOID_9283 3E-03 0.01354738 1.000 1.000 ACEVEDO_LIVER_CANCER_DN hepatitis DOID_2237 3.07E-03 0.0137541 3.07E-03 0.02031129 ACEVEDO_LIVER_CANCER_DN congenital diaphragmatic hernia DOID_3827 3.07E-03 0.01364665 3.07E-03 0.02007783 ACEVEDO_LIVER_CANCER_DN benign mesothelioma DOID_2645 3.506E-03 0.01546392 3.506E-03 0.0226687 ACEVEDO_LIVER_CANCER_DN cervix uteri carcinoma in situ DOID_8991 3.506E-03 0.01534497 3.506E-03 0.022414 ACEVEDO_LIVER_CANCER_DN larynx cancer DOID_2596 3.529E-03 0.01532943 0.08622253 0.20876859 ACEVEDO_LIVER_CANCER_DN laryngeal benign neoplasm DOID_2598 3.529E-03 0.01532943 0.08622253 0.20876859 ACEVEDO_LIVER_CANCER_DN endometriosis of uterus DOID_288 3.737E-03 0.01611008 0.03876928 0.12678 ACEVEDO_LIVER_CANCER_DN Human immunodeficiency virus infectious disease DOID_526 3.87E-03 0.0165587 0.02611763 0.09346496 ACEVEDO_LIVER_CANCER_DN endometriosis DOID_289 3.978E-03 0.01689103 0.04035071 0.12898625 ACEVEDO_LIVER_CANCER_DN Legionnaires' disease DOID_10457 4.099E-03 0.01727557 0.09253974 0.2193963 ACEVEDO_LIVER_CANCER_DN legionellosis DOID_10458 4.099E-03 0.01727557 0.09253974 0.2193963 ACEVEDO_LIVER_CANCER_DN eyelid disease DOID_530 4.099E-03 0.01714854 4.099E-03 0.02562859 ACEVEDO_LIVER_CANCER_DN diabetic autonomic neuropathy DOID_11503 4.228E-03 0.01755846 4.228E-03 0.02614683 ACEVEDO_LIVER_CANCER_DN autonomic neuropathy DOID_11504 4.228E-03 0.01755846 4.228E-03 0.02614683 ACEVEDO_LIVER_CANCER_DN diabetic polyneuropathy DOID_12785 4.228E-03 0.01755846 4.228E-03 0.02614683 ACEVEDO_LIVER_CANCER_DN diabetic neuropathy DOID_9743 4.228E-03 0.01755846 4.228E-03 0.02614683 ACEVEDO_LIVER_CANCER_DN cataract DOID_83 4.487E-03 0.01849942 0.04358529 0.13777793 ACEVEDO_LIVER_CANCER_DN mouth disease DOID_403 4.504E-03 0.01843779 0.02912974 0.10168602 ACEVEDO_LIVER_CANCER_DN thalassemia DOID_10241 4.708E-03 0.01913414 4.708E-03 0.02880408 ACEVEDO_LIVER_CANCER_DN Ehlers-Danlos syndrome DOID_13359 4.708E-03 0.01899844 4.708E-03 0.02849766 ACEVEDO_LIVER_CANCER_DN hemangioma DOID_255 4.708E-03 0.01886465 4.708E-03 0.02819768 ACEVEDO_LIVER_CANCER_DN membranoproliferative glomerulonephritis DOID_2920 4.708E-03 0.01873273 0.09881344 0.22048961 ACEVEDO_LIVER_CANCER_DN varicose veins DOID_799 4.708E-03 0.01860264 0.09881344 0.21877373 ACEVEDO_LIVER_CANCER_DN intermediate coronary syndrome DOID_8805 4.708E-03 0.01847434 4.708E-03 0.02761629 ACEVEDO_LIVER_CANCER_DN leukodystrophy DOID_10579 4.755E-03 0.01853211 4.755E-03 0.02760906 ACEVEDO_LIVER_CANCER_DN lens disease DOID_110 5.033E-03 0.01948209 0.04691282 0.146667 ACEVEDO_LIVER_CANCER_DN autonomic nervous system disease DOID_11465 5.033E-03 0.01935045 5.033E-03 0.02863867 ACEVEDO_LIVER_CANCER_DN brain cancer DOID_1319 5.033E-03 0.01922058 0.293174 0.46209421 ACEVEDO_LIVER_CANCER_DN vascular skin disease DOID_9540 5.033E-03 0.01909244 5.033E-03 0.02807712 ACEVEDO_LIVER_CANCER_DN central nervous system cancer DOID_3620 5.321E-03 0.02004973 0.29806527 0.46721527 ACEVEDO_LIVER_CANCER_DN vein disease DOID_866 5.356E-03 0.02004978 0.10504394 0.22554718 ACEVEDO_LIVER_CANCER_DN autoimmune disease of gastrointestinal tract DOID_0060031 5.618E-03 0.02089324 0.05033015 0.15564052 ACEVEDO_LIVER_CANCER_DN aortic aneurysm DOID_3627 5.925E-03 0.02189211 5.925E-03 0.03241717 ACEVEDO_LIVER_CANCER_DN lymphatic system cancer DOID_0060073 6.043E-03 0.02218219 6.043E-03 0.03274513 ACEVEDO_LIVER_CANCER_DN drug-induced mental disorder DOID_1203 6.043E-03 0.02203999 0.11123152 0.23528155 ACEVEDO_LIVER_CANCER_DN drug psychosis DOID_1742 6.043E-03 0.02203999 0.11123152 0.23528155 ACEVEDO_LIVER_CANCER_DN bronchitis DOID_6132 6.043E-03 0.02189961 6.043E-03 0.03243622 ACEVEDO_LIVER_CANCER_DN reticulosarcoma DOID_8538 6.043E-03 0.02218219 6.043E-03 0.03274513 ACEVEDO_LIVER_CANCER_DN substance-induced psychosis DOID_8646 6.043E-03 0.02203999 0.11123152 0.23528155 ACEVEDO_LIVER_CANCER_DN lymphosarcoma DOID_8675 6.043E-03 0.02218219 6.043E-03 0.03274513 ACEVEDO_LIVER_CANCER_DN withdrawal disorder DOID_0060001 6.242E-03 0.02247921 0.0538342 0.16380566 ACEVEDO_LIVER_CANCER_DN male reproductive organ benign neoplasm DOID_0060087 6.767E-03 0.02421686 6.767E-03 0.03598581 ACEVEDO_LIVER_CANCER_DN keratosis DOID_161 6.767E-03 0.02406551 6.767E-03 0.0356526 ACEVEDO_LIVER_CANCER_DN inherited blood coagulation disease DOID_2214 6.767E-03 0.02391603 6.767E-03 0.03532552 ACEVEDO_LIVER_CANCER_DN osteosclerosis DOID_4254 6.767E-03 0.0237684 6.767E-03 0.03500437 ACEVEDO_LIVER_CANCER_DN ureteral obstruction DOID_5199 6.767E-03 0.02362258 6.767E-03 0.03468902 ACEVEDO_LIVER_CANCER_DN prion disease DOID_649 6.767E-03 0.02347854 0.11737649 0.23938073 ACEVEDO_LIVER_CANCER_DN bile duct adenocarcinoma DOID_4896 7.253E-03 0.02501091 0.05924628 0.17742701 ACEVEDO_LIVER_CANCER_DN cholangiocarcinoma DOID_4947 7.253E-03 0.02501091 0.05924628 0.17742701 ACEVEDO_LIVER_CANCER_DN bone marrow cancer DOID_4960 7.253E-03 0.02486025 7.253E-03 0.03684644 ACEVEDO_LIVER_CANCER_DN testicular cancer DOID_2998 7.529E-03 0.02565256 0.12347913 0.24914761 ACEVEDO_LIVER_CANCER_DN leishmaniasis DOID_9065 7.529E-03 0.02549987 0.12347913 0.24739305 ACEVEDO_LIVER_CANCER_DN reproductive organ benign neoplasm DOID_0050622 7.61E-03 0.02562131 7.61E-03 0.03831859 ACEVEDO_LIVER_CANCER_DN osteochondrodysplasia DOID_2256 7.61E-03 0.02547059 7.61E-03 0.03798246 ACEVEDO_LIVER_CANCER_DN smallpox DOID_8736 7.61E-03 0.02532164 7.61E-03 0.03700855 ACEVEDO_LIVER_CANCER_DN colon carcinoma DOID_1520 8.328E-03 0.02754894 8.328E-03 0.03981864 ACEVEDO_LIVER_CANCER_DN hypertrophic cardiomyopathy DOID_11984 8.743E-03 0.02875518 8.743E-03 0.04145539 ACEVEDO_LIVER_CANCER_DN oral cavity cancer DOID_8618 8.743E-03 0.02858993 8.743E-03 0.0407758 ACEVEDO_LIVER_CANCER_DN juvenile absence epilepsy DOID_0060172 9.163E-03 0.02979139 9.163E-03 0.04238613 ACEVEDO_LIVER_CANCER_DN neuroectodermal tumor DOID_171 9.969E-03 0.03223056 0.07255186 0.20137566 ACEVEDO_LIVER_CANCER_DN carotid artery disease DOID_3407 9.969E-03 0.03204846 0.07255186 0.20039811 ACEVEDO_LIVER_CANCER_DN benign glioma DOID_0060101 0.01003322 0.03207247 0.14153599 0.27770338 ACEVEDO_LIVER_CANCER_DN benign ependymoma DOID_4844 0.01003322 0.03207247 0.14153599 0.27770338 ACEVEDO_LIVER_CANCER_DN muscular atrophy DOID_767 0.01003322 0.0318933 0.01003322 0.04603952 ACEVEDO_LIVER_CANCER_DN placenta disease DOID_780 0.01003322 0.03171611 0.01003322 0.0456712 ACEVEDO_LIVER_CANCER_DN IgA glomerulonephritis DOID_2986 0.01093908 0.0343886 0.01093908 0.04939949 ACEVEDO_LIVER_CANCER_DN pulmonary embolism DOID_9477 0.01093908 0.03419965 0.01093908 0.04901052 ACEVEDO_LIVER_CANCER_DN lingual-facial-buccal dyskinesia DOID_9854 0.01093908 0.03401276 0.14747222 0.27693628 ACEVEDO_LIVER_CANCER_DN diabetic angiopathy DOID_11713 0.01187962 0.03673643 1.000 1.000 ACEVEDO_LIVER_CANCER_DN Lewy body dementia DOID_12217 0.01187962 0.03653785 0.01187962 0.05280861 ACEVEDO_LIVER_CANCER_DN ureteral disease DOID_1426 0.01187962 0.03634141 0.01187962 0.05239925 ACEVEDO_LIVER_CANCER_DN congenital hemolytic anemia DOID_589 0.01187962 0.03614707 0.01187962 0.05199617 ACEVEDO_LIVER_CANCER_DN tooth disease DOID_1091 0.01270899 0.03846499 0.08463988 0.21500042 ACEVEDO_LIVER_CANCER_DN toxic shock syndrome DOID_14115 0.01285432 0.03869897 0.01285432 0.05540989 ACEVEDO_LIVER_CANCER_DN commensal bacterial infectious disease DOID_0050339 0.01386266 0.04151501 0.01386266 0.05930716 ACEVEDO_LIVER_CANCER_DN bronchiolitis DOID_2942 0.01386266 0.04129765 1.000 1.000 ACEVEDO_LIVER_CANCER_DN osteosarcoma DOID_3347 0.01386266 0.04108256 0.16503665 0.30488914 ACEVEDO_LIVER_CANCER_DN pancreatic ductal carcinoma DOID_3587 0.01422424 0.04193571 0.09089691 0.21731236 ACEVEDO_LIVER_CANCER_DN spinal muscular atrophy DOID_12377 0.01490414 0.04371368 0.17081098 0.3135208 ACEVEDO_LIVER_CANCER_DN ankylosing spondylitis DOID_7147 0.01490414 0.0434895 1.000 1.000 ACEVEDO_LIVER_CANCER_DN pancreatic carcinoma DOID_4905 0.01583759 0.0459775 0.09728482 0.22230949 ACEVEDO_LIVER_CANCER_DN intracranial aneurysm DOID_10941 0.01597825 0.04615037 0.01597825 0.06734536 ACEVEDO_LIVER_CANCER_DN teeth hard tissue disease DOID_214 0.01597825 0.04591729 0.01597825 0.06685017 ACEVEDO_LIVER_CANCER_DN juvenile myoclonic epilepsy DOID_4890 0.01597825 0.04568655 0.01597825 0.06636221 ACEVEDO_LIVER_CANCER_DN fragments of torsion dystonia DOID_531 0.01597825 0.04545812 0.17654552 0.31589435 ACEVEDO_LIVER_CANCER_DN cystic fibrosis DOID_1485 0.01696799 0.04803375 0.01696799 0.06945887 ACEVEDO_LIVER_CANCER_DN migraine DOID_6364 0.0170845 0.04812415 0.0170845 0.0684583 ACEVEDO_LIVER_CANCER_DN electroclinical syndrome DOID_0050701 0.01814241 0.05085237 0.01814241 0.07218903 ACEVEDO_LIVER_CANCER_DN pleurisy DOID_10247 0.01822239 0.05082618 0.18789636 0.33410321 ACEVEDO_LIVER_CANCER_DN sarcoma DOID_1115 0.01822239 0.05057825 0.18789636 0.33306239 ACEVEDO_LIVER_CANCER_DN hepatic vascular disease DOID_272 0.01822239 0.05033273 0.01822239 0.0705343 ACEVEDO_LIVER_CANCER_DN renal tubular transport disease DOID_447 0.01822239 0.05008957 0.01822239 0.07005771 ACEVEDO_LIVER_CANCER_DN central nervous system hereditary degenerative disease DOID_481 0.01822239 0.04984876 0.18789636 0.32896316 ACEVEDO_LIVER_CANCER_DN polycystic ovary syndrome DOID_11612 0.01939145 0.05279298 0.01939145 0.0740519 ACEVEDO_LIVER_CANCER_DN multiple epiphyseal dysplasia DOID_12721 0.01939145 0.05254158 0.01939145 0.07307108 ACEVEDO_LIVER_CANCER_DN supratentorial cancer DOID_1659 0.01939145 0.05229257 1.000 1.000 ACEVEDO_LIVER_CANCER_DN cerebrum cancer DOID_368 0.01939145 0.05229257 1.000 1.000 ACEVEDO_LIVER_CANCER_DN focal glomerulosclerosis DOID_3945 0.01939145 0.05204591 0.01939145 0.07259035 ACEVEDO_LIVER_CANCER_DN dystonic disease DOID_544 0.01939145 0.05180156 0.19351319 0.33775768 ACEVEDO_LIVER_CANCER_DN congenital disorder of glycosylation DOID_5212 0.02059118 0.05474943 0.02059118 0.07608038 ACEVEDO_LIVER_CANCER_DN opportunistic mycosis DOID_2473 0.02182111 0.05774981 0.20463101 0.35176751 ACEVEDO_LIVER_CANCER_DN bone development disease DOID_0080006 0.02193082 0.05777147 0.02193082 0.07999127 ACEVEDO_LIVER_CANCER_DN celiac disease DOID_10608 0.02308077 0.06052053 0.21013254 0.36013679 ACEVEDO_LIVER_CANCER_DN allergic rhinitis DOID_4481 0.02308077 0.06024292 0.21013254 0.35691168 ACEVEDO_LIVER_CANCER_DN pleural disease DOID_1532 0.02436969 0.06331668 0.21559615 0.36294145 ACEVEDO_LIVER_CANCER_DN systemic mycosis DOID_0050136 0.02568741 0.06643699 0.22102211 0.37097812 ACEVEDO_LIVER_CANCER_DN fungal infectious disease DOID_1564 0.02568741 0.06643699 0.22102211 0.37097812 ACEVEDO_LIVER_CANCER_DN papilloma DOID_2615 0.02568741 0.06613637 0.02568741 0.0925072 ACEVEDO_LIVER_CANCER_DN nervous system cancer DOID_3093 0.02611763 0.06694112 0.47206479 0.71059489 ACEVEDO_LIVER_CANCER_DN nephroblastoma DOID_2154 0.02703348 0.06897781 0.02703348 0.09613782 ACEVEDO_LIVER_CANCER_DN spindle cell carcinoma DOID_4015 0.02703348 0.06866987 0.02703348 0.09554069 ACEVEDO_LIVER_CANCER_DN leukopenia DOID_615 0.02703348 0.06836467 0.02703348 0.09495093 ACEVEDO_LIVER_CANCER_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.02980885 0.07504972 0.02980885 0.10279538 ACEVEDO_LIVER_CANCER_DN adolescence-adult electroclinical syndrome DOID_0050705 0.03123727 0.07829958 0.03123727 0.10643117 ACEVEDO_LIVER_CANCER_DN multiple myeloma DOID_9538 0.03123727 0.07795616 0.03123727 0.10517163 ACEVEDO_LIVER_CANCER_DN ulcerative colitis DOID_8577 0.03231767 0.08030023 0.15219602 0.28486689 ACEVEDO_LIVER_CANCER_DN systemic scleroderma DOID_418 0.03417337 0.08454194 0.03417337 0.11438027 ACEVEDO_LIVER_CANCER_DN peptic ulcer DOID_750 0.03417337 0.08417595 0.03417337 0.11371138 ACEVEDO_LIVER_CANCER_DN adenoid cystic carcinoma DOID_4866 0.03568019 0.08750875 0.03568019 0.11803505 ACEVEDO_LIVER_CANCER_DN pulmonary emphysema DOID_9675 0.0372123 0.09087468 0.2631051 0.42290057 ACEVEDO_LIVER_CANCER_DN autoimmune disease of urogenital tract DOID_0060049 0.03876928 0.09427231 0.03876928 0.12751283 ACEVEDO_LIVER_CANCER_DN primary biliary cirrhosis DOID_12236 0.03876928 0.09427231 0.03876928 0.12751283 ACEVEDO_LIVER_CANCER_DN salivary gland cancer DOID_8850 0.03876928 0.09387115 0.03876928 0.12605554 ACEVEDO_LIVER_CANCER_DN nephrotic syndrome DOID_1184 0.04035071 0.09728624 0.04035071 0.130452 ACEVEDO_LIVER_CANCER_DN rheumatic disease DOID_1575 0.04035071 0.09687575 0.04035071 0.12971498 ACEVEDO_LIVER_CANCER_DN primitive neuroectodermal tumor DOID_168 0.04035071 0.09646871 0.27326704 0.4367667 ACEVEDO_LIVER_CANCER_DN scleroderma DOID_419 0.04035071 0.09687575 0.04035071 0.12971498 ACEVEDO_LIVER_CANCER_DN gallbladder cancer DOID_3121 0.04195618 0.0998873 0.27829553 0.44231888 WEIGEL_OXIDATIVE_STRESS_RESPONSE withdrawal disorder DOID_0060001 8.726E-06 4.965E-03 8.726E-06 4.965E-03 WEIGEL_OXIDATIVE_STRESS_RESPONSE oral cavity cancer DOID_8618 1.262E-05 3.59E-03 1.262E-05 3.59E-03 WEIGEL_OXIDATIVE_STRESS_RESPONSE nervous system cancer DOID_3093 4.336E-05 8.223E-03 4.336E-05 8.223E-03 WEIGEL_OXIDATIVE_STRESS_RESPONSE lymphoblastic leukemia DOID_1037 4.772E-05 6.788E-03 2.251E-03 0.0985266 WEIGEL_OXIDATIVE_STRESS_RESPONSE X-linked disease DOID_0050735 1.691E-04 0.01924259 1.691E-04 0.02405324 WEIGEL_OXIDATIVE_STRESS_RESPONSE chronic leukemia DOID_1036 3.083E-04 0.02923683 3.083E-04 0.03508419 WEIGEL_OXIDATIVE_STRESS_RESPONSE chronic lymphocytic leukemia DOID_1040 3.083E-04 0.02923683 3.083E-04 0.03508419 WEIGEL_OXIDATIVE_STRESS_RESPONSE adenoid cystic carcinoma DOID_4866 4.662E-04 0.03789374 4.662E-04 0.04420936 WEIGEL_OXIDATIVE_STRESS_RESPONSE salivary gland cancer DOID_8850 5.106E-04 0.03631837 5.106E-04 0.0415067 WEIGEL_OXIDATIVE_STRESS_RESPONSE cerebral infarction DOID_3526 5.81E-04 0.0367327 5.81E-04 0.04132428 WEIGEL_OXIDATIVE_STRESS_RESPONSE brain cancer DOID_1319 6.304E-04 0.03586954 6.304E-04 0.03985504 WEIGEL_OXIDATIVE_STRESS_RESPONSE central nervous system cancer DOID_3620 6.558E-04 0.03392415 6.558E-04 0.03731656 WEIGEL_OXIDATIVE_STRESS_RESPONSE brain infarction DOID_3454 1.267E-03 0.06005828 1.267E-03 0.06551813 WEIGEL_OXIDATIVE_STRESS_RESPONSE chronic kidney failure DOID_784 1.808E-03 0.07913706 1.808E-03 0.08573181 WEIGEL_OXIDATIVE_STRESS_RESPONSE lymphoma DOID_0060058 2.205E-03 0.08960373 0.06717417 0.47777626 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN muscular atrophy DOID_767 7.868E-07 4.477E-04 5.147E-05 0.01464409 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN alcohol-related neurodevelopmental disorder DOID_0050667 8.281E-07 2.356E-04 1.729E-05 9.837E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN focal glomerulosclerosis DOID_3945 3.307E-06 6.273E-04 1.47E-04 0.01673079 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN cannabis abuse DOID_9505 4.129E-06 5.873E-04 4.77E-04 0.02714068 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN blood coagulation disease DOID_1247 4.513E-06 5.136E-04 1.028E-04 0.01462385 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN cannabis dependence DOID_1849 9.769E-06 9.264E-04 8.214E-04 0.03338565 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN hallucinogen dependence DOID_9977 9.769E-06 9.264E-04 8.214E-04 0.03338565 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN hemorrhagic disease DOID_2213 3.135E-05 2.548E-03 7.676E-04 0.03359925 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN integumentary system cancer DOID_0060122 4.163E-05 2.961E-03 0.01580481 0.21933998 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN skin cancer DOID_4159 4.163E-05 2.961E-03 0.01580481 0.21933998 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN congenital heart defect DOID_1682 6.93E-05 4.381E-03 6.93E-05 0.01314304 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN spinal muscular atrophy DOID_12377 9.659E-05 5.496E-03 3.587E-03 0.09276196 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN thrombocytopenia DOID_1588 1.331E-04 6.886E-03 4.416E-03 0.09306969 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN chronic leukemia DOID_1036 2.12E-04 0.0100532 2.12E-04 0.02010641 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN chronic lymphocytic leukemia DOID_1040 2.12E-04 0.0100532 2.12E-04 0.02010641 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN nervous system cancer DOID_3093 2.515E-04 0.01100713 0.03723368 0.3115583 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN adenoma DOID_657 2.932E-04 0.01191704 7.379E-03 0.12723069 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN calcinosis DOID_182 3.162E-04 0.01199553 3.162E-04 0.0257047 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN peripheral nervous system neoplasm DOID_1192 3.404E-04 0.0121045 8.131E-03 0.13218144 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN blood platelet disease DOID_2218 3.404E-04 0.01139247 8.131E-03 0.12850973 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN ulcerative colitis DOID_8577 3.458E-04 0.01093212 3.458E-04 0.02459726 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN lateral sclerosis DOID_230 4.77E-04 0.01428457 4.77E-04 0.03015631 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN insulinoma DOID_3892 4.77E-04 0.01357034 0.03249082 0.29344883 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN heart valve disease DOID_4079 6.124E-04 0.01659423 0.01191454 0.17383007 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN integumentary system benign neoplasm DOID_0060121 6.873E-04 0.01777482 0.15789729 0.54122625 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN skin benign neoplasm DOID_3165 6.873E-04 0.01777482 0.15789729 0.54122625 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN islet cell tumor DOID_1799 6.966E-04 0.01723247 0.0388622 0.3029122 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN calcium metabolism disease DOID_10575 7.267E-04 0.0172298 7.267E-04 0.03759229 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN withdrawal disorder DOID_0060001 7.676E-04 0.01747161 7.676E-04 0.03639919 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN aspergillosis DOID_13564 9.563E-04 0.0209278 9.563E-04 0.03627484 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN hypersensitivity reaction type IV disease DOID_2916 1.095E-03 0.02308231 0.01738551 0.22482624 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN pre-malignant neoplasm DOID_0060071 1.376E-03 0.02796319 0.02016206 0.23900437 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN in situ carcinoma DOID_8719 1.376E-03 0.02796319 0.02016206 0.23900437 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN penile disease DOID_1529 1.42E-03 0.02786021 0.05460913 0.33774558 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN mineral metabolism disease DOID_0050032 1.437E-03 0.02725701 1.437E-03 0.0511069 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN hyperglycemia DOID_4195 1.564E-03 0.0287117 1.564E-03 0.05235663 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN psoriasis DOID_8893 1.778E-03 0.03160938 1.778E-03 0.05619446 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN nephrosis DOID_2527 1.912E-03 0.03297346 0.02495967 0.2679632 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN male reproductive system disease DOID_48 1.912E-03 0.03200366 0.21700709 0.66030499 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN esophagitis DOID_11963 1.971E-03 0.03204196 0.06393416 0.35318967 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN bone resorption disease DOID_0080011 2.305E-03 0.03643417 0.0281704 0.29683254 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN osteoporosis DOID_11476 2.305E-03 0.03643417 0.0281704 0.29683254 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN contact dermatitis DOID_2773 2.563E-03 0.03941599 2.563E-03 0.07675745 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN glycogen metabolism disorder DOID_0050728 2.608E-03 0.03904475 2.608E-03 0.07418503 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN glycogen storage disease DOID_2747 2.608E-03 0.03904475 2.608E-03 0.07418503 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN IgA glomerulonephritis DOID_2986 2.608E-03 0.03804361 0.07316794 0.38195006 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN biliary tract cancer DOID_4607 2.838E-03 0.04037285 0.03222866 0.32172117 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN primary bacterial infectious disease DOID_0050338 3.232E-03 0.04485736 3.232E-03 0.08757865 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN myopia DOID_11830 3.854E-03 0.05221479 3.854E-03 0.09534874 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN lymphoblastic leukemia DOID_1037 3.884E-03 0.05138958 3.884E-03 0.092073 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN Crohn's disease DOID_8778 3.999E-03 0.05171823 3.999E-03 0.09102408 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN dilated cardiomyopathy DOID_12930 4.117E-03 0.05205858 4.117E-03 0.09010138 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN autoimmune disease of cardiovascular system DOID_0060051 4.416E-03 0.05462786 0.09436352 0.4227783 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN Behcet's disease DOID_13241 4.416E-03 0.05462786 0.09436352 0.4227783 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN coronary stenosis DOID_4248 4.416E-03 0.05346557 0.09436352 0.40986904 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN polycystic ovary syndrome DOID_11612 4.711E-03 0.05584197 0.09735195 0.4196459 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN opportunistic mycosis DOID_2473 5.326E-03 0.0618472 5.326E-03 0.1082326 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN autonomic nervous system neoplasm DOID_2621 5.976E-03 0.06800852 0.10920814 0.44704628 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN neuroblastoma DOID_769 5.976E-03 0.06800852 0.10920814 0.44704628 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN systemic mycosis DOID_0050136 6.314E-03 0.07044565 6.314E-03 0.12388718 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN fungal infectious disease DOID_1564 6.314E-03 0.07044565 6.314E-03 0.12388718 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN papilloma DOID_2615 6.314E-03 0.06909093 0.11214797 0.4558014 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN metal metabolism disorder DOID_896 6.314E-03 0.06778733 6.314E-03 0.11975761 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN pneumoconiosis DOID_10316 6.661E-03 0.07018301 0.11507818 0.46439349 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN thyroid carcinoma DOID_3963 6.661E-03 0.06890695 6.661E-03 0.12225427 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN esophageal disease DOID_6050 6.661E-03 0.06767647 0.11507818 0.46112312 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN paraplegia DOID_607 6.661E-03 0.06648917 0.11507818 0.45789848 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN thyroid cancer DOID_1781 7.379E-03 0.07238987 7.379E-03 0.13120665 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN refractive error DOID_9835 7.379E-03 0.07116293 7.379E-03 0.12348861 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN autoimmune disease of urogenital tract DOID_0060049 9.733E-03 0.09229659 9.733E-03 0.14967014 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN primary biliary cirrhosis DOID_12236 9.733E-03 0.09229659 9.733E-03 0.14967014 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN gallbladder cancer DOID_3121 0.01058169 0.09870463 0.14385769 0.52136958 WHITEFORD_PEDIATRIC_CANCER_MARKERS oral cavity cancer DOID_8618 2.024E-08 1.152E-05 2.024E-08 1.152E-05 WHITEFORD_PEDIATRIC_CANCER_MARKERS lymphoma DOID_0060058 1.806E-07 5.139E-05 8.1E-06 9.217E-04 WHITEFORD_PEDIATRIC_CANCER_MARKERS embryonal cancer DOID_688 2.561E-07 4.857E-05 2.188E-05 1.556E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS adenoid cystic carcinoma DOID_4866 3.448E-07 4.904E-05 3.448E-07 9.809E-05 WHITEFORD_PEDIATRIC_CANCER_MARKERS salivary gland cancer DOID_8850 4.154E-07 4.728E-05 4.154E-07 7.879E-05 WHITEFORD_PEDIATRIC_CANCER_MARKERS reproductive organ benign neoplasm DOID_0050622 1.168E-06 1.107E-04 2.795E-03 0.06626433 WHITEFORD_PEDIATRIC_CANCER_MARKERS neuroectodermal tumor DOID_171 1.738E-06 1.413E-04 1.738E-06 2.473E-04 WHITEFORD_PEDIATRIC_CANCER_MARKERS pre-malignant neoplasm DOID_0060071 1.968E-06 1.4E-04 9.886E-05 5.625E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS in situ carcinoma DOID_8719 1.968E-06 1.4E-04 9.886E-05 5.625E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS nervous system cancer DOID_3093 7.436E-06 4.701E-04 2.647E-04 0.01158536 WHITEFORD_PEDIATRIC_CANCER_MARKERS nephroblastoma DOID_2154 1.725E-05 9.817E-04 1.147E-03 0.03433759 WHITEFORD_PEDIATRIC_CANCER_MARKERS medullomyoblastoma DOID_3861 1.871E-05 9.681E-04 1.871E-05 1.775E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS adult medulloblastoma DOID_3864 1.871E-05 9.681E-04 1.871E-05 1.775E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS childhood medulloblastoma DOID_3869 1.871E-05 9.681E-04 1.871E-05 1.775E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS medulloblastoma DOID_3858 2.188E-05 1.037E-03 2.188E-05 1.778E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS primitive neuroectodermal tumor DOID_168 3.342E-05 1.463E-03 3.342E-05 2.113E-03 WHITEFORD_PEDIATRIC_CANCER_MARKERS B-cell lymphocytic neoplasm DOID_707 5.42E-05 2.203E-03 2.428E-03 0.06006486 WHITEFORD_PEDIATRIC_CANCER_MARKERS pustulosis of palm and sole DOID_4398 6.717E-05 2.548E-03 0.07516152 0.54829364 WHITEFORD_PEDIATRIC_CANCER_MARKERS mixed glioma DOID_5076 1.752E-04 6.229E-03 5.243E-03 0.09944798 WHITEFORD_PEDIATRIC_CANCER_MARKERS urinary system benign neoplasm DOID_731 2.382E-04 7.973E-03 2.382E-04 0.0123216 WHITEFORD_PEDIATRIC_CANCER_MARKERS transitional cell carcinoma DOID_2671 2.481E-04 7.842E-03 2.481E-04 0.01176351 WHITEFORD_PEDIATRIC_CANCER_MARKERS infertility DOID_5223 2.99E-04 8.954E-03 2.99E-04 0.01215182 WHITEFORD_PEDIATRIC_CANCER_MARKERS colon carcinoma DOID_1520 3.319E-04 9.443E-03 3.319E-04 0.01259104 WHITEFORD_PEDIATRIC_CANCER_MARKERS synostosis DOID_11971 4.805E-04 0.01301949 4.805E-04 0.01708808 WHITEFORD_PEDIATRIC_CANCER_MARKERS diffuse large B-cell lymphoma DOID_0050745 7.038E-04 0.01820286 0.03830038 0.41909453 WHITEFORD_PEDIATRIC_CANCER_MARKERS invasive ductal carcinoma DOID_3008 7.534E-04 0.01863907 0.0395951 0.40962933 WHITEFORD_PEDIATRIC_CANCER_MARKERS female reproductive organ benign neoplasm DOID_0060086 8.576E-04 0.02033229 1.000 1.000 WHITEFORD_PEDIATRIC_CANCER_MARKERS uterine benign neoplasm DOID_0060095 8.576E-04 0.02033229 1.000 1.000 WHITEFORD_PEDIATRIC_CANCER_MARKERS uterine fibroid DOID_13223 8.576E-04 0.02033229 1.000 1.000 WHITEFORD_PEDIATRIC_CANCER_MARKERS dysostosis DOID_1934 8.576E-04 0.019519 8.576E-04 0.02870441 WHITEFORD_PEDIATRIC_CANCER_MARKERS leiomyoma DOID_127 1.026E-03 0.02245636 1.000 1.000 WHITEFORD_PEDIATRIC_CANCER_MARKERS autonomic nervous system neoplasm DOID_2621 1.026E-03 0.02162464 1.026E-03 0.03243696 WHITEFORD_PEDIATRIC_CANCER_MARKERS neuroblastoma DOID_769 1.026E-03 0.02162464 1.026E-03 0.03243696 WHITEFORD_PEDIATRIC_CANCER_MARKERS peripheral nervous system neoplasm DOID_1192 1.407E-03 0.02858987 1.407E-03 0.04002582 WHITEFORD_PEDIATRIC_CANCER_MARKERS cervix uteri carcinoma in situ DOID_8991 1.619E-03 0.03176365 1.619E-03 0.04386408 WHITEFORD_PEDIATRIC_CANCER_MARKERS uterine cancer DOID_363 1.845E-03 0.03499635 1.845E-03 0.04772229 WHITEFORD_PEDIATRIC_CANCER_MARKERS brain cancer DOID_1319 2.086E-03 0.03828019 0.0651336 0.53711621 WHITEFORD_PEDIATRIC_CANCER_MARKERS central nervous system cancer DOID_3620 2.169E-03 0.03856444 0.0663929 0.5246883 WHITEFORD_PEDIATRIC_CANCER_MARKERS congenital nervous system abnormality DOID_2490 2.988E-03 0.05151485 2.988E-03 0.06799961 WHITEFORD_PEDIATRIC_CANCER_MARKERS endocrine organ benign neoplasm DOID_0060089 4.155E-03 0.0695385 4.155E-03 0.09093496 WHITEFORD_PEDIATRIC_CANCER_MARKERS pancreatic ductal carcinoma DOID_3587 4.387E-03 0.07131666 4.387E-03 0.09244752 WHITEFORD_PEDIATRIC_CANCER_MARKERS pancreatic carcinoma DOID_4905 4.745E-03 0.07499979 4.745E-03 0.0964283 WHITEFORD_PEDIATRIC_CANCER_MARKERS bone resorption disease DOID_0080011 5.117E-03 0.078685 5.117E-03 0.10039121 WHITEFORD_PEDIATRIC_CANCER_MARKERS osteoporosis DOID_11476 5.117E-03 0.078685 5.117E-03 0.10039121 WHITEFORD_PEDIATRIC_CANCER_MARKERS biliary tract cancer DOID_4607 5.898E-03 0.08831941 0.10823335 0.73315208 WHITEFORD_PEDIATRIC_CANCER_MARKERS bone development disease DOID_0080006 6.034E-03 0.08802837 6.034E-03 0.11074537 WHITEFORD_PEDIATRIC_CANCER_MARKERS Human immunodeficiency virus infectious disease DOID_526 6.875E-03 0.09779352 0.11661649 0.77156727 FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP hypothyroidism DOID_1459 2.677E-07 1.523E-04 0.01363556 0.77586327 FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP benign mesothelioma DOID_2645 3.67E-05 0.01044041 1.000 1.000 RIGGINS_TAMOXIFEN_RESISTANCE_DN pancreatic ductal carcinoma DOID_3587 5.402E-08 3.074E-05 1.826E-06 1.039E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN pancreatic carcinoma DOID_4905 6.891E-08 1.961E-05 2.231E-06 6.348E-04 RIGGINS_TAMOXIFEN_RESISTANCE_DN temporal lobe epilepsy DOID_3328 1.378E-06 2.614E-04 4.028E-05 2.546E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN syndrome DOID_225 2.539E-06 3.611E-04 2.539E-06 4.815E-04 RIGGINS_TAMOXIFEN_RESISTANCE_DN focal epilepsy DOID_2234 3.885E-06 4.421E-04 9.121E-05 3.992E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN cleft palate DOID_674 4.526E-06 4.292E-04 4.526E-06 6.438E-04 RIGGINS_TAMOXIFEN_RESISTANCE_DN mouth disease DOID_403 7.069E-06 5.746E-04 7.069E-06 8.044E-04 RIGGINS_TAMOXIFEN_RESISTANCE_DN dilated cardiomyopathy DOID_12930 7.437E-06 5.289E-04 7.437E-06 7.053E-04 RIGGINS_TAMOXIFEN_RESISTANCE_DN endometriosis DOID_289 7.98E-06 5.045E-04 2.794E-04 9.351E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN proteinuria DOID_576 1.03E-05 5.858E-04 3.371E-04 0.01065553 RIGGINS_TAMOXIFEN_RESISTANCE_DN Graves' disease DOID_12361 1.326E-05 6.859E-04 1.326E-05 1.078E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN orofacial cleft DOID_0050567 1.636E-05 7.76E-04 1.636E-05 1.164E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN tooth disease DOID_1091 4.263E-05 1.866E-03 4.263E-05 2.426E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN mixed glioma DOID_5076 7.2E-05 2.926E-03 7.2E-05 3.724E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN female reproductive system disease DOID_229 8.313E-05 3.153E-03 1.571E-03 0.02554449 RIGGINS_TAMOXIFEN_RESISTANCE_DN autoimmune disease of endocrine system DOID_0060005 8.524E-05 3.031E-03 8.524E-05 4.042E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN hyperthyroidism DOID_7998 1.456E-04 4.873E-03 1.456E-04 5.917E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN peripheral nervous system neoplasm DOID_1192 1.982E-04 6.264E-03 1.982E-04 7.517E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN adult respiratory distress syndrome DOID_11394 2.285E-04 6.843E-03 6.255E-03 0.06844023 RIGGINS_TAMOXIFEN_RESISTANCE_DN endometriosis of uterus DOID_288 2.617E-04 7.445E-03 6.833E-03 0.07068928 RIGGINS_TAMOXIFEN_RESISTANCE_DN arrhythmogenic right ventricular dysplasia DOID_0050431 2.65E-04 7.179E-03 2.65E-04 9.423E-03 RIGGINS_TAMOXIFEN_RESISTANCE_DN nephrotic syndrome DOID_1184 2.794E-04 7.226E-03 7.131E-03 0.07118258 RIGGINS_TAMOXIFEN_RESISTANCE_DN aortic valve insufficiency DOID_57 4.832E-04 0.01195336 4.832E-04 0.01446985 RIGGINS_TAMOXIFEN_RESISTANCE_DN variable age at onset electroclinical syndrome DOID_0050706 5.7E-04 0.01351385 5.7E-04 0.01621662 RIGGINS_TAMOXIFEN_RESISTANCE_DN impotence DOID_1875 5.7E-04 0.01297329 5.7E-04 0.0154444 RIGGINS_TAMOXIFEN_RESISTANCE_DN hypertrophic cardiomyopathy DOID_11984 6.429E-04 0.01407048 6.429E-04 0.01662875 RIGGINS_TAMOXIFEN_RESISTANCE_DN peripheral neuropathy DOID_0060053 7.646E-04 0.01611259 7.646E-04 0.01891478 RIGGINS_TAMOXIFEN_RESISTANCE_DN respiratory failure DOID_11162 7.741E-04 0.01573164 0.01385504 0.11593404 RIGGINS_TAMOXIFEN_RESISTANCE_DN pre-malignant neoplasm DOID_0060071 8.094E-04 0.01588089 0.01426271 0.11761569 RIGGINS_TAMOXIFEN_RESISTANCE_DN congenital heart defect DOID_1682 8.094E-04 0.01535153 8.094E-04 0.01918941 RIGGINS_TAMOXIFEN_RESISTANCE_DN in situ carcinoma DOID_8719 8.094E-04 0.01588089 0.01426271 0.11761569 RIGGINS_TAMOXIFEN_RESISTANCE_DN uterine disease DOID_345 8.829E-04 0.01620604 0.0150935 0.12268861 RIGGINS_TAMOXIFEN_RESISTANCE_DN drug-induced mental disorder DOID_1203 9.868E-04 0.01754582 0.0456354 0.24496736 RIGGINS_TAMOXIFEN_RESISTANCE_DN penile disease DOID_1529 9.868E-04 0.01701413 9.868E-04 0.02245865 RIGGINS_TAMOXIFEN_RESISTANCE_DN drug psychosis DOID_1742 9.868E-04 0.01754582 0.0456354 0.24496736 RIGGINS_TAMOXIFEN_RESISTANCE_DN substance-induced psychosis DOID_8646 9.868E-04 0.01754582 0.0456354 0.24496736 RIGGINS_TAMOXIFEN_RESISTANCE_DN endocrine organ benign neoplasm DOID_0060089 1.001E-03 0.0167514 1.001E-03 0.02190568 RIGGINS_TAMOXIFEN_RESISTANCE_DN sexual dysfunction DOID_1876 1.108E-03 0.01801486 1.108E-03 0.02335259 RIGGINS_TAMOXIFEN_RESISTANCE_DN dental caries DOID_216 1.108E-03 0.01751445 1.108E-03 0.02251857 RIGGINS_TAMOXIFEN_RESISTANCE_DN prion disease DOID_649 1.108E-03 0.01704108 1.108E-03 0.02174207 RIGGINS_TAMOXIFEN_RESISTANCE_DN nephrosis DOID_2527 1.129E-03 0.01689828 0.01770718 0.13993588 RIGGINS_TAMOXIFEN_RESISTANCE_DN male reproductive system disease DOID_48 1.129E-03 0.01646499 1.129E-03 0.02140449 RIGGINS_TAMOXIFEN_RESISTANCE_DN cystic fibrosis DOID_1485 1.314E-03 0.01869099 1.314E-03 0.0241174 RIGGINS_TAMOXIFEN_RESISTANCE_DN aneurysm disease DOID_2403 1.363E-03 0.01891737 1.363E-03 0.02423788 RIGGINS_TAMOXIFEN_RESISTANCE_DN electroclinical syndrome DOID_0050701 1.413E-03 0.01914844 1.413E-03 0.02437074 RIGGINS_TAMOXIFEN_RESISTANCE_DN contact dermatitis DOID_2773 1.517E-03 0.02008027 1.517E-03 0.02539563 RIGGINS_TAMOXIFEN_RESISTANCE_DN sexual disorder DOID_0060043 1.816E-03 0.02348503 1.816E-03 0.02870393 RIGGINS_TAMOXIFEN_RESISTANCE_DN lingual-facial-buccal dyskinesia DOID_9854 1.816E-03 0.02296314 0.06124449 0.2856403 RIGGINS_TAMOXIFEN_RESISTANCE_DN aortic valve disease DOID_62 1.978E-03 0.02446235 1.978E-03 0.03041265 RIGGINS_TAMOXIFEN_RESISTANCE_DN nervous system cancer DOID_3093 2.11E-03 0.02553994 2.11E-03 0.03158887 RIGGINS_TAMOXIFEN_RESISTANCE_DN infantile epileptic encephalopathy DOID_2481 2.502E-03 0.0296541 2.502E-03 0.03649735 RIGGINS_TAMOXIFEN_RESISTANCE_DN papillary adenoma DOID_3172 2.502E-03 0.02904891 2.502E-03 0.03558492 RIGGINS_TAMOXIFEN_RESISTANCE_DN microcystic adenoma DOID_5403 2.502E-03 0.02904891 2.502E-03 0.03558492 RIGGINS_TAMOXIFEN_RESISTANCE_DN follicular adenoma DOID_6204 2.502E-03 0.02904891 2.502E-03 0.03558492 RIGGINS_TAMOXIFEN_RESISTANCE_DN ulcerative colitis DOID_8577 2.674E-03 0.0304272 2.674E-03 0.03710635 RIGGINS_TAMOXIFEN_RESISTANCE_DN B cell deficiency DOID_2115 2.689E-03 0.03000301 2.689E-03 0.03643222 RIGGINS_TAMOXIFEN_RESISTANCE_DN teeth hard tissue disease DOID_214 2.689E-03 0.02942603 2.689E-03 0.03558496 RIGGINS_TAMOXIFEN_RESISTANCE_DN fragments of torsion dystonia DOID_531 2.689E-03 0.02887082 0.07405873 0.31214384 RIGGINS_TAMOXIFEN_RESISTANCE_DN lung adenocarcinoma DOID_3910 2.883E-03 0.03038085 0.07660071 0.31814457 RIGGINS_TAMOXIFEN_RESISTANCE_DN migraine DOID_6364 2.883E-03 0.02982847 0.07660071 0.31583917 RIGGINS_TAMOXIFEN_RESISTANCE_DN renal tubular transport disease DOID_447 3.084E-03 0.03133239 3.084E-03 0.03987758 RIGGINS_TAMOXIFEN_RESISTANCE_DN central nervous system hereditary degenerative disease DOID_481 3.084E-03 0.03078269 0.07913578 0.31488294 RIGGINS_TAMOXIFEN_RESISTANCE_DN polycystic ovary syndrome DOID_11612 3.29E-03 0.03228063 3.29E-03 0.04160614 RIGGINS_TAMOXIFEN_RESISTANCE_DN dystonic disease DOID_544 3.29E-03 0.0317335 0.08166396 0.32046064 RIGGINS_TAMOXIFEN_RESISTANCE_DN opportunistic mycosis DOID_2473 3.723E-03 0.0353061 3.723E-03 0.04605143 RIGGINS_TAMOXIFEN_RESISTANCE_DN autonomic nervous system neoplasm DOID_2621 4.18E-03 0.03899464 4.18E-03 0.05061006 RIGGINS_TAMOXIFEN_RESISTANCE_DN neuroblastoma DOID_769 4.18E-03 0.03899464 4.18E-03 0.05061006 RIGGINS_TAMOXIFEN_RESISTANCE_DN systemic mycosis DOID_0050136 4.418E-03 0.04055013 4.418E-03 0.05237725 RIGGINS_TAMOXIFEN_RESISTANCE_DN fungal infectious disease DOID_1564 4.418E-03 0.04055013 4.418E-03 0.05237725 RIGGINS_TAMOXIFEN_RESISTANCE_DN papilloma DOID_2615 4.418E-03 0.03990647 4.418E-03 0.05130832 RIGGINS_TAMOXIFEN_RESISTANCE_DN myocarditis DOID_820 4.418E-03 0.03928294 4.418E-03 0.05028216 RIGGINS_TAMOXIFEN_RESISTANCE_DN adenoma DOID_657 5.169E-03 0.04525077 5.169E-03 0.05767255 RIGGINS_TAMOXIFEN_RESISTANCE_DN uveitis DOID_13141 5.7E-03 0.04914097 0.10657068 0.37431306 RIGGINS_TAMOXIFEN_RESISTANCE_DN peptic ulcer DOID_750 5.974E-03 0.05073746 0.10902425 0.37596846 RIGGINS_TAMOXIFEN_RESISTANCE_DN adenoid cystic carcinoma DOID_4866 6.255E-03 0.05233665 6.255E-03 0.06714891 RIGGINS_TAMOXIFEN_RESISTANCE_DN benign mesothelioma DOID_2645 6.541E-03 0.05393815 0.11391138 0.39045528 RIGGINS_TAMOXIFEN_RESISTANCE_DN cervix uteri carcinoma in situ DOID_8991 6.541E-03 0.0531676 6.541E-03 0.06892096 RIGGINS_TAMOXIFEN_RESISTANCE_DN salivary gland cancer DOID_8850 6.833E-03 0.0547593 6.833E-03 0.06942697 RIGGINS_TAMOXIFEN_RESISTANCE_DN idiopathic generalized epilepsy DOID_1827 7.131E-03 0.05635288 7.131E-03 0.0699553 RIGGINS_TAMOXIFEN_RESISTANCE_DN uveal disease DOID_3480 7.131E-03 0.05558092 0.11877197 0.39988905 RIGGINS_TAMOXIFEN_RESISTANCE_DN pre-eclampsia DOID_10591 8.38E-03 0.06443519 8.38E-03 0.08081702 RIGGINS_TAMOXIFEN_RESISTANCE_DN thyroid adenoma DOID_2891 8.38E-03 0.06357606 8.38E-03 0.07947007 RIGGINS_TAMOXIFEN_RESISTANCE_DN heart valve disease DOID_4079 8.38E-03 0.06273953 8.38E-03 0.07816728 RIGGINS_TAMOXIFEN_RESISTANCE_DN integumentary system benign neoplasm DOID_0060121 9.039E-03 0.06679252 9.039E-03 0.082952 RIGGINS_TAMOXIFEN_RESISTANCE_DN skin benign neoplasm DOID_3165 9.039E-03 0.06679252 9.039E-03 0.082952 RIGGINS_TAMOXIFEN_RESISTANCE_DN lung small cell carcinoma DOID_5409 9.039E-03 0.0659362 9.039E-03 0.0816353 RIGGINS_TAMOXIFEN_RESISTANCE_DN movement disease DOID_480 9.376E-03 0.06753447 0.13557698 0.43338935 RIGGINS_TAMOXIFEN_RESISTANCE_DN bile duct adenocarcinoma DOID_4896 0.01078299 0.076694 0.14503694 0.45096186 RIGGINS_TAMOXIFEN_RESISTANCE_DN cholangiocarcinoma DOID_4947 0.01078299 0.076694 0.14503694 0.45096186 RIGGINS_TAMOXIFEN_RESISTANCE_DN bone marrow cancer DOID_4960 0.01078299 0.07574716 0.01078299 0.0958675 RIGGINS_TAMOXIFEN_RESISTANCE_DN integumentary system cancer DOID_0060122 0.01114829 0.07735825 0.01114829 0.09759041 RIGGINS_TAMOXIFEN_RESISTANCE_DN skin cancer DOID_4159 0.01114829 0.07735825 0.01114829 0.09759041 RIGGINS_TAMOXIFEN_RESISTANCE_DN pustulosis of palm and sole DOID_4398 0.01114829 0.07642623 0.14738586 0.44846287 RIGGINS_TAMOXIFEN_RESISTANCE_DN bile duct cancer DOID_4606 0.01227651 0.08315876 0.15439436 0.45994968 RIGGINS_TAMOXIFEN_RESISTANCE_DN bile duct carcinoma DOID_4897 0.01227651 0.08315876 0.15439436 0.45994968 RIGGINS_TAMOXIFEN_RESISTANCE_DN oral cavity cancer DOID_8618 0.01227651 0.08218042 0.01227651 0.10583842 RIGGINS_TAMOXIFEN_RESISTANCE_DN melancholia DOID_2848 0.01266325 0.08378362 0.15671782 0.46443978 RIGGINS_TAMOXIFEN_RESISTANCE_DN neurotic disorder DOID_4964 0.01305528 0.0853845 0.15903495 0.46644788 RIGGINS_TAMOXIFEN_RESISTANCE_DN collagen disease DOID_854 0.01345255 0.08698294 0.01345255 0.11424625 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN spindle cell carcinoma DOID_4015 8.042E-09 4.576E-06 0.02316921 0.34692841 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN sinusitis DOID_0050127 3.915E-07 1.114E-04 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN paranasal sinus disease DOID_1352 3.915E-07 1.114E-04 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN multiple myeloma DOID_9538 2.169E-06 4.113E-04 0.02502508 0.36510943 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN myeloma DOID_0070004 4.284E-06 6.094E-04 0.03118693 0.38576872 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN pre-eclampsia DOID_10591 4.284E-06 4.875E-04 4.618E-04 0.08759632 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN heart valve disease DOID_4079 4.284E-06 4.063E-04 4.618E-04 0.06569724 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN glaucoma DOID_1686 4.827E-06 3.923E-04 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bone marrow cancer DOID_4960 6.377E-06 4.536E-04 0.035478 0.40373961 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN mineral metabolism disease DOID_0050032 1.04E-05 6.574E-04 8.281E-04 0.05890029 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN pancreatic ductal carcinoma DOID_3587 1.347E-05 7.662E-04 0.04521787 0.45944587 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN pancreatic carcinoma DOID_4905 1.52E-05 7.863E-04 0.04703357 0.45359497 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN pancreatitis DOID_4989 1.774E-05 8.41E-04 1.178E-03 0.07445313 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN aortic valve insufficiency DOID_57 2.525E-05 1.105E-03 7.571E-03 0.33139608 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN thoracic aortic aneurysm DOID_14004 4.013E-05 1.631E-03 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN hemolytic-uremic syndrome DOID_12554 4.584E-05 1.739E-03 0.01008302 0.30195996 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN ureteral obstruction DOID_5199 5.84E-05 2.077E-03 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN urinary tract obstruction DOID_5200 9.639E-05 3.226E-03 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN ureteral disease DOID_1426 1.051E-04 3.323E-03 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN aortic valve disease DOID_62 1.051E-04 3.148E-03 0.01508792 0.31796402 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN meningitis DOID_9471 1.051E-04 2.99E-03 0.01508792 0.30660816 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN acute pancreatitis DOID_2913 1.142E-04 3.094E-03 1.142E-04 0.06498146 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN sarcoma DOID_1115 1.653E-04 4.275E-03 0.01882568 0.33474406 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN invasive ductal carcinoma DOID_3008 1.653E-04 4.089E-03 0.01882568 0.31505324 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN leiomyoma DOID_127 2.256E-04 5.349E-03 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN calcinosis DOID_182 2.952E-04 6.719E-03 2.952E-04 0.0839874 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN uveitis DOID_13141 3.102E-04 6.789E-03 0.02564295 0.36477092 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN uveal disease DOID_3480 3.908E-04 8.236E-03 0.02872668 0.37148817 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN cerebral infarction DOID_3526 4.256E-04 8.649E-03 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN neuritis DOID_1803 4.618E-04 9.062E-03 0.03118693 0.37756088 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN hemolytic anemia DOID_583 4.805E-04 9.114E-03 0.03180105 0.376975 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN normocytic anemia DOID_720 4.805E-04 9.114E-03 0.03180105 0.376975 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN calcium metabolism disease DOID_10575 5.189E-04 9.525E-03 5.189E-04 0.05905365 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN aortic aneurysm DOID_3627 5.189E-04 9.227E-03 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bile duct adenocarcinoma DOID_4896 6.001E-04 0.01034702 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN cholangiocarcinoma DOID_4947 6.001E-04 0.01034702 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN reproductive organ benign neoplasm DOID_0050622 6.213E-04 0.01039735 0.03608952 0.40264581 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN hypertrophic cardiomyopathy DOID_11984 6.87E-04 0.01116884 6.87E-04 0.06515159 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bile duct cancer DOID_4606 6.87E-04 0.0108586 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bile duct carcinoma DOID_4897 6.87E-04 0.0108586 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN pre-malignant neoplasm DOID_0060071 8.037E-04 0.01235981 8.037E-04 0.06533045 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN in situ carcinoma DOID_8719 8.037E-04 0.01235981 8.037E-04 0.06533045 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN cholestasis DOID_13580 8.529E-04 0.01277089 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN brain infarction DOID_3454 9.293E-04 0.01355843 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bile duct disease DOID_4138 1.009E-03 0.01435189 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN biliary tract disease DOID_9741 1.036E-03 0.0143799 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN aneurysm disease DOID_2403 1.149E-03 0.01556139 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN mixed glioma DOID_5076 1.178E-03 0.01558321 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN biliary tract cancer DOID_4607 1.328E-03 0.01717179 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN transitional cell carcinoma DOID_2671 1.487E-03 0.01879974 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN encephalomyelitis DOID_640 1.654E-03 0.02046385 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN Crohn's disease DOID_8778 1.689E-03 0.02044669 0.05905396 0.51694929 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN dilated cardiomyopathy DOID_12930 1.724E-03 0.02043432 1.724E-03 0.09808475 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN hypokalemia DOID_4500 6.313E-03 0.07331228 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN neuronal ceroid lipofuscinosis DOID_14503 6.943E-03 0.07900668 6.943E-03 0.35912127 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN prostatic adenoma DOID_2883 6.943E-03 0.07745753 6.943E-03 0.3291945 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN invasive lobular carcinoma DOID_3457 6.943E-03 0.07596796 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN eosinophilic pneumonia DOID_5870 6.943E-03 0.0745346 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN chronic monocytic leukemia DOID_8593 6.943E-03 0.07315433 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN pulmonary eosinophilia DOID_9498 6.943E-03 0.0745346 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN Loeffler syndrome DOID_9503 6.943E-03 0.0745346 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN familial atrial fibrillation DOID_0050650 7.571E-03 0.07832998 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN esophageal carcinoma DOID_1107 7.571E-03 0.07693123 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN esophagus squamous cell carcinoma DOID_3748 7.571E-03 0.07693123 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN lipodystrophy DOID_811 7.571E-03 0.07558156 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN peritonitis DOID_8283 7.571E-03 0.07427843 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN ocular hypertension DOID_9282 7.571E-03 0.07301948 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN borderline glaucoma DOID_9283 7.571E-03 0.07301948 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN obstructive hydrocephalus DOID_14159 8.2E-03 0.07776245 8.2E-03 0.33326765 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN communicating hydrocephalus DOID_1573 8.2E-03 0.07776245 8.2E-03 0.33326765 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN impotence DOID_1875 8.2E-03 0.07648766 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN Lynch syndrome DOID_3883 8.2E-03 0.07525398 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN monocytic leukemia DOID_8527 8.2E-03 0.07405948 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN open-angle glaucoma DOID_1067 8.828E-03 0.07848637 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN hydrocephalus DOID_10908 8.828E-03 0.07727889 8.828E-03 0.3348752 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bacterial meningitis DOID_9470 8.828E-03 0.076108 8.828E-03 0.3139455 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN skeletal system cancer DOID_0060124 9.456E-03 0.08030287 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bone cancer DOID_184 9.456E-03 0.08030287 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN membranoproliferative glomerulonephritis DOID_2920 9.456E-03 0.07912194 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN mesenchymal cell neoplasm DOID_3350 9.456E-03 0.07797525 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN spindle cell sarcoma DOID_4235 9.456E-03 0.07797525 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN lung oat cell carcinoma DOID_5411 9.456E-03 0.07686131 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN epithelioid sarcoma DOID_6193 9.456E-03 0.07797525 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN intracranial hypertension DOID_9428 9.456E-03 0.07577876 9.456E-03 0.31648776 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN angiosarcoma DOID_0001816 0.01008302 0.07968388 0.01008302 0.31873551 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN restrictive cardiomyopathy DOID_397 0.01008302 0.07859232 0.01008302 0.28686196 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN schizophreniform disorder DOID_11328 0.01070996 0.08235094 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN familial hypertrophic cardiomyopathy DOID_11986 0.01070996 0.08125293 0.01070996 0.29018904 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN penile disease DOID_1529 0.01070996 0.08018381 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN schizoaffective disorder DOID_5418 0.01070996 0.08235094 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN urinary system benign neoplasm DOID_731 0.01070996 0.07914247 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN male reproductive organ benign neoplasm DOID_0060087 0.01133653 0.08269851 0.01133653 0.29320381 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN neuroendocrine tumor DOID_169 0.01133653 0.0816517 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN sexual dysfunction DOID_1876 0.01133653 0.08063105 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN prion disease DOID_649 0.01133653 0.0796356 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN eosinophilia DOID_999 0.01133653 0.07866444 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN membranous glomerulonephritis DOID_10976 0.01258851 0.08629955 0.01258851 0.31142883 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN gastric ulcer DOID_10808 0.01383898 0.09374259 0.01383898 0.32809907 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN hepatitis B DOID_2043 0.01383898 0.09263974 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN muscular atrophy DOID_767 0.01383898 0.09156253 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN glycogen metabolism disorder DOID_0050728 0.01446364 0.09459553 0.01446364 0.32919244 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN sexual disorder DOID_0060043 0.01446364 0.09352058 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN heart conduction disease DOID_10273 0.01446364 0.09246979 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN glycogen storage disease DOID_2747 0.01446364 0.09459553 0.01446364 0.32919244 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN diabetic angiopathy DOID_11713 0.01508792 0.09538921 0.01508792 0.33019341 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN toxic shock syndrome DOID_14115 0.01571183 0.09824209 1.000 1.000 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN portal hypertension DOID_10762 0.01633535 0.09994427 0.01633535 0.32051093 GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN bronchiolitis DOID_2942 0.01633535 0.09888103 0.01633535 0.30982723 ELVIDGE_HYPOXIA_BY_DMOG_UP toxic shock syndrome DOID_14115 1.777E-09 1.011E-06 0.05082926 0.42532133 ELVIDGE_HYPOXIA_BY_DMOG_UP commensal bacterial infectious disease DOID_0050339 2.196E-09 6.248E-07 0.05280848 0.42321159 ELVIDGE_HYPOXIA_BY_DMOG_UP endometrial carcinoma DOID_2871 6.657E-09 1.263E-06 4.135E-05 0.01176479 ELVIDGE_HYPOXIA_BY_DMOG_UP endometrial cancer DOID_1380 9.169E-09 1.304E-06 4.974E-05 7.076E-03 ELVIDGE_HYPOXIA_BY_DMOG_UP nervous system cancer DOID_3093 4.172E-08 4.748E-06 0.01589994 0.2103969 ELVIDGE_HYPOXIA_BY_DMOG_UP uterine cancer DOID_363 4.949E-08 4.693E-06 1.322E-04 0.01504198 ELVIDGE_HYPOXIA_BY_DMOG_UP sarcoma DOID_1115 4.592E-07 3.733E-05 1.796E-03 0.06010507 ELVIDGE_HYPOXIA_BY_DMOG_UP nephrosis DOID_2527 4.974E-07 3.538E-05 5.075E-04 0.02887554 ELVIDGE_HYPOXIA_BY_DMOG_UP diabetic retinopathy DOID_8947 5.686E-07 3.595E-05 0.01105962 0.17480339 ELVIDGE_HYPOXIA_BY_DMOG_UP abdominal aortic aneurysm DOID_7693 6.824E-07 3.883E-05 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP aneurysm disease DOID_2403 6.902E-07 3.57E-05 0.15207586 0.67602473 ELVIDGE_HYPOXIA_BY_DMOG_UP spindle cell carcinoma DOID_4015 1.094E-06 5.189E-05 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP retinal vascular disease DOID_2462 1.117E-06 4.889E-05 0.01430499 0.19852529 ELVIDGE_HYPOXIA_BY_DMOG_UP cervix uteri carcinoma in situ DOID_8991 2.225E-06 9.042E-05 3.832E-03 0.0991159 ELVIDGE_HYPOXIA_BY_DMOG_UP nephrotic syndrome DOID_1184 2.666E-06 1.011E-04 4.182E-03 0.09913673 ELVIDGE_HYPOXIA_BY_DMOG_UP cerebral infarction DOID_3526 3.169E-06 1.127E-04 1.408E-04 0.01335062 ELVIDGE_HYPOXIA_BY_DMOG_UP aortic aneurysm DOID_3627 4.731E-06 1.584E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP angiosarcoma DOID_0001816 4.782E-06 1.512E-04 5.048E-04 0.03191706 ELVIDGE_HYPOXIA_BY_DMOG_UP giant cell tumor DOID_200 5.906E-06 1.769E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP malignant giant cell tumor DOID_2705 5.906E-06 1.769E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP giant cell glioblastoma DOID_3074 5.906E-06 1.769E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP glioblastoma DOID_3068 8.326E-06 2.369E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP neuroectodermal tumor DOID_171 1.009E-05 2.734E-04 7.95E-03 0.14136356 ELVIDGE_HYPOXIA_BY_DMOG_UP pre-malignant neoplasm DOID_0060071 1.141E-05 2.95E-04 8.436E-03 0.1454603 ELVIDGE_HYPOXIA_BY_DMOG_UP in situ carcinoma DOID_8719 1.141E-05 2.95E-04 8.436E-03 0.1454603 ELVIDGE_HYPOXIA_BY_DMOG_UP hepatitis B DOID_2043 1.303E-05 3.224E-04 0.04486709 0.40522816 ELVIDGE_HYPOXIA_BY_DMOG_UP muscular atrophy DOID_767 1.303E-05 3.09E-04 0.04486709 0.39889647 ELVIDGE_HYPOXIA_BY_DMOG_UP sinusitis DOID_0050127 1.497E-05 3.406E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP glycogen metabolism disorder DOID_0050728 1.497E-05 3.275E-04 1.497E-05 8.516E-03 ELVIDGE_HYPOXIA_BY_DMOG_UP paranasal sinus disease DOID_1352 1.497E-05 3.406E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP glycogen storage disease DOID_2747 1.497E-05 3.275E-04 1.497E-05 8.516E-03 ELVIDGE_HYPOXIA_BY_DMOG_UP brain infarction DOID_3454 1.526E-05 3.216E-04 4.495E-04 0.03196746 ELVIDGE_HYPOXIA_BY_DMOG_UP astrocytoma DOID_3069 1.613E-05 3.278E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP pancreatic ductal carcinoma DOID_3587 1.704E-05 3.343E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP aortic valve disease DOID_62 1.708E-05 3.239E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP pancreatic carcinoma DOID_4905 1.999E-05 3.669E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP osteosarcoma DOID_3347 2.187E-05 3.889E-04 1.349E-03 0.0511691 ELVIDGE_HYPOXIA_BY_DMOG_UP mixed glioma DOID_5076 2.449E-05 4.222E-04 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP transitional cell carcinoma DOID_2671 3.894E-05 6.517E-04 0.01525316 0.20664404 ELVIDGE_HYPOXIA_BY_DMOG_UP carbohydrate metabolic disorder DOID_2978 4.814E-05 7.825E-04 4.814E-05 9.13E-03 ELVIDGE_HYPOXIA_BY_DMOG_UP mouth disease DOID_403 5.015E-05 7.926E-04 0.01722821 0.22279204 ELVIDGE_HYPOXIA_BY_DMOG_UP dilated cardiomyopathy DOID_12930 5.222E-05 8.031E-04 1.115E-03 0.04532635 ELVIDGE_HYPOXIA_BY_DMOG_UP hepatitis C DOID_1883 6.43E-05 9.627E-04 0.0743127 0.49167353 ELVIDGE_HYPOXIA_BY_DMOG_UP peptic ulcer DOID_750 9.429E-05 1.376E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP autoimmune disease of urogenital tract DOID_0060049 1.16E-04 1.65E-03 0.08964866 0.52051111 ELVIDGE_HYPOXIA_BY_DMOG_UP primary biliary cirrhosis DOID_12236 1.16E-04 1.65E-03 0.08964866 0.52051111 ELVIDGE_HYPOXIA_BY_DMOG_UP endometriosis of uterus DOID_288 1.16E-04 1.61E-03 0.08964866 0.51525342 ELVIDGE_HYPOXIA_BY_DMOG_UP primitive neuroectodermal tumor DOID_168 1.239E-04 1.679E-03 4.182E-03 0.09517126 ELVIDGE_HYPOXIA_BY_DMOG_UP endometriosis DOID_289 1.239E-04 1.64E-03 0.09154793 0.51069385 ELVIDGE_HYPOXIA_BY_DMOG_UP pre-eclampsia DOID_10591 1.591E-04 2.057E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP brain cancer DOID_1319 1.591E-04 2.011E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP heart valve disease DOID_4079 1.591E-04 1.967E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP central nervous system cancer DOID_3620 1.687E-04 2.043E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP glaucoma DOID_1686 1.788E-04 2.12E-03 0.10286167 0.54192861 ELVIDGE_HYPOXIA_BY_DMOG_UP hypokalemia DOID_4500 1.909E-04 2.216E-03 0.02064638 0.23975086 ELVIDGE_HYPOXIA_BY_DMOG_UP sarcoidosis DOID_11335 2.229E-04 2.537E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP bile duct adenocarcinoma DOID_4896 2.35E-04 2.622E-03 0.11218342 0.56993186 ELVIDGE_HYPOXIA_BY_DMOG_UP cholangiocarcinoma DOID_4947 2.35E-04 2.622E-03 0.11218342 0.56993186 ELVIDGE_HYPOXIA_BY_DMOG_UP bone marrow cancer DOID_4960 2.35E-04 2.571E-03 0.11218342 0.56488822 ELVIDGE_HYPOXIA_BY_DMOG_UP aortic valve stenosis DOID_1712 2.792E-04 2.997E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP aortic valve insufficiency DOID_57 2.792E-04 2.942E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP hypersensitivity reaction type IV disease DOID_2916 2.873E-04 2.972E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP bile duct cancer DOID_4606 2.873E-04 2.919E-03 0.11957192 0.58150788 ELVIDGE_HYPOXIA_BY_DMOG_UP bile duct carcinoma DOID_4897 2.873E-04 2.919E-03 0.11957192 0.58150788 ELVIDGE_HYPOXIA_BY_DMOG_UP melancholia DOID_2848 3.014E-04 3.009E-03 7.477E-03 0.14181866 ELVIDGE_HYPOXIA_BY_DMOG_UP neurotic disorder DOID_4964 3.16E-04 3.1E-03 7.712E-03 0.14155347 ELVIDGE_HYPOXIA_BY_DMOG_UP collagen disease DOID_854 3.311E-04 3.193E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP respiratory failure DOID_11162 3.466E-04 3.287E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP congenital heart defect DOID_1682 3.626E-04 3.382E-03 8.436E-03 0.14118205 ELVIDGE_HYPOXIA_BY_DMOG_UP uterine disease DOID_345 3.959E-04 3.633E-03 0.13235598 0.61228093 ELVIDGE_HYPOXIA_BY_DMOG_UP temporal lobe epilepsy DOID_3328 4.133E-04 3.732E-03 0.13416725 0.61565457 ELVIDGE_HYPOXIA_BY_DMOG_UP allergic contact dermatitis DOID_3042 4.311E-04 3.833E-03 4.311E-04 0.03504295 ELVIDGE_HYPOXIA_BY_DMOG_UP tuberculosis DOID_399 4.495E-04 3.934E-03 0.1377786 0.62716818 ELVIDGE_HYPOXIA_BY_DMOG_UP bronchitis DOID_6132 5.714E-04 4.926E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP urinary system benign neoplasm DOID_731 5.714E-04 4.852E-03 5.714E-04 0.02955583 ELVIDGE_HYPOXIA_BY_DMOG_UP endogenous depression DOID_1595 5.92E-04 4.954E-03 0.01162216 0.17873 ELVIDGE_HYPOXIA_BY_DMOG_UP pancreatitis DOID_4989 6.374E-04 5.257E-03 0.15384648 0.67859416 ELVIDGE_HYPOXIA_BY_DMOG_UP contact dermatitis DOID_2773 6.851E-04 5.568E-03 6.851E-04 0.03248285 ELVIDGE_HYPOXIA_BY_DMOG_UP female reproductive system disease DOID_229 7.097E-04 5.687E-03 0.15913646 0.69652803 ELVIDGE_HYPOXIA_BY_DMOG_UP heart septal defect DOID_1681 7.165E-04 5.662E-03 7.165E-04 0.03135996 ELVIDGE_HYPOXIA_BY_DMOG_UP mental depression DOID_1596 7.606E-04 5.929E-03 0.01368768 0.19969978 ELVIDGE_HYPOXIA_BY_DMOG_UP focal epilepsy DOID_2234 7.606E-04 5.848E-03 0.16264496 0.70109833 ELVIDGE_HYPOXIA_BY_DMOG_UP biliary tract cancer DOID_4607 7.606E-04 5.771E-03 0.16264496 0.69582691 ELVIDGE_HYPOXIA_BY_DMOG_UP sex cord-gonadal stromal tumor DOID_192 7.95E-04 5.952E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP subependymal glioma DOID_4843 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP pilocytic astrocytoma DOID_4851 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP subependymal giant cell astrocytoma DOID_5077 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP fibrillary astrocytoma DOID_6726 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP juvenile pilocytic astrocytoma DOID_6811 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP childhood pilocytic astrocytoma DOID_6812 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP gemistocytic astrocytoma DOID_7005 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP childhood cerebral astrocytoma DOID_7007 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP protoplasmic astrocytoma DOID_7008 7.95E-04 5.875E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP primary bacterial infectious disease DOID_0050338 8.693E-04 6.342E-03 0.16961865 0.72024634 ELVIDGE_HYPOXIA_BY_DMOG_UP benign glioma DOID_0060101 9.64E-04 6.943E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP gastric ulcer DOID_10808 9.64E-04 6.856E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP benign ependymoma DOID_4844 9.64E-04 6.943E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP encephalomyelitis DOID_640 1.05E-03 7.377E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP portal hypertension DOID_10762 1.349E-03 9.36E-03 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP middle cerebral artery infarction DOID_3525 1.565E-03 0.01072647 1.565E-03 0.05564356 ELVIDGE_HYPOXIA_BY_DMOG_UP seminoma DOID_4440 1.565E-03 0.01059877 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP lung adenocarcinoma DOID_3910 1.678E-03 0.01123476 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP hepatic vascular disease DOID_272 1.796E-03 0.01188124 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP supratentorial cancer DOID_1659 1.917E-03 0.01253772 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP cerebrum cancer DOID_368 1.917E-03 0.01253772 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP focal glomerulosclerosis DOID_3945 1.917E-03 0.01239524 0.06264359 0.44555251 ELVIDGE_HYPOXIA_BY_DMOG_UP corneal disease DOID_10124 2.042E-03 0.01305541 0.06459847 0.45378434 ELVIDGE_HYPOXIA_BY_DMOG_UP congenital disorder of glycosylation DOID_5212 2.042E-03 0.01291035 2.042E-03 0.06455175 ELVIDGE_HYPOXIA_BY_DMOG_UP germinoma DOID_3304 2.303E-03 0.01440286 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP allergic rhinitis DOID_4481 2.303E-03 0.01424631 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP myocarditis DOID_820 2.58E-03 0.01578388 0.07237785 0.49027379 ELVIDGE_HYPOXIA_BY_DMOG_UP metal metabolism disorder DOID_896 2.58E-03 0.01561596 0.07237785 0.48450586 ELVIDGE_HYPOXIA_BY_DMOG_UP pneumoconiosis DOID_10316 2.724E-03 0.01631253 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP medullomyoblastoma DOID_3861 2.871E-03 0.01701647 2.871E-03 0.08597793 ELVIDGE_HYPOXIA_BY_DMOG_UP adult medulloblastoma DOID_3864 2.871E-03 0.01701647 2.871E-03 0.08597793 ELVIDGE_HYPOXIA_BY_DMOG_UP childhood medulloblastoma DOID_3869 2.871E-03 0.01701647 2.871E-03 0.08597793 ELVIDGE_HYPOXIA_BY_DMOG_UP adenoma DOID_657 3.022E-03 0.01772746 0.07817043 0.48877997 ELVIDGE_HYPOXIA_BY_DMOG_UP pulmonary sarcoidosis DOID_13406 3.177E-03 0.0184452 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP medulloblastoma DOID_3858 3.177E-03 0.01825888 3.177E-03 0.09038147 ELVIDGE_HYPOXIA_BY_DMOG_UP embryonal cancer DOID_688 3.177E-03 0.01807629 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP multiple myeloma DOID_9538 3.177E-03 0.01789732 0.08009335 0.49535993 ELVIDGE_HYPOXIA_BY_DMOG_UP peripheral nervous system neoplasm DOID_1192 3.335E-03 0.01860559 0.0820123 0.49643614 ELVIDGE_HYPOXIA_BY_DMOG_UP uveitis DOID_13141 3.335E-03 0.01842495 0.0820123 0.4912105 ELVIDGE_HYPOXIA_BY_DMOG_UP adult respiratory distress syndrome DOID_11394 3.663E-03 0.02004076 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP intracranial arterial disease DOID_13089 3.663E-03 0.01984989 3.663E-03 0.09924946 ELVIDGE_HYPOXIA_BY_DMOG_UP cerebral arterial disease DOID_3527 3.663E-03 0.01984989 3.663E-03 0.09924946 ELVIDGE_HYPOXIA_BY_DMOG_UP lymphatic system disease DOID_75 3.663E-03 0.01966263 0.08583835 0.50352601 ELVIDGE_HYPOXIA_BY_DMOG_UP benign mesothelioma DOID_2645 3.832E-03 0.02037897 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP spinocerebellar ataxia DOID_1441 4.005E-03 0.02110093 4.005E-03 0.09908262 ELVIDGE_HYPOXIA_BY_DMOG_UP hyperinsulinism DOID_2018 4.182E-03 0.02182827 0.09154793 0.51575023 ELVIDGE_HYPOXIA_BY_DMOG_UP uveal disease DOID_3480 4.182E-03 0.02162983 0.09154793 0.50573566 ELVIDGE_HYPOXIA_BY_DMOG_UP influenza DOID_8469 4.361E-03 0.02235752 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP spinocerebellar degeneration DOID_2478 4.732E-03 0.02404038 4.732E-03 0.10355856 ELVIDGE_HYPOXIA_BY_DMOG_UP proteinuria DOID_576 4.732E-03 0.02382763 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP myeloma DOID_0070004 4.923E-03 0.02456965 0.09910597 0.54222399 ELVIDGE_HYPOXIA_BY_DMOG_UP neuritis DOID_1803 4.923E-03 0.024356 0.09910597 0.53705995 ELVIDGE_HYPOXIA_BY_DMOG_UP bone marrow disease DOID_4961 4.923E-03 0.02414603 4.923E-03 0.10373852 ELVIDGE_HYPOXIA_BY_DMOG_UP vascular skin disease DOID_9540 4.923E-03 0.02393966 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP hemolytic anemia DOID_583 5.117E-03 0.02467242 5.117E-03 0.10397661 ELVIDGE_HYPOXIA_BY_DMOG_UP normocytic anemia DOID_720 5.117E-03 0.02467242 5.117E-03 0.10397661 ELVIDGE_HYPOXIA_BY_DMOG_UP pulmonary tuberculosis DOID_2957 5.314E-03 0.02540949 0.10286167 0.53695678 ELVIDGE_HYPOXIA_BY_DMOG_UP lung small cell carcinoma DOID_5409 5.314E-03 0.02519774 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP vasculitis DOID_865 6.353E-03 0.02987636 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP reproductive organ benign neoplasm DOID_0050622 6.571E-03 0.03064852 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP familial hyperlipidemia DOID_1168 6.793E-03 0.03142374 6.793E-03 0.13328002 ELVIDGE_HYPOXIA_BY_DMOG_UP leukocyte disease DOID_9500 7.477E-03 0.03431097 0.12140954 0.58052123 ELVIDGE_HYPOXIA_BY_DMOG_UP hypothyroidism DOID_1459 8.192E-03 0.03728785 0.1268997 0.60171607 ELVIDGE_HYPOXIA_BY_DMOG_UP mineral metabolism disease DOID_0050032 8.684E-03 0.03921629 0.13054097 0.61386623 ELVIDGE_HYPOXIA_BY_DMOG_UP endocrine pancreas disease DOID_1428 8.684E-03 0.0389075 0.13054097 0.60883453 ELVIDGE_HYPOXIA_BY_DMOG_UP cholestasis DOID_13580 8.935E-03 0.03972002 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP endocrine organ benign neoplasm DOID_0060089 9.708E-03 0.04282081 9.708E-03 0.15782526 ELVIDGE_HYPOXIA_BY_DMOG_UP bile duct disease DOID_4138 0.01050954 0.04599946 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP peripheral vascular disease DOID_341 0.01078301 0.04683614 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP biliary tract disease DOID_9741 0.01078301 0.04648132 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP syndrome DOID_225 0.01162216 0.04972188 0.15030159 0.67339844 ELVIDGE_HYPOXIA_BY_DMOG_UP lipid metabolism disorder DOID_3146 0.01278422 0.05428524 0.01278422 0.19142689 ELVIDGE_HYPOXIA_BY_DMOG_UP chronic kidney failure DOID_784 0.01368768 0.05769105 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP bone development disease DOID_0080006 0.01399484 0.05855196 0.01399484 0.19907665 ELVIDGE_HYPOXIA_BY_DMOG_UP Human immunodeficiency virus infectious disease DOID_526 0.01589994 0.06603698 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.01722821 0.07103514 0.18168489 0.75458906 ELVIDGE_HYPOXIA_BY_DMOG_UP Crohn's disease DOID_8778 0.01722821 0.0705241 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP arrhythmogenic right ventricular dysplasia DOID_0050431 0.01860083 0.07559909 0.01860083 0.23519718 ELVIDGE_HYPOXIA_BY_DMOG_UP Sjogren's syndrome DOID_12894 0.02064638 0.08331768 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP angioedema DOID_1558 0.02064638 0.08273093 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP ventricular septal defect DOID_1657 0.02064638 0.08215239 0.02064638 0.25538679 ELVIDGE_HYPOXIA_BY_DMOG_UP retinal vascular occlusion DOID_1729 0.02064638 0.08158189 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP rectal neoplasm DOID_1984 0.02064638 0.08101926 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP rectum cancer DOID_1993 0.02064638 0.08101926 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP acute kidney failure DOID_3021 0.02064638 0.08046433 0.02064638 0.24995303 ELVIDGE_HYPOXIA_BY_DMOG_UP teratoma DOID_3307 0.02064638 0.07991695 0.02064638 0.24474567 ELVIDGE_HYPOXIA_BY_DMOG_UP insulinoma DOID_3892 0.02064638 0.07937698 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP keratitis DOID_4677 0.02064638 0.07884424 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP malignant teratoma DOID_5563 0.02064638 0.07991695 0.02064638 0.24474567 ELVIDGE_HYPOXIA_BY_DMOG_UP mature teratoma DOID_5566 0.02064638 0.07991695 0.02064638 0.24474567 ELVIDGE_HYPOXIA_BY_DMOG_UP polycythemia DOID_8432 0.02064638 0.07831862 0.02064638 0.23495585 ELVIDGE_HYPOXIA_BY_DMOG_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.02268773 0.08549216 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP breast benign neoplasm DOID_0060082 0.02268773 0.08492971 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP thoracic benign neoplasm DOID_0060097 0.02268773 0.08492971 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP trypanosomiasis DOID_10113 0.02268773 0.08437462 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP migraine without aura DOID_12783 0.02268773 0.08382673 0.02268773 0.25312385 ELVIDGE_HYPOXIA_BY_DMOG_UP temporal arteritis DOID_13375 0.02268773 0.08328591 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP benign breast phyllodes tumor DOID_1631 0.02268773 0.08492971 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP central nervous system vasculitis DOID_525 0.02268773 0.08328591 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP bronchiectasis DOID_9563 0.02268773 0.08275203 0.02268773 0.24825608 ELVIDGE_HYPOXIA_BY_DMOG_UP familial atrial fibrillation DOID_0050650 0.02472487 0.08960796 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP pituitary cancer DOID_1785 0.02472487 0.08904082 0.02472487 0.26544245 ELVIDGE_HYPOXIA_BY_DMOG_UP islet cell tumor DOID_1799 0.02472487 0.08848082 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP pituitary carcinoma DOID_4916 0.02472487 0.08904082 0.02472487 0.26544245 ELVIDGE_HYPOXIA_BY_DMOG_UP stomach disease DOID_76 0.02472487 0.08792781 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP lipodystrophy DOID_811 0.02472487 0.08738168 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP peritonitis DOID_8283 0.02472487 0.08684228 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP ocular hypertension DOID_9282 0.02472487 0.08630951 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP borderline glaucoma DOID_9283 0.02472487 0.08630951 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP encephalitis DOID_9588 0.02472487 0.08578323 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP leprosy DOID_1024 0.02675782 0.09227393 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP berylliosis DOID_10322 0.02675782 0.09171806 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP newborn respiratory distress syndrome DOID_12716 0.02675782 0.09116885 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP polyneuropathy DOID_1389 0.02675782 0.09062618 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP larynx cancer DOID_2596 0.02675782 0.09008993 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP laryngeal benign neoplasm DOID_2598 0.02675782 0.09008993 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP Leydig cell tumor DOID_2696 0.02675782 0.08955999 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP sex cord-stromal neoplasm DOID_4757 0.02675782 0.08955999 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP open-angle glaucoma DOID_1067 0.02878658 0.09578693 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP rhabdomyosarcoma DOID_3247 0.02878658 0.09523003 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP narcolepsy DOID_8986 0.02878658 0.09467957 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP renovascular hypertension DOID_1591 0.03081117 0.09961112 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP hemangioma DOID_255 0.03081117 0.09904834 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP corneal dystrophy DOID_2566 0.03081117 0.09849189 0.03081117 0.32465845 ELVIDGE_HYPOXIA_BY_DMOG_UP mesenchymal cell neoplasm DOID_3350 0.03081117 0.09794166 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP adrenal cortex disease DOID_3952 0.03081117 0.09739754 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP skeletal muscle cancer DOID_4043 0.03081117 0.09685943 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP spindle cell sarcoma DOID_4235 0.03081117 0.09794166 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP nutritional deficiency disease DOID_5113 0.03081117 0.09632723 0.03081117 0.31875557 ELVIDGE_HYPOXIA_BY_DMOG_UP oral submucous fibrosis DOID_5773 0.03081117 0.09580086 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP epithelioid sarcoma DOID_6193 0.03081117 0.09794166 1.000 1.000 ELVIDGE_HYPOXIA_BY_DMOG_UP tongue cancer DOID_8649 0.03283159 0.09989934 0.03283159 0.32773994 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN aneurysm disease DOID_2403 1.608E-25 9.149E-23 4.747E-22 2.701E-19 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN transitional cell carcinoma DOID_2671 2.889E-16 8.218E-14 1.751E-10 1.661E-08 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN aortic valve insufficiency DOID_57 6.829E-16 1.295E-13 3.766E-11 7.142E-09 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN heart valve disease DOID_4079 8.055E-15 1.146E-12 6.097E-10 3.469E-08 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN aortic valve disease DOID_62 9.8E-15 1.115E-12 7.739E-11 8.807E-09 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN aortic aneurysm DOID_3627 1.618E-14 1.535E-12 7.232E-13 2.058E-10 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN intracranial aneurysm DOID_10941 5.071E-14 4.122E-12 2.595E-10 1.845E-08 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bone resorption disease DOID_0080011 5.41E-14 3.848E-12 4.669E-11 6.642E-09 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN osteoporosis DOID_11476 5.41E-14 3.848E-12 4.669E-11 6.642E-09 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN oral submucous fibrosis DOID_5773 1.506E-12 9.522E-11 1.594E-06 5.67E-05 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN reproductive organ benign neoplasm DOID_0050622 1.886E-12 1.073E-10 5.661E-08 2.928E-06 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pre-eclampsia DOID_10591 1.642E-11 8.494E-10 6.097E-10 3.855E-08 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Ehlers-Danlos syndrome DOID_13359 2.009E-10 9.528E-09 2.009E-10 1.633E-08 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hepatitis B DOID_2043 2.893E-09 1.266E-07 1.746E-07 8.28E-06 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN urinary tract obstruction DOID_5200 3.895E-09 1.583E-07 9.962E-06 2.983E-04 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pre-malignant neoplasm DOID_0060071 6.01E-09 2.28E-07 2.831E-06 8.948E-05 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN in situ carcinoma DOID_8719 6.01E-09 2.28E-07 2.831E-06 8.948E-05 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN diabetic autonomic neuropathy DOID_11503 1.252E-08 4.452E-07 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN autonomic neuropathy DOID_11504 1.252E-08 4.452E-07 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN diabetic polyneuropathy DOID_12785 1.252E-08 4.452E-07 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN diabetic neuropathy DOID_9743 1.252E-08 4.452E-07 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pancreatic ductal carcinoma DOID_3587 1.357E-08 4.542E-07 7.779E-05 1.475E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pancreatic carcinoma DOID_4905 1.875E-08 5.926E-07 9.43E-05 1.731E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN diabetic retinopathy DOID_8947 1.875E-08 5.614E-07 1.128E-03 0.01188174 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN autonomic nervous system disease DOID_11465 1.958E-08 5.571E-07 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN thoracic aortic aneurysm DOID_14004 2.06E-08 5.582E-07 1.594E-06 6.048E-05 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN focal glomerulosclerosis DOID_3945 2.73E-08 7.06E-07 3.41E-05 9.239E-04 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mixed glioma DOID_5076 2.824E-08 6.986E-07 1.204E-04 2.14E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN female reproductive organ benign neoplasm DOID_0060086 3.343E-08 7.926E-07 9.126E-04 0.01018188 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN uterine benign neoplasm DOID_0060095 3.343E-08 7.926E-07 9.126E-04 0.01018188 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN uterine fibroid DOID_13223 3.343E-08 7.926E-07 9.126E-04 0.01018188 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN endometrial carcinoma DOID_2871 3.343E-08 7.609E-07 3.879E-05 1.003E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN endometrial cancer DOID_1380 4.912E-08 1.075E-06 4.956E-05 1.128E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bile duct adenocarcinoma DOID_4896 5.003E-08 1.054E-06 4.826E-03 0.03017832 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN cholangiocarcinoma DOID_4947 5.003E-08 1.054E-06 4.826E-03 0.03017832 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bone development disease DOID_0080006 5.013E-08 1.019E-06 8.783E-07 3.57E-05 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN retinal vascular disease DOID_2462 5.492E-08 1.078E-06 1.859E-03 0.01627529 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN ureteral obstruction DOID_5199 5.793E-08 1.099E-06 1.597E-04 2.524E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN leiomyoma DOID_127 5.899E-08 1.083E-06 1.189E-03 0.01229563 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bile duct cancer DOID_4606 8.09E-08 1.439E-06 5.834E-03 0.034579 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bile duct carcinoma DOID_4897 8.09E-08 1.439E-06 5.834E-03 0.034579 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN spindle cell carcinoma DOID_4015 8.365E-08 1.442E-06 1.399E-03 0.01372117 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN collagen disease DOID_854 1.135E-07 1.899E-06 2.359E-06 7.896E-05 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mouth disease DOID_403 1.19E-07 1.935E-06 2.662E-03 0.01941671 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN dilated cardiomyopathy DOID_12930 1.291E-07 2.04E-06 2.973E-04 3.934E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pulmonary embolism DOID_9477 2.22E-07 3.415E-06 0.12851877 0.29250872 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN benign mesothelioma DOID_2645 2.453E-07 3.673E-06 2.312E-03 0.01827183 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN ureteral disease DOID_1426 2.791E-07 4.072E-06 3.857E-04 4.877E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN uterine cancer DOID_363 3.676E-07 5.23E-06 1.794E-04 2.759E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN neuritis DOID_1803 5.36E-07 7.439E-06 2.284E-04 3.332E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN glaucoma DOID_1686 6.799E-07 9.212E-06 2.66E-04 3.784E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lung adenocarcinoma DOID_3910 7.611E-07 1.007E-05 2.598E-05 7.392E-04 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN biliary tract cancer DOID_4607 8.109E-07 1.049E-05 0.01442922 0.06674979 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN osteogenesis imperfecta DOID_12347 8.43E-07 1.066E-05 8.43E-07 3.69E-05 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN abdominal aortic aneurysm DOID_7693 1.492E-06 1.845E-05 4.393E-05 1.042E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN skeletal system cancer DOID_0060124 1.594E-06 1.93E-05 0.0857984 0.24167966 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bone cancer DOID_184 1.594E-06 1.93E-05 0.0857984 0.24167966 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.852E-06 2.196E-05 0.01990656 0.08849087 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN myocarditis DOID_820 2.335E-06 2.712E-05 6.236E-05 1.314E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hypothyroidism DOID_1459 2.586E-06 2.943E-05 6.262E-04 7.423E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN brain infarction DOID_3454 4.353E-06 4.856E-05 8.871E-03 0.04807344 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN brain edema DOID_4724 5.528E-06 6.049E-05 6.263E-03 0.03636486 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN intracranial arterial disease DOID_13089 5.764E-06 6.188E-05 0.02721791 0.11471844 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN cerebral arterial disease DOID_3527 5.764E-06 6.188E-05 0.02721791 0.11471844 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN cervix uteri carcinoma in situ DOID_8991 6.472E-06 6.819E-05 2.312E-03 0.01802153 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN myeloma DOID_0070004 1.226E-05 1.269E-04 3.333E-03 0.02312899 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN calcium metabolism disease DOID_10575 1.637E-05 1.663E-04 2.864E-04 3.88E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN giant cell tumor DOID_200 2.148E-05 2.144E-04 0.04414808 0.17444623 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN malignant giant cell tumor DOID_2705 2.148E-05 2.144E-04 0.04414808 0.17444623 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN giant cell glioblastoma DOID_3074 2.148E-05 2.144E-04 0.04414808 0.17444623 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bone marrow cancer DOID_4960 2.343E-05 2.298E-04 4.826E-03 0.0298503 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN osteochondrodysplasia DOID_2256 2.552E-05 2.461E-04 4.054E-04 5.015E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Sciatic Neuropathy DOID_11446 2.598E-05 2.464E-04 0.01292122 0.06506348 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lesion of sciatic nerve DOID_12528 2.598E-05 2.464E-04 0.01292122 0.06506348 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mononeuritis of lower limb DOID_9473 2.598E-05 2.464E-04 0.01292122 0.06506348 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mononeuritis DOID_1802 2.984E-05 2.783E-04 0.01379033 0.06538917 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN glioblastoma DOID_3068 3.265E-05 2.996E-04 0.05146419 0.19785896 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mononeuropathy DOID_1188 3.41E-05 3.08E-04 0.0146841 0.06738109 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN corneal disease DOID_10124 3.879E-05 3.449E-04 9.126E-04 9.986E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN carotid artery disease DOID_3407 4.124E-05 3.61E-04 0.05604704 0.20980766 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN age related macular degeneration DOID_10871 4.393E-05 3.788E-04 4.393E-05 1.087E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN degeneration of macula and posterior pole DOID_2007 4.393E-05 3.788E-04 4.393E-05 1.087E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN peritonitis DOID_8283 4.42E-05 3.754E-04 0.0692462 0.2164895 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mineral metabolism disease DOID_0050032 5.149E-05 4.308E-04 7.024E-04 8.156E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN uterine disease DOID_345 5.531E-05 4.561E-04 7.881E-03 0.0443964 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN polyneuropathy DOID_1389 5.721E-05 4.65E-04 5.721E-05 1.252E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN epilepsy with generalized tonic-clonic seizures DOID_7725 5.721E-05 4.585E-04 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN papilloma DOID_2615 6.236E-05 4.928E-04 1.291E-03 0.01311628 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN metal metabolism disorder DOID_896 6.236E-05 4.861E-04 6.236E-05 1.267E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pneumoconiosis DOID_10316 6.959E-05 5.351E-04 0.02054659 0.090628 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN macular degeneration DOID_4448 6.959E-05 5.28E-04 6.959E-05 1.366E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN astrocytoma DOID_3069 7.281E-05 5.451E-04 0.06892059 0.22668101 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN peripheral vascular disease DOID_341 8.852E-05 6.542E-04 0.01030063 0.05377119 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN communication disorder DOID_2033 9.022E-05 6.581E-04 0.0857984 0.24048912 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hemangioma DOID_255 9.022E-05 6.498E-04 3.53E-03 0.02390968 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN calcinosis DOID_182 9.496E-05 6.754E-04 1.755E-03 0.01610864 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN peptic ulcer DOID_750 1.152E-04 8.094E-04 0.0260526 0.11145813 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN urinary system benign neoplasm DOID_731 1.336E-04 9.274E-04 1.336E-04 2.304E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN metabolic syndrome X DOID_14221 1.353E-04 9.275E-04 0.01310641 0.0642892 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pulmonary emphysema DOID_9675 1.385E-04 9.378E-04 0.0284039 0.1188369 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN female reproductive system disease DOID_229 1.433E-04 9.591E-04 0.01353927 0.0652868 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN autoimmune disease of urogenital tract DOID_0060049 1.513E-04 1.001E-03 1.513E-04 2.531E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN primary biliary cirrhosis DOID_12236 1.513E-04 1.001E-03 1.513E-04 2.531E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN salivary gland cancer DOID_8850 1.513E-04 9.892E-04 1.513E-04 2.459E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN chronic kidney failure DOID_784 1.603E-04 1.037E-03 0.09162293 0.24135856 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN gallbladder cancer DOID_3121 1.794E-04 1.147E-03 0.24511672 0.44559557 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN cerebral infarction DOID_3526 1.948E-04 1.231E-03 0.03334907 0.13750452 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN proteinuria DOID_576 2.111E-04 1.32E-03 3.147E-03 0.02210593 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN amyloidosis DOID_9120 2.211E-04 1.368E-03 2.211E-04 3.311E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN encephalomyelitis DOID_640 2.699E-04 1.651E-03 0.11034587 0.27063275 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Crohn's disease DOID_8778 2.833E-04 1.715E-03 2.833E-04 3.932E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN placenta disease DOID_780 2.961E-04 1.773E-03 7.555E-03 0.04299009 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN IgA glomerulonephritis DOID_2986 3.39E-04 2.009E-03 0.12851877 0.29368345 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN uremia DOID_4676 3.39E-04 1.989E-03 8.243E-03 0.04553465 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN atrophic muscular disease DOID_913 3.542E-04 2.057E-03 4.592E-03 0.02903383 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN muscular dystrophy DOID_9884 3.542E-04 2.057E-03 4.592E-03 0.02903383 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN vasculitis DOID_865 3.792E-04 2.179E-03 0.04557796 0.1788542 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN diabetic angiopathy DOID_11713 3.857E-04 2.195E-03 8.957E-03 0.04808006 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN synostosis DOID_11971 3.857E-04 2.173E-03 3.857E-04 4.988E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN meningitis DOID_9471 3.857E-04 2.152E-03 0.13371711 0.30192475 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN integumentary system cancer DOID_0060122 4.054E-04 2.24E-03 0.04702476 0.18326773 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN skin cancer DOID_4159 4.054E-04 2.24E-03 0.04702476 0.18326773 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN portal hypertension DOID_10762 4.912E-04 2.687E-03 0.01046506 0.05413288 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN urticaria DOID_1555 4.912E-04 2.662E-03 0.14402136 0.31640214 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN oral cavity cancer DOID_8618 4.917E-04 2.64E-03 4.917E-04 5.953E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN melancholia DOID_2848 5.232E-04 2.782E-03 0.30996158 0.53444891 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN neurotic disorder DOID_4964 5.561E-04 2.93E-03 0.31408187 0.53991717 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN middle cerebral artery infarction DOID_3525 6.134E-04 3.202E-03 0.15420358 0.32862112 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN respiratory failure DOID_11162 6.262E-04 3.239E-03 0.0576054 0.21423185 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN gestational diabetes DOID_11714 6.812E-04 3.492E-03 0.15924938 0.330704 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN periodontitis DOID_824 6.812E-04 3.461E-03 0.15924938 0.32950144 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hepatic vascular disease DOID_272 7.536E-04 3.795E-03 0.01379033 0.06484876 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN coronary stenosis DOID_4248 7.536E-04 3.761E-03 7.536E-04 8.576E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN allergic contact dermatitis DOID_3042 8.286E-04 4.1E-03 8.533E-03 0.04668693 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN toxic encephalopathy DOID_3602 8.307E-04 4.075E-03 0.0146841 0.06684204 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN dysostosis DOID_1934 9.126E-04 4.438E-03 9.126E-04 9.798E-03 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN blood coagulation disease DOID_1247 9.7E-04 4.678E-03 9.57E-03 0.05042123 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN biliary tract disease DOID_9741 1.073E-03 5.132E-03 0.07397545 0.22752449 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pleural disease DOID_1532 1.189E-03 5.635E-03 0.18890098 0.37063675 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bladder disease DOID_365 1.189E-03 5.589E-03 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN endogenous depression DOID_1595 1.242E-03 5.793E-03 0.37302647 0.62611228 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN electroclinical syndrome DOID_0050701 1.365E-03 6.312E-03 0.3804948 0.63676924 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hepatitis C DOID_1883 1.399E-03 6.418E-03 1.399E-03 0.01396189 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN periodontal disease DOID_3388 1.399E-03 6.367E-03 0.19855162 0.38558319 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN contact dermatitis DOID_2773 1.495E-03 6.752E-03 0.01310641 0.06373972 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lymphoid leukemia DOID_10747 1.512E-03 6.774E-03 1.512E-03 0.01458077 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN medullomyoblastoma DOID_3861 1.512E-03 6.721E-03 1.512E-03 0.01433776 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN adult medulloblastoma DOID_3864 1.512E-03 6.721E-03 1.512E-03 0.01433776 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN childhood medulloblastoma DOID_3869 1.512E-03 6.721E-03 1.512E-03 0.01433776 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN angioedema DOID_1558 1.543E-03 6.805E-03 0.05804598 0.21037048 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN chondrosarcoma DOID_3371 1.543E-03 6.752E-03 1.543E-03 0.01439051 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN keratitis DOID_4677 1.543E-03 6.701E-03 0.05804598 0.20772431 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mental depression DOID_1596 1.707E-03 7.358E-03 0.39878041 0.66153368 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN adolescence-adult electroclinical syndrome DOID_0050705 1.755E-03 7.509E-03 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pulmonary sarcoidosis DOID_13406 1.755E-03 7.453E-03 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN medulloblastoma DOID_3858 1.755E-03 7.398E-03 1.755E-03 0.01585295 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN multiple myeloma DOID_9538 1.755E-03 7.344E-03 1.755E-03 0.01560524 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN craniosynostosis DOID_2340 1.878E-03 7.801E-03 1.878E-03 0.01619216 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN heroin dependence DOID_9976 1.878E-03 7.744E-03 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN primary bacterial infectious disease DOID_0050338 2.021E-03 8.272E-03 2.021E-03 0.01716032 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN congenital diaphragmatic hernia DOID_3827 2.022E-03 8.217E-03 0.22218101 0.41585854 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN adult respiratory distress syndrome DOID_11394 2.164E-03 8.732E-03 0.02721791 0.11557455 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN adenoid cystic carcinoma DOID_4866 2.164E-03 8.671E-03 2.164E-03 0.01810654 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN mucopolysaccharidosis DOID_12798 2.245E-03 8.933E-03 2.245E-03 0.01851288 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN aortic valve stenosis DOID_1712 2.245E-03 8.871E-03 0.0692462 0.22135443 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN stomach disease DOID_76 2.245E-03 8.81E-03 0.0692462 0.21768557 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lipodystrophy DOID_811 2.245E-03 8.749E-03 2.245E-03 0.01824841 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Human immunodeficiency virus infectious disease DOID_526 2.281E-03 8.827E-03 2.281E-03 0.01827643 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lymphoblastic leukemia DOID_1037 2.563E-03 9.852E-03 2.563E-03 0.01970427 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN nephrotic syndrome DOID_1184 2.627E-03 0.01003194 0.24058409 0.44445568 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN primitive neuroectodermal tumor DOID_168 2.627E-03 9.965E-03 2.627E-03 0.01993012 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN carotid stenosis DOID_13001 2.643E-03 9.958E-03 0.07479649 0.22282305 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN larynx cancer DOID_2596 2.643E-03 9.893E-03 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN laryngeal benign neoplasm DOID_2598 2.643E-03 9.893E-03 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Leydig cell tumor DOID_2696 2.643E-03 9.828E-03 2.643E-03 0.01978583 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Lynch syndrome DOID_3883 2.643E-03 9.764E-03 2.643E-03 0.01952887 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN intracranial thrombosis DOID_4193 2.643E-03 9.701E-03 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN sex cord-stromal neoplasm DOID_4757 2.643E-03 9.828E-03 2.643E-03 0.01978583 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN open-angle glaucoma DOID_1067 3.071E-03 0.01120172 3.071E-03 0.02211986 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN polycystic kidney disease DOID_898 3.071E-03 0.01113037 3.071E-03 0.02184336 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN vascular skin disease DOID_9540 3.333E-03 0.01200365 0.25855364 0.46409155 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN congenital ichthyosiform erythroderma DOID_1699 3.53E-03 0.01263153 3.53E-03 0.02419775 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN corneal dystrophy DOID_2566 3.53E-03 0.01255258 3.53E-03 0.02362839 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN membranoproliferative glomerulonephritis DOID_2920 3.53E-03 0.01247461 3.53E-03 0.02335364 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN intermediate coronary syndrome DOID_8805 3.53E-03 0.01239761 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN autoimmune disease of gastrointestinal tract DOID_0060031 3.726E-03 0.01300559 0.03860287 0.15578038 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN integumentary system benign neoplasm DOID_0060121 3.726E-03 0.01292629 0.03860287 0.15468334 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN skin benign neoplasm DOID_3165 3.726E-03 0.01292629 0.03860287 0.15468334 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lung small cell carcinoma DOID_5409 3.726E-03 0.01284794 0.26737902 0.47543333 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN angiosarcoma DOID_0001816 4.018E-03 0.01377315 4.018E-03 0.02627981 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lymphatic system cancer DOID_0060073 4.536E-03 0.01545539 4.536E-03 0.02933011 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN penile disease DOID_1529 4.536E-03 0.01536339 0.09667006 0.25231773 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hyperostosis DOID_205 4.536E-03 0.01527248 4.536E-03 0.02900056 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN reticulosarcoma DOID_8538 4.536E-03 0.01545539 4.536E-03 0.02933011 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lymphosarcoma DOID_8675 4.536E-03 0.01545539 4.536E-03 0.02933011 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN sarcoidosis DOID_11335 4.592E-03 0.01537085 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN congenital muscular dystrophy DOID_0050557 5.083E-03 0.01691418 5.083E-03 0.03110027 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN male reproductive organ benign neoplasm DOID_0060087 5.083E-03 0.01681584 5.083E-03 0.03076941 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN glucose intolerance DOID_10603 5.083E-03 0.01671864 5.083E-03 0.03044552 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN osteosclerosis DOID_4254 5.083E-03 0.01662256 0.10205753 0.26276349 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN prion disease DOID_649 5.083E-03 0.01652757 0.10205753 0.26157988 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hypertrophic cardiomyopathy DOID_11984 5.834E-03 0.01886127 0.05146419 0.19920494 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hypersensitivity reaction type IV disease DOID_2916 5.834E-03 0.01875471 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN esophagitis DOID_11963 6.263E-03 0.0200211 6.263E-03 0.03673975 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN neuroectodermal tumor DOID_171 6.666E-03 0.0211907 6.666E-03 0.0383145 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN autoimmune hepatitis DOID_2048 6.895E-03 0.02179725 0.11802874 0.28099729 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN gastric ulcer DOID_10808 7.555E-03 0.02375143 0.12328937 0.28868993 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN cholestasis DOID_13580 7.881E-03 0.02463756 0.06236946 0.21771915 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN parasitic infectious disease DOID_1398 7.881E-03 0.02450293 0.06236946 0.21639159 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hyperglycemia DOID_4195 8.203E-03 0.02536715 8.203E-03 0.04576036 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN sinusitis DOID_0050127 8.243E-03 0.02535172 0.12851877 0.29970156 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN paranasal sinus disease DOID_1352 8.243E-03 0.02535172 0.12851877 0.29970156 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN opiate dependence DOID_2559 8.243E-03 0.02521542 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN tooth disease DOID_1091 8.533E-03 0.02596492 0.34224608 0.58130753 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Goodpasture syndrome DOID_9808 8.957E-03 0.02710897 8.957E-03 0.04763071 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN nephrosis DOID_2527 9.932E-03 0.0298997 0.35781985 0.60595088 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bile duct disease DOID_4138 9.932E-03 0.02974234 0.07227745 0.22351017 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bronchiolitis DOID_2942 0.01046506 0.031176 0.14402136 0.31518521 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN cystitis DOID_1679 0.01125825 0.03336429 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN myositis DOID_633 0.01125825 0.03319142 0.01125825 0.05771121 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN syndrome DOID_225 0.0114553 0.03359828 0.07914514 0.23213187 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN spinal cord disease DOID_319 0.01207708 0.0352403 0.01207708 0.06135589 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN extrinsic allergic alveolitis DOID_841 0.01207708 0.03506051 0.15420358 0.32258029 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pancreatitis DOID_4989 0.01226484 0.03542483 0.0826526 0.23397676 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN diffuse large B-cell lymphoma DOID_0050745 0.01292122 0.03713219 0.15924938 0.33191537 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN migraine DOID_6364 0.01292122 0.0369456 0.01292122 0.06449275 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN perinatal necrotizing enterocolitis DOID_8677 0.01292122 0.03676087 0.01292122 0.06393194 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lipid metabolism disorder DOID_3146 0.01310641 0.03710222 0.08620696 0.23696501 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN autoimmune disease of cardiovascular system DOID_0060051 0.01379033 0.03884505 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pleurisy DOID_10247 0.01379033 0.0386537 0.16426521 0.3386482 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN renal hypertension DOID_1073 0.01379033 0.03846422 0.16426521 0.33742565 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN secondary hypertension DOID_11130 0.01379033 0.03846422 0.16426521 0.33742565 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN sarcoma DOID_1115 0.01379033 0.03827659 0.01379033 0.06593866 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Behcet's disease DOID_13241 0.01379033 0.03884505 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN autoimmune disease of the nervous system DOID_438 0.01379033 0.03809078 0.01379033 0.06431722 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN congenital disorder of glycosylation DOID_5212 0.0156022 0.04288721 0.0156022 0.07045757 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN amino acid metabolic disorder DOID_9252 0.01729415 0.04730946 0.10273976 0.25981744 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN allergic rhinitis DOID_4481 0.01751012 0.04767109 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN lymphoma DOID_0060058 0.01883697 0.05103922 0.10843054 0.26824772 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hair disease DOID_421 0.01951157 0.05261651 0.01951157 0.08741798 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hypersensitivity reaction type I disease DOID_1205 0.02045368 0.05489691 0.11420309 0.27303175 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN nephroblastoma DOID_2154 0.02054659 0.05488738 0.02054659 0.08993086 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN esophageal disease DOID_6050 0.02054659 0.0546309 0.02054659 0.08924437 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN thyroid cancer DOID_1781 0.02268372 0.06003272 0.20808794 0.39866007 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN adenoma DOID_657 0.02268372 0.05975479 0.20808794 0.39732228 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN refractive error DOID_9835 0.02268372 0.05947943 0.20808794 0.39599344 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN cleft palate DOID_674 0.02378522 0.0620816 0.21281365 0.40363656 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN embryonal cancer DOID_688 0.02378522 0.06179812 0.02378522 0.1025287 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN respiratory syncytial virus infectious disease DOID_1273 0.0260526 0.06738151 1.000 1.000 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hepatitis DOID_2237 0.0260526 0.06707661 0.22218101 0.41723101 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN systemic scleroderma DOID_418 0.0260526 0.06677447 0.22218101 0.41449507 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN endometriosis of uterus DOID_288 0.02961029 0.07555272 0.23602437 0.43745233 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN Huntington's disease DOID_12858 0.03083681 0.078331 0.24058409 0.44301731 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN rheumatic disease DOID_1575 0.03083681 0.07798286 0.24058409 0.44158822 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN hyperinsulinism DOID_2018 0.03083681 0.0776378 0.24058409 0.44016832 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN endometriosis DOID_289 0.03083681 0.07729579 0.24058409 0.43875753 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN uveal disease DOID_3480 0.03083681 0.07695677 0.03083681 0.12807404 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN scleroderma DOID_419 0.03083681 0.07798286 0.24058409 0.44158822 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN influenza DOID_8469 0.03208316 0.07971755 0.24511672 0.44417648 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN spinocerebellar degeneration DOID_2478 0.03463427 0.08568218 0.03463427 0.14177627 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN brain cancer DOID_1319 0.03593849 0.0885238 0.25855364 0.46703816 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN bone marrow disease DOID_4961 0.03593849 0.08814223 0.03593849 0.14606427 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN central nervous system cancer DOID_3620 0.03726144 0.09099468 0.26297948 0.47055134 REN_ALVEOLAR_RHABDOMYOSARCOMA_DN pulmonary tuberculosis DOID_2957 0.03860287 0.09386767 0.03860287 0.15360164 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hemolytic anemia DOID_583 1.084E-08 6.166E-06 8.739E-07 2.486E-04 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP normocytic anemia DOID_720 1.084E-08 6.166E-06 8.739E-07 2.486E-04 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP dilated cardiomyopathy DOID_12930 2.829E-07 8.049E-05 2.829E-07 1.61E-04 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hyperglycemia DOID_4195 2.966E-06 5.626E-04 4.395E-03 0.07144723 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP bacterial pneumonia DOID_874 5.364E-06 7.631E-04 5.861E-03 0.08550813 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP osteosarcoma DOID_3347 6.939E-06 7.897E-04 6.939E-06 1.316E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP blood platelet disease DOID_2218 2.802E-05 2.658E-03 2.802E-05 3.986E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP proteinuria DOID_576 4.805E-05 3.905E-03 2.243E-03 0.04727948 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP pre-eclampsia DOID_10591 5.106E-05 3.632E-03 0.06883272 0.33191369 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP pulmonary tuberculosis DOID_2957 5.746E-05 3.633E-03 0.07148705 0.32540905 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hemorrhagic disease DOID_2213 6.436E-05 3.662E-03 6.436E-05 7.324E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP parasitic protozoa infectious disease DOID_2789 7.974E-05 4.125E-03 3.128E-03 0.05932288 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hypertrophic cardiomyopathy DOID_11984 9.273E-05 4.397E-03 9.273E-05 8.793E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP sickle cell anemia DOID_10923 1.086E-04 4.755E-03 1.086E-04 8.83E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP parasitic infectious disease DOID_1398 1.282E-04 5.211E-03 4.271E-03 0.07148173 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP beta thalassemia DOID_12241 1.302E-04 4.94E-03 1.302E-04 9.263E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP relapsing-remitting multiple sclerosis DOID_2378 1.302E-04 4.631E-03 1.302E-04 8.234E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP tuberculosis DOID_399 1.458E-04 4.879E-03 0.09633567 0.37037161 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP blood coagulation disease DOID_1247 1.583E-04 5.005E-03 1.583E-04 9.008E-03 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP thalassemia DOID_10241 2.066E-04 6.188E-03 2.066E-04 0.01068802 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP pancreatitis DOID_4989 2.077E-04 5.908E-03 0.10787711 0.39096865 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP metabolic syndrome X DOID_14221 2.234E-04 6.053E-03 6.148E-03 0.08745913 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hemolytic-uremic syndrome DOID_12554 2.359E-04 6.102E-03 0.02255278 0.19443229 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP chronic kidney failure DOID_784 2.484E-04 6.145E-03 0.11422638 0.39390795 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP primary bacterial infectious disease DOID_0050338 2.845E-04 6.744E-03 0.11927385 0.40638813 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP glucose intolerance DOID_10603 3.003E-04 6.834E-03 0.02533654 0.20304914 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP infertility DOID_5223 3.353E-04 7.337E-03 3.353E-04 0.01589748 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hypersensitivity reaction type I disease DOID_1205 3.664E-04 7.721E-03 3.664E-04 0.01603515 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP congenital hemolytic anemia DOID_589 5.387E-04 0.01094665 5.387E-04 0.02189331 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP Goodpasture syndrome DOID_9808 5.387E-04 0.01056918 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP acute pancreatitis DOID_2913 5.85E-04 0.01109517 0.03501854 0.22902933 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP bronchiolitis DOID_2942 6.332E-04 0.01162141 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP morbid obesity DOID_11981 6.832E-04 0.01214781 0.03776745 0.23877422 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP myositis DOID_633 6.832E-04 0.0117797 0.03776745 0.23615033 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP diffuse large B-cell lymphoma DOID_0050745 7.888E-04 0.01320065 7.888E-04 0.02992147 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP pleurisy DOID_10247 8.444E-04 0.01372692 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP malaria DOID_12365 8.444E-04 0.01334562 8.444E-04 0.03002764 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP thrombocytopenia DOID_1588 8.444E-04 0.01298492 8.444E-04 0.0282613 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP age related macular degeneration DOID_10871 1.022E-03 0.0153043 1.022E-03 0.03230908 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP degeneration of macula and posterior pole DOID_2007 1.022E-03 0.0153043 1.022E-03 0.03230908 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP bronchiolitis obliterans DOID_2799 1.022E-03 0.01491188 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP pleural disease DOID_1532 1.15E-03 0.01635415 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP metal metabolism disorder DOID_896 1.216E-03 0.01687841 1.216E-03 0.03642183 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP thyroid carcinoma DOID_3963 1.285E-03 0.01740218 1.285E-03 0.03654458 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP macular degeneration DOID_4448 1.285E-03 0.01699748 1.285E-03 0.03480436 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP thyroid cancer DOID_1781 1.427E-03 0.01844813 1.427E-03 0.03689626 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP pulmonary sarcoidosis DOID_13406 1.5E-03 0.01897024 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP microcephaly DOID_10907 1.576E-03 0.01949176 1.576E-03 0.03898351 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP lymphatic system disease DOID_75 1.732E-03 0.02096975 1.732E-03 0.04106575 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP endometriosis of uterus DOID_288 1.896E-03 0.02247014 0.06216426 0.32155877 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP endometriosis DOID_289 1.98E-03 0.02299113 0.06350169 0.31419532 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP diabetic autonomic neuropathy DOID_11503 2.066E-03 0.02351127 0.06483725 0.31803788 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP autonomic neuropathy DOID_11504 2.066E-03 0.02351127 0.06483725 0.31803788 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP diabetic polyneuropathy DOID_12785 2.066E-03 0.02351127 0.06483725 0.31803788 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP gallbladder cancer DOID_3121 2.066E-03 0.02305026 2.066E-03 0.04702254 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP influenza DOID_8469 2.066E-03 0.02260699 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP diabetic neuropathy DOID_9743 2.066E-03 0.02351127 0.06483725 0.31803788 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP cerebral infarction DOID_3526 2.154E-03 0.02312374 2.154E-03 0.04713684 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP autonomic nervous system disease DOID_11465 2.335E-03 0.02460231 0.06883272 0.3291245 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP movement disease DOID_480 2.619E-03 0.02709778 2.619E-03 0.05322778 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP B-cell lymphocytic neoplasm DOID_707 2.718E-03 0.02761235 2.718E-03 0.0533204 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP sarcoidosis DOID_11335 2.919E-03 0.02914117 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP congenital nervous system abnormality DOID_2490 3.343E-03 0.03279635 3.343E-03 0.06136091 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hypersensitivity reaction type IV disease DOID_2916 3.453E-03 0.03330306 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP oral cavity cancer DOID_8618 3.453E-03 0.03274801 3.453E-03 0.06140252 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP carotid artery disease DOID_3407 3.794E-03 0.03538838 3.794E-03 0.06541488 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP uterine disease DOID_345 4.271E-03 0.03919966 0.09245606 0.36532984 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP temporal lobe epilepsy DOID_3328 4.395E-03 0.03969291 0.09375108 0.36789215 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP allergic contact dermatitis DOID_3042 4.52E-03 0.04018536 0.09504428 0.3704123 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP brain infarction DOID_3454 4.647E-03 0.040677 4.647E-03 0.07344459 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP nephrosis DOID_2527 5.037E-03 0.04342427 0.10019901 0.38008824 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP bile duct disease DOID_4138 5.037E-03 0.04277615 5.037E-03 0.07745951 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP male reproductive system disease DOID_48 5.037E-03 0.04214709 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP biliary tract disease DOID_9741 5.17E-03 0.04263549 5.17E-03 0.07741707 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP diabetic retinopathy DOID_8947 5.305E-03 0.04312306 0.10276556 0.3821804 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP contact dermatitis DOID_2773 6.148E-03 0.04927275 0.11042216 0.39515856 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP female reproductive system disease DOID_229 6.294E-03 0.04974294 0.11169202 0.39230097 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP focal epilepsy DOID_2234 6.591E-03 0.05137583 0.11422638 0.39630983 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP biliary tract cancer DOID_4607 6.591E-03 0.05068157 6.591E-03 0.09147405 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP retinal vascular disease DOID_2462 6.894E-03 0.05230602 0.11675365 0.40019776 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP transitional cell carcinoma DOID_2671 7.361E-03 0.0551102 7.361E-03 0.09972322 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP primary immunodeficiency disease DOID_612 7.52E-03 0.0555664 7.52E-03 0.09950263 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP lymphoma DOID_0060058 8.005E-03 0.05839204 8.005E-03 0.10351315 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP encephalomyelitis DOID_640 8.169E-03 0.05883936 0.12679215 0.42689192 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.336E-03 0.05928634 8.336E-03 0.10539794 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP ulcerative colitis DOID_8577 9.016E-03 0.0633323 0.13300926 0.44518982 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP gallbladder disease DOID_0000000 0.0141546 0.09821913 0.0141546 0.17508628 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP Gilles de la Tourette syndrome DOID_11119 0.0141546 0.09703577 0.0141546 0.17136104 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP familial combined hyperlipidemia DOID_13809 0.0141546 0.09588058 0.0141546 0.16779102 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP childhood type dermatomyositis DOID_14203 0.0141546 0.09475258 0.0141546 0.16436671 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP Hermansky-Pudlak syndrome DOID_3753 0.0141546 0.0936508 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP conjunctival disease DOID_4251 0.0141546 0.09257436 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP keratitis DOID_4677 0.0141546 0.09152237 0.0141546 0.16107938 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP conjunctivitis DOID_6195 0.0141546 0.09257436 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP polycythemia DOID_8432 0.0141546 0.09049403 0.0141546 0.15792096 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP alopecia areata DOID_986 0.0141546 0.08948854 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP trypanosomiasis DOID_10113 0.0155592 0.09728775 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP dermatomyositis DOID_10223 0.0155592 0.09623027 0.0155592 0.17025356 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP hemochromatosis DOID_2352 0.0155592 0.09519554 0.0155592 0.16704122 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP chronic monocytic leukemia DOID_8593 0.0155592 0.09418282 0.0155592 0.16394787 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP porphyria DOID_13268 0.01696183 0.09949777 0.01696183 0.17547788 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP osteopetrosis DOID_13533 0.01696183 0.09848248 0.01696183 0.17234434 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP tic disorder DOID_2769 0.01696183 0.09748771 0.01696183 0.16932076 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP pituitary gland disease DOID_53 0.01696183 0.09651283 0.01696183 0.16640144 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP retinal detachment DOID_5327 0.01696183 0.09555726 0.01696183 0.16358107 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP lipodystrophy DOID_811 0.01696183 0.09462042 0.01696183 0.16085472 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP polyneuropathy DOID_1389 0.01836251 0.09950729 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP intracranial thrombosis DOID_4193 0.01836251 0.09856854 0.01836251 0.16584548 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP monocytic leukemia DOID_8527 0.01836251 0.09764734 0.01836251 0.16325415 KAAB_FAILED_HEART_VENTRICLE_DN vasculitis DOID_865 6.377E-06 3.629E-03 6.001E-04 0.11381722 KAAB_FAILED_HEART_VENTRICLE_DN primary immunodeficiency disease DOID_612 2.611E-05 7.427E-03 1.52E-03 0.10808318 KAAB_FAILED_HEART_VENTRICLE_DN heart septal defect DOID_1681 6.525E-05 0.01237516 6.525E-05 0.03712548 KAAB_FAILED_HEART_VENTRICLE_DN chronic leukemia DOID_1036 2.256E-04 0.03209563 0.02193008 0.41594058 KAAB_FAILED_HEART_VENTRICLE_DN chronic lymphocytic leukemia DOID_1040 2.256E-04 0.03209563 0.02193008 0.41594058 KAAB_FAILED_HEART_VENTRICLE_DN influenza DOID_8469 4.08E-04 0.04643337 4.08E-04 0.11608343 KAAB_FAILED_HEART_VENTRICLE_DN congenital heart defect DOID_1682 8.037E-04 0.07621886 8.037E-04 0.11432829 KAAB_FAILED_HEART_VENTRICLE_DN tuberculosis DOID_399 9.293E-04 0.07553984 9.293E-04 0.10575578 KAAB_FAILED_HEART_VENTRICLE_DN cystic fibrosis DOID_1485 1.12E-03 0.07965978 1.12E-03 0.10621304 KAAB_FAILED_HEART_VENTRICLE_DN bacterial pneumonia DOID_874 1.178E-03 0.07445313 0.04944936 0.45381754 KAAB_FAILED_HEART_VENTRICLE_DN primary bacterial infectious disease DOID_0050338 1.454E-03 0.08275079 1.454E-03 0.11821541 KAAB_FAILED_HEART_VENTRICLE_DN lymphoblastic leukemia DOID_1037 1.654E-03 0.0855761 0.05845641 0.519714 KAAB_FAILED_HEART_VENTRICLE_DN hypersensitivity reaction type I disease DOID_1205 1.724E-03 0.08173729 1.724E-03 0.10898305 AMIT_EGF_RESPONSE_120_MCF10A chronic kidney failure DOID_784 2.871E-07 1.634E-04 1.441E-03 0.16401302 AMIT_EGF_RESPONSE_120_MCF10A primary bacterial infectious disease DOID_0050338 3.456E-07 9.833E-05 1.578E-03 0.14968236 AMIT_EGF_RESPONSE_120_MCF10A pulmonary tuberculosis DOID_2957 5.48E-06 1.039E-03 0.03374282 0.39182993 AMIT_EGF_RESPONSE_120_MCF10A tuberculosis DOID_399 1.405E-05 1.999E-03 0.04579709 0.48256563 AMIT_EGF_RESPONSE_120_MCF10A leber hereditary optic neuropathy DOID_705 1.499E-05 1.705E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A childhood type dermatomyositis DOID_14203 1.873E-05 1.776E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A dermatomyositis DOID_10223 2.288E-05 1.86E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A intracranial arteriosclerosis DOID_13097 2.744E-05 1.952E-03 7.886E-03 0.28043779 AMIT_EGF_RESPONSE_120_MCF10A vascular dementia DOID_8725 2.744E-05 1.952E-03 7.886E-03 0.28043779 AMIT_EGF_RESPONSE_120_MCF10A mitochondrial encephalomyopathy DOID_890 2.744E-05 1.735E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A mouth disease DOID_403 3.475E-05 1.978E-03 0.06143818 0.58263872 AMIT_EGF_RESPONSE_120_MCF10A varicose veins DOID_799 4.361E-05 2.256E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A vein disease DOID_866 4.981E-05 2.362E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A mitochondrial myopathy DOID_699 8.7E-05 3.808E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A sinusitis DOID_0050127 1.047E-04 4.256E-03 0.01506193 0.29552541 AMIT_EGF_RESPONSE_120_MCF10A paranasal sinus disease DOID_1352 1.047E-04 4.256E-03 0.01506193 0.29552541 AMIT_EGF_RESPONSE_120_MCF10A optic nerve disease DOID_1891 1.047E-04 3.973E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A IgA glomerulonephritis DOID_2986 1.047E-04 3.724E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A myositis DOID_633 1.451E-04 4.855E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A extrinsic allergic alveolitis DOID_841 1.562E-04 4.936E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A periodontitis DOID_824 1.677E-04 5.021E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A perinatal necrotizing enterocolitis DOID_8677 1.677E-04 4.77E-03 1.677E-04 0.09539565 AMIT_EGF_RESPONSE_120_MCF10A cranial nerve disease DOID_5656 1.919E-04 5.199E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A pneumoconiosis DOID_10316 2.741E-04 7.09E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A periodontal disease DOID_3388 2.741E-04 6.782E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A intracranial arterial disease DOID_13089 3.708E-04 8.791E-03 0.02798201 0.37908965 AMIT_EGF_RESPONSE_120_MCF10A cerebral arterial disease DOID_3527 3.708E-04 8.791E-03 0.02798201 0.37908965 AMIT_EGF_RESPONSE_120_MCF10A influenza DOID_8469 4.432E-04 0.01008624 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A thyroid adenoma DOID_2891 5.016E-04 0.0109769 5.016E-04 0.14269975 AMIT_EGF_RESPONSE_120_MCF10A bone marrow disease DOID_4961 5.016E-04 0.01057035 5.016E-04 0.09513317 AMIT_EGF_RESPONSE_120_MCF10A giant cell tumor DOID_200 6.29E-04 0.01278284 0.03629265 0.41301035 AMIT_EGF_RESPONSE_120_MCF10A malignant giant cell tumor DOID_2705 6.29E-04 0.01278284 0.03629265 0.41301035 AMIT_EGF_RESPONSE_120_MCF10A giant cell glioblastoma DOID_3074 6.29E-04 0.01278284 0.03629265 0.41301035 AMIT_EGF_RESPONSE_120_MCF10A mitochondrial metabolism disease DOID_700 6.98E-04 0.01369589 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A glioblastoma DOID_3068 7.46E-04 0.01414873 0.03947085 0.44037085 AMIT_EGF_RESPONSE_120_MCF10A temporal lobe epilepsy DOID_3328 9.532E-04 0.0174965 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A hyperglycemia DOID_4195 9.532E-04 0.01694973 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A tooth disease DOID_1091 9.809E-04 0.01691269 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A endocrine organ benign neoplasm DOID_0060089 1.009E-03 0.01688424 1.009E-03 0.14351606 AMIT_EGF_RESPONSE_120_MCF10A astrocytoma DOID_3069 1.037E-03 0.01686365 0.04642751 0.48031368 AMIT_EGF_RESPONSE_120_MCF10A male reproductive system disease DOID_48 1.095E-03 0.01731132 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A diabetic retinopathy DOID_8947 1.155E-03 0.01775827 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A cystic fibrosis DOID_1485 1.216E-03 0.0182045 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A bone resorption disease DOID_0080011 1.247E-03 0.01819109 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A osteoporosis DOID_11476 1.247E-03 0.01819109 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A bacterial pneumonia DOID_874 1.278E-03 0.01818375 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A focal epilepsy DOID_2234 1.441E-03 0.02000159 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A retinal vascular disease DOID_2462 1.509E-03 0.0204441 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A Human immunodeficiency virus infectious disease DOID_526 1.685E-03 0.02229894 1.685E-03 0.13697923 AMIT_EGF_RESPONSE_120_MCF10A lymphoma DOID_0060058 1.758E-03 0.0227369 1.758E-03 0.12505295 AMIT_EGF_RESPONSE_120_MCF10A alcohol-related neurodevelopmental disorder DOID_0050667 1.833E-03 0.02317422 1.833E-03 0.11587109 AMIT_EGF_RESPONSE_120_MCF10A hypersensitivity reaction type I disease DOID_1205 1.871E-03 0.02313837 0.06205867 0.56953847 AMIT_EGF_RESPONSE_120_MCF10A ulcerative colitis DOID_8577 1.986E-03 0.02404692 0.0639178 0.57728932 AMIT_EGF_RESPONSE_120_MCF10A interstitial nephritis DOID_1063 6.576E-03 0.07794869 6.576E-03 0.37415369 AMIT_EGF_RESPONSE_120_MCF10A hypolipoproteinemia DOID_1387 6.576E-03 0.0763579 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A retinal vascular occlusion DOID_1729 6.576E-03 0.07483074 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A teratoma DOID_3307 6.576E-03 0.07336347 6.576E-03 0.34013972 AMIT_EGF_RESPONSE_120_MCF10A chondrosarcoma DOID_3371 6.576E-03 0.07195263 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A adrenal gland hyperfunction DOID_3947 6.576E-03 0.07059504 6.576E-03 0.31179474 AMIT_EGF_RESPONSE_120_MCF10A malignant teratoma DOID_5563 6.576E-03 0.07336347 6.576E-03 0.34013972 AMIT_EGF_RESPONSE_120_MCF10A mature teratoma DOID_5566 6.576E-03 0.07336347 6.576E-03 0.34013972 AMIT_EGF_RESPONSE_120_MCF10A acute T cell leukemia DOID_5603 6.576E-03 0.06928772 6.576E-03 0.28781053 AMIT_EGF_RESPONSE_120_MCF10A polycythemia DOID_8432 6.576E-03 0.06802794 6.576E-03 0.26725264 AMIT_EGF_RESPONSE_120_MCF10A cutaneous leishmaniasis DOID_9111 6.576E-03 0.06681316 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A chronic monocytic leukemia DOID_8593 7.231E-03 0.07218226 7.231E-03 0.27429259 AMIT_EGF_RESPONSE_120_MCF10A bronchiectasis DOID_9563 7.231E-03 0.07093774 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A common cold DOID_10459 7.886E-03 0.07605093 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A otitis media DOID_10754 7.886E-03 0.07478341 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A middle ear disease DOID_5100 7.886E-03 0.07478341 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A stomach disease DOID_76 7.886E-03 0.07355745 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A peritonitis DOID_8283 7.886E-03 0.07237104 7.886E-03 0.26394145 AMIT_EGF_RESPONSE_120_MCF10A encephalitis DOID_9588 7.886E-03 0.0712223 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A leprosy DOID_1024 8.54E-03 0.07592788 8.54E-03 0.26996581 AMIT_EGF_RESPONSE_120_MCF10A epilepsy with generalized tonic-clonic seizures DOID_7725 8.54E-03 0.07475976 8.54E-03 0.25575708 AMIT_EGF_RESPONSE_120_MCF10A monocytic leukemia DOID_8527 8.54E-03 0.07362704 8.54E-03 0.24296923 AMIT_EGF_RESPONSE_120_MCF10A T-cell leukemia DOID_715 9.194E-03 0.07808252 9.194E-03 0.24912041 AMIT_EGF_RESPONSE_120_MCF10A adrenal cortex disease DOID_3952 9.848E-03 0.08240349 9.848E-03 0.25470168 AMIT_EGF_RESPONSE_120_MCF10A long QT syndrome DOID_2843 0.01050107 0.08659579 0.01050107 0.25978738 AMIT_EGF_RESPONSE_120_MCF10A adrenal gland disease DOID_9553 0.01115386 0.09066496 0.01115386 0.26443947 AMIT_EGF_RESPONSE_120_MCF10A prion disease DOID_649 0.01180624 0.09461619 0.01180624 0.26870998 AMIT_EGF_RESPONSE_120_MCF10A dissociative disorder DOID_10935 0.0124582 0.0984544 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A dissociative amnesia DOID_11037 0.0124582 0.0984544 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A Down syndrome DOID_14250 0.0124582 0.09710571 0.0124582 0.27264295 AMIT_EGF_RESPONSE_120_MCF10A leishmaniasis DOID_9065 0.0124582 0.09579347 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A microphthalmia DOID_10629 0.01310975 0.09945932 0.01310975 0.27627588 AMIT_EGF_RESPONSE_120_MCF10A amnestic disorder DOID_10914 0.01310975 0.09815064 1.000 1.000 AMIT_EGF_RESPONSE_120_MCF10A pulmonary edema DOID_11396 0.01310975 0.09687596 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP respiratory failure DOID_11162 4.275E-14 2.433E-11 1.169E-03 0.01055724 NUYTTEN_EZH2_TARGETS_UP contact dermatitis DOID_2773 6.88E-14 1.957E-11 4.813E-09 2.738E-06 NUYTTEN_EZH2_TARGETS_UP pleural disease DOID_1532 2.393E-13 4.538E-11 8.316E-04 8.604E-03 NUYTTEN_EZH2_TARGETS_UP influenza DOID_8469 3.143E-13 4.47E-11 2.595E-04 4.101E-03 NUYTTEN_EZH2_TARGETS_UP aneurysm disease DOID_2403 7.474E-13 8.505E-11 0.07152174 0.19287142 NUYTTEN_EZH2_TARGETS_UP Crohn's disease DOID_8778 7.735E-13 7.335E-11 2.603E-08 4.937E-06 NUYTTEN_EZH2_TARGETS_UP allergic contact dermatitis DOID_3042 2.645E-12 2.15E-10 1.3E-08 3.698E-06 NUYTTEN_EZH2_TARGETS_UP lymphoma DOID_0060058 8.873E-12 6.311E-10 2.254E-06 1.832E-04 NUYTTEN_EZH2_TARGETS_UP dilated cardiomyopathy DOID_12930 1.378E-11 8.709E-10 2.904E-08 4.132E-06 NUYTTEN_EZH2_TARGETS_UP neuritis DOID_1803 1.819E-11 1.035E-09 3.124E-05 8.888E-04 NUYTTEN_EZH2_TARGETS_UP aortic aneurysm DOID_3627 3.592E-11 1.858E-09 0.13544971 0.29757098 NUYTTEN_EZH2_TARGETS_UP peptic ulcer DOID_750 6.527E-11 3.095E-09 0.09212234 0.22990181 NUYTTEN_EZH2_TARGETS_UP adult respiratory distress syndrome DOID_11394 8.414E-11 3.683E-09 0.01529702 0.06129582 NUYTTEN_EZH2_TARGETS_UP peripheral vascular disease DOID_341 1.156E-10 4.7E-09 3.068E-04 4.257E-03 NUYTTEN_EZH2_TARGETS_UP diabetic retinopathy DOID_8947 1.358E-10 5.152E-09 0.06525413 0.1785077 NUYTTEN_EZH2_TARGETS_UP encephalomyelitis DOID_640 1.478E-10 5.256E-09 2.137E-05 6.756E-04 NUYTTEN_EZH2_TARGETS_UP bacterial pneumonia DOID_874 2.525E-10 8.451E-09 0.07366889 0.19772452 NUYTTEN_EZH2_TARGETS_UP glaucoma DOID_1686 6.298E-10 1.991E-08 3.09E-06 2.197E-04 NUYTTEN_EZH2_TARGETS_UP retinal vascular disease DOID_2462 6.885E-10 2.062E-08 0.08947732 0.22527697 NUYTTEN_EZH2_TARGETS_UP primary bacterial infectious disease DOID_0050338 9.015E-10 2.565E-08 7.68E-04 8.245E-03 NUYTTEN_EZH2_TARGETS_UP transitional cell carcinoma DOID_2671 1.029E-09 2.788E-08 1.437E-05 5.109E-04 NUYTTEN_EZH2_TARGETS_UP astrocytoma DOID_3069 1.158E-09 2.995E-08 0.01150746 0.04960414 NUYTTEN_EZH2_TARGETS_UP giant cell tumor DOID_200 1.357E-09 3.358E-08 4.778E-03 0.02861542 NUYTTEN_EZH2_TARGETS_UP malignant giant cell tumor DOID_2705 1.357E-09 3.358E-08 4.778E-03 0.02861542 NUYTTEN_EZH2_TARGETS_UP giant cell glioblastoma DOID_3074 1.357E-09 3.358E-08 4.778E-03 0.02861542 NUYTTEN_EZH2_TARGETS_UP nephrosis DOID_2527 1.567E-09 3.716E-08 2.086E-03 0.01603896 NUYTTEN_EZH2_TARGETS_UP pustulosis of palm and sole DOID_4398 1.947E-09 4.431E-08 6.522E-06 3.374E-04 NUYTTEN_EZH2_TARGETS_UP pleurisy DOID_10247 2.048E-09 4.482E-08 0.05111485 0.14991934 NUYTTEN_EZH2_TARGETS_UP intracranial arterial disease DOID_13089 2.064E-09 4.349E-08 0.01529702 0.06086718 NUYTTEN_EZH2_TARGETS_UP cerebral arterial disease DOID_3527 2.064E-09 4.349E-08 0.01529702 0.06086718 NUYTTEN_EZH2_TARGETS_UP cystic fibrosis DOID_1485 2.792E-09 5.675E-08 0.01508147 0.06086068 NUYTTEN_EZH2_TARGETS_UP bone resorption disease DOID_0080011 3.209E-09 6.296E-08 5.431E-06 3.09E-04 NUYTTEN_EZH2_TARGETS_UP osteoporosis DOID_11476 3.209E-09 6.296E-08 5.431E-06 3.09E-04 NUYTTEN_EZH2_TARGETS_UP glioblastoma DOID_3068 3.257E-09 6.177E-08 6.475E-03 0.03318996 NUYTTEN_EZH2_TARGETS_UP abdominal aortic aneurysm DOID_7693 4.706E-09 8.638E-08 0.3317091 0.50331327 NUYTTEN_EZH2_TARGETS_UP carotid artery disease DOID_3407 5.296E-09 9.417E-08 1.278E-04 2.507E-03 NUYTTEN_EZH2_TARGETS_UP collagen disease DOID_854 5.296E-09 9.132E-08 7.663E-03 0.03791524 NUYTTEN_EZH2_TARGETS_UP proteinuria DOID_576 7.049E-09 1.18E-07 0.02165676 0.07799175 NUYTTEN_EZH2_TARGETS_UP congenital heart defect DOID_1682 7.219E-09 1.174E-07 1.372E-06 1.301E-04 NUYTTEN_EZH2_TARGETS_UP urinary tract obstruction DOID_5200 7.669E-09 1.212E-07 1.578E-04 2.896E-03 NUYTTEN_EZH2_TARGETS_UP endocrine pancreas disease DOID_1428 8.394E-09 1.291E-07 8.986E-03 0.04123611 NUYTTEN_EZH2_TARGETS_UP parasitic infectious disease DOID_1398 9.736E-09 1.458E-07 0.1998 0.36090858 NUYTTEN_EZH2_TARGETS_UP diabetic angiopathy DOID_11713 1.071E-08 1.563E-07 2.972E-03 0.02013155 NUYTTEN_EZH2_TARGETS_UP brain infarction DOID_3454 1.497E-08 2.129E-07 0.01097082 0.04801842 NUYTTEN_EZH2_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 1.729E-08 2.4E-07 4.99E-04 5.916E-03 NUYTTEN_EZH2_TARGETS_UP pancreatic ductal carcinoma DOID_3587 1.971E-08 2.67E-07 2.647E-04 4.07E-03 NUYTTEN_EZH2_TARGETS_UP mouth disease DOID_403 2.603E-08 3.445E-07 1.141E-03 0.01047396 NUYTTEN_EZH2_TARGETS_UP pancreatic carcinoma DOID_4905 2.932E-08 3.791E-07 3.297E-04 4.466E-03 NUYTTEN_EZH2_TARGETS_UP middle cerebral artery infarction DOID_3525 3.515E-08 4.444E-07 0.04512154 0.13512715 NUYTTEN_EZH2_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 3.636E-08 4.497E-07 0.0143565 0.05834891 NUYTTEN_EZH2_TARGETS_UP congenital diaphragmatic hernia DOID_3827 3.636E-08 4.402E-07 1.663E-03 0.01314213 NUYTTEN_EZH2_TARGETS_UP systemic scleroderma DOID_418 3.636E-08 4.31E-07 0.09212234 0.2309146 NUYTTEN_EZH2_TARGETS_UP pancreatitis DOID_4989 4.843E-08 5.624E-07 0.0164115 0.06352479 NUYTTEN_EZH2_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 5.232E-08 5.954E-07 0.52539631 0.74365796 NUYTTEN_EZH2_TARGETS_UP oral cavity cancer DOID_8618 5.232E-08 5.837E-07 9.172E-06 4.349E-04 NUYTTEN_EZH2_TARGETS_UP sarcoma DOID_1115 5.918E-08 6.476E-07 4.566E-04 5.648E-03 NUYTTEN_EZH2_TARGETS_UP hepatic vascular disease DOID_272 5.918E-08 6.353E-07 0.30675921 0.47430975 NUYTTEN_EZH2_TARGETS_UP metabolic syndrome X DOID_14221 6.158E-08 6.489E-07 3.266E-03 0.02064619 NUYTTEN_EZH2_TARGETS_UP rheumatic disease DOID_1575 7.704E-08 7.97E-07 0.10736328 0.26106712 NUYTTEN_EZH2_TARGETS_UP hyperinsulinism DOID_2018 7.704E-08 7.828E-07 2.334E-03 0.0168102 NUYTTEN_EZH2_TARGETS_UP scleroderma DOID_419 7.704E-08 7.97E-07 0.10736328 0.26106712 NUYTTEN_EZH2_TARGETS_UP hypothyroidism DOID_1459 9.239E-08 9.223E-07 1.218E-06 1.387E-04 NUYTTEN_EZH2_TARGETS_UP cerebral infarction DOID_3526 1.091E-07 1.07E-06 0.02051115 0.07433659 NUYTTEN_EZH2_TARGETS_UP learning disability DOID_8927 1.091E-07 1.052E-06 2.868E-04 4.184E-03 NUYTTEN_EZH2_TARGETS_UP vascular skin disease DOID_9540 1.519E-07 1.441E-06 0.0228367 0.08070859 NUYTTEN_EZH2_TARGETS_UP hyperglycemia DOID_4195 1.569E-07 1.464E-06 1.529E-03 0.01225212 NUYTTEN_EZH2_TARGETS_UP hemolytic anemia DOID_583 1.783E-07 1.636E-06 3.504E-05 9.064E-04 NUYTTEN_EZH2_TARGETS_UP normocytic anemia DOID_720 1.783E-07 1.636E-06 3.504E-05 9.064E-04 NUYTTEN_EZH2_TARGETS_UP spindle cell carcinoma DOID_4015 2.781E-07 2.512E-06 0.07408461 0.19515806 NUYTTEN_EZH2_TARGETS_UP male reproductive system disease DOID_48 2.901E-07 2.579E-06 0.06122365 0.16910804 NUYTTEN_EZH2_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 3.079E-07 2.695E-06 1.858E-04 3.303E-03 NUYTTEN_EZH2_TARGETS_UP sarcoidosis DOID_11335 3.772E-07 3.252E-06 0.49547687 0.7065823 NUYTTEN_EZH2_TARGETS_UP ulcerative colitis DOID_8577 4.103E-07 3.485E-06 0.0337698 0.10734645 NUYTTEN_EZH2_TARGETS_UP bone marrow cancer DOID_4960 4.342E-07 3.633E-06 0.03205515 0.10422503 NUYTTEN_EZH2_TARGETS_UP open-angle glaucoma DOID_1067 4.708E-07 3.882E-06 5.848E-04 6.791E-03 NUYTTEN_EZH2_TARGETS_UP parasitic protozoa infectious disease DOID_2789 4.983E-07 4.051E-06 0.50766408 0.72215216 NUYTTEN_EZH2_TARGETS_UP mixed glioma DOID_5076 5.708E-07 4.575E-06 4.351E-04 5.502E-03 NUYTTEN_EZH2_TARGETS_UP X-linked disease DOID_0050735 5.789E-07 4.575E-06 1.372E-05 5.203E-04 NUYTTEN_EZH2_TARGETS_UP portal hypertension DOID_10762 5.789E-07 4.512E-06 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP varicose veins DOID_799 6.991E-07 5.376E-06 0.013895 0.05687953 NUYTTEN_EZH2_TARGETS_UP leukocyte disease DOID_9500 8.425E-07 6.392E-06 0.03965637 0.12131439 NUYTTEN_EZH2_TARGETS_UP vitiligo DOID_12306 9.28E-07 6.948E-06 2.009E-05 6.724E-04 NUYTTEN_EZH2_TARGETS_UP extrinsic allergic alveolitis DOID_841 9.28E-07 6.858E-06 0.28961173 0.4539644 NUYTTEN_EZH2_TARGETS_UP pulmonary emphysema DOID_9675 9.621E-07 7.019E-06 0.41576626 0.60196183 NUYTTEN_EZH2_TARGETS_UP tongue cancer DOID_8649 1.007E-06 7.251E-06 8.836E-04 8.669E-03 NUYTTEN_EZH2_TARGETS_UP vein disease DOID_866 1.007E-06 7.161E-06 0.01575377 0.06181996 NUYTTEN_EZH2_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 1.158E-06 8.136E-06 5.13E-03 0.03040846 NUYTTEN_EZH2_TARGETS_UP renal hypertension DOID_1073 1.433E-06 9.943E-06 0.05111485 0.14915053 NUYTTEN_EZH2_TARGETS_UP secondary hypertension DOID_11130 1.433E-06 9.943E-06 0.05111485 0.14915053 NUYTTEN_EZH2_TARGETS_UP diabetic autonomic neuropathy DOID_11503 1.53E-06 1.049E-05 2.527E-03 0.0179726 NUYTTEN_EZH2_TARGETS_UP autonomic neuropathy DOID_11504 1.53E-06 1.049E-05 2.527E-03 0.0179726 NUYTTEN_EZH2_TARGETS_UP diabetic polyneuropathy DOID_12785 1.53E-06 1.049E-05 2.527E-03 0.0179726 NUYTTEN_EZH2_TARGETS_UP diabetic neuropathy DOID_9743 1.53E-06 1.049E-05 2.527E-03 0.0179726 NUYTTEN_EZH2_TARGETS_UP mineral metabolism disease DOID_0050032 1.541E-06 1.044E-05 8.986E-03 0.04157136 NUYTTEN_EZH2_TARGETS_UP amino acid metabolic disorder DOID_9252 1.715E-06 1.148E-05 1.246E-04 2.531E-03 NUYTTEN_EZH2_TARGETS_UP autoimmune disease of endocrine system DOID_0060005 1.759E-06 1.164E-05 3.371E-05 9.132E-04 NUYTTEN_EZH2_TARGETS_UP focal glomerulosclerosis DOID_3945 1.759E-06 1.15E-05 0.05421247 0.15346714 NUYTTEN_EZH2_TARGETS_UP nervous system cancer DOID_3093 1.881E-06 1.216E-05 5.336E-03 0.03066656 NUYTTEN_EZH2_TARGETS_UP temporal lobe epilepsy DOID_3328 1.935E-06 1.237E-05 1.529E-03 0.01242715 NUYTTEN_EZH2_TARGETS_UP ureteral obstruction DOID_5199 1.936E-06 1.224E-05 5.721E-05 1.302E-03 NUYTTEN_EZH2_TARGETS_UP prion disease DOID_649 1.936E-06 1.21E-05 1.265E-03 0.01106984 NUYTTEN_EZH2_TARGETS_UP myeloma DOID_0070004 2.355E-06 1.457E-05 0.0228367 0.08121302 NUYTTEN_EZH2_TARGETS_UP pre-eclampsia DOID_10591 2.355E-06 1.441E-05 3.171E-03 0.0209803 NUYTTEN_EZH2_TARGETS_UP autonomic nervous system disease DOID_11465 2.355E-06 1.426E-05 3.171E-03 0.02050348 NUYTTEN_EZH2_TARGETS_UP tuberculosis DOID_399 2.41E-06 1.444E-05 0.01097082 0.04765186 NUYTTEN_EZH2_TARGETS_UP leishmaniasis DOID_9065 2.601E-06 1.541E-05 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP pulmonary tuberculosis DOID_2957 3.09E-06 1.812E-05 0.02529955 0.08671953 NUYTTEN_EZH2_TARGETS_UP bile duct disease DOID_4138 3.308E-06 1.921E-05 0.59515885 0.83616144 NUYTTEN_EZH2_TARGETS_UP pulmonary edema DOID_11396 3.433E-06 1.973E-05 0.02416176 0.08486445 NUYTTEN_EZH2_TARGETS_UP biliary tract disease DOID_9741 3.664E-06 2.085E-05 0.60008067 0.84099975 NUYTTEN_EZH2_TARGETS_UP Paget's disease of bone DOID_5408 4.24E-06 2.389E-05 4.24E-06 2.681E-04 NUYTTEN_EZH2_TARGETS_UP myocarditis DOID_820 4.42E-06 2.465E-05 9.267E-04 8.937E-03 NUYTTEN_EZH2_TARGETS_UP periodontal disease DOID_3388 5.221E-06 2.884E-05 0.07408461 0.19606577 NUYTTEN_EZH2_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 6.522E-06 3.568E-05 7.333E-05 1.545E-03 NUYTTEN_EZH2_TARGETS_UP mitochondrial metabolism disease DOID_700 7.324E-06 3.969E-05 5.755E-03 0.03210109 NUYTTEN_EZH2_TARGETS_UP pulmonary sarcoidosis DOID_13406 8.36E-06 4.487E-05 0.38649613 0.56533753 NUYTTEN_EZH2_TARGETS_UP multiple myeloma DOID_9538 8.36E-06 4.445E-05 0.08476217 0.21725077 NUYTTEN_EZH2_TARGETS_UP ureteral disease DOID_1426 9.042E-06 4.764E-05 1.875E-04 3.233E-03 NUYTTEN_EZH2_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 9.172E-06 4.788E-05 0.03806927 0.11967631 NUYTTEN_EZH2_TARGETS_UP focal epilepsy DOID_2234 9.403E-06 4.864E-05 3.812E-03 0.02332194 NUYTTEN_EZH2_TARGETS_UP biliary tract cancer DOID_4607 9.403E-06 4.82E-05 0.02005052 0.07313298 NUYTTEN_EZH2_TARGETS_UP osteopetrosis DOID_13533 9.804E-06 4.981E-05 9.804E-06 4.291E-04 NUYTTEN_EZH2_TARGETS_UP encephalitis DOID_9588 9.804E-06 4.937E-05 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP bone development disease DOID_0080006 1.026E-05 5.12E-05 1.026E-05 4.169E-04 NUYTTEN_EZH2_TARGETS_UP acute pancreatitis DOID_2913 1.119E-05 5.537E-05 0.26309377 0.43265999 NUYTTEN_EZH2_TARGETS_UP lymphatic system disease DOID_75 1.288E-05 6.316E-05 0.09586992 0.23820954 NUYTTEN_EZH2_TARGETS_UP urticaria DOID_1555 1.372E-05 6.671E-05 0.03941163 0.12187618 NUYTTEN_EZH2_TARGETS_UP bronchiolitis DOID_2942 1.372E-05 6.614E-05 0.03941163 0.12121739 NUYTTEN_EZH2_TARGETS_UP primary immunodeficiency disease DOID_612 1.559E-05 7.453E-05 8.632E-04 8.771E-03 NUYTTEN_EZH2_TARGETS_UP cystitis DOID_1679 1.667E-05 7.903E-05 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP ankylosing spondylitis DOID_7147 1.667E-05 7.838E-05 3.009E-04 4.281E-03 NUYTTEN_EZH2_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 1.689E-05 7.878E-05 1.334E-04 2.531E-03 NUYTTEN_EZH2_TARGETS_UP cholestasis DOID_13580 1.895E-05 8.765E-05 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP cerebral degeneration DOID_1443 1.895E-05 8.695E-05 0.04986733 0.1477839 NUYTTEN_EZH2_TARGETS_UP uterine disease DOID_345 1.895E-05 8.625E-05 9.459E-03 0.04271371 NUYTTEN_EZH2_TARGETS_UP uveal disease DOID_3480 1.918E-05 8.663E-05 0.01832287 0.06904444 NUYTTEN_EZH2_TARGETS_UP viral pneumonia DOID_10533 1.945E-05 8.713E-05 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP tooth disease DOID_1091 2.295E-05 1.02E-04 0.05352809 0.15305267 NUYTTEN_EZH2_TARGETS_UP Sciatic Neuropathy DOID_11446 2.403E-05 1.06E-04 5.13E-03 0.03009497 NUYTTEN_EZH2_TARGETS_UP lesion of sciatic nerve DOID_12528 2.403E-05 1.06E-04 5.13E-03 0.03009497 NUYTTEN_EZH2_TARGETS_UP lung adenocarcinoma DOID_3910 2.403E-05 1.052E-04 5.13E-03 0.02978788 NUYTTEN_EZH2_TARGETS_UP periodontitis DOID_824 2.403E-05 1.044E-04 0.29823773 0.46365374 NUYTTEN_EZH2_TARGETS_UP mononeuritis of lower limb DOID_9473 2.403E-05 1.06E-04 5.13E-03 0.03009497 NUYTTEN_EZH2_TARGETS_UP peripheral neuropathy DOID_0060053 2.627E-05 1.132E-04 2.627E-05 7.866E-04 NUYTTEN_EZH2_TARGETS_UP mesenchymal cell neoplasm DOID_3350 2.627E-05 1.124E-04 0.013895 0.05770989 NUYTTEN_EZH2_TARGETS_UP arthropathy DOID_381 2.627E-05 1.115E-04 0.013895 0.0572917 NUYTTEN_EZH2_TARGETS_UP spindle cell sarcoma DOID_4235 2.627E-05 1.124E-04 0.013895 0.05770989 NUYTTEN_EZH2_TARGETS_UP epithelioid sarcoma DOID_6193 2.627E-05 1.124E-04 0.013895 0.05770989 NUYTTEN_EZH2_TARGETS_UP leukodystrophy DOID_10579 2.777E-05 1.171E-04 0.11920029 0.26808287 NUYTTEN_EZH2_TARGETS_UP mononeuritis DOID_1802 2.855E-05 1.195E-04 5.65E-03 0.03214702 NUYTTEN_EZH2_TARGETS_UP coronary stenosis DOID_4248 2.855E-05 1.186E-04 0.05111485 0.14763631 NUYTTEN_EZH2_TARGETS_UP bone marrow disease DOID_4961 3.124E-05 1.288E-04 3.171E-03 0.0202731 NUYTTEN_EZH2_TARGETS_UP mononeuropathy DOID_1188 3.371E-05 1.38E-04 6.199E-03 0.03206799 NUYTTEN_EZH2_TARGETS_UP restrictive cardiomyopathy DOID_397 3.469E-05 1.41E-04 0.1774658 0.33326086 NUYTTEN_EZH2_TARGETS_UP thyroiditis DOID_7166 3.469E-05 1.4E-04 8.836E-04 8.821E-03 NUYTTEN_EZH2_TARGETS_UP autoimmune thyroiditis DOID_7188 3.469E-05 1.4E-04 8.836E-04 8.821E-03 NUYTTEN_EZH2_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.921E-05 1.571E-04 4.183E-04 5.41E-03 NUYTTEN_EZH2_TARGETS_UP hyperostosis DOID_205 4.492E-05 1.787E-04 4.492E-05 1.111E-03 NUYTTEN_EZH2_TARGETS_UP bronchitis DOID_6132 4.492E-05 1.775E-04 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP opportunistic mycosis DOID_2473 4.615E-05 1.811E-04 0.06059934 0.16820013 NUYTTEN_EZH2_TARGETS_UP allergic rhinitis DOID_4481 5.357E-05 2.088E-04 0.33982499 0.51289236 NUYTTEN_EZH2_TARGETS_UP male reproductive organ benign neoplasm DOID_0060087 5.721E-05 2.214E-04 1.265E-03 0.01124281 NUYTTEN_EZH2_TARGETS_UP osteosclerosis DOID_4254 5.721E-05 2.199E-04 5.721E-05 1.356E-03 NUYTTEN_EZH2_TARGETS_UP leiomyoma DOID_127 6.188E-05 2.363E-04 8.316E-04 8.763E-03 NUYTTEN_EZH2_TARGETS_UP bladder disease DOID_365 6.188E-05 2.347E-04 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP bile duct adenocarcinoma DOID_4896 6.641E-05 2.503E-04 0.03205515 0.10482403 NUYTTEN_EZH2_TARGETS_UP cholangiocarcinoma DOID_4947 6.641E-05 2.503E-04 0.03205515 0.10482403 NUYTTEN_EZH2_TARGETS_UP female reproductive system disease DOID_229 6.943E-05 2.599E-04 0.01854047 0.06895117 NUYTTEN_EZH2_TARGETS_UP systemic mycosis DOID_0050136 7.115E-05 2.646E-04 0.07062912 0.19228694 NUYTTEN_EZH2_TARGETS_UP fungal infectious disease DOID_1564 7.115E-05 2.646E-04 0.07062912 0.19228694 NUYTTEN_EZH2_TARGETS_UP papilloma DOID_2615 7.115E-05 2.629E-04 9.418E-03 0.04287066 NUYTTEN_EZH2_TARGETS_UP granulosa cell tumor DOID_2999 7.177E-05 2.635E-04 0.0219191 0.07844005 NUYTTEN_EZH2_TARGETS_UP psoriasis DOID_8893 7.177E-05 2.618E-04 7.177E-05 1.571E-03 NUYTTEN_EZH2_TARGETS_UP integumentary system cancer DOID_0060122 7.333E-05 2.657E-04 0.03350823 0.10771855 NUYTTEN_EZH2_TARGETS_UP skin cancer DOID_4159 7.333E-05 2.657E-04 0.03350823 0.10771855 NUYTTEN_EZH2_TARGETS_UP pneumoconiosis DOID_10316 8.145E-05 2.933E-04 0.36358732 0.54299523 NUYTTEN_EZH2_TARGETS_UP hyperthyroidism DOID_7998 8.145E-05 2.915E-04 1.029E-03 9.6E-03 NUYTTEN_EZH2_TARGETS_UP amnestic disorder DOID_10914 8.885E-05 3.16E-04 0.21668431 0.38289868 NUYTTEN_EZH2_TARGETS_UP colon carcinoma DOID_1520 8.885E-05 3.14E-04 0.02416176 0.08434381 NUYTTEN_EZH2_TARGETS_UP sex cord-gonadal stromal tumor DOID_192 8.885E-05 3.121E-04 0.02416176 0.08382952 NUYTTEN_EZH2_TARGETS_UP brain edema DOID_4724 8.885E-05 3.102E-04 0.21668431 0.37936423 NUYTTEN_EZH2_TARGETS_UP bile duct cancer DOID_4606 9.756E-05 3.385E-04 0.03806927 0.11901875 NUYTTEN_EZH2_TARGETS_UP bile duct carcinoma DOID_4897 9.756E-05 3.385E-04 0.03806927 0.11901875 NUYTTEN_EZH2_TARGETS_UP Kawasaki disease DOID_13378 1.087E-04 3.749E-04 0.22619383 0.39239113 NUYTTEN_EZH2_TARGETS_UP lymphadenitis DOID_1602 1.087E-04 3.749E-04 0.22619383 0.39239113 NUYTTEN_EZH2_TARGETS_UP mitochondrial myopathy DOID_699 1.087E-04 3.726E-04 0.22619383 0.39001301 NUYTTEN_EZH2_TARGETS_UP lymph node disease DOID_9942 1.087E-04 3.749E-04 0.22619383 0.39239113 NUYTTEN_EZH2_TARGETS_UP gastric ulcer DOID_10808 1.316E-04 4.484E-04 0.23558816 0.40498387 NUYTTEN_EZH2_TARGETS_UP hepatitis DOID_2237 1.512E-04 5.122E-04 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP polyarteritis nodosa DOID_9810 1.578E-04 5.312E-04 0.24486867 0.40979492 NUYTTEN_EZH2_TARGETS_UP lymphoblastic leukemia DOID_1037 1.631E-04 5.461E-04 6.104E-03 0.03372291 NUYTTEN_EZH2_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.742E-04 5.795E-04 0.11166483 0.2669634 NUYTTEN_EZH2_TARGETS_UP Lewy body dementia DOID_12217 1.875E-04 6.203E-04 0.25403676 0.4226518 NUYTTEN_EZH2_TARGETS_UP congenital hemolytic anemia DOID_589 1.875E-04 6.168E-04 1.875E-04 3.138E-03 NUYTTEN_EZH2_TARGETS_UP retinal vascular occlusion DOID_1729 1.999E-04 6.537E-04 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP acute kidney failure DOID_3021 1.999E-04 6.499E-04 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP cutaneous leishmaniasis DOID_9111 1.999E-04 6.462E-04 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP nephrotic syndrome DOID_1184 2.342E-04 7.528E-04 0.01832287 0.06950474 NUYTTEN_EZH2_TARGETS_UP Huntington's disease DOID_12858 2.342E-04 7.486E-04 2.334E-03 0.01702572 NUYTTEN_EZH2_TARGETS_UP osteosarcoma DOID_3347 2.588E-04 8.227E-04 3.75E-03 0.02319234 NUYTTEN_EZH2_TARGETS_UP uterine cancer DOID_363 2.595E-04 8.202E-04 2.595E-04 4.218E-03 NUYTTEN_EZH2_TARGETS_UP blood coagulation disease DOID_1247 2.647E-04 8.32E-04 0.05925366 0.16608539 NUYTTEN_EZH2_TARGETS_UP neuronal ceroid lipofuscinosis DOID_14503 2.724E-04 8.515E-04 7.515E-03 0.03750932 NUYTTEN_EZH2_TARGETS_UP prostatic adenoma DOID_2883 2.724E-04 8.469E-04 2.724E-04 4.078E-03 NUYTTEN_EZH2_TARGETS_UP bronchiectasis DOID_9563 2.724E-04 8.423E-04 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP cataract DOID_83 2.868E-04 8.82E-04 2.731E-03 0.01894736 NUYTTEN_EZH2_TARGETS_UP myositis DOID_633 3.009E-04 9.206E-04 0.28087994 0.44767699 NUYTTEN_EZH2_TARGETS_UP lens disease DOID_110 3.479E-04 1.058E-03 3.171E-03 0.02073915 NUYTTEN_EZH2_TARGETS_UP brain cancer DOID_1319 3.479E-04 1.053E-03 0.4570793 0.65676293 NUYTTEN_EZH2_TARGETS_UP heart valve disease DOID_4079 3.479E-04 1.047E-03 0.12321544 0.27602199 NUYTTEN_EZH2_TARGETS_UP epidermolysis bullosa DOID_2730 3.599E-04 1.078E-03 3.599E-04 4.762E-03 NUYTTEN_EZH2_TARGETS_UP stomach disease DOID_76 3.599E-04 1.072E-03 0.1362882 0.2904419 NUYTTEN_EZH2_TARGETS_UP endogenous depression DOID_1595 3.795E-04 1.125E-03 0.24439199 0.41510163 NUYTTEN_EZH2_TARGETS_UP syndrome DOID_225 3.795E-04 1.119E-03 2.628E-03 0.01846138 NUYTTEN_EZH2_TARGETS_UP central nervous system cancer DOID_3620 3.819E-04 1.12E-03 0.46367563 0.66289305 NUYTTEN_EZH2_TARGETS_UP perinatal necrotizing enterocolitis DOID_8677 3.995E-04 1.166E-03 0.04808385 0.14324455 NUYTTEN_EZH2_TARGETS_UP integumentary system benign neoplasm DOID_0060121 4.183E-04 1.214E-03 0.02529955 0.0872451 NUYTTEN_EZH2_TARGETS_UP skin benign neoplasm DOID_3165 4.183E-04 1.214E-03 0.02529955 0.0872451 NUYTTEN_EZH2_TARGETS_UP lung small cell carcinoma DOID_5409 4.183E-04 1.208E-03 0.02529955 0.08620025 NUYTTEN_EZH2_TARGETS_UP electroclinical syndrome DOID_0050701 4.351E-04 1.25E-03 0.0164115 0.06395989 NUYTTEN_EZH2_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 4.566E-04 1.306E-03 0.05111485 0.15069613 NUYTTEN_EZH2_TARGETS_UP Behcet's disease DOID_13241 4.566E-04 1.306E-03 0.05111485 0.15069613 NUYTTEN_EZH2_TARGETS_UP autoimmune disease of the nervous system DOID_438 4.566E-04 1.299E-03 0.30675921 0.47302436 NUYTTEN_EZH2_TARGETS_UP calcium metabolism disease DOID_10575 4.573E-04 1.295E-03 0.02658239 0.08949929 NUYTTEN_EZH2_TARGETS_UP newborn respiratory distress syndrome DOID_12716 4.637E-04 1.306E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP polyneuropathy DOID_1389 4.637E-04 1.3E-03 0.14677153 0.29932974 NUYTTEN_EZH2_TARGETS_UP vesiculobullous skin disease DOID_2731 4.637E-04 1.293E-03 4.637E-04 5.613E-03 NUYTTEN_EZH2_TARGETS_UP atopic dermatitis DOID_3310 5.435E-04 1.509E-03 0.14374986 0.30182167 NUYTTEN_EZH2_TARGETS_UP aspergillosis DOID_13564 5.848E-04 1.615E-03 0.15712788 0.31480903 NUYTTEN_EZH2_TARGETS_UP eyelid disease DOID_530 5.848E-04 1.608E-03 0.01213893 0.0519327 NUYTTEN_EZH2_TARGETS_UP parasitic helminthiasis infectious disease DOID_883 5.848E-04 1.6E-03 0.15712788 0.31043668 NUYTTEN_EZH2_TARGETS_UP polycystic kidney disease DOID_898 5.848E-04 1.592E-03 0.15712788 0.3093625 NUYTTEN_EZH2_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 5.878E-04 1.593E-03 5.878E-04 6.689E-03 NUYTTEN_EZH2_TARGETS_UP uterine benign neoplasm DOID_0060095 5.878E-04 1.593E-03 5.878E-04 6.689E-03 NUYTTEN_EZH2_TARGETS_UP uterine fibroid DOID_13223 5.878E-04 1.593E-03 5.878E-04 6.689E-03 NUYTTEN_EZH2_TARGETS_UP atrophic muscular disease DOID_913 5.909E-04 1.594E-03 5.909E-04 6.593E-03 NUYTTEN_EZH2_TARGETS_UP muscular dystrophy DOID_9884 5.909E-04 1.594E-03 5.909E-04 6.593E-03 NUYTTEN_EZH2_TARGETS_UP mental depression DOID_1596 6.019E-04 1.616E-03 0.27585105 0.44590696 NUYTTEN_EZH2_TARGETS_UP chronic kidney failure DOID_784 6.019E-04 1.608E-03 0.64613135 0.90331386 NUYTTEN_EZH2_TARGETS_UP vasculitis DOID_865 6.413E-04 1.705E-03 0.03205515 0.10363285 NUYTTEN_EZH2_TARGETS_UP gonadal disease DOID_2277 6.625E-04 1.753E-03 0.06059934 0.16902464 NUYTTEN_EZH2_TARGETS_UP bronchiolitis obliterans DOID_2799 6.625E-04 1.745E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP osteochondrodysplasia DOID_2256 6.949E-04 1.822E-03 6.949E-04 7.604E-03 NUYTTEN_EZH2_TARGETS_UP skeletal system cancer DOID_0060124 7.244E-04 1.891E-03 0.1673588 0.32836951 NUYTTEN_EZH2_TARGETS_UP thoracic aortic aneurysm DOID_14004 7.244E-04 1.882E-03 0.1673588 0.3261204 NUYTTEN_EZH2_TARGETS_UP bone cancer DOID_184 7.244E-04 1.891E-03 0.1673588 0.32836951 NUYTTEN_EZH2_TARGETS_UP membranoproliferative glomerulonephritis DOID_2920 7.244E-04 1.874E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP intermediate coronary syndrome DOID_8805 7.244E-04 1.865E-03 0.1673588 0.32280392 NUYTTEN_EZH2_TARGETS_UP celiac disease DOID_10608 7.437E-04 1.906E-03 8.035E-03 0.03941334 NUYTTEN_EZH2_TARGETS_UP angiosarcoma DOID_0001816 8.836E-04 2.255E-03 0.01575377 0.06224926 NUYTTEN_EZH2_TARGETS_UP Barrett's esophagus DOID_9206 8.836E-04 2.245E-03 0.1774658 0.33107554 NUYTTEN_EZH2_TARGETS_UP melancholia DOID_2848 9.433E-04 2.386E-03 0.53116428 0.74995652 NUYTTEN_EZH2_TARGETS_UP neurotic disorder DOID_4964 1.015E-03 2.554E-03 0.5368623 0.75612537 NUYTTEN_EZH2_TARGETS_UP hepatitis C DOID_1883 1.029E-03 2.58E-03 1.029E-03 9.76E-03 NUYTTEN_EZH2_TARGETS_UP nephroblastoma DOID_2154 1.029E-03 2.568E-03 0.07408461 0.19698197 NUYTTEN_EZH2_TARGETS_UP esophageal disease DOID_6050 1.029E-03 2.557E-03 0.36358732 0.53875308 NUYTTEN_EZH2_TARGETS_UP carbohydrate metabolic disorder DOID_2978 1.081E-03 2.674E-03 6.104E-03 0.03339865 NUYTTEN_EZH2_TARGETS_UP aplastic anemia DOID_12449 1.139E-03 2.806E-03 0.07759313 0.20345848 NUYTTEN_EZH2_TARGETS_UP keratosis DOID_161 1.265E-03 3.101E-03 0.01976848 0.07304069 NUYTTEN_EZH2_TARGETS_UP eosinophilia DOID_999 1.265E-03 3.088E-03 0.01976848 0.07256946 NUYTTEN_EZH2_TARGETS_UP calcinosis DOID_182 1.384E-03 3.365E-03 0.01257683 0.05340461 NUYTTEN_EZH2_TARGETS_UP dissociative disorder DOID_10935 1.488E-03 3.603E-03 0.20705819 0.37283579 NUYTTEN_EZH2_TARGETS_UP dissociative amnesia DOID_11037 1.488E-03 3.603E-03 0.20705819 0.37283579 NUYTTEN_EZH2_TARGETS_UP heart septal defect DOID_1681 1.488E-03 3.588E-03 1.488E-03 0.01283026 NUYTTEN_EZH2_TARGETS_UP testicular cancer DOID_2998 1.488E-03 3.573E-03 1.488E-03 0.01263876 NUYTTEN_EZH2_TARGETS_UP infertility DOID_5223 1.488E-03 3.558E-03 1.488E-03 0.0124529 NUYTTEN_EZH2_TARGETS_UP peripheral nervous system neoplasm DOID_1192 1.519E-03 3.616E-03 1.519E-03 0.01252624 NUYTTEN_EZH2_TARGETS_UP uveitis DOID_13141 1.519E-03 3.601E-03 0.39394806 0.57329014 NUYTTEN_EZH2_TARGETS_UP esophagitis DOID_11963 1.735E-03 4.097E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP adenoid cystic carcinoma DOID_4866 1.816E-03 4.27E-03 1.816E-03 0.0141561 NUYTTEN_EZH2_TARGETS_UP benign mesothelioma DOID_2645 1.979E-03 4.634E-03 0.09966032 0.24655097 NUYTTEN_EZH2_TARGETS_UP autoimmune hepatitis DOID_2048 2.006E-03 4.678E-03 0.02649392 0.08973238 NUYTTEN_EZH2_TARGETS_UP coronary restenosis DOID_4247 2.006E-03 4.659E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP spinocerebellar ataxia DOID_1441 2.151E-03 4.976E-03 2.151E-03 0.01632152 NUYTTEN_EZH2_TARGETS_UP endometriosis of uterus DOID_288 2.151E-03 4.956E-03 0.10349196 0.25492175 NUYTTEN_EZH2_TARGETS_UP salivary gland cancer DOID_8850 2.151E-03 4.936E-03 2.151E-03 0.01610676 NUYTTEN_EZH2_TARGETS_UP familial hypercholesterolemia DOID_13810 2.302E-03 5.261E-03 2.302E-03 0.01701267 NUYTTEN_EZH2_TARGETS_UP hepatitis B DOID_2043 2.302E-03 5.24E-03 0.23558816 0.40376404 NUYTTEN_EZH2_TARGETS_UP placenta disease DOID_780 2.302E-03 5.219E-03 0.02891309 0.0967738 NUYTTEN_EZH2_TARGETS_UP endometriosis DOID_289 2.334E-03 5.27E-03 0.10736328 0.25885469 NUYTTEN_EZH2_TARGETS_UP gallbladder cancer DOID_3121 2.527E-03 5.683E-03 0.11127277 0.26714854 NUYTTEN_EZH2_TARGETS_UP IgA glomerulonephritis DOID_2986 2.624E-03 5.878E-03 0.24486867 0.41344295 NUYTTEN_EZH2_TARGETS_UP muscle cancer DOID_4045 2.624E-03 5.855E-03 0.24486867 0.41221975 NUYTTEN_EZH2_TARGETS_UP myasthenia gravis DOID_437 2.624E-03 5.832E-03 0.24486867 0.41100376 NUYTTEN_EZH2_TARGETS_UP uremia DOID_4676 2.624E-03 5.809E-03 0.03141682 0.10333046 NUYTTEN_EZH2_TARGETS_UP pulmonary embolism DOID_9477 2.624E-03 5.787E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP spinocerebellar degeneration DOID_2478 2.945E-03 6.47E-03 2.945E-03 0.02019032 NUYTTEN_EZH2_TARGETS_UP synostosis DOID_11971 2.972E-03 6.504E-03 2.972E-03 0.01989471 NUYTTEN_EZH2_TARGETS_UP aortic valve disease DOID_62 2.972E-03 6.479E-03 0.25403676 0.42141958 NUYTTEN_EZH2_TARGETS_UP meningitis DOID_9471 2.972E-03 6.454E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP Goodpasture syndrome DOID_9808 2.972E-03 6.43E-03 0.25403676 0.42019452 NUYTTEN_EZH2_TARGETS_UP lipid metabolism disorder DOID_3146 3.266E-03 7.038E-03 0.01781279 0.06802333 NUYTTEN_EZH2_TARGETS_UP toxic shock syndrome DOID_14115 3.347E-03 7.187E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP sphingolipidosis DOID_1927 3.347E-03 7.16E-03 3.347E-03 0.02092849 NUYTTEN_EZH2_TARGETS_UP chromosomal disease DOID_0080014 3.441E-03 7.333E-03 0.01854047 0.0694048 NUYTTEN_EZH2_TARGETS_UP commensal bacterial infectious disease DOID_0050339 3.75E-03 7.962E-03 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP hypogonadism DOID_1924 3.75E-03 7.932E-03 0.27204106 0.44226103 NUYTTEN_EZH2_TARGETS_UP neuromuscular junction disease DOID_439 4.181E-03 8.811E-03 0.28087994 0.44893451 NUYTTEN_EZH2_TARGETS_UP seminoma DOID_4440 4.641E-03 9.744E-03 0.28961173 0.45647943 NUYTTEN_EZH2_TARGETS_UP dystonia DOID_543 4.641E-03 9.709E-03 4.641E-03 0.028093 NUYTTEN_EZH2_TARGETS_UP gestational diabetes DOID_11714 5.13E-03 0.01069309 0.29823773 0.46620128 NUYTTEN_EZH2_TARGETS_UP malaria DOID_12365 5.65E-03 0.01173249 0.30675921 0.47560215 NUYTTEN_EZH2_TARGETS_UP invasive ductal carcinoma DOID_3008 5.65E-03 0.01168983 0.05111485 0.14838955 NUYTTEN_EZH2_TARGETS_UP renal tubular transport disease DOID_447 5.65E-03 0.01164747 0.05111485 0.14689067 NUYTTEN_EZH2_TARGETS_UP familial hyperlipidemia DOID_1168 5.755E-03 0.01182062 5.755E-03 0.03241892 NUYTTEN_EZH2_TARGETS_UP T cell deficiency DOID_11200 6.198E-03 0.01268624 0.11493442 0.27135969 NUYTTEN_EZH2_TARGETS_UP facioscapulohumeral muscular dystrophy DOID_11727 6.198E-03 0.01264077 6.198E-03 0.03358834 NUYTTEN_EZH2_TARGETS_UP hyperparathyroidism DOID_13543 6.198E-03 0.01259563 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP childhood type dermatomyositis DOID_14203 6.198E-03 0.0125508 0.11493442 0.26912628 NUYTTEN_EZH2_TARGETS_UP angioedema DOID_1558 6.198E-03 0.0125063 0.11493442 0.2680233 NUYTTEN_EZH2_TARGETS_UP transient cerebral ischemia DOID_224 6.198E-03 0.0124621 0.11493442 0.26584425 NUYTTEN_EZH2_TARGETS_UP conjunctival disease DOID_4251 6.198E-03 0.01241822 6.198E-03 0.03327147 NUYTTEN_EZH2_TARGETS_UP hypokalemia DOID_4500 6.198E-03 0.01237465 0.11493442 0.26054855 NUYTTEN_EZH2_TARGETS_UP conjunctivitis DOID_6195 6.198E-03 0.01241822 6.198E-03 0.03327147 NUYTTEN_EZH2_TARGETS_UP polycythemia DOID_8432 6.198E-03 0.01233138 6.198E-03 0.03296052 NUYTTEN_EZH2_TARGETS_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 6.198E-03 0.01228842 0.11493442 0.25951463 NUYTTEN_EZH2_TARGETS_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 6.198E-03 0.01228842 0.11493442 0.25951463 NUYTTEN_EZH2_TARGETS_UP Hodgkin's granuloma DOID_8651 6.198E-03 0.01228842 0.11493442 0.25951463 NUYTTEN_EZH2_TARGETS_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 6.198E-03 0.01228842 0.11493442 0.25951463 NUYTTEN_EZH2_TARGETS_UP visceral leishmaniasis DOID_9146 6.198E-03 0.01224575 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP cannabis abuse DOID_9505 6.198E-03 0.01220338 6.198E-03 0.03265533 NUYTTEN_EZH2_TARGETS_UP polycystic ovary syndrome DOID_11612 6.199E-03 0.01216372 6.199E-03 0.03236219 NUYTTEN_EZH2_TARGETS_UP corneal disease DOID_10124 6.78E-03 0.01325702 0.05737464 0.1616147 NUYTTEN_EZH2_TARGETS_UP dysostosis DOID_1934 6.78E-03 0.01321162 6.78E-03 0.03444458 NUYTTEN_EZH2_TARGETS_UP endometrial carcinoma DOID_2871 6.78E-03 0.01316653 6.78E-03 0.03413976 NUYTTEN_EZH2_TARGETS_UP spastic cerebral palsy DOID_0050669 7.392E-03 0.0143057 0.3317091 0.506012 NUYTTEN_EZH2_TARGETS_UP familial adenomatous polyposis DOID_0050424 7.515E-03 0.01449513 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 7.515E-03 0.01444616 0.12567636 0.28043078 NUYTTEN_EZH2_TARGETS_UP dermatomyositis DOID_10223 7.515E-03 0.01439752 0.12567636 0.27824844 NUYTTEN_EZH2_TARGETS_UP adrenoleukodystrophy DOID_10588 7.515E-03 0.0143492 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP pneumocystosis DOID_11339 7.515E-03 0.01430121 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP eosinophilic pneumonia DOID_5870 7.515E-03 0.01425354 0.12567636 0.27716996 NUYTTEN_EZH2_TARGETS_UP pulmonary eosinophilia DOID_9498 7.515E-03 0.01425354 0.12567636 0.27716996 NUYTTEN_EZH2_TARGETS_UP Loeffler syndrome DOID_9503 7.515E-03 0.01425354 0.12567636 0.27716996 NUYTTEN_EZH2_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 8.035E-03 0.01518919 0.06388461 0.17560553 NUYTTEN_EZH2_TARGETS_UP endometrial cancer DOID_1380 8.035E-03 0.0151389 8.035E-03 0.03907648 NUYTTEN_EZH2_TARGETS_UP germinoma DOID_3304 8.035E-03 0.01508894 0.33982499 0.51425644 NUYTTEN_EZH2_TARGETS_UP pre-malignant neoplasm DOID_0060071 8.53E-03 0.01596555 0.19099304 0.34831743 NUYTTEN_EZH2_TARGETS_UP in situ carcinoma DOID_8719 8.53E-03 0.01596555 0.19099304 0.34831743 NUYTTEN_EZH2_TARGETS_UP chronic leukemia DOID_1036 8.71E-03 0.01624985 0.34784254 0.52360424 NUYTTEN_EZH2_TARGETS_UP chronic lymphocytic leukemia DOID_1040 8.71E-03 0.01624985 0.34784254 0.52360424 NUYTTEN_EZH2_TARGETS_UP autonomic nervous system neoplasm DOID_2621 8.71E-03 0.01619675 8.71E-03 0.04200173 NUYTTEN_EZH2_TARGETS_UP neuroblastoma DOID_769 8.71E-03 0.01619675 8.71E-03 0.04200173 NUYTTEN_EZH2_TARGETS_UP familial atrial fibrillation DOID_0050650 8.946E-03 0.01658084 8.946E-03 0.04277579 NUYTTEN_EZH2_TARGETS_UP common cold DOID_10459 8.946E-03 0.01652701 0.1362882 0.29598469 NUYTTEN_EZH2_TARGETS_UP mucopolysaccharidosis DOID_12798 8.946E-03 0.01647352 8.946E-03 0.04241933 NUYTTEN_EZH2_TARGETS_UP intracranial arteriosclerosis DOID_13097 8.946E-03 0.01642038 0.1362882 0.29485927 NUYTTEN_EZH2_TARGETS_UP relapsing-remitting multiple sclerosis DOID_2378 8.946E-03 0.01636759 8.946E-03 0.04206875 NUYTTEN_EZH2_TARGETS_UP aortic valve insufficiency DOID_57 8.946E-03 0.01631513 0.1362882 0.29153379 NUYTTEN_EZH2_TARGETS_UP Hodgkin's lymphoma DOID_8567 8.946E-03 0.016263 0.1362882 0.28935816 NUYTTEN_EZH2_TARGETS_UP vascular dementia DOID_8725 8.946E-03 0.01642038 0.1362882 0.29485927 NUYTTEN_EZH2_TARGETS_UP mitochondrial encephalomyopathy DOID_890 8.946E-03 0.01621121 0.1362882 0.28828248 NUYTTEN_EZH2_TARGETS_UP progressive myoclonus epilepsy DOID_891 8.946E-03 0.01615974 8.946E-03 0.04172393 NUYTTEN_EZH2_TARGETS_UP thyroid carcinoma DOID_3963 0.01015817 0.01829114 0.36358732 0.54157378 NUYTTEN_EZH2_TARGETS_UP variable age at onset electroclinical syndrome DOID_0050706 0.01048834 0.01882607 0.01048834 0.04699105 NUYTTEN_EZH2_TARGETS_UP leprosy DOID_1024 0.01048834 0.01876687 0.14677153 0.30479196 NUYTTEN_EZH2_TARGETS_UP berylliosis DOID_10322 0.01048834 0.01870804 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP essential hypertension DOID_10825 0.01048834 0.01864957 0.14677153 0.30368363 NUYTTEN_EZH2_TARGETS_UP parathyroid gland disease DOID_11201 0.01048834 0.01859148 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP carotid stenosis DOID_13001 0.01048834 0.01853374 0.14677153 0.30040647 NUYTTEN_EZH2_TARGETS_UP cannabis dependence DOID_1849 0.01048834 0.01847636 0.01048834 0.04662394 NUYTTEN_EZH2_TARGETS_UP hallucinogen dependence DOID_9977 0.01048834 0.01847636 0.01048834 0.04662394 NUYTTEN_EZH2_TARGETS_UP lymphoid leukemia DOID_10747 0.01093122 0.01919711 0.01093122 0.048216 NUYTTEN_EZH2_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 0.01097082 0.01920737 0.21309557 0.37773015 NUYTTEN_EZH2_TARGETS_UP thyroid cancer DOID_1781 0.01173736 0.02048638 0.37895278 0.5571683 NUYTTEN_EZH2_TARGETS_UP rhabdomyosarcoma DOID_3247 0.01213893 0.02112247 0.15712788 0.31370443 NUYTTEN_EZH2_TARGETS_UP eating disorder DOID_8670 0.01213893 0.02105807 0.15712788 0.31151834 NUYTTEN_EZH2_TARGETS_UP bacterial meningitis DOID_9470 0.01213893 0.02099407 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP cleft palate DOID_674 0.01257683 0.02168551 0.01257683 0.05300902 NUYTTEN_EZH2_TARGETS_UP blood platelet disease DOID_2218 0.01344982 0.02312069 0.08841921 0.22360235 NUYTTEN_EZH2_TARGETS_UP renovascular hypertension DOID_1591 0.013895 0.02381402 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP communication disorder DOID_2033 0.013895 0.02374251 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP corneal dystrophy DOID_2566 0.013895 0.02367142 0.013895 0.05813422 NUYTTEN_EZH2_TARGETS_UP skeletal muscle cancer DOID_4043 0.013895 0.02360076 0.1673588 0.32500736 NUYTTEN_EZH2_TARGETS_UP lung oat cell carcinoma DOID_5411 0.013895 0.02353052 0.1673588 0.32390189 NUYTTEN_EZH2_TARGETS_UP hyperhomocysteinemia DOID_9279 0.013895 0.0234607 0.1673588 0.32171337 NUYTTEN_EZH2_TARGETS_UP silicosis DOID_10325 0.01575377 0.0265204 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP spastic diplegia DOID_10965 0.01575377 0.02644216 0.1774658 0.33885249 NUYTTEN_EZH2_TARGETS_UP hemolytic-uremic syndrome DOID_12554 0.01575377 0.02636439 0.1774658 0.3377192 NUYTTEN_EZH2_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 0.01627153 0.02715102 0.41576626 0.60349745 NUYTTEN_EZH2_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 0.01728011 0.02874966 0.4228634 0.61068344 NUYTTEN_EZH2_TARGETS_UP primary biliary cirrhosis DOID_12236 0.01728011 0.02874966 0.4228634 0.61068344 NUYTTEN_EZH2_TARGETS_UP schizophreniform disorder DOID_11328 0.01771249 0.02938311 0.18745038 0.34742433 NUYTTEN_EZH2_TARGETS_UP Graves' disease DOID_12361 0.01771249 0.0292977 0.01771249 0.06809735 NUYTTEN_EZH2_TARGETS_UP methylmalonic acidemia DOID_14749 0.01771249 0.02921277 0.18745038 0.34517562 NUYTTEN_EZH2_TARGETS_UP schizoaffective disorder DOID_5418 0.01771249 0.02938311 0.18745038 0.34742433 NUYTTEN_EZH2_TARGETS_UP urinary system benign neoplasm DOID_731 0.01771249 0.02912834 0.18745038 0.34295585 NUYTTEN_EZH2_TARGETS_UP alcohol abuse DOID_1574 0.02005052 0.03287823 0.08482494 0.21643674 NUYTTEN_EZH2_TARGETS_UP Down syndrome DOID_14250 0.0219191 0.03583899 0.20705819 0.37049091 NUYTTEN_EZH2_TARGETS_UP thyroid adenoma DOID_2891 0.0228367 0.03723233 0.4570793 0.65510862 NUYTTEN_EZH2_TARGETS_UP subependymal glioma DOID_4843 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP pilocytic astrocytoma DOID_4851 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP subependymal giant cell astrocytoma DOID_5077 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP fibrillary astrocytoma DOID_6726 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP juvenile pilocytic astrocytoma DOID_6811 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP childhood pilocytic astrocytoma DOID_6812 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP gemistocytic astrocytoma DOID_7005 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP childhood cerebral astrocytoma DOID_7007 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP protoplasmic astrocytoma DOID_7008 0.02416176 0.03928012 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP amyloidosis DOID_9120 0.02416176 0.03916821 0.21668431 0.37704396 NUYTTEN_EZH2_TARGETS_UP hemorrhagic disease DOID_2213 0.02789945 0.04509883 0.13958626 0.29416511 NUYTTEN_EZH2_TARGETS_UP benign glioma DOID_0060101 0.02891309 0.04660495 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP neutropenia DOID_1227 0.02891309 0.04647329 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP benign ependymoma DOID_4844 0.02891309 0.04660495 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP muscular atrophy DOID_767 0.02891309 0.04634238 0.23558816 0.40134629 NUYTTEN_EZH2_TARGETS_UP orofacial cleft DOID_0050567 0.02925066 0.04675175 0.02925066 0.09733113 NUYTTEN_EZH2_TARGETS_UP heart conduction disease DOID_10273 0.03141682 0.0500733 0.03141682 0.10393121 NUYTTEN_EZH2_TARGETS_UP agranulocytosis DOID_12987 0.03141682 0.04993343 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP hypoglycemia DOID_9993 0.03141682 0.04979434 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP smallpox DOID_8736 0.03350823 0.05296162 0.03350823 0.10711339 NUYTTEN_EZH2_TARGETS_UP congenital nervous system abnormality DOID_2490 0.03651543 0.0575548 0.03651543 0.11542934 NUYTTEN_EZH2_TARGETS_UP spastic quadriplegia DOID_10970 0.03666842 0.05763627 0.26309377 0.43391407 NUYTTEN_EZH2_TARGETS_UP severe combined immunodeficiency DOID_627 0.03666842 0.05747749 0.26309377 0.43141313 NUYTTEN_EZH2_TARGETS_UP organic acidemia DOID_0060159 0.03941163 0.06160774 0.27204106 0.44352826 NUYTTEN_EZH2_TARGETS_UP reading disorder DOID_13365 0.03941163 0.06143895 0.03941163 0.12254217 NUYTTEN_EZH2_TARGETS_UP dyslexia DOID_4428 0.03941163 0.06143895 0.03941163 0.12254217 NUYTTEN_EZH2_TARGETS_UP combined T cell and B cell immunodeficiency DOID_628 0.03941163 0.06127108 0.27204106 0.44100103 NUYTTEN_EZH2_TARGETS_UP morbid obesity DOID_11981 0.04223008 0.06547388 0.28087994 0.45274982 NUYTTEN_EZH2_TARGETS_UP cleft lip DOID_9296 0.04223008 0.06529596 0.04223008 0.12849686 NUYTTEN_EZH2_TARGETS_UP intracranial aneurysm DOID_10941 0.04512154 0.06957766 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP myopia DOID_11830 0.04512154 0.06938962 0.04512154 0.13656467 NUYTTEN_EZH2_TARGETS_UP B cell deficiency DOID_2115 0.04512154 0.06920258 0.04512154 0.1358421 NUYTTEN_EZH2_TARGETS_UP migraine DOID_6364 0.04808385 0.07354761 0.29823773 0.46492402 NUYTTEN_EZH2_TARGETS_UP multiple epiphyseal dysplasia DOID_12721 0.05421247 0.08269945 0.05421247 0.15423448 NUYTTEN_EZH2_TARGETS_UP supratentorial cancer DOID_1659 0.05421247 0.08247833 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP cerebrum cancer DOID_368 0.05421247 0.08247833 1.000 1.000 NUYTTEN_EZH2_TARGETS_UP age related macular degeneration DOID_10871 0.06059934 0.0919494 0.3317091 0.50465903 NUYTTEN_EZH2_TARGETS_UP degeneration of macula and posterior pole DOID_2007 0.06059934 0.0919494 0.3317091 0.50465903 RODWELL_AGING_KIDNEY_UP collagen disease DOID_854 1.143E-14 6.501E-12 3.819E-10 2.173E-07 RODWELL_AGING_KIDNEY_UP hypersensitivity reaction type I disease DOID_1205 8.39E-14 2.387E-11 9.142E-10 2.601E-07 RODWELL_AGING_KIDNEY_UP heart valve disease DOID_4079 3.762E-11 7.135E-09 1.269E-09 2.406E-07 RODWELL_AGING_KIDNEY_UP tuberculosis DOID_399 3.894E-11 5.539E-09 7.403E-06 1.56E-04 RODWELL_AGING_KIDNEY_UP peripheral vascular disease DOID_341 6.833E-11 7.775E-09 3.463E-08 3.284E-06 RODWELL_AGING_KIDNEY_UP systemic scleroderma DOID_418 2.917E-10 2.767E-08 3.177E-07 2.008E-05 RODWELL_AGING_KIDNEY_UP ankylosing spondylitis DOID_7147 3.741E-10 3.041E-08 8.258E-07 3.614E-05 RODWELL_AGING_KIDNEY_UP carotid artery disease DOID_3407 3.819E-10 2.716E-08 2.13E-07 1.515E-05 RODWELL_AGING_KIDNEY_UP primary bacterial infectious disease DOID_0050338 3.869E-10 2.446E-08 2.723E-05 4.304E-04 RODWELL_AGING_KIDNEY_UP primary immunodeficiency disease DOID_612 4.835E-10 2.751E-08 9.324E-09 1.061E-06 RODWELL_AGING_KIDNEY_UP thyroiditis DOID_7166 5.592E-10 2.892E-08 3.058E-06 8.286E-05 RODWELL_AGING_KIDNEY_UP autoimmune thyroiditis DOID_7188 5.592E-10 2.892E-08 3.058E-06 8.286E-05 RODWELL_AGING_KIDNEY_UP rheumatic disease DOID_1575 6.306E-10 2.99E-08 5.55E-07 2.871E-05 RODWELL_AGING_KIDNEY_UP scleroderma DOID_419 6.306E-10 2.99E-08 5.55E-07 2.871E-05 RODWELL_AGING_KIDNEY_UP parasitic infectious disease DOID_1398 6.68E-10 2.924E-08 5.751E-06 1.309E-04 RODWELL_AGING_KIDNEY_UP encephalomyelitis DOID_640 7.43E-10 3.02E-08 3.19E-06 7.891E-05 RODWELL_AGING_KIDNEY_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.758E-09 6.669E-08 3.781E-04 3.31E-03 RODWELL_AGING_KIDNEY_UP bone resorption disease DOID_0080011 2.621E-09 9.321E-08 2.621E-09 3.728E-07 RODWELL_AGING_KIDNEY_UP osteoporosis DOID_11476 2.621E-09 9.321E-08 2.621E-09 3.728E-07 RODWELL_AGING_KIDNEY_UP systemic mycosis DOID_0050136 3.344E-09 1.119E-07 8.931E-05 1.016E-03 RODWELL_AGING_KIDNEY_UP fungal infectious disease DOID_1564 3.344E-09 1.119E-07 8.931E-05 1.016E-03 RODWELL_AGING_KIDNEY_UP contact dermatitis DOID_2773 3.669E-09 1.16E-07 7.033E-08 5.717E-06 RODWELL_AGING_KIDNEY_UP autoimmune hepatitis DOID_2048 3.687E-09 1.104E-07 8.246E-03 0.03375523 RODWELL_AGING_KIDNEY_UP vasculitis DOID_865 3.753E-09 1.068E-07 2.025E-06 7.2E-05 RODWELL_AGING_KIDNEY_UP parasitic protozoa infectious disease DOID_2789 4.329E-09 1.173E-07 3.973E-05 5.383E-04 RODWELL_AGING_KIDNEY_UP Human immunodeficiency virus infectious disease DOID_526 1.028E-08 2.658E-07 3.287E-05 4.676E-04 RODWELL_AGING_KIDNEY_UP urticaria DOID_1555 1.522E-08 3.765E-07 2.386E-05 3.879E-04 RODWELL_AGING_KIDNEY_UP allergic contact dermatitis DOID_3042 1.993E-08 4.725E-07 3.975E-07 2.262E-05 RODWELL_AGING_KIDNEY_UP nephrosis DOID_2527 3.111E-08 7.081E-07 5.836E-07 2.767E-05 RODWELL_AGING_KIDNEY_UP vascular skin disease DOID_9540 3.702E-08 8.101E-07 1.917E-05 3.409E-04 RODWELL_AGING_KIDNEY_UP autoimmune disease of endocrine system DOID_0060005 4.735E-08 9.979E-07 4.894E-05 5.925E-04 RODWELL_AGING_KIDNEY_UP pulmonary tuberculosis DOID_2957 4.903E-08 9.964E-07 3.781E-04 3.26E-03 RODWELL_AGING_KIDNEY_UP aneurysm disease DOID_2403 5.236E-08 1.027E-06 1.375E-05 2.795E-04 RODWELL_AGING_KIDNEY_UP calcium metabolism disease DOID_10575 5.618E-08 1.066E-06 1.309E-06 4.966E-05 RODWELL_AGING_KIDNEY_UP opportunistic mycosis DOID_2473 7.046E-08 1.293E-06 6.3E-05 7.316E-04 RODWELL_AGING_KIDNEY_UP esophageal disease DOID_6050 1.447E-07 2.573E-06 9.962E-05 1.09E-03 RODWELL_AGING_KIDNEY_UP lymphoma DOID_0060058 2.053E-07 3.54E-06 2.971E-06 8.452E-05 RODWELL_AGING_KIDNEY_UP calcinosis DOID_182 2.35E-07 3.933E-06 6.279E-06 1.374E-04 RODWELL_AGING_KIDNEY_UP mineral metabolism disease DOID_0050032 2.932E-07 4.767E-06 5.272E-06 1.25E-04 RODWELL_AGING_KIDNEY_UP myasthenia gravis DOID_437 3.516E-07 5.558E-06 1.435E-05 2.816E-04 RODWELL_AGING_KIDNEY_UP angioedema DOID_1558 3.639E-07 5.597E-06 1.853E-03 0.01171322 RODWELL_AGING_KIDNEY_UP intracranial arterial disease DOID_13089 3.672E-07 5.498E-06 1.805E-04 1.834E-03 RODWELL_AGING_KIDNEY_UP cerebral arterial disease DOID_3527 3.672E-07 5.498E-06 1.805E-04 1.834E-03 RODWELL_AGING_KIDNEY_UP influenza DOID_8469 6.327E-07 9.231E-06 2.556E-04 2.384E-03 RODWELL_AGING_KIDNEY_UP neuromuscular junction disease DOID_439 8.258E-07 1.175E-05 2.787E-05 4.285E-04 RODWELL_AGING_KIDNEY_UP aortic valve insufficiency DOID_57 8.491E-07 1.178E-05 8.491E-07 3.451E-05 RODWELL_AGING_KIDNEY_UP autoimmune disease of the nervous system DOID_438 1.434E-06 1.943E-05 4.285E-05 5.3E-04 RODWELL_AGING_KIDNEY_UP biliary tract cancer DOID_4607 1.506E-06 1.993E-05 2.095E-05 3.612E-04 RODWELL_AGING_KIDNEY_UP transitional cell carcinoma DOID_2671 2.217E-06 2.867E-05 2.217E-06 7.421E-05 RODWELL_AGING_KIDNEY_UP Ehlers-Danlos syndrome DOID_13359 2.305E-06 2.915E-05 2.305E-06 7.288E-05 RODWELL_AGING_KIDNEY_UP varicose veins DOID_799 2.305E-06 2.852E-05 2.305E-06 6.904E-05 RODWELL_AGING_KIDNEY_UP hypersensitivity reaction type IV disease DOID_2916 3.031E-06 3.669E-05 7.528E-03 0.03173034 RODWELL_AGING_KIDNEY_UP bile duct cancer DOID_4606 3.031E-06 3.593E-05 5.077E-05 6.018E-04 RODWELL_AGING_KIDNEY_UP bile duct carcinoma DOID_4897 3.031E-06 3.593E-05 5.077E-05 6.018E-04 RODWELL_AGING_KIDNEY_UP vein disease DOID_866 3.058E-06 3.551E-05 3.058E-06 7.909E-05 RODWELL_AGING_KIDNEY_UP Crohn's disease DOID_8778 3.421E-06 3.894E-05 4.182E-05 5.408E-04 RODWELL_AGING_KIDNEY_UP juvenile rheumatoid arthritis DOID_676 3.979E-06 4.439E-05 5.433E-03 0.02533854 RODWELL_AGING_KIDNEY_UP hepatitis C DOID_1883 4.227E-06 4.625E-05 9.962E-05 1.111E-03 RODWELL_AGING_KIDNEY_UP hypothyroidism DOID_1459 4.411E-06 4.736E-05 8.85E-04 6.294E-03 RODWELL_AGING_KIDNEY_UP membranous glomerulonephritis DOID_10976 7.975E-06 8.403E-05 7.493E-03 0.03229842 RODWELL_AGING_KIDNEY_UP amyloidosis DOID_9120 7.975E-06 8.25E-05 2.904E-04 2.622E-03 RODWELL_AGING_KIDNEY_UP hepatitis B DOID_2043 1.192E-05 1.211E-04 3.885E-04 3.299E-03 RODWELL_AGING_KIDNEY_UP uveal disease DOID_3480 1.267E-05 1.265E-04 3.411E-03 0.01903072 RODWELL_AGING_KIDNEY_UP gallbladder cancer DOID_3121 1.41E-05 1.384E-04 2.556E-04 2.424E-03 RODWELL_AGING_KIDNEY_UP urinary tract obstruction DOID_5200 1.435E-05 1.384E-04 1.435E-05 2.722E-04 RODWELL_AGING_KIDNEY_UP pancreatitis DOID_4989 1.479E-05 1.402E-04 1.915E-03 0.01184548 RODWELL_AGING_KIDNEY_UP bacterial pneumonia DOID_874 1.479E-05 1.379E-04 1.855E-04 1.851E-03 RODWELL_AGING_KIDNEY_UP aortic valve disease DOID_62 1.713E-05 1.572E-04 1.713E-05 3.145E-04 RODWELL_AGING_KIDNEY_UP neuritis DOID_1803 1.917E-05 1.731E-04 3.25E-04 2.889E-03 RODWELL_AGING_KIDNEY_UP glaucoma DOID_1686 2.327E-05 2.069E-04 2.327E-05 3.894E-04 RODWELL_AGING_KIDNEY_UP myositis DOID_633 2.787E-05 2.439E-04 0.01343268 0.05199454 RODWELL_AGING_KIDNEY_UP Sjogren's syndrome DOID_12894 3.208E-05 2.766E-04 0.06353122 0.18443501 RODWELL_AGING_KIDNEY_UP Diamond-Blackfan anemia DOID_1339 3.208E-05 2.724E-04 3.208E-05 4.804E-04 RODWELL_AGING_KIDNEY_UP intracranial aneurysm DOID_10941 3.234E-05 2.706E-04 3.234E-05 4.719E-04 RODWELL_AGING_KIDNEY_UP vitiligo DOID_12306 3.234E-05 2.667E-04 0.01440421 0.05537836 RODWELL_AGING_KIDNEY_UP B cell deficiency DOID_2115 3.234E-05 2.629E-04 8.028E-04 5.932E-03 RODWELL_AGING_KIDNEY_UP extrinsic allergic alveolitis DOID_841 3.234E-05 2.592E-04 8.028E-04 5.782E-03 RODWELL_AGING_KIDNEY_UP sarcoidosis DOID_11335 3.348E-05 2.645E-04 0.05210878 0.15687775 RODWELL_AGING_KIDNEY_UP bile duct adenocarcinoma DOID_4896 3.65E-05 2.845E-04 3.65E-05 5.065E-04 RODWELL_AGING_KIDNEY_UP cholangiocarcinoma DOID_4947 3.65E-05 2.845E-04 3.65E-05 5.065E-04 RODWELL_AGING_KIDNEY_UP pustulosis of palm and sole DOID_4398 3.973E-05 3.055E-04 6.547E-03 0.02956751 RODWELL_AGING_KIDNEY_UP mouth disease DOID_403 4.182E-05 3.173E-04 4.182E-05 5.534E-04 RODWELL_AGING_KIDNEY_UP autoimmune disease of cardiovascular system DOID_0060051 4.285E-05 3.208E-04 4.285E-05 5.418E-04 RODWELL_AGING_KIDNEY_UP Behcet's disease DOID_13241 4.285E-05 3.208E-04 4.285E-05 5.418E-04 RODWELL_AGING_KIDNEY_UP trypanosomiasis DOID_10113 4.39E-05 3.244E-04 0.06965887 0.19240727 RODWELL_AGING_KIDNEY_UP temporal arteritis DOID_13375 4.39E-05 3.202E-04 0.06965887 0.18784786 RODWELL_AGING_KIDNEY_UP central nervous system vasculitis DOID_525 4.39E-05 3.202E-04 0.06965887 0.18784786 RODWELL_AGING_KIDNEY_UP encephalitis DOID_9588 5.825E-05 4.195E-04 0.07574659 0.18820878 RODWELL_AGING_KIDNEY_UP celiac disease DOID_10608 7.104E-05 5.052E-04 0.02083696 0.07318661 RODWELL_AGING_KIDNEY_UP pre-malignant neoplasm DOID_0060071 7.427E-05 5.217E-04 9.373E-04 6.584E-03 RODWELL_AGING_KIDNEY_UP in situ carcinoma DOID_8719 7.427E-05 5.217E-04 9.373E-04 6.584E-03 RODWELL_AGING_KIDNEY_UP pleural disease DOID_1532 7.979E-05 5.537E-04 0.02200583 0.07681788 RODWELL_AGING_KIDNEY_UP brain infarction DOID_3454 1.054E-04 7.223E-04 0.01139943 0.04535857 RODWELL_AGING_KIDNEY_UP adrenal cortex disease DOID_3952 1.187E-04 8.042E-04 0.09377273 0.21689708 RODWELL_AGING_KIDNEY_UP oral submucous fibrosis DOID_5773 1.187E-04 7.948E-04 1.187E-04 1.275E-03 RODWELL_AGING_KIDNEY_UP multiple myeloma DOID_9538 1.357E-04 8.981E-04 2.285E-03 0.01383306 RODWELL_AGING_KIDNEY_UP Barrett's esophagus DOID_9206 1.454E-04 9.511E-04 1.454E-04 1.532E-03 RODWELL_AGING_KIDNEY_UP uveitis DOID_13141 1.496E-04 9.676E-04 0.02956317 0.09723379 RODWELL_AGING_KIDNEY_UP syndrome DOID_225 1.646E-04 1.052E-03 1.646E-04 1.703E-03 RODWELL_AGING_KIDNEY_UP adrenal gland disease DOID_9553 1.757E-04 1.111E-03 0.10559518 0.22932695 RODWELL_AGING_KIDNEY_UP ureteral obstruction DOID_5199 2.099E-04 1.312E-03 2.099E-04 2.059E-03 RODWELL_AGING_KIDNEY_UP prion disease DOID_649 2.099E-04 1.298E-03 6.086E-03 0.02792572 RODWELL_AGING_KIDNEY_UP endometriosis of uterus DOID_288 2.157E-04 1.32E-03 0.03509166 0.11154834 RODWELL_AGING_KIDNEY_UP nephrotic syndrome DOID_1184 2.35E-04 1.423E-03 3.411E-03 0.01921914 RODWELL_AGING_KIDNEY_UP endometriosis DOID_289 2.35E-04 1.408E-03 0.03653167 0.11484264 RODWELL_AGING_KIDNEY_UP agammaglobulinemia DOID_2583 2.48E-04 1.47E-03 6.773E-03 0.03010605 RODWELL_AGING_KIDNEY_UP psoriasis DOID_8893 2.48E-04 1.455E-03 2.48E-04 2.392E-03 RODWELL_AGING_KIDNEY_UP leishmaniasis DOID_9065 2.48E-04 1.44E-03 6.773E-03 0.02964288 RODWELL_AGING_KIDNEY_UP bone development disease DOID_0080006 2.603E-04 1.496E-03 2.603E-04 2.389E-03 RODWELL_AGING_KIDNEY_UP blood protein disease DOID_620 2.904E-04 1.652E-03 7.493E-03 0.03181635 RODWELL_AGING_KIDNEY_UP myeloma DOID_0070004 3.25E-04 1.831E-03 4.321E-03 0.02138052 RODWELL_AGING_KIDNEY_UP pre-eclampsia DOID_10591 3.25E-04 1.813E-03 4.321E-03 0.02119621 RODWELL_AGING_KIDNEY_UP acquired immunodeficiency syndrome DOID_635 3.885E-04 2.146E-03 9.032E-03 0.03644731 RODWELL_AGING_KIDNEY_UP aortic aneurysm DOID_3627 4.069E-04 2.226E-03 0.04722046 0.14368151 RODWELL_AGING_KIDNEY_UP B-cell lymphocytic neoplasm DOID_707 4.372E-04 2.369E-03 5.365E-03 0.02543829 RODWELL_AGING_KIDNEY_UP uremia DOID_4676 4.446E-04 2.387E-03 4.446E-04 3.72E-03 RODWELL_AGING_KIDNEY_UP dilated cardiomyopathy DOID_12930 4.544E-04 2.416E-03 3.849E-03 0.0200931 RODWELL_AGING_KIDNEY_UP giant cell tumor DOID_200 5.026E-04 2.648E-03 5.026E-04 4.145E-03 RODWELL_AGING_KIDNEY_UP malignant giant cell tumor DOID_2705 5.026E-04 2.648E-03 5.026E-04 4.145E-03 RODWELL_AGING_KIDNEY_UP giant cell glioblastoma DOID_3074 5.026E-04 2.648E-03 5.026E-04 4.145E-03 RODWELL_AGING_KIDNEY_UP atrophic muscular disease DOID_913 5.026E-04 2.624E-03 5.938E-03 0.02747156 RODWELL_AGING_KIDNEY_UP muscular dystrophy DOID_9884 5.026E-04 2.624E-03 5.938E-03 0.02747156 RODWELL_AGING_KIDNEY_UP diabetic angiopathy DOID_11713 5.057E-04 2.616E-03 5.057E-04 4.11E-03 RODWELL_AGING_KIDNEY_UP ureteral disease DOID_1426 5.057E-04 2.592E-03 5.057E-04 4.052E-03 RODWELL_AGING_KIDNEY_UP Goodpasture syndrome DOID_9808 5.057E-04 2.569E-03 0.14577701 0.28309598 RODWELL_AGING_KIDNEY_UP bone marrow cancer DOID_4960 5.378E-04 2.708E-03 6.239E-03 0.02839778 RODWELL_AGING_KIDNEY_UP severe combined immunodeficiency DOID_627 5.718E-04 2.854E-03 5.718E-04 4.519E-03 RODWELL_AGING_KIDNEY_UP osteochondrodysplasia DOID_2256 5.747E-04 2.844E-03 5.747E-04 4.48E-03 RODWELL_AGING_KIDNEY_UP bronchiolitis DOID_2942 6.433E-04 3.156E-03 0.01249102 0.04868076 RODWELL_AGING_KIDNEY_UP combined T cell and B cell immunodeficiency DOID_628 6.433E-04 3.129E-03 6.433E-04 4.947E-03 RODWELL_AGING_KIDNEY_UP congenital nervous system abnormality DOID_2490 6.539E-04 3.153E-03 7.192E-03 0.03123976 RODWELL_AGING_KIDNEY_UP glioblastoma DOID_3068 6.962E-04 3.329E-03 6.962E-04 5.282E-03 RODWELL_AGING_KIDNEY_UP leukocyte disease DOID_9500 7.404E-04 3.511E-03 7.873E-03 0.03270061 RODWELL_AGING_KIDNEY_UP congenital hypoplastic anemia DOID_1342 8.028E-04 3.775E-03 8.028E-04 6.01E-03 RODWELL_AGING_KIDNEY_UP middle cerebral artery infarction DOID_3525 8.028E-04 3.744E-03 0.16792546 0.31022593 RODWELL_AGING_KIDNEY_UP seminoma DOID_4440 8.028E-04 3.714E-03 8.028E-04 5.856E-03 RODWELL_AGING_KIDNEY_UP uterine disease DOID_345 1.048E-03 4.81E-03 0.07329497 0.18870968 RODWELL_AGING_KIDNEY_UP tooth disease DOID_1091 1.168E-03 5.318E-03 1.168E-03 8.107E-03 RODWELL_AGING_KIDNEY_UP astrocytoma DOID_3069 1.298E-03 5.86E-03 1.298E-03 8.896E-03 RODWELL_AGING_KIDNEY_UP spastic cerebral palsy DOID_0050669 1.305E-03 5.848E-03 0.01969506 0.06960552 RODWELL_AGING_KIDNEY_UP pancreatic ductal carcinoma DOID_3587 1.366E-03 6.072E-03 1.366E-03 9.252E-03 RODWELL_AGING_KIDNEY_UP germinoma DOID_3304 1.425E-03 6.284E-03 1.425E-03 9.537E-03 RODWELL_AGING_KIDNEY_UP pancreatic carcinoma DOID_4905 1.586E-03 6.94E-03 1.586E-03 0.01049067 RODWELL_AGING_KIDNEY_UP myocarditis DOID_820 1.684E-03 7.313E-03 0.02320125 0.08000917 RODWELL_AGING_KIDNEY_UP periodontal disease DOID_3388 1.823E-03 7.86E-03 1.823E-03 0.01192485 RODWELL_AGING_KIDNEY_UP macular degeneration DOID_4448 1.823E-03 7.8E-03 0.02442285 0.08321318 RODWELL_AGING_KIDNEY_UP hyperthyroidism DOID_7998 1.823E-03 7.742E-03 1.823E-03 0.01178934 RODWELL_AGING_KIDNEY_UP facioscapulohumeral muscular dystrophy DOID_11727 1.853E-03 7.809E-03 1.853E-03 0.01184483 RODWELL_AGING_KIDNEY_UP conjunctival disease DOID_4251 1.853E-03 7.751E-03 0.06353122 0.17984707 RODWELL_AGING_KIDNEY_UP Paget's disease of bone DOID_5408 1.853E-03 7.695E-03 1.853E-03 0.01158451 RODWELL_AGING_KIDNEY_UP conjunctivitis DOID_6195 1.853E-03 7.751E-03 0.06353122 0.17984707 RODWELL_AGING_KIDNEY_UP cutaneous leishmaniasis DOID_9111 1.853E-03 7.639E-03 0.06353122 0.17895674 RODWELL_AGING_KIDNEY_UP aplastic anemia DOID_12449 1.97E-03 8.065E-03 1.97E-03 0.0120536 RODWELL_AGING_KIDNEY_UP metabolic syndrome X DOID_14221 2.097E-03 8.521E-03 0.10080115 0.22581046 RODWELL_AGING_KIDNEY_UP female reproductive system disease DOID_229 2.192E-03 8.844E-03 0.10286264 0.22773868 RODWELL_AGING_KIDNEY_UP pneumocystosis DOID_11339 2.255E-03 9.035E-03 1.000 1.000 RODWELL_AGING_KIDNEY_UP chronic kidney failure DOID_784 2.39E-03 9.512E-03 0.42792594 0.65454263 RODWELL_AGING_KIDNEY_UP microcephaly DOID_10907 2.454E-03 9.696E-03 0.02956317 0.09837103 RODWELL_AGING_KIDNEY_UP respiratory syncytial virus infectious disease DOID_1273 2.63E-03 0.01032029 0.03090984 0.10107871 RODWELL_AGING_KIDNEY_UP hepatitis DOID_2237 2.63E-03 0.0102496 0.03090984 0.10050112 RODWELL_AGING_KIDNEY_UP common cold DOID_10459 2.694E-03 0.01042759 2.694E-03 0.01613533 RODWELL_AGING_KIDNEY_UP diarrhea DOID_13250 2.694E-03 0.01035714 2.694E-03 0.01596725 RODWELL_AGING_KIDNEY_UP relapsing-remitting multiple sclerosis DOID_2378 2.694E-03 0.01028762 0.07574659 0.19327269 RODWELL_AGING_KIDNEY_UP stomach disease DOID_76 2.694E-03 0.01021904 1.000 1.000 RODWELL_AGING_KIDNEY_UP ocular hypertension DOID_9282 2.694E-03 0.01015136 2.694E-03 0.01580264 RODWELL_AGING_KIDNEY_UP borderline glaucoma DOID_9283 2.694E-03 0.01015136 2.694E-03 0.01580264 RODWELL_AGING_KIDNEY_UP pulmonary emphysema DOID_9675 3.005E-03 0.01124929 0.03367444 0.10764471 RODWELL_AGING_KIDNEY_UP Hirschsprung's disease DOID_10487 3.17E-03 0.01178929 3.17E-03 0.01840573 RODWELL_AGING_KIDNEY_UP osteogenesis imperfecta DOID_12347 3.17E-03 0.01171274 3.17E-03 0.01821981 RODWELL_AGING_KIDNEY_UP polyneuropathy DOID_1389 3.17E-03 0.01163717 1.000 1.000 RODWELL_AGING_KIDNEY_UP psoriatic arthritis DOID_9008 3.17E-03 0.01156257 3.17E-03 0.01803761 RODWELL_AGING_KIDNEY_UP lymphoblastic leukemia DOID_1037 3.573E-03 0.01294796 3.573E-03 0.01973621 RODWELL_AGING_KIDNEY_UP diabetic autonomic neuropathy DOID_11503 3.627E-03 0.01306055 0.03799411 0.11878378 RODWELL_AGING_KIDNEY_UP autonomic neuropathy DOID_11504 3.627E-03 0.01306055 0.03799411 0.11878378 RODWELL_AGING_KIDNEY_UP diabetic polyneuropathy DOID_12785 3.627E-03 0.01306055 0.03799411 0.11878378 RODWELL_AGING_KIDNEY_UP uterine cancer DOID_363 3.627E-03 0.01297841 3.627E-03 0.019842 RODWELL_AGING_KIDNEY_UP diabetic neuropathy DOID_9743 3.627E-03 0.01306055 0.03799411 0.11878378 RODWELL_AGING_KIDNEY_UP viral pneumonia DOID_10533 3.682E-03 0.01309586 3.682E-03 0.01995559 RODWELL_AGING_KIDNEY_UP megacolon DOID_11372 3.682E-03 0.01301452 3.682E-03 0.01976733 RODWELL_AGING_KIDNEY_UP aspergillosis DOID_13564 3.682E-03 0.01293418 3.682E-03 0.01958259 RODWELL_AGING_KIDNEY_UP eyelid disease DOID_530 3.682E-03 0.01285483 0.08780326 0.2081669 RODWELL_AGING_KIDNEY_UP parasitic helminthiasis infectious disease DOID_883 3.682E-03 0.01277645 3.682E-03 0.01940127 RODWELL_AGING_KIDNEY_UP narcolepsy DOID_8986 3.682E-03 0.01269901 1.000 1.000 RODWELL_AGING_KIDNEY_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.709E-03 0.01271382 0.02531591 0.08574257 RODWELL_AGING_KIDNEY_UP cerebral infarction DOID_3526 3.85E-03 0.01311746 0.27037618 0.43093571 RODWELL_AGING_KIDNEY_UP proteinuria DOID_576 4.081E-03 0.01382339 0.27515517 0.43610944 RODWELL_AGING_KIDNEY_UP hemangioma DOID_255 4.231E-03 0.0142444 4.231E-03 0.02188458 RODWELL_AGING_KIDNEY_UP corneal dystrophy DOID_2566 4.231E-03 0.01416061 4.231E-03 0.02168742 RODWELL_AGING_KIDNEY_UP membranoproliferative glomerulonephritis DOID_2920 4.231E-03 0.0140778 4.231E-03 0.02149378 RODWELL_AGING_KIDNEY_UP arthropathy DOID_381 4.231E-03 0.01399595 4.231E-03 0.02130357 RODWELL_AGING_KIDNEY_UP ulcerative colitis DOID_8577 4.29E-03 0.0141114 4.29E-03 0.02141467 RODWELL_AGING_KIDNEY_UP autonomic nervous system disease DOID_11465 4.321E-03 0.01413081 0.04251256 0.13005186 RODWELL_AGING_KIDNEY_UP bone marrow disease DOID_4961 4.321E-03 0.01405006 4.321E-03 0.02101504 RODWELL_AGING_KIDNEY_UP hemolytic anemia DOID_583 4.569E-03 0.01477247 4.569E-03 0.02203352 RODWELL_AGING_KIDNEY_UP normocytic anemia DOID_720 4.569E-03 0.01477247 4.569E-03 0.02203352 RODWELL_AGING_KIDNEY_UP spastic diplegia DOID_10965 4.814E-03 0.01547674 4.814E-03 0.02302003 RODWELL_AGING_KIDNEY_UP hyperostosis DOID_205 5.433E-03 0.01736687 5.433E-03 0.02554795 RODWELL_AGING_KIDNEY_UP eosinophilia DOID_999 6.086E-03 0.01934519 0.11144868 0.23750674 RODWELL_AGING_KIDNEY_UP smallpox DOID_8736 6.547E-03 0.02069726 6.547E-03 0.0293347 RODWELL_AGING_KIDNEY_UP MHC class II deficiency DOID_5812 6.773E-03 0.02129046 6.773E-03 0.02987267 RODWELL_AGING_KIDNEY_UP familial hyperlipidemia DOID_1168 6.865E-03 0.02146368 0.05716875 0.17120536 RODWELL_AGING_KIDNEY_UP esophagitis DOID_11963 7.493E-03 0.02329722 0.12304146 0.25366155 RODWELL_AGING_KIDNEY_UP colonic disease DOID_5353 7.493E-03 0.02317061 7.493E-03 0.03205557 RODWELL_AGING_KIDNEY_UP melancholia DOID_2848 7.873E-03 0.02421613 7.873E-03 0.03294106 RODWELL_AGING_KIDNEY_UP neurotic disorder DOID_4964 8.228E-03 0.02516992 8.228E-03 0.03392468 RODWELL_AGING_KIDNEY_UP respiratory failure DOID_11162 8.964E-03 0.02727628 8.964E-03 0.03643332 RODWELL_AGING_KIDNEY_UP funisitis DOID_0050698 9.032E-03 0.02733549 0.13448358 0.27039279 RODWELL_AGING_KIDNEY_UP familial hypercholesterolemia DOID_13810 9.032E-03 0.02719085 0.13448358 0.2684953 RODWELL_AGING_KIDNEY_UP sleep disorder DOID_535 9.85E-03 0.02949692 1.000 1.000 RODWELL_AGING_KIDNEY_UP cholestasis DOID_13580 0.0101392 0.03020526 0.07329497 0.19043305 RODWELL_AGING_KIDNEY_UP Lewy body dementia DOID_12217 0.01069903 0.03170703 0.01069903 0.04287148 RODWELL_AGING_KIDNEY_UP spastic quadriplegia DOID_10970 0.01157966 0.034139 0.15136857 0.29295482 RODWELL_AGING_KIDNEY_UP toxic shock syndrome DOID_14115 0.01157966 0.03396302 0.15136857 0.29196175 RODWELL_AGING_KIDNEY_UP sphingolipidosis DOID_1927 0.01157966 0.03378885 0.15136857 0.2909754 RODWELL_AGING_KIDNEY_UP blood coagulation disease DOID_1247 0.01228747 0.03567129 0.01228747 0.04855259 RODWELL_AGING_KIDNEY_UP commensal bacterial infectious disease DOID_0050339 0.01249102 0.03607813 0.15692367 0.29962943 RODWELL_AGING_KIDNEY_UP portal hypertension DOID_10762 0.01249102 0.03589591 0.01249102 0.04901649 RODWELL_AGING_KIDNEY_UP bile duct disease DOID_4138 0.01274596 0.03644449 0.08475526 0.20609293 RODWELL_AGING_KIDNEY_UP male reproductive system disease DOID_48 0.01274596 0.03626227 0.08475526 0.20521594 RODWELL_AGING_KIDNEY_UP biliary tract disease DOID_9741 0.01321414 0.03740719 0.08671529 0.20907205 RODWELL_AGING_KIDNEY_UP diabetic retinopathy DOID_8947 0.01369202 0.03856812 0.0886889 0.20939412 RODWELL_AGING_KIDNEY_UP cystic fibrosis DOID_1485 0.01467703 0.04113907 0.09267578 0.21790297 RODWELL_AGING_KIDNEY_UP endogenous depression DOID_1595 0.01467703 0.04093741 0.01467703 0.05604853 RODWELL_AGING_KIDNEY_UP diffuse large B-cell lymphoma DOID_0050745 0.01540518 0.04275878 0.01540518 0.058437 RODWELL_AGING_KIDNEY_UP Sciatic Neuropathy DOID_11446 0.01540518 0.04255121 0.17337261 0.31719941 RODWELL_AGING_KIDNEY_UP gestational diabetes DOID_11714 0.01540518 0.04234565 0.17337261 0.31618274 RODWELL_AGING_KIDNEY_UP lesion of sciatic nerve DOID_12528 0.01540518 0.04255121 0.17337261 0.31719941 RODWELL_AGING_KIDNEY_UP periodontitis DOID_824 0.01540518 0.04214206 0.01540518 0.05805 RODWELL_AGING_KIDNEY_UP mononeuritis of lower limb DOID_9473 0.01540518 0.04255121 0.17337261 0.31719941 RODWELL_AGING_KIDNEY_UP electroclinical syndrome DOID_0050701 0.01570117 0.04274625 0.01570117 0.05877609 RODWELL_AGING_KIDNEY_UP mixed glioma DOID_5076 0.01570117 0.0425427 0.01570117 0.05839194 RODWELL_AGING_KIDNEY_UP pleurisy DOID_10247 0.01643517 0.04432043 0.17878425 0.32294678 RODWELL_AGING_KIDNEY_UP malaria DOID_12365 0.01643517 0.04411138 0.01643517 0.06072475 RODWELL_AGING_KIDNEY_UP mononeuritis DOID_1802 0.01643517 0.04390428 0.17878425 0.31889729 RODWELL_AGING_KIDNEY_UP hepatic vascular disease DOID_272 0.01643517 0.04369912 0.01643517 0.06033298 RODWELL_AGING_KIDNEY_UP invasive ductal carcinoma DOID_3008 0.01643517 0.04349587 0.01643517 0.05994623 RODWELL_AGING_KIDNEY_UP coronary stenosis DOID_4248 0.01643517 0.0432945 0.01643517 0.05956441 RODWELL_AGING_KIDNEY_UP lipid metabolism disorder DOID_3146 0.0167646 0.04395878 0.10080115 0.22492493 RODWELL_AGING_KIDNEY_UP mononeuropathy DOID_1188 0.01749375 0.0456603 0.1841606 0.32746056 RODWELL_AGING_KIDNEY_UP toxic encephalopathy DOID_3602 0.01749375 0.04545181 0.01749375 0.06299966 RODWELL_AGING_KIDNEY_UP mental depression DOID_1596 0.01843366 0.04767616 0.01843366 0.06596701 RODWELL_AGING_KIDNEY_UP corneal disease DOID_10124 0.01858052 0.04783853 0.01858052 0.06607698 RODWELL_AGING_KIDNEY_UP retinal vascular disease DOID_2462 0.0195958 0.05022526 0.11122191 0.23971691 RODWELL_AGING_KIDNEY_UP age related macular degeneration DOID_10871 0.01969506 0.05025331 0.19480835 0.34106447 RODWELL_AGING_KIDNEY_UP degeneration of macula and posterior pole DOID_2007 0.01969506 0.05025331 0.19480835 0.34106447 RODWELL_AGING_KIDNEY_UP abdominal aortic aneurysm DOID_7693 0.01969506 0.05002896 1.000 1.000 RODWELL_AGING_KIDNEY_UP autonomic nervous system neoplasm DOID_2621 0.02200583 0.05565029 0.02200583 0.07634948 RODWELL_AGING_KIDNEY_UP neuroblastoma DOID_769 0.02200583 0.05565029 0.02200583 0.07634948 RODWELL_AGING_KIDNEY_UP metal metabolism disorder DOID_896 0.02320125 0.05841377 0.21052102 0.35971911 RODWELL_AGING_KIDNEY_UP pneumoconiosis DOID_10316 0.02442285 0.06121851 0.21569042 0.36744864 RODWELL_AGING_KIDNEY_UP nephroblastoma DOID_2154 0.02442285 0.06095001 0.02442285 0.08371447 RODWELL_AGING_KIDNEY_UP lymphoid leukemia DOID_10747 0.02567023 0.06378322 0.02567023 0.08642816 RODWELL_AGING_KIDNEY_UP adenoma DOID_657 0.02694299 0.06665462 0.02694299 0.09017978 RODWELL_AGING_KIDNEY_UP pulmonary sarcoidosis DOID_13406 0.02824077 0.06956276 0.2309972 0.38097798 RODWELL_AGING_KIDNEY_UP embryonal cancer DOID_688 0.02824077 0.06926292 0.2309972 0.37878214 RODWELL_AGING_KIDNEY_UP peripheral nervous system neoplasm DOID_1192 0.02956317 0.07219505 0.02956317 0.09779911 RODWELL_AGING_KIDNEY_UP peptic ulcer DOID_750 0.03090984 0.0751611 1.000 1.000 RODWELL_AGING_KIDNEY_UP adult respiratory distress syndrome DOID_11394 0.03228038 0.07815973 0.03228038 0.104361 RODWELL_AGING_KIDNEY_UP lymphatic system disease DOID_75 0.03228038 0.07782854 0.24600642 0.39879674 RODWELL_AGING_KIDNEY_UP benign mesothelioma DOID_2645 0.03367444 0.08084708 0.03367444 0.10825287 RODWELL_AGING_KIDNEY_UP cervix uteri carcinoma in situ DOID_8991 0.03367444 0.08050739 0.25094438 0.40564588 RODWELL_AGING_KIDNEY_UP Huntington's disease DOID_12858 0.03653167 0.08697288 0.03653167 0.11548065 RODWELL_AGING_KIDNEY_UP cataract DOID_83 0.03947864 0.09359727 0.03947864 0.12275052 RODWELL_AGING_KIDNEY_UP leukodystrophy DOID_10579 0.0409849 0.09676519 0.0409849 0.12674136 RODWELL_AGING_KIDNEY_UP lens disease DOID_110 0.04251256 0.09995721 0.04251256 0.13075484 LU_TUMOR_ANGIOGENESIS_UP giant cell tumor DOID_200 2.502E-15 1.423E-12 5.294E-06 1.004E-03 LU_TUMOR_ANGIOGENESIS_UP malignant giant cell tumor DOID_2705 2.502E-15 1.423E-12 5.294E-06 1.004E-03 LU_TUMOR_ANGIOGENESIS_UP giant cell glioblastoma DOID_3074 2.502E-15 1.423E-12 5.294E-06 1.004E-03 LU_TUMOR_ANGIOGENESIS_UP glioblastoma DOID_3068 4.697E-15 1.336E-12 6.86E-06 7.807E-04 LU_TUMOR_ANGIOGENESIS_UP astrocytoma DOID_3069 1.58E-14 2.996E-12 1.132E-05 1.073E-03 LU_TUMOR_ANGIOGENESIS_UP pancreatic ductal carcinoma DOID_3587 1.747E-14 2.484E-12 1.18E-05 9.591E-04 LU_TUMOR_ANGIOGENESIS_UP pancreatic carcinoma DOID_4905 2.341E-14 2.664E-12 1.332E-05 9.474E-04 LU_TUMOR_ANGIOGENESIS_UP brain cancer DOID_1319 1.073E-10 1.018E-08 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP central nervous system cancer DOID_3620 1.19E-10 9.67E-09 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP nervous system cancer DOID_3093 2.45E-09 1.743E-07 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP myeloma DOID_0070004 2.326E-08 1.471E-06 3.752E-06 1.068E-03 LU_TUMOR_ANGIOGENESIS_UP bone marrow cancer DOID_4960 3.979E-08 2.264E-06 5.586E-06 7.946E-04 LU_TUMOR_ANGIOGENESIS_UP congenital heart defect DOID_1682 7.234E-08 3.742E-06 0.03929481 0.25122185 LU_TUMOR_ANGIOGENESIS_UP uterine disease DOID_345 8.167E-08 3.873E-06 7.827E-04 0.01936383 LU_TUMOR_ANGIOGENESIS_UP aneurysm disease DOID_2403 1.5E-07 6.566E-06 1.054E-03 0.02499681 LU_TUMOR_ANGIOGENESIS_UP female reproductive system disease DOID_229 1.832E-07 7.445E-06 1.163E-03 0.02544793 LU_TUMOR_ANGIOGENESIS_UP subependymal glioma DOID_4843 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP pilocytic astrocytoma DOID_4851 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP subependymal giant cell astrocytoma DOID_5077 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP fibrillary astrocytoma DOID_6726 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP juvenile pilocytic astrocytoma DOID_6811 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP childhood pilocytic astrocytoma DOID_6812 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP gemistocytic astrocytoma DOID_7005 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP childhood cerebral astrocytoma DOID_7007 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP protoplasmic astrocytoma DOID_7008 2.208E-07 8.377E-06 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP benign glioma DOID_0060101 2.981E-07 1.06E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP benign ependymoma DOID_4844 2.981E-07 1.06E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP middle cerebral artery infarction DOID_3525 6.326E-07 2.117E-05 0.01685471 0.1844294 LU_TUMOR_ANGIOGENESIS_UP seminoma DOID_4440 6.326E-07 2E-05 1.318E-04 6.25E-03 LU_TUMOR_ANGIOGENESIS_UP supratentorial cancer DOID_1659 8.67E-07 2.596E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP cerebrum cancer DOID_368 8.67E-07 2.596E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP focal glomerulosclerosis DOID_3945 8.67E-07 2.467E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP germinoma DOID_3304 1.153E-06 3.124E-05 1.952E-04 7.404E-03 LU_TUMOR_ANGIOGENESIS_UP leiomyoma DOID_127 1.26E-06 3.26E-05 1.26E-06 7.172E-04 LU_TUMOR_ANGIOGENESIS_UP calcinosis DOID_182 1.899E-06 4.698E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP systemic scleroderma DOID_418 2.205E-06 5.227E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP peptic ulcer DOID_750 2.205E-06 5.018E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP intracranial arterial disease DOID_13089 2.369E-06 5.185E-05 0.02577189 0.2125247 LU_TUMOR_ANGIOGENESIS_UP cerebral arterial disease DOID_3527 2.369E-06 5.185E-05 0.02577189 0.2125247 LU_TUMOR_ANGIOGENESIS_UP endometriosis of uterus DOID_288 2.722E-06 5.736E-05 0.02695498 0.21301925 LU_TUMOR_ANGIOGENESIS_UP rheumatic disease DOID_1575 2.911E-06 5.915E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP endometriosis DOID_289 2.911E-06 5.711E-05 0.02754602 0.21180653 LU_TUMOR_ANGIOGENESIS_UP scleroderma DOID_419 2.911E-06 5.915E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP cerebral infarction DOID_3526 3.314E-06 6.285E-05 0.02872705 0.21228172 LU_TUMOR_ANGIOGENESIS_UP calcium metabolism disease DOID_10575 4.479E-06 8.222E-05 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP collagen disease DOID_854 7.932E-06 1.41E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP respiratory failure DOID_11162 8.313E-06 1.433E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP mineral metabolism disease DOID_0050032 9.109E-06 1.524E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP brain infarction DOID_3454 1.085E-05 1.764E-04 0.04221072 0.25550956 LU_TUMOR_ANGIOGENESIS_UP diabetic retinopathy DOID_8947 1.332E-05 2.105E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP keratitis DOID_4677 1.58E-05 2.429E-04 6.051E-03 0.1187252 LU_TUMOR_ANGIOGENESIS_UP biliary tract cancer DOID_4607 1.865E-05 2.792E-04 0.05033031 0.28076416 LU_TUMOR_ANGIOGENESIS_UP temporal arteritis DOID_13375 1.93E-05 2.816E-04 6.654E-03 0.12620786 LU_TUMOR_ANGIOGENESIS_UP invasive lobular carcinoma DOID_3457 1.93E-05 2.745E-04 1.93E-05 1.22E-03 LU_TUMOR_ANGIOGENESIS_UP central nervous system vasculitis DOID_525 1.93E-05 2.816E-04 6.654E-03 0.12620786 LU_TUMOR_ANGIOGENESIS_UP retinal vascular disease DOID_2462 2E-05 2.775E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP transitional cell carcinoma DOID_2671 2.214E-05 2.999E-04 2.214E-05 1.26E-03 LU_TUMOR_ANGIOGENESIS_UP encephalomyelitis DOID_640 2.603E-05 3.444E-04 0.05608966 0.30395252 LU_TUMOR_ANGIOGENESIS_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.686E-05 3.473E-04 0.05666375 0.30416674 LU_TUMOR_ANGIOGENESIS_UP larynx cancer DOID_2596 2.735E-05 3.458E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP laryngeal benign neoplasm DOID_2598 2.735E-05 3.458E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP bronchitis DOID_6132 4.762E-05 5.89E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP granulosa cell tumor DOID_2999 5.983E-05 7.243E-04 0.01146698 0.17170296 LU_TUMOR_ANGIOGENESIS_UP sex cord-gonadal stromal tumor DOID_192 6.645E-05 7.877E-04 0.01206701 0.17605458 LU_TUMOR_ANGIOGENESIS_UP brain edema DOID_4724 6.645E-05 7.716E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP gastric ulcer DOID_10808 8.073E-05 9.187E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP uremia DOID_4676 8.839E-05 9.861E-04 0.013865 0.17531527 LU_TUMOR_ANGIOGENESIS_UP pulmonary embolism DOID_9477 8.839E-05 9.671E-04 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP synostosis DOID_11971 9.639E-05 1.035E-03 9.639E-05 4.986E-03 LU_TUMOR_ANGIOGENESIS_UP portal hypertension DOID_10762 1.134E-04 1.195E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP hypogonadism DOID_1924 1.134E-04 1.173E-03 0.01565987 0.19370576 LU_TUMOR_ANGIOGENESIS_UP intracranial aneurysm DOID_10941 1.318E-04 1.339E-03 0.01685471 0.19572099 LU_TUMOR_ANGIOGENESIS_UP renal hypertension DOID_1073 1.516E-04 1.513E-03 0.01804816 0.19017413 LU_TUMOR_ANGIOGENESIS_UP secondary hypertension DOID_11130 1.516E-04 1.513E-03 0.01804816 0.19017413 LU_TUMOR_ANGIOGENESIS_UP hepatic vascular disease DOID_272 1.516E-04 1.487E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP coronary stenosis DOID_4248 1.516E-04 1.462E-03 0.01804816 0.1833822 LU_TUMOR_ANGIOGENESIS_UP female reproductive organ benign neoplasm DOID_0060086 1.727E-04 1.638E-03 1.727E-04 7.559E-03 LU_TUMOR_ANGIOGENESIS_UP uterine benign neoplasm DOID_0060095 1.727E-04 1.638E-03 1.727E-04 7.559E-03 LU_TUMOR_ANGIOGENESIS_UP corneal disease DOID_10124 1.727E-04 1.611E-03 0.01924023 0.19206472 LU_TUMOR_ANGIOGENESIS_UP uterine fibroid DOID_13223 1.727E-04 1.638E-03 1.727E-04 7.559E-03 LU_TUMOR_ANGIOGENESIS_UP dysostosis DOID_1934 1.727E-04 1.585E-03 1.727E-04 7.019E-03 LU_TUMOR_ANGIOGENESIS_UP endometrial carcinoma DOID_2871 1.727E-04 1.56E-03 0.01924023 0.18875326 LU_TUMOR_ANGIOGENESIS_UP gonadal disease DOID_2277 1.838E-04 1.634E-03 0.01983574 0.19129723 LU_TUMOR_ANGIOGENESIS_UP abdominal aortic aneurysm DOID_7693 1.838E-04 1.609E-03 0.01983574 0.18810894 LU_TUMOR_ANGIOGENESIS_UP endometrial cancer DOID_1380 1.952E-04 1.683E-03 0.02043091 0.19057684 LU_TUMOR_ANGIOGENESIS_UP nephroblastoma DOID_2154 2.315E-04 1.966E-03 2.315E-04 8.232E-03 LU_TUMOR_ANGIOGENESIS_UP embryonal cancer DOID_688 2.708E-04 2.266E-03 2.708E-04 9.064E-03 LU_TUMOR_ANGIOGENESIS_UP multiple myeloma DOID_9538 2.708E-04 2.233E-03 0.02399466 0.20377558 LU_TUMOR_ANGIOGENESIS_UP congenital diaphragmatic hernia DOID_3827 2.987E-04 2.428E-03 0.02517982 0.21069589 LU_TUMOR_ANGIOGENESIS_UP adult respiratory distress syndrome DOID_11394 3.131E-04 2.51E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP adenoid cystic carcinoma DOID_4866 3.131E-04 2.475E-03 3.131E-04 9.899E-03 LU_TUMOR_ANGIOGENESIS_UP benign mesothelioma DOID_2645 3.279E-04 2.556E-03 0.02636361 0.21429847 LU_TUMOR_ANGIOGENESIS_UP cervix uteri carcinoma in situ DOID_8991 3.279E-04 2.522E-03 0.02636361 0.21128019 LU_TUMOR_ANGIOGENESIS_UP salivary gland cancer DOID_8850 3.431E-04 2.603E-03 3.431E-04 0.0102738 LU_TUMOR_ANGIOGENESIS_UP primitive neuroectodermal tumor DOID_168 3.585E-04 2.684E-03 0.02754602 0.21470799 LU_TUMOR_ANGIOGENESIS_UP uterine cancer DOID_363 3.743E-04 2.766E-03 0.02813671 0.21065507 LU_TUMOR_ANGIOGENESIS_UP proteinuria DOID_576 4.069E-04 2.968E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP pre-eclampsia DOID_10591 4.237E-04 3.052E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP heart valve disease DOID_4079 4.237E-04 3.014E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP glaucoma DOID_1686 4.583E-04 3.219E-03 0.03108501 0.22676114 LU_TUMOR_ANGIOGENESIS_UP aortic aneurysm DOID_3627 4.761E-04 3.304E-03 0.03167364 0.22527876 LU_TUMOR_ANGIOGENESIS_UP bile duct adenocarcinoma DOID_4896 5.506E-04 3.775E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP cholangiocarcinoma DOID_4947 5.506E-04 3.775E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP vasculitis DOID_865 5.506E-04 3.73E-03 0.03402475 0.23325402 LU_TUMOR_ANGIOGENESIS_UP reproductive organ benign neoplasm DOID_0050622 5.701E-04 3.816E-03 5.701E-04 0.01621847 LU_TUMOR_ANGIOGENESIS_UP hypertrophic cardiomyopathy DOID_11984 6.304E-04 4.171E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP bile duct cancer DOID_4606 6.304E-04 4.123E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP bile duct carcinoma DOID_4897 6.304E-04 4.123E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP oral cavity cancer DOID_8618 6.304E-04 4.076E-03 6.304E-04 0.01708119 LU_TUMOR_ANGIOGENESIS_UP leukocyte disease DOID_9500 6.512E-04 4.163E-03 6.512E-04 0.01684206 LU_TUMOR_ANGIOGENESIS_UP neuroectodermal tumor DOID_171 6.937E-04 4.386E-03 0.03812606 0.24935323 LU_TUMOR_ANGIOGENESIS_UP pre-malignant neoplasm DOID_0060071 7.376E-04 4.612E-03 0.03929481 0.25407664 LU_TUMOR_ANGIOGENESIS_UP in situ carcinoma DOID_8719 7.376E-04 4.612E-03 0.03929481 0.25407664 LU_TUMOR_ANGIOGENESIS_UP cholestasis DOID_13580 7.827E-04 4.841E-03 0.04046219 0.25581095 LU_TUMOR_ANGIOGENESIS_UP temporal lobe epilepsy DOID_3328 8.058E-04 4.93E-03 0.04104537 0.25664633 LU_TUMOR_ANGIOGENESIS_UP hyperglycemia DOID_4195 8.058E-04 4.878E-03 0.04104537 0.25385669 LU_TUMOR_ANGIOGENESIS_UP allergic contact dermatitis DOID_3042 8.292E-04 4.966E-03 0.04162821 0.25469305 LU_TUMOR_ANGIOGENESIS_UP tuberculosis DOID_399 8.529E-04 5.055E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP bile duct disease DOID_4138 9.26E-04 5.432E-03 0.0439562 0.26327451 LU_TUMOR_ANGIOGENESIS_UP biliary tract disease DOID_9741 9.51E-04 5.522E-03 0.04453735 0.26397659 LU_TUMOR_ANGIOGENESIS_UP cystic fibrosis DOID_1485 1.028E-03 5.909E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP pancreatitis DOID_4989 1.081E-03 6.151E-03 1.081E-03 0.02460317 LU_TUMOR_ANGIOGENESIS_UP mixed glioma DOID_5076 1.081E-03 6.09E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP bacterial pneumonia DOID_874 1.081E-03 6.03E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP contact dermatitis DOID_2773 1.135E-03 6.271E-03 0.04859596 0.27930403 LU_TUMOR_ANGIOGENESIS_UP focal epilepsy DOID_2234 1.219E-03 6.669E-03 0.05033031 0.283544 LU_TUMOR_ANGIOGENESIS_UP bone development disease DOID_0080006 1.248E-03 6.761E-03 1.248E-03 0.02629101 LU_TUMOR_ANGIOGENESIS_UP primary bacterial infectious disease DOID_0050338 1.335E-03 7.167E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP lymphoma DOID_0060058 1.488E-03 7.91E-03 0.05551523 0.30373236 LU_TUMOR_ANGIOGENESIS_UP ulcerative colitis DOID_8577 1.681E-03 8.856E-03 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP retinal vascular occlusion DOID_1729 6.051E-03 0.03158744 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP acute kidney failure DOID_3021 6.051E-03 0.03130028 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP teratoma DOID_3307 6.051E-03 0.0310183 6.051E-03 0.12296539 LU_TUMOR_ANGIOGENESIS_UP malignant teratoma DOID_5563 6.051E-03 0.0310183 6.051E-03 0.12296539 LU_TUMOR_ANGIOGENESIS_UP mature teratoma DOID_5566 6.051E-03 0.0310183 6.051E-03 0.12296539 LU_TUMOR_ANGIOGENESIS_UP acute T cell leukemia DOID_5603 6.051E-03 0.03074135 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP eosinophilic pneumonia DOID_5870 6.654E-03 0.03350651 6.654E-03 0.12213664 LU_TUMOR_ANGIOGENESIS_UP pulmonary eosinophilia DOID_9498 6.654E-03 0.03350651 6.654E-03 0.12213664 LU_TUMOR_ANGIOGENESIS_UP Loeffler syndrome DOID_9503 6.654E-03 0.03350651 6.654E-03 0.12213664 LU_TUMOR_ANGIOGENESIS_UP bronchiectasis DOID_9563 6.654E-03 0.03321259 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP mitochondrial encephalomyopathy DOID_890 7.257E-03 0.03590645 7.257E-03 0.1290388 LU_TUMOR_ANGIOGENESIS_UP ocular hypertension DOID_9282 7.257E-03 0.03559691 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP borderline glaucoma DOID_9283 7.257E-03 0.03559691 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP encephalitis DOID_9588 7.257E-03 0.03529266 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP Leydig cell tumor DOID_2696 7.859E-03 0.03789871 7.859E-03 0.13551661 LU_TUMOR_ANGIOGENESIS_UP sex cord-stromal neoplasm DOID_4757 7.859E-03 0.03789871 7.859E-03 0.13551661 LU_TUMOR_ANGIOGENESIS_UP rhabdomyosarcoma DOID_3247 8.462E-03 0.04045929 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP T-cell leukemia DOID_715 8.462E-03 0.04012213 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP bacterial meningitis DOID_9470 8.462E-03 0.03979054 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP skeletal system cancer DOID_0060124 9.063E-03 0.04227102 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP thoracic aortic aneurysm DOID_14004 9.063E-03 0.04192735 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP renovascular hypertension DOID_1591 9.063E-03 0.04158923 9.063E-03 0.15167837 LU_TUMOR_ANGIOGENESIS_UP bone cancer DOID_184 9.063E-03 0.04227102 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP membranoproliferative glomerulonephritis DOID_2920 9.063E-03 0.04125652 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP arthropathy DOID_381 9.063E-03 0.04092908 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP skeletal muscle cancer DOID_4043 9.063E-03 0.04060681 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP oral submucous fibrosis DOID_5773 9.063E-03 0.04028957 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP varicose veins DOID_799 9.063E-03 0.03997724 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP angiosarcoma DOID_0001816 9.665E-03 0.04230211 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP vein disease DOID_866 9.665E-03 0.04197919 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP prion disease DOID_649 0.01086661 0.04684165 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP eosinophilia DOID_999 0.01086661 0.04648946 0.01086661 0.17665995 LU_TUMOR_ANGIOGENESIS_UP agammaglobulinemia DOID_2583 0.01146698 0.04869189 0.01146698 0.18124202 LU_TUMOR_ANGIOGENESIS_UP testicular cancer DOID_2998 0.01146698 0.0483312 0.01146698 0.17634358 LU_TUMOR_ANGIOGENESIS_UP pulmonary edema DOID_11396 0.01206701 0.05048624 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP blood protein disease DOID_620 0.01206701 0.05011773 0.01206701 0.17165321 LU_TUMOR_ANGIOGENESIS_UP Kawasaki disease DOID_13378 0.01266669 0.05222715 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP lymphadenitis DOID_1602 0.01266669 0.05222715 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP coronary restenosis DOID_4247 0.01266669 0.05185141 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP mitochondrial myopathy DOID_699 0.01266669 0.05148104 0.01266669 0.17578893 LU_TUMOR_ANGIOGENESIS_UP lymph node disease DOID_9942 0.01266669 0.05222715 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP neutropenia DOID_1227 0.01326602 0.05353451 0.01326602 0.17972299 LU_TUMOR_ANGIOGENESIS_UP familial hypercholesterolemia DOID_13810 0.01326602 0.05315751 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP placenta disease DOID_780 0.01326602 0.05278577 0.01326602 0.17554339 LU_TUMOR_ANGIOGENESIS_UP sinusitis DOID_0050127 0.013865 0.05478602 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP agranulocytosis DOID_12987 0.013865 0.05440819 0.013865 0.17929971 LU_TUMOR_ANGIOGENESIS_UP paranasal sinus disease DOID_1352 0.013865 0.05478602 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP opiate dependence DOID_2559 0.013865 0.05403553 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP muscle cancer DOID_4045 0.013865 0.05366794 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP polyarteritis nodosa DOID_9810 0.013865 0.05330532 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP Lewy body dementia DOID_12217 0.01446364 0.05523363 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP meningitis DOID_9471 0.01446364 0.05486541 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP Goodpasture syndrome DOID_9808 0.01446364 0.05450206 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP osteosarcoma DOID_3347 0.01565987 0.05862148 0.01565987 0.18958436 LU_TUMOR_ANGIOGENESIS_UP cleft lip DOID_9296 0.01625746 0.06046076 0.01625746 0.19271866 LU_TUMOR_ANGIOGENESIS_UP vitiligo DOID_12306 0.01685471 0.06227486 0.01685471 0.19180657 LU_TUMOR_ANGIOGENESIS_UP B cell deficiency DOID_2115 0.01685471 0.06187309 0.01685471 0.18804566 LU_TUMOR_ANGIOGENESIS_UP extrinsic allergic alveolitis DOID_841 0.01685471 0.06147647 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP diffuse large B-cell lymphoma DOID_0050745 0.01745161 0.06324818 0.01745161 0.18735782 LU_TUMOR_ANGIOGENESIS_UP sarcoma DOID_1115 0.01804816 0.06499622 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP malaria DOID_12365 0.01804816 0.06458744 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP invasive ductal carcinoma DOID_3008 0.01804816 0.06418377 0.01804816 0.18671642 LU_TUMOR_ANGIOGENESIS_UP age related macular degeneration DOID_10871 0.01983574 0.07010271 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP degeneration of macula and posterior pole DOID_2007 0.01983574 0.07010271 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP bronchiolitis obliterans DOID_2799 0.01983574 0.06966998 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP allergic rhinitis DOID_4481 0.02043091 0.07132017 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP myocarditis DOID_820 0.02162021 0.07501157 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP hepatitis C DOID_1883 0.02221434 0.07660581 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP thyroid carcinoma DOID_3963 0.02221434 0.07614433 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP spindle cell carcinoma DOID_4015 0.02221434 0.07568838 0.02221434 0.20387031 LU_TUMOR_ANGIOGENESIS_UP macular degeneration DOID_4448 0.02221434 0.07523785 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP leukopenia DOID_615 0.02221434 0.07479266 0.02221434 0.20063427 LU_TUMOR_ANGIOGENESIS_UP lymphoid leukemia DOID_10747 0.02280813 0.07634014 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP medullomyoblastoma DOID_3861 0.02280813 0.07589371 0.02280813 0.2027785 LU_TUMOR_ANGIOGENESIS_UP adult medulloblastoma DOID_3864 0.02280813 0.07589371 0.02280813 0.2027785 LU_TUMOR_ANGIOGENESIS_UP childhood medulloblastoma DOID_3869 0.02280813 0.07589371 0.02280813 0.2027785 LU_TUMOR_ANGIOGENESIS_UP thyroid cancer DOID_1781 0.02340157 0.07741565 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP medulloblastoma DOID_3858 0.02399466 0.07891887 0.02399466 0.2100456 LU_TUMOR_ANGIOGENESIS_UP cleft palate DOID_674 0.02399466 0.07846531 0.02399466 0.20686309 LU_TUMOR_ANGIOGENESIS_UP respiratory syncytial virus infectious disease DOID_1273 0.02517982 0.0818704 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP hepatitis DOID_2237 0.02517982 0.08140523 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP lymphatic system disease DOID_75 0.02577189 0.08284861 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP pulmonary emphysema DOID_9675 0.02636361 0.08427468 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP diabetic autonomic neuropathy DOID_11503 0.02813671 0.08944014 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP autonomic neuropathy DOID_11504 0.02813671 0.08944014 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP diabetic polyneuropathy DOID_12785 0.02813671 0.08944014 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP gallbladder cancer DOID_3121 0.02813671 0.08894325 0.02813671 0.21346381 LU_TUMOR_ANGIOGENESIS_UP influenza DOID_8469 0.02813671 0.08845185 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP diabetic neuropathy DOID_9743 0.02813671 0.08944014 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP learning disability DOID_8927 0.02872705 0.0898115 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP leukodystrophy DOID_10579 0.02931705 0.09115521 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP autonomic nervous system disease DOID_11465 0.02990671 0.09248326 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP thyroid adenoma DOID_2891 0.02990671 0.09198335 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP vascular skin disease DOID_9540 0.02990671 0.09148882 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP integumentary system benign neoplasm DOID_0060121 0.03108501 0.09458486 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP pulmonary tuberculosis DOID_2957 0.03108501 0.09408175 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP skin benign neoplasm DOID_3165 0.03108501 0.09458486 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP lung small cell carcinoma DOID_5409 0.03108501 0.09358396 0.03108501 0.22389075 LU_TUMOR_ANGIOGENESIS_UP withdrawal disorder DOID_0060001 0.03226193 0.09661599 1.000 1.000 LU_TUMOR_ANGIOGENESIS_UP B-cell lymphocytic neoplasm DOID_707 0.03226193 0.09611015 0.03226193 0.2266301 LU_TUMOR_ANGIOGENESIS_UP orofacial cleft DOID_0050567 0.03284988 0.09735199 0.03284988 0.22794611 MOREIRA_RESPONSE_TO_TSA_UP pancreatic carcinoma DOID_4905 4.466E-08 2.541E-05 5.943E-04 0.08453968 MOREIRA_RESPONSE_TO_TSA_UP toxic shock syndrome DOID_14115 2.053E-07 5.842E-05 2.053E-07 1.168E-04 MOREIRA_RESPONSE_TO_TSA_UP commensal bacterial infectious disease DOID_0050339 2.321E-07 4.401E-05 2.321E-07 6.602E-05 MOREIRA_RESPONSE_TO_TSA_UP carotid artery disease DOID_3407 3.677E-06 5.23E-04 0.02996145 0.29393213 MOREIRA_RESPONSE_TO_TSA_UP pancreatic ductal carcinoma DOID_3587 5.474E-06 6.23E-04 5.485E-04 0.104027 MOREIRA_RESPONSE_TO_TSA_UP cystic fibrosis DOID_1485 6.686E-06 6.34E-04 6.259E-04 0.07122245 MOREIRA_RESPONSE_TO_TSA_UP nervous system cancer DOID_3093 1.099E-05 8.934E-04 8.69E-04 0.07063565 MOREIRA_RESPONSE_TO_TSA_UP lymphoblastic leukemia DOID_1037 1.21E-05 8.608E-04 9.261E-04 0.06587006 MOREIRA_RESPONSE_TO_TSA_UP hypersensitivity reaction type I disease DOID_1205 1.288E-05 8.146E-04 9.652E-04 0.06102152 MOREIRA_RESPONSE_TO_TSA_UP angiosarcoma DOID_0001816 2.545E-05 1.448E-03 7.571E-03 0.30771684 MOREIRA_RESPONSE_TO_TSA_UP sarcoma DOID_1115 9.189E-05 4.753E-03 0.01415163 0.32209118 MOREIRA_RESPONSE_TO_TSA_UP chronic leukemia DOID_1036 1.255E-04 5.951E-03 0.01649177 0.29324431 MOREIRA_RESPONSE_TO_TSA_UP chronic lymphocytic leukemia DOID_1040 1.255E-04 5.951E-03 0.01649177 0.29324431 MOREIRA_RESPONSE_TO_TSA_UP autonomic nervous system neoplasm DOID_2621 1.255E-04 5.494E-03 0.01649177 0.27599464 MOREIRA_RESPONSE_TO_TSA_UP neuroblastoma DOID_769 1.255E-04 5.494E-03 0.01649177 0.27599464 MOREIRA_RESPONSE_TO_TSA_UP papilloma DOID_2615 1.329E-04 5.4E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP spindle cell carcinoma DOID_4015 1.404E-04 5.326E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP adenoma DOID_657 1.561E-04 5.553E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP peripheral nervous system neoplasm DOID_1192 1.727E-04 5.78E-03 0.01929301 0.27444308 MOREIRA_RESPONSE_TO_TSA_UP nephrotic syndrome DOID_1184 2.177E-04 6.88E-03 0.02162162 0.3000659 MOREIRA_RESPONSE_TO_TSA_UP myeloma DOID_0070004 2.573E-04 7.706E-03 0.02348075 0.30364874 MOREIRA_RESPONSE_TO_TSA_UP integumentary system benign neoplasm DOID_0060121 2.784E-04 7.92E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP skin benign neoplasm DOID_3165 2.784E-04 7.92E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP atrophic muscular disease DOID_913 3.229E-04 8.75E-03 0.02626318 0.30497449 MOREIRA_RESPONSE_TO_TSA_UP muscular dystrophy DOID_9884 3.229E-04 8.75E-03 0.02626318 0.30497449 MOREIRA_RESPONSE_TO_TSA_UP bile duct adenocarcinoma DOID_4896 3.346E-04 8.654E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP cholangiocarcinoma DOID_4947 3.346E-04 8.654E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP bone marrow cancer DOID_4960 3.346E-04 8.278E-03 0.02672619 0.30414406 MOREIRA_RESPONSE_TO_TSA_UP reproductive organ benign neoplasm DOID_0050622 3.464E-04 8.214E-03 0.02718899 0.30334387 MOREIRA_RESPONSE_TO_TSA_UP integumentary system cancer DOID_0060122 3.464E-04 7.885E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP skin cancer DOID_4159 3.464E-04 7.885E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP familial hyperlipidemia DOID_1168 3.585E-04 7.846E-03 0.02765159 0.30257219 MOREIRA_RESPONSE_TO_TSA_UP hypertrophic cardiomyopathy DOID_11984 3.832E-04 8.076E-03 0.02857615 0.30678929 MOREIRA_RESPONSE_TO_TSA_UP bile duct cancer DOID_4606 3.832E-04 7.788E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP bile duct carcinoma DOID_4897 3.832E-04 7.788E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP astrocytoma DOID_3069 5.336E-04 0.01046952 0.03364645 0.31384963 MOREIRA_RESPONSE_TO_TSA_UP nephrosis DOID_2527 5.635E-04 0.01068866 0.03456563 0.31722326 MOREIRA_RESPONSE_TO_TSA_UP pancreatitis DOID_4989 6.582E-04 0.01208128 6.582E-04 0.06241993 MOREIRA_RESPONSE_TO_TSA_UP lipid metabolism disorder DOID_3146 6.914E-04 0.01229312 0.0382341 0.33992507 MOREIRA_RESPONSE_TO_TSA_UP biliary tract cancer DOID_4607 7.426E-04 0.01280358 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP transitional cell carcinoma DOID_2671 8.319E-04 0.01392164 0.04188941 0.35574738 MOREIRA_RESPONSE_TO_TSA_UP lymphoma DOID_0060058 9.069E-04 0.01474319 0.04371214 0.36576776 MOREIRA_RESPONSE_TO_TSA_UP alcohol-related neurodevelopmental disorder DOID_0050667 9.456E-04 0.01494503 0.04462228 0.36797211 MOREIRA_RESPONSE_TO_TSA_UP facioscapulohumeral muscular dystrophy DOID_11727 4.738E-03 0.07286879 4.738E-03 0.26961451 MOREIRA_RESPONSE_TO_TSA_UP insulinoma DOID_3892 4.738E-03 0.07095119 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP breast benign neoplasm DOID_0060082 5.211E-03 0.07602808 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP thoracic benign neoplasm DOID_0060097 5.211E-03 0.07602808 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP migraine without aura DOID_12783 5.211E-03 0.07412737 5.211E-03 0.26955409 MOREIRA_RESPONSE_TO_TSA_UP benign breast phyllodes tumor DOID_1631 5.211E-03 0.07602808 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP intracranial arteriosclerosis DOID_13097 5.684E-03 0.0788762 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP islet cell tumor DOID_1799 5.684E-03 0.07699819 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP aortic valve insufficiency DOID_57 5.684E-03 0.07520754 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP vascular dementia DOID_8725 5.684E-03 0.0788762 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP berylliosis DOID_10322 6.156E-03 0.07960529 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP vulva cancer DOID_1245 6.156E-03 0.07783629 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP newborn respiratory distress syndrome DOID_12716 6.156E-03 0.07614419 6.156E-03 0.29188607 MOREIRA_RESPONSE_TO_TSA_UP viral pneumonia DOID_10533 6.628E-03 0.08023874 6.628E-03 0.29009392 MOREIRA_RESPONSE_TO_TSA_UP mesenchymal cell neoplasm DOID_3350 7.1E-03 0.08416018 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP spindle cell sarcoma DOID_4235 7.1E-03 0.08416018 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP lung oat cell carcinoma DOID_5411 7.1E-03 0.08244262 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP oral submucous fibrosis DOID_5773 7.1E-03 0.08079377 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP epithelioid sarcoma DOID_6193 7.1E-03 0.08416018 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP spastic diplegia DOID_10965 7.571E-03 0.08447129 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP tongue cancer DOID_8649 7.571E-03 0.08284684 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP penile disease DOID_1529 8.043E-03 0.08634458 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP basal cell carcinoma DOID_2513 8.043E-03 0.0847456 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP urinary system benign neoplasm DOID_731 8.043E-03 0.08320477 8.043E-03 0.30508417 MOREIRA_RESPONSE_TO_TSA_UP male reproductive organ benign neoplasm DOID_0060087 8.514E-03 0.08650659 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP keratosis DOID_161 8.514E-03 0.08498893 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP skin carcinoma DOID_3451 8.514E-03 0.08352361 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP osteosclerosis DOID_4254 8.514E-03 0.08210795 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP ureteral obstruction DOID_5199 8.514E-03 0.08073949 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP conduct disorder DOID_12995 8.985E-03 0.0838091 8.985E-03 0.31952221 MOREIRA_RESPONSE_TO_TSA_UP infertility DOID_5223 8.985E-03 0.08245734 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP pulmonary edema DOID_11396 9.456E-03 0.08540034 9.456E-03 0.31648361 MOREIRA_RESPONSE_TO_TSA_UP colon carcinoma DOID_1520 9.456E-03 0.08406596 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP subependymal glioma DOID_4843 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP pilocytic astrocytoma DOID_4851 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP subependymal giant cell astrocytoma DOID_5077 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP fibrillary astrocytoma DOID_6726 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP juvenile pilocytic astrocytoma DOID_6811 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP childhood pilocytic astrocytoma DOID_6812 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP gemistocytic astrocytoma DOID_7005 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP childhood cerebral astrocytoma DOID_7007 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP protoplasmic astrocytoma DOID_7008 9.456E-03 0.08277264 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP autoimmune hepatitis DOID_2048 9.926E-03 0.08557526 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP coronary restenosis DOID_4247 9.926E-03 0.08429802 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP benign glioma DOID_0060101 0.01039647 0.08699401 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP benign ependymoma DOID_4844 0.01039647 0.08699401 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP muscular atrophy DOID_767 0.01039647 0.08573323 0.01039647 0.32864404 MOREIRA_RESPONSE_TO_TSA_UP placenta disease DOID_780 0.01039647 0.08450847 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP optic nerve disease DOID_1891 0.01086661 0.08708589 0.01086661 0.32542623 MOREIRA_RESPONSE_TO_TSA_UP IgA glomerulonephritis DOID_2986 0.01086661 0.08587637 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP uremia DOID_4676 0.01086661 0.08469998 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP urinary tract obstruction DOID_5200 0.01086661 0.08355538 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP ureteral disease DOID_1426 0.01133653 0.08600645 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP aortic valve disease DOID_62 0.01133653 0.08487479 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP Goodpasture syndrome DOID_9808 0.01133653 0.08377252 0.01133653 0.3225242 MOREIRA_RESPONSE_TO_TSA_UP spastic quadriplegia DOID_10970 0.01180624 0.08612499 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP acute pancreatitis DOID_2913 0.01180624 0.0850348 0.01180624 0.31989283 MOREIRA_RESPONSE_TO_TSA_UP urticaria DOID_1555 0.01227574 0.08731119 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP osteosarcoma DOID_3347 0.01227574 0.08623327 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP cystitis DOID_1679 0.01274503 0.08843806 0.01274503 0.32963277 MOREIRA_RESPONSE_TO_TSA_UP papillary adenoma DOID_3172 0.01274503 0.08737254 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP microcystic adenoma DOID_5403 0.01274503 0.08737254 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP follicular adenoma DOID_6204 0.01274503 0.08737254 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP Sciatic Neuropathy DOID_11446 0.01368298 0.09268587 0.01368298 0.33850492 MOREIRA_RESPONSE_TO_TSA_UP lesion of sciatic nerve DOID_12528 0.01368298 0.09268587 0.01368298 0.33850492 MOREIRA_RESPONSE_TO_TSA_UP migraine DOID_6364 0.01368298 0.09159545 0.01368298 0.32440055 MOREIRA_RESPONSE_TO_TSA_UP mononeuritis of lower limb DOID_9473 0.01368298 0.09268587 0.01368298 0.33850492 MOREIRA_RESPONSE_TO_TSA_UP autoimmune disease of cardiovascular system DOID_0060051 0.01415163 0.09363116 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP Behcet's disease DOID_13241 0.01415163 0.09363116 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP mononeuritis DOID_1802 0.01415163 0.09255494 0.01415163 0.30970306 MOREIRA_RESPONSE_TO_TSA_UP coronary stenosis DOID_4248 0.01415163 0.09150318 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP mononeuropathy DOID_1188 0.01462008 0.09346996 0.01462008 0.30810468 MOREIRA_RESPONSE_TO_TSA_UP multiple epiphyseal dysplasia DOID_12721 0.01462008 0.0924314 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP supratentorial cancer DOID_1659 0.01462008 0.09141567 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP cerebrum cancer DOID_368 0.01462008 0.09141567 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP focal glomerulosclerosis DOID_3945 0.01462008 0.09042203 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP cranial nerve disease DOID_5656 0.01462008 0.08944975 0.01462008 0.29710094 MOREIRA_RESPONSE_TO_TSA_UP female reproductive organ benign neoplasm DOID_0060086 0.01508832 0.09133248 0.01508832 0.29604322 MOREIRA_RESPONSE_TO_TSA_UP uterine benign neoplasm DOID_0060095 0.01508832 0.09133248 0.01508832 0.29604322 MOREIRA_RESPONSE_TO_TSA_UP uterine fibroid DOID_13223 0.01508832 0.09133248 0.01508832 0.29604322 MOREIRA_RESPONSE_TO_TSA_UP endometrial carcinoma DOID_2871 0.01508832 0.09037109 0.01508832 0.28617512 MOREIRA_RESPONSE_TO_TSA_UP spastic cerebral palsy DOID_0050669 0.01555635 0.09220376 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP endometrial cancer DOID_1380 0.01602416 0.09399741 0.01602416 0.29412094 MOREIRA_RESPONSE_TO_TSA_UP leiomyoma DOID_127 0.01649177 0.09575324 0.01649177 0.28435811 MOREIRA_RESPONSE_TO_TSA_UP bladder disease DOID_365 0.01649177 0.09478604 0.01649177 0.26810908 MOREIRA_RESPONSE_TO_TSA_UP myocarditis DOID_820 0.01695917 0.09649767 0.01695917 0.26804908 MOREIRA_RESPONSE_TO_TSA_UP pneumoconiosis DOID_10316 0.01742636 0.09817423 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP thyroid carcinoma DOID_3963 0.01742636 0.09721173 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_UP medullomyoblastoma DOID_3861 0.01789333 0.09884764 0.01789333 0.27517047 MOREIRA_RESPONSE_TO_TSA_UP adult medulloblastoma DOID_3864 0.01789333 0.09884764 0.01789333 0.27517047 MOREIRA_RESPONSE_TO_TSA_UP childhood medulloblastoma DOID_3869 0.01789333 0.09884764 0.01789333 0.27517047 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN epidermolysis bullosa DOID_2730 3.596E-16 2.046E-13 3.596E-16 2.046E-13 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN vesiculobullous skin disease DOID_2731 7.775E-16 2.212E-13 7.775E-16 2.212E-13 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN oral cavity cancer DOID_8618 2.785E-12 5.283E-10 1.795E-10 3.404E-08 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN lung adenocarcinoma DOID_3910 9.533E-09 1.356E-06 2.364E-03 0.05605021 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN endocrine organ benign neoplasm DOID_0060089 2.486E-08 2.829E-06 0.16173889 0.58617469 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pancreatitis DOID_4989 5.123E-08 4.858E-06 1.056E-03 0.03338927 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN tongue cancer DOID_8649 6.304E-08 5.124E-06 8.075E-06 6.564E-04 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN benign mesothelioma DOID_2645 8.466E-08 6.021E-06 0.10353423 0.43963417 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN bone marrow cancer DOID_4960 3.182E-07 2.012E-05 0.1320414 0.50764566 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN congenital heart defect DOID_1682 6.673E-07 3.797E-05 6.673E-07 9.492E-05 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN mixed glioma DOID_5076 1.747E-06 9.035E-05 0.01695581 0.22436879 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN spindle cell carcinoma DOID_4015 2.198E-06 1.042E-04 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hyperthyroidism DOID_7998 2.198E-06 9.621E-05 3.829E-03 0.07780088 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN multiple myeloma DOID_9538 3.024E-06 1.229E-04 0.09457786 0.42373862 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hepatitis DOID_2237 3.69E-06 1.4E-04 0.09906706 0.4336089 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN adenoid cystic carcinoma DOID_4866 4.061E-06 1.444E-04 4.061E-06 4.621E-04 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pulmonary emphysema DOID_9675 4.459E-06 1.492E-04 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN salivary gland cancer DOID_8850 4.884E-06 1.544E-04 4.884E-06 4.632E-04 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN myeloma DOID_0070004 7.478E-06 2.24E-04 0.11680469 0.47136076 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN neuritis DOID_1803 7.478E-06 2.128E-04 2.659E-04 0.01512891 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN aortic aneurysm DOID_3627 9.455E-06 2.562E-04 3.161E-04 0.0163501 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN sarcoidosis DOID_11335 1.179E-05 3.05E-04 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hypersensitivity reaction type IV disease DOID_2916 1.66E-05 4.106E-04 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN cholestasis DOID_13580 2.556E-05 6.059E-04 0.01245982 0.1865694 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN nephrosis DOID_2527 3.57E-05 8.126E-04 8.424E-04 0.03195393 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN bile duct disease DOID_4138 3.57E-05 7.813E-04 0.01463245 0.20306982 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN biliary tract disease DOID_9741 3.764E-05 7.933E-04 0.01500934 0.20334081 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN aneurysm disease DOID_2403 4.618E-05 9.385E-04 1.018E-03 0.03408849 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN biliary tract cancer DOID_4607 6.153E-05 1.207E-03 0.01900361 0.24029007 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pneumoconiosis DOID_10316 1.079E-04 2.046E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN thyroid carcinoma DOID_3963 1.079E-04 1.98E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN thyroid cancer DOID_1781 1.264E-04 2.248E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pulmonary sarcoidosis DOID_13406 1.365E-04 2.353E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN uveitis DOID_13141 1.47E-04 2.459E-03 0.09682522 0.43041837 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN intracranial arterial disease DOID_13089 1.695E-04 2.756E-03 1.695E-04 0.01205775 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN cerebral arterial disease DOID_3527 1.695E-04 2.756E-03 1.695E-04 0.01205775 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN uveal disease DOID_3480 2.074E-04 3.278E-03 0.10797949 0.44846957 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN cerebral infarction DOID_3526 2.355E-04 3.621E-03 2.355E-04 0.01488719 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pre-eclampsia DOID_10591 2.659E-04 3.981E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN thyroid adenoma DOID_2891 2.659E-04 3.879E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN lung small cell carcinoma DOID_5409 2.987E-04 4.249E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN breast benign neoplasm DOID_0060082 3.297E-04 4.576E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN thoracic benign neoplasm DOID_0060097 3.297E-04 4.576E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN benign breast phyllodes tumor DOID_1631 3.297E-04 4.576E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN giant cell tumor DOID_200 3.72E-04 5.04E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN malignant giant cell tumor DOID_2705 3.72E-04 5.04E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN giant cell glioblastoma DOID_3074 3.72E-04 5.04E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN bile duct adenocarcinoma DOID_4896 3.92E-04 5.187E-03 0.1320414 0.51109903 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN cholangiocarcinoma DOID_4947 3.92E-04 5.187E-03 0.1320414 0.51109903 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN aortic valve stenosis DOID_1712 3.95E-04 5.108E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN integumentary system cancer DOID_0060122 4.126E-04 5.217E-03 9.187E-03 0.14935796 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN skin cancer DOID_4159 4.126E-04 5.217E-03 9.187E-03 0.14935796 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN glioblastoma DOID_3068 4.787E-04 5.921E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN bile duct cancer DOID_4606 4.787E-04 5.795E-03 0.14063103 0.52644115 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN bile duct carcinoma DOID_4897 4.787E-04 5.795E-03 0.14063103 0.52644115 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN respiratory failure DOID_11162 5.768E-04 6.838E-03 0.01143157 0.18068234 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN thoracic aortic aneurysm DOID_14004 6.254E-04 7.262E-03 6.254E-04 0.0296538 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN nutritional deficiency disease DOID_5113 6.254E-04 7.117E-03 0.03656036 0.31519465 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN varicose veins DOID_799 6.254E-04 6.977E-03 0.03656036 0.31049025 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN vein disease DOID_866 7.136E-04 7.808E-03 0.03895015 0.31214979 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN brain infarction DOID_3454 7.467E-04 8.017E-03 7.467E-04 0.03268301 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN astrocytoma DOID_3069 7.778E-04 8.196E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN basal cell carcinoma DOID_2513 8.074E-04 8.353E-03 8.074E-04 0.03281559 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pancreatic ductal carcinoma DOID_3587 8.097E-04 8.227E-03 0.16589849 0.59744457 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN male reproductive system disease DOID_48 8.424E-04 8.409E-03 0.16797063 0.60110244 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN skin carcinoma DOID_3451 9.069E-04 8.897E-03 9.069E-04 0.03225072 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pancreatic carcinoma DOID_4905 9.103E-04 8.779E-03 0.17209964 0.60822791 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN microphthalmia DOID_10629 1.123E-03 0.01064555 1.123E-03 0.03361753 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN brain edema DOID_4724 1.123E-03 0.01047104 0.04845079 0.34035182 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN focal epilepsy DOID_2234 1.258E-03 0.0115497 1.258E-03 0.03580407 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN muscular atrophy DOID_767 1.36E-03 0.01228671 1.36E-03 0.03686013 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hypoglycemia DOID_9993 1.488E-03 0.01322526 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN Lewy body dementia DOID_12217 1.62E-03 0.0141827 0.05785849 0.36579424 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN aortic valve disease DOID_62 1.62E-03 0.01396781 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN Goodpasture syndrome DOID_9808 1.62E-03 0.01375933 0.05785849 0.36177453 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hypersensitivity reaction type I disease DOID_1205 1.839E-03 0.01538637 0.02431541 0.29437163 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN osteosarcoma DOID_3347 1.902E-03 0.01568183 0.06252778 0.37450848 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN myositis DOID_633 2.05E-03 0.01666754 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN middle cerebral artery infarction DOID_3525 2.205E-03 0.01766834 2.205E-03 0.05702056 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hypotrichosis DOID_4535 2.205E-03 0.01742295 2.205E-03 0.0545414 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN extrinsic allergic alveolitis DOID_841 2.205E-03 0.01718428 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN migraine DOID_6364 2.364E-03 0.01817845 2.364E-03 0.05380821 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN perinatal necrotizing enterocolitis DOID_8677 2.364E-03 0.01793607 0.06948881 0.39147656 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN endometrial cancer DOID_1380 3.241E-03 0.02426132 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN germinoma DOID_3304 3.241E-03 0.02394624 0.08097706 0.40066043 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pleural disease DOID_1532 3.431E-03 0.02503159 0.08325782 0.40490341 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hair disease DOID_421 3.627E-03 0.02612646 3.627E-03 0.07938425 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN metal metabolism disorder DOID_896 3.627E-03 0.02579988 0.08553297 0.40556885 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN nephroblastoma DOID_2154 3.829E-03 0.02689413 3.829E-03 0.0806824 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN systemic scleroderma DOID_418 4.91E-03 0.03406948 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN adult respiratory distress syndrome DOID_11394 5.141E-03 0.03524422 0.10130339 0.43667902 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN nephrotic syndrome DOID_1184 5.864E-03 0.03972336 5.864E-03 0.11506077 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN Huntington's disease DOID_12858 5.864E-03 0.03925603 5.864E-03 0.11122541 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN rheumatic disease DOID_1575 5.864E-03 0.03879956 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN scleroderma DOID_419 5.864E-03 0.03879956 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN gallbladder cancer DOID_3121 6.115E-03 0.03999391 0.11019394 0.45435036 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN uterine cancer DOID_363 6.115E-03 0.03953943 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN influenza DOID_8469 6.115E-03 0.03909517 0.11019394 0.45108165 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN cataract DOID_83 6.371E-03 0.04027696 6.371E-03 0.1169331 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN leukodystrophy DOID_10579 6.631E-03 0.04146281 0.11460652 0.46579365 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN lens disease DOID_110 6.896E-03 0.04265245 6.896E-03 0.12262579 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN heart valve disease DOID_4079 6.896E-03 0.04219382 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN glaucoma DOID_1686 7.441E-03 0.04504199 7.441E-03 0.12830142 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN withdrawal disorder DOID_0060001 8.005E-03 0.04794293 8.005E-03 0.1339582 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN vasculitis DOID_865 8.885E-03 0.05266005 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN leukocyte disease DOID_9500 0.01044287 0.06125767 0.14276526 0.53093747 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN collagen disease DOID_854 0.01109758 0.06443391 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN pre-malignant neoplasm DOID_0060071 0.01176996 0.06764754 0.01176996 0.18100287 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN in situ carcinoma DOID_8719 0.01176996 0.06764754 0.01176996 0.18100287 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN mineral metabolism disease DOID_0050032 0.01211271 0.06892135 0.15335801 0.56297232 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN endocrine pancreas disease DOID_1428 0.01211271 0.06823896 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN cerebral degeneration DOID_1443 0.01245982 0.06950625 0.15546097 0.56703393 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN temporal lobe epilepsy DOID_3328 0.01281125 0.07077281 0.01281125 0.18691282 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN hyperglycemia DOID_4195 0.01281125 0.07009231 0.01281125 0.18224 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN diabetic retinopathy DOID_8947 0.0153904 0.08340129 0.17209964 0.60447342 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN bone resorption disease DOID_0080011 0.01655832 0.08888384 0.17825517 0.6222527 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN osteoporosis DOID_11476 0.01655832 0.08888384 0.17825517 0.6222527 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP transitional cell carcinoma DOID_2671 3.971E-27 2.26E-24 4.681E-06 8.879E-04 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP reproductive organ benign neoplasm DOID_0050622 6.288E-18 1.789E-15 1.874E-05 2.666E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pre-malignant neoplasm DOID_0060071 2.353E-15 4.462E-13 2.606E-08 1.483E-05 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP in situ carcinoma DOID_8719 2.353E-15 4.462E-13 2.606E-08 1.483E-05 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP biliary tract cancer DOID_4607 3.346E-14 4.759E-12 0.20487516 0.6980477 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bile duct adenocarcinoma DOID_4896 4.161E-14 4.735E-12 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cholangiocarcinoma DOID_4947 4.161E-14 4.735E-12 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bile duct cancer DOID_4606 7.95E-14 7.539E-12 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bile duct carcinoma DOID_4897 7.95E-14 7.539E-12 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mixed glioma DOID_5076 1.019E-12 8.286E-11 0.19406825 0.67332216 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP endometrial carcinoma DOID_2871 2.636E-12 1.875E-10 8.861E-05 7.203E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP endometrial cancer DOID_1380 4.195E-12 2.652E-10 1.065E-04 7.574E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mouth disease DOID_403 5.501E-12 3.13E-10 2.253E-03 0.04748979 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP testicular cancer DOID_2998 8.617E-12 4.457E-10 1.19E-03 0.03076904 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP diabetic autonomic neuropathy DOID_11503 4.766E-11 2.26E-09 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP autonomic neuropathy DOID_11504 4.766E-11 2.26E-09 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP diabetic polyneuropathy DOID_12785 4.766E-11 2.26E-09 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP uterine cancer DOID_363 4.766E-11 2.086E-09 2.813E-04 0.01455194 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP diabetic neuropathy DOID_9743 4.766E-11 2.26E-09 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP autonomic nervous system disease DOID_11465 7.52E-11 3.056E-09 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP brain cancer DOID_1319 7.52E-11 2.853E-09 8.073E-03 0.10682292 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP central nervous system cancer DOID_3620 8.697E-11 3.093E-09 8.388E-03 0.10846693 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP nervous system cancer DOID_3093 1.604E-10 5.368E-09 0.02564642 0.23536792 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hypersensitivity reaction type I disease DOID_1205 2.463E-10 7.785E-09 2.321E-03 0.04716364 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP tuberculosis DOID_399 9.562E-10 2.863E-08 0.01578874 0.17276526 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP astrocytoma DOID_3069 1.057E-09 3.007E-08 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cleft palate DOID_674 1.165E-09 3.156E-08 1.738E-04 0.01098613 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cervix uteri carcinoma in situ DOID_8991 2.123E-09 5.492E-08 2.311E-04 0.01315098 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP gallbladder cancer DOID_3121 3.209E-09 7.939E-08 0.11900336 0.48023343 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP placenta disease DOID_780 3.242E-09 7.687E-08 1.599E-03 0.03638543 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP primary bacterial infectious disease DOID_0050338 4.762E-09 1.084E-07 0.02411693 0.22495959 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lymphoma DOID_0060058 6.997E-09 1.531E-07 0.02668749 0.22664453 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.112E-09 1.71E-07 0.02774546 0.22553097 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP orofacial cleft DOID_0050567 8.514E-09 1.73E-07 4.481E-04 0.01821268 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cleft lip DOID_9296 9.834E-09 1.929E-07 5.277E-05 5.004E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP periodontitis DOID_824 1.44E-08 2.732E-07 0.07518254 0.37525322 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP neuroectodermal tumor DOID_171 2.159E-08 3.964E-07 0.15849931 0.57811608 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP peritonitis DOID_8283 2.404E-08 4.275E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP female reproductive organ benign neoplasm DOID_0060086 2.427E-08 4.185E-07 0.08263306 0.38858023 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP uterine benign neoplasm DOID_0060095 2.427E-08 4.185E-07 0.08263306 0.38858023 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP uterine fibroid DOID_13223 2.427E-08 4.185E-07 0.08263306 0.38858023 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP uterine disease DOID_345 3.125E-08 5.23E-07 0.01454912 0.165569 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP allergic rhinitis DOID_4481 3.339E-08 5.429E-07 3.802E-03 0.06362293 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP leiomyoma DOID_127 3.887E-08 6.144E-07 0.09002413 0.41309459 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP periodontal disease DOID_3388 5.198E-08 7.993E-07 0.09491872 0.43207001 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP male reproductive system disease DOID_48 5.221E-08 7.818E-07 4.917E-05 5.596E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP diabetic retinopathy DOID_8947 6.135E-08 8.951E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP oral submucous fibrosis DOID_5773 6.589E-08 9.373E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP varicose veins DOID_799 6.589E-08 9.144E-07 0.03961357 0.27156772 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP aneurysm disease DOID_2403 7.75E-08 1.05E-06 0.19188948 0.66984732 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP vein disease DOID_866 8.767E-08 1.16E-06 0.04219852 0.26385669 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP female reproductive system disease DOID_229 1.043E-07 1.349E-06 0.02117627 0.20774654 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP intracranial arterial disease DOID_13089 1.133E-07 1.433E-06 0.10944662 0.45790535 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cerebral arterial disease DOID_3527 1.133E-07 1.433E-06 0.10944662 0.45790535 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP benign mesothelioma DOID_2645 1.276E-07 1.578E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP retinal vascular disease DOID_2462 1.384E-07 1.675E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP leishmaniasis DOID_9065 1.856E-07 2.2E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Human immunodeficiency virus infectious disease DOID_526 1.933E-07 2.244E-06 0.02564642 0.23163192 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP encephalomyelitis DOID_640 2.34E-07 2.663E-06 0.02721438 0.22442003 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pre-eclampsia DOID_10591 2.457E-07 2.742E-06 0.12610421 0.49485031 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP glaucoma DOID_1686 3.001E-07 3.284E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pulmonary tuberculosis DOID_2957 3.001E-07 3.222E-06 0.13080659 0.49952317 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lung small cell carcinoma DOID_5409 3.001E-07 3.163E-06 8.708E-03 0.11010678 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP calcium metabolism disease DOID_10575 3.307E-07 3.421E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP integumentary system cancer DOID_0060122 5.225E-07 5.309E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP parasitic protozoa infectious disease DOID_2789 5.225E-07 5.215E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP skin cancer DOID_4159 5.225E-07 5.309E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hypertrophic cardiomyopathy DOID_11984 6.74E-07 6.612E-06 0.01183089 0.14634301 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP oral cavity cancer DOID_8618 6.74E-07 6.5E-06 6.076E-04 0.02033648 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP carotid artery disease DOID_3407 8.583E-07 8.14E-06 0.15849931 0.57443381 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP intracranial aneurysm DOID_10941 9.621E-07 8.974E-06 0.07268575 0.37598356 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mineral metabolism disease DOID_0050032 1.08E-06 9.914E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP parasitic infectious disease DOID_1398 1.164E-06 1.051E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP sarcoma DOID_1115 1.282E-06 1.14E-05 0.07767268 0.38099789 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP tooth disease DOID_1091 1.345E-06 1.178E-05 0.17201622 0.60793311 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP endocrine organ benign neoplasm DOID_0060089 1.444E-06 1.245E-05 0.01578874 0.17615281 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP supratentorial cancer DOID_1659 1.469E-06 1.248E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP toxic encephalopathy DOID_3602 1.469E-06 1.23E-05 0.08015618 0.38007388 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cerebrum cancer DOID_368 1.469E-06 1.248E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP biliary tract disease DOID_9741 1.898E-06 1.565E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pancreatic carcinoma DOID_4905 2.027E-06 1.648E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP facioscapulohumeral muscular dystrophy DOID_11727 2.238E-06 1.794E-05 3.181E-04 0.01508117 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cutaneous leishmaniasis DOID_9111 2.238E-06 1.769E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP metabolic syndrome X DOID_14221 2.956E-06 2.304E-05 0.02070181 0.2103452 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP male infertility DOID_12336 3.046E-06 2.342E-05 3.046E-06 8.667E-04 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP medullomyoblastoma DOID_3861 3.398E-06 2.578E-05 0.09735623 0.42942399 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP adult medulloblastoma DOID_3864 3.398E-06 2.578E-05 0.09735623 0.42942399 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP childhood medulloblastoma DOID_3869 3.398E-06 2.578E-05 0.09735623 0.42942399 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pituitary cancer DOID_1785 4.087E-06 3.06E-05 4.648E-04 0.01763316 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pituitary carcinoma DOID_4916 4.087E-06 3.06E-05 4.648E-04 0.01763316 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP retinal detachment DOID_5327 4.087E-06 3.02E-05 0.03181719 0.24464837 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP calcinosis DOID_182 4.189E-06 3.056E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP medulloblastoma DOID_3858 4.189E-06 3.017E-05 0.10221177 0.44737305 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP larynx cancer DOID_2596 5.303E-06 3.772E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP laryngeal benign neoplasm DOID_2598 5.303E-06 3.772E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Leydig cell tumor DOID_2696 5.303E-06 3.725E-05 0.03442292 0.25111078 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP sex cord-stromal neoplasm DOID_4757 5.303E-06 3.725E-05 0.03442292 0.25111078 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lymphoblastic leukemia DOID_1037 6.106E-06 4.237E-05 0.02721438 0.22772032 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP dilated cardiomyopathy DOID_12930 6.763E-06 4.636E-05 0.23022981 0.77059272 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP primitive neuroectodermal tumor DOID_168 7.388E-06 5.005E-05 0.11662374 0.48086166 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP influenza DOID_8469 8.059E-06 5.395E-05 7.161E-03 0.09938264 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mesenchymal cell neoplasm DOID_3350 8.403E-06 5.56E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP spindle cell sarcoma DOID_4235 8.403E-06 5.56E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP epithelioid sarcoma DOID_6193 8.403E-06 5.56E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pituitary adenoma DOID_3829 1.032E-05 6.751E-05 8.393E-04 0.02387691 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP tongue cancer DOID_8649 1.032E-05 6.674E-05 0.04219852 0.26678844 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP neuritis DOID_1803 1.034E-05 6.611E-05 0.12610421 0.48811766 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP male reproductive organ benign neoplasm DOID_0060087 1.498E-05 9.472E-05 1.066E-03 0.0288918 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP ureteral obstruction DOID_5199 1.498E-05 9.368E-05 0.04734778 0.28968695 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP atopic dermatitis DOID_3310 1.516E-05 9.374E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP giant cell tumor DOID_200 1.629E-05 9.966E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP malignant giant cell tumor DOID_2705 1.629E-05 9.966E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP giant cell glioblastoma DOID_3074 1.629E-05 9.966E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP atrophic muscular disease DOID_913 1.629E-05 9.86E-05 4.726E-04 0.01680535 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP muscular dystrophy DOID_9884 1.629E-05 9.86E-05 4.726E-04 0.01680535 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP subependymal glioma DOID_4843 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pilocytic astrocytoma DOID_4851 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP subependymal giant cell astrocytoma DOID_5077 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP fibrillary astrocytoma DOID_6726 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP juvenile pilocytic astrocytoma DOID_6811 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP childhood pilocytic astrocytoma DOID_6812 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP gemistocytic astrocytoma DOID_7005 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP childhood cerebral astrocytoma DOID_7007 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP protoplasmic astrocytoma DOID_7008 2.085E-05 1.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP glioblastoma DOID_3068 2.291E-05 1.358E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mitochondrial myopathy DOID_699 2.428E-05 1.424E-04 0.05502031 0.32954271 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP melancholia DOID_2848 2.444E-05 1.419E-04 0.01220402 0.14774648 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP neurotic disorder DOID_4964 2.604E-05 1.497E-04 0.01258225 0.14915211 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP benign glioma DOID_0060101 2.806E-05 1.596E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hepatitis B DOID_2043 2.806E-05 1.581E-04 0.0575642 0.33767041 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP benign ependymoma DOID_4844 2.806E-05 1.596E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP urinary tract obstruction DOID_5200 3.22E-05 1.796E-04 0.06010131 0.33859053 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cholestasis DOID_13580 3.523E-05 1.946E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP synostosis DOID_11971 3.673E-05 2.01E-04 1.903E-03 0.04165516 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP ureteral disease DOID_1426 3.673E-05 1.99E-04 0.06263165 0.34599427 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP meningitis DOID_9471 3.673E-05 1.972E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP brain infarction DOID_3454 4.178E-05 2.222E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pancreatic ductal carcinoma DOID_3587 4.661E-05 2.456E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP osteosarcoma DOID_3347 4.7E-05 2.453E-04 0.06767212 0.35653182 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP nephrosis DOID_2527 4.917E-05 2.543E-04 0.01707203 0.18328273 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bile duct disease DOID_4138 4.917E-05 2.521E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP spinal cord disease DOID_319 5.899E-05 2.997E-04 2.589E-03 0.05079064 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP seminoma DOID_4440 5.899E-05 2.97E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP endogenous depression DOID_1595 6.046E-05 3.017E-04 0.01884968 0.19861983 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Sciatic Neuropathy DOID_11446 6.566E-05 3.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP gestational diabetes DOID_11714 6.566E-05 3.221E-04 0.07518254 0.37857405 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lesion of sciatic nerve DOID_12528 6.566E-05 3.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lung adenocarcinoma DOID_3910 6.566E-05 3.193E-04 2.776E-03 0.05264222 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mononeuritis of lower limb DOID_9473 6.566E-05 3.249E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mononeuritis DOID_1802 7.282E-05 3.511E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mononeuropathy DOID_1188 8.046E-05 3.847E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mental depression DOID_1596 8.459E-05 4.011E-04 0.02213872 0.21350728 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bone development disease DOID_0080006 8.853E-05 4.163E-04 0.02262664 0.21457601 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP dysostosis DOID_1934 8.861E-05 4.133E-04 3.373E-03 0.06191119 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP gonadal disease DOID_2277 9.728E-05 4.5E-04 3.584E-03 0.06373431 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP germinoma DOID_3304 1.065E-04 4.886E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP chronic leukemia DOID_1036 1.162E-04 5.291E-04 0.09002413 0.41645308 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP chronic lymphocytic leukemia DOID_1040 1.162E-04 5.291E-04 0.09002413 0.41645308 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP papilloma DOID_2615 1.266E-04 5.715E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP myocarditis DOID_820 1.266E-04 5.67E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pneumoconiosis DOID_10316 1.375E-04 6.111E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP spindle cell carcinoma DOID_4015 1.375E-04 6.063E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP aplastic anemia DOID_12449 1.49E-04 6.52E-04 0.09735623 0.43277887 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP adenoma DOID_657 1.611E-04 6.995E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP refractive error DOID_9835 1.611E-04 6.942E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP respiratory syncytial virus infectious disease DOID_1273 2.011E-04 8.604E-04 0.10704144 0.45452672 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hepatitis DOID_2237 2.011E-04 8.54E-04 5.754E-03 0.09094083 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP congenital diaphragmatic hernia DOID_3827 2.011E-04 8.477E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pulmonary emphysema DOID_9675 2.311E-04 9.67E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP nephrotic syndrome DOID_1184 2.639E-04 1.096E-03 6.868E-03 0.10020792 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cerebral infarction DOID_3526 2.995E-04 1.235E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP brachydactyly DOID_0050581 3.181E-04 1.302E-03 0.02658482 0.23635562 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP rectal neoplasm DOID_1984 3.181E-04 1.293E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP rectum cancer DOID_1993 3.181E-04 1.293E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP chondrosarcoma DOID_3371 3.181E-04 1.284E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 3.181E-04 1.274E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 3.181E-04 1.274E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Hodgkin's granuloma DOID_8651 3.181E-04 1.274E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 3.181E-04 1.274E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP visceral leishmaniasis DOID_9146 3.181E-04 1.266E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP leukodystrophy DOID_10579 3.184E-04 1.258E-03 7.763E-03 0.10517487 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP myeloma DOID_0070004 3.381E-04 1.327E-03 0.12610421 0.49828677 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP heart valve disease DOID_4079 3.381E-04 1.318E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bone marrow disease DOID_4961 3.381E-04 1.309E-03 0.12610421 0.48481956 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP integumentary system benign neoplasm DOID_0060121 3.797E-04 1.46E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP skin benign neoplasm DOID_3165 3.797E-04 1.46E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP breast benign neoplasm DOID_0060082 3.881E-04 1.482E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thoracic benign neoplasm DOID_0060097 3.881E-04 1.482E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP adrenoleukodystrophy DOID_10588 3.881E-04 1.472E-03 0.02920449 0.23404726 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP benign breast phyllodes tumor DOID_1631 3.881E-04 1.482E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP prostatic adenoma DOID_2883 3.881E-04 1.462E-03 3.881E-04 0.01698478 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP intracranial arteriosclerosis DOID_13097 4.648E-04 1.74E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP aortic valve insufficiency DOID_57 4.648E-04 1.729E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Hodgkin's lymphoma DOID_8567 4.648E-04 1.718E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP vascular dementia DOID_8725 4.648E-04 1.74E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP ocular hypertension DOID_9282 4.648E-04 1.706E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP borderline glaucoma DOID_9283 4.648E-04 1.706E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bone marrow cancer DOID_4960 4.978E-04 1.816E-03 0.14245322 0.53679392 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pustulosis of palm and sole DOID_4398 5.24E-04 1.899E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP vulva cancer DOID_1245 5.484E-04 1.975E-03 0.03442292 0.25771896 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Lynch syndrome DOID_3883 5.484E-04 1.963E-03 0.03442292 0.24793216 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mitochondrial metabolism disease DOID_700 5.51E-04 1.959E-03 0.14706848 0.54338939 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP leukocyte disease DOID_9500 6.372E-04 2.252E-03 0.1539453 0.56512822 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP tethered spinal cord syndrome DOID_1089 6.387E-04 2.243E-03 0.03702171 0.26006606 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP parasitic helminthiasis infectious disease DOID_883 6.387E-04 2.229E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP collagen disease DOID_854 6.993E-04 2.426E-03 6.993E-04 0.02210517 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP skeletal system cancer DOID_0060124 7.356E-04 2.537E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Ehlers-Danlos syndrome DOID_13359 7.356E-04 2.522E-03 7.356E-04 0.02203053 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thoracic aortic aneurysm DOID_14004 7.356E-04 2.506E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bone cancer DOID_184 7.356E-04 2.537E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lung oat cell carcinoma DOID_5411 7.356E-04 2.492E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP intermediate coronary syndrome DOID_8805 7.356E-04 2.477E-03 0.03961357 0.26833477 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cerebral degeneration DOID_1443 8.346E-04 2.794E-03 0.01454912 0.16894796 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP angiosarcoma DOID_0001816 8.393E-04 2.793E-03 0.04219852 0.2791972 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thyroiditis DOID_7166 8.393E-04 2.776E-03 0.04219852 0.27285181 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP autoimmune thyroiditis DOID_7188 8.393E-04 2.776E-03 0.04219852 0.27285181 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP chronic myeloid leukemia DOID_8552 8.393E-04 2.76E-03 0.04219852 0.26978606 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Barrett's esophagus DOID_9206 8.393E-04 2.744E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hyperglycemia DOID_4195 8.709E-04 2.832E-03 0.16977843 0.60377454 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lymphatic system cancer DOID_0060073 9.495E-04 3.07E-03 0.04477659 0.27693346 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP basal cell carcinoma DOID_2513 9.495E-04 3.052E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bronchitis DOID_6132 9.495E-04 3.035E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP reticulosarcoma DOID_8538 9.495E-04 3.07E-03 0.04477659 0.27693346 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lymphosarcoma DOID_8675 9.495E-04 3.07E-03 0.04477659 0.27693346 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP blood coagulation disease DOID_1247 1.026E-03 3.261E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP neuroendocrine tumor DOID_169 1.066E-03 3.371E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP skin carcinoma DOID_3451 1.066E-03 3.352E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP peripheral vascular disease DOID_341 1.109E-03 3.468E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP dissociative disorder DOID_10935 1.19E-03 3.699E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP dissociative amnesia DOID_11037 1.19E-03 3.699E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Down syndrome DOID_14250 1.19E-03 3.679E-03 0.04991212 0.30212762 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP granulosa cell tumor DOID_2999 1.19E-03 3.659E-03 1.19E-03 0.02943126 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cystic fibrosis DOID_1485 1.243E-03 3.801E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bone resorption disease DOID_0080011 1.289E-03 3.922E-03 0.19188948 0.67398218 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP osteoporosis DOID_11476 1.289E-03 3.922E-03 0.19188948 0.67398218 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP amnestic disorder DOID_10914 1.32E-03 3.994E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP sex cord-gonadal stromal tumor DOID_192 1.32E-03 3.973E-03 1.32E-03 0.03128391 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pancreatitis DOID_4989 1.337E-03 4.003E-03 0.01976655 0.20449395 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP autoimmune hepatitis DOID_2048 1.456E-03 4.337E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP chromosomal disease DOID_0080014 1.486E-03 4.404E-03 0.02117627 0.21139121 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP auditory system disease DOID_2742 1.538E-03 4.535E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP chronic kidney failure DOID_784 1.591E-03 4.668E-03 0.20487516 0.69389266 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP neutropenia DOID_1227 1.599E-03 4.665E-03 0.0575642 0.34118781 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP agranulocytosis DOID_12987 1.748E-03 5.074E-03 0.06010131 0.34543074 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP optic nerve disease DOID_1891 1.748E-03 5.048E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP pulmonary embolism DOID_9477 1.748E-03 5.023E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lingual-facial-buccal dyskinesia DOID_9854 1.748E-03 4.998E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP diabetic angiopathy DOID_11713 1.903E-03 5.415E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP aortic valve disease DOID_62 1.903E-03 5.388E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP acute pancreatitis DOID_2913 2.065E-03 5.818E-03 0.06515525 0.35647439 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP portal hypertension DOID_10762 2.233E-03 6.26E-03 0.06767212 0.36671844 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP urticaria DOID_1555 2.233E-03 6.23E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hypogonadism DOID_1924 2.233E-03 6.199E-03 0.06767212 0.36325883 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bronchiolitis DOID_2942 2.233E-03 6.169E-03 0.06767212 0.35986389 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Crohn's disease DOID_8778 2.253E-03 6.194E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP papillary adenoma DOID_3172 2.408E-03 6.587E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP microcystic adenoma DOID_5403 2.408E-03 6.587E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP follicular adenoma DOID_6204 2.408E-03 6.587E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP ulcerative colitis DOID_8577 2.531E-03 6.889E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP congenital hypoplastic anemia DOID_1342 2.589E-03 7.014E-03 0.07268575 0.36926957 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP middle cerebral artery infarction DOID_3525 2.589E-03 6.981E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP fragments of torsion dystonia DOID_531 2.589E-03 6.948E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP perinatal necrotizing enterocolitis DOID_8677 2.776E-03 7.414E-03 0.07518254 0.37199015 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP renal hypertension DOID_1073 2.969E-03 7.893E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP secondary hypertension DOID_11130 2.969E-03 7.893E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thrombocytopenia DOID_1588 2.969E-03 7.856E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hepatic vascular disease DOID_272 2.969E-03 7.82E-03 0.07767268 0.3777415 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP central nervous system hereditary degenerative disease DOID_481 2.969E-03 7.784E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP autoimmune disease of endocrine system DOID_0060005 3.168E-03 8.268E-03 0.08015618 0.38326778 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP dystonic disease DOID_544 3.168E-03 8.23E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cranial nerve disease DOID_5656 3.168E-03 8.193E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP corneal disease DOID_10124 3.373E-03 8.684E-03 0.08263306 0.38539515 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP spastic cerebral palsy DOID_0050669 3.584E-03 9.187E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bronchiolitis obliterans DOID_2799 3.584E-03 9.146E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Charcot-Marie-Tooth disease DOID_10595 3.802E-03 9.657E-03 3.802E-03 0.0655509 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP autonomic nervous system neoplasm DOID_2621 4.025E-03 0.01017899 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP neuroblastoma DOID_769 4.025E-03 0.01017899 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP metal metabolism disorder DOID_896 4.254E-03 0.01071132 4.254E-03 0.06916453 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP nephroblastoma DOID_2154 4.49E-03 0.01125382 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thyroid carcinoma DOID_3963 4.49E-03 0.01120447 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP esophageal disease DOID_6050 4.49E-03 0.01115554 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP leukopenia DOID_615 4.49E-03 0.01110704 0.09491872 0.42864088 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lymphoid leukemia DOID_10747 4.731E-03 0.01165296 0.09735623 0.43618658 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thyroid cancer DOID_1781 4.978E-03 0.01220855 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP embryonal cancer DOID_688 5.231E-03 0.01277362 0.10221177 0.44395799 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP multiple myeloma DOID_9538 5.231E-03 0.01271903 0.10221177 0.44059467 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP peripheral nervous system neoplasm DOID_1192 5.489E-03 0.01329115 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP blood platelet disease DOID_2218 5.489E-03 0.01323483 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP adenoid cystic carcinoma DOID_4866 6.024E-03 0.01446237 6.024E-03 0.09263734 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP salivary gland cancer DOID_8850 6.581E-03 0.01573411 6.581E-03 0.09854524 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Huntington's disease DOID_12858 6.868E-03 0.01635192 6.868E-03 0.09770272 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hyperinsulinism DOID_2018 6.868E-03 0.01628379 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cataract DOID_83 7.459E-03 0.01761178 0.12137664 0.48636131 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP proteinuria DOID_576 7.763E-03 0.01825349 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lens disease DOID_110 8.073E-03 0.01890282 0.12610421 0.49146093 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thyroid adenoma DOID_2891 8.073E-03 0.01882535 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP vascular skin disease DOID_9540 8.073E-03 0.01874851 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hemolytic anemia DOID_583 8.388E-03 0.01940059 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP normocytic anemia DOID_720 8.388E-03 0.01940059 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP autoimmune disease of gastrointestinal tract DOID_0060031 8.708E-03 0.02005994 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP aortic aneurysm DOID_3627 9.034E-03 0.0207264 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP movement disease DOID_480 9.034E-03 0.02064316 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hemorrhagic disease DOID_2213 9.365E-03 0.02131422 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP congenital heart defect DOID_1682 0.01374735 0.03116432 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP endocrine pancreas disease DOID_1428 0.01414575 0.03194021 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP allergic contact dermatitis DOID_3042 0.01537064 0.03456876 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP syndrome DOID_225 0.01884968 0.04222626 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP bacterial pneumonia DOID_874 0.01976655 0.04410654 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP contact dermatitis DOID_2773 0.02070181 0.04601301 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP leber hereditary optic neuropathy DOID_705 0.02395814 0.05304351 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP interstitial nephritis DOID_1063 0.02658482 0.05863085 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hyperparathyroidism DOID_13543 0.02658482 0.05840448 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP childhood type dermatomyositis DOID_14203 0.02658482 0.05817985 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP gonadal dysgenesis DOID_14447 0.02658482 0.05795693 0.02658482 0.23271938 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP angioedema DOID_1558 0.02658482 0.05773572 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP retinal vascular occlusion DOID_1729 0.02658482 0.0575162 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP phagocyte bactericidal dysfunction DOID_3262 0.02658482 0.05729833 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP teratoma DOID_3307 0.02658482 0.05708211 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP labyrinthine disease DOID_4539 0.02658482 0.05686752 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP keratitis DOID_4677 0.02658482 0.05665453 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP malignant teratoma DOID_5563 0.02658482 0.05708211 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mature teratoma DOID_5566 0.02658482 0.05708211 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP acute T cell leukemia DOID_5603 0.02658482 0.05644313 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cannabis abuse DOID_9505 0.02658482 0.05623331 0.02658482 0.22919333 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP familial adenomatous polyposis DOID_0050424 0.02920449 0.06154576 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP nervous system benign neoplasm DOID_0060115 0.02920449 0.06131866 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP dermatomyositis DOID_10223 0.02920449 0.06109322 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP sickle cell anemia DOID_10923 0.02920449 0.06086943 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP polydactyly DOID_1148 0.02920449 0.06064728 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP prediabetes syndrome DOID_11716 0.02920449 0.06042675 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hemochromatosis DOID_2352 0.02920449 0.06020781 0.02920449 0.23079661 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP inner ear disease DOID_2952 0.02920449 0.05999045 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP invasive lobular carcinoma DOID_3457 0.02920449 0.05977466 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP chronic monocytic leukemia DOID_8593 0.02920449 0.05956041 0.02920449 0.22763501 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP familial atrial fibrillation DOID_0050650 0.03181719 0.06465707 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP common cold DOID_10459 0.03181719 0.06442697 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP otitis media DOID_10754 0.03181719 0.06419851 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP beta thalassemia DOID_12241 0.03181719 0.06397166 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP islet cell tumor DOID_1799 0.03181719 0.06374641 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP middle ear disease DOID_5100 0.03181719 0.06419851 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP stomach disease DOID_76 0.03181719 0.06352273 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP lipodystrophy DOID_811 0.03181719 0.06330063 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP mitochondrial encephalomyopathy DOID_890 0.03181719 0.06308007 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 0.03442292 0.06800917 0.03442292 0.26115521 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP berylliosis DOID_10322 0.03442292 0.06777384 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP parathyroid gland disease DOID_11201 0.03442292 0.06754014 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP carotid stenosis DOID_13001 0.03442292 0.06730804 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP polyneuropathy DOID_1389 0.03442292 0.06707754 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP cannabis dependence DOID_1849 0.03442292 0.0668486 0.03442292 0.25437196 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP intracranial thrombosis DOID_4193 0.03442292 0.06662123 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.03442292 0.06639539 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP monocytic leukemia DOID_8527 0.03442292 0.06617108 0.03442292 0.24483301 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hallucinogen dependence DOID_9977 0.03442292 0.0668486 0.03442292 0.25437196 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Legionnaires' disease DOID_10457 0.03702171 0.07092711 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP legionellosis DOID_10458 0.03702171 0.07092711 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP open-angle glaucoma DOID_1067 0.03702171 0.0706891 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hypercalcemia DOID_12678 0.03702171 0.07045268 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP eyelid disease DOID_530 0.03702171 0.07021784 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP T-cell leukemia DOID_715 0.03702171 0.06998456 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP thalassemia DOID_10241 0.03961357 0.07463616 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP communication disorder DOID_2033 0.03961357 0.07438984 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hemangioma DOID_255 0.03961357 0.07414513 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP corneal dystrophy DOID_2566 0.03961357 0.07390203 0.03961357 0.27487952 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP membranoproliferative glomerulonephritis DOID_2920 0.03961357 0.07366052 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hyperhomocysteinemia DOID_9279 0.03961357 0.07342059 0.03961357 0.26517789 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP spastic diplegia DOID_10965 0.04219852 0.07795766 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP hemolytic-uremic syndrome DOID_12554 0.04219852 0.07770537 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP Fanconi's anemia DOID_13636 0.04219852 0.07745471 0.04219852 0.27598804 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP long QT syndrome DOID_2843 0.04219852 0.07720566 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP drug-induced mental disorder DOID_1203 0.04477659 0.08165986 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP drug psychosis DOID_1742 0.04477659 0.08165986 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP urinary system benign neoplasm DOID_731 0.04477659 0.08139897 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP substance-induced psychosis DOID_8646 0.04477659 0.08165986 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP keratosis DOID_161 0.04734778 0.085799 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP prion disease DOID_649 0.04734778 0.08552662 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP eosinophilia DOID_999 0.04734778 0.08525597 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP heart septal defect DOID_1681 0.04991212 0.08958989 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP infertility DOID_5223 0.04991212 0.08930816 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP esophagitis DOID_11963 0.05246962 0.09359002 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP colon carcinoma DOID_1520 0.05246962 0.09329755 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP brain edema DOID_4724 0.05246962 0.0930069 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP alopecia DOID_987 0.05246962 0.09271806 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP coronary restenosis DOID_4247 0.05502031 0.09692433 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP Ehlers-Danlos syndrome DOID_13359 9.274E-10 5.277E-07 9.134E-05 6.497E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP heart valve disease DOID_4079 1.187E-09 3.378E-07 1.495E-05 1.701E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP bone development disease DOID_0080006 1.904E-08 3.612E-06 1.375E-06 1.956E-04 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP adenoid cystic carcinoma DOID_4866 8.228E-08 1.17E-05 8.228E-08 4.682E-05 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP salivary gland cancer DOID_8850 9.92E-08 1.129E-05 9.92E-08 2.822E-05 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP aortic valve insufficiency DOID_57 1.72E-07 1.631E-05 0.01133742 0.35838844 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP osteochondrodysplasia DOID_2256 2.8E-07 2.276E-05 2.341E-05 2.22E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP oral cavity cancer DOID_8618 3.437E-07 2.445E-05 3.437E-07 6.519E-05 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP collagen disease DOID_854 4.176E-07 2.64E-05 1.703E-03 0.08075987 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP aortic valve disease DOID_62 1.57E-06 8.932E-05 0.02254983 0.33765409 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP bone resorption disease DOID_0080011 5.917E-05 3.061E-03 2.58E-03 0.11291543 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP osteoporosis DOID_11476 5.917E-05 3.061E-03 2.58E-03 0.11291543 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP aneurysm disease DOID_2403 5.917E-05 2.806E-03 5.917E-05 4.81E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP osteogenesis imperfecta DOID_12347 6.793E-05 2.973E-03 0.01227654 0.33263588 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP oral submucous fibrosis DOID_5773 9.134E-05 3.712E-03 0.01415219 0.29824431 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP ureteral obstruction DOID_5199 1.329E-04 5.04E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP urinary tract obstruction DOID_5200 2.19E-04 7.79E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP ureteral disease DOID_1426 2.388E-04 7.993E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP intracranial aneurysm DOID_10941 3.263E-04 0.01031417 3.263E-04 0.02062833 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP multiple epiphyseal dysplasia DOID_12721 4.007E-04 0.01199875 4.007E-04 0.02279763 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP smallpox DOID_8736 1.402E-03 0.03987334 1.402E-03 0.07249698 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP Crohn's disease DOID_8778 3.78E-03 0.09775798 3.78E-03 0.15361969 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bacterial pneumonia DOID_874 3.739E-22 2.127E-19 5.045E-03 0.06834167 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pleural disease DOID_1532 1.091E-21 3.103E-19 0.04516044 0.28551433 LINDSTEDT_DENDRITIC_CELL_MATURATION_A primary bacterial infectious disease DOID_0050338 1.461E-21 2.771E-19 6.017E-06 1.712E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A influenza DOID_8469 3.041E-20 4.326E-18 1.774E-03 0.03256497 LINDSTEDT_DENDRITIC_CELL_MATURATION_A ulcerative colitis DOID_8577 8.363E-19 9.517E-17 9.56E-06 1.36E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A tuberculosis DOID_399 2.65E-18 2.513E-16 2.437E-06 1.386E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pulmonary tuberculosis DOID_2957 1.985E-17 1.613E-15 4.558E-05 3.242E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pleurisy DOID_10247 2.908E-17 2.068E-15 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A parasitic protozoa infectious disease DOID_2789 5.711E-17 3.611E-15 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A leishmaniasis DOID_9065 2.228E-16 1.268E-14 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A parasitic infectious disease DOID_1398 2.617E-16 1.354E-14 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A respiratory syncytial virus infectious disease DOID_1273 5.795E-16 2.748E-14 1.419E-03 0.03105586 LINDSTEDT_DENDRITIC_CELL_MATURATION_A cystic fibrosis DOID_1485 9.592E-16 4.198E-14 0.09791377 0.4529507 LINDSTEDT_DENDRITIC_CELL_MATURATION_A cerebral infarction DOID_3526 1.842E-15 7.485E-14 1.85E-03 0.03289126 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bronchiolitis DOID_2942 2.889E-15 1.096E-13 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A extrinsic allergic alveolitis DOID_841 5.189E-15 1.845E-13 6.304E-04 0.01992752 LINDSTEDT_DENDRITIC_CELL_MATURATION_A sarcoidosis DOID_11335 6.878E-15 2.302E-13 5.696E-05 3.601E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hypersensitivity reaction type I disease DOID_1205 7.379E-15 2.333E-13 8.472E-06 1.607E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hypersensitivity reaction type IV disease DOID_2916 1.419E-14 4.249E-13 7.361E-05 4.188E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A brain infarction DOID_3454 5.076E-14 1.444E-12 3.997E-03 0.05831623 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pulmonary sarcoidosis DOID_13406 8.074E-14 2.188E-12 2.06E-05 2.345E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A rheumatic disease DOID_1575 2.304E-13 5.96E-12 1.7E-03 0.03224565 LINDSTEDT_DENDRITIC_CELL_MATURATION_A scleroderma DOID_419 2.304E-13 5.96E-12 1.7E-03 0.03224565 LINDSTEDT_DENDRITIC_CELL_MATURATION_A cystitis DOID_1679 1.118E-12 2.765E-11 5.859E-04 0.02083469 LINDSTEDT_DENDRITIC_CELL_MATURATION_A leukocyte disease DOID_9500 2.084E-12 4.941E-11 7.728E-05 3.997E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A collagen disease DOID_854 2.627E-12 5.979E-11 3.262E-03 0.05155473 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bronchiolitis obliterans DOID_2799 4.157E-12 9.097E-11 0.04263458 0.28208225 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bladder disease DOID_365 6.08E-12 1.281E-10 9.865E-04 0.02551334 LINDSTEDT_DENDRITIC_CELL_MATURATION_A metabolic syndrome X DOID_14221 1.579E-11 3.209E-10 5.293E-03 0.07003574 LINDSTEDT_DENDRITIC_CELL_MATURATION_A systemic scleroderma DOID_418 1.951E-11 3.828E-10 1.419E-03 0.02990565 LINDSTEDT_DENDRITIC_CELL_MATURATION_A adult respiratory distress syndrome DOID_11394 2.265E-11 4.297E-10 0.05519874 0.31408084 LINDSTEDT_DENDRITIC_CELL_MATURATION_A intracranial arterial disease DOID_13089 2.265E-11 4.158E-10 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A cerebral arterial disease DOID_3527 2.265E-11 4.158E-10 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Crohn's disease DOID_8778 4.883E-11 8.682E-10 7.183E-03 0.08340501 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autoimmune disease of gastrointestinal tract DOID_0060031 7.497E-11 1.293E-09 4.558E-05 3.705E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A respiratory failure DOID_11162 3.003E-10 5.025E-09 0.08227383 0.41064743 LINDSTEDT_DENDRITIC_CELL_MATURATION_A middle cerebral artery infarction DOID_3525 3.12E-10 5.072E-09 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A perinatal necrotizing enterocolitis DOID_8677 3.766E-10 5.952E-09 6.765E-04 0.02026005 LINDSTEDT_DENDRITIC_CELL_MATURATION_A cholestasis DOID_13580 3.967E-10 6.101E-09 0.08590646 0.42505024 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hyperglycemia DOID_4195 4.341E-10 6.5E-09 0.08711421 0.42006766 LINDSTEDT_DENDRITIC_CELL_MATURATION_A cutaneous leishmaniasis DOID_9111 5.587E-10 8.152E-09 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A visceral leishmaniasis DOID_9146 5.587E-10 7.948E-09 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bile duct disease DOID_4138 6.674E-10 9.263E-09 0.09312951 0.4379396 LINDSTEDT_DENDRITIC_CELL_MATURATION_A biliary tract disease DOID_9741 7.248E-10 9.819E-09 0.0943279 0.43993915 LINDSTEDT_DENDRITIC_CELL_MATURATION_A contact dermatitis DOID_2773 1.252E-09 1.656E-08 5.293E-03 0.06844402 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pneumoconiosis DOID_10316 1.371E-09 1.774E-08 0.04767977 0.29488901 LINDSTEDT_DENDRITIC_CELL_MATURATION_A chronic kidney failure DOID_784 1.559E-09 1.971E-08 0.10622678 0.46494644 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hepatitis DOID_2237 2.663E-09 3.294E-08 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A peptic ulcer DOID_750 2.663E-09 3.224E-08 0.05394963 0.31007415 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pulmonary emphysema DOID_9675 3.393E-09 4.022E-08 1.557E-03 0.03054049 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autoimmune disease of urogenital tract DOID_0060049 3.814E-09 4.429E-08 2.946E-05 2.793E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A primary biliary cirrhosis DOID_12236 3.814E-09 4.429E-08 2.946E-05 2.793E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pre-eclampsia DOID_10591 6.581E-09 7.489E-08 2.005E-03 0.03457904 LINDSTEDT_DENDRITIC_CELL_MATURATION_A neuritis DOID_1803 6.581E-09 7.342E-08 0.06389736 0.34959231 LINDSTEDT_DENDRITIC_CELL_MATURATION_A vascular skin disease DOID_9540 6.581E-09 7.201E-08 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A atopic dermatitis DOID_3310 1.075E-08 1.154E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A esophagitis DOID_11963 1.277E-08 1.345E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autoimmune hepatitis DOID_2048 1.575E-08 1.63E-07 0.02734132 0.22546679 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mitochondrial myopathy DOID_699 1.575E-08 1.601E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Goodpasture syndrome DOID_9808 2.789E-08 2.784E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A acute pancreatitis DOID_2913 3.317E-08 3.254E-07 0.03246548 0.24630479 LINDSTEDT_DENDRITIC_CELL_MATURATION_A allergic contact dermatitis DOID_3042 3.686E-08 3.554E-07 3.888E-03 0.05978713 LINDSTEDT_DENDRITIC_CELL_MATURATION_A urticaria DOID_1555 3.916E-08 3.714E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A myositis DOID_633 4.593E-08 4.284E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A peripheral vascular disease DOID_341 5.23E-08 4.8E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A diabetic retinopathy DOID_8947 5.593E-08 5.051E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A gestational diabetes DOID_11714 6.204E-08 5.515E-07 0.03756319 0.2606519 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bone resorption disease DOID_0080011 6.802E-08 5.955E-07 0.09910597 0.44754996 LINDSTEDT_DENDRITIC_CELL_MATURATION_A osteoporosis DOID_11476 6.802E-08 5.955E-07 0.09910597 0.44754996 LINDSTEDT_DENDRITIC_CELL_MATURATION_A aneurysm disease DOID_2403 6.802E-08 5.864E-07 4.923E-03 0.0700235 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pancreatitis DOID_4989 7.249E-08 6.156E-07 0.10029662 0.44936044 LINDSTEDT_DENDRITIC_CELL_MATURATION_A opportunistic mycosis DOID_2473 1.065E-07 8.909E-07 8.769E-04 0.02494644 LINDSTEDT_DENDRITIC_CELL_MATURATION_A retinal vascular disease DOID_2462 1.106E-07 9.124E-07 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Human immunodeficiency virus infectious disease DOID_526 1.465E-07 1.191E-06 6.616E-03 0.08009033 LINDSTEDT_DENDRITIC_CELL_MATURATION_A systemic mycosis DOID_0050136 1.528E-07 1.225E-06 1.044E-03 0.02581785 LINDSTEDT_DENDRITIC_CELL_MATURATION_A fungal infectious disease DOID_1564 1.528E-07 1.225E-06 1.044E-03 0.02581785 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lymphoma DOID_0060058 1.632E-07 1.29E-06 6.896E-03 0.08175053 LINDSTEDT_DENDRITIC_CELL_MATURATION_A esophageal disease DOID_6050 1.712E-07 1.334E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A leukopenia DOID_615 1.712E-07 1.316E-06 0.04767977 0.28557673 LINDSTEDT_DENDRITIC_CELL_MATURATION_A encephalomyelitis DOID_640 1.721E-07 1.306E-06 2.743E-04 0.01040518 LINDSTEDT_DENDRITIC_CELL_MATURATION_A multiple myeloma DOID_9538 2.362E-07 1.768E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pneumocystosis DOID_11339 3.535E-07 2.612E-06 0.01441426 0.15772526 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bronchiectasis DOID_9563 3.535E-07 2.579E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A common cold DOID_10459 4.709E-07 3.392E-06 0.0157145 0.16558432 LINDSTEDT_DENDRITIC_CELL_MATURATION_A peritonitis DOID_8283 4.709E-07 3.349E-06 0.0157145 0.16257369 LINDSTEDT_DENDRITIC_CELL_MATURATION_A encephalitis DOID_9588 4.709E-07 3.308E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A myeloma DOID_0070004 5.894E-07 4.09E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A psoriatic arthritis DOID_9008 6.116E-07 4.193E-06 0.01701307 0.16690407 LINDSTEDT_DENDRITIC_CELL_MATURATION_A calcium metabolism disease DOID_10575 7.472E-07 5.062E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A aortic aneurysm DOID_3627 7.472E-07 5.002E-06 2.25E-03 0.03658275 LINDSTEDT_DENDRITIC_CELL_MATURATION_A viral pneumonia DOID_10533 7.777E-07 5.145E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A eyelid disease DOID_530 7.777E-07 5.086E-06 0.01830995 0.17363939 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hyperhomocysteinemia DOID_9279 9.712E-07 6.28E-06 0.01960516 0.17706884 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bone marrow cancer DOID_4960 1.004E-06 6.419E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pustulosis of palm and sole DOID_4398 1.077E-06 6.812E-06 0.07374257 0.3780137 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mitochondrial metabolism disease DOID_700 1.155E-06 7.22E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hemolytic-uremic syndrome DOID_12554 1.194E-06 7.386E-06 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mineral metabolism disease DOID_0050032 1.93E-06 1.181E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A endocrine pancreas disease DOID_1428 1.93E-06 1.168E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A uterine disease DOID_345 2.048E-06 1.227E-05 0.08590646 0.42138601 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Kawasaki disease DOID_13378 2.823E-06 1.673E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lymphadenitis DOID_1602 2.823E-06 1.673E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lymph node disease DOID_9942 2.823E-06 1.673E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A male reproductive system disease DOID_48 2.877E-06 1.688E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A neutropenia DOID_1227 3.266E-06 1.896E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A acquired immunodeficiency syndrome DOID_635 3.266E-06 1.877E-05 0.02862485 0.22940193 LINDSTEDT_DENDRITIC_CELL_MATURATION_A sinusitis DOID_0050127 3.752E-06 2.135E-05 0.02990671 0.23634612 LINDSTEDT_DENDRITIC_CELL_MATURATION_A agranulocytosis DOID_12987 3.752E-06 2.114E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A paranasal sinus disease DOID_1352 3.752E-06 2.135E-05 0.02990671 0.23634612 LINDSTEDT_DENDRITIC_CELL_MATURATION_A polyarteritis nodosa DOID_9810 3.752E-06 2.093E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hypoglycemia DOID_9993 3.752E-06 2.073E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A diabetic angiopathy DOID_11713 4.284E-06 2.344E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A meningitis DOID_9471 4.284E-06 2.322E-05 0.03118693 0.24308714 LINDSTEDT_DENDRITIC_CELL_MATURATION_A female reproductive system disease DOID_229 4.555E-06 2.445E-05 0.10385932 0.46168715 LINDSTEDT_DENDRITIC_CELL_MATURATION_A focal epilepsy DOID_2234 5.009E-06 2.664E-05 5.675E-03 0.07176001 LINDSTEDT_DENDRITIC_CELL_MATURATION_A amino acid metabolic disorder DOID_9252 6.573E-06 3.463E-05 0.11329242 0.488359 LINDSTEDT_DENDRITIC_CELL_MATURATION_A diffuse large B-cell lymphoma DOID_0050745 7.699E-06 4.019E-05 0.03756319 0.26386983 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Sciatic Neuropathy DOID_11446 7.699E-06 3.982E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lesion of sciatic nerve DOID_12528 7.699E-06 3.982E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A periodontitis DOID_824 7.699E-06 3.946E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mononeuritis of lower limb DOID_9473 7.699E-06 3.982E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mouth disease DOID_403 8.131E-06 4.131E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A malaria DOID_12365 8.546E-06 4.303E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mononeuritis DOID_1802 8.546E-06 4.266E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mononeuropathy DOID_1188 9.453E-06 4.677E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A spastic cerebral palsy DOID_0050669 1.145E-05 5.618E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A celiac disease DOID_10608 1.255E-05 6.103E-05 9.309E-04 0.02522217 LINDSTEDT_DENDRITIC_CELL_MATURATION_A papilloma DOID_2615 1.495E-05 7.207E-05 1.044E-03 0.02474211 LINDSTEDT_DENDRITIC_CELL_MATURATION_A myocarditis DOID_820 1.495E-05 7.146E-05 0.04642092 0.29025828 LINDSTEDT_DENDRITIC_CELL_MATURATION_A periodontal disease DOID_3388 1.625E-05 7.705E-05 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A spindle cell carcinoma DOID_4015 1.625E-05 7.641E-05 0.04767977 0.28861478 LINDSTEDT_DENDRITIC_CELL_MATURATION_A uveitis DOID_13141 2.221E-05 1.036E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A congenital diaphragmatic hernia DOID_3827 2.39E-05 1.105E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lymphatic system disease DOID_75 2.567E-05 1.178E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A benign mesothelioma DOID_2645 2.752E-05 1.253E-04 1.557E-03 0.03163122 LINDSTEDT_DENDRITIC_CELL_MATURATION_A uveal disease DOID_3480 3.148E-05 1.422E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A proteinuria DOID_576 3.81E-05 1.707E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A thyroid adenoma DOID_2891 4.05E-05 1.8E-04 2.005E-03 0.03356201 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hemolytic anemia DOID_583 4.299E-05 1.896E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A normocytic anemia DOID_720 4.299E-05 1.896E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A B-cell lymphocytic neoplasm DOID_707 5.106E-05 2.235E-04 0.06883272 0.36603566 LINDSTEDT_DENDRITIC_CELL_MATURATION_A giant cell tumor DOID_200 5.696E-05 2.474E-04 0.07129082 0.37559701 LINDSTEDT_DENDRITIC_CELL_MATURATION_A malignant giant cell tumor DOID_2705 5.696E-05 2.474E-04 0.07129082 0.37559701 LINDSTEDT_DENDRITIC_CELL_MATURATION_A giant cell glioblastoma DOID_3074 5.696E-05 2.474E-04 0.07129082 0.37559701 LINDSTEDT_DENDRITIC_CELL_MATURATION_A vasculitis DOID_865 6.007E-05 2.589E-04 0.07251749 0.37855459 LINDSTEDT_DENDRITIC_CELL_MATURATION_A integumentary system cancer DOID_0060122 6.328E-05 2.707E-04 0.07374257 0.38145018 LINDSTEDT_DENDRITIC_CELL_MATURATION_A skin cancer DOID_4159 6.328E-05 2.707E-04 0.07374257 0.38145018 LINDSTEDT_DENDRITIC_CELL_MATURATION_A glioblastoma DOID_3068 7.361E-05 3.126E-04 0.0774083 0.39326179 LINDSTEDT_DENDRITIC_CELL_MATURATION_A interstitial nephritis DOID_1063 7.619E-05 3.211E-04 0.01311233 0.14921833 LINDSTEDT_DENDRITIC_CELL_MATURATION_A childhood type dermatomyositis DOID_14203 7.619E-05 3.188E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A retinal vascular occlusion DOID_1729 7.619E-05 3.165E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A acute kidney failure DOID_3021 7.619E-05 3.142E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A conjunctival disease DOID_4251 7.619E-05 3.119E-04 0.01311233 0.14629248 LINDSTEDT_DENDRITIC_CELL_MATURATION_A conjunctivitis DOID_6195 7.619E-05 3.119E-04 0.01311233 0.14629248 LINDSTEDT_DENDRITIC_CELL_MATURATION_A carotid artery disease DOID_3407 8.498E-05 3.454E-04 0.08105981 0.4081684 LINDSTEDT_DENDRITIC_CELL_MATURATION_A dermatomyositis DOID_10223 9.305E-05 3.755E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A eosinophilic pneumonia DOID_5870 9.305E-05 3.728E-04 9.305E-05 4.412E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pulmonary eosinophilia DOID_9498 9.305E-05 3.728E-04 9.305E-05 4.412E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Loeffler syndrome DOID_9503 9.305E-05 3.728E-04 9.305E-05 4.412E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_A temporal lobe epilepsy DOID_3328 1.064E-04 4.232E-04 0.08711421 0.42365798 LINDSTEDT_DENDRITIC_CELL_MATURATION_A tooth disease DOID_1091 1.11E-04 4.387E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A endocrine organ benign neoplasm DOID_0060089 1.158E-04 4.545E-04 3.997E-03 0.05985087 LINDSTEDT_DENDRITIC_CELL_MATURATION_A astrocytoma DOID_3069 1.207E-04 4.705E-04 0.09072807 0.43381739 LINDSTEDT_DENDRITIC_CELL_MATURATION_A blood coagulation disease DOID_1247 1.258E-04 4.869E-04 0.09192957 0.43589936 LINDSTEDT_DENDRITIC_CELL_MATURATION_A berylliosis DOID_10322 1.317E-04 5.065E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A polyneuropathy DOID_1389 1.317E-04 5.031E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A endogenous depression DOID_1595 1.532E-04 5.81E-04 0.09791377 0.44929787 LINDSTEDT_DENDRITIC_CELL_MATURATION_A syndrome DOID_225 1.532E-04 5.771E-04 0.09791377 0.44570349 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hypercalcemia DOID_12678 1.536E-04 5.749E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mesenchymal cell neoplasm DOID_3350 1.77E-04 6.584E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A spindle cell sarcoma DOID_4235 1.77E-04 6.584E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lung oat cell carcinoma DOID_5411 1.77E-04 6.541E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A epithelioid sarcoma DOID_6193 1.77E-04 6.584E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A varicose veins DOID_799 1.77E-04 6.499E-04 0.01960516 0.17992479 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mental depression DOID_1596 1.976E-04 7.206E-04 0.10622678 0.46855067 LINDSTEDT_DENDRITIC_CELL_MATURATION_A silicosis DOID_10325 2.022E-04 7.327E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A thyroiditis DOID_7166 2.022E-04 7.28E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autoimmune thyroiditis DOID_7188 2.022E-04 7.28E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A vein disease DOID_866 2.022E-04 7.235E-04 0.0208987 0.18580246 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lymphatic system cancer DOID_0060073 2.289E-04 8.141E-04 0.02219056 0.19425271 LINDSTEDT_DENDRITIC_CELL_MATURATION_A reticulosarcoma DOID_8538 2.289E-04 8.141E-04 0.02219056 0.19425271 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lymphosarcoma DOID_8675 2.289E-04 8.141E-04 0.02219056 0.19425271 LINDSTEDT_DENDRITIC_CELL_MATURATION_A prion disease DOID_649 2.573E-04 9.094E-04 2.573E-04 0.01126272 LINDSTEDT_DENDRITIC_CELL_MATURATION_A eosinophilia DOID_999 2.573E-04 9.038E-04 2.573E-04 0.01045824 LINDSTEDT_DENDRITIC_CELL_MATURATION_A carbohydrate metabolic disorder DOID_2978 2.743E-04 9.575E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A dissociative disorder DOID_10935 2.874E-04 9.97E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A dissociative amnesia DOID_11037 2.874E-04 9.97E-04 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A amnestic disorder DOID_10914 3.19E-04 1.1E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pulmonary edema DOID_11396 3.19E-04 1.093E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A brain edema DOID_4724 3.19E-04 1.087E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A coronary restenosis DOID_4247 3.523E-04 1.193E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A placenta disease DOID_780 3.872E-04 1.304E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A IgA glomerulonephritis DOID_2986 4.237E-04 1.418E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A spastic quadriplegia DOID_10970 5.016E-04 1.669E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A ankylosing spondylitis DOID_7147 5.859E-04 1.938E-03 5.859E-04 0.01960912 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autoimmune disease of cardiovascular system DOID_0060051 7.242E-04 2.382E-03 0.0388335 0.26622002 LINDSTEDT_DENDRITIC_CELL_MATURATION_A sarcoma DOID_1115 7.242E-04 2.368E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Behcet's disease DOID_13241 7.242E-04 2.382E-03 0.0388335 0.26622002 LINDSTEDT_DENDRITIC_CELL_MATURATION_A coronary stenosis DOID_4248 7.242E-04 2.355E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autoimmune disease of endocrine system DOID_0060005 7.735E-04 2.501E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A abdominal aortic aneurysm DOID_7693 8.769E-04 2.819E-03 0.04263458 0.27883993 LINDSTEDT_DENDRITIC_CELL_MATURATION_A allergic rhinitis DOID_4481 9.309E-04 2.976E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A chronic leukemia DOID_1036 9.865E-04 3.136E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A chronic lymphocytic leukemia DOID_1040 9.865E-04 3.136E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A nephroblastoma DOID_2154 1.102E-03 3.485E-03 1.102E-03 0.02508857 LINDSTEDT_DENDRITIC_CELL_MATURATION_A thyroid carcinoma DOID_3963 1.102E-03 3.465E-03 0.04767977 0.29171816 LINDSTEDT_DENDRITIC_CELL_MATURATION_A aplastic anemia DOID_12449 1.163E-03 3.635E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A thyroid cancer DOID_1781 1.224E-03 3.807E-03 0.05019259 0.29749564 LINDSTEDT_DENDRITIC_CELL_MATURATION_A adenoma DOID_657 1.224E-03 3.786E-03 0.05019259 0.29442868 LINDSTEDT_DENDRITIC_CELL_MATURATION_A calcinosis DOID_182 1.288E-03 3.961E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A blood platelet disease DOID_2218 1.353E-03 4.138E-03 0.05269891 0.3059763 LINDSTEDT_DENDRITIC_CELL_MATURATION_A endometriosis of uterus DOID_288 1.628E-03 4.952E-03 0.05769211 0.32501795 LINDSTEDT_DENDRITIC_CELL_MATURATION_A endometriosis DOID_289 1.7E-03 5.146E-03 0.05893638 0.32877255 LINDSTEDT_DENDRITIC_CELL_MATURATION_A diabetic autonomic neuropathy DOID_11503 1.774E-03 5.341E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autonomic neuropathy DOID_11504 1.774E-03 5.341E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A diabetic polyneuropathy DOID_12785 1.774E-03 5.341E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A diabetic neuropathy DOID_9743 1.774E-03 5.341E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autonomic nervous system disease DOID_11465 2.005E-03 6.006E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A heart valve disease DOID_4079 2.005E-03 5.974E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bone marrow disease DOID_4961 2.005E-03 5.943E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A integumentary system benign neoplasm DOID_0060121 2.167E-03 6.389E-03 0.06636824 0.35965263 LINDSTEDT_DENDRITIC_CELL_MATURATION_A skin benign neoplasm DOID_3165 2.167E-03 6.389E-03 0.06636824 0.35965263 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lung small cell carcinoma DOID_5409 2.167E-03 6.356E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hemorrhagic disease DOID_2213 2.335E-03 6.813E-03 0.06883272 0.36948883 LINDSTEDT_DENDRITIC_CELL_MATURATION_A melancholia DOID_2848 3.065E-03 8.897E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A neurotic disorder DOID_4964 3.163E-03 9.134E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A nephrosis DOID_2527 4.334E-03 0.01245356 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mixed glioma DOID_5076 5.045E-03 0.01442387 5.045E-03 0.07000854 LINDSTEDT_DENDRITIC_CELL_MATURATION_A biliary tract cancer DOID_4607 5.675E-03 0.016146 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A transitional cell carcinoma DOID_2671 6.34E-03 0.01794788 6.34E-03 0.07842441 LINDSTEDT_DENDRITIC_CELL_MATURATION_A primary immunodeficiency disease DOID_612 6.477E-03 0.01824505 0.11329242 0.49208693 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lymphoblastic leukemia DOID_1037 7.039E-03 0.01972934 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A alcohol-related neurodevelopmental disorder DOID_0050667 7.183E-03 0.02003356 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A dilated cardiomyopathy DOID_12930 7.328E-03 0.02033849 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A leber hereditary optic neuropathy DOID_705 0.01180872 0.03261728 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hyperparathyroidism DOID_13543 0.01311233 0.03604308 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hypolipoproteinemia DOID_1387 0.01311233 0.03586979 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A angioedema DOID_1558 0.01311233 0.03569817 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A transient cerebral ischemia DOID_224 0.01311233 0.03552817 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bilirubin metabolic disorder DOID_2741 0.01311233 0.03535979 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Hermansky-Pudlak syndrome DOID_3753 0.01311233 0.035193 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A insulinoma DOID_3892 0.01311233 0.03502778 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A alopecia areata DOID_986 0.01311233 0.0348641 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A familial adenomatous polyposis DOID_0050424 0.01441426 0.03814751 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A trypanosomiasis DOID_10113 0.01441426 0.0379709 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A adrenoleukodystrophy DOID_10588 0.01441426 0.03779592 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A sickle cell anemia DOID_10923 0.01441426 0.03762254 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A prediabetes syndrome DOID_11716 0.01441426 0.03745075 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A migraine without aura DOID_12783 0.01441426 0.03728052 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A temporal arteritis DOID_13375 0.01441426 0.03711183 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A neuronal ceroid lipofuscinosis DOID_14503 0.01441426 0.03694466 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hemochromatosis DOID_2352 0.01441426 0.03677899 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A invasive lobular carcinoma DOID_3457 0.01441426 0.03661479 0.01441426 0.15474932 LINDSTEDT_DENDRITIC_CELL_MATURATION_A central nervous system vasculitis DOID_525 0.01441426 0.03711183 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A otitis media DOID_10754 0.0157145 0.03974024 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A intracranial arteriosclerosis DOID_13097 0.0157145 0.03956439 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A diarrhea DOID_13250 0.0157145 0.0393901 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A islet cell tumor DOID_1799 0.0157145 0.03921734 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A middle ear disease DOID_5100 0.0157145 0.03974024 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A stomach disease DOID_76 0.0157145 0.03904608 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lipodystrophy DOID_811 0.0157145 0.03887632 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A vascular dementia DOID_8725 0.0157145 0.03956439 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A mitochondrial encephalomyopathy DOID_890 0.0157145 0.03870802 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A leprosy DOID_1024 0.01701307 0.04172602 0.01701307 0.17286493 LINDSTEDT_DENDRITIC_CELL_MATURATION_A parathyroid gland disease DOID_11201 0.01701307 0.04154694 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hepatic coma DOID_12550 0.01701307 0.04136938 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A newborn respiratory distress syndrome DOID_12716 0.01701307 0.04119334 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A carotid stenosis DOID_13001 0.01701307 0.0410188 0.01701307 0.16983221 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hepatic encephalopathy DOID_13413 0.01701307 0.04136938 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A intracranial thrombosis DOID_4193 0.01701307 0.04084572 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Legionnaires' disease DOID_10457 0.01830995 0.04377464 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A legionellosis DOID_10458 0.01830995 0.04377464 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A tethered spinal cord syndrome DOID_1089 0.01830995 0.04359148 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A aspergillosis DOID_13564 0.01830995 0.04340985 0.01830995 0.17658243 LINDSTEDT_DENDRITIC_CELL_MATURATION_A polycystic kidney disease DOID_898 0.01830995 0.04322972 0.01830995 0.17079285 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bacterial meningitis DOID_9470 0.01830995 0.04305109 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A thoracic aortic aneurysm DOID_14004 0.01960516 0.04590674 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A renovascular hypertension DOID_1591 0.01960516 0.04571859 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A communication disorder DOID_2033 0.01960516 0.04553199 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A oral submucous fibrosis DOID_5773 0.01960516 0.0453469 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A intermediate coronary syndrome DOID_8805 0.01960516 0.04516331 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A spastic diplegia DOID_10965 0.0208987 0.04794902 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A restrictive cardiomyopathy DOID_397 0.0208987 0.04775646 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A tongue cancer DOID_8649 0.0208987 0.04756543 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Barrett's esophagus DOID_9206 0.0208987 0.04737593 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A drug-induced mental disorder DOID_1203 0.02219056 0.05010487 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A methylmalonic acidemia DOID_14749 0.02219056 0.04990682 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A drug psychosis DOID_1742 0.02219056 0.05010487 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A basal cell carcinoma DOID_2513 0.02219056 0.04971034 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A bronchitis DOID_6132 0.02219056 0.0495154 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A substance-induced psychosis DOID_8646 0.02219056 0.05010487 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A glucose intolerance DOID_10603 0.02348075 0.05218963 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A skin carcinoma DOID_3451 0.02348075 0.05198655 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A ureteral obstruction DOID_5199 0.02348075 0.05178506 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Down syndrome DOID_14250 0.02476927 0.05441588 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A MHC class II deficiency DOID_5812 0.02476927 0.05420659 0.02476927 0.21354112 LINDSTEDT_DENDRITIC_CELL_MATURATION_A psoriasis DOID_8893 0.02476927 0.0539989 0.02476927 0.21035393 LINDSTEDT_DENDRITIC_CELL_MATURATION_A colon carcinoma DOID_1520 0.02605612 0.05658754 0.02605612 0.21802845 LINDSTEDT_DENDRITIC_CELL_MATURATION_A alopecia DOID_987 0.02605612 0.05637237 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A funisitis DOID_0050698 0.02862485 0.06169522 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A gastric ulcer DOID_10808 0.02862485 0.0614624 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hepatitis B DOID_2043 0.02862485 0.06123134 0.02862485 0.2326791 LINDSTEDT_DENDRITIC_CELL_MATURATION_A thrombophilia DOID_2452 0.02862485 0.06100201 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A optic nerve disease DOID_1891 0.02990671 0.06349597 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A myasthenia gravis DOID_437 0.02990671 0.06325993 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A uremia DOID_4676 0.02990671 0.06302563 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A urinary tract obstruction DOID_5200 0.02990671 0.06279307 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A sleep disorder DOID_535 0.02990671 0.06256221 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A pulmonary embolism DOID_9477 0.02990671 0.06233304 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A Lewy body dementia DOID_12217 0.03118693 0.06476409 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A ureteral disease DOID_1426 0.03118693 0.06452859 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A toxic shock syndrome DOID_14115 0.03246548 0.06693065 0.03246548 0.24963324 LINDSTEDT_DENDRITIC_CELL_MATURATION_A severe combined immunodeficiency DOID_627 0.03246548 0.06668902 0.03246548 0.24306394 LINDSTEDT_DENDRITIC_CELL_MATURATION_A commensal bacterial infectious disease DOID_0050339 0.03374238 0.06906265 0.03374238 0.24934308 LINDSTEDT_DENDRITIC_CELL_MATURATION_A organic acidemia DOID_0060159 0.03374238 0.06881511 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A portal hypertension DOID_10762 0.03374238 0.06856935 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hypogonadism DOID_1924 0.03374238 0.06832533 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A combined T cell and B cell immunodeficiency DOID_628 0.03374238 0.06808304 0.03374238 0.24614637 LINDSTEDT_DENDRITIC_CELL_MATURATION_A morbid obesity DOID_11981 0.03501764 0.07040648 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A papillary adenoma DOID_3172 0.03501764 0.07015857 0.03501764 0.25221563 LINDSTEDT_DENDRITIC_CELL_MATURATION_A neuromuscular junction disease DOID_439 0.03501764 0.0699124 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A microcystic adenoma DOID_5403 0.03501764 0.07015857 0.03501764 0.25221563 LINDSTEDT_DENDRITIC_CELL_MATURATION_A follicular adenoma DOID_6204 0.03501764 0.07015857 0.03501764 0.25221563 LINDSTEDT_DENDRITIC_CELL_MATURATION_A intracranial aneurysm DOID_10941 0.03629124 0.0722018 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A vitiligo DOID_12306 0.03629124 0.07195022 0.03629124 0.25812143 LINDSTEDT_DENDRITIC_CELL_MATURATION_A B cell deficiency DOID_2115 0.03629124 0.0717004 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A spinal cord disease DOID_319 0.03629124 0.0714523 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hypotrichosis DOID_4535 0.03629124 0.07120591 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A lung adenocarcinoma DOID_3910 0.03756319 0.0734483 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A migraine DOID_6364 0.03756319 0.07319677 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A renal hypertension DOID_1073 0.0388335 0.07541386 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A secondary hypertension DOID_11130 0.0388335 0.07541386 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A thrombocytopenia DOID_1588 0.0388335 0.07515735 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hepatic vascular disease DOID_272 0.0388335 0.07490258 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A invasive ductal carcinoma DOID_3008 0.0388335 0.07464953 0.0388335 0.26305073 LINDSTEDT_DENDRITIC_CELL_MATURATION_A autoimmune disease of the nervous system DOID_438 0.0388335 0.07439819 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A toxic encephalopathy DOID_3602 0.04010217 0.07657091 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A cranial nerve disease DOID_5656 0.04010217 0.07631482 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A endometrial carcinoma DOID_2871 0.04136919 0.07846356 0.04136919 0.27693023 LINDSTEDT_DENDRITIC_CELL_MATURATION_A gonadal disease DOID_2277 0.04263458 0.08059493 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A endometrial cancer DOID_1380 0.04389832 0.0827091 0.04389832 0.28384258 LINDSTEDT_DENDRITIC_CELL_MATURATION_A leiomyoma DOID_127 0.04516044 0.08480624 0.04516044 0.28872235 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hair disease DOID_421 0.04642092 0.08688652 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A metal metabolism disorder DOID_896 0.04642092 0.08660165 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_A hyperthyroidism DOID_7998 0.04767977 0.08865944 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pleurisy DOID_10247 8.608E-13 4.898E-10 2.059E-10 5.858E-08 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pleural disease DOID_1532 2.343E-12 6.666E-10 4.671E-10 8.859E-08 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bacterial pneumonia DOID_874 4.316E-12 8.186E-10 4.316E-12 2.456E-09 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP sarcoidosis DOID_11335 4.605E-11 6.551E-09 5.401E-09 6.146E-07 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hypersensitivity reaction type IV disease DOID_2916 7.843E-11 8.925E-09 8.376E-09 7.943E-07 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP primary bacterial infectious disease DOID_0050338 8.018E-10 7.604E-08 8.018E-10 1.141E-07 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary emphysema DOID_9675 1.551E-09 1.261E-07 1.884E-07 1.34E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cystitis DOID_1679 2.47E-08 1.756E-06 3.9E-06 1.48E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cystic fibrosis DOID_1485 2.93E-08 1.853E-06 1.925E-06 7.823E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bladder disease DOID_365 7.32E-08 4.165E-06 8.673E-06 2.903E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary sarcoidosis DOID_13406 1.272E-07 6.581E-06 1.272E-07 1.034E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP systemic scleroderma DOID_418 1.556E-07 7.377E-06 1.513E-05 4.53E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP rheumatic disease DOID_1575 2.261E-07 9.895E-06 1.994E-05 5.403E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP scleroderma DOID_419 2.261E-07 9.895E-06 1.994E-05 5.403E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP influenza DOID_8469 2.469E-07 1.003E-05 2.128E-05 5.265E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP common cold DOID_10459 2.969E-07 1.126E-05 2.969E-07 1.877E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary tuberculosis DOID_2957 3.732E-07 1.327E-05 3.732E-07 2.123E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP aortic aneurysm DOID_3627 4.033E-07 1.35E-05 3.06E-05 7.255E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP Legionnaires' disease DOID_10457 4.904E-07 1.55E-05 4.904E-07 2.537E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP legionellosis DOID_10458 4.904E-07 1.55E-05 4.904E-07 2.537E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP viral pneumonia DOID_10533 4.904E-07 1.469E-05 4.904E-07 2.325E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP melancholia DOID_2848 7.627E-07 2.17E-05 4.906E-05 1.074E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP neurotic disorder DOID_4964 8.137E-07 2.205E-05 5.147E-05 1.085E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP collagen disease DOID_854 8.673E-07 2.243E-05 5.396E-05 1.096E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP tuberculosis DOID_399 1.319E-06 3.262E-05 1.319E-06 5.772E-05 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP male reproductive system disease DOID_48 1.558E-06 3.693E-05 8.329E-05 1.481E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP endogenous depression DOID_1595 1.925E-06 4.381E-05 9.744E-05 1.68E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP aneurysm disease DOID_2403 2.026E-06 4.433E-05 1.012E-04 1.694E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP mental depression DOID_1596 2.716E-06 5.725E-05 1.258E-04 2.045E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP portal hypertension DOID_10762 3.47E-06 7.051E-05 4.014E-04 5.438E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP extrinsic allergic alveolitis DOID_841 4.365E-06 8.565E-05 4.365E-06 1.552E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP mouth disease DOID_403 4.417E-06 8.377E-05 1.804E-04 2.852E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hepatic vascular disease DOID_272 5.401E-06 9.914E-05 5.357E-04 6.35E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP papilloma DOID_2615 9.454E-06 1.681E-04 7.725E-04 8.453E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hepatitis DOID_2237 1.513E-05 2.608E-04 1.513E-05 4.782E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP intracranial arterial disease DOID_13089 1.625E-05 2.719E-04 1.625E-05 4.623E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cerebral arterial disease DOID_3527 1.625E-05 2.719E-04 1.625E-05 4.623E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP uveal disease DOID_3480 1.994E-05 3.242E-04 1.994E-05 5.157E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP thyroid adenoma DOID_2891 2.567E-05 4.057E-04 1.487E-03 0.01410213 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP atopic dermatitis DOID_3310 3.422E-05 5.262E-04 3.422E-05 7.788E-04 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP giant cell tumor DOID_200 3.613E-05 5.409E-04 1.861E-03 0.01681154 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP malignant giant cell tumor DOID_2705 3.613E-05 5.409E-04 1.861E-03 0.01681154 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP giant cell glioblastoma DOID_3074 3.613E-05 5.409E-04 1.861E-03 0.01681154 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP glioblastoma DOID_3068 4.672E-05 6.816E-04 2.204E-03 0.01900091 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP oral cavity cancer DOID_8618 4.672E-05 6.646E-04 2.204E-03 0.01871731 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP respiratory failure DOID_11162 5.652E-05 7.844E-04 5.652E-05 1.109E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP familial adenomatous polyposis DOID_0050424 6.867E-05 9.303E-04 0.0124077 0.07278331 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP tooth disease DOID_1091 7.056E-05 9.336E-04 7.056E-05 1.338E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP endocrine organ benign neoplasm DOID_0060089 7.361E-05 9.519E-04 2.971E-03 0.02348241 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP astrocytoma DOID_3069 7.675E-05 9.705E-04 3.054E-03 0.02348369 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP stomach disease DOID_76 8.234E-05 1.019E-03 0.01352819 0.07473339 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP encephalitis DOID_9588 8.234E-05 9.968E-04 8.234E-05 1.511E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pancreatitis DOID_4989 1.051E-04 1.245E-03 3.754E-03 0.02670185 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP mixed glioma DOID_5076 1.051E-04 1.22E-03 3.754E-03 0.0263722 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP open-angle glaucoma DOID_1067 1.134E-04 1.29E-03 0.01576544 0.08383677 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP biliary tract cancer DOID_4607 1.258E-04 1.404E-03 4.226E-03 0.028627 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP tongue cancer DOID_8649 1.493E-04 1.633E-03 0.01799773 0.08828198 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hypersensitivity reaction type I disease DOID_1205 1.86E-04 1.997E-03 1.86E-04 2.861E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pulmonary edema DOID_11396 2.357E-04 2.483E-03 2.357E-04 3.529E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP esophagitis DOID_11963 2.357E-04 2.438E-03 0.0224475 0.10300504 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP mitochondrial myopathy DOID_699 2.603E-04 2.645E-03 2.603E-04 3.798E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hypoglycemia DOID_9993 3.131E-04 3.126E-03 3.131E-04 4.454E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP acute pancreatitis DOID_2913 3.708E-04 3.638E-03 3.708E-04 5.146E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP urticaria DOID_1555 4.014E-04 3.871E-03 4.014E-04 5.311E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP myositis DOID_633 4.332E-04 4.108E-03 4.332E-04 5.602E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP middle cerebral artery infarction DOID_3525 4.662E-04 4.348E-03 4.662E-04 5.895E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP gestational diabetes DOID_11714 5.004E-04 4.592E-03 5.004E-04 6.189E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP periodontitis DOID_824 5.004E-04 4.519E-03 5.004E-04 6.057E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP endometrial carcinoma DOID_2871 6.099E-04 5.423E-03 6.099E-04 7.083E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bronchiolitis obliterans DOID_2799 6.488E-04 5.68E-03 6.488E-04 7.384E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP abdominal aortic aneurysm DOID_7693 6.488E-04 5.594E-03 0.03677364 0.13243165 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP endometrial cancer DOID_1380 6.889E-04 5.85E-03 6.889E-04 7.686E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP myocarditis DOID_820 7.725E-04 6.464E-03 0.04005043 0.1415447 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP nephroblastoma DOID_2154 8.161E-04 6.73E-03 0.04114028 0.1427367 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP periodontal disease DOID_3388 8.161E-04 6.633E-03 8.161E-04 8.761E-03 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP thyroid carcinoma DOID_3963 8.161E-04 6.54E-03 0.04114028 0.14187163 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP spindle cell carcinoma DOID_4015 8.161E-04 6.449E-03 0.04114028 0.14101698 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP esophageal disease DOID_6050 8.161E-04 6.361E-03 0.04114028 0.14017257 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP thyroid cancer DOID_1781 9.067E-04 6.971E-03 0.04331634 0.14413449 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP uveitis DOID_13141 1.002E-03 7.601E-03 1.002E-03 0.01055676 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP respiratory syncytial virus infectious disease DOID_1273 1.051E-03 7.87E-03 1.051E-03 0.01087524 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP peptic ulcer DOID_750 1.051E-03 7.768E-03 0.04657139 0.14971256 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP adult respiratory distress syndrome DOID_11394 1.102E-03 8.037E-03 1.102E-03 0.01119401 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune disease of urogenital tract DOID_0060049 1.206E-03 8.687E-03 1.206E-03 0.01203986 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP primary biliary cirrhosis DOID_12236 1.206E-03 8.687E-03 1.206E-03 0.01203986 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP nephrotic syndrome DOID_1184 1.26E-03 8.962E-03 0.05089464 0.15824619 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP Huntington's disease DOID_12858 1.26E-03 8.851E-03 0.05089464 0.15738615 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP gallbladder cancer DOID_3121 1.315E-03 9.125E-03 0.05197246 0.15985043 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP uterine cancer DOID_363 1.315E-03 9.015E-03 1.315E-03 0.01290133 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cerebral infarction DOID_3526 1.371E-03 9.289E-03 1.371E-03 0.01322457 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP proteinuria DOID_576 1.429E-03 9.563E-03 0.05412451 0.16294627 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP vascular skin disease DOID_9540 1.487E-03 9.839E-03 1.487E-03 0.01387095 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.607E-03 0.01051235 1.607E-03 0.0147512 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP integumentary system benign neoplasm DOID_0060121 1.607E-03 0.01039289 0.05734364 0.16647209 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP glaucoma DOID_1686 1.607E-03 0.01027612 0.05734364 0.16562705 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP skin benign neoplasm DOID_3165 1.607E-03 0.01039289 0.05734364 0.16647209 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP B-cell lymphocytic neoplasm DOID_707 1.732E-03 0.01095087 0.05948377 0.16923134 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bile duct adenocarcinoma DOID_4896 1.928E-03 0.01205332 0.06268509 0.17745181 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cholangiocarcinoma DOID_4947 1.928E-03 0.01205332 0.06268509 0.17745181 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP integumentary system cancer DOID_0060122 1.995E-03 0.01233923 0.06374982 0.177812 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP skin cancer DOID_4159 1.995E-03 0.01233923 0.06374982 0.177812 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pustulosis of palm and sole DOID_4398 1.995E-03 0.01220655 1.995E-03 0.01773765 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP mitochondrial metabolism disease DOID_700 2.064E-03 0.01249146 2.064E-03 0.01806458 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bile duct cancer DOID_4606 2.204E-03 0.01320063 0.06693695 0.18488895 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bile duct carcinoma DOID_4897 2.204E-03 0.01320063 0.06693695 0.18488895 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP pre-malignant neoplasm DOID_0060071 2.574E-03 0.01525681 0.07222529 0.19663249 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP in situ carcinoma DOID_8719 2.574E-03 0.01525681 0.07222529 0.19663249 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP endocrine pancreas disease DOID_1428 2.651E-03 0.01555296 2.651E-03 0.02218583 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cholestasis DOID_13580 2.73E-03 0.01584936 2.73E-03 0.02251069 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP temporal lobe epilepsy DOID_3328 2.809E-03 0.01614601 2.809E-03 0.02283507 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperglycemia DOID_4195 2.809E-03 0.01598455 0.07538423 0.20137854 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP allergic contact dermatitis DOID_3042 2.89E-03 0.01628007 2.89E-03 0.02315898 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP brain infarction DOID_3454 2.971E-03 0.01657582 2.971E-03 0.02316074 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP nephrosis DOID_2527 3.223E-03 0.01780333 0.08062581 0.21337714 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bile duct disease DOID_4138 3.223E-03 0.01763214 3.223E-03 0.0244499 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP peripheral vascular disease DOID_341 3.309E-03 0.01792982 3.309E-03 0.02477146 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP biliary tract disease DOID_9741 3.309E-03 0.01776067 3.309E-03 0.02444975 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP diabetic retinopathy DOID_8947 3.396E-03 0.01805725 3.396E-03 0.02477084 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bone resorption disease DOID_0080011 3.663E-03 0.01929851 3.663E-03 0.02638277 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP osteoporosis DOID_11476 3.663E-03 0.01929851 3.663E-03 0.02638277 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP contact dermatitis DOID_2773 3.94E-03 0.02056665 3.94E-03 0.0273386 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP focal epilepsy DOID_2234 4.226E-03 0.02186062 4.226E-03 0.0289719 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP chronic kidney failure DOID_784 4.226E-03 0.02166368 0.09205531 0.23808851 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP retinal vascular disease DOID_2462 4.422E-03 0.02246642 4.422E-03 0.02960281 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP transitional cell carcinoma DOID_2671 4.724E-03 0.0237878 0.09720455 0.25026873 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP amino acid metabolic disorder DOID_9252 4.827E-03 0.02409173 4.827E-03 0.03193554 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP nervous system cancer DOID_3093 4.931E-03 0.02439546 4.931E-03 0.03224687 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphoma DOID_0060058 5.141E-03 0.02521785 0.10130339 0.25848265 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP encephalomyelitis DOID_640 5.248E-03 0.0255217 0.10232526 0.25992443 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP dilated cardiomyopathy DOID_12930 5.465E-03 0.02635012 5.465E-03 0.03533312 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP ulcerative colitis DOID_8577 5.797E-03 0.02771894 0.1074176 0.27044519 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP leber hereditary optic neuropathy DOID_705 0.010163 0.04818954 0.010163 0.06497465 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperparathyroidism DOID_13543 0.01128597 0.05307204 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hypolipoproteinemia DOID_1387 0.01128597 0.05263702 0.01128597 0.07135241 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP childhood type dermatomyositis DOID_14203 0.01128597 0.05220908 0.01128597 0.07056832 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP retinal vascular occlusion DOID_1729 0.01128597 0.05178804 0.01128597 0.06980127 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP transient cerebral ischemia DOID_224 0.01128597 0.05137374 0.01128597 0.06905072 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP acute kidney failure DOID_3021 0.01128597 0.05096601 0.01128597 0.06831614 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP Paget's disease of bone DOID_5408 0.01128597 0.0505647 0.01128597 0.06759702 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cutaneous leishmaniasis DOID_9111 0.01128597 0.05016966 0.01128597 0.06689288 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP dermatomyositis DOID_10223 0.0124077 0.05472854 0.0124077 0.07204063 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP adrenoleukodystrophy DOID_10588 0.0124077 0.05430755 0.0124077 0.07131294 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP neuronal ceroid lipofuscinosis DOID_14503 0.0124077 0.05389299 0.0124077 0.07059982 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bronchiectasis DOID_9563 0.0124077 0.05348471 0.0124077 0.06990081 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP intracranial arteriosclerosis DOID_13097 0.01352819 0.05787623 0.01352819 0.07546607 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP vascular dementia DOID_8725 0.01352819 0.05787623 0.01352819 0.07546607 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP mitochondrial encephalomyopathy DOID_890 0.01352819 0.05744432 0.01352819 0.0740148 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP progressive myoclonus epilepsy DOID_891 0.01352819 0.05701881 0.01352819 0.07330989 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP variable age at onset electroclinical syndrome DOID_0050706 0.01464743 0.06128228 0.01464743 0.07862632 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP parathyroid gland disease DOID_11201 0.01464743 0.06083496 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP larynx cancer DOID_2596 0.01464743 0.06039413 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP laryngeal benign neoplasm DOID_2598 0.01464743 0.06039413 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP polycystic kidney disease DOID_898 0.01576544 0.06453622 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bacterial meningitis DOID_9470 0.01576544 0.06407525 0.01576544 0.0830605 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP idiopathic pulmonary fibrosis DOID_0050156 0.0168822 0.06812748 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP skeletal system cancer DOID_0060124 0.0168822 0.06764771 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP thoracic aortic aneurysm DOID_14004 0.0168822 0.06717465 0.0168822 0.08812821 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP renovascular hypertension DOID_1591 0.0168822 0.06670816 0.0168822 0.08732704 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bone cancer DOID_184 0.0168822 0.06764771 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP lung oat cell carcinoma DOID_5411 0.0168822 0.0662481 0.0168822 0.08654031 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP oral submucous fibrosis DOID_5773 0.0168822 0.06579435 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP varicose veins DOID_799 0.0168822 0.06534676 0.0168822 0.08576763 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperhomocysteinemia DOID_9279 0.0168822 0.06490523 0.0168822 0.08500862 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP restrictive cardiomyopathy DOID_397 0.01799773 0.0687296 0.01799773 0.08983079 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP chronic myeloid leukemia DOID_8552 0.01799773 0.0682714 0.01799773 0.08904965 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP vein disease DOID_866 0.01799773 0.06781927 0.01799773 0.08752744 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP Barrett's esophagus DOID_9206 0.01799773 0.06737309 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP drug-induced mental disorder DOID_1203 0.01911203 0.07107675 0.01911203 0.09215883 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP methylmalonic acidemia DOID_14749 0.01911203 0.07061521 0.01911203 0.09138439 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP drug psychosis DOID_1742 0.01911203 0.07107675 0.01911203 0.09215883 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP hyperostosis DOID_205 0.01911203 0.07015963 0.01911203 0.09062285 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP urinary system benign neoplasm DOID_731 0.01911203 0.06970989 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP substance-induced psychosis DOID_8646 0.01911203 0.07107675 0.01911203 0.09215883 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP dental caries DOID_216 0.02022508 0.07329982 0.02022508 0.09510803 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP prion disease DOID_649 0.02022508 0.0728359 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP granulosa cell tumor DOID_2999 0.02133691 0.0763566 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP MHC class II deficiency DOID_5812 0.02133691 0.07587937 0.02133691 0.09951393 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP leishmaniasis DOID_9065 0.02133691 0.07540807 0.02133691 0.09870487 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP amnestic disorder DOID_10914 0.0224475 0.07884337 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP sex cord-gonadal stromal tumor DOID_192 0.0224475 0.07835967 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP brain edema DOID_4724 0.0224475 0.07788186 0.0224475 0.102181 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP Kawasaki disease DOID_13378 0.02355686 0.08123546 0.02355686 0.10637977 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP lymphadenitis DOID_1602 0.02355686 0.08123546 0.02355686 0.10637977 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune hepatitis DOID_2048 0.02355686 0.08074609 0.02355686 0.10554214 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP coronary restenosis DOID_4247 0.02355686 0.08026258 0.02355686 0.10471759 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP lymph node disease DOID_9942 0.02355686 0.08123546 0.02355686 0.10637977 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP gastric ulcer DOID_10808 0.02466499 0.08353796 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP neutropenia DOID_1227 0.02466499 0.08304365 0.02466499 0.10879362 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP thrombophilia DOID_2452 0.02466499 0.08255516 0.02466499 0.10795675 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP sinusitis DOID_0050127 0.02577189 0.08575558 0.02577189 0.11194049 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP agranulocytosis DOID_12987 0.02577189 0.085257 0.02577189 0.11109246 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP paranasal sinus disease DOID_1352 0.02577189 0.08575558 0.02577189 0.11194049 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP optic nerve disease DOID_1891 0.02577189 0.08476419 0.02577189 0.11025718 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP IgA glomerulonephritis DOID_2986 0.02577189 0.08427704 0.02577189 0.10943436 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP muscle cancer DOID_4045 0.02577189 0.08379545 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP myasthenia gravis DOID_437 0.02577189 0.08331934 0.02577189 0.10862374 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP urinary tract obstruction DOID_5200 0.02577189 0.08284861 1.000 1.000 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP sleep disorder DOID_535 0.02577189 0.08238317 0.02577189 0.10782503 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP polyarteritis nodosa DOID_9810 0.02577189 0.08192293 0.02577189 0.10703799 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP Lewy body dementia DOID_12217 0.02687756 0.08496296 0.02687756 0.11082126 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP meningitis DOID_9471 0.02687756 0.08449356 0.02687756 0.11002398 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP severe combined immunodeficiency DOID_627 0.02798201 0.08748223 0.02798201 0.11372689 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP commensal bacterial infectious disease DOID_0050339 0.02908524 0.09043443 0.02908524 0.11737234 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP organic acidemia DOID_0060159 0.02908524 0.08994293 0.02908524 0.11654577 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP bronchiolitis DOID_2942 0.02908524 0.08945676 0.02908524 0.11573077 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP combined T cell and B cell immunodeficiency DOID_628 0.02908524 0.08897581 0.02908524 0.11492708 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP papillary adenoma DOID_3172 0.03018724 0.09185315 0.03018724 0.11845889 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP neuromuscular junction disease DOID_439 0.03018724 0.09136457 0.03018724 0.11764753 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP microcystic adenoma DOID_5403 0.03018724 0.09185315 0.03018724 0.11845889 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP follicular adenoma DOID_6204 0.03018724 0.09185315 0.03018724 0.11845889 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP myopia DOID_11830 0.03128802 0.09419515 0.03128802 0.12110805 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP teeth hard tissue disease DOID_214 0.03128802 0.09369938 0.03128802 0.12028975 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP diffuse large B-cell lymphoma DOID_0050745 0.03238758 0.09648446 0.03238758 0.12368142 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP lung adenocarcinoma DOID_3910 0.03238758 0.09598194 0.03238758 0.12285688 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP perinatal necrotizing enterocolitis DOID_8677 0.03238758 0.09548462 0.03238758 0.12204326 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune disease of cardiovascular system DOID_0060051 0.03348592 0.09821386 0.03348592 0.12535189 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP renal hypertension DOID_1073 0.03348592 0.09771019 0.03348592 0.1245326 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP secondary hypertension DOID_11130 0.03348592 0.09771019 0.03348592 0.1245326 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP Behcet's disease DOID_13241 0.03348592 0.09821386 0.03348592 0.12535189 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP coronary stenosis DOID_4248 0.03348592 0.09721167 0.03348592 0.12372395 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP autoimmune disease of the nervous system DOID_438 0.03348592 0.09671821 0.03348592 0.12292573 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP polycystic ovary syndrome DOID_11612 0.03458304 0.09938258 0.03458304 0.12613943 GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP cranial nerve disease DOID_5656 0.03458304 0.09888317 0.03458304 0.12533599 DOANE_RESPONSE_TO_ANDROGEN_UP endogenous depression DOID_1595 7.339E-07 4.176E-04 2.446E-05 0.01391513 DOANE_RESPONSE_TO_ANDROGEN_UP mental depression DOID_1596 1.127E-06 3.206E-04 3.432E-05 9.765E-03 DOANE_RESPONSE_TO_ANDROGEN_UP sinusitis DOID_0050127 1.613E-05 3.06E-03 1.108E-03 0.12608371 DOANE_RESPONSE_TO_ANDROGEN_UP paranasal sinus disease DOID_1352 1.613E-05 3.06E-03 1.108E-03 0.12608371 DOANE_RESPONSE_TO_ANDROGEN_UP periodontal disease DOID_3388 6.928E-05 9.855E-03 2.861E-03 0.23252398 DOANE_RESPONSE_TO_ANDROGEN_UP learning disability DOID_8927 1.516E-04 0.01725444 4.772E-03 0.24683554 DOANE_RESPONSE_TO_ANDROGEN_UP prostatic adenoma DOID_2883 2.449E-04 0.02322464 2.449E-04 0.04644928 DOANE_RESPONSE_TO_ANDROGEN_UP parasitic protozoa infectious disease DOID_2789 2.664E-04 0.02165146 6.897E-03 0.23084736 DOANE_RESPONSE_TO_ANDROGEN_UP melancholia DOID_2848 3.245E-04 0.02307846 7.847E-03 0.23498787 DOANE_RESPONSE_TO_ANDROGEN_UP neurotic disorder DOID_4964 3.402E-04 0.02150682 8.093E-03 0.23024046 DOANE_RESPONSE_TO_ANDROGEN_UP parasitic infectious disease DOID_1398 4.26E-04 0.02424086 9.375E-03 0.23192421 DOANE_RESPONSE_TO_ANDROGEN_UP tooth disease DOID_1091 4.639E-04 0.02399659 9.911E-03 0.22558089 DOANE_RESPONSE_TO_ANDROGEN_UP male reproductive organ benign neoplasm DOID_0060087 6.747E-04 0.0319911 6.747E-04 0.09597329 DOANE_RESPONSE_TO_ANDROGEN_UP chronic kidney failure DOID_784 8.18E-04 0.0358031 0.01435261 0.26343978 DOANE_RESPONSE_TO_ANDROGEN_UP neutropenia DOID_1227 1.013E-03 0.04117127 0.04597764 0.3737325 DOANE_RESPONSE_TO_ANDROGEN_UP agranulocytosis DOID_12987 1.108E-03 0.0420279 0.04801717 0.3742708 DOANE_RESPONSE_TO_ANDROGEN_UP mouth disease DOID_403 1.164E-03 0.0413777 0.01805833 0.30221146 DOANE_RESPONSE_TO_ANDROGEN_UP portal hypertension DOID_10762 1.417E-03 0.04743924 0.05410996 0.37094659 DOANE_RESPONSE_TO_ANDROGEN_UP periodontitis DOID_824 1.763E-03 0.05573814 0.06016423 0.38037166 DOANE_RESPONSE_TO_ANDROGEN_UP hepatic vascular disease DOID_272 1.887E-03 0.05649804 0.06217381 0.38039675 DOANE_RESPONSE_TO_ANDROGEN_UP supratentorial cancer DOID_1659 2.014E-03 0.05729537 0.06417914 0.38439927 DOANE_RESPONSE_TO_ANDROGEN_UP cerebrum cancer DOID_368 2.014E-03 0.05729537 0.06417914 0.38439927 DOANE_RESPONSE_TO_ANDROGEN_UP chronic leukemia DOID_1036 2.563E-03 0.06943693 2.563E-03 0.24302926 DOANE_RESPONSE_TO_ANDROGEN_UP chronic lymphocytic leukemia DOID_1040 2.563E-03 0.06943693 2.563E-03 0.24302926 DOANE_RESPONSE_TO_ANDROGEN_UP leukopenia DOID_615 2.861E-03 0.0739849 0.07612249 0.4288485 DOANE_RESPONSE_TO_ANDROGEN_UP adult respiratory distress syndrome DOID_11394 3.846E-03 0.09515901 0.08791528 0.47641708 DOANE_RESPONSE_TO_ANDROGEN_UP intracranial arterial disease DOID_13089 3.846E-03 0.09119405 0.08791528 0.47192258 DOANE_RESPONSE_TO_ANDROGEN_UP cerebral arterial disease DOID_3527 3.846E-03 0.09119405 0.08791528 0.47192258 DOANE_RESPONSE_TO_ANDROGEN_UP spinocerebellar ataxia DOID_1441 4.205E-03 0.09571619 4.205E-03 0.2991131 DOANE_RESPONSE_TO_ANDROGEN_UP nephrotic syndrome DOID_1184 4.391E-03 0.09608542 4.391E-03 0.27758009 DOANE_RESPONSE_TO_ANDROGEN_UP diabetic autonomic neuropathy DOID_11503 4.579E-03 0.09650565 4.579E-03 0.26056527 DOANE_RESPONSE_TO_ANDROGEN_UP autonomic neuropathy DOID_11504 4.579E-03 0.09650565 4.579E-03 0.26056527 DOANE_RESPONSE_TO_ANDROGEN_UP diabetic polyneuropathy DOID_12785 4.579E-03 0.09650565 4.579E-03 0.26056527 DOANE_RESPONSE_TO_ANDROGEN_UP diabetic neuropathy DOID_9743 4.579E-03 0.09650565 4.579E-03 0.26056527 DOANE_RESPONSE_TO_ANDROGEN_UP brain cancer DOID_1319 5.168E-03 0.09801833 0.10148573 0.49355024 DOANE_RESPONSE_TO_ANDROGEN_UP central nervous system cancer DOID_3620 5.371E-03 0.098592 0.10340801 0.49863694 DOANE_RESPONSE_TO_ANDROGEN_UP lung small cell carcinoma DOID_5409 5.579E-03 0.09919449 0.10532624 0.49529445 DOANE_RESPONSE_TO_ANDROGEN_UP movement disease DOID_480 5.789E-03 0.09982291 5.789E-03 0.23529685 DANG_REGULATED_BY_MYC_DN aortic valve insufficiency DOID_57 5.557E-17 3.162E-14 1.222E-03 0.07726138 DANG_REGULATED_BY_MYC_DN pre-malignant neoplasm DOID_0060071 7.075E-15 2.013E-12 1.091E-05 3.104E-03 DANG_REGULATED_BY_MYC_DN in situ carcinoma DOID_8719 7.075E-15 2.013E-12 1.091E-05 3.104E-03 DANG_REGULATED_BY_MYC_DN heart valve disease DOID_4079 1.74E-14 3.299E-12 0.02034649 0.26923606 DANG_REGULATED_BY_MYC_DN nephrosis DOID_2527 2.672E-14 3.8E-12 1.912E-05 3.627E-03 DANG_REGULATED_BY_MYC_DN aortic valve disease DOID_62 7.897E-14 8.987E-12 4.937E-03 0.17558125 DANG_REGULATED_BY_MYC_DN transitional cell carcinoma DOID_2671 2.504E-13 2.375E-11 7.331E-03 0.1986255 DANG_REGULATED_BY_MYC_DN peripheral vascular disease DOID_341 1.278E-12 1.039E-10 0.04294521 0.3593504 DANG_REGULATED_BY_MYC_DN retinal vascular disease DOID_2462 5.898E-12 4.195E-10 0.05597608 0.35786955 DANG_REGULATED_BY_MYC_DN adenoma DOID_657 6.248E-12 3.95E-10 0.01269896 0.22580343 DANG_REGULATED_BY_MYC_DN hypertrophic cardiomyopathy DOID_11984 6.783E-12 3.86E-10 7.393E-06 4.207E-03 DANG_REGULATED_BY_MYC_DN collagen disease DOID_854 1.065E-11 5.51E-10 0.24503565 0.75365018 DANG_REGULATED_BY_MYC_DN portal hypertension DOID_10762 1.666E-11 7.901E-10 1.99E-04 0.02831423 DANG_REGULATED_BY_MYC_DN membranoproliferative glomerulonephritis DOID_2920 3.117E-11 1.364E-09 1.000 1.000 DANG_REGULATED_BY_MYC_DN pancreatic ductal carcinoma DOID_3587 3.631E-11 1.476E-09 0.04089997 0.38786803 DANG_REGULATED_BY_MYC_DN hepatic vascular disease DOID_272 5.081E-11 1.928E-09 3.068E-04 0.02909926 DANG_REGULATED_BY_MYC_DN pancreatic carcinoma DOID_4905 5.269E-11 1.874E-09 0.04398194 0.36269168 DANG_REGULATED_BY_MYC_DN diabetic retinopathy DOID_8947 5.269E-11 1.764E-09 0.04398194 0.35751037 DANG_REGULATED_BY_MYC_DN aneurysm disease DOID_2403 7.527E-11 2.379E-09 0.29321792 0.85559485 DANG_REGULATED_BY_MYC_DN bile duct adenocarcinoma DOID_4896 1.57E-10 4.701E-09 0.02598733 0.30805814 DANG_REGULATED_BY_MYC_DN cholangiocarcinoma DOID_4947 1.57E-10 4.701E-09 0.02598733 0.30805814 DANG_REGULATED_BY_MYC_DN bile duct cancer DOID_4606 2.756E-10 7.842E-09 0.02946194 0.32238161 DANG_REGULATED_BY_MYC_DN bile duct carcinoma DOID_4897 2.756E-10 7.842E-09 0.02946194 0.32238161 DANG_REGULATED_BY_MYC_DN mineral metabolism disease DOID_0050032 5.971E-10 1.618E-08 3.216E-03 0.14076838 DANG_REGULATED_BY_MYC_DN cerebral degeneration DOID_1443 6.742E-10 1.744E-08 2.321E-04 0.02641093 DANG_REGULATED_BY_MYC_DN nephrotic syndrome DOID_1184 1.26E-09 3.116E-08 1.09E-03 0.07751702 DANG_REGULATED_BY_MYC_DN proteinuria DOID_576 2E-09 4.741E-08 0.0195882 0.27864213 DANG_REGULATED_BY_MYC_DN biliary tract cancer DOID_4607 4.121E-09 9.38E-08 0.05371777 0.37735075 DANG_REGULATED_BY_MYC_DN focal glomerulosclerosis DOID_3945 4.328E-09 9.471E-08 8.153E-03 0.18556551 DANG_REGULATED_BY_MYC_DN Ehlers-Danlos syndrome DOID_13359 4.391E-09 9.254E-08 0.06371611 0.38568581 DANG_REGULATED_BY_MYC_DN giant cell tumor DOID_200 5.262E-09 1.069E-07 0.02514666 0.30443505 DANG_REGULATED_BY_MYC_DN malignant giant cell tumor DOID_2705 5.262E-09 1.069E-07 0.02514666 0.30443505 DANG_REGULATED_BY_MYC_DN giant cell glioblastoma DOID_3074 5.262E-09 1.069E-07 0.02514666 0.30443505 DANG_REGULATED_BY_MYC_DN reproductive organ benign neoplasm DOID_0050622 6.772E-09 1.329E-07 0.22486093 0.72696517 DANG_REGULATED_BY_MYC_DN glioblastoma DOID_3068 9.718E-09 1.843E-07 0.02946194 0.32870282 DANG_REGULATED_BY_MYC_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.09E-08 2.001E-07 8.748E-03 0.18434606 DANG_REGULATED_BY_MYC_DN papilloma DOID_2615 1.124E-08 1.999E-07 0.14619428 0.54368982 DANG_REGULATED_BY_MYC_DN astrocytoma DOID_3069 3.152E-08 5.434E-07 0.03989165 0.38471781 DANG_REGULATED_BY_MYC_DN cervix uteri carcinoma in situ DOID_8991 3.959E-08 6.625E-07 0.01598285 0.25261783 DANG_REGULATED_BY_MYC_DN diabetic angiopathy DOID_11713 6.02E-08 9.787E-07 4.937E-03 0.18728667 DANG_REGULATED_BY_MYC_DN pancreatitis DOID_4989 6.6E-08 1.043E-06 0.04822056 0.37077697 DANG_REGULATED_BY_MYC_DN insulinoma DOID_3892 7.293E-08 1.122E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN myeloma DOID_0070004 8.72E-08 1.306E-06 0.19712543 0.66764505 DANG_REGULATED_BY_MYC_DN pre-eclampsia DOID_10591 8.72E-08 1.272E-06 0.02034649 0.28236952 DANG_REGULATED_BY_MYC_DN vascular skin disease DOID_9540 8.72E-08 1.24E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN aortic aneurysm DOID_3627 1.246E-07 1.729E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN islet cell tumor DOID_1799 1.707E-07 2.313E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN nervous system cancer DOID_3093 1.742E-07 2.305E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN Human immunodeficiency virus infectious disease DOID_526 1.742E-07 2.252E-06 7.787E-03 0.1846051 DANG_REGULATED_BY_MYC_DN atrophic muscular disease DOID_913 1.743E-07 2.204E-06 1.928E-03 0.09970576 DANG_REGULATED_BY_MYC_DN muscular dystrophy DOID_9884 1.743E-07 2.204E-06 1.928E-03 0.09970576 DANG_REGULATED_BY_MYC_DN bone marrow cancer DOID_4960 1.941E-07 2.402E-06 0.22144677 0.72415638 DANG_REGULATED_BY_MYC_DN renal hypertension DOID_1073 1.976E-07 2.392E-06 0.12339537 0.49445048 DANG_REGULATED_BY_MYC_DN secondary hypertension DOID_11130 1.976E-07 2.392E-06 0.12339537 0.49445048 DANG_REGULATED_BY_MYC_DN autoimmune disease of the nervous system DOID_438 1.976E-07 2.342E-06 0.12339537 0.48090389 DANG_REGULATED_BY_MYC_DN Leydig cell tumor DOID_2696 2.458E-07 2.854E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN sex cord-stromal neoplasm DOID_4757 2.458E-07 2.854E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN endometrial carcinoma DOID_2871 2.773E-07 3.155E-06 0.13106146 0.50049644 DANG_REGULATED_BY_MYC_DN hypersensitivity reaction type IV disease DOID_2916 2.928E-07 3.267E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN endometrial cancer DOID_1380 3.804E-07 4.163E-06 0.1386609 0.52250365 DANG_REGULATED_BY_MYC_DN germinoma DOID_3304 3.804E-07 4.084E-06 0.1386609 0.51906613 DANG_REGULATED_BY_MYC_DN respiratory failure DOID_11162 4.293E-07 4.524E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN oral submucous fibrosis DOID_5773 4.66E-07 4.821E-06 1.000 1.000 DANG_REGULATED_BY_MYC_DN spindle cell carcinoma DOID_4015 5.897E-07 5.991E-06 0.14993637 0.55398567 DANG_REGULATED_BY_MYC_DN calcinosis DOID_182 8.807E-07 8.792E-06 0.01332927 0.22306926 DANG_REGULATED_BY_MYC_DN ureteral obstruction DOID_5199 1.034E-06 1.014E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN systemic scleroderma DOID_418 1.131E-06 1.09E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN peptic ulcer DOID_750 1.131E-06 1.072E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN adult respiratory distress syndrome DOID_11394 1.275E-06 1.189E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN lymphatic system disease DOID_75 1.275E-06 1.17E-05 0.17204903 0.61569747 DANG_REGULATED_BY_MYC_DN electroclinical syndrome DOID_0050701 1.48E-06 1.336E-05 5.292E-03 0.17713284 DANG_REGULATED_BY_MYC_DN mixed glioma DOID_5076 1.48E-06 1.315E-05 4.327E-04 0.03517421 DANG_REGULATED_BY_MYC_DN rheumatic disease DOID_1575 1.796E-06 1.572E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN scleroderma DOID_419 1.796E-06 1.572E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN coronary restenosis DOID_4247 2.002E-06 1.726E-05 0.08805763 0.42824607 DANG_REGULATED_BY_MYC_DN uterine cancer DOID_363 2.003E-06 1.701E-05 0.1864722 0.65093669 DANG_REGULATED_BY_MYC_DN chronic kidney failure DOID_784 2.115E-06 1.77E-05 0.31162359 0.88656912 DANG_REGULATED_BY_MYC_DN placenta disease DOID_780 2.438E-06 2.011E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN leukodystrophy DOID_10579 2.472E-06 2.01E-05 0.0195882 0.2857868 DANG_REGULATED_BY_MYC_DN uremia DOID_4676 2.942E-06 2.357E-05 0.09603086 0.4442403 DANG_REGULATED_BY_MYC_DN urinary tract obstruction DOID_5200 2.942E-06 2.325E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN hemolytic anemia DOID_583 3.024E-06 2.357E-05 1.471E-03 0.0837238 DANG_REGULATED_BY_MYC_DN normocytic anemia DOID_720 3.024E-06 2.357E-05 1.471E-03 0.0837238 DANG_REGULATED_BY_MYC_DN ureteral disease DOID_1426 3.518E-06 2.705E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN meningitis DOID_9471 3.518E-06 2.669E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN calcium metabolism disease DOID_10575 3.668E-06 2.747E-05 0.02269361 0.29346967 DANG_REGULATED_BY_MYC_DN toxic shock syndrome DOID_14115 4.174E-06 3.084E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN dilated cardiomyopathy DOID_12930 4.576E-06 3.338E-05 8.998E-03 0.18285512 DANG_REGULATED_BY_MYC_DN sarcoidosis DOID_11335 4.832E-06 3.48E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN commensal bacterial infectious disease DOID_0050339 4.916E-06 3.496E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN seminoma DOID_4440 6.687E-06 4.697E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN melancholia DOID_2848 8.014E-06 5.561E-05 0.03035801 0.31988345 DANG_REGULATED_BY_MYC_DN neurotic disorder DOID_4964 8.674E-06 5.946E-05 0.03126482 0.32344875 DANG_REGULATED_BY_MYC_DN sarcoma DOID_1115 8.889E-06 6.021E-05 0.12339537 0.49099279 DANG_REGULATED_BY_MYC_DN coronary stenosis DOID_4248 8.889E-06 5.95E-05 0.12339537 0.48422047 DANG_REGULATED_BY_MYC_DN renal tubular transport disease DOID_447 8.889E-06 5.881E-05 7.649E-03 0.18922911 DANG_REGULATED_BY_MYC_DN neuroectodermal tumor DOID_171 9.376E-06 6.132E-05 0.24503565 0.7618868 DANG_REGULATED_BY_MYC_DN congenital heart defect DOID_1682 1.091E-05 7.056E-05 0.03404861 0.34595824 DANG_REGULATED_BY_MYC_DN parasitic infectious disease DOID_1398 1.264E-05 8.08E-05 0.0359562 0.35893116 DANG_REGULATED_BY_MYC_DN uterine disease DOID_345 1.264E-05 7.99E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN abdominal aortic aneurysm DOID_7693 1.314E-05 8.214E-05 1.000 1.000 DANG_REGULATED_BY_MYC_DN endocrine organ benign neoplasm DOID_0060089 1.562E-05 9.66E-05 0.267914 0.80657707 DANG_REGULATED_BY_MYC_DN blood coagulation disease DOID_1247 1.789E-05 1.095E-04 0.27432316 0.81722449 DANG_REGULATED_BY_MYC_DN male reproductive system disease DOID_48 1.912E-05 1.157E-04 0.2775068 0.82240295 DANG_REGULATED_BY_MYC_DN osteogenesis imperfecta DOID_12347 2.283E-05 1.367E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN endogenous depression DOID_1595 2.471E-05 1.465E-04 0.04608311 0.36931393 DANG_REGULATED_BY_MYC_DN adolescence-adult electroclinical syndrome DOID_0050705 2.865E-05 1.681E-04 0.01332927 0.22982893 DANG_REGULATED_BY_MYC_DN pulmonary sarcoidosis DOID_13406 2.865E-05 1.663E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN multiple myeloma DOID_9538 2.865E-05 1.647E-04 0.16106511 0.5837328 DANG_REGULATED_BY_MYC_DN female reproductive system disease DOID_229 3.339E-05 1.9E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN renovascular hypertension DOID_1591 3.609E-05 2.033E-04 0.06371611 0.38162596 DANG_REGULATED_BY_MYC_DN hemangioma DOID_255 3.609E-05 2.013E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN varicose veins DOID_799 3.609E-05 1.994E-04 0.06371611 0.37375738 DANG_REGULATED_BY_MYC_DN mental depression DOID_1596 3.746E-05 2.049E-04 0.05371777 0.38206764 DANG_REGULATED_BY_MYC_DN intracranial arterial disease DOID_13089 3.829E-05 2.075E-04 0.01529986 0.24873195 DANG_REGULATED_BY_MYC_DN cerebral arterial disease DOID_3527 3.829E-05 2.075E-04 0.01529986 0.24873195 DANG_REGULATED_BY_MYC_DN angiosarcoma DOID_0001816 4.427E-05 2.377E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN spastic diplegia DOID_10965 4.427E-05 2.354E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN vein disease DOID_866 4.427E-05 2.333E-04 0.06781742 0.3783148 DANG_REGULATED_BY_MYC_DN autoimmune disease of urogenital tract DOID_0060049 4.592E-05 2.397E-04 0.17929211 0.63760755 DANG_REGULATED_BY_MYC_DN primary biliary cirrhosis DOID_12236 4.592E-05 2.397E-04 0.17929211 0.63760755 DANG_REGULATED_BY_MYC_DN penile disease DOID_1529 5.359E-05 2.772E-04 0.07190087 0.3933807 DANG_REGULATED_BY_MYC_DN diabetic autonomic neuropathy DOID_11503 5.459E-05 2.799E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN autonomic neuropathy DOID_11504 5.459E-05 2.799E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN diabetic polyneuropathy DOID_12785 5.459E-05 2.799E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN diabetic neuropathy DOID_9743 5.459E-05 2.799E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN lymphoblastic leukemia DOID_1037 6.387E-05 3.245E-04 8.501E-03 0.18604269 DANG_REGULATED_BY_MYC_DN encephalomyelitis DOID_640 6.387E-05 3.216E-04 0.34124689 0.95649992 DANG_REGULATED_BY_MYC_DN mouth disease DOID_403 6.715E-05 3.351E-04 0.34413861 0.9598768 DANG_REGULATED_BY_MYC_DN Crohn's disease DOID_8778 6.715E-05 3.322E-04 0.34413861 0.95519448 DANG_REGULATED_BY_MYC_DN autonomic nervous system disease DOID_11465 6.977E-05 3.423E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN brain cancer DOID_1319 6.977E-05 3.393E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN hypersensitivity reaction type I disease DOID_1205 7.055E-05 3.402E-04 0.06774545 0.38547163 DANG_REGULATED_BY_MYC_DN central nervous system cancer DOID_3620 7.546E-05 3.608E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN glaucoma DOID_1686 8.147E-05 3.863E-04 0.20415043 0.6753581 DANG_REGULATED_BY_MYC_DN ulcerative colitis DOID_8577 8.155E-05 3.835E-04 0.35557983 0.98215982 DANG_REGULATED_BY_MYC_DN membranous glomerulonephritis DOID_10976 8.898E-05 4.15E-04 0.08404484 0.41948696 DANG_REGULATED_BY_MYC_DN brain edema DOID_4724 8.898E-05 4.116E-04 0.08404484 0.41225442 DANG_REGULATED_BY_MYC_DN withdrawal disorder DOID_0060001 9.452E-05 4.337E-04 0.02349968 0.29714042 DANG_REGULATED_BY_MYC_DN hemorrhagic disease DOID_2213 9.452E-05 4.303E-04 0.21111433 0.69435868 DANG_REGULATED_BY_MYC_DN Kawasaki disease DOID_13378 1.035E-04 4.673E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN lymphadenitis DOID_1602 1.035E-04 4.673E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN lymph node disease DOID_9942 1.035E-04 4.673E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN vasculitis DOID_865 1.169E-04 5.236E-04 0.22144677 0.72001834 DANG_REGULATED_BY_MYC_DN hepatitis B DOID_2043 1.194E-04 5.309E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN osteochondrodysplasia DOID_2256 1.251E-04 5.517E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN parasitic protozoa infectious disease DOID_2789 1.251E-04 5.475E-04 0.02683931 0.31166462 DANG_REGULATED_BY_MYC_DN pustulosis of palm and sole DOID_4398 1.251E-04 5.433E-04 0.02683931 0.30543133 DANG_REGULATED_BY_MYC_DN familial hyperlipidemia DOID_1168 1.337E-04 5.765E-04 0.22826022 0.72558694 DANG_REGULATED_BY_MYC_DN myasthenia gravis DOID_437 1.369E-04 5.857E-04 0.09603086 0.44788161 DANG_REGULATED_BY_MYC_DN polyarteritis nodosa DOID_9810 1.369E-04 5.813E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN oral cavity cancer DOID_8618 1.523E-04 6.419E-04 0.02946194 0.31629894 DANG_REGULATED_BY_MYC_DN Lewy body dementia DOID_12217 1.559E-04 6.525E-04 0.09999145 0.45883172 DANG_REGULATED_BY_MYC_DN spastic quadriplegia DOID_10970 1.766E-04 7.337E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN sphingolipidosis DOID_1927 1.766E-04 7.283E-04 5.351E-03 0.16915816 DANG_REGULATED_BY_MYC_DN carotid artery disease DOID_3407 1.835E-04 7.514E-04 0.24503565 0.75774611 DANG_REGULATED_BY_MYC_DN urticaria DOID_1555 1.99E-04 8.09E-04 1.000 1.000 DANG_REGULATED_BY_MYC_DN papillary adenoma DOID_3172 2.232E-04 9.007E-04 0.11177003 0.47817402 DANG_REGULATED_BY_MYC_DN neuromuscular junction disease DOID_439 2.232E-04 8.944E-04 0.11177003 0.47460556 DANG_REGULATED_BY_MYC_DN microcystic adenoma DOID_5403 2.232E-04 9.007E-04 0.11177003 0.47817402 DANG_REGULATED_BY_MYC_DN follicular adenoma DOID_6204 2.232E-04 9.007E-04 0.11177003 0.47817402 DANG_REGULATED_BY_MYC_DN intracranial aneurysm DOID_10941 2.492E-04 9.915E-04 0.11566207 0.48749421 DANG_REGULATED_BY_MYC_DN brain infarction DOID_3454 2.741E-04 1.083E-03 0.267914 0.80233193 DANG_REGULATED_BY_MYC_DN Sciatic Neuropathy DOID_11446 2.771E-04 1.087E-03 0.11953716 0.48932838 DANG_REGULATED_BY_MYC_DN lesion of sciatic nerve DOID_12528 2.771E-04 1.087E-03 0.11953716 0.48932838 DANG_REGULATED_BY_MYC_DN lung adenocarcinoma DOID_3910 2.771E-04 1.08E-03 7.16E-03 0.2036879 DANG_REGULATED_BY_MYC_DN mononeuritis of lower limb DOID_9473 2.771E-04 1.087E-03 0.11953716 0.48932838 DANG_REGULATED_BY_MYC_DN autoimmune disease of cardiovascular system DOID_0060051 3.068E-04 1.188E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN malaria DOID_12365 3.068E-04 1.18E-03 7.649E-03 0.19783043 DANG_REGULATED_BY_MYC_DN Behcet's disease DOID_13241 3.068E-04 1.188E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN mononeuritis DOID_1802 3.068E-04 1.172E-03 0.12339537 0.48758311 DANG_REGULATED_BY_MYC_DN mononeuropathy DOID_1188 3.386E-04 1.285E-03 0.12723678 0.49250156 DANG_REGULATED_BY_MYC_DN spastic cerebral palsy DOID_0050669 4.084E-04 1.539E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN age related macular degeneration DOID_10871 4.084E-04 1.529E-03 9.205E-03 0.18060805 DANG_REGULATED_BY_MYC_DN degeneration of macula and posterior pole DOID_2007 4.084E-04 1.529E-03 9.205E-03 0.18060805 DANG_REGULATED_BY_MYC_DN bone resorption disease DOID_0080011 4.125E-04 1.534E-03 0.29321792 0.86000513 DANG_REGULATED_BY_MYC_DN osteoporosis DOID_11476 4.125E-04 1.534E-03 0.29321792 0.86000513 DANG_REGULATED_BY_MYC_DN bacterial pneumonia DOID_874 4.327E-04 1.599E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN Charcot-Marie-Tooth disease DOID_10595 4.465E-04 1.639E-03 0.1386609 0.52598701 DANG_REGULATED_BY_MYC_DN lipid metabolism disorder DOID_3146 4.753E-04 1.734E-03 0.3024811 0.86925123 DANG_REGULATED_BY_MYC_DN bone development disease DOID_0080006 5.693E-04 2.063E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN nephroblastoma DOID_2154 5.742E-04 2.068E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN macular degeneration DOID_4448 5.742E-04 2.055E-03 0.01147895 0.21771741 DANG_REGULATED_BY_MYC_DN medullomyoblastoma DOID_3861 6.214E-04 2.21E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN adult medulloblastoma DOID_3864 6.214E-04 2.21E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN childhood medulloblastoma DOID_3869 6.214E-04 2.21E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN medulloblastoma DOID_3858 7.231E-04 2.556E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN embryonal cancer DOID_688 7.231E-04 2.54E-03 0.16106511 0.58747467 DANG_REGULATED_BY_MYC_DN uveitis DOID_13141 7.777E-04 2.715E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN hepatitis DOID_2237 8.349E-04 2.897E-03 0.1684037 0.60646648 DANG_REGULATED_BY_MYC_DN congenital diaphragmatic hernia DOID_3827 8.349E-04 2.879E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN facioscapulohumeral muscular dystrophy DOID_11727 8.38E-04 2.873E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN hyperparathyroidism DOID_13543 8.38E-04 2.855E-03 0.04293898 0.38781398 DANG_REGULATED_BY_MYC_DN retinal vascular occlusion DOID_1729 8.38E-04 2.838E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN rectal neoplasm DOID_1984 8.38E-04 2.822E-03 0.04293898 0.37588124 DANG_REGULATED_BY_MYC_DN rectum cancer DOID_1993 8.38E-04 2.822E-03 0.04293898 0.37588124 DANG_REGULATED_BY_MYC_DN acute kidney failure DOID_3021 8.38E-04 2.805E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN pulmonary emphysema DOID_9675 9.57E-04 3.184E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN familial adenomatous polyposis DOID_0050424 1.021E-03 3.379E-03 0.04713075 0.37246383 DANG_REGULATED_BY_MYC_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 1.021E-03 3.359E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN breast benign neoplasm DOID_0060082 1.021E-03 3.34E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN thoracic benign neoplasm DOID_0060097 1.021E-03 3.34E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN sickle cell anemia DOID_10923 1.021E-03 3.321E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN benign breast phyllodes tumor DOID_1631 1.021E-03 3.34E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN invasive lobular carcinoma DOID_3457 1.021E-03 3.302E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN primitive neuroectodermal tumor DOID_168 1.09E-03 3.504E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN idiopathic generalized epilepsy DOID_1827 1.09E-03 3.484E-03 0.01738728 0.26738823 DANG_REGULATED_BY_MYC_DN uveal disease DOID_3480 1.09E-03 3.464E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN gallbladder cancer DOID_3121 1.16E-03 3.668E-03 0.1864722 0.65495482 DANG_REGULATED_BY_MYC_DN neonatoal period electroclinical syndrome DOID_0050702 1.222E-03 3.842E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN pituitary cancer DOID_1785 1.222E-03 3.821E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN pituitary carcinoma DOID_4916 1.222E-03 3.821E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN retinal detachment DOID_5327 1.222E-03 3.8E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN lipodystrophy DOID_811 1.222E-03 3.779E-03 0.05130427 0.38410693 DANG_REGULATED_BY_MYC_DN peritonitis DOID_8283 1.222E-03 3.759E-03 0.05130427 0.37911853 DANG_REGULATED_BY_MYC_DN cerebral infarction DOID_3526 1.234E-03 3.775E-03 0.19003879 0.6553459 DANG_REGULATED_BY_MYC_DN cataract DOID_83 1.234E-03 3.754E-03 0.01884216 0.28213648 DANG_REGULATED_BY_MYC_DN learning disability DOID_8927 1.234E-03 3.734E-03 0.19003879 0.65139803 DANG_REGULATED_BY_MYC_DN lens disease DOID_110 1.389E-03 4.183E-03 0.02034649 0.27564644 DANG_REGULATED_BY_MYC_DN neuritis DOID_1803 1.389E-03 4.161E-03 0.19712543 0.66369448 DANG_REGULATED_BY_MYC_DN thyroid adenoma DOID_2891 1.389E-03 4.139E-03 0.19712543 0.6597904 DANG_REGULATED_BY_MYC_DN berylliosis DOID_10322 1.44E-03 4.268E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN parathyroid gland disease DOID_11201 1.44E-03 4.246E-03 0.05545961 0.37567285 DANG_REGULATED_BY_MYC_DN newborn respiratory distress syndrome DOID_12716 1.44E-03 4.224E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN polyneuropathy DOID_1389 1.44E-03 4.202E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN obstructive hydrocephalus DOID_14159 1.44E-03 4.181E-03 0.05545961 0.36693627 DANG_REGULATED_BY_MYC_DN communicating hydrocephalus DOID_1573 1.44E-03 4.181E-03 0.05545961 0.36693627 DANG_REGULATED_BY_MYC_DN epilepsy with generalized tonic-clonic seizures DOID_7725 1.44E-03 4.159E-03 0.05545961 0.35859681 DANG_REGULATED_BY_MYC_DN integumentary system benign neoplasm DOID_0060121 1.557E-03 4.473E-03 0.20415043 0.67930756 DANG_REGULATED_BY_MYC_DN skin benign neoplasm DOID_3165 1.557E-03 4.473E-03 0.20415043 0.67930756 DANG_REGULATED_BY_MYC_DN lung small cell carcinoma DOID_5409 1.557E-03 4.451E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN viral pneumonia DOID_10533 1.675E-03 4.766E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN hydrocephalus DOID_10908 1.675E-03 4.742E-03 0.05959687 0.37678464 DANG_REGULATED_BY_MYC_DN parasitic helminthiasis infectious disease DOID_883 1.675E-03 4.719E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN bacterial meningitis DOID_9470 1.675E-03 4.696E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN orofacial cleft DOID_0050567 1.83E-03 5.105E-03 0.0243174 0.30079568 DANG_REGULATED_BY_MYC_DN thoracic aortic aneurysm DOID_14004 1.927E-03 5.35E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN intermediate coronary syndrome DOID_8805 1.927E-03 5.324E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN intracranial hypertension DOID_9428 1.927E-03 5.298E-03 0.06371611 0.36994353 DANG_REGULATED_BY_MYC_DN integumentary system cancer DOID_0060122 2.132E-03 5.832E-03 0.22486093 0.72285802 DANG_REGULATED_BY_MYC_DN skin cancer DOID_4159 2.132E-03 5.832E-03 0.22486093 0.72285802 DANG_REGULATED_BY_MYC_DN hemolytic-uremic syndrome DOID_12554 2.197E-03 5.98E-03 0.06781742 0.38206049 DANG_REGULATED_BY_MYC_DN pituitary adenoma DOID_3829 2.197E-03 5.951E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN restrictive cardiomyopathy DOID_397 2.197E-03 5.923E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN tongue cancer DOID_8649 2.197E-03 5.895E-03 2.197E-03 0.104151 DANG_REGULATED_BY_MYC_DN drug-induced mental disorder DOID_1203 2.482E-03 6.631E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN drug psychosis DOID_1742 2.482E-03 6.631E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN bronchitis DOID_6132 2.482E-03 6.6E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN urinary system benign neoplasm DOID_731 2.482E-03 6.569E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN substance-induced psychosis DOID_8646 2.482E-03 6.631E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN leukocyte disease DOID_9500 2.58E-03 6.796E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN male reproductive organ benign neoplasm DOID_0060087 2.784E-03 7.301E-03 0.07596653 0.40397157 DANG_REGULATED_BY_MYC_DN neuroendocrine tumor DOID_169 2.784E-03 7.268E-03 0.07596653 0.39655925 DANG_REGULATED_BY_MYC_DN hypothyroidism DOID_1459 2.951E-03 7.668E-03 0.24834698 0.75972813 DANG_REGULATED_BY_MYC_DN granulosa cell tumor DOID_2999 3.103E-03 8.026E-03 0.0800145 0.41016442 DANG_REGULATED_BY_MYC_DN colon carcinoma DOID_1520 3.438E-03 8.852E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN sex cord-gonadal stromal tumor DOID_192 3.438E-03 8.812E-03 0.08404484 0.41583924 DANG_REGULATED_BY_MYC_DN subependymal glioma DOID_4843 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN pilocytic astrocytoma DOID_4851 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN subependymal giant cell astrocytoma DOID_5077 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN fibrillary astrocytoma DOID_6726 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN juvenile pilocytic astrocytoma DOID_6811 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN childhood pilocytic astrocytoma DOID_6812 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN gemistocytic astrocytoma DOID_7005 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN childhood cerebral astrocytoma DOID_7007 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN protoplasmic astrocytoma DOID_7008 3.438E-03 8.772E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN amyloidosis DOID_9120 3.438E-03 8.733E-03 3.438E-03 0.13973279 DANG_REGULATED_BY_MYC_DN temporal lobe epilepsy DOID_3328 3.495E-03 8.839E-03 1.000 1.000 DANG_REGULATED_BY_MYC_DN benign glioma DOID_0060101 4.156E-03 0.01046366 1.000 1.000 DANG_REGULATED_BY_MYC_DN gastric ulcer DOID_10808 4.156E-03 0.01041756 1.000 1.000 DANG_REGULATED_BY_MYC_DN benign ependymoma DOID_4844 4.156E-03 0.01046366 1.000 1.000 DANG_REGULATED_BY_MYC_DN muscular atrophy DOID_767 4.156E-03 0.01037187 1.000 1.000 DANG_REGULATED_BY_MYC_DN sinusitis DOID_0050127 4.539E-03 0.01127767 1.000 1.000 DANG_REGULATED_BY_MYC_DN glycogen metabolism disorder DOID_0050728 4.539E-03 0.01122864 0.09603086 0.4553463 DANG_REGULATED_BY_MYC_DN paranasal sinus disease DOID_1352 4.539E-03 0.01127767 1.000 1.000 DANG_REGULATED_BY_MYC_DN glycogen storage disease DOID_2747 4.539E-03 0.01122864 0.09603086 0.4553463 DANG_REGULATED_BY_MYC_DN pulmonary embolism DOID_9477 4.539E-03 0.01118003 1.000 1.000 DANG_REGULATED_BY_MYC_DN cystic fibrosis DOID_1485 4.932E-03 0.01209512 1.000 1.000 DANG_REGULATED_BY_MYC_DN acute pancreatitis DOID_2913 5.351E-03 0.01306801 1.000 1.000 DANG_REGULATED_BY_MYC_DN metabolic syndrome X DOID_14221 5.668E-03 0.01378312 0.3024811 0.87812114 DANG_REGULATED_BY_MYC_DN X-linked disease DOID_0050735 5.781E-03 0.01399637 0.10786096 0.47947566 DANG_REGULATED_BY_MYC_DN morbid obesity DOID_11981 6.225E-03 0.01500897 1.000 1.000 DANG_REGULATED_BY_MYC_DN cystitis DOID_1679 6.225E-03 0.01494564 1.000 1.000 DANG_REGULATED_BY_MYC_DN cleft lip DOID_9296 6.225E-03 0.01488285 6.225E-03 0.18642722 DANG_REGULATED_BY_MYC_DN focal epilepsy DOID_2234 6.262E-03 0.01490776 1.000 1.000 DANG_REGULATED_BY_MYC_DN spinal cord disease DOID_319 6.685E-03 0.01584867 0.11566207 0.48390969 DANG_REGULATED_BY_MYC_DN middle cerebral artery infarction DOID_3525 6.685E-03 0.01578291 0.11566207 0.4803775 DANG_REGULATED_BY_MYC_DN juvenile myoclonic epilepsy DOID_4890 6.685E-03 0.01571769 0.11566207 0.47689651 DANG_REGULATED_BY_MYC_DN extrinsic allergic alveolitis DOID_841 6.685E-03 0.01565301 1.000 1.000 DANG_REGULATED_BY_MYC_DN primary bacterial infectious disease DOID_0050338 7.109E-03 0.01657752 1.000 1.000 DANG_REGULATED_BY_MYC_DN migraine DOID_6364 7.16E-03 0.01662758 1.000 1.000 DANG_REGULATED_BY_MYC_DN perinatal necrotizing enterocolitis DOID_8677 7.16E-03 0.01655999 0.11953716 0.48238755 DANG_REGULATED_BY_MYC_DN thrombocytopenia DOID_1588 7.649E-03 0.01762052 1.000 1.000 DANG_REGULATED_BY_MYC_DN supratentorial cancer DOID_1659 8.153E-03 0.0187062 1.000 1.000 DANG_REGULATED_BY_MYC_DN cerebrum cancer DOID_368 8.153E-03 0.0187062 1.000 1.000 DANG_REGULATED_BY_MYC_DN lymphoma DOID_0060058 8.259E-03 0.01887243 0.33834251 0.9530539 DANG_REGULATED_BY_MYC_DN carbohydrate metabolic disorder DOID_2978 8.501E-03 0.01934844 0.06533028 0.37548414 DANG_REGULATED_BY_MYC_DN female reproductive organ benign neoplasm DOID_0060086 8.672E-03 0.0196585 1.000 1.000 DANG_REGULATED_BY_MYC_DN uterine benign neoplasm DOID_0060095 8.672E-03 0.0196585 1.000 1.000 DANG_REGULATED_BY_MYC_DN uterine fibroid DOID_13223 8.672E-03 0.0196585 1.000 1.000 DANG_REGULATED_BY_MYC_DN bronchiolitis obliterans DOID_2799 9.205E-03 0.02078426 1.000 1.000 DANG_REGULATED_BY_MYC_DN allergic rhinitis DOID_4481 9.752E-03 0.02193323 1.000 1.000 DANG_REGULATED_BY_MYC_DN leiomyoma DOID_127 0.01031394 0.02310484 1.000 1.000 DANG_REGULATED_BY_MYC_DN pleural disease DOID_1532 0.01031394 0.02301424 1.000 1.000 DANG_REGULATED_BY_MYC_DN autonomic nervous system neoplasm DOID_2621 0.01031394 0.02292434 1.000 1.000 DANG_REGULATED_BY_MYC_DN bladder disease DOID_365 0.01031394 0.02283514 1.000 1.000 DANG_REGULATED_BY_MYC_DN neuroblastoma DOID_769 0.01031394 0.02292434 1.000 1.000 DANG_REGULATED_BY_MYC_DN myocarditis DOID_820 0.0108895 0.024016 1.000 1.000 DANG_REGULATED_BY_MYC_DN metal metabolism disorder DOID_896 0.0108895 0.02392327 1.000 1.000 DANG_REGULATED_BY_MYC_DN pneumoconiosis DOID_10316 0.01147895 0.02512124 1.000 1.000 DANG_REGULATED_BY_MYC_DN hepatitis C DOID_1883 0.01147895 0.02502499 1.000 1.000 DANG_REGULATED_BY_MYC_DN hyperthyroidism DOID_7998 0.01147895 0.02492947 1.000 1.000 DANG_REGULATED_BY_MYC_DN lymphoid leukemia DOID_10747 0.01208215 0.0261397 0.01208215 0.22176584 DANG_REGULATED_BY_MYC_DN cleft palate DOID_674 0.01332927 0.02872862 0.16106511 0.59126483 DANG_REGULATED_BY_MYC_DN peripheral nervous system neoplasm DOID_1192 0.01397294 0.03000227 1.000 1.000 DANG_REGULATED_BY_MYC_DN blood platelet disease DOID_2218 0.01397294 0.02988948 1.000 1.000 DANG_REGULATED_BY_MYC_DN adenoid cystic carcinoma DOID_4866 0.01529986 0.03260531 1.000 1.000 DANG_REGULATED_BY_MYC_DN salivary gland cancer DOID_8850 0.0166787 0.03541112 1.000 1.000 DANG_REGULATED_BY_MYC_DN hyperinsulinism DOID_2018 0.01738728 0.03677831 1.000 1.000 DANG_REGULATED_BY_MYC_DN pulmonary tuberculosis DOID_2957 0.02189931 0.04615077 1.000 1.000 DANG_REGULATED_BY_MYC_DN atopic dermatitis DOID_3310 0.0243174 0.05105757 1.000 1.000 DANG_REGULATED_BY_MYC_DN smallpox DOID_8736 0.02683931 0.05614547 0.22486093 0.71879702 DANG_REGULATED_BY_MYC_DN endocrine pancreas disease DOID_1428 0.0349973 0.0729431 1.000 1.000 DANG_REGULATED_BY_MYC_DN cholestasis DOID_13580 0.0359562 0.07466816 1.000 1.000 DANG_REGULATED_BY_MYC_DN DiGeorge syndrome DOID_11198 0.03872889 0.08013359 0.03872889 0.37994374 DANG_REGULATED_BY_MYC_DN velocardiofacial syndrome DOID_12583 0.03872889 0.08013359 0.03872889 0.37994374 DANG_REGULATED_BY_MYC_DN tuberculosis DOID_399 0.03889302 0.08018162 1.000 1.000 DANG_REGULATED_BY_MYC_DN bile duct disease DOID_4138 0.04191786 0.08610563 1.000 1.000 DANG_REGULATED_BY_MYC_DN gallbladder disease DOID_0000000 0.04293898 0.0878859 1.000 1.000 DANG_REGULATED_BY_MYC_DN brachydactyly DOID_0050581 0.04293898 0.0875709 1.000 1.000 DANG_REGULATED_BY_MYC_DN interstitial nephritis DOID_1063 0.04293898 0.08725815 1.000 1.000 DANG_REGULATED_BY_MYC_DN T cell deficiency DOID_11200 0.04293898 0.08694762 0.04293898 0.40052919 DANG_REGULATED_BY_MYC_DN Sjogren's syndrome DOID_12894 0.04293898 0.08663929 0.04293898 0.39406904 DANG_REGULATED_BY_MYC_DN gonadal dysgenesis DOID_14447 0.04293898 0.08633315 0.04293898 0.38175439 DANG_REGULATED_BY_MYC_DN angioedema DOID_1558 0.04293898 0.08602916 1.000 1.000 DANG_REGULATED_BY_MYC_DN transient cerebral ischemia DOID_224 0.04293898 0.0857273 0.04293898 0.37018607 DANG_REGULATED_BY_MYC_DN bilirubin metabolic disorder DOID_2741 0.04293898 0.08542755 1.000 1.000 DANG_REGULATED_BY_MYC_DN chondrosarcoma DOID_3371 0.04293898 0.0851299 1.000 1.000 DANG_REGULATED_BY_MYC_DN hypokalemia DOID_4500 0.04293898 0.08483431 1.000 1.000 DANG_REGULATED_BY_MYC_DN holoprosencephaly DOID_4621 0.04293898 0.08454076 0.04293898 0.36466091 DANG_REGULATED_BY_MYC_DN keratitis DOID_4677 0.04293898 0.08424924 1.000 1.000 DANG_REGULATED_BY_MYC_DN polycythemia DOID_8432 0.04293898 0.08395973 1.000 1.000 DANG_REGULATED_BY_MYC_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.04293898 0.08367219 1.000 1.000 DANG_REGULATED_BY_MYC_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.04293898 0.08367219 1.000 1.000 DANG_REGULATED_BY_MYC_DN Hodgkin's granuloma DOID_8651 0.04293898 0.08367219 1.000 1.000 DANG_REGULATED_BY_MYC_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 0.04293898 0.08367219 1.000 1.000 DANG_REGULATED_BY_MYC_DN cutaneous leishmaniasis DOID_9111 0.04293898 0.08338662 1.000 1.000 DANG_REGULATED_BY_MYC_DN visceral leishmaniasis DOID_9146 0.04293898 0.083103 1.000 1.000 DANG_REGULATED_BY_MYC_DN cannabis abuse DOID_9505 0.04293898 0.08282129 1.000 1.000 DANG_REGULATED_BY_MYC_DN biliary tract disease DOID_9741 0.04294521 0.08255347 1.000 1.000 DANG_REGULATED_BY_MYC_DN syndrome DOID_225 0.04608311 0.08828717 0.2901031 0.85527805 DANG_REGULATED_BY_MYC_DN nervous system benign neoplasm DOID_0060115 0.04713075 0.08999126 1.000 1.000 DANG_REGULATED_BY_MYC_DN adrenoleukodystrophy DOID_10588 0.04713075 0.08969029 1.000 1.000 DANG_REGULATED_BY_MYC_DN obsessive-compulsive disorder DOID_10933 0.04713075 0.08939132 1.000 1.000 DANG_REGULATED_BY_MYC_DN prostatic adenoma DOID_2883 0.04713075 0.08909434 0.04713075 0.36736158 DANG_REGULATED_BY_MYC_DN chronic monocytic leukemia DOID_8593 0.04713075 0.08879932 1.000 1.000 DANG_REGULATED_BY_MYC_DN heroin dependence DOID_9976 0.04713075 0.08850626 1.000 1.000 DANG_REGULATED_BY_MYC_DN familial atrial fibrillation DOID_0050650 0.05130427 0.09602673 1.000 1.000 DANG_REGULATED_BY_MYC_DN common cold DOID_10459 0.05130427 0.09571189 1.000 1.000 DANG_REGULATED_BY_MYC_DN otitis media DOID_10754 0.05130427 0.09539911 1.000 1.000 DANG_REGULATED_BY_MYC_DN esophageal carcinoma DOID_1107 0.05130427 0.09508836 1.000 1.000 DANG_REGULATED_BY_MYC_DN intracranial arteriosclerosis DOID_13097 0.05130427 0.09477963 1.000 1.000 DANG_REGULATED_BY_MYC_DN relapsing-remitting multiple sclerosis DOID_2378 0.05130427 0.0944729 0.05130427 0.38922836 DANG_REGULATED_BY_MYC_DN esophagus squamous cell carcinoma DOID_3748 0.05130427 0.09508836 1.000 1.000 DANG_REGULATED_BY_MYC_DN middle ear disease DOID_5100 0.05130427 0.09539911 1.000 1.000 DANG_REGULATED_BY_MYC_DN Hodgkin's lymphoma DOID_8567 0.05130427 0.09416815 1.000 1.000 DANG_REGULATED_BY_MYC_DN vascular dementia DOID_8725 0.05130427 0.09477963 1.000 1.000 DANG_REGULATED_BY_MYC_DN progressive myoclonus epilepsy DOID_891 0.05130427 0.09386536 0.05130427 0.37425804 DANG_REGULATED_BY_MYC_DN ocular hypertension DOID_9282 0.05130427 0.09356451 1.000 1.000 DANG_REGULATED_BY_MYC_DN borderline glaucoma DOID_9283 0.05130427 0.09356451 1.000 1.000 DANG_REGULATED_BY_MYC_DN encephalitis DOID_9588 0.05130427 0.09326558 1.000 1.000 DANG_REGULATED_BY_MYC_DN chromosomal disease DOID_0080014 0.05149304 0.09331063 0.05149304 0.37088022 DANG_REGULATED_BY_MYC_DN auditory system disease DOID_2742 0.05260116 0.09501606 0.3085894 0.8823486 DANG_REGULATED_BY_MYC_DN alcohol abuse DOID_1574 0.05371777 0.09672598 1.000 1.000 DANG_REGULATED_BY_MYC_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 0.05545961 0.09954738 0.05545961 0.3848356 DANG_REGULATED_BY_MYC_DN infancy electroclinical syndrome DOID_0050703 0.05545961 0.09923434 1.000 1.000 DANG_REGULATED_BY_MYC_DN variable age at onset electroclinical syndrome DOID_0050706 0.05545961 0.09892326 0.05545961 0.38019903 DANG_REGULATED_BY_MYC_DN nicotine dependence DOID_0050742 0.05545961 0.09861412 1.000 1.000 DANG_REGULATED_BY_MYC_DN leprosy DOID_1024 0.05545961 0.09830691 1.000 1.000 DANG_REGULATED_BY_MYC_DN vulva cancer DOID_1245 0.05545961 0.09800161 0.05545961 0.37125317 DANG_REGULATED_BY_MYC_DN hepatic coma DOID_12550 0.05545961 0.0976982 1.000 1.000 DANG_REGULATED_BY_MYC_DN hepatic encephalopathy DOID_13413 0.05545961 0.0976982 1.000 1.000 DANG_REGULATED_BY_MYC_DN cannabis dependence DOID_1849 0.05545961 0.09739666 1.000 1.000 DANG_REGULATED_BY_MYC_DN impotence DOID_1875 0.05545961 0.09709698 1.000 1.000 DANG_REGULATED_BY_MYC_DN Lynch syndrome DOID_3883 0.05545961 0.09679914 1.000 1.000 DANG_REGULATED_BY_MYC_DN intracranial thrombosis DOID_4193 0.05545961 0.09650312 0.05545961 0.36271861 DANG_REGULATED_BY_MYC_DN monocytic leukemia DOID_8527 0.05545961 0.0962089 1.000 1.000 DANG_REGULATED_BY_MYC_DN hallucinogen dependence DOID_9977 0.05545961 0.09739666 1.000 1.000 HUANG_FOXA2_TARGETS_DN glioblastoma DOID_3068 1.398E-07 7.952E-05 1.005E-03 0.14301612 HUANG_FOXA2_TARGETS_DN brain infarction DOID_3454 2.588E-07 7.364E-05 1.000 1.000 HUANG_FOXA2_TARGETS_DN astrocytoma DOID_3069 2.739E-07 5.196E-05 1.397E-03 0.15897238 HUANG_FOXA2_TARGETS_DN primary bacterial infectious disease DOID_0050338 6.443E-07 9.165E-05 1.000 1.000 HUANG_FOXA2_TARGETS_DN cerebral infarction DOID_3526 6.801E-06 7.739E-04 1.000 1.000 HUANG_FOXA2_TARGETS_DN giant cell tumor DOID_200 1.085E-05 1.029E-03 0.04197815 0.38525107 HUANG_FOXA2_TARGETS_DN malignant giant cell tumor DOID_2705 1.085E-05 1.029E-03 0.04197815 0.38525107 HUANG_FOXA2_TARGETS_DN giant cell glioblastoma DOID_3074 1.085E-05 1.029E-03 0.04197815 0.38525107 HUANG_FOXA2_TARGETS_DN cholestasis DOID_13580 1.95E-05 1.585E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN parasitic infectious disease DOID_1398 1.95E-05 1.387E-03 0.05074947 0.40106181 HUANG_FOXA2_TARGETS_DN tuberculosis DOID_399 2.221E-05 1.404E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN bile duct disease DOID_4138 2.515E-05 1.431E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN biliary tract disease DOID_9741 2.618E-05 1.354E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN peritonitis DOID_8283 3.711E-05 1.76E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN intracranial thrombosis DOID_4193 4.384E-05 1.919E-03 9.9E-03 0.40238011 HUANG_FOXA2_TARGETS_DN transitional cell carcinoma DOID_2671 4.521E-05 1.837E-03 0.06662927 0.48605195 HUANG_FOXA2_TARGETS_DN membranoproliferative glomerulonephritis DOID_2920 5.896E-05 2.236E-03 5.896E-05 0.03354732 HUANG_FOXA2_TARGETS_DN vein disease DOID_866 6.735E-05 2.395E-03 0.01217162 0.38475838 HUANG_FOXA2_TARGETS_DN prion disease DOID_649 8.579E-05 2.871E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN hepatitis B DOID_2043 1.293E-04 4.087E-03 0.01669899 0.41311861 HUANG_FOXA2_TARGETS_DN thrombophilia DOID_2452 1.293E-04 3.872E-03 0.01669899 0.39590534 HUANG_FOXA2_TARGETS_DN uremia DOID_4676 1.415E-04 4.026E-03 0.01745161 0.39719858 HUANG_FOXA2_TARGETS_DN pulmonary embolism DOID_9477 1.415E-04 3.835E-03 0.01745161 0.38192171 HUANG_FOXA2_TARGETS_DN diabetic angiopathy DOID_11713 1.543E-04 3.991E-03 0.01820366 0.38362535 HUANG_FOXA2_TARGETS_DN meningitis DOID_9471 1.543E-04 3.818E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN acute pancreatitis DOID_2913 1.677E-04 3.975E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN middle cerebral artery infarction DOID_3525 2.109E-04 4.801E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN gestational diabetes DOID_11714 2.265E-04 4.956E-03 0.02195562 0.35693557 HUANG_FOXA2_TARGETS_DN malaria DOID_12365 2.425E-04 5.111E-03 0.02270434 0.34915597 HUANG_FOXA2_TARGETS_DN leiomyoma DOID_127 3.309E-04 6.725E-03 0.02643969 0.34986467 HUANG_FOXA2_TARGETS_DN pleural disease DOID_1532 3.309E-04 6.493E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN hair disease DOID_421 3.502E-04 6.643E-03 3.502E-04 0.09964409 HUANG_FOXA2_TARGETS_DN hepatitis C DOID_1883 3.701E-04 6.793E-03 0.02792996 0.34548145 HUANG_FOXA2_TARGETS_DN multiple myeloma DOID_9538 4.328E-04 7.696E-03 0.03016124 0.35023973 HUANG_FOXA2_TARGETS_DN hepatitis DOID_2237 4.773E-04 8.23E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN intracranial arterial disease DOID_13089 5.004E-04 8.374E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN cerebral arterial disease DOID_3527 5.004E-04 8.374E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN benign mesothelioma DOID_2645 5.239E-04 8.518E-03 1.000 1.000 HUANG_FOXA2_TARGETS_DN proteinuria DOID_576 6.498E-04 0.01026996 1.000 1.000 HUANG_FOXA2_TARGETS_DN myeloma DOID_0070004 6.765E-04 0.01040381 0.03756319 0.38860829 HUANG_FOXA2_TARGETS_DN pre-eclampsia DOID_10591 6.765E-04 0.01013002 0.03756319 0.38166886 HUANG_FOXA2_TARGETS_DN brain cancer DOID_1319 6.765E-04 9.87E-03 0.03756319 0.37497291 HUANG_FOXA2_TARGETS_DN heart valve disease DOID_4079 6.765E-04 9.624E-03 0.03756319 0.36850786 HUANG_FOXA2_TARGETS_DN central nervous system cancer DOID_3620 7.038E-04 9.767E-03 0.03830038 0.36937145 HUANG_FOXA2_TARGETS_DN atrophic muscular disease DOID_913 8.481E-04 0.01148932 8.481E-04 0.16085049 HUANG_FOXA2_TARGETS_DN muscular dystrophy DOID_9884 8.481E-04 0.01148932 8.481E-04 0.16085049 HUANG_FOXA2_TARGETS_DN bone marrow cancer DOID_4960 8.785E-04 0.01162469 0.04271207 0.38576457 HUANG_FOXA2_TARGETS_DN parasitic protozoa infectious disease DOID_2789 9.094E-04 0.01176065 0.04344545 0.36896211 HUANG_FOXA2_TARGETS_DN blood coagulation disease DOID_1247 1.436E-03 0.01815256 0.05438126 0.41814781 HUANG_FOXA2_TARGETS_DN peripheral vascular disease DOID_341 1.514E-03 0.0187335 0.05583022 0.42356525 HUANG_FOXA2_TARGETS_DN aneurysm disease DOID_2403 1.678E-03 0.02031819 1.000 1.000 HUANG_FOXA2_TARGETS_DN pancreatitis DOID_4989 1.721E-03 0.02039536 1.000 1.000 HUANG_FOXA2_TARGETS_DN mixed glioma DOID_5076 1.721E-03 0.01997913 1.000 1.000 HUANG_FOXA2_TARGETS_DN bacterial pneumonia DOID_874 1.721E-03 0.01957955 0.05944324 0.44504212 HUANG_FOXA2_TARGETS_DN primary immunodeficiency disease DOID_612 2.218E-03 0.02474617 2.218E-03 0.21034244 HUANG_FOXA2_TARGETS_DN nervous system cancer DOID_3093 2.266E-03 0.02479788 0.0680601 0.490205 HUANG_FOXA2_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 2.266E-03 0.02433 0.0680601 0.48407743 HUANG_FOXA2_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.464E-03 0.02596377 1.000 1.000 HUANG_FOXA2_TARGETS_DN dilated cardiomyopathy DOID_12930 2.515E-03 0.02601606 0.07162791 0.50316399 HUANG_FOXA2_TARGETS_DN facioscapulohumeral muscular dystrophy DOID_11727 7.624E-03 0.07746649 7.624E-03 0.61973194 HUANG_FOXA2_TARGETS_DN angioedema DOID_1558 7.624E-03 0.07610743 1.000 1.000 HUANG_FOXA2_TARGETS_DN conjunctival disease DOID_4251 7.624E-03 0.07479523 1.000 1.000 HUANG_FOXA2_TARGETS_DN conjunctivitis DOID_6195 7.624E-03 0.07479523 1.000 1.000 HUANG_FOXA2_TARGETS_DN breast benign neoplasm DOID_0060082 8.383E-03 0.08085043 8.383E-03 0.59627192 HUANG_FOXA2_TARGETS_DN thoracic benign neoplasm DOID_0060097 8.383E-03 0.08085043 8.383E-03 0.59627192 HUANG_FOXA2_TARGETS_DN benign breast phyllodes tumor DOID_1631 8.383E-03 0.08085043 8.383E-03 0.59627192 HUANG_FOXA2_TARGETS_DN invasive lobular carcinoma DOID_3457 8.383E-03 0.07950292 1.000 1.000 HUANG_FOXA2_TARGETS_DN eosinophilic pneumonia DOID_5870 8.383E-03 0.0781996 1.000 1.000 HUANG_FOXA2_TARGETS_DN pulmonary eosinophilia DOID_9498 8.383E-03 0.0781996 1.000 1.000 HUANG_FOXA2_TARGETS_DN Loeffler syndrome DOID_9503 8.383E-03 0.0781996 1.000 1.000 HUANG_FOXA2_TARGETS_DN otitis media DOID_10754 9.142E-03 0.08390174 1.000 1.000 HUANG_FOXA2_TARGETS_DN esophageal carcinoma DOID_1107 9.142E-03 0.08256997 9.142E-03 0.57798977 HUANG_FOXA2_TARGETS_DN epidermolysis bullosa DOID_2730 9.142E-03 0.08127981 9.142E-03 0.52019079 HUANG_FOXA2_TARGETS_DN esophagus squamous cell carcinoma DOID_3748 9.142E-03 0.08256997 9.142E-03 0.57798977 HUANG_FOXA2_TARGETS_DN middle ear disease DOID_5100 9.142E-03 0.08390174 1.000 1.000 HUANG_FOXA2_TARGETS_DN pituitary gland disease DOID_53 9.142E-03 0.08002935 9.142E-03 0.47290072 HUANG_FOXA2_TARGETS_DN osteogenesis imperfecta DOID_12347 9.9E-03 0.08535336 9.9E-03 0.46944346 HUANG_FOXA2_TARGETS_DN polyneuropathy DOID_1389 9.9E-03 0.08407943 1.000 1.000 HUANG_FOXA2_TARGETS_DN larynx cancer DOID_2596 9.9E-03 0.08284296 1.000 1.000 HUANG_FOXA2_TARGETS_DN laryngeal benign neoplasm DOID_2598 9.9E-03 0.08284296 1.000 1.000 HUANG_FOXA2_TARGETS_DN vesiculobullous skin disease DOID_2731 9.9E-03 0.08164234 9.9E-03 0.43333243 HUANG_FOXA2_TARGETS_DN Legionnaires' disease DOID_10457 0.01065803 0.08663452 1.000 1.000 HUANG_FOXA2_TARGETS_DN legionellosis DOID_10458 0.01065803 0.08663452 1.000 1.000 HUANG_FOXA2_TARGETS_DN viral pneumonia DOID_10533 0.01065803 0.08541432 1.000 1.000 HUANG_FOXA2_TARGETS_DN eyelid disease DOID_530 0.01065803 0.08422801 1.000 1.000 HUANG_FOXA2_TARGETS_DN parasitic helminthiasis infectious disease DOID_883 0.01065803 0.0830742 1.000 1.000 HUANG_FOXA2_TARGETS_DN polycystic kidney disease DOID_898 0.01065803 0.08195157 1.000 1.000 HUANG_FOXA2_TARGETS_DN bacterial meningitis DOID_9470 0.01065803 0.08085889 1.000 1.000 HUANG_FOXA2_TARGETS_DN communication disorder DOID_2033 0.0114151 0.08546306 1.000 1.000 HUANG_FOXA2_TARGETS_DN corneal dystrophy DOID_2566 0.0114151 0.08435315 0.0114151 0.43301285 HUANG_FOXA2_TARGETS_DN varicose veins DOID_799 0.0114151 0.0832717 1.000 1.000 HUANG_FOXA2_TARGETS_DN spastic diplegia DOID_10965 0.01217162 0.08766647 0.01217162 0.43285318 HUANG_FOXA2_TARGETS_DN hemolytic-uremic syndrome DOID_12554 0.01217162 0.08657064 0.01217162 0.40739123 HUANG_FOXA2_TARGETS_DN congenital muscular dystrophy DOID_0050557 0.01368298 0.09611868 0.01368298 0.40976911 HUANG_FOXA2_TARGETS_DN eosinophilia DOID_999 0.01368298 0.0949465 1.000 1.000 HUANG_FOXA2_TARGETS_DN infertility DOID_5223 0.01443782 0.09897732 0.01443782 0.41075588 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP pancreatic ductal carcinoma DOID_3587 3.136E-08 1.785E-05 3.527E-05 0.02007028 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP pancreatic carcinoma DOID_4905 4.004E-08 1.139E-05 4.134E-05 0.01176107 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP diabetic retinopathy DOID_8947 1.426E-06 2.704E-04 4.134E-05 7.841E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP retinal vascular disease DOID_2462 2.79E-06 3.969E-04 7.023E-05 9.99E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.534E-06 5.16E-04 1.03E-04 0.01172378 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP bronchiolitis DOID_2942 3.801E-05 3.604E-03 0.06317231 0.35945044 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP B cell deficiency DOID_2115 4.772E-05 3.879E-03 2.251E-03 0.08005287 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP primary immunodeficiency disease DOID_612 8.368E-05 5.952E-03 0.02202122 0.31325184 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP Human immunodeficiency virus infectious disease DOID_526 8.732E-05 5.52E-03 0.02247438 0.29063462 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP lymphoblastic leukemia DOID_1037 9.892E-05 5.628E-03 1.786E-03 0.07257503 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP esophageal disease DOID_6050 1.113E-04 5.759E-03 1.113E-04 0.01055841 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP adenoma DOID_657 1.305E-04 6.187E-03 0.09326104 0.39898897 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP congenital diaphragmatic hernia DOID_3827 1.63E-04 7.135E-03 5.012E-03 0.15009381 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP gallbladder cancer DOID_3121 2.282E-04 9.273E-03 2.282E-04 0.01854669 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP learning disability DOID_8927 2.429E-04 9.215E-03 2.429E-04 0.01727888 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP proteinuria DOID_576 2.583E-04 9.186E-03 2.583E-04 0.01633103 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP neuritis DOID_1803 2.743E-04 9.181E-03 0.11797241 0.44750868 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP glaucoma DOID_1686 3.082E-04 9.742E-03 7.594E-03 0.18005119 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP atopic dermatitis DOID_3310 3.638E-04 0.01089622 8.464E-03 0.18522713 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP temporal lobe epilepsy DOID_3328 7.084E-04 0.0201553 0.01307152 0.23242802 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP bone resorption disease DOID_0080011 1.05E-03 0.02845277 1.05E-03 0.05975082 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP osteoporosis DOID_11476 1.05E-03 0.02845277 1.05E-03 0.05975082 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP bacterial pneumonia DOID_874 1.089E-03 0.02816666 0.18203097 0.56909683 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP esophagitis DOID_11963 1.146E-03 0.02835927 1.146E-03 0.05929665 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP chromosomal disease DOID_0080014 1.211E-03 0.02871822 1.211E-03 0.05743644 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP Kawasaki disease DOID_13378 1.265E-03 0.02878989 0.05133848 0.33576546 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP lymphadenitis DOID_1602 1.265E-03 0.02878989 0.05133848 0.33576546 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP lymph node disease DOID_9942 1.265E-03 0.02878989 0.05133848 0.33576546 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP focal epilepsy DOID_2234 1.297E-03 0.02839392 0.01938439 0.29810042 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP biliary tract cancer DOID_4607 1.297E-03 0.0273423 1.297E-03 0.05678785 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP muscular atrophy DOID_767 1.389E-03 0.02822971 0.05371702 0.33222808 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP polyarteritis nodosa DOID_9810 1.519E-03 0.02980346 0.05608966 0.33244807 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP hypersensitivity reaction type I disease DOID_1205 1.895E-03 0.03594669 1.895E-03 0.07189338 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP papillary adenoma DOID_3172 2.094E-03 0.03842891 0.06552149 0.36195851 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP microcystic adenoma DOID_5403 2.094E-03 0.03842891 0.06552149 0.36195851 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP follicular adenoma DOID_6204 2.094E-03 0.03842891 0.06552149 0.36195851 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP pleurisy DOID_10247 2.582E-03 0.04591236 0.07253411 0.37519916 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP age related macular degeneration DOID_10871 3.119E-03 0.05377609 0.07949465 0.38010468 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP degeneration of macula and posterior pole DOID_2007 3.119E-03 0.05377609 0.07949465 0.38010468 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP allergic rhinitis DOID_4481 3.308E-03 0.05536642 0.08180333 0.38467846 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP chronic leukemia DOID_1036 3.503E-03 0.05695145 0.08410627 0.39226614 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP chronic lymphocytic leukemia DOID_1040 3.503E-03 0.05695145 0.08410627 0.39226614 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP pleural disease DOID_1532 3.503E-03 0.05536947 0.08410627 0.38907699 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP papilloma DOID_2615 3.703E-03 0.05694928 0.0864035 0.39330875 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP metal metabolism disorder DOID_896 3.703E-03 0.05545061 3.703E-03 0.12394843 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP hepatitis C DOID_1883 3.908E-03 0.05702334 0.08869503 0.39738168 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP macular degeneration DOID_4448 3.908E-03 0.05559776 0.08869503 0.39122073 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP lymphoid leukemia DOID_10747 4.119E-03 0.05716211 4.119E-03 0.13020259 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP hepatitis DOID_2237 5.012E-03 0.06789958 0.10006765 0.41259776 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP intracranial arterial disease DOID_13089 5.248E-03 0.06944276 0.10232526 0.4158791 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP cerebral arterial disease DOID_3527 5.248E-03 0.06944276 0.10232526 0.4158791 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP lymphatic system disease DOID_75 5.248E-03 0.06786452 0.10232526 0.4129296 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP pulmonary emphysema DOID_9675 5.489E-03 0.06940342 5.489E-03 0.1561577 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP influenza DOID_8469 6.242E-03 0.07720664 1.000 1.000 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP brain cancer DOID_1319 7.039E-03 0.08521397 7.039E-03 0.19071697 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP thyroid adenoma DOID_2891 7.039E-03 0.08343867 0.11797241 0.44454504 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP vascular skin disease DOID_9540 7.039E-03 0.08173584 0.11797241 0.438734 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP central nervous system cancer DOID_3620 7.314E-03 0.08323543 7.314E-03 0.18917144 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP integumentary system benign neoplasm DOID_0060121 7.594E-03 0.08472997 7.594E-03 0.1878795 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP pulmonary tuberculosis DOID_2957 7.594E-03 0.08310055 0.12239324 0.44930165 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP skin benign neoplasm DOID_3165 7.594E-03 0.08472997 7.594E-03 0.1878795 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP lung small cell carcinoma DOID_5409 7.594E-03 0.08153261 7.594E-03 0.17284914 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP movement disease DOID_480 7.879E-03 0.08302616 0.12459543 0.45155924 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP bile duct adenocarcinoma DOID_4896 9.067E-03 0.09380245 9.067E-03 0.19107907 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP cholangiocarcinoma DOID_4947 9.067E-03 0.09380245 9.067E-03 0.19107907 GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP osteochondrodysplasia DOID_2256 9.376E-03 0.09526323 9.376E-03 0.19052645 JAZAG_TGFB1_SIGNALING_DN acute pancreatitis DOID_2913 3.781E-05 0.02151186 3.781E-05 0.02151186 JAZAG_TGFB1_SIGNALING_DN peptic ulcer DOID_750 1.081E-04 0.03075898 0.01540144 0.3651424 JAZAG_TGFB1_SIGNALING_DN pancreatitis DOID_4989 3.936E-04 0.07465912 3.936E-04 0.11198868 HASINA_NOL7_TARGETS_DN proteinuria DOID_576 4.427E-07 2.519E-04 1.071E-04 0.01219031 HASINA_NOL7_TARGETS_DN giant cell tumor DOID_200 6.653E-07 1.893E-04 1.401E-04 0.01328655 HASINA_NOL7_TARGETS_DN malignant giant cell tumor DOID_2705 6.653E-07 1.893E-04 1.401E-04 0.01328655 HASINA_NOL7_TARGETS_DN giant cell glioblastoma DOID_3074 6.653E-07 1.893E-04 1.401E-04 0.01328655 HASINA_NOL7_TARGETS_DN glioblastoma DOID_3068 8.63E-07 1.637E-04 1.663E-04 0.01183102 HASINA_NOL7_TARGETS_DN astrocytoma DOID_3069 1.427E-06 2.03E-04 2.319E-04 0.01319416 HASINA_NOL7_TARGETS_DN pancreatic ductal carcinoma DOID_3587 1.488E-06 1.694E-04 2.384E-04 0.0123304 HASINA_NOL7_TARGETS_DN pancreatic carcinoma DOID_4905 1.681E-06 1.594E-04 2.584E-04 0.01225121 HASINA_NOL7_TARGETS_DN diabetic retinopathy DOID_8947 1.681E-06 1.367E-04 2.584E-04 0.01130881 HASINA_NOL7_TARGETS_DN mixed glioma DOID_5076 1.963E-06 1.396E-04 1.963E-06 1.117E-03 HASINA_NOL7_TARGETS_DN retinal vascular disease DOID_2462 2.53E-06 1.599E-04 3.385E-04 0.01203769 HASINA_NOL7_TARGETS_DN nervous system cancer DOID_3093 2.995E-06 1.704E-04 3.784E-04 0.01196245 HASINA_NOL7_TARGETS_DN gastric ulcer DOID_10808 2.114E-05 1.094E-03 6.942E-03 0.13621662 HASINA_NOL7_TARGETS_DN sarcoma DOID_1115 3.976E-05 1.885E-03 9.456E-03 0.15372869 HASINA_NOL7_TARGETS_DN autonomic nervous system neoplasm DOID_2621 5.433E-05 2.378E-03 5.433E-05 0.0154573 HASINA_NOL7_TARGETS_DN neuroblastoma DOID_769 5.433E-05 2.378E-03 5.433E-05 0.0154573 HASINA_NOL7_TARGETS_DN spindle cell carcinoma DOID_4015 6.079E-05 2.471E-03 6.079E-05 0.01153047 HASINA_NOL7_TARGETS_DN peripheral nervous system neoplasm DOID_1192 7.48E-05 2.837E-03 7.48E-05 0.01064002 HASINA_NOL7_TARGETS_DN peptic ulcer DOID_750 7.852E-05 2.793E-03 0.01321549 0.17090036 HASINA_NOL7_TARGETS_DN bile duct adenocarcinoma DOID_4896 1.452E-04 4.859E-03 1.452E-04 0.01180052 HASINA_NOL7_TARGETS_DN cholangiocarcinoma DOID_4947 1.452E-04 4.859E-03 1.452E-04 0.01180052 HASINA_NOL7_TARGETS_DN bile duct cancer DOID_4606 1.663E-04 5.258E-03 1.663E-04 0.01051646 HASINA_NOL7_TARGETS_DN bile duct carcinoma DOID_4897 1.663E-04 5.258E-03 1.663E-04 0.01051646 HASINA_NOL7_TARGETS_DN pre-malignant neoplasm DOID_0060071 1.948E-04 5.834E-03 0.02069513 0.18399265 HASINA_NOL7_TARGETS_DN congenital heart defect DOID_1682 1.948E-04 5.542E-03 0.02069513 0.181162 HASINA_NOL7_TARGETS_DN in situ carcinoma DOID_8719 1.948E-04 5.834E-03 0.02069513 0.18399265 HASINA_NOL7_TARGETS_DN pancreatitis DOID_4989 2.863E-04 7.757E-03 2.863E-04 0.01163507 HASINA_NOL7_TARGETS_DN biliary tract cancer DOID_4607 3.231E-04 8.357E-03 3.231E-04 0.01225759 HASINA_NOL7_TARGETS_DN transitional cell carcinoma DOID_2671 3.622E-04 8.96E-03 3.622E-04 0.01212271 HASINA_NOL7_TARGETS_DN encephalomyelitis DOID_640 4.034E-04 9.565E-03 0.02966368 0.23121413 HASINA_NOL7_TARGETS_DN retinal vascular occlusion DOID_1729 3.161E-03 0.07194841 1.000 1.000 HASINA_NOL7_TARGETS_DN rectal neoplasm DOID_1984 3.161E-03 0.06918117 3.161E-03 0.09466897 HASINA_NOL7_TARGETS_DN rectum cancer DOID_1993 3.161E-03 0.06918117 3.161E-03 0.09466897 HASINA_NOL7_TARGETS_DN keratitis DOID_4677 3.161E-03 0.0666189 1.000 1.000 HASINA_NOL7_TARGETS_DN breast benign neoplasm DOID_0060082 3.477E-03 0.07065337 3.477E-03 0.09891472 HASINA_NOL7_TARGETS_DN thoracic benign neoplasm DOID_0060097 3.477E-03 0.07065337 3.477E-03 0.09891472 HASINA_NOL7_TARGETS_DN temporal arteritis DOID_13375 3.477E-03 0.06821705 3.477E-03 0.0942045 HASINA_NOL7_TARGETS_DN benign breast phyllodes tumor DOID_1631 3.477E-03 0.07065337 3.477E-03 0.09891472 HASINA_NOL7_TARGETS_DN central nervous system vasculitis DOID_525 3.477E-03 0.06821705 3.477E-03 0.0942045 HASINA_NOL7_TARGETS_DN aortic valve stenosis DOID_1712 3.792E-03 0.07192754 3.792E-03 0.09808302 HASINA_NOL7_TARGETS_DN aortic valve insufficiency DOID_57 3.792E-03 0.0696073 3.792E-03 0.09381854 HASINA_NOL7_TARGETS_DN larynx cancer DOID_2596 4.108E-03 0.07304082 4.108E-03 0.09738776 HASINA_NOL7_TARGETS_DN laryngeal benign neoplasm DOID_2598 4.108E-03 0.07304082 4.108E-03 0.09738776 HASINA_NOL7_TARGETS_DN rhabdomyosarcoma DOID_3247 4.423E-03 0.07626466 1.000 1.000 HASINA_NOL7_TARGETS_DN thoracic aortic aneurysm DOID_14004 4.738E-03 0.07929734 4.738E-03 0.10784438 HASINA_NOL7_TARGETS_DN mesenchymal cell neoplasm DOID_3350 4.738E-03 0.0770317 4.738E-03 0.10369652 HASINA_NOL7_TARGETS_DN skeletal muscle cancer DOID_4043 4.738E-03 0.07489193 1.000 1.000 HASINA_NOL7_TARGETS_DN spindle cell sarcoma DOID_4235 4.738E-03 0.0770317 4.738E-03 0.10369652 HASINA_NOL7_TARGETS_DN epithelioid sarcoma DOID_6193 4.738E-03 0.0770317 4.738E-03 0.10369652 HASINA_NOL7_TARGETS_DN angiosarcoma DOID_0001816 5.053E-03 0.07771441 1.000 1.000 HASINA_NOL7_TARGETS_DN bronchitis DOID_6132 5.369E-03 0.08038697 1.000 1.000 HASINA_NOL7_TARGETS_DN neuroendocrine tumor DOID_169 5.684E-03 0.08292113 5.684E-03 0.11977497 HASINA_NOL7_TARGETS_DN skin carcinoma DOID_3451 5.684E-03 0.0808481 5.684E-03 0.11549729 HASINA_NOL7_TARGETS_DN granulosa cell tumor DOID_2999 5.998E-03 0.08324614 1.000 1.000 HASINA_NOL7_TARGETS_DN pulmonary edema DOID_11396 6.313E-03 0.08552874 1.000 1.000 HASINA_NOL7_TARGETS_DN sex cord-gonadal stromal tumor DOID_192 6.313E-03 0.0835397 1.000 1.000 HASINA_NOL7_TARGETS_DN brain edema DOID_4724 6.313E-03 0.08164107 1.000 1.000 HASINA_NOL7_TARGETS_DN Kawasaki disease DOID_13378 6.628E-03 0.08380601 1.000 1.000 HASINA_NOL7_TARGETS_DN lymphadenitis DOID_1602 6.628E-03 0.08380601 1.000 1.000 HASINA_NOL7_TARGETS_DN lymph node disease DOID_9942 6.628E-03 0.08380601 1.000 1.000 HASINA_NOL7_TARGETS_DN sinusitis DOID_0050127 7.257E-03 0.08976612 7.257E-03 0.13764138 HASINA_NOL7_TARGETS_DN paranasal sinus disease DOID_1352 7.257E-03 0.08976612 7.257E-03 0.13764138 HASINA_NOL7_TARGETS_DN muscle cancer DOID_4045 7.257E-03 0.0878562 1.000 1.000 HASINA_NOL7_TARGETS_DN uremia DOID_4676 7.257E-03 0.08602587 7.257E-03 0.13320134 HASINA_NOL7_TARGETS_DN polyarteritis nodosa DOID_9810 7.257E-03 0.08427024 1.000 1.000 HASINA_NOL7_TARGETS_DN aortic valve disease DOID_62 7.571E-03 0.08616298 7.571E-03 0.13462966 HASINA_NOL7_TARGETS_DN portal hypertension DOID_10762 8.2E-03 0.09148644 1.000 1.000 HASINA_NOL7_TARGETS_DN seminoma DOID_4440 8.828E-03 0.09660115 1.000 1.000 HASINA_NOL7_TARGETS_DN extrinsic allergic alveolitis DOID_841 8.828E-03 0.09477849 1.000 1.000 HASINA_NOL7_TARGETS_DN lung adenocarcinoma DOID_3910 9.142E-03 0.09633163 9.142E-03 0.15763357 HASINA_NOL7_TARGETS_DN periodontitis DOID_824 9.142E-03 0.09458014 9.142E-03 0.15299729 HASINA_NOL7_TARGETS_DN hepatic vascular disease DOID_272 9.456E-03 0.09608043 1.000 1.000 HASINA_NOL7_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 9.77E-03 0.09752716 9.77E-03 0.15441801 HASINA_NOL7_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 0.01008355 0.09892311 0.01008355 0.15506867 HASINA_NOL7_TARGETS_DN uterine benign neoplasm DOID_0060095 0.01008355 0.09892311 0.01008355 0.15506867 HASINA_NOL7_TARGETS_DN corneal disease DOID_10124 0.01008355 0.09724645 1.000 1.000 HASINA_NOL7_TARGETS_DN uterine fibroid DOID_13223 0.01008355 0.09892311 0.01008355 0.15506867 HASINA_NOL7_TARGETS_DN endometrial carcinoma DOID_2871 0.01008355 0.09562568 0.01008355 0.15098791 HASINA_NOL7_TARGETS_DN age related macular degeneration DOID_10871 0.01039715 0.0969833 1.000 1.000 HASINA_NOL7_TARGETS_DN degeneration of macula and posterior pole DOID_2007 0.01039715 0.0969833 1.000 1.000 HASINA_NOL7_TARGETS_DN endometrial cancer DOID_1380 0.01071067 0.09829629 0.01071067 0.1562659 HASINA_NOL7_TARGETS_DN germinoma DOID_3304 0.01071067 0.09673603 1.000 1.000 HASINA_NOL7_TARGETS_DN leiomyoma DOID_127 0.01102409 0.09801104 0.01102409 0.15681767 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER nervous system cancer DOID_3093 1.052E-08 5.986E-06 0.01033418 0.196005 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER calcium metabolism disease DOID_10575 2.908E-08 8.273E-06 2.908E-08 1.655E-05 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER mineral metabolism disease DOID_0050032 9.614E-08 1.823E-05 9.614E-08 2.735E-05 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER leiomyoma DOID_127 3.487E-07 4.96E-05 1.561E-03 0.05224435 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER autonomic nervous system neoplasm DOID_2621 3.487E-07 3.968E-05 0.05657373 0.33186032 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER neuroblastoma DOID_769 3.487E-07 3.968E-05 0.05657373 0.33186032 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER transitional cell carcinoma DOID_2671 4.248E-07 4.029E-05 0.13917267 0.5108984 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER nephroblastoma DOID_2154 4.387E-07 3.566E-05 1.743E-03 0.05511176 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER lymphoblastic leukemia DOID_1037 5.565E-07 3.958E-05 0.0109879 0.20168116 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER peripheral nervous system neoplasm DOID_1192 6.694E-07 4.232E-05 0.06595061 0.34114452 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER congenital diaphragmatic hernia DOID_3827 7.39E-07 4.205E-05 7.39E-07 1.402E-04 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER heart valve disease DOID_4079 1.505E-06 7.787E-05 8.107E-05 6.59E-03 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER hypercalcemia DOID_12678 1.571E-06 7.45E-05 1.571E-06 2.235E-04 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER reproductive organ benign neoplasm DOID_0050622 2.746E-06 1.202E-04 4.231E-03 0.10467659 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER alcohol-related neurodevelopmental disorder DOID_0050667 2.051E-05 8.335E-04 0.01120978 0.19328377 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER female reproductive organ benign neoplasm DOID_0060086 2.096E-05 7.95E-04 1.305E-03 0.04642227 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER uterine benign neoplasm DOID_0060095 2.096E-05 7.95E-04 1.305E-03 0.04642227 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER corneal disease DOID_10124 2.096E-05 7.453E-04 2.096E-05 2.385E-03 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER uterine fibroid DOID_13223 2.096E-05 7.95E-04 1.305E-03 0.04642227 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER Charcot-Marie-Tooth disease DOID_10595 2.522E-05 8.443E-04 0.05500193 0.32943263 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER chronic leukemia DOID_1036 2.756E-05 8.711E-04 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER chronic lymphocytic leukemia DOID_1040 2.756E-05 8.711E-04 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER neuritis DOID_1803 8.107E-05 2.428E-03 8.107E-05 7.688E-03 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER giant cell tumor DOID_200 1.138E-04 3.239E-03 3.95E-03 0.10217132 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER malignant giant cell tumor DOID_2705 1.138E-04 3.239E-03 3.95E-03 0.10217132 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER giant cell glioblastoma DOID_3074 1.138E-04 3.239E-03 3.95E-03 0.10217132 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER brachydactyly DOID_0050581 1.213E-04 3.285E-03 0.01649609 0.26817932 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER ventricular septal defect DOID_1657 1.213E-04 3.136E-03 1.213E-04 8.624E-03 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER keratitis DOID_4677 1.213E-04 3E-03 1.213E-04 7.666E-03 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER glioblastoma DOID_3068 1.469E-04 3.483E-03 4.669E-03 0.11070193 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER Charcot-Marie-Tooth disease type 4 DOID_0050541 1.48E-04 3.369E-03 0.0181309 0.25791201 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER pre-malignant neoplasm DOID_0060071 1.857E-04 4.064E-03 0.10404353 0.43529977 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER congenital heart defect DOID_1682 1.857E-04 3.914E-03 1.857E-04 0.01056719 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER in situ carcinoma DOID_8719 1.857E-04 4.064E-03 0.10404353 0.43529977 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER astrocytoma DOID_3069 2.403E-04 4.884E-03 6.446E-03 0.14106308 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER rhabdomyosarcoma DOID_3247 2.442E-04 4.79E-03 0.02301928 0.25188408 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER idiopathic pulmonary fibrosis DOID_0050156 2.814E-04 5.338E-03 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER skeletal muscle cancer DOID_4043 2.814E-04 5.165E-03 0.02464342 0.24600182 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER chromosomal disease DOID_0080014 3.655E-04 6.499E-03 3.655E-04 0.01890488 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER mental depression DOID_1596 3.919E-04 6.758E-03 8.879E-03 0.17421668 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER biliary tract cancer DOID_4607 3.919E-04 6.559E-03 0.1319677 0.49728227 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER heart septal defect DOID_1681 4.563E-04 7.419E-03 4.563E-04 0.02163831 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER muscle cancer DOID_4045 6.723E-04 0.0106259 0.03754118 0.29261553 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER hypotrichosis DOID_4535 9.991E-04 0.01536432 0.0455169 0.31203753 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER Sciatic Neuropathy DOID_11446 1.072E-03 0.01605096 1.072E-03 0.04691819 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER lesion of sciatic nerve DOID_12528 1.072E-03 0.01605096 1.072E-03 0.04691819 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER mononeuritis of lower limb DOID_9473 1.072E-03 0.01605096 1.072E-03 0.04691819 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER mononeuritis DOID_1802 1.147E-03 0.01673858 1.147E-03 0.04662889 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER mononeuropathy DOID_1188 1.225E-03 0.01742698 1.225E-03 0.04647196 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER supratentorial cancer DOID_1659 1.225E-03 0.01700193 0.05027107 0.31433228 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER cerebrum cancer DOID_368 1.225E-03 0.01700193 0.05027107 0.31433228 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER hair disease DOID_421 1.651E-03 0.02236651 0.05814295 0.33758508 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER metal metabolism disorder DOID_896 1.651E-03 0.02184635 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER lymphoid leukemia DOID_10747 1.838E-03 0.02377283 1.838E-03 0.05505288 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER adenoma DOID_657 1.936E-03 0.02447484 0.06283522 0.34378115 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER calcinosis DOID_182 2.035E-03 0.025176 2.035E-03 0.0579048 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER multiple myeloma DOID_9538 2.035E-03 0.02464034 0.06439419 0.33614949 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER benign mesothelioma DOID_2645 2.458E-03 0.02913693 2.458E-03 0.0665987 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER cervix uteri carcinoma in situ DOID_8991 2.458E-03 0.0285423 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER endometriosis of uterus DOID_288 2.57E-03 0.0292412 0.07215085 0.36985435 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER endometriosis DOID_289 2.683E-03 0.02993894 0.07369457 0.36462791 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER gallbladder cancer DOID_3121 2.8E-03 0.03063549 0.07523576 0.36589015 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER myeloma DOID_0070004 3.163E-03 0.03395249 0.07984421 0.38177611 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER brain cancer DOID_1319 3.163E-03 0.03332374 0.07984421 0.37859464 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER central nervous system cancer DOID_3620 3.288E-03 0.03401695 0.08137533 0.37952922 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER hemolytic anemia DOID_583 3.288E-03 0.03340951 0.08137533 0.37644362 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER normocytic anemia DOID_720 3.288E-03 0.03340951 0.08137533 0.37644362 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER pulmonary tuberculosis DOID_2957 3.416E-03 0.0340999 0.08290395 0.37737878 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER lung small cell carcinoma DOID_5409 3.416E-03 0.03351197 0.08290395 0.37438371 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER hemorrhagic disease DOID_2213 3.679E-03 0.03547686 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER bone marrow cancer DOID_4960 4.09E-03 0.03878371 0.09050955 0.39922431 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER melancholia DOID_2848 4.82E-03 0.04495874 0.09805308 0.41949023 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER neurotic disorder DOID_4964 4.973E-03 0.04563521 0.09955437 0.42273462 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER neuroectodermal tumor DOID_171 5.127E-03 0.0463102 5.127E-03 0.1167017 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER uterine disease DOID_345 5.769E-03 0.05129199 0.10702406 0.44128035 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER temporal lobe epilepsy DOID_3328 5.935E-03 0.05195506 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER endocrine organ benign neoplasm DOID_0060089 6.273E-03 0.05408424 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER tuberculosis DOID_399 6.273E-03 0.05327701 0.11147656 0.44985931 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER blood coagulation disease DOID_1247 6.62E-03 0.0553962 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER diabetic retinopathy DOID_8947 7.157E-03 0.05901637 0.1188489 0.46961821 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER endogenous depression DOID_1595 7.525E-03 0.06116597 0.12178095 0.47788523 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER electroclinical syndrome DOID_0050701 7.901E-03 0.06332239 7.901E-03 0.16651443 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER female reproductive system disease DOID_229 8.482E-03 0.06703049 0.12906913 0.49288814 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER alcohol abuse DOID_1574 8.879E-03 0.06920937 8.879E-03 0.1804387 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER focal epilepsy DOID_2234 8.879E-03 0.0682741 1.000 1.000 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER bone development disease DOID_0080006 9.081E-03 0.06889441 0.13341343 0.49942264 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER retinal vascular disease DOID_2462 9.285E-03 0.0695137 0.13485678 0.50152621 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER primary bacterial infectious disease DOID_0050338 9.698E-03 0.07166799 0.1377364 0.50890918 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER Human immunodeficiency virus infectious disease DOID_526 0.01033418 0.07538654 0.14203815 0.51477522 SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER encephalomyelitis DOID_640 0.0109879 0.07914071 0.0109879 0.19537863 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN aneurysm disease DOID_2403 1.229E-13 6.996E-11 1.255E-09 7.14E-07 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN mouth disease DOID_403 8.668E-09 2.466E-06 1.223E-07 3.479E-05 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN astrocytoma DOID_3069 9.567E-09 1.815E-06 1.646E-07 2.341E-05 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN glioblastoma DOID_3068 4.385E-08 6.238E-06 7.926E-07 7.517E-05 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN tooth disease DOID_1091 1.317E-07 1.499E-05 1.317E-07 2.498E-05 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN dilated cardiomyopathy DOID_12930 1.338E-07 1.269E-05 1.658E-06 1.348E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN endocrine organ benign neoplasm DOID_0060089 1.474E-07 1.198E-05 3.283E-04 4.061E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pre-eclampsia DOID_10591 1.963E-07 1.396E-05 1.963E-07 2.234E-05 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN aortic aneurysm DOID_3627 2.965E-07 1.875E-05 8.181E-05 1.724E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN female reproductive system disease DOID_229 5.008E-07 2.85E-05 6.749E-04 5.818E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN biliary tract cancer DOID_4607 6.023E-07 3.116E-05 7.556E-06 4.777E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bone development disease DOID_0080006 6.593E-07 3.126E-05 8.167E-06 4.647E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN retinal vascular disease DOID_2462 7.208E-07 3.155E-05 9.323E-05 1.658E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN transitional cell carcinoma DOID_2671 9.357E-07 3.803E-05 1.104E-05 5.233E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN congenital heart defect DOID_1682 1.365E-06 5.179E-05 1.943E-05 7.37E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN invasive lobular carcinoma DOID_3457 1.511E-06 5.375E-05 9.092E-05 1.669E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.533E-06 5.13E-05 8.726E-03 0.03790235 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN uterine disease DOID_345 1.675E-06 5.296E-05 2.565E-03 0.01586623 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN endometriosis of uterus DOID_288 2.018E-06 6.043E-05 5.455E-04 5.261E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN endometriosis DOID_289 2.304E-06 6.556E-05 5.935E-04 5.447E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN diabetic autonomic neuropathy DOID_11503 2.623E-06 7.108E-05 6.445E-04 5.821E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN autonomic neuropathy DOID_11504 2.623E-06 7.108E-05 6.445E-04 5.821E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN diabetic polyneuropathy DOID_12785 2.623E-06 7.108E-05 6.445E-04 5.821E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN uterine cancer DOID_363 2.623E-06 6.784E-05 6.445E-04 5.73E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN diabetic neuropathy DOID_9743 2.623E-06 7.108E-05 6.445E-04 5.821E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN myositis DOID_633 2.749E-06 6.801E-05 7.232E-05 1.646E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN nephrosis DOID_2527 2.98E-06 7.064E-05 3.746E-05 1.254E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bile duct disease DOID_4138 2.98E-06 6.782E-05 3.98E-04 4.53E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN variable age at onset electroclinical syndrome DOID_0050706 3.232E-06 7.072E-05 3.232E-06 2.298E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN polyneuropathy DOID_1389 3.232E-06 6.81E-05 1.556E-04 2.16E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN biliary tract disease DOID_9741 3.263E-06 6.631E-05 4.236E-04 4.726E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN vitiligo DOID_12306 3.324E-06 6.522E-05 8.382E-05 1.645E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN proteinuria DOID_576 3.369E-06 6.389E-05 8.032E-03 0.03570454 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN diabetic retinopathy DOID_8947 3.569E-06 6.55E-05 4.503E-04 4.659E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN autonomic nervous system disease DOID_11465 3.801E-06 6.759E-05 8.16E-04 6.539E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN mixed glioma DOID_5076 5.04E-06 8.689E-05 5.703E-04 5.319E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN focal glomerulosclerosis DOID_3945 5.63E-06 9.422E-05 2.189E-03 0.01399198 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN giant cell tumor DOID_200 7.447E-06 1.211E-04 1.067E-04 1.84E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN malignant giant cell tumor DOID_2705 7.447E-06 1.211E-04 1.067E-04 1.84E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN giant cell glioblastoma DOID_3074 7.447E-06 1.211E-04 1.067E-04 1.84E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bile duct adenocarcinoma DOID_4896 8.265E-06 1.306E-04 8.265E-06 4.275E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN cholangiocarcinoma DOID_4947 8.265E-06 1.306E-04 8.265E-06 4.275E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN vasculitis DOID_865 8.265E-06 1.271E-04 1.337E-03 9.509E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bile duct cancer DOID_4606 1.23E-05 1.841E-04 1.23E-05 5.382E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bile duct carcinoma DOID_4897 1.23E-05 1.841E-04 1.23E-05 5.382E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN nephroblastoma DOID_2154 1.386E-05 2.022E-04 1.386E-05 5.634E-04 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lymphoma DOID_0060058 1.47E-05 2.091E-04 1.184E-03 8.866E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN endocrine pancreas disease DOID_1428 2.119E-05 2.941E-04 2.43E-03 0.01536454 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN parasitic infectious disease DOID_1398 2.308E-05 3.127E-04 2.565E-03 0.01604058 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hepatitis B DOID_2043 3.115E-05 4.122E-04 3.115E-05 1.108E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pancreatic ductal carcinoma DOID_3587 3.466E-05 4.482E-04 3.737E-04 4.429E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN male reproductive system disease DOID_48 3.746E-05 4.736E-04 3.746E-05 1.184E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN heart conduction disease DOID_10273 3.746E-05 4.634E-04 3.746E-05 1.122E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN peripheral vascular disease DOID_341 4.043E-05 4.894E-04 3.658E-03 0.02020916 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hyperinsulinism DOID_2018 4.099E-05 4.859E-04 6.74E-03 0.0316963 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pancreatic carcinoma DOID_4905 4.359E-05 5.062E-04 4.503E-04 4.745E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN synostosis DOID_11971 4.466E-05 5.083E-04 4.466E-05 1.271E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN ureteral disease DOID_1426 4.466E-05 4.983E-04 0.01703894 0.06336704 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Goodpasture syndrome DOID_9808 4.466E-05 4.887E-04 0.18256646 0.31767681 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN cataract DOID_83 5.051E-05 5.422E-04 5.051E-05 1.369E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN learning disability DOID_8927 5.051E-05 5.322E-04 5.051E-05 1.306E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bone resorption disease DOID_0080011 5.427E-05 5.614E-04 5.383E-04 5.373E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN osteoporosis DOID_11476 5.427E-05 5.614E-04 5.383E-04 5.373E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lens disease DOID_110 6.165E-05 6.264E-04 6.165E-05 1.525E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN heart valve disease DOID_4079 6.165E-05 6.154E-04 8.16E-04 6.448E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN vascular skin disease DOID_9540 6.165E-05 6.048E-04 8.493E-03 0.03745937 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN angioedema DOID_1558 6.654E-05 6.417E-04 0.08054893 0.20279798 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN metabolic syndrome X DOID_14221 6.695E-05 6.349E-04 5.03E-03 0.0257862 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN spinal muscular atrophy DOID_12377 7.232E-05 6.746E-04 7.232E-05 1.715E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN ankylosing spondylitis DOID_7147 7.232E-05 6.637E-04 1.46E-03 0.01000694 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN glaucoma DOID_1686 7.46E-05 6.737E-04 7.46E-05 1.632E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN intracranial aneurysm DOID_10941 8.382E-05 7.452E-04 8.382E-05 1.703E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN teeth hard tissue disease DOID_214 8.382E-05 7.337E-04 8.382E-05 1.59E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN diffuse large B-cell lymphoma DOID_0050745 9.659E-05 8.327E-04 0.02438913 0.08410553 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN atrophic muscular disease DOID_913 1.067E-04 9.06E-04 1.067E-04 1.785E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN muscular dystrophy DOID_9884 1.067E-04 9.06E-04 1.067E-04 1.785E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN invasive ductal carcinoma DOID_3008 1.107E-04 9.265E-04 1.107E-04 1.8E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bone marrow cancer DOID_4960 1.161E-04 9.578E-04 0.01214791 0.04902243 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN amino acid metabolic disorder DOID_9252 1.197E-04 9.728E-04 1.197E-04 1.892E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Hodgkin's lymphoma DOID_8567 1.205E-04 9.655E-04 1.205E-04 1.853E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN progressive myoclonus epilepsy DOID_891 1.205E-04 9.521E-04 1.205E-04 1.804E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN reproductive organ benign neoplasm DOID_0050622 1.262E-04 9.84E-04 0.01273271 0.05102052 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN integumentary system cancer DOID_0060122 1.262E-04 9.707E-04 1.427E-03 0.01002121 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN osteochondrodysplasia DOID_2256 1.262E-04 9.578E-04 1.427E-03 9.899E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN skin cancer DOID_4159 1.262E-04 9.707E-04 1.427E-03 0.01002121 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN multiple epiphyseal dysplasia DOID_12721 1.263E-04 9.455E-04 2.189E-03 0.01415098 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN nervous system cancer DOID_3093 1.271E-04 9.395E-04 7.532E-03 0.0342857 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN female reproductive organ benign neoplasm DOID_0060086 1.434E-04 1.046E-03 0.02931259 0.0964096 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN uterine benign neoplasm DOID_0060095 1.434E-04 1.046E-03 0.02931259 0.0964096 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN uterine fibroid DOID_13223 1.434E-04 1.046E-03 0.02931259 0.0964096 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN dysostosis DOID_1934 1.434E-04 1.033E-03 1.434E-04 2.092E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN endometrial carcinoma DOID_2871 1.434E-04 1.02E-03 0.02931259 0.09530778 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN congenital nervous system abnormality DOID_2490 1.484E-04 1.043E-03 1.484E-04 2.111E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN essential hypertension DOID_10825 1.556E-04 1.08E-03 5.115E-03 0.02575779 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN impotence DOID_1875 1.556E-04 1.067E-03 1.556E-04 2.109E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Lynch syndrome DOID_3883 1.556E-04 1.054E-03 1.556E-04 2.06E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN endometrial cancer DOID_1380 1.825E-04 1.222E-03 0.03279533 0.10253044 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN narcolepsy DOID_8986 1.969E-04 1.303E-03 5.935E-03 0.0286192 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN leiomyoma DOID_127 2.047E-04 1.339E-03 0.03459449 0.10697969 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN skeletal system cancer DOID_0060124 2.446E-04 1.581E-03 6.811E-03 0.03176397 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN thoracic aortic aneurysm DOID_14004 2.446E-04 1.564E-03 2.446E-04 3.163E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bone cancer DOID_184 2.446E-04 1.581E-03 6.811E-03 0.03176397 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pneumoconiosis DOID_10316 2.548E-04 1.611E-03 0.0383046 0.11655251 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN cholestasis DOID_13580 2.683E-04 1.678E-03 0.01946086 0.07053013 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN temporal lobe epilepsy DOID_3328 2.873E-04 1.777E-03 2.873E-04 3.633E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN adenoma DOID_657 3.132E-04 1.916E-03 4.236E-03 0.02317557 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN brain infarction DOID_3454 3.283E-04 1.987E-03 3.002E-03 0.01760677 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN tuberculosis DOID_399 3.283E-04 1.967E-03 0.02179436 0.07702479 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN embryonal cancer DOID_688 3.457E-04 2.049E-03 4.551E-03 0.02375904 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN multiple myeloma DOID_9538 3.457E-04 2.028E-03 0.04413817 0.12684152 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN penile disease DOID_1529 3.61E-04 2.096E-03 3.61E-04 4.37E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN microcephaly DOID_10907 3.806E-04 2.188E-03 3.806E-04 4.42E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hepatitis DOID_2237 4.179E-04 2.378E-03 0.04819775 0.1371226 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN congenital diaphragmatic hernia DOID_3827 4.179E-04 2.354E-03 5.224E-03 0.02607387 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN sexual dysfunction DOID_1876 4.305E-04 2.402E-03 4.305E-04 4.711E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN dental caries DOID_216 4.305E-04 2.378E-03 4.305E-04 4.622E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN ureteral obstruction DOID_5199 4.305E-04 2.355E-03 9.761E-03 0.04176158 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lymphatic system disease DOID_75 4.578E-04 2.481E-03 4.578E-04 4.651E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN spinocerebellar ataxia DOID_1441 5.455E-04 2.928E-03 5.455E-04 5.351E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN electroclinical syndrome DOID_0050701 5.703E-04 3.033E-03 5.703E-04 5.408E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN nephrotic syndrome DOID_1184 5.935E-04 3.127E-03 6.74E-03 0.03222901 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN contact dermatitis DOID_2773 6.385E-04 3.333E-03 0.03159863 0.10044481 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN chromosomal disease DOID_0080014 6.749E-04 3.491E-03 6.749E-04 5.908E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN auditory system disease DOID_2742 7.127E-04 3.654E-03 7.127E-04 6.053E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN alcohol abuse DOID_1574 7.522E-04 3.821E-03 7.522E-04 6.294E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN focal epilepsy DOID_2234 7.522E-04 3.787E-03 7.522E-04 6.203E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN spinocerebellar degeneration DOID_2478 7.556E-04 3.771E-03 7.556E-04 6.142E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN myeloma DOID_0070004 8.16E-04 4.037E-03 0.06568162 0.18054513 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN brain cancer DOID_1319 8.16E-04 4.002E-03 0.06568162 0.17967713 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN thyroid adenoma DOID_2891 8.16E-04 3.968E-03 0.06568162 0.17881743 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN central nervous system cancer DOID_3620 8.796E-04 4.242E-03 0.06799645 0.18423799 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN sexual disorder DOID_0060043 9.059E-04 4.332E-03 9.059E-04 7.061E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN urinary tract obstruction DOID_5200 9.059E-04 4.296E-03 0.01570478 0.0603785 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN sleep disorder DOID_535 9.059E-04 4.26E-03 0.01570478 0.05997327 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pulmonary embolism DOID_9477 9.059E-04 4.225E-03 0.17566948 0.31042216 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN primary bacterial infectious disease DOID_0050338 9.263E-04 4.285E-03 0.03884921 0.11513125 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN integumentary system benign neoplasm DOID_0060121 9.467E-04 4.344E-03 9.467E-04 7.279E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN skin benign neoplasm DOID_3165 9.467E-04 4.344E-03 9.467E-04 7.279E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN aortic valve disease DOID_62 1.029E-03 4.684E-03 1.029E-03 7.806E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN B-cell lymphocytic neoplasm DOID_707 1.092E-03 4.929E-03 0.07509843 0.19511875 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lymphoblastic leukemia DOID_1037 1.242E-03 5.563E-03 1.242E-03 9.175E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN reading disorder DOID_13365 1.306E-03 5.804E-03 1.306E-03 9.524E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN urticaria DOID_1555 1.306E-03 5.759E-03 0.19618832 0.3352287 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN osteosarcoma DOID_3347 1.306E-03 5.714E-03 1.306E-03 9.403E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN dyslexia DOID_4428 1.306E-03 5.804E-03 1.306E-03 9.524E-03 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN parasitic protozoa infectious disease DOID_2789 1.427E-03 6.196E-03 0.08491321 0.2030068 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pustulosis of palm and sole DOID_4398 1.427E-03 6.149E-03 0.01273271 0.05066373 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN papillary adenoma DOID_3172 1.46E-03 6.245E-03 0.02131658 0.0758071 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN microcystic adenoma DOID_5403 1.46E-03 6.245E-03 0.02131658 0.0758071 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN follicular adenoma DOID_6204 1.46E-03 6.245E-03 0.02131658 0.0758071 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN gestational diabetes DOID_11714 1.801E-03 7.648E-03 0.02438913 0.08359887 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN periodontitis DOID_824 1.801E-03 7.592E-03 1.801E-03 0.01220066 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN perinatal necrotizing enterocolitis DOID_8677 1.801E-03 7.536E-03 1.801E-03 0.01205712 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN leukocyte disease DOID_9500 1.827E-03 7.59E-03 0.01523107 0.05895565 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN autoimmune disease of cardiovascular system DOID_0060051 1.989E-03 8.201E-03 0.02598914 0.08854981 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Behcet's disease DOID_13241 1.989E-03 8.201E-03 0.02598914 0.08854981 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN autoimmune disease of the nervous system DOID_438 1.989E-03 8.142E-03 1.989E-03 0.01315963 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN renal tubular transport disease DOID_447 1.989E-03 8.084E-03 1.989E-03 0.01300837 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN carotid artery disease DOID_3407 2.054E-03 8.29E-03 0.01657642 0.06205253 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hypothyroidism DOID_1459 2.175E-03 8.715E-03 0.01727327 0.06382138 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN supratentorial cancer DOID_1659 2.189E-03 8.708E-03 0.02763056 0.0924811 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN toxic encephalopathy DOID_3602 2.189E-03 8.648E-03 0.02763056 0.09194027 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN cerebrum cancer DOID_368 2.189E-03 8.708E-03 0.02763056 0.0924811 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN gonadal disease DOID_2277 2.624E-03 0.01029664 2.624E-03 0.0160539 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN allergic contact dermatitis DOID_3042 2.851E-03 0.01111072 0.11639137 0.24170324 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN celiac disease DOID_10608 2.86E-03 0.01107108 0.03279533 0.10309691 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN brachydactyly DOID_0050581 3E-03 0.0115355 3E-03 0.01816227 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Sjogren's syndrome DOID_12894 3E-03 0.01145808 0.08054893 0.2055262 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN progressive muscular atrophy DOID_318 3E-03 0.01138169 3E-03 0.01797109 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 3E-03 0.01130632 3E-03 0.01778389 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 3E-03 0.01130632 3E-03 0.01778389 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Hodgkin's granuloma DOID_8651 3E-03 0.01130632 3E-03 0.01778389 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 3E-03 0.01130632 3E-03 0.01778389 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN chronic leukemia DOID_1036 3.109E-03 0.01163883 3.109E-03 0.01805206 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN chronic lymphocytic leukemia DOID_1040 3.109E-03 0.01163883 3.109E-03 0.01805206 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN papilloma DOID_2615 3.371E-03 0.01253657 0.03643116 0.11205044 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN myocarditis DOID_820 3.371E-03 0.01245517 3.371E-03 0.0193747 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN periodontal disease DOID_3388 3.646E-03 0.01338416 3.646E-03 0.02074545 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN spindle cell carcinoma DOID_4015 3.646E-03 0.01329837 0.26716263 0.42942241 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN nervous system benign neoplasm DOID_0060115 3.647E-03 0.0132175 0.08823913 0.20577075 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN trypanosomiasis DOID_10113 3.647E-03 0.01313384 0.08823913 0.20493087 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN sickle cell anemia DOID_10923 3.647E-03 0.01305124 3.647E-03 0.02054601 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN craniosynostosis DOID_2340 3.647E-03 0.01296967 3.647E-03 0.02034458 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN familial atrial fibrillation DOID_0050650 4.352E-03 0.01538178 4.352E-03 0.02358539 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN otitis media DOID_10754 4.352E-03 0.01528683 4.352E-03 0.02336289 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN esophageal carcinoma DOID_1107 4.352E-03 0.01519305 4.352E-03 0.02314455 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pituitary cancer DOID_1785 4.352E-03 0.0151004 0.0958652 0.21060733 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN esophagus squamous cell carcinoma DOID_3748 4.352E-03 0.01519305 4.352E-03 0.02314455 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pituitary carcinoma DOID_4916 4.352E-03 0.0151004 0.0958652 0.21060733 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN middle ear disease DOID_5100 4.352E-03 0.01528683 4.352E-03 0.02336289 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN aortic valve insufficiency DOID_57 4.352E-03 0.01500889 4.352E-03 0.02293024 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN stomach disease DOID_76 4.352E-03 0.01491847 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN encephalitis DOID_9588 4.352E-03 0.01482914 0.0958652 0.20740418 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN calcinosis DOID_182 4.551E-03 0.01541509 0.04413817 0.12813582 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN peripheral nervous system neoplasm DOID_1192 4.881E-03 0.01643249 4.881E-03 0.02524628 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN berylliosis DOID_10322 5.115E-03 0.01712136 0.10342769 0.22041331 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Hirschsprung's disease DOID_10487 5.115E-03 0.01702123 5.115E-03 0.02598777 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN intracranial arterial disease DOID_13089 5.581E-03 0.01846405 0.0502766 0.14162072 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN cerebral arterial disease DOID_3527 5.581E-03 0.01846405 0.0502766 0.14162072 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN megacolon DOID_11372 5.935E-03 0.01952061 5.935E-03 0.02936579 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN parasitic helminthiasis infectious disease DOID_883 5.935E-03 0.01940842 5.935E-03 0.02911263 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN polycystic kidney disease DOID_898 5.935E-03 0.01929752 5.935E-03 0.02886381 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN benign mesothelioma DOID_2645 5.953E-03 0.0192464 0.30903888 0.48710006 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN cervix uteri carcinoma in situ DOID_8991 5.953E-03 0.01913766 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN primitive neuroectodermal tumor DOID_168 6.74E-03 0.02154636 6.74E-03 0.03196043 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN communication disorder DOID_2033 6.811E-03 0.02164919 0.11836402 0.24139471 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN corneal dystrophy DOID_2566 6.811E-03 0.02152892 6.811E-03 0.03150573 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN membranoproliferative glomerulonephritis DOID_2920 6.811E-03 0.02140997 6.811E-03 0.03125165 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN adrenal cortex disease DOID_3952 6.811E-03 0.02129233 0.11836402 0.2396766 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN gallbladder cancer DOID_3121 7.156E-03 0.02224996 0.05890322 0.16269869 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN influenza DOID_8469 7.156E-03 0.02212904 0.32624741 0.50858843 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Human immunodeficiency virus infectious disease DOID_526 7.532E-03 0.02316602 0.04219315 0.12311746 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN long QT syndrome DOID_2843 7.741E-03 0.02368005 0.1257389 0.24928723 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pituitary adenoma DOID_3829 7.741E-03 0.02355342 0.1257389 0.24842164 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN restrictive cardiomyopathy DOID_397 7.741E-03 0.02342813 7.741E-03 0.03495626 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN chronic myeloid leukemia DOID_8552 7.741E-03 0.02330417 7.741E-03 0.03468102 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lymphatic system cancer DOID_0060073 8.725E-03 0.02612824 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Bardet-Biedl syndrome DOID_1935 8.725E-03 0.02599145 8.725E-03 0.03818743 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN reticulosarcoma DOID_8538 8.725E-03 0.02612824 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lymphosarcoma DOID_8675 8.725E-03 0.02612824 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN adrenal gland disease DOID_9553 8.725E-03 0.02585607 0.13305229 0.25750595 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN autoimmune disease of gastrointestinal tract DOID_0060031 9.459E-03 0.0278883 0.07033793 0.18967905 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lung small cell carcinoma DOID_5409 9.459E-03 0.02774455 0.07033793 0.18789803 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN osteosclerosis DOID_4254 9.761E-03 0.02848354 9.761E-03 0.04207796 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN eosinophilia DOID_999 9.761E-03 0.02833822 0.14030469 0.2678972 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN calcium metabolism disease DOID_10575 9.966E-03 0.02878506 0.07270545 0.19331497 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN heart septal defect DOID_1681 0.01085013 0.03118042 0.01085013 0.04607257 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN testicular cancer DOID_2998 0.01085013 0.03102374 0.01085013 0.04573129 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN granulosa cell tumor DOID_2999 0.01085013 0.03086862 0.01085013 0.04539503 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN infertility DOID_5223 0.01085013 0.03071504 0.01085013 0.04506368 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN sarcoidosis DOID_11335 0.01157891 0.03261585 0.37535147 0.57567382 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN sex cord-gonadal stromal tumor DOID_192 0.01198969 0.03360657 0.01198969 0.04943576 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN brain edema DOID_4724 0.01198969 0.03344184 0.15462855 0.28941988 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN colonic disease DOID_5353 0.01198969 0.03327871 0.01198969 0.0490801 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN amyloidosis DOID_9120 0.01198969 0.03311716 0.01198969 0.04872953 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN smallpox DOID_8736 0.01273271 0.03499958 0.01273271 0.0503119 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN Kawasaki disease DOID_13378 0.01317926 0.03605288 0.01317926 0.05171723 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lymphadenitis DOID_1602 0.01317926 0.03605288 0.01317926 0.05171723 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN coronary restenosis DOID_4247 0.01317926 0.03588037 0.16170101 0.2967996 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lymph node disease DOID_9942 0.01317926 0.03605288 0.01317926 0.05171723 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hypertrophic cardiomyopathy DOID_11984 0.01458251 0.03951165 0.01458251 0.05683182 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hypersensitivity reaction type IV disease DOID_2916 0.01458251 0.03932439 0.40107264 0.61182395 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN IgA glomerulonephritis DOID_2986 0.01570478 0.04215103 0.17566948 0.31432684 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN uremia DOID_4676 0.01570478 0.04195314 0.17566948 0.3113892 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN polyarteritis nodosa DOID_9810 0.01570478 0.04175709 0.01570478 0.05957345 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN neuroectodermal tumor DOID_171 0.01657642 0.04386969 0.01657642 0.06246347 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN collagen disease DOID_854 0.01657642 0.04366659 0.10030256 0.21618242 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN diabetic angiopathy DOID_11713 0.01703894 0.04467815 0.18256646 0.31963174 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN respiratory failure DOID_11162 0.01727327 0.04508483 0.10293841 0.22102625 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pre-malignant neoplasm DOID_0060071 0.01798628 0.04673148 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN in situ carcinoma DOID_8719 0.01798628 0.04673148 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN spastic quadriplegia DOID_10970 0.01841954 0.04763963 0.01841954 0.06761753 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN acute pancreatitis DOID_2913 0.01841954 0.04742406 0.01841954 0.06718409 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN mineral metabolism disease DOID_0050032 0.01871547 0.04796893 0.10826633 0.22900944 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN portal hypertension DOID_10762 0.0198457 0.05063769 0.19618832 0.33623842 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hypogonadism DOID_1924 0.0198457 0.05041163 0.0198457 0.07146966 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hyperglycemia DOID_4195 0.02022247 0.05114037 0.11366591 0.23690806 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN morbid obesity DOID_11981 0.02131658 0.05366874 0.02131658 0.07628388 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN spinal cord disease DOID_319 0.02283133 0.05722921 0.02283133 0.08019154 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN seminoma DOID_4440 0.02283133 0.0569782 0.02283133 0.07969957 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN fragments of torsion dystonia DOID_531 0.02283133 0.05672939 0.02283133 0.0792136 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN blood coagulation disease DOID_1247 0.0234312 0.05796674 0.12466479 0.24889217 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN sarcoma DOID_1115 0.02598914 0.06401653 0.02598914 0.08802273 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN malaria DOID_12365 0.02598914 0.0637406 0.22275692 0.37061019 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hepatic vascular disease DOID_272 0.02598914 0.06346703 0.22275692 0.36845548 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN coronary stenosis DOID_4248 0.02598914 0.06319581 0.22275692 0.3673875 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN central nervous system hereditary degenerative disease DOID_481 0.02598914 0.06292689 0.02598914 0.08750189 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN autoimmune disease of endocrine system DOID_0060005 0.02763056 0.06661774 0.22926113 0.37702192 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN dystonic disease DOID_544 0.02763056 0.06633665 0.02763056 0.09140574 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN syndrome DOID_225 0.02780711 0.06648002 0.13875028 0.26671929 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN corneal disease DOID_10124 0.02931259 0.06978603 0.02931259 0.09585552 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN pancreatitis DOID_4989 0.02967068 0.07034423 0.02967068 0.09592394 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN bacterial pneumonia DOID_874 0.02967068 0.07005234 0.14447811 0.2749433 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN spastic cerebral palsy DOID_0050669 0.03103443 0.07296939 0.03103443 0.09976606 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN age related macular degeneration DOID_10871 0.03103443 0.07266911 0.03103443 0.09920558 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN degeneration of macula and posterior pole DOID_2007 0.03103443 0.07266911 0.03103443 0.09920558 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN abdominal aortic aneurysm DOID_7693 0.03103443 0.07237128 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN lipid metabolism disorder DOID_3146 0.03159863 0.07338621 0.03159863 0.09988678 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN germinoma DOID_3304 0.03279533 0.07585585 0.03279533 0.10197016 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN allergic rhinitis DOID_4481 0.03279533 0.07554874 0.24845001 0.40506607 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN chronic kidney failure DOID_784 0.03461069 0.0794092 0.15900305 0.29374265 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN metal metabolism disorder DOID_896 0.03643116 0.08325033 0.03643116 0.11144802 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN male infertility DOID_12336 0.0383046 0.08718128 0.0383046 0.11593255 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hepatitis C DOID_1883 0.0383046 0.08683394 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN thyroid carcinoma DOID_3963 0.0383046 0.08648937 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN macular degeneration DOID_4448 0.0383046 0.08614751 0.0383046 0.11531915 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN leukopenia DOID_615 0.0383046 0.08580835 0.0383046 0.11471221 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN hyperthyroidism DOID_7998 0.0383046 0.08547184 0.0383046 0.11411162 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN medullomyoblastoma DOID_3861 0.04021407 0.08938206 0.04021407 0.11855858 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN adult medulloblastoma DOID_3864 0.04021407 0.08938206 0.04021407 0.11855858 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN childhood medulloblastoma DOID_3869 0.04021407 0.08938206 0.04021407 0.11855858 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN primary immunodeficiency disease DOID_612 0.0410629 0.09091358 0.0410629 0.12043706 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN thyroid cancer DOID_1781 0.04215883 0.0929782 1.000 1.000 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN refractive error DOID_9835 0.04215883 0.09261921 0.27937894 0.44528464 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN medulloblastoma DOID_3858 0.04413817 0.0965947 0.04413817 0.12748539 RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN encephalomyelitis DOID_640 0.0456768 0.09957893 0.55008427 0.83244135 KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP adenoid cystic carcinoma DOID_4866 2.629E-05 0.01496113 7.913E-03 1.000 KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP benign mesothelioma DOID_2645 2.754E-05 7.836E-03 8.097E-03 1.000 KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP salivary gland cancer DOID_8850 2.882E-05 5.467E-03 8.28E-03 1.000 KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP oral cavity cancer DOID_8618 5.32E-05 7.568E-03 0.01120988 0.70871362 MURAKAMI_UV_RESPONSE_6HR_DN integumentary system cancer DOID_0060122 2.345E-08 1.335E-05 4.294E-04 0.08143908 MURAKAMI_UV_RESPONSE_6HR_DN skin cancer DOID_4159 2.345E-08 1.335E-05 4.294E-04 0.08143908 MURAKAMI_UV_RESPONSE_6HR_DN autoimmune hepatitis DOID_2048 1.66E-07 4.722E-05 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN encephalomyelitis DOID_640 1.738E-07 3.297E-05 0.04895402 0.53567 MURAKAMI_UV_RESPONSE_6HR_DN aortic valve disease DOID_62 2.523E-07 3.589E-05 0.01258851 0.28651452 MURAKAMI_UV_RESPONSE_6HR_DN pneumoconiosis DOID_10316 9.644E-07 1.097E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN pulmonary emphysema DOID_9675 1.64E-06 1.555E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN influenza DOID_8469 2.006E-06 1.63E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN heart valve disease DOID_4079 2.422E-06 1.723E-04 0.02605612 0.39015617 MURAKAMI_UV_RESPONSE_6HR_DN autoimmune disease of gastrointestinal tract DOID_0060031 2.729E-06 1.725E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN bone marrow cancer DOID_4960 3.607E-06 2.053E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN osteochondrodysplasia DOID_2256 3.803E-06 1.967E-04 4.294E-04 0.06107931 MURAKAMI_UV_RESPONSE_6HR_DN pancreatic ductal carcinoma DOID_3587 7.627E-06 3.616E-04 6.794E-04 0.07731731 MURAKAMI_UV_RESPONSE_6HR_DN pancreatic carcinoma DOID_4905 8.612E-06 3.769E-04 7.361E-04 0.06980766 MURAKAMI_UV_RESPONSE_6HR_DN cystic fibrosis DOID_1485 9.313E-06 3.785E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN aneurysm disease DOID_2403 9.677E-06 3.671E-04 7.95E-04 0.06462362 MURAKAMI_UV_RESPONSE_6HR_DN pancreatitis DOID_4989 1.005E-05 3.574E-04 0.04137883 0.4905115 MURAKAMI_UV_RESPONSE_6HR_DN bone development disease DOID_0080006 1.249E-05 4.182E-04 9.41E-04 0.06693204 MURAKAMI_UV_RESPONSE_6HR_DN aortic valve insufficiency DOID_57 1.74E-05 5.499E-04 6.313E-03 0.27632362 MURAKAMI_UV_RESPONSE_6HR_DN hypersensitivity reaction type I disease DOID_1205 1.793E-05 5.371E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN berylliosis DOID_10322 2.055E-05 5.847E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN basal cell carcinoma DOID_2513 3.579E-05 9.697E-04 8.932E-03 0.26750486 MURAKAMI_UV_RESPONSE_6HR_DN bronchitis DOID_6132 3.579E-05 9.256E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN skin carcinoma DOID_3451 4.025E-05 9.957E-04 9.456E-03 0.26901106 MURAKAMI_UV_RESPONSE_6HR_DN ureteral obstruction DOID_5199 4.025E-05 9.542E-04 9.456E-03 0.25620101 MURAKAMI_UV_RESPONSE_6HR_DN placenta disease DOID_780 6.069E-05 1.381E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN urinary tract obstruction DOID_5200 6.645E-05 1.454E-03 0.01206701 0.29852733 MURAKAMI_UV_RESPONSE_6HR_DN ureteral disease DOID_1426 7.247E-05 1.527E-03 0.01258851 0.29845263 MURAKAMI_UV_RESPONSE_6HR_DN spastic quadriplegia DOID_10970 7.875E-05 1.6E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN multiple epiphyseal dysplasia DOID_12721 1.218E-04 2.39E-03 0.01623171 0.34206822 MURAKAMI_UV_RESPONSE_6HR_DN spastic cerebral palsy DOID_0050669 1.382E-04 2.622E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN bronchiolitis obliterans DOID_2799 1.382E-04 2.537E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN allergic rhinitis DOID_4481 1.468E-04 2.611E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN spindle cell carcinoma DOID_4015 1.742E-04 3.003E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN pulmonary sarcoidosis DOID_13406 2.038E-04 3.41E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN respiratory syncytial virus infectious disease DOID_1273 2.248E-04 3.654E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN congenital diaphragmatic hernia DOID_3827 2.248E-04 3.553E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN systemic scleroderma DOID_418 2.248E-04 3.457E-03 0.02193094 0.38995957 MURAKAMI_UV_RESPONSE_6HR_DN peptic ulcer DOID_750 2.248E-04 3.366E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN rheumatic disease DOID_1575 2.699E-04 3.937E-03 0.0239956 0.41374238 MURAKAMI_UV_RESPONSE_6HR_DN scleroderma DOID_419 2.699E-04 3.937E-03 0.0239956 0.41374238 MURAKAMI_UV_RESPONSE_6HR_DN diabetic autonomic neuropathy DOID_11503 2.818E-04 4.008E-03 0.02451112 0.41020083 MURAKAMI_UV_RESPONSE_6HR_DN autonomic neuropathy DOID_11504 2.818E-04 4.008E-03 0.02451112 0.41020083 MURAKAMI_UV_RESPONSE_6HR_DN diabetic polyneuropathy DOID_12785 2.818E-04 4.008E-03 0.02451112 0.41020083 MURAKAMI_UV_RESPONSE_6HR_DN diabetic neuropathy DOID_9743 2.818E-04 4.008E-03 0.02451112 0.41020083 MURAKAMI_UV_RESPONSE_6HR_DN proteinuria DOID_576 3.063E-04 4.251E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN myeloma DOID_0070004 3.19E-04 4.322E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN autonomic nervous system disease DOID_11465 3.19E-04 4.221E-03 0.02605612 0.40070093 MURAKAMI_UV_RESPONSE_6HR_DN vascular skin disease DOID_9540 3.19E-04 4.125E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN integumentary system benign neoplasm DOID_0060121 3.451E-04 4.364E-03 0.02708483 0.39516078 MURAKAMI_UV_RESPONSE_6HR_DN glaucoma DOID_1686 3.451E-04 4.269E-03 3.451E-04 0.19635813 MURAKAMI_UV_RESPONSE_6HR_DN pulmonary tuberculosis DOID_2957 3.451E-04 4.178E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN skin benign neoplasm DOID_3165 3.451E-04 4.364E-03 0.02708483 0.39516078 MURAKAMI_UV_RESPONSE_6HR_DN aortic aneurysm DOID_3627 3.585E-04 4.25E-03 3.585E-04 0.10199696 MURAKAMI_UV_RESPONSE_6HR_DN atopic dermatitis DOID_3310 3.861E-04 4.484E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN sarcoidosis DOID_11335 4.003E-04 4.555E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN atrophic muscular disease DOID_913 4.003E-04 4.466E-03 0.02913916 0.40439465 MURAKAMI_UV_RESPONSE_6HR_DN muscular dystrophy DOID_9884 4.003E-04 4.466E-03 0.02913916 0.40439465 MURAKAMI_UV_RESPONSE_6HR_DN bile duct adenocarcinoma DOID_4896 4.147E-04 4.538E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN cholangiocarcinoma DOID_4947 4.147E-04 4.538E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN vasculitis DOID_865 4.147E-04 4.452E-03 0.02965209 0.40171527 MURAKAMI_UV_RESPONSE_6HR_DN parasitic protozoa infectious disease DOID_2789 4.294E-04 4.524E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN pustulosis of palm and sole DOID_4398 4.294E-04 4.442E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hypersensitivity reaction type IV disease DOID_2916 4.749E-04 4.825E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN bile duct cancer DOID_4606 4.749E-04 4.741E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN bile duct carcinoma DOID_4897 4.749E-04 4.741E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN collagen disease DOID_854 5.227E-04 5.128E-03 0.03323545 0.42979478 MURAKAMI_UV_RESPONSE_6HR_DN respiratory failure DOID_11162 5.391E-04 5.199E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN cholestasis DOID_13580 5.899E-04 5.594E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN parasitic infectious disease DOID_1398 5.899E-04 5.502E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN uterine disease DOID_345 5.899E-04 5.413E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN tuberculosis DOID_399 6.429E-04 5.806E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN bile duct disease DOID_4138 6.981E-04 6.206E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN peripheral vascular disease DOID_341 7.17E-04 6.276E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN biliary tract disease DOID_9741 7.17E-04 6.181E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN diabetic retinopathy DOID_8947 7.361E-04 6.251E-03 0.03934911 0.47637543 MURAKAMI_UV_RESPONSE_6HR_DN bone resorption disease DOID_0080011 7.95E-04 6.652E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN osteoporosis DOID_11476 7.95E-04 6.652E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN bacterial pneumonia DOID_874 8.151E-04 6.722E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN metabolic syndrome X DOID_14221 8.561E-04 6.959E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN female reproductive system disease DOID_229 8.77E-04 7.028E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN biliary tract cancer DOID_4607 9.195E-04 7.266E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN retinal vascular disease DOID_2462 9.629E-04 7.505E-03 0.04492102 0.5011777 MURAKAMI_UV_RESPONSE_6HR_DN primary bacterial infectious disease DOID_0050338 1.007E-03 7.745E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN mouth disease DOID_403 1.17E-03 8.879E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN Crohn's disease DOID_8778 1.17E-03 8.762E-03 0.04945701 0.530963 MURAKAMI_UV_RESPONSE_6HR_DN arrhythmogenic right ventricular dysplasia DOID_0050431 4.738E-03 0.03501533 4.738E-03 0.29957562 MURAKAMI_UV_RESPONSE_6HR_DN facioscapulohumeral muscular dystrophy DOID_11727 5.264E-03 0.03839751 5.264E-03 0.29950059 MURAKAMI_UV_RESPONSE_6HR_DN hyperparathyroidism DOID_13543 5.264E-03 0.03791147 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN retinal vascular occlusion DOID_1729 5.264E-03 0.03743757 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN insulinoma DOID_3892 5.264E-03 0.03697538 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN visceral leishmaniasis DOID_9146 5.264E-03 0.03652446 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN alopecia areata DOID_986 5.264E-03 0.03608441 5.264E-03 0.27227326 MURAKAMI_UV_RESPONSE_6HR_DN prediabetes syndrome DOID_11716 5.789E-03 0.03921049 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN prostatic adenoma DOID_2883 5.789E-03 0.03874919 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN aortic valve stenosis DOID_1712 6.313E-03 0.04176985 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN islet cell tumor DOID_1799 6.313E-03 0.04128974 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN epidermolysis bullosa DOID_2730 6.313E-03 0.04082054 6.313E-03 0.29935059 MURAKAMI_UV_RESPONSE_6HR_DN Hodgkin's lymphoma DOID_8567 6.313E-03 0.04036188 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN ocular hypertension DOID_9282 6.313E-03 0.03991341 6.313E-03 0.25658622 MURAKAMI_UV_RESPONSE_6HR_DN borderline glaucoma DOID_9283 6.313E-03 0.03991341 6.313E-03 0.25658622 MURAKAMI_UV_RESPONSE_6HR_DN parathyroid gland disease DOID_11201 6.838E-03 0.04275366 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN polyneuropathy DOID_1389 6.838E-03 0.04228895 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN vesiculobullous skin disease DOID_2731 6.838E-03 0.04183423 6.838E-03 0.25937221 MURAKAMI_UV_RESPONSE_6HR_DN hypercalcemia DOID_12678 7.362E-03 0.04456181 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN thoracic aortic aneurysm DOID_14004 7.886E-03 0.04723039 7.886E-03 0.28043042 MURAKAMI_UV_RESPONSE_6HR_DN Williams-Beuren syndrome DOID_1928 7.886E-03 0.0467384 7.886E-03 0.26393451 MURAKAMI_UV_RESPONSE_6HR_DN lung oat cell carcinoma DOID_5411 7.886E-03 0.04625656 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN oral submucous fibrosis DOID_5773 7.886E-03 0.04578456 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN silicosis DOID_10325 8.409E-03 0.04833146 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN spastic diplegia DOID_10965 8.409E-03 0.04784814 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hemolytic-uremic syndrome DOID_12554 8.409E-03 0.0473744 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN thyroiditis DOID_7166 8.409E-03 0.04690994 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN autoimmune thyroiditis DOID_7188 8.409E-03 0.04690994 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN tongue cancer DOID_8649 8.409E-03 0.04645451 8.409E-03 0.26582301 MURAKAMI_UV_RESPONSE_6HR_DN penile disease DOID_1529 8.932E-03 0.04887108 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN male reproductive organ benign neoplasm DOID_0060087 9.456E-03 0.0512402 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN osteosclerosis DOID_4254 9.456E-03 0.0507568 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN dissociative disorder DOID_10935 9.978E-03 0.05306263 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN dissociative amnesia DOID_11037 9.978E-03 0.05306263 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN psoriasis DOID_8893 9.978E-03 0.0525713 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN leishmaniasis DOID_9065 9.978E-03 0.052089 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN amnestic disorder DOID_10914 0.01050093 0.05431847 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN pulmonary edema DOID_11396 0.01050093 0.05382911 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN esophagitis DOID_11963 0.01050093 0.05334849 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN alopecia DOID_987 0.01050093 0.05287638 0.01050093 0.27159234 MURAKAMI_UV_RESPONSE_6HR_DN Kawasaki disease DOID_13378 0.01102322 0.05501941 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN lymphadenitis DOID_1602 0.01102322 0.05501941 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN mitochondrial myopathy DOID_699 0.01102322 0.05454098 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN lymph node disease DOID_9942 0.01102322 0.05501941 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN sinusitis DOID_0050127 0.01206701 0.05919076 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN paranasal sinus disease DOID_1352 0.01206701 0.05919076 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN IgA glomerulonephritis DOID_2986 0.01206701 0.05868486 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN uremia DOID_4676 0.01206701 0.05818753 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN polyarteritis nodosa DOID_9810 0.01206701 0.05769856 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN meningitis DOID_9471 0.01258851 0.05969053 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN Goodpasture syndrome DOID_9808 0.01258851 0.05919722 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN urticaria DOID_1555 0.01363073 0.06357283 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hypogonadism DOID_1924 0.01363073 0.06305598 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN bronchiolitis DOID_2942 0.01363073 0.06254747 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN osteosarcoma DOID_3347 0.01363073 0.06204709 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN intracranial aneurysm DOID_10941 0.0146719 0.06625646 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN middle cerebral artery infarction DOID_3525 0.0146719 0.06573475 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hypotrichosis DOID_4535 0.0146719 0.0652212 0.0146719 0.32108899 MURAKAMI_UV_RESPONSE_6HR_DN extrinsic allergic alveolitis DOID_841 0.0146719 0.06471561 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN Sciatic Neuropathy DOID_11446 0.0151921 0.06649465 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN lesion of sciatic nerve DOID_12528 0.0151921 0.06649465 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN lung adenocarcinoma DOID_3910 0.0151921 0.06598706 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN periodontitis DOID_824 0.0151921 0.06548716 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN mononeuritis of lower limb DOID_9473 0.0151921 0.06649465 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN autoimmune disease of cardiovascular system DOID_0060051 0.01571203 0.06721915 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN pleurisy DOID_10247 0.01571203 0.06671752 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN malaria DOID_12365 0.01571203 0.06622332 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN Behcet's disease DOID_13241 0.01571203 0.06721915 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN mononeuritis DOID_1802 0.01571203 0.06573638 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN autoimmune disease of endocrine system DOID_0060005 0.01623171 0.0674149 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN mononeuropathy DOID_1188 0.01623171 0.06692639 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN focal glomerulosclerosis DOID_3945 0.01623171 0.06644491 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN age related macular degeneration DOID_10871 0.01727027 0.07019133 0.01727027 0.35095663 MURAKAMI_UV_RESPONSE_6HR_DN degeneration of macula and posterior pole DOID_2007 0.01727027 0.07019133 0.01727027 0.35095663 MURAKAMI_UV_RESPONSE_6HR_DN gonadal disease DOID_2277 0.01727027 0.06969352 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN celiac disease DOID_10608 0.01778917 0.07128194 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN chronic leukemia DOID_1036 0.0183078 0.07284711 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN chronic lymphocytic leukemia DOID_1040 0.0183078 0.07284711 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN pleural disease DOID_1532 0.0183078 0.07234123 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN papilloma DOID_2615 0.01882617 0.07387648 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hair disease DOID_421 0.01882617 0.07337048 0.01882617 0.36938242 MURAKAMI_UV_RESPONSE_6HR_DN periodontal disease DOID_3388 0.01934428 0.07487684 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN macular degeneration DOID_4448 0.01934428 0.07437092 0.01934428 0.36689653 MURAKAMI_UV_RESPONSE_6HR_DN esophageal disease DOID_6050 0.01934428 0.07387178 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN adenoma DOID_657 0.02037972 0.07730709 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN cleft palate DOID_674 0.02089706 0.07874454 0.02089706 0.3835621 MURAKAMI_UV_RESPONSE_6HR_DN multiple myeloma DOID_9538 0.02089706 0.07822648 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN uveitis DOID_13141 0.02141413 0.07963817 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hepatitis DOID_2237 0.02193094 0.08103056 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN adult respiratory distress syndrome DOID_11394 0.0224475 0.08240404 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN intracranial arterial disease DOID_13089 0.0224475 0.0818758 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN cerebral arterial disease DOID_3527 0.0224475 0.0818758 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN lymphatic system disease DOID_75 0.0224475 0.0813543 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN benign mesothelioma DOID_2645 0.02296379 0.08269872 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN nephrotic syndrome DOID_1184 0.0239956 0.08587106 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hyperinsulinism DOID_2018 0.0239956 0.08533437 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN uveal disease DOID_3480 0.0239956 0.08480434 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN gallbladder cancer DOID_3121 0.02451112 0.08609153 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN cerebral infarction DOID_3526 0.02502638 0.08736203 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN spinocerebellar degeneration DOID_2478 0.02554138 0.08861614 0.02554138 0.41522989 MURAKAMI_UV_RESPONSE_6HR_DN pre-eclampsia DOID_10591 0.02605612 0.08985415 0.02605612 0.41183151 MURAKAMI_UV_RESPONSE_6HR_DN neuritis DOID_1803 0.02605612 0.08931286 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN hemolytic anemia DOID_583 0.02657061 0.09053099 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN normocytic anemia DOID_720 0.02657061 0.09053099 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN lung small cell carcinoma DOID_5409 0.02708483 0.09173375 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN calcium metabolism disease DOID_10575 0.0275988 0.09292141 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_DN orofacial cleft DOID_0050567 0.02862596 0.09581278 0.02862596 0.40720432 AMUNDSON_GENOTOXIC_SIGNATURE invasive ductal carcinoma DOID_3008 7.55E-06 4.296E-03 7.55E-06 4.296E-03 AMUNDSON_GENOTOXIC_SIGNATURE cleft palate DOID_674 1.821E-05 5.181E-03 1.821E-05 5.181E-03 AMUNDSON_GENOTOXIC_SIGNATURE orofacial cleft DOID_0050567 4.771E-05 9.049E-03 4.771E-05 9.049E-03 AMUNDSON_GENOTOXIC_SIGNATURE bone marrow cancer DOID_4960 5.312E-05 7.556E-03 5.312E-05 7.556E-03 AMUNDSON_GENOTOXIC_SIGNATURE silicosis DOID_10325 1.862E-04 0.02119462 0.02007067 0.346067 AMUNDSON_GENOTOXIC_SIGNATURE urinary system benign neoplasm DOID_731 2.109E-04 0.02000097 2.109E-04 0.02400116 AMUNDSON_GENOTOXIC_SIGNATURE colon carcinoma DOID_1520 2.939E-04 0.02389274 2.939E-04 0.02787486 AMUNDSON_GENOTOXIC_SIGNATURE neutropenia DOID_1227 3.568E-04 0.02537643 0.02749503 0.38157731 AMUNDSON_GENOTOXIC_SIGNATURE agranulocytosis DOID_12987 3.905E-04 0.02468514 0.02872705 0.38013238 AMUNDSON_GENOTOXIC_SIGNATURE sarcoma DOID_1115 6.675E-04 0.03798318 0.03730855 0.37243092 AMUNDSON_GENOTOXIC_SIGNATURE malaria DOID_12365 6.675E-04 0.03453017 0.03730855 0.3660097 AMUNDSON_GENOTOXIC_SIGNATURE germinoma DOID_3304 8.581E-04 0.0406894 8.581E-04 0.06975325 AMUNDSON_GENOTOXIC_SIGNATURE metal metabolism disorder DOID_896 9.621E-04 0.04211102 0.04460499 0.37323879 AMUNDSON_GENOTOXIC_SIGNATURE pneumoconiosis DOID_10316 1.016E-03 0.04130421 0.04581578 0.37781423 AMUNDSON_GENOTOXIC_SIGNATURE esophageal disease DOID_6050 1.016E-03 0.03855059 0.04581578 0.36207197 AMUNDSON_GENOTOXIC_SIGNATURE leukopenia DOID_615 1.016E-03 0.03614118 0.04581578 0.35711208 AMUNDSON_GENOTOXIC_SIGNATURE pulmonary sarcoidosis DOID_13406 1.187E-03 0.03974134 0.04943917 0.3653362 AMUNDSON_GENOTOXIC_SIGNATURE multiple myeloma DOID_9538 1.187E-03 0.03753349 1.187E-03 0.08445034 AMUNDSON_GENOTOXIC_SIGNATURE hepatitis DOID_2237 1.309E-03 0.03918733 0.05184727 0.35120354 AMUNDSON_GENOTOXIC_SIGNATURE congenital diaphragmatic hernia DOID_3827 1.309E-03 0.03722796 0.05184727 0.34707173 AMUNDSON_GENOTOXIC_SIGNATURE adult respiratory distress syndrome DOID_11394 1.371E-03 0.03715474 0.05304908 0.35098752 AMUNDSON_GENOTOXIC_SIGNATURE influenza DOID_8469 1.636E-03 0.04232021 0.05784142 0.33583438 AMUNDSON_GENOTOXIC_SIGNATURE cerebral infarction DOID_3526 1.706E-03 0.04220617 0.05903579 0.33930672 AMUNDSON_GENOTOXIC_SIGNATURE myeloma DOID_0070004 1.85E-03 0.04385501 1.85E-03 0.1169467 AMUNDSON_GENOTOXIC_SIGNATURE pre-eclampsia DOID_10591 1.85E-03 0.04210081 0.06142008 0.34262773 AMUNDSON_GENOTOXIC_SIGNATURE calcium metabolism disease DOID_10575 2.076E-03 0.04542763 0.06498544 0.34237698 AMUNDSON_GENOTOXIC_SIGNATURE movement disease DOID_480 2.076E-03 0.04374513 2.076E-03 0.11811184 AMUNDSON_GENOTOXIC_SIGNATURE withdrawal disorder DOID_0060001 2.154E-03 0.04376993 2.154E-03 0.11141436 AMUNDSON_GENOTOXIC_SIGNATURE sarcoidosis DOID_11335 2.314E-03 0.0454064 0.06853753 0.35452593 AMUNDSON_GENOTOXIC_SIGNATURE parasitic protozoa infectious disease DOID_2789 2.48E-03 0.04703771 0.07089824 0.35079217 AMUNDSON_GENOTOXIC_SIGNATURE pustulosis of palm and sole DOID_4398 2.48E-03 0.04552036 0.07089824 0.3477681 AMUNDSON_GENOTOXIC_SIGNATURE hypertrophic cardiomyopathy DOID_11984 2.739E-03 0.04870193 2.739E-03 0.12987182 AMUNDSON_GENOTOXIC_SIGNATURE hypersensitivity reaction type IV disease DOID_2916 2.739E-03 0.04722611 0.07442833 0.35588002 AMUNDSON_GENOTOXIC_SIGNATURE leukocyte disease DOID_9500 2.828E-03 0.04732688 0.07560211 0.34973659 AMUNDSON_GENOTOXIC_SIGNATURE respiratory failure DOID_11162 3.103E-03 0.05044771 0.0791147 0.35727195 AMUNDSON_GENOTOXIC_SIGNATURE mineral metabolism disease DOID_0050032 3.293E-03 0.05205149 0.08144916 0.35649673 AMUNDSON_GENOTOXIC_SIGNATURE endocrine pancreas disease DOID_1428 3.293E-03 0.05064469 0.08144916 0.35377538 AMUNDSON_GENOTOXIC_SIGNATURE cholestasis DOID_13580 3.39E-03 0.05076536 0.08261422 0.35611737 AMUNDSON_GENOTOXIC_SIGNATURE parasitic infectious disease DOID_1398 3.39E-03 0.04946368 0.08261422 0.35343979 AMUNDSON_GENOTOXIC_SIGNATURE allergic contact dermatitis DOID_3042 3.588E-03 0.05104526 0.08494 0.35800636 AMUNDSON_GENOTOXIC_SIGNATURE brain infarction DOID_3454 3.689E-03 0.05120251 0.08610072 0.3576008 AMUNDSON_GENOTOXIC_SIGNATURE bile duct disease DOID_4138 4E-03 0.05419706 0.08957424 0.36667442 AMUNDSON_GENOTOXIC_SIGNATURE biliary tract disease DOID_9741 4.107E-03 0.05434325 0.09072921 0.36874943 AMUNDSON_GENOTOXIC_SIGNATURE endogenous depression DOID_1595 4.433E-03 0.05733314 4.433E-03 0.19405063 AMUNDSON_GENOTOXIC_SIGNATURE syndrome DOID_225 4.433E-03 0.05605907 0.0941855 0.38008193 AMUNDSON_GENOTOXIC_SIGNATURE bacterial pneumonia DOID_874 4.658E-03 0.05761477 0.09648255 0.3839061 AMUNDSON_GENOTOXIC_SIGNATURE contact dermatitis DOID_2773 4.887E-03 0.05916668 0.09877389 0.38760239 AMUNDSON_GENOTOXIC_SIGNATURE mental depression DOID_1596 5.241E-03 0.06212778 5.241E-03 0.21300952 AMUNDSON_GENOTOXIC_SIGNATURE nervous system cancer DOID_3093 6.111E-03 0.07096091 6.111E-03 0.23180564 AMUNDSON_GENOTOXIC_SIGNATURE lymphoblastic leukemia DOID_1037 6.502E-03 0.07399817 6.502E-03 0.2312443 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hypersensitivity reaction type IV disease DOID_2916 2.863E-17 1.629E-14 2.347E-12 4.452E-10 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN contact dermatitis DOID_2773 4.709E-17 1.34E-14 1.749E-15 9.953E-13 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN allergic contact dermatitis DOID_3042 1.978E-16 3.751E-14 8.077E-15 2.298E-12 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN sarcoidosis DOID_11335 4.55E-16 6.473E-14 3.636E-11 5.173E-09 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pulmonary sarcoidosis DOID_13406 2.452E-14 2.79E-12 7.155E-11 8.143E-09 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN bacterial pneumonia DOID_874 3.896E-11 3.695E-09 2.213E-08 2.098E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN influenza DOID_8469 2.826E-10 2.297E-08 3.057E-07 2.174E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN respiratory syncytial virus infectious disease DOID_1273 4.43E-09 3.151E-07 4.392E-06 1.47E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pulmonary emphysema DOID_9675 6.232E-09 3.94E-07 5.555E-06 1.756E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pancreatitis DOID_4989 2.213E-08 1.259E-06 7.301E-06 1.978E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN vasculitis DOID_865 4.034E-08 2.087E-06 2.015E-05 4.41E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN primary bacterial infectious disease DOID_0050338 5.156E-08 2.445E-06 8.992E-07 4.651E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN primary immunodeficiency disease DOID_612 6.143E-08 2.689E-06 1.046E-06 4.578E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hyperthyroidism DOID_7998 6.946E-08 2.823E-06 2.304E-06 9.365E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN carotid artery disease DOID_3407 9.16E-08 3.475E-06 5.247E-04 6.353E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN respiratory failure DOID_11162 1.022E-07 3.633E-06 3.829E-05 8.069E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN tuberculosis DOID_399 1.895E-07 6.343E-06 3.633E-06 1.292E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN myasthenia gravis DOID_437 1.9E-07 6.005E-06 1.9E-07 1.544E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN male reproductive system disease DOID_48 2.527E-07 7.568E-06 9.085E-04 9.231E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN peripheral vascular disease DOID_341 2.774E-07 7.891E-06 9.554E-04 9.373E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN aneurysm disease DOID_2403 3.972E-07 1.076E-05 9.784E-05 1.591E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN cystitis DOID_1679 4.473E-07 1.157E-05 1.713E-05 4.061E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN neuromuscular junction disease DOID_439 4.473E-07 1.107E-05 4.473E-07 2.828E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN aortic aneurysm DOID_3627 6.35E-07 1.506E-05 2.541E-04 3.527E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autoimmune disease of the nervous system DOID_438 7.785E-07 1.772E-05 7.785E-07 4.43E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autoimmune disease of endocrine system DOID_0060005 9.238E-07 2.022E-05 9.238E-07 4.38E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN parasitic protozoa infectious disease DOID_2789 1.093E-06 2.303E-05 3.6E-04 4.764E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN encephalomyelitis DOID_640 1.4E-06 2.846E-05 1.965E-05 4.472E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN allergic rhinitis DOID_4481 1.492E-06 2.927E-05 9.969E-04 9.454E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pleural disease DOID_1532 1.732E-06 3.285E-05 1.086E-03 0.01012794 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN bladder disease DOID_365 1.732E-06 3.179E-05 4.929E-05 9.349E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hepatitis C DOID_1883 2.304E-06 4.097E-05 6.161E-05 1.131E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Graves' disease DOID_12361 2.431E-06 4.191E-05 2.431E-06 9.221E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN parasitic infectious disease DOID_1398 2.817E-06 4.714E-05 6.606E-04 7.518E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN uveitis DOID_13141 3.888E-06 6.32E-05 9.278E-05 1.553E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN endometriosis of uterus DOID_288 6.22E-06 9.831E-05 6.22E-06 1.863E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN endometriosis DOID_289 6.946E-06 1.068E-04 6.946E-06 1.976E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN uveal disease DOID_3480 6.946E-06 1.04E-04 1.462E-04 2.248E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN female reproductive system disease DOID_229 9.039E-06 1.319E-04 9.039E-06 2.338E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN heart valve disease DOID_4079 1.054E-05 1.499E-04 3.051E-03 0.02066875 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN vascular skin disease DOID_9540 1.054E-05 1.462E-04 3.051E-03 0.02042559 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.28E-05 1.735E-04 3.412E-03 0.02205847 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pulmonary tuberculosis DOID_2957 1.28E-05 1.694E-04 2.36E-04 3.357E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN urticaria DOID_1555 1.466E-05 1.896E-04 4.481E-04 5.667E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN osteosarcoma DOID_3347 1.466E-05 1.853E-04 1.466E-05 3.626E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN myositis DOID_633 1.713E-05 2.119E-04 0.01060246 0.05484365 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hypersensitivity reaction type I disease DOID_1205 2.213E-05 2.679E-04 2.468E-03 0.01800189 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN dilated cardiomyopathy DOID_12930 2.213E-05 2.623E-04 2.468E-03 0.01777402 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN childhood type dermatomyositis DOID_14203 2.214E-05 2.572E-04 1.45E-03 0.01231314 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN transient cerebral ischemia DOID_224 2.214E-05 2.52E-04 0.05629463 0.19296171 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN acute kidney failure DOID_3021 2.214E-05 2.471E-04 0.05629463 0.19066455 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autoimmune disease of cardiovascular system DOID_0060051 2.639E-05 2.887E-04 0.01299175 0.06484478 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pleurisy DOID_10247 2.639E-05 2.833E-04 6.88E-04 7.676E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Behcet's disease DOID_13241 2.639E-05 2.887E-04 0.01299175 0.06484478 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN coronary stenosis DOID_4248 2.639E-05 2.781E-04 0.01299175 0.06428091 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN dermatomyositis DOID_10223 3.032E-05 3.137E-04 1.765E-03 0.01434966 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN neuronal ceroid lipofuscinosis DOID_14503 3.032E-05 3.081E-04 1.765E-03 0.01414755 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN age related macular degeneration DOID_10871 3.887E-05 3.88E-04 3.887E-05 7.899E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN degeneration of macula and posterior pole DOID_2007 3.887E-05 3.88E-04 3.887E-05 7.899E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN bronchiolitis obliterans DOID_2799 3.887E-05 3.813E-04 9.128E-04 9.112E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN mineral metabolism disease DOID_0050032 4.435E-05 4.277E-04 6.942E-03 0.03910698 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN uterine disease DOID_345 4.765E-05 4.518E-04 4.765E-05 9.348E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN myocarditis DOID_820 5.52E-05 5.149E-04 1.179E-03 0.01065258 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spindle cell carcinoma DOID_4015 6.161E-05 5.654E-04 1.278E-03 0.01136305 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN macular degeneration DOID_4448 6.161E-05 5.565E-04 6.161E-05 1.096E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN viral pneumonia DOID_10533 6.603E-05 5.871E-04 2.888E-03 0.02028499 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN diabetic retinopathy DOID_8947 8.134E-05 7.12E-04 9.809E-03 0.05216039 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN thoracic aortic aneurysm DOID_14004 8.219E-05 7.086E-04 8.219E-05 1.417E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN cystic fibrosis DOID_1485 9.208E-05 7.82E-04 0.01052593 0.05545605 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN adult respiratory distress syndrome DOID_11394 1.12E-04 9.376E-04 1.979E-03 0.01563949 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autoimmune disease of urogenital tract DOID_0060049 1.341E-04 1.105E-03 1.341E-04 2.119E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN primary biliary cirrhosis DOID_12236 1.341E-04 1.105E-03 1.341E-04 2.119E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN retinal vascular disease DOID_2462 1.545E-04 1.256E-03 0.01412296 0.06810137 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN cataract DOID_83 1.727E-04 1.384E-03 1.727E-04 2.586E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN nervous system cancer DOID_3093 2.009E-04 1.588E-03 0.01638641 0.07642514 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pulmonary edema DOID_11396 2.016E-04 1.571E-03 5.893E-03 0.03457037 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN lens disease DOID_110 2.026E-04 1.558E-03 2.026E-04 2.956E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hemolytic anemia DOID_583 2.188E-04 1.66E-03 3.228E-03 0.02135934 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN normocytic anemia DOID_720 2.188E-04 1.66E-03 3.228E-03 0.02135934 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN lymphoma DOID_0060058 2.222E-04 1.663E-03 2.201E-03 0.01648064 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autoimmune hepatitis DOID_2048 2.342E-04 1.73E-03 0.11458107 0.26829888 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN coronary restenosis DOID_4247 2.342E-04 1.708E-03 6.489E-03 0.03692281 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN muscular atrophy DOID_767 2.7E-04 1.945E-03 2.7E-04 3.658E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN atopic dermatitis DOID_3310 2.933E-04 2.086E-03 3.999E-03 0.02500356 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN bone marrow cancer DOID_4960 3.367E-04 2.365E-03 4.422E-03 0.02735156 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN diabetic angiopathy DOID_11713 3.518E-04 2.441E-03 0.12984577 0.29087497 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN severe combined immunodeficiency DOID_627 3.981E-04 2.729E-03 3.981E-04 5.149E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN glioblastoma DOID_3068 4.369E-04 2.959E-03 5.349E-03 0.03170148 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN combined T cell and B cell immunodeficiency DOID_628 4.481E-04 3E-03 4.481E-04 5.543E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN extrinsic allergic alveolitis DOID_841 5.599E-04 3.704E-03 0.01137497 0.0577889 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN congenital heart defect DOID_1682 5.899E-04 3.858E-03 5.899E-04 6.993E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN perinatal necrotizing enterocolitis DOID_8677 6.218E-04 4.021E-03 0.15470697 0.31105394 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN cholestasis DOID_13580 6.606E-04 4.223E-03 6.606E-04 7.671E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN malaria DOID_12365 6.88E-04 4.35E-03 6.88E-04 7.528E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN polycystic ovary syndrome DOID_11612 7.585E-04 4.743E-03 0.01383542 0.06728509 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN brain infarction DOID_3454 7.776E-04 4.809E-03 7.776E-04 8.348E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN astrocytoma DOID_3069 8.196E-04 5.015E-03 8.462E-03 0.04674817 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN corneal disease DOID_10124 8.334E-04 5.045E-03 0.01470223 0.07029888 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN blood coagulation disease DOID_1247 8.633E-04 5.171E-03 0.06684164 0.21247426 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN nephrosis DOID_2527 9.085E-04 5.385E-03 9.085E-04 9.573E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN bile duct disease DOID_4138 9.085E-04 5.329E-03 9.085E-04 9.399E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN biliary tract disease DOID_9741 9.554E-04 5.547E-03 9.554E-04 9.214E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN syndrome DOID_225 1.106E-03 6.358E-03 0.07498286 0.21439822 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN DiGeorge syndrome DOID_11198 1.164E-03 6.625E-03 1.164E-03 0.01068556 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN velocardiofacial syndrome DOID_12583 1.164E-03 6.625E-03 1.164E-03 0.01068556 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN papilloma DOID_2615 1.179E-03 6.645E-03 0.0183949 0.08241495 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pneumoconiosis DOID_10316 1.278E-03 7.13E-03 0.019373 0.08611906 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN chromosomal disease DOID_0080014 1.393E-03 7.698E-03 1.393E-03 0.01219842 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN T cell deficiency DOID_11200 1.45E-03 7.933E-03 1.45E-03 0.01249971 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Sjogren's syndrome DOID_12894 1.45E-03 7.857E-03 0.05629463 0.19651315 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN angioedema DOID_1558 1.45E-03 7.783E-03 1.45E-03 0.01213207 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN keratitis DOID_4677 1.45E-03 7.71E-03 0.05629463 0.18842144 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN alcohol abuse DOID_1574 1.522E-03 8.017E-03 1.522E-03 0.01254864 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN calcinosis DOID_182 1.605E-03 8.376E-03 0.02243466 0.09597988 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN multiple myeloma DOID_9538 1.605E-03 8.3E-03 0.02243466 0.09526361 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN familial adenomatous polyposis DOID_0050424 1.765E-03 9.049E-03 0.06174756 0.20426954 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN adrenoleukodystrophy DOID_10588 1.765E-03 8.969E-03 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hepatitis DOID_2237 1.849E-03 9.309E-03 0.21608636 0.39032742 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN amino acid metabolic disorder DOID_9252 1.955E-03 9.76E-03 0.01591843 0.07485609 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN common cold DOID_10459 2.11E-03 0.01044165 0.06716912 0.21115597 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN otitis media DOID_10754 2.11E-03 0.01035164 2.11E-03 0.01644918 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN middle ear disease DOID_5100 2.11E-03 0.01035164 2.11E-03 0.01644918 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN progressive myoclonus epilepsy DOID_891 2.11E-03 0.01026317 2.11E-03 0.0162269 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN ocular hypertension DOID_9282 2.11E-03 0.01017619 2.11E-03 0.01601054 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN borderline glaucoma DOID_9283 2.11E-03 0.01017619 2.11E-03 0.01601054 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN lymphoblastic leukemia DOID_1037 2.288E-03 0.01093904 2.288E-03 0.0169058 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Crohn's disease DOID_8778 2.377E-03 0.011269 0.01833509 0.08279893 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN variable age at onset electroclinical syndrome DOID_0050706 2.485E-03 0.01168368 2.485E-03 0.01767157 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN berylliosis DOID_10322 2.485E-03 0.01158791 0.0725595 0.21281627 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN leukodystrophy DOID_10579 2.88E-03 0.01332456 0.24727762 0.43695952 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Legionnaires' disease DOID_10457 2.888E-03 0.01325068 0.07791887 0.22167919 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN legionellosis DOID_10458 2.888E-03 0.01325068 0.07791887 0.22167919 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN megacolon DOID_11372 2.888E-03 0.01314467 2.888E-03 0.02003761 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN myeloma DOID_0070004 3.051E-03 0.01377917 0.03393802 0.13317749 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN neuritis DOID_1803 3.051E-03 0.01367067 3.051E-03 0.02091777 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN thyroid adenoma DOID_2891 3.051E-03 0.01356387 0.03393802 0.13136555 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN peripheral neuropathy DOID_0060053 3.319E-03 0.01464086 3.319E-03 0.02170886 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN mesenchymal cell neoplasm DOID_3350 3.319E-03 0.01452824 0.08324742 0.22343292 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spindle cell sarcoma DOID_4235 3.319E-03 0.01452824 0.08324742 0.22343292 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN epithelioid sarcoma DOID_6193 3.319E-03 0.01452824 0.08324742 0.22343292 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN varicose veins DOID_799 3.319E-03 0.01441734 0.08324742 0.22031525 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN glaucoma DOID_1686 3.412E-03 0.01470564 3.412E-03 0.02181062 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN calcium metabolism disease DOID_10575 3.601E-03 0.01540555 0.03775138 0.14416465 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN silicosis DOID_10325 3.779E-03 0.01604697 0.0885453 0.23111137 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hemolytic-uremic syndrome DOID_12554 3.779E-03 0.0159281 3.779E-03 0.02389215 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN vein disease DOID_866 3.779E-03 0.01581098 0.0885453 0.2259295 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hemorrhagic disease DOID_2213 3.797E-03 0.01576875 0.03905733 0.14717628 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN B-cell lymphocytic neoplasm DOID_707 3.797E-03 0.01565448 0.03905733 0.14620802 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN giant cell tumor DOID_200 4.207E-03 0.01722293 0.04172003 0.15414737 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN malignant giant cell tumor DOID_2705 4.207E-03 0.01722293 0.04172003 0.15414737 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN giant cell glioblastoma DOID_3074 4.207E-03 0.01722293 0.04172003 0.15414737 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN bronchitis DOID_6132 4.267E-03 0.01734114 0.09381272 0.2351517 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN glucose intolerance DOID_10603 4.782E-03 0.01929701 4.782E-03 0.02925676 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN infertility DOID_5223 5.324E-03 0.02133425 5.324E-03 0.03222833 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN MHC class II deficiency DOID_5812 5.324E-03 0.02118506 5.324E-03 0.03188909 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN leishmaniasis DOID_9065 5.324E-03 0.02103794 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN oral cavity cancer DOID_8618 5.349E-03 0.02098857 0.04866216 0.17414321 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN leukocyte disease DOID_9500 5.597E-03 0.02181259 0.30196304 0.50984264 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN esophagitis DOID_11963 5.893E-03 0.02281174 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN colon carcinoma DOID_1520 5.893E-03 0.02265761 5.893E-03 0.03421761 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN colonic disease DOID_5353 5.893E-03 0.02250554 5.893E-03 0.03387198 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN collagen disease DOID_854 6.114E-03 0.02319259 0.05301397 0.18735993 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN cerebral degeneration DOID_1443 7.232E-03 0.02725003 0.32585042 0.54372108 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hyperglycemia DOID_4195 7.529E-03 0.02818246 7.529E-03 0.04199739 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN endocrine organ benign neoplasm DOID_0060089 8.144E-03 0.0302867 0.06367366 0.20354109 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Lewy body dementia DOID_12217 8.432E-03 0.03115506 0.12984577 0.28973429 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Goodpasture syndrome DOID_9808 8.432E-03 0.03095406 0.12984577 0.28636528 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pancreatic ductal carcinoma DOID_3587 8.788E-03 0.03205365 8.788E-03 0.04808048 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spastic quadriplegia DOID_10970 9.131E-03 0.03309164 9.131E-03 0.04947988 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN toxic shock syndrome DOID_14115 9.131E-03 0.0328822 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN pancreatic carcinoma DOID_4905 9.809E-03 0.03510164 9.809E-03 0.05265247 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN commensal bacterial infectious disease DOID_0050339 9.854E-03 0.03504429 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN organic acidemia DOID_0060159 9.854E-03 0.03482662 0.13987642 0.3049413 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN portal hypertension DOID_10762 9.854E-03 0.03461164 0.13987642 0.30377741 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spinal muscular atrophy DOID_12377 0.01060246 0.03701105 0.14484849 0.30984508 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN papillary adenoma DOID_3172 0.01060246 0.03678537 0.01060246 0.0553468 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN microcystic adenoma DOID_5403 0.01060246 0.03678537 0.01060246 0.0553468 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN follicular adenoma DOID_6204 0.01060246 0.03678537 0.01060246 0.0553468 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN mixed glioma DOID_5076 0.01127278 0.03887402 0.07832373 0.21739612 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN B cell deficiency DOID_2115 0.01137497 0.0389901 0.14979195 0.31335155 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spinal cord disease DOID_319 0.01137497 0.03875663 0.14979195 0.31220374 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN seminoma DOID_4440 0.01137497 0.03852594 0.01137497 0.05830953 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN metabolic syndrome X DOID_14221 0.01204948 0.04056896 0.08171054 0.22569562 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN diffuse large B-cell lymphoma DOID_0050745 0.0121715 0.04073872 0.15470697 0.31664844 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN lung adenocarcinoma DOID_3910 0.0121715 0.04050048 0.15470697 0.31438666 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN periodontitis DOID_824 0.0121715 0.04026501 0.15470697 0.31215697 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN auditory system disease DOID_2742 0.01285621 0.04228429 0.01285621 0.06473612 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN renal hypertension DOID_1073 0.01299175 0.04248451 0.1595937 0.31974935 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN secondary hypertension DOID_11130 0.01299175 0.04248451 0.1595937 0.31974935 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN sarcoma DOID_1115 0.01299175 0.04224174 0.1595937 0.31862743 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hepatic vascular disease DOID_272 0.01299175 0.04200173 0.1595937 0.31640703 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN biliary tract cancer DOID_4607 0.01327088 0.04266177 0.08687361 0.22779302 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN chronic kidney failure DOID_784 0.01327088 0.0424221 0.01327088 0.06509597 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spastic cerebral palsy DOID_0050669 0.01559186 0.04956296 0.01559186 0.07393142 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN abdominal aortic aneurysm DOID_7693 0.01559186 0.04928761 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN Human immunodeficiency virus infectious disease DOID_526 0.01638641 0.05151308 0.09928232 0.24141726 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN celiac disease DOID_10608 0.01650405 0.05159782 0.01650405 0.07634799 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN germinoma DOID_3304 0.01650405 0.05131586 0.01650405 0.07573228 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN hereditary spastic paraplegia DOID_2476 0.01743849 0.05392663 0.01743849 0.07938 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autonomic nervous system neoplasm DOID_2621 0.01743849 0.05363513 0.18360873 0.3470876 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN neuroblastoma DOID_769 0.01743849 0.05363513 0.18360873 0.3470876 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.01833509 0.0560896 0.10658249 0.25481277 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN male infertility DOID_12336 0.019373 0.0589478 0.019373 0.08545147 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN periodontal disease DOID_3388 0.019373 0.05863425 0.19302235 0.36009744 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN thyroid carcinoma DOID_3963 0.019373 0.05832402 0.19302235 0.35892065 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN esophageal disease DOID_6050 0.019373 0.05801705 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN paraplegia DOID_607 0.019373 0.0577133 0.019373 0.08479415 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN lymphoid leukemia DOID_10747 0.02037252 0.0603748 0.02037252 0.08848826 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN aplastic anemia DOID_12449 0.02037252 0.06006198 0.19768856 0.36521037 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN ulcerative colitis DOID_8577 0.02040697 0.05985343 0.11402176 0.26809248 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN thyroid cancer DOID_1781 0.02139316 0.06242415 0.20232792 0.37136963 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN adenoma DOID_657 0.02139316 0.06210566 0.02139316 0.0922175 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN peripheral nervous system neoplasm DOID_1192 0.02349675 0.06786625 0.21152666 0.38453249 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN blood platelet disease DOID_2218 0.02349675 0.06752349 0.21152666 0.38330787 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN systemic scleroderma DOID_418 0.02457915 0.07027908 0.02457915 0.10359658 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN intracranial arterial disease DOID_13089 0.0256816 0.07306415 0.0256816 0.10744728 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN cerebral arterial disease DOID_3527 0.0256816 0.07306415 0.0256816 0.10744728 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN adenoid cystic carcinoma DOID_4866 0.0256816 0.07270065 0.0256816 0.10666299 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN lymphatic system disease DOID_75 0.0256816 0.07234074 0.2206198 0.39725528 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN benign mesothelioma DOID_2645 0.02680383 0.07512994 0.22512715 0.40409258 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spinocerebellar ataxia DOID_1441 0.02794557 0.07794623 0.02794557 0.11522486 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN salivary gland cancer DOID_8850 0.02794557 0.07756601 0.02794557 0.11439591 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN nephrotic syndrome DOID_1184 0.02910658 0.08039632 0.02910658 0.11829744 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN rheumatic disease DOID_1575 0.02910658 0.08000793 0.02910658 0.11745845 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN scleroderma DOID_419 0.02910658 0.08000793 0.02910658 0.11745845 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN diabetic autonomic neuropathy DOID_11503 0.03028658 0.08285126 0.03028658 0.12135959 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autonomic neuropathy DOID_11504 0.03028658 0.08285126 0.03028658 0.12135959 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN diabetic polyneuropathy DOID_12785 0.03028658 0.08285126 0.03028658 0.12135959 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN gallbladder cancer DOID_3121 0.03028658 0.08245484 0.2384941 0.42407232 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN diabetic neuropathy DOID_9743 0.03028658 0.08285126 0.03028658 0.12135959 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN cerebral infarction DOID_3526 0.03148532 0.08531023 0.03148532 0.12528075 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN learning disability DOID_8927 0.03148532 0.08490591 0.24289854 0.43055847 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN spinocerebellar degeneration DOID_2478 0.03270255 0.08777242 0.03270255 0.12922051 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN autonomic nervous system disease DOID_11465 0.03393802 0.09066073 0.03393802 0.13226531 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN brain cancer DOID_1319 0.03393802 0.09023708 0.25163149 0.44054867 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN bone marrow disease DOID_4961 0.03393802 0.08981737 0.25163149 0.4391973 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN central nervous system cancer DOID_3620 0.03519148 0.09270349 0.25596029 0.44538656 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN lung small cell carcinoma DOID_5409 0.03646268 0.09560952 0.03646268 0.14018423 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN movement disease DOID_480 0.03775138 0.09853456 0.03775138 0.14320356 GRUETZMANN_PANCREATIC_CANCER_UP proteinuria DOID_576 2.804E-15 1.595E-12 2.877E-10 1.637E-07 GRUETZMANN_PANCREATIC_CANCER_UP aneurysm disease DOID_2403 2.248E-14 6.396E-12 2.993E-07 2.839E-05 GRUETZMANN_PANCREATIC_CANCER_UP intracranial arterial disease DOID_13089 1.98E-12 3.755E-10 1.756E-03 0.01332402 GRUETZMANN_PANCREATIC_CANCER_UP cerebral arterial disease DOID_3527 1.98E-12 3.755E-10 1.756E-03 0.01332402 GRUETZMANN_PANCREATIC_CANCER_UP middle cerebral artery infarction DOID_3525 2.191E-12 3.116E-10 4.956E-04 4.779E-03 GRUETZMANN_PANCREATIC_CANCER_UP transitional cell carcinoma DOID_2671 3.286E-12 3.739E-10 4.073E-08 7.725E-06 GRUETZMANN_PANCREATIC_CANCER_UP pre-malignant neoplasm DOID_0060071 3.531E-12 3.349E-10 8.546E-08 9.726E-06 GRUETZMANN_PANCREATIC_CANCER_UP in situ carcinoma DOID_8719 3.531E-12 3.349E-10 8.546E-08 9.726E-06 GRUETZMANN_PANCREATIC_CANCER_UP prion disease DOID_649 4.374E-12 3.555E-10 2.634E-06 1.499E-04 GRUETZMANN_PANCREATIC_CANCER_UP cerebral infarction DOID_3526 5.749E-12 4.089E-10 1.471E-04 1.902E-03 GRUETZMANN_PANCREATIC_CANCER_UP encephalomyelitis DOID_640 6.02E-12 3.806E-10 6.237E-08 8.872E-06 GRUETZMANN_PANCREATIC_CANCER_UP pancreatic ductal carcinoma DOID_3587 1.005E-11 5.721E-10 3.361E-06 1.594E-04 GRUETZMANN_PANCREATIC_CANCER_UP glaucoma DOID_1686 1.237E-11 6.4E-10 1.046E-05 3.5E-04 GRUETZMANN_PANCREATIC_CANCER_UP aortic aneurysm DOID_3627 1.483E-11 7.033E-10 1.149E-05 3.442E-04 GRUETZMANN_PANCREATIC_CANCER_UP pancreatic carcinoma DOID_4905 1.523E-11 6.664E-10 4.257E-06 1.863E-04 GRUETZMANN_PANCREATIC_CANCER_UP Human immunodeficiency virus infectious disease DOID_526 1.065E-10 4.329E-09 2.413E-09 6.866E-07 GRUETZMANN_PANCREATIC_CANCER_UP brain infarction DOID_3454 2.287E-10 8.676E-09 6.65E-04 5.821E-03 GRUETZMANN_PANCREATIC_CANCER_UP pre-eclampsia DOID_10591 3.409E-10 1.212E-08 8.601E-06 3.496E-04 GRUETZMANN_PANCREATIC_CANCER_UP neuritis DOID_1803 3.409E-10 1.141E-08 8.601E-06 3.263E-04 GRUETZMANN_PANCREATIC_CANCER_UP calcinosis DOID_182 2.311E-09 7.305E-08 2.794E-06 1.445E-04 GRUETZMANN_PANCREATIC_CANCER_UP hyperglycemia DOID_4195 4.853E-09 1.453E-07 4.189E-05 8.513E-04 GRUETZMANN_PANCREATIC_CANCER_UP nephrosis DOID_2527 8.542E-09 2.43E-07 7.774E-04 6.702E-03 GRUETZMANN_PANCREATIC_CANCER_UP skeletal system cancer DOID_0060124 1.427E-08 3.867E-07 0.07995781 0.21160928 GRUETZMANN_PANCREATIC_CANCER_UP bone cancer DOID_184 1.427E-08 3.867E-07 0.07995781 0.21160928 GRUETZMANN_PANCREATIC_CANCER_UP focal glomerulosclerosis DOID_3945 1.764E-08 4.562E-07 2.56E-05 6.07E-04 GRUETZMANN_PANCREATIC_CANCER_UP calcium metabolism disease DOID_10575 1.798E-08 4.447E-07 1.149E-05 3.633E-04 GRUETZMANN_PANCREATIC_CANCER_UP biliary tract cancer DOID_4607 2.589E-08 6.138E-07 1.305E-03 0.01017 GRUETZMANN_PANCREATIC_CANCER_UP chronic kidney failure DOID_784 2.589E-08 5.893E-07 1.138E-04 1.58E-03 GRUETZMANN_PANCREATIC_CANCER_UP giant cell tumor DOID_200 2.667E-08 5.837E-07 3.742E-03 0.02289622 GRUETZMANN_PANCREATIC_CANCER_UP malignant giant cell tumor DOID_2705 2.667E-08 5.837E-07 3.742E-03 0.02289622 GRUETZMANN_PANCREATIC_CANCER_UP giant cell glioblastoma DOID_3074 2.667E-08 5.837E-07 3.742E-03 0.02289622 GRUETZMANN_PANCREATIC_CANCER_UP bile duct adenocarcinoma DOID_4896 3.026E-08 6.378E-07 3.934E-03 0.02331841 GRUETZMANN_PANCREATIC_CANCER_UP cholangiocarcinoma DOID_4947 3.026E-08 6.378E-07 3.934E-03 0.02331841 GRUETZMANN_PANCREATIC_CANCER_UP vasculitis DOID_865 3.026E-08 6.15E-07 1.647E-05 4.463E-04 GRUETZMANN_PANCREATIC_CANCER_UP allergic rhinitis DOID_4481 3.178E-08 6.235E-07 0.01524865 0.06379765 GRUETZMANN_PANCREATIC_CANCER_UP glioblastoma DOID_3068 4.901E-08 9.296E-07 4.761E-03 0.02709268 GRUETZMANN_PANCREATIC_CANCER_UP bile duct cancer DOID_4606 4.901E-08 8.996E-07 4.761E-03 0.02682443 GRUETZMANN_PANCREATIC_CANCER_UP bile duct carcinoma DOID_4897 4.901E-08 8.996E-07 4.761E-03 0.02682443 GRUETZMANN_PANCREATIC_CANCER_UP collagen disease DOID_854 6.881E-08 1.224E-06 4.482E-04 4.397E-03 GRUETZMANN_PANCREATIC_CANCER_UP brain edema DOID_4724 7.204E-08 1.242E-06 5.433E-03 0.02972621 GRUETZMANN_PANCREATIC_CANCER_UP mineral metabolism disease DOID_0050032 9.499E-08 1.59E-06 3.633E-05 7.655E-04 GRUETZMANN_PANCREATIC_CANCER_UP systemic scleroderma DOID_418 1.195E-07 1.942E-06 1.64E-03 0.01261306 GRUETZMANN_PANCREATIC_CANCER_UP allergic contact dermatitis DOID_3042 1.291E-07 2.041E-06 4.491E-05 8.813E-04 GRUETZMANN_PANCREATIC_CANCER_UP tuberculosis DOID_399 1.426E-07 2.192E-06 7.262E-03 0.03689568 GRUETZMANN_PANCREATIC_CANCER_UP astrocytoma DOID_3069 1.572E-07 2.354E-06 7.548E-03 0.03800565 GRUETZMANN_PANCREATIC_CANCER_UP cervix uteri carcinoma in situ DOID_8991 1.593E-07 2.324E-06 1.044E-04 1.485E-03 GRUETZMANN_PANCREATIC_CANCER_UP male reproductive system disease DOID_48 1.902E-07 2.706E-06 7.774E-04 6.602E-03 GRUETZMANN_PANCREATIC_CANCER_UP diabetic angiopathy DOID_11713 1.94E-07 2.692E-06 3.112E-04 3.405E-03 GRUETZMANN_PANCREATIC_CANCER_UP nephrotic syndrome DOID_1184 2.094E-07 2.837E-06 2.134E-03 0.01537095 GRUETZMANN_PANCREATIC_CANCER_UP rheumatic disease DOID_1575 2.094E-07 2.771E-06 2.134E-03 0.01517881 GRUETZMANN_PANCREATIC_CANCER_UP scleroderma DOID_419 2.094E-07 2.771E-06 2.134E-03 0.01517881 GRUETZMANN_PANCREATIC_CANCER_UP bronchiectasis DOID_9563 2.929E-07 3.787E-06 2.676E-05 6.089E-04 GRUETZMANN_PANCREATIC_CANCER_UP mixed glioma DOID_5076 3.265E-07 4.128E-06 8.53E-05 1.348E-03 GRUETZMANN_PANCREATIC_CANCER_UP heart valve disease DOID_4079 3.488E-07 4.314E-06 8.601E-06 3.059E-04 GRUETZMANN_PANCREATIC_CANCER_UP contact dermatitis DOID_2773 3.871E-07 4.686E-06 9.596E-05 1.4E-03 GRUETZMANN_PANCREATIC_CANCER_UP intracranial aneurysm DOID_10941 4.405E-07 5.222E-06 0.01049997 0.04897119 GRUETZMANN_PANCREATIC_CANCER_UP pulmonary tuberculosis DOID_2957 4.427E-07 5.141E-06 0.03378189 0.11792574 GRUETZMANN_PANCREATIC_CANCER_UP lung adenocarcinoma DOID_3910 5.299E-07 6.03E-06 5.299E-07 4.307E-05 GRUETZMANN_PANCREATIC_CANCER_UP primary bacterial infectious disease DOID_0050338 6.79E-07 7.575E-06 0.01342255 0.05874948 GRUETZMANN_PANCREATIC_CANCER_UP primary immunodeficiency disease DOID_612 7.902E-07 8.646E-06 7.902E-07 5.62E-05 GRUETZMANN_PANCREATIC_CANCER_UP reproductive organ benign neoplasm DOID_0050622 8.562E-07 9.192E-06 1.795E-05 4.641E-04 GRUETZMANN_PANCREATIC_CANCER_UP open-angle glaucoma DOID_1067 8.769E-07 9.24E-06 5.83E-05 1.005E-03 GRUETZMANN_PANCREATIC_CANCER_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.137E-06 1.176E-05 2.019E-04 2.497E-03 GRUETZMANN_PANCREATIC_CANCER_UP mouth disease DOID_403 1.137E-06 1.155E-05 0.01642046 0.06721755 GRUETZMANN_PANCREATIC_CANCER_UP thoracic aortic aneurysm DOID_14004 1.191E-06 1.188E-05 3.058E-03 0.01977109 GRUETZMANN_PANCREATIC_CANCER_UP oral submucous fibrosis DOID_5773 1.191E-06 1.168E-05 0.07995781 0.20493691 GRUETZMANN_PANCREATIC_CANCER_UP hypersensitivity reaction type I disease DOID_1205 1.219E-06 1.176E-05 1.219E-06 7.709E-05 GRUETZMANN_PANCREATIC_CANCER_UP pleural disease DOID_1532 1.41E-06 1.337E-05 0.17675511 0.35919163 GRUETZMANN_PANCREATIC_CANCER_UP myocarditis DOID_820 1.63E-06 1.52E-05 0.01700091 0.06764697 GRUETZMANN_PANCREATIC_CANCER_UP respiratory failure DOID_11162 1.692E-06 1.553E-05 0.05058663 0.16931641 GRUETZMANN_PANCREATIC_CANCER_UP endocrine organ benign neoplasm DOID_0060089 2.854E-06 2.577E-05 6.65E-04 5.912E-03 GRUETZMANN_PANCREATIC_CANCER_UP peripheral vascular disease DOID_341 3.939E-06 3.502E-05 8.443E-03 0.04106004 GRUETZMANN_PANCREATIC_CANCER_UP adult respiratory distress syndrome DOID_11394 4.033E-06 3.53E-05 0.0237609 0.08556932 GRUETZMANN_PANCREATIC_CANCER_UP bone resorption disease DOID_0080011 5.338E-06 4.602E-05 8.033E-05 1.306E-03 GRUETZMANN_PANCREATIC_CANCER_UP osteoporosis DOID_11476 5.338E-06 4.602E-05 8.033E-05 1.306E-03 GRUETZMANN_PANCREATIC_CANCER_UP hepatitis B DOID_2043 6.189E-06 5.256E-05 2.387E-04 2.83E-03 GRUETZMANN_PANCREATIC_CANCER_UP influenza DOID_8469 6.312E-06 5.282E-05 0.22989569 0.44043988 GRUETZMANN_PANCREATIC_CANCER_UP urinary tract obstruction DOID_5200 7.459E-06 6.151E-05 7.156E-03 0.03701799 GRUETZMANN_PANCREATIC_CANCER_UP pulmonary embolism DOID_9477 7.459E-06 6.063E-05 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP thyroid adenoma DOID_2891 8.601E-06 6.893E-05 2.711E-03 0.01858606 GRUETZMANN_PANCREATIC_CANCER_UP bronchiolitis DOID_2942 1.243E-05 9.824E-05 9.093E-03 0.04384887 GRUETZMANN_PANCREATIC_CANCER_UP combined T cell and B cell immunodeficiency DOID_628 1.243E-05 9.689E-05 1.243E-05 3.536E-04 GRUETZMANN_PANCREATIC_CANCER_UP myositis DOID_633 1.453E-05 1.117E-04 4.443E-04 4.435E-03 GRUETZMANN_PANCREATIC_CANCER_UP Sciatic Neuropathy DOID_11446 1.949E-05 1.479E-04 0.01123697 0.05198242 GRUETZMANN_PANCREATIC_CANCER_UP lesion of sciatic nerve DOID_12528 1.949E-05 1.479E-04 0.01123697 0.05198242 GRUETZMANN_PANCREATIC_CANCER_UP periodontitis DOID_824 1.949E-05 1.459E-04 0.01123697 0.05156321 GRUETZMANN_PANCREATIC_CANCER_UP mononeuritis of lower limb DOID_9473 1.949E-05 1.479E-04 0.01123697 0.05198242 GRUETZMANN_PANCREATIC_CANCER_UP ulcerative colitis DOID_8577 2.079E-05 1.536E-04 0.01828834 0.06891435 GRUETZMANN_PANCREATIC_CANCER_UP autoimmune disease of cardiovascular system DOID_0060051 2.239E-05 1.634E-04 6.092E-04 5.591E-03 GRUETZMANN_PANCREATIC_CANCER_UP pleurisy DOID_10247 2.239E-05 1.613E-04 0.15355038 0.32479615 GRUETZMANN_PANCREATIC_CANCER_UP renal hypertension DOID_1073 2.239E-05 1.593E-04 0.0119961 0.05460626 GRUETZMANN_PANCREATIC_CANCER_UP secondary hypertension DOID_11130 2.239E-05 1.593E-04 0.0119961 0.05460626 GRUETZMANN_PANCREATIC_CANCER_UP Behcet's disease DOID_13241 2.239E-05 1.634E-04 6.092E-04 5.591E-03 GRUETZMANN_PANCREATIC_CANCER_UP mononeuritis DOID_1802 2.239E-05 1.573E-04 0.0119961 0.05417287 GRUETZMANN_PANCREATIC_CANCER_UP oral cavity cancer DOID_8618 2.299E-05 1.595E-04 3.729E-04 3.858E-03 GRUETZMANN_PANCREATIC_CANCER_UP leukocyte disease DOID_9500 2.489E-05 1.706E-04 2.489E-05 6.158E-04 GRUETZMANN_PANCREATIC_CANCER_UP mononeuropathy DOID_1188 2.56E-05 1.734E-04 0.0127771 0.05635789 GRUETZMANN_PANCREATIC_CANCER_UP abdominal aortic aneurysm DOID_7693 3.301E-05 2.209E-04 0.16755018 0.34542047 GRUETZMANN_PANCREATIC_CANCER_UP epidermolysis bullosa DOID_2730 3.553E-05 2.351E-04 3.553E-05 7.775E-04 GRUETZMANN_PANCREATIC_CANCER_UP peritonitis DOID_8283 3.553E-05 2.324E-04 0.06449235 0.1825679 GRUETZMANN_PANCREATIC_CANCER_UP ocular hypertension DOID_9282 3.553E-05 2.297E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP borderline glaucoma DOID_9283 3.553E-05 2.297E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP osteogenesis imperfecta DOID_12347 4.6E-05 2.941E-04 4.6E-05 8.724E-04 GRUETZMANN_PANCREATIC_CANCER_UP hepatic coma DOID_12550 4.6E-05 2.908E-04 4.6E-05 8.443E-04 GRUETZMANN_PANCREATIC_CANCER_UP hepatic encephalopathy DOID_13413 4.6E-05 2.908E-04 4.6E-05 8.443E-04 GRUETZMANN_PANCREATIC_CANCER_UP larynx cancer DOID_2596 4.6E-05 2.876E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP laryngeal benign neoplasm DOID_2598 4.6E-05 2.876E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP vesiculobullous skin disease DOID_2731 4.6E-05 2.845E-04 4.6E-05 8.179E-04 GRUETZMANN_PANCREATIC_CANCER_UP papilloma DOID_2615 4.69E-05 2.869E-04 0.01700091 0.06812336 GRUETZMANN_PANCREATIC_CANCER_UP periodontal disease DOID_3388 5.236E-05 3.169E-04 0.01790764 0.06931598 GRUETZMANN_PANCREATIC_CANCER_UP parasitic helminthiasis infectious disease DOID_883 5.83E-05 3.492E-04 2.66E-03 0.01845587 GRUETZMANN_PANCREATIC_CANCER_UP embryonal cancer DOID_688 7.151E-05 4.239E-04 7.151E-05 1.197E-03 GRUETZMANN_PANCREATIC_CANCER_UP varicose veins DOID_799 7.258E-05 4.258E-04 3.058E-03 0.01933173 GRUETZMANN_PANCREATIC_CANCER_UP pancreatitis DOID_4989 8.53E-05 4.953E-04 0.01006819 0.04734545 GRUETZMANN_PANCREATIC_CANCER_UP bacterial pneumonia DOID_874 8.53E-05 4.903E-04 0.35907318 0.65907303 GRUETZMANN_PANCREATIC_CANCER_UP hepatitis DOID_2237 8.683E-05 4.941E-04 8.683E-05 1.335E-03 GRUETZMANN_PANCREATIC_CANCER_UP vein disease DOID_866 8.897E-05 5.012E-04 3.482E-03 0.02153451 GRUETZMANN_PANCREATIC_CANCER_UP adenoid cystic carcinoma DOID_4866 9.532E-05 5.317E-04 9.532E-05 1.427E-03 GRUETZMANN_PANCREATIC_CANCER_UP lipid metabolism disorder DOID_3146 9.596E-05 5.301E-04 1.142E-03 9.15E-03 GRUETZMANN_PANCREATIC_CANCER_UP pulmonary emphysema DOID_9675 1.044E-04 5.712E-04 0.21693955 0.41985919 GRUETZMANN_PANCREATIC_CANCER_UP urinary system benign neoplasm DOID_731 1.076E-04 5.83E-04 3.932E-03 0.02354915 GRUETZMANN_PANCREATIC_CANCER_UP focal epilepsy DOID_2234 1.138E-04 6.109E-04 1.305E-03 0.01031125 GRUETZMANN_PANCREATIC_CANCER_UP salivary gland cancer DOID_8850 1.141E-04 6.067E-04 1.141E-04 1.546E-03 GRUETZMANN_PANCREATIC_CANCER_UP bone development disease DOID_0080006 1.203E-04 6.338E-04 1.203E-04 1.592E-03 GRUETZMANN_PANCREATIC_CANCER_UP ureteral obstruction DOID_5199 1.286E-04 6.712E-04 4.407E-03 0.02533 GRUETZMANN_PANCREATIC_CANCER_UP diabetic autonomic neuropathy DOID_11503 1.354E-04 7.004E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP autonomic neuropathy DOID_11504 1.354E-04 7.004E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP diabetic polyneuropathy DOID_12785 1.354E-04 7.004E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP gallbladder cancer DOID_3121 1.354E-04 6.941E-04 0.02803857 0.09909285 GRUETZMANN_PANCREATIC_CANCER_UP diabetic neuropathy DOID_9743 1.354E-04 7.004E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP autonomic nervous system disease DOID_11465 1.726E-04 8.767E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP hemolytic anemia DOID_583 1.865E-04 9.389E-04 2.869E-03 0.01943366 GRUETZMANN_PANCREATIC_CANCER_UP normocytic anemia DOID_720 1.865E-04 9.389E-04 2.869E-03 0.01943366 GRUETZMANN_PANCREATIC_CANCER_UP carbohydrate metabolic disorder DOID_2978 1.922E-04 9.595E-04 1.922E-04 2.431E-03 GRUETZMANN_PANCREATIC_CANCER_UP Crohn's disease DOID_8778 2.019E-04 9.99E-04 2.042E-03 0.0148954 GRUETZMANN_PANCREATIC_CANCER_UP gastric ulcer DOID_10808 2.387E-04 1.171E-03 0.11506147 0.26613811 GRUETZMANN_PANCREATIC_CANCER_UP neutropenia DOID_1227 2.387E-04 1.161E-03 2.387E-04 2.89E-03 GRUETZMANN_PANCREATIC_CANCER_UP sinusitis DOID_0050127 2.734E-04 1.318E-03 0.11996625 0.27304317 GRUETZMANN_PANCREATIC_CANCER_UP agranulocytosis DOID_12987 2.734E-04 1.307E-03 2.734E-04 3.175E-03 GRUETZMANN_PANCREATIC_CANCER_UP paranasal sinus disease DOID_1352 2.734E-04 1.318E-03 0.11996625 0.27304317 GRUETZMANN_PANCREATIC_CANCER_UP IgA glomerulonephritis DOID_2986 2.734E-04 1.296E-03 0.11996625 0.27087616 GRUETZMANN_PANCREATIC_CANCER_UP osteochondrodysplasia DOID_2256 3.071E-04 1.444E-03 3.071E-04 3.495E-03 GRUETZMANN_PANCREATIC_CANCER_UP pustulosis of palm and sole DOID_4398 3.071E-04 1.432E-03 3.071E-04 3.427E-03 GRUETZMANN_PANCREATIC_CANCER_UP ureteral disease DOID_1426 3.112E-04 1.44E-03 7.779E-03 0.03882509 GRUETZMANN_PANCREATIC_CANCER_UP meningitis DOID_9471 3.112E-04 1.428E-03 0.12484397 0.27748522 GRUETZMANN_PANCREATIC_CANCER_UP familial hyperlipidemia DOID_1168 3.28E-04 1.493E-03 4.336E-03 0.02543395 GRUETZMANN_PANCREATIC_CANCER_UP toxic shock syndrome DOID_14115 3.522E-04 1.59E-03 3.522E-04 3.781E-03 GRUETZMANN_PANCREATIC_CANCER_UP severe combined immunodeficiency DOID_627 3.522E-04 1.578E-03 3.522E-04 3.711E-03 GRUETZMANN_PANCREATIC_CANCER_UP hypertrophic cardiomyopathy DOID_11984 3.729E-04 1.658E-03 0.04514564 0.15290399 GRUETZMANN_PANCREATIC_CANCER_UP commensal bacterial infectious disease DOID_0050339 3.965E-04 1.749E-03 3.965E-04 4.029E-03 GRUETZMANN_PANCREATIC_CANCER_UP papillary adenoma DOID_3172 4.443E-04 1.945E-03 9.785E-03 0.04678888 GRUETZMANN_PANCREATIC_CANCER_UP microcystic adenoma DOID_5403 4.443E-04 1.945E-03 9.785E-03 0.04678888 GRUETZMANN_PANCREATIC_CANCER_UP follicular adenoma DOID_6204 4.443E-04 1.945E-03 9.785E-03 0.04678888 GRUETZMANN_PANCREATIC_CANCER_UP carotid artery disease DOID_3407 4.482E-04 1.947E-03 0.29938487 0.55852457 GRUETZMANN_PANCREATIC_CANCER_UP endocrine pancreas disease DOID_1428 5.337E-04 2.301E-03 5.337E-04 5.061E-03 GRUETZMANN_PANCREATIC_CANCER_UP perinatal necrotizing enterocolitis DOID_8677 5.505E-04 2.355E-03 5.505E-04 5.135E-03 GRUETZMANN_PANCREATIC_CANCER_UP parasitic infectious disease DOID_1398 5.646E-04 2.398E-03 0.05481375 0.17231506 GRUETZMANN_PANCREATIC_CANCER_UP uterine disease DOID_345 5.646E-04 2.38E-03 0.31480643 0.58537535 GRUETZMANN_PANCREATIC_CANCER_UP temporal lobe epilepsy DOID_3328 5.968E-04 2.497E-03 6.711E-03 0.03568941 GRUETZMANN_PANCREATIC_CANCER_UP autoimmune disease of the nervous system DOID_438 6.092E-04 2.53E-03 6.092E-04 5.502E-03 GRUETZMANN_PANCREATIC_CANCER_UP tooth disease DOID_1091 6.302E-04 2.599E-03 0.05769865 0.1794018 GRUETZMANN_PANCREATIC_CANCER_UP female reproductive organ benign neoplasm DOID_0060086 7.382E-04 3.022E-03 0.01357969 0.05898355 GRUETZMANN_PANCREATIC_CANCER_UP uterine benign neoplasm DOID_0060095 7.382E-04 3.022E-03 0.01357969 0.05898355 GRUETZMANN_PANCREATIC_CANCER_UP uterine fibroid DOID_13223 7.382E-04 3.022E-03 0.01357969 0.05898355 GRUETZMANN_PANCREATIC_CANCER_UP opportunistic mycosis DOID_2473 8.087E-04 3.287E-03 0.01440363 0.06116168 GRUETZMANN_PANCREATIC_CANCER_UP bronchiolitis obliterans DOID_2799 8.087E-04 3.263E-03 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP diabetic retinopathy DOID_8947 8.594E-04 3.444E-03 0.34464329 0.63876884 GRUETZMANN_PANCREATIC_CANCER_UP cystic fibrosis DOID_1485 9.473E-04 3.769E-03 0.3518982 0.65009765 GRUETZMANN_PANCREATIC_CANCER_UP leiomyoma DOID_127 9.622E-04 3.802E-03 0.01611449 0.06692808 GRUETZMANN_PANCREATIC_CANCER_UP electroclinical syndrome DOID_0050701 1.041E-03 4.086E-03 1.041E-03 8.713E-03 GRUETZMANN_PANCREATIC_CANCER_UP systemic mycosis DOID_0050136 1.045E-03 4.074E-03 0.01700091 0.0686065 GRUETZMANN_PANCREATIC_CANCER_UP fungal infectious disease DOID_1564 1.045E-03 4.074E-03 0.01700091 0.0686065 GRUETZMANN_PANCREATIC_CANCER_UP metal metabolism disorder DOID_896 1.045E-03 4.047E-03 1.045E-03 8.621E-03 GRUETZMANN_PANCREATIC_CANCER_UP nephroblastoma DOID_2154 1.133E-03 4.356E-03 0.01790764 0.06979075 GRUETZMANN_PANCREATIC_CANCER_UP spindle cell carcinoma DOID_4015 1.133E-03 4.327E-03 0.01790764 0.06884763 GRUETZMANN_PANCREATIC_CANCER_UP esophageal disease DOID_6050 1.133E-03 4.298E-03 0.01790764 0.06838557 GRUETZMANN_PANCREATIC_CANCER_UP leukopenia DOID_615 1.133E-03 4.27E-03 1.133E-03 9.21E-03 GRUETZMANN_PANCREATIC_CANCER_UP hyperthyroidism DOID_7998 1.133E-03 4.241E-03 0.01790764 0.06792966 GRUETZMANN_PANCREATIC_CANCER_UP female reproductive system disease DOID_229 1.194E-03 4.442E-03 0.36968768 0.67420606 GRUETZMANN_PANCREATIC_CANCER_UP adenoma DOID_657 1.322E-03 4.884E-03 0.01978107 0.0735649 GRUETZMANN_PANCREATIC_CANCER_UP retinal vascular disease DOID_2462 1.422E-03 5.22E-03 0.38356868 0.69728619 GRUETZMANN_PANCREATIC_CANCER_UP familial adenomatous polyposis DOID_0050424 1.625E-03 5.928E-03 0.05927992 0.1833167 GRUETZMANN_PANCREATIC_CANCER_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 1.625E-03 5.89E-03 0.05927992 0.1823258 GRUETZMANN_PANCREATIC_CANCER_UP temporal arteritis DOID_13375 1.625E-03 5.853E-03 0.05927992 0.17941635 GRUETZMANN_PANCREATIC_CANCER_UP central nervous system vasculitis DOID_525 1.625E-03 5.853E-03 0.05927992 0.17941635 GRUETZMANN_PANCREATIC_CANCER_UP respiratory syncytial virus infectious disease DOID_1273 1.64E-03 5.87E-03 0.20818183 0.40566939 GRUETZMANN_PANCREATIC_CANCER_UP peptic ulcer DOID_750 1.64E-03 5.834E-03 0.20818183 0.40428485 GRUETZMANN_PANCREATIC_CANCER_UP nervous system cancer DOID_3093 1.747E-03 6.175E-03 0.09253009 0.22891139 GRUETZMANN_PANCREATIC_CANCER_UP common cold DOID_10459 1.943E-03 6.825E-03 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP beta thalassemia DOID_12241 1.943E-03 6.783E-03 1.943E-03 0.01454808 GRUETZMANN_PANCREATIC_CANCER_UP diarrhea DOID_13250 1.943E-03 6.742E-03 0.06449235 0.18722524 GRUETZMANN_PANCREATIC_CANCER_UP aortic valve insufficiency DOID_57 1.943E-03 6.701E-03 1.943E-03 0.01435914 GRUETZMANN_PANCREATIC_CANCER_UP stomach disease DOID_76 1.943E-03 6.661E-03 0.06449235 0.18440275 GRUETZMANN_PANCREATIC_CANCER_UP lymphoblastic leukemia DOID_1037 1.965E-03 6.696E-03 0.09766275 0.23747908 GRUETZMANN_PANCREATIC_CANCER_UP endometriosis of uterus DOID_288 2.003E-03 6.784E-03 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP dilated cardiomyopathy DOID_12930 2.121E-03 7.14E-03 0.01687683 0.06859227 GRUETZMANN_PANCREATIC_CANCER_UP hyperinsulinism DOID_2018 2.134E-03 7.143E-03 2.134E-03 0.01499142 GRUETZMANN_PANCREATIC_CANCER_UP endometriosis DOID_289 2.134E-03 7.101E-03 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP intracranial thrombosis DOID_4193 2.288E-03 7.569E-03 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP polycystic kidney disease DOID_898 2.66E-03 8.748E-03 0.07483114 0.19990103 GRUETZMANN_PANCREATIC_CANCER_UP idiopathic pulmonary fibrosis DOID_0050156 3.058E-03 9.999E-03 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP peripheral neuropathy DOID_0060053 3.058E-03 9.942E-03 3.058E-03 0.02046889 GRUETZMANN_PANCREATIC_CANCER_UP thalassemia DOID_10241 3.058E-03 9.886E-03 3.058E-03 0.02023088 GRUETZMANN_PANCREATIC_CANCER_UP Ehlers-Danlos syndrome DOID_13359 3.058E-03 9.83E-03 3.058E-03 0.01999834 GRUETZMANN_PANCREATIC_CANCER_UP communication disorder DOID_2033 3.058E-03 9.774E-03 0.07995781 0.20869722 GRUETZMANN_PANCREATIC_CANCER_UP membranoproliferative glomerulonephritis DOID_2920 3.058E-03 9.72E-03 3.058E-03 0.01954894 GRUETZMANN_PANCREATIC_CANCER_UP nutritional deficiency disease DOID_5113 3.058E-03 9.666E-03 0.07995781 0.20586423 GRUETZMANN_PANCREATIC_CANCER_UP intermediate coronary syndrome DOID_8805 3.058E-03 9.612E-03 0.07995781 0.20401791 GRUETZMANN_PANCREATIC_CANCER_UP spastic diplegia DOID_10965 3.482E-03 0.01088558 3.482E-03 0.02177115 GRUETZMANN_PANCREATIC_CANCER_UP Barrett's esophagus DOID_9206 3.482E-03 0.01082609 0.08505621 0.2150977 GRUETZMANN_PANCREATIC_CANCER_UP atrophic muscular disease DOID_913 3.742E-03 0.01157255 3.742E-03 0.02265264 GRUETZMANN_PANCREATIC_CANCER_UP muscular dystrophy DOID_9884 3.742E-03 0.01157255 3.742E-03 0.02265264 GRUETZMANN_PANCREATIC_CANCER_UP male reproductive organ benign neoplasm DOID_0060087 4.407E-03 0.01355497 4.407E-03 0.02558847 GRUETZMANN_PANCREATIC_CANCER_UP MHC class II deficiency DOID_5812 4.908E-03 0.0150135 4.908E-03 0.02737756 GRUETZMANN_PANCREATIC_CANCER_UP membranous glomerulonephritis DOID_10976 5.433E-03 0.01653222 5.433E-03 0.03001481 GRUETZMANN_PANCREATIC_CANCER_UP esophagitis DOID_11963 5.433E-03 0.01644429 0.10517015 0.24934089 GRUETZMANN_PANCREATIC_CANCER_UP subependymal glioma DOID_4843 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP pilocytic astrocytoma DOID_4851 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP subependymal giant cell astrocytoma DOID_5077 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP fibrillary astrocytoma DOID_6726 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP juvenile pilocytic astrocytoma DOID_6811 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP childhood pilocytic astrocytoma DOID_6812 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP gemistocytic astrocytoma DOID_7005 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP childhood cerebral astrocytoma DOID_7007 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP protoplasmic astrocytoma DOID_7008 5.433E-03 0.01635728 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP congenital heart defect DOID_1682 5.933E-03 0.0177677 5.933E-03 0.03215107 GRUETZMANN_PANCREATIC_CANCER_UP coronary restenosis DOID_4247 5.983E-03 0.01782487 5.983E-03 0.0321184 GRUETZMANN_PANCREATIC_CANCER_UP funisitis DOID_0050698 6.558E-03 0.01943449 0.11506147 0.26722439 GRUETZMANN_PANCREATIC_CANCER_UP benign glioma DOID_0060101 6.558E-03 0.01933379 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP benign ependymoma DOID_4844 6.558E-03 0.01933379 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP glycogen metabolism disorder DOID_0050728 7.156E-03 0.02098958 7.156E-03 0.0377035 GRUETZMANN_PANCREATIC_CANCER_UP glycogen storage disease DOID_2747 7.156E-03 0.02098958 7.156E-03 0.0377035 GRUETZMANN_PANCREATIC_CANCER_UP uremia DOID_4676 7.156E-03 0.02088194 7.156E-03 0.0373576 GRUETZMANN_PANCREATIC_CANCER_UP hypoglycemia DOID_9993 7.156E-03 0.0207754 7.156E-03 0.03668449 GRUETZMANN_PANCREATIC_CANCER_UP aortic valve disease DOID_62 7.779E-03 0.02246731 7.779E-03 0.03848748 GRUETZMANN_PANCREATIC_CANCER_UP Goodpasture syndrome DOID_9808 7.779E-03 0.02235384 0.12484397 0.27640551 GRUETZMANN_PANCREATIC_CANCER_UP blood coagulation disease DOID_1247 7.84E-03 0.0224155 0.06212242 0.18506627 GRUETZMANN_PANCREATIC_CANCER_UP spastic quadriplegia DOID_10970 8.424E-03 0.02396754 8.424E-03 0.04132335 GRUETZMANN_PANCREATIC_CANCER_UP portal hypertension DOID_10762 9.093E-03 0.02574212 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP urticaria DOID_1555 9.093E-03 0.02561469 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP morbid obesity DOID_11981 9.785E-03 0.02742796 0.13931627 0.30372015 GRUETZMANN_PANCREATIC_CANCER_UP ankylosing spondylitis DOID_7147 9.785E-03 0.02729351 9.785E-03 0.04639897 GRUETZMANN_PANCREATIC_CANCER_UP extrinsic allergic alveolitis DOID_841 0.01049997 0.02914383 0.14408725 0.30706234 GRUETZMANN_PANCREATIC_CANCER_UP metabolic syndrome X DOID_14221 0.01076557 0.02973597 0.3661691 0.66993639 GRUETZMANN_PANCREATIC_CANCER_UP hepatic vascular disease DOID_272 0.0119961 0.03297479 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP coronary stenosis DOID_4248 0.0119961 0.03281626 0.0119961 0.05374632 GRUETZMANN_PANCREATIC_CANCER_UP renal tubular transport disease DOID_447 0.0119961 0.03265924 0.0119961 0.05332642 GRUETZMANN_PANCREATIC_CANCER_UP supratentorial cancer DOID_1659 0.0127771 0.03461985 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP toxic encephalopathy DOID_3602 0.0127771 0.03445577 0.15824282 0.32981745 GRUETZMANN_PANCREATIC_CANCER_UP cerebrum cancer DOID_368 0.0127771 0.03461985 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP corneal disease DOID_10124 0.01357969 0.03644738 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP endometrial carcinoma DOID_2871 0.01357969 0.03627627 0.01357969 0.0585367 GRUETZMANN_PANCREATIC_CANCER_UP spastic cerebral palsy DOID_0050669 0.01440363 0.0382975 0.01440363 0.06162154 GRUETZMANN_PANCREATIC_CANCER_UP age related macular degeneration DOID_10871 0.01440363 0.03811937 0.16755018 0.34667655 GRUETZMANN_PANCREATIC_CANCER_UP degeneration of macula and posterior pole DOID_2007 0.01440363 0.03811937 0.16755018 0.34667655 GRUETZMANN_PANCREATIC_CANCER_UP Charcot-Marie-Tooth disease DOID_10595 0.01524865 0.04016889 0.17216537 0.35365378 GRUETZMANN_PANCREATIC_CANCER_UP endometrial cancer DOID_1380 0.01524865 0.03998378 0.01524865 0.06427023 GRUETZMANN_PANCREATIC_CANCER_UP lymphoma DOID_0060058 0.01552883 0.04053168 0.09594293 0.2342984 GRUETZMANN_PANCREATIC_CANCER_UP chronic leukemia DOID_1036 0.01611449 0.04186825 0.17675511 0.36047905 GRUETZMANN_PANCREATIC_CANCER_UP chronic lymphocytic leukemia DOID_1040 0.01611449 0.04186825 0.17675511 0.36047905 GRUETZMANN_PANCREATIC_CANCER_UP autonomic nervous system neoplasm DOID_2621 0.01611449 0.04167794 0.01611449 0.06644309 GRUETZMANN_PANCREATIC_CANCER_UP neuroblastoma DOID_769 0.01611449 0.04167794 0.01611449 0.06644309 GRUETZMANN_PANCREATIC_CANCER_UP pneumoconiosis DOID_10316 0.01790764 0.0461061 0.18585873 0.37368769 GRUETZMANN_PANCREATIC_CANCER_UP male infertility DOID_12336 0.01790764 0.04589842 0.01790764 0.07076006 GRUETZMANN_PANCREATIC_CANCER_UP hepatitis C DOID_1883 0.01790764 0.0456926 0.01790764 0.07027206 GRUETZMANN_PANCREATIC_CANCER_UP thyroid carcinoma DOID_3963 0.01790764 0.04548861 0.18585873 0.37237189 GRUETZMANN_PANCREATIC_CANCER_UP macular degeneration DOID_4448 0.01790764 0.04528644 0.18585873 0.37106532 GRUETZMANN_PANCREATIC_CANCER_UP medullomyoblastoma DOID_3861 0.01883445 0.04741947 0.01883445 0.07050527 GRUETZMANN_PANCREATIC_CANCER_UP adult medulloblastoma DOID_3864 0.01883445 0.04741947 0.01883445 0.07050527 GRUETZMANN_PANCREATIC_CANCER_UP childhood medulloblastoma DOID_3869 0.01883445 0.04741947 0.01883445 0.07050527 GRUETZMANN_PANCREATIC_CANCER_UP thyroid cancer DOID_1781 0.01978107 0.04958339 0.19486216 0.38498808 GRUETZMANN_PANCREATIC_CANCER_UP medulloblastoma DOID_3858 0.02074727 0.05177719 0.02074727 0.07665713 GRUETZMANN_PANCREATIC_CANCER_UP cleft palate DOID_674 0.02074727 0.05155109 0.02074727 0.07616257 GRUETZMANN_PANCREATIC_CANCER_UP multiple myeloma DOID_9538 0.02074727 0.05132695 0.19932664 0.39109262 GRUETZMANN_PANCREATIC_CANCER_UP peripheral nervous system neoplasm DOID_1192 0.02173281 0.05353232 0.02173281 0.07926902 GRUETZMANN_PANCREATIC_CANCER_UP blood platelet disease DOID_2218 0.02173281 0.05330158 0.02173281 0.07876412 GRUETZMANN_PANCREATIC_CANCER_UP benign mesothelioma DOID_2645 0.02480299 0.06057038 0.02480299 0.08876037 GRUETZMANN_PANCREATIC_CANCER_UP Huntington's disease DOID_12858 0.02694205 0.06551295 0.22560085 0.43367191 GRUETZMANN_PANCREATIC_CANCER_UP primitive neuroectodermal tumor DOID_168 0.02694205 0.06523417 0.02694205 0.09581268 GRUETZMANN_PANCREATIC_CANCER_UP uterine cancer DOID_363 0.02803857 0.06760148 0.02803857 0.09848116 GRUETZMANN_PANCREATIC_CANCER_UP myeloma DOID_0070004 0.03143332 0.07546649 0.24263846 0.46020429 GRUETZMANN_PANCREATIC_CANCER_UP brain cancer DOID_1319 0.03143332 0.07514941 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP vascular skin disease DOID_9540 0.03143332 0.07483497 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP central nervous system cancer DOID_3620 0.03259921 0.0772873 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP integumentary system benign neoplasm DOID_0060121 0.03378189 0.0797589 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP skin benign neoplasm DOID_3165 0.03378189 0.0797589 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP withdrawal disorder DOID_0060001 0.03619672 0.08510717 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP hemorrhagic disease DOID_2213 0.03619672 0.08475693 0.03619672 0.12558496 GRUETZMANN_PANCREATIC_CANCER_UP B-cell lymphocytic neoplasm DOID_707 0.03619672 0.08440957 0.25930298 0.49017738 GRUETZMANN_PANCREATIC_CANCER_UP orofacial cleft DOID_0050567 0.03742844 0.08692564 0.03742844 0.12907141 GRUETZMANN_PANCREATIC_CANCER_UP sarcoidosis DOID_11335 0.03867608 0.08945808 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP bone marrow cancer DOID_4960 0.03993942 0.09200619 0.27156141 0.51165047 GRUETZMANN_PANCREATIC_CANCER_UP integumentary system cancer DOID_0060122 0.04121825 0.09456929 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP skin cancer DOID_4159 0.04121825 0.09456929 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_UP mitochondrial metabolism disease DOID_700 0.04251237 0.09714674 0.04251237 0.14572012 GRUETZMANN_PANCREATIC_CANCER_UP congenital nervous system abnormality DOID_2490 0.04382157 0.09973789 0.04382157 0.14930822 WU_CELL_MIGRATION oral cavity cancer DOID_8618 3.651E-11 2.078E-08 1.678E-09 9.547E-07 WU_CELL_MIGRATION pancreatic ductal carcinoma DOID_3587 1.611E-10 4.583E-08 1.95E-07 3.698E-05 WU_CELL_MIGRATION nephrosis DOID_2527 1.801E-10 3.416E-08 2.116E-07 3.01E-05 WU_CELL_MIGRATION pancreatic carcinoma DOID_4905 2.24E-10 3.187E-08 2.483E-07 2.826E-05 WU_CELL_MIGRATION pre-malignant neoplasm DOID_0060071 2.953E-09 3.361E-07 1.061E-07 3.019E-05 WU_CELL_MIGRATION in situ carcinoma DOID_8719 2.953E-09 3.361E-07 1.061E-07 3.019E-05 WU_CELL_MIGRATION uterine disease DOID_345 3.656E-09 3.467E-07 3.704E-06 1.916E-04 WU_CELL_MIGRATION endometriosis of uterus DOID_288 1.008E-08 8.197E-07 4.622E-07 3.757E-05 WU_CELL_MIGRATION nephrotic syndrome DOID_1184 1.156E-08 8.225E-07 1.869E-05 6.646E-04 WU_CELL_MIGRATION endometriosis DOID_289 1.156E-08 7.311E-07 5.171E-07 3.269E-05 WU_CELL_MIGRATION female reproductive system disease DOID_229 1.501E-08 8.54E-07 9.904E-06 4.696E-04 WU_CELL_MIGRATION transitional cell carcinoma DOID_2671 2.648E-08 1.37E-06 1.471E-05 6.438E-04 WU_CELL_MIGRATION adenoid cystic carcinoma DOID_4866 3.661E-07 1.736E-05 3.661E-07 3.472E-05 WU_CELL_MIGRATION salivary gland cancer DOID_8850 4.622E-07 2.023E-05 4.622E-07 3.287E-05 WU_CELL_MIGRATION lymphoma DOID_0060058 8.797E-07 3.575E-05 1.817E-05 6.894E-04 WU_CELL_MIGRATION giant cell tumor DOID_200 1.402E-06 5.319E-05 4.097E-05 1.295E-03 WU_CELL_MIGRATION malignant giant cell tumor DOID_2705 1.402E-06 5.319E-05 4.097E-05 1.295E-03 WU_CELL_MIGRATION giant cell glioblastoma DOID_3074 1.402E-06 5.319E-05 4.097E-05 1.295E-03 WU_CELL_MIGRATION integumentary system cancer DOID_0060122 1.673E-06 5.95E-05 1.036E-03 0.01551059 WU_CELL_MIGRATION skin cancer DOID_4159 1.673E-06 5.95E-05 1.036E-03 0.01551059 WU_CELL_MIGRATION glioblastoma DOID_3068 2.154E-06 7.211E-05 5.745E-05 1.721E-03 WU_CELL_MIGRATION invasive ductal carcinoma DOID_3008 3.274E-06 1.035E-04 3.274E-06 1.863E-04 WU_CELL_MIGRATION astrocytoma DOID_3069 4.918E-06 1.473E-04 1.1E-04 3.131E-03 WU_CELL_MIGRATION papilloma DOID_2615 6.926E-06 1.97E-04 2.531E-04 5.54E-03 WU_CELL_MIGRATION cystic fibrosis DOID_1485 7.3E-06 1.978E-04 2.431E-03 0.03143374 WU_CELL_MIGRATION aneurysm disease DOID_2403 7.772E-06 2.01E-04 1.578E-04 4.081E-03 WU_CELL_MIGRATION peptic ulcer DOID_750 1.295E-05 3.205E-04 4.01E-04 8.149E-03 WU_CELL_MIGRATION nervous system cancer DOID_3093 1.637E-05 3.881E-04 1.637E-05 6.653E-04 WU_CELL_MIGRATION tongue cancer DOID_8649 2.087E-05 4.749E-04 1.336E-03 0.01854465 WU_CELL_MIGRATION ulcerative colitis DOID_8577 2.452E-05 5.367E-04 3.897E-04 8.213E-03 WU_CELL_MIGRATION pre-eclampsia DOID_10591 2.61E-05 5.5E-04 2.61E-05 8.735E-04 WU_CELL_MIGRATION integumentary system benign neoplasm DOID_0060121 3.052E-05 6.202E-04 0.01363278 0.09944937 WU_CELL_MIGRATION skin benign neoplasm DOID_3165 3.052E-05 6.202E-04 0.01363278 0.09944937 WU_CELL_MIGRATION esophagitis DOID_11963 4.206E-05 8.252E-04 2.097E-03 0.02774841 WU_CELL_MIGRATION bile duct adenocarcinoma DOID_4896 4.395E-05 8.335E-04 0.01622876 0.11261173 WU_CELL_MIGRATION cholangiocarcinoma DOID_4947 4.395E-05 8.335E-04 0.01622876 0.11261173 WU_CELL_MIGRATION reproductive organ benign neoplasm DOID_0050622 4.708E-05 8.641E-04 1.036E-03 0.01592979 WU_CELL_MIGRATION bile duct cancer DOID_4606 5.745E-05 1.022E-03 0.01844494 0.12644785 WU_CELL_MIGRATION bile duct carcinoma DOID_4897 5.745E-05 1.022E-03 0.01844494 0.12644785 WU_CELL_MIGRATION endocrine organ benign neoplasm DOID_0060089 1.042E-04 1.797E-03 1.858E-03 0.02517175 WU_CELL_MIGRATION biliary tract disease DOID_9741 1.29E-04 2.159E-03 0.02712256 0.16774711 WU_CELL_MIGRATION syndrome DOID_225 1.502E-04 2.442E-03 1.502E-04 4.069E-03 WU_CELL_MIGRATION focal glomerulosclerosis DOID_3945 1.614E-04 2.55E-03 1.614E-04 3.992E-03 WU_CELL_MIGRATION female reproductive organ benign neoplasm DOID_0060086 1.776E-04 2.731E-03 5.33E-03 0.05832442 WU_CELL_MIGRATION uterine benign neoplasm DOID_0060095 1.776E-04 2.731E-03 5.33E-03 0.05832442 WU_CELL_MIGRATION corneal disease DOID_10124 1.776E-04 2.659E-03 5.33E-03 0.05722396 WU_CELL_MIGRATION uterine fibroid DOID_13223 1.776E-04 2.731E-03 5.33E-03 0.05832442 WU_CELL_MIGRATION endometrial carcinoma DOID_2871 1.776E-04 2.591E-03 1.776E-04 4.211E-03 WU_CELL_MIGRATION biliary tract cancer DOID_4607 2.093E-04 2.977E-03 0.03413702 0.19231646 WU_CELL_MIGRATION chronic kidney failure DOID_784 2.093E-04 2.905E-03 0.03413702 0.19043101 WU_CELL_MIGRATION endometrial cancer DOID_1380 2.132E-04 2.888E-03 2.132E-04 4.853E-03 WU_CELL_MIGRATION allergic rhinitis DOID_4481 2.132E-04 2.821E-03 0.10947121 0.34605067 WU_CELL_MIGRATION leiomyoma DOID_127 2.326E-04 3.008E-03 6.352E-03 0.06571083 WU_CELL_MIGRATION bladder disease DOID_365 2.326E-04 2.941E-03 0.11250414 0.35367324 WU_CELL_MIGRATION myocarditis DOID_820 2.531E-04 3.131E-03 6.71E-03 0.06698626 WU_CELL_MIGRATION nephroblastoma DOID_2154 2.748E-04 3.327E-03 7.078E-03 0.06943907 WU_CELL_MIGRATION esophageal disease DOID_6050 2.748E-04 3.257E-03 7.078E-03 0.06826214 WU_CELL_MIGRATION encephalomyelitis DOID_640 3.206E-04 3.723E-03 4.241E-03 0.05027416 WU_CELL_MIGRATION congenital diaphragmatic hernia DOID_3827 4.01E-04 4.563E-03 9.05E-03 0.07572581 WU_CELL_MIGRATION benign mesothelioma DOID_2645 4.603E-04 5.136E-03 9.899E-03 0.08163386 WU_CELL_MIGRATION cervix uteri carcinoma in situ DOID_8991 4.603E-04 5.037E-03 9.899E-03 0.08046767 WU_CELL_MIGRATION pulmonary emphysema DOID_9675 4.603E-04 4.942E-03 9.899E-03 0.07933432 WU_CELL_MIGRATION diabetic autonomic neuropathy DOID_11503 5.594E-04 5.894E-03 0.14810955 0.44122689 WU_CELL_MIGRATION autonomic neuropathy DOID_11504 5.594E-04 5.894E-03 0.14810955 0.44122689 WU_CELL_MIGRATION diabetic polyneuropathy DOID_12785 5.594E-04 5.894E-03 0.14810955 0.44122689 WU_CELL_MIGRATION gallbladder cancer DOID_3121 5.594E-04 5.787E-03 0.14810955 0.43892884 WU_CELL_MIGRATION uterine cancer DOID_363 5.594E-04 5.684E-03 5.594E-04 0.01097561 WU_CELL_MIGRATION diabetic neuropathy DOID_9743 5.594E-04 5.894E-03 0.14810955 0.44122689 WU_CELL_MIGRATION familial adenomatous polyposis DOID_0050424 6.193E-04 6.182E-03 0.03680419 0.20136136 WU_CELL_MIGRATION proteinuria DOID_576 6.325E-04 6.205E-03 0.01217095 0.09358473 WU_CELL_MIGRATION autonomic nervous system disease DOID_11465 6.712E-04 6.473E-03 0.15678715 0.45285221 WU_CELL_MIGRATION brain cancer DOID_1319 6.712E-04 6.365E-03 6.712E-04 0.01272958 WU_CELL_MIGRATION thyroid adenoma DOID_2891 6.712E-04 6.26E-03 0.01265011 0.09597214 WU_CELL_MIGRATION central nervous system cancer DOID_3620 7.113E-04 6.528E-03 7.113E-04 0.01305648 WU_CELL_MIGRATION common cold DOID_10459 7.415E-04 6.697E-03 0.04008261 0.20546851 WU_CELL_MIGRATION epidermolysis bullosa DOID_2730 7.415E-04 6.593E-03 7.415E-04 0.01318523 WU_CELL_MIGRATION progressive myoclonus epilepsy DOID_891 7.415E-04 6.491E-03 7.415E-04 0.01278568 WU_CELL_MIGRATION aortic aneurysm DOID_3627 7.962E-04 6.864E-03 0.01413617 0.10054353 WU_CELL_MIGRATION B-cell lymphocytic neoplasm DOID_707 8.41E-04 7.142E-03 0.01464753 0.10289435 WU_CELL_MIGRATION variable age at onset electroclinical syndrome DOID_0050706 8.744E-04 7.317E-03 8.744E-04 0.01463326 WU_CELL_MIGRATION parathyroid gland disease DOID_11201 8.744E-04 7.211E-03 0.04334996 0.2108216 WU_CELL_MIGRATION larynx cancer DOID_2596 8.744E-04 7.108E-03 0.04334996 0.20385229 WU_CELL_MIGRATION laryngeal benign neoplasm DOID_2598 8.744E-04 7.108E-03 0.04334996 0.20385229 WU_CELL_MIGRATION vesiculobullous skin disease DOID_2731 8.744E-04 7.007E-03 8.744E-04 0.01421516 WU_CELL_MIGRATION vasculitis DOID_865 9.847E-04 7.782E-03 9.847E-04 0.01556393 WU_CELL_MIGRATION polycystic kidney disease DOID_898 1.018E-03 7.934E-03 0.04660628 0.21386267 WU_CELL_MIGRATION skeletal system cancer DOID_0060124 1.172E-03 9.01E-03 0.04985159 0.22692445 WU_CELL_MIGRATION bone cancer DOID_184 1.172E-03 9.01E-03 0.04985159 0.22692445 WU_CELL_MIGRATION corneal dystrophy DOID_2566 1.172E-03 8.89E-03 1.172E-03 0.01709676 WU_CELL_MIGRATION oral submucous fibrosis DOID_5773 1.172E-03 8.773E-03 1.000 1.000 WU_CELL_MIGRATION panic disorder DOID_594 1.172E-03 8.659E-03 1.172E-03 0.01666934 WU_CELL_MIGRATION Barrett's esophagus DOID_9206 1.336E-03 9.748E-03 0.05308595 0.23598363 WU_CELL_MIGRATION cholestasis DOID_13580 1.641E-03 0.01182164 0.02260967 0.14454946 WU_CELL_MIGRATION temporal lobe epilepsy DOID_3328 1.712E-03 0.01217437 0.02323349 0.14688728 WU_CELL_MIGRATION granulosa cell tumor DOID_2999 1.891E-03 0.01328712 0.06272361 0.26050902 WU_CELL_MIGRATION bile duct disease DOID_4138 2.092E-03 0.01451483 0.02645725 0.16543049 WU_CELL_MIGRATION amnestic disorder DOID_10914 2.097E-03 0.01437568 1.000 1.000 WU_CELL_MIGRATION sex cord-gonadal stromal tumor DOID_192 2.097E-03 0.01420454 0.06591449 0.26982262 WU_CELL_MIGRATION diabetic retinopathy DOID_8947 2.257E-03 0.01511059 0.22841133 0.60731797 WU_CELL_MIGRATION gastric ulcer DOID_10808 2.538E-03 0.01679321 0.07226394 0.28753973 WU_CELL_MIGRATION electroclinical syndrome DOID_0050701 2.612E-03 0.01708436 0.03054895 0.18491864 WU_CELL_MIGRATION mixed glioma DOID_5076 2.612E-03 0.01689022 0.2388811 0.62927475 WU_CELL_MIGRATION bacterial pneumonia DOID_874 2.612E-03 0.01670044 0.03054895 0.18297213 WU_CELL_MIGRATION urinary tract obstruction DOID_5200 2.774E-03 0.01753607 0.07542259 0.29394145 WU_CELL_MIGRATION alcohol abuse DOID_1574 3.102E-03 0.01939481 3.102E-03 0.03922061 WU_CELL_MIGRATION focal epilepsy DOID_2234 3.102E-03 0.01918399 0.03413702 0.19423963 WU_CELL_MIGRATION sphingolipidosis DOID_1927 3.274E-03 0.02003371 0.0817079 0.30386794 WU_CELL_MIGRATION retinal vascular disease DOID_2462 3.312E-03 0.02005018 0.2568651 0.67044148 WU_CELL_MIGRATION spinal muscular atrophy DOID_12377 3.814E-03 0.02284423 3.814E-03 0.04717829 WU_CELL_MIGRATION cystitis DOID_1679 3.814E-03 0.02260627 0.08795082 0.31875169 WU_CELL_MIGRATION papillary adenoma DOID_3172 3.814E-03 0.02237321 3.814E-03 0.0461745 WU_CELL_MIGRATION microcystic adenoma DOID_5403 3.814E-03 0.02237321 3.814E-03 0.0461745 WU_CELL_MIGRATION follicular adenoma DOID_6204 3.814E-03 0.02237321 3.814E-03 0.0461745 WU_CELL_MIGRATION myositis DOID_633 3.814E-03 0.02214491 0.08795082 0.31673427 WU_CELL_MIGRATION cleft lip DOID_9296 3.814E-03 0.02192123 0.08795082 0.31277509 WU_CELL_MIGRATION Human immunodeficiency virus infectious disease DOID_526 3.876E-03 0.02205623 0.03941986 0.2039082 WU_CELL_MIGRATION lymphoblastic leukemia DOID_1037 4.241E-03 0.02389267 0.04177294 0.20849825 WU_CELL_MIGRATION mouth disease DOID_403 4.367E-03 0.02436156 1.000 1.000 WU_CELL_MIGRATION Crohn's disease DOID_8778 4.367E-03 0.02412504 0.0425688 0.21062304 WU_CELL_MIGRATION gestational diabetes DOID_11714 4.392E-03 0.02403015 0.09415162 0.32272452 WU_CELL_MIGRATION lung adenocarcinoma DOID_3910 4.392E-03 0.02380129 4.392E-03 0.05100277 WU_CELL_MIGRATION periodontitis DOID_824 4.392E-03 0.02357675 1.000 1.000 WU_CELL_MIGRATION autoimmune disease of cardiovascular system DOID_0060051 4.695E-03 0.02496923 4.695E-03 0.05343415 WU_CELL_MIGRATION Behcet's disease DOID_13241 4.695E-03 0.02496923 4.695E-03 0.05343415 WU_CELL_MIGRATION polycystic ovary syndrome DOID_11612 5.008E-03 0.02638548 5.008E-03 0.05587513 WU_CELL_MIGRATION abdominal aortic aneurysm DOID_7693 5.661E-03 0.02955399 0.106428 0.34021086 WU_CELL_MIGRATION germinoma DOID_3304 6.002E-03 0.03104672 6.002E-03 0.06324332 WU_CELL_MIGRATION autonomic nervous system neoplasm DOID_2621 6.352E-03 0.03255942 6.352E-03 0.06453742 WU_CELL_MIGRATION neuroblastoma DOID_769 6.352E-03 0.03255942 6.352E-03 0.06453742 WU_CELL_MIGRATION periodontal disease DOID_3388 7.078E-03 0.03595952 1.000 1.000 WU_CELL_MIGRATION spindle cell carcinoma DOID_4015 7.078E-03 0.03564129 0.11853928 0.36458839 WU_CELL_MIGRATION hyperthyroidism DOID_7998 7.078E-03 0.03532865 7.078E-03 0.06712444 WU_CELL_MIGRATION lymphoid leukemia DOID_10747 7.455E-03 0.03688528 7.455E-03 0.06953782 WU_CELL_MIGRATION medullomyoblastoma DOID_3861 7.455E-03 0.0365673 7.455E-03 0.06841624 WU_CELL_MIGRATION adult medulloblastoma DOID_3864 7.455E-03 0.0365673 7.455E-03 0.06841624 WU_CELL_MIGRATION childhood medulloblastoma DOID_3869 7.455E-03 0.0365673 7.455E-03 0.06841624 WU_CELL_MIGRATION adenoma DOID_657 7.84E-03 0.03812993 7.84E-03 0.07081273 WU_CELL_MIGRATION calcinosis DOID_182 8.235E-03 0.03970861 8.235E-03 0.07321275 WU_CELL_MIGRATION medulloblastoma DOID_3858 8.235E-03 0.03937493 8.235E-03 0.0720864 WU_CELL_MIGRATION embryonal cancer DOID_688 8.235E-03 0.0390468 8.235E-03 0.07099418 WU_CELL_MIGRATION peripheral nervous system neoplasm DOID_1192 8.638E-03 0.04061994 8.638E-03 0.07335839 WU_CELL_MIGRATION autoimmune disease of urogenital tract DOID_0060049 0.01033691 0.04821069 0.01033691 0.08169034 WU_CELL_MIGRATION primary biliary cirrhosis DOID_12236 0.01033691 0.04821069 0.01033691 0.08169034 WU_CELL_MIGRATION Huntington's disease DOID_12858 0.01078291 0.04988192 0.14519738 0.43712862 WU_CELL_MIGRATION primitive neuroectodermal tumor DOID_168 0.01078291 0.04947965 0.01078291 0.08404763 WU_CELL_MIGRATION influenza DOID_8469 0.01123729 0.05115215 1.000 1.000 WU_CELL_MIGRATION heart valve disease DOID_4079 0.01265011 0.05712628 0.01265011 0.09470935 WU_CELL_MIGRATION autoimmune disease of gastrointestinal tract DOID_0060031 0.01363278 0.06107914 0.01363278 0.10074092 WU_CELL_MIGRATION glaucoma DOID_1686 0.01363278 0.06060196 0.16252342 0.46470265 WU_CELL_MIGRATION calcium metabolism disease DOID_10575 0.01413617 0.06235258 0.01413617 0.10181623 WU_CELL_MIGRATION orofacial cleft DOID_0050567 0.01516678 0.06638383 0.17105531 0.48183403 WU_CELL_MIGRATION melancholia DOID_2848 0.01901787 0.08260433 1.000 1.000 WU_CELL_MIGRATION neurotic disorder DOID_4964 0.01959823 0.08448026 1.000 1.000 WU_CELL_MIGRATION neuroectodermal tumor DOID_171 0.02018598 0.08635957 0.02018598 0.13673598 WU_CELL_MIGRATION carotid artery disease DOID_3407 0.02018598 0.08571509 0.02018598 0.13512732 WU_CELL_MIGRATION hypothyroidism DOID_1459 0.02078105 0.08758829 0.02078105 0.13749324 WU_CELL_MIGRATION congenital heart defect DOID_1682 0.0213834 0.08946435 0.0213834 0.13985232 WU_CELL_MIGRATION mineral metabolism disease DOID_0050032 0.02199295 0.09134299 0.02199295 0.14220443 WU_CELL_MIGRATION hyperglycemia DOID_4195 0.02323349 0.09579605 1.000 1.000 WU_CELL_MIGRATION tooth disease DOID_1091 0.02386436 0.09768935 1.000 1.000 WU_CELL_MIGRATION brain infarction DOID_3454 0.02450222 0.09958404 0.21512295 0.57738188 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bacterial pneumonia DOID_874 1.015E-21 5.777E-19 6.567E-07 7.473E-05 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP influenza DOID_8469 9.437E-17 2.685E-14 1.044E-05 3.494E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP retinal vascular disease DOID_2462 2.691E-16 5.104E-14 2.06E-04 2.726E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP diabetic retinopathy DOID_8947 1.382E-15 1.966E-13 1.262E-03 0.01216705 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pleurisy DOID_10247 1.708E-15 1.944E-13 8.231E-04 8.216E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cystic fibrosis DOID_1485 1.974E-15 1.872E-13 8.97E-06 3.403E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP rheumatic disease DOID_1575 4.115E-15 3.345E-13 2.863E-03 0.01986593 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP scleroderma DOID_419 4.115E-15 3.345E-13 2.863E-03 0.01986593 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pleural disease DOID_1532 1.016E-14 7.228E-13 1.297E-03 0.01209999 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP nervous system cancer DOID_3093 1.853E-14 1.172E-12 2.941E-10 1.674E-07 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP respiratory syncytial virus infectious disease DOID_1273 7.845E-14 4.464E-12 1.296E-04 1.992E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pancreatitis DOID_4989 9.106E-14 4.71E-12 3.575E-08 1.017E-05 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP collagen disease DOID_854 2.082E-13 9.872E-12 7.247E-03 0.04003676 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP primary bacterial infectious disease DOID_0050338 3.418E-13 1.496E-11 1.918E-05 4.366E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hypersensitivity reaction type I disease DOID_1205 9.831E-13 3.995E-11 2.431E-06 1.976E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pustulosis of palm and sole DOID_4398 2.553E-12 9.686E-11 6.971E-08 1.322E-05 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP portal hypertension DOID_10762 2.563E-12 9.114E-11 1.869E-05 4.624E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP systemic scleroderma DOID_418 4.005E-12 1.341E-10 2.205E-03 0.01672481 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hepatic vascular disease DOID_272 9.4E-12 2.971E-10 3.361E-05 6.374E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cholestasis DOID_13580 1.349E-11 4.039E-10 4.023E-06 2.543E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bile duct disease DOID_4138 3.227E-11 9.18E-10 6.603E-06 3.131E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP ulcerative colitis DOID_8577 3.268E-11 8.854E-10 3.439E-03 0.02198666 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP biliary tract disease DOID_9741 3.703E-11 9.578E-10 7.141E-06 3.125E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP aneurysm disease DOID_2403 6.3E-11 1.559E-09 9.658E-06 3.435E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP parasitic protozoa infectious disease DOID_2789 8.784E-11 2.083E-09 5.514E-03 0.03268039 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP chronic kidney failure DOID_784 1.325E-10 3.016E-09 1.847E-04 2.627E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP peptic ulcer DOID_750 1.779E-10 3.894E-09 2.205E-03 0.01650475 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pulmonary emphysema DOID_9675 2.643E-10 5.571E-09 1.556E-04 2.33E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP extrinsic allergic alveolitis DOID_841 3.21E-10 6.524E-09 0.15859313 0.3222839 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP parasitic infectious disease DOID_1398 3.854E-10 7.562E-09 8.563E-03 0.04511395 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP encephalomyelitis DOID_640 4.056E-10 7.693E-09 2.783E-05 5.46E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Crohn's disease DOID_8778 4.504E-10 8.266E-09 2.969E-03 0.02011443 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pancreatic ductal carcinoma DOID_3587 7.393E-10 1.315E-08 6.099E-06 3.155E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP brain cancer DOID_1319 7.758E-10 1.338E-08 1.421E-05 4.254E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP central nervous system cancer DOID_3620 9.153E-10 1.532E-08 1.567E-05 4.458E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pancreatic carcinoma DOID_4905 1.068E-09 1.736E-08 7.713E-06 3.135E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pulmonary tuberculosis DOID_2957 1.076E-09 1.701E-08 4.057E-03 0.02482181 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP aortic aneurysm DOID_3627 1.261E-09 1.939E-08 1.895E-05 4.494E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP leishmaniasis DOID_9065 1.282E-09 1.92E-08 0.11055866 0.25062899 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP sarcoidosis DOID_11335 1.989E-09 2.901E-08 0.04662768 0.16686258 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP giant cell tumor DOID_200 1.989E-09 2.829E-08 4.998E-03 0.03025406 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP malignant giant cell tumor DOID_2705 1.989E-09 2.829E-08 4.998E-03 0.03025406 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP giant cell glioblastoma DOID_3074 1.989E-09 2.829E-08 4.998E-03 0.03025406 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hypersensitivity reaction type IV disease DOID_2916 4.015E-09 5.572E-08 0.05432305 0.18733221 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP glioblastoma DOID_3068 4.015E-09 5.44E-08 6.345E-03 0.03610407 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP respiratory failure DOID_11162 6.738E-09 8.916E-08 0.33039053 0.58747567 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lymphoma DOID_0060058 7.244E-09 9.368E-08 2.62E-05 5.734E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP congenital heart defect DOID_1682 7.627E-09 9.644E-08 3.374E-06 2.4E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP endocrine pancreas disease DOID_1428 8.616E-09 1.066E-07 7.869E-04 7.995E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP commensal bacterial infectious disease DOID_0050339 1.05E-08 1.271E-07 4.973E-07 7.074E-05 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hyperglycemia DOID_4195 1.093E-08 1.296E-07 8.912E-03 0.04568504 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cystitis DOID_1679 1.343E-08 1.559E-07 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP tuberculosis DOID_399 1.376E-08 1.566E-07 9.635E-03 0.04726373 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP astrocytoma DOID_3069 1.54E-08 1.718E-07 0.01000959 0.04867911 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP nephrosis DOID_2527 1.919E-08 2.1E-07 9.581E-05 1.514E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP B-cell lymphocytic neoplasm DOID_707 4.192E-08 4.501E-07 3.455E-04 4.369E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP metabolic syndrome X DOID_14221 4.35E-08 4.584E-07 1.671E-03 0.01440901 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP abdominal aortic aneurysm DOID_7693 4.871E-08 5.039E-07 4.946E-05 8.795E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bronchitis DOID_6132 4.894E-08 4.973E-07 0.09951893 0.23302991 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP biliary tract cancer DOID_4607 5.781E-08 5.771E-07 1.907E-03 0.0150731 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP allergic rhinitis DOID_4481 5.885E-08 5.773E-07 0.01854176 0.07873332 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP vasculitis DOID_865 6.162E-08 5.942E-07 5.252E-03 0.03145712 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bladder disease DOID_365 7.066E-08 6.701E-07 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lymphoblastic leukemia DOID_1037 1.385E-07 1.292E-06 2.783E-05 5.655E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP mouth disease DOID_403 1.503E-07 1.38E-06 0.11803539 0.25931328 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP mitochondrial myopathy DOID_699 1.577E-07 1.425E-06 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pulmonary sarcoidosis DOID_13406 1.629E-07 1.448E-06 0.02516855 0.09945073 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP congenital diaphragmatic hernia DOID_3827 2.203E-07 1.928E-06 0.02756126 0.1066827 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP adult respiratory distress syndrome DOID_11394 2.547E-07 2.196E-06 0.23297795 0.43606728 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP intracranial arterial disease DOID_13089 2.547E-07 2.163E-06 0.02879063 0.1106883 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cerebral arterial disease DOID_3527 2.547E-07 2.163E-06 0.02879063 0.1106883 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP sinusitis DOID_0050127 2.582E-07 2.161E-06 1.123E-05 3.551E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP paranasal sinus disease DOID_1352 2.582E-07 2.161E-06 1.123E-05 3.551E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP childhood type dermatomyositis DOID_14203 2.837E-07 2.339E-06 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.837E-07 2.306E-06 2.664E-05 5.614E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.837E-07 2.306E-06 2.664E-05 5.614E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Hodgkin's granuloma DOID_8651 2.837E-07 2.306E-06 2.664E-05 5.614E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 2.837E-07 2.306E-06 2.664E-05 5.614E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP visceral leishmaniasis DOID_9146 2.837E-07 2.273E-06 0.05979441 0.18797249 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP brain infarction DOID_3454 2.881E-07 2.277E-06 9.635E-03 0.04767472 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Goodpasture syndrome DOID_9808 3.246E-07 2.53E-06 4.216E-04 5.215E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP toxic shock syndrome DOID_14115 4.037E-07 3.104E-06 1.589E-05 4.306E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP acute pancreatitis DOID_2913 4.037E-07 3.063E-06 1.589E-05 4.11E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP familial adenomatous polyposis DOID_0050424 4.436E-07 3.321E-06 1.994E-03 0.01554525 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP dermatomyositis DOID_10223 4.436E-07 3.278E-06 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bronchiectasis DOID_9563 4.436E-07 3.236E-06 0.06557442 0.19332561 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cerebral infarction DOID_3526 4.997E-07 3.599E-06 0.03525523 0.13284917 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP endogenous depression DOID_1595 5.519E-07 3.925E-06 0.08337842 0.2166316 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP proteinuria DOID_576 5.665E-07 3.98E-06 0.03660957 0.13704505 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP myositis DOID_633 6.073E-07 4.214E-06 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP myeloma DOID_0070004 6.405E-07 4.391E-06 0.0379837 0.14125964 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP mixed glioma DOID_5076 6.567E-07 4.448E-06 1.526E-03 0.01378069 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP common cold DOID_10459 6.622E-07 4.433E-06 0.07131904 0.2081053 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Hodgkin's lymphoma DOID_8567 6.622E-07 4.381E-06 4.84E-05 8.883E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP encephalitis DOID_9588 6.622E-07 4.331E-06 0.07131904 0.2018932 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP contact dermatitis DOID_2773 7.778E-07 5.029E-06 1.671E-03 0.01419395 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autoimmune disease of gastrointestinal tract DOID_0060031 8.122E-07 5.193E-06 4.057E-03 0.02509162 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP perinatal necrotizing enterocolitis DOID_8677 8.844E-07 5.591E-06 0.01369071 0.06282269 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP mental depression DOID_1596 9.942E-07 6.216E-06 0.09644698 0.23155414 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP focal epilepsy DOID_2234 9.942E-07 6.149E-06 1.907E-03 0.0152854 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autoimmune disease of cardiovascular system DOID_0060051 1.056E-06 6.461E-06 0.01460983 0.06650393 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Behcet's disease DOID_13241 1.056E-06 6.461E-06 0.01460983 0.06650393 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP viral pneumonia DOID_10533 1.326E-06 8.028E-06 7.935E-05 1.29E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bile duct adenocarcinoma DOID_4896 1.411E-06 8.452E-06 4.254E-04 5.15E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cholangiocarcinoma DOID_4947 1.411E-06 8.452E-06 4.254E-04 5.15E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bone marrow cancer DOID_4960 1.411E-06 8.364E-06 0.04813225 0.17117031 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hyperhomocysteinemia DOID_9279 1.8E-06 1.056E-05 3.746E-03 0.02342453 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Charcot-Marie-Tooth disease DOID_10595 2.021E-06 1.173E-05 5.579E-05 9.619E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bile duct cancer DOID_4606 2.115E-06 1.216E-05 5.514E-04 6.274E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bile duct carcinoma DOID_4897 2.115E-06 1.216E-05 5.514E-04 6.274E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP melancholia DOID_2848 2.33E-06 1.326E-05 0.05591255 0.19165206 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP leukocyte disease DOID_9500 2.33E-06 1.313E-05 0.31786994 0.56876728 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP chronic leukemia DOID_1036 2.346E-06 1.309E-05 1.297E-03 0.01230165 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP chronic lymphocytic leukemia DOID_1040 2.346E-06 1.309E-05 1.297E-03 0.01230165 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autonomic nervous system neoplasm DOID_2621 2.346E-06 1.296E-05 2.346E-06 2.225E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP neuroblastoma DOID_769 2.346E-06 1.296E-05 2.346E-06 2.225E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP neurotic disorder DOID_4964 2.562E-06 1.402E-05 0.05751825 0.19597536 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP carotid artery disease DOID_3407 2.813E-06 1.524E-05 6.617E-04 7.241E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP periodontal disease DOID_3388 3.119E-06 1.674E-05 0.02174934 0.08903148 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP esophageal disease DOID_6050 3.119E-06 1.659E-05 0.02174934 0.08839554 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP uterine disease DOID_345 4.023E-06 2.12E-05 0.34268228 0.60554726 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP temporal lobe epilepsy DOID_3328 4.384E-06 2.288E-05 8.912E-03 0.04610036 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP multiple myeloma DOID_9538 4.638E-06 2.399E-05 0.21864433 0.41058952 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP endocrine organ benign neoplasm DOID_0060089 5.184E-06 2.657E-05 9.635E-03 0.04809292 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP peripheral nervous system neoplasm DOID_1192 5.256E-06 2.67E-05 5.256E-06 2.99E-04 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pulmonary edema DOID_11396 6.235E-06 3.14E-05 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP esophagitis DOID_11963 6.235E-06 3.112E-05 0.11602788 0.25992073 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP male reproductive system disease DOID_48 6.603E-06 3.267E-05 0.07617819 0.21352409 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP peripheral vascular disease DOID_341 7.141E-06 3.503E-05 0.37049632 0.65266998 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autoimmune hepatitis DOID_2048 7.665E-06 3.728E-05 0.12146362 0.26581846 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autoimmune disease of urogenital tract DOID_0060049 8.399E-06 4.05E-05 1.7E-04 2.48E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP primary biliary cirrhosis DOID_12236 8.399E-06 4.05E-05 1.7E-04 2.48E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP syndrome DOID_225 8.97E-06 4.289E-05 0.01243064 0.05943727 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP gastric ulcer DOID_10808 9.324E-06 4.421E-05 0.12686607 0.27552212 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP placenta disease DOID_780 9.324E-06 4.384E-05 0.12686607 0.272403 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP nephrotic syndrome DOID_1184 9.376E-06 4.373E-05 1.853E-04 2.571E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hyperinsulinism DOID_2018 9.376E-06 4.337E-05 1.853E-04 2.51E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP gallbladder cancer DOID_3121 1.044E-05 4.791E-05 0.03392096 0.1286735 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP muscle cancer DOID_4045 1.123E-05 5.113E-05 0.13223545 0.28180513 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hypoglycemia DOID_9993 1.123E-05 5.072E-05 0.13223545 0.28075362 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP learning disability DOID_8927 1.16E-05 5.195E-05 3.233E-03 0.02138882 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP female reproductive system disease DOID_229 1.285E-05 5.712E-05 0.40085146 0.70396445 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP meningitis DOID_9471 1.341E-05 5.917E-05 9.496E-03 0.04781639 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP auditory system disease DOID_2742 1.377E-05 6.026E-05 1.826E-03 0.01484483 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pre-eclampsia DOID_10591 1.421E-05 6.17E-05 0.0379837 0.14034237 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP thyroid adenoma DOID_2891 1.421E-05 6.123E-05 0.0379837 0.13943693 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP vascular skin disease DOID_9540 1.421E-05 6.077E-05 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP spastic quadriplegia DOID_10970 1.589E-05 6.748E-05 0.01028032 0.04957205 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lung small cell carcinoma DOID_5409 1.725E-05 7.271E-05 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP urticaria DOID_1555 1.869E-05 7.82E-05 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP calcium metabolism disease DOID_10575 1.895E-05 7.872E-05 0.27889223 0.50377676 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP atopic dermatitis DOID_3310 2.275E-05 9.38E-05 0.28774126 0.51811639 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP middle cerebral artery infarction DOID_3525 2.535E-05 1.038E-04 0.15859313 0.32577434 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP retinal vascular occlusion DOID_1729 2.664E-05 1.083E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP acute kidney failure DOID_3021 2.664E-05 1.075E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP chondrosarcoma DOID_3371 2.664E-05 1.067E-04 0.05979441 0.19441726 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cutaneous leishmaniasis DOID_9111 2.664E-05 1.06E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP periodontitis DOID_824 2.927E-05 1.156E-04 0.16376822 0.33044013 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP integumentary system cancer DOID_0060122 2.952E-05 1.158E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP skin cancer DOID_4159 2.952E-05 1.158E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.953E-05 1.151E-04 3.259E-04 4.214E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP dilated cardiomyopathy DOID_12930 3.132E-05 1.212E-04 0.02213964 0.08934366 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP mitochondrial metabolism disease DOID_700 3.209E-05 1.234E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP oral cavity cancer DOID_8618 3.775E-05 1.442E-04 6.345E-03 0.03574661 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP supratentorial cancer DOID_1659 3.84E-05 1.457E-04 9.071E-04 8.899E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cerebrum cancer DOID_368 3.84E-05 1.457E-04 9.071E-04 8.899E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP peritonitis DOID_8283 4.84E-05 1.824E-04 2.384E-03 0.0173879 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP spastic cerebral palsy DOID_0050669 4.946E-05 1.852E-04 0.01752115 0.07668874 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP mineral metabolism disease DOID_0050032 5.948E-05 2.212E-04 0.3386102 0.60021559 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP leprosy DOID_1024 6.263E-05 2.314E-04 6.263E-05 1.048E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP psoriatic arthritis DOID_9008 6.263E-05 2.299E-04 2.806E-03 0.01970826 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP myocarditis DOID_820 7.018E-05 2.56E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP tooth disease DOID_1091 7.344E-05 2.662E-04 0.06919038 0.20293468 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP allergic contact dermatitis DOID_3042 7.344E-05 2.645E-04 9.27E-03 0.0470934 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pneumoconiosis DOID_10316 7.831E-05 2.802E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP thyroid carcinoma DOID_3963 7.831E-05 2.785E-04 0.20404402 0.39223328 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP spindle cell carcinoma DOID_4015 7.831E-05 2.768E-04 0.20404402 0.39091263 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Legionnaires' disease DOID_10457 7.935E-05 2.787E-04 3.26E-03 0.02132075 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP legionellosis DOID_10458 7.935E-05 2.787E-04 3.26E-03 0.02132075 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP thyroid cancer DOID_1781 9.659E-05 3.372E-04 0.21380744 0.40417419 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lung oat cell carcinoma DOID_5411 9.874E-05 3.426E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hepatitis DOID_2237 1.296E-04 4.468E-04 0.02756126 0.1074134 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bone resorption disease DOID_0080011 1.308E-04 4.482E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP osteoporosis DOID_11476 1.308E-04 4.482E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP transitional cell carcinoma DOID_2671 2.414E-04 8.225E-04 0.01819746 0.07844207 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP amnestic disorder DOID_10914 2.418E-04 8.19E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP brain edema DOID_4724 2.418E-04 8.142E-04 0.11602788 0.2578901 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP subependymal glioma DOID_4843 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pilocytic astrocytoma DOID_4851 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP subependymal giant cell astrocytoma DOID_5077 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP fibrillary astrocytoma DOID_6726 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP juvenile pilocytic astrocytoma DOID_6811 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP childhood pilocytic astrocytoma DOID_6812 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP gemistocytic astrocytoma DOID_7005 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP childhood cerebral astrocytoma DOID_7007 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP protoplasmic astrocytoma DOID_7008 2.418E-04 8.094E-04 6.643E-03 0.03705977 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP amino acid metabolic disorder DOID_9252 2.542E-04 8.458E-04 0.10807608 0.24796487 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP heart valve disease DOID_4079 2.565E-04 8.486E-04 0.26541303 0.4840385 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Human immunodeficiency virus infectious disease DOID_526 2.674E-04 8.796E-04 0.01928011 0.08126208 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Kawasaki disease DOID_13378 2.809E-04 9.184E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lymphadenitis DOID_1602 2.809E-04 9.184E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP coronary restenosis DOID_4247 2.809E-04 9.132E-04 0.12146362 0.2648 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lymph node disease DOID_9942 2.809E-04 9.184E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP integumentary system benign neoplasm DOID_0060121 2.987E-04 9.655E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP skin benign neoplasm DOID_3165 2.987E-04 9.655E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP benign glioma DOID_0060101 3.237E-04 1.041E-03 8.012E-03 0.04383536 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP neutropenia DOID_1227 3.237E-04 1.035E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP benign ependymoma DOID_4844 3.237E-04 1.041E-03 8.012E-03 0.04383536 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP agranulocytosis DOID_12987 3.706E-04 1.178E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP IgA glomerulonephritis DOID_2986 3.706E-04 1.172E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP polyarteritis nodosa DOID_9810 3.706E-04 1.165E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP diabetic angiopathy DOID_11713 4.216E-04 1.318E-03 0.13757194 0.2909979 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP reading disorder DOID_13365 5.367E-04 1.669E-03 5.367E-04 6.362E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bronchiolitis DOID_2942 5.367E-04 1.66E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP dyslexia DOID_4428 5.367E-04 1.669E-03 5.367E-04 6.362E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP nonsyndromic deafness DOID_0050563 5.514E-04 1.696E-03 5.514E-04 6.403E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hypertrophic cardiomyopathy DOID_11984 5.514E-04 1.687E-03 0.05432305 0.18847448 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP spinal muscular atrophy DOID_12377 6.011E-04 1.829E-03 6.011E-04 6.706E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP myopia DOID_11830 6.702E-04 2.028E-03 6.702E-04 7.195E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP vitiligo DOID_12306 6.702E-04 2.018E-03 6.702E-04 7.062E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP spinal cord disease DOID_319 6.702E-04 2.007E-03 6.702E-04 6.933E-03 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP diffuse large B-cell lymphoma DOID_0050745 7.441E-04 2.217E-03 0.01369071 0.06385257 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP gestational diabetes DOID_11714 7.441E-04 2.205E-03 0.16376822 0.33161607 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP migraine DOID_6364 7.441E-04 2.194E-03 0.01369071 0.06333345 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP sarcoma DOID_1115 8.231E-04 2.414E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP malaria DOID_12365 8.231E-04 2.402E-03 0.16891161 0.33841798 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP coronary stenosis DOID_4248 8.231E-04 2.389E-03 0.16891161 0.33605142 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP focal glomerulosclerosis DOID_3945 9.071E-04 2.62E-03 0.01555484 0.06861011 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP celiac disease DOID_10608 1.191E-03 3.424E-03 0.01854176 0.0793253 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP childhood absence epilepsy DOID_1825 1.297E-03 3.709E-03 1.297E-03 0.01190483 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP leber hereditary optic neuropathy DOID_705 1.316E-03 3.744E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP papilloma DOID_2615 1.409E-03 3.988E-03 0.19911714 0.38933901 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP nephroblastoma DOID_2154 1.526E-03 4.299E-03 0.02174934 0.08967663 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP leukopenia DOID_615 1.526E-03 4.278E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP brachydactyly DOID_0050581 1.638E-03 4.57E-03 1.638E-03 0.01456637 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Sjogren's syndrome DOID_12894 1.638E-03 4.548E-03 0.05979441 0.19896504 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hyperparathyroidism DOID_13543 1.638E-03 4.525E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hypolipoproteinemia DOID_1387 1.638E-03 4.504E-03 0.05979441 0.19780826 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bilirubin metabolic disorder DOID_2741 1.638E-03 4.482E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP childhood electroclinical syndrome DOID_0050704 1.649E-03 4.491E-03 1.649E-03 0.01443919 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autosomal recessive nonsyndromic deafness DOID_0050565 1.779E-03 4.82E-03 1.779E-03 0.014885 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP refractive error DOID_9835 1.779E-03 4.797E-03 1.779E-03 0.01466927 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP calcinosis DOID_182 1.914E-03 5.138E-03 0.21864433 0.41194908 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP migraine without aura DOID_12783 1.994E-03 5.328E-03 0.06557442 0.19846725 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP temporal arteritis DOID_13375 1.994E-03 5.303E-03 0.06557442 0.19741716 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP invasive lobular carcinoma DOID_3457 1.994E-03 5.278E-03 1.994E-03 0.01533518 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP central nervous system vasculitis DOID_525 1.994E-03 5.303E-03 0.06557442 0.19741716 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP eosinophilic pneumonia DOID_5870 1.994E-03 5.254E-03 0.06557442 0.19637812 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP pulmonary eosinophilia DOID_9498 1.994E-03 5.254E-03 0.06557442 0.19637812 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Loeffler syndrome DOID_9503 1.994E-03 5.254E-03 0.06557442 0.19637812 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP adenoid cystic carcinoma DOID_4866 2.359E-03 6.186E-03 2.359E-03 0.01743339 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lymphatic system disease DOID_75 2.359E-03 6.158E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP otitis media DOID_10754 2.384E-03 6.193E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP middle ear disease DOID_5100 2.384E-03 6.193E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP stomach disease DOID_76 2.384E-03 6.165E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP mitochondrial encephalomyopathy DOID_890 2.384E-03 6.137E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP benign mesothelioma DOID_2645 2.52E-03 6.46E-03 0.03004159 0.11472259 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP salivary gland cancer DOID_8850 2.688E-03 6.859E-03 2.688E-03 0.01936256 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 2.806E-03 7.127E-03 2.806E-03 0.01995461 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP berylliosis DOID_10322 2.806E-03 7.095E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP parathyroid gland disease DOID_11201 2.806E-03 7.064E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hepatic coma DOID_12550 2.806E-03 7.032E-03 0.07702849 0.21276317 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP newborn respiratory distress syndrome DOID_12716 2.806E-03 7.002E-03 0.07702849 0.21173533 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hepatic encephalopathy DOID_13413 2.806E-03 7.032E-03 0.07702849 0.21276317 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP idiopathic generalized epilepsy DOID_1827 2.863E-03 7.114E-03 2.863E-03 0.01962658 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cataract DOID_83 3.233E-03 7.998E-03 3.233E-03 0.02164045 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP open-angle glaucoma DOID_1067 3.26E-03 8.03E-03 0.082703 0.22092961 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hypercalcemia DOID_12678 3.26E-03 7.995E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP aspergillosis DOID_13564 3.26E-03 7.961E-03 3.26E-03 0.02107847 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP rhabdomyosarcoma DOID_3247 3.26E-03 7.927E-03 0.082703 0.21786114 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bacterial meningitis DOID_9470 3.26E-03 7.893E-03 0.082703 0.21586241 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lens disease DOID_110 3.631E-03 8.753E-03 3.631E-03 0.02295325 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP neuritis DOID_1803 3.631E-03 8.716E-03 0.26541303 0.4855949 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP skeletal system cancer DOID_0060124 3.746E-03 8.956E-03 0.08834276 0.22848651 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP thoracic aortic aneurysm DOID_14004 3.746E-03 8.919E-03 0.08834276 0.22642808 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP renovascular hypertension DOID_1591 3.746E-03 8.882E-03 0.08834276 0.2254127 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bone cancer DOID_184 3.746E-03 8.956E-03 0.08834276 0.22848651 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP membranoproliferative glomerulonephritis DOID_2920 3.746E-03 8.845E-03 0.08834276 0.2224205 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP skeletal muscle cancer DOID_4043 3.746E-03 8.808E-03 0.08834276 0.22144067 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP oral submucous fibrosis DOID_5773 3.746E-03 8.772E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP varicose veins DOID_799 3.746E-03 8.736E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hemolytic anemia DOID_583 3.84E-03 8.919E-03 0.26993374 0.49071022 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP normocytic anemia DOID_720 3.84E-03 8.919E-03 0.26993374 0.49071022 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP angiosarcoma DOID_0001816 4.264E-03 9.863E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hemolytic-uremic syndrome DOID_12554 4.264E-03 9.823E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP restrictive cardiomyopathy DOID_397 4.264E-03 9.784E-03 0.093948 0.22942667 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP thyroiditis DOID_7166 4.264E-03 9.744E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autoimmune thyroiditis DOID_7188 4.264E-03 9.744E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP tongue cancer DOID_8649 4.264E-03 9.705E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP vein disease DOID_866 4.264E-03 9.667E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Barrett's esophagus DOID_9206 4.264E-03 9.628E-03 0.093948 0.22651023 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP withdrawal disorder DOID_0060001 4.513E-03 0.01014895 0.0436722 0.15827697 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hemorrhagic disease DOID_2213 4.513E-03 0.010109 0.0436722 0.15727522 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP prion disease DOID_649 5.393E-03 0.01203393 0.10505574 0.2439866 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP eosinophilia DOID_999 5.393E-03 0.01198692 0.10505574 0.24299478 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP smallpox DOID_8736 5.514E-03 0.01220746 5.514E-03 0.03234348 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP dissociative disorder DOID_10935 6.003E-03 0.01323972 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP dissociative amnesia DOID_11037 6.003E-03 0.01323972 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP granulosa cell tumor DOID_2999 6.003E-03 0.0131886 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP psoriasis DOID_8893 6.003E-03 0.01313787 6.003E-03 0.03485558 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP congenital nervous system abnormality DOID_2490 6.06E-03 0.01321178 6.06E-03 0.03483106 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP sex cord-gonadal stromal tumor DOID_192 6.643E-03 0.01442785 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP familial hypercholesterolemia DOID_13810 8.012E-03 0.01733414 8.012E-03 0.04341788 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hepatitis B DOID_2043 8.012E-03 0.01726848 8.012E-03 0.04300828 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP acquired immunodeficiency syndrome DOID_635 8.012E-03 0.01720331 0.12686607 0.27343483 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP muscular atrophy DOID_767 8.012E-03 0.01713864 8.012E-03 0.04260633 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP optic nerve disease DOID_1891 8.74E-03 0.01862537 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP opiate dependence DOID_2559 8.74E-03 0.01855587 8.74E-03 0.04562361 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Lewy body dementia DOID_12217 9.496E-03 0.02008644 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP blood coagulation disease DOID_1247 0.01039204 0.02190026 0.07441075 0.20960256 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hypogonadism DOID_1924 0.01109229 0.02328971 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP intracranial aneurysm DOID_10941 0.01279784 0.02677196 0.15859313 0.32695468 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP seminoma DOID_4440 0.01279784 0.02667389 0.15859313 0.32460249 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP juvenile myoclonic epilepsy DOID_4890 0.01279784 0.02657654 0.01279784 0.0606831 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP electroclinical syndrome DOID_0050701 0.01330557 0.02753044 0.01330557 0.06256919 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP lipid metabolism disorder DOID_3146 0.01421479 0.02930514 0.09077667 0.22360141 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP renal hypertension DOID_1073 0.01460983 0.0300108 0.16891161 0.3396138 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP secondary hypertension DOID_11130 0.01460983 0.0300108 0.16891161 0.3396138 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP renal tubular transport disease DOID_447 0.01460983 0.02990285 0.01460983 0.06597612 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP chromosomal disease DOID_0080014 0.01468231 0.0299435 0.01468231 0.06578139 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autoimmune disease of endocrine system DOID_0060005 0.01555484 0.03160966 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP multiple epiphyseal dysplasia DOID_12721 0.01555484 0.03149717 0.01555484 0.06914612 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cranial nerve disease DOID_5656 0.01555484 0.03138547 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP age related macular degeneration DOID_10871 0.01752115 0.03522804 0.18415355 0.36257222 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP degeneration of macula and posterior pole DOID_2007 0.01752115 0.03522804 0.18415355 0.36257222 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP gonadal disease DOID_2277 0.01752115 0.035104 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP opportunistic mycosis DOID_2473 0.01752115 0.03498083 0.01752115 0.07610333 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bronchiolitis obliterans DOID_2799 0.01752115 0.03485852 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP germinoma DOID_3304 0.01854176 0.0367605 0.18917209 0.37116869 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP leiomyoma DOID_127 0.01958689 0.03869771 0.01958689 0.0819481 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP systemic mycosis DOID_0050136 0.02065619 0.04066912 0.02065619 0.08579106 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP fungal infectious disease DOID_1564 0.02065619 0.04066912 0.02065619 0.08579106 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP metal metabolism disorder DOID_896 0.02065619 0.04052888 0.19911714 0.38668141 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP carbohydrate metabolic disorder DOID_2978 0.02096959 0.0410024 0.11602529 0.26197773 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hepatitis C DOID_1883 0.02174934 0.04238142 0.20404402 0.39356288 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP macular degeneration DOID_4448 0.02174934 0.04223678 0.20404402 0.38960084 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP hyperthyroidism DOID_7998 0.02174934 0.04209311 0.20404402 0.38829783 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP aplastic anemia DOID_12449 0.022866 0.04410425 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP adenoma DOID_657 0.02400585 0.04614637 0.02400585 0.09619244 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP adolescence-adult electroclinical syndrome DOID_0050705 0.02516855 0.04821854 0.02516855 0.10014619 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP microcephaly DOID_10907 0.02635379 0.05031983 0.02635379 0.10341593 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP uveitis DOID_13141 0.02635379 0.05015154 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP cervix uteri carcinoma in situ DOID_8991 0.03004159 0.05697889 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP endometriosis of uterus DOID_288 0.03131384 0.0591946 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP Huntington's disease DOID_12858 0.03260706 0.06143516 0.24704973 0.45938332 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP endometriosis DOID_289 0.03260706 0.0612324 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP uveal disease DOID_3480 0.03260706 0.06103098 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP diabetic autonomic neuropathy DOID_11503 0.03392096 0.06328205 0.25168297 0.46495976 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autonomic neuropathy DOID_11504 0.03392096 0.06328205 0.25168297 0.46495976 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP diabetic polyneuropathy DOID_12785 0.03392096 0.06328205 0.25168297 0.46495976 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP diabetic neuropathy DOID_9743 0.03392096 0.06328205 0.25168297 0.46495976 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP leukodystrophy DOID_10579 0.03660957 0.06807466 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP autonomic nervous system disease DOID_11465 0.0379837 0.07039975 0.26541303 0.48716133 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP bone marrow disease DOID_4961 0.0379837 0.07017118 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP glaucoma DOID_1686 0.04079012 0.07511191 0.27442675 0.49728924 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP movement disease DOID_480 0.04222185 0.07749752 0.04222185 0.15400149 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP osteochondrodysplasia DOID_2256 0.04965434 0.09084668 0.04965434 0.17548645 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP familial hyperlipidemia DOID_1168 0.05119368 0.09336283 0.05119368 0.1798099 ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP retinitis pigmentosa DOID_10584 0.05432305 0.0987534 0.05432305 0.18963077 SANA_RESPONSE_TO_IFNG_UP hypersensitivity reaction type I disease DOID_1205 1.502E-13 8.549E-11 1.734E-04 0.0197298 SANA_RESPONSE_TO_IFNG_UP myasthenia gravis DOID_437 4.324E-11 1.23E-08 0.02517982 0.38722487 SANA_RESPONSE_TO_IFNG_UP neuromuscular junction disease DOID_439 1.034E-10 1.961E-08 0.02949528 0.41957042 SANA_RESPONSE_TO_IFNG_UP autoimmune disease of the nervous system DOID_438 1.821E-10 2.59E-08 0.03271963 0.39611643 SANA_RESPONSE_TO_IFNG_UP autoimmune disease of endocrine system DOID_0060005 2.169E-10 2.468E-08 5.459E-04 0.03882713 SANA_RESPONSE_TO_IFNG_UP angioedema DOID_1558 2.718E-10 2.578E-08 5.361E-05 7.627E-03 SANA_RESPONSE_TO_IFNG_UP encephalitis DOID_9588 6.397E-10 5.2E-08 0.01321549 0.35807695 SANA_RESPONSE_TO_IFNG_UP thyroiditis DOID_7166 2.345E-09 1.668E-07 0.01758265 0.33348431 SANA_RESPONSE_TO_IFNG_UP autoimmune thyroiditis DOID_7188 2.345E-09 1.668E-07 0.01758265 0.33348431 SANA_RESPONSE_TO_IFNG_UP sarcoidosis DOID_11335 4.778E-09 3.021E-07 0.06022945 0.46945968 SANA_RESPONSE_TO_IFNG_UP pustulosis of palm and sole DOID_4398 5.722E-09 3.256E-07 3.739E-05 7.092E-03 SANA_RESPONSE_TO_IFNG_UP hypersensitivity reaction type IV disease DOID_2916 7.411E-09 3.834E-07 0.06543153 0.48351352 SANA_RESPONSE_TO_IFNG_UP collagen disease DOID_854 9.475E-09 4.493E-07 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP urticaria DOID_1555 1.91E-08 8.362E-07 3.829E-04 0.03631029 SANA_RESPONSE_TO_IFNG_UP cystitis DOID_1679 2.241E-08 9.108E-07 0.02949528 0.43032864 SANA_RESPONSE_TO_IFNG_UP myositis DOID_633 2.241E-08 8.501E-07 0.02949528 0.409337 SANA_RESPONSE_TO_IFNG_UP ankylosing spondylitis DOID_7147 2.241E-08 7.969E-07 0.02949528 0.39959088 SANA_RESPONSE_TO_IFNG_UP primary bacterial infectious disease DOID_0050338 5.054E-08 1.692E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP Human immunodeficiency virus infectious disease DOID_526 5.974E-08 1.888E-06 4.709E-03 0.16745003 SANA_RESPONSE_TO_IFNG_UP bladder disease DOID_365 6.643E-08 1.989E-06 0.03807033 0.4087173 SANA_RESPONSE_TO_IFNG_UP uveitis DOID_13141 1.279E-07 3.638E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP systemic scleroderma DOID_418 1.412E-07 3.826E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP Sjogren's syndrome DOID_12894 1.509E-07 3.903E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP rheumatic disease DOID_1575 2.052E-07 5.077E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP uveal disease DOID_3480 2.052E-07 4.865E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP scleroderma DOID_419 2.052E-07 5.077E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP proteinuria DOID_576 2.658E-07 6.05E-06 0.05289902 0.45605369 SANA_RESPONSE_TO_IFNG_UP vascular skin disease DOID_9540 2.887E-07 6.318E-06 1.419E-03 0.08074525 SANA_RESPONSE_TO_IFNG_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.388E-07 7.14E-06 0.05604744 0.45558564 SANA_RESPONSE_TO_IFNG_UP aortic aneurysm DOID_3627 3.662E-07 7.441E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP narcolepsy DOID_8986 4.563E-07 8.953E-06 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP juvenile rheumatoid arthritis DOID_676 8.504E-07 1.613E-05 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP psoriasis DOID_8893 1.21E-06 2.221E-05 1.21E-06 6.885E-04 SANA_RESPONSE_TO_IFNG_UP membranous glomerulonephritis DOID_10976 1.422E-06 2.529E-05 0.02193094 0.37814261 SANA_RESPONSE_TO_IFNG_UP peripheral vascular disease DOID_341 1.493E-06 2.575E-05 3.159E-03 0.14978006 SANA_RESPONSE_TO_IFNG_UP autoimmune hepatitis DOID_2048 1.658E-06 2.775E-05 0.02301508 0.38516406 SANA_RESPONSE_TO_IFNG_UP aneurysm disease DOID_2403 1.84E-06 2.992E-05 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP mixed glioma DOID_5076 1.935E-06 3.059E-05 1.935E-06 5.506E-04 SANA_RESPONSE_TO_IFNG_UP sleep disorder DOID_535 2.205E-06 3.39E-05 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP encephalomyelitis DOID_640 3.849E-06 5.764E-05 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP vitiligo DOID_12306 4.063E-06 5.927E-05 0.03057123 0.4045356 SANA_RESPONSE_TO_IFNG_UP bronchiolitis obliterans DOID_2799 6.74E-06 9.588E-05 0.03593353 0.40090543 SANA_RESPONSE_TO_IFNG_UP celiac disease DOID_10608 7.386E-06 1.025E-04 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP myocarditis DOID_820 8.8E-06 1.192E-04 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP pulmonary sarcoidosis DOID_13406 1.214E-05 1.606E-04 0.04339212 0.43315998 SANA_RESPONSE_TO_IFNG_UP pulmonary emphysema DOID_9675 1.622E-05 2.098E-04 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP autoimmune disease of urogenital tract DOID_0060049 1.737E-05 2.196E-04 0.04868518 0.43971214 SANA_RESPONSE_TO_IFNG_UP primary biliary cirrhosis DOID_12236 1.737E-05 2.196E-04 0.04868518 0.43971214 SANA_RESPONSE_TO_IFNG_UP influenza DOID_8469 1.982E-05 2.451E-04 1.255E-03 0.0793374 SANA_RESPONSE_TO_IFNG_UP vasculitis DOID_865 3.548E-05 4.296E-04 1.84E-03 0.09516765 SANA_RESPONSE_TO_IFNG_UP dermatomyositis DOID_10223 6.548E-05 7.762E-04 0.01212075 0.36298445 SANA_RESPONSE_TO_IFNG_UP tuberculosis DOID_399 6.857E-05 7.962E-04 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP common cold DOID_10459 7.852E-05 8.936E-04 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP stomach disease DOID_76 7.852E-05 8.761E-04 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP syndrome DOID_225 9.077E-05 9.933E-04 3.411E-03 0.14930422 SANA_RESPONSE_TO_IFNG_UP viral pneumonia DOID_10533 1.081E-04 1.161E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP thoracic aortic aneurysm DOID_14004 1.247E-04 1.314E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP adrenal cortex disease DOID_3952 1.247E-04 1.29E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP primary immunodeficiency disease DOID_612 1.435E-04 1.458E-03 4.609E-03 0.1748527 SANA_RESPONSE_TO_IFNG_UP adrenal gland disease DOID_9553 1.612E-04 1.61E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP prion disease DOID_649 1.813E-04 1.778E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP eosinophilia DOID_999 1.813E-04 1.748E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP hepatitis B DOID_2043 2.729E-04 2.588E-03 0.02409804 0.39176522 SANA_RESPONSE_TO_IFNG_UP Goodpasture syndrome DOID_9808 3.256E-04 3.037E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP B cell deficiency DOID_2115 4.447E-04 4.081E-03 0.03057123 0.38655624 SANA_RESPONSE_TO_IFNG_UP extrinsic allergic alveolitis DOID_841 4.447E-04 4.016E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP autoimmune disease of cardiovascular system DOID_0060051 5.11E-04 4.543E-03 5.11E-04 0.04154019 SANA_RESPONSE_TO_IFNG_UP pleurisy DOID_10247 5.11E-04 4.474E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP Behcet's disease DOID_13241 5.11E-04 4.543E-03 5.11E-04 0.04154019 SANA_RESPONSE_TO_IFNG_UP abdominal aortic aneurysm DOID_7693 6.19E-04 5.336E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP pleural disease DOID_1532 6.966E-04 5.916E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP systemic mycosis DOID_0050136 7.37E-04 6.167E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP fungal infectious disease DOID_1564 7.37E-04 6.167E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP esophageal disease DOID_6050 7.786E-04 6.42E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP respiratory syncytial virus infectious disease DOID_1273 1.003E-03 8.153E-03 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP hemorrhagic disease DOID_2213 1.653E-03 0.0132478 0.05814071 0.45947313 SANA_RESPONSE_TO_IFNG_UP B-cell lymphocytic neoplasm DOID_707 1.653E-03 0.01306381 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP leukocyte disease DOID_9500 2.172E-03 0.01693151 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP hypothyroidism DOID_1459 2.384E-03 0.01833351 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP pre-malignant neoplasm DOID_0060071 2.457E-03 0.01864129 0.0706055 0.50853833 SANA_RESPONSE_TO_IFNG_UP in situ carcinoma DOID_8719 2.457E-03 0.01864129 0.0706055 0.50853833 SANA_RESPONSE_TO_IFNG_UP parasitic infectious disease DOID_1398 2.606E-03 0.01950929 0.07266724 0.51684578 SANA_RESPONSE_TO_IFNG_UP brain infarction DOID_3454 2.837E-03 0.0209616 0.0757515 0.52564149 SANA_RESPONSE_TO_IFNG_UP blood coagulation disease DOID_1247 2.996E-03 0.02185301 0.0778021 0.52701661 SANA_RESPONSE_TO_IFNG_UP nephrosis DOID_2527 3.077E-03 0.02216021 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP cystic fibrosis DOID_1485 3.411E-03 0.02426194 0.0829092 0.54855038 SANA_RESPONSE_TO_IFNG_UP pancreatitis DOID_4989 3.584E-03 0.02517991 0.0849443 0.55555522 SANA_RESPONSE_TO_IFNG_UP bacterial pneumonia DOID_874 3.584E-03 0.02487284 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP contact dermatitis DOID_2773 3.762E-03 0.02578903 3.762E-03 0.1528921 SANA_RESPONSE_TO_IFNG_UP lymphoma DOID_0060058 4.91E-03 0.0332583 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP childhood type dermatomyositis DOID_14203 0.01102481 0.0738014 0.01102481 0.36900698 SANA_RESPONSE_TO_IFNG_UP cannabis abuse DOID_9505 0.01102481 0.07294324 0.01102481 0.34850659 SANA_RESPONSE_TO_IFNG_UP trypanosomiasis DOID_10113 0.01212075 0.07927247 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP pneumocystosis DOID_11339 0.01212075 0.07837164 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP common variable immunodeficiency DOID_12177 0.01212075 0.07749106 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP temporal arteritis DOID_13375 0.01212075 0.07663005 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP prostatic adenoma DOID_2883 0.01212075 0.07578796 0.01212075 0.34483523 SANA_RESPONSE_TO_IFNG_UP central nervous system vasculitis DOID_525 0.01212075 0.07663005 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP leprosy DOID_1024 0.01430906 0.08849841 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP berylliosis DOID_10322 0.01430906 0.08754681 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP polyneuropathy DOID_1389 0.01430906 0.08661546 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP cannabis dependence DOID_1849 0.01430906 0.08570372 0.01430906 0.37008424 SANA_RESPONSE_TO_IFNG_UP psoriatic arthritis DOID_9008 0.01430906 0.08481097 0.01430906 0.35399362 SANA_RESPONSE_TO_IFNG_UP hallucinogen dependence DOID_9977 0.01430906 0.08570372 0.01430906 0.37008424 SANA_RESPONSE_TO_IFNG_UP Legionnaires' disease DOID_10457 0.01540144 0.09034451 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP legionellosis DOID_10458 0.01540144 0.09034451 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP parasitic helminthiasis infectious disease DOID_883 0.01540144 0.08942263 0.01540144 0.3651424 SANA_RESPONSE_TO_IFNG_UP idiopathic pulmonary fibrosis DOID_0050156 0.01649264 0.094791 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP renovascular hypertension DOID_1591 0.01649264 0.09384309 1.000 1.000 SANA_RESPONSE_TO_IFNG_UP membranoproliferative glomerulonephritis DOID_2920 0.01649264 0.09291395 0.01649264 0.37537237 SANA_RESPONSE_TO_IFNG_UP arthropathy DOID_381 0.01649264 0.09200303 0.01649264 0.36093497 SANA_RESPONSE_TO_IFNG_UP lung oat cell carcinoma DOID_5411 0.01649264 0.0911098 0.01649264 0.34756701 SANA_RESPONSE_TO_IFNG_UP hemolytic-uremic syndrome DOID_12554 0.01758265 0.0961974 0.01758265 0.35730462 SANA_RESPONSE_TO_IFNG_UP Fanconi's anemia DOID_13636 0.01758265 0.09528123 0.01758265 0.34498377 SANA_RESPONSE_TO_IFNG_UP Graves' disease DOID_12361 0.01867149 0.09929045 0.01867149 0.34271221 OHM_METHYLATED_IN_ADULT_CANCERS pre-malignant neoplasm DOID_0060071 3.801E-19 2.163E-16 1.431E-05 2.713E-03 OHM_METHYLATED_IN_ADULT_CANCERS in situ carcinoma DOID_8719 3.801E-19 2.163E-16 1.431E-05 2.713E-03 OHM_METHYLATED_IN_ADULT_CANCERS cervix uteri carcinoma in situ DOID_8991 1.499E-15 4.264E-13 4.536E-04 0.04301847 OHM_METHYLATED_IN_ADULT_CANCERS nervous system cancer DOID_3093 3.351E-13 6.356E-11 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS transitional cell carcinoma DOID_2671 4.296E-11 6.112E-09 0.06217859 0.76912206 OHM_METHYLATED_IN_ADULT_CANCERS lymphoid leukemia DOID_10747 6.113E-11 6.956E-09 1.481E-08 8.425E-06 OHM_METHYLATED_IN_ADULT_CANCERS benign mesothelioma DOID_2645 1.319E-10 1.251E-08 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS vulva cancer DOID_1245 1.452E-10 1.18E-08 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS brain cancer DOID_1319 2.565E-10 1.825E-08 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS central nervous system cancer DOID_3620 2.843E-10 1.797E-08 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS granulosa cell tumor DOID_2999 7.847E-10 4.465E-08 8.29E-05 0.0117929 OHM_METHYLATED_IN_ADULT_CANCERS sex cord-gonadal stromal tumor DOID_192 9.804E-10 5.071E-08 9.207E-05 0.01047797 OHM_METHYLATED_IN_ADULT_CANCERS mixed glioma DOID_5076 2.869E-09 1.36E-07 0.0554582 0.76965159 OHM_METHYLATED_IN_ADULT_CANCERS invasive ductal carcinoma DOID_3008 5.519E-09 2.416E-07 0.02115466 0.85978574 OHM_METHYLATED_IN_ADULT_CANCERS lymphoblastic leukemia DOID_1037 6.864E-09 2.79E-07 6.212E-07 1.767E-04 OHM_METHYLATED_IN_ADULT_CANCERS reproductive organ benign neoplasm DOID_0050622 8.429E-08 3.197E-06 0.04050972 0.72031349 OHM_METHYLATED_IN_ADULT_CANCERS oral cavity cancer DOID_8618 1.035E-07 3.681E-06 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS lymphoma DOID_0060058 5.953E-07 1.993E-05 0.06485383 0.76878807 OHM_METHYLATED_IN_ADULT_CANCERS autonomic nervous system neoplasm DOID_2621 2.076E-06 6.564E-05 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS neuroblastoma DOID_769 2.076E-06 6.564E-05 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS embryonal cancer DOID_688 3.127E-06 9.365E-05 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS peripheral nervous system neoplasm DOID_1192 3.372E-06 9.594E-05 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS adenoid cystic carcinoma DOID_4866 3.9E-06 1.057E-04 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS salivary gland cancer DOID_8850 4.481E-06 1.159E-04 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS gallbladder cancer DOID_3121 5.115E-06 1.265E-04 0.03295031 0.74994904 OHM_METHYLATED_IN_ADULT_CANCERS bile duct adenocarcinoma DOID_4896 9.187E-06 2.178E-04 0.03982486 0.73097889 OHM_METHYLATED_IN_ADULT_CANCERS cholangiocarcinoma DOID_4947 9.187E-06 2.178E-04 0.03982486 0.73097889 OHM_METHYLATED_IN_ADULT_CANCERS bile duct cancer DOID_4606 1.128E-05 2.567E-04 0.04256148 0.73386315 OHM_METHYLATED_IN_ADULT_CANCERS bile duct carcinoma DOID_4897 1.128E-05 2.567E-04 0.04256148 0.73386315 OHM_METHYLATED_IN_ADULT_CANCERS neuroectodermal tumor DOID_171 1.304E-05 2.853E-04 0.04460902 0.74654507 OHM_METHYLATED_IN_ADULT_CANCERS pancreatic ductal carcinoma DOID_3587 1.938E-05 4.084E-04 0.05072636 0.75956052 OHM_METHYLATED_IN_ADULT_CANCERS pancreatic carcinoma DOID_4905 2.187E-05 4.445E-04 0.05275708 0.76971227 OHM_METHYLATED_IN_ADULT_CANCERS invasive lobular carcinoma DOID_3457 2.676E-05 5.25E-04 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS biliary tract cancer DOID_4607 3.06E-05 5.804E-04 0.05882417 0.76070345 OHM_METHYLATED_IN_ADULT_CANCERS alcohol-related neurodevelopmental disorder DOID_0050667 4.404E-05 8.083E-04 0.06618869 0.7532273 OHM_METHYLATED_IN_ADULT_CANCERS lung oat cell carcinoma DOID_5411 5.099E-05 9.067E-04 0.01063177 0.75618496 OHM_METHYLATED_IN_ADULT_CANCERS drug-induced mental disorder DOID_1203 6.599E-05 1.138E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS drug psychosis DOID_1742 6.599E-05 1.138E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS substance-induced psychosis DOID_8646 6.599E-05 1.138E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS male reproductive organ benign neoplasm DOID_0060087 7.421E-05 1.242E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS testicular cancer DOID_2998 8.29E-05 1.348E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS muscle cancer DOID_4045 1.224E-04 1.935E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS myopia DOID_11830 1.825E-04 2.807E-03 0.01975786 0.93685185 OHM_METHYLATED_IN_ADULT_CANCERS sarcoma DOID_1115 2.099E-04 3.143E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS toxic encephalopathy DOID_3602 2.243E-04 3.272E-03 0.02185234 0.82893203 OHM_METHYLATED_IN_ADULT_CANCERS female reproductive organ benign neoplasm DOID_0060086 2.391E-04 3.401E-03 0.02254954 0.801918 OHM_METHYLATED_IN_ADULT_CANCERS uterine benign neoplasm DOID_0060095 2.391E-04 3.401E-03 0.02254954 0.801918 OHM_METHYLATED_IN_ADULT_CANCERS uterine fibroid DOID_13223 2.391E-04 3.401E-03 0.02254954 0.801918 OHM_METHYLATED_IN_ADULT_CANCERS germinoma DOID_3304 2.702E-04 3.75E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS leiomyoma DOID_127 2.864E-04 3.881E-03 0.02463827 0.82465751 OHM_METHYLATED_IN_ADULT_CANCERS nephroblastoma DOID_2154 3.203E-04 4.239E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS spindle cell carcinoma DOID_4015 3.203E-04 4.143E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS medullomyoblastoma DOID_3861 3.38E-04 4.274E-03 0.02672271 0.80027481 OHM_METHYLATED_IN_ADULT_CANCERS adult medulloblastoma DOID_3864 3.38E-04 4.274E-03 0.02672271 0.80027481 OHM_METHYLATED_IN_ADULT_CANCERS childhood medulloblastoma DOID_3869 3.38E-04 4.274E-03 0.02672271 0.80027481 OHM_METHYLATED_IN_ADULT_CANCERS refractive error DOID_9835 3.561E-04 4.405E-03 0.02741657 0.78000133 OHM_METHYLATED_IN_ADULT_CANCERS medulloblastoma DOID_3858 3.747E-04 4.536E-03 0.02810995 0.72702549 OHM_METHYLATED_IN_ADULT_CANCERS multiple myeloma DOID_9538 3.747E-04 4.442E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS primitive neuroectodermal tumor DOID_168 4.959E-04 5.758E-03 0.03226025 0.76483684 OHM_METHYLATED_IN_ADULT_CANCERS myeloma DOID_0070004 5.859E-04 6.667E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS glaucoma DOID_1686 6.336E-04 7.069E-03 0.03639349 0.73956768 OHM_METHYLATED_IN_ADULT_CANCERS lung small cell carcinoma DOID_5409 6.336E-04 6.933E-03 0.03639349 0.71406534 OHM_METHYLATED_IN_ADULT_CANCERS orofacial cleft DOID_0050567 7.087E-04 7.608E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS bone marrow cancer DOID_4960 7.61E-04 8.018E-03 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS astrocytoma DOID_3069 1.211E-03 0.01252496 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS hyperparathyroidism DOID_13543 7.1E-03 0.07214109 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS ventricular septal defect DOID_1657 7.1E-03 0.07087546 7.1E-03 0.57712873 OHM_METHYLATED_IN_ADULT_CANCERS labyrinthine disease DOID_4539 7.1E-03 0.06965347 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.1E-03 0.0684729 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.1E-03 0.0684729 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Hodgkin's granuloma DOID_8651 7.1E-03 0.0684729 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Hodgkin's lymphoma, mixed cellularity DOID_8654 7.1E-03 0.0684729 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS prostatic adenoma DOID_2883 7.807E-03 0.07403948 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS inner ear disease DOID_2952 7.807E-03 0.07282572 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS islet cell tumor DOID_1799 8.514E-03 0.07813807 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS peritonitis DOID_8283 8.514E-03 0.07689778 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Hodgkin's lymphoma DOID_8567 8.514E-03 0.07569625 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS parathyroid gland disease DOID_11201 9.221E-03 0.08071501 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS larynx cancer DOID_2596 9.221E-03 0.07949206 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS laryngeal benign neoplasm DOID_2598 9.221E-03 0.07949206 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Leydig cell tumor DOID_2696 9.221E-03 0.07830561 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Lynch syndrome DOID_3883 9.221E-03 0.07715405 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS sex cord-stromal neoplasm DOID_4757 9.221E-03 0.07830561 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS alcohol dependence DOID_0050741 9.926E-03 0.08185675 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS rhabdomyosarcoma DOID_3247 9.926E-03 0.08068736 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS hemangioma DOID_255 0.01063177 0.08520394 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS mesenchymal cell neoplasm DOID_3350 0.01063177 0.08402055 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS skeletal muscle cancer DOID_4043 0.01063177 0.08286958 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS spindle cell sarcoma DOID_4235 0.01063177 0.08402055 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS epithelioid sarcoma DOID_6193 0.01063177 0.08402055 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS angiosarcoma DOID_0001816 0.01133668 0.08716985 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS Fanconi's anemia DOID_13636 0.01133668 0.08600758 0.01133668 0.71672984 OHM_METHYLATED_IN_ADULT_CANCERS chronic myeloid leukemia DOID_8552 0.01133668 0.0848759 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS tongue cancer DOID_8649 0.01133668 0.08377362 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS urinary system benign neoplasm DOID_731 0.01204109 0.08783823 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS neuroendocrine tumor DOID_169 0.01274503 0.09179647 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS heart septal defect DOID_1681 0.01344848 0.09565231 0.01344848 0.76521848 OHM_METHYLATED_IN_ADULT_CANCERS psoriasis DOID_8893 0.01344848 0.09447142 0.01344848 0.69565316 OHM_METHYLATED_IN_ADULT_CANCERS colon carcinoma DOID_1520 0.01415145 0.09819724 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS subependymal glioma DOID_4843 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS pilocytic astrocytoma DOID_4851 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS subependymal giant cell astrocytoma DOID_5077 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS fibrillary astrocytoma DOID_6726 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS juvenile pilocytic astrocytoma DOID_6811 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS childhood pilocytic astrocytoma DOID_6812 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS gemistocytic astrocytoma DOID_7005 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS childhood cerebral astrocytoma DOID_7007 0.01415145 0.09701414 1.000 1.000 OHM_METHYLATED_IN_ADULT_CANCERS protoplasmic astrocytoma DOID_7008 0.01415145 0.09701414 1.000 1.000 KERLEY_RESPONSE_TO_CISPLATIN_UP transitional cell carcinoma DOID_2671 5.82E-07 3.312E-04 5.82E-07 3.312E-04 KERLEY_RESPONSE_TO_CISPLATIN_UP neuritis DOID_1803 6.909E-06 1.966E-03 6.304E-04 0.0512422 KERLEY_RESPONSE_TO_CISPLATIN_UP lipodystrophy DOID_811 3.456E-05 6.555E-03 3.456E-05 9.832E-03 KERLEY_RESPONSE_TO_CISPLATIN_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 4.082E-05 5.807E-03 4.082E-05 7.743E-03 KERLEY_RESPONSE_TO_CISPLATIN_UP diabetic angiopathy DOID_11713 1.437E-04 0.01635634 0.01758127 0.28582125 KERLEY_RESPONSE_TO_CISPLATIN_UP Sciatic Neuropathy DOID_11446 2.109E-04 0.02000459 0.02120633 0.28061405 KERLEY_RESPONSE_TO_CISPLATIN_UP lesion of sciatic nerve DOID_12528 2.109E-04 0.02000459 0.02120633 0.28061405 KERLEY_RESPONSE_TO_CISPLATIN_UP lung adenocarcinoma DOID_3910 2.109E-04 0.01714679 2.109E-04 0.03000689 KERLEY_RESPONSE_TO_CISPLATIN_UP mononeuritis of lower limb DOID_9473 2.109E-04 0.02000459 0.02120633 0.28061405 KERLEY_RESPONSE_TO_CISPLATIN_UP mononeuritis DOID_1802 2.259E-04 0.01606778 0.0219298 0.25995947 KERLEY_RESPONSE_TO_CISPLATIN_UP mononeuropathy DOID_1188 2.414E-04 0.01526049 0.02265274 0.25778823 KERLEY_RESPONSE_TO_CISPLATIN_UP focal glomerulosclerosis DOID_3945 2.414E-04 0.01373444 2.414E-04 0.02746888 KERLEY_RESPONSE_TO_CISPLATIN_UP Charcot-Marie-Tooth disease DOID_10595 2.908E-04 0.01504295 2.908E-04 0.02757874 KERLEY_RESPONSE_TO_CISPLATIN_UP intracranial arterial disease DOID_13089 4.662E-04 0.02210468 0.03128802 0.28714327 KERLEY_RESPONSE_TO_CISPLATIN_UP cerebral arterial disease DOID_3527 4.662E-04 0.02210468 0.03128802 0.28714327 KERLEY_RESPONSE_TO_CISPLATIN_UP glaucoma DOID_1686 6.817E-04 0.02983962 6.817E-04 0.04848939 KERLEY_RESPONSE_TO_CISPLATIN_UP aortic aneurysm DOID_3627 7.082E-04 0.02878168 7.082E-04 0.0447715 KERLEY_RESPONSE_TO_CISPLATIN_UP atrophic muscular disease DOID_913 7.903E-04 0.02997987 7.903E-04 0.0449698 KERLEY_RESPONSE_TO_CISPLATIN_UP muscular dystrophy DOID_9884 7.903E-04 0.02997987 7.903E-04 0.0449698 KERLEY_RESPONSE_TO_CISPLATIN_UP nephrosis DOID_2527 1.375E-03 0.04889203 1.375E-03 0.07111568 KERLEY_RESPONSE_TO_CISPLATIN_UP peripheral vascular disease DOID_341 1.412E-03 0.04725519 0.05395726 0.36119625 KERLEY_RESPONSE_TO_CISPLATIN_UP aneurysm disease DOID_2403 1.565E-03 0.04946094 1.565E-03 0.07419141 KERLEY_RESPONSE_TO_CISPLATIN_UP metabolic syndrome X DOID_14221 1.684E-03 0.05043875 0.05884752 0.3720471 KERLEY_RESPONSE_TO_CISPLATIN_UP Human immunodeficiency virus infectious disease DOID_526 2.113E-03 0.06012269 2.113E-03 0.09249645 KERLEY_RESPONSE_TO_CISPLATIN_UP encephalomyelitis DOID_640 2.251E-03 0.06099266 2.251E-03 0.09148899 KERLEY_RESPONSE_TO_CISPLATIN_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.298E-03 0.0594319 0.06855502 0.41943875 KERLEY_RESPONSE_TO_CISPLATIN_UP mouth disease DOID_403 2.298E-03 0.05684791 2.298E-03 0.08716679 KERLEY_RESPONSE_TO_CISPLATIN_UP dilated cardiomyopathy DOID_12930 2.345E-03 0.05560083 2.345E-03 0.08340125 BILD_E2F3_ONCOGENIC_SIGNATURE nervous system cancer DOID_3093 1.174E-12 6.681E-10 9.148E-08 5.205E-05 BILD_E2F3_ONCOGENIC_SIGNATURE giant cell tumor DOID_200 4.46E-09 1.269E-06 9.924E-06 1.412E-03 BILD_E2F3_ONCOGENIC_SIGNATURE malignant giant cell tumor DOID_2705 4.46E-09 1.269E-06 9.924E-06 1.412E-03 BILD_E2F3_ONCOGENIC_SIGNATURE giant cell glioblastoma DOID_3074 4.46E-09 1.269E-06 9.924E-06 1.412E-03 BILD_E2F3_ONCOGENIC_SIGNATURE glioblastoma DOID_3068 7.555E-09 1.433E-06 1.397E-05 1.59E-03 BILD_E2F3_ONCOGENIC_SIGNATURE astrocytoma DOID_3069 2.082E-08 2.961E-06 2.7E-05 2.195E-03 BILD_E2F3_ONCOGENIC_SIGNATURE peripheral nervous system neoplasm DOID_1192 4.72E-08 5.371E-06 2.812E-06 7.999E-04 BILD_E2F3_ONCOGENIC_SIGNATURE germinoma DOID_3304 1.304E-06 1.237E-04 2.976E-03 0.04703494 BILD_E2F3_ONCOGENIC_SIGNATURE autonomic nervous system neoplasm DOID_2621 1.47E-06 1.195E-04 8.014E-05 4.56E-03 BILD_E2F3_ONCOGENIC_SIGNATURE neuroblastoma DOID_769 1.47E-06 1.195E-04 8.014E-05 4.56E-03 BILD_E2F3_ONCOGENIC_SIGNATURE embryonal cancer DOID_688 2.542E-06 1.808E-04 4.1E-03 0.05981071 BILD_E2F3_ONCOGENIC_SIGNATURE primitive neuroectodermal tumor DOID_168 4.49E-06 2.839E-04 4.49E-06 8.516E-04 BILD_E2F3_ONCOGENIC_SIGNATURE brain cancer DOID_1319 6.291E-06 3.579E-04 0.11211863 0.45568214 BILD_E2F3_ONCOGENIC_SIGNATURE central nervous system cancer DOID_3620 6.814E-06 3.524E-04 0.11422923 0.44825124 BILD_E2F3_ONCOGENIC_SIGNATURE oral cavity cancer DOID_8618 1.397E-05 6.626E-04 4.215E-04 0.01262168 BILD_E2F3_ONCOGENIC_SIGNATURE neuroectodermal tumor DOID_171 1.692E-05 7.406E-04 1.692E-05 1.605E-03 BILD_E2F3_ONCOGENIC_SIGNATURE pre-malignant neoplasm DOID_0060071 1.912E-05 7.772E-04 0.01083257 0.11414316 BILD_E2F3_ONCOGENIC_SIGNATURE in situ carcinoma DOID_8719 1.912E-05 7.772E-04 0.01083257 0.11414316 BILD_E2F3_ONCOGENIC_SIGNATURE hyperglycemia DOID_4195 2.281E-05 8.654E-04 6.052E-04 0.0172183 BILD_E2F3_ONCOGENIC_SIGNATURE cleft lip DOID_9296 3.631E-05 1.291E-03 3.631E-05 2.583E-03 BILD_E2F3_ONCOGENIC_SIGNATURE seminoma DOID_4440 4.06E-05 1.359E-03 2.024E-03 0.04264851 BILD_E2F3_ONCOGENIC_SIGNATURE invasive ductal carcinoma DOID_3008 5.014E-05 1.585E-03 0.06884677 0.33481889 BILD_E2F3_ONCOGENIC_SIGNATURE bone development disease DOID_0080006 5.434E-05 1.627E-03 5.434E-05 3.436E-03 BILD_E2F3_ONCOGENIC_SIGNATURE transitional cell carcinoma DOID_2671 6.492E-05 1.847E-03 1.309E-03 0.03385967 BILD_E2F3_ONCOGENIC_SIGNATURE paraplegia DOID_607 9.481E-05 2.569E-03 3.517E-03 0.05265562 BILD_E2F3_ONCOGENIC_SIGNATURE medullomyoblastoma DOID_3861 1.028E-04 2.658E-03 1.028E-04 5.316E-03 BILD_E2F3_ONCOGENIC_SIGNATURE adult medulloblastoma DOID_3864 1.028E-04 2.658E-03 1.028E-04 5.316E-03 BILD_E2F3_ONCOGENIC_SIGNATURE childhood medulloblastoma DOID_3869 1.028E-04 2.658E-03 1.028E-04 5.316E-03 BILD_E2F3_ONCOGENIC_SIGNATURE medulloblastoma DOID_3858 1.199E-04 2.967E-03 1.199E-04 5.687E-03 BILD_E2F3_ONCOGENIC_SIGNATURE cleft palate DOID_674 1.199E-04 2.844E-03 1.199E-04 5.25E-03 BILD_E2F3_ONCOGENIC_SIGNATURE adenoid cystic carcinoma DOID_4866 1.491E-04 3.392E-03 1.491E-04 6.058E-03 BILD_E2F3_ONCOGENIC_SIGNATURE salivary gland cancer DOID_8850 1.708E-04 3.738E-03 1.708E-04 6.479E-03 BILD_E2F3_ONCOGENIC_SIGNATURE diabetic autonomic neuropathy DOID_11503 1.945E-04 4.099E-03 1.945E-04 6.917E-03 BILD_E2F3_ONCOGENIC_SIGNATURE autonomic neuropathy DOID_11504 1.945E-04 4.099E-03 1.945E-04 6.917E-03 BILD_E2F3_ONCOGENIC_SIGNATURE diabetic polyneuropathy DOID_12785 1.945E-04 4.099E-03 1.945E-04 6.917E-03 BILD_E2F3_ONCOGENIC_SIGNATURE diabetic neuropathy DOID_9743 1.945E-04 4.099E-03 1.945E-04 6.917E-03 BILD_E2F3_ONCOGENIC_SIGNATURE myeloma DOID_0070004 2.339E-04 4.753E-03 6.34E-03 0.08016718 BILD_E2F3_ONCOGENIC_SIGNATURE autonomic nervous system disease DOID_11465 2.339E-04 4.589E-03 2.339E-04 7.829E-03 BILD_E2F3_ONCOGENIC_SIGNATURE integumentary system benign neoplasm DOID_0060121 2.628E-04 4.985E-03 6.842E-03 0.08282948 BILD_E2F3_ONCOGENIC_SIGNATURE skin benign neoplasm DOID_3165 2.628E-04 4.985E-03 6.842E-03 0.08282948 BILD_E2F3_ONCOGENIC_SIGNATURE bronchiectasis DOID_9563 3.023E-04 5.549E-03 0.02580939 0.2068386 BILD_E2F3_ONCOGENIC_SIGNATURE orofacial cleft DOID_0050567 3.104E-04 5.519E-03 3.104E-04 9.812E-03 BILD_E2F3_ONCOGENIC_SIGNATURE bone marrow cancer DOID_4960 3.45E-04 5.949E-03 8.172E-03 0.09299719 BILD_E2F3_ONCOGENIC_SIGNATURE integumentary system cancer DOID_0060122 3.632E-04 6.078E-03 8.451E-03 0.0942852 BILD_E2F3_ONCOGENIC_SIGNATURE skin cancer DOID_4159 3.632E-04 6.078E-03 8.451E-03 0.0942852 BILD_E2F3_ONCOGENIC_SIGNATURE endocrine pancreas disease DOID_1428 5.553E-04 9.027E-03 0.01114879 0.11533932 BILD_E2F3_ONCOGENIC_SIGNATURE varicose veins DOID_799 5.735E-04 9.065E-03 0.03503037 0.23449739 BILD_E2F3_ONCOGENIC_SIGNATURE vein disease DOID_866 6.545E-04 0.01006466 0.03732209 0.23860978 BILD_E2F3_ONCOGENIC_SIGNATURE testicular cancer DOID_2998 9.283E-04 0.01390016 0.04416503 0.25642756 BILD_E2F3_ONCOGENIC_SIGNATURE psoriasis DOID_8893 9.283E-04 0.01354374 9.283E-04 0.02515266 BILD_E2F3_ONCOGENIC_SIGNATURE colon carcinoma DOID_1520 1.03E-03 0.01464975 0.0464353 0.26160085 BILD_E2F3_ONCOGENIC_SIGNATURE subependymal glioma DOID_4843 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE pilocytic astrocytoma DOID_4851 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE subependymal giant cell astrocytoma DOID_5077 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE fibrillary astrocytoma DOID_6726 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE juvenile pilocytic astrocytoma DOID_6811 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE childhood pilocytic astrocytoma DOID_6812 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE gemistocytic astrocytoma DOID_7005 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE childhood cerebral astrocytoma DOID_7007 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE protoplasmic astrocytoma DOID_7008 1.03E-03 0.01429244 0.0464353 0.25903613 BILD_E2F3_ONCOGENIC_SIGNATURE biliary tract cancer DOID_4607 1.11E-03 0.01503931 0.01751288 0.17482155 BILD_E2F3_ONCOGENIC_SIGNATURE chronic kidney failure DOID_784 1.11E-03 0.01468956 0.01751288 0.17180738 BILD_E2F3_ONCOGENIC_SIGNATURE benign glioma DOID_0060101 1.248E-03 0.01614191 0.05095986 0.28151611 BILD_E2F3_ONCOGENIC_SIGNATURE benign ependymoma DOID_4844 1.248E-03 0.01614191 0.05095986 0.28151611 BILD_E2F3_ONCOGENIC_SIGNATURE muscle cancer DOID_4045 1.365E-03 0.01725971 0.05321417 0.29114291 BILD_E2F3_ONCOGENIC_SIGNATURE synostosis DOID_11971 1.487E-03 0.01839105 1.487E-03 0.0367821 BILD_E2F3_ONCOGENIC_SIGNATURE hypersensitivity reaction type I disease DOID_1205 1.624E-03 0.01965473 0.0224263 0.20254865 BILD_E2F3_ONCOGENIC_SIGNATURE hypogonadism DOID_1924 1.745E-03 0.02068985 1.745E-03 0.04137971 BILD_E2F3_ONCOGENIC_SIGNATURE osteosarcoma DOID_3347 1.745E-03 0.02026761 1.745E-03 0.03972452 BILD_E2F3_ONCOGENIC_SIGNATURE infantile epileptic encephalopathy DOID_2481 1.882E-03 0.02141818 1.882E-03 0.04118881 BILD_E2F3_ONCOGENIC_SIGNATURE fragments of torsion dystonia DOID_531 2.024E-03 0.02257862 2.024E-03 0.04112535 BILD_E2F3_ONCOGENIC_SIGNATURE dystonia DOID_543 2.024E-03 0.02214442 2.024E-03 0.03970723 BILD_E2F3_ONCOGENIC_SIGNATURE extrinsic allergic alveolitis DOID_841 2.024E-03 0.0217266 0.06440654 0.32720824 BILD_E2F3_ONCOGENIC_SIGNATURE diffuse large B-cell lymphoma DOID_0050745 2.17E-03 0.02286855 0.06662927 0.33550488 BILD_E2F3_ONCOGENIC_SIGNATURE central nervous system hereditary degenerative disease DOID_481 2.322E-03 0.02401947 2.322E-03 0.04403569 BILD_E2F3_ONCOGENIC_SIGNATURE supratentorial cancer DOID_1659 2.478E-03 0.02517865 0.07105906 0.33415375 BILD_E2F3_ONCOGENIC_SIGNATURE cerebrum cancer DOID_368 2.478E-03 0.02517865 0.07105906 0.33415375 BILD_E2F3_ONCOGENIC_SIGNATURE dystonic disease DOID_544 2.478E-03 0.02473692 2.478E-03 0.04548401 BILD_E2F3_ONCOGENIC_SIGNATURE dysostosis DOID_1934 2.639E-03 0.02589119 2.639E-03 0.04692778 BILD_E2F3_ONCOGENIC_SIGNATURE endometrial carcinoma DOID_2871 2.639E-03 0.02545236 2.639E-03 0.04550573 BILD_E2F3_ONCOGENIC_SIGNATURE gonadal disease DOID_2277 2.805E-03 0.02660185 2.805E-03 0.04694445 BILD_E2F3_ONCOGENIC_SIGNATURE endometrial cancer DOID_1380 2.976E-03 0.02775833 2.976E-03 0.0483788 BILD_E2F3_ONCOGENIC_SIGNATURE pleural disease DOID_1532 3.151E-03 0.02892123 0.07985636 0.36062119 BILD_E2F3_ONCOGENIC_SIGNATURE hereditary spastic paraplegia DOID_2476 3.151E-03 0.02846216 3.151E-03 0.04846259 BILD_E2F3_ONCOGENIC_SIGNATURE pneumoconiosis DOID_10316 3.517E-03 0.03126427 0.08422407 0.37440231 BILD_E2F3_ONCOGENIC_SIGNATURE nephroblastoma DOID_2154 3.517E-03 0.03078328 1.000 1.000 BILD_E2F3_ONCOGENIC_SIGNATURE multiple myeloma DOID_9538 4.1E-03 0.03534269 0.09073722 0.39411814 BILD_E2F3_ONCOGENIC_SIGNATURE benign mesothelioma DOID_2645 4.941E-03 0.0419656 0.0993502 0.42825959 BILD_E2F3_ONCOGENIC_SIGNATURE cervix uteri carcinoma in situ DOID_8991 4.941E-03 0.04134846 0.0993502 0.42503959 BILD_E2F3_ONCOGENIC_SIGNATURE idiopathic generalized epilepsy DOID_1827 5.39E-03 0.04444606 5.39E-03 0.07666944 BILD_E2F3_ONCOGENIC_SIGNATURE hyperinsulinism DOID_2018 5.39E-03 0.04381111 5.39E-03 0.07479946 BILD_E2F3_ONCOGENIC_SIGNATURE gallbladder cancer DOID_3121 5.621E-03 0.04504451 0.10575695 0.44246842 BILD_E2F3_ONCOGENIC_SIGNATURE uterine cancer DOID_363 5.621E-03 0.04441889 5.621E-03 0.07614668 BILD_E2F3_ONCOGENIC_SIGNATURE cataract DOID_83 5.856E-03 0.04564503 5.856E-03 0.0774904 BILD_E2F3_ONCOGENIC_SIGNATURE learning disability DOID_8927 5.856E-03 0.0450282 0.1078825 0.44806675 BILD_E2F3_ONCOGENIC_SIGNATURE proteinuria DOID_576 6.096E-03 0.04624727 6.096E-03 0.07883058 BILD_E2F3_ONCOGENIC_SIGNATURE lens disease DOID_110 6.34E-03 0.04746741 6.34E-03 0.07842441 BILD_E2F3_ONCOGENIC_SIGNATURE heart valve disease DOID_4079 6.34E-03 0.04685095 0.11211863 0.44926408 BILD_E2F3_ONCOGENIC_SIGNATURE vascular skin disease DOID_9540 6.34E-03 0.04625029 0.11211863 0.4430243 BILD_E2F3_ONCOGENIC_SIGNATURE glaucoma DOID_1686 6.842E-03 0.0492783 0.11633486 0.45030297 BILD_E2F3_ONCOGENIC_SIGNATURE movement disease DOID_480 7.099E-03 0.05049307 7.099E-03 0.08415512 BILD_E2F3_ONCOGENIC_SIGNATURE B-cell lymphocytic neoplasm DOID_707 7.361E-03 0.05170834 0.12053129 0.45721538 BILD_E2F3_ONCOGENIC_SIGNATURE bile duct adenocarcinoma DOID_4896 8.172E-03 0.0567056 8.172E-03 0.09489509 BILD_E2F3_ONCOGENIC_SIGNATURE cholangiocarcinoma DOID_4947 8.172E-03 0.0567056 8.172E-03 0.09489509 BILD_E2F3_ONCOGENIC_SIGNATURE osteochondrodysplasia DOID_2256 8.451E-03 0.05793428 8.451E-03 0.09247202 BILD_E2F3_ONCOGENIC_SIGNATURE pustulosis of palm and sole DOID_4398 8.451E-03 0.05724458 0.12886513 0.48239643 BILD_E2F3_ONCOGENIC_SIGNATURE bile duct cancer DOID_4606 9.313E-03 0.06234124 9.313E-03 0.09998123 BILD_E2F3_ONCOGENIC_SIGNATURE bile duct carcinoma DOID_4897 9.313E-03 0.06234124 9.313E-03 0.09998123 BILD_E2F3_ONCOGENIC_SIGNATURE mineral metabolism disease DOID_0050032 0.01114879 0.07376352 0.14733179 0.53738328 BILD_E2F3_ONCOGENIC_SIGNATURE tuberculosis DOID_399 0.01245393 0.08145159 0.15541443 0.55616863 BILD_E2F3_ONCOGENIC_SIGNATURE peripheral vascular disease DOID_341 0.01382249 0.08937495 0.1634213 0.56699218 BILD_E2F3_ONCOGENIC_SIGNATURE diabetic retinopathy DOID_8947 0.01417438 0.09062049 0.16541126 0.56358685 BILD_E2F3_ONCOGENIC_SIGNATURE cystic fibrosis DOID_1485 0.01488974 0.09413625 0.16937714 0.57366425 BILD_E2F3_ONCOGENIC_SIGNATURE mixed glioma DOID_5076 0.01562039 0.09767035 0.17332439 0.57673437 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bacterial pneumonia DOID_874 4.368E-20 2.485E-17 1.014E-05 4.437E-04 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cholestasis DOID_13580 1.332E-19 3.789E-17 3.711E-10 2.111E-07 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP retinal vascular disease DOID_2462 1.848E-19 3.506E-17 1.132E-06 5.855E-05 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bile duct disease DOID_4138 5.301E-19 7.541E-17 8.062E-10 2.294E-07 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP biliary tract disease DOID_9741 6.591E-19 7.5E-17 9.112E-10 1.728E-07 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP diabetic retinopathy DOID_8947 3.416E-17 3.24E-15 1.066E-04 3.193E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cystic fibrosis DOID_1485 1.867E-15 1.518E-13 1.368E-03 0.0204779 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP influenza DOID_8469 5.096E-15 3.625E-13 1.983E-04 5.372E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pancreatitis DOID_4989 8.652E-14 5.47E-12 3.458E-08 4.92E-06 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP chronic kidney failure DOID_784 1.839E-13 1.047E-11 9.66E-07 5.497E-05 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP primary bacterial infectious disease DOID_0050338 3.248E-13 1.68E-11 2.246E-04 5.557E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP transitional cell carcinoma DOID_2671 3.728E-13 1.768E-11 8.775E-08 9.986E-06 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP encephalomyelitis DOID_640 7.242E-13 3.17E-11 1.34E-07 1.09E-05 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hypersensitivity reaction type I disease DOID_1205 9.344E-13 3.798E-11 1.577E-07 1.122E-05 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP collagen disease DOID_854 6.879E-12 2.609E-10 7.163E-03 0.0515891 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pleurisy DOID_10247 9.082E-12 3.23E-10 0.16824937 0.34560972 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pulmonary tuberculosis DOID_2957 3.015E-11 1.009E-09 2.938E-04 6.687E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP ulcerative colitis DOID_8577 3.12E-11 9.863E-10 3.387E-03 0.03058831 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pleural disease DOID_1532 3.557E-11 1.065E-09 0.19341065 0.36929752 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pustulosis of palm and sole DOID_4398 8.455E-11 2.405E-09 1.527E-06 7.242E-05 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP acute pancreatitis DOID_2913 1.285E-10 3.481E-09 3.952E-07 2.499E-05 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP respiratory syncytial virus infectious disease DOID_1273 1.719E-10 4.447E-09 0.0273436 0.12752878 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP uterine disease DOID_345 3.711E-10 9.18E-09 8.189E-04 0.01370405 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP rheumatic disease DOID_1575 3.722E-10 8.825E-09 0.24612938 0.42828017 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP scleroderma DOID_419 3.722E-10 8.825E-09 0.24612938 0.42828017 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cerebral infarction DOID_3526 5.326E-10 1.212E-08 3.194E-03 0.02979275 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP tuberculosis DOID_399 5.519E-10 1.208E-08 9.631E-04 0.01565761 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP leishmaniasis DOID_9065 1.25E-09 2.633E-08 0.11010992 0.26435673 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP female reproductive system disease DOID_229 2.286E-09 4.645E-08 1.72E-03 0.02330788 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP parasitic protozoa infectious disease DOID_2789 2.567E-09 5.037E-08 0.04927545 0.19606804 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP nervous system cancer DOID_3093 5.76E-09 1.093E-07 1.043E-07 9.889E-06 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP encephalitis DOID_9588 6.286E-09 1.154E-07 2.364E-03 0.02689702 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP respiratory failure DOID_11162 6.516E-09 1.159E-07 0.3292334 0.54616269 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP peptic ulcer DOID_750 6.6E-09 1.138E-07 0.22736817 0.40053402 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP intracranial arterial disease DOID_13089 7.843E-09 1.312E-07 0.02856375 0.13213637 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cerebral arterial disease DOID_3527 7.843E-09 1.312E-07 0.02856375 0.13213637 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP parasitic infectious disease DOID_1398 9.393E-09 1.527E-07 0.06528965 0.23074418 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hyperglycemia DOID_4195 1.057E-08 1.671E-07 8.809E-03 0.05966889 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cystitis DOID_1679 1.309E-08 2.012E-07 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP brain infarction DOID_3454 1.331E-08 1.993E-07 9.524E-03 0.06088956 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP middle cerebral artery infarction DOID_3525 1.657E-08 2.418E-07 0.01269374 0.07370142 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP extrinsic allergic alveolitis DOID_841 1.657E-08 2.357E-07 0.1579674 0.32924341 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP heart valve disease DOID_4079 2.344E-08 3.253E-07 2.523E-04 5.983E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP aneurysm disease DOID_2403 3.129E-08 4.239E-07 1.282E-04 3.646E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP giant cell tumor DOID_200 5.276E-08 6.981E-07 0.04627034 0.19078135 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP malignant giant cell tumor DOID_2705 5.276E-08 6.981E-07 0.04627034 0.19078135 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP giant cell glioblastoma DOID_3074 5.276E-08 6.981E-07 0.04627034 0.19078135 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP allergic rhinitis DOID_4481 5.737E-08 7.419E-07 0.01839283 0.09344217 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bladder disease DOID_365 6.888E-08 8.71E-07 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP glioblastoma DOID_3068 9.67E-08 1.196E-06 0.05391122 0.2072668 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP nephroblastoma DOID_2154 9.766E-08 1.182E-06 7.702E-05 2.435E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP spindle cell carcinoma DOID_4015 9.766E-08 1.158E-06 0.02157575 0.10316473 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lymphoma DOID_0060058 1.234E-07 1.433E-06 2.558E-05 9.096E-04 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mouth disease DOID_403 1.455E-07 1.655E-06 0.1172072 0.27444812 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Crohn's disease DOID_8778 1.455E-07 1.623E-06 0.02131101 0.10364071 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP systemic scleroderma DOID_418 2.148E-07 2.35E-06 0.22736817 0.40177791 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP adult respiratory distress syndrome DOID_11394 2.484E-07 2.666E-06 0.23210161 0.40761054 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP childhood type dermatomyositis DOID_14203 2.788E-07 2.938E-06 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pulmonary emphysema DOID_9675 2.861E-07 2.96E-06 0.02980536 0.13676814 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP astrocytoma DOID_3069 3.084E-07 3.134E-06 0.07211907 0.21944251 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP dermatomyositis DOID_10223 4.36E-07 4.353E-06 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP proteinuria DOID_576 5.525E-07 5.42E-06 0.03632475 0.15899065 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP brain cancer DOID_1319 6.246E-07 6.024E-06 1.391E-05 5.655E-04 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP central nervous system cancer DOID_3620 7.043E-07 6.679E-06 1.535E-05 5.823E-04 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP metabolic syndrome X DOID_14221 7.557E-07 7.049E-06 0.01405329 0.07839531 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lung small cell carcinoma DOID_5409 7.921E-07 7.27E-06 0.04047482 0.1693395 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP aortic aneurysm DOID_3627 8.887E-07 8.026E-06 3.163E-04 6.922E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mental depression DOID_1596 9.66E-07 8.589E-06 0.0154664 0.08148504 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP B-cell lymphocytic neoplasm DOID_707 9.947E-07 8.707E-06 3.4E-04 7.164E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP viral pneumonia DOID_10533 1.304E-06 1.124E-05 3.233E-03 0.02966728 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.204E-06 1.871E-05 2.883E-05 9.649E-04 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP melancholia DOID_2848 2.273E-06 1.902E-05 0.05548959 0.21190322 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP leukocyte disease DOID_9500 2.273E-06 1.874E-05 0.05548959 0.21049053 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP neurotic disorder DOID_4964 2.499E-06 2.032E-05 0.05708409 0.21510496 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP periodontal disease DOID_3388 3.054E-06 2.448E-05 0.02157575 0.104039 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP esophageal disease DOID_6050 3.054E-06 2.414E-05 0.02157575 0.10230502 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP congenital heart defect DOID_1682 3.292E-06 2.566E-05 7.316E-04 0.01261512 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP congenital diaphragmatic hernia DOID_3827 5.813E-06 4.47E-05 0.22736817 0.40302956 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pulmonary edema DOID_11396 6.13E-06 4.651E-05 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP esophagitis DOID_11963 6.13E-06 4.59E-05 0.11555842 0.27627202 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP nephrosis DOID_2527 6.443E-06 4.761E-05 0.01065874 0.06592201 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP male reproductive system disease DOID_48 6.443E-06 4.7E-05 0.07561686 0.22765075 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cervix uteri carcinoma in situ DOID_8991 7.348E-06 5.293E-05 2.49E-03 0.02778018 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mitochondrial myopathy DOID_699 7.537E-06 5.36E-05 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP endometriosis of uterus DOID_288 8.226E-06 5.778E-05 2.656E-03 0.02851306 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP endogenous depression DOID_1595 8.753E-06 6.074E-05 0.08276942 0.22973562 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP placenta disease DOID_780 9.167E-06 6.285E-05 0.12635597 0.28530376 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP endometriosis DOID_289 9.183E-06 6.22E-05 2.828E-03 0.02682315 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bone resorption disease DOID_0080011 9.425E-06 6.309E-05 0.08458897 0.23364623 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP osteoporosis DOID_11476 9.425E-06 6.309E-05 0.08458897 0.23364623 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mixed glioma DOID_5076 1.014E-05 6.707E-05 1.502E-03 0.02191371 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP sinusitis DOID_0050127 1.104E-05 7.223E-05 3.66E-04 7.437E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP paranasal sinus disease DOID_1352 1.104E-05 7.223E-05 3.66E-04 7.437E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP muscle cancer DOID_4045 1.104E-05 7.141E-05 0.13170542 0.29388386 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP contact dermatitis DOID_2773 1.169E-05 7.475E-05 1.645E-03 0.02283396 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP aortic valve disease DOID_62 1.319E-05 8.338E-05 4.164E-04 8.169E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP meningitis DOID_9471 1.319E-05 8.247E-05 9.418E-03 0.06159692 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Goodpasture syndrome DOID_9808 1.319E-05 8.157E-05 9.418E-03 0.06089695 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP myeloma DOID_0070004 1.391E-05 8.513E-05 0.03768882 0.16370183 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pre-eclampsia DOID_10591 1.391E-05 8.423E-05 3.587E-03 0.03189178 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP vascular skin disease DOID_9540 1.391E-05 8.334E-05 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.69E-05 1.002E-04 4.009E-03 0.03305644 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP portal hypertension DOID_10762 1.838E-05 1.078E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP urticaria DOID_1555 1.838E-05 1.067E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP calcium metabolism disease DOID_10575 1.857E-05 1.067E-04 0.27787648 0.47197527 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP myositis DOID_633 2.147E-05 1.222E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP sarcoidosis DOID_11335 2.435E-05 1.372E-04 0.29107151 0.48855365 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP retinal vascular occlusion DOID_1729 2.63E-05 1.467E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.63E-05 1.453E-04 1.625E-03 0.02310939 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.63E-05 1.453E-04 1.625E-03 0.02310939 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Hodgkin's granuloma DOID_8651 2.63E-05 1.453E-04 1.625E-03 0.02310939 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 2.63E-05 1.453E-04 1.625E-03 0.02310939 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cutaneous leishmaniasis DOID_9111 2.63E-05 1.439E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP visceral leishmaniasis DOID_9146 2.63E-05 1.425E-04 0.05954482 0.21175625 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bone marrow cancer DOID_4960 2.656E-05 1.426E-04 0.04776418 0.19412727 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP vasculitis DOID_865 2.656E-05 1.412E-04 5.19E-03 0.04045296 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP periodontitis DOID_824 2.878E-05 1.516E-04 0.16312411 0.33629572 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP perinatal necrotizing enterocolitis DOID_8677 2.878E-05 1.502E-04 0.01357958 0.07650279 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autoimmune disease of cardiovascular system DOID_0060051 3.305E-05 1.71E-04 0.01449149 0.08005491 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP sarcoma DOID_1115 3.305E-05 1.694E-04 0.16824937 0.34313223 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Behcet's disease DOID_13241 3.305E-05 1.71E-04 0.01449149 0.08005491 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hepatic vascular disease DOID_272 3.305E-05 1.679E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bronchiectasis DOID_9563 3.6E-05 1.813E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hypersensitivity reaction type IV disease DOID_2916 3.699E-05 1.846E-04 0.31253185 0.52149742 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP common cold DOID_10459 4.778E-05 2.364E-04 0.07102318 0.22451216 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP aortic valve insufficiency DOID_57 4.778E-05 2.344E-04 2.364E-03 0.02861385 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP peritonitis DOID_8283 4.778E-05 2.324E-04 2.364E-03 0.02801773 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Hodgkin's lymphoma DOID_8567 4.778E-05 2.304E-04 2.364E-03 0.02744594 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP spastic cerebral palsy DOID_0050669 4.864E-05 2.326E-04 0.18343839 0.35745358 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pre-malignant neoplasm DOID_0060071 5.42E-05 2.57E-04 7.797E-03 0.0554558 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP in situ carcinoma DOID_8719 5.42E-05 2.57E-04 7.797E-03 0.0554558 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mineral metabolism disease DOID_0050032 5.829E-05 2.741E-04 0.33743204 0.55651835 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP psoriatic arthritis DOID_9008 6.184E-05 2.884E-04 2.782E-03 0.02729262 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP temporal lobe epilepsy DOID_3328 6.716E-05 3.107E-04 0.06697565 0.2153059 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP tooth disease DOID_1091 7.196E-05 3.302E-04 0.06867604 0.21953185 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pneumoconiosis DOID_10316 7.702E-05 3.506E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Legionnaires' disease DOID_10457 7.834E-05 3.538E-04 0.08236204 0.23910205 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP legionellosis DOID_10458 7.834E-05 3.538E-04 0.08236204 0.23910205 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pancreatic ductal carcinoma DOID_3587 8.799E-05 3.942E-04 0.01027221 0.06422956 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP thoracic aortic aneurysm DOID_14004 9.749E-05 4.334E-04 3.715E-03 0.03202754 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP varicose veins DOID_799 9.749E-05 4.3E-04 0.08797969 0.23283927 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP intermediate coronary syndrome DOID_8805 9.749E-05 4.267E-04 3.715E-03 0.03108555 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hyperhomocysteinemia DOID_9279 9.749E-05 4.234E-04 0.08797969 0.23176131 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP peripheral vascular disease DOID_341 1.001E-04 4.315E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pulmonary sarcoidosis DOID_13406 1.051E-04 4.494E-04 0.21781396 0.39596212 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP multiple myeloma DOID_9538 1.051E-04 4.461E-04 0.21781396 0.39220299 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pancreatic carcinoma DOID_4905 1.066E-04 4.494E-04 0.01145683 0.06935038 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP angiosarcoma DOID_0001816 1.194E-04 4.997E-04 0.09356309 0.24309315 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP vein disease DOID_866 1.194E-04 4.961E-04 0.09356309 0.24089321 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Barrett's esophagus DOID_9206 1.194E-04 4.925E-04 0.09356309 0.23980811 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP syndrome DOID_225 1.206E-04 4.939E-04 0.01228848 0.07283483 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bronchitis DOID_6132 1.444E-04 5.868E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autoimmune disease of urogenital tract DOID_0060049 1.672E-04 6.748E-04 2.656E-03 0.02906139 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP primary biliary cirrhosis DOID_12236 1.672E-04 6.748E-04 2.656E-03 0.02906139 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP auditory system disease DOID_2742 1.713E-04 6.862E-04 0.0149868 0.08121421 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP focal epilepsy DOID_2234 1.811E-04 7.204E-04 0.09575339 0.24432142 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP biliary tract cancer DOID_4607 1.811E-04 7.154E-04 0.40687165 0.66145705 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP nephrotic syndrome DOID_1184 1.823E-04 7.152E-04 2.828E-03 0.02727778 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP uterine cancer DOID_363 1.983E-04 7.727E-04 0.25074836 0.43104477 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP testicular cancer DOID_2998 2.039E-04 7.892E-04 2.039E-04 5.273E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP learning disability DOID_8927 2.153E-04 8.276E-04 0.03498036 0.15549862 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP amnestic disorder DOID_10914 2.388E-04 9.119E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP brain edema DOID_4724 2.388E-04 9.058E-04 0.11555842 0.27511607 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP neuritis DOID_1803 2.523E-04 9.509E-04 0.03768882 0.16003686 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP thyroid adenoma DOID_2891 2.523E-04 9.447E-04 0.03768882 0.1588514 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Kawasaki disease DOID_13378 2.773E-04 1.031E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lymphadenitis DOID_1602 2.773E-04 1.031E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autoimmune hepatitis DOID_2048 2.773E-04 1.025E-03 0.1209737 0.28095525 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP coronary restenosis DOID_4247 2.773E-04 1.018E-03 0.1209737 0.27981316 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lymph node disease DOID_9942 2.773E-04 1.031E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP integumentary system benign neoplasm DOID_0060121 2.938E-04 1.072E-03 0.27342402 0.46720201 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP skin benign neoplasm DOID_3165 2.938E-04 1.072E-03 0.27342402 0.46720201 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lymphoblastic leukemia DOID_1037 3.044E-04 1.103E-03 0.02073641 0.10260017 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP gastric ulcer DOID_10808 3.197E-04 1.151E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP neutropenia DOID_1227 3.197E-04 1.144E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP dilated cardiomyopathy DOID_12930 3.352E-04 1.192E-03 0.11921378 0.27800263 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP atopic dermatitis DOID_3310 3.649E-04 1.29E-03 0.28670006 0.48264004 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP agranulocytosis DOID_12987 3.66E-04 1.285E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP IgA glomerulonephritis DOID_2986 3.66E-04 1.278E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP urinary tract obstruction DOID_5200 3.66E-04 1.27E-03 8.668E-03 0.05942286 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP polyarteritis nodosa DOID_9810 3.66E-04 1.262E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hypoglycemia DOID_9993 3.66E-04 1.254E-03 0.13170542 0.29046661 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bile duct adenocarcinoma DOID_4896 4.186E-04 1.426E-03 0.29541628 0.49438784 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cholangiocarcinoma DOID_4947 4.186E-04 1.426E-03 0.29541628 0.49438784 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP integumentary system cancer DOID_0060122 4.475E-04 1.515E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP skin cancer DOID_4159 4.475E-04 1.515E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP smallpox DOID_8736 4.475E-04 1.507E-03 4.475E-04 8.487E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP spastic quadriplegia DOID_10970 4.71E-04 1.577E-03 0.14230668 0.31023947 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mitochondrial metabolism disease DOID_700 4.777E-04 1.59E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP commensal bacterial infectious disease DOID_0050339 5.301E-04 1.754E-03 5.301E-04 9.729E-03 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bronchiolitis DOID_2942 5.301E-04 1.743E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hypertrophic cardiomyopathy DOID_11984 5.425E-04 1.774E-03 0.05391122 0.20867677 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bile duct cancer DOID_4606 5.425E-04 1.764E-03 0.31253185 0.51997258 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bile duct carcinoma DOID_4897 5.425E-04 1.764E-03 0.31253185 0.51997258 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP oral cavity cancer DOID_8618 5.425E-04 1.754E-03 6.271E-03 0.04633715 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP carotid artery disease DOID_3407 6.512E-04 2.093E-03 6.512E-04 0.01157875 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP gestational diabetes DOID_11714 7.349E-04 2.349E-03 0.01357958 0.07726781 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP endocrine pancreas disease DOID_1428 7.744E-04 2.462E-03 0.33743204 0.55490991 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP malaria DOID_12365 8.129E-04 2.57E-03 0.16824937 0.34190676 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP coronary stenosis DOID_4248 8.129E-04 2.556E-03 0.16824937 0.3382823 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP focal glomerulosclerosis DOID_3945 8.96E-04 2.801E-03 0.01542911 0.08204825 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP allergic contact dermatitis DOID_3042 9.132E-04 2.839E-03 9.162E-03 0.0613335 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP endocrine organ benign neoplasm DOID_0060089 9.631E-04 2.978E-03 0.07039059 0.22375558 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bronchiolitis obliterans DOID_2799 1.078E-03 3.315E-03 0.18343839 0.35502192 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP abdominal aortic aneurysm DOID_7693 1.078E-03 3.297E-03 0.01738012 0.08990264 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Charcot-Marie-Tooth disease DOID_10595 1.177E-03 3.581E-03 1.177E-03 0.0185992 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP celiac disease DOID_10608 1.177E-03 3.562E-03 0.01839283 0.09428399 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP chronic leukemia DOID_1036 1.281E-03 3.857E-03 0.19341065 0.37054095 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP chronic lymphocytic leukemia DOID_1040 1.281E-03 3.857E-03 0.19341065 0.37054095 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP leiomyoma DOID_127 1.281E-03 3.837E-03 0.0194299 0.09697905 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autonomic nervous system neoplasm DOID_2621 1.281E-03 3.817E-03 1.281E-03 0.01970419 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP neuroblastoma DOID_769 1.281E-03 3.817E-03 1.281E-03 0.01970419 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP leber hereditary optic neuropathy DOID_705 1.305E-03 3.867E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP papilloma DOID_2615 1.391E-03 4.102E-03 0.19835121 0.37371471 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP myocarditis DOID_820 1.391E-03 4.081E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP leukopenia DOID_615 1.507E-03 4.399E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hyperparathyroidism DOID_13543 1.625E-03 4.716E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bilirubin metabolic disorder DOID_2741 1.625E-03 4.692E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP acute kidney failure DOID_3021 1.625E-03 4.669E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP calcinosis DOID_182 1.891E-03 5.407E-03 0.21781396 0.3947011 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cleft palate DOID_674 1.891E-03 5.38E-03 1.891E-03 0.02502506 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP familial adenomatous polyposis DOID_0050424 1.978E-03 5.598E-03 0.06530154 0.22795446 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP migraine without aura DOID_12783 1.978E-03 5.57E-03 0.06530154 0.2198614 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP invasive lobular carcinoma DOID_3457 1.978E-03 5.543E-03 1.978E-03 0.02557364 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP peripheral nervous system neoplasm DOID_1192 2.031E-03 5.666E-03 2.031E-03 0.02568505 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hepatitis DOID_2237 2.178E-03 6.045E-03 0.22736817 0.40428903 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP adenoid cystic carcinoma DOID_4866 2.331E-03 6.438E-03 2.331E-03 0.02882889 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lymphatic system disease DOID_75 2.331E-03 6.406E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP otitis media DOID_10754 2.364E-03 6.466E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP diarrhea DOID_13250 2.364E-03 6.435E-03 0.07102318 0.22204499 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP aortic valve stenosis DOID_1712 2.364E-03 6.404E-03 0.07102318 0.21963146 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP middle ear disease DOID_5100 2.364E-03 6.466E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP stomach disease DOID_76 2.364E-03 6.374E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mitochondrial encephalomyopathy DOID_890 2.364E-03 6.344E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP amino acid metabolic disorder DOID_9252 2.409E-03 6.435E-03 0.1073092 0.26093561 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Human immunodeficiency virus infectious disease DOID_526 2.507E-03 6.665E-03 0.01906464 0.09599806 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP salivary gland cancer DOID_8850 2.656E-03 7.029E-03 2.656E-03 0.02798504 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 2.782E-03 7.329E-03 2.782E-03 0.02878131 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP leprosy DOID_1024 2.782E-03 7.295E-03 2.782E-03 0.02826736 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP berylliosis DOID_10322 2.782E-03 7.261E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP parathyroid gland disease DOID_11201 2.782E-03 7.228E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP newborn respiratory distress syndrome DOID_12716 2.782E-03 7.195E-03 0.07670994 0.22733311 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP larynx cancer DOID_2596 2.782E-03 7.163E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP laryngeal benign neoplasm DOID_2598 2.782E-03 7.163E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP monocytic leukemia DOID_8527 2.782E-03 7.131E-03 2.782E-03 0.02777144 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP carbohydrate metabolic disorder DOID_2978 2.816E-03 7.184E-03 0.02073641 0.10171569 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP diabetic autonomic neuropathy DOID_11503 3.008E-03 7.64E-03 0.03365592 0.15198588 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autonomic neuropathy DOID_11504 3.008E-03 7.64E-03 0.03365592 0.15198588 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP diabetic polyneuropathy DOID_12785 3.008E-03 7.64E-03 0.03365592 0.15198588 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP gallbladder cancer DOID_3121 3.008E-03 7.606E-03 0.25074836 0.43235097 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP diabetic neuropathy DOID_9743 3.008E-03 7.64E-03 0.03365592 0.15198588 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hypercalcemia DOID_12678 3.233E-03 8.139E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP rhabdomyosarcoma DOID_3247 3.233E-03 8.103E-03 0.08236204 0.23432001 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bacterial meningitis DOID_9470 3.233E-03 8.067E-03 0.08236204 0.2297255 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP leukodystrophy DOID_10579 3.387E-03 8.416E-03 0.03632475 0.16022314 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autonomic nervous system disease DOID_11465 3.587E-03 8.874E-03 0.03768882 0.16124015 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP skeletal system cancer DOID_0060124 3.715E-03 9.151E-03 0.08797969 0.24183789 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Ehlers-Danlos syndrome DOID_13359 3.715E-03 9.111E-03 3.715E-03 0.03252027 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP renovascular hypertension DOID_1591 3.715E-03 9.072E-03 0.08797969 0.23952365 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP congenital ichthyosiform erythroderma DOID_1699 3.715E-03 9.033E-03 3.715E-03 0.03154951 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bone cancer DOID_184 3.715E-03 9.151E-03 0.08797969 0.24183789 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP membranoproliferative glomerulonephritis DOID_2920 3.715E-03 8.995E-03 0.08797969 0.23725328 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP skeletal muscle cancer DOID_4043 3.715E-03 8.957E-03 0.08797969 0.23613417 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lung oat cell carcinoma DOID_5411 3.715E-03 8.919E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP oral submucous fibrosis DOID_5773 3.715E-03 8.882E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hemolytic anemia DOID_583 3.794E-03 9.033E-03 0.26894423 0.46093153 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP normocytic anemia DOID_720 3.794E-03 9.033E-03 0.26894423 0.46093153 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP glaucoma DOID_1686 4.009E-03 9.504E-03 0.27342402 0.4658032 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hemolytic-uremic syndrome DOID_12554 4.229E-03 9.984E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP restrictive cardiomyopathy DOID_397 4.229E-03 9.942E-03 4.229E-03 0.0343726 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP thyroiditis DOID_7166 4.229E-03 9.902E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autoimmune thyroiditis DOID_7188 4.229E-03 9.902E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP night blindness DOID_8499 4.229E-03 9.861E-03 4.229E-03 0.03388848 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP orofacial cleft DOID_0050567 4.695E-03 0.0109043 4.695E-03 0.0371049 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lymphatic system cancer DOID_0060073 4.773E-03 0.0110404 0.09911246 0.25176336 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP reticulosarcoma DOID_8538 4.773E-03 0.0110404 0.09911246 0.25176336 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lymphosarcoma DOID_8675 4.773E-03 0.0110404 0.09911246 0.25176336 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP ureteral obstruction DOID_5199 5.348E-03 0.0123205 5.348E-03 0.04112384 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP prion disease DOID_649 5.348E-03 0.01227082 0.104628 0.25772006 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP reproductive organ benign neoplasm DOID_0050622 5.449E-03 0.01245082 0.04927545 0.19884915 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP dissociative disorder DOID_10935 5.953E-03 0.01355014 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP dissociative amnesia DOID_11037 5.953E-03 0.01355014 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP granulosa cell tumor DOID_2999 5.953E-03 0.01349615 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP psoriasis DOID_8893 5.953E-03 0.0134426 5.953E-03 0.04516713 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP nonsyndromic deafness DOID_0050563 6.271E-03 0.01410261 6.271E-03 0.04694685 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP colon carcinoma DOID_1520 6.588E-03 0.01475917 6.588E-03 0.04806193 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP sex cord-gonadal stromal tumor DOID_192 6.588E-03 0.0147013 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP muscular atrophy DOID_767 7.946E-03 0.01766143 7.946E-03 0.05581885 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cerebral degeneration DOID_1443 8.463E-03 0.01873801 0.06528965 0.22931983 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP sexual disorder DOID_0060043 8.668E-03 0.01911666 8.668E-03 0.06014753 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP optic nerve disease DOID_1891 8.668E-03 0.01904285 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP pulmonary embolism DOID_9477 8.668E-03 0.0189696 0.13170542 0.29273588 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP diabetic angiopathy DOID_11713 9.418E-03 0.02053231 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP ureteral disease DOID_1426 9.418E-03 0.02045394 9.418E-03 0.06231316 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP toxic shock syndrome DOID_14115 0.01019617 0.02205939 0.01019617 0.06446245 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP blood coagulation disease DOID_1247 0.01027221 0.02213973 0.07386123 0.2235481 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP reading disorder DOID_13365 0.01100168 0.02362247 0.01100168 0.06731135 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hypogonadism DOID_1924 0.01100168 0.02353367 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP dyslexia DOID_4428 0.01100168 0.02362247 0.01100168 0.06731135 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP papillary adenoma DOID_3172 0.01183432 0.02521996 0.15277906 0.32680933 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP microcystic adenoma DOID_5403 0.01183432 0.02521996 0.15277906 0.32680933 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP follicular adenoma DOID_6204 0.01183432 0.02521996 0.15277906 0.32680933 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cleft lip DOID_9296 0.01183432 0.02512586 0.01183432 0.07088137 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP vitiligo DOID_12306 0.01269374 0.02685033 0.01269374 0.07446123 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP seminoma DOID_4440 0.01269374 0.02675089 0.1579674 0.33290167 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP diffuse large B-cell lymphoma DOID_0050745 0.01357958 0.02851211 0.01357958 0.0780483 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Sciatic Neuropathy DOID_11446 0.01357958 0.02840728 0.16312411 0.33875043 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lesion of sciatic nerve DOID_12528 0.01357958 0.02840728 0.16312411 0.33875043 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP migraine DOID_6364 0.01357958 0.02830323 0.16312411 0.33751861 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mononeuritis of lower limb DOID_9473 0.01357958 0.02840728 0.16312411 0.33875043 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lipid metabolism disorder DOID_3146 0.01405329 0.02918366 0.09011949 0.23522013 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP renal hypertension DOID_1073 0.01449149 0.0299842 0.16824937 0.34436652 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP secondary hypertension DOID_11130 0.01449149 0.0299842 0.16824937 0.34436652 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mononeuritis DOID_1802 0.01449149 0.02987556 0.16824937 0.34069001 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP renal tubular transport disease DOID_447 0.01449149 0.02976771 0.01449149 0.07928515 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autoimmune disease of endocrine system DOID_0060005 0.01542911 0.03157972 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP mononeuropathy DOID_1188 0.01542911 0.03146653 0.17334338 0.34607854 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP supratentorial cancer DOID_1659 0.01542911 0.03135415 0.01542911 0.08282229 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cerebrum cancer DOID_368 0.01542911 0.03135415 0.01542911 0.08282229 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cranial nerve disease DOID_5656 0.01542911 0.03124257 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP bone development disease DOID_0080006 0.01595459 0.03219206 0.01595459 0.08328587 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP female reproductive organ benign neoplasm DOID_0060086 0.0163921 0.03295797 0.17840632 0.35247638 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP uterine benign neoplasm DOID_0060095 0.0163921 0.03295797 0.17840632 0.35247638 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP uterine fibroid DOID_13223 0.0163921 0.03295797 0.17840632 0.35247638 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP endometrial carcinoma DOID_2871 0.0163921 0.03284192 0.17840632 0.35004551 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP gonadal disease DOID_2277 0.01738012 0.03469926 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP endometrial cancer DOID_1380 0.01839283 0.03659274 0.18843977 0.36346519 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP germinoma DOID_3304 0.01839283 0.03646524 0.18843977 0.36223727 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP thyroid carcinoma DOID_3963 0.02157575 0.04262709 0.20326164 0.37796038 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP autosomal recessive nonsyndromic deafness DOID_0050565 0.02381506 0.04688847 0.02381506 0.11198981 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP thyroid cancer DOID_1781 0.02381506 0.04672678 0.21299284 0.39094492 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP adenoma DOID_657 0.02381506 0.04656621 0.21299284 0.38968786 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP uveitis DOID_13141 0.02614523 0.05094739 0.22260568 0.39831016 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP blood platelet disease DOID_2218 0.02614523 0.05077351 0.22260568 0.39706154 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP benign mesothelioma DOID_2645 0.02980536 0.05768452 0.23680617 0.41459296 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP Huntington's disease DOID_12858 0.03235175 0.06240049 0.24612938 0.42959391 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP idiopathic generalized epilepsy DOID_1827 0.03235175 0.06218968 0.03235175 0.14726515 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hyperinsulinism DOID_2018 0.03235175 0.06198028 0.24612938 0.42697444 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP uveal disease DOID_3480 0.03235175 0.0617723 0.24612938 0.42567664 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP cataract DOID_83 0.03498036 0.06656797 0.03498036 0.15672302 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP lens disease DOID_110 0.03768882 0.07148313 0.03768882 0.16246166 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP movement disease DOID_480 0.04189618 0.07919909 0.04189618 0.17400676 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP withdrawal disorder DOID_0060001 0.04333607 0.08164975 0.28230177 0.47806461 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP hemorrhagic disease DOID_2213 0.04333607 0.08138028 0.28230177 0.47664602 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP atrophic muscular disease DOID_913 0.04627034 0.08660469 0.04627034 0.18940882 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP muscular dystrophy DOID_9884 0.04627034 0.08660469 0.04627034 0.18940882 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP osteochondrodysplasia DOID_2256 0.04927545 0.09192698 0.04927545 0.19744881 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP familial hyperlipidemia DOID_1168 0.05080389 0.09446867 0.05080389 0.20074592 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP congenital nervous system abnormality DOID_2490 0.05234923 0.09702513 0.05234923 0.20542562 ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP retinitis pigmentosa DOID_10584 0.05391122 0.09959573 0.05391122 0.21010607 DAZARD_UV_RESPONSE_CLUSTER_G3 renovascular hypertension DOID_1591 8.02E-06 4.563E-03 1.000 1.000 DAZARD_UV_RESPONSE_CLUSTER_G3 renal hypertension DOID_1073 3.315E-05 9.43E-03 1.000 1.000 DAZARD_UV_RESPONSE_CLUSTER_G3 secondary hypertension DOID_11130 3.315E-05 9.43E-03 1.000 1.000 DAZARD_UV_RESPONSE_CLUSTER_G3 peptic ulcer DOID_750 6.548E-05 0.0124199 1.000 1.000 DAZARD_UV_RESPONSE_CLUSTER_G3 pancreatitis DOID_4989 2.389E-04 0.03398217 2.389E-04 0.13592867 TSAI_RESPONSE_TO_IONIZING_RADIATION lymphoma DOID_0060058 6.997E-09 3.981E-06 5.797E-06 6.597E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION hypersensitivity reaction type I disease DOID_1205 8.724E-09 2.482E-06 6.763E-06 6.413E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION bone marrow cancer DOID_4960 1.061E-08 2.013E-06 4.784E-07 1.361E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION encephalitis DOID_9588 2.404E-08 3.42E-06 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION pre-malignant neoplasm DOID_0060071 2.606E-08 2.965E-06 1.002E-06 1.9E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION in situ carcinoma DOID_8719 2.606E-08 2.965E-06 1.002E-06 1.9E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION embryonal cancer DOID_688 7.796E-08 7.393E-06 4.189E-06 5.959E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION systemic scleroderma DOID_418 1.004E-07 8.158E-06 5.754E-03 0.06681367 TSAI_RESPONSE_TO_IONIZING_RADIATION prion disease DOID_649 1.468E-07 1.044E-05 1.066E-03 0.0224714 TSAI_RESPONSE_TO_IONIZING_RADIATION rheumatic disease DOID_1575 1.603E-07 1.014E-05 6.868E-03 0.07515594 TSAI_RESPONSE_TO_IONIZING_RADIATION scleroderma DOID_419 1.603E-07 1.014E-05 6.868E-03 0.07515594 TSAI_RESPONSE_TO_IONIZING_RADIATION transitional cell carcinoma DOID_2671 1.695E-07 9.644E-06 1.057E-04 4.624E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION myeloma DOID_0070004 2.457E-07 1.271E-05 1.034E-05 8.406E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION lung small cell carcinoma DOID_5409 3.001E-07 1.423E-05 3.001E-07 1.708E-04 TSAI_RESPONSE_TO_IONIZING_RADIATION myasthenia gravis DOID_437 4.204E-07 1.84E-05 0.06010131 0.28262515 TSAI_RESPONSE_TO_IONIZING_RADIATION neuromuscular junction disease DOID_439 8.264E-07 3.359E-05 0.07018228 0.30252816 TSAI_RESPONSE_TO_IONIZING_RADIATION collagen disease DOID_854 8.583E-07 3.256E-05 0.01296557 0.11527205 TSAI_RESPONSE_TO_IONIZING_RADIATION seminoma DOID_4440 9.621E-07 3.422E-05 2.589E-03 0.04091468 TSAI_RESPONSE_TO_IONIZING_RADIATION autoimmune disease of the nervous system DOID_438 1.282E-06 4.292E-05 0.07767268 0.30479831 TSAI_RESPONSE_TO_IONIZING_RADIATION nephrosis DOID_2527 1.775E-06 5.612E-05 4.917E-05 2.331E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION germinoma DOID_3304 2.152E-06 6.446E-05 3.802E-03 0.05407949 TSAI_RESPONSE_TO_IONIZING_RADIATION Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.238E-06 6.367E-05 3.181E-04 0.01064553 TSAI_RESPONSE_TO_IONIZING_RADIATION Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.238E-06 6.367E-05 3.181E-04 0.01064553 TSAI_RESPONSE_TO_IONIZING_RADIATION Hodgkin's granuloma DOID_8651 2.238E-06 6.367E-05 3.181E-04 0.01064553 TSAI_RESPONSE_TO_IONIZING_RADIATION Hodgkin's lymphoma, mixed cellularity DOID_8654 2.238E-06 6.367E-05 3.181E-04 0.01064553 TSAI_RESPONSE_TO_IONIZING_RADIATION breast benign neoplasm DOID_0060082 3.071E-06 8.322E-05 3.881E-04 0.01162116 TSAI_RESPONSE_TO_IONIZING_RADIATION thoracic benign neoplasm DOID_0060097 3.071E-06 8.322E-05 3.881E-04 0.01162116 TSAI_RESPONSE_TO_IONIZING_RADIATION benign breast phyllodes tumor DOID_1631 3.071E-06 8.322E-05 3.881E-04 0.01162116 TSAI_RESPONSE_TO_IONIZING_RADIATION Hodgkin's lymphoma DOID_8567 4.087E-06 1.057E-04 4.648E-04 0.01202261 TSAI_RESPONSE_TO_IONIZING_RADIATION multiple myeloma DOID_9538 4.189E-06 1.036E-04 1.738E-04 6.592E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION uveitis DOID_13141 4.633E-06 1.098E-04 0.10462983 0.35437127 TSAI_RESPONSE_TO_IONIZING_RADIATION nervous system cancer DOID_3093 5.216E-06 1.187E-04 1.996E-03 0.03785845 TSAI_RESPONSE_TO_IONIZING_RADIATION cervix uteri carcinoma in situ DOID_8991 6.171E-06 1.351E-04 2.311E-04 8.219E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION viral pneumonia DOID_10533 6.736E-06 1.42E-04 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION uveal disease DOID_3480 7.388E-06 1.501E-04 0.11662374 0.38137304 TSAI_RESPONSE_TO_IONIZING_RADIATION heart valve disease DOID_4079 1.034E-05 2.029E-04 3.381E-04 0.01068657 TSAI_RESPONSE_TO_IONIZING_RADIATION B-cell lymphocytic neoplasm DOID_707 1.408E-05 2.671E-04 4.245E-04 0.012077 TSAI_RESPONSE_TO_IONIZING_RADIATION giant cell tumor DOID_200 1.629E-05 2.99E-04 1.629E-05 1.159E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION malignant giant cell tumor DOID_2705 1.629E-05 2.99E-04 1.629E-05 1.159E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION giant cell glioblastoma DOID_3074 1.629E-05 2.99E-04 1.629E-05 1.159E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION pustulosis of palm and sole DOID_4398 1.874E-05 3.332E-04 0.01074252 0.10020478 TSAI_RESPONSE_TO_IONIZING_RADIATION glioblastoma DOID_3068 2.291E-05 3.95E-04 2.291E-05 1.448E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION congenital heart defect DOID_1682 3.131E-05 5.24E-04 3.131E-05 1.782E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION acute pancreatitis DOID_2913 4.166E-05 6.772E-04 2.065E-03 0.03672344 TSAI_RESPONSE_TO_IONIZING_RADIATION astrocytoma DOID_3069 4.415E-05 6.977E-04 4.415E-05 2.284E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION syndrome DOID_225 6.046E-05 9.297E-04 0.01884968 0.15106297 TSAI_RESPONSE_TO_IONIZING_RADIATION aneurysm disease DOID_2403 6.355E-05 9.516E-04 0.0193058 0.15256948 TSAI_RESPONSE_TO_IONIZING_RADIATION renal hypertension DOID_1073 7.282E-05 1.062E-03 0.07767268 0.31123771 TSAI_RESPONSE_TO_IONIZING_RADIATION secondary hypertension DOID_11130 7.282E-05 1.062E-03 0.07767268 0.31123771 TSAI_RESPONSE_TO_IONIZING_RADIATION chronic kidney failure DOID_784 8.459E-05 1.203E-03 0.02213872 0.16574907 TSAI_RESPONSE_TO_IONIZING_RADIATION primary immunodeficiency disease DOID_612 1.103E-04 1.531E-03 1.935E-03 0.03796045 TSAI_RESPONSE_TO_IONIZING_RADIATION Human immunodeficiency virus infectious disease DOID_526 1.151E-04 1.559E-03 1.996E-03 0.03663721 TSAI_RESPONSE_TO_IONIZING_RADIATION lymphoblastic leukemia DOID_1037 1.303E-04 1.724E-03 1.303E-04 5.295E-03 TSAI_RESPONSE_TO_IONIZING_RADIATION encephalomyelitis DOID_640 1.303E-04 1.685E-03 2.187E-03 0.03771415 TSAI_RESPONSE_TO_IONIZING_RADIATION mouth disease DOID_403 1.357E-04 1.715E-03 2.253E-03 0.03771248 TSAI_RESPONSE_TO_IONIZING_RADIATION Crohn's disease DOID_8778 1.357E-04 1.678E-03 2.253E-03 0.03663498 TSAI_RESPONSE_TO_IONIZING_RADIATION nephroblastoma DOID_2154 1.375E-04 1.664E-03 4.49E-03 0.06082424 TSAI_RESPONSE_TO_IONIZING_RADIATION periodontal disease DOID_3388 1.375E-04 1.63E-03 4.49E-03 0.05940973 TSAI_RESPONSE_TO_IONIZING_RADIATION autoimmune disease of urogenital tract DOID_0060049 2.472E-04 2.87E-03 6.581E-03 0.07489438 TSAI_RESPONSE_TO_IONIZING_RADIATION primary biliary cirrhosis DOID_12236 2.472E-04 2.87E-03 6.581E-03 0.07489438 TSAI_RESPONSE_TO_IONIZING_RADIATION neuritis DOID_1803 3.381E-04 3.847E-03 0.12610421 0.4008564 TSAI_RESPONSE_TO_IONIZING_RADIATION aortic aneurysm DOID_3627 4.017E-04 4.482E-03 9.034E-03 0.09017803 TSAI_RESPONSE_TO_IONIZING_RADIATION relapsing-remitting multiple sclerosis DOID_2378 4.648E-04 5.086E-03 4.648E-04 0.01259511 TSAI_RESPONSE_TO_IONIZING_RADIATION reproductive organ benign neoplasm DOID_0050622 5.24E-04 5.625E-03 0.01074252 0.10187486 TSAI_RESPONSE_TO_IONIZING_RADIATION parasitic protozoa infectious disease DOID_2789 5.24E-04 5.521E-03 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION Lynch syndrome DOID_3883 5.484E-04 5.673E-03 5.484E-04 0.01356692 TSAI_RESPONSE_TO_IONIZING_RADIATION psoriatic arthritis DOID_9008 5.484E-04 5.572E-03 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION renovascular hypertension DOID_1591 7.356E-04 7.344E-03 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION intermediate coronary syndrome DOID_8805 7.356E-04 7.217E-03 0.03961357 0.22316951 TSAI_RESPONSE_TO_IONIZING_RADIATION parasitic infectious disease DOID_1398 8.346E-04 8.049E-03 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION uterine disease DOID_345 8.346E-04 7.915E-03 0.01454912 0.12543106 TSAI_RESPONSE_TO_IONIZING_RADIATION angiosarcoma DOID_0001816 8.393E-04 7.828E-03 8.393E-04 0.01989742 TSAI_RESPONSE_TO_IONIZING_RADIATION tongue cancer DOID_8649 8.393E-04 7.702E-03 8.393E-04 0.01910153 TSAI_RESPONSE_TO_IONIZING_RADIATION tooth disease DOID_1091 9.081E-04 8.202E-03 0.01537064 0.13053577 TSAI_RESPONSE_TO_IONIZING_RADIATION urinary system benign neoplasm DOID_731 9.495E-04 8.442E-03 9.495E-04 0.02077926 TSAI_RESPONSE_TO_IONIZING_RADIATION diabetic retinopathy DOID_8947 1.153E-03 0.01009034 0.01795144 0.14591953 TSAI_RESPONSE_TO_IONIZING_RADIATION leishmaniasis DOID_9065 1.19E-03 0.01025635 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION pancreatitis DOID_4989 1.337E-03 0.01135199 0.01976655 0.15407079 TSAI_RESPONSE_TO_IONIZING_RADIATION mixed glioma DOID_5076 1.337E-03 0.01118505 1.337E-03 0.02716369 TSAI_RESPONSE_TO_IONIZING_RADIATION bacterial pneumonia DOID_874 1.337E-03 0.01102295 0.19406825 0.54937728 TSAI_RESPONSE_TO_IONIZING_RADIATION female reproductive system disease DOID_229 1.486E-03 0.01208042 0.02117627 0.16282837 TSAI_RESPONSE_TO_IONIZING_RADIATION hepatitis B DOID_2043 1.599E-03 0.01281177 0.0575642 0.27994897 TSAI_RESPONSE_TO_IONIZING_RADIATION acquired immunodeficiency syndrome DOID_635 1.599E-03 0.01263383 0.0575642 0.27757652 TSAI_RESPONSE_TO_IONIZING_RADIATION retinal vascular disease DOID_2462 1.701E-03 0.01325996 0.02311901 0.17084046 TSAI_RESPONSE_TO_IONIZING_RADIATION sinusitis DOID_0050127 1.748E-03 0.0134395 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION paranasal sinus disease DOID_1352 1.748E-03 0.0134395 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION primary bacterial infectious disease DOID_0050338 1.816E-03 0.01377439 0.21341727 0.58663974 TSAI_RESPONSE_TO_IONIZING_RADIATION diabetic angiopathy DOID_11713 1.903E-03 0.01425045 0.06263165 0.28973504 TSAI_RESPONSE_TO_IONIZING_RADIATION Goodpasture syndrome DOID_9808 1.903E-03 0.01406538 0.06263165 0.28283658 TSAI_RESPONSE_TO_IONIZING_RADIATION ulcerative colitis DOID_8577 2.531E-03 0.01846029 0.02991125 0.18910556 TSAI_RESPONSE_TO_IONIZING_RADIATION vitiligo DOID_12306 2.589E-03 0.01864466 0.07268575 0.30635697 TSAI_RESPONSE_TO_IONIZING_RADIATION middle cerebral artery infarction DOID_3525 2.589E-03 0.01841161 0.07268575 0.29969704 TSAI_RESPONSE_TO_IONIZING_RADIATION diffuse large B-cell lymphoma DOID_0050745 2.776E-03 0.01949712 0.07518254 0.30776164 TSAI_RESPONSE_TO_IONIZING_RADIATION lung adenocarcinoma DOID_3910 2.776E-03 0.01925935 2.776E-03 0.04268288 TSAI_RESPONSE_TO_IONIZING_RADIATION periodontitis DOID_824 2.776E-03 0.01902731 0.07518254 0.30556334 TSAI_RESPONSE_TO_IONIZING_RADIATION perinatal necrotizing enterocolitis DOID_8677 2.776E-03 0.01880079 2.776E-03 0.04155965 TSAI_RESPONSE_TO_IONIZING_RADIATION autoimmune disease of cardiovascular system DOID_0060051 2.969E-03 0.01987191 0.07767268 0.31344507 TSAI_RESPONSE_TO_IONIZING_RADIATION sarcoma DOID_1115 2.969E-03 0.01964084 2.969E-03 0.04331057 TSAI_RESPONSE_TO_IONIZING_RADIATION malaria DOID_12365 2.969E-03 0.01941508 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION Behcet's disease DOID_13241 2.969E-03 0.01987191 0.07767268 0.31344507 TSAI_RESPONSE_TO_IONIZING_RADIATION invasive ductal carcinoma DOID_3008 2.969E-03 0.01919445 0.07767268 0.30691497 TSAI_RESPONSE_TO_IONIZING_RADIATION focal glomerulosclerosis DOID_3945 3.168E-03 0.02025219 0.08015618 0.31026439 TSAI_RESPONSE_TO_IONIZING_RADIATION female reproductive organ benign neoplasm DOID_0060086 3.373E-03 0.02132496 0.08263306 0.3176906 TSAI_RESPONSE_TO_IONIZING_RADIATION uterine benign neoplasm DOID_0060095 3.373E-03 0.02132496 0.08263306 0.3176906 TSAI_RESPONSE_TO_IONIZING_RADIATION uterine fibroid DOID_13223 3.373E-03 0.02132496 0.08263306 0.3176906 TSAI_RESPONSE_TO_IONIZING_RADIATION opportunistic mycosis DOID_2473 3.584E-03 0.02241207 0.08510333 0.32068737 TSAI_RESPONSE_TO_IONIZING_RADIATION leiomyoma DOID_127 4.025E-03 0.02489427 0.09002413 0.32835723 TSAI_RESPONSE_TO_IONIZING_RADIATION pleural disease DOID_1532 4.025E-03 0.02462659 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION autonomic nervous system neoplasm DOID_2621 4.025E-03 0.0243646 4.025E-03 0.05586031 TSAI_RESPONSE_TO_IONIZING_RADIATION neuroblastoma DOID_769 4.025E-03 0.0243646 4.025E-03 0.05586031 TSAI_RESPONSE_TO_IONIZING_RADIATION systemic mycosis DOID_0050136 4.254E-03 0.02548167 0.09247469 0.33514713 TSAI_RESPONSE_TO_IONIZING_RADIATION fungal infectious disease DOID_1564 4.254E-03 0.02548167 0.09247469 0.33514713 TSAI_RESPONSE_TO_IONIZING_RADIATION hyperthyroidism DOID_7998 4.49E-03 0.02661061 0.09491872 0.33338735 TSAI_RESPONSE_TO_IONIZING_RADIATION medullomyoblastoma DOID_3861 4.731E-03 0.02775085 4.731E-03 0.06117802 TSAI_RESPONSE_TO_IONIZING_RADIATION adult medulloblastoma DOID_3864 4.731E-03 0.02775085 4.731E-03 0.06117802 TSAI_RESPONSE_TO_IONIZING_RADIATION childhood medulloblastoma DOID_3869 4.731E-03 0.02775085 4.731E-03 0.06117802 TSAI_RESPONSE_TO_IONIZING_RADIATION calcinosis DOID_182 5.231E-03 0.03036993 5.231E-03 0.06613895 TSAI_RESPONSE_TO_IONIZING_RADIATION medulloblastoma DOID_3858 5.231E-03 0.03006316 5.231E-03 0.06470115 TSAI_RESPONSE_TO_IONIZING_RADIATION peripheral nervous system neoplasm DOID_1192 5.489E-03 0.03123421 5.489E-03 0.06645577 TSAI_RESPONSE_TO_IONIZING_RADIATION blood platelet disease DOID_2218 5.489E-03 0.03092496 5.489E-03 0.06507127 TSAI_RESPONSE_TO_IONIZING_RADIATION adult respiratory distress syndrome DOID_11394 6.024E-03 0.03360374 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION intracranial arterial disease DOID_13089 6.024E-03 0.03327749 0.10944662 0.36849188 TSAI_RESPONSE_TO_IONIZING_RADIATION cerebral arterial disease DOID_3527 6.024E-03 0.03327749 0.10944662 0.36849188 TSAI_RESPONSE_TO_IONIZING_RADIATION lymphatic system disease DOID_75 6.024E-03 0.03295752 0.10944662 0.36632428 TSAI_RESPONSE_TO_IONIZING_RADIATION endometriosis of uterus DOID_288 6.581E-03 0.03566399 0.11423775 0.38012446 TSAI_RESPONSE_TO_IONIZING_RADIATION nephrotic syndrome DOID_1184 6.868E-03 0.03686895 6.868E-03 0.07662959 TSAI_RESPONSE_TO_IONIZING_RADIATION primitive neuroectodermal tumor DOID_168 6.868E-03 0.03652438 6.868E-03 0.0737379 TSAI_RESPONSE_TO_IONIZING_RADIATION endometriosis DOID_289 6.868E-03 0.03618619 0.11662374 0.38357751 TSAI_RESPONSE_TO_IONIZING_RADIATION influenza DOID_8469 7.161E-03 0.03738246 7.161E-03 0.07545719 TSAI_RESPONSE_TO_IONIZING_RADIATION cerebral infarction DOID_3526 7.459E-03 0.03858581 0.12137664 0.39018817 TSAI_RESPONSE_TO_IONIZING_RADIATION brain cancer DOID_1319 8.073E-03 0.04138185 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION bone marrow disease DOID_4961 8.073E-03 0.04101237 8.073E-03 0.0835161 TSAI_RESPONSE_TO_IONIZING_RADIATION central nervous system cancer DOID_3620 8.388E-03 0.04223491 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION calcium metabolism disease DOID_10575 9.034E-03 0.04508901 9.034E-03 0.09178835 TSAI_RESPONSE_TO_IONIZING_RADIATION hemorrhagic disease DOID_2213 9.365E-03 0.04633527 9.365E-03 0.09187165 TSAI_RESPONSE_TO_IONIZING_RADIATION atrophic muscular disease DOID_913 0.01004305 0.04926291 0.01004305 0.09685589 TSAI_RESPONSE_TO_IONIZING_RADIATION muscular dystrophy DOID_9884 0.01004305 0.04926291 0.01004305 0.09685589 TSAI_RESPONSE_TO_IONIZING_RADIATION vasculitis DOID_865 0.01039015 0.05052989 0.14245322 0.4405211 TSAI_RESPONSE_TO_IONIZING_RADIATION hypersensitivity reaction type IV disease DOID_2916 0.01183089 0.05704897 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION oral cavity cancer DOID_8618 0.01183089 0.05656957 0.01183089 0.10857707 TSAI_RESPONSE_TO_IONIZING_RADIATION neuroectodermal tumor DOID_171 0.01296557 0.06147843 0.01296557 0.11710176 TSAI_RESPONSE_TO_IONIZING_RADIATION respiratory failure DOID_11162 0.01335395 0.06279668 1.000 1.000 TSAI_RESPONSE_TO_IONIZING_RADIATION hypothyroidism DOID_1459 0.01335395 0.06228195 0.16076721 0.47644032 TSAI_RESPONSE_TO_IONIZING_RADIATION mineral metabolism disease DOID_0050032 0.01414575 0.06543849 0.01414575 0.12382975 TSAI_RESPONSE_TO_IONIZING_RADIATION endocrine organ benign neoplasm DOID_0060089 0.01578874 0.07244995 0.01578874 0.13211461 TSAI_RESPONSE_TO_IONIZING_RADIATION brain infarction DOID_3454 0.01578874 0.07187035 0.17424804 0.51106772 TSAI_RESPONSE_TO_IONIZING_RADIATION tuberculosis DOID_399 0.01578874 0.07129995 0.17424804 0.50844686 TSAI_RESPONSE_TO_IONIZING_RADIATION blood coagulation disease DOID_1247 0.01663946 0.07455003 0.01663946 0.13721527 TSAI_RESPONSE_TO_IONIZING_RADIATION male reproductive system disease DOID_48 0.01707203 0.07589051 0.18090783 0.5251865 TSAI_RESPONSE_TO_IONIZING_RADIATION peripheral vascular disease DOID_341 0.01750936 0.07723123 0.18311592 0.52889825 TSAI_RESPONSE_TO_IONIZING_RADIATION alcohol abuse DOID_1574 0.02213872 0.09689946 0.20487516 0.57144101 TSAI_RESPONSE_TO_IONIZING_RADIATION mental depression DOID_1596 0.02213872 0.09615977 0.02213872 0.16795906 ZHAN_LATE_DIFFERENTIATION_GENES_UP giant cell tumor DOID_200 6.861E-06 3.904E-03 6.29E-04 0.11930649 ZHAN_LATE_DIFFERENTIATION_GENES_UP malignant giant cell tumor DOID_2705 6.861E-06 3.904E-03 6.29E-04 0.11930649 ZHAN_LATE_DIFFERENTIATION_GENES_UP giant cell glioblastoma DOID_3074 6.861E-06 3.904E-03 6.29E-04 0.11930649 ZHAN_LATE_DIFFERENTIATION_GENES_UP glioblastoma DOID_3068 8.889E-06 2.529E-03 7.46E-04 0.10611548 ZHAN_LATE_DIFFERENTIATION_GENES_UP allergic contact dermatitis DOID_3042 1.347E-05 2.554E-03 9.809E-04 0.11162374 ZHAN_LATE_DIFFERENTIATION_GENES_UP astrocytoma DOID_3069 1.466E-05 2.085E-03 1.037E-03 0.0983713 ZHAN_LATE_DIFFERENTIATION_GENES_UP progressive muscular atrophy DOID_318 1.873E-05 2.131E-03 6.576E-03 0.37415369 ZHAN_LATE_DIFFERENTIATION_GENES_UP contact dermatitis DOID_2773 2.167E-05 2.055E-03 1.342E-03 0.10911306 ZHAN_LATE_DIFFERENTIATION_GENES_UP open-angle glaucoma DOID_1067 3.781E-05 3.073E-03 3.781E-05 0.02151186 ZHAN_LATE_DIFFERENTIATION_GENES_UP muscular atrophy DOID_767 9.566E-05 6.804E-03 0.01441161 0.41001043 ZHAN_LATE_DIFFERENTIATION_GENES_UP spinal muscular atrophy DOID_12377 1.451E-04 9.171E-03 0.01765906 0.40192027 ZHAN_LATE_DIFFERENTIATION_GENES_UP papillary adenoma DOID_3172 1.451E-04 8.254E-03 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP microcystic adenoma DOID_5403 1.451E-04 8.254E-03 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP follicular adenoma DOID_6204 1.451E-04 8.254E-03 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP spinal cord disease DOID_319 1.562E-04 8.078E-03 0.01830732 0.38580979 ZHAN_LATE_DIFFERENTIATION_GENES_UP female reproductive organ benign neoplasm DOID_0060086 2.046E-04 9.7E-03 0.02089624 0.34970468 ZHAN_LATE_DIFFERENTIATION_GENES_UP uterine benign neoplasm DOID_0060095 2.046E-04 9.7E-03 0.02089624 0.34970468 ZHAN_LATE_DIFFERENTIATION_GENES_UP corneal disease DOID_10124 2.046E-04 8.954E-03 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP uterine fibroid DOID_13223 2.046E-04 9.7E-03 0.02089624 0.34970468 ZHAN_LATE_DIFFERENTIATION_GENES_UP leiomyoma DOID_127 2.451E-04 9.962E-03 0.02283362 0.34190347 ZHAN_LATE_DIFFERENTIATION_GENES_UP papilloma DOID_2615 2.594E-04 9.841E-03 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP adenoma DOID_657 3.048E-04 0.01083791 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP thyroid adenoma DOID_2891 5.016E-04 0.01678821 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP glaucoma DOID_1686 5.425E-04 0.01714894 5.425E-04 0.15434046 ZHAN_LATE_DIFFERENTIATION_GENES_UP reproductive organ benign neoplasm DOID_0050622 6.746E-04 0.0202038 0.03756514 0.38168864 ZHAN_LATE_DIFFERENTIATION_GENES_UP hypertrophic cardiomyopathy DOID_11984 7.46E-04 0.0212231 0.03947085 0.39401602 ZHAN_LATE_DIFFERENTIATION_GENES_UP carotid artery disease DOID_3407 8.208E-04 0.0222399 0.04137294 0.38592133 ZHAN_LATE_DIFFERENTIATION_GENES_UP endocrine organ benign neoplasm DOID_0060089 1.009E-03 0.02609383 1.000 1.000 ZHAN_LATE_DIFFERENTIATION_GENES_UP pancreatic ductal carcinoma DOID_3587 1.066E-03 0.0263743 0.04705753 0.40569294 ZHAN_LATE_DIFFERENTIATION_GENES_UP pancreatic carcinoma DOID_4905 1.155E-03 0.02737734 0.04894519 0.40955608 ZHAN_LATE_DIFFERENTIATION_GENES_UP chronic kidney failure DOID_784 1.441E-03 0.0328026 0.05458666 0.43138627 ZHAN_LATE_DIFFERENTIATION_GENES_UP transitional cell carcinoma DOID_2671 1.614E-03 0.03531288 0.05770692 0.44371942 ZHAN_LATE_DIFFERENTIATION_GENES_UP lymphoblastic leukemia DOID_1037 1.795E-03 0.03783429 1.795E-03 0.12769074 ZHAN_LATE_DIFFERENTIATION_GENES_UP encephalomyelitis DOID_640 1.795E-03 0.03648307 1.795E-03 0.11350288 ZHAN_LATE_DIFFERENTIATION_GENES_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.833E-03 0.03595999 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 colon carcinoma DOID_1520 3.237E-06 1.842E-03 0.02862596 0.7403715 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 metabolic syndrome X DOID_14221 6.374E-06 1.813E-03 0.11234903 0.9988531 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 chronic kidney failure DOID_784 7.355E-06 1.395E-03 0.1162152 0.95835435 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 transitional cell carcinoma DOID_2671 9.232E-06 1.313E-03 0.12262211 0.96905532 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 nephroblastoma DOID_2154 2.168E-05 2.467E-03 0.05232425 0.82701377 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 cleft palate DOID_674 2.748E-05 2.606E-03 0.05644696 0.74693767 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 cataract DOID_83 4.771E-05 3.878E-03 2.233E-03 0.2541562 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 leukodystrophy DOID_10579 5.077E-05 3.611E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 lens disease DOID_110 5.396E-05 3.411E-03 2.421E-03 0.22958324 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 integumentary system benign neoplasm DOID_0060121 6.071E-05 3.455E-03 2.616E-03 0.18603847 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 skin benign neoplasm DOID_3165 6.071E-05 3.455E-03 2.616E-03 0.18603847 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 orofacial cleft DOID_0050567 7.185E-05 3.717E-03 0.07679784 0.84034561 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 osteochondrodysplasia DOID_2256 8.425E-05 3.995E-03 0.08081599 0.85156112 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 Diamond-Blackfan anemia DOID_1339 9.23E-05 4.04E-03 9.23E-05 0.05251985 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 breast benign neoplasm DOID_0060082 1.127E-04 4.581E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 thoracic benign neoplasm DOID_0060097 1.127E-04 4.581E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 benign breast phyllodes tumor DOID_1631 1.127E-04 4.581E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 pre-malignant neoplasm DOID_0060071 1.239E-04 4.701E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 in situ carcinoma DOID_8719 1.239E-04 4.701E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 cerebral degeneration DOID_1443 1.354E-04 4.816E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 parasitic helminthiasis infectious disease DOID_883 1.86E-04 6.224E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 bone development disease DOID_0080006 2.715E-04 8.583E-03 0.11750025 0.95510917 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 infertility DOID_5223 3.478E-04 0.01041629 3.478E-04 0.09895473 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 lymphoma DOID_0060058 3.527E-04 0.0100348 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 hypoglycemia DOID_9993 5.127E-04 0.01389168 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 Lewy body dementia DOID_12217 5.588E-04 0.01445226 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 meningitis DOID_9471 5.588E-04 0.0138239 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 cleft lip DOID_9296 7.087E-04 0.01680092 0.03845373 0.841545 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 congenital hypoplastic anemia DOID_1342 7.625E-04 0.01735341 7.625E-04 0.14461177 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 multiple epiphyseal dysplasia DOID_12721 9.353E-04 0.0204692 0.04402569 0.83502059 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 endometrial carcinoma DOID_2871 9.968E-04 0.02100562 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 endometrial cancer DOID_1380 1.125E-03 0.0228673 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 metal metabolism disorder DOID_896 1.261E-03 0.02474829 0.05094608 0.82823773 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 thyroid carcinoma DOID_3963 1.332E-03 0.0252669 0.05232425 0.80466205 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 aplastic anemia DOID_12449 1.405E-03 0.0257863 1.405E-03 0.19984381 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 thyroid cancer DOID_1781 1.479E-03 0.02630632 0.05507468 0.78343735 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 uterine cancer DOID_363 2.142E-03 0.03693827 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 pre-eclampsia DOID_10591 2.421E-03 0.04051469 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 thyroid adenoma DOID_2891 2.421E-03 0.03935713 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 bone marrow disease DOID_4961 2.421E-03 0.03826387 2.421E-03 0.19678563 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 lung small cell carcinoma DOID_5409 2.616E-03 0.04022453 2.616E-03 0.16536753 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 B-cell lymphocytic neoplasm DOID_707 2.818E-03 0.04218901 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 integumentary system cancer DOID_0060122 3.243E-03 0.0473086 3.243E-03 0.18450353 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 skin cancer DOID_4159 3.243E-03 0.0473086 3.243E-03 0.18450353 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 carotid artery disease DOID_3407 3.933E-03 0.05594309 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 endocrine pancreas disease DOID_1428 4.301E-03 0.05969161 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 parasitic infectious disease DOID_1398 4.427E-03 0.05998055 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 endocrine organ benign neoplasm DOID_0060089 4.816E-03 0.06373192 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 diabetic retinopathy DOID_8947 5.498E-03 0.07110178 0.1045668 0.97538543 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 pancreatitis DOID_4989 6.074E-03 0.07679889 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 chromosomal disease DOID_0080014 6.523E-03 0.08068244 0.1136396 0.99478354 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 retinal vascular disease DOID_2462 7.144E-03 0.08648842 0.11878346 0.95194069 HOSHIDA_LIVER_CANCER_SUBCLASS_S2 encephalomyelitis DOID_640 8.464E-03 0.09828378 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP tuberculosis DOID_399 3.825E-31 2.177E-28 0.03889302 0.38824783 MCLACHLAN_DENTAL_CARIES_UP contact dermatitis DOID_2773 1.012E-29 2.879E-27 9.256E-19 5.266E-16 MCLACHLAN_DENTAL_CARIES_UP primary bacterial infectious disease DOID_0050338 6.299E-29 1.195E-26 0.05826722 0.46695843 MCLACHLAN_DENTAL_CARIES_UP hypersensitivity reaction type I disease DOID_1205 4.201E-28 5.976E-26 8.949E-04 0.03637221 MCLACHLAN_DENTAL_CARIES_UP allergic contact dermatitis DOID_3042 2.585E-27 2.942E-25 5.156E-18 1.467E-15 MCLACHLAN_DENTAL_CARIES_UP primary immunodeficiency disease DOID_612 7.343E-27 6.963E-25 7.765E-15 1.473E-12 MCLACHLAN_DENTAL_CARIES_UP aneurysm disease DOID_2403 2.967E-26 2.412E-24 5.11E-03 0.11630277 MCLACHLAN_DENTAL_CARIES_UP parasitic infectious disease DOID_1398 1.278E-25 9.089E-24 2.321E-04 0.01200497 MCLACHLAN_DENTAL_CARIES_UP pulmonary tuberculosis DOID_2957 8.502E-24 5.375E-22 0.20415043 0.79562735 MCLACHLAN_DENTAL_CARIES_UP sarcoidosis DOID_11335 3.038E-23 1.729E-21 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP parasitic protozoa infectious disease DOID_2789 5.519E-23 2.855E-21 2.132E-03 0.06384546 MCLACHLAN_DENTAL_CARIES_UP hypersensitivity reaction type IV disease DOID_2916 1.294E-22 6.136E-21 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP bacterial pneumonia DOID_874 1.134E-20 4.962E-19 0.29631915 0.99179763 MCLACHLAN_DENTAL_CARIES_UP carotid artery disease DOID_3407 2.155E-20 8.76E-19 3.911E-07 3.179E-05 MCLACHLAN_DENTAL_CARIES_UP brain infarction DOID_3454 1.056E-19 4.006E-18 0.03889302 0.39518082 MCLACHLAN_DENTAL_CARIES_UP encephalomyelitis DOID_640 1.783E-19 6.34E-18 8.501E-03 0.13820314 MCLACHLAN_DENTAL_CARIES_UP collagen disease DOID_854 1.46E-18 4.886E-17 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP pleural disease DOID_1532 3.087E-18 9.76E-17 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP aortic aneurysm DOID_3627 7.574E-18 2.268E-16 0.02269361 0.24832049 MCLACHLAN_DENTAL_CARIES_UP chronic kidney failure DOID_784 7.586E-17 2.158E-15 0.31162359 1.000 MCLACHLAN_DENTAL_CARIES_UP rheumatic disease DOID_1575 9.473E-17 2.567E-15 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP scleroderma DOID_419 9.473E-17 2.567E-15 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP proteinuria DOID_576 2.046E-16 5.291E-15 0.19358985 0.78680445 MCLACHLAN_DENTAL_CARIES_UP peripheral vascular disease DOID_341 6.828E-16 1.689E-14 0.04294521 0.40058733 MCLACHLAN_DENTAL_CARIES_UP cystic fibrosis DOID_1485 1.122E-15 2.661E-14 0.04608311 0.42292401 MCLACHLAN_DENTAL_CARIES_UP vasculitis DOID_865 1.257E-15 2.861E-14 1.169E-04 7.388E-03 MCLACHLAN_DENTAL_CARIES_UP urticaria DOID_1555 1.393E-15 3.048E-14 5.781E-03 0.12182022 MCLACHLAN_DENTAL_CARIES_UP systemic scleroderma DOID_418 2.568E-15 5.411E-14 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP B cell deficiency DOID_2115 3.056E-15 6.21E-14 2.239E-09 3.184E-07 MCLACHLAN_DENTAL_CARIES_UP pleurisy DOID_10247 6.283E-15 1.233E-13 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP agammaglobulinemia DOID_2583 8.267E-15 1.568E-13 1.676E-08 1.908E-06 MCLACHLAN_DENTAL_CARIES_UP influenza DOID_8469 8.868E-15 1.628E-13 0.1864722 0.77447212 MCLACHLAN_DENTAL_CARIES_UP Human immunodeficiency virus infectious disease DOID_526 8.896E-15 1.582E-13 7.787E-03 0.13030948 MCLACHLAN_DENTAL_CARIES_UP cerebral infarction DOID_3526 1.116E-14 1.924E-13 0.01884216 0.23306927 MCLACHLAN_DENTAL_CARIES_UP blood protein disease DOID_620 1.373E-14 2.297E-13 2.227E-08 2.112E-06 MCLACHLAN_DENTAL_CARIES_UP abdominal aortic aneurysm DOID_7693 1.675E-14 2.723E-13 0.13486947 0.68518509 MCLACHLAN_DENTAL_CARIES_UP vascular skin disease DOID_9540 1.74E-14 2.75E-13 0.02034649 0.24119064 MCLACHLAN_DENTAL_CARIES_UP ulcerative colitis DOID_8577 2.499E-14 3.843E-13 9.775E-03 0.14636899 MCLACHLAN_DENTAL_CARIES_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.659E-14 3.982E-13 0.02189931 0.24921417 MCLACHLAN_DENTAL_CARIES_UP funisitis DOID_0050698 3.459E-14 5.047E-13 1.194E-04 6.795E-03 MCLACHLAN_DENTAL_CARIES_UP esophageal disease DOID_6050 5.322E-14 7.571E-13 0.14993637 0.70507268 MCLACHLAN_DENTAL_CARIES_UP pancreatitis DOID_4989 6.548E-14 9.087E-13 0.29631915 0.99766625 MCLACHLAN_DENTAL_CARIES_UP metabolic syndrome X DOID_14221 8.685E-14 1.177E-12 0.0503935 0.44802968 MCLACHLAN_DENTAL_CARIES_UP myositis DOID_633 2.357E-13 3.119E-12 0.11177003 0.6296747 MCLACHLAN_DENTAL_CARIES_UP adult respiratory distress syndrome DOID_11394 2.359E-13 3.051E-12 0.17204903 0.75888292 MCLACHLAN_DENTAL_CARIES_UP intracranial arterial disease DOID_13089 2.359E-13 2.983E-12 0.17204903 0.75304536 MCLACHLAN_DENTAL_CARIES_UP cerebral arterial disease DOID_3527 2.359E-13 2.983E-12 0.17204903 0.75304536 MCLACHLAN_DENTAL_CARIES_UP respiratory failure DOID_11162 2.866E-13 3.545E-12 0.24834698 0.8943635 MCLACHLAN_DENTAL_CARIES_UP middle cerebral artery infarction DOID_3525 3.288E-13 3.981E-12 0.11566207 0.63280498 MCLACHLAN_DENTAL_CARIES_UP endometriosis of uterus DOID_288 3.68E-13 4.362E-12 0.0166787 0.22070188 MCLACHLAN_DENTAL_CARIES_UP endometriosis DOID_289 4.558E-13 5.292E-12 0.01738728 0.2248492 MCLACHLAN_DENTAL_CARIES_UP uterine disease DOID_345 4.603E-13 5.238E-12 0.0359562 0.3719832 MCLACHLAN_DENTAL_CARIES_UP mouth disease DOID_403 5.19E-13 5.79E-12 0.34413861 1.000 MCLACHLAN_DENTAL_CARIES_UP prion disease DOID_649 8.302E-13 9.084E-12 0.07596653 0.52078263 MCLACHLAN_DENTAL_CARIES_UP pre-eclampsia DOID_10591 1.021E-12 1.096E-11 0.19712543 0.78988991 MCLACHLAN_DENTAL_CARIES_UP bronchiolitis obliterans DOID_2799 1.442E-12 1.519E-11 9.205E-03 0.14155766 MCLACHLAN_DENTAL_CARIES_UP calcium metabolism disease DOID_10575 1.786E-12 1.848E-11 0.20763998 0.8037221 MCLACHLAN_DENTAL_CARIES_UP female reproductive system disease DOID_229 3.64E-12 3.699E-11 0.05149304 0.43087555 MCLACHLAN_DENTAL_CARIES_UP pneumoconiosis DOID_10316 3.95E-12 3.943E-11 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP pulmonary sarcoidosis DOID_13406 7.781E-12 7.634E-11 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP calcinosis DOID_182 7.781E-12 7.504E-11 0.16106511 0.74508983 MCLACHLAN_DENTAL_CARIES_UP mineral metabolism disease DOID_0050032 1.635E-11 1.551E-10 0.2549264 0.90095108 MCLACHLAN_DENTAL_CARIES_UP pulmonary emphysema DOID_9675 1.767E-11 1.648E-10 0.17567847 0.7572807 MCLACHLAN_DENTAL_CARIES_UP cholestasis DOID_13580 1.878E-11 1.723E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP periodontitis DOID_824 3.91E-11 3.532E-10 0.11953716 0.64166646 MCLACHLAN_DENTAL_CARIES_UP bile duct disease DOID_4138 4.118E-11 3.662E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP biliary tract disease DOID_9741 4.663E-11 4.082E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP malaria DOID_12365 5.081E-11 4.381E-10 7.649E-03 0.13188696 MCLACHLAN_DENTAL_CARIES_UP heart valve disease DOID_4079 5.235E-11 4.445E-10 0.19712543 0.77891922 MCLACHLAN_DENTAL_CARIES_UP diabetic retinopathy DOID_8947 5.269E-11 4.409E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP celiac disease DOID_10608 1.323E-10 1.091E-09 0.1386609 0.69821285 MCLACHLAN_DENTAL_CARIES_UP giant cell tumor DOID_200 1.354E-10 1.101E-09 0.21801765 0.82701363 MCLACHLAN_DENTAL_CARIES_UP malignant giant cell tumor DOID_2705 1.354E-10 1.101E-09 0.21801765 0.82701363 MCLACHLAN_DENTAL_CARIES_UP giant cell glioblastoma DOID_3074 1.354E-10 1.101E-09 0.21801765 0.82701363 MCLACHLAN_DENTAL_CARIES_UP leishmaniasis DOID_9065 1.666E-10 1.335E-09 0.0800145 0.52939826 MCLACHLAN_DENTAL_CARIES_UP pustulosis of palm and sole DOID_4398 1.814E-10 1.434E-09 0.22486093 0.83624752 MCLACHLAN_DENTAL_CARIES_UP retinal vascular disease DOID_2462 1.821E-10 1.419E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP systemic mycosis DOID_0050136 2.038E-10 1.567E-09 0.0108895 0.15490318 MCLACHLAN_DENTAL_CARIES_UP fungal infectious disease DOID_1564 2.038E-10 1.567E-09 0.0108895 0.15490318 MCLACHLAN_DENTAL_CARIES_UP periodontal disease DOID_3388 2.505E-10 1.9E-09 0.14993637 0.72299825 MCLACHLAN_DENTAL_CARIES_UP glioblastoma DOID_3068 2.756E-10 2.064E-09 0.23501439 0.85719994 MCLACHLAN_DENTAL_CARIES_UP leukocyte disease DOID_9500 3.153E-10 2.33E-09 0.03035801 0.31988345 MCLACHLAN_DENTAL_CARIES_UP autoimmune hepatitis DOID_2048 3.307E-10 2.413E-09 0.08805763 0.56297516 MCLACHLAN_DENTAL_CARIES_UP Crohn's disease DOID_8778 4.451E-10 3.206E-09 0.06653417 0.49166158 MCLACHLAN_DENTAL_CARIES_UP multiple myeloma DOID_9538 4.486E-10 3.19E-09 0.16106511 0.73316839 MCLACHLAN_DENTAL_CARIES_UP uveitis DOID_13141 5.389E-10 3.786E-09 0.16474242 0.73809791 MCLACHLAN_DENTAL_CARIES_UP peptic ulcer DOID_750 6.444E-10 4.471E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP temporal arteritis DOID_13375 6.852E-10 4.697E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP central nervous system vasculitis DOID_525 6.852E-10 4.697E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hyperglycemia DOID_4195 7.598E-10 5.147E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP astrocytoma DOID_3069 1.076E-09 7.2E-09 0.27112558 0.94644452 MCLACHLAN_DENTAL_CARIES_UP common cold DOID_10459 1.171E-09 7.744E-09 0.05130427 0.44910964 MCLACHLAN_DENTAL_CARIES_UP encephalitis DOID_9588 1.171E-09 7.655E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP uveal disease DOID_3480 1.26E-09 8.145E-09 0.18288999 0.77084744 MCLACHLAN_DENTAL_CARIES_UP ankylosing spondylitis DOID_7147 1.765E-09 1.129E-08 0.11177003 0.62350142 MCLACHLAN_DENTAL_CARIES_UP intracranial aneurysm DOID_10941 2.239E-09 1.415E-08 0.11566207 0.63894872 MCLACHLAN_DENTAL_CARIES_UP myeloma DOID_0070004 2.317E-09 1.448E-08 0.19712543 0.79549197 MCLACHLAN_DENTAL_CARIES_UP neuritis DOID_1803 2.317E-09 1.433E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP autoimmune disease of the nervous system DOID_438 3.503E-09 2.143E-08 0.12339537 0.65011082 MCLACHLAN_DENTAL_CARIES_UP biliary tract cancer DOID_4607 4.121E-09 2.495E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP autoimmune disease of endocrine system DOID_0060005 4.328E-09 2.592E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP varicose veins DOID_799 4.391E-09 2.603E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP atopic dermatitis DOID_3310 4.621E-09 2.711E-08 1.83E-03 0.0612548 MCLACHLAN_DENTAL_CARIES_UP bone marrow cancer DOID_4960 5.976E-09 3.47E-08 0.22144677 0.82896849 MCLACHLAN_DENTAL_CARIES_UP hemolytic-uremic syndrome DOID_12554 6.365E-09 3.658E-08 2.197E-03 0.0624906 MCLACHLAN_DENTAL_CARIES_UP thyroiditis DOID_7166 6.365E-09 3.622E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP autoimmune thyroiditis DOID_7188 6.365E-09 3.622E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP vein disease DOID_866 6.365E-09 3.586E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP opportunistic mycosis DOID_2473 6.463E-09 3.605E-08 9.205E-03 0.14548982 MCLACHLAN_DENTAL_CARIES_UP chronic leukemia DOID_1036 9.404E-09 5.195E-08 4.868E-04 0.02308137 MCLACHLAN_DENTAL_CARIES_UP chronic lymphocytic leukemia DOID_1040 9.404E-09 5.195E-08 4.868E-04 0.02308137 MCLACHLAN_DENTAL_CARIES_UP lymphoblastic leukemia DOID_1037 1.003E-08 5.488E-08 6.387E-05 4.543E-03 MCLACHLAN_DENTAL_CARIES_UP myocarditis DOID_820 1.124E-08 6.093E-08 5.293E-04 0.0231683 MCLACHLAN_DENTAL_CARIES_UP membranous glomerulonephritis DOID_10976 2.227E-08 1.196E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP esophagitis DOID_11963 2.227E-08 1.184E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP tooth disease DOID_1091 2.583E-08 1.361E-07 0.26468835 0.92967699 MCLACHLAN_DENTAL_CARIES_UP endocrine organ benign neoplasm DOID_0060089 2.856E-08 1.491E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP mitochondrial myopathy DOID_699 2.913E-08 1.507E-07 0.08805763 0.55671988 MCLACHLAN_DENTAL_CARIES_UP hepatitis B DOID_2043 3.756E-08 1.926E-07 0.09205294 0.57558377 MCLACHLAN_DENTAL_CARIES_UP nephrosis DOID_2527 3.822E-08 1.942E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP male reproductive system disease DOID_48 3.822E-08 1.924E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP sinusitis DOID_0050127 4.783E-08 2.387E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP paranasal sinus disease DOID_1352 4.783E-08 2.387E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP IgA glomerulonephritis DOID_2986 4.783E-08 2.367E-07 4.539E-03 0.10760776 MCLACHLAN_DENTAL_CARIES_UP myasthenia gravis DOID_437 4.783E-08 2.346E-07 0.09603086 0.58129316 MCLACHLAN_DENTAL_CARIES_UP diabetic autonomic neuropathy DOID_11503 5.956E-08 2.897E-07 0.01810848 0.22897162 MCLACHLAN_DENTAL_CARIES_UP autonomic neuropathy DOID_11504 5.956E-08 2.897E-07 0.01810848 0.22897162 MCLACHLAN_DENTAL_CARIES_UP diabetic polyneuropathy DOID_12785 5.956E-08 2.897E-07 0.01810848 0.22897162 MCLACHLAN_DENTAL_CARIES_UP diabetic neuropathy DOID_9743 5.956E-08 2.897E-07 0.01810848 0.22897162 MCLACHLAN_DENTAL_CARIES_UP meningitis DOID_9471 6.02E-08 2.903E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Goodpasture syndrome DOID_9808 6.02E-08 2.879E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Sjogren's syndrome DOID_12894 7.293E-08 3.458E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP phagocyte bactericidal dysfunction DOID_3262 7.293E-08 3.43E-07 0.04293898 0.41410645 MCLACHLAN_DENTAL_CARIES_UP cutaneous leishmaniasis DOID_9111 7.293E-08 3.402E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP toxic shock syndrome DOID_14115 7.499E-08 3.469E-07 0.10393479 0.61603015 MCLACHLAN_DENTAL_CARIES_UP autonomic nervous system disease DOID_11465 8.72E-08 4.001E-07 0.02034649 0.24632235 MCLACHLAN_DENTAL_CARIES_UP commensal bacterial infectious disease DOID_0050339 9.251E-08 4.211E-07 0.10786096 0.62625393 MCLACHLAN_DENTAL_CARIES_UP bronchiolitis DOID_2942 9.251E-08 4.178E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hemolytic anemia DOID_583 9.847E-08 4.412E-07 0.0211169 0.24521458 MCLACHLAN_DENTAL_CARIES_UP normocytic anemia DOID_720 9.847E-08 4.412E-07 0.0211169 0.24521458 MCLACHLAN_DENTAL_CARIES_UP cystitis DOID_1679 1.131E-07 5.029E-07 6.225E-03 0.12214197 MCLACHLAN_DENTAL_CARIES_UP neuromuscular junction disease DOID_439 1.131E-07 4.99E-07 0.11177003 0.63597145 MCLACHLAN_DENTAL_CARIES_UP common variable immunodeficiency DOID_12177 1.142E-07 4.999E-07 0.04713075 0.42567295 MCLACHLAN_DENTAL_CARIES_UP bronchiectasis DOID_9563 1.142E-07 4.961E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP vitiligo DOID_12306 1.372E-07 5.916E-07 6.685E-03 0.12678937 MCLACHLAN_DENTAL_CARIES_UP extrinsic allergic alveolitis DOID_841 1.372E-07 5.872E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP transitional cell carcinoma DOID_2671 1.496E-07 6.354E-07 0.32659714 1.000 MCLACHLAN_DENTAL_CARIES_UP Sciatic Neuropathy DOID_11446 1.653E-07 6.965E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lesion of sciatic nerve DOID_12528 1.653E-07 6.965E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP mononeuritis of lower limb DOID_9473 1.653E-07 6.965E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP stomach disease DOID_76 1.707E-07 7.144E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP ocular hypertension DOID_9282 1.707E-07 7.091E-07 0.05130427 0.43570338 MCLACHLAN_DENTAL_CARIES_UP borderline glaucoma DOID_9283 1.707E-07 7.091E-07 0.05130427 0.43570338 MCLACHLAN_DENTAL_CARIES_UP mononeuritis DOID_1802 1.976E-07 8.148E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lymphoma DOID_0060058 2.02E-07 8.269E-07 0.06413388 0.4801602 MCLACHLAN_DENTAL_CARIES_UP integumentary system cancer DOID_0060122 2.158E-07 8.77E-07 0.02683931 0.28814277 MCLACHLAN_DENTAL_CARIES_UP skin cancer DOID_4159 2.158E-07 8.77E-07 0.02683931 0.28814277 MCLACHLAN_DENTAL_CARIES_UP mononeuropathy DOID_1188 2.348E-07 9.474E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP carotid stenosis DOID_13001 2.458E-07 9.849E-07 1.44E-03 0.05462788 MCLACHLAN_DENTAL_CARIES_UP polyneuropathy DOID_1389 2.458E-07 9.78E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP allergic rhinitis DOID_4481 3.804E-07 1.503E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP bladder disease DOID_365 4.423E-07 1.735E-06 0.01031394 0.1504777 MCLACHLAN_DENTAL_CARIES_UP idiopathic pulmonary fibrosis DOID_0050156 4.66E-07 1.816E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP adrenal cortex disease DOID_3952 4.66E-07 1.804E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP oral submucous fibrosis DOID_5773 4.66E-07 1.792E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP spindle cell carcinoma DOID_4015 5.897E-07 2.252E-06 0.14993637 0.71692264 MCLACHLAN_DENTAL_CARIES_UP Barrett's esophagus DOID_9206 6.193E-07 2.349E-06 0.06781742 0.48845709 MCLACHLAN_DENTAL_CARIES_UP adrenal gland disease DOID_9553 8.07E-07 3.041E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP respiratory syncytial virus infectious disease DOID_1273 1.131E-06 4.232E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hepatitis DOID_2237 1.131E-06 4.204E-06 0.1684037 0.74860707 MCLACHLAN_DENTAL_CARIES_UP bone resorption disease DOID_0080011 1.374E-06 5.075E-06 0.29321792 0.99310116 MCLACHLAN_DENTAL_CARIES_UP osteoporosis DOID_11476 1.374E-06 5.075E-06 0.29321792 0.99310116 MCLACHLAN_DENTAL_CARIES_UP brain edema DOID_4724 1.626E-06 5.969E-06 0.08404484 0.54967257 MCLACHLAN_DENTAL_CARIES_UP nephrotic syndrome DOID_1184 1.796E-06 6.551E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP gallbladder cancer DOID_3121 2.003E-06 7.259E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP thyroid adenoma DOID_2891 2.737E-06 9.858E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP uremia DOID_4676 2.942E-06 1.053E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP sleep disorder DOID_535 2.942E-06 1.046E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP integumentary system benign neoplasm DOID_0060121 3.334E-06 1.178E-05 0.02189931 0.24432762 MCLACHLAN_DENTAL_CARIES_UP glaucoma DOID_1686 3.334E-06 1.171E-05 0.20415043 0.80111443 MCLACHLAN_DENTAL_CARIES_UP skin benign neoplasm DOID_3165 3.334E-06 1.178E-05 0.02189931 0.24432762 MCLACHLAN_DENTAL_CARIES_UP nervous system cancer DOID_3093 3.362E-06 1.174E-05 0.3324955 1.000 MCLACHLAN_DENTAL_CARIES_UP acute pancreatitis DOID_2913 4.174E-06 1.448E-05 0.10393479 0.60967933 MCLACHLAN_DENTAL_CARIES_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.308E-06 1.486E-05 0.34413861 1.000 MCLACHLAN_DENTAL_CARIES_UP portal hypertension DOID_10762 4.916E-06 1.685E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP mitochondrial metabolism disease DOID_700 6.266E-06 2.135E-05 0.22826022 0.84337703 MCLACHLAN_DENTAL_CARIES_UP hypertrophic cardiomyopathy DOID_11984 7.393E-06 2.504E-05 0.23501439 0.86273026 MCLACHLAN_DENTAL_CARIES_UP bile duct cancer DOID_4606 7.393E-06 2.489E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP bile duct carcinoma DOID_4897 7.393E-06 2.489E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hepatic vascular disease DOID_272 8.889E-06 2.975E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hyperparathyroidism DOID_13543 9.673E-06 3.219E-05 0.04293898 0.42124622 MCLACHLAN_DENTAL_CARIES_UP angioedema DOID_1558 9.673E-06 3.2E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP pre-malignant neoplasm DOID_0060071 1.091E-05 3.589E-05 0.25164388 0.89490855 MCLACHLAN_DENTAL_CARIES_UP in situ carcinoma DOID_8719 1.091E-05 3.589E-05 0.25164388 0.89490855 MCLACHLAN_DENTAL_CARIES_UP endocrine pancreas disease DOID_1428 1.175E-05 3.843E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP spastic cerebral palsy DOID_0050669 1.314E-05 4.272E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP pneumocystosis DOID_11339 1.326E-05 4.286E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP prediabetes syndrome DOID_11716 1.326E-05 4.262E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP mitochondrial encephalomyopathy DOID_890 1.762E-05 5.632E-05 0.05130427 0.44230495 MCLACHLAN_DENTAL_CARIES_UP pancreatic ductal carcinoma DOID_3587 1.789E-05 5.688E-05 0.27432316 0.94599926 MCLACHLAN_DENTAL_CARIES_UP thyroid carcinoma DOID_3963 2.092E-05 6.612E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP pancreatic carcinoma DOID_4905 2.178E-05 6.846E-05 0.28383247 0.97289565 MCLACHLAN_DENTAL_CARIES_UP berylliosis DOID_10322 2.283E-05 7.138E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP parathyroid gland disease DOID_11201 2.283E-05 7.099E-05 0.05545961 0.45080742 MCLACHLAN_DENTAL_CARIES_UP larynx cancer DOID_2596 2.283E-05 7.06E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP laryngeal benign neoplasm DOID_2598 2.283E-05 7.06E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP thyroid cancer DOID_1781 2.587E-05 7.957E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP aspergillosis DOID_13564 2.896E-05 8.861E-05 1.675E-03 0.05957757 MCLACHLAN_DENTAL_CARIES_UP polycystic kidney disease DOID_898 2.896E-05 8.813E-05 0.05959687 0.46452901 MCLACHLAN_DENTAL_CARIES_UP narcolepsy DOID_8986 2.896E-05 8.766E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lipid metabolism disorder DOID_3146 3.149E-05 9.48E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP skeletal system cancer DOID_0060124 3.609E-05 1.081E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP thoracic aortic aneurysm DOID_14004 3.609E-05 1.075E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP bone cancer DOID_184 3.609E-05 1.081E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP intermediate coronary syndrome DOID_8805 3.609E-05 1.07E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hyperhomocysteinemia DOID_9279 3.609E-05 1.064E-04 0.06371611 0.48339288 MCLACHLAN_DENTAL_CARIES_UP cervix uteri carcinoma in situ DOID_8991 4.198E-05 1.231E-04 0.17567847 0.76306146 MCLACHLAN_DENTAL_CARIES_UP silicosis DOID_10325 4.427E-05 1.292E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP tongue cancer DOID_8649 4.427E-05 1.285E-04 0.06781742 0.49471936 MCLACHLAN_DENTAL_CARIES_UP juvenile rheumatoid arthritis DOID_676 5.359E-05 1.548E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP eosinophilia DOID_999 6.41E-05 1.842E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP amyloidosis DOID_9120 8.898E-05 2.544E-04 0.08404484 0.54342629 MCLACHLAN_DENTAL_CARIES_UP hemorrhagic disease DOID_2213 9.452E-05 2.689E-04 0.21111433 0.80620169 MCLACHLAN_DENTAL_CARIES_UP B-cell lymphocytic neoplasm DOID_707 9.452E-05 2.676E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP bile duct adenocarcinoma DOID_4896 1.169E-04 3.292E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP cholangiocarcinoma DOID_4947 1.169E-04 3.292E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP gastric ulcer DOID_10808 1.194E-04 3.347E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP neutropenia DOID_1227 1.194E-04 3.331E-04 4.156E-03 0.10749031 MCLACHLAN_DENTAL_CARIES_UP familial hypercholesterolemia DOID_13810 1.194E-04 3.315E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP acquired immunodeficiency syndrome DOID_635 1.194E-04 3.299E-04 0.09205294 0.56320562 MCLACHLAN_DENTAL_CARIES_UP familial hyperlipidemia DOID_1168 1.337E-04 3.676E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP agranulocytosis DOID_12987 1.369E-04 3.745E-04 4.539E-03 0.11228636 MCLACHLAN_DENTAL_CARIES_UP pulmonary embolism DOID_9477 1.369E-04 3.727E-04 0.09603086 0.57517428 MCLACHLAN_DENTAL_CARIES_UP hypoglycemia DOID_9993 1.369E-04 3.709E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP diabetic angiopathy DOID_11713 1.559E-04 4.205E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP spastic quadriplegia DOID_10970 1.766E-04 4.741E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP temporal lobe epilepsy DOID_3328 2.455E-04 6.559E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP gestational diabetes DOID_11714 2.771E-04 7.366E-04 0.11953716 0.64777757 MCLACHLAN_DENTAL_CARIES_UP lung adenocarcinoma DOID_3910 2.771E-04 7.332E-04 7.16E-03 0.13141155 MCLACHLAN_DENTAL_CARIES_UP blood coagulation disease DOID_1247 3.05E-04 8.033E-04 0.27432316 0.95176755 MCLACHLAN_DENTAL_CARIES_UP autoimmune disease of cardiovascular system DOID_0060051 3.068E-04 8.046E-04 7.649E-03 0.13600842 MCLACHLAN_DENTAL_CARIES_UP Behcet's disease DOID_13241 3.068E-04 8.046E-04 7.649E-03 0.13600842 MCLACHLAN_DENTAL_CARIES_UP coronary stenosis DOID_4248 3.068E-04 8.009E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP syndrome DOID_225 3.929E-04 1.021E-03 0.2901031 0.98843511 MCLACHLAN_DENTAL_CARIES_UP age related macular degeneration DOID_10871 4.084E-04 1.056E-03 0.13486947 0.69135793 MCLACHLAN_DENTAL_CARIES_UP degeneration of macula and posterior pole DOID_2007 4.084E-04 1.056E-03 0.13486947 0.69135793 MCLACHLAN_DENTAL_CARIES_UP mixed glioma DOID_5076 4.327E-04 1.114E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP autonomic nervous system neoplasm DOID_2621 4.868E-04 1.248E-03 0.14243581 0.69867221 MCLACHLAN_DENTAL_CARIES_UP neuroblastoma DOID_769 4.868E-04 1.248E-03 0.14243581 0.69867221 MCLACHLAN_DENTAL_CARIES_UP papilloma DOID_2615 5.293E-04 1.351E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP focal epilepsy DOID_2234 5.447E-04 1.384E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hepatitis C DOID_1883 5.742E-04 1.452E-03 0.14993637 0.72917772 MCLACHLAN_DENTAL_CARIES_UP macular degeneration DOID_4448 5.742E-04 1.446E-03 0.14993637 0.71094828 MCLACHLAN_DENTAL_CARIES_UP leukopenia DOID_615 5.742E-04 1.439E-03 0.01147895 0.15930542 MCLACHLAN_DENTAL_CARIES_UP adenoma DOID_657 6.71E-04 1.675E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP amino acid metabolic disorder DOID_9252 7.045E-04 1.75E-03 0.32955277 1.000 MCLACHLAN_DENTAL_CARIES_UP peripheral nervous system neoplasm DOID_1192 7.777E-04 1.924E-03 0.16474242 0.74395583 MCLACHLAN_DENTAL_CARIES_UP congenital diaphragmatic hernia DOID_3827 8.349E-04 2.056E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hypolipoproteinemia DOID_1387 8.38E-04 2.055E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP retinal vascular occlusion DOID_1729 8.38E-04 2.047E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP transient cerebral ischemia DOID_224 8.38E-04 2.038E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP insulinoma DOID_3892 8.38E-04 2.029E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP adrenal gland hyperfunction DOID_3947 8.38E-04 2.021E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP visceral leishmaniasis DOID_9146 8.38E-04 2.012E-03 0.04293898 0.40720468 MCLACHLAN_DENTAL_CARIES_UP lymphatic system disease DOID_75 8.946E-04 2.139E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP familial adenomatous polyposis DOID_0050424 1.021E-03 2.432E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP trypanosomiasis DOID_10113 1.021E-03 2.421E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP dermatomyositis DOID_10223 1.021E-03 2.411E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP sickle cell anemia DOID_10923 1.021E-03 2.401E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP autoimmune disease of urogenital tract DOID_0060049 1.022E-03 2.393E-03 0.17929211 0.76704668 MCLACHLAN_DENTAL_CARIES_UP primary biliary cirrhosis DOID_12236 1.022E-03 2.393E-03 0.17929211 0.76704668 MCLACHLAN_DENTAL_CARIES_UP diarrhea DOID_13250 1.222E-03 2.85E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP islet cell tumor DOID_1799 1.222E-03 2.838E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP peritonitis DOID_8283 1.222E-03 2.827E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP brain cancer DOID_1319 1.389E-03 3.2E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP psoriatic arthritis DOID_9008 1.44E-03 3.304E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP central nervous system cancer DOID_3620 1.471E-03 3.362E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP viral pneumonia DOID_10533 1.675E-03 3.813E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP parasitic helminthiasis infectious disease DOID_883 1.675E-03 3.798E-03 0.05959687 0.4709808 MCLACHLAN_DENTAL_CARIES_UP bacterial meningitis DOID_9470 1.675E-03 3.783E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP membranoproliferative glomerulonephritis DOID_2920 1.927E-03 4.335E-03 1.927E-03 0.06092969 MCLACHLAN_DENTAL_CARIES_UP mesenchymal cell neoplasm DOID_3350 1.927E-03 4.318E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP spindle cell sarcoma DOID_4235 1.927E-03 4.318E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lung oat cell carcinoma DOID_5411 1.927E-03 4.301E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP epithelioid sarcoma DOID_6193 1.927E-03 4.318E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP spastic diplegia DOID_10965 2.197E-03 4.882E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP oral cavity cancer DOID_8618 2.463E-03 5.453E-03 0.23501439 0.85174007 MCLACHLAN_DENTAL_CARIES_UP bronchitis DOID_6132 2.482E-03 5.474E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP melancholia DOID_2848 2.58E-03 5.668E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP neurotic disorder DOID_4964 2.7E-03 5.909E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP glucose intolerance DOID_10603 2.784E-03 6.07E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hypothyroidism DOID_1459 2.951E-03 6.409E-03 0.24834698 0.88873857 MCLACHLAN_DENTAL_CARIES_UP Down syndrome DOID_14250 3.103E-03 6.714E-03 0.0800145 0.54200298 MCLACHLAN_DENTAL_CARIES_UP MHC class II deficiency DOID_5812 3.103E-03 6.688E-03 3.103E-03 0.08408075 MCLACHLAN_DENTAL_CARIES_UP amnestic disorder DOID_10914 3.438E-03 7.382E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP pulmonary edema DOID_11396 3.438E-03 7.354E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Kawasaki disease DOID_13378 3.789E-03 8.075E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lymphadenitis DOID_1602 3.789E-03 8.075E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP coronary restenosis DOID_4247 3.789E-03 8.045E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lymph node disease DOID_9942 3.789E-03 8.075E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP urinary tract obstruction DOID_5200 4.539E-03 9.601E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP polyarteritis nodosa DOID_9810 4.539E-03 9.565E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP endogenous depression DOID_1595 4.932E-03 0.01035449 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Lewy body dementia DOID_12217 4.937E-03 0.01032831 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP aortic valve disease DOID_62 4.937E-03 0.01029048 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP severe combined immunodeficiency DOID_627 5.351E-03 0.01111258 5.351E-03 0.11710949 MCLACHLAN_DENTAL_CARIES_UP combined T cell and B cell immunodeficiency DOID_628 5.781E-03 0.01196053 5.781E-03 0.1174695 MCLACHLAN_DENTAL_CARIES_UP mental depression DOID_1596 6.262E-03 0.01290926 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP spinal cord disease DOID_319 6.685E-03 0.0137317 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP perinatal necrotizing enterocolitis DOID_8677 7.16E-03 0.01465381 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP renal hypertension DOID_1073 7.649E-03 0.01559953 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP secondary hypertension DOID_11130 7.649E-03 0.01559953 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP sarcoma DOID_1115 7.649E-03 0.01554382 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP thrombocytopenia DOID_1588 7.649E-03 0.0154885 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP invasive ductal carcinoma DOID_3008 7.649E-03 0.01543358 0.12339537 0.65618662 MCLACHLAN_DENTAL_CARIES_UP toxic encephalopathy DOID_3602 8.153E-03 0.01639271 0.12723678 0.66419935 MCLACHLAN_DENTAL_CARIES_UP focal glomerulosclerosis DOID_3945 8.153E-03 0.01633499 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP carbohydrate metabolic disorder DOID_2978 8.501E-03 0.01697232 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP endometrial carcinoma DOID_2871 8.672E-03 0.01725274 0.13106146 0.67794518 MCLACHLAN_DENTAL_CARIES_UP dilated cardiomyopathy DOID_12930 8.998E-03 0.01783952 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP endometrial cancer DOID_1380 9.752E-03 0.01926773 0.1386609 0.69208817 MCLACHLAN_DENTAL_CARIES_UP germinoma DOID_3304 9.752E-03 0.01920106 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP nephroblastoma DOID_2154 0.01147895 0.02252249 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hyperthyroidism DOID_7998 0.01147895 0.02244509 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lymphoid leukemia DOID_10747 0.01208215 0.02354363 0.01208215 0.16368431 MCLACHLAN_DENTAL_CARIES_UP embryonal cancer DOID_688 0.01332927 0.02588517 0.16106511 0.73908104 MCLACHLAN_DENTAL_CARIES_UP blood platelet disease DOID_2218 0.01397294 0.02704287 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP benign mesothelioma DOID_2645 0.01598285 0.03082794 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Huntington's disease DOID_12858 0.01738728 0.03342353 0.18288999 0.77660003 MCLACHLAN_DENTAL_CARIES_UP hyperinsulinism DOID_2018 0.01738728 0.03331099 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP uterine cancer DOID_363 0.01810848 0.03457625 0.1864722 0.78016677 MCLACHLAN_DENTAL_CARIES_UP learning disability DOID_8927 0.01884216 0.03585681 0.19003879 0.77792859 MCLACHLAN_DENTAL_CARIES_UP leukodystrophy DOID_10579 0.0195882 0.03715228 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP bone marrow disease DOID_4961 0.02034649 0.03846229 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lung small cell carcinoma DOID_5409 0.02189931 0.04126062 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP withdrawal disorder DOID_0060001 0.02349968 0.04412976 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP atrophic muscular disease DOID_913 0.02514666 0.04706726 0.21801765 0.82153672 MCLACHLAN_DENTAL_CARIES_UP muscular dystrophy DOID_9884 0.02514666 0.04706726 0.21801765 0.82153672 MCLACHLAN_DENTAL_CARIES_UP cerebral degeneration DOID_1443 0.0359562 0.06707894 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP leber hereditary optic neuropathy DOID_705 0.03872889 0.07201548 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP gallbladder disease DOID_0000000 0.04293898 0.07958398 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP interstitial nephritis DOID_1063 0.04293898 0.07932559 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP familial combined hyperlipidemia DOID_13809 0.04293898 0.07906887 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP childhood type dermatomyositis DOID_14203 0.04293898 0.07881381 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP acute kidney failure DOID_3021 0.04293898 0.07856039 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP progressive muscular atrophy DOID_318 0.04293898 0.07830859 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP teratoma DOID_3307 0.04293898 0.0780584 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP chondrosarcoma DOID_3371 0.04293898 0.07780981 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Hermansky-Pudlak syndrome DOID_3753 0.04293898 0.0775628 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP conjunctival disease DOID_4251 0.04293898 0.07731734 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP keratitis DOID_4677 0.04293898 0.07707344 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP malignant teratoma DOID_5563 0.04293898 0.0780584 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP mature teratoma DOID_5566 0.04293898 0.0780584 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP conjunctivitis DOID_6195 0.04293898 0.07731734 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP polycythemia DOID_8432 0.04293898 0.07683107 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP alopecia areata DOID_986 0.04293898 0.07659022 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP nervous system benign neoplasm DOID_0060115 0.04713075 0.08380436 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP adrenoleukodystrophy DOID_10588 0.04713075 0.08354329 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP neuronal ceroid lipofuscinosis DOID_14503 0.04713075 0.08328384 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP invasive lobular carcinoma DOID_3457 0.04713075 0.08302599 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP eosinophilic pneumonia DOID_5870 0.04713075 0.08276974 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP pulmonary eosinophilia DOID_9498 0.04713075 0.08276974 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Loeffler syndrome DOID_9503 0.04713075 0.08276974 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP otitis media DOID_10754 0.05130427 0.08982193 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP beta thalassemia DOID_12241 0.05130427 0.0895464 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP intracranial arteriosclerosis DOID_13097 0.05130427 0.08927256 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP aortic valve stenosis DOID_1712 0.05130427 0.08900039 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP relapsing-remitting multiple sclerosis DOID_2378 0.05130427 0.08872987 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP epidermolysis bullosa DOID_2730 0.05130427 0.08846099 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP middle ear disease DOID_5100 0.05130427 0.08982193 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP retinal detachment DOID_5327 0.05130427 0.08819374 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP aortic valve insufficiency DOID_57 0.05130427 0.08792809 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP lipodystrophy DOID_811 0.05130427 0.08766404 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP vascular dementia DOID_8725 0.05130427 0.08927256 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP chromosomal disease DOID_0080014 0.05149304 0.08772317 0.30554193 1.000 MCLACHLAN_DENTAL_CARIES_UP leprosy DOID_1024 0.05545961 0.09419856 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP essential hypertension DOID_10825 0.05545961 0.09391821 0.05545961 0.45734086 MCLACHLAN_DENTAL_CARIES_UP newborn respiratory distress syndrome DOID_12716 0.05545961 0.09363952 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP vesiculobullous skin disease DOID_2731 0.05545961 0.09336248 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP intracranial thrombosis DOID_4193 0.05545961 0.09308708 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP Legionnaires' disease DOID_10457 0.05959687 0.09973711 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP legionellosis DOID_10458 0.05959687 0.09973711 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP open-angle glaucoma DOID_1067 0.05959687 0.09944463 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP tethered spinal cord syndrome DOID_1089 0.05959687 0.09915385 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP hypercalcemia DOID_12678 0.05959687 0.09886477 1.000 1.000 MCLACHLAN_DENTAL_CARIES_UP eyelid disease DOID_530 0.05959687 0.09857738 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP astrocytoma DOID_3069 1.427E-06 8.121E-04 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP lung adenocarcinoma DOID_3910 3.711E-05 0.01055847 9.142E-03 0.65023849 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP giant cell tumor DOID_200 1.401E-04 0.0265731 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP malignant giant cell tumor DOID_2705 1.401E-04 0.0265731 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP giant cell glioblastoma DOID_3074 1.401E-04 0.0265731 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP glioblastoma DOID_3068 1.663E-04 0.02366203 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP mixed glioma DOID_5076 2.863E-04 0.03257819 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP auditory system disease DOID_2742 3.156E-04 0.0299282 0.02627072 0.51544955 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP nervous system cancer DOID_3093 3.784E-04 0.03076059 1.000 1.000 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP Human immunodeficiency virus infectious disease DOID_526 3.784E-04 0.02691552 3.784E-04 0.21532415 XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP encephalomyelitis DOID_640 4.034E-04 0.02550606 4.034E-04 0.11477727 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 bile duct cancer DOID_4606 8.829E-08 5.024E-05 0.04101739 0.42434355 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 bile duct carcinoma DOID_4897 8.829E-08 5.024E-05 0.04101739 0.42434355 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 angiosarcoma DOID_0001816 1.594E-07 4.535E-05 0.01091896 0.41419242 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 biliary tract cancer DOID_4607 3.388E-07 6.425E-05 0.05670777 0.52896262 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 sarcoma DOID_1115 1.148E-06 1.633E-04 0.02037893 0.38652028 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 medullomyoblastoma DOID_3861 2.377E-06 2.705E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 adult medulloblastoma DOID_3864 2.377E-06 2.705E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 childhood medulloblastoma DOID_3869 2.377E-06 2.705E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 medulloblastoma DOID_3858 2.782E-06 2.638E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 primitive neuroectodermal tumor DOID_168 4.262E-06 3.465E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 gallbladder cancer DOID_3121 4.551E-06 3.237E-04 0.0317491 0.39272257 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 bile duct adenocarcinoma DOID_4896 8.175E-06 5.168E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 cholangiocarcinoma DOID_4947 8.175E-06 5.168E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 melancholia DOID_2848 1.054E-05 5.998E-04 1.054E-05 5.998E-03 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 neurotic disorder DOID_4964 1.106E-05 5.723E-04 1.106E-05 3.148E-03 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 neuroectodermal tumor DOID_171 1.16E-05 5.502E-04 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 endogenous depression DOID_1595 2.105E-05 9.214E-04 2.105E-05 3.993E-03 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 invasive lobular carcinoma DOID_3457 2.478E-05 1.007E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 mental depression DOID_1596 2.724E-05 1.033E-03 2.724E-05 3.876E-03 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 transitional cell carcinoma DOID_2671 3.233E-05 1.15E-03 0.05994538 0.53295191 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 leishmaniasis DOID_9065 7.678E-05 2.57E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 colon carcinoma DOID_1520 8.528E-05 2.696E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 papillary adenoma DOID_3172 1.571E-04 4.704E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 microcystic adenoma DOID_5403 1.571E-04 4.704E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 follicular adenoma DOID_6204 1.571E-04 4.704E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 cleft lip DOID_9296 1.571E-04 4.469E-03 1.571E-04 0.01787566 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 perinatal necrotizing enterocolitis DOID_8677 1.815E-04 4.919E-03 0.01970611 0.38664744 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 endometrial carcinoma DOID_2871 2.215E-04 5.729E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 endometrial cancer DOID_1380 2.503E-04 6.193E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 autonomic nervous system neoplasm DOID_2621 2.654E-04 6.292E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 neuroblastoma DOID_769 2.654E-04 6.292E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 papilloma DOID_2615 2.809E-04 6.393E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 nephroblastoma DOID_2154 2.968E-04 6.495E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 esophageal disease DOID_6050 2.968E-04 6.255E-03 0.02507622 0.37548347 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 adenoma DOID_657 3.299E-04 6.705E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 calcinosis DOID_182 3.472E-04 6.811E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 cleft palate DOID_674 3.472E-04 6.584E-03 3.472E-04 0.03292209 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 peripheral nervous system neoplasm DOID_1192 3.648E-04 6.696E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 uveitis DOID_13141 3.648E-04 6.487E-03 0.02775066 0.40487508 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 hepatitis DOID_2237 3.829E-04 6.602E-03 0.02841817 0.40424848 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 uveal disease DOID_3480 4.595E-04 7.69E-03 0.03108379 0.39303731 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 uterine cancer DOID_363 4.797E-04 7.799E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 pre-eclampsia DOID_10591 5.429E-04 8.581E-03 0.03374238 0.39182484 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 thyroid adenoma DOID_2891 5.429E-04 8.349E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 pulmonary tuberculosis DOID_2957 5.872E-04 8.792E-03 0.03506905 0.39908577 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 calcium metabolism disease DOID_10575 6.1E-04 8.899E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 B-cell lymphocytic neoplasm DOID_707 6.332E-04 9.007E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 orofacial cleft DOID_0050567 6.568E-04 9.115E-03 6.568E-04 0.05338589 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 giant cell tumor DOID_200 6.808E-04 9.223E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 malignant giant cell tumor DOID_2705 6.808E-04 9.223E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 giant cell glioblastoma DOID_3074 6.808E-04 9.223E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 parasitic protozoa infectious disease DOID_2789 7.301E-04 9.662E-03 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 glioblastoma DOID_3068 8.073E-04 0.01043995 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 pre-malignant neoplasm DOID_0060071 9.443E-04 0.01193988 0.04430677 0.45018847 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 in situ carcinoma DOID_8719 9.443E-04 0.01193988 0.04430677 0.45018847 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 mineral metabolism disease DOID_0050032 9.729E-04 0.01203464 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 cholestasis DOID_13580 1.002E-03 0.0121304 1.002E-03 0.07126611 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 parasitic infectious disease DOID_1398 1.002E-03 0.01187768 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 endocrine organ benign neoplasm DOID_0060089 1.092E-03 0.01267654 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 tuberculosis DOID_399 1.092E-03 0.01242301 0.04758531 0.46682827 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 astrocytoma DOID_3069 1.122E-03 0.01252213 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 bile duct disease DOID_4138 1.185E-03 0.01296711 1.185E-03 0.07492105 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 biliary tract disease DOID_9741 1.217E-03 0.0130655 1.217E-03 0.06924715 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 diabetic retinopathy DOID_8947 1.249E-03 0.01316458 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 metabolic syndrome X DOID_14221 1.452E-03 0.01502329 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 retinal vascular disease DOID_2462 1.632E-03 0.0165861 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 primary bacterial infectious disease DOID_0050338 1.707E-03 0.01704303 0.05929871 0.53557093 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 nervous system cancer DOID_3093 1.823E-03 0.01788141 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 lymphoma DOID_0060058 1.902E-03 0.01833977 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 encephalomyelitis DOID_640 1.942E-03 0.01841418 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 hypersensitivity reaction type I disease DOID_1205 2.023E-03 0.01887121 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 childhood type dermatomyositis DOID_14203 6.838E-03 0.06275382 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 rectal neoplasm DOID_1984 6.838E-03 0.06175773 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 rectum cancer DOID_1993 6.838E-03 0.06175773 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 teratoma DOID_3307 6.838E-03 0.06079276 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 malignant teratoma DOID_5563 6.838E-03 0.06079276 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 mature teratoma DOID_5566 6.838E-03 0.06079276 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 cutaneous leishmaniasis DOID_9111 6.838E-03 0.05985749 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 familial adenomatous polyposis DOID_0050424 7.519E-03 0.06482425 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 breast benign neoplasm DOID_0060082 7.519E-03 0.06385672 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 thoracic benign neoplasm DOID_0060097 7.519E-03 0.06385672 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 dermatomyositis DOID_10223 7.519E-03 0.06291765 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 benign breast phyllodes tumor DOID_1631 7.519E-03 0.06385672 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 porphyria DOID_13268 8.2E-03 0.06762041 8.2E-03 0.4241644 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 encephalitis DOID_9588 8.2E-03 0.06665441 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 nicotine dependence DOID_0050742 8.88E-03 0.07116846 8.88E-03 0.42108006 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 vulva cancer DOID_1245 8.88E-03 0.07018001 8.88E-03 0.38868929 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 Lynch syndrome DOID_3883 8.88E-03 0.06921864 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 Legionnaires' disease DOID_10457 9.56E-03 0.07351159 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 legionellosis DOID_10458 9.56E-03 0.07351159 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 viral pneumonia DOID_10533 9.56E-03 0.07253144 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 aspergillosis DOID_13564 9.56E-03 0.07157708 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 peripheral neuropathy DOID_0060053 0.01023989 0.07566883 0.01023989 0.41617854 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 Barrett's esophagus DOID_9206 0.01091896 0.07965239 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 drug-induced mental disorder DOID_1203 0.01159757 0.08353187 0.01159757 0.41243863 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 drug psychosis DOID_1742 0.01159757 0.08353187 0.01159757 0.41243863 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 urinary system benign neoplasm DOID_731 0.01159757 0.08248773 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 substance-induced psychosis DOID_8646 0.01159757 0.08353187 0.01159757 0.41243863 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 congenital muscular dystrophy DOID_0050557 0.01227574 0.08623327 0.01227574 0.41087619 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 prion disease DOID_649 0.01227574 0.08518165 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 dissociative disorder DOID_10935 0.01295346 0.08880142 0.01295346 0.4094732 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 dissociative amnesia DOID_11037 0.01295346 0.08880142 0.01295346 0.4094732 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 granulosa cell tumor DOID_2999 0.01295346 0.08774426 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 amnestic disorder DOID_10914 0.01363073 0.09124571 0.01363073 0.40820451 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 pulmonary edema DOID_11396 0.01363073 0.09018472 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 esophagitis DOID_11963 0.01363073 0.08914811 0.01363073 0.38779429 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 sex cord-gonadal stromal tumor DOID_192 0.01363073 0.08813506 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 brain edema DOID_4724 0.01363073 0.08714478 0.01363073 0.36932789 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 amyloidosis DOID_9120 0.01363073 0.08617651 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 autoimmune hepatitis DOID_2048 0.01430756 0.08946153 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 coronary restenosis DOID_4247 0.01430756 0.08848913 0.01430756 0.37004543 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 muscular atrophy DOID_767 0.01498394 0.09167591 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 IgA glomerulonephritis DOID_2986 0.01565987 0.09479218 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 lingual-facial-buccal dyskinesia DOID_9854 0.01565987 0.09379437 0.01565987 0.38741152 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 synostosis DOID_11971 0.01633535 0.09682101 0.01633535 0.38728404 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 Lewy body dementia DOID_12217 0.01633535 0.09582286 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 Goodpasture syndrome DOID_9808 0.01633535 0.09484507 1.000 1.000 WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 osteosarcoma DOID_3347 0.01768499 0.09963129 0.01768499 0.38702924 HELLER_SILENCED_BY_METHYLATION_DN amino acid metabolic disorder DOID_9252 1.193E-05 6.79E-03 1.193E-05 6.79E-03 HELLER_SILENCED_BY_METHYLATION_DN bone marrow disease DOID_4961 6.328E-05 0.01800408 6.328E-05 0.01800408 HELLER_SILENCED_BY_METHYLATION_DN bile duct adenocarcinoma DOID_4896 9.376E-05 0.01778266 3.478E-03 0.10994806 HELLER_SILENCED_BY_METHYLATION_DN cholangiocarcinoma DOID_4947 9.376E-05 0.01778266 3.478E-03 0.10994806 HELLER_SILENCED_BY_METHYLATION_DN bile duct cancer DOID_4606 1.148E-04 0.01633351 3.973E-03 0.10763597 HELLER_SILENCED_BY_METHYLATION_DN bile duct carcinoma DOID_4897 1.148E-04 0.01633351 3.973E-03 0.10763597 HELLER_SILENCED_BY_METHYLATION_DN beta thalassemia DOID_12241 1.503E-04 0.01710775 1.503E-04 0.02851292 HELLER_SILENCED_BY_METHYLATION_DN pancreatic ductal carcinoma DOID_3587 1.959E-04 0.01857435 1.959E-04 0.02786153 HELLER_SILENCED_BY_METHYLATION_DN pancreatic carcinoma DOID_4905 2.207E-04 0.01793687 2.207E-04 0.02511161 HELLER_SILENCED_BY_METHYLATION_DN diabetic retinopathy DOID_8947 2.207E-04 0.01569476 6.097E-03 0.14453897 HELLER_SILENCED_BY_METHYLATION_DN cystic fibrosis DOID_1485 2.383E-04 0.01506442 6.411E-03 0.1459209 HELLER_SILENCED_BY_METHYLATION_DN thalassemia DOID_10241 2.385E-04 0.01356832 2.385E-04 0.02261386 HELLER_SILENCED_BY_METHYLATION_DN metabolic syndrome X DOID_14221 2.762E-04 0.01428593 7.063E-03 0.14883654 HELLER_SILENCED_BY_METHYLATION_DN lipid metabolism disorder DOID_3146 2.762E-04 0.01309543 2.762E-04 0.02244931 HELLER_SILENCED_BY_METHYLATION_DN biliary tract cancer DOID_4607 3.07E-04 0.01343794 7.57E-03 0.15383027 HELLER_SILENCED_BY_METHYLATION_DN retinal vascular disease DOID_2462 3.288E-04 0.01336185 7.917E-03 0.15533632 HELLER_SILENCED_BY_METHYLATION_DN mouth disease DOID_403 4.389E-04 0.01664768 4.389E-04 0.0312144 HELLER_SILENCED_BY_METHYLATION_DN toxic shock syndrome DOID_14115 6.746E-04 0.02399201 0.03756514 0.38168864 HELLER_SILENCED_BY_METHYLATION_DN commensal bacterial infectious disease DOID_0050339 7.301E-04 0.02443841 0.03903854 0.38298153 HELLER_SILENCED_BY_METHYLATION_DN middle cerebral artery infarction DOID_3525 8.475E-04 0.02679194 8.475E-04 0.05358388 HELLER_SILENCED_BY_METHYLATION_DN allergic rhinitis DOID_4481 1.25E-03 0.03744849 0.05074621 0.41249416 HELLER_SILENCED_BY_METHYLATION_DN autonomic nervous system neoplasm DOID_2621 1.325E-03 0.03769515 0.05219977 0.41833338 HELLER_SILENCED_BY_METHYLATION_DN neuroblastoma DOID_769 1.325E-03 0.03769515 0.05219977 0.41833338 HELLER_SILENCED_BY_METHYLATION_DN aplastic anemia DOID_12449 1.561E-03 0.04229172 1.561E-03 0.08881261 HELLER_SILENCED_BY_METHYLATION_DN multiple myeloma DOID_9538 1.728E-03 0.04470321 1.728E-03 0.08940641 HELLER_SILENCED_BY_METHYLATION_DN peripheral nervous system neoplasm DOID_1192 1.815E-03 0.04490829 0.06087534 0.4224155 HELLER_SILENCED_BY_METHYLATION_DN hepatitis DOID_2237 1.904E-03 0.04514465 0.06231367 0.42718645 HELLER_SILENCED_BY_METHYLATION_DN intracranial arterial disease DOID_13089 1.995E-03 0.04540838 1.995E-03 0.09460079 HELLER_SILENCED_BY_METHYLATION_DN cerebral arterial disease DOID_3527 1.995E-03 0.04540838 1.995E-03 0.09460079 HELLER_SILENCED_BY_METHYLATION_DN gallbladder cancer DOID_3121 2.379E-03 0.05206388 0.06947286 0.45965184 HELLER_SILENCED_BY_METHYLATION_DN cerebral infarction DOID_3526 2.48E-03 0.05226412 2.48E-03 0.10854855 HELLER_SILENCED_BY_METHYLATION_DN cataract DOID_83 2.48E-03 0.05039754 2.48E-03 0.10079508 HELLER_SILENCED_BY_METHYLATION_DN myeloma DOID_0070004 2.688E-03 0.05274056 2.688E-03 0.10196508 HELLER_SILENCED_BY_METHYLATION_DN lens disease DOID_110 2.688E-03 0.05098254 2.688E-03 0.09559226 HELLER_SILENCED_BY_METHYLATION_DN hemolytic anemia DOID_583 2.795E-03 0.05130141 0.07516152 0.48052701 HELLER_SILENCED_BY_METHYLATION_DN normocytic anemia DOID_720 2.795E-03 0.05130141 0.07516152 0.48052701 HELLER_SILENCED_BY_METHYLATION_DN B-cell lymphocytic neoplasm DOID_707 3.128E-03 0.0556152 3.128E-03 0.10468743 HELLER_SILENCED_BY_METHYLATION_DN bone marrow cancer DOID_4960 3.478E-03 0.05997167 3.478E-03 0.10416132 HELLER_SILENCED_BY_METHYLATION_DN familial hyperlipidemia DOID_1168 3.721E-03 0.06227983 3.721E-03 0.10587571 HELLER_SILENCED_BY_METHYLATION_DN carotid artery disease DOID_3407 4.363E-03 0.07093694 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_DN respiratory failure DOID_11162 4.498E-03 0.07108626 0.09480396 0.55044342 HELLER_SILENCED_BY_METHYLATION_DN hypothyroidism DOID_1459 4.498E-03 0.06916501 4.498E-03 0.11632297 HELLER_SILENCED_BY_METHYLATION_DN mineral metabolism disease DOID_0050032 4.771E-03 0.07144632 0.09757635 0.56081759 HELLER_SILENCED_BY_METHYLATION_DN brain infarction DOID_3454 5.342E-03 0.07793576 5.342E-03 0.13215194 HELLER_SILENCED_BY_METHYLATION_DN syndrome DOID_225 6.411E-03 0.09120057 6.411E-03 0.14030856 HELLER_SILENCED_BY_METHYLATION_DN aneurysm disease DOID_2403 6.571E-03 0.09119804 0.11403627 0.60080219 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP endometriosis of uterus DOID_288 1.386E-05 7.887E-03 1.386E-05 7.887E-03 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP endometriosis DOID_289 1.482E-05 4.215E-03 1.482E-05 4.215E-03 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP uterine disease DOID_345 4.816E-05 9.134E-03 4.816E-05 9.134E-03 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP endocrine organ benign neoplasm DOID_0060089 5.48E-05 7.796E-03 2.45E-03 0.11617772 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP female reproductive system disease DOID_229 8.735E-05 9.941E-03 8.735E-05 0.01242618 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP malaria DOID_12365 4.405E-04 0.04177063 4.405E-04 0.05012476 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP toxic encephalopathy DOID_3602 4.705E-04 0.03824774 1.000 1.000 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP cleft palate DOID_674 7.847E-04 0.05581058 0.04035455 0.42521742 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP thyroid adenoma DOID_2891 1.224E-03 0.07740806 0.05019259 0.46818986 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP bone marrow disease DOID_4961 1.224E-03 0.06966725 1.224E-03 0.11611208 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP hemolytic anemia DOID_583 1.274E-03 0.06587616 1.274E-03 0.10351967 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP normocytic anemia DOID_720 1.274E-03 0.06587616 1.274E-03 0.10351967 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP orofacial cleft DOID_0050567 1.479E-03 0.07015018 0.05507468 0.48964834 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP atrophic muscular disease DOID_913 1.533E-03 0.06710876 1.533E-03 0.10905173 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP muscular dystrophy DOID_9884 1.533E-03 0.06710876 1.533E-03 0.10905173 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP parasitic protozoa infectious disease DOID_2789 1.644E-03 0.06680104 1.644E-03 0.10391272 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP oral cavity cancer DOID_8618 1.816E-03 0.06888952 0.06090093 0.50959747 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP neuroectodermal tumor DOID_171 1.997E-03 0.07100992 0.06380091 0.52612634 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP cholestasis DOID_13580 2.25E-03 0.0753229 2.25E-03 0.12804892 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP parasitic infectious disease DOID_1398 2.25E-03 0.07113829 2.25E-03 0.11640811 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP bile duct disease DOID_4138 2.658E-03 0.0795984 2.658E-03 0.11633613 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP biliary tract disease DOID_9741 2.729E-03 0.0776399 2.729E-03 0.11091414 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP diabetic retinopathy DOID_8947 2.801E-03 0.07589202 0.07531383 0.55653985 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP bone resorption disease DOID_0080011 3.022E-03 0.07816197 3.022E-03 0.11463756 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP osteoporosis DOID_11476 3.022E-03 0.07816197 3.022E-03 0.11463756 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP metabolic syndrome X DOID_14221 3.251E-03 0.08043103 3.251E-03 0.1156196 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP retinal vascular disease DOID_2462 3.65E-03 0.08654717 0.08574608 0.5878255 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP transitional cell carcinoma DOID_2671 3.901E-03 0.08877597 0.08857127 0.59996493 PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP lymphoma DOID_0060058 4.246E-03 0.09292145 0.09232497 0.61084779 LI_LUNG_CANCER mesenchymal cell neoplasm DOID_3350 2.714E-07 1.545E-04 7.66E-05 0.01089704 LI_LUNG_CANCER spindle cell sarcoma DOID_4235 2.714E-07 1.545E-04 7.66E-05 0.01089704 LI_LUNG_CANCER epithelioid sarcoma DOID_6193 2.714E-07 1.545E-04 7.66E-05 0.01089704 LI_LUNG_CANCER dilated cardiomyopathy DOID_12930 1.556E-06 4.428E-04 1.556E-06 8.856E-04 LI_LUNG_CANCER sarcoma DOID_1115 2.401E-06 4.553E-04 3.148E-04 0.03582198 LI_LUNG_CANCER parasitic infectious disease DOID_1398 2.897E-05 4.121E-03 2.897E-05 8.243E-03 LI_LUNG_CANCER pancreatic ductal carcinoma DOID_3587 3.585E-05 4.08E-03 1.858E-03 0.05872513 LI_LUNG_CANCER pancreatic carcinoma DOID_4905 4.045E-05 3.836E-03 2.011E-03 0.05449902 LI_LUNG_CANCER Human immunodeficiency virus infectious disease DOID_526 7.157E-05 5.818E-03 7.157E-05 0.0135752 LI_LUNG_CANCER lymphoma DOID_0060058 7.631E-05 5.427E-03 3.055E-03 0.07900883 LI_LUNG_CANCER lung adenocarcinoma DOID_3910 2.94E-04 0.01858448 0.02494721 0.26782943 LI_LUNG_CANCER endometrial carcinoma DOID_2871 3.585E-04 0.02040042 3.585E-04 0.03400069 LI_LUNG_CANCER endometrial cancer DOID_1380 4.051E-04 0.0209534 4.051E-04 0.03292678 LI_LUNG_CANCER embryonal cancer DOID_688 5.614E-04 0.02661823 5.614E-04 0.03992735 LI_LUNG_CANCER multiple myeloma DOID_9538 5.614E-04 0.02457067 5.614E-04 0.03549097 LI_LUNG_CANCER cervix uteri carcinoma in situ DOID_8991 6.794E-04 0.02761108 6.794E-04 0.03865552 LI_LUNG_CANCER uterine cancer DOID_363 7.75E-04 0.0293999 7.75E-04 0.04009077 LI_LUNG_CANCER myeloma DOID_0070004 8.769E-04 0.03118305 8.769E-04 0.0415774 LI_LUNG_CANCER hemolytic anemia DOID_583 9.121E-04 0.03053005 9.121E-04 0.03992391 LI_LUNG_CANCER normocytic anemia DOID_720 9.121E-04 0.03053005 9.121E-04 0.03992391 LI_LUNG_CANCER bile duct adenocarcinoma DOID_4896 1.138E-03 0.03597569 0.04846093 0.30982322 LI_LUNG_CANCER cholangiocarcinoma DOID_4947 1.138E-03 0.03597569 0.04846093 0.30982322 LI_LUNG_CANCER bone marrow cancer DOID_4960 1.138E-03 0.03408224 1.138E-03 0.04625446 LI_LUNG_CANCER parasitic protozoa infectious disease DOID_2789 1.178E-03 0.03351625 1.178E-03 0.04468834 LI_LUNG_CANCER bile duct cancer DOID_4606 1.302E-03 0.03528059 0.05177482 0.31340287 LI_LUNG_CANCER bile duct carcinoma DOID_4897 1.302E-03 0.03528059 0.05177482 0.31340287 LI_LUNG_CANCER pre-malignant neoplasm DOID_0060071 1.522E-03 0.03936662 1.522E-03 0.0541291 LI_LUNG_CANCER in situ carcinoma DOID_8719 1.522E-03 0.03936662 1.522E-03 0.0541291 LI_LUNG_CANCER cholestasis DOID_13580 1.615E-03 0.03994636 1.615E-03 0.05404508 LI_LUNG_CANCER bile duct disease DOID_4138 1.908E-03 0.04524269 1.908E-03 0.05714867 LI_LUNG_CANCER biliary tract disease DOID_9741 1.96E-03 0.04459869 1.96E-03 0.05574836 LI_LUNG_CANCER biliary tract cancer DOID_4607 2.507E-03 0.05486997 0.07142438 0.36286138 LI_LUNG_CANCER hypersensitivity reaction type I disease DOID_1205 3.249E-03 0.06846356 0.08110052 0.38455165 LU_IL4_SIGNALING contact dermatitis DOID_2773 1.038E-12 5.903E-10 7.615E-11 4.333E-08 LU_IL4_SIGNALING allergic contact dermatitis DOID_3042 2.438E-11 6.937E-09 1.803E-09 5.13E-07 LU_IL4_SIGNALING tuberculosis DOID_399 2.701E-11 5.124E-09 6.082E-03 0.12358592 LU_IL4_SIGNALING respiratory syncytial virus infectious disease DOID_1273 7.475E-11 1.063E-08 4.569E-05 3.714E-03 LU_IL4_SIGNALING primary bacterial infectious disease DOID_0050338 1.368E-10 1.557E-08 9.405E-03 0.16216209 LU_IL4_SIGNALING bacterial pneumonia DOID_874 4.081E-09 3.87E-07 7.661E-03 0.14061571 LU_IL4_SIGNALING lymphoblastic leukemia DOID_1037 1.158E-08 9.413E-07 1.846E-05 2.101E-03 LU_IL4_SIGNALING influenza DOID_8469 1.443E-08 1.027E-06 0.07408598 0.35724512 LU_IL4_SIGNALING bronchiolitis DOID_2942 9.434E-08 5.964E-06 1.000 1.000 LU_IL4_SIGNALING bone resorption disease DOID_0080011 2.037E-07 1.159E-05 8.886E-06 1.685E-03 LU_IL4_SIGNALING osteoporosis DOID_11476 2.037E-07 1.159E-05 8.886E-06 1.685E-03 LU_IL4_SIGNALING chronic leukemia DOID_1036 3.268E-07 1.69E-05 2.626E-05 2.49E-03 LU_IL4_SIGNALING chronic lymphocytic leukemia DOID_1040 3.268E-07 1.69E-05 2.626E-05 2.49E-03 LU_IL4_SIGNALING Human immunodeficiency virus infectious disease DOID_526 4.374E-07 2.074E-05 1.626E-05 2.314E-03 LU_IL4_SIGNALING pulmonary tuberculosis DOID_2957 1.655E-06 7.243E-05 1.000 1.000 LU_IL4_SIGNALING bile duct adenocarcinoma DOID_4896 2.4E-06 9.753E-05 0.08913781 0.38423798 LU_IL4_SIGNALING cholangiocarcinoma DOID_4947 2.4E-06 9.753E-05 0.08913781 0.38423798 LU_IL4_SIGNALING parasitic protozoa infectious disease DOID_2789 2.574E-06 9.765E-05 4.101E-03 0.10145281 LU_IL4_SIGNALING bile duct cancer DOID_4606 3.155E-06 1.122E-04 0.0950909 0.39493958 LU_IL4_SIGNALING bile duct carcinoma DOID_4897 3.155E-06 1.122E-04 0.0950909 0.39493958 LU_IL4_SIGNALING collagen disease DOID_854 3.827E-06 1.281E-04 1.616E-04 0.01149492 LU_IL4_SIGNALING respiratory failure DOID_11162 4.073E-06 1.288E-04 5.123E-03 0.12144599 LU_IL4_SIGNALING parasitic infectious disease DOID_1398 4.881E-06 1.462E-04 5.593E-03 0.12728562 LU_IL4_SIGNALING uterine disease DOID_345 4.881E-06 1.389E-04 5.593E-03 0.11785705 LU_IL4_SIGNALING Goodpasture syndrome DOID_9808 8.226E-06 2.229E-04 0.03853189 0.26100769 LU_IL4_SIGNALING pancreatitis DOID_4989 9.342E-06 2.416E-04 7.661E-03 0.1453029 LU_IL4_SIGNALING female reproductive system disease DOID_229 1.081E-05 2.675E-04 8.224E-03 0.14623702 LU_IL4_SIGNALING biliary tract cancer DOID_4607 1.189E-05 2.818E-04 0.13001392 0.48991999 LU_IL4_SIGNALING middle cerebral artery infarction DOID_3525 1.325E-05 3.016E-04 1.000 1.000 LU_IL4_SIGNALING pleurisy DOID_10247 1.639E-05 3.586E-04 1.000 1.000 LU_IL4_SIGNALING encephalomyelitis DOID_640 1.846E-05 3.891E-04 0.14417067 0.53268255 LU_IL4_SIGNALING Crohn's disease DOID_8778 1.924E-05 3.91E-04 5.34E-04 0.0276219 LU_IL4_SIGNALING bronchiolitis obliterans DOID_2799 2.194E-05 4.305E-04 1.000 1.000 LU_IL4_SIGNALING pleural disease DOID_1532 2.626E-05 4.981E-04 1.000 1.000 LU_IL4_SIGNALING pneumoconiosis DOID_10316 3.11E-05 5.709E-04 0.0587895 0.3126283 LU_IL4_SIGNALING systemic scleroderma DOID_418 4.569E-05 8.124E-04 2.172E-03 0.07270591 LU_IL4_SIGNALING adult respiratory distress syndrome DOID_11394 4.906E-05 8.458E-04 2.276E-03 0.07194064 LU_IL4_SIGNALING intracranial arterial disease DOID_13089 4.906E-05 8.21E-04 1.000 1.000 LU_IL4_SIGNALING cerebral arterial disease DOID_3527 4.906E-05 8.21E-04 1.000 1.000 LU_IL4_SIGNALING autoimmune disease of urogenital tract DOID_0060049 5.627E-05 9.149E-04 2.49E-03 0.07456379 LU_IL4_SIGNALING primary biliary cirrhosis DOID_12236 5.627E-05 9.149E-04 2.49E-03 0.07456379 LU_IL4_SIGNALING rheumatic disease DOID_1575 6.013E-05 9.504E-04 2.6E-03 0.07397764 LU_IL4_SIGNALING scleroderma DOID_419 6.013E-05 9.504E-04 2.6E-03 0.07397764 LU_IL4_SIGNALING cerebral infarction DOID_3526 6.835E-05 1.051E-03 1.000 1.000 LU_IL4_SIGNALING autoimmune disease of gastrointestinal tract DOID_0060031 8.693E-05 1.302E-03 0.08164224 0.36578293 LU_IL4_SIGNALING bone marrow cancer DOID_4960 1.144E-04 1.669E-03 1.000 1.000 LU_IL4_SIGNALING conjunctival disease DOID_4251 1.174E-04 1.67E-03 1.000 1.000 LU_IL4_SIGNALING conjunctivitis DOID_6195 1.174E-04 1.67E-03 1.000 1.000 LU_IL4_SIGNALING visceral leishmaniasis DOID_9146 1.174E-04 1.63E-03 0.01623617 0.22532641 LU_IL4_SIGNALING berylliosis DOID_10322 2.029E-04 2.749E-03 0.02105625 0.23492169 LU_IL4_SIGNALING polyneuropathy DOID_1389 2.029E-04 2.685E-03 1.000 1.000 LU_IL4_SIGNALING brain infarction DOID_3454 2.199E-04 2.844E-03 1.000 1.000 LU_IL4_SIGNALING eyelid disease DOID_530 2.365E-04 2.99E-03 1.000 1.000 LU_IL4_SIGNALING diabetic retinopathy DOID_8947 2.689E-04 3.326E-03 0.117076 0.45010977 LU_IL4_SIGNALING cystic fibrosis DOID_1485 2.903E-04 3.515E-03 7.296E-03 0.14314454 LU_IL4_SIGNALING aneurysm disease DOID_2403 3.014E-04 3.573E-03 0.12140954 0.46054684 LU_IL4_SIGNALING silicosis DOID_10325 3.111E-04 3.613E-03 0.02585309 0.25807733 LU_IL4_SIGNALING thyroiditis DOID_7166 3.111E-04 3.541E-03 0.02585309 0.24517346 LU_IL4_SIGNALING autoimmune thyroiditis DOID_7188 3.111E-04 3.541E-03 0.02585309 0.24517346 LU_IL4_SIGNALING retinal vascular disease DOID_2462 4.003E-04 4.466E-03 0.13286358 0.49736432 LU_IL4_SIGNALING psoriasis DOID_8893 4.42E-04 4.836E-03 4.42E-04 0.02794351 LU_IL4_SIGNALING leishmaniasis DOID_9065 4.42E-04 4.745E-03 0.0306268 0.26009925 LU_IL4_SIGNALING esophagitis DOID_11963 4.906E-04 5.169E-03 1.000 1.000 LU_IL4_SIGNALING lymphoma DOID_0060058 5.021E-04 5.195E-03 5.021E-04 0.02857138 LU_IL4_SIGNALING autoimmune hepatitis DOID_2048 5.417E-04 5.504E-03 1.000 1.000 LU_IL4_SIGNALING hypersensitivity reaction type I disease DOID_1205 5.504E-04 5.494E-03 0.1469747 0.53608081 LU_IL4_SIGNALING acquired immunodeficiency syndrome DOID_635 5.952E-04 5.839E-03 0.0353775 0.28351824 LU_IL4_SIGNALING placenta disease DOID_780 5.952E-04 5.74E-03 0.0353775 0.27958048 LU_IL4_SIGNALING myasthenia gravis DOID_437 6.512E-04 6.175E-03 0.03695596 0.2841614 LU_IL4_SIGNALING aortic valve disease DOID_62 7.096E-04 6.619E-03 0.03853189 0.26415236 LU_IL4_SIGNALING toxic shock syndrome DOID_14115 7.705E-04 7.072E-03 7.705E-04 0.03653613 LU_IL4_SIGNALING commensal bacterial infectious disease DOID_0050339 8.339E-04 7.531E-03 8.339E-04 0.03649768 LU_IL4_SIGNALING neuromuscular junction disease DOID_439 8.996E-04 7.998E-03 0.04324446 0.28282874 LU_IL4_SIGNALING extrinsic allergic alveolitis DOID_841 9.678E-04 8.472E-03 1.000 1.000 LU_IL4_SIGNALING diffuse large B-cell lymphoma DOID_0050745 1.038E-03 8.952E-03 1.038E-03 0.04220381 LU_IL4_SIGNALING Sciatic Neuropathy DOID_11446 1.038E-03 8.819E-03 1.000 1.000 LU_IL4_SIGNALING lesion of sciatic nerve DOID_12528 1.038E-03 8.819E-03 1.000 1.000 LU_IL4_SIGNALING periodontitis DOID_824 1.038E-03 8.689E-03 0.04637355 0.28372633 LU_IL4_SIGNALING mononeuritis of lower limb DOID_9473 1.038E-03 8.819E-03 1.000 1.000 LU_IL4_SIGNALING malaria DOID_12365 1.111E-03 9.165E-03 1.111E-03 0.04215941 LU_IL4_SIGNALING mononeuritis DOID_1802 1.111E-03 9.034E-03 1.000 1.000 LU_IL4_SIGNALING autoimmune disease of the nervous system DOID_438 1.111E-03 8.907E-03 0.04793431 0.27831248 LU_IL4_SIGNALING autoimmune disease of endocrine system DOID_0060005 1.187E-03 9.379E-03 0.04949256 0.28445724 LU_IL4_SIGNALING mononeuropathy DOID_1188 1.187E-03 9.251E-03 1.000 1.000 LU_IL4_SIGNALING opportunistic mycosis DOID_2473 1.345E-03 0.01034017 1.000 1.000 LU_IL4_SIGNALING celiac disease DOID_10608 1.427E-03 0.01082855 0.05415227 0.30208473 LU_IL4_SIGNALING allergic rhinitis DOID_4481 1.427E-03 0.01068607 1.000 1.000 LU_IL4_SIGNALING systemic mycosis DOID_0050136 1.599E-03 0.01181966 1.000 1.000 LU_IL4_SIGNALING fungal infectious disease DOID_1564 1.599E-03 0.01181966 1.000 1.000 LU_IL4_SIGNALING nephroblastoma DOID_2154 1.689E-03 0.01232191 1.689E-03 0.0600693 LU_IL4_SIGNALING periodontal disease DOID_3388 1.689E-03 0.01216593 0.0587895 0.30973359 LU_IL4_SIGNALING esophageal disease DOID_6050 1.689E-03 0.01201386 1.000 1.000 LU_IL4_SIGNALING pulmonary sarcoidosis DOID_13406 1.972E-03 0.01385281 1.000 1.000 LU_IL4_SIGNALING multiple myeloma DOID_9538 1.972E-03 0.01368388 1.000 1.000 LU_IL4_SIGNALING congenital diaphragmatic hernia DOID_3827 2.172E-03 0.01489157 0.06646857 0.33469571 LU_IL4_SIGNALING endometriosis of uterus DOID_288 2.49E-03 0.01686562 0.07104638 0.35152515 LU_IL4_SIGNALING nephrotic syndrome DOID_1184 2.6E-03 0.0174065 0.07256741 0.35595565 LU_IL4_SIGNALING endometriosis DOID_289 2.6E-03 0.0172041 0.07256741 0.35291329 LU_IL4_SIGNALING leukodystrophy DOID_10579 2.945E-03 0.01926237 2.945E-03 0.07980124 LU_IL4_SIGNALING proteinuria DOID_576 2.945E-03 0.01904348 0.0771158 0.36263544 LU_IL4_SIGNALING myeloma DOID_0070004 3.065E-03 0.01959348 1.000 1.000 LU_IL4_SIGNALING pre-eclampsia DOID_10591 3.065E-03 0.01937578 0.07862704 0.36671137 LU_IL4_SIGNALING neuritis DOID_1803 3.065E-03 0.01916286 1.000 1.000 LU_IL4_SIGNALING heart valve disease DOID_4079 3.065E-03 0.01895457 0.07862704 0.36079667 LU_IL4_SIGNALING hemolytic anemia DOID_583 3.186E-03 0.01949561 0.08013585 0.36188334 LU_IL4_SIGNALING normocytic anemia DOID_720 3.186E-03 0.01949561 0.08013585 0.36188334 LU_IL4_SIGNALING aortic aneurysm DOID_3627 3.437E-03 0.02080267 0.08314619 0.36961079 LU_IL4_SIGNALING B-cell lymphocytic neoplasm DOID_707 3.565E-03 0.02135295 3.565E-03 0.09220593 LU_IL4_SIGNALING atopic dermatitis DOID_3310 3.696E-03 0.0219049 1.000 1.000 LU_IL4_SIGNALING sarcoidosis DOID_11335 3.829E-03 0.02245843 1.000 1.000 LU_IL4_SIGNALING pustulosis of palm and sole DOID_4398 4.101E-03 0.02381035 0.09062968 0.38483799 LU_IL4_SIGNALING hypersensitivity reaction type IV disease DOID_2916 4.526E-03 0.02601168 1.000 1.000 LU_IL4_SIGNALING endocrine pancreas disease DOID_1428 5.434E-03 0.03091786 0.10394883 0.41948146 LU_IL4_SIGNALING cholestasis DOID_13580 5.593E-03 0.03150634 1.000 1.000 LU_IL4_SIGNALING cerebral degeneration DOID_1443 5.593E-03 0.03119746 5.593E-03 0.12239002 LU_IL4_SIGNALING hyperglycemia DOID_4195 5.753E-03 0.03178347 1.000 1.000 LU_IL4_SIGNALING tooth disease DOID_1091 5.916E-03 0.03236975 0.10834575 0.43414601 LU_IL4_SIGNALING endocrine organ benign neoplasm DOID_0060089 6.082E-03 0.03295624 0.10980667 0.43692304 LU_IL4_SIGNALING nephrosis DOID_2527 6.589E-03 0.03537161 0.11417531 0.44497088 LU_IL4_SIGNALING bile duct disease DOID_4138 6.589E-03 0.03504103 1.000 1.000 LU_IL4_SIGNALING male reproductive system disease DOID_48 6.589E-03 0.03471658 1.000 1.000 LU_IL4_SIGNALING peripheral vascular disease DOID_341 6.763E-03 0.03530351 0.11562682 0.44756233 LU_IL4_SIGNALING biliary tract disease DOID_9741 6.763E-03 0.03498257 1.000 1.000 LU_IL4_SIGNALING metabolic syndrome X DOID_14221 8.034E-03 0.04118562 1.000 1.000 LU_IL4_SIGNALING primary immunodeficiency disease DOID_612 9.814E-03 0.04985958 9.814E-03 0.16424333 LU_IL4_SIGNALING carbohydrate metabolic disorder DOID_2978 0.01065631 0.05365877 1.000 1.000 LU_IL4_SIGNALING alcohol-related neurodevelopmental disorder DOID_0050667 0.01087168 0.05426304 0.01087168 0.17674246 LU_IL4_SIGNALING mouth disease DOID_403 0.01087168 0.05379118 0.14557382 0.5343968 LU_IL4_SIGNALING ulcerative colitis DOID_8577 0.01175231 0.05764708 0.15116381 0.54438107 LU_IL4_SIGNALING brachydactyly DOID_0050581 0.01623617 0.07896054 0.01623617 0.25662174 LU_IL4_SIGNALING Diamond-Blackfan anemia DOID_1339 0.01623617 0.07829138 0.01623617 0.24968602 LU_IL4_SIGNALING hyperparathyroidism DOID_13543 0.01623617 0.07763347 1.000 1.000 LU_IL4_SIGNALING retinal vascular occlusion DOID_1729 0.01623617 0.07698652 1.000 1.000 LU_IL4_SIGNALING phagocyte bactericidal dysfunction DOID_3262 0.01623617 0.07635027 0.01623617 0.24311534 LU_IL4_SIGNALING Hermansky-Pudlak syndrome DOID_3753 0.01623617 0.07572445 1.000 1.000 LU_IL4_SIGNALING Paget's disease of bone DOID_5408 0.01623617 0.0751088 0.01623617 0.23688161 LU_IL4_SIGNALING acute T cell leukemia DOID_5603 0.01623617 0.07450309 1.000 1.000 LU_IL4_SIGNALING Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01623617 0.07390706 0.01623617 0.23095957 LU_IL4_SIGNALING Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01623617 0.07390706 0.01623617 0.23095957 LU_IL4_SIGNALING Hodgkin's granuloma DOID_8651 0.01623617 0.07390706 0.01623617 0.23095957 LU_IL4_SIGNALING Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01623617 0.07390706 0.01623617 0.23095957 LU_IL4_SIGNALING alopecia areata DOID_986 0.01623617 0.0733205 0.01623617 0.2199615 LU_IL4_SIGNALING trypanosomiasis DOID_10113 0.01784545 0.07995326 1.000 1.000 LU_IL4_SIGNALING prediabetes syndrome DOID_11716 0.01784545 0.07932862 1.000 1.000 LU_IL4_SIGNALING neuronal ceroid lipofuscinosis DOID_14503 0.01784545 0.07871367 0.01784545 0.23614102 LU_IL4_SIGNALING common cold DOID_10459 0.01945215 0.08514054 1.000 1.000 LU_IL4_SIGNALING esophageal carcinoma DOID_1107 0.01945215 0.08449062 0.01945215 0.25155161 LU_IL4_SIGNALING diarrhea DOID_13250 0.01945215 0.08385054 0.01945215 0.24596157 LU_IL4_SIGNALING osteopetrosis DOID_13533 0.01945215 0.08322008 0.01945215 0.24061458 LU_IL4_SIGNALING aortic valve stenosis DOID_1712 0.01945215 0.08259904 1.000 1.000 LU_IL4_SIGNALING pituitary cancer DOID_1785 0.01945215 0.08198719 0.01945215 0.23549512 LU_IL4_SIGNALING esophagus squamous cell carcinoma DOID_3748 0.01945215 0.08449062 0.01945215 0.25155161 LU_IL4_SIGNALING pituitary carcinoma DOID_4916 0.01945215 0.08198719 0.01945215 0.23549512 LU_IL4_SIGNALING aortic valve insufficiency DOID_57 0.01945215 0.08138434 0.01945215 0.23058897 LU_IL4_SIGNALING Hodgkin's lymphoma DOID_8567 0.01945215 0.0807903 0.01945215 0.22588308 LU_IL4_SIGNALING encephalitis DOID_9588 0.01945215 0.08020486 0.01945215 0.22136541 LU_IL4_SIGNALING parathyroid gland disease DOID_11201 0.02105625 0.08619429 1.000 1.000 LU_IL4_SIGNALING psoriatic arthritis DOID_9008 0.02105625 0.08557862 0.02105625 0.23040397 LU_IL4_SIGNALING viral pneumonia DOID_10533 0.02265777 0.09143456 0.02265777 0.24325043 LU_IL4_SIGNALING hypercalcemia DOID_12678 0.02265777 0.09079065 1.000 1.000 LU_IL4_SIGNALING T-cell leukemia DOID_715 0.02265777 0.09015575 1.000 1.000 LU_IL4_SIGNALING idiopathic pulmonary fibrosis DOID_0050156 0.02425672 0.09584773 0.02425672 0.25559394 LU_IL4_SIGNALING membranoproliferative glomerulonephritis DOID_2920 0.02425672 0.09518671 0.02425672 0.25094677 LU_IL4_SIGNALING lung oat cell carcinoma DOID_5411 0.02425672 0.09453474 1.000 1.000 LU_IL4_SIGNALING hemolytic-uremic syndrome DOID_12554 0.02585309 0.09939465 1.000 1.000 LU_IL4_SIGNALING pituitary adenoma DOID_3829 0.02585309 0.09872757 0.02585309 0.25362772 LU_IL4_SIGNALING restrictive cardiomyopathy DOID_397 0.02585309 0.09806939 0.02585309 0.24932895 LU_IL4_SIGNALING chronic myeloid leukemia DOID_8552 0.02585309 0.09741992 1.000 1.000 LU_IL4_SIGNALING tongue cancer DOID_8649 0.02585309 0.096779 0.02585309 0.24115423 LY_AGING_OLD_DN nephroblastoma DOID_2154 3.072E-06 1.748E-03 3.701E-04 0.04211523 LY_AGING_OLD_DN embryonal cancer DOID_688 3.901E-06 1.11E-03 3.901E-06 2.22E-03 LY_AGING_OLD_DN pre-malignant neoplasm DOID_0060071 1.783E-05 3.381E-03 1.176E-03 0.06689481 LY_AGING_OLD_DN in situ carcinoma DOID_8719 1.783E-05 3.381E-03 1.176E-03 0.06689481 LY_AGING_OLD_DN nervous system cancer DOID_3093 4.827E-05 6.867E-03 4.827E-05 0.01373362 LY_AGING_OLD_DN skeletal system cancer DOID_0060124 5.896E-05 6.709E-03 0.0114151 0.3092949 LY_AGING_OLD_DN bone cancer DOID_184 5.896E-05 6.709E-03 0.0114151 0.3092949 LY_AGING_OLD_DN spastic diplegia DOID_10965 6.735E-05 6.387E-03 6.735E-05 0.01277387 LY_AGING_OLD_DN tongue cancer DOID_8649 6.735E-05 5.475E-03 0.01217162 0.27702604 LY_AGING_OLD_DN Barrett's esophagus DOID_9206 6.735E-05 4.79E-03 0.01217162 0.26637119 LY_AGING_OLD_DN esophagitis DOID_11963 1.064E-04 6.729E-03 0.0151921 0.24698014 LY_AGING_OLD_DN spastic cerebral palsy DOID_0050669 2.94E-04 0.01672603 2.94E-04 0.04181508 LY_AGING_OLD_DN spindle cell carcinoma DOID_4015 3.701E-04 0.01914329 0.02792996 0.29429902 LY_AGING_OLD_DN esophageal disease DOID_6050 3.701E-04 0.01754801 0.02792996 0.28894813 LY_AGING_OLD_DN peptic ulcer DOID_750 4.773E-04 0.02089128 0.03164602 0.30010971 LY_AGING_OLD_DN cervix uteri carcinoma in situ DOID_8991 5.239E-04 0.02129396 0.03312859 0.29920904 LY_AGING_OLD_DN endometriosis of uterus DOID_288 5.48E-04 0.02078889 0.03386906 0.30111712 LY_AGING_OLD_DN endometriosis DOID_289 5.727E-04 0.02036582 0.03460898 0.30296169 LY_AGING_OLD_DN diabetic autonomic neuropathy DOID_11503 5.978E-04 0.02001025 0.03534835 0.30474565 LY_AGING_OLD_DN autonomic neuropathy DOID_11504 5.978E-04 0.02001025 0.03534835 0.30474565 LY_AGING_OLD_DN diabetic polyneuropathy DOID_12785 5.978E-04 0.02001025 0.03534835 0.30474565 LY_AGING_OLD_DN diabetic neuropathy DOID_9743 5.978E-04 0.02001025 0.03534835 0.30474565 LY_AGING_OLD_DN autonomic nervous system disease DOID_11465 6.765E-04 0.02138561 0.03756319 0.30533508 LY_AGING_OLD_DN brain cancer DOID_1319 6.765E-04 0.02026005 6.765E-04 0.06415682 LY_AGING_OLD_DN central nervous system cancer DOID_3620 7.038E-04 0.02002315 7.038E-04 0.05720899 LY_AGING_OLD_DN aortic aneurysm DOID_3627 7.599E-04 0.02059066 0.03977312 0.31874514 LY_AGING_OLD_DN giant cell tumor DOID_200 8.481E-04 0.02193416 0.04197815 0.32719954 LY_AGING_OLD_DN malignant giant cell tumor DOID_2705 8.481E-04 0.02193416 0.04197815 0.32719954 LY_AGING_OLD_DN giant cell glioblastoma DOID_3074 8.481E-04 0.02193416 0.04197815 0.32719954 LY_AGING_OLD_DN bile duct adenocarcinoma DOID_4896 8.785E-04 0.02173312 0.04271207 0.32404224 LY_AGING_OLD_DN cholangiocarcinoma DOID_4947 8.785E-04 0.02173312 0.04271207 0.32404224 LY_AGING_OLD_DN reproductive organ benign neoplasm DOID_0050622 9.094E-04 0.0215612 9.094E-04 0.0646836 LY_AGING_OLD_DN congenital nervous system abnormality DOID_2490 9.729E-04 0.02214282 9.729E-04 0.06150784 LY_AGING_OLD_DN glioblastoma DOID_3068 1.005E-03 0.02200248 0.04564234 0.32874036 LY_AGING_OLD_DN bile duct cancer DOID_4606 1.005E-03 0.02118757 0.04564234 0.32463111 LY_AGING_OLD_DN bile duct carcinoma DOID_4897 1.005E-03 0.02118757 0.04564234 0.32463111 LY_AGING_OLD_DN oral cavity cancer DOID_8618 1.005E-03 0.02043087 0.04564234 0.32062332 LY_AGING_OLD_DN uterine disease DOID_345 1.247E-03 0.02447425 0.05074947 0.33577267 LY_AGING_OLD_DN astrocytoma DOID_3069 1.397E-03 0.0264954 0.05365598 0.33922502 LY_AGING_OLD_DN pancreatic ductal carcinoma DOID_3587 1.436E-03 0.0263505 0.05438126 0.34003228 LY_AGING_OLD_DN male reproductive system disease DOID_48 1.475E-03 0.02622371 0.05510601 0.33715396 LY_AGING_OLD_DN pancreatic carcinoma DOID_4905 1.555E-03 0.02680644 0.05655389 0.33872804 LY_AGING_OLD_DN cystic fibrosis DOID_1485 1.637E-03 0.02738882 0.05799963 0.34376866 LY_AGING_OLD_DN aneurysm disease DOID_2403 1.678E-03 0.02728443 0.0587217 0.34094539 LY_AGING_OLD_DN mixed glioma DOID_5076 1.721E-03 0.02719382 0.05944324 0.34164849 LY_AGING_OLD_DN female reproductive system disease DOID_229 1.85E-03 0.02845306 0.06160463 0.34365722 LY_AGING_OLD_DN biliary tract cancer DOID_4607 1.939E-03 0.02903636 0.0630429 0.34826613 LY_AGING_OLD_DN transitional cell carcinoma DOID_2671 2.17E-03 0.03166414 0.06662927 0.36453896 LY_AGING_OLD_DN lymphoma DOID_0060058 2.364E-03 0.03363013 0.06948881 0.37656317 LY_AGING_OLD_DN encephalomyelitis DOID_640 2.414E-03 0.03349961 0.07020237 0.37684104 LY_AGING_OLD_DN mouth disease DOID_403 2.464E-03 0.03338199 0.07091541 0.37711091 LY_AGING_OLD_DN ulcerative colitis DOID_8577 2.67E-03 0.03532739 0.07376227 0.38505259 LY_AGING_OLD_DN hyperparathyroidism DOID_13543 7.624E-03 0.09859372 1.000 1.000 LY_AGING_OLD_DN rectal neoplasm DOID_1984 7.624E-03 0.09640275 7.624E-03 0.39437487 LY_AGING_OLD_DN rectum cancer DOID_1993 7.624E-03 0.09640275 7.624E-03 0.39437487 LY_AGING_OLD_DN cutaneous leishmaniasis DOID_9111 7.624E-03 0.09430703 7.624E-03 0.3615103 LY_AGING_OLD_DN breast benign neoplasm DOID_0060082 8.383E-03 0.09937865 8.383E-03 0.36693657 LY_AGING_OLD_DN thoracic benign neoplasm DOID_0060097 8.383E-03 0.09937865 8.383E-03 0.36693657 LY_AGING_OLD_DN benign breast phyllodes tumor DOID_1631 8.383E-03 0.09937865 8.383E-03 0.36693657 LY_AGING_OLD_DN Lynch syndrome DOID_3883 9.9E-03 0.0988302 9.9E-03 0.29649061 LY_AGING_OLD_DN intermediate coronary syndrome DOID_8805 0.0114151 0.09992604 0.0114151 0.27063303 CONRAD_STEM_CELL embryonal cancer DOID_688 3.347E-11 1.904E-08 3.347E-11 1.904E-08 CONRAD_STEM_CELL thyroid adenoma DOID_2891 3.752E-06 1.068E-03 3.752E-06 1.068E-03 CONRAD_STEM_CELL endocrine organ benign neoplasm DOID_0060089 1.085E-05 2.058E-03 1.085E-05 2.058E-03 CONRAD_STEM_CELL microphthalmia DOID_10629 6.645E-05 9.453E-03 6.645E-05 9.453E-03 CONRAD_STEM_CELL papillary adenoma DOID_3172 1.224E-04 0.01393387 1.224E-04 0.01393387 CONRAD_STEM_CELL microcystic adenoma DOID_5403 1.224E-04 0.01393387 1.224E-04 0.01393387 CONRAD_STEM_CELL follicular adenoma DOID_6204 1.224E-04 0.01393387 1.224E-04 0.01393387 CONRAD_STEM_CELL autonomic nervous system neoplasm DOID_2621 2.069E-04 0.01962537 0.02102573 0.32334165 CONRAD_STEM_CELL neuroblastoma DOID_769 2.069E-04 0.01962537 0.02102573 0.32334165 CONRAD_STEM_CELL papilloma DOID_2615 2.19E-04 0.01780469 2.19E-04 0.02077214 CONRAD_STEM_CELL adenoma DOID_657 2.573E-04 0.01830372 2.573E-04 0.02091854 CONRAD_STEM_CELL peripheral nervous system neoplasm DOID_1192 2.846E-04 0.01799128 0.02458742 0.30413565 CONRAD_STEM_CELL adult respiratory distress syndrome DOID_11394 3.131E-04 0.01781796 3.131E-04 0.02227245 CONRAD_STEM_CELL giant cell tumor DOID_200 5.315E-04 0.02749257 0.03343749 0.33378824 CONRAD_STEM_CELL malignant giant cell tumor DOID_2705 5.315E-04 0.02749257 0.03343749 0.33378824 CONRAD_STEM_CELL giant cell glioblastoma DOID_3074 5.315E-04 0.02749257 0.03343749 0.33378824 CONRAD_STEM_CELL glioblastoma DOID_3068 6.304E-04 0.02989209 0.0363704 0.32848824 CONRAD_STEM_CELL respiratory failure DOID_11162 7.155E-04 0.03131596 7.155E-04 0.04523417 CONRAD_STEM_CELL congenital heart defect DOID_1682 7.376E-04 0.02997678 7.376E-04 0.04196749 CONRAD_STEM_CELL astrocytoma DOID_3069 8.769E-04 0.03326553 0.04279288 0.35288625 CONRAD_STEM_CELL transitional cell carcinoma DOID_2671 1.365E-03 0.04854293 1.365E-03 0.07060789 CONRAD_STEM_CELL nervous system cancer DOID_3093 1.426E-03 0.04771705 0.05436537 0.40173889 CONRAD_STEM_CELL lymphoblastic leukemia DOID_1037 1.519E-03 0.04801669 0.05608966 0.40916685 SANA_TNF_SIGNALING_UP pulmonary emphysema DOID_9675 3.818E-13 2.173E-10 1.000 1.000 SANA_TNF_SIGNALING_UP primary bacterial infectious disease DOID_0050338 8.659E-13 2.464E-10 0.12341012 0.96192274 SANA_TNF_SIGNALING_UP hypersensitivity reaction type I disease DOID_1205 1.756E-12 3.331E-10 9.121E-03 0.32435638 SANA_TNF_SIGNALING_UP cholestasis DOID_13580 9.401E-12 1.337E-09 1.000 1.000 SANA_TNF_SIGNALING_UP pleural disease DOID_1532 1.237E-11 1.408E-09 1.000 1.000 SANA_TNF_SIGNALING_UP bile duct disease DOID_4138 1.733E-11 1.644E-09 1.000 1.000 SANA_TNF_SIGNALING_UP biliary tract disease DOID_9741 1.91E-11 1.552E-09 1.000 1.000 SANA_TNF_SIGNALING_UP bacterial pneumonia DOID_874 3.039E-11 2.162E-09 1.000 1.000 SANA_TNF_SIGNALING_UP influenza DOID_8469 8.075E-11 5.105E-09 0.06715787 0.72099679 SANA_TNF_SIGNALING_UP ulcerative colitis DOID_8577 1.497E-10 8.518E-09 4.46E-04 0.03171933 SANA_TNF_SIGNALING_UP aortic aneurysm DOID_3627 1.715E-10 8.87E-09 2.814E-03 0.13341993 SANA_TNF_SIGNALING_UP pleurisy DOID_10247 8.113E-10 3.847E-08 1.000 1.000 SANA_TNF_SIGNALING_UP aneurysm disease DOID_2403 2.016E-09 8.824E-08 6.139E-03 0.2686836 SANA_TNF_SIGNALING_UP Legionnaires' disease DOID_10457 4.226E-09 1.717E-07 1.000 1.000 SANA_TNF_SIGNALING_UP legionellosis DOID_10458 4.226E-09 1.717E-07 1.000 1.000 SANA_TNF_SIGNALING_UP viral pneumonia DOID_10533 4.226E-09 1.603E-07 1.000 1.000 SANA_TNF_SIGNALING_UP respiratory syncytial virus infectious disease DOID_1273 4.778E-09 1.699E-07 1.000 1.000 SANA_TNF_SIGNALING_UP cerebral infarction DOID_3526 9.553E-09 3.198E-07 0.06853753 0.72218245 SANA_TNF_SIGNALING_UP pustulosis of palm and sole DOID_4398 2.528E-08 7.991E-07 1.707E-06 9.711E-04 SANA_TNF_SIGNALING_UP acute pancreatitis DOID_2913 5.276E-08 1.58E-06 1.000 1.000 SANA_TNF_SIGNALING_UP brain infarction DOID_3454 7.079E-08 2.014E-06 0.09972215 0.84689404 SANA_TNF_SIGNALING_UP middle cerebral artery infarction DOID_3525 8.512E-08 2.306E-06 1.000 1.000 SANA_TNF_SIGNALING_UP cystic fibrosis DOID_1485 1.139E-07 2.945E-06 1.000 1.000 SANA_TNF_SIGNALING_UP pancreatitis DOID_4989 1.294E-07 3.201E-06 1.000 1.000 SANA_TNF_SIGNALING_UP mixed glioma DOID_5076 1.294E-07 3.068E-06 2.314E-04 0.03291378 SANA_TNF_SIGNALING_UP metabolic syndrome X DOID_14221 1.465E-07 3.335E-06 6.598E-03 0.26816709 SANA_TNF_SIGNALING_UP contact dermatitis DOID_2773 1.465E-07 3.207E-06 2.489E-04 0.02832287 SANA_TNF_SIGNALING_UP abdominal aortic aneurysm DOID_7693 1.692E-07 3.565E-06 0.0476307 0.71320706 SANA_TNF_SIGNALING_UP Human immunodeficiency virus infectious disease DOID_526 2.612E-07 5.307E-06 8.239E-03 0.3125226 SANA_TNF_SIGNALING_UP multiple myeloma DOID_9538 3.749E-07 7.357E-06 0.05744395 0.69543847 SANA_TNF_SIGNALING_UP hepatitis DOID_2237 4.582E-07 8.691E-06 0.06022945 0.69939912 SANA_TNF_SIGNALING_UP systemic scleroderma DOID_418 4.582E-07 8.41E-06 0.06022945 0.68541114 SANA_TNF_SIGNALING_UP intracranial arterial disease DOID_13089 5.046E-07 8.973E-06 1.000 1.000 SANA_TNF_SIGNALING_UP cerebral arterial disease DOID_3527 5.046E-07 8.973E-06 1.000 1.000 SANA_TNF_SIGNALING_UP rheumatic disease DOID_1575 6.651E-07 1.147E-05 0.06577621 0.73385619 SANA_TNF_SIGNALING_UP scleroderma DOID_419 6.651E-07 1.147E-05 0.06577621 0.73385619 SANA_TNF_SIGNALING_UP myeloma DOID_0070004 9.345E-07 1.564E-05 0.07129082 0.73753595 SANA_TNF_SIGNALING_UP pulmonary tuberculosis DOID_2957 1.096E-06 1.782E-05 1.000 1.000 SANA_TNF_SIGNALING_UP sarcoidosis DOID_11335 1.481E-06 2.34E-05 0.07950284 0.75395191 SANA_TNF_SIGNALING_UP bone marrow cancer DOID_4960 1.591E-06 2.446E-05 0.08086456 0.75429397 SANA_TNF_SIGNALING_UP vasculitis DOID_865 1.591E-06 2.382E-05 1.000 1.000 SANA_TNF_SIGNALING_UP hypersensitivity reaction type IV disease DOID_2916 2.092E-06 3.053E-05 0.08629167 0.79193486 SANA_TNF_SIGNALING_UP carotid artery disease DOID_3407 2.539E-06 3.612E-05 1.000 1.000 SANA_TNF_SIGNALING_UP collagen disease DOID_854 2.539E-06 3.524E-05 0.09034134 0.79083421 SANA_TNF_SIGNALING_UP psoriasis DOID_8893 2.909E-06 3.941E-05 2.909E-06 8.276E-04 SANA_TNF_SIGNALING_UP allergic contact dermatitis DOID_3042 3.64E-06 4.817E-05 1.558E-04 0.02954616 SANA_TNF_SIGNALING_UP tuberculosis DOID_399 3.853E-06 4.983E-05 1.000 1.000 SANA_TNF_SIGNALING_UP acquired immunodeficiency syndrome DOID_635 4.608E-06 5.827E-05 0.03200679 0.7004563 SANA_TNF_SIGNALING_UP urticaria DOID_1555 7.748E-06 9.584E-05 1.000 1.000 SANA_TNF_SIGNALING_UP cystitis DOID_1679 8.707E-06 1.054E-04 0.03913953 0.82482933 SANA_TNF_SIGNALING_UP extrinsic allergic alveolitis DOID_841 9.742E-06 1.155E-04 1.000 1.000 SANA_TNF_SIGNALING_UP primary immunodeficiency disease DOID_612 1.037E-05 1.204E-04 3.382E-04 0.0320743 SANA_TNF_SIGNALING_UP gestational diabetes DOID_11714 1.085E-05 1.235E-04 0.04197815 0.77050214 SANA_TNF_SIGNALING_UP periodontitis DOID_824 1.085E-05 1.211E-04 1.000 1.000 SANA_TNF_SIGNALING_UP autoimmune disease of cardiovascular system DOID_0060051 1.205E-05 1.318E-04 1.000 1.000 SANA_TNF_SIGNALING_UP Behcet's disease DOID_13241 1.205E-05 1.318E-04 1.000 1.000 SANA_TNF_SIGNALING_UP coronary stenosis DOID_4248 1.205E-05 1.293E-04 0.04339437 0.74822409 SANA_TNF_SIGNALING_UP encephalomyelitis DOID_640 1.23E-05 1.296E-04 1.000 1.000 SANA_TNF_SIGNALING_UP mouth disease DOID_403 1.282E-05 1.326E-04 0.13245586 1.000 SANA_TNF_SIGNALING_UP bronchiolitis obliterans DOID_2799 1.614E-05 1.64E-04 0.0476307 0.73248293 SANA_TNF_SIGNALING_UP bladder disease DOID_365 1.932E-05 1.929E-04 0.05044468 0.70007372 SANA_TNF_SIGNALING_UP myocarditis DOID_820 2.106E-05 2.066E-04 1.000 1.000 SANA_TNF_SIGNALING_UP periodontal disease DOID_3388 2.289E-05 2.207E-04 1.000 1.000 SANA_TNF_SIGNALING_UP esophageal disease DOID_6050 2.289E-05 2.171E-04 0.05325049 0.70464024 SANA_TNF_SIGNALING_UP pulmonary sarcoidosis DOID_13406 2.901E-05 2.706E-04 0.05744395 0.7105567 SANA_TNF_SIGNALING_UP uveitis DOID_13141 3.127E-05 2.87E-04 1.000 1.000 SANA_TNF_SIGNALING_UP adult respiratory distress syndrome DOID_11394 3.613E-05 3.263E-04 1.000 1.000 SANA_TNF_SIGNALING_UP autoimmune disease of urogenital tract DOID_0060049 4.145E-05 3.685E-04 2.037E-03 0.10536124 SANA_TNF_SIGNALING_UP primary biliary cirrhosis DOID_12236 4.145E-05 3.685E-04 2.037E-03 0.10536124 SANA_TNF_SIGNALING_UP uveal disease DOID_3480 4.43E-05 3.878E-04 1.000 1.000 SANA_TNF_SIGNALING_UP vascular skin disease DOID_9540 5.696E-05 4.91E-04 1.000 1.000 SANA_TNF_SIGNALING_UP autoimmune disease of gastrointestinal tract DOID_0060031 6.409E-05 5.443E-04 0.07403612 0.7263199 SANA_TNF_SIGNALING_UP parasitic protozoa infectious disease DOID_2789 8.892E-05 7.44E-04 1.000 1.000 SANA_TNF_SIGNALING_UP interstitial nephritis DOID_1063 9.571E-05 7.892E-04 1.000 1.000 SANA_TNF_SIGNALING_UP conjunctival disease DOID_4251 9.571E-05 7.78E-04 1.000 1.000 SANA_TNF_SIGNALING_UP conjunctivitis DOID_6195 9.571E-05 7.78E-04 1.000 1.000 SANA_TNF_SIGNALING_UP cutaneous leishmaniasis DOID_9111 9.571E-05 7.67E-04 1.000 1.000 SANA_TNF_SIGNALING_UP pneumocystosis DOID_11339 1.169E-04 9.236E-04 1.000 1.000 SANA_TNF_SIGNALING_UP respiratory failure DOID_11162 1.25E-04 9.74E-04 1.000 1.000 SANA_TNF_SIGNALING_UP common cold DOID_10459 1.401E-04 1.077E-03 1.000 1.000 SANA_TNF_SIGNALING_UP encephalitis DOID_9588 1.401E-04 1.063E-03 1.000 1.000 SANA_TNF_SIGNALING_UP parasitic infectious disease DOID_1398 1.429E-04 1.07E-03 1.000 1.000 SANA_TNF_SIGNALING_UP tooth disease DOID_1091 1.558E-04 1.151E-03 1.000 1.000 SANA_TNF_SIGNALING_UP leprosy DOID_1024 1.654E-04 1.207E-03 0.01903658 0.57009554 SANA_TNF_SIGNALING_UP newborn respiratory distress syndrome DOID_12716 1.654E-04 1.191E-03 1.000 1.000 SANA_TNF_SIGNALING_UP nephrosis DOID_2527 1.837E-04 1.307E-03 1.000 1.000 SANA_TNF_SIGNALING_UP male reproductive system disease DOID_48 1.837E-04 1.29E-03 1.000 1.000 SANA_TNF_SIGNALING_UP peripheral vascular disease DOID_341 1.912E-04 1.326E-03 1.000 1.000 SANA_TNF_SIGNALING_UP eyelid disease DOID_530 1.928E-04 1.322E-03 1.000 1.000 SANA_TNF_SIGNALING_UP diabetic retinopathy DOID_8947 1.988E-04 1.347E-03 1.000 1.000 SANA_TNF_SIGNALING_UP arthropathy DOID_381 2.223E-04 1.488E-03 1.000 1.000 SANA_TNF_SIGNALING_UP Barrett's esophagus DOID_9206 2.538E-04 1.679E-03 0.02337884 0.55427327 SANA_TNF_SIGNALING_UP chronic kidney failure DOID_784 2.767E-04 1.81E-03 1.000 1.000 SANA_TNF_SIGNALING_UP bronchitis DOID_6132 2.873E-04 1.858E-03 1.000 1.000 SANA_TNF_SIGNALING_UP retinal vascular disease DOID_2462 2.963E-04 1.895E-03 1.000 1.000 SANA_TNF_SIGNALING_UP MHC class II deficiency DOID_5812 3.606E-04 2.28E-03 3.606E-04 0.02931116 SANA_TNF_SIGNALING_UP leishmaniasis DOID_9065 3.606E-04 2.255E-03 1.000 1.000 SANA_TNF_SIGNALING_UP Crohn's disease DOID_8778 3.957E-04 2.447E-03 0.13245586 1.000 SANA_TNF_SIGNALING_UP esophagitis DOID_11963 4.003E-04 2.449E-03 1.000 1.000 SANA_TNF_SIGNALING_UP brain edema DOID_4724 4.003E-04 2.423E-03 1.000 1.000 SANA_TNF_SIGNALING_UP autoimmune hepatitis DOID_2048 4.42E-04 2.647E-03 1.000 1.000 SANA_TNF_SIGNALING_UP coronary restenosis DOID_4247 4.42E-04 2.62E-03 1.000 1.000 SANA_TNF_SIGNALING_UP myasthenia gravis DOID_437 5.315E-04 3.118E-03 1.000 1.000 SANA_TNF_SIGNALING_UP uremia DOID_4676 5.315E-04 3.086E-03 1.000 1.000 SANA_TNF_SIGNALING_UP severe combined immunodeficiency DOID_627 6.29E-04 3.615E-03 6.29E-04 0.03976883 SANA_TNF_SIGNALING_UP commensal bacterial infectious disease DOID_0050339 6.808E-04 3.874E-03 1.000 1.000 SANA_TNF_SIGNALING_UP bronchiolitis DOID_2942 6.808E-04 3.835E-03 1.000 1.000 SANA_TNF_SIGNALING_UP combined T cell and B cell immunodeficiency DOID_628 6.808E-04 3.798E-03 6.808E-04 0.03873787 SANA_TNF_SIGNALING_UP neuromuscular junction disease DOID_439 7.346E-04 4.058E-03 1.000 1.000 SANA_TNF_SIGNALING_UP myositis DOID_633 7.346E-04 4.019E-03 1.000 1.000 SANA_TNF_SIGNALING_UP diffuse large B-cell lymphoma DOID_0050745 8.481E-04 4.596E-03 1.000 1.000 SANA_TNF_SIGNALING_UP perinatal necrotizing enterocolitis DOID_8677 8.481E-04 4.552E-03 1.000 1.000 SANA_TNF_SIGNALING_UP autoimmune disease of the nervous system DOID_438 9.078E-04 4.827E-03 1.000 1.000 SANA_TNF_SIGNALING_UP autoimmune disease of endocrine system DOID_0060005 9.695E-04 5.108E-03 0.04480853 0.74988394 SANA_TNF_SIGNALING_UP opportunistic mycosis DOID_2473 1.099E-03 5.736E-03 1.000 1.000 SANA_TNF_SIGNALING_UP systemic mycosis DOID_0050136 1.307E-03 6.762E-03 1.000 1.000 SANA_TNF_SIGNALING_UP fungal infectious disease DOID_1564 1.307E-03 6.762E-03 1.000 1.000 SANA_TNF_SIGNALING_UP spindle cell carcinoma DOID_4015 1.381E-03 7.077E-03 0.05325049 0.72141739 SANA_TNF_SIGNALING_UP hyperthyroidism DOID_7998 1.381E-03 7.014E-03 0.05325049 0.68862569 SANA_TNF_SIGNALING_UP aplastic anemia DOID_12449 1.456E-03 7.331E-03 0.05465034 0.69102324 SANA_TNF_SIGNALING_UP congenital diaphragmatic hernia DOID_3827 1.776E-03 8.867E-03 1.000 1.000 SANA_TNF_SIGNALING_UP proteinuria DOID_576 2.41E-03 0.01192627 1.000 1.000 SANA_TNF_SIGNALING_UP pre-eclampsia DOID_10591 2.508E-03 0.01230446 0.07129082 0.72436567 SANA_TNF_SIGNALING_UP brain cancer DOID_1319 2.508E-03 0.0121993 1.000 1.000 SANA_TNF_SIGNALING_UP neuritis DOID_1803 2.508E-03 0.01209591 1.000 1.000 SANA_TNF_SIGNALING_UP bone marrow disease DOID_4961 2.508E-03 0.01199427 0.07129082 0.7116575 SANA_TNF_SIGNALING_UP central nervous system cancer DOID_3620 2.608E-03 0.0123681 1.000 1.000 SANA_TNF_SIGNALING_UP B-cell lymphocytic neoplasm DOID_707 2.919E-03 0.01372766 1.000 1.000 SANA_TNF_SIGNALING_UP atopic dermatitis DOID_3310 3.027E-03 0.01411557 1.000 1.000 SANA_TNF_SIGNALING_UP leukocyte disease DOID_9500 3.829E-03 0.01771112 1.000 1.000 SANA_TNF_SIGNALING_UP hyperglycemia DOID_4195 4.719E-03 0.02165189 0.09705165 0.8367029 SANA_TNF_SIGNALING_UP astrocytoma DOID_3069 5.126E-03 0.02333516 1.000 1.000 SANA_TNF_SIGNALING_UP alcohol abuse DOID_1574 7.073E-03 0.03193997 0.11819961 0.94726166 SANA_TNF_SIGNALING_UP amino acid metabolic disorder DOID_9252 8.067E-03 0.0361437 1.000 1.000 SANA_TNF_SIGNALING_UP nervous system cancer DOID_3093 8.239E-03 0.03662374 1.000 1.000 SANA_TNF_SIGNALING_UP lymphoma DOID_0060058 8.587E-03 0.03787449 1.000 1.000 SANA_TNF_SIGNALING_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.941E-03 0.03913449 1.000 1.000 SANA_TNF_SIGNALING_UP dilated cardiomyopathy DOID_12930 9.121E-03 0.03961605 1.000 1.000 SANA_TNF_SIGNALING_UP T cell deficiency DOID_11200 0.01467537 0.06325972 1.000 1.000 SANA_TNF_SIGNALING_UP childhood type dermatomyositis DOID_14203 0.01467537 0.06278409 1.000 1.000 SANA_TNF_SIGNALING_UP angioedema DOID_1558 0.01467537 0.06231555 1.000 1.000 SANA_TNF_SIGNALING_UP transient cerebral ischemia DOID_224 0.01467537 0.06185395 1.000 1.000 SANA_TNF_SIGNALING_UP acute kidney failure DOID_3021 0.01467537 0.06139914 1.000 1.000 SANA_TNF_SIGNALING_UP keratitis DOID_4677 0.01467537 0.06095098 0.01467537 0.49119316 SANA_TNF_SIGNALING_UP Paget's disease of bone DOID_5408 0.01467537 0.0605093 1.000 1.000 SANA_TNF_SIGNALING_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01467537 0.06007398 1.000 1.000 SANA_TNF_SIGNALING_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01467537 0.06007398 1.000 1.000 SANA_TNF_SIGNALING_UP Hodgkin's granuloma DOID_8651 0.01467537 0.06007398 1.000 1.000 SANA_TNF_SIGNALING_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01467537 0.06007398 1.000 1.000 SANA_TNF_SIGNALING_UP familial adenomatous polyposis DOID_0050424 0.01613122 0.06556187 1.000 1.000 SANA_TNF_SIGNALING_UP dermatomyositis DOID_10223 0.01613122 0.0650969 1.000 1.000 SANA_TNF_SIGNALING_UP adrenoleukodystrophy DOID_10588 0.01613122 0.06463847 1.000 1.000 SANA_TNF_SIGNALING_UP sickle cell anemia DOID_10923 0.01613122 0.06418645 1.000 1.000 SANA_TNF_SIGNALING_UP temporal arteritis DOID_13375 0.01613122 0.06374071 1.000 1.000 SANA_TNF_SIGNALING_UP neuronal ceroid lipofuscinosis DOID_14503 0.01613122 0.06330112 1.000 1.000 SANA_TNF_SIGNALING_UP prostatic adenoma DOID_2883 0.01613122 0.06286755 1.000 1.000 SANA_TNF_SIGNALING_UP central nervous system vasculitis DOID_525 0.01613122 0.06374071 1.000 1.000 SANA_TNF_SIGNALING_UP eosinophilic pneumonia DOID_5870 0.01613122 0.06243988 1.000 1.000 SANA_TNF_SIGNALING_UP pulmonary eosinophilia DOID_9498 0.01613122 0.06243988 1.000 1.000 SANA_TNF_SIGNALING_UP Loeffler syndrome DOID_9503 0.01613122 0.06243988 1.000 1.000 SANA_TNF_SIGNALING_UP bronchiectasis DOID_9563 0.01613122 0.06201799 1.000 1.000 SANA_TNF_SIGNALING_UP osteopetrosis DOID_13533 0.01758495 0.06715328 1.000 1.000 SANA_TNF_SIGNALING_UP epidermolysis bullosa DOID_2730 0.01758495 0.06670559 0.01758495 0.55587995 SANA_TNF_SIGNALING_UP lipodystrophy DOID_811 0.01758495 0.06626383 1.000 1.000 SANA_TNF_SIGNALING_UP Hodgkin's lymphoma DOID_8567 0.01758495 0.06582789 1.000 1.000 SANA_TNF_SIGNALING_UP carotid stenosis DOID_13001 0.01903658 0.07079618 1.000 1.000 SANA_TNF_SIGNALING_UP vesiculobullous skin disease DOID_2731 0.01903658 0.07033646 0.01903658 0.54159076 SANA_TNF_SIGNALING_UP Lynch syndrome DOID_3883 0.01903658 0.06988268 0.01903658 0.51580073 SANA_TNF_SIGNALING_UP psoriatic arthritis DOID_9008 0.01903658 0.06943471 0.01903658 0.49235524 SANA_TNF_SIGNALING_UP tethered spinal cord syndrome DOID_1089 0.0204861 0.07424581 1.000 1.000 SANA_TNF_SIGNALING_UP aspergillosis DOID_13564 0.0204861 0.0737759 1.000 1.000 SANA_TNF_SIGNALING_UP bacterial meningitis DOID_9470 0.0204861 0.0733119 1.000 1.000 SANA_TNF_SIGNALING_UP thoracic aortic aneurysm DOID_14004 0.02193352 0.07800108 1.000 1.000 SANA_TNF_SIGNALING_UP renovascular hypertension DOID_1591 0.02193352 0.0775166 1.000 1.000 SANA_TNF_SIGNALING_UP intermediate coronary syndrome DOID_8805 0.02193352 0.07703811 1.000 1.000 SANA_TNF_SIGNALING_UP hyperhomocysteinemia DOID_9279 0.02193352 0.07656548 1.000 1.000 SANA_TNF_SIGNALING_UP silicosis DOID_10325 0.02337884 0.08111316 1.000 1.000 SANA_TNF_SIGNALING_UP spastic diplegia DOID_10965 0.02337884 0.08062157 1.000 1.000 SANA_TNF_SIGNALING_UP Fanconi's anemia DOID_13636 0.02337884 0.08013589 0.02337884 0.57837211 SANA_TNF_SIGNALING_UP restrictive cardiomyopathy DOID_397 0.02337884 0.07965604 1.000 1.000 SANA_TNF_SIGNALING_UP thyroiditis DOID_7166 0.02337884 0.0791819 1.000 1.000 SANA_TNF_SIGNALING_UP autoimmune thyroiditis DOID_7188 0.02337884 0.0791819 1.000 1.000 SANA_TNF_SIGNALING_UP tongue cancer DOID_8649 0.02337884 0.07871336 1.000 1.000 SANA_TNF_SIGNALING_UP drug-induced mental disorder DOID_1203 0.02482206 0.08308088 1.000 1.000 SANA_TNF_SIGNALING_UP Graves' disease DOID_12361 0.02482206 0.08259503 0.02482206 0.56495001 SANA_TNF_SIGNALING_UP methylmalonic acidemia DOID_14749 0.02482206 0.08211483 1.000 1.000 SANA_TNF_SIGNALING_UP drug psychosis DOID_1742 0.02482206 0.08308088 1.000 1.000 SANA_TNF_SIGNALING_UP hyperostosis DOID_205 0.02482206 0.08164017 1.000 1.000 SANA_TNF_SIGNALING_UP substance-induced psychosis DOID_8646 0.02482206 0.08308088 1.000 1.000 SANA_TNF_SIGNALING_UP male reproductive organ benign neoplasm DOID_0060087 0.02626318 0.08588362 1.000 1.000 SANA_TNF_SIGNALING_UP osteosclerosis DOID_4254 0.02626318 0.08539286 1.000 1.000 SANA_TNF_SIGNALING_UP prion disease DOID_649 0.02626318 0.08490767 1.000 1.000 SANA_TNF_SIGNALING_UP eosinophilia DOID_999 0.02626318 0.08442797 1.000 1.000 SANA_TNF_SIGNALING_UP Down syndrome DOID_14250 0.02770221 0.0885537 1.000 1.000 SANA_TNF_SIGNALING_UP colon carcinoma DOID_1520 0.02913916 0.09262671 1.000 1.000 SANA_TNF_SIGNALING_UP subependymal glioma DOID_4843 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP pilocytic astrocytoma DOID_4851 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP subependymal giant cell astrocytoma DOID_5077 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP fibrillary astrocytoma DOID_6726 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP juvenile pilocytic astrocytoma DOID_6811 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP childhood pilocytic astrocytoma DOID_6812 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP gemistocytic astrocytoma DOID_7005 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP childhood cerebral astrocytoma DOID_7007 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP protoplasmic astrocytoma DOID_7008 0.02913916 0.09211211 1.000 1.000 SANA_TNF_SIGNALING_UP mitochondrial myopathy DOID_699 0.03057402 0.09611389 1.000 1.000 SANA_TNF_SIGNALING_UP muscular atrophy DOID_767 0.03200679 0.09951838 1.000 1.000 WANG_SMARCE1_TARGETS_DN diabetic autonomic neuropathy DOID_11503 5.956E-08 3.389E-05 5.459E-05 1.827E-03 WANG_SMARCE1_TARGETS_DN autonomic neuropathy DOID_11504 5.956E-08 3.389E-05 5.459E-05 1.827E-03 WANG_SMARCE1_TARGETS_DN diabetic polyneuropathy DOID_12785 5.956E-08 3.389E-05 5.459E-05 1.827E-03 WANG_SMARCE1_TARGETS_DN diabetic neuropathy DOID_9743 5.956E-08 3.389E-05 5.459E-05 1.827E-03 WANG_SMARCE1_TARGETS_DN autonomic nervous system disease DOID_11465 8.72E-08 2.481E-05 6.977E-05 1.985E-03 WANG_SMARCE1_TARGETS_DN ankylosing spondylitis DOID_7147 1.131E-07 2.146E-05 1.131E-07 6.438E-05 WANG_SMARCE1_TARGETS_DN pleurisy DOID_10247 1.976E-07 2.811E-05 1.976E-07 5.622E-05 WANG_SMARCE1_TARGETS_DN lymphoma DOID_0060058 2.02E-07 2.299E-05 3.811E-06 2.711E-04 WANG_SMARCE1_TARGETS_DN mouth disease DOID_403 2.335E-07 2.214E-05 4.308E-06 2.724E-04 WANG_SMARCE1_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 2.508E-07 2.038E-05 2.508E-07 4.756E-05 WANG_SMARCE1_TARGETS_DN pleural disease DOID_1532 4.423E-07 3.146E-05 4.423E-07 6.291E-05 WANG_SMARCE1_TARGETS_DN diabetic retinopathy DOID_8947 1.092E-06 6.904E-05 3.558E-04 6.327E-03 WANG_SMARCE1_TARGETS_DN benign mesothelioma DOID_2645 1.433E-06 8.155E-05 0.01598285 0.08829361 WANG_SMARCE1_TARGETS_DN mixed glioma DOID_5076 1.48E-06 7.653E-05 4.327E-04 7.035E-03 WANG_SMARCE1_TARGETS_DN uterine cancer DOID_363 2.003E-06 9.497E-05 5.459E-05 1.726E-03 WANG_SMARCE1_TARGETS_DN retinal vascular disease DOID_2462 2.424E-06 1.061E-04 5.947E-04 8.905E-03 WANG_SMARCE1_TARGETS_DN neuritis DOID_1803 2.737E-06 1.113E-04 2.737E-06 3.115E-04 WANG_SMARCE1_TARGETS_DN primary bacterial infectious disease DOID_0050338 2.77E-06 1.051E-04 2.77E-06 2.627E-04 WANG_SMARCE1_TARGETS_DN glaucoma DOID_1686 3.334E-06 1.186E-04 3.334E-06 2.71E-04 WANG_SMARCE1_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 4.029E-06 1.348E-04 9.452E-05 2.445E-03 WANG_SMARCE1_TARGETS_DN dilated cardiomyopathy DOID_12930 4.576E-06 1.447E-04 8.949E-04 0.01083427 WANG_SMARCE1_TARGETS_DN mononeuritis DOID_1802 8.889E-06 2.662E-04 8.889E-06 5.058E-04 WANG_SMARCE1_TARGETS_DN mononeuropathy DOID_1188 1.017E-05 2.894E-04 1.017E-05 5.261E-04 WANG_SMARCE1_TARGETS_DN tuberculosis DOID_399 1.562E-05 4.232E-04 1.562E-05 7.406E-04 WANG_SMARCE1_TARGETS_DN leiomyoma DOID_127 1.67E-05 4.318E-04 4.868E-04 7.694E-03 WANG_SMARCE1_TARGETS_DN myocarditis DOID_820 1.872E-05 4.631E-04 1.872E-05 8.193E-04 WANG_SMARCE1_TARGETS_DN biliary tract disease DOID_9741 2.042E-05 4.84E-04 3.382E-04 6.208E-03 WANG_SMARCE1_TARGETS_DN aplastic anemia DOID_12449 2.33E-05 5.302E-04 6.214E-04 9.066E-03 WANG_SMARCE1_TARGETS_DN bacterial pneumonia DOID_874 2.794E-05 6.114E-04 2.794E-05 1.136E-03 WANG_SMARCE1_TARGETS_DN Legionnaires' disease DOID_10457 2.896E-05 6.104E-04 2.896E-05 1.099E-03 WANG_SMARCE1_TARGETS_DN legionellosis DOID_10458 2.896E-05 6.104E-04 2.896E-05 1.099E-03 WANG_SMARCE1_TARGETS_DN open-angle glaucoma DOID_1067 2.896E-05 5.886E-04 2.896E-05 1.03E-03 WANG_SMARCE1_TARGETS_DN hepatitis DOID_2237 3.485E-05 6.838E-04 8.349E-04 0.0113103 WANG_SMARCE1_TARGETS_DN intermediate coronary syndrome DOID_8805 3.609E-05 6.845E-04 1.927E-03 0.01994063 WANG_SMARCE1_TARGETS_DN focal epilepsy DOID_2234 3.746E-05 6.875E-04 5.447E-04 8.376E-03 WANG_SMARCE1_TARGETS_DN biliary tract cancer DOID_4607 3.746E-05 6.66E-04 6.262E-03 0.0451007 WANG_SMARCE1_TARGETS_DN influenza DOID_8469 5.459E-05 9.413E-04 5.459E-05 1.635E-03 WANG_SMARCE1_TARGETS_DN myeloma DOID_0070004 6.977E-05 1.168E-03 0.02034649 0.10155395 WANG_SMARCE1_TARGETS_DN bone marrow disease DOID_4961 6.977E-05 1.134E-03 1.389E-03 0.01491536 WANG_SMARCE1_TARGETS_DN pulmonary tuberculosis DOID_2957 8.147E-05 1.288E-03 8.147E-05 2.207E-03 WANG_SMARCE1_TARGETS_DN esophagitis DOID_11963 8.898E-05 1.368E-03 3.438E-03 0.03009629 WANG_SMARCE1_TARGETS_DN giant cell tumor DOID_200 1.09E-04 1.633E-03 1.928E-03 0.01924146 WANG_SMARCE1_TARGETS_DN malignant giant cell tumor DOID_2705 1.09E-04 1.633E-03 1.928E-03 0.01924146 WANG_SMARCE1_TARGETS_DN giant cell glioblastoma DOID_3074 1.09E-04 1.633E-03 1.928E-03 0.01924146 WANG_SMARCE1_TARGETS_DN bone marrow cancer DOID_4960 1.169E-04 1.705E-03 0.02598733 0.12638283 WANG_SMARCE1_TARGETS_DN pustulosis of palm and sole DOID_4398 1.251E-04 1.779E-03 1.251E-04 3.095E-03 WANG_SMARCE1_TARGETS_DN glioblastoma DOID_3068 1.523E-04 2.114E-03 2.463E-03 0.02375267 WANG_SMARCE1_TARGETS_DN severe combined immunodeficiency DOID_627 1.766E-04 2.393E-03 1.766E-04 4.188E-03 WANG_SMARCE1_TARGETS_DN respiratory failure DOID_11162 1.949E-04 2.579E-03 1.949E-04 4.436E-03 WANG_SMARCE1_TARGETS_DN combined T cell and B cell immunodeficiency DOID_628 1.99E-04 2.574E-03 1.99E-04 4.356E-03 WANG_SMARCE1_TARGETS_DN spinal muscular atrophy DOID_12377 2.232E-04 2.822E-03 2.232E-04 4.704E-03 WANG_SMARCE1_TARGETS_DN cholestasis DOID_13580 2.321E-04 2.871E-03 2.321E-04 4.716E-03 WANG_SMARCE1_TARGETS_DN cerebral degeneration DOID_1443 2.321E-04 2.81E-03 3.354E-03 0.02981805 WANG_SMARCE1_TARGETS_DN temporal lobe epilepsy DOID_3328 2.455E-04 2.911E-03 3.495E-03 0.03013255 WANG_SMARCE1_TARGETS_DN extrinsic allergic alveolitis DOID_841 2.492E-04 2.894E-03 6.685E-03 0.04582748 WANG_SMARCE1_TARGETS_DN tooth disease DOID_1091 2.595E-04 2.953E-03 3.64E-03 0.0309132 WANG_SMARCE1_TARGETS_DN diffuse large B-cell lymphoma DOID_0050745 2.771E-04 3.091E-03 7.16E-03 0.04849712 WANG_SMARCE1_TARGETS_DN Sciatic Neuropathy DOID_11446 2.771E-04 3.032E-03 2.771E-04 5.436E-03 WANG_SMARCE1_TARGETS_DN lesion of sciatic nerve DOID_12528 2.771E-04 3.032E-03 2.771E-04 5.436E-03 WANG_SMARCE1_TARGETS_DN periodontitis DOID_824 2.771E-04 2.974E-03 7.16E-03 0.04792656 WANG_SMARCE1_TARGETS_DN mononeuritis of lower limb DOID_9473 2.771E-04 3.032E-03 2.771E-04 5.436E-03 WANG_SMARCE1_TARGETS_DN astrocytoma DOID_3069 2.892E-04 3.048E-03 3.941E-03 0.03297426 WANG_SMARCE1_TARGETS_DN bile duct disease DOID_4138 3.213E-04 3.324E-03 3.213E-04 6.094E-03 WANG_SMARCE1_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 3.725E-04 3.785E-03 8.672E-03 0.05482538 WANG_SMARCE1_TARGETS_DN uterine benign neoplasm DOID_0060095 3.725E-04 3.785E-03 8.672E-03 0.05482538 WANG_SMARCE1_TARGETS_DN uterine fibroid DOID_13223 3.725E-04 3.785E-03 8.672E-03 0.05482538 WANG_SMARCE1_TARGETS_DN cystic fibrosis DOID_1485 3.929E-04 3.922E-03 3.929E-04 6.775E-03 WANG_SMARCE1_TARGETS_DN bone resorption disease DOID_0080011 4.125E-04 4.047E-03 5.11E-03 0.03929148 WANG_SMARCE1_TARGETS_DN osteoporosis DOID_11476 4.125E-04 4.047E-03 5.11E-03 0.03929148 WANG_SMARCE1_TARGETS_DN electroclinical syndrome DOID_0050701 4.327E-04 4.173E-03 0.04822056 0.18170527 WANG_SMARCE1_TARGETS_DN pancreatitis DOID_4989 4.327E-04 4.104E-03 4.327E-04 7.242E-03 WANG_SMARCE1_TARGETS_DN bladder disease DOID_365 4.868E-04 4.541E-03 0.14243581 0.31782736 WANG_SMARCE1_TARGETS_DN periodontal disease DOID_3388 5.742E-04 5.27E-03 0.01147895 0.07099481 WANG_SMARCE1_TARGETS_DN esophageal disease DOID_6050 5.742E-04 5.186E-03 0.01147895 0.07023142 WANG_SMARCE1_TARGETS_DN thyroid cancer DOID_1781 6.71E-04 5.966E-03 0.01269896 0.0760601 WANG_SMARCE1_TARGETS_DN transitional cell carcinoma DOID_2671 6.758E-04 5.916E-03 0.05942487 0.20126638 WANG_SMARCE1_TARGETS_DN primary immunodeficiency disease DOID_612 7.045E-04 6.073E-03 7.045E-04 0.01002127 WANG_SMARCE1_TARGETS_DN amino acid metabolic disorder DOID_9252 7.045E-04 5.983E-03 7.557E-03 0.04999614 WANG_SMARCE1_TARGETS_DN adolescence-adult electroclinical syndrome DOID_0050705 7.231E-04 6.051E-03 0.16106511 0.34714412 WANG_SMARCE1_TARGETS_DN multiple myeloma DOID_9538 7.231E-04 5.963E-03 0.01332927 0.07739138 WANG_SMARCE1_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 7.34E-04 5.966E-03 7.34E-04 0.01018669 WANG_SMARCE1_TARGETS_DN congenital diaphragmatic hernia DOID_3827 8.349E-04 6.691E-03 0.01462984 0.08324381 WANG_SMARCE1_TARGETS_DN systemic scleroderma DOID_418 8.349E-04 6.598E-03 8.349E-04 0.01104727 WANG_SMARCE1_TARGETS_DN peptic ulcer DOID_750 8.349E-04 6.507E-03 8.349E-04 0.01079619 WANG_SMARCE1_TARGETS_DN transient cerebral ischemia DOID_224 8.38E-04 6.444E-03 0.04293898 0.17833782 WANG_SMARCE1_TARGETS_DN lateral sclerosis DOID_230 8.38E-04 6.358E-03 8.38E-04 0.0105965 WANG_SMARCE1_TARGETS_DN adult respiratory distress syndrome DOID_11394 8.946E-04 6.698E-03 8.946E-04 0.01106578 WANG_SMARCE1_TARGETS_DN pulmonary emphysema DOID_9675 9.57E-04 7.072E-03 9.57E-04 0.01134425 WANG_SMARCE1_TARGETS_DN obsessive-compulsive disorder DOID_10933 1.021E-03 7.45E-03 0.04713075 0.18368079 WANG_SMARCE1_TARGETS_DN rheumatic disease DOID_1575 1.09E-03 7.85E-03 1.09E-03 0.01265584 WANG_SMARCE1_TARGETS_DN uveal disease DOID_3480 1.09E-03 7.752E-03 0.01738728 0.09160523 WANG_SMARCE1_TARGETS_DN scleroderma DOID_419 1.09E-03 7.85E-03 1.09E-03 0.01265584 WANG_SMARCE1_TARGETS_DN gallbladder cancer DOID_3121 1.16E-03 8.152E-03 0.01810848 0.09452957 WANG_SMARCE1_TARGETS_DN common cold DOID_10459 1.222E-03 8.48E-03 1.222E-03 0.01390705 WANG_SMARCE1_TARGETS_DN cataract DOID_83 1.234E-03 8.459E-03 1.234E-03 0.01376605 WANG_SMARCE1_TARGETS_DN leukodystrophy DOID_10579 1.31E-03 8.875E-03 0.0195882 0.10041158 WANG_SMARCE1_TARGETS_DN lens disease DOID_110 1.389E-03 9.3E-03 1.389E-03 0.0152022 WANG_SMARCE1_TARGETS_DN epilepsy with generalized tonic-clonic seizures DOID_7725 1.44E-03 9.528E-03 1.000 1.000 WANG_SMARCE1_TARGETS_DN viral pneumonia DOID_10533 1.675E-03 0.01095679 1.675E-03 0.01765261 WANG_SMARCE1_TARGETS_DN bacterial meningitis DOID_9470 1.675E-03 0.01083229 0.05959687 0.19715475 WANG_SMARCE1_TARGETS_DN oral submucous fibrosis DOID_5773 1.927E-03 0.01232286 0.06371611 0.2014137 WANG_SMARCE1_TARGETS_DN hyperhomocysteinemia DOID_9279 1.927E-03 0.01218594 1.927E-03 0.01958454 WANG_SMARCE1_TARGETS_DN sarcoidosis DOID_11335 1.928E-03 0.01205234 0.21801765 0.44304302 WANG_SMARCE1_TARGETS_DN bile duct adenocarcinoma DOID_4896 2.028E-03 0.01254348 0.22144677 0.44681989 WANG_SMARCE1_TARGETS_DN cholangiocarcinoma DOID_4947 2.028E-03 0.01254348 0.22144677 0.44681989 WANG_SMARCE1_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 2.132E-03 0.0130437 0.02683931 0.12833249 WANG_SMARCE1_TARGETS_DN Fanconi's anemia DOID_13636 2.197E-03 0.01329587 2.197E-03 0.02154848 WANG_SMARCE1_TARGETS_DN mitochondrial metabolism disease DOID_700 2.239E-03 0.01341024 0.02770248 0.12920254 WANG_SMARCE1_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 2.463E-03 0.014598 0.23501439 0.4675636 WANG_SMARCE1_TARGETS_DN bile duct cancer DOID_4606 2.463E-03 0.0144475 0.23501439 0.46593446 WANG_SMARCE1_TARGETS_DN bile duct carcinoma DOID_4897 2.463E-03 0.0144475 0.23501439 0.46593446 WANG_SMARCE1_TARGETS_DN oral cavity cancer DOID_8618 2.463E-03 0.01430008 0.02946194 0.13629141 WANG_SMARCE1_TARGETS_DN keratosis DOID_161 2.784E-03 0.01600381 2.784E-03 0.02640629 WANG_SMARCE1_TARGETS_DN neuroectodermal tumor DOID_171 2.824E-03 0.01606885 2.824E-03 0.02634238 WANG_SMARCE1_TARGETS_DN collagen disease DOID_854 2.824E-03 0.01590975 2.824E-03 0.0259175 WANG_SMARCE1_TARGETS_DN Down syndrome DOID_14250 3.103E-03 0.01731074 3.103E-03 0.02802692 WANG_SMARCE1_TARGETS_DN brain infarction DOID_3454 3.789E-03 0.02092893 0.03889302 0.16893226 WANG_SMARCE1_TARGETS_DN mitochondrial myopathy DOID_699 3.789E-03 0.02073061 0.08805763 0.23746346 WANG_SMARCE1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 4.097E-03 0.02219914 0.04089997 0.17630365 WANG_SMARCE1_TARGETS_DN gastric ulcer DOID_10808 4.156E-03 0.02230931 4.156E-03 0.03427227 WANG_SMARCE1_TARGETS_DN acquired immunodeficiency syndrome DOID_635 4.156E-03 0.02210081 4.156E-03 0.03378267 WANG_SMARCE1_TARGETS_DN male reproductive system disease DOID_48 4.256E-03 0.02242291 4.256E-03 0.03410809 WANG_SMARCE1_TARGETS_DN myasthenia gravis DOID_437 4.539E-03 0.02369345 4.539E-03 0.03586925 WANG_SMARCE1_TARGETS_DN uremia DOID_4676 4.539E-03 0.02347806 4.539E-03 0.03537789 WANG_SMARCE1_TARGETS_DN hypoglycemia DOID_9993 4.539E-03 0.02326654 0.09603086 0.24837071 WANG_SMARCE1_TARGETS_DN pancreatic carcinoma DOID_4905 4.586E-03 0.02329979 0.04398194 0.17500507 WANG_SMARCE1_TARGETS_DN Lewy body dementia DOID_12217 4.937E-03 0.02486106 0.09999145 0.25628438 WANG_SMARCE1_TARGETS_DN meningitis DOID_9471 4.937E-03 0.02464298 0.09999145 0.25399613 WANG_SMARCE1_TARGETS_DN aneurysm disease DOID_2403 5.11E-03 0.02528321 0.04714735 0.1788456 WANG_SMARCE1_TARGETS_DN acute pancreatitis DOID_2913 5.351E-03 0.02624868 5.351E-03 0.04059796 WANG_SMARCE1_TARGETS_DN X-linked disease DOID_0050735 5.781E-03 0.02811236 0.10786096 0.27036513 WANG_SMARCE1_TARGETS_DN bronchiolitis DOID_2942 5.781E-03 0.02787412 5.781E-03 0.04327824 WANG_SMARCE1_TARGETS_DN chromosomal disease DOID_0080014 5.862E-03 0.02803006 5.862E-03 0.04331919 WANG_SMARCE1_TARGETS_DN cystitis DOID_1679 6.225E-03 0.02951764 0.11177003 0.27650933 WANG_SMARCE1_TARGETS_DN neuromuscular junction disease DOID_439 6.225E-03 0.0292737 6.225E-03 0.04541176 WANG_SMARCE1_TARGETS_DN myositis DOID_633 6.225E-03 0.02903375 0.11177003 0.27412563 WANG_SMARCE1_TARGETS_DN vitiligo DOID_12306 6.685E-03 0.03092424 6.685E-03 0.04754601 WANG_SMARCE1_TARGETS_DN congenital hypoplastic anemia DOID_1342 6.685E-03 0.03067485 6.685E-03 0.04695902 WANG_SMARCE1_TARGETS_DN middle cerebral artery infarction DOID_3525 6.685E-03 0.03042945 6.685E-03 0.04638635 WANG_SMARCE1_TARGETS_DN lung adenocarcinoma DOID_3910 7.16E-03 0.03233141 1.000 1.000 WANG_SMARCE1_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 7.16E-03 0.03207683 0.11953716 0.28578422 WANG_SMARCE1_TARGETS_DN autoimmune disease of cardiovascular system DOID_0060051 7.649E-03 0.03400211 7.649E-03 0.05002609 WANG_SMARCE1_TARGETS_DN Behcet's disease DOID_13241 7.649E-03 0.03400211 7.649E-03 0.05002609 WANG_SMARCE1_TARGETS_DN autoimmune disease of the nervous system DOID_438 7.649E-03 0.03373852 7.649E-03 0.04945761 WANG_SMARCE1_TARGETS_DN carbohydrate metabolic disorder DOID_2978 8.501E-03 0.03720854 8.501E-03 0.05434955 WANG_SMARCE1_TARGETS_DN endometrial carcinoma DOID_2871 8.672E-03 0.03766629 0.13106146 0.30070149 WANG_SMARCE1_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 8.748E-03 0.03770715 0.34413861 0.6483936 WANG_SMARCE1_TARGETS_DN endometrial cancer DOID_1380 9.752E-03 0.04172261 0.1386609 0.31185001 WANG_SMARCE1_TARGETS_DN ulcerative colitis DOID_8577 9.775E-03 0.04150762 9.775E-03 0.06112112 WANG_SMARCE1_TARGETS_DN papilloma DOID_2615 0.0108895 0.04589724 0.14619428 0.32367527 WANG_SMARCE1_TARGETS_DN thyroid carcinoma DOID_3963 0.01147895 0.0480259 0.14993637 0.32812998 WANG_SMARCE1_TARGETS_DN spindle cell carcinoma DOID_4015 0.01147895 0.04767534 1.000 1.000 WANG_SMARCE1_TARGETS_DN medullomyoblastoma DOID_3861 0.01208215 0.04981696 0.01208215 0.07313554 WANG_SMARCE1_TARGETS_DN adult medulloblastoma DOID_3864 0.01208215 0.04981696 0.01208215 0.07313554 WANG_SMARCE1_TARGETS_DN childhood medulloblastoma DOID_3869 0.01208215 0.04981696 0.01208215 0.07313554 WANG_SMARCE1_TARGETS_DN pulmonary sarcoidosis DOID_13406 0.01332927 0.0545637 0.16106511 0.34583415 WANG_SMARCE1_TARGETS_DN medulloblastoma DOID_3858 0.01332927 0.05417396 0.01332927 0.0790037 WANG_SMARCE1_TARGETS_DN embryonal cancer DOID_688 0.01332927 0.05378975 0.01332927 0.07818922 WANG_SMARCE1_TARGETS_DN uveitis DOID_13141 0.01397294 0.05599016 0.16474242 0.35108028 WANG_SMARCE1_TARGETS_DN respiratory syncytial virus infectious disease DOID_1273 0.01462984 0.05821246 0.01462984 0.08408466 WANG_SMARCE1_TARGETS_DN intracranial arterial disease DOID_13089 0.01529986 0.06045568 0.01529986 0.08619424 WANG_SMARCE1_TARGETS_DN cerebral arterial disease DOID_3527 0.01529986 0.06045568 0.01529986 0.08619424 WANG_SMARCE1_TARGETS_DN adenoid cystic carcinoma DOID_4866 0.01529986 0.06003875 0.01529986 0.0853492 WANG_SMARCE1_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 0.01598285 0.06228933 0.01598285 0.08744463 WANG_SMARCE1_TARGETS_DN salivary gland cancer DOID_8850 0.0166787 0.06455905 0.0166787 0.09038267 WANG_SMARCE1_TARGETS_DN Huntington's disease DOID_12858 0.01738728 0.06684706 0.01738728 0.09333363 WANG_SMARCE1_TARGETS_DN primitive neuroectodermal tumor DOID_168 0.01738728 0.06639842 0.01738728 0.09246135 WANG_SMARCE1_TARGETS_DN cerebral infarction DOID_3526 0.01884216 0.07147458 0.01884216 0.09746533 WANG_SMARCE1_TARGETS_DN spinocerebellar degeneration DOID_2478 0.0195882 0.07381248 0.0195882 0.09951505 WANG_SMARCE1_TARGETS_DN proteinuria DOID_576 0.0195882 0.07332688 0.0195882 0.09863438 WANG_SMARCE1_TARGETS_DN brain cancer DOID_1319 0.02034649 0.07566765 0.19712543 0.41389066 WANG_SMARCE1_TARGETS_DN thyroid adenoma DOID_2891 0.02034649 0.0751763 0.19712543 0.412369 WANG_SMARCE1_TARGETS_DN central nervous system cancer DOID_3620 0.0211169 0.07751945 0.2006456 0.4181954 WANG_SMARCE1_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 0.02189931 0.07987634 0.02189931 0.10835399 WANG_SMARCE1_TARGETS_DN integumentary system benign neoplasm DOID_0060121 0.02189931 0.07936757 0.20415043 0.42240579 WANG_SMARCE1_TARGETS_DN skin benign neoplasm DOID_3165 0.02189931 0.07936757 0.20415043 0.42240579 WANG_SMARCE1_TARGETS_DN lung small cell carcinoma DOID_5409 0.02189931 0.07886524 0.20415043 0.42087534 WANG_SMARCE1_TARGETS_DN aortic aneurysm DOID_3627 0.02269361 0.08121173 0.20763998 0.42498974 WANG_SMARCE1_TARGETS_DN movement disease DOID_480 0.02269361 0.08070416 0.02269361 0.11131608 WANG_SMARCE1_TARGETS_DN vasculitis DOID_865 0.02598733 0.09184342 0.02598733 0.12531179 WANG_SMARCE1_TARGETS_DN integumentary system cancer DOID_0060122 0.02683931 0.09426893 0.22486093 0.45210555 WANG_SMARCE1_TARGETS_DN parasitic protozoa infectious disease DOID_2789 0.02683931 0.09369059 0.02683931 0.12726305 WANG_SMARCE1_TARGETS_DN skin cancer DOID_4159 0.02683931 0.09426893 0.22486093 0.45210555 WANG_SMARCE1_TARGETS_DN smallpox DOID_8736 0.02683931 0.09311931 0.02683931 0.12621129 SMID_BREAST_CANCER_LUMINAL_B_DN primary immunodeficiency disease DOID_612 3.174E-22 1.806E-19 5.266E-15 2.997E-12 SMID_BREAST_CANCER_LUMINAL_B_DN hypersensitivity reaction type IV disease DOID_2916 2.186E-19 6.218E-17 1.981E-05 3.636E-04 SMID_BREAST_CANCER_LUMINAL_B_DN collagen disease DOID_854 5.137E-19 9.744E-17 2.977E-04 3.258E-03 SMID_BREAST_CANCER_LUMINAL_B_DN aneurysm disease DOID_2403 6.503E-19 9.251E-17 6.452E-07 1.748E-05 SMID_BREAST_CANCER_LUMINAL_B_DN aortic aneurysm DOID_3627 8.196E-19 9.327E-17 5.234E-07 1.567E-05 SMID_BREAST_CANCER_LUMINAL_B_DN sarcoidosis DOID_11335 2.079E-18 1.972E-16 1.204E-05 2.361E-04 SMID_BREAST_CANCER_LUMINAL_B_DN rheumatic disease DOID_1575 3.784E-18 3.076E-16 8.136E-04 6.91E-03 SMID_BREAST_CANCER_LUMINAL_B_DN scleroderma DOID_419 3.784E-18 3.076E-16 8.136E-04 6.91E-03 SMID_BREAST_CANCER_LUMINAL_B_DN systemic scleroderma DOID_418 4.712E-17 3.351E-15 5.742E-04 5.356E-03 SMID_BREAST_CANCER_LUMINAL_B_DN primary bacterial infectious disease DOID_0050338 1.512E-16 9.559E-15 1.347E-03 0.01064759 SMID_BREAST_CANCER_LUMINAL_B_DN oral cavity cancer DOID_8618 3.141E-16 1.787E-14 8.425E-12 2.397E-09 SMID_BREAST_CANCER_LUMINAL_B_DN blood protein disease DOID_620 5.827E-16 3.014E-14 3.406E-10 3.876E-08 SMID_BREAST_CANCER_LUMINAL_B_DN hypersensitivity reaction type I disease DOID_1205 6.362E-16 3.017E-14 1.498E-09 1.42E-07 SMID_BREAST_CANCER_LUMINAL_B_DN bacterial pneumonia DOID_874 6.974E-16 3.053E-14 8.339E-04 6.978E-03 SMID_BREAST_CANCER_LUMINAL_B_DN retinal vascular disease DOID_2462 2.612E-15 1.062E-13 1.478E-04 1.956E-03 SMID_BREAST_CANCER_LUMINAL_B_DN uveal disease DOID_3480 7.857E-15 2.98E-13 6.118E-05 9.161E-04 SMID_BREAST_CANCER_LUMINAL_B_DN diabetic retinopathy DOID_8947 8.483E-15 3.017E-13 6.601E-04 5.869E-03 SMID_BREAST_CANCER_LUMINAL_B_DN pleural disease DOID_1532 1.038E-14 3.474E-13 0.27393191 0.47232501 SMID_BREAST_CANCER_LUMINAL_B_DN myocarditis DOID_820 1.482E-14 4.686E-13 8.414E-07 2.176E-05 SMID_BREAST_CANCER_LUMINAL_B_DN agammaglobulinemia DOID_2583 3.288E-14 9.848E-13 1.335E-08 8.442E-07 SMID_BREAST_CANCER_LUMINAL_B_DN B cell deficiency DOID_2115 3.88E-14 1.104E-12 4.887E-09 3.476E-07 SMID_BREAST_CANCER_LUMINAL_B_DN uterine disease DOID_345 4.685E-14 1.269E-12 1.994E-07 7.091E-06 SMID_BREAST_CANCER_LUMINAL_B_DN pulmonary sarcoidosis DOID_13406 5.522E-14 1.428E-12 3.071E-05 5.296E-04 SMID_BREAST_CANCER_LUMINAL_B_DN uveitis DOID_13141 7.486E-14 1.852E-12 5.233E-04 5.133E-03 SMID_BREAST_CANCER_LUMINAL_B_DN tuberculosis DOID_399 8.468E-14 2.008E-12 4.056E-03 0.02284889 SMID_BREAST_CANCER_LUMINAL_B_DN astrocytoma DOID_3069 1.025E-13 2.333E-12 4.264E-03 0.02378679 SMID_BREAST_CANCER_LUMINAL_B_DN peripheral vascular disease DOID_341 1.786E-13 3.908E-12 2.858E-08 1.478E-06 SMID_BREAST_CANCER_LUMINAL_B_DN mixed glioma DOID_5076 4.268E-13 8.993E-12 9.276E-05 1.353E-03 SMID_BREAST_CANCER_LUMINAL_B_DN ulcerative colitis DOID_8577 4.482E-13 9.108E-12 2.867E-08 1.36E-06 SMID_BREAST_CANCER_LUMINAL_B_DN contact dermatitis DOID_2773 5.943E-13 1.166E-11 4.095E-09 3.329E-07 SMID_BREAST_CANCER_LUMINAL_B_DN female reproductive system disease DOID_229 6.99E-13 1.326E-11 9.452E-07 2.338E-05 SMID_BREAST_CANCER_LUMINAL_B_DN giant cell tumor DOID_200 3.124E-12 5.735E-11 1.705E-03 0.01311263 SMID_BREAST_CANCER_LUMINAL_B_DN malignant giant cell tumor DOID_2705 3.124E-12 5.735E-11 1.705E-03 0.01311263 SMID_BREAST_CANCER_LUMINAL_B_DN giant cell glioblastoma DOID_3074 3.124E-12 5.735E-11 1.705E-03 0.01311263 SMID_BREAST_CANCER_LUMINAL_B_DN lymphoma DOID_0060058 3.639E-12 6.47E-11 2.527E-05 4.493E-04 SMID_BREAST_CANCER_LUMINAL_B_DN pleurisy DOID_10247 4.664E-12 8.042E-11 0.23994393 0.43342253 SMID_BREAST_CANCER_LUMINAL_B_DN pulmonary emphysema DOID_9675 6.449E-12 1.079E-10 0.06082701 0.18708414 SMID_BREAST_CANCER_LUMINAL_B_DN endometriosis of uterus DOID_288 8.225E-12 1.337E-10 1.64E-07 6.666E-06 SMID_BREAST_CANCER_LUMINAL_B_DN glioblastoma DOID_3068 8.425E-12 1.332E-10 2.338E-03 0.01642643 SMID_BREAST_CANCER_LUMINAL_B_DN endometriosis DOID_289 1.043E-11 1.603E-10 1.919E-07 7.281E-06 SMID_BREAST_CANCER_LUMINAL_B_DN abdominal aortic aneurysm DOID_7693 1.227E-11 1.838E-10 3.33E-03 0.0208192 SMID_BREAST_CANCER_LUMINAL_B_DN glaucoma DOID_1686 3.855E-11 5.625E-10 0.01188143 0.04898936 SMID_BREAST_CANCER_LUMINAL_B_DN pulmonary tuberculosis DOID_2957 3.855E-11 5.484E-10 0.01188143 0.04863692 SMID_BREAST_CANCER_LUMINAL_B_DN transitional cell carcinoma DOID_2671 3.867E-11 5.367E-10 1.902E-05 3.608E-04 SMID_BREAST_CANCER_LUMINAL_B_DN allergic contact dermatitis DOID_3042 4.054E-11 5.492E-10 1.54E-08 8.762E-07 SMID_BREAST_CANCER_LUMINAL_B_DN atopic dermatitis DOID_3310 6.958E-11 9.207E-10 1.452E-04 1.967E-03 SMID_BREAST_CANCER_LUMINAL_B_DN encephalomyelitis DOID_640 7.41E-11 9.582E-10 2.394E-04 2.724E-03 SMID_BREAST_CANCER_LUMINAL_B_DN nephrosis DOID_2527 7.581E-11 9.586E-10 5.986E-05 9.205E-04 SMID_BREAST_CANCER_LUMINAL_B_DN mouth disease DOID_403 8.4E-11 1.039E-09 1.884E-03 0.01392461 SMID_BREAST_CANCER_LUMINAL_B_DN dilated cardiomyopathy DOID_12930 9.508E-11 1.151E-09 1.972E-03 0.01420478 SMID_BREAST_CANCER_LUMINAL_B_DN bile duct adenocarcinoma DOID_4896 1.011E-10 1.198E-09 1.722E-04 2.13E-03 SMID_BREAST_CANCER_LUMINAL_B_DN cholangiocarcinoma DOID_4947 1.011E-10 1.198E-09 1.722E-04 2.13E-03 SMID_BREAST_CANCER_LUMINAL_B_DN gestational diabetes DOID_11714 1.576E-10 1.83E-09 2.165E-07 7.247E-06 SMID_BREAST_CANCER_LUMINAL_B_DN adenoid cystic carcinoma DOID_4866 1.657E-10 1.885E-09 1.657E-10 3.142E-08 SMID_BREAST_CANCER_LUMINAL_B_DN bile duct cancer DOID_4606 2.044E-10 2.28E-09 2.375E-04 2.816E-03 SMID_BREAST_CANCER_LUMINAL_B_DN bile duct carcinoma DOID_4897 2.044E-10 2.28E-09 2.375E-04 2.816E-03 SMID_BREAST_CANCER_LUMINAL_B_DN common variable immunodeficiency DOID_12177 2.418E-10 2.646E-09 1.168E-04 1.621E-03 SMID_BREAST_CANCER_LUMINAL_B_DN autoimmune disease of urogenital tract DOID_0060049 2.562E-10 2.751E-09 5.494E-05 8.684E-04 SMID_BREAST_CANCER_LUMINAL_B_DN primary biliary cirrhosis DOID_12236 2.562E-10 2.751E-09 5.494E-05 8.684E-04 SMID_BREAST_CANCER_LUMINAL_B_DN salivary gland cancer DOID_8850 2.562E-10 2.7E-09 2.562E-10 3.645E-08 SMID_BREAST_CANCER_LUMINAL_B_DN carotid artery disease DOID_3407 3.351E-10 3.467E-09 2.787E-03 0.01887909 SMID_BREAST_CANCER_LUMINAL_B_DN uterine cancer DOID_363 3.877E-10 3.94E-09 4.264E-06 8.664E-05 SMID_BREAST_CANCER_LUMINAL_B_DN bronchiolitis obliterans DOID_2799 4.94E-10 4.931E-09 3.33E-03 0.02105053 SMID_BREAST_CANCER_LUMINAL_B_DN vascular skin disease DOID_9540 6.96E-10 6.828E-09 3.472E-07 1.097E-05 SMID_BREAST_CANCER_LUMINAL_B_DN vesiculobullous skin disease DOID_2731 8.844E-10 8.529E-09 7.35E-08 3.217E-06 SMID_BREAST_CANCER_LUMINAL_B_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.006E-09 9.539E-09 1.109E-04 1.578E-03 SMID_BREAST_CANCER_LUMINAL_B_DN pancreatic ductal carcinoma DOID_3587 1.279E-09 1.193E-08 5.487E-04 5.292E-03 SMID_BREAST_CANCER_LUMINAL_B_DN pancreatic carcinoma DOID_4905 1.918E-09 1.76E-08 6.601E-04 5.962E-03 SMID_BREAST_CANCER_LUMINAL_B_DN multiple myeloma DOID_9538 2.589E-09 2.338E-08 0.05134462 0.16052247 SMID_BREAST_CANCER_LUMINAL_B_DN urticaria DOID_1555 2.758E-09 2.452E-08 3.408E-06 7.459E-05 SMID_BREAST_CANCER_LUMINAL_B_DN parasitic protozoa infectious disease DOID_2789 2.775E-09 2.429E-08 0.09796131 0.25686628 SMID_BREAST_CANCER_LUMINAL_B_DN pancreatitis DOID_4989 3.203E-09 2.761E-08 0.03672294 0.12148459 SMID_BREAST_CANCER_LUMINAL_B_DN adult respiratory distress syndrome DOID_11394 4.766E-09 4.048E-08 6.286E-04 5.769E-03 SMID_BREAST_CANCER_LUMINAL_B_DN biliary tract cancer DOID_4607 5.847E-09 4.893E-08 1.097E-03 8.914E-03 SMID_BREAST_CANCER_LUMINAL_B_DN periodontitis DOID_824 6.391E-09 5.271E-08 0.02851875 0.09834648 SMID_BREAST_CANCER_LUMINAL_B_DN respiratory failure DOID_11162 7.878E-09 6.403E-08 2.949E-03 0.01973986 SMID_BREAST_CANCER_LUMINAL_B_DN pre-malignant neoplasm DOID_0060071 9.049E-09 7.252E-08 3.12E-05 5.222E-04 SMID_BREAST_CANCER_LUMINAL_B_DN in situ carcinoma DOID_8719 9.049E-09 7.252E-08 3.12E-05 5.222E-04 SMID_BREAST_CANCER_LUMINAL_B_DN cholestasis DOID_13580 1.186E-08 9.37E-08 3.472E-03 0.021476 SMID_BREAST_CANCER_LUMINAL_B_DN parasitic infectious disease DOID_1398 1.186E-08 9.242E-08 0.12743307 0.29475372 SMID_BREAST_CANCER_LUMINAL_B_DN Human immunodeficiency virus infectious disease DOID_526 1.274E-08 9.794E-08 2.009E-04 2.432E-03 SMID_BREAST_CANCER_LUMINAL_B_DN tooth disease DOID_1091 1.54E-08 1.168E-07 3.854E-03 0.02193199 SMID_BREAST_CANCER_LUMINAL_B_DN myeloma DOID_0070004 1.67E-08 1.25E-07 0.07605194 0.22421532 SMID_BREAST_CANCER_LUMINAL_B_DN neuritis DOID_1803 1.67E-08 1.234E-07 0.01067832 0.04534302 SMID_BREAST_CANCER_LUMINAL_B_DN lung small cell carcinoma DOID_5409 2.304E-08 1.68E-07 0.01188143 0.04828951 SMID_BREAST_CANCER_LUMINAL_B_DN bile duct disease DOID_4138 2.535E-08 1.826E-07 4.702E-03 0.02477277 SMID_BREAST_CANCER_LUMINAL_B_DN bladder disease DOID_365 2.628E-08 1.869E-07 2.824E-04 3.151E-03 SMID_BREAST_CANCER_LUMINAL_B_DN autoimmune hepatitis DOID_2048 2.63E-08 1.847E-07 0.01546995 0.06155527 SMID_BREAST_CANCER_LUMINAL_B_DN biliary tract disease DOID_9741 2.858E-08 1.983E-07 4.932E-03 0.02574563 SMID_BREAST_CANCER_LUMINAL_B_DN B-cell lymphocytic neoplasm DOID_707 3.135E-08 2.149E-07 0.0131593 0.05310386 SMID_BREAST_CANCER_LUMINAL_B_DN periodontal disease DOID_3388 3.961E-08 2.683E-07 0.04462131 0.14344363 SMID_BREAST_CANCER_LUMINAL_B_DN cystic fibrosis DOID_1485 4.051E-08 2.712E-07 0.15865022 0.33809728 SMID_BREAST_CANCER_LUMINAL_B_DN epidermolysis bullosa DOID_2730 4.557E-08 3.015E-07 3.15E-06 7.168E-05 SMID_BREAST_CANCER_LUMINAL_B_DN bone marrow cancer DOID_4960 4.862E-08 3.18E-07 0.09513305 0.25776526 SMID_BREAST_CANCER_LUMINAL_B_DN metabolic syndrome X DOID_14221 6.306E-08 4.077E-07 0.03906869 0.12775911 SMID_BREAST_CANCER_LUMINAL_B_DN severe combined immunodeficiency DOID_627 8.324E-08 5.321E-07 2.774E-06 6.576E-05 SMID_BREAST_CANCER_LUMINAL_B_DN respiratory syncytial virus infectious disease DOID_1273 9.981E-08 6.31E-07 0.31898397 0.53226357 SMID_BREAST_CANCER_LUMINAL_B_DN hepatitis DOID_2237 9.981E-08 6.241E-07 6.597E-03 0.03263931 SMID_BREAST_CANCER_LUMINAL_B_DN congenital diaphragmatic hernia DOID_3827 9.981E-08 6.173E-07 6.597E-03 0.03235794 SMID_BREAST_CANCER_LUMINAL_B_DN peptic ulcer DOID_750 9.981E-08 6.107E-07 0.05601468 0.17416588 SMID_BREAST_CANCER_LUMINAL_B_DN combined T cell and B cell immunodeficiency DOID_628 1.074E-07 6.5E-07 3.408E-06 7.183E-05 SMID_BREAST_CANCER_LUMINAL_B_DN intracranial arterial disease DOID_13089 1.183E-07 7.085E-07 0.32518826 0.5410296 SMID_BREAST_CANCER_LUMINAL_B_DN cerebral arterial disease DOID_3527 1.183E-07 7.085E-07 0.32518826 0.5410296 SMID_BREAST_CANCER_LUMINAL_B_DN cystitis DOID_1679 1.37E-07 8.12E-07 1.858E-03 0.0140987 SMID_BREAST_CANCER_LUMINAL_B_DN thoracic aortic aneurysm DOID_14004 1.689E-07 9.91E-07 8.018E-03 0.03770237 SMID_BREAST_CANCER_LUMINAL_B_DN middle cerebral artery infarction DOID_3525 1.73E-07 1.005E-06 0.22590867 0.4119937 SMID_BREAST_CANCER_LUMINAL_B_DN extrinsic allergic alveolitis DOID_841 1.73E-07 9.945E-07 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN influenza DOID_8469 2.238E-07 1.273E-06 0.34944692 0.5746685 SMID_BREAST_CANCER_LUMINAL_B_DN hyperglycemia DOID_4195 2.238E-07 1.261E-06 3.66E-03 0.02103608 SMID_BREAST_CANCER_LUMINAL_B_DN lymphoblastic leukemia DOID_1037 2.279E-07 1.272E-06 2.394E-04 2.78E-03 SMID_BREAST_CANCER_LUMINAL_B_DN thyroiditis DOID_7166 2.439E-07 1.347E-06 9.108E-03 0.04113138 SMID_BREAST_CANCER_LUMINAL_B_DN autoimmune thyroiditis DOID_7188 2.439E-07 1.347E-06 9.108E-03 0.04113138 SMID_BREAST_CANCER_LUMINAL_B_DN tongue cancer DOID_8649 2.439E-07 1.334E-06 9.108E-03 0.04080752 SMID_BREAST_CANCER_LUMINAL_B_DN vein disease DOID_866 2.439E-07 1.322E-06 9.108E-03 0.04048871 SMID_BREAST_CANCER_LUMINAL_B_DN Crohn's disease DOID_8778 2.495E-07 1.339E-06 0.21760505 0.40595828 SMID_BREAST_CANCER_LUMINAL_B_DN cerebral infarction DOID_3526 2.599E-07 1.382E-06 0.070852 0.2110722 SMID_BREAST_CANCER_LUMINAL_B_DN endocrine organ benign neoplasm DOID_0060089 2.803E-07 1.477E-06 0.02710118 0.09577994 SMID_BREAST_CANCER_LUMINAL_B_DN brain infarction DOID_3454 2.803E-07 1.463E-06 0.02710118 0.09518871 SMID_BREAST_CANCER_LUMINAL_B_DN male reproductive system disease DOID_48 3.878E-07 2.006E-06 0.14598956 0.31705366 SMID_BREAST_CANCER_LUMINAL_B_DN endometrial cancer DOID_1380 5.899E-07 3.024E-06 3.627E-03 0.02106141 SMID_BREAST_CANCER_LUMINAL_B_DN MHC class II deficiency DOID_5812 6.349E-07 3.225E-06 6.349E-07 1.806E-05 SMID_BREAST_CANCER_LUMINAL_B_DN esophagitis DOID_11963 8.402E-07 4.231E-06 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN brain edema DOID_4724 8.402E-07 4.194E-06 7.592E-04 6.646E-03 SMID_BREAST_CANCER_LUMINAL_B_DN papilloma DOID_2615 8.414E-07 4.163E-06 4.271E-03 0.0235922 SMID_BREAST_CANCER_LUMINAL_B_DN vasculitis DOID_865 8.701E-07 4.268E-06 0.09513305 0.25654362 SMID_BREAST_CANCER_LUMINAL_B_DN esophageal disease DOID_6050 9.966E-07 4.847E-06 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN chronic kidney failure DOID_784 1.135E-06 5.474E-06 0.18125483 0.35935191 SMID_BREAST_CANCER_LUMINAL_B_DN conjunctival disease DOID_4251 1.356E-06 6.482E-06 3.541E-03 0.0212077 SMID_BREAST_CANCER_LUMINAL_B_DN conjunctivitis DOID_6195 1.356E-06 6.482E-06 3.541E-03 0.0212077 SMID_BREAST_CANCER_LUMINAL_B_DN funisitis DOID_0050698 1.406E-06 6.666E-06 4.331E-05 7.041E-04 SMID_BREAST_CANCER_LUMINAL_B_DN myasthenia gravis DOID_437 1.783E-06 8.385E-06 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN nervous system cancer DOID_3093 2.078E-06 9.691E-06 0.56918325 0.89962575 SMID_BREAST_CANCER_LUMINAL_B_DN temporal arteritis DOID_13375 2.115E-06 9.783E-06 0.09568223 0.25560182 SMID_BREAST_CANCER_LUMINAL_B_DN central nervous system vasculitis DOID_525 2.115E-06 9.783E-06 0.09568223 0.25560182 SMID_BREAST_CANCER_LUMINAL_B_DN diabetic angiopathy DOID_11713 2.235E-06 1.026E-05 0.01997167 0.07575919 SMID_BREAST_CANCER_LUMINAL_B_DN meningitis DOID_9471 2.235E-06 1.018E-05 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN Goodpasture syndrome DOID_9808 2.235E-06 1.01E-05 0.01997167 0.07476236 SMID_BREAST_CANCER_LUMINAL_B_DN neuromuscular junction disease DOID_439 4.152E-06 1.86E-05 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN myositis DOID_633 4.152E-06 1.846E-05 0.02494973 0.08985062 SMID_BREAST_CANCER_LUMINAL_B_DN ankylosing spondylitis DOID_7147 4.152E-06 1.831E-05 1.858E-03 0.01391319 SMID_BREAST_CANCER_LUMINAL_B_DN gallbladder cancer DOID_3121 4.264E-06 1.866E-05 9.012E-03 0.04102348 SMID_BREAST_CANCER_LUMINAL_B_DN larynx cancer DOID_2596 4.517E-06 1.962E-05 0.11207134 0.27368495 SMID_BREAST_CANCER_LUMINAL_B_DN laryngeal benign neoplasm DOID_2598 4.517E-06 1.962E-05 0.11207134 0.27368495 SMID_BREAST_CANCER_LUMINAL_B_DN intracranial aneurysm DOID_10941 5.017E-06 2.163E-05 2.067E-03 0.01470453 SMID_BREAST_CANCER_LUMINAL_B_DN diffuse large B-cell lymphoma DOID_0050745 6.017E-06 2.574E-05 0.02851875 0.09955319 SMID_BREAST_CANCER_LUMINAL_B_DN lung adenocarcinoma DOID_3910 6.017E-06 2.555E-05 0.02851875 0.09894616 SMID_BREAST_CANCER_LUMINAL_B_DN thyroid adenoma DOID_2891 6.167E-06 2.599E-05 0.07605194 0.22191567 SMID_BREAST_CANCER_LUMINAL_B_DN heart valve disease DOID_4079 6.167E-06 2.58E-05 0.07605194 0.22078345 SMID_BREAST_CANCER_LUMINAL_B_DN viral pneumonia DOID_10533 6.278E-06 2.607E-05 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN open-angle glaucoma DOID_1067 6.278E-06 2.588E-05 0.1201545 0.28486628 SMID_BREAST_CANCER_LUMINAL_B_DN eyelid disease DOID_530 6.278E-06 2.57E-05 6.99E-03 0.03314583 SMID_BREAST_CANCER_LUMINAL_B_DN mononeuritis DOID_1802 7.166E-06 2.913E-05 0.23994393 0.43068801 SMID_BREAST_CANCER_LUMINAL_B_DN coronary stenosis DOID_4248 7.166E-06 2.892E-05 0.03037523 0.10226928 SMID_BREAST_CANCER_LUMINAL_B_DN autoimmune disease of the nervous system DOID_438 7.166E-06 2.872E-05 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN autoimmune disease of endocrine system DOID_0060005 8.481E-06 3.375E-05 0.03227834 0.10803751 SMID_BREAST_CANCER_LUMINAL_B_DN mononeuropathy DOID_1188 8.481E-06 3.351E-05 0.24686612 0.43759135 SMID_BREAST_CANCER_LUMINAL_B_DN lung oat cell carcinoma DOID_5411 8.499E-06 3.335E-05 8.018E-03 0.03739333 SMID_BREAST_CANCER_LUMINAL_B_DN varicose veins DOID_799 8.499E-06 3.312E-05 0.12816428 0.28710816 SMID_BREAST_CANCER_LUMINAL_B_DN calcium metabolism disease DOID_10575 8.707E-06 3.37E-05 1.389E-03 0.01082604 SMID_BREAST_CANCER_LUMINAL_B_DN corneal disease DOID_10124 9.977E-06 3.836E-05 3.047E-03 0.01992985 SMID_BREAST_CANCER_LUMINAL_B_DN endometrial carcinoma DOID_2871 9.977E-06 3.81E-05 3.047E-03 0.01970338 SMID_BREAST_CANCER_LUMINAL_B_DN restrictive cardiomyopathy DOID_397 1.125E-05 4.268E-05 0.13610135 0.29785257 SMID_BREAST_CANCER_LUMINAL_B_DN opportunistic mycosis DOID_2473 1.167E-05 4.398E-05 0.03622046 0.12052307 SMID_BREAST_CANCER_LUMINAL_B_DN atrophic muscular disease DOID_913 1.204E-05 4.505E-05 1.583E-04 2.001E-03 SMID_BREAST_CANCER_LUMINAL_B_DN muscular dystrophy DOID_9884 1.204E-05 4.505E-05 1.583E-04 2.001E-03 SMID_BREAST_CANCER_LUMINAL_B_DN celiac disease DOID_10608 1.358E-05 5.051E-05 3.627E-03 0.02127854 SMID_BREAST_CANCER_LUMINAL_B_DN germinoma DOID_3304 1.358E-05 5.018E-05 0.26725778 0.46362706 SMID_BREAST_CANCER_LUMINAL_B_DN allergic rhinitis DOID_4481 1.358E-05 4.986E-05 0.03825753 0.12582967 SMID_BREAST_CANCER_LUMINAL_B_DN basal cell carcinoma DOID_2513 1.461E-05 5.328E-05 4.621E-04 4.613E-03 SMID_BREAST_CANCER_LUMINAL_B_DN integumentary system cancer DOID_0060122 1.478E-05 5.355E-05 0.0159418 0.06299224 SMID_BREAST_CANCER_LUMINAL_B_DN skin cancer DOID_4159 1.478E-05 5.355E-05 0.0159418 0.06299224 SMID_BREAST_CANCER_LUMINAL_B_DN pustulosis of palm and sole DOID_4398 1.478E-05 5.321E-05 0.0159418 0.06255781 SMID_BREAST_CANCER_LUMINAL_B_DN systemic mycosis DOID_0050136 1.813E-05 6.487E-05 0.04245888 0.13726764 SMID_BREAST_CANCER_LUMINAL_B_DN fungal infectious disease DOID_1564 1.813E-05 6.487E-05 0.04245888 0.13726764 SMID_BREAST_CANCER_LUMINAL_B_DN hair disease DOID_421 1.813E-05 6.447E-05 3.154E-04 3.324E-03 SMID_BREAST_CANCER_LUMINAL_B_DN skin carcinoma DOID_3451 1.865E-05 6.59E-05 5.508E-04 5.224E-03 SMID_BREAST_CANCER_LUMINAL_B_DN prion disease DOID_649 1.865E-05 6.549E-05 0.15176 0.32462947 SMID_BREAST_CANCER_LUMINAL_B_DN hypertrophic cardiomyopathy DOID_11984 1.981E-05 6.916E-05 0.42770518 0.68169257 SMID_BREAST_CANCER_LUMINAL_B_DN nephroblastoma DOID_2154 2.081E-05 7.218E-05 4.616E-03 0.02454933 SMID_BREAST_CANCER_LUMINAL_B_DN granulosa cell tumor DOID_2999 2.345E-05 8.086E-05 0.15948287 0.33118888 SMID_BREAST_CANCER_LUMINAL_B_DN lymphoid leukemia DOID_10747 2.378E-05 8.151E-05 3.897E-04 3.959E-03 SMID_BREAST_CANCER_LUMINAL_B_DN adenoma DOID_657 2.707E-05 9.225E-05 5.358E-03 0.02746451 SMID_BREAST_CANCER_LUMINAL_B_DN hypothyroidism DOID_1459 2.858E-05 9.681E-05 2.949E-03 0.01951032 SMID_BREAST_CANCER_LUMINAL_B_DN sex cord-gonadal stromal tumor DOID_192 2.91E-05 9.798E-05 0.16713563 0.33843478 SMID_BREAST_CANCER_LUMINAL_B_DN embryonal cancer DOID_688 3.071E-05 1.028E-04 0.05134462 0.16140933 SMID_BREAST_CANCER_LUMINAL_B_DN congenital heart defect DOID_1682 3.12E-05 1.038E-04 3.438E-04 3.557E-03 SMID_BREAST_CANCER_LUMINAL_B_DN mineral metabolism disease DOID_0050032 3.401E-05 1.125E-04 3.291E-03 0.02104265 SMID_BREAST_CANCER_LUMINAL_B_DN muscle cancer DOID_4045 5.205E-05 1.712E-04 0.18967956 0.36585651 SMID_BREAST_CANCER_LUMINAL_B_DN aortic valve disease DOID_62 6.202E-05 2.028E-04 0.19705817 0.37251195 SMID_BREAST_CANCER_LUMINAL_B_DN diabetic autonomic neuropathy DOID_11503 6.796E-05 2.21E-04 0.06829772 0.2045337 SMID_BREAST_CANCER_LUMINAL_B_DN autonomic neuropathy DOID_11504 6.796E-05 2.21E-04 0.06829772 0.2045337 SMID_BREAST_CANCER_LUMINAL_B_DN diabetic polyneuropathy DOID_12785 6.796E-05 2.21E-04 0.06829772 0.2045337 SMID_BREAST_CANCER_LUMINAL_B_DN diabetic neuropathy DOID_9743 6.796E-05 2.21E-04 0.06829772 0.2045337 SMID_BREAST_CANCER_LUMINAL_B_DN angioedema DOID_1558 8.55E-05 2.764E-04 3.541E-03 0.02143332 SMID_BREAST_CANCER_LUMINAL_B_DN pre-eclampsia DOID_10591 9.18E-05 2.951E-04 0.01067832 0.04603004 SMID_BREAST_CANCER_LUMINAL_B_DN autonomic nervous system disease DOID_11465 9.18E-05 2.934E-04 0.07605194 0.22305957 SMID_BREAST_CANCER_LUMINAL_B_DN brain cancer DOID_1319 9.18E-05 2.918E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN central nervous system cancer DOID_3620 1.01E-04 3.193E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN hemolytic anemia DOID_583 1.01E-04 3.176E-04 0.01127057 0.04750337 SMID_BREAST_CANCER_LUMINAL_B_DN normocytic anemia DOID_720 1.01E-04 3.176E-04 0.01127057 0.04750337 SMID_BREAST_CANCER_LUMINAL_B_DN spinal cord disease DOID_319 1.161E-04 3.63E-04 0.22590867 0.41331843 SMID_BREAST_CANCER_LUMINAL_B_DN seminoma DOID_4440 1.161E-04 3.61E-04 0.22590867 0.41067742 SMID_BREAST_CANCER_LUMINAL_B_DN familial adenomatous polyposis DOID_0050424 1.168E-04 3.611E-04 0.09568223 0.25680749 SMID_BREAST_CANCER_LUMINAL_B_DN pneumocystosis DOID_11339 1.168E-04 3.592E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN prediabetes syndrome DOID_11716 1.168E-04 3.572E-04 4.302E-03 0.02331128 SMID_BREAST_CANCER_LUMINAL_B_DN Sciatic Neuropathy DOID_11446 1.337E-04 4.069E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN lesion of sciatic nerve DOID_12528 1.337E-04 4.069E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN mononeuritis of lower limb DOID_9473 1.337E-04 4.069E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN malaria DOID_12365 1.532E-04 4.637E-04 0.03037523 0.10287802 SMID_BREAST_CANCER_LUMINAL_B_DN common cold DOID_10459 1.546E-04 4.656E-04 5.131E-03 0.02654202 SMID_BREAST_CANCER_LUMINAL_B_DN beta thalassemia DOID_12241 1.546E-04 4.631E-04 1.546E-04 2E-03 SMID_BREAST_CANCER_LUMINAL_B_DN aortic valve stenosis DOID_1712 1.546E-04 4.607E-04 0.10391414 0.26875976 SMID_BREAST_CANCER_LUMINAL_B_DN stomach disease DOID_76 1.546E-04 4.583E-04 0.10391414 0.26396048 SMID_BREAST_CANCER_LUMINAL_B_DN lipodystrophy DOID_811 1.546E-04 4.559E-04 0.10391414 0.26278732 SMID_BREAST_CANCER_LUMINAL_B_DN ocular hypertension DOID_9282 1.546E-04 4.536E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN borderline glaucoma DOID_9283 1.546E-04 4.536E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN toxic encephalopathy DOID_3602 1.746E-04 5.096E-04 2.78E-03 0.01905922 SMID_BREAST_CANCER_LUMINAL_B_DN amino acid metabolic disorder DOID_9252 1.892E-04 5.494E-04 9.688E-03 0.04240272 SMID_BREAST_CANCER_LUMINAL_B_DN carotid stenosis DOID_13001 1.997E-04 5.768E-04 0.11207134 0.27605452 SMID_BREAST_CANCER_LUMINAL_B_DN bacterial meningitis DOID_9470 2.524E-04 7.254E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.534E-04 7.245E-04 0.05753422 0.17791831 SMID_BREAST_CANCER_LUMINAL_B_DN melancholia DOID_2848 2.565E-04 7.296E-04 0.10950321 0.27569613 SMID_BREAST_CANCER_LUMINAL_B_DN neurotic disorder DOID_4964 2.765E-04 7.828E-04 0.11244268 0.2711012 SMID_BREAST_CANCER_LUMINAL_B_DN chronic leukemia DOID_1036 2.824E-04 7.955E-04 0.04033731 0.1311539 SMID_BREAST_CANCER_LUMINAL_B_DN chronic lymphocytic leukemia DOID_1040 2.824E-04 7.955E-04 0.04033731 0.1311539 SMID_BREAST_CANCER_LUMINAL_B_DN autonomic nervous system neoplasm DOID_2621 2.824E-04 7.916E-04 0.27393191 0.47089805 SMID_BREAST_CANCER_LUMINAL_B_DN neuroblastoma DOID_769 2.824E-04 7.916E-04 0.27393191 0.47089805 SMID_BREAST_CANCER_LUMINAL_B_DN thalassemia DOID_10241 3.134E-04 8.742E-04 3.134E-04 3.365E-03 SMID_BREAST_CANCER_LUMINAL_B_DN membranoproliferative glomerulonephritis DOID_2920 3.134E-04 8.699E-04 0.12816428 0.29053974 SMID_BREAST_CANCER_LUMINAL_B_DN mesenchymal cell neoplasm DOID_3350 3.134E-04 8.657E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN arthropathy DOID_381 3.134E-04 8.615E-04 0.12816428 0.2893868 SMID_BREAST_CANCER_LUMINAL_B_DN spindle cell sarcoma DOID_4235 3.134E-04 8.657E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN epithelioid sarcoma DOID_6193 3.134E-04 8.657E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN pneumoconiosis DOID_10316 3.512E-04 9.606E-04 0.28709887 0.49204595 SMID_BREAST_CANCER_LUMINAL_B_DN spindle cell carcinoma DOID_4015 3.512E-04 9.56E-04 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN hyperthyroidism DOID_7998 3.512E-04 9.515E-04 0.04462131 0.14263777 SMID_BREAST_CANCER_LUMINAL_B_DN endocrine pancreas disease DOID_1428 3.688E-04 9.946E-04 0.12439791 0.28890779 SMID_BREAST_CANCER_LUMINAL_B_DN hemolytic-uremic syndrome DOID_12554 3.831E-04 1.028E-03 0.13610135 0.30016151 SMID_BREAST_CANCER_LUMINAL_B_DN cerebral degeneration DOID_1443 3.952E-04 1.056E-03 0.02423753 0.08840485 SMID_BREAST_CANCER_LUMINAL_B_DN calcinosis DOID_182 4.756E-04 1.265E-03 5.754E-03 0.02923034 SMID_BREAST_CANCER_LUMINAL_B_DN peripheral nervous system neoplasm DOID_1192 5.233E-04 1.385E-03 0.31272279 0.5248946 SMID_BREAST_CANCER_LUMINAL_B_DN Down syndrome DOID_14250 6.497E-04 1.711E-03 0.15948287 0.33485518 SMID_BREAST_CANCER_LUMINAL_B_DN testicular cancer DOID_2998 6.497E-04 1.704E-03 0.15948287 0.33240203 SMID_BREAST_CANCER_LUMINAL_B_DN leishmaniasis DOID_9065 6.497E-04 1.696E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN benign mesothelioma DOID_2645 6.866E-04 1.784E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN endogenous depression DOID_1595 7.432E-04 1.922E-03 0.15865022 0.33683572 SMID_BREAST_CANCER_LUMINAL_B_DN amnestic disorder DOID_10914 7.592E-04 1.955E-03 0.16713563 0.34086084 SMID_BREAST_CANCER_LUMINAL_B_DN membranous glomerulonephritis DOID_10976 7.592E-04 1.946E-03 0.01408042 0.05642082 SMID_BREAST_CANCER_LUMINAL_B_DN subependymal glioma DOID_4843 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN pilocytic astrocytoma DOID_4851 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN subependymal giant cell astrocytoma DOID_5077 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN fibrillary astrocytoma DOID_6726 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN juvenile pilocytic astrocytoma DOID_6811 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN childhood pilocytic astrocytoma DOID_6812 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN gemistocytic astrocytoma DOID_7005 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN childhood cerebral astrocytoma DOID_7007 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN protoplasmic astrocytoma DOID_7008 7.592E-04 1.937E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN amyloidosis DOID_9120 7.592E-04 1.929E-03 7.592E-04 6.545E-03 SMID_BREAST_CANCER_LUMINAL_B_DN nephrotic syndrome DOID_1184 8.136E-04 2.058E-03 0.06577493 0.20121471 SMID_BREAST_CANCER_LUMINAL_B_DN hyperinsulinism DOID_2018 8.136E-04 2.048E-03 0.06577493 0.19802083 SMID_BREAST_CANCER_LUMINAL_B_DN coronary restenosis DOID_4247 8.798E-04 2.205E-03 0.17471891 0.35128997 SMID_BREAST_CANCER_LUMINAL_B_DN cataract DOID_83 9.564E-04 2.387E-03 9.549E-03 0.04212029 SMID_BREAST_CANCER_LUMINAL_B_DN benign glioma DOID_0060101 1.012E-03 2.514E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN gastric ulcer DOID_10808 1.012E-03 2.503E-03 0.18223335 0.36003742 SMID_BREAST_CANCER_LUMINAL_B_DN hepatitis B DOID_2043 1.012E-03 2.492E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN benign ependymoma DOID_4844 1.012E-03 2.514E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN placenta disease DOID_780 1.012E-03 2.482E-03 0.18223335 0.35632569 SMID_BREAST_CANCER_LUMINAL_B_DN proteinuria DOID_576 1.034E-03 2.525E-03 0.36124817 0.58896909 SMID_BREAST_CANCER_LUMINAL_B_DN alcohol abuse DOID_1574 1.097E-03 2.667E-03 1.097E-03 9.043E-03 SMID_BREAST_CANCER_LUMINAL_B_DN mental depression DOID_1596 1.097E-03 2.655E-03 0.18125483 0.36187368 SMID_BREAST_CANCER_LUMINAL_B_DN lens disease DOID_110 1.116E-03 2.691E-03 0.01067832 0.04568395 SMID_BREAST_CANCER_LUMINAL_B_DN bone development disease DOID_0080006 1.156E-03 2.775E-03 1.156E-03 9.262E-03 SMID_BREAST_CANCER_LUMINAL_B_DN IgA glomerulonephritis DOID_2986 1.156E-03 2.763E-03 0.01841671 0.07080476 SMID_BREAST_CANCER_LUMINAL_B_DN uremia DOID_4676 1.156E-03 2.752E-03 0.01841671 0.07032956 SMID_BREAST_CANCER_LUMINAL_B_DN pulmonary embolism DOID_9477 1.156E-03 2.74E-03 0.18967956 0.36462051 SMID_BREAST_CANCER_LUMINAL_B_DN Lewy body dementia DOID_12217 1.312E-03 3.098E-03 0.19705817 0.37375365 SMID_BREAST_CANCER_LUMINAL_B_DN toxic shock syndrome DOID_14115 1.481E-03 3.482E-03 0.02157955 0.08025335 SMID_BREAST_CANCER_LUMINAL_B_DN acute pancreatitis DOID_2913 1.481E-03 3.468E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN commensal bacterial infectious disease DOID_0050339 1.663E-03 3.878E-03 0.02323926 0.08586454 SMID_BREAST_CANCER_LUMINAL_B_DN portal hypertension DOID_10762 1.663E-03 3.862E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN hypogonadism DOID_1924 1.663E-03 3.847E-03 0.211615 0.39738922 SMID_BREAST_CANCER_LUMINAL_B_DN bronchiolitis DOID_2942 1.663E-03 3.831E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN papillary adenoma DOID_3172 1.858E-03 4.264E-03 0.02494973 0.09042291 SMID_BREAST_CANCER_LUMINAL_B_DN microcystic adenoma DOID_5403 1.858E-03 4.264E-03 0.02494973 0.09042291 SMID_BREAST_CANCER_LUMINAL_B_DN follicular adenoma DOID_6204 1.858E-03 4.264E-03 0.02494973 0.09042291 SMID_BREAST_CANCER_LUMINAL_B_DN reproductive organ benign neoplasm DOID_0050622 1.942E-03 4.438E-03 0.09796131 0.25805548 SMID_BREAST_CANCER_LUMINAL_B_DN osteochondrodysplasia DOID_2256 1.942E-03 4.42E-03 1.942E-03 0.01416719 SMID_BREAST_CANCER_LUMINAL_B_DN vitiligo DOID_12306 2.067E-03 4.687E-03 0.22590867 0.41465172 SMID_BREAST_CANCER_LUMINAL_B_DN hypotrichosis DOID_4535 2.067E-03 4.668E-03 0.02670991 0.09498712 SMID_BREAST_CANCER_LUMINAL_B_DN perinatal necrotizing enterocolitis DOID_8677 2.291E-03 5.151E-03 0.02851875 0.09775404 SMID_BREAST_CANCER_LUMINAL_B_DN autoimmune disease of cardiovascular system DOID_0060051 2.528E-03 5.663E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN renal hypertension DOID_1073 2.528E-03 5.641E-03 0.23994393 0.43205094 SMID_BREAST_CANCER_LUMINAL_B_DN secondary hypertension DOID_11130 2.528E-03 5.641E-03 0.23994393 0.43205094 SMID_BREAST_CANCER_LUMINAL_B_DN sarcoma DOID_1115 2.528E-03 5.619E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN Behcet's disease DOID_13241 2.528E-03 5.663E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN hepatic vascular disease DOID_272 2.528E-03 5.597E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN invasive ductal carcinoma DOID_3008 2.528E-03 5.575E-03 0.23994393 0.42933364 SMID_BREAST_CANCER_LUMINAL_B_DN multiple epiphyseal dysplasia DOID_12721 2.78E-03 6.108E-03 2.78E-03 0.01929165 SMID_BREAST_CANCER_LUMINAL_B_DN supratentorial cancer DOID_1659 2.78E-03 6.084E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN cerebrum cancer DOID_368 2.78E-03 6.084E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN neuroectodermal tumor DOID_171 2.787E-03 6.076E-03 0.11540249 0.27706335 SMID_BREAST_CANCER_LUMINAL_B_DN gonadal disease DOID_2277 3.33E-03 7.231E-03 0.26052247 0.45332504 SMID_BREAST_CANCER_LUMINAL_B_DN facioscapulohumeral muscular dystrophy DOID_11727 3.541E-03 7.661E-03 3.541E-03 0.02166378 SMID_BREAST_CANCER_LUMINAL_B_DN hyperparathyroidism DOID_13543 3.541E-03 7.632E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN retinal vascular occlusion DOID_1729 3.541E-03 7.603E-03 0.08737491 0.244908 SMID_BREAST_CANCER_LUMINAL_B_DN transient cerebral ischemia DOID_224 3.541E-03 7.574E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN acute kidney failure DOID_3021 3.541E-03 7.546E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN chondrosarcoma DOID_3371 3.541E-03 7.518E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN insulinoma DOID_3892 3.541E-03 7.49E-03 0.08737491 0.24134138 SMID_BREAST_CANCER_LUMINAL_B_DN keratitis DOID_4677 3.541E-03 7.462E-03 0.08737491 0.23902079 SMID_BREAST_CANCER_LUMINAL_B_DN Paget's disease of bone DOID_5408 3.541E-03 7.434E-03 3.541E-03 0.02098679 SMID_BREAST_CANCER_LUMINAL_B_DN cutaneous leishmaniasis DOID_9111 3.541E-03 7.407E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN breast benign neoplasm DOID_0060082 4.302E-03 8.966E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN thoracic benign neoplasm DOID_0060097 4.302E-03 8.966E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN trypanosomiasis DOID_10113 4.302E-03 8.933E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN sickle cell anemia DOID_10923 4.302E-03 8.901E-03 4.302E-03 0.02353543 SMID_BREAST_CANCER_LUMINAL_B_DN benign breast phyllodes tumor DOID_1631 4.302E-03 8.966E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN bronchiectasis DOID_9563 4.302E-03 8.868E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN blood coagulation disease DOID_1247 4.479E-03 9.201E-03 0.02910615 0.09917007 SMID_BREAST_CANCER_LUMINAL_B_DN hepatitis C DOID_1883 4.616E-03 9.449E-03 4.616E-03 0.02478093 SMID_BREAST_CANCER_LUMINAL_B_DN thyroid carcinoma DOID_3963 4.616E-03 9.415E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN medullomyoblastoma DOID_3861 4.979E-03 0.01011759 0.04682367 0.14884172 SMID_BREAST_CANCER_LUMINAL_B_DN adult medulloblastoma DOID_3864 4.979E-03 0.01011759 0.04682367 0.14884172 SMID_BREAST_CANCER_LUMINAL_B_DN childhood medulloblastoma DOID_3869 4.979E-03 0.01011759 0.04682367 0.14884172 SMID_BREAST_CANCER_LUMINAL_B_DN islet cell tumor DOID_1799 5.131E-03 0.01039012 0.10391414 0.26754366 SMID_BREAST_CANCER_LUMINAL_B_DN aortic valve insufficiency DOID_57 5.131E-03 0.01035327 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN encephalitis DOID_9588 5.131E-03 0.01031669 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN thyroid cancer DOID_1781 5.358E-03 0.01073437 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN syndrome DOID_225 5.667E-03 0.01131331 0.15865022 0.33558354 SMID_BREAST_CANCER_LUMINAL_B_DN medulloblastoma DOID_3858 5.754E-03 0.01144685 0.05134462 0.16230605 SMID_BREAST_CANCER_LUMINAL_B_DN bone resorption disease DOID_0080011 5.927E-03 0.01175036 0.16184689 0.33245806 SMID_BREAST_CANCER_LUMINAL_B_DN osteoporosis DOID_11476 5.927E-03 0.01175036 0.16184689 0.33245806 SMID_BREAST_CANCER_LUMINAL_B_DN essential hypertension DOID_10825 6.028E-03 0.01190904 6.028E-03 0.03035225 SMID_BREAST_CANCER_LUMINAL_B_DN parathyroid gland disease DOID_11201 6.028E-03 0.01186784 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN vulva cancer DOID_1245 6.028E-03 0.01182691 0.11207134 0.27725475 SMID_BREAST_CANCER_LUMINAL_B_DN polyneuropathy DOID_1389 6.028E-03 0.01178627 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN obstructive hydrocephalus DOID_14159 6.028E-03 0.01174591 6.028E-03 0.03008601 SMID_BREAST_CANCER_LUMINAL_B_DN communicating hydrocephalus DOID_1573 6.028E-03 0.01174591 6.028E-03 0.03008601 SMID_BREAST_CANCER_LUMINAL_B_DN psoriatic arthritis DOID_9008 6.028E-03 0.01170582 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN lipid metabolism disorder DOID_3146 6.755E-03 0.01307316 6.755E-03 0.0328505 SMID_BREAST_CANCER_LUMINAL_B_DN Legionnaires' disease DOID_10457 6.99E-03 0.01348305 0.1201545 0.28605819 SMID_BREAST_CANCER_LUMINAL_B_DN legionellosis DOID_10458 6.99E-03 0.01348305 0.1201545 0.28605819 SMID_BREAST_CANCER_LUMINAL_B_DN tethered spinal cord syndrome DOID_1089 6.99E-03 0.0134375 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN hydrocephalus DOID_10908 6.99E-03 0.01339225 6.99E-03 0.03370762 SMID_BREAST_CANCER_LUMINAL_B_DN hypercalcemia DOID_12678 6.99E-03 0.01334731 0.1201545 0.28368427 SMID_BREAST_CANCER_LUMINAL_B_DN congenital structural myopathy DOID_422 6.99E-03 0.01330267 6.99E-03 0.03342437 SMID_BREAST_CANCER_LUMINAL_B_DN polycystic kidney disease DOID_898 6.99E-03 0.01325833 0.1201545 0.28019634 SMID_BREAST_CANCER_LUMINAL_B_DN chromosomal disease DOID_0080014 7.047E-03 0.01332138 0.17474519 0.35010568 SMID_BREAST_CANCER_LUMINAL_B_DN cervix uteri carcinoma in situ DOID_8991 7.51E-03 0.0141487 0.3313362 0.54805319 SMID_BREAST_CANCER_LUMINAL_B_DN renovascular hypertension DOID_1591 8.018E-03 0.01505606 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN adrenal cortex disease DOID_3952 8.018E-03 0.01500653 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN oral submucous fibrosis DOID_5773 8.018E-03 0.01495733 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN panic disorder DOID_594 8.018E-03 0.01490845 8.018E-03 0.03708932 SMID_BREAST_CANCER_LUMINAL_B_DN intermediate coronary syndrome DOID_8805 8.018E-03 0.01485989 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN hyperhomocysteinemia DOID_9279 8.018E-03 0.01481164 0.12816428 0.28598225 SMID_BREAST_CANCER_LUMINAL_B_DN intracranial hypertension DOID_9428 8.018E-03 0.01476371 8.018E-03 0.03679021 SMID_BREAST_CANCER_LUMINAL_B_DN Huntington's disease DOID_12858 8.493E-03 0.01558932 0.06577493 0.2001387 SMID_BREAST_CANCER_LUMINAL_B_DN primitive neuroectodermal tumor DOID_168 8.493E-03 0.01553919 0.06577493 0.19907413 SMID_BREAST_CANCER_LUMINAL_B_DN silicosis DOID_10325 9.108E-03 0.01661075 0.13610135 0.30132945 SMID_BREAST_CANCER_LUMINAL_B_DN Barrett's esophagus DOID_9206 9.108E-03 0.01655768 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN learning disability DOID_8927 9.549E-03 0.0173042 0.070852 0.20997286 SMID_BREAST_CANCER_LUMINAL_B_DN leukodystrophy DOID_10579 0.01010458 0.0182524 0.36124817 0.59236372 SMID_BREAST_CANCER_LUMINAL_B_DN drug-induced mental disorder DOID_1203 0.01026099 0.01847627 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN drug psychosis DOID_1742 0.01026099 0.01847627 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN hyperostosis DOID_205 0.01026099 0.01841799 0.01026099 0.04456872 SMID_BREAST_CANCER_LUMINAL_B_DN bronchitis DOID_6132 0.01026099 0.01836007 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN juvenile rheumatoid arthritis DOID_676 0.01026099 0.01830251 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN substance-induced psychosis DOID_8646 0.01026099 0.01847627 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN adrenal gland disease DOID_9553 0.01026099 0.01824532 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN carbohydrate metabolic disorder DOID_2978 0.01121969 0.01988786 0.58086658 0.91554871 SMID_BREAST_CANCER_LUMINAL_B_DN keratosis DOID_161 0.01147476 0.02027683 0.01147476 0.04800837 SMID_BREAST_CANCER_LUMINAL_B_DN dental caries DOID_216 0.01147476 0.02021405 0.01147476 0.04765794 SMID_BREAST_CANCER_LUMINAL_B_DN movement disease DOID_480 0.01251098 0.02197144 0.08406897 0.24159214 SMID_BREAST_CANCER_LUMINAL_B_DN dissociative disorder DOID_10935 0.0127483 0.02231932 0.15948287 0.33609538 SMID_BREAST_CANCER_LUMINAL_B_DN dissociative amnesia DOID_11037 0.0127483 0.02231932 0.15948287 0.33609538 SMID_BREAST_CANCER_LUMINAL_B_DN mitochondrial myopathy DOID_699 0.01546995 0.02700124 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN familial hyperlipidemia DOID_1168 0.01668501 0.02903293 0.01668501 0.06502581 SMID_BREAST_CANCER_LUMINAL_B_DN thrombophilia DOID_2452 0.01691576 0.02934472 0.01691576 0.06547665 SMID_BREAST_CANCER_LUMINAL_B_DN acquired immunodeficiency syndrome DOID_635 0.01691576 0.02925553 0.18223335 0.3575544 SMID_BREAST_CANCER_LUMINAL_B_DN heart conduction disease DOID_10273 0.01841671 0.03175486 0.18967956 0.36835382 SMID_BREAST_CANCER_LUMINAL_B_DN urinary tract obstruction DOID_5200 0.01841671 0.03165893 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN lingual-facial-buccal dyskinesia DOID_9854 0.01841671 0.03156357 0.18967956 0.36217339 SMID_BREAST_CANCER_LUMINAL_B_DN leukocyte disease DOID_9500 0.01902953 0.03251592 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN congenital hemolytic anemia DOID_589 0.01997167 0.03402359 0.01997167 0.07525748 SMID_BREAST_CANCER_LUMINAL_B_DN X-linked disease DOID_0050735 0.02323926 0.03947206 0.02323926 0.08531057 SMID_BREAST_CANCER_LUMINAL_B_DN reading disorder DOID_13365 0.02323926 0.03935458 0.211615 0.39870507 SMID_BREAST_CANCER_LUMINAL_B_DN osteosarcoma DOID_3347 0.02323926 0.0392378 0.211615 0.39608201 SMID_BREAST_CANCER_LUMINAL_B_DN dyslexia DOID_4428 0.02323926 0.03935458 0.211615 0.39870507 SMID_BREAST_CANCER_LUMINAL_B_DN temporal lobe epilepsy DOID_3328 0.02517287 0.04237682 0.13048561 0.29002466 SMID_BREAST_CANCER_LUMINAL_B_DN teeth hard tissue disease DOID_214 0.02670991 0.04483168 0.02670991 0.09558452 SMID_BREAST_CANCER_LUMINAL_B_DN fragments of torsion dystonia DOID_531 0.02670991 0.04469982 0.22590867 0.40936953 SMID_BREAST_CANCER_LUMINAL_B_DN central nervous system hereditary degenerative disease DOID_481 0.03037523 0.05068477 0.23994393 0.42798777 SMID_BREAST_CANCER_LUMINAL_B_DN polycystic ovary syndrome DOID_11612 0.03227834 0.05370285 0.24686612 0.43895882 SMID_BREAST_CANCER_LUMINAL_B_DN focal glomerulosclerosis DOID_3945 0.03227834 0.05354629 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN dystonic disease DOID_544 0.03227834 0.05339063 0.24686612 0.43623237 SMID_BREAST_CANCER_LUMINAL_B_DN female reproductive organ benign neoplasm DOID_0060086 0.03422708 0.05644988 0.25372544 0.44558573 SMID_BREAST_CANCER_LUMINAL_B_DN uterine benign neoplasm DOID_0060095 0.03422708 0.05644988 0.25372544 0.44558573 SMID_BREAST_CANCER_LUMINAL_B_DN uterine fibroid DOID_13223 0.03422708 0.05644988 0.25372544 0.44558573 SMID_BREAST_CANCER_LUMINAL_B_DN spastic cerebral palsy DOID_0050669 0.03622046 0.05956487 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_DN age related macular degeneration DOID_10871 0.03622046 0.05939321 0.26052247 0.45471561 SMID_BREAST_CANCER_LUMINAL_B_DN degeneration of macula and posterior pole DOID_2007 0.03622046 0.05939321 0.26052247 0.45471561 SMID_BREAST_CANCER_LUMINAL_B_DN leiomyoma DOID_127 0.04033731 0.06595383 0.27393191 0.47376065 SMID_BREAST_CANCER_LUMINAL_B_DN focal epilepsy DOID_2234 0.04272663 0.06966032 0.18125483 0.36060839 SMID_BREAST_CANCER_LUMINAL_B_DN male infertility DOID_12336 0.04462131 0.07254149 0.28709887 0.49056834 SMID_BREAST_CANCER_LUMINAL_B_DN macular degeneration DOID_4448 0.04462131 0.07233482 0.28709887 0.48909957 SMID_BREAST_CANCER_LUMINAL_B_DN refractive error DOID_9835 0.04906507 0.07931257 0.30002773 0.50808268 SMID_BREAST_CANCER_LUMINAL_B_DN adolescence-adult electroclinical syndrome DOID_0050705 0.05134462 0.08276229 0.30640422 0.51734126 SMID_BREAST_CANCER_LUMINAL_B_DN cleft palate DOID_674 0.05134462 0.0825285 0.30640422 0.51581066 SMID_BREAST_CANCER_LUMINAL_B_DN blood platelet disease DOID_2218 0.05366145 0.08600947 0.31272279 0.52335079 SMID_BREAST_CANCER_LUMINAL_B_DN lymphatic system disease DOID_75 0.05840348 0.09334714 0.32518826 0.53945225 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP middle cerebral artery infarction DOID_3525 5.625E-10 3.201E-07 0.01248443 0.32289272 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP intracranial arterial disease DOID_13089 3.377E-09 9.607E-07 0.01911203 0.31984536 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP cerebral arterial disease DOID_3527 3.377E-09 9.607E-07 0.01911203 0.31984536 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP cerebral infarction DOID_3526 5.317E-09 1.008E-06 0.0213119 0.3368465 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP brain infarction DOID_3454 2.638E-08 3.753E-06 0.03137168 0.37979754 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP intracranial aneurysm DOID_10941 2.436E-07 2.773E-05 0.01248443 0.33826856 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pleural disease DOID_1532 4.858E-07 4.607E-05 0.01558253 0.29554874 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP adult respiratory distress syndrome DOID_11394 9.14E-07 7.429E-05 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP benign mesothelioma DOID_2645 9.806E-07 6.974E-05 1.771E-04 0.02518734 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pulmonary emphysema DOID_9675 9.806E-07 6.199E-05 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP heart valve disease DOID_4079 1.449E-06 8.244E-05 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP atrophic muscular disease DOID_913 2.046E-06 1.058E-04 2.873E-04 0.0326985 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP muscular dystrophy DOID_9884 2.046E-06 1.058E-04 2.873E-04 0.0326985 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP bone marrow cancer DOID_4960 2.159E-06 1.024E-04 0.02525999 0.35055939 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP carotid artery disease DOID_3407 3.068E-06 1.343E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP respiratory failure DOID_11162 3.215E-06 1.307E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP uterine disease DOID_345 3.686E-06 1.398E-04 4.237E-04 0.03443967 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP tuberculosis DOID_399 4.2E-06 1.494E-04 0.03137168 0.37188509 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP aneurysm disease DOID_2403 5.798E-06 1.941E-04 0.03484786 0.39656861 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP female reproductive system disease DOID_229 6.73E-06 2.127E-04 6.304E-04 0.04483924 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP primary bacterial infectious disease DOID_0050338 8.304E-06 2.487E-04 0.03917657 0.41280498 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP temporal arteritis DOID_13375 1.038E-05 2.954E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP central nervous system vasculitis DOID_525 1.038E-05 2.954E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP Leydig cell tumor DOID_2696 1.472E-05 3.988E-04 1.472E-05 8.375E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP sex cord-stromal neoplasm DOID_4757 1.472E-05 3.988E-04 1.472E-05 8.375E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP skeletal system cancer DOID_0060124 1.98E-05 5.122E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP bone cancer DOID_184 1.98E-05 5.122E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP varicose veins DOID_799 1.98E-05 4.899E-04 6.706E-03 0.2543977 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP vein disease DOID_866 2.263E-05 5.364E-04 7.152E-03 0.23938264 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP congenital muscular dystrophy DOID_0050557 2.883E-05 6.563E-04 2.883E-05 8.203E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP brain edema DOID_4724 3.579E-05 7.832E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP placenta disease DOID_780 4.349E-05 9.165E-04 4.349E-05 8.248E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP sinusitis DOID_0050127 4.762E-05 9.677E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP paranasal sinus disease DOID_1352 4.762E-05 9.677E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pulmonary embolism DOID_9477 4.762E-05 9.343E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP meningitis DOID_9471 5.193E-05 9.85E-04 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP renal hypertension DOID_1073 8.172E-05 1.5E-03 0.01337054 0.31699314 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP secondary hypertension DOID_11130 8.172E-05 1.5E-03 0.01337054 0.31699314 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP allergic rhinitis DOID_4481 1.053E-04 1.872E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pneumoconiosis DOID_10316 1.249E-04 2.153E-03 0.01646603 0.30223125 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pulmonary sarcoidosis DOID_13406 1.461E-04 2.446E-03 0.01778986 0.30674039 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP calcinosis DOID_182 1.461E-04 2.376E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP systemic scleroderma DOID_418 1.612E-04 2.548E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP rheumatic disease DOID_1575 1.936E-04 2.978E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP scleroderma DOID_419 1.936E-04 2.978E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP influenza DOID_8469 2.022E-04 3.027E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP myeloma DOID_0070004 2.289E-04 3.34E-03 0.02219056 0.34125477 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pulmonary tuberculosis DOID_2957 2.477E-04 3.523E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP calcium metabolism disease DOID_10575 2.573E-04 3.571E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP withdrawal disorder DOID_0060001 2.671E-04 3.619E-03 0.02394563 0.35855432 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP sarcoidosis DOID_11335 2.873E-04 3.802E-03 0.02482206 0.36214744 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP giant cell tumor DOID_200 2.873E-04 3.716E-03 0.02482206 0.35309375 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP malignant giant cell tumor DOID_2705 2.873E-04 3.716E-03 0.02482206 0.35309375 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP giant cell glioblastoma DOID_3074 2.873E-04 3.716E-03 0.02482206 0.35309375 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP vasculitis DOID_865 2.977E-04 3.764E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP reproductive organ benign neoplasm DOID_0050622 3.083E-04 3.813E-03 3.083E-04 0.02923276 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP integumentary system cancer DOID_0060122 3.083E-04 3.732E-03 0.02569774 0.34814321 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP skin cancer DOID_4159 3.083E-04 3.732E-03 0.02569774 0.34814321 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP hypersensitivity reaction type IV disease DOID_2916 3.41E-04 4.042E-03 0.02700988 0.34928687 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP glioblastoma DOID_3068 3.41E-04 3.96E-03 0.02700988 0.34152494 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP collagen disease DOID_854 3.754E-04 4.272E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP mineral metabolism disease DOID_0050032 4.113E-04 4.589E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP astrocytoma DOID_3069 4.749E-04 5.196E-03 0.03180684 0.36934885 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP cystic fibrosis DOID_1485 5.571E-04 5.981E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pancreatitis DOID_4989 5.859E-04 6.173E-03 0.03528155 0.39363144 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP chronic kidney failure DOID_784 6.61E-04 6.839E-03 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP interstitial nephritis DOID_1063 4.476E-03 0.0454761 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP conjunctival disease DOID_4251 4.476E-03 0.04467827 4.476E-03 0.28296238 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP conjunctivitis DOID_6195 4.476E-03 0.04467827 4.476E-03 0.28296238 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP cutaneous leishmaniasis DOID_9111 4.476E-03 0.04390796 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pneumocystosis DOID_11339 4.922E-03 0.04747011 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP bronchiectasis DOID_9563 4.922E-03 0.04667894 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP otitis media DOID_10754 5.369E-03 0.05007713 5.369E-03 0.30547047 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP beta thalassemia DOID_12241 5.369E-03 0.04926943 5.369E-03 0.27770043 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP aortic valve stenosis DOID_1712 5.369E-03 0.04848738 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP middle ear disease DOID_5100 5.369E-03 0.05007713 5.369E-03 0.30547047 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP lipodystrophy DOID_811 5.369E-03 0.04772976 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP peritonitis DOID_8283 5.369E-03 0.04699546 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP ocular hypertension DOID_9282 5.369E-03 0.0462834 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP borderline glaucoma DOID_9283 5.369E-03 0.0462834 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP encephalitis DOID_9588 5.369E-03 0.04559261 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP larynx cancer DOID_2596 5.815E-03 0.04865537 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP laryngeal benign neoplasm DOID_2598 5.815E-03 0.04865537 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP intracranial thrombosis DOID_4193 5.815E-03 0.04795022 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP tethered spinal cord syndrome DOID_1089 6.261E-03 0.05089027 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP eyelid disease DOID_530 6.261E-03 0.05017351 6.261E-03 0.29685992 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP bacterial meningitis DOID_9470 6.261E-03 0.04947665 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP idiopathic pulmonary fibrosis DOID_0050156 6.706E-03 0.0522735 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP thalassemia DOID_10241 6.706E-03 0.0515671 6.706E-03 0.29353581 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP thoracic aortic aneurysm DOID_14004 6.706E-03 0.05087954 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP renovascular hypertension DOID_1591 6.706E-03 0.05021007 6.706E-03 0.27256897 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP oral submucous fibrosis DOID_5773 6.706E-03 0.04955799 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP intermediate coronary syndrome DOID_8805 6.706E-03 0.04892264 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP silicosis DOID_10325 7.152E-03 0.05151272 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP tongue cancer DOID_8649 7.152E-03 0.05086881 7.152E-03 0.25434406 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP Barrett's esophagus DOID_9206 7.152E-03 0.0502408 7.152E-03 0.22608361 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP basal cell carcinoma DOID_2513 7.597E-03 0.05271875 7.597E-03 0.22752302 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP bronchitis DOID_6132 7.597E-03 0.05208358 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP skin carcinoma DOID_3451 8.043E-03 0.05447932 8.043E-03 0.22881313 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP prion disease DOID_649 8.043E-03 0.05383838 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP leishmaniasis DOID_9065 8.488E-03 0.05615676 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP subependymal glioma DOID_4843 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP pilocytic astrocytoma DOID_4851 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP subependymal giant cell astrocytoma DOID_5077 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP fibrillary astrocytoma DOID_6726 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP juvenile pilocytic astrocytoma DOID_6811 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP childhood pilocytic astrocytoma DOID_6812 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP gemistocytic astrocytoma DOID_7005 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP childhood cerebral astrocytoma DOID_7007 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP protoplasmic astrocytoma DOID_7008 8.932E-03 0.0584206 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP autoimmune hepatitis DOID_2048 9.377E-03 0.06063178 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP benign glioma DOID_0060101 9.822E-03 0.06279208 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP gastric ulcer DOID_10808 9.822E-03 0.06209439 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP familial hypercholesterolemia DOID_13810 9.822E-03 0.06141203 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP hepatitis B DOID_2043 9.822E-03 0.06074451 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP benign ependymoma DOID_4844 9.822E-03 0.06279208 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP acquired immunodeficiency syndrome DOID_635 9.822E-03 0.06009134 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP opiate dependence DOID_2559 0.01026588 0.06214134 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP IgA glomerulonephritis DOID_2986 0.01026588 0.06148722 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP aortic valve disease DOID_62 0.01070996 0.06347885 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP osteosarcoma DOID_3347 0.01159757 0.06803111 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP spinal cord disease DOID_319 0.01248443 0.07248612 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP extrinsic allergic alveolitis DOID_841 0.01248443 0.07175394 0.01248443 0.30885391 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP Sciatic Neuropathy DOID_11446 0.01292758 0.07355791 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP gestational diabetes DOID_11714 0.01292758 0.07282961 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP lesion of sciatic nerve DOID_12528 0.01292758 0.07355791 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP lung adenocarcinoma DOID_3910 0.01292758 0.0721156 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP mononeuritis of lower limb DOID_9473 0.01292758 0.07355791 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP mononeuritis DOID_1802 0.01337054 0.07386248 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP mononeuropathy DOID_1188 0.01381331 0.07557475 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP supratentorial cancer DOID_1659 0.01381331 0.07485499 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP toxic encephalopathy DOID_3602 0.01381331 0.07414881 0.01381331 0.31439094 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP cerebrum cancer DOID_368 0.01381331 0.07485499 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP focal glomerulosclerosis DOID_3945 0.01381331 0.07345583 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP female reproductive organ benign neoplasm DOID_0060086 0.0142559 0.07510746 0.0142559 0.31198482 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP uterine benign neoplasm DOID_0060095 0.0142559 0.07510746 0.0142559 0.31198482 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP uterine fibroid DOID_13223 0.0142559 0.07510746 0.0142559 0.31198482 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP endometrial carcinoma DOID_2871 0.0142559 0.0744184 0.0142559 0.30042982 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP opportunistic mycosis DOID_2473 0.0146983 0.07603028 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP bronchiolitis obliterans DOID_2799 0.0146983 0.07534532 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP abdominal aortic aneurysm DOID_7693 0.0146983 0.07467259 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP endometrial cancer DOID_1380 0.01514051 0.07623849 0.01514051 0.30767677 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP leiomyoma DOID_127 0.01558253 0.07777598 0.01558253 0.30574007 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP systemic mycosis DOID_0050136 0.01602437 0.07928581 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP fungal infectious disease DOID_1564 0.01602437 0.07928581 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP myocarditis DOID_820 0.01602437 0.07860232 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP spindle cell carcinoma DOID_4015 0.01646603 0.08007837 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP esophageal disease DOID_6050 0.01646603 0.07939974 0.01646603 0.29278653 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP multiple myeloma DOID_9538 0.01778986 0.08506246 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP respiratory syncytial virus infectious disease DOID_1273 0.01867149 0.08853399 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP peptic ulcer DOID_750 0.01867149 0.0878023 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP endometriosis of uterus DOID_288 0.01999253 0.09324387 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP endometriosis DOID_289 0.02043251 0.09452113 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP diabetic autonomic neuropathy DOID_11503 0.0208723 0.09577693 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP autonomic neuropathy DOID_11504 0.0208723 0.09577693 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP diabetic polyneuropathy DOID_12785 0.0208723 0.09577693 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP uterine cancer DOID_363 0.0208723 0.09501071 0.0208723 0.33932398 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP diabetic neuropathy DOID_9743 0.0208723 0.09577693 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP autonomic nervous system disease DOID_11465 0.02219056 0.09942068 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP brain cancer DOID_1319 0.02219056 0.09864396 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP neuritis DOID_1803 0.02219056 0.09787927 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP central nervous system cancer DOID_3620 0.0226296 0.09904803 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP integumentary system benign neoplasm DOID_0060121 0.02306846 0.09943906 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP glaucoma DOID_1686 0.02306846 0.0986914 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP skin benign neoplasm DOID_3165 0.02306846 0.09943906 1.000 1.000 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP aortic aneurysm DOID_3627 0.02350714 0.09981763 1.000 1.000 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN heart valve disease DOID_4079 6.157E-13 3.504E-10 1.57E-09 2.979E-07 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN aortic valve insufficiency DOID_57 4.147E-12 1.18E-09 8.839E-10 2.515E-07 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN aortic valve disease DOID_62 5.955E-12 1.129E-09 5.798E-10 3.299E-07 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN aneurysm disease DOID_2403 1.47E-09 2.091E-07 2.011E-05 9.537E-04 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN bone development disease DOID_0080006 2.917E-09 3.32E-07 7.458E-08 1.061E-05 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN Ehlers-Danlos syndrome DOID_13359 3.318E-09 3.147E-07 3.729E-07 4.243E-05 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN collagen disease DOID_854 2.818E-07 2.29E-05 7.153E-06 5.088E-04 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN nephrosis DOID_2527 6.728E-07 4.786E-05 1.462E-05 7.561E-04 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN aortic aneurysm DOID_3627 2.793E-06 1.766E-04 1.402E-03 0.0249341 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN synostosis DOID_11971 2.82E-06 1.604E-04 2.82E-06 2.674E-04 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN mouth disease DOID_403 3.124E-06 1.616E-04 5.155E-05 2.095E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN dilated cardiomyopathy DOID_12930 3.319E-06 1.574E-04 3.319E-06 2.698E-04 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN osteochondrodysplasia DOID_2256 4.386E-06 1.92E-04 1.009E-04 3.588E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN dysostosis DOID_1934 9.299E-06 3.779E-04 9.299E-06 5.879E-04 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN craniosynostosis DOID_2340 1.122E-05 4.256E-04 1.122E-05 6.384E-04 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN skeletal system cancer DOID_0060124 3.056E-05 1.087E-03 0.06036115 0.27258328 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN thoracic aortic aneurysm DOID_14004 3.056E-05 1.023E-03 1.727E-03 0.02890328 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN bone cancer DOID_184 3.056E-05 1.087E-03 0.06036115 0.27258328 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN nutritional deficiency disease DOID_5113 3.056E-05 9.662E-04 3.056E-05 1.338E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN oral submucous fibrosis DOID_5773 3.056E-05 9.153E-04 1.727E-03 0.02807748 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN ureteral obstruction DOID_5199 5.432E-05 1.545E-03 2.496E-03 0.03550815 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN atrophic muscular disease DOID_913 8.792E-05 2.382E-03 8.792E-05 3.335E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN muscular dystrophy DOID_9884 8.792E-05 2.382E-03 8.792E-05 3.335E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN urinary tract obstruction DOID_5200 1.161E-04 3.003E-03 4.072E-03 0.04827068 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN ureteral disease DOID_1426 1.323E-04 3.273E-03 4.43E-03 0.0504157 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN sphingolipidosis DOID_1927 1.499E-04 3.553E-03 1.499E-04 5.016E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN congenital heart defect DOID_1682 1.671E-04 3.802E-03 1.671E-04 5.281E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN uterine disease DOID_345 1.876E-04 4.105E-03 1.876E-04 5.617E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN intracranial aneurysm DOID_10941 2.115E-04 4.458E-03 6.002E-03 0.06443727 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN brain infarction DOID_3454 2.216E-04 4.504E-03 3.24E-03 0.04097269 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN multiple epiphyseal dysplasia DOID_12721 2.876E-04 5.643E-03 2.876E-04 8.183E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN mixed glioma DOID_5076 3.505E-04 6.648E-03 3.505E-04 9.497E-03 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN female reproductive system disease DOID_229 4.033E-04 7.403E-03 4.033E-04 0.01043204 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN metal metabolism disorder DOID_896 4.5E-04 8.001E-03 4.5E-04 0.011132 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN adenoma DOID_657 5.707E-04 9.841E-03 0.01142139 0.10154333 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN adenoid cystic carcinoma DOID_4866 7.614E-04 0.01274264 7.614E-04 0.01805208 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN endometriosis of uterus DOID_288 8.702E-04 0.01414724 8.702E-04 0.01980614 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN salivary gland cancer DOID_8850 8.702E-04 0.01375427 8.702E-04 0.01904437 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN nephrotic syndrome DOID_1184 9.281E-04 0.01427292 0.01565495 0.13295023 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN endometriosis DOID_289 9.281E-04 0.01389731 9.281E-04 0.01955918 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN cataract DOID_83 1.051E-03 0.01533539 1.051E-03 0.02136 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN mucopolysaccharidosis DOID_12798 1.094E-03 0.01556913 1.094E-03 0.02147466 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN peritonitis DOID_8283 1.094E-03 0.0151894 0.0485858 0.25597517 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN lens disease DOID_110 1.184E-03 0.01603956 1.184E-03 0.02245538 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN neuritis DOID_1803 1.184E-03 0.01566654 0.01833058 0.14094731 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN essential hypertension DOID_10825 1.29E-03 0.01668172 1.29E-03 0.02367728 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN osteogenesis imperfecta DOID_12347 1.29E-03 0.01631101 0.05252712 0.25989503 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN calcium metabolism disease DOID_10575 1.402E-03 0.01734546 0.02045456 0.15518193 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN giant cell tumor DOID_200 1.644E-03 0.01990687 1.644E-03 0.02835221 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN malignant giant cell tumor DOID_2705 1.644E-03 0.01990687 1.644E-03 0.02835221 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN giant cell glioblastoma DOID_3074 1.644E-03 0.01990687 1.644E-03 0.02835221 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN membranoproliferative glomerulonephritis DOID_2920 1.727E-03 0.02047316 0.06036115 0.26832416 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN varicose veins DOID_799 1.727E-03 0.02005534 1.727E-03 0.02729755 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN vein disease DOID_866 1.968E-03 0.02240101 1.968E-03 0.03027164 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN hypertrophic cardiomyopathy DOID_11984 2.103E-03 0.0234618 0.02658754 0.18910389 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN glioblastoma DOID_3068 2.103E-03 0.02301061 2.103E-03 0.0314882 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN oral cavity cancer DOID_8618 2.103E-03 0.02257645 2.103E-03 0.03068081 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN mineral metabolism disease DOID_0050032 2.749E-03 0.02896513 0.03161165 0.21671116 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN cerebral degeneration DOID_1443 2.867E-03 0.02966148 2.867E-03 0.03978979 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN membranous glomerulonephritis DOID_10976 3.083E-03 0.03132594 3.083E-03 0.04176791 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN amyloidosis DOID_9120 3.083E-03 0.03077636 3.083E-03 0.04079657 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN tooth disease DOID_1091 3.113E-03 0.03053782 0.03425283 0.23202217 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN allergic contact dermatitis DOID_3042 3.113E-03 0.03002023 3.113E-03 0.0402544 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN astrocytoma DOID_3069 3.371E-03 0.03196913 3.371E-03 0.04169887 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN gastric ulcer DOID_10808 3.728E-03 0.03477475 0.08727682 0.33782661 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN hepatitis B DOID_2043 3.728E-03 0.03421386 0.08727682 0.33107008 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN diabetic retinopathy DOID_8947 3.926E-03 0.03545918 0.03978112 0.25722112 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN uremia DOID_4676 4.072E-03 0.03620301 4.072E-03 0.04929771 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN bone resorption disease DOID_0080011 4.377E-03 0.03831259 0.04266342 0.25026274 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN osteoporosis DOID_11476 4.377E-03 0.03831259 0.04266342 0.25026274 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN diabetic angiopathy DOID_11713 4.43E-03 0.03819371 4.43E-03 0.0514446 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN metabolic syndrome X DOID_14221 4.857E-03 0.04125139 4.857E-03 0.054193 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN contact dermatitis DOID_2773 4.857E-03 0.04064475 4.857E-03 0.05315083 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN portal hypertension DOID_10762 5.189E-03 0.04278657 0.10231178 0.36845193 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN retinal vascular disease DOID_2462 5.727E-03 0.04655201 0.05071317 0.26232542 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN transitional cell carcinoma DOID_2671 6.291E-03 0.05041329 0.05386178 0.25972331 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN Sciatic Neuropathy DOID_11446 6.429E-03 0.05080885 0.11342628 0.38879247 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN gestational diabetes DOID_11714 6.429E-03 0.05011284 6.429E-03 0.06774513 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN lesion of sciatic nerve DOID_12528 6.429E-03 0.05080885 0.11342628 0.38879247 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN lung adenocarcinoma DOID_3910 6.429E-03 0.04943564 6.429E-03 0.0665134 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN migraine DOID_6364 6.429E-03 0.0487765 0.11342628 0.38646437 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN mononeuritis of lower limb DOID_9473 6.429E-03 0.05080885 0.11342628 0.38879247 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN mononeuritis DOID_1802 6.87E-03 0.05143355 0.11710063 0.3942619 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN hepatic vascular disease DOID_272 6.87E-03 0.05076558 0.11710063 0.39194271 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN lymphoma DOID_0060058 7.092E-03 0.05173451 7.092E-03 0.07205878 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN lymphoblastic leukemia DOID_1037 7.301E-03 0.05258735 7.301E-03 0.07288423 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN mononeuropathy DOID_1188 7.324E-03 0.05209057 0.12075986 0.39264206 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN female reproductive organ benign neoplasm DOID_0060086 7.791E-03 0.05472914 7.791E-03 0.07643207 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN uterine benign neoplasm DOID_0060095 7.791E-03 0.05472914 7.791E-03 0.07643207 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN uterine fibroid DOID_13223 7.791E-03 0.05472914 7.791E-03 0.07643207 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN age related macular degeneration DOID_10871 8.271E-03 0.05739422 8.271E-03 0.07976824 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN degeneration of macula and posterior pole DOID_2007 8.271E-03 0.05739422 8.271E-03 0.07976824 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN abdominal aortic aneurysm DOID_7693 8.271E-03 0.05670272 0.12803317 0.40249101 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN pleural disease DOID_1532 9.271E-03 0.06279705 0.13524669 0.40933706 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN hair disease DOID_421 9.789E-03 0.06553156 9.789E-03 0.09283637 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN macular degeneration DOID_4448 0.01032092 0.06828611 0.01032092 0.09627221 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN hyperthyroidism DOID_7998 0.01032092 0.06750121 0.01032092 0.09471944 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN lymphoid leukemia DOID_10747 0.01086495 0.07025178 0.01086495 0.09812947 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN calcinosis DOID_182 0.01199014 0.07665608 0.15302212 0.43753561 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN multiple myeloma DOID_9538 0.01199014 0.07580435 0.01199014 0.10495987 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN hepatitis DOID_2237 0.01316412 0.08231192 0.16003021 0.44855758 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN peptic ulcer DOID_750 0.01316412 0.08141722 0.16003021 0.44635877 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN intracranial arterial disease DOID_13089 0.01376913 0.08424339 0.16351262 0.45384721 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN cerebral arterial disease DOID_3527 0.01376913 0.08424339 0.16351262 0.45384721 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN benign mesothelioma DOID_2645 0.01438601 0.08708127 0.01438601 0.12402484 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN Huntington's disease DOID_12858 0.01565495 0.0937649 0.01565495 0.13099508 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN rheumatic disease DOID_1575 0.01565495 0.09278818 0.17387399 0.47111573 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN primitive neuroectodermal tumor DOID_168 0.01565495 0.0918316 0.01565495 0.1290966 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN scleroderma DOID_419 0.01565495 0.09278818 0.17387399 0.47111573 KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN cerebral infarction DOID_3526 0.01697009 0.09853039 0.18071063 0.47825278 WAKASUGI_HAVE_ZNF143_BINDING_SITES Fanconi's anemia DOID_13636 3.823E-12 2.175E-09 3.823E-12 2.175E-09 WAKASUGI_HAVE_ZNF143_BINDING_SITES congenital hypoplastic anemia DOID_1342 8.525E-11 2.425E-08 8.525E-11 2.425E-08 WAKASUGI_HAVE_ZNF143_BINDING_SITES aplastic anemia DOID_12449 4.322E-10 8.197E-08 4.322E-10 8.197E-08 WAKASUGI_HAVE_ZNF143_BINDING_SITES Lynch syndrome DOID_3883 6.789E-10 9.657E-08 6.789E-10 9.657E-08 WAKASUGI_HAVE_ZNF143_BINDING_SITES bone marrow disease DOID_4961 1.808E-09 2.057E-07 1.808E-09 2.057E-07 WAKASUGI_HAVE_ZNF143_BINDING_SITES lung adenocarcinoma DOID_3910 2.229E-08 2.113E-06 2.229E-08 2.113E-06 WAKASUGI_HAVE_ZNF143_BINDING_SITES vulva cancer DOID_1245 2.858E-07 2.323E-05 7.986E-05 6.491E-03 WAKASUGI_HAVE_ZNF143_BINDING_SITES supratentorial cancer DOID_1659 4.435E-06 3.154E-04 0.03141548 0.48311916 WAKASUGI_HAVE_ZNF143_BINDING_SITES cerebrum cancer DOID_368 4.435E-06 3.154E-04 0.03141548 0.48311916 WAKASUGI_HAVE_ZNF143_BINDING_SITES brain cancer DOID_1319 1.908E-05 1.206E-03 0.05019259 0.60765068 WAKASUGI_HAVE_ZNF143_BINDING_SITES central nervous system cancer DOID_3620 2.025E-05 1.153E-03 0.05117097 0.60658918 WAKASUGI_HAVE_ZNF143_BINDING_SITES nervous system cancer DOID_3093 1.186E-04 6.137E-03 0.09045001 0.88734579 WAKASUGI_HAVE_ZNF143_BINDING_SITES subependymal glioma DOID_4843 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES pilocytic astrocytoma DOID_4851 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES subependymal giant cell astrocytoma DOID_5077 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES fibrillary astrocytoma DOID_6726 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES juvenile pilocytic astrocytoma DOID_6811 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES childhood pilocytic astrocytoma DOID_6812 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES gemistocytic astrocytoma DOID_7005 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES childhood cerebral astrocytoma DOID_7007 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES protoplasmic astrocytoma DOID_7008 1.936E-04 9.182E-03 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES benign glioma DOID_0060101 2.351E-04 0.01029105 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES benign ependymoma DOID_4844 2.351E-04 0.01029105 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES severe combined immunodeficiency DOID_627 3.048E-04 0.01238618 3.048E-04 0.02167582 WAKASUGI_HAVE_ZNF143_BINDING_SITES osteosarcoma DOID_3347 3.299E-04 0.01251567 0.02641433 0.46967976 WAKASUGI_HAVE_ZNF143_BINDING_SITES combined T cell and B cell immunodeficiency DOID_628 3.299E-04 0.01173344 3.299E-04 0.02085945 WAKASUGI_HAVE_ZNF143_BINDING_SITES endometrial carcinoma DOID_2871 5.016E-04 0.0167881 5.016E-04 0.02853976 WAKASUGI_HAVE_ZNF143_BINDING_SITES endometrial cancer DOID_1380 5.666E-04 0.01790996 5.666E-04 0.02930722 WAKASUGI_HAVE_ZNF143_BINDING_SITES chronic leukemia DOID_1036 6.005E-04 0.01798397 0.03539837 0.50354187 WAKASUGI_HAVE_ZNF143_BINDING_SITES chronic lymphocytic leukemia DOID_1040 6.005E-04 0.01798397 0.03539837 0.50354187 WAKASUGI_HAVE_ZNF143_BINDING_SITES embryonal cancer DOID_688 7.847E-04 0.02232423 7.847E-04 0.03720705 WAKASUGI_HAVE_ZNF143_BINDING_SITES cervix uteri carcinoma in situ DOID_8991 9.492E-04 0.0257191 9.492E-04 0.04154624 WAKASUGI_HAVE_ZNF143_BINDING_SITES uterine cancer DOID_363 1.083E-03 0.02799892 1.083E-03 0.0439983 WAKASUGI_HAVE_ZNF143_BINDING_SITES integumentary system benign neoplasm DOID_0060121 1.324E-03 0.03274497 0.05214837 0.60555961 WAKASUGI_HAVE_ZNF143_BINDING_SITES skin benign neoplasm DOID_3165 1.324E-03 0.03274497 0.05214837 0.60555961 WAKASUGI_HAVE_ZNF143_BINDING_SITES pre-malignant neoplasm DOID_0060071 2.122E-03 0.05030387 2.122E-03 0.08048619 WAKASUGI_HAVE_ZNF143_BINDING_SITES in situ carcinoma DOID_8719 2.122E-03 0.05030387 2.122E-03 0.08048619 WAKASUGI_HAVE_ZNF143_BINDING_SITES astrocytoma DOID_3069 2.519E-03 0.05732144 1.000 1.000 WAKASUGI_HAVE_ZNF143_BINDING_SITES pancreatic carcinoma DOID_4905 2.801E-03 0.0612974 0.07531383 0.77915579 WAKASUGI_HAVE_ZNF143_BINDING_SITES primary immunodeficiency disease DOID_612 3.986E-03 0.08399277 3.986E-03 0.14173781 WAKASUGI_HAVE_ZNF143_BINDING_SITES lymphoblastic leukemia DOID_1037 4.334E-03 0.08808275 0.09326104 0.89941582 WAKASUGI_HAVE_ZNF143_BINDING_SITES mouth disease DOID_403 4.424E-03 0.08679871 4.424E-03 0.14806838 CHIBA_RESPONSE_TO_TSA_DN glioblastoma DOID_3068 1.825E-08 1.038E-05 3.832E-04 0.21805105 CHIBA_RESPONSE_TO_TSA_DN astrocytoma DOID_3069 3.585E-08 1.02E-05 5.336E-04 0.15180809 CHIBA_RESPONSE_TO_TSA_DN giant cell tumor DOID_200 2.452E-06 4.651E-04 0.02626318 0.37359375 CHIBA_RESPONSE_TO_TSA_DN malignant giant cell tumor DOID_2705 2.452E-06 4.651E-04 0.02626318 0.37359375 CHIBA_RESPONSE_TO_TSA_DN giant cell glioblastoma DOID_3074 2.452E-06 4.651E-04 0.02626318 0.37359375 CHIBA_RESPONSE_TO_TSA_DN dilated cardiomyopathy DOID_12930 1.288E-05 1.833E-03 9.652E-04 0.09153227 CHIBA_RESPONSE_TO_TSA_DN aortic valve insufficiency DOID_57 1.401E-05 1.595E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_DN aortic valve disease DOID_62 5.84E-05 5.538E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_DN uterine cancer DOID_363 2.273E-04 0.0184733 0.02208671 0.36962767 CHIBA_RESPONSE_TO_TSA_DN heart valve disease DOID_4079 2.573E-04 0.01830191 1.000 1.000 CHIBA_RESPONSE_TO_TSA_DN aortic aneurysm DOID_3627 2.892E-04 0.01828482 0.0248729 0.36288925 CHIBA_RESPONSE_TO_TSA_DN bile duct adenocarcinoma DOID_4896 3.346E-04 0.01903831 0.02672619 0.36207626 CHIBA_RESPONSE_TO_TSA_DN cholangiocarcinoma DOID_4947 3.346E-04 0.01903831 0.02672619 0.36207626 CHIBA_RESPONSE_TO_TSA_DN bile duct cancer DOID_4606 3.832E-04 0.01982282 0.02857615 0.3613296 CHIBA_RESPONSE_TO_TSA_DN bile duct carcinoma DOID_4897 3.832E-04 0.01982282 0.02857615 0.3613296 CHIBA_RESPONSE_TO_TSA_DN pancreatic ductal carcinoma DOID_3587 5.485E-04 0.02600675 5.485E-04 0.104027 CHIBA_RESPONSE_TO_TSA_DN pancreatic carcinoma DOID_4905 5.943E-04 0.02601221 5.943E-04 0.08453968 CHIBA_RESPONSE_TO_TSA_DN aneurysm disease DOID_2403 6.419E-04 0.02608995 0.03685997 0.40333314 CHIBA_RESPONSE_TO_TSA_DN biliary tract cancer DOID_4607 7.426E-04 0.02816787 0.03960638 0.40242915 CHIBA_RESPONSE_TO_TSA_DN Human immunodeficiency virus infectious disease DOID_526 8.69E-04 0.0309031 8.69E-04 0.0988899 CHIBA_RESPONSE_TO_TSA_DN ulcerative colitis DOID_8577 1.025E-03 0.03431648 0.0464401 0.46358622 VANHARANTA_UTERINE_FIBROID_DN osteosarcoma DOID_3347 3.722E-06 2.118E-03 3.722E-06 2.118E-03 VANHARANTA_UTERINE_FIBROID_DN Human immunodeficiency virus infectious disease DOID_526 4.092E-06 1.164E-03 4.092E-06 1.164E-03 VANHARANTA_UTERINE_FIBROID_DN alcohol abuse DOID_1574 1.348E-04 0.02556612 1.348E-04 0.02556612 VANHARANTA_UTERINE_FIBROID_DN muscular atrophy DOID_767 2.996E-04 0.04262388 0.02523162 0.28150575 VANHARANTA_UTERINE_FIBROID_DN autosomal dominant nonsyndromic deafness DOID_0050564 4.536E-04 0.05162216 4.536E-04 0.0645277 VANHARANTA_UTERINE_FIBROID_DN cleft lip DOID_9296 4.536E-04 0.04301847 4.536E-04 0.05162216 VANHARANTA_UTERINE_FIBROID_DN allergic rhinitis DOID_4481 7.213E-04 0.05863031 0.03873097 0.30188936 VANHARANTA_UTERINE_FIBROID_DN spindle cell carcinoma DOID_4015 8.544E-04 0.06076889 8.544E-04 0.08102518 VANHARANTA_UTERINE_FIBROID_DN pulmonary sarcoidosis DOID_13406 9.984E-04 0.0631232 0.04541196 0.32708109 VANHARANTA_UTERINE_FIBROID_DN cleft palate DOID_674 9.984E-04 0.05681088 9.984E-04 0.08115839 VANHARANTA_UTERINE_FIBROID_DN adenoid cystic carcinoma DOID_4866 1.153E-03 0.05965846 1.153E-03 0.08203038 VANHARANTA_UTERINE_FIBROID_DN salivary gland cancer DOID_8850 1.263E-03 0.05986749 1.263E-03 0.07982332 VANHARANTA_UTERINE_FIBROID_DN cerebral infarction DOID_3526 1.435E-03 0.06282656 1.435E-03 0.08167453 VANHARANTA_UTERINE_FIBROID_DN brain cancer DOID_1319 1.557E-03 0.06326244 1.557E-03 0.08051584 VANHARANTA_UTERINE_FIBROID_DN central nervous system cancer DOID_3620 1.619E-03 0.06140971 1.619E-03 0.07676214 VANHARANTA_UTERINE_FIBROID_DN orofacial cleft DOID_0050567 1.88E-03 0.06685683 1.88E-03 0.08228533 VANHARANTA_UTERINE_FIBROID_DN sarcoidosis DOID_11335 1.948E-03 0.06520659 0.06300686 0.35850905 VANHARANTA_UTERINE_FIBROID_DN integumentary system cancer DOID_0060122 2.088E-03 0.0660056 2.088E-03 0.08486435 VANHARANTA_UTERINE_FIBROID_DN skin cancer DOID_4159 2.088E-03 0.0660056 2.088E-03 0.08486435 VANHARANTA_UTERINE_FIBROID_DN smallpox DOID_8736 2.088E-03 0.06253162 2.088E-03 0.07920672 VANHARANTA_UTERINE_FIBROID_DN nonsyndromic deafness DOID_0050563 2.307E-03 0.06562101 2.307E-03 0.08202626 VANHARANTA_UTERINE_FIBROID_DN hypersensitivity reaction type IV disease DOID_2916 2.307E-03 0.0624962 0.06843998 0.36394719 VANHARANTA_UTERINE_FIBROID_DN oral cavity cancer DOID_8618 2.307E-03 0.05965546 2.307E-03 0.07720118 VANHARANTA_UTERINE_FIBROID_DN melancholia DOID_2848 2.382E-03 0.05892044 0.0695229 0.35962302 VANHARANTA_UTERINE_FIBROID_DN neurotic disorder DOID_4964 2.458E-03 0.05827386 0.0706046 0.36192807 VANHARANTA_UTERINE_FIBROID_DN congenital heart defect DOID_1682 2.694E-03 0.06130724 2.694E-03 0.08514895 VANHARANTA_UTERINE_FIBROID_DN hyperglycemia DOID_4195 2.94E-03 0.06433111 2.94E-03 0.08803205 VANHARANTA_UTERINE_FIBROID_DN brain infarction DOID_3454 3.109E-03 0.06552249 3.109E-03 0.08845537 VANHARANTA_UTERINE_FIBROID_DN endogenous depression DOID_1595 3.738E-03 0.07596101 0.08668328 0.37940604 VANHARANTA_UTERINE_FIBROID_DN auditory system disease DOID_2742 4.32E-03 0.08476344 4.32E-03 0.11705427 VANHARANTA_UTERINE_FIBROID_DN mental depression DOID_1596 4.421E-03 0.08385079 0.09409332 0.39079635 VANHARANTA_UTERINE_FIBROID_DN nervous system cancer DOID_3093 5.157E-03 0.09465982 5.157E-03 0.1333843 WILCOX_PRESPONSE_TO_ROGESTERONE_UP metabolic syndrome X DOID_14221 4.534E-07 2.58E-04 1.672E-05 9.513E-03 WILCOX_PRESPONSE_TO_ROGESTERONE_UP adult respiratory distress syndrome DOID_11394 1.245E-06 3.543E-04 2.89E-03 0.09672278 WILCOX_PRESPONSE_TO_ROGESTERONE_UP idiopathic pulmonary fibrosis DOID_0050156 2.7E-06 5.12E-04 3.474E-04 0.03953751 WILCOX_PRESPONSE_TO_ROGESTERONE_UP respiratory failure DOID_11162 6.626E-06 9.426E-04 6.485E-03 0.13665775 WILCOX_PRESPONSE_TO_ROGESTERONE_UP lipid metabolism disorder DOID_3146 1.672E-05 1.903E-03 4.809E-04 0.0304028 WILCOX_PRESPONSE_TO_ROGESTERONE_UP chronic kidney failure DOID_784 1.927E-05 1.828E-03 5.342E-04 0.02763326 WILCOX_PRESPONSE_TO_ROGESTERONE_UP cerebral infarction DOID_3526 9.823E-05 7.985E-03 9.823E-05 0.02794719 WILCOX_PRESPONSE_TO_ROGESTERONE_UP hemolytic anemia DOID_583 1.178E-04 8.379E-03 0.09000596 0.42325118 WILCOX_PRESPONSE_TO_ROGESTERONE_UP normocytic anemia DOID_720 1.178E-04 8.379E-03 0.09000596 0.42325118 WILCOX_PRESPONSE_TO_ROGESTERONE_UP oral cavity cancer DOID_8618 2.009E-04 0.01270278 2.009E-04 0.03810835 WILCOX_PRESPONSE_TO_ROGESTERONE_UP brain infarction DOID_3454 3.149E-04 0.01791751 3.149E-04 0.04479378 WILCOX_PRESPONSE_TO_ROGESTERONE_UP blood coagulation disease DOID_1247 3.418E-04 0.01767855 0.1263211 0.50976388 WILCOX_PRESPONSE_TO_ROGESTERONE_UP congenital ichthyosiform erythroderma DOID_1699 3.474E-04 0.01647396 3.474E-04 0.03294793 WILCOX_PRESPONSE_TO_ROGESTERONE_UP lymphatic system cancer DOID_0060073 4.489E-04 0.01964935 4.489E-04 0.03649164 WILCOX_PRESPONSE_TO_ROGESTERONE_UP Bardet-Biedl syndrome DOID_1935 4.489E-04 0.01824582 4.489E-04 0.03193019 WILCOX_PRESPONSE_TO_ROGESTERONE_UP reticulosarcoma DOID_8538 4.489E-04 0.01964935 4.489E-04 0.03649164 WILCOX_PRESPONSE_TO_ROGESTERONE_UP lymphosarcoma DOID_8675 4.489E-04 0.01964935 4.489E-04 0.03649164 WILCOX_PRESPONSE_TO_ROGESTERONE_UP neuroendocrine tumor DOID_169 5.044E-04 0.01913525 5.044E-04 0.02870287 WILCOX_PRESPONSE_TO_ROGESTERONE_UP transitional cell carcinoma DOID_2671 6.312E-04 0.02244812 6.312E-04 0.02993083 WILCOX_PRESPONSE_TO_ROGESTERONE_UP Kawasaki disease DOID_13378 6.899E-04 0.02309132 0.03807724 0.30515418 WILCOX_PRESPONSE_TO_ROGESTERONE_UP lymphadenitis DOID_1602 6.899E-04 0.02309132 0.03807724 0.30515418 WILCOX_PRESPONSE_TO_ROGESTERONE_UP coronary restenosis DOID_4247 6.899E-04 0.02180847 0.03807724 0.30091593 WILCOX_PRESPONSE_TO_ROGESTERONE_UP lymph node disease DOID_9942 6.899E-04 0.02309132 0.03807724 0.30515418 WILCOX_PRESPONSE_TO_ROGESTERONE_UP sinusitis DOID_0050127 8.292E-04 0.02483183 8.292E-04 0.03629267 WILCOX_PRESPONSE_TO_ROGESTERONE_UP paranasal sinus disease DOID_1352 8.292E-04 0.02483183 8.292E-04 0.03629267 WILCOX_PRESPONSE_TO_ROGESTERONE_UP polyarteritis nodosa DOID_9810 8.292E-04 0.02359023 0.04162821 0.31166386 WILCOX_PRESPONSE_TO_ROGESTERONE_UP cleft lip DOID_9296 1.145E-03 0.03102109 1.145E-03 0.04653163 WILCOX_PRESPONSE_TO_ROGESTERONE_UP coronary stenosis DOID_4248 1.414E-03 0.03656639 0.05395518 0.35698253 WILCOX_PRESPONSE_TO_ROGESTERONE_UP papilloma DOID_2615 2.033E-03 0.05029475 2.033E-03 0.07711862 WILCOX_PRESPONSE_TO_ROGESTERONE_UP pulmonary sarcoidosis DOID_13406 2.505E-03 0.05939151 0.07129445 0.4182118 WILCOX_PRESPONSE_TO_ROGESTERONE_UP cleft palate DOID_674 2.505E-03 0.05701585 2.505E-03 0.08908726 WILCOX_PRESPONSE_TO_ROGESTERONE_UP hepatitis DOID_2237 2.759E-03 0.06037216 0.07472453 0.41684565 WILCOX_PRESPONSE_TO_ROGESTERONE_UP peptic ulcer DOID_750 2.759E-03 0.05813615 0.07472453 0.40882939 WILCOX_PRESPONSE_TO_ROGESTERONE_UP adenoid cystic carcinoma DOID_4866 2.89E-03 0.05872455 2.89E-03 0.0913493 WILCOX_PRESPONSE_TO_ROGESTERONE_UP lymphatic system disease DOID_75 2.89E-03 0.05669956 0.07643488 0.41029666 WILCOX_PRESPONSE_TO_ROGESTERONE_UP salivary gland cancer DOID_8850 3.161E-03 0.05994738 3.161E-03 0.09465376 WILCOX_PRESPONSE_TO_ROGESTERONE_UP learning disability DOID_8927 3.588E-03 0.06586485 0.08494 0.42026834 WILCOX_PRESPONSE_TO_ROGESTERONE_UP thyroid adenoma DOID_2891 3.888E-03 0.06912886 3.888E-03 0.11060618 WILCOX_PRESPONSE_TO_ROGESTERONE_UP bone marrow disease DOID_4961 3.888E-03 0.06703405 3.888E-03 0.10533922 WILCOX_PRESPONSE_TO_ROGESTERONE_UP vascular skin disease DOID_9540 3.888E-03 0.06506246 0.08832039 0.41878584 WILCOX_PRESPONSE_TO_ROGESTERONE_UP hemorrhagic disease DOID_2213 4.52E-03 0.07348179 0.09504428 0.43264156 WILCOX_PRESPONSE_TO_ROGESTERONE_UP orofacial cleft DOID_0050567 4.685E-03 0.07404845 4.685E-03 0.1211702 WILCOX_PRESPONSE_TO_ROGESTERONE_UP sarcoidosis DOID_11335 4.853E-03 0.07462683 0.09838787 0.44080865 WILCOX_PRESPONSE_TO_ROGESTERONE_UP parasitic protozoa infectious disease DOID_2789 5.196E-03 0.07780963 5.196E-03 0.12855505 WILCOX_PRESPONSE_TO_ROGESTERONE_UP familial hyperlipidemia DOID_1168 5.372E-03 0.07838152 0.10338044 0.44228172 WILCOX_PRESPONSE_TO_ROGESTERONE_UP hypersensitivity reaction type IV disease DOID_2916 5.732E-03 0.08154323 0.10669367 0.44969405 WILCOX_PRESPONSE_TO_ROGESTERONE_UP melancholia DOID_2848 5.916E-03 0.08210864 5.916E-03 0.14026892 WILCOX_PRESPONSE_TO_ROGESTERONE_UP neurotic disorder DOID_4964 6.103E-03 0.08268345 6.103E-03 0.13890819 WILCOX_PRESPONSE_TO_ROGESTERONE_UP neuroectodermal tumor DOID_171 6.293E-03 0.08326686 6.293E-03 0.13771058 WILCOX_PRESPONSE_TO_ROGESTERONE_UP carotid artery disease DOID_3407 6.293E-03 0.08137443 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_UP pre-malignant neoplasm DOID_0060071 6.679E-03 0.0844567 6.679E-03 0.13573399 WILCOX_PRESPONSE_TO_ROGESTERONE_UP in situ carcinoma DOID_8719 6.679E-03 0.0844567 6.679E-03 0.13573399 WILCOX_PRESPONSE_TO_ROGESTERONE_UP mineral metabolism disease DOID_0050032 6.877E-03 0.08506188 0.11656111 0.47714585 WILCOX_PRESPONSE_TO_ROGESTERONE_UP parasitic infectious disease DOID_1398 7.077E-03 0.08567314 7.077E-03 0.13884958 WILCOX_PRESPONSE_TO_ROGESTERONE_UP temporal lobe epilepsy DOID_3328 7.279E-03 0.08629 7.279E-03 0.138064 WILCOX_PRESPONSE_TO_ROGESTERONE_UP hyperglycemia DOID_4195 7.279E-03 0.08452898 7.279E-03 0.13361032 WILCOX_PRESPONSE_TO_ROGESTERONE_UP endocrine organ benign neoplasm DOID_0060089 7.692E-03 0.08753868 7.692E-03 0.13677918 WILCOX_PRESPONSE_TO_ROGESTERONE_UP peripheral vascular disease DOID_341 8.549E-03 0.09538434 0.12955075 0.51548516 WILCOX_PRESPONSE_TO_ROGESTERONE_UP endogenous depression DOID_1595 9.219E-03 0.09897373 9.219E-03 0.15895781 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP aneurysm disease DOID_2403 2.014E-27 1.146E-24 4.094E-11 3.883E-09 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP collagen disease DOID_854 1.451E-18 4.127E-16 1.492E-10 9.43E-09 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP heart valve disease DOID_4079 1.269E-16 2.408E-14 1.457E-11 2.073E-09 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP aortic aneurysm DOID_3627 2.747E-16 3.908E-14 3.788E-03 0.02155345 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP peripheral vascular disease DOID_341 6.511E-16 7.409E-14 5.558E-06 1.318E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bone development disease DOID_0080006 4.229E-15 4.011E-13 4.229E-15 2.406E-12 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Ehlers-Danlos syndrome DOID_13359 7.846E-15 6.378E-13 7.846E-15 2.232E-12 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP encephalomyelitis DOID_640 1.619E-14 1.151E-12 2.176E-05 3.869E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP osteochondrodysplasia DOID_2256 4.066E-14 2.571E-12 4.066E-14 7.712E-12 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP contact dermatitis DOID_2773 7.347E-14 4.18E-12 5.987E-11 4.258E-09 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP abdominal aortic aneurysm DOID_7693 2.446E-13 1.265E-11 0.01613312 0.06651988 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hepatitis B DOID_2043 3.764E-13 1.785E-11 2.671E-09 1.52E-07 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hypersensitivity reaction type I disease DOID_1205 5.852E-13 2.561E-11 1.165E-07 3.9E-06 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP intracranial aneurysm DOID_10941 3.549E-12 1.442E-10 1.309E-08 5.321E-07 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP allergic contact dermatitis DOID_3042 1.181E-11 4.478E-10 8.72E-09 3.817E-07 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP vascular skin disease DOID_9540 1.457E-11 5.182E-10 3.21E-03 0.01864044 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.118E-11 7.089E-10 2.528E-04 2.616E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP aortic valve insufficiency DOID_57 3.474E-11 1.098E-09 3.474E-11 3.953E-09 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP atrophic muscular disease DOID_913 4.273E-11 1.28E-09 4.273E-11 3.474E-09 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP muscular dystrophy DOID_9884 4.273E-11 1.28E-09 4.273E-11 3.474E-09 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP aortic valve disease DOID_62 7.047E-11 2.005E-09 4.77E-09 2.468E-07 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP urticaria DOID_1555 1.326E-10 3.593E-09 4.724E-04 4.267E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP carotid artery disease DOID_3407 1.492E-10 3.858E-09 6.426E-03 0.03354552 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP thyroiditis DOID_7166 2.952E-10 7.303E-09 1.063E-04 1.286E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autoimmune thyroiditis DOID_7188 2.952E-10 7.303E-09 1.063E-04 1.286E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP corneal disease DOID_10124 6.585E-10 1.561E-08 3.088E-08 1.098E-06 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP prion disease DOID_649 6.776E-10 1.542E-08 3.342E-06 8.269E-05 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP membranous glomerulonephritis DOID_10976 1.401E-09 3.066E-08 2.126E-04 2.326E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP angioedema DOID_1558 1.656E-09 3.491E-08 2.337E-05 3.912E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP parasitic infectious disease DOID_1398 6.897E-09 1.402E-07 7.598E-03 0.0379251 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP osteogenesis imperfecta DOID_12347 8.339E-09 1.636E-07 8.339E-09 3.954E-07 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP nephrotic syndrome DOID_1184 9.766E-09 1.852E-07 1.567E-04 1.783E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP nephrosis DOID_2527 1.364E-08 2.504E-07 7.796E-05 1.032E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP corneal dystrophy DOID_2566 1.927E-08 3.427E-07 1.927E-08 7.31E-07 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP membranoproliferative glomerulonephritis DOID_2920 1.927E-08 3.323E-07 1.512E-06 4.301E-05 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP oral submucous fibrosis DOID_5773 1.927E-08 3.225E-07 8.672E-05 1.121E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP glaucoma DOID_1686 2.369E-08 3.851E-07 1.397E-05 2.564E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autoimmune disease of endocrine system DOID_0060005 2.521E-08 3.985E-07 7.992E-04 6.688E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP vein disease DOID_866 2.79E-08 4.29E-07 1.063E-04 1.26E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP celiac disease DOID_10608 4.538E-08 6.796E-07 1.05E-03 8.3E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP vasculitis DOID_865 4.566E-08 6.662E-07 3.605E-04 3.477E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP parasitic protozoa infectious disease DOID_2789 5.167E-08 7.35E-07 0.04591416 0.15738045 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pleural disease DOID_1532 5.45E-08 7.564E-07 0.01804137 0.07332529 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hypersensitivity reaction type IV disease DOID_2916 7.386E-08 1.001E-06 0.05025627 0.1702132 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP mouth disease DOID_403 1.074E-07 1.422E-06 2.537E-03 0.01640262 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP dilated cardiomyopathy DOID_12930 1.165E-07 1.507E-06 2.796E-04 2.841E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autoimmune hepatitis DOID_2048 1.269E-07 1.604E-06 0.11655273 0.27982491 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP uterine disease DOID_345 1.585E-07 1.961E-06 7.067E-04 6.002E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP funisitis DOID_0050698 1.634E-07 1.978E-06 7.844E-06 1.717E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP intracranial arterial disease DOID_13089 1.968E-07 2.333E-06 0.02655499 0.10006484 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cerebral arterial disease DOID_3527 1.968E-07 2.333E-06 0.02655499 0.10006484 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pulmonary embolism DOID_9477 2.078E-07 2.413E-06 3.26E-04 3.198E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP brain infarction DOID_3454 2.142E-07 2.438E-06 8.555E-03 0.04160501 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP tuberculosis DOID_399 2.142E-07 2.39E-06 0.06571601 0.19784345 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP diabetic angiopathy DOID_11713 2.612E-07 2.859E-06 3.71E-04 3.518E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP uveal disease DOID_3480 2.98E-07 3.199E-06 2.53E-03 0.01654485 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP uterine cancer DOID_363 3.399E-07 3.582E-06 3.399E-07 1.075E-05 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cerebral infarction DOID_3526 3.866E-07 4E-06 2.858E-03 0.0176736 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP myositis DOID_633 4.891E-07 4.97E-06 0.14729625 0.33127101 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP ocular hypertension DOID_9282 5.559E-07 5.549E-06 2.187E-03 0.01463862 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP borderline glaucoma DOID_9283 5.559E-07 5.549E-06 2.187E-03 0.01463862 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP middle cerebral artery infarction DOID_3525 5.926E-07 5.813E-06 0.01177388 0.05233858 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pulmonary tuberculosis DOID_2957 6.289E-07 6.066E-06 0.03767982 0.13234456 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP female reproductive system disease DOID_229 6.3E-07 5.974E-06 1.489E-03 0.01100319 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP periodontitis DOID_824 7.126E-07 6.647E-06 0.01259748 0.05513819 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP chronic kidney failure DOID_784 7.415E-07 6.805E-06 1.626E-03 0.01170952 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP carotid stenosis DOID_13001 7.993E-07 7.219E-06 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP coronary stenosis DOID_4248 8.51E-07 7.566E-06 0.01344551 0.05752252 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP sarcoidosis DOID_11335 9.836E-07 8.61E-06 0.2815192 0.53573386 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP focal glomerulosclerosis DOID_3945 1.01E-06 8.706E-06 3.237E-05 4.978E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP primary bacterial infectious disease DOID_0050338 1.015E-06 8.618E-06 0.09680319 0.24589738 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP transitional cell carcinoma DOID_2671 1.095E-06 9.161E-06 1.971E-04 2.199E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP endometrial carcinoma DOID_2871 1.191E-06 9.823E-06 1.191E-06 3.567E-05 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP congenital nervous system abnormality DOID_2490 1.487E-06 1.209E-05 2.826E-05 4.594E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP thoracic aortic aneurysm DOID_14004 1.512E-06 1.212E-05 0.08470594 0.22628017 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP varicose veins DOID_799 1.512E-06 1.195E-05 3.439E-03 0.01976432 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP endometrial cancer DOID_1380 1.63E-06 1.271E-05 1.63E-06 4.417E-05 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP metal metabolism disorder DOID_896 2.188E-06 1.682E-05 5.921E-05 8.639E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hypothyroidism DOID_1459 2.394E-06 1.816E-05 5.957E-04 5.215E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hepatitis C DOID_1883 2.517E-06 1.885E-05 6.609E-05 9.401E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP periodontal disease DOID_3388 2.517E-06 1.86E-05 0.02004003 0.07973971 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP spindle cell carcinoma DOID_4015 2.517E-06 1.836E-05 6.609E-05 9.172E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP esophageal disease DOID_6050 2.517E-06 1.813E-05 0.19618646 0.40299674 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pre-malignant neoplasm DOID_0060071 2.621E-06 1.864E-05 6.998E-03 0.03587067 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP in situ carcinoma DOID_8719 2.621E-06 1.864E-05 6.998E-03 0.03587067 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP mineral metabolism disease DOID_0050032 2.865E-06 2.012E-05 7.294E-03 0.03705769 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP ureteral obstruction DOID_5199 3.342E-06 2.319E-05 3.342E-06 8.645E-05 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP microcephaly DOID_10907 4.246E-06 2.911E-05 9.948E-05 1.231E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP uveitis DOID_13141 4.246E-06 2.876E-05 0.02429914 0.09342035 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP astrocytoma DOID_3069 4.376E-06 2.93E-05 8.889E-03 0.04250203 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP blood coagulation disease DOID_1247 4.745E-06 3.139E-05 0.06897653 0.19922664 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hepatitis DOID_2237 4.797E-06 3.137E-05 1.946E-03 0.01350614 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP male reproductive system disease DOID_48 5.139E-06 3.323E-05 0.07062646 0.20194199 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP brain edema DOID_4724 5.244E-06 3.352E-05 2.126E-04 2.282E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP blood protein disease DOID_620 5.244E-06 3.315E-05 0.1113226 0.26840067 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP amyloidosis DOID_9120 5.244E-06 3.279E-05 2.126E-04 2.24E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP diabetic retinopathy DOID_8947 6.005E-06 3.714E-05 0.01029994 0.04651324 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pulmonary emphysema DOID_9675 6.065E-06 3.711E-05 0.22873917 0.45191872 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP coronary restenosis DOID_4247 6.447E-06 3.903E-05 6.72E-03 0.03476015 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP endometriosis of uterus DOID_288 6.791E-06 4.067E-05 0.02889205 0.1074482 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP rheumatic disease DOID_1575 7.583E-06 4.494E-05 0.03009033 0.11046065 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP primitive neuroectodermal tumor DOID_168 7.583E-06 4.448E-05 7.583E-06 1.726E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP endometriosis DOID_289 7.583E-06 4.403E-05 0.03009033 0.10975256 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP scleroderma DOID_419 7.583E-06 4.494E-05 0.03009033 0.11046065 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP diabetic autonomic neuropathy DOID_11503 8.445E-06 4.854E-05 2.691E-03 0.01682341 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autonomic neuropathy DOID_11504 8.445E-06 4.854E-05 2.691E-03 0.01682341 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP diabetic polyneuropathy DOID_12785 8.445E-06 4.854E-05 2.691E-03 0.01682341 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP diabetic neuropathy DOID_9743 8.445E-06 4.854E-05 2.691E-03 0.01682341 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cataract DOID_83 9.382E-06 5.338E-05 9.382E-06 1.977E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP myasthenia gravis DOID_437 9.452E-06 5.325E-05 8.034E-03 0.03940637 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP urinary tract obstruction DOID_5200 9.452E-06 5.272E-05 9.452E-06 1.921E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP ureteral disease DOID_1426 1.129E-05 6.237E-05 1.129E-05 2.215E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pre-eclampsia DOID_10591 1.15E-05 6.291E-05 3.21E-03 0.01902878 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lens disease DOID_110 1.15E-05 6.231E-05 1.15E-05 2.181E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autonomic nervous system disease DOID_11465 1.15E-05 6.172E-05 3.21E-03 0.01883261 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP retinal vascular disease DOID_2462 1.314E-05 6.99E-05 0.01481788 0.06245462 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP spastic quadriplegia DOID_10970 1.338E-05 7.048E-05 4.197E-04 3.852E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP toxic shock syndrome DOID_14115 1.338E-05 6.984E-05 9.453E-03 0.04482249 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP commensal bacterial infectious disease DOID_0050339 1.574E-05 8.141E-05 0.01020127 0.04719125 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP primary immunodeficiency disease DOID_612 1.702E-05 8.722E-05 0.01669666 0.06834821 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP nervous system cancer DOID_3093 1.811E-05 9.202E-05 2.173E-03 0.01471938 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP neuromuscular junction disease DOID_439 1.839E-05 9.26E-05 0.01097504 0.04917163 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP ankylosing spondylitis DOID_7147 1.839E-05 9.179E-05 0.14729625 0.32996679 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP giant cell tumor DOID_200 2.014E-05 9.967E-05 4.425E-03 0.02420896 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP malignant giant cell tumor DOID_2705 2.014E-05 9.967E-05 4.425E-03 0.02420896 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP giant cell glioblastoma DOID_3074 2.014E-05 9.967E-05 4.425E-03 0.02420896 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP facioscapulohumeral muscular dystrophy DOID_11727 2.337E-05 1.146E-04 2.337E-05 4.03E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Sjogren's syndrome DOID_12894 2.337E-05 1.137E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP reproductive organ benign neoplasm DOID_0050622 2.393E-05 1.154E-04 3.855E-04 3.596E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pustulosis of palm and sole DOID_4398 2.393E-05 1.144E-04 0.28995937 0.54995627 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pleurisy DOID_10247 2.832E-05 1.343E-04 0.01344551 0.05795829 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autoimmune disease of the nervous system DOID_438 2.832E-05 1.332E-04 0.01344551 0.05709325 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP glioblastoma DOID_3068 3.063E-05 1.429E-04 5.623E-03 0.03018321 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP common variable immunodeficiency DOID_12177 3.2E-05 1.48E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP multiple epiphyseal dysplasia DOID_12721 3.237E-05 1.485E-04 3.237E-05 5.116E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP leukocyte disease DOID_9500 3.316E-05 1.51E-04 0.05173536 0.17214867 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP neuroectodermal tumor DOID_171 3.87E-05 1.748E-04 3.87E-05 5.795E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP spastic cerebral palsy DOID_0050669 4.171E-05 1.869E-04 9.617E-04 7.818E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP age related macular degeneration DOID_10871 4.171E-05 1.854E-04 9.617E-04 7.707E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP degeneration of macula and posterior pole DOID_2007 4.171E-05 1.854E-04 9.617E-04 7.707E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP respiratory failure DOID_11162 4.173E-05 1.841E-04 0.31873015 0.60052138 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP stomach disease DOID_76 4.248E-05 1.859E-04 0.06835654 0.20152784 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP encephalitis DOID_9588 4.248E-05 1.845E-04 0.06835654 0.19844323 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP allergic rhinitis DOID_4481 4.705E-05 2.028E-04 0.18181995 0.38459313 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP berylliosis DOID_10322 5.498E-05 2.352E-04 0.07383839 0.21007022 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP systemic mycosis DOID_0050136 5.921E-05 2.514E-04 0.01902955 0.07625221 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP fungal infectious disease DOID_1564 5.921E-05 2.514E-04 0.01902955 0.07625221 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP tooth disease DOID_1091 5.97E-05 2.516E-04 0.06410584 0.19402248 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP macular degeneration DOID_4448 6.609E-05 2.765E-04 1.346E-03 0.01007833 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP narcolepsy DOID_8986 6.968E-05 2.894E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP medullomyoblastoma DOID_3861 7.352E-05 3.031E-04 7.352E-05 9.96E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP adult medulloblastoma DOID_3864 7.352E-05 3.031E-04 7.352E-05 9.96E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP childhood medulloblastoma DOID_3869 7.352E-05 3.031E-04 7.352E-05 9.96E-04 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP skeletal system cancer DOID_0060124 8.672E-05 3.55E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bone cancer DOID_184 8.672E-05 3.55E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP medulloblastoma DOID_3858 9.019E-05 3.666E-04 9.019E-05 1.14E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP embryonal cancer DOID_688 9.019E-05 3.64E-04 1.69E-03 0.01201765 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP respiratory syncytial virus infectious disease DOID_1273 1.095E-04 4.386E-04 0.2195747 0.43992255 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP systemic scleroderma DOID_418 1.095E-04 4.355E-04 0.02541678 0.09641431 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bacterial pneumonia DOID_874 1.131E-04 4.468E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lymphatic system disease DOID_75 1.201E-04 4.714E-04 0.22417041 0.44598938 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP juvenile rheumatoid arthritis DOID_676 1.285E-04 5.007E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autoimmune disease of urogenital tract DOID_0060049 1.437E-04 5.562E-04 2.375E-03 0.01571327 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP primary biliary cirrhosis DOID_12236 1.437E-04 5.562E-04 2.375E-03 0.01571327 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP focal epilepsy DOID_2234 1.507E-04 5.792E-04 1.626E-03 0.01185964 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP biliary tract cancer DOID_4607 1.507E-04 5.753E-04 0.39469398 0.73392443 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP congenital muscular dystrophy DOID_0050557 1.535E-04 5.823E-04 1.535E-04 1.783E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP eosinophilia DOID_999 1.535E-04 5.784E-04 0.10076967 0.25370772 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP influenza DOID_8469 1.704E-04 6.381E-04 0.24228538 0.47374702 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP agammaglobulinemia DOID_2583 1.815E-04 6.75E-04 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP leishmaniasis DOID_9065 1.815E-04 6.706E-04 0.10606164 0.25900889 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP proteinuria DOID_576 2.006E-04 7.365E-04 0.25118434 0.48779484 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP neuritis DOID_1803 2.171E-04 7.917E-04 0.03507561 0.12473763 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Human immunodeficiency virus infectious disease DOID_526 2.185E-04 7.918E-04 0.10232693 0.25649348 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Crohn's disease DOID_8778 2.664E-04 9.595E-04 2.537E-03 0.01621832 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hemorrhagic disease DOID_2213 2.927E-04 1.047E-03 0.27297915 0.52298026 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP ulcerative colitis DOID_8577 3.22E-04 1.145E-03 2.94E-03 0.01798993 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP IgA glomerulonephritis DOID_2986 3.26E-04 1.152E-03 0.12692125 0.2971942 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP uremia DOID_4676 3.26E-04 1.145E-03 3.26E-04 3.254E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP sleep disorder DOID_535 3.26E-04 1.138E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Goodpasture syndrome DOID_9808 3.71E-04 1.287E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bile duct cancer DOID_4606 4.676E-04 1.613E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bile duct carcinoma DOID_4897 4.676E-04 1.613E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP portal hypertension DOID_10762 4.724E-04 1.619E-03 0.14224731 0.32636581 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP vitiligo DOID_12306 5.901E-04 2.011E-03 0.15231559 0.33722791 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP B cell deficiency DOID_2115 5.901E-04 1.999E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP seminoma DOID_4440 5.901E-04 1.987E-03 5.901E-04 5.246E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP congenital heart defect DOID_1682 6.312E-04 2.113E-03 6.312E-04 5.442E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autoimmune disease of cardiovascular system DOID_0060051 7.25E-04 2.412E-03 0.01344551 0.05840072 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Behcet's disease DOID_13241 7.25E-04 2.412E-03 0.01344551 0.05840072 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP thrombocytopenia DOID_1588 7.25E-04 2.398E-03 0.16226622 0.34973287 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hepatic vascular disease DOID_272 7.25E-04 2.385E-03 0.16226622 0.34841312 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP temporal lobe epilepsy DOID_3328 7.468E-04 2.442E-03 7.91E-03 0.03913623 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hyperglycemia DOID_4195 7.468E-04 2.428E-03 0.06250935 0.19435968 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP toxic encephalopathy DOID_3602 7.992E-04 2.584E-03 7.992E-04 6.591E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pancreatic ductal carcinoma DOID_3587 9.232E-04 2.968E-03 0.06897653 0.19822044 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP opportunistic mycosis DOID_2473 9.617E-04 3.074E-03 0.01613312 0.06700542 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bile duct disease DOID_4138 9.715E-04 3.088E-03 9.579E-03 0.04504585 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP biliary tract disease DOID_9741 1.022E-03 3.229E-03 9.936E-03 0.04633963 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP germinoma DOID_3304 1.05E-03 3.302E-03 1.05E-03 8.186E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pancreatic carcinoma DOID_4905 1.073E-03 3.356E-03 0.07396461 0.20630324 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP mixed glioma DOID_5076 1.299E-03 4.04E-03 1.299E-03 9.99E-03 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pneumoconiosis DOID_10316 1.346E-03 4.163E-03 0.19618646 0.40740912 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP nephroblastoma DOID_2154 1.346E-03 4.14E-03 1.346E-03 0.01021271 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP transient cerebral ischemia DOID_224 1.503E-03 4.597E-03 0.05729576 0.18523459 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP keratitis DOID_4677 1.503E-03 4.572E-03 0.05729576 0.18111827 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cutaneous leishmaniasis DOID_9111 1.503E-03 4.548E-03 0.05729576 0.18011762 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pulmonary sarcoidosis DOID_13406 1.69E-03 5.087E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP calcinosis DOID_182 1.69E-03 5.06E-03 0.21030183 0.42584249 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP peripheral nervous system neoplasm DOID_1192 1.815E-03 5.408E-03 0.02429914 0.09405586 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP blood platelet disease DOID_2218 1.815E-03 5.379E-03 0.21495189 0.43218243 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP trypanosomiasis DOID_10113 1.829E-03 5.393E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP dermatomyositis DOID_10223 1.829E-03 5.366E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP temporal arteritis DOID_13375 1.829E-03 5.338E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP craniosynostosis DOID_2340 1.829E-03 5.311E-03 1.829E-03 0.012851 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP central nervous system vasculitis DOID_525 1.829E-03 5.338E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP peptic ulcer DOID_750 1.946E-03 5.622E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP adult respiratory distress syndrome DOID_11394 2.083E-03 5.987E-03 0.22417041 0.44755426 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP amino acid metabolic disorder DOID_9252 2.088E-03 5.97E-03 2.088E-03 0.01431415 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP peritonitis DOID_8283 2.187E-03 6.221E-03 0.06835654 0.19946089 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cervix uteri carcinoma in situ DOID_8991 2.226E-03 6.302E-03 0.22873917 0.45349335 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lymphoma DOID_0060058 2.35E-03 6.62E-03 0.10605674 0.26467668 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lymphoblastic leukemia DOID_1037 2.442E-03 6.845E-03 0.01870275 0.07547423 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP polyneuropathy DOID_1389 2.574E-03 7.181E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Leydig cell tumor DOID_2696 2.574E-03 7.146E-03 2.574E-03 0.01627586 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP intracranial thrombosis DOID_4193 2.574E-03 7.111E-03 0.07383839 0.20696573 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP sex cord-stromal neoplasm DOID_4757 2.574E-03 7.146E-03 2.574E-03 0.01627586 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP gallbladder cancer DOID_3121 2.691E-03 7.396E-03 0.24228538 0.47538063 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP learning disability DOID_8927 2.858E-03 7.817E-03 0.03254508 0.11795 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP viral pneumonia DOID_10533 2.992E-03 8.145E-03 0.07928812 0.21794659 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP aspergillosis DOID_13564 2.992E-03 8.106E-03 2.992E-03 0.01811019 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP parasitic helminthiasis infectious disease DOID_883 2.992E-03 8.068E-03 2.992E-03 0.01791956 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP brain cancer DOID_1319 3.21E-03 8.617E-03 0.03507561 0.12552215 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP central nervous system cancer DOID_3620 3.396E-03 9.073E-03 0.03636863 0.12853263 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP idiopathic pulmonary fibrosis DOID_0050156 3.439E-03 9.143E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP mesenchymal cell neoplasm DOID_3350 3.439E-03 9.101E-03 0.08470594 0.22417524 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP adrenal cortex disease DOID_3952 3.439E-03 9.059E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP spindle cell sarcoma DOID_4235 3.439E-03 9.101E-03 0.08470594 0.22417524 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP epithelioid sarcoma DOID_6193 3.439E-03 9.101E-03 0.08470594 0.22417524 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP intermediate coronary syndrome DOID_8805 3.439E-03 9.017E-03 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP calcium metabolism disease DOID_10575 3.788E-03 9.887E-03 0.26867131 0.51821686 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP spastic diplegia DOID_10965 3.915E-03 0.01017148 3.915E-03 0.02205499 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP restrictive cardiomyopathy DOID_397 3.915E-03 0.01012525 3.915E-03 0.02183877 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP B-cell lymphocytic neoplasm DOID_707 3.994E-03 0.01028206 0.27297915 0.52122529 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP methylmalonic acidemia DOID_14749 4.42E-03 0.01132799 4.42E-03 0.02441568 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP adrenal gland disease DOID_9553 4.42E-03 0.0112772 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bile duct adenocarcinoma DOID_4896 4.651E-03 0.01181343 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cholangiocarcinoma DOID_4947 4.651E-03 0.01181343 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP glucose intolerance DOID_10603 4.953E-03 0.01252555 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP granulosa cell tumor DOID_2999 5.514E-03 0.01388344 5.514E-03 0.02988245 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pulmonary edema DOID_11396 6.103E-03 0.01529888 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP limb-girdle muscular dystrophy DOID_11724 6.103E-03 0.01523178 6.103E-03 0.0324565 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP esophagitis DOID_11963 6.103E-03 0.01516526 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP sex cord-gonadal stromal tumor DOID_192 6.103E-03 0.01509933 6.103E-03 0.03215598 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP subependymal glioma DOID_4843 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pilocytic astrocytoma DOID_4851 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP subependymal giant cell astrocytoma DOID_5077 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP fibrillary astrocytoma DOID_6726 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP juvenile pilocytic astrocytoma DOID_6811 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP childhood pilocytic astrocytoma DOID_6812 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP gemistocytic astrocytoma DOID_7005 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP childhood cerebral astrocytoma DOID_7007 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP protoplasmic astrocytoma DOID_7008 6.103E-03 0.01503396 0.1113226 0.27069469 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Kawasaki disease DOID_13378 6.72E-03 0.01648111 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lymphadenitis DOID_1602 6.72E-03 0.01648111 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lymph node disease DOID_9942 6.72E-03 0.01648111 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP benign glioma DOID_0060101 7.363E-03 0.01798188 0.12175222 0.2910799 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP benign ependymoma DOID_4844 7.363E-03 0.01798188 0.12175222 0.2910799 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP placenta disease DOID_780 7.363E-03 0.01790504 7.363E-03 0.03707768 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cholestasis DOID_13580 7.598E-03 0.01839771 0.06092676 0.19047981 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP sinusitis DOID_0050127 8.034E-03 0.01936923 0.12692125 0.29966055 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP paranasal sinus disease DOID_1352 8.034E-03 0.01936923 0.12692125 0.29966055 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP polyarteritis nodosa DOID_9810 8.034E-03 0.01928751 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP synostosis DOID_11971 8.73E-03 0.02087188 8.73E-03 0.04209753 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP meningitis DOID_9471 8.73E-03 0.02078455 0.13205999 0.30670259 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP organic acidemia DOID_0060159 0.01020127 0.02418551 0.01020127 0.04681067 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP reading disorder DOID_13365 0.01020127 0.02408516 0.01020127 0.04643619 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bronchiolitis DOID_2942 0.01020127 0.02398563 0.14224731 0.32505511 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP dyslexia DOID_4428 0.01020127 0.02408516 0.01020127 0.04643619 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP spinal cord disease DOID_319 0.01177388 0.02756929 0.15231559 0.33592082 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP pancreatitis DOID_4989 0.01183373 0.02759587 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP Sciatic Neuropathy DOID_11446 0.01259748 0.029257 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP gestational diabetes DOID_11714 0.01259748 0.02913807 0.01259748 0.05556561 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lesion of sciatic nerve DOID_12528 0.01259748 0.029257 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP migraine DOID_6364 0.01259748 0.0290201 0.15730553 0.34425709 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP perinatal necrotizing enterocolitis DOID_8677 0.01259748 0.02890308 0.15730553 0.3429381 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP mononeuritis of lower limb DOID_9473 0.01259748 0.029257 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP renal hypertension DOID_1073 0.01344551 0.03072488 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP secondary hypertension DOID_11130 0.01344551 0.03072488 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP sarcoma DOID_1115 0.01344551 0.03060198 0.16226622 0.35240258 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP malaria DOID_12365 0.01344551 0.03048006 0.16226622 0.35106265 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP mononeuritis DOID_1802 0.01344551 0.03035911 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP mononeuropathy DOID_1188 0.01431767 0.0322006 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP supratentorial cancer DOID_1659 0.01431767 0.03207383 0.16719783 0.35631299 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP cerebrum cancer DOID_368 0.01431767 0.03207383 0.16719783 0.35631299 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP female reproductive organ benign neoplasm DOID_0060086 0.01521364 0.03394729 0.17210055 0.36539259 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP uterine benign neoplasm DOID_0060095 0.01521364 0.03394729 0.17210055 0.36539259 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP uterine fibroid DOID_13223 0.01521364 0.03394729 0.17210055 0.36539259 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP dysostosis DOID_1934 0.01521364 0.03381469 0.01521364 0.06365118 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bronchiolitis obliterans DOID_2799 0.01613312 0.03571884 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP chronic leukemia DOID_1036 0.01804137 0.03978892 0.18663697 0.39332013 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP chronic lymphocytic leukemia DOID_1040 0.01804137 0.03978892 0.18663697 0.39332013 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP leiomyoma DOID_127 0.01804137 0.03963529 0.18663697 0.39186876 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP autonomic nervous system neoplasm DOID_2621 0.01804137 0.03948285 0.18663697 0.39042807 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP neuroblastoma DOID_769 0.01804137 0.03948285 0.18663697 0.39042807 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP myocarditis DOID_820 0.01902955 0.04148588 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lymphoid leukemia DOID_10747 0.02107252 0.04576437 0.02107252 0.08326573 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP refractive error DOID_9835 0.02212673 0.04787113 0.02212673 0.08682833 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP multiple myeloma DOID_9538 0.02320236 0.05000812 0.02320236 0.09042565 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP congenital diaphragmatic hernia DOID_3827 0.02541678 0.05457414 0.02541678 0.09706139 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP adenoid cystic carcinoma DOID_4866 0.02655499 0.05680373 0.02655499 0.09940652 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP salivary gland cancer DOID_8850 0.02889205 0.06157144 0.02889205 0.10675048 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP leukodystrophy DOID_10579 0.033801 0.07176407 0.25118434 0.48946537 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP myeloma DOID_0070004 0.03507561 0.07419339 0.03507561 0.12631659 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP hemolytic anemia DOID_583 0.03636863 0.07664353 0.25997924 0.50315711 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP normocytic anemia DOID_720 0.03636863 0.07664353 0.25997924 0.50315711 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP lung small cell carcinoma DOID_5409 0.03767982 0.07911372 0.03767982 0.13153263 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP orofacial cleft DOID_0050567 0.0417198 0.08727415 0.0417198 0.14474737 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP atopic dermatitis DOID_3310 0.0417198 0.08695446 1.000 1.000 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP bone marrow cancer DOID_4960 0.0444993 0.09240913 0.0444993 0.15345515 SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP smallpox DOID_8736 0.04591416 0.09500056 0.04591416 0.15643805 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN diffuse large B-cell lymphoma DOID_0050745 8.857E-10 5.039E-07 1.271E-05 3.616E-03 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN B-cell lymphocytic neoplasm DOID_707 2.29E-08 6.514E-06 8.393E-05 0.01591789 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN spastic quadriplegia DOID_10970 6.529E-08 1.238E-05 6.98E-04 0.03055238 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN aneurysm disease DOID_2403 1.584E-07 2.253E-05 7.284E-06 4.145E-03 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN spastic cerebral palsy DOID_0050669 2.092E-07 2.381E-05 1.219E-03 0.03302229 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN lymphoma DOID_0060058 3.79E-07 3.594E-05 4.339E-04 0.02469151 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN myeloma DOID_0070004 1.155E-06 9.386E-05 0.07496606 0.44900724 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN bone marrow cancer DOID_4960 1.964E-06 1.397E-04 0.08501037 0.46510481 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN pustulosis of palm and sole DOID_4398 2.108E-06 1.332E-04 0.08643649 0.45539225 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN pancreatic ductal carcinoma DOID_3587 5.313E-06 3.023E-04 2.061E-04 0.01954241 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN pancreatic carcinoma DOID_4905 6.241E-06 3.229E-04 2.322E-04 0.01887059 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN biliary tract cancer DOID_4607 9.748E-06 4.622E-04 7.824E-03 0.1436107 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN bone development disease DOID_0080006 1.021E-05 4.47E-04 3.342E-04 0.02113181 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN intracranial aneurysm DOID_10941 1.141E-05 4.637E-04 8.769E-04 0.03326322 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN focal glomerulosclerosis DOID_3945 1.56E-05 5.918E-04 1.075E-03 0.03399706 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN multiple myeloma DOID_9538 3.395E-05 1.207E-03 1.000 1.000 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN congenital diaphragmatic hernia DOID_3827 3.936E-05 1.317E-03 1.97E-03 0.05094101 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN intracranial arterial disease DOID_13089 4.227E-05 1.336E-03 2.064E-03 0.05105206 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN cerebral arterial disease DOID_3527 4.227E-05 1.336E-03 2.064E-03 0.05105206 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN atrophic muscular disease DOID_913 9.358E-05 2.803E-03 9.358E-05 0.01331245 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN muscular dystrophy DOID_9884 9.358E-05 2.803E-03 9.358E-05 0.01331245 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN bile duct adenocarcinoma DOID_4896 9.867E-05 2.807E-03 0.08501037 0.46962039 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN cholangiocarcinoma DOID_4947 9.867E-05 2.807E-03 0.08501037 0.46962039 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN bile duct cancer DOID_4606 1.208E-04 3.274E-03 0.09070176 0.45271315 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN bile duct carcinoma DOID_4897 1.208E-04 3.274E-03 0.09070176 0.45271315 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN pre-malignant neoplasm DOID_0060071 1.528E-04 3.952E-03 4.791E-03 0.0939984 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN in situ carcinoma DOID_8719 1.528E-04 3.952E-03 4.791E-03 0.0939984 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN osteogenesis imperfecta DOID_12347 1.837E-04 4.544E-03 0.0200469 0.29247908 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN endocrine organ benign neoplasm DOID_0060089 1.898E-04 4.5E-03 1.898E-04 0.02159785 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN membranoproliferative glomerulonephritis DOID_2920 2.468E-04 5.616E-03 1.000 1.000 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN mixed glioma DOID_5076 2.701E-04 5.911E-03 0.11726409 0.51723464 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN spastic diplegia DOID_10965 2.817E-04 5.937E-03 0.0246167 0.29801918 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN familial hypertrophic cardiomyopathy DOID_11986 3.19E-04 6.482E-03 3.19E-04 0.02268787 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN Crohn's disease DOID_8778 4.615E-04 9.056E-03 0.13903956 0.586026 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN hypersensitivity reaction type I disease DOID_1205 4.757E-04 9.023E-03 0.01008333 0.17386104 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN mitochondrial myopathy DOID_699 4.906E-04 9.005E-03 0.03218653 0.31576091 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN lingual-facial-buccal dyskinesia DOID_9854 5.899E-04 0.01048834 5.899E-04 0.03051154 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN synostosis DOID_11971 6.428E-04 0.01108401 6.428E-04 0.03048102 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN Goodpasture syndrome DOID_9808 6.428E-04 0.01075801 0.03670067 0.35394374 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN osteosarcoma DOID_3347 7.554E-04 0.0122814 7.554E-04 0.03070351 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN middle cerebral artery infarction DOID_3525 8.769E-04 0.01385968 0.04268734 0.36801664 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN fragments of torsion dystonia DOID_531 8.769E-04 0.01348509 8.769E-04 0.03118427 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN central nervous system hereditary degenerative disease DOID_481 1.007E-03 0.01507998 1.007E-03 0.03370819 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN dystonic disease DOID_544 1.075E-03 0.01569095 1.075E-03 0.03220774 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN dysostosis DOID_1934 1.146E-03 0.01630228 1.146E-03 0.03260456 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN celiac disease DOID_10608 1.294E-03 0.01795302 0.05159884 0.39146317 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN respiratory syncytial virus infectious disease DOID_1273 1.97E-03 0.02668339 0.06335408 0.41435025 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN gallbladder cancer DOID_3121 2.461E-03 0.03255939 2.461E-03 0.05833558 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN uterine cancer DOID_363 2.461E-03 0.03181941 2.461E-03 0.05600216 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN cerebral infarction DOID_3526 2.565E-03 0.03243263 0.0720764 0.43629226 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN thyroid adenoma DOID_2891 2.78E-03 0.03438722 2.78E-03 0.06083893 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN heart valve disease DOID_4079 2.78E-03 0.03365558 0.07496606 0.44433008 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN autoimmune disease of gastrointestinal tract DOID_0060031 3.003E-03 0.03560037 0.07784687 0.45664814 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN pulmonary tuberculosis DOID_2957 3.003E-03 0.03487383 0.07784687 0.44742292 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN movement disease DOID_480 3.118E-03 0.03548119 3.118E-03 0.06570591 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN giant cell tumor DOID_200 3.474E-03 0.03875878 0.08358206 0.46625678 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN malignant giant cell tumor DOID_2705 3.474E-03 0.03875878 0.08358206 0.46625678 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN giant cell glioblastoma DOID_3074 3.474E-03 0.03875878 0.08358206 0.46625678 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN integumentary system cancer DOID_0060122 3.721E-03 0.04072143 0.08643649 0.46398456 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN osteochondrodysplasia DOID_2256 3.721E-03 0.0399531 0.08643649 0.45964825 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN skin cancer DOID_4159 3.721E-03 0.04072143 0.08643649 0.46398456 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN mitochondrial metabolism disease DOID_700 3.848E-03 0.04054869 0.08786043 0.45447802 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN glioblastoma DOID_3068 4.108E-03 0.04249552 0.09070176 0.45671946 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN oral cavity cancer DOID_8618 4.108E-03 0.04173667 4.108E-03 0.08347335 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN melancholia DOID_2848 4.24E-03 0.04232906 0.09211916 0.45578956 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN neurotic disorder DOID_4964 4.375E-03 0.04292037 0.09353438 0.45880228 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN hyperglycemia DOID_4195 5.224E-03 0.05038132 0.10198032 0.4835567 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN brain infarction DOID_3454 5.523E-03 0.05237257 0.10477841 0.4927183 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN tuberculosis DOID_399 5.523E-03 0.05151401 0.10477841 0.48867962 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN astrocytoma DOID_3069 5.675E-03 0.05207935 0.10617423 0.49116373 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN diabetic retinopathy DOID_8947 6.302E-03 0.05692091 1.000 1.000 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN cystic fibrosis DOID_1485 6.627E-03 0.05892217 0.11450438 0.52122392 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN endogenous depression DOID_1595 6.627E-03 0.05801567 0.11450438 0.51708722 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN bone resorption disease DOID_0080011 6.793E-03 0.05856243 0.11588529 0.51514634 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN osteoporosis DOID_11476 6.793E-03 0.05856243 0.11588529 0.51514634 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN pancreatitis DOID_4989 6.96E-03 0.05910874 6.96E-03 0.13200951 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN bacterial pneumonia DOID_874 6.96E-03 0.05823949 0.11726409 0.51325591 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN mental depression DOID_1596 7.824E-03 0.06452075 0.12412645 0.53914465 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN retinal vascular disease DOID_2462 8.183E-03 0.06651301 1.000 1.000 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN primary bacterial infectious disease DOID_0050338 8.548E-03 0.06850751 0.12957855 0.55856208 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN transitional cell carcinoma DOID_2671 8.734E-03 0.06902277 8.734E-03 0.15530123 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN primary immunodeficiency disease DOID_612 8.921E-03 0.06953796 0.13229208 0.56597136 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN mouth disease DOID_403 9.885E-03 0.07600944 0.13903956 0.59039933 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN dilated cardiomyopathy DOID_12930 0.01008333 0.07649886 0.01008333 0.16874748 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN ulcerative colitis DOID_8577 0.01068816 0.08002057 0.14440039 0.60414574 NAGASHIMA_EGF_SIGNALING_UP middle cerebral artery infarction DOID_3525 2.135E-08 1.215E-05 3.5E-06 1.991E-03 NAGASHIMA_EGF_SIGNALING_UP intracranial arterial disease DOID_13089 1.272E-07 3.62E-05 1.304E-05 2.473E-03 NAGASHIMA_EGF_SIGNALING_UP cerebral arterial disease DOID_3527 1.272E-07 3.62E-05 1.304E-05 2.473E-03 NAGASHIMA_EGF_SIGNALING_UP cerebral infarction DOID_3526 1.998E-07 3.79E-05 1.821E-05 2.59E-03 NAGASHIMA_EGF_SIGNALING_UP brain infarction DOID_3454 9.806E-07 1.395E-04 5.917E-05 6.733E-03 NAGASHIMA_EGF_SIGNALING_UP sarcoma DOID_1115 4.331E-06 4.929E-04 4.331E-06 1.232E-03 NAGASHIMA_EGF_SIGNALING_UP bone marrow cancer DOID_4960 3.06E-05 2.902E-03 1.67E-03 0.05278836 NAGASHIMA_EGF_SIGNALING_UP membranoproliferative glomerulonephritis DOID_2920 1.13E-04 9.184E-03 0.01571306 0.25544952 NAGASHIMA_EGF_SIGNALING_UP angiosarcoma DOID_0001816 1.29E-04 9.178E-03 1.29E-04 0.01223728 NAGASHIMA_EGF_SIGNALING_UP tongue cancer DOID_8649 1.29E-04 8.158E-03 1.29E-04 0.0104891 NAGASHIMA_EGF_SIGNALING_UP lymphoma DOID_0060058 1.365E-04 7.764E-03 1.365E-04 9.705E-03 NAGASHIMA_EGF_SIGNALING_UP bronchitis DOID_6132 1.461E-04 7.56E-03 1.000 1.000 NAGASHIMA_EGF_SIGNALING_UP pulmonary embolism DOID_9477 2.708E-04 0.01283998 0.02399466 0.3033992 NAGASHIMA_EGF_SIGNALING_UP lingual-facial-buccal dyskinesia DOID_9854 2.708E-04 0.01185229 2.708E-04 0.01711997 NAGASHIMA_EGF_SIGNALING_UP aortic valve disease DOID_62 2.952E-04 0.0119982 0.02502508 0.30296315 NAGASHIMA_EGF_SIGNALING_UP portal hypertension DOID_10762 3.472E-04 0.01316883 0.02708272 0.31449114 NAGASHIMA_EGF_SIGNALING_UP osteosarcoma DOID_3347 3.472E-04 0.01234578 0.02708272 0.30820131 NAGASHIMA_EGF_SIGNALING_UP fragments of torsion dystonia DOID_531 4.032E-04 0.01349641 4.032E-04 0.0229439 NAGASHIMA_EGF_SIGNALING_UP hepatic vascular disease DOID_272 4.634E-04 0.01464916 0.0311853 0.33480072 NAGASHIMA_EGF_SIGNALING_UP central nervous system hereditary degenerative disease DOID_481 4.634E-04 0.01387815 4.634E-04 0.02397135 NAGASHIMA_EGF_SIGNALING_UP focal glomerulosclerosis DOID_3945 4.95E-04 0.0140841 0.03220831 0.32151807 NAGASHIMA_EGF_SIGNALING_UP dystonic disease DOID_544 4.95E-04 0.01341343 4.95E-04 0.0234735 NAGASHIMA_EGF_SIGNALING_UP allergic rhinitis DOID_4481 5.961E-04 0.01541619 0.03527102 0.32369697 NAGASHIMA_EGF_SIGNALING_UP multiple myeloma DOID_9538 8.254E-04 0.02042046 8.254E-04 0.0361285 NAGASHIMA_EGF_SIGNALING_UP adult respiratory distress syndrome DOID_11394 9.537E-04 0.0226103 1.000 1.000 NAGASHIMA_EGF_SIGNALING_UP primitive neuroectodermal tumor DOID_168 1.091E-03 0.02482914 1.091E-03 0.04433775 NAGASHIMA_EGF_SIGNALING_UP myeloma DOID_0070004 1.288E-03 0.02818163 1.288E-03 0.04884816 NAGASHIMA_EGF_SIGNALING_UP heart valve disease DOID_4079 1.288E-03 0.02713787 0.05144656 0.39030788 NAGASHIMA_EGF_SIGNALING_UP movement disease DOID_480 1.446E-03 0.02937828 1.446E-03 0.05141199 NAGASHIMA_EGF_SIGNALING_UP giant cell tumor DOID_200 1.612E-03 0.0316366 1.612E-03 0.05396832 NAGASHIMA_EGF_SIGNALING_UP malignant giant cell tumor DOID_2705 1.612E-03 0.0316366 1.612E-03 0.05396832 NAGASHIMA_EGF_SIGNALING_UP giant cell glioblastoma DOID_3074 1.612E-03 0.0316366 1.612E-03 0.05396832 NAGASHIMA_EGF_SIGNALING_UP hypertrophic cardiomyopathy DOID_11984 1.91E-03 0.03622018 0.06241352 0.42787102 NAGASHIMA_EGF_SIGNALING_UP glioblastoma DOID_3068 1.91E-03 0.03505178 1.91E-03 0.05718975 NAGASHIMA_EGF_SIGNALING_UP oral cavity cancer DOID_8618 1.91E-03 0.03395642 1.91E-03 0.05433027 NAGASHIMA_EGF_SIGNALING_UP neuroectodermal tumor DOID_171 2.1E-03 0.03620176 2.1E-03 0.05688849 NAGASHIMA_EGF_SIGNALING_UP respiratory failure DOID_11162 2.165E-03 0.03622834 1.000 1.000 NAGASHIMA_EGF_SIGNALING_UP allergic contact dermatitis DOID_3042 2.505E-03 0.0407256 2.505E-03 0.06479073 NAGASHIMA_EGF_SIGNALING_UP astrocytoma DOID_3069 2.648E-03 0.04185031 2.648E-03 0.06550484 NAGASHIMA_EGF_SIGNALING_UP diabetic retinopathy DOID_8947 2.945E-03 0.04528221 0.07716945 0.47727628 NAGASHIMA_EGF_SIGNALING_UP pancreatitis DOID_4989 3.256E-03 0.04875647 0.08106597 0.48048475 NAGASHIMA_EGF_SIGNALING_UP contact dermatitis DOID_2773 3.417E-03 0.04986036 3.417E-03 0.08102308 NAGASHIMA_EGF_SIGNALING_UP chronic kidney failure DOID_784 3.666E-03 0.05215464 0.08591406 0.49378891 NAGASHIMA_EGF_SIGNALING_UP retinal vascular disease DOID_2462 3.837E-03 0.05324895 0.08784631 0.4998455 NAGASHIMA_EGF_SIGNALING_UP nervous system cancer DOID_3093 4.279E-03 0.05797138 4.279E-03 0.09739192 SAGIV_CD24_TARGETS_DN middle cerebral artery infarction DOID_3525 1.043E-06 5.934E-04 0.01975786 0.27420054 SAGIV_CD24_TARGETS_DN intracranial arterial disease DOID_13089 3.9E-06 1.11E-03 0.03018724 0.31808406 SAGIV_CD24_TARGETS_DN cerebral arterial disease DOID_3527 3.9E-06 1.11E-03 0.03018724 0.31808406 SAGIV_CD24_TARGETS_DN cerebral infarction DOID_3526 5.454E-06 1.034E-03 0.03363989 0.33001894 SAGIV_CD24_TARGETS_DN bile duct adenocarcinoma DOID_4896 9.187E-06 1.307E-03 9.187E-06 5.227E-03 SAGIV_CD24_TARGETS_DN cholangiocarcinoma DOID_4947 9.187E-06 1.307E-03 9.187E-06 5.227E-03 SAGIV_CD24_TARGETS_DN bile duct cancer DOID_4606 1.128E-05 1.283E-03 1.128E-05 3.209E-03 SAGIV_CD24_TARGETS_DN bile duct carcinoma DOID_4897 1.128E-05 1.283E-03 1.128E-05 3.209E-03 SAGIV_CD24_TARGETS_DN respiratory failure DOID_11162 1.366E-05 1.296E-03 0.04529059 0.36296265 SAGIV_CD24_TARGETS_DN brain infarction DOID_3454 1.783E-05 1.449E-03 0.04937022 0.36962704 SAGIV_CD24_TARGETS_DN chromosomal disease DOID_0080014 2.849E-05 2.027E-03 2.849E-05 5.404E-03 SAGIV_CD24_TARGETS_DN biliary tract cancer DOID_4607 3.06E-05 1.935E-03 3.06E-05 4.353E-03 SAGIV_CD24_TARGETS_DN transitional cell carcinoma DOID_2671 3.631E-05 2.066E-03 1.882E-03 0.07139394 SAGIV_CD24_TARGETS_DN ulcerative colitis DOID_8577 4.974E-05 2.573E-03 2.316E-03 0.08236294 SAGIV_CD24_TARGETS_DN intermediate coronary syndrome DOID_8805 5.099E-05 2.418E-03 0.01063177 0.20164932 SAGIV_CD24_TARGETS_DN Down syndrome DOID_14250 8.29E-05 3.629E-03 8.29E-05 9.434E-03 SAGIV_CD24_TARGETS_DN brain edema DOID_4724 9.207E-05 3.742E-03 1.000 1.000 SAGIV_CD24_TARGETS_DN sinusitis DOID_0050127 1.224E-04 4.645E-03 0.01625746 0.24343409 SAGIV_CD24_TARGETS_DN paranasal sinus disease DOID_1352 1.224E-04 4.645E-03 0.01625746 0.24343409 SAGIV_CD24_TARGETS_DN Sciatic Neuropathy DOID_11446 1.96E-04 6.969E-03 0.0204565 0.27713685 SAGIV_CD24_TARGETS_DN lesion of sciatic nerve DOID_12528 1.96E-04 6.969E-03 0.0204565 0.27713685 SAGIV_CD24_TARGETS_DN mononeuritis of lower limb DOID_9473 1.96E-04 6.969E-03 0.0204565 0.27713685 SAGIV_CD24_TARGETS_DN renal hypertension DOID_1073 2.099E-04 7.025E-03 2.099E-04 0.01990323 SAGIV_CD24_TARGETS_DN secondary hypertension DOID_11130 2.099E-04 7.025E-03 2.099E-04 0.01990323 SAGIV_CD24_TARGETS_DN mononeuritis DOID_1802 2.099E-04 6.634E-03 0.02115466 0.27993024 SAGIV_CD24_TARGETS_DN mononeuropathy DOID_1188 2.243E-04 6.716E-03 0.02185234 0.27631068 SAGIV_CD24_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 2.391E-04 6.802E-03 2.391E-04 0.01943513 SAGIV_CD24_TARGETS_DN uterine benign neoplasm DOID_0060095 2.391E-04 6.802E-03 2.391E-04 0.01943513 SAGIV_CD24_TARGETS_DN uterine fibroid DOID_13223 2.391E-04 6.802E-03 2.391E-04 0.01943513 SAGIV_CD24_TARGETS_DN leiomyoma DOID_127 2.864E-04 7.761E-03 2.864E-04 0.02037317 SAGIV_CD24_TARGETS_DN pleural disease DOID_1532 2.864E-04 7.408E-03 1.000 1.000 SAGIV_CD24_TARGETS_DN myocarditis DOID_820 3.032E-04 7.5E-03 3.032E-04 0.01916633 SAGIV_CD24_TARGETS_DN adult respiratory distress syndrome DOID_11394 4.332E-04 0.01027028 1.000 1.000 SAGIV_CD24_TARGETS_DN gallbladder cancer DOID_3121 5.177E-04 0.01178226 5.177E-04 0.02945565 SAGIV_CD24_TARGETS_DN neuritis DOID_1803 5.859E-04 0.01282135 0.03501764 0.33208391 SAGIV_CD24_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 7.878E-04 0.01660179 7.878E-04 0.04074986 SAGIV_CD24_TARGETS_DN parasitic protozoa infectious disease DOID_2789 7.878E-04 0.01600887 0.04050972 0.34403032 SAGIV_CD24_TARGETS_DN cholestasis DOID_13580 1.081E-03 0.02120782 0.04733251 0.36893422 SAGIV_CD24_TARGETS_DN parasitic infectious disease DOID_1398 1.081E-03 0.02050089 0.04733251 0.36394863 SAGIV_CD24_TARGETS_DN bile duct disease DOID_4138 1.278E-03 0.02346173 0.05140373 0.37023701 SAGIV_CD24_TARGETS_DN biliary tract disease DOID_9741 1.313E-03 0.02334101 0.05208064 0.37042355 SAGIV_CD24_TARGETS_DN diabetic retinopathy DOID_8947 1.348E-03 0.02323524 0.05275708 0.36608267 SAGIV_CD24_TARGETS_DN cystic fibrosis DOID_1485 1.419E-03 0.02374169 1.419E-03 0.06726812 SAGIV_CD24_TARGETS_DN aneurysm disease DOID_2403 1.455E-03 0.02365203 0.05478362 0.37109378 SAGIV_CD24_TARGETS_DN pancreatitis DOID_4989 1.492E-03 0.0235743 0.0554582 0.37124371 SAGIV_CD24_TARGETS_DN mixed glioma DOID_5076 1.492E-03 0.02293716 1.492E-03 0.06528269 SAGIV_CD24_TARGETS_DN metabolic syndrome X DOID_14221 1.566E-03 0.02345086 0.05680598 0.37584419 SAGIV_CD24_TARGETS_DN lipid metabolism disorder DOID_3146 1.566E-03 0.02284955 1.566E-03 0.06365232 SAGIV_CD24_TARGETS_DN chronic kidney failure DOID_784 1.681E-03 0.0239172 1.000 1.000 SAGIV_CD24_TARGETS_DN retinal vascular disease DOID_2462 1.76E-03 0.02443009 0.06016732 0.38903642 SAGIV_CD24_TARGETS_DN facioscapulohumeral muscular dystrophy DOID_11727 7.1E-03 0.09618812 7.1E-03 0.23764124 SAGIV_CD24_TARGETS_DN hypokalemia DOID_4500 7.1E-03 0.09395119 7.1E-03 0.22443895 SAGIV_CD24_TARGETS_DN cutaneous leishmaniasis DOID_9111 7.1E-03 0.09181593 7.1E-03 0.21262637 SAGIV_CD24_TARGETS_DN breast benign neoplasm DOID_0060082 7.807E-03 0.0987193 7.807E-03 0.22211843 SAGIV_CD24_TARGETS_DN thoracic benign neoplasm DOID_0060097 7.807E-03 0.0987193 7.807E-03 0.22211843 SAGIV_CD24_TARGETS_DN benign breast phyllodes tumor DOID_1631 7.807E-03 0.0987193 7.807E-03 0.22211843 SAGIV_CD24_TARGETS_DN chronic monocytic leukemia DOID_8593 7.807E-03 0.09657323 7.807E-03 0.21154137 SAGIV_CD24_TARGETS_DN bronchiectasis DOID_9563 7.807E-03 0.09451848 1.000 1.000 SAGIV_CD24_TARGETS_DN porphyria DOID_13268 8.514E-03 0.09886857 8.514E-03 0.21063305 SAGIV_CD24_TARGETS_DN lipodystrophy DOID_811 8.514E-03 0.0968912 8.514E-03 0.20185667 SAGIV_CD24_TARGETS_DN peritonitis DOID_8283 8.514E-03 0.09499137 1.000 1.000 SAGIV_CD24_TARGETS_DN newborn respiratory distress syndrome DOID_12716 9.221E-03 0.09899011 1.000 1.000 SAGIV_CD24_TARGETS_DN Leydig cell tumor DOID_2696 9.221E-03 0.09715696 9.221E-03 0.20178753 SAGIV_CD24_TARGETS_DN intracranial thrombosis DOID_4193 9.221E-03 0.09539047 1.000 1.000 SAGIV_CD24_TARGETS_DN sex cord-stromal neoplasm DOID_4757 9.221E-03 0.09715696 9.221E-03 0.20178753 SAGIV_CD24_TARGETS_DN monocytic leukemia DOID_8527 9.221E-03 0.09368707 9.221E-03 0.19431391 SAGIV_CD24_TARGETS_DN open-angle glaucoma DOID_1067 9.926E-03 0.09908974 9.926E-03 0.20171841 SAGIV_CD24_TARGETS_DN hyperhomocysteinemia DOID_9279 0.01063177 0.0991718 1.000 1.000 VECCHI_GASTRIC_CANCER_EARLY_DN metabolic syndrome X DOID_14221 1.286E-13 7.316E-11 9.994E-08 2.843E-05 VECCHI_GASTRIC_CANCER_EARLY_DN hyperglycemia DOID_4195 1.007E-09 2.864E-07 1.611E-05 4.168E-04 VECCHI_GASTRIC_CANCER_EARLY_DN primary bacterial infectious disease DOID_0050338 7.874E-09 1.494E-06 3.4E-06 1.382E-04 VECCHI_GASTRIC_CANCER_EARLY_DN primary immunodeficiency disease DOID_612 9.403E-09 1.338E-06 2.056E-07 2.925E-05 VECCHI_GASTRIC_CANCER_EARLY_DN familial hyperlipidemia DOID_1168 9.789E-09 1.114E-06 2.95E-07 3.357E-05 VECCHI_GASTRIC_CANCER_EARLY_DN endocrine pancreas disease DOID_1428 2.42E-08 2.295E-06 6.34E-07 6.013E-05 VECCHI_GASTRIC_CANCER_EARLY_DN endocrine organ benign neoplasm DOID_0060089 3.645E-08 2.963E-06 8.964E-07 7.286E-05 VECCHI_GASTRIC_CANCER_EARLY_DN familial hypercholesterolemia DOID_13810 4.486E-08 3.191E-06 4.486E-08 2.552E-05 VECCHI_GASTRIC_CANCER_EARLY_DN hyperinsulinism DOID_2018 6.439E-08 4.071E-06 2.138E-06 1.217E-04 VECCHI_GASTRIC_CANCER_EARLY_DN lipid metabolism disorder DOID_3146 9.994E-08 5.687E-06 2.103E-06 1.33E-04 VECCHI_GASTRIC_CANCER_EARLY_DN alcohol abuse DOID_1574 1.283E-07 6.636E-06 1.283E-07 2.433E-05 VECCHI_GASTRIC_CANCER_EARLY_DN retinal vascular disease DOID_2462 1.507E-07 7.146E-06 4.961E-05 1.129E-03 VECCHI_GASTRIC_CANCER_EARLY_DN atrophic muscular disease DOID_913 2.15E-07 9.409E-06 5.744E-06 1.816E-04 VECCHI_GASTRIC_CANCER_EARLY_DN muscular dystrophy DOID_9884 2.15E-07 9.409E-06 5.744E-06 1.816E-04 VECCHI_GASTRIC_CANCER_EARLY_DN encephalomyelitis DOID_640 2.765E-07 1.124E-05 4.972E-06 1.768E-04 VECCHI_GASTRIC_CANCER_EARLY_DN dilated cardiomyopathy DOID_12930 3.19E-07 1.21E-05 5.611E-06 1.878E-04 VECCHI_GASTRIC_CANCER_EARLY_DN adenoma DOID_657 9.214E-07 3.277E-05 9.214E-07 6.554E-05 VECCHI_GASTRIC_CANCER_EARLY_DN glucose intolerance DOID_10603 1.191E-06 3.987E-05 0.0786075 0.2171246 VECCHI_GASTRIC_CANCER_EARLY_DN diabetic retinopathy DOID_8947 1.343E-06 4.245E-05 4.069E-04 5.937E-03 VECCHI_GASTRIC_CANCER_EARLY_DN female reproductive system disease DOID_229 2.259E-06 6.764E-05 6.464E-03 0.04277038 VECCHI_GASTRIC_CANCER_EARLY_DN focal epilepsy DOID_2234 2.598E-06 7.39E-05 2.598E-06 1.344E-04 VECCHI_GASTRIC_CANCER_EARLY_DN chronic kidney failure DOID_784 2.598E-06 7.038E-05 4.436E-05 1.052E-03 VECCHI_GASTRIC_CANCER_EARLY_DN muscular atrophy DOID_767 2.808E-06 7.262E-05 2.808E-06 1.331E-04 VECCHI_GASTRIC_CANCER_EARLY_DN thyroid adenoma DOID_2891 3.257E-06 8.057E-05 3.257E-06 1.425E-04 VECCHI_GASTRIC_CANCER_EARLY_DN pulmonary tuberculosis DOID_2957 3.966E-06 9.402E-05 9.345E-05 1.834E-03 VECCHI_GASTRIC_CANCER_EARLY_DN lung small cell carcinoma DOID_5409 3.966E-06 9.026E-05 3.966E-06 1.504E-04 VECCHI_GASTRIC_CANCER_EARLY_DN sarcoidosis DOID_11335 5.744E-06 1.257E-04 2.132E-03 0.02205855 VECCHI_GASTRIC_CANCER_EARLY_DN hypersensitivity reaction type IV disease DOID_2916 8.783E-06 1.851E-04 2.723E-03 0.02539855 VECCHI_GASTRIC_CANCER_EARLY_DN insulinoma DOID_3892 1.076E-05 2.186E-04 1.076E-05 3.222E-04 VECCHI_GASTRIC_CANCER_EARLY_DN hypokalemia DOID_4500 1.076E-05 2.111E-04 1.076E-05 3.061E-04 VECCHI_GASTRIC_CANCER_EARLY_DN mineral metabolism disease DOID_0050032 1.395E-05 2.646E-04 1.395E-05 3.78E-04 VECCHI_GASTRIC_CANCER_EARLY_DN trypanosomiasis DOID_10113 1.474E-05 2.706E-04 0.04879581 0.17797959 VECCHI_GASTRIC_CANCER_EARLY_DN uterine disease DOID_345 1.5E-05 2.667E-04 0.03834822 0.15366295 VECCHI_GASTRIC_CANCER_EARLY_DN tuberculosis DOID_399 1.853E-05 3.195E-04 3.137E-04 4.958E-03 VECCHI_GASTRIC_CANCER_EARLY_DN islet cell tumor DOID_1799 1.959E-05 3.279E-04 1.959E-05 4.847E-04 VECCHI_GASTRIC_CANCER_EARLY_DN nephrosis DOID_2527 2.268E-05 3.687E-04 3.675E-04 5.503E-03 VECCHI_GASTRIC_CANCER_EARLY_DN uveitis DOID_13141 3.634E-05 5.744E-04 8.618E-04 0.01140381 VECCHI_GASTRIC_CANCER_EARLY_DN peptic ulcer DOID_750 4.003E-05 6.155E-04 9.25E-04 0.01169627 VECCHI_GASTRIC_CANCER_EARLY_DN endometriosis of uterus DOID_288 5.272E-05 7.894E-04 0.01782989 0.08248137 VECCHI_GASTRIC_CANCER_EARLY_DN endometriosis DOID_289 5.753E-05 8.394E-04 0.01858548 0.08528336 VECCHI_GASTRIC_CANCER_EARLY_DN uveal disease DOID_3480 5.753E-05 8.184E-04 1.207E-03 0.01430801 VECCHI_GASTRIC_CANCER_EARLY_DN learning disability DOID_8927 6.812E-05 9.454E-04 6.812E-05 1.491E-03 VECCHI_GASTRIC_CANCER_EARLY_DN neuroendocrine tumor DOID_169 7.122E-05 9.649E-04 7.122E-05 1.501E-03 VECCHI_GASTRIC_CANCER_EARLY_DN leukodystrophy DOID_10579 7.391E-05 9.781E-04 7.391E-05 1.502E-03 VECCHI_GASTRIC_CANCER_EARLY_DN membranous glomerulonephritis DOID_10976 9.884E-05 1.278E-03 9.884E-05 1.875E-03 VECCHI_GASTRIC_CANCER_EARLY_DN movement disease DOID_480 1.007E-04 1.274E-03 1.82E-03 0.01991401 VECCHI_GASTRIC_CANCER_EARLY_DN parasitic protozoa infectious disease DOID_2789 1.434E-04 1.774E-03 0.2319806 0.44443422 VECCHI_GASTRIC_CANCER_EARLY_DN Goodpasture syndrome DOID_9808 1.732E-04 2.096E-03 0.10341982 0.24829484 VECCHI_GASTRIC_CANCER_EARLY_DN papillary adenoma DOID_3172 2.477E-04 2.937E-03 2.477E-04 4.547E-03 VECCHI_GASTRIC_CANCER_EARLY_DN microcystic adenoma DOID_5403 2.477E-04 2.937E-03 2.477E-04 4.547E-03 VECCHI_GASTRIC_CANCER_EARLY_DN follicular adenoma DOID_6204 2.477E-04 2.937E-03 2.477E-04 4.547E-03 VECCHI_GASTRIC_CANCER_EARLY_DN myositis DOID_633 2.477E-04 2.877E-03 6.667E-03 0.04310958 VECCHI_GASTRIC_CANCER_EARLY_DN parasitic infectious disease DOID_1398 2.657E-04 3.024E-03 0.26617757 0.49985161 VECCHI_GASTRIC_CANCER_EARLY_DN cerebral degeneration DOID_1443 2.657E-04 2.964E-03 2.657E-04 4.724E-03 VECCHI_GASTRIC_CANCER_EARLY_DN B cell deficiency DOID_2115 2.766E-04 3.026E-03 2.766E-04 4.768E-03 VECCHI_GASTRIC_CANCER_EARLY_DN fragments of torsion dystonia DOID_531 2.766E-04 2.969E-03 7.159E-03 0.04476216 VECCHI_GASTRIC_CANCER_EARLY_DN temporal lobe epilepsy DOID_3328 2.81E-04 2.961E-03 2.81E-04 4.703E-03 VECCHI_GASTRIC_CANCER_EARLY_DN allergic contact dermatitis DOID_3042 2.97E-04 3.073E-03 0.04041764 0.1586044 VECCHI_GASTRIC_CANCER_EARLY_DN Sciatic Neuropathy DOID_11446 3.074E-04 3.124E-03 7.666E-03 0.04741445 VECCHI_GASTRIC_CANCER_EARLY_DN lesion of sciatic nerve DOID_12528 3.074E-04 3.124E-03 7.666E-03 0.04741445 VECCHI_GASTRIC_CANCER_EARLY_DN migraine DOID_6364 3.074E-04 3.069E-03 3.074E-04 4.998E-03 VECCHI_GASTRIC_CANCER_EARLY_DN mononeuritis of lower limb DOID_9473 3.074E-04 3.124E-03 7.666E-03 0.04741445 VECCHI_GASTRIC_CANCER_EARLY_DN mononeuritis DOID_1802 3.405E-04 3.34E-03 8.19E-03 0.04957311 VECCHI_GASTRIC_CANCER_EARLY_DN renal tubular transport disease DOID_447 3.405E-04 3.283E-03 3.405E-04 5.236E-03 VECCHI_GASTRIC_CANCER_EARLY_DN central nervous system hereditary degenerative disease DOID_481 3.405E-04 3.229E-03 8.19E-03 0.04905129 VECCHI_GASTRIC_CANCER_EARLY_DN pancreatic ductal carcinoma DOID_3587 3.489E-04 3.255E-03 4.523E-03 0.0347748 VECCHI_GASTRIC_CANCER_EARLY_DN male reproductive system disease DOID_48 3.675E-04 3.373E-03 4.698E-03 0.03564308 VECCHI_GASTRIC_CANCER_EARLY_DN mononeuropathy DOID_1188 3.757E-04 3.393E-03 8.728E-03 0.05016667 VECCHI_GASTRIC_CANCER_EARLY_DN dystonic disease DOID_544 3.757E-04 3.34E-03 8.728E-03 0.04917327 VECCHI_GASTRIC_CANCER_EARLY_DN pancreatic carcinoma DOID_4905 4.069E-04 3.562E-03 5.061E-03 0.03740242 VECCHI_GASTRIC_CANCER_EARLY_DN electroclinical syndrome DOID_0050701 4.946E-04 4.264E-03 5.838E-03 0.04100939 VECCHI_GASTRIC_CANCER_EARLY_DN bacterial pneumonia DOID_874 4.946E-04 4.201E-03 5.838E-03 0.04002121 VECCHI_GASTRIC_CANCER_EARLY_DN contact dermatitis DOID_2773 5.432E-04 4.545E-03 0.0536707 0.17652386 VECCHI_GASTRIC_CANCER_EARLY_DN papilloma DOID_2615 5.869E-04 4.84E-03 5.869E-04 8.349E-03 VECCHI_GASTRIC_CANCER_EARLY_DN mental depression DOID_1596 6.222E-04 5.058E-03 6.222E-04 8.635E-03 VECCHI_GASTRIC_CANCER_EARLY_DN adolescence-adult electroclinical syndrome DOID_0050705 8.014E-04 6.422E-03 0.0142566 0.06933337 VECCHI_GASTRIC_CANCER_EARLY_DN pulmonary sarcoidosis DOID_13406 8.014E-04 6.333E-03 0.0142566 0.0687458 VECCHI_GASTRIC_CANCER_EARLY_DN multiple myeloma DOID_9538 8.014E-04 6.247E-03 8.014E-04 0.01085706 VECCHI_GASTRIC_CANCER_EARLY_DN hypolipoproteinemia DOID_1387 8.991E-04 6.914E-03 8.991E-04 0.01162755 VECCHI_GASTRIC_CANCER_EARLY_DN hepatitis DOID_2237 9.25E-04 7.018E-03 0.01564444 0.0741807 VECCHI_GASTRIC_CANCER_EARLY_DN lymphoblastic leukemia DOID_1037 9.446E-04 7.072E-03 9.446E-04 0.01168386 VECCHI_GASTRIC_CANCER_EARLY_DN autoimmune disease of urogenital tract DOID_0060049 1.132E-03 8.365E-03 0.01782989 0.08315744 VECCHI_GASTRIC_CANCER_EARLY_DN primary biliary cirrhosis DOID_12236 1.132E-03 8.365E-03 0.01782989 0.08315744 VECCHI_GASTRIC_CANCER_EARLY_DN nephrotic syndrome DOID_1184 1.207E-03 8.805E-03 1.207E-03 0.01461244 VECCHI_GASTRIC_CANCER_EARLY_DN myeloma DOID_0070004 1.538E-03 0.01107677 1.538E-03 0.01785846 VECCHI_GASTRIC_CANCER_EARLY_DN pre-eclampsia DOID_10591 1.538E-03 0.01093831 0.02173971 0.09740073 VECCHI_GASTRIC_CANCER_EARLY_DN neuritis DOID_1803 1.538E-03 0.01080327 0.02173971 0.09589065 VECCHI_GASTRIC_CANCER_EARLY_DN epilepsy with generalized tonic-clonic seizures DOID_7725 1.545E-03 0.01071817 0.05740995 0.18147924 VECCHI_GASTRIC_CANCER_EARLY_DN glaucoma DOID_1686 1.723E-03 0.01180913 1.723E-03 0.01960315 VECCHI_GASTRIC_CANCER_EARLY_DN congenital structural myopathy DOID_422 1.797E-03 0.01217045 1.797E-03 0.02004545 VECCHI_GASTRIC_CANCER_EARLY_DN renovascular hypertension DOID_1591 2.067E-03 0.01383631 0.06594654 0.1995935 VECCHI_GASTRIC_CANCER_EARLY_DN lung oat cell carcinoma DOID_5411 2.067E-03 0.01367542 2.067E-03 0.0221903 VECCHI_GASTRIC_CANCER_EARLY_DN varicose veins DOID_799 2.067E-03 0.01351823 2.067E-03 0.02177937 VECCHI_GASTRIC_CANCER_EARLY_DN bile duct adenocarcinoma DOID_4896 2.243E-03 0.01450439 2.243E-03 0.02279262 VECCHI_GASTRIC_CANCER_EARLY_DN cholangiocarcinoma DOID_4947 2.243E-03 0.01450439 2.243E-03 0.02279262 VECCHI_GASTRIC_CANCER_EARLY_DN bone marrow cancer DOID_4960 2.243E-03 0.01434142 2.243E-03 0.02239275 VECCHI_GASTRIC_CANCER_EARLY_DN hemolytic-uremic syndrome DOID_12554 2.355E-03 0.01488999 0.07018596 0.20479903 VECCHI_GASTRIC_CANCER_EARLY_DN vein disease DOID_866 2.355E-03 0.01472636 2.355E-03 0.02310515 VECCHI_GASTRIC_CANCER_EARLY_DN smallpox DOID_8736 2.358E-03 0.01458215 2.358E-03 0.02273827 VECCHI_GASTRIC_CANCER_EARLY_DN Graves' disease DOID_12361 2.661E-03 0.01628237 2.661E-03 0.02523768 VECCHI_GASTRIC_CANCER_EARLY_DN hypertrophic cardiomyopathy DOID_11984 2.723E-03 0.01648204 0.03144415 0.13253125 VECCHI_GASTRIC_CANCER_EARLY_DN bile duct cancer DOID_4606 2.723E-03 0.01630854 2.723E-03 0.0249889 VECCHI_GASTRIC_CANCER_EARLY_DN bile duct carcinoma DOID_4897 2.723E-03 0.01630854 2.723E-03 0.0249889 VECCHI_GASTRIC_CANCER_EARLY_DN congenital muscular dystrophy DOID_0050557 2.985E-03 0.01769247 2.985E-03 0.02695996 VECCHI_GASTRIC_CANCER_EARLY_DN neuroectodermal tumor DOID_171 3.121E-03 0.0183078 3.121E-03 0.02774776 VECCHI_GASTRIC_CANCER_EARLY_DN hypothyroidism DOID_1459 3.261E-03 0.01893509 0.03532361 0.14356523 VECCHI_GASTRIC_CANCER_EARLY_DN agammaglobulinemia DOID_2583 3.326E-03 0.01911773 3.326E-03 0.02911778 VECCHI_GASTRIC_CANCER_EARLY_DN granulosa cell tumor DOID_2999 3.326E-03 0.01892656 3.326E-03 0.0286766 VECCHI_GASTRIC_CANCER_EARLY_DN infertility DOID_5223 3.326E-03 0.01873917 3.326E-03 0.02824859 VECCHI_GASTRIC_CANCER_EARLY_DN pulmonary edema DOID_11396 3.685E-03 0.0205559 3.685E-03 0.03083385 VECCHI_GASTRIC_CANCER_EARLY_DN sex cord-gonadal stromal tumor DOID_192 3.685E-03 0.02035633 3.685E-03 0.03038698 VECCHI_GASTRIC_CANCER_EARLY_DN blood protein disease DOID_620 3.685E-03 0.0201606 3.685E-03 0.02995288 VECCHI_GASTRIC_CANCER_EARLY_DN amyloidosis DOID_9120 3.685E-03 0.01996859 3.685E-03 0.02953101 VECCHI_GASTRIC_CANCER_EARLY_DN juvenile absence epilepsy DOID_0060172 4.061E-03 0.02179739 4.061E-03 0.03209061 VECCHI_GASTRIC_CANCER_EARLY_DN autoimmune hepatitis DOID_2048 4.061E-03 0.02159368 0.09109783 0.23886944 VECCHI_GASTRIC_CANCER_EARLY_DN coronary restenosis DOID_4247 4.061E-03 0.02139374 0.09109783 0.2377737 VECCHI_GASTRIC_CANCER_EARLY_DN brain infarction DOID_3454 4.184E-03 0.02183881 0.04146791 0.16161122 VECCHI_GASTRIC_CANCER_EARLY_DN gastric ulcer DOID_10808 4.453E-03 0.02303663 4.453E-03 0.03471273 VECCHI_GASTRIC_CANCER_EARLY_DN IgA glomerulonephritis DOID_2986 4.863E-03 0.02492908 0.09933106 0.24898401 VECCHI_GASTRIC_CANCER_EARLY_DN lingual-facial-buccal dyskinesia DOID_9854 4.863E-03 0.0247065 4.863E-03 0.03640957 VECCHI_GASTRIC_CANCER_EARLY_DN ureteral disease DOID_1426 5.29E-03 0.02663476 0.10341982 0.25040799 VECCHI_GASTRIC_CANCER_EARLY_DN endogenous depression DOID_1595 5.441E-03 0.027159 5.441E-03 0.03969392 VECCHI_GASTRIC_CANCER_EARLY_DN syndrome DOID_225 5.441E-03 0.02692283 5.441E-03 0.03919146 VECCHI_GASTRIC_CANCER_EARLY_DN sphingolipidosis DOID_1927 5.732E-03 0.02811845 5.732E-03 0.04077175 VECCHI_GASTRIC_CANCER_EARLY_DN mixed glioma DOID_5076 5.838E-03 0.02839112 5.838E-03 0.04050928 VECCHI_GASTRIC_CANCER_EARLY_DN bronchiolitis DOID_2942 6.192E-03 0.02985656 0.11154207 0.26011244 VECCHI_GASTRIC_CANCER_EARLY_DN osteosarcoma DOID_3347 6.192E-03 0.02960567 6.192E-03 0.04194136 VECCHI_GASTRIC_CANCER_EARLY_DN chromosomal disease DOID_0080014 6.464E-03 0.0306521 6.464E-03 0.04327356 VECCHI_GASTRIC_CANCER_EARLY_DN morbid obesity DOID_11981 6.667E-03 0.03135242 6.667E-03 0.04360509 VECCHI_GASTRIC_CANCER_EARLY_DN biliary tract cancer DOID_4607 6.903E-03 0.03219743 6.903E-03 0.04413581 VECCHI_GASTRIC_CANCER_EARLY_DN juvenile myoclonic epilepsy DOID_4890 7.159E-03 0.03311672 7.159E-03 0.04525952 VECCHI_GASTRIC_CANCER_EARLY_DN gestational diabetes DOID_11714 7.666E-03 0.03517846 7.666E-03 0.04690461 VECCHI_GASTRIC_CANCER_EARLY_DN pleurisy DOID_10247 8.19E-03 0.03727898 0.12756774 0.28465116 VECCHI_GASTRIC_CANCER_EARLY_DN renal hypertension DOID_1073 8.19E-03 0.03698311 0.12756774 0.28353924 VECCHI_GASTRIC_CANCER_EARLY_DN secondary hypertension DOID_11130 8.19E-03 0.03698311 0.12756774 0.28353924 VECCHI_GASTRIC_CANCER_EARLY_DN coronary stenosis DOID_4248 8.19E-03 0.03669191 0.12756774 0.28134126 VECCHI_GASTRIC_CANCER_EARLY_DN amino acid metabolic disorder DOID_9252 8.325E-03 0.03700811 0.06447321 0.19723255 VECCHI_GASTRIC_CANCER_EARLY_DN Human immunodeficiency virus infectious disease DOID_526 8.578E-03 0.03783445 8.578E-03 0.05084005 VECCHI_GASTRIC_CANCER_EARLY_DN autoimmune disease of endocrine system DOID_0060005 8.728E-03 0.03820385 8.728E-03 0.05120104 VECCHI_GASTRIC_CANCER_EARLY_DN polycystic ovary syndrome DOID_11612 8.728E-03 0.03791222 8.728E-03 0.05067858 VECCHI_GASTRIC_CANCER_EARLY_DN multiple epiphyseal dysplasia DOID_12721 8.728E-03 0.037625 8.728E-03 0.049665 VECCHI_GASTRIC_CANCER_EARLY_DN toxic encephalopathy DOID_3602 8.728E-03 0.03734211 0.13152905 0.28784627 VECCHI_GASTRIC_CANCER_EARLY_DN focal glomerulosclerosis DOID_3945 8.728E-03 0.03706344 0.13152905 0.28674341 VECCHI_GASTRIC_CANCER_EARLY_DN age related macular degeneration DOID_10871 9.852E-03 0.04152643 0.1393981 0.2993114 VECCHI_GASTRIC_CANCER_EARLY_DN degeneration of macula and posterior pole DOID_2007 9.852E-03 0.04152643 0.1393981 0.2993114 VECCHI_GASTRIC_CANCER_EARLY_DN bronchiolitis obliterans DOID_2799 9.852E-03 0.04122109 0.1393981 0.29706937 VECCHI_GASTRIC_CANCER_EARLY_DN hypersensitivity reaction type I disease DOID_1205 9.907E-03 0.04114515 9.907E-03 0.05526359 VECCHI_GASTRIC_CANCER_EARLY_DN endometrial cancer DOID_1380 0.01043733 0.04303506 0.01043733 0.05765862 VECCHI_GASTRIC_CANCER_EARLY_DN allergic rhinitis DOID_4481 0.01043733 0.04272545 0.01043733 0.05710421 VECCHI_GASTRIC_CANCER_EARLY_DN leiomyoma DOID_127 0.01103718 0.04485824 0.01103718 0.05981098 VECCHI_GASTRIC_CANCER_EARLY_DN pleural disease DOID_1532 0.01103718 0.04454009 0.14719627 0.3102025 VECCHI_GASTRIC_CANCER_EARLY_DN childhood absence epilepsy DOID_1825 0.01103718 0.04422643 0.01103718 0.05924673 VECCHI_GASTRIC_CANCER_EARLY_DN hereditary spastic paraplegia DOID_2476 0.01103718 0.04391715 0.01103718 0.05869302 VECCHI_GASTRIC_CANCER_EARLY_DN myocarditis DOID_820 0.0116519 0.04604118 0.0116519 0.06138824 VECCHI_GASTRIC_CANCER_EARLY_DN male infertility DOID_12336 0.01228135 0.04819369 0.01228135 0.06411087 VECCHI_GASTRIC_CANCER_EARLY_DN hepatitis C DOID_1883 0.01228135 0.0478636 0.01228135 0.06352805 VECCHI_GASTRIC_CANCER_EARLY_DN thyroid carcinoma DOID_3963 0.01228135 0.047538 0.01228135 0.06295572 VECCHI_GASTRIC_CANCER_EARLY_DN macular degeneration DOID_4448 0.01228135 0.04721679 0.15492417 0.3217221 VECCHI_GASTRIC_CANCER_EARLY_DN esophageal disease DOID_6050 0.01228135 0.0468999 0.15492417 0.3205522 VECCHI_GASTRIC_CANCER_EARLY_DN paraplegia DOID_607 0.01228135 0.04658724 0.01228135 0.06239362 VECCHI_GASTRIC_CANCER_EARLY_DN hyperthyroidism DOID_7998 0.01228135 0.04627871 0.01228135 0.06184146 VECCHI_GASTRIC_CANCER_EARLY_DN childhood electroclinical syndrome DOID_0050704 0.01292537 0.04838511 0.01292537 0.06451349 VECCHI_GASTRIC_CANCER_EARLY_DN lymphoid leukemia DOID_10747 0.01292537 0.04806887 0.01292537 0.0639525 VECCHI_GASTRIC_CANCER_EARLY_DN thyroid cancer DOID_1781 0.01358384 0.05018964 0.01358384 0.06663107 VECCHI_GASTRIC_CANCER_EARLY_DN calcinosis DOID_182 0.0142566 0.05233551 0.0142566 0.06816811 VECCHI_GASTRIC_CANCER_EARLY_DN lymphatic system disease DOID_75 0.01635923 0.05966926 0.01635923 0.07692896 VECCHI_GASTRIC_CANCER_EARLY_DN Huntington's disease DOID_12858 0.01858548 0.06735756 0.1888471 0.37969612 VECCHI_GASTRIC_CANCER_EARLY_DN uterine cancer DOID_363 0.01935439 0.06970029 0.01935439 0.08810117 VECCHI_GASTRIC_CANCER_EARLY_DN cerebral infarction DOID_3526 0.02013648 0.07206075 0.19619971 0.391711 VECCHI_GASTRIC_CANCER_EARLY_DN cataract DOID_83 0.02013648 0.07161037 0.02013648 0.0909338 VECCHI_GASTRIC_CANCER_EARLY_DN proteinuria DOID_576 0.02093163 0.07397578 0.19985113 0.39622053 VECCHI_GASTRIC_CANCER_EARLY_DN lens disease DOID_110 0.02173971 0.07635737 0.02173971 0.09663979 VECCHI_GASTRIC_CANCER_EARLY_DN autonomic nervous system disease DOID_11465 0.02173971 0.07588892 0.20348606 0.40202627 VECCHI_GASTRIC_CANCER_EARLY_DN heart valve disease DOID_4079 0.02173971 0.07542618 0.02173971 0.09515303 VECCHI_GASTRIC_CANCER_EARLY_DN hemolytic anemia DOID_583 0.02256057 0.07779978 0.20710457 0.4035702 VECCHI_GASTRIC_CANCER_EARLY_DN normocytic anemia DOID_720 0.02256057 0.07779978 0.20710457 0.4035702 VECCHI_GASTRIC_CANCER_EARLY_DN autoimmune disease of gastrointestinal tract DOID_0060031 0.02339409 0.08018817 0.21070673 0.40918816 VECCHI_GASTRIC_CANCER_EARLY_DN calcium metabolism disease DOID_10575 0.02424013 0.08259063 0.02424013 0.1052873 VECCHI_GASTRIC_CANCER_EARLY_DN withdrawal disorder DOID_0060001 0.02509858 0.08500649 0.02509858 0.10819008 VECCHI_GASTRIC_CANCER_EARLY_DN hemorrhagic disease DOID_2213 0.02509858 0.08450349 0.21786233 0.42164512 VECCHI_GASTRIC_CANCER_EARLY_DN vasculitis DOID_865 0.02774702 0.0928709 0.22847497 0.44068562 VECCHI_GASTRIC_CANCER_EARLY_DN osteochondrodysplasia DOID_2256 0.02865378 0.09534502 0.02865378 0.12258646 PARK_APL_PATHOGENESIS_DN esophagitis DOID_11963 1.468E-04 0.08354898 0.01778917 0.33740118 PARK_APL_PATHOGENESIS_DN amyloidosis DOID_9120 1.468E-04 0.04177449 1.468E-04 0.08354898 PARK_APL_PATHOGENESIS_DN spinal muscular atrophy DOID_12377 2.702E-04 0.05124647 0.02394251 0.36819693 PARK_APL_PATHOGENESIS_DN spinal cord disease DOID_319 2.908E-04 0.04136812 0.0248185 0.37162431 PARK_APL_PATHOGENESIS_DN esophageal disease DOID_6050 5.098E-04 0.05801514 0.03266813 0.43228296 PARK_APL_PATHOGENESIS_DN astrocytoma DOID_3069 1.918E-03 0.09923652 0.06261562 0.49483733 BENPORATH_PRC2_TARGETS congenital diaphragmatic hernia DOID_3827 5.243E-14 2.983E-11 5.243E-14 2.983E-11 BENPORATH_PRC2_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 1.113E-13 3.167E-11 7.161E-10 1.358E-07 BENPORATH_PRC2_TARGETS refractive error DOID_9835 3.785E-11 7.179E-09 1.307E-09 1.859E-07 BENPORATH_PRC2_TARGETS endogenous depression DOID_1595 7.243E-11 1.03E-08 1.403E-09 1.597E-07 BENPORATH_PRC2_TARGETS mental depression DOID_1596 1.884E-10 2.144E-08 3.309E-09 3.138E-07 BENPORATH_PRC2_TARGETS microphthalmia DOID_10629 2.247E-10 2.131E-08 2.247E-10 6.393E-08 BENPORATH_PRC2_TARGETS orofacial cleft DOID_0050567 1.007E-09 8.185E-08 2.296E-08 1.452E-06 BENPORATH_PRC2_TARGETS melancholia DOID_2848 3.048E-09 2.168E-07 6.053E-08 3.444E-06 BENPORATH_PRC2_TARGETS neurotic disorder DOID_4964 3.53E-09 2.231E-07 6.882E-08 3.56E-06 BENPORATH_PRC2_TARGETS hypothyroidism DOID_1459 4.696E-09 2.672E-07 4.696E-09 3.817E-07 BENPORATH_PRC2_TARGETS congenital heart defect DOID_1682 5.397E-09 2.792E-07 5.397E-09 3.839E-07 BENPORATH_PRC2_TARGETS leiomyoma DOID_127 1.746E-08 8.278E-07 4.99E-07 1.893E-05 BENPORATH_PRC2_TARGETS reproductive organ benign neoplasm DOID_0050622 3.535E-08 1.547E-06 1.054E-05 2.5E-04 BENPORATH_PRC2_TARGETS female reproductive system disease DOID_229 4.219E-08 1.715E-06 8.217E-05 1.169E-03 BENPORATH_PRC2_TARGETS peripheral nervous system neoplasm DOID_1192 5.585E-08 2.119E-06 2.612E-05 4.504E-04 BENPORATH_PRC2_TARGETS neuroectodermal tumor DOID_171 7.807E-08 2.776E-06 1.871E-05 3.67E-04 BENPORATH_PRC2_TARGETS hypercalcemia DOID_12678 8.437E-08 2.824E-06 8.437E-08 4E-06 BENPORATH_PRC2_TARGETS nervous system cancer DOID_3093 1.042E-07 3.295E-06 1.455E-04 1.725E-03 BENPORATH_PRC2_TARGETS myopia DOID_11830 1.218E-07 3.648E-06 1.218E-07 5.332E-06 BENPORATH_PRC2_TARGETS movement disease DOID_480 3.506E-07 9.976E-06 3.506E-07 1.425E-05 BENPORATH_PRC2_TARGETS autonomic nervous system neoplasm DOID_2621 4.99E-07 1.352E-05 2.251E-04 2.247E-03 BENPORATH_PRC2_TARGETS neuroblastoma DOID_769 4.99E-07 1.352E-05 2.251E-04 2.247E-03 BENPORATH_PRC2_TARGETS colonic disease DOID_5353 6.263E-07 1.62E-05 6.386E-04 5.266E-03 BENPORATH_PRC2_TARGETS focal epilepsy DOID_2234 7.263E-07 1.797E-05 8.882E-06 2.297E-04 BENPORATH_PRC2_TARGETS bone development disease DOID_0080006 7.948E-07 1.884E-05 9.599E-06 2.375E-04 BENPORATH_PRC2_TARGETS cleft palate DOID_674 1.138E-06 2.59E-05 2.31E-05 4.107E-04 BENPORATH_PRC2_TARGETS mineral metabolism disease DOID_0050032 1.785E-06 3.907E-05 1.785E-06 6.349E-05 BENPORATH_PRC2_TARGETS mouth disease DOID_403 1.844E-06 3.887E-05 1.979E-05 3.754E-04 BENPORATH_PRC2_TARGETS uterine disease DOID_345 1.976E-06 4.015E-05 2.805E-03 0.01716482 BENPORATH_PRC2_TARGETS temporal lobe epilepsy DOID_3328 2.183E-06 4.283E-05 2.885E-05 4.829E-04 BENPORATH_PRC2_TARGETS endometriosis of uterus DOID_288 2.33E-06 4.419E-05 5.988E-04 5.085E-03 BENPORATH_PRC2_TARGETS tooth disease DOID_1091 2.408E-06 4.419E-05 3.133E-05 5.094E-04 BENPORATH_PRC2_TARGETS endometriosis DOID_289 2.66E-06 4.73E-05 6.514E-04 5.221E-03 BENPORATH_PRC2_TARGETS Hirschsprung's disease DOID_10487 3.567E-06 6.15E-05 5.369E-03 0.02679743 BENPORATH_PRC2_TARGETS megacolon DOID_11372 4.96E-06 8.3E-05 6.228E-03 0.029289 BENPORATH_PRC2_TARGETS syndrome DOID_225 5.004E-06 8.135E-05 5.004E-06 1.675E-04 BENPORATH_PRC2_TARGETS electroclinical syndrome DOID_0050701 5.93E-06 9.372E-05 5.93E-06 1.874E-04 BENPORATH_PRC2_TARGETS calcium metabolism disease DOID_10575 6.199E-06 9.533E-05 6.199E-06 1.856E-04 BENPORATH_PRC2_TARGETS panic disorder DOID_594 6.717E-06 1.006E-04 6.717E-06 1.911E-04 BENPORATH_PRC2_TARGETS female reproductive organ benign neoplasm DOID_0060086 7.477E-06 1.091E-04 1.577E-04 1.795E-03 BENPORATH_PRC2_TARGETS uterine benign neoplasm DOID_0060095 7.477E-06 1.091E-04 1.577E-04 1.795E-03 BENPORATH_PRC2_TARGETS uterine fibroid DOID_13223 7.477E-06 1.091E-04 1.577E-04 1.795E-03 BENPORATH_PRC2_TARGETS auditory system disease DOID_2742 8.211E-06 1.168E-04 8.211E-06 2.225E-04 BENPORATH_PRC2_TARGETS familial hyperlipidemia DOID_1168 1.165E-05 1.617E-04 1.538E-04 1.786E-03 BENPORATH_PRC2_TARGETS childhood absence epilepsy DOID_1825 1.18E-05 1.599E-04 1.18E-05 2.686E-04 BENPORATH_PRC2_TARGETS nonsyndromic deafness DOID_0050563 1.415E-05 1.873E-04 1.415E-05 3.098E-04 BENPORATH_PRC2_TARGETS childhood electroclinical syndrome DOID_0050704 1.787E-05 2.311E-04 1.787E-05 3.765E-04 BENPORATH_PRC2_TARGETS lymphoblastic leukemia DOID_1037 1.848E-05 2.337E-04 1.736E-04 1.864E-03 BENPORATH_PRC2_TARGETS encephalomyelitis DOID_640 1.848E-05 2.286E-04 1.736E-04 1.83E-03 BENPORATH_PRC2_TARGETS heart septal defect DOID_1681 1.856E-05 2.247E-04 1.856E-05 3.773E-04 BENPORATH_PRC2_TARGETS adolescence-adult electroclinical syndrome DOID_0050705 2.31E-05 2.738E-04 2.31E-05 4.239E-04 BENPORATH_PRC2_TARGETS primitive neuroectodermal tumor DOID_168 4.613E-05 5.357E-04 7.217E-03 0.03258939 BENPORATH_PRC2_TARGETS cerebral infarction DOID_3526 5.682E-05 6.467E-04 5.682E-05 8.981E-04 BENPORATH_PRC2_TARGETS learning disability DOID_8927 5.682E-05 6.34E-04 5.682E-05 8.739E-04 BENPORATH_PRC2_TARGETS ventricular septal defect DOID_1657 7.164E-05 7.839E-04 7.164E-05 1.073E-03 BENPORATH_PRC2_TARGETS chondrosarcoma DOID_3371 7.164E-05 7.691E-04 0.08250389 0.25239092 BENPORATH_PRC2_TARGETS lipid metabolism disorder DOID_3146 7.678E-05 8.09E-04 7.142E-04 5.644E-03 BENPORATH_PRC2_TARGETS cleft lip DOID_9296 7.963E-05 8.238E-04 7.963E-05 1.162E-03 BENPORATH_PRC2_TARGETS spinal cord disease DOID_319 9.228E-05 9.376E-04 1.744E-03 0.0118168 BENPORATH_PRC2_TARGETS juvenile myoclonic epilepsy DOID_4890 9.228E-05 9.211E-04 9.228E-05 1.281E-03 BENPORATH_PRC2_TARGETS maturity-onset diabetes of the young DOID_0050524 9.788E-05 9.602E-04 9.788E-05 1.326E-03 BENPORATH_PRC2_TARGETS obsessive-compulsive disorder DOID_10933 9.788E-05 9.439E-04 9.788E-05 1.295E-03 BENPORATH_PRC2_TARGETS polydactyly DOID_1148 9.788E-05 9.282E-04 9.788E-05 1.266E-03 BENPORATH_PRC2_TARGETS prediabetes syndrome DOID_11716 9.788E-05 9.13E-04 9.788E-05 1.238E-03 BENPORATH_PRC2_TARGETS withdrawal disorder DOID_0060001 1.006E-04 9.236E-04 1.006E-04 1.245E-03 BENPORATH_PRC2_TARGETS diarrhea DOID_13250 1.297E-04 1.171E-03 1.297E-04 1.57E-03 BENPORATH_PRC2_TARGETS multiple epiphyseal dysplasia DOID_12721 1.39E-04 1.235E-03 2.349E-03 0.01484861 BENPORATH_PRC2_TARGETS corneal disease DOID_10124 1.577E-04 1.381E-03 1.577E-04 1.76E-03 BENPORATH_PRC2_TARGETS dysostosis DOID_1934 1.577E-04 1.36E-03 1.577E-04 1.726E-03 BENPORATH_PRC2_TARGETS polyneuropathy DOID_1389 1.675E-04 1.423E-03 5.369E-03 0.02656441 BENPORATH_PRC2_TARGETS endometrial cancer DOID_1380 2.007E-04 1.679E-03 3.068E-03 0.01837555 BENPORATH_PRC2_TARGETS tethered spinal cord syndrome DOID_1089 2.118E-04 1.747E-03 6.228E-03 0.02953307 BENPORATH_PRC2_TARGETS rhabdomyosarcoma DOID_3247 2.118E-04 1.722E-03 2.118E-04 2.192E-03 BENPORATH_PRC2_TARGETS eating disorder DOID_8670 2.118E-04 1.698E-03 2.118E-04 2.152E-03 BENPORATH_PRC2_TARGETS pre-malignant neoplasm DOID_0060071 2.615E-04 2.067E-03 0.01919882 0.07586199 BENPORATH_PRC2_TARGETS in situ carcinoma DOID_8719 2.615E-04 2.067E-03 0.01919882 0.07586199 BENPORATH_PRC2_TARGETS skeletal muscle cancer DOID_4043 2.631E-04 2.051E-03 2.631E-04 2.581E-03 BENPORATH_PRC2_TARGETS lymphoid leukemia DOID_10747 3.11E-04 2.391E-03 3.11E-04 2.999E-03 BENPORATH_PRC2_TARGETS medullomyoblastoma DOID_3861 3.11E-04 2.359E-03 4.217E-03 0.02242712 BENPORATH_PRC2_TARGETS adult medulloblastoma DOID_3864 3.11E-04 2.359E-03 4.217E-03 0.02242712 BENPORATH_PRC2_TARGETS childhood medulloblastoma DOID_3869 3.11E-04 2.359E-03 4.217E-03 0.02242712 BENPORATH_PRC2_TARGETS brain infarction DOID_3454 3.679E-04 2.755E-03 3.679E-04 3.489E-03 BENPORATH_PRC2_TARGETS medulloblastoma DOID_3858 3.799E-04 2.807E-03 4.877E-03 0.02456013 BENPORATH_PRC2_TARGETS drug-induced mental disorder DOID_1203 3.883E-04 2.832E-03 3.883E-04 3.622E-03 BENPORATH_PRC2_TARGETS drug psychosis DOID_1742 3.883E-04 2.832E-03 3.883E-04 3.622E-03 BENPORATH_PRC2_TARGETS substance-induced psychosis DOID_8646 3.883E-04 2.832E-03 3.883E-04 3.622E-03 BENPORATH_PRC2_TARGETS nephrosis DOID_2527 4.458E-04 3.211E-03 4.458E-04 4.091E-03 BENPORATH_PRC2_TARGETS neuroendocrine tumor DOID_169 4.63E-04 3.293E-03 4.63E-04 4.181E-03 BENPORATH_PRC2_TARGETS diabetic retinopathy DOID_8947 5.042E-04 3.542E-03 5.042E-04 4.483E-03 BENPORATH_PRC2_TARGETS conduct disorder DOID_12995 5.463E-04 3.791E-03 5.463E-04 4.782E-03 BENPORATH_PRC2_TARGETS infertility DOID_5223 5.463E-04 3.745E-03 5.463E-04 4.71E-03 BENPORATH_PRC2_TARGETS pancreatitis DOID_4989 6.381E-04 4.322E-03 6.381E-04 5.339E-03 BENPORATH_PRC2_TARGETS hyperinsulinism DOID_2018 6.514E-04 4.361E-03 6.514E-04 5.295E-03 BENPORATH_PRC2_TARGETS uterine cancer DOID_363 7.073E-04 4.679E-03 7.66E-03 0.03432123 BENPORATH_PRC2_TARGETS juvenile absence epilepsy DOID_0060172 7.403E-04 4.842E-03 7.403E-04 5.771E-03 BENPORATH_PRC2_TARGETS chromosomal disease DOID_0080014 7.547E-04 4.88E-03 7.547E-04 5.803E-03 BENPORATH_PRC2_TARGETS alcohol abuse DOID_1574 8.409E-04 5.376E-03 8.409E-04 6.379E-03 BENPORATH_PRC2_TARGETS neuritis DOID_1803 8.95E-04 5.658E-03 9.087E-03 0.03977349 BENPORATH_PRC2_TARGETS retinal vascular disease DOID_2462 9.341E-04 5.841E-03 9.341E-04 6.994E-03 BENPORATH_PRC2_TARGETS muscle cancer DOID_4045 9.734E-04 6.02E-03 9.734E-04 7.193E-03 BENPORATH_PRC2_TARGETS synostosis DOID_11971 1.105E-03 6.763E-03 1.105E-03 8.064E-03 BENPORATH_PRC2_TARGETS ureteral disease DOID_1426 1.105E-03 6.691E-03 1.105E-03 7.962E-03 BENPORATH_PRC2_TARGETS Human immunodeficiency virus infectious disease DOID_526 1.201E-03 7.192E-03 1.201E-03 8.541E-03 BENPORATH_PRC2_TARGETS acute pancreatitis DOID_2913 1.248E-03 7.398E-03 1.248E-03 8.769E-03 BENPORATH_PRC2_TARGETS osteochondrodysplasia DOID_2256 1.563E-03 9.167E-03 0.01360752 0.05610635 BENPORATH_PRC2_TARGETS smallpox DOID_8736 1.563E-03 9.073E-03 1.563E-03 0.01084339 BENPORATH_PRC2_TARGETS autosomal dominant nonsyndromic deafness DOID_0050564 1.567E-03 9.009E-03 1.567E-03 0.01074561 BENPORATH_PRC2_TARGETS morbid obesity DOID_11981 1.567E-03 8.919E-03 0.02233005 0.08762619 BENPORATH_PRC2_TARGETS hypotrichosis DOID_4535 1.744E-03 9.828E-03 1.744E-03 0.01167778 BENPORATH_PRC2_TARGETS fragments of torsion dystonia DOID_531 1.744E-03 9.731E-03 1.744E-03 0.01154199 BENPORATH_PRC2_TARGETS congenital nervous system abnormality DOID_2490 1.772E-03 9.79E-03 1.772E-03 0.01159035 BENPORATH_PRC2_TARGETS Sciatic Neuropathy DOID_11446 1.934E-03 0.01057849 0.0255417 0.0981975 BENPORATH_PRC2_TARGETS lesion of sciatic nerve DOID_12528 1.934E-03 0.01057849 0.0255417 0.0981975 BENPORATH_PRC2_TARGETS migraine DOID_6364 1.934E-03 0.01047774 1.934E-03 0.01250185 BENPORATH_PRC2_TARGETS mononeuritis of lower limb DOID_9473 1.934E-03 0.01057849 0.0255417 0.0981975 BENPORATH_PRC2_TARGETS mononeuritis DOID_1802 2.135E-03 0.01145943 0.02721363 0.10323035 BENPORATH_PRC2_TARGETS central nervous system hereditary degenerative disease DOID_481 2.135E-03 0.01135234 2.135E-03 0.01364831 BENPORATH_PRC2_TARGETS mononeuropathy DOID_1188 2.349E-03 0.01237384 0.02892845 0.106885 BENPORATH_PRC2_TARGETS dystonic disease DOID_544 2.349E-03 0.01226032 2.349E-03 0.01468544 BENPORATH_PRC2_TARGETS endometrial carcinoma DOID_2871 2.575E-03 0.01332123 0.03068533 0.11192278 BENPORATH_PRC2_TARGETS endocrine pancreas disease DOID_1428 2.658E-03 0.01362608 2.658E-03 0.01644016 BENPORATH_PRC2_TARGETS hyperglycemia DOID_4195 2.958E-03 0.01502935 2.958E-03 0.01790731 BENPORATH_PRC2_TARGETS Charcot-Marie-Tooth disease DOID_10595 3.068E-03 0.01544847 0.03432188 0.1243895 BENPORATH_PRC2_TARGETS brachydactyly DOID_0050581 3.15E-03 0.01572483 3.15E-03 0.01867324 BENPORATH_PRC2_TARGETS familial combined hyperlipidemia DOID_13809 3.15E-03 0.0155881 0.08250389 0.2551343 BENPORATH_PRC2_TARGETS holoprosencephaly DOID_4621 3.15E-03 0.01545372 3.15E-03 0.01848073 BENPORATH_PRC2_TARGETS keratitis DOID_4677 3.15E-03 0.01532163 3.15E-03 0.01829215 BENPORATH_PRC2_TARGETS polycythemia DOID_8432 3.15E-03 0.01519179 3.15E-03 0.01810739 BENPORATH_PRC2_TARGETS chronic leukemia DOID_1036 3.334E-03 0.01594393 0.03619991 0.13036549 BENPORATH_PRC2_TARGETS chronic lymphocytic leukemia DOID_1040 3.334E-03 0.01594393 0.03619991 0.13036549 BENPORATH_PRC2_TARGETS bladder disease DOID_365 3.334E-03 0.01581106 3.334E-03 0.01897328 BENPORATH_PRC2_TARGETS hair disease DOID_421 3.615E-03 0.01699836 3.615E-03 0.02036437 BENPORATH_PRC2_TARGETS migraine without aura DOID_12783 3.829E-03 0.01785752 3.829E-03 0.021359 BENPORATH_PRC2_TARGETS craniosynostosis DOID_2340 3.829E-03 0.01771234 3.829E-03 0.02115163 BENPORATH_PRC2_TARGETS prostatic adenoma DOID_2883 3.829E-03 0.0175695 3.829E-03 0.02094825 BENPORATH_PRC2_TARGETS inner ear disease DOID_2952 3.829E-03 0.01742894 3.829E-03 0.02074874 BENPORATH_PRC2_TARGETS nephroblastoma DOID_2154 3.909E-03 0.01765255 3.909E-03 0.02098322 BENPORATH_PRC2_TARGETS peripheral vascular disease DOID_341 3.996E-03 0.01790384 0.02679114 0.10230977 BENPORATH_PRC2_TARGETS autosomal recessive nonsyndromic deafness DOID_0050565 4.54E-03 0.02018248 4.54E-03 0.02391998 BENPORATH_PRC2_TARGETS Usher syndrome DOID_0050439 4.569E-03 0.02015182 4.569E-03 0.0238494 BENPORATH_PRC2_TARGETS ovarian disease DOID_1100 4.569E-03 0.0199968 4.569E-03 0.02363258 BENPORATH_PRC2_TARGETS tic disorder DOID_2769 4.569E-03 0.01984415 4.569E-03 0.02341968 BENPORATH_PRC2_TARGETS retinal detachment DOID_5327 4.569E-03 0.01969382 0.09817163 0.26348896 BENPORATH_PRC2_TARGETS cystic fibrosis DOID_1485 4.597E-03 0.01966671 4.597E-03 0.02335422 BENPORATH_PRC2_TARGETS mixed glioma DOID_5076 5.03E-03 0.02135698 0.15030052 0.35193826 BENPORATH_PRC2_TARGETS major depressive disorder DOID_1470 5.369E-03 0.02262894 5.369E-03 0.0263354 BENPORATH_PRC2_TARGETS adenoid cystic carcinoma DOID_4866 5.979E-03 0.02501322 5.979E-03 0.02907519 BENPORATH_PRC2_TARGETS lymphatic system disease DOID_75 5.979E-03 0.02483064 5.979E-03 0.02882879 BENPORATH_PRC2_TARGETS alcohol dependence DOID_0050741 6.228E-03 0.02568093 6.228E-03 0.02978125 BENPORATH_PRC2_TARGETS eyelid disease DOID_530 6.228E-03 0.02549618 6.228E-03 0.02904892 BENPORATH_PRC2_TARGETS narcolepsy DOID_8986 6.228E-03 0.02531406 6.228E-03 0.02881275 BENPORATH_PRC2_TARGETS biliary tract cancer DOID_4607 6.228E-03 0.02513482 0.0368395 0.13183443 BENPORATH_PRC2_TARGETS cervix uteri carcinoma in situ DOID_8991 6.376E-03 0.02554818 0.05475232 0.1854409 BENPORATH_PRC2_TARGETS salivary gland cancer DOID_8850 6.788E-03 0.02701145 6.788E-03 0.0311503 BENPORATH_PRC2_TARGETS idiopathic pulmonary fibrosis DOID_0050156 7.146E-03 0.02823723 1.000 1.000 BENPORATH_PRC2_TARGETS peripheral neuropathy DOID_0060053 7.146E-03 0.02804249 0.12117453 0.30780495 BENPORATH_PRC2_TARGETS thalassemia DOID_10241 7.146E-03 0.02785042 7.146E-03 0.03252929 BENPORATH_PRC2_TARGETS transitional cell carcinoma DOID_2671 7.603E-03 0.02943111 0.04248949 0.14923776 BENPORATH_PRC2_TARGETS gallbladder cancer DOID_3121 7.66E-03 0.02945133 0.06153798 0.20357622 BENPORATH_PRC2_TARGETS cataract DOID_83 8.12E-03 0.0310088 8.12E-03 0.03609618 BENPORATH_PRC2_TARGETS leukodystrophy DOID_10579 8.596E-03 0.03260584 0.34435915 0.63616999 BENPORATH_PRC2_TARGETS lymphoma DOID_0060058 8.837E-03 0.03329941 0.04730327 0.16411929 BENPORATH_PRC2_TARGETS lens disease DOID_110 9.087E-03 0.0340168 9.087E-03 0.04008181 BENPORATH_PRC2_TARGETS schizophreniform disorder DOID_11328 9.152E-03 0.03403626 0.13618389 0.32695625 BENPORATH_PRC2_TARGETS schizoaffective disorder DOID_5418 9.152E-03 0.03403626 0.13618389 0.32695625 BENPORATH_PRC2_TARGETS Crohn's disease DOID_8778 9.5E-03 0.03509988 0.04980652 0.17072234 BENPORATH_PRC2_TARGETS glaucoma DOID_1686 0.01011862 0.03714513 0.36109876 0.65020631 BENPORATH_PRC2_TARGETS male reproductive organ benign neoplasm DOID_0060087 0.01023825 0.03734335 0.01023825 0.04446995 BENPORATH_PRC2_TARGETS glucose intolerance DOID_10603 0.01023825 0.0371055 0.01023825 0.04413305 BENPORATH_PRC2_TARGETS ulcerative colitis DOID_8577 0.01092061 0.03932803 0.05500246 0.18518581 BENPORATH_PRC2_TARGETS dissociative disorder DOID_10935 0.01137848 0.04071921 0.01137848 0.04867935 BENPORATH_PRC2_TARGETS dissociative amnesia DOID_11037 0.01137848 0.04071921 0.01137848 0.04867935 BENPORATH_PRC2_TARGETS giant cell tumor DOID_200 0.0123782 0.04401997 0.38275727 0.67847006 BENPORATH_PRC2_TARGETS malignant giant cell tumor DOID_2705 0.0123782 0.04401997 0.38275727 0.67847006 BENPORATH_PRC2_TARGETS giant cell glioblastoma DOID_3074 0.0123782 0.04401997 0.38275727 0.67847006 BENPORATH_PRC2_TARGETS amnestic disorder DOID_10914 0.0125718 0.04443076 0.0125718 0.05338322 BENPORATH_PRC2_TARGETS membranous glomerulonephritis DOID_10976 0.0125718 0.04415649 0.0125718 0.05298779 BENPORATH_PRC2_TARGETS brain edema DOID_4724 0.0125718 0.04388559 0.0125718 0.05259817 BENPORATH_PRC2_TARGETS alopecia DOID_987 0.0125718 0.043618 0.0125718 0.05221425 BENPORATH_PRC2_TARGETS benign glioma DOID_0060101 0.01511375 0.05211954 1.000 1.000 BENPORATH_PRC2_TARGETS familial hypercholesterolemia DOID_13810 0.01511375 0.05180557 0.01511375 0.06186852 BENPORATH_PRC2_TARGETS benign ependymoma DOID_4844 0.01511375 0.05211954 1.000 1.000 BENPORATH_PRC2_TARGETS glioblastoma DOID_3068 0.01557732 0.05307482 0.4088039 0.7157213 BENPORATH_PRC2_TARGETS oral cavity cancer DOID_8618 0.01557732 0.0527589 0.01557732 0.06331068 BENPORATH_PRC2_TARGETS leukocyte disease DOID_9500 0.01626767 0.05477105 0.09914835 0.26118247 BENPORATH_PRC2_TARGETS opiate dependence DOID_2559 0.01646045 0.05509409 0.01646045 0.0664255 BENPORATH_PRC2_TARGETS sleep disorder DOID_535 0.01646045 0.05477191 0.01646045 0.06595772 BENPORATH_PRC2_TARGETS polyarteritis nodosa DOID_9810 0.01646045 0.05445346 0.17969583 0.39630591 BENPORATH_PRC2_TARGETS lingual-facial-buccal dyskinesia DOID_9854 0.01646045 0.05413871 0.01646045 0.06549648 BENPORATH_PRC2_TARGETS Lewy body dementia DOID_12217 0.01785636 0.05839235 1.000 1.000 BENPORATH_PRC2_TARGETS cerebral degeneration DOID_1443 0.02076656 0.06752098 0.44343846 0.76925758 BENPORATH_PRC2_TARGETS cystitis DOID_1679 0.02233005 0.07219203 0.02233005 0.08702601 BENPORATH_PRC2_TARGETS papillary adenoma DOID_3172 0.02233005 0.07178416 0.20748282 0.43563737 BENPORATH_PRC2_TARGETS microcystic adenoma DOID_5403 0.02233005 0.07178416 0.20748282 0.43563737 BENPORATH_PRC2_TARGETS follicular adenoma DOID_6204 0.02233005 0.07178416 0.20748282 0.43563737 BENPORATH_PRC2_TARGETS ankylosing spondylitis DOID_7147 0.02233005 0.07138088 0.20748282 0.43244588 BENPORATH_PRC2_TARGETS teeth hard tissue disease DOID_214 0.02391355 0.07601571 0.02391355 0.09256334 BENPORATH_PRC2_TARGETS astrocytoma DOID_3069 0.02410683 0.07620438 0.46231357 0.79714067 BENPORATH_PRC2_TARGETS periodontitis DOID_824 0.0255417 0.08029409 0.2210224 0.45401352 BENPORATH_PRC2_TARGETS coronary stenosis DOID_4248 0.02721363 0.08507996 0.02721363 0.10254671 BENPORATH_PRC2_TARGETS autoimmune disease of the nervous system DOID_438 0.02721363 0.08461504 0.22770546 0.46273002 BENPORATH_PRC2_TARGETS renal tubular transport disease DOID_447 0.02721363 0.08415518 0.02721363 0.10187206 BENPORATH_PRC2_TARGETS polycystic ovary syndrome DOID_11612 0.02892845 0.08897454 0.02892845 0.10758359 BENPORATH_PRC2_TARGETS supratentorial cancer DOID_1659 0.02892845 0.08849618 0.23433136 0.47281753 BENPORATH_PRC2_TARGETS cerebrum cancer DOID_368 0.02892845 0.08849618 0.23433136 0.47281753 BENPORATH_PRC2_TARGETS bone resorption disease DOID_0080011 0.03060817 0.09313394 0.03060817 0.11236159 BENPORATH_PRC2_TARGETS osteoporosis DOID_11476 0.03060817 0.09313394 0.03060817 0.11236159 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS hypoglycemia DOID_9993 3.915E-07 2.228E-04 0.01446364 0.37408232 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS endocrine pancreas disease DOID_1428 1.04E-05 2.958E-03 0.04157652 0.36395443 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS nervous system cancer DOID_3093 2.698E-05 5.116E-03 2.698E-05 0.01534883 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS muscle cancer DOID_4045 9.639E-05 0.01371086 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS Lewy body dementia DOID_12217 1.051E-04 0.01196121 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS polycystic ovary syndrome DOID_11612 1.766E-04 0.01674798 0.01944731 0.35695228 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS autonomic nervous system neoplasm DOID_2621 2.256E-04 0.01834036 2.256E-04 0.06419127 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS neuroblastoma DOID_769 2.256E-04 0.01834036 2.256E-04 0.06419127 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS nephroblastoma DOID_2154 2.524E-04 0.01794888 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS aplastic anemia DOID_12449 2.663E-04 0.01683442 0.02378821 0.34706383 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS peripheral nervous system neoplasm DOID_1192 3.102E-04 0.01765206 3.102E-04 0.05884022 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS leukodystrophy DOID_10579 4.435E-04 0.02294317 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS thyroid adenoma DOID_2891 4.618E-04 0.02189908 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS bone marrow disease DOID_4961 4.618E-04 0.02021453 0.03118693 0.32264293 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS movement disease DOID_480 5.189E-04 0.02109059 5.189E-04 0.07381707 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS integumentary system cancer DOID_0060122 6.213E-04 0.02356732 0.03608952 0.33120865 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS skin cancer DOID_4159 6.213E-04 0.02356732 0.03608952 0.33120865 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS cerebral degeneration DOID_1443 8.529E-04 0.03033085 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS uterine disease DOID_345 8.529E-04 0.02854669 0.04218433 0.36368007 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS endocrine organ benign neoplasm DOID_0060089 9.293E-04 0.0293766 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS brain infarction DOID_3454 9.293E-04 0.02783047 0.04400556 0.37371888 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS diabetic retinopathy DOID_8947 1.064E-03 0.03026384 0.04703357 0.38785657 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS syndrome DOID_225 1.12E-03 0.03034658 0.0482422 0.39214019 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS metabolic syndrome X DOID_14221 1.237E-03 0.03198521 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS chromosomal disease DOID_0080014 1.267E-03 0.03133787 1.000 1.000 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS female reproductive system disease DOID_229 1.267E-03 0.03003213 0.05125735 0.39412748 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS retinal vascular disease DOID_2462 1.39E-03 0.03164553 0.05366288 0.39654776 CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS Human immunodeficiency virus infectious disease DOID_526 1.553E-03 0.03398227 0.05666157 0.41333887 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL gestational diabetes DOID_11714 3.48E-09 1.98E-06 8.893E-06 1.012E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL oral cavity cancer DOID_8618 1.242E-08 3.534E-06 3.608E-07 2.053E-04 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL invasive ductal carcinoma DOID_3008 2.357E-07 4.471E-05 8.19E-03 0.08629393 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL adenoid cystic carcinoma DOID_4866 1.518E-06 2.159E-04 1.518E-06 4.319E-04 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL mixed glioma DOID_5076 1.818E-06 2.069E-04 3.311E-05 2.093E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL salivary gland cancer DOID_8850 1.913E-06 1.814E-04 1.913E-06 3.628E-04 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL congenital hemolytic anemia DOID_589 4.05E-06 3.292E-04 4.05E-06 5.761E-04 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL neuroectodermal tumor DOID_171 1.113E-05 7.919E-04 1.113E-05 1.056E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL endocrine organ benign neoplasm DOID_0060089 1.853E-05 1.172E-03 3.137E-04 0.01189826 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL medullomyoblastoma DOID_3861 2.677E-05 1.523E-03 2.677E-05 2.176E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL adult medulloblastoma DOID_3864 2.677E-05 1.523E-03 2.677E-05 2.176E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL childhood medulloblastoma DOID_3869 2.677E-05 1.523E-03 2.677E-05 2.176E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL medulloblastoma DOID_3858 3.291E-05 1.702E-03 3.291E-05 2.341E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL peripheral nervous system neoplasm DOID_1192 3.634E-05 1.723E-03 8.618E-04 0.02580863 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL panic disorder DOID_594 4.011E-05 1.756E-03 4.011E-05 2.282E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL primitive neuroectodermal tumor DOID_168 5.753E-05 2.338E-03 5.753E-05 2.976E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL uterine cancer DOID_363 6.267E-05 2.377E-03 1.285E-03 0.02708072 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL lymphoma DOID_0060058 7.183E-05 2.555E-03 9.08E-04 0.02460179 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL carbohydrate metabolic disorder DOID_2978 7.555E-05 2.529E-03 9.446E-04 0.02442988 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL granulosa cell tumor DOID_2999 8.429E-05 2.665E-03 0.08278979 0.29814805 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL hemolytic anemia DOID_583 8.657E-05 2.592E-03 8.657E-05 4.105E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL normocytic anemia DOID_720 8.657E-05 2.592E-03 8.657E-05 4.105E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL sex cord-gonadal stromal tumor DOID_192 9.884E-05 2.812E-03 0.08695321 0.30730668 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL B-cell lymphocytic neoplasm DOID_707 1.084E-04 2.937E-03 1.921E-03 0.03642713 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL orofacial cleft DOID_0050567 1.165E-04 3.013E-03 1.165E-04 5.099E-03 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL bone marrow cancer DOID_4960 1.34E-04 3.314E-03 0.02774702 0.20241093 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL reproductive organ benign neoplasm DOID_0050622 1.434E-04 3.399E-03 2.358E-03 0.03945758 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL muscle cancer DOID_4045 1.52E-04 3.46E-03 0.09933106 0.33246689 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL pre-malignant neoplasm DOID_0060071 2.368E-04 5.182E-03 3.405E-03 0.05098913 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL in situ carcinoma DOID_8719 2.368E-04 5.182E-03 3.405E-03 0.05098913 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL papillary adenoma DOID_3172 2.477E-04 5.221E-03 2.477E-04 0.0100692 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL microcystic adenoma DOID_5403 2.477E-04 5.221E-03 2.477E-04 0.0100692 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL follicular adenoma DOID_6204 2.477E-04 5.221E-03 2.477E-04 0.0100692 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL male reproductive system disease DOID_48 3.675E-04 7.469E-03 0.04467955 0.26760701 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL endometrial cancer DOID_1380 4.952E-04 9.716E-03 0.01043733 0.10239376 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL autonomic nervous system neoplasm DOID_2621 5.398E-04 0.010238 0.01103718 0.10466922 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL neuroblastoma DOID_769 5.398E-04 0.010238 0.01103718 0.10466922 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL metabolic syndrome X DOID_14221 5.432E-04 9.97E-03 6.251E-03 0.07568084 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL papilloma DOID_2615 5.869E-04 0.0104359 5.869E-04 0.0208718 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL hair disease DOID_421 5.869E-04 0.01011966 0.0116519 0.10868737 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL chronic kidney failure DOID_784 6.222E-04 0.0104132 6.903E-03 0.07702131 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL male infertility DOID_12336 6.366E-04 0.0103488 0.15492417 0.43639532 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL adenoma DOID_657 7.438E-04 0.0117556 7.438E-04 0.02489421 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL embryonal cancer DOID_688 8.014E-04 0.01232424 0.16638568 0.45082597 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL multiple myeloma DOID_9538 8.014E-04 0.01199991 0.16638568 0.44868935 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL amino acid metabolic disorder DOID_9252 8.042E-04 0.01173307 8.042E-04 0.02542166 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL nervous system cancer DOID_3093 8.378E-04 0.01191782 8.578E-03 0.08873899 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL rectal neoplasm DOID_1984 8.991E-04 0.01247834 8.991E-04 0.0255806 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL rectum cancer DOID_1993 8.991E-04 0.01247834 8.991E-04 0.0255806 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL encephalomyelitis DOID_640 9.446E-04 0.01279661 9.446E-04 0.02336772 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL cervix uteri carcinoma in situ DOID_8991 1.06E-03 0.01402761 0.01708776 0.14298438 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL breast benign neoplasm DOID_0060082 1.096E-03 0.01416908 0.04879581 0.28045268 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL thoracic benign neoplasm DOID_0060097 1.096E-03 0.01416908 0.04879581 0.28045268 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL benign breast phyllodes tumor DOID_1631 1.096E-03 0.01416908 0.04879581 0.28045268 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL Huntington's disease DOID_12858 1.207E-03 0.01526188 1.207E-03 0.02861602 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL uveal disease DOID_3480 1.207E-03 0.0149301 1.207E-03 0.02747138 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL diabetic autonomic neuropathy DOID_11503 1.285E-03 0.01555701 1.285E-03 0.02812229 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL autonomic neuropathy DOID_11504 1.285E-03 0.01555701 1.285E-03 0.02812229 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL diabetic polyneuropathy DOID_12785 1.285E-03 0.01555701 1.285E-03 0.02812229 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL diabetic neuropathy DOID_9743 1.285E-03 0.01555701 1.285E-03 0.02812229 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL myeloma DOID_0070004 1.538E-03 0.01823051 0.20348606 0.51459363 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL autonomic nervous system disease DOID_11465 1.538E-03 0.01785846 1.538E-03 0.03125231 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL thyroid adenoma DOID_2891 1.538E-03 0.01750129 1.538E-03 0.03017465 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL peripheral neuropathy DOID_0060053 2.067E-03 0.02306051 2.067E-03 0.03793826 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL hemangioma DOID_255 2.067E-03 0.02261704 2.067E-03 0.03675269 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL giant cell tumor DOID_200 2.132E-03 0.02289095 2.132E-03 0.03676425 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL malignant giant cell tumor DOID_2705 2.132E-03 0.02289095 2.132E-03 0.03676425 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL giant cell glioblastoma DOID_3074 2.132E-03 0.02289095 2.132E-03 0.03676425 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL tongue cancer DOID_8649 2.355E-03 0.02481664 0.07018596 0.27927141 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL glioblastoma DOID_3068 2.723E-03 0.0281693 2.723E-03 0.04426605 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL male reproductive organ benign neoplasm DOID_0060087 2.985E-03 0.03032996 2.985E-03 0.04717993 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL dental caries DOID_216 2.985E-03 0.02979785 2.985E-03 0.0459048 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL conduct disorder DOID_12995 3.326E-03 0.03263199 0.08278979 0.30004708 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL tooth disease DOID_1091 4.02E-03 0.03876932 4.02E-03 0.05865102 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL astrocytoma DOID_3069 4.351E-03 0.04126233 4.351E-03 0.0618935 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL familial hypercholesterolemia DOID_13810 4.453E-03 0.04154147 4.453E-03 0.0618056 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL pancreatic ductal carcinoma DOID_3587 4.523E-03 0.0415054 4.523E-03 0.06126988 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL nephrosis DOID_2527 4.698E-03 0.04243223 4.698E-03 0.06216816 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL sinusitis DOID_0050127 4.863E-03 0.04323637 4.863E-03 0.06288926 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL paranasal sinus disease DOID_1352 4.863E-03 0.04323637 4.863E-03 0.06288926 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL pancreatic carcinoma DOID_4905 5.061E-03 0.04430748 5.061E-03 0.0639997 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL syndrome DOID_225 5.441E-03 0.04691099 0.04909958 0.2563088 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL pancreatitis DOID_4989 5.838E-03 0.04957852 5.838E-03 0.07221219 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL lipid metabolism disorder DOID_3146 6.251E-03 0.05230882 6.251E-03 0.07410416 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL female reproductive system disease DOID_229 6.464E-03 0.05330801 0.05483629 0.26001539 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL spinal muscular atrophy DOID_12377 6.667E-03 0.0541949 0.11557571 0.36534767 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL cleft lip DOID_9296 6.667E-03 0.05343159 6.667E-03 0.07742128 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL biliary tract cancer DOID_4607 6.903E-03 0.05455676 6.903E-03 0.07856173 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL teeth hard tissue disease DOID_214 7.159E-03 0.05579941 7.159E-03 0.07833379 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL spinal cord disease DOID_319 7.159E-03 0.05504536 1.000 1.000 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL hypotrichosis DOID_4535 7.159E-03 0.05431143 0.11959116 0.37184354 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL diffuse large B-cell lymphoma DOID_0050745 7.666E-03 0.05739644 0.12358847 0.38011805 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL perinatal necrotizing enterocolitis DOID_8677 7.666E-03 0.05665103 7.666E-03 0.08230432 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL transitional cell carcinoma DOID_2671 8.077E-03 0.05892253 0.06323918 0.27468012 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL Human immunodeficiency virus infectious disease DOID_526 8.578E-03 0.06178031 0.06571533 0.28327291 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL female reproductive organ benign neoplasm DOID_0060086 9.283E-03 0.06602409 0.13547248 0.39733938 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL uterine benign neoplasm DOID_0060095 9.283E-03 0.06602409 0.13547248 0.39733938 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL uterine fibroid DOID_13223 9.283E-03 0.06602409 0.13547248 0.39733938 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL endometrial carcinoma DOID_2871 9.283E-03 0.06520898 9.283E-03 0.09432013 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL mouth disease DOID_403 9.632E-03 0.06683553 9.632E-03 0.09614937 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL germinoma DOID_3304 0.01043733 0.07155227 1.000 1.000 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL ulcerative colitis DOID_8577 0.01075835 0.07287504 0.01075835 0.1037543 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL leiomyoma DOID_127 0.01103718 0.07388415 0.14719627 0.42300341 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL metal metabolism disorder DOID_896 0.0116519 0.07709221 0.0116519 0.10693435 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL nephroblastoma DOID_2154 0.01228135 0.08032282 0.15492417 0.43424559 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL spindle cell carcinoma DOID_4015 0.01228135 0.07941006 0.01228135 0.11092199 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL calcinosis DOID_182 0.0142566 0.09114612 0.16638568 0.45298303 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL cleft palate DOID_674 0.0142566 0.09013338 0.0142566 0.12675007 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL microcephaly DOID_10907 0.01494351 0.093438 0.01494351 0.1308132 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL uveitis DOID_13141 0.01494351 0.09242237 0.01494351 0.12883118 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL hepatitis DOID_2237 0.01564444 0.09571703 0.01564444 0.13286096 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL systemic scleroderma DOID_418 0.01564444 0.09469877 0.1739407 0.46465848 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL intracranial arterial disease DOID_13089 0.01635923 0.0979832 0.17769264 0.47026563 FARMER_BREAST_CANCER_APOCRINE_VS_BASAL cerebral arterial disease DOID_3527 0.01635923 0.0979832 0.17769264 0.47026563 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cystic fibrosis DOID_1485 1.791E-20 1.019E-17 2.65E-03 0.05799836 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pleural disease DOID_1532 3.408E-17 9.697E-15 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bacterial pneumonia DOID_874 1.029E-16 1.952E-14 0.03230617 0.23268619 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pleurisy DOID_10247 8.217E-16 1.169E-13 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP influenza DOID_8469 9.279E-16 1.056E-13 0.15234075 0.50396447 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bile duct disease DOID_4138 2.251E-15 2.135E-13 0.02799045 0.21235418 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP biliary tract disease DOID_9741 2.63E-15 2.138E-13 0.02869237 0.21481522 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP primary bacterial infectious disease DOID_0050338 1.881E-14 1.338E-12 0.03923103 0.24002641 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP intracranial arterial disease DOID_13089 3.117E-14 1.971E-12 1.607E-05 1.306E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cerebral arterial disease DOID_3527 3.117E-14 1.971E-12 1.607E-05 1.306E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cholestasis DOID_13580 4.897E-14 2.786E-12 0.21273468 0.62394864 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP middle cerebral artery infarction DOID_3525 5.43E-14 2.809E-12 2.776E-06 3.949E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cerebral infarction DOID_3526 9.134E-14 4.331E-12 2.499E-05 1.58E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pulmonary tuberculosis DOID_2957 1.98E-13 8.668E-12 0.01444442 0.139303 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypersensitivity reaction type I disease DOID_1205 1.944E-12 7.902E-11 2.451E-05 1.744E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP uterine disease DOID_345 2.53E-12 9.598E-11 4.301E-06 4.895E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP ulcerative colitis DOID_8577 2.652E-12 9.432E-11 5.327E-03 0.07216462 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP brain infarction DOID_3454 3.79E-12 1.269E-10 1.172E-04 6.064E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP tuberculosis DOID_399 3.79E-12 1.198E-10 0.02592739 0.19936063 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pancreatitis DOID_4989 1.149E-11 3.442E-10 2.848E-03 0.05786729 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP female reproductive system disease DOID_229 1.615E-11 4.594E-10 1.149E-05 1.089E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bone marrow cancer DOID_4960 2.651E-11 7.184E-10 0.01718907 0.15047048 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP leishmaniasis DOID_9065 4.348E-11 1.124E-09 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lymphoma DOID_0060058 5.059E-11 1.251E-09 1.052E-06 1.995E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hyperglycemia DOID_4195 1.295E-10 3.071E-09 0.0245882 0.19165321 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pulmonary emphysema DOID_9675 1.918E-10 4.365E-09 0.0104945 0.11708568 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP diabetic retinopathy DOID_8947 2.862E-10 6.262E-09 2.461E-03 0.05602322 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP retinal vascular disease DOID_2462 8.586E-10 1.809E-08 3.609E-03 0.06624037 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP sarcoidosis DOID_11335 1.121E-09 2.278E-08 0.17876724 0.56826011 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP parasitic protozoa infectious disease DOID_2789 1.445E-09 2.834E-08 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypersensitivity reaction type IV disease DOID_2916 2.078E-09 3.941E-08 0.1930936 0.58441626 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pneumoconiosis DOID_10316 3.538E-09 6.493E-08 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP esophageal disease DOID_6050 3.538E-09 6.29E-08 7.507E-03 0.09708308 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP parasitic infectious disease DOID_1398 4.524E-09 7.801E-08 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP multiple myeloma DOID_9538 5.791E-09 9.691E-08 8.732E-03 0.10140163 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP adult respiratory distress syndrome DOID_11394 9.118E-09 1.482E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mitochondrial myopathy DOID_699 9.583E-09 1.515E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP endometriosis of uterus DOID_288 1.211E-08 1.863E-07 5.378E-07 3.06E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP rheumatic disease DOID_1575 1.389E-08 2.08E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP endometriosis DOID_289 1.389E-08 2.026E-07 6.017E-07 1.712E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP scleroderma DOID_419 1.389E-08 2.08E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP proteinuria DOID_576 2.056E-08 2.924E-07 0.01289822 0.1384733 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP myeloma DOID_0070004 2.329E-08 3.233E-07 0.01340509 0.14124988 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP acute pancreatitis DOID_2913 2.474E-08 3.352E-07 0.08413609 0.36825718 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hemolytic anemia DOID_583 2.632E-08 3.483E-07 7.772E-04 0.02601303 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP normocytic anemia DOID_720 2.632E-08 3.483E-07 7.772E-04 0.02601303 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cutaneous leishmaniasis DOID_9111 2.991E-08 3.867E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cystitis DOID_1679 3.738E-08 4.727E-07 0.09055522 0.39034789 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP myositis DOID_633 3.738E-08 4.624E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP extrinsic allergic alveolitis DOID_841 4.538E-08 5.494E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mouth disease DOID_403 5.127E-08 6.078E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP periodontitis DOID_824 5.468E-08 6.349E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP sarcoma DOID_1115 6.543E-08 7.446E-07 1.599E-04 7.581E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hepatic vascular disease DOID_272 6.543E-08 7.3E-07 1.599E-04 6.998E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP common cold DOID_10459 7.011E-08 7.672E-07 0.0413016 0.24737485 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP encephalitis DOID_9588 7.011E-08 7.527E-07 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP collagen disease DOID_854 1.056E-07 1.112E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP respiratory failure DOID_11162 1.16E-07 1.2E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP viral pneumonia DOID_10533 1.41E-07 1.433E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bladder disease DOID_365 1.47E-07 1.467E-06 0.11578829 0.42505509 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mesenchymal cell neoplasm DOID_3350 1.918E-07 1.881E-06 1.245E-03 0.03727811 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP spindle cell sarcoma DOID_4235 1.918E-07 1.881E-06 1.245E-03 0.03727811 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP epithelioid sarcoma DOID_6193 1.918E-07 1.881E-06 1.245E-03 0.03727811 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP periodontal disease DOID_3388 1.962E-07 1.892E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP tongue cancer DOID_8649 2.55E-07 2.418E-06 1.419E-03 0.03845759 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Barrett's esophagus DOID_9206 2.55E-07 2.378E-06 1.419E-03 0.03670952 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP aneurysm disease DOID_2403 3.749E-07 3.441E-06 0.0315697 0.2332878 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP respiratory syncytial virus infectious disease DOID_1273 3.776E-07 3.41E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP systemic scleroderma DOID_418 3.776E-07 3.357E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP metabolic syndrome X DOID_14221 4.683E-07 4.099E-06 0.03379926 0.24039723 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP contact dermatitis DOID_2773 4.683E-07 4.037E-06 2.049E-04 8.326E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP chronic kidney failure DOID_784 5.799E-07 4.925E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP esophagitis DOID_11963 6.714E-07 5.618E-06 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP integumentary system benign neoplasm DOID_0060121 1.122E-06 9.25E-06 0.01444442 0.14419082 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP skin benign neoplasm DOID_3165 1.122E-06 9.25E-06 0.01444442 0.14419082 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP aortic aneurysm DOID_3627 1.235E-06 1.004E-05 0.01497676 0.14202962 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP B-cell lymphocytic neoplasm DOID_707 1.357E-06 1.088E-05 0.01551746 0.14014975 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Goodpasture syndrome DOID_9808 1.457E-06 1.151E-05 0.08090968 0.3596688 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP integumentary system cancer DOID_0060122 1.945E-06 1.516E-05 0.18452783 0.57375046 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP skin cancer DOID_4159 1.945E-06 1.516E-05 0.18452783 0.57375046 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pustulosis of palm and sole DOID_4398 1.945E-06 1.495E-05 0.01776257 0.15313487 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP portal hypertension DOID_10762 2.038E-06 1.546E-05 3.757E-03 0.06680162 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bronchiolitis DOID_2942 2.038E-06 1.526E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mitochondrial metabolism disease DOID_700 2.119E-06 1.566E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP oral cavity cancer DOID_8618 2.504E-06 1.826E-05 1.309E-03 0.03724883 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP carotid artery disease DOID_3407 3.182E-06 2.292E-05 1.504E-03 0.03721081 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP temporal lobe epilepsy DOID_3328 4.624E-06 3.289E-05 0.0245882 0.19431506 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP tooth disease DOID_1091 4.966E-06 3.489E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP allergic contact dermatitis DOID_3042 4.966E-06 3.446E-05 1.109E-04 6.312E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP childhood type dermatomyositis DOID_14203 4.975E-06 3.411E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP visceral leishmaniasis DOID_9146 4.975E-06 3.37E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP spastic cerebral palsy DOID_0050669 5.474E-06 3.664E-05 0.10954593 0.42402474 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP astrocytoma DOID_3069 5.709E-06 3.777E-05 0.22374435 0.64954355 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP allergic rhinitis DOID_4481 6.187E-06 4.046E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP male reproductive system disease DOID_48 6.536E-06 4.226E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP dermatomyositis DOID_10223 6.823E-06 4.362E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bronchiectasis DOID_9563 6.823E-06 4.314E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP papilloma DOID_2615 7.816E-06 4.887E-05 7.118E-03 0.09418603 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP myocarditis DOID_820 7.816E-06 4.834E-05 0.11889317 0.4336552 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bone resorption disease DOID_0080011 9.017E-06 5.517E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP osteoporosis DOID_11476 9.017E-06 5.517E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pulmonary sarcoidosis DOID_13406 1.199E-05 7.261E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP focal epilepsy DOID_2234 1.29E-05 7.729E-05 0.03608848 0.23334482 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hepatitis DOID_2237 1.461E-05 8.66E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP peptic ulcer DOID_750 1.461E-05 8.571E-05 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP transitional cell carcinoma DOID_2671 1.705E-05 9.899E-05 3.97E-03 0.06643136 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP amino acid metabolic disorder DOID_9252 1.799E-05 1.034E-04 0.04084002 0.24721248 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lung oat cell carcinoma DOID_5411 1.862E-05 1.06E-04 0.05135965 0.26566944 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hyperhomocysteinemia DOID_9279 1.862E-05 1.049E-04 0.05135965 0.26092534 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Human immunodeficiency virus infectious disease DOID_526 1.897E-05 1.058E-04 0.04165376 0.23466328 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP silicosis DOID_10325 2.286E-05 1.263E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hemolytic-uremic syndrome DOID_12554 2.286E-05 1.251E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP diabetic autonomic neuropathy DOID_11503 2.297E-05 1.245E-04 6.114E-04 0.02319119 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autonomic neuropathy DOID_11504 2.297E-05 1.245E-04 6.114E-04 0.02319119 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP diabetic polyneuropathy DOID_12785 2.297E-05 1.245E-04 6.114E-04 0.02319119 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP diabetic neuropathy DOID_9743 2.297E-05 1.245E-04 6.114E-04 0.02319119 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Crohn's disease DOID_8778 2.332E-05 1.252E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pre-eclampsia DOID_10591 2.942E-05 1.564E-04 0.01340509 0.1386817 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autonomic nervous system disease DOID_11465 2.942E-05 1.55E-04 7.333E-04 0.02607962 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP heart valve disease DOID_4079 2.942E-05 1.536E-04 0.16124204 0.51834305 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.439E-05 1.779E-04 0.01444442 0.14676566 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP calcium metabolism disease DOID_10575 3.71E-05 1.902E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP amnestic disorder DOID_10914 4.606E-05 2.34E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP brain edema DOID_4724 4.606E-05 2.319E-04 0.06789084 0.31925527 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP giant cell tumor DOID_200 4.616E-05 2.304E-04 0.17876724 0.56510311 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP malignant giant cell tumor DOID_2705 4.616E-05 2.304E-04 0.17876724 0.56510311 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP giant cell glioblastoma DOID_3074 4.616E-05 2.304E-04 0.17876724 0.56510311 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autoimmune hepatitis DOID_2048 5.36E-05 2.652E-04 0.07116261 0.33189773 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP placenta disease DOID_780 6.191E-05 3.037E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP glioblastoma DOID_3068 6.47E-05 3.146E-04 0.1930936 0.58132411 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP melancholia DOID_2848 6.897E-05 3.326E-04 0.19592896 0.58368366 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP leukocyte disease DOID_9500 6.897E-05 3.298E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP IgA glomerulonephritis DOID_2986 7.101E-05 3.367E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypoglycemia DOID_9993 7.101E-05 3.339E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP neurotic disorder DOID_4964 7.345E-05 3.426E-04 0.19875444 0.58901705 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP diabetic angiopathy DOID_11713 8.095E-05 3.745E-04 0.08090968 0.36830085 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP spastic quadriplegia DOID_10970 9.175E-05 4.21E-04 0.08413609 0.37111189 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mineral metabolism disease DOID_0050032 9.349E-05 4.256E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP endocrine pancreas disease DOID_1428 9.349E-05 4.222E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP urticaria DOID_1555 1.034E-04 4.635E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP osteosarcoma DOID_3347 1.034E-04 4.599E-04 3.757E-03 0.06477732 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP nephrosis DOID_2527 1.377E-04 6.074E-04 0.22919174 0.65863687 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP diffuse large B-cell lymphoma DOID_0050745 1.443E-04 6.315E-04 0.0969297 0.40257666 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP peripheral vascular disease DOID_341 1.451E-04 6.301E-04 0.23190119 0.66307426 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP renal hypertension DOID_1073 1.599E-04 6.892E-04 4.983E-03 0.07460712 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP secondary hypertension DOID_11130 1.599E-04 6.892E-04 4.983E-03 0.07460712 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP malaria DOID_12365 1.599E-04 6.84E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP endogenous depression DOID_1595 1.689E-04 7.171E-04 0.23997296 0.67932644 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bronchiolitis obliterans DOID_2799 2.132E-04 8.987E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP alcohol abuse DOID_1574 2.352E-04 9.841E-04 3.38E-03 0.06410782 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mental depression DOID_1596 2.352E-04 9.77E-04 0.25848117 0.71396014 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP biliary tract cancer DOID_4607 2.352E-04 9.699E-04 0.25848117 0.71051106 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP chronic leukemia DOID_1036 2.545E-04 1.042E-03 0.11578829 0.43344433 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP chronic lymphocytic leukemia DOID_1040 2.545E-04 1.042E-03 0.11578829 0.43344433 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP nephroblastoma DOID_2154 3.006E-04 1.222E-03 0.12198722 0.4393084 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP spindle cell carcinoma DOID_4015 3.006E-04 1.213E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lymphoblastic leukemia DOID_1037 3.6E-04 1.442E-03 0.04413133 0.2461836 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP leber hereditary optic neuropathy DOID_705 4.327E-04 1.722E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP congenital diaphragmatic hernia DOID_3827 4.384E-04 1.732E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP benign mesothelioma DOID_2645 5.032E-04 1.975E-03 0.14334572 0.49134768 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cervix uteri carcinoma in situ DOID_8991 5.032E-04 1.961E-03 0.0104945 0.1194274 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hyperparathyroidism DOID_13543 5.397E-04 2.089E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP retinal vascular occlusion DOID_1729 5.397E-04 2.075E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP transient cerebral ischemia DOID_224 5.397E-04 2.061E-03 0.03453751 0.23119815 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bilirubin metabolic disorder DOID_2741 5.397E-04 2.047E-03 0.03453751 0.2285098 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP acute kidney failure DOID_3021 5.397E-04 2.034E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 5.397E-04 2.02E-03 0.03453751 0.22588325 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 5.397E-04 2.02E-03 0.03453751 0.22588325 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Hodgkin's granuloma DOID_8651 5.397E-04 2.02E-03 0.03453751 0.22588325 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 5.397E-04 2.02E-03 0.03453751 0.22588325 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP nephrotic syndrome DOID_1184 5.738E-04 2.134E-03 0.14935287 0.5028508 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP gallbladder cancer DOID_3121 6.114E-04 2.259E-03 0.15234075 0.50989346 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP familial adenomatous polyposis DOID_0050424 6.581E-04 2.416E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP neuritis DOID_1803 7.333E-04 2.675E-03 0.16124204 0.52426697 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP thyroid adenoma DOID_2891 7.333E-04 2.658E-03 0.16124204 0.52128818 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP vascular skin disease DOID_9540 7.333E-04 2.641E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP otitis media DOID_10754 7.879E-04 2.819E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP diarrhea DOID_13250 7.879E-04 2.802E-03 0.0413016 0.24479803 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP middle ear disease DOID_5100 7.879E-04 2.819E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP stomach disease DOID_76 7.879E-04 2.784E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Hodgkin's lymphoma DOID_8567 7.879E-04 2.767E-03 0.0413016 0.23737991 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mitochondrial encephalomyopathy DOID_890 7.879E-04 2.75E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP glaucoma DOID_1686 8.227E-04 2.854E-03 0.01444442 0.14170477 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lung small cell carcinoma DOID_5409 8.227E-04 2.837E-03 0.16712463 0.53423547 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP withdrawal disorder DOID_0060001 9.186E-04 3.149E-03 0.01551746 0.14241023 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hemorrhagic disease DOID_2213 9.186E-04 3.13E-03 9.186E-04 0.02903849 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP berylliosis DOID_10322 9.29E-04 3.146E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP parathyroid gland disease DOID_11201 9.29E-04 3.128E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP psoriatic arthritis DOID_9008 9.29E-04 3.109E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP atopic dermatitis DOID_3310 9.691E-04 3.225E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bile duct adenocarcinoma DOID_4896 1.075E-03 3.557E-03 0.18165256 0.56791379 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cholangiocarcinoma DOID_4947 1.075E-03 3.557E-03 0.18165256 0.56791379 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Legionnaires' disease DOID_10457 1.081E-03 3.556E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP legionellosis DOID_10458 1.081E-03 3.556E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypercalcemia DOID_12678 1.081E-03 3.536E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP thoracic aortic aneurysm DOID_14004 1.245E-03 4.047E-03 0.05135965 0.2756947 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP renovascular hypertension DOID_1591 1.245E-03 4.024E-03 0.05135965 0.27311812 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP oral submucous fibrosis DOID_5773 1.245E-03 4.002E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP varicose veins DOID_799 1.245E-03 3.979E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP intermediate coronary syndrome DOID_8805 1.245E-03 3.957E-03 0.05135965 0.26327602 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bile duct cancer DOID_4606 1.309E-03 4.139E-03 0.1930936 0.57826451 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bile duct carcinoma DOID_4897 1.309E-03 4.139E-03 0.1930936 0.57826451 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP thyroiditis DOID_7166 1.419E-03 4.462E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autoimmune thyroiditis DOID_7188 1.419E-03 4.462E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP vein disease DOID_866 1.419E-03 4.437E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bronchitis DOID_6132 1.605E-03 4.99E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pre-malignant neoplasm DOID_0060071 1.644E-03 5.083E-03 0.02263484 0.18139752 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP in situ carcinoma DOID_8719 1.644E-03 5.083E-03 0.02263484 0.18139752 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP dissociative disorder DOID_10935 2.009E-03 6.178E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP dissociative amnesia DOID_11037 2.009E-03 6.178E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP granulosa cell tumor DOID_2999 2.009E-03 6.145E-03 0.06460764 0.31420295 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP endocrine organ benign neoplasm DOID_0060089 2.027E-03 6.167E-03 0.22100634 0.64488518 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP blood coagulation disease DOID_1247 2.194E-03 6.642E-03 2.194E-03 0.05202624 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pulmonary edema DOID_11396 2.227E-03 6.704E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP sex cord-gonadal stromal tumor DOID_192 2.227E-03 6.669E-03 0.06789084 0.32191573 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Kawasaki disease DOID_13378 2.456E-03 7.315E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lymphadenitis DOID_1602 2.456E-03 7.315E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP coronary restenosis DOID_4247 2.456E-03 7.277E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lymph node disease DOID_9942 2.456E-03 7.315E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP syndrome DOID_225 2.65E-03 7.813E-03 0.23997296 0.67596344 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP gastric ulcer DOID_10808 2.695E-03 7.904E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP neutropenia DOID_1227 2.695E-03 7.863E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP thrombophilia DOID_2452 2.695E-03 7.823E-03 2.695E-03 0.05679173 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP acquired immunodeficiency syndrome DOID_635 2.695E-03 7.784E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mixed glioma DOID_5076 2.848E-03 8.183E-03 0.03230617 0.23566934 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP sinusitis DOID_0050127 2.945E-03 8.42E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP agranulocytosis DOID_12987 2.945E-03 8.378E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP paranasal sinus disease DOID_1352 2.945E-03 8.42E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP optic nerve disease DOID_1891 2.945E-03 8.336E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP myasthenia gravis DOID_437 2.945E-03 8.295E-03 0.07767199 0.35931187 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP uremia DOID_4676 2.945E-03 8.254E-03 0.07767199 0.35641419 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP urinary tract obstruction DOID_5200 2.945E-03 8.214E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP polyarteritis nodosa DOID_9810 2.945E-03 8.173E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lingual-facial-buccal dyskinesia DOID_9854 2.945E-03 8.134E-03 2.945E-03 0.05777809 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lipid metabolism disorder DOID_3146 3.054E-03 8.394E-03 0.03379926 0.23742936 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP meningitis DOID_9471 3.205E-03 8.768E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP auditory system disease DOID_2742 3.269E-03 8.9E-03 0.25586479 0.71018081 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypogonadism DOID_1924 3.757E-03 0.01017929 0.08735126 0.37941118 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP neuromuscular junction disease DOID_439 4.048E-03 0.01091649 0.09055522 0.38452181 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP ankylosing spondylitis DOID_7147 4.048E-03 0.010865 4.048E-03 0.06581085 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP nervous system cancer DOID_3093 4.222E-03 0.01127776 0.27654198 0.75650187 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP myopia DOID_11830 4.35E-03 0.01156489 4.35E-03 0.06874686 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP spinal cord disease DOID_319 4.35E-03 0.0115111 0.09374803 0.3922252 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP fragments of torsion dystonia DOID_531 4.35E-03 0.01145781 4.35E-03 0.06688883 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP encephalomyelitis DOID_640 4.618E-03 0.01210869 0.28414804 0.77358963 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Sciatic Neuropathy DOID_11446 4.661E-03 0.01216574 0.0969297 0.39965943 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP gestational diabetes DOID_11714 4.661E-03 0.01211019 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lesion of sciatic nerve DOID_12528 4.661E-03 0.01216574 0.0969297 0.39965943 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lung adenocarcinoma DOID_3910 4.661E-03 0.01205514 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP perinatal necrotizing enterocolitis DOID_8677 4.661E-03 0.01200059 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mononeuritis of lower limb DOID_9473 4.661E-03 0.01216574 0.0969297 0.39965943 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP dilated cardiomyopathy DOID_12930 4.894E-03 0.01254387 0.28917459 0.77981206 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mononeuritis DOID_1802 4.983E-03 0.01271332 0.1001003 0.40976308 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP coronary stenosis DOID_4248 4.983E-03 0.01265657 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autoimmune disease of the nervous system DOID_438 4.983E-03 0.01260031 0.1001003 0.4068362 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP central nervous system hereditary degenerative disease DOID_481 4.983E-03 0.01254456 4.983E-03 0.07269412 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autoimmune disease of endocrine system DOID_0060005 5.314E-03 0.01332011 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP mononeuropathy DOID_1188 5.314E-03 0.01326168 0.10325984 0.41376654 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP toxic encephalopathy DOID_3602 5.314E-03 0.01320377 5.314E-03 0.0755916 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP dystonic disease DOID_544 5.314E-03 0.01314636 5.314E-03 0.0737479 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cranial nerve disease DOID_5656 5.314E-03 0.01308945 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP gonadal disease DOID_2277 6.006E-03 0.01473124 0.10954593 0.42115971 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP abdominal aortic aneurysm DOID_7693 6.006E-03 0.01466801 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP celiac disease DOID_10608 6.367E-03 0.01548271 0.11267256 0.42740458 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP leiomyoma DOID_127 6.738E-03 0.01631384 0.11578829 0.43061136 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP metal metabolism disorder DOID_896 7.118E-03 0.01716101 0.11889317 0.43089306 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP thyroid carcinoma DOID_3963 7.507E-03 0.01802386 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP leukopenia DOID_615 7.507E-03 0.01794813 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP medullomyoblastoma DOID_3861 7.906E-03 0.01882293 7.906E-03 0.09997068 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP adult medulloblastoma DOID_3864 7.906E-03 0.01882293 7.906E-03 0.09997068 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP childhood medulloblastoma DOID_3869 7.906E-03 0.01882293 7.906E-03 0.09997068 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP thyroid cancer DOID_1781 8.315E-03 0.01971265 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP refractive error DOID_9835 8.315E-03 0.01963085 8.315E-03 0.1028486 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP calcinosis DOID_182 8.732E-03 0.02053173 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP medulloblastoma DOID_3858 8.732E-03 0.02044724 8.732E-03 0.10571659 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP cleft palate DOID_674 8.732E-03 0.02036344 8.732E-03 0.10351416 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP peripheral nervous system neoplasm DOID_1192 9.159E-03 0.02127173 0.13425596 0.46866038 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP uveitis DOID_13141 9.159E-03 0.02118526 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lymphatic system disease DOID_75 0.01004035 0.02312939 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP autoimmune disease of urogenital tract DOID_0060049 0.0109576 0.02514063 0.14635454 0.49865709 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP primary biliary cirrhosis DOID_12236 0.0109576 0.02514063 0.14635454 0.49865709 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP primitive neuroectodermal tumor DOID_168 0.01142959 0.02611823 0.01142959 0.12506613 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP uveal disease DOID_3480 0.01142959 0.02601375 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP learning disability DOID_8927 0.01239997 0.02810988 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP brain cancer DOID_1319 0.01340509 0.03026783 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP central nervous system cancer DOID_3620 0.01392051 0.03130739 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP movement disease DOID_480 0.01497676 0.0335503 0.01497676 0.13970126 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP orofacial cleft DOID_0050567 0.01606645 0.03585024 0.01606645 0.1428408 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP atrophic muscular disease DOID_913 0.01662368 0.03694872 0.17876724 0.56198099 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP muscular dystrophy DOID_9884 0.01662368 0.03694872 0.17876724 0.56198099 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP vasculitis DOID_865 0.01718907 0.03805674 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP smallpox DOID_8736 0.01776257 0.03917404 0.01776257 0.15084927 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP familial hyperlipidemia DOID_1168 0.01834411 0.04030038 0.01834411 0.15349702 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypertrophic cardiomyopathy DOID_11984 0.01953106 0.04274298 0.1930936 0.58754148 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP neuroectodermal tumor DOID_171 0.02137025 0.04658879 0.02137025 0.17622716 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypothyroidism DOID_1459 0.02199874 0.04777589 0.02199874 0.17881834 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP congenital heart defect DOID_1682 0.02263484 0.04897043 0.20717188 0.61078133 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pancreatic ductal carcinoma DOID_3587 0.0272956 0.0588303 0.22647281 0.65412704 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pancreatic carcinoma DOID_4905 0.02940131 0.0631296 0.23460119 0.66744039 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP interstitial nephritis DOID_1063 0.03453751 0.07387911 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP T cell deficiency DOID_11200 0.03453751 0.07360241 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP facioscapulohumeral muscular dystrophy DOID_11727 0.03453751 0.07332777 0.03453751 0.23965662 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP gout DOID_13189 0.03453751 0.07305518 0.03453751 0.23676919 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP familial combined hyperlipidemia DOID_13809 0.03453751 0.0727846 0.03453751 0.23395051 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hypolipoproteinemia DOID_1387 0.03453751 0.07251603 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP chondrosarcoma DOID_3371 0.03453751 0.07224942 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP alopecia areata DOID_986 0.03453751 0.07198477 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP chromosomal disease DOID_0080014 0.03455578 0.07175999 0.25323924 0.70633887 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bone development disease DOID_0080006 0.03686455 0.07627611 0.03686455 0.23568462 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.03792545 0.0781869 0.03792545 0.23977315 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP breast benign neoplasm DOID_0060082 0.03792545 0.07790463 0.03792545 0.23713828 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP thoracic benign neoplasm DOID_0060097 0.03792545 0.07790463 0.03792545 0.23713828 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP adrenoleukodystrophy DOID_10588 0.03792545 0.0776244 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP sickle cell anemia DOID_10923 0.03792545 0.07734618 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pneumocystosis DOID_11339 0.03792545 0.07706994 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP prediabetes syndrome DOID_11716 0.03792545 0.07679567 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP migraine without aura DOID_12783 0.03792545 0.07652335 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP temporal arteritis DOID_13375 0.03792545 0.07625295 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP neuronal ceroid lipofuscinosis DOID_14503 0.03792545 0.07598445 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP benign breast phyllodes tumor DOID_1631 0.03792545 0.07790463 0.03792545 0.23713828 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP craniosynostosis DOID_2340 0.03792545 0.07571784 0.03792545 0.23456069 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hemochromatosis DOID_2352 0.03792545 0.07545309 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP invasive lobular carcinoma DOID_3457 0.03792545 0.07519019 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP central nervous system vasculitis DOID_525 0.03792545 0.07625295 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP eosinophilic pneumonia DOID_5870 0.03792545 0.07492911 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP pulmonary eosinophilia DOID_9498 0.03792545 0.07492911 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP Loeffler syndrome DOID_9503 0.03792545 0.07492911 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP intracranial arteriosclerosis DOID_13097 0.0413016 0.08131699 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP porphyria DOID_13268 0.0413016 0.08103659 0.0413016 0.24227434 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP aortic valve stenosis DOID_1712 0.0413016 0.08075811 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP retinal detachment DOID_5327 0.0413016 0.08048154 0.0413016 0.23980215 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP lipodystrophy DOID_811 0.0413016 0.08020686 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP peritonitis DOID_8283 0.0413016 0.07993405 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP vascular dementia DOID_8725 0.0413016 0.08131699 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP ocular hypertension DOID_9282 0.0413016 0.07966309 0.0413016 0.23500611 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP borderline glaucoma DOID_9283 0.0413016 0.07966309 0.0413016 0.23500611 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP carbohydrate metabolic disorder DOID_2978 0.04413133 0.08483354 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP essential hypertension DOID_10825 0.04466599 0.08557221 0.04466599 0.24674705 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hepatic coma DOID_12550 0.04466599 0.08528506 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP newborn respiratory distress syndrome DOID_12716 0.04466599 0.08499982 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP hepatic encephalopathy DOID_13413 0.04466599 0.08528506 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP polyneuropathy DOID_1389 0.04466599 0.08471649 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP larynx cancer DOID_2596 0.04466599 0.08443504 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP laryngeal benign neoplasm DOID_2598 0.04466599 0.08443504 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP intracranial thrombosis DOID_4193 0.04466599 0.08415545 0.04466599 0.24437449 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.04496913 0.08444698 0.28666571 0.77672757 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP open-angle glaucoma DOID_1067 0.04801866 0.08987702 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP tethered spinal cord syndrome DOID_1089 0.04801866 0.08958234 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP polycystic kidney disease DOID_898 0.04801866 0.08928959 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bacterial meningitis DOID_9470 0.04801866 0.08899875 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP idiopathic pulmonary fibrosis DOID_0050156 0.05135965 0.09488194 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP peripheral neuropathy DOID_0060053 0.05135965 0.09457488 0.05135965 0.27832037 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP skeletal system cancer DOID_0060124 0.05135965 0.0942698 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP congenital ichthyosiform erythroderma DOID_1699 0.05135965 0.09396668 0.05135965 0.27058925 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP bone cancer DOID_184 0.05135965 0.0942698 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP corneal dystrophy DOID_2566 0.05135965 0.09366551 0.05135965 0.26810678 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP angiosarcoma DOID_0001816 0.054689 0.09941866 0.054689 0.27538089 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP spastic diplegia DOID_10965 0.054689 0.09910204 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP long QT syndrome DOID_2843 0.054689 0.09878743 0.054689 0.27296527 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP restrictive cardiomyopathy DOID_397 0.054689 0.09847481 1.000 1.000 BROWNE_HCMV_INFECTION_8HR_UP middle cerebral artery infarction DOID_3525 1.466E-07 8.344E-05 1.458E-05 8.299E-03 BROWNE_HCMV_INFECTION_8HR_UP intracranial arterial disease DOID_13089 8.673E-07 2.467E-04 5.396E-05 0.01023384 BROWNE_HCMV_INFECTION_8HR_UP cerebral arterial disease DOID_3527 8.673E-07 2.467E-04 5.396E-05 0.01023384 BROWNE_HCMV_INFECTION_8HR_UP cerebral infarction DOID_3526 1.359E-06 2.577E-04 7.517E-05 8.554E-03 BROWNE_HCMV_INFECTION_8HR_UP aortic aneurysm DOID_3627 2.032E-06 2.89E-04 1.012E-04 9.597E-03 BROWNE_HCMV_INFECTION_8HR_UP oral cavity cancer DOID_8618 3.585E-06 4.079E-04 1.54E-04 9.735E-03 BROWNE_HCMV_INFECTION_8HR_UP brain infarction DOID_3454 6.591E-06 6.25E-04 2.416E-04 0.0124978 BROWNE_HCMV_INFECTION_8HR_UP aneurysm disease DOID_2403 1.009E-05 8.201E-04 3.311E-04 0.01449147 BROWNE_HCMV_INFECTION_8HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.183E-05 1.553E-03 5.861E-04 0.02223334 BROWNE_HCMV_INFECTION_8HR_UP embryonal cancer DOID_688 4.335E-05 2.741E-03 4.335E-05 0.01233406 BROWNE_HCMV_INFECTION_8HR_UP adult respiratory distress syndrome DOID_11394 5.396E-05 3.07E-03 2.423E-03 0.08109108 BROWNE_HCMV_INFECTION_8HR_UP cervix uteri carcinoma in situ DOID_8991 5.784E-05 2.992E-03 5.784E-05 8.227E-03 BROWNE_HCMV_INFECTION_8HR_UP withdrawal disorder DOID_0060001 1.07E-04 5.075E-03 1.07E-04 8.699E-03 BROWNE_HCMV_INFECTION_8HR_UP bone marrow cancer DOID_4960 1.258E-04 5.506E-03 4.218E-03 0.10433822 BROWNE_HCMV_INFECTION_8HR_UP breast benign neoplasm DOID_0060082 1.528E-04 6.21E-03 1.528E-04 0.01086737 BROWNE_HCMV_INFECTION_8HR_UP thoracic benign neoplasm DOID_0060097 1.528E-04 6.21E-03 1.528E-04 0.01086737 BROWNE_HCMV_INFECTION_8HR_UP benign breast phyllodes tumor DOID_1631 1.528E-04 6.21E-03 1.528E-04 0.01086737 BROWNE_HCMV_INFECTION_8HR_UP leukocyte disease DOID_9500 1.616E-04 6.131E-03 4.97E-03 0.11311935 BROWNE_HCMV_INFECTION_8HR_UP carotid artery disease DOID_3407 1.776E-04 6.316E-03 5.287E-03 0.11570756 BROWNE_HCMV_INFECTION_8HR_UP respiratory failure DOID_11162 1.86E-04 6.225E-03 5.449E-03 0.11483488 BROWNE_HCMV_INFECTION_8HR_UP pre-malignant neoplasm DOID_0060071 1.946E-04 6.152E-03 1.946E-04 0.01107312 BROWNE_HCMV_INFECTION_8HR_UP in situ carcinoma DOID_8719 1.946E-04 6.152E-03 1.946E-04 0.01107312 BROWNE_HCMV_INFECTION_8HR_UP thoracic aortic aneurysm DOID_14004 2.904E-04 8.698E-03 2.904E-04 0.01377105 BROWNE_HCMV_INFECTION_8HR_UP tongue cancer DOID_8649 3.316E-04 9.433E-03 0.02667653 0.23717105 BROWNE_HCMV_INFECTION_8HR_UP metabolic syndrome X DOID_14221 3.694E-04 0.0100103 8.542E-03 0.15188204 BROWNE_HCMV_INFECTION_8HR_UP contact dermatitis DOID_2773 3.694E-04 9.555E-03 8.542E-03 0.14727956 BROWNE_HCMV_INFECTION_8HR_UP nervous system cancer DOID_3093 5.176E-04 0.0128057 0.01065085 0.16379273 BROWNE_HCMV_INFECTION_8HR_UP amyloidosis DOID_9120 5.227E-04 0.01239186 5.227E-04 0.02124319 BROWNE_HCMV_INFECTION_8HR_UP uremia DOID_4676 6.937E-04 0.01578907 0.03812606 0.26455769 BROWNE_HCMV_INFECTION_8HR_UP extrinsic allergic alveolitis DOID_841 1.031E-03 0.02255963 0.04622303 0.2890209 BROWNE_HCMV_INFECTION_8HR_UP pleurisy DOID_10247 1.184E-03 0.02494562 0.04944299 0.30579415 BROWNE_HCMV_INFECTION_8HR_UP abdominal aortic aneurysm DOID_7693 1.432E-03 0.02910236 0.05425288 0.29122539 BROWNE_HCMV_INFECTION_8HR_UP chronic leukemia DOID_1036 1.61E-03 0.03159564 1.61E-03 0.0572671 BROWNE_HCMV_INFECTION_8HR_UP chronic lymphocytic leukemia DOID_1040 1.61E-03 0.03159564 1.61E-03 0.0572671 BROWNE_HCMV_INFECTION_8HR_UP pleural disease DOID_1532 1.61E-03 0.03054246 0.05744616 0.29715333 BROWNE_HCMV_INFECTION_8HR_UP papilloma DOID_2615 1.703E-03 0.03126188 0.05903882 0.29728396 BROWNE_HCMV_INFECTION_8HR_UP multiple myeloma DOID_9538 2.1E-03 0.03733307 0.06538299 0.3024628 BROWNE_HCMV_INFECTION_8HR_UP uveitis DOID_13141 2.205E-03 0.03801695 0.06696245 0.30239391 BROWNE_HCMV_INFECTION_8HR_UP respiratory syncytial virus infectious disease DOID_1273 2.313E-03 0.0387017 0.06853927 0.30467849 BROWNE_HCMV_INFECTION_8HR_UP congenital diaphragmatic hernia DOID_3827 2.313E-03 0.03759594 0.06853927 0.30231664 BROWNE_HCMV_INFECTION_8HR_UP adenoid cystic carcinoma DOID_4866 2.423E-03 0.03829301 2.423E-03 0.07658602 BROWNE_HCMV_INFECTION_8HR_UP salivary gland cancer DOID_8850 2.65E-03 0.04075912 2.65E-03 0.07937302 BROWNE_HCMV_INFECTION_8HR_UP uveal disease DOID_3480 2.768E-03 0.04144543 0.07482039 0.30627915 BROWNE_HCMV_INFECTION_8HR_UP learning disability DOID_8927 3.01E-03 0.0439159 3.01E-03 0.08563601 BROWNE_HCMV_INFECTION_8HR_UP proteinuria DOID_576 3.135E-03 0.04459164 3.135E-03 0.08493645 BROWNE_HCMV_INFECTION_8HR_UP myeloma DOID_0070004 3.262E-03 0.04526757 0.08105981 0.32481007 BROWNE_HCMV_INFECTION_8HR_UP integumentary system benign neoplasm DOID_0060121 3.523E-03 0.04772951 0.08416396 0.33489017 BROWNE_HCMV_INFECTION_8HR_UP skin benign neoplasm DOID_3165 3.523E-03 0.04772951 0.08416396 0.33489017 BROWNE_HCMV_INFECTION_8HR_UP lung small cell carcinoma DOID_5409 3.523E-03 0.04661952 3.523E-03 0.09111998 BROWNE_HCMV_INFECTION_8HR_UP sarcoidosis DOID_11335 4.074E-03 0.05268381 0.09034134 0.34499479 BROWNE_HCMV_INFECTION_8HR_UP integumentary system cancer DOID_0060122 4.363E-03 0.05517318 0.09341463 0.3496903 BROWNE_HCMV_INFECTION_8HR_UP skin cancer DOID_4159 4.363E-03 0.05517318 0.09341463 0.3496903 BROWNE_HCMV_INFECTION_8HR_UP familial hyperlipidemia DOID_1168 4.512E-03 0.05580706 4.512E-03 0.10696354 BROWNE_HCMV_INFECTION_8HR_UP hypersensitivity reaction type IV disease DOID_2916 4.815E-03 0.05829202 0.09800541 0.3551916 BROWNE_HCMV_INFECTION_8HR_UP mineral metabolism disease DOID_0050032 5.78E-03 0.06851431 5.78E-03 0.1174531 BROWNE_HCMV_INFECTION_8HR_UP cholestasis DOID_13580 5.948E-03 0.06907506 0.10862843 0.37234685 BROWNE_HCMV_INFECTION_8HR_UP hyperglycemia DOID_4195 6.119E-03 0.06963884 0.11013592 0.37301986 BROWNE_HCMV_INFECTION_8HR_UP allergic contact dermatitis DOID_3042 6.293E-03 0.07020539 6.293E-03 0.12346466 BROWNE_HCMV_INFECTION_8HR_UP nephrosis DOID_2527 7.007E-03 0.07667701 0.11763578 0.38915558 BROWNE_HCMV_INFECTION_8HR_UP bile duct disease DOID_4138 7.007E-03 0.07523028 0.11763578 0.38690613 BROWNE_HCMV_INFECTION_8HR_UP biliary tract disease DOID_9741 7.192E-03 0.07577805 0.11912827 0.38956314 BROWNE_HCMV_INFECTION_8HR_UP diabetic retinopathy DOID_8947 7.378E-03 0.07632849 0.12061828 0.3899534 BROWNE_HCMV_INFECTION_8HR_UP syndrome DOID_225 7.757E-03 0.0788193 7.757E-03 0.14712936 BROWNE_HCMV_INFECTION_8HR_UP mixed glioma DOID_5076 8.145E-03 0.08130898 8.145E-03 0.14950361 BROWNE_HCMV_INFECTION_8HR_UP bacterial pneumonia DOID_874 8.145E-03 0.0799071 0.12655352 0.40454469 BROWNE_HCMV_INFECTION_8HR_UP lipid metabolism disorder DOID_3146 8.542E-03 0.0823767 8.542E-03 0.1429478 BROWNE_HCMV_INFECTION_8HR_UP chronic kidney failure DOID_784 9.152E-03 0.08679541 0.13391715 0.41638721 BROWNE_HCMV_INFECTION_8HR_UP retinal vascular disease DOID_2462 9.57E-03 0.08926876 0.13684546 0.42089226 BROWNE_HCMV_INFECTION_8HR_UP transitional cell carcinoma DOID_2671 0.01021233 0.09372287 0.01021233 0.16602337 BROWNE_HCMV_INFECTION_8HR_UP primary immunodeficiency disease DOID_612 0.01043056 0.09420615 0.01043056 0.16486077 BROWNE_HCMV_INFECTION_8HR_UP amino acid metabolic disorder DOID_9252 0.01043056 0.09273418 1.000 1.000 BROWNE_HCMV_INFECTION_8HR_UP lymphoblastic leukemia DOID_1037 0.01132401 0.09912866 0.01132401 0.16956218 BROWNE_HCMV_INFECTION_8HR_UP Crohn's disease DOID_8778 0.01155248 0.09959636 0.14990271 0.45369489 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE oral cavity cancer DOID_8618 1.999E-07 1.137E-04 1.999E-07 1.137E-04 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE toxic shock syndrome DOID_14115 2.248E-07 6.395E-05 1.278E-03 0.03828158 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE commensal bacterial infectious disease DOID_0050339 2.652E-07 5.031E-05 1.383E-03 0.03934428 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE pancreatic ductal carcinoma DOID_3587 4.948E-07 7.038E-05 5.059E-04 0.02878772 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE pancreatic carcinoma DOID_4905 6.055E-07 6.891E-05 5.693E-04 0.02699257 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE giant cell tumor DOID_200 6.21E-06 5.889E-04 0.11164368 0.49244381 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE malignant giant cell tumor DOID_2705 6.21E-06 5.889E-04 0.11164368 0.49244381 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE giant cell glioblastoma DOID_3074 6.21E-06 5.889E-04 0.11164368 0.49244381 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE glioblastoma DOID_3068 8.753E-06 7.115E-04 0.12099151 0.5025122 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE uterine disease DOID_345 1.351E-05 9.607E-04 4.108E-04 0.02596995 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE astrocytoma DOID_3069 1.696E-05 1.072E-03 0.1412162 0.54661238 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE nephrosis DOID_2527 1.89E-05 1.076E-03 1.89E-05 5.378E-03 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE aneurysm disease DOID_2403 2.449E-05 1.267E-03 0.01219707 0.17350327 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE female reproductive system disease DOID_229 2.976E-05 1.411E-03 7.362E-04 0.02992002 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE supratentorial cancer DOID_1659 3.897E-05 1.706E-03 0.06341167 0.38797031 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE cerebrum cancer DOID_368 3.897E-05 1.706E-03 0.06341167 0.38797031 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE amino acid metabolic disorder DOID_9252 4.273E-05 1.737E-03 4.273E-05 8.104E-03 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE nervous system cancer DOID_3093 4.46E-05 1.692E-03 0.01628218 0.20587915 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE abdominal aortic aneurysm DOID_7693 4.716E-05 1.677E-03 0.06736356 0.39926946 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE peptic ulcer DOID_750 9.788E-05 3.276E-03 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE adenoid cystic carcinoma DOID_4866 1.051E-04 3.321E-03 1.051E-04 0.01494549 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE endometriosis of uterus DOID_288 1.204E-04 3.607E-03 1.204E-04 0.01370605 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE salivary gland cancer DOID_8850 1.204E-04 3.427E-03 1.204E-04 0.01142171 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE endometriosis DOID_289 1.286E-04 3.486E-03 1.286E-04 0.01045716 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE learning disability DOID_8927 1.461E-04 3.78E-03 4.658E-03 0.09138894 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE brain cancer DOID_1319 1.651E-04 4.084E-03 0.10029662 0.47557313 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE central nervous system cancer DOID_3620 1.752E-04 4.153E-03 0.10219768 0.4766433 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE acute kidney failure DOID_3021 1.957E-04 4.455E-03 0.02090525 0.24781435 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE aortic aneurysm DOID_3627 1.964E-04 4.299E-03 0.10598792 0.47485928 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE migraine without aura DOID_12783 2.389E-04 5.034E-03 2.389E-04 0.01699108 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE newborn respiratory distress syndrome DOID_12716 3.379E-04 6.866E-03 0.02709225 0.29085827 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE neuroectodermal tumor DOID_171 3.436E-04 6.741E-03 0.12655352 0.5107018 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE carotid artery disease DOID_3407 3.436E-04 6.516E-03 8.145E-03 0.13631212 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE pre-malignant neoplasm DOID_0060071 3.762E-04 6.905E-03 8.643E-03 0.14050808 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE in situ carcinoma DOID_8719 3.762E-04 6.905E-03 8.643E-03 0.14050808 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE mineral metabolism disease DOID_0050032 3.932E-04 6.992E-03 8.897E-03 0.13681661 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE varicose veins DOID_799 4.536E-04 7.821E-03 0.03119544 0.27308012 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE tongue cancer DOID_8649 5.177E-04 8.663E-03 5.177E-04 0.02677696 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE vein disease DOID_866 5.177E-04 8.416E-03 0.03324063 0.27814587 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE cystic fibrosis DOID_1485 6.142E-04 9.707E-03 0.15205345 0.57296962 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE mixed glioma DOID_5076 6.613E-04 0.01016943 0.01249286 0.16924845 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE metabolic syndrome X DOID_14221 7.106E-04 0.01064084 7.106E-04 0.03110401 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE alcohol abuse DOID_1574 7.89E-04 0.0115109 7.89E-04 0.02992834 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE subependymal glioma DOID_4843 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE pilocytic astrocytoma DOID_4851 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE subependymal giant cell astrocytoma DOID_5077 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE fibrillary astrocytoma DOID_6726 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE juvenile pilocytic astrocytoma DOID_6811 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE childhood pilocytic astrocytoma DOID_6812 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE gemistocytic astrocytoma DOID_7005 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE childhood cerebral astrocytoma DOID_7007 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE protoplasmic astrocytoma DOID_7008 8.151E-04 0.01159545 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE retinal vascular disease DOID_2462 8.441E-04 0.01171481 0.01465014 0.18945289 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE primary bacterial infectious disease DOID_0050338 9.017E-04 0.01221546 9.017E-04 0.03206559 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE benign glioma DOID_0060101 9.883E-04 0.01307821 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE benign ependymoma DOID_4844 9.883E-04 0.01307821 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE lingual-facial-buccal dyskinesia DOID_9854 1.081E-03 0.01397908 1.081E-03 0.03618114 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE encephalomyelitis DOID_640 1.089E-03 0.01377037 1.089E-03 0.03442592 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE portal hypertension DOID_10762 1.383E-03 0.01710621 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE osteosarcoma DOID_3347 1.383E-03 0.01674225 1.383E-03 0.03747074 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE spinal cord disease DOID_319 1.604E-03 0.01901477 0.0574528 0.38012374 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE fragments of torsion dystonia DOID_531 1.604E-03 0.01862671 1.604E-03 0.04148676 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE migraine DOID_6364 1.721E-03 0.01957955 1.721E-03 0.04256424 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE renal hypertension DOID_1073 1.841E-03 0.02053866 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE secondary hypertension DOID_11130 1.841E-03 0.02053866 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE hepatic vascular disease DOID_272 1.841E-03 0.02014368 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE central nervous system hereditary degenerative disease DOID_481 1.841E-03 0.01976361 1.841E-03 0.04364465 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE dystonic disease DOID_544 1.965E-03 0.02070707 1.965E-03 0.04472726 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE endometrial carcinoma DOID_2871 2.093E-03 0.02165633 0.06538968 0.39164976 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE endometrial cancer DOID_1380 2.361E-03 0.02399131 0.06933333 0.40670791 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE germinoma DOID_3304 2.361E-03 0.02357041 0.06933333 0.40255783 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE adult respiratory distress syndrome DOID_11394 3.754E-03 0.03683014 0.08687739 0.45771515 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE cervix uteri carcinoma in situ DOID_8991 3.928E-03 0.03787829 3.928E-03 0.08595457 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE pulmonary emphysema DOID_9675 3.928E-03 0.03724698 0.08880646 0.45937158 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE nephrotic syndrome DOID_1184 4.285E-03 0.03997396 4.285E-03 0.09031154 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE primitive neuroectodermal tumor DOID_168 4.285E-03 0.03932922 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE hyperinsulinism DOID_2018 4.285E-03 0.03870495 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE uterine cancer DOID_363 4.47E-03 0.03973931 0.09456954 0.47201812 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE cataract DOID_83 4.658E-03 0.04077353 4.658E-03 0.09465283 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE leukodystrophy DOID_10579 4.849E-03 0.04180748 0.09839158 0.48262765 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE lens disease DOID_110 5.045E-03 0.04284105 5.045E-03 0.09567834 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE hemolytic anemia DOID_583 5.243E-03 0.04387411 0.10219768 0.47276815 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE normocytic anemia DOID_720 5.243E-03 0.04387411 0.10219768 0.47276815 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE lung small cell carcinoma DOID_5409 5.446E-03 0.04490657 0.10409478 0.47007882 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE calcium metabolism disease DOID_10575 5.651E-03 0.04593831 5.651E-03 0.10373167 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE movement disease DOID_480 5.651E-03 0.04529129 5.651E-03 0.10049006 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE vasculitis DOID_865 6.51E-03 0.05144687 6.51E-03 0.11224771 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE reproductive organ benign neoplasm DOID_0050622 6.733E-03 0.05248286 0.11539453 0.49742037 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE parasitic protozoa infectious disease DOID_2789 6.733E-03 0.05177363 0.11539453 0.49368037 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE hypertrophic cardiomyopathy DOID_11984 7.424E-03 0.05632284 0.12099151 0.50620714 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE leukocyte disease DOID_9500 7.661E-03 0.05735641 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE respiratory failure DOID_11162 8.392E-03 0.06201618 0.12839979 0.51450339 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE congenital heart defect DOID_1682 8.643E-03 0.0630485 8.643E-03 0.13660508 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE endocrine pancreas disease DOID_1428 8.897E-03 0.06407866 1.000 1.000 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE cholestasis DOID_13580 9.154E-03 0.06510665 0.1339155 0.5328526 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE parasitic infectious disease DOID_1398 9.154E-03 0.06430287 0.1339155 0.52915223 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE cerebral degeneration DOID_1443 9.154E-03 0.06351868 0.1339155 0.52550291 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE allergic contact dermatitis DOID_3042 9.678E-03 0.0663469 9.678E-03 0.14491559 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE brain infarction DOID_3454 9.945E-03 0.0673657 9.945E-03 0.14509534 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE bile duct disease DOID_4138 0.01076552 0.07206564 0.14484373 0.55686542 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE biliary tract disease DOID_9741 0.01104546 0.07307984 0.14665181 0.56003277 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE diabetic retinopathy DOID_8947 0.0113286 0.07409165 0.14845612 0.56314356 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE pancreatitis DOID_4989 0.01249286 0.08077767 0.01249286 0.17337646 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE bacterial pneumonia DOID_874 0.01249286 0.07987006 0.15563576 0.57133387 KAN_RESPONSE_TO_ARSENIC_TRIOXIDE contact dermatitis DOID_2773 0.0130938 0.08278191 0.0130938 0.17326447 PUJANA_BREAST_CANCER_LIT_INT_NETWORK pre-malignant neoplasm DOID_0060071 9.041E-21 5.144E-18 1.04E-12 5.92E-10 PUJANA_BREAST_CANCER_LIT_INT_NETWORK in situ carcinoma DOID_8719 9.041E-21 5.144E-18 1.04E-12 5.92E-10 PUJANA_BREAST_CANCER_LIT_INT_NETWORK nervous system cancer DOID_3093 5.425E-17 1.543E-14 1.298E-06 5.68E-05 PUJANA_BREAST_CANCER_LIT_INT_NETWORK cervix uteri carcinoma in situ DOID_8991 2.427E-16 4.603E-14 3.889E-12 7.376E-10 PUJANA_BREAST_CANCER_LIT_INT_NETWORK vulva cancer DOID_1245 9.76E-14 1.388E-11 3.848E-11 5.474E-09 PUJANA_BREAST_CANCER_LIT_INT_NETWORK embryonal cancer DOID_688 1.904E-12 2.167E-10 1.904E-12 5.418E-10 PUJANA_BREAST_CANCER_LIT_INT_NETWORK colon carcinoma DOID_1520 2.18E-12 2.067E-10 8.958E-06 3.398E-04 PUJANA_BREAST_CANCER_LIT_INT_NETWORK brain cancer DOID_1319 1.004E-11 8.16E-10 0.09672003 0.59819236 PUJANA_BREAST_CANCER_LIT_INT_NETWORK central nervous system cancer DOID_3620 1.162E-11 8.263E-10 0.09855708 0.59658488 PUJANA_BREAST_CANCER_LIT_INT_NETWORK uterine cancer DOID_363 5.783E-10 3.656E-08 5.783E-10 6.581E-08 PUJANA_BREAST_CANCER_LIT_INT_NETWORK lymphoma DOID_0060058 9.581E-10 5.452E-08 4.175E-05 1.397E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK osteosarcoma DOID_3347 1.927E-09 9.967E-08 2.273E-07 1.616E-05 PUJANA_BREAST_CANCER_LIT_INT_NETWORK astrocytoma DOID_3069 8.083E-09 3.833E-07 9.493E-03 0.12003992 PUJANA_BREAST_CANCER_LIT_INT_NETWORK Lynch syndrome DOID_3883 1.109E-08 4.853E-07 1.109E-08 1.052E-06 PUJANA_BREAST_CANCER_LIT_INT_NETWORK Fanconi's anemia DOID_13636 2.81E-08 1.142E-06 2.81E-08 2.284E-06 PUJANA_BREAST_CANCER_LIT_INT_NETWORK transitional cell carcinoma DOID_2671 3.129E-08 1.187E-06 3.52E-05 1.252E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK bone marrow disease DOID_4961 5.975E-08 2.125E-06 3.374E-06 1.371E-04 PUJANA_BREAST_CANCER_LIT_INT_NETWORK subependymal glioma DOID_4843 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK pilocytic astrocytoma DOID_4851 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK subependymal giant cell astrocytoma DOID_5077 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK fibrillary astrocytoma DOID_6726 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK juvenile pilocytic astrocytoma DOID_6811 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK childhood pilocytic astrocytoma DOID_6812 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK gemistocytic astrocytoma DOID_7005 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK childhood cerebral astrocytoma DOID_7007 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK protoplasmic astrocytoma DOID_7008 7.433E-08 2.488E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK benign glioma DOID_0060101 1.119E-07 3.537E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK benign ependymoma DOID_4844 1.119E-07 3.537E-06 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK reproductive organ benign neoplasm DOID_0050622 1.276E-07 3.821E-06 0.11131359 0.6333743 PUJANA_BREAST_CANCER_LIT_INT_NETWORK congenital hypoplastic anemia DOID_1342 3.103E-07 8.828E-06 3.103E-07 1.962E-05 PUJANA_BREAST_CANCER_LIT_INT_NETWORK sarcoma DOID_1115 4.14E-07 1.122E-05 1.707E-03 0.03349432 PUJANA_BREAST_CANCER_LIT_INT_NETWORK supratentorial cancer DOID_1659 4.746E-07 1.228E-05 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK cerebrum cancer DOID_368 4.746E-07 1.228E-05 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK endometrial carcinoma DOID_2871 5.416E-07 1.34E-05 5.416E-07 3.082E-05 PUJANA_BREAST_CANCER_LIT_INT_NETWORK endometrial cancer DOID_1380 6.963E-07 1.651E-05 6.963E-07 3.602E-05 PUJANA_BREAST_CANCER_LIT_INT_NETWORK aplastic anemia DOID_12449 1.102E-06 2.507E-05 1.102E-06 5.223E-05 PUJANA_BREAST_CANCER_LIT_INT_NETWORK lymphoblastic leukemia DOID_1037 1.522E-06 3.33E-05 4.352E-05 1.376E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK myeloma DOID_0070004 3.374E-06 7.11E-05 0.09672003 0.60476591 PUJANA_BREAST_CANCER_LIT_INT_NETWORK integumentary system benign neoplasm DOID_0060121 3.954E-06 8.035E-05 5.056E-03 0.0737598 PUJANA_BREAST_CANCER_LIT_INT_NETWORK skin benign neoplasm DOID_3165 3.954E-06 8.035E-05 5.056E-03 0.0737598 PUJANA_BREAST_CANCER_LIT_INT_NETWORK lung small cell carcinoma DOID_5409 3.954E-06 7.758E-05 1.657E-04 4.286E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK angiosarcoma DOID_0001816 4.426E-06 8.395E-05 0.03201303 0.29861337 PUJANA_BREAST_CANCER_LIT_INT_NETWORK urinary system benign neoplasm DOID_731 5.367E-06 9.851E-05 5.429E-04 0.01188158 PUJANA_BREAST_CANCER_LIT_INT_NETWORK bone marrow cancer DOID_4960 5.725E-06 1.018E-04 0.1095022 0.62936111 PUJANA_BREAST_CANCER_LIT_INT_NETWORK integumentary system cancer DOID_0060122 6.139E-06 1.059E-04 6.253E-03 0.08677951 PUJANA_BREAST_CANCER_LIT_INT_NETWORK skin cancer DOID_4159 6.139E-06 1.059E-04 6.253E-03 0.08677951 PUJANA_BREAST_CANCER_LIT_INT_NETWORK glioblastoma DOID_3068 7.517E-06 1.258E-04 6.895E-03 0.09124429 PUJANA_BREAST_CANCER_LIT_INT_NETWORK oral cavity cancer DOID_8618 7.517E-06 1.222E-04 6.895E-03 0.08917055 PUJANA_BREAST_CANCER_LIT_INT_NETWORK uterine disease DOID_345 1.16E-05 1.834E-04 0.12922864 0.70029613 PUJANA_BREAST_CANCER_LIT_INT_NETWORK female reproductive system disease DOID_229 2.559E-05 3.935E-04 0.15543487 0.76243483 PUJANA_BREAST_CANCER_LIT_INT_NETWORK biliary tract cancer DOID_4607 2.811E-05 4.209E-04 7.059E-04 0.01487529 PUJANA_BREAST_CANCER_LIT_INT_NETWORK invasive ductal carcinoma DOID_3008 3.144E-05 4.587E-04 1.707E-03 0.03237784 PUJANA_BREAST_CANCER_LIT_INT_NETWORK alcohol-related neurodevelopmental disorder DOID_0050667 4.534E-05 6.45E-04 0.17751619 0.83476621 PUJANA_BREAST_CANCER_LIT_INT_NETWORK autonomic nervous system neoplasm DOID_2621 5.031E-05 6.982E-04 2.32E-03 0.0412471 PUJANA_BREAST_CANCER_LIT_INT_NETWORK neuroblastoma DOID_769 5.031E-05 6.982E-04 2.32E-03 0.0412471 PUJANA_BREAST_CANCER_LIT_INT_NETWORK nephroblastoma DOID_2154 5.956E-05 8.068E-04 5.956E-05 1.784E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK medulloblastoma DOID_3858 7.54E-05 9.977E-04 7.54E-05 2.145E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK multiple myeloma DOID_9538 7.54E-05 9.75E-04 0.07814509 0.55580694 PUJANA_BREAST_CANCER_LIT_INT_NETWORK peripheral nervous system neoplasm DOID_1192 8.123E-05 1.027E-03 3.172E-03 0.05156453 PUJANA_BREAST_CANCER_LIT_INT_NETWORK benign mesothelioma DOID_2645 1.005E-04 1.243E-03 0.08561988 0.57997274 PUJANA_BREAST_CANCER_LIT_INT_NETWORK endometriosis of uterus DOID_288 1.075E-04 1.301E-03 0.08747921 0.58559611 PUJANA_BREAST_CANCER_LIT_INT_NETWORK primitive neuroectodermal tumor DOID_168 1.148E-04 1.361E-03 1.148E-04 3.111E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK endometriosis DOID_289 1.148E-04 1.333E-03 0.08933481 0.57763074 PUJANA_BREAST_CANCER_LIT_INT_NETWORK B-cell lymphocytic neoplasm DOID_707 1.855E-04 2.11E-03 5.442E-03 0.07740742 PUJANA_BREAST_CANCER_LIT_INT_NETWORK giant cell tumor DOID_200 2.067E-04 2.306E-03 0.10768716 0.63169067 PUJANA_BREAST_CANCER_LIT_INT_NETWORK malignant giant cell tumor DOID_2705 2.067E-04 2.306E-03 0.10768716 0.63169067 PUJANA_BREAST_CANCER_LIT_INT_NETWORK giant cell glioblastoma DOID_3074 2.067E-04 2.306E-03 0.10768716 0.63169067 PUJANA_BREAST_CANCER_LIT_INT_NETWORK breast benign neoplasm DOID_0060082 2.213E-04 2.422E-03 0.02211918 0.26778322 PUJANA_BREAST_CANCER_LIT_INT_NETWORK thoracic benign neoplasm DOID_0060097 2.213E-04 2.422E-03 0.02211918 0.26778322 PUJANA_BREAST_CANCER_LIT_INT_NETWORK benign breast phyllodes tumor DOID_1631 2.213E-04 2.422E-03 0.02211918 0.26778322 PUJANA_BREAST_CANCER_LIT_INT_NETWORK invasive lobular carcinoma DOID_3457 2.213E-04 2.376E-03 0.02211918 0.25685329 PUJANA_BREAST_CANCER_LIT_INT_NETWORK Seckel syndrome DOID_0050569 2.652E-04 2.795E-03 2.652E-04 6.561E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK encephalitis DOID_9588 2.652E-04 2.744E-03 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK neuroectodermal tumor DOID_171 3.07E-04 3.119E-03 3.07E-04 7.279E-03 PUJANA_BREAST_CANCER_LIT_INT_NETWORK Leydig cell tumor DOID_2696 3.13E-04 3.125E-03 0.02608864 0.28546992 PUJANA_BREAST_CANCER_LIT_INT_NETWORK sex cord-stromal neoplasm DOID_4757 3.13E-04 3.125E-03 0.02608864 0.28546992 PUJANA_BREAST_CANCER_LIT_INT_NETWORK mesenchymal cell neoplasm DOID_3350 4.203E-04 4.123E-03 0.0300422 0.28972899 PUJANA_BREAST_CANCER_LIT_INT_NETWORK spindle cell sarcoma DOID_4235 4.203E-04 4.123E-03 0.0300422 0.28972899 PUJANA_BREAST_CANCER_LIT_INT_NETWORK epithelioid sarcoma DOID_6193 4.203E-04 4.123E-03 0.0300422 0.28972899 PUJANA_BREAST_CANCER_LIT_INT_NETWORK chronic myeloid leukemia DOID_8552 4.797E-04 4.626E-03 4.797E-04 0.01091746 PUJANA_BREAST_CANCER_LIT_INT_NETWORK tongue cancer DOID_8649 4.797E-04 4.549E-03 0.03201303 0.29379702 PUJANA_BREAST_CANCER_LIT_INT_NETWORK drug-induced mental disorder DOID_1203 5.429E-04 5.064E-03 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK drug psychosis DOID_1742 5.429E-04 5.064E-03 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK substance-induced psychosis DOID_8646 5.429E-04 5.064E-03 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK male reproductive organ benign neoplasm DOID_0060087 6.1E-04 5.598E-03 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK prion disease DOID_649 6.1E-04 5.509E-03 0.03594285 0.31955442 PUJANA_BREAST_CANCER_LIT_INT_NETWORK seminoma DOID_4440 1.487E-03 0.01322311 1.487E-03 0.03022425 PUJANA_BREAST_CANCER_LIT_INT_NETWORK diffuse large B-cell lymphoma DOID_0050745 1.595E-03 0.01396572 0.05727703 0.45264764 PUJANA_BREAST_CANCER_LIT_INT_NETWORK female reproductive organ benign neoplasm DOID_0060086 1.941E-03 0.01673694 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK uterine benign neoplasm DOID_0060095 1.941E-03 0.01673694 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK uterine fibroid DOID_13223 1.941E-03 0.01673694 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK germinoma DOID_3304 2.19E-03 0.01859881 2.19E-03 0.04019742 PUJANA_BREAST_CANCER_LIT_INT_NETWORK chronic leukemia DOID_1036 2.32E-03 0.0194104 0.06871674 0.51447141 PUJANA_BREAST_CANCER_LIT_INT_NETWORK chronic lymphocytic leukemia DOID_1040 2.32E-03 0.0194104 0.06871674 0.51447141 PUJANA_BREAST_CANCER_LIT_INT_NETWORK leiomyoma DOID_127 2.32E-03 0.01912909 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK papilloma DOID_2615 2.453E-03 0.01993878 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK thyroid carcinoma DOID_3963 2.59E-03 0.02075399 0.07249945 0.52887418 PUJANA_BREAST_CANCER_LIT_INT_NETWORK lymphoid leukemia DOID_10747 2.73E-03 0.02157438 2.73E-03 0.04707137 PUJANA_BREAST_CANCER_LIT_INT_NETWORK medullomyoblastoma DOID_3861 2.73E-03 0.02127884 2.73E-03 0.04568692 PUJANA_BREAST_CANCER_LIT_INT_NETWORK adult medulloblastoma DOID_3864 2.73E-03 0.02127884 2.73E-03 0.04568692 PUJANA_BREAST_CANCER_LIT_INT_NETWORK childhood medulloblastoma DOID_3869 2.73E-03 0.02127884 2.73E-03 0.04568692 PUJANA_BREAST_CANCER_LIT_INT_NETWORK thyroid cancer DOID_1781 2.874E-03 0.02209692 0.07626699 0.54931539 PUJANA_BREAST_CANCER_LIT_INT_NETWORK intracranial arterial disease DOID_13089 3.484E-03 0.02642968 0.08375681 0.58119053 PUJANA_BREAST_CANCER_LIT_INT_NETWORK cerebral arterial disease DOID_3527 3.484E-03 0.02642968 0.08375681 0.58119053 PUJANA_BREAST_CANCER_LIT_INT_NETWORK adenoid cystic carcinoma DOID_4866 3.484E-03 0.02608192 0.08375681 0.57418823 PUJANA_BREAST_CANCER_LIT_INT_NETWORK salivary gland cancer DOID_8850 3.809E-03 0.02814949 0.08747921 0.57878685 PUJANA_BREAST_CANCER_LIT_INT_NETWORK gallbladder cancer DOID_3121 4.149E-03 0.03026343 4.149E-03 0.06557076 PUJANA_BREAST_CANCER_LIT_INT_NETWORK cataract DOID_83 4.323E-03 0.03113864 4.323E-03 0.0664852 PUJANA_BREAST_CANCER_LIT_INT_NETWORK lens disease DOID_110 4.683E-03 0.0333062 4.683E-03 0.07011832 PUJANA_BREAST_CANCER_LIT_INT_NETWORK thyroid adenoma DOID_2891 4.683E-03 0.03289502 0.09672003 0.59176019 PUJANA_BREAST_CANCER_LIT_INT_NETWORK bile duct adenocarcinoma DOID_4896 6.045E-03 0.04194844 0.1095022 0.63578316 PUJANA_BREAST_CANCER_LIT_INT_NETWORK cholangiocarcinoma DOID_4947 6.045E-03 0.04194844 0.1095022 0.63578316 PUJANA_BREAST_CANCER_LIT_INT_NETWORK pustulosis of palm and sole DOID_4398 6.253E-03 0.04286699 1.000 1.000 PUJANA_BREAST_CANCER_LIT_INT_NETWORK congenital nervous system abnormality DOID_2490 6.678E-03 0.04523612 6.678E-03 0.09047224 PUJANA_BREAST_CANCER_LIT_INT_NETWORK hypertrophic cardiomyopathy DOID_11984 6.895E-03 0.04615887 0.11672596 0.65114776 PUJANA_BREAST_CANCER_LIT_INT_NETWORK bile duct cancer DOID_4606 6.895E-03 0.04562214 0.11672596 0.64482594 PUJANA_BREAST_CANCER_LIT_INT_NETWORK bile duct carcinoma DOID_4897 6.895E-03 0.04562214 0.11672596 0.64482594 PUJANA_BREAST_CANCER_LIT_INT_NETWORK endocrine organ benign neoplasm DOID_0060089 9.242E-03 0.06044382 0.1345333 0.71541541 PUJANA_BREAST_CANCER_LIT_INT_NETWORK pancreatic carcinoma DOID_4905 0.01053032 0.06808806 0.14330362 0.74127054 PUJANA_BREAST_CANCER_LIT_INT_NETWORK pancreatitis DOID_4989 0.01161492 0.07425721 0.15025667 0.76335752 PUJANA_BREAST_CANCER_LIT_INT_NETWORK mixed glioma DOID_5076 0.01161492 0.07343213 0.15025667 0.75660215 PUJANA_BREAST_CANCER_LIT_INT_NETWORK primary immunodeficiency disease DOID_612 0.01483732 0.09277401 0.16909164 0.8153656 PUJANA_BREAST_CANCER_LIT_INT_NETWORK encephalomyelitis DOID_640 0.01609389 0.0995372 0.17583805 0.83376542 GENTILE_UV_RESPONSE_CLUSTER_D9 renovascular hypertension DOID_1591 9.622E-06 5.475E-03 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 muscular atrophy DOID_767 2.114E-05 6.015E-03 2.114E-05 0.01202961 GENTILE_UV_RESPONSE_CLUSTER_D9 renal hypertension DOID_1073 3.976E-05 7.54E-03 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 secondary hypertension DOID_11130 3.976E-05 7.54E-03 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 focal glomerulosclerosis DOID_3945 4.249E-05 6.044E-03 9.77E-03 0.61767203 GENTILE_UV_RESPONSE_CLUSTER_D9 abdominal aortic aneurysm DOID_7693 4.823E-05 5.489E-03 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 hyperinsulinism DOID_2018 9.433E-05 8.945E-03 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 aortic aneurysm DOID_3627 1.254E-04 0.01019584 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 congenital heart defect DOID_1682 1.948E-04 0.01385532 0.02069513 0.6541961 GENTILE_UV_RESPONSE_CLUSTER_D9 endocrine pancreas disease DOID_1428 2.008E-04 0.01269255 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 pancreatic ductal carcinoma DOID_3587 2.384E-04 0.01356344 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 pancreatic carcinoma DOID_4905 2.584E-04 0.01336496 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 diabetic retinopathy DOID_8947 2.584E-04 0.01225121 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 aneurysm disease DOID_2403 2.792E-04 0.01221897 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D9 retinal vascular disease DOID_2462 3.385E-04 0.01375736 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP congenital heart defect DOID_1682 3.057E-10 1.74E-07 3.145E-07 8.947E-05 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP congenital diaphragmatic hernia DOID_3827 1.968E-08 5.6E-06 6.845E-04 0.02291141 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP aneurysm disease DOID_2403 3.774E-08 7.159E-06 1.891E-05 1.793E-03 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP bone development disease DOID_0080006 6.831E-08 9.717E-06 2.856E-05 2.321E-03 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP aortic valve insufficiency DOID_57 1.297E-07 1.476E-05 0.04798072 0.24375921 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP osteochondrodysplasia DOID_2256 1.439E-07 1.365E-05 4.119E-06 5.86E-04 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.464E-07 1.19E-05 2.901E-06 5.502E-04 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP multiple epiphyseal dysplasia DOID_12721 1.67E-07 1.187E-05 7.76E-06 8.831E-04 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP hypothyroidism DOID_1459 2.868E-07 1.814E-05 2.868E-07 1.632E-04 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP aortic aneurysm DOID_3627 2.623E-06 1.492E-04 1.352E-03 0.03343931 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP aortic valve disease DOID_62 2.68E-06 1.386E-04 0.09367344 0.33734295 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP hypertrophic cardiomyopathy DOID_11984 5.296E-06 2.511E-04 1.17E-04 8.322E-03 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP focal glomerulosclerosis DOID_3945 7.76E-06 3.396E-04 0.11931424 0.38573752 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP endometrial carcinoma DOID_2871 8.84E-06 3.593E-04 7.601E-03 0.08009272 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP uterine disease DOID_345 9.068E-06 3.44E-04 0.03172992 0.22289288 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP endometrial cancer DOID_1380 1.133E-05 4.029E-04 8.551E-03 0.08688858 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP diabetic retinopathy DOID_8947 1.565E-05 5.24E-04 0.26777961 0.65959567 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP female reproductive system disease DOID_229 2.404E-05 7.6E-04 0.04556616 0.24692522 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP retinal vascular disease DOID_2462 3.02E-05 9.044E-04 0.30011299 0.7235775 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP hyperinsulinism DOID_2018 3.837E-05 1.092E-03 0.01528073 0.14023764 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP uterine cancer DOID_363 4.181E-05 1.133E-03 0.01591754 0.14151685 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP heart valve disease DOID_4079 5.347E-05 1.383E-03 0.18533473 0.49743143 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP integumentary system benign neoplasm DOID_0060121 6.245E-05 1.545E-03 0.01926779 0.16122606 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP skin benign neoplasm DOID_3165 6.245E-05 1.545E-03 0.01926779 0.16122606 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP bone marrow cancer DOID_4960 8.969E-05 2.126E-03 1.668E-03 0.03955192 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP integumentary system cancer DOID_0060122 9.603E-05 2.186E-03 0.02364067 0.18682693 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP skin cancer DOID_4159 9.603E-05 2.186E-03 0.02364067 0.18682693 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP heart conduction disease DOID_10273 1.118E-04 2.446E-03 3.972E-03 0.05946874 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP ureteral disease DOID_1426 1.274E-04 2.684E-03 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP carotid artery disease DOID_3407 1.411E-04 2.867E-03 0.02837852 0.21529838 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP portal hypertension DOID_10762 1.626E-04 3.191E-03 5.061E-03 0.07023695 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP endocrine pancreas disease DOID_1428 1.686E-04 3.198E-03 0.03087802 0.22239989 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP morbid obesity DOID_11981 1.824E-04 3.348E-03 1.824E-04 0.01153324 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP migraine DOID_6364 2.265E-04 4.028E-03 2.265E-04 0.01288938 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP pancreatic ductal carcinoma DOID_3587 2.349E-04 4.051E-03 0.25870671 0.65134567 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP autoimmune disease of cardiovascular system DOID_0060051 2.509E-04 4.2E-03 6.702E-03 0.07782465 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP renal hypertension DOID_1073 2.509E-04 4.08E-03 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP secondary hypertension DOID_11130 2.509E-04 4.08E-03 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP Behcet's disease DOID_13241 2.509E-04 4.2E-03 6.702E-03 0.07782465 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP hepatic vascular disease DOID_272 2.509E-04 3.966E-03 6.702E-03 0.07626815 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP pancreatic carcinoma DOID_4905 2.743E-04 4.218E-03 0.26777961 0.66246348 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP mixed glioma DOID_5076 3.339E-04 4.999E-03 3.339E-04 0.01727053 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP metabolic syndrome X DOID_14221 3.669E-04 5.353E-03 0.04458502 0.24629978 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP contact dermatitis DOID_2773 3.669E-04 5.219E-03 3.669E-04 0.01739733 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP leiomyoma DOID_127 3.985E-04 5.531E-03 3.985E-04 0.01744306 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP childhood absence epilepsy DOID_1825 3.985E-04 5.399E-03 3.985E-04 0.01619712 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP childhood electroclinical syndrome DOID_0050704 5.091E-04 6.736E-03 5.091E-04 0.01931084 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP lymphoblastic leukemia DOID_1037 6.409E-04 8.288E-03 6.409E-04 0.02279319 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP hypersensitivity reaction type I disease DOID_1205 6.932E-04 8.765E-03 7.465E-03 0.08167921 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP dilated cardiomyopathy DOID_12930 6.932E-04 8.574E-03 0.06010084 0.2533139 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP insulinoma DOID_3892 7.315E-04 8.855E-03 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP endometriosis of uterus DOID_288 8.386E-04 9.94E-03 0.01465523 0.1367021 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP sickle cell anemia DOID_10923 8.916E-04 0.01035368 8.916E-04 0.02818501 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP invasive lobular carcinoma DOID_3457 8.916E-04 0.01014661 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP endometriosis DOID_289 8.944E-04 9.979E-03 0.01528073 0.13801165 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP cataract DOID_83 1.013E-03 0.01108442 1.013E-03 0.0303363 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP familial atrial fibrillation DOID_0050650 1.067E-03 0.0114559 0.04798072 0.25278733 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP islet cell tumor DOID_1799 1.067E-03 0.01124376 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP leukodystrophy DOID_10579 1.076E-03 0.01112998 1.076E-03 0.03060746 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP myeloma DOID_0070004 1.141E-03 0.0115943 0.01789485 0.15664875 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP lens disease DOID_110 1.141E-03 0.01139089 1.141E-03 0.03091812 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP essential hypertension DOID_10825 1.258E-03 0.01233848 0.05187431 0.25891651 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.279E-03 0.01233455 0.01926779 0.16363242 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP glaucoma DOID_1686 1.279E-03 0.01212898 1.279E-03 0.03307903 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP lung small cell carcinoma DOID_5409 1.279E-03 0.01193014 0.19199152 0.51048213 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP vasculitis DOID_865 1.668E-03 0.01531042 0.02288595 0.18340998 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP idiopathic pulmonary fibrosis DOID_0050156 1.684E-03 0.0152094 1.684E-03 0.03832769 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP thoracic aortic aneurysm DOID_14004 1.684E-03 0.01497175 1.684E-03 0.03685354 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP renovascular hypertension DOID_1591 1.684E-03 0.01474142 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP membranoproliferative glomerulonephritis DOID_2920 1.684E-03 0.01451806 0.05961408 0.26092623 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP nutritional deficiency disease DOID_5113 1.684E-03 0.01430138 1.684E-03 0.0354886 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP reproductive organ benign neoplasm DOID_0050622 1.754E-03 0.0146771 1.754E-03 0.03564439 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP restrictive cardiomyopathy DOID_397 1.919E-03 0.01582815 0.06346039 0.26165914 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP melancholia DOID_2848 2.124E-03 0.01726854 2.124E-03 0.04168268 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP urinary system benign neoplasm DOID_731 2.17E-03 0.01738656 0.06729107 0.26963816 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP neurotic disorder DOID_4964 2.224E-03 0.01757586 2.224E-03 0.04218207 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP ureteral obstruction DOID_5199 2.434E-03 0.01897305 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP mineral metabolism disease DOID_0050032 2.651E-03 0.0203852 0.03087802 0.22525117 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP infertility DOID_5223 2.713E-03 0.02058446 2.713E-03 0.0498011 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP cerebral degeneration DOID_1443 2.765E-03 0.02070313 2.765E-03 0.04916994 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP temporal lobe epilepsy DOID_3328 2.882E-03 0.02129962 2.882E-03 0.04969911 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP allergic contact dermatitis DOID_3042 3.002E-03 0.02190278 3.002E-03 0.05024755 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP brain edema DOID_4724 3.007E-03 0.02165545 3.007E-03 0.04887945 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP brain infarction DOID_3454 3.126E-03 0.02223113 3.126E-03 0.0494025 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP juvenile absence epilepsy DOID_0060172 3.314E-03 0.02328154 3.314E-03 0.05096769 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP nephrosis DOID_2527 3.514E-03 0.02438066 0.03703185 0.25386895 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP placenta disease DOID_780 3.636E-03 0.02492575 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP IgA glomerulonephritis DOID_2986 3.972E-03 0.02690252 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP urinary tract obstruction DOID_5200 3.972E-03 0.02658602 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP endogenous depression DOID_1595 4.075E-03 0.02695945 4.075E-03 0.05944905 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP electroclinical syndrome DOID_0050701 4.375E-03 0.02861039 4.375E-03 0.0622276 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP spastic quadriplegia DOID_10970 4.684E-03 0.0302877 0.09738132 0.34631233 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP toxic shock syndrome DOID_14115 4.684E-03 0.02994739 0.09738132 0.34416132 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP commensal bacterial infectious disease DOID_0050339 5.061E-03 0.03199683 0.10107414 0.35282935 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP mental depression DOID_1596 5.181E-03 0.03239832 5.181E-03 0.07019636 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP focal epilepsy DOID_2234 5.181E-03 0.03204616 5.181E-03 0.06856388 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP myositis DOID_633 5.451E-03 0.03335256 0.10475194 0.35478484 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP intracranial aneurysm DOID_10941 5.855E-03 0.03544119 5.855E-03 0.07571526 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP juvenile myoclonic epilepsy DOID_4890 5.855E-03 0.03506812 5.855E-03 0.0740327 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP dystonia DOID_543 5.855E-03 0.03470283 5.855E-03 0.0724233 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP transitional cell carcinoma DOID_2671 6.072E-03 0.03561997 0.30868226 0.74109792 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP primary immunodeficiency disease DOID_612 6.261E-03 0.03635057 6.261E-03 0.0757948 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP diffuse large B-cell lymphoma DOID_0050745 6.272E-03 0.03604747 6.272E-03 0.07434791 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP nervous system cancer DOID_3093 6.453E-03 0.03671543 0.05474458 0.26398023 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP coronary stenosis DOID_4248 6.702E-03 0.03775651 0.11569588 0.37833883 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP encephalomyelitis DOID_640 7.049E-03 0.03932359 0.05793721 0.25957695 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP toxic encephalopathy DOID_3602 7.145E-03 0.03947118 7.145E-03 0.0797163 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP female reproductive organ benign neoplasm DOID_0060086 7.601E-03 0.04158661 7.601E-03 0.08160391 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP uterine benign neoplasm DOID_0060095 7.601E-03 0.04158661 7.601E-03 0.08160391 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP uterine fibroid DOID_13223 7.601E-03 0.04158661 7.601E-03 0.08160391 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP spastic cerebral palsy DOID_0050669 8.07E-03 0.04373115 0.12650689 0.40439563 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP abdominal aortic aneurysm DOID_7693 8.07E-03 0.0433186 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP Charcot-Marie-Tooth disease DOID_10595 8.551E-03 0.04547439 0.1300813 0.41120145 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP celiac disease DOID_10608 8.551E-03 0.04505334 8.551E-03 0.08846837 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP chronic leukemia DOID_1036 9.046E-03 0.04721937 9.046E-03 0.0902967 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP chronic lymphocytic leukemia DOID_1040 9.046E-03 0.04721937 9.046E-03 0.0902967 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP hyperthyroidism DOID_7998 0.01007109 0.05209503 0.01007109 0.09880091 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP adenoma DOID_657 0.0111457 0.05713424 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP adolescence-adult electroclinical syndrome DOID_0050705 0.01170112 0.05944586 0.01170112 0.11284638 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP cleft palate DOID_674 0.01170112 0.05891979 0.15122461 0.44583835 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP peptic ulcer DOID_750 0.01284768 0.0641257 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP adult respiratory distress syndrome DOID_11394 0.01343861 0.06649189 0.01343861 0.12744279 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP pulmonary emphysema DOID_9675 0.01404116 0.06887431 0.16503569 0.46258771 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP autoimmune disease of urogenital tract DOID_0060049 0.01465523 0.07127204 0.16845342 0.46985293 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP primary biliary cirrhosis DOID_12236 0.01465523 0.07127204 0.16845342 0.46985293 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP nephrotic syndrome DOID_1184 0.01528073 0.07368419 0.17185726 0.47469312 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP diabetic autonomic neuropathy DOID_11503 0.01591754 0.0761099 0.17524726 0.47710856 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP autonomic neuropathy DOID_11504 0.01591754 0.0761099 0.17524726 0.47710856 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP diabetic polyneuropathy DOID_12785 0.01591754 0.0761099 0.17524726 0.47710856 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP diabetic neuropathy DOID_9743 0.01591754 0.0761099 0.17524726 0.47710856 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP proteinuria DOID_576 0.0172247 0.08167378 1.000 1.000 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP autonomic nervous system disease DOID_11465 0.01789485 0.08415015 0.18533473 0.49978893 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP vascular skin disease DOID_9540 0.01789485 0.0834604 0.18533473 0.49509608 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP hemolytic anemia DOID_583 0.01857591 0.08593247 0.01857591 0.16014688 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP normocytic anemia DOID_720 0.01857591 0.08593247 0.01857591 0.16014688 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP calcium metabolism disease DOID_10575 0.01997038 0.09163828 0.19529962 0.51686272 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP withdrawal disorder DOID_0060001 0.02068359 0.09415171 0.02068359 0.17056469 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP B-cell lymphocytic neoplasm DOID_707 0.02068359 0.09340447 0.02068359 0.16812805 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP orofacial cleft DOID_0050567 0.02140732 0.09591154 0.2018755 0.52934175 KAAB_HEART_ATRIUM_VS_VENTRICLE_UP sarcoidosis DOID_11335 0.02214147 0.09842577 1.000 1.000 HUANG_DASATINIB_RESISTANCE_UP spindle cell carcinoma DOID_4015 1.856E-07 1.056E-04 1.725E-05 9.817E-03 HUANG_DASATINIB_RESISTANCE_UP biliary tract cancer DOID_4607 5.426E-06 1.544E-03 2.096E-04 0.0170348 HUANG_DASATINIB_RESISTANCE_UP transitional cell carcinoma DOID_2671 6.814E-06 1.292E-03 6.589E-03 0.13389311 HUANG_DASATINIB_RESISTANCE_UP neuritis DOID_1803 4.299E-05 6.115E-03 2.086E-03 0.07911239 HUANG_DASATINIB_RESISTANCE_UP heart valve disease DOID_4079 4.299E-05 4.892E-03 0.0651336 0.32226973 HUANG_DASATINIB_RESISTANCE_UP bile duct adenocarcinoma DOID_4896 6.375E-05 6.046E-03 2.701E-03 0.09040131 HUANG_DASATINIB_RESISTANCE_UP cholangiocarcinoma DOID_4947 6.375E-05 6.046E-03 2.701E-03 0.09040131 HUANG_DASATINIB_RESISTANCE_UP bile duct cancer DOID_4606 7.812E-05 6.35E-03 3.086E-03 0.08780551 HUANG_DASATINIB_RESISTANCE_UP bile duct carcinoma DOID_4897 7.812E-05 6.35E-03 3.086E-03 0.08780551 HUANG_DASATINIB_RESISTANCE_UP aortic valve insufficiency DOID_57 1.161E-04 8.257E-03 0.01602647 0.22797658 HUANG_DASATINIB_RESISTANCE_UP lipodystrophy DOID_811 1.161E-04 7.34E-03 1.161E-04 0.03302972 HUANG_DASATINIB_RESISTANCE_UP pancreatic ductal carcinoma DOID_3587 1.335E-04 7.595E-03 1.335E-04 0.02531551 HUANG_DASATINIB_RESISTANCE_UP intracranial thrombosis DOID_4193 1.371E-04 7.091E-03 0.01735059 0.21938855 HUANG_DASATINIB_RESISTANCE_UP pancreatic carcinoma DOID_4905 1.504E-04 7.133E-03 1.504E-04 0.02139966 HUANG_DASATINIB_RESISTANCE_UP open-angle glaucoma DOID_1067 1.598E-04 6.994E-03 1.598E-04 0.01818504 HUANG_DASATINIB_RESISTANCE_UP pancreatitis DOID_4989 1.752E-04 7.119E-03 1.752E-04 0.01661022 HUANG_DASATINIB_RESISTANCE_UP mixed glioma DOID_5076 1.752E-04 6.644E-03 5.243E-03 0.11474767 HUANG_DASATINIB_RESISTANCE_UP skeletal system cancer DOID_0060124 1.842E-04 6.551E-03 0.01999358 0.2473119 HUANG_DASATINIB_RESISTANCE_UP bone cancer DOID_184 1.842E-04 6.551E-03 0.01999358 0.2473119 HUANG_DASATINIB_RESISTANCE_UP prion disease DOID_649 2.677E-04 8.962E-03 0.02394501 0.23092726 HUANG_DASATINIB_RESISTANCE_UP lymphoma DOID_0060058 2.82E-04 8.914E-03 2.82E-04 0.02005707 HUANG_DASATINIB_RESISTANCE_UP thrombophilia DOID_2452 4.029E-04 0.01206452 4.029E-04 0.02546955 HUANG_DASATINIB_RESISTANCE_UP sinusitis DOID_0050127 4.408E-04 0.01254205 0.03049603 0.27987487 HUANG_DASATINIB_RESISTANCE_UP paranasal sinus disease DOID_1352 4.408E-04 0.01254205 0.03049603 0.27987487 HUANG_DASATINIB_RESISTANCE_UP aortic valve disease DOID_62 4.805E-04 0.01301949 0.03180105 0.2661 HUANG_DASATINIB_RESISTANCE_UP ankylosing spondylitis DOID_7147 6.095E-04 0.01576405 6.095E-04 0.03468091 HUANG_DASATINIB_RESISTANCE_UP middle cerebral artery infarction DOID_3525 6.558E-04 0.01622459 0.03700395 0.29243396 HUANG_DASATINIB_RESISTANCE_UP Sciatic Neuropathy DOID_11446 7.038E-04 0.01668595 0.03830038 0.29853309 HUANG_DASATINIB_RESISTANCE_UP lesion of sciatic nerve DOID_12528 7.038E-04 0.01668595 0.03830038 0.29853309 HUANG_DASATINIB_RESISTANCE_UP lung adenocarcinoma DOID_3910 7.038E-04 0.01601852 0.03830038 0.29449886 HUANG_DASATINIB_RESISTANCE_UP mononeuritis of lower limb DOID_9473 7.038E-04 0.01668595 0.03830038 0.29853309 HUANG_DASATINIB_RESISTANCE_UP mononeuritis DOID_1802 7.534E-04 0.01648841 0.0395951 0.28162016 HUANG_DASATINIB_RESISTANCE_UP mononeuropathy DOID_1188 8.047E-04 0.01695815 0.04088812 0.28030527 HUANG_DASATINIB_RESISTANCE_UP pleural disease DOID_1532 1.026E-03 0.02085233 0.04604312 0.29109487 HUANG_DASATINIB_RESISTANCE_UP periodontal disease DOID_3388 1.147E-03 0.02249704 1.147E-03 0.05931038 HUANG_DASATINIB_RESISTANCE_UP adult respiratory distress syndrome DOID_11394 1.547E-03 0.02933437 0.05627178 0.31390829 HUANG_DASATINIB_RESISTANCE_UP intracranial arterial disease DOID_13089 1.547E-03 0.0283881 0.05627178 0.31086063 HUANG_DASATINIB_RESISTANCE_UP cerebral arterial disease DOID_3527 1.547E-03 0.0283881 0.05627178 0.31086063 HUANG_DASATINIB_RESISTANCE_UP benign mesothelioma DOID_2645 1.619E-03 0.0287858 0.05754278 0.31182708 HUANG_DASATINIB_RESISTANCE_UP endometriosis of uterus DOID_288 1.693E-03 0.02918673 1.693E-03 0.08026351 HUANG_DASATINIB_RESISTANCE_UP endometriosis DOID_289 1.768E-03 0.02959052 1.768E-03 0.0773906 HUANG_DASATINIB_RESISTANCE_UP gallbladder cancer DOID_3121 1.845E-03 0.02999687 1.845E-03 0.07499217 HUANG_DASATINIB_RESISTANCE_UP uterine cancer DOID_363 1.845E-03 0.02916362 0.06134571 0.32023588 HUANG_DASATINIB_RESISTANCE_UP cerebral infarction DOID_3526 1.924E-03 0.02958372 0.06261001 0.32094682 HUANG_DASATINIB_RESISTANCE_UP glaucoma DOID_1686 2.254E-03 0.03374536 2.254E-03 0.08014522 HUANG_DASATINIB_RESISTANCE_UP giant cell tumor DOID_200 2.608E-03 0.03805568 0.07266447 0.3445507 HUANG_DASATINIB_RESISTANCE_UP malignant giant cell tumor DOID_2705 2.608E-03 0.03805568 0.07266447 0.3445507 HUANG_DASATINIB_RESISTANCE_UP giant cell glioblastoma DOID_3074 2.608E-03 0.03805568 0.07266447 0.3445507 HUANG_DASATINIB_RESISTANCE_UP vasculitis DOID_865 2.701E-03 0.03842056 2.701E-03 0.08537901 HUANG_DASATINIB_RESISTANCE_UP pustulosis of palm and sole DOID_4398 2.795E-03 0.03878887 2.795E-03 0.08370231 HUANG_DASATINIB_RESISTANCE_UP glioblastoma DOID_3068 3.086E-03 0.04181215 0.07889474 0.35912883 HUANG_DASATINIB_RESISTANCE_UP carotid artery disease DOID_3407 3.391E-03 0.04487511 0.08261318 0.36439455 HUANG_DASATINIB_RESISTANCE_UP respiratory failure DOID_11162 3.496E-03 0.04520868 0.08384938 0.36420076 HUANG_DASATINIB_RESISTANCE_UP hypothyroidism DOID_1459 3.496E-03 0.04420404 3.496E-03 0.09472294 HUANG_DASATINIB_RESISTANCE_UP uterine disease DOID_345 3.819E-03 0.04723786 3.819E-03 0.09877007 HUANG_DASATINIB_RESISTANCE_UP tooth disease DOID_1091 4.042E-03 0.04892933 4.042E-03 0.09998602 HUANG_DASATINIB_RESISTANCE_UP brain infarction DOID_3454 4.155E-03 0.04925644 0.0912324 0.37891414 HUANG_DASATINIB_RESISTANCE_UP astrocytoma DOID_3069 4.27E-03 0.0495873 0.09245722 0.38121854 HUANG_DASATINIB_RESISTANCE_UP blood coagulation disease DOID_1247 4.387E-03 0.04992166 4.387E-03 0.10400346 HUANG_DASATINIB_RESISTANCE_UP diabetic retinopathy DOID_8947 4.745E-03 0.05294103 0.09734033 0.39004683 HUANG_DASATINIB_RESISTANCE_UP syndrome DOID_225 4.991E-03 0.05461675 4.991E-03 0.11360284 HUANG_DASATINIB_RESISTANCE_UP aneurysm disease DOID_2403 5.117E-03 0.05493104 0.10098575 0.39903399 HUANG_DASATINIB_RESISTANCE_UP female reproductive system disease DOID_229 5.632E-03 0.05934485 5.632E-03 0.11868971 HUANG_DASATINIB_RESISTANCE_UP retinal vascular disease DOID_2462 6.17E-03 0.06383419 0.11063646 0.41968097 HUANG_DASATINIB_RESISTANCE_UP amino acid metabolic disorder DOID_9252 6.731E-03 0.06839245 6.731E-03 0.13206818 HUANG_DASATINIB_RESISTANCE_UP lymphoblastic leukemia DOID_1037 7.314E-03 0.07301354 7.314E-03 0.13872572 HUANG_DASATINIB_RESISTANCE_UP encephalomyelitis DOID_640 7.314E-03 0.07175468 7.314E-03 0.1342507 HUANG_DASATINIB_RESISTANCE_UP mouth disease DOID_403 7.463E-03 0.07197776 7.463E-03 0.132709 WANG_BARRETTS_ESOPHAGUS_DN keratosis DOID_161 6.085E-08 3.463E-05 6.085E-08 3.463E-05 WANG_BARRETTS_ESOPHAGUS_DN seminoma DOID_4440 7.105E-05 0.02021368 7.105E-05 0.02021368 WANG_BARRETTS_ESOPHAGUS_DN renal tubular transport disease DOID_447 8.172E-05 0.01549967 0.01337054 0.38039177 WANG_BARRETTS_ESOPHAGUS_DN germinoma DOID_3304 1.053E-04 0.01497612 1.053E-04 0.01996816 WANG_BARRETTS_ESOPHAGUS_DN integumentary system benign neoplasm DOID_0060121 2.477E-04 0.02818439 2.477E-04 0.03523049 WANG_BARRETTS_ESOPHAGUS_DN skin benign neoplasm DOID_3165 2.477E-04 0.02818439 2.477E-04 0.03523049 WANG_BARRETTS_ESOPHAGUS_DN atopic dermatitis DOID_3310 2.771E-04 0.02628251 2.771E-04 0.03153901 WANG_BARRETTS_ESOPHAGUS_DN integumentary system cancer DOID_0060122 3.083E-04 0.02505665 3.083E-04 0.02923276 WANG_BARRETTS_ESOPHAGUS_DN skin cancer DOID_4159 3.083E-04 0.02505665 3.083E-04 0.02923276 WANG_BARRETTS_ESOPHAGUS_DN transitional cell carcinoma DOID_2671 7.406E-04 0.05267417 0.03960844 0.5122091 HELLER_HDAC_TARGETS_UP female reproductive system disease DOID_229 3.704E-08 2.107E-05 1.863E-05 1.767E-03 HELLER_HDAC_TARGETS_UP encephalomyelitis DOID_640 9.483E-08 2.698E-05 2.007E-06 2.855E-04 HELLER_HDAC_TARGETS_UP glioblastoma DOID_3068 1.429E-07 2.71E-05 1.429E-07 8.129E-05 HELLER_HDAC_TARGETS_UP oral cavity cancer DOID_8618 1.429E-07 2.032E-05 1.429E-07 4.064E-05 HELLER_HDAC_TARGETS_UP uterine disease DOID_345 2.754E-07 3.134E-05 1.457E-04 5.922E-03 HELLER_HDAC_TARGETS_UP astrocytoma DOID_3069 3.881E-07 3.681E-05 3.881E-07 7.362E-05 HELLER_HDAC_TARGETS_UP endometriosis of uterus DOID_288 8.826E-07 7.174E-05 7.193E-04 0.01574128 HELLER_HDAC_TARGETS_UP endometriosis DOID_289 9.872E-07 7.021E-05 7.673E-04 0.01616996 HELLER_HDAC_TARGETS_UP giant cell tumor DOID_200 2.666E-06 1.686E-04 2.666E-06 3.034E-04 HELLER_HDAC_TARGETS_UP malignant giant cell tumor DOID_2705 2.666E-06 1.686E-04 2.666E-06 3.034E-04 HELLER_HDAC_TARGETS_UP giant cell glioblastoma DOID_3074 2.666E-06 1.686E-04 2.666E-06 3.034E-04 HELLER_HDAC_TARGETS_UP celiac disease DOID_10608 9.191E-06 5.23E-04 7.723E-03 0.07204094 HELLER_HDAC_TARGETS_UP embryonal cancer DOID_688 1.779E-05 9.202E-04 5.08E-04 0.01256649 HELLER_HDAC_TARGETS_UP alcohol abuse DOID_1574 2.092E-05 9.92E-04 2.092E-05 1.701E-03 HELLER_HDAC_TARGETS_UP adenoid cystic carcinoma DOID_4866 2.381E-05 1.042E-03 2.381E-05 1.693E-03 HELLER_HDAC_TARGETS_UP primary bacterial infectious disease DOID_0050338 2.615E-05 1.063E-03 0.04696684 0.24075794 HELLER_HDAC_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 2.857E-05 1.084E-03 7.193E-04 0.01637093 HELLER_HDAC_TARGETS_UP primary biliary cirrhosis DOID_12236 2.857E-05 1.084E-03 7.193E-04 0.01637093 HELLER_HDAC_TARGETS_UP salivary gland cancer DOID_8850 2.857E-05 1.016E-03 2.857E-05 1.806E-03 HELLER_HDAC_TARGETS_UP gallbladder cancer DOID_3121 3.399E-05 1.138E-03 3.399E-05 1.934E-03 HELLER_HDAC_TARGETS_UP lymphoma DOID_0060058 3.404E-05 1.076E-03 3.404E-05 1.761E-03 HELLER_HDAC_TARGETS_UP learning disability DOID_8927 3.697E-05 1.107E-03 3.697E-05 1.753E-03 HELLER_HDAC_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 5.083E-05 1.446E-03 0.01744472 0.13597325 HELLER_HDAC_TARGETS_UP atrophic muscular disease DOID_913 6.813E-05 1.846E-03 6.813E-05 2.982E-03 HELLER_HDAC_TARGETS_UP muscular dystrophy DOID_9884 6.813E-05 1.846E-03 6.813E-05 2.982E-03 HELLER_HDAC_TARGETS_UP hypothyroidism DOID_1459 1.222E-04 3.162E-03 2.092E-03 0.0283468 HELLER_HDAC_TARGETS_UP ankylosing spondylitis DOID_7147 1.56E-04 3.86E-03 4.919E-03 0.05597313 HELLER_HDAC_TARGETS_UP pancreatic ductal carcinoma DOID_3587 1.919E-04 4.548E-03 1.919E-04 7.278E-03 HELLER_HDAC_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 1.938E-04 4.411E-03 1.938E-04 6.893E-03 HELLER_HDAC_TARGETS_UP autoimmune disease of the nervous system DOID_438 2.147E-04 4.7E-03 0.11005523 0.35783672 HELLER_HDAC_TARGETS_UP pancreatic carcinoma DOID_4905 2.241E-04 4.723E-03 2.241E-04 7.501E-03 HELLER_HDAC_TARGETS_UP syndrome DOID_225 2.477E-04 5.033E-03 2.477E-04 7.83E-03 HELLER_HDAC_TARGETS_UP mixed glioma DOID_5076 2.73E-04 5.356E-03 2.73E-04 8.175E-03 HELLER_HDAC_TARGETS_UP biliary tract cancer DOID_4607 3.443E-04 6.53E-03 3.443E-04 9.795E-03 HELLER_HDAC_TARGETS_UP papilloma DOID_2615 3.713E-04 6.815E-03 3.713E-04 0.01005983 HELLER_HDAC_TARGETS_UP pneumoconiosis DOID_10316 4.029E-04 7.164E-03 0.13395195 0.39491535 HELLER_HDAC_TARGETS_UP nephroblastoma DOID_2154 4.029E-04 6.947E-03 4.029E-04 0.01042025 HELLER_HDAC_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 4.652E-04 7.786E-03 5.575E-03 0.05874641 HELLER_HDAC_TARGETS_UP Sjogren's syndrome DOID_12894 6.584E-04 0.01070401 0.03810984 0.2357011 HELLER_HDAC_TARGETS_UP angioedema DOID_1558 6.584E-04 0.01040667 1.000 1.000 HELLER_HDAC_TARGETS_UP polycythemia DOID_8432 6.584E-04 0.01012541 6.584E-04 0.01561001 HELLER_HDAC_TARGETS_UP relapsing-remitting multiple sclerosis DOID_2378 9.608E-04 0.01438634 9.608E-04 0.01952432 HELLER_HDAC_TARGETS_UP epidermolysis bullosa DOID_2730 9.608E-04 0.01401746 9.608E-04 0.01885106 HELLER_HDAC_TARGETS_UP encephalitis DOID_9588 9.608E-04 0.01366702 1.000 1.000 HELLER_HDAC_TARGETS_UP hemolytic anemia DOID_583 1.038E-03 0.01440306 1.038E-03 0.01968419 HELLER_HDAC_TARGETS_UP normocytic anemia DOID_720 1.038E-03 0.01440306 1.038E-03 0.01968419 HELLER_HDAC_TARGETS_UP berylliosis DOID_10322 1.133E-03 0.01534369 1.000 1.000 HELLER_HDAC_TARGETS_UP obstructive hydrocephalus DOID_14159 1.133E-03 0.01498686 1.133E-03 0.02078822 HELLER_HDAC_TARGETS_UP communicating hydrocephalus DOID_1573 1.133E-03 0.01498686 1.133E-03 0.02078822 HELLER_HDAC_TARGETS_UP vesiculobullous skin disease DOID_2731 1.133E-03 0.01464625 1.133E-03 0.02013859 HELLER_HDAC_TARGETS_UP aortic aneurysm DOID_3627 1.161E-03 0.01467851 0.18620657 0.47725918 HELLER_HDAC_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 1.226E-03 0.01516114 1.226E-03 0.02113371 HELLER_HDAC_TARGETS_UP hydrocephalus DOID_10908 1.318E-03 0.01595595 1.318E-03 0.02205676 HELLER_HDAC_TARGETS_UP sarcoidosis DOID_11335 1.362E-03 0.01614596 1.000 1.000 HELLER_HDAC_TARGETS_UP thalassemia DOID_10241 1.517E-03 0.01761439 1.517E-03 0.02466015 HELLER_HDAC_TARGETS_UP communication disorder DOID_2033 1.517E-03 0.0172621 1.517E-03 0.02397514 HELLER_HDAC_TARGETS_UP panic disorder DOID_594 1.517E-03 0.01692363 1.517E-03 0.02332717 HELLER_HDAC_TARGETS_UP intracranial hypertension DOID_9428 1.517E-03 0.01659818 1.517E-03 0.02271329 HELLER_HDAC_TARGETS_UP chronic myeloid leukemia DOID_8552 1.729E-03 0.01856416 1.729E-03 0.02522822 HELLER_HDAC_TARGETS_UP tongue cancer DOID_8649 1.729E-03 0.01822038 1.729E-03 0.02459751 HELLER_HDAC_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 1.744E-03 0.01803827 1.744E-03 0.02419768 HELLER_HDAC_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 1.744E-03 0.01771616 1.000 1.000 HELLER_HDAC_TARGETS_UP parasitic infectious disease DOID_1398 2.38E-03 0.0237627 0.02879018 0.19977576 HELLER_HDAC_TARGETS_UP cerebral degeneration DOID_1443 2.38E-03 0.023353 2.38E-03 0.03149939 HELLER_HDAC_TARGETS_UP membranous glomerulonephritis DOID_10976 2.71E-03 0.02613706 0.07477683 0.28365345 HELLER_HDAC_TARGETS_UP peripheral vascular disease DOID_341 3.145E-03 0.02982201 0.25297996 0.60481344 HELLER_HDAC_TARGETS_UP hepatitis B DOID_2043 3.278E-03 0.03057962 0.0819419 0.29697414 HELLER_HDAC_TARGETS_UP myasthenia gravis DOID_437 3.581E-03 0.03286825 1.000 1.000 HELLER_HDAC_TARGETS_UP lingual-facial-buccal dyskinesia DOID_9854 3.581E-03 0.03234653 3.581E-03 0.04631435 HELLER_HDAC_TARGETS_UP aneurysm disease DOID_2403 3.641E-03 0.03237517 0.26452219 0.6245358 HELLER_HDAC_TARGETS_UP electroclinical syndrome DOID_0050701 3.773E-03 0.03302595 3.773E-03 0.04770416 HELLER_HDAC_TARGETS_UP synostosis DOID_11971 3.897E-03 0.03359782 3.897E-03 0.04820557 HELLER_HDAC_TARGETS_UP congenital hemolytic anemia DOID_589 3.897E-03 0.03309636 3.897E-03 0.04717992 HELLER_HDAC_TARGETS_UP Goodpasture syndrome DOID_9808 3.897E-03 0.03260965 0.08905185 0.31086198 HELLER_HDAC_TARGETS_UP chromosomal disease DOID_0080014 4.184E-03 0.03449995 4.184E-03 0.04959368 HELLER_HDAC_TARGETS_UP urticaria DOID_1555 4.566E-03 0.03711322 1.000 1.000 HELLER_HDAC_TARGETS_UP cystitis DOID_1679 4.919E-03 0.0394177 0.09961437 0.34351863 HELLER_HDAC_TARGETS_UP papillary adenoma DOID_3172 4.919E-03 0.03887023 4.919E-03 0.05711544 HELLER_HDAC_TARGETS_UP neuromuscular junction disease DOID_439 4.919E-03 0.03833776 1.000 1.000 HELLER_HDAC_TARGETS_UP microcystic adenoma DOID_5403 4.919E-03 0.03887023 4.919E-03 0.05711544 HELLER_HDAC_TARGETS_UP follicular adenoma DOID_6204 4.919E-03 0.03887023 4.919E-03 0.05711544 HELLER_HDAC_TARGETS_UP transitional cell carcinoma DOID_2671 5.245E-03 0.04032987 5.245E-03 0.05851785 HELLER_HDAC_TARGETS_UP vitiligo DOID_12306 5.283E-03 0.04008414 0.1031081 0.34921732 HELLER_HDAC_TARGETS_UP juvenile myoclonic epilepsy DOID_4890 5.283E-03 0.03955672 5.283E-03 0.05781367 HELLER_HDAC_TARGETS_UP fragments of torsion dystonia DOID_531 5.283E-03 0.03904299 5.283E-03 0.05672284 HELLER_HDAC_TARGETS_UP renal hypertension DOID_1073 6.049E-03 0.04413029 0.11005523 0.36407806 HELLER_HDAC_TARGETS_UP secondary hypertension DOID_11130 6.049E-03 0.04413029 0.11005523 0.36407806 HELLER_HDAC_TARGETS_UP central nervous system hereditary degenerative disease DOID_481 6.049E-03 0.04357168 6.049E-03 0.06258478 HELLER_HDAC_TARGETS_UP Crohn's disease DOID_8778 6.272E-03 0.04461272 6.272E-03 0.06373245 HELLER_HDAC_TARGETS_UP autoimmune disease of endocrine system DOID_0060005 6.45E-03 0.04531173 0.11350873 0.36696855 HELLER_HDAC_TARGETS_UP dystonic disease DOID_544 6.45E-03 0.04475915 6.45E-03 0.06439035 HELLER_HDAC_TARGETS_UP dilated cardiomyopathy DOID_12930 6.454E-03 0.0442482 6.454E-03 0.06332071 HELLER_HDAC_TARGETS_UP dysostosis DOID_1934 6.863E-03 0.04648855 6.863E-03 0.06618708 HELLER_HDAC_TARGETS_UP bronchiolitis obliterans DOID_2799 7.287E-03 0.04878202 0.12037584 0.37023703 HELLER_HDAC_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 7.723E-03 0.05109881 7.723E-03 0.07324163 HELLER_HDAC_TARGETS_UP bladder disease DOID_365 8.171E-03 0.05343748 0.12719011 0.38090091 HELLER_HDAC_TARGETS_UP systemic mycosis DOID_0050136 8.629E-03 0.05579668 0.13057756 0.38899808 HELLER_HDAC_TARGETS_UP fungal infectious disease DOID_1564 8.629E-03 0.05579668 0.13057756 0.38899808 HELLER_HDAC_TARGETS_UP myocarditis DOID_820 8.629E-03 0.05516976 0.13057756 0.38697204 HELLER_HDAC_TARGETS_UP male infertility DOID_12336 9.099E-03 0.05752873 9.099E-03 0.08350945 HELLER_HDAC_TARGETS_UP hyperthyroidism DOID_7998 9.099E-03 0.05689655 9.099E-03 0.08218391 HELLER_HDAC_TARGETS_UP adenoma DOID_657 0.01007315 0.06230023 0.01007315 0.08955659 HELLER_HDAC_TARGETS_UP adolescence-adult electroclinical syndrome DOID_0050705 0.01057658 0.06471047 0.01057658 0.09258575 HELLER_HDAC_TARGETS_UP hepatitis DOID_2237 0.01161614 0.07031475 0.01161614 0.10014525 HELLER_HDAC_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 0.01269871 0.07605859 0.15721125 0.43214108 HELLER_HDAC_TARGETS_UP primitive neuroectodermal tumor DOID_168 0.01382356 0.08193337 0.01382356 0.11739707 HELLER_HDAC_TARGETS_UP hyperinsulinism DOID_2018 0.01382356 0.0810887 0.01382356 0.11567064 HELLER_HDAC_TARGETS_UP uterine cancer DOID_363 0.01440161 0.08361753 0.01440161 0.11876112 HELLER_HDAC_TARGETS_UP influenza DOID_8469 0.01440161 0.0827729 0.16698859 0.45031522 HELLER_HDAC_TARGETS_UP cerebral infarction DOID_3526 0.01498997 0.08529295 0.01498997 0.12184707 HELLER_HDAC_TARGETS_UP proteinuria DOID_576 0.01558855 0.08782065 1.000 1.000 HELLER_HDAC_TARGETS_UP thyroid adenoma DOID_2891 0.01619726 0.0903553 0.01619726 0.12980621 HELLER_HDAC_TARGETS_UP bone marrow disease DOID_4961 0.01619726 0.08947807 0.01619726 0.12800335 HELLER_HDAC_TARGETS_UP vascular skin disease DOID_9540 0.01619726 0.0886177 1.000 1.000 HELLER_HDAC_TARGETS_UP movement disease DOID_480 0.0180833 0.09799429 0.0180833 0.13904595 ZHAN_MULTIPLE_MYELOMA_DN carotid artery disease DOID_3407 3.717E-07 2.115E-04 2.889E-05 5.48E-03 ZHAN_MULTIPLE_MYELOMA_DN brain infarction DOID_3454 5.658E-07 1.61E-04 3.946E-05 5.613E-03 ZHAN_MULTIPLE_MYELOMA_DN spastic quadriplegia DOID_10970 1.635E-06 3.101E-04 2.451E-04 0.01549615 ZHAN_MULTIPLE_MYELOMA_DN mouth disease DOID_403 1.903E-06 2.707E-04 1.903E-06 1.083E-03 ZHAN_MULTIPLE_MYELOMA_DN spastic cerebral palsy DOID_0050669 3.859E-06 4.391E-04 4.294E-04 0.02036028 ZHAN_MULTIPLE_MYELOMA_DN heart valve disease DOID_4079 1.371E-05 1.3E-03 1.371E-05 3.901E-03 ZHAN_MULTIPLE_MYELOMA_DN peripheral vascular disease DOID_341 4.65E-05 3.78E-03 4.65E-05 5.292E-03 ZHAN_MULTIPLE_MYELOMA_DN aneurysm disease DOID_2403 5.432E-05 3.864E-03 2.44E-03 0.05339312 ZHAN_MULTIPLE_MYELOMA_DN carotid stenosis DOID_13001 6.417E-05 4.057E-03 0.01193742 0.16172356 ZHAN_MULTIPLE_MYELOMA_DN spastic diplegia DOID_10965 9.856E-05 5.608E-03 9.856E-05 9.346E-03 ZHAN_MULTIPLE_MYELOMA_DN hypersensitivity reaction type I disease DOID_1205 1.001E-04 5.18E-03 1.001E-04 8.14E-03 ZHAN_MULTIPLE_MYELOMA_DN amyloidosis DOID_9120 1.557E-04 7.382E-03 0.0183078 0.20032955 ZHAN_MULTIPLE_MYELOMA_DN funisitis DOID_0050698 1.891E-04 8.275E-03 1.891E-04 0.01344691 ZHAN_MULTIPLE_MYELOMA_DN sphingolipidosis DOID_1927 2.451E-04 9.962E-03 0.02283362 0.21298905 ZHAN_MULTIPLE_MYELOMA_DN urticaria DOID_1555 2.654E-04 0.01006666 2.654E-04 0.01509999 ZHAN_MULTIPLE_MYELOMA_DN thrombocytopenia DOID_1588 3.544E-04 0.01260246 3.544E-04 0.01833086 ZHAN_MULTIPLE_MYELOMA_DN abdominal aortic aneurysm DOID_7693 4.294E-04 0.01437196 0.03003282 0.25130402 ZHAN_MULTIPLE_MYELOMA_DN myocarditis DOID_820 5.115E-04 0.01616754 5.115E-04 0.02238583 ZHAN_MULTIPLE_MYELOMA_DN adenoma DOID_657 6.005E-04 0.01798397 6.005E-04 0.02440682 ZHAN_MULTIPLE_MYELOMA_DN calcinosis DOID_182 6.318E-04 0.01797356 6.318E-04 0.02396474 ZHAN_MULTIPLE_MYELOMA_DN blood platelet disease DOID_2218 6.638E-04 0.01798508 6.638E-04 0.02360542 ZHAN_MULTIPLE_MYELOMA_DN lymphatic system disease DOID_75 7.301E-04 0.01888338 0.03895938 0.29956605 ZHAN_MULTIPLE_MYELOMA_DN cerebral infarction DOID_3526 9.094E-04 0.02249771 0.04339269 0.31253719 ZHAN_MULTIPLE_MYELOMA_DN vascular skin disease DOID_9540 9.865E-04 0.02338723 9.865E-04 0.03301727 ZHAN_MULTIPLE_MYELOMA_DN calcium metabolism disease DOID_10575 1.108E-03 0.02521209 1.108E-03 0.03501679 ZHAN_MULTIPLE_MYELOMA_DN aortic aneurysm DOID_3627 1.108E-03 0.02424239 0.04780612 0.32382955 ZHAN_MULTIPLE_MYELOMA_DN hemorrhagic disease DOID_2213 1.15E-03 0.02422836 1.15E-03 0.03442978 ZHAN_MULTIPLE_MYELOMA_DN pustulosis of palm and sole DOID_4398 1.325E-03 0.02692511 0.05219977 0.33001856 ZHAN_MULTIPLE_MYELOMA_DN familial hyperlipidemia DOID_1168 1.371E-03 0.02689325 0.05307614 0.32826436 ZHAN_MULTIPLE_MYELOMA_DN leukocyte disease DOID_9500 1.512E-03 0.02868188 1.512E-03 0.04302281 ZHAN_MULTIPLE_MYELOMA_DN mineral metabolism disease DOID_0050032 1.763E-03 0.03235996 1.763E-03 0.04776946 ZHAN_MULTIPLE_MYELOMA_DN cholestasis DOID_13580 1.815E-03 0.03227999 0.06092807 0.36112576 ZHAN_MULTIPLE_MYELOMA_DN tooth disease DOID_1091 1.922E-03 0.03314595 1.922E-03 0.04971892 ZHAN_MULTIPLE_MYELOMA_DN blood coagulation disease DOID_1247 2.088E-03 0.03494782 2.088E-03 0.051662 ZHAN_MULTIPLE_MYELOMA_DN nephrosis DOID_2527 2.145E-03 0.03487218 2.145E-03 0.05085526 ZHAN_MULTIPLE_MYELOMA_DN bile duct disease DOID_4138 2.145E-03 0.0339035 0.06612752 0.37254018 ZHAN_MULTIPLE_MYELOMA_DN biliary tract disease DOID_9741 2.203E-03 0.03387136 0.06699137 0.37370676 ZHAN_MULTIPLE_MYELOMA_DN diabetic retinopathy DOID_8947 2.261E-03 0.03385178 2.261E-03 0.0514547 ZHAN_MULTIPLE_MYELOMA_DN pancreatitis DOID_4989 2.501E-03 0.03648702 2.501E-03 0.05270347 ZHAN_MULTIPLE_MYELOMA_DN metabolic syndrome X DOID_14221 2.625E-03 0.03734416 2.625E-03 0.05334879 ZHAN_MULTIPLE_MYELOMA_DN lipid metabolism disorder DOID_3146 2.625E-03 0.03643332 0.07301663 0.3882847 ZHAN_MULTIPLE_MYELOMA_DN chromosomal disease DOID_0080014 2.689E-03 0.03642297 2.689E-03 0.05275051 ZHAN_MULTIPLE_MYELOMA_DN retinal vascular disease DOID_2462 2.949E-03 0.03901917 2.949E-03 0.05592747 ZHAN_MULTIPLE_MYELOMA_DN encephalomyelitis DOID_640 3.503E-03 0.04530229 3.503E-03 0.06430003 ZHAN_MULTIPLE_MYELOMA_DN ulcerative colitis DOID_8577 3.872E-03 0.04896547 3.872E-03 0.06885769 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP oral cavity cancer DOID_8618 2.187E-06 1.244E-03 2.187E-06 1.244E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP adenoid cystic carcinoma DOID_4866 1.493E-04 0.04246966 1.493E-04 0.04246966 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP salivary gland cancer DOID_8850 1.636E-04 0.03102567 1.636E-04 0.03102567 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP gallbladder cancer DOID_3121 1.785E-04 0.02539564 0.01965641 0.53259513 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP allergic contact dermatitis DOID_3042 3.966E-04 0.04513179 0.02914295 0.51819809 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP contact dermatitis DOID_2773 5.438E-04 0.05156688 0.03405822 0.52376017 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP biliary tract cancer DOID_4607 5.841E-04 0.04747914 0.03528339 0.48966454 RICKMAN_HEAD_AND_NECK_CANCER_D myositis DOID_633 5.651E-07 3.215E-04 1.224E-04 0.03483467 RICKMAN_HEAD_AND_NECK_CANCER_D Sjogren's syndrome DOID_12894 1.58E-05 4.494E-03 6.051E-03 0.21518943 RICKMAN_HEAD_AND_NECK_CANCER_D common variable immunodeficiency DOID_12177 1.93E-05 3.661E-03 6.654E-03 0.21034643 RICKMAN_HEAD_AND_NECK_CANCER_D hypersensitivity reaction type I disease DOID_1205 2.771E-05 3.941E-03 1.583E-03 0.06004059 RICKMAN_HEAD_AND_NECK_CANCER_D narcolepsy DOID_8986 3.19E-05 3.63E-03 8.462E-03 0.22926932 RICKMAN_HEAD_AND_NECK_CANCER_D thyroiditis DOID_7166 4.203E-05 3.986E-03 9.665E-03 0.21997098 RICKMAN_HEAD_AND_NECK_CANCER_D autoimmune thyroiditis DOID_7188 4.203E-05 3.986E-03 9.665E-03 0.21997098 RICKMAN_HEAD_AND_NECK_CANCER_D juvenile rheumatoid arthritis DOID_676 4.762E-05 3.871E-03 0.01026588 0.22466483 RICKMAN_HEAD_AND_NECK_CANCER_D agammaglobulinemia DOID_2583 5.983E-05 4.255E-03 0.01146698 0.21749042 RICKMAN_HEAD_AND_NECK_CANCER_D blood protein disease DOID_620 6.645E-05 4.201E-03 0.01206701 0.21456652 RICKMAN_HEAD_AND_NECK_CANCER_D sinusitis DOID_0050127 8.839E-05 5.029E-03 8.839E-05 0.05029171 RICKMAN_HEAD_AND_NECK_CANCER_D paranasal sinus disease DOID_1352 8.839E-05 5.029E-03 8.839E-05 0.05029171 RICKMAN_HEAD_AND_NECK_CANCER_D myasthenia gravis DOID_437 8.839E-05 4.572E-03 0.013865 0.23906628 RICKMAN_HEAD_AND_NECK_CANCER_D sleep disorder DOID_535 8.839E-05 4.191E-03 0.013865 0.23203492 RICKMAN_HEAD_AND_NECK_CANCER_D neuromuscular junction disease DOID_439 1.224E-04 5.359E-03 0.01625746 0.25001339 RICKMAN_HEAD_AND_NECK_CANCER_D ankylosing spondylitis DOID_7147 1.224E-04 4.976E-03 0.01625746 0.24343409 RICKMAN_HEAD_AND_NECK_CANCER_D B cell deficiency DOID_2115 1.318E-04 5E-03 0.01685471 0.24590586 RICKMAN_HEAD_AND_NECK_CANCER_D autoimmune disease of the nervous system DOID_438 1.516E-04 5.39E-03 0.01804816 0.23339552 RICKMAN_HEAD_AND_NECK_CANCER_D autoimmune disease of endocrine system DOID_0060005 1.62E-04 5.421E-03 0.01864437 0.23062271 RICKMAN_HEAD_AND_NECK_CANCER_D opportunistic mycosis DOID_2473 1.838E-04 5.809E-03 0.01983574 0.23513617 RICKMAN_HEAD_AND_NECK_CANCER_D celiac disease DOID_10608 1.952E-04 5.846E-03 0.02043091 0.23250374 RICKMAN_HEAD_AND_NECK_CANCER_D chronic leukemia DOID_1036 2.069E-04 5.888E-03 2.069E-04 0.03925075 RICKMAN_HEAD_AND_NECK_CANCER_D chronic lymphocytic leukemia DOID_1040 2.069E-04 5.888E-03 2.069E-04 0.03925075 RICKMAN_HEAD_AND_NECK_CANCER_D systemic mycosis DOID_0050136 2.19E-04 5.935E-03 0.02162021 0.24121369 RICKMAN_HEAD_AND_NECK_CANCER_D fungal infectious disease DOID_1564 2.19E-04 5.935E-03 0.02162021 0.24121369 RICKMAN_HEAD_AND_NECK_CANCER_D esophageal disease DOID_6050 2.315E-04 5.987E-03 0.02221434 0.2384898 RICKMAN_HEAD_AND_NECK_CANCER_D multiple myeloma DOID_9538 2.708E-04 6.699E-03 2.708E-04 0.03851993 RICKMAN_HEAD_AND_NECK_CANCER_D uveitis DOID_13141 2.846E-04 6.747E-03 0.02458742 0.254368 RICKMAN_HEAD_AND_NECK_CANCER_D hepatitis DOID_2237 2.987E-04 6.798E-03 2.987E-04 0.03399097 RICKMAN_HEAD_AND_NECK_CANCER_D uveal disease DOID_3480 3.585E-04 7.846E-03 0.02754602 0.27497691 RICKMAN_HEAD_AND_NECK_CANCER_D myeloma DOID_0070004 4.237E-04 8.929E-03 4.237E-04 0.04018217 RICKMAN_HEAD_AND_NECK_CANCER_D autoimmune disease of gastrointestinal tract DOID_0060031 4.583E-04 9.314E-03 0.03108501 0.28995687 RICKMAN_HEAD_AND_NECK_CANCER_D B-cell lymphocytic neoplasm DOID_707 4.942E-04 9.697E-03 0.03226193 0.28241597 RICKMAN_HEAD_AND_NECK_CANCER_D sarcoidosis DOID_11335 5.315E-04 0.01008061 0.03343749 0.28827166 RICKMAN_HEAD_AND_NECK_CANCER_D giant cell tumor DOID_200 5.315E-04 9.755E-03 5.315E-04 0.04320261 RICKMAN_HEAD_AND_NECK_CANCER_D malignant giant cell tumor DOID_2705 5.315E-04 9.755E-03 5.315E-04 0.04320261 RICKMAN_HEAD_AND_NECK_CANCER_D giant cell glioblastoma DOID_3074 5.315E-04 9.755E-03 5.315E-04 0.04320261 RICKMAN_HEAD_AND_NECK_CANCER_D bone marrow cancer DOID_4960 5.506E-04 9.791E-03 5.506E-04 0.03916247 RICKMAN_HEAD_AND_NECK_CANCER_D pustulosis of palm and sole DOID_4398 5.701E-04 9.829E-03 0.03461168 0.28961829 RICKMAN_HEAD_AND_NECK_CANCER_D hypersensitivity reaction type IV disease DOID_2916 6.304E-04 0.01055015 0.0363704 0.29563942 RICKMAN_HEAD_AND_NECK_CANCER_D glioblastoma DOID_3068 6.304E-04 0.01024872 6.304E-04 0.03985612 RICKMAN_HEAD_AND_NECK_CANCER_D hyperglycemia DOID_4195 8.058E-04 0.01273593 8.058E-04 0.04584936 RICKMAN_HEAD_AND_NECK_CANCER_D astrocytoma DOID_3069 8.769E-04 0.01348603 8.769E-04 0.04536209 RICKMAN_HEAD_AND_NECK_CANCER_D pancreatic ductal carcinoma DOID_3587 9.013E-04 0.01349604 9.013E-04 0.04273748 RICKMAN_HEAD_AND_NECK_CANCER_D pancreatic carcinoma DOID_4905 9.764E-04 0.01424507 9.764E-04 0.04273522 RICKMAN_HEAD_AND_NECK_CANCER_D primary immunodeficiency disease DOID_612 1.395E-03 0.0198462 0.05378994 0.34780084 RICKMAN_HEAD_AND_NECK_CANCER_D Human immunodeficiency virus infectious disease DOID_526 1.426E-03 0.01978512 0.05436537 0.34757185 RICKMAN_HEAD_AND_NECK_CANCER_D lymphoma DOID_0060058 1.488E-03 0.02015277 0.05551523 0.35097961 RICKMAN_HEAD_AND_NECK_CANCER_D lymphoblastic leukemia DOID_1037 1.519E-03 0.02010001 1.519E-03 0.06173574 RICKMAN_HEAD_AND_NECK_CANCER_D encephalomyelitis DOID_640 1.519E-03 0.01964319 0.05608966 0.35071445 RICKMAN_HEAD_AND_NECK_CANCER_D angioedema DOID_1558 6.051E-03 0.0765118 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_D dermatomyositis DOID_10223 6.654E-03 0.08230947 6.654E-03 0.22271975 RICKMAN_HEAD_AND_NECK_CANCER_D pneumocystosis DOID_11339 6.654E-03 0.08055821 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_D diarrhea DOID_13250 7.257E-03 0.08602587 7.257E-03 0.2173285 RICKMAN_HEAD_AND_NECK_CANCER_D stomach disease DOID_76 7.257E-03 0.08427024 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_D encephalitis DOID_9588 7.257E-03 0.08258483 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_D cone-rod dystrophy DOID_0050572 7.859E-03 0.08768722 7.859E-03 0.22360241 RICKMAN_HEAD_AND_NECK_CANCER_D idiopathic pulmonary fibrosis DOID_0050156 9.063E-03 0.09917432 9.063E-03 0.23441202 RICKMAN_HEAD_AND_NECK_CANCER_D arthropathy DOID_381 9.063E-03 0.0973031 9.063E-03 0.22422019 RICKMAN_HEAD_AND_NECK_CANCER_D adrenal cortex disease DOID_3952 9.063E-03 0.09550119 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_D nutritional deficiency disease DOID_5113 9.063E-03 0.09376481 9.063E-03 0.21487769 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP renovascular hypertension DOID_1591 9.418E-07 5.359E-04 2.725E-03 0.03975611 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP parasitic infectious disease DOID_1398 1.573E-06 4.475E-04 4.527E-04 0.01609793 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP endocrine organ benign neoplasm DOID_0060089 2.031E-06 3.853E-04 5.335E-04 0.0178576 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP aneurysm disease DOID_2403 3.808E-06 5.418E-04 6.085E-05 8.656E-03 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP metabolic syndrome X DOID_14221 4.736E-06 5.389E-04 9.183E-03 0.06699175 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP thyroid adenoma DOID_2891 6.467E-06 6.133E-04 1.377E-04 0.01119587 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP integumentary system benign neoplasm DOID_0060121 7.865E-06 6.393E-04 7.865E-06 4.475E-03 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP skin benign neoplasm DOID_3165 7.865E-06 6.393E-04 7.865E-06 4.475E-03 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP transitional cell carcinoma DOID_2671 8.134E-06 5.785E-04 8.134E-06 2.314E-03 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP lymphoma DOID_0060058 1.045E-05 6.61E-04 1.045E-05 1.983E-03 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP papillary adenoma DOID_3172 1.153E-05 6.56E-04 3.742E-04 0.01774205 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP microcystic adenoma DOID_5403 1.153E-05 6.56E-04 3.742E-04 0.01774205 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP follicular adenoma DOID_6204 1.153E-05 6.56E-04 3.742E-04 0.01774205 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP parasitic protozoa infectious disease DOID_2789 1.352E-05 6.993E-04 3.505E-03 0.04155356 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP renal hypertension DOID_1073 1.778E-05 8.432E-04 0.01072385 0.0726413 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP secondary hypertension DOID_11130 1.778E-05 8.432E-04 0.01072385 0.0726413 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP carotid artery disease DOID_3407 2.193E-05 9.6E-04 4.626E-03 0.04786051 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP tuberculosis DOID_399 3.636E-05 1.478E-03 6.18E-03 0.05247975 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP papilloma DOID_2615 3.73E-05 1.415E-03 8.823E-04 0.02390733 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP adenoma DOID_657 5.145E-05 1.83E-03 1.116E-03 0.02762029 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP mesenchymal cell neoplasm DOID_3350 6.096E-05 2.04E-03 2.725E-03 0.03781679 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP spindle cell sarcoma DOID_4235 6.096E-05 2.04E-03 2.725E-03 0.03781679 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP epithelioid sarcoma DOID_6193 6.096E-05 2.04E-03 2.725E-03 0.03781679 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pancreatitis DOID_4989 6.464E-05 2.043E-03 8.373E-04 0.0250754 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP mixed glioma DOID_5076 6.464E-05 1.936E-03 8.373E-04 0.02382163 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP bone development disease DOID_0080006 9.13E-05 2.597E-03 9.13E-05 0.01038962 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP primary bacterial infectious disease DOID_0050338 1.074E-04 2.911E-03 0.01146817 0.07250432 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP primary immunodeficiency disease DOID_612 1.194E-04 3.087E-03 1.353E-03 0.0275009 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Down syndrome DOID_14250 1.278E-04 3.162E-03 1.278E-04 0.01212269 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP leishmaniasis DOID_9065 1.278E-04 3.031E-03 0.09472466 0.25788676 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP encephalomyelitis DOID_640 1.462E-04 3.328E-03 1.586E-03 0.0291126 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP dilated cardiomyopathy DOID_12930 1.613E-04 3.53E-03 1.613E-04 0.01147197 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP calcium metabolism disease DOID_10575 1.73E-04 3.646E-03 2.713E-03 0.04171513 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hepatitis B DOID_2043 2.008E-04 4.081E-03 5.853E-03 0.05123313 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP placenta disease DOID_780 2.008E-04 3.94E-03 5.853E-03 0.05045688 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP atrophic muscular disease DOID_913 2.144E-04 4.066E-03 2.144E-04 0.01355245 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP muscular dystrophy DOID_9884 2.144E-04 4.066E-03 2.144E-04 0.01355245 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP uremia DOID_4676 2.301E-04 4.223E-03 2.301E-04 0.01309055 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP reproductive organ benign neoplasm DOID_0050622 2.456E-04 4.367E-03 3.505E-03 0.04336024 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP integumentary system cancer DOID_0060122 2.456E-04 4.235E-03 2.456E-04 0.01270475 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP skin cancer DOID_4159 2.456E-04 4.235E-03 2.456E-04 0.01270475 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP neuroectodermal tumor DOID_171 3.59E-04 6.007E-03 4.626E-03 0.04874681 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP cleft lip DOID_9296 3.742E-04 6.083E-03 3.742E-04 0.01637727 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP congenital heart defect DOID_1682 4.039E-04 6.383E-03 5.042E-03 0.04627713 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP intracranial aneurysm DOID_10941 4.175E-04 6.42E-03 4.175E-04 0.01696703 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP vitiligo DOID_12306 4.175E-04 6.251E-03 4.175E-04 0.0158359 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP mineral metabolism disease DOID_0050032 4.278E-04 6.241E-03 5.259E-03 0.04749628 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP uterine disease DOID_345 4.527E-04 6.439E-03 0.04937977 0.21613145 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP sarcoma DOID_1115 5.134E-04 7.125E-03 0.01072385 0.07178669 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pancreatic ductal carcinoma DOID_3587 5.928E-04 8.031E-03 6.674E-03 0.054247 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pancreatic carcinoma DOID_4905 6.903E-04 9.135E-03 7.458E-03 0.05893672 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP leiomyoma DOID_127 8.119E-04 0.01049965 8.119E-04 0.02566582 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP chromosomal disease DOID_0080014 9.611E-04 0.01215269 9.611E-04 0.02485778 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP female reproductive system disease DOID_229 9.611E-04 0.01188851 0.07015561 0.22941692 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP congenital disorder of glycosylation type II DOID_0050571 1.188E-03 0.01438336 1.188E-03 0.02816742 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP phagocyte bactericidal dysfunction DOID_3262 1.188E-03 0.01408371 0.05102297 0.2119129 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Paget's disease of bone DOID_5408 1.188E-03 0.01379629 1.188E-03 0.02704072 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP visceral leishmaniasis DOID_9146 1.188E-03 0.01352036 0.05102297 0.20445118 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP alopecia areata DOID_986 1.188E-03 0.01325526 1.188E-03 0.02600069 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP peripheral nervous system neoplasm DOID_1192 1.292E-03 0.0141411 1.292E-03 0.02723472 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP amino acid metabolic disorder DOID_9252 1.353E-03 0.01452878 1.353E-03 0.02655259 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hepatitis DOID_2237 1.386E-03 0.01460879 0.02037617 0.10540037 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP congenital diaphragmatic hernia DOID_3827 1.386E-03 0.01434318 0.02037617 0.10445082 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP prostatic adenoma DOID_2883 1.447E-03 0.01470367 0.05598055 0.21668663 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP invasive lobular carcinoma DOID_3457 1.447E-03 0.01444571 0.05598055 0.21522253 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP carbohydrate metabolic disorder DOID_2978 1.586E-03 0.01556018 1.586E-03 0.03008302 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pulmonary emphysema DOID_9675 1.587E-03 0.01530763 0.0222363 0.11296833 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.648E-03 0.01563215 1.648E-03 0.02931028 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pituitary cancer DOID_1785 1.731E-03 0.01614252 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pituitary carcinoma DOID_4916 1.731E-03 0.01614252 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP peritonitis DOID_8283 1.731E-03 0.01588216 0.06091237 0.217982 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP diabetic autonomic neuropathy DOID_11503 1.921E-03 0.01735131 0.02515242 0.12554145 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP autonomic neuropathy DOID_11504 1.921E-03 0.01735131 0.02515242 0.12554145 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP diabetic polyneuropathy DOID_12785 1.921E-03 0.01735131 0.02515242 0.12554145 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP diabetic neuropathy DOID_9743 1.921E-03 0.01735131 0.02515242 0.12554145 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP essential hypertension DOID_10825 2.038E-03 0.01812085 0.06581855 0.22835826 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Leydig cell tumor DOID_2696 2.038E-03 0.01784207 0.06581855 0.22029856 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP sex cord-stromal neoplasm DOID_4757 2.038E-03 0.01784207 0.06581855 0.22029856 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP proteinuria DOID_576 2.166E-03 0.0186756 0.22643749 0.45049976 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP myeloma DOID_0070004 2.296E-03 0.01949647 2.296E-03 0.03958373 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP autonomic nervous system disease DOID_11465 2.296E-03 0.01920975 0.02821491 0.13605323 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP neuritis DOID_1803 2.296E-03 0.01893135 2.296E-03 0.03841951 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Legionnaires' disease DOID_10457 2.37E-03 0.01926259 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP legionellosis DOID_10458 2.37E-03 0.01926259 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hypercalcemia DOID_12678 2.37E-03 0.01899128 2.37E-03 0.03852517 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP eyelid disease DOID_530 2.37E-03 0.01872752 0.07069923 0.22856739 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP parasitic helminthiasis infectious disease DOID_883 2.37E-03 0.01847097 0.07069923 0.22727605 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP polycystic kidney disease DOID_898 2.37E-03 0.01822137 2.37E-03 0.03745503 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pulmonary tuberculosis DOID_2957 2.569E-03 0.01948888 0.0303353 0.1450486 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Ehlers-Danlos syndrome DOID_13359 2.725E-03 0.02040116 2.725E-03 0.04080232 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP corneal dystrophy DOID_2566 2.725E-03 0.02013621 2.725E-03 0.03876221 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP B-cell lymphocytic neoplasm DOID_707 2.861E-03 0.02087209 2.861E-03 0.03876246 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP orofacial cleft DOID_0050567 3.015E-03 0.02171376 3.015E-03 0.03989272 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pituitary adenoma DOID_3829 3.104E-03 0.0220739 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP sarcoidosis DOID_11335 3.173E-03 0.02229111 0.25431677 0.49052963 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP bone marrow cancer DOID_4960 3.337E-03 0.02315405 3.337E-03 0.04315073 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP vasculitis DOID_865 3.337E-03 0.02287509 0.03590082 0.16607778 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hyperostosis DOID_205 3.505E-03 0.02374415 3.505E-03 0.04432241 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP osteochondrodysplasia DOID_2256 3.505E-03 0.02346554 3.505E-03 0.04243768 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP congenital muscular dystrophy DOID_0050557 3.93E-03 0.02600158 3.93E-03 0.04563543 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP male reproductive organ benign neoplasm DOID_0060087 3.93E-03 0.02570271 0.08996954 0.25854882 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP neuroendocrine tumor DOID_169 3.93E-03 0.02541064 0.08996954 0.25724958 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP sexual dysfunction DOID_1876 3.93E-03 0.02512512 0.08996954 0.25596333 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP prion disease DOID_649 3.93E-03 0.02484595 3.93E-03 0.04472272 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hypersensitivity reaction type IV disease DOID_2916 4.042E-03 0.02527452 0.27361626 0.51723473 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP leukocyte disease DOID_9500 4.232E-03 0.02617106 4.232E-03 0.04721054 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP dissociative disorder DOID_10935 4.377E-03 0.02678122 4.377E-03 0.04789718 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP dissociative amnesia DOID_11037 4.377E-03 0.02678122 4.377E-03 0.04789718 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP MHC class II deficiency DOID_5812 4.377E-03 0.02649631 4.377E-03 0.04699346 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP collagen disease DOID_854 4.626E-03 0.02770871 4.626E-03 0.04700585 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP amnestic disorder DOID_10914 4.847E-03 0.02872835 4.847E-03 0.04838459 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP colon carcinoma DOID_1520 4.847E-03 0.02843218 4.847E-03 0.04755037 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP brain edema DOID_4724 4.847E-03 0.02814205 4.847E-03 0.04674443 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP alopecia DOID_987 4.847E-03 0.02785779 4.847E-03 0.04596536 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pre-malignant neoplasm DOID_0060071 5.042E-03 0.02869182 5.042E-03 0.04703577 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP in situ carcinoma DOID_8719 5.042E-03 0.02869182 5.042E-03 0.04703577 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP autoimmune hepatitis DOID_2048 5.339E-03 0.03007723 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP neutropenia DOID_1227 5.853E-03 0.03264857 5.853E-03 0.05203365 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP allergic contact dermatitis DOID_3042 5.941E-03 0.03281943 0.05199936 0.20546969 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP sinusitis DOID_0050127 6.388E-03 0.03495042 6.388E-03 0.05345359 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP sexual disorder DOID_0060043 6.388E-03 0.03461756 0.11349923 0.2962434 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP agranulocytosis DOID_12987 6.388E-03 0.03429098 6.388E-03 0.0526789 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP paranasal sinus disease DOID_1352 6.388E-03 0.03495042 6.388E-03 0.05345359 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP IgA glomerulonephritis DOID_2986 6.388E-03 0.03397051 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP synostosis DOID_11971 6.945E-03 0.03659015 6.945E-03 0.05565825 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP ureteral disease DOID_1426 6.945E-03 0.03625446 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Goodpasture syndrome DOID_9808 6.945E-03 0.03592487 1.000 1.000 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP diabetic retinopathy DOID_8947 7.458E-03 0.03822922 0.3285831 0.60310898 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP severe combined immunodeficiency DOID_627 7.523E-03 0.03822049 7.523E-03 0.05863966 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP X-linked disease DOID_0050735 8.122E-03 0.04089901 8.122E-03 0.0624539 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP portal hypertension DOID_10762 8.122E-03 0.04054025 0.12732546 0.32634317 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hypogonadism DOID_1924 8.122E-03 0.04018773 0.12732546 0.32342939 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP combined T cell and B cell immunodeficiency DOID_628 8.122E-03 0.03984128 8.122E-03 0.06162118 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP bone resorption disease DOID_0080011 8.294E-03 0.04033612 8.294E-03 0.06209639 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP osteoporosis DOID_11476 8.294E-03 0.04033612 8.294E-03 0.06209639 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP electroclinical syndrome DOID_0050701 8.585E-03 0.0413952 8.585E-03 0.0634368 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP myositis DOID_633 8.742E-03 0.0418007 0.13188635 0.32913743 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP contact dermatitis DOID_2773 9.183E-03 0.04354464 0.06869383 0.22724878 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP myopia DOID_11830 9.383E-03 0.04412106 9.383E-03 0.06757783 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hypotrichosis DOID_4535 9.383E-03 0.04375941 9.383E-03 0.0667331 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP extrinsic allergic alveolitis DOID_841 9.383E-03 0.04340364 9.383E-03 0.06590924 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Sciatic Neuropathy DOID_11446 0.01004315 0.04608511 0.01004315 0.06968967 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP lesion of sciatic nerve DOID_12528 0.01004315 0.04608511 0.01004315 0.06968967 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP perinatal necrotizing enterocolitis DOID_8677 0.01004315 0.04571643 0.14093712 0.33553648 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP mononeuritis of lower limb DOID_9473 0.01004315 0.04608511 0.01004315 0.06968967 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP chronic kidney failure DOID_784 0.01012639 0.04572948 0.01012639 0.06942066 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP autoimmune disease of cardiovascular system DOID_0060051 0.01072385 0.04804621 0.14542723 0.34478372 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP malaria DOID_12365 0.01072385 0.04767085 0.01072385 0.07095197 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Behcet's disease DOID_13241 0.01072385 0.04804621 0.14542723 0.34478372 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP mononeuritis DOID_1802 0.01072385 0.04730131 0.01072385 0.07013643 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hepatic vascular disease DOID_272 0.01072385 0.04693745 0.14542723 0.34052713 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP coronary stenosis DOID_4248 0.01072385 0.04657915 0.01072385 0.06933942 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP retinal vascular disease DOID_2462 0.01078514 0.04649051 0.36624293 0.65738873 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP mononeuropathy DOID_1188 0.01142437 0.0488757 0.01142437 0.07303896 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP female reproductive organ benign neoplasm DOID_0060086 0.0121445 0.05156882 0.0121445 0.0759365 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP uterine benign neoplasm DOID_0060095 0.0121445 0.05156882 0.0121445 0.0759365 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP corneal disease DOID_10124 0.0121445 0.05118682 0.0121445 0.0751111 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP uterine fibroid DOID_13223 0.0121445 0.05156882 0.0121445 0.0759365 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP dysostosis DOID_1934 0.0121445 0.05081045 0.0121445 0.07430345 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP congenital disorder of glycosylation DOID_5212 0.0121445 0.05043957 0.0121445 0.07351299 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP nervous system cancer DOID_3093 0.01253852 0.0516987 0.01253852 0.07509916 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP gonadal disease DOID_2277 0.01288401 0.05274104 0.15875795 0.35846536 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP opportunistic mycosis DOID_2473 0.01288401 0.05236432 0.01288401 0.07636463 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP bronchiolitis obliterans DOID_2799 0.01288401 0.05199294 0.15875795 0.3570485 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP allergic rhinitis DOID_4481 0.01364269 0.05466684 0.16315538 0.36406043 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP lymphoblastic leukemia DOID_1037 0.01366424 0.05437031 0.01366424 0.08015416 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP Crohn's disease DOID_8778 0.01405185 0.05552433 0.09003186 0.25111826 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pleural disease DOID_1532 0.01442031 0.0565873 0.01442031 0.08372611 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP autonomic nervous system neoplasm DOID_2621 0.01442031 0.05619972 0.01442031 0.08288039 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP neuroblastoma DOID_769 0.01442031 0.05619972 0.01442031 0.08288039 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hypersensitivity reaction type I disease DOID_1205 0.01444567 0.05591553 0.39865174 0.70885262 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP systemic mycosis DOID_0050136 0.01521667 0.05850191 0.01521667 0.08658282 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP fungal infectious disease DOID_1564 0.01521667 0.05850191 0.01521667 0.08658282 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP hair disease DOID_421 0.01521667 0.05810928 0.01521667 0.08572557 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP myocarditis DOID_820 0.01521667 0.05772188 0.01521667 0.08488512 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP leukopenia DOID_615 0.01603153 0.0604102 0.01603153 0.08856253 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP childhood electroclinical syndrome DOID_0050704 0.0168647 0.06313166 0.0168647 0.09226935 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP lymphoid leukemia DOID_10747 0.0168647 0.06271903 0.0168647 0.09139059 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP aplastic anemia DOID_12449 0.0168647 0.06231177 0.18051757 0.3846985 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP refractive error DOID_9835 0.01771595 0.06503469 0.01771595 0.0950979 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pulmonary sarcoidosis DOID_13406 0.01858509 0.06778792 0.18906379 0.39550477 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP calcinosis DOID_182 0.01858509 0.06735615 0.18906379 0.39405604 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP cleft palate DOID_674 0.01858509 0.06692984 0.01858509 0.09883098 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP multiple myeloma DOID_9538 0.01858509 0.0665089 0.01858509 0.09791588 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP blood platelet disease DOID_2218 0.0194719 0.06924693 0.0194719 0.10164687 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP benign mesothelioma DOID_2645 0.0222363 0.07858667 0.20589111 0.41989978 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP primitive neuroectodermal tumor DOID_168 0.02416385 0.0848718 0.02416385 0.12167462 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP gallbladder cancer DOID_3121 0.02515242 0.087802 0.02515242 0.12444979 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP influenza DOID_8469 0.02515242 0.08726662 0.21828319 0.43580047 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP learning disability DOID_8927 0.02615724 0.09020286 0.02615724 0.12830579 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP pre-eclampsia DOID_10591 0.02821491 0.09671254 0.02821491 0.13721608 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP heart valve disease DOID_4079 0.02821491 0.09613342 0.23048285 0.45536368 BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP bone marrow disease DOID_4961 0.02821491 0.0955612 0.23048285 0.45378803 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN coronary stenosis DOID_4248 9.873E-09 5.618E-06 0.02425165 0.36313662 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN metabolic syndrome X DOID_14221 6.117E-07 1.74E-04 4.196E-05 0.02387645 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN coronary restenosis DOID_4247 6.518E-07 1.236E-04 0.01703656 0.35902983 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Sciatic Neuropathy DOID_11446 1.783E-06 2.536E-04 0.02345252 0.40437823 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN lesion of sciatic nerve DOID_12528 1.783E-06 2.536E-04 0.02345252 0.40437823 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN mononeuritis of lower limb DOID_9473 1.783E-06 2.536E-04 0.02345252 0.40437823 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN mononeuritis DOID_1802 1.98E-06 2.253E-04 0.02425165 0.37295112 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN polycystic ovary syndrome DOID_11612 2.191E-06 2.078E-04 0.02505016 0.36547542 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN mononeuropathy DOID_1188 2.191E-06 1.781E-04 0.02505016 0.35633854 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN corneal disease DOID_10124 2.416E-06 1.718E-04 0.02584803 0.35872028 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN hepatitis DOID_2237 5.561E-06 3.516E-04 5.459E-04 0.0621234 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN neuritis DOID_1803 9.453E-06 5.379E-04 0.04010217 0.40031811 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN glaucoma DOID_1686 1.065E-05 5.507E-04 8.365E-04 0.07932376 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN aortic aneurysm DOID_3627 1.128E-05 5.348E-04 0.04245815 0.40264476 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN allergic contact dermatitis DOID_3042 2.611E-05 1.143E-03 1.51E-03 0.09543511 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN male reproductive system disease DOID_48 3.085E-05 1.254E-03 0.05879403 0.46463613 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN peripheral vascular disease DOID_341 3.212E-05 1.218E-03 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN syndrome DOID_225 3.613E-05 1.285E-03 0.0618749 0.47576778 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN aneurysm disease DOID_2403 3.753E-05 1.256E-03 0.06264359 0.47525601 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN contact dermatitis DOID_2773 4.196E-05 1.326E-03 2.063E-03 0.10672346 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN alcohol abuse DOID_1574 4.672E-05 1.399E-03 2.215E-03 0.10500463 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Crohn's disease DOID_8778 6.718E-05 1.911E-03 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN papillary adenoma DOID_3172 2.243E-04 6.076E-03 0.02185234 0.40109614 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN microcystic adenoma DOID_5403 2.243E-04 6.076E-03 0.02185234 0.40109614 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN follicular adenoma DOID_6204 2.243E-04 6.076E-03 0.02185234 0.40109614 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN ankylosing spondylitis DOID_7147 2.243E-04 5.8E-03 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN diffuse large B-cell lymphoma DOID_0050745 2.591E-04 6.411E-03 2.591E-04 0.07372147 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN periodontitis DOID_824 2.591E-04 6.143E-03 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN sarcoma DOID_1115 2.775E-04 6.316E-03 0.02425165 0.38331088 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN female reproductive organ benign neoplasm DOID_0060086 3.161E-04 6.917E-03 3.161E-04 0.05995074 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN uterine benign neoplasm DOID_0060095 3.161E-04 6.917E-03 3.161E-04 0.05995074 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN uterine fibroid DOID_13223 3.161E-04 6.917E-03 3.161E-04 0.05995074 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN abdominal aortic aneurysm DOID_7693 3.363E-04 7.087E-03 0.02664528 0.35258516 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN leiomyoma DOID_127 3.786E-04 7.694E-03 3.786E-04 0.05385517 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN papilloma DOID_2615 4.007E-04 7.861E-03 0.02903321 0.37545224 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN myocarditis DOID_820 4.007E-04 7.599E-03 0.02903321 0.36710885 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN periodontal disease DOID_3388 4.233E-04 7.77E-03 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN adenoma DOID_657 4.705E-04 8.367E-03 0.03141548 0.35750818 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN blood platelet disease DOID_2218 5.202E-04 8.969E-03 0.03300052 0.36818224 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN congenital diaphragmatic hernia DOID_3827 5.459E-04 9.136E-03 0.03379209 0.36976348 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN hyperinsulinism DOID_2018 6.549E-04 0.01064657 0.03695213 0.38228659 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN diabetic autonomic neuropathy DOID_11503 6.836E-04 0.01080537 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN autonomic neuropathy DOID_11504 6.836E-04 0.01080537 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN diabetic polyneuropathy DOID_12785 6.836E-04 0.01080537 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN diabetic neuropathy DOID_9743 6.836E-04 0.01080537 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN pre-eclampsia DOID_10591 7.735E-04 0.01189563 0.04010217 0.40746665 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN autonomic nervous system disease DOID_11465 7.735E-04 0.01158259 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN thyroid adenoma DOID_2891 7.735E-04 0.0112856 0.04010217 0.39341608 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN vascular skin disease DOID_9540 7.735E-04 0.01100346 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN hemorrhagic disease DOID_2213 9.018E-04 0.01251482 0.04324223 0.40335784 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN B-cell lymphocytic neoplasm DOID_707 9.018E-04 0.01221685 9.018E-04 0.0733011 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN reproductive organ benign neoplasm DOID_0050622 1.04E-03 0.01375591 1.04E-03 0.073938 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN carotid artery disease DOID_3407 1.264E-03 0.01634545 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN collagen disease DOID_854 1.264E-03 0.01598222 0.05104896 0.45385715 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN endocrine pancreas disease DOID_1428 1.384E-03 0.01712092 0.05337893 0.4601911 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN cholestasis DOID_13580 1.425E-03 0.01725565 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN tooth disease DOID_1091 1.51E-03 0.01789408 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN endocrine organ benign neoplasm DOID_0060089 1.552E-03 0.01802781 0.05647695 0.46573024 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN tuberculosis DOID_399 1.552E-03 0.01766725 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN astrocytoma DOID_3069 1.596E-03 0.01780666 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN blood coagulation disease DOID_1247 1.64E-03 0.01794705 0.05802228 0.47163826 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN pancreatic ductal carcinoma DOID_3587 1.64E-03 0.01760842 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN bile duct disease DOID_4138 1.685E-03 0.01775338 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN biliary tract disease DOID_9741 1.73E-03 0.01789903 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN pancreatic carcinoma DOID_4905 1.776E-03 0.01804535 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN diabetic retinopathy DOID_8947 1.776E-03 0.01772876 0.06033568 0.47028772 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN mixed glioma DOID_5076 1.965E-03 0.01927899 1.965E-03 0.11181816 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN retinal vascular disease DOID_2462 2.318E-03 0.02235711 0.06877121 0.50819243 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN primary bacterial infectious disease DOID_0050338 2.424E-03 0.02298953 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN nervous system cancer DOID_3093 2.587E-03 0.02413493 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN lymphoma DOID_0060058 2.699E-03 0.02476991 2.699E-03 0.11813342 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.813E-03 0.02540495 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN mouth disease DOID_403 2.813E-03 0.025008 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN facioscapulohumeral muscular dystrophy DOID_11727 8.148E-03 0.07132622 8.148E-03 0.33115745 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN transient cerebral ischemia DOID_224 8.148E-03 0.07024552 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN progressive muscular atrophy DOID_318 8.148E-03 0.06919708 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN keratitis DOID_4677 8.148E-03 0.06817948 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN nervous system benign neoplasm DOID_0060115 8.959E-03 0.07388129 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN common variable immunodeficiency DOID_12177 8.959E-03 0.07282584 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN heroin dependence DOID_9976 8.959E-03 0.07180013 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN familial atrial fibrillation DOID_0050650 9.77E-03 0.077209 9.77E-03 0.37060322 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN esophageal carcinoma DOID_1107 9.77E-03 0.07615135 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN intracranial arteriosclerosis DOID_13097 9.77E-03 0.07512227 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN aortic valve stenosis DOID_1712 9.77E-03 0.07412064 9.77E-03 0.34744052 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN pituitary cancer DOID_1785 9.77E-03 0.07314537 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN esophagus squamous cell carcinoma DOID_3748 9.77E-03 0.07615135 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN pituitary carcinoma DOID_4916 9.77E-03 0.07314537 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN retinal detachment DOID_5327 9.77E-03 0.07219543 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN lipodystrophy DOID_811 9.77E-03 0.07126985 9.77E-03 0.32700284 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN vascular dementia DOID_8725 9.77E-03 0.07512227 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Hirschsprung's disease DOID_10487 0.01057983 0.07620155 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN carotid stenosis DOID_13001 0.01057983 0.07524903 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN impotence DOID_1875 0.01057983 0.07432003 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Lynch syndrome DOID_3883 0.01057983 0.07341369 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN intracranial thrombosis DOID_4193 0.01057983 0.07252919 0.01057983 0.33444013 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN psoriatic arthritis DOID_9008 0.01057983 0.07166574 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Legionnaires' disease DOID_10457 0.01138916 0.07624037 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN legionellosis DOID_10458 0.01138916 0.07624037 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN open-angle glaucoma DOID_1067 0.01138916 0.07535386 0.01138916 0.34107535 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN megacolon DOID_11372 0.01138916 0.07448772 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN skeletal system cancer DOID_0060124 0.01219785 0.07887019 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Ehlers-Danlos syndrome DOID_13359 0.01219785 0.07798401 0.01219785 0.34702883 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN thoracic aortic aneurysm DOID_14004 0.01219785 0.07711752 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN bone cancer DOID_184 0.01219785 0.07887019 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN membranoproliferative glomerulonephritis DOID_2920 0.01219785 0.07627007 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN mesenchymal cell neoplasm DOID_3350 0.01219785 0.07544105 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN arthropathy DOID_381 0.01219785 0.07462986 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN spindle cell sarcoma DOID_4235 0.01219785 0.07544105 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN nutritional deficiency disease DOID_5113 0.01219785 0.07383592 0.01219785 0.33050364 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN epithelioid sarcoma DOID_6193 0.01219785 0.07544105 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN varicose veins DOID_799 0.01219785 0.0730587 0.01219785 0.31548075 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN angiosarcoma DOID_0001816 0.0130059 0.07708705 0.0130059 0.32175465 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN silicosis DOID_10325 0.0130059 0.07629234 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN pituitary adenoma DOID_3829 0.0130059 0.07551385 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN vein disease DOID_866 0.0130059 0.07475108 0.0130059 0.30834821 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Graves' disease DOID_12361 0.01381331 0.07859774 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN penile disease DOID_1529 0.01381331 0.07781954 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN sexual dysfunction DOID_1876 0.01462008 0.08155712 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN inherited blood coagulation disease DOID_2214 0.01462008 0.0807653 0.01462008 0.33275305 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN agammaglobulinemia DOID_2583 0.01542621 0.08439919 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN esophagitis DOID_11963 0.01623171 0.0879604 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN brain edema DOID_4724 0.01623171 0.08713058 0.01623171 0.35522469 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN subependymal glioma DOID_4843 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN pilocytic astrocytoma DOID_4851 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN subependymal giant cell astrocytoma DOID_5077 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN colonic disease DOID_5353 0.01623171 0.08551705 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN blood protein disease DOID_620 0.01623171 0.08473249 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN fibrillary astrocytoma DOID_6726 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN juvenile pilocytic astrocytoma DOID_6811 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN childhood pilocytic astrocytoma DOID_6812 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN gemistocytic astrocytoma DOID_7005 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN childhood cerebral astrocytoma DOID_7007 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN protoplasmic astrocytoma DOID_7008 0.01623171 0.08631628 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN Kawasaki disease DOID_13378 0.01703656 0.0881255 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN lymphadenitis DOID_1602 0.01703656 0.0881255 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN autoimmune hepatitis DOID_2048 0.01703656 0.08733158 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN lymph node disease DOID_9942 0.01703656 0.0881255 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN benign glioma DOID_0060101 0.01784078 0.09063755 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN gastric ulcer DOID_10808 0.01784078 0.08983545 0.01784078 0.36255021 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN benign ependymoma DOID_4844 0.01784078 0.09063755 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN muscular atrophy DOID_767 0.01784078 0.08904742 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN sexual disorder DOID_0060043 0.01864437 0.09224908 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN heart conduction disease DOID_10273 0.01864437 0.09145383 0.01864437 0.36581533 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN opiate dependence DOID_2559 0.01864437 0.09067217 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN polyarteritis nodosa DOID_9810 0.01864437 0.08990377 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN diabetic angiopathy DOID_11713 0.01944731 0.09298757 1.000 1.000 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN aortic valve disease DOID_62 0.01944731 0.09221267 0.01944731 0.36885069 BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN urticaria DOID_1555 0.0210513 0.09899329 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN retinal vascular disease DOID_2462 6.797E-09 3.867E-06 9.003E-03 0.39406965 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN diabetic retinopathy DOID_8947 1.676E-07 4.769E-05 0.117076 0.85405443 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN corneal disease DOID_10124 2.252E-07 4.272E-05 0.0510483 0.69158294 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN metabolic syndrome X DOID_14221 2.457E-07 3.496E-05 0.12572214 0.89419873 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN alcohol abuse DOID_1574 2.943E-07 3.349E-05 8.61E-03 0.4082478 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN Crohn's disease DOID_8778 5.409E-07 5.13E-05 0.01087168 0.44185614 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN endometriosis of uterus DOID_288 9.186E-07 7.467E-05 5.627E-05 0.03202039 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN endometriosis DOID_289 1.005E-06 7.147E-05 6.013E-05 0.01710724 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN familial hyperlipidemia DOID_1168 2.758E-06 1.744E-04 4.24E-03 0.30159456 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN carotid artery disease DOID_3407 3.827E-06 2.178E-04 0.09953058 0.83283679 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN uterine disease DOID_345 4.881E-06 2.525E-04 1.935E-04 0.03670019 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN nephrosis DOID_2527 6.847E-06 3.246E-04 0.11417531 0.87791552 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN pancreatitis DOID_4989 9.342E-06 4.089E-04 0.12284939 0.88482663 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN lipid metabolism disorder DOID_3146 1.031E-05 4.189E-04 8.034E-03 0.41560031 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN female reproductive system disease DOID_229 1.081E-05 4.102E-04 3.486E-04 0.04959088 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN migraine DOID_6364 1.476E-05 5.25E-04 0.04637355 0.75390138 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN aortic aneurysm DOID_3627 9.204E-05 3.081E-03 3.437E-03 0.27935016 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN familial combined hyperlipidemia DOID_13809 1.174E-04 3.712E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN hypertrophic cardiomyopathy DOID_11984 1.401E-04 4.195E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN melancholia DOID_2848 1.47E-04 4.183E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN neurotic disorder DOID_4964 1.542E-04 4.179E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN lipodystrophy DOID_811 1.719E-04 4.445E-03 0.01945215 0.65107475 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN cholestasis DOID_13580 1.935E-04 4.787E-03 0.10541684 0.8568883 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN brain infarction DOID_3454 2.199E-04 5.214E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN alcohol dependence DOID_0050741 2.365E-04 5.382E-03 0.02265777 0.71623738 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN bile duct disease DOID_4138 2.485E-04 5.439E-03 0.11417531 0.86620998 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN biliary tract disease DOID_9741 2.586E-04 5.45E-03 0.11562682 0.85443718 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN endogenous depression DOID_1595 2.903E-04 5.9E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN aneurysm disease DOID_2403 3.014E-04 5.915E-03 7.477E-03 0.42545598 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN mental depression DOID_1596 3.739E-04 7.091E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN focal epilepsy DOID_2234 3.739E-04 6.863E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.34E-04 9.495E-03 0.14557382 0.98608933 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN familial hypercholesterolemia DOID_13810 5.952E-04 0.01026249 0.0353775 0.83874145 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN ulcerative colitis DOID_8577 6.015E-04 0.01006672 0.01175231 0.44580411 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN opiate dependence DOID_2559 6.512E-04 0.01058644 0.03695596 0.84111773 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN morbid obesity DOID_11981 8.996E-04 0.01421912 0.04324446 0.82020335 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN gestational diabetes DOID_11714 1.038E-03 0.01596901 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN renal hypertension DOID_1073 1.111E-03 0.01664187 0.04793431 0.75762841 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN secondary hypertension DOID_11130 1.111E-03 0.01664187 0.04793431 0.75762841 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN malaria DOID_12365 1.111E-03 0.01621516 0.04793431 0.73715197 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN polycystic ovary syndrome DOID_11612 1.187E-03 0.01688233 1.187E-03 0.13505866 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN abdominal aortic aneurysm DOID_7693 1.345E-03 0.01866275 0.05260154 0.68023351 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN nephroblastoma DOID_2154 1.689E-03 0.02288354 1.689E-03 0.1601848 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN esophageal disease DOID_6050 1.689E-03 0.02235137 0.0587895 0.71172826 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN hepatitis DOID_2237 2.172E-03 0.02809092 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN congenital diaphragmatic hernia DOID_3827 2.172E-03 0.02746668 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN peptic ulcer DOID_750 2.172E-03 0.02686957 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN hyperinsulinism DOID_2018 2.6E-03 0.03147985 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN cerebral infarction DOID_3526 2.828E-03 0.03352321 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN leukodystrophy DOID_10579 2.945E-03 0.03420053 0.0771158 0.76980505 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN pre-eclampsia DOID_10591 3.065E-03 0.0348764 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN thyroid adenoma DOID_2891 3.065E-03 0.03419255 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN vascular skin disease DOID_9540 3.065E-03 0.033535 0.07862704 0.75828453 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN parasitic protozoa infectious disease DOID_2789 4.101E-03 0.04402669 0.09062968 0.79335831 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN respiratory failure DOID_11162 5.123E-03 0.053976 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN pre-malignant neoplasm DOID_0060071 5.277E-03 0.05459344 0.10247846 0.84507598 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN in situ carcinoma DOID_8719 5.277E-03 0.05459344 0.10247846 0.84507598 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN endocrine pancreas disease DOID_1428 5.434E-03 0.05521047 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN parasitic infectious disease DOID_1398 5.593E-03 0.05582703 0.10541684 0.84481945 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN cerebral degeneration DOID_1443 5.593E-03 0.05486449 0.10541684 0.83308584 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN temporal lobe epilepsy DOID_3328 5.753E-03 0.0554864 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN hyperglycemia DOID_4195 5.753E-03 0.05456163 0.10688248 0.83309766 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN endocrine organ benign neoplasm DOID_0060089 6.082E-03 0.05672796 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN pancreatic ductal carcinoma DOID_3587 6.418E-03 0.05890126 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN peripheral vascular disease DOID_341 6.763E-03 0.06108067 0.11562682 0.86567978 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN pancreatic carcinoma DOID_4905 6.938E-03 0.0616867 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN syndrome DOID_225 7.296E-03 0.06386449 7.296E-03 0.46124352 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN mixed glioma DOID_5076 7.661E-03 0.06604677 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN chronic kidney failure DOID_784 8.61E-03 0.07311901 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN primary immunodeficiency disease DOID_612 9.814E-03 0.08212166 0.13853538 0.96130037 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN hypersensitivity reaction type I disease DOID_1205 0.01108897 0.09144383 0.1469747 0.98386596 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN dilated cardiomyopathy DOID_12930 0.01108897 0.09013749 1.000 1.000 GAURNIER_PSMD4_TARGETS hypersensitivity reaction type I disease DOID_1205 6.867E-35 3.908E-32 1.595E-08 9.076E-06 GAURNIER_PSMD4_TARGETS primary bacterial infectious disease DOID_0050338 2.472E-33 7.032E-31 0.13976403 1.000 GAURNIER_PSMD4_TARGETS influenza DOID_8469 3.149E-31 5.973E-29 2.888E-03 0.09665523 GAURNIER_PSMD4_TARGETS encephalomyelitis DOID_640 1.669E-30 2.375E-28 0.14846156 1.000 GAURNIER_PSMD4_TARGETS tuberculosis DOID_399 1.688E-30 1.921E-28 0.11314336 1.000 GAURNIER_PSMD4_TARGETS sarcoidosis DOID_11335 1.82E-27 1.726E-25 2.539E-06 4.816E-04 GAURNIER_PSMD4_TARGETS bacterial pneumonia DOID_874 2.671E-27 2.171E-25 8.145E-03 0.2317306 GAURNIER_PSMD4_TARGETS hypersensitivity reaction type IV disease DOID_2916 7.014E-27 4.988E-25 3.585E-06 5.099E-04 GAURNIER_PSMD4_TARGETS pulmonary tuberculosis DOID_2957 1.484E-25 9.38E-24 1.000 1.000 GAURNIER_PSMD4_TARGETS pleural disease DOID_1532 5.173E-23 2.943E-21 1.000 1.000 GAURNIER_PSMD4_TARGETS pulmonary sarcoidosis DOID_13406 2.848E-22 1.473E-20 6.447E-07 1.834E-04 GAURNIER_PSMD4_TARGETS extrinsic allergic alveolitis DOID_841 1.15E-21 5.455E-20 0.04622303 0.65752255 GAURNIER_PSMD4_TARGETS pleurisy DOID_10247 2.627E-21 1.15E-19 1.000 1.000 GAURNIER_PSMD4_TARGETS pneumoconiosis DOID_10316 3.018E-20 1.227E-18 0.06062883 0.76661781 GAURNIER_PSMD4_TARGETS Human immunodeficiency virus infectious disease DOID_526 5.861E-20 2.223E-18 0.01065085 0.2754696 GAURNIER_PSMD4_TARGETS respiratory syncytial virus infectious disease DOID_1273 1.267E-19 4.505E-18 0.06853927 0.76468328 GAURNIER_PSMD4_TARGETS autoimmune disease of gastrointestinal tract DOID_0060031 1.344E-18 4.5E-17 0.08416396 0.88683879 GAURNIER_PSMD4_TARGETS bronchiolitis obliterans DOID_2799 2.311E-18 7.306E-17 1.432E-03 0.07407873 GAURNIER_PSMD4_TARGETS vasculitis DOID_865 3.646E-18 1.092E-16 4.218E-03 0.13332105 GAURNIER_PSMD4_TARGETS systemic mycosis DOID_0050136 5.62E-18 1.599E-16 1.703E-03 0.07454757 GAURNIER_PSMD4_TARGETS fungal infectious disease DOID_1564 5.62E-18 1.599E-16 1.703E-03 0.07454757 GAURNIER_PSMD4_TARGETS periodontal disease DOID_3388 7.417E-18 2.01E-16 0.06062883 0.73399578 GAURNIER_PSMD4_TARGETS autoimmune hepatitis DOID_2048 8.373E-18 2.166E-16 0.03486837 0.64000326 GAURNIER_PSMD4_TARGETS mouth disease DOID_403 1.011E-17 2.501E-16 0.14990271 1.000 GAURNIER_PSMD4_TARGETS collagen disease DOID_854 1.267E-17 3.005E-16 5.287E-03 0.15833666 GAURNIER_PSMD4_TARGETS uveitis DOID_13141 2.078E-17 4.729E-16 1.000 1.000 GAURNIER_PSMD4_TARGETS parasitic infectious disease DOID_1398 2.42E-17 5.296E-16 0.10862843 1.000 GAURNIER_PSMD4_TARGETS pulmonary emphysema DOID_9675 4.188E-17 8.826E-16 2.535E-03 0.09617509 GAURNIER_PSMD4_TARGETS berylliosis DOID_10322 4.739E-17 9.629E-16 0.02172862 0.49454338 GAURNIER_PSMD4_TARGETS rheumatic disease DOID_1575 6.491E-17 1.274E-15 2.768E-03 0.0984329 GAURNIER_PSMD4_TARGETS uveal disease DOID_3480 6.491E-17 1.231E-15 1.000 1.000 GAURNIER_PSMD4_TARGETS scleroderma DOID_419 6.491E-17 1.274E-15 2.768E-03 0.0984329 GAURNIER_PSMD4_TARGETS cystic fibrosis DOID_1485 1.034E-16 1.898E-15 0.12359084 1.000 GAURNIER_PSMD4_TARGETS periodontitis DOID_824 1.748E-16 3.107E-15 0.04783435 0.66384743 GAURNIER_PSMD4_TARGETS parasitic protozoa infectious disease DOID_2789 6.177E-16 1.065E-14 1.000 1.000 GAURNIER_PSMD4_TARGETS tooth disease DOID_1091 3.713E-15 6.214E-14 0.11164089 1.000 GAURNIER_PSMD4_TARGETS systemic scleroderma DOID_418 4.724E-15 7.68E-14 2.313E-03 0.09398984 GAURNIER_PSMD4_TARGETS myositis DOID_633 2.407E-14 3.805E-13 1.000 1.000 GAURNIER_PSMD4_TARGETS viral pneumonia DOID_10533 5.405E-14 8.313E-13 1.000 1.000 GAURNIER_PSMD4_TARGETS autoimmune disease of cardiovascular system DOID_0060051 5.497E-14 8.231E-13 1.184E-03 0.07483686 GAURNIER_PSMD4_TARGETS Behcet's disease DOID_13241 5.497E-14 8.231E-13 1.184E-03 0.07483686 GAURNIER_PSMD4_TARGETS opportunistic mycosis DOID_2473 1.149E-13 1.676E-12 1.432E-03 0.08148661 GAURNIER_PSMD4_TARGETS thyroiditis DOID_7166 1.438E-13 2.045E-12 1.000 1.000 GAURNIER_PSMD4_TARGETS autoimmune thyroiditis DOID_7188 1.438E-13 2.045E-12 1.000 1.000 GAURNIER_PSMD4_TARGETS leishmaniasis DOID_9065 4.852E-13 6.733E-12 1.000 1.000 GAURNIER_PSMD4_TARGETS male reproductive system disease DOID_48 5.784E-13 7.836E-12 1.000 1.000 GAURNIER_PSMD4_TARGETS aneurysm disease DOID_2403 9.946E-13 1.316E-11 0.12507342 1.000 GAURNIER_PSMD4_TARGETS contact dermatitis DOID_2773 1.353E-12 1.75E-11 8.542E-03 0.2314393 GAURNIER_PSMD4_TARGETS myasthenia gravis DOID_437 1.796E-12 2.271E-11 1.000 1.000 GAURNIER_PSMD4_TARGETS proteinuria DOID_576 2.262E-12 2.798E-11 1.000 1.000 GAURNIER_PSMD4_TARGETS aortic aneurysm DOID_3627 4.038E-12 4.889E-11 0.08571217 0.88673134 GAURNIER_PSMD4_TARGETS urticaria DOID_1555 4.079E-12 4.836E-11 1.000 1.000 GAURNIER_PSMD4_TARGETS neuromuscular junction disease DOID_439 5.238E-12 6.082E-11 1.000 1.000 GAURNIER_PSMD4_TARGETS ankylosing spondylitis DOID_7147 5.238E-12 5.961E-11 0.04460902 0.65083416 GAURNIER_PSMD4_TARGETS atopic dermatitis DOID_3310 5.302E-12 5.915E-11 1.000 1.000 GAURNIER_PSMD4_TARGETS dermatomyositis DOID_10223 5.357E-12 5.862E-11 1.000 1.000 GAURNIER_PSMD4_TARGETS ulcerative colitis DOID_8577 6.901E-12 7.409E-11 0.01248653 0.30890596 GAURNIER_PSMD4_TARGETS encephalitis DOID_9588 9.172E-12 9.665E-11 1.000 1.000 GAURNIER_PSMD4_TARGETS autoimmune disease of the nervous system DOID_438 1.047E-11 1.083E-10 1.000 1.000 GAURNIER_PSMD4_TARGETS leukocyte disease DOID_9500 1.273E-11 1.294E-10 0.09953058 0.95987969 GAURNIER_PSMD4_TARGETS autoimmune disease of endocrine system DOID_0060005 1.296E-11 1.294E-10 1.000 1.000 GAURNIER_PSMD4_TARGETS uterine disease DOID_345 2.49E-11 2.443E-10 1.000 1.000 GAURNIER_PSMD4_TARGETS allergic contact dermatitis DOID_3042 3.071E-11 2.962E-10 0.11164089 1.000 GAURNIER_PSMD4_TARGETS brain infarction DOID_3454 3.402E-11 3.227E-10 1.000 1.000 GAURNIER_PSMD4_TARGETS myocarditis DOID_820 3.406E-11 3.177E-10 1.000 1.000 GAURNIER_PSMD4_TARGETS pancreatitis DOID_4989 8.031E-11 7.371E-10 0.12655352 1.000 GAURNIER_PSMD4_TARGETS eosinophilia DOID_999 9.845E-11 8.892E-10 1.000 1.000 GAURNIER_PSMD4_TARGETS female reproductive system disease DOID_229 1.046E-10 9.296E-10 1.000 1.000 GAURNIER_PSMD4_TARGETS cerebral infarction DOID_3526 2.112E-10 1.849E-09 1.000 1.000 GAURNIER_PSMD4_TARGETS vascular skin disease DOID_9540 2.728E-10 2.352E-09 1.000 1.000 GAURNIER_PSMD4_TARGETS Crohn's disease DOID_8778 2.951E-10 2.506E-09 0.14990271 1.000 GAURNIER_PSMD4_TARGETS funisitis DOID_0050698 3.01E-10 2.519E-09 0.03649857 0.64899022 GAURNIER_PSMD4_TARGETS hepatitis B DOID_2043 3.01E-10 2.482E-09 6.341E-04 0.05154216 GAURNIER_PSMD4_TARGETS pustulosis of palm and sole DOID_4398 6.877E-10 5.59E-09 0.09341463 0.91642976 GAURNIER_PSMD4_TARGETS commensal bacterial infectious disease DOID_0050339 7.481E-10 5.995E-09 0.04299232 0.67951758 GAURNIER_PSMD4_TARGETS bronchiolitis DOID_2942 7.481E-10 5.912E-09 1.000 1.000 GAURNIER_PSMD4_TARGETS middle cerebral artery infarction DOID_3525 1.115E-09 8.689E-09 1.000 1.000 GAURNIER_PSMD4_TARGETS Sjogren's syndrome DOID_12894 1.539E-09 1.183E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS childhood type dermatomyositis DOID_14203 1.539E-09 1.167E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS cutaneous leishmaniasis DOID_9111 1.539E-09 1.152E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS visceral leishmaniasis DOID_9146 1.539E-09 1.137E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS cholestasis DOID_13580 1.835E-09 1.339E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS bile duct disease DOID_4138 3.082E-09 2.22E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS celiac disease DOID_10608 3.132E-09 2.227E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS allergic rhinitis DOID_4481 3.132E-09 2.2E-08 1.52E-03 0.07207122 GAURNIER_PSMD4_TARGETS peripheral vascular disease DOID_341 3.346E-09 2.322E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS biliary tract disease DOID_9741 3.346E-09 2.294E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS common cold DOID_10459 3.618E-09 2.451E-08 0.02007382 0.4759168 GAURNIER_PSMD4_TARGETS esophageal disease DOID_6050 4.887E-09 3.271E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS mixed glioma DOID_5076 4.96E-09 3.282E-08 3.436E-04 0.03258231 GAURNIER_PSMD4_TARGETS chronic kidney failure DOID_784 7.172E-09 4.691E-08 0.13391715 1.000 GAURNIER_PSMD4_TARGETS hepatitis DOID_2237 9.475E-09 6.127E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS intracranial arterial disease DOID_13089 1.071E-08 6.846E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS cerebral arterial disease DOID_3527 1.071E-08 6.846E-08 1.000 1.000 GAURNIER_PSMD4_TARGETS autoimmune disease of urogenital tract DOID_0060049 1.356E-08 8.57E-08 0.07325403 0.80156814 GAURNIER_PSMD4_TARGETS primary biliary cirrhosis DOID_12236 1.356E-08 8.57E-08 0.07325403 0.80156814 GAURNIER_PSMD4_TARGETS juvenile rheumatoid arthritis DOID_676 1.729E-08 1.081E-07 1.000 1.000 GAURNIER_PSMD4_TARGETS myeloma DOID_0070004 2.336E-08 1.445E-07 0.08105981 0.87024584 GAURNIER_PSMD4_TARGETS psoriasis DOID_8893 2.808E-08 1.718E-07 4.361E-06 4.963E-04 GAURNIER_PSMD4_TARGETS bone marrow cancer DOID_4960 4.574E-08 2.769E-07 0.09187927 0.91718076 GAURNIER_PSMD4_TARGETS acquired immunodeficiency syndrome DOID_635 5.279E-08 3.162E-07 6.341E-04 0.04509939 GAURNIER_PSMD4_TARGETS placenta disease DOID_780 5.279E-08 3.129E-07 1.000 1.000 GAURNIER_PSMD4_TARGETS Goodpasture syndrome DOID_9808 7.649E-08 4.487E-07 1.000 1.000 GAURNIER_PSMD4_TARGETS toxic shock syndrome DOID_14115 9.095E-08 5.28E-07 0.04137294 0.71336973 GAURNIER_PSMD4_TARGETS acute pancreatitis DOID_2913 9.095E-08 5.227E-07 0.04137294 0.69238827 GAURNIER_PSMD4_TARGETS cystitis DOID_1679 1.259E-07 7.161E-07 0.04460902 0.66796138 GAURNIER_PSMD4_TARGETS diabetic retinopathy DOID_8947 1.969E-07 1.109E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS syndrome DOID_225 2.244E-07 1.252E-06 0.12359084 1.000 GAURNIER_PSMD4_TARGETS metabolic syndrome X DOID_14221 2.886E-07 1.594E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS abdominal aortic aneurysm DOID_7693 2.912E-07 1.593E-06 0.05425288 0.71790445 GAURNIER_PSMD4_TARGETS bladder disease DOID_365 3.717E-07 2.014E-06 0.05744616 0.74288333 GAURNIER_PSMD4_TARGETS retinal vascular disease DOID_2462 3.882E-07 2.084E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS hepatitis C DOID_1883 4.677E-07 2.487E-06 0.06062883 0.74995221 GAURNIER_PSMD4_TARGETS interstitial nephritis DOID_1063 5.46E-07 2.876E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS angioedema DOID_1558 5.46E-07 2.85E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS conjunctival disease DOID_4251 5.46E-07 2.824E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS conjunctivitis DOID_6195 5.46E-07 2.824E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS multiple myeloma DOID_9538 6.447E-07 3.305E-06 0.06538299 0.75924335 GAURNIER_PSMD4_TARGETS trypanosomiasis DOID_10113 7.498E-07 3.809E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS pneumocystosis DOID_11339 7.498E-07 3.775E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS temporal arteritis DOID_13375 7.498E-07 3.742E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS central nervous system vasculitis DOID_525 7.498E-07 3.742E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS eosinophilic pneumonia DOID_5870 7.498E-07 3.71E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS pulmonary eosinophilia DOID_9498 7.498E-07 3.71E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS Loeffler syndrome DOID_9503 7.498E-07 3.71E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS peptic ulcer DOID_750 7.876E-07 3.863E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS polyneuropathy DOID_1389 1.297E-06 6.305E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS psoriatic arthritis DOID_9008 1.297E-06 6.252E-06 0.02172862 0.47552248 GAURNIER_PSMD4_TARGETS neuritis DOID_1803 1.604E-06 7.67E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS Legionnaires' disease DOID_10457 1.648E-06 7.815E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS legionellosis DOID_10458 1.648E-06 7.815E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS eyelid disease DOID_530 1.648E-06 7.75E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS narcolepsy DOID_8986 1.648E-06 7.687E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS thoracic aortic aneurysm DOID_14004 2.058E-06 9.519E-06 1.000 1.000 GAURNIER_PSMD4_TARGETS B-cell lymphocytic neoplasm DOID_707 2.192E-06 1.006E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS silicosis DOID_10325 2.529E-06 1.151E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS hemolytic-uremic syndrome DOID_12554 2.529E-06 1.142E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS integumentary system cancer DOID_0060122 2.926E-06 1.311E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS skin cancer DOID_4159 2.926E-06 1.311E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS carotid artery disease DOID_3407 4.348E-06 1.933E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS respiratory failure DOID_11162 4.627E-06 2.041E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS membranous glomerulonephritis DOID_10976 5.124E-06 2.243E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS esophagitis DOID_11963 5.124E-06 2.226E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS hyperglycemia DOID_4195 5.879E-06 2.534E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS mitochondrial myopathy DOID_699 5.971E-06 2.555E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS IgA glomerulonephritis DOID_2986 7.932E-06 3.368E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS sleep disorder DOID_535 7.932E-06 3.343E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS meningitis DOID_9471 9.054E-06 3.788E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS bone resorption disease DOID_0080011 1.009E-05 4.19E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS osteoporosis DOID_11476 1.009E-05 4.19E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS spastic quadriplegia DOID_10970 1.028E-05 4.237E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS biliary tract cancer DOID_4607 1.349E-05 5.523E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS Sciatic Neuropathy DOID_11446 1.625E-05 6.604E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS lesion of sciatic nerve DOID_12528 1.625E-05 6.604E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS mononeuritis of lower limb DOID_9473 1.625E-05 6.604E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS primary immunodeficiency disease DOID_612 1.768E-05 7.133E-05 0.14267288 1.000 GAURNIER_PSMD4_TARGETS mononeuritis DOID_1802 1.803E-05 7.225E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS mononeuropathy DOID_1188 1.994E-05 7.934E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS lymphoma DOID_0060058 2.009E-05 7.939E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS carbohydrate metabolic disorder DOID_2978 2.095E-05 8.221E-05 0.14846156 1.000 GAURNIER_PSMD4_TARGETS spastic cerebral palsy DOID_0050669 2.414E-05 9.409E-05 1.000 1.000 GAURNIER_PSMD4_TARGETS congenital diaphragmatic hernia DOID_3827 5.025E-05 1.945E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS adult respiratory distress syndrome DOID_11394 5.396E-05 2.074E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS endometriosis of uterus DOID_288 6.189E-05 2.364E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS endometriosis DOID_289 6.613E-05 2.509E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS gallbladder cancer DOID_3121 7.055E-05 2.659E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS heart valve disease DOID_4079 8.498E-05 3.181E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS hemolytic anemia DOID_583 9.018E-05 3.354E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS normocytic anemia DOID_720 9.018E-05 3.354E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS integumentary system benign neoplasm DOID_0060121 9.558E-05 3.532E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS skin benign neoplasm DOID_3165 9.558E-05 3.532E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS calcium metabolism disease DOID_10575 1.012E-04 3.715E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS mitochondrial metabolism disease DOID_700 1.394E-04 5.085E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS prediabetes syndrome DOID_11716 1.528E-04 5.538E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS common variable immunodeficiency DOID_12177 1.528E-04 5.502E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS otitis media DOID_10754 1.832E-04 6.554E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS middle ear disease DOID_5100 1.832E-04 6.554E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS stomach disease DOID_76 1.832E-04 6.513E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS mineral metabolism disease DOID_0050032 2.035E-04 7.191E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS hypercalcemia DOID_12678 2.52E-04 8.85E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS aspergillosis DOID_13564 2.52E-04 8.796E-04 0.02338067 0.49272595 GAURNIER_PSMD4_TARGETS adrenal cortex disease DOID_3952 2.904E-04 1.008E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS lung oat cell carcinoma DOID_5411 2.904E-04 1.002E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS oral submucous fibrosis DOID_5773 2.904E-04 9.955E-04 1.000 1.000 GAURNIER_PSMD4_TARGETS hyperhomocysteinemia DOID_9279 2.904E-04 9.895E-04 0.02502997 0.49110531 GAURNIER_PSMD4_TARGETS adrenal gland disease DOID_9553 3.754E-04 1.271E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS glucose intolerance DOID_10603 4.218E-04 1.42E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS skin carcinoma DOID_3451 4.218E-04 1.412E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS ureteral obstruction DOID_5199 4.218E-04 1.404E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS prion disease DOID_649 4.218E-04 1.395E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS dissociative disorder DOID_10935 4.709E-04 1.549E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS dissociative amnesia DOID_11037 4.709E-04 1.549E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS agammaglobulinemia DOID_2583 4.709E-04 1.54E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS amnestic disorder DOID_10914 5.227E-04 1.699E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS pulmonary edema DOID_11396 5.227E-04 1.69E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS blood protein disease DOID_620 5.227E-04 1.68E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS lymphoblastic leukemia DOID_1037 5.685E-04 1.817E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS coronary restenosis DOID_4247 5.771E-04 1.834E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS uremia DOID_4676 6.937E-04 2.193E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS urinary tract obstruction DOID_5200 6.937E-04 2.181E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS ureteral disease DOID_1426 7.56E-04 2.363E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS intracranial aneurysm DOID_10941 1.031E-03 3.205E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS vitiligo DOID_12306 1.031E-03 3.188E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS B cell deficiency DOID_2115 1.031E-03 3.171E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS diffuse large B-cell lymphoma DOID_0050745 1.106E-03 3.383E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS gestational diabetes DOID_11714 1.106E-03 3.365E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS coronary stenosis DOID_4248 1.184E-03 3.583E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS multiple epiphyseal dysplasia DOID_12721 1.264E-03 3.805E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS corneal disease DOID_10124 1.347E-03 4.033E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS age related macular degeneration DOID_10871 1.432E-03 4.266E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS degeneration of macula and posterior pole DOID_2007 1.432E-03 4.266E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS chronic leukemia DOID_1036 1.61E-03 4.772E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS chronic lymphocytic leukemia DOID_1040 1.61E-03 4.772E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS macular degeneration DOID_4448 1.799E-03 5.303E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS leukopenia DOID_615 1.799E-03 5.275E-03 0.06062883 0.7187042 GAURNIER_PSMD4_TARGETS nephrotic syndrome DOID_1184 2.768E-03 8.077E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS diabetic autonomic neuropathy DOID_11503 2.888E-03 8.383E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS autonomic neuropathy DOID_11504 2.888E-03 8.383E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS diabetic polyneuropathy DOID_12785 2.888E-03 8.383E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS diabetic neuropathy DOID_9743 2.888E-03 8.383E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS pre-eclampsia DOID_10591 3.262E-03 9.421E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS autonomic nervous system disease DOID_11465 3.262E-03 9.374E-03 1.000 1.000 GAURNIER_PSMD4_TARGETS lung small cell carcinoma DOID_5409 3.523E-03 0.01007357 1.000 1.000 GAURNIER_PSMD4_TARGETS hemorrhagic disease DOID_2213 3.794E-03 0.01079345 0.0872578 0.88660154 GAURNIER_PSMD4_TARGETS atrophic muscular disease DOID_913 4.074E-03 0.01153277 1.000 1.000 GAURNIER_PSMD4_TARGETS muscular dystrophy DOID_9884 4.074E-03 0.01153277 1.000 1.000 GAURNIER_PSMD4_TARGETS bile duct adenocarcinoma DOID_4896 4.218E-03 0.01188009 1.000 1.000 GAURNIER_PSMD4_TARGETS cholangiocarcinoma DOID_4947 4.218E-03 0.01188009 1.000 1.000 GAURNIER_PSMD4_TARGETS osteochondrodysplasia DOID_2256 4.363E-03 0.01223051 1.000 1.000 GAURNIER_PSMD4_TARGETS bile duct cancer DOID_4606 4.815E-03 0.01343002 1.000 1.000 GAURNIER_PSMD4_TARGETS bile duct carcinoma DOID_4897 4.815E-03 0.01343002 1.000 1.000 GAURNIER_PSMD4_TARGETS hypothyroidism DOID_1459 5.449E-03 0.01512459 1.000 1.000 GAURNIER_PSMD4_TARGETS endocrine pancreas disease DOID_1428 5.78E-03 0.0159645 1.000 1.000 GAURNIER_PSMD4_TARGETS temporal lobe epilepsy DOID_3328 6.119E-03 0.01682098 1.000 1.000 GAURNIER_PSMD4_TARGETS blood coagulation disease DOID_1247 6.825E-03 0.01867135 0.1161408 1.000 GAURNIER_PSMD4_TARGETS nephrosis DOID_2527 7.007E-03 0.01907753 1.000 1.000 GAURNIER_PSMD4_TARGETS endogenous depression DOID_1595 7.757E-03 0.02101848 1.000 1.000 GAURNIER_PSMD4_TARGETS auditory system disease DOID_2742 8.947E-03 0.02412648 1.000 1.000 GAURNIER_PSMD4_TARGETS mental depression DOID_1596 9.152E-03 0.02456474 1.000 1.000 GAURNIER_PSMD4_TARGETS focal epilepsy DOID_2234 9.152E-03 0.02444941 1.000 1.000 GAURNIER_PSMD4_TARGETS bone development disease DOID_0080006 9.36E-03 0.02488767 1.000 1.000 GAURNIER_PSMD4_TARGETS amino acid metabolic disorder DOID_9252 0.01043056 0.02760459 0.14267288 1.000 GAURNIER_PSMD4_TARGETS dilated cardiomyopathy DOID_12930 0.01178297 0.0310394 1.000 1.000 GAURNIER_PSMD4_TARGETS leber hereditary optic neuropathy DOID_705 0.01509287 0.03957531 1.000 1.000 GAURNIER_PSMD4_TARGETS hyperparathyroidism DOID_13543 0.01675595 0.04373456 1.000 1.000 GAURNIER_PSMD4_TARGETS retinal vascular occlusion DOID_1729 0.01675595 0.04353486 1.000 1.000 GAURNIER_PSMD4_TARGETS bilirubin metabolic disorder DOID_2741 0.01675595 0.04333697 1.000 1.000 GAURNIER_PSMD4_TARGETS acute kidney failure DOID_3021 0.01675595 0.04314088 1.000 1.000 GAURNIER_PSMD4_TARGETS chondrosarcoma DOID_3371 0.01675595 0.04294655 1.000 1.000 GAURNIER_PSMD4_TARGETS Hermansky-Pudlak syndrome DOID_3753 0.01675595 0.04275397 1.000 1.000 GAURNIER_PSMD4_TARGETS insulinoma DOID_3892 0.01675595 0.0425631 1.000 1.000 GAURNIER_PSMD4_TARGETS keratitis DOID_4677 0.01675595 0.04237393 1.000 1.000 GAURNIER_PSMD4_TARGETS acute T cell leukemia DOID_5603 0.01675595 0.04218644 1.000 1.000 GAURNIER_PSMD4_TARGETS sickle cell anemia DOID_10923 0.01841626 0.04616235 1.000 1.000 GAURNIER_PSMD4_TARGETS migraine without aura DOID_12783 0.01841626 0.04595989 1.000 1.000 GAURNIER_PSMD4_TARGETS hemochromatosis DOID_2352 0.01841626 0.04575919 1.000 1.000 GAURNIER_PSMD4_TARGETS bronchiectasis DOID_9563 0.01841626 0.04556023 1.000 1.000 GAURNIER_PSMD4_TARGETS islet cell tumor DOID_1799 0.02007382 0.0494459 1.000 1.000 GAURNIER_PSMD4_TARGETS aortic valve insufficiency DOID_57 0.02007382 0.04923277 1.000 1.000 GAURNIER_PSMD4_TARGETS lipodystrophy DOID_811 0.02007382 0.04902147 1.000 1.000 GAURNIER_PSMD4_TARGETS peritonitis DOID_8283 0.02007382 0.04881198 1.000 1.000 GAURNIER_PSMD4_TARGETS mitochondrial encephalomyopathy DOID_890 0.02007382 0.04860427 1.000 1.000 GAURNIER_PSMD4_TARGETS ocular hypertension DOID_9282 0.02007382 0.04839832 1.000 1.000 GAURNIER_PSMD4_TARGETS borderline glaucoma DOID_9283 0.02007382 0.04839832 1.000 1.000 GAURNIER_PSMD4_TARGETS leprosy DOID_1024 0.02172862 0.05216702 1.000 1.000 GAURNIER_PSMD4_TARGETS parathyroid gland disease DOID_11201 0.02172862 0.05194783 1.000 1.000 GAURNIER_PSMD4_TARGETS hepatic coma DOID_12550 0.02172862 0.05173048 1.000 1.000 GAURNIER_PSMD4_TARGETS carotid stenosis DOID_13001 0.02172862 0.05151494 1.000 1.000 GAURNIER_PSMD4_TARGETS hepatic encephalopathy DOID_13413 0.02172862 0.05173048 1.000 1.000 GAURNIER_PSMD4_TARGETS tethered spinal cord syndrome DOID_1089 0.02338067 0.05520166 1.000 1.000 GAURNIER_PSMD4_TARGETS T-cell leukemia DOID_715 0.02338067 0.05497356 1.000 1.000 GAURNIER_PSMD4_TARGETS parasitic helminthiasis infectious disease DOID_883 0.02338067 0.05474733 0.02338067 0.47512859 GAURNIER_PSMD4_TARGETS bacterial meningitis DOID_9470 0.02338067 0.05452295 1.000 1.000 GAURNIER_PSMD4_TARGETS idiopathic pulmonary fibrosis DOID_0050156 0.02502997 0.05813083 1.000 1.000 GAURNIER_PSMD4_TARGETS renovascular hypertension DOID_1591 0.02502997 0.05789453 1.000 1.000 GAURNIER_PSMD4_TARGETS mesenchymal cell neoplasm DOID_3350 0.02502997 0.05766014 1.000 1.000 GAURNIER_PSMD4_TARGETS arthropathy DOID_381 0.02502997 0.05742764 1.000 1.000 GAURNIER_PSMD4_TARGETS spindle cell sarcoma DOID_4235 0.02502997 0.05766014 1.000 1.000 GAURNIER_PSMD4_TARGETS epithelioid sarcoma DOID_6193 0.02502997 0.05766014 1.000 1.000 GAURNIER_PSMD4_TARGETS varicose veins DOID_799 0.02502997 0.057197 1.000 1.000 GAURNIER_PSMD4_TARGETS spastic diplegia DOID_10965 0.02667653 0.06071579 1.000 1.000 GAURNIER_PSMD4_TARGETS restrictive cardiomyopathy DOID_397 0.02667653 0.06047389 1.000 1.000 GAURNIER_PSMD4_TARGETS vein disease DOID_866 0.02667653 0.06023392 1.000 1.000 GAURNIER_PSMD4_TARGETS lymphatic system cancer DOID_0060073 0.02832036 0.06369282 1.000 1.000 GAURNIER_PSMD4_TARGETS penile disease DOID_1529 0.02832036 0.06344206 1.000 1.000 GAURNIER_PSMD4_TARGETS basal cell carcinoma DOID_2513 0.02832036 0.06319327 1.000 1.000 GAURNIER_PSMD4_TARGETS bronchitis DOID_6132 0.02832036 0.06294642 1.000 1.000 GAURNIER_PSMD4_TARGETS reticulosarcoma DOID_8538 0.02832036 0.06369282 1.000 1.000 GAURNIER_PSMD4_TARGETS lymphosarcoma DOID_8675 0.02832036 0.06369282 1.000 1.000 GAURNIER_PSMD4_TARGETS osteosclerosis DOID_4254 0.02996145 0.06633488 1.000 1.000 GAURNIER_PSMD4_TARGETS MHC class II deficiency DOID_5812 0.03159981 0.06969105 0.03159981 0.59934306 GAURNIER_PSMD4_TARGETS brain edema DOID_4724 0.03323545 0.07301533 1.000 1.000 GAURNIER_PSMD4_TARGETS subependymal glioma DOID_4843 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS pilocytic astrocytoma DOID_4851 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS subependymal giant cell astrocytoma DOID_5077 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS fibrillary astrocytoma DOID_6726 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS juvenile pilocytic astrocytoma DOID_6811 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS childhood pilocytic astrocytoma DOID_6812 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS gemistocytic astrocytoma DOID_7005 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS childhood cerebral astrocytoma DOID_7007 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS protoplasmic astrocytoma DOID_7008 0.03323545 0.0727345 1.000 1.000 GAURNIER_PSMD4_TARGETS amyloidosis DOID_9120 0.03323545 0.07245582 1.000 1.000 GAURNIER_PSMD4_TARGETS Kawasaki disease DOID_13378 0.03486837 0.07572558 1.000 1.000 GAURNIER_PSMD4_TARGETS lymphadenitis DOID_1602 0.03486837 0.07572558 1.000 1.000 GAURNIER_PSMD4_TARGETS lymph node disease DOID_9942 0.03486837 0.07572558 1.000 1.000 GAURNIER_PSMD4_TARGETS benign glioma DOID_0060101 0.03649857 0.07896459 1.000 1.000 GAURNIER_PSMD4_TARGETS gastric ulcer DOID_10808 0.03649857 0.07866548 1.000 1.000 GAURNIER_PSMD4_TARGETS neutropenia DOID_1227 0.03649857 0.07836863 1.000 1.000 GAURNIER_PSMD4_TARGETS benign ependymoma DOID_4844 0.03649857 0.07896459 1.000 1.000 GAURNIER_PSMD4_TARGETS sinusitis DOID_0050127 0.03812606 0.08155538 1.000 1.000 GAURNIER_PSMD4_TARGETS agranulocytosis DOID_12987 0.03812606 0.08124993 1.000 1.000 GAURNIER_PSMD4_TARGETS paranasal sinus disease DOID_1352 0.03812606 0.08155538 1.000 1.000 GAURNIER_PSMD4_TARGETS optic nerve disease DOID_1891 0.03812606 0.08094676 1.000 1.000 GAURNIER_PSMD4_TARGETS polyarteritis nodosa DOID_9810 0.03812606 0.08064584 1.000 1.000 GAURNIER_PSMD4_TARGETS hypoglycemia DOID_9993 0.03812606 0.08034715 1.000 1.000 GAURNIER_PSMD4_TARGETS diabetic angiopathy DOID_11713 0.03975085 0.08346212 1.000 1.000 GAURNIER_PSMD4_TARGETS Lewy body dementia DOID_12217 0.03975085 0.08315527 1.000 1.000 GAURNIER_PSMD4_TARGETS aortic valve disease DOID_62 0.03975085 0.08285068 1.000 1.000 GAURNIER_PSMD4_TARGETS sphingolipidosis DOID_1927 0.04137294 0.08591679 1.000 1.000 GAURNIER_PSMD4_TARGETS severe combined immunodeficiency DOID_627 0.04137294 0.08560437 0.04137294 0.67260575 GAURNIER_PSMD4_TARGETS hypogonadism DOID_1924 0.04299232 0.08863273 1.000 1.000 GAURNIER_PSMD4_TARGETS combined T cell and B cell immunodeficiency DOID_628 0.04299232 0.08831275 0.04299232 0.66115224 GAURNIER_PSMD4_TARGETS spinal cord disease DOID_319 0.04622303 0.09460756 1.000 1.000 GAURNIER_PSMD4_TARGETS migraine DOID_6364 0.04783435 0.09755464 1.000 1.000 GAURNIER_PSMD4_TARGETS perinatal necrotizing enterocolitis DOID_8677 0.04783435 0.09720623 1.000 1.000 GAURNIER_PSMD4_TARGETS sarcoma DOID_1115 0.04944299 0.09976263 1.000 1.000 GAURNIER_PSMD4_TARGETS malaria DOID_12365 0.04944299 0.09941011 1.000 1.000 GAURNIER_PSMD4_TARGETS thrombocytopenia DOID_1588 0.04944299 0.09906008 0.04944299 0.66983481 VALK_AML_CLUSTER_8 congenital hemolytic anemia DOID_589 1.009E-07 5.742E-05 1.009E-07 5.742E-05 VALK_AML_CLUSTER_8 hemolytic anemia DOID_583 1.032E-06 2.935E-04 1.032E-06 2.935E-04 VALK_AML_CLUSTER_8 normocytic anemia DOID_720 1.032E-06 2.935E-04 1.032E-06 2.935E-04 VALK_AML_CLUSTER_8 malaria DOID_12365 6.316E-05 0.01197845 6.316E-05 0.01197845 VALK_AML_CLUSTER_8 parasitic protozoa infectious disease DOID_2789 2.385E-04 0.0339208 2.385E-04 0.0339208 VALK_AML_CLUSTER_8 parasitic infectious disease DOID_1398 3.279E-04 0.03731165 3.279E-04 0.03731165 APPEL_IMATINIB_RESPONSE sphingolipidosis DOID_1927 1.26E-14 7.172E-12 6.511E-12 3.705E-09 APPEL_IMATINIB_RESPONSE proteinuria DOID_576 4.228E-08 1.203E-05 5.806E-06 1.101E-03 APPEL_IMATINIB_RESPONSE cerebral degeneration DOID_1443 1.61E-07 3.054E-05 1.61E-07 4.58E-05 APPEL_IMATINIB_RESPONSE pustulosis of palm and sole DOID_4398 9.683E-06 1.377E-03 0.04050972 0.4904262 APPEL_IMATINIB_RESPONSE carotid artery disease DOID_3407 1.304E-05 1.484E-03 0.04460902 0.52880276 APPEL_IMATINIB_RESPONSE brain infarction DOID_3454 1.783E-05 1.69E-03 1.178E-03 0.06091193 APPEL_IMATINIB_RESPONSE diabetic retinopathy DOID_8947 2.187E-05 1.778E-03 1.348E-03 0.05898175 APPEL_IMATINIB_RESPONSE familial combined hyperlipidemia DOID_13809 2.19E-05 1.558E-03 1.000 1.000 APPEL_IMATINIB_RESPONSE pancreatitis DOID_4989 2.552E-05 1.613E-03 1.492E-03 0.06061964 APPEL_IMATINIB_RESPONSE chronic kidney failure DOID_784 3.06E-05 1.741E-03 0.05882417 0.59769557 APPEL_IMATINIB_RESPONSE mucopolysaccharidosis DOID_12798 3.21E-05 1.66E-03 3.21E-05 4.566E-03 APPEL_IMATINIB_RESPONSE retinal vascular disease DOID_2462 3.281E-05 1.556E-03 1.76E-03 0.06260212 APPEL_IMATINIB_RESPONSE polycystic kidney disease DOID_898 4.421E-05 1.935E-03 4.421E-05 5.032E-03 APPEL_IMATINIB_RESPONSE Barrett's esophagus DOID_9206 5.825E-05 2.368E-03 0.01133668 0.2224334 APPEL_IMATINIB_RESPONSE acute pancreatitis DOID_2913 1.451E-04 5.503E-03 1.451E-04 0.01375655 APPEL_IMATINIB_RESPONSE spinal muscular atrophy DOID_12377 1.696E-04 6.03E-03 1.696E-04 0.01378374 APPEL_IMATINIB_RESPONSE middle cerebral artery infarction DOID_3525 1.825E-04 6.11E-03 0.01975786 0.29584795 APPEL_IMATINIB_RESPONSE esophageal disease DOID_6050 3.203E-04 0.01012632 0.02602837 0.3526225 APPEL_IMATINIB_RESPONSE intracranial arterial disease DOID_13089 4.332E-04 0.01297298 0.03018724 0.39945439 APPEL_IMATINIB_RESPONSE cerebral arterial disease DOID_3527 4.332E-04 0.01297298 0.03018724 0.39945439 APPEL_IMATINIB_RESPONSE cerebral infarction DOID_3526 5.399E-04 0.01536142 0.03363989 0.42535774 APPEL_IMATINIB_RESPONSE giant cell tumor DOID_200 7.346E-04 0.01990346 7.346E-04 0.05224658 APPEL_IMATINIB_RESPONSE malignant giant cell tumor DOID_2705 7.346E-04 0.01990346 7.346E-04 0.05224658 APPEL_IMATINIB_RESPONSE giant cell glioblastoma DOID_3074 7.346E-04 0.01990346 7.346E-04 0.05224658 APPEL_IMATINIB_RESPONSE familial hyperlipidemia DOID_1168 8.151E-04 0.02108058 1.000 1.000 APPEL_IMATINIB_RESPONSE hypertrophic cardiomyopathy DOID_11984 8.71E-04 0.02154752 8.71E-04 0.0550659 APPEL_IMATINIB_RESPONSE glioblastoma DOID_3068 8.71E-04 0.02064971 8.71E-04 0.04955931 APPEL_IMATINIB_RESPONSE astrocytoma DOID_3069 1.211E-03 0.02755491 1.211E-03 0.05740606 APPEL_IMATINIB_RESPONSE pancreatic ductal carcinoma DOID_3587 1.244E-03 0.0272295 0.05072636 0.57726599 APPEL_IMATINIB_RESPONSE pancreatic carcinoma DOID_4905 1.348E-03 0.02839862 0.05275708 0.5772842 APPEL_IMATINIB_RESPONSE aneurysm disease DOID_2403 1.455E-03 0.02956504 0.05478362 0.58814863 APPEL_IMATINIB_RESPONSE mixed glioma DOID_5076 1.492E-03 0.02926465 1.492E-03 0.05657833 APPEL_IMATINIB_RESPONSE lipid metabolism disorder DOID_3146 1.566E-03 0.02970442 1.000 1.000 APPEL_IMATINIB_RESPONSE transitional cell carcinoma DOID_2671 1.882E-03 0.03454546 1.882E-03 0.06299466 FINETTI_BREAST_CANCER_KINOME_GREEN primary immunodeficiency disease DOID_612 1.586E-06 9.024E-04 1.586E-06 9.024E-04 FINETTI_BREAST_CANCER_KINOME_GREEN MHC class II deficiency DOID_5812 1.068E-05 3.039E-03 1.068E-05 3.039E-03 FINETTI_BREAST_CANCER_KINOME_GREEN severe combined immunodeficiency DOID_627 1.873E-05 3.552E-03 1.873E-05 3.552E-03 FINETTI_BREAST_CANCER_KINOME_GREEN combined T cell and B cell immunodeficiency DOID_628 2.028E-05 2.885E-03 2.028E-05 2.885E-03 FINETTI_BREAST_CANCER_KINOME_GREEN dilated cardiomyopathy DOID_12930 2.877E-04 0.03273959 0.02529662 0.68541783 BLUM_RESPONSE_TO_SALIRASIB_DN oral cavity cancer DOID_8618 5.38E-15 3.061E-12 5.38E-15 3.061E-12 BLUM_RESPONSE_TO_SALIRASIB_DN congenital nervous system abnormality DOID_2490 9.832E-12 2.797E-09 9.832E-12 2.797E-09 BLUM_RESPONSE_TO_SALIRASIB_DN microcephaly DOID_10907 8.113E-10 1.539E-07 8.113E-10 1.539E-07 BLUM_RESPONSE_TO_SALIRASIB_DN adenoid cystic carcinoma DOID_4866 1.154E-09 1.641E-07 1.154E-09 1.641E-07 BLUM_RESPONSE_TO_SALIRASIB_DN salivary gland cancer DOID_8850 1.612E-09 1.835E-07 1.612E-09 1.835E-07 BLUM_RESPONSE_TO_SALIRASIB_DN lymphoma DOID_0060058 1.457E-08 1.382E-06 1.457E-08 1.382E-06 BLUM_RESPONSE_TO_SALIRASIB_DN diffuse large B-cell lymphoma DOID_0050745 2.21E-07 1.796E-05 2.21E-07 1.796E-05 BLUM_RESPONSE_TO_SALIRASIB_DN vulva cancer DOID_1245 3.106E-07 2.209E-05 3.106E-07 2.209E-05 BLUM_RESPONSE_TO_SALIRASIB_DN mouth disease DOID_403 3.471E-07 2.194E-05 6.028E-06 2.639E-04 BLUM_RESPONSE_TO_SALIRASIB_DN neuroectodermal tumor DOID_171 5.512E-07 3.136E-05 1.244E-05 4.72E-04 BLUM_RESPONSE_TO_SALIRASIB_DN pre-malignant neoplasm DOID_0060071 6.629E-07 3.429E-05 6.629E-07 4.191E-05 BLUM_RESPONSE_TO_SALIRASIB_DN in situ carcinoma DOID_8719 6.629E-07 3.429E-05 6.629E-07 4.191E-05 BLUM_RESPONSE_TO_SALIRASIB_DN tongue cancer DOID_8649 7.821E-07 3.709E-05 7.821E-07 4.45E-05 BLUM_RESPONSE_TO_SALIRASIB_DN cervix uteri carcinoma in situ DOID_8991 1.91E-06 8.361E-05 1.91E-06 9.882E-05 BLUM_RESPONSE_TO_SALIRASIB_DN primitive neuroectodermal tumor DOID_168 2.393E-06 9.727E-05 6.29E-05 2.105E-03 BLUM_RESPONSE_TO_SALIRASIB_DN myeloma DOID_0070004 3.644E-06 1.382E-04 8.75E-05 2.489E-03 BLUM_RESPONSE_TO_SALIRASIB_DN nervous system cancer DOID_3093 4.709E-06 1.674E-04 7.227E-05 2.164E-03 BLUM_RESPONSE_TO_SALIRASIB_DN B-cell lymphocytic neoplasm DOID_707 5.358E-06 1.793E-04 5.358E-06 2.541E-04 BLUM_RESPONSE_TO_SALIRASIB_DN bone marrow cancer DOID_4960 7.015E-06 2.217E-04 1.463E-04 3.965E-03 BLUM_RESPONSE_TO_SALIRASIB_DN reproductive organ benign neoplasm DOID_0050622 7.648E-06 2.29E-04 1.566E-04 4.05E-03 BLUM_RESPONSE_TO_SALIRASIB_DN middle cerebral artery infarction DOID_3525 8.424E-06 2.397E-04 2.958E-04 6.733E-03 BLUM_RESPONSE_TO_SALIRASIB_DN lung adenocarcinoma DOID_3910 9.737E-06 2.638E-04 9.737E-06 3.957E-04 BLUM_RESPONSE_TO_SALIRASIB_DN endocrine organ benign neoplasm DOID_0060089 2.07E-05 5.353E-04 3.422E-04 7.489E-03 BLUM_RESPONSE_TO_SALIRASIB_DN Lynch syndrome DOID_3883 2.718E-05 6.725E-04 1.616E-03 0.02189654 BLUM_RESPONSE_TO_SALIRASIB_DN medullomyoblastoma DOID_3861 2.929E-05 6.944E-04 7.363E-04 0.01309205 BLUM_RESPONSE_TO_SALIRASIB_DN adult medulloblastoma DOID_3864 2.929E-05 6.944E-04 7.363E-04 0.01309205 BLUM_RESPONSE_TO_SALIRASIB_DN childhood medulloblastoma DOID_3869 2.929E-05 6.944E-04 7.363E-04 0.01309205 BLUM_RESPONSE_TO_SALIRASIB_DN bone resorption disease DOID_0080011 3.477E-05 7.914E-04 5.142E-04 0.01044859 BLUM_RESPONSE_TO_SALIRASIB_DN osteoporosis DOID_11476 3.477E-05 7.914E-04 5.142E-04 0.01044859 BLUM_RESPONSE_TO_SALIRASIB_DN medulloblastoma DOID_3858 3.6E-05 7.879E-04 8.565E-04 0.01476755 BLUM_RESPONSE_TO_SALIRASIB_DN multiple myeloma DOID_9538 3.6E-05 7.587E-04 8.565E-04 0.01392369 BLUM_RESPONSE_TO_SALIRASIB_DN mixed glioma DOID_5076 3.695E-05 7.509E-04 3.695E-05 1.314E-03 BLUM_RESPONSE_TO_SALIRASIB_DN intracranial arterial disease DOID_13089 4.809E-05 9.436E-04 1.059E-03 0.01585627 BLUM_RESPONSE_TO_SALIRASIB_DN cerebral arterial disease DOID_3527 4.809E-05 9.436E-04 1.059E-03 0.01585627 BLUM_RESPONSE_TO_SALIRASIB_DN uterine cancer DOID_363 6.851E-05 1.299E-03 6.851E-05 2.166E-03 BLUM_RESPONSE_TO_SALIRASIB_DN cerebral infarction DOID_3526 7.447E-05 1.367E-03 1.459E-03 0.02128808 BLUM_RESPONSE_TO_SALIRASIB_DN brain cancer DOID_1319 8.75E-05 1.556E-03 1.642E-03 0.02173171 BLUM_RESPONSE_TO_SALIRASIB_DN thyroid adenoma DOID_2891 8.75E-05 1.509E-03 1.642E-03 0.0212378 BLUM_RESPONSE_TO_SALIRASIB_DN central nervous system cancer DOID_3620 9.461E-05 1.583E-03 1.739E-03 0.02198895 BLUM_RESPONSE_TO_SALIRASIB_DN colon carcinoma DOID_1520 1.058E-04 1.72E-03 3.854E-03 0.04217076 BLUM_RESPONSE_TO_SALIRASIB_DN reading disorder DOID_13365 2.364E-04 3.736E-03 2.364E-04 5.848E-03 BLUM_RESPONSE_TO_SALIRASIB_DN dyslexia DOID_4428 2.364E-04 3.736E-03 2.364E-04 5.848E-03 BLUM_RESPONSE_TO_SALIRASIB_DN papillary adenoma DOID_3172 2.65E-04 4.076E-03 6.97E-03 0.06294813 BLUM_RESPONSE_TO_SALIRASIB_DN microcystic adenoma DOID_5403 2.65E-04 4.076E-03 6.97E-03 0.06294813 BLUM_RESPONSE_TO_SALIRASIB_DN follicular adenoma DOID_6204 2.65E-04 4.076E-03 6.97E-03 0.06294813 BLUM_RESPONSE_TO_SALIRASIB_DN uterine disease DOID_345 2.9E-04 4.342E-03 2.9E-04 6.874E-03 BLUM_RESPONSE_TO_SALIRASIB_DN brain infarction DOID_3454 3.422E-04 4.993E-03 4.46E-03 0.04699786 BLUM_RESPONSE_TO_SALIRASIB_DN invasive ductal carcinoma DOID_3008 3.641E-04 5.18E-03 8.559E-03 0.07269023 BLUM_RESPONSE_TO_SALIRASIB_DN female reproductive organ benign neoplasm DOID_0060086 4.418E-04 6.132E-03 9.701E-03 0.07774114 BLUM_RESPONSE_TO_SALIRASIB_DN uterine benign neoplasm DOID_0060095 4.418E-04 6.132E-03 9.701E-03 0.07774114 BLUM_RESPONSE_TO_SALIRASIB_DN uterine fibroid DOID_13223 4.418E-04 6.132E-03 9.701E-03 0.07774114 BLUM_RESPONSE_TO_SALIRASIB_DN endometrial carcinoma DOID_2871 4.418E-04 5.986E-03 4.418E-04 9.311E-03 BLUM_RESPONSE_TO_SALIRASIB_DN Charcot-Marie-Tooth disease DOID_10595 5.294E-04 7.006E-03 5.294E-04 0.01038795 BLUM_RESPONSE_TO_SALIRASIB_DN endometrial cancer DOID_1380 5.294E-04 6.847E-03 5.294E-04 0.01004169 BLUM_RESPONSE_TO_SALIRASIB_DN leiomyoma DOID_127 5.771E-04 7.297E-03 0.01153148 0.08866773 BLUM_RESPONSE_TO_SALIRASIB_DN lipid metabolism disorder DOID_3146 5.921E-04 7.324E-03 6.659E-03 0.06211601 BLUM_RESPONSE_TO_SALIRASIB_DN female reproductive system disease DOID_229 6.199E-04 7.504E-03 6.199E-04 0.0113774 BLUM_RESPONSE_TO_SALIRASIB_DN papilloma DOID_2615 6.274E-04 7.438E-03 0.01217289 0.09113654 BLUM_RESPONSE_TO_SALIRASIB_DN biliary tract cancer DOID_4607 6.781E-04 7.874E-03 7.352E-03 0.06536586 BLUM_RESPONSE_TO_SALIRASIB_DN bone development disease DOID_0080006 7.086E-04 8.064E-03 7.592E-03 0.0664623 BLUM_RESPONSE_TO_SALIRASIB_DN adenoma DOID_657 7.949E-04 8.869E-03 0.01418829 0.10484597 BLUM_RESPONSE_TO_SALIRASIB_DN cleft palate DOID_674 8.565E-04 9.372E-03 8.565E-04 0.01433321 BLUM_RESPONSE_TO_SALIRASIB_DN embryonal cancer DOID_688 8.565E-04 9.195E-03 0.01488997 0.10724548 BLUM_RESPONSE_TO_SALIRASIB_DN amino acid metabolic disorder DOID_9252 8.76E-04 9.23E-03 8.76E-04 0.01384518 BLUM_RESPONSE_TO_SALIRASIB_DN Human immunodeficiency virus infectious disease DOID_526 9.125E-04 9.44E-03 9.13E-03 0.07421591 BLUM_RESPONSE_TO_SALIRASIB_DN peripheral nervous system neoplasm DOID_1192 9.209E-04 9.357E-03 9.209E-04 0.01416262 BLUM_RESPONSE_TO_SALIRASIB_DN rectal neoplasm DOID_1984 9.41E-04 9.394E-03 0.04547186 0.26673699 BLUM_RESPONSE_TO_SALIRASIB_DN rectum cancer DOID_1993 9.41E-04 9.394E-03 0.04547186 0.26673699 BLUM_RESPONSE_TO_SALIRASIB_DN hepatitis DOID_2237 9.884E-04 9.697E-03 0.01633723 0.11619852 BLUM_RESPONSE_TO_SALIRASIB_DN carbohydrate metabolic disorder DOID_2978 1.029E-03 9.919E-03 9.962E-03 0.07873094 BLUM_RESPONSE_TO_SALIRASIB_DN familial adenomatous polyposis DOID_0050424 1.147E-03 0.01087412 0.04990438 0.28114448 BLUM_RESPONSE_TO_SALIRASIB_DN rheumatic disease DOID_1575 1.289E-03 0.01202674 0.19279489 0.61629376 BLUM_RESPONSE_TO_SALIRASIB_DN scleroderma DOID_419 1.289E-03 0.01202674 0.19279489 0.61629376 BLUM_RESPONSE_TO_SALIRASIB_DN lipodystrophy DOID_811 1.372E-03 0.0125895 0.05431643 0.29156651 BLUM_RESPONSE_TO_SALIRASIB_DN gallbladder cancer DOID_3121 1.373E-03 0.01239672 0.02020456 0.13686186 BLUM_RESPONSE_TO_SALIRASIB_DN learning disability DOID_8927 1.459E-03 0.01297242 1.459E-03 0.02075588 BLUM_RESPONSE_TO_SALIRASIB_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 1.616E-03 0.01414853 1.616E-03 0.0224306 BLUM_RESPONSE_TO_SALIRASIB_DN tethered spinal cord syndrome DOID_1089 1.88E-03 0.01620698 0.06307952 0.31484425 BLUM_RESPONSE_TO_SALIRASIB_DN rhabdomyosarcoma DOID_3247 1.88E-03 0.01596508 1.88E-03 0.02325349 BLUM_RESPONSE_TO_SALIRASIB_DN orofacial cleft DOID_0050567 2.161E-03 0.01808468 2.161E-03 0.02616507 BLUM_RESPONSE_TO_SALIRASIB_DN skeletal muscle cancer DOID_4043 2.163E-03 0.0178328 2.163E-03 0.02563465 BLUM_RESPONSE_TO_SALIRASIB_DN osteochondrodysplasia DOID_2256 2.516E-03 0.02045332 0.02989012 0.19548825 BLUM_RESPONSE_TO_SALIRASIB_DN pustulosis of palm and sole DOID_4398 2.516E-03 0.02016524 0.02989012 0.19326679 BLUM_RESPONSE_TO_SALIRASIB_DN familial hyperlipidemia DOID_1168 2.642E-03 0.02087958 0.03084619 0.19720767 BLUM_RESPONSE_TO_SALIRASIB_DN lymphatic system cancer DOID_0060073 2.784E-03 0.02169935 2.784E-03 0.0323276 BLUM_RESPONSE_TO_SALIRASIB_DN reticulosarcoma DOID_8538 2.784E-03 0.02169935 2.784E-03 0.0323276 BLUM_RESPONSE_TO_SALIRASIB_DN lymphosarcoma DOID_8675 2.784E-03 0.02169935 2.784E-03 0.0323276 BLUM_RESPONSE_TO_SALIRASIB_DN osteosclerosis DOID_4254 3.122E-03 0.02400859 3.122E-03 0.03553272 BLUM_RESPONSE_TO_SALIRASIB_DN collagen disease DOID_854 3.329E-03 0.02525791 0.25774101 0.74067997 BLUM_RESPONSE_TO_SALIRASIB_DN MHC class II deficiency DOID_5812 3.479E-03 0.02604752 3.479E-03 0.03881591 BLUM_RESPONSE_TO_SALIRASIB_DN brain edema DOID_4724 3.854E-03 0.02847896 3.854E-03 0.04137509 BLUM_RESPONSE_TO_SALIRASIB_DN tooth disease DOID_1091 4.286E-03 0.03126766 0.04212756 0.2523219 BLUM_RESPONSE_TO_SALIRASIB_DN placenta disease DOID_780 4.657E-03 0.03354302 4.657E-03 0.04817998 BLUM_RESPONSE_TO_SALIRASIB_DN muscle cancer DOID_4045 5.085E-03 0.03616818 5.085E-03 0.05166883 BLUM_RESPONSE_TO_SALIRASIB_DN congenital hemolytic anemia DOID_589 5.531E-03 0.03885076 5.531E-03 0.05520897 BLUM_RESPONSE_TO_SALIRASIB_DN severe combined immunodeficiency DOID_627 5.993E-03 0.04158748 5.993E-03 0.0587961 BLUM_RESPONSE_TO_SALIRASIB_DN osteosarcoma DOID_3347 6.473E-03 0.04437525 6.473E-03 0.06242619 BLUM_RESPONSE_TO_SALIRASIB_DN combined T cell and B cell immunodeficiency DOID_628 6.473E-03 0.04384697 6.473E-03 0.06138576 BLUM_RESPONSE_TO_SALIRASIB_DN metabolic syndrome X DOID_14221 6.659E-03 0.04457738 0.05589663 0.29724469 BLUM_RESPONSE_TO_SALIRASIB_DN spinal muscular atrophy DOID_12377 6.97E-03 0.04611317 6.97E-03 0.06396343 BLUM_RESPONSE_TO_SALIRASIB_DN spinal cord disease DOID_319 7.483E-03 0.04894069 0.12220119 0.44007896 BLUM_RESPONSE_TO_SALIRASIB_DN perinatal necrotizing enterocolitis DOID_8677 8.013E-03 0.05181109 8.013E-03 0.06908145 BLUM_RESPONSE_TO_SALIRASIB_DN primary immunodeficiency disease DOID_612 8.862E-03 0.05665886 8.862E-03 0.07415645 BLUM_RESPONSE_TO_SALIRASIB_DN supratentorial cancer DOID_1659 9.122E-03 0.05767064 9.122E-03 0.07522258 BLUM_RESPONSE_TO_SALIRASIB_DN cerebrum cancer DOID_368 9.122E-03 0.05767064 9.122E-03 0.07522258 BLUM_RESPONSE_TO_SALIRASIB_DN dilated cardiomyopathy DOID_12930 0.01054095 0.06590988 0.01054095 0.08216163 BLUM_RESPONSE_TO_SALIRASIB_DN autonomic nervous system neoplasm DOID_2621 0.01153148 0.07131969 0.01153148 0.08748549 BLUM_RESPONSE_TO_SALIRASIB_DN neuroblastoma DOID_769 0.01153148 0.07131969 0.01153148 0.08748549 BLUM_RESPONSE_TO_SALIRASIB_DN nephroblastoma DOID_2154 0.0128296 0.07849511 0.15823354 0.52961698 BLUM_RESPONSE_TO_SALIRASIB_DN refractive error DOID_9835 0.01418829 0.08588446 0.01418829 0.10350179 BLUM_RESPONSE_TO_SALIRASIB_DN calcinosis DOID_182 0.01488997 0.08918308 1.000 1.000 BLUM_RESPONSE_TO_SALIRASIB_DN systemic scleroderma DOID_418 0.01633723 0.0968321 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Barrett's esophagus DOID_9206 2.486E-07 1.415E-04 0.01258884 0.42135594 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN pancreatitis DOID_4989 4.831E-07 1.374E-04 0.06142952 0.59243048 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN esophageal disease DOID_6050 3.412E-06 6.471E-04 0.0288794 0.44411829 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN pulmonary emphysema DOID_9675 5.793E-06 8.241E-04 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN influenza DOID_8469 7.082E-06 8.059E-04 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN giant cell tumor DOID_200 1.205E-05 1.143E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN malignant giant cell tumor DOID_2705 1.205E-05 1.143E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN giant cell glioblastoma DOID_3074 1.205E-05 1.143E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN glioblastoma DOID_3068 1.56E-05 1.268E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN congenital heart defect DOID_1682 1.978E-05 1.407E-03 1.978E-05 0.01125645 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN cholestasis DOID_13580 2.164E-05 1.368E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN astrocytoma DOID_3069 2.57E-05 1.462E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN bile duct disease DOID_4138 2.791E-05 1.443E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN biliary tract disease DOID_9741 2.905E-05 1.378E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN cystic fibrosis DOID_1485 3.268E-05 1.43E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Charcot-Marie-Tooth disease type 4 DOID_0050541 3.315E-05 1.347E-03 8.671E-03 0.54822376 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Down syndrome DOID_14250 1.027E-04 3.894E-03 0.01493213 0.42481918 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN esophagitis DOID_11963 1.14E-04 4.054E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN portal hypertension DOID_10762 1.944E-04 6.508E-03 0.02037893 0.41412887 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN osteosarcoma DOID_3347 1.944E-04 6.146E-03 0.02037893 0.38652028 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN middle cerebral artery infarction DOID_3525 2.259E-04 6.765E-03 0.0219298 0.40251788 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN pleurisy DOID_10247 2.597E-04 7.389E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN hepatic vascular disease DOID_272 2.597E-04 7.037E-03 0.02347829 0.39291617 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Charcot-Marie-Tooth disease DOID_10595 3.343E-04 8.646E-03 0.02656818 0.41992491 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN allergic rhinitis DOID_4481 3.343E-04 8.27E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN pleural disease DOID_1532 3.544E-04 8.402E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN metal metabolism disorder DOID_896 3.75E-04 8.536E-03 3.75E-04 0.10669778 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN spindle cell carcinoma DOID_4015 3.963E-04 8.672E-03 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN peptic ulcer DOID_750 5.11E-04 0.01076968 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN intracranial arterial disease DOID_13089 5.357E-04 0.01088628 0.03348592 0.45365447 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN cerebral arterial disease DOID_3527 5.357E-04 0.01088628 0.03348592 0.45365447 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN nephrotic syndrome DOID_1184 6.131E-04 0.01202961 0.03578125 0.4734775 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Huntington's disease DOID_12858 6.131E-04 0.01162863 0.03578125 0.46271664 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN cerebral infarction DOID_3526 6.675E-04 0.01225264 0.03730855 0.47174583 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN sarcoidosis DOID_11335 9.078E-04 0.01614155 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN bone marrow cancer DOID_4960 9.403E-04 0.01621363 0.04415248 0.50245517 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN hypersensitivity reaction type IV disease DOID_2916 1.076E-03 0.01800859 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN hyperglycemia DOID_4195 1.374E-03 0.02233885 0.05320459 0.58218099 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN allergic contact dermatitis DOID_3042 1.414E-03 0.02234613 1.414E-03 0.26815352 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN brain infarction DOID_3454 1.454E-03 0.0223614 0.0547052 0.58730673 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN pancreatic ductal carcinoma DOID_3587 1.536E-03 0.02300327 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN nephrosis DOID_2527 1.578E-03 0.02302473 0.0569518 0.58919222 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN male reproductive system disease DOID_48 1.578E-03 0.02244911 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN peripheral vascular disease DOID_341 1.621E-03 0.02249057 1.621E-03 0.23052831 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN pancreatic carcinoma DOID_4905 1.664E-03 0.02253739 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN metabolic syndrome X DOID_14221 1.933E-03 0.0255758 0.06291753 0.59666787 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN contact dermatitis DOID_2773 1.933E-03 0.02499453 1.933E-03 0.21995185 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN chromosomal disease DOID_0080014 1.98E-03 0.02503024 0.06366067 0.5938184 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN chronic kidney failure DOID_784 2.075E-03 0.02566254 0.06514526 0.59786533 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Human immunodeficiency virus infectious disease DOID_526 2.424E-03 0.02934937 0.0703234 0.62521898 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN lymphoma DOID_0060058 2.529E-03 0.02997856 0.07179777 0.62850663 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN lymphoblastic leukemia DOID_1037 2.582E-03 0.02998358 0.07253411 0.62533193 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN dilated cardiomyopathy DOID_12930 2.69E-03 0.03061082 0.07400509 0.61924846 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN ulcerative colitis DOID_8577 2.856E-03 0.03185869 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN brachydactyly DOID_0050581 7.886E-03 0.08629196 7.886E-03 0.74786361 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN hyperparathyroidism DOID_13543 7.886E-03 0.08466381 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN ventricular septal defect DOID_1657 7.886E-03 0.08309596 7.886E-03 0.64102595 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN chondrosarcoma DOID_3371 7.886E-03 0.08158512 7.886E-03 0.56089771 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN cutaneous leishmaniasis DOID_9111 7.886E-03 0.08012824 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN familial adenomatous polyposis DOID_0050424 8.671E-03 0.08656165 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN hemochromatosis DOID_2352 8.671E-03 0.0850692 8.671E-03 0.49340138 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN aortic valve stenosis DOID_1712 9.456E-03 0.09119498 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN stomach disease DOID_76 9.456E-03 0.08967507 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN essential hypertension DOID_10825 0.01024016 0.0955189 0.01024016 0.52969569 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN parathyroid gland disease DOID_11201 0.01024016 0.09397827 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN larynx cancer DOID_2596 0.01024016 0.09248655 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN laryngeal benign neoplasm DOID_2598 0.01024016 0.09248655 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN intracranial thrombosis DOID_4193 0.01024016 0.09104145 0.01024016 0.48555438 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN epilepsy with generalized tonic-clonic seizures DOID_7725 0.01024016 0.08964081 0.01024016 0.44820405 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Legionnaires' disease DOID_10457 0.01102366 0.09503727 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN legionellosis DOID_10458 0.01102366 0.09503727 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN viral pneumonia DOID_10533 0.01102366 0.0936188 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN open-angle glaucoma DOID_1067 0.01102366 0.09224206 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN polycystic kidney disease DOID_898 0.01102366 0.09090521 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN bacterial meningitis DOID_9470 0.01102366 0.08960657 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN idiopathic pulmonary fibrosis DOID_0050156 0.01180655 0.09461867 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN peripheral neuropathy DOID_0060053 0.01180655 0.09330453 0.01180655 0.47985184 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN skeletal system cancer DOID_0060124 0.01180655 0.09202638 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN bone cancer DOID_184 0.01180655 0.09202638 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN hemangioma DOID_255 0.01180655 0.09078278 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN mesenchymal cell neoplasm DOID_3350 0.01180655 0.08957234 0.01180655 0.44786172 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN spindle cell sarcoma DOID_4235 0.01180655 0.08957234 0.01180655 0.44786172 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN oral submucous fibrosis DOID_5773 0.01180655 0.08839376 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN epithelioid sarcoma DOID_6193 0.01180655 0.08957234 0.01180655 0.44786172 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN intermediate coronary syndrome DOID_8805 0.01180655 0.08724579 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN silicosis DOID_10325 0.01258884 0.09183399 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN spastic diplegia DOID_10965 0.01258884 0.09067153 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN long QT syndrome DOID_2843 0.01258884 0.08953814 0.01258884 0.44769068 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN tongue cancer DOID_8649 0.01258884 0.08843273 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN Graves' disease DOID_12361 0.01337054 0.09277848 0.01337054 0.42265753 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN bronchitis DOID_6132 0.01337054 0.09166067 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN urinary system benign neoplasm DOID_731 0.01337054 0.09056947 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN glucose intolerance DOID_10603 0.01415163 0.0947327 0.01415163 0.42380419 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN prion disease DOID_649 0.01415163 0.09363116 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN heart septal defect DOID_1681 0.01493213 0.09765958 0.01493213 0.40458969 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN granulosa cell tumor DOID_2999 0.01493213 0.09654981 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN leishmaniasis DOID_9065 0.01493213 0.09546498 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN amnestic disorder DOID_10914 0.01571203 0.09933497 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN sex cord-gonadal stromal tumor DOID_192 0.01571203 0.09824338 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN subependymal glioma DOID_4843 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN pilocytic astrocytoma DOID_4851 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN subependymal giant cell astrocytoma DOID_5077 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN fibrillary astrocytoma DOID_6726 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN juvenile pilocytic astrocytoma DOID_6811 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN childhood pilocytic astrocytoma DOID_6812 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN gemistocytic astrocytoma DOID_7005 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN childhood cerebral astrocytoma DOID_7007 0.01571203 0.09717552 1.000 1.000 UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN protoplasmic astrocytoma DOID_7008 0.01571203 0.09717552 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_UP allergic contact dermatitis DOID_3042 2.698E-06 1.535E-03 1.249E-04 0.01014892 HAHTOLA_SEZARY_SYNDROM_UP pulmonary embolism DOID_9477 4.227E-06 1.203E-03 0.03108501 0.22389075 HAHTOLA_SEZARY_SYNDROM_UP diabetic angiopathy DOID_11713 4.827E-06 9.155E-04 4.995E-04 0.02030256 HAHTOLA_SEZARY_SYNDROM_UP contact dermatitis DOID_2773 5.084E-06 7.233E-04 1.997E-04 0.0126232 HAHTOLA_SEZARY_SYNDROM_UP nervous system cancer DOID_3093 8.041E-06 9.15E-04 2.804E-04 0.01595505 HAHTOLA_SEZARY_SYNDROM_UP malaria DOID_12365 9.626E-06 9.129E-04 7.832E-04 0.02345407 HAHTOLA_SEZARY_SYNDROM_UP autonomic nervous system neoplasm DOID_2621 1.544E-05 1.255E-03 1.544E-05 8.787E-03 HAHTOLA_SEZARY_SYNDROM_UP neuroblastoma DOID_769 1.544E-05 1.255E-03 1.544E-05 8.787E-03 HAHTOLA_SEZARY_SYNDROM_UP systemic mycosis DOID_0050136 1.683E-05 1.197E-03 1.683E-05 4.788E-03 HAHTOLA_SEZARY_SYNDROM_UP fungal infectious disease DOID_1564 1.683E-05 1.197E-03 1.683E-05 4.788E-03 HAHTOLA_SEZARY_SYNDROM_UP leukopenia DOID_615 1.83E-05 1.157E-03 1.83E-05 3.47E-03 HAHTOLA_SEZARY_SYNDROM_UP peripheral nervous system neoplasm DOID_1192 2.501E-05 1.423E-03 2.501E-05 3.557E-03 HAHTOLA_SEZARY_SYNDROM_UP respiratory syncytial virus infectious disease DOID_1273 2.69E-05 1.392E-03 1.534E-03 0.03356927 HAHTOLA_SEZARY_SYNDROM_UP pre-eclampsia DOID_10591 4.558E-05 2.161E-03 0.06636824 0.35293016 HAHTOLA_SEZARY_SYNDROM_UP bone marrow disease DOID_4961 4.558E-05 1.995E-03 4.558E-05 5.187E-03 HAHTOLA_SEZARY_SYNDROM_UP parasitic protozoa infectious disease DOID_2789 7.12E-05 2.894E-03 2.904E-03 0.05901204 HAHTOLA_SEZARY_SYNDROM_UP leukocyte disease DOID_9500 8.693E-05 3.298E-03 8.693E-05 8.244E-03 HAHTOLA_SEZARY_SYNDROM_UP sickle cell anemia DOID_10923 1.007E-04 3.581E-03 0.01498688 0.21318838 HAHTOLA_SEZARY_SYNDROM_UP parasitic infectious disease DOID_1398 1.145E-04 3.833E-03 3.967E-03 0.0778363 HAHTOLA_SEZARY_SYNDROM_UP hyperglycemia DOID_4195 1.196E-04 3.781E-03 0.09043861 0.39584282 HAHTOLA_SEZARY_SYNDROM_UP retinal detachment DOID_5327 1.207E-04 3.615E-03 0.01633835 0.19367753 HAHTOLA_SEZARY_SYNDROM_UP ocular hypertension DOID_9282 1.207E-04 3.434E-03 0.01633835 0.18972493 HAHTOLA_SEZARY_SYNDROM_UP borderline glaucoma DOID_9283 1.207E-04 3.434E-03 0.01633835 0.18972493 HAHTOLA_SEZARY_SYNDROM_UP tuberculosis DOID_399 1.302E-04 3.529E-03 0.09293664 0.40061325 HAHTOLA_SEZARY_SYNDROM_UP berylliosis DOID_10322 1.425E-04 3.687E-03 1.425E-04 0.01013843 HAHTOLA_SEZARY_SYNDROM_UP peripheral vascular disease DOID_341 1.533E-04 3.792E-03 4.803E-03 0.09109839 HAHTOLA_SEZARY_SYNDROM_UP varicose veins DOID_799 1.915E-04 4.541E-03 0.02038186 0.19995303 HAHTOLA_SEZARY_SYNDROM_UP vein disease DOID_866 2.187E-04 4.978E-03 0.02172606 0.1962243 HAHTOLA_SEZARY_SYNDROM_UP primary bacterial infectious disease DOID_0050338 2.543E-04 5.565E-03 0.11511827 0.45173998 HAHTOLA_SEZARY_SYNDROM_UP Human immunodeficiency virus infectious disease DOID_526 2.804E-04 5.909E-03 7.139E-03 0.12308571 HAHTOLA_SEZARY_SYNDROM_UP lymphoma DOID_0060058 2.987E-04 6.071E-03 2.987E-04 0.01545231 HAHTOLA_SEZARY_SYNDROM_UP encephalomyelitis DOID_640 3.082E-04 6.047E-03 3.082E-04 0.01461238 HAHTOLA_SEZARY_SYNDROM_UP hepatitis B DOID_2043 4.188E-04 7.944E-03 0.02975341 0.22275909 HAHTOLA_SEZARY_SYNDROM_UP opiate dependence DOID_2559 4.583E-04 8.412E-03 0.03108501 0.22676114 HAHTOLA_SEZARY_SYNDROM_UP myasthenia gravis DOID_437 4.583E-04 8.149E-03 4.583E-04 0.02005988 HAHTOLA_SEZARY_SYNDROM_UP osteosarcoma DOID_3347 5.872E-04 0.01012457 5.872E-04 0.02227406 HAHTOLA_SEZARY_SYNDROM_UP neuromuscular junction disease DOID_439 6.336E-04 0.01060362 6.336E-04 0.0225327 HAHTOLA_SEZARY_SYNDROM_UP hypotrichosis DOID_4535 6.817E-04 0.01108329 6.817E-04 0.02281854 HAHTOLA_SEZARY_SYNDROM_UP diffuse large B-cell lymphoma DOID_0050745 7.316E-04 0.01156345 7.316E-04 0.02312689 HAHTOLA_SEZARY_SYNDROM_UP renal hypertension DOID_1073 7.832E-04 0.01204398 0.04035612 0.24959383 HAHTOLA_SEZARY_SYNDROM_UP secondary hypertension DOID_11130 7.832E-04 0.01204398 0.04035612 0.24959383 HAHTOLA_SEZARY_SYNDROM_UP autoimmune disease of the nervous system DOID_438 7.832E-04 0.01172704 7.832E-04 0.02228137 HAHTOLA_SEZARY_SYNDROM_UP opportunistic mycosis DOID_2473 9.481E-04 0.01383276 9.481E-04 0.02568941 HAHTOLA_SEZARY_SYNDROM_UP hair disease DOID_421 1.128E-03 0.01605008 1.128E-03 0.02918197 HAHTOLA_SEZARY_SYNDROM_UP pneumoconiosis DOID_10316 1.192E-03 0.01653889 1.192E-03 0.02948236 HAHTOLA_SEZARY_SYNDROM_UP nephroblastoma DOID_2154 1.192E-03 0.0161451 1.192E-03 0.02825393 HAHTOLA_SEZARY_SYNDROM_UP aplastic anemia DOID_12449 1.257E-03 0.01663114 1.257E-03 0.02860555 HAHTOLA_SEZARY_SYNDROM_UP intracranial arterial disease DOID_13089 1.607E-03 0.02078579 0.05734364 0.32628529 HAHTOLA_SEZARY_SYNDROM_UP cerebral arterial disease DOID_3527 1.607E-03 0.02078579 0.05734364 0.32628529 HAHTOLA_SEZARY_SYNDROM_UP lymphatic system disease DOID_75 1.607E-03 0.02032388 0.05734364 0.32305474 HAHTOLA_SEZARY_SYNDROM_UP influenza DOID_8469 1.917E-03 0.02371794 0.06251097 0.34871318 HAHTOLA_SEZARY_SYNDROM_UP hemolytic anemia DOID_583 2.254E-03 0.02728348 0.06765053 0.34993773 HAHTOLA_SEZARY_SYNDROM_UP normocytic anemia DOID_720 2.254E-03 0.02728348 0.06765053 0.34993773 HAHTOLA_SEZARY_SYNDROM_UP glaucoma DOID_1686 2.342E-03 0.02775936 0.06893109 0.35334948 HAHTOLA_SEZARY_SYNDROM_UP pulmonary tuberculosis DOID_2957 2.342E-03 0.02719284 0.06893109 0.35019457 HAHTOLA_SEZARY_SYNDROM_UP B-cell lymphocytic neoplasm DOID_707 2.523E-03 0.02870887 2.523E-03 0.05316458 HAHTOLA_SEZARY_SYNDROM_UP giant cell tumor DOID_200 2.71E-03 0.03023686 0.07403612 0.36005602 HAHTOLA_SEZARY_SYNDROM_UP malignant giant cell tumor DOID_2705 2.71E-03 0.03023686 0.07403612 0.36005602 HAHTOLA_SEZARY_SYNDROM_UP giant cell glioblastoma DOID_3074 2.71E-03 0.03023686 0.07403612 0.36005602 HAHTOLA_SEZARY_SYNDROM_UP hypersensitivity reaction type IV disease DOID_2916 3.206E-03 0.03508596 0.08037882 0.37797974 HAHTOLA_SEZARY_SYNDROM_UP glioblastoma DOID_3068 3.206E-03 0.03442396 0.08037882 0.37488154 HAHTOLA_SEZARY_SYNDROM_UP astrocytoma DOID_3069 4.436E-03 0.0467385 0.09418313 0.40293386 HAHTOLA_SEZARY_SYNDROM_UP syndrome DOID_225 5.184E-03 0.05363191 5.184E-03 0.09515338 HAHTOLA_SEZARY_SYNDROM_UP bone resorption disease DOID_0080011 5.314E-03 0.05399517 0.10286167 0.42411804 HAHTOLA_SEZARY_SYNDROM_UP osteoporosis DOID_11476 5.314E-03 0.05399517 0.10286167 0.42411804 HAHTOLA_SEZARY_SYNDROM_UP bacterial pneumonia DOID_874 5.446E-03 0.05436058 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_UP retinal vascular disease DOID_2462 6.408E-03 0.06286039 0.11268016 0.44524314 HAHTOLA_SEZARY_SYNDROM_UP primary immunodeficiency disease DOID_612 6.989E-03 0.06740672 6.989E-03 0.12428114 HAHTOLA_SEZARY_SYNDROM_UP mouth disease DOID_403 7.749E-03 0.0734887 0.12360002 0.47842458 HAHTOLA_SEZARY_SYNDROM_UP Crohn's disease DOID_8778 7.749E-03 0.07228397 7.749E-03 0.12968595 HAHTOLA_SEZARY_SYNDROM_UP dilated cardiomyopathy DOID_12930 7.905E-03 0.07255202 0.12480517 0.4798253 DELYS_THYROID_CANCER_UP brain infarction DOID_3454 7.389E-18 4.204E-15 3.781E-09 5.378E-07 DELYS_THYROID_CANCER_UP transitional cell carcinoma DOID_2671 1.109E-17 3.155E-15 1.019E-10 1.933E-08 DELYS_THYROID_CANCER_UP contact dermatitis DOID_2773 2.257E-15 4.28E-13 3.621E-11 1.03E-08 DELYS_THYROID_CANCER_UP allergic contact dermatitis DOID_3042 7.213E-15 1.026E-12 6.066E-12 3.451E-09 DELYS_THYROID_CANCER_UP bacterial pneumonia DOID_874 4.475E-14 5.093E-12 0.45818298 0.80217266 DELYS_THYROID_CANCER_UP cholestasis DOID_13580 1.526E-13 1.447E-11 1.836E-03 0.0217682 DELYS_THYROID_CANCER_UP bile duct disease DOID_4138 4.415E-13 3.589E-11 2.504E-03 0.02456256 DELYS_THYROID_CANCER_UP biliary tract disease DOID_9741 5.221E-13 3.713E-11 2.629E-03 0.02535579 DELYS_THYROID_CANCER_UP aneurysm disease DOID_2403 9.961E-13 6.298E-11 0.02266162 0.11512913 DELYS_THYROID_CANCER_UP hypersensitivity reaction type IV disease DOID_2916 1.245E-12 7.086E-11 0.37322197 0.66571568 DELYS_THYROID_CANCER_UP respiratory failure DOID_11162 2.595E-12 1.342E-10 0.08812399 0.28490085 DELYS_THYROID_CANCER_UP cerebral infarction DOID_3526 2.873E-12 1.362E-10 3.256E-05 1.544E-03 DELYS_THYROID_CANCER_UP proteinuria DOID_576 3.586E-12 1.569E-10 3.604E-05 1.577E-03 DELYS_THYROID_CANCER_UP pleural disease DOID_1532 4.555E-12 1.851E-10 0.23505542 0.47093851 DELYS_THYROID_CANCER_UP sarcoidosis DOID_11335 1.482E-11 5.623E-10 0.34873742 0.62994156 DELYS_THYROID_CANCER_UP pancreatitis DOID_4989 2.746E-11 9.765E-10 0.02341514 0.11687032 DELYS_THYROID_CANCER_UP prion disease DOID_649 4.12E-11 1.379E-09 3.286E-04 7.792E-03 DELYS_THYROID_CANCER_UP primary bacterial infectious disease DOID_0050338 9.008E-11 2.847E-09 0.14779176 0.35482494 DELYS_THYROID_CANCER_UP parasitic infectious disease DOID_1398 1.117E-10 3.345E-09 0.40596676 0.71737605 DELYS_THYROID_CANCER_UP opportunistic mycosis DOID_2473 1.218E-10 3.466E-09 0.02617692 0.12730487 DELYS_THYROID_CANCER_UP neuritis DOID_1803 1.463E-10 3.963E-09 5.78E-04 0.0117466 DELYS_THYROID_CANCER_UP encephalomyelitis DOID_640 1.85E-10 4.784E-09 9.172E-05 2.899E-03 DELYS_THYROID_CANCER_UP pancreatic ductal carcinoma DOID_3587 2.308E-10 5.71E-09 1.475E-06 1.678E-04 DELYS_THYROID_CANCER_UP systemic mycosis DOID_0050136 2.603E-10 6.171E-09 0.03077265 0.14352161 DELYS_THYROID_CANCER_UP fungal infectious disease DOID_1564 2.603E-10 6.171E-09 0.03077265 0.14352161 DELYS_THYROID_CANCER_UP nephrosis DOID_2527 2.651E-10 6.034E-09 2.504E-03 0.02499348 DELYS_THYROID_CANCER_UP pancreatic carcinoma DOID_4905 3.475E-10 7.606E-09 1.94E-06 1.38E-04 DELYS_THYROID_CANCER_UP diabetic angiopathy DOID_11713 4.309E-10 9.081E-09 7.881E-04 0.01318833 DELYS_THYROID_CANCER_UP parasitic protozoa infectious disease DOID_2789 5.895E-10 1.198E-08 0.35864358 0.64578544 DELYS_THYROID_CANCER_UP pulmonary sarcoidosis DOID_13406 6.443E-10 1.264E-08 0.26379821 0.50881757 DELYS_THYROID_CANCER_UP biliary tract cancer DOID_4607 1.073E-09 2.034E-08 4.919E-05 1.866E-03 DELYS_THYROID_CANCER_UP adult respiratory distress syndrome DOID_11394 1.191E-09 2.186E-08 0.2805246 0.53029401 DELYS_THYROID_CANCER_UP intracranial arterial disease DOID_13089 1.191E-09 2.118E-08 4.319E-03 0.03723545 DELYS_THYROID_CANCER_UP cerebral arterial disease DOID_3527 1.191E-09 2.118E-08 4.319E-03 0.03723545 DELYS_THYROID_CANCER_UP vein disease DOID_866 1.399E-09 2.413E-08 6.476E-03 0.04664406 DELYS_THYROID_CANCER_UP middle cerebral artery infarction DOID_3525 1.436E-09 2.404E-08 0.01921196 0.10511159 DELYS_THYROID_CANCER_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.592E-09 5.84E-08 9.722E-05 2.911E-03 DELYS_THYROID_CANCER_UP mouth disease DOID_403 3.592E-09 5.677E-08 6.347E-03 0.04629827 DELYS_THYROID_CANCER_UP dilated cardiomyopathy DOID_12930 3.978E-09 6.118E-08 6.581E-03 0.0468056 DELYS_THYROID_CANCER_UP heart valve disease DOID_4079 4.211E-09 6.305E-08 5.78E-04 0.01134155 DELYS_THYROID_CANCER_UP astrocytoma DOID_3069 4.292E-09 6.263E-08 2.292E-04 5.929E-03 DELYS_THYROID_CANCER_UP ulcerative colitis DOID_8577 5.367E-09 7.634E-08 1.038E-03 0.01553559 DELYS_THYROID_CANCER_UP peripheral vascular disease DOID_341 6.209E-09 8.617E-08 0.01978236 0.1061902 DELYS_THYROID_CANCER_UP cystic fibrosis DOID_1485 8.837E-09 1.197E-07 0.11947514 0.32526963 DELYS_THYROID_CANCER_UP giant cell tumor DOID_200 1.071E-08 1.417E-07 8.895E-04 0.0140587 DELYS_THYROID_CANCER_UP malignant giant cell tumor DOID_2705 1.071E-08 1.417E-07 8.895E-04 0.0140587 DELYS_THYROID_CANCER_UP giant cell glioblastoma DOID_3074 1.071E-08 1.417E-07 8.895E-04 0.0140587 DELYS_THYROID_CANCER_UP epidermolysis bullosa DOID_2730 1.885E-08 2.438E-07 1.56E-06 1.268E-04 DELYS_THYROID_CANCER_UP multiple myeloma DOID_9538 2.091E-08 2.644E-07 0.03735294 0.16349094 DELYS_THYROID_CANCER_UP glioblastoma DOID_3068 2.148E-08 2.657E-07 1.227E-03 0.01745012 DELYS_THYROID_CANCER_UP bile duct cancer DOID_4606 2.148E-08 2.601E-07 1.227E-03 0.01702451 DELYS_THYROID_CANCER_UP bile duct carcinoma DOID_4897 2.148E-08 2.601E-07 1.227E-03 0.01702451 DELYS_THYROID_CANCER_UP acute pancreatitis DOID_2913 2.921E-08 3.463E-07 1.000 1.000 DELYS_THYROID_CANCER_UP hepatitis DOID_2237 2.987E-08 3.469E-07 0.27499165 0.52506794 DELYS_THYROID_CANCER_UP vesiculobullous skin disease DOID_2731 3.044E-08 3.465E-07 2.24E-06 1.416E-04 DELYS_THYROID_CANCER_UP collagen disease DOID_854 3.165E-08 3.532E-07 0.01297208 0.07936682 DELYS_THYROID_CANCER_UP lymphatic system disease DOID_75 3.545E-08 3.879E-07 0.0426076 0.18092332 DELYS_THYROID_CANCER_UP pulmonary emphysema DOID_9675 4.188E-08 4.496E-07 0.28601547 0.53710496 DELYS_THYROID_CANCER_UP intracranial aneurysm DOID_10941 6.096E-08 6.424E-07 1.247E-03 0.01650278 DELYS_THYROID_CANCER_UP uterine cancer DOID_363 6.74E-08 6.973E-07 1.539E-06 1.459E-04 DELYS_THYROID_CANCER_UP varicose veins DOID_799 7.015E-08 7.128E-07 0.10846101 0.31168846 DELYS_THYROID_CANCER_UP tuberculosis DOID_399 7.266E-08 7.253E-07 0.41947302 0.73666712 DELYS_THYROID_CANCER_UP periodontitis DOID_824 7.637E-08 7.493E-07 0.19908435 0.41955183 DELYS_THYROID_CANCER_UP pleurisy DOID_10247 9.486E-08 9.148E-07 0.20519449 0.42924878 DELYS_THYROID_CANCER_UP myeloma DOID_0070004 1.05E-07 9.956E-07 0.0558444 0.22696761 DELYS_THYROID_CANCER_UP pre-eclampsia DOID_10591 1.05E-07 9.793E-07 6.597E-03 0.04633883 DELYS_THYROID_CANCER_UP glaucoma DOID_1686 1.388E-07 1.274E-06 6.714E-04 0.01273508 DELYS_THYROID_CANCER_UP endometrial carcinoma DOID_2871 1.429E-07 1.291E-06 4.23E-06 2.407E-04 DELYS_THYROID_CANCER_UP bronchiolitis obliterans DOID_2799 1.736E-07 1.543E-06 0.22324762 0.45205657 DELYS_THYROID_CANCER_UP endometrial cancer DOID_1380 2.094E-07 1.833E-06 5.773E-06 2.986E-04 DELYS_THYROID_CANCER_UP bile duct adenocarcinoma DOID_4896 2.655E-07 2.289E-06 9.509E-04 0.01462372 DELYS_THYROID_CANCER_UP cholangiocarcinoma DOID_4947 2.655E-07 2.289E-06 9.509E-04 0.01462372 DELYS_THYROID_CANCER_UP bone marrow cancer DOID_4960 2.655E-07 2.255E-06 0.07030568 0.27213557 DELYS_THYROID_CANCER_UP vasculitis DOID_865 2.655E-07 2.222E-06 9.471E-03 0.0634015 DELYS_THYROID_CANCER_UP focal epilepsy DOID_2234 2.997E-07 2.472E-06 4.959E-04 0.01045012 DELYS_THYROID_CANCER_UP chronic kidney failure DOID_784 2.997E-07 2.436E-06 4.128E-03 0.03670066 DELYS_THYROID_CANCER_UP pneumoconiosis DOID_10316 3.551E-07 2.846E-06 1.000 1.000 DELYS_THYROID_CANCER_UP periodontal disease DOID_3388 3.551E-07 2.806E-06 0.24668434 0.48401169 DELYS_THYROID_CANCER_UP macular degeneration DOID_4448 3.551E-07 2.768E-06 1.792E-04 4.854E-03 DELYS_THYROID_CANCER_UP calcinosis DOID_182 5.752E-07 4.423E-06 2.435E-04 6.024E-03 DELYS_THYROID_CANCER_UP pre-malignant neoplasm DOID_0060071 7.376E-07 5.596E-06 1.52E-04 4.323E-03 DELYS_THYROID_CANCER_UP in situ carcinoma DOID_8719 7.376E-07 5.596E-06 1.52E-04 4.323E-03 DELYS_THYROID_CANCER_UP IgA glomerulonephritis DOID_2986 7.477E-07 5.598E-06 0.01318349 0.07980218 DELYS_THYROID_CANCER_UP respiratory syncytial virus infectious disease DOID_1273 7.761E-07 5.735E-06 0.04082674 0.17466477 DELYS_THYROID_CANCER_UP mineral metabolism disease DOID_0050032 8.184E-07 5.97E-06 1.739E-03 0.0210483 DELYS_THYROID_CANCER_UP endocrine pancreas disease DOID_1428 8.184E-07 5.894E-06 0.01466926 0.08694595 DELYS_THYROID_CANCER_UP aortic valve disease DOID_62 9.386E-07 6.676E-06 7.881E-04 0.01281152 DELYS_THYROID_CANCER_UP Goodpasture syndrome DOID_9808 9.386E-07 6.594E-06 0.16782429 0.37447851 DELYS_THYROID_CANCER_UP temporal lobe epilepsy DOID_3328 1.002E-06 6.954E-06 1.938E-03 0.02205211 DELYS_THYROID_CANCER_UP pneumocystosis DOID_11339 1.046E-06 7.174E-06 0.08074037 0.28534952 DELYS_THYROID_CANCER_UP tooth disease DOID_1091 1.106E-06 7.494E-06 0.09986553 0.30386891 DELYS_THYROID_CANCER_UP nephrotic syndrome DOID_1184 1.351E-06 9.042E-06 0.04811955 0.20132371 DELYS_THYROID_CANCER_UP rheumatic disease DOID_1575 1.351E-06 8.937E-06 0.29687225 0.55565892 DELYS_THYROID_CANCER_UP hyperinsulinism DOID_2018 1.351E-06 8.835E-06 5.224E-03 0.04128653 DELYS_THYROID_CANCER_UP scleroderma DOID_419 1.351E-06 8.937E-06 0.29687225 0.55565892 DELYS_THYROID_CANCER_UP gallbladder cancer DOID_3121 1.539E-06 9.949E-06 5.549E-03 0.0421017 DELYS_THYROID_CANCER_UP influenza DOID_8469 1.539E-06 9.837E-06 1.000 1.000 DELYS_THYROID_CANCER_UP aortic valve insufficiency DOID_57 1.56E-06 9.865E-06 9.166E-05 3.068E-03 DELYS_THYROID_CANCER_UP ocular hypertension DOID_9282 1.56E-06 9.756E-06 0.08775003 0.28531296 DELYS_THYROID_CANCER_UP borderline glaucoma DOID_9283 1.56E-06 9.756E-06 0.08775003 0.28531296 DELYS_THYROID_CANCER_UP male reproductive system disease DOID_48 1.618E-06 1.001E-05 0.10955275 0.31167757 DELYS_THYROID_CANCER_UP hemolytic anemia DOID_583 2.516E-06 1.539E-05 0.05783928 0.22854549 DELYS_THYROID_CANCER_UP normocytic anemia DOID_720 2.516E-06 1.539E-05 0.05783928 0.22854549 DELYS_THYROID_CANCER_UP Sciatic Neuropathy DOID_11446 2.542E-06 1.539E-05 0.02053261 0.10817642 DELYS_THYROID_CANCER_UP lesion of sciatic nerve DOID_12528 2.542E-06 1.539E-05 0.02053261 0.10817642 DELYS_THYROID_CANCER_UP mononeuritis of lower limb DOID_9473 2.542E-06 1.539E-05 0.02053261 0.10817642 DELYS_THYROID_CANCER_UP malaria DOID_12365 3.031E-06 1.816E-05 1.000 1.000 DELYS_THYROID_CANCER_UP mononeuritis DOID_1802 3.031E-06 1.797E-05 0.02189006 0.11221119 DELYS_THYROID_CANCER_UP viral pneumonia DOID_10533 3.118E-06 1.829E-05 1.000 1.000 DELYS_THYROID_CANCER_UP aspergillosis DOID_13564 3.118E-06 1.81E-05 1.000 1.000 DELYS_THYROID_CANCER_UP calcium metabolism disease DOID_10575 3.166E-06 1.82E-05 7.219E-04 0.01244798 DELYS_THYROID_CANCER_UP aortic aneurysm DOID_3627 3.166E-06 1.801E-05 1.000 1.000 DELYS_THYROID_CANCER_UP lipid metabolism disorder DOID_3146 3.246E-06 1.828E-05 4.014E-05 1.631E-03 DELYS_THYROID_CANCER_UP mononeuropathy DOID_1188 3.592E-06 2.004E-05 0.02328367 0.11724257 DELYS_THYROID_CANCER_UP focal glomerulosclerosis DOID_3945 3.592E-06 1.984E-05 8.848E-05 3.147E-03 DELYS_THYROID_CANCER_UP intermediate coronary syndrome DOID_8805 4.226E-06 2.312E-05 0.10846101 0.31012218 DELYS_THYROID_CANCER_UP age related macular degeneration DOID_10871 4.955E-06 2.685E-05 2.019E-03 0.02209797 DELYS_THYROID_CANCER_UP degeneration of macula and posterior pole DOID_2007 4.955E-06 2.685E-05 2.019E-03 0.02209797 DELYS_THYROID_CANCER_UP abdominal aortic aneurysm DOID_7693 4.955E-06 2.66E-05 1.000 1.000 DELYS_THYROID_CANCER_UP silicosis DOID_10325 5.6E-06 2.978E-05 1.000 1.000 DELYS_THYROID_CANCER_UP hemolytic-uremic syndrome DOID_12554 5.6E-06 2.951E-05 0.11526001 0.32306869 DELYS_THYROID_CANCER_UP primary immunodeficiency disease DOID_612 6.518E-06 3.402E-05 6.775E-04 0.01243454 DELYS_THYROID_CANCER_UP nervous system cancer DOID_3093 7.009E-06 3.626E-05 5.466E-03 0.04202738 DELYS_THYROID_CANCER_UP Human immunodeficiency virus infectious disease DOID_526 7.009E-06 3.593E-05 7.12E-04 0.01265987 DELYS_THYROID_CANCER_UP hypertrophic cardiomyopathy DOID_11984 7.276E-06 3.697E-05 0.01139359 0.07284214 DELYS_THYROID_CANCER_UP carotid artery disease DOID_3407 9.638E-06 4.853E-05 0.08582862 0.29419569 DELYS_THYROID_CANCER_UP uveitis DOID_13141 1.488E-05 7.429E-05 0.26941629 0.51615444 DELYS_THYROID_CANCER_UP hyperglycemia DOID_4195 1.493E-05 7.386E-05 0.01586718 0.09028424 DELYS_THYROID_CANCER_UP systemic scleroderma DOID_418 1.679E-05 8.236E-05 0.27499165 0.52156749 DELYS_THYROID_CANCER_UP uveal disease DOID_3480 2.639E-05 1.283E-04 0.29687225 0.55383709 DELYS_THYROID_CANCER_UP meningitis DOID_9471 3.116E-05 1.503E-04 1.000 1.000 DELYS_THYROID_CANCER_UP bone resorption disease DOID_0080011 3.248E-05 1.553E-04 3.536E-04 8.048E-03 DELYS_THYROID_CANCER_UP osteoporosis DOID_11476 3.248E-05 1.553E-04 3.536E-04 8.048E-03 DELYS_THYROID_CANCER_UP mixed glioma DOID_5076 3.489E-05 1.654E-04 0.12451733 0.32649935 DELYS_THYROID_CANCER_UP toxic shock syndrome DOID_14115 3.688E-05 1.734E-04 0.01547729 0.08986305 DELYS_THYROID_CANCER_UP vascular skin disease DOID_9540 3.979E-05 1.856E-04 1.000 1.000 DELYS_THYROID_CANCER_UP commensal bacterial infectious disease DOID_0050339 4.332E-05 2.004E-04 0.01668365 0.09399007 DELYS_THYROID_CANCER_UP bronchiolitis DOID_2942 4.332E-05 1.988E-04 0.18047162 0.39801686 DELYS_THYROID_CANCER_UP pulmonary tuberculosis DOID_2957 4.821E-05 2.194E-04 0.32846535 0.59711432 DELYS_THYROID_CANCER_UP temporal arteritis DOID_13375 6.914E-05 3.122E-04 0.08074037 0.2835881 DELYS_THYROID_CANCER_UP invasive lobular carcinoma DOID_3457 6.914E-05 3.098E-04 0.08074037 0.27843195 DELYS_THYROID_CANCER_UP central nervous system vasculitis DOID_525 6.914E-05 3.122E-04 0.08074037 0.2835881 DELYS_THYROID_CANCER_UP renal hypertension DOID_1073 7.753E-05 3.446E-04 0.02189006 0.11323129 DELYS_THYROID_CANCER_UP secondary hypertension DOID_11130 7.753E-05 3.446E-04 0.02189006 0.11323129 DELYS_THYROID_CANCER_UP familial hyperlipidemia DOID_1168 8.891E-05 3.922E-04 1.083E-03 0.01579595 DELYS_THYROID_CANCER_UP common cold DOID_10459 9.166E-05 4.012E-04 0.08775003 0.297201 DELYS_THYROID_CANCER_UP hypersensitivity reaction type I disease DOID_1205 1.03E-04 4.473E-04 0.52442003 0.90697568 DELYS_THYROID_CANCER_UP oral cavity cancer DOID_8618 1.043E-04 4.498E-04 1.227E-03 0.01661916 DELYS_THYROID_CANCER_UP leukocyte disease DOID_9500 1.128E-04 4.826E-04 0.37800768 0.6721449 DELYS_THYROID_CANCER_UP newborn respiratory distress syndrome DOID_12716 1.185E-04 5.031E-04 0.09470642 0.29446969 DELYS_THYROID_CANCER_UP germinoma DOID_3304 1.281E-04 5.399E-04 2.203E-03 0.02364611 DELYS_THYROID_CANCER_UP leiomyoma DOID_127 1.438E-04 6.014E-04 2.396E-03 0.02524199 DELYS_THYROID_CANCER_UP bacterial meningitis DOID_9470 1.5E-04 6.228E-04 1.000 1.000 DELYS_THYROID_CANCER_UP papilloma DOID_2615 1.608E-04 6.628E-04 0.03077265 0.14235477 DELYS_THYROID_CANCER_UP hepatitis C DOID_1883 1.792E-04 7.334E-04 0.03237039 0.14853831 DELYS_THYROID_CANCER_UP Ehlers-Danlos syndrome DOID_13359 1.864E-04 7.575E-04 5.695E-03 0.04263808 DELYS_THYROID_CANCER_UP oral submucous fibrosis DOID_5773 1.864E-04 7.521E-04 0.10846101 0.31486895 DELYS_THYROID_CANCER_UP endocrine organ benign neoplasm DOID_0060089 2.146E-04 8.601E-04 0.41947302 0.73894782 DELYS_THYROID_CANCER_UP adenoma DOID_657 2.205E-04 8.773E-04 0.03566111 0.15729589 DELYS_THYROID_CANCER_UP blood coagulation disease DOID_1247 2.446E-04 9.664E-04 0.01842356 0.10177676 DELYS_THYROID_CANCER_UP diabetic retinopathy DOID_8947 2.953E-04 1.159E-03 0.02048195 0.10891806 DELYS_THYROID_CANCER_UP adenoid cystic carcinoma DOID_4866 3.23E-04 1.259E-03 4.319E-03 0.0366797 DELYS_THYROID_CANCER_UP ureteral obstruction DOID_5199 3.286E-04 1.272E-03 0.12870337 0.32839561 DELYS_THYROID_CANCER_UP benign mesothelioma DOID_2645 3.532E-04 1.358E-03 0.28601547 0.53888346 DELYS_THYROID_CANCER_UP autoimmune disease of urogenital tract DOID_0060049 3.853E-04 1.471E-03 4.911E-03 0.04109308 DELYS_THYROID_CANCER_UP primary biliary cirrhosis DOID_12236 3.853E-04 1.471E-03 4.911E-03 0.04109308 DELYS_THYROID_CANCER_UP salivary gland cancer DOID_8850 3.853E-04 1.462E-03 4.911E-03 0.03991899 DELYS_THYROID_CANCER_UP Down syndrome DOID_14250 3.881E-04 1.462E-03 0.13534853 0.34228138 DELYS_THYROID_CANCER_UP testicular cancer DOID_2998 3.881E-04 1.453E-03 3.881E-04 8.493E-03 DELYS_THYROID_CANCER_UP leishmaniasis DOID_9065 3.881E-04 1.443E-03 0.13534853 0.33777768 DELYS_THYROID_CANCER_UP metabolic syndrome X DOID_14221 4.202E-04 1.553E-03 0.46642961 0.81410566 DELYS_THYROID_CANCER_UP membranous glomerulonephritis DOID_10976 4.54E-04 1.667E-03 0.14194317 0.35115506 DELYS_THYROID_CANCER_UP pulmonary edema DOID_11396 4.54E-04 1.656E-03 0.14194317 0.34963491 DELYS_THYROID_CANCER_UP colon carcinoma DOID_1520 4.54E-04 1.645E-03 0.14194317 0.34812786 DELYS_THYROID_CANCER_UP brain edema DOID_4724 4.54E-04 1.635E-03 1.000 1.000 DELYS_THYROID_CANCER_UP amyloidosis DOID_9120 4.54E-04 1.625E-03 0.14194317 0.34222739 DELYS_THYROID_CANCER_UP auditory system disease DOID_2742 4.696E-04 1.67E-03 0.02656393 0.12809219 DELYS_THYROID_CANCER_UP bone development disease DOID_0080006 5.232E-04 1.849E-03 4.304E-03 0.03767534 DELYS_THYROID_CANCER_UP Kawasaki disease DOID_13378 5.267E-04 1.85E-03 1.000 1.000 DELYS_THYROID_CANCER_UP lymphadenitis DOID_1602 5.267E-04 1.85E-03 1.000 1.000 DELYS_THYROID_CANCER_UP lymph node disease DOID_9942 5.267E-04 1.85E-03 1.000 1.000 DELYS_THYROID_CANCER_UP leukodystrophy DOID_10579 5.35E-04 1.868E-03 0.05387449 0.22053658 DELYS_THYROID_CANCER_UP retinal vascular disease DOID_2462 5.517E-04 1.914E-03 0.02906666 0.13898262 DELYS_THYROID_CANCER_UP brain cancer DOID_1319 5.78E-04 1.993E-03 0.0558444 0.22377088 DELYS_THYROID_CANCER_UP thyroid adenoma DOID_2891 5.78E-04 1.981E-03 0.31809472 0.58574724 DELYS_THYROID_CANCER_UP familial hypercholesterolemia DOID_13810 6.064E-04 2.066E-03 0.0120974 0.07648244 DELYS_THYROID_CANCER_UP hepatitis B DOID_2043 6.064E-04 2.054E-03 0.15498247 0.36440092 DELYS_THYROID_CANCER_UP central nervous system cancer DOID_3620 6.235E-04 2.099E-03 0.05783928 0.23014371 DELYS_THYROID_CANCER_UP urinary tract obstruction DOID_5200 6.934E-04 2.321E-03 0.16142788 0.36888539 DELYS_THYROID_CANCER_UP pulmonary embolism DOID_9477 6.934E-04 2.307E-03 0.16142788 0.36740984 DELYS_THYROID_CANCER_UP polyarteritis nodosa DOID_9810 6.934E-04 2.294E-03 1.000 1.000 DELYS_THYROID_CANCER_UP Lewy body dementia DOID_12217 7.881E-04 2.592E-03 0.01431035 0.08571145 DELYS_THYROID_CANCER_UP ureteral disease DOID_1426 7.881E-04 2.577E-03 0.16782429 0.37595284 DELYS_THYROID_CANCER_UP Crohn's disease DOID_8778 8.634E-04 2.807E-03 0.16644972 0.3758329 DELYS_THYROID_CANCER_UP sphingolipidosis DOID_1927 8.905E-04 2.879E-03 0.01547729 0.08895534 DELYS_THYROID_CANCER_UP portal hypertension DOID_10762 1.001E-03 3.218E-03 1.000 1.000 DELYS_THYROID_CANCER_UP reproductive organ benign neoplasm DOID_0050622 1.015E-03 3.246E-03 9.932E-03 0.06571592 DELYS_THYROID_CANCER_UP osteochondrodysplasia DOID_2256 1.015E-03 3.227E-03 9.932E-03 0.06496056 DELYS_THYROID_CANCER_UP myositis DOID_633 1.12E-03 3.54E-03 0.18672327 0.40092656 DELYS_THYROID_CANCER_UP seminoma DOID_4440 1.247E-03 3.921E-03 0.01921196 0.10411053 DELYS_THYROID_CANCER_UP gestational diabetes DOID_11714 1.383E-03 4.325E-03 0.02053261 0.10718397 DELYS_THYROID_CANCER_UP lung adenocarcinoma DOID_3910 1.383E-03 4.301E-03 1.383E-03 0.01788774 DELYS_THYROID_CANCER_UP neuroectodermal tumor DOID_171 1.467E-03 4.537E-03 0.01297208 0.0802295 DELYS_THYROID_CANCER_UP sarcoma DOID_1115 1.528E-03 4.701E-03 0.20519449 0.42767644 DELYS_THYROID_CANCER_UP hepatic vascular disease DOID_272 1.528E-03 4.675E-03 1.000 1.000 DELYS_THYROID_CANCER_UP coronary stenosis DOID_4248 1.528E-03 4.65E-03 0.20519449 0.42611557 DELYS_THYROID_CANCER_UP autoimmune disease of the nervous system DOID_438 1.528E-03 4.626E-03 0.20519449 0.42456606 DELYS_THYROID_CANCER_UP multiple epiphyseal dysplasia DOID_12721 1.683E-03 5.066E-03 1.683E-03 0.02127531 DELYS_THYROID_CANCER_UP toxic encephalopathy DOID_3602 1.683E-03 5.039E-03 1.683E-03 0.0208128 DELYS_THYROID_CANCER_UP cerebral degeneration DOID_1443 1.836E-03 5.471E-03 0.09511758 0.29097797 DELYS_THYROID_CANCER_UP female reproductive organ benign neoplasm DOID_0060086 1.846E-03 5.471E-03 1.846E-03 0.02143903 DELYS_THYROID_CANCER_UP uterine benign neoplasm DOID_0060095 1.846E-03 5.471E-03 1.846E-03 0.02143903 DELYS_THYROID_CANCER_UP uterine fibroid DOID_13223 1.846E-03 5.471E-03 1.846E-03 0.02143903 DELYS_THYROID_CANCER_UP arrhythmogenic right ventricular dysplasia DOID_0050431 2.012E-03 5.933E-03 2.012E-03 0.02245235 DELYS_THYROID_CANCER_UP spastic cerebral palsy DOID_0050669 2.019E-03 5.923E-03 0.22324762 0.45367105 DELYS_THYROID_CANCER_UP allergic rhinitis DOID_4481 2.203E-03 6.427E-03 0.22917405 0.46077751 DELYS_THYROID_CANCER_UP autonomic nervous system neoplasm DOID_2621 2.396E-03 6.954E-03 0.02920743 0.13734733 DELYS_THYROID_CANCER_UP neuroblastoma DOID_769 2.396E-03 6.954E-03 0.02920743 0.13734733 DELYS_THYROID_CANCER_UP facioscapulohumeral muscular dystrophy DOID_11727 2.503E-03 7.229E-03 2.503E-03 0.02589353 DELYS_THYROID_CANCER_UP familial combined hyperlipidemia DOID_13809 2.503E-03 7.193E-03 0.07367704 0.2776307 DELYS_THYROID_CANCER_UP phagocyte bactericidal dysfunction DOID_3262 2.503E-03 7.157E-03 2.503E-03 0.02543115 DELYS_THYROID_CANCER_UP insulinoma DOID_3892 2.503E-03 7.121E-03 0.07367704 0.26873228 DELYS_THYROID_CANCER_UP cutaneous leishmaniasis DOID_9111 2.503E-03 7.085E-03 1.000 1.000 DELYS_THYROID_CANCER_UP metal metabolism disorder DOID_896 2.599E-03 7.32E-03 0.24089207 0.47592913 DELYS_THYROID_CANCER_UP nephroblastoma DOID_2154 2.812E-03 7.882E-03 0.03237039 0.14735001 DELYS_THYROID_CANCER_UP hyperthyroidism DOID_7998 2.812E-03 7.844E-03 2.812E-03 0.02666905 DELYS_THYROID_CANCER_UP medullomyoblastoma DOID_3861 3.036E-03 8.427E-03 3.036E-03 0.02832115 DELYS_THYROID_CANCER_UP adult medulloblastoma DOID_3864 3.036E-03 8.427E-03 3.036E-03 0.02832115 DELYS_THYROID_CANCER_UP childhood medulloblastoma DOID_3869 3.036E-03 8.427E-03 3.036E-03 0.02832115 DELYS_THYROID_CANCER_UP breast benign neoplasm DOID_0060082 3.044E-03 8.407E-03 3.044E-03 0.02793353 DELYS_THYROID_CANCER_UP thoracic benign neoplasm DOID_0060097 3.044E-03 8.407E-03 3.044E-03 0.02793353 DELYS_THYROID_CANCER_UP benign breast phyllodes tumor DOID_1631 3.044E-03 8.407E-03 3.044E-03 0.02793353 DELYS_THYROID_CANCER_UP eosinophilic pneumonia DOID_5870 3.044E-03 8.367E-03 1.000 1.000 DELYS_THYROID_CANCER_UP pulmonary eosinophilia DOID_9498 3.044E-03 8.367E-03 1.000 1.000 DELYS_THYROID_CANCER_UP Loeffler syndrome DOID_9503 3.044E-03 8.367E-03 1.000 1.000 DELYS_THYROID_CANCER_UP bronchiectasis DOID_9563 3.044E-03 8.326E-03 1.000 1.000 DELYS_THYROID_CANCER_UP medulloblastoma DOID_3858 3.516E-03 9.573E-03 3.516E-03 0.03175822 DELYS_THYROID_CANCER_UP otitis media DOID_10754 3.634E-03 9.847E-03 1.000 1.000 DELYS_THYROID_CANCER_UP diarrhea DOID_13250 3.634E-03 9.8E-03 0.08775003 0.29198694 DELYS_THYROID_CANCER_UP islet cell tumor DOID_1799 3.634E-03 9.754E-03 0.08775003 0.29028935 DELYS_THYROID_CANCER_UP relapsing-remitting multiple sclerosis DOID_2378 3.634E-03 9.708E-03 1.000 1.000 DELYS_THYROID_CANCER_UP middle ear disease DOID_5100 3.634E-03 9.847E-03 1.000 1.000 DELYS_THYROID_CANCER_UP retinal detachment DOID_5327 3.634E-03 9.663E-03 1.000 1.000 DELYS_THYROID_CANCER_UP peripheral nervous system neoplasm DOID_1192 3.773E-03 9.985E-03 0.039075 0.16972271 DELYS_THYROID_CANCER_UP blood platelet disease DOID_2218 3.773E-03 9.938E-03 0.039075 0.16843694 DELYS_THYROID_CANCER_UP peptic ulcer DOID_750 4.04E-03 0.01059403 1.000 1.000 DELYS_THYROID_CANCER_UP leprosy DOID_1024 4.273E-03 0.01115382 0.09470642 0.30105002 DELYS_THYROID_CANCER_UP carotid stenosis DOID_13001 4.273E-03 0.01110289 1.000 1.000 DELYS_THYROID_CANCER_UP intracranial thrombosis DOID_4193 4.273E-03 0.01105242 0.09470642 0.29128624 DELYS_THYROID_CANCER_UP cervix uteri carcinoma in situ DOID_8991 4.609E-03 0.01186722 0.04441705 0.18720963 DELYS_THYROID_CANCER_UP endometriosis of uterus DOID_288 4.911E-03 0.01258707 4.911E-03 0.04049753 DELYS_THYROID_CANCER_UP Legionnaires' disease DOID_10457 4.961E-03 0.01265726 1.000 1.000 DELYS_THYROID_CANCER_UP legionellosis DOID_10458 4.961E-03 0.01265726 1.000 1.000 DELYS_THYROID_CANCER_UP parasitic helminthiasis infectious disease DOID_883 4.961E-03 0.01260075 1.000 1.000 DELYS_THYROID_CANCER_UP polycystic kidney disease DOID_898 4.961E-03 0.01254475 0.10160995 0.30112531 DELYS_THYROID_CANCER_UP primitive neuroectodermal tumor DOID_168 5.224E-03 0.01315323 5.224E-03 0.04186803 DELYS_THYROID_CANCER_UP idiopathic generalized epilepsy DOID_1827 5.224E-03 0.01309529 0.04811955 0.19840597 DELYS_THYROID_CANCER_UP endometriosis DOID_289 5.224E-03 0.01303785 5.224E-03 0.04072096 DELYS_THYROID_CANCER_UP corneal dystrophy DOID_2566 5.695E-03 0.01415063 5.695E-03 0.04208434 DELYS_THYROID_CANCER_UP angiosarcoma DOID_0001816 6.476E-03 0.01602122 0.11526001 0.3262833 DELYS_THYROID_CANCER_UP spastic diplegia DOID_10965 6.476E-03 0.01595186 0.11526001 0.32466804 DELYS_THYROID_CANCER_UP restrictive cardiomyopathy DOID_397 6.476E-03 0.01588311 0.11526001 0.32148502 DELYS_THYROID_CANCER_UP chronic myeloid leukemia DOID_8552 6.476E-03 0.01581494 0.11526001 0.3183638 DELYS_THYROID_CANCER_UP Barrett's esophagus DOID_9206 6.476E-03 0.01574735 0.11526001 0.31530261 DELYS_THYROID_CANCER_UP withdrawal disorder DOID_0060001 8.164E-03 0.01976733 8.164E-03 0.05665027 DELYS_THYROID_CANCER_UP hemorrhagic disease DOID_2213 8.164E-03 0.01968357 0.06396882 0.25102245 DELYS_THYROID_CANCER_UP eosinophilia DOID_999 8.175E-03 0.01962591 1.000 1.000 DELYS_THYROID_CANCER_UP atrophic muscular disease DOID_913 9.023E-03 0.02157129 9.023E-03 0.06185502 DELYS_THYROID_CANCER_UP muscular dystrophy DOID_9884 9.023E-03 0.02157129 9.023E-03 0.06185502 DELYS_THYROID_CANCER_UP granulosa cell tumor DOID_2999 9.091E-03 0.02164259 9.091E-03 0.06157832 DELYS_THYROID_CANCER_UP pustulosis of palm and sole DOID_4398 9.932E-03 0.0235482 0.35864358 0.64374826 DELYS_THYROID_CANCER_UP sex cord-gonadal stromal tumor DOID_192 0.01005028 0.02372866 0.01005028 0.06498418 DELYS_THYROID_CANCER_UP blood protein disease DOID_620 0.01005028 0.02363061 0.14194317 0.34368368 DELYS_THYROID_CANCER_UP coronary restenosis DOID_4247 0.01105276 0.02588075 1.000 1.000 DELYS_THYROID_CANCER_UP funisitis DOID_0050698 0.0120974 0.02821074 0.15498247 0.368975 DELYS_THYROID_CANCER_UP acquired immunodeficiency syndrome DOID_635 0.0120974 0.02809559 0.0120974 0.07564197 DELYS_THYROID_CANCER_UP sinusitis DOID_0050127 0.01318349 0.03049352 1.000 1.000 DELYS_THYROID_CANCER_UP paranasal sinus disease DOID_1352 0.01318349 0.03049352 1.000 1.000 DELYS_THYROID_CANCER_UP myasthenia gravis DOID_437 0.01318349 0.03037006 0.16142788 0.37037283 DELYS_THYROID_CANCER_UP uremia DOID_4676 0.01318349 0.0302476 1.000 1.000 DELYS_THYROID_CANCER_UP uterine disease DOID_345 0.01526155 0.03487479 0.01526155 0.08952395 DELYS_THYROID_CANCER_UP spastic quadriplegia DOID_10970 0.01547729 0.03522631 0.17417208 0.38712466 DELYS_THYROID_CANCER_UP urticaria DOID_1555 0.01668365 0.0378207 1.000 1.000 DELYS_THYROID_CANCER_UP autosomal dominant nonsyndromic deafness DOID_0050564 0.01792876 0.040482 0.01792876 0.10001435 DELYS_THYROID_CANCER_UP morbid obesity DOID_11981 0.01792876 0.04032199 0.18672327 0.40707103 DELYS_THYROID_CANCER_UP papillary adenoma DOID_3172 0.01792876 0.04016324 0.18672327 0.40397543 DELYS_THYROID_CANCER_UP neuromuscular junction disease DOID_439 0.01792876 0.04000574 0.18672327 0.40244522 DELYS_THYROID_CANCER_UP microcystic adenoma DOID_5403 0.01792876 0.04016324 0.18672327 0.40397543 DELYS_THYROID_CANCER_UP follicular adenoma DOID_6204 0.01792876 0.04016324 0.18672327 0.40397543 DELYS_THYROID_CANCER_UP vitiligo DOID_12306 0.01921196 0.04270158 0.19292739 0.41269054 DELYS_THYROID_CANCER_UP hypotrichosis DOID_4535 0.01921196 0.04253543 0.19292739 0.40961076 DELYS_THYROID_CANCER_UP extrinsic allergic alveolitis DOID_841 0.01921196 0.04237056 1.000 1.000 DELYS_THYROID_CANCER_UP autoimmune disease of cardiovascular system DOID_0060051 0.02189006 0.04809051 0.20519449 0.43083272 DELYS_THYROID_CANCER_UP Behcet's disease DOID_13241 0.02189006 0.04809051 0.20519449 0.43083272 DELYS_THYROID_CANCER_UP corneal disease DOID_10124 0.02471284 0.05408309 0.02471284 0.12227482 DELYS_THYROID_CANCER_UP chromosomal disease DOID_0080014 0.02575655 0.05615125 0.47050589 0.81870903 DELYS_THYROID_CANCER_UP female reproductive system disease DOID_229 0.02575655 0.05593693 0.02575655 0.1263403 DELYS_THYROID_CANCER_UP childhood absence epilepsy DOID_1825 0.02920743 0.06319022 0.02920743 0.1384919 DELYS_THYROID_CANCER_UP hair disease DOID_421 0.03077265 0.06632438 0.24089207 0.47925731 DELYS_THYROID_CANCER_UP thyroid carcinoma DOID_3963 0.03237039 0.06950472 1.000 1.000 DELYS_THYROID_CANCER_UP esophageal disease DOID_6050 0.03237039 0.06924342 0.24668434 0.48234842 DELYS_THYROID_CANCER_UP amino acid metabolic disorder DOID_9252 0.03259089 0.06945399 0.15307852 0.36597343 DELYS_THYROID_CANCER_UP childhood electroclinical syndrome DOID_0050704 0.03400007 0.07218671 0.03400007 0.15353998 DELYS_THYROID_CANCER_UP lymphoma DOID_0060058 0.0353736 0.07482371 0.0353736 0.15848486 DELYS_THYROID_CANCER_UP autosomal recessive nonsyndromic deafness DOID_0050565 0.03566111 0.07515248 0.03566111 0.15852476 DELYS_THYROID_CANCER_UP thyroid cancer DOID_1781 0.03566111 0.07487516 1.000 1.000 DELYS_THYROID_CANCER_UP congenital diaphragmatic hernia DOID_3827 0.04082674 0.08540593 0.27499165 0.52331186 LENAOUR_DENDRITIC_CELL_MATURATION_DN primary bacterial infectious disease DOID_0050338 7.914E-22 4.503E-19 2.963E-06 4.215E-04 LENAOUR_DENDRITIC_CELL_MATURATION_DN tuberculosis DOID_399 2.912E-21 8.286E-19 9.627E-07 2.739E-04 LENAOUR_DENDRITIC_CELL_MATURATION_DN pulmonary tuberculosis DOID_2957 6.603E-19 1.252E-16 8.758E-06 8.305E-04 LENAOUR_DENDRITIC_CELL_MATURATION_DN bacterial pneumonia DOID_874 1.083E-16 1.54E-14 0.01695581 0.33268476 LENAOUR_DENDRITIC_CELL_MATURATION_DN sarcoidosis DOID_11335 1.645E-14 1.873E-12 8.587E-03 0.2326576 LENAOUR_DENDRITIC_CELL_MATURATION_DN hypersensitivity reaction type IV disease DOID_2916 3.729E-14 3.536E-12 0.0101222 0.23998055 LENAOUR_DENDRITIC_CELL_MATURATION_DN hypersensitivity reaction type I disease DOID_1205 5.652E-14 4.594E-12 4.529E-06 5.154E-04 LENAOUR_DENDRITIC_CELL_MATURATION_DN rheumatic disease DOID_1575 2.27E-11 1.614E-09 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN scleroderma DOID_419 2.27E-11 1.614E-09 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN influenza DOID_8469 2.661E-11 1.683E-09 0.11019394 0.61470931 LENAOUR_DENDRITIC_CELL_MATURATION_DN ulcerative colitis DOID_8577 1.627E-10 9.256E-09 0.02572776 0.37536141 LENAOUR_DENDRITIC_CELL_MATURATION_DN collagen disease DOID_854 2.541E-10 1.314E-08 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN allergic contact dermatitis DOID_3042 4.844E-10 2.297E-08 8.967E-07 5.102E-04 LENAOUR_DENDRITIC_CELL_MATURATION_DN systemic scleroderma DOID_418 9.646E-10 4.222E-08 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN cystic fibrosis DOID_1485 1.05E-09 4.269E-08 0.17620837 0.789469 LENAOUR_DENDRITIC_CELL_MATURATION_DN adult respiratory distress syndrome DOID_11394 1.119E-09 4.244E-08 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN bone resorption disease DOID_0080011 1.15E-09 4.091E-08 0.01655832 0.34895136 LENAOUR_DENDRITIC_CELL_MATURATION_DN osteoporosis DOID_11476 1.15E-09 4.091E-08 0.01655832 0.34895136 LENAOUR_DENDRITIC_CELL_MATURATION_DN pancreatitis DOID_4989 1.258E-09 4.211E-08 4.852E-05 3.451E-03 LENAOUR_DENDRITIC_CELL_MATURATION_DN contact dermatitis DOID_2773 1.5E-09 4.74E-08 1.975E-06 3.745E-04 LENAOUR_DENDRITIC_CELL_MATURATION_DN hypoglycemia DOID_9993 2.733E-09 8.185E-08 0.05551523 0.56407437 LENAOUR_DENDRITIC_CELL_MATURATION_DN pre-eclampsia DOID_10591 2.876E-09 8.181E-08 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN meningitis DOID_9471 3.445E-09 9.336E-08 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN vasculitis DOID_865 6.476E-09 1.675E-07 0.1320414 0.65331789 LENAOUR_DENDRITIC_CELL_MATURATION_DN parasitic protozoa infectious disease DOID_2789 7.209E-09 1.783E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN cutaneous leishmaniasis DOID_9111 7.357E-09 1.744E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pleurisy DOID_10247 1.142E-08 2.598E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN bronchiectasis DOID_9563 1.154E-08 2.525E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN carotid artery disease DOID_3407 1.32E-08 2.781E-07 2.009E-05 1.633E-03 LENAOUR_DENDRITIC_CELL_MATURATION_DN respiratory failure DOID_11162 1.451E-08 2.948E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN encephalitis DOID_9588 1.728E-08 3.39E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN endocrine pancreas disease DOID_1428 1.746E-08 3.311E-07 0.01211271 0.27568539 LENAOUR_DENDRITIC_CELL_MATURATION_DN cholestasis DOID_13580 1.911E-08 3.508E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN parasitic infectious disease DOID_1398 1.911E-08 3.398E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pleural disease DOID_1532 2.575E-08 4.441E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN bile duct disease DOID_4138 3.196E-08 5.349E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pneumoconiosis DOID_10316 3.445E-08 5.6E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN biliary tract disease DOID_9741 3.467E-08 5.48E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN bacterial meningitis DOID_9470 3.48E-08 5.352E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pulmonary sarcoidosis DOID_13406 5.17E-08 7.741E-07 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN leishmaniasis DOID_9065 1.335E-07 1.948E-06 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN integumentary system benign neoplasm DOID_0060121 1.994E-07 2.837E-06 2.987E-04 0.01888615 LENAOUR_DENDRITIC_CELL_MATURATION_DN skin benign neoplasm DOID_3165 1.994E-07 2.837E-06 2.987E-04 0.01888615 LENAOUR_DENDRITIC_CELL_MATURATION_DN giant cell tumor DOID_200 2.909E-07 4.036E-06 0.12988076 0.64826448 LENAOUR_DENDRITIC_CELL_MATURATION_DN malignant giant cell tumor DOID_2705 2.909E-07 4.036E-06 0.12988076 0.64826448 LENAOUR_DENDRITIC_CELL_MATURATION_DN giant cell glioblastoma DOID_3074 2.909E-07 4.036E-06 0.12988076 0.64826448 LENAOUR_DENDRITIC_CELL_MATURATION_DN sinusitis DOID_0050127 3.027E-07 4.1E-06 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN paranasal sinus disease DOID_1352 3.027E-07 4.1E-06 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN acute pancreatitis DOID_2913 4.307E-07 5.7E-06 1.758E-03 0.06252648 LENAOUR_DENDRITIC_CELL_MATURATION_DN glioblastoma DOID_3068 4.486E-07 5.801E-06 0.14063103 0.68392354 LENAOUR_DENDRITIC_CELL_MATURATION_DN myositis DOID_633 5.953E-07 7.527E-06 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN extrinsic allergic alveolitis DOID_841 6.932E-07 8.575E-06 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN uterine disease DOID_345 7.753E-07 9.386E-06 0.01245982 0.27267835 LENAOUR_DENDRITIC_CELL_MATURATION_DN perinatal necrotizing enterocolitis DOID_8677 8.026E-07 9.514E-06 0.06948881 0.55688919 LENAOUR_DENDRITIC_CELL_MATURATION_DN brain infarction DOID_3454 9.627E-07 1.118E-05 0.16173889 0.76057377 LENAOUR_DENDRITIC_CELL_MATURATION_DN astrocytoma DOID_3069 1.033E-06 1.175E-05 0.16382125 0.76405156 LENAOUR_DENDRITIC_CELL_MATURATION_DN spastic cerebral palsy DOID_0050669 1.372E-06 1.531E-05 3.055E-03 0.10224672 LENAOUR_DENDRITIC_CELL_MATURATION_DN myocarditis DOID_820 1.964E-06 2.149E-05 3.627E-03 0.11466614 LENAOUR_DENDRITIC_CELL_MATURATION_DN female reproductive system disease DOID_229 2.097E-06 2.251E-05 0.01817251 0.33355346 LENAOUR_DENDRITIC_CELL_MATURATION_DN chronic kidney failure DOID_784 2.36E-06 2.487E-05 1.258E-03 0.05967345 LENAOUR_DENDRITIC_CELL_MATURATION_DN temporal arteritis DOID_13375 2.401E-06 2.484E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN central nervous system vasculitis DOID_525 2.401E-06 2.484E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN primary immunodeficiency disease DOID_612 3.307E-06 3.36E-05 0.02159085 0.37227857 LENAOUR_DENDRITIC_CELL_MATURATION_DN hepatitis DOID_2237 3.69E-06 3.684E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN peptic ulcer DOID_750 3.69E-06 3.62E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN intracranial arterial disease DOID_13089 4.061E-06 3.916E-05 0.10130339 0.61980248 LENAOUR_DENDRITIC_CELL_MATURATION_DN cerebral arterial disease DOID_3527 4.061E-06 3.916E-05 0.10130339 0.61980248 LENAOUR_DENDRITIC_CELL_MATURATION_DN lymphatic system disease DOID_75 4.061E-06 3.851E-05 0.10130339 0.61320884 LENAOUR_DENDRITIC_CELL_MATURATION_DN mouth disease DOID_403 4.304E-06 4.015E-05 0.21229076 0.8881871 LENAOUR_DENDRITIC_CELL_MATURATION_DN Crohn's disease DOID_8778 4.304E-06 3.95E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pulmonary emphysema DOID_9675 4.459E-06 4.027E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN endometriosis of uterus DOID_288 4.884E-06 4.342E-05 5.618E-03 0.16825352 LENAOUR_DENDRITIC_CELL_MATURATION_DN Legionnaires' disease DOID_10457 5.268E-06 4.611E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN legionellosis DOID_10458 5.268E-06 4.611E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN endometriosis DOID_289 5.339E-06 4.603E-05 5.864E-03 0.16683812 LENAOUR_DENDRITIC_CELL_MATURATION_DN cerebral infarction DOID_3526 6.343E-06 5.386E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN silicosis DOID_10325 8.075E-06 6.757E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN spastic diplegia DOID_10965 8.075E-06 6.659E-05 7.136E-04 0.04060242 LENAOUR_DENDRITIC_CELL_MATURATION_DN atopic dermatitis DOID_3310 1.097E-05 8.917E-05 0.12771479 0.64309483 LENAOUR_DENDRITIC_CELL_MATURATION_DN integumentary system cancer DOID_0060122 1.357E-05 1.087E-04 9.187E-03 0.23761494 LENAOUR_DENDRITIC_CELL_MATURATION_DN skin cancer DOID_4159 1.357E-05 1.087E-04 9.187E-03 0.23761494 LENAOUR_DENDRITIC_CELL_MATURATION_DN esophagitis DOID_11963 1.632E-05 1.29E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Kawasaki disease DOID_13378 1.901E-05 1.482E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN lymphadenitis DOID_1602 1.901E-05 1.482E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN mitochondrial myopathy DOID_699 1.901E-05 1.461E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN lymph node disease DOID_9942 1.901E-05 1.482E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN polyarteritis nodosa DOID_9810 2.522E-05 1.913E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN endocrine organ benign neoplasm DOID_0060089 3.032E-05 2.27E-04 0.16173889 0.76691189 LENAOUR_DENDRITIC_CELL_MATURATION_DN male reproductive system disease DOID_48 3.57E-05 2.638E-04 0.16797063 0.7646023 LENAOUR_DENDRITIC_CELL_MATURATION_DN commensal bacterial infectious disease DOID_0050339 3.682E-05 2.686E-04 0.06252778 0.57384363 LENAOUR_DENDRITIC_CELL_MATURATION_DN bronchiolitis DOID_2942 3.682E-05 2.652E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN peripheral vascular disease DOID_341 3.764E-05 2.677E-04 0.17003767 0.76786854 LENAOUR_DENDRITIC_CELL_MATURATION_DN aneurysm disease DOID_2403 4.618E-05 3.244E-04 0.01655832 0.33648881 LENAOUR_DENDRITIC_CELL_MATURATION_DN diffuse large B-cell lymphoma DOID_0050745 5.147E-05 3.572E-04 0.06948881 0.58145783 LENAOUR_DENDRITIC_CELL_MATURATION_DN Sciatic Neuropathy DOID_11446 5.147E-05 3.529E-04 0.06948881 0.57303091 LENAOUR_DENDRITIC_CELL_MATURATION_DN lesion of sciatic nerve DOID_12528 5.147E-05 3.529E-04 0.06948881 0.57303091 LENAOUR_DENDRITIC_CELL_MATURATION_DN mononeuritis of lower limb DOID_9473 5.147E-05 3.529E-04 0.06948881 0.57303091 LENAOUR_DENDRITIC_CELL_MATURATION_DN malaria DOID_12365 5.709E-05 3.867E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN mononeuritis DOID_1802 5.709E-05 3.822E-04 0.07179777 0.5596292 LENAOUR_DENDRITIC_CELL_MATURATION_DN mononeuropathy DOID_1188 6.309E-05 4.174E-04 0.07410106 0.56218006 LENAOUR_DENDRITIC_CELL_MATURATION_DN dilated cardiomyopathy DOID_12930 1.029E-04 6.732E-04 0.02431541 0.40692549 LENAOUR_DENDRITIC_CELL_MATURATION_DN thyroid carcinoma DOID_3963 1.079E-04 6.976E-04 0.08780254 0.60192346 LENAOUR_DENDRITIC_CELL_MATURATION_DN esophageal disease DOID_6050 1.079E-04 6.898E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN thyroid cancer DOID_1781 1.264E-04 7.994E-04 0.09232497 0.59696489 LENAOUR_DENDRITIC_CELL_MATURATION_DN multiple myeloma DOID_9538 1.365E-04 8.532E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN uveitis DOID_13141 1.47E-04 9.089E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN respiratory syncytial virus infectious disease DOID_1273 1.58E-04 9.666E-04 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN uveal disease DOID_3480 2.074E-04 1.255E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN myeloma DOID_0070004 2.659E-04 1.593E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN neuritis DOID_1803 2.659E-04 1.576E-03 0.11680469 0.62699875 LENAOUR_DENDRITIC_CELL_MATURATION_DN vascular skin disease DOID_9540 2.659E-04 1.56E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN childhood type dermatomyositis DOID_14203 2.702E-04 1.569E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN retinal vascular occlusion DOID_1729 2.702E-04 1.553E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN acute kidney failure DOID_3021 2.702E-04 1.537E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN adrenal gland hyperfunction DOID_3947 2.702E-04 1.522E-03 0.02452296 0.37712335 LENAOUR_DENDRITIC_CELL_MATURATION_DN visceral leishmaniasis DOID_9146 2.702E-04 1.507E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hemolytic anemia DOID_583 2.82E-04 1.558E-03 0.11899746 0.63279955 LENAOUR_DENDRITIC_CELL_MATURATION_DN normocytic anemia DOID_720 2.82E-04 1.558E-03 0.11899746 0.63279955 LENAOUR_DENDRITIC_CELL_MATURATION_DN glaucoma DOID_1686 2.987E-04 1.634E-03 0.12118484 0.63260708 LENAOUR_DENDRITIC_CELL_MATURATION_DN calcium metabolism disease DOID_10575 3.161E-04 1.713E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN aortic aneurysm DOID_3627 3.161E-04 1.697E-03 0.12336684 0.63814304 LENAOUR_DENDRITIC_CELL_MATURATION_DN dermatomyositis DOID_10223 3.297E-04 1.753E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN B-cell lymphocytic neoplasm DOID_707 3.341E-04 1.76E-03 0.12554349 0.63780577 LENAOUR_DENDRITIC_CELL_MATURATION_DN bone marrow cancer DOID_4960 3.92E-04 2.046E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN otitis media DOID_10754 3.95E-04 2.043E-03 0.02935567 0.40739947 LENAOUR_DENDRITIC_CELL_MATURATION_DN intracranial arteriosclerosis DOID_13097 3.95E-04 2.025E-03 0.02935567 0.38845066 LENAOUR_DENDRITIC_CELL_MATURATION_DN middle ear disease DOID_5100 3.95E-04 2.043E-03 0.02935567 0.40739947 LENAOUR_DENDRITIC_CELL_MATURATION_DN peritonitis DOID_8283 3.95E-04 2.007E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN vascular dementia DOID_8725 3.95E-04 2.025E-03 0.02935567 0.38845066 LENAOUR_DENDRITIC_CELL_MATURATION_DN ocular hypertension DOID_9282 3.95E-04 1.989E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN borderline glaucoma DOID_9283 3.95E-04 1.989E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN osteochondrodysplasia DOID_2256 4.126E-04 2.059E-03 9.187E-03 0.22728386 LENAOUR_DENDRITIC_CELL_MATURATION_DN pustulosis of palm and sole DOID_4398 4.126E-04 2.042E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN mitochondrial metabolism disease DOID_700 4.339E-04 2.129E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN leprosy DOID_1024 4.661E-04 2.267E-03 0.03176314 0.40162726 LENAOUR_DENDRITIC_CELL_MATURATION_DN osteogenesis imperfecta DOID_12347 4.661E-04 2.247E-03 0.03176314 0.39289623 LENAOUR_DENDRITIC_CELL_MATURATION_DN leukocyte disease DOID_9500 5.021E-04 2.401E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN viral pneumonia DOID_10533 5.429E-04 2.574E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN thoracic aortic aneurysm DOID_14004 6.254E-04 2.941E-03 0.03656036 0.42454789 LENAOUR_DENDRITIC_CELL_MATURATION_DN adrenal cortex disease DOID_3952 6.254E-04 2.917E-03 0.03656036 0.40789896 LENAOUR_DENDRITIC_CELL_MATURATION_DN lung oat cell carcinoma DOID_5411 6.254E-04 2.893E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN oral submucous fibrosis DOID_5773 6.254E-04 2.87E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN varicose veins DOID_799 6.254E-04 2.847E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hyperhomocysteinemia DOID_9279 6.254E-04 2.824E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN mineral metabolism disease DOID_0050032 6.304E-04 2.824E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hemolytic-uremic syndrome DOID_12554 7.136E-04 3.172E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN vein disease DOID_866 7.136E-04 3.147E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN adrenal gland disease DOID_9553 8.074E-04 3.534E-03 0.04133407 0.44375634 LENAOUR_DENDRITIC_CELL_MATURATION_DN diabetic retinopathy DOID_8947 9.103E-04 3.954E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pulmonary edema DOID_11396 1.123E-03 4.839E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN brain edema DOID_4724 1.123E-03 4.803E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN amyloidosis DOID_9120 1.123E-03 4.767E-03 1.123E-03 0.05806665 LENAOUR_DENDRITIC_CELL_MATURATION_DN metabolic syndrome X DOID_14221 1.134E-03 4.782E-03 0.01776293 0.33690353 LENAOUR_DENDRITIC_CELL_MATURATION_DN bone development disease DOID_0080006 1.302E-03 5.446E-03 0.01942508 0.34540226 LENAOUR_DENDRITIC_CELL_MATURATION_DN retinal vascular disease DOID_2462 1.346E-03 5.589E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN funisitis DOID_0050698 1.36E-03 5.609E-03 1.36E-03 0.05954329 LENAOUR_DENDRITIC_CELL_MATURATION_DN gastric ulcer DOID_10808 1.36E-03 5.569E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN neutropenia DOID_1227 1.36E-03 5.529E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN agranulocytosis DOID_12987 1.488E-03 6.003E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN opiate dependence DOID_2559 1.488E-03 5.961E-03 0.05551523 0.57433027 LENAOUR_DENDRITIC_CELL_MATURATION_DN amino acid metabolic disorder DOID_9252 1.531E-03 6.094E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Human immunodeficiency virus infectious disease DOID_526 1.58E-03 6.244E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN diabetic angiopathy DOID_11713 1.62E-03 6.358E-03 0.05785849 0.57756986 LENAOUR_DENDRITIC_CELL_MATURATION_DN lymphoma DOID_0060058 1.681E-03 6.55E-03 0.20836012 0.89815838 LENAOUR_DENDRITIC_CELL_MATURATION_DN carbohydrate metabolic disorder DOID_2978 1.732E-03 6.706E-03 1.732E-03 0.07041015 LENAOUR_DENDRITIC_CELL_MATURATION_DN toxic shock syndrome DOID_14115 1.758E-03 6.76E-03 0.060196 0.57085877 LENAOUR_DENDRITIC_CELL_MATURATION_DN sphingolipidosis DOID_1927 1.758E-03 6.714E-03 1.758E-03 0.06669491 LENAOUR_DENDRITIC_CELL_MATURATION_DN urticaria DOID_1555 1.902E-03 7.214E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN cystitis DOID_1679 2.05E-03 7.727E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN ankylosing spondylitis DOID_7147 2.05E-03 7.676E-03 0.06485383 0.57659105 LENAOUR_DENDRITIC_CELL_MATURATION_DN intracranial aneurysm DOID_10941 2.205E-03 8.199E-03 0.06717417 0.58803232 LENAOUR_DENDRITIC_CELL_MATURATION_DN middle cerebral artery infarction DOID_3525 2.205E-03 8.146E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN lung adenocarcinoma DOID_3910 2.364E-03 8.679E-03 0.06948881 0.56484475 LENAOUR_DENDRITIC_CELL_MATURATION_DN periodontitis DOID_824 2.364E-03 8.623E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN thrombocytopenia DOID_1588 2.529E-03 9.165E-03 0.07179777 0.56740182 LENAOUR_DENDRITIC_CELL_MATURATION_DN age related macular degeneration DOID_10871 3.055E-03 0.01100123 0.0786907 0.58149358 LENAOUR_DENDRITIC_CELL_MATURATION_DN degeneration of macula and posterior pole DOID_2007 3.055E-03 0.01100123 0.0786907 0.58149358 LENAOUR_DENDRITIC_CELL_MATURATION_DN opportunistic mycosis DOID_2473 3.055E-03 0.01093204 0.0786907 0.57403854 LENAOUR_DENDRITIC_CELL_MATURATION_DN bronchiolitis obliterans DOID_2799 3.055E-03 0.01086371 0.0786907 0.56677223 LENAOUR_DENDRITIC_CELL_MATURATION_DN abdominal aortic aneurysm DOID_7693 3.055E-03 0.01079624 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN allergic rhinitis DOID_4481 3.241E-03 0.01138185 0.08097706 0.56883889 LENAOUR_DENDRITIC_CELL_MATURATION_DN bladder disease DOID_365 3.431E-03 0.01197831 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN systemic mycosis DOID_0050136 3.627E-03 0.01258531 0.08553297 0.5935154 LENAOUR_DENDRITIC_CELL_MATURATION_DN fungal infectious disease DOID_1564 3.627E-03 0.01258531 0.08553297 0.5935154 LENAOUR_DENDRITIC_CELL_MATURATION_DN nephroblastoma DOID_2154 3.829E-03 0.01320257 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN periodontal disease DOID_3388 3.829E-03 0.01312304 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN spindle cell carcinoma DOID_4015 3.829E-03 0.01304446 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN macular degeneration DOID_4448 3.829E-03 0.01296681 0.08780254 0.5947577 LENAOUR_DENDRITIC_CELL_MATURATION_DN leukopenia DOID_615 3.829E-03 0.01289009 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hyperthyroidism DOID_7998 3.829E-03 0.01281426 0.08780254 0.58776055 LENAOUR_DENDRITIC_CELL_MATURATION_DN calcinosis DOID_182 4.462E-03 0.01484811 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN blood platelet disease DOID_2218 4.684E-03 0.01549387 0.09682522 0.59884295 LENAOUR_DENDRITIC_CELL_MATURATION_DN benign mesothelioma DOID_2645 5.377E-03 0.01768583 0.10353423 0.62011557 LENAOUR_DENDRITIC_CELL_MATURATION_DN brain cancer DOID_1319 6.896E-03 0.02255187 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN thyroid adenoma DOID_2891 6.896E-03 0.022423 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN central nervous system cancer DOID_3620 7.166E-03 0.02316841 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN lung small cell carcinoma DOID_5409 7.441E-03 0.0239206 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hemorrhagic disease DOID_2213 8.005E-03 0.02558752 0.12554349 0.64355177 LENAOUR_DENDRITIC_CELL_MATURATION_DN oral cavity cancer DOID_8618 0.0101222 0.03217616 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN temporal lobe epilepsy DOID_3328 0.01281125 0.04049778 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hyperglycemia DOID_4195 0.01281125 0.04027403 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN tooth disease DOID_1091 0.01316698 0.04116489 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN blood coagulation disease DOID_1247 0.01425974 0.04433767 0.16589849 0.76744912 LENAOUR_DENDRITIC_CELL_MATURATION_DN pancreatic ductal carcinoma DOID_3587 0.01425974 0.0440967 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pancreatic carcinoma DOID_4905 0.0153904 0.04733586 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN syndrome DOID_225 0.01616491 0.04945072 0.17620837 0.78330128 LENAOUR_DENDRITIC_CELL_MATURATION_DN lipid metabolism disorder DOID_3146 0.01776293 0.05404869 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN auditory system disease DOID_2742 0.01858608 0.05625254 0.18841392 0.82467322 LENAOUR_DENDRITIC_CELL_MATURATION_DN focal epilepsy DOID_2234 0.01900361 0.05721192 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN biliary tract cancer DOID_4607 0.01900361 0.0569108 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN transitional cell carcinoma DOID_2671 0.02114998 0.06300701 0.20044052 0.87061567 LENAOUR_DENDRITIC_CELL_MATURATION_DN nervous system cancer DOID_3093 0.02203553 0.06530321 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN leber hereditary optic neuropathy DOID_705 0.02209768 0.06514809 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN encephalomyelitis DOID_640 0.02339225 0.06860921 0.21032786 0.8931086 LENAOUR_DENDRITIC_CELL_MATURATION_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.02385197 0.06959883 0.21229076 0.89476626 LENAOUR_DENDRITIC_CELL_MATURATION_DN gallbladder disease DOID_0000000 0.02452296 0.07119165 0.02452296 0.39867326 LENAOUR_DENDRITIC_CELL_MATURATION_DN T cell deficiency DOID_11200 0.02452296 0.07083027 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hypolipoproteinemia DOID_1387 0.02452296 0.07047255 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN transient cerebral ischemia DOID_224 0.02452296 0.07011841 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN bilirubin metabolic disorder DOID_2741 0.02452296 0.06976782 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN phagocyte bactericidal dysfunction DOID_3262 0.02452296 0.06942072 0.02452296 0.387599 LENAOUR_DENDRITIC_CELL_MATURATION_DN chondrosarcoma DOID_3371 0.02452296 0.06907705 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN keratitis DOID_4677 0.02452296 0.06873677 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN acute T cell leukemia DOID_5603 0.02452296 0.06839982 0.02452296 0.36719906 LENAOUR_DENDRITIC_CELL_MATURATION_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.02452296 0.06806617 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.02452296 0.06806617 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Hodgkin's granuloma DOID_8651 0.02452296 0.06806617 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 0.02452296 0.06806617 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN familial adenomatous polyposis DOID_0050424 0.02694228 0.07441825 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN adrenoleukodystrophy DOID_10588 0.02694228 0.07405874 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN sickle cell anemia DOID_10923 0.02694228 0.07370269 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pneumocystosis DOID_11339 0.02694228 0.07335005 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN prediabetes syndrome DOID_11716 0.02694228 0.07300076 0.02694228 0.383254 LENAOUR_DENDRITIC_CELL_MATURATION_DN common variable immunodeficiency DOID_12177 0.02694228 0.07265479 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN migraine without aura DOID_12783 0.02694228 0.07231208 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN neuronal ceroid lipofuscinosis DOID_14503 0.02694228 0.07197258 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hemochromatosis DOID_2352 0.02694228 0.07163626 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN invasive lobular carcinoma DOID_3457 0.02694228 0.07130307 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN eosinophilic pneumonia DOID_5870 0.02694228 0.07097296 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN pulmonary eosinophilia DOID_9498 0.02694228 0.07097296 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Loeffler syndrome DOID_9503 0.02694228 0.07097296 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN common cold DOID_10459 0.02935567 0.07697409 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN mucopolysaccharidosis DOID_12798 0.02935567 0.076621 0.02935567 0.39769948 LENAOUR_DENDRITIC_CELL_MATURATION_DN diarrhea DOID_13250 0.02935567 0.07627113 0.02935567 0.37962223 LENAOUR_DENDRITIC_CELL_MATURATION_DN retinal detachment DOID_5327 0.02935567 0.07592445 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN stomach disease DOID_76 0.02935567 0.0755809 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Hodgkin's lymphoma DOID_8567 0.02935567 0.07524044 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN mitochondrial encephalomyopathy DOID_890 0.02935567 0.07490304 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN berylliosis DOID_10322 0.03176314 0.08068405 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hepatic coma DOID_12550 0.03176314 0.08032545 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hepatic encephalopathy DOID_13413 0.03176314 0.08032545 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN larynx cancer DOID_2596 0.03176314 0.07997003 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN laryngeal benign neoplasm DOID_2598 0.03176314 0.07997003 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN psoriatic arthritis DOID_9008 0.03176314 0.07961774 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hypercalcemia DOID_12678 0.0341647 0.0852619 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN aspergillosis DOID_13564 0.0341647 0.08488958 0.0341647 0.41361092 LENAOUR_DENDRITIC_CELL_MATURATION_DN T-cell leukemia DOID_715 0.0341647 0.08452049 0.0341647 0.40499403 LENAOUR_DENDRITIC_CELL_MATURATION_DN idiopathic pulmonary fibrosis DOID_0050156 0.03656036 0.09005561 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN skeletal system cancer DOID_0060124 0.03656036 0.08966744 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN bone cancer DOID_184 0.03656036 0.08966744 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN hemangioma DOID_255 0.03656036 0.0892826 0.03656036 0.41605694 LENAOUR_DENDRITIC_CELL_MATURATION_DN mesenchymal cell neoplasm DOID_3350 0.03656036 0.08890105 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN spindle cell sarcoma DOID_4235 0.03656036 0.08890105 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN epithelioid sarcoma DOID_6193 0.03656036 0.08890105 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN intermediate coronary syndrome DOID_8805 0.03656036 0.08852275 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN restrictive cardiomyopathy DOID_397 0.03895015 0.09390947 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN thyroiditis DOID_7166 0.03895015 0.09351323 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN autoimmune thyroiditis DOID_7188 0.03895015 0.09351323 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN tongue cancer DOID_8649 0.03895015 0.09312031 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN Barrett's esophagus DOID_9206 0.03895015 0.09273069 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN congenital disorder of glycosylation type I DOID_0050570 0.04133407 0.09799619 0.04133407 0.45229011 LENAOUR_DENDRITIC_CELL_MATURATION_DN drug-induced mental disorder DOID_1203 0.04133407 0.09758957 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN methylmalonic acidemia DOID_14749 0.04133407 0.09718631 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN drug psychosis DOID_1742 0.04133407 0.09758957 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN juvenile rheumatoid arthritis DOID_676 0.04133407 0.09678636 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_DN substance-induced psychosis DOID_8646 0.04133407 0.09758957 1.000 1.000 TAVAZOIE_METASTASIS mouth disease DOID_403 9.097E-09 5.176E-06 9.885E-03 0.26784278 TAVAZOIE_METASTASIS lymphoma DOID_0060058 3.79E-07 1.078E-04 4.339E-04 0.24691513 TAVAZOIE_METASTASIS dilated cardiomyopathy DOID_12930 4.434E-07 8.409E-05 4.757E-04 0.13534696 TAVAZOIE_METASTASIS rheumatic disease DOID_1575 8.22E-07 1.169E-04 0.06917787 0.36112117 TAVAZOIE_METASTASIS scleroderma DOID_419 8.22E-07 1.169E-04 0.06917787 0.36112117 TAVAZOIE_METASTASIS oral submucous fibrosis DOID_5773 1.607E-06 1.829E-04 0.02309576 0.32052414 TAVAZOIE_METASTASIS collagen disease DOID_854 3.134E-06 2.972E-04 0.09494744 0.39724335 TAVAZOIE_METASTASIS nephrosis DOID_2527 5.611E-06 4.561E-04 5.985E-03 0.26194681 TAVAZOIE_METASTASIS cystitis DOID_1679 1.02E-05 7.253E-04 1.000 1.000 TAVAZOIE_METASTASIS periodontitis DOID_824 1.271E-05 8.036E-04 9.409E-04 0.17845727 TAVAZOIE_METASTASIS Human immunodeficiency virus infectious disease DOID_526 1.334E-05 7.592E-04 9.111E-03 0.25919626 TAVAZOIE_METASTASIS bladder disease DOID_365 2.262E-05 1.17E-03 1.000 1.000 TAVAZOIE_METASTASIS periodontal disease DOID_3388 2.679E-05 1.27E-03 1.531E-03 0.14520424 TAVAZOIE_METASTASIS spindle cell carcinoma DOID_4015 2.679E-05 1.173E-03 0.05602395 0.35419587 TAVAZOIE_METASTASIS nephrotic syndrome DOID_1184 5.182E-05 2.106E-03 0.06917787 0.36446489 TAVAZOIE_METASTASIS B-cell lymphocytic neoplasm DOID_707 8.393E-05 3.184E-03 0.08071886 0.37646748 TAVAZOIE_METASTASIS sarcoidosis DOID_11335 9.358E-05 3.328E-03 0.08358206 0.38353381 TAVAZOIE_METASTASIS giant cell tumor DOID_200 9.358E-05 3.132E-03 3.474E-03 0.21963308 TAVAZOIE_METASTASIS malignant giant cell tumor DOID_2705 9.358E-05 3.132E-03 3.474E-03 0.21963308 TAVAZOIE_METASTASIS giant cell glioblastoma DOID_3074 9.358E-05 3.132E-03 3.474E-03 0.21963308 TAVAZOIE_METASTASIS hyperparathyroidism DOID_13543 1.063E-04 3.36E-03 1.000 1.000 TAVAZOIE_METASTASIS hypersensitivity reaction type IV disease DOID_2916 1.208E-04 3.619E-03 0.09070176 0.39396411 TAVAZOIE_METASTASIS glioblastoma DOID_3068 1.208E-04 3.438E-03 4.108E-03 0.23372537 TAVAZOIE_METASTASIS melancholia DOID_2848 1.268E-04 3.437E-03 1.000 1.000 TAVAZOIE_METASTASIS neurotic disorder DOID_4964 1.33E-04 3.441E-03 1.000 1.000 TAVAZOIE_METASTASIS tooth disease DOID_1091 1.82E-04 4.502E-03 5.372E-03 0.27789812 TAVAZOIE_METASTASIS parathyroid gland disease DOID_11201 1.837E-04 4.355E-03 1.000 1.000 TAVAZOIE_METASTASIS astrocytoma DOID_3069 1.978E-04 4.502E-03 5.675E-03 0.26907666 TAVAZOIE_METASTASIS male reproductive system disease DOID_48 2.145E-04 4.695E-03 5.985E-03 0.24323632 TAVAZOIE_METASTASIS varicose veins DOID_799 2.468E-04 5.2E-03 0.02309576 0.31289261 TAVAZOIE_METASTASIS endogenous depression DOID_1595 2.507E-04 5.094E-03 1.000 1.000 TAVAZOIE_METASTASIS vein disease DOID_866 2.817E-04 5.528E-03 0.0246167 0.31126448 TAVAZOIE_METASTASIS mental depression DOID_1596 3.229E-04 6.125E-03 1.000 1.000 TAVAZOIE_METASTASIS biliary tract cancer DOID_4607 3.229E-04 5.928E-03 7.824E-03 0.26187833 TAVAZOIE_METASTASIS retinal vascular disease DOID_2462 3.458E-04 6.149E-03 8.183E-03 0.25866172 TAVAZOIE_METASTASIS prion disease DOID_649 3.585E-04 6.181E-03 0.02765159 0.32109702 TAVAZOIE_METASTASIS primary bacterial infectious disease DOID_0050338 3.697E-04 6.187E-03 8.548E-03 0.25600174 TAVAZOIE_METASTASIS transitional cell carcinoma DOID_2671 3.82E-04 6.21E-03 0.13093635 0.47153662 TAVAZOIE_METASTASIS muscle cancer DOID_4045 5.899E-04 9.323E-03 1.000 1.000 TAVAZOIE_METASTASIS urinary tract obstruction DOID_5200 5.899E-04 9.071E-03 0.03519826 0.35763945 TAVAZOIE_METASTASIS aortic valve disease DOID_62 6.428E-04 9.626E-03 0.03670067 0.34804468 TAVAZOIE_METASTASIS sarcoma DOID_1115 1.007E-03 0.01469332 0.04566695 0.36597879 TAVAZOIE_METASTASIS abdominal aortic aneurysm DOID_7693 1.219E-03 0.0173367 1.000 1.000 TAVAZOIE_METASTASIS pleural disease DOID_1532 1.371E-03 0.01902205 0.05307614 0.3682966 TAVAZOIE_METASTASIS myocarditis DOID_820 1.45E-03 0.01964181 1.000 1.000 TAVAZOIE_METASTASIS pneumoconiosis DOID_10316 1.531E-03 0.02026106 1.531E-03 0.21780635 TAVAZOIE_METASTASIS male infertility DOID_12336 1.531E-03 0.01980058 1.531E-03 0.17424508 TAVAZOIE_METASTASIS hepatitis C DOID_1883 1.531E-03 0.01936056 0.05602395 0.36640952 TAVAZOIE_METASTASIS nephroblastoma DOID_2154 1.531E-03 0.01893968 0.05602395 0.36224578 TAVAZOIE_METASTASIS thyroid carcinoma DOID_3963 1.531E-03 0.01853671 0.05602395 0.3581756 TAVAZOIE_METASTASIS thyroid cancer DOID_1781 1.7E-03 0.02015419 0.05896275 0.36075056 TAVAZOIE_METASTASIS refractive error DOID_9835 1.7E-03 0.01974288 1.7E-03 0.13820019 TAVAZOIE_METASTASIS pulmonary sarcoidosis DOID_13406 1.788E-03 0.02034601 0.06042877 0.36193651 TAVAZOIE_METASTASIS systemic scleroderma DOID_418 1.97E-03 0.02197455 0.06335408 0.34998516 TAVAZOIE_METASTASIS pulmonary emphysema DOID_9675 2.16E-03 0.02363238 1.000 1.000 TAVAZOIE_METASTASIS uterine cancer DOID_363 2.461E-03 0.02641611 0.07062825 0.35564135 TAVAZOIE_METASTASIS influenza DOID_8469 2.461E-03 0.02592692 1.000 1.000 TAVAZOIE_METASTASIS learning disability DOID_8927 2.565E-03 0.02653579 2.565E-03 0.18243355 TAVAZOIE_METASTASIS neuritis DOID_1803 2.78E-03 0.02824664 0.07496606 0.36772145 TAVAZOIE_METASTASIS thyroid adenoma DOID_2891 2.78E-03 0.02775109 0.07496606 0.36457853 TAVAZOIE_METASTASIS heart valve disease DOID_4079 2.78E-03 0.02727262 0.07496606 0.36148888 TAVAZOIE_METASTASIS integumentary system benign neoplasm DOID_0060121 3.003E-03 0.02896301 1.000 1.000 TAVAZOIE_METASTASIS glaucoma DOID_1686 3.003E-03 0.02848029 1.000 1.000 TAVAZOIE_METASTASIS skin benign neoplasm DOID_3165 3.003E-03 0.02896301 1.000 1.000 TAVAZOIE_METASTASIS lung small cell carcinoma DOID_5409 3.003E-03 0.0280134 0.07784687 0.37222579 TAVAZOIE_METASTASIS aortic aneurysm DOID_3627 3.118E-03 0.02861386 1.000 1.000 TAVAZOIE_METASTASIS withdrawal disorder DOID_0060001 3.235E-03 0.02921358 1.000 1.000 TAVAZOIE_METASTASIS bile duct adenocarcinoma DOID_4896 3.597E-03 0.03197712 0.08501037 0.3869672 TAVAZOIE_METASTASIS cholangiocarcinoma DOID_4947 3.597E-03 0.03197712 0.08501037 0.3869672 TAVAZOIE_METASTASIS integumentary system cancer DOID_0060122 3.721E-03 0.03257714 1.000 1.000 TAVAZOIE_METASTASIS skin cancer DOID_4159 3.721E-03 0.03257714 1.000 1.000 TAVAZOIE_METASTASIS hypertrophic cardiomyopathy DOID_11984 4.108E-03 0.03541294 0.09070176 0.39699461 TAVAZOIE_METASTASIS bile duct cancer DOID_4606 4.108E-03 0.03488438 0.09070176 0.39097954 TAVAZOIE_METASTASIS bile duct carcinoma DOID_4897 4.108E-03 0.03488438 0.09070176 0.39097954 TAVAZOIE_METASTASIS oral cavity cancer DOID_8618 4.108E-03 0.03437138 0.09070176 0.38803984 TAVAZOIE_METASTASIS leukocyte disease DOID_9500 4.24E-03 0.03496748 0.09211916 0.39116268 TAVAZOIE_METASTASIS pre-malignant neoplasm DOID_0060071 4.791E-03 0.0389422 0.09776707 0.40605447 TAVAZOIE_METASTASIS in situ carcinoma DOID_8719 4.791E-03 0.0389422 0.09776707 0.40605447 TAVAZOIE_METASTASIS uterine disease DOID_345 5.078E-03 0.04069316 0.10057806 0.40302053 TAVAZOIE_METASTASIS endocrine organ benign neoplasm DOID_0060089 5.523E-03 0.04364381 0.10477841 0.41691548 TAVAZOIE_METASTASIS tuberculosis DOID_399 5.523E-03 0.04304595 0.10477841 0.41116492 TAVAZOIE_METASTASIS blood coagulation disease DOID_1247 5.829E-03 0.04481855 0.10756792 0.41922018 TAVAZOIE_METASTASIS pancreatic ductal carcinoma DOID_3587 5.829E-03 0.04422097 0.10756792 0.41636835 TAVAZOIE_METASTASIS pancreatic carcinoma DOID_4905 6.302E-03 0.04718444 0.11173618 0.42104559 TAVAZOIE_METASTASIS diabetic retinopathy DOID_8947 6.302E-03 0.04657165 0.11173618 0.41827556 TAVAZOIE_METASTASIS bone resorption disease DOID_0080011 6.793E-03 0.04955283 6.793E-03 0.25767471 TAVAZOIE_METASTASIS osteoporosis DOID_11476 6.793E-03 0.04955283 6.793E-03 0.25767471 TAVAZOIE_METASTASIS aneurysm disease DOID_2403 6.793E-03 0.04892558 1.000 1.000 TAVAZOIE_METASTASIS pancreatitis DOID_4989 6.96E-03 0.04950357 0.11726409 0.43326798 TAVAZOIE_METASTASIS bacterial pneumonia DOID_874 6.96E-03 0.04889241 1.000 1.000 TAVAZOIE_METASTASIS metabolic syndrome X DOID_14221 7.3E-03 0.05065597 1.000 1.000 TAVAZOIE_METASTASIS chromosomal disease DOID_0080014 7.473E-03 0.05123039 7.473E-03 0.26575763 TAVAZOIE_METASTASIS female reproductive system disease DOID_229 7.473E-03 0.0506205 0.12138782 0.4427543 TAVAZOIE_METASTASIS chronic kidney failure DOID_784 7.824E-03 0.05237567 1.000 1.000 TAVAZOIE_METASTASIS Crohn's disease DOID_8778 9.885E-03 0.06540347 1.000 1.000 TAVAZOIE_METASTASIS ulcerative colitis DOID_8577 0.01068816 0.06990303 0.14440039 0.50718408 TAVAZOIE_METASTASIS interstitial nephritis DOID_1063 0.01545605 0.0999374 1.000 1.000 TAVAZOIE_METASTASIS Gilles de la Tourette syndrome DOID_11119 0.01545605 0.09881451 0.01545605 0.39974962 TAVAZOIE_METASTASIS bilirubin metabolic disorder DOID_2741 0.01545605 0.09771657 1.000 1.000 TAVAZOIE_METASTASIS chondrosarcoma DOID_3371 0.01545605 0.09664277 0.01545605 0.3823692 TAVAZOIE_METASTASIS insulinoma DOID_3892 0.01545605 0.0955923 0.01545605 0.36643715 TAVAZOIE_METASTASIS conjunctival disease DOID_4251 0.01545605 0.09456443 0.01545605 0.35177966 TAVAZOIE_METASTASIS conjunctivitis DOID_6195 0.01545605 0.09456443 0.01545605 0.35177966 TAVAZOIE_METASTASIS Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01545605 0.09355842 1.000 1.000 TAVAZOIE_METASTASIS Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01545605 0.09355842 1.000 1.000 TAVAZOIE_METASTASIS Hodgkin's granuloma DOID_8651 0.01545605 0.09355842 1.000 1.000 TAVAZOIE_METASTASIS Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01545605 0.09355842 1.000 1.000 TAVAZOIE_METASTASIS visceral leishmaniasis DOID_9146 0.01545605 0.0925736 1.000 1.000 TAVAZOIE_METASTASIS obsessive-compulsive disorder DOID_10933 0.01698868 0.09965522 0.01698868 0.37179063 TAVAZOIE_METASTASIS prediabetes syndrome DOID_11716 0.01698868 0.09863833 0.01698868 0.35802061 TAVAZOIE_METASTASIS speech disorder DOID_92 0.01698868 0.09764198 0.01698868 0.34523415 TAVAZOIE_METASTASIS aortic valve insufficiency DOID_57 0.01851896 0.09940836 0.01851896 0.3292902 TAVAZOIE_METASTASIS stomach disease DOID_76 0.01851896 0.09847931 1.000 1.000 TAVAZOIE_METASTASIS Hodgkin's lymphoma DOID_8567 0.01851896 0.09756747 1.000 1.000 TAVAZOIE_METASTASIS ocular hypertension DOID_9282 0.01851896 0.09667235 1.000 1.000 TAVAZOIE_METASTASIS borderline glaucoma DOID_9283 0.01851896 0.09667235 1.000 1.000 TAVAZOIE_METASTASIS vesiculobullous skin disease DOID_2731 0.0200469 0.09918856 1.000 1.000 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP pulmonary tuberculosis DOID_2957 2.322E-06 1.321E-03 3.109E-04 0.1768776 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP tuberculosis DOID_399 5.969E-06 1.698E-03 5.793E-04 0.10986763 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP primary bacterial infectious disease DOID_0050338 1.179E-05 2.237E-03 9.079E-04 0.07380318 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP sinusitis DOID_0050127 5.983E-05 8.51E-03 0.01146698 0.29657785 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP paranasal sinus disease DOID_1352 5.983E-05 8.51E-03 0.01146698 0.29657785 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP pulmonary sarcoidosis DOID_13406 1.835E-04 0.02088387 0.01986239 0.25685684 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP hyperinsulinism DOID_2018 2.431E-04 0.02305138 0.02280932 0.26486738 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP cerebral infarction DOID_3526 2.648E-04 0.02152085 0.02378976 0.26031486 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP sarcoidosis DOID_11335 3.606E-04 0.02564727 0.02770221 0.26270932 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP hypersensitivity reaction type IV disease DOID_2916 4.279E-04 0.02705019 0.03013995 0.26796299 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP endocrine pancreas disease DOID_1428 5.16E-04 0.02936109 0.03305759 0.28499649 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP cholestasis DOID_13580 5.315E-04 0.02749253 5.315E-04 0.15120894 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP brain infarction DOID_3454 5.793E-04 0.02746691 0.03499806 0.2765819 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP bile duct disease DOID_4138 6.291E-04 0.02753321 6.291E-04 0.08948292 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP biliary tract disease DOID_9741 6.461E-04 0.02625916 6.461E-04 0.07352564 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP cystic fibrosis DOID_1485 6.986E-04 0.02649847 0.03838501 0.28365028 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP syndrome DOID_225 6.986E-04 0.02484232 0.03838501 0.28001374 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP pancreatitis DOID_4989 7.346E-04 0.0245887 7.346E-04 0.06966799 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.055E-03 0.03335149 1.055E-03 0.07504085 WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP mouth disease DOID_403 1.055E-03 0.03159615 1.055E-03 0.06670298 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM multiple myeloma DOID_9538 8.781E-07 4.997E-04 1.643E-04 0.04674513 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM myeloma DOID_0070004 1.737E-06 4.942E-04 2.573E-04 0.0488051 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM bone marrow cancer DOID_4960 2.588E-06 4.908E-04 3.346E-04 0.04759578 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM glycogen metabolism disorder DOID_0050728 5.355E-05 7.617E-03 5.355E-05 0.03046976 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM glycogen storage disease DOID_2747 5.355E-05 7.617E-03 5.355E-05 0.03046976 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM medullomyoblastoma DOID_3861 1.482E-04 0.0168617 0.01789333 0.84844227 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM adult medulloblastoma DOID_3864 1.482E-04 0.0168617 0.01789333 0.84844227 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM childhood medulloblastoma DOID_3869 1.482E-04 0.0168617 0.01789333 0.84844227 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM medulloblastoma DOID_3858 1.643E-04 0.01558171 0.01882666 0.8240285 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM primitive neuroectodermal tumor DOID_168 2.177E-04 0.01769217 0.02162162 0.87876441 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM hypertrophic cardiomyopathy DOID_11984 3.832E-04 0.02725638 1.000 1.000 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM neuroectodermal tumor DOID_171 4.218E-04 0.0266679 0.02996145 0.89726651 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM transitional cell carcinoma DOID_2671 8.319E-04 0.04733358 1.000 1.000 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM lymphoma DOID_0060058 9.069E-04 0.04691014 0.04371214 1.000 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM lymphoblastic leukemia DOID_1037 9.261E-04 0.04391338 0.04416731 1.000 SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM carbohydrate metabolic disorder DOID_2978 9.261E-04 0.04053542 9.261E-04 0.1053921 RICKMAN_METASTASIS_DN transitional cell carcinoma DOID_2671 4.339E-10 2.469E-07 2.836E-03 0.06205792 RICKMAN_METASTASIS_DN papilloma DOID_2615 9.36E-08 2.663E-05 5.647E-03 0.09451218 RICKMAN_METASTASIS_DN rheumatic disease DOID_1575 3.32E-07 6.297E-05 9.092E-03 0.12933599 RICKMAN_METASTASIS_DN scleroderma DOID_419 3.32E-07 6.297E-05 9.092E-03 0.12933599 RICKMAN_METASTASIS_DN primary bacterial infectious disease DOID_0050338 3.765E-07 5.356E-05 1.775E-04 0.01683648 RICKMAN_METASTASIS_DN lymphoma DOID_0060058 5.209E-07 5.928E-05 1.18E-05 6.716E-03 RICKMAN_METASTASIS_DN integumentary system cancer DOID_0060122 1.077E-06 1.022E-04 8.006E-04 0.02846968 RICKMAN_METASTASIS_DN skin cancer DOID_4159 1.077E-06 1.022E-04 8.006E-04 0.02846968 RICKMAN_METASTASIS_DN oral cavity cancer DOID_8618 1.388E-06 1.128E-04 9.274E-04 0.02931748 RICKMAN_METASTASIS_DN collagen disease DOID_854 1.766E-06 1.256E-04 0.01707869 0.18688024 RICKMAN_METASTASIS_DN tuberculosis DOID_399 2.964E-06 1.874E-04 1.44E-03 0.03562329 RICKMAN_METASTASIS_DN pancreatic ductal carcinoma DOID_3587 3.402E-06 1.936E-04 0.20370649 0.68181762 RICKMAN_METASTASIS_DN pancreatic carcinoma DOID_4905 4.154E-06 2.149E-04 0.21113334 0.69442123 RICKMAN_METASTASIS_DN nephroblastoma DOID_2154 5.44E-06 2.579E-04 0.1089894 0.4559924 RICKMAN_METASTASIS_DN systemic scleroderma DOID_418 9.109E-06 3.987E-04 0.12278403 0.48182149 RICKMAN_METASTASIS_DN gallbladder cancer DOID_3121 1.434E-05 5.829E-04 0.13636689 0.51385933 RICKMAN_METASTASIS_DN influenza DOID_8469 1.434E-05 5.441E-04 9.477E-03 0.12839198 RICKMAN_METASTASIS_DN thyroid adenoma DOID_2891 1.839E-05 6.539E-04 0.14441628 0.53707755 RICKMAN_METASTASIS_DN glaucoma DOID_1686 2.151E-05 7.2E-04 0.14974118 0.54269254 RICKMAN_METASTASIS_DN pulmonary tuberculosis DOID_2957 2.151E-05 6.8E-04 0.01150822 0.14551508 RICKMAN_METASTASIS_DN reproductive organ benign neoplasm DOID_0050622 3.323E-05 9.951E-04 0.0141737 0.16801743 RICKMAN_METASTASIS_DN parasitic protozoa infectious disease DOID_2789 3.323E-05 9.453E-04 8.006E-04 0.02679499 RICKMAN_METASTASIS_DN respiratory failure DOID_11162 5.214E-05 1.413E-03 0.01758545 0.18879478 RICKMAN_METASTASIS_DN parasitic infectious disease DOID_1398 6.227E-05 1.611E-03 1.271E-03 0.03616559 RICKMAN_METASTASIS_DN severe combined immunodeficiency DOID_627 6.431E-05 1.591E-03 2.75E-03 0.06258898 RICKMAN_METASTASIS_DN combined T cell and B cell immunodeficiency DOID_628 7.253E-05 1.72E-03 2.973E-03 0.06041711 RICKMAN_METASTASIS_DN endocrine organ benign neoplasm DOID_0060089 7.376E-05 1.679E-03 0.19871679 0.67303484 RICKMAN_METASTASIS_DN ankylosing spondylitis DOID_7147 8.141E-05 1.782E-03 3.204E-03 0.06077692 RICKMAN_METASTASIS_DN cleft lip DOID_9296 8.141E-05 1.716E-03 8.141E-05 0.02316149 RICKMAN_METASTASIS_DN seminoma DOID_4440 9.097E-05 1.849E-03 0.08361486 0.41734085 RICKMAN_METASTASIS_DN lung adenocarcinoma DOID_3910 1.012E-04 1.986E-03 1.012E-04 0.01920197 RICKMAN_METASTASIS_DN cystic fibrosis DOID_1485 1.065E-04 2.02E-03 0.21604638 0.70649649 RICKMAN_METASTASIS_DN bone resorption disease DOID_0080011 1.119E-04 2.054E-03 1.119E-04 0.01591739 RICKMAN_METASTASIS_DN osteoporosis DOID_11476 1.119E-04 2.054E-03 1.119E-04 0.01591739 RICKMAN_METASTASIS_DN malaria DOID_12365 1.122E-04 1.996E-03 1.122E-04 0.01277229 RICKMAN_METASTASIS_DN biliary tract cancer DOID_4607 1.486E-04 2.563E-03 0.23300428 0.7448283 RICKMAN_METASTASIS_DN Charcot-Marie-Tooth disease DOID_10595 1.639E-04 2.743E-03 5.049E-03 0.08706329 RICKMAN_METASTASIS_DN germinoma DOID_3304 1.639E-04 2.665E-03 0.1006096 0.44377411 RICKMAN_METASTASIS_DN leiomyoma DOID_127 1.789E-04 2.827E-03 0.10341151 0.44916907 RICKMAN_METASTASIS_DN primary immunodeficiency disease DOID_612 1.934E-04 2.974E-03 2.926E-03 0.06165779 RICKMAN_METASTASIS_DN nervous system cancer DOID_3093 2.017E-04 3.02E-03 0.03352606 0.28903531 RICKMAN_METASTASIS_DN Human immunodeficiency virus infectious disease DOID_526 2.017E-04 2.943E-03 3.018E-03 0.05920713 RICKMAN_METASTASIS_DN thyroid carcinoma DOID_3963 2.114E-04 3.007E-03 0.1089894 0.45266399 RICKMAN_METASTASIS_DN spindle cell carcinoma DOID_4015 2.114E-04 2.934E-03 1.000 1.000 RICKMAN_METASTASIS_DN encephalomyelitis DOID_640 2.282E-04 3.091E-03 0.03554698 0.28487653 RICKMAN_METASTASIS_DN thyroid cancer DOID_1781 2.475E-04 3.275E-03 0.11453287 0.47224062 RICKMAN_METASTASIS_DN adenoma DOID_657 2.475E-04 3.201E-03 0.11453287 0.4688432 RICKMAN_METASTASIS_DN cleft palate DOID_674 2.67E-04 3.376E-03 2.67E-04 0.02170303 RICKMAN_METASTASIS_DN adenoid cystic carcinoma DOID_4866 3.312E-04 4.097E-03 3.312E-04 0.02355966 RICKMAN_METASTASIS_DN pulmonary emphysema DOID_9675 3.547E-04 4.294E-03 0.12824241 0.49304007 RICKMAN_METASTASIS_DN salivary gland cancer DOID_8850 3.791E-04 4.495E-03 3.791E-04 0.0239707 RICKMAN_METASTASIS_DN Noonan syndrome DOID_3490 4.253E-04 4.938E-03 0.03069676 0.27291341 RICKMAN_METASTASIS_DN proteinuria DOID_576 4.878E-04 5.552E-03 0.01026838 0.13587699 RICKMAN_METASTASIS_DN neuritis DOID_1803 5.178E-04 5.777E-03 0.01067466 0.13804274 RICKMAN_METASTASIS_DN chronic monocytic leukemia DOID_8593 5.187E-04 5.676E-03 5.187E-04 0.02951547 RICKMAN_METASTASIS_DN integumentary system benign neoplasm DOID_0060121 5.812E-04 6.24E-03 0.14974118 0.54617134 RICKMAN_METASTASIS_DN skin benign neoplasm DOID_3165 5.812E-04 6.24E-03 0.14974118 0.54617134 RICKMAN_METASTASIS_DN epidermolysis bullosa DOID_2730 6.212E-04 6.546E-03 6.212E-04 0.03213315 RICKMAN_METASTASIS_DN mitochondrial encephalomyopathy DOID_890 6.212E-04 6.427E-03 0.03672305 0.2862386 RICKMAN_METASTASIS_DN B-cell lymphocytic neoplasm DOID_707 6.494E-04 6.598E-03 0.0123695 0.15300532 RICKMAN_METASTASIS_DN orofacial cleft DOID_0050567 6.853E-04 6.841E-03 6.853E-04 0.03249447 RICKMAN_METASTASIS_DN sarcoidosis DOID_11335 7.225E-04 7.087E-03 1.000 1.000 RICKMAN_METASTASIS_DN leprosy DOID_1024 7.327E-04 7.066E-03 7.327E-04 0.03206775 RICKMAN_METASTASIS_DN vesiculobullous skin disease DOID_2731 7.327E-04 6.948E-03 7.327E-04 0.0297772 RICKMAN_METASTASIS_DN monocytic leukemia DOID_8527 7.327E-04 6.834E-03 7.327E-04 0.02779205 RICKMAN_METASTASIS_DN open-angle glaucoma DOID_1067 8.53E-04 7.829E-03 1.000 1.000 RICKMAN_METASTASIS_DN hypersensitivity reaction type IV disease DOID_2916 9.274E-04 8.376E-03 1.000 1.000 RICKMAN_METASTASIS_DN hemangioma DOID_255 9.823E-04 8.733E-03 0.04569291 0.32499079 RICKMAN_METASTASIS_DN tongue cancer DOID_8649 1.12E-03 9.807E-03 1.000 1.000 RICKMAN_METASTASIS_DN pre-malignant neoplasm DOID_0060071 1.166E-03 0.01005201 0.01809856 0.18723787 RICKMAN_METASTASIS_DN in situ carcinoma DOID_8719 1.166E-03 0.01005201 0.01809856 0.18723787 RICKMAN_METASTASIS_DN basal cell carcinoma DOID_2513 1.267E-03 0.0107608 1.267E-03 0.03794597 RICKMAN_METASTASIS_DN urinary system benign neoplasm DOID_731 1.267E-03 0.01060255 0.05162675 0.33381384 RICKMAN_METASTASIS_DN male reproductive organ benign neoplasm DOID_0060087 1.423E-03 0.01173111 0.05457993 0.34506646 RICKMAN_METASTASIS_DN keratosis DOID_161 1.423E-03 0.01156352 1.423E-03 0.03854506 RICKMAN_METASTASIS_DN skin carcinoma DOID_3451 1.423E-03 0.01140065 1.423E-03 0.03679301 RICKMAN_METASTASIS_DN Down syndrome DOID_14250 1.587E-03 0.0125394 1.587E-03 0.0376182 RICKMAN_METASTASIS_DN pulmonary edema DOID_11396 1.759E-03 0.01371389 0.06045898 0.36211745 RICKMAN_METASTASIS_DN mitochondrial myopathy DOID_699 1.941E-03 0.01492225 0.06338489 0.36430307 RICKMAN_METASTASIS_DN hepatitis B DOID_2043 2.13E-03 0.01616273 0.06630177 0.37352186 RICKMAN_METASTASIS_DN metabolic syndrome X DOID_14221 2.176E-03 0.01629509 0.22578161 0.73411278 RICKMAN_METASTASIS_DN urinary tract obstruction DOID_5200 2.329E-03 0.01720723 0.06920964 0.38233289 RICKMAN_METASTASIS_DN auditory system disease DOID_2742 2.331E-03 0.01700594 0.02836999 0.27360211 RICKMAN_METASTASIS_DN Goodpasture syndrome DOID_9808 2.535E-03 0.01825916 0.07210854 0.38345568 RICKMAN_METASTASIS_DN bronchiolitis DOID_2942 2.973E-03 0.02114599 0.07787949 0.41030956 RICKMAN_METASTASIS_DN cystitis DOID_1679 3.204E-03 0.02250997 1.000 1.000 RICKMAN_METASTASIS_DN papillary adenoma DOID_3172 3.204E-03 0.02223546 0.08075161 0.41770607 RICKMAN_METASTASIS_DN microcystic adenoma DOID_5403 3.204E-03 0.02223546 0.08075161 0.41770607 RICKMAN_METASTASIS_DN follicular adenoma DOID_6204 3.204E-03 0.02223546 0.08075161 0.41770607 RICKMAN_METASTASIS_DN vitiligo DOID_12306 3.444E-03 0.0236094 0.08361486 0.42479336 RICKMAN_METASTASIS_DN dystonia DOID_543 3.444E-03 0.02332833 3.444E-03 0.06321226 RICKMAN_METASTASIS_DN hypersensitivity reaction type I disease DOID_1205 3.503E-03 0.02345106 0.03691991 0.28388419 RICKMAN_METASTASIS_DN invasive ductal carcinoma DOID_3008 3.947E-03 0.02611557 0.08931486 0.42350128 RICKMAN_METASTASIS_DN female reproductive organ benign neoplasm DOID_0060086 4.482E-03 0.02931632 0.0949797 0.43234758 RICKMAN_METASTASIS_DN uterine benign neoplasm DOID_0060095 4.482E-03 0.02931632 0.0949797 0.43234758 RICKMAN_METASTASIS_DN uterine fibroid DOID_13223 4.482E-03 0.02931632 0.0949797 0.43234758 RICKMAN_METASTASIS_DN dysostosis DOID_1934 4.482E-03 0.02898318 4.482E-03 0.07970374 RICKMAN_METASTASIS_DN opportunistic mycosis DOID_2473 4.762E-03 0.03044461 0.097799 0.43817032 RICKMAN_METASTASIS_DN allergic rhinitis DOID_4481 5.049E-03 0.03192321 1.000 1.000 RICKMAN_METASTASIS_DN chronic leukemia DOID_1036 5.345E-03 0.03341809 0.10341151 0.45262422 RICKMAN_METASTASIS_DN chronic lymphocytic leukemia DOID_1040 5.345E-03 0.03341809 0.10341151 0.45262422 RICKMAN_METASTASIS_DN autonomic nervous system neoplasm DOID_2621 5.345E-03 0.03305485 0.10341151 0.44576628 RICKMAN_METASTASIS_DN bladder disease DOID_365 5.345E-03 0.03269942 1.000 1.000 RICKMAN_METASTASIS_DN neuroblastoma DOID_769 5.345E-03 0.03305485 0.10341151 0.44576628 RICKMAN_METASTASIS_DN systemic mycosis DOID_0050136 5.647E-03 0.03418526 0.10620477 0.45436475 RICKMAN_METASTASIS_DN fungal infectious disease DOID_1564 5.647E-03 0.03418526 0.10620477 0.45436475 RICKMAN_METASTASIS_DN myocarditis DOID_820 5.647E-03 0.03382541 0.10620477 0.44763342 RICKMAN_METASTASIS_DN medullomyoblastoma DOID_3861 6.276E-03 0.0372007 6.276E-03 0.10203621 RICKMAN_METASTASIS_DN adult medulloblastoma DOID_3864 6.276E-03 0.0372007 6.276E-03 0.10203621 RICKMAN_METASTASIS_DN childhood medulloblastoma DOID_3869 6.276E-03 0.0372007 6.276E-03 0.10203621 RICKMAN_METASTASIS_DN autosomal recessive nonsyndromic deafness DOID_0050565 6.602E-03 0.03872882 6.602E-03 0.10435265 RICKMAN_METASTASIS_DN pulmonary sarcoidosis DOID_13406 6.936E-03 0.0402696 1.000 1.000 RICKMAN_METASTASIS_DN medulloblastoma DOID_3858 6.936E-03 0.03986283 6.936E-03 0.10666001 RICKMAN_METASTASIS_DN embryonal cancer DOID_688 6.936E-03 0.0394642 6.936E-03 0.10385317 RICKMAN_METASTASIS_DN multiple myeloma DOID_9538 6.936E-03 0.03907347 1.000 1.000 RICKMAN_METASTASIS_DN peripheral nervous system neoplasm DOID_1192 7.277E-03 0.04059229 0.12004215 0.48101398 RICKMAN_METASTASIS_DN adult respiratory distress syndrome DOID_11394 7.981E-03 0.04408831 0.12551744 0.48917415 RICKMAN_METASTASIS_DN lymphatic system disease DOID_75 7.981E-03 0.04366438 7.981E-03 0.11643836 RICKMAN_METASTASIS_DN benign mesothelioma DOID_2645 8.344E-03 0.04521646 0.12824241 0.49639408 RICKMAN_METASTASIS_DN Huntington's disease DOID_12858 9.092E-03 0.04880603 0.1336671 0.50704388 RICKMAN_METASTASIS_DN primitive neuroectodermal tumor DOID_168 9.092E-03 0.0483499 9.092E-03 0.12618145 RICKMAN_METASTASIS_DN uterine cancer DOID_363 9.477E-03 0.04993021 0.13636689 0.51047868 RICKMAN_METASTASIS_DN myeloma DOID_0070004 0.01067466 0.05572367 1.000 1.000 RICKMAN_METASTASIS_DN autoimmune disease of gastrointestinal tract DOID_0060031 0.01150822 0.0595289 0.14974118 0.54969503 RICKMAN_METASTASIS_DN lung small cell carcinoma DOID_5409 0.01150822 0.0589926 0.14974118 0.53925778 RICKMAN_METASTASIS_DN giant cell tumor DOID_200 0.01325811 0.06735595 1.000 1.000 RICKMAN_METASTASIS_DN malignant giant cell tumor DOID_2705 0.01325811 0.06735595 1.000 1.000 RICKMAN_METASTASIS_DN giant cell glioblastoma DOID_3074 0.01325811 0.06735595 1.000 1.000 RICKMAN_METASTASIS_DN atrophic muscular disease DOID_913 0.01325811 0.06675988 0.01325811 0.1605078 RICKMAN_METASTASIS_DN muscular dystrophy DOID_9884 0.01325811 0.06675988 0.01325811 0.1605078 RICKMAN_METASTASIS_DN bile duct adenocarcinoma DOID_4896 0.01371256 0.06844251 1.000 1.000 RICKMAN_METASTASIS_DN cholangiocarcinoma DOID_4947 0.01371256 0.06844251 1.000 1.000 RICKMAN_METASTASIS_DN bone marrow cancer DOID_4960 0.01371256 0.06784736 1.000 1.000 RICKMAN_METASTASIS_DN pustulosis of palm and sole DOID_4398 0.0141737 0.06952445 0.0141737 0.1645885 RICKMAN_METASTASIS_DN mitochondrial metabolism disease DOID_700 0.0146415 0.07120523 0.16812083 0.59049848 RICKMAN_METASTASIS_DN nonsyndromic deafness DOID_0050563 0.01559686 0.07520861 0.01559686 0.17749232 RICKMAN_METASTASIS_DN glioblastoma DOID_3068 0.01559686 0.07457661 1.000 1.000 RICKMAN_METASTASIS_DN bile duct cancer DOID_4606 0.01559686 0.07395513 1.000 1.000 RICKMAN_METASTASIS_DN bile duct carcinoma DOID_4897 0.01559686 0.07395513 1.000 1.000 RICKMAN_METASTASIS_DN neuroectodermal tumor DOID_171 0.01707869 0.08031217 0.01707869 0.19054455 RICKMAN_METASTASIS_DN hypothyroidism DOID_1459 0.01758545 0.08201741 0.01758545 0.18529858 RICKMAN_METASTASIS_DN cholestasis DOID_13580 0.01914363 0.08855874 0.19117405 0.6592608 RICKMAN_METASTASIS_DN hyperglycemia DOID_4195 0.0196755 0.09028515 0.19369608 0.66393416 RICKMAN_METASTASIS_DN astrocytoma DOID_3069 0.02130794 0.09699375 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN endometrial carcinoma DOID_2871 1.283E-07 7.3E-05 9.61E-04 0.18227192 ELVIDGE_HIF1A_TARGETS_DN endometrial cancer DOID_1380 1.651E-07 4.698E-05 1.085E-03 0.15433693 ELVIDGE_HIF1A_TARGETS_DN uterine cancer DOID_363 6.264E-07 1.188E-04 2.066E-03 0.13061816 ELVIDGE_HIF1A_TARGETS_DN uterine disease DOID_345 2.797E-06 3.979E-04 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN glycogen metabolism disorder DOID_0050728 4.741E-06 5.395E-04 4.741E-06 2.698E-03 ELVIDGE_HIF1A_TARGETS_DN glycogen storage disease DOID_2747 4.741E-06 5.395E-04 4.741E-06 2.698E-03 ELVIDGE_HIF1A_TARGETS_DN aneurysm disease DOID_2403 5.102E-06 4.838E-04 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN toxic shock syndrome DOID_14115 6.145E-06 4.995E-04 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN female reproductive system disease DOID_229 6.213E-06 4.419E-04 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN commensal bacterial infectious disease DOID_0050339 6.939E-06 4.387E-04 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN transitional cell carcinoma DOID_2671 8.576E-06 4.88E-04 7.361E-03 0.27922502 ELVIDGE_HIF1A_TARGETS_DN abdominal aortic aneurysm DOID_7693 1.446E-05 7.479E-04 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN hepatitis C DOID_1883 2.051E-05 9.725E-04 0.05139712 0.62223319 ELVIDGE_HIF1A_TARGETS_DN autoimmune disease of urogenital tract DOID_0060049 3.715E-05 1.626E-03 0.06216426 0.63163329 ELVIDGE_HIF1A_TARGETS_DN primary biliary cirrhosis DOID_12236 3.715E-05 1.626E-03 0.06216426 0.63163329 ELVIDGE_HIF1A_TARGETS_DN endometriosis of uterus DOID_288 3.715E-05 1.51E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN nephrotic syndrome DOID_1184 3.971E-05 1.506E-03 1.98E-03 0.16093791 ELVIDGE_HIF1A_TARGETS_DN endometriosis DOID_289 3.971E-05 1.412E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN glaucoma DOID_1686 5.746E-05 1.923E-03 0.07148705 0.62578663 ELVIDGE_HIF1A_TARGETS_DN aortic aneurysm DOID_3627 6.084E-05 1.923E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN Sjogren's syndrome DOID_12894 8.896E-05 2.664E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN hypokalemia DOID_4500 8.896E-05 2.531E-03 0.0141546 0.40269845 ELVIDGE_HIF1A_TARGETS_DN aortic valve insufficiency DOID_57 1.302E-04 3.529E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN lipodystrophy DOID_811 1.302E-04 3.368E-03 0.01696183 0.41962101 ELVIDGE_HIF1A_TARGETS_DN nephrosis DOID_2527 1.648E-04 4.078E-03 5.037E-03 0.22046169 ELVIDGE_HIF1A_TARGETS_DN diabetic retinopathy DOID_8947 1.784E-04 4.23E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN retinal vascular disease DOID_2462 2.66E-04 6.055E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN urinary system benign neoplasm DOID_731 2.671E-04 5.846E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN nervous system cancer DOID_3093 3.136E-04 6.609E-03 0.12304091 0.8643244 ELVIDGE_HIF1A_TARGETS_DN heart septal defect DOID_1681 3.353E-04 6.813E-03 0.02672549 0.54310023 ELVIDGE_HIF1A_TARGETS_DN carbohydrate metabolic disorder DOID_2978 3.446E-04 6.762E-03 3.446E-04 0.0980454 ELVIDGE_HIF1A_TARGETS_DN dilated cardiomyopathy DOID_12930 3.664E-04 6.949E-03 0.12928423 0.89710642 ELVIDGE_HIF1A_TARGETS_DN hepatitis B DOID_2043 4.517E-04 8.29E-03 0.03088073 0.54909791 ELVIDGE_HIF1A_TARGETS_DN muscular atrophy DOID_767 4.517E-04 8.031E-03 0.03088073 0.53245858 ELVIDGE_HIF1A_TARGETS_DN sinusitis DOID_0050127 4.942E-04 8.522E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN paranasal sinus disease DOID_1352 4.942E-04 8.522E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN aortic valve disease DOID_62 5.387E-04 9.015E-03 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN ankylosing spondylitis DOID_7147 6.832E-04 0.01110657 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 9.018E-04 0.01425299 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 9.61E-04 0.0147788 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN uterine benign neoplasm DOID_0060095 9.61E-04 0.0147788 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN uterine fibroid DOID_13223 9.61E-04 0.0147788 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN leiomyoma DOID_127 1.15E-03 0.01721489 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN myocarditis DOID_820 1.216E-03 0.01774397 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN metal metabolism disorder DOID_896 1.216E-03 0.01730037 0.05004272 0.61900672 ELVIDGE_HIF1A_TARGETS_DN medullomyoblastoma DOID_3861 1.355E-03 0.01879984 1.355E-03 0.15415871 ELVIDGE_HIF1A_TARGETS_DN adult medulloblastoma DOID_3864 1.355E-03 0.01879984 1.355E-03 0.15415871 ELVIDGE_HIF1A_TARGETS_DN childhood medulloblastoma DOID_3869 1.355E-03 0.01879984 1.355E-03 0.15415871 ELVIDGE_HIF1A_TARGETS_DN adenoma DOID_657 1.427E-03 0.01932661 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN medulloblastoma DOID_3858 1.5E-03 0.01985258 1.5E-03 0.14227683 ELVIDGE_HIF1A_TARGETS_DN peptic ulcer DOID_750 1.653E-03 0.02137714 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 1.813E-03 0.02292377 0.06082496 0.62926182 ELVIDGE_HIF1A_TARGETS_DN primitive neuroectodermal tumor DOID_168 1.98E-03 0.02449055 1.98E-03 0.14082067 ELVIDGE_HIF1A_TARGETS_DN uveal disease DOID_3480 1.98E-03 0.02396948 0.06350169 0.61241461 ELVIDGE_HIF1A_TARGETS_DN cerebral infarction DOID_3526 2.154E-03 0.02553246 0.06617094 0.62752106 ELVIDGE_HIF1A_TARGETS_DN myeloma DOID_0070004 2.335E-03 0.02711275 0.06883272 0.63170671 ELVIDGE_HIF1A_TARGETS_DN heart valve disease DOID_4079 2.335E-03 0.0265705 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN lung small cell carcinoma DOID_5409 2.523E-03 0.02814595 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN sarcoidosis DOID_11335 2.919E-03 0.03194321 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN giant cell tumor DOID_200 2.919E-03 0.0313405 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN malignant giant cell tumor DOID_2705 2.919E-03 0.0313405 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN giant cell glioblastoma DOID_3074 2.919E-03 0.0313405 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN bone marrow cancer DOID_4960 3.023E-03 0.03184967 0.07809043 0.66318592 ELVIDGE_HIF1A_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 3.128E-03 0.03235793 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN familial hyperlipidemia DOID_1168 3.235E-03 0.03286528 3.235E-03 0.18404558 ELVIDGE_HIF1A_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 3.453E-03 0.03447159 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN glioblastoma DOID_3068 3.453E-03 0.03387725 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN oral cavity cancer DOID_8618 3.453E-03 0.03330306 3.453E-03 0.17862552 ELVIDGE_HIF1A_TARGETS_DN leukocyte disease DOID_9500 3.565E-03 0.03380884 0.08464772 0.68806503 ELVIDGE_HIF1A_TARGETS_DN neuroectodermal tumor DOID_171 3.794E-03 0.03538838 3.794E-03 0.17989091 ELVIDGE_HIF1A_TARGETS_DN collagen disease DOID_854 3.794E-03 0.0348176 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN hypothyroidism DOID_1459 3.911E-03 0.03532057 0.0885601 0.70972809 ELVIDGE_HIF1A_TARGETS_DN pre-malignant neoplasm DOID_0060071 4.029E-03 0.03582262 0.08986057 0.71014811 ELVIDGE_HIF1A_TARGETS_DN congenital heart defect DOID_1682 4.029E-03 0.0352715 0.08986057 0.70042006 ELVIDGE_HIF1A_TARGETS_DN in situ carcinoma DOID_8719 4.029E-03 0.03582262 0.08986057 0.71014811 ELVIDGE_HIF1A_TARGETS_DN mineral metabolism disease DOID_0050032 4.149E-03 0.03577338 0.09115922 0.70094051 ELVIDGE_HIF1A_TARGETS_DN temporal lobe epilepsy DOID_3328 4.395E-03 0.03732318 0.09375108 0.71125816 ELVIDGE_HIF1A_TARGETS_DN brain infarction DOID_3454 4.647E-03 0.03888243 0.09633567 0.72124997 ELVIDGE_HIF1A_TARGETS_DN astrocytoma DOID_3069 4.775E-03 0.03937794 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN cystic fibrosis DOID_1485 5.58E-03 0.04535562 0.10532492 0.77831011 ELVIDGE_HIF1A_TARGETS_DN syndrome DOID_225 5.58E-03 0.0447168 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN mixed glioma DOID_5076 5.861E-03 0.0463169 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN lipid metabolism disorder DOID_3146 6.148E-03 0.04792281 6.148E-03 0.24988322 ELVIDGE_HIF1A_TARGETS_DN focal epilepsy DOID_2234 6.591E-03 0.05068157 0.11422638 0.83326682 ELVIDGE_HIF1A_TARGETS_DN biliary tract cancer DOID_4607 6.591E-03 0.05000581 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN encephalomyelitis DOID_640 8.169E-03 0.06116197 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 8.503E-03 0.06283597 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN arrhythmogenic right ventricular dysplasia DOID_0050431 0.01274804 0.0929953 0.01274804 0.45335211 ELVIDGE_HIF1A_TARGETS_DN rectal neoplasm DOID_1984 0.0141546 0.09943171 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN rectum cancer DOID_1993 0.0141546 0.09943171 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN acute kidney failure DOID_3021 0.0141546 0.09821913 0.0141546 0.44744272 ELVIDGE_HIF1A_TARGETS_DN teratoma DOID_3307 0.0141546 0.09703577 0.0141546 0.4238931 ELVIDGE_HIF1A_TARGETS_DN insulinoma DOID_3892 0.0141546 0.09588058 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN malignant teratoma DOID_5563 0.0141546 0.09703577 0.0141546 0.4238931 ELVIDGE_HIF1A_TARGETS_DN mature teratoma DOID_5566 0.0141546 0.09703577 0.0141546 0.4238931 ELVIDGE_HIF1A_TARGETS_DN polycythemia DOID_8432 0.0141546 0.09475258 0.0141546 0.38352233 ELVIDGE_HIF1A_TARGETS_DN migraine without aura DOID_12783 0.0155592 0.09947399 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN temporal arteritis DOID_13375 0.0155592 0.09836872 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN central nervous system vasculitis DOID_525 0.0155592 0.09836872 1.000 1.000 ELVIDGE_HIF1A_TARGETS_DN bronchiectasis DOID_9563 0.0155592 0.09728775 0.0155592 0.4024175 ELVIDGE_HIF1A_TARGETS_DN encephalitis DOID_9588 0.01696183 0.09949777 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN toxic shock syndrome DOID_14115 8.257E-10 4.698E-07 1.164E-07 6.621E-05 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN commensal bacterial infectious disease DOID_0050339 1.021E-09 2.904E-07 1.373E-07 3.907E-05 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN aneurysm disease DOID_2403 3.25E-07 6.164E-05 1.285E-05 1.462E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN endometrial carcinoma DOID_2871 3.277E-07 4.661E-05 2.637E-05 2.501E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN abdominal aortic aneurysm DOID_7693 3.724E-07 4.238E-05 2.897E-05 2.061E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN endometrial cancer DOID_1380 4.214E-07 3.997E-05 3.174E-05 2.006E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN nervous system cancer DOID_3093 6.965E-07 5.662E-05 0.01195989 0.12373051 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN nephrotic syndrome DOID_1184 1.459E-06 1.038E-04 7.928E-05 4.511E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN uterine cancer DOID_363 1.593E-06 1.007E-04 8.457E-05 4.375E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN aortic aneurysm DOID_3627 2.594E-06 1.476E-04 1.212E-04 5.307E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN giant cell tumor DOID_200 3.24E-06 1.676E-04 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN malignant giant cell tumor DOID_2705 3.24E-06 1.676E-04 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN giant cell glioblastoma DOID_3074 3.24E-06 1.676E-04 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN glioblastoma DOID_3068 4.573E-06 2.168E-04 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN uterine disease DOID_345 7.069E-06 3.094E-04 6.691E-03 0.07931186 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN hepatitis B DOID_2043 8.294E-06 3.371E-04 8.294E-06 1.573E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN astrocytoma DOID_3069 8.882E-06 3.369E-04 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN glycogen metabolism disorder DOID_0050728 9.526E-06 3.388E-04 9.526E-06 1.355E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN glycogen storage disease DOID_2747 9.526E-06 3.388E-04 9.526E-06 1.355E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN nephrosis DOID_2527 9.907E-06 3.316E-04 3.266E-04 0.01161465 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN aortic valve disease DOID_62 1.087E-05 3.437E-04 0.04218433 0.26090092 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN diabetic retinopathy DOID_8947 1.102E-05 3.299E-04 8.294E-03 0.09631083 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN female reproductive system disease DOID_229 1.563E-05 4.447E-04 9.824E-03 0.10960293 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN retinal vascular disease DOID_2462 1.883E-05 5.103E-04 0.01075003 0.11327344 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN transitional cell carcinoma DOID_2671 2.153E-05 5.569E-04 5.799E-04 0.01736621 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN carbohydrate metabolic disorder DOID_2978 2.665E-05 6.592E-04 2.665E-05 2.166E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN dilated cardiomyopathy DOID_12930 2.892E-05 6.857E-04 7.213E-04 0.01954348 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN hepatitis C DOID_1883 4.105E-05 9.343E-04 2.027E-03 0.03977756 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN spindle cell carcinoma DOID_4015 4.105E-05 8.983E-04 0.06429698 0.30743683 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN peptic ulcer DOID_750 6.026E-05 1.27E-03 0.07266724 0.32815605 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 6.934E-05 1.409E-03 0.07599465 0.33008365 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN endometriosis of uterus DOID_288 7.42E-05 1.456E-03 0.07765395 0.33473557 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN primitive neuroectodermal tumor DOID_168 7.928E-05 1.504E-03 3.118E-03 0.05068942 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN endometriosis DOID_289 7.928E-05 1.455E-03 0.0793103 0.3318203 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN cerebral infarction DOID_3526 9.009E-05 1.602E-03 9.009E-05 4.272E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN pre-eclampsia DOID_10591 1.018E-04 1.756E-03 3.673E-03 0.05500367 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN brain cancer DOID_1319 1.018E-04 1.704E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN heart valve disease DOID_4079 1.018E-04 1.656E-03 0.08590646 0.34914841 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN central nervous system cancer DOID_3620 1.081E-04 1.708E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN bone marrow cancer DOID_4960 1.507E-04 2.317E-03 4.747E-03 0.06588407 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN aortic valve stenosis DOID_1712 2.068E-04 3.097E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN aortic valve insufficiency DOID_57 2.068E-04 3.017E-03 0.02131608 0.18102763 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN lipodystrophy DOID_811 2.068E-04 2.942E-03 2.068E-04 8.405E-03 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN neuroectodermal tumor DOID_171 2.126E-04 2.951E-03 5.948E-03 0.07521507 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN collagen disease DOID_854 2.126E-04 2.88E-03 0.10862843 0.40664196 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN respiratory failure DOID_11162 2.226E-04 2.946E-03 0.11022997 0.4099402 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN hypothyroidism DOID_1459 2.226E-04 2.879E-03 6.13E-03 0.07582841 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN pre-malignant neoplasm DOID_0060071 2.329E-04 2.945E-03 0.11182867 0.41318513 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN congenital heart defect DOID_1682 2.329E-04 2.881E-03 6.315E-03 0.07644614 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN in situ carcinoma DOID_8719 2.329E-04 2.945E-03 0.11182867 0.41318513 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN brain infarction DOID_3454 2.891E-04 3.5E-03 2.891E-04 0.01096534 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN pancreatic ductal carcinoma DOID_3587 3.138E-04 3.719E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN pancreatic carcinoma DOID_4905 3.533E-04 4.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN angiosarcoma DOID_0001816 3.743E-04 4.259E-03 0.02832146 0.21203832 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN mixed glioma DOID_5076 4.108E-04 4.583E-03 0.1339155 0.45902362 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN bronchitis DOID_6132 4.237E-04 4.636E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN urinary system benign neoplasm DOID_731 4.237E-04 4.549E-03 4.237E-04 0.01418104 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN heart septal defect DOID_1681 5.315E-04 5.6E-03 5.315E-04 0.01680099 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN subependymal glioma DOID_4843 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN pilocytic astrocytoma DOID_4851 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN subependymal giant cell astrocytoma DOID_5077 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN fibrillary astrocytoma DOID_6726 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN juvenile pilocytic astrocytoma DOID_6811 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN childhood pilocytic astrocytoma DOID_6812 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN gemistocytic astrocytoma DOID_7005 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN childhood cerebral astrocytoma DOID_7007 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN protoplasmic astrocytoma DOID_7008 5.899E-04 6.102E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN benign glioma DOID_0060101 7.155E-04 7.27E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN gastric ulcer DOID_10808 7.155E-04 7.142E-03 0.03873699 0.25930999 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN benign ependymoma DOID_4844 7.155E-04 7.27E-03 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN muscular atrophy DOID_767 7.155E-04 7.019E-03 7.155E-04 0.02035559 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN sinusitis DOID_0050127 7.827E-04 7.549E-03 7.827E-04 0.020244 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN paranasal sinus disease DOID_1352 7.827E-04 7.549E-03 7.827E-04 0.020244 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN portal hypertension DOID_10762 1.002E-03 9.502E-03 0.04561949 0.2703905 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN osteosarcoma DOID_3347 1.002E-03 9.346E-03 0.04561949 0.26760297 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN lung adenocarcinoma DOID_3910 1.247E-03 0.01144763 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN sarcoma DOID_1115 1.335E-03 0.01205667 0.05245342 0.27893456 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN hepatic vascular disease DOID_272 1.335E-03 0.01186829 0.05245342 0.27381649 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN supratentorial cancer DOID_1659 1.425E-03 0.01247716 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN cerebrum cancer DOID_368 1.425E-03 0.01247716 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN focal glomerulosclerosis DOID_3945 1.425E-03 0.01228811 1.425E-03 0.03526154 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 1.519E-03 0.01289676 1.519E-03 0.03600344 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN uterine benign neoplasm DOID_0060095 1.519E-03 0.01289676 1.519E-03 0.03600344 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN uterine fibroid DOID_13223 1.519E-03 0.01289676 1.519E-03 0.03600344 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN congenital disorder of glycosylation DOID_5212 1.519E-03 0.0127071 1.519E-03 0.0345633 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN leiomyoma DOID_127 1.815E-03 0.01497043 1.815E-03 0.03972922 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN myocarditis DOID_820 1.92E-03 0.01560654 1.92E-03 0.0404614 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN metal metabolism disorder DOID_896 1.92E-03 0.01538673 1.92E-03 0.03901635 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN pneumoconiosis DOID_10316 2.027E-03 0.01602152 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN medullomyoblastoma DOID_3861 2.137E-03 0.01666066 2.137E-03 0.04054095 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN adult medulloblastoma DOID_3864 2.137E-03 0.01666066 2.137E-03 0.04054095 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN childhood medulloblastoma DOID_3869 2.137E-03 0.01666066 2.137E-03 0.04054095 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN adenoma DOID_657 2.25E-03 0.01730391 2.25E-03 0.0413061 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN medulloblastoma DOID_3858 2.366E-03 0.01795102 2.366E-03 0.0420727 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN adult respiratory distress syndrome DOID_11394 2.73E-03 0.02043733 0.07433242 0.33303267 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN lymphatic system disease DOID_75 2.73E-03 0.02017191 0.07433242 0.3253473 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN benign mesothelioma DOID_2645 2.856E-03 0.02083746 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN autoimmune disease of urogenital tract DOID_0060049 2.986E-03 0.02150576 2.986E-03 0.05148348 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN primary biliary cirrhosis DOID_12236 2.986E-03 0.02150576 2.986E-03 0.05148348 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN spinocerebellar ataxia DOID_1441 2.986E-03 0.02123694 2.986E-03 0.04996926 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN influenza DOID_8469 3.253E-03 0.02284989 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN spinocerebellar degeneration DOID_2478 3.53E-03 0.02449819 3.53E-03 0.05580143 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN proteinuria DOID_576 3.53E-03 0.02420303 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN myeloma DOID_0070004 3.673E-03 0.02488261 3.673E-03 0.05649025 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN vascular skin disease DOID_9540 3.673E-03 0.02458988 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN hemolytic anemia DOID_583 3.819E-03 0.02526676 3.819E-03 0.05571645 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN normocytic anemia DOID_720 3.819E-03 0.02526676 3.819E-03 0.05571645 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN glaucoma DOID_1686 3.967E-03 0.02594543 3.967E-03 0.05643131 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN lung small cell carcinoma DOID_5409 3.967E-03 0.0256506 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN sarcoidosis DOID_11335 4.586E-03 0.02931994 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN vasculitis DOID_865 4.747E-03 0.03001386 0.09733789 0.3819673 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 4.911E-03 0.03070874 4.911E-03 0.06653561 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN familial hyperlipidemia DOID_1168 5.078E-03 0.03140451 5.078E-03 0.06719104 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 5.418E-03 0.03315099 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN oral cavity cancer DOID_8618 5.418E-03 0.03279832 5.418E-03 0.07006915 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN leukocyte disease DOID_9500 5.593E-03 0.03349622 0.10541684 0.39723299 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN cholestasis DOID_13580 6.691E-03 0.03965593 0.11501758 0.41684714 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN temporal lobe epilepsy DOID_3328 6.882E-03 0.04037214 0.1166078 0.41993569 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN tuberculosis DOID_399 7.273E-03 0.04223045 0.1197798 0.42596693 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN bile duct disease DOID_4138 7.878E-03 0.04528091 0.12451678 0.44006241 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN peripheral vascular disease DOID_341 8.085E-03 0.0460033 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN biliary tract disease DOID_9741 8.085E-03 0.04554782 0.12609018 0.44287231 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN syndrome DOID_225 8.719E-03 0.04863874 0.1307937 0.45379032 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN pancreatitis DOID_4989 9.154E-03 0.05056827 0.1339155 0.46180559 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN lipid metabolism disorder DOID_3146 9.598E-03 0.0525128 9.598E-03 0.10922662 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN focal epilepsy DOID_2234 0.01028225 0.05571999 0.14167177 0.47698959 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN chronic kidney failure DOID_784 0.01028225 0.05519433 0.01028225 0.11251152 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN bone development disease DOID_0080006 0.01051497 0.05591608 0.01051497 0.11288718 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN primary bacterial infectious disease DOID_0050338 0.01122708 0.05915008 0.14782748 0.49478727 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 0.01195989 0.06243283 0.15241569 0.50129786 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN encephalomyelitis DOID_640 0.01271317 0.06576178 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN Crohn's disease DOID_8778 0.01296877 0.06647958 0.15849547 0.51240864 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN arrhythmogenic right ventricular dysplasia DOID_0050431 0.01602941 0.08143514 0.01602941 0.16287028 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN Sjogren's syndrome DOID_12894 0.01779476 0.08960368 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN angioedema DOID_1558 0.01779476 0.08881768 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN ventricular septal defect DOID_1657 0.01779476 0.08804535 0.01779476 0.17763536 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN retinal vascular occlusion DOID_1729 0.01779476 0.08728634 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN rectal neoplasm DOID_1984 0.01779476 0.0865403 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN rectum cancer DOID_1993 0.01779476 0.0865403 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN acute kidney failure DOID_3021 0.01779476 0.08580691 0.01779476 0.17457268 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN teratoma DOID_3307 0.01779476 0.08508585 0.01779476 0.17161382 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN insulinoma DOID_3892 0.01779476 0.0843768 0.01779476 0.16875359 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN hypokalemia DOID_4500 0.01779476 0.08367947 0.01779476 0.16598714 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN keratitis DOID_4677 0.01779476 0.08299357 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN malignant teratoma DOID_5563 0.01779476 0.08508585 0.01779476 0.17161382 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN mature teratoma DOID_5566 0.01779476 0.08508585 0.01779476 0.17161382 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN polycythemia DOID_8432 0.01779476 0.08231883 0.01779476 0.16330993 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 0.01955698 0.08974129 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN breast benign neoplasm DOID_0060082 0.01955698 0.08902336 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN thoracic benign neoplasm DOID_0060097 0.01955698 0.08902336 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN trypanosomiasis DOID_10113 0.01955698 0.08831682 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN migraine without aura DOID_12783 0.01955698 0.08762141 0.01955698 0.17663365 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN temporal arteritis DOID_13375 0.01955698 0.08693687 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN benign breast phyllodes tumor DOID_1631 0.01955698 0.08902336 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN central nervous system vasculitis DOID_525 0.01955698 0.08693687 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN bronchiectasis DOID_9563 0.01955698 0.08626294 0.01955698 0.17387375 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN familial atrial fibrillation DOID_0050650 0.02131608 0.09329885 0.02131608 0.18659771 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN islet cell tumor DOID_1799 0.02131608 0.09258665 0.02131608 0.18377047 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN stomach disease DOID_76 0.02131608 0.09188524 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN peritonitis DOID_8283 0.02131608 0.09119437 0.02131608 0.17836546 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN encephalitis DOID_9588 0.02131608 0.09051381 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN leprosy DOID_1024 0.02307208 0.09724454 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN berylliosis DOID_10322 0.02307208 0.09652951 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN newborn respiratory distress syndrome DOID_12716 0.02307208 0.09582491 0.02307208 0.19026106 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN polyneuropathy DOID_1389 0.02307208 0.09513053 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN larynx cancer DOID_2596 0.02307208 0.09444614 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN laryngeal benign neoplasm DOID_2598 0.02307208 0.09444614 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN Leydig cell tumor DOID_2696 0.02307208 0.09377152 0.02307208 0.18754304 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN sex cord-stromal neoplasm DOID_4757 0.02307208 0.09377152 0.02307208 0.18754304 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN rhabdomyosarcoma DOID_3247 0.02482497 0.09947471 1.000 1.000 ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN narcolepsy DOID_8986 0.02482497 0.09877908 1.000 1.000 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP synostosis DOID_11971 4.584E-05 0.02608322 4.584E-05 0.02608322 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP dysostosis DOID_1934 8.222E-05 0.02339099 8.222E-05 0.02339099 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP calcinosis DOID_182 1.29E-04 0.02447457 1.29E-04 0.02447457 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP endometriosis DOID_289 1.71E-04 0.02432096 0.01924199 0.33177852 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP calcium metabolism disease DOID_10575 2.272E-04 0.02586017 2.272E-04 0.03232521 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP atrophic muscular disease DOID_913 2.538E-04 0.02406584 2.538E-04 0.02887901 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP muscular dystrophy DOID_9884 2.538E-04 0.02406584 2.538E-04 0.02887901 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP pre-malignant neoplasm DOID_0060071 3.526E-04 0.02866105 3.526E-04 0.03343789 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP congenital heart defect DOID_1682 3.526E-04 0.02507842 3.526E-04 0.02866105 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP in situ carcinoma DOID_8719 3.526E-04 0.02866105 3.526E-04 0.03343789 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP mineral metabolism disease DOID_0050032 3.634E-04 0.02297218 3.634E-04 0.0258437 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP female reproductive system disease DOID_229 5.571E-04 0.03169628 0.03446677 0.38454102 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP bone development disease DOID_0080006 5.979E-04 0.03092577 5.979E-04 0.03779816 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP transitional cell carcinoma DOID_2671 6.545E-04 0.03103271 6.545E-04 0.03723926 MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP dilated cardiomyopathy DOID_12930 7.595E-04 0.03324454 7.595E-04 0.039289 RUTELLA_RESPONSE_TO_HGF_UP primary bacterial infectious disease DOID_0050338 5.743E-19 3.268E-16 2.626E-03 0.04393855 RUTELLA_RESPONSE_TO_HGF_UP hypersensitivity reaction type I disease DOID_1205 2.466E-18 7.016E-16 2.245E-07 6.388E-05 RUTELLA_RESPONSE_TO_HGF_UP bacterial pneumonia DOID_874 3.754E-18 7.121E-16 0.09346025 0.31466795 RUTELLA_RESPONSE_TO_HGF_UP tuberculosis DOID_399 2.358E-17 3.355E-15 0.01079219 0.09594936 RUTELLA_RESPONSE_TO_HGF_UP aneurysm disease DOID_2403 1.165E-16 1.326E-14 1.698E-03 0.03716198 RUTELLA_RESPONSE_TO_HGF_UP retinal vascular disease DOID_2462 4.84E-16 4.59E-14 2.501E-04 8.371E-03 RUTELLA_RESPONSE_TO_HGF_UP diabetic retinopathy DOID_8947 2.384E-15 1.938E-13 1.472E-03 0.0348945 RUTELLA_RESPONSE_TO_HGF_UP pulmonary emphysema DOID_9675 3.804E-15 2.706E-13 0.03244506 0.19432882 RUTELLA_RESPONSE_TO_HGF_UP influenza DOID_8469 8.495E-15 5.371E-13 0.26096644 0.57111502 RUTELLA_RESPONSE_TO_HGF_UP pulmonary tuberculosis DOID_2957 2.864E-14 1.63E-12 0.04399432 0.23615818 RUTELLA_RESPONSE_TO_HGF_UP sarcoidosis DOID_11335 6.904E-14 3.571E-12 5.614E-03 0.06263584 RUTELLA_RESPONSE_TO_HGF_UP multiple myeloma DOID_9538 6.961E-14 3.301E-12 2.157E-03 0.04091276 RUTELLA_RESPONSE_TO_HGF_UP hypersensitivity reaction type IV disease DOID_2916 1.885E-13 8.25E-12 7.12E-03 0.0723491 RUTELLA_RESPONSE_TO_HGF_UP uveal disease DOID_3480 3.237E-13 1.316E-11 3.222E-03 0.04471547 RUTELLA_RESPONSE_TO_HGF_UP parasitic infectious disease DOID_1398 6.644E-13 2.52E-11 0.07076014 0.28758943 RUTELLA_RESPONSE_TO_HGF_UP myeloma DOID_0070004 7.976E-13 2.836E-11 4.083E-03 0.04942791 RUTELLA_RESPONSE_TO_HGF_UP encephalomyelitis DOID_640 1.251E-12 4.188E-11 0.02338087 0.15469434 RUTELLA_RESPONSE_TO_HGF_UP systemic mycosis DOID_0050136 1.275E-12 4.029E-11 8.256E-05 5.219E-03 RUTELLA_RESPONSE_TO_HGF_UP fungal infectious disease DOID_1564 1.275E-12 4.029E-11 8.256E-05 5.219E-03 RUTELLA_RESPONSE_TO_HGF_UP aortic aneurysm DOID_3627 1.489E-12 4.459E-11 0.04553089 0.24212223 RUTELLA_RESPONSE_TO_HGF_UP sphingolipidosis DOID_1927 2.499E-12 7.109E-11 1.043E-08 5.932E-06 RUTELLA_RESPONSE_TO_HGF_UP bone marrow cancer DOID_4960 3.224E-12 8.736E-11 5.898E-03 0.06332349 RUTELLA_RESPONSE_TO_HGF_UP vasculitis DOID_865 3.224E-12 8.339E-11 0.0518699 0.2635176 RUTELLA_RESPONSE_TO_HGF_UP pulmonary sarcoidosis DOID_13406 3.62E-12 8.957E-11 2.157E-03 0.04232355 RUTELLA_RESPONSE_TO_HGF_UP uveitis DOID_13141 4.613E-12 1.094E-10 0.02847667 0.17422821 RUTELLA_RESPONSE_TO_HGF_UP carotid artery disease DOID_3407 1.087E-11 2.475E-10 7.739E-04 0.02001564 RUTELLA_RESPONSE_TO_HGF_UP mineral metabolism disease DOID_0050032 1.751E-11 3.832E-10 0.06896121 0.28434004 RUTELLA_RESPONSE_TO_HGF_UP opportunistic mycosis DOID_2473 3.069E-11 6.468E-10 5.822E-05 4.733E-03 RUTELLA_RESPONSE_TO_HGF_UP abdominal aortic aneurysm DOID_7693 3.069E-11 6.237E-10 0.01895833 0.1348411 RUTELLA_RESPONSE_TO_HGF_UP parasitic protozoa infectious disease DOID_2789 1.276E-10 2.503E-09 0.3115025 0.65646268 RUTELLA_RESPONSE_TO_HGF_UP contact dermatitis DOID_2773 1.389E-10 2.634E-09 1.895E-04 7.704E-03 RUTELLA_RESPONSE_TO_HGF_UP lipid metabolism disorder DOID_3146 1.389E-10 2.549E-09 1.03E-06 1.953E-04 RUTELLA_RESPONSE_TO_HGF_UP chronic kidney failure DOID_784 1.997E-10 3.552E-09 2.221E-03 0.04076636 RUTELLA_RESPONSE_TO_HGF_UP respiratory syncytial virus infectious disease DOID_1273 2.483E-10 4.281E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP intracranial arterial disease DOID_13089 3.033E-10 5.077E-09 0.03109927 0.18824981 RUTELLA_RESPONSE_TO_HGF_UP cerebral arterial disease DOID_3527 3.033E-10 5.077E-09 0.03109927 0.18824981 RUTELLA_RESPONSE_TO_HGF_UP respiratory failure DOID_11162 3.683E-10 5.987E-09 0.06541009 0.28410946 RUTELLA_RESPONSE_TO_HGF_UP intracranial aneurysm DOID_10941 4.304E-10 6.802E-09 7.569E-04 0.020508 RUTELLA_RESPONSE_TO_HGF_UP cholestasis DOID_13580 5.584E-10 8.587E-09 9.596E-03 0.09254792 RUTELLA_RESPONSE_TO_HGF_UP allergic contact dermatitis DOID_3042 7.287E-10 1.091E-08 1.084E-03 0.02681262 RUTELLA_RESPONSE_TO_HGF_UP bile duct disease DOID_4138 1.211E-09 1.767E-08 0.01207043 0.10406177 RUTELLA_RESPONSE_TO_HGF_UP biliary tract disease DOID_9741 1.369E-09 1.947E-08 0.01251498 0.10628394 RUTELLA_RESPONSE_TO_HGF_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.498E-09 2.079E-08 3.501E-04 0.01048605 RUTELLA_RESPONSE_TO_HGF_UP leishmaniasis DOID_9065 1.65E-09 2.235E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP calcium metabolism disease DOID_10575 1.755E-09 2.322E-08 0.28897297 0.62047404 RUTELLA_RESPONSE_TO_HGF_UP cystic fibrosis DOID_1485 1.955E-09 2.528E-08 0.39473042 0.8021486 RUTELLA_RESPONSE_TO_HGF_UP bone resorption disease DOID_0080011 2.194E-09 2.774E-08 1.698E-03 0.03864846 RUTELLA_RESPONSE_TO_HGF_UP osteoporosis DOID_11476 2.194E-09 2.774E-08 1.698E-03 0.03864846 RUTELLA_RESPONSE_TO_HGF_UP pleural disease DOID_1532 2.353E-09 2.91E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP atopic dermatitis DOID_3310 2.384E-09 2.886E-08 0.04866248 0.25637915 RUTELLA_RESPONSE_TO_HGF_UP pancreatitis DOID_4989 2.458E-09 2.914E-08 0.01487745 0.11757321 RUTELLA_RESPONSE_TO_HGF_UP mixed glioma DOID_5076 2.458E-09 2.854E-08 0.01487745 0.11596262 RUTELLA_RESPONSE_TO_HGF_UP cutaneous leishmaniasis DOID_9111 2.549E-09 2.901E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP giant cell tumor DOID_200 2.766E-09 3.086E-08 0.05025686 0.26235003 RUTELLA_RESPONSE_TO_HGF_UP malignant giant cell tumor DOID_2705 2.766E-09 3.086E-08 0.05025686 0.26235003 RUTELLA_RESPONSE_TO_HGF_UP giant cell glioblastoma DOID_3074 2.766E-09 3.086E-08 0.05025686 0.26235003 RUTELLA_RESPONSE_TO_HGF_UP myocarditis DOID_820 2.905E-09 3.178E-08 0.02233908 0.15132067 RUTELLA_RESPONSE_TO_HGF_UP periodontal disease DOID_3388 3.563E-09 3.825E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP biliary tract cancer DOID_4607 4.244E-09 4.472E-08 0.01747482 0.1291321 RUTELLA_RESPONSE_TO_HGF_UP temporal arteritis DOID_13375 4.648E-09 4.809E-08 0.06829919 0.28786845 RUTELLA_RESPONSE_TO_HGF_UP central nervous system vasculitis DOID_525 4.648E-09 4.809E-08 0.06829919 0.28786845 RUTELLA_RESPONSE_TO_HGF_UP hypertrophic cardiomyopathy DOID_11984 5.578E-09 5.668E-08 4.61E-05 6.557E-03 RUTELLA_RESPONSE_TO_HGF_UP glioblastoma DOID_3068 5.578E-09 5.568E-08 0.05850258 0.28451257 RUTELLA_RESPONSE_TO_HGF_UP calcinosis DOID_182 6.347E-09 6.227E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP common cold DOID_10459 7.927E-09 7.645E-08 2.588E-03 0.0460263 RUTELLA_RESPONSE_TO_HGF_UP Goodpasture syndrome DOID_9808 7.966E-09 7.555E-08 0.14305034 0.39899825 RUTELLA_RESPONSE_TO_HGF_UP systemic scleroderma DOID_418 9.085E-09 8.474E-08 0.23679039 0.5325444 RUTELLA_RESPONSE_TO_HGF_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.257E-08 1.154E-07 0.0240238 0.15359034 RUTELLA_RESPONSE_TO_HGF_UP carotid stenosis DOID_13001 1.281E-08 1.157E-07 3.046E-03 0.04561294 RUTELLA_RESPONSE_TO_HGF_UP rheumatic disease DOID_1575 1.764E-08 1.568E-07 0.25619303 0.56721337 RUTELLA_RESPONSE_TO_HGF_UP scleroderma DOID_419 1.764E-08 1.568E-07 0.25619303 0.56721337 RUTELLA_RESPONSE_TO_HGF_UP brain infarction DOID_3454 1.907E-08 1.67E-07 0.01079219 0.09747236 RUTELLA_RESPONSE_TO_HGF_UP viral pneumonia DOID_10533 1.983E-08 1.71E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP aspergillosis DOID_13564 1.983E-08 1.684E-07 8.986E-05 5.113E-03 RUTELLA_RESPONSE_TO_HGF_UP diabetic autonomic neuropathy DOID_11503 2.061E-08 1.725E-07 2.365E-04 8.412E-03 RUTELLA_RESPONSE_TO_HGF_UP autonomic neuropathy DOID_11504 2.061E-08 1.725E-07 2.365E-04 8.412E-03 RUTELLA_RESPONSE_TO_HGF_UP diabetic polyneuropathy DOID_12785 2.061E-08 1.725E-07 2.365E-04 8.412E-03 RUTELLA_RESPONSE_TO_HGF_UP gallbladder cancer DOID_3121 2.061E-08 1.7E-07 0.03661627 0.21479027 RUTELLA_RESPONSE_TO_HGF_UP diabetic neuropathy DOID_9743 2.061E-08 1.725E-07 2.365E-04 8.412E-03 RUTELLA_RESPONSE_TO_HGF_UP astrocytoma DOID_3069 2.134E-08 1.735E-07 0.07810545 0.29826845 RUTELLA_RESPONSE_TO_HGF_UP pancreatic ductal carcinoma DOID_3587 2.383E-08 1.91E-07 1.093E-04 5.656E-03 RUTELLA_RESPONSE_TO_HGF_UP periodontitis DOID_824 2.737E-08 2.163E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP autonomic nervous system disease DOID_11465 3.22E-08 2.51E-07 3.009E-04 9.511E-03 RUTELLA_RESPONSE_TO_HGF_UP heart valve disease DOID_4079 3.22E-08 2.476E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP pancreatic carcinoma DOID_4905 3.288E-08 2.495E-07 1.324E-04 6.278E-03 RUTELLA_RESPONSE_TO_HGF_UP pleurisy DOID_10247 3.403E-08 2.548E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP glaucoma DOID_1686 4.266E-08 3.153E-07 3.501E-04 9.962E-03 RUTELLA_RESPONSE_TO_HGF_UP bronchiolitis obliterans DOID_2799 6.247E-08 4.557E-07 0.19127183 0.46115964 RUTELLA_RESPONSE_TO_HGF_UP allergic rhinitis DOID_4481 7.545E-08 5.434E-07 0.1964601 0.46968821 RUTELLA_RESPONSE_TO_HGF_UP transitional cell carcinoma DOID_2671 1.252E-07 8.902E-07 0.11373861 0.35755397 RUTELLA_RESPONSE_TO_HGF_UP oral cavity cancer DOID_8618 1.325E-07 9.306E-07 4.61E-05 5.246E-03 RUTELLA_RESPONSE_TO_HGF_UP Human immunodeficiency virus infectious disease DOID_526 1.486E-07 1.031E-06 0.02150918 0.14745449 RUTELLA_RESPONSE_TO_HGF_UP collagen disease DOID_854 1.856E-07 1.272E-06 0.33760137 0.6934844 RUTELLA_RESPONSE_TO_HGF_UP autoimmune hepatitis DOID_2048 1.943E-07 1.316E-06 7.929E-03 0.07915452 RUTELLA_RESPONSE_TO_HGF_UP mouth disease DOID_403 2.071E-07 1.387E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP IgA glomerulonephritis DOID_2986 3.179E-07 2.104E-06 0.13751869 0.39320672 RUTELLA_RESPONSE_TO_HGF_UP adult respiratory distress syndrome DOID_11394 3.259E-07 2.131E-06 0.2416878 0.54141873 RUTELLA_RESPONSE_TO_HGF_UP chondrosarcoma DOID_3371 3.355E-07 2.169E-06 1.78E-03 0.03750886 RUTELLA_RESPONSE_TO_HGF_UP tooth disease DOID_1091 3.466E-07 2.216E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP acute pancreatitis DOID_2913 4.968E-07 3.141E-06 0.14854665 0.41030604 RUTELLA_RESPONSE_TO_HGF_UP cerebral infarction DOID_3526 6.387E-07 3.993E-06 0.03805016 0.22092386 RUTELLA_RESPONSE_TO_HGF_UP proteinuria DOID_576 7.239E-07 4.477E-06 0.03950523 0.22255917 RUTELLA_RESPONSE_TO_HGF_UP encephalitis DOID_9588 7.829E-07 4.79E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP pre-eclampsia DOID_10591 8.182E-07 4.953E-06 0.04098117 0.22861062 RUTELLA_RESPONSE_TO_HGF_UP brain cancer DOID_1319 8.182E-07 4.901E-06 0.27510439 0.59974866 RUTELLA_RESPONSE_TO_HGF_UP middle cerebral artery infarction DOID_3525 9.046E-07 5.362E-06 0.16482583 0.43021053 RUTELLA_RESPONSE_TO_HGF_UP extrinsic allergic alveolitis DOID_841 9.046E-07 5.307E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP central nervous system cancer DOID_3620 9.224E-07 5.355E-06 0.27975693 0.60296095 RUTELLA_RESPONSE_TO_HGF_UP integumentary system benign neoplasm DOID_0060121 1.037E-06 5.961E-06 4.561E-03 0.05406187 RUTELLA_RESPONSE_TO_HGF_UP skin benign neoplasm DOID_3165 1.037E-06 5.961E-06 4.561E-03 0.05406187 RUTELLA_RESPONSE_TO_HGF_UP larynx cancer DOID_2596 1.125E-06 6.402E-06 0.08020845 0.29255519 RUTELLA_RESPONSE_TO_HGF_UP laryngeal benign neoplasm DOID_2598 1.125E-06 6.402E-06 0.08020845 0.29255519 RUTELLA_RESPONSE_TO_HGF_UP autoimmune disease of cardiovascular system DOID_0060051 1.298E-06 7.313E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP Behcet's disease DOID_13241 1.298E-06 7.313E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP focal glomerulosclerosis DOID_3945 1.54E-06 8.589E-06 0.18079502 0.44727115 RUTELLA_RESPONSE_TO_HGF_UP thoracic aortic aneurysm DOID_14004 2.126E-06 1.175E-05 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP dilated cardiomyopathy DOID_12930 3.207E-06 1.755E-05 0.02467624 0.15600866 RUTELLA_RESPONSE_TO_HGF_UP pneumoconiosis DOID_10316 3.828E-06 2.074E-05 0.21182683 0.49805565 RUTELLA_RESPONSE_TO_HGF_UP hepatitis C DOID_1883 3.828E-06 2.055E-05 0.02351728 0.15380842 RUTELLA_RESPONSE_TO_HGF_UP uterine disease DOID_345 5.119E-06 2.722E-05 9.596E-03 0.09100546 RUTELLA_RESPONSE_TO_HGF_UP endocrine organ benign neoplasm DOID_0060089 6.591E-06 3.473E-05 0.01079219 0.0990445 RUTELLA_RESPONSE_TO_HGF_UP pulmonary edema DOID_11396 7.36E-06 3.842E-05 0.12070949 0.37126325 RUTELLA_RESPONSE_TO_HGF_UP adenoid cystic carcinoma DOID_4866 8.192E-06 4.238E-05 1.67E-04 7.309E-03 RUTELLA_RESPONSE_TO_HGF_UP lymphatic system disease DOID_75 8.192E-06 4.2E-05 2.657E-03 0.04318928 RUTELLA_RESPONSE_TO_HGF_UP mitochondrial myopathy DOID_699 9.046E-06 4.596E-05 0.1263485 0.37443904 RUTELLA_RESPONSE_TO_HGF_UP endometriosis of uterus DOID_288 1.029E-05 5.181E-05 3.026E-03 0.04653623 RUTELLA_RESPONSE_TO_HGF_UP salivary gland cancer DOID_8850 1.029E-05 5.136E-05 1.996E-04 7.571E-03 RUTELLA_RESPONSE_TO_HGF_UP endometriosis DOID_289 1.148E-05 5.683E-05 3.222E-03 0.04583336 RUTELLA_RESPONSE_TO_HGF_UP uremia DOID_4676 1.325E-05 6.499E-05 0.13751869 0.39124068 RUTELLA_RESPONSE_TO_HGF_UP female reproductive system disease DOID_229 1.629E-05 7.924E-05 0.01640754 0.1261607 RUTELLA_RESPONSE_TO_HGF_UP focal epilepsy DOID_2234 1.868E-05 9.007E-05 0.42142707 0.84137545 RUTELLA_RESPONSE_TO_HGF_UP cystitis DOID_1679 2.574E-05 1.231E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP myositis DOID_633 2.574E-05 1.22E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP nervous system cancer DOID_3093 2.934E-05 1.38E-04 0.44695085 0.8892134 RUTELLA_RESPONSE_TO_HGF_UP childhood type dermatomyositis DOID_14203 3.019E-05 1.408E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP lymphoblastic leukemia DOID_1037 3.519E-05 1.628E-04 0.12426473 0.37214017 RUTELLA_RESPONSE_TO_HGF_UP familial hyperlipidemia DOID_1168 3.92E-05 1.799E-04 6.492E-03 0.06840871 RUTELLA_RESPONSE_TO_HGF_UP renal hypertension DOID_1073 3.958E-05 1.802E-04 0.17550603 0.44983303 RUTELLA_RESPONSE_TO_HGF_UP secondary hypertension DOID_11130 3.958E-05 1.802E-04 0.17550603 0.44983303 RUTELLA_RESPONSE_TO_HGF_UP dermatomyositis DOID_10223 4.132E-05 1.866E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP bile duct cancer DOID_4606 4.61E-05 2.065E-04 0.05850258 0.28210144 RUTELLA_RESPONSE_TO_HGF_UP bile duct carcinoma DOID_4897 4.61E-05 2.065E-04 0.05850258 0.28210144 RUTELLA_RESPONSE_TO_HGF_UP ulcerative colitis DOID_8577 4.7E-05 2.089E-04 0.02669058 0.16688946 RUTELLA_RESPONSE_TO_HGF_UP otitis media DOID_10754 5.483E-05 2.418E-04 0.07427289 0.29553341 RUTELLA_RESPONSE_TO_HGF_UP middle ear disease DOID_5100 5.483E-05 2.418E-04 0.07427289 0.29553341 RUTELLA_RESPONSE_TO_HGF_UP mitochondrial encephalomyopathy DOID_890 5.483E-05 2.4E-04 0.07427289 0.28554917 RUTELLA_RESPONSE_TO_HGF_UP progressive myoclonus epilepsy DOID_891 5.483E-05 2.382E-04 5.483E-05 5.2E-03 RUTELLA_RESPONSE_TO_HGF_UP ocular hypertension DOID_9282 5.483E-05 2.364E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP borderline glaucoma DOID_9283 5.483E-05 2.364E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP spastic cerebral palsy DOID_0050669 5.822E-05 2.491E-04 0.01895833 0.13829857 RUTELLA_RESPONSE_TO_HGF_UP variable age at onset electroclinical syndrome DOID_0050706 7.094E-05 3.012E-04 7.094E-05 5.046E-03 RUTELLA_RESPONSE_TO_HGF_UP bladder disease DOID_365 7.375E-05 3.109E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP metal metabolism disorder DOID_896 8.256E-05 3.454E-04 0.02233908 0.14954042 RUTELLA_RESPONSE_TO_HGF_UP temporal lobe epilepsy DOID_3328 8.353E-05 3.469E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP hyperglycemia DOID_4195 8.353E-05 3.444E-04 0.0725743 0.29080828 RUTELLA_RESPONSE_TO_HGF_UP thyroid carcinoma DOID_3963 9.21E-05 3.77E-04 0.21182683 0.49600604 RUTELLA_RESPONSE_TO_HGF_UP hemangioma DOID_255 1.118E-04 4.544E-04 0.0919661 0.32103504 RUTELLA_RESPONSE_TO_HGF_UP varicose veins DOID_799 1.118E-04 4.511E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP thyroid cancer DOID_1781 1.136E-04 4.55E-04 0.22190837 0.50913655 RUTELLA_RESPONSE_TO_HGF_UP peripheral vascular disease DOID_341 1.243E-04 4.947E-04 0.08376414 0.30165695 RUTELLA_RESPONSE_TO_HGF_UP vein disease DOID_866 1.369E-04 5.411E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP hepatitis DOID_2237 1.522E-04 5.973E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP metabolic syndrome X DOID_14221 1.895E-04 7.387E-04 0.09742574 0.32608968 RUTELLA_RESPONSE_TO_HGF_UP prion disease DOID_649 1.977E-04 7.651E-04 0.10932251 0.3455806 RUTELLA_RESPONSE_TO_HGF_UP auditory system disease DOID_2742 2.122E-04 8.16E-04 0.01693645 0.1284912 RUTELLA_RESPONSE_TO_HGF_UP learning disability DOID_8927 2.568E-04 9.805E-04 3.637E-03 0.04812469 RUTELLA_RESPONSE_TO_HGF_UP membranous glomerulonephritis DOID_10976 2.735E-04 1.038E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP neuritis DOID_1803 3.009E-04 1.134E-03 0.04098117 0.22421426 RUTELLA_RESPONSE_TO_HGF_UP thyroid adenoma DOID_2891 3.009E-04 1.126E-03 0.27510439 0.59745954 RUTELLA_RESPONSE_TO_HGF_UP amino acid metabolic disorder DOID_9252 3.083E-04 1.147E-03 2.846E-03 0.04497503 RUTELLA_RESPONSE_TO_HGF_UP hemolytic anemia DOID_583 3.248E-04 1.2E-03 0.04247764 0.23018833 RUTELLA_RESPONSE_TO_HGF_UP normocytic anemia DOID_720 3.248E-04 1.2E-03 0.04247764 0.23018833 RUTELLA_RESPONSE_TO_HGF_UP familial hypercholesterolemia DOID_13810 3.66E-04 1.344E-03 0.13195149 0.38701236 RUTELLA_RESPONSE_TO_HGF_UP acquired immunodeficiency syndrome DOID_635 3.66E-04 1.335E-03 0.13195149 0.38502768 RUTELLA_RESPONSE_TO_HGF_UP carbohydrate metabolic disorder DOID_2978 3.763E-04 1.364E-03 3.323E-03 0.04501552 RUTELLA_RESPONSE_TO_HGF_UP sinusitis DOID_0050127 4.19E-04 1.509E-03 0.13751869 0.39922519 RUTELLA_RESPONSE_TO_HGF_UP paranasal sinus disease DOID_1352 4.19E-04 1.509E-03 0.13751869 0.39922519 RUTELLA_RESPONSE_TO_HGF_UP hypoglycemia DOID_9993 4.19E-04 1.499E-03 0.13751869 0.38736701 RUTELLA_RESPONSE_TO_HGF_UP bile duct adenocarcinoma DOID_4896 4.983E-04 1.772E-03 0.0518699 0.26589164 RUTELLA_RESPONSE_TO_HGF_UP cholangiocarcinoma DOID_4947 4.983E-04 1.772E-03 0.0518699 0.26589164 RUTELLA_RESPONSE_TO_HGF_UP integumentary system cancer DOID_0060122 5.325E-04 1.882E-03 0.3115025 0.65890306 RUTELLA_RESPONSE_TO_HGF_UP skin cancer DOID_4159 5.325E-04 1.882E-03 0.3115025 0.65890306 RUTELLA_RESPONSE_TO_HGF_UP spastic quadriplegia DOID_10970 5.39E-04 1.893E-03 0.14854665 0.41230753 RUTELLA_RESPONSE_TO_HGF_UP mitochondrial metabolism disease DOID_700 5.684E-04 1.984E-03 0.31592236 0.6608817 RUTELLA_RESPONSE_TO_HGF_UP commensal bacterial infectious disease DOID_0050339 6.064E-04 2.104E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP urticaria DOID_1555 6.064E-04 2.091E-03 0.15400785 0.41928454 RUTELLA_RESPONSE_TO_HGF_UP bronchiolitis DOID_2942 6.064E-04 2.079E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP leukocyte disease DOID_9500 6.863E-04 2.338E-03 0.32901311 0.68075803 RUTELLA_RESPONSE_TO_HGF_UP gestational diabetes DOID_11714 8.402E-04 2.846E-03 0.17018304 0.43816358 RUTELLA_RESPONSE_TO_HGF_UP lung adenocarcinoma DOID_3910 8.402E-04 2.829E-03 0.01482385 0.12224303 RUTELLA_RESPONSE_TO_HGF_UP endocrine pancreas disease DOID_1428 9.197E-04 3.078E-03 0.06896121 0.28229443 RUTELLA_RESPONSE_TO_HGF_UP autoimmune disease of the nervous system DOID_438 9.292E-04 3.092E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP cerebral degeneration DOID_1443 9.723E-04 3.217E-03 0.07076014 0.28554979 RUTELLA_RESPONSE_TO_HGF_UP cranial nerve disease DOID_5656 1.024E-03 3.368E-03 0.18079502 0.44341537 RUTELLA_RESPONSE_TO_HGF_UP Charcot-Marie-Tooth disease DOID_10595 1.344E-03 4.395E-03 0.02005923 0.14090988 RUTELLA_RESPONSE_TO_HGF_UP celiac disease DOID_10608 1.344E-03 4.37E-03 0.02005923 0.13919146 RUTELLA_RESPONSE_TO_HGF_UP leber hereditary optic neuropathy DOID_705 1.43E-03 4.623E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP chronic leukemia DOID_1036 1.463E-03 4.703E-03 0.20161521 0.47999604 RUTELLA_RESPONSE_TO_HGF_UP chronic lymphocytic leukemia DOID_1040 1.463E-03 4.703E-03 0.20161521 0.47999604 RUTELLA_RESPONSE_TO_HGF_UP papilloma DOID_2615 1.589E-03 5.078E-03 0.20673738 0.49013988 RUTELLA_RESPONSE_TO_HGF_UP gallbladder disease DOID_0000000 1.78E-03 5.658E-03 0.0622871 0.29782657 RUTELLA_RESPONSE_TO_HGF_UP hyperparathyroidism DOID_13543 1.78E-03 5.626E-03 0.0622871 0.29534468 RUTELLA_RESPONSE_TO_HGF_UP retinal vascular occlusion DOID_1729 1.78E-03 5.595E-03 0.0622871 0.29050296 RUTELLA_RESPONSE_TO_HGF_UP transient cerebral ischemia DOID_224 1.78E-03 5.565E-03 0.0622871 0.28814115 RUTELLA_RESPONSE_TO_HGF_UP Paget's disease of bone DOID_5408 1.78E-03 5.534E-03 1.78E-03 0.03616925 RUTELLA_RESPONSE_TO_HGF_UP pneumocystosis DOID_11339 2.166E-03 6.699E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP common variable immunodeficiency DOID_12177 2.166E-03 6.663E-03 0.06829919 0.2921973 RUTELLA_RESPONSE_TO_HGF_UP neuronal ceroid lipofuscinosis DOID_14503 2.166E-03 6.627E-03 0.06829919 0.28575177 RUTELLA_RESPONSE_TO_HGF_UP eosinophilic pneumonia DOID_5870 2.166E-03 6.591E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP pulmonary eosinophilia DOID_9498 2.166E-03 6.591E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP Loeffler syndrome DOID_9503 2.166E-03 6.591E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP bronchiectasis DOID_9563 2.166E-03 6.556E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP microcephaly DOID_10907 2.316E-03 6.974E-03 0.02847667 0.17612199 RUTELLA_RESPONSE_TO_HGF_UP intracranial arteriosclerosis DOID_13097 2.588E-03 7.752E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP osteopetrosis DOID_13533 2.588E-03 7.711E-03 2.588E-03 0.04463157 RUTELLA_RESPONSE_TO_HGF_UP relapsing-remitting multiple sclerosis DOID_2378 2.588E-03 7.671E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP vascular dementia DOID_8725 2.588E-03 7.752E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP cervix uteri carcinoma in situ DOID_8991 2.838E-03 8.366E-03 0.24655391 0.55015363 RUTELLA_RESPONSE_TO_HGF_UP primary immunodeficiency disease DOID_612 2.846E-03 8.346E-03 0.11582477 0.35817552 RUTELLA_RESPONSE_TO_HGF_UP autoimmune disease of urogenital tract DOID_0060049 3.026E-03 8.83E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP primary biliary cirrhosis DOID_12236 3.026E-03 8.83E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP berylliosis DOID_10322 3.046E-03 8.843E-03 0.08020845 0.29829156 RUTELLA_RESPONSE_TO_HGF_UP parathyroid gland disease DOID_11201 3.046E-03 8.798E-03 0.08020845 0.29635461 RUTELLA_RESPONSE_TO_HGF_UP osteogenesis imperfecta DOID_12347 3.046E-03 8.754E-03 0.08020845 0.29444264 RUTELLA_RESPONSE_TO_HGF_UP lymphoma DOID_0060058 3.199E-03 9.146E-03 0.12214086 0.36771508 RUTELLA_RESPONSE_TO_HGF_UP Huntington's disease DOID_12858 3.222E-03 9.167E-03 3.222E-03 0.04700857 RUTELLA_RESPONSE_TO_HGF_UP Legionnaires' disease DOID_10457 3.539E-03 0.01001817 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP legionellosis DOID_10458 3.539E-03 0.01001817 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP parasitic helminthiasis infectious disease DOID_883 3.539E-03 9.969E-03 0.08610611 0.30431289 RUTELLA_RESPONSE_TO_HGF_UP bacterial meningitis DOID_9470 3.539E-03 9.919E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP peripheral neuropathy DOID_0060053 4.066E-03 0.01134146 4.066E-03 0.05258314 RUTELLA_RESPONSE_TO_HGF_UP skeletal system cancer DOID_0060124 4.066E-03 0.01128614 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP bone cancer DOID_184 4.066E-03 0.01128614 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP membranoproliferative glomerulonephritis DOID_2920 4.066E-03 0.01123135 0.0919661 0.31907751 RUTELLA_RESPONSE_TO_HGF_UP arthropathy DOID_381 4.066E-03 0.01117709 4.066E-03 0.05141463 RUTELLA_RESPONSE_TO_HGF_UP nutritional deficiency disease DOID_5113 4.066E-03 0.01112336 0.0919661 0.31523321 RUTELLA_RESPONSE_TO_HGF_UP lung oat cell carcinoma DOID_5411 4.066E-03 0.01107013 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP oral submucous fibrosis DOID_5773 4.066E-03 0.01101742 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP hyperhomocysteinemia DOID_9279 4.066E-03 0.0109652 4.066E-03 0.05029692 RUTELLA_RESPONSE_TO_HGF_UP vascular skin disease DOID_9540 4.083E-03 0.01095808 0.27510439 0.59518783 RUTELLA_RESPONSE_TO_HGF_UP lung small cell carcinoma DOID_5409 4.561E-03 0.01218296 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP spastic diplegia DOID_10965 4.628E-03 0.01230397 0.09778868 0.32539039 RUTELLA_RESPONSE_TO_HGF_UP hemolytic-uremic syndrome DOID_12554 4.628E-03 0.01224674 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP restrictive cardiomyopathy DOID_397 4.628E-03 0.01219004 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP tongue cancer DOID_8649 4.628E-03 0.01213387 0.09778868 0.31978021 RUTELLA_RESPONSE_TO_HGF_UP movement disease DOID_480 4.812E-03 0.01255873 4.812E-03 0.05587353 RUTELLA_RESPONSE_TO_HGF_UP B-cell lymphocytic neoplasm DOID_707 5.071E-03 0.01317487 0.29353686 0.62321817 RUTELLA_RESPONSE_TO_HGF_UP methylmalonic acidemia DOID_14749 5.222E-03 0.01350712 0.10357407 0.33295844 RUTELLA_RESPONSE_TO_HGF_UP hyperostosis DOID_205 5.222E-03 0.013446 5.222E-03 0.05943133 RUTELLA_RESPONSE_TO_HGF_UP urinary system benign neoplasm DOID_731 5.222E-03 0.01338543 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP atrophic muscular disease DOID_913 5.614E-03 0.01432479 0.05025686 0.25996503 RUTELLA_RESPONSE_TO_HGF_UP muscular dystrophy DOID_9884 5.614E-03 0.01432479 0.05025686 0.25996503 RUTELLA_RESPONSE_TO_HGF_UP osteosclerosis DOID_4254 5.851E-03 0.0148614 5.851E-03 0.06401833 RUTELLA_RESPONSE_TO_HGF_UP eosinophilia DOID_999 5.851E-03 0.01479535 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP osteochondrodysplasia DOID_2256 6.191E-03 0.01558708 0.05350129 0.26940028 RUTELLA_RESPONSE_TO_HGF_UP conduct disorder DOID_12995 6.511E-03 0.01632139 6.511E-03 0.06736284 RUTELLA_RESPONSE_TO_HGF_UP agammaglobulinemia DOID_2583 6.511E-03 0.01624981 0.11503424 0.35964001 RUTELLA_RESPONSE_TO_HGF_UP congenital nervous system abnormality DOID_2490 6.802E-03 0.01690109 0.05681792 0.28112521 RUTELLA_RESPONSE_TO_HGF_UP brain edema DOID_4724 7.204E-03 0.01782315 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP subependymal glioma DOID_4843 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP pilocytic astrocytoma DOID_4851 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP subependymal giant cell astrocytoma DOID_5077 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP blood protein disease DOID_620 7.204E-03 0.0176695 0.12070949 0.36533884 RUTELLA_RESPONSE_TO_HGF_UP fibrillary astrocytoma DOID_6726 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP juvenile pilocytic astrocytoma DOID_6811 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP childhood pilocytic astrocytoma DOID_6812 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP gemistocytic astrocytoma DOID_7005 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP childhood cerebral astrocytoma DOID_7007 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP protoplasmic astrocytoma DOID_7008 7.204E-03 0.01774599 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP amyloidosis DOID_9120 7.204E-03 0.01759367 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP coronary restenosis DOID_4247 7.929E-03 0.01928123 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP benign glioma DOID_0060101 8.686E-03 0.02103047 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP neutropenia DOID_1227 8.686E-03 0.02094136 0.13195149 0.3890176 RUTELLA_RESPONSE_TO_HGF_UP benign ependymoma DOID_4844 8.686E-03 0.02103047 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP muscular atrophy DOID_767 8.686E-03 0.020853 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP pre-malignant neoplasm DOID_0060071 8.844E-03 0.02114484 0.34608015 0.70834391 RUTELLA_RESPONSE_TO_HGF_UP congenital heart defect DOID_1682 8.844E-03 0.02105636 8.844E-03 0.08676674 RUTELLA_RESPONSE_TO_HGF_UP in situ carcinoma DOID_8719 8.844E-03 0.02114484 0.34608015 0.70834391 RUTELLA_RESPONSE_TO_HGF_UP agranulocytosis DOID_12987 9.473E-03 0.02245891 0.13751869 0.39719866 RUTELLA_RESPONSE_TO_HGF_UP optic nerve disease DOID_1891 9.473E-03 0.02236572 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP opiate dependence DOID_2559 9.473E-03 0.0222733 0.13751869 0.39519261 RUTELLA_RESPONSE_TO_HGF_UP myasthenia gravis DOID_437 9.473E-03 0.02218164 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP pulmonary embolism DOID_9477 9.473E-03 0.02209074 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP diabetic angiopathy DOID_11713 0.01029086 0.02390001 0.14305034 0.40096376 RUTELLA_RESPONSE_TO_HGF_UP Lewy body dementia DOID_12217 0.01029086 0.02380285 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP congenital hemolytic anemia DOID_589 0.01029086 0.02370648 0.01029086 0.09599183 RUTELLA_RESPONSE_TO_HGF_UP meningitis DOID_9471 0.01029086 0.02361089 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP toxic shock syndrome DOID_14115 0.01113885 0.02545385 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP organic acidemia DOID_0060159 0.01201656 0.02734968 0.15400785 0.4233356 RUTELLA_RESPONSE_TO_HGF_UP portal hypertension DOID_10762 0.01201656 0.02724072 0.15400785 0.42130033 RUTELLA_RESPONSE_TO_HGF_UP reading disorder DOID_13365 0.01201656 0.02713262 0.01201656 0.10519109 RUTELLA_RESPONSE_TO_HGF_UP dyslexia DOID_4428 0.01201656 0.02713262 0.01201656 0.10519109 RUTELLA_RESPONSE_TO_HGF_UP nephrosis DOID_2527 0.01207043 0.02714655 0.08186417 0.29669242 RUTELLA_RESPONSE_TO_HGF_UP male reproductive system disease DOID_48 0.01207043 0.02703967 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP spinal muscular atrophy DOID_12377 0.01292356 0.02883728 0.01292356 0.10813981 RUTELLA_RESPONSE_TO_HGF_UP neuromuscular junction disease DOID_439 0.01292356 0.02872464 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP B cell deficiency DOID_2115 0.01385946 0.03068495 0.16482583 0.43419397 RUTELLA_RESPONSE_TO_HGF_UP spinal cord disease DOID_319 0.01385946 0.03056602 0.16482583 0.43219307 RUTELLA_RESPONSE_TO_HGF_UP endogenous depression DOID_1595 0.01390442 0.03054677 0.39473042 0.79929397 RUTELLA_RESPONSE_TO_HGF_UP diffuse large B-cell lymphoma DOID_0050745 0.01482385 0.03244142 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP Sciatic Neuropathy DOID_11446 0.01482385 0.03231712 0.17018304 0.44015523 RUTELLA_RESPONSE_TO_HGF_UP lesion of sciatic nerve DOID_12528 0.01482385 0.03231712 0.17018304 0.44015523 RUTELLA_RESPONSE_TO_HGF_UP migraine DOID_6364 0.01482385 0.03219378 0.01482385 0.1204967 RUTELLA_RESPONSE_TO_HGF_UP perinatal necrotizing enterocolitis DOID_8677 0.01482385 0.03207137 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP mononeuritis of lower limb DOID_9473 0.01482385 0.03231712 0.17018304 0.44015523 RUTELLA_RESPONSE_TO_HGF_UP electroclinical syndrome DOID_0050701 0.01487745 0.03206542 0.01487745 0.11922917 RUTELLA_RESPONSE_TO_HGF_UP mononeuritis DOID_1802 0.01581632 0.03396033 0.17550603 0.44781584 RUTELLA_RESPONSE_TO_HGF_UP hepatic vascular disease DOID_272 0.01581632 0.03383266 0.17550603 0.44581666 RUTELLA_RESPONSE_TO_HGF_UP coronary stenosis DOID_4248 0.01581632 0.03370594 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP mononeuropathy DOID_1188 0.01683649 0.03574613 0.18079502 0.45119458 RUTELLA_RESPONSE_TO_HGF_UP supratentorial cancer DOID_1659 0.01683649 0.03561324 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP toxic encephalopathy DOID_3602 0.01683649 0.03548134 0.18079502 0.4492243 RUTELLA_RESPONSE_TO_HGF_UP cerebrum cancer DOID_368 0.01683649 0.03561324 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP alcohol abuse DOID_1574 0.01747482 0.03669067 0.01747482 0.13083121 RUTELLA_RESPONSE_TO_HGF_UP mental depression DOID_1596 0.01747482 0.03655578 0.42142707 0.84433804 RUTELLA_RESPONSE_TO_HGF_UP endometrial carcinoma DOID_2871 0.01788395 0.03727461 0.18605021 0.45240415 RUTELLA_RESPONSE_TO_HGF_UP bone development disease DOID_0080006 0.01802266 0.03742663 0.1054956 0.33534635 RUTELLA_RESPONSE_TO_HGF_UP age related macular degeneration DOID_10871 0.01895833 0.0392265 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP degeneration of macula and posterior pole DOID_2007 0.01895833 0.0392265 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP gonadal disease DOID_2277 0.01895833 0.03908438 0.01895833 0.13654795 RUTELLA_RESPONSE_TO_HGF_UP endometrial cancer DOID_1380 0.02005923 0.04120469 0.1964601 0.47167002 RUTELLA_RESPONSE_TO_HGF_UP hair disease DOID_421 0.02233908 0.04572279 0.20673738 0.4881061 RUTELLA_RESPONSE_TO_HGF_UP nephroblastoma DOID_2154 0.02351728 0.04796177 0.02351728 0.1520606 RUTELLA_RESPONSE_TO_HGF_UP spindle cell carcinoma DOID_4015 0.02351728 0.04779047 0.21182683 0.49397322 RUTELLA_RESPONSE_TO_HGF_UP macular degeneration DOID_4448 0.02351728 0.0476204 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP leukopenia DOID_615 0.02351728 0.04745153 0.21182683 0.49195701 RUTELLA_RESPONSE_TO_HGF_UP hyperthyroidism DOID_7998 0.02351728 0.04728386 0.21182683 0.48995718 RUTELLA_RESPONSE_TO_HGF_UP Crohn's disease DOID_8778 0.0240238 0.04813218 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP lymphoid leukemia DOID_10747 0.02472051 0.04935427 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP peptic ulcer DOID_750 0.02977635 0.05924037 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP benign mesothelioma DOID_2645 0.03244506 0.06432487 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP spinocerebellar ataxia DOID_1441 0.03381338 0.06680491 0.03381338 0.20041473 RUTELLA_RESPONSE_TO_HGF_UP nephrotic syndrome DOID_1184 0.0352039 0.06931148 0.25619303 0.56942905 RUTELLA_RESPONSE_TO_HGF_UP uterine cancer DOID_363 0.03661627 0.07184364 0.26096644 0.5733201 RUTELLA_RESPONSE_TO_HGF_UP cataract DOID_83 0.03805016 0.07440048 0.03805016 0.21869231 RUTELLA_RESPONSE_TO_HGF_UP leukodystrophy DOID_10579 0.03950523 0.07698108 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_UP spinocerebellar degeneration DOID_2478 0.03950523 0.07671835 0.03950523 0.22478477 RUTELLA_RESPONSE_TO_HGF_UP lens disease DOID_110 0.04098117 0.07931389 0.04098117 0.2263911 RUTELLA_RESPONSE_TO_HGF_UP withdrawal disorder DOID_0060001 0.04708705 0.09082214 0.29353686 0.62790403 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS transitional cell carcinoma DOID_2671 5.219E-09 2.97E-06 1.882E-03 0.08237763 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS medullomyoblastoma DOID_3861 2.673E-06 7.604E-04 2.673E-06 1.521E-03 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS adult medulloblastoma DOID_3864 2.673E-06 7.604E-04 2.673E-06 1.521E-03 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS childhood medulloblastoma DOID_3869 2.673E-06 7.604E-04 2.673E-06 1.521E-03 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS medulloblastoma DOID_3858 3.127E-06 5.931E-04 3.127E-06 8.897E-04 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS cervix uteri carcinoma in situ DOID_8991 4.184E-06 5.952E-04 4.536E-04 0.03226385 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS primitive neuroectodermal tumor DOID_168 4.791E-06 5.452E-04 4.791E-06 9.087E-04 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS neuroectodermal tumor DOID_171 1.304E-05 1.236E-03 1.304E-05 1.855E-03 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS pre-malignant neoplasm DOID_0060071 1.431E-05 1.163E-03 1.019E-03 0.0579627 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS in situ carcinoma DOID_8719 1.431E-05 1.163E-03 1.019E-03 0.0579627 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS pancreatic ductal carcinoma DOID_3587 1.938E-05 1.378E-03 1.244E-03 0.06436063 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS pancreatic carcinoma DOID_4905 2.187E-05 1.383E-03 1.348E-03 0.0638969 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS invasive lobular carcinoma DOID_3457 2.676E-05 1.523E-03 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS Human immunodeficiency virus infectious disease DOID_526 3.878E-05 2.006E-03 3.878E-05 4.413E-03 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS cleft lip DOID_9296 1.696E-04 8.041E-03 1.696E-04 0.01608103 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS sarcoma DOID_1115 2.099E-04 9.186E-03 0.02115466 0.46296155 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS nephroblastoma DOID_2154 3.203E-04 0.01301956 0.02602837 0.4936715 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS cleft palate DOID_674 3.747E-04 0.01421285 3.747E-04 0.03045611 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS adenoid cystic carcinoma DOID_4866 4.332E-04 0.01540542 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS salivary gland cancer DOID_8850 4.745E-04 0.0158822 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS lung small cell carcinoma DOID_5409 6.336E-04 0.02002907 0.03639349 0.60905573 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS orofacial cleft DOID_0050567 7.087E-04 0.02122221 7.087E-04 0.04480244 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS giant cell tumor DOID_200 7.346E-04 0.02089863 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS malignant giant cell tumor DOID_2705 7.346E-04 0.02089863 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS giant cell glioblastoma DOID_3074 7.346E-04 0.02089863 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS bile duct adenocarcinoma DOID_4896 7.61E-04 0.02061817 0.03982486 0.62945405 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS cholangiocarcinoma DOID_4947 7.61E-04 0.02061817 0.03982486 0.62945405 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS glioblastoma DOID_3068 8.71E-04 0.02252696 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS bile duct cancer DOID_4606 8.71E-04 0.02154752 0.04256148 0.63730221 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS bile duct carcinoma DOID_4897 8.71E-04 0.02154752 0.04256148 0.63730221 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS oral cavity cancer DOID_8618 8.71E-04 0.02064971 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS astrocytoma DOID_3069 1.211E-03 0.02755491 1.000 1.000 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS pancreatitis DOID_4989 1.492E-03 0.03264134 0.0554582 0.71717534 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS biliary tract cancer DOID_4607 1.681E-03 0.03543289 0.05882417 0.71214791 SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS dilated cardiomyopathy DOID_12930 2.181E-03 0.04432743 0.06685543 0.7458969 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP lymphoma DOID_0060058 1.489E-09 8.471E-07 9.505E-08 2.704E-05 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP encephalomyelitis DOID_640 1.588E-09 4.517E-07 1.588E-09 9.034E-07 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP B-cell lymphocytic neoplasm DOID_707 5.672E-09 1.076E-06 5.244E-07 9.945E-05 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP diffuse large B-cell lymphoma DOID_0050745 4.024E-08 5.724E-06 5.588E-06 4.542E-04 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP dilated cardiomyopathy DOID_12930 1.113E-07 1.267E-05 5.535E-06 5.249E-04 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP colon carcinoma DOID_1520 1.756E-06 1.666E-04 1.756E-06 2.499E-04 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP nervous system cancer DOID_3093 4.483E-06 3.644E-04 1.823E-04 6.914E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP hypersensitivity reaction type I disease DOID_1205 5.535E-06 3.937E-04 5.535E-06 6.299E-04 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP hepatitis DOID_2237 1.737E-05 1.098E-03 1.151E-03 0.02425357 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP influenza DOID_8469 2.443E-05 1.39E-03 2.443E-05 1.738E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP brain cancer DOID_1319 2.946E-05 1.524E-03 1.628E-03 0.03086963 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP central nervous system cancer DOID_3620 3.127E-05 1.483E-03 1.693E-03 0.03009882 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP sarcoidosis DOID_11335 4.145E-05 1.814E-03 2.037E-03 0.03408746 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP reproductive organ benign neoplasm DOID_0050622 4.607E-05 1.872E-03 4.607E-05 2.912E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP hypersensitivity reaction type IV disease DOID_2916 5.36E-05 2.033E-03 2.411E-03 0.03518063 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP facioscapulohumeral muscular dystrophy DOID_11727 6.162E-05 2.191E-03 6.162E-05 3.506E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP transient cerebral ischemia DOID_224 6.162E-05 2.063E-03 0.0118081 0.11584151 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP prediabetes syndrome DOID_11716 7.526E-05 2.379E-03 7.526E-05 3.893E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP retinal detachment DOID_5327 9.024E-05 2.702E-03 9.024E-05 4.279E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP bone resorption disease DOID_0080011 1.16E-04 3.301E-03 4.005E-03 0.04650817 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP osteoporosis DOID_11476 1.16E-04 3.301E-03 4.005E-03 0.04650817 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP aneurysm disease DOID_2403 1.16E-04 3.144E-03 4.005E-03 0.04557801 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP bacterial pneumonia DOID_874 1.204E-04 3.115E-03 1.204E-04 5.272E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP aspergillosis DOID_13564 1.242E-04 3.073E-03 1.242E-04 5.049E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.067E-04 4.9E-03 5.852E-03 0.05946498 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP mouth disease DOID_403 2.067E-04 4.704E-03 2.067E-04 7.35E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP male reproductive organ benign neoplasm DOID_0060087 2.082E-04 4.557E-03 2.082E-04 6.97E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP keratosis DOID_161 2.082E-04 4.389E-03 2.082E-04 6.583E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP prion disease DOID_649 2.082E-04 4.232E-03 2.082E-04 6.237E-03 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP Lewy body dementia DOID_12217 3.74E-04 7.337E-03 0.02811068 0.17385845 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP bronchiolitis DOID_2942 4.397E-04 8.34E-03 4.397E-04 0.01250932 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP extrinsic allergic alveolitis DOID_841 5.106E-04 9.372E-03 0.03272006 0.17563881 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP perinatal necrotizing enterocolitis DOID_8677 5.48E-04 9.745E-03 0.03386906 0.17843977 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP sarcoma DOID_1115 5.867E-04 0.01011682 5.867E-04 0.01589786 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP invasive ductal carcinoma DOID_3008 5.867E-04 9.819E-03 5.867E-04 0.01517523 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP opportunistic mycosis DOID_2473 7.106E-04 0.01155184 7.106E-04 0.01757889 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP allergic rhinitis DOID_4481 7.544E-04 0.01192389 7.544E-04 0.01788583 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP systemic mycosis DOID_0050136 8.459E-04 0.01300891 8.459E-04 0.01925318 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP fungal infectious disease DOID_1564 8.459E-04 0.01300891 8.459E-04 0.01925318 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP nephroblastoma DOID_2154 8.936E-04 0.01338027 8.936E-04 0.01955578 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP thyroid carcinoma DOID_3963 8.936E-04 0.01303719 0.04301315 0.19271246 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP spindle cell carcinoma DOID_4015 8.936E-04 0.01271126 0.04301315 0.19120689 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP thyroid cancer DOID_1781 9.927E-04 0.01377696 0.04528592 0.19821298 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP multiple myeloma DOID_9538 1.044E-03 0.0141461 0.04642032 0.19711315 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP uveitis DOID_13141 1.097E-03 0.01451474 0.04755341 0.19895506 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP benign mesothelioma DOID_2645 1.263E-03 0.0163275 0.05094477 0.2013026 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP nephrotic syndrome DOID_1184 1.379E-03 0.0174403 1.379E-03 0.02802906 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP Huntington's disease DOID_12858 1.379E-03 0.01706117 1.379E-03 0.02706254 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP uveal disease DOID_3480 1.379E-03 0.01669816 0.05319912 0.20180198 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP leukodystrophy DOID_10579 1.564E-03 0.01853574 0.05657082 0.2103843 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP myeloma DOID_0070004 1.628E-03 0.01889977 0.05769211 0.21042829 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP neuritis DOID_1803 1.628E-03 0.01852178 1.628E-03 0.02987383 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP thyroid adenoma DOID_2891 1.628E-03 0.0181586 0.05769211 0.20776464 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP integumentary system benign neoplasm DOID_0060121 1.759E-03 0.01924873 0.05993079 0.2144693 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP pulmonary tuberculosis DOID_2957 1.759E-03 0.01888555 1.759E-03 0.03033133 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP skin benign neoplasm DOID_3165 1.759E-03 0.01924873 0.05993079 0.2144693 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP giant cell tumor DOID_200 2.037E-03 0.02146247 2.037E-03 0.03311353 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP malignant giant cell tumor DOID_2705 2.037E-03 0.02146247 2.037E-03 0.03311353 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP giant cell glioblastoma DOID_3074 2.037E-03 0.02146247 2.037E-03 0.03311353 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP atrophic muscular disease DOID_913 2.037E-03 0.02107225 2.037E-03 0.03219371 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP muscular dystrophy DOID_9884 2.037E-03 0.02107225 2.037E-03 0.03219371 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP bone marrow cancer DOID_4960 2.109E-03 0.02143238 0.06550475 0.23150435 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP integumentary system cancer DOID_0060122 2.183E-03 0.02179197 0.06661565 0.23254176 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP parasitic protozoa infectious disease DOID_2789 2.183E-03 0.02141625 2.183E-03 0.03357141 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP skin cancer DOID_4159 2.183E-03 0.02179197 0.06661565 0.23254176 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP pustulosis of palm and sole DOID_4398 2.183E-03 0.02105326 2.183E-03 0.03268795 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP glioblastoma DOID_3068 2.411E-03 0.02286741 2.411E-03 0.03430111 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP oral cavity cancer DOID_8618 2.411E-03 0.02249253 0.06994063 0.23973626 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP carotid artery disease DOID_3407 2.65E-03 0.02432399 0.07325403 0.24810442 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP respiratory failure DOID_11162 2.732E-03 0.02467924 2.732E-03 0.03792176 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP parasitic infectious disease DOID_1398 2.986E-03 0.02654617 2.986E-03 0.04045131 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP cerebral degeneration DOID_1443 2.986E-03 0.02613777 0.07765395 0.25689009 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP allergic contact dermatitis DOID_3042 3.161E-03 0.02724881 3.161E-03 0.04182376 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP endocrine organ benign neoplasm DOID_0060089 3.25E-03 0.02759936 0.08094047 0.26468464 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP tuberculosis DOID_399 3.25E-03 0.02719349 3.25E-03 0.04202631 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP astrocytoma DOID_3069 3.34E-03 0.02754434 3.34E-03 0.04223466 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP nephrosis DOID_2527 3.524E-03 0.02864796 3.524E-03 0.04359472 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP male reproductive system disease DOID_48 3.524E-03 0.02824446 3.524E-03 0.04266717 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP diabetic retinopathy DOID_8947 3.713E-03 0.02934445 3.713E-03 0.04401668 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP contact dermatitis DOID_2773 4.307E-03 0.03357375 4.307E-03 0.04805654 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP chromosomal disease DOID_0080014 4.41E-03 0.03391232 4.41E-03 0.04825984 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP retinal vascular disease DOID_2462 4.834E-03 0.03667312 4.834E-03 0.05189592 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP primary bacterial infectious disease DOID_0050338 5.052E-03 0.03782663 5.052E-03 0.05323748 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP Human immunodeficiency virus infectious disease DOID_526 5.389E-03 0.0398197 5.389E-03 0.05574758 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP rectal neoplasm DOID_1984 0.0118081 0.08613856 0.0118081 0.11787382 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP rectum cancer DOID_1993 0.0118081 0.08613856 0.0118081 0.11787382 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP lateral sclerosis DOID_230 0.0118081 0.0850482 0.0118081 0.11387809 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP acute kidney failure DOID_3021 0.0118081 0.08398509 1.000 1.000 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP cutaneous leishmaniasis DOID_9111 0.0118081 0.08294824 0.0118081 0.11198013 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP familial adenomatous polyposis DOID_0050424 0.01298138 0.09007812 1.000 1.000 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP breast benign neoplasm DOID_0060082 0.01298138 0.08899285 0.01298138 0.12108863 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP thoracic benign neoplasm DOID_0060097 0.01298138 0.08899285 0.01298138 0.12108863 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP trypanosomiasis DOID_10113 0.01298138 0.08793341 0.01298138 0.11913558 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP adrenoleukodystrophy DOID_10588 0.01298138 0.0868989 1.000 1.000 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP pneumocystosis DOID_11339 0.01298138 0.08588844 0.01298138 0.11724454 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP neuronal ceroid lipofuscinosis DOID_14503 0.01298138 0.08490122 1.000 1.000 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP benign breast phyllodes tumor DOID_1631 0.01298138 0.08899285 0.01298138 0.12108863 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP prostatic adenoma DOID_2883 0.01298138 0.08393643 0.01298138 0.1154126 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP encephalitis DOID_9588 0.0141533 0.09048573 0.0141533 0.12389584 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP leprosy DOID_1024 0.01532386 0.09688088 0.01532386 0.13211029 LEE_LIVER_CANCER_E2F1_UP peripheral vascular disease DOID_341 2.164E-06 1.231E-03 1.062E-04 0.0120834 LEE_LIVER_CANCER_E2F1_UP diabetic angiopathy DOID_11713 3.324E-06 9.456E-04 3.324E-06 1.891E-03 LEE_LIVER_CANCER_E2F1_UP myocarditis DOID_820 1.161E-05 2.201E-03 1.161E-05 3.302E-03 LEE_LIVER_CANCER_E2F1_UP hepatitis DOID_2237 1.857E-05 2.641E-03 1.857E-05 3.521E-03 LEE_LIVER_CANCER_E2F1_UP pulmonary emphysema DOID_9675 2.138E-05 2.433E-03 1.319E-03 0.03002048 LEE_LIVER_CANCER_E2F1_UP collagen disease DOID_854 6.613E-05 6.271E-03 6.613E-05 9.407E-03 LEE_LIVER_CANCER_E2F1_UP osteogenesis imperfecta DOID_12347 1.114E-04 9.054E-03 1.114E-04 0.01056356 LEE_LIVER_CANCER_E2F1_UP bone resorption disease DOID_0080011 1.239E-04 8.814E-03 1.239E-04 0.01007356 LEE_LIVER_CANCER_E2F1_UP osteoporosis DOID_11476 1.239E-04 8.814E-03 1.239E-04 0.01007356 LEE_LIVER_CANCER_E2F1_UP aneurysm disease DOID_2403 1.239E-04 7.835E-03 1.239E-04 8.814E-03 LEE_LIVER_CANCER_E2F1_UP chromosomal disease DOID_0080014 1.435E-04 8.165E-03 1.435E-04 9.073E-03 LEE_LIVER_CANCER_E2F1_UP Ehlers-Danlos syndrome DOID_13359 1.497E-04 7.744E-03 1.497E-04 8.519E-03 LEE_LIVER_CANCER_E2F1_UP transitional cell carcinoma DOID_2671 1.824E-04 8.649E-03 5.39E-03 0.05786373 LEE_LIVER_CANCER_E2F1_UP Down syndrome DOID_14250 2.431E-04 0.0106391 2.431E-04 0.01257348 LEE_LIVER_CANCER_E2F1_UP pulmonary embolism DOID_9477 3.585E-04 0.01457142 3.585E-04 0.01699999 LEE_LIVER_CANCER_E2F1_UP urticaria DOID_1555 4.595E-04 0.01742989 0.03108379 0.18423624 LEE_LIVER_CANCER_E2F1_UP morbid obesity DOID_11981 4.959E-04 0.01763413 4.959E-04 0.02170354 LEE_LIVER_CANCER_E2F1_UP intracranial aneurysm DOID_10941 5.336E-04 0.0178597 5.336E-04 0.02168678 LEE_LIVER_CANCER_E2F1_UP middle cerebral artery infarction DOID_3525 5.336E-04 0.0168675 5.336E-04 0.020241 LEE_LIVER_CANCER_E2F1_UP gestational diabetes DOID_11714 5.727E-04 0.01715016 5.727E-04 0.02036582 LEE_LIVER_CANCER_E2F1_UP lung adenocarcinoma DOID_3910 5.727E-04 0.01629266 5.727E-04 0.01916783 LEE_LIVER_CANCER_E2F1_UP pleurisy DOID_10247 6.131E-04 0.01661232 6.131E-04 0.01938104 LEE_LIVER_CANCER_E2F1_UP toxic encephalopathy DOID_3602 6.549E-04 0.01693773 0.03695213 0.18773002 LEE_LIVER_CANCER_E2F1_UP pleural disease DOID_1532 8.354E-04 0.02066677 8.354E-04 0.02501766 LEE_LIVER_CANCER_E2F1_UP pulmonary sarcoidosis DOID_13406 1.091E-03 0.02586368 1.091E-03 0.03103642 LEE_LIVER_CANCER_E2F1_UP calcinosis DOID_182 1.091E-03 0.02482914 1.091E-03 0.0295585 LEE_LIVER_CANCER_E2F1_UP multiple myeloma DOID_9538 1.091E-03 0.02387417 1.091E-03 0.02821493 LEE_LIVER_CANCER_E2F1_UP systemic scleroderma DOID_418 1.202E-03 0.02533822 1.202E-03 0.02974486 LEE_LIVER_CANCER_E2F1_UP intracranial arterial disease DOID_13089 1.26E-03 0.02560538 1.26E-03 0.02987295 LEE_LIVER_CANCER_E2F1_UP cerebral arterial disease DOID_3527 1.26E-03 0.02560538 1.26E-03 0.02987295 LEE_LIVER_CANCER_E2F1_UP benign mesothelioma DOID_2645 1.319E-03 0.02587972 0.05204757 0.23136769 LEE_LIVER_CANCER_E2F1_UP autoimmune disease of urogenital tract DOID_0060049 1.379E-03 0.02616045 1.379E-03 0.03018514 LEE_LIVER_CANCER_E2F1_UP primary biliary cirrhosis DOID_12236 1.379E-03 0.02616045 1.379E-03 0.03018514 LEE_LIVER_CANCER_E2F1_UP rheumatic disease DOID_1575 1.441E-03 0.02644691 1.441E-03 0.03036497 LEE_LIVER_CANCER_E2F1_UP scleroderma DOID_419 1.441E-03 0.02644691 1.441E-03 0.03036497 LEE_LIVER_CANCER_E2F1_UP diabetic autonomic neuropathy DOID_11503 1.504E-03 0.0267385 1.504E-03 0.03055828 LEE_LIVER_CANCER_E2F1_UP autonomic neuropathy DOID_11504 1.504E-03 0.0267385 1.504E-03 0.03055828 LEE_LIVER_CANCER_E2F1_UP diabetic polyneuropathy DOID_12785 1.504E-03 0.0267385 1.504E-03 0.03055828 LEE_LIVER_CANCER_E2F1_UP diabetic neuropathy DOID_9743 1.504E-03 0.0267385 1.504E-03 0.03055828 LEE_LIVER_CANCER_E2F1_UP cerebral infarction DOID_3526 1.568E-03 0.02703469 1.568E-03 0.03076361 LEE_LIVER_CANCER_E2F1_UP myeloma DOID_0070004 1.7E-03 0.02845205 1.7E-03 0.03224565 LEE_LIVER_CANCER_E2F1_UP pre-eclampsia DOID_10591 1.7E-03 0.02763913 1.7E-03 0.03120547 LEE_LIVER_CANCER_E2F1_UP autonomic nervous system disease DOID_11465 1.7E-03 0.02687138 1.7E-03 0.0302303 LEE_LIVER_CANCER_E2F1_UP neuritis DOID_1803 1.7E-03 0.02614512 1.7E-03 0.02931423 LEE_LIVER_CANCER_E2F1_UP heart valve disease DOID_4079 1.7E-03 0.02545709 1.7E-03 0.02845205 LEE_LIVER_CANCER_E2F1_UP vascular skin disease DOID_9540 1.7E-03 0.02480435 0.05893638 0.24477956 LEE_LIVER_CANCER_E2F1_UP calcium metabolism disease DOID_10575 1.908E-03 0.02714194 1.908E-03 0.03101936 LEE_LIVER_CANCER_E2F1_UP aortic aneurysm DOID_3627 1.908E-03 0.02647994 1.908E-03 0.03015771 LEE_LIVER_CANCER_E2F1_UP atopic dermatitis DOID_3310 2.053E-03 0.02781372 0.06463963 0.26460395 LEE_LIVER_CANCER_E2F1_UP sarcoidosis DOID_11335 2.127E-03 0.02815136 2.127E-03 0.03271645 LEE_LIVER_CANCER_E2F1_UP bone marrow cancer DOID_4960 2.203E-03 0.02849001 2.203E-03 0.03298843 LEE_LIVER_CANCER_E2F1_UP osteochondrodysplasia DOID_2256 2.28E-03 0.02882956 2.28E-03 0.03326487 LEE_LIVER_CANCER_E2F1_UP hypersensitivity reaction type IV disease DOID_2916 2.518E-03 0.03115063 2.518E-03 0.03582322 LEE_LIVER_CANCER_E2F1_UP carotid artery disease DOID_3407 2.768E-03 0.03350907 2.768E-03 0.03841284 LEE_LIVER_CANCER_E2F1_UP mineral metabolism disease DOID_0050032 3.029E-03 0.03590159 3.029E-03 0.04103038 LEE_LIVER_CANCER_E2F1_UP allergic contact dermatitis DOID_3042 3.3E-03 0.03832515 3.3E-03 0.04367284 LEE_LIVER_CANCER_E2F1_UP brain infarction DOID_3454 3.393E-03 0.03861755 3.393E-03 0.04388358 LEE_LIVER_CANCER_E2F1_UP blood coagulation disease DOID_1247 3.583E-03 0.03997743 3.583E-03 0.04530775 LEE_LIVER_CANCER_E2F1_UP pancreatic ductal carcinoma DOID_3587 3.583E-03 0.03920863 3.583E-03 0.0443228 LEE_LIVER_CANCER_E2F1_UP pancreatic carcinoma DOID_4905 3.877E-03 0.04162227 3.877E-03 0.04693575 LEE_LIVER_CANCER_E2F1_UP pancreatitis DOID_4989 4.285E-03 0.04515577 4.285E-03 0.05080024 LEE_LIVER_CANCER_E2F1_UP bacterial pneumonia DOID_874 4.285E-03 0.04433476 4.285E-03 0.0497635 LEE_LIVER_CANCER_E2F1_UP metabolic syndrome X DOID_14221 4.497E-03 0.0456912 4.497E-03 0.05117414 LEE_LIVER_CANCER_E2F1_UP contact dermatitis DOID_2773 4.497E-03 0.0448896 4.497E-03 0.05017073 LEE_LIVER_CANCER_E2F1_UP bone development disease DOID_0080006 4.934E-03 0.04840329 4.934E-03 0.05398829 LEE_LIVER_CANCER_E2F1_UP primary bacterial infectious disease DOID_0050338 5.274E-03 0.05086328 0.10253487 0.36463965 LEE_LIVER_CANCER_E2F1_UP primary immunodeficiency disease DOID_612 5.507E-03 0.05222141 5.507E-03 0.05802379 LEE_LIVER_CANCER_E2F1_UP encephalomyelitis DOID_640 5.986E-03 0.05583446 5.986E-03 0.06192549 LEE_LIVER_CANCER_E2F1_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.108E-03 0.05605962 0.11014828 0.38687884 LEE_LIVER_CANCER_E2F1_UP hypersensitivity reaction type I disease DOID_1205 6.232E-03 0.05628798 0.11123074 0.38591641 LEE_LIVER_CANCER_E2F1_UP ulcerative colitis DOID_8577 6.611E-03 0.0587716 0.11447039 0.39237141 LEE_LIVER_CANCER_E2F1_UP DiGeorge syndrome DOID_11198 0.0108686 0.09514208 0.0108686 0.11043277 LEE_LIVER_CANCER_E2F1_UP velocardiofacial syndrome DOID_12583 0.0108686 0.09514208 0.0108686 0.11043277 LU_AGING_BRAIN_UP nervous system cancer DOID_3093 5.536E-09 3.15E-06 2.621E-06 1.147E-04 LU_AGING_BRAIN_UP leiomyoma DOID_127 7.265E-09 2.067E-06 3.572E-07 2.904E-05 LU_AGING_BRAIN_UP cerebral degeneration DOID_1443 1.563E-08 2.965E-06 1.563E-08 8.894E-06 LU_AGING_BRAIN_UP pancreatic ductal carcinoma DOID_3587 2.582E-08 3.672E-06 1.454E-05 4.866E-04 LU_AGING_BRAIN_UP pancreatic carcinoma DOID_4905 3.428E-08 3.901E-06 1.77E-05 5.036E-04 LU_AGING_BRAIN_UP leukodystrophy DOID_10579 5.963E-08 5.655E-06 5.963E-08 1.697E-05 LU_AGING_BRAIN_UP keratitis DOID_4677 6.134E-08 4.986E-06 0.04116237 0.15013711 LU_AGING_BRAIN_UP thyroid adenoma DOID_2891 6.753E-08 4.803E-06 6.753E-08 1.281E-05 LU_AGING_BRAIN_UP glaucoma DOID_1686 8.592E-08 5.432E-06 8.592E-08 1.222E-05 LU_AGING_BRAIN_UP papillary adenoma DOID_3172 9.128E-08 5.194E-06 9.128E-08 1.039E-05 LU_AGING_BRAIN_UP microcystic adenoma DOID_5403 9.128E-08 5.194E-06 9.128E-08 1.039E-05 LU_AGING_BRAIN_UP follicular adenoma DOID_6204 9.128E-08 5.194E-06 9.128E-08 1.039E-05 LU_AGING_BRAIN_UP transitional cell carcinoma DOID_2671 1.115E-07 5.769E-06 2.304E-06 1.093E-04 LU_AGING_BRAIN_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.742E-07 8.261E-06 1.742E-07 1.652E-05 LU_AGING_BRAIN_UP female reproductive organ benign neoplasm DOID_0060086 2.239E-07 9.798E-06 9.775E-06 3.708E-04 LU_AGING_BRAIN_UP uterine benign neoplasm DOID_0060095 2.239E-07 9.798E-06 9.775E-06 3.708E-04 LU_AGING_BRAIN_UP uterine fibroid DOID_13223 2.239E-07 9.798E-06 9.775E-06 3.708E-04 LU_AGING_BRAIN_UP papilloma DOID_2615 4.135E-07 1.68E-05 4.135E-07 2.941E-05 LU_AGING_BRAIN_UP endocrine organ benign neoplasm DOID_0060089 5.66E-07 2.147E-05 5.66E-07 3.579E-05 LU_AGING_BRAIN_UP adenoma DOID_657 6.251E-07 2.223E-05 6.251E-07 3.557E-05 LU_AGING_BRAIN_UP male reproductive system disease DOID_48 7.246E-07 2.425E-05 1.554E-05 4.912E-04 LU_AGING_BRAIN_UP bone development disease DOID_0080006 1.764E-06 5.577E-05 1.764E-06 9.126E-05 LU_AGING_BRAIN_UP brain cancer DOID_1319 2.216E-06 6.637E-05 5.903E-05 1.292E-03 LU_AGING_BRAIN_UP central nervous system cancer DOID_3620 2.449E-06 6.967E-05 6.385E-05 1.346E-03 LU_AGING_BRAIN_UP giant cell tumor DOID_200 3.915E-06 1.061E-04 1.705E-03 0.01469774 LU_AGING_BRAIN_UP malignant giant cell tumor DOID_2705 3.915E-06 1.061E-04 1.705E-03 0.01469774 LU_AGING_BRAIN_UP giant cell glioblastoma DOID_3074 3.915E-06 1.061E-04 1.705E-03 0.01469774 LU_AGING_BRAIN_UP reproductive organ benign neoplasm DOID_0050622 4.665E-06 1.207E-04 1.06E-04 2.153E-03 LU_AGING_BRAIN_UP glioblastoma DOID_3068 5.996E-06 1.483E-04 2.18E-03 0.01610832 LU_AGING_BRAIN_UP oral cavity cancer DOID_8618 5.996E-06 1.422E-04 5.996E-06 2.437E-04 LU_AGING_BRAIN_UP congenital heart defect DOID_1682 8.856E-06 2.016E-04 1.754E-04 3.024E-03 LU_AGING_BRAIN_UP corneal disease DOID_10124 9.775E-06 2.139E-04 0.12588771 0.28200829 LU_AGING_BRAIN_UP Charcot-Marie-Tooth disease DOID_10595 1.252E-05 2.639E-04 1.252E-05 4.454E-04 LU_AGING_BRAIN_UP germinoma DOID_3304 1.252E-05 2.545E-04 3.937E-04 5.464E-03 LU_AGING_BRAIN_UP astrocytoma DOID_3069 1.359E-05 2.666E-04 3.493E-03 0.02233144 LU_AGING_BRAIN_UP spindle cell carcinoma DOID_4015 1.766E-05 3.35E-04 1.766E-05 5.289E-04 LU_AGING_BRAIN_UP aneurysm disease DOID_2403 2.138E-05 3.923E-04 2.138E-05 5.792E-04 LU_AGING_BRAIN_UP skeletal system cancer DOID_0060124 3.174E-05 5.644E-04 3.174E-05 8.209E-04 LU_AGING_BRAIN_UP bone cancer DOID_184 3.174E-05 5.644E-04 3.174E-05 8.209E-04 LU_AGING_BRAIN_UP hyperinsulinism DOID_2018 4.238E-05 7.307E-04 9.626E-04 0.01053353 LU_AGING_BRAIN_UP endometriosis DOID_289 4.238E-05 7.092E-04 9.626E-04 0.01033478 LU_AGING_BRAIN_UP lymphoma DOID_0060058 4.949E-05 8.046E-04 4.949E-05 1.224E-03 LU_AGING_BRAIN_UP cataract DOID_83 5.02E-05 7.935E-04 5.02E-05 1.19E-03 LU_AGING_BRAIN_UP dilated cardiomyopathy DOID_12930 5.753E-05 8.847E-04 7.623E-04 9.229E-03 LU_AGING_BRAIN_UP pre-eclampsia DOID_10591 5.903E-05 8.839E-04 0.0187708 0.08153117 LU_AGING_BRAIN_UP lens disease DOID_110 5.903E-05 8.613E-04 5.903E-05 1.344E-03 LU_AGING_BRAIN_UP brain edema DOID_4724 7.831E-05 1.114E-03 3.16E-03 0.02066944 LU_AGING_BRAIN_UP parasitic protozoa infectious disease DOID_2789 1.06E-04 1.47E-03 1.886E-03 0.01470146 LU_AGING_BRAIN_UP diabetic angiopathy DOID_11713 1.373E-04 1.86E-03 0.0959758 0.23743578 LU_AGING_BRAIN_UP synostosis DOID_11971 1.373E-04 1.817E-03 1.373E-04 2.694E-03 LU_AGING_BRAIN_UP Lewy body dementia DOID_12217 1.373E-04 1.776E-03 1.373E-04 2.605E-03 LU_AGING_BRAIN_UP spastic quadriplegia DOID_10970 1.556E-04 1.967E-03 1.556E-04 2.856E-03 LU_AGING_BRAIN_UP carotid artery disease DOID_3407 1.556E-04 1.925E-03 1.556E-04 2.767E-03 LU_AGING_BRAIN_UP endocrine pancreas disease DOID_1428 1.859E-04 2.251E-03 2.849E-03 0.01929739 LU_AGING_BRAIN_UP morbid obesity DOID_11981 1.966E-04 2.331E-03 1.966E-04 3.291E-03 LU_AGING_BRAIN_UP cleft lip DOID_9296 1.966E-04 2.283E-03 5.727E-03 0.03258774 LU_AGING_BRAIN_UP parasitic infectious disease DOID_1398 1.969E-04 2.24E-03 2.971E-03 0.01965843 LU_AGING_BRAIN_UP spinal cord disease DOID_319 2.196E-04 2.45E-03 6.151E-03 0.03465187 LU_AGING_BRAIN_UP seminoma DOID_4440 2.196E-04 2.402E-03 6.151E-03 0.03431215 LU_AGING_BRAIN_UP diffuse large B-cell lymphoma DOID_0050745 2.441E-04 2.621E-03 2.441E-04 3.969E-03 LU_AGING_BRAIN_UP gestational diabetes DOID_11714 2.441E-04 2.573E-03 6.588E-03 0.03604612 LU_AGING_BRAIN_UP migraine DOID_6364 2.441E-04 2.526E-03 2.441E-04 3.859E-03 LU_AGING_BRAIN_UP malaria DOID_12365 2.704E-04 2.748E-03 7.04E-03 0.03778846 LU_AGING_BRAIN_UP coronary stenosis DOID_4248 2.704E-04 2.7E-03 7.04E-03 0.03674841 LU_AGING_BRAIN_UP nephrosis DOID_2527 2.728E-04 2.676E-03 3.773E-03 0.02385685 LU_AGING_BRAIN_UP peripheral vascular disease DOID_341 2.872E-04 2.77E-03 0.27059246 0.52728463 LU_AGING_BRAIN_UP supratentorial cancer DOID_1659 2.985E-04 2.831E-03 2.985E-04 4.59E-03 LU_AGING_BRAIN_UP cerebrum cancer DOID_368 2.985E-04 2.831E-03 2.985E-04 4.59E-03 LU_AGING_BRAIN_UP diabetic retinopathy DOID_8947 3.022E-04 2.819E-03 0.0407007 0.15439131 LU_AGING_BRAIN_UP dysostosis DOID_1934 3.284E-04 3.013E-03 3.284E-04 4.917E-03 LU_AGING_BRAIN_UP syndrome DOID_225 3.338E-04 3.015E-03 0.04265508 0.15074993 LU_AGING_BRAIN_UP spastic cerebral palsy DOID_0050669 3.601E-04 3.201E-03 3.601E-04 5.254E-03 LU_AGING_BRAIN_UP celiac disease DOID_10608 3.937E-04 3.447E-03 3.937E-04 5.601E-03 LU_AGING_BRAIN_UP metabolic syndrome X DOID_14221 4.04E-04 3.483E-03 5.031E-03 0.02981945 LU_AGING_BRAIN_UP female reproductive system disease DOID_229 4.231E-04 3.593E-03 5.204E-03 0.03052566 LU_AGING_BRAIN_UP autonomic nervous system neoplasm DOID_2621 4.293E-04 3.592E-03 9.498E-03 0.04658976 LU_AGING_BRAIN_UP neuroblastoma DOID_769 4.293E-04 3.592E-03 9.498E-03 0.04658976 LU_AGING_BRAIN_UP biliary tract cancer DOID_4607 4.632E-04 3.82E-03 5.56E-03 0.03195638 LU_AGING_BRAIN_UP myocarditis DOID_820 4.669E-04 3.795E-03 4.669E-04 6.325E-03 LU_AGING_BRAIN_UP retinal vascular disease DOID_2462 5.059E-04 4.054E-03 0.05186643 0.15952432 LU_AGING_BRAIN_UP male infertility DOID_12336 5.065E-04 4.003E-03 5.065E-04 6.703E-03 LU_AGING_BRAIN_UP lymphoid leukemia DOID_10747 5.483E-04 4.273E-03 5.483E-04 7.09E-03 LU_AGING_BRAIN_UP amino acid metabolic disorder DOID_9252 5.996E-04 4.61E-03 5.996E-04 7.582E-03 LU_AGING_BRAIN_UP cleft palate DOID_674 6.382E-04 4.842E-03 0.0122823 0.05922565 LU_AGING_BRAIN_UP peripheral nervous system neoplasm DOID_1192 6.865E-04 5.139E-03 0.01287696 0.06105823 LU_AGING_BRAIN_UP lymphoblastic leukemia DOID_1037 7.05E-04 5.21E-03 7.05E-04 8.721E-03 LU_AGING_BRAIN_UP congenital diaphragmatic hernia DOID_3827 7.37E-04 5.376E-03 0.01348395 0.06340801 LU_AGING_BRAIN_UP Sjogren's syndrome DOID_12894 7.694E-04 5.542E-03 7.694E-04 9.121E-03 LU_AGING_BRAIN_UP adenoid cystic carcinoma DOID_4866 7.898E-04 5.618E-03 7.898E-04 9.172E-03 LU_AGING_BRAIN_UP lymphatic system disease DOID_75 7.898E-04 5.548E-03 0.16541699 0.34731465 LU_AGING_BRAIN_UP benign mesothelioma DOID_2645 8.45E-04 5.864E-03 0.01473452 0.06816212 LU_AGING_BRAIN_UP endometriosis of uterus DOID_288 9.026E-04 6.188E-03 0.01537786 0.07056454 LU_AGING_BRAIN_UP salivary gland cancer DOID_8850 9.026E-04 6.114E-03 9.026E-04 0.01027188 LU_AGING_BRAIN_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 9.378E-04 6.278E-03 9.378E-04 0.01046279 LU_AGING_BRAIN_UP nervous system benign neoplasm DOID_0060115 9.378E-04 6.205E-03 0.04518483 0.1558192 LU_AGING_BRAIN_UP sickle cell anemia DOID_10923 9.378E-04 6.133E-03 0.04518483 0.15303671 LU_AGING_BRAIN_UP diabetic autonomic neuropathy DOID_11503 1.025E-03 6.628E-03 0.01670012 0.07601895 LU_AGING_BRAIN_UP autonomic neuropathy DOID_11504 1.025E-03 6.628E-03 0.01670012 0.07601895 LU_AGING_BRAIN_UP diabetic polyneuropathy DOID_12785 1.025E-03 6.628E-03 0.01670012 0.07601895 LU_AGING_BRAIN_UP gallbladder cancer DOID_3121 1.025E-03 6.554E-03 0.01670012 0.07541562 LU_AGING_BRAIN_UP diabetic neuropathy DOID_9743 1.025E-03 6.628E-03 0.01670012 0.07601895 LU_AGING_BRAIN_UP learning disability DOID_8927 1.09E-03 6.892E-03 0.01737882 0.07725427 LU_AGING_BRAIN_UP relapsing-remitting multiple sclerosis DOID_2378 1.122E-03 7.017E-03 1.122E-03 0.01182518 LU_AGING_BRAIN_UP proteinuria DOID_576 1.158E-03 7.16E-03 0.01806908 0.07970004 LU_AGING_BRAIN_UP myeloma DOID_0070004 1.228E-03 7.512E-03 0.0187708 0.08215834 LU_AGING_BRAIN_UP autonomic nervous system disease DOID_11465 1.228E-03 7.432E-03 0.0187708 0.08091351 LU_AGING_BRAIN_UP polyneuropathy DOID_1389 1.323E-03 7.922E-03 1.323E-03 0.01368336 LU_AGING_BRAIN_UP impotence DOID_1875 1.323E-03 7.839E-03 1.323E-03 0.01343902 LU_AGING_BRAIN_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.376E-03 8.071E-03 1.376E-03 0.01373527 LU_AGING_BRAIN_UP integumentary system benign neoplasm DOID_0060121 1.376E-03 7.989E-03 1.376E-03 0.01349846 LU_AGING_BRAIN_UP skin benign neoplasm DOID_3165 1.376E-03 7.989E-03 1.376E-03 0.01349846 LU_AGING_BRAIN_UP aortic aneurysm DOID_3627 1.454E-03 8.357E-03 1.454E-03 0.01402284 LU_AGING_BRAIN_UP B-cell lymphocytic neoplasm DOID_707 1.535E-03 8.733E-03 1.535E-03 0.01455562 LU_AGING_BRAIN_UP open-angle glaucoma DOID_1067 1.539E-03 8.669E-03 1.539E-03 0.0143541 LU_AGING_BRAIN_UP tethered spinal cord syndrome DOID_1089 1.539E-03 8.584E-03 1.539E-03 0.01412258 LU_AGING_BRAIN_UP congenital structural myopathy DOID_422 1.539E-03 8.501E-03 1.539E-03 0.01389842 LU_AGING_BRAIN_UP Zellweger syndrome DOID_905 1.539E-03 8.419E-03 1.539E-03 0.01368125 LU_AGING_BRAIN_UP bacterial meningitis DOID_9470 1.539E-03 8.339E-03 1.539E-03 0.01347077 LU_AGING_BRAIN_UP orofacial cleft DOID_0050567 1.618E-03 8.688E-03 0.02244756 0.0946123 LU_AGING_BRAIN_UP peripheral neuropathy DOID_0060053 1.771E-03 9.416E-03 1.771E-03 0.01503775 LU_AGING_BRAIN_UP hemangioma DOID_255 1.771E-03 9.329E-03 1.771E-03 0.01481661 LU_AGING_BRAIN_UP hyperhomocysteinemia DOID_9279 1.771E-03 9.243E-03 1.771E-03 0.01460188 LU_AGING_BRAIN_UP bile duct adenocarcinoma DOID_4896 1.794E-03 9.28E-03 0.02399478 0.10038992 LU_AGING_BRAIN_UP cholangiocarcinoma DOID_4947 1.794E-03 9.28E-03 0.02399478 0.10038992 LU_AGING_BRAIN_UP bone marrow cancer DOID_4960 1.794E-03 9.197E-03 0.02399478 0.09965715 LU_AGING_BRAIN_UP vasculitis DOID_865 1.794E-03 9.114E-03 1.794E-03 0.01458306 LU_AGING_BRAIN_UP integumentary system cancer DOID_0060122 1.886E-03 9.497E-03 1.886E-03 0.01511559 LU_AGING_BRAIN_UP osteochondrodysplasia DOID_2256 1.886E-03 9.414E-03 1.886E-03 0.01490565 LU_AGING_BRAIN_UP skin cancer DOID_4159 1.886E-03 9.497E-03 1.886E-03 0.01511559 LU_AGING_BRAIN_UP pustulosis of palm and sole DOID_4398 1.886E-03 9.332E-03 0.02478437 0.10219064 LU_AGING_BRAIN_UP smallpox DOID_8736 1.886E-03 9.252E-03 1.886E-03 0.01450279 LU_AGING_BRAIN_UP tongue cancer DOID_8649 2.018E-03 9.815E-03 2.018E-03 0.01531062 LU_AGING_BRAIN_UP hypertrophic cardiomyopathy DOID_11984 2.18E-03 0.01051136 2.18E-03 0.01632027 LU_AGING_BRAIN_UP bile duct cancer DOID_4606 2.18E-03 0.01042303 0.02721588 0.1098286 LU_AGING_BRAIN_UP bile duct carcinoma DOID_4897 2.18E-03 0.01042303 0.02721588 0.1098286 LU_AGING_BRAIN_UP lymphatic system cancer DOID_0060073 2.281E-03 0.01081522 2.281E-03 0.0166388 LU_AGING_BRAIN_UP penile disease DOID_1529 2.281E-03 0.01072584 2.281E-03 0.01642818 LU_AGING_BRAIN_UP hyperostosis DOID_205 2.281E-03 0.01063792 2.281E-03 0.01622283 LU_AGING_BRAIN_UP reticulosarcoma DOID_8538 2.281E-03 0.01081522 2.281E-03 0.0166388 LU_AGING_BRAIN_UP lymphosarcoma DOID_8675 2.281E-03 0.01081522 2.281E-03 0.0166388 LU_AGING_BRAIN_UP peroxisomal disease DOID_906 2.281E-03 0.01055143 2.281E-03 0.01602254 LU_AGING_BRAIN_UP melancholia DOID_2848 2.284E-03 0.01047928 0.02804695 0.1123853 LU_AGING_BRAIN_UP neurotic disorder DOID_4964 2.391E-03 0.0108819 0.02888814 0.11494651 LU_AGING_BRAIN_UP sexual dysfunction DOID_1876 2.559E-03 0.0115559 2.559E-03 0.01775662 LU_AGING_BRAIN_UP pre-malignant neoplasm DOID_0060071 2.73E-03 0.01222941 0.03147146 0.12349835 LU_AGING_BRAIN_UP in situ carcinoma DOID_8719 2.73E-03 0.01222941 0.03147146 0.12349835 LU_AGING_BRAIN_UP mineral metabolism disease DOID_0050032 2.849E-03 0.01266391 2.849E-03 0.01952989 LU_AGING_BRAIN_UP Down syndrome DOID_14250 2.852E-03 0.01258041 2.852E-03 0.01909262 LU_AGING_BRAIN_UP uterine disease DOID_345 2.971E-03 0.01300481 0.03324249 0.12955462 LU_AGING_BRAIN_UP temporal lobe epilepsy DOID_3328 3.097E-03 0.01345102 0.03414236 0.13215647 LU_AGING_BRAIN_UP hyperglycemia DOID_4195 3.097E-03 0.01334912 0.03414236 0.13126352 LU_AGING_BRAIN_UP pulmonary edema DOID_11396 3.16E-03 0.01352061 0.08064062 0.21047941 LU_AGING_BRAIN_UP subependymal glioma DOID_4843 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP pilocytic astrocytoma DOID_4851 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP subependymal giant cell astrocytoma DOID_5077 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP fibrillary astrocytoma DOID_6726 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP juvenile pilocytic astrocytoma DOID_6811 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP childhood pilocytic astrocytoma DOID_6812 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP gemistocytic astrocytoma DOID_7005 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP childhood cerebral astrocytoma DOID_7007 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP protoplasmic astrocytoma DOID_7008 3.16E-03 0.01341971 3.16E-03 0.02043456 LU_AGING_BRAIN_UP brain infarction DOID_3454 3.358E-03 0.0141519 0.03597034 0.13736325 LU_AGING_BRAIN_UP Kawasaki disease DOID_13378 3.483E-03 0.01457408 1.000 1.000 LU_AGING_BRAIN_UP lymphadenitis DOID_1602 3.483E-03 0.01457408 1.000 1.000 LU_AGING_BRAIN_UP lymph node disease DOID_9942 3.483E-03 0.01457408 1.000 1.000 LU_AGING_BRAIN_UP benign glioma DOID_0060101 3.821E-03 0.0158708 3.821E-03 0.0238934 LU_AGING_BRAIN_UP benign ependymoma DOID_4844 3.821E-03 0.0158708 3.821E-03 0.0238934 LU_AGING_BRAIN_UP biliary tract disease DOID_9741 3.919E-03 0.01615776 0.27059246 0.52548502 LU_AGING_BRAIN_UP sexual disorder DOID_0060043 4.174E-03 0.01708521 4.174E-03 0.02581352 LU_AGING_BRAIN_UP polyarteritis nodosa DOID_9810 4.174E-03 0.01696317 1.000 1.000 LU_AGING_BRAIN_UP endogenous depression DOID_1595 4.375E-03 0.0176544 0.04265508 0.15169212 LU_AGING_BRAIN_UP bone resorption disease DOID_0080011 4.534E-03 0.01816662 4.534E-03 0.02773828 LU_AGING_BRAIN_UP osteoporosis DOID_11476 4.534E-03 0.01816662 4.534E-03 0.02773828 LU_AGING_BRAIN_UP meningitis DOID_9471 4.541E-03 0.01806738 4.541E-03 0.02748548 LU_AGING_BRAIN_UP electroclinical syndrome DOID_0050701 4.696E-03 0.01855565 0.04464394 0.15680496 LU_AGING_BRAIN_UP mixed glioma DOID_5076 4.696E-03 0.01842768 0.04464394 0.15584297 LU_AGING_BRAIN_UP sphingolipidosis DOID_1927 4.922E-03 0.0191822 4.922E-03 0.02948002 LU_AGING_BRAIN_UP alcohol abuse DOID_1574 5.56E-03 0.02152164 5.56E-03 0.03228246 LU_AGING_BRAIN_UP mental depression DOID_1596 5.56E-03 0.02137623 0.04976237 0.15557576 LU_AGING_BRAIN_UP focal epilepsy DOID_2234 5.56E-03 0.02123276 0.04976237 0.15472562 LU_AGING_BRAIN_UP spinal muscular atrophy DOID_12377 5.727E-03 0.02172516 0.10731013 0.25872653 LU_AGING_BRAIN_UP B cell deficiency DOID_2115 6.151E-03 0.02317774 0.11105677 0.26329708 LU_AGING_BRAIN_UP Sciatic Neuropathy DOID_11446 6.588E-03 0.02466314 6.588E-03 0.03639608 LU_AGING_BRAIN_UP lesion of sciatic nerve DOID_12528 6.588E-03 0.02466314 6.588E-03 0.03639608 LU_AGING_BRAIN_UP periodontitis DOID_824 6.588E-03 0.02450194 1.000 1.000 LU_AGING_BRAIN_UP mononeuritis of lower limb DOID_9473 6.588E-03 0.02466314 6.588E-03 0.03639608 LU_AGING_BRAIN_UP primary immunodeficiency disease DOID_612 6.715E-03 0.02481108 0.05616803 0.16474026 LU_AGING_BRAIN_UP autoimmune disease of cardiovascular system DOID_0060051 7.04E-03 0.02584243 7.04E-03 0.03814835 LU_AGING_BRAIN_UP sarcoma DOID_1115 7.04E-03 0.02567677 1.000 1.000 LU_AGING_BRAIN_UP Behcet's disease DOID_13241 7.04E-03 0.02584243 7.04E-03 0.03814835 LU_AGING_BRAIN_UP mononeuritis DOID_1802 7.04E-03 0.02551323 7.04E-03 0.0374353 LU_AGING_BRAIN_UP invasive ductal carcinoma DOID_3008 7.04E-03 0.02535175 7.04E-03 0.03708867 LU_AGING_BRAIN_UP renal tubular transport disease DOID_447 7.04E-03 0.02519231 7.04E-03 0.03641433 LU_AGING_BRAIN_UP polycystic ovary syndrome DOID_11612 7.505E-03 0.02668819 0.12220319 0.27925146 LU_AGING_BRAIN_UP mononeuropathy DOID_1188 7.505E-03 0.02652242 7.505E-03 0.03846946 LU_AGING_BRAIN_UP toxic encephalopathy DOID_3602 7.505E-03 0.02635871 7.505E-03 0.03812598 LU_AGING_BRAIN_UP encephalomyelitis DOID_640 7.559E-03 0.0263853 0.06058988 0.1723782 LU_AGING_BRAIN_UP mouth disease DOID_403 7.779E-03 0.02698829 0.33234342 0.63245286 LU_AGING_BRAIN_UP endometrial carcinoma DOID_2871 7.983E-03 0.02752926 7.983E-03 0.0401976 LU_AGING_BRAIN_UP age related macular degeneration DOID_10871 8.475E-03 0.02904918 0.12955686 0.28908962 LU_AGING_BRAIN_UP degeneration of macula and posterior pole DOID_2007 8.475E-03 0.02904918 0.12955686 0.28908962 LU_AGING_BRAIN_UP abdominal aortic aneurysm DOID_7693 8.475E-03 0.02887523 8.475E-03 0.04229968 LU_AGING_BRAIN_UP endometrial cancer DOID_1380 8.98E-03 0.03041397 8.98E-03 0.04443085 LU_AGING_BRAIN_UP metal metabolism disorder DOID_896 0.01002933 0.03376741 0.14047274 0.30860614 LU_AGING_BRAIN_UP nephroblastoma DOID_2154 0.01057349 0.03539011 0.01057349 0.05142153 LU_AGING_BRAIN_UP periodontal disease DOID_3388 0.01057349 0.03518315 1.000 1.000 LU_AGING_BRAIN_UP macular degeneration DOID_4448 0.01057349 0.0349786 0.14408106 0.31410774 LU_AGING_BRAIN_UP multiple myeloma DOID_9538 0.0122823 0.04039669 0.0122823 0.05872796 LU_AGING_BRAIN_UP blood platelet disease DOID_2218 0.01287696 0.04210912 0.1583644 0.33622889 LU_AGING_BRAIN_UP peptic ulcer DOID_750 0.01348395 0.04384211 0.16189807 0.34118519 LU_AGING_BRAIN_UP intracranial arterial disease DOID_13089 0.01410318 0.04559493 0.01410318 0.0657763 LU_AGING_BRAIN_UP cerebral arterial disease DOID_3527 0.01410318 0.04559493 0.01410318 0.0657763 LU_AGING_BRAIN_UP cervix uteri carcinoma in situ DOID_8991 0.01473452 0.0473669 0.16892124 0.35336832 LU_AGING_BRAIN_UP nephrotic syndrome DOID_1184 0.0160331 0.05125187 0.17588592 0.36392396 LU_AGING_BRAIN_UP uterine cancer DOID_363 0.01670012 0.05308586 0.01670012 0.0748218 LU_AGING_BRAIN_UP neuritis DOID_1803 0.0187708 0.05933658 0.0187708 0.08030514 LU_AGING_BRAIN_UP vascular skin disease DOID_9540 0.0187708 0.05900875 1.000 1.000 LU_AGING_BRAIN_UP hemolytic anemia DOID_583 0.01948387 0.06091386 0.19304492 0.39229486 LU_AGING_BRAIN_UP normocytic anemia DOID_720 0.01948387 0.06091386 0.19304492 0.39229486 LU_AGING_BRAIN_UP calcium metabolism disease DOID_10575 0.02094364 0.06511985 0.02094364 0.08893234 LU_AGING_BRAIN_UP hemorrhagic disease DOID_2213 0.02169013 0.06707438 0.20316942 0.40849257 LU_AGING_BRAIN_UP congenital nervous system abnormality DOID_2490 0.02639502 0.08118253 0.02639502 0.10804869 LU_AGING_BRAIN_UP nonsyndromic deafness DOID_0050563 0.02721588 0.08325717 0.02721588 0.11061309 LU_AGING_BRAIN_UP collagen disease DOID_854 0.02973935 0.09049033 1.000 1.000 LU_AGING_BRAIN_UP respiratory failure DOID_11162 0.03060049 0.09261532 0.23922436 0.47428105 LU_AGING_BRAIN_UP hypothyroidism DOID_1459 0.03060049 0.09212529 0.03060049 0.12091445 LU_AGING_BRAIN_UP cholestasis DOID_13580 0.03324249 0.0995525 0.24877298 0.49149939 VALK_AML_CLUSTER_1 tooth disease DOID_1091 5.719E-06 3.254E-03 5.631E-04 0.0801035 VALK_AML_CLUSTER_1 mouth disease DOID_403 1.48E-05 4.212E-03 1.055E-03 0.10005447 VALK_AML_CLUSTER_1 dental caries DOID_216 3.623E-05 6.872E-03 8.985E-03 0.56803948 VALK_AML_CLUSTER_1 agammaglobulinemia DOID_2583 4.049E-05 5.759E-03 4.049E-05 0.02303606 VALK_AML_CLUSTER_1 blood protein disease DOID_620 4.497E-05 5.118E-03 4.497E-05 0.01279399 VALK_AML_CLUSTER_1 osteosarcoma DOID_3347 7.678E-05 7.282E-03 0.01295346 0.5669629 VALK_AML_CLUSTER_1 B cell deficiency DOID_2115 8.925E-05 7.255E-03 8.925E-05 0.01692834 VALK_AML_CLUSTER_1 teeth hard tissue disease DOID_214 8.925E-05 6.348E-03 0.01394327 0.56669415 VALK_AML_CLUSTER_1 giant cell tumor DOID_200 3.606E-04 0.02279757 0.02770221 0.75059807 VALK_AML_CLUSTER_1 malignant giant cell tumor DOID_2705 3.606E-04 0.02279757 0.02770221 0.75059807 VALK_AML_CLUSTER_1 giant cell glioblastoma DOID_3074 3.606E-04 0.02279757 0.02770221 0.75059807 VALK_AML_CLUSTER_1 glioblastoma DOID_3068 4.279E-04 0.02434517 0.03013995 0.68598524 VALK_AML_CLUSTER_1 allergic contact dermatitis DOID_3042 5.631E-04 0.02912854 0.03451329 0.75531005 VALK_AML_CLUSTER_1 astrocytoma DOID_3069 5.956E-04 0.02824324 0.0354826 0.72105716 VALK_AML_CLUSTER_1 endogenous depression DOID_1595 6.986E-04 0.03057516 1.000 1.000 VALK_AML_CLUSTER_1 contact dermatitis DOID_2773 7.716E-04 0.03136021 0.04031535 0.79101503 VALK_AML_CLUSTER_1 mental depression DOID_1596 8.287E-04 0.03143591 1.000 1.000 VALK_AML_CLUSTER_1 primary immunodeficiency disease DOID_612 9.489E-04 0.03374466 9.489E-04 0.10798291 ROZANOV_MMP14_TARGETS_SUBSET giant cell tumor DOID_200 5.294E-06 3.012E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_SUBSET malignant giant cell tumor DOID_2705 5.294E-06 3.012E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_SUBSET giant cell glioblastoma DOID_3074 5.294E-06 3.012E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_SUBSET glioblastoma DOID_3068 6.86E-06 1.952E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_SUBSET mineral metabolism disease DOID_0050032 9.109E-06 1.728E-03 0.03987867 0.46308084 ROZANOV_MMP14_TARGETS_SUBSET astrocytoma DOID_3069 1.132E-05 1.61E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_SUBSET encephalomyelitis DOID_640 2.603E-05 2.962E-03 0.05608966 0.59101879 ROZANOV_MMP14_TARGETS_SUBSET osteogenesis imperfecta DOID_12347 2.735E-05 2.594E-03 2.735E-05 0.01556231 ROZANOV_MMP14_TARGETS_SUBSET ulcerative colitis DOID_8577 3.035E-05 2.467E-03 1.681E-03 0.08694722 ROZANOV_MMP14_TARGETS_SUBSET congenital muscular dystrophy DOID_0050557 5.355E-05 3.809E-03 5.355E-05 0.01523488 ROZANOV_MMP14_TARGETS_SUBSET spastic quadriplegia DOID_10970 1.047E-04 6.621E-03 1.047E-04 0.01986348 ROZANOV_MMP14_TARGETS_SUBSET coronary stenosis DOID_4248 1.516E-04 8.625E-03 0.01804816 0.39497704 ROZANOV_MMP14_TARGETS_SUBSET focal glomerulosclerosis DOID_3945 1.62E-04 8.378E-03 0.01864437 0.37888016 ROZANOV_MMP14_TARGETS_SUBSET spastic cerebral palsy DOID_0050669 1.838E-04 8.714E-03 1.838E-04 0.02614248 ROZANOV_MMP14_TARGETS_SUBSET allergic rhinitis DOID_4481 1.952E-04 8.543E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_SUBSET nephrotic syndrome DOID_1184 3.585E-04 0.01457142 3.585E-04 0.04079996 ROZANOV_MMP14_TARGETS_SUBSET heart valve disease DOID_4079 4.237E-04 0.01607287 0.02990671 0.4478137 ROZANOV_MMP14_TARGETS_SUBSET integumentary system benign neoplasm DOID_0060121 4.583E-04 0.01629865 0.03108501 0.45352228 ROZANOV_MMP14_TARGETS_SUBSET glaucoma DOID_1686 4.583E-04 0.01533991 1.000 1.000 ROZANOV_MMP14_TARGETS_SUBSET skin benign neoplasm DOID_3165 4.583E-04 0.01629865 0.03108501 0.45352228 ROZANOV_MMP14_TARGETS_SUBSET calcium metabolism disease DOID_10575 4.761E-04 0.01505028 0.03167364 0.43956832 ROZANOV_MMP14_TARGETS_SUBSET atrophic muscular disease DOID_913 5.315E-04 0.01591675 5.315E-04 0.05040305 ROZANOV_MMP14_TARGETS_SUBSET muscular dystrophy DOID_9884 5.315E-04 0.01591675 5.315E-04 0.05040305 ROZANOV_MMP14_TARGETS_SUBSET integumentary system cancer DOID_0060122 5.701E-04 0.01621847 0.03461168 0.4689058 ROZANOV_MMP14_TARGETS_SUBSET osteochondrodysplasia DOID_2256 5.701E-04 0.01544616 5.701E-04 0.04633848 ROZANOV_MMP14_TARGETS_SUBSET skin cancer DOID_4159 5.701E-04 0.01621847 0.03461168 0.4689058 ROZANOV_MMP14_TARGETS_SUBSET brain infarction DOID_3454 8.529E-04 0.02205915 8.529E-04 0.06066265 ROZANOV_MMP14_TARGETS_SUBSET nephrosis DOID_2527 9.26E-04 0.02290875 9.26E-04 0.05854458 ROZANOV_MMP14_TARGETS_SUBSET bone development disease DOID_0080006 1.248E-03 0.02957738 1.248E-03 0.07098572 FOURNIER_ACINAR_DEVELOPMENT_LATE_UP microcephaly DOID_10907 4.088E-05 0.02326239 9.692E-03 0.78784891 FOURNIER_ACINAR_DEVELOPMENT_LATE_UP congenital nervous system abnormality DOID_2490 8.804E-05 0.02504769 0.01415553 0.4239209 FOURNIER_ACINAR_DEVELOPMENT_LATE_UP oral cavity cancer DOID_8618 9.101E-05 0.01726238 9.101E-05 0.05178714 FOURNIER_ACINAR_DEVELOPMENT_LATE_UP bile duct disease DOID_4138 1.341E-04 0.01907832 0.01743275 0.47234441 FOURNIER_ACINAR_DEVELOPMENT_LATE_UP biliary tract disease DOID_9741 1.378E-04 0.01567888 0.01766646 0.45691895 RICKMAN_HEAD_AND_NECK_CANCER_B glaucoma DOID_1686 2.322E-06 1.321E-03 2.322E-06 1.321E-03 RICKMAN_HEAD_AND_NECK_CANCER_B lymphoma DOID_0060058 1.39E-05 3.954E-03 1.012E-03 0.0261722 RICKMAN_HEAD_AND_NECK_CANCER_B lymphoblastic leukemia DOID_1037 1.435E-05 2.721E-03 1.033E-03 0.02556502 RICKMAN_HEAD_AND_NECK_CANCER_B granulosa cell tumor DOID_2999 4.049E-05 5.759E-03 4.049E-05 0.01151803 RICKMAN_HEAD_AND_NECK_CANCER_B sex cord-gonadal stromal tumor DOID_192 4.497E-05 5.118E-03 4.497E-05 8.529E-03 RICKMAN_HEAD_AND_NECK_CANCER_B autosomal dominant nonsyndromic deafness DOID_0050564 8.29E-05 7.862E-03 8.29E-05 0.0117929 RICKMAN_HEAD_AND_NECK_CANCER_B multiple epiphyseal dysplasia DOID_12721 1.097E-04 8.917E-03 1.097E-04 0.01248353 RICKMAN_HEAD_AND_NECK_CANCER_B autonomic nervous system neoplasm DOID_2621 1.402E-04 9.972E-03 1.402E-04 0.01329539 RICKMAN_HEAD_AND_NECK_CANCER_B neuroblastoma DOID_769 1.402E-04 9.972E-03 1.402E-04 0.01329539 RICKMAN_HEAD_AND_NECK_CANCER_B nephroblastoma DOID_2154 1.568E-04 9.915E-03 1.568E-04 0.01274829 RICKMAN_HEAD_AND_NECK_CANCER_B lymphoid leukemia DOID_10747 1.655E-04 9.417E-03 1.655E-04 0.01177094 RICKMAN_HEAD_AND_NECK_CANCER_B peripheral nervous system neoplasm DOID_1192 1.929E-04 9.976E-03 1.929E-04 0.01219349 RICKMAN_HEAD_AND_NECK_CANCER_B benign mesothelioma DOID_2645 2.223E-04 0.01054089 2.223E-04 0.01264907 RICKMAN_HEAD_AND_NECK_CANCER_B cervix uteri carcinoma in situ DOID_8991 2.223E-04 9.73E-03 2.223E-04 0.01149915 RICKMAN_HEAD_AND_NECK_CANCER_B movement disease DOID_480 3.23E-04 0.01312565 3.23E-04 0.01531326 RICKMAN_HEAD_AND_NECK_CANCER_B B-cell lymphocytic neoplasm DOID_707 3.353E-04 0.01271798 0.02672549 0.21724009 RICKMAN_HEAD_AND_NECK_CANCER_B atrophic muscular disease DOID_913 3.606E-04 0.01282363 3.606E-04 0.01578293 RICKMAN_HEAD_AND_NECK_CANCER_B muscular dystrophy DOID_9884 3.606E-04 0.01282363 3.606E-04 0.01578293 RICKMAN_HEAD_AND_NECK_CANCER_B osteochondrodysplasia DOID_2256 3.868E-04 0.01294717 3.868E-04 0.01572156 RICKMAN_HEAD_AND_NECK_CANCER_B nonsyndromic deafness DOID_0050563 4.279E-04 0.01352509 4.279E-04 0.01623011 RICKMAN_HEAD_AND_NECK_CANCER_B pre-malignant neoplasm DOID_0060071 5.008E-04 0.01499639 5.008E-04 0.01780822 RICKMAN_HEAD_AND_NECK_CANCER_B in situ carcinoma DOID_8719 5.008E-04 0.01499639 5.008E-04 0.01780822 RICKMAN_HEAD_AND_NECK_CANCER_B mixed glioma DOID_5076 7.346E-04 0.0209004 7.346E-04 0.0245887 RICKMAN_HEAD_AND_NECK_CANCER_B auditory system disease DOID_2742 8.095E-04 0.02193243 8.095E-04 0.02558784 RICKMAN_HEAD_AND_NECK_CANCER_B bone development disease DOID_0080006 8.482E-04 0.02193735 8.482E-04 0.02540114 RICKMAN_HEAD_AND_NECK_CANCER_B transitional cell carcinoma DOID_2671 9.283E-04 0.02296548 9.283E-04 0.0264103 RICKMAN_HEAD_AND_NECK_CANCER_B nervous system cancer DOID_3093 9.697E-04 0.0229895 9.697E-04 0.02627371 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN oral cavity cancer DOID_8618 8.376E-09 4.766E-06 7.141E-07 1.354E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN adenoid cystic carcinoma DOID_4866 1.714E-07 4.876E-05 1.625E-05 1.541E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN salivary gland cancer DOID_8850 2.066E-07 3.918E-05 1.865E-05 1.516E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN epidermolysis bullosa DOID_2730 2.969E-07 4.223E-05 2.969E-07 1.689E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN vesiculobullous skin disease DOID_2731 3.856E-07 4.388E-05 3.856E-07 1.097E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN mineral metabolism disease DOID_0050032 1.044E-06 9.897E-05 1.044E-06 1.485E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN cystitis DOID_1679 3.9E-06 3.171E-04 0.03018724 0.40896521 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN bladder disease DOID_365 8.673E-06 6.168E-04 0.03895938 0.42630554 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN calcinosis DOID_182 1.304E-05 8.244E-04 1.304E-05 1.484E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN calcium metabolism disease DOID_10575 3.06E-05 1.741E-03 3.06E-05 2.177E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN aortic aneurysm DOID_3627 3.06E-05 1.583E-03 3.06E-05 1.935E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN pre-malignant neoplasm DOID_0060071 5.917E-05 2.806E-03 2.574E-03 0.07708705 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN in situ carcinoma DOID_8719 5.917E-05 2.806E-03 2.574E-03 0.07708705 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN aneurysm disease DOID_2403 1.012E-04 4.43E-03 1.012E-04 5.759E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN basal cell carcinoma DOID_2513 1.691E-04 6.871E-03 1.691E-04 8.745E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN skin carcinoma DOID_3451 1.901E-04 7.209E-03 1.901E-04 9.012E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN prion disease DOID_649 1.901E-04 6.759E-03 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN brain edema DOID_4724 2.357E-04 7.888E-03 2.357E-04 0.0103154 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN sinusitis DOID_0050127 3.131E-04 9.899E-03 3.131E-04 0.01272711 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN paranasal sinus disease DOID_1352 3.131E-04 9.899E-03 3.131E-04 0.01272711 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN Goodpasture syndrome DOID_9808 3.414E-04 0.01022304 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN renal hypertension DOID_1073 5.357E-04 0.01524079 5.357E-04 0.02032106 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN secondary hypertension DOID_11130 5.357E-04 0.01524079 5.357E-04 0.02032106 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN invasive ductal carcinoma DOID_3008 5.357E-04 0.01451504 0.03348592 0.41420626 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN myocarditis DOID_820 7.725E-04 0.01997978 0.04005043 0.42997542 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN uveitis DOID_13141 1.002E-03 0.02478544 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN systemic scleroderma DOID_418 1.051E-03 0.02492242 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN adult respiratory distress syndrome DOID_11394 1.102E-03 0.02507458 1.102E-03 0.03917903 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN cervix uteri carcinoma in situ DOID_8991 1.153E-03 0.02524012 0.04873542 0.43328832 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN rheumatic disease DOID_1575 1.26E-03 0.02655373 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN uveal disease DOID_3480 1.26E-03 0.02560538 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN scleroderma DOID_419 1.26E-03 0.02655373 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN leukodystrophy DOID_10579 1.429E-03 0.0280299 0.05412451 0.45289478 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN neuritis DOID_1803 1.487E-03 0.02820427 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN glaucoma DOID_1686 1.607E-03 0.02950241 0.05734364 0.45955675 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN integumentary system cancer DOID_0060122 1.995E-03 0.0354753 1.995E-03 0.06677703 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN skin cancer DOID_4159 1.995E-03 0.0354753 1.995E-03 0.06677703 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN collagen disease DOID_854 2.423E-03 0.04177419 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN respiratory failure DOID_11162 2.498E-03 0.04180267 2.498E-03 0.0789606 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN cerebral degeneration DOID_1443 2.73E-03 0.04437821 0.07433242 0.51579449 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN nephrosis DOID_2527 3.223E-03 0.05093729 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN encephalomyelitis DOID_640 5.248E-03 0.08070375 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN hypersensitivity reaction type I disease DOID_1205 5.465E-03 0.08182406 0.10436559 0.59384022 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN dilated cardiomyopathy DOID_12930 5.465E-03 0.07972601 5.465E-03 0.15546571 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN ulcerative colitis DOID_8577 5.797E-03 0.08246384 0.1074176 0.60515458 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN lymphoma DOID_0060058 1.324E-07 7.536E-05 6.343E-06 1.203E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN Ehlers-Danlos syndrome DOID_13359 8.574E-07 2.439E-04 8.574E-07 4.879E-04 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN collagen disease DOID_854 1.359E-06 2.577E-04 1.359E-06 3.866E-04 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN lung adenocarcinoma DOID_3910 6.801E-06 9.674E-04 6.235E-04 0.02087036 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN cleft palate DOID_674 1.821E-05 2.072E-03 1.821E-05 2.59E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN orofacial cleft DOID_0050567 4.771E-05 4.525E-03 4.771E-05 5.43E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN atrophic muscular disease DOID_913 5.037E-05 4.094E-03 5.037E-05 4.776E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN muscular dystrophy DOID_9884 5.037E-05 4.094E-03 5.037E-05 4.776E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN facioscapulohumeral muscular dystrophy DOID_11727 7.018E-05 4.992E-03 7.018E-05 5.705E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.018E-05 4.437E-03 0.01259082 0.20469082 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.018E-05 4.437E-03 0.01259082 0.20469082 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN Hodgkin's granuloma DOID_8651 7.018E-05 4.437E-03 0.01259082 0.20469082 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 7.018E-05 4.437E-03 0.01259082 0.20469082 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN carotid artery disease DOID_3407 7.517E-05 4.277E-03 3.01E-03 0.07136334 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN cerebral degeneration DOID_1443 9.009E-05 4.66E-03 9.009E-05 6.408E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN peritonitis DOID_8283 1.028E-04 4.873E-03 0.0150903 0.20443759 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN Hodgkin's lymphoma DOID_8567 1.028E-04 4.498E-03 0.0150903 0.19968322 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN obstructive hydrocephalus DOID_14159 1.214E-04 4.932E-03 1.214E-04 7.672E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN communicating hydrocephalus DOID_1573 1.214E-04 4.932E-03 1.214E-04 7.672E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN hydrocephalus DOID_10908 1.415E-04 5.366E-03 1.415E-04 8.049E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN varicose veins DOID_799 1.631E-04 5.8E-03 1.631E-04 8.436E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN intracranial hypertension DOID_9428 1.631E-04 5.459E-03 1.631E-04 7.733E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN vein disease DOID_866 1.862E-04 5.887E-03 1.862E-04 8.152E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN ureteral obstruction DOID_5199 2.371E-04 7.1E-03 2.371E-04 9.636E-03 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN urinary tract obstruction DOID_5200 3.905E-04 0.01110831 3.905E-04 0.01481108 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN ureteral disease DOID_1426 4.256E-04 0.01153178 4.256E-04 0.01513547 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN hyperthyroidism DOID_7998 1.016E-03 0.0262845 1.016E-03 0.03212549 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN leukodystrophy DOID_10579 1.777E-03 0.04396671 1.777E-03 0.05322286 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN heart valve disease DOID_4079 1.85E-03 0.04385501 1.85E-03 0.05262601 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN B-cell lymphocytic neoplasm DOID_707 2.154E-03 0.04902232 2.154E-03 0.0583599 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN osteochondrodysplasia DOID_2256 2.48E-03 0.05427428 2.48E-03 0.06414233 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN hypertrophic cardiomyopathy DOID_11984 2.739E-03 0.05772081 2.739E-03 0.06775921 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN parasitic infectious disease DOID_1398 3.39E-03 0.06889585 3.39E-03 0.07716335 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN hyperglycemia DOID_4195 3.489E-03 0.06845068 3.489E-03 0.07634884 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN aneurysm disease DOID_2403 4.545E-03 0.08620337 4.545E-03 0.09578152 WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN bone development disease DOID_0080006 5.361E-03 0.09840915 5.361E-03 0.10895298 NAGASHIMA_NRG1_SIGNALING_UP cerebral infarction DOID_3526 3.182E-07 1.811E-04 1.27E-05 7.228E-03 NAGASHIMA_NRG1_SIGNALING_UP giant cell tumor DOID_200 6.966E-07 1.982E-04 6.208E-04 0.01766106 NAGASHIMA_NRG1_SIGNALING_UP malignant giant cell tumor DOID_2705 6.966E-07 1.982E-04 6.208E-04 0.01766106 NAGASHIMA_NRG1_SIGNALING_UP giant cell glioblastoma DOID_3074 6.966E-07 1.982E-04 6.208E-04 0.01766106 NAGASHIMA_NRG1_SIGNALING_UP portal hypertension DOID_10762 1.026E-06 1.946E-04 0.07406439 0.33714108 NAGASHIMA_NRG1_SIGNALING_UP glioblastoma DOID_3068 1.072E-06 1.525E-04 7.974E-04 0.01890465 NAGASHIMA_NRG1_SIGNALING_UP middle cerebral artery infarction DOID_3525 1.399E-06 1.592E-04 7.791E-05 0.01108316 NAGASHIMA_NRG1_SIGNALING_UP sarcoma DOID_1115 1.864E-06 1.768E-04 9.614E-05 9.118E-03 NAGASHIMA_NRG1_SIGNALING_UP hepatic vascular disease DOID_272 1.864E-06 1.515E-04 0.08496579 0.37188871 NAGASHIMA_NRG1_SIGNALING_UP brain infarction DOID_3454 2.292E-06 1.63E-04 6.021E-05 0.01141901 NAGASHIMA_NRG1_SIGNALING_UP astrocytoma DOID_3069 2.458E-06 1.554E-04 1.291E-03 0.02294848 NAGASHIMA_NRG1_SIGNALING_UP diabetic retinopathy DOID_8947 3.215E-06 1.829E-04 0.20154864 0.64067695 NAGASHIMA_NRG1_SIGNALING_UP pancreatitis DOID_4989 4.144E-06 2.144E-04 9.602E-05 0.01092688 NAGASHIMA_NRG1_SIGNALING_UP chronic kidney failure DOID_784 5.588E-06 2.65E-04 1.215E-04 7.684E-03 NAGASHIMA_NRG1_SIGNALING_UP retinal vascular disease DOID_2462 6.266E-06 2.742E-04 0.22717007 0.68755198 NAGASHIMA_NRG1_SIGNALING_UP peptic ulcer DOID_750 7.408E-06 3.011E-04 0.11691257 0.44948144 NAGASHIMA_NRG1_SIGNALING_UP intracranial arterial disease DOID_13089 8.149E-06 3.091E-04 2.842E-04 0.01347539 NAGASHIMA_NRG1_SIGNALING_UP cerebral arterial disease DOID_3527 8.149E-06 3.091E-04 2.842E-04 0.01347539 NAGASHIMA_NRG1_SIGNALING_UP lymphatic system disease DOID_75 8.149E-06 2.898E-04 2.842E-04 0.01243882 NAGASHIMA_NRG1_SIGNALING_UP nervous system cancer DOID_3093 8.242E-06 2.759E-04 2.604E-03 0.03445503 NAGASHIMA_NRG1_SIGNALING_UP angiosarcoma DOID_0001816 1.367E-05 4.32E-04 1.01E-03 0.02129098 NAGASHIMA_NRG1_SIGNALING_UP tongue cancer DOID_8649 1.367E-05 4.093E-04 1.367E-05 3.888E-03 NAGASHIMA_NRG1_SIGNALING_UP bronchitis DOID_6132 1.656E-05 4.711E-04 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP ureteral obstruction DOID_5199 1.983E-05 5.373E-04 1.283E-03 0.0235522 NAGASHIMA_NRG1_SIGNALING_UP pustulosis of palm and sole DOID_4398 2.708E-05 7.003E-04 6.88E-04 0.01779541 NAGASHIMA_NRG1_SIGNALING_UP hypertrophic cardiomyopathy DOID_11984 3.308E-05 8.183E-04 0.01413128 0.12182872 NAGASHIMA_NRG1_SIGNALING_UP urinary tract obstruction DOID_5200 4.258E-05 1.009E-03 2.101E-03 0.03146668 NAGASHIMA_NRG1_SIGNALING_UP congenital heart defect DOID_1682 4.517E-05 1.028E-03 0.01640631 0.13933119 NAGASHIMA_NRG1_SIGNALING_UP ureteral disease DOID_1426 4.855E-05 1.063E-03 2.288E-03 0.03254814 NAGASHIMA_NRG1_SIGNALING_UP aortic valve disease DOID_62 4.855E-05 1.023E-03 0.06856552 0.32784688 NAGASHIMA_NRG1_SIGNALING_UP osteosarcoma DOID_3347 6.21E-05 1.262E-03 2.684E-03 0.03470838 NAGASHIMA_NRG1_SIGNALING_UP pancreatic ductal carcinoma DOID_3587 6.714E-05 1.317E-03 1.343E-03 0.02315716 NAGASHIMA_NRG1_SIGNALING_UP pancreatic carcinoma DOID_4905 7.86E-05 1.491E-03 1.508E-03 0.02524211 NAGASHIMA_NRG1_SIGNALING_UP mononeuritis DOID_1802 9.614E-05 1.765E-03 9.614E-05 7.815E-03 NAGASHIMA_NRG1_SIGNALING_UP mononeuropathy DOID_1188 1.062E-04 1.889E-03 1.062E-04 7.555E-03 NAGASHIMA_NRG1_SIGNALING_UP Human immunodeficiency virus infectious disease DOID_526 1.651E-04 2.846E-03 1.651E-04 9.393E-03 NAGASHIMA_NRG1_SIGNALING_UP lymphoma DOID_0060058 1.794E-04 3.001E-03 1.794E-04 9.277E-03 NAGASHIMA_NRG1_SIGNALING_UP primitive neuroectodermal tumor DOID_168 3.473E-04 5.646E-03 3.473E-04 0.01411619 NAGASHIMA_NRG1_SIGNALING_UP transient cerebral ischemia DOID_224 3.833E-04 6.058E-03 3.833E-04 0.01453896 NAGASHIMA_NRG1_SIGNALING_UP brain cancer DOID_1319 4.446E-04 6.838E-03 0.13759375 0.51848243 NAGASHIMA_NRG1_SIGNALING_UP neuritis DOID_1803 4.446E-04 6.658E-03 4.446E-04 0.01581176 NAGASHIMA_NRG1_SIGNALING_UP heart valve disease DOID_4079 4.446E-04 6.487E-03 0.13759375 0.51507136 NAGASHIMA_NRG1_SIGNALING_UP central nervous system cancer DOID_3620 4.714E-04 6.706E-03 0.14014492 0.51446746 NAGASHIMA_NRG1_SIGNALING_UP pulmonary tuberculosis DOID_2957 4.992E-04 6.928E-03 4.992E-04 0.01670797 NAGASHIMA_NRG1_SIGNALING_UP withdrawal disorder DOID_0060001 5.579E-04 7.558E-03 5.579E-04 0.01763461 NAGASHIMA_NRG1_SIGNALING_UP epidermolysis bullosa DOID_2730 5.6E-04 7.41E-03 5.6E-04 0.01676964 NAGASHIMA_NRG1_SIGNALING_UP aortic valve insufficiency DOID_57 5.6E-04 7.241E-03 0.03488603 0.23631133 NAGASHIMA_NRG1_SIGNALING_UP bone marrow cancer DOID_4960 6.539E-04 8.268E-03 0.01241892 0.10871335 NAGASHIMA_NRG1_SIGNALING_UP vesiculobullous skin disease DOID_2731 6.605E-04 8.17E-03 6.605E-04 0.01789656 NAGASHIMA_NRG1_SIGNALING_UP hypercalcemia DOID_12678 7.691E-04 9.311E-03 7.691E-04 0.01902694 NAGASHIMA_NRG1_SIGNALING_UP oral cavity cancer DOID_8618 7.974E-04 9.452E-03 7.974E-04 0.01814846 NAGASHIMA_NRG1_SIGNALING_UP membranoproliferative glomerulonephritis DOID_2920 8.857E-04 0.01028513 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP neuroectodermal tumor DOID_171 9.172E-04 0.01043751 9.172E-04 0.02007214 NAGASHIMA_NRG1_SIGNALING_UP respiratory failure DOID_11162 9.595E-04 0.01070504 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP chronic myeloid leukemia DOID_8552 1.01E-03 0.01105493 1.01E-03 0.02053059 NAGASHIMA_NRG1_SIGNALING_UP allergic contact dermatitis DOID_3042 1.19E-03 0.01277187 1.19E-03 0.02334169 NAGASHIMA_NRG1_SIGNALING_UP tuberculosis DOID_399 1.239E-03 0.01306039 1.239E-03 0.02350871 NAGASHIMA_NRG1_SIGNALING_UP granulosa cell tumor DOID_2999 1.431E-03 0.01480803 0.05467634 0.29349847 NAGASHIMA_NRG1_SIGNALING_UP sex cord-gonadal stromal tumor DOID_192 1.587E-03 0.01612841 0.0574705 0.30000655 NAGASHIMA_NRG1_SIGNALING_UP bone resorption disease DOID_0080011 1.686E-03 0.01682864 1.686E-03 0.02740665 NAGASHIMA_NRG1_SIGNALING_UP osteoporosis DOID_11476 1.686E-03 0.01682864 1.686E-03 0.02740665 NAGASHIMA_NRG1_SIGNALING_UP aneurysm disease DOID_2403 1.686E-03 0.01653849 0.02298881 0.18686622 NAGASHIMA_NRG1_SIGNALING_UP Kawasaki disease DOID_13378 1.751E-03 0.01688713 0.06025647 0.30888227 NAGASHIMA_NRG1_SIGNALING_UP lymphadenitis DOID_1602 1.751E-03 0.01688713 0.06025647 0.30888227 NAGASHIMA_NRG1_SIGNALING_UP lymph node disease DOID_9942 1.751E-03 0.01688713 0.06025647 0.30888227 NAGASHIMA_NRG1_SIGNALING_UP contact dermatitis DOID_2773 1.876E-03 0.0177895 1.876E-03 0.02964917 NAGASHIMA_NRG1_SIGNALING_UP gastric ulcer DOID_10808 1.922E-03 0.01793219 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP hepatitis B DOID_2043 1.922E-03 0.01764296 0.06303428 0.31461848 NAGASHIMA_NRG1_SIGNALING_UP uremia DOID_4676 2.101E-03 0.0189799 2.101E-03 0.03231713 NAGASHIMA_NRG1_SIGNALING_UP pulmonary embolism DOID_9477 2.101E-03 0.01868334 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP polyarteritis nodosa DOID_9810 2.101E-03 0.01839591 0.06580396 0.31730891 NAGASHIMA_NRG1_SIGNALING_UP lingual-facial-buccal dyskinesia DOID_9854 2.101E-03 0.01811718 2.101E-03 0.03065984 NAGASHIMA_NRG1_SIGNALING_UP primary bacterial infectious disease DOID_0050338 2.37E-03 0.02012557 2.37E-03 0.03288813 NAGASHIMA_NRG1_SIGNALING_UP transitional cell carcinoma DOID_2671 2.446E-03 0.02046963 2.446E-03 0.03314131 NAGASHIMA_NRG1_SIGNALING_UP toxic shock syndrome DOID_14115 2.482E-03 0.02046974 0.07131898 0.33262707 NAGASHIMA_NRG1_SIGNALING_UP commensal bacterial infectious disease DOID_0050339 2.684E-03 0.02181669 0.07406439 0.33985996 NAGASHIMA_NRG1_SIGNALING_UP encephalomyelitis DOID_640 2.852E-03 0.02285308 0.03231841 0.23277438 NAGASHIMA_NRG1_SIGNALING_UP Crohn's disease DOID_8778 2.937E-03 0.02321306 0.03294354 0.2314182 NAGASHIMA_NRG1_SIGNALING_UP dilated cardiomyopathy DOID_12930 3.025E-03 0.02357541 3.025E-03 0.03824456 NAGASHIMA_NRG1_SIGNALING_UP fragments of torsion dystonia DOID_531 3.11E-03 0.02391063 3.11E-03 0.03846493 NAGASHIMA_NRG1_SIGNALING_UP Sciatic Neuropathy DOID_11446 3.334E-03 0.02529063 3.334E-03 0.0403574 NAGASHIMA_NRG1_SIGNALING_UP lesion of sciatic nerve DOID_12528 3.334E-03 0.02529063 3.334E-03 0.0403574 NAGASHIMA_NRG1_SIGNALING_UP lung adenocarcinoma DOID_3910 3.334E-03 0.02495786 0.08225242 0.36563771 NAGASHIMA_NRG1_SIGNALING_UP perinatal necrotizing enterocolitis DOID_8677 3.334E-03 0.02463373 3.334E-03 0.03951662 NAGASHIMA_NRG1_SIGNALING_UP mononeuritis of lower limb DOID_9473 3.334E-03 0.02529063 3.334E-03 0.0403574 NAGASHIMA_NRG1_SIGNALING_UP invasive ductal carcinoma DOID_3008 3.565E-03 0.02600481 3.565E-03 0.04139542 NAGASHIMA_NRG1_SIGNALING_UP central nervous system hereditary degenerative disease DOID_481 3.565E-03 0.02567564 3.565E-03 0.04056751 NAGASHIMA_NRG1_SIGNALING_UP supratentorial cancer DOID_1659 3.803E-03 0.02705119 0.0876712 0.37507454 NAGASHIMA_NRG1_SIGNALING_UP cerebrum cancer DOID_368 3.803E-03 0.02705119 0.0876712 0.37507454 NAGASHIMA_NRG1_SIGNALING_UP focal glomerulosclerosis DOID_3945 3.803E-03 0.02671723 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP dystonic disease DOID_544 3.803E-03 0.02639141 3.803E-03 0.04243324 NAGASHIMA_NRG1_SIGNALING_UP allergic rhinitis DOID_4481 4.562E-03 0.03127537 0.09573997 0.3891146 NAGASHIMA_NRG1_SIGNALING_UP autonomic nervous system neoplasm DOID_2621 4.829E-03 0.032713 4.829E-03 0.05284408 NAGASHIMA_NRG1_SIGNALING_UP neuroblastoma DOID_769 4.829E-03 0.032713 4.829E-03 0.05284408 NAGASHIMA_NRG1_SIGNALING_UP spindle cell carcinoma DOID_4015 5.385E-03 0.03604697 0.10373801 0.41277573 NAGASHIMA_NRG1_SIGNALING_UP esophageal disease DOID_6050 5.385E-03 0.03562782 5.385E-03 0.05781118 NAGASHIMA_NRG1_SIGNALING_UP medullomyoblastoma DOID_3861 5.673E-03 0.03710353 5.673E-03 0.05977791 NAGASHIMA_NRG1_SIGNALING_UP adult medulloblastoma DOID_3864 5.673E-03 0.03710353 5.673E-03 0.05977791 NAGASHIMA_NRG1_SIGNALING_UP childhood medulloblastoma DOID_3869 5.673E-03 0.03710353 5.673E-03 0.05977791 NAGASHIMA_NRG1_SIGNALING_UP medulloblastoma DOID_3858 6.27E-03 0.04054367 6.27E-03 0.06486987 NAGASHIMA_NRG1_SIGNALING_UP multiple myeloma DOID_9538 6.27E-03 0.04008812 6.27E-03 0.06371148 NAGASHIMA_NRG1_SIGNALING_UP peripheral nervous system neoplasm DOID_1192 6.579E-03 0.04159572 6.579E-03 0.06567746 NAGASHIMA_NRG1_SIGNALING_UP congenital diaphragmatic hernia DOID_3827 6.895E-03 0.04311273 0.11691257 0.45253914 NAGASHIMA_NRG1_SIGNALING_UP systemic scleroderma DOID_418 6.895E-03 0.04264412 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP adult respiratory distress syndrome DOID_11394 7.217E-03 0.04415859 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP rheumatic disease DOID_1575 8.225E-03 0.04978792 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP scleroderma DOID_419 8.225E-03 0.04978792 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP diabetic autonomic neuropathy DOID_11503 8.574E-03 0.05135479 8.574E-03 0.0841156 NAGASHIMA_NRG1_SIGNALING_UP autonomic neuropathy DOID_11504 8.574E-03 0.05135479 8.574E-03 0.0841156 NAGASHIMA_NRG1_SIGNALING_UP diabetic polyneuropathy DOID_12785 8.574E-03 0.05135479 8.574E-03 0.0841156 NAGASHIMA_NRG1_SIGNALING_UP diabetic neuropathy DOID_9743 8.574E-03 0.05135479 8.574E-03 0.0841156 NAGASHIMA_NRG1_SIGNALING_UP cataract DOID_83 8.93E-03 0.05292786 8.93E-03 0.0861199 NAGASHIMA_NRG1_SIGNALING_UP myeloma DOID_0070004 9.661E-03 0.05666913 9.661E-03 0.09161509 NAGASHIMA_NRG1_SIGNALING_UP pre-eclampsia DOID_10591 9.661E-03 0.05609087 0.13759375 0.52193897 NAGASHIMA_NRG1_SIGNALING_UP lens disease DOID_110 9.661E-03 0.0555243 9.661E-03 0.09011321 NAGASHIMA_NRG1_SIGNALING_UP autonomic nervous system disease DOID_11465 9.661E-03 0.05496906 9.661E-03 0.08865977 NAGASHIMA_NRG1_SIGNALING_UP vascular skin disease DOID_9540 9.661E-03 0.05442481 0.13759375 0.50838212 NAGASHIMA_NRG1_SIGNALING_UP calcium metabolism disease DOID_10575 0.01080499 0.06027487 0.01080499 0.09758789 NAGASHIMA_NRG1_SIGNALING_UP aortic aneurysm DOID_3627 0.01080499 0.05968968 0.14522482 0.51970391 NAGASHIMA_NRG1_SIGNALING_UP movement disease DOID_480 0.01080499 0.05911574 0.01080499 0.09606308 NAGASHIMA_NRG1_SIGNALING_UP collagen disease DOID_854 0.01547862 0.08387937 1.000 1.000 NAGASHIMA_NRG1_SIGNALING_UP pre-malignant neoplasm DOID_0060071 0.01640631 0.08806783 0.17752683 0.58388882 NAGASHIMA_NRG1_SIGNALING_UP in situ carcinoma DOID_8719 0.01640631 0.08806783 0.17752683 0.58388882 NAGASHIMA_NRG1_SIGNALING_UP mineral metabolism disease DOID_0050032 0.01687888 0.08975777 0.01687888 0.14123649 NAGASHIMA_NRG1_SIGNALING_UP uterine disease DOID_345 0.01735721 0.0914468 0.18238781 0.59302093 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN giant cell tumor DOID_200 2.909E-06 1.655E-03 2.909E-06 1.655E-03 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN malignant giant cell tumor DOID_2705 2.909E-06 1.655E-03 2.909E-06 1.655E-03 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN giant cell glioblastoma DOID_3074 2.909E-06 1.655E-03 2.909E-06 1.655E-03 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN glioblastoma DOID_3068 3.771E-06 1.073E-03 3.771E-06 1.073E-03 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN allergic contact dermatitis DOID_3042 5.719E-06 1.085E-03 5.719E-06 1.085E-03 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN astrocytoma DOID_3069 6.227E-06 8.858E-04 6.227E-06 8.858E-04 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN mixed glioma DOID_5076 8.556E-06 9.737E-04 7.346E-04 0.05225099 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN contact dermatitis DOID_2773 9.217E-06 8.741E-04 9.217E-06 1.049E-03 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN nervous system cancer DOID_3093 1.303E-05 1.059E-03 9.697E-04 0.06130532 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN autonomic nervous system neoplasm DOID_2621 1.402E-04 9.972E-03 0.01740019 0.31937772 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN neuroblastoma DOID_769 1.402E-04 9.972E-03 0.01740019 0.31937772 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN lymphoid leukemia DOID_10747 1.655E-04 0.01046306 0.01887821 0.32550618 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN peripheral nervous system neoplasm DOID_1192 1.929E-04 0.01097414 0.02035413 0.32170834 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN primitive neuroectodermal tumor DOID_168 2.431E-04 0.01257348 2.431E-04 0.02305138 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN brain cancer DOID_1319 2.874E-04 0.01362522 0.02476927 0.35234284 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN central nervous system cancer DOID_3620 2.99E-04 0.01308657 0.02525867 0.35054111 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN neuroectodermal tumor DOID_171 4.709E-04 0.0191397 4.709E-04 0.03827939 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN transitional cell carcinoma DOID_2671 9.283E-04 0.03521373 0.04416503 0.44874823 BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN lymphoblastic leukemia DOID_1037 1.033E-03 0.03674972 0.04656364 0.45680537 WEINMANN_ADAPTATION_TO_HYPOXIA_DN cystic fibrosis DOID_1485 6.482E-07 3.688E-04 2.117E-03 0.08030735 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mitochondrial myopathy DOID_699 7.906E-07 2.249E-04 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN dilated cardiomyopathy DOID_12930 1.556E-06 2.952E-04 8.378E-05 0.01191833 WEINMANN_ADAPTATION_TO_HYPOXIA_DN pulmonary tuberculosis DOID_2957 1.29E-05 1.835E-03 0.04430277 0.3273802 WEINMANN_ADAPTATION_TO_HYPOXIA_DN atrophic muscular disease DOID_913 1.614E-05 1.837E-03 1.614E-05 9.184E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_DN muscular dystrophy DOID_9884 1.614E-05 1.837E-03 1.614E-05 9.184E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_DN integumentary system cancer DOID_0060122 1.794E-05 1.702E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN skin cancer DOID_4159 1.794E-05 1.702E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mitochondrial metabolism disease DOID_700 1.889E-05 1.536E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN cholestasis DOID_13580 2.897E-05 2.061E-03 0.05754721 0.35208993 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hyperglycemia DOID_4195 3.027E-05 1.914E-03 0.05836905 0.34959991 WEINMANN_ADAPTATION_TO_HYPOXIA_DN facioscapulohumeral muscular dystrophy DOID_11727 3.292E-05 1.873E-03 3.292E-05 9.366E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_DN tuberculosis DOID_399 3.298E-05 1.706E-03 0.06001065 0.35202124 WEINMANN_ADAPTATION_TO_HYPOXIA_DN bile duct disease DOID_4138 3.734E-05 1.771E-03 0.06246785 0.34847259 WEINMANN_ADAPTATION_TO_HYPOXIA_DN biliary tract disease DOID_9741 3.888E-05 1.702E-03 0.06328553 0.34960645 WEINMANN_ADAPTATION_TO_HYPOXIA_DN bone resorption disease DOID_0080011 4.542E-05 1.846E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN osteoporosis DOID_11476 4.542E-05 1.846E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN aneurysm disease DOID_2403 4.542E-05 1.723E-03 0.06654934 0.35723182 WEINMANN_ADAPTATION_TO_HYPOXIA_DN primary bacterial infectious disease DOID_0050338 6.484E-05 2.306E-03 0.07466069 0.37930298 WEINMANN_ADAPTATION_TO_HYPOXIA_DN varicose veins DOID_799 7.66E-05 2.564E-03 0.01298002 0.23080097 WEINMANN_ADAPTATION_TO_HYPOXIA_DN intermediate coronary syndrome DOID_8805 7.66E-05 2.422E-03 7.66E-05 0.01452939 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mouth disease DOID_403 8.124E-05 2.433E-03 0.08029793 0.39387518 WEINMANN_ADAPTATION_TO_HYPOXIA_DN restrictive cardiomyopathy DOID_397 8.75E-05 2.489E-03 0.01383952 0.22499107 WEINMANN_ADAPTATION_TO_HYPOXIA_DN vein disease DOID_866 8.75E-05 2.371E-03 0.01383952 0.21874131 WEINMANN_ADAPTATION_TO_HYPOXIA_DN dissociative disorder DOID_10935 1.245E-04 3.22E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN dissociative amnesia DOID_11037 1.245E-04 3.22E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN leishmaniasis DOID_9065 1.245E-04 3.08E-03 0.01641367 0.22236618 WEINMANN_ADAPTATION_TO_HYPOXIA_DN amnestic disorder DOID_10914 1.382E-04 3.277E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN esophagitis DOID_11963 1.382E-04 3.146E-03 0.01727027 0.2285299 WEINMANN_ADAPTATION_TO_HYPOXIA_DN placenta disease DOID_780 1.679E-04 3.674E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN aortic valve disease DOID_62 2.004E-04 4.223E-03 2.004E-04 0.02280283 WEINMANN_ADAPTATION_TO_HYPOXIA_DN meningitis DOID_9471 2.004E-04 4.072E-03 0.02068945 0.24025098 WEINMANN_ADAPTATION_TO_HYPOXIA_DN toxic shock syndrome DOID_14115 2.177E-04 4.271E-03 2.177E-04 0.02064349 WEINMANN_ADAPTATION_TO_HYPOXIA_DN commensal bacterial infectious disease DOID_0050339 2.357E-04 4.47E-03 2.357E-04 0.01915851 WEINMANN_ADAPTATION_TO_HYPOXIA_DN myositis DOID_633 2.544E-04 4.67E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN extrinsic allergic alveolitis DOID_841 2.738E-04 4.869E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN periodontitis DOID_824 2.94E-04 5.068E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN perinatal necrotizing enterocolitis DOID_8677 2.94E-04 4.919E-03 0.02494721 0.28389919 WEINMANN_ADAPTATION_TO_HYPOXIA_DN spastic cerebral palsy DOID_0050669 3.815E-04 6.201E-03 0.02834048 0.3042591 WEINMANN_ADAPTATION_TO_HYPOXIA_DN abdominal aortic aneurysm DOID_7693 3.815E-04 6.029E-03 0.02834048 0.29862467 WEINMANN_ADAPTATION_TO_HYPOXIA_DN papilloma DOID_2615 4.544E-04 6.988E-03 0.03087792 0.30823744 WEINMANN_ADAPTATION_TO_HYPOXIA_DN pneumoconiosis DOID_10316 4.801E-04 7.189E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN periodontal disease DOID_3388 4.801E-04 7.005E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN spindle cell carcinoma DOID_4015 4.801E-04 6.83E-03 0.0317223 0.30083314 WEINMANN_ADAPTATION_TO_HYPOXIA_DN esophageal disease DOID_6050 4.801E-04 6.663E-03 0.0317223 0.29590145 WEINMANN_ADAPTATION_TO_HYPOXIA_DN multiple myeloma DOID_9538 5.614E-04 7.605E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN peptic ulcer DOID_750 6.19E-04 8.191E-03 6.19E-04 0.0440257 WEINMANN_ADAPTATION_TO_HYPOXIA_DN cervix uteri carcinoma in situ DOID_8991 6.794E-04 8.785E-03 6.794E-04 0.04295057 WEINMANN_ADAPTATION_TO_HYPOXIA_DN influenza DOID_8469 7.75E-04 9.8E-03 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN cerebral infarction DOID_3526 8.083E-04 9.998E-03 0.04096356 0.31929132 WEINMANN_ADAPTATION_TO_HYPOXIA_DN proteinuria DOID_576 8.422E-04 0.01019643 0.04179942 0.32140366 WEINMANN_ADAPTATION_TO_HYPOXIA_DN myeloma DOID_0070004 8.769E-04 0.01039435 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN pre-eclampsia DOID_10591 8.769E-04 0.01018222 8.769E-04 0.04989288 WEINMANN_ADAPTATION_TO_HYPOXIA_DN heart valve disease DOID_4079 8.769E-04 9.979E-03 8.769E-04 0.04535716 WEINMANN_ADAPTATION_TO_HYPOXIA_DN bone marrow disease DOID_4961 8.769E-04 9.783E-03 0.04263458 0.32345432 WEINMANN_ADAPTATION_TO_HYPOXIA_DN integumentary system benign neoplasm DOID_0060121 9.481E-04 0.01037457 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN skin benign neoplasm DOID_3165 9.481E-04 0.01037457 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN calcium metabolism disease DOID_10575 9.848E-04 0.01057224 0.04513581 0.32925992 WEINMANN_ADAPTATION_TO_HYPOXIA_DN aortic aneurysm DOID_3627 9.848E-04 0.01037646 0.04513581 0.32509208 WEINMANN_ADAPTATION_TO_HYPOXIA_DN sarcoidosis DOID_11335 1.099E-03 0.01136693 0.0476307 0.33459097 WEINMANN_ADAPTATION_TO_HYPOXIA_DN bone marrow cancer DOID_4960 1.138E-03 0.01156362 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN parasitic protozoa infectious disease DOID_2789 1.178E-03 0.01176009 0.04929045 0.33790681 WEINMANN_ADAPTATION_TO_HYPOXIA_DN familial hyperlipidemia DOID_1168 1.219E-03 0.01195635 1.219E-03 0.057789 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hypersensitivity reaction type IV disease DOID_2916 1.302E-03 0.0125575 0.05177482 0.3465867 WEINMANN_ADAPTATION_TO_HYPOXIA_DN oral cavity cancer DOID_8618 1.302E-03 0.01234821 0.05177482 0.33861919 WEINMANN_ADAPTATION_TO_HYPOXIA_DN melancholia DOID_2848 1.345E-03 0.01254382 0.05260154 0.34011676 WEINMANN_ADAPTATION_TO_HYPOXIA_DN neurotic disorder DOID_4964 1.388E-03 0.01273921 0.05342756 0.3415762 WEINMANN_ADAPTATION_TO_HYPOXIA_DN carotid artery disease DOID_3407 1.432E-03 0.01293438 0.05425288 0.34299879 WEINMANN_ADAPTATION_TO_HYPOXIA_DN collagen disease DOID_854 1.432E-03 0.01273228 1.432E-03 0.062682 WEINMANN_ADAPTATION_TO_HYPOXIA_DN pre-malignant neoplasm DOID_0060071 1.522E-03 0.01332409 1.522E-03 0.06186183 WEINMANN_ADAPTATION_TO_HYPOXIA_DN in situ carcinoma DOID_8719 1.522E-03 0.01332409 1.522E-03 0.06186183 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mineral metabolism disease DOID_0050032 1.568E-03 0.01351862 0.05672467 0.35082978 WEINMANN_ADAPTATION_TO_HYPOXIA_DN endocrine pancreas disease DOID_1428 1.568E-03 0.01331684 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN parasitic infectious disease DOID_1398 1.615E-03 0.01351127 0.05754721 0.34834429 WEINMANN_ADAPTATION_TO_HYPOXIA_DN uterine disease DOID_345 1.615E-03 0.01331545 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN tooth disease DOID_1091 1.71E-03 0.01389947 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN brain infarction DOID_3454 1.759E-03 0.01409325 0.06001065 0.35568813 WEINMANN_ADAPTATION_TO_HYPOXIA_DN diabetic retinopathy DOID_8947 2.011E-03 0.01589555 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN endogenous depression DOID_1595 2.117E-03 0.01650151 0.06573442 0.35621795 WEINMANN_ADAPTATION_TO_HYPOXIA_DN bacterial pneumonia DOID_874 2.225E-03 0.01711097 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN metabolic syndrome X DOID_14221 2.336E-03 0.01772373 0.06898996 0.36347486 WEINMANN_ADAPTATION_TO_HYPOXIA_DN lipid metabolism disorder DOID_3146 2.336E-03 0.01749052 2.336E-03 0.08307998 WEINMANN_ADAPTATION_TO_HYPOXIA_DN female reproductive system disease DOID_229 2.393E-03 0.01768002 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mental depression DOID_1596 2.507E-03 0.01828999 0.07142438 0.36945886 WEINMANN_ADAPTATION_TO_HYPOXIA_DN chronic kidney failure DOID_784 2.507E-03 0.01805847 0.07142438 0.36613041 WEINMANN_ADAPTATION_TO_HYPOXIA_DN retinal vascular disease DOID_2462 2.624E-03 0.01866663 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN transitional cell carcinoma DOID_2671 2.805E-03 0.01970508 2.805E-03 0.0938889 WEINMANN_ADAPTATION_TO_HYPOXIA_DN nervous system cancer DOID_3093 2.929E-03 0.02032237 0.07708074 0.38813222 WEINMANN_ADAPTATION_TO_HYPOXIA_DN encephalomyelitis DOID_640 3.119E-03 0.02138086 0.07949465 0.39332571 WEINMANN_ADAPTATION_TO_HYPOXIA_DN Crohn's disease DOID_8778 3.183E-03 0.02156411 0.08029793 0.39050873 WEINMANN_ADAPTATION_TO_HYPOXIA_DN ulcerative colitis DOID_8577 3.448E-03 0.02308285 0.08350424 0.40266027 WEINMANN_ADAPTATION_TO_HYPOXIA_DN leber hereditary optic neuropathy DOID_705 7.808E-03 0.05165817 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hyperparathyroidism DOID_13543 8.672E-03 0.05671429 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN familial combined hyperlipidemia DOID_13809 8.672E-03 0.05606981 8.672E-03 0.27411908 WEINMANN_ADAPTATION_TO_HYPOXIA_DN childhood type dermatomyositis DOID_14203 8.672E-03 0.05543981 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN retinal vascular occlusion DOID_1729 8.672E-03 0.05482382 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN transient cerebral ischemia DOID_224 8.672E-03 0.05422136 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN acute kidney failure DOID_3021 8.672E-03 0.05363199 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN chondrosarcoma DOID_3371 8.672E-03 0.05305531 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN polycythemia DOID_8432 8.672E-03 0.05249089 8.672E-03 0.25969176 WEINMANN_ADAPTATION_TO_HYPOXIA_DN cutaneous leishmaniasis DOID_9111 8.672E-03 0.05193835 8.672E-03 0.24670718 WEINMANN_ADAPTATION_TO_HYPOXIA_DN visceral leishmaniasis DOID_9146 8.672E-03 0.05139733 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN familial adenomatous polyposis DOID_0050424 9.535E-03 0.05593062 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN dermatomyositis DOID_10223 9.535E-03 0.05535989 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN adrenoleukodystrophy DOID_10588 9.535E-03 0.0548007 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN prediabetes syndrome DOID_11716 9.535E-03 0.0542527 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN neuronal ceroid lipofuscinosis DOID_14503 9.535E-03 0.05371554 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN common cold DOID_10459 0.01039715 0.05799982 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN otitis media DOID_10754 0.01039715 0.05743671 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN aortic valve stenosis DOID_1712 0.01039715 0.05688443 0.01039715 0.28171339 WEINMANN_ADAPTATION_TO_HYPOXIA_DN epidermolysis bullosa DOID_2730 0.01039715 0.05634268 0.01039715 0.26890824 WEINMANN_ADAPTATION_TO_HYPOXIA_DN middle ear disease DOID_5100 0.01039715 0.05743671 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN aortic valve insufficiency DOID_57 0.01039715 0.05581114 0.01039715 0.25721657 WEINMANN_ADAPTATION_TO_HYPOXIA_DN peritonitis DOID_8283 0.01039715 0.05528954 0.01039715 0.24649922 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mitochondrial encephalomyopathy DOID_890 0.01039715 0.0547776 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN ocular hypertension DOID_9282 0.01039715 0.05427506 0.01039715 0.23663925 WEINMANN_ADAPTATION_TO_HYPOXIA_DN borderline glaucoma DOID_9283 0.01039715 0.05427506 0.01039715 0.23663925 WEINMANN_ADAPTATION_TO_HYPOXIA_DN berylliosis DOID_10322 0.01125884 0.05823889 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN parathyroid gland disease DOID_11201 0.01125884 0.05771422 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN carotid stenosis DOID_13001 0.01125884 0.05719891 0.01125884 0.24639532 WEINMANN_ADAPTATION_TO_HYPOXIA_DN polyneuropathy DOID_1389 0.01125884 0.05669273 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN vesiculobullous skin disease DOID_2731 0.01125884 0.05619542 0.01125884 0.23726957 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hypercalcemia DOID_12678 0.01211979 0.05996662 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN polycystic kidney disease DOID_898 0.01211979 0.05944967 0.01211979 0.24629148 WEINMANN_ADAPTATION_TO_HYPOXIA_DN Ehlers-Danlos syndrome DOID_13359 0.01298002 0.06312505 0.01298002 0.25467693 WEINMANN_ADAPTATION_TO_HYPOXIA_DN thoracic aortic aneurysm DOID_14004 0.01298002 0.06259009 0.01298002 0.2461877 WEINMANN_ADAPTATION_TO_HYPOXIA_DN lung oat cell carcinoma DOID_5411 0.01298002 0.06206413 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN oral submucous fibrosis DOID_5773 0.01298002 0.06154693 0.01298002 0.23824616 WEINMANN_ADAPTATION_TO_HYPOXIA_DN angiosarcoma DOID_0001816 0.01383952 0.06508006 0.01383952 0.23862689 WEINMANN_ADAPTATION_TO_HYPOXIA_DN spastic diplegia DOID_10965 0.01383952 0.06454662 0.01383952 0.23160845 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hemolytic-uremic syndrome DOID_12554 0.01383952 0.06402185 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN thyroiditis DOID_7166 0.01383952 0.06350554 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN autoimmune thyroiditis DOID_7188 0.01383952 0.06350554 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN tongue cancer DOID_8649 0.01383952 0.0629975 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN Barrett's esophagus DOID_9206 0.01383952 0.06249752 0.01383952 0.21282939 WEINMANN_ADAPTATION_TO_HYPOXIA_DN familial hypertrophic cardiomyopathy DOID_11986 0.0146983 0.065853 0.0146983 0.22008765 WEINMANN_ADAPTATION_TO_HYPOXIA_DN drug-induced mental disorder DOID_1203 0.0146983 0.06533852 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN methylmalonic acidemia DOID_14749 0.0146983 0.06483202 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN drug psychosis DOID_1742 0.0146983 0.06533852 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN basal cell carcinoma DOID_2513 0.0146983 0.06433331 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN substance-induced psychosis DOID_8646 0.0146983 0.06533852 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN skin carcinoma DOID_3451 0.01555635 0.06756917 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN ureteral obstruction DOID_5199 0.01555635 0.06705728 0.01555635 0.22696311 WEINMANN_ADAPTATION_TO_HYPOXIA_DN prion disease DOID_649 0.01555635 0.06655309 0.01555635 0.22128903 WEINMANN_ADAPTATION_TO_HYPOXIA_DN Down syndrome DOID_14250 0.01641367 0.06969686 0.01641367 0.22778974 WEINMANN_ADAPTATION_TO_HYPOXIA_DN autoimmune hepatitis DOID_2048 0.01812615 0.07639837 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN familial hypercholesterolemia DOID_13810 0.01898131 0.07941444 0.01898131 0.24546281 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hepatitis B DOID_2043 0.01898131 0.07883477 0.01898131 0.24000809 WEINMANN_ADAPTATION_TO_HYPOXIA_DN sinusitis DOID_0050127 0.01983574 0.08178649 0.01983574 0.24535948 WEINMANN_ADAPTATION_TO_HYPOXIA_DN paranasal sinus disease DOID_1352 0.01983574 0.08178649 0.01983574 0.24535948 WEINMANN_ADAPTATION_TO_HYPOXIA_DN optic nerve disease DOID_1891 0.01983574 0.0811981 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN IgA glomerulonephritis DOID_2986 0.01983574 0.08061812 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN urinary tract obstruction DOID_5200 0.01983574 0.08004636 0.01983574 0.24013907 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hypoglycemia DOID_9993 0.01983574 0.07948265 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN Lewy body dementia DOID_12217 0.02068945 0.08232376 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN ureteral disease DOID_1426 0.02068945 0.08175207 0.02068945 0.24525621 WEINMANN_ADAPTATION_TO_HYPOXIA_DN Goodpasture syndrome DOID_9808 0.02068945 0.08118826 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN spastic quadriplegia DOID_10970 0.02154244 0.0839565 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN sphingolipidosis DOID_1927 0.02154244 0.08338537 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN organic acidemia DOID_0060159 0.02239471 0.08609859 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN hypogonadism DOID_1924 0.02239471 0.08552075 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN bronchiolitis DOID_2942 0.02239471 0.08495061 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN intracranial aneurysm DOID_10941 0.02409709 0.09080295 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN middle cerebral artery infarction DOID_3525 0.02409709 0.09020557 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN diffuse large B-cell lymphoma DOID_0050745 0.02494721 0.09277751 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN Sciatic Neuropathy DOID_11446 0.02494721 0.09217506 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN lesion of sciatic nerve DOID_12528 0.02494721 0.09217506 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN lung adenocarcinoma DOID_3910 0.02494721 0.09158039 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mononeuritis of lower limb DOID_9473 0.02494721 0.09217506 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN pleurisy DOID_10247 0.0257966 0.09409144 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN sarcoma DOID_1115 0.0257966 0.09349213 0.0257966 0.28780912 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mononeuritis DOID_1802 0.0257966 0.09290041 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN autoimmune disease of endocrine system DOID_0060005 0.02664528 0.09535322 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN mononeuropathy DOID_1188 0.02664528 0.09475726 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN cranial nerve disease DOID_5656 0.02664528 0.09416871 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN endometrial carcinoma DOID_2871 0.02749324 0.09656575 0.02749324 0.30083944 WEINMANN_ADAPTATION_TO_HYPOXIA_DN gonadal disease DOID_2277 0.02834048 0.09893087 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN bronchiolitis obliterans DOID_2799 0.02834048 0.09832763 1.000 1.000 WEINMANN_ADAPTATION_TO_HYPOXIA_DN allergic rhinitis DOID_4481 0.02918701 0.09944555 1.000 1.000 UDAYAKUMAR_MED1_TARGETS_DN allergic contact dermatitis DOID_3042 1.568E-09 8.922E-07 1.568E-09 8.922E-07 UDAYAKUMAR_MED1_TARGETS_DN contact dermatitis DOID_2773 4.831E-09 1.375E-06 4.831E-09 1.375E-06 UDAYAKUMAR_MED1_TARGETS_DN hyperinsulinism DOID_2018 2.447E-07 4.642E-05 3.383E-04 0.01283308 UDAYAKUMAR_MED1_TARGETS_DN nervous system cancer DOID_3093 3.194E-07 4.543E-05 7.889E-06 1.496E-03 UDAYAKUMAR_MED1_TARGETS_DN endocrine pancreas disease DOID_1428 1.642E-06 1.869E-04 1.021E-03 0.02234486 UDAYAKUMAR_MED1_TARGETS_DN supratentorial cancer DOID_1659 2.06E-06 1.954E-04 1.034E-04 5.885E-03 UDAYAKUMAR_MED1_TARGETS_DN cerebrum cancer DOID_368 2.06E-06 1.954E-04 1.034E-04 5.885E-03 UDAYAKUMAR_MED1_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 7.889E-06 6.413E-04 7.889E-06 1.122E-03 UDAYAKUMAR_MED1_TARGETS_DN learning disability DOID_8927 1.226E-05 8.721E-04 3.838E-04 0.01213321 UDAYAKUMAR_MED1_TARGETS_DN brain cancer DOID_1319 1.445E-05 9.134E-04 4.331E-04 0.01297052 UDAYAKUMAR_MED1_TARGETS_DN central nervous system cancer DOID_3620 1.564E-05 8.9E-04 4.592E-04 0.01306431 UDAYAKUMAR_MED1_TARGETS_DN lung small cell carcinoma DOID_5409 1.691E-05 8.745E-04 4.863E-04 0.01317592 UDAYAKUMAR_MED1_TARGETS_DN congenital heart defect DOID_1682 4.361E-05 2.068E-03 4.361E-05 4.963E-03 UDAYAKUMAR_MED1_TARGETS_DN portal hypertension DOID_10762 6.047E-05 2.647E-03 0.07342706 0.33158728 UDAYAKUMAR_MED1_TARGETS_DN reading disorder DOID_13365 6.047E-05 2.458E-03 6.047E-05 5.734E-03 UDAYAKUMAR_MED1_TARGETS_DN dyslexia DOID_4428 6.047E-05 2.458E-03 6.047E-05 5.734E-03 UDAYAKUMAR_MED1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 6.483E-05 2.459E-03 6.483E-05 5.27E-03 UDAYAKUMAR_MED1_TARGETS_DN male reproductive system disease DOID_48 6.838E-05 2.432E-03 0.02000783 0.1866304 UDAYAKUMAR_MED1_TARGETS_DN middle cerebral artery infarction DOID_3525 7.586E-05 2.539E-03 7.586E-05 5.396E-03 UDAYAKUMAR_MED1_TARGETS_DN pancreatic carcinoma DOID_4905 7.591E-05 2.4E-03 7.591E-05 4.799E-03 UDAYAKUMAR_MED1_TARGETS_DN renal hypertension DOID_1073 9.362E-05 2.804E-03 3.503E-03 0.05862151 UDAYAKUMAR_MED1_TARGETS_DN secondary hypertension DOID_11130 9.362E-05 2.804E-03 3.503E-03 0.05862151 UDAYAKUMAR_MED1_TARGETS_DN hepatic vascular disease DOID_272 9.362E-05 2.663E-03 0.08423899 0.34483443 UDAYAKUMAR_MED1_TARGETS_DN chromosomal disease DOID_0080014 1.07E-04 2.9E-03 1.07E-04 5.536E-03 UDAYAKUMAR_MED1_TARGETS_DN lymphoblastic leukemia DOID_1037 1.805E-04 4.668E-03 1.805E-04 8.558E-03 UDAYAKUMAR_MED1_TARGETS_DN lymphoid leukemia DOID_10747 1.912E-04 4.731E-03 1.912E-04 8.37E-03 UDAYAKUMAR_MED1_TARGETS_DN intracranial arterial disease DOID_13089 2.768E-04 6.562E-03 2.768E-04 0.01124982 UDAYAKUMAR_MED1_TARGETS_DN cerebral arterial disease DOID_3527 2.768E-04 6.562E-03 2.768E-04 0.01124982 UDAYAKUMAR_MED1_TARGETS_DN acute T cell leukemia DOID_5603 3.765E-04 8.569E-03 3.765E-04 0.01338876 UDAYAKUMAR_MED1_TARGETS_DN cerebral infarction DOID_3526 3.838E-04 8.4E-03 3.838E-04 0.01284692 UDAYAKUMAR_MED1_TARGETS_DN cataract DOID_83 3.838E-04 8.089E-03 8.777E-03 0.11350783 UDAYAKUMAR_MED1_TARGETS_DN lens disease DOID_110 4.331E-04 8.801E-03 9.496E-03 0.12007254 UDAYAKUMAR_MED1_TARGETS_DN nervous system benign neoplasm DOID_0060115 4.593E-04 9.011E-03 0.03174376 0.234574 UDAYAKUMAR_MED1_TARGETS_DN adrenoleukodystrophy DOID_10588 4.593E-04 8.711E-03 0.03174376 0.23156665 UDAYAKUMAR_MED1_TARGETS_DN aortic aneurysm DOID_3627 5.144E-04 9.441E-03 0.01062147 0.12858756 UDAYAKUMAR_MED1_TARGETS_DN giant cell tumor DOID_200 6.048E-04 0.01075371 0.01180281 0.13431592 UDAYAKUMAR_MED1_TARGETS_DN malignant giant cell tumor DOID_2705 6.048E-04 0.01075371 0.01180281 0.13431592 UDAYAKUMAR_MED1_TARGETS_DN giant cell glioblastoma DOID_3074 6.048E-04 0.01075371 0.01180281 0.13431592 UDAYAKUMAR_MED1_TARGETS_DN atrophic muscular disease DOID_913 6.048E-04 0.01042784 6.048E-04 0.01564177 UDAYAKUMAR_MED1_TARGETS_DN muscular dystrophy DOID_9884 6.048E-04 0.01042784 6.048E-04 0.01564177 UDAYAKUMAR_MED1_TARGETS_DN osteochondrodysplasia DOID_2256 6.703E-04 0.01121838 6.703E-04 0.0165837 UDAYAKUMAR_MED1_TARGETS_DN T-cell leukemia DOID_715 7.555E-04 0.01228273 7.555E-04 0.01791232 UDAYAKUMAR_MED1_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 7.769E-04 0.01227952 7.769E-04 0.01768251 UDAYAKUMAR_MED1_TARGETS_DN glioblastoma DOID_3068 7.769E-04 0.01194764 0.01389317 0.15202334 UDAYAKUMAR_MED1_TARGETS_DN skeletal system cancer DOID_0060124 8.701E-04 0.01302856 0.04303763 0.26051501 UDAYAKUMAR_MED1_TARGETS_DN bone cancer DOID_184 8.701E-04 0.01302856 0.04303763 0.26051501 UDAYAKUMAR_MED1_TARGETS_DN hemangioma DOID_255 8.701E-04 0.01269449 0.04303763 0.24988174 UDAYAKUMAR_MED1_TARGETS_DN varicose veins DOID_799 8.701E-04 0.01237713 1.000 1.000 UDAYAKUMAR_MED1_TARGETS_DN vein disease DOID_866 9.925E-04 0.0137739 1.000 1.000 UDAYAKUMAR_MED1_TARGETS_DN mineral metabolism disease DOID_0050032 1.021E-03 0.01383253 0.01659618 0.16567064 UDAYAKUMAR_MED1_TARGETS_DN brain infarction DOID_3454 1.208E-03 0.01598344 1.208E-03 0.02545511 UDAYAKUMAR_MED1_TARGETS_DN astrocytoma DOID_3069 1.258E-03 0.01626479 0.01900537 0.18328912 UDAYAKUMAR_MED1_TARGETS_DN blood coagulation disease DOID_1247 1.309E-03 0.01654979 0.01950387 0.18496168 UDAYAKUMAR_MED1_TARGETS_DN Down syndrome DOID_14250 1.406E-03 0.01739428 1.406E-03 0.02857631 UDAYAKUMAR_MED1_TARGETS_DN subependymal glioma DOID_4843 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN pilocytic astrocytoma DOID_4851 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN subependymal giant cell astrocytoma DOID_5077 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN fibrillary astrocytoma DOID_6726 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN juvenile pilocytic astrocytoma DOID_6811 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN childhood pilocytic astrocytoma DOID_6812 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN gemistocytic astrocytoma DOID_7005 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN childhood cerebral astrocytoma DOID_7007 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN protoplasmic astrocytoma DOID_7008 1.559E-03 0.01887964 1.559E-03 0.03059804 UDAYAKUMAR_MED1_TARGETS_DN aneurysm disease DOID_2403 1.643E-03 0.01947776 0.0226084 0.20419336 UDAYAKUMAR_MED1_TARGETS_DN mixed glioma DOID_5076 1.704E-03 0.01978168 0.02314443 0.20260275 UDAYAKUMAR_MED1_TARGETS_DN benign glioma DOID_0060101 1.889E-03 0.02149415 1.889E-03 0.03582358 UDAYAKUMAR_MED1_TARGETS_DN benign ependymoma DOID_4844 1.889E-03 0.02149415 1.889E-03 0.03582358 UDAYAKUMAR_MED1_TARGETS_DN bone development disease DOID_0080006 2.095E-03 0.02337522 2.095E-03 0.038456 UDAYAKUMAR_MED1_TARGETS_DN diabetic angiopathy DOID_11713 2.248E-03 0.02459943 1.000 1.000 UDAYAKUMAR_MED1_TARGETS_DN transitional cell carcinoma DOID_2671 2.385E-03 0.02560306 0.02878616 0.24446755 UDAYAKUMAR_MED1_TARGETS_DN toxic shock syndrome DOID_14115 2.439E-03 0.02569908 0.07070437 0.32707957 UDAYAKUMAR_MED1_TARGETS_DN commensal bacterial infectious disease DOID_0050339 2.637E-03 0.02728234 0.07342706 0.33693546 UDAYAKUMAR_MED1_TARGETS_DN osteosarcoma DOID_3347 2.637E-03 0.02679516 2.637E-03 0.04689152 UDAYAKUMAR_MED1_TARGETS_DN encephalomyelitis DOID_640 2.78E-03 0.02775359 2.78E-03 0.04793802 UDAYAKUMAR_MED1_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 3.737E-03 0.03666431 3.737E-03 0.060758 UDAYAKUMAR_MED1_TARGETS_DN abdominal aortic aneurysm DOID_7693 4.228E-03 0.04077039 0.09226581 0.35958386 UDAYAKUMAR_MED1_TARGETS_DN Charcot-Marie-Tooth disease DOID_10595 4.483E-03 0.04251547 4.483E-03 0.07085912 UDAYAKUMAR_MED1_TARGETS_DN autonomic nervous system neoplasm DOID_2621 4.746E-03 0.04426854 4.746E-03 0.07298326 UDAYAKUMAR_MED1_TARGETS_DN neuroblastoma DOID_769 4.746E-03 0.04426854 4.746E-03 0.07298326 UDAYAKUMAR_MED1_TARGETS_DN metal metabolism disorder DOID_896 5.015E-03 0.04602881 5.015E-03 0.07509963 UDAYAKUMAR_MED1_TARGETS_DN spindle cell carcinoma DOID_4015 5.292E-03 0.04779556 0.10285986 0.38253112 UDAYAKUMAR_MED1_TARGETS_DN refractive error DOID_9835 5.866E-03 0.05214812 0.10811085 0.3893359 UDAYAKUMAR_MED1_TARGETS_DN peripheral nervous system neoplasm DOID_1192 6.466E-03 0.05660415 6.466E-03 0.09434025 UDAYAKUMAR_MED1_TARGETS_DN hepatitis DOID_2237 6.777E-03 0.05842261 0.11593027 0.39737545 UDAYAKUMAR_MED1_TARGETS_DN peptic ulcer DOID_750 6.777E-03 0.05755063 0.11593027 0.39264479 UDAYAKUMAR_MED1_TARGETS_DN lymphatic system disease DOID_75 7.094E-03 0.05935738 1.000 1.000 UDAYAKUMAR_MED1_TARGETS_DN benign mesothelioma DOID_2645 7.417E-03 0.06116631 7.417E-03 0.10551188 UDAYAKUMAR_MED1_TARGETS_DN Huntington's disease DOID_12858 8.084E-03 0.06571458 8.084E-03 0.11219562 UDAYAKUMAR_MED1_TARGETS_DN primitive neuroectodermal tumor DOID_168 8.084E-03 0.06478902 8.084E-03 0.1095243 UDAYAKUMAR_MED1_TARGETS_DN idiopathic generalized epilepsy DOID_1827 8.084E-03 0.06388918 8.084E-03 0.10697722 UDAYAKUMAR_MED1_TARGETS_DN leukodystrophy DOID_10579 9.134E-03 0.07119166 0.13391239 0.43540656 UDAYAKUMAR_MED1_TARGETS_DN glaucoma DOID_1686 0.01024007 0.07873782 0.1415076 0.44732125 UDAYAKUMAR_MED1_TARGETS_DN calcium metabolism disease DOID_10575 0.01062147 0.08058154 0.01062147 0.13138294 UDAYAKUMAR_MED1_TARGETS_DN movement disease DOID_480 0.01062147 0.07952125 0.01062147 0.12590865 UDAYAKUMAR_MED1_TARGETS_DN orofacial cleft DOID_0050567 0.01140288 0.08426281 0.01140288 0.13241298 UDAYAKUMAR_MED1_TARGETS_DN bile duct adenocarcinoma DOID_4896 0.01220883 0.08906188 0.01220883 0.13621228 UDAYAKUMAR_MED1_TARGETS_DN cholangiocarcinoma DOID_4947 0.01220883 0.08906188 0.01220883 0.13621228 UDAYAKUMAR_MED1_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 0.01262092 0.09090259 0.15650057 0.47875711 UDAYAKUMAR_MED1_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 0.01389317 0.09881517 1.000 1.000 UDAYAKUMAR_MED1_TARGETS_DN bile duct cancer DOID_4606 0.01389317 0.09759523 0.01389317 0.14915498 UDAYAKUMAR_MED1_TARGETS_DN bile duct carcinoma DOID_4897 0.01389317 0.09759523 0.01389317 0.14915498 UDAYAKUMAR_MED1_TARGETS_DN oral cavity cancer DOID_8618 0.01389317 0.09640505 0.01389317 0.14639285 ROSS_LEUKEMIA_WITH_MLL_FUSIONS focal glomerulosclerosis DOID_3945 5.167E-06 2.94E-03 5.167E-06 2.94E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS nephrotic syndrome DOID_1184 1.725E-05 4.909E-03 1.725E-05 4.909E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS giant cell tumor DOID_200 3.127E-05 5.931E-03 3.127E-05 5.931E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS malignant giant cell tumor DOID_2705 3.127E-05 5.931E-03 3.127E-05 5.931E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS giant cell glioblastoma DOID_3074 3.127E-05 5.931E-03 3.127E-05 5.931E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS glioblastoma DOID_3068 4.045E-05 5.754E-03 4.045E-05 5.754E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS astrocytoma DOID_3069 6.648E-05 7.565E-03 6.648E-05 7.565E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS nephrosis DOID_2527 7.215E-05 6.842E-03 7.215E-05 6.842E-03 ROSS_LEUKEMIA_WITH_MLL_FUSIONS polyneuropathy DOID_1389 8.834E-05 7.181E-03 0.01397057 0.27411228 ROSS_LEUKEMIA_WITH_MLL_FUSIONS chronic kidney failure DOID_784 1.09E-04 7.754E-03 3.849E-03 0.1094994 ROSS_LEUKEMIA_WITH_MLL_FUSIONS MHC class II deficiency DOID_5812 1.929E-04 0.01219349 1.929E-04 0.01567734 ROSS_LEUKEMIA_WITH_MLL_FUSIONS severe combined immunodeficiency DOID_627 3.37E-04 0.01917389 3.37E-04 0.02396736 ROSS_LEUKEMIA_WITH_MLL_FUSIONS combined T cell and B cell immunodeficiency DOID_628 3.648E-04 0.01887044 3.648E-04 0.02306387 ROSS_LEUKEMIA_WITH_MLL_FUSIONS autosomal dominant nonsyndromic deafness DOID_0050564 3.937E-04 0.01866894 3.937E-04 0.02240273 ROSS_LEUKEMIA_WITH_MLL_FUSIONS lung adenocarcinoma DOID_3910 4.548E-04 0.01990589 4.548E-04 0.02352515 ROSS_LEUKEMIA_WITH_MLL_FUSIONS nephroblastoma DOID_2154 7.42E-04 0.03015548 7.42E-04 0.0351814 ROSS_LEUKEMIA_WITH_MLL_FUSIONS hepatitis DOID_2237 9.559E-04 0.0362615 0.04445303 0.33725032 ROSS_LEUKEMIA_WITH_MLL_FUSIONS pre-eclampsia DOID_10591 1.353E-03 0.04810311 0.05269891 0.36567899 ROSS_LEUKEMIA_WITH_MLL_FUSIONS familial hyperlipidemia DOID_1168 1.878E-03 0.06284718 1.878E-03 0.08218477 ROSS_LEUKEMIA_WITH_MLL_FUSIONS nonsyndromic deafness DOID_0050563 2.006E-03 0.06339713 2.006E-03 0.0815106 ROSS_LEUKEMIA_WITH_MLL_FUSIONS cerebral degeneration DOID_1443 2.485E-03 0.07440704 2.485E-03 0.09424892 ROSS_LEUKEMIA_WITH_MLL_FUSIONS pancreatic ductal carcinoma DOID_3587 2.857E-03 0.08126924 2.857E-03 0.10158655 ROSS_LEUKEMIA_WITH_MLL_FUSIONS pancreatic carcinoma DOID_4905 3.092E-03 0.08376581 3.092E-03 0.10347542 ROSS_LEUKEMIA_WITH_MLL_FUSIONS lipid metabolism disorder DOID_3146 3.588E-03 0.09279162 3.588E-03 0.11341199 ROSS_LEUKEMIA_WITH_MLL_FUSIONS auditory system disease DOID_2742 3.761E-03 0.09303994 3.761E-03 0.11262729 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN contact dermatitis DOID_2773 2.09E-07 1.189E-04 2.09E-07 1.189E-04 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN endometrial carcinoma DOID_2871 1.092E-06 3.108E-04 1.883E-04 0.02142912 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN endometrial cancer DOID_1380 1.317E-06 2.497E-04 2.128E-04 0.01729903 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN uterine cancer DOID_363 3.549E-06 5.048E-04 4.08E-04 0.02321669 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN allergic contact dermatitis DOID_3042 1.187E-05 1.35E-03 1.187E-05 3.376E-03 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN mixed glioma DOID_5076 1.774E-05 1.682E-03 1.178E-03 0.04786273 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN hemangioma DOID_255 4.013E-05 3.262E-03 9.456E-03 0.15372263 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN glucose intolerance DOID_10603 5.84E-05 4.154E-03 5.84E-05 0.0110768 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN invasive ductal carcinoma DOID_3008 1.653E-04 0.01044901 1.653E-04 0.02351028 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN supratentorial cancer DOID_1659 1.766E-04 0.01004879 0.01944731 0.19078484 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN cerebrum cancer DOID_368 1.766E-04 0.01004879 0.01944731 0.19078484 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN age related macular degeneration DOID_10871 2.004E-04 0.01036492 2.004E-04 0.01900236 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN degeneration of macula and posterior pole DOID_2007 2.004E-04 0.01036492 2.004E-04 0.01900236 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN macular degeneration DOID_4448 2.524E-04 0.01196592 2.524E-04 0.01794888 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN lymphoid leukemia DOID_10747 2.663E-04 0.0116546 2.663E-04 0.01683442 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN refractive error DOID_9835 2.806E-04 0.0114027 0.02440683 0.21041645 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN brain cancer DOID_1319 4.618E-04 0.01751926 0.03118693 0.24646335 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN central nervous system cancer DOID_3620 4.805E-04 0.01708808 0.03180105 0.24787398 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN reproductive organ benign neoplasm DOID_0050622 6.213E-04 0.02079469 0.03608952 0.2566867 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN osteochondrodysplasia DOID_2256 6.213E-04 0.01963943 6.213E-04 0.03213725 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN uterine disease DOID_345 8.529E-04 0.02554177 8.529E-04 0.04044114 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN hyperglycemia DOID_4195 8.78E-04 0.02497935 8.78E-04 0.03842977 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN syndrome DOID_225 1.12E-03 0.03034658 0.0482422 0.28010014 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN metabolic syndrome X DOID_14221 1.237E-03 0.03198521 1.237E-03 0.04691164 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN female reproductive system disease DOID_229 1.267E-03 0.03133787 1.267E-03 0.04504819 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN bone development disease DOID_0080006 1.359E-03 0.03221874 1.359E-03 0.04548528 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN nervous system cancer DOID_3093 1.553E-03 0.03534157 0.05666157 0.30131245 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN lymphoblastic leukemia DOID_1037 1.654E-03 0.03620527 1.654E-03 0.05229651 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN Crohn's disease DOID_8778 1.689E-03 0.03559239 1.689E-03 0.05057866 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN dilated cardiomyopathy DOID_12930 1.724E-03 0.03503027 1.724E-03 0.04904237 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN ulcerative colitis DOID_8577 1.831E-03 0.03591641 1.831E-03 0.04959885 AMIT_EGF_RESPONSE_60_MCF10A pulmonary emphysema DOID_9675 3.668E-08 2.087E-05 5.218E-06 2.969E-03 AMIT_EGF_RESPONSE_60_MCF10A influenza DOID_8469 4.812E-08 1.369E-05 5.978E-04 0.02616724 AMIT_EGF_RESPONSE_60_MCF10A giant cell tumor DOID_200 9.863E-08 1.871E-05 1.085E-05 3.088E-03 AMIT_EGF_RESPONSE_60_MCF10A malignant giant cell tumor DOID_2705 9.863E-08 1.871E-05 1.085E-05 3.088E-03 AMIT_EGF_RESPONSE_60_MCF10A giant cell glioblastoma DOID_3074 9.863E-08 1.871E-05 1.085E-05 3.088E-03 AMIT_EGF_RESPONSE_60_MCF10A glioblastoma DOID_3068 1.398E-07 1.988E-05 1.406E-05 2.666E-03 AMIT_EGF_RESPONSE_60_MCF10A cholestasis DOID_13580 2.173E-07 2.473E-05 1.95E-05 2.774E-03 AMIT_EGF_RESPONSE_60_MCF10A astrocytoma DOID_3069 2.739E-07 2.598E-05 2.316E-05 2.636E-03 AMIT_EGF_RESPONSE_60_MCF10A bile duct disease DOID_4138 3.06E-07 2.488E-05 2.515E-05 2.385E-03 AMIT_EGF_RESPONSE_60_MCF10A biliary tract disease DOID_9741 3.231E-07 2.298E-05 2.618E-05 2.128E-03 AMIT_EGF_RESPONSE_60_MCF10A cystic fibrosis DOID_1485 3.786E-07 2.394E-05 1.637E-03 0.04232817 AMIT_EGF_RESPONSE_60_MCF10A ulcerative colitis DOID_8577 1.029E-06 5.854E-05 2.67E-03 0.05425278 AMIT_EGF_RESPONSE_60_MCF10A middle cerebral artery infarction DOID_3525 1.301E-06 6.732E-05 2.109E-04 0.01200275 AMIT_EGF_RESPONSE_60_MCF10A pleurisy DOID_10247 1.611E-06 7.64E-05 0.02270434 0.19281747 AMIT_EGF_RESPONSE_60_MCF10A pleural disease DOID_1532 2.591E-06 1.134E-04 0.02643969 0.20058908 AMIT_EGF_RESPONSE_60_MCF10A intracranial arterial disease DOID_13089 4.865E-06 1.977E-04 5.004E-04 0.02372498 AMIT_EGF_RESPONSE_60_MCF10A cerebral arterial disease DOID_3527 4.865E-06 1.977E-04 5.004E-04 0.02372498 AMIT_EGF_RESPONSE_60_MCF10A cerebral infarction DOID_3526 6.801E-06 2.58E-04 6.235E-04 0.02534258 AMIT_EGF_RESPONSE_60_MCF10A bile duct adenocarcinoma DOID_4896 1.145E-05 4.073E-04 0.04271207 0.23826635 AMIT_EGF_RESPONSE_60_MCF10A cholangiocarcinoma DOID_4947 1.145E-05 4.073E-04 0.04271207 0.23826635 AMIT_EGF_RESPONSE_60_MCF10A bile duct cancer DOID_4606 1.406E-05 4.705E-04 0.04564234 0.24271485 AMIT_EGF_RESPONSE_60_MCF10A bile duct carcinoma DOID_4897 1.406E-05 4.705E-04 0.04564234 0.24271485 AMIT_EGF_RESPONSE_60_MCF10A melancholia DOID_2848 1.476E-05 4.667E-04 0.04637355 0.24207843 AMIT_EGF_RESPONSE_60_MCF10A neurotic disorder DOID_4964 1.549E-05 4.64E-04 0.04710422 0.24365727 AMIT_EGF_RESPONSE_60_MCF10A uterine disease DOID_345 1.95E-05 5.549E-04 0.05074947 0.25330219 AMIT_EGF_RESPONSE_60_MCF10A brain infarction DOID_3454 2.221E-05 6.018E-04 1.359E-03 0.04069203 AMIT_EGF_RESPONSE_60_MCF10A pancreatic ductal carcinoma DOID_3587 2.414E-05 6.244E-04 1.436E-03 0.04084327 AMIT_EGF_RESPONSE_60_MCF10A hyperparathyroidism DOID_13543 2.533E-05 6.266E-04 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A pancreatic carcinoma DOID_4905 2.725E-05 6.46E-04 1.555E-03 0.0421244 AMIT_EGF_RESPONSE_60_MCF10A endogenous depression DOID_1595 2.945E-05 6.704E-04 0.05799963 0.2796762 AMIT_EGF_RESPONSE_60_MCF10A aneurysm disease DOID_2403 3.06E-05 6.697E-04 0.0587217 0.28077855 AMIT_EGF_RESPONSE_60_MCF10A pancreatitis DOID_4989 3.178E-05 6.697E-04 1.721E-03 0.04256424 AMIT_EGF_RESPONSE_60_MCF10A mixed glioma DOID_5076 3.178E-05 6.458E-04 1.721E-03 0.04079073 AMIT_EGF_RESPONSE_60_MCF10A female reproductive system disease DOID_229 3.548E-05 6.962E-04 0.06160463 0.28731997 AMIT_EGF_RESPONSE_60_MCF10A mental depression DOID_1596 3.81E-05 7.227E-04 0.0630429 0.29163749 AMIT_EGF_RESPONSE_60_MCF10A biliary tract cancer DOID_4607 3.81E-05 6.994E-04 0.0630429 0.28928557 AMIT_EGF_RESPONSE_60_MCF10A primary bacterial infectious disease DOID_0050338 4.372E-05 7.774E-04 2.123E-03 0.04832123 AMIT_EGF_RESPONSE_60_MCF10A parathyroid gland disease DOID_11201 4.384E-05 7.559E-04 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A lymphoblastic leukemia DOID_1037 5.312E-05 8.891E-04 0.07020237 0.30965233 AMIT_EGF_RESPONSE_60_MCF10A skeletal system cancer DOID_0060124 5.896E-05 9.585E-04 0.0114151 0.17554575 AMIT_EGF_RESPONSE_60_MCF10A bone cancer DOID_184 5.896E-05 9.585E-04 0.0114151 0.17554575 AMIT_EGF_RESPONSE_60_MCF10A tongue cancer DOID_8649 6.735E-05 1.064E-03 0.01217162 0.15740116 AMIT_EGF_RESPONSE_60_MCF10A Barrett's esophagus DOID_9206 6.735E-05 1.036E-03 0.01217162 0.15390335 AMIT_EGF_RESPONSE_60_MCF10A urinary system benign neoplasm DOID_731 7.629E-05 1.142E-03 0.01292758 0.15324564 AMIT_EGF_RESPONSE_60_MCF10A leishmaniasis DOID_9065 9.584E-05 1.398E-03 0.01443782 0.15213181 AMIT_EGF_RESPONSE_60_MCF10A amnestic disorder DOID_10914 1.064E-04 1.514E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A esophagitis DOID_11963 1.064E-04 1.477E-03 0.0151921 0.15716918 AMIT_EGF_RESPONSE_60_MCF10A urinary tract obstruction DOID_5200 1.415E-04 1.917E-03 0.01745161 0.1742099 AMIT_EGF_RESPONSE_60_MCF10A aortic valve disease DOID_62 1.543E-04 2.042E-03 1.543E-04 0.01097571 AMIT_EGF_RESPONSE_60_MCF10A meningitis DOID_9471 1.543E-04 1.996E-03 0.01820366 0.17263141 AMIT_EGF_RESPONSE_60_MCF10A osteosarcoma DOID_3347 1.815E-04 2.295E-03 1.815E-04 0.01147736 AMIT_EGF_RESPONSE_60_MCF10A cystitis DOID_1679 1.96E-04 2.424E-03 0.0204565 0.18773787 AMIT_EGF_RESPONSE_60_MCF10A lung adenocarcinoma DOID_3910 2.265E-04 2.742E-03 2.265E-04 0.0117143 AMIT_EGF_RESPONSE_60_MCF10A spastic cerebral palsy DOID_0050669 2.94E-04 3.485E-03 0.02494721 0.19715222 AMIT_EGF_RESPONSE_60_MCF10A allergic rhinitis DOID_4481 3.122E-04 3.625E-03 0.02569372 0.19756388 AMIT_EGF_RESPONSE_60_MCF10A chronic leukemia DOID_1036 3.309E-04 3.766E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A chronic lymphocytic leukemia DOID_1040 3.309E-04 3.766E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A bladder disease DOID_365 3.309E-04 3.692E-03 0.02643969 0.19794975 AMIT_EGF_RESPONSE_60_MCF10A myocarditis DOID_820 3.502E-04 3.832E-03 0.0271851 0.20088728 AMIT_EGF_RESPONSE_60_MCF10A pneumoconiosis DOID_10316 3.701E-04 3.973E-03 0.02792996 0.20374547 AMIT_EGF_RESPONSE_60_MCF10A nephroblastoma DOID_2154 3.701E-04 3.9E-03 0.02792996 0.19865184 AMIT_EGF_RESPONSE_60_MCF10A spindle cell carcinoma DOID_4015 3.701E-04 3.829E-03 0.02792996 0.19619934 AMIT_EGF_RESPONSE_60_MCF10A esophageal disease DOID_6050 3.701E-04 3.76E-03 0.02792996 0.19380667 AMIT_EGF_RESPONSE_60_MCF10A respiratory syncytial virus infectious disease DOID_1273 4.773E-04 4.765E-03 0.03164602 0.21184215 AMIT_EGF_RESPONSE_60_MCF10A peptic ulcer DOID_750 4.773E-04 4.683E-03 0.03164602 0.20697221 AMIT_EGF_RESPONSE_60_MCF10A cervix uteri carcinoma in situ DOID_8991 5.239E-04 5.053E-03 0.03312859 0.20944633 AMIT_EGF_RESPONSE_60_MCF10A endometriosis of uterus DOID_288 5.48E-04 5.197E-03 0.03386906 0.20947278 AMIT_EGF_RESPONSE_60_MCF10A endometriosis DOID_289 5.727E-04 5.342E-03 0.03460898 0.20949479 AMIT_EGF_RESPONSE_60_MCF10A gallbladder cancer DOID_3121 5.978E-04 5.487E-03 0.03534835 0.21171803 AMIT_EGF_RESPONSE_60_MCF10A proteinuria DOID_576 6.498E-04 5.869E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A brain cancer DOID_1319 6.765E-04 6.015E-03 6.765E-04 0.02566273 AMIT_EGF_RESPONSE_60_MCF10A neuritis DOID_1803 6.765E-04 5.922E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A heart valve disease DOID_4079 6.765E-04 5.832E-03 6.765E-04 0.02405881 AMIT_EGF_RESPONSE_60_MCF10A central nervous system cancer DOID_3620 7.038E-04 5.977E-03 7.038E-04 0.02355664 AMIT_EGF_RESPONSE_60_MCF10A pulmonary tuberculosis DOID_2957 7.316E-04 6.122E-03 0.03903702 0.22665373 AMIT_EGF_RESPONSE_60_MCF10A aortic aneurysm DOID_3627 7.599E-04 6.267E-03 0.03977312 0.228595 AMIT_EGF_RESPONSE_60_MCF10A sarcoidosis DOID_11335 8.481E-04 6.894E-03 0.04197815 0.23649075 AMIT_EGF_RESPONSE_60_MCF10A bone marrow cancer DOID_4960 8.785E-04 7.04E-03 0.04271207 0.23595309 AMIT_EGF_RESPONSE_60_MCF10A integumentary system cancer DOID_0060122 9.094E-04 7.187E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A parasitic protozoa infectious disease DOID_2789 9.094E-04 7.089E-03 0.04344545 0.23769674 AMIT_EGF_RESPONSE_60_MCF10A skin cancer DOID_4159 9.094E-04 7.187E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A pustulosis of palm and sole DOID_4398 9.094E-04 6.993E-03 0.04344545 0.23543296 AMIT_EGF_RESPONSE_60_MCF10A hypersensitivity reaction type IV disease DOID_2916 1.005E-03 7.628E-03 0.04564234 0.24500461 AMIT_EGF_RESPONSE_60_MCF10A oral cavity cancer DOID_8618 1.005E-03 7.527E-03 0.04564234 0.24046749 AMIT_EGF_RESPONSE_60_MCF10A neuroectodermal tumor DOID_171 1.106E-03 8.173E-03 1.106E-03 0.03496187 AMIT_EGF_RESPONSE_60_MCF10A pre-malignant neoplasm DOID_0060071 1.176E-03 8.576E-03 0.04929299 0.25042599 AMIT_EGF_RESPONSE_60_MCF10A in situ carcinoma DOID_8719 1.176E-03 8.576E-03 0.04929299 0.25042599 AMIT_EGF_RESPONSE_60_MCF10A parasitic infectious disease DOID_1398 1.247E-03 8.984E-03 0.05074947 0.25554381 AMIT_EGF_RESPONSE_60_MCF10A hyperglycemia DOID_4195 1.284E-03 9.132E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A tuberculosis DOID_399 1.359E-03 9.545E-03 0.05293016 0.26188922 AMIT_EGF_RESPONSE_60_MCF10A male reproductive system disease DOID_48 1.475E-03 0.01023364 0.05510601 0.27030447 AMIT_EGF_RESPONSE_60_MCF10A diabetic retinopathy DOID_8947 1.555E-03 0.01065798 0.05655389 0.27503559 AMIT_EGF_RESPONSE_60_MCF10A bacterial pneumonia DOID_874 1.721E-03 0.01165449 0.05944324 0.28186001 AMIT_EGF_RESPONSE_60_MCF10A metabolic syndrome X DOID_14221 1.806E-03 0.01209273 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A retinal vascular disease DOID_2462 2.03E-03 0.01343185 0.06447904 0.29350859 AMIT_EGF_RESPONSE_60_MCF10A transitional cell carcinoma DOID_2671 2.17E-03 0.01419427 0.06662927 0.3008893 AMIT_EGF_RESPONSE_60_MCF10A nervous system cancer DOID_3093 2.266E-03 0.01465329 2.266E-03 0.04959577 AMIT_EGF_RESPONSE_60_MCF10A Human immunodeficiency virus infectious disease DOID_526 2.266E-03 0.01448865 0.0680601 0.30493067 AMIT_EGF_RESPONSE_60_MCF10A lymphoma DOID_0060058 2.364E-03 0.01494672 0.06948881 0.30889947 AMIT_EGF_RESPONSE_60_MCF10A encephalomyelitis DOID_640 2.414E-03 0.01509323 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A mouth disease DOID_403 2.464E-03 0.01523961 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A Crohn's disease DOID_8778 2.464E-03 0.01507574 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A dilated cardiomyopathy DOID_12930 2.515E-03 0.01522216 2.515E-03 0.05299568 AMIT_EGF_RESPONSE_60_MCF10A retinal vascular occlusion DOID_1729 7.624E-03 0.04566446 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A cutaneous leishmaniasis DOID_9111 7.624E-03 0.04518879 7.624E-03 0.14959047 AMIT_EGF_RESPONSE_60_MCF10A visceral leishmaniasis DOID_9146 7.624E-03 0.04472292 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A familial adenomatous polyposis DOID_0050424 8.383E-03 0.04867526 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A nervous system benign neoplasm DOID_0060115 8.383E-03 0.04818359 8.383E-03 0.15900585 AMIT_EGF_RESPONSE_60_MCF10A prediabetes syndrome DOID_11716 8.383E-03 0.04770175 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A aortic valve stenosis DOID_1712 9.142E-03 0.05150404 9.142E-03 0.16780348 AMIT_EGF_RESPONSE_60_MCF10A islet cell tumor DOID_1799 9.142E-03 0.0509991 9.142E-03 0.16255962 AMIT_EGF_RESPONSE_60_MCF10A aortic valve insufficiency DOID_57 9.142E-03 0.05050396 9.142E-03 0.15763357 AMIT_EGF_RESPONSE_60_MCF10A stomach disease DOID_76 9.142E-03 0.05001835 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A berylliosis DOID_10322 9.9E-03 0.05365068 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A polyneuropathy DOID_1389 9.9E-03 0.05314454 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A larynx cancer DOID_2596 9.9E-03 0.05264787 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A laryngeal benign neoplasm DOID_2598 9.9E-03 0.05264787 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A Legionnaires' disease DOID_10457 0.01065803 0.056152 0.01065803 0.17836519 AMIT_EGF_RESPONSE_60_MCF10A legionellosis DOID_10458 0.01065803 0.056152 0.01065803 0.17836519 AMIT_EGF_RESPONSE_60_MCF10A viral pneumonia DOID_10533 0.01065803 0.05563685 0.01065803 0.17326904 AMIT_EGF_RESPONSE_60_MCF10A open-angle glaucoma DOID_1067 0.01065803 0.05513106 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A hypercalcemia DOID_12678 0.01065803 0.05463438 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A polycystic kidney disease DOID_898 0.01065803 0.05414658 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A bacterial meningitis DOID_9470 0.01065803 0.0536674 0.01065803 0.16845601 AMIT_EGF_RESPONSE_60_MCF10A idiopathic pulmonary fibrosis DOID_0050156 0.0114151 0.05697538 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A membranoproliferative glomerulonephritis DOID_2920 0.0114151 0.05647994 0.0114151 0.17092613 AMIT_EGF_RESPONSE_60_MCF10A lung oat cell carcinoma DOID_5411 0.0114151 0.05599304 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A oral submucous fibrosis DOID_5773 0.0114151 0.05551447 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A intermediate coronary syndrome DOID_8805 0.0114151 0.05504401 0.0114151 0.16654341 AMIT_EGF_RESPONSE_60_MCF10A angiosarcoma DOID_0001816 0.01217162 0.05819875 0.01217162 0.17314127 AMIT_EGF_RESPONSE_60_MCF10A silicosis DOID_10325 0.01217162 0.05771376 0.01217162 0.16891831 AMIT_EGF_RESPONSE_60_MCF10A spastic diplegia DOID_10965 0.01217162 0.05723678 0.01217162 0.16489645 AMIT_EGF_RESPONSE_60_MCF10A hemolytic-uremic syndrome DOID_12554 0.01217162 0.05676763 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A restrictive cardiomyopathy DOID_397 0.01217162 0.0563061 0.01217162 0.16106165 AMIT_EGF_RESPONSE_60_MCF10A thyroiditis DOID_7166 0.01217162 0.05585202 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A autoimmune thyroiditis DOID_7188 0.01217162 0.05585202 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A familial hypertrophic cardiomyopathy DOID_11986 0.01292758 0.05884633 0.01292758 0.1599085 AMIT_EGF_RESPONSE_60_MCF10A basal cell carcinoma DOID_2513 0.01292758 0.05837929 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A bronchitis DOID_6132 0.01292758 0.05791961 0.01292758 0.15650619 AMIT_EGF_RESPONSE_60_MCF10A neuroendocrine tumor DOID_169 0.01368298 0.0608251 0.01368298 0.15889006 AMIT_EGF_RESPONSE_60_MCF10A skin carcinoma DOID_3451 0.01368298 0.06035359 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A ureteral obstruction DOID_5199 0.01368298 0.05988933 0.01368298 0.15571226 AMIT_EGF_RESPONSE_60_MCF10A prion disease DOID_649 0.01368298 0.05943216 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A dissociative disorder DOID_10935 0.01443782 0.06223574 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A dissociative amnesia DOID_11037 0.01443782 0.06223574 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A Down syndrome DOID_14250 0.01443782 0.0617678 0.01443782 0.16108074 AMIT_EGF_RESPONSE_60_MCF10A testicular cancer DOID_2998 0.01443782 0.06130685 0.01443782 0.15798303 AMIT_EGF_RESPONSE_60_MCF10A granulosa cell tumor DOID_2999 0.01443782 0.06085272 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A psoriasis DOID_8893 0.01443782 0.06040528 0.01443782 0.15500222 AMIT_EGF_RESPONSE_60_MCF10A sex cord-gonadal stromal tumor DOID_192 0.0151921 0.06309712 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A autoimmune hepatitis DOID_2048 0.01594583 0.06574764 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A mitochondrial myopathy DOID_699 0.01594583 0.06527464 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A gastric ulcer DOID_10808 0.01669899 0.06786949 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A hepatitis B DOID_2043 0.01669899 0.06738814 0.01669899 0.16967372 AMIT_EGF_RESPONSE_60_MCF10A placenta disease DOID_780 0.01669899 0.06691358 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A muscle cancer DOID_4045 0.01745161 0.06944031 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A pulmonary embolism DOID_9477 0.01745161 0.06895809 0.01745161 0.17120628 AMIT_EGF_RESPONSE_60_MCF10A ureteral disease DOID_1426 0.01820366 0.07143369 0.01820366 0.17555736 AMIT_EGF_RESPONSE_60_MCF10A Goodpasture syndrome DOID_9808 0.01820366 0.07094441 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A spastic quadriplegia DOID_10970 0.01895516 0.07337067 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A acute pancreatitis DOID_2913 0.01895516 0.07287492 0.01895516 0.17681128 AMIT_EGF_RESPONSE_60_MCF10A portal hypertension DOID_10762 0.01970611 0.07525353 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A hypogonadism DOID_1924 0.01970611 0.07475184 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A bronchiolitis DOID_2942 0.01970611 0.07425679 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A myositis DOID_633 0.0204565 0.07657729 0.0204565 0.1847579 AMIT_EGF_RESPONSE_60_MCF10A ankylosing spondylitis DOID_7147 0.0204565 0.07607678 0.0204565 0.18187106 AMIT_EGF_RESPONSE_60_MCF10A cleft lip DOID_9296 0.0204565 0.07558278 0.0204565 0.17907304 AMIT_EGF_RESPONSE_60_MCF10A intracranial aneurysm DOID_10941 0.02120633 0.07784777 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A Sciatic Neuropathy DOID_11446 0.02195562 0.0800817 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A gestational diabetes DOID_11714 0.02195562 0.07957162 0.02195562 0.18928401 AMIT_EGF_RESPONSE_60_MCF10A lesion of sciatic nerve DOID_12528 0.02195562 0.0800817 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A periodontitis DOID_824 0.02195562 0.07906801 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A mononeuritis of lower limb DOID_9473 0.02195562 0.0800817 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A sarcoma DOID_1115 0.02270434 0.08125013 0.02270434 0.18998192 AMIT_EGF_RESPONSE_60_MCF10A mononeuritis DOID_1802 0.02270434 0.08074232 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A hepatic vascular disease DOID_272 0.02270434 0.08024081 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A autoimmune disease of endocrine system DOID_0060005 0.02345252 0.08237334 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A mononeuropathy DOID_1188 0.02345252 0.08186799 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A supratentorial cancer DOID_1659 0.02345252 0.08136879 0.02345252 0.19339829 AMIT_EGF_RESPONSE_60_MCF10A cerebrum cancer DOID_368 0.02345252 0.08136879 0.02345252 0.19339829 AMIT_EGF_RESPONSE_60_MCF10A focal glomerulosclerosis DOID_3945 0.02345252 0.08087565 0.02345252 0.19063545 AMIT_EGF_RESPONSE_60_MCF10A endometrial carcinoma DOID_2871 0.02420014 0.08295107 0.02420014 0.19394194 AMIT_EGF_RESPONSE_60_MCF10A gonadal disease DOID_2277 0.02494721 0.08499976 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A bronchiolitis obliterans DOID_2799 0.02494721 0.08449381 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A abdominal aortic aneurysm DOID_7693 0.02494721 0.08399384 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A celiac disease DOID_10608 0.02569372 0.0859984 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A endometrial cancer DOID_1380 0.02569372 0.08549548 0.02569372 0.20027024 AMIT_EGF_RESPONSE_60_MCF10A papilloma DOID_2615 0.0271851 0.0899321 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A hepatitis C DOID_1883 0.02792996 0.09186212 0.02792996 0.20116642 AMIT_EGF_RESPONSE_60_MCF10A periodontal disease DOID_3388 0.02792996 0.09133418 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A thyroid carcinoma DOID_3963 0.02792996 0.09081227 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A thyroid cancer DOID_1781 0.02941803 0.09510716 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A pulmonary sarcoidosis DOID_13406 0.03016124 0.09695902 0.03016124 0.20676803 AMIT_EGF_RESPONSE_60_MCF10A cleft palate DOID_674 0.03016124 0.09641431 0.03016124 0.20430651 AMIT_EGF_RESPONSE_60_MCF10A multiple myeloma DOID_9538 0.03016124 0.09587568 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A congenital diaphragmatic hernia DOID_3827 0.03164602 0.09948388 1.000 1.000 AMIT_EGF_RESPONSE_60_MCF10A systemic scleroderma DOID_418 0.03164602 0.09893727 1.000 1.000 KIM_WT1_TARGETS_UP bone marrow cancer DOID_4960 1.146E-09 6.518E-07 4.667E-05 5.311E-03 KIM_WT1_TARGETS_UP uterine cancer DOID_363 1.45E-08 4.125E-06 6.228E-07 3.544E-04 KIM_WT1_TARGETS_UP myeloma DOID_0070004 2.127E-08 4.035E-06 2.772E-05 3.943E-03 KIM_WT1_TARGETS_UP endometrial carcinoma DOID_2871 8.523E-08 1.212E-05 4.542E-06 1.292E-03 KIM_WT1_TARGETS_UP endometrial cancer DOID_1380 1.171E-07 1.333E-05 5.826E-06 1.105E-03 KIM_WT1_TARGETS_UP encephalomyelitis DOID_640 1.025E-06 9.718E-05 4.427E-03 0.09329571 KIM_WT1_TARGETS_UP Crohn's disease DOID_8778 1.09E-06 8.86E-05 3.537E-04 0.0201255 KIM_WT1_TARGETS_UP bile duct disease DOID_4138 6.07E-06 4.318E-04 0.22616323 0.6565657 KIM_WT1_TARGETS_UP biliary tract disease DOID_9741 6.486E-06 4.101E-04 0.22884242 0.66097126 KIM_WT1_TARGETS_UP leiomyoma DOID_127 6.561E-06 3.733E-04 2.434E-04 0.01538739 KIM_WT1_TARGETS_UP multiple myeloma DOID_9538 1.13E-05 5.844E-04 8.482E-03 0.12700542 KIM_WT1_TARGETS_UP chronic kidney failure DOID_784 1.199E-05 5.686E-04 3.239E-03 0.09215176 KIM_WT1_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.241E-05 1.419E-03 7.874E-04 0.03733368 KIM_WT1_TARGETS_UP giant cell tumor DOID_200 4.351E-05 1.768E-03 0.01615588 0.18024893 KIM_WT1_TARGETS_UP malignant giant cell tumor DOID_2705 4.351E-05 1.768E-03 0.01615588 0.18024893 KIM_WT1_TARGETS_UP giant cell glioblastoma DOID_3074 4.351E-05 1.768E-03 0.01615588 0.18024893 KIM_WT1_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 4.999E-05 1.896E-03 1.083E-03 0.0440094 KIM_WT1_TARGETS_UP glioblastoma DOID_3068 6.1E-05 2.169E-03 0.01898469 0.20004237 KIM_WT1_TARGETS_UP toxic shock syndrome DOID_14115 8.772E-05 2.936E-03 3.374E-03 0.08727435 KIM_WT1_TARGETS_UP cholestasis DOID_13580 9.343E-05 2.953E-03 1.000 1.000 KIM_WT1_TARGETS_UP commensal bacterial infectious disease DOID_0050339 9.891E-05 2.962E-03 3.647E-03 0.09023256 KIM_WT1_TARGETS_UP astrocytoma DOID_3069 1.168E-04 3.322E-03 0.02587322 0.24952311 KIM_WT1_TARGETS_UP vitiligo DOID_12306 1.24E-04 3.36E-03 4.223E-03 0.09611689 KIM_WT1_TARGETS_UP spinal cord disease DOID_319 1.24E-04 3.207E-03 0.09240321 0.40757694 KIM_WT1_TARGETS_UP nephrosis DOID_2527 1.299E-04 3.214E-03 0.02721944 0.25813098 KIM_WT1_TARGETS_UP lung adenocarcinoma DOID_3910 1.38E-04 3.271E-03 4.526E-03 0.09196793 KIM_WT1_TARGETS_UP bone resorption disease DOID_0080011 1.674E-04 3.81E-03 1.674E-04 0.01587366 KIM_WT1_TARGETS_UP osteoporosis DOID_11476 1.674E-04 3.81E-03 1.674E-04 0.01587366 KIM_WT1_TARGETS_UP aneurysm disease DOID_2403 1.674E-04 3.663E-03 2.633E-03 0.07883957 KIM_WT1_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 1.858E-04 3.917E-03 1.858E-04 0.01510672 KIM_WT1_TARGETS_UP uterine benign neoplasm DOID_0060095 1.858E-04 3.917E-03 1.858E-04 0.01510672 KIM_WT1_TARGETS_UP uterine fibroid DOID_13223 1.858E-04 3.917E-03 1.858E-04 0.01510672 KIM_WT1_TARGETS_UP celiac disease DOID_10608 2.231E-04 4.533E-03 2.231E-04 0.01586702 KIM_WT1_TARGETS_UP primary bacterial infectious disease DOID_0050338 2.649E-04 5.197E-03 0.26539869 0.72952587 KIM_WT1_TARGETS_UP transitional cell carcinoma DOID_2671 2.764E-04 5.243E-03 3.805E-03 0.09020403 KIM_WT1_TARGETS_UP nephroblastoma DOID_2154 2.875E-04 5.277E-03 7.291E-03 0.12202172 KIM_WT1_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 3.007E-04 5.347E-03 0.27300556 0.74682772 KIM_WT1_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.537E-04 6.099E-03 4.558E-03 0.08645832 KIM_WT1_TARGETS_UP cleft palate DOID_674 3.628E-04 6.072E-03 8.482E-03 0.130438 KIM_WT1_TARGETS_UP systemic scleroderma DOID_418 4.194E-04 6.819E-03 0.1353751 0.48142771 KIM_WT1_TARGETS_UP benign mesothelioma DOID_2645 4.814E-04 7.61E-03 0.01019498 0.1450236 KIM_WT1_TARGETS_UP pulmonary emphysema DOID_9675 4.814E-04 7.404E-03 1.000 1.000 KIM_WT1_TARGETS_UP cutaneous leishmaniasis DOID_9111 5.236E-04 7.841E-03 1.000 1.000 KIM_WT1_TARGETS_UP nephrotic syndrome DOID_1184 5.49E-04 8.01E-03 0.01110415 0.15410396 KIM_WT1_TARGETS_UP rheumatic disease DOID_1575 5.49E-04 7.81E-03 0.1472776 0.51098144 KIM_WT1_TARGETS_UP scleroderma DOID_419 5.49E-04 7.81E-03 0.1472776 0.51098144 KIM_WT1_TARGETS_UP cerebral infarction DOID_3526 6.224E-04 8.638E-03 0.01204772 0.15942219 KIM_WT1_TARGETS_UP cataract DOID_83 6.224E-04 8.433E-03 0.01204772 0.15579896 KIM_WT1_TARGETS_UP pre-eclampsia DOID_10591 7.018E-04 9.287E-03 0.01302518 0.16469621 KIM_WT1_TARGETS_UP lens disease DOID_110 7.018E-04 9.076E-03 0.01302518 0.16111585 KIM_WT1_TARGETS_UP osteopetrosis DOID_13533 7.645E-04 9.667E-03 7.645E-04 0.03954644 KIM_WT1_TARGETS_UP aortic aneurysm DOID_3627 8.325E-04 0.01029762 0.01455381 0.17252334 KIM_WT1_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 8.793E-04 0.01064456 0.01507976 0.17510985 KIM_WT1_TARGETS_UP Leydig cell tumor DOID_2696 9.015E-04 0.01068626 0.04400818 0.3130082 KIM_WT1_TARGETS_UP Lynch syndrome DOID_3883 9.015E-04 0.01046817 9.015E-04 0.03945696 KIM_WT1_TARGETS_UP sex cord-stromal neoplasm DOID_4757 9.015E-04 0.01068626 0.04400818 0.3130082 KIM_WT1_TARGETS_UP orofacial cleft DOID_0050567 9.276E-04 0.01055655 0.0156138 0.17768506 KIM_WT1_TARGETS_UP tethered spinal cord syndrome DOID_1089 1.049E-03 0.01170739 1.000 1.000 KIM_WT1_TARGETS_UP pustulosis of palm and sole DOID_4398 1.083E-03 0.01184869 0.0172639 0.18534263 KIM_WT1_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 1.254E-03 0.01345749 1.254E-03 0.04754982 KIM_WT1_TARGETS_UP leukocyte disease DOID_9500 1.314E-03 0.01384505 1.000 1.000 KIM_WT1_TARGETS_UP silicosis DOID_10325 1.378E-03 0.01425087 1.000 1.000 KIM_WT1_TARGETS_UP neuroectodermal tumor DOID_171 1.44E-03 0.0146338 0.02077455 0.21492218 KIM_WT1_TARGETS_UP carotid artery disease DOID_3407 1.44E-03 0.01437707 0.02077455 0.21108428 KIM_WT1_TARGETS_UP collagen disease DOID_854 1.44E-03 0.01412918 0.19885802 0.60833449 KIM_WT1_TARGETS_UP Graves' disease DOID_12361 1.558E-03 0.01502197 1.558E-03 0.05539352 KIM_WT1_TARGETS_UP mineral metabolism disease DOID_0050032 1.644E-03 0.01558623 0.20714847 0.62695468 KIM_WT1_TARGETS_UP osteosclerosis DOID_4254 1.748E-03 0.0163087 1.748E-03 0.05851944 KIM_WT1_TARGETS_UP prion disease DOID_649 1.748E-03 0.01604565 0.06041784 0.34377752 KIM_WT1_TARGETS_UP eosinophilia DOID_999 1.748E-03 0.01579096 1.000 1.000 KIM_WT1_TARGETS_UP brain infarction DOID_3454 1.941E-03 0.01725936 0.02521065 0.24732518 KIM_WT1_TARGETS_UP tuberculosis DOID_399 1.941E-03 0.01699383 0.2180701 0.64291134 KIM_WT1_TARGETS_UP psoriasis DOID_8893 1.95E-03 0.01680845 1.95E-03 0.06163098 KIM_WT1_TARGETS_UP leishmaniasis DOID_9065 1.95E-03 0.01655758 1.000 1.000 KIM_WT1_TARGETS_UP esophagitis DOID_11963 2.161E-03 0.01808582 1.000 1.000 KIM_WT1_TARGETS_UP acquired immunodeficiency syndrome DOID_635 2.616E-03 0.02157215 1.000 1.000 KIM_WT1_TARGETS_UP muscular atrophy DOID_767 2.616E-03 0.02126398 1.000 1.000 KIM_WT1_TARGETS_UP placenta disease DOID_780 2.616E-03 0.02096449 0.07334406 0.37597089 KIM_WT1_TARGETS_UP pancreatitis DOID_4989 2.728E-03 0.02156136 0.03142264 0.28380131 KIM_WT1_TARGETS_UP sinusitis DOID_0050127 2.859E-03 0.02228164 0.07654794 0.38889088 KIM_WT1_TARGETS_UP paranasal sinus disease DOID_1352 2.859E-03 0.02228164 0.07654794 0.38889088 KIM_WT1_TARGETS_UP myasthenia gravis DOID_437 2.859E-03 0.02198054 1.000 1.000 KIM_WT1_TARGETS_UP alcohol abuse DOID_1574 3.239E-03 0.0245738 0.03510742 0.28950899 KIM_WT1_TARGETS_UP bone development disease DOID_0080006 3.348E-03 0.02506415 3.348E-03 0.09070836 KIM_WT1_TARGETS_UP osteosarcoma DOID_3347 3.647E-03 0.02695258 0.08609378 0.39505937 KIM_WT1_TARGETS_UP cystitis DOID_1679 3.93E-03 0.02867083 0.08925392 0.39988566 KIM_WT1_TARGETS_UP neuromuscular junction disease DOID_439 3.93E-03 0.0283079 1.000 1.000 KIM_WT1_TARGETS_UP nervous system cancer DOID_3093 4.047E-03 0.02878265 0.04053092 0.32030684 KIM_WT1_TARGETS_UP middle cerebral artery infarction DOID_3525 4.223E-03 0.02966571 0.09240321 0.40444173 KIM_WT1_TARGETS_UP lymphoma DOID_0060058 4.298E-03 0.02982371 0.04213508 0.31545867 KIM_WT1_TARGETS_UP lymphoblastic leukemia DOID_1037 4.427E-03 0.03034921 4.427E-03 0.09688401 KIM_WT1_TARGETS_UP carbohydrate metabolic disorder DOID_2978 4.427E-03 0.02998791 0.042946 0.31735423 KIM_WT1_TARGETS_UP gestational diabetes DOID_11714 4.526E-03 0.03029532 0.09554169 0.40569569 KIM_WT1_TARGETS_UP perinatal necrotizing enterocolitis DOID_8677 4.526E-03 0.02994305 4.526E-03 0.08879662 KIM_WT1_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 4.692E-03 0.0306879 1.000 1.000 KIM_WT1_TARGETS_UP autoimmune disease of the nervous system DOID_438 4.838E-03 0.03128209 1.000 1.000 KIM_WT1_TARGETS_UP autoimmune disease of endocrine system DOID_0060005 5.16E-03 0.0329893 5.16E-03 0.09471122 KIM_WT1_TARGETS_UP toxic encephalopathy DOID_3602 5.16E-03 0.03262275 5.16E-03 0.09175149 KIM_WT1_TARGETS_UP focal glomerulosclerosis DOID_3945 5.16E-03 0.03226426 0.10178638 0.40219759 KIM_WT1_TARGETS_UP cranial nerve disease DOID_5656 5.16E-03 0.03191356 5.16E-03 0.08897114 KIM_WT1_TARGETS_UP opportunistic mycosis DOID_2473 5.833E-03 0.0356865 1.000 1.000 KIM_WT1_TARGETS_UP abdominal aortic aneurysm DOID_7693 5.833E-03 0.03530686 0.10798829 0.40963558 KIM_WT1_TARGETS_UP allergic rhinitis DOID_4481 6.183E-03 0.03703514 1.000 1.000 KIM_WT1_TARGETS_UP bladder disease DOID_365 6.543E-03 0.03878311 0.1141477 0.42451006 KIM_WT1_TARGETS_UP systemic mycosis DOID_0050136 6.913E-03 0.04054974 1.000 1.000 KIM_WT1_TARGETS_UP fungal infectious disease DOID_1564 6.913E-03 0.04054974 1.000 1.000 KIM_WT1_TARGETS_UP pneumoconiosis DOID_10316 7.291E-03 0.04233407 1.000 1.000 KIM_WT1_TARGETS_UP spindle cell carcinoma DOID_4015 7.291E-03 0.04190645 0.12026489 0.44435535 KIM_WT1_TARGETS_UP esophageal disease DOID_6050 7.291E-03 0.04148738 1.000 1.000 KIM_WT1_TARGETS_UP hyperthyroidism DOID_7998 7.291E-03 0.04107662 7.291E-03 0.11853538 KIM_WT1_TARGETS_UP lymphoid leukemia DOID_10747 7.679E-03 0.04283708 7.679E-03 0.12137172 KIM_WT1_TARGETS_UP medullomyoblastoma DOID_3861 7.679E-03 0.04242118 0.12330775 0.45265879 KIM_WT1_TARGETS_UP adult medulloblastoma DOID_3864 7.679E-03 0.04242118 0.12330775 0.45265879 KIM_WT1_TARGETS_UP childhood medulloblastoma DOID_3869 7.679E-03 0.04242118 0.12330775 0.45265879 KIM_WT1_TARGETS_UP pulmonary sarcoidosis DOID_13406 8.482E-03 0.04640583 1.000 1.000 KIM_WT1_TARGETS_UP medulloblastoma DOID_3858 8.482E-03 0.04596387 0.12936218 0.46883489 KIM_WT1_TARGETS_UP uveitis DOID_13141 8.897E-03 0.04775765 1.000 1.000 KIM_WT1_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 9.321E-03 0.04956536 1.000 1.000 KIM_WT1_TARGETS_UP adult respiratory distress syndrome DOID_11394 9.753E-03 0.05138627 1.000 1.000 KIM_WT1_TARGETS_UP intracranial arterial disease DOID_13089 9.753E-03 0.05091483 0.1383661 0.48900813 KIM_WT1_TARGETS_UP cerebral arterial disease DOID_3527 9.753E-03 0.05091483 0.1383661 0.48900813 KIM_WT1_TARGETS_UP lymphatic system disease DOID_75 9.753E-03 0.05045197 9.753E-03 0.14230043 KIM_WT1_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 0.01064523 0.05456881 0.14431731 0.50689228 KIM_WT1_TARGETS_UP primary biliary cirrhosis DOID_12236 0.01064523 0.05456881 0.14431731 0.50689228 KIM_WT1_TARGETS_UP primitive neuroectodermal tumor DOID_168 0.01110415 0.05641306 0.1472776 0.50788458 KIM_WT1_TARGETS_UP uveal disease DOID_3480 0.01110415 0.05591383 1.000 1.000 KIM_WT1_TARGETS_UP diabetic autonomic neuropathy DOID_11503 0.01157167 0.05775684 0.01157167 0.15676856 KIM_WT1_TARGETS_UP autonomic neuropathy DOID_11504 0.01157167 0.05775684 0.01157167 0.15676856 KIM_WT1_TARGETS_UP diabetic polyneuropathy DOID_12785 0.01157167 0.05775684 0.01157167 0.15676856 KIM_WT1_TARGETS_UP gallbladder cancer DOID_3121 0.01157167 0.05725461 0.15022773 0.51185377 KIM_WT1_TARGETS_UP diabetic neuropathy DOID_9743 0.01157167 0.05775684 0.01157167 0.15676856 KIM_WT1_TARGETS_UP autonomic nervous system disease DOID_11465 0.01302518 0.06389077 0.01302518 0.15768786 KIM_WT1_TARGETS_UP neuritis DOID_1803 0.01302518 0.06334469 0.15901748 0.52912835 KIM_WT1_TARGETS_UP heart valve disease DOID_4079 0.01302518 0.06280787 1.000 1.000 KIM_WT1_TARGETS_UP pulmonary tuberculosis DOID_2957 0.01403603 0.06711345 0.16482713 0.53592365 KIM_WT1_TARGETS_UP calcium metabolism disease DOID_10575 0.01455381 0.06900934 0.167717 0.54222145 KIM_WT1_TARGETS_UP sarcoidosis DOID_11335 0.01615588 0.07597269 1.000 1.000 KIM_WT1_TARGETS_UP bile duct adenocarcinoma DOID_4896 0.01670593 0.07791538 0.17917759 0.56640028 KIM_WT1_TARGETS_UP cholangiocarcinoma DOID_4947 0.01670593 0.07791538 0.17917759 0.56640028 KIM_WT1_TARGETS_UP vasculitis DOID_865 0.01670593 0.07728192 1.000 1.000 KIM_WT1_TARGETS_UP osteochondrodysplasia DOID_2256 0.0172639 0.07921903 0.0172639 0.18890691 KIM_WT1_TARGETS_UP parasitic protozoa infectious disease DOID_2789 0.0172639 0.07858528 1.000 1.000 KIM_WT1_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 0.01898469 0.08573244 1.000 1.000 KIM_WT1_TARGETS_UP bile duct cancer DOID_4606 0.01898469 0.08505738 0.19048156 0.58904351 KIM_WT1_TARGETS_UP bile duct carcinoma DOID_4897 0.01898469 0.08505738 0.19048156 0.58904351 KIM_WT1_TARGETS_UP respiratory failure DOID_11162 0.02138625 0.09506855 1.000 1.000 KIM_WT1_TARGETS_UP pre-malignant neoplasm DOID_0060071 0.02200538 0.0970625 0.20439449 0.62192762 KIM_WT1_TARGETS_UP congenital heart defect DOID_1682 0.02200538 0.09631587 0.02200538 0.21966777 KIM_WT1_TARGETS_UP in situ carcinoma DOID_8719 0.02200538 0.0970625 0.20439449 0.62192762 MARCHINI_TRABECTEDIN_RESISTANCE_DN aortic valve insufficiency DOID_57 5.433E-05 0.0309146 0.01102409 0.41818046 MARCHINI_TRABECTEDIN_RESISTANCE_DN mixed glioma DOID_5076 5.64E-05 0.01604653 2.501E-03 0.2032848 MARCHINI_TRABECTEDIN_RESISTANCE_DN dilated cardiomyopathy DOID_12930 1.001E-04 0.0189923 1.001E-04 0.05697689 MARCHINI_TRABECTEDIN_RESISTANCE_DN congenital hemolytic anemia DOID_589 2.256E-04 0.03209563 2.256E-04 0.06419127 MARCHINI_TRABECTEDIN_RESISTANCE_DN aortic valve disease DOID_62 2.256E-04 0.02567651 0.02193008 0.44565062 MARCHINI_TRABECTEDIN_RESISTANCE_DN heart valve disease DOID_4079 9.865E-04 0.09354893 0.04516044 0.54672957 MARCHINI_TRABECTEDIN_RESISTANCE_DN hemolytic anemia DOID_583 1.026E-03 0.08340934 1.026E-03 0.19462179 MARCHINI_TRABECTEDIN_RESISTANCE_DN normocytic anemia DOID_720 1.026E-03 0.08340934 1.026E-03 0.19462179 MARCHINI_TRABECTEDIN_RESISTANCE_DN aortic aneurysm DOID_3627 1.108E-03 0.07878778 0.04780612 0.52310927 MARCHINI_TRABECTEDIN_RESISTANCE_DN hypertrophic cardiomyopathy DOID_11984 1.464E-03 0.09257574 0.0548265 0.54730316 FALVELLA_SMOKERS_WITH_LUNG_CANCER pancreatitis DOID_4989 2.949E-08 1.678E-05 1.935E-06 1.101E-03 FALVELLA_SMOKERS_WITH_LUNG_CANCER mesenchymal cell neoplasm DOID_3350 5.699E-07 1.621E-04 1.247E-04 0.01773309 FALVELLA_SMOKERS_WITH_LUNG_CANCER spindle cell sarcoma DOID_4235 5.699E-07 1.621E-04 1.247E-04 0.01773309 FALVELLA_SMOKERS_WITH_LUNG_CANCER epithelioid sarcoma DOID_6193 5.699E-07 1.621E-04 1.247E-04 0.01773309 FALVELLA_SMOKERS_WITH_LUNG_CANCER sarcoma DOID_1115 5.027E-06 9.535E-04 5.11E-04 0.04154019 FALVELLA_SMOKERS_WITH_LUNG_CANCER multiple myeloma DOID_9538 1.214E-05 1.727E-03 0.04339212 0.4256917 FALVELLA_SMOKERS_WITH_LUNG_CANCER leukodystrophy DOID_10579 2.248E-05 2.558E-03 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER myeloma DOID_0070004 2.39E-05 2.266E-03 0.05394963 0.444889 FALVELLA_SMOKERS_WITH_LUNG_CANCER aortic aneurysm DOID_3627 2.85E-05 2.316E-03 1.593E-03 0.08239933 FALVELLA_SMOKERS_WITH_LUNG_CANCER bone marrow cancer DOID_4960 3.548E-05 2.524E-03 0.06127212 0.47758682 FALVELLA_SMOKERS_WITH_LUNG_CANCER carotid artery disease DOID_3407 5.025E-05 3.177E-03 0.06853927 0.51314273 FALVELLA_SMOKERS_WITH_LUNG_CANCER cerebral degeneration DOID_1443 6.026E-05 3.429E-03 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER adrenoleukodystrophy DOID_10588 6.548E-05 3.387E-03 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER invasive lobular carcinoma DOID_3457 6.548E-05 3.105E-03 6.548E-05 0.01862985 FALVELLA_SMOKERS_WITH_LUNG_CANCER cystic fibrosis DOID_1485 9.077E-05 3.973E-03 9.077E-05 0.01721696 FALVELLA_SMOKERS_WITH_LUNG_CANCER obstructive hydrocephalus DOID_14159 9.274E-05 3.769E-03 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER communicating hydrocephalus DOID_1573 9.274E-05 3.769E-03 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER aneurysm disease DOID_2403 9.429E-05 3.577E-03 3.497E-03 0.14214113 FALVELLA_SMOKERS_WITH_LUNG_CANCER hydrocephalus DOID_10908 1.081E-04 3.845E-03 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER intracranial hypertension DOID_9428 1.247E-04 4.172E-03 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER hypersensitivity reaction type I disease DOID_1205 1.734E-04 5.48E-03 1.734E-04 0.0197298 FALVELLA_SMOKERS_WITH_LUNG_CANCER muscular atrophy DOID_767 2.729E-04 8.173E-03 2.729E-04 0.02588087 FALVELLA_SMOKERS_WITH_LUNG_CANCER sinusitis DOID_0050127 2.987E-04 8.498E-03 0.02517982 0.40935201 FALVELLA_SMOKERS_WITH_LUNG_CANCER paranasal sinus disease DOID_1352 2.987E-04 8.498E-03 0.02517982 0.40935201 FALVELLA_SMOKERS_WITH_LUNG_CANCER hypoglycemia DOID_9993 2.987E-04 8.093E-03 0.02517982 0.36736719 FALVELLA_SMOKERS_WITH_LUNG_CANCER autoimmune disease of endocrine system DOID_0060005 5.459E-04 0.01411895 5.459E-04 0.03882713 FALVELLA_SMOKERS_WITH_LUNG_CANCER focal glomerulosclerosis DOID_3945 5.459E-04 0.01350509 5.459E-04 0.034513 FALVELLA_SMOKERS_WITH_LUNG_CANCER abdominal aortic aneurysm DOID_7693 6.19E-04 0.01467523 0.03593353 0.37863291 FALVELLA_SMOKERS_WITH_LUNG_CANCER spindle cell carcinoma DOID_4015 7.786E-04 0.01772053 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER esophageal disease DOID_6050 7.786E-04 0.01703898 0.04020251 0.40848618 FALVELLA_SMOKERS_WITH_LUNG_CANCER hyperthyroidism DOID_7998 7.786E-04 0.0164079 0.04020251 0.40131975 FALVELLA_SMOKERS_WITH_LUNG_CANCER uveitis DOID_13141 9.559E-04 0.01942581 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER hepatitis DOID_2237 1.003E-03 0.01967993 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER benign mesothelioma DOID_2645 1.1E-03 0.02087271 0.04762886 0.44427574 FALVELLA_SMOKERS_WITH_LUNG_CANCER uveal disease DOID_3480 1.202E-03 0.02206877 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER gallbladder cancer DOID_3121 1.255E-03 0.02231364 0.05079438 0.42502945 FALVELLA_SMOKERS_WITH_LUNG_CANCER pre-eclampsia DOID_10591 1.419E-03 0.02446826 1.419E-03 0.08074525 FALVELLA_SMOKERS_WITH_LUNG_CANCER bone marrow disease DOID_4961 1.419E-03 0.0237486 0.05394963 0.43853344 FALVELLA_SMOKERS_WITH_LUNG_CANCER congenital heart defect DOID_1682 2.457E-03 0.03994561 2.457E-03 0.11650803 FALVELLA_SMOKERS_WITH_LUNG_CANCER endocrine pancreas disease DOID_1428 2.531E-03 0.04000293 0.07163693 0.51596725 FALVELLA_SMOKERS_WITH_LUNG_CANCER hyperglycemia DOID_4195 2.682E-03 0.04124045 0.07369644 0.51138142 FALVELLA_SMOKERS_WITH_LUNG_CANCER allergic contact dermatitis DOID_3042 2.759E-03 0.04130727 2.759E-03 0.12074432 FALVELLA_SMOKERS_WITH_LUNG_CANCER endocrine organ benign neoplasm DOID_0060089 2.837E-03 0.04138572 0.0757515 0.51930846 FALVELLA_SMOKERS_WITH_LUNG_CANCER bone resorption disease DOID_0080011 3.497E-03 0.0497494 0.0839273 0.52477618 FALVELLA_SMOKERS_WITH_LUNG_CANCER osteoporosis DOID_11476 3.497E-03 0.0497494 0.0839273 0.52477618 FALVELLA_SMOKERS_WITH_LUNG_CANCER contact dermatitis DOID_2773 3.762E-03 0.05220706 3.762E-03 0.1426993 FALVELLA_SMOKERS_WITH_LUNG_CANCER biliary tract cancer DOID_4607 4.035E-03 0.0546703 0.09001277 0.52801307 FALVELLA_SMOKERS_WITH_LUNG_CANCER chronic kidney failure DOID_784 4.035E-03 0.0533989 4.035E-03 0.14350953 FALVELLA_SMOKERS_WITH_LUNG_CANCER retinal vascular disease DOID_2462 4.223E-03 0.05460845 0.09203248 0.53435186 FALVELLA_SMOKERS_WITH_LUNG_CANCER nervous system cancer DOID_3093 4.709E-03 0.05953779 1.000 1.000 FALVELLA_SMOKERS_WITH_LUNG_CANCER lymphoma DOID_0060058 4.91E-03 0.06073256 0.09906706 0.56369157 FALVELLA_SMOKERS_WITH_LUNG_CANCER alcohol-related neurodevelopmental disorder DOID_0050667 5.115E-03 0.0619239 0.10106715 0.56937829 FALVELLA_SMOKERS_WITH_LUNG_CANCER dilated cardiomyopathy DOID_12930 5.219E-03 0.06186705 0.10206557 0.56383794 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN hypersensitivity reaction type I disease DOID_1205 1.993E-14 1.134E-11 5.6E-11 3.186E-08 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN abdominal aortic aneurysm DOID_7693 9.015E-13 2.565E-10 5.653E-05 8.041E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN aneurysm disease DOID_2403 1.044E-11 1.981E-09 7.606E-04 0.03091341 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN bacterial pneumonia DOID_874 1.158E-11 1.648E-09 7.89E-04 0.02805782 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN acute pancreatitis DOID_2913 1.816E-11 2.067E-09 2.414E-05 6.868E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN aortic aneurysm DOID_3627 3.138E-11 2.976E-09 2.35E-04 0.02674078 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN viral pneumonia DOID_10533 9.907E-11 8.053E-09 4.442E-04 0.03611014 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pulmonary emphysema DOID_9675 6.998E-10 4.978E-08 4.421E-03 0.08984013 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN mouth disease DOID_403 2.245E-09 1.42E-07 1.337E-03 0.03458319 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN brain infarction DOID_3454 1.353E-08 7.699E-07 0.14744268 0.59499917 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN bacterial meningitis DOID_9470 2.315E-08 1.198E-06 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pancreatitis DOID_4989 2.794E-08 1.325E-06 7.89E-04 0.02992834 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN rheumatic disease DOID_1575 6.412E-08 2.807E-06 4.823E-03 0.09462802 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN scleroderma DOID_419 6.412E-08 2.807E-06 4.823E-03 0.09462802 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN cerebral infarction DOID_3526 7.982E-08 3.244E-06 0.10220024 0.51010473 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN sinusitis DOID_0050127 2.017E-07 7.651E-06 1.219E-03 0.03302878 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN paranasal sinus disease DOID_1352 2.017E-07 7.651E-06 1.219E-03 0.03302878 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN meningitis DOID_9471 2.416E-07 8.592E-06 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN carotid artery disease DOID_3407 3.455E-07 1.157E-05 9.152E-03 0.16799112 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN collagen disease DOID_854 3.455E-07 1.092E-05 9.152E-03 0.1627414 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN intracranial aneurysm DOID_10941 4.624E-07 1.385E-05 0.06093588 0.41276802 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN middle cerebral artery infarction DOID_3525 4.624E-07 1.315E-05 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN cholestasis DOID_13580 4.691E-07 1.271E-05 0.01028225 0.17729088 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN tooth disease DOID_1091 5.428E-07 1.404E-05 5.342E-04 0.03039659 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN bile duct disease DOID_4138 7.173E-07 1.775E-05 0.01208637 0.19103176 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN biliary tract disease DOID_9741 7.672E-07 1.819E-05 0.01239959 0.19068562 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN bronchiolitis obliterans DOID_2799 9.162E-07 2.085E-05 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN cystic fibrosis DOID_1485 9.335E-07 2.043E-05 7.329E-04 0.03475207 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN ocular hypertension DOID_9282 2.358E-06 4.97E-05 0.02657962 0.30247602 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN borderline glaucoma DOID_9283 2.358E-06 4.97E-05 0.02657962 0.30247602 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN systemic scleroderma DOID_418 2.468E-06 5.015E-05 4.035E-03 0.08504269 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN intracranial arterial disease DOID_13089 2.716E-06 5.33E-05 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN cerebral arterial disease DOID_3527 2.716E-06 5.33E-05 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN carotid stenosis DOID_13001 3.061E-06 5.805E-05 0.02876281 0.30879314 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN influenza DOID_8469 3.899E-06 7.157E-05 0.10018026 0.5044475 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN brain edema DOID_4724 1.206E-05 2.145E-04 0.04391024 0.37855948 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN IgA glomerulonephritis DOID_2986 1.865E-05 3.215E-04 0.05033031 0.40335133 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN sphingolipidosis DOID_1927 2.414E-05 4.04E-04 0.05458666 0.40868173 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN diabetic retinopathy DOID_8947 2.669E-05 4.34E-04 6.795E-04 0.03514616 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN periodontitis DOID_824 3.81E-05 6.023E-04 0.0630429 0.41231507 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN retinal vascular disease DOID_2462 4.545E-05 6.99E-04 1.006E-03 0.03014008 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN corneal disease DOID_10124 5.147E-05 7.707E-04 5.147E-05 9.763E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN dilated cardiomyopathy DOID_12930 6.956E-05 1.015E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN myocarditis DOID_820 7.362E-05 1.047E-03 0.07766183 0.46030815 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN ulcerative colitis DOID_8577 7.832E-05 1.087E-03 0.02133605 0.28905268 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN periodontal disease DOID_3388 7.998E-05 1.084E-03 0.07973177 0.45825631 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN uveitis DOID_13141 1.09E-04 1.443E-03 3.849E-03 0.08423031 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN respiratory syncytial virus infectious disease DOID_1273 1.172E-04 1.516E-03 0.09001277 0.49725503 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN uveal disease DOID_3480 1.54E-04 1.947E-03 4.823E-03 0.09147375 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pre-eclampsia DOID_10591 1.976E-04 2.444E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN glaucoma DOID_1686 2.22E-04 2.688E-03 0.11023546 0.50179184 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN temporal arteritis DOID_13375 2.697E-04 3.197E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN central nervous system vasculitis DOID_525 2.697E-04 3.197E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN giant cell tumor DOID_200 2.767E-04 3.213E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN malignant giant cell tumor DOID_2705 2.767E-04 3.213E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN giant cell glioblastoma DOID_3074 2.767E-04 3.213E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN common cold DOID_10459 3.231E-04 3.677E-03 3.231E-04 0.03064397 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN relapsing-remitting multiple sclerosis DOID_2378 3.231E-04 3.605E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN hypertrophic cardiomyopathy DOID_11984 3.564E-04 3.9E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN glioblastoma DOID_3068 3.564E-04 3.826E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN respiratory failure DOID_11162 4.297E-04 4.528E-03 0.13586227 0.56842378 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN Legionnaires' disease DOID_10457 4.442E-04 4.596E-03 0.03094116 0.31438425 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN legionellosis DOID_10458 4.442E-04 4.596E-03 0.03094116 0.31438425 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN parasitic infectious disease DOID_1398 4.907E-04 4.986E-03 0.14167177 0.58413942 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN thoracic aortic aneurysm DOID_14004 5.118E-04 5.109E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN corneal dystrophy DOID_2566 5.118E-04 5.021E-03 5.118E-04 0.03640424 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN oral submucous fibrosis DOID_5773 5.118E-04 4.936E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN varicose veins DOID_799 5.118E-04 4.854E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN hyperhomocysteinemia DOID_9279 5.118E-04 4.774E-03 5.118E-04 0.03235932 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN allergic contact dermatitis DOID_3042 5.342E-04 4.903E-03 0.01086918 0.18189889 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN astrocytoma DOID_3069 5.802E-04 5.24E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN vein disease DOID_866 5.841E-04 5.193E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN nephrosis DOID_2527 6.286E-04 5.502E-03 0.01208637 0.19648981 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN male reproductive system disease DOID_48 6.286E-04 5.419E-03 0.15317523 0.6052549 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN dental caries DOID_216 7.426E-04 6.306E-03 7.426E-04 0.03250139 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN bone resorption disease DOID_0080011 7.606E-04 6.365E-03 0.16264496 0.63386972 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN osteoporosis DOID_11476 7.606E-04 6.365E-03 0.16264496 0.63386972 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN granulosa cell tumor DOID_2999 8.287E-04 6.834E-03 8.287E-04 0.02773757 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN contact dermatitis DOID_2773 8.477E-04 6.891E-03 0.01469023 0.21432668 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN sex cord-gonadal stromal tumor DOID_192 9.195E-04 7.369E-03 9.195E-04 0.02906496 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN biliary tract cancer DOID_4607 9.409E-04 7.435E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN primary bacterial infectious disease DOID_0050338 1.075E-03 8.378E-03 0.18127156 0.68306964 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN familial hypercholesterolemia DOID_13810 1.115E-03 8.57E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN primary immunodeficiency disease DOID_612 1.146E-03 8.695E-03 1.146E-03 0.03260666 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pulmonary embolism DOID_9477 1.219E-03 9.126E-03 0.05033031 0.39230061 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN Goodpasture syndrome DOID_9808 1.328E-03 9.812E-03 0.05246085 0.40338138 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN commensal bacterial infectious disease DOID_0050339 1.559E-03 0.01137323 1.559E-03 0.03857009 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN reading disorder DOID_13365 1.559E-03 0.01122927 0.05670777 0.41367589 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN dyslexia DOID_4428 1.559E-03 0.01122927 0.05670777 0.41367589 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN teeth hard tissue disease DOID_214 1.808E-03 0.01285977 1.808E-03 0.04286591 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN extrinsic allergic alveolitis DOID_841 1.808E-03 0.01270101 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN migraine DOID_6364 1.939E-03 0.01345588 0.0630429 0.41710943 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pleurisy DOID_10247 2.075E-03 0.01422261 0.06514526 0.4212233 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN renal hypertension DOID_1073 2.075E-03 0.0140533 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN secondary hypertension DOID_11130 2.075E-03 0.0140533 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN allergic rhinitis DOID_4481 2.66E-03 0.01780684 0.07350815 0.44974342 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pleural disease DOID_1532 2.817E-03 0.01863934 0.0755873 0.45754439 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pneumoconiosis DOID_10316 3.144E-03 0.02056388 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN male infertility DOID_12336 3.144E-03 0.0203302 0.07973177 0.4677049 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN adenoma DOID_657 3.488E-03 0.02230062 3.488E-03 0.07939022 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pulmonary sarcoidosis DOID_13406 3.666E-03 0.02317984 0.08591406 0.48401091 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN hepatitis DOID_2237 4.035E-03 0.02523245 0.09001277 0.49247373 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN adult respiratory distress syndrome DOID_11394 4.226E-03 0.0261377 0.09205531 0.49885212 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN spinocerebellar ataxia DOID_1441 4.62E-03 0.02826569 0.09612681 0.50644587 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN nephrotic syndrome DOID_1184 4.823E-03 0.02919375 0.09815578 0.5077331 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN diabetic autonomic neuropathy DOID_11503 5.03E-03 0.03012657 0.10018026 0.51353665 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN autonomic neuropathy DOID_11504 5.03E-03 0.03012657 0.10018026 0.51353665 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN diabetic polyneuropathy DOID_12785 5.03E-03 0.03012657 0.10018026 0.51353665 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN gallbladder cancer DOID_3121 5.03E-03 0.02981275 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN diabetic neuropathy DOID_9743 5.03E-03 0.03012657 0.10018026 0.51353665 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN learning disability DOID_8927 5.241E-03 0.03074364 0.10220024 0.50130982 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN spinocerebellar degeneration DOID_2478 5.456E-03 0.03167887 0.10421575 0.50682701 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN proteinuria DOID_576 5.456E-03 0.03135888 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN autonomic nervous system disease DOID_11465 5.675E-03 0.032292 0.10622678 0.50792468 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN thyroid adenoma DOID_2891 5.675E-03 0.03197228 0.10622678 0.49952923 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pulmonary tuberculosis DOID_2957 6.125E-03 0.0341699 0.11023546 0.49780936 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN sarcoidosis DOID_11335 7.073E-03 0.0390722 0.11819961 0.52136107 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN vasculitis DOID_865 7.319E-03 0.04004563 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN parasitic protozoa infectious disease DOID_2789 7.57E-03 0.04102141 0.12215522 0.53058261 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN familial hyperlipidemia DOID_1168 7.824E-03 0.04199936 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN hypersensitivity reaction type IV disease DOID_2916 8.344E-03 0.04437201 0.12805579 0.54375927 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN bile duct cancer DOID_4606 8.344E-03 0.04396116 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN bile duct carcinoma DOID_4897 8.344E-03 0.04396116 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN temporal lobe epilepsy DOID_3328 0.01057389 0.05519766 0.14359968 0.58782893 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN endocrine organ benign neoplasm DOID_0060089 0.01116809 0.05776946 0.14744268 0.59924916 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN tuberculosis DOID_399 0.01116809 0.05724901 0.14744268 0.59080903 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pancreatic ductal carcinoma DOID_3587 0.0117767 0.05982983 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN pancreatic carcinoma DOID_4905 0.01271635 0.0640319 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN syndrome DOID_225 0.01336042 0.06668488 0.01336042 0.20005464 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN mixed glioma DOID_5076 0.01401842 0.0693607 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN lipid metabolism disorder DOID_3146 0.01469023 0.07205811 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN auditory system disease DOID_2742 0.01537571 0.07477591 0.17201002 0.66130878 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN alcohol abuse DOID_1574 0.01572354 0.07581945 0.01572354 0.22366738 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN focal epilepsy DOID_2234 0.01572354 0.07518231 0.17387057 0.66397553 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN chronic kidney failure DOID_784 0.01572354 0.07455579 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN transitional cell carcinoma DOID_2671 0.01751288 0.08235395 0.18311154 0.6854636 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN amino acid metabolic disorder DOID_9252 0.01788067 0.08339428 0.01788067 0.24814883 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.01976837 0.0914488 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN familial combined hyperlipidemia DOID_13809 0.02219867 0.09945705 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN ventricular septal defect DOID_1657 0.02219867 0.09868005 0.02219867 0.28706923 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN retinal vascular occlusion DOID_1729 0.02219867 0.09791508 0.02219867 0.28068991 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN transient cerebral ischemia DOID_224 0.02219867 0.09716189 0.02219867 0.27458796 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN chondrosarcoma DOID_3371 0.02219867 0.0964202 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN conjunctival disease DOID_4251 0.02219867 0.09568974 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN keratitis DOID_4677 0.02219867 0.09497027 0.02219867 0.26874566 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN conjunctivitis DOID_6195 0.02219867 0.09568974 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN visceral leishmaniasis DOID_9146 0.02219867 0.09426154 0.02219867 0.26314679 GRESHOCK_CANCER_COPY_NUMBER_UP nervous system cancer DOID_3093 1.769E-39 1.006E-36 2.247E-06 1.066E-04 GRESHOCK_CANCER_COPY_NUMBER_UP lymphoma DOID_0060058 7.134E-32 2.03E-29 2.586E-11 1.471E-08 GRESHOCK_CANCER_COPY_NUMBER_UP bone marrow cancer DOID_4960 6.06E-30 1.149E-27 1.8E-06 9.31E-05 GRESHOCK_CANCER_COPY_NUMBER_UP transitional cell carcinoma DOID_2671 4.187E-27 5.956E-25 0.11373861 0.77972613 GRESHOCK_CANCER_COPY_NUMBER_UP thyroid carcinoma DOID_3963 5.622E-26 6.397E-24 1.283E-07 1.46E-05 GRESHOCK_CANCER_COPY_NUMBER_UP thyroid cancer DOID_1781 1.628E-25 1.544E-23 1.782E-07 1.448E-05 GRESHOCK_CANCER_COPY_NUMBER_UP central nervous system cancer DOID_3620 2.894E-23 2.352E-21 4.318E-03 0.08189181 GRESHOCK_CANCER_COPY_NUMBER_UP peripheral nervous system neoplasm DOID_1192 4.475E-23 3.183E-21 6.445E-06 2.619E-04 GRESHOCK_CANCER_COPY_NUMBER_UP germinoma DOID_3304 1.681E-22 1.063E-20 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP myeloma DOID_0070004 1.509E-21 8.586E-20 3.009E-04 7.133E-03 GRESHOCK_CANCER_COPY_NUMBER_UP brain cancer DOID_1319 1.509E-21 7.805E-20 0.04098117 0.46636567 GRESHOCK_CANCER_COPY_NUMBER_UP uterine cancer DOID_363 3.834E-20 1.818E-18 0.03661627 0.44329056 GRESHOCK_CANCER_COPY_NUMBER_UP lymphoblastic leukemia DOID_1037 4.861E-20 2.128E-18 6.099E-10 1.157E-07 GRESHOCK_CANCER_COPY_NUMBER_UP neuroectodermal tumor DOID_171 9.88E-20 4.015E-18 5.816E-05 1.839E-03 GRESHOCK_CANCER_COPY_NUMBER_UP multiple myeloma DOID_9538 2.302E-19 8.732E-18 1.255E-04 3.106E-03 GRESHOCK_CANCER_COPY_NUMBER_UP endocrine organ benign neoplasm DOID_0060089 5.445E-19 1.937E-17 0.36680722 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP reproductive organ benign neoplasm DOID_0050622 1.069E-18 3.58E-17 0.05350129 0.58542754 GRESHOCK_CANCER_COPY_NUMBER_UP endometrial cancer DOID_1380 1.771E-18 5.597E-17 0.1964601 0.97205039 GRESHOCK_CANCER_COPY_NUMBER_UP thyroid adenoma DOID_2891 6.415E-18 1.921E-16 0.27510439 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP seminoma DOID_4440 1.166E-17 3.316E-16 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP colon carcinoma DOID_1520 1.697E-17 4.598E-16 7.204E-03 0.11387012 GRESHOCK_CANCER_COPY_NUMBER_UP endometrial carcinoma DOID_2871 6.847E-17 1.771E-15 0.18605021 0.93683691 GRESHOCK_CANCER_COPY_NUMBER_UP primitive neuroectodermal tumor DOID_168 1.174E-16 2.905E-15 1.148E-05 4.357E-04 GRESHOCK_CANCER_COPY_NUMBER_UP autonomic nervous system neoplasm DOID_2621 2.177E-16 5.161E-15 7.375E-05 2.209E-03 GRESHOCK_CANCER_COPY_NUMBER_UP neuroblastoma DOID_769 2.177E-16 5.161E-15 7.375E-05 2.209E-03 GRESHOCK_CANCER_COPY_NUMBER_UP sarcoma DOID_1115 2.609E-15 5.939E-14 0.17550603 0.97904836 GRESHOCK_CANCER_COPY_NUMBER_UP supratentorial cancer DOID_1659 3.83E-15 8.383E-14 0.18079502 0.94378317 GRESHOCK_CANCER_COPY_NUMBER_UP cerebrum cancer DOID_368 3.83E-15 8.383E-14 0.18079502 0.94378317 GRESHOCK_CANCER_COPY_NUMBER_UP biliary tract cancer DOID_4607 1.096E-14 2.31E-13 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP muscle cancer DOID_4045 1.189E-14 2.417E-13 1.325E-05 4.712E-04 GRESHOCK_CANCER_COPY_NUMBER_UP pre-malignant neoplasm DOID_0060071 1.327E-14 2.604E-13 0.34608015 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP in situ carcinoma DOID_8719 1.327E-14 2.604E-13 0.34608015 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP papilloma DOID_2615 2.135E-14 4.049E-13 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP lung small cell carcinoma DOID_5409 2.864E-14 5.258E-13 3.501E-04 7.969E-03 GRESHOCK_CANCER_COPY_NUMBER_UP spindle cell carcinoma DOID_4015 2.909E-14 5.172E-13 0.21182683 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP B-cell lymphocytic neoplasm DOID_707 4.489E-14 7.739E-13 4.05E-04 8.862E-03 GRESHOCK_CANCER_COPY_NUMBER_UP adenoma DOID_657 5.25E-14 8.786E-13 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP medulloblastoma DOID_3858 6.961E-14 1.132E-12 1.255E-04 3.247E-03 GRESHOCK_CANCER_COPY_NUMBER_UP embryonal cancer DOID_688 6.961E-14 1.1E-12 0.22690088 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP cervix uteri carcinoma in situ DOID_8991 1.992E-13 3.064E-12 0.24655391 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP Lynch syndrome DOID_3883 6.769E-13 1.014E-11 0.08020845 0.71310327 GRESHOCK_CANCER_COPY_NUMBER_UP astrocytoma DOID_3069 1.281E-12 1.869E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP medullomyoblastoma DOID_3861 2.182E-12 3.105E-11 1.024E-04 2.914E-03 GRESHOCK_CANCER_COPY_NUMBER_UP adult medulloblastoma DOID_3864 2.182E-12 3.105E-11 1.024E-04 2.914E-03 GRESHOCK_CANCER_COPY_NUMBER_UP childhood medulloblastoma DOID_3869 2.182E-12 3.105E-11 1.024E-04 2.914E-03 GRESHOCK_CANCER_COPY_NUMBER_UP pancreatic carcinoma DOID_4905 2.373E-12 3.293E-11 0.38687992 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP bile duct adenocarcinoma DOID_4896 3.224E-12 4.368E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP cholangiocarcinoma DOID_4947 3.224E-12 4.368E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP Fanconi's anemia DOID_13636 4.44E-12 5.875E-11 4.281E-08 6.09E-06 GRESHOCK_CANCER_COPY_NUMBER_UP papillary adenoma DOID_3172 5.073E-12 6.56E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP microcystic adenoma DOID_5403 5.073E-12 6.56E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP follicular adenoma DOID_6204 5.073E-12 6.56E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP bile duct cancer DOID_4606 6.584E-12 8.325E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP bile duct carcinoma DOID_4897 6.584E-12 8.325E-11 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP chondrosarcoma DOID_3371 1.34E-11 1.657E-10 3.355E-07 2.386E-05 GRESHOCK_CANCER_COPY_NUMBER_UP breast benign neoplasm DOID_0060082 2.932E-11 3.55E-10 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP thoracic benign neoplasm DOID_0060097 2.932E-11 3.55E-10 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP benign breast phyllodes tumor DOID_1631 2.932E-11 3.55E-10 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP bone marrow disease DOID_4961 3.138E-11 3.719E-10 1.739E-05 5.819E-04 GRESHOCK_CANCER_COPY_NUMBER_UP nephroblastoma DOID_2154 8.348E-11 9.694E-10 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP lymphoid leukemia DOID_10747 1.052E-10 1.197E-09 1.516E-07 1.437E-05 GRESHOCK_CANCER_COPY_NUMBER_UP mixed glioma DOID_5076 1.081E-10 1.206E-09 0.01487745 0.21705824 GRESHOCK_CANCER_COPY_NUMBER_UP bone development disease DOID_0080006 2.248E-10 2.459E-09 0.01802266 0.24416418 GRESHOCK_CANCER_COPY_NUMBER_UP skeletal muscle cancer DOID_4043 3.109E-10 3.338E-09 1.118E-04 3.029E-03 GRESHOCK_CANCER_COPY_NUMBER_UP benign mesothelioma DOID_2645 3.687E-10 3.885E-09 0.24655391 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP congenital hypoplastic anemia DOID_1342 4.304E-10 4.452E-09 9.046E-07 5.719E-05 GRESHOCK_CANCER_COPY_NUMBER_UP angiosarcoma DOID_0001816 4.948E-10 5.027E-09 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP chronic myeloid leukemia DOID_8552 4.948E-10 4.939E-09 4.948E-10 1.408E-07 GRESHOCK_CANCER_COPY_NUMBER_UP uterine disease DOID_345 5.584E-10 5.478E-09 0.35445085 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP pancreatic ductal carcinoma DOID_3587 1.07E-09 1.032E-08 0.37491366 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP male reproductive organ benign neoplasm DOID_0060087 1.135E-09 1.076E-08 0.10932251 0.76795688 GRESHOCK_CANCER_COPY_NUMBER_UP orofacial cleft DOID_0050567 2.384E-09 2.224E-08 5.338E-03 0.09204518 GRESHOCK_CANCER_COPY_NUMBER_UP Noonan syndrome DOID_3490 2.549E-09 2.339E-08 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP female reproductive system disease DOID_229 3.426E-09 3.095E-08 0.41392144 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP integumentary system cancer DOID_0060122 3.691E-09 3.282E-08 6.191E-03 0.10360826 GRESHOCK_CANCER_COPY_NUMBER_UP skin cancer DOID_4159 3.691E-09 3.282E-08 6.191E-03 0.10360826 GRESHOCK_CANCER_COPY_NUMBER_UP aplastic anemia DOID_12449 4.344E-09 3.802E-08 4.385E-06 1.919E-04 GRESHOCK_CANCER_COPY_NUMBER_UP nervous system benign neoplasm DOID_0060115 4.648E-09 4.008E-08 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP invasive lobular carcinoma DOID_3457 4.648E-09 3.948E-08 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP glioblastoma DOID_3068 5.578E-09 4.668E-08 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.257E-08 1.037E-07 0.12639752 0.83628125 GRESHOCK_CANCER_COPY_NUMBER_UP vulva cancer DOID_1245 1.281E-08 1.042E-07 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP rhabdomyosarcoma DOID_3247 1.983E-08 1.589E-07 3.539E-03 0.06943627 GRESHOCK_CANCER_COPY_NUMBER_UP T-cell leukemia DOID_715 1.983E-08 1.567E-07 1.567E-06 8.918E-05 GRESHOCK_CANCER_COPY_NUMBER_UP diffuse large B-cell lymphoma DOID_0050745 2.737E-08 2.133E-07 0.01482385 0.22196761 GRESHOCK_CANCER_COPY_NUMBER_UP mesenchymal cell neoplasm DOID_3350 2.959E-08 2.275E-07 0.0919661 0.71683167 GRESHOCK_CANCER_COPY_NUMBER_UP spindle cell sarcoma DOID_4235 2.959E-08 2.275E-07 0.0919661 0.71683167 GRESHOCK_CANCER_COPY_NUMBER_UP epithelioid sarcoma DOID_6193 2.959E-08 2.275E-07 0.0919661 0.71683167 GRESHOCK_CANCER_COPY_NUMBER_UP integumentary system benign neoplasm DOID_0060121 4.266E-08 3.237E-07 4.561E-03 0.08370871 GRESHOCK_CANCER_COPY_NUMBER_UP skin benign neoplasm DOID_3165 4.266E-08 3.237E-07 4.561E-03 0.08370871 GRESHOCK_CANCER_COPY_NUMBER_UP giant cell tumor DOID_200 7.236E-08 5.418E-07 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP malignant giant cell tumor DOID_2705 7.236E-08 5.418E-07 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP giant cell glioblastoma DOID_3074 7.236E-08 5.418E-07 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP leiomyoma DOID_127 9.057E-08 6.693E-07 0.02118627 0.27397699 GRESHOCK_CANCER_COPY_NUMBER_UP granulosa cell tumor DOID_2999 1.122E-07 8.184E-07 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP oral cavity cancer DOID_8618 1.325E-07 9.541E-07 0.32467748 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP sex cord-gonadal stromal tumor DOID_192 1.488E-07 1.058E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP placenta disease DOID_780 2.501E-07 1.757E-06 0.13195149 0.82505931 GRESHOCK_CANCER_COPY_NUMBER_UP rectal neoplasm DOID_1984 3.355E-07 2.328E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP rectum cancer DOID_1993 3.355E-07 2.328E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP gallbladder cancer DOID_3121 5.618E-07 3.852E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP osteosarcoma DOID_3347 6.119E-07 4.145E-06 0.15400785 0.9034069 GRESHOCK_CANCER_COPY_NUMBER_UP cleft lip DOID_9296 7.47E-07 5E-06 0.15943417 0.92569433 GRESHOCK_CANCER_COPY_NUMBER_UP glaucoma DOID_1686 1.037E-06 6.862E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP Leydig cell tumor DOID_2696 1.125E-06 7.359E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP sex cord-stromal neoplasm DOID_4757 1.125E-06 7.359E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP monocytic leukemia DOID_8527 1.125E-06 7.275E-06 0.08020845 0.70213245 GRESHOCK_CANCER_COPY_NUMBER_UP invasive ductal carcinoma DOID_3008 1.298E-06 8.299E-06 0.01581632 0.22498718 GRESHOCK_CANCER_COPY_NUMBER_UP hemorrhagic disease DOID_2213 1.302E-06 8.229E-06 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP female reproductive organ benign neoplasm DOID_0060086 1.815E-06 1.135E-05 0.18605021 0.95371686 GRESHOCK_CANCER_COPY_NUMBER_UP uterine benign neoplasm DOID_0060095 1.815E-06 1.135E-05 0.18605021 0.95371686 GRESHOCK_CANCER_COPY_NUMBER_UP uterine fibroid DOID_13223 1.815E-06 1.135E-05 0.18605021 0.95371686 GRESHOCK_CANCER_COPY_NUMBER_UP dysostosis DOID_1934 1.815E-06 1.123E-05 0.18605021 0.94520153 GRESHOCK_CANCER_COPY_NUMBER_UP skeletal system cancer DOID_0060124 2.126E-06 1.301E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP bone cancer DOID_184 2.126E-06 1.301E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP hemangioma DOID_255 2.126E-06 1.287E-05 0.0919661 0.72678767 GRESHOCK_CANCER_COPY_NUMBER_UP chronic leukemia DOID_1036 2.881E-06 1.725E-05 0.02118627 0.28034855 GRESHOCK_CANCER_COPY_NUMBER_UP chronic lymphocytic leukemia DOID_1040 2.881E-06 1.725E-05 0.02118627 0.28034855 GRESHOCK_CANCER_COPY_NUMBER_UP leukocyte disease DOID_9500 2.969E-06 1.759E-05 0.32901311 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP lymphatic system cancer DOID_0060073 3.67E-06 2.153E-05 0.10357407 0.75555953 GRESHOCK_CANCER_COPY_NUMBER_UP hyperostosis DOID_205 3.67E-06 2.131E-05 5.222E-03 0.09286145 GRESHOCK_CANCER_COPY_NUMBER_UP reticulosarcoma DOID_8538 3.67E-06 2.153E-05 0.10357407 0.75555953 GRESHOCK_CANCER_COPY_NUMBER_UP lymphosarcoma DOID_8675 3.67E-06 2.153E-05 0.10357407 0.75555953 GRESHOCK_CANCER_COPY_NUMBER_UP mineral metabolism disease DOID_0050032 4.692E-06 2.697E-05 0.35027892 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP refractive error DOID_9835 5.004E-06 2.847E-05 0.22190837 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP cleft palate DOID_674 5.689E-06 3.205E-05 0.22690088 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP testicular cancer DOID_2998 5.918E-06 3.301E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP blood platelet disease DOID_2218 6.445E-06 3.56E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP subependymal glioma DOID_4843 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP pilocytic astrocytoma DOID_4851 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP subependymal giant cell astrocytoma DOID_5077 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP fibrillary astrocytoma DOID_6726 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP juvenile pilocytic astrocytoma DOID_6811 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP childhood pilocytic astrocytoma DOID_6812 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP gemistocytic astrocytoma DOID_7005 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP childhood cerebral astrocytoma DOID_7007 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP protoplasmic astrocytoma DOID_7008 7.36E-06 4.027E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP blood coagulation disease DOID_1247 7.751E-06 4.2E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP nephrosis DOID_2527 8.39E-06 4.504E-05 0.37892803 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP benign glioma DOID_0060101 1.1E-05 5.85E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP benign ependymoma DOID_4844 1.1E-05 5.85E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP synostosis DOID_11971 1.582E-05 8.334E-05 0.14305034 0.87522196 GRESHOCK_CANCER_COPY_NUMBER_UP heart valve disease DOID_4079 1.739E-05 9.076E-05 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP calcium metabolism disease DOID_10575 2.318E-05 1.199E-04 0.28897297 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP Human immunodeficiency virus infectious disease DOID_526 2.934E-05 1.504E-04 0.11792068 0.7987722 GRESHOCK_CANCER_COPY_NUMBER_UP brachydactyly DOID_0050581 3.019E-05 1.534E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP acute T cell leukemia DOID_5603 3.019E-05 1.52E-04 1.78E-03 0.03616925 GRESHOCK_CANCER_COPY_NUMBER_UP lung adenocarcinoma DOID_3910 3.448E-05 1.721E-04 8.402E-04 0.01770729 GRESHOCK_CANCER_COPY_NUMBER_UP periodontitis DOID_824 3.448E-05 1.706E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP osteochondrodysplasia DOID_2256 3.606E-05 1.769E-04 0.05350129 0.57438174 GRESHOCK_CANCER_COPY_NUMBER_UP mouth disease DOID_403 3.734E-05 1.816E-04 0.12639752 0.82666882 GRESHOCK_CANCER_COPY_NUMBER_UP familial adenomatous polyposis DOID_0050424 4.132E-05 1.992E-04 0.06829919 0.6817937 GRESHOCK_CANCER_COPY_NUMBER_UP polydactyly DOID_1148 4.132E-05 1.976E-04 0.06829919 0.67003864 GRESHOCK_CANCER_COPY_NUMBER_UP chronic monocytic leukemia DOID_8593 4.132E-05 1.959E-04 0.06829919 0.64770402 GRESHOCK_CANCER_COPY_NUMBER_UP congenital heart defect DOID_1682 6.747E-05 3.173E-04 0.06717776 0.68257406 GRESHOCK_CANCER_COPY_NUMBER_UP tethered spinal cord syndrome DOID_1089 8.986E-05 4.191E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP periodontal disease DOID_3388 9.21E-05 4.26E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP adrenal cortex disease DOID_3952 1.118E-04 5.13E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP calcinosis DOID_182 1.255E-04 5.714E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP tongue cancer DOID_8649 1.369E-04 6.184E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP syndrome DOID_225 1.497E-04 6.709E-04 0.08954354 0.73840981 GRESHOCK_CANCER_COPY_NUMBER_UP basal cell carcinoma DOID_2513 1.655E-04 7.357E-04 0.10357407 0.74599548 GRESHOCK_CANCER_COPY_NUMBER_UP urinary system benign neoplasm DOID_731 1.655E-04 7.3E-04 0.10357407 0.73667054 GRESHOCK_CANCER_COPY_NUMBER_UP adrenal gland disease DOID_9553 1.655E-04 7.244E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP adenoid cystic carcinoma DOID_4866 1.67E-04 7.253E-04 0.2416878 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP pancreatitis DOID_4989 1.687E-04 7.274E-04 0.4024808 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP neuroendocrine tumor DOID_169 1.977E-04 8.456E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP skin carcinoma DOID_3451 1.977E-04 8.393E-04 0.10932251 0.75859155 GRESHOCK_CANCER_COPY_NUMBER_UP endometriosis of uterus DOID_288 1.996E-04 8.412E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP salivary gland cancer DOID_8850 1.996E-04 8.35E-04 0.25138892 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP nephrotic syndrome DOID_1184 2.175E-04 9.034E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP endometriosis DOID_289 2.175E-04 8.968E-04 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP cataract DOID_83 2.568E-04 1.051E-03 0.03805016 0.45105289 GRESHOCK_CANCER_COPY_NUMBER_UP lens disease DOID_110 3.009E-04 1.223E-03 0.04098117 0.47588333 GRESHOCK_CANCER_COPY_NUMBER_UP muscular atrophy DOID_767 3.66E-04 1.477E-03 0.13195149 0.83422664 GRESHOCK_CANCER_COPY_NUMBER_UP dilated cardiomyopathy DOID_12930 4.142E-04 1.66E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP ulcerative colitis DOID_8577 4.764E-04 1.896E-03 0.47475044 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP hypersensitivity reaction type IV disease DOID_2916 6.452E-04 2.55E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP spinal cord disease DOID_319 7.569E-04 2.97E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP thrombocytopenia DOID_1588 9.292E-04 3.621E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP hepatic vascular disease DOID_272 9.292E-04 3.597E-03 0.17550603 0.95107555 GRESHOCK_CANCER_COPY_NUMBER_UP tooth disease DOID_1091 1.084E-03 4.167E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP allergic contact dermatitis DOID_3042 1.084E-03 4.139E-03 0.07440341 0.6719927 GRESHOCK_CANCER_COPY_NUMBER_UP bone resorption disease DOID_0080011 1.698E-03 6.441E-03 0.01438625 0.22123713 GRESHOCK_CANCER_COPY_NUMBER_UP osteoporosis DOID_11476 1.698E-03 6.441E-03 0.01438625 0.22123713 GRESHOCK_CANCER_COPY_NUMBER_UP leukopenia DOID_615 1.721E-03 6.483E-03 0.21182683 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP hyperparathyroidism DOID_13543 1.78E-03 6.663E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP adrenal gland hyperfunction DOID_3947 1.78E-03 6.619E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP polycythemia DOID_8432 1.78E-03 6.576E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP contact dermatitis DOID_2773 1.947E-03 7.149E-03 0.09742574 0.73913661 GRESHOCK_CANCER_COPY_NUMBER_UP microcephaly DOID_10907 2.316E-03 8.449E-03 0.02847667 0.36007163 GRESHOCK_CANCER_COPY_NUMBER_UP systemic scleroderma DOID_418 2.483E-03 8.999E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP beta thalassemia DOID_12241 2.588E-03 9.322E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP pituitary cancer DOID_1785 2.588E-03 9.263E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP pituitary carcinoma DOID_4916 2.588E-03 9.263E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP retinal detachment DOID_5327 2.588E-03 9.205E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP aortic valve insufficiency DOID_57 2.588E-03 9.148E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP lipodystrophy DOID_811 2.588E-03 9.092E-03 0.07427289 0.6816335 GRESHOCK_CANCER_COPY_NUMBER_UP ocular hypertension DOID_9282 2.588E-03 9.036E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP borderline glaucoma DOID_9283 2.588E-03 9.036E-03 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP lymphatic system disease DOID_75 2.657E-03 9.217E-03 0.03109927 0.3846844 GRESHOCK_CANCER_COPY_NUMBER_UP Hirschsprung's disease DOID_10487 3.046E-03 0.0105048 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP parathyroid gland disease DOID_11201 3.046E-03 0.01044152 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP rheumatic disease DOID_1575 3.222E-03 0.01097805 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP scleroderma DOID_419 3.222E-03 0.01097805 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP Crohn's disease DOID_8778 3.45E-03 0.01168503 0.46102911 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP megacolon DOID_11372 3.539E-03 0.0119151 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP peripheral neuropathy DOID_0060053 4.066E-03 0.01360975 0.0919661 0.74755303 GRESHOCK_CANCER_COPY_NUMBER_UP thalassemia DOID_10241 4.066E-03 0.01353016 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP nutritional deficiency disease DOID_5113 4.066E-03 0.0134515 0.0919661 0.70714476 GRESHOCK_CANCER_COPY_NUMBER_UP neuritis DOID_1803 4.083E-03 0.01342839 0.04098117 0.45722124 GRESHOCK_CANCER_COPY_NUMBER_UP pituitary adenoma DOID_3829 4.628E-03 0.01513247 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP juvenile rheumatoid arthritis DOID_676 5.222E-03 0.01698038 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP keratosis DOID_161 5.851E-03 0.01891451 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP vasculitis DOID_865 5.898E-03 0.01896127 0.30705421 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP parasitic protozoa infectious disease DOID_2789 6.191E-03 0.01979034 0.3115025 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP pustulosis of palm and sole DOID_4398 6.191E-03 0.01967978 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP smallpox DOID_8736 6.191E-03 0.01957045 0.05350129 0.56374504 GRESHOCK_CANCER_COPY_NUMBER_UP conduct disorder DOID_12995 6.511E-03 0.02046937 6.511E-03 0.1058559 GRESHOCK_CANCER_COPY_NUMBER_UP MHC class II deficiency DOID_5812 6.511E-03 0.0203569 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP congenital nervous system abnormality DOID_2490 6.802E-03 0.02114945 0.05681792 0.58780726 GRESHOCK_CANCER_COPY_NUMBER_UP colonic disease DOID_5353 7.204E-03 0.02227894 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP coronary restenosis DOID_4247 7.929E-03 0.02438815 0.1263485 0.84579172 GRESHOCK_CANCER_COPY_NUMBER_UP collagen disease DOID_854 8.128E-03 0.0248656 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP neutropenia DOID_1227 8.686E-03 0.02642867 0.13195149 0.84359997 GRESHOCK_CANCER_COPY_NUMBER_UP endocrine pancreas disease DOID_1428 9.216E-03 0.02789276 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP sinusitis DOID_0050127 9.473E-03 0.02851926 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP agranulocytosis DOID_12987 9.473E-03 0.02836915 0.13751869 0.85052322 GRESHOCK_CANCER_COPY_NUMBER_UP paranasal sinus disease DOID_1352 9.473E-03 0.02851926 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP parasitic infectious disease DOID_1398 9.596E-03 0.0285881 0.35445085 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP aortic valve disease DOID_62 0.01029086 0.0304974 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP severe combined immunodeficiency DOID_627 0.01113885 0.03283942 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP portal hypertension DOID_10762 0.01201656 0.03524444 0.15400785 0.92242599 GRESHOCK_CANCER_COPY_NUMBER_UP combined T cell and B cell immunodeficiency DOID_628 0.01201656 0.0350637 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP male reproductive system disease DOID_48 0.01207043 0.03504121 0.37892803 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP infantile epileptic encephalopathy DOID_2481 0.01292356 0.03732745 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP diabetic retinopathy DOID_8947 0.01296881 0.03726895 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP myopia DOID_11830 0.01385946 0.03962831 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP Sciatic Neuropathy DOID_11446 0.01482385 0.04217385 0.17018304 0.96834151 GRESHOCK_CANCER_COPY_NUMBER_UP gestational diabetes DOID_11714 0.01482385 0.04196403 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP lesion of sciatic nerve DOID_12528 0.01482385 0.04217385 0.17018304 0.96834151 GRESHOCK_CANCER_COPY_NUMBER_UP mononeuritis of lower limb DOID_9473 0.01482385 0.04217385 0.17018304 0.96834151 GRESHOCK_CANCER_COPY_NUMBER_UP autoimmune disease of cardiovascular system DOID_0060051 0.01581632 0.04455192 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP malaria DOID_12365 0.01581632 0.04433245 0.17550603 0.96954304 GRESHOCK_CANCER_COPY_NUMBER_UP Behcet's disease DOID_13241 0.01581632 0.04455192 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP mononeuritis DOID_1802 0.01581632 0.04411513 0.17550603 0.96022051 GRESHOCK_CANCER_COPY_NUMBER_UP coronary stenosis DOID_4248 0.01581632 0.04389994 0.17550603 0.94210314 GRESHOCK_CANCER_COPY_NUMBER_UP metabolic syndrome X DOID_14221 0.01588808 0.04388505 0.41013234 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP polycystic ovary syndrome DOID_11612 0.01683649 0.04628001 0.01683649 0.2336576 GRESHOCK_CANCER_COPY_NUMBER_UP mononeuropathy DOID_1188 0.01683649 0.04605751 0.18079502 0.96142397 GRESHOCK_CANCER_COPY_NUMBER_UP multiple epiphyseal dysplasia DOID_12721 0.01683649 0.04583714 0.18079502 0.9525219 GRESHOCK_CANCER_COPY_NUMBER_UP alcohol abuse DOID_1574 0.01747482 0.04734844 0.10346135 0.76453904 GRESHOCK_CANCER_COPY_NUMBER_UP chronic kidney failure DOID_784 0.01747482 0.04712404 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP retinal vascular disease DOID_2462 0.01857999 0.049868 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP primary immunodeficiency disease DOID_612 0.02090432 0.05584299 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP myocarditis DOID_820 0.02233908 0.0593969 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP encephalomyelitis DOID_640 0.02338087 0.06187774 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP male infertility DOID_12336 0.02351728 0.06195062 0.21182683 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP hypersensitivity reaction type I disease DOID_1205 0.02467624 0.06470405 0.12853902 0.8311216 GRESHOCK_CANCER_COPY_NUMBER_UP pulmonary sarcoidosis DOID_13406 0.02720056 0.07099595 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP hepatitis DOID_2237 0.02977635 0.07736413 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP congenital diaphragmatic hernia DOID_3827 0.02977635 0.07701248 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP intracranial arterial disease DOID_13089 0.03109927 0.08007006 0.2416878 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP cerebral arterial disease DOID_3527 0.03109927 0.08007006 0.2416878 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP idiopathic generalized epilepsy DOID_1827 0.0352039 0.09022981 1.000 1.000 GRESHOCK_CANCER_COPY_NUMBER_UP learning disability DOID_8927 0.03805016 0.09708762 0.26570934 1.000 SWEET_KRAS_ONCOGENIC_SIGNATURE coronary stenosis DOID_4248 1.889E-05 0.01075053 1.889E-05 0.01075053 SWEET_KRAS_ONCOGENIC_SIGNATURE encephalomyelitis DOID_640 2.228E-05 6.339E-03 5.949E-04 0.02820871 SWEET_KRAS_ONCOGENIC_SIGNATURE calcinosis DOID_182 4.542E-05 8.614E-03 2.165E-03 0.0684313 SWEET_KRAS_ONCOGENIC_SIGNATURE multiple myeloma DOID_9538 4.542E-05 6.461E-03 2.165E-03 0.06482966 SWEET_KRAS_ONCOGENIC_SIGNATURE myeloma DOID_0070004 8.9E-05 0.01012867 3.363E-03 0.08696737 SWEET_KRAS_ONCOGENIC_SIGNATURE heart valve disease DOID_4079 8.9E-05 8.441E-03 3.363E-03 0.07972009 SWEET_KRAS_ONCOGENIC_SIGNATURE calcium metabolism disease DOID_10575 1.06E-04 8.615E-03 3.77E-03 0.07944976 SWEET_KRAS_ONCOGENIC_SIGNATURE hemorrhagic disease DOID_2213 1.121E-04 7.972E-03 3.911E-03 0.07947129 SWEET_KRAS_ONCOGENIC_SIGNATURE bone marrow cancer DOID_4960 1.317E-04 8.329E-03 4.347E-03 0.08245276 SWEET_KRAS_ONCOGENIC_SIGNATURE parasitic protozoa infectious disease DOID_2789 1.388E-04 7.895E-03 0.09480396 0.32109199 SWEET_KRAS_ONCOGENIC_SIGNATURE pustulosis of palm and sole DOID_4398 1.388E-04 7.177E-03 1.388E-04 0.03947525 SWEET_KRAS_ONCOGENIC_SIGNATURE dermatomyositis DOID_10223 1.576E-04 7.474E-03 0.01870155 0.19705898 SWEET_KRAS_ONCOGENIC_SIGNATURE pneumocystosis DOID_11339 1.576E-04 6.899E-03 0.01870155 0.19347609 SWEET_KRAS_ONCOGENIC_SIGNATURE leukocyte disease DOID_9500 1.692E-04 6.878E-03 5.123E-03 0.08572658 SWEET_KRAS_ONCOGENIC_SIGNATURE mineral metabolism disease DOID_0050032 2.131E-04 8.082E-03 5.956E-03 0.09414558 SWEET_KRAS_ONCOGENIC_SIGNATURE parasitic infectious disease DOID_1398 2.226E-04 7.917E-03 0.11022997 0.35636847 SWEET_KRAS_ONCOGENIC_SIGNATURE allergic contact dermatitis DOID_3042 2.426E-04 8.119E-03 2.426E-04 0.04600722 SWEET_KRAS_ONCOGENIC_SIGNATURE blood coagulation disease DOID_1247 2.746E-04 8.68E-03 7.033E-03 0.10261465 SWEET_KRAS_ONCOGENIC_SIGNATURE peripheral vascular disease DOID_341 2.974E-04 8.906E-03 7.41E-03 0.10541369 SWEET_KRAS_ONCOGENIC_SIGNATURE hemangioma DOID_255 2.996E-04 8.523E-03 2.996E-04 0.04261493 SWEET_KRAS_ONCOGENIC_SIGNATURE nutritional deficiency disease DOID_5113 2.996E-04 8.117E-03 2.996E-04 0.03409194 SWEET_KRAS_ONCOGENIC_SIGNATURE aneurysm disease DOID_2403 3.466E-04 8.964E-03 3.466E-04 0.0328682 SWEET_KRAS_ONCOGENIC_SIGNATURE bacterial pneumonia DOID_874 3.597E-04 8.898E-03 8.392E-03 0.11646941 SWEET_KRAS_ONCOGENIC_SIGNATURE contact dermatitis DOID_2773 3.867E-04 9.169E-03 3.867E-04 0.03143505 SWEET_KRAS_ONCOGENIC_SIGNATURE urinary system benign neoplasm DOID_731 3.872E-04 8.812E-03 3.872E-04 0.02753722 SWEET_KRAS_ONCOGENIC_SIGNATURE leishmaniasis DOID_9065 4.857E-04 0.01062999 1.000 1.000 SWEET_KRAS_ONCOGENIC_SIGNATURE transitional cell carcinoma DOID_2671 5.08E-04 0.01070612 5.08E-04 0.03211836 SWEET_KRAS_ONCOGENIC_SIGNATURE nervous system cancer DOID_3093 5.417E-04 0.01100865 5.417E-04 0.03082422 SWEET_KRAS_ONCOGENIC_SIGNATURE Human immunodeficiency virus infectious disease DOID_526 5.417E-04 0.01062904 5.417E-04 0.02802202 SWEET_KRAS_ONCOGENIC_SIGNATURE coronary restenosis DOID_4247 5.952E-04 0.01128879 5.952E-04 0.02605105 SWEET_KRAS_ONCOGENIC_SIGNATURE hypersensitivity reaction type I disease DOID_1205 6.322E-04 0.01160313 0.01213696 0.15346517 SWEET_KRAS_ONCOGENIC_SIGNATURE osteosarcoma DOID_3347 9.161E-04 0.01628852 9.161E-04 0.03723089 SWEET_KRAS_ONCOGENIC_SIGNATURE cystitis DOID_1679 9.882E-04 0.01703967 1.000 1.000 SWEET_KRAS_ONCOGENIC_SIGNATURE myositis DOID_633 9.882E-04 0.01653851 0.04529059 0.24543189 SWEET_KRAS_ONCOGENIC_SIGNATURE intracranial aneurysm DOID_10941 1.063E-03 0.01728271 1.063E-03 0.04032632 SWEET_KRAS_ONCOGENIC_SIGNATURE sarcoma DOID_1115 1.221E-03 0.01929368 0.05019646 0.25731341 SWEET_KRAS_ONCOGENIC_SIGNATURE thrombocytopenia DOID_1588 1.221E-03 0.01877223 0.05019646 0.25275919 SWEET_KRAS_ONCOGENIC_SIGNATURE autoimmune disease of the nervous system DOID_438 1.221E-03 0.01827822 1.221E-03 0.04341078 SWEET_KRAS_ONCOGENIC_SIGNATURE opportunistic mycosis DOID_2473 1.477E-03 0.02154559 0.05507751 0.25900086 SWEET_KRAS_ONCOGENIC_SIGNATURE bladder disease DOID_365 1.66E-03 0.02362037 1.000 1.000 SWEET_KRAS_ONCOGENIC_SIGNATURE systemic mycosis DOID_0050136 1.756E-03 0.02437288 0.05993386 0.26852257 SWEET_KRAS_ONCOGENIC_SIGNATURE fungal infectious disease DOID_1564 1.756E-03 0.02437288 0.05993386 0.26852257 SWEET_KRAS_ONCOGENIC_SIGNATURE papilloma DOID_2615 1.756E-03 0.02379258 1.756E-03 0.05878166 SWEET_KRAS_ONCOGENIC_SIGNATURE spindle cell carcinoma DOID_4015 1.855E-03 0.02454011 0.06154717 0.26733085 SWEET_KRAS_ONCOGENIC_SIGNATURE blood platelet disease DOID_2218 2.273E-03 0.02939779 0.06797322 0.27825007 SWEET_KRAS_ONCOGENIC_SIGNATURE respiratory syncytial virus infectious disease DOID_1273 2.384E-03 0.03014845 0.06957295 0.28276433 SWEET_KRAS_ONCOGENIC_SIGNATURE hepatitis DOID_2237 2.384E-03 0.02949304 2.384E-03 0.067834 SWEET_KRAS_ONCOGENIC_SIGNATURE lymphatic system disease DOID_75 2.498E-03 0.03024023 2.498E-03 0.06768051 SWEET_KRAS_ONCOGENIC_SIGNATURE influenza DOID_8469 2.977E-03 0.03529098 1.000 1.000 SWEET_KRAS_ONCOGENIC_SIGNATURE brain cancer DOID_1319 3.363E-03 0.03904658 3.363E-03 0.08318618 SWEET_KRAS_ONCOGENIC_SIGNATURE vascular skin disease DOID_9540 3.363E-03 0.03826564 0.08227383 0.29817711 SWEET_KRAS_ONCOGENIC_SIGNATURE central nervous system cancer DOID_3620 3.496E-03 0.03900356 3.496E-03 0.07956727 SWEET_KRAS_ONCOGENIC_SIGNATURE autoimmune disease of gastrointestinal tract DOID_0060031 3.632E-03 0.03973982 0.08542228 0.30762833 SWEET_KRAS_ONCOGENIC_SIGNATURE integumentary system benign neoplasm DOID_0060121 3.632E-03 0.03899001 3.632E-03 0.07947963 SWEET_KRAS_ONCOGENIC_SIGNATURE skin benign neoplasm DOID_3165 3.632E-03 0.03899001 3.632E-03 0.07947963 SWEET_KRAS_ONCOGENIC_SIGNATURE giant cell tumor DOID_200 4.199E-03 0.04424853 4.199E-03 0.08239381 SWEET_KRAS_ONCOGENIC_SIGNATURE malignant giant cell tumor DOID_2705 4.199E-03 0.04424853 4.199E-03 0.08239381 SWEET_KRAS_ONCOGENIC_SIGNATURE giant cell glioblastoma DOID_3074 4.199E-03 0.04424853 4.199E-03 0.08239381 SWEET_KRAS_ONCOGENIC_SIGNATURE vasculitis DOID_865 4.347E-03 0.04497423 0.09324696 0.32156071 SWEET_KRAS_ONCOGENIC_SIGNATURE integumentary system cancer DOID_0060122 4.498E-03 0.04569831 4.498E-03 0.08255179 SWEET_KRAS_ONCOGENIC_SIGNATURE skin cancer DOID_4159 4.498E-03 0.04569831 4.498E-03 0.08255179 SWEET_KRAS_ONCOGENIC_SIGNATURE familial hyperlipidemia DOID_1168 4.65E-03 0.04642076 4.65E-03 0.08268699 SWEET_KRAS_ONCOGENIC_SIGNATURE glioblastoma DOID_3068 4.963E-03 0.04868599 4.963E-03 0.08556932 SWEET_KRAS_ONCOGENIC_SIGNATURE carotid artery disease DOID_3407 5.449E-03 0.05255155 5.449E-03 0.08858691 SWEET_KRAS_ONCOGENIC_SIGNATURE respiratory failure DOID_11162 5.616E-03 0.05325756 0.10562955 0.34741741 SWEET_KRAS_ONCOGENIC_SIGNATURE hyperglycemia DOID_4195 6.306E-03 0.05882428 6.306E-03 0.09698057 SWEET_KRAS_ONCOGENIC_SIGNATURE astrocytoma DOID_3069 6.848E-03 0.06284853 6.848E-03 0.10254234 SWEET_KRAS_ONCOGENIC_SIGNATURE cystic fibrosis DOID_1485 7.993E-03 0.07219006 0.12539706 0.39420402 SWEET_KRAS_ONCOGENIC_SIGNATURE pancreatitis DOID_4989 8.392E-03 0.07461322 0.12839979 0.39923214 SWEET_KRAS_ONCOGENIC_SIGNATURE metabolic syndrome X DOID_14221 8.801E-03 0.07703896 0.13139237 0.40631661 SWEET_KRAS_ONCOGENIC_SIGNATURE lipid metabolism disorder DOID_3146 8.801E-03 0.07587171 8.801E-03 0.11922697 SWEET_KRAS_ONCOGENIC_SIGNATURE primary immunodeficiency disease DOID_612 0.01074503 0.09125257 0.01074503 0.14218423 SWEET_KRAS_ONCOGENIC_SIGNATURE lymphoma DOID_0060058 0.01143157 0.09565536 0.14913654 0.45137602 SWEET_KRAS_ONCOGENIC_SIGNATURE alcohol-related neurodevelopmental disorder DOID_0050667 0.01189975 0.09812984 0.01189975 0.15388542 SWEET_KRAS_ONCOGENIC_SIGNATURE dilated cardiomyopathy DOID_12930 0.01213696 0.09865618 0.01213696 0.15012897 NOJIMA_SFRP2_TARGETS_DN transitional cell carcinoma DOID_2671 8.858E-08 5.04E-05 0.04188941 0.44139027 NOJIMA_SFRP2_TARGETS_DN sarcoma DOID_1115 3.619E-07 1.03E-04 0.01415163 0.40261398 NOJIMA_SFRP2_TARGETS_DN nephroblastoma DOID_2154 6.912E-07 1.311E-04 1.404E-04 0.07989368 NOJIMA_SFRP2_TARGETS_DN spindle cell carcinoma DOID_4015 6.912E-07 9.833E-05 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN multiple myeloma DOID_9538 8.781E-07 9.993E-05 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN myeloma DOID_0070004 1.737E-06 1.647E-04 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN bile duct adenocarcinoma DOID_4896 2.588E-06 2.103E-04 0.02672619 0.38018007 NOJIMA_SFRP2_TARGETS_DN cholangiocarcinoma DOID_4947 2.588E-06 2.103E-04 0.02672619 0.38018007 NOJIMA_SFRP2_TARGETS_DN bone marrow cancer DOID_4960 2.588E-06 1.84E-04 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN bile duct cancer DOID_4606 3.179E-06 2.01E-04 0.02857615 0.38713886 NOJIMA_SFRP2_TARGETS_DN bile duct carcinoma DOID_4897 3.179E-06 2.01E-04 0.02857615 0.38713886 NOJIMA_SFRP2_TARGETS_DN biliary tract cancer DOID_4607 8.662E-06 4.929E-04 0.03960638 0.42520816 NOJIMA_SFRP2_TARGETS_DN nervous system cancer DOID_3093 1.099E-05 5.685E-04 0.04280119 0.43489062 NOJIMA_SFRP2_TARGETS_DN invasive lobular carcinoma DOID_3457 1.168E-05 5.539E-04 5.211E-03 1.000 NOJIMA_SFRP2_TARGETS_DN mesenchymal cell neoplasm DOID_3350 2.227E-05 9.749E-04 7.1E-03 0.44885429 NOJIMA_SFRP2_TARGETS_DN spindle cell sarcoma DOID_4235 2.227E-05 9.749E-04 7.1E-03 0.44885429 NOJIMA_SFRP2_TARGETS_DN epithelioid sarcoma DOID_6193 2.227E-05 9.749E-04 7.1E-03 0.44885429 NOJIMA_SFRP2_TARGETS_DN sinusitis DOID_0050127 5.355E-05 2.176E-03 0.01086661 0.38644365 NOJIMA_SFRP2_TARGETS_DN paranasal sinus disease DOID_1352 5.355E-05 2.176E-03 0.01086661 0.38644365 NOJIMA_SFRP2_TARGETS_DN leiomyoma DOID_127 1.255E-04 4.761E-03 0.01649177 0.39099241 NOJIMA_SFRP2_TARGETS_DN autonomic nervous system neoplasm DOID_2621 1.255E-04 4.464E-03 0.01649177 0.37535271 NOJIMA_SFRP2_TARGETS_DN neuroblastoma DOID_769 1.255E-04 4.464E-03 0.01649177 0.37535271 NOJIMA_SFRP2_TARGETS_DN papilloma DOID_2615 1.329E-04 4.447E-03 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN peripheral nervous system neoplasm DOID_1192 1.727E-04 5.459E-03 0.01929301 0.36592411 NOJIMA_SFRP2_TARGETS_DN uterine cancer DOID_363 2.273E-04 6.806E-03 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN heart valve disease DOID_4079 2.573E-04 7.321E-03 0.02348075 0.38172985 NOJIMA_SFRP2_TARGETS_DN lung small cell carcinoma DOID_5409 2.784E-04 7.543E-03 0.02440906 0.37537173 NOJIMA_SFRP2_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 3.464E-04 8.96E-03 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN pancreatic ductal carcinoma DOID_3587 5.485E-04 0.01356874 0.03410614 0.40429987 NOJIMA_SFRP2_TARGETS_DN pancreatic carcinoma DOID_4905 5.943E-04 0.01408995 0.03548398 0.39588993 NOJIMA_SFRP2_TARGETS_DN pancreatitis DOID_4989 6.582E-04 0.01498078 0.03731822 0.40834745 NOJIMA_SFRP2_TARGETS_DN mixed glioma DOID_5076 6.582E-04 0.0144046 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 9.456E-04 0.01992671 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN hyperparathyroidism DOID_13543 4.738E-03 0.09629089 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN rectal neoplasm DOID_1984 4.738E-03 0.09297052 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN rectum cancer DOID_1993 4.738E-03 0.09297052 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN breast benign neoplasm DOID_0060082 5.211E-03 0.0988365 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN thoracic benign neoplasm DOID_0060097 5.211E-03 0.0988365 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN benign breast phyllodes tumor DOID_1631 5.211E-03 0.0988365 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN eosinophilic pneumonia DOID_5870 5.211E-03 0.09564822 5.211E-03 0.98836498 NOJIMA_SFRP2_TARGETS_DN pulmonary eosinophilia DOID_9498 5.211E-03 0.09564822 5.211E-03 0.98836498 NOJIMA_SFRP2_TARGETS_DN Loeffler syndrome DOID_9503 5.211E-03 0.09564822 5.211E-03 0.98836498 NOJIMA_SFRP2_TARGETS_DN aortic valve stenosis DOID_1712 5.684E-03 0.0979977 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN relapsing-remitting multiple sclerosis DOID_2378 5.684E-03 0.09511542 5.684E-03 0.64678484 NOJIMA_SFRP2_TARGETS_DN aortic valve insufficiency DOID_57 5.684E-03 0.09239783 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN ocular hypertension DOID_9282 5.684E-03 0.08983123 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN borderline glaucoma DOID_9283 5.684E-03 0.08983123 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN parathyroid gland disease DOID_11201 6.156E-03 0.09466575 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN larynx cancer DOID_2596 6.156E-03 0.09217455 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN laryngeal benign neoplasm DOID_2598 6.156E-03 0.09217455 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN hemangioma DOID_255 7.1E-03 0.09852899 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN corneal dystrophy DOID_2566 7.1E-03 0.09618306 7.1E-03 0.50496107 NOJIMA_SFRP2_TARGETS_DN lung oat cell carcinoma DOID_5411 7.1E-03 0.09394625 7.1E-03 0.40396886 NOJIMA_SFRP2_TARGETS_DN hyperhomocysteinemia DOID_9279 7.1E-03 0.0918111 7.1E-03 0.36724442 NOJIMA_SFRP2_TARGETS_DN angiosarcoma DOID_0001816 7.571E-03 0.09573413 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN Fanconi's anemia DOID_13636 7.571E-03 0.09365295 7.571E-03 0.35900298 NOJIMA_SFRP2_TARGETS_DN urinary system benign neoplasm DOID_731 8.043E-03 0.09736729 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN neuroendocrine tumor DOID_169 8.514E-03 0.09886468 1.000 1.000 NOJIMA_SFRP2_TARGETS_DN prion disease DOID_649 8.514E-03 0.09688738 8.514E-03 0.37264378 NOJIMA_SFRP2_TARGETS_DN eosinophilia DOID_999 8.514E-03 0.09498763 8.514E-03 0.34602636 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 cannabis dependence DOID_1849 9.214E-08 5.243E-05 1.099E-05 3.126E-03 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 hallucinogen dependence DOID_9977 9.214E-08 5.243E-05 1.099E-05 3.126E-03 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 cannabis abuse DOID_9505 4.645E-06 1.322E-03 5.157E-04 0.02257216 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 bone resorption disease DOID_0080011 8.07E-06 1.531E-03 8.07E-06 4.592E-03 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 osteoporosis DOID_11476 8.07E-06 1.531E-03 8.07E-06 4.592E-03 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 uterine cancer DOID_363 2.1E-05 2.987E-03 5.721E-04 0.02325207 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 integumentary system benign neoplasm DOID_0060121 3.146E-05 3.58E-03 7.701E-04 0.02738543 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 skin benign neoplasm DOID_3165 3.146E-05 3.58E-03 7.701E-04 0.02738543 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 colon carcinoma DOID_1520 4.304E-05 4.081E-03 2.129E-03 0.0526714 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 integumentary system cancer DOID_0060122 4.852E-05 3.944E-03 1.059E-03 0.03013366 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 skin cancer DOID_4159 4.852E-05 3.944E-03 1.059E-03 0.03013366 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 congenital nervous system abnormality DOID_2490 5.547E-05 3.945E-03 5.547E-05 0.01052069 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 oral cavity cancer DOID_8618 5.92E-05 3.743E-03 5.92E-05 8.422E-03 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 spinal muscular atrophy DOID_12377 1.085E-04 6.174E-03 1.085E-04 0.01234729 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 pancreatic ductal carcinoma DOID_3587 1.196E-04 6.188E-03 1.196E-04 0.01134415 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 diffuse large B-cell lymphoma DOID_0050745 1.349E-04 6.395E-03 1.349E-04 0.01096249 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 pancreatic carcinoma DOID_4905 1.399E-04 6.123E-03 1.399E-04 9.95E-03 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 endometrial carcinoma DOID_2871 1.817E-04 7.385E-03 5.411E-03 0.07893956 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 endometrial cancer DOID_1380 2.181E-04 8.274E-03 6.092E-03 0.08666404 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 carbohydrate metabolic disorder DOID_2978 3.301E-04 0.01173977 3.301E-04 0.02087071 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 microcephaly DOID_10907 3.818E-04 0.01277901 3.818E-04 0.02172431 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 adenoid cystic carcinoma DOID_4866 4.398E-04 0.01390253 4.398E-04 0.0227496 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 salivary gland cancer DOID_8850 5.032E-04 0.0150686 5.032E-04 0.02385862 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 hemolytic anemia DOID_583 7.275E-04 0.02069603 7.275E-04 0.02759471 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 normocytic anemia DOID_720 7.275E-04 0.02069603 7.275E-04 0.02759471 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 B-cell lymphocytic neoplasm DOID_707 8.6E-04 0.02330133 8.6E-04 0.02878399 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 vesiculobullous skin disease DOID_2731 8.879E-04 0.02296395 8.879E-04 0.02806706 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 Lynch syndrome DOID_3883 8.879E-04 0.02196552 8.879E-04 0.02658984 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 giant cell tumor DOID_200 9.563E-04 0.02267211 0.01592415 0.20135205 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 malignant giant cell tumor DOID_2705 9.563E-04 0.02267211 0.01592415 0.20135205 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 giant cell glioblastoma DOID_3074 9.563E-04 0.02267211 0.01592415 0.20135205 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 membranoproliferative glomerulonephritis DOID_2920 1.19E-03 0.02708149 1.19E-03 0.03223987 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 intermediate coronary syndrome DOID_8805 1.19E-03 0.0260399 0.05022882 0.31065431 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 nonsyndromic deafness DOID_0050563 1.226E-03 0.02584104 1.226E-03 0.03171401 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 glioblastoma DOID_3068 1.226E-03 0.02491815 0.01871398 0.21731136 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 urinary system benign neoplasm DOID_731 1.534E-03 0.03010328 0.05673399 0.31648669 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 astrocytoma DOID_3069 1.977E-03 0.03749761 0.02550906 0.26878992 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 congenital hemolytic anemia DOID_589 3.065E-03 0.05626028 3.065E-03 0.07266952 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 auditory system disease DOID_2742 3.066E-03 0.05451218 3.066E-03 0.06977558 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 bone development disease DOID_0080006 3.276E-03 0.05649327 3.276E-03 0.071703 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 X-linked disease DOID_0050735 3.593E-03 0.06013304 3.593E-03 0.07572309 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 transitional cell carcinoma DOID_2671 3.724E-03 0.0605406 0.0384141 0.30357812 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 autosomal dominant nonsyndromic deafness DOID_0050564 3.872E-03 0.06119851 3.872E-03 0.07868379 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 myositis DOID_633 3.872E-03 0.05954449 3.872E-03 0.07597056 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 nervous system cancer DOID_3093 3.961E-03 0.0593105 0.03997391 0.30736694 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 Human immunodeficiency virus infectious disease DOID_526 3.961E-03 0.05778971 0.03997391 0.30326872 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 congenital hypoplastic anemia DOID_1342 4.16E-03 0.05918284 4.16E-03 0.07891045 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 seminoma DOID_4440 4.16E-03 0.05773935 4.16E-03 0.07636495 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 lymphoma DOID_0060058 4.207E-03 0.05699507 4.207E-03 0.07480603 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 gestational diabetes DOID_11714 4.459E-03 0.05899967 4.459E-03 0.07687836 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 lung adenocarcinoma DOID_3910 4.459E-03 0.05765877 4.459E-03 0.07461723 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 alcohol-related neurodevelopmental disorder DOID_0050667 4.462E-03 0.05642133 0.04316422 0.29590893 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 dilated cardiomyopathy DOID_12930 4.593E-03 0.05681522 4.593E-03 0.07467144 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 multiple epiphyseal dysplasia DOID_12721 5.084E-03 0.06154658 5.084E-03 0.08035248 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 focal glomerulosclerosis DOID_3945 5.084E-03 0.06026436 5.084E-03 0.07818079 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 dysostosis DOID_1934 5.411E-03 0.06282945 5.411E-03 0.08101692 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 germinoma DOID_3304 6.092E-03 0.06933123 6.092E-03 0.08455028 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 myocarditis DOID_820 6.811E-03 0.07599165 6.811E-03 0.09227558 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 spindle cell carcinoma DOID_4015 7.184E-03 0.07861339 0.1194025 0.47845086 FOURNIER_ACINAR_DEVELOPMENT_LATE_2 aplastic anemia DOID_12449 7.567E-03 0.08123356 7.567E-03 0.10012508 NAKAMURA_CANCER_MICROENVIRONMENT_UP Ehlers-Danlos syndrome DOID_13359 3.396E-08 1.932E-05 3.396E-08 1.932E-05 NAKAMURA_CANCER_MICROENVIRONMENT_UP hepatitis DOID_2237 8.504E-07 2.42E-04 8.504E-07 2.42E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP heart valve disease DOID_4079 1.449E-06 2.748E-04 1.449E-06 2.748E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP osteochondrodysplasia DOID_2256 2.276E-06 3.237E-04 2.276E-06 3.237E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP collagen disease DOID_854 3.068E-06 3.491E-04 3.068E-06 3.491E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP mineral metabolism disease DOID_0050032 3.524E-06 3.342E-04 3.524E-06 3.342E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP bone development disease DOID_0080006 7.49E-06 6.088E-04 7.49E-06 6.088E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP aortic valve insufficiency DOID_57 1.246E-05 8.861E-04 1.246E-05 8.861E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP osteogenesis imperfecta DOID_12347 1.472E-05 9.306E-04 1.472E-05 9.306E-04 NAKAMURA_CANCER_MICROENVIRONMENT_UP oral submucous fibrosis DOID_5773 1.98E-05 1.127E-03 1.98E-05 1.127E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP ureteral obstruction DOID_5199 2.883E-05 1.492E-03 2.883E-05 1.492E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP amyloidosis DOID_9120 3.579E-05 1.697E-03 8.932E-03 0.13736736 NAKAMURA_CANCER_MICROENVIRONMENT_UP urinary tract obstruction DOID_5200 4.762E-05 2.084E-03 4.762E-05 2.258E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP ureteral disease DOID_1426 5.193E-05 2.111E-03 5.193E-05 2.273E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP aortic valve disease DOID_62 5.193E-05 1.97E-03 5.193E-05 2.111E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP spastic quadriplegia DOID_10970 5.643E-05 2.007E-03 0.01115386 0.15479384 NAKAMURA_CANCER_MICROENVIRONMENT_UP spastic cerebral palsy DOID_0050669 9.911E-05 3.317E-03 0.0146983 0.1779432 NAKAMURA_CANCER_MICROENVIRONMENT_UP metal metabolism disorder DOID_896 1.182E-04 3.735E-03 0.01602437 0.18235737 NAKAMURA_CANCER_MICROENVIRONMENT_UP calcinosis DOID_182 1.461E-04 4.377E-03 1.461E-04 5.544E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP thyroid adenoma DOID_2891 2.289E-04 6.513E-03 2.289E-04 8.141E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP calcium metabolism disease DOID_10575 2.573E-04 6.972E-03 2.573E-04 8.612E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP atrophic muscular disease DOID_913 2.873E-04 7.431E-03 2.873E-04 9.083E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP muscular dystrophy DOID_9884 2.873E-04 7.431E-03 2.873E-04 9.083E-03 NAKAMURA_CANCER_MICROENVIRONMENT_UP endocrine organ benign neoplasm DOID_0060089 4.618E-04 0.01142506 4.618E-04 0.01383033 NAKAMURA_CANCER_MICROENVIRONMENT_UP bone resorption disease DOID_0080011 5.714E-04 0.01354642 5.714E-04 0.01625571 NAKAMURA_CANCER_MICROENVIRONMENT_UP osteoporosis DOID_11476 5.714E-04 0.01354642 5.714E-04 0.01625571 NAKAMURA_CANCER_MICROENVIRONMENT_UP aneurysm disease DOID_2403 5.714E-04 0.01300456 0.03484786 0.2609004 NAKAMURA_CANCER_MICROENVIRONMENT_UP pancreatitis DOID_4989 5.859E-04 0.01282164 5.859E-04 0.01587441 NAKAMURA_CANCER_MICROENVIRONMENT_UP chronic kidney failure DOID_784 6.61E-04 0.01393034 0.03744728 0.2663438 NAKAMURA_CANCER_MICROENVIRONMENT_UP mouth disease DOID_403 8.419E-04 0.01710824 8.419E-04 0.02177412 NAKAMURA_CANCER_MICROENVIRONMENT_UP dilated cardiomyopathy DOID_12930 8.594E-04 0.01686161 0.04262638 0.29222181 NAKAMURA_CANCER_MICROENVIRONMENT_UP gallbladder disease DOID_0000000 4.476E-03 0.08488871 1.000 1.000 NAKAMURA_CANCER_MICROENVIRONMENT_UP facioscapulohumeral muscular dystrophy DOID_11727 4.476E-03 0.08215037 4.476E-03 0.11072441 NAKAMURA_CANCER_MICROENVIRONMENT_UP familial combined hyperlipidemia DOID_13809 4.476E-03 0.07958317 1.000 1.000 NAKAMURA_CANCER_MICROENVIRONMENT_UP teratoma DOID_3307 4.476E-03 0.07717156 4.476E-03 0.10611089 NAKAMURA_CANCER_MICROENVIRONMENT_UP insulinoma DOID_3892 4.476E-03 0.07490181 4.476E-03 0.10186646 NAKAMURA_CANCER_MICROENVIRONMENT_UP hypokalemia DOID_4500 4.476E-03 0.07276175 4.476E-03 0.09794852 NAKAMURA_CANCER_MICROENVIRONMENT_UP malignant teratoma DOID_5563 4.476E-03 0.07717156 4.476E-03 0.10611089 NAKAMURA_CANCER_MICROENVIRONMENT_UP mature teratoma DOID_5566 4.476E-03 0.07717156 4.476E-03 0.10611089 NAKAMURA_CANCER_MICROENVIRONMENT_UP maturity-onset diabetes of the young DOID_0050524 4.922E-03 0.07779824 4.922E-03 0.10373099 NAKAMURA_CANCER_MICROENVIRONMENT_UP islet cell tumor DOID_1799 5.369E-03 0.08255959 5.369E-03 0.1090966 NAKAMURA_CANCER_MICROENVIRONMENT_UP relapsing-remitting multiple sclerosis DOID_2378 5.369E-03 0.08038697 1.000 1.000 NAKAMURA_CANCER_MICROENVIRONMENT_UP Hirschsprung's disease DOID_10487 5.815E-03 0.08483501 5.815E-03 0.11408846 NAKAMURA_CANCER_MICROENVIRONMENT_UP carotid stenosis DOID_13001 5.815E-03 0.08271414 1.000 1.000 NAKAMURA_CANCER_MICROENVIRONMENT_UP megacolon DOID_11372 6.261E-03 0.08688583 6.261E-03 0.11874397 NAKAMURA_CANCER_MICROENVIRONMENT_UP narcolepsy DOID_8986 6.261E-03 0.08481712 6.261E-03 0.11491352 NAKAMURA_CANCER_MICROENVIRONMENT_UP panic disorder DOID_594 6.706E-03 0.08874339 6.706E-03 0.11924892 NAKAMURA_CANCER_MICROENVIRONMENT_UP spastic diplegia DOID_10965 7.152E-03 0.09248875 7.152E-03 0.12331833 NAKAMURA_CANCER_MICROENVIRONMENT_UP restrictive cardiomyopathy DOID_397 7.152E-03 0.09043344 7.152E-03 0.11969132 NAKAMURA_CANCER_MICROENVIRONMENT_UP glucose intolerance DOID_10603 8.043E-03 0.09948397 8.043E-03 0.13075036 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP nephrosis DOID_2527 6.588E-08 3.748E-05 6.588E-08 3.748E-05 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP ulcerative colitis DOID_8577 2.996E-07 8.522E-05 3.79E-04 0.0215679 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP primary immunodeficiency disease DOID_612 8.312E-06 1.577E-03 2.873E-04 0.02724717 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP lymphoma DOID_0060058 9.455E-06 1.345E-03 3.161E-04 0.02569301 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP vasculitis DOID_865 7.156E-05 8.144E-03 2.913E-03 0.09751636 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP congenital nervous system abnormality DOID_2490 8.344E-05 7.913E-03 8.344E-05 0.02374001 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP parasitic infectious disease DOID_1398 1.212E-04 9.856E-03 1.212E-04 0.02299624 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP bile duct disease DOID_4138 1.559E-04 0.01108859 4.856E-03 0.12560581 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP biliary tract disease DOID_9741 1.622E-04 0.01025709 4.985E-03 0.12332636 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP congenital structural myopathy DOID_422 1.726E-04 9.823E-03 1.726E-04 0.02455726 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP pancreatitis DOID_4989 1.964E-04 0.0101608 5.651E-03 0.13398674 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP contact dermatitis DOID_2773 2.113E-04 0.01001982 2.113E-04 0.02404758 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP prion disease DOID_649 2.892E-04 0.01265872 0.0248729 0.32165183 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP MHC class II deficiency DOID_5812 3.23E-04 0.01312565 3.23E-04 0.02296988 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP psoriasis DOID_8893 3.23E-04 0.01225061 3.23E-04 0.02041768 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP encephalomyelitis DOID_640 3.261E-04 0.0115958 7.879E-03 0.17243895 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP acute pancreatitis DOID_2913 5.635E-04 0.01886215 0.03438089 0.3315716 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP severe combined immunodeficiency DOID_627 5.635E-04 0.01781425 5.635E-04 0.02915059 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP X-linked disease DOID_0050735 6.1E-04 0.01826668 6.1E-04 0.02892225 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP combined T cell and B cell immunodeficiency DOID_628 6.1E-04 0.01735335 6.1E-04 0.02669746 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP cystitis DOID_1679 6.582E-04 0.01783319 6.582E-04 0.02674978 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP autoimmune disease of cardiovascular system DOID_0060051 8.135E-04 0.02103979 0.04111656 0.359928 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP Behcet's disease DOID_13241 8.135E-04 0.02103979 0.04111656 0.359928 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP bladder disease DOID_365 1.108E-03 0.02740444 1.108E-03 0.04202015 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP uveitis DOID_13141 1.518E-03 0.03600013 0.05577318 0.39178935 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP cervix uteri carcinoma in situ DOID_8991 1.747E-03 0.0397638 1.000 1.000 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP uveal disease DOID_3480 1.908E-03 0.04175683 0.0623624 0.38569788 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP giant cell tumor DOID_200 2.814E-03 0.05929775 2.814E-03 0.10006495 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP malignant giant cell tumor DOID_2705 2.814E-03 0.05929775 2.814E-03 0.10006495 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP giant cell glioblastoma DOID_3074 2.814E-03 0.05929775 2.814E-03 0.10006495 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP parasitic protozoa infectious disease DOID_2789 3.015E-03 0.06126616 3.015E-03 0.09530291 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP glioblastoma DOID_3068 3.329E-03 0.06531246 3.329E-03 0.09968744 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP pre-malignant neoplasm DOID_0060071 3.884E-03 0.07367356 1.000 1.000 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP in situ carcinoma DOID_8719 3.884E-03 0.07367356 1.000 1.000 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP cholestasis DOID_13580 4.118E-03 0.0755828 0.09082301 0.45331834 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP allergic contact dermatitis DOID_3042 4.358E-03 0.07748606 4.358E-03 0.1239777 FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP astrocytoma DOID_3069 4.604E-03 0.07938326 4.604E-03 0.12474513 SCHEIDEREIT_IKK_INTERACTING_PROTEINS lymphoma DOID_0060058 3.345E-06 1.903E-03 1.47E-04 0.08362236 SCHEIDEREIT_IKK_INTERACTING_PROTEINS integumentary system benign neoplasm DOID_0060121 2.501E-05 7.114E-03 1.462E-03 0.1663936 SCHEIDEREIT_IKK_INTERACTING_PROTEINS skin benign neoplasm DOID_3165 2.501E-05 7.114E-03 1.462E-03 0.1663936 SCHEIDEREIT_IKK_INTERACTING_PROTEINS pre-malignant neoplasm DOID_0060071 5.124E-05 9.718E-03 0.06898292 0.5164642 SCHEIDEREIT_IKK_INTERACTING_PROTEINS in situ carcinoma DOID_8719 5.124E-05 9.718E-03 0.06898292 0.5164642 SCHEIDEREIT_IKK_INTERACTING_PROTEINS invasive lobular carcinoma DOID_3457 6.237E-05 8.873E-03 1.000 1.000 SCHEIDEREIT_IKK_INTERACTING_PROTEINS transitional cell carcinoma DOID_2671 1.292E-04 0.01470185 0.09289807 0.52859001 SCHEIDEREIT_IKK_INTERACTING_PROTEINS angiosarcoma DOID_0001816 1.356E-04 0.01286167 1.000 1.000 SCHEIDEREIT_IKK_INTERACTING_PROTEINS alcohol-related neurodevelopmental disorder DOID_0050667 1.564E-04 0.01271443 4.879E-03 0.25239885 SCHEIDEREIT_IKK_INTERACTING_PROTEINS psoriasis DOID_8893 1.929E-04 0.01371767 1.929E-04 0.0548707 SCHEIDEREIT_IKK_INTERACTING_PROTEINS colon carcinoma DOID_1520 2.142E-04 0.01353904 1.000 1.000 SCHEIDEREIT_IKK_INTERACTING_PROTEINS sarcoma DOID_1115 4.869E-04 0.02770708 1.000 1.000 SCHEIDEREIT_IKK_INTERACTING_PROTEINS papilloma DOID_2615 7.023E-04 0.03632999 1.000 1.000 SCHEIDEREIT_IKK_INTERACTING_PROTEINS adenoid cystic carcinoma DOID_4866 1.002E-03 0.04750543 0.04548758 0.55069007 SCHEIDEREIT_IKK_INTERACTING_PROTEINS cervix uteri carcinoma in situ DOID_8991 1.049E-03 0.04590789 0.04652104 0.55146815 SCHEIDEREIT_IKK_INTERACTING_PROTEINS salivary gland cancer DOID_8850 1.097E-03 0.04458098 0.04755341 0.54115776 SCHEIDEREIT_IKK_INTERACTING_PROTEINS Huntington's disease DOID_12858 1.146E-03 0.04347048 1.146E-03 0.2173524 SCHEIDEREIT_IKK_INTERACTING_PROTEINS brain cancer DOID_1319 1.353E-03 0.04810311 0.05269891 0.49976128 SCHEIDEREIT_IKK_INTERACTING_PROTEINS bone marrow disease DOID_4961 1.353E-03 0.04527352 1.353E-03 0.19241246 SCHEIDEREIT_IKK_INTERACTING_PROTEINS central nervous system cancer DOID_3620 1.407E-03 0.04447314 0.05372475 0.50113738 SCHEIDEREIT_IKK_INTERACTING_PROTEINS integumentary system cancer DOID_0060122 1.815E-03 0.05436267 1.815E-03 0.17214846 SCHEIDEREIT_IKK_INTERACTING_PROTEINS skin cancer DOID_4159 1.815E-03 0.05436267 1.815E-03 0.17214846 SCHEIDEREIT_IKK_INTERACTING_PROTEINS pustulosis of palm and sole DOID_4398 1.815E-03 0.05164454 1.815E-03 0.14755582 SCHEIDEREIT_IKK_INTERACTING_PROTEINS oral cavity cancer DOID_8618 2.006E-03 0.0543404 0.06392372 0.50517498 SCHEIDEREIT_IKK_INTERACTING_PROTEINS hyperglycemia DOID_4195 2.557E-03 0.06613366 2.557E-03 0.18186757 SCHEIDEREIT_IKK_INTERACTING_PROTEINS metabolic syndrome X DOID_14221 3.588E-03 0.08875721 3.588E-03 0.22682397 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN oral cavity cancer DOID_8618 2.821E-16 1.605E-13 8.751E-10 1.66E-07 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN biliary tract cancer DOID_4607 1.974E-11 5.616E-09 2.708E-07 2.568E-05 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN tongue cancer DOID_8649 1.198E-10 2.272E-08 2.922E-03 0.04055352 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN osteochondrodysplasia DOID_2256 5.77E-10 8.208E-08 5.77E-10 3.283E-07 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bone development disease DOID_0080006 5.966E-10 6.789E-08 5.966E-10 1.697E-07 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bile duct cancer DOID_4606 8.751E-10 8.298E-08 1.495E-05 9.449E-04 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bile duct carcinoma DOID_4897 8.751E-10 8.298E-08 1.495E-05 9.449E-04 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN astrocytoma DOID_3069 3.392E-09 2.757E-07 0.05176744 0.27023553 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN giant cell tumor DOID_200 1.44E-08 1.024E-06 0.03286153 0.20547482 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN malignant giant cell tumor DOID_2705 1.44E-08 1.024E-06 0.03286153 0.20547482 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN giant cell glioblastoma DOID_3074 1.44E-08 1.024E-06 0.03286153 0.20547482 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bile duct adenocarcinoma DOID_4896 1.634E-08 1.033E-06 2.042E-04 7.261E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cholangiocarcinoma DOID_4947 1.634E-08 1.033E-06 2.042E-04 7.261E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN transitional cell carcinoma DOID_2671 2.032E-08 1.156E-06 0.01088125 0.09105049 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN glioblastoma DOID_3068 2.651E-08 1.371E-06 0.0384164 0.2253498 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.388E-08 1.606E-06 1.473E-03 0.02703581 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN adenoid cystic carcinoma DOID_4866 8.139E-08 3.562E-06 8.139E-08 1.158E-05 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN salivary gland cancer DOID_8850 1.078E-07 4.382E-06 1.078E-07 1.227E-05 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN pancreatic carcinoma DOID_4905 1.246E-07 4.727E-06 6.855E-03 0.07091948 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN uterine cancer DOID_363 1.41E-07 5.013E-06 9.591E-05 4.548E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN vesiculobullous skin disease DOID_2731 4.399E-07 1.472E-05 4.399E-07 3.576E-05 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN multiple epiphyseal dysplasia DOID_12721 4.828E-07 1.526E-05 4.828E-07 3.434E-05 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN abdominal aortic aneurysm DOID_7693 6.689E-07 2.003E-05 6.238E-04 0.01543261 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN carotid artery disease DOID_3407 9.164E-07 2.607E-05 4.247E-03 0.04931213 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN papilloma DOID_2615 1.049E-06 2.843E-05 0.01435702 0.11190607 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN pre-malignant neoplasm DOID_0060071 1.101E-06 2.848E-05 4.63E-03 0.04970412 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN in situ carcinoma DOID_8719 1.101E-06 2.848E-05 4.63E-03 0.04970412 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN nephroblastoma DOID_2154 1.208E-06 2.99E-05 0.0151274 0.11476657 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN esophageal disease DOID_6050 1.208E-06 2.865E-05 0.0151274 0.11325648 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cerebral degeneration DOID_1443 1.316E-06 2.994E-05 0.04674151 0.26332593 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN uterine disease DOID_345 1.316E-06 2.879E-05 4.031E-04 0.01207151 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN pancreatic ductal carcinoma DOID_3587 2.004E-06 4.222E-05 6.132E-03 0.06461602 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN peptic ulcer DOID_750 2.31E-06 4.695E-05 0.19213867 0.51813699 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN granulosa cell tumor DOID_2999 2.328E-06 4.569E-05 0.09198359 0.3376688 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN esophagitis DOID_11963 2.899E-06 5.499E-05 0.09658454 0.34563902 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN sex cord-gonadal stromal tumor DOID_192 2.899E-06 5.321E-05 0.09658454 0.34347877 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN benign mesothelioma DOID_2645 2.925E-06 5.202E-05 0.2003099 0.53762423 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN endometriosis of uterus DOID_288 3.278E-06 5.651E-05 1.552E-03 0.02759073 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN endometriosis DOID_289 3.662E-06 6.129E-05 1.654E-03 0.02851528 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN gallbladder cancer DOID_3121 4.081E-06 6.635E-05 9.591E-05 4.961E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN female reproductive system disease DOID_229 4.26E-06 6.733E-05 8.574E-04 0.01806988 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN thyroid adenoma DOID_2891 5.569E-06 8.564E-05 0.02665906 0.17435639 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN lung small cell carcinoma DOID_5409 6.775E-06 1.014E-04 2.355E-03 0.03721789 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN amino acid metabolic disorder DOID_9252 7.275E-06 1.061E-04 1.033E-04 4.2E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN aortic aneurysm DOID_3627 7.45E-06 1.06E-04 2.487E-03 0.03824284 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN lymphoma DOID_0060058 8.775E-06 1.218E-04 0.08244418 0.32352232 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN integumentary system cancer DOID_0060122 1.165E-05 1.579E-04 0.03504269 0.20988729 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN skin cancer DOID_4159 1.165E-05 1.579E-04 0.03504269 0.20988729 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN lung adenocarcinoma DOID_3910 1.371E-05 1.815E-04 9.469E-03 0.08552101 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN sarcoma DOID_1115 1.576E-05 2.038E-04 0.01011176 0.08851676 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN collagen disease DOID_854 1.892E-05 2.392E-04 0.04190854 0.24332609 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN respiratory failure DOID_11162 2.041E-05 2.525E-04 4.436E-03 0.05047752 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN familial adenomatous polyposis DOID_0050424 2.048E-05 2.479E-04 0.05432693 0.28101838 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN endometrial carcinoma DOID_2871 2.052E-05 2.432E-04 5.692E-04 0.01472204 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN endometrial cancer DOID_1380 2.625E-05 3.048E-04 6.816E-04 0.0161606 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN epidermolysis bullosa DOID_2730 2.72E-05 3.096E-04 2.72E-05 1.548E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN endocrine organ benign neoplasm DOID_0060089 3.14E-05 3.503E-04 0.0504934 0.26602541 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN myocarditis DOID_820 3.308E-05 3.62E-04 8.073E-04 0.01837407 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN thyroid carcinoma DOID_3963 3.694E-05 3.966E-04 0.17134539 0.49240165 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN spindle cell carcinoma DOID_4015 3.694E-05 3.893E-04 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN diabetic retinopathy DOID_8947 4.365E-05 4.516E-04 0.0569767 0.27709183 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN thyroid cancer DOID_1781 4.565E-05 4.638E-04 0.17972583 0.50625742 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN multiple myeloma DOID_9538 5.052E-05 5.043E-04 0.01754235 0.12172679 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN aneurysm disease DOID_2403 5.26E-05 5.16E-04 7.627E-03 0.07749096 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN mesenchymal cell neoplasm DOID_3350 5.563E-05 5.365E-04 2.565E-03 0.03841341 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN spindle cell sarcoma DOID_4235 5.563E-05 5.365E-04 2.565E-03 0.03841341 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN lung oat cell carcinoma DOID_5411 5.563E-05 5.276E-04 2.565E-03 0.03742845 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN epithelioid sarcoma DOID_6193 5.563E-05 5.365E-04 2.565E-03 0.03841341 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN congenital diaphragmatic hernia DOID_3827 6.139E-05 5.726E-04 1.269E-03 0.02490634 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN systemic scleroderma DOID_418 6.139E-05 5.634E-04 0.19213867 0.52060431 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN adult respiratory distress syndrome DOID_11394 6.742E-05 6.089E-04 1.36E-03 0.02578594 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN Barrett's esophagus DOID_9206 6.822E-05 6.065E-04 0.07804042 0.31052447 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN basal cell carcinoma DOID_2513 8.253E-05 7.224E-04 3.301E-03 0.04367735 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN retinal vascular disease DOID_2462 8.346E-05 7.195E-04 0.07217247 0.31110711 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN rheumatic disease DOID_1575 8.809E-05 7.481E-04 0.20839891 0.55153015 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN scleroderma DOID_419 8.809E-05 7.481E-04 0.20839891 0.55153015 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN keratosis DOID_161 9.866E-05 8.256E-04 3.701E-03 0.04679721 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN skin carcinoma DOID_3451 9.866E-05 8.136E-04 3.701E-03 0.04577988 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN primary immunodeficiency disease DOID_612 1.033E-04 8.4E-04 1.033E-04 4.523E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN learning disability DOID_8927 1.042E-04 8.352E-04 0.02470984 0.16737975 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN leukodystrophy DOID_10579 1.13E-04 8.933E-04 0.22038006 0.56998297 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN Down syndrome DOID_14250 1.167E-04 9.098E-04 0.09198359 0.34433331 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN myeloma DOID_0070004 1.224E-04 9.41E-04 0.02665906 0.17638379 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN brain cancer DOID_1319 1.224E-04 9.284E-04 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN lymphoblastic leukemia DOID_1037 1.267E-04 9.483E-04 0.08394647 0.32493566 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN central nervous system cancer DOID_3620 1.323E-04 9.774E-04 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN brain edema DOID_4724 1.368E-04 9.98E-04 0.09658454 0.34134536 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN ulcerative colitis DOID_8577 1.613E-04 1.162E-03 0.09158083 0.34739661 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN funisitis DOID_0050698 1.834E-04 1.305E-03 1.834E-04 6.959E-03 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN sarcoidosis DOID_11335 1.906E-04 1.339E-03 0.03286153 0.20775788 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bone marrow cancer DOID_4960 2.042E-04 1.417E-03 0.0339452 0.20768624 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN muscle cancer DOID_4045 2.102E-04 1.441E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN reproductive organ benign neoplasm DOID_0050622 2.184E-04 1.48E-03 3.215E-03 0.04356209 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN Lewy body dementia DOID_12217 2.393E-04 1.602E-03 0.11475757 0.37963406 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hypersensitivity reaction type IV disease DOID_2916 2.655E-04 1.757E-03 0.0384164 0.22769719 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN portal hypertension DOID_10762 3.051E-04 1.996E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN autosomal dominant nonsyndromic deafness DOID_0050564 3.42E-04 2.211E-03 3.42E-04 0.01144647 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN myositis DOID_633 3.42E-04 2.186E-03 8.241E-03 0.08084322 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN B cell deficiency DOID_2115 3.816E-04 2.413E-03 3.816E-04 0.0120628 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN gestational diabetes DOID_11714 4.24E-04 2.651E-03 4.24E-04 0.01206418 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN perinatal necrotizing enterocolitis DOID_8677 4.24E-04 2.623E-03 9.469E-03 0.08418474 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN allergic contact dermatitis DOID_3042 4.503E-04 2.755E-03 4.503E-04 0.01220018 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hepatic vascular disease DOID_272 4.694E-04 2.841E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN invasive ductal carcinoma DOID_3008 4.694E-04 2.812E-03 0.14133745 0.43005887 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN coronary stenosis DOID_4248 4.694E-04 2.782E-03 0.01011176 0.0871756 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN nephrosis DOID_2527 5.562E-04 3.263E-03 0.05434974 0.26891308 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cystic fibrosis DOID_1485 6.788E-04 3.941E-03 0.32728797 0.76322482 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN germinoma DOID_3304 6.816E-04 3.918E-03 0.15861476 0.4676259 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN leiomyoma DOID_127 7.428E-04 4.226E-03 0.01360426 0.10751141 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN mixed glioma DOID_5076 7.467E-04 4.207E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN contact dermatitis DOID_2773 8.193E-04 4.571E-03 8.193E-04 0.01793085 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN lymphoid leukemia DOID_10747 9.468E-04 5.23E-03 0.01591522 0.11760725 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN embryonal cancer DOID_688 1.101E-03 6.022E-03 0.01754235 0.12322959 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN facioscapulohumeral muscular dystrophy DOID_11727 1.118E-03 6.058E-03 1.118E-03 0.02271801 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN acute kidney failure DOID_3021 1.118E-03 6.001E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN keratitis DOID_4677 1.118E-03 5.945E-03 0.04951192 0.26577623 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN nervous system cancer DOID_3093 1.259E-03 6.63E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN intracranial arterial disease DOID_13089 1.36E-03 7.097E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cerebral arterial disease DOID_3527 1.36E-03 7.097E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN breast benign neoplasm DOID_0060082 1.362E-03 7.044E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN thoracic benign neoplasm DOID_0060097 1.362E-03 7.044E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN benign breast phyllodes tumor DOID_1631 1.362E-03 7.044E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cervix uteri carcinoma in situ DOID_8991 1.454E-03 7.451E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN Crohn's disease DOID_8778 1.473E-03 7.483E-03 0.08545712 0.32854799 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN dilated cardiomyopathy DOID_12930 1.53E-03 7.706E-03 0.38928828 0.87551397 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN aortic valve stenosis DOID_1712 1.629E-03 8.129E-03 0.05911767 0.2803163 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cataract DOID_83 1.87E-03 9.254E-03 1.87E-03 0.03130154 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN vulva cancer DOID_1245 1.918E-03 9.41E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN obstructive hydrocephalus DOID_14159 1.918E-03 9.33E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN communicating hydrocephalus DOID_1573 1.918E-03 9.33E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN larynx cancer DOID_2596 1.918E-03 9.251E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN laryngeal benign neoplasm DOID_2598 1.918E-03 9.251E-03 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN spinocerebellar degeneration DOID_2478 1.985E-03 9.491E-03 0.02567685 0.17188388 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN proteinuria DOID_576 1.985E-03 9.412E-03 0.22038006 0.56740386 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN lens disease DOID_110 2.104E-03 9.894E-03 2.104E-03 0.03420328 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hydrocephalus DOID_10908 2.231E-03 0.01040412 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN polycystic kidney disease DOID_898 2.231E-03 0.01031953 0.06862685 0.29808151 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN integumentary system benign neoplasm DOID_0060121 2.355E-03 0.01080519 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN skin benign neoplasm DOID_3165 2.355E-03 0.01080519 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN idiopathic pulmonary fibrosis DOID_0050156 2.565E-03 0.01167768 0.07334553 0.3137865 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN skeletal system cancer DOID_0060124 2.565E-03 0.011585 0.07334553 0.31144481 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bone cancer DOID_184 2.565E-03 0.011585 0.07334553 0.31144481 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN arthropathy DOID_381 2.565E-03 0.01149378 0.07334553 0.30241743 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN panic disorder DOID_594 2.565E-03 0.01140398 2.565E-03 0.03649274 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN intracranial hypertension DOID_9428 2.565E-03 0.01131558 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN B-cell lymphocytic neoplasm DOID_707 2.623E-03 0.01148218 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN angiosarcoma DOID_0001816 2.922E-03 0.01269232 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN spastic diplegia DOID_10965 2.922E-03 0.01259617 0.07804042 0.31492907 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN restrictive cardiomyopathy DOID_397 2.922E-03 0.01250146 0.07804042 0.31271126 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN pustulosis of palm and sole DOID_4398 3.215E-03 0.01365379 0.25525181 0.62334026 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bronchitis DOID_6132 3.301E-03 0.01391204 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN congenital nervous system abnormality DOID_2490 3.54E-03 0.01480976 3.54E-03 0.04577562 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN male reproductive organ benign neoplasm DOID_0060087 3.701E-03 0.01537135 0.08735933 0.33360712 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN prion disease DOID_649 3.701E-03 0.01525996 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN nonsyndromic deafness DOID_0050563 3.709E-03 0.01518339 3.709E-03 0.04490408 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hypertrophic cardiomyopathy DOID_11984 3.709E-03 0.01507494 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN melancholia DOID_2848 3.883E-03 0.0156711 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN neurotic disorder DOID_4964 4.062E-03 0.01627853 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN agammaglobulinemia DOID_2583 4.123E-03 0.01640427 4.123E-03 0.04887105 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN infertility DOID_5223 4.123E-03 0.01629035 0.09198359 0.33550425 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hypothyroidism DOID_1459 4.436E-03 0.01740604 4.436E-03 0.04948776 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN amnestic disorder DOID_10914 4.566E-03 0.0177932 0.09658454 0.3478266 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN blood protein disease DOID_620 4.566E-03 0.01767215 4.566E-03 0.04995782 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN congenital heart defect DOID_1682 4.63E-03 0.01779945 0.28494383 0.68123125 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN coronary restenosis DOID_4247 5.029E-03 0.01920628 0.1011623 0.35531696 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hyperglycemia DOID_4195 5.243E-03 0.01988683 0.29577213 0.69831677 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN gastric ulcer DOID_10808 5.514E-03 0.02077795 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN aortic valve disease DOID_62 6.545E-03 0.0244991 0.11475757 0.37527045 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN peripheral vascular disease DOID_341 6.609E-03 0.02457792 0.05565771 0.27301069 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN endogenous depression DOID_1595 7.364E-03 0.02720838 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bone resorption disease DOID_0080011 7.627E-03 0.02799673 0.06099835 0.28217935 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN osteoporosis DOID_11476 7.627E-03 0.02799673 0.06099835 0.28217935 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN X-linked disease DOID_0050735 7.656E-03 0.02792304 7.656E-03 0.07642096 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN reading disorder DOID_13365 7.656E-03 0.02774519 0.12370724 0.39544619 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN dyslexia DOID_4428 7.656E-03 0.02774519 0.12370724 0.39544619 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN papillary adenoma DOID_3172 8.241E-03 0.02967663 0.12814827 0.40509091 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN microcystic adenoma DOID_5403 8.241E-03 0.02967663 0.12814827 0.40509091 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN follicular adenoma DOID_6204 8.241E-03 0.02967663 0.12814827 0.40509091 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN ankylosing spondylitis DOID_7147 8.241E-03 0.02948998 8.241E-03 0.079473 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN metabolic syndrome X DOID_14221 8.447E-03 0.03004029 0.06511405 0.28945229 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN chromosomal disease DOID_0080014 8.732E-03 0.03085958 0.34418632 0.79288266 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN intracranial aneurysm DOID_10941 8.845E-03 0.03106722 8.845E-03 0.08388149 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN middle cerebral artery infarction DOID_3525 8.845E-03 0.03087662 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN seminoma DOID_4440 8.845E-03 0.03068835 0.1325669 0.41445367 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN extrinsic allergic alveolitis DOID_841 8.845E-03 0.03050236 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN auditory system disease DOID_2742 9.022E-03 0.03092475 9.022E-03 0.08415587 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN alcohol abuse DOID_1574 9.318E-03 0.03174734 9.318E-03 0.08551299 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN mental depression DOID_1596 9.318E-03 0.03155837 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN chronic kidney failure DOID_784 9.318E-03 0.03137163 0.35082682 0.80168859 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN diffuse large B-cell lymphoma DOID_0050745 9.469E-03 0.03169308 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cranial nerve disease DOID_5656 0.01077341 0.03584837 0.01077341 0.09149359 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN female reproductive organ benign neoplasm DOID_0060086 0.01145369 0.03789041 0.01145369 0.09445145 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN uterine benign neoplasm DOID_0060095 0.01145369 0.03789041 0.01145369 0.09445145 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN corneal disease DOID_10124 0.01145369 0.03767139 0.15001977 0.44926974 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN uterine fibroid DOID_13223 0.01145369 0.03789041 0.01145369 0.09445145 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN Human immunodeficiency virus infectious disease DOID_526 0.01154648 0.03775833 0.07946514 0.31399767 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN spastic cerebral palsy DOID_0050669 0.01215239 0.03951263 0.15432813 0.45735784 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN celiac disease DOID_10608 0.01286931 0.04160591 0.01286931 0.10460914 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN allergic rhinitis DOID_4481 0.01286931 0.04137084 0.15861476 0.46521545 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hypersensitivity reaction type I disease DOID_1205 0.01331028 0.04254804 0.01331028 0.10666974 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN chronic leukemia DOID_1036 0.01360426 0.04324481 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN chronic lymphocytic leukemia DOID_1040 0.01360426 0.04324481 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN autonomic nervous system neoplasm DOID_2621 0.01360426 0.04300456 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN bladder disease DOID_365 0.01360426 0.04276697 0.16287977 0.47527483 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN neuroblastoma DOID_769 0.01360426 0.04300456 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hair disease DOID_421 0.01435702 0.0448854 0.01435702 0.11039382 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hyperthyroidism DOID_7998 0.0151274 0.04703548 0.17134539 0.48747763 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.01672026 0.05170559 0.01672026 0.12197217 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN adenoma DOID_657 0.01672026 0.05142611 0.17972583 0.50376355 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN pulmonary sarcoidosis DOID_13406 0.01754235 0.0536645 0.01754235 0.12634933 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cleft palate DOID_674 0.01754235 0.05337752 0.01754235 0.12476996 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN peripheral nervous system neoplasm DOID_1192 0.01838128 0.05563272 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN hepatitis DOID_2237 0.01923688 0.0579142 0.19213867 0.52309524 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN autoimmune disease of urogenital tract DOID_0060049 0.02190174 0.06558995 0.02190174 0.15014567 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN primary biliary cirrhosis DOID_12236 0.02190174 0.06558995 0.02190174 0.15014567 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN spinocerebellar ataxia DOID_1441 0.02190174 0.06524655 0.20436464 0.54593182 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN nephrotic syndrome DOID_1184 0.0228221 0.06763425 0.20839891 0.55410739 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN Huntington's disease DOID_12858 0.0228221 0.06728382 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN uveal disease DOID_3480 0.0228221 0.06693699 0.20839891 0.54394029 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN influenza DOID_8469 0.0237582 0.0693252 0.21241284 0.55188542 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN cerebral infarction DOID_3526 0.02470984 0.07173418 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN pre-eclampsia DOID_10591 0.02665906 0.07700003 0.22433355 0.57498103 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN neuritis DOID_1803 0.02665906 0.07661114 0.22433355 0.57240264 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN heart valve disease DOID_4079 0.02665906 0.07622616 0.22433355 0.56984727 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN vascular skin disease DOID_9540 0.02665906 0.07584503 0.22433355 0.56731462 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN autoimmune disease of gastrointestinal tract DOID_0060031 0.02866835 0.08115566 0.02866835 0.18536691 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN glaucoma DOID_1686 0.02866835 0.0807539 1.000 1.000 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN withdrawal disorder DOID_0060001 0.03073629 0.08615247 0.23994906 0.59361311 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN orofacial cleft DOID_0050567 0.03179183 0.08867428 0.03179183 0.20325341 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN atrophic muscular disease DOID_913 0.03286153 0.09121078 0.03286153 0.2032414 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN muscular dystrophy DOID_9884 0.03286153 0.09121078 0.03286153 0.2032414 SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN vasculitis DOID_865 0.0339452 0.09376126 0.0339452 0.20547681 LIU_TARGETS_OF_VMYB_VS_CMYB_DN bronchiolitis DOID_2942 3.239E-07 1.843E-04 0.01363073 0.31023543 LIU_TARGETS_OF_VMYB_VS_CMYB_DN influenza DOID_8469 2.006E-06 5.706E-04 0.02451112 0.30319192 LIU_TARGETS_OF_VMYB_VS_CMYB_DN myeloma DOID_0070004 2.422E-06 4.594E-04 0.02605612 0.31544542 LIU_TARGETS_OF_VMYB_VS_CMYB_DN bone marrow cancer DOID_4960 3.607E-06 5.131E-04 0.02965209 0.33082434 LIU_TARGETS_OF_VMYB_VS_CMYB_DN pustulosis of palm and sole DOID_4398 3.803E-06 4.328E-04 4.294E-04 0.12215862 LIU_TARGETS_OF_VMYB_VS_CMYB_DN visceral leishmaniasis DOID_9146 1.187E-05 1.125E-03 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN lymphoma DOID_0060058 1.632E-05 1.327E-03 1.123E-03 0.10645552 LIU_TARGETS_OF_VMYB_VS_CMYB_DN ulcerative colitis DOID_8577 1.965E-05 1.398E-03 1.269E-03 0.10313887 LIU_TARGETS_OF_VMYB_VS_CMYB_DN parathyroid gland disease DOID_11201 2.055E-05 1.299E-03 6.838E-03 0.32421527 LIU_TARGETS_OF_VMYB_VS_CMYB_DN dissociative disorder DOID_10935 4.497E-05 2.559E-03 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN dissociative amnesia DOID_11037 4.497E-05 2.559E-03 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN leishmaniasis DOID_9065 4.497E-05 2.326E-03 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN amnestic disorder DOID_10914 4.995E-05 2.369E-03 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN placenta disease DOID_780 6.069E-05 2.656E-03 0.01154525 0.27371855 LIU_TARGETS_OF_VMYB_VS_CMYB_DN intracranial aneurysm DOID_10941 9.912E-05 4.029E-03 0.0146719 0.29815406 LIU_TARGETS_OF_VMYB_VS_CMYB_DN bronchiolitis obliterans DOID_2799 1.382E-04 5.244E-03 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN multiple myeloma DOID_9538 2.038E-04 7.247E-03 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN thyroid adenoma DOID_2891 3.19E-04 0.01067744 3.19E-04 0.18151653 LIU_TARGETS_OF_VMYB_VS_CMYB_DN lung small cell carcinoma DOID_5409 3.451E-04 0.01090878 0.02708483 0.32106813 LIU_TARGETS_OF_VMYB_VS_CMYB_DN bile duct adenocarcinoma DOID_4896 4.147E-04 0.01241932 0.02965209 0.33744083 LIU_TARGETS_OF_VMYB_VS_CMYB_DN cholangiocarcinoma DOID_4947 4.147E-04 0.01241932 0.02965209 0.33744083 LIU_TARGETS_OF_VMYB_VS_CMYB_DN parasitic protozoa infectious disease DOID_2789 4.294E-04 0.01221586 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN bile duct cancer DOID_4606 4.749E-04 0.0128677 0.03170127 0.33403743 LIU_TARGETS_OF_VMYB_VS_CMYB_DN bile duct carcinoma DOID_4897 4.749E-04 0.0128677 0.03170127 0.33403743 LIU_TARGETS_OF_VMYB_VS_CMYB_DN mineral metabolism disease DOID_0050032 5.727E-04 0.01481192 0.03476732 0.34706325 LIU_TARGETS_OF_VMYB_VS_CMYB_DN parasitic infectious disease DOID_1398 5.899E-04 0.01459264 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN uterine disease DOID_345 5.899E-04 0.01398461 0.03527743 0.34608377 LIU_TARGETS_OF_VMYB_VS_CMYB_DN endocrine organ benign neoplasm DOID_0060089 6.429E-04 0.01463128 6.429E-04 0.12192735 LIU_TARGETS_OF_VMYB_VS_CMYB_DN nephrosis DOID_2527 6.981E-04 0.0152769 6.981E-04 0.09929987 LIU_TARGETS_OF_VMYB_VS_CMYB_DN cystic fibrosis DOID_1485 7.751E-04 0.01633528 0.04036448 0.37651457 LIU_TARGETS_OF_VMYB_VS_CMYB_DN syndrome DOID_225 7.751E-04 0.01575187 7.751E-04 0.08821049 LIU_TARGETS_OF_VMYB_VS_CMYB_DN aneurysm disease DOID_2403 7.95E-04 0.0155988 0.04087178 0.37509746 LIU_TARGETS_OF_VMYB_VS_CMYB_DN metabolic syndrome X DOID_14221 8.561E-04 0.01623803 0.04239215 0.37109439 LIU_TARGETS_OF_VMYB_VS_CMYB_DN female reproductive system disease DOID_229 8.77E-04 0.01609714 0.04289844 0.36431657 LIU_TARGETS_OF_VMYB_VS_CMYB_DN biliary tract cancer DOID_4607 9.195E-04 0.01634904 0.04391024 0.36742538 LIU_TARGETS_OF_VMYB_VS_CMYB_DN lymphoblastic leukemia DOID_1037 1.146E-03 0.01976555 0.04895402 0.40369334 LIU_TARGETS_OF_VMYB_VS_CMYB_DN encephalomyelitis DOID_640 1.146E-03 0.01918421 0.04895402 0.39792629 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Crohn's disease DOID_8778 1.17E-03 0.01902659 0.04945701 0.39635267 LIU_TARGETS_OF_VMYB_VS_CMYB_DN hypersensitivity reaction type I disease DOID_1205 1.195E-03 0.01888154 0.04995974 0.39482076 LIU_TARGETS_OF_VMYB_VS_CMYB_DN hyperparathyroidism DOID_13543 5.264E-03 0.0809461 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN retinal vascular occlusion DOID_1729 5.264E-03 0.07881594 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN hypokalemia DOID_4500 5.264E-03 0.07679502 5.264E-03 0.37437573 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 5.264E-03 0.07487515 5.264E-03 0.33277843 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 5.264E-03 0.07487515 5.264E-03 0.33277843 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Hodgkin's granuloma DOID_8651 5.264E-03 0.07487515 5.264E-03 0.33277843 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 5.264E-03 0.07487515 5.264E-03 0.33277843 LIU_TARGETS_OF_VMYB_VS_CMYB_DN familial adenomatous polyposis DOID_0050424 5.789E-03 0.08033369 5.789E-03 0.32936813 LIU_TARGETS_OF_VMYB_VS_CMYB_DN pneumocystosis DOID_11339 5.789E-03 0.07842098 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN prediabetes syndrome DOID_11716 5.789E-03 0.07659724 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Hodgkin's lymphoma DOID_8567 6.313E-03 0.08164107 6.313E-03 0.32656428 LIU_TARGETS_OF_VMYB_VS_CMYB_DN berylliosis DOID_10322 6.838E-03 0.0864574 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN polyneuropathy DOID_1389 6.838E-03 0.0845779 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Leydig cell tumor DOID_2696 6.838E-03 0.08277837 6.838E-03 0.29927563 LIU_TARGETS_OF_VMYB_VS_CMYB_DN sex cord-stromal neoplasm DOID_4757 6.838E-03 0.08277837 6.838E-03 0.29927563 LIU_TARGETS_OF_VMYB_VS_CMYB_DN psoriatic arthritis DOID_9008 6.838E-03 0.08105382 6.838E-03 0.2778988 LIU_TARGETS_OF_VMYB_VS_CMYB_DN alcohol dependence DOID_0050741 7.362E-03 0.08548591 7.362E-03 0.27925398 LIU_TARGETS_OF_VMYB_VS_CMYB_DN hypercalcemia DOID_12678 7.362E-03 0.08377619 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN eyelid disease DOID_530 7.362E-03 0.08213352 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN renovascular hypertension DOID_1591 7.886E-03 0.08628628 7.886E-03 0.28043042 LIU_TARGETS_OF_VMYB_VS_CMYB_DN mesenchymal cell neoplasm DOID_3350 7.886E-03 0.08465824 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN spindle cell sarcoma DOID_4235 7.886E-03 0.08465824 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN lung oat cell carcinoma DOID_5411 7.886E-03 0.08309049 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN epithelioid sarcoma DOID_6193 7.886E-03 0.08465824 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN hemolytic-uremic syndrome DOID_12554 8.409E-03 0.08699662 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN thyroiditis DOID_7166 8.409E-03 0.08544311 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN autoimmune thyroiditis DOID_7188 8.409E-03 0.08544311 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN lymphatic system cancer DOID_0060073 8.932E-03 0.08916829 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN basal cell carcinoma DOID_2513 8.932E-03 0.0876309 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN reticulosarcoma DOID_8538 8.932E-03 0.08916829 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN lymphosarcoma DOID_8675 8.932E-03 0.08916829 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN skin carcinoma DOID_3451 9.456E-03 0.09119019 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN testicular cancer DOID_2998 9.978E-03 0.09462835 9.978E-03 0.33398241 LIU_TARGETS_OF_VMYB_VS_CMYB_DN psoriasis DOID_8893 9.978E-03 0.09307706 9.978E-03 0.31542783 LIU_TARGETS_OF_VMYB_VS_CMYB_DN pulmonary edema DOID_11396 0.01050093 0.09637147 0.01050093 0.31447534 LIU_TARGETS_OF_VMYB_VS_CMYB_DN colon carcinoma DOID_1520 0.01050093 0.09484177 0.01050093 0.29875157 LIU_TARGETS_OF_VMYB_VS_CMYB_DN autoimmune hepatitis DOID_2048 0.01102322 0.09800332 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN coronary restenosis DOID_4247 0.01102322 0.09649558 0.01102322 0.2986768 LIU_TARGETS_OF_VMYB_VS_CMYB_DN mitochondrial myopathy DOID_699 0.01102322 0.09503353 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN gastric ulcer DOID_10808 0.01154525 0.09804843 0.01154525 0.29860205 LIU_TARGETS_OF_VMYB_VS_CMYB_DN neutropenia DOID_1227 0.01154525 0.09660655 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN familial hypercholesterolemia DOID_13810 0.01154525 0.09520645 0.01154525 0.28561935 LIU_TARGETS_OF_VMYB_VS_CMYB_DN agranulocytosis DOID_12987 0.01206701 0.09808755 1.000 1.000 LIU_TARGETS_OF_VMYB_VS_CMYB_DN Goodpasture syndrome DOID_9808 0.01258851 0.09948421 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN mixed glioma DOID_5076 2.652E-07 1.509E-04 2.652E-07 1.509E-04 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN nervous system cancer DOID_3093 4.66E-07 1.326E-04 4.66E-07 1.326E-04 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN integumentary system benign neoplasm DOID_0060121 6.188E-06 1.174E-03 5.872E-04 0.01856172 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN skin benign neoplasm DOID_3165 6.188E-06 1.174E-03 5.872E-04 0.01856172 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN integumentary system cancer DOID_0060122 8.617E-06 1.226E-03 7.301E-04 0.02077265 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN skin cancer DOID_4159 8.617E-06 1.226E-03 7.301E-04 0.02077265 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN larynx cancer DOID_2596 3.511E-05 3.996E-03 3.511E-05 6.66E-03 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN laryngeal benign neoplasm DOID_2598 3.511E-05 3.996E-03 3.511E-05 6.66E-03 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.922E-05 3.719E-03 3.922E-05 5.578E-03 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN prion disease DOID_649 6.873E-05 5.587E-03 6.873E-05 7.822E-03 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN uremia DOID_4676 1.134E-04 8.067E-03 1.134E-04 0.01075541 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN osteosarcoma DOID_3347 1.455E-04 9.199E-03 1.455E-04 0.01182751 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN polycystic ovary syndrome DOID_11612 2.077E-04 0.01182075 2.077E-04 0.01477594 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN age related macular degeneration DOID_10871 2.357E-04 0.01219178 2.357E-04 0.01490107 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN degeneration of macula and posterior pole DOID_2007 2.357E-04 0.01219178 2.357E-04 0.01490107 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN autonomic nervous system neoplasm DOID_2621 2.654E-04 0.01258332 2.654E-04 0.01509999 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN neuroblastoma DOID_769 2.654E-04 0.01258332 2.654E-04 0.01509999 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN macular degeneration DOID_4448 2.968E-04 0.01299045 2.968E-04 0.01535235 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN multiple myeloma DOID_9538 3.472E-04 0.01410947 0.02708272 0.22333429 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN peripheral nervous system neoplasm DOID_1192 3.648E-04 0.01383832 3.648E-04 0.0172979 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN uterine cancer DOID_363 4.797E-04 0.01705957 0.0317491 0.23461348 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN cataract DOID_83 5.004E-04 0.0167471 5.004E-04 0.02190005 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN proteinuria DOID_576 5.214E-04 0.0164828 5.214E-04 0.02119218 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN myeloma DOID_0070004 5.429E-04 0.01625907 0.03374238 0.2430306 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN lens disease DOID_110 5.429E-04 0.01544612 5.429E-04 0.02059482 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN brain cancer DOID_1319 5.429E-04 0.01471059 5.429E-04 0.01930765 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN central nervous system cancer DOID_3620 5.648E-04 0.0146089 5.648E-04 0.01890564 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN lung small cell carcinoma DOID_5409 5.872E-04 0.01452656 0.03506905 0.24041312 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN giant cell tumor DOID_200 6.808E-04 0.01614078 6.808E-04 0.02038835 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN malignant giant cell tumor DOID_2705 6.808E-04 0.01614078 6.808E-04 0.02038835 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN giant cell glioblastoma DOID_3074 6.808E-04 0.01614078 6.808E-04 0.02038835 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN bone marrow cancer DOID_4960 7.053E-04 0.01605184 0.03837805 0.25391988 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN glioblastoma DOID_3068 8.073E-04 0.01766761 8.073E-04 0.02187418 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN melancholia DOID_2848 8.339E-04 0.01757296 0.04167614 0.25775785 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN neurotic disorder DOID_4964 8.608E-04 0.01749356 0.04233445 0.25901399 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN cholestasis DOID_13580 1.002E-03 0.01965962 1.002E-03 0.02591495 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN parasitic infectious disease DOID_1398 1.002E-03 0.0190043 1.002E-03 0.02478821 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN astrocytoma DOID_3069 1.122E-03 0.02060093 1.122E-03 0.02660953 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN blood coagulation disease DOID_1247 1.154E-03 0.02051068 0.04889369 0.28388275 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN bile duct disease DOID_4138 1.185E-03 0.02043301 1.185E-03 0.02697158 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN biliary tract disease DOID_9741 1.217E-03 0.02036681 1.217E-03 0.02663352 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN endogenous depression DOID_1595 1.315E-03 0.02138344 0.05215709 0.28812994 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN syndrome DOID_225 1.315E-03 0.02078945 1.315E-03 0.02771927 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN female reproductive system disease DOID_229 1.487E-03 0.02287369 1.487E-03 0.03022594 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN mental depression DOID_1596 1.559E-03 0.02334505 0.05670777 0.30155813 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN encephalomyelitis DOID_640 1.942E-03 0.02832951 1.942E-03 0.03809831 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN dilated cardiomyopathy DOID_12930 2.023E-03 0.0287786 0.0644601 0.32458225 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN transient cerebral ischemia DOID_224 6.838E-03 0.09489602 6.838E-03 0.12969122 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN lateral sclerosis DOID_230 6.838E-03 0.09263659 6.838E-03 0.12550764 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN bilirubin metabolic disorder DOID_2741 6.838E-03 0.09048225 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN acute kidney failure DOID_3021 6.838E-03 0.08842583 6.838E-03 0.12158552 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 6.838E-03 0.08646082 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 6.838E-03 0.08646082 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN Hodgkin's granuloma DOID_8651 6.838E-03 0.08646082 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 6.838E-03 0.08646082 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN nervous system benign neoplasm DOID_0060115 7.519E-03 0.0930087 7.519E-03 0.1296485 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN ovarian disease DOID_1100 8.2E-03 0.09927252 8.2E-03 0.13722966 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN mucopolysaccharidosis DOID_12798 8.2E-03 0.09720434 8.2E-03 0.13330881 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN diarrhea DOID_13250 8.2E-03 0.09522058 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN pituitary gland disease DOID_53 8.2E-03 0.09331617 8.2E-03 0.12960579 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN Hodgkin's lymphoma DOID_8567 8.2E-03 0.09148644 1.000 1.000 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN ocular hypertension DOID_9282 8.2E-03 0.08972708 8.2E-03 0.12610293 LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN borderline glaucoma DOID_9283 8.2E-03 0.08972708 8.2E-03 0.12610293 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP primary bacterial infectious disease DOID_0050338 4.672E-20 2.659E-17 3.16E-03 0.09989088 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bacterial pneumonia DOID_874 6.727E-19 1.914E-16 0.02840838 0.37591553 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP tuberculosis DOID_399 6.318E-16 1.198E-13 0.022768 0.30845223 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pulmonary tuberculosis DOID_2957 1.363E-15 1.939E-13 0.15673685 0.61932823 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pleural disease DOID_1532 2.095E-15 2.384E-13 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP chronic kidney failure DOID_784 5.066E-15 4.804E-13 2.774E-03 0.09866807 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pleurisy DOID_10247 5.739E-14 4.665E-12 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cystic fibrosis DOID_1485 1.01E-13 7.182E-12 2.173E-03 0.09510013 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP influenza DOID_8469 2.944E-12 1.861E-10 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP brain infarction DOID_3454 9.33E-11 5.309E-09 0.022768 0.31597546 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP adult respiratory distress syndrome DOID_11394 9.86E-11 5.1E-09 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP intracranial arterial disease DOID_13089 9.86E-11 4.675E-09 8.779E-03 0.16113666 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cerebral arterial disease DOID_3527 9.86E-11 4.675E-09 8.779E-03 0.16113666 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP acute pancreatitis DOID_2913 1.824E-10 7.982E-09 0.07866398 0.50291912 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cerebral infarction DOID_3526 2.223E-10 9.034E-09 0.01085055 0.17639898 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pancreatitis DOID_4989 2.48E-10 9.409E-09 0.2307723 0.80066731 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP middle cerebral artery infarction DOID_3525 3.849E-10 1.369E-08 3.794E-03 0.10280549 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP extrinsic allergic alveolitis DOID_841 3.849E-10 1.288E-08 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP sarcoidosis DOID_11335 6.851E-10 2.166E-08 0.16773092 0.64485738 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hypersensitivity reaction type IV disease DOID_2916 1.272E-09 3.808E-08 0.18127376 0.67414882 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP respiratory failure DOID_11162 2.007E-09 5.711E-08 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP periodontal disease DOID_3388 2.319E-09 6.282E-08 0.11421084 0.54610055 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pulmonary sarcoidosis DOID_13406 3.797E-09 9.822E-08 0.12288287 0.55936282 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP respiratory syncytial virus infectious disease DOID_1273 5.162E-09 1.277E-07 0.12861738 0.56731233 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP systemic scleroderma DOID_418 5.162E-09 1.224E-07 8.388E-03 0.15910125 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP rheumatic disease DOID_1575 9.12E-09 2.076E-07 9.998E-03 0.16732508 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP scleroderma DOID_419 9.12E-09 2.076E-07 9.998E-03 0.16732508 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Human immunodeficiency virus infectious disease DOID_526 2.348E-08 5.139E-07 1.352E-05 7.693E-03 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP mouth disease DOID_403 3.161E-08 6.661E-07 0.03963924 0.38887463 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP periodontitis DOID_824 3.849E-08 7.821E-07 0.09066741 0.51078964 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP ulcerative colitis DOID_8577 4.199E-08 8.239E-07 4.384E-03 0.0959387 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP common cold DOID_10459 5.288E-08 1.003E-06 0.03855687 0.39176537 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP collagen disease DOID_854 6.958E-08 1.277E-06 0.0187461 0.27350073 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP viral pneumonia DOID_10533 1.064E-07 1.892E-06 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP tooth disease DOID_1091 1.197E-07 2.065E-06 0.2051023 0.74809748 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP diabetic retinopathy DOID_8947 1.965E-07 3.288E-06 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP aneurysm disease DOID_2403 2.478E-07 4.029E-06 2.253E-03 0.09157568 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP contact dermatitis DOID_2773 3.097E-07 4.895E-06 1.566E-04 0.02227011 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pulmonary emphysema DOID_9675 3.384E-07 5.204E-06 9.177E-03 0.16318729 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP retinal vascular disease DOID_2462 4.407E-07 6.6E-06 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP primary immunodeficiency disease DOID_612 5.756E-07 8.398E-06 2.339E-04 0.02661413 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pre-eclampsia DOID_10591 6.5E-07 9.246E-06 0.01173371 0.18044536 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hepatitis B DOID_2043 7.619E-07 1.057E-05 0.06955838 0.47685204 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP integumentary system benign neoplasm DOID_0060121 7.931E-07 1.074E-05 6.714E-04 0.04775365 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP skin benign neoplasm DOID_3165 7.931E-07 1.074E-05 6.714E-04 0.04775365 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP aortic aneurysm DOID_3627 8.734E-07 1.156E-05 7.1E-04 0.04488758 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP IgA glomerulonephritis DOID_2986 9.199E-07 1.19E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pustulosis of palm and sole DOID_4398 1.377E-06 1.741E-05 4.034E-05 0.01147812 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP myositis DOID_633 1.805E-06 2.233E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP perinatal necrotizing enterocolitis DOID_8677 2.43E-06 2.942E-05 0.09066741 0.5057819 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cholestasis DOID_13580 3.051E-06 3.617E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hyperglycemia DOID_4195 3.281E-06 3.81E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP allergic contact dermatitis DOID_3042 3.524E-06 4.01E-05 8.459E-05 0.01604388 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bronchiolitis obliterans DOID_2799 4.145E-06 4.624E-05 0.1025157 0.53028573 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bile duct disease DOID_4138 4.641E-06 5.079E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP male reproductive system disease DOID_48 4.641E-06 4.983E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP biliary tract disease DOID_9741 4.96E-06 5.226E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bronchiectasis DOID_9563 5.528E-06 5.719E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP encephalitis DOID_9588 7.353E-06 7.472E-05 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hepatitis DOID_2237 1.108E-05 1.106E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP peptic ulcer DOID_750 1.108E-05 1.087E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP autoimmune disease of urogenital tract DOID_0060049 1.464E-05 1.412E-04 9.584E-03 0.16525078 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP primary biliary cirrhosis DOID_12236 1.464E-05 1.412E-04 9.584E-03 0.16525078 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Crohn's disease DOID_8778 1.663E-05 1.577E-04 3.91E-03 0.10113769 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bronchitis DOID_6132 2.246E-05 2.095E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.614E-05 2.399E-04 6.714E-04 0.0545756 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP giant cell tumor DOID_200 3.51E-05 3.17E-04 0.16773092 0.64052948 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP malignant giant cell tumor DOID_2705 3.51E-05 3.17E-04 0.16773092 0.64052948 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP giant cell glioblastoma DOID_3074 3.51E-05 3.17E-04 0.16773092 0.64052948 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP esophagitis DOID_11963 3.738E-05 3.323E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP brain edema DOID_4724 3.738E-05 3.272E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP integumentary system cancer DOID_0060122 4.034E-05 3.478E-04 0.01556707 0.23309639 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP parasitic protozoa infectious disease DOID_2789 4.034E-05 3.426E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP skin cancer DOID_4159 4.034E-05 3.478E-04 0.01556707 0.23309639 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP mitochondrial myopathy DOID_699 4.351E-05 3.641E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP glioblastoma DOID_3068 4.925E-05 4.061E-04 0.18127376 0.66977123 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP sinusitis DOID_0050127 5.766E-05 4.687E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP paranasal sinus disease DOID_1352 5.766E-05 4.687E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP uremia DOID_4676 5.766E-05 4.621E-04 2.567E-03 0.09736661 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP meningitis DOID_9471 6.574E-05 5.195E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP severe combined immunodeficiency DOID_627 7.452E-05 5.809E-04 3.031E-03 0.10143728 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP parasitic infectious disease DOID_1398 7.551E-05 5.806E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bronchiolitis DOID_2942 8.404E-05 6.376E-04 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP combined T cell and B cell immunodeficiency DOID_628 8.404E-05 6.292E-04 3.276E-03 0.09320758 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cystitis DOID_1679 9.432E-05 6.97E-04 0.08468521 0.5353987 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP astrocytoma DOID_3069 9.444E-05 6.889E-04 0.21030338 0.75735838 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP nephrosis DOID_2527 1.051E-04 7.569E-04 0.21547071 0.771087 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP renal hypertension DOID_1073 1.3E-04 9.245E-04 4.348E-03 0.10307864 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP secondary hypertension DOID_11130 1.3E-04 9.245E-04 4.348E-03 0.10307864 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bone resorption disease DOID_0080011 1.355E-04 9.519E-04 0.22824275 0.80166745 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP osteoporosis DOID_11476 1.355E-04 9.519E-04 0.22824275 0.80166745 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP abdominal aortic aneurysm DOID_7693 1.734E-04 1.203E-03 5.244E-03 0.11050524 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP allergic rhinitis DOID_4481 1.898E-04 1.301E-03 0.10545376 0.53100168 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bladder disease DOID_365 2.071E-04 1.403E-03 0.10838229 0.5362567 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP papilloma DOID_2615 2.253E-04 1.508E-03 6.217E-03 0.12197742 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP amino acid metabolic disorder DOID_9252 2.339E-04 1.547E-03 0.03597244 0.37215121 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pneumoconiosis DOID_10316 2.446E-04 1.6E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP esophageal disease DOID_6050 2.446E-04 1.582E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hypersensitivity reaction type I disease DOID_1205 2.986E-04 1.909E-03 4.026E-03 0.09959207 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP dilated cardiomyopathy DOID_12930 2.986E-04 1.888E-03 0.040389 0.38951426 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP multiple myeloma DOID_9538 3.089E-04 1.931E-03 0.12288287 0.55055395 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP uveitis DOID_13141 3.325E-04 2.056E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP leber hereditary optic neuropathy DOID_705 3.763E-04 2.303E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP uveal disease DOID_3480 4.678E-04 2.832E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP T cell deficiency DOID_11200 4.694E-04 2.812E-03 0.03223471 0.39024573 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP childhood type dermatomyositis DOID_14203 4.694E-04 2.782E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP transient cerebral ischemia DOID_224 4.694E-04 2.754E-03 0.03223471 0.37431733 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP acute kidney failure DOID_3021 4.694E-04 2.726E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP conjunctival disease DOID_4251 4.694E-04 2.698E-03 0.03223471 0.36683099 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Paget's disease of bone DOID_5408 4.694E-04 2.671E-03 4.694E-04 0.04451697 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP conjunctivitis DOID_6195 4.694E-04 2.698E-03 0.03223471 0.36683099 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cutaneous leishmaniasis DOID_9111 4.694E-04 2.645E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP learning disability DOID_8927 5.305E-04 2.959E-03 0.01085055 0.17149901 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP proteinuria DOID_576 5.637E-04 3.114E-03 0.14839687 0.61186824 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP dermatomyositis DOID_10223 5.725E-04 3.132E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP neuronal ceroid lipofuscinosis DOID_14503 5.725E-04 3.102E-03 0.03540093 0.38005903 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP myeloma DOID_0070004 5.983E-04 3.212E-03 0.15118591 0.61888334 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP neuritis DOID_1803 5.983E-04 3.182E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP vascular skin disease DOID_9540 5.983E-04 3.152E-03 0.15118591 0.60580834 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP peritonitis DOID_8283 6.855E-04 3.579E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP mitochondrial encephalomyopathy DOID_890 6.855E-04 3.546E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP atopic dermatitis DOID_3310 7.914E-04 4.057E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP leprosy DOID_1024 8.085E-04 4.107E-03 0.04170257 0.39547942 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP atrophic muscular disease DOID_913 8.342E-04 4.2E-03 8.342E-04 0.04746391 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP muscular dystrophy DOID_9884 8.342E-04 4.2E-03 8.342E-04 0.04746391 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bone marrow cancer DOID_4960 8.784E-04 4.384E-03 0.17045715 0.64660077 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Legionnaires' disease DOID_10457 9.412E-04 4.657E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP legionellosis DOID_10458 9.412E-04 4.657E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP aspergillosis DOID_13564 9.412E-04 4.617E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP eyelid disease DOID_530 9.412E-04 4.577E-03 0.04483807 0.39250554 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP mitochondrial metabolism disease DOID_700 9.713E-04 4.684E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP renovascular hypertension DOID_1591 1.084E-03 5.181E-03 0.04796338 0.41350249 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP varicose veins DOID_799 1.084E-03 5.138E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP intermediate coronary syndrome DOID_8805 1.084E-03 5.096E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hyperhomocysteinemia DOID_9279 1.084E-03 5.054E-03 0.04796338 0.38987378 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP vein disease DOID_866 1.236E-03 5.717E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP congenital heart defect DOID_1682 1.345E-03 6.17E-03 0.01986148 0.28252955 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hyperostosis DOID_205 1.398E-03 6.362E-03 1.398E-03 0.07229348 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP uterine disease DOID_345 1.466E-03 6.619E-03 0.19986724 0.73370618 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP temporal lobe epilepsy DOID_3328 1.529E-03 6.849E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP ureteral obstruction DOID_5199 1.569E-03 6.974E-03 0.0572786 0.44645919 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP prion disease DOID_649 1.569E-03 6.92E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Down syndrome DOID_14250 1.75E-03 7.659E-03 0.06036353 0.45795799 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP MHC class II deficiency DOID_5812 1.75E-03 7.6E-03 1.75E-03 0.08296777 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP leishmaniasis DOID_9065 1.75E-03 7.543E-03 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP peripheral vascular disease DOID_341 1.942E-03 8.31E-03 0.21804178 0.77541108 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Kawasaki disease DOID_13378 2.14E-03 9.086E-03 0.06650339 0.4671658 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP lymphadenitis DOID_1602 2.14E-03 9.086E-03 0.06650339 0.4671658 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP autoimmune hepatitis DOID_2048 2.14E-03 9.018E-03 0.06650339 0.46146866 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP lymph node disease DOID_9942 2.14E-03 9.086E-03 0.06650339 0.4671658 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP optic nerve disease DOID_1891 2.567E-03 0.01073896 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP myasthenia gravis DOID_437 2.567E-03 0.01066058 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP urinary tract obstruction DOID_5200 2.567E-03 0.01058333 0.07260345 0.48601607 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pulmonary embolism DOID_9477 2.567E-03 0.01050719 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP polyarteritis nodosa DOID_9810 2.567E-03 0.01043214 0.07260345 0.48036472 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hypoglycemia DOID_9993 2.567E-03 0.01035815 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP chromosomal disease DOID_0080014 2.593E-03 0.01039123 0.0304004 0.38439617 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP female reproductive system disease DOID_229 2.593E-03 0.01031856 0.23831171 0.81686363 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP focal epilepsy DOID_2234 2.774E-03 0.01096312 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Lewy body dementia DOID_12217 2.794E-03 0.01096463 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP ureteral disease DOID_1426 2.794E-03 0.01088953 0.07563864 0.48907258 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Goodpasture syndrome DOID_9808 2.794E-03 0.01081545 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP commensal bacterial infectious disease DOID_0050339 3.276E-03 0.01259562 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP portal hypertension DOID_10762 3.276E-03 0.01251108 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP reading disorder DOID_13365 3.276E-03 0.01242768 3.276E-03 0.09811324 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP urticaria DOID_1555 3.276E-03 0.01234538 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP dyslexia DOID_4428 3.276E-03 0.01242768 3.276E-03 0.09811324 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP nervous system cancer DOID_3093 3.47E-03 0.01298825 0.26049292 0.87188512 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP neuromuscular junction disease DOID_439 3.531E-03 0.01313066 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP ankylosing spondylitis DOID_7147 3.531E-03 0.01304539 0.08468521 0.5295152 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hypotrichosis DOID_4535 3.794E-03 0.01392849 0.08768117 0.51433594 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP diffuse large B-cell lymphoma DOID_0050745 4.067E-03 0.01483264 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Sciatic Neuropathy DOID_11446 4.067E-03 0.01473817 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP gestational diabetes DOID_11714 4.067E-03 0.01464489 0.09066741 0.51589754 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP lesion of sciatic nerve DOID_12528 4.067E-03 0.01473817 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP mononeuritis of lower limb DOID_9473 4.067E-03 0.01473817 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP mononeuritis DOID_1802 4.348E-03 0.01555904 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hepatic vascular disease DOID_272 4.348E-03 0.0154618 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP invasive ductal carcinoma DOID_3008 4.348E-03 0.01536576 4.348E-03 0.09895549 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP autoimmune disease of the nervous system DOID_438 4.348E-03 0.01527091 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP mononeuropathy DOID_1188 4.638E-03 0.01618936 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP focal glomerulosclerosis DOID_3945 4.638E-03 0.01609065 0.09661082 0.51859958 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cranial nerve disease DOID_5656 4.638E-03 0.01599313 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP opportunistic mycosis DOID_2473 5.244E-03 0.01797374 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP celiac disease DOID_10608 5.56E-03 0.01894234 5.56E-03 0.11297752 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP systemic mycosis DOID_0050136 6.217E-03 0.02105563 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP fungal infectious disease DOID_1564 6.217E-03 0.02105563 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hair disease DOID_421 6.217E-03 0.02093104 0.1113013 0.54595207 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP thyroid carcinoma DOID_3963 6.558E-03 0.02195015 0.11421084 0.54154971 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP spindle cell carcinoma DOID_4015 6.558E-03 0.02182178 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hyperthyroidism DOID_7998 6.558E-03 0.02169491 0.11421084 0.5370741 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP thyroid cancer DOID_1781 7.266E-03 0.02389656 0.12000159 0.55967954 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP adolescence-adult electroclinical syndrome DOID_0050705 7.632E-03 0.02495655 0.12288287 0.56387381 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP congenital diaphragmatic hernia DOID_3827 8.388E-03 0.0272745 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP lymphatic system disease DOID_75 8.779E-03 0.02838203 0.13147068 0.57543704 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP endometriosis of uterus DOID_288 9.584E-03 0.03080947 0.1371495 0.5957104 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP nephrotic syndrome DOID_1184 9.998E-03 0.03196097 0.13997508 0.60337741 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP endometriosis DOID_289 9.998E-03 0.03178242 0.13997508 0.59437178 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP diabetic autonomic neuropathy DOID_11503 0.01042055 0.03294051 0.14279148 0.60183964 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP autonomic neuropathy DOID_11504 0.01042055 0.03294051 0.14279148 0.60183964 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP diabetic polyneuropathy DOID_12785 0.01042055 0.03294051 0.14279148 0.60183964 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP gallbladder cancer DOID_3121 0.01042055 0.03275852 0.14279148 0.59741435 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP diabetic neuropathy DOID_9743 0.01042055 0.03294051 0.14279148 0.60183964 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP leukodystrophy DOID_10579 0.01128829 0.03529141 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP autonomic nervous system disease DOID_11465 0.01173371 0.03648349 0.15118591 0.61446274 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP brain cancer DOID_1319 0.01173371 0.03628521 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP thyroid adenoma DOID_2891 0.01173371 0.03608907 0.15118591 0.61010485 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP heart valve disease DOID_4079 0.01173371 0.03589504 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP central nervous system cancer DOID_3620 0.01218675 0.0370816 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hemolytic anemia DOID_583 0.01218675 0.03688436 0.15396589 0.61263352 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP normocytic anemia DOID_720 0.01218675 0.03688436 0.15396589 0.61263352 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP B-cell lymphocytic neoplasm DOID_707 0.01359109 0.04091709 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hypertrophic cardiomyopathy DOID_11984 0.01712487 0.05128447 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP leukocyte disease DOID_9500 0.0176583 0.05260508 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP carotid artery disease DOID_3407 0.0187461 0.05555484 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP endocrine pancreas disease DOID_1428 0.02042939 0.06022965 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP cerebral degeneration DOID_1443 0.02100405 0.06160466 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP endocrine organ benign neoplasm DOID_0060089 0.022768 0.06643587 0.20770707 0.75277277 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP electroclinical syndrome DOID_0050701 0.02840838 0.08247127 0.2307723 0.80557938 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP DiGeorge syndrome DOID_11198 0.02905818 0.08392947 0.02905818 0.3757751 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP velocardiofacial syndrome DOID_12583 0.02905818 0.08392947 0.02905818 0.3757751 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP metabolic syndrome X DOID_14221 0.02973035 0.08543721 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP alcohol abuse DOID_1574 0.03175841 0.09080671 0.24329721 0.82895876 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP biliary tract cancer DOID_4607 0.03175841 0.09035268 0.24329721 0.82402448 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP brachydactyly DOID_0050581 0.03223471 0.09125149 0.03223471 0.39872933 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP facioscapulohumeral muscular dystrophy DOID_11727 0.03223471 0.09079975 0.03223471 0.38211561 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hypolipoproteinemia DOID_1387 0.03223471 0.09035246 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP retinal vascular occlusion DOID_1729 0.03223471 0.08990956 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP chondrosarcoma DOID_3371 0.03223471 0.08947097 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Hermansky-Pudlak syndrome DOID_3753 0.03223471 0.08903665 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.03223471 0.08860652 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.03223471 0.08860652 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Hodgkin's granuloma DOID_8651 0.03223471 0.08860652 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.03223471 0.08860652 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP alopecia areata DOID_986 0.03223471 0.08818053 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP bone development disease DOID_0080006 0.03244628 0.0883346 0.03244628 0.36199867 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP transitional cell carcinoma DOID_2671 0.03525578 0.09552637 0.2556198 0.86063709 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP familial adenomatous polyposis DOID_0050424 0.03540093 0.09546506 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP breast benign neoplasm DOID_0060082 0.03540093 0.09501476 0.03540093 0.38736785 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP thoracic benign neoplasm DOID_0060097 0.03540093 0.09501476 0.03540093 0.38736785 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP trypanosomiasis DOID_10113 0.03540093 0.09456868 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP adrenoleukodystrophy DOID_10588 0.03540093 0.09412677 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP pneumocystosis DOID_11339 0.03540093 0.09368897 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP prediabetes syndrome DOID_11716 0.03540093 0.09325522 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP benign breast phyllodes tumor DOID_1631 0.03540093 0.09501476 0.03540093 0.38736785 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP hemochromatosis DOID_2352 0.03540093 0.09282548 0.03540093 0.3730209 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP lymphoma DOID_0060058 0.03815599 0.09959064 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP intracranial arteriosclerosis DOID_13097 0.03855687 0.09972209 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP diarrhea DOID_13250 0.03855687 0.09927086 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP epidermolysis bullosa DOID_2730 0.03855687 0.0988237 0.03855687 0.38489229 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP stomach disease DOID_76 0.03855687 0.09838054 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP Hodgkin's lymphoma DOID_8567 0.03855687 0.09794134 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP vascular dementia DOID_8725 0.03855687 0.09972209 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP carbohydrate metabolic disorder DOID_2978 0.03889489 0.09836086 0.26774332 0.88573225 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP encephalomyelitis DOID_640 0.03889489 0.09792563 1.000 1.000 ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.03963924 0.09936004 0.27014441 0.88850966 CHIBA_RESPONSE_TO_TSA Paget's disease of bone DOID_5408 3.292E-05 0.01873162 3.292E-05 0.01873162 CHIBA_RESPONSE_TO_TSA hyperostosis DOID_205 9.911E-05 0.02819778 9.911E-05 0.02819778 CHIBA_RESPONSE_TO_TSA myositis DOID_633 2.544E-04 0.04825316 0.02324626 0.52908493 CHIBA_RESPONSE_TO_TSA papilloma DOID_2615 4.544E-04 0.06463862 4.544E-04 0.08618482 PROVENZANI_METASTASIS_DN transitional cell carcinoma DOID_2671 9.73E-12 5.536E-09 7.424E-04 0.14081103 PROVENZANI_METASTASIS_DN invasive lobular carcinoma DOID_3457 4.367E-09 1.242E-06 0.02126579 0.43215117 PROVENZANI_METASTASIS_DN multiple myeloma DOID_9538 1.159E-06 2.198E-04 1.000 1.000 PROVENZANI_METASTASIS_DN uterine cancer DOID_363 2.238E-06 3.184E-04 3.839E-03 0.18201499 PROVENZANI_METASTASIS_DN myeloma DOID_0070004 2.877E-06 3.274E-04 1.000 1.000 PROVENZANI_METASTASIS_DN giant cell tumor DOID_200 4.548E-06 4.313E-04 0.10371334 0.71099871 PROVENZANI_METASTASIS_DN malignant giant cell tumor DOID_2705 4.548E-06 4.313E-04 0.10371334 0.71099871 PROVENZANI_METASTASIS_DN giant cell glioblastoma DOID_3074 4.548E-06 4.313E-04 0.10371334 0.71099871 PROVENZANI_METASTASIS_DN bone marrow cancer DOID_4960 4.884E-06 3.97E-04 1.000 1.000 PROVENZANI_METASTASIS_DN glioblastoma DOID_3068 6.414E-06 4.562E-04 0.11244005 0.71885829 PROVENZANI_METASTASIS_DN oral cavity cancer DOID_8618 6.414E-06 4.055E-04 6.385E-03 0.17300021 PROVENZANI_METASTASIS_DN astrocytoma DOID_3069 1.244E-05 7.079E-04 0.13134484 0.7704661 PROVENZANI_METASTASIS_DN lung adenocarcinoma DOID_3910 2.515E-05 1.301E-03 0.05510601 0.59160978 PROVENZANI_METASTASIS_DN endometrial carcinoma DOID_2871 3.4E-05 1.612E-03 1.795E-03 0.12766311 PROVENZANI_METASTASIS_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.878E-05 1.697E-03 1.000 1.000 PROVENZANI_METASTASIS_DN endometrial cancer DOID_1380 4.09E-05 1.662E-03 2.025E-03 0.12802603 PROVENZANI_METASTASIS_DN nephroblastoma DOID_2154 5.288E-05 2.006E-03 0.0697731 0.6508343 PROVENZANI_METASTASIS_DN adult respiratory distress syndrome DOID_11394 8.329E-05 2.962E-03 1.000 1.000 PROVENZANI_METASTASIS_DN intracranial arterial disease DOID_13089 8.329E-05 2.788E-03 0.08062581 0.68471767 PROVENZANI_METASTASIS_DN cerebral arterial disease DOID_3527 8.329E-05 2.788E-03 0.08062581 0.68471767 PROVENZANI_METASTASIS_DN cervix uteri carcinoma in situ DOID_8991 8.926E-05 2.822E-03 3.372E-03 0.17442228 PROVENZANI_METASTASIS_DN cataract DOID_83 1.159E-04 3.471E-03 4E-03 0.17509819 PROVENZANI_METASTASIS_DN pre-eclampsia DOID_10591 1.31E-04 3.727E-03 4.334E-03 0.16438698 PROVENZANI_METASTASIS_DN lens disease DOID_110 1.31E-04 3.549E-03 4.334E-03 0.15411279 PROVENZANI_METASTASIS_DN brain cancer DOID_1319 1.31E-04 3.388E-03 0.09312951 0.69724595 PROVENZANI_METASTASIS_DN central nervous system cancer DOID_3620 1.39E-04 3.438E-03 0.09490201 0.6835347 PROVENZANI_METASTASIS_DN lung small cell carcinoma DOID_5409 1.473E-04 3.492E-03 4.679E-03 0.14791104 PROVENZANI_METASTASIS_DN acute kidney failure DOID_3021 1.674E-04 3.811E-03 0.01935111 0.42349168 PROVENZANI_METASTASIS_DN epidermolysis bullosa DOID_2730 2.45E-04 5.361E-03 2.45E-04 0.13937752 PROVENZANI_METASTASIS_DN respiratory failure DOID_11162 2.859E-04 6.024E-03 1.000 1.000 PROVENZANI_METASTASIS_DN vesiculobullous skin disease DOID_2731 2.891E-04 5.875E-03 2.891E-04 0.0822553 PROVENZANI_METASTASIS_DN pre-malignant neoplasm DOID_0060071 2.99E-04 5.867E-03 7.437E-03 0.19234982 PROVENZANI_METASTASIS_DN in situ carcinoma DOID_8719 2.99E-04 5.867E-03 7.437E-03 0.19234982 PROVENZANI_METASTASIS_DN cholestasis DOID_13580 3.266E-04 6.194E-03 0.12451678 0.75372391 PROVENZANI_METASTASIS_DN parasitic infectious disease DOID_1398 3.266E-04 5.995E-03 1.000 1.000 PROVENZANI_METASTASIS_DN parasitic helminthiasis infectious disease DOID_883 3.369E-04 5.99E-03 1.000 1.000 PROVENZANI_METASTASIS_DN nephrosis DOID_2527 4.189E-04 7.223E-03 0.13473914 0.78231193 PROVENZANI_METASTASIS_DN bile duct disease DOID_4138 4.189E-04 7.011E-03 0.13473914 0.77440979 PROVENZANI_METASTASIS_DN peripheral vascular disease DOID_341 4.358E-04 7.084E-03 0.13643138 0.77629454 PROVENZANI_METASTASIS_DN biliary tract disease DOID_9741 4.358E-04 6.887E-03 0.13643138 0.76860845 PROVENZANI_METASTASIS_DN tongue cancer DOID_8649 4.431E-04 6.814E-03 0.03078397 0.51517884 PROVENZANI_METASTASIS_DN aneurysm disease DOID_2403 5.075E-04 7.599E-03 0.14316775 0.7832928 PROVENZANI_METASTASIS_DN mixed glioma DOID_5076 5.265E-04 7.682E-03 1.000 1.000 PROVENZANI_METASTASIS_DN granulosa cell tumor DOID_2999 6.291E-04 8.948E-03 0.03645099 0.54580565 PROVENZANI_METASTASIS_DN sex cord-gonadal stromal tumor DOID_192 6.981E-04 9.688E-03 0.03833273 0.55926464 PROVENZANI_METASTASIS_DN nervous system cancer DOID_3093 7.914E-04 0.01072142 0.16470496 0.8442984 PROVENZANI_METASTASIS_DN lingual-facial-buccal dyskinesia DOID_9854 9.26E-04 0.01225352 9.26E-04 0.13172531 PROVENZANI_METASTASIS_DN diabetic angiopathy DOID_11713 1.009E-03 0.01304717 1.000 1.000 PROVENZANI_METASTASIS_DN intracranial aneurysm DOID_10941 1.375E-03 0.01738383 0.05325666 0.60606074 PROVENZANI_METASTASIS_DN vitiligo DOID_12306 1.375E-03 0.01700592 1.000 1.000 PROVENZANI_METASTASIS_DN fragments of torsion dystonia DOID_531 1.375E-03 0.0166441 1.375E-03 0.1564545 PROVENZANI_METASTASIS_DN autoimmune disease of cardiovascular system DOID_0060051 1.578E-03 0.01870759 1.000 1.000 PROVENZANI_METASTASIS_DN Behcet's disease DOID_13241 1.578E-03 0.01870759 1.000 1.000 PROVENZANI_METASTASIS_DN central nervous system hereditary degenerative disease DOID_481 1.578E-03 0.0183258 1.578E-03 0.14966073 PROVENZANI_METASTASIS_DN dystonic disease DOID_544 1.685E-03 0.01917365 1.685E-03 0.13695461 PROVENZANI_METASTASIS_DN corneal disease DOID_10124 1.795E-03 0.02002559 0.06063271 0.62727293 PROVENZANI_METASTASIS_DN germinoma DOID_3304 2.025E-03 0.02215835 0.06429945 0.63079975 PROVENZANI_METASTASIS_DN embryonal cancer DOID_688 2.794E-03 0.0299993 0.07521516 0.66870975 PROVENZANI_METASTASIS_DN microcephaly DOID_10907 2.934E-03 0.03091471 2.934E-03 0.16693941 PROVENZANI_METASTASIS_DN adenoid cystic carcinoma DOID_4866 3.223E-03 0.03334077 0.08062581 0.6746483 PROVENZANI_METASTASIS_DN benign mesothelioma DOID_2645 3.372E-03 0.03426152 0.08242241 0.67968623 PROVENZANI_METASTASIS_DN salivary gland cancer DOID_8850 3.524E-03 0.0351817 0.08421555 0.68455208 PROVENZANI_METASTASIS_DN nephrotic syndrome DOID_1184 3.68E-03 0.03610122 0.08600523 0.68925315 PROVENZANI_METASTASIS_DN Huntington's disease DOID_12858 3.68E-03 0.03548934 0.08600523 0.67968019 PROVENZANI_METASTASIS_DN learning disability DOID_8927 4E-03 0.03793794 4E-03 0.16259118 PROVENZANI_METASTASIS_DN proteinuria DOID_576 4.165E-03 0.03885498 1.000 1.000 PROVENZANI_METASTASIS_DN heart valve disease DOID_4079 4.334E-03 0.03977104 0.09312951 0.6881908 PROVENZANI_METASTASIS_DN bone marrow disease DOID_4961 4.334E-03 0.03913976 4.334E-03 0.14504734 PROVENZANI_METASTASIS_DN glaucoma DOID_1686 4.679E-03 0.04159998 1.000 1.000 PROVENZANI_METASTASIS_DN movement disease DOID_480 4.856E-03 0.04251273 4.856E-03 0.1454383 PROVENZANI_METASTASIS_DN atrophic muscular disease DOID_913 5.407E-03 0.04661452 0.10371334 0.70253444 PROVENZANI_METASTASIS_DN muscular dystrophy DOID_9884 5.407E-03 0.04661452 0.10371334 0.70253444 PROVENZANI_METASTASIS_DN vasculitis DOID_865 5.597E-03 0.04752876 1.000 1.000 PROVENZANI_METASTASIS_DN pustulosis of palm and sole DOID_4398 5.789E-03 0.04844136 0.10721414 0.70935865 PROVENZANI_METASTASIS_DN congenital nervous system abnormality DOID_2490 6.183E-03 0.05098997 6.183E-03 0.17591541 PROVENZANI_METASTASIS_DN hypertrophic cardiomyopathy DOID_11984 6.385E-03 0.05190006 0.11244005 0.72702714 PROVENZANI_METASTASIS_DN melancholia DOID_2848 6.589E-03 0.05280832 0.11417531 0.72184165 PROVENZANI_METASTASIS_DN neurotic disorder DOID_4964 6.797E-03 0.05371472 0.11590721 0.72473852 PROVENZANI_METASTASIS_DN hypothyroidism DOID_1459 7.221E-03 0.05628245 0.11936102 0.73028407 PROVENZANI_METASTASIS_DN mineral metabolism disease DOID_0050032 7.656E-03 0.05887066 7.656E-03 0.18940994 PROVENZANI_METASTASIS_DN brain infarction DOID_3454 8.562E-03 0.06495709 1.000 1.000 PROVENZANI_METASTASIS_DN diabetic retinopathy DOID_8947 9.758E-03 0.0730582 1.000 1.000 PROVENZANI_METASTASIS_DN endogenous depression DOID_1595 0.01025633 0.07579025 0.14148853 0.78928408 PROVENZANI_METASTASIS_DN mental depression DOID_1596 0.01208637 0.08816851 0.15317523 0.81454865 PROVENZANI_METASTASIS_DN retinal vascular disease DOID_2462 0.01263362 0.09099404 1.000 1.000 BEIER_GLIOMA_STEM_CELL_UP familial hypercholesterolemia DOID_13810 5.464E-05 0.031091 0.01097102 0.48019304 BEIER_GLIOMA_STEM_CELL_UP uterine cancer DOID_363 2.538E-04 0.07220608 1.000 1.000 BEIER_GLIOMA_STEM_CELL_UP osteochondrodysplasia DOID_2256 3.868E-04 0.07336729 3.868E-04 0.22010188 BEIER_GLIOMA_STEM_CELL_UP familial hyperlipidemia DOID_1168 4.003E-04 0.05693918 0.02916555 0.47414852 BEIER_GLIOMA_STEM_CELL_UP retinitis pigmentosa DOID_10584 4.279E-04 0.04869034 0.03013995 0.46350354 BEIER_GLIOMA_STEM_CELL_UP lipid metabolism disorder DOID_3146 7.716E-04 0.07317382 0.04031535 0.5734859 BEIER_GLIOMA_STEM_CELL_UP bone development disease DOID_0080006 8.482E-04 0.06894595 8.482E-04 0.24131082 HSIAO_LIVER_SPECIFIC_GENES lipid metabolism disorder DOID_3146 1.697E-28 9.655E-26 1.187E-26 6.757E-24 HSIAO_LIVER_SPECIFIC_GENES blood coagulation disease DOID_1247 7.549E-26 2.148E-23 7.549E-26 2.148E-23 HSIAO_LIVER_SPECIFIC_GENES thrombophilia DOID_2452 3.964E-25 7.519E-23 3.964E-25 7.519E-23 HSIAO_LIVER_SPECIFIC_GENES familial hyperlipidemia DOID_1168 7.559E-24 1.075E-21 5.925E-22 8.428E-20 HSIAO_LIVER_SPECIFIC_GENES amino acid metabolic disorder DOID_9252 1.562E-20 1.778E-18 1.562E-20 1.778E-18 HSIAO_LIVER_SPECIFIC_GENES chronic kidney failure DOID_784 2.386E-19 2.263E-17 4.477E-16 2.831E-14 HSIAO_LIVER_SPECIFIC_GENES cholestasis DOID_13580 3.772E-19 3.066E-17 2.047E-17 1.941E-15 HSIAO_LIVER_SPECIFIC_GENES bile duct disease DOID_4138 1.36E-18 9.673E-17 6.653E-17 5.408E-15 HSIAO_LIVER_SPECIFIC_GENES biliary tract disease DOID_9741 1.665E-18 1.053E-16 8.013E-17 5.699E-15 HSIAO_LIVER_SPECIFIC_GENES retinal vascular disease DOID_2462 1.524E-17 8.674E-16 2.259E-14 1.071E-12 HSIAO_LIVER_SPECIFIC_GENES metabolic syndrome X DOID_14221 2.739E-16 1.417E-14 1.079E-14 6.137E-13 HSIAO_LIVER_SPECIFIC_GENES familial hypercholesterolemia DOID_13810 7.748E-16 3.674E-14 1.033E-13 4.199E-12 HSIAO_LIVER_SPECIFIC_GENES diabetic retinopathy DOID_8947 4.145E-15 1.814E-13 5.644E-12 1.606E-10 HSIAO_LIVER_SPECIFIC_GENES vasculitis DOID_865 5.646E-15 2.295E-13 2.772E-13 9.858E-12 HSIAO_LIVER_SPECIFIC_GENES inherited blood coagulation disease DOID_2214 1.438E-14 5.456E-13 1.438E-14 7.44E-13 HSIAO_LIVER_SPECIFIC_GENES pre-eclampsia DOID_10591 6.797E-14 2.417E-12 6.797E-14 2.975E-12 HSIAO_LIVER_SPECIFIC_GENES nephrosis DOID_2527 1.188E-13 3.977E-12 4.285E-12 1.283E-10 HSIAO_LIVER_SPECIFIC_GENES peripheral vascular disease DOID_341 1.386E-13 4.382E-12 1.557E-10 3.408E-09 HSIAO_LIVER_SPECIFIC_GENES pulmonary embolism DOID_9477 1.578E-13 4.724E-12 1.578E-13 5.984E-12 HSIAO_LIVER_SPECIFIC_GENES hepatitis DOID_2237 6.372E-13 1.813E-11 3.501E-11 9.487E-10 HSIAO_LIVER_SPECIFIC_GENES respiratory failure DOID_11162 1.11E-12 3.008E-11 4.138E-11 1.07E-09 HSIAO_LIVER_SPECIFIC_GENES hyperglycemia DOID_4195 2.072E-12 5.36E-11 2.072E-12 6.936E-11 HSIAO_LIVER_SPECIFIC_GENES hypolipoproteinemia DOID_1387 3.023E-12 7.479E-11 3.023E-12 9.556E-11 HSIAO_LIVER_SPECIFIC_GENES vascular skin disease DOID_9540 3.459E-12 8.201E-11 1.539E-10 3.503E-09 HSIAO_LIVER_SPECIFIC_GENES spastic cerebral palsy DOID_0050669 4.28E-12 9.742E-11 2.719E-10 5.731E-09 HSIAO_LIVER_SPECIFIC_GENES bacterial pneumonia DOID_874 9.569E-12 2.094E-10 7.311E-09 1.156E-07 HSIAO_LIVER_SPECIFIC_GENES carotid artery disease DOID_3407 3.58E-11 7.545E-10 1.195E-09 2.345E-08 HSIAO_LIVER_SPECIFIC_GENES carbohydrate metabolic disorder DOID_2978 5.504E-11 1.118E-09 5.504E-11 1.362E-09 HSIAO_LIVER_SPECIFIC_GENES nephrotic syndrome DOID_1184 7.609E-11 1.493E-09 7.609E-11 1.804E-09 HSIAO_LIVER_SPECIFIC_GENES autoimmune disease of cardiovascular system DOID_0060051 1.312E-10 2.489E-09 7.865E-09 1.209E-07 HSIAO_LIVER_SPECIFIC_GENES Behcet's disease DOID_13241 1.312E-10 2.489E-09 7.865E-09 1.209E-07 HSIAO_LIVER_SPECIFIC_GENES pancreatitis DOID_4989 2.814E-10 5.165E-09 7.311E-09 1.189E-07 HSIAO_LIVER_SPECIFIC_GENES amyloidosis DOID_9120 5.352E-10 9.517E-09 4.375E-08 5.789E-07 HSIAO_LIVER_SPECIFIC_GENES angioedema DOID_1558 7.406E-10 1.277E-08 7.406E-10 1.505E-08 HSIAO_LIVER_SPECIFIC_GENES uveitis DOID_13141 1.383E-09 2.315E-08 5.689E-08 7.357E-07 HSIAO_LIVER_SPECIFIC_GENES endocrine pancreas disease DOID_1428 1.739E-09 2.827E-08 1.739E-09 3.298E-08 HSIAO_LIVER_SPECIFIC_GENES parasitic infectious disease DOID_1398 1.962E-09 3.102E-08 2.42E-05 2.119E-04 HSIAO_LIVER_SPECIFIC_GENES adult respiratory distress syndrome DOID_11394 1.966E-09 3.024E-08 1.966E-09 3.609E-08 HSIAO_LIVER_SPECIFIC_GENES spastic quadriplegia DOID_10970 2.395E-09 3.586E-08 1.469E-07 1.817E-06 HSIAO_LIVER_SPECIFIC_GENES urticaria DOID_1555 3.101E-09 4.524E-08 3.101E-09 5.513E-08 HSIAO_LIVER_SPECIFIC_GENES hyperinsulinism DOID_2018 3.225E-09 4.587E-08 3.225E-09 5.56E-08 HSIAO_LIVER_SPECIFIC_GENES uveal disease DOID_3480 3.225E-09 4.475E-08 1.161E-07 1.468E-06 HSIAO_LIVER_SPECIFIC_GENES intracranial thrombosis DOID_4193 3.736E-09 5.062E-08 3.736E-09 6.253E-08 HSIAO_LIVER_SPECIFIC_GENES proteinuria DOID_576 5.11E-09 6.762E-08 4.782E-06 4.947E-05 HSIAO_LIVER_SPECIFIC_GENES nutritional deficiency disease DOID_5113 8.647E-09 1.118E-07 5.393E-05 4.262E-04 HSIAO_LIVER_SPECIFIC_GENES hemorrhagic disease DOID_2213 1.032E-08 1.304E-07 1.032E-08 1.545E-07 HSIAO_LIVER_SPECIFIC_GENES alcohol abuse DOID_1574 1.188E-08 1.47E-07 1.188E-08 1.733E-07 HSIAO_LIVER_SPECIFIC_GENES hemolytic-uremic syndrome DOID_12554 1.253E-08 1.517E-07 1.253E-08 1.782E-07 HSIAO_LIVER_SPECIFIC_GENES lymphatic system cancer DOID_0060073 1.767E-08 2.095E-07 1.767E-08 2.453E-07 HSIAO_LIVER_SPECIFIC_GENES reticulosarcoma DOID_8538 1.767E-08 2.095E-07 1.767E-08 2.453E-07 HSIAO_LIVER_SPECIFIC_GENES lymphosarcoma DOID_8675 1.767E-08 2.095E-07 1.767E-08 2.453E-07 HSIAO_LIVER_SPECIFIC_GENES pneumoconiosis DOID_10316 2.991E-08 3.473E-07 2.991E-08 4.052E-07 HSIAO_LIVER_SPECIFIC_GENES hypersensitivity reaction type I disease DOID_1205 3.39E-08 3.858E-07 6.241E-07 7.102E-06 HSIAO_LIVER_SPECIFIC_GENES membranous glomerulonephritis DOID_10976 4.375E-08 4.881E-07 2.781E-06 2.986E-05 HSIAO_LIVER_SPECIFIC_GENES brain infarction DOID_3454 7.21E-08 7.889E-07 1.6E-06 1.75E-05 HSIAO_LIVER_SPECIFIC_GENES meningitis DOID_9471 1.18E-07 1.267E-06 6.004E-06 5.994E-05 HSIAO_LIVER_SPECIFIC_GENES interstitial nephritis DOID_1063 1.254E-07 1.321E-06 1.449E-05 1.374E-04 HSIAO_LIVER_SPECIFIC_GENES familial combined hyperlipidemia DOID_13809 1.254E-07 1.297E-06 1.449E-05 1.351E-04 HSIAO_LIVER_SPECIFIC_GENES female reproductive system disease DOID_229 2.14E-07 2.174E-06 2.14E-07 2.59E-06 HSIAO_LIVER_SPECIFIC_GENES hemolytic anemia DOID_583 2.186E-07 2.182E-06 2.186E-07 2.591E-06 HSIAO_LIVER_SPECIFIC_GENES normocytic anemia DOID_720 2.186E-07 2.182E-06 2.186E-07 2.591E-06 HSIAO_LIVER_SPECIFIC_GENES primary bacterial infectious disease DOID_0050338 3.462E-07 3.397E-06 8.853E-05 6.807E-04 HSIAO_LIVER_SPECIFIC_GENES renal hypertension DOID_1073 3.861E-07 3.723E-06 1.513E-05 1.366E-04 HSIAO_LIVER_SPECIFIC_GENES secondary hypertension DOID_11130 3.861E-07 3.723E-06 1.513E-05 1.366E-04 HSIAO_LIVER_SPECIFIC_GENES primary immunodeficiency disease DOID_612 4.033E-07 3.825E-06 4.033E-07 4.683E-06 HSIAO_LIVER_SPECIFIC_GENES pustulosis of palm and sole DOID_4398 4.772E-07 4.451E-06 3.122E-03 0.01377176 HSIAO_LIVER_SPECIFIC_GENES age related macular degeneration DOID_10871 6.352E-07 5.829E-06 6.051E-04 3.55E-03 HSIAO_LIVER_SPECIFIC_GENES degeneration of macula and posterior pole DOID_2007 6.352E-07 5.829E-06 6.051E-04 3.55E-03 HSIAO_LIVER_SPECIFIC_GENES bile duct cancer DOID_4606 6.465E-07 5.839E-06 1.421E-05 1.37E-04 HSIAO_LIVER_SPECIFIC_GENES bile duct carcinoma DOID_4897 6.465E-07 5.839E-06 1.421E-05 1.37E-04 HSIAO_LIVER_SPECIFIC_GENES spastic diplegia DOID_10965 1.061E-06 9.435E-06 1.061E-06 1.184E-05 HSIAO_LIVER_SPECIFIC_GENES macular degeneration DOID_4448 1.148E-06 1.005E-05 8.492E-04 4.737E-03 HSIAO_LIVER_SPECIFIC_GENES hyperthyroidism DOID_7998 1.148E-06 9.895E-06 3.547E-05 2.925E-04 HSIAO_LIVER_SPECIFIC_GENES tuberculosis DOID_399 1.6E-06 1.359E-05 4.569E-04 2.708E-03 HSIAO_LIVER_SPECIFIC_GENES aneurysm disease DOID_2403 3.003E-06 2.513E-05 5.005E-05 4.011E-04 HSIAO_LIVER_SPECIFIC_GENES autoimmune hepatitis DOID_2048 3.422E-06 2.822E-05 1.542E-04 1.07E-03 HSIAO_LIVER_SPECIFIC_GENES contact dermatitis DOID_2773 3.737E-06 3.037E-05 3.737E-06 3.937E-05 HSIAO_LIVER_SPECIFIC_GENES cerebral infarction DOID_3526 4.312E-06 3.455E-05 1.001E-04 7.396E-04 HSIAO_LIVER_SPECIFIC_GENES biliary tract cancer DOID_4607 4.609E-06 3.643E-05 7.11E-05 5.542E-04 HSIAO_LIVER_SPECIFIC_GENES glycogen metabolism disorder DOID_0050728 5.023E-06 3.916E-05 5.023E-06 5.104E-05 HSIAO_LIVER_SPECIFIC_GENES glycogen storage disease DOID_2747 5.023E-06 3.916E-05 5.023E-06 5.104E-05 HSIAO_LIVER_SPECIFIC_GENES autoimmune disease of gastrointestinal tract DOID_0060031 6.439E-06 4.951E-05 1.371E-04 9.631E-04 HSIAO_LIVER_SPECIFIC_GENES pulmonary tuberculosis DOID_2957 6.439E-06 4.885E-05 2.286E-03 0.01074952 HSIAO_LIVER_SPECIFIC_GENES Human immunodeficiency virus infectious disease DOID_526 7.3E-06 5.465E-05 1.036E-04 7.559E-04 HSIAO_LIVER_SPECIFIC_GENES parasitic protozoa infectious disease DOID_2789 1.108E-05 8.187E-05 3.122E-03 0.01387935 HSIAO_LIVER_SPECIFIC_GENES lung adenocarcinoma DOID_3910 1.316E-05 9.6E-05 1.316E-05 1.291E-04 HSIAO_LIVER_SPECIFIC_GENES retinal vascular occlusion DOID_1729 1.449E-05 1.044E-04 1.449E-05 1.33E-04 HSIAO_LIVER_SPECIFIC_GENES focal glomerulosclerosis DOID_3945 1.73E-05 1.23E-04 1.73E-05 1.538E-04 HSIAO_LIVER_SPECIFIC_GENES abdominal aortic aneurysm DOID_7693 2.232E-05 1.568E-04 6.051E-04 3.514E-03 HSIAO_LIVER_SPECIFIC_GENES uterine disease DOID_345 2.42E-05 1.68E-04 2.42E-05 2.087E-04 HSIAO_LIVER_SPECIFIC_GENES ocular hypertension DOID_9282 2.637E-05 1.808E-04 1.595E-03 7.963E-03 HSIAO_LIVER_SPECIFIC_GENES borderline glaucoma DOID_9283 2.637E-05 1.808E-04 1.595E-03 7.963E-03 HSIAO_LIVER_SPECIFIC_GENES endocrine organ benign neoplasm DOID_0060089 2.987E-05 2.023E-04 2.987E-05 2.536E-04 HSIAO_LIVER_SPECIFIC_GENES metal metabolism disorder DOID_896 3.176E-05 2.126E-04 7.832E-04 4.457E-03 HSIAO_LIVER_SPECIFIC_GENES carotid stenosis DOID_13001 3.415E-05 2.259E-04 1.879E-03 9.14E-03 HSIAO_LIVER_SPECIFIC_GENES pancreatic ductal carcinoma DOID_3587 3.418E-05 2.235E-04 3.418E-05 2.86E-04 HSIAO_LIVER_SPECIFIC_GENES hepatitis C DOID_1883 3.547E-05 2.293E-04 8.492E-04 4.784E-03 HSIAO_LIVER_SPECIFIC_GENES pancreatic carcinoma DOID_4905 4.153E-05 2.655E-04 4.153E-05 3.376E-04 HSIAO_LIVER_SPECIFIC_GENES parasitic helminthiasis infectious disease DOID_883 4.33E-05 2.738E-04 2.185E-03 0.0103621 HSIAO_LIVER_SPECIFIC_GENES cystic fibrosis DOID_1485 4.707E-05 2.943E-04 6.527E-04 3.752E-03 HSIAO_LIVER_SPECIFIC_GENES endogenous depression DOID_1595 4.707E-05 2.911E-04 7.156E-03 0.02769882 HSIAO_LIVER_SPECIFIC_GENES peptic ulcer DOID_750 5.894E-05 3.606E-04 1.232E-03 6.551E-03 HSIAO_LIVER_SPECIFIC_GENES pulmonary emphysema DOID_9675 7.093E-05 4.294E-04 1.411E-03 7.167E-03 HSIAO_LIVER_SPECIFIC_GENES mental depression DOID_1596 7.11E-05 4.258E-04 9.057E-03 0.03368243 HSIAO_LIVER_SPECIFIC_GENES diabetic autonomic neuropathy DOID_11503 9.211E-05 5.459E-04 9.211E-05 6.988E-04 HSIAO_LIVER_SPECIFIC_GENES autonomic neuropathy DOID_11504 9.211E-05 5.459E-04 9.211E-05 6.988E-04 HSIAO_LIVER_SPECIFIC_GENES diabetic polyneuropathy DOID_12785 9.211E-05 5.459E-04 9.211E-05 6.988E-04 HSIAO_LIVER_SPECIFIC_GENES influenza DOID_8469 9.211E-05 5.403E-04 0.02330083 0.07490492 HSIAO_LIVER_SPECIFIC_GENES diabetic neuropathy DOID_9743 9.211E-05 5.459E-04 9.211E-05 6.988E-04 HSIAO_LIVER_SPECIFIC_GENES glucose intolerance DOID_10603 9.565E-05 5.554E-04 9.565E-05 7.161E-04 HSIAO_LIVER_SPECIFIC_GENES autonomic nervous system disease DOID_11465 1.175E-04 6.756E-04 1.175E-04 8.466E-04 HSIAO_LIVER_SPECIFIC_GENES alcohol-related neurodevelopmental disorder DOID_0050667 1.267E-04 7.211E-04 0.01258886 0.04367721 HSIAO_LIVER_SPECIFIC_GENES Crohn's disease DOID_8778 1.267E-04 7.139E-04 1.417E-03 7.138E-03 HSIAO_LIVER_SPECIFIC_GENES pulmonary edema DOID_11396 1.326E-04 7.4E-04 4.474E-03 0.01899576 HSIAO_LIVER_SPECIFIC_GENES brain edema DOID_4724 1.326E-04 7.328E-04 1.326E-04 9.435E-04 HSIAO_LIVER_SPECIFIC_GENES aortic aneurysm DOID_3627 1.477E-04 8.082E-04 2.414E-03 0.01125976 HSIAO_LIVER_SPECIFIC_GENES hepatitis B DOID_2043 1.779E-04 9.639E-04 1.779E-04 1.219E-03 HSIAO_LIVER_SPECIFIC_GENES placenta disease DOID_780 1.779E-04 9.548E-04 1.779E-04 1.205E-03 HSIAO_LIVER_SPECIFIC_GENES sarcoidosis DOID_11335 1.831E-04 9.738E-04 2.826E-03 0.01275973 HSIAO_LIVER_SPECIFIC_GENES bile duct adenocarcinoma DOID_4896 1.962E-04 1.034E-03 1.962E-04 1.313E-03 HSIAO_LIVER_SPECIFIC_GENES cholangiocarcinoma DOID_4947 1.962E-04 1.034E-03 1.962E-04 1.313E-03 HSIAO_LIVER_SPECIFIC_GENES urinary tract obstruction DOID_5200 2.038E-04 1.064E-03 2.038E-04 1.348E-03 HSIAO_LIVER_SPECIFIC_GENES hypoglycemia DOID_9993 2.038E-04 1.054E-03 2.038E-04 1.333E-03 HSIAO_LIVER_SPECIFIC_GENES diabetic angiopathy DOID_11713 2.321E-04 1.19E-03 6.414E-03 0.02516754 HSIAO_LIVER_SPECIFIC_GENES ureteral disease DOID_1426 2.321E-04 1.179E-03 2.321E-04 1.5E-03 HSIAO_LIVER_SPECIFIC_GENES hypersensitivity reaction type IV disease DOID_2916 2.552E-04 1.285E-03 3.602E-03 0.0156453 HSIAO_LIVER_SPECIFIC_GENES toxic shock syndrome DOID_14115 2.627E-04 1.311E-03 2.627E-04 1.68E-03 HSIAO_LIVER_SPECIFIC_GENES acute pancreatitis DOID_2913 2.627E-04 1.3E-03 2.627E-04 1.661E-03 HSIAO_LIVER_SPECIFIC_GENES melancholia DOID_2848 2.717E-04 1.333E-03 0.03882544 0.12006344 HSIAO_LIVER_SPECIFIC_GENES neurotic disorder DOID_4964 2.89E-04 1.405E-03 0.03996904 0.12227089 HSIAO_LIVER_SPECIFIC_GENES commensal bacterial infectious disease DOID_0050339 2.959E-04 1.427E-03 2.959E-04 1.85E-03 HSIAO_LIVER_SPECIFIC_GENES organic acidemia DOID_0060159 2.959E-04 1.415E-03 2.959E-04 1.83E-03 HSIAO_LIVER_SPECIFIC_GENES bronchiolitis DOID_2942 2.959E-04 1.403E-03 7.503E-03 0.02865142 HSIAO_LIVER_SPECIFIC_GENES hypothyroidism DOID_1459 3.259E-04 1.533E-03 3.259E-04 1.994E-03 HSIAO_LIVER_SPECIFIC_GENES myositis DOID_633 3.317E-04 1.547E-03 3.317E-04 2.008E-03 HSIAO_LIVER_SPECIFIC_GENES extrinsic allergic alveolitis DOID_841 3.701E-04 1.712E-03 8.669E-03 0.03245256 HSIAO_LIVER_SPECIFIC_GENES temporal lobe epilepsy DOID_3328 4.097E-04 1.88E-03 5.093E-03 0.02115152 HSIAO_LIVER_SPECIFIC_GENES gestational diabetes DOID_11714 4.113E-04 1.872E-03 4.113E-04 2.463E-03 HSIAO_LIVER_SPECIFIC_GENES malaria DOID_12365 4.553E-04 2.056E-03 0.13996999 0.28751958 HSIAO_LIVER_SPECIFIC_GENES corneal disease DOID_10124 5.522E-04 2.474E-03 0.01122743 0.03992756 HSIAO_LIVER_SPECIFIC_GENES bronchiolitis obliterans DOID_2799 6.051E-04 2.69E-03 0.01191274 0.04158498 HSIAO_LIVER_SPECIFIC_GENES allergic rhinitis DOID_4481 6.613E-04 2.917E-03 0.01261596 0.04324387 HSIAO_LIVER_SPECIFIC_GENES focal epilepsy DOID_2234 9.017E-04 3.947E-03 9.057E-03 0.03346371 HSIAO_LIVER_SPECIFIC_GENES adenoma DOID_657 9.915E-04 4.307E-03 9.915E-04 5.477E-03 HSIAO_LIVER_SPECIFIC_GENES gallbladder disease DOID_0000000 1.095E-03 4.72E-03 0.04900775 0.14832666 HSIAO_LIVER_SPECIFIC_GENES gout DOID_13189 1.095E-03 4.685E-03 1.095E-03 5.991E-03 HSIAO_LIVER_SPECIFIC_GENES childhood type dermatomyositis DOID_14203 1.095E-03 4.65E-03 1.095E-03 5.934E-03 HSIAO_LIVER_SPECIFIC_GENES bilirubin metabolic disorder DOID_2741 1.095E-03 4.615E-03 1.095E-03 5.878E-03 HSIAO_LIVER_SPECIFIC_GENES acute kidney failure DOID_3021 1.095E-03 4.581E-03 0.04900775 0.14676532 HSIAO_LIVER_SPECIFIC_GENES lymphoma DOID_0060058 1.311E-03 5.447E-03 0.0118963 0.04204345 HSIAO_LIVER_SPECIFIC_GENES lymphatic system disease DOID_75 1.319E-03 5.44E-03 0.19439895 0.36030295 HSIAO_LIVER_SPECIFIC_GENES dermatomyositis DOID_10223 1.334E-03 5.461E-03 1.334E-03 7.028E-03 HSIAO_LIVER_SPECIFIC_GENES hemochromatosis DOID_2352 1.334E-03 5.422E-03 1.334E-03 6.963E-03 HSIAO_LIVER_SPECIFIC_GENES bronchiectasis DOID_9563 1.334E-03 5.383E-03 1.334E-03 6.9E-03 HSIAO_LIVER_SPECIFIC_GENES benign mesothelioma DOID_2645 1.411E-03 5.653E-03 1.411E-03 7.231E-03 HSIAO_LIVER_SPECIFIC_GENES ulcerative colitis DOID_8577 1.647E-03 6.555E-03 1.647E-03 8.151E-03 HSIAO_LIVER_SPECIFIC_GENES essential hypertension DOID_10825 1.879E-03 7.426E-03 1.879E-03 9.218E-03 HSIAO_LIVER_SPECIFIC_GENES larynx cancer DOID_2596 1.879E-03 7.375E-03 1.879E-03 9.062E-03 HSIAO_LIVER_SPECIFIC_GENES laryngeal benign neoplasm DOID_2598 1.879E-03 7.375E-03 1.879E-03 9.062E-03 HSIAO_LIVER_SPECIFIC_GENES thyroid adenoma DOID_2891 2.042E-03 7.959E-03 2.042E-03 9.765E-03 HSIAO_LIVER_SPECIFIC_GENES glaucoma DOID_1686 2.286E-03 8.848E-03 0.02812122 0.08889429 HSIAO_LIVER_SPECIFIC_GENES movement disease DOID_480 2.414E-03 9.282E-03 2.414E-03 0.01116822 HSIAO_LIVER_SPECIFIC_GENES membranoproliferative glomerulonephritis DOID_2920 2.513E-03 9.598E-03 2.513E-03 0.01153251 HSIAO_LIVER_SPECIFIC_GENES intermediate coronary syndrome DOID_8805 2.513E-03 9.534E-03 2.513E-03 0.01144025 HSIAO_LIVER_SPECIFIC_GENES silicosis DOID_10325 2.863E-03 0.01078772 2.863E-03 0.01282635 HSIAO_LIVER_SPECIFIC_GENES bronchitis DOID_6132 3.234E-03 0.01210572 0.08188428 0.19332844 HSIAO_LIVER_SPECIFIC_GENES juvenile rheumatoid arthritis DOID_676 3.234E-03 0.01202659 0.08188428 0.19252956 HSIAO_LIVER_SPECIFIC_GENES peroxisomal disease DOID_906 3.234E-03 0.0119485 3.234E-03 0.01415438 HSIAO_LIVER_SPECIFIC_GENES glioblastoma DOID_3068 3.602E-03 0.0132228 3.602E-03 0.01552677 HSIAO_LIVER_SPECIFIC_GENES ureteral obstruction DOID_5199 3.626E-03 0.01322612 3.626E-03 0.01551334 HSIAO_LIVER_SPECIFIC_GENES Down syndrome DOID_14250 4.039E-03 0.01463972 0.09106816 0.20644534 HSIAO_LIVER_SPECIFIC_GENES leishmaniasis DOID_9065 4.039E-03 0.01454707 0.09106816 0.20481336 HSIAO_LIVER_SPECIFIC_GENES esophagitis DOID_11963 4.474E-03 0.01600901 0.09562577 0.21421678 HSIAO_LIVER_SPECIFIC_GENES blood protein disease DOID_620 4.474E-03 0.01590895 4.474E-03 0.01885505 HSIAO_LIVER_SPECIFIC_GENES mineral metabolism disease DOID_0050032 4.691E-03 0.01657702 4.691E-03 0.01962426 HSIAO_LIVER_SPECIFIC_GENES Kawasaki disease DOID_13378 4.928E-03 0.01730949 0.10016065 0.22349572 HSIAO_LIVER_SPECIFIC_GENES lymphadenitis DOID_1602 4.928E-03 0.01730949 0.10016065 0.22349572 HSIAO_LIVER_SPECIFIC_GENES lymph node disease DOID_9942 4.928E-03 0.01730949 0.10016065 0.22349572 HSIAO_LIVER_SPECIFIC_GENES allergic contact dermatitis DOID_3042 5.301E-03 0.01850601 5.301E-03 0.02185855 HSIAO_LIVER_SPECIFIC_GENES muscular atrophy DOID_767 5.403E-03 0.01874653 5.403E-03 0.02211821 HSIAO_LIVER_SPECIFIC_GENES astrocytoma DOID_3069 5.734E-03 0.01977337 5.734E-03 0.02330433 HSIAO_LIVER_SPECIFIC_GENES sinusitis DOID_0050127 5.898E-03 0.02021801 0.10916266 0.23982066 HSIAO_LIVER_SPECIFIC_GENES sexual disorder DOID_0060043 5.898E-03 0.02009694 5.898E-03 0.02380276 HSIAO_LIVER_SPECIFIC_GENES paranasal sinus disease DOID_1352 5.898E-03 0.02021801 0.10916266 0.23982066 HSIAO_LIVER_SPECIFIC_GENES opiate dependence DOID_2559 5.898E-03 0.01997732 5.898E-03 0.02363514 HSIAO_LIVER_SPECIFIC_GENES IgA glomerulonephritis DOID_2986 5.898E-03 0.01985911 5.898E-03 0.02346986 HSIAO_LIVER_SPECIFIC_GENES polyarteritis nodosa DOID_9810 5.898E-03 0.01974229 0.10916266 0.2361732 HSIAO_LIVER_SPECIFIC_GENES male reproductive system disease DOID_48 6.187E-03 0.02058732 6.187E-03 0.02444744 HSIAO_LIVER_SPECIFIC_GENES Goodpasture syndrome DOID_9808 6.414E-03 0.02121682 6.414E-03 0.02499516 HSIAO_LIVER_SPECIFIC_GENES bone resorption disease DOID_0080011 7.411E-03 0.02437612 7.411E-03 0.02849371 HSIAO_LIVER_SPECIFIC_GENES osteoporosis DOID_11476 7.411E-03 0.02437612 7.411E-03 0.02849371 HSIAO_LIVER_SPECIFIC_GENES papillary adenoma DOID_3172 8.076E-03 0.02641086 8.076E-03 0.0306366 HSIAO_LIVER_SPECIFIC_GENES microcystic adenoma DOID_5403 8.076E-03 0.02641086 8.076E-03 0.0306366 HSIAO_LIVER_SPECIFIC_GENES follicular adenoma DOID_6204 8.076E-03 0.02641086 8.076E-03 0.0306366 HSIAO_LIVER_SPECIFIC_GENES dystonia DOID_543 8.669E-03 0.02818737 8.669E-03 0.03266748 HSIAO_LIVER_SPECIFIC_GENES diffuse large B-cell lymphoma DOID_0050745 9.281E-03 0.03000481 9.281E-03 0.03406998 HSIAO_LIVER_SPECIFIC_GENES perinatal necrotizing enterocolitis DOID_8677 9.281E-03 0.02983529 9.281E-03 0.03385158 HSIAO_LIVER_SPECIFIC_GENES pleurisy DOID_10247 9.911E-03 0.03168284 9.911E-03 0.03592067 HSIAO_LIVER_SPECIFIC_GENES hepatic vascular disease DOID_272 9.911E-03 0.03150584 9.911E-03 0.03569332 HSIAO_LIVER_SPECIFIC_GENES polycystic ovary syndrome DOID_11612 0.01056023 0.03338206 0.01056023 0.03779101 HSIAO_LIVER_SPECIFIC_GENES opportunistic mycosis DOID_2473 0.01191274 0.03744945 0.01191274 0.04184167 HSIAO_LIVER_SPECIFIC_GENES Charcot-Marie-Tooth disease DOID_10595 0.01261596 0.03944221 0.01261596 0.04350595 HSIAO_LIVER_SPECIFIC_GENES dilated cardiomyopathy DOID_12930 0.01294363 0.0402455 0.08544339 0.19763126 HSIAO_LIVER_SPECIFIC_GENES pleural disease DOID_1532 0.01333689 0.04124289 0.01333689 0.04544127 HSIAO_LIVER_SPECIFIC_GENES systemic mycosis DOID_0050136 0.01407534 0.04329119 0.01407534 0.04767185 HSIAO_LIVER_SPECIFIC_GENES fungal infectious disease DOID_1564 0.01407534 0.04329119 0.01407534 0.04767185 HSIAO_LIVER_SPECIFIC_GENES papilloma DOID_2615 0.01407534 0.04305844 0.01407534 0.04738977 HSIAO_LIVER_SPECIFIC_GENES esophageal disease DOID_6050 0.01483112 0.04512786 0.16971734 0.32735311 HSIAO_LIVER_SPECIFIC_GENES leukopenia DOID_615 0.01483112 0.04488782 0.01483112 0.04964064 HSIAO_LIVER_SPECIFIC_GENES pulmonary sarcoidosis DOID_13406 0.01720054 0.05178363 0.18215076 0.34547927 HSIAO_LIVER_SPECIFIC_GENES microcephaly DOID_10907 0.01802374 0.05397637 0.18625393 0.34976399 HSIAO_LIVER_SPECIFIC_GENES blood platelet disease DOID_2218 0.01802374 0.05369377 0.01802374 0.05997374 HSIAO_LIVER_SPECIFIC_GENES congenital diaphragmatic hernia DOID_3827 0.01886334 0.05590229 0.01886334 0.06240256 HSIAO_LIVER_SPECIFIC_GENES systemic scleroderma DOID_418 0.01886334 0.05561264 0.19033663 0.35625508 HSIAO_LIVER_SPECIFIC_GENES intracranial arterial disease DOID_13089 0.01971914 0.05783604 0.19439895 0.36266559 HSIAO_LIVER_SPECIFIC_GENES cerebral arterial disease DOID_3527 0.01971914 0.05783604 0.19439895 0.36266559 HSIAO_LIVER_SPECIFIC_GENES autoimmune disease of urogenital tract DOID_0060049 0.02147865 0.0626736 0.02147865 0.07064365 HSIAO_LIVER_SPECIFIC_GENES primary biliary cirrhosis DOID_12236 0.02147865 0.0626736 0.02147865 0.07064365 HSIAO_LIVER_SPECIFIC_GENES endometriosis of uterus DOID_288 0.02147865 0.06235384 0.02147865 0.07023766 HSIAO_LIVER_SPECIFIC_GENES Huntington's disease DOID_12858 0.02238199 0.06464647 0.02238199 0.07277346 HSIAO_LIVER_SPECIFIC_GENES rheumatic disease DOID_1575 0.02238199 0.06431997 0.20646467 0.38018898 HSIAO_LIVER_SPECIFIC_GENES idiopathic generalized epilepsy DOID_1827 0.02238199 0.06399676 0.20646467 0.37896257 HSIAO_LIVER_SPECIFIC_GENES endometriosis DOID_289 0.02238199 0.06367677 0.02238199 0.07235997 HSIAO_LIVER_SPECIFIC_GENES scleroderma DOID_419 0.02238199 0.06431997 0.20646467 0.38018898 HSIAO_LIVER_SPECIFIC_GENES gallbladder cancer DOID_3121 0.02330083 0.06596105 0.21044649 0.38502911 HSIAO_LIVER_SPECIFIC_GENES learning disability DOID_8927 0.02423497 0.06826584 0.02423497 0.07747023 HSIAO_LIVER_SPECIFIC_GENES myeloma DOID_0070004 0.02614851 0.07329311 0.02614851 0.08312012 HSIAO_LIVER_SPECIFIC_GENES B-cell lymphocytic neoplasm DOID_707 0.03015174 0.0840997 0.03015174 0.0947864 HSIAO_LIVER_SPECIFIC_GENES atopic dermatitis DOID_3310 0.03118826 0.08656643 0.24159378 0.4309306 HSIAO_LIVER_SPECIFIC_GENES bone marrow cancer DOID_4960 0.03330299 0.09198738 0.03330299 0.10411758 ALONSO_METASTASIS_UP aneurysm disease DOID_2403 6.098E-08 3.47E-05 5.436E-05 7.733E-03 ALONSO_METASTASIS_UP transitional cell carcinoma DOID_2671 3.845E-06 1.094E-03 9.046E-05 8.579E-03 ALONSO_METASTASIS_UP Human immunodeficiency virus infectious disease DOID_526 4.285E-06 8.127E-04 4.285E-06 2.438E-03 ALONSO_METASTASIS_UP membranoproliferative glomerulonephritis DOID_2920 7.451E-06 1.06E-03 6.794E-04 0.02416194 ALONSO_METASTASIS_UP aortic aneurysm DOID_3627 1.115E-05 1.269E-03 8.365E-03 0.09714048 ALONSO_METASTASIS_UP diabetic angiopathy DOID_11713 3.259E-05 3.091E-03 3.259E-05 9.272E-03 ALONSO_METASTASIS_UP sphingolipidosis DOID_1927 3.696E-05 3.005E-03 3.696E-05 7.011E-03 ALONSO_METASTASIS_UP intracranial aneurysm DOID_10941 5.235E-05 3.724E-03 2.393E-03 0.05673332 ALONSO_METASTASIS_UP lung adenocarcinoma DOID_3910 5.829E-05 3.685E-03 5.829E-05 6.633E-03 ALONSO_METASTASIS_UP papilloma DOID_2615 1.124E-04 6.396E-03 1.124E-04 9.137E-03 ALONSO_METASTASIS_UP myocarditis DOID_820 1.124E-04 5.814E-03 3.935E-03 0.06996988 ALONSO_METASTASIS_UP adenoma DOID_657 1.431E-04 6.784E-03 1.431E-04 0.01017581 ALONSO_METASTASIS_UP respiratory syncytial virus infectious disease DOID_1273 1.787E-04 7.822E-03 5.324E-03 0.07573417 ALONSO_METASTASIS_UP facioscapulohumeral muscular dystrophy DOID_11727 2.936E-04 0.01193463 2.936E-04 0.01856498 ALONSO_METASTASIS_UP Diamond-Blackfan anemia DOID_1339 2.936E-04 0.01113899 2.936E-04 0.01670848 ALONSO_METASTASIS_UP neuritis DOID_1803 3.006E-04 0.01068927 3.006E-04 0.01554803 ALONSO_METASTASIS_UP glaucoma DOID_1686 3.376E-04 0.01130133 8.063E-03 0.095582 ALONSO_METASTASIS_UP atrophic muscular disease DOID_913 4.204E-04 0.01328789 4.204E-04 0.01993184 ALONSO_METASTASIS_UP muscular dystrophy DOID_9884 4.204E-04 0.01328789 4.204E-04 0.01993184 ALONSO_METASTASIS_UP bile duct adenocarcinoma DOID_4896 4.429E-04 0.01326306 0.13726274 0.40467617 ALONSO_METASTASIS_UP cholangiocarcinoma DOID_4947 4.429E-04 0.01326306 0.13726274 0.40467617 ALONSO_METASTASIS_UP reproductive organ benign neoplasm DOID_0050622 4.662E-04 0.01326234 9.951E-03 0.1110244 ALONSO_METASTASIS_UP polyneuropathy DOID_1389 5.064E-04 0.01372152 5.064E-04 0.02216553 ALONSO_METASTASIS_UP impotence DOID_1875 5.064E-04 0.01309781 0.03309387 0.20467841 ALONSO_METASTASIS_UP congenital nervous system abnormality DOID_2490 5.151E-04 0.01274202 5.151E-04 0.02093332 ALONSO_METASTASIS_UP hypertrophic cardiomyopathy DOID_11984 5.407E-04 0.01281872 0.01096169 0.11768305 ALONSO_METASTASIS_UP bile duct cancer DOID_4606 5.407E-04 0.01230597 0.1461626 0.41792221 ALONSO_METASTASIS_UP bile duct carcinoma DOID_4897 5.407E-04 0.01230597 0.1461626 0.41792221 ALONSO_METASTASIS_UP open-angle glaucoma DOID_1067 5.898E-04 0.01290811 5.898E-04 0.02237405 ALONSO_METASTASIS_UP carotid artery disease DOID_3407 6.224E-04 0.01311703 0.01201548 0.12430562 ALONSO_METASTASIS_UP skeletal system cancer DOID_0060124 6.794E-04 0.01380682 1.000 1.000 ALONSO_METASTASIS_UP thoracic aortic aneurysm DOID_14004 6.794E-04 0.01333072 1.000 1.000 ALONSO_METASTASIS_UP bone cancer DOID_184 6.794E-04 0.01380682 1.000 1.000 ALONSO_METASTASIS_UP tooth disease DOID_1091 8.087E-04 0.01533744 0.01425017 0.14225173 ALONSO_METASTASIS_UP endocrine organ benign neoplasm DOID_0060089 8.428E-04 0.01546858 8.428E-04 0.02820742 ALONSO_METASTASIS_UP penile disease DOID_1529 8.771E-04 0.01559508 0.04305679 0.22071451 ALONSO_METASTASIS_UP adrenal gland disease DOID_9553 8.771E-04 0.0151225 8.771E-04 0.02772458 ALONSO_METASTASIS_UP pancreatic ductal carcinoma DOID_3587 9.137E-04 0.01529042 0.17232055 0.46250185 ALONSO_METASTASIS_UP male reproductive system disease DOID_48 9.505E-04 0.01545229 0.01583186 0.15013885 ALONSO_METASTASIS_UP sexual dysfunction DOID_1876 9.85E-04 0.01556882 0.0455316 0.23131676 ALONSO_METASTASIS_UP peripheral vascular disease DOID_341 9.882E-04 0.01519767 9.882E-04 0.02959546 ALONSO_METASTASIS_UP pancreatic carcinoma DOID_4905 1.027E-03 0.01537712 0.17873512 0.47746611 ALONSO_METASTASIS_UP pancreatitis DOID_4989 1.191E-03 0.01738029 1.191E-03 0.03389157 ALONSO_METASTASIS_UP membranous glomerulonephritis DOID_10976 1.219E-03 0.01734193 1.219E-03 0.03303225 ALONSO_METASTASIS_UP biliary tract cancer DOID_4607 1.419E-03 0.01969027 0.19768506 0.49992354 ALONSO_METASTASIS_UP acquired immunodeficiency syndrome DOID_635 1.477E-03 0.02001263 1.477E-03 0.03820593 ALONSO_METASTASIS_UP sexual disorder DOID_0060043 1.615E-03 0.02137286 0.05781094 0.27185474 ALONSO_METASTASIS_UP pulmonary embolism DOID_9477 1.615E-03 0.02088711 0.05781094 0.26106685 ALONSO_METASTASIS_UP mouth disease DOID_403 2.011E-03 0.02542529 0.02576847 0.19041896 ALONSO_METASTASIS_UP dilated cardiomyopathy DOID_12930 2.071E-03 0.02561861 0.02626736 0.19161704 ALONSO_METASTASIS_UP papillary adenoma DOID_3172 2.226E-03 0.02694618 2.226E-03 0.05506393 ALONSO_METASTASIS_UP microcystic adenoma DOID_5403 2.226E-03 0.02694618 2.226E-03 0.05506393 ALONSO_METASTASIS_UP follicular adenoma DOID_6204 2.226E-03 0.02694618 2.226E-03 0.05506393 ALONSO_METASTASIS_UP congenital hypoplastic anemia DOID_1342 2.393E-03 0.02836666 2.393E-03 0.05446399 ALONSO_METASTASIS_UP Sciatic Neuropathy DOID_11446 2.566E-03 0.02979597 2.566E-03 0.05615394 ALONSO_METASTASIS_UP lesion of sciatic nerve DOID_12528 2.566E-03 0.02979597 2.566E-03 0.05615394 ALONSO_METASTASIS_UP periodontitis DOID_824 2.566E-03 0.02920005 0.07233989 0.28986901 ALONSO_METASTASIS_UP perinatal necrotizing enterocolitis DOID_8677 2.566E-03 0.0286275 2.566E-03 0.05407416 ALONSO_METASTASIS_UP mononeuritis of lower limb DOID_9473 2.566E-03 0.02979597 2.566E-03 0.05615394 ALONSO_METASTASIS_UP renal hypertension DOID_1073 2.745E-03 0.03003194 0.07473973 0.29739097 ALONSO_METASTASIS_UP secondary hypertension DOID_11130 2.745E-03 0.03003194 0.07473973 0.29739097 ALONSO_METASTASIS_UP mononeuritis DOID_1802 2.745E-03 0.0294653 2.745E-03 0.05577361 ALONSO_METASTASIS_UP autoimmune disease of the nervous system DOID_438 2.745E-03 0.02891965 2.745E-03 0.05385038 ALONSO_METASTASIS_UP mononeuropathy DOID_1188 2.929E-03 0.03030107 2.929E-03 0.05555196 ALONSO_METASTASIS_UP female reproductive organ benign neoplasm DOID_0060086 3.119E-03 0.03169068 0.07952099 0.30164962 ALONSO_METASTASIS_UP uterine benign neoplasm DOID_0060095 3.119E-03 0.03169068 0.07952099 0.30164962 ALONSO_METASTASIS_UP uterine fibroid DOID_13223 3.119E-03 0.03169068 0.07952099 0.30164962 ALONSO_METASTASIS_UP abdominal aortic aneurysm DOID_7693 3.315E-03 0.03308777 0.08190244 0.2987339 ALONSO_METASTASIS_UP Charcot-Marie-Tooth disease DOID_10595 3.516E-03 0.03449164 3.516E-03 0.06453275 ALONSO_METASTASIS_UP leiomyoma DOID_127 3.723E-03 0.03590167 0.08664706 0.30813861 ALONSO_METASTASIS_UP periodontal disease DOID_3388 4.153E-03 0.03938352 0.09136741 0.31700034 ALONSO_METASTASIS_UP thyroid carcinoma DOID_3963 4.153E-03 0.03873789 4.153E-03 0.0716064 ALONSO_METASTASIS_UP spindle cell carcinoma DOID_4015 4.153E-03 0.03811309 0.09136741 0.31507913 ALONSO_METASTASIS_UP macular degeneration DOID_4448 4.153E-03 0.03750812 4.153E-03 0.06950033 ALONSO_METASTASIS_UP aplastic anemia DOID_12449 4.376E-03 0.03890792 4.376E-03 0.07114592 ALONSO_METASTASIS_UP thyroid cancer DOID_1781 4.605E-03 0.04031242 4.605E-03 0.07278631 ALONSO_METASTASIS_UP calcinosis DOID_182 4.839E-03 0.04172113 0.09840269 0.33130848 ALONSO_METASTASIS_UP multiple myeloma DOID_9538 4.839E-03 0.04109843 4.839E-03 0.07442148 ALONSO_METASTASIS_UP microcephaly DOID_10907 5.079E-03 0.04249932 5.079E-03 0.07605141 ALONSO_METASTASIS_UP uveitis DOID_13141 5.079E-03 0.04188338 5.079E-03 0.07410137 ALONSO_METASTASIS_UP lymphatic system disease DOID_75 5.574E-03 0.04531169 5.574E-03 0.07736143 ALONSO_METASTASIS_UP benign mesothelioma DOID_2645 5.83E-03 0.04672243 5.83E-03 0.07898315 ALONSO_METASTASIS_UP autoimmune disease of urogenital tract DOID_0060049 6.091E-03 0.04813572 6.091E-03 0.08059934 ALONSO_METASTASIS_UP primary biliary cirrhosis DOID_12236 6.091E-03 0.04813572 6.091E-03 0.08059934 ALONSO_METASTASIS_UP uveal disease DOID_3480 6.357E-03 0.04955124 6.357E-03 0.08221001 ALONSO_METASTASIS_UP diabetic autonomic neuropathy DOID_11503 6.629E-03 0.05096869 0.11460937 0.35831172 ALONSO_METASTASIS_UP autonomic neuropathy DOID_11504 6.629E-03 0.05096869 0.11460937 0.35831172 ALONSO_METASTASIS_UP diabetic polyneuropathy DOID_12785 6.629E-03 0.05096869 0.11460937 0.35831172 ALONSO_METASTASIS_UP diabetic neuropathy DOID_9743 6.629E-03 0.05096869 0.11460937 0.35831172 ALONSO_METASTASIS_UP myeloma DOID_0070004 7.474E-03 0.05670253 7.474E-03 0.09450422 ALONSO_METASTASIS_UP pre-eclampsia DOID_10591 7.474E-03 0.05595645 0.12146651 0.37158303 ALONSO_METASTASIS_UP autonomic nervous system disease DOID_11465 7.474E-03 0.05522974 0.12146651 0.36959595 ALONSO_METASTASIS_UP thyroid adenoma DOID_2891 7.474E-03 0.05452167 7.474E-03 0.09244978 ALONSO_METASTASIS_UP bone marrow disease DOID_4961 7.474E-03 0.05383152 7.474E-03 0.09048277 ALONSO_METASTASIS_UP calcium metabolism disease DOID_10575 8.365E-03 0.05949854 0.12827107 0.38413811 ALONSO_METASTASIS_UP giant cell tumor DOID_200 9.302E-03 0.06534368 0.13502347 0.40014767 ALONSO_METASTASIS_UP malignant giant cell tumor DOID_2705 9.302E-03 0.06534368 0.13502347 0.40014767 ALONSO_METASTASIS_UP giant cell glioblastoma DOID_3074 9.302E-03 0.06534368 0.13502347 0.40014767 ALONSO_METASTASIS_UP bone marrow cancer DOID_4960 9.624E-03 0.06678221 9.624E-03 0.10952282 ALONSO_METASTASIS_UP mitochondrial metabolism disease DOID_700 0.01028319 0.07049557 0.01028319 0.11252178 ALONSO_METASTASIS_UP glioblastoma DOID_3068 0.01096169 0.0742524 0.1461626 0.42003293 ALONSO_METASTASIS_UP oral cavity cancer DOID_8618 0.01096169 0.07337884 0.01096169 0.11550373 ALONSO_METASTASIS_UP mineral metabolism disease DOID_0050032 0.01311188 0.08675185 0.15934227 0.44012501 ALONSO_METASTASIS_UP parasitic infectious disease DOID_1398 0.01348669 0.08820605 0.16151922 0.44398279 ALONSO_METASTASIS_UP uterine disease DOID_345 0.01348669 0.08720371 0.16151922 0.43973415 ALONSO_METASTASIS_UP hyperglycemia DOID_4195 0.01386613 0.08864975 0.01386613 0.14088978 ALONSO_METASTASIS_UP brain infarction DOID_3454 0.01463879 0.09254971 0.01463879 0.14361162 ALONSO_METASTASIS_UP astrocytoma DOID_3069 0.01503197 0.09399109 0.17017136 0.46108335 ALONSO_METASTASIS_UP nephrosis DOID_2527 0.01583186 0.09791664 0.01583186 0.15268358 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP transitional cell carcinoma DOID_2671 7.067E-11 4.021E-08 9.924E-06 5.647E-03 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP parasitic infectious disease DOID_1398 8.038E-10 2.287E-07 0.09571349 0.56145338 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP parasitic helminthiasis infectious disease DOID_883 4.226E-09 8.015E-07 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP encephalomyelitis DOID_640 6.19E-09 8.806E-07 3.837E-04 0.05458768 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP hypersensitivity reaction type I disease DOID_1205 3.403E-07 3.873E-05 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP retinal detachment DOID_5327 6.653E-07 6.309E-05 1.401E-04 0.03985965 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP parasitic protozoa infectious disease DOID_2789 1.707E-06 1.387E-04 0.0822243 0.52568117 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP hypersensitivity reaction type IV disease DOID_2916 2.092E-06 1.488E-04 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP tuberculosis DOID_399 3.853E-06 2.436E-04 0.09972215 0.56741901 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP benign glioma DOID_0060101 4.608E-06 2.622E-04 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP benign ependymoma DOID_4844 4.608E-06 2.622E-04 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP acquired immunodeficiency syndrome DOID_635 4.608E-06 2.384E-04 0.03200679 0.53564306 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP peripheral vascular disease DOID_341 4.799E-06 2.275E-04 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP myasthenia gravis DOID_437 5.294E-06 2.317E-04 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cystic fibrosis DOID_1485 5.613E-06 2.281E-04 0.10900792 0.59071911 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP mixed glioma DOID_5076 6.21E-06 2.356E-04 0.11164368 0.58819677 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP bacterial pneumonia DOID_874 6.21E-06 2.209E-04 6.29E-03 0.3253702 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP neuromuscular junction disease DOID_439 8.707E-06 2.914E-04 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP primary bacterial infectious disease DOID_0050338 9.493E-06 3.001E-04 0.12341012 0.62141912 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP Human immunodeficiency virus infectious disease DOID_526 1.083E-05 3.243E-04 0.12729815 0.63537411 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP autoimmune disease of the nervous system DOID_438 1.205E-05 3.428E-04 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP respiratory syncytial virus infectious disease DOID_1273 3.364E-05 9.115E-04 0.06022945 0.51150085 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP benign mesothelioma DOID_2645 3.873E-05 1.002E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP influenza DOID_8469 4.727E-05 1.169E-03 2.22E-03 0.1804448 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP proteinuria DOID_576 5.36E-05 1.271E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP reproductive organ benign neoplasm DOID_0050622 8.892E-05 2.024E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP familial hyperlipidemia DOID_1168 9.358E-05 2.048E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP childhood type dermatomyositis DOID_14203 9.571E-05 2.017E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cannabis abuse DOID_9505 9.571E-05 1.945E-03 0.01467537 0.52189273 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP dermatomyositis DOID_10223 1.169E-04 2.293E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP carotid artery disease DOID_3407 1.193E-04 2.263E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pre-malignant neoplasm DOID_0060071 1.308E-04 2.4E-03 0.09303132 0.55720867 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP in situ carcinoma DOID_8719 1.308E-04 2.4E-03 0.09303132 0.55720867 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP endocrine pancreas disease DOID_1428 1.368E-04 2.432E-03 0.09437338 0.55935891 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cerebral degeneration DOID_1443 1.429E-04 2.464E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cannabis dependence DOID_1849 1.654E-04 2.768E-03 0.01903658 0.54159076 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP hallucinogen dependence DOID_9977 1.654E-04 2.768E-03 0.01903658 0.54159076 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP astrocytoma DOID_3069 1.694E-04 2.753E-03 0.10105448 0.56930693 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP male reproductive system disease DOID_48 1.837E-04 2.904E-03 0.10371334 0.5729407 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP Legionnaires' disease DOID_10457 1.928E-04 2.965E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP legionellosis DOID_10458 1.928E-04 2.965E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP eyelid disease DOID_530 1.928E-04 2.887E-03 0.0204861 0.52984513 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP diabetic retinopathy DOID_8947 1.988E-04 2.901E-03 0.10636448 0.58193645 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP mesenchymal cell neoplasm DOID_3350 2.223E-04 3.162E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP spindle cell sarcoma DOID_4235 2.223E-04 3.162E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP epithelioid sarcoma DOID_6193 2.223E-04 3.162E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP varicose veins DOID_799 2.223E-04 3.085E-03 0.02193352 0.49920693 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pancreatitis DOID_4989 2.314E-04 3.135E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP metabolic syndrome X DOID_14221 2.489E-04 3.293E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP lipid metabolism disorder DOID_3146 2.489E-04 3.219E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP vein disease DOID_866 2.538E-04 3.209E-03 0.02337884 0.47509138 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP retinal vascular disease DOID_2462 2.963E-04 3.665E-03 0.12080866 0.61375113 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP ureteral obstruction DOID_5199 3.229E-04 3.91E-03 0.02626318 0.51530172 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP leishmaniasis DOID_9065 3.606E-04 4.275E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP carbohydrate metabolic disorder DOID_2978 3.837E-04 4.456E-03 3.837E-04 0.07278357 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.957E-04 4.503E-03 0.13245586 0.64971881 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP mouth disease DOID_403 3.957E-04 4.415E-03 0.13245586 0.64416566 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP colon carcinoma DOID_1520 4.003E-04 4.38E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP subependymal glioma DOID_4843 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pilocytic astrocytoma DOID_4851 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP subependymal giant cell astrocytoma DOID_5077 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP fibrillary astrocytoma DOID_6726 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP juvenile pilocytic astrocytoma DOID_6811 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP childhood pilocytic astrocytoma DOID_6812 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP gemistocytic astrocytoma DOID_7005 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP childhood cerebral astrocytoma DOID_7007 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP protoplasmic astrocytoma DOID_7008 4.003E-04 4.297E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP autoimmune hepatitis DOID_2048 4.42E-04 4.657E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP coronary restenosis DOID_4247 4.42E-04 4.573E-03 0.03057402 0.54364421 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP ulcerative colitis DOID_8577 4.46E-04 4.531E-03 0.13758362 0.66343287 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP muscular atrophy DOID_767 4.857E-04 4.849E-03 0.03200679 0.52033897 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP placenta disease DOID_780 4.857E-04 4.765E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP urinary tract obstruction DOID_5200 5.315E-04 5.126E-03 0.03343749 0.51421431 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP hypoglycemia DOID_9993 5.315E-04 5.04E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP diabetic angiopathy DOID_11713 5.793E-04 5.403E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP ureteral disease DOID_1426 5.793E-04 5.316E-03 0.0348661 0.49597034 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP Goodpasture syndrome DOID_9808 5.793E-04 5.232E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP urticaria DOID_1555 6.808E-04 6.053E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cystitis DOID_1679 7.346E-04 6.43E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP myositis DOID_633 7.346E-04 6.333E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cleft lip DOID_9296 7.346E-04 6.238E-03 7.346E-04 0.08359453 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP seminoma DOID_4440 7.903E-04 6.613E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP perinatal necrotizing enterocolitis DOID_8677 8.481E-04 6.993E-03 0.04197815 0.49761596 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP autoimmune disease of cardiovascular system DOID_0060051 9.078E-04 7.379E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP renal hypertension DOID_1073 9.078E-04 7.275E-03 0.04339437 0.50390602 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP secondary hypertension DOID_11130 9.078E-04 7.275E-03 0.04339437 0.50390602 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP sarcoma DOID_1115 9.078E-04 7.174E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP Behcet's disease DOID_13241 9.078E-04 7.379E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP coronary stenosis DOID_4248 9.078E-04 7.076E-03 0.04339437 0.484145 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP supratentorial cancer DOID_1659 9.695E-04 7.454E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cerebrum cancer DOID_368 9.695E-04 7.454E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP female reproductive organ benign neoplasm DOID_0060086 1.033E-03 7.838E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP uterine benign neoplasm DOID_0060095 1.033E-03 7.838E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP uterine fibroid DOID_13223 1.033E-03 7.838E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP bronchiolitis obliterans DOID_2799 1.099E-03 8.226E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP germinoma DOID_3304 1.166E-03 8.619E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP leiomyoma DOID_127 1.236E-03 9.015E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP bladder disease DOID_365 1.236E-03 8.901E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP hepatitis C DOID_1883 1.381E-03 9.82E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP nephroblastoma DOID_2154 1.381E-03 9.699E-03 0.05325049 0.4887021 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pulmonary sarcoidosis DOID_13406 1.612E-03 0.01118855 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cleft palate DOID_674 1.612E-03 0.01105375 1.612E-03 0.15291025 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP hepatitis DOID_2237 1.776E-03 0.01203359 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP congenital diaphragmatic hernia DOID_3827 1.776E-03 0.01189201 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP intracranial arterial disease DOID_13089 1.861E-03 0.01231543 0.06161917 0.50087579 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cerebral arterial disease DOID_3527 1.861E-03 0.01231543 0.06161917 0.50087579 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP lymphatic system disease DOID_75 1.861E-03 0.01217387 0.06161917 0.4938212 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cervix uteri carcinoma in situ DOID_8991 1.948E-03 0.01259673 0.06300686 0.49792924 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pulmonary emphysema DOID_9675 1.948E-03 0.01245519 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP autoimmune disease of urogenital tract DOID_0060049 2.037E-03 0.01287748 0.06439255 0.50190902 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP primary biliary cirrhosis DOID_12236 2.037E-03 0.01287748 0.06439255 0.50190902 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP diabetic autonomic neuropathy DOID_11503 2.22E-03 0.01388037 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP autonomic neuropathy DOID_11504 2.22E-03 0.01388037 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP diabetic polyneuropathy DOID_12785 2.22E-03 0.01388037 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP diabetic neuropathy DOID_9743 2.22E-03 0.01388037 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP leukodystrophy DOID_10579 2.41E-03 0.01490784 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP autonomic nervous system disease DOID_11465 2.508E-03 0.0153475 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP brain cancer DOID_1319 2.508E-03 0.01518423 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP heart valve disease DOID_4079 2.508E-03 0.0150244 0.07129082 0.48291045 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP vascular skin disease DOID_9540 2.508E-03 0.01486789 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP central nervous system cancer DOID_3620 2.608E-03 0.01530074 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.71E-03 0.01573551 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP integumentary system benign neoplasm DOID_0060121 2.71E-03 0.01557656 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pulmonary tuberculosis DOID_2957 2.71E-03 0.0154208 0.07403612 0.49560652 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP skin benign neoplasm DOID_3165 2.71E-03 0.01557656 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP aortic aneurysm DOID_3627 2.814E-03 0.01585187 0.07540578 0.49890571 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP withdrawal disorder DOID_0060001 2.919E-03 0.01628477 2.919E-03 0.20763084 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP orofacial cleft DOID_0050567 3.027E-03 0.01671941 3.027E-03 0.19134437 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP atopic dermatitis DOID_3310 3.027E-03 0.01655865 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP sarcoidosis DOID_11335 3.136E-03 0.01699232 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP giant cell tumor DOID_200 3.136E-03 0.01683202 0.07950284 0.51996683 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP malignant giant cell tumor DOID_2705 3.136E-03 0.01683202 0.07950284 0.51996683 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP giant cell glioblastoma DOID_3074 3.136E-03 0.01683202 0.07950284 0.51996683 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP bile duct adenocarcinoma DOID_4896 3.247E-03 0.01726474 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cholangiocarcinoma DOID_4947 3.247E-03 0.01726474 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP vasculitis DOID_865 3.247E-03 0.01710488 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP integumentary system cancer DOID_0060122 3.359E-03 0.01753666 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP skin cancer DOID_4159 3.359E-03 0.01753666 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pustulosis of palm and sole DOID_4398 3.359E-03 0.01737724 0.0822243 0.51984027 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP glioblastoma DOID_3068 3.709E-03 0.01901069 0.08629167 0.53369523 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP bile duct cancer DOID_4606 3.709E-03 0.01884095 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP bile duct carcinoma DOID_4897 3.709E-03 0.01884095 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP respiratory failure DOID_11162 4.199E-03 0.02114531 0.09168731 0.5609686 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP uterine disease DOID_345 4.586E-03 0.02289013 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP allergic contact dermatitis DOID_3042 4.853E-03 0.02401037 0.09838787 0.57125203 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP brain infarction DOID_3454 4.989E-03 0.02447024 0.09972215 0.57315051 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP nephrosis DOID_2527 5.407E-03 0.02629537 0.10371334 0.57855777 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pancreatic carcinoma DOID_4905 5.694E-03 0.02745897 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP syndrome DOID_225 5.989E-03 0.02863589 5.989E-03 0.34076707 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP aneurysm disease DOID_2403 6.139E-03 0.02910739 0.11032676 0.5922257 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP contact dermatitis DOID_2773 6.598E-03 0.0310276 0.11427177 0.59651963 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP female reproductive system disease DOID_229 6.755E-03 0.0315034 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP biliary tract cancer DOID_4607 7.073E-03 0.03271899 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP chronic kidney failure DOID_784 7.073E-03 0.03245513 0.11819961 0.61141434 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP nervous system cancer DOID_3093 8.239E-03 0.03750271 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP lymphoblastic leukemia DOID_1037 8.763E-03 0.0395729 0.13116924 0.6490026 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP Crohn's disease DOID_8778 8.941E-03 0.04005893 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP dilated cardiomyopathy DOID_12930 9.121E-03 0.04054455 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP facioscapulohumeral muscular dystrophy DOID_11727 0.01467537 0.06473088 0.01467537 0.69585697 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP familial combined hyperlipidemia DOID_13809 0.01467537 0.06423295 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP transient cerebral ischemia DOID_224 0.01467537 0.06374262 0.01467537 0.64232951 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP acute kidney failure DOID_3021 0.01467537 0.06325972 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP phagocyte bactericidal dysfunction DOID_3262 0.01467537 0.06278409 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP conjunctival disease DOID_4251 0.01467537 0.06231555 0.01467537 0.59644883 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP acute T cell leukemia DOID_5603 0.01467537 0.06185395 0.01467537 0.55668558 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP conjunctivitis DOID_6195 0.01467537 0.06231555 0.01467537 0.59644883 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP cutaneous leishmaniasis DOID_9111 0.01467537 0.06139914 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP visceral leishmaniasis DOID_9146 0.01467537 0.06095098 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP familial adenomatous polyposis DOID_0050424 0.01613122 0.06651205 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP breast benign neoplasm DOID_0060082 0.01613122 0.06603354 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP thoracic benign neoplasm DOID_0060097 0.01613122 0.06603354 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP trypanosomiasis DOID_10113 0.01613122 0.06556187 0.01613122 0.53992132 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP adrenoleukodystrophy DOID_10588 0.01613122 0.0650969 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP sickle cell anemia DOID_10923 0.01613122 0.06463847 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP benign breast phyllodes tumor DOID_1631 0.01613122 0.06603354 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP craniosynostosis DOID_2340 0.01613122 0.06418645 0.01613122 0.50992569 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP invasive lobular carcinoma DOID_3457 0.01613122 0.06374071 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP intracranial arteriosclerosis DOID_13097 0.01758495 0.06900579 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP aortic valve stenosis DOID_1712 0.01758495 0.06853314 0.01758495 0.52662311 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP peritonitis DOID_8283 0.01758495 0.06806693 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP vascular dementia DOID_8725 0.01758495 0.06900579 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP ocular hypertension DOID_9282 0.01758495 0.06760702 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP borderline glaucoma DOID_9283 0.01758495 0.06760702 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP vulva cancer DOID_1245 0.01903658 0.07269675 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP obstructive hydrocephalus DOID_14159 0.01903658 0.0722121 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP communicating hydrocephalus DOID_1573 0.01903658 0.0722121 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP Leydig cell tumor DOID_2696 0.01903658 0.07173388 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP sex cord-stromal neoplasm DOID_4757 0.01903658 0.07173388 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP psoriatic arthritis DOID_9008 0.01903658 0.07126194 0.01903658 0.51580073 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP viral pneumonia DOID_10533 0.0204861 0.07618688 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP hydrocephalus DOID_10908 0.0204861 0.07569216 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP rhabdomyosarcoma DOID_3247 0.0204861 0.07520382 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP T-cell leukemia DOID_715 0.0204861 0.07472175 0.0204861 0.50680838 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP primary ciliary dyskinesia DOID_9562 0.0204861 0.07424581 0.0204861 0.48569137 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP thoracic aortic aneurysm DOID_14004 0.02193352 0.07898844 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP renovascular hypertension DOID_1591 0.02193352 0.07849166 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP arthropathy DOID_381 0.02193352 0.07800108 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP skeletal muscle cancer DOID_4043 0.02193352 0.0775166 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP lung oat cell carcinoma DOID_5411 0.02193352 0.07703811 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP oral submucous fibrosis DOID_5773 0.02193352 0.07656548 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP intermediate coronary syndrome DOID_8805 0.02193352 0.07609862 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP intracranial hypertension DOID_9428 0.02193352 0.07563741 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP angiosarcoma DOID_0001816 0.02337884 0.08013589 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP restrictive cardiomyopathy DOID_397 0.02337884 0.07965604 0.02337884 0.51163687 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP chronic myeloid leukemia DOID_8552 0.02337884 0.0791819 0.02337884 0.49268735 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP tongue cancer DOID_8649 0.02337884 0.07871336 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP drug-induced mental disorder DOID_1203 0.02482206 0.08308088 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP drug psychosis DOID_1742 0.02482206 0.08308088 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP basal cell carcinoma DOID_2513 0.02482206 0.08259503 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP bronchitis DOID_6132 0.02482206 0.08211483 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP substance-induced psychosis DOID_8646 0.02482206 0.08308088 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP male reproductive organ benign neoplasm DOID_0060087 0.02626318 0.08638006 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP keratosis DOID_161 0.02626318 0.08588362 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP skin carcinoma DOID_3451 0.02626318 0.08539286 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP prion disease DOID_649 0.02626318 0.08490767 0.02626318 0.498125 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP infertility DOID_5223 0.02770221 0.08905401 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP psoriasis DOID_8893 0.02770221 0.0885537 0.02770221 0.50846966 NATSUME_RESPONSE_TO_INTERFERON_BETA_UP pulmonary edema DOID_11396 0.02913916 0.09262671 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA pancreatitis DOID_4989 1.891E-07 1.076E-04 1.774E-05 2.018E-03 AMIT_EGF_RESPONSE_40_HELA middle cerebral artery infarction DOID_3525 7.227E-07 2.056E-04 7.227E-07 4.112E-04 AMIT_EGF_RESPONSE_40_HELA intracranial arterial disease DOID_13089 2.705E-06 5.131E-04 2.705E-06 7.697E-04 AMIT_EGF_RESPONSE_40_HELA cerebral arterial disease DOID_3527 2.705E-06 5.131E-04 2.705E-06 7.697E-04 AMIT_EGF_RESPONSE_40_HELA influenza DOID_8469 3.549E-06 5.048E-04 4.08E-04 0.02579632 AMIT_EGF_RESPONSE_40_HELA cerebral infarction DOID_3526 3.784E-06 4.306E-04 3.784E-06 7.177E-04 AMIT_EGF_RESPONSE_40_HELA melancholia DOID_2848 8.226E-06 7.801E-04 7.096E-04 0.0288417 AMIT_EGF_RESPONSE_40_HELA neurotic disorder DOID_4964 8.633E-06 7.018E-04 7.326E-04 0.02779077 AMIT_EGF_RESPONSE_40_HELA hyperglycemia DOID_4195 1.136E-05 8.082E-04 8.78E-04 0.02775484 AMIT_EGF_RESPONSE_40_HELA brain infarction DOID_3454 1.238E-05 7.83E-04 1.238E-05 1.762E-03 AMIT_EGF_RESPONSE_40_HELA endogenous depression DOID_1595 1.644E-05 9.353E-04 1.12E-03 0.02896719 AMIT_EGF_RESPONSE_40_HELA hyperparathyroidism DOID_13543 1.723E-05 8.913E-04 6.313E-03 0.13816545 AMIT_EGF_RESPONSE_40_HELA mental depression DOID_1596 2.128E-05 1.009E-03 1.328E-03 0.03148162 AMIT_EGF_RESPONSE_40_HELA parathyroid gland disease DOID_11201 2.983E-05 1.306E-03 8.2E-03 0.13330706 AMIT_EGF_RESPONSE_40_HELA skeletal system cancer DOID_0060124 4.013E-05 1.631E-03 9.456E-03 0.14158663 AMIT_EGF_RESPONSE_40_HELA bone cancer DOID_184 4.013E-05 1.631E-03 9.456E-03 0.14158663 AMIT_EGF_RESPONSE_40_HELA tongue cancer DOID_8649 4.584E-05 1.739E-03 0.01008302 0.1303918 AMIT_EGF_RESPONSE_40_HELA granulosa cell tumor DOID_2999 6.525E-05 2.32E-03 0.01196271 0.13346631 AMIT_EGF_RESPONSE_40_HELA amnestic disorder DOID_10914 7.247E-05 2.426E-03 0.01258851 0.13514836 AMIT_EGF_RESPONSE_40_HELA sex cord-gonadal stromal tumor DOID_192 7.247E-05 2.291E-03 0.01258851 0.13264561 AMIT_EGF_RESPONSE_40_HELA Goodpasture syndrome DOID_9808 1.051E-04 3.148E-03 1.051E-04 9.968E-03 AMIT_EGF_RESPONSE_40_HELA portal hypertension DOID_10762 1.237E-04 3.518E-03 0.01633535 0.14299718 AMIT_EGF_RESPONSE_40_HELA osteosarcoma DOID_3347 1.237E-04 3.351E-03 1.237E-04 0.01005277 AMIT_EGF_RESPONSE_40_HELA pleurisy DOID_10247 1.653E-04 4.275E-03 0.01882568 0.14282413 AMIT_EGF_RESPONSE_40_HELA hepatic vascular disease DOID_272 1.653E-04 4.089E-03 0.01882568 0.1373309 AMIT_EGF_RESPONSE_40_HELA allergic rhinitis DOID_4481 2.128E-04 5.046E-03 0.02130996 0.13937201 AMIT_EGF_RESPONSE_40_HELA chronic leukemia DOID_1036 2.256E-04 5.135E-03 0.02193008 0.14179792 AMIT_EGF_RESPONSE_40_HELA chronic lymphocytic leukemia DOID_1040 2.256E-04 5.135E-03 0.02193008 0.14179792 AMIT_EGF_RESPONSE_40_HELA pleural disease DOID_1532 2.256E-04 4.938E-03 0.02193008 0.14020469 AMIT_EGF_RESPONSE_40_HELA pneumoconiosis DOID_10316 2.524E-04 5.318E-03 2.524E-04 0.01794888 AMIT_EGF_RESPONSE_40_HELA spindle cell carcinoma DOID_4015 2.524E-04 5.128E-03 0.02316921 0.14329652 AMIT_EGF_RESPONSE_40_HELA pulmonary emphysema DOID_9675 3.575E-04 7.014E-03 0.02749431 0.15644262 AMIT_EGF_RESPONSE_40_HELA diabetic autonomic neuropathy DOID_11503 4.08E-04 7.739E-03 0.0293423 0.16209485 AMIT_EGF_RESPONSE_40_HELA autonomic neuropathy DOID_11504 4.08E-04 7.739E-03 0.0293423 0.16209485 AMIT_EGF_RESPONSE_40_HELA diabetic polyneuropathy DOID_12785 4.08E-04 7.739E-03 0.0293423 0.16209485 AMIT_EGF_RESPONSE_40_HELA diabetic neuropathy DOID_9743 4.08E-04 7.739E-03 0.0293423 0.16209485 AMIT_EGF_RESPONSE_40_HELA proteinuria DOID_576 4.435E-04 8.141E-03 0.03057242 0.16411047 AMIT_EGF_RESPONSE_40_HELA autonomic nervous system disease DOID_11465 4.618E-04 8.212E-03 0.03118693 0.16280148 AMIT_EGF_RESPONSE_40_HELA neuritis DOID_1803 4.618E-04 7.963E-03 0.03118693 0.15986812 AMIT_EGF_RESPONSE_40_HELA pulmonary tuberculosis DOID_2957 4.995E-04 8.36E-03 4.995E-04 0.02842359 AMIT_EGF_RESPONSE_40_HELA sarcoidosis DOID_11335 5.793E-04 9.417E-03 0.0348661 0.16671272 AMIT_EGF_RESPONSE_40_HELA giant cell tumor DOID_200 5.793E-04 9.156E-03 0.0348661 0.16532345 AMIT_EGF_RESPONSE_40_HELA malignant giant cell tumor DOID_2705 5.793E-04 9.156E-03 0.0348661 0.16532345 AMIT_EGF_RESPONSE_40_HELA giant cell glioblastoma DOID_3074 5.793E-04 9.156E-03 0.0348661 0.16532345 AMIT_EGF_RESPONSE_40_HELA bile duct adenocarcinoma DOID_4896 6.001E-04 9.228E-03 0.035478 0.16683455 AMIT_EGF_RESPONSE_40_HELA cholangiocarcinoma DOID_4947 6.001E-04 9.228E-03 0.035478 0.16683455 AMIT_EGF_RESPONSE_40_HELA bone marrow cancer DOID_4960 6.001E-04 8.986E-03 6.001E-04 0.03104106 AMIT_EGF_RESPONSE_40_HELA integumentary system cancer DOID_0060122 6.213E-04 9.064E-03 0.03608952 0.16831915 AMIT_EGF_RESPONSE_40_HELA parasitic protozoa infectious disease DOID_2789 6.213E-04 8.838E-03 6.213E-04 0.02945915 AMIT_EGF_RESPONSE_40_HELA skin cancer DOID_4159 6.213E-04 9.064E-03 0.03608952 0.16831915 AMIT_EGF_RESPONSE_40_HELA smallpox DOID_8736 6.213E-04 8.622E-03 6.213E-04 0.02719306 AMIT_EGF_RESPONSE_40_HELA hypersensitivity reaction type IV disease DOID_2916 6.87E-04 9.307E-03 0.03792185 0.17125028 AMIT_EGF_RESPONSE_40_HELA glioblastoma DOID_3068 6.87E-04 9.091E-03 0.03792185 0.16990185 AMIT_EGF_RESPONSE_40_HELA bile duct cancer DOID_4606 6.87E-04 8.884E-03 0.03792185 0.16857449 AMIT_EGF_RESPONSE_40_HELA bile duct carcinoma DOID_4897 6.87E-04 8.884E-03 0.03792185 0.16857449 AMIT_EGF_RESPONSE_40_HELA oral cavity cancer DOID_8618 6.87E-04 8.687E-03 0.03792185 0.16726771 AMIT_EGF_RESPONSE_40_HELA cholestasis DOID_13580 8.529E-04 0.01054986 8.529E-04 0.03033085 AMIT_EGF_RESPONSE_40_HELA parasitic infectious disease DOID_1398 8.529E-04 0.0103254 8.529E-04 0.02854669 AMIT_EGF_RESPONSE_40_HELA uterine disease DOID_345 8.529E-04 0.01011028 0.04218433 0.17912601 AMIT_EGF_RESPONSE_40_HELA tuberculosis DOID_399 9.293E-04 0.01079141 9.293E-04 0.02783047 AMIT_EGF_RESPONSE_40_HELA astrocytoma DOID_3069 9.555E-04 0.01087354 0.0446119 0.18528592 AMIT_EGF_RESPONSE_40_HELA pancreatic ductal carcinoma DOID_3587 9.82E-04 0.01095639 0.04521787 0.1864418 AMIT_EGF_RESPONSE_40_HELA bile duct disease DOID_4138 1.009E-03 0.01103992 1.009E-03 0.02870378 AMIT_EGF_RESPONSE_40_HELA biliary tract disease DOID_9741 1.036E-03 0.01112408 1.036E-03 0.02807505 AMIT_EGF_RESPONSE_40_HELA pancreatic carcinoma DOID_4905 1.064E-03 0.01120883 0.04703357 0.19253312 AMIT_EGF_RESPONSE_40_HELA cystic fibrosis DOID_1485 1.12E-03 0.01158688 0.0482422 0.19467953 AMIT_EGF_RESPONSE_40_HELA aneurysm disease DOID_2403 1.149E-03 0.01167104 0.04884597 0.19435912 AMIT_EGF_RESPONSE_40_HELA mixed glioma DOID_5076 1.178E-03 0.01175576 0.04944936 0.19539366 AMIT_EGF_RESPONSE_40_HELA metabolic syndrome X DOID_14221 1.237E-03 0.01213232 0.05065506 0.19741593 AMIT_EGF_RESPONSE_40_HELA female reproductive system disease DOID_229 1.267E-03 0.01221646 0.05125735 0.19574116 AMIT_EGF_RESPONSE_40_HELA alcohol abuse DOID_1574 1.328E-03 0.01259265 1.328E-03 0.03285038 AMIT_EGF_RESPONSE_40_HELA biliary tract cancer DOID_4607 1.328E-03 0.01238621 0.05246085 0.19900148 AMIT_EGF_RESPONSE_40_HELA primary bacterial infectious disease DOID_0050338 1.454E-03 0.0133469 1.454E-03 0.03310031 AMIT_EGF_RESPONSE_40_HELA lymphoblastic leukemia DOID_1037 1.654E-03 0.01494186 0.05845641 0.21739671 AMIT_EGF_RESPONSE_40_HELA encephalomyelitis DOID_640 1.654E-03 0.01470839 0.05845641 0.21459159 AMIT_EGF_RESPONSE_40_HELA mouth disease DOID_403 1.689E-03 0.01478453 0.05905396 0.21539554 AMIT_EGF_RESPONSE_40_HELA Crohn's disease DOID_8778 1.689E-03 0.01456052 0.05905396 0.21402359 AMIT_EGF_RESPONSE_40_HELA ulcerative colitis DOID_8577 1.831E-03 0.01554591 0.06144054 0.21987212 AMIT_EGF_RESPONSE_40_HELA retinal vascular occlusion DOID_1729 6.313E-03 0.05282797 6.313E-03 0.13304821 AMIT_EGF_RESPONSE_40_HELA transient cerebral ischemia DOID_224 6.313E-03 0.05206234 6.313E-03 0.12829649 AMIT_EGF_RESPONSE_40_HELA visceral leishmaniasis DOID_9146 6.313E-03 0.05131859 6.313E-03 0.12387247 AMIT_EGF_RESPONSE_40_HELA familial adenomatous polyposis DOID_0050424 6.943E-03 0.05563851 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA nervous system benign neoplasm DOID_0060115 6.943E-03 0.05486575 6.943E-03 0.1316778 AMIT_EGF_RESPONSE_40_HELA prediabetes syndrome DOID_11716 6.943E-03 0.05411416 6.943E-03 0.12743013 AMIT_EGF_RESPONSE_40_HELA migraine without aura DOID_12783 6.943E-03 0.05338289 6.943E-03 0.12344794 AMIT_EGF_RESPONSE_40_HELA aortic valve stenosis DOID_1712 7.571E-03 0.05744199 7.571E-03 0.13054997 AMIT_EGF_RESPONSE_40_HELA stomach disease DOID_76 7.571E-03 0.05668617 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA berylliosis DOID_10322 8.2E-03 0.06059412 8.2E-03 0.13722785 AMIT_EGF_RESPONSE_40_HELA polyneuropathy DOID_1389 8.2E-03 0.05981727 8.2E-03 0.12960408 AMIT_EGF_RESPONSE_40_HELA larynx cancer DOID_2596 8.2E-03 0.05906009 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA laryngeal benign neoplasm DOID_2598 8.2E-03 0.05906009 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA open-angle glaucoma DOID_1067 8.828E-03 0.0627891 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA hypercalcemia DOID_12678 8.828E-03 0.06201393 8.828E-03 0.13576021 AMIT_EGF_RESPONSE_40_HELA polycystic kidney disease DOID_898 8.828E-03 0.06125766 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA idiopathic pulmonary fibrosis DOID_0050156 9.456E-03 0.06482279 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA lung oat cell carcinoma DOID_5411 9.456E-03 0.06405109 9.456E-03 0.1379562 AMIT_EGF_RESPONSE_40_HELA oral submucous fibrosis DOID_5773 9.456E-03 0.06329755 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA angiosarcoma DOID_0001816 0.01008302 0.06671208 0.01008302 0.14343098 AMIT_EGF_RESPONSE_40_HELA silicosis DOID_10325 0.01008302 0.06594528 0.01008302 0.13993266 AMIT_EGF_RESPONSE_40_HELA hemolytic-uremic syndrome DOID_12554 0.01008302 0.0651959 0.01008302 0.13660093 AMIT_EGF_RESPONSE_40_HELA thyroiditis DOID_7166 0.01008302 0.06446336 0.01008302 0.13342417 AMIT_EGF_RESPONSE_40_HELA autoimmune thyroiditis DOID_7188 0.01008302 0.06446336 0.01008302 0.13342417 AMIT_EGF_RESPONSE_40_HELA Barrett's esophagus DOID_9206 0.01008302 0.0637471 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA basal cell carcinoma DOID_2513 0.01070996 0.0669667 0.01070996 0.13542155 AMIT_EGF_RESPONSE_40_HELA bronchitis DOID_6132 0.01070996 0.0662388 0.01070996 0.1324776 AMIT_EGF_RESPONSE_40_HELA urinary system benign neoplasm DOID_731 0.01070996 0.06552656 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA glucose intolerance DOID_10603 0.01133653 0.06862217 0.01133653 0.13724434 AMIT_EGF_RESPONSE_40_HELA skin carcinoma DOID_3451 0.01133653 0.06789983 0.01133653 0.13438508 AMIT_EGF_RESPONSE_40_HELA prion disease DOID_649 0.01133653 0.06719254 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA dissociative disorder DOID_10935 0.01196271 0.07017301 0.01196271 0.13891391 AMIT_EGF_RESPONSE_40_HELA dissociative amnesia DOID_11037 0.01196271 0.07017301 0.01196271 0.13891391 AMIT_EGF_RESPONSE_40_HELA testicular cancer DOID_2998 0.01196271 0.06945696 0.01196271 0.13613563 AMIT_EGF_RESPONSE_40_HELA leishmaniasis DOID_9065 0.01196271 0.06875537 0.01196271 0.13089965 AMIT_EGF_RESPONSE_40_HELA esophagitis DOID_11963 0.01258851 0.07162863 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA autoimmune hepatitis DOID_2048 0.01321393 0.07444285 0.01321393 0.13670415 AMIT_EGF_RESPONSE_40_HELA mitochondrial myopathy DOID_699 0.01321393 0.07371302 0.01321393 0.13426301 AMIT_EGF_RESPONSE_40_HELA funisitis DOID_0050698 0.01383898 0.07645027 0.01383898 0.13814697 AMIT_EGF_RESPONSE_40_HELA gastric ulcer DOID_10808 0.01383898 0.07571517 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA familial hypercholesterolemia DOID_13810 0.01383898 0.07499407 0.01383898 0.13576513 AMIT_EGF_RESPONSE_40_HELA placenta disease DOID_780 0.01383898 0.07428658 0.01383898 0.13346403 AMIT_EGF_RESPONSE_40_HELA muscle cancer DOID_4045 0.01446364 0.07691412 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA uremia DOID_4676 0.01446364 0.07620195 0.01446364 0.13716352 AMIT_EGF_RESPONSE_40_HELA urinary tract obstruction DOID_5200 0.01446364 0.07550285 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA aortic valve disease DOID_62 0.01508792 0.07804571 0.01508792 0.14073817 AMIT_EGF_RESPONSE_40_HELA meningitis DOID_9471 0.01508792 0.0773426 0.01508792 0.1384682 AMIT_EGF_RESPONSE_40_HELA spastic quadriplegia DOID_10970 0.01571183 0.0798217 0.01571183 0.14190525 AMIT_EGF_RESPONSE_40_HELA acute pancreatitis DOID_2913 0.01571183 0.07911531 0.01571183 0.13968798 AMIT_EGF_RESPONSE_40_HELA reading disorder DOID_13365 0.01633535 0.08153348 0.01633535 0.14083056 AMIT_EGF_RESPONSE_40_HELA hypogonadism DOID_1924 0.01633535 0.0808245 0.01633535 0.13872861 AMIT_EGF_RESPONSE_40_HELA bronchiolitis DOID_2942 0.01633535 0.08012773 0.01633535 0.13668848 AMIT_EGF_RESPONSE_40_HELA dyslexia DOID_4428 0.01633535 0.08153348 0.01633535 0.14083056 AMIT_EGF_RESPONSE_40_HELA cystitis DOID_1679 0.0169585 0.0824734 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA intracranial aneurysm DOID_10941 0.01758127 0.08477749 0.01758127 0.14498179 AMIT_EGF_RESPONSE_40_HELA spinal cord disease DOID_319 0.01758127 0.08406507 0.01758127 0.14291063 AMIT_EGF_RESPONSE_40_HELA Sciatic Neuropathy DOID_11446 0.01820366 0.0863157 0.01820366 0.1458857 AMIT_EGF_RESPONSE_40_HELA lesion of sciatic nerve DOID_12528 0.01820366 0.0863157 0.01820366 0.1458857 AMIT_EGF_RESPONSE_40_HELA lung adenocarcinoma DOID_3910 0.01820366 0.08560235 0.01820366 0.14385951 AMIT_EGF_RESPONSE_40_HELA migraine DOID_6364 0.01820366 0.08490069 0.01820366 0.14188883 AMIT_EGF_RESPONSE_40_HELA periodontitis DOID_824 0.01820366 0.08421044 0.01820366 0.13997141 AMIT_EGF_RESPONSE_40_HELA mononeuritis of lower limb DOID_9473 0.01820366 0.0863157 0.01820366 0.1458857 AMIT_EGF_RESPONSE_40_HELA sarcoma DOID_1115 0.01882568 0.08638557 0.01882568 0.14094487 AMIT_EGF_RESPONSE_40_HELA mononeuritis DOID_1802 0.01882568 0.08569448 0.01882568 0.13911442 AMIT_EGF_RESPONSE_40_HELA invasive ductal carcinoma DOID_3008 0.01882568 0.08501437 0.01882568 0.13559253 AMIT_EGF_RESPONSE_40_HELA autoimmune disease of endocrine system DOID_0060005 0.01944731 0.08713009 0.01944731 0.13831901 AMIT_EGF_RESPONSE_40_HELA mononeuropathy DOID_1188 0.01944731 0.08644938 0.01944731 0.13661137 AMIT_EGF_RESPONSE_40_HELA supratentorial cancer DOID_1659 0.01944731 0.08577923 0.01944731 0.13494538 AMIT_EGF_RESPONSE_40_HELA cerebrum cancer DOID_368 0.01944731 0.08577923 0.01944731 0.13494538 AMIT_EGF_RESPONSE_40_HELA spastic cerebral palsy DOID_0050669 0.02068945 0.09055614 0.02068945 0.14183492 AMIT_EGF_RESPONSE_40_HELA gonadal disease DOID_2277 0.02068945 0.08986487 0.02068945 0.14014641 AMIT_EGF_RESPONSE_40_HELA bronchiolitis obliterans DOID_2799 0.02068945 0.08918408 0.02068945 0.13849762 AMIT_EGF_RESPONSE_40_HELA abdominal aortic aneurysm DOID_7693 0.02068945 0.08851352 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA celiac disease DOID_10608 0.02130996 0.0904878 0.02130996 0.14099262 AMIT_EGF_RESPONSE_40_HELA bladder disease DOID_365 0.02193008 0.09243124 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA papilloma DOID_2615 0.02254983 0.09434453 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA myocarditis DOID_820 0.02254983 0.09365588 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA hepatitis C DOID_1883 0.02316921 0.09553101 0.02316921 0.14648088 AMIT_EGF_RESPONSE_40_HELA nephroblastoma DOID_2154 0.02316921 0.09484374 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA periodontal disease DOID_3388 0.02316921 0.09416628 0.02316921 0.1448712 AMIT_EGF_RESPONSE_40_HELA thyroid carcinoma DOID_3963 0.02316921 0.09349844 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA esophageal disease DOID_6050 0.02316921 0.09284 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA thyroid cancer DOID_1781 0.02440683 0.09711528 1.000 1.000 AMIT_EGF_RESPONSE_40_HELA pulmonary sarcoidosis DOID_13406 0.02502508 0.09888381 0.02502508 0.15311041 AMIT_EGF_RESPONSE_40_HELA embryonal cancer DOID_688 0.02502508 0.09820185 0.02502508 0.15148157 AMIT_EGF_RESPONSE_40_HELA multiple myeloma DOID_9538 0.02502508 0.09752923 0.02502508 0.14988703 AMIT_EGF_RESPONSE_40_HELA peptic ulcer DOID_750 0.02626044 0.09961461 1.000 1.000 AIYAR_COBRA1_TARGETS_DN testicular cancer DOID_2998 1.566E-05 8.91E-03 1.566E-05 8.91E-03 AIYAR_COBRA1_TARGETS_DN invasive ductal carcinoma DOID_3008 3.976E-05 0.01131066 3.976E-05 0.01131066 AIYAR_COBRA1_TARGETS_DN Charcot-Marie-Tooth disease DOID_10595 5.124E-05 9.718E-03 0.01071067 0.38089812 AIYAR_COBRA1_TARGETS_DN oral cavity cancer DOID_8618 1.663E-04 0.02366203 0.01914117 0.4033825 AIYAR_COBRA1_TARGETS_DN lymphoma DOID_0060058 3.95E-04 0.04495227 3.95E-04 0.07492044 LOPES_METHYLATED_IN_COLON_CANCER_UP pre-malignant neoplasm DOID_0060071 7.234E-08 4.116E-05 0.03929481 0.69871076 LOPES_METHYLATED_IN_COLON_CANCER_UP in situ carcinoma DOID_8719 7.234E-08 4.116E-05 0.03929481 0.69871076 LOPES_METHYLATED_IN_COLON_CANCER_UP mixed glioma DOID_5076 1.579E-07 4.491E-05 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP benign mesothelioma DOID_2645 2.541E-06 4.82E-04 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP transitional cell carcinoma DOID_2671 2.214E-05 3.149E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP lymphoblastic leukemia DOID_1037 2.603E-05 2.962E-03 1.519E-03 0.8643004 LOPES_METHYLATED_IN_COLON_CANCER_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.686E-05 2.547E-03 1.551E-03 0.4411823 LOPES_METHYLATED_IN_COLON_CANCER_UP testicular cancer DOID_2998 5.983E-05 4.863E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP granulosa cell tumor DOID_2999 5.983E-05 4.255E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP sex cord-gonadal stromal tumor DOID_192 6.645E-05 4.201E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP Sciatic Neuropathy DOID_11446 1.415E-04 8.053E-03 0.01745161 0.82749704 LOPES_METHYLATED_IN_COLON_CANCER_UP lesion of sciatic nerve DOID_12528 1.415E-04 8.053E-03 0.01745161 0.82749704 LOPES_METHYLATED_IN_COLON_CANCER_UP mononeuritis of lower limb DOID_9473 1.415E-04 8.053E-03 0.01745161 0.82749704 LOPES_METHYLATED_IN_COLON_CANCER_UP mononeuritis DOID_1802 1.516E-04 7.841E-03 0.01804816 0.78995408 LOPES_METHYLATED_IN_COLON_CANCER_UP invasive ductal carcinoma DOID_3008 1.516E-04 7.187E-03 0.01804816 0.73352879 LOPES_METHYLATED_IN_COLON_CANCER_UP autoimmune disease of the nervous system DOID_438 1.516E-04 6.634E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP mononeuropathy DOID_1188 1.62E-04 6.583E-03 0.01864437 0.70724296 LOPES_METHYLATED_IN_COLON_CANCER_UP female reproductive organ benign neoplasm DOID_0060086 1.727E-04 6.551E-03 0.01924023 0.68423055 LOPES_METHYLATED_IN_COLON_CANCER_UP uterine benign neoplasm DOID_0060095 1.727E-04 6.551E-03 0.01924023 0.68423055 LOPES_METHYLATED_IN_COLON_CANCER_UP uterine fibroid DOID_13223 1.727E-04 6.551E-03 0.01924023 0.68423055 LOPES_METHYLATED_IN_COLON_CANCER_UP germinoma DOID_3304 1.952E-04 6.942E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP leiomyoma DOID_127 2.069E-04 6.927E-03 0.02102573 0.54380186 LOPES_METHYLATED_IN_COLON_CANCER_UP nephroblastoma DOID_2154 2.315E-04 7.317E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP lymphoid leukemia DOID_10747 2.442E-04 7.314E-03 0.02280813 0.5642532 LOPES_METHYLATED_IN_COLON_CANCER_UP embryonal cancer DOID_688 2.708E-04 7.704E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP multiple myeloma DOID_9538 2.708E-04 7.337E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP endometriosis of uterus DOID_288 3.431E-04 8.873E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP endometriosis DOID_289 3.585E-04 8.87E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP myeloma DOID_0070004 4.237E-04 0.01004554 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP brain cancer DOID_1319 4.237E-04 9.644E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP neuritis DOID_1803 4.237E-04 9.273E-03 0.02990671 0.58679037 LOPES_METHYLATED_IN_COLON_CANCER_UP central nervous system cancer DOID_3620 4.408E-04 9.29E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP glaucoma DOID_1686 4.583E-04 9.314E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP giant cell tumor DOID_200 5.315E-04 0.01042822 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP malignant giant cell tumor DOID_2705 5.315E-04 0.01042822 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP giant cell glioblastoma DOID_3074 5.315E-04 0.01042822 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP bone marrow cancer DOID_4960 5.506E-04 0.01044332 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP reproductive organ benign neoplasm DOID_0050622 5.701E-04 0.01046353 0.03461168 0.65646812 LOPES_METHYLATED_IN_COLON_CANCER_UP glioblastoma DOID_3068 6.304E-04 0.01120953 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP neuroectodermal tumor DOID_171 6.937E-04 0.01196141 0.03812606 0.69979777 LOPES_METHYLATED_IN_COLON_CANCER_UP uterine disease DOID_345 7.827E-04 0.01309906 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP allergic contact dermatitis DOID_3042 8.292E-04 0.01348013 0.04162821 0.71777132 LOPES_METHYLATED_IN_COLON_CANCER_UP astrocytoma DOID_3069 8.769E-04 0.01386064 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP contact dermatitis DOID_2773 1.135E-03 0.01745786 0.04859596 0.81326763 LOPES_METHYLATED_IN_COLON_CANCER_UP female reproductive system disease DOID_229 1.163E-03 0.01741174 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP nervous system cancer DOID_3093 1.426E-03 0.02079974 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP Human immunodeficiency virus infectious disease DOID_526 1.426E-03 0.02027975 0.05436537 0.85927486 LOPES_METHYLATED_IN_COLON_CANCER_UP Crohn's disease DOID_8778 1.551E-03 0.02152109 0.05666375 0.8713966 LOPES_METHYLATED_IN_COLON_CANCER_UP Sjogren's syndrome DOID_12894 6.051E-03 0.08197693 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP phagocyte bactericidal dysfunction DOID_3262 6.051E-03 0.08007049 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP cutaneous leishmaniasis DOID_9111 6.051E-03 0.0782507 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP visceral leishmaniasis DOID_9146 6.051E-03 0.0765118 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP adrenoleukodystrophy DOID_10588 6.654E-03 0.08230947 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP craniosynostosis DOID_2340 6.654E-03 0.08055821 6.654E-03 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP invasive lobular carcinoma DOID_3457 6.654E-03 0.07887991 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP esophageal carcinoma DOID_1107 7.257E-03 0.08427024 7.257E-03 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP aortic valve stenosis DOID_1712 7.257E-03 0.08258483 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP islet cell tumor DOID_1799 7.257E-03 0.08096552 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP esophagus squamous cell carcinoma DOID_3748 7.257E-03 0.08427024 7.257E-03 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP peritonitis DOID_8283 7.257E-03 0.07940849 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP Hirschsprung's disease DOID_10487 7.859E-03 0.08437827 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP vulva cancer DOID_1245 7.859E-03 0.08281571 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP polyneuropathy DOID_1389 7.859E-03 0.08130997 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP Leydig cell tumor DOID_2696 7.859E-03 0.079858 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP sex cord-stromal neoplasm DOID_4757 7.859E-03 0.079858 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP alcohol dependence DOID_0050741 8.462E-03 0.08446764 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP Legionnaires' disease DOID_10457 8.462E-03 0.08301131 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP legionellosis DOID_10458 8.462E-03 0.08301131 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP megacolon DOID_11372 8.462E-03 0.08160433 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP eyelid disease DOID_530 8.462E-03 0.08024426 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP parasitic helminthiasis infectious disease DOID_883 8.462E-03 0.07892878 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP narcolepsy DOID_8986 8.462E-03 0.07765574 8.462E-03 0.96293115 LOPES_METHYLATED_IN_COLON_CANCER_UP mesenchymal cell neoplasm DOID_3350 9.063E-03 0.08185817 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP spindle cell sarcoma DOID_4235 9.063E-03 0.08185817 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP oral submucous fibrosis DOID_5773 9.063E-03 0.08057913 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP epithelioid sarcoma DOID_6193 9.063E-03 0.08185817 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP tongue cancer DOID_8649 9.665E-03 0.08460422 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP drug-induced mental disorder DOID_1203 0.01026588 0.08850433 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP drug psychosis DOID_1742 0.01026588 0.08850433 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP bronchitis DOID_6132 0.01026588 0.08718337 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP substance-induced psychosis DOID_8646 0.01026588 0.08850433 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP neuroendocrine tumor DOID_169 0.01086661 0.09092792 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP ureteral obstruction DOID_5199 0.01086661 0.08961012 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP psoriasis DOID_8893 0.01146698 0.09321018 0.01146698 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP leishmaniasis DOID_9065 0.01146698 0.09189736 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP colonic disease DOID_5353 0.01206701 0.0953629 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP autoimmune hepatitis DOID_2048 0.01266669 0.09873077 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP acquired immunodeficiency syndrome DOID_635 0.01326602 0.0993206 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP myasthenia gravis DOID_437 0.013865 0.09986313 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP urinary tract obstruction DOID_5200 0.013865 0.09861484 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP sleep disorder DOID_535 0.013865 0.09739737 0.013865 0.98614841 LOPES_METHYLATED_IN_COLON_CANCER_UP polyarteritis nodosa DOID_9810 0.013865 0.0962096 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP synostosis DOID_11971 0.01446364 0.09915435 0.01446364 0.91442344 LOPES_METHYLATED_IN_COLON_CANCER_UP ureteral disease DOID_1426 0.01446364 0.09797394 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP aortic valve disease DOID_62 0.01446364 0.09682131 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_UP spastic quadriplegia DOID_10970 0.01506193 0.09965392 0.01506193 0.85702368 DUTTA_APOPTOSIS_VIA_NFKB transitional cell carcinoma DOID_2671 6.521E-13 3.71E-10 0.06884677 0.55962585 DUTTA_APOPTOSIS_VIA_NFKB lymphoma DOID_0060058 1.118E-10 3.181E-08 5.709E-05 0.01624211 DUTTA_APOPTOSIS_VIA_NFKB lung oat cell carcinoma DOID_5411 4.321E-10 8.195E-08 6.316E-05 0.01197845 DUTTA_APOPTOSIS_VIA_NFKB thyroid adenoma DOID_2891 4.515E-10 6.422E-08 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB integumentary system cancer DOID_0060122 9.721E-10 1.106E-07 9.734E-04 0.07912662 DUTTA_APOPTOSIS_VIA_NFKB skin cancer DOID_4159 9.721E-10 1.106E-07 9.734E-04 0.07912662 DUTTA_APOPTOSIS_VIA_NFKB hypersensitivity reaction type IV disease DOID_2916 1.26E-09 1.195E-07 0.0471791 0.53689819 DUTTA_APOPTOSIS_VIA_NFKB endocrine organ benign neoplasm DOID_0060089 2.743E-09 2.229E-07 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB alcohol-related neurodevelopmental disorder DOID_0050667 1.27E-08 9.032E-07 0.07326988 0.56338597 DUTTA_APOPTOSIS_VIA_NFKB papilloma DOID_2615 1.843E-08 1.165E-06 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB spindle cell carcinoma DOID_4015 2.065E-08 1.175E-06 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB multiple myeloma DOID_9538 2.853E-08 1.476E-06 0.0311853 0.4669589 DUTTA_APOPTOSIS_VIA_NFKB cervix uteri carcinoma in situ DOID_8991 4.229E-08 2.005E-06 0.03425162 0.4753456 DUTTA_APOPTOSIS_VIA_NFKB myeloma DOID_0070004 7.151E-08 3.13E-06 0.0388335 0.51386655 DUTTA_APOPTOSIS_VIA_NFKB integumentary system benign neoplasm DOID_0060121 8.397E-08 3.413E-06 7.832E-04 0.08912548 DUTTA_APOPTOSIS_VIA_NFKB skin benign neoplasm DOID_3165 8.397E-08 3.413E-06 7.832E-04 0.08912548 DUTTA_APOPTOSIS_VIA_NFKB lung small cell carcinoma DOID_5409 8.397E-08 3.185E-06 7.832E-04 0.07427124 DUTTA_APOPTOSIS_VIA_NFKB bone marrow cancer DOID_4960 1.222E-07 4.345E-06 0.04415248 0.5233908 DUTTA_APOPTOSIS_VIA_NFKB reproductive organ benign neoplasm DOID_0050622 1.312E-07 4.39E-06 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB mesenchymal cell neoplasm DOID_3350 2.021E-07 6.39E-06 0.01180655 0.39517211 DUTTA_APOPTOSIS_VIA_NFKB spindle cell sarcoma DOID_4235 2.021E-07 6.39E-06 0.01180655 0.39517211 DUTTA_APOPTOSIS_VIA_NFKB epithelioid sarcoma DOID_6193 2.021E-07 6.39E-06 0.01180655 0.39517211 DUTTA_APOPTOSIS_VIA_NFKB pre-malignant neoplasm DOID_0060071 2.218E-07 6.643E-06 0.05094936 0.5176819 DUTTA_APOPTOSIS_VIA_NFKB in situ carcinoma DOID_8719 2.218E-07 6.643E-06 0.05094936 0.5176819 DUTTA_APOPTOSIS_VIA_NFKB mixed glioma DOID_5076 4.831E-07 1.374E-05 1.841E-03 0.13093394 DUTTA_APOPTOSIS_VIA_NFKB biliary tract cancer DOID_4607 6.168E-07 1.671E-05 0.06514526 0.53721232 DUTTA_APOPTOSIS_VIA_NFKB Human immunodeficiency virus infectious disease DOID_526 8.479E-07 2.193E-05 8.479E-07 4.824E-04 DUTTA_APOPTOSIS_VIA_NFKB diabetic angiopathy DOID_11713 8.949E-07 2.214E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hypersensitivity reaction type I disease DOID_1205 1.048E-06 2.486E-05 2.69E-03 0.17006012 DUTTA_APOPTOSIS_VIA_NFKB papillary adenoma DOID_3172 1.291E-06 2.939E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB microcystic adenoma DOID_5403 1.291E-06 2.939E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB follicular adenoma DOID_6204 1.291E-06 2.939E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB sarcoma DOID_1115 1.789E-06 3.916E-05 0.02347829 0.49478332 DUTTA_APOPTOSIS_VIA_NFKB female reproductive organ benign neoplasm DOID_0060086 2.184E-06 4.602E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB uterine benign neoplasm DOID_0060095 2.184E-06 4.602E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB uterine fibroid DOID_13223 2.184E-06 4.602E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB leiomyoma DOID_127 2.877E-06 5.846E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB thyroid carcinoma DOID_3963 3.412E-06 6.694E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB thyroid cancer DOID_1781 4.008E-06 7.602E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB adenoma DOID_657 4.008E-06 7.357E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hepatitis DOID_2237 5.027E-06 8.939E-05 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB uterine cancer DOID_363 7.082E-06 1.221E-04 0.03654519 0.49510033 DUTTA_APOPTOSIS_VIA_NFKB B-cell lymphocytic neoplasm DOID_707 1.079E-05 1.806E-04 0.04187641 0.52950391 DUTTA_APOPTOSIS_VIA_NFKB bile duct adenocarcinoma DOID_4896 1.271E-05 2.066E-04 0.04415248 0.53452677 DUTTA_APOPTOSIS_VIA_NFKB cholangiocarcinoma DOID_4947 1.271E-05 2.066E-04 0.04415248 0.53452677 DUTTA_APOPTOSIS_VIA_NFKB pustulosis of palm and sole DOID_4398 1.34E-05 2.117E-04 0.04491 0.52150594 DUTTA_APOPTOSIS_VIA_NFKB bile duct cancer DOID_4606 1.56E-05 2.399E-04 0.0471791 0.51624826 DUTTA_APOPTOSIS_VIA_NFKB bile duct carcinoma DOID_4897 1.56E-05 2.399E-04 0.0471791 0.51624826 DUTTA_APOPTOSIS_VIA_NFKB carotid artery disease DOID_3407 1.803E-05 2.7E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB parasitic infectious disease DOID_1398 2.164E-05 3.158E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB allergic contact dermatitis DOID_3042 2.361E-05 3.359E-04 0.05395518 0.52034742 DUTTA_APOPTOSIS_VIA_NFKB acute kidney failure DOID_3021 2.713E-05 3.766E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB teratoma DOID_3307 2.713E-05 3.676E-04 7.886E-03 0.40792561 DUTTA_APOPTOSIS_VIA_NFKB malignant teratoma DOID_5563 2.713E-05 3.676E-04 7.886E-03 0.40792561 DUTTA_APOPTOSIS_VIA_NFKB mature teratoma DOID_5566 2.713E-05 3.676E-04 7.886E-03 0.40792561 DUTTA_APOPTOSIS_VIA_NFKB peripheral vascular disease DOID_341 2.905E-05 3.844E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB pancreatic carcinoma DOID_4905 3.023E-05 3.909E-04 0.05844666 0.5278754 DUTTA_APOPTOSIS_VIA_NFKB contact dermatitis DOID_2773 3.796E-05 4.8E-04 0.06291753 0.53432943 DUTTA_APOPTOSIS_VIA_NFKB ocular hypertension DOID_9282 3.976E-05 4.918E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB borderline glaucoma DOID_9283 3.976E-05 4.918E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB encephalitis DOID_9588 3.976E-05 4.813E-04 9.456E-03 0.35870027 DUTTA_APOPTOSIS_VIA_NFKB nervous system cancer DOID_3093 5.354E-05 6.347E-04 0.0703234 0.56357767 DUTTA_APOPTOSIS_VIA_NFKB parasitic helminthiasis infectious disease DOID_883 5.476E-05 6.359E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB dilated cardiomyopathy DOID_12930 6.269E-05 7.135E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB tongue cancer DOID_8649 7.214E-05 8.049E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB basal cell carcinoma DOID_2513 8.172E-05 8.942E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB skin carcinoma DOID_3451 9.189E-05 9.865E-04 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB infertility DOID_5223 1.027E-04 1.082E-03 0.01493213 0.40458969 DUTTA_APOPTOSIS_VIA_NFKB esophagitis DOID_11963 1.14E-04 1.179E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB coronary restenosis DOID_4247 1.259E-04 1.28E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB mitochondrial myopathy DOID_699 1.259E-04 1.257E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB neutropenia DOID_1227 1.385E-04 1.358E-03 0.01727005 0.40944405 DUTTA_APOPTOSIS_VIA_NFKB agranulocytosis DOID_12987 1.516E-04 1.462E-03 0.01804816 0.41077612 DUTTA_APOPTOSIS_VIA_NFKB hypoglycemia DOID_9993 1.516E-04 1.437E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB myositis DOID_633 2.099E-04 1.958E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB seminoma DOID_4440 2.259E-04 2.073E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB extrinsic allergic alveolitis DOID_841 2.259E-04 2.04E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB diffuse large B-cell lymphoma DOID_0050745 2.425E-04 2.156E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB lung adenocarcinoma DOID_3910 2.425E-04 2.123E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB perinatal necrotizing enterocolitis DOID_8677 2.425E-04 2.091E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB malaria DOID_12365 2.597E-04 2.206E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB coronary stenosis DOID_4248 2.597E-04 2.173E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB germinoma DOID_3304 3.343E-04 2.757E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB autonomic nervous system neoplasm DOID_2621 3.544E-04 2.881E-03 0.02733918 0.47139372 DUTTA_APOPTOSIS_VIA_NFKB neuroblastoma DOID_769 3.544E-04 2.881E-03 0.02733918 0.47139372 DUTTA_APOPTOSIS_VIA_NFKB nephroblastoma DOID_2154 3.963E-04 3.176E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB esophageal disease DOID_6050 3.963E-04 3.132E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB leukopenia DOID_615 3.963E-04 3.089E-03 0.0288794 0.45645491 DUTTA_APOPTOSIS_VIA_NFKB aplastic anemia DOID_12449 4.181E-04 3.215E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB embryonal cancer DOID_688 4.634E-04 3.516E-03 4.634E-04 0.0659212 DUTTA_APOPTOSIS_VIA_NFKB peripheral nervous system neoplasm DOID_1192 4.869E-04 3.646E-03 0.03195276 0.46618263 DUTTA_APOPTOSIS_VIA_NFKB lymphatic system disease DOID_75 5.357E-04 3.959E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB benign mesothelioma DOID_2645 5.609E-04 4.092E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB gallbladder cancer DOID_3121 6.4E-04 4.61E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB brain cancer DOID_1319 7.242E-04 5.151E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB bone marrow disease DOID_4961 7.242E-04 5.088E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB central nervous system cancer DOID_3620 7.534E-04 5.228E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB glaucoma DOID_1686 7.832E-04 5.369E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB sarcoidosis DOID_11335 9.078E-04 6.149E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB parasitic protozoa infectious disease DOID_2789 9.734E-04 6.516E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB mitochondrial metabolism disease DOID_700 1.007E-03 6.663E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB oral cavity cancer DOID_8618 1.076E-03 7.038E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB leukocyte disease DOID_9500 1.111E-03 7.186E-03 0.04793431 0.50508561 DUTTA_APOPTOSIS_VIA_NFKB endocrine pancreas disease DOID_1428 1.296E-03 8.288E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB uterine disease DOID_345 1.335E-03 8.44E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB astrocytoma DOID_3069 1.495E-03 9.347E-03 0.05545464 0.52589481 DUTTA_APOPTOSIS_VIA_NFKB pancreatic ductal carcinoma DOID_3587 1.536E-03 9.501E-03 0.0562035 0.51580312 DUTTA_APOPTOSIS_VIA_NFKB male reproductive system disease DOID_48 1.578E-03 9.656E-03 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB syndrome DOID_225 1.751E-03 0.01060008 0.05993924 0.52469885 DUTTA_APOPTOSIS_VIA_NFKB bone resorption disease DOID_0080011 1.796E-03 0.01075564 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB osteoporosis DOID_11476 1.796E-03 0.01075564 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB female reproductive system disease DOID_229 1.98E-03 0.01173292 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB amino acid metabolic disorder DOID_9252 2.373E-03 0.01391851 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB lymphoblastic leukemia DOID_1037 2.582E-03 0.01499179 0.07253411 0.57322093 DUTTA_APOPTOSIS_VIA_NFKB interstitial nephritis DOID_1063 7.886E-03 0.04532507 7.886E-03 0.44871817 DUTTA_APOPTOSIS_VIA_NFKB familial combined hyperlipidemia DOID_13809 7.886E-03 0.04487182 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB childhood type dermatomyositis DOID_14203 7.886E-03 0.04442754 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB transient cerebral ischemia DOID_224 7.886E-03 0.04399198 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB bilirubin metabolic disorder DOID_2741 7.886E-03 0.04356487 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB chondrosarcoma DOID_3371 7.886E-03 0.04314598 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB acute T cell leukemia DOID_5603 7.886E-03 0.04273506 7.886E-03 0.37393181 DUTTA_APOPTOSIS_VIA_NFKB Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.886E-03 0.0423319 7.886E-03 0.34516782 DUTTA_APOPTOSIS_VIA_NFKB Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.886E-03 0.0423319 7.886E-03 0.34516782 DUTTA_APOPTOSIS_VIA_NFKB Hodgkin's granuloma DOID_8651 7.886E-03 0.0423319 7.886E-03 0.34516782 DUTTA_APOPTOSIS_VIA_NFKB Hodgkin's lymphoma, mixed cellularity DOID_8654 7.886E-03 0.0423319 7.886E-03 0.34516782 DUTTA_APOPTOSIS_VIA_NFKB cutaneous leishmaniasis DOID_9111 7.886E-03 0.04193628 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB visceral leishmaniasis DOID_9146 7.886E-03 0.04154798 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB familial adenomatous polyposis DOID_0050424 8.671E-03 0.04526618 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB breast benign neoplasm DOID_0060082 8.671E-03 0.04485467 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB thoracic benign neoplasm DOID_0060097 8.671E-03 0.04485467 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB dermatomyositis DOID_10223 8.671E-03 0.04445057 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB adrenoleukodystrophy DOID_10588 8.671E-03 0.04405369 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB sickle cell anemia DOID_10923 8.671E-03 0.04366384 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB migraine without aura DOID_12783 8.671E-03 0.04328082 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB neuronal ceroid lipofuscinosis DOID_14503 8.671E-03 0.04290447 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB benign breast phyllodes tumor DOID_1631 8.671E-03 0.04485467 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hemochromatosis DOID_2352 8.671E-03 0.0425346 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB invasive lobular carcinoma DOID_3457 8.671E-03 0.04217106 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB bronchiectasis DOID_9563 8.671E-03 0.04181368 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB otitis media DOID_10754 9.456E-03 0.04521432 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB intracranial arteriosclerosis DOID_13097 9.456E-03 0.04483753 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB middle ear disease DOID_5100 9.456E-03 0.04521432 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB retinal detachment DOID_5327 9.456E-03 0.04446698 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB peritonitis DOID_8283 9.456E-03 0.04410249 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB Hodgkin's lymphoma DOID_8567 9.456E-03 0.04374394 9.456E-03 0.38432172 DUTTA_APOPTOSIS_VIA_NFKB vascular dementia DOID_8725 9.456E-03 0.04483753 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB berylliosis DOID_10322 0.01024016 0.04698913 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB vulva cancer DOID_1245 0.01024016 0.04661322 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hepatic coma DOID_12550 0.01024016 0.04624327 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hepatic encephalopathy DOID_13413 0.01024016 0.04624327 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB psoriatic arthritis DOID_9008 0.01024016 0.04587915 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hypercalcemia DOID_12678 0.01102366 0.04900359 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB T-cell leukemia DOID_715 0.01102366 0.04862372 0.01102366 0.39202874 DUTTA_APOPTOSIS_VIA_NFKB idiopathic pulmonary fibrosis DOID_0050156 0.01180655 0.05167635 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB oral submucous fibrosis DOID_5773 0.01180655 0.05128188 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB panic disorder DOID_594 0.01180655 0.05089338 0.01180655 0.3732181 DUTTA_APOPTOSIS_VIA_NFKB varicose veins DOID_799 0.01180655 0.05051072 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hyperhomocysteinemia DOID_9279 0.01180655 0.05013377 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB angiosarcoma DOID_0001816 0.01258884 0.05305964 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB silicosis DOID_10325 0.01258884 0.05266949 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hemolytic-uremic syndrome DOID_12554 0.01258884 0.05228504 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB restrictive cardiomyopathy DOID_397 0.01258884 0.05190617 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB thyroiditis DOID_7166 0.01258884 0.05153274 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB autoimmune thyroiditis DOID_7188 0.01258884 0.05153274 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB chronic myeloid leukemia DOID_8552 0.01258884 0.05116465 0.01258884 0.37700268 DUTTA_APOPTOSIS_VIA_NFKB vein disease DOID_866 0.01258884 0.05080178 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB lymphatic system cancer DOID_0060073 0.01337054 0.05357631 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB drug-induced mental disorder DOID_1203 0.01337054 0.05320165 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB methylmalonic acidemia DOID_14749 0.01337054 0.05283219 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB drug psychosis DOID_1742 0.01337054 0.05320165 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB urinary system benign neoplasm DOID_731 0.01337054 0.05246783 0.01337054 0.38039177 DUTTA_APOPTOSIS_VIA_NFKB reticulosarcoma DOID_8538 0.01337054 0.05357631 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB substance-induced psychosis DOID_8646 0.01337054 0.05320165 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB lymphosarcoma DOID_8675 0.01337054 0.05357631 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB male reproductive organ benign neoplasm DOID_0060087 0.01415163 0.0551526 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB keratosis DOID_161 0.01415163 0.05477741 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB testicular cancer DOID_2998 0.01493213 0.057408 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB psoriasis DOID_8893 0.01493213 0.05702271 0.01493213 0.38619925 DUTTA_APOPTOSIS_VIA_NFKB leishmaniasis DOID_9065 0.01493213 0.05664256 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB pulmonary edema DOID_11396 0.01571203 0.05920628 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB colon carcinoma DOID_1520 0.01571203 0.05881676 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB subependymal glioma DOID_4843 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB pilocytic astrocytoma DOID_4851 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB subependymal giant cell astrocytoma DOID_5077 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB fibrillary astrocytoma DOID_6726 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB juvenile pilocytic astrocytoma DOID_6811 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB childhood pilocytic astrocytoma DOID_6812 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB gemistocytic astrocytoma DOID_7005 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB childhood cerebral astrocytoma DOID_7007 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB protoplasmic astrocytoma DOID_7008 0.01571203 0.05843234 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB alopecia DOID_987 0.01571203 0.05805291 0.01571203 0.38870207 DUTTA_APOPTOSIS_VIA_NFKB Kawasaki disease DOID_13378 0.01649134 0.06053917 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB lymphadenitis DOID_1602 0.01649134 0.06053917 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB lymph node disease DOID_9942 0.01649134 0.06053917 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB benign glioma DOID_0060101 0.01727005 0.06299139 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB gastric ulcer DOID_10808 0.01727005 0.06259017 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB benign ependymoma DOID_4844 0.01727005 0.06299139 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB placenta disease DOID_780 0.01727005 0.06219403 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB muscle cancer DOID_4045 0.01804816 0.06458744 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB myasthenia gravis DOID_437 0.01804816 0.06418377 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB polyarteritis nodosa DOID_9810 0.01804816 0.06378511 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB Lewy body dementia DOID_12217 0.01882568 0.06612228 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB spastic quadriplegia DOID_10970 0.0196026 0.0684287 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB organic acidemia DOID_0060159 0.02037893 0.07070493 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB urticaria DOID_1555 0.02037893 0.07027642 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB bronchiolitis DOID_2942 0.02037893 0.06985306 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB osteosarcoma DOID_3347 0.02037893 0.06943478 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB cystitis DOID_1679 0.02115466 0.07164881 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB neuromuscular junction disease DOID_439 0.02115466 0.07122485 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hypotrichosis DOID_4535 0.0219298 0.07340032 0.0219298 0.47992517 DUTTA_APOPTOSIS_VIA_NFKB migraine DOID_6364 0.02270434 0.07554837 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB pleurisy DOID_10247 0.02347829 0.07766948 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB thrombocytopenia DOID_1588 0.02347829 0.07722052 0.02347829 0.47711249 DUTTA_APOPTOSIS_VIA_NFKB autoimmune disease of the nervous system DOID_438 0.02347829 0.07677672 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB autoimmune disease of endocrine system DOID_0060005 0.02425165 0.07885252 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB polycystic ovary syndrome DOID_11612 0.02425165 0.0784045 0.02425165 0.47583419 DUTTA_APOPTOSIS_VIA_NFKB multiple epiphyseal dysplasia DOID_12721 0.02425165 0.07796153 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB supratentorial cancer DOID_1659 0.02425165 0.07752355 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB toxic encephalopathy DOID_3602 0.02425165 0.07709046 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB cerebrum cancer DOID_368 0.02425165 0.07752355 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB endometrial carcinoma DOID_2871 0.02502442 0.07910498 0.02502442 0.47462989 DUTTA_APOPTOSIS_VIA_NFKB spastic cerebral palsy DOID_0050669 0.0257966 0.08109539 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB age related macular degeneration DOID_10871 0.0257966 0.08064981 0.0257966 0.47349242 DUTTA_APOPTOSIS_VIA_NFKB degeneration of macula and posterior pole DOID_2007 0.0257966 0.08064981 0.0257966 0.47349242 DUTTA_APOPTOSIS_VIA_NFKB abdominal aortic aneurysm DOID_7693 0.0257966 0.0802091 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB endometrial cancer DOID_1380 0.02656818 0.08215922 0.02656818 0.47241553 DUTTA_APOPTOSIS_VIA_NFKB chronic leukemia DOID_1036 0.02733918 0.08408645 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB chronic lymphocytic leukemia DOID_1040 0.02733918 0.08408645 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB pleural disease DOID_1532 0.02733918 0.08363437 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB bladder disease DOID_365 0.02733918 0.08318713 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB hair disease DOID_421 0.02810958 0.08507634 0.02810958 0.47042213 DUTTA_APOPTOSIS_VIA_NFKB myocarditis DOID_820 0.02810958 0.0846262 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB metal metabolism disorder DOID_896 0.02810958 0.0841808 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB pneumoconiosis DOID_10316 0.0288794 0.08603339 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB macular degeneration DOID_4448 0.0288794 0.0855853 0.0288794 0.46949648 DUTTA_APOPTOSIS_VIA_NFKB hyperthyroidism DOID_7998 0.0288794 0.08514185 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB lymphoid leukemia DOID_10747 0.02964862 0.0869591 0.02964862 0.45594772 DUTTA_APOPTOSIS_VIA_NFKB pulmonary sarcoidosis DOID_13406 0.0311853 0.09099712 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB uveitis DOID_13141 0.03195276 0.09276083 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB blood platelet disease DOID_2218 0.03195276 0.09228996 0.03195276 0.45452806 DUTTA_APOPTOSIS_VIA_NFKB respiratory syncytial virus infectious disease DOID_1273 0.03271963 0.09402764 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB congenital diaphragmatic hernia DOID_3827 0.03271963 0.09355514 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB peptic ulcer DOID_750 0.03271963 0.09308736 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB adult respiratory distress syndrome DOID_11394 0.03348592 0.09479347 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB intracranial arterial disease DOID_13089 0.03348592 0.0943242 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB cerebral arterial disease DOID_3527 0.03348592 0.0943242 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB endometriosis of uterus DOID_288 0.03501673 0.09815033 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB rheumatic disease DOID_1575 0.03578125 0.09980163 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB endometriosis DOID_289 0.03578125 0.09931479 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB uveal disease DOID_3480 0.03578125 0.09883268 1.000 1.000 DUTTA_APOPTOSIS_VIA_NFKB scleroderma DOID_419 0.03578125 0.09980163 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN proteinuria DOID_576 1.21E-12 6.885E-10 4.605E-03 0.04852827 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hepatitis DOID_2237 1.033E-11 2.939E-09 9.907E-06 2.818E-03 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN giant cell tumor DOID_200 1.615E-10 3.063E-08 6.691E-03 0.05857291 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN malignant giant cell tumor DOID_2705 1.615E-10 3.063E-08 6.691E-03 0.05857291 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN giant cell glioblastoma DOID_3074 1.615E-10 3.063E-08 6.691E-03 0.05857291 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mixed glioma DOID_5076 2.014E-10 2.865E-08 2.241E-03 0.03643676 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN glioblastoma DOID_3068 3.589E-10 4.084E-08 8.473E-03 0.06790701 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN oral cavity cancer DOID_8618 3.589E-10 3.403E-08 3.889E-06 2.213E-03 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN nervous system cancer DOID_3093 8.21E-10 6.674E-08 3.716E-03 0.04698153 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hyperglycemia DOID_4195 1.118E-09 7.954E-08 1.299E-03 0.03359322 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN astrocytoma DOID_3069 1.65E-09 1.043E-07 0.01329433 0.09224968 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pancreatic ductal carcinoma DOID_3587 1.871E-09 1.064E-07 1.601E-03 0.03503444 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pancreatic carcinoma DOID_4905 2.697E-09 1.395E-07 1.857E-03 0.03522409 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN thyroid carcinoma DOID_3963 5.536E-09 2.625E-07 0.22412556 0.50807745 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pustulosis of palm and sole DOID_4398 6.078E-09 2.66E-07 6.759E-04 0.02403735 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN thyroid cancer DOID_1781 8.174E-09 3.322E-07 0.23470099 0.51561723 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN endocrine pancreas disease DOID_1428 1.961E-08 7.44E-07 0.3685284 0.7156746 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cervix uteri carcinoma in situ DOID_8991 1.978E-08 7.035E-07 3.395E-03 0.04598808 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypersensitivity reaction type I disease DOID_1205 2.388E-08 7.994E-07 4.487E-03 0.05106388 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN ulcerative colitis DOID_8577 3.123E-08 9.872E-07 6.356E-04 0.02411042 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN middle cerebral artery infarction DOID_3525 3.187E-08 9.543E-07 9.099E-04 0.02725059 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN uterine cancer DOID_363 3.19E-08 9.077E-07 3.014E-04 0.02449591 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bile duct disease DOID_4138 4.349E-08 1.178E-06 0.01430726 0.09250942 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN biliary tract disease DOID_9741 4.84E-08 1.252E-06 0.01482969 0.09272632 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN brain cancer DOID_1319 4.979E-08 1.232E-06 0.29035054 0.60295423 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN thyroid adenoma DOID_2891 4.979E-08 1.181E-06 0.0459562 0.20270603 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN central nervous system cancer DOID_3620 5.738E-08 1.306E-06 0.29520512 0.60639608 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hemolytic anemia DOID_583 5.738E-08 1.256E-06 4.133E-04 0.0213781 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN normocytic anemia DOID_720 5.738E-08 1.256E-06 4.133E-04 0.0213781 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hemolytic-uremic syndrome DOID_12554 5.881E-08 1.239E-06 5.238E-03 0.0532185 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN tongue cancer DOID_8649 5.881E-08 1.195E-06 1.653E-04 0.01880652 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN aneurysm disease DOID_2403 7.31E-08 1.434E-06 0.41848777 0.79638643 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN endometrial carcinoma DOID_2871 7.491E-08 1.421E-06 1.35E-03 0.03201186 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN endometrial cancer DOID_1380 1.099E-07 2.017E-06 1.613E-03 0.03398601 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN sarcoidosis DOID_11335 1.117E-07 1.985E-06 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hepatitis C DOID_1883 1.868E-07 3.22E-06 0.02646486 0.13209214 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypersensitivity reaction type IV disease DOID_2916 2.04E-07 3.414E-06 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN collagen disease DOID_854 2.855E-07 4.641E-06 0.35538444 0.69251282 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN multiple myeloma DOID_9538 3.031E-07 4.791E-06 0.23993474 0.52107964 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Crohn's disease DOID_8778 3.362E-07 5.17E-06 4.325E-03 0.05126848 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pre-malignant neoplasm DOID_0060071 3.538E-07 5.297E-06 0.01050892 0.07972765 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN in situ carcinoma DOID_8719 3.538E-07 5.297E-06 0.01050892 0.07972765 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mineral metabolism disease DOID_0050032 3.927E-07 5.73E-06 0.01094696 0.0798567 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN systemic scleroderma DOID_418 4.096E-07 5.826E-06 0.25029551 0.53742695 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cholestasis DOID_13580 4.353E-07 6.041E-06 0.07897321 0.2899081 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN intracranial arterial disease DOID_13089 4.733E-07 6.411E-06 3.179E-03 0.0452212 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cerebral arterial disease DOID_3527 4.733E-07 6.411E-06 3.179E-03 0.0452212 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN endocrine organ benign neoplasm DOID_0060089 5.868E-07 7.765E-06 0.08503051 0.29865656 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN brain infarction DOID_3454 5.868E-07 7.588E-06 1.444E-03 0.03287385 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN rheumatic disease DOID_1575 7.148E-07 9.038E-06 0.27059686 0.57666523 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hyperinsulinism DOID_2018 7.148E-07 8.841E-06 0.27059686 0.57237775 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN scleroderma DOID_419 7.148E-07 9.038E-06 0.27059686 0.57666523 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN portal hypertension DOID_10762 8.376E-07 1.014E-05 0.1633045 0.42045367 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN peripheral vascular disease DOID_341 8.557E-07 1.014E-05 1.769E-03 0.03470482 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cerebral infarction DOID_3526 9.258E-07 1.075E-05 4.345E-03 0.05045764 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN diabetic retinopathy DOID_8947 9.37E-07 1.066E-05 0.01536281 0.09501565 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN myeloma DOID_0070004 1.185E-06 1.322E-05 0.29035054 0.60516285 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN vascular skin disease DOID_9540 1.185E-06 1.297E-05 4.875E-03 0.05043431 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lung small cell carcinoma DOID_5409 1.501E-06 1.612E-05 0.04930878 0.21255072 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN calcium metabolism disease DOID_10575 1.683E-06 1.774E-05 5.74E-03 0.05631079 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hepatic vascular disease DOID_272 1.774E-06 1.836E-05 0.18595203 0.4521654 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN B-cell lymphocytic neoplasm DOID_707 1.883E-06 1.913E-05 6.047E-03 0.05640848 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN biliary tract cancer DOID_4607 2.008E-06 2.004E-05 2.794E-03 0.04297076 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN retinal vascular disease DOID_2462 2.35E-06 2.305E-05 0.02193701 0.11887772 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bile duct adenocarcinoma DOID_4896 2.6E-06 2.508E-05 7.028E-03 0.06058717 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cholangiocarcinoma DOID_4947 2.6E-06 2.508E-05 7.028E-03 0.06058717 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bone marrow cancer DOID_4960 2.6E-06 2.466E-05 0.32364568 0.65072224 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN idiopathic pulmonary fibrosis DOID_0050156 2.738E-06 2.554E-05 4.604E-03 0.05136197 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN integumentary system cancer DOID_0060122 2.884E-06 2.647E-05 0.05986857 0.24865121 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN skin cancer DOID_4159 2.884E-06 2.647E-05 0.05986857 0.24865121 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN transitional cell carcinoma DOID_2671 2.953E-06 2.667E-05 3.921E-04 0.02479023 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN amino acid metabolic disorder DOID_9252 3.18E-06 2.827E-05 4.126E-04 0.02347818 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bile duct cancer DOID_4606 3.889E-06 3.405E-05 8.473E-03 0.06696386 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bile duct carcinoma DOID_4897 3.889E-06 3.405E-05 8.473E-03 0.06696386 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lymphoma DOID_0060058 3.952E-06 3.407E-05 4.012E-03 0.04857615 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lymphoblastic leukemia DOID_1037 4.242E-06 3.602E-05 5.028E-04 0.02384343 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mouth disease DOID_403 4.549E-06 3.807E-05 0.48259597 0.89445313 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN spindle cell carcinoma DOID_4015 5.22E-06 4.304E-05 0.22412556 0.50606127 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN coronary restenosis DOID_4247 1.162E-05 9.449E-05 8.962E-03 0.06985806 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN benign mesothelioma DOID_2645 1.251E-05 1.002E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN gastric ulcer DOID_10808 1.413E-05 1.117E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cystic fibrosis DOID_1485 1.633E-05 1.273E-04 0.0996773 0.31509102 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN syndrome DOID_225 1.633E-05 1.256E-04 0.01646118 0.09964267 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN urinary tract obstruction DOID_5200 1.702E-05 1.291E-04 0.01070129 0.07907839 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pulmonary embolism DOID_9477 1.702E-05 1.274E-04 0.14590795 0.39161142 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN influenza DOID_8469 1.737E-05 1.284E-04 0.27558605 0.578629 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bacterial pneumonia DOID_874 1.889E-05 1.378E-04 0.42246884 0.79862049 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN learning disability DOID_8927 1.929E-05 1.389E-04 3.27E-04 0.02325776 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Goodpasture syndrome DOID_9808 2.031E-05 1.444E-04 0.15174647 0.39789742 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN metabolic syndrome X DOID_14221 2.176E-05 1.529E-04 0.4303497 0.81082444 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pre-eclampsia DOID_10591 2.36E-05 1.638E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN neuritis DOID_1803 2.36E-05 1.618E-04 0.29035054 0.60076167 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN reading disorder DOID_13365 2.827E-05 1.915E-04 2.827E-05 5.362E-03 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bronchiolitis DOID_2942 2.827E-05 1.892E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN dyslexia DOID_4428 2.827E-05 1.915E-04 2.827E-05 5.362E-03 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN aortic aneurysm DOID_3627 3.143E-05 2.08E-04 0.30481526 0.62164832 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN retinal vascular occlusion DOID_1729 3.65E-05 2.388E-04 0.06626304 0.26366201 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bilirubin metabolic disorder DOID_2741 3.65E-05 2.36E-04 3.65E-05 5.193E-03 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN atopic dermatitis DOID_3310 3.769E-05 2.409E-04 6.364E-03 0.05840819 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Human immunodeficiency virus infectious disease DOID_526 4.186E-05 2.647E-04 0.02535747 0.12882501 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN diffuse large B-cell lymphoma DOID_0050745 4.419E-05 2.763E-04 0.0167183 0.10013382 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Sciatic Neuropathy DOID_11446 4.419E-05 2.733E-04 0.18034805 0.45007913 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lesion of sciatic nerve DOID_12528 4.419E-05 2.733E-04 0.18034805 0.45007913 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mononeuritis of lower limb DOID_9473 4.419E-05 2.733E-04 0.18034805 0.45007913 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN vasculitis DOID_865 4.486E-05 2.744E-04 0.05805842 0.24653164 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN familial adenomatous polyposis DOID_0050424 4.994E-05 3.023E-04 0.07264381 0.27741161 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN encephalomyelitis DOID_640 5.016E-05 3.004E-04 0.47902786 0.89366181 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pleurisy DOID_10247 5.072E-05 3.006E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mononeuritis DOID_1802 5.072E-05 2.975E-04 0.18595203 0.45410603 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN coronary stenosis DOID_4248 5.072E-05 2.945E-04 0.01783272 0.10353896 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.32E-05 3.058E-04 0.48259597 0.89737618 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mononeuropathy DOID_1188 5.792E-05 3.296E-04 0.19151784 0.45980443 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN toxic encephalopathy DOID_3602 5.792E-05 3.263E-04 1.23E-03 0.03332239 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN abdominal aortic aneurysm DOID_7693 7.452E-05 4.157E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN allergic rhinitis DOID_4481 8.4E-05 4.641E-04 0.02259183 0.12013785 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN respiratory failure DOID_11162 8.464E-05 4.631E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pleural disease DOID_1532 9.434E-05 5.112E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hereditary spastic paraplegia DOID_2476 9.434E-05 5.064E-04 1.755E-03 0.03566489 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cerebral degeneration DOID_1443 1.051E-04 5.587E-04 0.37285012 0.71915836 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN papilloma DOID_2615 1.056E-04 5.561E-04 0.02514582 0.13007248 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN myocarditis DOID_820 1.056E-04 5.51E-04 1.905E-03 0.03496581 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN metal metabolism disorder DOID_896 1.056E-04 5.46E-04 0.21878337 0.50196669 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pneumoconiosis DOID_10316 1.177E-04 6.035E-04 0.22412556 0.5121584 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN paraplegia DOID_607 1.177E-04 5.981E-04 2.063E-03 0.0355658 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hyperthyroidism DOID_7998 1.177E-04 5.928E-04 0.02646486 0.13094351 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN skeletal system cancer DOID_0060124 1.35E-04 6.736E-04 0.0977355 0.32521344 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bone cancer DOID_184 1.35E-04 6.736E-04 0.0977355 0.32521344 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lung oat cell carcinoma DOID_5411 1.35E-04 6.677E-04 0.0977355 0.31597442 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN oral submucous fibrosis DOID_5773 1.35E-04 6.62E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN varicose veins DOID_799 1.35E-04 6.563E-04 0.0977355 0.31242415 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pulmonary sarcoidosis DOID_13406 1.603E-04 7.73E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN calcinosis DOID_182 1.603E-04 7.665E-04 0.03058488 0.14748133 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN vein disease DOID_866 1.653E-04 7.836E-04 0.10390202 0.3178508 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN peptic ulcer DOID_750 1.942E-04 9.134E-04 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN urinary system benign neoplasm DOID_731 1.997E-04 9.312E-04 5.909E-03 0.05699073 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN adenoid cystic carcinoma DOID_4866 2.13E-04 9.854E-04 3.179E-03 0.04411825 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lymphatic system disease DOID_75 2.13E-04 9.775E-04 0.03494032 0.16163449 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN glucose intolerance DOID_10603 2.384E-04 1.085E-03 6.618E-03 0.05977468 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN ureteral obstruction DOID_5199 2.384E-04 1.077E-03 6.618E-03 0.0588407 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autoimmune disease of urogenital tract DOID_0060049 2.544E-04 1.14E-03 3.619E-03 0.04788657 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN primary biliary cirrhosis DOID_12236 2.544E-04 1.14E-03 3.619E-03 0.04788657 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN salivary gland cancer DOID_8850 2.544E-04 1.131E-03 3.619E-03 0.04679823 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN nephrotic syndrome DOID_1184 2.772E-04 1.223E-03 3.852E-03 0.04764736 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN psoriasis DOID_8893 2.817E-04 1.233E-03 2.817E-04 0.0267102 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mental depression DOID_1596 3.009E-04 1.307E-03 0.02064455 0.11404608 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN chronic kidney failure DOID_784 3.009E-04 1.297E-03 0.11496309 0.34428419 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN diabetic autonomic neuropathy DOID_11503 3.014E-04 1.289E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autonomic neuropathy DOID_11504 3.014E-04 1.289E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN diabetic polyneuropathy DOID_12785 3.014E-04 1.289E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN gallbladder cancer DOID_3121 3.014E-04 1.28E-03 0.04109445 0.18706192 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN diabetic neuropathy DOID_9743 3.014E-04 1.289E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN esophagitis DOID_11963 3.297E-04 1.39E-03 0.12815111 0.36642202 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN brain edema DOID_4724 3.297E-04 1.379E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN leukodystrophy DOID_10579 3.542E-04 1.471E-03 0.28546266 0.59716269 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN primary bacterial infectious disease DOID_0050338 3.724E-04 1.535E-03 0.45709854 0.85555616 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Kawasaki disease DOID_13378 3.827E-04 1.567E-03 0.13411054 0.38154449 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lymphadenitis DOID_1602 3.827E-04 1.567E-03 0.13411054 0.38154449 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lymph node disease DOID_9942 3.827E-04 1.567E-03 0.13411054 0.38154449 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autonomic nervous system disease DOID_11465 3.829E-04 1.556E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN heart valve disease DOID_4079 3.829E-04 1.545E-03 0.29035054 0.598585 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hepatitis B DOID_2043 4.409E-04 1.767E-03 0.1400294 0.39249619 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autoimmune disease of gastrointestinal tract DOID_0060031 4.453E-04 1.772E-03 5.442E-03 0.0543261 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN integumentary system benign neoplasm DOID_0060121 4.453E-04 1.76E-03 0.04930878 0.21417324 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN skin benign neoplasm DOID_3165 4.453E-04 1.76E-03 0.04930878 0.21417324 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN carbohydrate metabolic disorder DOID_2978 5.028E-04 1.973E-03 0.02753937 0.13508536 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN glycogen metabolism disorder DOID_0050728 5.045E-04 1.966E-03 5.045E-04 0.02208048 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN glycogen storage disease DOID_2747 5.045E-04 1.966E-03 5.045E-04 0.02208048 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN polyarteritis nodosa DOID_9810 5.045E-04 1.953E-03 0.14590795 0.38977287 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN dilated cardiomyopathy DOID_12930 5.532E-04 2.127E-03 0.14239411 0.39141182 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN diabetic angiopathy DOID_11713 5.736E-04 2.191E-03 0.15174647 0.40347542 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN ureteral disease DOID_1426 5.736E-04 2.176E-03 0.01162199 0.08370775 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN atrophic muscular disease DOID_913 5.914E-04 2.229E-03 5.914E-04 0.024037 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN muscular dystrophy DOID_9884 5.914E-04 2.229E-03 5.914E-04 0.024037 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN toxic shock syndrome DOID_14115 6.486E-04 2.428E-03 0.0125762 0.08834391 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN parasitic protozoa infectious disease DOID_2789 6.759E-04 2.514E-03 0.32827335 0.65539486 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN smallpox DOID_8736 6.759E-04 2.497E-03 6.759E-04 0.02262339 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN familial hyperlipidemia DOID_1168 7.212E-04 2.648E-03 7.731E-03 0.06374905 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN commensal bacterial infectious disease DOID_0050339 7.295E-04 2.661E-03 0.01356342 0.09298299 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN urticaria DOID_1555 7.295E-04 2.644E-03 0.01356342 0.09187605 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypogonadism DOID_1924 7.295E-04 2.627E-03 0.01356342 0.09079515 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypertrophic cardiomyopathy DOID_11984 8.182E-04 2.928E-03 0.06541316 0.26971078 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN vitiligo DOID_12306 9.099E-04 3.236E-03 9.099E-04 0.02876451 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN seminoma DOID_4440 9.099E-04 3.216E-03 0.17470565 0.43791856 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN extrinsic allergic alveolitis DOID_841 9.099E-04 3.196E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN carotid artery disease DOID_3407 9.804E-04 3.422E-03 0.07112182 0.27343456 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypothyroidism DOID_1459 1.039E-03 3.605E-03 1.039E-03 0.02956259 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN congenital heart defect DOID_1682 1.1E-03 3.794E-03 0.01050892 0.0786786 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autoimmune disease of cardiovascular system DOID_0060051 1.116E-03 3.827E-03 0.18595203 0.46002915 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN malaria DOID_12365 1.116E-03 3.804E-03 0.18595203 0.45803768 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Behcet's disease DOID_13241 1.116E-03 3.827E-03 0.18595203 0.46002915 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN invasive ductal carcinoma DOID_3008 1.116E-03 3.781E-03 0.01783272 0.10460637 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autoimmune disease of endocrine system DOID_0060005 1.23E-03 4.141E-03 0.01897775 0.10691425 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN supratentorial cancer DOID_1659 1.23E-03 4.116E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cerebrum cancer DOID_368 1.23E-03 4.116E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN parasitic infectious disease DOID_1398 1.23E-03 4.093E-03 0.37285012 0.72160448 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN uterine disease DOID_345 1.23E-03 4.069E-03 0.37285012 0.71672878 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN temporal lobe epilepsy DOID_3328 1.299E-03 4.272E-03 0.08097675 0.28618493 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN dysostosis DOID_1934 1.35E-03 4.415E-03 1.35E-03 0.03340368 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN allergic contact dermatitis DOID_3042 1.37E-03 4.455E-03 0.01232381 0.08765308 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN tuberculosis DOID_399 1.444E-03 4.67E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN age related macular degeneration DOID_10871 1.478E-03 4.751E-03 0.20253599 0.47425094 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN degeneration of macula and posterior pole DOID_2007 1.478E-03 4.751E-03 0.20253599 0.47425094 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN gonadal disease DOID_2277 1.478E-03 4.724E-03 0.02135776 0.1168516 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN blood coagulation disease DOID_1247 1.601E-03 5.089E-03 0.01379548 0.09127473 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN celiac disease DOID_10608 1.613E-03 5.098E-03 0.02259183 0.12127123 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN germinoma DOID_3304 1.613E-03 5.07E-03 0.20798884 0.48304347 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN nephrosis DOID_2527 1.683E-03 5.263E-03 0.01430726 0.09357275 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN male reproductive system disease DOID_48 1.683E-03 5.234E-03 0.09122329 0.31081468 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN chronic leukemia DOID_1036 1.755E-03 5.427E-03 0.21340455 0.49360647 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN chronic lymphocytic leukemia DOID_1040 1.755E-03 5.427E-03 0.21340455 0.49360647 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN leiomyoma DOID_127 1.755E-03 5.398E-03 0.02385466 0.12567874 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hair disease DOID_421 1.905E-03 5.828E-03 0.02514582 0.12890065 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hyperparathyroidism DOID_13543 2.018E-03 6.14E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN angioedema DOID_1558 2.018E-03 6.107E-03 0.06626304 0.2674019 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN acute kidney failure DOID_3021 2.018E-03 6.075E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN teratoma DOID_3307 2.018E-03 6.043E-03 2.018E-03 0.03588123 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN keratitis DOID_4677 2.018E-03 6.012E-03 0.06626304 0.2582443 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN malignant teratoma DOID_5563 2.018E-03 6.043E-03 2.018E-03 0.03588123 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mature teratoma DOID_5566 2.018E-03 6.043E-03 2.018E-03 0.03588123 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN endogenous depression DOID_1595 2.043E-03 6.054E-03 0.0996773 0.31335018 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN macular degeneration DOID_4448 2.063E-03 6.081E-03 0.22412556 0.50406103 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN esophageal disease DOID_6050 2.063E-03 6.05E-03 0.22412556 0.50207654 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bone resorption disease DOID_0080011 2.141E-03 6.246E-03 0.41848777 0.79905886 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN osteoporosis DOID_11476 2.141E-03 6.246E-03 0.41848777 0.79905886 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lymphoid leukemia DOID_10747 2.228E-03 6.469E-03 2.228E-03 0.03729086 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN adenoma DOID_657 2.402E-03 6.937E-03 0.02918482 0.14193301 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN contact dermatitis DOID_2773 2.452E-03 7.048E-03 0.01878693 0.10797743 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lipid metabolism disorder DOID_3146 2.452E-03 7.012E-03 0.01878693 0.10689766 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pneumocystosis DOID_11339 2.455E-03 6.985E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN neuronal ceroid lipofuscinosis DOID_14503 2.455E-03 6.95E-03 0.07264381 0.27015902 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hemochromatosis DOID_2352 2.455E-03 6.916E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN female reproductive system disease DOID_229 2.563E-03 7.184E-03 0.43424987 0.81547253 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN uveitis DOID_13141 2.774E-03 7.736E-03 0.24513283 0.53034441 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN alcohol abuse DOID_1574 2.794E-03 7.756E-03 2.794E-03 0.0441644 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN focal epilepsy DOID_2234 2.794E-03 7.718E-03 0.11496309 0.3461058 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bone development disease DOID_0080006 2.915E-03 8.013E-03 2.915E-03 0.04364889 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN otitis media DOID_10754 2.933E-03 8.024E-03 0.07898116 0.28624381 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN beta thalassemia DOID_12241 2.933E-03 7.985E-03 2.933E-03 0.04279253 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN islet cell tumor DOID_1799 2.933E-03 7.947E-03 0.07898116 0.28087674 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN middle ear disease DOID_5100 2.933E-03 8.024E-03 0.07898116 0.28624381 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN aortic valve insufficiency DOID_57 2.933E-03 7.91E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN stomach disease DOID_76 2.933E-03 7.872E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN respiratory syncytial virus infectious disease DOID_1273 2.972E-03 7.939E-03 0.03346305 0.15606947 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN adult respiratory distress syndrome DOID_11394 3.179E-03 8.453E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN parathyroid gland disease DOID_11201 3.451E-03 9.132E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN obstructive hydrocephalus DOID_14159 3.451E-03 9.09E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN communicating hydrocephalus DOID_1573 3.451E-03 9.09E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN larynx cancer DOID_2596 3.451E-03 9.048E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN laryngeal benign neoplasm DOID_2598 3.451E-03 9.048E-03 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN primary immunodeficiency disease DOID_612 3.573E-03 9.326E-03 0.02465176 0.12868669 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Huntington's disease DOID_12858 3.852E-03 0.01000812 0.27059686 0.57883314 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN uveal disease DOID_3480 3.852E-03 9.963E-03 0.27059686 0.57025783 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hydrocephalus DOID_10908 4.008E-03 0.01031872 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypercalcemia DOID_12678 4.008E-03 0.01027224 0.09152671 0.30999224 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN polycystic kidney disease DOID_898 4.008E-03 0.01022618 0.09152671 0.30634527 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN thalassemia DOID_10241 4.604E-03 0.01169402 4.604E-03 0.05037424 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN communication disorder DOID_2033 4.604E-03 0.01164205 0.0977355 0.32145375 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hemangioma DOID_255 4.604E-03 0.01159053 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN membranoproliferative glomerulonephritis DOID_2920 4.604E-03 0.01153947 4.604E-03 0.04942379 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN nutritional deficiency disease DOID_5113 4.604E-03 0.01148886 0.0977355 0.31777999 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN intracranial hypertension DOID_9428 4.604E-03 0.01143869 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bone marrow disease DOID_4961 4.875E-03 0.01206038 0.0459562 0.20114675 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN silicosis DOID_10325 5.238E-03 0.01290145 0.10390202 0.32483654 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN thyroiditis DOID_7166 5.238E-03 0.01284585 0.10390202 0.3213057 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autoimmune thyroiditis DOID_7188 5.238E-03 0.01284585 0.10390202 0.3213057 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN glaucoma DOID_1686 5.442E-03 0.01329008 0.30002662 0.61408326 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN adrenal gland disease DOID_9553 5.909E-03 0.01436946 5.909E-03 0.05604089 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN keratosis DOID_161 6.618E-03 0.0160247 0.1161094 0.34409504 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN prion disease DOID_649 6.618E-03 0.0159568 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Down syndrome DOID_14250 7.364E-03 0.01767927 7.364E-03 0.06253711 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN granulosa cell tumor DOID_2999 7.364E-03 0.01760499 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN infertility DOID_5223 7.364E-03 0.01753132 7.364E-03 0.06161745 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN reproductive organ benign neoplasm DOID_0050622 7.374E-03 0.01748287 0.05986857 0.25047953 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN amnestic disorder DOID_10914 8.145E-03 0.01923111 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN membranous glomerulonephritis DOID_10976 8.145E-03 0.01915164 0.12815111 0.36827264 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pulmonary edema DOID_11396 8.145E-03 0.01907283 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN colon carcinoma DOID_1520 8.145E-03 0.01899466 8.145E-03 0.06620996 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN sex cord-gonadal stromal tumor DOID_192 8.145E-03 0.01891713 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN subependymal glioma DOID_4843 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pilocytic astrocytoma DOID_4851 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN subependymal giant cell astrocytoma DOID_5077 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN fibrillary astrocytoma DOID_6726 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN juvenile pilocytic astrocytoma DOID_6811 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN childhood pilocytic astrocytoma DOID_6812 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN gemistocytic astrocytoma DOID_7005 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN childhood cerebral astrocytoma DOID_7007 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN protoplasmic astrocytoma DOID_7008 8.145E-03 0.01884023 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN melancholia DOID_2848 8.86E-03 0.02041046 0.34647074 0.68452033 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN autoimmune hepatitis DOID_2048 8.962E-03 0.02056306 0.13411054 0.37964626 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN mitochondrial myopathy DOID_699 8.962E-03 0.02048047 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN neurotic disorder DOID_4964 9.257E-03 0.02106866 0.35094283 0.68857404 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN funisitis DOID_0050698 9.815E-03 0.02224906 9.815E-03 0.07546642 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN benign glioma DOID_0060101 9.815E-03 0.02216077 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN thrombophilia DOID_2452 9.815E-03 0.02207318 0.1400294 0.39057219 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN benign ependymoma DOID_4844 9.815E-03 0.02216077 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN sinusitis DOID_0050127 0.01070129 0.02397258 0.14590795 0.39914241 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN paranasal sinus disease DOID_1352 0.01070129 0.02397258 0.14590795 0.39914241 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN muscle cancer DOID_4045 0.01070129 0.02387857 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypoglycemia DOID_9993 0.01070129 0.0237853 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Lewy body dementia DOID_12217 0.01162199 0.02573117 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN aortic valve disease DOID_62 0.01162199 0.02563144 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN meningitis DOID_9471 0.01162199 0.02553248 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN tooth disease DOID_1091 0.01232381 0.02697018 0.38140537 0.7307059 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN spastic quadriplegia DOID_10970 0.0125762 0.02741708 0.15754523 0.4112075 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN morbid obesity DOID_11981 0.01458317 0.03167109 0.01458317 0.09323399 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN papillary adenoma DOID_3172 0.01458317 0.03155067 0.01458317 0.09219806 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN microcystic adenoma DOID_5403 0.01458317 0.03155067 0.01458317 0.09219806 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN follicular adenoma DOID_6204 0.01458317 0.03155067 0.01458317 0.09219806 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN myositis DOID_633 0.01458317 0.03143116 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cleft lip DOID_9296 0.01458317 0.03131255 0.16902455 0.42744431 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN intracranial aneurysm DOID_10941 0.01563496 0.03344471 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hypotrichosis DOID_4535 0.01563496 0.03331944 0.01563496 0.09565905 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN gestational diabetes DOID_11714 0.0167183 0.0354952 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lung adenocarcinoma DOID_3910 0.0167183 0.03536325 0.18034805 0.44811372 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN migraine DOID_6364 0.0167183 0.03523227 0.0167183 0.09909076 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN periodontitis DOID_824 0.0167183 0.03510226 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN polycystic ovary syndrome DOID_11612 0.01897775 0.03969978 0.19151784 0.46175276 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN focal glomerulosclerosis DOID_3945 0.01897775 0.03955436 0.19151784 0.45787248 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN chromosomal disease DOID_0080014 0.01939533 0.04027717 0.01939533 0.10819553 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN auditory system disease DOID_2742 0.02001453 0.04141189 0.11274383 0.34122998 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN female reproductive organ benign neoplasm DOID_0060086 0.02015292 0.04154713 0.19704574 0.46911726 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN uterine benign neoplasm DOID_0060095 0.02015292 0.04154713 0.19704574 0.46911726 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN corneal disease DOID_10124 0.02015292 0.04139715 0.19704574 0.46716261 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN uterine fibroid DOID_13223 0.02015292 0.04154713 0.19704574 0.46911726 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN spastic cerebral palsy DOID_0050669 0.02135776 0.04371427 0.20253599 0.47621065 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN opportunistic mycosis DOID_2473 0.02135776 0.04355759 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN bronchiolitis obliterans DOID_2799 0.02135776 0.04340202 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN Charcot-Marie-Tooth disease DOID_10595 0.02259183 0.04574644 0.20798884 0.48502316 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN systemic mycosis DOID_0050136 0.02514582 0.05073749 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN fungal infectious disease DOID_1564 0.02514582 0.05073749 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN male infertility DOID_12336 0.02646486 0.05321026 0.02646486 0.1332611 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN nephroblastoma DOID_2154 0.02646486 0.0530229 0.22412556 0.51010976 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN periodontal disease DOID_3388 0.02646486 0.05283686 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN aplastic anemia DOID_12449 0.02781133 0.05533094 0.22943134 0.50994701 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN embryonal cancer DOID_688 0.03058488 0.06063692 0.03058488 0.14624199 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN peripheral nervous system neoplasm DOID_1192 0.0320111 0.06324415 0.0320111 0.15178596 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN blood platelet disease DOID_2218 0.0320111 0.06302531 0.0320111 0.15053153 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN congenital diaphragmatic hernia DOID_3827 0.03346305 0.06565681 0.25029551 0.53946266 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pulmonary emphysema DOID_9675 0.0364425 0.07125698 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN spinocerebellar ataxia DOID_1441 0.03796918 0.07398789 0.03796918 0.17422955 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN endometriosis of uterus DOID_288 0.03796918 0.07373537 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN primitive neuroectodermal tumor DOID_168 0.03951996 0.07648592 0.27059686 0.57451349 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN endometriosis DOID_289 0.03951996 0.07622664 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN cataract DOID_83 0.04269224 0.08206718 0.04269224 0.19279274 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN spinocerebellar degeneration DOID_2478 0.04431295 0.08489586 0.04431295 0.19853599 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN lens disease DOID_110 0.0459562 0.08774858 0.0459562 0.20428967 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN pulmonary tuberculosis DOID_2957 0.04930878 0.0938351 1.000 1.000 NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN hemorrhagic disease DOID_2213 0.05274698 0.09971106 0.05274698 0.22566188 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP primary immunodeficiency disease DOID_612 1.603E-10 9.121E-08 1.603E-10 9.121E-08 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP tuberculosis DOID_399 1.967E-09 5.597E-07 5.803E-06 4.717E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP calcinosis DOID_182 6.246E-09 1.185E-06 5.669E-07 1.613E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP primary bacterial infectious disease DOID_0050338 7.802E-09 1.11E-06 1.426E-05 1.015E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP calcium metabolism disease DOID_10575 2.68E-08 3.05E-06 1.788E-06 2.034E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP mineral metabolism disease DOID_0050032 8.863E-08 8.405E-06 4.6E-06 4.362E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP conjunctival disease DOID_4251 4.957E-07 4.03E-05 1.174E-04 5.568E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP conjunctivitis DOID_6195 4.957E-07 4.03E-05 1.174E-04 5.568E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP hypersensitivity reaction type I disease DOID_1205 5.696E-07 4.051E-05 5.696E-07 1.08E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP heart valve disease DOID_4079 1.411E-06 8.922E-05 1.411E-06 2.007E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP eyelid disease DOID_530 1.497E-06 8.516E-05 2.365E-04 7.914E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP parasitic protozoa infectious disease DOID_2789 2.574E-06 1.332E-04 1.205E-04 5.276E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP parasitic infectious disease DOID_1398 4.881E-06 2.315E-04 1.935E-04 6.881E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP allergic contact dermatitis DOID_3042 5.483E-06 2.4E-04 5.916E-03 0.08015367 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP pancreatic ductal carcinoma DOID_3587 6.484E-06 2.635E-04 2.387E-04 7.547E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP pancreatic carcinoma DOID_4905 7.615E-06 2.889E-04 2.689E-04 8.053E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP bone resorption disease DOID_0080011 8.886E-06 3.16E-04 3.014E-04 8.576E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP osteoporosis DOID_11476 8.886E-06 3.16E-04 3.014E-04 8.576E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP bacterial pneumonia DOID_874 9.342E-06 3.127E-04 7.661E-03 0.0968686 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP contact dermatitis DOID_2773 1.031E-05 3.258E-04 8.034E-03 0.09938268 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP Human immunodeficiency virus infectious disease DOID_526 1.626E-05 4.871E-04 1.626E-05 1.028E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP encephalomyelitis DOID_640 1.846E-05 5.253E-04 5.179E-04 0.01227867 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP opportunistic mycosis DOID_2473 2.194E-05 5.945E-04 2.194E-05 1.249E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP systemic mycosis DOID_0050136 2.861E-05 7.401E-04 2.861E-05 1.48E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP fungal infectious disease DOID_1564 2.861E-05 7.401E-04 2.861E-05 1.48E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP myocarditis DOID_820 2.861E-05 7.079E-04 1.599E-03 0.0275792 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP respiratory syncytial virus infectious disease DOID_1273 4.569E-05 1.083E-03 0.06646857 0.34382377 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP endometriosis of uterus DOID_288 5.627E-05 1.281E-03 0.07104638 0.35152515 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP endometriosis DOID_289 6.013E-05 1.316E-03 0.07256741 0.3499225 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP influenza DOID_8469 6.416E-05 1.352E-03 0.07408598 0.35424306 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP pre-eclampsia DOID_10591 7.728E-05 1.57E-03 0.07862704 0.36671137 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP neuritis DOID_1803 7.728E-05 1.516E-03 3.065E-03 0.04713027 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP pulmonary tuberculosis DOID_2957 8.693E-05 1.649E-03 0.08164224 0.36868597 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP sarcoidosis DOID_11335 1.085E-04 1.992E-03 3.829E-03 0.05732809 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP hypersensitivity reaction type IV disease DOID_2916 1.401E-04 2.491E-03 4.526E-03 0.06602964 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP temporal arteritis DOID_13375 1.434E-04 2.472E-03 0.01784545 0.18803822 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP central nervous system vasculitis DOID_525 1.434E-04 2.472E-03 0.01784545 0.18803822 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP leukocyte disease DOID_9500 1.47E-04 2.461E-03 1.47E-04 5.976E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP carotid artery disease DOID_3407 1.616E-04 2.627E-03 4.97E-03 0.07069959 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP diarrhea DOID_13250 1.719E-04 2.716E-03 1.719E-04 6.519E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP ocular hypertension DOID_9282 1.719E-04 2.643E-03 0.01945215 0.19083225 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP borderline glaucoma DOID_9283 1.719E-04 2.643E-03 0.01945215 0.19083225 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP uterine disease DOID_345 1.935E-04 2.897E-03 0.10541684 0.43152648 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP hyperglycemia DOID_4195 2.021E-04 2.948E-03 0.10688248 0.43440092 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP silicosis DOID_10325 3.111E-04 4.426E-03 3.111E-04 8.431E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP pancreatitis DOID_4989 3.128E-04 4.341E-03 7.661E-03 0.09907016 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP female reproductive system disease DOID_229 3.486E-04 4.723E-03 0.12715504 0.49897393 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP focal epilepsy DOID_2234 3.739E-04 4.947E-03 3.739E-04 9.67E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP biliary tract cancer DOID_4607 3.739E-04 4.835E-03 8.61E-03 0.10423348 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP MHC class II deficiency DOID_5812 4.42E-04 5.589E-03 4.42E-04 0.01093442 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP esophagitis DOID_11963 4.906E-04 6.068E-03 0.03221292 0.26954633 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP neutropenia DOID_1227 5.952E-04 7.206E-03 5.952E-04 0.01354649 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP agranulocytosis DOID_12987 6.512E-04 7.719E-03 6.512E-04 0.01425097 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP Goodpasture syndrome DOID_9808 7.096E-04 8.24E-03 0.03853189 0.28473566 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP severe combined immunodeficiency DOID_627 7.705E-04 8.769E-03 7.705E-04 0.01623828 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP bronchiolitis DOID_2942 8.339E-04 9.303E-03 0.04167614 0.29642153 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP combined T cell and B cell immunodeficiency DOID_628 8.339E-04 9.124E-03 8.339E-04 0.01694535 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP ankylosing spondylitis DOID_7147 8.996E-04 9.658E-03 8.996E-04 0.01765132 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP extrinsic allergic alveolitis DOID_841 9.678E-04 0.01019785 0.04481027 0.28973911 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP Sciatic Neuropathy DOID_11446 1.038E-03 0.01074279 0.04637355 0.29647807 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP lesion of sciatic nerve DOID_12528 1.038E-03 0.01074279 0.04637355 0.29647807 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP perinatal necrotizing enterocolitis DOID_8677 1.038E-03 0.01055095 1.038E-03 0.01969511 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP mononeuritis of lower limb DOID_9473 1.038E-03 0.01074279 0.04637355 0.29647807 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP malaria DOID_12365 1.111E-03 0.01109458 1.111E-03 0.02039971 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP mononeuritis DOID_1802 1.111E-03 0.0109033 0.04793431 0.29646329 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP autoimmune disease of the nervous system DOID_438 1.111E-03 0.01071849 1.111E-03 0.01976222 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP mononeuropathy DOID_1188 1.187E-03 0.01125489 0.04949256 0.29643439 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP bronchiolitis obliterans DOID_2799 1.345E-03 0.01254382 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP allergic rhinitis DOID_4481 1.427E-03 0.01309905 0.05415227 0.30507567 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP pneumoconiosis DOID_10316 1.689E-03 0.0152557 1.689E-03 0.02826791 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP esophageal disease DOID_6050 1.689E-03 0.01501733 0.0587895 0.31858313 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP leukopenia DOID_615 1.689E-03 0.01478629 1.689E-03 0.02746025 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP pulmonary sarcoidosis DOID_13406 1.972E-03 0.01700118 0.06340437 0.33716902 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP hepatitis DOID_2237 2.172E-03 0.01844777 0.06646857 0.34072626 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP peptic ulcer DOID_750 2.172E-03 0.01817648 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP adult respiratory distress syndrome DOID_11394 2.276E-03 0.01876712 0.06799697 0.34544888 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP autoimmune disease of urogenital tract DOID_0060049 2.49E-03 0.02023874 0.07104638 0.3546087 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP primary biliary cirrhosis DOID_12236 2.49E-03 0.02023874 0.07104638 0.3546087 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP diabetic autonomic neuropathy DOID_11503 2.713E-03 0.02174209 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP autonomic neuropathy DOID_11504 2.713E-03 0.02174209 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP diabetic polyneuropathy DOID_12785 2.713E-03 0.02174209 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP gallbladder cancer DOID_3121 2.713E-03 0.02144011 2.713E-03 0.04288023 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP diabetic neuropathy DOID_9743 2.713E-03 0.02174209 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP autonomic nervous system disease DOID_11465 3.065E-03 0.02388795 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.31E-03 0.02545455 0.08164224 0.37463251 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP glaucoma DOID_1686 3.31E-03 0.02511516 0.08164224 0.37163545 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP atopic dermatitis DOID_3310 3.696E-03 0.02766935 0.08614683 0.38596493 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP bile duct adenocarcinoma DOID_4896 3.964E-03 0.02928983 0.08913781 0.39317375 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP cholangiocarcinoma DOID_4947 3.964E-03 0.02928983 0.08913781 0.39317375 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP vasculitis DOID_865 3.964E-03 0.02891432 0.08913781 0.38717109 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP bile duct cancer DOID_4606 4.526E-03 0.03259691 0.0950909 0.40378151 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP bile duct carcinoma DOID_4897 4.526E-03 0.03259691 0.0950909 0.40378151 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP respiratory failure DOID_11162 5.123E-03 0.0364338 0.10100571 0.42259006 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP temporal lobe epilepsy DOID_3328 5.753E-03 0.04041602 5.753E-03 0.07984629 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP brain infarction DOID_3454 6.082E-03 0.04220007 0.10980667 0.44312053 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP nephrosis DOID_2527 6.589E-03 0.04517338 6.589E-03 0.08719513 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP diabetic retinopathy DOID_8947 6.938E-03 0.04699939 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP cystic fibrosis DOID_1485 7.296E-03 0.04883755 0.11996736 0.47735263 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP retinal vascular disease DOID_2462 9.003E-03 0.05956867 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP transitional cell carcinoma DOID_2671 9.609E-03 0.06284199 9.609E-03 0.1139011 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP dilated cardiomyopathy DOID_12930 0.01108897 0.07170027 0.01108897 0.12876784 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP ulcerative colitis DOID_8577 0.01175231 0.07513552 0.15116381 0.57341472 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP Hermansky-Pudlak syndrome DOID_3753 0.01623617 0.09933745 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP visceral leishmaniasis DOID_9146 0.01623617 0.09828067 0.01623617 0.17430911 ALONSO_METASTASIS_NEURAL_UP seminoma DOID_4440 4.082E-05 0.02322872 9.561E-03 0.33999558 ALONSO_METASTASIS_NEURAL_UP endometrial cancer DOID_1380 6.052E-05 0.01721719 0.01159818 0.27497352 ALONSO_METASTASIS_NEURAL_UP germinoma DOID_3304 6.052E-05 0.01147813 0.01159818 0.26397458 ALONSO_METASTASIS_NEURAL_UP male infertility DOID_12336 7.18E-05 0.0102139 7.18E-05 0.0408556 ALONSO_METASTASIS_NEURAL_UP medullomyoblastoma DOID_3861 7.578E-05 8.623E-03 0.01295448 0.27300362 ALONSO_METASTASIS_NEURAL_UP adult medulloblastoma DOID_3864 7.578E-05 8.623E-03 0.01295448 0.27300362 ALONSO_METASTASIS_NEURAL_UP childhood medulloblastoma DOID_3869 7.578E-05 8.623E-03 0.01295448 0.27300362 ALONSO_METASTASIS_NEURAL_UP refractive error DOID_9835 7.986E-05 7.573E-03 0.01329328 0.26082339 ALONSO_METASTASIS_NEURAL_UP medulloblastoma DOID_3858 8.404E-05 6.832E-03 0.01363198 0.25855325 ALONSO_METASTASIS_NEURAL_UP embryonal cancer DOID_688 8.404E-05 5.978E-03 0.01363198 0.25021283 ALONSO_METASTASIS_NEURAL_UP primitive neuroectodermal tumor DOID_168 1.114E-04 7.042E-03 0.01566192 0.27004946 ALONSO_METASTASIS_NEURAL_UP uterine cancer DOID_363 1.163E-04 6.619E-03 0.01599987 0.26011213 ALONSO_METASTASIS_NEURAL_UP leukocyte disease DOID_9500 2.029E-04 0.01049485 0.02105625 0.28526206 ALONSO_METASTASIS_NEURAL_UP neuroectodermal tumor DOID_171 2.162E-04 0.01025224 0.02172862 0.28752522 ALONSO_METASTASIS_NEURAL_UP endocrine organ benign neoplasm DOID_0060089 2.662E-04 0.01164942 2.662E-04 0.07572124 ALONSO_METASTASIS_NEURAL_UP male reproductive system disease DOID_48 2.891E-04 0.01175076 2.891E-04 0.05483687 SENESE_HDAC1_AND_HDAC2_TARGETS_DN aortic valve insufficiency DOID_57 9.376E-13 5.335E-10 0.03825146 0.30229278 SENESE_HDAC1_AND_HDAC2_TARGETS_DN aortic valve disease DOID_62 1.052E-12 2.994E-10 2.75E-03 0.07451579 SENESE_HDAC1_AND_HDAC2_TARGETS_DN heart valve disease DOID_4079 4.668E-12 8.854E-10 0.0115541 0.19922073 SENESE_HDAC1_AND_HDAC2_TARGETS_DN Ehlers-Danlos syndrome DOID_13359 1.401E-07 1.993E-05 0.04758532 0.31121893 SENESE_HDAC1_AND_HDAC2_TARGETS_DN aneurysm disease DOID_2403 2.362E-07 2.688E-05 0.02734521 0.30508676 SENESE_HDAC1_AND_HDAC2_TARGETS_DN familial hypertrophic cardiomyopathy DOID_11986 2.43E-07 2.305E-05 2.43E-07 1.383E-04 SENESE_HDAC1_AND_HDAC2_TARGETS_DN ureteral obstruction DOID_5199 3.117E-07 2.533E-05 0.05682932 0.31394063 SENESE_HDAC1_AND_HDAC2_TARGETS_DN aortic aneurysm DOID_3627 8.391E-07 5.968E-05 0.0129154 0.20996757 SENESE_HDAC1_AND_HDAC2_TARGETS_DN urinary tract obstruction DOID_5200 8.906E-07 5.631E-05 0.07203864 0.37605493 SENESE_HDAC1_AND_HDAC2_TARGETS_DN ureteral disease DOID_1426 1.066E-06 6.066E-05 0.07505119 0.38821932 SENESE_HDAC1_AND_HDAC2_TARGETS_DN cleft palate DOID_674 8.808E-06 4.556E-04 3.016E-04 0.02860268 SENESE_HDAC1_AND_HDAC2_TARGETS_DN bone development disease DOID_0080006 9.35E-06 4.433E-04 2.803E-03 0.07249953 SENESE_HDAC1_AND_HDAC2_TARGETS_DN nephrotic syndrome DOID_1184 1.549E-05 6.781E-04 9.845E-03 0.18069636 SENESE_HDAC1_AND_HDAC2_TARGETS_DN uveal disease DOID_3480 1.549E-05 6.297E-04 1.549E-05 4.408E-03 SENESE_HDAC1_AND_HDAC2_TARGETS_DN dilated cardiomyopathy DOID_12930 1.682E-05 6.379E-04 2.896E-04 0.03295342 SENESE_HDAC1_AND_HDAC2_TARGETS_DN basal cell carcinoma DOID_2513 2.192E-05 7.796E-04 1.375E-03 0.05590058 SENESE_HDAC1_AND_HDAC2_TARGETS_DN glaucoma DOID_1686 2.532E-05 8.475E-04 0.0124542 0.20842471 SENESE_HDAC1_AND_HDAC2_TARGETS_DN skin carcinoma DOID_3451 2.624E-05 8.296E-04 1.544E-03 0.05857117 SENESE_HDAC1_AND_HDAC2_TARGETS_DN orofacial cleft DOID_0050567 3.166E-05 9.481E-04 7.73E-04 0.0439838 SENESE_HDAC1_AND_HDAC2_TARGETS_DN brain edema DOID_4724 3.649E-05 1.038E-03 3.649E-05 6.921E-03 SENESE_HDAC1_AND_HDAC2_TARGETS_DN congenital nervous system abnormality DOID_2490 4.47E-05 1.211E-03 9.965E-04 0.05154382 SENESE_HDAC1_AND_HDAC2_TARGETS_DN oral cavity cancer DOID_8618 4.772E-05 1.234E-03 4.772E-05 6.788E-03 SENESE_HDAC1_AND_HDAC2_TARGETS_DN collagen disease DOID_854 5.766E-05 1.427E-03 0.18791891 0.63646345 SENESE_HDAC1_AND_HDAC2_TARGETS_DN nephrosis DOID_2527 1.018E-04 2.415E-03 0.02422443 0.28716039 SENESE_HDAC1_AND_HDAC2_TARGETS_DN bile duct disease DOID_4138 1.018E-04 2.318E-03 1.826E-03 0.06495042 SENESE_HDAC1_AND_HDAC2_TARGETS_DN biliary tract disease DOID_9741 1.073E-04 2.349E-03 1.898E-03 0.06352722 SENESE_HDAC1_AND_HDAC2_TARGETS_DN hepatitis C DOID_1883 2.389E-04 5.034E-03 0.11334267 0.48490209 SENESE_HDAC1_AND_HDAC2_TARGETS_DN encephalomyelitis DOID_640 2.674E-04 5.434E-03 0.0383288 0.29078782 SENESE_HDAC1_AND_HDAC2_TARGETS_DN uveitis DOID_13141 3.247E-04 6.37E-03 3.247E-04 0.02638963 SENESE_HDAC1_AND_HDAC2_TARGETS_DN hepatitis DOID_2237 3.488E-04 6.616E-03 0.12764779 0.51879711 SENESE_HDAC1_AND_HDAC2_TARGETS_DN benign mesothelioma DOID_2645 4.005E-04 7.351E-03 9.036E-03 0.18362612 SENESE_HDAC1_AND_HDAC2_TARGETS_DN facioscapulohumeral muscular dystrophy DOID_11727 4.619E-04 8.213E-03 0.03197854 0.30326313 SENESE_HDAC1_AND_HDAC2_TARGETS_DN holoprosencephaly DOID_4621 4.619E-04 7.965E-03 0.03197854 0.28882203 SENESE_HDAC1_AND_HDAC2_TARGETS_DN cataract DOID_83 5.181E-04 8.671E-03 5.181E-04 0.03685064 SENESE_HDAC1_AND_HDAC2_TARGETS_DN lens disease DOID_110 5.844E-04 9.5E-03 5.844E-04 0.03694463 SENESE_HDAC1_AND_HDAC2_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 9.027E-04 0.01426839 0.01533089 0.24231329 SENESE_HDAC1_AND_HDAC2_TARGETS_DN integumentary system cancer DOID_0060122 9.027E-04 0.01388276 0.01533089 0.23576429 SENESE_HDAC1_AND_HDAC2_TARGETS_DN osteochondrodysplasia DOID_2256 9.027E-04 0.01351742 0.17190349 0.61133178 SENESE_HDAC1_AND_HDAC2_TARGETS_DN skin cancer DOID_4159 9.027E-04 0.01388276 0.01533089 0.23576429 SENESE_HDAC1_AND_HDAC2_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 1.046E-03 0.01525395 1.046E-03 0.04957535 SENESE_HDAC1_AND_HDAC2_TARGETS_DN oral submucous fibrosis DOID_5773 1.066E-03 0.01516976 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN restrictive cardiomyopathy DOID_397 1.216E-03 0.01687815 0.0506766 0.30675514 SENESE_HDAC1_AND_HDAC2_TARGETS_DN tongue cancer DOID_8649 1.216E-03 0.01647628 1.216E-03 0.05323107 SENESE_HDAC1_AND_HDAC2_TARGETS_DN respiratory failure DOID_11162 1.257E-03 0.01663354 0.01900982 0.26381922 SENESE_HDAC1_AND_HDAC2_TARGETS_DN pre-malignant neoplasm DOID_0060071 1.314E-03 0.0169895 0.01956282 0.26502966 SENESE_HDAC1_AND_HDAC2_TARGETS_DN in situ carcinoma DOID_8719 1.314E-03 0.0169895 0.01956282 0.26502966 SENESE_HDAC1_AND_HDAC2_TARGETS_DN mineral metabolism disease DOID_0050032 1.372E-03 0.01734972 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN cholestasis DOID_13580 1.432E-03 0.01771412 0.02068891 0.27376725 SENESE_HDAC1_AND_HDAC2_TARGETS_DN hyperglycemia DOID_4195 1.494E-03 0.01808264 0.02126191 0.27495511 SENESE_HDAC1_AND_HDAC2_TARGETS_DN coronary restenosis DOID_4247 2.106E-03 0.02496308 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN pancreatitis DOID_4989 2.282E-03 0.02650336 2.282E-03 0.07214804 SENESE_HDAC1_AND_HDAC2_TARGETS_DN mixed glioma DOID_5076 2.282E-03 0.02597329 0.22914033 0.74080029 SENESE_HDAC1_AND_HDAC2_TARGETS_DN thrombophilia DOID_2452 2.312E-03 0.02578939 2.312E-03 0.06922416 SENESE_HDAC1_AND_HDAC2_TARGETS_DN biliary tract cancer DOID_4607 2.712E-03 0.02967252 0.03129093 0.31793818 SENESE_HDAC1_AND_HDAC2_TARGETS_DN synostosis DOID_11971 2.75E-03 0.02952512 2.75E-03 0.07824158 SENESE_HDAC1_AND_HDAC2_TARGETS_DN Goodpasture syndrome DOID_9808 2.75E-03 0.02897836 0.07505119 0.38472185 SENESE_HDAC1_AND_HDAC2_TARGETS_DN portal hypertension DOID_10762 3.225E-03 0.03336102 0.0810472 0.40810494 SENESE_HDAC1_AND_HDAC2_TARGETS_DN nervous system cancer DOID_3093 3.392E-03 0.03446087 0.03615883 0.29817936 SENESE_HDAC1_AND_HDAC2_TARGETS_DN cleft lip DOID_9296 3.475E-03 0.03469215 0.08403074 0.41218525 SENESE_HDAC1_AND_HDAC2_TARGETS_DN mouth disease DOID_403 3.823E-03 0.03750258 0.2682855 0.83417732 SENESE_HDAC1_AND_HDAC2_TARGETS_DN hepatic vascular disease DOID_272 4.28E-03 0.04127422 0.09292381 0.44061375 SENESE_HDAC1_AND_HDAC2_TARGETS_DN coronary stenosis DOID_4248 4.28E-03 0.04058631 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 4.565E-03 0.04258396 0.0958691 0.44712719 SENESE_HDAC1_AND_HDAC2_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 4.859E-03 0.04459585 0.0988049 0.4497599 SENESE_HDAC1_AND_HDAC2_TARGETS_DN uterine benign neoplasm DOID_0060095 4.859E-03 0.04459585 0.0988049 0.4497599 SENESE_HDAC1_AND_HDAC2_TARGETS_DN uterine fibroid DOID_13223 4.859E-03 0.04459585 0.0988049 0.4497599 SENESE_HDAC1_AND_HDAC2_TARGETS_DN dysostosis DOID_1934 4.859E-03 0.04388798 4.859E-03 0.12021491 SENESE_HDAC1_AND_HDAC2_TARGETS_DN leiomyoma DOID_127 5.792E-03 0.05149767 0.10755569 0.47811864 SENESE_HDAC1_AND_HDAC2_TARGETS_DN hair disease DOID_421 6.12E-03 0.05357476 0.11045384 0.47975754 SENESE_HDAC1_AND_HDAC2_TARGETS_DN metal metabolism disorder DOID_896 6.12E-03 0.05276302 0.11045384 0.47612301 SENESE_HDAC1_AND_HDAC2_TARGETS_DN spindle cell carcinoma DOID_4015 6.456E-03 0.05482961 6.456E-03 0.15306601 SENESE_HDAC1_AND_HDAC2_TARGETS_DN hyperthyroidism DOID_7998 6.456E-03 0.0540233 6.456E-03 0.14694337 SENESE_HDAC1_AND_HDAC2_TARGETS_DN lymphoid leukemia DOID_10747 6.801E-03 0.05607961 6.801E-03 0.14882665 SENESE_HDAC1_AND_HDAC2_TARGETS_DN medullomyoblastoma DOID_3861 6.801E-03 0.05527847 0.11622219 0.48985499 SENESE_HDAC1_AND_HDAC2_TARGETS_DN adult medulloblastoma DOID_3864 6.801E-03 0.05527847 0.11622219 0.48985499 SENESE_HDAC1_AND_HDAC2_TARGETS_DN childhood medulloblastoma DOID_3869 6.801E-03 0.05527847 0.11622219 0.48985499 SENESE_HDAC1_AND_HDAC2_TARGETS_DN calcinosis DOID_182 7.514E-03 0.06021457 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN medulloblastoma DOID_3858 7.514E-03 0.05937826 0.12195342 0.50650728 SENESE_HDAC1_AND_HDAC2_TARGETS_DN adenoid cystic carcinoma DOID_4866 8.644E-03 0.06737238 8.644E-03 0.18215495 SENESE_HDAC1_AND_HDAC2_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 9.036E-03 0.06948015 9.036E-03 0.17729418 SENESE_HDAC1_AND_HDAC2_TARGETS_DN salivary gland cancer DOID_8850 9.436E-03 0.07159124 9.436E-03 0.17897809 SENESE_HDAC1_AND_HDAC2_TARGETS_DN primitive neuroectodermal tumor DOID_168 9.845E-03 0.07370509 0.13892688 0.5414342 SENESE_HDAC1_AND_HDAC2_TARGETS_DN proteinuria DOID_576 0.01111531 0.08213783 0.14729115 0.55872444 SENESE_HDAC1_AND_HDAC2_TARGETS_DN pre-eclampsia DOID_10591 0.0115541 0.08428569 0.0115541 0.20544638 SENESE_HDAC1_AND_HDAC2_TARGETS_DN brain cancer DOID_1319 0.0115541 0.08321879 0.1500613 0.56546277 SENESE_HDAC1_AND_HDAC2_TARGETS_DN neuritis DOID_1803 0.0115541 0.08217855 0.1500613 0.56174262 SENESE_HDAC1_AND_HDAC2_TARGETS_DN thyroid adenoma DOID_2891 0.0115541 0.081164 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN vascular skin disease DOID_9540 0.0115541 0.0801742 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN central nervous system cancer DOID_3620 0.01200042 0.08226791 0.15282251 0.56833994 SENESE_HDAC1_AND_HDAC2_TARGETS_DN calcium metabolism disease DOID_10575 0.0129154 0.08748649 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_DN atrophic muscular disease DOID_913 0.01434301 0.0960138 0.1664957 0.59959529 SENESE_HDAC1_AND_HDAC2_TARGETS_DN muscular dystrophy DOID_9884 0.01434301 0.0960138 0.1664957 0.59959529 SMID_BREAST_CANCER_LUMINAL_A_UP metabolic syndrome X DOID_14221 6.374E-06 3.627E-03 0.11234903 0.51553708 SMID_BREAST_CANCER_LUMINAL_A_UP alcohol abuse DOID_1574 7.355E-06 2.092E-03 6.83E-03 0.14947421 SMID_BREAST_CANCER_LUMINAL_A_UP gestational diabetes DOID_11714 1.028E-05 1.949E-03 0.04124368 0.32593966 SMID_BREAST_CANCER_LUMINAL_A_UP migraine DOID_6364 1.028E-05 1.462E-03 8.182E-04 0.06650544 SMID_BREAST_CANCER_LUMINAL_A_UP Crohn's disease DOID_8778 1.192E-05 1.357E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP endometriosis of uterus DOID_288 3.926E-05 3.724E-03 0.06327905 0.38715892 SMID_BREAST_CANCER_LUMINAL_A_UP hyperinsulinism DOID_2018 4.196E-05 3.411E-03 0.06463963 0.38715736 SMID_BREAST_CANCER_LUMINAL_A_UP endometriosis DOID_289 4.196E-05 2.984E-03 0.06463963 0.38312447 SMID_BREAST_CANCER_LUMINAL_A_UP pre-eclampsia DOID_10591 5.396E-05 3.411E-03 0.07006257 0.40268282 SMID_BREAST_CANCER_LUMINAL_A_UP thyroid adenoma DOID_2891 5.396E-05 3.07E-03 0.07006257 0.398656 SMID_BREAST_CANCER_LUMINAL_A_UP vascular skin disease DOID_9540 5.396E-05 2.791E-03 2.421E-03 0.09839282 SMID_BREAST_CANCER_LUMINAL_A_UP atrophic muscular disease DOID_913 7.584E-05 3.596E-03 7.584E-05 0.04315321 SMID_BREAST_CANCER_LUMINAL_A_UP muscular dystrophy DOID_9884 7.584E-05 3.596E-03 7.584E-05 0.04315321 SMID_BREAST_CANCER_LUMINAL_A_UP heroin dependence DOID_9976 1.127E-04 4.933E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP endocrine pancreas disease DOID_1428 1.296E-04 5.267E-03 0.09276771 0.47129307 SMID_BREAST_CANCER_LUMINAL_A_UP pituitary gland disease DOID_53 1.351E-04 5.126E-03 0.01727344 0.2730163 SMID_BREAST_CANCER_LUMINAL_A_UP lipodystrophy DOID_811 1.351E-04 4.805E-03 0.01727344 0.26563748 SMID_BREAST_CANCER_LUMINAL_A_UP cholestasis DOID_13580 1.354E-04 4.533E-03 0.09408622 0.47376157 SMID_BREAST_CANCER_LUMINAL_A_UP uterine disease DOID_345 1.354E-04 4.281E-03 0.09408622 0.46552224 SMID_BREAST_CANCER_LUMINAL_A_UP endocrine organ benign neoplasm DOID_0060089 1.54E-04 4.611E-03 0.09803048 0.48085639 SMID_BREAST_CANCER_LUMINAL_A_UP larynx cancer DOID_2596 1.595E-04 4.539E-03 1.595E-04 0.04539016 SMID_BREAST_CANCER_LUMINAL_A_UP laryngeal benign neoplasm DOID_2598 1.595E-04 4.539E-03 1.595E-04 0.04539016 SMID_BREAST_CANCER_LUMINAL_A_UP bile duct disease DOID_4138 1.741E-04 4.718E-03 0.10195787 0.49164432 SMID_BREAST_CANCER_LUMINAL_A_UP peripheral vascular disease DOID_341 1.812E-04 4.686E-03 5.358E-03 0.13858961 SMID_BREAST_CANCER_LUMINAL_A_UP biliary tract disease DOID_9741 1.812E-04 4.482E-03 0.10326327 0.48964 SMID_BREAST_CANCER_LUMINAL_A_UP alcohol dependence DOID_0050741 1.86E-04 4.409E-03 0.02012372 0.28625996 SMID_BREAST_CANCER_LUMINAL_A_UP panic disorder DOID_594 2.144E-04 4.879E-03 2.144E-04 0.04065895 SMID_BREAST_CANCER_LUMINAL_A_UP pancreatitis DOID_4989 2.193E-04 4.8E-03 6.074E-03 0.13823801 SMID_BREAST_CANCER_LUMINAL_A_UP contact dermatitis DOID_2773 2.359E-04 4.972E-03 2.359E-04 0.03355918 SMID_BREAST_CANCER_LUMINAL_A_UP female reproductive system disease DOID_229 2.445E-04 4.969E-03 0.1136396 0.51728744 SMID_BREAST_CANCER_LUMINAL_A_UP congenital muscular dystrophy DOID_0050557 3.115E-04 6.112E-03 3.115E-04 0.03544837 SMID_BREAST_CANCER_LUMINAL_A_UP autoimmune hepatitis DOID_2048 4.264E-04 8.086E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP opiate dependence DOID_2559 5.127E-04 9.41E-03 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP polyarteritis nodosa DOID_9810 5.127E-04 9.116E-03 0.03284988 0.31680646 SMID_BREAST_CANCER_LUMINAL_A_UP hypogonadism DOID_1924 6.568E-04 0.01132428 0.03705576 0.31946557 SMID_BREAST_CANCER_LUMINAL_A_UP morbid obesity DOID_11981 7.087E-04 0.01185947 0.03845373 0.3265697 SMID_BREAST_CANCER_LUMINAL_A_UP Sciatic Neuropathy DOID_11446 8.182E-04 0.01330109 8.182E-04 0.07758968 SMID_BREAST_CANCER_LUMINAL_A_UP lesion of sciatic nerve DOID_12528 8.182E-04 0.01330109 8.182E-04 0.07758968 SMID_BREAST_CANCER_LUMINAL_A_UP mononeuritis of lower limb DOID_9473 8.182E-04 0.01330109 8.182E-04 0.07758968 SMID_BREAST_CANCER_LUMINAL_A_UP renal hypertension DOID_1073 8.758E-04 0.01384242 8.758E-04 0.06229089 SMID_BREAST_CANCER_LUMINAL_A_UP secondary hypertension DOID_11130 8.758E-04 0.01384242 8.758E-04 0.06229089 SMID_BREAST_CANCER_LUMINAL_A_UP mononeuritis DOID_1802 8.758E-04 0.0134683 8.758E-04 0.05536968 SMID_BREAST_CANCER_LUMINAL_A_UP mononeuropathy DOID_1188 9.353E-04 0.01400525 9.353E-04 0.05321993 SMID_BREAST_CANCER_LUMINAL_A_UP female reproductive organ benign neoplasm DOID_0060086 9.968E-04 0.01454235 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP uterine benign neoplasm DOID_0060095 9.968E-04 0.01454235 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP corneal disease DOID_10124 9.968E-04 0.01417879 0.04541372 0.33128727 SMID_BREAST_CANCER_LUMINAL_A_UP uterine fibroid DOID_13223 9.968E-04 0.01454235 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP gonadal disease DOID_2277 1.06E-03 0.01471173 0.04679977 0.33286338 SMID_BREAST_CANCER_LUMINAL_A_UP leiomyoma DOID_127 1.192E-03 0.01615377 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP thyroid carcinoma DOID_3963 1.332E-03 0.01762807 0.05232425 0.34619181 SMID_BREAST_CANCER_LUMINAL_A_UP thyroid cancer DOID_1781 1.479E-03 0.01913187 0.05507468 0.35210667 SMID_BREAST_CANCER_LUMINAL_A_UP multiple myeloma DOID_9538 1.556E-03 0.01967299 1.556E-03 0.08048042 SMID_BREAST_CANCER_LUMINAL_A_UP hepatitis DOID_2237 1.714E-03 0.02120444 0.05918565 0.36605036 SMID_BREAST_CANCER_LUMINAL_A_UP benign mesothelioma DOID_2645 1.88E-03 0.02275977 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP Huntington's disease DOID_12858 2.053E-03 0.02433701 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP myeloma DOID_0070004 2.421E-03 0.02811223 2.421E-03 0.11479162 SMID_BREAST_CANCER_LUMINAL_A_UP neuritis DOID_1803 2.421E-03 0.02754999 2.421E-03 0.10596149 SMID_BREAST_CANCER_LUMINAL_A_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.616E-03 0.0291825 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP aortic aneurysm DOID_3627 2.716E-03 0.02971612 2.716E-03 0.10301588 SMID_BREAST_CANCER_LUMINAL_A_UP hemorrhagic disease DOID_2213 2.818E-03 0.03024872 2.818E-03 0.10019889 SMID_BREAST_CANCER_LUMINAL_A_UP bone marrow cancer DOID_4960 3.134E-03 0.03301975 3.134E-03 0.10488626 SMID_BREAST_CANCER_LUMINAL_A_UP reproductive organ benign neoplasm DOID_0050622 3.243E-03 0.0335461 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP pustulosis of palm and sole DOID_4398 3.243E-03 0.03294706 0.08081599 0.42975982 SMID_BREAST_CANCER_LUMINAL_A_UP hypertrophic cardiomyopathy DOID_11984 3.58E-03 0.0357355 0.08481697 0.44276017 SMID_BREAST_CANCER_LUMINAL_A_UP carotid artery disease DOID_3407 3.933E-03 0.03858144 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP congenital heart defect DOID_1682 4.177E-03 0.04027969 4.177E-03 0.13202789 SMID_BREAST_CANCER_LUMINAL_A_UP hyperglycemia DOID_4195 4.555E-03 0.04319967 4.555E-03 0.13642001 SMID_BREAST_CANCER_LUMINAL_A_UP allergic contact dermatitis DOID_3042 4.685E-03 0.04370073 4.685E-03 0.13328722 SMID_BREAST_CANCER_LUMINAL_A_UP brain infarction DOID_3454 4.816E-03 0.04420117 0.09803048 0.4767465 SMID_BREAST_CANCER_LUMINAL_A_UP blood coagulation disease DOID_1247 5.084E-03 0.04591763 5.084E-03 0.13775289 SMID_BREAST_CANCER_LUMINAL_A_UP pancreatic ductal carcinoma DOID_3587 5.084E-03 0.04520017 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP pancreatic carcinoma DOID_4905 5.498E-03 0.04813044 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP diabetic retinopathy DOID_8947 5.498E-03 0.04740119 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP syndrome DOID_225 5.783E-03 0.04910942 5.783E-03 0.14305787 SMID_BREAST_CANCER_LUMINAL_A_UP aneurysm disease DOID_2403 5.927E-03 0.04959811 5.927E-03 0.14052797 SMID_BREAST_CANCER_LUMINAL_A_UP bacterial pneumonia DOID_874 6.074E-03 0.05008623 0.10976236 0.50776247 SMID_BREAST_CANCER_LUMINAL_A_UP chronic kidney failure DOID_784 6.83E-03 0.05551899 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP retinal vascular disease DOID_2462 7.144E-03 0.0572529 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_A_UP primary immunodeficiency disease DOID_612 7.791E-03 0.06157202 7.791E-03 0.16419204 SMID_BREAST_CANCER_LUMINAL_A_UP dilated cardiomyopathy DOID_12930 8.81E-03 0.06866637 0.13151524 0.57123796 SMID_BREAST_CANCER_LUMINAL_A_UP ulcerative colitis DOID_8577 9.34E-03 0.07181646 0.13529943 0.58322256 DAZARD_RESPONSE_TO_UV_SCC_UP leishmaniasis DOID_9065 1.195E-12 6.801E-10 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP cystic fibrosis DOID_1485 2.998E-12 8.53E-10 0.01025633 0.34328525 DAZARD_RESPONSE_TO_UV_SCC_UP influenza DOID_8469 4.766E-12 9.04E-10 0.08779146 0.54893779 DAZARD_RESPONSE_TO_UV_SCC_UP pleurisy DOID_10247 2.572E-11 3.659E-09 0.0569518 0.46293674 DAZARD_RESPONSE_TO_UV_SCC_UP pleural disease DOID_1532 6.977E-11 7.94E-09 0.06612752 0.49508629 DAZARD_RESPONSE_TO_UV_SCC_UP bone resorption disease DOID_0080011 2.091E-10 1.983E-08 1.798E-05 0.01023288 DAZARD_RESPONSE_TO_UV_SCC_UP osteoporosis DOID_11476 2.091E-10 1.983E-08 1.798E-05 0.01023288 DAZARD_RESPONSE_TO_UV_SCC_UP ulcerative colitis DOID_8577 1.118E-09 9.085E-08 0.17769225 0.77774533 DAZARD_RESPONSE_TO_UV_SCC_UP parasitic protozoa infectious disease DOID_2789 1.679E-09 1.194E-07 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP cutaneous leishmaniasis DOID_9111 2.783E-09 1.76E-07 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP visceral leishmaniasis DOID_9146 2.783E-09 1.584E-07 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP parasitic infectious disease DOID_1398 4.472E-09 2.313E-07 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP brain infarction DOID_3454 5.824E-09 2.762E-07 3.709E-04 0.0422096 DAZARD_RESPONSE_TO_UV_SCC_UP bacterial pneumonia DOID_874 1.205E-08 5.275E-07 0.01076552 0.30627897 DAZARD_RESPONSE_TO_UV_SCC_UP intracranial arterial disease DOID_13089 2.244E-08 9.118E-07 3.223E-03 0.14105712 DAZARD_RESPONSE_TO_UV_SCC_UP cerebral arterial disease DOID_3527 2.244E-08 9.118E-07 3.223E-03 0.14105712 DAZARD_RESPONSE_TO_UV_SCC_UP primary bacterial infectious disease DOID_0050338 2.299E-08 8.72E-07 0.15978273 0.73319657 DAZARD_RESPONSE_TO_UV_SCC_UP lymphoma DOID_0060058 3.196E-08 1.137E-06 3.57E-05 6.772E-03 DAZARD_RESPONSE_TO_UV_SCC_UP hypersensitivity reaction type I disease DOID_1205 3.861E-08 1.292E-06 0.01552816 0.36814687 DAZARD_RESPONSE_TO_UV_SCC_UP cerebral infarction DOID_3526 3.961E-08 1.252E-06 4E-03 0.16259118 DAZARD_RESPONSE_TO_UV_SCC_UP pulmonary tuberculosis DOID_2957 5.975E-08 1.789E-06 0.09667108 0.539273 DAZARD_RESPONSE_TO_UV_SCC_UP bronchiolitis DOID_2942 1.935E-07 5.505E-06 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP cystitis DOID_1679 2.268E-07 6.146E-06 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP cholestasis DOID_13580 2.339E-07 6.05E-06 0.12451678 0.63828872 DAZARD_RESPONSE_TO_UV_SCC_UP middle cerebral artery infarction DOID_3525 2.642E-07 6.537E-06 1.375E-03 0.08691917 DAZARD_RESPONSE_TO_UV_SCC_UP tuberculosis DOID_399 2.908E-07 6.895E-06 0.12964276 0.64144985 DAZARD_RESPONSE_TO_UV_SCC_UP bile duct disease DOID_4138 3.582E-07 8.153E-06 0.13473914 0.65526982 DAZARD_RESPONSE_TO_UV_SCC_UP biliary tract disease DOID_9741 3.832E-07 8.386E-06 0.13643138 0.65787673 DAZARD_RESPONSE_TO_UV_SCC_UP bladder disease DOID_365 6.687E-07 1.409E-05 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP biliary tract cancer DOID_4607 7.173E-07 1.458E-05 0.01208637 0.32748302 DAZARD_RESPONSE_TO_UV_SCC_UP mouth disease DOID_403 1.315E-06 2.579E-05 0.1712237 0.75524253 DAZARD_RESPONSE_TO_UV_SCC_UP peptic ulcer DOID_750 1.415E-06 2.684E-05 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP rheumatic disease DOID_1575 2.051E-06 3.764E-05 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP scleroderma DOID_419 2.051E-06 3.764E-05 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hemolytic anemia DOID_583 3.117E-06 5.543E-05 4.505E-03 0.17088147 DAZARD_RESPONSE_TO_UV_SCC_UP normocytic anemia DOID_720 3.117E-06 5.543E-05 4.505E-03 0.17088147 DAZARD_RESPONSE_TO_UV_SCC_UP B-cell lymphocytic neoplasm DOID_707 3.927E-06 6.772E-05 1.648E-04 0.02344887 DAZARD_RESPONSE_TO_UV_SCC_UP collagen disease DOID_854 7.775E-06 1.301E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP amnestic disorder DOID_10914 7.946E-06 1.292E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP esophagitis DOID_11963 7.946E-06 1.256E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP mitochondrial myopathy DOID_699 9.258E-06 1.424E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP endocrine pancreas disease DOID_1428 9.338E-06 1.398E-04 0.12280151 0.63521872 DAZARD_RESPONSE_TO_UV_SCC_UP neutropenia DOID_1227 1.07E-05 1.562E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP agranulocytosis DOID_12987 1.229E-05 1.749E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP meningitis DOID_9471 1.403E-05 1.947E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP pancreatitis DOID_4989 1.89E-05 2.561E-04 0.01076552 0.32239892 DAZARD_RESPONSE_TO_UV_SCC_UP female reproductive system disease DOID_229 2.187E-05 2.893E-04 0.14985228 0.69890122 DAZARD_RESPONSE_TO_UV_SCC_UP diffuse large B-cell lymphoma DOID_0050745 2.515E-05 3.252E-04 2.515E-05 7.155E-03 DAZARD_RESPONSE_TO_UV_SCC_UP periodontitis DOID_824 2.515E-05 3.18E-04 0.05510601 0.46110762 DAZARD_RESPONSE_TO_UV_SCC_UP spastic cerebral palsy DOID_0050669 3.734E-05 4.619E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP bronchiolitis obliterans DOID_2799 3.734E-05 4.521E-04 0.06246785 0.47392273 DAZARD_RESPONSE_TO_UV_SCC_UP Crohn's disease DOID_8778 3.878E-05 4.597E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP dilated cardiomyopathy DOID_12930 4.039E-05 4.69E-04 9.227E-04 0.0750009 DAZARD_RESPONSE_TO_UV_SCC_UP pneumoconiosis DOID_10316 5.288E-05 6.018E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP periodontal disease DOID_3388 5.288E-05 5.9E-04 0.0697731 0.50254294 DAZARD_RESPONSE_TO_UV_SCC_UP thyroid carcinoma DOID_3963 5.288E-05 5.787E-04 2.395E-03 0.12388432 DAZARD_RESPONSE_TO_UV_SCC_UP esophageal disease DOID_6050 5.288E-05 5.677E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP leukopenia DOID_615 5.288E-05 5.572E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP thyroid cancer DOID_1781 6.203E-05 6.417E-04 2.658E-03 0.1260308 DAZARD_RESPONSE_TO_UV_SCC_UP respiratory syncytial virus infectious disease DOID_1273 7.759E-05 7.883E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hepatitis DOID_2237 7.759E-05 7.745E-04 0.07882574 0.52766875 DAZARD_RESPONSE_TO_UV_SCC_UP systemic scleroderma DOID_418 7.759E-05 7.612E-04 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP pulmonary emphysema DOID_9675 8.926E-05 8.608E-04 0.08242241 0.5390615 DAZARD_RESPONSE_TO_UV_SCC_UP gallbladder cancer DOID_3121 1.088E-04 1.032E-03 0.08779146 0.5550371 DAZARD_RESPONSE_TO_UV_SCC_UP proteinuria DOID_576 1.233E-04 1.15E-03 0.09135359 0.55298079 DAZARD_RESPONSE_TO_UV_SCC_UP calcium metabolism disease DOID_10575 1.559E-04 1.431E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hyperparathyroidism DOID_13543 1.674E-04 1.512E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP childhood type dermatomyositis DOID_14203 1.674E-04 1.489E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP retinal vascular occlusion DOID_1729 1.674E-04 1.466E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP atopic dermatitis DOID_3310 1.741E-04 1.501E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP sarcoidosis DOID_11335 1.837E-04 1.56E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP giant cell tumor DOID_200 1.837E-04 1.537E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP malignant giant cell tumor DOID_2705 1.837E-04 1.537E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP giant cell glioblastoma DOID_3074 1.837E-04 1.537E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP bile duct adenocarcinoma DOID_4896 1.936E-04 1.597E-03 0.10546543 0.57701759 DAZARD_RESPONSE_TO_UV_SCC_UP cholangiocarcinoma DOID_4947 1.936E-04 1.597E-03 0.10546543 0.57701759 DAZARD_RESPONSE_TO_UV_SCC_UP dermatomyositis DOID_10223 2.044E-04 1.661E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP bronchiectasis DOID_9563 2.044E-04 1.638E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP mitochondrial metabolism disease DOID_700 2.145E-04 1.695E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hypersensitivity reaction type IV disease DOID_2916 2.368E-04 1.846E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP glioblastoma DOID_3068 2.368E-04 1.821E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP bile duct cancer DOID_4606 2.368E-04 1.797E-03 0.11244005 0.59792886 DAZARD_RESPONSE_TO_UV_SCC_UP bile duct carcinoma DOID_4897 2.368E-04 1.797E-03 0.11244005 0.59792886 DAZARD_RESPONSE_TO_UV_SCC_UP stomach disease DOID_76 2.45E-04 1.834E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP encephalitis DOID_9588 2.45E-04 1.81E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP melancholia DOID_2848 2.485E-04 1.813E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP leukocyte disease DOID_9500 2.485E-04 1.79E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP neurotic disorder DOID_4964 2.606E-04 1.854E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP berylliosis DOID_10322 2.891E-04 2.031E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP parathyroid gland disease DOID_11201 2.891E-04 2.006E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP polyneuropathy DOID_1389 2.891E-04 1.982E-03 0.02508408 0.39646776 DAZARD_RESPONSE_TO_UV_SCC_UP mineral metabolism disease DOID_0050032 3.126E-04 2.118E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP uterine disease DOID_345 3.266E-04 2.186E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP Legionnaires' disease DOID_10457 3.369E-04 2.229E-03 0.02698771 0.40410539 DAZARD_RESPONSE_TO_UV_SCC_UP legionellosis DOID_10458 3.369E-04 2.229E-03 0.02698771 0.40410539 DAZARD_RESPONSE_TO_UV_SCC_UP viral pneumonia DOID_10533 3.369E-04 2.203E-03 0.02698771 0.39374371 DAZARD_RESPONSE_TO_UV_SCC_UP hypercalcemia DOID_12678 3.369E-04 2.178E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP bacterial meningitis DOID_9470 3.369E-04 2.154E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hyperglycemia DOID_4195 3.41E-04 2.156E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP tooth disease DOID_1091 3.557E-04 2.224E-03 0.1279374 0.64421576 DAZARD_RESPONSE_TO_UV_SCC_UP astrocytoma DOID_3069 3.865E-04 2.39E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP skeletal system cancer DOID_0060124 3.882E-04 2.375E-03 0.02888767 0.40090449 DAZARD_RESPONSE_TO_UV_SCC_UP bone cancer DOID_184 3.882E-04 2.375E-03 0.02888767 0.40090449 DAZARD_RESPONSE_TO_UV_SCC_UP mesenchymal cell neoplasm DOID_3350 3.882E-04 2.35E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP spindle cell sarcoma DOID_4235 3.882E-04 2.35E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP lung oat cell carcinoma DOID_5411 3.882E-04 2.325E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP oral submucous fibrosis DOID_5773 3.882E-04 2.301E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP epithelioid sarcoma DOID_6193 3.882E-04 2.35E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hyperhomocysteinemia DOID_9279 3.882E-04 2.277E-03 0.02888767 0.36526853 DAZARD_RESPONSE_TO_UV_SCC_UP male reproductive system disease DOID_48 4.189E-04 2.432E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hemolytic-uremic syndrome DOID_12554 4.431E-04 2.547E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP thyroiditis DOID_7166 4.431E-04 2.521E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP autoimmune thyroiditis DOID_7188 4.431E-04 2.521E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP tongue cancer DOID_8649 4.431E-04 2.496E-03 0.03078397 0.37268256 DAZARD_RESPONSE_TO_UV_SCC_UP Barrett's esophagus DOID_9206 4.431E-04 2.472E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP endogenous depression DOID_1595 4.889E-04 2.701E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP mental depression DOID_1596 6.286E-04 3.439E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP dissociative disorder DOID_10935 6.291E-04 3.409E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP dissociative amnesia DOID_11037 6.291E-04 3.409E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP pulmonary edema DOID_11396 6.981E-04 3.747E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP amino acid metabolic disorder DOID_9252 7.667E-04 4.077E-03 0.01376004 0.35588479 DAZARD_RESPONSE_TO_UV_SCC_UP Kawasaki disease DOID_13378 7.706E-04 4.06E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP lymphadenitis DOID_1602 7.706E-04 4.06E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP autoimmune hepatitis DOID_2048 7.706E-04 4.023E-03 0.04021083 0.42370304 DAZARD_RESPONSE_TO_UV_SCC_UP lymph node disease DOID_9942 7.706E-04 4.06E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP Human immunodeficiency virus infectious disease DOID_526 7.914E-04 4.094E-03 0.16470496 0.73793009 DAZARD_RESPONSE_TO_UV_SCC_UP gastric ulcer DOID_10808 8.466E-04 4.34E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP muscular atrophy DOID_767 8.466E-04 4.301E-03 8.466E-04 0.08028199 DAZARD_RESPONSE_TO_UV_SCC_UP placenta disease DOID_780 8.466E-04 4.263E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP carbohydrate metabolic disorder DOID_2978 8.686E-04 4.336E-03 0.01492844 0.36931672 DAZARD_RESPONSE_TO_UV_SCC_UP encephalomyelitis DOID_640 8.686E-04 4.298E-03 0.16959874 0.75391939 DAZARD_RESPONSE_TO_UV_SCC_UP urinary tract obstruction DOID_5200 9.26E-04 4.542E-03 0.0439562 0.43879084 DAZARD_RESPONSE_TO_UV_SCC_UP polyarteritis nodosa DOID_9810 9.26E-04 4.503E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hypoglycemia DOID_9993 9.26E-04 4.465E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP spastic quadriplegia DOID_10970 1.095E-03 5.237E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP acute pancreatitis DOID_2913 1.095E-03 5.193E-03 0.04768715 0.43764496 DAZARD_RESPONSE_TO_UV_SCC_UP commensal bacterial infectious disease DOID_0050339 1.185E-03 5.573E-03 1.185E-03 0.08428618 DAZARD_RESPONSE_TO_UV_SCC_UP portal hypertension DOID_10762 1.185E-03 5.527E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP urticaria DOID_1555 1.185E-03 5.482E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP myositis DOID_633 1.278E-03 5.865E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP dystonia DOID_543 1.375E-03 6.258E-03 1.375E-03 0.07822725 DAZARD_RESPONSE_TO_UV_SCC_UP extrinsic allergic alveolitis DOID_841 1.375E-03 6.209E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP perinatal necrotizing enterocolitis DOID_8677 1.475E-03 6.608E-03 0.05510601 0.4544249 DAZARD_RESPONSE_TO_UV_SCC_UP sarcoma DOID_1115 1.578E-03 7.015E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hepatic vascular disease DOID_272 1.578E-03 6.961E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP autoimmune disease of endocrine system DOID_0060005 1.685E-03 7.374E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP chronic leukemia DOID_1036 2.145E-03 9.317E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP chronic lymphocytic leukemia DOID_1040 2.145E-03 9.317E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP myocarditis DOID_820 2.268E-03 9.778E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP spindle cell carcinoma DOID_4015 2.395E-03 0.01024607 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP aplastic anemia DOID_12449 2.525E-03 0.01072106 0.07159062 0.49676904 DAZARD_RESPONSE_TO_UV_SCC_UP multiple myeloma DOID_9538 2.794E-03 0.0117775 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP congenital diaphragmatic hernia DOID_3827 3.077E-03 0.01287247 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP adult respiratory distress syndrome DOID_11394 3.223E-03 0.01338498 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP lymphatic system disease DOID_75 3.223E-03 0.01328799 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hyperinsulinism DOID_2018 3.68E-03 0.01506382 0.08600523 0.54985364 DAZARD_RESPONSE_TO_UV_SCC_UP myeloma DOID_0070004 4.334E-03 0.01761289 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP neuritis DOID_1803 4.334E-03 0.01748798 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP thyroid adenoma DOID_2891 4.334E-03 0.01736482 0.09312951 0.54629579 DAZARD_RESPONSE_TO_UV_SCC_UP heart valve disease DOID_4079 4.334E-03 0.01724339 0.09312951 0.54072135 DAZARD_RESPONSE_TO_UV_SCC_UP bone marrow disease DOID_4961 4.334E-03 0.01712364 0.09312951 0.53525951 DAZARD_RESPONSE_TO_UV_SCC_UP vascular skin disease DOID_9540 4.334E-03 0.01700555 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP autoimmune disease of gastrointestinal tract DOID_0060031 4.679E-03 0.01823561 0.09667108 0.54461234 DAZARD_RESPONSE_TO_UV_SCC_UP lung small cell carcinoma DOID_5409 4.679E-03 0.01811156 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP withdrawal disorder DOID_0060001 5.037E-03 0.01936488 0.10019901 0.55352657 DAZARD_RESPONSE_TO_UV_SCC_UP bone marrow cancer DOID_4960 5.597E-03 0.02137199 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP integumentary system cancer DOID_0060122 5.789E-03 0.02196008 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP skin cancer DOID_4159 5.789E-03 0.02196008 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP pustulosis of palm and sole DOID_4398 5.789E-03 0.02181465 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP oral cavity cancer DOID_8618 6.385E-03 0.02390134 0.11244005 0.59239248 DAZARD_RESPONSE_TO_UV_SCC_UP respiratory failure DOID_11162 7.221E-03 0.02685372 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP congenital heart defect DOID_1682 7.437E-03 0.02747855 7.437E-03 0.264481 DAZARD_RESPONSE_TO_UV_SCC_UP endocrine organ benign neoplasm DOID_0060089 8.562E-03 0.03143085 0.12964276 0.6470766 DAZARD_RESPONSE_TO_UV_SCC_UP pancreatic ductal carcinoma DOID_3587 9.032E-03 0.03294371 0.13304363 0.65260192 DAZARD_RESPONSE_TO_UV_SCC_UP peripheral vascular disease DOID_341 9.513E-03 0.03447828 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP pancreatic carcinoma DOID_4905 9.758E-03 0.03514192 0.13812035 0.66042421 DAZARD_RESPONSE_TO_UV_SCC_UP diabetic retinopathy DOID_8947 9.758E-03 0.0349209 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP aneurysm disease DOID_2403 0.01050954 0.03737456 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP electroclinical syndrome DOID_0050701 0.01076552 0.03804708 0.01076552 0.34030997 DAZARD_RESPONSE_TO_UV_SCC_UP mixed glioma DOID_5076 0.01076552 0.03781222 0.14484373 0.68680068 DAZARD_RESPONSE_TO_UV_SCC_UP metabolic syndrome X DOID_14221 0.0112857 0.03939608 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP chromosomal disease DOID_0080014 0.01154988 0.04007244 0.14985228 0.70467726 DAZARD_RESPONSE_TO_UV_SCC_UP chronic kidney failure DOID_784 0.01208637 0.04167966 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP retinal vascular disease DOID_2462 0.01263362 0.04330439 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP transitional cell carcinoma DOID_2671 0.01347448 0.04591004 0.16142665 0.73481409 DAZARD_RESPONSE_TO_UV_SCC_UP lymphoblastic leukemia DOID_1037 0.01492844 0.05056122 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP arrhythmogenic right ventricular dysplasia DOID_0050431 0.01743275 0.05869368 0.01743275 0.3967693 DAZARD_RESPONSE_TO_UV_SCC_UP leber hereditary optic neuropathy DOID_705 0.01743275 0.05834843 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP gout DOID_13189 0.01935111 0.06439055 0.01935111 0.42349168 DAZARD_RESPONSE_TO_UV_SCC_UP hypolipoproteinemia DOID_1387 0.01935111 0.06401618 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP ventricular septal defect DOID_1657 0.01935111 0.06364615 0.01935111 0.40780681 DAZARD_RESPONSE_TO_UV_SCC_UP lateral sclerosis DOID_230 0.01935111 0.06328037 0.01935111 0.39324228 DAZARD_RESPONSE_TO_UV_SCC_UP bilirubin metabolic disorder DOID_2741 0.01935111 0.06291876 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP acute kidney failure DOID_3021 0.01935111 0.06256127 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP Noonan syndrome DOID_3490 0.01935111 0.06220782 0.01935111 0.3796822 DAZARD_RESPONSE_TO_UV_SCC_UP adrenal gland hyperfunction DOID_3947 0.01935111 0.06185834 0.01935111 0.36702613 DAZARD_RESPONSE_TO_UV_SCC_UP familial adenomatous polyposis DOID_0050424 0.02126579 0.06759907 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP nervous system benign neoplasm DOID_0060115 0.02126579 0.06722351 0.02126579 0.39033009 DAZARD_RESPONSE_TO_UV_SCC_UP sickle cell anemia DOID_10923 0.02126579 0.06685211 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP pneumocystosis DOID_11339 0.02126579 0.06648479 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP prediabetes syndrome DOID_11716 0.02126579 0.06612149 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP migraine without aura DOID_12783 0.02126579 0.06576213 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hemochromatosis DOID_2352 0.02126579 0.06540666 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP common cold DOID_10459 0.02317677 0.07090098 0.02317677 0.41211197 DAZARD_RESPONSE_TO_UV_SCC_UP otitis media DOID_10754 0.02317677 0.07052184 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP intracranial arteriosclerosis DOID_13097 0.02317677 0.07014672 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP middle ear disease DOID_5100 0.02317677 0.07052184 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP aortic valve insufficiency DOID_57 0.02317677 0.06977557 0.02317677 0.39962373 DAZARD_RESPONSE_TO_UV_SCC_UP peritonitis DOID_8283 0.02317677 0.06940833 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP vascular dementia DOID_8725 0.02317677 0.07014672 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP mitochondrial encephalomyopathy DOID_890 0.02317677 0.06904494 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP progressive myoclonus epilepsy DOID_891 0.02317677 0.06868533 0.02317677 0.38787009 DAZARD_RESPONSE_TO_UV_SCC_UP variable age at onset electroclinical syndrome DOID_0050706 0.02508408 0.07395253 0.02508408 0.40779541 DAZARD_RESPONSE_TO_UV_SCC_UP leprosy DOID_1024 0.02508408 0.07357134 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hepatic coma DOID_12550 0.02508408 0.07319405 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP hepatic encephalopathy DOID_13413 0.02508408 0.07319405 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP larynx cancer DOID_2596 0.02508408 0.07282061 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP laryngeal benign neoplasm DOID_2598 0.02508408 0.07282061 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP Lynch syndrome DOID_3883 0.02508408 0.07245096 0.02508408 0.38575241 DAZARD_RESPONSE_TO_UV_SCC_UP psoriatic arthritis DOID_9008 0.02508408 0.07208505 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP open-angle glaucoma DOID_1067 0.02698771 0.07716585 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP eyelid disease DOID_530 0.02698771 0.07678002 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP polycystic kidney disease DOID_898 0.02698771 0.07639803 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP idiopathic pulmonary fibrosis DOID_0050156 0.02888767 0.0813717 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP peripheral neuropathy DOID_0060053 0.02888767 0.08097086 0.02888767 0.4109271 DAZARD_RESPONSE_TO_UV_SCC_UP corneal dystrophy DOID_2566 0.02888767 0.08057394 0.02888767 0.39135914 DAZARD_RESPONSE_TO_UV_SCC_UP adrenal cortex disease DOID_3952 0.02888767 0.0801809 0.02888767 0.38225777 DAZARD_RESPONSE_TO_UV_SCC_UP nutritional deficiency disease DOID_5113 0.02888767 0.07979167 0.02888767 0.37357009 DAZARD_RESPONSE_TO_UV_SCC_UP varicose veins DOID_799 0.02888767 0.0794062 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP intermediate coronary syndrome DOID_8805 0.02888767 0.07902444 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP silicosis DOID_10325 0.03078397 0.083809 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP spastic diplegia DOID_10965 0.03078397 0.08340991 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP Fanconi's anemia DOID_13636 0.03078397 0.0830146 0.03078397 0.38078436 DAZARD_RESPONSE_TO_UV_SCC_UP vein disease DOID_866 0.03078397 0.08262302 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP lymphatic system cancer DOID_0060073 0.03267662 0.08729107 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP familial hypertrophic cardiomyopathy DOID_11986 0.03267662 0.08688317 0.03267662 0.38735414 DAZARD_RESPONSE_TO_UV_SCC_UP basal cell carcinoma DOID_2513 0.03267662 0.08647906 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP juvenile rheumatoid arthritis DOID_676 0.03267662 0.0860787 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP urinary system benign neoplasm DOID_731 0.03267662 0.08568202 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP reticulosarcoma DOID_8538 0.03267662 0.08729107 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP lymphosarcoma DOID_8675 0.03267662 0.08729107 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP adrenal gland disease DOID_9553 0.03267662 0.08528898 0.03267662 0.37944895 DAZARD_RESPONSE_TO_UV_SCC_UP skin carcinoma DOID_3451 0.03456563 0.0898075 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP ureteral obstruction DOID_5199 0.03456563 0.08939928 0.03456563 0.39335684 DAZARD_RESPONSE_TO_UV_SCC_UP prion disease DOID_649 0.03456563 0.08899476 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP Down syndrome DOID_14250 0.03645099 0.09342619 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP heart septal defect DOID_1681 0.03645099 0.09300724 0.03645099 0.40667872 DAZARD_RESPONSE_TO_UV_SCC_UP granulosa cell tumor DOID_2999 0.03645099 0.09259203 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP sex cord-gonadal stromal tumor DOID_192 0.03833273 0.0969392 1.000 1.000 DAZARD_RESPONSE_TO_UV_SCC_UP brain edema DOID_4724 0.03833273 0.09651027 0.03833273 0.41944848 BROWNE_HCMV_INFECTION_1HR_DN nephroblastoma DOID_2154 3.167E-06 1.802E-03 1.415E-04 0.01150121 BROWNE_HCMV_INFECTION_1HR_DN chronic kidney failure DOID_784 3.705E-06 1.054E-03 8.786E-05 0.01249738 BROWNE_HCMV_INFECTION_1HR_DN transitional cell carcinoma DOID_2671 4.911E-06 9.314E-04 1.097E-04 0.01040533 BROWNE_HCMV_INFECTION_1HR_DN pulmonary tuberculosis DOID_2957 1.258E-05 1.79E-03 1.258E-05 7.159E-03 BROWNE_HCMV_INFECTION_1HR_DN testicular cancer DOID_2998 1.828E-05 2.081E-03 1.213E-03 0.03286272 BROWNE_HCMV_INFECTION_1HR_DN tuberculosis DOID_399 4.341E-05 4.116E-03 4.341E-05 0.01234887 BROWNE_HCMV_INFECTION_1HR_DN alcohol abuse DOID_1574 8.786E-05 7.141E-03 1.637E-03 0.03879886 BROWNE_HCMV_INFECTION_1HR_DN biliary tract cancer DOID_4607 8.786E-05 6.249E-03 8.786E-05 0.01666317 BROWNE_HCMV_INFECTION_1HR_DN endometrial carcinoma DOID_2871 9.122E-05 5.767E-03 3.438E-03 0.04657676 BROWNE_HCMV_INFECTION_1HR_DN primary bacterial infectious disease DOID_0050338 1.051E-04 5.978E-03 1.051E-04 0.01195628 BROWNE_HCMV_INFECTION_1HR_DN endometrial cancer DOID_1380 1.096E-04 5.67E-03 3.875E-03 0.05010863 BROWNE_HCMV_INFECTION_1HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.409E-04 6.68E-03 2.317E-03 0.04394287 BROWNE_HCMV_INFECTION_1HR_DN adenoma DOID_657 1.658E-04 7.255E-03 5.073E-03 0.06141708 BROWNE_HCMV_INFECTION_1HR_DN gallbladder cancer DOID_3121 2.895E-04 0.01176646 2.895E-04 0.02059131 BROWNE_HCMV_INFECTION_1HR_DN uterine cancer DOID_363 2.895E-04 0.01098203 7.297E-03 0.07414488 BROWNE_HCMV_INFECTION_1HR_DN pre-eclampsia DOID_10591 3.479E-04 0.0123716 8.226E-03 0.08069697 BROWNE_HCMV_INFECTION_1HR_DN islet cell tumor DOID_1799 4.74E-04 0.01586397 4.74E-04 0.02996528 BROWNE_HCMV_INFECTION_1HR_DN sarcoidosis DOID_11335 4.862E-04 0.01537017 0.0102323 0.09097152 BROWNE_HCMV_INFECTION_1HR_DN giant cell tumor DOID_200 4.862E-04 0.01456122 4.862E-04 0.02766631 BROWNE_HCMV_INFECTION_1HR_DN malignant giant cell tumor DOID_2705 4.862E-04 0.01456122 4.862E-04 0.02766631 BROWNE_HCMV_INFECTION_1HR_DN giant cell glioblastoma DOID_3074 4.862E-04 0.01456122 4.862E-04 0.02766631 BROWNE_HCMV_INFECTION_1HR_DN reproductive organ benign neoplasm DOID_0050622 5.391E-04 0.01533762 0.01094456 0.0943554 BROWNE_HCMV_INFECTION_1HR_DN carotid stenosis DOID_13001 5.592E-04 0.01515032 5.592E-04 0.02892334 BROWNE_HCMV_INFECTION_1HR_DN hypertrophic cardiomyopathy DOID_11984 6.251E-04 0.01616752 6.251E-04 0.02964046 BROWNE_HCMV_INFECTION_1HR_DN hypersensitivity reaction type IV disease DOID_2916 6.251E-04 0.01546459 0.01205279 0.09525052 BROWNE_HCMV_INFECTION_1HR_DN glioblastoma DOID_3068 6.251E-04 0.01482023 6.251E-04 0.02736042 BROWNE_HCMV_INFECTION_1HR_DN bacterial meningitis DOID_9470 6.512E-04 0.014821 6.512E-04 0.02646607 BROWNE_HCMV_INFECTION_1HR_DN neuroectodermal tumor DOID_171 7.194E-04 0.01574378 7.194E-04 0.02728921 BROWNE_HCMV_INFECTION_1HR_DN carotid artery disease DOID_3407 7.194E-04 0.01516067 0.01320807 0.10020524 BROWNE_HCMV_INFECTION_1HR_DN pre-malignant neoplasm DOID_0060071 7.87E-04 0.01599341 0.01400399 0.10484569 BROWNE_HCMV_INFECTION_1HR_DN in situ carcinoma DOID_8719 7.87E-04 0.01599341 0.01400399 0.10484569 BROWNE_HCMV_INFECTION_1HR_DN endocrine pancreas disease DOID_1428 8.223E-04 0.016134 8.223E-04 0.02924287 BROWNE_HCMV_INFECTION_1HR_DN cerebral degeneration DOID_1443 8.586E-04 0.01628398 0.01482022 0.10811162 BROWNE_HCMV_INFECTION_1HR_DN juvenile rheumatoid arthritis DOID_676 9.68E-04 0.01776819 9.68E-04 0.03240082 BROWNE_HCMV_INFECTION_1HR_DN endocrine organ benign neoplasm DOID_0060089 9.734E-04 0.01730807 0.17579869 0.40497755 BROWNE_HCMV_INFECTION_1HR_DN astrocytoma DOID_3069 1.014E-03 0.01747892 1.014E-03 0.03204469 BROWNE_HCMV_INFECTION_1HR_DN pancreatic ductal carcinoma DOID_3587 1.055E-03 0.01765717 0.01694806 0.11905492 BROWNE_HCMV_INFECTION_1HR_DN male reproductive organ benign neoplasm DOID_0060087 1.087E-03 0.01767338 1.087E-03 0.03255623 BROWNE_HCMV_INFECTION_1HR_DN peripheral vascular disease DOID_341 1.141E-03 0.01803405 1.141E-03 0.03246129 BROWNE_HCMV_INFECTION_1HR_DN pancreatic carcinoma DOID_4905 1.186E-03 0.01823189 0.01828343 0.1268692 BROWNE_HCMV_INFECTION_1HR_DN auditory system disease DOID_2742 1.582E-03 0.02368611 1.582E-03 0.04091237 BROWNE_HCMV_INFECTION_1HR_DN funisitis DOID_0050698 1.63E-03 0.02377751 1.63E-03 0.04031839 BROWNE_HCMV_INFECTION_1HR_DN mental depression DOID_1596 1.637E-03 0.02327932 0.0225447 0.1527135 BROWNE_HCMV_INFECTION_1HR_DN myasthenia gravis DOID_437 1.782E-03 0.02472787 1.782E-03 0.04055371 BROWNE_HCMV_INFECTION_1HR_DN hypoglycemia DOID_9993 1.782E-03 0.02413911 1.782E-03 0.03899395 BROWNE_HCMV_INFECTION_1HR_DN ureteral disease DOID_1426 1.94E-03 0.02567568 1.94E-03 0.0408909 BROWNE_HCMV_INFECTION_1HR_DN meningitis DOID_9471 1.94E-03 0.02509214 1.94E-03 0.03943051 BROWNE_HCMV_INFECTION_1HR_DN lymphoma DOID_0060058 2.182E-03 0.0275915 0.02717275 0.15461294 BROWNE_HCMV_INFECTION_1HR_DN carbohydrate metabolic disorder DOID_2978 2.249E-03 0.02781728 2.249E-03 0.04412395 BROWNE_HCMV_INFECTION_1HR_DN Crohn's disease DOID_8778 2.317E-03 0.02804864 0.028249 0.15758511 BROWNE_HCMV_INFECTION_1HR_DN hypersensitivity reaction type I disease DOID_1205 2.386E-03 0.02828534 2.386E-03 0.04379665 BROWNE_HCMV_INFECTION_1HR_DN autosomal dominant nonsyndromic deafness DOID_0050564 2.455E-03 0.02850277 2.455E-03 0.04364486 BROWNE_HCMV_INFECTION_1HR_DN spinal muscular atrophy DOID_12377 2.455E-03 0.02793271 2.455E-03 0.04232229 BROWNE_HCMV_INFECTION_1HR_DN infantile epileptic encephalopathy DOID_2481 2.455E-03 0.02738501 2.455E-03 0.04107752 BROWNE_HCMV_INFECTION_1HR_DN neuromuscular junction disease DOID_439 2.455E-03 0.02685838 2.455E-03 0.03990387 BROWNE_HCMV_INFECTION_1HR_DN ulcerative colitis DOID_8577 2.602E-03 0.02792989 2.602E-03 0.04111901 BROWNE_HCMV_INFECTION_1HR_DN spinal cord disease DOID_319 2.639E-03 0.02780391 2.639E-03 0.04057868 BROWNE_HCMV_INFECTION_1HR_DN middle cerebral artery infarction DOID_3525 2.639E-03 0.02729839 2.639E-03 0.03951082 BROWNE_HCMV_INFECTION_1HR_DN dystonia DOID_543 2.639E-03 0.02681091 2.639E-03 0.03849772 BROWNE_HCMV_INFECTION_1HR_DN autoimmune disease of the nervous system DOID_438 3.026E-03 0.03020553 3.026E-03 0.04304288 BROWNE_HCMV_INFECTION_1HR_DN dystonic disease DOID_544 3.229E-03 0.03167593 3.229E-03 0.04480985 BROWNE_HCMV_INFECTION_1HR_DN celiac disease DOID_10608 3.875E-03 0.03736915 3.875E-03 0.05127395 BROWNE_HCMV_INFECTION_1HR_DN pneumoconiosis DOID_10316 4.576E-03 0.04339351 4.576E-03 0.05785801 BROWNE_HCMV_INFECTION_1HR_DN thyroid carcinoma DOID_3963 4.576E-03 0.04268214 0.09580443 0.27955243 BROWNE_HCMV_INFECTION_1HR_DN esophageal disease DOID_6050 4.576E-03 0.04199372 0.09580443 0.27531678 BROWNE_HCMV_INFECTION_1HR_DN medullomyoblastoma DOID_3861 4.821E-03 0.04354617 4.821E-03 0.05963933 BROWNE_HCMV_INFECTION_1HR_DN adult medulloblastoma DOID_3864 4.821E-03 0.04354617 4.821E-03 0.05963933 BROWNE_HCMV_INFECTION_1HR_DN childhood medulloblastoma DOID_3869 4.821E-03 0.04354617 4.821E-03 0.05963933 BROWNE_HCMV_INFECTION_1HR_DN thyroid cancer DOID_1781 5.073E-03 0.04510317 0.10071581 0.28369949 BROWNE_HCMV_INFECTION_1HR_DN medulloblastoma DOID_3858 5.331E-03 0.0466642 5.331E-03 0.06319111 BROWNE_HCMV_INFECTION_1HR_DN embryonal cancer DOID_688 5.331E-03 0.04595717 5.331E-03 0.0619015 BROWNE_HCMV_INFECTION_1HR_DN congenital diaphragmatic hernia DOID_3827 5.864E-03 0.04979652 5.864E-03 0.06672734 BROWNE_HCMV_INFECTION_1HR_DN systemic scleroderma DOID_418 5.864E-03 0.04906422 0.10803338 0.29553363 BROWNE_HCMV_INFECTION_1HR_DN peptic ulcer DOID_750 5.864E-03 0.04835314 5.864E-03 0.06541896 BROWNE_HCMV_INFECTION_1HR_DN intracranial arterial disease DOID_13089 6.139E-03 0.04989932 6.139E-03 0.06717216 BROWNE_HCMV_INFECTION_1HR_DN cerebral arterial disease DOID_3527 6.139E-03 0.04989932 6.139E-03 0.06717216 BROWNE_HCMV_INFECTION_1HR_DN benign mesothelioma DOID_2645 6.42E-03 0.05144843 0.11287897 0.30439875 BROWNE_HCMV_INFECTION_1HR_DN cervix uteri carcinoma in situ DOID_8991 6.42E-03 0.05073386 0.11287897 0.3029629 BROWNE_HCMV_INFECTION_1HR_DN Huntington's disease DOID_12858 6.999E-03 0.05455394 6.999E-03 0.07514033 BROWNE_HCMV_INFECTION_1HR_DN rheumatic disease DOID_1575 6.999E-03 0.05381672 0.11769849 0.30861955 BROWNE_HCMV_INFECTION_1HR_DN primitive neuroectodermal tumor DOID_168 6.999E-03 0.05309916 6.999E-03 0.07374884 BROWNE_HCMV_INFECTION_1HR_DN idiopathic generalized epilepsy DOID_1827 6.999E-03 0.05240049 6.999E-03 0.07240795 BROWNE_HCMV_INFECTION_1HR_DN scleroderma DOID_419 6.999E-03 0.05381672 0.11769849 0.30861955 BROWNE_HCMV_INFECTION_1HR_DN cerebral infarction DOID_3526 7.601E-03 0.05616903 7.601E-03 0.07587746 BROWNE_HCMV_INFECTION_1HR_DN leukodystrophy DOID_10579 7.911E-03 0.05770673 0.1248792 0.32152156 BROWNE_HCMV_INFECTION_1HR_DN thyroid adenoma DOID_2891 8.226E-03 0.05924588 0.12725988 0.31899063 BROWNE_HCMV_INFECTION_1HR_DN vascular skin disease DOID_9540 8.226E-03 0.0585053 8.226E-03 0.07932922 BROWNE_HCMV_INFECTION_1HR_DN autoimmune disease of gastrointestinal tract DOID_0060031 8.873E-03 0.06232738 8.873E-03 0.08414196 BROWNE_HCMV_INFECTION_1HR_DN integumentary system benign neoplasm DOID_0060121 8.873E-03 0.06156729 8.873E-03 0.08276258 BROWNE_HCMV_INFECTION_1HR_DN glaucoma DOID_1686 8.873E-03 0.06082551 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_DN skin benign neoplasm DOID_3165 8.873E-03 0.06156729 8.873E-03 0.08276258 BROWNE_HCMV_INFECTION_1HR_DN movement disease DOID_480 9.204E-03 0.06234852 9.204E-03 0.08447218 BROWNE_HCMV_INFECTION_1HR_DN atopic dermatitis DOID_3310 9.884E-03 0.06616616 9.884E-03 0.0892718 BROWNE_HCMV_INFECTION_1HR_DN bile duct adenocarcinoma DOID_4896 0.01058575 0.07003831 0.01058575 0.09266607 BROWNE_HCMV_INFECTION_1HR_DN cholangiocarcinoma DOID_4947 0.01058575 0.07003831 0.01058575 0.09266607 BROWNE_HCMV_INFECTION_1HR_DN integumentary system cancer DOID_0060122 0.01094456 0.07157996 0.01094456 0.09294711 BROWNE_HCMV_INFECTION_1HR_DN osteochondrodysplasia DOID_2256 0.01094456 0.07076655 0.01094456 0.09158024 BROWNE_HCMV_INFECTION_1HR_DN parasitic protozoa infectious disease DOID_2789 0.01094456 0.06997142 0.01094456 0.09025299 BROWNE_HCMV_INFECTION_1HR_DN skin cancer DOID_4159 0.01094456 0.07157996 0.01094456 0.09294711 BROWNE_HCMV_INFECTION_1HR_DN mitochondrial metabolism disease DOID_700 0.01130869 0.07149607 0.01130869 0.09192352 BROWNE_HCMV_INFECTION_1HR_DN nonsyndromic deafness DOID_0050563 0.01205279 0.07536305 0.01205279 0.09659208 BROWNE_HCMV_INFECTION_1HR_DN retinitis pigmentosa DOID_10584 0.01205279 0.07454389 0.15302784 0.36432151 BROWNE_HCMV_INFECTION_1HR_DN bile duct cancer DOID_4606 0.01205279 0.07374234 0.01205279 0.09394572 BROWNE_HCMV_INFECTION_1HR_DN bile duct carcinoma DOID_4897 0.01205279 0.07374234 0.01205279 0.09394572 BROWNE_HCMV_INFECTION_1HR_DN oral cavity cancer DOID_8618 0.01205279 0.07295785 0.01205279 0.09267619 BROWNE_HCMV_INFECTION_1HR_DN leukocyte disease DOID_9500 0.0124327 0.07446531 0.15533268 0.36826789 BROWNE_HCMV_INFECTION_1HR_DN collagen disease DOID_854 0.01320807 0.07828534 0.15992374 0.37757928 BROWNE_HCMV_INFECTION_1HR_DN parasitic infectious disease DOID_1398 0.01482022 0.08693511 0.01482022 0.10951566 BROWNE_HCMV_INFECTION_1HR_DN temporal lobe epilepsy DOID_3328 0.01523588 0.08846136 0.01523588 0.10973687 BROWNE_HCMV_INFECTION_1HR_DN brain infarction DOID_3454 0.01608211 0.09243154 0.01608211 0.11438404 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN aneurysm disease DOID_2403 3.986E-07 2.268E-04 1.678E-03 0.13642215 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN chronic kidney failure DOID_784 5.354E-07 1.523E-04 0.0630429 0.39857123 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN myocarditis DOID_820 2.825E-06 5.358E-04 2.825E-06 1.607E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN heart valve disease DOID_4079 7.699E-06 1.095E-03 0.03756319 0.39580474 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN carotid artery disease DOID_3407 1.625E-05 1.849E-03 0.04783435 0.37802423 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN congenital heart defect DOID_1682 1.783E-05 1.691E-03 1.783E-05 5.072E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN parasitic infectious disease DOID_1398 1.95E-05 1.585E-03 0.05074947 0.38501933 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN brain infarction DOID_3454 2.221E-05 1.58E-03 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN astrocytoma DOID_3069 2.316E-05 1.464E-03 0.05365598 0.38162815 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN syndrome DOID_225 2.945E-05 1.676E-03 2.945E-05 5.587E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN mixed glioma DOID_5076 3.178E-05 1.644E-03 1.721E-03 0.12237218 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN intracranial thrombosis DOID_4193 4.384E-05 2.079E-03 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN heart septal defect DOID_1681 9.584E-05 4.195E-03 9.584E-05 0.01363264 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN acquired immunodeficiency syndrome DOID_635 1.293E-04 5.254E-03 0.01669899 0.41311861 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN pulmonary embolism DOID_9477 1.415E-04 5.368E-03 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN intracranial aneurysm DOID_10941 2.109E-04 7.502E-03 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN middle cerebral artery infarction DOID_3525 2.109E-04 7.06E-03 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN autoimmune disease of the nervous system DOID_438 2.425E-04 7.666E-03 0.02270434 0.35885474 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN dysostosis DOID_1934 2.763E-04 8.274E-03 2.763E-04 0.03143958 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN pleural disease DOID_1532 3.309E-04 9.415E-03 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN adenoma DOID_657 4.114E-04 0.01114608 4.114E-04 0.03901126 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN calcinosis DOID_182 4.328E-04 0.0111941 0.03016124 0.39003969 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN intracranial arterial disease DOID_13089 5.004E-04 0.01237825 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN cerebral arterial disease DOID_3527 5.004E-04 0.01237825 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN cerebral infarction DOID_3526 6.235E-04 0.01478317 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN proteinuria DOID_576 6.498E-04 0.01478874 0.03682546 0.40295549 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN autoimmune disease of gastrointestinal tract DOID_0060031 7.316E-04 0.01601093 0.03903702 0.38968536 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN pulmonary tuberculosis DOID_2957 7.316E-04 0.01541793 0.03903702 0.37647569 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN calcium metabolism disease DOID_10575 7.599E-04 0.015443 0.03977312 0.37099844 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN giant cell tumor DOID_200 8.481E-04 0.01663971 0.04197815 0.36747025 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN malignant giant cell tumor DOID_2705 8.481E-04 0.01663971 0.04197815 0.36747025 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN giant cell glioblastoma DOID_3074 8.481E-04 0.01663971 0.04197815 0.36747025 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN parasitic protozoa infectious disease DOID_2789 9.094E-04 0.01724896 0.04344545 0.36896211 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN glioblastoma DOID_3068 1.005E-03 0.01845369 0.04564234 0.37100698 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN mineral metabolism disease DOID_0050032 1.211E-03 0.02153764 0.0500215 0.38462478 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN tuberculosis DOID_399 1.359E-03 0.02342874 0.05293016 0.38123114 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN cystic fibrosis DOID_1485 1.637E-03 0.02738882 0.05799963 0.39761194 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN pancreatitis DOID_4989 1.721E-03 0.02797078 0.05944324 0.39792001 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN bone development disease DOID_0080006 1.984E-03 0.03136439 1.984E-03 0.12545757 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN retinal vascular disease DOID_2462 2.03E-03 0.03121997 0.06447904 0.40317115 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN primary bacterial infectious disease DOID_0050338 2.123E-03 0.03179029 0.06591305 0.40765791 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN transitional cell carcinoma DOID_2671 2.17E-03 0.03166414 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN nervous system cancer DOID_3093 2.266E-03 0.03223725 0.0680601 0.4164107 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN Human immunodeficiency virus infectious disease DOID_526 2.266E-03 0.03145097 0.0680601 0.4119808 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN hypersensitivity reaction type I disease DOID_1205 2.515E-03 0.03406865 0.07162791 0.41167963 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN ventricular septal defect DOID_1657 7.624E-03 0.09859372 7.624E-03 0.43381236 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN retinal vascular occlusion DOID_1729 7.624E-03 0.09640275 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN insulinoma DOID_3892 7.624E-03 0.09430703 7.624E-03 0.39437487 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN polycythemia DOID_8432 7.624E-03 0.0923005 7.624E-03 0.3615103 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN cutaneous leishmaniasis DOID_9111 7.624E-03 0.09037757 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN sickle cell anemia DOID_10923 8.383E-03 0.09735052 8.383E-03 0.36693657 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN pneumocystosis DOID_11339 8.383E-03 0.09540351 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN temporal arteritis DOID_13375 8.383E-03 0.09353285 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN central nervous system vasculitis DOID_525 8.383E-03 0.09353285 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN beta thalassemia DOID_12241 9.142E-03 0.09814921 9.142E-03 0.37156485 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN diarrhea DOID_13250 9.142E-03 0.09633163 9.142E-03 0.34679386 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN islet cell tumor DOID_1799 9.142E-03 0.09458014 9.142E-03 0.32511925 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN lipodystrophy DOID_811 9.142E-03 0.09289121 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN peritonitis DOID_8283 9.142E-03 0.09126154 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN essential hypertension DOID_10825 9.9E-03 0.09712623 9.9E-03 0.33137186 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN polyneuropathy DOID_1389 9.9E-03 0.09548003 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN major depressive disorder DOID_1470 9.9E-03 0.09388869 9.9E-03 0.31296231 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN tethered spinal cord syndrome DOID_1089 0.01065803 0.09941666 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN parasitic helminthiasis infectious disease DOID_883 0.01065803 0.09781317 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN polycystic kidney disease DOID_898 0.01065803 0.09626058 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN skeletal system cancer DOID_0060124 0.0114151 0.09992604 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN thalassemia DOID_10241 0.0114151 0.09841201 0.0114151 0.34185225 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN bone cancer DOID_184 0.0114151 0.09992604 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN hemangioma DOID_255 0.0114151 0.09694318 0.0114151 0.32475964 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN corneal dystrophy DOID_2566 0.0114151 0.09551754 0.0114151 0.3092949 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN lung oat cell carcinoma DOID_5411 0.0114151 0.09413323 0.0114151 0.29523604 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN intermediate coronary syndrome DOID_8805 0.0114151 0.09278847 1.000 1.000 ABE_VEGFA_TARGETS_2HR gallbladder cancer DOID_3121 1.2E-06 6.825E-04 0.0208723 0.35988906 ABE_VEGFA_TARGETS_2HR biliary tract cancer DOID_4607 7.23E-06 2.057E-03 0.03744728 0.40975969 ABE_VEGFA_TARGETS_2HR chronic kidney failure DOID_784 7.23E-06 1.371E-03 0.03744728 0.40202838 ABE_VEGFA_TARGETS_2HR familial hypercholesterolemia DOID_13810 4.349E-05 6.186E-03 9.822E-03 0.42988421 ABE_VEGFA_TARGETS_2HR portal hypertension DOID_10762 6.112E-05 6.955E-03 0.01159757 0.47135844 ABE_VEGFA_TARGETS_2HR middle cerebral artery infarction DOID_3525 7.105E-05 6.738E-03 0.01248443 0.44397749 ABE_VEGFA_TARGETS_2HR hepatic vascular disease DOID_272 8.172E-05 6.643E-03 0.01337054 0.38039177 ABE_VEGFA_TARGETS_2HR abdominal aortic aneurysm DOID_7693 9.911E-05 7.049E-03 1.000 1.000 ABE_VEGFA_TARGETS_2HR papilloma DOID_2615 1.182E-04 7.471E-03 0.01602437 0.39642907 ABE_VEGFA_TARGETS_2HR intracranial arterial disease DOID_13089 1.691E-04 9.62E-03 0.01911203 0.38838365 ABE_VEGFA_TARGETS_2HR cerebral arterial disease DOID_3527 1.691E-04 9.62E-03 0.01911203 0.38838365 ABE_VEGFA_TARGETS_2HR endometriosis of uterus DOID_288 1.853E-04 9.583E-03 0.01999253 0.39226732 ABE_VEGFA_TARGETS_2HR Huntington's disease DOID_12858 1.936E-04 9.181E-03 0.02043251 0.38753662 ABE_VEGFA_TARGETS_2HR endometriosis DOID_289 1.936E-04 8.475E-03 0.02043251 0.36331558 ABE_VEGFA_TARGETS_2HR cerebral infarction DOID_3526 2.109E-04 8.572E-03 0.0213119 0.356661 ABE_VEGFA_TARGETS_2HR proteinuria DOID_576 2.198E-04 8.339E-03 1.000 1.000 ABE_VEGFA_TARGETS_2HR aortic aneurysm DOID_3627 2.573E-04 9.151E-03 1.000 1.000 ABE_VEGFA_TARGETS_2HR pustulosis of palm and sole DOID_4398 3.083E-04 0.01031744 0.02569774 0.38478986 ABE_VEGFA_TARGETS_2HR familial hyperlipidemia DOID_1168 3.19E-04 0.0100835 0.02613531 0.38130741 ABE_VEGFA_TARGETS_2HR bile duct cancer DOID_4606 3.41E-04 0.0102118 1.000 1.000 ABE_VEGFA_TARGETS_2HR bile duct carcinoma DOID_4897 3.41E-04 0.0102118 1.000 1.000 ABE_VEGFA_TARGETS_2HR uterine disease DOID_345 4.237E-04 0.01205388 0.03006507 0.39783784 ABE_VEGFA_TARGETS_2HR allergic contact dermatitis DOID_3042 4.489E-04 0.01216388 4.489E-04 0.25544151 ABE_VEGFA_TARGETS_2HR brain infarction DOID_3454 4.618E-04 0.01194438 0.03137168 0.40569282 ABE_VEGFA_TARGETS_2HR male reproductive system disease DOID_48 5.016E-04 0.01240833 0.03267662 0.41317775 ABE_VEGFA_TARGETS_2HR cystic fibrosis DOID_1485 5.571E-04 0.01320695 0.03441398 0.42568594 ABE_VEGFA_TARGETS_2HR aneurysm disease DOID_2403 5.714E-04 0.01300456 1.000 1.000 ABE_VEGFA_TARGETS_2HR contact dermatitis DOID_2773 6.154E-04 0.01346779 6.154E-04 0.17508125 ABE_VEGFA_TARGETS_2HR lipid metabolism disorder DOID_3146 6.154E-04 0.01296898 0.03614839 0.41976401 ABE_VEGFA_TARGETS_2HR female reproductive system disease DOID_229 6.304E-04 0.01281121 0.03658154 0.40813523 ABE_VEGFA_TARGETS_2HR transitional cell carcinoma DOID_2671 7.406E-04 0.01453081 0.03960844 0.41735556 ABE_VEGFA_TARGETS_2HR Human immunodeficiency virus infectious disease DOID_526 7.736E-04 0.01467352 0.04047162 0.41869729 ABE_VEGFA_TARGETS_2HR alcohol-related neurodevelopmental disorder DOID_0050667 8.419E-04 0.0154526 0.04219579 0.42873939 ABE_VEGFA_TARGETS_2HR Crohn's disease DOID_8778 8.419E-04 0.01496971 0.04219579 0.42121765 ABE_VEGFA_TARGETS_2HR gallbladder disease DOID_0000000 4.476E-03 0.07717156 1.000 1.000 ABE_VEGFA_TARGETS_2HR facioscapulohumeral muscular dystrophy DOID_11727 4.476E-03 0.07490181 4.476E-03 0.84888714 ABE_VEGFA_TARGETS_2HR Sjogren's syndrome DOID_12894 4.476E-03 0.07276175 4.476E-03 0.63666535 ABE_VEGFA_TARGETS_2HR hyperparathyroidism DOID_13543 4.476E-03 0.07074059 1.000 1.000 ABE_VEGFA_TARGETS_2HR familial combined hyperlipidemia DOID_13809 4.476E-03 0.06882869 1.000 1.000 ABE_VEGFA_TARGETS_2HR familial adenomatous polyposis DOID_0050424 4.922E-03 0.0737036 1.000 1.000 ABE_VEGFA_TARGETS_2HR breast benign neoplasm DOID_0060082 4.922E-03 0.07181376 4.922E-03 0.56014734 ABE_VEGFA_TARGETS_2HR thoracic benign neoplasm DOID_0060097 4.922E-03 0.07181376 4.922E-03 0.56014734 ABE_VEGFA_TARGETS_2HR migraine without aura DOID_12783 4.922E-03 0.07001842 4.922E-03 0.46678945 ABE_VEGFA_TARGETS_2HR benign breast phyllodes tumor DOID_1631 4.922E-03 0.07181376 4.922E-03 0.56014734 ABE_VEGFA_TARGETS_2HR relapsing-remitting multiple sclerosis DOID_2378 5.369E-03 0.07450499 1.000 1.000 ABE_VEGFA_TARGETS_2HR stomach disease DOID_76 5.369E-03 0.07273106 1.000 1.000 ABE_VEGFA_TARGETS_2HR parathyroid gland disease DOID_11201 5.815E-03 0.07694338 1.000 1.000 ABE_VEGFA_TARGETS_2HR carotid stenosis DOID_13001 5.815E-03 0.07519467 1.000 1.000 ABE_VEGFA_TARGETS_2HR larynx cancer DOID_2596 5.815E-03 0.07352368 1.000 1.000 ABE_VEGFA_TARGETS_2HR laryngeal benign neoplasm DOID_2598 5.815E-03 0.07352368 1.000 1.000 ABE_VEGFA_TARGETS_2HR epilepsy with generalized tonic-clonic seizures DOID_7725 5.815E-03 0.07192534 5.815E-03 0.47265221 ABE_VEGFA_TARGETS_2HR psoriatic arthritis DOID_9008 5.815E-03 0.07039501 5.815E-03 0.41357068 ABE_VEGFA_TARGETS_2HR open-angle glaucoma DOID_1067 6.261E-03 0.07421498 1.000 1.000 ABE_VEGFA_TARGETS_2HR polycystic kidney disease DOID_898 6.261E-03 0.07270039 1.000 1.000 ABE_VEGFA_TARGETS_2HR idiopathic pulmonary fibrosis DOID_0050156 6.706E-03 0.07631931 1.000 1.000 ABE_VEGFA_TARGETS_2HR skeletal system cancer DOID_0060124 6.706E-03 0.07482285 1.000 1.000 ABE_VEGFA_TARGETS_2HR bone cancer DOID_184 6.706E-03 0.07482285 1.000 1.000 ABE_VEGFA_TARGETS_2HR oral submucous fibrosis DOID_5773 6.706E-03 0.07338395 1.000 1.000 ABE_VEGFA_TARGETS_2HR restrictive cardiomyopathy DOID_397 7.152E-03 0.07678311 7.152E-03 0.45216722 ABE_VEGFA_TARGETS_2HR tongue cancer DOID_8649 7.152E-03 0.0753612 1.000 1.000 ABE_VEGFA_TARGETS_2HR Barrett's esophagus DOID_9206 7.152E-03 0.073991 1.000 1.000 ABE_VEGFA_TARGETS_2HR Graves' disease DOID_12361 7.597E-03 0.07719531 7.597E-03 0.43229373 ABE_VEGFA_TARGETS_2HR bronchitis DOID_6132 7.597E-03 0.07584101 7.597E-03 0.3929943 ABE_VEGFA_TARGETS_2HR urinary system benign neoplasm DOID_731 7.597E-03 0.0745334 1.000 1.000 ABE_VEGFA_TARGETS_2HR prion disease DOID_649 8.043E-03 0.07756377 1.000 1.000 ABE_VEGFA_TARGETS_2HR Down syndrome DOID_14250 8.488E-03 0.08049135 8.488E-03 0.40245675 ABE_VEGFA_TARGETS_2HR granulosa cell tumor DOID_2999 8.488E-03 0.07917182 1.000 1.000 ABE_VEGFA_TARGETS_2HR amnestic disorder DOID_10914 8.932E-03 0.0819773 1.000 1.000 ABE_VEGFA_TARGETS_2HR membranous glomerulonephritis DOID_10976 8.932E-03 0.08067607 1.000 1.000 ABE_VEGFA_TARGETS_2HR esophagitis DOID_11963 8.932E-03 0.07941551 1.000 1.000 ABE_VEGFA_TARGETS_2HR sex cord-gonadal stromal tumor DOID_192 8.932E-03 0.07819373 1.000 1.000 ABE_VEGFA_TARGETS_2HR amyloidosis DOID_9120 8.932E-03 0.07700898 1.000 1.000 ABE_VEGFA_TARGETS_2HR gastric ulcer DOID_10808 9.822E-03 0.08341037 1.000 1.000 ABE_VEGFA_TARGETS_2HR muscle cancer DOID_4045 0.01026588 0.08590126 1.000 1.000 ABE_VEGFA_TARGETS_2HR urinary tract obstruction DOID_5200 0.01026588 0.08465631 1.000 1.000 ABE_VEGFA_TARGETS_2HR spastic quadriplegia DOID_10970 0.01115386 0.09066496 1.000 1.000 ABE_VEGFA_TARGETS_2HR sphingolipidosis DOID_1927 0.01115386 0.08938799 1.000 1.000 ABE_VEGFA_TARGETS_2HR cystitis DOID_1679 0.01204109 0.09515809 1.000 1.000 ABE_VEGFA_TARGETS_2HR ankylosing spondylitis DOID_7147 0.01204109 0.09385455 0.01204109 0.45675882 ABE_VEGFA_TARGETS_2HR migraine DOID_6364 0.01292758 0.09940258 0.01292758 0.43269358 ABE_VEGFA_TARGETS_2HR perinatal necrotizing enterocolitis DOID_8677 0.01292758 0.09807721 0.01292758 0.40865505 ABE_VEGFA_TARGETS_2HR renal hypertension DOID_1073 0.01337054 0.09880306 0.01337054 0.40041239 ABE_VEGFA_TARGETS_2HR secondary hypertension DOID_11130 0.01337054 0.09880306 0.01337054 0.40041239 ABE_VEGFA_TARGETS_2HR esophageal disease DOID_6050 0.01646603 0.09967201 1.000 1.000 ABE_VEGFA_TARGETS_2HR hyperthyroidism DOID_7998 0.01646603 0.09862283 0.01646603 0.36035265 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN astrocytoma DOID_3069 1.425E-18 8.106E-16 0.01712169 0.28653657 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pancreatic ductal carcinoma DOID_3587 1.701E-18 4.839E-16 5.22E-05 4.95E-03 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pancreatic carcinoma DOID_4905 2.851E-18 5.407E-16 6.114E-05 4.349E-03 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN giant cell tumor DOID_200 5.479E-16 7.794E-14 0.01061553 0.20828398 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN malignant giant cell tumor DOID_2705 5.479E-16 7.794E-14 0.01061553 0.20828398 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN giant cell glioblastoma DOID_3074 5.479E-16 7.794E-14 0.01061553 0.20828398 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN glioblastoma DOID_3068 1.372E-15 1.561E-13 0.01250206 0.23712231 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN diabetic retinopathy DOID_8947 1.403E-14 1.331E-12 0.01895521 0.29959769 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN biliary tract cancer DOID_4607 4.507E-14 3.663E-12 1.729E-03 0.06149132 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN retinal vascular disease DOID_2462 5.736E-14 4.08E-12 0.02439804 0.31551102 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN reproductive organ benign neoplasm DOID_0050622 6.425E-14 4.062E-12 6.036E-07 3.434E-04 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN uterine disease DOID_345 2.906E-13 1.654E-11 0.01536895 0.26499802 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN diabetic autonomic neuropathy DOID_11503 7.586E-13 3.924E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN autonomic neuropathy DOID_11504 7.586E-13 3.924E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN diabetic polyneuropathy DOID_12785 7.586E-13 3.924E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN gallbladder cancer DOID_3121 7.586E-13 3.597E-11 3.063E-04 0.01936774 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN diabetic neuropathy DOID_9743 7.586E-13 3.924E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN autonomic nervous system disease DOID_11465 1.286E-12 5.631E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN female reproductive system disease DOID_229 1.873E-12 7.613E-11 0.02235238 0.31020741 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN female reproductive organ benign neoplasm DOID_0060086 3.243E-12 1.23E-10 1.882E-06 5.354E-04 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN uterine benign neoplasm DOID_0060095 3.243E-12 1.23E-10 1.882E-06 5.354E-04 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN uterine fibroid DOID_13223 3.243E-12 1.23E-10 1.882E-06 5.354E-04 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN leiomyoma DOID_127 6.436E-12 2.289E-10 2.723E-06 5.164E-04 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cleft palate DOID_674 1.764E-11 5.905E-10 4.702E-06 6.688E-04 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN autoimmune hepatitis DOID_2048 2.049E-11 6.476E-10 0.05659407 0.41820813 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN brain cancer DOID_1319 9.241E-11 2.767E-09 0.12956673 0.64669712 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN central nervous system cancer DOID_3620 1.069E-10 3.04E-09 0.13198071 0.6418549 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN transitional cell carcinoma DOID_2671 1.696E-10 4.594E-09 0.02598069 0.31453213 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN orofacial cleft DOID_0050567 1.856E-10 4.801E-09 1.699E-05 1.934E-03 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN nervous system cancer DOID_3093 2.027E-10 5.014E-09 0.22544607 0.89082509 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bile duct adenocarcinoma DOID_4896 2.408E-10 5.708E-09 0.14632593 0.67690614 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cholangiocarcinoma DOID_4947 2.408E-10 5.708E-09 0.14632593 0.67690614 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bile duct cancer DOID_4606 3.937E-10 8.96E-09 0.1557587 0.68702871 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bile duct carcinoma DOID_4897 3.937E-10 8.96E-09 0.1557587 0.68702871 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN carotid artery disease DOID_3407 5.568E-10 1.219E-08 0.16276547 0.69634249 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN blood coagulation disease DOID_1247 1.431E-09 3.016E-08 0.01757258 0.2856799 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN peptic ulcer DOID_750 1.89E-09 3.84E-08 6.086E-03 0.13851988 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cystic fibrosis DOID_1485 2.294E-09 4.501E-08 0.01990165 0.30605517 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN endometriosis of uterus DOID_288 2.914E-09 5.527E-08 0.11739676 0.63017694 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN endometriosis DOID_289 3.344E-09 6.137E-08 0.11984416 0.63140118 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN uterine cancer DOID_363 3.825E-09 6.801E-08 0.12228484 0.63834931 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN myeloma DOID_0070004 5.622E-09 9.694E-08 0.12956673 0.66417542 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pre-eclampsia DOID_10591 5.622E-09 9.409E-08 0.12956673 0.65824528 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN heart valve disease DOID_4079 5.622E-09 9.14E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN autoimmune disease of gastrointestinal tract DOID_0060031 7.171E-09 1.133E-07 0.13438805 0.64802374 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hemorrhagic disease DOID_2213 9.056E-09 1.393E-07 0.13918292 0.65450479 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN encephalomyelitis DOID_640 9.233E-09 1.383E-07 0.02870832 0.2865795 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Crohn's disease DOID_8778 9.937E-09 1.45E-07 0.23401248 0.89968312 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN dilated cardiomyopathy DOID_12930 1.069E-08 1.52E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cleft lip DOID_9296 1.138E-08 1.58E-07 5.753E-05 4.676E-03 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cutaneous leishmaniasis DOID_9111 1.152E-08 1.56E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bone marrow cancer DOID_4960 1.264E-08 1.672E-07 0.14632593 0.67144722 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN parasitic protozoa infectious disease DOID_2789 1.407E-08 1.819E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN supratentorial cancer DOID_1659 2.375E-08 3.003E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cerebrum cancer DOID_368 2.375E-08 3.003E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN aortic valve insufficiency DOID_57 2.703E-08 3.344E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN endometrial carcinoma DOID_2871 2.809E-08 3.4E-07 0.08496041 0.54317387 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pre-malignant neoplasm DOID_0060071 3.101E-08 3.677E-07 0.0145235 0.25824596 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN in situ carcinoma DOID_8719 3.101E-08 3.677E-07 0.0145235 0.25824596 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN mineral metabolism disease DOID_0050032 3.399E-08 3.947E-07 0.16971463 0.71531572 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN parasitic infectious disease DOID_1398 3.72E-08 4.233E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN endometrial cancer DOID_1380 3.864E-08 4.311E-07 0.0900264 0.56291232 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN germinoma DOID_3304 3.864E-08 4.228E-07 0.0900264 0.55679371 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN brain infarction DOID_3454 4.834E-08 5.19E-07 0.17889138 0.73760285 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN oral submucous fibrosis DOID_5773 7.406E-08 7.804E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN calcinosis DOID_182 9.017E-08 9.329E-07 0.10505827 0.6099812 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN mixed glioma DOID_5076 9.941E-08 1.01E-06 0.02086756 0.3044523 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN chronic kidney failure DOID_784 1.431E-07 1.428E-06 0.02336589 0.31655223 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pulmonary emphysema DOID_9675 1.475E-07 1.447E-06 0.11494262 0.62287951 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bone development disease DOID_0080006 1.535E-07 1.48E-06 0.02387965 0.31598889 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN ureteral obstruction DOID_5199 1.65E-07 1.565E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN leishmaniasis DOID_9065 2.085E-07 1.945E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN subependymal glioma DOID_4843 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pilocytic astrocytoma DOID_4851 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN subependymal giant cell astrocytoma DOID_5077 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN fibrillary astrocytoma DOID_6726 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN juvenile pilocytic astrocytoma DOID_6811 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN childhood pilocytic astrocytoma DOID_6812 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN gemistocytic astrocytoma DOID_7005 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN childhood cerebral astrocytoma DOID_7007 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN protoplasmic astrocytoma DOID_7008 2.601E-07 2.387E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN mouth disease DOID_403 2.959E-07 2.673E-06 0.23401248 0.90580341 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hypersensitivity reaction type I disease DOID_1205 3.147E-07 2.798E-06 0.23613938 0.90176716 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN ulcerative colitis DOID_8577 3.771E-07 3.301E-06 0.03154524 0.29915405 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN calcium metabolism disease DOID_10575 3.822E-07 3.295E-06 0.13678878 0.65405729 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN benign glioma DOID_0060101 3.91E-07 3.321E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN gastric ulcer DOID_10808 3.91E-07 3.272E-06 1.693E-03 0.06421259 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN benign ependymoma DOID_4844 3.91E-07 3.321E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN urinary tract obstruction DOID_5200 4.723E-07 3.895E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN ureteral disease DOID_1426 5.656E-07 4.598E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN aortic valve disease DOID_62 5.656E-07 4.533E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN seminoma DOID_4440 1.081E-06 8.54E-06 0.07474449 0.51865381 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN congenital heart defect DOID_1682 1.157E-06 9.016E-06 0.16740461 0.71084495 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN focal glomerulosclerosis DOID_3945 1.65E-06 1.269E-05 0.08241695 0.53902582 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN corneal disease DOID_10124 1.882E-06 1.428E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN nephrosis DOID_2527 2.049E-06 1.534E-05 0.18570794 0.76020015 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN age related macular degeneration DOID_10871 2.137E-06 1.579E-05 3.793E-03 0.10791639 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN degeneration of macula and posterior pole DOID_2007 2.137E-06 1.579E-05 3.793E-03 0.10791639 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN keratitis DOID_4677 2.443E-06 1.782E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bacterial pneumonia DOID_874 3.017E-06 2.173E-05 0.19917338 0.80375639 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN metabolic syndrome X DOID_14221 3.41E-06 2.425E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN spindle cell carcinoma DOID_4015 3.419E-06 2.402E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN macular degeneration DOID_4448 3.419E-06 2.373E-05 4.75E-03 0.12285899 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN adenoma DOID_657 4.24E-06 2.907E-05 5.266E-03 0.12485309 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN common cold DOID_10459 4.46E-06 3.021E-05 4.925E-04 0.02802163 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN multiple myeloma DOID_9538 4.702E-06 3.147E-05 0.10505827 0.60381977 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN primary bacterial infectious disease DOID_0050338 5.108E-06 3.38E-05 0.02544859 0.31478794 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN blood platelet disease DOID_2218 5.199E-06 3.4E-05 0.10753956 0.61190011 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN intracranial arterial disease DOID_13089 6.308E-06 4.079E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cerebral arterial disease DOID_3527 6.308E-06 4.079E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Legionnaires' disease DOID_10457 7.349E-06 4.699E-05 0.03809106 0.32348975 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN legionellosis DOID_10458 7.349E-06 4.699E-05 0.03809106 0.32348975 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN tethered spinal cord syndrome DOID_1089 7.349E-06 4.646E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN alcohol-related neurodevelopmental disorder DOID_0050667 7.407E-06 4.632E-05 0.02926707 0.28712004 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN rheumatic disease DOID_1575 8.289E-06 5.126E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN scleroderma DOID_419 8.289E-06 5.126E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cerebral infarction DOID_3526 9.841E-06 6.021E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN proteinuria DOID_576 1.069E-05 6.473E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hemolytic-uremic syndrome DOID_12554 1.126E-05 6.745E-05 8.889E-04 0.04215096 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN vascular skin disease DOID_9540 1.16E-05 6.874E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lung small cell carcinoma DOID_5409 1.358E-05 7.964E-05 9.206E-03 0.18708291 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN vasculitis DOID_865 1.96E-05 1.138E-04 0.14632593 0.66607564 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN osteochondrodysplasia DOID_2256 2.101E-05 1.207E-04 0.14869387 0.67148262 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hypertrophic cardiomyopathy DOID_11984 2.567E-05 1.461E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN thrombophilia DOID_2452 3.06E-05 1.724E-04 0.05920842 0.43191781 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN placenta disease DOID_780 3.06E-05 1.707E-04 0.05920842 0.4264505 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN collagen disease DOID_854 3.106E-05 1.716E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN respiratory failure DOID_11162 3.303E-05 1.807E-04 0.01410861 0.25896126 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN IgA glomerulonephritis DOID_2986 3.511E-05 1.903E-04 1.851E-03 0.06194225 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hypogonadism DOID_1924 5.124E-05 2.751E-04 2.364E-03 0.07474376 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN peripheral vascular disease DOID_341 5.805E-05 3.087E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN biliary tract disease DOID_9741 5.805E-05 3.058E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN spinal cord disease DOID_319 6.43E-05 3.357E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN gestational diabetes DOID_11714 7.158E-05 3.703E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN sarcoma DOID_1115 7.937E-05 4.069E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN thrombocytopenia DOID_1588 7.937E-05 4.032E-04 0.07986649 0.5410004 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hepatic vascular disease DOID_272 7.937E-05 3.997E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lipid metabolism disorder DOID_3146 8.23E-05 4.108E-04 0.02185268 0.31085441 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN chromosomal disease DOID_0080014 8.628E-05 4.269E-04 1.615E-03 0.06563636 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN multiple epiphyseal dysplasia DOID_12721 8.77E-05 4.302E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN dysostosis DOID_1934 9.658E-05 4.697E-04 0.08496041 0.5493463 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN spastic cerebral palsy DOID_0050669 1.06E-04 5.112E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN gonadal disease DOID_2277 1.06E-04 5.069E-04 3.793E-03 0.10277752 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN allergic rhinitis DOID_4481 1.16E-04 5.503E-04 0.0900264 0.55080668 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN primary immunodeficiency disease DOID_612 1.234E-04 5.802E-04 0.0265173 0.31434048 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN papilloma DOID_2615 1.379E-04 6.432E-04 0.0950646 0.56938694 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN esophageal disease DOID_6050 1.498E-04 6.929E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymphoid leukemia DOID_10747 1.623E-04 7.447E-04 5.005E-03 0.12382298 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN refractive error DOID_9835 1.755E-04 7.987E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hepatitis DOID_2237 2.191E-04 9.893E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN congenital diaphragmatic hernia DOID_3827 2.191E-04 9.815E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN systemic scleroderma DOID_418 2.191E-04 9.739E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymphatic system disease DOID_75 2.35E-04 1.037E-03 0.11248171 0.62137957 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN benign mesothelioma DOID_2645 2.517E-04 1.102E-03 0.11494262 0.62886874 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cervix uteri carcinoma in situ DOID_8991 2.517E-04 1.093E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN autoimmune disease of urogenital tract DOID_0060049 2.692E-04 1.16E-03 6.96E-03 0.15232422 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN primary biliary cirrhosis DOID_12236 2.692E-04 1.16E-03 6.96E-03 0.15232422 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN primitive neuroectodermal tumor DOID_168 2.874E-04 1.229E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bilirubin metabolic disorder DOID_2741 3.37E-04 1.431E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN teratoma DOID_3307 3.37E-04 1.42E-03 0.027357 0.2993487 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN insulinoma DOID_3892 3.37E-04 1.41E-03 0.027357 0.29370061 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN malignant teratoma DOID_5563 3.37E-04 1.42E-03 0.027357 0.2993487 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN mature teratoma DOID_5566 3.37E-04 1.42E-03 0.027357 0.2993487 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bone marrow disease DOID_4961 3.681E-04 1.529E-03 0.12956673 0.63554717 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hemolytic anemia DOID_583 3.903E-04 1.609E-03 8.868E-03 0.18688495 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN normocytic anemia DOID_720 3.903E-04 1.609E-03 8.868E-03 0.18688495 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN sickle cell anemia DOID_10923 4.111E-04 1.683E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN temporal arteritis DOID_13375 4.111E-04 1.671E-03 0.03005159 0.28981953 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN central nervous system vasculitis DOID_525 4.111E-04 1.671E-03 0.03005159 0.28981953 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN glaucoma DOID_1686 4.134E-04 1.668E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN intracranial arteriosclerosis DOID_13097 4.925E-04 1.973E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN islet cell tumor DOID_1799 4.925E-04 1.96E-03 0.03273878 0.30538302 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN relapsing-remitting multiple sclerosis DOID_2378 4.925E-04 1.946E-03 0.03273878 0.30045749 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN vascular dementia DOID_8725 4.925E-04 1.973E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN integumentary system cancer DOID_0060122 5.702E-04 2.238E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN skin cancer DOID_4159 5.702E-04 2.238E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN carotid stenosis DOID_13001 5.81E-04 2.264E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Leydig cell tumor DOID_2696 5.81E-04 2.249E-03 0.0354186 0.31004894 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN intracranial thrombosis DOID_4193 5.81E-04 2.234E-03 0.0354186 0.30535123 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN sex cord-stromal neoplasm DOID_4757 5.81E-04 2.249E-03 0.0354186 0.31004894 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN familial hyperlipidemia DOID_1168 5.996E-04 2.29E-03 0.15105529 0.67148799 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN melancholia DOID_2848 6.933E-04 2.63E-03 0.15810072 0.68671229 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN neurotic disorder DOID_4964 7.265E-04 2.738E-03 0.1604363 0.6915777 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN neuroectodermal tumor DOID_171 7.607E-04 2.848E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN skeletal system cancer DOID_0060124 7.792E-04 2.898E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN thoracic aortic aneurysm DOID_14004 7.792E-04 2.879E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bone cancer DOID_184 7.792E-04 2.898E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hemangioma DOID_255 7.792E-04 2.861E-03 0.04075619 0.3360909 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN membranoproliferative glomerulonephritis DOID_2920 7.792E-04 2.842E-03 0.04075619 0.3312896 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN nutritional deficiency disease DOID_5113 7.792E-04 2.824E-03 7.792E-04 0.04030783 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN intermediate coronary syndrome DOID_8805 7.792E-04 2.806E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hyperhomocysteinemia DOID_9279 7.792E-04 2.789E-03 0.04075619 0.32662355 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN angiosarcoma DOID_0001816 8.889E-04 3.161E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN spastic diplegia DOID_10965 8.889E-04 3.142E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Barrett's esophagus DOID_9206 8.889E-04 3.122E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN cholestasis DOID_13580 9.077E-04 3.169E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hyperglycemia DOID_4195 9.471E-04 3.286E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN tooth disease DOID_1091 9.875E-04 3.405E-03 0.17660665 0.73889106 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bronchitis DOID_6132 1.006E-03 3.447E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN urinary system benign neoplasm DOID_731 1.006E-03 3.426E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN inherited blood coagulation disease DOID_2214 1.129E-03 3.825E-03 0.04870778 0.38492673 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bile duct disease DOID_4138 1.16E-03 3.906E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Down syndrome DOID_14250 1.26E-03 4.217E-03 0.05134377 0.40020006 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN endogenous depression DOID_1595 1.351E-03 4.494E-03 0.19470959 0.79135539 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN membranous glomerulonephritis DOID_10976 1.397E-03 4.623E-03 1.397E-03 0.06116154 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pulmonary edema DOID_11396 1.397E-03 4.596E-03 0.05397253 0.40947157 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN esophagitis DOID_11963 1.397E-03 4.57E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN brain edema DOID_4724 1.397E-03 4.543E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pancreatitis DOID_4989 1.453E-03 4.697E-03 0.02086756 0.31246421 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Kawasaki disease DOID_13378 1.542E-03 4.956E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymphadenitis DOID_1602 1.542E-03 4.956E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymph node disease DOID_9942 1.542E-03 4.956E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hepatitis B DOID_2043 1.693E-03 5.411E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN acquired immunodeficiency syndrome DOID_635 1.693E-03 5.381E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN mental depression DOID_1596 1.729E-03 5.466E-03 0.21022591 0.84238412 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN muscle cancer DOID_4045 1.851E-03 5.818E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pulmonary embolism DOID_9477 1.851E-03 5.786E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN polyarteritis nodosa DOID_9810 1.851E-03 5.754E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN synostosis DOID_11971 2.015E-03 6.232E-03 0.0644156 0.45815598 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Human immunodeficiency virus infectious disease DOID_526 2.168E-03 6.668E-03 0.22544607 0.88468147 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN spastic quadriplegia DOID_10970 2.187E-03 6.689E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymphoma DOID_0060058 2.305E-03 7.013E-03 0.22974107 0.89536074 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN portal hypertension DOID_10762 2.364E-03 7.156E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymphoblastic leukemia DOID_1037 2.375E-03 7.151E-03 0.02870832 0.29169699 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN morbid obesity DOID_11981 2.549E-03 7.634E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN papillary adenoma DOID_3172 2.549E-03 7.594E-03 0.0721729 0.50699237 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN microcystic adenoma DOID_5403 2.549E-03 7.594E-03 0.0721729 0.50699237 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN follicular adenoma DOID_6204 2.549E-03 7.594E-03 0.0721729 0.50699237 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN myositis DOID_633 2.549E-03 7.554E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN middle cerebral artery infarction DOID_3525 2.74E-03 8.079E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN periodontitis DOID_824 2.938E-03 8.617E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN renal hypertension DOID_1073 3.142E-03 9.168E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN secondary hypertension DOID_11130 3.142E-03 9.168E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN toxic encephalopathy DOID_3602 3.353E-03 9.733E-03 3.353E-03 0.10040328 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN opportunistic mycosis DOID_2473 3.793E-03 0.01095598 0.08749689 0.55317477 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pleural disease DOID_1532 4.259E-03 0.0122397 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bladder disease DOID_365 4.259E-03 0.0121782 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN systemic mycosis DOID_0050136 4.502E-03 0.01280701 0.0950646 0.57544425 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN fungal infectious disease DOID_1564 4.502E-03 0.01280701 0.0950646 0.57544425 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN nephroblastoma DOID_2154 4.75E-03 0.01344725 0.09757334 0.57236318 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN periodontal disease DOID_3388 4.75E-03 0.01338068 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN aplastic anemia DOID_12449 5.005E-03 0.0140292 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN medullomyoblastoma DOID_3861 5.005E-03 0.01396043 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN adult medulloblastoma DOID_3864 5.005E-03 0.01396043 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN childhood medulloblastoma DOID_3869 5.005E-03 0.01396043 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pulmonary sarcoidosis DOID_13406 5.533E-03 0.01535861 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN medulloblastoma DOID_3858 5.533E-03 0.01528405 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN respiratory syncytial virus infectious disease DOID_1273 6.086E-03 0.01672945 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN adult respiratory distress syndrome DOID_11394 6.372E-03 0.01742981 0.11248171 0.63368412 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN nephrotic syndrome DOID_1184 7.264E-03 0.0197752 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Huntington's disease DOID_12858 7.264E-03 0.01968103 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hyperinsulinism DOID_2018 7.264E-03 0.01958776 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN thyroid adenoma DOID_2891 8.536E-03 0.02290908 0.12956673 0.64107366 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN integumentary system benign neoplasm DOID_0060121 9.206E-03 0.02459306 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN skin benign neoplasm DOID_3165 9.206E-03 0.02459306 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN aortic aneurysm DOID_3627 9.55E-03 0.02539247 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN B-cell lymphocytic neoplasm DOID_707 9.9E-03 0.02619942 0.13918292 0.64914 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN sarcoidosis DOID_11335 0.01061553 0.02796405 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN atrophic muscular disease DOID_913 0.01061553 0.02783519 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN muscular dystrophy DOID_9884 0.01061553 0.02783519 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hypersensitivity reaction type IV disease DOID_2916 0.01250206 0.03263151 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN leukocyte disease DOID_9500 0.01289568 0.03350521 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN endocrine pancreas disease DOID_1428 0.01494362 0.03864964 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN allergic contact dermatitis DOID_3042 0.0162351 0.04179988 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN endocrine organ benign neoplasm DOID_0060089 0.01667586 0.04274127 0.17889138 0.74298681 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN tuberculosis DOID_399 0.01667586 0.04254961 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN male reproductive system disease DOID_48 0.01802848 0.04579556 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN syndrome DOID_225 0.01990165 0.05032907 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bone resorption disease DOID_0080011 0.02038219 0.05131622 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN osteoporosis DOID_11476 0.02038219 0.05131622 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN aneurysm disease DOID_2403 0.02038219 0.05109015 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN contact dermatitis DOID_2773 0.02185268 0.05453586 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN DiGeorge syndrome DOID_11198 0.024655 0.06126067 0.024655 0.31174876 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN velocardiofacial syndrome DOID_12583 0.024655 0.06126067 0.024655 0.31174876 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN amino acid metabolic disorder DOID_9252 0.0265173 0.06560149 0.22328968 0.88847432 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN interstitial nephritis DOID_1063 0.027357 0.06738586 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Gilles de la Tourette syndrome DOID_11119 0.027357 0.0670954 0.027357 0.31767617 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN T cell deficiency DOID_11200 0.027357 0.06680744 0.027357 0.31132265 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hypolipoproteinemia DOID_1387 0.027357 0.06652193 0.027357 0.30521829 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN childhood type dermatomyositis DOID_14203 0.027357 0.06623886 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN retinal vascular occlusion DOID_1729 0.027357 0.06595819 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN phagocyte bactericidal dysfunction DOID_3262 0.027357 0.06567988 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN chondrosarcoma DOID_3371 0.027357 0.06540392 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN conjunctival disease DOID_4251 0.027357 0.06513026 0.027357 0.28826171 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hypokalemia DOID_4500 0.027357 0.06485889 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN acute T cell leukemia DOID_5603 0.027357 0.06458976 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN conjunctivitis DOID_6195 0.027357 0.06513026 0.027357 0.28826171 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN polycythemia DOID_8432 0.027357 0.06432286 0.027357 0.28302059 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.027357 0.06405816 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.027357 0.06405816 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Hodgkin's granuloma DOID_8651 0.027357 0.06405816 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 0.027357 0.06405816 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN visceral leishmaniasis DOID_9146 0.027357 0.06379563 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN nervous system benign neoplasm DOID_0060115 0.03005159 0.06979327 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN trypanosomiasis DOID_10113 0.03005159 0.06950956 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN dermatomyositis DOID_10223 0.03005159 0.06922815 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN adrenoleukodystrophy DOID_10588 0.03005159 0.068949 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pneumocystosis DOID_11339 0.03005159 0.0686721 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN polydactyly DOID_1148 0.03005159 0.06839741 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN craniosynostosis DOID_2340 0.03005159 0.06812491 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN invasive lobular carcinoma DOID_3457 0.03005159 0.06785457 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN heroin dependence DOID_9976 0.03005159 0.06758637 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN diarrhea DOID_13250 0.03273878 0.07334002 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pituitary cancer DOID_1785 0.03273878 0.07305241 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN tic disorder DOID_2769 0.03273878 0.07276705 0.03273878 0.29568833 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pituitary carcinoma DOID_4916 0.03273878 0.07305241 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN stomach disease DOID_76 0.03273878 0.07248391 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lipodystrophy DOID_811 0.03273878 0.07220296 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN peritonitis DOID_8283 0.03273878 0.07192419 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Hodgkin's lymphoma DOID_8567 0.03273878 0.07164756 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN mitochondrial encephalomyopathy DOID_890 0.03273878 0.07137304 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN ocular hypertension DOID_9282 0.03273878 0.07110063 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN borderline glaucoma DOID_9283 0.03273878 0.07110063 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN leprosy DOID_1024 0.0354186 0.07662806 0.0354186 0.31489345 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN berylliosis DOID_10322 0.0354186 0.07633781 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hepatic coma DOID_12550 0.0354186 0.07604974 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN hepatic encephalopathy DOID_13413 0.0354186 0.07604974 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN larynx cancer DOID_2596 0.0354186 0.07576384 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN laryngeal benign neoplasm DOID_2598 0.0354186 0.07576384 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN epilepsy with generalized tonic-clonic seizures DOID_7725 0.0354186 0.07548008 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN viral pneumonia DOID_10533 0.03809106 0.08087244 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN rhabdomyosarcoma DOID_3247 0.03809106 0.0805718 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN eyelid disease DOID_530 0.03809106 0.08027338 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN T-cell leukemia DOID_715 0.03809106 0.07997717 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN parasitic helminthiasis infectious disease DOID_883 0.03809106 0.07968314 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN polycystic kidney disease DOID_898 0.03809106 0.07939126 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN bacterial meningitis DOID_9470 0.03809106 0.07910151 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN idiopathic pulmonary fibrosis DOID_0050156 0.04075619 0.08432826 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN renovascular hypertension DOID_1591 0.04075619 0.08402273 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN Williams-Beuren syndrome DOID_1928 0.04075619 0.08371939 0.04075619 0.34103342 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN mesenchymal cell neoplasm DOID_3350 0.04075619 0.08341825 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN arthropathy DOID_381 0.04075619 0.08311926 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN skeletal muscle cancer DOID_4043 0.04075619 0.0828224 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN spindle cell sarcoma DOID_4235 0.04075619 0.08341825 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN epithelioid sarcoma DOID_6193 0.04075619 0.08341825 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN long QT syndrome DOID_2843 0.04341401 0.0879095 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN pituitary adenoma DOID_3829 0.04341401 0.08759776 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN restrictive cardiomyopathy DOID_397 0.04341401 0.08728823 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymphatic system cancer DOID_0060073 0.04606453 0.09229126 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN penile disease DOID_1529 0.04606453 0.09196743 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN reticulosarcoma DOID_8538 0.04606453 0.09229126 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN lymphosarcoma DOID_8675 0.04606453 0.09229126 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN glucose intolerance DOID_10603 0.04870778 0.09690463 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN osteosclerosis DOID_4254 0.04870778 0.09656698 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN prion disease DOID_649 0.04870778 0.09623168 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN eosinophilia DOID_999 0.04870778 0.0958987 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER collagen disease DOID_854 7.876E-07 4.481E-04 2.313E-03 0.07310321 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER primary immunodeficiency disease DOID_612 3.242E-06 9.223E-04 4.609E-03 0.08742635 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER coronary stenosis DOID_4248 5.027E-06 9.535E-04 5.11E-04 0.04846356 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER uveal disease DOID_3480 1.857E-05 2.641E-03 1.202E-03 0.05701099 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER thyroid adenoma DOID_2891 2.39E-05 2.719E-03 2.39E-05 0.01359738 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER autoimmune disease of gastrointestinal tract DOID_0060031 2.69E-05 2.551E-03 1.534E-03 0.06234293 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER common variable immunodeficiency DOID_12177 6.548E-05 5.323E-03 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER endocrine organ benign neoplasm DOID_0060089 6.857E-05 4.877E-03 6.857E-05 0.01950724 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER peripheral vascular disease DOID_341 8.076E-05 5.106E-03 0.07984826 0.32222455 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER pancreatitis DOID_4989 9.788E-05 5.57E-03 3.584E-03 0.07553973 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER hypersensitivity reaction type I disease DOID_1205 1.734E-04 8.968E-03 5.219E-03 0.09280057 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER congenital muscular dystrophy DOID_0050557 1.813E-04 8.595E-03 1.813E-04 0.03438028 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER prion disease DOID_649 1.813E-04 7.934E-03 0.01975915 0.20076709 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER agammaglobulinemia DOID_2583 2.024E-04 8.228E-03 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER blood protein disease DOID_620 2.248E-04 8.527E-03 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER autoimmune hepatitis DOID_2048 2.483E-04 8.829E-03 0.02301508 0.22195895 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER coronary restenosis DOID_4247 2.483E-04 8.31E-03 2.483E-04 0.03531691 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER papillary adenoma DOID_3172 4.132E-04 0.01306252 4.132E-04 0.04702509 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER microcystic adenoma DOID_5403 4.132E-04 0.01306252 4.132E-04 0.04702509 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER follicular adenoma DOID_6204 4.132E-04 0.01306252 4.132E-04 0.04702509 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER ankylosing spondylitis DOID_7147 4.132E-04 0.01237502 0.02949528 0.2299016 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER B cell deficiency DOID_2115 4.447E-04 0.01265171 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER autoimmune disease of endocrine system DOID_0060005 5.459E-04 0.01479129 0.03379209 0.23737902 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER corneal disease DOID_10124 5.819E-04 0.01504965 0.03486339 0.24191791 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER celiac disease DOID_10608 6.572E-04 0.01625894 0.03700251 0.25064793 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER papilloma DOID_2615 7.37E-04 0.01747337 7.37E-04 0.05990871 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER myocarditis DOID_820 7.37E-04 0.01677444 0.03913699 0.25596494 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER esophageal disease DOID_6050 7.786E-04 0.01703898 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER adenoma DOID_657 8.65E-04 0.01823003 8.65E-04 0.06152634 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER uveitis DOID_13141 9.559E-04 0.01942581 0.04445303 0.26076055 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER systemic scleroderma DOID_418 1.003E-03 0.01967993 0.04551279 0.25640371 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER adenoid cystic carcinoma DOID_4866 1.051E-03 0.01993793 1.051E-03 0.06645978 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER salivary gland cancer DOID_8850 1.151E-03 0.02112407 1.151E-03 0.06548463 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER rheumatic disease DOID_1575 1.202E-03 0.02137912 0.04974035 0.26450709 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER hyperinsulinism DOID_2018 1.202E-03 0.02073127 1.202E-03 0.06219381 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER scleroderma DOID_419 1.202E-03 0.02137912 0.04974035 0.26450709 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER uterine cancer DOID_363 1.255E-03 0.02100108 1.255E-03 0.05492589 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER vascular skin disease DOID_9540 1.419E-03 0.02307007 0.05394963 0.26463225 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER glaucoma DOID_1686 1.534E-03 0.02424447 1.534E-03 0.05818673 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER pulmonary tuberculosis DOID_2957 1.534E-03 0.02358922 0.05604744 0.27026267 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER giant cell tumor DOID_200 1.776E-03 0.02660056 0.06022945 0.28322774 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER malignant giant cell tumor DOID_2705 1.776E-03 0.02660056 0.06022945 0.28322774 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER giant cell glioblastoma DOID_3074 1.776E-03 0.02660056 0.06022945 0.28322774 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER atrophic muscular disease DOID_913 1.776E-03 0.02591849 1.776E-03 0.06317632 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER muscular dystrophy DOID_9884 1.776E-03 0.02591849 1.776E-03 0.06317632 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER pustulosis of palm and sole DOID_4398 1.904E-03 0.02708679 0.06231367 0.28593932 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER glioblastoma DOID_3068 2.104E-03 0.02919434 0.06543153 0.2908636 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER oral cavity cancer DOID_8618 2.104E-03 0.02849924 2.104E-03 0.07040988 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER congenital heart defect DOID_1682 2.457E-03 0.03251387 2.457E-03 0.07358402 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER endocrine pancreas disease DOID_1428 2.531E-03 0.03272967 2.531E-03 0.07200527 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER cholestasis DOID_13580 2.606E-03 0.03294902 2.606E-03 0.07060505 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER tooth disease DOID_1091 2.759E-03 0.03412339 0.07472453 0.31495005 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER allergic contact dermatitis DOID_3042 2.759E-03 0.03339736 2.759E-03 0.07134891 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER tuberculosis DOID_399 2.837E-03 0.0336259 0.0757515 0.31461753 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER astrocytoma DOID_3069 2.916E-03 0.03385707 0.07677735 0.3165675 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER nephrosis DOID_2527 3.077E-03 0.03501313 3.077E-03 0.0761155 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER bile duct disease DOID_4138 3.077E-03 0.0343266 3.077E-03 0.07294402 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER male reproductive system disease DOID_48 3.077E-03 0.03366647 0.07882574 0.32037031 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER biliary tract disease DOID_9741 3.159E-03 0.03391247 3.159E-03 0.07189443 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER aneurysm disease DOID_2403 3.497E-03 0.0368514 3.497E-03 0.07653753 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER contact dermatitis DOID_2773 3.762E-03 0.03891799 3.762E-03 0.07644605 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER primary bacterial infectious disease DOID_0050338 4.414E-03 0.04485097 0.09404781 0.35206057 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER transitional cell carcinoma DOID_2671 4.511E-03 0.04503406 4.511E-03 0.08851523 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER Human immunodeficiency virus infectious disease DOID_526 4.709E-03 0.04619311 0.09706263 0.3586275 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER encephalomyelitis DOID_640 5.012E-03 0.0483353 0.10006765 0.36499033 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER mouth disease DOID_403 5.115E-03 0.04850705 0.10106715 0.36396967 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER Crohn's disease DOID_8778 5.115E-03 0.04771185 5.115E-03 0.09388462 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER angioedema DOID_1558 0.01102481 0.09957331 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER transient cerebral ischemia DOID_224 0.01102481 0.09801748 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER progressive muscular atrophy DOID_318 0.01102481 0.09650952 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER phagocyte bactericidal dysfunction DOID_3262 0.01102481 0.09504725 0.01102481 0.1900945 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER chondrosarcoma DOID_3371 0.01102481 0.09362864 0.01102481 0.18450349 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER keratitis DOID_4677 0.01102481 0.09225174 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER polycythemia DOID_8432 0.01102481 0.09091476 0.01102481 0.17923196 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER breast benign neoplasm DOID_0060082 0.01212075 0.09852435 0.01212075 0.19157513 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER thoracic benign neoplasm DOID_0060097 0.01212075 0.09852435 0.01212075 0.19157513 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER nervous system benign neoplasm DOID_0060115 0.01212075 0.09713668 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER sickle cell anemia DOID_10923 0.01212075 0.09578756 0.01212075 0.18639742 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER pneumocystosis DOID_11339 0.01212075 0.0944754 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER benign breast phyllodes tumor DOID_1631 0.01212075 0.09852435 0.01212075 0.19157513 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER heroin dependence DOID_9976 0.01212075 0.09319871 0.01212075 0.18149222 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER beta thalassemia DOID_12241 0.01321549 0.09894231 0.01321549 0.1879904 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER intracranial arteriosclerosis DOID_13097 0.01321549 0.09765735 0.01321549 0.18340526 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER pituitary cancer DOID_1785 0.01321549 0.09640533 0.01321549 0.17903847 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER pituitary carcinoma DOID_4916 0.01321549 0.09640533 0.01321549 0.17903847 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER stomach disease DOID_76 0.01321549 0.09518501 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER vascular dementia DOID_8725 0.01321549 0.09765735 0.01321549 0.18340526 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER encephalitis DOID_9588 0.01321549 0.0939952 1.000 1.000 WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER psoriatic arthritis DOID_9008 0.01430906 0.09929089 1.000 1.000 BENPORATH_NOS_TARGETS congenital nervous system abnormality DOID_2490 2.643E-07 1.504E-04 2.643E-07 1.504E-04 BENPORATH_NOS_TARGETS nephroblastoma DOID_2154 1.539E-06 4.379E-04 1.539E-06 4.379E-04 BENPORATH_NOS_TARGETS orofacial cleft DOID_0050567 7.705E-06 1.461E-03 2.715E-04 0.01188378 BENPORATH_NOS_TARGETS pre-malignant neoplasm DOID_0060071 1.598E-05 2.273E-03 1.598E-05 3.03E-03 BENPORATH_NOS_TARGETS in situ carcinoma DOID_8719 1.598E-05 2.273E-03 1.598E-05 3.03E-03 BENPORATH_NOS_TARGETS synostosis DOID_11971 2.204E-05 2.508E-03 2.204E-05 3.135E-03 BENPORATH_NOS_TARGETS cleft lip DOID_9296 3.169E-05 3.005E-03 1.721E-03 0.03916148 BENPORATH_NOS_TARGETS bone development disease DOID_0080006 4.548E-05 3.697E-03 1.007E-03 0.03015201 BENPORATH_NOS_TARGETS dysostosis DOID_1934 5.33E-05 3.791E-03 5.33E-05 6.066E-03 BENPORATH_NOS_TARGETS transitional cell carcinoma DOID_2671 5.434E-05 3.436E-03 0.01790251 0.1958948 BENPORATH_NOS_TARGETS germinoma DOID_3304 6.41E-05 3.647E-03 6.41E-05 6.078E-03 BENPORATH_NOS_TARGETS lymphoblastic leukemia DOID_1037 6.713E-05 3.472E-03 6.713E-05 5.456E-03 BENPORATH_NOS_TARGETS lymphoid leukemia DOID_10747 8.977E-05 4.257E-03 8.977E-05 6.385E-03 BENPORATH_NOS_TARGETS cleft palate DOID_674 1.048E-04 4.587E-03 3.751E-03 0.06277755 BENPORATH_NOS_TARGETS embryonal cancer DOID_688 1.048E-04 4.259E-03 1.048E-04 6.625E-03 BENPORATH_NOS_TARGETS microcephaly DOID_10907 1.129E-04 4.282E-03 1.129E-04 6.423E-03 BENPORATH_NOS_TARGETS holoprosencephaly DOID_4621 2.262E-04 8.044E-03 2.262E-04 0.01170031 BENPORATH_NOS_TARGETS lung small cell carcinoma DOID_5409 2.298E-04 7.693E-03 2.298E-04 0.01089832 BENPORATH_NOS_TARGETS reproductive organ benign neoplasm DOID_0050622 3.178E-04 0.01004507 7.743E-03 0.10745113 BENPORATH_NOS_TARGETS retinitis pigmentosa DOID_10584 3.688E-04 0.01104546 3.688E-04 0.01499026 BENPORATH_NOS_TARGETS melancholia DOID_2848 3.869E-04 0.01100872 8.806E-03 0.11652032 BENPORATH_NOS_TARGETS neurotic disorder DOID_4964 4.056E-04 0.01099074 9.081E-03 0.11743365 BENPORATH_NOS_TARGETS rhabdomyosarcoma DOID_3247 4.547E-04 0.01176067 4.547E-04 0.01724898 BENPORATH_NOS_TARGETS congenital structural myopathy DOID_422 4.547E-04 0.01124934 4.547E-04 0.01617092 BENPORATH_NOS_TARGETS mesenchymal cell neoplasm DOID_3350 5.239E-04 0.01242083 0.0334981 0.24127113 BENPORATH_NOS_TARGETS skeletal muscle cancer DOID_4043 5.239E-04 0.011924 5.239E-04 0.01753529 BENPORATH_NOS_TARGETS spindle cell sarcoma DOID_4235 5.239E-04 0.01242083 0.0334981 0.24127113 BENPORATH_NOS_TARGETS epithelioid sarcoma DOID_6193 5.239E-04 0.01242083 0.0334981 0.24127113 BENPORATH_NOS_TARGETS endogenous depression DOID_1595 7.583E-04 0.01659465 0.01366047 0.15862868 BENPORATH_NOS_TARGETS ureteral obstruction DOID_5199 7.6E-04 0.01601691 7.6E-04 0.02402536 BENPORATH_NOS_TARGETS mixed glioma DOID_5076 8.163E-04 0.01658741 0.16629329 0.57695659 BENPORATH_NOS_TARGETS mental depression DOID_1596 9.733E-04 0.01909677 0.01607474 0.17934364 BENPORATH_NOS_TARGETS muscle cancer DOID_4045 1.248E-03 0.02366191 1.248E-03 0.03549286 BENPORATH_NOS_TARGETS urinary tract obstruction DOID_5200 1.248E-03 0.02289862 1.248E-03 0.03380272 BENPORATH_NOS_TARGETS ureteral disease DOID_1426 1.359E-03 0.02416405 1.359E-03 0.03514771 BENPORATH_NOS_TARGETS Crohn's disease DOID_8778 1.383E-03 0.02384521 0.02020612 0.21291262 BENPORATH_NOS_TARGETS dilated cardiomyopathy DOID_12930 1.425E-03 0.02384363 1.425E-03 0.0352471 BENPORATH_NOS_TARGETS ulcerative colitis DOID_8577 1.555E-03 0.02527872 0.02180703 0.21768771 BENPORATH_NOS_TARGETS papillary adenoma DOID_3172 1.721E-03 0.02719547 1.721E-03 0.04079321 BENPORATH_NOS_TARGETS microcystic adenoma DOID_5403 1.721E-03 0.02719547 1.721E-03 0.04079321 BENPORATH_NOS_TARGETS follicular adenoma DOID_6204 1.721E-03 0.02719547 1.721E-03 0.04079321 BENPORATH_NOS_TARGETS spinal cord disease DOID_319 1.85E-03 0.02845396 1.85E-03 0.04049217 BENPORATH_NOS_TARGETS seminoma DOID_4440 1.85E-03 0.02770517 1.85E-03 0.03899246 BENPORATH_NOS_TARGETS sarcoma DOID_1115 2.123E-03 0.03097411 0.06588669 0.3377435 BENPORATH_NOS_TARGETS invasive ductal carcinoma DOID_3008 2.123E-03 0.03019976 2.123E-03 0.04314251 BENPORATH_NOS_TARGETS female reproductive organ benign neoplasm DOID_0060086 2.414E-03 0.03349609 0.07012331 0.34102703 BENPORATH_NOS_TARGETS uterine benign neoplasm DOID_0060095 2.414E-03 0.03349609 0.07012331 0.34102703 BENPORATH_NOS_TARGETS uterine fibroid DOID_13223 2.414E-03 0.03349609 0.07012331 0.34102703 BENPORATH_NOS_TARGETS endometrial carcinoma DOID_2871 2.414E-03 0.03269856 0.07012331 0.33813697 BENPORATH_NOS_TARGETS celiac disease DOID_10608 2.722E-03 0.03601746 2.722E-03 0.0534052 BENPORATH_NOS_TARGETS endometrial cancer DOID_1380 2.722E-03 0.03519889 0.07434093 0.34958669 BENPORATH_NOS_TARGETS leiomyoma DOID_127 2.883E-03 0.03644891 0.07644265 0.35362493 BENPORATH_NOS_TARGETS papilloma DOID_2615 3.048E-03 0.03769852 3.048E-03 0.0578044 BENPORATH_NOS_TARGETS medullomyoblastoma DOID_3861 3.391E-03 0.04105087 3.391E-03 0.06223842 BENPORATH_NOS_TARGETS adult medulloblastoma DOID_3864 3.391E-03 0.04105087 3.391E-03 0.06223842 BENPORATH_NOS_TARGETS childhood medulloblastoma DOID_3869 3.391E-03 0.04105087 3.391E-03 0.06223842 BENPORATH_NOS_TARGETS adenoma DOID_657 3.569E-03 0.04230617 3.569E-03 0.06345926 BENPORATH_NOS_TARGETS medulloblastoma DOID_3858 3.751E-03 0.04355994 3.751E-03 0.0646799 BENPORATH_NOS_TARGETS congenital diaphragmatic hernia DOID_3827 4.129E-03 0.04698357 0.09102318 0.39236505 BENPORATH_NOS_TARGETS benign mesothelioma DOID_2645 4.523E-03 0.0504613 0.09514709 0.40402011 BENPORATH_NOS_TARGETS cervix uteri carcinoma in situ DOID_8991 4.523E-03 0.0494909 4.523E-03 0.07352933 BENPORATH_NOS_TARGETS primitive neuroectodermal tumor DOID_168 4.934E-03 0.05296964 4.934E-03 0.07798309 BENPORATH_NOS_TARGETS gallbladder cancer DOID_3121 5.146E-03 0.05421971 0.10129831 0.4146672 BENPORATH_NOS_TARGETS uterine cancer DOID_363 5.146E-03 0.0532339 0.10129831 0.41170529 BENPORATH_NOS_TARGETS thyroid adenoma DOID_2891 5.805E-03 0.05898778 5.805E-03 0.0892788 BENPORATH_NOS_TARGETS autoimmune disease of gastrointestinal tract DOID_0060031 6.266E-03 0.06254736 6.266E-03 0.09382104 BENPORATH_NOS_TARGETS giant cell tumor DOID_200 7.234E-03 0.070972 7.234E-03 0.1055481 BENPORATH_NOS_TARGETS malignant giant cell tumor DOID_2705 7.234E-03 0.070972 7.234E-03 0.1055481 BENPORATH_NOS_TARGETS giant cell glioblastoma DOID_3074 7.234E-03 0.070972 7.234E-03 0.1055481 BENPORATH_NOS_TARGETS vasculitis DOID_865 7.486E-03 0.07220029 7.486E-03 0.10649543 BENPORATH_NOS_TARGETS glioblastoma DOID_3068 8.534E-03 0.08093085 8.534E-03 0.1156155 BENPORATH_NOS_TARGETS neuroectodermal tumor DOID_171 9.36E-03 0.08731085 9.36E-03 0.11835471 BENPORATH_NOS_TARGETS congenital heart defect DOID_1682 9.93E-03 0.09113234 9.93E-03 0.12283055 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION bile duct adenocarcinoma DOID_4896 3.548E-05 0.02018973 1.84E-03 0.20936882 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION cholangiocarcinoma DOID_4947 3.548E-05 0.02018973 1.84E-03 0.20936882 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION bile duct cancer DOID_4606 4.351E-05 0.01237854 2.104E-03 0.19949466 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION bile duct carcinoma DOID_4897 4.351E-05 0.01237854 2.104E-03 0.19949466 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION neuroectodermal tumor DOID_171 5.025E-05 9.531E-03 2.313E-03 0.18797968 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION male reproductive system disease DOID_48 7.759E-05 0.01103682 7.759E-05 0.04414727 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION syndrome DOID_225 9.077E-05 0.01033018 9.077E-05 0.02582545 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION pancreatitis DOID_4989 9.788E-05 9.283E-03 1.000 1.000 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION biliary tract cancer DOID_4607 1.172E-04 9.528E-03 4.035E-03 0.28701907 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION chronic kidney failure DOID_784 1.172E-04 8.337E-03 1.172E-04 0.02223274 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION adrenal cortex disease DOID_3952 1.247E-04 7.881E-03 0.01649264 0.3351539 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION penile disease DOID_1529 1.612E-04 9.175E-03 1.612E-04 0.0229363 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION adrenal gland disease DOID_9553 1.612E-04 8.34E-03 0.01867149 0.33200245 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION neuroendocrine tumor DOID_169 1.813E-04 8.595E-03 0.01975915 0.34069567 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION periodontitis DOID_824 4.773E-04 0.02089128 1.000 1.000 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION autonomic nervous system neoplasm DOID_2621 6.966E-04 0.0283101 0.03807033 0.39385485 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION neuroblastoma DOID_769 6.966E-04 0.0283101 0.03807033 0.39385485 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION periodontal disease DOID_3388 7.786E-04 0.02953422 1.000 1.000 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION spindle cell carcinoma DOID_4015 7.786E-04 0.02768833 0.04020251 0.39440045 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION peripheral nervous system neoplasm DOID_1192 9.559E-04 0.03199544 0.04445303 0.40148847 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION uveitis DOID_13141 9.559E-04 0.03021792 1.000 1.000 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION hepatitis DOID_2237 1.003E-03 0.03003779 0.04551279 0.39841193 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION uveal disease DOID_3480 1.202E-03 0.03420659 1.000 1.000 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION hypothyroidism DOID_1459 2.384E-03 0.06460381 0.06957295 0.50752572 KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION tooth disease DOID_1091 2.759E-03 0.07134891 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN cervix uteri carcinoma in situ DOID_8991 2.133E-09 1.214E-06 6.572E-07 3.739E-04 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN pre-malignant neoplasm DOID_0060071 1.127E-08 3.206E-06 2.259E-06 6.426E-04 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN in situ carcinoma DOID_8719 1.127E-08 3.206E-06 2.259E-06 6.426E-04 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN nervous system cancer DOID_3093 4.342E-08 8.236E-06 6.161E-06 1.169E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN brain cancer DOID_1319 9.712E-07 1.382E-04 1.77E-04 9.158E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN central nervous system cancer DOID_3620 1.032E-06 1.174E-04 1.842E-04 8.735E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN astrocytoma DOID_3069 2.94E-06 2.788E-04 3.675E-04 0.01394227 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN mixed glioma DOID_5076 4.042E-06 3.286E-04 4.536E-04 0.0161301 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN alcohol dependence DOID_0050741 1.326E-05 9.431E-04 1.326E-05 1.886E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN granulosa cell tumor DOID_2999 2.489E-05 1.574E-03 2.489E-05 2.832E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN sex cord-gonadal stromal tumor DOID_192 2.765E-05 1.573E-03 2.765E-05 2.622E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN supratentorial cancer DOID_1659 6.75E-05 3.491E-03 0.01219785 0.19830219 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN cerebrum cancer DOID_368 6.75E-05 3.491E-03 0.01219785 0.19830219 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN germinoma DOID_3304 8.137E-05 3.858E-03 8.137E-05 6.615E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN embryonal cancer DOID_688 1.13E-04 4.945E-03 1.13E-04 8.036E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN peripheral nervous system neoplasm DOID_1192 1.188E-04 4.826E-03 1.188E-04 7.508E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN learning disability DOID_8927 1.631E-04 6.187E-03 1.631E-04 9.28E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN glaucoma DOID_1686 1.915E-04 6.812E-03 1.915E-04 8.384E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN lung small cell carcinoma DOID_5409 1.915E-04 6.411E-03 0.02038186 0.27612562 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN giant cell tumor DOID_200 2.223E-04 7.026E-03 0.02193352 0.2836403 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN malignant giant cell tumor DOID_2705 2.223E-04 7.026E-03 0.02193352 0.2836403 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN giant cell glioblastoma DOID_3074 2.223E-04 7.026E-03 0.02193352 0.2836403 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN bone marrow cancer DOID_4960 2.303E-04 6.897E-03 2.303E-04 9.36E-03 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN glioblastoma DOID_3068 2.638E-04 7.505E-03 0.02386988 0.29525999 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN transitional cell carcinoma DOID_2671 5.735E-04 0.01554035 5.735E-04 0.01919691 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN lymphoma DOID_0060058 6.254E-04 0.0161748 6.254E-04 0.0197692 TCGA_GLIOBLASTOMA_COPY_NUMBER_DN polydactyly DOID_1148 4.344E-03 0.0988756 1.000 1.000 SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER endogenous depression DOID_1595 1.085E-05 6.173E-03 1.085E-05 6.173E-03 SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER mental depression DOID_1596 1.405E-05 3.997E-03 1.405E-05 3.997E-03 SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER panic disorder DOID_594 3.055E-05 5.795E-03 3.055E-05 5.795E-03 SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER ureteral disease DOID_1426 8.007E-05 0.01138936 0.01321393 0.44227814 SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER melancholia DOID_2848 5.417E-04 0.06163985 5.417E-04 0.07704981 SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER neurotic disorder DOID_4964 5.592E-04 0.05303298 5.592E-04 0.06363958 SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER nephrosis DOID_2527 7.706E-04 0.0626365 0.04021083 0.71499888 KYNG_DNA_DAMAGE_DN aortic valve disease DOID_62 8.741E-09 4.973E-06 8.741E-09 4.973E-06 KYNG_DNA_DAMAGE_DN heart valve disease DOID_4079 8.756E-09 2.491E-06 8.756E-09 2.491E-06 KYNG_DNA_DAMAGE_DN lymphoma DOID_0060058 1.431E-08 2.715E-06 4.034E-07 5.738E-05 KYNG_DNA_DAMAGE_DN aortic valve insufficiency DOID_57 3.636E-08 5.172E-06 3.636E-08 6.896E-06 KYNG_DNA_DAMAGE_DN corneal disease DOID_10124 4.063E-08 4.624E-06 0.09113877 0.33030547 KYNG_DNA_DAMAGE_DN diabetic autonomic neuropathy DOID_11503 2.987E-07 2.833E-05 8.722E-03 0.10127987 KYNG_DNA_DAMAGE_DN autonomic neuropathy DOID_11504 2.987E-07 2.833E-05 8.722E-03 0.10127987 KYNG_DNA_DAMAGE_DN diabetic polyneuropathy DOID_12785 2.987E-07 2.833E-05 8.722E-03 0.10127987 KYNG_DNA_DAMAGE_DN diabetic neuropathy DOID_9743 2.987E-07 2.833E-05 8.722E-03 0.10127987 KYNG_DNA_DAMAGE_DN autonomic nervous system disease DOID_11465 4.096E-07 3.33E-05 9.826E-03 0.10549567 KYNG_DNA_DAMAGE_DN dilated cardiomyopathy DOID_12930 4.86E-07 3.457E-05 2.094E-04 0.01323977 KYNG_DNA_DAMAGE_DN hepatitis B DOID_2043 5.251E-07 3.32E-05 5.251E-07 5.976E-05 KYNG_DNA_DAMAGE_DN B-cell lymphocytic neoplasm DOID_707 6.057E-07 3.446E-05 2.109E-05 1.715E-03 KYNG_DNA_DAMAGE_DN hypertrophic cardiomyopathy DOID_11984 1.121E-06 5.796E-05 0.01437115 0.13405221 KYNG_DNA_DAMAGE_DN focal glomerulosclerosis DOID_3945 2.212E-06 1.049E-04 2.212E-06 2.098E-04 KYNG_DNA_DAMAGE_DN brain infarction DOID_3454 2.395E-06 1.048E-04 0.01914274 0.15341154 KYNG_DNA_DAMAGE_DN biliary tract disease DOID_9741 3.145E-06 1.278E-04 1.489E-03 0.0446027 KYNG_DNA_DAMAGE_DN diabetic retinopathy DOID_8947 3.358E-06 1.274E-04 0.02174446 0.17184163 KYNG_DNA_DAMAGE_DN retinal vascular disease DOID_2462 6.544E-06 2.327E-04 0.02794642 0.19876892 KYNG_DNA_DAMAGE_DN transitional cell carcinoma DOID_2671 7.729E-06 2.587E-04 2.509E-03 0.06206355 KYNG_DNA_DAMAGE_DN nervous system cancer DOID_3093 8.607E-06 2.721E-04 2.67E-03 0.06330508 KYNG_DNA_DAMAGE_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.06E-05 3.174E-04 0.24943675 0.60395537 KYNG_DNA_DAMAGE_DN glucose intolerance DOID_10603 2.036E-05 5.794E-04 0.05232547 0.24810995 KYNG_DNA_DAMAGE_DN melancholia DOID_2848 3.653E-05 9.898E-04 0.16908393 0.46032898 KYNG_DNA_DAMAGE_DN neurotic disorder DOID_4964 3.892E-05 1.007E-03 0.17156467 0.46485856 KYNG_DNA_DAMAGE_DN pre-malignant neoplasm DOID_0060071 4.676E-05 1.157E-03 0.01668338 0.14383092 KYNG_DNA_DAMAGE_DN in situ carcinoma DOID_8719 4.676E-05 1.157E-03 0.01668338 0.14383092 KYNG_DNA_DAMAGE_DN parasitic infectious disease DOID_1398 5.26E-05 1.247E-03 0.01764974 0.14554637 KYNG_DNA_DAMAGE_DN pancreatic ductal carcinoma DOID_3587 6.95E-05 1.582E-03 1.000 1.000 KYNG_DNA_DAMAGE_DN spinal muscular atrophy DOID_12377 7.158E-05 1.567E-03 2.944E-03 0.06442675 KYNG_DNA_DAMAGE_DN myositis DOID_633 7.158E-05 1.509E-03 0.07746119 0.31708932 KYNG_DNA_DAMAGE_DN nephrosis DOID_2527 7.33E-05 1.49E-03 0.19837301 0.51074317 KYNG_DNA_DAMAGE_DN bile duct disease DOID_4138 7.33E-05 1.438E-03 1.433E-03 0.0479595 KYNG_DNA_DAMAGE_DN male reproductive system disease DOID_48 7.33E-05 1.39E-03 1.433E-03 0.04529509 KYNG_DNA_DAMAGE_DN pancreatic carcinoma DOID_4905 8.136E-05 1.493E-03 1.000 1.000 KYNG_DNA_DAMAGE_DN lung adenocarcinoma DOID_3910 8.904E-05 1.583E-03 8.904E-05 6.333E-03 KYNG_DNA_DAMAGE_DN endogenous depression DOID_1595 9.004E-05 1.553E-03 0.20790679 0.52812037 KYNG_DNA_DAMAGE_DN mental depression DOID_1596 1.258E-04 2.105E-03 0.22432125 0.55254888 KYNG_DNA_DAMAGE_DN biliary tract cancer DOID_4607 1.258E-04 2.045E-03 0.02677142 0.19529405 KYNG_DNA_DAMAGE_DN Charcot-Marie-Tooth disease DOID_10595 1.442E-04 2.28E-03 4.642E-03 0.0825359 KYNG_DNA_DAMAGE_DN bladder disease DOID_365 1.574E-04 2.421E-03 0.09924864 0.34019564 KYNG_DNA_DAMAGE_DN hyperthyroidism DOID_7998 1.861E-04 2.786E-03 5.479E-03 0.082034 KYNG_DNA_DAMAGE_DN encephalomyelitis DOID_640 1.933E-04 2.82E-03 0.03284804 0.20315797 KYNG_DNA_DAMAGE_DN mouth disease DOID_403 2.012E-04 2.863E-03 3.012E-03 0.06347404 KYNG_DNA_DAMAGE_DN cleft palate DOID_674 2.351E-04 3.262E-03 6.379E-03 0.08852971 KYNG_DNA_DAMAGE_DN benign mesothelioma DOID_2645 3.124E-04 4.232E-03 7.677E-03 0.09707179 KYNG_DNA_DAMAGE_DN cervix uteri carcinoma in situ DOID_8991 3.124E-04 4.134E-03 7.677E-03 0.09496153 KYNG_DNA_DAMAGE_DN gallbladder cancer DOID_3121 3.8E-04 4.914E-03 0.13097708 0.40284302 KYNG_DNA_DAMAGE_DN Sjogren's syndrome DOID_12894 3.901E-04 4.933E-03 0.02941346 0.20410073 KYNG_DNA_DAMAGE_DN transient cerebral ischemia DOID_224 3.901E-04 4.826E-03 0.02941346 0.20164169 KYNG_DNA_DAMAGE_DN lateral sclerosis DOID_230 3.901E-04 4.723E-03 0.02941346 0.19924119 KYNG_DNA_DAMAGE_DN keratitis DOID_4677 3.901E-04 4.625E-03 1.000 1.000 KYNG_DNA_DAMAGE_DN cataract DOID_83 4.044E-04 4.696E-03 9.083E-03 0.10134272 KYNG_DNA_DAMAGE_DN lens disease DOID_110 4.563E-04 5.193E-03 9.826E-03 0.10752443 KYNG_DNA_DAMAGE_DN brain cancer DOID_1319 4.563E-04 5.091E-03 0.13873453 0.41547342 KYNG_DNA_DAMAGE_DN dermatomyositis DOID_10223 4.759E-04 5.207E-03 1.000 1.000 KYNG_DNA_DAMAGE_DN central nervous system cancer DOID_3620 4.838E-04 5.194E-03 0.14130507 0.41876346 KYNG_DNA_DAMAGE_DN glaucoma DOID_1686 5.123E-04 5.398E-03 0.143868 0.42196335 KYNG_DNA_DAMAGE_DN aortic aneurysm DOID_3627 5.419E-04 5.606E-03 0.01098991 0.11369558 KYNG_DNA_DAMAGE_DN hemorrhagic disease DOID_2213 5.725E-04 5.817E-03 0.14897113 0.43027703 KYNG_DNA_DAMAGE_DN orofacial cleft DOID_0050567 6.042E-04 6.032E-03 0.01179761 0.11987213 KYNG_DNA_DAMAGE_DN bile duct adenocarcinoma DOID_4896 6.71E-04 6.583E-03 0.0126306 0.12391053 KYNG_DNA_DAMAGE_DN cholangiocarcinoma DOID_4947 6.71E-04 6.583E-03 0.0126306 0.12391053 KYNG_DNA_DAMAGE_DN bone marrow cancer DOID_4960 6.71E-04 6.471E-03 0.15656936 0.44543983 KYNG_DNA_DAMAGE_DN vasculitis DOID_865 6.71E-04 6.363E-03 0.15656936 0.44322371 KYNG_DNA_DAMAGE_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 6.723E-04 6.271E-03 6.723E-04 0.03825255 KYNG_DNA_DAMAGE_DN epilepsy with generalized tonic-clonic seizures DOID_7725 6.723E-04 6.17E-03 1.000 1.000 KYNG_DNA_DAMAGE_DN reproductive organ benign neoplasm DOID_0050622 7.06E-04 6.377E-03 0.15908713 0.44812167 KYNG_DNA_DAMAGE_DN parasitic protozoa infectious disease DOID_2789 7.06E-04 6.277E-03 0.01305648 0.12591754 KYNG_DNA_DAMAGE_DN viral pneumonia DOID_10533 7.828E-04 6.852E-03 0.04093728 0.22836581 KYNG_DNA_DAMAGE_DN bile duct cancer DOID_4606 8.182E-04 7.054E-03 0.01437115 0.13189008 KYNG_DNA_DAMAGE_DN bile duct carcinoma DOID_4897 8.182E-04 7.054E-03 0.01437115 0.13189008 KYNG_DNA_DAMAGE_DN thalassemia DOID_10241 9.015E-04 7.656E-03 9.015E-04 0.04663045 KYNG_DNA_DAMAGE_DN Ehlers-Danlos syndrome DOID_13359 9.015E-04 7.543E-03 9.015E-04 0.04274458 KYNG_DNA_DAMAGE_DN hemangioma DOID_255 9.015E-04 7.434E-03 1.000 1.000 KYNG_DNA_DAMAGE_DN oral submucous fibrosis DOID_5773 9.015E-04 7.328E-03 0.04379698 0.22654984 KYNG_DNA_DAMAGE_DN carotid artery disease DOID_3407 9.411E-04 7.542E-03 0.01574056 0.13994339 KYNG_DNA_DAMAGE_DN collagen disease DOID_854 9.411E-04 7.437E-03 0.01574056 0.13779041 KYNG_DNA_DAMAGE_DN restrictive cardiomyopathy DOID_397 1.028E-03 8.015E-03 1.028E-03 0.04500541 KYNG_DNA_DAMAGE_DN cholestasis DOID_13580 1.122E-03 8.629E-03 0.01764974 0.14768675 KYNG_DNA_DAMAGE_DN cerebral degeneration DOID_1443 1.122E-03 8.514E-03 0.01764974 0.14346713 KYNG_DNA_DAMAGE_DN methylmalonic acidemia DOID_14749 1.163E-03 8.708E-03 1.163E-03 0.04727068 KYNG_DNA_DAMAGE_DN hyperglycemia DOID_4195 1.171E-03 8.651E-03 0.1862957 0.49303374 KYNG_DNA_DAMAGE_DN neuroendocrine tumor DOID_169 1.306E-03 9.526E-03 1.306E-03 0.04953765 KYNG_DNA_DAMAGE_DN ureteral obstruction DOID_5199 1.306E-03 9.406E-03 1.306E-03 0.04644155 KYNG_DNA_DAMAGE_DN blood coagulation disease DOID_1247 1.378E-03 9.799E-03 0.19597184 0.50685445 KYNG_DNA_DAMAGE_DN colon carcinoma DOID_1520 1.615E-03 0.01134783 0.0579692 0.26600385 KYNG_DNA_DAMAGE_DN aneurysm disease DOID_2403 1.729E-03 0.01199909 0.02337187 0.18217252 KYNG_DNA_DAMAGE_DN coronary restenosis DOID_4247 1.782E-03 0.01221632 0.06077857 0.27446828 KYNG_DNA_DAMAGE_DN pancreatitis DOID_4989 1.793E-03 0.01214353 0.02392518 0.18396525 KYNG_DNA_DAMAGE_DN contact dermatitis DOID_2773 1.924E-03 0.01287979 0.02504785 0.19002968 KYNG_DNA_DAMAGE_DN IgA glomerulonephritis DOID_2986 2.139E-03 0.01414919 0.0663724 0.29736925 KYNG_DNA_DAMAGE_DN urinary tract obstruction DOID_5200 2.139E-03 0.01398656 2.139E-03 0.06084152 KYNG_DNA_DAMAGE_DN diabetic angiopathy DOID_11713 2.328E-03 0.01505537 0.06915692 0.30269451 KYNG_DNA_DAMAGE_DN ureteral disease DOID_1426 2.328E-03 0.01488621 2.328E-03 0.06308916 KYNG_DNA_DAMAGE_DN primary bacterial infectious disease DOID_0050338 2.43E-03 0.01536507 2.43E-03 0.06285709 KYNG_DNA_DAMAGE_DN sphingolipidosis DOID_1927 2.526E-03 0.0157943 0.07193321 0.30544773 KYNG_DNA_DAMAGE_DN amino acid metabolic disorder DOID_9252 2.589E-03 0.01601031 0.03035747 0.19854482 KYNG_DNA_DAMAGE_DN Human immunodeficiency virus infectious disease DOID_526 2.67E-03 0.0163368 0.03097274 0.20026693 KYNG_DNA_DAMAGE_DN organic acidemia DOID_0060159 2.731E-03 0.01653225 2.731E-03 0.06216126 KYNG_DNA_DAMAGE_DN cystitis DOID_1679 2.944E-03 0.01763258 0.07746119 0.31938707 KYNG_DNA_DAMAGE_DN ankylosing spondylitis DOID_7147 2.944E-03 0.01744891 0.07746119 0.3148244 KYNG_DNA_DAMAGE_DN Crohn's disease DOID_8778 3.012E-03 0.01766803 0.03348285 0.20485743 KYNG_DNA_DAMAGE_DN ulcerative colitis DOID_8577 3.379E-03 0.01962156 3.379E-03 0.06867547 KYNG_DNA_DAMAGE_DN gestational diabetes DOID_11714 3.392E-03 0.01949557 0.08295653 0.32110385 KYNG_DNA_DAMAGE_DN periodontitis DOID_824 3.392E-03 0.01930061 0.08295653 0.31893423 KYNG_DNA_DAMAGE_DN autoimmune disease of cardiovascular system DOID_0060051 3.627E-03 0.02043476 0.08569202 0.32505841 KYNG_DNA_DAMAGE_DN pleurisy DOID_10247 3.627E-03 0.02023442 3.627E-03 0.07116934 KYNG_DNA_DAMAGE_DN malaria DOID_12365 3.627E-03 0.02003797 0.08569202 0.3229057 KYNG_DNA_DAMAGE_DN Behcet's disease DOID_13241 3.627E-03 0.02043476 0.08569202 0.32505841 KYNG_DNA_DAMAGE_DN invasive ductal carcinoma DOID_3008 3.627E-03 0.0198453 3.627E-03 0.06879703 KYNG_DNA_DAMAGE_DN coronary stenosis DOID_4248 3.627E-03 0.01965629 0.08569202 0.31868471 KYNG_DNA_DAMAGE_DN female reproductive organ benign neoplasm DOID_0060086 4.12E-03 0.02211522 0.09113877 0.33242281 KYNG_DNA_DAMAGE_DN uterine benign neoplasm DOID_0060095 4.12E-03 0.02211522 0.09113877 0.33242281 KYNG_DNA_DAMAGE_DN uterine fibroid DOID_13223 4.12E-03 0.02211522 0.09113877 0.33242281 KYNG_DNA_DAMAGE_DN dysostosis DOID_1934 4.12E-03 0.02190854 4.12E-03 0.07561978 KYNG_DNA_DAMAGE_DN age related macular degeneration DOID_10871 4.377E-03 0.02306125 1.000 1.000 KYNG_DNA_DAMAGE_DN degeneration of macula and posterior pole DOID_2007 4.377E-03 0.02306125 1.000 1.000 KYNG_DNA_DAMAGE_DN abdominal aortic aneurysm DOID_7693 4.377E-03 0.02284968 0.09385007 0.33168129 KYNG_DNA_DAMAGE_DN allergic rhinitis DOID_4481 4.642E-03 0.02401044 4.642E-03 0.08003481 KYNG_DNA_DAMAGE_DN chronic leukemia DOID_1036 4.914E-03 0.0251873 0.09924864 0.34434436 KYNG_DNA_DAMAGE_DN chronic lymphocytic leukemia DOID_1040 4.914E-03 0.0251873 0.09924864 0.34434436 KYNG_DNA_DAMAGE_DN leiomyoma DOID_127 4.914E-03 0.02496241 0.09924864 0.34225743 KYNG_DNA_DAMAGE_DN pleural disease DOID_1532 4.914E-03 0.0247415 4.914E-03 0.08222911 KYNG_DNA_DAMAGE_DN autonomic nervous system neoplasm DOID_2621 4.914E-03 0.02452447 4.914E-03 0.07987971 KYNG_DNA_DAMAGE_DN neuroblastoma DOID_769 4.914E-03 0.02452447 4.914E-03 0.07987971 KYNG_DNA_DAMAGE_DN papilloma DOID_2615 5.192E-03 0.02569142 1.000 1.000 KYNG_DNA_DAMAGE_DN myocarditis DOID_820 5.192E-03 0.02546994 5.192E-03 0.0820698 KYNG_DNA_DAMAGE_DN pneumoconiosis DOID_10316 5.479E-03 0.02664352 0.10461533 0.35222558 KYNG_DNA_DAMAGE_DN male infertility DOID_12336 5.479E-03 0.02641773 0.10461533 0.35015367 KYNG_DNA_DAMAGE_DN periodontal disease DOID_3388 5.479E-03 0.02619573 0.10461533 0.34408164 KYNG_DNA_DAMAGE_DN spindle cell carcinoma DOID_4015 5.479E-03 0.02597743 5.479E-03 0.08425114 KYNG_DNA_DAMAGE_DN macular degeneration DOID_4448 5.479E-03 0.02576275 1.000 1.000 KYNG_DNA_DAMAGE_DN esophageal disease DOID_6050 5.479E-03 0.02555158 0.10461533 0.34210416 KYNG_DNA_DAMAGE_DN autosomal recessive nonsyndromic deafness DOID_0050565 6.072E-03 0.02808878 6.072E-03 0.08858769 KYNG_DNA_DAMAGE_DN adolescence-adult electroclinical syndrome DOID_0050705 6.379E-03 0.02927192 1.000 1.000 KYNG_DNA_DAMAGE_DN pulmonary sarcoidosis DOID_13406 6.379E-03 0.02903775 0.112606 0.36405008 KYNG_DNA_DAMAGE_DN calcinosis DOID_182 6.379E-03 0.02880729 6.379E-03 0.09074296 KYNG_DNA_DAMAGE_DN embryonal cancer DOID_688 6.379E-03 0.02858046 6.379E-03 0.08642186 KYNG_DNA_DAMAGE_DN peripheral nervous system neoplasm DOID_1192 6.693E-03 0.0297537 6.693E-03 0.08856914 KYNG_DNA_DAMAGE_DN blood platelet disease DOID_2218 6.693E-03 0.02952305 0.11525382 0.36842373 KYNG_DNA_DAMAGE_DN respiratory syncytial virus infectious disease DOID_1273 7.014E-03 0.03070123 0.11789381 0.37475741 KYNG_DNA_DAMAGE_DN hepatitis DOID_2237 7.014E-03 0.03046687 7.014E-03 0.09070818 KYNG_DNA_DAMAGE_DN congenital diaphragmatic hernia DOID_3827 7.014E-03 0.03023606 1.000 1.000 KYNG_DNA_DAMAGE_DN intracranial arterial disease DOID_13089 7.342E-03 0.03141168 0.12052599 0.37889108 KYNG_DNA_DAMAGE_DN cerebral arterial disease DOID_3527 7.342E-03 0.03141168 0.12052599 0.37889108 KYNG_DNA_DAMAGE_DN pulmonary emphysema DOID_9675 7.677E-03 0.03259874 7.677E-03 0.09294108 KYNG_DNA_DAMAGE_DN autoimmune disease of urogenital tract DOID_0060049 8.019E-03 0.03379678 8.019E-03 0.09505345 KYNG_DNA_DAMAGE_DN primary biliary cirrhosis DOID_12236 8.019E-03 0.03379678 8.019E-03 0.09505345 KYNG_DNA_DAMAGE_DN endometriosis of uterus DOID_288 8.019E-03 0.03354828 0.12576701 0.39104607 KYNG_DNA_DAMAGE_DN endometriosis DOID_289 8.367E-03 0.03474989 0.12837591 0.39698853 KYNG_DNA_DAMAGE_DN influenza DOID_8469 8.722E-03 0.03596169 8.722E-03 0.09925428 KYNG_DNA_DAMAGE_DN cerebral infarction DOID_3526 9.083E-03 0.0371833 0.13357056 0.40642594 KYNG_DNA_DAMAGE_DN proteinuria DOID_576 9.452E-03 0.03841433 1.000 1.000 KYNG_DNA_DAMAGE_DN myeloma DOID_0070004 9.826E-03 0.0396544 1.000 1.000 KYNG_DNA_DAMAGE_DN hemolytic anemia DOID_583 0.01020782 0.04090317 0.14130507 0.4165937 KYNG_DNA_DAMAGE_DN normocytic anemia DOID_720 0.01020782 0.04090317 0.14130507 0.4165937 KYNG_DNA_DAMAGE_DN lung small cell carcinoma DOID_5409 0.01059564 0.04216028 0.143868 0.41979944 KYNG_DNA_DAMAGE_DN calcium metabolism disease DOID_10575 0.01098991 0.0434254 0.01098991 0.11580105 KYNG_DNA_DAMAGE_DN sarcoidosis DOID_11335 0.01221096 0.0479175 0.15404412 0.44268234 KYNG_DNA_DAMAGE_DN giant cell tumor DOID_200 0.01221096 0.0475893 0.15404412 0.44045781 KYNG_DNA_DAMAGE_DN malignant giant cell tumor DOID_2705 0.01221096 0.0475893 0.15404412 0.44045781 KYNG_DNA_DAMAGE_DN giant cell glioblastoma DOID_3074 0.01221096 0.0475893 0.15404412 0.44045781 KYNG_DNA_DAMAGE_DN atrophic muscular disease DOID_913 0.01221096 0.04726556 0.01221096 0.1218954 KYNG_DNA_DAMAGE_DN muscular dystrophy DOID_9884 0.01221096 0.04726556 0.01221096 0.1218954 KYNG_DNA_DAMAGE_DN pustulosis of palm and sole DOID_4398 0.01305648 0.05019686 0.15908713 0.44591417 KYNG_DNA_DAMAGE_DN nonsyndromic deafness DOID_0050563 0.01437115 0.05488043 0.01437115 0.13628641 KYNG_DNA_DAMAGE_DN retinitis pigmentosa DOID_10584 0.01437115 0.05451456 0.16659583 0.46240501 KYNG_DNA_DAMAGE_DN hypersensitivity reaction type IV disease DOID_2916 0.01437115 0.05415354 0.16659583 0.46016033 KYNG_DNA_DAMAGE_DN glioblastoma DOID_3068 0.01437115 0.05379727 0.16659583 0.45793733 KYNG_DNA_DAMAGE_DN oral cavity cancer DOID_8618 0.01437115 0.05344565 0.16659583 0.45573571 KYNG_DNA_DAMAGE_DN neuroectodermal tumor DOID_171 0.01574056 0.05815829 0.01574056 0.14216471 KYNG_DNA_DAMAGE_DN hypothyroidism DOID_1459 0.016209 0.05950273 0.17650415 0.47373048 KYNG_DNA_DAMAGE_DN mineral metabolism disease DOID_0050032 0.01716363 0.06260325 0.01716363 0.14576278 KYNG_DNA_DAMAGE_DN uterine disease DOID_345 0.01764974 0.06396624 0.18385868 0.49115301 KYNG_DNA_DAMAGE_DN tooth disease DOID_1091 0.01863933 0.06712517 0.1887255 0.4971519 KYNG_DNA_DAMAGE_DN allergic contact dermatitis DOID_3042 0.01863933 0.066703 0.1887255 0.49486088 KYNG_DNA_DAMAGE_DN astrocytoma DOID_3069 0.01965185 0.06988688 0.19356355 0.5029117 KYNG_DNA_DAMAGE_DN peripheral vascular disease DOID_341 0.02121295 0.07497 0.20076706 0.51457864 KYNG_DNA_DAMAGE_DN syndrome DOID_225 0.02282395 0.08016562 0.20790679 0.52577317 KYNG_DNA_DAMAGE_DN bone resorption disease DOID_0080011 0.02337187 0.08158647 0.21027262 0.52940319 KYNG_DNA_DAMAGE_DN osteoporosis DOID_11476 0.02337187 0.08158647 0.21027262 0.52940319 KYNG_DNA_DAMAGE_DN electroclinical syndrome DOID_0050701 0.02392518 0.08300871 1.000 1.000 KYNG_DNA_DAMAGE_DN mixed glioma DOID_5076 0.02392518 0.08250563 1.000 1.000 KYNG_DNA_DAMAGE_DN bacterial pneumonia DOID_874 0.02392518 0.0820086 0.21263145 0.53298368 KYNG_DNA_DAMAGE_DN metabolic syndrome X DOID_14221 0.02504785 0.08534267 0.21732818 0.54236725 KYNG_DNA_DAMAGE_DN female reproductive system disease DOID_229 0.02561713 0.08676278 0.21966612 0.54580795 KYNG_DNA_DAMAGE_DN auditory system disease DOID_2742 0.02619167 0.08818377 0.02619167 0.19609286 KYNG_DNA_DAMAGE_DN arrhythmogenic right ventricular dysplasia DOID_0050431 0.02651113 0.08873431 0.02651113 0.19590691 KYNG_DNA_DAMAGE_DN chronic kidney failure DOID_784 0.02677142 0.08908149 1.000 1.000 KYNG_DNA_DAMAGE_DN bone development disease DOID_0080006 0.02735635 0.09049861 0.02735635 0.19703495 KYNG_DNA_DAMAGE_DN interstitial nephritis DOID_1063 0.02941346 0.09674139 1.000 1.000 KYNG_DNA_DAMAGE_DN facioscapulohumeral muscular dystrophy DOID_11727 0.02941346 0.0961854 0.02941346 0.20662049 KYNG_DNA_DAMAGE_DN hyperparathyroidism DOID_13543 0.02941346 0.09563577 1.000 1.000 KYNG_DNA_DAMAGE_DN childhood type dermatomyositis DOID_14203 0.02941346 0.09509239 1.000 1.000 KYNG_DNA_DAMAGE_DN acute kidney failure DOID_3021 0.02941346 0.09455514 1.000 1.000 KYNG_DNA_DAMAGE_DN progressive muscular atrophy DOID_318 0.02941346 0.09402393 0.02941346 0.19689718 KYNG_DNA_DAMAGE_DN conjunctival disease DOID_4251 0.02941346 0.09349866 0.02941346 0.19460767 KYNG_DNA_DAMAGE_DN conjunctivitis DOID_6195 0.02941346 0.09349866 0.02941346 0.19460767 KYNG_DNA_DAMAGE_DN craniosynostosis DOID_2340 0.03230722 0.09990656 0.03230722 0.20200887 KYNG_DNA_DAMAGE_DN invasive lobular carcinoma DOID_3457 0.03230722 0.09936653 1.000 1.000 KYNG_DNA_DAMAGE_DN heroin dependence DOID_9976 0.03230722 0.0988323 1.000 1.000 KYNG_DNA_DAMAGE_DN lymphoblastic leukemia DOID_1037 0.03284804 0.09994938 0.24718723 0.60364608 KYNG_DNA_DAMAGE_DN carbohydrate metabolic disorder DOID_2978 0.03284804 0.09941773 0.24718723 0.60106639 POOLA_INVASIVE_BREAST_CANCER_DN myeloma DOID_0070004 8.211E-08 4.672E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN bone marrow cancer DOID_4960 1.604E-07 4.562E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN leiomyoma DOID_127 1.011E-06 1.918E-04 0.07301663 0.48878191 POOLA_INVASIVE_BREAST_CANCER_DN Hirschsprung's disease DOID_10487 2.746E-06 3.906E-04 0.02776079 0.39489722 POOLA_INVASIVE_BREAST_CANCER_DN megacolon DOID_11372 3.489E-06 3.971E-04 0.02986442 0.40459185 POOLA_INVASIVE_BREAST_CANCER_DN neuritis DOID_1803 4.34E-06 4.115E-04 5.293E-03 0.13093638 POOLA_INVASIVE_BREAST_CANCER_DN lung oat cell carcinoma DOID_5411 4.355E-06 3.54E-04 0.03196357 0.3953754 POOLA_INVASIVE_BREAST_CANCER_DN integumentary system cancer DOID_0060122 7.89E-06 5.612E-04 7.063E-03 0.15456102 POOLA_INVASIVE_BREAST_CANCER_DN skin cancer DOID_4159 7.89E-06 5.612E-04 7.063E-03 0.15456102 POOLA_INVASIVE_BREAST_CANCER_DN colonic disease DOID_5353 1.083E-05 6.845E-04 0.04239215 0.38905057 POOLA_INVASIVE_BREAST_CANCER_DN brain infarction DOID_3454 1.769E-05 1.006E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN nephrosis DOID_2527 2.084E-05 1.078E-03 0.0112857 0.2006738 POOLA_INVASIVE_BREAST_CANCER_DN mixed glioma DOID_5076 2.837E-05 1.345E-03 0.15920314 0.72469268 POOLA_INVASIVE_BREAST_CANCER_DN Sciatic Neuropathy DOID_11446 3.422E-05 1.498E-03 0.0608847 0.46191193 POOLA_INVASIVE_BREAST_CANCER_DN lesion of sciatic nerve DOID_12528 3.422E-05 1.498E-03 0.0608847 0.46191193 POOLA_INVASIVE_BREAST_CANCER_DN mononeuritis of lower limb DOID_9473 3.422E-05 1.498E-03 0.0608847 0.46191193 POOLA_INVASIVE_BREAST_CANCER_DN mononeuritis DOID_1802 3.796E-05 1.543E-03 0.06291753 0.464936 POOLA_INVASIVE_BREAST_CANCER_DN mononeuropathy DOID_1188 4.196E-05 1.592E-03 0.064946 0.46192845 POOLA_INVASIVE_BREAST_CANCER_DN toxic encephalopathy DOID_3602 4.196E-05 1.492E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN transitional cell carcinoma DOID_2671 4.509E-05 1.509E-03 0.17725309 0.78794537 POOLA_INVASIVE_BREAST_CANCER_DN female reproductive organ benign neoplasm DOID_0060086 4.623E-05 1.461E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN uterine benign neoplasm DOID_0060095 4.623E-05 1.461E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN uterine fibroid DOID_13223 4.623E-05 1.461E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.804E-05 1.738E-03 0.01847965 0.29208114 POOLA_INVASIVE_BREAST_CANCER_DN lymphoid leukemia DOID_10747 7.79E-05 2.216E-03 3.089E-03 0.10338264 POOLA_INVASIVE_BREAST_CANCER_DN multiple myeloma DOID_9538 9.095E-05 2.464E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN adenoid cystic carcinoma DOID_4866 1.131E-04 2.924E-03 1.131E-04 0.06433708 POOLA_INVASIVE_BREAST_CANCER_DN benign mesothelioma DOID_2645 1.212E-04 2.997E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN salivary gland cancer DOID_8850 1.296E-04 3.073E-03 1.296E-04 0.03687308 POOLA_INVASIVE_BREAST_CANCER_DN uterine cancer DOID_363 1.476E-04 3.36E-03 4.69E-03 0.12708066 POOLA_INVASIVE_BREAST_CANCER_DN autonomic nervous system disease DOID_11465 1.776E-04 3.887E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN lung small cell carcinoma DOID_5409 1.997E-04 4.208E-03 0.10655603 0.58864446 POOLA_INVASIVE_BREAST_CANCER_DN vasculitis DOID_865 2.623E-04 5.33E-03 0.1161904 0.61215129 POOLA_INVASIVE_BREAST_CANCER_DN reproductive organ benign neoplasm DOID_0050622 2.762E-04 5.419E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN epidermolysis bullosa DOID_2730 3.008E-04 5.704E-03 3.008E-04 0.05704332 POOLA_INVASIVE_BREAST_CANCER_DN oral cavity cancer DOID_8618 3.206E-04 5.885E-03 3.206E-04 0.04560947 POOLA_INVASIVE_BREAST_CANCER_DN Leydig cell tumor DOID_2696 3.549E-04 6.311E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN vesiculobullous skin disease DOID_2731 3.549E-04 6.12E-03 3.549E-04 0.04039208 POOLA_INVASIVE_BREAST_CANCER_DN sex cord-stromal neoplasm DOID_4757 3.549E-04 6.311E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN alcohol dependence DOID_0050741 4.135E-04 6.92E-03 0.02986442 0.41445995 POOLA_INVASIVE_BREAST_CANCER_DN uterine disease DOID_345 4.416E-04 7.18E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN arthropathy DOID_381 4.765E-04 7.531E-03 4.765E-04 0.04518446 POOLA_INVASIVE_BREAST_CANCER_DN tooth disease DOID_1091 4.809E-04 7.395E-03 0.01014705 0.18624741 POOLA_INVASIVE_BREAST_CANCER_DN peripheral vascular disease DOID_341 5.886E-04 8.814E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN biliary tract disease DOID_9741 5.886E-04 8.588E-03 0.15003203 0.72345955 POOLA_INVASIVE_BREAST_CANCER_DN drug-induced mental disorder DOID_1203 6.154E-04 8.754E-03 0.03614839 0.41136873 POOLA_INVASIVE_BREAST_CANCER_DN Graves' disease DOID_12361 6.154E-04 8.541E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN drug psychosis DOID_1742 6.154E-04 8.754E-03 0.03614839 0.41136873 POOLA_INVASIVE_BREAST_CANCER_DN basal cell carcinoma DOID_2513 6.154E-04 8.337E-03 6.154E-04 0.05002322 POOLA_INVASIVE_BREAST_CANCER_DN bronchitis DOID_6132 6.154E-04 8.143E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN juvenile rheumatoid arthritis DOID_676 6.154E-04 7.958E-03 0.03614839 0.40330268 POOLA_INVASIVE_BREAST_CANCER_DN substance-induced psychosis DOID_8646 6.154E-04 8.754E-03 0.03614839 0.41136873 POOLA_INVASIVE_BREAST_CANCER_DN skin carcinoma DOID_3451 6.914E-04 8.742E-03 6.914E-04 0.04917249 POOLA_INVASIVE_BREAST_CANCER_DN osteosclerosis DOID_4254 6.914E-04 8.552E-03 6.914E-04 0.04370888 POOLA_INVASIVE_BREAST_CANCER_DN metabolic syndrome X DOID_14221 7.636E-04 9.245E-03 0.01372271 0.2366128 POOLA_INVASIVE_BREAST_CANCER_DN testicular cancer DOID_2998 7.716E-04 9.147E-03 7.716E-04 0.04390429 POOLA_INVASIVE_BREAST_CANCER_DN female reproductive system disease DOID_229 7.91E-04 9.186E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN alcohol abuse DOID_1574 8.477E-04 9.647E-03 8.477E-04 0.04384881 POOLA_INVASIVE_BREAST_CANCER_DN brain edema DOID_4724 8.561E-04 9.552E-03 0.04239215 0.39542845 POOLA_INVASIVE_BREAST_CANCER_DN bone development disease DOID_0080006 8.77E-04 9.596E-03 8.77E-04 0.04158292 POOLA_INVASIVE_BREAST_CANCER_DN lymphoblastic leukemia DOID_1037 1.17E-03 0.01255711 0.01811977 0.29457573 POOLA_INVASIVE_BREAST_CANCER_DN mouth disease DOID_403 1.206E-03 0.01270241 0.01847965 0.28418706 POOLA_INVASIVE_BREAST_CANCER_DN synostosis DOID_11971 1.237E-03 0.01279408 1.237E-03 0.05412882 POOLA_INVASIVE_BREAST_CANCER_DN hypersensitivity reaction type I disease DOID_1205 1.242E-03 0.01262007 0.18965977 0.83012622 POOLA_INVASIVE_BREAST_CANCER_DN ulcerative colitis DOID_8577 1.356E-03 0.01353468 0.19492017 0.84022408 POOLA_INVASIVE_BREAST_CANCER_DN cleft lip DOID_9296 1.566E-03 0.01536435 0.05680598 0.448925 POOLA_INVASIVE_BREAST_CANCER_DN middle cerebral artery infarction DOID_3525 1.684E-03 0.01624299 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN gestational diabetes DOID_11714 1.806E-03 0.01713137 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN lung adenocarcinoma DOID_3910 1.806E-03 0.01685052 1.806E-03 0.07342014 POOLA_INVASIVE_BREAST_CANCER_DN autoimmune disease of endocrine system DOID_0060005 2.063E-03 0.01893481 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN dysostosis DOID_1934 2.198E-03 0.0198487 2.198E-03 0.08336455 POOLA_INVASIVE_BREAST_CANCER_DN endometrial carcinoma DOID_2871 2.198E-03 0.01953857 0.06697014 0.46470746 POOLA_INVASIVE_BREAST_CANCER_DN endometrial cancer DOID_1380 2.479E-03 0.02169819 0.07100545 0.48097738 POOLA_INVASIVE_BREAST_CANCER_DN germinoma DOID_3304 2.479E-03 0.02136943 2.479E-03 0.0881489 POOLA_INVASIVE_BREAST_CANCER_DN hyperthyroidism DOID_7998 2.93E-03 0.02488563 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN medullomyoblastoma DOID_3861 3.089E-03 0.02584566 0.07902441 0.50522346 POOLA_INVASIVE_BREAST_CANCER_DN adult medulloblastoma DOID_3864 3.089E-03 0.02584566 0.07902441 0.50522346 POOLA_INVASIVE_BREAST_CANCER_DN childhood medulloblastoma DOID_3869 3.089E-03 0.02584566 0.07902441 0.50522346 POOLA_INVASIVE_BREAST_CANCER_DN medulloblastoma DOID_3858 3.417E-03 0.02818194 0.08300821 0.51902934 POOLA_INVASIVE_BREAST_CANCER_DN cleft palate DOID_674 3.417E-03 0.02777934 0.08300821 0.51338772 POOLA_INVASIVE_BREAST_CANCER_DN uveitis DOID_13141 3.588E-03 0.02875233 3.588E-03 0.11341199 POOLA_INVASIVE_BREAST_CANCER_DN adult respiratory distress syndrome DOID_11394 3.94E-03 0.03113563 3.94E-03 0.11798764 POOLA_INVASIVE_BREAST_CANCER_DN intracranial arterial disease DOID_13089 3.94E-03 0.03070911 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN cerebral arterial disease DOID_3527 3.94E-03 0.03070911 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN pulmonary emphysema DOID_9675 4.122E-03 0.03169234 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN endometriosis of uterus DOID_288 4.307E-03 0.03267845 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN nephrotic syndrome DOID_1184 4.497E-03 0.0336672 0.09485776 0.55075575 POOLA_INVASIVE_BREAST_CANCER_DN primitive neuroectodermal tumor DOID_168 4.497E-03 0.03322996 0.09485776 0.53974064 POOLA_INVASIVE_BREAST_CANCER_DN endometriosis DOID_289 4.497E-03 0.03280394 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN uveal disease DOID_3480 4.497E-03 0.0323887 4.497E-03 0.12793536 POOLA_INVASIVE_BREAST_CANCER_DN diabetic autonomic neuropathy DOID_11503 4.69E-03 0.03335867 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN autonomic neuropathy DOID_11504 4.69E-03 0.03335867 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN diabetic polyneuropathy DOID_12785 4.69E-03 0.03335867 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN gallbladder cancer DOID_3121 4.69E-03 0.03294684 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN diabetic neuropathy DOID_9743 4.69E-03 0.03335867 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN cerebral infarction DOID_3526 4.887E-03 0.03391261 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN learning disability DOID_8927 4.887E-03 0.03350402 4.887E-03 0.12640155 POOLA_INVASIVE_BREAST_CANCER_DN vascular skin disease DOID_9540 5.293E-03 0.03585163 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN hemolytic anemia DOID_583 5.501E-03 0.03682447 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN normocytic anemia DOID_720 5.501E-03 0.03682447 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN integumentary system benign neoplasm DOID_0060121 5.713E-03 0.03779929 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN skin benign neoplasm DOID_3165 5.713E-03 0.03779929 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN withdrawal disorder DOID_0060001 6.148E-03 0.04021109 6.148E-03 0.14576521 POOLA_INVASIVE_BREAST_CANCER_DN orofacial cleft DOID_0050567 6.371E-03 0.04119674 0.11234903 0.59744484 POOLA_INVASIVE_BREAST_CANCER_DN giant cell tumor DOID_200 6.598E-03 0.04218359 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN malignant giant cell tumor DOID_2705 6.598E-03 0.04218359 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN giant cell glioblastoma DOID_3074 6.598E-03 0.04218359 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN atrophic muscular disease DOID_913 6.598E-03 0.04171488 6.598E-03 0.15017357 POOLA_INVASIVE_BREAST_CANCER_DN muscular dystrophy DOID_9884 6.598E-03 0.04171488 6.598E-03 0.15017357 POOLA_INVASIVE_BREAST_CANCER_DN osteochondrodysplasia DOID_2256 7.063E-03 0.04416029 7.063E-03 0.14883654 POOLA_INVASIVE_BREAST_CANCER_DN glioblastoma DOID_3068 7.786E-03 0.04815551 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN melancholia DOID_2848 8.034E-03 0.04915703 0.12572214 0.65629265 POOLA_INVASIVE_BREAST_CANCER_DN neurotic disorder DOID_4964 8.286E-03 0.05015864 0.12761627 0.66012415 POOLA_INVASIVE_BREAST_CANCER_DN neuroectodermal tumor DOID_171 8.542E-03 0.05116027 0.12950634 0.66386583 POOLA_INVASIVE_BREAST_CANCER_DN respiratory failure DOID_11162 8.801E-03 0.0521618 8.801E-03 0.17884045 POOLA_INVASIVE_BREAST_CANCER_DN hypothyroidism DOID_1459 8.801E-03 0.05162405 8.801E-03 0.17267354 POOLA_INVASIVE_BREAST_CANCER_DN pre-malignant neoplasm DOID_0060071 9.063E-03 0.05262067 0.13327436 0.67708134 POOLA_INVASIVE_BREAST_CANCER_DN congenital heart defect DOID_1682 9.063E-03 0.05208915 0.13327436 0.67108947 POOLA_INVASIVE_BREAST_CANCER_DN in situ carcinoma DOID_8719 9.063E-03 0.05262067 0.13327436 0.67708134 POOLA_INVASIVE_BREAST_CANCER_DN cholestasis DOID_13580 9.598E-03 0.05461331 0.13702626 0.67798213 POOLA_INVASIVE_BREAST_CANCER_DN temporal lobe epilepsy DOID_3328 9.871E-03 0.05560916 9.871E-03 0.18721752 POOLA_INVASIVE_BREAST_CANCER_DN allergic contact dermatitis DOID_3042 0.01014705 0.05660461 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN astrocytoma DOID_3069 0.01070961 0.05916282 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN pancreatic ductal carcinoma DOID_3587 0.01099597 0.06016066 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN bile duct disease DOID_4138 0.0112857 0.06115773 0.14818599 0.72066519 POOLA_INVASIVE_BREAST_CANCER_DN pancreatic carcinoma DOID_4905 0.01187517 0.06374502 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN diabetic retinopathy DOID_8947 0.01187517 0.06314927 0.15187412 0.72618804 POOLA_INVASIVE_BREAST_CANCER_DN cystic fibrosis DOID_1485 0.01247791 0.06574012 0.15554648 0.73754958 POOLA_INVASIVE_BREAST_CANCER_DN endogenous depression DOID_1595 0.01247791 0.065137 0.15554648 0.73145413 POOLA_INVASIVE_BREAST_CANCER_DN pancreatitis DOID_4989 0.0130938 0.06773066 0.15920314 0.73053697 POOLA_INVASIVE_BREAST_CANCER_DN contact dermatitis DOID_2773 0.01372271 0.07034435 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN mental depression DOID_1596 0.01469023 0.07463161 0.16827648 0.75991521 POOLA_INVASIVE_BREAST_CANCER_DN focal epilepsy DOID_2234 0.01469023 0.07397116 0.01469023 0.24584531 POOLA_INVASIVE_BREAST_CANCER_DN biliary tract cancer DOID_4607 0.01469023 0.07332229 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN retinal vascular disease DOID_2462 0.01535117 0.07595492 0.17187867 0.77007059 POOLA_INVASIVE_BREAST_CANCER_DN dilated cardiomyopathy DOID_12930 0.01884255 0.09242594 0.18965977 0.82378938 POOLA_INVASIVE_BREAST_CANCER_DN polycythemia DOID_8432 0.02142281 0.09991456 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.02142281 0.09910225 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.02142281 0.09910225 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN Hodgkin's granuloma DOID_8651 0.02142281 0.09910225 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 0.02142281 0.09910225 1.000 1.000 MELLMAN_TUT1_TARGETS_DN dilated cardiomyopathy DOID_12930 4.114E-07 2.341E-04 1.724E-03 0.1961695 MELLMAN_TUT1_TARGETS_DN cholestasis DOID_13580 1.087E-05 3.093E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN brain infarction DOID_3454 1.238E-05 2.349E-03 0.04400556 0.54432967 MELLMAN_TUT1_TARGETS_DN bile duct disease DOID_4138 1.403E-05 1.996E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN biliary tract disease DOID_9741 1.461E-05 1.662E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN aneurysm disease DOID_2403 1.708E-05 1.62E-03 0.04884597 0.56721132 MELLMAN_TUT1_TARGETS_DN ureteral obstruction DOID_5199 5.84E-05 4.747E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN coronary restenosis DOID_4247 8.007E-05 5.695E-03 0.01321393 0.39572254 MELLMAN_TUT1_TARGETS_DN urinary tract obstruction DOID_5200 9.639E-05 6.094E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN ureteral disease DOID_1426 1.051E-04 5.981E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN middle cerebral artery infarction DOID_3525 1.437E-04 7.435E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 1.543E-04 7.317E-03 1.543E-04 0.08780566 MELLMAN_TUT1_TARGETS_DN coronary stenosis DOID_4248 1.653E-04 7.234E-03 0.01882568 0.44632542 MELLMAN_TUT1_TARGETS_DN abdominal aortic aneurysm DOID_7693 2.004E-04 8.144E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN allergic rhinitis DOID_4481 2.128E-04 8.073E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN pleural disease DOID_1532 2.256E-04 8.024E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN pneumoconiosis DOID_10316 2.524E-04 8.447E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN multiple myeloma DOID_9538 2.952E-04 9.332E-03 0.02502508 0.45933122 MELLMAN_TUT1_TARGETS_DN hepatitis DOID_2237 3.256E-04 9.751E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN peptic ulcer DOID_750 3.256E-04 9.264E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN intracranial arterial disease DOID_13089 3.414E-04 9.249E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN cerebral arterial disease DOID_3527 3.414E-04 9.249E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN lymphatic system disease DOID_75 3.414E-04 8.829E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN pulmonary emphysema DOID_9675 3.575E-04 8.844E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN diabetic autonomic neuropathy DOID_11503 4.08E-04 9.674E-03 0.0293423 0.49105203 MELLMAN_TUT1_TARGETS_DN autonomic neuropathy DOID_11504 4.08E-04 9.674E-03 0.0293423 0.49105203 MELLMAN_TUT1_TARGETS_DN diabetic polyneuropathy DOID_12785 4.08E-04 9.674E-03 0.0293423 0.49105203 MELLMAN_TUT1_TARGETS_DN diabetic neuropathy DOID_9743 4.08E-04 9.674E-03 0.0293423 0.49105203 MELLMAN_TUT1_TARGETS_DN cerebral infarction DOID_3526 4.256E-04 9.687E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN myeloma DOID_0070004 4.618E-04 0.01010727 0.03118693 0.50701032 MELLMAN_TUT1_TARGETS_DN autonomic nervous system disease DOID_11465 4.618E-04 9.733E-03 0.03118693 0.4929267 MELLMAN_TUT1_TARGETS_DN hemolytic anemia DOID_583 4.805E-04 9.765E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN normocytic anemia DOID_720 4.805E-04 9.765E-03 1.000 1.000 MELLMAN_TUT1_TARGETS_DN aortic aneurysm DOID_3627 5.189E-04 0.01018166 1.000 1.000 MELLMAN_TUT1_TARGETS_DN bone marrow cancer DOID_4960 6.001E-04 0.01138172 0.035478 0.50467452 MELLMAN_TUT1_TARGETS_DN pustulosis of palm and sole DOID_4398 6.213E-04 0.01140354 1.000 1.000 MELLMAN_TUT1_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 6.87E-04 0.01221592 6.87E-04 0.19545478 MELLMAN_TUT1_TARGETS_DN carotid artery disease DOID_3407 7.56E-04 0.01303462 1.000 1.000 MELLMAN_TUT1_TARGETS_DN respiratory failure DOID_11162 7.797E-04 0.01304784 1.000 1.000 MELLMAN_TUT1_TARGETS_DN mineral metabolism disease DOID_0050032 8.281E-04 0.01346292 0.04157652 0.57700092 MELLMAN_TUT1_TARGETS_DN cerebral degeneration DOID_1443 8.529E-04 0.01348038 0.04218433 0.55820662 MELLMAN_TUT1_TARGETS_DN cystic fibrosis DOID_1485 1.12E-03 0.01722374 0.0482422 0.58403858 MELLMAN_TUT1_TARGETS_DN syndrome DOID_225 1.12E-03 0.01677048 1.12E-03 0.21242608 MELLMAN_TUT1_TARGETS_DN bone resorption disease DOID_0080011 1.149E-03 0.01675842 0.04884597 0.57902822 MELLMAN_TUT1_TARGETS_DN osteoporosis DOID_11476 1.149E-03 0.01675842 0.04884597 0.57902822 MELLMAN_TUT1_TARGETS_DN bacterial pneumonia DOID_874 1.178E-03 0.01675195 1.000 1.000 MELLMAN_TUT1_TARGETS_DN alcohol abuse DOID_1574 1.328E-03 0.01842826 1.328E-03 0.18888969 MELLMAN_TUT1_TARGETS_DN chronic kidney failure DOID_784 1.328E-03 0.01798949 1.000 1.000 MELLMAN_TUT1_TARGETS_DN lymphoblastic leukemia DOID_1037 1.654E-03 0.02189156 0.05845641 0.61595734 MELLMAN_TUT1_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.689E-03 0.02184079 1.000 1.000 MELLMAN_TUT1_TARGETS_DN gallbladder disease DOID_0000000 6.313E-03 0.07982893 1.000 1.000 MELLMAN_TUT1_TARGETS_DN facioscapulohumeral muscular dystrophy DOID_11727 6.313E-03 0.07809351 6.313E-03 0.59871694 MELLMAN_TUT1_TARGETS_DN familial combined hyperlipidemia DOID_13809 6.313E-03 0.07643195 1.000 1.000 MELLMAN_TUT1_TARGETS_DN acute kidney failure DOID_3021 6.313E-03 0.07483962 1.000 1.000 MELLMAN_TUT1_TARGETS_DN progressive muscular atrophy DOID_318 6.313E-03 0.07331228 6.313E-03 0.51318595 MELLMAN_TUT1_TARGETS_DN familial adenomatous polyposis DOID_0050424 6.943E-03 0.07900668 6.943E-03 0.49379175 MELLMAN_TUT1_TARGETS_DN adrenoleukodystrophy DOID_10588 6.943E-03 0.07745753 1.000 1.000 MELLMAN_TUT1_TARGETS_DN chronic monocytic leukemia DOID_8593 6.943E-03 0.07596796 1.000 1.000 MELLMAN_TUT1_TARGETS_DN osteopetrosis DOID_13533 7.571E-03 0.08128583 7.571E-03 0.47868323 MELLMAN_TUT1_TARGETS_DN relapsing-remitting multiple sclerosis DOID_2378 7.571E-03 0.07978054 1.000 1.000 MELLMAN_TUT1_TARGETS_DN berylliosis DOID_10322 8.2E-03 0.08483176 1.000 1.000 MELLMAN_TUT1_TARGETS_DN newborn respiratory distress syndrome DOID_12716 8.2E-03 0.08331691 1.000 1.000 MELLMAN_TUT1_TARGETS_DN carotid stenosis DOID_13001 8.2E-03 0.08185521 1.000 1.000 MELLMAN_TUT1_TARGETS_DN obstructive hydrocephalus DOID_14159 8.2E-03 0.08044391 8.2E-03 0.4665747 MELLMAN_TUT1_TARGETS_DN communicating hydrocephalus DOID_1573 8.2E-03 0.08044391 8.2E-03 0.4665747 MELLMAN_TUT1_TARGETS_DN monocytic leukemia DOID_8527 8.2E-03 0.07908046 1.000 1.000 MELLMAN_TUT1_TARGETS_DN viral pneumonia DOID_10533 8.828E-03 0.0837188 1.000 1.000 MELLMAN_TUT1_TARGETS_DN hydrocephalus DOID_10908 8.828E-03 0.08234636 8.828E-03 0.456648 MELLMAN_TUT1_TARGETS_DN congenital structural myopathy DOID_422 8.828E-03 0.08101819 8.828E-03 0.418594 MELLMAN_TUT1_TARGETS_DN parasitic helminthiasis infectious disease DOID_883 8.828E-03 0.07973219 8.828E-03 0.38639446 MELLMAN_TUT1_TARGETS_DN hemangioma DOID_255 9.456E-03 0.08406706 9.456E-03 0.38430657 MELLMAN_TUT1_TARGETS_DN lung oat cell carcinoma DOID_5411 9.456E-03 0.08277372 1.000 1.000 MELLMAN_TUT1_TARGETS_DN varicose veins DOID_799 9.456E-03 0.08151958 1.000 1.000 MELLMAN_TUT1_TARGETS_DN intracranial hypertension DOID_9428 9.456E-03 0.08030287 9.456E-03 0.35868613 MELLMAN_TUT1_TARGETS_DN silicosis DOID_10325 0.01008302 0.08437117 1.000 1.000 MELLMAN_TUT1_TARGETS_DN hemolytic-uremic syndrome DOID_12554 0.01008302 0.08314839 1.000 1.000 MELLMAN_TUT1_TARGETS_DN vein disease DOID_866 0.01008302 0.08196056 1.000 1.000 MELLMAN_TUT1_TARGETS_DN urinary system benign neoplasm DOID_731 0.01070996 0.08583056 1.000 1.000 MELLMAN_TUT1_TARGETS_DN peroxisomal disease DOID_906 0.01070996 0.08463847 1.000 1.000 MELLMAN_TUT1_TARGETS_DN keratosis DOID_161 0.01133653 0.08836279 1.000 1.000 MELLMAN_TUT1_TARGETS_DN osteosclerosis DOID_4254 0.01133653 0.0871687 0.01133653 0.40315524 MELLMAN_TUT1_TARGETS_DN testicular cancer DOID_2998 0.01196271 0.09075709 0.01196271 0.40039892 MELLMAN_TUT1_TARGETS_DN microphthalmia DOID_10629 0.01258851 0.0942482 0.01258851 0.39793683 MELLMAN_TUT1_TARGETS_DN membranous glomerulonephritis DOID_10976 0.01258851 0.0930242 1.000 1.000 MELLMAN_TUT1_TARGETS_DN pulmonary edema DOID_11396 0.01258851 0.09183158 1.000 1.000 MELLMAN_TUT1_TARGETS_DN amyloidosis DOID_9120 0.01258851 0.09066915 1.000 1.000 MELLMAN_TUT1_TARGETS_DN Kawasaki disease DOID_13378 0.01321393 0.0939841 1.000 1.000 MELLMAN_TUT1_TARGETS_DN lymphadenitis DOID_1602 0.01321393 0.0939841 1.000 1.000 MELLMAN_TUT1_TARGETS_DN lymph node disease DOID_9942 0.01321393 0.0939841 1.000 1.000 MELLMAN_TUT1_TARGETS_DN gastric ulcer DOID_10808 0.01383898 0.09721454 1.000 1.000 MELLMAN_TUT1_TARGETS_DN familial hypercholesterolemia DOID_13810 0.01383898 0.09602899 1.000 1.000 MELLMAN_TUT1_TARGETS_DN pulmonary embolism DOID_9477 0.01446364 0.09915435 1.000 1.000 MELLMAN_TUT1_TARGETS_DN polyarteritis nodosa DOID_9810 0.01446364 0.09797394 1.000 1.000 KAYO_AGING_MUSCLE_DN lung adenocarcinoma DOID_3910 1.625E-05 9.245E-03 0.04783435 0.46927146 KAYO_AGING_MUSCLE_DN leiomyoma DOID_127 2.889E-05 8.22E-03 1.61E-03 0.30542456 KAYO_AGING_MUSCLE_DN spindle cell carcinoma DOID_4015 3.422E-05 6.49E-03 0.06062883 0.45997069 KAYO_AGING_MUSCLE_DN leukodystrophy DOID_10579 7.997E-05 0.01137614 3.135E-03 0.25480935 KAYO_AGING_MUSCLE_DN giant cell tumor DOID_200 1.193E-04 0.01357793 4.074E-03 0.28976095 KAYO_AGING_MUSCLE_DN malignant giant cell tumor DOID_2705 1.193E-04 0.01357793 4.074E-03 0.28976095 KAYO_AGING_MUSCLE_DN giant cell glioblastoma DOID_3074 1.193E-04 0.01357793 4.074E-03 0.28976095 KAYO_AGING_MUSCLE_DN rectal neoplasm DOID_1984 1.251E-04 0.01186824 1.000 1.000 KAYO_AGING_MUSCLE_DN rectum cancer DOID_1993 1.251E-04 0.01186824 1.000 1.000 KAYO_AGING_MUSCLE_DN mitochondrial metabolism disease DOID_700 1.394E-04 0.01133308 4.512E-03 0.25671249 KAYO_AGING_MUSCLE_DN glioblastoma DOID_3068 1.54E-04 0.01095188 4.815E-03 0.2283104 KAYO_AGING_MUSCLE_DN tic disorder DOID_2769 1.832E-04 0.01157923 0.02007382 0.43930781 KAYO_AGING_MUSCLE_DN cerebral degeneration DOID_1443 2.126E-04 0.01209806 5.948E-03 0.2256452 KAYO_AGING_MUSCLE_DN astrocytoma DOID_3069 2.518E-04 0.01302551 6.646E-03 0.22243112 KAYO_AGING_MUSCLE_DN drug-induced mental disorder DOID_1203 3.754E-04 0.01779797 1.000 1.000 KAYO_AGING_MUSCLE_DN drug psychosis DOID_1742 3.754E-04 0.01779797 1.000 1.000 KAYO_AGING_MUSCLE_DN substance-induced psychosis DOID_8646 3.754E-04 0.01779797 1.000 1.000 KAYO_AGING_MUSCLE_DN mental depression DOID_1596 4.106E-04 0.01796986 4.106E-04 0.23360816 KAYO_AGING_MUSCLE_DN carbohydrate metabolic disorder DOID_2978 5.685E-04 0.02310474 5.685E-04 0.16173318 KAYO_AGING_MUSCLE_DN mitochondrial myopathy DOID_699 5.771E-04 0.02189018 0.03486837 0.49600253 KAYO_AGING_MUSCLE_DN dilated cardiomyopathy DOID_12930 6.041E-04 0.02148317 0.15134145 0.72977361 KAYO_AGING_MUSCLE_DN hypoglycemia DOID_9993 6.937E-04 0.02321922 0.03812606 0.47160284 KAYO_AGING_MUSCLE_DN diabetic angiopathy DOID_11713 7.56E-04 0.02389681 0.03975085 0.48123903 KAYO_AGING_MUSCLE_DN Lewy body dementia DOID_12217 7.56E-04 0.02263908 0.03975085 0.47121322 KAYO_AGING_MUSCLE_DN female reproductive organ benign neoplasm DOID_0060086 1.347E-03 0.03831564 0.05265226 0.45392626 KAYO_AGING_MUSCLE_DN uterine benign neoplasm DOID_0060095 1.347E-03 0.03831564 0.05265226 0.45392626 KAYO_AGING_MUSCLE_DN uterine fibroid DOID_13223 1.347E-03 0.03831564 0.05265226 0.45392626 KAYO_AGING_MUSCLE_DN endometrial carcinoma DOID_2871 1.347E-03 0.03649109 0.05265226 0.44715124 KAYO_AGING_MUSCLE_DN abdominal aortic aneurysm DOID_7693 1.432E-03 0.03703937 0.05425288 0.44738973 KAYO_AGING_MUSCLE_DN endometrial cancer DOID_1380 1.52E-03 0.03760237 0.05585085 0.44759345 KAYO_AGING_MUSCLE_DN papilloma DOID_2615 1.703E-03 0.04037993 1.000 1.000 KAYO_AGING_MUSCLE_DN esophageal disease DOID_6050 1.799E-03 0.04093536 0.06062883 0.45391844 KAYO_AGING_MUSCLE_DN hyperthyroidism DOID_7998 1.799E-03 0.03936092 0.06062883 0.4480234 KAYO_AGING_MUSCLE_DN aplastic anemia DOID_12449 1.896E-03 0.0399654 0.06221619 0.45385911 KAYO_AGING_MUSCLE_DN embryonal cancer DOID_688 2.1E-03 0.04266636 2.1E-03 0.29866455 KAYO_AGING_MUSCLE_DN multiple myeloma DOID_9538 2.1E-03 0.04119511 1.000 1.000 KAYO_AGING_MUSCLE_DN benign mesothelioma DOID_2645 2.535E-03 0.04808755 1.000 1.000 KAYO_AGING_MUSCLE_DN nephrotic syndrome DOID_1184 2.768E-03 0.05080408 2.768E-03 0.31498527 KAYO_AGING_MUSCLE_DN Huntington's disease DOID_12858 2.768E-03 0.04921645 2.768E-03 0.26248773 KAYO_AGING_MUSCLE_DN uterine cancer DOID_363 2.888E-03 0.04979209 0.07638414 0.51132443 KAYO_AGING_MUSCLE_DN myeloma DOID_0070004 3.262E-03 0.05458736 1.000 1.000 KAYO_AGING_MUSCLE_DN thyroid adenoma DOID_2891 3.262E-03 0.05302772 1.000 1.000 KAYO_AGING_MUSCLE_DN bone marrow disease DOID_4961 3.262E-03 0.05155473 0.08105981 0.50684648 KAYO_AGING_MUSCLE_DN aortic aneurysm DOID_3627 3.657E-03 0.0562431 0.08571217 0.51883217 KAYO_AGING_MUSCLE_DN movement disease DOID_480 3.657E-03 0.05476302 0.08571217 0.51337077 KAYO_AGING_MUSCLE_DN bile duct adenocarcinoma DOID_4896 4.218E-03 0.06153279 1.000 1.000 KAYO_AGING_MUSCLE_DN cholangiocarcinoma DOID_4947 4.218E-03 0.06153279 1.000 1.000 KAYO_AGING_MUSCLE_DN bone marrow cancer DOID_4960 4.218E-03 0.05999447 1.000 1.000 KAYO_AGING_MUSCLE_DN reproductive organ benign neoplasm DOID_0050622 4.363E-03 0.06055593 0.09341463 0.5423768 KAYO_AGING_MUSCLE_DN familial hyperlipidemia DOID_1168 4.512E-03 0.06112202 4.512E-03 0.2852361 KAYO_AGING_MUSCLE_DN retinitis pigmentosa DOID_10584 4.815E-03 0.06371453 4.815E-03 0.24906589 KAYO_AGING_MUSCLE_DN bile duct cancer DOID_4606 4.815E-03 0.06226647 1.000 1.000 KAYO_AGING_MUSCLE_DN bile duct carcinoma DOID_4897 4.815E-03 0.06226647 1.000 1.000 KAYO_AGING_MUSCLE_DN melancholia DOID_2848 4.97E-03 0.06284408 4.97E-03 0.2175372 KAYO_AGING_MUSCLE_DN neurotic disorder DOID_4964 5.127E-03 0.06342483 5.127E-03 0.20839589 KAYO_AGING_MUSCLE_DN endocrine pancreas disease DOID_1428 5.78E-03 0.06997206 0.10711843 0.59755282 KAYO_AGING_MUSCLE_DN allergic contact dermatitis DOID_3042 6.293E-03 0.07459323 6.293E-03 0.22377969 KAYO_AGING_MUSCLE_DN endocrine organ benign neoplasm DOID_0060089 6.468E-03 0.07510759 1.000 1.000 KAYO_AGING_MUSCLE_DN nephrosis DOID_2527 7.007E-03 0.07974409 7.007E-03 0.22151137 KAYO_AGING_MUSCLE_DN peripheral vascular disease DOID_341 7.192E-03 0.08023558 0.11912827 0.62187144 KAYO_AGING_MUSCLE_DN diabetic retinopathy DOID_8947 7.378E-03 0.08073206 0.12061828 0.6183045 KAYO_AGING_MUSCLE_DN endogenous depression DOID_1595 7.757E-03 0.08328077 7.757E-03 0.23230952 KAYO_AGING_MUSCLE_DN aneurysm disease DOID_2403 7.95E-03 0.083771 0.12507342 0.63541763 KAYO_AGING_MUSCLE_DN mixed glioma DOID_5076 8.145E-03 0.08426567 1.000 1.000 KAYO_AGING_MUSCLE_DN contact dermatitis DOID_2773 8.542E-03 0.08678974 8.542E-03 0.24301127 KAYO_AGING_MUSCLE_DN lipid metabolism disorder DOID_3146 8.542E-03 0.08526711 8.542E-03 0.2314393 KAYO_AGING_MUSCLE_DN alcohol abuse DOID_1574 9.152E-03 0.08978836 1.000 1.000 KAYO_AGING_MUSCLE_DN biliary tract cancer DOID_4607 9.152E-03 0.08826652 1.000 1.000 KAYO_AGING_MUSCLE_DN chronic kidney failure DOID_784 9.152E-03 0.08679541 9.152E-03 0.23671476 KAYO_AGING_MUSCLE_DN retinal vascular disease DOID_2462 9.57E-03 0.08926876 0.13684546 0.68302691 KAYO_AGING_MUSCLE_DN transitional cell carcinoma DOID_2671 0.01021233 0.09372287 0.14121966 0.69873033 KAYO_AGING_MUSCLE_DN amino acid metabolic disorder DOID_9252 0.01043056 0.09420615 0.14267288 0.69983505 AMUNDSON_RESPONSE_TO_ARSENITE encephalomyelitis DOID_640 4.924E-09 2.802E-06 1.631E-07 1.856E-05 AMUNDSON_RESPONSE_TO_ARSENITE middle cerebral artery infarction DOID_3525 8.793E-09 2.502E-06 8.793E-09 5.003E-06 AMUNDSON_RESPONSE_TO_ARSENITE brain infarction DOID_3454 2.822E-08 5.352E-06 2.822E-08 8.028E-06 AMUNDSON_RESPONSE_TO_ARSENITE intracranial arterial disease DOID_13089 8.358E-08 1.189E-05 8.358E-08 1.585E-05 AMUNDSON_RESPONSE_TO_ARSENITE cerebral arterial disease DOID_3527 8.358E-08 1.189E-05 8.358E-08 1.585E-05 AMUNDSON_RESPONSE_TO_ARSENITE cerebral infarction DOID_3526 1.472E-07 1.675E-05 1.472E-07 2.094E-05 AMUNDSON_RESPONSE_TO_ARSENITE oral cavity cancer DOID_8618 1.804E-05 1.71E-03 1.804E-05 1.71E-03 AMUNDSON_RESPONSE_TO_ARSENITE pre-malignant neoplasm DOID_0060071 2.467E-05 2.005E-03 6.414E-04 0.04054983 AMUNDSON_RESPONSE_TO_ARSENITE in situ carcinoma DOID_8719 2.467E-05 2.005E-03 6.414E-04 0.04054983 AMUNDSON_RESPONSE_TO_ARSENITE seminoma DOID_4440 4.923E-05 3.502E-03 2.298E-03 0.06537509 AMUNDSON_RESPONSE_TO_ARSENITE germinoma DOID_3304 8.894E-05 5.623E-03 3.377E-03 0.07685735 AMUNDSON_RESPONSE_TO_ARSENITE cataract DOID_83 2.506E-04 0.01425635 6.635E-03 0.12585323 AMUNDSON_RESPONSE_TO_ARSENITE learning disability DOID_8927 2.506E-04 0.01296032 6.635E-03 0.12179345 AMUNDSON_RESPONSE_TO_ARSENITE lateral sclerosis DOID_230 2.818E-04 0.01336211 0.02503879 0.29681401 AMUNDSON_RESPONSE_TO_ARSENITE lens disease DOID_110 2.829E-04 0.01238178 7.183E-03 0.12771392 AMUNDSON_RESPONSE_TO_ARSENITE atrophic muscular disease DOID_913 3.957E-04 0.01608279 3.957E-04 0.03216557 AMUNDSON_RESPONSE_TO_ARSENITE muscular dystrophy DOID_9884 3.957E-04 0.01608279 3.957E-04 0.03216557 AMUNDSON_RESPONSE_TO_ARSENITE pituitary cancer DOID_1785 4.119E-04 0.0156265 4.119E-04 0.02929968 AMUNDSON_RESPONSE_TO_ARSENITE pituitary carcinoma DOID_4916 4.119E-04 0.0156265 4.119E-04 0.02929968 AMUNDSON_RESPONSE_TO_ARSENITE collagen disease DOID_854 5.861E-04 0.02084375 0.01155248 0.18259333 AMUNDSON_RESPONSE_TO_ARSENITE parasitic infectious disease DOID_1398 6.999E-04 0.02342523 0.01296877 0.19943873 AMUNDSON_RESPONSE_TO_ARSENITE hyperglycemia DOID_4195 7.304E-04 0.02308719 7.304E-04 0.04155693 AMUNDSON_RESPONSE_TO_ARSENITE pituitary adenoma DOID_3829 7.441E-04 0.02228275 7.441E-04 0.03848838 AMUNDSON_RESPONSE_TO_ARSENITE chronic myeloid leukemia DOID_8552 7.441E-04 0.02116861 7.441E-04 0.03528102 AMUNDSON_RESPONSE_TO_ARSENITE tongue cancer DOID_8649 7.441E-04 0.02016058 7.441E-04 0.03256709 AMUNDSON_RESPONSE_TO_ARSENITE allergic contact dermatitis DOID_3042 7.617E-04 0.01969925 7.617E-04 0.03095597 AMUNDSON_RESPONSE_TO_ARSENITE prion disease DOID_649 9.456E-04 0.02339223 0.04462228 0.33853434 AMUNDSON_RESPONSE_TO_ARSENITE contact dermatitis DOID_2773 1.206E-03 0.02858041 1.206E-03 0.04572866 AMUNDSON_RESPONSE_TO_ARSENITE primary bacterial infectious disease DOID_0050338 1.526E-03 0.03473697 1.526E-03 0.05427651 AMUNDSON_RESPONSE_TO_ARSENITE lingual-facial-buccal dyskinesia DOID_9854 1.551E-03 0.0339371 1.551E-03 0.0519038 AMUNDSON_RESPONSE_TO_ARSENITE sphingolipidosis DOID_1927 1.833E-03 0.0386237 1.833E-03 0.05793554 AMUNDSON_RESPONSE_TO_ARSENITE Crohn's disease DOID_8778 1.896E-03 0.03852636 0.02480257 0.31361474 AMUNDSON_RESPONSE_TO_ARSENITE spinal muscular atrophy DOID_12377 2.137E-03 0.04193482 0.06618869 0.41386115 AMUNDSON_RESPONSE_TO_ARSENITE ankylosing spondylitis DOID_7147 2.137E-03 0.04053699 2.137E-03 0.06400578 AMUNDSON_RESPONSE_TO_ARSENITE fragments of torsion dystonia DOID_531 2.298E-03 0.04217748 2.298E-03 0.06226199 AMUNDSON_RESPONSE_TO_ARSENITE extrinsic allergic alveolitis DOID_841 2.298E-03 0.04085943 0.06855502 0.41060846 AMUNDSON_RESPONSE_TO_ARSENITE central nervous system hereditary degenerative disease DOID_481 2.636E-03 0.04544603 2.636E-03 0.06816905 AMUNDSON_RESPONSE_TO_ARSENITE dystonic disease DOID_544 2.813E-03 0.04707388 2.813E-03 0.06958747 AMUNDSON_RESPONSE_TO_ARSENITE corneal disease DOID_10124 2.995E-03 0.04869731 1.000 1.000 AMUNDSON_RESPONSE_TO_ARSENITE age related macular degeneration DOID_10871 3.183E-03 0.05031626 1.000 1.000 AMUNDSON_RESPONSE_TO_ARSENITE degeneration of macula and posterior pole DOID_2007 3.183E-03 0.05031626 1.000 1.000 AMUNDSON_RESPONSE_TO_ARSENITE gonadal disease DOID_2277 3.183E-03 0.04895636 3.183E-03 0.07547438 AMUNDSON_RESPONSE_TO_ARSENITE macular degeneration DOID_4448 3.989E-03 0.05973255 1.000 1.000 AMUNDSON_RESPONSE_TO_ARSENITE uveitis DOID_13141 4.879E-03 0.07118942 4.879E-03 0.10678413 AMUNDSON_RESPONSE_TO_ARSENITE systemic scleroderma DOID_418 5.115E-03 0.07276058 0.10106715 0.50006267 AMUNDSON_RESPONSE_TO_ARSENITE adenoid cystic carcinoma DOID_4866 5.356E-03 0.07432652 5.356E-03 0.11286619 AMUNDSON_RESPONSE_TO_ARSENITE endometriosis of uterus DOID_288 5.852E-03 0.07928664 0.10788654 0.51586087 AMUNDSON_RESPONSE_TO_ARSENITE salivary gland cancer DOID_8850 5.852E-03 0.07744277 5.852E-03 0.11892997 AMUNDSON_RESPONSE_TO_ARSENITE rheumatic disease DOID_1575 6.108E-03 0.0789931 0.11014828 0.52228643 AMUNDSON_RESPONSE_TO_ARSENITE endometriosis DOID_289 6.108E-03 0.07723769 0.11014828 0.50543848 AMUNDSON_RESPONSE_TO_ARSENITE uveal disease DOID_3480 6.108E-03 0.07555861 6.108E-03 0.11985159 AMUNDSON_RESPONSE_TO_ARSENITE scleroderma DOID_419 6.108E-03 0.0789931 0.11014828 0.52228643 AMUNDSON_RESPONSE_TO_ARSENITE proteinuria DOID_576 6.907E-03 0.08361299 1.000 1.000 AMUNDSON_RESPONSE_TO_ARSENITE pre-eclampsia DOID_10591 7.183E-03 0.08514262 0.11913862 0.5296084 AMUNDSON_RESPONSE_TO_ARSENITE integumentary system benign neoplasm DOID_0060121 7.749E-03 0.08998617 7.749E-03 0.13361582 AMUNDSON_RESPONSE_TO_ARSENITE glaucoma DOID_1686 7.749E-03 0.08818644 0.12360002 0.5409878 AMUNDSON_RESPONSE_TO_ARSENITE skin benign neoplasm DOID_3165 7.749E-03 0.08998617 7.749E-03 0.13361582 AMUNDSON_RESPONSE_TO_ARSENITE movement disease DOID_480 8.04E-03 0.08970066 8.04E-03 0.13455099 AMUNDSON_RESPONSE_TO_ARSENITE giant cell tumor DOID_200 8.941E-03 0.09783622 0.13245586 0.56244315 AMUNDSON_RESPONSE_TO_ARSENITE malignant giant cell tumor DOID_2705 8.941E-03 0.09783622 0.13245586 0.56244315 AMUNDSON_RESPONSE_TO_ARSENITE giant cell glioblastoma DOID_3074 8.941E-03 0.09783622 0.13245586 0.56244315 CHANG_IMMORTALIZED_BY_HPV31_DN nephrosis DOID_2527 8.41E-07 4.786E-04 5.288E-05 0.01504518 CHANG_IMMORTALIZED_BY_HPV31_DN nephrotic syndrome DOID_1184 1.262E-05 3.59E-03 9.336E-04 0.04829413 CHANG_IMMORTALIZED_BY_HPV31_DN influenza DOID_8469 1.347E-05 2.555E-03 9.745E-04 0.04620877 CHANG_IMMORTALIZED_BY_HPV31_DN sarcoidosis DOID_11335 2.289E-05 3.256E-03 1.381E-03 0.05237326 CHANG_IMMORTALIZED_BY_HPV31_DN hypersensitivity reaction type IV disease DOID_2916 2.962E-05 3.371E-03 1.636E-03 0.05816726 CHANG_IMMORTALIZED_BY_HPV31_DN arrhythmogenic right ventricular dysplasia DOID_0050431 3.322E-05 3.15E-03 3.322E-05 0.0189029 CHANG_IMMORTALIZED_BY_HPV31_DN pre-malignant neoplasm DOID_0060071 3.753E-05 3.051E-03 1.911E-03 0.06397254 CHANG_IMMORTALIZED_BY_HPV31_DN in situ carcinoma DOID_8719 3.753E-05 3.051E-03 1.911E-03 0.06397254 CHANG_IMMORTALIZED_BY_HPV31_DN male reproductive system disease DOID_48 5.288E-05 3.761E-03 2.395E-03 0.0717225 CHANG_IMMORTALIZED_BY_HPV31_DN beta thalassemia DOID_12241 6.079E-05 3.843E-03 6.079E-05 0.01153047 CHANG_IMMORTALIZED_BY_HPV31_DN epidermolysis bullosa DOID_2730 6.079E-05 3.459E-03 6.079E-05 8.648E-03 CHANG_IMMORTALIZED_BY_HPV31_DN pancreatitis DOID_4989 6.676E-05 3.453E-03 2.792E-03 0.07942259 CHANG_IMMORTALIZED_BY_HPV31_DN vesiculobullous skin disease DOID_2731 7.18E-05 3.405E-03 7.18E-05 8.171E-03 CHANG_IMMORTALIZED_BY_HPV31_DN thalassemia DOID_10241 9.654E-05 4.225E-03 9.654E-05 9.155E-03 CHANG_IMMORTALIZED_BY_HPV31_DN tongue cancer DOID_8649 1.103E-04 4.481E-03 0.01550478 0.25206347 CHANG_IMMORTALIZED_BY_HPV31_DN ulcerative colitis DOID_8577 1.296E-04 4.917E-03 4.32E-03 0.11172457 CHANG_IMMORTALIZED_BY_HPV31_DN prion disease DOID_649 1.404E-04 4.993E-03 0.01742636 0.26093676 CHANG_IMMORTALIZED_BY_HPV31_DN esophagitis DOID_11963 1.742E-04 5.829E-03 0.01934428 0.26846087 CHANG_IMMORTALIZED_BY_HPV31_DN alopecia DOID_987 1.742E-04 5.505E-03 1.742E-04 0.01415606 CHANG_IMMORTALIZED_BY_HPV31_DN urinary tract obstruction DOID_5200 2.315E-04 6.932E-03 0.02221434 0.27478172 CHANG_IMMORTALIZED_BY_HPV31_DN hypotrichosis DOID_4535 3.448E-04 9.809E-03 3.448E-04 0.02452178 CHANG_IMMORTALIZED_BY_HPV31_DN pleurisy DOID_10247 3.963E-04 0.01073708 0.0288794 0.2528058 CHANG_IMMORTALIZED_BY_HPV31_DN abdominal aortic aneurysm DOID_7693 4.801E-04 0.01241728 0.0317223 0.24066651 CHANG_IMMORTALIZED_BY_HPV31_DN chronic leukemia DOID_1036 5.404E-04 0.01336813 0.03361307 0.25165572 CHANG_IMMORTALIZED_BY_HPV31_DN chronic lymphocytic leukemia DOID_1040 5.404E-04 0.01336813 0.03361307 0.25165572 CHANG_IMMORTALIZED_BY_HPV31_DN pleural disease DOID_1532 5.404E-04 0.01281113 0.03361307 0.24520301 CHANG_IMMORTALIZED_BY_HPV31_DN papilloma DOID_2615 5.718E-04 0.01301413 0.0345571 0.24275298 CHANG_IMMORTALIZED_BY_HPV31_DN hair disease DOID_421 5.718E-04 0.01251359 5.718E-04 0.03615037 CHANG_IMMORTALIZED_BY_HPV31_DN myocarditis DOID_820 5.718E-04 0.01205012 0.0345571 0.23979258 CHANG_IMMORTALIZED_BY_HPV31_DN nephroblastoma DOID_2154 6.041E-04 0.0122762 0.03550024 0.2376428 CHANG_IMMORTALIZED_BY_HPV31_DN esophageal disease DOID_6050 6.041E-04 0.01185288 0.03550024 0.23217974 CHANG_IMMORTALIZED_BY_HPV31_DN pulmonary sarcoidosis DOID_13406 7.062E-04 0.01339432 7.062E-04 0.04018296 CHANG_IMMORTALIZED_BY_HPV31_DN cervix uteri carcinoma in situ DOID_8991 8.544E-04 0.01568229 0.04207716 0.24939483 CHANG_IMMORTALIZED_BY_HPV31_DN endometriosis of uterus DOID_288 8.936E-04 0.01588907 0.04301315 0.25231425 CHANG_IMMORTALIZED_BY_HPV31_DN endometriosis DOID_289 9.336E-04 0.01609804 0.04394825 0.25516892 CHANG_IMMORTALIZED_BY_HPV31_DN proteinuria DOID_576 1.059E-03 0.01772046 0.04674822 0.26336374 CHANG_IMMORTALIZED_BY_HPV31_DN bone marrow disease DOID_4961 1.102E-03 0.01792041 1.102E-03 0.04824725 CHANG_IMMORTALIZED_BY_HPV31_DN hemolytic anemia DOID_583 1.147E-03 0.01812262 1.147E-03 0.04660101 CHANG_IMMORTALIZED_BY_HPV31_DN normocytic anemia DOID_720 1.147E-03 0.01812262 1.147E-03 0.04660101 CHANG_IMMORTALIZED_BY_HPV31_DN aortic aneurysm DOID_3627 1.238E-03 0.01903388 0.05046911 0.27091435 CHANG_IMMORTALIZED_BY_HPV31_DN withdrawal disorder DOID_0060001 1.285E-03 0.01923399 0.05139712 0.27331738 CHANG_IMMORTALIZED_BY_HPV31_DN oral cavity cancer DOID_8618 1.636E-03 0.02386349 0.05786853 0.29664139 CHANG_IMMORTALIZED_BY_HPV31_DN uterine disease DOID_345 2.027E-03 0.02883873 0.06429698 0.31269216 CHANG_IMMORTALIZED_BY_HPV31_DN temporal lobe epilepsy DOID_3328 2.087E-03 0.02895744 2.087E-03 0.06595862 CHANG_IMMORTALIZED_BY_HPV31_DN hyperglycemia DOID_4195 2.087E-03 0.02826798 0.06521184 0.3144537 CHANG_IMMORTALIZED_BY_HPV31_DN cystic fibrosis DOID_1485 2.656E-03 0.03514846 0.0734065 0.33957968 CHANG_IMMORTALIZED_BY_HPV31_DN aneurysm disease DOID_2403 2.724E-03 0.03522023 0.0743127 0.3355867 CHANG_IMMORTALIZED_BY_HPV31_DN female reproductive system disease DOID_229 3.001E-03 0.03794354 0.07792885 0.34373267 CHANG_IMMORTALIZED_BY_HPV31_DN focal epilepsy DOID_2234 3.144E-03 0.03889256 3.144E-03 0.08519323 CHANG_IMMORTALIZED_BY_HPV31_DN chronic kidney failure DOID_784 3.144E-03 0.03806506 0.07973177 0.34631584 CHANG_IMMORTALIZED_BY_HPV31_DN transitional cell carcinoma DOID_2671 3.517E-03 0.0416857 0.08422407 0.36032703 CHANG_IMMORTALIZED_BY_HPV31_DN lymphoblastic leukemia DOID_1037 3.908E-03 0.04538592 0.08869503 0.37662294 CHANG_IMMORTALIZED_BY_HPV31_DN encephalomyelitis DOID_640 3.908E-03 0.0444782 0.08869503 0.37383314 CHANG_IMMORTALIZED_BY_HPV31_DN mouth disease DOID_403 3.989E-03 0.04450661 0.08958667 0.37481483 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP congenital heart defect DOID_1682 5.919E-08 3.368E-05 5.919E-08 3.368E-05 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pancreatitis DOID_4989 2.269E-07 6.456E-05 2.269E-07 6.456E-05 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP transitional cell carcinoma DOID_2671 5.106E-07 9.685E-05 1.16E-04 4.4E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP dilated cardiomyopathy DOID_12930 8.512E-07 1.211E-04 1.289E-05 1.833E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP focal epilepsy DOID_2234 6.01E-06 6.839E-04 6.01E-06 1.14E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lung small cell carcinoma DOID_5409 8.06E-06 7.643E-04 0.03061682 0.12809535 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.214E-05 9.871E-04 1.573E-04 5.593E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP vitiligo DOID_12306 1.366E-05 9.718E-04 1.366E-05 1.555E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP renal tubular transport disease DOID_447 1.814E-05 1.147E-03 1.814E-05 1.72E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP cholestasis DOID_13580 3.02E-05 1.718E-03 5.557E-03 0.04650289 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP uterine disease DOID_345 3.02E-05 1.562E-03 5.557E-03 0.04517424 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP temporal lobe epilepsy DOID_3328 3.242E-05 1.537E-03 3.242E-05 2.636E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP allergic contact dermatitis DOID_3042 3.477E-05 1.522E-03 6.024E-03 0.04570206 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP blood coagulation disease DOID_1247 4.26E-05 1.732E-03 4.26E-05 3.03E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bile duct disease DOID_4138 4.55E-05 1.726E-03 7.026E-03 0.04935236 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP biliary tract disease DOID_9741 4.854E-05 1.726E-03 7.29E-03 0.05058831 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP diabetic retinopathy DOID_8947 5.174E-05 1.732E-03 7.034E-04 0.01601023 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP endogenous depression DOID_1595 5.862E-05 1.853E-03 5.862E-05 3.706E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lung oat cell carcinoma DOID_5411 6.187E-05 1.853E-03 0.07592222 0.20571307 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP mixed glioma DOID_5076 6.619E-05 1.883E-03 8.531E-04 0.01673907 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP peptic ulcer DOID_750 7.052E-05 1.911E-03 1.407E-03 0.02000838 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP contact dermatitis DOID_2773 7.449E-05 1.927E-03 9.31E-03 0.0601953 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Leber congenital amaurosis DOID_14791 7.586E-05 1.877E-03 7.586E-05 4.316E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP intracranial arterial disease DOID_13089 7.744E-05 1.836E-03 1.506E-03 0.01993153 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP cerebral arterial disease DOID_3527 7.744E-05 1.836E-03 1.506E-03 0.01993153 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP female reproductive system disease DOID_229 7.893E-05 1.797E-03 9.622E-03 0.05887029 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP alcohol abuse DOID_1574 8.842E-05 1.935E-03 8.842E-05 4.574E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP mental depression DOID_1596 8.842E-05 1.863E-03 8.842E-05 4.193E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP biliary tract cancer DOID_4607 8.842E-05 1.797E-03 0.010265 0.06148196 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP drug-induced mental disorder DOID_1203 9.176E-05 1.8E-03 9.176E-05 4.016E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP drug psychosis DOID_1742 9.176E-05 1.8E-03 9.176E-05 4.016E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP substance-induced psychosis DOID_8646 9.176E-05 1.8E-03 9.176E-05 4.016E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP retinal vascular disease DOID_2462 9.877E-05 1.873E-03 1.167E-03 0.01897116 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP inherited blood coagulation disease DOID_2214 1.097E-04 2.013E-03 1.097E-04 4.458E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP influenza DOID_8469 1.101E-04 1.958E-03 1.949E-03 0.0221781 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP cerebral infarction DOID_3526 1.196E-04 2.063E-03 0.02640178 0.11828827 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lymphoma DOID_0060058 1.424E-04 2.384E-03 1.554E-03 0.02009403 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP esophagitis DOID_11963 1.521E-04 2.472E-03 4.895E-03 0.0428468 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP mouth disease DOID_403 1.573E-04 2.486E-03 1.679E-03 0.0207681 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hemorrhagic disease DOID_2213 1.897E-04 2.917E-03 1.897E-04 6.349E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP funisitis DOID_0050698 2.038E-04 3.052E-03 2.038E-04 6.443E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP sinusitis DOID_0050127 2.335E-04 3.407E-03 2.335E-04 6.992E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP paranasal sinus disease DOID_1352 2.335E-04 3.407E-03 2.335E-04 6.992E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP urinary tract obstruction DOID_5200 2.335E-04 3.321E-03 6.451E-03 0.04705638 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bone marrow cancer DOID_4960 2.341E-04 3.248E-03 0.03623094 0.1451789 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP reproductive organ benign neoplasm DOID_0050622 2.504E-04 3.392E-03 3.555E-03 0.03612357 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP parasitic protozoa infectious disease DOID_2789 2.504E-04 3.313E-03 3.555E-03 0.03548982 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP aortic valve disease DOID_62 2.658E-04 3.438E-03 7.013E-03 0.049879 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Goodpasture syndrome DOID_9808 2.658E-04 3.361E-03 2.658E-04 7.563E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP melancholia DOID_2848 3.238E-04 4.006E-03 3.238E-04 8.775E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP neurotic disorder DOID_4964 3.444E-04 4.169E-03 3.444E-04 8.907E-03 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP parasitic infectious disease DOID_1398 4.613E-04 5.469E-03 5.557E-03 0.04582893 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP malaria DOID_12365 5.21E-04 6.05E-03 0.01082743 0.06351348 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP coronary stenosis DOID_4248 5.21E-04 5.929E-03 0.01082743 0.06160807 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP brain infarction DOID_3454 5.437E-04 6.066E-03 0.05380525 0.19254836 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP astrocytoma DOID_3069 5.733E-04 6.274E-03 6.513E-03 0.04691205 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP focal glomerulosclerosis DOID_3945 5.746E-04 6.169E-03 5.746E-04 0.01421491 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP female reproductive organ benign neoplasm DOID_0060086 6.316E-04 6.655E-03 0.01226138 0.06581818 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP uterine benign neoplasm DOID_0060095 6.316E-04 6.655E-03 0.01226138 0.06581818 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP uterine fibroid DOID_13223 6.316E-04 6.655E-03 0.01226138 0.06581818 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP nephrosis DOID_2527 6.36E-04 6.58E-03 6.36E-04 0.01507942 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP spastic cerebral palsy DOID_0050669 6.921E-04 7.032E-03 0.01300779 0.06853179 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Charcot-Marie-Tooth disease DOID_10595 7.561E-04 7.548E-03 7.561E-04 0.01654756 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP cystic fibrosis DOID_1485 7.757E-04 7.61E-03 8.12E-03 0.05435727 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP aneurysm disease DOID_2403 8.138E-04 7.848E-03 8.138E-04 0.0171498 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP leiomyoma DOID_127 8.238E-04 7.813E-03 0.01455835 0.07530637 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hereditary spastic paraplegia DOID_2476 8.238E-04 7.685E-03 8.238E-04 0.01674144 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bacterial pneumonia DOID_874 8.531E-04 7.83E-03 8.703E-03 0.05758103 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hair disease DOID_421 8.953E-04 8.086E-03 8.953E-04 0.01698024 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP metal metabolism disorder DOID_896 8.953E-04 7.959E-03 0.01536206 0.07735409 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP arrhythmogenic right ventricular dysplasia DOID_0050431 9.633E-04 8.433E-03 9.633E-04 0.01768134 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP spindle cell carcinoma DOID_4015 9.705E-04 8.367E-03 0.17701913 0.34732375 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP esophageal disease DOID_6050 9.705E-04 8.242E-03 0.01618443 0.08007776 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP paraplegia DOID_607 9.705E-04 8.121E-03 9.705E-04 0.01725695 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP auditory system disease DOID_2742 1.024E-03 8.444E-03 9.94E-03 0.06017163 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP chronic kidney failure DOID_784 1.07E-03 8.699E-03 1.07E-03 0.01845263 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autosomal recessive nonsyndromic deafness DOID_0050565 1.133E-03 9.078E-03 1.133E-03 0.01895686 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bilirubin metabolic disorder DOID_2741 1.2E-03 9.483E-03 0.0512746 0.18944965 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.2E-03 9.353E-03 1.2E-03 0.01896625 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.2E-03 9.353E-03 1.2E-03 0.01896625 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Hodgkin's granuloma DOID_8651 1.2E-03 9.353E-03 1.2E-03 0.01896625 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 1.2E-03 9.353E-03 1.2E-03 0.01896625 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP primary bacterial infectious disease DOID_0050338 1.27E-03 9.763E-03 0.01162427 0.06299247 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP microcephaly DOID_10907 1.311E-03 9.947E-03 1.311E-03 0.0201631 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP peripheral nervous system neoplasm DOID_1192 1.311E-03 9.816E-03 1.311E-03 0.01963249 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP blood platelet disease DOID_2218 1.311E-03 9.689E-03 1.311E-03 0.01912909 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP amino acid metabolic disorder DOID_9252 1.379E-03 0.01005633 0.01234087 0.06562575 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP congenital diaphragmatic hernia DOID_3827 1.407E-03 0.01013082 0.02056875 0.09918323 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP nervous system cancer DOID_3093 1.435E-03 0.010209 1.435E-03 0.01992 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Human immunodeficiency virus infectious disease DOID_526 1.435E-03 0.01008296 1.435E-03 0.01944571 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP migraine without aura DOID_12783 1.462E-03 0.01014187 0.0562559 0.19399762 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hemochromatosis DOID_2352 1.462E-03 0.01001968 0.0562559 0.19282896 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP chronic monocytic leukemia DOID_8593 1.462E-03 9.9E-03 0.0562559 0.1916743 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bronchiectasis DOID_9563 1.462E-03 9.784E-03 0.0562559 0.18940596 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pulmonary emphysema DOID_9675 1.61E-03 0.0106539 0.0224457 0.10732439 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lymphoblastic leukemia DOID_1037 1.616E-03 0.01056616 0.01384866 0.07229255 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP carbohydrate metabolic disorder DOID_2978 1.616E-03 0.01044609 1.616E-03 0.02042791 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP endometriosis of uterus DOID_288 1.719E-03 0.01098777 0.02340975 0.11008386 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hypersensitivity reaction type I disease DOID_1205 1.744E-03 0.01102646 0.01464008 0.07437682 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP aortic valve stenosis DOID_1712 1.748E-03 0.01092875 0.06121118 0.19677492 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP aortic valve insufficiency DOID_57 1.748E-03 0.01080995 0.06121118 0.1924263 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lipodystrophy DOID_811 1.748E-03 0.01069372 1.748E-03 0.02115991 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP peritonitis DOID_8283 1.748E-03 0.01057996 0.06121118 0.19136902 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Hodgkin's lymphoma DOID_8567 1.748E-03 0.01046859 1.748E-03 0.02071908 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP nephrotic syndrome DOID_1184 1.831E-03 0.01085545 1.831E-03 0.02126781 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP rheumatic disease DOID_1575 1.831E-03 0.01074353 0.02439058 0.11283121 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP endometriosis DOID_289 1.831E-03 0.01063391 0.02439058 0.11192128 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP scleroderma DOID_419 1.831E-03 0.01074353 0.02439058 0.11283121 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hepatic coma DOID_12550 2.058E-03 0.01183113 0.06614057 0.19912161 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hepatic encephalopathy DOID_13413 2.058E-03 0.01183113 0.06614057 0.19912161 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP monocytic leukemia DOID_8527 2.058E-03 0.01171282 0.06614057 0.19201012 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP myeloma DOID_0070004 2.329E-03 0.01311915 0.23150308 0.43047468 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pre-eclampsia DOID_10591 2.329E-03 0.01299053 0.02847771 0.12561098 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP heart valve disease DOID_4079 2.329E-03 0.01286441 0.02847771 0.12275619 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pulmonary tuberculosis DOID_2957 2.606E-03 0.01425589 0.03061682 0.12904421 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP thoracic aortic aneurysm DOID_14004 2.752E-03 0.01491307 2.752E-03 0.03070337 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP mesenchymal cell neoplasm DOID_3350 2.752E-03 0.01477238 0.07592222 0.20769108 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP arthropathy DOID_381 2.752E-03 0.01463432 2.752E-03 0.03011292 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP spindle cell sarcoma DOID_4235 2.752E-03 0.01477238 0.07592222 0.20769108 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP epithelioid sarcoma DOID_6193 2.752E-03 0.01477238 0.07592222 0.20769108 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hyperhomocysteinemia DOID_9279 2.752E-03 0.01449881 0.07592222 0.20281571 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP withdrawal disorder DOID_0060001 2.902E-03 0.01514945 2.902E-03 0.03115641 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP B-cell lymphocytic neoplasm DOID_707 2.902E-03 0.01501173 0.03281756 0.13433949 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP silicosis DOID_10325 3.134E-03 0.01606668 0.08077475 0.21377133 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP spastic diplegia DOID_10965 3.134E-03 0.01592323 3.134E-03 0.03302596 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hemolytic-uremic syndrome DOID_12554 3.134E-03 0.01578232 1.000 1.000 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP long QT syndrome DOID_2843 3.134E-03 0.01564387 3.134E-03 0.03242548 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP giant cell tumor DOID_200 3.218E-03 0.01592447 0.03507842 0.14256873 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP malignant giant cell tumor DOID_2705 3.218E-03 0.01592447 0.03507842 0.14256873 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP giant cell glioblastoma DOID_3074 3.218E-03 0.01592447 0.03507842 0.14256873 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP familial hyperlipidemia DOID_1168 3.731E-03 0.01830291 3.731E-03 0.03660581 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP congenital nervous system abnormality DOID_2490 3.913E-03 0.01902849 3.913E-03 0.03773447 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP congenital muscular dystrophy DOID_0050557 3.969E-03 0.01913732 3.969E-03 0.03763674 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP glucose intolerance DOID_10603 3.969E-03 0.01897651 3.969E-03 0.03701974 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP ureteral obstruction DOID_5199 3.969E-03 0.01881837 0.09040388 0.22964201 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP nonsyndromic deafness DOID_0050563 4.099E-03 0.01927716 4.099E-03 0.03762155 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP retinitis pigmentosa DOID_10584 4.099E-03 0.01911915 4.099E-03 0.03702439 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP glioblastoma DOID_3068 4.099E-03 0.01896371 0.04098394 0.16307595 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP heart septal defect DOID_1681 4.42E-03 0.02028379 4.42E-03 0.03929984 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP leishmaniasis DOID_9065 4.42E-03 0.02012152 0.09518074 0.23858081 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP collagen disease DOID_854 4.691E-03 0.02118597 0.04469376 0.17538449 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pulmonary edema DOID_11396 4.895E-03 0.02192947 0.09993265 0.24722468 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP subependymal glioma DOID_4843 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pilocytic astrocytoma DOID_4851 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP subependymal giant cell astrocytoma DOID_5077 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP fibrillary astrocytoma DOID_6726 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP juvenile pilocytic astrocytoma DOID_6811 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP childhood pilocytic astrocytoma DOID_6812 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP gemistocytic astrocytoma DOID_7005 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP childhood cerebral astrocytoma DOID_7007 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP protoplasmic astrocytoma DOID_7008 4.895E-03 0.02175814 4.895E-03 0.04219761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP alopecia DOID_987 4.895E-03 0.02158947 4.895E-03 0.04156779 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pre-malignant neoplasm DOID_0060071 5.113E-03 0.02238087 0.04723343 0.18282873 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP in situ carcinoma DOID_8719 5.113E-03 0.02238087 0.04723343 0.18282873 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Kawasaki disease DOID_13378 5.391E-03 0.02341695 0.10465972 0.25341012 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lymphadenitis DOID_1602 5.391E-03 0.02341695 0.10465972 0.25341012 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP coronary restenosis DOID_4247 5.391E-03 0.02323955 0.10465972 0.25127164 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lymph node disease DOID_9942 5.391E-03 0.02341695 0.10465972 0.25341012 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hyperglycemia DOID_4195 5.788E-03 0.02476179 5.788E-03 0.04638477 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP benign glioma DOID_0060101 5.91E-03 0.02509541 5.91E-03 0.04670535 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP gastric ulcer DOID_10808 5.91E-03 0.02490952 0.10936208 0.26145809 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP benign ependymoma DOID_4844 5.91E-03 0.02509541 5.91E-03 0.04670535 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP muscular atrophy DOID_767 5.91E-03 0.02472636 5.91E-03 0.04606555 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP placenta disease DOID_780 5.91E-03 0.02454588 0.10936208 0.25820342 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP tooth disease DOID_1091 6.024E-03 0.02483808 6.024E-03 0.04631966 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP tuberculosis DOID_399 6.266E-03 0.02564911 0.05380525 0.19134493 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP optic nerve disease DOID_1891 6.451E-03 0.02621712 6.451E-03 0.0482947 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP uremia DOID_4676 6.451E-03 0.02603119 6.451E-03 0.0476675 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP polyarteritis nodosa DOID_9810 6.451E-03 0.02584787 0.11403988 0.26270725 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP diabetic angiopathy DOID_11713 7.013E-03 0.02790433 0.11869323 0.2712307 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP ureteral disease DOID_1426 7.013E-03 0.02771055 0.11869323 0.2690695 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP peripheral vascular disease DOID_341 7.29E-03 0.02860856 0.05928079 0.19725597 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP sphingolipidosis DOID_1927 7.597E-03 0.02960559 7.597E-03 0.0520773 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP acute pancreatitis DOID_2913 7.597E-03 0.02940419 7.597E-03 0.05145733 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP syndrome DOID_225 8.12E-03 0.0312187 0.06350791 0.1974645 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bronchiolitis DOID_2942 8.201E-03 0.03131913 0.12792709 0.28433795 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autosomal dominant nonsyndromic deafness DOID_0050564 8.827E-03 0.03348393 8.827E-03 0.05773092 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP cystitis DOID_1679 8.827E-03 0.03326219 0.13250786 0.29110801 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP myositis DOID_633 8.827E-03 0.03304336 0.13250786 0.28998836 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lipid metabolism disorder DOID_3146 9.31E-03 0.03462213 9.31E-03 0.05951895 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP intracranial aneurysm DOID_10941 9.473E-03 0.0350026 9.473E-03 0.05989334 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP middle cerebral artery infarction DOID_3525 9.473E-03 0.03477678 0.13706469 0.2965392 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hypotrichosis DOID_4535 9.473E-03 0.03455385 9.473E-03 0.05923517 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP fragments of torsion dystonia DOID_531 9.473E-03 0.03433376 9.473E-03 0.05859131 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP diffuse large B-cell lymphoma DOID_0050745 0.01014033 0.03651804 0.14159771 0.30289133 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lung adenocarcinoma DOID_3910 0.01014033 0.03628836 0.14159771 0.30063095 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP migraine DOID_6364 0.01014033 0.03606156 0.14159771 0.29951336 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP perinatal necrotizing enterocolitis DOID_8677 0.01014033 0.03583758 0.14159771 0.29730293 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bone development disease DOID_0080006 0.01059562 0.03721549 0.07525114 0.20989166 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP renal hypertension DOID_1073 0.01082743 0.03779636 0.01082743 0.06417508 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP secondary hypertension DOID_11130 0.01082743 0.03779636 0.01082743 0.06417508 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP sarcoma DOID_1115 0.01082743 0.0375659 0.14610703 0.30452344 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP thrombocytopenia DOID_1588 0.01082743 0.03733823 0.01082743 0.06286538 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hepatic vascular disease DOID_272 0.01082743 0.0371133 0.01082743 0.06223038 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP central nervous system hereditary degenerative disease DOID_481 0.01082743 0.03689106 0.01082743 0.06099809 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autoimmune disease of endocrine system DOID_0060005 0.01153452 0.03906633 0.15059278 0.31159014 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP multiple epiphyseal dysplasia DOID_12721 0.01153452 0.03883516 0.15059278 0.30822766 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP supratentorial cancer DOID_1659 0.01153452 0.03860672 0.01153452 0.06434454 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP cerebrum cancer DOID_368 0.01153452 0.03860672 0.01153452 0.06434454 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP dystonic disease DOID_544 0.01153452 0.03838095 0.01153452 0.06371983 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP cranial nerve disease DOID_5656 0.01153452 0.03815781 0.01153452 0.06310714 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autonomic nervous system neoplasm DOID_2621 0.01455835 0.04788266 0.01455835 0.07462793 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP bladder disease DOID_365 0.01455835 0.04760748 0.16830252 0.33483963 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP neuroblastoma DOID_769 0.01455835 0.04788266 0.01455835 0.07462793 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP papilloma DOID_2615 0.01536206 0.04994864 0.17267225 0.34233627 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP myocarditis DOID_820 0.01536206 0.04966484 0.17267225 0.3411476 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP ulcerative colitis DOID_8577 0.01587437 0.05103117 0.09726393 0.24273324 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pneumoconiosis DOID_10316 0.01618443 0.05173563 0.17701913 0.34852556 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP periodontal disease DOID_3388 0.01618443 0.05144661 0.01618443 0.0807802 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lymphoid leukemia DOID_10747 0.01702526 0.05381872 0.18134329 0.35216496 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP pulmonary sarcoidosis DOID_13406 0.01876138 0.05897916 0.18992391 0.36509021 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP embryonal cancer DOID_688 0.01876138 0.0586551 0.01876138 0.09202783 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP multiple myeloma DOID_9538 0.01876138 0.05833458 1.000 1.000 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP uveitis DOID_13141 0.01965627 0.06078488 0.01965627 0.09559331 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hepatitis DOID_2237 0.02056875 0.06326282 0.19841503 0.38012846 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP lymphatic system disease DOID_75 0.02149863 0.06576732 0.20262733 0.38560184 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autoimmune disease of urogenital tract DOID_0060049 0.02340975 0.07123073 0.02340975 0.11100122 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP primary biliary cirrhosis DOID_12236 0.02340975 0.07123073 0.02340975 0.11100122 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP Huntington's disease DOID_12858 0.02439058 0.07382042 0.02439058 0.11375605 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP uveal disease DOID_3480 0.02439058 0.07342983 0.02439058 0.11102591 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP diabetic autonomic neuropathy DOID_11503 0.02538799 0.07603034 0.02538799 0.11464892 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autonomic neuropathy DOID_11504 0.02538799 0.07603034 0.02538799 0.11464892 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP diabetic polyneuropathy DOID_12785 0.02538799 0.07603034 0.02538799 0.11464892 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP gallbladder cancer DOID_3121 0.02538799 0.07563227 0.2192574 0.41310418 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP diabetic neuropathy DOID_9743 0.02538799 0.07603034 0.02538799 0.11464892 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP proteinuria DOID_576 0.02743175 0.08129513 0.02743175 0.1219427 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autonomic nervous system disease DOID_11465 0.02847771 0.0839576 0.02847771 0.12464475 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP brain cancer DOID_1319 0.02847771 0.08352483 0.02847771 0.12369326 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP vascular skin disease DOID_9540 0.02847771 0.0830965 0.23150308 0.42767938 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP central nervous system cancer DOID_3620 0.02953946 0.08575487 0.02953946 0.1263756 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP hemolytic anemia DOID_583 0.02953946 0.08531956 1.000 1.000 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP normocytic anemia DOID_720 0.02953946 0.08531956 1.000 1.000 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.03061682 0.08798469 0.03061682 0.13000722 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP aortic aneurysm DOID_3627 0.03170958 0.09066708 0.03170958 0.1316989 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP movement disease DOID_480 0.03170958 0.09021375 0.03170958 0.13074456 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP sarcoidosis DOID_11335 0.03507842 0.09930161 0.25542403 0.46582139 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP atrophic muscular disease DOID_913 0.03507842 0.09881001 0.03507842 0.14155761 MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP muscular dystrophy DOID_9884 0.03507842 0.09881001 0.03507842 0.14155761 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mouth disease DOID_403 4.145E-12 2.358E-09 2.69E-05 1.53E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lymphoma DOID_0060058 5.707E-11 1.624E-08 2.122E-04 4.313E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP middle cerebral artery infarction DOID_3525 1.049E-10 1.99E-08 4.741E-06 4.496E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cystic fibrosis DOID_1485 1.207E-10 1.717E-08 5.441E-03 0.03685344 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pulmonary emphysema DOID_9675 1.864E-10 2.121E-08 6.573E-04 8.501E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP neurotic disorder DOID_4964 2.546E-10 2.414E-08 1.609E-06 1.831E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP influenza DOID_8469 3.499E-10 2.844E-08 0.06692652 0.21274408 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP transitional cell carcinoma DOID_2671 5.865E-10 4.172E-08 1.292E-07 7.352E-05 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP brain infarction DOID_3454 8.631E-10 5.457E-08 4.579E-04 6.68E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pancreatic ductal carcinoma DOID_3587 1.143E-09 6.504E-08 0.02825466 0.11734964 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pancreatic carcinoma DOID_4905 1.715E-09 8.87E-08 0.03132009 0.12729379 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP thyroid cancer DOID_1781 1.905E-09 9.033E-08 2.561E-05 1.619E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pancreatitis DOID_4989 2.865E-09 1.254E-07 7.916E-04 9.583E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bacterial pneumonia DOID_874 2.865E-09 1.165E-07 5.949E-03 0.036396 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP metabolic syndrome X DOID_14221 3.664E-09 1.39E-07 8.854E-04 0.01049578 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP glioblastoma DOID_3068 3.987E-09 1.418E-07 0.10454 0.27161305 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP intracranial arterial disease DOID_13089 4.352E-09 1.457E-07 4.157E-05 1.82E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cerebral arterial disease DOID_3527 4.352E-09 1.457E-07 4.157E-05 1.82E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP melancholia DOID_2848 4.628E-09 1.463E-07 2.039E-05 1.45E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP carotid artery disease DOID_3407 6.184E-09 1.852E-07 0.02006982 0.09284332 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP primary bacterial infectious disease DOID_0050338 8.238E-09 2.344E-07 1.28E-03 0.01324104 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cerebral infarction DOID_3526 1.089E-08 2.951E-07 7.128E-05 2.704E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP encephalomyelitis DOID_640 1.561E-08 4.037E-07 1.71E-03 0.01677782 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP amnestic disorder DOID_10914 1.766E-08 4.37E-07 0.01377264 0.06874241 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP astrocytoma DOID_3069 1.794E-08 4.254E-07 0.13715706 0.30846786 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP integumentary system benign neoplasm DOID_0060121 2.105E-08 4.791E-07 1.051E-04 2.846E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pulmonary tuberculosis DOID_2957 2.105E-08 4.607E-07 1.239E-03 0.01305602 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP skin benign neoplasm DOID_3165 2.105E-08 4.791E-07 1.051E-04 2.846E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP male reproductive system disease DOID_48 2.294E-08 4.834E-07 4.513E-03 0.03209889 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pleural disease DOID_1532 2.426E-08 4.93E-07 0.03949592 0.14982118 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP B-cell lymphocytic neoplasm DOID_707 2.865E-08 5.622E-07 1.26E-04 2.987E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP thyroid carcinoma DOID_3963 3.658E-08 6.937E-07 3.36E-04 5.794E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP endogenous depression DOID_1595 3.667E-08 6.731E-07 7.551E-05 2.527E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP giant cell tumor DOID_200 3.851E-08 6.848E-07 0.3973111 0.65909626 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP malignant giant cell tumor DOID_2705 3.851E-08 6.848E-07 0.3973111 0.65909626 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP giant cell glioblastoma DOID_3074 3.851E-08 6.848E-07 0.3973111 0.65909626 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP aneurysm disease DOID_2403 4.106E-08 7.08E-07 5.691E-03 0.03721962 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bone marrow cancer DOID_4960 4.445E-08 7.439E-07 0.01475477 0.07237467 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP integumentary system cancer DOID_0060122 5.116E-08 8.318E-07 1.862E-03 0.0173645 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP skin cancer DOID_4159 5.116E-08 8.318E-07 1.862E-03 0.0173645 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mental depression DOID_1596 7.835E-08 1.238E-06 1.22E-04 3.018E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP peptic ulcer DOID_750 9.222E-08 1.418E-06 6.389E-03 0.03867215 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP portal hypertension DOID_10762 1.003E-07 1.501E-06 1.609E-03 0.01605761 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP congenital heart defect DOID_1682 1.44E-07 2.101E-06 2.924E-05 1.386E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP nervous system cancer DOID_3093 1.564E-07 2.225E-06 9.667E-03 0.05140643 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP endocrine pancreas disease DOID_1428 1.623E-07 2.252E-06 3.497E-04 5.853E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hyperinsulinism DOID_2018 1.774E-07 2.403E-06 5.791E-05 2.353E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP allergic contact dermatitis DOID_3042 2.295E-07 3.036E-06 2.295E-07 6.528E-05 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP chronic myeloid leukemia DOID_8552 2.302E-07 2.977E-06 2.302E-07 4.367E-05 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP dilated cardiomyopathy DOID_12930 2.474E-07 3.129E-06 2.519E-04 4.777E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pleurisy DOID_10247 2.508E-07 3.103E-06 0.0297316 0.12258898 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hepatic vascular disease DOID_272 2.508E-07 3.037E-06 2.446E-03 0.02141234 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP tuberculosis DOID_399 2.566E-07 3.042E-06 3.892E-03 0.02875885 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP myeloma DOID_0070004 3.21E-07 3.728E-06 0.07453975 0.23303912 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP thyroid adenoma DOID_2891 3.21E-07 3.653E-06 1.069E-03 0.01147653 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lung small cell carcinoma DOID_5409 4.234E-07 4.724E-06 1.051E-04 2.717E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP diabetic retinopathy DOID_8947 4.373E-07 4.786E-06 0.14951416 0.32720599 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP abdominal aortic aneurysm DOID_7693 4.574E-07 4.91E-06 0.03546016 0.13915058 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP aortic aneurysm DOID_3627 4.841E-07 5.101E-06 0.01212673 0.0616081 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP allergic rhinitis DOID_4481 5.512E-07 5.702E-06 0.2645992 0.46612057 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP withdrawal disorder DOID_0060001 5.519E-07 5.608E-06 9.099E-06 7.396E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP dissociative disorder DOID_10935 5.994E-07 5.984E-06 0.01246878 0.06278529 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP dissociative amnesia DOID_11037 5.994E-07 5.984E-06 0.01246878 0.06278529 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP papilloma DOID_2615 7.863E-07 7.714E-06 3.018E-04 5.367E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP contact dermatitis DOID_2773 7.889E-07 7.608E-06 7.889E-07 1.122E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP periodontal disease DOID_3388 9.314E-07 8.832E-06 0.04369641 0.1563727 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP chronic kidney failure DOID_784 1.041E-06 9.706E-06 0.04151345 0.1533841 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP retinal vascular disease DOID_2462 1.244E-06 1.142E-05 0.18449795 0.37492619 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hypersensitivity reaction type IV disease DOID_2916 1.288E-06 1.163E-05 0.10454 0.27285898 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP multiple myeloma DOID_9538 1.503E-06 1.336E-05 0.05029045 0.17663745 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP respiratory failure DOID_11162 1.993E-06 1.745E-05 0.11614074 0.28984246 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP familial adenomatous polyposis DOID_0050424 2.019E-06 1.741E-05 4.205E-03 0.03067549 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mineral metabolism disease DOID_0050032 2.452E-06 2.082E-05 0.02262903 0.10218983 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Crohn's disease DOID_8778 2.632E-06 2.202E-05 0.05594542 0.18836061 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hyperglycemia DOID_4195 2.996E-06 2.47E-05 0.02442916 0.10610835 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP tooth disease DOID_1091 3.303E-06 2.685E-05 0.02535741 0.10930581 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP ulcerative colitis DOID_8577 3.58E-06 2.869E-05 0.22710286 0.42367714 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP endocrine organ benign neoplasm DOID_0060089 3.636E-06 2.874E-05 3.892E-03 0.02913726 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP myositis DOID_633 3.923E-06 3.058E-05 0.21654462 0.41626313 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP biliary tract disease DOID_9741 5.262E-06 4.046E-05 0.14640379 0.32163613 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pre-eclampsia DOID_10591 5.77E-06 4.377E-05 1.069E-03 0.01169723 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP neuritis DOID_1803 5.77E-06 4.32E-05 0.010348 0.05451861 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP viral pneumonia DOID_10533 5.996E-06 4.431E-05 0.11884177 0.29273145 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP polycystic kidney disease DOID_898 5.996E-06 4.374E-05 6.835E-03 0.0400922 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mixed glioma DOID_5076 8.105E-06 5.838E-05 5.949E-03 0.03679161 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP oral submucous fibrosis DOID_5773 8.118E-06 5.774E-05 0.12677049 0.29085649 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP varicose veins DOID_799 8.118E-06 5.703E-05 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP orofacial cleft DOID_0050567 1.014E-05 7.033E-05 1.376E-04 3.131E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP female reproductive system disease DOID_229 1.035E-05 7.097E-05 0.03912034 0.14939245 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP vein disease DOID_866 1.075E-05 7.28E-05 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP sarcoidosis DOID_11335 1.127E-05 7.542E-05 0.3973111 0.66102344 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP parasitic protozoa infectious disease DOID_2789 1.383E-05 9.154E-05 0.09606346 0.26153163 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bladder disease DOID_365 1.487E-05 9.726E-05 0.27121988 0.47484342 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bile duct cancer DOID_4606 1.855E-05 1.2E-04 0.10454 0.27037845 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bile duct carcinoma DOID_4897 1.855E-05 1.2E-04 0.10454 0.27037845 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pneumoconiosis DOID_10316 1.968E-05 1.258E-04 0.04369641 0.15937987 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP esophageal disease DOID_6050 1.968E-05 1.244E-04 0.28428349 0.48869276 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Human immunodeficiency virus infectious disease DOID_526 2.039E-05 1.275E-04 1.484E-03 0.01507443 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP leishmaniasis DOID_9065 2.24E-05 1.386E-04 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP neuroectodermal tumor DOID_171 2.449E-05 1.499E-04 2.822E-04 5.18E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP collagen disease DOID_854 2.449E-05 1.483E-04 0.02006982 0.09209459 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.69E-05 1.611E-04 1.791E-03 0.01727354 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP esophagitis DOID_11963 2.781E-05 1.648E-04 0.16535973 0.34719441 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP colon carcinoma DOID_1520 2.781E-05 1.631E-04 2.781E-05 1.438E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cleft palate DOID_674 2.905E-05 1.687E-04 4.552E-04 6.816E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cholestasis DOID_13580 3.469E-05 1.994E-04 0.12504428 0.2989504 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP parasitic infectious disease DOID_1398 3.469E-05 1.974E-04 0.12504428 0.29769957 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP uterine disease DOID_345 3.469E-05 1.955E-04 0.12504428 0.29522903 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP respiratory syncytial virus infectious disease DOID_1273 3.701E-05 2.065E-04 0.05487194 0.18695887 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP adult respiratory distress syndrome DOID_11394 4.157E-05 2.297E-04 0.0572158 0.19150464 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lymphatic system disease DOID_75 4.157E-05 2.274E-04 6.823E-03 0.04086461 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP blood coagulation disease DOID_1247 5.196E-05 2.816E-04 0.02825466 0.1182125 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bile duct disease DOID_4138 5.613E-05 3.013E-04 0.14330715 0.31605336 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP rheumatic disease DOID_1575 5.791E-05 3.079E-04 0.06445013 0.21075934 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP primitive neuroectodermal tumor DOID_168 5.791E-05 3.051E-04 7.791E-04 9.637E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP scleroderma DOID_419 5.791E-05 3.079E-04 0.06445013 0.21075934 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cataract DOID_83 7.128E-05 3.721E-04 7.128E-05 2.535E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP learning disability DOID_8927 7.128E-05 3.687E-04 9.252E-03 0.05013936 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP leukodystrophy DOID_10579 7.88E-05 4.039E-04 0.07197208 0.22751175 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP proteinuria DOID_576 7.88E-05 4.003E-04 0.07197208 0.22625478 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bone resorption disease DOID_0080011 8.11E-05 4.084E-04 0.03455266 0.136531 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP osteoporosis DOID_11476 8.11E-05 4.084E-04 0.03455266 0.136531 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP brachydactyly DOID_0050581 8.26E-05 4.123E-04 8.26E-05 2.611E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP childhood type dermatomyositis DOID_14203 8.26E-05 4.087E-04 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP retinal vascular occlusion DOID_1729 8.26E-05 4.052E-04 0.08640257 0.25605762 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Paget's disease of bone DOID_5408 8.26E-05 4.017E-04 8.26E-05 2.474E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lens disease DOID_110 8.691E-05 4.191E-04 8.691E-05 2.473E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP brain cancer DOID_1319 8.691E-05 4.156E-04 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP central nervous system cancer DOID_3620 9.565E-05 4.536E-04 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cystitis DOID_1679 9.584E-05 4.507E-04 0.21654462 0.41909486 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cleft lip DOID_9296 9.584E-05 4.47E-04 1.798E-03 0.01704795 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP glaucoma DOID_1686 1.051E-04 4.86E-04 0.07976119 0.24400064 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP chromosomal disease DOID_0080014 1.069E-04 4.904E-04 9.353E-04 0.01086111 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP seminoma DOID_4440 1.11E-04 5.054E-04 2E-03 0.01806415 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP dermatomyositis DOID_10223 1.128E-04 5.095E-04 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP calcium metabolism disease DOID_10575 1.151E-04 5.159E-04 0.08241353 0.25076629 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP biliary tract cancer DOID_4607 1.22E-04 5.422E-04 0.17804598 0.36973781 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP diffuse large B-cell lymphoma DOID_0050745 1.279E-04 5.641E-04 0.02791256 0.1194154 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP gestational diabetes DOID_11714 1.279E-04 5.597E-04 2.216E-03 0.01970247 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP periodontitis DOID_824 1.279E-04 5.555E-04 0.23058534 0.42737153 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP perinatal necrotizing enterocolitis DOID_8677 1.279E-04 5.512E-04 0.02791256 0.11764628 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP coronary stenosis DOID_4248 1.465E-04 6.268E-04 2.446E-03 0.02077316 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bile duct adenocarcinoma DOID_4896 1.631E-04 6.928E-04 0.40274016 0.66616032 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cholangiocarcinoma DOID_4947 1.631E-04 6.928E-04 0.40274016 0.66616032 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pustulosis of palm and sole DOID_4398 1.772E-04 7.47E-04 0.40812045 0.67115762 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP berylliosis DOID_10322 1.93E-04 8.073E-04 0.11084126 0.28409314 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Hirschsprung's disease DOID_10487 1.93E-04 8.014E-04 1.93E-04 4.223E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP congenital nervous system abnormality DOID_2490 2.082E-04 8.583E-04 2.082E-04 4.387E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bronchiolitis obliterans DOID_2799 2.142E-04 8.767E-04 0.25791854 0.45576289 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lymphoblastic leukemia DOID_1037 2.249E-04 9.139E-04 0.21060493 0.41039111 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Charcot-Marie-Tooth disease DOID_10595 2.41E-04 9.726E-04 3.511E-03 0.02736592 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP germinoma DOID_3304 2.41E-04 9.657E-04 3.511E-03 0.02699611 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Legionnaires' disease DOID_10457 2.439E-04 9.707E-04 0.11884177 0.29400419 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP legionellosis DOID_10458 2.439E-04 9.707E-04 0.11884177 0.29400419 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP megacolon DOID_11372 2.439E-04 9.639E-04 2.439E-04 4.786E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hypercalcemia DOID_12678 2.439E-04 9.573E-04 6.835E-03 0.04050983 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP chronic leukemia DOID_1036 2.702E-04 1.053E-03 0.27121988 0.47630899 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP chronic lymphocytic leukemia DOID_1040 2.702E-04 1.053E-03 0.27121988 0.47630899 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hereditary spastic paraplegia DOID_2476 2.702E-04 1.046E-03 3.815E-03 0.02894113 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP intermediate coronary syndrome DOID_8805 3.029E-04 1.165E-03 0.12677049 0.28968839 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP spindle cell carcinoma DOID_4015 3.36E-04 1.283E-03 0.28428349 0.49017365 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP paraplegia DOID_607 3.36E-04 1.275E-03 4.469E-03 0.03218966 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP restrictive cardiomyopathy DOID_397 3.703E-04 1.395E-03 8.907E-03 0.04872954 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP tongue cancer DOID_8649 3.703E-04 1.386E-03 0.13462808 0.30398166 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Barrett's esophagus DOID_9206 3.703E-04 1.377E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP aplastic anemia DOID_12449 3.729E-04 1.378E-03 0.0458562 0.1630761 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP medullomyoblastoma DOID_3861 3.729E-04 1.369E-03 3.729E-04 6.062E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP adult medulloblastoma DOID_3864 3.729E-04 1.369E-03 3.729E-04 6.062E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP childhood medulloblastoma DOID_3869 3.729E-04 1.369E-03 3.729E-04 6.062E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cerebral degeneration DOID_1443 3.747E-04 1.367E-03 0.12504428 0.29645915 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP temporal lobe epilepsy DOID_3328 4.01E-04 1.453E-03 0.02442916 0.10692457 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hyperostosis DOID_205 4.467E-04 1.609E-03 4.467E-04 7.06E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pulmonary sarcoidosis DOID_13406 4.552E-04 1.629E-03 0.3034424 0.51386525 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP medulloblastoma DOID_3858 4.552E-04 1.619E-03 4.552E-04 7E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP peripheral nervous system neoplasm DOID_1192 5.009E-04 1.77E-03 5.009E-04 7.125E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP prion disease DOID_649 5.325E-04 1.87E-03 0.1501324 0.32235975 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hepatitis DOID_2237 5.497E-04 1.919E-03 0.31593005 0.53342492 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP systemic scleroderma DOID_418 5.497E-04 1.907E-03 0.05487194 0.18584602 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP conduct disorder DOID_12995 6.281E-04 2.166E-03 6.281E-04 8.717E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP testicular cancer DOID_2998 6.281E-04 2.153E-03 6.281E-04 8.509E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP psoriasis DOID_8893 6.281E-04 2.14E-03 6.281E-04 8.311E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP benign mesothelioma DOID_2645 6.573E-04 2.226E-03 0.05959399 0.19829812 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP syndrome DOID_225 7.054E-04 2.375E-03 5.441E-03 0.03641987 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP endometriosis of uterus DOID_288 7.164E-04 2.398E-03 0.06200569 0.2039378 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP subependymal glioma DOID_4843 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pilocytic astrocytoma DOID_4851 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP subependymal giant cell astrocytoma DOID_5077 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP colonic disease DOID_5353 7.34E-04 2.428E-03 7.34E-04 9.281E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP fibrillary astrocytoma DOID_6726 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP juvenile pilocytic astrocytoma DOID_6811 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP childhood pilocytic astrocytoma DOID_6812 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP gemistocytic astrocytoma DOID_7005 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP childhood cerebral astrocytoma DOID_7007 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP protoplasmic astrocytoma DOID_7008 7.34E-04 2.442E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Huntington's disease DOID_12858 7.791E-04 2.563E-03 8.228E-03 0.04589964 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP endometriosis DOID_289 7.791E-04 2.548E-03 0.06445013 0.20836435 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP uveal disease DOID_3480 7.791E-04 2.533E-03 8.228E-03 0.04545401 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP electroclinical syndrome DOID_0050701 7.916E-04 2.559E-03 5.949E-03 0.03719591 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP diabetic autonomic neuropathy DOID_11503 8.456E-04 2.718E-03 0.06692652 0.21514797 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autonomic neuropathy DOID_11504 8.456E-04 2.718E-03 0.06692652 0.21514797 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP diabetic polyneuropathy DOID_12785 8.456E-04 2.718E-03 0.06692652 0.21514797 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP diabetic neuropathy DOID_9743 8.456E-04 2.718E-03 0.06692652 0.21514797 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP coronary restenosis DOID_4247 8.507E-04 2.719E-03 0.01513285 0.07359481 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mitochondrial myopathy DOID_699 8.507E-04 2.704E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lipid metabolism disorder DOID_3146 8.854E-04 2.799E-03 0.037951 0.14590623 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP benign glioma DOID_0060101 9.785E-04 3.076E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP gastric ulcer DOID_10808 9.785E-04 3.059E-03 0.18031502 0.37173639 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP benign ependymoma DOID_4844 9.785E-04 3.076E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP muscular atrophy DOID_767 9.785E-04 3.042E-03 9.785E-04 0.01113486 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP spinocerebellar degeneration DOID_2478 9.904E-04 3.063E-03 9.904E-04 0.01105004 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP alcohol abuse DOID_1574 1.041E-03 3.203E-03 0.04151345 0.15540231 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP focal epilepsy DOID_2234 1.041E-03 3.186E-03 0.04151345 0.15438661 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autonomic nervous system disease DOID_11465 1.069E-03 3.253E-03 0.07453975 0.23176568 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP heart valve disease DOID_4079 1.069E-03 3.235E-03 0.36368778 0.6086422 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bone marrow disease DOID_4961 1.069E-03 3.218E-03 0.07453975 0.23050608 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP IgA glomerulonephritis DOID_2986 1.118E-03 3.347E-03 0.18769216 0.38005992 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP urinary tract obstruction DOID_5200 1.118E-03 3.33E-03 0.01801787 0.08543471 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hemolytic anemia DOID_583 1.152E-03 3.413E-03 0.36941881 0.61642025 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP normocytic anemia DOID_720 1.152E-03 3.413E-03 0.36941881 0.61642025 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.239E-03 3.653E-03 0.07976119 0.24531956 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Lewy body dementia DOID_12217 1.269E-03 3.722E-03 0.01954049 0.09188876 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Goodpasture syndrome DOID_9808 1.269E-03 3.703E-03 0.1950031 0.38660894 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP amino acid metabolic disorder DOID_9252 1.413E-03 4.103E-03 9.311E-03 0.04998151 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hemorrhagic disease DOID_2213 1.427E-03 4.122E-03 0.08509266 0.25617842 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP acute pancreatitis DOID_2913 1.432E-03 4.117E-03 0.0211151 0.09611595 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP vasculitis DOID_865 1.745E-03 4.991E-03 0.09328397 0.26807362 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hypersensitivity reaction type I disease DOID_1205 1.875E-03 5.334E-03 0.21719101 0.41470364 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP familial hyperlipidemia DOID_1168 1.983E-03 5.614E-03 0.0988664 0.26661128 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP vitiligo DOID_12306 2E-03 5.634E-03 2E-03 0.01835551 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP extrinsic allergic alveolitis DOID_841 2E-03 5.606E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Sciatic Neuropathy DOID_11446 2.216E-03 6.181E-03 0.02791256 0.11852424 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lesion of sciatic nerve DOID_12528 2.216E-03 6.181E-03 0.02791256 0.11852424 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mononeuritis of lower limb DOID_9473 2.216E-03 6.181E-03 0.02791256 0.11852424 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hypertrophic cardiomyopathy DOID_11984 2.242E-03 6.223E-03 0.10454 0.2741164 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP leukocyte disease DOID_9500 2.38E-03 6.574E-03 0.42916267 0.69969501 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP renal hypertension DOID_1073 2.446E-03 6.724E-03 0.23751133 0.43735906 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP secondary hypertension DOID_11130 2.446E-03 6.724E-03 0.23751133 0.43735906 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP sarcoma DOID_1115 2.446E-03 6.691E-03 0.23751133 0.43594822 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mononeuritis DOID_1802 2.446E-03 6.659E-03 0.0297316 0.12170705 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP invasive ductal carcinoma DOID_3008 2.446E-03 6.628E-03 2.446E-03 0.02108791 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mononeuropathy DOID_1188 2.69E-03 7.255E-03 0.03159652 0.12660859 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP supratentorial cancer DOID_1659 2.69E-03 7.22E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP toxic encephalopathy DOID_3602 2.69E-03 7.187E-03 2.69E-03 0.02251089 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cerebrum cancer DOID_368 2.69E-03 7.22E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hypothyroidism DOID_1459 2.828E-03 7.52E-03 2.828E-03 0.0233226 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pre-malignant neoplasm DOID_0060071 2.99E-03 7.912E-03 0.11909023 0.28591704 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP in situ carcinoma DOID_8719 2.99E-03 7.912E-03 0.11909023 0.28591704 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP opportunistic mycosis DOID_2473 3.222E-03 8.489E-03 0.25791854 0.45718271 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP facioscapulohumeral muscular dystrophy DOID_11727 3.461E-03 9.075E-03 3.461E-03 0.02813323 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hyperparathyroidism DOID_13543 3.461E-03 9.034E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP familial combined hyperlipidemia DOID_13809 3.461E-03 8.992E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP rectal neoplasm DOID_1984 3.461E-03 8.951E-03 3.461E-03 0.02773698 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP rectum cancer DOID_1993 3.461E-03 8.951E-03 3.461E-03 0.02773698 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP acute kidney failure DOID_3021 3.461E-03 8.911E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Noonan syndrome DOID_3490 3.461E-03 8.871E-03 3.461E-03 0.02735175 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP keratitis DOID_4677 3.461E-03 8.831E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP visceral leishmaniasis DOID_9146 3.461E-03 8.792E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP celiac disease DOID_10608 3.511E-03 8.879E-03 0.03745699 0.14597965 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP systemic mycosis DOID_0050136 4.134E-03 0.0104084 0.27778113 0.48483885 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP fungal infectious disease DOID_1564 4.134E-03 0.0104084 0.27778113 0.48483885 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 4.205E-03 0.01054048 0.09462232 0.2692005 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP adrenoleukodystrophy DOID_10588 4.205E-03 0.01049425 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pneumocystosis DOID_11339 4.205E-03 0.01044842 0.09462232 0.26392206 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP prediabetes syndrome DOID_11716 4.205E-03 0.01040299 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP nephrosis DOID_2527 4.513E-03 0.0111165 0.48791806 0.79321537 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP peripheral vascular disease DOID_341 4.734E-03 0.01161072 0.49253312 0.79843689 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Seckel syndrome DOID_0050569 5.016E-03 0.01224988 5.016E-03 0.03523731 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP esophageal carcinoma DOID_1107 5.016E-03 0.01219753 5.016E-03 0.03480759 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP esophagus squamous cell carcinoma DOID_3748 5.016E-03 0.01219753 5.016E-03 0.03480759 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP progressive myoclonus epilepsy DOID_891 5.016E-03 0.01214563 5.016E-03 0.03438822 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP embryonal cancer DOID_688 5.571E-03 0.01343261 5.571E-03 0.03686159 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 5.893E-03 0.01414856 5.893E-03 0.03810465 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP variable age at onset electroclinical syndrome DOID_0050706 5.893E-03 0.01408912 5.893E-03 0.03767651 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP leprosy DOID_1024 5.893E-03 0.01403017 5.893E-03 0.03725788 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP parathyroid gland disease DOID_11201 5.893E-03 0.01397171 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP polyneuropathy DOID_1389 5.893E-03 0.01391373 0.11084126 0.28030523 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP uveitis DOID_13141 5.972E-03 0.01404078 0.05256321 0.1823687 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP blood platelet disease DOID_2218 5.972E-03 0.013983 0.05256321 0.18126344 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP open-angle glaucoma DOID_1067 6.835E-03 0.01593829 0.11884177 0.29146968 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP aspergillosis DOID_13564 6.835E-03 0.01587324 0.11884177 0.28897848 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP eyelid disease DOID_530 6.835E-03 0.01580871 0.11884177 0.28774879 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cervix uteri carcinoma in situ DOID_8991 7.274E-03 0.01675639 0.32819447 0.55249305 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bone development disease DOID_0080006 7.66E-03 0.01757487 7.66E-03 0.04447518 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP spinocerebellar ataxia DOID_1441 7.742E-03 0.01769214 7.742E-03 0.04449841 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP idiopathic pulmonary fibrosis DOID_0050156 7.84E-03 0.01784291 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP peripheral neuropathy DOID_0060053 7.84E-03 0.01777182 7.84E-03 0.04460727 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP thoracic aortic aneurysm DOID_14004 7.84E-03 0.0177013 0.12677049 0.29684119 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Williams-Beuren syndrome DOID_1928 7.84E-03 0.01763133 7.84E-03 0.04416562 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mesenchymal cell neoplasm DOID_3350 7.84E-03 0.01756192 0.12677049 0.294418 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP spindle cell sarcoma DOID_4235 7.84E-03 0.01756192 0.12677049 0.294418 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lung oat cell carcinoma DOID_5411 7.84E-03 0.01749305 0.12677049 0.29203405 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP epithelioid sarcoma DOID_6193 7.84E-03 0.01756192 0.12677049 0.294418 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP nephrotic syndrome DOID_1184 8.228E-03 0.01828814 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP gallbladder cancer DOID_3121 8.731E-03 0.01933139 0.34618122 0.58105344 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP silicosis DOID_10325 8.907E-03 0.01964292 0.13462808 0.30641352 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hemolytic-uremic syndrome DOID_12554 8.907E-03 0.01956708 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bronchitis DOID_6132 0.01003462 0.02196039 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP juvenile rheumatoid arthritis DOID_676 0.01003462 0.02187625 0.14241517 0.31653998 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP urinary system benign neoplasm DOID_731 0.01003462 0.02179275 0.14241517 0.31530831 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP vascular skin disease DOID_9540 0.010348 0.02238787 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP carbohydrate metabolic disorder DOID_2978 0.01078694 0.02324912 0.05454644 0.18696942 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP glucose intolerance DOID_10603 0.01122239 0.02409639 0.01122239 0.05858296 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP keratosis DOID_161 0.01122239 0.0240058 0.01122239 0.05805038 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP ureteral obstruction DOID_5199 0.01122239 0.02391589 0.01122239 0.05752741 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Down syndrome DOID_14250 0.01246878 0.0264729 0.15778038 0.33750765 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP granulosa cell tumor DOID_2999 0.01246878 0.02637449 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP pulmonary edema DOID_11396 0.01377264 0.02902457 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP sex cord-gonadal stromal tumor DOID_192 0.01377264 0.02891747 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP brain edema DOID_4724 0.01377264 0.02881116 0.16535973 0.34591796 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP atrophic muscular disease DOID_913 0.01407006 0.02932552 0.01407006 0.06961623 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP muscular dystrophy DOID_9884 0.01407006 0.02932552 0.01407006 0.06961623 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Kawasaki disease DOID_13378 0.01513285 0.03142552 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lymphadenitis DOID_1602 0.01513285 0.03142552 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autoimmune hepatitis DOID_2048 0.01513285 0.03131125 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP lymph node disease DOID_9942 0.01513285 0.03142552 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP osteochondrodysplasia DOID_2256 0.01545803 0.03186819 0.01545803 0.07453915 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP mitochondrial metabolism disease DOID_700 0.01617991 0.03323599 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP thrombophilia DOID_2452 0.01654829 0.03387042 0.18031502 0.36773923 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP placenta disease DOID_780 0.01654829 0.03374902 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP oral cavity cancer DOID_8618 0.01767967 0.03592762 0.4239731 0.69322038 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP muscle cancer DOID_4045 0.01801787 0.03648457 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP uremia DOID_4676 0.01801787 0.0363552 0.01801787 0.08615265 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP polyarteritis nodosa DOID_9810 0.01801787 0.03622673 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP diabetic angiopathy DOID_11713 0.01954049 0.03914979 0.1950031 0.39069283 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP ureteral disease DOID_1426 0.01954049 0.03901242 0.01954049 0.09113557 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP aortic valve disease DOID_62 0.01954049 0.03887601 0.1950031 0.38796072 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP meningitis DOID_9471 0.01954049 0.03874056 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP sphingolipidosis DOID_1927 0.0211151 0.04171699 0.20224843 0.39819847 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP commensal bacterial infectious disease DOID_0050339 0.02274065 0.0447731 0.20942875 0.41091364 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP reading disorder DOID_13365 0.02274065 0.04461871 0.02274065 0.10188525 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hypogonadism DOID_1924 0.02274065 0.04446539 0.20942875 0.40950157 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP bronchiolitis DOID_2942 0.02274065 0.04431311 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP osteosarcoma DOID_3347 0.02274065 0.04416187 0.02274065 0.10108928 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP dyslexia DOID_4428 0.02274065 0.04461871 0.02274065 0.10188525 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP papillary adenoma DOID_3172 0.02441608 0.04725426 0.02441608 0.10769575 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP microcystic adenoma DOID_5403 0.02441608 0.04725426 0.02441608 0.10769575 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP follicular adenoma DOID_6204 0.02441608 0.04725426 0.02441608 0.10769575 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP ankylosing spondylitis DOID_7147 0.02441608 0.04709407 0.21654462 0.41486157 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP intracranial aneurysm DOID_10941 0.02614039 0.0502496 0.22359663 0.42550662 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autoimmune disease of cardiovascular system DOID_0060051 0.0297316 0.05696054 0.23751133 0.43877906 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP Behcet's disease DOID_13241 0.0297316 0.05696054 0.23751133 0.43877906 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autoimmune disease of the nervous system DOID_438 0.0297316 0.05676939 0.23751133 0.43315368 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autoimmune disease of endocrine system DOID_0060005 0.03159652 0.0601285 0.24437516 0.44142688 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP polycystic ovary syndrome DOID_11612 0.03159652 0.05992807 0.03159652 0.12750653 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP cranial nerve disease DOID_5656 0.03159652 0.05972897 0.24437516 0.43726247 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP corneal disease DOID_10124 0.03350636 0.06312953 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP endometrial carcinoma DOID_2871 0.03350636 0.06292118 0.03350636 0.13332251 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP spastic cerebral palsy DOID_0050669 0.03546016 0.06637116 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP gonadal disease DOID_2277 0.03546016 0.06615355 0.25791854 0.45861141 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP endometrial cancer DOID_1380 0.03745699 0.06965042 0.03745699 0.14498659 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP autonomic nervous system neoplasm DOID_2621 0.03949592 0.07320253 0.03949592 0.14882899 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP neuroblastoma DOID_769 0.03949592 0.07320253 0.03949592 0.14882899 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP auditory system disease DOID_2742 0.04030785 0.07446482 0.17483345 0.36439645 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP myocarditis DOID_820 0.04157602 0.07655909 0.27778113 0.48188252 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP metal metabolism disorder DOID_896 0.04157602 0.07631212 0.04157602 0.15262424 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP male infertility DOID_12336 0.04369641 0.07994617 0.04369641 0.15836471 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hepatitis C DOID_1883 0.04369641 0.07968993 0.04369641 0.1573624 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP nephroblastoma DOID_2154 0.04369641 0.07943533 0.28428349 0.49166354 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP hyperthyroidism DOID_7998 0.04369641 0.07918235 0.28428349 0.4872208 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP adenoma DOID_657 0.0480545 0.0868032 0.0480545 0.16983235 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP primary immunodeficiency disease DOID_612 0.04912255 0.08845169 0.19749794 0.39019559 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP adolescence-adult electroclinical syndrome DOID_0050705 0.05029045 0.09026898 0.3034424 0.51539918 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP calcinosis DOID_182 0.05029045 0.08998512 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP microcephaly DOID_10907 0.05256321 0.09375695 0.05256321 0.18348753 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP congenital diaphragmatic hernia DOID_3827 0.05487194 0.09756916 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS colon carcinoma DOID_1520 4.078E-07 2.321E-04 0.0146719 0.46379521 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS adenoid cystic carcinoma DOID_4866 4.365E-06 1.242E-03 4.662E-04 0.13262808 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS salivary gland cancer DOID_8850 5.014E-06 9.51E-04 5.106E-04 0.09684898 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS neuritis DOID_1803 6.909E-06 9.828E-04 0.03629124 0.57360317 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS oral cavity cancer DOID_8618 1.262E-05 1.436E-03 9.37E-04 0.10663268 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS invasive lobular carcinoma DOID_3457 2.881E-05 2.732E-03 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS transitional cell carcinoma DOID_2671 4.06E-05 3.3E-03 0.06440654 0.64293548 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS Human immunodeficiency virus infectious disease DOID_526 4.336E-05 3.084E-03 2.113E-03 0.17177913 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS alcohol-related neurodevelopmental disorder DOID_0050667 4.923E-05 3.112E-03 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS testicular cancer DOID_2998 8.925E-05 5.079E-03 0.01394327 0.4666893 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS acquired immunodeficiency syndrome DOID_635 1.204E-04 6.228E-03 0.01612763 0.48297994 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS bronchiolitis DOID_2942 1.691E-04 8.018E-03 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS cleft lip DOID_9296 1.825E-04 7.989E-03 1.825E-04 0.10386253 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS seminoma DOID_4440 1.965E-04 7.986E-03 0.02048235 0.52974818 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS germinoma DOID_3304 2.908E-04 0.0110315 0.0248185 0.486956 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS macular degeneration DOID_4448 3.448E-04 0.01226089 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS multiple myeloma DOID_9538 4.032E-04 0.01349641 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS uveitis DOID_13141 4.237E-04 0.01339417 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS respiratory syncytial virus infectious disease DOID_1273 4.447E-04 0.01331759 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS uveal disease DOID_3480 5.336E-04 0.01518075 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS leukodystrophy DOID_10579 6.055E-04 0.01640499 0.03557802 0.59540864 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS myeloma DOID_0070004 6.304E-04 0.01630434 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS glaucoma DOID_1686 6.817E-04 0.01686587 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS pulmonary tuberculosis DOID_2957 6.817E-04 0.01616313 0.03771615 0.58001316 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS orofacial cleft DOID_0050567 7.625E-04 0.01735341 7.625E-04 0.10845883 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS bone marrow cancer DOID_4960 8.187E-04 0.01791685 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS congenital heart defect DOID_1682 1.096E-03 0.02309308 1.096E-03 0.10391888 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS cerebral degeneration DOID_1443 1.163E-03 0.0236275 0.0490425 0.66440916 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS tuberculosis DOID_399 1.267E-03 0.0248517 0.05115184 0.63272597 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS diabetic retinopathy DOID_8947 1.449E-03 0.02748913 0.05465737 0.62200083 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS retinal vascular disease DOID_2462 1.893E-03 0.03474442 0.06232563 0.64478697 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS primary bacterial infectious disease DOID_0050338 1.98E-03 0.03520106 0.0637134 0.64737365 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS nervous system cancer DOID_3093 2.113E-03 0.036438 1.000 1.000 MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS encephalomyelitis DOID_640 2.251E-03 0.03767194 1.000 1.000 MARKS_HDAC_TARGETS_DN leishmaniasis DOID_9065 6.127E-11 3.486E-08 1.000 1.000 MARKS_HDAC_TARGETS_DN sarcoma DOID_1115 4.321E-10 1.229E-07 0.01180655 0.13710053 MARKS_HDAC_TARGETS_DN multiple myeloma DOID_9538 1.438E-09 2.727E-07 4.907E-07 4.654E-05 MARKS_HDAC_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 2.133E-09 3.035E-07 6.572E-07 5.342E-05 MARKS_HDAC_TARGETS_DN myeloma DOID_0070004 3.614E-09 4.113E-07 9.712E-07 6.908E-05 MARKS_HDAC_TARGETS_DN retinal vascular occlusion DOID_1729 6.003E-09 5.693E-07 1.000 1.000 MARKS_HDAC_TARGETS_DN cutaneous leishmaniasis DOID_9111 6.003E-09 4.879E-07 1.000 1.000 MARKS_HDAC_TARGETS_DN visceral leishmaniasis DOID_9146 6.003E-09 4.27E-07 1.000 1.000 MARKS_HDAC_TARGETS_DN bone marrow cancer DOID_4960 6.189E-09 3.913E-07 1.447E-06 8.236E-05 MARKS_HDAC_TARGETS_DN parasitic protozoa infectious disease DOID_2789 6.646E-09 3.781E-07 1.000 1.000 MARKS_HDAC_TARGETS_DN pre-malignant neoplasm DOID_0060071 1.127E-08 5.829E-07 2.259E-06 1.071E-04 MARKS_HDAC_TARGETS_DN in situ carcinoma DOID_8719 1.127E-08 5.829E-07 2.259E-06 1.071E-04 MARKS_HDAC_TARGETS_DN parasitic infectious disease DOID_1398 1.273E-08 6.035E-07 1.000 1.000 MARKS_HDAC_TARGETS_DN uterine disease DOID_345 1.273E-08 5.571E-07 0.02657476 0.20713754 MARKS_HDAC_TARGETS_DN tuberculosis DOID_399 1.517E-08 6.167E-07 1.000 1.000 MARKS_HDAC_TARGETS_DN lung oat cell carcinoma DOID_5411 2.273E-08 8.624E-07 5.92E-03 0.09103436 MARKS_HDAC_TARGETS_DN female reproductive system disease DOID_229 2.862E-08 1.018E-06 0.03234741 0.23903477 MARKS_HDAC_TARGETS_DN urinary system benign neoplasm DOID_731 3.396E-08 1.137E-06 3.396E-08 1.932E-05 MARKS_HDAC_TARGETS_DN primary bacterial infectious disease DOID_0050338 3.797E-08 1.2E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN transitional cell carcinoma DOID_2671 3.973E-08 1.19E-06 3.973E-08 1.13E-05 MARKS_HDAC_TARGETS_DN lymphoma DOID_0060058 4.737E-08 1.348E-06 4.737E-08 8.984E-06 MARKS_HDAC_TARGETS_DN mouth disease DOID_403 5.158E-08 1.398E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN Crohn's disease DOID_8778 5.158E-08 1.334E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 5.378E-08 1.331E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN pulmonary edema DOID_11396 5.689E-08 1.349E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN ulcerative colitis DOID_8577 6.083E-08 1.384E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN Kawasaki disease DOID_13378 6.636E-08 1.452E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN lymphadenitis DOID_1602 6.636E-08 1.452E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN mitochondrial myopathy DOID_699 6.636E-08 1.398E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN lymph node disease DOID_9942 6.636E-08 1.452E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN polyarteritis nodosa DOID_9810 8.832E-08 1.795E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN bronchiolitis DOID_2942 1.296E-07 2.542E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN extrinsic allergic alveolitis DOID_841 1.632E-07 3.095E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN pleurisy DOID_10247 2.021E-07 3.71E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN pleural disease DOID_1532 3.255E-07 5.787E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN papilloma DOID_2615 3.55E-07 6.121E-06 3.55E-07 5.05E-05 MARKS_HDAC_TARGETS_DN pneumoconiosis DOID_10316 3.862E-07 6.463E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN spindle cell carcinoma DOID_4015 3.862E-07 6.279E-06 3.862E-07 4.395E-05 MARKS_HDAC_TARGETS_DN peptic ulcer DOID_750 5.699E-07 9.008E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN lymphatic system disease DOID_75 6.125E-07 9.42E-06 1.000 1.000 MARKS_HDAC_TARGETS_DN rheumatic disease DOID_1575 7.529E-07 1.127E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN scleroderma DOID_419 7.529E-07 1.127E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN influenza DOID_8469 8.04E-07 1.173E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN proteinuria DOID_576 9.131E-07 1.299E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN brain cancer DOID_1319 9.712E-07 1.348E-05 1.77E-04 4.029E-03 MARKS_HDAC_TARGETS_DN thyroid adenoma DOID_2891 9.712E-07 1.316E-05 9.712E-07 6.14E-05 MARKS_HDAC_TARGETS_DN vascular skin disease DOID_9540 9.712E-07 1.285E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN central nervous system cancer DOID_3620 1.032E-06 1.334E-05 1.842E-04 4.032E-03 MARKS_HDAC_TARGETS_DN pulmonary tuberculosis DOID_2957 1.095E-06 1.384E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN lung small cell carcinoma DOID_5409 1.095E-06 1.354E-05 0.02038186 0.1757163 MARKS_HDAC_TARGETS_DN calcium metabolism disease DOID_10575 1.16E-06 1.404E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN atopic dermatitis DOID_3310 1.298E-06 1.539E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN giant cell tumor DOID_200 1.372E-06 1.593E-05 0.02193352 0.18353196 MARKS_HDAC_TARGETS_DN malignant giant cell tumor DOID_2705 1.372E-06 1.593E-05 0.02193352 0.18353196 MARKS_HDAC_TARGETS_DN giant cell glioblastoma DOID_3074 1.372E-06 1.593E-05 0.02193352 0.18353196 MARKS_HDAC_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 1.526E-06 1.737E-05 1.526E-06 7.894E-05 MARKS_HDAC_TARGETS_DN pustulosis of palm and sole DOID_4398 1.526E-06 1.703E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN mitochondrial metabolism disease DOID_700 1.607E-06 1.759E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN glioblastoma DOID_3068 1.779E-06 1.91E-05 0.02386988 0.19129521 MARKS_HDAC_TARGETS_DN collagen disease DOID_854 2.058E-06 2.168E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN respiratory failure DOID_11162 2.157E-06 2.231E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN mineral metabolism disease DOID_0050032 2.364E-06 2.402E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN endocrine pancreas disease DOID_1428 2.364E-06 2.36E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN allergic contact dermatitis DOID_3042 2.7E-06 2.648E-05 0.0273463 0.2102709 MARKS_HDAC_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 2.818E-06 2.718E-05 2.818E-06 1.233E-04 MARKS_HDAC_TARGETS_DN astrocytoma DOID_3069 2.94E-06 2.788E-05 0.02811727 0.21331637 MARKS_HDAC_TARGETS_DN peripheral vascular disease DOID_341 3.326E-06 3.103E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN diabetic retinopathy DOID_8947 3.462E-06 3.177E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN cystic fibrosis DOID_1485 3.745E-06 3.382E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN bone resorption disease DOID_0080011 3.892E-06 3.46E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN osteoporosis DOID_11476 3.892E-06 3.46E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN bacterial pneumonia DOID_874 4.042E-06 3.538E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN contact dermatitis DOID_2773 4.355E-06 3.755E-05 0.03196357 0.23930617 MARKS_HDAC_TARGETS_DN biliary tract cancer DOID_4607 4.854E-06 4.122E-05 0.03311468 0.24156734 MARKS_HDAC_TARGETS_DN retinal vascular disease DOID_2462 5.206E-06 4.356E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN nervous system cancer DOID_3093 6.161E-06 5.08E-05 5.992E-04 0.01175656 MARKS_HDAC_TARGETS_DN hyperparathyroidism DOID_13543 6.563E-06 5.335E-05 3.95E-03 0.07491959 MARKS_HDAC_TARGETS_DN childhood type dermatomyositis DOID_14203 6.563E-06 5.26E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 7.003E-06 5.534E-05 7.003E-06 2.846E-04 MARKS_HDAC_TARGETS_DN dermatomyositis DOID_10223 8.02E-06 6.251E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN invasive lobular carcinoma DOID_3457 8.02E-06 6.167E-05 8.02E-06 3.042E-04 MARKS_HDAC_TARGETS_DN bronchiectasis DOID_9563 8.02E-06 6.084E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN peritonitis DOID_8283 9.622E-06 7.204E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN encephalitis DOID_9588 9.622E-06 7.11E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN berylliosis DOID_10322 1.137E-05 8.293E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN parathyroid gland disease DOID_11201 1.137E-05 8.188E-05 5.132E-03 0.08111795 MARKS_HDAC_TARGETS_DN hypercalcemia DOID_12678 1.326E-05 9.431E-05 1.000 1.000 MARKS_HDAC_TARGETS_DN hemangioma DOID_255 1.53E-05 1.075E-04 1.53E-05 5.44E-04 MARKS_HDAC_TARGETS_DN mesenchymal cell neoplasm DOID_3350 1.53E-05 1.061E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN spindle cell sarcoma DOID_4235 1.53E-05 1.061E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN oral submucous fibrosis DOID_5773 1.53E-05 1.049E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN epithelioid sarcoma DOID_6193 1.53E-05 1.061E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN angiosarcoma DOID_0001816 1.748E-05 1.184E-04 6.313E-03 0.09453052 MARKS_HDAC_TARGETS_DN hemolytic-uremic syndrome DOID_12554 1.748E-05 1.17E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN thyroiditis DOID_7166 1.748E-05 1.156E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN autoimmune thyroiditis DOID_7188 1.748E-05 1.156E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN lymphatic system cancer DOID_0060073 1.98E-05 1.295E-04 1.98E-05 6.628E-04 MARKS_HDAC_TARGETS_DN bronchitis DOID_6132 1.98E-05 1.28E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN reticulosarcoma DOID_8538 1.98E-05 1.295E-04 1.98E-05 6.628E-04 MARKS_HDAC_TARGETS_DN lymphosarcoma DOID_8675 1.98E-05 1.295E-04 1.98E-05 6.628E-04 MARKS_HDAC_TARGETS_DN autoimmune hepatitis DOID_2048 3.055E-05 1.953E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN gastric ulcer DOID_10808 3.36E-05 2.124E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN neutropenia DOID_1227 3.36E-05 2.101E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN placenta disease DOID_780 3.36E-05 2.078E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN agranulocytosis DOID_12987 3.679E-05 2.251E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN hypoglycemia DOID_9993 3.679E-05 2.227E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN spastic quadriplegia DOID_10970 4.361E-05 2.612E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN portal hypertension DOID_10762 4.723E-05 2.799E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN urticaria DOID_1555 4.723E-05 2.77E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN cystitis DOID_1679 5.099E-05 2.961E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN papillary adenoma DOID_3172 5.099E-05 2.931E-04 5.099E-05 1.612E-03 MARKS_HDAC_TARGETS_DN microcystic adenoma DOID_5403 5.099E-05 2.931E-04 5.099E-05 1.612E-03 MARKS_HDAC_TARGETS_DN follicular adenoma DOID_6204 5.099E-05 2.931E-04 5.099E-05 1.612E-03 MARKS_HDAC_TARGETS_DN myositis DOID_633 5.099E-05 2.902E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN periodontitis DOID_824 5.896E-05 3.322E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN hepatic vascular disease DOID_272 6.316E-05 3.523E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 6.75E-05 3.729E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 7.198E-05 3.938E-04 7.198E-05 2.156E-03 MARKS_HDAC_TARGETS_DN uterine benign neoplasm DOID_0060095 7.198E-05 3.938E-04 7.198E-05 2.156E-03 MARKS_HDAC_TARGETS_DN uterine fibroid DOID_13223 7.198E-05 3.938E-04 7.198E-05 2.156E-03 MARKS_HDAC_TARGETS_DN spastic cerebral palsy DOID_0050669 7.66E-05 4.151E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN bronchiolitis obliterans DOID_2799 7.66E-05 4.112E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN leiomyoma DOID_127 8.629E-05 4.588E-04 8.629E-05 2.455E-03 MARKS_HDAC_TARGETS_DN bladder disease DOID_365 8.629E-05 4.546E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN nephroblastoma DOID_2154 9.654E-05 5.039E-04 9.654E-05 2.616E-03 MARKS_HDAC_TARGETS_DN periodontal disease DOID_3388 9.654E-05 4.994E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN leukopenia DOID_615 9.654E-05 4.949E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN adenoma DOID_657 1.074E-04 5.454E-04 1.074E-04 2.777E-03 MARKS_HDAC_TARGETS_DN embryonal cancer DOID_688 1.13E-04 5.689E-04 1.13E-04 2.795E-03 MARKS_HDAC_TARGETS_DN respiratory syncytial virus infectious disease DOID_1273 1.247E-04 6.222E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN hepatitis DOID_2237 1.247E-04 6.168E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN congenital diaphragmatic hernia DOID_3827 1.247E-04 6.115E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN systemic scleroderma DOID_418 1.247E-04 6.063E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN adult respiratory distress syndrome DOID_11394 1.307E-04 6.303E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN intracranial arterial disease DOID_13089 1.307E-04 6.25E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN cerebral arterial disease DOID_3527 1.307E-04 6.25E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN endometriosis of uterus DOID_288 1.432E-04 6.792E-04 0.01766091 0.16748431 MARKS_HDAC_TARGETS_DN endometriosis DOID_289 1.497E-04 7.04E-04 0.01805005 0.16565287 MARKS_HDAC_TARGETS_DN gallbladder cancer DOID_3121 1.563E-04 7.291E-04 0.01843904 0.16653675 MARKS_HDAC_TARGETS_DN uterine cancer DOID_363 1.563E-04 7.232E-04 1.563E-04 3.706E-03 MARKS_HDAC_TARGETS_DN cerebral infarction DOID_3526 1.631E-04 7.484E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN learning disability DOID_8927 1.631E-04 7.424E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN pre-eclampsia DOID_10591 1.77E-04 7.995E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN hemolytic anemia DOID_583 1.842E-04 8.254E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN normocytic anemia DOID_720 1.842E-04 8.254E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.915E-04 8.515E-04 1.000 1.000 MARKS_HDAC_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 2.066E-04 9.114E-04 2.066E-04 4.354E-03 MARKS_HDAC_TARGETS_DN integumentary system cancer DOID_0060122 2.385E-04 1.044E-03 0.02270849 0.18726279 MARKS_HDAC_TARGETS_DN skin cancer DOID_4159 2.385E-04 1.044E-03 0.02270849 0.18726279 MARKS_HDAC_TARGETS_DN oral cavity cancer DOID_8618 2.638E-04 1.146E-03 2.638E-04 5.361E-03 MARKS_HDAC_TARGETS_DN melancholia DOID_2848 2.725E-04 1.175E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN leukocyte disease DOID_9500 2.725E-04 1.166E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN neurotic disorder DOID_4964 2.814E-04 1.195E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN cholestasis DOID_13580 3.279E-04 1.382E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN temporal lobe epilepsy DOID_3328 3.376E-04 1.412E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN hyperglycemia DOID_4195 3.376E-04 1.402E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN tooth disease DOID_1091 3.474E-04 1.433E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN brain infarction DOID_3454 3.574E-04 1.463E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN bile duct disease DOID_4138 3.882E-04 1.578E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN biliary tract disease DOID_9741 3.988E-04 1.609E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN endogenous depression DOID_1595 4.312E-04 1.728E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN syndrome DOID_225 4.312E-04 1.716E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN mental depression DOID_1596 5.118E-04 2.022E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN focal epilepsy DOID_2234 5.118E-04 2.009E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN encephalomyelitis DOID_640 6.387E-04 2.489E-03 1.000 1.000 MARKS_HDAC_TARGETS_DN leber hereditary optic neuropathy DOID_705 3.556E-03 0.01376328 1.000 1.000 MARKS_HDAC_TARGETS_DN hypolipoproteinemia DOID_1387 3.95E-03 0.0151864 1.000 1.000 MARKS_HDAC_TARGETS_DN rectal neoplasm DOID_1984 3.95E-03 0.01508448 3.95E-03 0.07250282 MARKS_HDAC_TARGETS_DN rectum cancer DOID_1993 3.95E-03 0.01508448 3.95E-03 0.07250282 MARKS_HDAC_TARGETS_DN bilirubin metabolic disorder DOID_2741 3.95E-03 0.01498392 1.000 1.000 MARKS_HDAC_TARGETS_DN acute kidney failure DOID_3021 3.95E-03 0.01488469 1.000 1.000 MARKS_HDAC_TARGETS_DN phagocyte bactericidal dysfunction DOID_3262 3.95E-03 0.01478676 1.000 1.000 MARKS_HDAC_TARGETS_DN chondrosarcoma DOID_3371 3.95E-03 0.01469011 3.95E-03 0.07023711 MARKS_HDAC_TARGETS_DN keratitis DOID_4677 3.95E-03 0.01459472 1.000 1.000 MARKS_HDAC_TARGETS_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 3.95E-03 0.01450056 3.95E-03 0.06810871 MARKS_HDAC_TARGETS_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 3.95E-03 0.01450056 3.95E-03 0.06810871 MARKS_HDAC_TARGETS_DN Hodgkin's granuloma DOID_8651 3.95E-03 0.01450056 3.95E-03 0.06810871 MARKS_HDAC_TARGETS_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 3.95E-03 0.01450056 3.95E-03 0.06810871 MARKS_HDAC_TARGETS_DN adrenoleukodystrophy DOID_10588 4.344E-03 0.01584545 1.000 1.000 MARKS_HDAC_TARGETS_DN sickle cell anemia DOID_10923 4.344E-03 0.01574452 1.000 1.000 MARKS_HDAC_TARGETS_DN prediabetes syndrome DOID_11716 4.344E-03 0.01564487 1.000 1.000 MARKS_HDAC_TARGETS_DN migraine without aura DOID_12783 4.344E-03 0.01554648 1.000 1.000 MARKS_HDAC_TARGETS_DN hemochromatosis DOID_2352 4.344E-03 0.01544931 1.000 1.000 MARKS_HDAC_TARGETS_DN otitis media DOID_10754 4.738E-03 0.01674602 1.000 1.000 MARKS_HDAC_TARGETS_DN intracranial arteriosclerosis DOID_13097 4.738E-03 0.01664265 1.000 1.000 MARKS_HDAC_TARGETS_DN middle ear disease DOID_5100 4.738E-03 0.01674602 1.000 1.000 MARKS_HDAC_TARGETS_DN stomach disease DOID_76 4.738E-03 0.01654055 1.000 1.000 MARKS_HDAC_TARGETS_DN Hodgkin's lymphoma DOID_8567 4.738E-03 0.01643969 4.738E-03 0.07929734 MARKS_HDAC_TARGETS_DN vascular dementia DOID_8725 4.738E-03 0.01664265 1.000 1.000 MARKS_HDAC_TARGETS_DN mitochondrial encephalomyopathy DOID_890 4.738E-03 0.01634006 1.000 1.000 MARKS_HDAC_TARGETS_DN ocular hypertension DOID_9282 4.738E-03 0.01624162 4.738E-03 0.0770317 MARKS_HDAC_TARGETS_DN borderline glaucoma DOID_9283 4.738E-03 0.01624162 4.738E-03 0.0770317 MARKS_HDAC_TARGETS_DN hepatic coma DOID_12550 5.132E-03 0.0174865 1.000 1.000 MARKS_HDAC_TARGETS_DN hepatic encephalopathy DOID_13413 5.132E-03 0.0174865 1.000 1.000 MARKS_HDAC_TARGETS_DN polyneuropathy DOID_1389 5.132E-03 0.01738242 1.000 1.000 MARKS_HDAC_TARGETS_DN psoriatic arthritis DOID_9008 5.132E-03 0.01727956 1.000 1.000 MARKS_HDAC_TARGETS_DN Legionnaires' disease DOID_10457 5.526E-03 0.01849588 1.000 1.000 MARKS_HDAC_TARGETS_DN legionellosis DOID_10458 5.526E-03 0.01849588 1.000 1.000 MARKS_HDAC_TARGETS_DN rhabdomyosarcoma DOID_3247 5.526E-03 0.01838772 1.000 1.000 MARKS_HDAC_TARGETS_DN eyelid disease DOID_530 5.526E-03 0.01828082 1.000 1.000 MARKS_HDAC_TARGETS_DN parasitic helminthiasis infectious disease DOID_883 5.526E-03 0.01817515 1.000 1.000 MARKS_HDAC_TARGETS_DN skeletal muscle cancer DOID_4043 5.92E-03 0.01935788 1.000 1.000 MARKS_HDAC_TARGETS_DN varicose veins DOID_799 5.92E-03 0.01924727 1.000 1.000 MARKS_HDAC_TARGETS_DN hyperhomocysteinemia DOID_9279 5.92E-03 0.01913791 1.000 1.000 MARKS_HDAC_TARGETS_DN silicosis DOID_10325 6.313E-03 0.02029469 1.000 1.000 MARKS_HDAC_TARGETS_DN chronic myeloid leukemia DOID_8552 6.313E-03 0.02018067 6.313E-03 0.09210666 MARKS_HDAC_TARGETS_DN tongue cancer DOID_8649 6.313E-03 0.02006793 6.313E-03 0.089804 MARKS_HDAC_TARGETS_DN vein disease DOID_866 6.313E-03 0.01995644 1.000 1.000 MARKS_HDAC_TARGETS_DN basal cell carcinoma DOID_2513 6.706E-03 0.02108268 1.000 1.000 MARKS_HDAC_TARGETS_DN male reproductive organ benign neoplasm DOID_0060087 7.1E-03 0.02219609 7.1E-03 0.09852899 MARKS_HDAC_TARGETS_DN neuroendocrine tumor DOID_169 7.1E-03 0.0220748 7.1E-03 0.09618306 MARKS_HDAC_TARGETS_DN skin carcinoma DOID_3451 7.1E-03 0.02195483 1.000 1.000 MARKS_HDAC_TARGETS_DN ureteral obstruction DOID_5199 7.1E-03 0.02183615 1.000 1.000 MARKS_HDAC_TARGETS_DN dissociative disorder DOID_10935 7.493E-03 0.02292112 1.000 1.000 MARKS_HDAC_TARGETS_DN dissociative amnesia DOID_11037 7.493E-03 0.02292112 1.000 1.000 MARKS_HDAC_TARGETS_DN granulosa cell tumor DOID_2999 7.493E-03 0.02279855 1.000 1.000 MARKS_HDAC_TARGETS_DN amnestic disorder DOID_10914 7.886E-03 0.02386642 1.000 1.000 MARKS_HDAC_TARGETS_DN esophagitis DOID_11963 7.886E-03 0.02374014 1.000 1.000 MARKS_HDAC_TARGETS_DN colon carcinoma DOID_1520 7.886E-03 0.02361519 7.886E-03 0.1043462 MARKS_HDAC_TARGETS_DN sex cord-gonadal stromal tumor DOID_192 7.886E-03 0.02349155 1.000 1.000 MARKS_HDAC_TARGETS_DN brain edema DOID_4724 7.886E-03 0.0233692 1.000 1.000 MARKS_HDAC_TARGETS_DN subependymal glioma DOID_4843 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN pilocytic astrocytoma DOID_4851 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN subependymal giant cell astrocytoma DOID_5077 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN fibrillary astrocytoma DOID_6726 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN juvenile pilocytic astrocytoma DOID_6811 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN childhood pilocytic astrocytoma DOID_6812 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN gemistocytic astrocytoma DOID_7005 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN childhood cerebral astrocytoma DOID_7007 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN protoplasmic astrocytoma DOID_7008 7.886E-03 0.02324812 7.886E-03 0.1019747 MARKS_HDAC_TARGETS_DN coronary restenosis DOID_4247 8.278E-03 0.02428022 1.000 1.000 MARKS_HDAC_TARGETS_DN benign glioma DOID_0060101 8.671E-03 0.0253013 8.671E-03 0.10963899 MARKS_HDAC_TARGETS_DN hepatitis B DOID_2043 8.671E-03 0.02517222 1.000 1.000 MARKS_HDAC_TARGETS_DN benign ependymoma DOID_4844 8.671E-03 0.0253013 8.671E-03 0.10963899 MARKS_HDAC_TARGETS_DN acquired immunodeficiency syndrome DOID_635 8.671E-03 0.02504444 1.000 1.000 MARKS_HDAC_TARGETS_DN sinusitis DOID_0050127 9.063E-03 0.02604578 1.000 1.000 MARKS_HDAC_TARGETS_DN paranasal sinus disease DOID_1352 9.063E-03 0.02604578 1.000 1.000 MARKS_HDAC_TARGETS_DN optic nerve disease DOID_1891 9.063E-03 0.0259149 1.000 1.000 MARKS_HDAC_TARGETS_DN IgA glomerulonephritis DOID_2986 9.063E-03 0.02578532 1.000 1.000 MARKS_HDAC_TARGETS_DN muscle cancer DOID_4045 9.063E-03 0.02565704 1.000 1.000 MARKS_HDAC_TARGETS_DN urinary tract obstruction DOID_5200 9.063E-03 0.02553002 1.000 1.000 MARKS_HDAC_TARGETS_DN sleep disorder DOID_535 9.063E-03 0.02540426 1.000 1.000 MARKS_HDAC_TARGETS_DN diabetic angiopathy DOID_11713 9.456E-03 0.02637398 1.000 1.000 MARKS_HDAC_TARGETS_DN ureteral disease DOID_1426 9.456E-03 0.02624533 1.000 1.000 MARKS_HDAC_TARGETS_DN meningitis DOID_9471 9.456E-03 0.02611792 1.000 1.000 MARKS_HDAC_TARGETS_DN Goodpasture syndrome DOID_9808 9.456E-03 0.02599175 1.000 1.000 MARKS_HDAC_TARGETS_DN hypogonadism DOID_1924 0.01023989 0.02801202 1.000 1.000 MARKS_HDAC_TARGETS_DN morbid obesity DOID_11981 0.01063177 0.02894488 0.01063177 0.13151043 MARKS_HDAC_TARGETS_DN cleft lip DOID_9296 0.01063177 0.02880705 0.01063177 0.12871233 MARKS_HDAC_TARGETS_DN intracranial aneurysm DOID_10941 0.01102351 0.02972691 1.000 1.000 MARKS_HDAC_TARGETS_DN B cell deficiency DOID_2115 0.01102351 0.02958669 1.000 1.000 MARKS_HDAC_TARGETS_DN middle cerebral artery infarction DOID_3525 0.01102351 0.02944778 1.000 1.000 MARKS_HDAC_TARGETS_DN seminoma DOID_4440 0.01102351 0.02931017 1.000 1.000 MARKS_HDAC_TARGETS_DN diffuse large B-cell lymphoma DOID_0050745 0.0114151 0.0302102 0.0114151 0.13531652 MARKS_HDAC_TARGETS_DN Sciatic Neuropathy DOID_11446 0.0114151 0.03007034 1.000 1.000 MARKS_HDAC_TARGETS_DN lesion of sciatic nerve DOID_12528 0.0114151 0.03007034 1.000 1.000 MARKS_HDAC_TARGETS_DN migraine DOID_6364 0.0114151 0.02993176 1.000 1.000 MARKS_HDAC_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 0.0114151 0.02979446 1.000 1.000 MARKS_HDAC_TARGETS_DN mononeuritis of lower limb DOID_9473 0.0114151 0.03007034 1.000 1.000 MARKS_HDAC_TARGETS_DN malaria DOID_12365 0.01180655 0.03067546 1.000 1.000 MARKS_HDAC_TARGETS_DN mononeuritis DOID_1802 0.01180655 0.03053603 1.000 1.000 MARKS_HDAC_TARGETS_DN invasive ductal carcinoma DOID_3008 0.01180655 0.03039785 0.01180655 0.13435852 MARKS_HDAC_TARGETS_DN coronary stenosis DOID_4248 0.01180655 0.03026093 1.000 1.000 MARKS_HDAC_TARGETS_DN mononeuropathy DOID_1188 0.01219785 0.03112366 1.000 1.000 MARKS_HDAC_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 0.01219785 0.03098472 0.01219785 0.13608974 MARKS_HDAC_TARGETS_DN supratentorial cancer DOID_1659 0.01219785 0.03084701 0.01219785 0.13347263 MARKS_HDAC_TARGETS_DN toxic encephalopathy DOID_3602 0.01219785 0.03071052 0.01219785 0.13095427 MARKS_HDAC_TARGETS_DN cerebrum cancer DOID_368 0.01219785 0.03084701 0.01219785 0.13347263 MARKS_HDAC_TARGETS_DN cranial nerve disease DOID_5656 0.01219785 0.03057523 1.000 1.000 MARKS_HDAC_TARGETS_DN corneal disease DOID_10124 0.01258901 0.0314173 1.000 1.000 MARKS_HDAC_TARGETS_DN endometrial carcinoma DOID_2871 0.01258901 0.03128011 0.01258901 0.13265083 MARKS_HDAC_TARGETS_DN age related macular degeneration DOID_10871 0.01298002 0.03211144 1.000 1.000 MARKS_HDAC_TARGETS_DN degeneration of macula and posterior pole DOID_2007 0.01298002 0.03211144 1.000 1.000 MARKS_HDAC_TARGETS_DN gonadal disease DOID_2277 0.01298002 0.03197243 1.000 1.000 MARKS_HDAC_TARGETS_DN celiac disease DOID_10608 0.01337089 0.03279325 1.000 1.000 MARKS_HDAC_TARGETS_DN endometrial cancer DOID_1380 0.01337089 0.03265251 0.01337089 0.13832791 MARKS_HDAC_TARGETS_DN germinoma DOID_3304 0.01337089 0.03251297 1.000 1.000 MARKS_HDAC_TARGETS_DN chronic leukemia DOID_1036 0.01376161 0.03332067 1.000 1.000 MARKS_HDAC_TARGETS_DN chronic lymphocytic leukemia DOID_1040 0.01376161 0.03332067 1.000 1.000 MARKS_HDAC_TARGETS_DN myocarditis DOID_820 0.01415219 0.03412117 1.000 1.000 MARKS_HDAC_TARGETS_DN metal metabolism disorder DOID_896 0.01415219 0.0339772 1.000 1.000 MARKS_HDAC_TARGETS_DN hepatitis C DOID_1883 0.01454262 0.03476787 1.000 1.000 MARKS_HDAC_TARGETS_DN thyroid carcinoma DOID_3963 0.01454262 0.0346224 0.01454262 0.14776346 MARKS_HDAC_TARGETS_DN macular degeneration DOID_4448 0.01454262 0.03447814 1.000 1.000 MARKS_HDAC_TARGETS_DN esophageal disease DOID_6050 0.01454262 0.03433508 1.000 1.000 MARKS_HDAC_TARGETS_DN aplastic anemia DOID_12449 0.01493292 0.03511086 1.000 1.000 MARKS_HDAC_TARGETS_DN thyroid cancer DOID_1781 0.01532306 0.03587993 0.01532306 0.15296179 MARKS_HDAC_TARGETS_DN pulmonary sarcoidosis DOID_13406 0.01571306 0.03664235 1.000 1.000 MARKS_HDAC_TARGETS_DN calcinosis DOID_182 0.01571306 0.03649279 1.000 1.000 MARKS_HDAC_TARGETS_DN cleft palate DOID_674 0.01571306 0.03634444 0.01571306 0.15415057 MARKS_HDAC_TARGETS_DN adenoid cystic carcinoma DOID_4866 0.0168822 0.03889058 0.0168822 0.16281313 MARKS_HDAC_TARGETS_DN benign mesothelioma DOID_2645 0.01727163 0.03962725 1.000 1.000 MARKS_HDAC_TARGETS_DN salivary gland cancer DOID_8850 0.01766091 0.04035767 0.01766091 0.16473867 MARKS_HDAC_TARGETS_DN hyperinsulinism DOID_2018 0.01805005 0.04108191 1.000 1.000 MARKS_HDAC_TARGETS_DN diabetic autonomic neuropathy DOID_11503 0.01843904 0.04180006 1.000 1.000 MARKS_HDAC_TARGETS_DN autonomic neuropathy DOID_11504 0.01843904 0.04180006 1.000 1.000 MARKS_HDAC_TARGETS_DN diabetic polyneuropathy DOID_12785 0.01843904 0.04180006 1.000 1.000 MARKS_HDAC_TARGETS_DN diabetic neuropathy DOID_9743 0.01843904 0.04180006 1.000 1.000 MARKS_HDAC_TARGETS_DN leukodystrophy DOID_10579 0.0192166 0.04338986 1.000 1.000 MARKS_HDAC_TARGETS_DN autonomic nervous system disease DOID_11465 0.01960516 0.04409224 1.000 1.000 MARKS_HDAC_TARGETS_DN neuritis DOID_1803 0.01960516 0.04391865 1.000 1.000 MARKS_HDAC_TARGETS_DN heart valve disease DOID_4079 0.01960516 0.04374642 1.000 1.000 MARKS_HDAC_TARGETS_DN bone marrow disease DOID_4961 0.01960516 0.04357554 1.000 1.000 MARKS_HDAC_TARGETS_DN integumentary system benign neoplasm DOID_0060121 0.02038186 0.04512559 0.02038186 0.18120743 MARKS_HDAC_TARGETS_DN glaucoma DOID_1686 0.02038186 0.04495068 0.02038186 0.17841963 MARKS_HDAC_TARGETS_DN skin benign neoplasm DOID_3165 0.02038186 0.04512559 0.02038186 0.18120743 MARKS_HDAC_TARGETS_DN orofacial cleft DOID_0050567 0.02154582 0.04733425 0.02154582 0.18297868 MARKS_HDAC_TARGETS_DN sarcoidosis DOID_11335 0.02193352 0.04800067 1.000 1.000 MARKS_HDAC_TARGETS_DN bile duct adenocarcinoma DOID_4896 0.02232108 0.04866166 1.000 1.000 MARKS_HDAC_TARGETS_DN cholangiocarcinoma DOID_4947 0.02232108 0.04866166 1.000 1.000 MARKS_HDAC_TARGETS_DN osteochondrodysplasia DOID_2256 0.02270849 0.0493173 0.02270849 0.18458761 MARKS_HDAC_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 0.02386988 0.05164243 1.000 1.000 MARKS_HDAC_TARGETS_DN bile duct cancer DOID_4606 0.02386988 0.05144682 1.000 1.000 MARKS_HDAC_TARGETS_DN bile duct carcinoma DOID_4897 0.02386988 0.05144682 1.000 1.000 MARKS_HDAC_TARGETS_DN neuroectodermal tumor DOID_171 0.02502997 0.0537436 0.02502997 0.19780631 MARKS_HDAC_TARGETS_DN congenital heart defect DOID_1682 0.02580265 0.0551944 1.000 1.000 MARKS_HDAC_TARGETS_DN cerebral degeneration DOID_1443 0.02657476 0.05663311 1.000 1.000 MARKS_HDAC_TARGETS_DN pancreatic ductal carcinoma DOID_3587 0.02850254 0.06051472 1.000 1.000 MARKS_HDAC_TARGETS_DN male reproductive system disease DOID_48 0.02888767 0.0611044 1.000 1.000 MARKS_HDAC_TARGETS_DN pancreatic carcinoma DOID_4905 0.0296575 0.06250043 1.000 1.000 MARKS_HDAC_TARGETS_DN aneurysm disease DOID_2403 0.03081117 0.06469209 1.000 1.000 MARKS_HDAC_TARGETS_DN mixed glioma DOID_5076 0.03119544 0.06525812 1.000 1.000 MARKS_HDAC_TARGETS_DN metabolic syndrome X DOID_14221 0.03196357 0.06662003 1.000 1.000 MARKS_HDAC_TARGETS_DN lipid metabolism disorder DOID_3146 0.03196357 0.06637689 1.000 1.000 MARKS_HDAC_TARGETS_DN auditory system disease DOID_2742 0.03273112 0.06772366 1.000 1.000 MARKS_HDAC_TARGETS_DN chronic kidney failure DOID_784 0.03311468 0.06826903 1.000 1.000 MARKS_HDAC_TARGETS_DN bone development disease DOID_0080006 0.0334981 0.06881018 0.0334981 0.24127113 MARKS_HDAC_TARGETS_DN primary immunodeficiency disease DOID_612 0.03541308 0.07248216 1.000 1.000 MARKS_HDAC_TARGETS_DN amino acid metabolic disorder DOID_9252 0.03541308 0.07222237 1.000 1.000 MARKS_HDAC_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 0.03579565 0.07274187 1.000 1.000 MARKS_HDAC_TARGETS_DN lymphoblastic leukemia DOID_1037 0.03694251 0.07480529 1.000 1.000 MARKS_HDAC_TARGETS_DN carbohydrate metabolic disorder DOID_2978 0.03694251 0.07454003 1.000 1.000 SMITH_TERT_TARGETS_UP transitional cell carcinoma DOID_2671 1.912E-08 1.088E-05 0.01245393 0.22144652 SMITH_TERT_TARGETS_UP mixed glioma DOID_5076 4.303E-07 1.224E-04 0.13939675 0.55856865 SMITH_TERT_TARGETS_UP benign mesothelioma DOID_2645 1.448E-06 2.747E-04 0.07921401 0.43339205 SMITH_TERT_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 1.448E-06 2.06E-04 3.109E-03 0.11056921 SMITH_TERT_TARGETS_UP granulosa cell tumor DOID_2999 5.969E-06 6.793E-04 0.03499806 0.32119188 SMITH_TERT_TARGETS_UP sex cord-gonadal stromal tumor DOID_192 7.013E-06 6.651E-04 0.03680623 0.32723039 SMITH_TERT_TARGETS_UP pre-malignant neoplasm DOID_0060071 7.455E-06 6.06E-04 6.865E-03 0.16276449 SMITH_TERT_TARGETS_UP in situ carcinoma DOID_8719 7.455E-06 6.06E-04 6.865E-03 0.16276449 SMITH_TERT_TARGETS_UP male reproductive system disease DOID_48 1.177E-05 8.37E-04 3.709E-04 0.07034934 SMITH_TERT_TARGETS_UP nervous system cancer DOID_3093 2.786E-05 1.761E-03 7.014E-04 0.06651953 SMITH_TERT_TARGETS_UP mouth disease DOID_403 3.294E-05 1.874E-03 0.01407808 0.23560087 SMITH_TERT_TARGETS_UP pleural disease DOID_1532 3.946E-05 2.041E-03 1.977E-03 0.12498558 SMITH_TERT_TARGETS_UP nephroblastoma DOID_2154 4.672E-05 2.215E-03 0.06703895 0.39734543 SMITH_TERT_TARGETS_UP embryonal cancer DOID_688 5.917E-05 2.59E-03 2.576E-03 0.12214468 SMITH_TERT_TARGETS_UP peripheral nervous system neoplasm DOID_1192 6.375E-05 2.591E-03 2.705E-03 0.11838783 SMITH_TERT_TARGETS_UP nephrotic syndrome DOID_1184 9.018E-05 3.421E-03 0.08266374 0.43958567 SMITH_TERT_TARGETS_UP proteinuria DOID_576 1.09E-04 3.877E-03 3.842E-03 0.1150524 SMITH_TERT_TARGETS_UP brain cancer DOID_1319 1.158E-04 3.876E-03 3.997E-03 0.10830157 SMITH_TERT_TARGETS_UP central nervous system cancer DOID_3620 1.229E-04 3.885E-03 4.155E-03 0.10746859 SMITH_TERT_TARGETS_UP hemolytic anemia DOID_583 1.229E-04 3.68E-03 1.229E-04 0.06992341 SMITH_TERT_TARGETS_UP normocytic anemia DOID_720 1.229E-04 3.68E-03 1.229E-04 0.06992341 SMITH_TERT_TARGETS_UP glaucoma DOID_1686 1.302E-04 3.705E-03 0.09293664 0.46386798 SMITH_TERT_TARGETS_UP giant cell tumor DOID_200 1.625E-04 4.402E-03 0.09972215 0.48086357 SMITH_TERT_TARGETS_UP malignant giant cell tumor DOID_2705 1.625E-04 4.402E-03 0.09972215 0.48086357 SMITH_TERT_TARGETS_UP giant cell glioblastoma DOID_3074 1.625E-04 4.402E-03 0.09972215 0.48086357 SMITH_TERT_TARGETS_UP bile duct adenocarcinoma DOID_4896 1.713E-04 4.43E-03 1.000 1.000 SMITH_TERT_TARGETS_UP cholangiocarcinoma DOID_4947 1.713E-04 4.43E-03 1.000 1.000 SMITH_TERT_TARGETS_UP familial adenomatous polyposis DOID_0050424 1.881E-04 4.654E-03 0.02041172 0.28327485 SMITH_TERT_TARGETS_UP glioblastoma DOID_3068 2.095E-04 4.968E-03 0.10813368 0.49222453 SMITH_TERT_TARGETS_UP bile duct cancer DOID_4606 2.095E-04 4.769E-03 1.000 1.000 SMITH_TERT_TARGETS_UP bile duct carcinoma DOID_4897 2.095E-04 4.769E-03 1.000 1.000 SMITH_TERT_TARGETS_UP vulva cancer DOID_1245 2.662E-04 5.825E-03 0.02407856 0.29150422 SMITH_TERT_TARGETS_UP larynx cancer DOID_2596 2.662E-04 5.609E-03 1.000 1.000 SMITH_TERT_TARGETS_UP laryngeal benign neoplasm DOID_2598 2.662E-04 5.609E-03 1.000 1.000 SMITH_TERT_TARGETS_UP Lynch syndrome DOID_3883 2.662E-04 5.409E-03 2.662E-04 0.07572124 SMITH_TERT_TARGETS_UP open-angle glaucoma DOID_1067 3.101E-04 6.085E-03 0.0259069 0.28903968 SMITH_TERT_TARGETS_UP brain infarction DOID_3454 3.283E-04 6.228E-03 7.906E-03 0.1666069 SMITH_TERT_TARGETS_UP astrocytoma DOID_3069 3.422E-04 6.28E-03 0.12636728 0.53261467 SMITH_TERT_TARGETS_UP pancreatic ductal carcinoma DOID_3587 3.564E-04 6.336E-03 0.12800654 0.53555676 SMITH_TERT_TARGETS_UP oral submucous fibrosis DOID_5773 3.574E-04 6.163E-03 1.000 1.000 SMITH_TERT_TARGETS_UP nephrosis DOID_2527 3.709E-04 6.207E-03 0.12964276 0.5384433 SMITH_TERT_TARGETS_UP biliary tract disease DOID_9741 3.858E-04 6.273E-03 8.786E-03 0.1723876 SMITH_TERT_TARGETS_UP pancreatic carcinoma DOID_4905 4.012E-04 6.341E-03 0.13290614 0.54799706 SMITH_TERT_TARGETS_UP tongue cancer DOID_8649 4.08E-04 6.274E-03 1.000 1.000 SMITH_TERT_TARGETS_UP urinary system benign neoplasm DOID_731 4.618E-04 6.915E-03 0.03137168 0.31316639 SMITH_TERT_TARGETS_UP pancreatitis DOID_4989 4.663E-04 6.804E-03 9.945E-03 0.18862395 SMITH_TERT_TARGETS_UP biliary tract cancer DOID_4607 5.569E-04 7.922E-03 1.000 1.000 SMITH_TERT_TARGETS_UP testicular cancer DOID_2998 5.793E-04 8.039E-03 5.793E-04 0.08240072 SMITH_TERT_TARGETS_UP amino acid metabolic disorder DOID_9252 6.795E-04 9.205E-03 6.795E-04 0.07732388 SMITH_TERT_TARGETS_UP lymphoma DOID_0060058 7.467E-04 9.881E-03 0.16173889 0.61352951 SMITH_TERT_TARGETS_UP carbohydrate metabolic disorder DOID_2978 7.7E-04 9.958E-03 7.7E-04 0.06259248 SMITH_TERT_TARGETS_UP encephalomyelitis DOID_640 7.7E-04 9.737E-03 0.01380133 0.23796835 SMITH_TERT_TARGETS_UP dilated cardiomyopathy DOID_12930 8.18E-04 0.01011889 0.01435724 0.23340774 SMITH_TERT_TARGETS_UP muscle cancer DOID_4045 8.529E-04 0.01032556 1.000 1.000 SMITH_TERT_TARGETS_UP portal hypertension DOID_10762 1.092E-03 0.01294064 0.04758531 0.36101386 SMITH_TERT_TARGETS_UP middle cerebral artery infarction DOID_3525 1.267E-03 0.01470815 1.267E-03 0.09008743 SMITH_TERT_TARGETS_UP lung adenocarcinoma DOID_3910 1.359E-03 0.01546297 0.05293016 0.37646576 SMITH_TERT_TARGETS_UP pleurisy DOID_10247 1.454E-03 0.01622298 0.0547052 0.37960069 SMITH_TERT_TARGETS_UP hepatic vascular disease DOID_272 1.454E-03 0.015911 0.0547052 0.37056258 SMITH_TERT_TARGETS_UP abdominal aortic aneurysm DOID_7693 1.759E-03 0.01887964 0.06001065 0.37940067 SMITH_TERT_TARGETS_UP autonomic nervous system neoplasm DOID_2621 1.977E-03 0.02083093 0.0635313 0.38870226 SMITH_TERT_TARGETS_UP bladder disease DOID_365 1.977E-03 0.02045219 1.000 1.000 SMITH_TERT_TARGETS_UP neuroblastoma DOID_769 1.977E-03 0.02083093 0.0635313 0.38870226 SMITH_TERT_TARGETS_UP papilloma DOID_2615 2.091E-03 0.02124286 0.06528675 0.39519318 SMITH_TERT_TARGETS_UP pneumoconiosis DOID_10316 2.207E-03 0.02203611 2.207E-03 0.12560582 SMITH_TERT_TARGETS_UP male infertility DOID_12336 2.207E-03 0.02165618 2.207E-03 0.11418711 SMITH_TERT_TARGETS_UP spindle cell carcinoma DOID_4015 2.207E-03 0.02128912 1.000 1.000 SMITH_TERT_TARGETS_UP congenital diaphragmatic hernia DOID_3827 2.837E-03 0.02690072 0.0757515 0.41847186 SMITH_TERT_TARGETS_UP intracranial arterial disease DOID_13089 2.971E-03 0.02771695 2.971E-03 0.1207667 SMITH_TERT_TARGETS_UP cerebral arterial disease DOID_3527 2.971E-03 0.02771695 2.971E-03 0.1207667 SMITH_TERT_TARGETS_UP lymphatic system disease DOID_75 2.971E-03 0.0272699 2.971E-03 0.11271559 SMITH_TERT_TARGETS_UP pulmonary emphysema DOID_9675 3.109E-03 0.02808107 0.07921401 0.42926451 SMITH_TERT_TARGETS_UP diabetic autonomic neuropathy DOID_11503 3.54E-03 0.03147284 1.000 1.000 SMITH_TERT_TARGETS_UP autonomic neuropathy DOID_11504 3.54E-03 0.03147284 1.000 1.000 SMITH_TERT_TARGETS_UP diabetic polyneuropathy DOID_12785 3.54E-03 0.03147284 1.000 1.000 SMITH_TERT_TARGETS_UP gallbladder cancer DOID_3121 3.54E-03 0.03098864 1.000 1.000 SMITH_TERT_TARGETS_UP influenza DOID_8469 3.54E-03 0.03051912 0.08438382 0.43649448 SMITH_TERT_TARGETS_UP diabetic neuropathy DOID_9743 3.54E-03 0.03147284 1.000 1.000 SMITH_TERT_TARGETS_UP cerebral infarction DOID_3526 3.689E-03 0.03133288 3.689E-03 0.12348842 SMITH_TERT_TARGETS_UP cataract DOID_83 3.689E-03 0.0308721 3.689E-03 0.11662795 SMITH_TERT_TARGETS_UP myeloma DOID_0070004 3.997E-03 0.03296135 1.000 1.000 SMITH_TERT_TARGETS_UP lens disease DOID_110 3.997E-03 0.03249047 3.997E-03 0.11371665 SMITH_TERT_TARGETS_UP autonomic nervous system disease DOID_11465 3.997E-03 0.03203286 1.000 1.000 SMITH_TERT_TARGETS_UP neuritis DOID_1803 3.997E-03 0.03158796 0.08952501 0.45481901 SMITH_TERT_TARGETS_UP thyroid adenoma DOID_2891 3.997E-03 0.03115525 0.08952501 0.45079406 SMITH_TERT_TARGETS_UP lung small cell carcinoma DOID_5409 4.316E-03 0.03318807 0.09293664 0.45983434 SMITH_TERT_TARGETS_UP aortic aneurysm DOID_3627 4.48E-03 0.03398868 0.09463773 0.46421438 SMITH_TERT_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 4.647E-03 0.03478954 1.000 1.000 SMITH_TERT_TARGETS_UP sarcoidosis DOID_11335 4.989E-03 0.03686425 0.09972215 0.48497351 SMITH_TERT_TARGETS_UP bone marrow cancer DOID_4960 5.164E-03 0.03766953 1.000 1.000 SMITH_TERT_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 5.342E-03 0.03847461 0.10309611 0.49295533 SMITH_TERT_TARGETS_UP congenital nervous system abnormality DOID_2490 5.706E-03 0.04058496 5.706E-03 0.14116508 SMITH_TERT_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 5.892E-03 0.04139279 0.10813368 0.49619408 SMITH_TERT_TARGETS_UP oral cavity cancer DOID_8618 5.892E-03 0.040888 1.000 1.000 SMITH_TERT_TARGETS_UP melancholia DOID_2848 6.082E-03 0.04169163 1.000 1.000 SMITH_TERT_TARGETS_UP neurotic disorder DOID_4964 6.273E-03 0.04249476 1.000 1.000 SMITH_TERT_TARGETS_UP congenital heart defect DOID_1682 6.865E-03 0.04595703 6.865E-03 0.15625391 SMITH_TERT_TARGETS_UP cholestasis DOID_13580 7.273E-03 0.04812307 7.273E-03 0.15917632 SMITH_TERT_TARGETS_UP hyperglycemia DOID_4195 7.482E-03 0.04893101 0.12143125 0.52743802 SMITH_TERT_TARGETS_UP tooth disease DOID_1091 7.692E-03 0.04973789 0.12307964 0.53054784 SMITH_TERT_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 7.906E-03 0.05054367 0.12472498 0.53359785 SMITH_TERT_TARGETS_UP bile duct disease DOID_4138 8.562E-03 0.05413091 8.562E-03 0.17399221 SMITH_TERT_TARGETS_UP diabetic retinopathy DOID_8947 9.013E-03 0.05635369 1.000 1.000 SMITH_TERT_TARGETS_UP cystic fibrosis DOID_1485 9.474E-03 0.05859254 0.13615745 0.55736396 SMITH_TERT_TARGETS_UP endogenous depression DOID_1595 9.474E-03 0.05796251 1.000 1.000 SMITH_TERT_TARGETS_UP aneurysm disease DOID_2403 9.708E-03 0.05876473 0.1377786 0.55600016 SMITH_TERT_TARGETS_UP metabolic syndrome X DOID_14221 0.01042663 0.06245005 0.14262406 0.56356313 SMITH_TERT_TARGETS_UP mental depression DOID_1596 0.01116809 0.06619417 1.000 1.000 SMITH_TERT_TARGETS_UP chronic kidney failure DOID_784 0.01116809 0.06551176 0.14744268 0.57462248 SMITH_TERT_TARGETS_UP retinal vascular disease DOID_2462 0.01167496 0.06778625 1.000 1.000 SMITH_TERT_TARGETS_UP primary bacterial infectious disease DOID_0050338 0.0121918 0.07007207 0.0121918 0.22377855 SMITH_TERT_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 0.01298558 0.07388793 0.15858252 0.60559364 SMITH_TERT_TARGETS_UP lymphoblastic leukemia DOID_1037 0.01380133 0.07775204 1.000 1.000 SMITH_TERT_TARGETS_UP ulcerative colitis DOID_8577 0.01520904 0.08484258 0.17113812 0.64064203 SMITH_TERT_TARGETS_UP rectal neoplasm DOID_1984 0.01857321 0.0996996 1.000 1.000 SMITH_TERT_TARGETS_UP rectum cancer DOID_1993 0.01857321 0.0996996 1.000 1.000 SMITH_TERT_TARGETS_UP phagocyte bactericidal dysfunction DOID_3262 0.01857321 0.09876783 0.01857321 0.27810941 SMITH_TERT_TARGETS_UP conjunctival disease DOID_4251 0.01857321 0.09785331 0.01857321 0.2709784 SMITH_TERT_TARGETS_UP holoprosencephaly DOID_4621 0.01857321 0.09695558 0.01857321 0.26420394 SMITH_TERT_TARGETS_UP keratitis DOID_4677 0.01857321 0.09607416 1.000 1.000 SMITH_TERT_TARGETS_UP conjunctivitis DOID_6195 0.01857321 0.09785331 0.01857321 0.2709784 KANG_IMMORTALIZED_BY_TERT_DN bacterial meningitis DOID_9470 2.163E-06 1.23E-03 3.015E-04 0.01319493 KANG_IMMORTALIZED_BY_TERT_DN heart valve disease DOID_4079 2.301E-06 6.548E-04 3.888E-03 0.07900442 KANG_IMMORTALIZED_BY_TERT_DN glaucoma DOID_1686 2.698E-06 5.117E-04 4.198E-03 0.08237324 KANG_IMMORTALIZED_BY_TERT_DN calcium metabolism disease DOID_10575 2.914E-06 4.145E-04 4.358E-03 0.07998561 KANG_IMMORTALIZED_BY_TERT_DN carotid artery disease DOID_3407 6.227E-06 7.086E-04 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN mineral metabolism disease DOID_0050032 7.481E-06 7.094E-04 6.877E-03 0.10869018 KANG_IMMORTALIZED_BY_TERT_DN temporal lobe epilepsy DOID_3328 8.414E-06 6.839E-04 8.414E-06 4.788E-03 KANG_IMMORTALIZED_BY_TERT_DN meningitis DOID_9471 1.187E-05 8.44E-04 9.035E-04 0.02856012 KANG_IMMORTALIZED_BY_TERT_DN endogenous depression DOID_1595 1.371E-05 8.668E-04 1.371E-05 3.901E-03 KANG_IMMORTALIZED_BY_TERT_DN mental depression DOID_1596 1.927E-05 1.097E-03 1.927E-05 3.656E-03 KANG_IMMORTALIZED_BY_TERT_DN focal epilepsy DOID_2234 1.927E-05 9.97E-04 1.927E-05 2.742E-03 KANG_IMMORTALIZED_BY_TERT_DN dysostosis DOID_1934 2.877E-05 1.364E-03 2.877E-05 3.274E-03 KANG_IMMORTALIZED_BY_TERT_DN mouth disease DOID_403 3.114E-05 1.363E-03 0.16275956 0.52920108 KANG_IMMORTALIZED_BY_TERT_DN abdominal aortic aneurysm DOID_7693 3.161E-05 1.285E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN calcinosis DOID_182 5.671E-05 2.151E-03 0.07129445 0.3073223 KANG_IMMORTALIZED_BY_TERT_DN pulmonary emphysema DOID_9675 7.562E-05 2.689E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN Huntington's disease DOID_12858 8.644E-05 2.893E-03 8.644E-05 8.198E-03 KANG_IMMORTALIZED_BY_TERT_DN rheumatic disease DOID_1575 8.644E-05 2.733E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN scleroderma DOID_419 8.644E-05 2.733E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN neuritis DOID_1803 1.11E-04 3.325E-03 1.11E-04 9.025E-03 KANG_IMMORTALIZED_BY_TERT_DN aortic aneurysm DOID_3627 1.322E-04 3.76E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN movement disease DOID_480 1.322E-04 3.581E-03 1.322E-04 9.401E-03 KANG_IMMORTALIZED_BY_TERT_DN withdrawal disorder DOID_0060001 1.398E-04 3.615E-03 4.52E-03 0.08037071 KANG_IMMORTALIZED_BY_TERT_DN orofacial cleft DOID_0050567 1.476E-04 3.652E-03 1.476E-04 9.333E-03 KANG_IMMORTALIZED_BY_TERT_DN temporal arteritis DOID_13375 1.829E-04 4.335E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN central nervous system vasculitis DOID_525 1.829E-04 4.335E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN melancholia DOID_2848 2.109E-04 4.799E-03 2.109E-04 0.01199796 KANG_IMMORTALIZED_BY_TERT_DN ocular hypertension DOID_9282 2.192E-04 4.796E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN borderline glaucoma DOID_9283 2.192E-04 4.796E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN neurotic disorder DOID_4964 2.211E-04 4.66E-03 2.211E-04 0.01143748 KANG_IMMORTALIZED_BY_TERT_DN collagen disease DOID_854 2.317E-04 4.708E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN carotid stenosis DOID_13001 2.587E-04 5.076E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN alcohol dependence DOID_0050741 3.015E-04 5.718E-03 3.015E-04 0.0142945 KANG_IMMORTALIZED_BY_TERT_DN allergic contact dermatitis DOID_3042 3.02E-04 5.543E-03 0.12145447 0.44299738 KANG_IMMORTALIZED_BY_TERT_DN astrocytoma DOID_3069 3.282E-04 5.835E-03 0.12470185 0.45194492 KANG_IMMORTALIZED_BY_TERT_DN thoracic aortic aneurysm DOID_14004 3.474E-04 5.991E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN oral submucous fibrosis DOID_5773 3.474E-04 5.814E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN varicose veins DOID_799 3.474E-04 5.648E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN vein disease DOID_866 3.966E-04 6.268E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN aneurysm disease DOID_2403 4.311E-04 6.63E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN contact dermatitis DOID_2773 4.809E-04 7.201E-03 0.14076213 0.48249187 KANG_IMMORTALIZED_BY_TERT_DN alcohol abuse DOID_1574 5.342E-04 7.794E-03 5.342E-04 0.02171185 KANG_IMMORTALIZED_BY_TERT_DN bone development disease DOID_0080006 5.528E-04 7.863E-03 5.528E-04 0.02096916 KANG_IMMORTALIZED_BY_TERT_DN subependymal glioma DOID_4843 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN pilocytic astrocytoma DOID_4851 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN subependymal giant cell astrocytoma DOID_5077 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN fibrillary astrocytoma DOID_6726 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN juvenile pilocytic astrocytoma DOID_6811 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN childhood pilocytic astrocytoma DOID_6812 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN gemistocytic astrocytoma DOID_7005 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN childhood cerebral astrocytoma DOID_7007 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN protoplasmic astrocytoma DOID_7008 6.249E-04 8.673E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN nervous system cancer DOID_3093 6.73E-04 9.117E-03 0.15653186 0.51782923 KANG_IMMORTALIZED_BY_TERT_DN benign glioma DOID_0060101 7.58E-04 0.01003006 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN familial hypercholesterolemia DOID_13810 7.58E-04 9.802E-03 0.03985434 0.23139919 KANG_IMMORTALIZED_BY_TERT_DN benign ependymoma DOID_4844 7.58E-04 0.01003006 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN hypersensitivity reaction type I disease DOID_1205 7.849E-04 9.925E-03 0.01397586 0.18933958 KANG_IMMORTALIZED_BY_TERT_DN opiate dependence DOID_2559 8.292E-04 0.01025662 0.04162821 0.22996557 KANG_IMMORTALIZED_BY_TERT_DN lingual-facial-buccal dyskinesia DOID_9854 8.292E-04 0.0100384 8.292E-04 0.02948779 KANG_IMMORTALIZED_BY_TERT_DN synostosis DOID_11971 9.035E-04 0.01071005 9.035E-04 0.03024013 KANG_IMMORTALIZED_BY_TERT_DN cleft lip DOID_9296 1.145E-03 0.01329475 1.145E-03 0.03428646 KANG_IMMORTALIZED_BY_TERT_DN middle cerebral artery infarction DOID_3525 1.231E-03 0.01401435 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN fragments of torsion dystonia DOID_531 1.231E-03 0.01373956 1.231E-03 0.03503588 KANG_IMMORTALIZED_BY_TERT_DN Sciatic Neuropathy DOID_11446 1.321E-03 0.01445626 1.321E-03 0.03579646 KANG_IMMORTALIZED_BY_TERT_DN lesion of sciatic nerve DOID_12528 1.321E-03 0.01445626 1.321E-03 0.03579646 KANG_IMMORTALIZED_BY_TERT_DN mononeuritis of lower limb DOID_9473 1.321E-03 0.01445626 1.321E-03 0.03579646 KANG_IMMORTALIZED_BY_TERT_DN renal hypertension DOID_1073 1.414E-03 0.0151785 0.05395518 0.25798738 KANG_IMMORTALIZED_BY_TERT_DN secondary hypertension DOID_11130 1.414E-03 0.0151785 0.05395518 0.25798738 KANG_IMMORTALIZED_BY_TERT_DN mononeuritis DOID_1802 1.414E-03 0.01489742 1.414E-03 0.03656639 KANG_IMMORTALIZED_BY_TERT_DN autoimmune disease of the nervous system DOID_438 1.414E-03 0.01462656 1.414E-03 0.03497655 KANG_IMMORTALIZED_BY_TERT_DN central nervous system hereditary degenerative disease DOID_481 1.414E-03 0.01436537 1.414E-03 0.03351919 KANG_IMMORTALIZED_BY_TERT_DN mononeuropathy DOID_1188 1.51E-03 0.0150687 1.51E-03 0.03435664 KANG_IMMORTALIZED_BY_TERT_DN supratentorial cancer DOID_1659 1.51E-03 0.0148089 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN cerebrum cancer DOID_368 1.51E-03 0.0148089 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN dystonic disease DOID_544 1.51E-03 0.0145579 1.51E-03 0.03303523 KANG_IMMORTALIZED_BY_TERT_DN Charcot-Marie-Tooth disease DOID_10595 1.815E-03 0.01720903 1.815E-03 0.0382423 KANG_IMMORTALIZED_BY_TERT_DN allergic rhinitis DOID_4481 1.815E-03 0.01692692 0.06092885 0.27958481 KANG_IMMORTALIZED_BY_TERT_DN systemic scleroderma DOID_418 2.759E-03 0.02531736 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN peptic ulcer DOID_750 2.759E-03 0.02491549 0.07472453 0.31263424 KANG_IMMORTALIZED_BY_TERT_DN intracranial arterial disease DOID_13089 2.89E-03 0.02569199 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN cerebral arterial disease DOID_3527 2.89E-03 0.02569199 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN nephrotic syndrome DOID_1184 3.3E-03 0.02889126 0.08154726 0.3362347 KANG_IMMORTALIZED_BY_TERT_DN diabetic autonomic neuropathy DOID_11503 3.443E-03 0.02968279 0.08324517 0.34076622 KANG_IMMORTALIZED_BY_TERT_DN autonomic neuropathy DOID_11504 3.443E-03 0.02968279 0.08324517 0.34076622 KANG_IMMORTALIZED_BY_TERT_DN diabetic polyneuropathy DOID_12785 3.443E-03 0.02968279 0.08324517 0.34076622 KANG_IMMORTALIZED_BY_TERT_DN influenza DOID_8469 3.443E-03 0.02923976 0.08324517 0.33833217 KANG_IMMORTALIZED_BY_TERT_DN diabetic neuropathy DOID_9743 3.443E-03 0.02968279 0.08324517 0.34076622 KANG_IMMORTALIZED_BY_TERT_DN cerebral infarction DOID_3526 3.588E-03 0.03002662 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN autonomic nervous system disease DOID_11465 3.888E-03 0.03205976 0.08832039 0.35142867 KANG_IMMORTALIZED_BY_TERT_DN brain cancer DOID_1319 3.888E-03 0.03160177 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN central nervous system cancer DOID_3620 4.042E-03 0.03238984 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN pulmonary tuberculosis DOID_2957 4.198E-03 0.03317811 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN lung small cell carcinoma DOID_5409 4.198E-03 0.03272361 4.198E-03 0.07962746 KANG_IMMORTALIZED_BY_TERT_DN giant cell tumor DOID_200 4.853E-03 0.03731342 0.09838787 0.38608758 KANG_IMMORTALIZED_BY_TERT_DN malignant giant cell tumor DOID_2705 4.853E-03 0.03731342 0.09838787 0.38608758 KANG_IMMORTALIZED_BY_TERT_DN giant cell glioblastoma DOID_3074 4.853E-03 0.03731342 0.09838787 0.38608758 KANG_IMMORTALIZED_BY_TERT_DN vasculitis DOID_865 5.023E-03 0.03810936 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN smallpox DOID_8736 5.196E-03 0.03890482 5.196E-03 0.08959897 KANG_IMMORTALIZED_BY_TERT_DN familial hyperlipidemia DOID_1168 5.372E-03 0.03969973 0.10338044 0.39745587 KANG_IMMORTALIZED_BY_TERT_DN hypertrophic cardiomyopathy DOID_11984 5.732E-03 0.04181704 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN glioblastoma DOID_3068 5.732E-03 0.04128771 0.10669367 0.40472464 KANG_IMMORTALIZED_BY_TERT_DN leukocyte disease DOID_9500 5.916E-03 0.04208068 5.916E-03 0.09901336 KANG_IMMORTALIZED_BY_TERT_DN congenital heart defect DOID_1682 6.679E-03 0.04692039 6.679E-03 0.10858719 KANG_IMMORTALIZED_BY_TERT_DN hyperglycemia DOID_4195 7.279E-03 0.05051122 0.11982632 0.44273492 KANG_IMMORTALIZED_BY_TERT_DN tooth disease DOID_1091 7.485E-03 0.05130948 0.12145447 0.44585543 KANG_IMMORTALIZED_BY_TERT_DN brain infarction DOID_3454 7.692E-03 0.05210636 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN tuberculosis DOID_399 7.692E-03 0.05149334 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN nephrosis DOID_2527 8.331E-03 0.05512202 0.1279374 0.45783887 KANG_IMMORTALIZED_BY_TERT_DN male reproductive system disease DOID_48 8.331E-03 0.05448843 8.331E-03 0.12812145 KANG_IMMORTALIZED_BY_TERT_DN cystic fibrosis DOID_1485 9.219E-03 0.05960918 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN bone resorption disease DOID_0080011 9.447E-03 0.06039872 0.13597479 0.47466046 KANG_IMMORTALIZED_BY_TERT_DN osteoporosis DOID_11476 9.447E-03 0.06039872 0.13597479 0.47466046 KANG_IMMORTALIZED_BY_TERT_DN pancreatitis DOID_4989 9.678E-03 0.06118658 9.678E-03 0.14491559 KANG_IMMORTALIZED_BY_TERT_DN metabolic syndrome X DOID_14221 0.01014705 0.06344692 0.14076213 0.48541606 KANG_IMMORTALIZED_BY_TERT_DN lipid metabolism disorder DOID_3146 0.01014705 0.06275728 0.14076213 0.47960269 KANG_IMMORTALIZED_BY_TERT_DN chromosomal disease DOID_0080014 0.01038529 0.0635401 0.01038529 0.1515187 KANG_IMMORTALIZED_BY_TERT_DN female reproductive system disease DOID_229 0.01038529 0.06286414 0.14235209 0.48213296 KANG_IMMORTALIZED_BY_TERT_DN chronic kidney failure DOID_784 0.01086918 0.06510065 0.14552332 0.4899572 KANG_IMMORTALIZED_BY_TERT_DN primary bacterial infectious disease DOID_0050338 0.01186631 0.07033261 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN encephalomyelitis DOID_640 0.01343425 0.07880503 0.01343425 0.19110219 KANG_IMMORTALIZED_BY_TERT_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.01370388 0.0795664 0.01370388 0.1901831 KANG_IMMORTALIZED_BY_TERT_DN dilated cardiomyopathy DOID_12930 0.01397586 0.08032588 0.16430939 0.53120479 KANG_IMMORTALIZED_BY_TERT_DN ulcerative colitis DOID_8577 0.01480579 0.08424492 0.16894193 0.54309582 KANG_IMMORTALIZED_BY_TERT_DN cutaneous leishmaniasis DOID_9111 0.01831379 0.09924329 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN cannabis abuse DOID_9505 0.01831379 0.09830703 0.01831379 0.2265336 KANG_IMMORTALIZED_BY_TERT_DN eosinophilic pneumonia DOID_5870 0.02012688 0.09958431 0.02012688 0.21207769 KANG_IMMORTALIZED_BY_TERT_DN pulmonary eosinophilia DOID_9498 0.02012688 0.09958431 0.02012688 0.21207769 KANG_IMMORTALIZED_BY_TERT_DN Loeffler syndrome DOID_9503 0.02012688 0.09958431 0.02012688 0.21207769 KANG_IMMORTALIZED_BY_TERT_DN bronchiectasis DOID_9563 0.02012688 0.09872582 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_DN peritonitis DOID_8283 0.02193667 0.09985574 0.02193667 0.20803278 KANG_IMMORTALIZED_BY_TERT_DN encephalitis DOID_9588 0.02193667 0.09906323 1.000 1.000 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP atrophic muscular disease DOID_913 2.909E-06 1.655E-03 3.606E-04 0.20517814 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP muscular dystrophy DOID_9884 2.909E-06 1.655E-03 3.606E-04 0.20517814 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP angiosarcoma DOID_0001816 2.844E-05 8.09E-03 7.99E-03 0.90929444 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP uremia DOID_4676 5.983E-05 0.01134729 0.01146698 0.59315569 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP sarcoma DOID_1115 1.027E-04 0.01460204 0.01493213 0.53102397 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP nephroblastoma DOID_2154 1.568E-04 0.01784761 0.01838577 0.49816693 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP uveitis DOID_13141 1.929E-04 0.01829023 0.02035413 0.42894445 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP uveal disease DOID_3480 2.431E-04 0.01975833 0.02280932 0.37081433 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP leukodystrophy DOID_10579 2.759E-04 0.01962619 0.02427963 0.37338134 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP reproductive organ benign neoplasm DOID_0050622 3.868E-04 0.02445576 0.028678 0.37948335 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP cerebral degeneration DOID_1443 5.315E-04 0.03024179 0.03354305 0.38171995 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP retinal vascular disease DOID_2462 8.679E-04 0.04489363 1.000 1.000 FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP encephalomyelitis DOID_640 1.033E-03 0.04899962 0.04656364 0.43433953 DAUER_STAT3_TARGETS_UP pancreatitis DOID_4989 1.752E-08 9.966E-06 1.285E-06 7.309E-04 DAUER_STAT3_TARGETS_UP metabolic syndrome X DOID_14221 1.985E-08 5.648E-06 7.79E-05 8.865E-03 DAUER_STAT3_TARGETS_UP carotid artery disease DOID_3407 5.22E-07 9.901E-05 1.896E-03 0.0599481 DAUER_STAT3_TARGETS_UP parasitic infectious disease DOID_1398 6.672E-07 9.491E-05 2.137E-03 0.05528311 DAUER_STAT3_TARGETS_UP brain infarction DOID_3454 7.943E-07 9.039E-05 2.327E-03 0.05757556 DAUER_STAT3_TARGETS_UP diabetic retinopathy DOID_8947 1.045E-06 9.911E-05 6.209E-05 0.01177692 DAUER_STAT3_TARGETS_UP aneurysm disease DOID_2403 1.221E-06 9.927E-05 6.97E-05 9.915E-03 DAUER_STAT3_TARGETS_UP pulmonary embolism DOID_9477 1.623E-06 1.154E-04 1.623E-06 4.616E-04 DAUER_STAT3_TARGETS_UP retinal vascular disease DOID_2462 1.799E-06 1.137E-04 9.291E-05 8.811E-03 DAUER_STAT3_TARGETS_UP middle cerebral artery infarction DOID_3525 2.991E-06 1.702E-04 0.02769897 0.21590016 DAUER_STAT3_TARGETS_UP abdominal aortic aneurysm DOID_7693 4.965E-06 2.568E-04 5.065E-04 0.02882 DAUER_STAT3_TARGETS_UP pleural disease DOID_1532 5.947E-06 2.82E-04 0.03450612 0.20887216 DAUER_STAT3_TARGETS_UP intracranial arterial disease DOID_13089 1.115E-05 4.881E-04 0.04222891 0.21843865 DAUER_STAT3_TARGETS_UP cerebral arterial disease DOID_3527 1.115E-05 4.881E-04 0.04222891 0.21843865 DAUER_STAT3_TARGETS_UP cerebral infarction DOID_3526 1.558E-05 6.33E-04 0.04702508 0.22675653 DAUER_STAT3_TARGETS_UP pulmonary tuberculosis DOID_2957 1.985E-05 7.528E-04 1.257E-03 0.05108135 DAUER_STAT3_TARGETS_UP aortic aneurysm DOID_3627 2.102E-05 7.476E-04 1.305E-03 0.04951429 DAUER_STAT3_TARGETS_UP vasculitis DOID_865 2.619E-05 8.765E-04 0.05559931 0.24335392 DAUER_STAT3_TARGETS_UP parasitic protozoa infectious disease DOID_2789 2.76E-05 8.723E-04 0.05654736 0.24375338 DAUER_STAT3_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 3.212E-05 9.619E-04 1.725E-03 0.05772736 DAUER_STAT3_TARGETS_UP respiratory failure DOID_11162 3.888E-05 1.106E-03 1.955E-03 0.05855892 DAUER_STAT3_TARGETS_UP endocrine pancreas disease DOID_1428 4.258E-05 1.154E-03 2.076E-03 0.05624771 DAUER_STAT3_TARGETS_UP tuberculosis DOID_399 5.066E-05 1.31E-03 2.327E-03 0.05517658 DAUER_STAT3_TARGETS_UP pneumocystosis DOID_11339 5.35E-05 1.324E-03 0.01097217 0.17837615 DAUER_STAT3_TARGETS_UP bone resorption disease DOID_0080011 6.97E-05 1.653E-03 2.871E-03 0.06534323 DAUER_STAT3_TARGETS_UP osteoporosis DOID_11476 6.97E-05 1.653E-03 2.871E-03 0.06534323 DAUER_STAT3_TARGETS_UP bacterial pneumonia DOID_874 7.237E-05 1.647E-03 2.943E-03 0.06440044 DAUER_STAT3_TARGETS_UP chronic kidney failure DOID_784 8.67E-05 1.897E-03 0.08179711 0.29272047 DAUER_STAT3_TARGETS_UP primary bacterial infectious disease DOID_0050338 9.941E-05 2.095E-03 3.626E-03 0.07368798 DAUER_STAT3_TARGETS_UP restrictive cardiomyopathy DOID_397 1.164E-04 2.365E-03 0.01592069 0.18117741 DAUER_STAT3_TARGETS_UP Crohn's disease DOID_8778 1.245E-04 2.442E-03 0.09189432 0.31498715 DAUER_STAT3_TARGETS_UP membranous glomerulonephritis DOID_10976 1.838E-04 3.485E-03 1.838E-04 0.01493778 DAUER_STAT3_TARGETS_UP familial hypercholesterolemia DOID_13810 2.231E-04 4.096E-03 2.231E-04 0.01587095 DAUER_STAT3_TARGETS_UP diabetic angiopathy DOID_11713 2.663E-04 4.735E-03 0.02378821 0.22941508 DAUER_STAT3_TARGETS_UP acute pancreatitis DOID_2913 2.892E-04 4.987E-03 0.02476733 0.22019704 DAUER_STAT3_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 3.905E-04 6.534E-03 0.02867427 0.22048189 DAUER_STAT3_TARGETS_UP gestational diabetes DOID_11714 3.905E-04 6.348E-03 1.000 1.000 DAUER_STAT3_TARGETS_UP lung adenocarcinoma DOID_3910 3.905E-04 6.171E-03 0.02867427 0.21467973 DAUER_STAT3_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 4.181E-04 6.429E-03 0.02964862 0.21628289 DAUER_STAT3_TARGETS_UP pleurisy DOID_10247 4.181E-04 6.26E-03 0.02964862 0.21354514 DAUER_STAT3_TARGETS_UP renal hypertension DOID_1073 4.181E-04 6.1E-03 4.181E-04 0.02643203 DAUER_STAT3_TARGETS_UP secondary hypertension DOID_11130 4.181E-04 6.1E-03 4.181E-04 0.02643203 DAUER_STAT3_TARGETS_UP Behcet's disease DOID_13241 4.181E-04 6.429E-03 0.02964862 0.21628289 DAUER_STAT3_TARGETS_UP opportunistic mycosis DOID_2473 5.065E-04 7.205E-03 0.03256597 0.20141344 DAUER_STAT3_TARGETS_UP systemic mycosis DOID_0050136 6.032E-04 8.371E-03 0.03547478 0.21247524 DAUER_STAT3_TARGETS_UP fungal infectious disease DOID_1564 6.032E-04 8.371E-03 0.03547478 0.21247524 DAUER_STAT3_TARGETS_UP multiple myeloma DOID_9538 7.449E-04 0.01009216 1.000 1.000 DAUER_STAT3_TARGETS_UP uveitis DOID_13141 7.826E-04 0.01035642 0.04030387 0.21634815 DAUER_STAT3_TARGETS_UP hepatitis DOID_2237 8.213E-04 0.01062039 0.04126686 0.21944716 DAUER_STAT3_TARGETS_UP congenital diaphragmatic hernia DOID_3827 8.213E-04 0.01038438 0.04126686 0.21741524 DAUER_STAT3_TARGETS_UP peptic ulcer DOID_750 8.213E-04 0.01015863 8.213E-04 0.04248155 DAUER_STAT3_TARGETS_UP adult respiratory distress syndrome DOID_11394 8.608E-04 0.0104209 0.04222891 0.22044268 DAUER_STAT3_TARGETS_UP hyperinsulinism DOID_2018 9.847E-04 0.01167324 9.847E-04 0.04669298 DAUER_STAT3_TARGETS_UP uveal disease DOID_3480 9.847E-04 0.01143501 0.04510943 0.2231936 DAUER_STAT3_TARGETS_UP proteinuria DOID_576 1.117E-03 0.01270887 1.117E-03 0.04888026 DAUER_STAT3_TARGETS_UP myeloma DOID_0070004 1.163E-03 0.01297063 1.000 1.000 DAUER_STAT3_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 1.355E-03 0.01482295 0.05274962 0.23821057 DAUER_STAT3_TARGETS_UP sarcoidosis DOID_11335 1.456E-03 0.01563129 0.05465034 0.24485075 DAUER_STAT3_TARGETS_UP bone marrow cancer DOID_4960 1.508E-03 0.01588968 1.000 1.000 DAUER_STAT3_TARGETS_UP familial hyperlipidemia DOID_1168 1.615E-03 0.01670379 1.615E-03 0.05741928 DAUER_STAT3_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 1.725E-03 0.01752438 0.05938593 0.25406462 DAUER_STAT3_TARGETS_UP pre-malignant neoplasm DOID_0060071 2.015E-03 0.02011693 2.015E-03 0.05733326 DAUER_STAT3_TARGETS_UP in situ carcinoma DOID_8719 2.015E-03 0.02011693 2.015E-03 0.05733326 DAUER_STAT3_TARGETS_UP mineral metabolism disease DOID_0050032 2.076E-03 0.02036555 0.06503815 0.26623531 DAUER_STAT3_TARGETS_UP cholestasis DOID_13580 2.137E-03 0.02061404 0.06597697 0.26814925 DAUER_STAT3_TARGETS_UP nephrosis DOID_2527 2.525E-03 0.0239437 0.07159062 0.27900727 DAUER_STAT3_TARGETS_UP bile duct disease DOID_4138 2.525E-03 0.02355118 0.07159062 0.27710926 DAUER_STAT3_TARGETS_UP peripheral vascular disease DOID_341 2.592E-03 0.02379115 0.07252303 0.27882164 DAUER_STAT3_TARGETS_UP biliary tract disease DOID_9741 2.592E-03 0.02341351 0.07252303 0.27695035 DAUER_STAT3_TARGETS_UP contact dermatitis DOID_2773 3.089E-03 0.02746101 0.07902441 0.29388815 DAUER_STAT3_TARGETS_UP lipid metabolism disorder DOID_3146 3.089E-03 0.02703854 3.089E-03 0.06509277 DAUER_STAT3_TARGETS_UP transitional cell carcinoma DOID_2671 3.706E-03 0.03195192 3.706E-03 0.07271817 DAUER_STAT3_TARGETS_UP primary immunodeficiency disease DOID_612 3.787E-03 0.03216206 3.787E-03 0.07182861 DAUER_STAT3_TARGETS_UP amino acid metabolic disorder DOID_9252 3.787E-03 0.03168909 1.000 1.000 DAUER_STAT3_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 3.869E-03 0.03190372 0.08823518 0.31183737 DAUER_STAT3_TARGETS_UP lymphoma DOID_0060058 4.035E-03 0.03279646 0.09006654 0.31634482 DAUER_STAT3_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.204E-03 0.03369021 0.09189432 0.31689616 DAUER_STAT3_TARGETS_UP ulcerative colitis DOID_8577 4.552E-03 0.03597295 0.09553916 0.32551964 DAUER_STAT3_TARGETS_UP interstitial nephritis DOID_1063 9.98E-03 0.07778592 1.000 1.000 DAUER_STAT3_TARGETS_UP hypolipoproteinemia DOID_1387 9.98E-03 0.07673476 9.98E-03 0.1831733 DAUER_STAT3_TARGETS_UP transient cerebral ischemia DOID_224 9.98E-03 0.07571163 1.000 1.000 DAUER_STAT3_TARGETS_UP acute kidney failure DOID_3021 9.98E-03 0.07471542 1.000 1.000 DAUER_STAT3_TARGETS_UP insulinoma DOID_3892 9.98E-03 0.07374509 9.98E-03 0.17744913 DAUER_STAT3_TARGETS_UP hypokalemia DOID_4500 9.98E-03 0.07279964 9.98E-03 0.17207188 DAUER_STAT3_TARGETS_UP cutaneous leishmaniasis DOID_9111 9.98E-03 0.07187813 1.000 1.000 DAUER_STAT3_TARGETS_UP familial adenomatous polyposis DOID_0050424 0.01097217 0.07803957 1.000 1.000 DAUER_STAT3_TARGETS_UP maturity-onset diabetes of the young DOID_0050524 0.01097217 0.07707611 0.01097217 0.18362251 DAUER_STAT3_TARGETS_UP adrenoleukodystrophy DOID_10588 0.01097217 0.07613616 1.000 1.000 DAUER_STAT3_TARGETS_UP migraine without aura DOID_12783 0.01097217 0.07521886 0.01097217 0.17342126 DAUER_STAT3_TARGETS_UP temporal arteritis DOID_13375 0.01097217 0.0743234 1.000 1.000 DAUER_STAT3_TARGETS_UP neuronal ceroid lipofuscinosis DOID_14503 0.01097217 0.073449 1.000 1.000 DAUER_STAT3_TARGETS_UP central nervous system vasculitis DOID_525 0.01097217 0.0743234 1.000 1.000 DAUER_STAT3_TARGETS_UP bronchiectasis DOID_9563 0.01097217 0.07259494 1.000 1.000 DAUER_STAT3_TARGETS_UP otitis media DOID_10754 0.01196381 0.07824606 0.01196381 0.18398397 DAUER_STAT3_TARGETS_UP islet cell tumor DOID_1799 0.01196381 0.0773569 0.01196381 0.17914229 DAUER_STAT3_TARGETS_UP middle ear disease DOID_5100 0.01196381 0.07824606 0.01196381 0.18398397 DAUER_STAT3_TARGETS_UP lipodystrophy DOID_811 0.01196381 0.07648772 1.000 1.000 DAUER_STAT3_TARGETS_UP ocular hypertension DOID_9282 0.01196381 0.07563785 0.01196381 0.17454889 DAUER_STAT3_TARGETS_UP borderline glaucoma DOID_9283 0.01196381 0.07563785 0.01196381 0.17454889 DAUER_STAT3_TARGETS_UP essential hypertension DOID_10825 0.01295448 0.08100107 0.01295448 0.18427744 DAUER_STAT3_TARGETS_UP vulva cancer DOID_1245 0.01295448 0.08012063 0.01295448 0.17978287 DAUER_STAT3_TARGETS_UP newborn respiratory distress syndrome DOID_12716 0.01295448 0.07925912 1.000 1.000 DAUER_STAT3_TARGETS_UP polyneuropathy DOID_1389 0.01295448 0.07841593 0.01295448 0.17550233 DAUER_STAT3_TARGETS_UP tethered spinal cord syndrome DOID_1089 0.01394418 0.0835183 1.000 1.000 DAUER_STAT3_TARGETS_UP parasitic helminthiasis infectious disease DOID_883 0.01394418 0.08264831 0.01394418 0.18451717 DAUER_STAT3_TARGETS_UP polycystic kidney disease DOID_898 0.01394418 0.08179627 0.01394418 0.1803236 DAUER_STAT3_TARGETS_UP idiopathic pulmonary fibrosis DOID_0050156 0.01493292 0.08670234 0.01493292 0.18881842 DAUER_STAT3_TARGETS_UP renovascular hypertension DOID_1591 0.01493292 0.08582655 0.01493292 0.18471367 DAUER_STAT3_TARGETS_UP hyperhomocysteinemia DOID_9279 0.01493292 0.08496829 1.000 1.000 DAUER_STAT3_TARGETS_UP angiosarcoma DOID_0001816 0.01592069 0.08969178 0.01592069 0.19274192 DAUER_STAT3_TARGETS_UP silicosis DOID_10325 0.01592069 0.08881245 0.01592069 0.18872646 DAUER_STAT3_TARGETS_UP hemolytic-uremic syndrome DOID_12554 0.01592069 0.0879502 0.01592069 0.1848749 DAUER_STAT3_TARGETS_UP tongue cancer DOID_8649 0.01592069 0.08710452 1.000 1.000 DAUER_STAT3_TARGETS_UP drug-induced mental disorder DOID_1203 0.01690749 0.0916225 1.000 1.000 DAUER_STAT3_TARGETS_UP methylmalonic acidemia DOID_14749 0.01690749 0.09075814 1.000 1.000 DAUER_STAT3_TARGETS_UP drug psychosis DOID_1742 0.01690749 0.0916225 1.000 1.000 DAUER_STAT3_TARGETS_UP bronchitis DOID_6132 0.01690749 0.08990993 1.000 1.000 DAUER_STAT3_TARGETS_UP substance-induced psychosis DOID_8646 0.01690749 0.0916225 1.000 1.000 DAUER_STAT3_TARGETS_UP prion disease DOID_649 0.01789333 0.09427136 0.01789333 0.19963348 DAUER_STAT3_TARGETS_UP leishmaniasis DOID_9065 0.01887821 0.09854774 1.000 1.000 SABATES_COLORECTAL_ADENOMA_UP cystic fibrosis DOID_1485 2.101E-10 1.196E-07 2.101E-10 1.196E-07 SABATES_COLORECTAL_ADENOMA_UP hepatitis DOID_2237 2.126E-08 6.048E-06 2.126E-08 6.048E-06 SABATES_COLORECTAL_ADENOMA_UP pulmonary emphysema DOID_9675 2.706E-08 5.132E-06 9.29E-05 3.524E-03 SABATES_COLORECTAL_ADENOMA_UP cholestasis DOID_13580 2.503E-07 3.56E-05 2.503E-07 4.747E-05 SABATES_COLORECTAL_ADENOMA_UP hypotrichosis DOID_4535 2.79E-07 3.175E-05 2.79E-07 3.968E-05 SABATES_COLORECTAL_ADENOMA_UP bile duct disease DOID_4138 3.832E-07 3.634E-05 3.832E-07 4.361E-05 SABATES_COLORECTAL_ADENOMA_UP biliary tract disease DOID_9741 4.1E-07 3.332E-05 4.1E-07 3.888E-05 SABATES_COLORECTAL_ADENOMA_UP hair disease DOID_421 7.93E-07 5.64E-05 7.93E-07 6.446E-05 SABATES_COLORECTAL_ADENOMA_UP mouth disease DOID_403 1.406E-06 8.887E-05 4.088E-05 1.789E-03 SABATES_COLORECTAL_ADENOMA_UP hypothyroidism DOID_1459 8.728E-06 4.966E-04 8.728E-06 6.207E-04 SABATES_COLORECTAL_ADENOMA_UP tooth disease DOID_1091 1.173E-05 6.068E-04 1.173E-05 7.417E-04 SABATES_COLORECTAL_ADENOMA_UP allergic contact dermatitis DOID_3042 1.173E-05 5.563E-04 1.173E-05 6.675E-04 SABATES_COLORECTAL_ADENOMA_UP astrocytoma DOID_3069 1.312E-05 5.744E-04 4.021E-04 0.01204043 SABATES_COLORECTAL_ADENOMA_UP pancreatitis DOID_4989 1.994E-05 8.102E-04 1.994E-05 1.031E-03 SABATES_COLORECTAL_ADENOMA_UP bacterial pneumonia DOID_874 1.994E-05 7.562E-04 5.476E-04 0.01557984 SABATES_COLORECTAL_ADENOMA_UP contact dermatitis DOID_2773 2.198E-05 7.817E-04 2.198E-05 1.042E-03 SABATES_COLORECTAL_ADENOMA_UP myocarditis DOID_820 5.066E-05 1.696E-03 5.066E-05 2.059E-03 SABATES_COLORECTAL_ADENOMA_UP lung small cell carcinoma DOID_5409 1.533E-04 4.845E-03 4.803E-03 0.07191978 SABATES_COLORECTAL_ADENOMA_UP giant cell tumor DOID_200 1.912E-04 5.725E-03 5.55E-03 0.0789467 SABATES_COLORECTAL_ADENOMA_UP malignant giant cell tumor DOID_2705 1.912E-04 5.725E-03 5.55E-03 0.0789467 SABATES_COLORECTAL_ADENOMA_UP giant cell glioblastoma DOID_3074 1.912E-04 5.725E-03 5.55E-03 0.0789467 SABATES_COLORECTAL_ADENOMA_UP glioblastoma DOID_3068 2.464E-04 7.011E-03 6.553E-03 0.09094383 SABATES_COLORECTAL_ADENOMA_UP carotid stenosis DOID_13001 2.97E-04 8.047E-03 0.02541904 0.23328116 SABATES_COLORECTAL_ADENOMA_UP Legionnaires' disease DOID_10457 3.46E-04 8.95E-03 3.46E-04 0.01230603 SABATES_COLORECTAL_ADENOMA_UP legionellosis DOID_10458 3.46E-04 8.95E-03 3.46E-04 0.01230603 SABATES_COLORECTAL_ADENOMA_UP viral pneumonia DOID_10533 3.46E-04 8.561E-03 3.46E-04 0.01158215 SABATES_COLORECTAL_ADENOMA_UP bacterial meningitis DOID_9470 3.46E-04 8.204E-03 0.02734773 0.2431384 SABATES_COLORECTAL_ADENOMA_UP corneal dystrophy DOID_2566 3.988E-04 9.076E-03 3.988E-04 0.0126054 SABATES_COLORECTAL_ADENOMA_UP lung oat cell carcinoma DOID_5411 3.988E-04 8.727E-03 0.02927265 0.24859911 SABATES_COLORECTAL_ADENOMA_UP intermediate coronary syndrome DOID_8805 3.988E-04 8.404E-03 0.02927265 0.24494324 SABATES_COLORECTAL_ADENOMA_UP amino acid metabolic disorder DOID_9252 7.972E-04 0.01620053 7.972E-04 0.02160071 SABATES_COLORECTAL_ADENOMA_UP hypersensitivity reaction type I disease DOID_1205 9.594E-04 0.01882318 9.594E-04 0.02481237 SABATES_COLORECTAL_ADENOMA_UP dilated cardiomyopathy DOID_12930 9.594E-04 0.01819574 0.01592731 0.18495181 SABATES_COLORECTAL_ADENOMA_UP meningitis DOID_9471 1.036E-03 0.01901858 0.04642871 0.28715146 SABATES_COLORECTAL_ADENOMA_UP ulcerative colitis DOID_8577 1.048E-03 0.01862909 1.048E-03 0.02591874 SABATES_COLORECTAL_ADENOMA_UP acute pancreatitis DOID_2913 1.125E-03 0.01939465 1.125E-03 0.02666764 SABATES_COLORECTAL_ADENOMA_UP middle cerebral artery infarction DOID_3525 1.412E-03 0.02362759 1.412E-03 0.03213353 SABATES_COLORECTAL_ADENOMA_UP periodontitis DOID_824 1.514E-03 0.02462117 1.514E-03 0.03314389 SABATES_COLORECTAL_ADENOMA_UP pleurisy DOID_10247 1.621E-03 0.02561426 1.621E-03 0.03415234 SABATES_COLORECTAL_ADENOMA_UP invasive ductal carcinoma DOID_3008 1.621E-03 0.02492198 1.621E-03 0.03293262 SABATES_COLORECTAL_ADENOMA_UP corneal disease DOID_10124 1.843E-03 0.02759827 1.843E-03 0.03616325 SABATES_COLORECTAL_ADENOMA_UP bronchiolitis obliterans DOID_2799 1.96E-03 0.0285889 1.96E-03 0.03716558 SABATES_COLORECTAL_ADENOMA_UP abdominal aortic aneurysm DOID_7693 1.96E-03 0.02787418 0.06328553 0.32151308 SABATES_COLORECTAL_ADENOMA_UP pleural disease DOID_1532 2.203E-03 0.03056684 2.203E-03 0.04042711 SABATES_COLORECTAL_ADENOMA_UP hepatitis C DOID_1883 2.459E-03 0.03331439 2.459E-03 0.04372513 SABATES_COLORECTAL_ADENOMA_UP periodontal disease DOID_3388 2.459E-03 0.03253964 2.459E-03 0.04240013 SABATES_COLORECTAL_ADENOMA_UP pulmonary sarcoidosis DOID_13406 2.869E-03 0.03710084 0.07619281 0.35829511 SABATES_COLORECTAL_ADENOMA_UP multiple myeloma DOID_9538 2.869E-03 0.03627637 0.07619281 0.34962668 SABATES_COLORECTAL_ADENOMA_UP intracranial arterial disease DOID_13089 3.309E-03 0.04092675 3.309E-03 0.05537149 SABATES_COLORECTAL_ADENOMA_UP cerebral arterial disease DOID_3527 3.309E-03 0.04092675 3.309E-03 0.05537149 SABATES_COLORECTAL_ADENOMA_UP rheumatic disease DOID_1575 3.778E-03 0.04573579 1.000 1.000 SABATES_COLORECTAL_ADENOMA_UP scleroderma DOID_419 3.778E-03 0.04573579 1.000 1.000 SABATES_COLORECTAL_ADENOMA_UP uterine cancer DOID_363 3.941E-03 0.04671364 3.941E-03 0.06406442 SABATES_COLORECTAL_ADENOMA_UP influenza DOID_8469 3.941E-03 0.0457603 3.941E-03 0.06228485 SABATES_COLORECTAL_ADENOMA_UP cerebral infarction DOID_3526 4.107E-03 0.04673519 4.107E-03 0.06315567 SABATES_COLORECTAL_ADENOMA_UP myeloma DOID_0070004 4.449E-03 0.04963208 0.0943279 0.39757464 SABATES_COLORECTAL_ADENOMA_UP pre-eclampsia DOID_10591 4.449E-03 0.04867761 0.0943279 0.3946513 SABATES_COLORECTAL_ADENOMA_UP heart valve disease DOID_4079 4.449E-03 0.04775917 0.0943279 0.38893171 SABATES_COLORECTAL_ADENOMA_UP aortic aneurysm DOID_3627 4.985E-03 0.05252789 0.09969961 0.39395193 SABATES_COLORECTAL_ADENOMA_UP atopic dermatitis DOID_3310 5.358E-03 0.05543585 5.358E-03 0.07817876 SABATES_COLORECTAL_ADENOMA_UP sarcoidosis DOID_11335 5.55E-03 0.0563905 0.10503988 0.40658293 SABATES_COLORECTAL_ADENOMA_UP bone marrow cancer DOID_4960 5.744E-03 0.05734264 0.10681301 0.40789667 SABATES_COLORECTAL_ADENOMA_UP vasculitis DOID_865 5.744E-03 0.05635397 0.10681301 0.40517736 SABATES_COLORECTAL_ADENOMA_UP hypersensitivity reaction type IV disease DOID_2916 6.553E-03 0.06319826 0.11387095 0.42348087 SABATES_COLORECTAL_ADENOMA_UP bile duct cancer DOID_4606 6.553E-03 0.06214495 6.553E-03 0.0887785 SABATES_COLORECTAL_ADENOMA_UP bile duct carcinoma DOID_4897 6.553E-03 0.06214495 6.553E-03 0.0887785 SABATES_COLORECTAL_ADENOMA_UP carotid artery disease DOID_3407 7.192E-03 0.06708221 0.11912827 0.43451274 SABATES_COLORECTAL_ADENOMA_UP collagen disease DOID_854 7.192E-03 0.06600024 1.000 1.000 SABATES_COLORECTAL_ADENOMA_UP brain infarction DOID_3454 8.786E-03 0.07935302 8.786E-03 0.1162614 SABATES_COLORECTAL_ADENOMA_UP pancreatic ductal carcinoma DOID_3587 9.268E-03 0.08239831 9.268E-03 0.11985209 SABATES_COLORECTAL_ADENOMA_UP pancreatic carcinoma DOID_4905 0.01001265 0.0876492 0.01001265 0.1266044 SABATES_COLORECTAL_ADENOMA_UP aneurysm disease DOID_2403 0.01078301 0.09296265 0.14495673 0.4998811 SABATES_COLORECTAL_ADENOMA_UP mixed glioma DOID_5076 0.01104546 0.09380398 0.14665181 0.50268001 SABATES_COLORECTAL_ADENOMA_UP chromosomal disease DOID_0080014 0.01184961 0.09915332 0.01184961 0.14657447 NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER chronic leukemia DOID_1036 6.417E-05 0.03651424 0.01193742 0.5224915 NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER chronic lymphocytic leukemia DOID_1040 6.417E-05 0.03651424 0.01193742 0.5224915 NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER adenoma DOID_657 7.986E-05 0.02271944 1.000 1.000 NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER autoimmune disease of urogenital tract DOID_0060049 1.066E-04 0.02021246 1.066E-04 0.06063739 NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER primary biliary cirrhosis DOID_12236 1.066E-04 0.02021246 1.066E-04 0.06063739 NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER lymphoblastic leukemia DOID_1037 4.76E-04 0.06771221 0.03209598 0.67639309 KLEIN_TARGETS_OF_BCR_ABL1_FUSION primary immunodeficiency disease DOID_612 6.615E-21 3.764E-18 1.258E-18 7.16E-16 KLEIN_TARGETS_OF_BCR_ABL1_FUSION B cell deficiency DOID_2115 5.383E-16 1.531E-13 2.092E-13 2.976E-11 KLEIN_TARGETS_OF_BCR_ABL1_FUSION agammaglobulinemia DOID_2583 1.516E-14 2.876E-12 1.516E-14 4.314E-12 KLEIN_TARGETS_OF_BCR_ABL1_FUSION blood protein disease DOID_620 2.165E-14 3.079E-12 2.165E-14 4.106E-12 KLEIN_TARGETS_OF_BCR_ABL1_FUSION MHC class II deficiency DOID_5812 2.944E-09 3.35E-07 2.944E-09 3.35E-07 KLEIN_TARGETS_OF_BCR_ABL1_FUSION severe combined immunodeficiency DOID_627 9.567E-09 9.073E-07 9.567E-09 9.073E-07 KLEIN_TARGETS_OF_BCR_ABL1_FUSION combined T cell and B cell immunodeficiency DOID_628 1.13E-08 9.185E-07 1.13E-08 9.185E-07 KLEIN_TARGETS_OF_BCR_ABL1_FUSION ulcerative colitis DOID_8577 4.705E-08 3.346E-06 1.296E-04 7.376E-03 KLEIN_TARGETS_OF_BCR_ABL1_FUSION lymphoma DOID_0060058 2.198E-06 1.39E-04 1.079E-04 6.821E-03 KLEIN_TARGETS_OF_BCR_ABL1_FUSION neuritis DOID_1803 1.625E-05 9.246E-04 1.102E-03 0.04181429 KLEIN_TARGETS_OF_BCR_ABL1_FUSION B-cell lymphocytic neoplasm DOID_707 2.051E-05 1.061E-03 1.285E-03 0.04299362 KLEIN_TARGETS_OF_BCR_ABL1_FUSION common variable immunodeficiency DOID_12177 5.069E-05 2.404E-03 5.069E-05 3.605E-03 KLEIN_TARGETS_OF_BCR_ABL1_FUSION bacterial pneumonia DOID_874 6.676E-05 2.922E-03 0.07521803 0.69030736 KLEIN_TARGETS_OF_BCR_ABL1_FUSION lymphoblastic leukemia DOID_1037 1.113E-04 4.525E-03 3.908E-03 0.11119551 KLEIN_TARGETS_OF_BCR_ABL1_FUSION bronchiolitis DOID_2942 2.968E-04 0.01125839 1.000 1.000 KLEIN_TARGETS_OF_BCR_ABL1_FUSION chronic leukemia DOID_1036 5.404E-04 0.01921669 0.03361307 0.50331145 KLEIN_TARGETS_OF_BCR_ABL1_FUSION chronic lymphocytic leukemia DOID_1040 5.404E-04 0.01921669 0.03361307 0.50331145 KLEIN_TARGETS_OF_BCR_ABL1_FUSION multiple myeloma DOID_9538 7.062E-04 0.02363703 7.062E-04 0.03652996 KLEIN_TARGETS_OF_BCR_ABL1_FUSION blood platelet disease DOID_2218 7.42E-04 0.02345426 7.42E-04 0.0351814 KLEIN_TARGETS_OF_BCR_ABL1_FUSION autoimmune disease of urogenital tract DOID_0060049 8.936E-04 0.02676055 8.936E-04 0.03911157 KLEIN_TARGETS_OF_BCR_ABL1_FUSION primary biliary cirrhosis DOID_12236 8.936E-04 0.02676055 8.936E-04 0.03911157 KLEIN_TARGETS_OF_BCR_ABL1_FUSION myeloma DOID_0070004 1.102E-03 0.03136072 1.102E-03 0.04480102 KLEIN_TARGETS_OF_BCR_ABL1_FUSION vascular skin disease DOID_9540 1.102E-03 0.02986735 1.000 1.000 KLEIN_TARGETS_OF_BCR_ABL1_FUSION hemorrhagic disease DOID_2213 1.285E-03 0.03322235 1.285E-03 0.04568073 KLEIN_TARGETS_OF_BCR_ABL1_FUSION atopic dermatitis DOID_3310 1.332E-03 0.03295682 0.05232425 0.59544992 KLEIN_TARGETS_OF_BCR_ABL1_FUSION bone marrow cancer DOID_4960 1.43E-03 0.03390278 1.43E-03 0.0452037 KLEIN_TARGETS_OF_BCR_ABL1_FUSION parasitic infectious disease DOID_1398 2.027E-03 0.04614197 0.06429698 0.63077556 KLEIN_TARGETS_OF_BCR_ABL1_FUSION blood coagulation disease DOID_1247 2.332E-03 0.05102732 2.332E-03 0.06982686 KLEIN_TARGETS_OF_BCR_ABL1_FUSION peripheral vascular disease DOID_341 2.459E-03 0.05182238 1.000 1.000 KLEIN_TARGETS_OF_BCR_ABL1_FUSION Crohn's disease DOID_8778 3.989E-03 0.08106561 0.08958667 0.77234572 STREICHER_LSM1_TARGETS_UP lymphoma DOID_0060058 4.307E-07 2.451E-04 4.307E-07 2.451E-04 STREICHER_LSM1_TARGETS_UP myeloma DOID_0070004 4.864E-06 1.384E-03 5.016E-04 0.14269975 STREICHER_LSM1_TARGETS_UP bone marrow cancer DOID_4960 7.239E-06 1.373E-03 6.516E-04 0.09269623 STREICHER_LSM1_TARGETS_UP uterine disease DOID_345 1.234E-05 1.755E-03 9.26E-04 0.08781376 STREICHER_LSM1_TARGETS_UP female reproductive system disease DOID_229 2.248E-05 2.558E-03 1.375E-03 0.09779183 STREICHER_LSM1_TARGETS_UP parathyroid gland disease DOID_11201 3.242E-05 3.074E-03 8.54E-03 0.32395897 STREICHER_LSM1_TARGETS_UP lung oat cell carcinoma DOID_5411 4.361E-05 3.544E-03 9.848E-03 0.28017185 STREICHER_LSM1_TARGETS_UP placenta disease DOID_780 9.566E-05 6.804E-03 0.01441161 0.28276582 STREICHER_LSM1_TARGETS_UP bronchiolitis obliterans DOID_2799 2.177E-04 0.01376232 0.02154244 0.27858295 STREICHER_LSM1_TARGETS_UP multiple myeloma DOID_9538 3.207E-04 0.01824595 0.02605443 0.27971638 STREICHER_LSM1_TARGETS_UP congenital diaphragmatic hernia DOID_3827 3.537E-04 0.01829495 0.02733989 0.2828436 STREICHER_LSM1_TARGETS_UP influenza DOID_8469 4.432E-04 0.02101299 0.03054643 0.27588761 STREICHER_LSM1_TARGETS_UP lung small cell carcinoma DOID_5409 5.425E-04 0.02374469 0.03374282 0.29537948 STREICHER_LSM1_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 5.85E-04 0.02377536 5.85E-04 0.11095166 STREICHER_LSM1_TARGETS_UP oral cavity cancer DOID_8618 7.46E-04 0.02829746 7.46E-04 0.08489238 STREICHER_LSM1_TARGETS_UP aneurysm disease DOID_2403 1.247E-03 0.04434079 0.05082926 0.37079296 STREICHER_LSM1_TARGETS_UP mixed glioma DOID_5076 1.278E-03 0.0427853 1.278E-03 0.10390716 STREICHER_LSM1_TARGETS_UP bacterial pneumonia DOID_874 1.278E-03 0.04040834 0.05145649 0.36598429 STREICHER_LSM1_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 1.871E-03 0.0560192 0.06205867 0.40126574 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN prion disease DOID_649 5.328E-07 3.032E-04 0.01602416 0.60784995 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN nephroblastoma DOID_2154 5.015E-06 1.427E-03 0.03266813 0.74352669 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN encephalomyelitis DOID_640 8.621E-05 0.01635178 0.08180333 0.81659813 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN alcohol-related neurodevelopmental disorder DOID_0050667 8.894E-05 0.01265169 0.08262887 0.8106177 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN focal glomerulosclerosis DOID_3945 3.571E-04 0.04064288 1.000 1.000 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN endometrial carcinoma DOID_2871 3.807E-04 0.03610671 0.02831483 0.84795452 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN endometrial cancer DOID_1380 4.301E-04 0.03496504 0.03005843 0.74361931 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN gallbladder cancer DOID_3121 8.228E-04 0.05852387 8.228E-04 0.46819094 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN uterine cancer DOID_363 8.228E-04 0.05202122 0.04131803 0.67171308 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN pre-eclampsia DOID_10591 9.309E-04 0.05296655 9.309E-04 0.26483277 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN heart valve disease DOID_4079 9.309E-04 0.04815141 1.000 1.000 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN familial hyperlipidemia DOID_1168 1.294E-03 0.06133947 0.05159884 0.71609117 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN cholestasis DOID_13580 1.714E-03 0.07500466 1.000 1.000 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN pancreatic ductal carcinoma DOID_3587 1.971E-03 0.08012298 1.971E-03 0.37390725 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN bile duct disease DOID_4138 2.025E-03 0.07681562 1.000 1.000 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN biliary tract disease DOID_9741 2.079E-03 0.07394616 1.000 1.000 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN pancreatic carcinoma DOID_4905 2.134E-03 0.0714373 2.134E-03 0.30360851 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN metabolic syndrome X DOID_14221 2.479E-03 0.07835458 0.07100545 0.80804199 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN lipid metabolism disorder DOID_3146 2.479E-03 0.07423065 0.07100545 0.79219803 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN biliary tract cancer DOID_4607 2.66E-03 0.07567908 2.66E-03 0.30271633 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN primary immunodeficiency disease DOID_612 3.041E-03 0.08239709 0.07849394 0.81205553 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN lymphoblastic leukemia DOID_1037 3.308E-03 0.08556629 0.08180333 0.83118024 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN Crohn's disease DOID_8778 3.377E-03 0.0835406 1.000 1.000 SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN hypersensitivity reaction type I disease DOID_1205 3.446E-03 0.08169943 0.08345369 0.80483305 BROWNE_HCMV_INFECTION_16HR_DN collagen disease DOID_854 3.468E-08 1.973E-05 0.0872578 0.62847704 BROWNE_HCMV_INFECTION_16HR_DN dilated cardiomyopathy DOID_12930 2.829E-07 8.049E-05 3.664E-04 0.10422847 BROWNE_HCMV_INFECTION_16HR_DN osteogenesis imperfecta DOID_12347 7.734E-07 1.467E-04 0.01836251 0.5804592 BROWNE_HCMV_INFECTION_16HR_DN Ehlers-Danlos syndrome DOID_13359 1.228E-06 1.747E-04 0.02115798 0.52342991 BROWNE_HCMV_INFECTION_16HR_DN oral submucous fibrosis DOID_5773 1.228E-06 1.397E-04 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN alcohol abuse DOID_1574 6.832E-06 6.479E-04 6.832E-06 3.887E-03 BROWNE_HCMV_INFECTION_16HR_DN bone development disease DOID_0080006 7.157E-06 5.818E-04 0.1154909 0.65714324 BROWNE_HCMV_INFECTION_16HR_DN rheumatic disease DOID_1575 3.971E-05 2.824E-03 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN scleroderma DOID_419 3.971E-05 2.824E-03 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN heart valve disease DOID_4079 5.106E-05 3.228E-03 0.06883272 0.60255101 BROWNE_HCMV_INFECTION_16HR_DN osteochondrodysplasia DOID_2256 7.974E-05 4.537E-03 0.07940557 0.62752456 BROWNE_HCMV_INFECTION_16HR_DN smallpox DOID_8736 7.974E-05 4.125E-03 3.128E-03 0.22246078 BROWNE_HCMV_INFECTION_16HR_DN brain infarction DOID_3454 1.458E-04 6.912E-03 4.647E-03 0.26440052 BROWNE_HCMV_INFECTION_16HR_DN aneurysm disease DOID_2403 2.001E-04 8.757E-03 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN retinal vascular disease DOID_2462 2.66E-04 0.01081246 6.894E-03 0.32691262 BROWNE_HCMV_INFECTION_16HR_DN mouth disease DOID_403 3.554E-04 0.01348086 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN limb-girdle muscular dystrophy DOID_11724 3.722E-04 0.0132358 0.02811251 0.57128639 BROWNE_HCMV_INFECTION_16HR_DN aortic valve disease DOID_62 5.387E-04 0.01802978 0.0336412 0.59818263 BROWNE_HCMV_INFECTION_16HR_DN periodontitis DOID_824 7.888E-04 0.02493456 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN bladder disease DOID_365 1.15E-03 0.03442978 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN periodontal disease DOID_3388 1.285E-03 0.03654458 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN congenital diaphragmatic hernia DOID_3827 1.653E-03 0.04479019 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN systemic scleroderma DOID_418 1.653E-03 0.04275428 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN benign mesothelioma DOID_2645 1.813E-03 0.04485086 0.06082496 0.57682333 BROWNE_HCMV_INFECTION_16HR_DN endometriosis of uterus DOID_288 1.896E-03 0.04494027 1.896E-03 0.35952218 BROWNE_HCMV_INFECTION_16HR_DN nephrotic syndrome DOID_1184 1.98E-03 0.04506261 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN endometriosis DOID_289 1.98E-03 0.04332944 1.98E-03 0.28164134 BROWNE_HCMV_INFECTION_16HR_DN gallbladder cancer DOID_3121 2.066E-03 0.04353939 0.06483725 0.60479335 BROWNE_HCMV_INFECTION_16HR_DN cerebral infarction DOID_3526 2.154E-03 0.04376993 2.154E-03 0.24511159 BROWNE_HCMV_INFECTION_16HR_DN learning disability DOID_8927 2.154E-03 0.04226062 2.154E-03 0.20425966 BROWNE_HCMV_INFECTION_16HR_DN myeloma DOID_0070004 2.335E-03 0.04428416 0.06883272 0.62167962 BROWNE_HCMV_INFECTION_16HR_DN lung small cell carcinoma DOID_5409 2.523E-03 0.04630463 2.523E-03 0.20506338 BROWNE_HCMV_INFECTION_16HR_DN atrophic muscular disease DOID_913 2.919E-03 0.05190771 0.07677345 0.63310283 BROWNE_HCMV_INFECTION_16HR_DN muscular dystrophy DOID_9884 2.919E-03 0.05190771 0.07677345 0.63310283 BROWNE_HCMV_INFECTION_16HR_DN bile duct adenocarcinoma DOID_4896 3.023E-03 0.05211765 0.07809043 0.63476367 BROWNE_HCMV_INFECTION_16HR_DN cholangiocarcinoma DOID_4947 3.023E-03 0.05211765 0.07809043 0.63476367 BROWNE_HCMV_INFECTION_16HR_DN bone marrow cancer DOID_4960 3.023E-03 0.05058477 0.07809043 0.62582333 BROWNE_HCMV_INFECTION_16HR_DN bile duct cancer DOID_4606 3.453E-03 0.05613945 0.08333993 0.60795414 BROWNE_HCMV_INFECTION_16HR_DN bile duct carcinoma DOID_4897 3.453E-03 0.05613945 0.08333993 0.60795414 BROWNE_HCMV_INFECTION_16HR_DN uterine disease DOID_345 4.271E-03 0.06751052 4.271E-03 0.2700421 BROWNE_HCMV_INFECTION_16HR_DN tooth disease DOID_1091 4.52E-03 0.06950981 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN pancreatic ductal carcinoma DOID_3587 4.905E-03 0.07344941 0.09891304 0.63956269 BROWNE_HCMV_INFECTION_16HR_DN nephrosis DOID_2527 5.037E-03 0.07348723 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN biliary tract disease DOID_9741 5.17E-03 0.07354621 0.10148318 0.64159923 BROWNE_HCMV_INFECTION_16HR_DN pancreatic carcinoma DOID_4905 5.305E-03 0.07362474 0.10276556 0.64256705 BROWNE_HCMV_INFECTION_16HR_DN diabetic retinopathy DOID_8947 5.305E-03 0.07187177 0.10276556 0.63558263 BROWNE_HCMV_INFECTION_16HR_DN syndrome DOID_225 5.58E-03 0.07383472 0.10532492 0.6444073 BROWNE_HCMV_INFECTION_16HR_DN bone resorption disease DOID_0080011 5.72E-03 0.07396365 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN osteoporosis DOID_11476 5.72E-03 0.07396365 1.000 1.000 BROWNE_HCMV_INFECTION_16HR_DN female reproductive system disease DOID_229 6.294E-03 0.0795887 6.294E-03 0.32559014 BROWNE_HCMV_INFECTION_16HR_DN mental depression DOID_1596 6.591E-03 0.08153121 0.11422638 0.67004961 BROWNE_HCMV_INFECTION_16HR_DN biliary tract cancer DOID_4607 6.591E-03 0.07979651 0.11422638 0.65651325 BROWNE_HCMV_INFECTION_16HR_DN primary bacterial infectious disease DOID_0050338 7.204E-03 0.0853962 0.11927385 0.6719487 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP embryonal cancer DOID_688 1.128E-05 6.419E-03 8.672E-04 0.24671351 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP cervix uteri carcinoma in situ DOID_8991 1.508E-05 4.289E-03 1.049E-03 0.19893421 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP pustulosis of palm and sole DOID_4398 3.476E-05 6.592E-03 0.06087534 0.48786015 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP hypothyroidism DOID_1459 4.894E-05 6.962E-03 0.06797322 0.50229559 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP facioscapulohumeral muscular dystrophy DOID_11727 5.107E-05 5.812E-03 5.107E-05 0.02905805 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP pre-malignant neoplasm DOID_0060071 5.124E-05 4.859E-03 2.343E-03 0.22216893 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP in situ carcinoma DOID_8719 5.124E-05 4.859E-03 2.343E-03 0.22216893 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP transitional cell carcinoma DOID_2671 1.292E-04 0.01050132 4.303E-03 0.24484695 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP encephalomyelitis DOID_640 1.516E-04 0.01078555 4.781E-03 0.2473091 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP ulcerative colitis DOID_8577 1.765E-04 0.01115805 5.282E-03 0.25046954 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP intracranial aneurysm DOID_10941 4.237E-04 0.0241095 0.02985393 0.41431435 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP invasive ductal carcinoma DOID_3008 4.869E-04 0.02518826 1.000 1.000 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP nephroblastoma DOID_2154 7.42E-04 0.0351814 0.03926384 0.39194957 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP autoimmune disease of urogenital tract DOID_0060049 1.097E-03 0.04801029 1.097E-03 0.15603343 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP primary biliary cirrhosis DOID_12236 1.097E-03 0.04801029 1.097E-03 0.15603343 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP uterine cancer DOID_363 1.196E-03 0.04861227 1.000 1.000 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP atrophic muscular disease DOID_913 1.693E-03 0.06423989 1.693E-03 0.19271966 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP muscular dystrophy DOID_9884 1.693E-03 0.06423989 1.693E-03 0.19271966 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP carotid artery disease DOID_3407 2.205E-03 0.07840997 0.06696245 0.50133728 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP allergic contact dermatitis DOID_3042 2.63E-03 0.08804178 2.63E-03 0.21381576 HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP aneurysm disease DOID_2403 3.335E-03 0.09988262 0.0820123 0.53028406 SHEPARD_BMYB_TARGETS congenital nervous system abnormality DOID_2490 2.818E-05 0.01603455 2.818E-05 0.01603455 SHEPARD_BMYB_TARGETS pre-malignant neoplasm DOID_0060071 3.753E-05 0.0106778 3.753E-05 0.0106778 SHEPARD_BMYB_TARGETS in situ carcinoma DOID_8719 3.753E-05 0.0106778 3.753E-05 0.0106778 SHEPARD_BMYB_TARGETS mixed glioma DOID_5076 6.676E-05 0.01266136 6.676E-05 0.01266136 SHEPARD_BMYB_TARGETS subependymal glioma DOID_4843 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS pilocytic astrocytoma DOID_4851 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS subependymal giant cell astrocytoma DOID_5077 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS fibrillary astrocytoma DOID_6726 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS juvenile pilocytic astrocytoma DOID_6811 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS childhood pilocytic astrocytoma DOID_6812 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS gemistocytic astrocytoma DOID_7005 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS childhood cerebral astrocytoma DOID_7007 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS protoplasmic astrocytoma DOID_7008 1.742E-04 0.0247731 0.01934428 0.3057471 SHEPARD_BMYB_TARGETS benign glioma DOID_0060101 2.115E-04 0.02406548 0.02125856 0.32692222 SHEPARD_BMYB_TARGETS benign ependymoma DOID_4844 2.115E-04 0.02406548 0.02125856 0.32692222 SHEPARD_BMYB_TARGETS diffuse large B-cell lymphoma DOID_0050745 3.701E-04 0.03509603 3.701E-04 0.05264404 SHEPARD_BMYB_TARGETS supratentorial cancer DOID_1659 4.233E-04 0.03441154 0.02982793 0.37715763 SHEPARD_BMYB_TARGETS cerebrum cancer DOID_368 4.233E-04 0.03441154 0.02982793 0.37715763 SHEPARD_BMYB_TARGETS female reproductive organ benign neoplasm DOID_0060086 4.513E-04 0.03209771 4.513E-04 0.05135633 SHEPARD_BMYB_TARGETS uterine benign neoplasm DOID_0060095 4.513E-04 0.03209771 4.513E-04 0.05135633 SHEPARD_BMYB_TARGETS uterine fibroid DOID_13223 4.513E-04 0.03209771 4.513E-04 0.05135633 SHEPARD_BMYB_TARGETS leiomyoma DOID_127 5.404E-04 0.034163 5.404E-04 0.0512445 SHEPARD_BMYB_TARGETS lymphoid leukemia DOID_10747 6.373E-04 0.03626071 6.373E-04 0.05180101 SHEPARD_BMYB_TARGETS microcephaly DOID_10907 7.42E-04 0.0383797 7.42E-04 0.05277209 SHEPARD_BMYB_TARGETS adenoid cystic carcinoma DOID_4866 8.161E-04 0.03869487 8.161E-04 0.05159316 SHEPARD_BMYB_TARGETS salivary gland cancer DOID_8850 8.936E-04 0.03911157 8.936E-04 0.05084504 SHEPARD_BMYB_TARGETS primitive neuroectodermal tumor DOID_168 9.336E-04 0.03794538 0.04394825 0.41677591 SHEPARD_BMYB_TARGETS diabetic autonomic neuropathy DOID_11503 9.745E-04 0.03696701 9.745E-04 0.05040956 SHEPARD_BMYB_TARGETS autonomic neuropathy DOID_11504 9.745E-04 0.03696701 9.745E-04 0.05040956 SHEPARD_BMYB_TARGETS diabetic polyneuropathy DOID_12785 9.745E-04 0.03696701 9.745E-04 0.05040956 SHEPARD_BMYB_TARGETS uterine cancer DOID_363 9.745E-04 0.03465657 9.745E-04 0.04620877 SHEPARD_BMYB_TARGETS diabetic neuropathy DOID_9743 9.745E-04 0.03696701 9.745E-04 0.05040956 SHEPARD_BMYB_TARGETS autonomic nervous system disease DOID_11465 1.102E-03 0.03689496 1.102E-03 0.04824725 SHEPARD_BMYB_TARGETS brain cancer DOID_1319 1.102E-03 0.03484524 0.04767977 0.41738137 SHEPARD_BMYB_TARGETS central nervous system cancer DOID_3620 1.147E-03 0.03433759 0.04861043 0.41282592 SHEPARD_BMYB_TARGETS B-cell lymphocytic neoplasm DOID_707 1.285E-03 0.03654458 1.285E-03 0.05220654 SHEPARD_BMYB_TARGETS giant cell tumor DOID_200 1.381E-03 0.03740947 0.05325049 0.43285043 SHEPARD_BMYB_TARGETS malignant giant cell tumor DOID_2705 1.381E-03 0.03740947 0.05325049 0.43285043 SHEPARD_BMYB_TARGETS giant cell glioblastoma DOID_3074 1.381E-03 0.03740947 0.05325049 0.43285043 SHEPARD_BMYB_TARGETS reproductive organ benign neoplasm DOID_0050622 1.48E-03 0.03828223 1.48E-03 0.05614727 SHEPARD_BMYB_TARGETS hypertrophic cardiomyopathy DOID_11984 1.636E-03 0.04046418 1.636E-03 0.05816726 SHEPARD_BMYB_TARGETS glioblastoma DOID_3068 1.636E-03 0.03877817 0.05786853 0.44496208 SHEPARD_BMYB_TARGETS oral cavity cancer DOID_8618 1.636E-03 0.03722705 1.636E-03 0.05474566 SHEPARD_BMYB_TARGETS neuroectodermal tumor DOID_171 1.799E-03 0.03936092 0.06062883 0.45391844 SHEPARD_BMYB_TARGETS carotid artery disease DOID_3407 1.799E-03 0.03790311 1.799E-03 0.05685467 SHEPARD_BMYB_TARGETS astrocytoma DOID_3069 2.269E-03 0.04611263 0.0679512 0.46583412 SHEPARD_BMYB_TARGETS biliary tract cancer DOID_4607 3.144E-03 0.06169165 3.144E-03 0.09416094 SHEPARD_BMYB_TARGETS transitional cell carcinoma DOID_2671 3.517E-03 0.06669712 3.517E-03 0.10004567 SHEPARD_BMYB_TARGETS nervous system cancer DOID_3093 3.671E-03 0.06738004 0.08601501 0.54380601 SHEPARD_BMYB_TARGETS Human immunodeficiency virus infectious disease DOID_526 3.671E-03 0.06527442 3.671E-03 0.09946578 SHEPARD_BMYB_TARGETS lymphoma DOID_0060058 3.829E-03 0.06601287 3.829E-03 0.09901931 SHEPARD_BMYB_TARGETS lymphoblastic leukemia DOID_1037 3.908E-03 0.06540912 3.908E-03 0.09669175 SUZUKI_AMPLIFIED_IN_ORAL_CANCER transitional cell carcinoma DOID_2671 3.637E-06 2.069E-03 4.274E-04 0.01870616 SUZUKI_AMPLIFIED_IN_ORAL_CANCER hyperparathyroidism DOID_13543 4.877E-06 1.387E-03 4.877E-06 2.775E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER invasive lobular carcinoma DOID_3457 5.96E-06 1.13E-03 5.96E-06 1.695E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER aortic valve stenosis DOID_1712 7.15E-06 1.017E-03 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER parathyroid gland disease DOID_11201 8.448E-06 9.614E-04 8.448E-06 1.602E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER aortic valve disease DOID_62 2.983E-05 2.829E-03 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER multiple myeloma DOID_9538 8.404E-05 6.832E-03 8.404E-05 0.01195528 SUZUKI_AMPLIFIED_IN_ORAL_CANCER adenoid cystic carcinoma DOID_4866 9.724E-05 6.916E-03 9.724E-05 0.01106601 SUZUKI_AMPLIFIED_IN_ORAL_CANCER benign mesothelioma DOID_2645 1.019E-04 6.439E-03 0.0149857 0.20302059 SUZUKI_AMPLIFIED_IN_ORAL_CANCER salivary gland cancer DOID_8850 1.066E-04 6.064E-03 1.066E-04 0.01010623 SUZUKI_AMPLIFIED_IN_ORAL_CANCER myeloma DOID_0070004 1.317E-04 6.814E-03 1.317E-04 0.01070837 SUZUKI_AMPLIFIED_IN_ORAL_CANCER brain cancer DOID_1319 1.317E-04 6.247E-03 1.317E-04 9.37E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER heart valve disease DOID_4079 1.317E-04 5.766E-03 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER central nervous system cancer DOID_3620 1.371E-04 5.572E-03 1.371E-04 8.667E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER glaucoma DOID_1686 1.425E-04 5.407E-03 0.017688 0.21879288 SUZUKI_AMPLIFIED_IN_ORAL_CANCER bone marrow cancer DOID_4960 1.714E-04 6.096E-03 1.714E-04 9.753E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER reproductive organ benign neoplasm DOID_0050622 1.775E-04 5.941E-03 1.775E-04 9.181E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER oral cavity cancer DOID_8618 1.964E-04 6.208E-03 1.964E-04 9.312E-03 SUZUKI_AMPLIFIED_IN_ORAL_CANCER nervous system cancer DOID_3093 4.465E-04 0.01337221 4.465E-04 0.018148 SUZUKI_AMPLIFIED_IN_ORAL_CANCER alcohol-related neurodevelopmental disorder DOID_0050667 4.86E-04 0.01382791 4.86E-04 0.01843721 SUZUKI_AMPLIFIED_IN_ORAL_CANCER dilated cardiomyopathy DOID_12930 4.962E-04 0.01344408 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER rectal neoplasm DOID_1984 3.424E-03 0.08856235 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER rectum cancer DOID_1993 3.424E-03 0.08856235 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER breast benign neoplasm DOID_0060082 3.766E-03 0.09316825 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER thoracic benign neoplasm DOID_0060097 3.766E-03 0.09316825 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER nervous system benign neoplasm DOID_0060115 3.766E-03 0.08928624 3.766E-03 0.13392936 SUZUKI_AMPLIFIED_IN_ORAL_CANCER benign breast phyllodes tumor DOID_1631 3.766E-03 0.09316825 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER epidermolysis bullosa DOID_2730 4.108E-03 0.09349225 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER aortic valve insufficiency DOID_57 4.108E-03 0.08989639 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER ocular hypertension DOID_9282 4.108E-03 0.0865669 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER borderline glaucoma DOID_9283 4.108E-03 0.0865669 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER carotid stenosis DOID_13001 4.449E-03 0.09041718 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER larynx cancer DOID_2596 4.449E-03 0.08729935 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER laryngeal benign neoplasm DOID_2598 4.449E-03 0.08729935 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER vesiculobullous skin disease DOID_2731 4.449E-03 0.08438937 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER hypercalcemia DOID_12678 4.791E-03 0.08793531 4.791E-03 0.16035262 SUZUKI_AMPLIFIED_IN_ORAL_CANCER skeletal system cancer DOID_0060124 5.132E-03 0.0912577 5.132E-03 0.16223591 SUZUKI_AMPLIFIED_IN_ORAL_CANCER thoracic aortic aneurysm DOID_14004 5.132E-03 0.08849231 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER bone cancer DOID_184 5.132E-03 0.0912577 5.132E-03 0.16223591 SUZUKI_AMPLIFIED_IN_ORAL_CANCER hemangioma DOID_255 5.132E-03 0.0858896 5.132E-03 0.15369717 SUZUKI_AMPLIFIED_IN_ORAL_CANCER arthropathy DOID_381 5.132E-03 0.08343561 5.132E-03 0.14601232 SUZUKI_AMPLIFIED_IN_ORAL_CANCER oral submucous fibrosis DOID_5773 5.132E-03 0.08111795 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER varicose veins DOID_799 5.132E-03 0.07892558 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER intermediate coronary syndrome DOID_8805 5.132E-03 0.07684859 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER angiosarcoma DOID_0001816 5.474E-03 0.07985735 5.474E-03 0.14830651 SUZUKI_AMPLIFIED_IN_ORAL_CANCER vein disease DOID_866 5.474E-03 0.07786092 1.000 1.000 SUZUKI_AMPLIFIED_IN_ORAL_CANCER urinary system benign neoplasm DOID_731 5.815E-03 0.08069672 5.815E-03 0.15038934 SUZUKI_AMPLIFIED_IN_ORAL_CANCER male reproductive organ benign neoplasm DOID_0060087 6.156E-03 0.08339602 6.156E-03 0.15228838 SUZUKI_AMPLIFIED_IN_ORAL_CANCER testicular cancer DOID_2998 6.497E-03 0.08596834 6.497E-03 0.15402661 SUZUKI_AMPLIFIED_IN_ORAL_CANCER granulosa cell tumor DOID_2999 6.497E-03 0.08401452 6.497E-03 0.14786555 SUZUKI_AMPLIFIED_IN_ORAL_CANCER colon carcinoma DOID_1520 6.838E-03 0.0864574 6.838E-03 0.14963782 SUZUKI_AMPLIFIED_IN_ORAL_CANCER sex cord-gonadal stromal tumor DOID_192 6.838E-03 0.0845779 6.838E-03 0.14409567 SUZUKI_AMPLIFIED_IN_ORAL_CANCER uremia DOID_4676 7.859E-03 0.09514996 7.859E-03 0.15971601 LINDGREN_BLADDER_CANCER_CLUSTER_2B peripheral vascular disease DOID_341 7.313E-16 4.161E-13 8.835E-13 5.027E-10 LINDGREN_BLADDER_CANCER_CLUSTER_2B aneurysm disease DOID_2403 1.493E-15 4.248E-13 1.597E-12 4.542E-10 LINDGREN_BLADDER_CANCER_CLUSTER_2B primary immunodeficiency disease DOID_612 2.97E-13 5.633E-11 7.857E-12 1.118E-09 LINDGREN_BLADDER_CANCER_CLUSTER_2B vascular skin disease DOID_9540 3.702E-13 5.266E-11 5.887E-10 4.187E-08 LINDGREN_BLADDER_CANCER_CLUSTER_2B atrophic muscular disease DOID_913 1.244E-12 1.416E-10 4.627E-11 5.266E-09 LINDGREN_BLADDER_CANCER_CLUSTER_2B muscular dystrophy DOID_9884 1.244E-12 1.416E-10 4.627E-11 5.266E-09 LINDGREN_BLADDER_CANCER_CLUSTER_2B urticaria DOID_1555 1.936E-12 1.836E-10 8.522E-09 4.849E-07 LINDGREN_BLADDER_CANCER_CLUSTER_2B contact dermatitis DOID_2773 2.436E-12 1.98E-10 2.436E-12 4.62E-10 LINDGREN_BLADDER_CANCER_CLUSTER_2B intracranial aneurysm DOID_10941 3.812E-12 2.712E-10 2.515E-10 2.045E-08 LINDGREN_BLADDER_CANCER_CLUSTER_2B primary bacterial infectious disease DOID_0050338 6.126E-12 3.873E-10 1.077E-06 2.664E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B encephalomyelitis DOID_640 1.27E-11 7.225E-10 1.06E-07 3.77E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B aortic aneurysm DOID_3627 2.749E-11 1.422E-09 2.887E-08 1.264E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B uremia DOID_4676 5.341E-11 2.533E-09 5.341E-11 5.065E-09 LINDGREN_BLADDER_CANCER_CLUSTER_2B uterine disease DOID_345 2.83E-10 1.239E-08 3.291E-06 6.458E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B tuberculosis DOID_399 4.212E-10 1.712E-08 6.667E-05 6.774E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B astrocytoma DOID_3069 4.789E-10 1.817E-08 1.173E-08 5.564E-07 LINDGREN_BLADDER_CANCER_CLUSTER_2B giant cell tumor DOID_200 1.511E-09 5.373E-08 4.279E-08 1.739E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B malignant giant cell tumor DOID_2705 1.511E-09 5.373E-08 4.279E-08 1.739E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B giant cell glioblastoma DOID_3074 1.511E-09 5.373E-08 4.279E-08 1.739E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B angioedema DOID_1558 1.732E-09 5.798E-08 2.4E-05 2.845E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B female reproductive system disease DOID_229 1.748E-09 5.525E-08 1.054E-05 1.499E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B retinal vascular disease DOID_2462 2.672E-09 8.002E-08 9.226E-07 2.386E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B glioblastoma DOID_3068 3.053E-09 8.686E-08 7.85E-08 2.978E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B Human immunodeficiency virus infectious disease DOID_526 4.411E-09 1.195E-07 1.905E-05 2.409E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B carotid artery disease DOID_3407 4.519E-09 1.169E-07 2.3E-06 4.846E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B collagen disease DOID_854 4.519E-09 1.118E-07 4.038E-05 4.335E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B respiratory failure DOID_11162 5.128E-09 1.216E-07 5.128E-09 3.242E-07 LINDGREN_BLADDER_CANCER_CLUSTER_2B ulcerative colitis DOID_8577 9.27E-09 2.11E-07 9.27E-09 4.795E-07 LINDGREN_BLADDER_CANCER_CLUSTER_2B brain infarction DOID_3454 1.048E-08 2.294E-07 2.276E-07 6.815E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B diabetic retinopathy DOID_8947 1.811E-08 3.817E-07 6.319E-06 9.988E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B pulmonary tuberculosis DOID_2957 2.519E-08 5.118E-07 2.616E-04 2.067E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B autoimmune disease of endocrine system DOID_0060005 2.659E-08 5.217E-07 3.351E-05 3.739E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B vein disease DOID_866 2.917E-08 5.532E-07 2.079E-06 4.55E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B vasculitis DOID_865 4.854E-08 8.909E-07 2.294E-05 2.777E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B parasitic protozoa infectious disease DOID_2789 5.492E-08 9.766E-07 3.987E-04 2.836E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B periodontal disease DOID_3388 8.149E-08 1.405E-06 6.841E-05 6.829E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B blood protein disease DOID_620 1.015E-07 1.699E-06 5.432E-06 9.09E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B uveitis DOID_13141 1.545E-07 2.512E-06 4.434E-06 8.139E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B parasitic infectious disease DOID_1398 1.684E-07 2.662E-06 7.307E-04 4.519E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B funisitis DOID_0050698 1.708E-07 2.627E-06 8.125E-06 1.185E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B allergic contact dermatitis DOID_3042 2.061E-07 3.087E-06 2.061E-07 6.9E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B adult respiratory distress syndrome DOID_11394 2.074E-07 3.027E-06 2.074E-07 6.558E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B nephrosis DOID_2527 3.033E-07 4.315E-06 5.408E-06 9.616E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B uveal disease DOID_3480 3.14E-07 4.358E-06 7.918E-06 1.186E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B severe combined immunodeficiency DOID_627 3.397E-07 4.602E-06 3.397E-07 9.663E-06 LINDGREN_BLADDER_CANCER_CLUSTER_2B combined T cell and B cell immunodeficiency DOID_628 4.185E-07 5.538E-06 4.185E-07 1.134E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B myositis DOID_633 5.111E-07 6.61E-06 0.01116349 0.03714634 LINDGREN_BLADDER_CANCER_CLUSTER_2B heart valve disease DOID_4079 5.223E-07 6.604E-06 1.2E-05 1.626E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B autoimmune disease of gastrointestinal tract DOID_0060031 6.626E-07 8.196E-06 3.68E-03 0.01474493 LINDGREN_BLADDER_CANCER_CLUSTER_2B periodontitis DOID_824 7.447E-07 9.015E-06 6.725E-04 4.3E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B chronic kidney failure DOID_784 7.872E-07 9.331E-06 1.57E-04 1.396E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B bone marrow cancer DOID_4960 1.152E-06 1.338E-05 2.294E-05 2.837E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B reproductive organ benign neoplasm DOID_0050622 1.279E-06 1.455E-05 2.498E-05 2.901E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B abdominal aortic aneurysm DOID_7693 1.46E-06 1.629E-05 9.868E-04 5.672E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B adrenal cortex disease DOID_3952 1.566E-06 1.714E-05 3.499E-03 0.0142221 LINDGREN_BLADDER_CANCER_CLUSTER_2B varicose veins DOID_799 1.566E-06 1.682E-05 8.904E-05 8.444E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B allergic rhinitis DOID_4481 1.703E-06 1.795E-05 1.078E-03 6.071E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B oral cavity cancer DOID_8618 1.728E-06 1.788E-05 1.728E-06 4.098E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B mouth disease DOID_403 1.799E-06 1.828E-05 2.776E-04 2.164E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B leukocyte disease DOID_9500 1.904E-06 1.901E-05 3.46E-05 3.786E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B hypersensitivity reaction type I disease DOID_1205 1.929E-06 1.892E-05 2.72E-03 0.0119041 LINDGREN_BLADDER_CANCER_CLUSTER_2B spastic diplegia DOID_10965 2.079E-06 2.005E-05 2.079E-06 4.732E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B thyroiditis DOID_7166 2.079E-06 1.971E-05 3.984E-03 0.01563218 LINDGREN_BLADDER_CANCER_CLUSTER_2B autoimmune thyroiditis DOID_7188 2.079E-06 1.971E-05 3.984E-03 0.01563218 LINDGREN_BLADDER_CANCER_CLUSTER_2B hypothyroidism DOID_1459 2.521E-06 2.351E-05 6.159E-04 4.123E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B pneumoconiosis DOID_10316 2.63E-06 2.413E-05 1.381E-03 7.484E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B adrenal gland disease DOID_9553 2.706E-06 2.444E-05 4.497E-03 0.01705921 LINDGREN_BLADDER_CANCER_CLUSTER_2B pre-malignant neoplasm DOID_0060071 2.759E-06 2.453E-05 6.526E-04 4.318E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B congenital heart defect DOID_1682 2.759E-06 2.415E-05 2.759E-06 5.607E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B in situ carcinoma DOID_8719 2.759E-06 2.453E-05 6.526E-04 4.318E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B tooth disease DOID_1091 3.904E-06 3.366E-05 8.151E-04 4.934E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B agammaglobulinemia DOID_2583 4.366E-06 3.708E-05 1.863E-04 1.582E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B MHC class II deficiency DOID_5812 4.366E-06 3.653E-05 4.366E-06 8.28E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B bile duct disease DOID_4138 5.408E-06 4.46E-05 8.131E-05 7.977E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B brain edema DOID_4724 5.432E-06 4.415E-05 5.432E-06 9.366E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B intracranial arterial disease DOID_13089 5.641E-06 4.521E-05 2.137E-03 0.0106654 LINDGREN_BLADDER_CANCER_CLUSTER_2B cerebral arterial disease DOID_3527 5.641E-06 4.521E-05 2.137E-03 0.0106654 LINDGREN_BLADDER_CANCER_CLUSTER_2B adenoid cystic carcinoma DOID_4866 5.641E-06 4.458E-05 5.641E-06 9.171E-05 LINDGREN_BLADDER_CANCER_CLUSTER_2B biliary tract disease DOID_9741 5.849E-06 4.559E-05 8.67E-05 8.361E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B autoimmune hepatitis DOID_2048 6.679E-06 5.135E-05 0.117537 0.20965063 LINDGREN_BLADDER_CANCER_CLUSTER_2B endometriosis of uterus DOID_288 7.091E-06 5.38E-05 2.436E-03 0.01135989 LINDGREN_BLADDER_CANCER_CLUSTER_2B salivary gland cancer DOID_8850 7.091E-06 5.309E-05 7.091E-06 1.091E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B endometriosis DOID_289 7.918E-06 5.851E-05 2.594E-03 0.0118093 LINDGREN_BLADDER_CANCER_CLUSTER_2B hepatitis B DOID_2043 8.125E-06 5.927E-05 2.923E-04 2.217E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B placenta disease DOID_780 8.125E-06 5.852E-05 2.923E-04 2.188E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B pancreatitis DOID_4989 8.517E-06 6.057E-05 1.179E-04 1.082E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B diabetic autonomic neuropathy DOID_11503 8.818E-06 6.194E-05 1.764E-04 1.521E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B autonomic neuropathy DOID_11504 8.818E-06 6.194E-05 1.764E-04 1.521E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B diabetic polyneuropathy DOID_12785 8.818E-06 6.194E-05 1.764E-04 1.521E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B influenza DOID_8469 8.818E-06 6.119E-05 2.759E-03 0.01198449 LINDGREN_BLADDER_CANCER_CLUSTER_2B diabetic neuropathy DOID_9743 8.818E-06 6.194E-05 1.764E-04 1.521E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B pulmonary embolism DOID_9477 9.79E-06 6.711E-05 3.346E-04 2.441E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B diabetic angiopathy DOID_11713 1.169E-05 7.921E-05 1.169E-05 1.623E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B myeloma DOID_0070004 1.2E-05 8.036E-05 2.246E-04 1.852E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B autonomic nervous system disease DOID_11465 1.2E-05 7.943E-05 2.246E-04 1.826E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B bone development disease DOID_0080006 1.294E-05 8.461E-05 1.294E-05 1.712E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B spastic quadriplegia DOID_10970 1.386E-05 8.959E-05 1.386E-05 1.792E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B toxic shock syndrome DOID_14115 1.386E-05 8.858E-05 4.308E-04 3.026E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B commensal bacterial infectious disease DOID_0050339 1.63E-05 1.03E-04 4.849E-04 3.324E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B B-cell lymphocytic neoplasm DOID_707 1.758E-05 1.099E-04 3.027E-04 2.237E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B ankylosing spondylitis DOID_7147 1.904E-05 1.178E-04 0.01116349 0.03693038 LINDGREN_BLADDER_CANCER_CLUSTER_2B sarcoidosis DOID_11335 2.103E-05 1.286E-04 4.536E-03 0.01709294 LINDGREN_BLADDER_CANCER_CLUSTER_2B lymphoma DOID_0060058 2.154E-05 1.304E-04 2.517E-04 2.017E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B vitiligo DOID_12306 2.212E-05 1.325E-04 0.01197563 0.0391617 LINDGREN_BLADDER_CANCER_CLUSTER_2B B cell deficiency DOID_2115 2.212E-05 1.311E-04 6.056E-04 4.102E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B Crohn's disease DOID_8778 2.428E-05 1.424E-04 2.776E-04 2.135E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B osteochondrodysplasia DOID_2256 2.498E-05 1.45E-04 2.498E-05 2.843E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B hypertrophic cardiomyopathy DOID_11984 3.197E-05 1.837E-04 4.836E-04 3.356E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B hypersensitivity reaction type IV disease DOID_2916 3.197E-05 1.819E-04 5.763E-03 0.02129372 LINDGREN_BLADDER_CANCER_CLUSTER_2B female reproductive organ benign neoplasm DOID_0060086 3.812E-05 2.148E-04 9.01E-04 5.34E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B uterine benign neoplasm DOID_0060095 3.812E-05 2.148E-04 9.01E-04 5.34E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B uterine fibroid DOID_13223 3.812E-05 2.148E-04 9.01E-04 5.34E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B spastic cerebral palsy DOID_0050669 4.318E-05 2.409E-04 4.318E-05 4.55E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B lipodystrophy DOID_811 4.362E-05 2.41E-04 2.225E-03 0.01082314 LINDGREN_BLADDER_CANCER_CLUSTER_2B encephalitis DOID_9588 4.362E-05 2.387E-04 0.06894974 0.14804679 LINDGREN_BLADDER_CANCER_CLUSTER_2B celiac disease DOID_10608 4.871E-05 2.64E-04 0.01736482 0.04990194 LINDGREN_BLADDER_CANCER_CLUSTER_2B cholestasis DOID_13580 5.416E-05 2.907E-04 7.307E-04 4.569E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B leiomyoma DOID_127 5.474E-05 2.911E-04 1.173E-03 6.546E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B pleural disease DOID_1532 5.474E-05 2.884E-04 1.173E-03 6.483E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B osteogenesis imperfecta DOID_12347 5.646E-05 2.947E-04 5.646E-05 5.841E-04 LINDGREN_BLADDER_CANCER_CLUSTER_2B narcolepsy DOID_8986 7.154E-05 3.701E-04 0.07997204 0.16079185 LINDGREN_BLADDER_CANCER_CLUSTER_2B thoracic aortic aneurysm DOID_14004 8.904E-05 4.564E-04 3.499E-03 0.01442821 LINDGREN_BLADDER_CANCER_CLUSTER_2B calcinosis DOID_182 9.335E-05 4.743E-04 0.02359026 0.06391837 LINDGREN_BLADDER_CANCER_CLUSTER_2B multiple myeloma DOID_9538 9.335E-05 4.701E-04 1.733E-03 8.805E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B congenital diaphragmatic hernia DOID_3827 1.133E-04 5.654E-04 1.133E-04 1.057E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B systemic scleroderma DOID_418 1.133E-04 5.605E-04 0.02583994 0.06870526 LINDGREN_BLADDER_CANCER_CLUSTER_2B juvenile rheumatoid arthritis DOID_676 1.319E-04 6.47E-04 0.09626239 0.17958459 LINDGREN_BLADDER_CANCER_CLUSTER_2B pulmonary emphysema DOID_9675 1.361E-04 6.62E-04 0.028173 0.07421498 LINDGREN_BLADDER_CANCER_CLUSTER_2B alcohol abuse DOID_1574 1.57E-04 7.573E-04 1.57E-04 1.418E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B congenital muscular dystrophy DOID_0050557 1.576E-04 7.535E-04 1.576E-04 1.38E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B nephrotic syndrome DOID_1184 1.621E-04 7.687E-04 2.594E-03 0.01190454 LINDGREN_BLADDER_CANCER_CLUSTER_2B rheumatic disease DOID_1575 1.621E-04 7.623E-04 0.03058716 0.08020321 LINDGREN_BLADDER_CANCER_CLUSTER_2B scleroderma DOID_419 1.621E-04 7.623E-04 0.03058716 0.08020321 LINDGREN_BLADDER_CANCER_CLUSTER_2B leishmaniasis DOID_9065 1.863E-04 8.69E-04 0.10696276 0.19506991 LINDGREN_BLADDER_CANCER_CLUSTER_2B amyloidosis DOID_9120 2.182E-04 1.01E-03 2.182E-04 1.826E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B calcium metabolism disease DOID_10575 2.816E-04 1.292E-03 0.03964366 0.0998108 LINDGREN_BLADDER_CANCER_CLUSTER_2B IgA glomerulonephritis DOID_2986 3.346E-04 1.523E-03 8.173E-03 0.02870537 LINDGREN_BLADDER_CANCER_CLUSTER_2B sleep disorder DOID_535 3.346E-04 1.511E-03 0.12798657 0.22338761 LINDGREN_BLADDER_CANCER_CLUSTER_2B aortic valve disease DOID_62 3.808E-04 1.706E-03 3.808E-04 2.742E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B spinal cord disease DOID_319 6.056E-04 2.692E-03 0.01197563 0.03893792 LINDGREN_BLADDER_CANCER_CLUSTER_2B diffuse large B-cell lymphoma DOID_0050745 6.725E-04 2.966E-03 6.725E-04 4.398E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B migraine DOID_6364 6.725E-04 2.944E-03 6.725E-04 4.348E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B perinatal necrotizing enterocolitis DOID_8677 6.725E-04 2.921E-03 6.725E-04 4.252E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B mineral metabolism disease DOID_0050032 6.909E-04 2.978E-03 0.06029603 0.13890058 LINDGREN_BLADDER_CANCER_CLUSTER_2B sarcoma DOID_1115 7.44E-04 3.183E-03 7.44E-04 4.552E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B autoimmune disease of the nervous system DOID_438 7.44E-04 3.159E-03 0.01367497 0.04138859 LINDGREN_BLADDER_CANCER_CLUSTER_2B toxic encephalopathy DOID_3602 8.201E-04 3.457E-03 8.201E-04 4.912E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B focal glomerulosclerosis DOID_3945 8.201E-04 3.431E-03 0.01456151 0.04293004 LINDGREN_BLADDER_CANCER_CLUSTER_2B corneal disease DOID_10124 9.01E-04 3.742E-03 9.01E-04 5.285E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B blood coagulation disease DOID_1247 9.542E-04 3.934E-03 9.542E-04 5.54E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B male reproductive system disease DOID_48 1.004E-03 4.11E-03 9.813E-03 0.03343557 LINDGREN_BLADDER_CANCER_CLUSTER_2B germinoma DOID_3304 1.078E-03 4.38E-03 1.078E-03 6.131E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B systemic mycosis DOID_0050136 1.275E-03 5.143E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B fungal infectious disease DOID_1564 1.275E-03 5.143E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B myocarditis DOID_820 1.275E-03 5.107E-03 0.19296975 0.31281991 LINDGREN_BLADDER_CANCER_CLUSTER_2B bone resorption disease DOID_0080011 1.281E-03 5.098E-03 0.01171598 0.03853406 LINDGREN_BLADDER_CANCER_CLUSTER_2B osteoporosis DOID_11476 1.281E-03 5.098E-03 0.01171598 0.03853406 LINDGREN_BLADDER_CANCER_CLUSTER_2B electroclinical syndrome DOID_0050701 1.343E-03 5.305E-03 1.343E-03 7.345E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B bacterial pneumonia DOID_874 1.343E-03 5.268E-03 0.01212014 0.0387436 LINDGREN_BLADDER_CANCER_CLUSTER_2B hyperthyroidism DOID_7998 1.381E-03 5.382E-03 1.381E-03 7.413E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B metabolic syndrome X DOID_14221 1.471E-03 5.694E-03 0.01295228 0.04071738 LINDGREN_BLADDER_CANCER_CLUSTER_2B facioscapulohumeral muscular dystrophy DOID_11727 1.529E-03 5.88E-03 1.529E-03 8.132E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B Sjogren's syndrome DOID_12894 1.529E-03 5.84E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B childhood type dermatomyositis DOID_14203 1.529E-03 5.801E-03 0.05779597 0.13934706 LINDGREN_BLADDER_CANCER_CLUSTER_2B retinal vascular occlusion DOID_1729 1.529E-03 5.763E-03 1.529E-03 8.057E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B chondrosarcoma DOID_3371 1.529E-03 5.725E-03 0.05779597 0.13645605 LINDGREN_BLADDER_CANCER_CLUSTER_2B adrenal gland hyperfunction DOID_3947 1.529E-03 5.687E-03 1.529E-03 7.983E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B conjunctival disease DOID_4251 1.529E-03 5.65E-03 1.529E-03 7.911E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B keratitis DOID_4677 1.529E-03 5.614E-03 1.529E-03 7.839E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B conjunctivitis DOID_6195 1.529E-03 5.65E-03 1.529E-03 7.911E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B cutaneous leishmaniasis DOID_9111 1.529E-03 5.578E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B focal epilepsy DOID_2234 1.68E-03 6.087E-03 0.01426034 0.04270596 LINDGREN_BLADDER_CANCER_CLUSTER_2B embryonal cancer DOID_688 1.733E-03 6.242E-03 0.02359026 0.06361544 LINDGREN_BLADDER_CANCER_CLUSTER_2B trypanosomiasis DOID_10113 1.862E-03 6.663E-03 0.06338938 0.14427423 LINDGREN_BLADDER_CANCER_CLUSTER_2B dermatomyositis DOID_10223 1.862E-03 6.621E-03 0.06338938 0.14369944 LINDGREN_BLADDER_CANCER_CLUSTER_2B sickle cell anemia DOID_10923 1.862E-03 6.58E-03 1.862E-03 9.375E-03 LINDGREN_BLADDER_CANCER_CLUSTER_2B pneumocystosis DOID_11339 1.862E-03 6.539E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B common variable immunodeficiency DOID_12177 1.862E-03 6.499E-03 0.06338938 0.14256347 LINDGREN_BLADDER_CANCER_CLUSTER_2B temporal arteritis DOID_13375 1.862E-03 6.46E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B central nervous system vasculitis DOID_525 1.862E-03 6.46E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B neonatoal period electroclinical syndrome DOID_0050702 2.225E-03 7.675E-03 2.225E-03 0.01101137 LINDGREN_BLADDER_CANCER_CLUSTER_2B common cold DOID_10459 2.225E-03 7.628E-03 0.06894974 0.15265525 LINDGREN_BLADDER_CANCER_CLUSTER_2B aortic valve stenosis DOID_1712 2.225E-03 7.583E-03 2.225E-03 0.01091644 LINDGREN_BLADDER_CANCER_CLUSTER_2B stomach disease DOID_76 2.225E-03 7.538E-03 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B peritonitis DOID_8283 2.225E-03 7.493E-03 2.225E-03 0.01073142 LINDGREN_BLADDER_CANCER_CLUSTER_2B nervous system cancer DOID_3093 2.244E-03 7.512E-03 2.244E-03 0.01073109 LINDGREN_BLADDER_CANCER_CLUSTER_2B benign mesothelioma DOID_2645 2.283E-03 7.597E-03 2.283E-03 0.01082628 LINDGREN_BLADDER_CANCER_CLUSTER_2B cervix uteri carcinoma in situ DOID_8991 2.283E-03 7.553E-03 0.23053901 0.35840628 LINDGREN_BLADDER_CANCER_CLUSTER_2B autoimmune disease of urogenital tract DOID_0060049 2.436E-03 8.011E-03 2.436E-03 0.01145378 LINDGREN_BLADDER_CANCER_CLUSTER_2B primary biliary cirrhosis DOID_12236 2.436E-03 8.011E-03 2.436E-03 0.01145378 LINDGREN_BLADDER_CANCER_CLUSTER_2B lymphoblastic leukemia DOID_1037 2.522E-03 8.247E-03 2.522E-03 0.01166688 LINDGREN_BLADDER_CANCER_CLUSTER_2B berylliosis DOID_10322 2.62E-03 8.518E-03 0.07447722 0.15871738 LINDGREN_BLADDER_CANCER_CLUSTER_2B essential hypertension DOID_10825 2.62E-03 8.47E-03 2.62E-03 0.01183098 LINDGREN_BLADDER_CANCER_CLUSTER_2B carotid stenosis DOID_13001 2.62E-03 8.422E-03 0.07447722 0.15695385 LINDGREN_BLADDER_CANCER_CLUSTER_2B polyneuropathy DOID_1389 2.62E-03 8.375E-03 0.07447722 0.15637469 LINDGREN_BLADDER_CANCER_CLUSTER_2B Leydig cell tumor DOID_2696 2.62E-03 8.328E-03 2.62E-03 0.01173782 LINDGREN_BLADDER_CANCER_CLUSTER_2B intracranial thrombosis DOID_4193 2.62E-03 8.282E-03 2.62E-03 0.01164612 LINDGREN_BLADDER_CANCER_CLUSTER_2B sex cord-stromal neoplasm DOID_4757 2.62E-03 8.328E-03 2.62E-03 0.01173782 LINDGREN_BLADDER_CANCER_CLUSTER_2B epilepsy with generalized tonic-clonic seizures DOID_7725 2.62E-03 8.236E-03 2.62E-03 0.01155584 LINDGREN_BLADDER_CANCER_CLUSTER_2B dilated cardiomyopathy DOID_12930 2.72E-03 8.503E-03 0.02021885 0.05695311 LINDGREN_BLADDER_CANCER_CLUSTER_2B cerebral infarction DOID_3526 2.93E-03 9.111E-03 0.03308021 0.08594812 LINDGREN_BLADDER_CANCER_CLUSTER_2B learning disability DOID_8927 2.93E-03 9.062E-03 2.93E-03 0.01263157 LINDGREN_BLADDER_CANCER_CLUSTER_2B tethered spinal cord syndrome DOID_1089 3.045E-03 9.364E-03 0.07997204 0.1630971 LINDGREN_BLADDER_CANCER_CLUSTER_2B congenital structural myopathy DOID_422 3.045E-03 9.314E-03 3.045E-03 0.01302533 LINDGREN_BLADDER_CANCER_CLUSTER_2B eyelid disease DOID_530 3.045E-03 9.264E-03 3.045E-03 0.01292813 LINDGREN_BLADDER_CANCER_CLUSTER_2B pre-eclampsia DOID_10591 3.292E-03 9.963E-03 0.03564994 0.09178651 LINDGREN_BLADDER_CANCER_CLUSTER_2B neuritis DOID_1803 3.292E-03 9.911E-03 3.292E-03 0.01387501 LINDGREN_BLADDER_CANCER_CLUSTER_2B hemolytic anemia DOID_583 3.483E-03 0.01042932 3.483E-03 0.01457037 LINDGREN_BLADDER_CANCER_CLUSTER_2B normocytic anemia DOID_720 3.483E-03 0.01042932 3.483E-03 0.01457037 LINDGREN_BLADDER_CANCER_CLUSTER_2B idiopathic pulmonary fibrosis DOID_0050156 3.499E-03 0.01042457 0.08543438 0.17056899 LINDGREN_BLADDER_CANCER_CLUSTER_2B Ehlers-Danlos syndrome DOID_13359 3.499E-03 0.01037028 3.499E-03 0.01453353 LINDGREN_BLADDER_CANCER_CLUSTER_2B membranoproliferative glomerulonephritis DOID_2920 3.499E-03 0.01031655 3.499E-03 0.01432441 LINDGREN_BLADDER_CANCER_CLUSTER_2B oral submucous fibrosis DOID_5773 3.499E-03 0.01026337 0.08543438 0.16648001 LINDGREN_BLADDER_CANCER_CLUSTER_2B hyperhomocysteinemia DOID_9279 3.499E-03 0.01021074 3.499E-03 0.01412123 LINDGREN_BLADDER_CANCER_CLUSTER_2B integumentary system benign neoplasm DOID_0060121 3.68E-03 0.01068255 0.03829422 0.09727417 LINDGREN_BLADDER_CANCER_CLUSTER_2B glaucoma DOID_1686 3.68E-03 0.01062832 0.03829422 0.09684184 LINDGREN_BLADDER_CANCER_CLUSTER_2B skin benign neoplasm DOID_3165 3.68E-03 0.01068255 0.03829422 0.09727417 LINDGREN_BLADDER_CANCER_CLUSTER_2B angiosarcoma DOID_0001816 3.984E-03 0.01144781 3.984E-03 0.01585082 LINDGREN_BLADDER_CANCER_CLUSTER_2B restrictive cardiomyopathy DOID_397 3.984E-03 0.01139029 3.984E-03 0.01574074 LINDGREN_BLADDER_CANCER_CLUSTER_2B hemorrhagic disease DOID_2213 4.094E-03 0.01164824 4.094E-03 0.01595649 LINDGREN_BLADDER_CANCER_CLUSTER_2B lymphatic system cancer DOID_0060073 4.497E-03 0.01273075 0.09626239 0.18257767 LINDGREN_BLADDER_CANCER_CLUSTER_2B familial hypertrophic cardiomyopathy DOID_11986 4.497E-03 0.01266773 4.497E-03 0.01740736 LINDGREN_BLADDER_CANCER_CLUSTER_2B Graves' disease DOID_12361 4.497E-03 0.01260533 4.497E-03 0.01728974 LINDGREN_BLADDER_CANCER_CLUSTER_2B bronchitis DOID_6132 4.497E-03 0.01254354 4.497E-03 0.0171737 LINDGREN_BLADDER_CANCER_CLUSTER_2B reticulosarcoma DOID_8538 4.497E-03 0.01273075 0.09626239 0.18257767 LINDGREN_BLADDER_CANCER_CLUSTER_2B lymphosarcoma DOID_8675 4.497E-03 0.01273075 0.09626239 0.18257767 LINDGREN_BLADDER_CANCER_CLUSTER_2B pustulosis of palm and sole DOID_4398 5.006E-03 0.01389378 0.04665346 0.11491696 LINDGREN_BLADDER_CANCER_CLUSTER_2B ureteral obstruction DOID_5199 5.04E-03 0.01392006 5.04E-03 0.01886535 LINDGREN_BLADDER_CANCER_CLUSTER_2B prion disease DOID_649 5.04E-03 0.01385282 0.10162844 0.18653736 LINDGREN_BLADDER_CANCER_CLUSTER_2B eosinophilia DOID_999 5.04E-03 0.01378622 0.10162844 0.18593756 LINDGREN_BLADDER_CANCER_CLUSTER_2B psoriasis DOID_8893 5.611E-03 0.01527472 5.611E-03 0.02086547 LINDGREN_BLADDER_CANCER_CLUSTER_2B membranous glomerulonephritis DOID_10976 6.21E-03 0.01682539 0.11226555 0.20408658 LINDGREN_BLADDER_CANCER_CLUSTER_2B pulmonary edema DOID_11396 6.21E-03 0.01674565 6.21E-03 0.02279569 LINDGREN_BLADDER_CANCER_CLUSTER_2B subependymal glioma DOID_4843 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B pilocytic astrocytoma DOID_4851 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B subependymal giant cell astrocytoma DOID_5077 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B fibrillary astrocytoma DOID_6726 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B juvenile pilocytic astrocytoma DOID_6811 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B childhood pilocytic astrocytoma DOID_6812 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B gemistocytic astrocytoma DOID_7005 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B childhood cerebral astrocytoma DOID_7007 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B protoplasmic astrocytoma DOID_7008 6.21E-03 0.01666666 6.21E-03 0.02264956 LINDGREN_BLADDER_CANCER_CLUSTER_2B benign glioma DOID_0060101 7.491E-03 0.02001153 7.491E-03 0.0271494 LINDGREN_BLADDER_CANCER_CLUSTER_2B neutropenia DOID_1227 7.491E-03 0.01991802 7.491E-03 0.02697757 LINDGREN_BLADDER_CANCER_CLUSTER_2B thrombophilia DOID_2452 7.491E-03 0.01982538 7.491E-03 0.0268079 LINDGREN_BLADDER_CANCER_CLUSTER_2B benign ependymoma DOID_4844 7.491E-03 0.02001153 7.491E-03 0.0271494 LINDGREN_BLADDER_CANCER_CLUSTER_2B acquired immunodeficiency syndrome DOID_635 7.491E-03 0.01973359 0.12277728 0.21763324 LINDGREN_BLADDER_CANCER_CLUSTER_2B cerebral degeneration DOID_1443 7.786E-03 0.02041532 7.786E-03 0.02768828 LINDGREN_BLADDER_CANCER_CLUSTER_2B agranulocytosis DOID_12987 8.173E-03 0.02133152 8.173E-03 0.02888367 LINDGREN_BLADDER_CANCER_CLUSTER_2B myasthenia gravis DOID_437 8.173E-03 0.02123411 0.12798657 0.22407496 LINDGREN_BLADDER_CANCER_CLUSTER_2B urinary tract obstruction DOID_5200 8.173E-03 0.02113759 8.173E-03 0.02852927 LINDGREN_BLADDER_CANCER_CLUSTER_2B lingual-facial-buccal dyskinesia DOID_9854 8.173E-03 0.02104195 8.173E-03 0.02835531 LINDGREN_BLADDER_CANCER_CLUSTER_2B ureteral disease DOID_1426 8.881E-03 0.02276273 8.881E-03 0.03062622 LINDGREN_BLADDER_CANCER_CLUSTER_2B Goodpasture syndrome DOID_9808 8.881E-03 0.02266066 0.13316507 0.22891519 LINDGREN_BLADDER_CANCER_CLUSTER_2B acute pancreatitis DOID_2913 9.616E-03 0.02442603 9.616E-03 0.03296043 LINDGREN_BLADDER_CANCER_CLUSTER_2B portal hypertension DOID_10762 0.01037679 0.02624175 0.01037679 0.0351452 LINDGREN_BLADDER_CANCER_CLUSTER_2B osteosarcoma DOID_3347 0.01037679 0.02612564 0.01037679 0.03493724 LINDGREN_BLADDER_CANCER_CLUSTER_2B spinal muscular atrophy DOID_12377 0.01116349 0.02798249 0.01116349 0.03736485 LINDGREN_BLADDER_CANCER_CLUSTER_2B neuromuscular junction disease DOID_439 0.01116349 0.02785976 0.14851759 0.25301351 LINDGREN_BLADDER_CANCER_CLUSTER_2B cystic fibrosis DOID_1485 0.01131973 0.02812631 0.37172611 0.54373306 LINDGREN_BLADDER_CANCER_CLUSTER_2B middle cerebral artery infarction DOID_3525 0.01197563 0.02962668 0.1535747 0.26007145 LINDGREN_BLADDER_CANCER_CLUSTER_2B seminoma DOID_4440 0.01197563 0.02949842 0.01197563 0.03871668 LINDGREN_BLADDER_CANCER_CLUSTER_2B fragments of torsion dystonia DOID_531 0.01197563 0.02937127 0.01197563 0.03849794 LINDGREN_BLADDER_CANCER_CLUSTER_2B extrinsic allergic alveolitis DOID_841 0.01197563 0.02924522 0.1535747 0.25701178 LINDGREN_BLADDER_CANCER_CLUSTER_2B Sciatic Neuropathy DOID_11446 0.0128129 0.03115616 0.0128129 0.04072928 LINDGREN_BLADDER_CANCER_CLUSTER_2B gestational diabetes DOID_11714 0.0128129 0.03102358 0.15860191 0.26464659 LINDGREN_BLADDER_CANCER_CLUSTER_2B lesion of sciatic nerve DOID_12528 0.0128129 0.03115616 0.0128129 0.04072928 LINDGREN_BLADDER_CANCER_CLUSTER_2B lung adenocarcinoma DOID_3910 0.0128129 0.03089212 0.0128129 0.040503 LINDGREN_BLADDER_CANCER_CLUSTER_2B mononeuritis of lower limb DOID_9473 0.0128129 0.03115616 0.0128129 0.04072928 LINDGREN_BLADDER_CANCER_CLUSTER_2B autoimmune disease of cardiovascular system DOID_0060051 0.01367497 0.03283146 0.01367497 0.04275305 LINDGREN_BLADDER_CANCER_CLUSTER_2B pleurisy DOID_10247 0.01367497 0.03269351 0.01367497 0.04251943 LINDGREN_BLADDER_CANCER_CLUSTER_2B malaria DOID_12365 0.01367497 0.03255672 0.01367497 0.04228834 LINDGREN_BLADDER_CANCER_CLUSTER_2B Behcet's disease DOID_13241 0.01367497 0.03283146 0.01367497 0.04275305 LINDGREN_BLADDER_CANCER_CLUSTER_2B mononeuritis DOID_1802 0.01367497 0.03242106 0.01367497 0.04205976 LINDGREN_BLADDER_CANCER_CLUSTER_2B hepatic vascular disease DOID_272 0.01367497 0.03228654 0.01367497 0.04183363 LINDGREN_BLADDER_CANCER_CLUSTER_2B invasive ductal carcinoma DOID_3008 0.01367497 0.03215312 0.01367497 0.04160992 LINDGREN_BLADDER_CANCER_CLUSTER_2B central nervous system hereditary degenerative disease DOID_481 0.01367497 0.0320208 0.01367497 0.0411696 LINDGREN_BLADDER_CANCER_CLUSTER_2B mononeuropathy DOID_1188 0.01456151 0.03395696 0.01456151 0.04337957 LINDGREN_BLADDER_CANCER_CLUSTER_2B supratentorial cancer DOID_1659 0.01456151 0.03381836 0.01456151 0.04315363 LINDGREN_BLADDER_CANCER_CLUSTER_2B cerebrum cancer DOID_368 0.01456151 0.03381836 0.01456151 0.04315363 LINDGREN_BLADDER_CANCER_CLUSTER_2B dystonic disease DOID_544 0.01456151 0.03368088 0.01456151 0.04270875 LINDGREN_BLADDER_CANCER_CLUSTER_2B endometrial carcinoma DOID_2871 0.01547221 0.03564245 0.01547221 0.0451471 LINDGREN_BLADDER_CANCER_CLUSTER_2B opportunistic mycosis DOID_2473 0.01640675 0.0376429 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_2B bronchiolitis obliterans DOID_2799 0.01640675 0.03749173 0.01640675 0.0476298 LINDGREN_BLADDER_CANCER_CLUSTER_2B transitional cell carcinoma DOID_2671 0.01660124 0.03778442 0.10011789 0.18616693 LINDGREN_BLADDER_CANCER_CLUSTER_2B amino acid metabolic disorder DOID_9252 0.01709367 0.03875019 0.01709367 0.04937207 LINDGREN_BLADDER_CANCER_CLUSTER_2B endometrial cancer DOID_1380 0.01736482 0.03920867 0.01736482 0.04965117 LINDGREN_BLADDER_CANCER_CLUSTER_2B chronic leukemia DOID_1036 0.01834612 0.04126063 0.01834612 0.0521947 LINDGREN_BLADDER_CANCER_CLUSTER_2B chronic lymphocytic leukemia DOID_1040 0.01834612 0.04126063 0.01834612 0.0521947 LINDGREN_BLADDER_CANCER_CLUSTER_2B autonomic nervous system neoplasm DOID_2621 0.01834612 0.04109819 0.01834612 0.05193503 LINDGREN_BLADDER_CANCER_CLUSTER_2B neuroblastoma DOID_769 0.01834612 0.04109819 0.01834612 0.05193503 LINDGREN_BLADDER_CANCER_CLUSTER_2B nephroblastoma DOID_2154 0.02037714 0.045469 0.02037714 0.05711623 LINDGREN_BLADDER_CANCER_CLUSTER_2B spindle cell carcinoma DOID_4015 0.02037714 0.04529138 0.02037714 0.05683625 LINDGREN_BLADDER_CANCER_CLUSTER_2B esophageal disease DOID_6050 0.02037714 0.04511515 0.19776399 0.31787489 LINDGREN_BLADDER_CANCER_CLUSTER_2B leukopenia DOID_615 0.02037714 0.04494029 0.02037714 0.056559 LINDGREN_BLADDER_CANCER_CLUSTER_2B lymphoid leukemia DOID_10747 0.02142627 0.04707161 0.02142627 0.05918227 LINDGREN_BLADDER_CANCER_CLUSTER_2B adenoma DOID_657 0.02249741 0.04923471 0.02249741 0.0618407 LINDGREN_BLADDER_CANCER_CLUSTER_2B adolescence-adult electroclinical syndrome DOID_0050705 0.02359026 0.05142858 0.02359026 0.06453297 LINDGREN_BLADDER_CANCER_CLUSTER_2B pulmonary sarcoidosis DOID_13406 0.02359026 0.05123229 0.02359026 0.0642242 LINDGREN_BLADDER_CANCER_CLUSTER_2B peripheral nervous system neoplasm DOID_1192 0.02470454 0.05344822 0.02470454 0.06630604 LINDGREN_BLADDER_CANCER_CLUSTER_2B blood platelet disease DOID_2218 0.02470454 0.05324576 0.02470454 0.06599475 LINDGREN_BLADDER_CANCER_CLUSTER_2B respiratory syncytial virus infectious disease DOID_1273 0.02583994 0.05548274 0.22131319 0.3469069 LINDGREN_BLADDER_CANCER_CLUSTER_2B peptic ulcer DOID_750 0.02583994 0.05527416 0.22131319 0.34500604 LINDGREN_BLADDER_CANCER_CLUSTER_2B lymphatic system disease DOID_75 0.02699619 0.05753121 0.02699619 0.07144573 LINDGREN_BLADDER_CANCER_CLUSTER_2B gallbladder cancer DOID_3121 0.03182396 0.06756655 0.24417409 0.37651778 LINDGREN_BLADDER_CANCER_CLUSTER_2B uterine cancer DOID_363 0.03182396 0.06731537 0.03182396 0.08306346 LINDGREN_BLADDER_CANCER_CLUSTER_2B leukodystrophy DOID_10579 0.03435562 0.0724013 0.03435562 0.08885614 LINDGREN_BLADDER_CANCER_CLUSTER_2B proteinuria DOID_576 0.03435562 0.07213413 0.25313024 0.38822401 LINDGREN_BLADDER_CANCER_CLUSTER_2B brain cancer DOID_1319 0.03564994 0.07457654 0.03564994 0.09137305 LINDGREN_BLADDER_CANCER_CLUSTER_2B central nervous system cancer DOID_3620 0.0369629 0.07703989 0.0369629 0.0943134 LINDGREN_BLADDER_CANCER_CLUSTER_2B movement disease DOID_480 0.03964366 0.0823257 0.03964366 0.09937111 LINDGREN_BLADDER_CANCER_CLUSTER_2B withdrawal disorder DOID_0060001 0.04101094 0.08485537 0.04101094 0.10234748 LINDGREN_BLADDER_CANCER_CLUSTER_2B orofacial cleft DOID_0050567 0.04239582 0.08740297 0.04239582 0.10534157 LINDGREN_BLADDER_CANCER_CLUSTER_2B atopic dermatitis DOID_3310 0.04239582 0.08708744 0.04239582 0.10488357 LINDGREN_BLADDER_CANCER_CLUSTER_2B bile duct adenocarcinoma DOID_4896 0.04521733 0.09254913 0.28791057 0.43802437 LINDGREN_BLADDER_CANCER_CLUSTER_2B cholangiocarcinoma DOID_4947 0.04521733 0.09254913 0.28791057 0.43802437 LINDGREN_BLADDER_CANCER_CLUSTER_2B integumentary system cancer DOID_0060122 0.04665346 0.0951463 0.29214315 0.44327855 LINDGREN_BLADDER_CANCER_CLUSTER_2B skin cancer DOID_4159 0.04665346 0.0951463 0.29214315 0.44327855 LINDGREN_BLADDER_CANCER_CLUSTER_2B familial hyperlipidemia DOID_1168 0.04810617 0.09775862 0.04810617 0.11798454 MOOTHA_GLYCOLYSIS carbohydrate metabolic disorder DOID_2978 4.928E-17 2.804E-14 7.416E-10 4.22E-07 MOOTHA_GLYCOLYSIS glycogen metabolism disorder DOID_0050728 4.396E-13 1.251E-10 5.355E-05 6.094E-03 MOOTHA_GLYCOLYSIS glycogen storage disease DOID_2747 4.396E-13 1.251E-10 5.355E-05 6.094E-03 MOOTHA_GLYCOLYSIS hemolytic anemia DOID_583 8.763E-09 1.662E-06 8.763E-09 2.493E-06 MOOTHA_GLYCOLYSIS normocytic anemia DOID_720 8.763E-09 1.662E-06 8.763E-09 2.493E-06 MOOTHA_GLYCOLYSIS congenital hemolytic anemia DOID_589 1.808E-07 2.571E-05 1.808E-07 3.428E-05 MOOTHA_GLYCOLYSIS nutritional deficiency disease DOID_5113 2.227E-05 2.535E-03 2.227E-05 3.169E-03 MOOTHA_GLYCOLYSIS lung adenocarcinoma DOID_3910 8.579E-05 8.136E-03 1.000 1.000 MOOTHA_GLYCOLYSIS bone resorption disease DOID_0080011 6.419E-04 0.05217989 0.03685997 1.000 MOOTHA_GLYCOLYSIS osteoporosis DOID_11476 6.419E-04 0.05217989 0.03685997 1.000 VALK_AML_WITH_11Q23_REARRANGED amyloidosis DOID_9120 1.45E-05 8.251E-03 1.45E-05 8.251E-03 VALK_AML_WITH_11Q23_REARRANGED opiate dependence DOID_2559 1.93E-05 5.491E-03 1.93E-05 5.491E-03 VALK_AML_WITH_11Q23_REARRANGED thyroid carcinoma DOID_3963 5.069E-05 9.615E-03 0.01068484 0.60796725 VALK_AML_WITH_11Q23_REARRANGED thyroid cancer DOID_1781 5.638E-05 8.02E-03 0.01125943 0.58241953 VALK_AML_WITH_11Q23_REARRANGED thyroid adenoma DOID_2891 9.305E-05 0.01058894 0.01441426 0.54678092 VALK_AML_WITH_11Q23_REARRANGED endocrine organ benign neoplasm DOID_0060089 1.881E-04 0.01784094 0.02041172 0.50496821 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP primary bacterial infectious disease DOID_0050338 8.659E-13 4.927E-10 0.12341012 0.76326478 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP allergic contact dermatitis DOID_3042 1.16E-11 3.3E-09 9.607E-10 5.466E-07 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP tuberculosis DOID_399 1.285E-11 2.438E-09 0.09972215 0.70927376 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bacterial pneumonia DOID_874 3.039E-11 4.323E-09 0.11164368 0.71376687 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP contact dermatitis DOID_2773 3.629E-11 4.13E-09 2.531E-09 7.201E-07 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP myasthenia gravis DOID_437 1.931E-10 1.831E-08 0.03343749 0.47564824 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP sarcoidosis DOID_11335 2.417E-10 1.965E-08 0.07950284 0.64624449 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP hypersensitivity reaction type IV disease DOID_2916 4.11E-10 2.923E-08 0.08629167 0.67260221 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP neuromuscular junction disease DOID_439 4.611E-10 2.915E-08 0.03913953 0.4948976 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP collagen disease DOID_854 5.531E-10 3.147E-08 0.09034134 0.67637137 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autoimmune disease of the nervous system DOID_438 8.113E-10 4.196E-08 0.04339437 0.484145 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pleural disease DOID_1532 1.838E-09 8.714E-08 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP uveitis DOID_13141 4.214E-09 1.844E-07 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP systemic scleroderma DOID_418 4.778E-09 1.942E-07 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP encephalomyelitis DOID_640 6.19E-09 2.348E-07 0.13116924 0.8025301 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP hypersensitivity reaction type I disease DOID_1205 7.023E-09 2.497E-07 0.1337406 0.80103578 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP rheumatic disease DOID_1575 7.665E-09 2.565E-07 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP uveal disease DOID_3480 7.665E-09 2.423E-07 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP scleroderma DOID_419 7.665E-09 2.565E-07 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.444E-08 4.323E-07 2.71E-03 0.10280531 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pulmonary tuberculosis DOID_2957 1.444E-08 4.107E-07 0.07403612 0.62875454 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autoimmune hepatitis DOID_2048 2.507E-08 6.793E-07 0.03057402 0.51166514 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP parasitic infectious disease DOID_1398 5.687E-08 1.471E-06 4.586E-03 0.1449708 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pleurisy DOID_10247 1.137E-07 2.812E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP aneurysm disease DOID_2403 1.214E-07 2.879E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pancreatitis DOID_4989 1.294E-07 2.945E-06 0.11164368 0.73017531 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP opportunistic mycosis DOID_2473 1.692E-07 3.702E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bronchiolitis obliterans DOID_2799 1.692E-07 3.565E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP systemic mycosis DOID_0050136 2.427E-07 4.933E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP fungal infectious disease DOID_1564 2.427E-07 4.933E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Human immunodeficiency virus infectious disease DOID_526 2.612E-07 5.124E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pulmonary sarcoidosis DOID_13406 3.749E-07 7.111E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP respiratory syncytial virus infectious disease DOID_1273 4.582E-07 8.41E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pneumocystosis DOID_11339 4.995E-07 8.881E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pulmonary emphysema DOID_9675 5.545E-07 9.561E-06 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP influenza DOID_8469 7.262E-07 1.215E-05 0.06715787 0.61633597 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pre-eclampsia DOID_10591 9.345E-07 1.519E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP viral pneumonia DOID_10533 1.098E-06 1.736E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP aortic aneurysm DOID_3627 1.184E-06 1.821E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP hemolytic-uremic syndrome DOID_12554 1.686E-06 2.525E-05 2.538E-04 0.02406584 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP thyroiditis DOID_7166 1.686E-06 2.46E-05 0.02337884 0.45870892 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autoimmune thyroiditis DOID_7188 1.686E-06 2.46E-05 0.02337884 0.45870892 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP parasitic protozoa infectious disease DOID_2789 1.707E-06 2.428E-05 0.0822243 0.64980034 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP carotid artery disease DOID_3407 2.539E-06 3.524E-05 1.193E-04 0.01697242 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP respiratory failure DOID_11162 2.703E-06 3.661E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP cholestasis DOID_13580 3.24E-06 4.288E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP membranous glomerulonephritis DOID_10976 3.419E-06 4.421E-05 4.003E-04 0.03253708 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bile duct disease DOID_4138 4.548E-06 5.751E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP biliary tract disease DOID_9741 4.799E-06 5.936E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bronchiolitis DOID_2942 7.748E-06 9.38E-05 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP vitiligo DOID_12306 9.742E-06 1.155E-04 0.04055987 0.50170795 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP extrinsic allergic alveolitis DOID_841 9.742E-06 1.131E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP primary immunodeficiency disease DOID_612 1.037E-05 1.18E-04 8.067E-03 0.22951248 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autoimmune disease of endocrine system DOID_0060005 1.332E-05 1.487E-04 0.04480853 0.49030873 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP age related macular degeneration DOID_10871 1.614E-05 1.766E-04 1.099E-03 0.06946455 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP degeneration of macula and posterior pole DOID_2007 1.614E-05 1.766E-04 1.099E-03 0.06946455 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP macular degeneration DOID_4448 2.289E-05 2.457E-04 1.381E-03 0.07855989 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP esophageal disease DOID_6050 2.289E-05 2.412E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP adult respiratory distress syndrome DOID_11394 3.613E-05 3.737E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autoimmune disease of urogenital tract DOID_0060049 4.145E-05 4.212E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP primary biliary cirrhosis DOID_12236 4.145E-05 4.212E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP neuritis DOID_1803 5.696E-05 5.686E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP hemolytic anemia DOID_583 6.045E-05 5.931E-04 2.608E-03 0.10601225 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP normocytic anemia DOID_720 6.045E-05 5.931E-04 2.608E-03 0.10601225 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP atopic dermatitis DOID_3310 7.584E-05 7.314E-04 0.07813914 0.64436478 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP atrophic muscular disease DOID_913 8.005E-05 7.591E-04 3.136E-03 0.11151211 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP muscular dystrophy DOID_9884 8.005E-05 7.591E-04 3.136E-03 0.11151211 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP vasculitis DOID_865 8.441E-05 7.873E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP facioscapulohumeral muscular dystrophy DOID_11727 9.571E-05 8.783E-04 9.571E-05 0.01815246 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP angioedema DOID_1558 9.571E-05 8.644E-04 0.01467537 0.37955835 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP conjunctival disease DOID_4251 9.571E-05 8.509E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP conjunctivitis DOID_6195 9.571E-05 8.509E-04 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP trypanosomiasis DOID_10113 1.169E-04 1.023E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP ocular hypertension DOID_9282 1.401E-04 1.208E-03 0.01758495 0.41690996 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP borderline glaucoma DOID_9283 1.401E-04 1.208E-03 0.01758495 0.41690996 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP encephalitis DOID_9588 1.401E-04 1.19E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP brain infarction DOID_3454 1.625E-04 1.36E-03 0.09972215 0.71825191 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pancreatic ductal carcinoma DOID_3587 1.764E-04 1.455E-03 0.10238488 0.71045117 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP male reproductive system disease DOID_48 1.837E-04 1.493E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP eyelid disease DOID_530 1.928E-04 1.545E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pancreatic carcinoma DOID_4905 1.988E-04 1.571E-03 0.10636448 0.72049275 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP diabetic retinopathy DOID_8947 1.988E-04 1.55E-03 0.10636448 0.71201636 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP cystic fibrosis DOID_1485 2.147E-04 1.651E-03 0.10900792 0.72122682 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP thoracic aortic aneurysm DOID_14004 2.223E-04 1.686E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP membranoproliferative glomerulonephritis DOID_2920 2.223E-04 1.664E-03 2.223E-04 0.02529312 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP adrenal cortex disease DOID_3952 2.223E-04 1.642E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP varicose veins DOID_799 2.223E-04 1.621E-03 0.02193352 0.44572048 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP metabolic syndrome X DOID_14221 2.489E-04 1.793E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP vein disease DOID_866 2.538E-04 1.805E-03 0.02337884 0.44341862 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP chronic kidney failure DOID_784 2.767E-04 1.944E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP adrenal gland disease DOID_9553 2.873E-04 1.994E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP retinal vascular disease DOID_2462 2.963E-04 2.031E-03 0.12080866 0.755386 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP mouth disease DOID_403 3.957E-04 2.68E-03 0.13245586 0.80178066 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Crohn's disease DOID_8778 3.957E-04 2.649E-03 8.941E-03 0.24226112 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP esophagitis DOID_11963 4.003E-04 2.648E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP amyloidosis DOID_9120 4.003E-04 2.618E-03 4.003E-04 0.02846995 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP funisitis DOID_0050698 4.857E-04 3.141E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP hepatitis B DOID_2043 4.857E-04 3.105E-03 0.03200679 0.50588511 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP acquired immunodeficiency syndrome DOID_635 4.857E-04 3.071E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP IgA glomerulonephritis DOID_2986 5.315E-04 3.323E-03 0.03343749 0.48784435 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Goodpasture syndrome DOID_9808 5.793E-04 3.583E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP toxic shock syndrome DOID_14115 6.29E-04 3.849E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP commensal bacterial infectious disease DOID_0050339 6.808E-04 4.121E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP urticaria DOID_1555 6.808E-04 4.078E-03 0.03771712 0.48775098 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP cystitis DOID_1679 7.346E-04 4.354E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP myositis DOID_633 7.346E-04 4.309E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP intracranial aneurysm DOID_10941 7.903E-04 4.589E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP middle cerebral artery infarction DOID_3525 7.903E-04 4.542E-03 0.04055987 0.49103331 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Sciatic Neuropathy DOID_11446 8.481E-04 4.826E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP gestational diabetes DOID_11714 8.481E-04 4.778E-03 0.04197815 0.49761596 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP lesion of sciatic nerve DOID_12528 8.481E-04 4.826E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP periodontitis DOID_824 8.481E-04 4.731E-03 0.04197815 0.48746054 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP mononeuritis of lower limb DOID_9473 8.481E-04 4.826E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP mononeuritis DOID_1802 9.078E-04 5.015E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP mononeuropathy DOID_1188 9.695E-04 5.304E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP abdominal aortic aneurysm DOID_7693 1.099E-03 5.954E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP celiac disease DOID_10608 1.166E-03 6.261E-03 0.04903871 0.51672273 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bladder disease DOID_365 1.236E-03 6.572E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP myocarditis DOID_820 1.307E-03 6.887E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pneumoconiosis DOID_10316 1.381E-03 7.207E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP periodontal disease DOID_3388 1.381E-03 7.142E-03 0.05325049 0.55090055 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP medullomyoblastoma DOID_3861 1.456E-03 7.464E-03 1.456E-03 0.07531442 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP adult medulloblastoma DOID_3864 1.456E-03 7.464E-03 1.456E-03 0.07531442 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP childhood medulloblastoma DOID_3869 1.456E-03 7.464E-03 1.456E-03 0.07531442 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP calcinosis DOID_182 1.612E-03 8.192E-03 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP medulloblastoma DOID_3858 1.612E-03 8.119E-03 1.612E-03 0.07645512 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP intracranial arterial disease DOID_13089 1.861E-03 9.291E-03 0.06161917 0.60450526 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP cerebral arterial disease DOID_3527 1.861E-03 9.291E-03 0.06161917 0.60450526 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP primitive neuroectodermal tumor DOID_168 2.127E-03 0.01052616 2.127E-03 0.09311604 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP diabetic autonomic neuropathy DOID_11503 2.22E-03 0.01088891 0.06715787 0.6368805 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autonomic neuropathy DOID_11504 2.22E-03 0.01088891 0.06715787 0.6368805 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP diabetic polyneuropathy DOID_12785 2.22E-03 0.01088891 0.06715787 0.6368805 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP gallbladder cancer DOID_3121 2.22E-03 0.01079584 0.06715787 0.62643984 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP diabetic neuropathy DOID_9743 2.22E-03 0.01088891 0.06715787 0.6368805 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP cerebral infarction DOID_3526 2.314E-03 0.0111592 0.06853753 0.61901353 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP proteinuria DOID_576 2.41E-03 0.01152539 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP autonomic nervous system disease DOID_11465 2.508E-03 0.01189431 0.07129082 0.63381996 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP heart valve disease DOID_4079 2.508E-03 0.01179601 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP vascular skin disease DOID_9540 2.508E-03 0.01169932 0.07129082 0.62406888 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP glaucoma DOID_1686 2.71E-03 0.01253723 0.07403612 0.63828112 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP calcium metabolism disease DOID_10575 2.814E-03 0.01291161 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bile duct adenocarcinoma DOID_4896 3.247E-03 0.01477862 0.08086456 0.64805538 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP cholangiocarcinoma DOID_4947 3.247E-03 0.01477862 0.08086456 0.64805538 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bile duct cancer DOID_4606 3.709E-03 0.01674751 0.08629167 0.66351299 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bile duct carcinoma DOID_4897 3.709E-03 0.01674751 0.08629167 0.66351299 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP leukocyte disease DOID_9500 3.829E-03 0.01715329 0.08764353 0.66492221 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP neuroectodermal tumor DOID_171 4.074E-03 0.01811006 4.074E-03 0.1363581 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP mineral metabolism disease DOID_0050032 4.455E-03 0.01965207 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP tooth disease DOID_1091 4.853E-03 0.02123994 0.09838787 0.71772691 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP peripheral vascular disease DOID_341 5.55E-03 0.02410586 0.10503988 0.72009265 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP lipid metabolism disorder DOID_3146 6.598E-03 0.02844196 6.598E-03 0.1975968 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP biliary tract cancer DOID_4607 7.073E-03 0.03025892 0.11819961 0.7472842 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP transitional cell carcinoma DOID_2671 7.897E-03 0.03353429 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP carbohydrate metabolic disorder DOID_2978 8.763E-03 0.0369347 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP interstitial nephritis DOID_1063 0.01467537 0.06139914 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Sjogren's syndrome DOID_12894 0.01467537 0.06095098 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP lateral sclerosis DOID_230 0.01467537 0.0605093 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Hermansky-Pudlak syndrome DOID_3753 0.01467537 0.06007398 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP adrenal gland hyperfunction DOID_3947 0.01467537 0.05964488 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP cutaneous leishmaniasis DOID_9111 0.01467537 0.05922187 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP prediabetes syndrome DOID_11716 0.01613122 0.06463847 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP common variable immunodeficiency DOID_12177 0.01613122 0.06418645 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP temporal arteritis DOID_13375 0.01613122 0.06374071 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP invasive lobular carcinoma DOID_3457 0.01613122 0.06330112 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP central nervous system vasculitis DOID_525 0.01613122 0.06374071 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP eosinophilic pneumonia DOID_5870 0.01613122 0.06286755 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pulmonary eosinophilia DOID_9498 0.01613122 0.06286755 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Loeffler syndrome DOID_9503 0.01613122 0.06286755 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP bronchiectasis DOID_9563 0.01613122 0.06243988 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP common cold DOID_10459 0.01758495 0.06760702 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP diarrhea DOID_13250 0.01758495 0.06715328 0.01758495 0.43503648 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP aortic valve insufficiency DOID_57 0.01758495 0.06670559 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP stomach disease DOID_76 0.01758495 0.06626383 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP lipodystrophy DOID_811 0.01758495 0.06582789 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP newborn respiratory distress syndrome DOID_12716 0.01903658 0.07079618 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP polyneuropathy DOID_1389 0.01903658 0.07033646 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP tethered spinal cord syndrome DOID_1089 0.0204861 0.07520382 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP parasitic helminthiasis infectious disease DOID_883 0.0204861 0.07472175 0.0204861 0.46626371 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP narcolepsy DOID_8986 0.0204861 0.07424581 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP Ehlers-Danlos syndrome DOID_13359 0.02193352 0.07898844 0.02193352 0.48000667 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP renovascular hypertension DOID_1591 0.02193352 0.07849166 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP corneal dystrophy DOID_2566 0.02193352 0.07800108 0.02193352 0.46222864 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP oral submucous fibrosis DOID_5773 0.02193352 0.0775166 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP silicosis DOID_10325 0.02337884 0.08211456 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP spastic diplegia DOID_10965 0.02337884 0.08161079 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP restrictive cardiomyopathy DOID_397 0.02337884 0.08111316 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP juvenile rheumatoid arthritis DOID_676 0.02482206 0.08559849 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP glucose intolerance DOID_10603 0.02626318 0.09002259 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP keratosis DOID_161 0.02626318 0.08948353 0.02626318 0.48205645 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP inherited blood coagulation disease DOID_2214 0.02626318 0.08895089 0.02626318 0.46699218 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP ureteral obstruction DOID_5199 0.02626318 0.08842456 0.02626318 0.45284091 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP prion disease DOID_649 0.02626318 0.08790441 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP eosinophilia DOID_999 0.02626318 0.08739035 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP agammaglobulinemia DOID_2583 0.02770221 0.09164279 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP leishmaniasis DOID_9065 0.02770221 0.09111306 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP pulmonary edema DOID_11396 0.02913916 0.09528839 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP blood protein disease DOID_620 0.02913916 0.09474389 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP coronary restenosis DOID_4247 0.03057402 0.0988444 1.000 1.000 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 hypersensitivity reaction type IV disease DOID_2916 2.396E-07 1.364E-04 2.089E-05 0.01188806 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 allergic contact dermatitis DOID_3042 3.161E-05 8.993E-03 3.161E-05 8.993E-03 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 contact dermatitis DOID_2773 5.077E-05 9.63E-03 5.077E-05 9.63E-03 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 endometriosis DOID_289 7.425E-04 0.08449247 0.03928972 0.49679665 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 integumentary system benign neoplasm DOID_0060121 9.481E-04 0.08991294 9.481E-04 0.13486941 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 skin benign neoplasm DOID_3165 9.481E-04 0.08991294 9.481E-04 0.13486941 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 sarcoidosis DOID_11335 1.099E-03 0.08931156 0.0476307 0.55309935 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 integumentary system cancer DOID_0060122 1.178E-03 0.08379063 1.178E-03 0.13406501 CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 skin cancer DOID_4159 1.178E-03 0.08379063 1.178E-03 0.13406501 HOEGERKORP_CD44_TARGETS_DIRECT_UP hemolytic anemia DOID_583 1.109E-08 6.31E-06 2.99E-04 0.08506272 HOEGERKORP_CD44_TARGETS_DIRECT_UP normocytic anemia DOID_720 1.109E-08 6.31E-06 2.99E-04 0.08506272 HOEGERKORP_CD44_TARGETS_DIRECT_UP hemolytic-uremic syndrome DOID_12554 5.951E-08 1.693E-05 7.99E-03 0.32474802 HOEGERKORP_CD44_TARGETS_DIRECT_UP proteinuria DOID_576 1.938E-06 3.675E-04 0.02427963 0.36355551 HOEGERKORP_CD44_TARGETS_DIRECT_UP bile duct adenocarcinoma DOID_4896 3.069E-06 4.366E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP cholangiocarcinoma DOID_4947 3.069E-06 4.366E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP bile duct cancer DOID_4606 3.771E-06 4.291E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP bile duct carcinoma DOID_4897 3.771E-06 4.291E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP respiratory failure DOID_11162 4.571E-06 4.334E-04 0.03208597 0.42457943 HOEGERKORP_CD44_TARGETS_DIRECT_UP cholestasis DOID_13580 5.239E-06 4.259E-04 0.03354305 0.43377267 HOEGERKORP_CD44_TARGETS_DIRECT_UP blood coagulation disease DOID_1247 6.492E-06 4.617E-04 6.122E-04 0.11612062 HOEGERKORP_CD44_TARGETS_DIRECT_UP bile duct disease DOID_4138 6.764E-06 4.276E-04 0.03645099 0.45088293 HOEGERKORP_CD44_TARGETS_DIRECT_UP biliary tract disease DOID_9741 7.043E-06 4.008E-04 0.03693484 0.43783178 HOEGERKORP_CD44_TARGETS_DIRECT_UP cystic fibrosis DOID_1485 7.928E-06 4.101E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP biliary tract cancer DOID_4607 1.027E-05 4.87E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP retinal vascular occlusion DOID_1729 1.068E-05 4.676E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP retinal vascular disease DOID_2462 1.101E-05 4.476E-04 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP membranoproliferative glomerulonephritis DOID_2920 2.489E-05 9.441E-04 7.493E-03 0.35527741 HOEGERKORP_CD44_TARGETS_DIRECT_UP dissociative disorder DOID_10935 4.049E-05 1.44E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP dissociative amnesia DOID_11037 4.049E-05 1.44E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP amnestic disorder DOID_10914 4.497E-05 1.505E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP membranous glomerulonephritis DOID_10976 4.497E-05 1.422E-03 9.978E-03 0.31542783 HOEGERKORP_CD44_TARGETS_DIRECT_UP mitochondrial myopathy DOID_699 4.969E-05 1.488E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP thrombophilia DOID_2452 5.464E-05 1.555E-03 5.464E-05 0.031091 HOEGERKORP_CD44_TARGETS_DIRECT_UP placenta disease DOID_780 5.464E-05 1.481E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP meningitis DOID_9471 6.525E-05 1.688E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP bronchiolitis DOID_2942 7.678E-05 1.9E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP periodontitis DOID_824 9.584E-05 2.272E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP allergic rhinitis DOID_4481 1.322E-04 3.009E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP pneumoconiosis DOID_10316 1.568E-04 3.432E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP periodontal disease DOID_3388 1.568E-04 3.305E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP uveitis DOID_13141 1.929E-04 3.919E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP adult respiratory distress syndrome DOID_11394 2.123E-04 4.165E-03 0.02133691 0.36789998 HOEGERKORP_CD44_TARGETS_DIRECT_UP nephrotic syndrome DOID_1184 2.431E-04 4.61E-03 0.02280932 0.38172063 HOEGERKORP_CD44_TARGETS_DIRECT_UP uveal disease DOID_3480 2.431E-04 4.462E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP influenza DOID_8469 2.538E-04 4.513E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP pulmonary tuberculosis DOID_2957 3.109E-04 5.36E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP hemorrhagic disease DOID_2213 3.353E-04 5.611E-03 0.02672549 0.38017016 HOEGERKORP_CD44_TARGETS_DIRECT_UP integumentary system cancer DOID_0060122 3.868E-04 6.289E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP skin cancer DOID_4159 3.868E-04 6.289E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP pustulosis of palm and sole DOID_4398 3.868E-04 6.114E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP familial hyperlipidemia DOID_1168 4.003E-04 6.156E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP mitochondrial metabolism disease DOID_700 4.003E-04 5.994E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP melancholia DOID_2848 4.42E-04 6.449E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP neurotic disorder DOID_4964 4.563E-04 6.491E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP mineral metabolism disease DOID_0050032 5.16E-04 7.161E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP uterine disease DOID_345 5.315E-04 7.2E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP hyperglycemia DOID_4195 5.472E-04 7.241E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP tooth disease DOID_1091 5.631E-04 7.282E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP tuberculosis DOID_399 5.793E-04 7.325E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP nephrosis DOID_2527 6.291E-04 7.781E-03 0.03645099 0.46090255 HOEGERKORP_CD44_TARGETS_DIRECT_UP male reproductive system disease DOID_48 6.291E-04 7.616E-03 0.03645099 0.44128968 HOEGERKORP_CD44_TARGETS_DIRECT_UP diabetic retinopathy DOID_8947 6.634E-04 7.864E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP endogenous depression DOID_1595 6.986E-04 8.112E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP bone resorption disease DOID_0080011 7.165E-04 8.154E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP osteoporosis DOID_11476 7.165E-04 8.154E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP electroclinical syndrome DOID_0050701 7.346E-04 8.196E-03 7.346E-04 0.10450198 HOEGERKORP_CD44_TARGETS_DIRECT_UP bacterial pneumonia DOID_874 7.346E-04 8.039E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP metabolic syndrome X DOID_14221 7.716E-04 8.284E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP lipid metabolism disorder DOID_3146 7.716E-04 8.13E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP female reproductive system disease DOID_229 7.904E-04 8.177E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP mental depression DOID_1596 8.287E-04 8.42E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP focal epilepsy DOID_2234 8.287E-04 8.273E-03 0.0417607 0.47523676 HOEGERKORP_CD44_TARGETS_DIRECT_UP chronic kidney failure DOID_784 8.287E-04 8.13E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP primary bacterial infectious disease DOID_0050338 9.079E-04 8.756E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP Human immunodeficiency virus infectious disease DOID_526 9.697E-04 9.196E-03 0.04512516 0.49377336 HOEGERKORP_CD44_TARGETS_DIRECT_UP lymphoblastic leukemia DOID_1037 1.033E-03 9.639E-03 0.04656364 0.49990021 HOEGERKORP_CD44_TARGETS_DIRECT_UP carbohydrate metabolic disorder DOID_2978 1.033E-03 9.484E-03 0.04656364 0.4906428 HOEGERKORP_CD44_TARGETS_DIRECT_UP mouth disease DOID_403 1.055E-03 9.529E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP hypersensitivity reaction type I disease DOID_1205 1.077E-03 9.575E-03 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP leber hereditary optic neuropathy DOID_705 4.502E-03 0.03940987 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP interstitial nephritis DOID_1063 5.001E-03 0.04311505 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP hyperparathyroidism DOID_13543 5.001E-03 0.04247154 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP childhood type dermatomyositis DOID_14203 5.001E-03 0.04184696 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP angioedema DOID_1558 5.001E-03 0.04124048 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP chondrosarcoma DOID_3371 5.001E-03 0.04065133 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP conjunctival disease DOID_4251 5.001E-03 0.04007878 5.001E-03 0.56911864 HOEGERKORP_CD44_TARGETS_DIRECT_UP hypokalemia DOID_4500 5.001E-03 0.03952213 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP conjunctivitis DOID_6195 5.001E-03 0.04007878 5.001E-03 0.56911864 HOEGERKORP_CD44_TARGETS_DIRECT_UP visceral leishmaniasis DOID_9146 5.001E-03 0.03898073 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP dermatomyositis DOID_10223 5.5E-03 0.04228932 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP prediabetes syndrome DOID_11716 5.5E-03 0.04172546 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP neonatoal period electroclinical syndrome DOID_0050702 5.998E-03 0.0449091 5.998E-03 0.56884861 HOEGERKORP_CD44_TARGETS_DIRECT_UP common cold DOID_10459 5.998E-03 0.04432587 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP otitis media DOID_10754 5.998E-03 0.04375759 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP middle ear disease DOID_5100 5.998E-03 0.04375759 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP mitochondrial encephalomyopathy DOID_890 5.998E-03 0.04320369 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP infancy electroclinical syndrome DOID_0050703 6.497E-03 0.04620798 6.497E-03 0.52809125 HOEGERKORP_CD44_TARGETS_DIRECT_UP berylliosis DOID_10322 6.497E-03 0.04563752 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP Hirschsprung's disease DOID_10487 6.497E-03 0.04508096 6.497E-03 0.46207984 HOEGERKORP_CD44_TARGETS_DIRECT_UP parathyroid gland disease DOID_11201 6.497E-03 0.04453782 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP polyneuropathy DOID_1389 6.497E-03 0.0440076 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP obstructive hydrocephalus DOID_14159 6.497E-03 0.04348987 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP communicating hydrocephalus DOID_1573 6.497E-03 0.04348987 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP intracranial thrombosis DOID_4193 6.497E-03 0.04298417 6.497E-03 0.41073764 HOEGERKORP_CD44_TARGETS_DIRECT_UP epilepsy with generalized tonic-clonic seizures DOID_7725 6.497E-03 0.0424901 6.497E-03 0.36966387 HOEGERKORP_CD44_TARGETS_DIRECT_UP hydrocephalus DOID_10908 6.995E-03 0.04522785 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP megacolon DOID_11372 6.995E-03 0.04471968 6.995E-03 0.36182283 HOEGERKORP_CD44_TARGETS_DIRECT_UP hypercalcemia DOID_12678 6.995E-03 0.04422279 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP arthropathy DOID_381 7.493E-03 0.04684977 7.493E-03 0.32794838 HOEGERKORP_CD44_TARGETS_DIRECT_UP lung oat cell carcinoma DOID_5411 7.493E-03 0.04634053 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP varicose veins DOID_799 7.493E-03 0.04584225 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP intracranial hypertension DOID_9428 7.493E-03 0.04535456 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP thyroiditis DOID_7166 7.99E-03 0.0478576 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP autoimmune thyroiditis DOID_7188 7.99E-03 0.0478576 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP chronic myeloid leukemia DOID_8552 7.99E-03 0.04735909 7.99E-03 0.30309815 HOEGERKORP_CD44_TARGETS_DIRECT_UP vein disease DOID_866 7.99E-03 0.04687085 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP basal cell carcinoma DOID_2513 8.488E-03 0.04928042 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP inherited blood coagulation disease DOID_2214 8.985E-03 0.05163995 8.985E-03 0.31952221 HOEGERKORP_CD44_TARGETS_DIRECT_UP skin carcinoma DOID_3451 8.985E-03 0.05112355 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP prion disease DOID_649 8.985E-03 0.05061738 8.985E-03 0.30072678 HOEGERKORP_CD44_TARGETS_DIRECT_UP leishmaniasis DOID_9065 9.482E-03 0.05289309 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP pulmonary edema DOID_11396 9.978E-03 0.05512331 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP brain edema DOID_4724 9.978E-03 0.05459328 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP colonic disease DOID_5353 9.978E-03 0.05407334 9.978E-03 0.29882636 HOEGERKORP_CD44_TARGETS_DIRECT_UP juvenile absence epilepsy DOID_0060172 0.01047482 0.05622804 0.01047482 0.29800862 HOEGERKORP_CD44_TARGETS_DIRECT_UP autoimmune hepatitis DOID_2048 0.01047482 0.05570255 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP familial hypercholesterolemia DOID_13810 0.01097102 0.05780101 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP acquired immunodeficiency syndrome DOID_635 0.01097102 0.05727073 0.01097102 0.29726236 HOEGERKORP_CD44_TARGETS_DIRECT_UP glycogen metabolism disorder DOID_0050728 0.01146698 0.05931557 0.01146698 0.29657785 HOEGERKORP_CD44_TARGETS_DIRECT_UP optic nerve disease DOID_1891 0.01146698 0.05878119 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP glycogen storage disease DOID_2747 0.01146698 0.05931557 0.01146698 0.29657785 HOEGERKORP_CD44_TARGETS_DIRECT_UP IgA glomerulonephritis DOID_2986 0.01146698 0.05825636 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP Goodpasture syndrome DOID_9808 0.01196271 0.06023701 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP spastic quadriplegia DOID_10970 0.0124582 0.06218172 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP toxic shock syndrome DOID_14115 0.0124582 0.06164101 0.0124582 0.30820507 HOEGERKORP_CD44_TARGETS_DIRECT_UP sphingolipidosis DOID_1927 0.0124582 0.06110963 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP commensal bacterial infectious disease DOID_0050339 0.01295346 0.06299588 0.01295346 0.3071049 HOEGERKORP_CD44_TARGETS_DIRECT_UP urticaria DOID_1555 0.01295346 0.06246201 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP hypogonadism DOID_1924 0.01295346 0.06193712 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP infantile epileptic encephalopathy DOID_2481 0.01344848 0.06376821 0.01344848 0.30608739 HOEGERKORP_CD44_TARGETS_DIRECT_UP myositis DOID_633 0.01344848 0.0632412 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP intracranial aneurysm DOID_10941 0.01394327 0.06503048 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP middle cerebral artery infarction DOID_3525 0.01394327 0.06450177 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP juvenile myoclonic epilepsy DOID_4890 0.01394327 0.0639816 0.01394327 0.305143 HOEGERKORP_CD44_TARGETS_DIRECT_UP extrinsic allergic alveolitis DOID_841 0.01394327 0.06346974 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP Sciatic Neuropathy DOID_11446 0.01443782 0.06519935 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP lesion of sciatic nerve DOID_12528 0.01443782 0.06519935 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP lung adenocarcinoma DOID_3910 0.01443782 0.06468597 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP migraine DOID_6364 0.01443782 0.06418061 0.01443782 0.30426362 HOEGERKORP_CD44_TARGETS_DIRECT_UP mononeuritis of lower limb DOID_9473 0.01443782 0.06519935 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP pleurisy DOID_10247 0.01493213 0.06586344 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP thrombocytopenia DOID_1588 0.01493213 0.0653568 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP mononeuritis DOID_1802 0.01493213 0.06485789 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP autoimmune disease of endocrine system DOID_0060005 0.01542621 0.06649633 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP polycystic ovary syndrome DOID_11612 0.01542621 0.06599636 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP mononeuropathy DOID_1188 0.01542621 0.06550385 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP cranial nerve disease DOID_5656 0.01542621 0.06501863 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP spastic cerebral palsy DOID_0050669 0.01641367 0.06867191 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP gonadal disease DOID_2277 0.01641367 0.06817065 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP bronchiolitis obliterans DOID_2799 0.01641367 0.06767666 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP celiac disease DOID_10608 0.01690705 0.06920943 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP chronic leukemia DOID_1036 0.01740019 0.07071935 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP chronic lymphocytic leukemia DOID_1040 0.01740019 0.07071935 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP pleural disease DOID_1532 0.01740019 0.0702178 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP childhood absence epilepsy DOID_1825 0.01740019 0.0697233 0.01740019 0.35359676 HOEGERKORP_CD44_TARGETS_DIRECT_UP myocarditis DOID_820 0.0178931 0.07119702 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP male infertility DOID_12336 0.01838577 0.07264934 0.01838577 0.36074157 HOEGERKORP_CD44_TARGETS_DIRECT_UP hyperthyroidism DOID_7998 0.01838577 0.07214831 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP childhood electroclinical syndrome DOID_0050704 0.01887821 0.07357331 0.01887821 0.3580568 HOEGERKORP_CD44_TARGETS_DIRECT_UP adolescence-adult electroclinical syndrome DOID_0050705 0.01986239 0.07688232 0.01986239 0.364571 HOEGERKORP_CD44_TARGETS_DIRECT_UP multiple myeloma DOID_9538 0.01986239 0.07636285 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP blood platelet disease DOID_2218 0.02035413 0.07772819 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP respiratory syncytial virus infectious disease DOID_1273 0.02084563 0.07907444 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP congenital diaphragmatic hernia DOID_3827 0.02084563 0.07855077 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP systemic scleroderma DOID_418 0.02084563 0.07803399 0.02084563 0.37066144 HOEGERKORP_CD44_TARGETS_DIRECT_UP intracranial arterial disease DOID_13089 0.02133691 0.07935098 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP cerebral arterial disease DOID_3527 0.02133691 0.07935098 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP adenoid cystic carcinoma DOID_4866 0.02133691 0.07883571 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP salivary gland cancer DOID_8850 0.02231875 0.0819314 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP rheumatic disease DOID_1575 0.02280932 0.08319552 0.02280932 0.37081433 HOEGERKORP_CD44_TARGETS_DIRECT_UP idiopathic generalized epilepsy DOID_1827 0.02280932 0.08266561 0.02280932 0.36051393 HOEGERKORP_CD44_TARGETS_DIRECT_UP hyperinsulinism DOID_2018 0.02280932 0.08214241 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP scleroderma DOID_419 0.02280932 0.08319552 0.02280932 0.37081433 HOEGERKORP_CD44_TARGETS_DIRECT_UP diabetic autonomic neuropathy DOID_11503 0.02329965 0.08338052 0.02329965 0.3583109 HOEGERKORP_CD44_TARGETS_DIRECT_UP autonomic neuropathy DOID_11504 0.02329965 0.08338052 0.02329965 0.3583109 HOEGERKORP_CD44_TARGETS_DIRECT_UP diabetic polyneuropathy DOID_12785 0.02329965 0.08338052 0.02329965 0.3583109 HOEGERKORP_CD44_TARGETS_DIRECT_UP diabetic neuropathy DOID_9743 0.02329965 0.08338052 0.02329965 0.3583109 HOEGERKORP_CD44_TARGETS_DIRECT_UP cerebral infarction DOID_3526 0.02378976 0.08460233 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP myeloma DOID_0070004 0.02476927 0.08753859 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP autonomic nervous system disease DOID_11465 0.02476927 0.08699823 0.02476927 0.36137727 HOEGERKORP_CD44_TARGETS_DIRECT_UP neuritis DOID_1803 0.02476927 0.0864645 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP vascular skin disease DOID_9540 0.02476927 0.08593728 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.02574785 0.08879106 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP integumentary system benign neoplasm DOID_0060121 0.02574785 0.08825617 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP skin benign neoplasm DOID_3165 0.02574785 0.08825617 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP lung small cell carcinoma DOID_5409 0.02574785 0.08772769 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP calcium metabolism disease DOID_10575 0.02623679 0.0888615 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP atopic dermatitis DOID_3310 0.02721397 0.09162573 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP bone marrow cancer DOID_4960 0.02819022 0.09435434 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP parasitic protozoa infectious disease DOID_2789 0.028678 0.09542564 1.000 1.000 HOEGERKORP_CD44_TARGETS_DIRECT_UP retinitis pigmentosa DOID_10584 0.03013995 0.09970716 0.03013995 0.41828368 HOEGERKORP_CD44_TARGETS_DIRECT_UP oral cavity cancer DOID_8618 0.03013995 0.09913082 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP heart valve disease DOID_4079 1.828E-08 1.04E-05 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP atrophic muscular disease DOID_913 3.271E-08 9.306E-06 1.034E-04 0.02941423 KAYO_CALORIE_RESTRICTION_MUSCLE_UP muscular dystrophy DOID_9884 3.271E-08 9.306E-06 1.034E-04 0.02941423 KAYO_CALORIE_RESTRICTION_MUSCLE_UP aneurysm disease DOID_2403 1.876E-07 3.558E-05 0.11957192 0.6942492 KAYO_CALORIE_RESTRICTION_MUSCLE_UP chronic kidney failure DOID_784 2.71E-07 3.856E-05 0.12805579 0.71435042 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bone development disease DOID_0080006 2.874E-07 3.271E-05 3.688E-04 0.06995456 KAYO_CALORIE_RESTRICTION_MUSCLE_UP uveitis DOID_13141 5.874E-07 5.57E-05 0.06392372 0.51960855 KAYO_CALORIE_RESTRICTION_MUSCLE_UP aortic valve insufficiency DOID_57 8.63E-07 7.015E-05 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP uveal disease DOID_3480 9.408E-07 6.692E-05 0.07143891 0.54930726 KAYO_CALORIE_RESTRICTION_MUSCLE_UP Ehlers-Danlos syndrome DOID_13359 1.779E-06 1.125E-04 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP restrictive cardiomyopathy DOID_397 2.187E-06 1.244E-04 0.02544112 0.42576467 KAYO_CALORIE_RESTRICTION_MUSCLE_UP osteochondrodysplasia DOID_2256 2.411E-06 1.247E-04 3.973E-03 0.15069036 KAYO_CALORIE_RESTRICTION_MUSCLE_UP congenital nervous system abnormality DOID_2490 2.764E-06 1.311E-04 2.764E-06 1.573E-03 KAYO_CALORIE_RESTRICTION_MUSCLE_UP ureteral obstruction DOID_5199 3.179E-06 1.391E-04 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP nephrosis DOID_2527 6.414E-06 2.607E-04 0.11244005 0.68062115 KAYO_CALORIE_RESTRICTION_MUSCLE_UP urinary tract obstruction DOID_5200 6.86E-06 2.602E-04 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP ureteral disease DOID_1426 7.831E-06 2.785E-04 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP aortic valve disease DOID_62 7.831E-06 2.621E-04 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP intracranial aneurysm DOID_10941 1.262E-05 3.988E-04 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP migraine DOID_6364 1.406E-05 4.21E-04 0.04564234 0.49943248 KAYO_CALORIE_RESTRICTION_MUSCLE_UP focal glomerulosclerosis DOID_3945 1.725E-05 4.908E-04 1.149E-03 0.07264914 KAYO_CALORIE_RESTRICTION_MUSCLE_UP aortic aneurysm DOID_3627 8.767E-05 2.376E-03 0.08186055 0.57504511 KAYO_CALORIE_RESTRICTION_MUSCLE_UP facioscapulohumeral muscular dystrophy DOID_11727 1.136E-04 2.939E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP carotid artery disease DOID_3407 1.54E-04 3.809E-03 0.09800541 0.6336941 KAYO_CALORIE_RESTRICTION_MUSCLE_UP collagen disease DOID_854 1.54E-04 3.651E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP respiratory failure DOID_11162 1.612E-04 3.67E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP ocular hypertension DOID_9282 1.663E-04 3.64E-03 0.01914117 0.38897598 KAYO_CALORIE_RESTRICTION_MUSCLE_UP borderline glaucoma DOID_9283 1.663E-04 3.64E-03 0.01914117 0.38897598 KAYO_CALORIE_RESTRICTION_MUSCLE_UP osteogenesis imperfecta DOID_12347 1.964E-04 4.139E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP endocrine organ benign neoplasm DOID_0060089 2.095E-04 4.258E-03 5.892E-03 0.176464 KAYO_CALORIE_RESTRICTION_MUSCLE_UP peripheral vascular disease DOID_341 2.464E-04 4.835E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP skeletal system cancer DOID_0060124 2.638E-04 5.004E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bone cancer DOID_184 2.638E-04 5.004E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP membranoproliferative glomerulonephritis DOID_2920 2.638E-04 4.842E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP oral submucous fibrosis DOID_5773 2.638E-04 4.691E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP varicose veins DOID_799 2.638E-04 4.549E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bone resorption disease DOID_0080011 2.873E-04 4.808E-03 0.11957192 0.70140641 KAYO_CALORIE_RESTRICTION_MUSCLE_UP osteoporosis DOID_11476 2.873E-04 4.808E-03 0.11957192 0.70140641 KAYO_CALORIE_RESTRICTION_MUSCLE_UP vein disease DOID_866 3.012E-04 4.896E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP biliary tract cancer DOID_4607 3.564E-04 5.633E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP congenital muscular dystrophy DOID_0050557 3.832E-04 5.893E-03 3.832E-04 0.05451276 KAYO_CALORIE_RESTRICTION_MUSCLE_UP Human immunodeficiency virus infectious disease DOID_526 4.495E-04 6.731E-03 0.13785204 0.74702675 KAYO_CALORIE_RESTRICTION_MUSCLE_UP encephalomyelitis DOID_640 4.937E-04 7.204E-03 0.14201722 0.75521305 KAYO_CALORIE_RESTRICTION_MUSCLE_UP alcohol-related neurodevelopmental disorder DOID_0050667 5.091E-04 7.242E-03 5.091E-04 0.05793374 KAYO_CALORIE_RESTRICTION_MUSCLE_UP mouth disease DOID_403 5.091E-04 7.065E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP IgA glomerulonephritis DOID_2986 6.304E-04 8.541E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP diabetic angiopathy DOID_11713 6.87E-04 9.091E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP meningitis DOID_9471 6.87E-04 8.884E-03 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP spastic quadriplegia DOID_10970 7.46E-04 9.432E-03 0.03947085 0.52230031 KAYO_CALORIE_RESTRICTION_MUSCLE_UP X-linked disease DOID_0050735 8.073E-04 9.986E-03 8.073E-04 0.07655964 KAYO_CALORIE_RESTRICTION_MUSCLE_UP middle cerebral artery infarction DOID_3525 9.37E-04 0.0113439 0.04410313 0.51213635 KAYO_CALORIE_RESTRICTION_MUSCLE_UP dystonia DOID_543 9.37E-04 0.01110757 0.04410313 0.50189362 KAYO_CALORIE_RESTRICTION_MUSCLE_UP periodontitis DOID_824 1.005E-03 0.01167479 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP renal hypertension DOID_1073 1.076E-03 0.01224584 1.076E-03 0.08747031 KAYO_CALORIE_RESTRICTION_MUSCLE_UP secondary hypertension DOID_11130 1.076E-03 0.01224584 1.076E-03 0.08747031 KAYO_CALORIE_RESTRICTION_MUSCLE_UP thrombocytopenia DOID_1588 1.076E-03 0.01200573 0.0471791 0.50650772 KAYO_CALORIE_RESTRICTION_MUSCLE_UP multiple epiphyseal dysplasia DOID_12721 1.149E-03 0.01257389 1.149E-03 0.08173028 KAYO_CALORIE_RESTRICTION_MUSCLE_UP spastic cerebral palsy DOID_0050669 1.302E-03 0.0139791 0.05177482 0.51683982 KAYO_CALORIE_RESTRICTION_MUSCLE_UP abdominal aortic aneurysm DOID_7693 1.302E-03 0.01372023 0.05177482 0.50792879 KAYO_CALORIE_RESTRICTION_MUSCLE_UP allergic rhinitis DOID_4481 1.382E-03 0.0142979 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP periodontal disease DOID_3388 1.636E-03 0.01661922 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP medullomyoblastoma DOID_3861 1.725E-03 0.01721693 1.725E-03 0.09813651 KAYO_CALORIE_RESTRICTION_MUSCLE_UP adult medulloblastoma DOID_3864 1.725E-03 0.01721693 1.725E-03 0.09813651 KAYO_CALORIE_RESTRICTION_MUSCLE_UP childhood medulloblastoma DOID_3869 1.725E-03 0.01721693 1.725E-03 0.09813651 KAYO_CALORIE_RESTRICTION_MUSCLE_UP calcinosis DOID_182 1.91E-03 0.01873457 0.06241352 0.53004918 KAYO_CALORIE_RESTRICTION_MUSCLE_UP medulloblastoma DOID_3858 1.91E-03 0.01841704 1.91E-03 0.0987823 KAYO_CALORIE_RESTRICTION_MUSCLE_UP blood platelet disease DOID_2218 2.006E-03 0.01901914 0.06392372 0.51229012 KAYO_CALORIE_RESTRICTION_MUSCLE_UP adult respiratory distress syndrome DOID_11394 2.204E-03 0.02055836 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP intracranial arterial disease DOID_13089 2.204E-03 0.02022677 0.06693695 0.52898783 KAYO_CALORIE_RESTRICTION_MUSCLE_UP cerebral arterial disease DOID_3527 2.204E-03 0.02022677 0.06693695 0.52898783 KAYO_CALORIE_RESTRICTION_MUSCLE_UP nephrotic syndrome DOID_1184 2.518E-03 0.0227449 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP primitive neuroectodermal tumor DOID_168 2.518E-03 0.02238951 2.518E-03 0.11941074 KAYO_CALORIE_RESTRICTION_MUSCLE_UP influenza DOID_8469 2.628E-03 0.02300107 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP cerebral infarction DOID_3526 2.739E-03 0.02361306 0.07442833 0.56466296 KAYO_CALORIE_RESTRICTION_MUSCLE_UP learning disability DOID_8927 2.739E-03 0.02326062 2.739E-03 0.11988168 KAYO_CALORIE_RESTRICTION_MUSCLE_UP proteinuria DOID_576 2.853E-03 0.02386915 0.0759195 0.56839728 KAYO_CALORIE_RESTRICTION_MUSCLE_UP thyroid adenoma DOID_2891 2.968E-03 0.02447806 2.968E-03 0.12064187 KAYO_CALORIE_RESTRICTION_MUSCLE_UP hemolytic anemia DOID_583 3.086E-03 0.02508729 0.07889474 0.58300135 KAYO_CALORIE_RESTRICTION_MUSCLE_UP normocytic anemia DOID_720 3.086E-03 0.02508729 0.07889474 0.58300135 KAYO_CALORIE_RESTRICTION_MUSCLE_UP glaucoma DOID_1686 3.206E-03 0.02569676 0.08037882 0.58635318 KAYO_CALORIE_RESTRICTION_MUSCLE_UP calcium metabolism disease DOID_10575 3.329E-03 0.02630641 0.08186055 0.58223317 KAYO_CALORIE_RESTRICTION_MUSCLE_UP movement disease DOID_480 3.329E-03 0.02594605 0.08186055 0.56803236 KAYO_CALORIE_RESTRICTION_MUSCLE_UP hemorrhagic disease DOID_2213 3.453E-03 0.02655244 0.08333993 0.5713304 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bile duct adenocarcinoma DOID_4896 3.839E-03 0.02912887 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP cholangiocarcinoma DOID_4947 3.839E-03 0.02912887 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP parasitic protozoa infectious disease DOID_2789 3.973E-03 0.02974152 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP familial hyperlipidemia DOID_1168 4.108E-03 0.03035394 0.09070176 0.60010813 KAYO_CALORIE_RESTRICTION_MUSCLE_UP nonsyndromic deafness DOID_0050563 4.384E-03 0.03198279 4.384E-03 0.15591612 KAYO_CALORIE_RESTRICTION_MUSCLE_UP hypersensitivity reaction type IV disease DOID_2916 4.384E-03 0.03157795 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bile duct cancer DOID_4606 4.384E-03 0.03118322 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bile duct carcinoma DOID_4897 4.384E-03 0.03118322 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP melancholia DOID_2848 4.526E-03 0.03179205 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP neurotic disorder DOID_4964 4.669E-03 0.03240057 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP neuroectodermal tumor DOID_171 4.815E-03 0.03300873 4.815E-03 0.16116028 KAYO_CALORIE_RESTRICTION_MUSCLE_UP mineral metabolism disease DOID_0050032 5.264E-03 0.03566012 0.10235988 0.65441316 KAYO_CALORIE_RESTRICTION_MUSCLE_UP parasitic infectious disease DOID_1398 5.418E-03 0.03627109 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP temporal lobe epilepsy DOID_3328 5.574E-03 0.03688143 5.574E-03 0.1762113 KAYO_CALORIE_RESTRICTION_MUSCLE_UP tooth disease DOID_1091 5.732E-03 0.03749114 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP allergic contact dermatitis DOID_3042 5.732E-03 0.0370651 0.10669367 0.66712853 KAYO_CALORIE_RESTRICTION_MUSCLE_UP brain infarction DOID_3454 5.892E-03 0.03767209 0.10813368 0.66878333 KAYO_CALORIE_RESTRICTION_MUSCLE_UP blood coagulation disease DOID_1247 6.219E-03 0.03931619 0.11100687 0.67917107 KAYO_CALORIE_RESTRICTION_MUSCLE_UP pancreatic ductal carcinoma DOID_3587 6.219E-03 0.03888415 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP male reproductive system disease DOID_48 6.385E-03 0.03948918 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP pancreatic carcinoma DOID_4905 6.723E-03 0.04113475 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP endogenous depression DOID_1595 7.07E-03 0.04279374 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP pancreatitis DOID_4989 7.424E-03 0.0444654 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bacterial pneumonia DOID_874 7.424E-03 0.04400222 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP contact dermatitis DOID_2773 7.786E-03 0.04567327 0.12382395 0.71167504 KAYO_CALORIE_RESTRICTION_MUSCLE_UP lipid metabolism disorder DOID_3146 7.786E-03 0.04520721 0.12382395 0.70455829 KAYO_CALORIE_RESTRICTION_MUSCLE_UP auditory system disease DOID_2742 8.156E-03 0.0468774 8.156E-03 0.23204315 KAYO_CALORIE_RESTRICTION_MUSCLE_UP mental depression DOID_1596 8.344E-03 0.04747805 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP focal epilepsy DOID_2234 8.344E-03 0.04700797 8.344E-03 0.22608595 KAYO_CALORIE_RESTRICTION_MUSCLE_UP transitional cell carcinoma DOID_2671 9.313E-03 0.05195103 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP dilated cardiomyopathy DOID_12930 0.01074902 0.05938049 0.144783 0.76279191 KAYO_CALORIE_RESTRICTION_MUSCLE_UP interstitial nephritis DOID_1063 0.01597619 0.08740821 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP Gilles de la Tourette syndrome DOID_11119 0.01597619 0.08657575 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP gonadal dysgenesis DOID_14447 0.01597619 0.085759 0.01597619 0.41320247 KAYO_CALORIE_RESTRICTION_MUSCLE_UP angioedema DOID_1558 0.01597619 0.08495752 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP bilirubin metabolic disorder DOID_2741 0.01597619 0.08417087 0.01597619 0.39523714 KAYO_CALORIE_RESTRICTION_MUSCLE_UP chondrosarcoma DOID_3371 0.01597619 0.08339866 0.01597619 0.37876893 KAYO_CALORIE_RESTRICTION_MUSCLE_UP holoprosencephaly DOID_4621 0.01597619 0.08264049 0.01597619 0.36361817 KAYO_CALORIE_RESTRICTION_MUSCLE_UP trypanosomiasis DOID_10113 0.01755994 0.09001445 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP migraine without aura DOID_12783 0.01755994 0.08921075 0.01755994 0.38429247 KAYO_CALORIE_RESTRICTION_MUSCLE_UP heroin dependence DOID_9976 0.01755994 0.08842128 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP esophageal carcinoma DOID_1107 0.01914117 0.09553796 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP mucopolysaccharidosis DOID_12798 0.01914117 0.0947072 0.01914117 0.4033825 KAYO_CALORIE_RESTRICTION_MUSCLE_UP pituitary cancer DOID_1785 0.01914117 0.09389075 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP tic disorder DOID_2769 0.01914117 0.09308827 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP esophagus squamous cell carcinoma DOID_3748 0.01914117 0.09553796 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP pituitary carcinoma DOID_4916 0.01914117 0.09389075 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP retinal detachment DOID_5327 0.01914117 0.09229939 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP peritonitis DOID_8283 0.01914117 0.09152376 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP berylliosis DOID_10322 0.02071991 0.09824689 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP impotence DOID_1875 0.02071991 0.09743493 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP Lynch syndrome DOID_3883 0.02071991 0.09663628 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP intracranial thrombosis DOID_4193 0.02071991 0.09585062 1.000 1.000 KAYO_CALORIE_RESTRICTION_MUSCLE_UP narcolepsy DOID_8986 0.02229614 0.09989372 0.02229614 0.42288343 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN aneurysm disease DOID_2403 3.722E-12 2.118E-09 6.039E-09 3.436E-06 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN hypersensitivity reaction type I disease DOID_1205 2.466E-11 7.015E-09 2.555E-08 4.845E-06 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN carotid artery disease DOID_3407 2.837E-11 5.38E-09 5.442E-08 7.742E-06 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN contact dermatitis DOID_2773 2.18E-10 3.101E-08 2.428E-07 2.302E-05 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pre-eclampsia DOID_10591 2.243E-10 2.552E-08 1.195E-08 3.401E-06 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN aortic aneurysm DOID_3627 3.435E-10 3.257E-08 7.123E-07 4.053E-05 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN abdominal aortic aneurysm DOID_7693 8.702E-10 7.074E-08 3.519E-06 1.43E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN allergic contact dermatitis DOID_3042 2.556E-09 1.818E-07 2.879E-06 1.365E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN brain infarction DOID_3454 2.828E-09 1.788E-07 3.089E-06 1.352E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN tuberculosis DOID_399 2.828E-09 1.609E-07 1.021E-07 1.162E-05 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pulmonary emphysema DOID_9675 5.393E-09 2.789E-07 2.757E-07 2.241E-05 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN primary bacterial infectious disease DOID_0050338 1.399E-08 6.633E-07 3.957E-07 2.815E-05 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pulmonary tuberculosis DOID_2957 1.524E-08 6.67E-07 6.467E-07 4.089E-05 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN intracranial aneurysm DOID_10941 2.597E-08 1.055E-06 1.782E-06 9.22E-05 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN vasculitis DOID_865 2.682E-08 1.017E-06 3.205E-05 7.93E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN common cold DOID_10459 4.48E-08 1.593E-06 6.498E-06 2.175E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN carotid stenosis DOID_13001 6.455E-08 2.161E-06 8.428E-06 2.664E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN bacterial meningitis DOID_9470 9.015E-08 2.85E-06 1.07E-05 3.205E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN myocarditis DOID_820 9.764E-08 2.924E-06 1.996E-04 3.549E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pancreatitis DOID_4989 2.094E-07 5.957E-06 5.577E-06 2.116E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN bacterial pneumonia DOID_874 2.094E-07 5.674E-06 5.577E-06 1.983E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN rheumatic disease DOID_1575 3.462E-07 8.955E-06 1.36E-05 3.869E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN scleroderma DOID_419 3.462E-07 8.955E-06 1.36E-05 3.869E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN mouth disease DOID_403 6.201E-07 1.534E-05 1.362E-05 3.692E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN autoimmune disease of gastrointestinal tract DOID_0060031 6.467E-07 1.533E-05 5.957E-04 9.16E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN meningitis DOID_9471 9.34E-07 2.126E-05 5.816E-05 1.226E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN collagen disease DOID_854 1.841E-06 4.029E-05 5.069E-05 1.109E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN parasitic infectious disease DOID_1398 2.492E-06 5.252E-05 6.435E-05 1.308E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN ocular hypertension DOID_9282 6.498E-06 1.321E-04 6.317E-04 9.459E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN borderline glaucoma DOID_9283 6.498E-06 1.321E-04 6.317E-04 9.459E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN systemic scleroderma DOID_418 9.419E-06 1.848E-04 3.166E-04 5.298E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN Human immunodeficiency virus infectious disease DOID_526 1.107E-05 2.1E-04 3.09E-03 0.03031631 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN thoracic aortic aneurysm DOID_14004 1.335E-05 2.45E-04 9.988E-04 0.01386168 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN influenza DOID_8469 1.483E-05 2.637E-04 9.632E-03 0.07507318 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN ulcerative colitis DOID_8577 1.661E-05 2.865E-04 3.908E-03 0.03586083 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN atopic dermatitis DOID_3310 2.781E-05 4.654E-04 7.023E-04 0.01024638 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN sarcoidosis DOID_11335 2.988E-05 4.857E-04 2.988E-05 7.727E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN brain edema DOID_4724 3.306E-05 5.225E-04 1.789E-03 0.02077358 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN parasitic protozoa infectious disease DOID_2789 3.434E-05 5.282E-04 8.204E-04 0.01166975 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN hypersensitivity reaction type IV disease DOID_2916 4.194E-05 6.28E-04 4.194E-05 9.943E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN funisitis DOID_0050698 4.446E-05 6.486E-04 4.446E-05 1.012E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN acute pancreatitis DOID_2913 6.594E-05 9.38E-04 6.594E-05 1.294E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN hyperglycemia DOID_4195 6.814E-05 9.457E-04 0.01998861 0.12362521 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN commensal bacterial infectious disease DOID_0050339 7.437E-05 1.008E-03 3.023E-03 0.03071202 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN endocrine organ benign neoplasm DOID_0060089 7.622E-05 1.009E-03 7.622E-05 1.446E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN myositis DOID_633 8.348E-05 1.08E-03 3.258E-03 0.03141802 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN cystic fibrosis DOID_1485 1.1E-04 1.391E-03 1.933E-03 0.0219926 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pleurisy DOID_10247 1.151E-04 1.423E-03 4.013E-03 0.03624146 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN focal epilepsy DOID_2234 1.536E-04 1.859E-03 1.536E-04 2.818E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN retinal vascular disease DOID_2462 1.68E-04 1.991E-03 0.03073524 0.16655571 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN celiac disease DOID_10608 1.681E-04 1.952E-03 5.133E-03 0.04359055 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pleural disease DOID_1532 1.834E-04 2.087E-03 5.433E-03 0.0454595 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN primary immunodeficiency disease DOID_612 1.998E-04 2.229E-03 1.998E-04 3.445E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN dilated cardiomyopathy DOID_12930 2.553E-04 2.793E-03 3.587E-03 0.03401893 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN respiratory syncytial virus infectious disease DOID_1273 3.166E-04 3.399E-03 0.1237589 0.32302208 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN Sjogren's syndrome DOID_12894 4.325E-04 4.557E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN phagocyte bactericidal dysfunction DOID_3262 4.325E-04 4.474E-03 4.325E-04 7.031E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN adrenal gland hyperfunction DOID_3947 4.325E-04 4.394E-03 4.325E-04 6.836E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN cutaneous leishmaniasis DOID_9111 4.325E-04 4.317E-03 0.03095324 0.15725351 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN visceral leishmaniasis DOID_9146 4.325E-04 4.243E-03 0.03095324 0.15586189 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN diabetic autonomic neuropathy DOID_11503 4.421E-04 4.263E-03 9.632E-03 0.07611586 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN autonomic neuropathy DOID_11504 4.421E-04 4.263E-03 9.632E-03 0.07611586 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN diabetic polyneuropathy DOID_12785 4.421E-04 4.263E-03 9.632E-03 0.07611586 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN diabetic neuropathy DOID_9743 4.421E-04 4.263E-03 9.632E-03 0.07611586 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN cerebral infarction DOID_3526 4.705E-04 4.462E-03 0.01002984 0.07712134 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN proteinuria DOID_576 5E-04 4.664E-03 0.01043536 0.07711328 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN temporal arteritis DOID_13375 5.275E-04 4.841E-03 0.03399581 0.16820537 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN central nervous system vasculitis DOID_525 5.275E-04 4.841E-03 0.03399581 0.16820537 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN bronchiectasis DOID_9563 5.275E-04 4.764E-03 0.03399581 0.16675533 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN autonomic nervous system disease DOID_11465 5.307E-04 4.718E-03 0.01084806 0.07813349 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN glaucoma DOID_1686 5.957E-04 5.214E-03 0.01169476 0.08215209 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN giant cell tumor DOID_200 7.404E-04 6.383E-03 0.01347209 0.09235687 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN malignant giant cell tumor DOID_2705 7.404E-04 6.383E-03 0.01347209 0.09235687 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN giant cell glioblastoma DOID_3074 7.404E-04 6.383E-03 0.01347209 0.09235687 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN glioblastoma DOID_3068 9.503E-04 8.071E-03 0.01584723 0.10608324 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN leukocyte disease DOID_9500 9.964E-04 8.337E-03 0.17722871 0.41843625 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN adrenal cortex disease DOID_3952 9.988E-04 8.237E-03 9.988E-04 0.01353164 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN oral submucous fibrosis DOID_5773 9.988E-04 8.119E-03 0.04607167 0.18461112 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN varicose veins DOID_799 9.988E-04 8.005E-03 0.04607167 0.18332014 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN hyperhomocysteinemia DOID_9279 9.988E-04 7.893E-03 9.988E-04 0.01321695 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN angiosarcoma DOID_0001816 1.139E-03 8.879E-03 1.139E-03 0.0147315 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN vein disease DOID_866 1.139E-03 8.759E-03 0.04906717 0.18992666 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN respiratory failure DOID_11162 1.143E-03 8.671E-03 0.01786652 0.11552331 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN juvenile rheumatoid arthritis DOID_676 1.288E-03 9.646E-03 0.05205334 0.20012399 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN adrenal gland disease DOID_9553 1.288E-03 9.521E-03 1.288E-03 0.01629121 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN temporal lobe epilepsy DOID_3328 1.359E-03 9.91E-03 1.359E-03 0.01680421 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN tooth disease DOID_1091 1.416E-03 0.0101996 1.416E-03 0.01714401 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN prion disease DOID_649 1.446E-03 0.01028815 1.446E-03 0.01714691 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN eosinophilia DOID_999 1.446E-03 0.01016113 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN astrocytoma DOID_3069 1.536E-03 0.01065741 0.02164593 0.13243583 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pancreatic ductal carcinoma DOID_3587 1.598E-03 0.01095529 0.02221066 0.13444535 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN leishmaniasis DOID_9065 1.613E-03 0.01092852 0.05799782 0.21290812 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pancreatic carcinoma DOID_4905 1.794E-03 0.01200912 0.02394111 0.13760091 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN diabetic retinopathy DOID_8947 1.794E-03 0.01186948 0.21271972 0.49403069 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN endogenous depression DOID_1595 1.933E-03 0.01263943 0.02512454 0.14295862 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN syndrome DOID_225 1.933E-03 0.0124958 0.21766436 0.50345944 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN autoimmune hepatitis DOID_2048 1.973E-03 0.01261515 0.06390533 0.23014008 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN mixed glioma DOID_5076 2.078E-03 0.01313535 0.02633141 0.14834229 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN metabolic syndrome X DOID_14221 2.229E-03 0.01393944 2.229E-03 0.02487233 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN sinusitis DOID_0050127 2.368E-03 0.0146425 0.0697761 0.2450778 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN paranasal sinus disease DOID_1352 2.368E-03 0.0146425 0.0697761 0.2450778 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN IgA glomerulonephritis DOID_2986 2.368E-03 0.01448505 2.368E-03 0.02590596 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pulmonary embolism DOID_9477 2.368E-03 0.01433095 0.0697761 0.24062184 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN mental depression DOID_1596 2.469E-03 0.01479072 0.02944894 0.1611197 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN biliary tract cancer DOID_4607 2.469E-03 0.01463665 0.23472933 0.53424396 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN chronic kidney failure DOID_784 2.469E-03 0.01448576 2.469E-03 0.02651168 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN toxic shock syndrome DOID_14115 2.796E-03 0.01623296 0.07561037 0.25012964 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN transitional cell carcinoma DOID_2671 2.904E-03 0.01669108 2.904E-03 0.03060032 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN amino acid metabolic disorder DOID_9252 2.996E-03 0.01704875 2.996E-03 0.03099772 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN reading disorder DOID_13365 3.023E-03 0.01702845 3.023E-03 0.03017322 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN dyslexia DOID_4428 3.023E-03 0.01702845 3.023E-03 0.03017322 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN ankylosing spondylitis DOID_7147 3.258E-03 0.01817317 0.08140834 0.25591904 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN Crohn's disease DOID_8778 3.484E-03 0.01924758 0.03679068 0.17740591 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN middle cerebral artery infarction DOID_3525 3.501E-03 0.01915548 0.08429379 0.26209381 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN gestational diabetes DOID_11714 3.753E-03 0.02033679 0.08717025 0.26666599 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN periodontitis DOID_824 3.753E-03 0.02014493 3.753E-03 0.03500595 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN autoimmune disease of cardiovascular system DOID_0060051 4.013E-03 0.02133843 0.09003776 0.27106605 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN renal hypertension DOID_1073 4.013E-03 0.02114085 0.09003776 0.26963939 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN secondary hypertension DOID_11130 4.013E-03 0.02114085 0.09003776 0.26963939 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN sarcoma DOID_1115 4.013E-03 0.0209469 4.013E-03 0.03567518 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN malaria DOID_12365 4.013E-03 0.02075647 4.013E-03 0.03512633 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN Behcet's disease DOID_13241 4.013E-03 0.02133843 0.09003776 0.27106605 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN hepatic vascular disease DOID_272 4.013E-03 0.02056948 4.013E-03 0.03459412 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN autoimmune disease of the nervous system DOID_438 4.013E-03 0.02038582 0.09003776 0.26822766 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN allergic rhinitis DOID_4481 5.133E-03 0.02584572 0.10141872 0.28710076 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN hepatitis C DOID_1883 6.056E-03 0.03022814 0.10986171 0.30198702 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN periodontal disease DOID_3388 6.056E-03 0.02996528 6.056E-03 0.04994214 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pulmonary sarcoidosis DOID_13406 7.05E-03 0.03457947 7.05E-03 0.05730312 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN adult respiratory distress syndrome DOID_11394 8.111E-03 0.03944802 0.12651241 0.32572652 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN intracranial arterial disease DOID_13089 8.111E-03 0.03911372 0.12651241 0.32425929 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN cerebral arterial disease DOID_3527 8.111E-03 0.03911372 0.12651241 0.32425929 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN nephrotic syndrome DOID_1184 9.24E-03 0.04418353 9.24E-03 0.07405408 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN cataract DOID_83 0.01002984 0.04755816 0.01002984 0.07609305 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN learning disability DOID_8927 0.01002984 0.04716512 0.01002984 0.07509183 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN lens disease DOID_110 0.01084806 0.05059464 0.01084806 0.0791352 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN thyroid adenoma DOID_2891 0.01084806 0.0501833 0.01084806 0.07715682 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN heart valve disease DOID_4079 0.01084806 0.04977859 0.14554822 0.36323218 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN movement disease DOID_480 0.01212868 0.05520973 0.01212868 0.08416117 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN withdrawal disorder DOID_0060001 0.01256957 0.05676257 0.15624053 0.38319336 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN B-cell lymphocytic neoplasm DOID_707 0.01256957 0.05631562 0.15624053 0.38154875 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN bile duct adenocarcinoma DOID_4896 0.01393363 0.06193936 0.16417259 0.399206 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN cholangiocarcinoma DOID_4947 0.01393363 0.06193936 0.16417259 0.399206 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN smallpox DOID_8736 0.01440196 0.06352494 0.01440196 0.09755616 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN familial hyperlipidemia DOID_1168 0.01487704 0.06511565 0.16941951 0.40847331 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN hypertrophic cardiomyopathy DOID_11984 0.01584723 0.06883264 0.17463377 0.41575989 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN bile duct cancer DOID_4606 0.01584723 0.06831118 0.17463377 0.41402755 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN bile duct carcinoma DOID_4897 0.01584723 0.06831118 0.17463377 0.41402755 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN melancholia DOID_2848 0.01634226 0.06991539 0.01634226 0.10812496 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN neurotic disorder DOID_4964 0.01684385 0.07152351 0.01684385 0.11016264 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN pre-malignant neoplasm DOID_0060071 0.01838752 0.07749999 0.01838752 0.11755616 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN congenital heart defect DOID_1682 0.01838752 0.07693014 0.01838752 0.11624998 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN in situ carcinoma DOID_8719 0.01838752 0.07749999 0.01838752 0.11755616 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN cholestasis DOID_13580 0.01944861 0.0807756 0.01944861 0.12160723 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN blood coagulation disease DOID_1247 0.02221066 0.09157872 0.20524459 0.48059331 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN nephrosis DOID_2527 0.02278146 0.09325647 0.02278146 0.13644894 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN bile duct disease DOID_4138 0.02278146 0.09259035 0.02278146 0.13502759 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN male reproductive system disease DOID_48 0.02278146 0.09193368 0.20774409 0.48445241 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN peripheral vascular disease DOID_341 0.02335829 0.09359765 0.02335829 0.13701924 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN biliary tract disease DOID_9741 0.02335829 0.09294312 0.02335829 0.13562109 HUMMEL_BURKITTS_LYMPHOMA_DN primary immunodeficiency disease DOID_612 1.112E-06 6.328E-04 0.0213992 0.38050453 HUMMEL_BURKITTS_LYMPHOMA_DN lymphoma DOID_0060058 1.227E-06 3.49E-04 2.165E-04 0.0307983 HUMMEL_BURKITTS_LYMPHOMA_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.252E-06 4.272E-04 2.252E-06 1.281E-03 HUMMEL_BURKITTS_LYMPHOMA_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.252E-06 4.272E-04 2.252E-06 1.281E-03 HUMMEL_BURKITTS_LYMPHOMA_DN Hodgkin's granuloma DOID_8651 2.252E-06 4.272E-04 2.252E-06 1.281E-03 HUMMEL_BURKITTS_LYMPHOMA_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 2.252E-06 4.272E-04 2.252E-06 1.281E-03 HUMMEL_BURKITTS_LYMPHOMA_DN Hodgkin's lymphoma DOID_8567 3.302E-06 4.698E-04 3.302E-06 9.395E-04 HUMMEL_BURKITTS_LYMPHOMA_DN B cell deficiency DOID_2115 1.888E-05 2.148E-03 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN diffuse large B-cell lymphoma DOID_0050745 2.027E-05 1.922E-03 6.864E-03 0.27898231 HUMMEL_BURKITTS_LYMPHOMA_DN chronic leukemia DOID_1036 2.969E-05 2.413E-03 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN chronic lymphocytic leukemia DOID_1040 2.969E-05 2.413E-03 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN nephroblastoma DOID_2154 3.322E-05 2.363E-03 8.75E-03 0.29288229 HUMMEL_BURKITTS_LYMPHOMA_DN B-cell lymphocytic neoplasm DOID_707 7.123E-05 4.503E-03 0.01274804 0.34541113 HUMMEL_BURKITTS_LYMPHOMA_DN pustulosis of palm and sole DOID_4398 8.224E-05 4.68E-03 0.01368656 0.32448564 HUMMEL_BURKITTS_LYMPHOMA_DN bacterial pneumonia DOID_874 1.568E-04 8.111E-03 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN transitional cell carcinoma DOID_2671 1.985E-04 9.411E-03 1.985E-04 0.03764446 HUMMEL_BURKITTS_LYMPHOMA_DN lymphoblastic leukemia DOID_1037 2.211E-04 9.679E-03 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN Crohn's disease DOID_8778 2.258E-04 9.178E-03 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN ulcerative colitis DOID_8577 2.45E-04 9.294E-03 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN T cell deficiency DOID_11200 2.372E-03 0.08434457 2.372E-03 0.26990264 HUMMEL_BURKITTS_LYMPHOMA_DN insulinoma DOID_3892 2.372E-03 0.07938313 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN Paget's disease of bone DOID_5408 2.372E-03 0.07497295 2.372E-03 0.22491886 HUMMEL_BURKITTS_LYMPHOMA_DN invasive lobular carcinoma DOID_3457 2.609E-03 0.07812147 2.609E-03 0.21204398 HUMMEL_BURKITTS_LYMPHOMA_DN eosinophilic pneumonia DOID_5870 2.609E-03 0.07421539 2.609E-03 0.18553849 HUMMEL_BURKITTS_LYMPHOMA_DN pulmonary eosinophilia DOID_9498 2.609E-03 0.07421539 2.609E-03 0.18553849 HUMMEL_BURKITTS_LYMPHOMA_DN Loeffler syndrome DOID_9503 2.609E-03 0.07421539 2.609E-03 0.18553849 HUMMEL_BURKITTS_LYMPHOMA_DN islet cell tumor DOID_1799 2.845E-03 0.07709877 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN encephalitis DOID_9588 2.845E-03 0.07359428 2.845E-03 0.17989713 HUMMEL_BURKITTS_LYMPHOMA_DN polycystic kidney disease DOID_898 3.319E-03 0.08210962 3.319E-03 0.18885213 HUMMEL_BURKITTS_LYMPHOMA_DN idiopathic pulmonary fibrosis DOID_0050156 3.556E-03 0.08430009 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN hyperostosis DOID_205 4.029E-03 0.09169915 4.029E-03 0.20840717 HUMMEL_BURKITTS_LYMPHOMA_DN prion disease DOID_649 4.266E-03 0.09334902 1.000 1.000 HUMMEL_BURKITTS_LYMPHOMA_DN eosinophilia DOID_999 4.266E-03 0.08989165 4.266E-03 0.20225621 BROCKE_APOPTOSIS_REVERSED_BY_IL6 bone marrow cancer DOID_4960 2.62E-09 1.491E-06 1.507E-07 8.578E-05 BROCKE_APOPTOSIS_REVERSED_BY_IL6 multiple myeloma DOID_9538 2.437E-08 6.934E-06 1.666E-06 3.161E-04 BROCKE_APOPTOSIS_REVERSED_BY_IL6 primary bacterial infectious disease DOID_0050338 3.975E-08 7.538E-06 1.417E-06 4.03E-04 BROCKE_APOPTOSIS_REVERSED_BY_IL6 myeloma DOID_0070004 7.718E-08 1.098E-05 4.132E-06 5.878E-04 BROCKE_APOPTOSIS_REVERSED_BY_IL6 parasitic protozoa infectious disease DOID_2789 1.647E-07 1.874E-05 2.664E-04 7.217E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 parasitic infectious disease DOID_1398 3.685E-07 3.494E-05 4.26E-04 9.696E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 tuberculosis DOID_399 4.579E-07 3.722E-05 1.685E-05 1.198E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 contact dermatitis DOID_2773 9.422E-07 6.701E-05 2.979E-05 1.884E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 hypersensitivity reaction type I disease DOID_1205 2.17E-06 1.372E-04 5.76E-05 2.341E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 prion disease DOID_649 7.492E-06 4.263E-04 7.492E-06 8.525E-04 BROCKE_APOPTOSIS_REVERSED_BY_IL6 oral cavity cancer DOID_8618 9.197E-06 4.757E-04 9.197E-06 8.722E-04 BROCKE_APOPTOSIS_REVERSED_BY_IL6 leukocyte disease DOID_9500 9.815E-06 4.654E-04 3.245E-04 8.027E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 allergic contact dermatitis DOID_3042 1.592E-05 6.97E-04 1.592E-05 1.294E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 uremia DOID_4676 1.613E-05 6.558E-04 1.108E-03 0.01970058 BROCKE_APOPTOSIS_REVERSED_BY_IL6 bile duct disease DOID_4138 1.986E-05 7.532E-04 5.46E-04 0.01194902 BROCKE_APOPTOSIS_REVERSED_BY_IL6 biliary tract disease DOID_9741 2.094E-05 7.447E-04 5.679E-04 0.01196752 BROCKE_APOPTOSIS_REVERSED_BY_IL6 middle cerebral artery infarction DOID_3525 2.962E-05 9.913E-04 0.05815041 0.2506635 BROCKE_APOPTOSIS_REVERSED_BY_IL6 malaria DOID_12365 3.659E-05 1.157E-03 1.887E-03 0.02752468 BROCKE_APOPTOSIS_REVERSED_BY_IL6 invasive ductal carcinoma DOID_3008 3.659E-05 1.096E-03 3.659E-05 2.082E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 nervous system cancer DOID_3093 4.683E-05 1.332E-03 4.683E-05 2.422E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 Human immunodeficiency virus infectious disease DOID_526 4.683E-05 1.269E-03 1.029E-03 0.01888583 BROCKE_APOPTOSIS_REVERSED_BY_IL6 opportunistic mycosis DOID_2473 4.895E-05 1.266E-03 2.28E-03 0.03164788 BROCKE_APOPTOSIS_REVERSED_BY_IL6 lymphoma DOID_0060058 5.094E-05 1.26E-03 5.094E-05 2.416E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 encephalomyelitis DOID_640 5.31E-05 1.259E-03 5.31E-05 2.324E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 Crohn's disease DOID_8778 5.532E-05 1.259E-03 0.01805833 0.13700253 BROCKE_APOPTOSIS_REVERSED_BY_IL6 systemic mycosis DOID_0050136 6.376E-05 1.395E-03 2.71E-03 0.03426259 BROCKE_APOPTOSIS_REVERSED_BY_IL6 fungal infectious disease DOID_1564 6.376E-05 1.395E-03 2.71E-03 0.03426259 BROCKE_APOPTOSIS_REVERSED_BY_IL6 nephroblastoma DOID_2154 6.928E-05 1.46E-03 6.928E-05 2.628E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 embryonal cancer DOID_688 8.768E-05 1.782E-03 8.768E-05 3.118E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 adult respiratory distress syndrome DOID_11394 1.09E-04 2.139E-03 3.846E-03 0.04377314 BROCKE_APOPTOSIS_REVERSED_BY_IL6 intracranial arterial disease DOID_13089 1.09E-04 2.068E-03 0.08791528 0.29599878 BROCKE_APOPTOSIS_REVERSED_BY_IL6 cerebral arterial disease DOID_3527 1.09E-04 2.068E-03 0.08791528 0.29599878 BROCKE_APOPTOSIS_REVERSED_BY_IL6 adenoid cystic carcinoma DOID_4866 1.09E-04 2.001E-03 1.09E-04 3.649E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 salivary gland cancer DOID_8850 1.25E-04 2.222E-03 1.25E-04 3.95E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 cerebral infarction DOID_3526 1.516E-04 2.614E-03 0.09762894 0.31743351 BROCKE_APOPTOSIS_REVERSED_BY_IL6 pulmonary tuberculosis DOID_2957 1.925E-04 3.222E-03 5.579E-03 0.0538004 BROCKE_APOPTOSIS_REVERSED_BY_IL6 lung small cell carcinoma DOID_5409 1.925E-04 3.13E-03 1.925E-04 5.766E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 movement disease DOID_480 2.038E-04 3.221E-03 2.038E-04 5.798E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 pneumocystosis DOID_11339 2.449E-04 3.766E-03 0.02325598 0.15942952 BROCKE_APOPTOSIS_REVERSED_BY_IL6 vasculitis DOID_865 2.53E-04 3.788E-03 0.11485672 0.34578558 BROCKE_APOPTOSIS_REVERSED_BY_IL6 smallpox DOID_8736 2.664E-04 3.886E-03 2.664E-04 6.889E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 respiratory failure DOID_11162 3.73E-04 5.306E-03 8.595E-03 0.0788833 BROCKE_APOPTOSIS_REVERSED_BY_IL6 pre-malignant neoplasm DOID_0060071 3.902E-04 5.415E-03 3.902E-04 9.251E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 in situ carcinoma DOID_8719 3.902E-04 5.415E-03 3.902E-04 9.251E-03 BROCKE_APOPTOSIS_REVERSED_BY_IL6 tethered spinal cord syndrome DOID_1089 4.035E-04 5.467E-03 0.02950527 0.18052148 BROCKE_APOPTOSIS_REVERSED_BY_IL6 cholestasis DOID_13580 4.26E-04 5.637E-03 9.375E-03 0.08467074 BROCKE_APOPTOSIS_REVERSED_BY_IL6 brain infarction DOID_3454 4.836E-04 6.254E-03 0.1410119 0.38761242 BROCKE_APOPTOSIS_REVERSED_BY_IL6 cystic fibrosis DOID_1485 6.369E-04 8.053E-03 0.01218967 0.10352125 BROCKE_APOPTOSIS_REVERSED_BY_IL6 eosinophilia DOID_999 6.747E-04 8.346E-03 6.747E-04 0.01371047 BROCKE_APOPTOSIS_REVERSED_BY_IL6 mixed glioma DOID_5076 6.857E-04 8.301E-03 6.857E-04 0.01345342 BROCKE_APOPTOSIS_REVERSED_BY_IL6 bacterial pneumonia DOID_874 6.857E-04 8.128E-03 0.01279177 0.10397883 BROCKE_APOPTOSIS_REVERSED_BY_IL6 metabolic syndrome X DOID_14221 7.368E-04 8.556E-03 0.16102559 0.43218661 BROCKE_APOPTOSIS_REVERSED_BY_IL6 chronic kidney failure DOID_784 8.18E-04 9.309E-03 0.16640348 0.43432834 BROCKE_APOPTOSIS_REVERSED_BY_IL6 brain edema DOID_4724 8.355E-04 9.322E-03 0.04188562 0.20906067 BROCKE_APOPTOSIS_REVERSED_BY_IL6 muscular atrophy DOID_767 1.013E-03 0.01108457 1.013E-03 0.01921326 BROCKE_APOPTOSIS_REVERSED_BY_IL6 lymphoblastic leukemia DOID_1037 1.129E-03 0.01211958 1.129E-03 0.01946478 BROCKE_APOPTOSIS_REVERSED_BY_IL6 ulcerative colitis DOID_8577 1.309E-03 0.01379017 0.01949571 0.14596131 BROCKE_APOPTOSIS_REVERSED_BY_IL6 osteosarcoma DOID_3347 1.417E-03 0.01466304 1.417E-03 0.02371962 BROCKE_APOPTOSIS_REVERSED_BY_IL6 vitiligo DOID_12306 1.644E-03 0.01670337 1.644E-03 0.02672539 BROCKE_APOPTOSIS_REVERSED_BY_IL6 B cell deficiency DOID_2115 1.644E-03 0.01641033 1.644E-03 0.02598302 BROCKE_APOPTOSIS_REVERSED_BY_IL6 spinal cord disease DOID_319 1.644E-03 0.01612739 0.05815041 0.25257696 BROCKE_APOPTOSIS_REVERSED_BY_IL6 seminoma DOID_4440 1.644E-03 0.01585405 1.644E-03 0.02528077 BROCKE_APOPTOSIS_REVERSED_BY_IL6 gestational diabetes DOID_11714 1.763E-03 0.01672144 1.000 1.000 BROCKE_APOPTOSIS_REVERSED_BY_IL6 autoimmune disease of cardiovascular system DOID_0060051 1.887E-03 0.01759775 0.06217381 0.25269212 BROCKE_APOPTOSIS_REVERSED_BY_IL6 sarcoma DOID_1115 1.887E-03 0.01731391 1.887E-03 0.02824902 BROCKE_APOPTOSIS_REVERSED_BY_IL6 Behcet's disease DOID_13241 1.887E-03 0.01759775 0.06217381 0.25269212 BROCKE_APOPTOSIS_REVERSED_BY_IL6 endometrial carcinoma DOID_2871 2.145E-03 0.01937477 2.145E-03 0.03051527 BROCKE_APOPTOSIS_REVERSED_BY_IL6 endometrial cancer DOID_1380 2.42E-03 0.02151179 2.42E-03 0.03277987 BROCKE_APOPTOSIS_REVERSED_BY_IL6 germinoma DOID_3304 2.42E-03 0.02118084 2.42E-03 0.03201755 BROCKE_APOPTOSIS_REVERSED_BY_IL6 allergic rhinitis DOID_4481 2.42E-03 0.02085992 0.07016976 0.26441451 BROCKE_APOPTOSIS_REVERSED_BY_IL6 chronic leukemia DOID_1036 2.563E-03 0.02176381 2.563E-03 0.03314035 BROCKE_APOPTOSIS_REVERSED_BY_IL6 chronic lymphocytic leukemia DOID_1040 2.563E-03 0.02176381 2.563E-03 0.03314035 BROCKE_APOPTOSIS_REVERSED_BY_IL6 pleural disease DOID_1532 2.563E-03 0.02144376 1.000 1.000 BROCKE_APOPTOSIS_REVERSED_BY_IL6 hepatitis C DOID_1883 2.861E-03 0.02358939 2.861E-03 0.03538408 BROCKE_APOPTOSIS_REVERSED_BY_IL6 medullomyoblastoma DOID_3861 3.015E-03 0.02451028 3.015E-03 0.03650468 BROCKE_APOPTOSIS_REVERSED_BY_IL6 adult medulloblastoma DOID_3864 3.015E-03 0.02451028 3.015E-03 0.03650468 BROCKE_APOPTOSIS_REVERSED_BY_IL6 childhood medulloblastoma DOID_3869 3.015E-03 0.02451028 3.015E-03 0.03650468 BROCKE_APOPTOSIS_REVERSED_BY_IL6 refractive error DOID_9835 3.174E-03 0.0254361 3.174E-03 0.03762423 BROCKE_APOPTOSIS_REVERSED_BY_IL6 calcinosis DOID_182 3.336E-03 0.0263665 0.08203759 0.28637661 BROCKE_APOPTOSIS_REVERSED_BY_IL6 medulloblastoma DOID_3858 3.336E-03 0.02600531 3.336E-03 0.03874261 BROCKE_APOPTOSIS_REVERSED_BY_IL6 respiratory syncytial virus infectious disease DOID_1273 3.673E-03 0.02823979 0.08596019 0.29464668 BROCKE_APOPTOSIS_REVERSED_BY_IL6 systemic scleroderma DOID_418 3.673E-03 0.02786326 0.08596019 0.29113898 BROCKE_APOPTOSIS_REVERSED_BY_IL6 benign mesothelioma DOID_2645 4.024E-03 0.03012781 4.024E-03 0.04489635 BROCKE_APOPTOSIS_REVERSED_BY_IL6 cervix uteri carcinoma in situ DOID_8991 4.024E-03 0.02973654 4.024E-03 0.04403296 BROCKE_APOPTOSIS_REVERSED_BY_IL6 rheumatic disease DOID_1575 4.391E-03 0.03202847 0.09375579 0.31380616 BROCKE_APOPTOSIS_REVERSED_BY_IL6 primitive neuroectodermal tumor DOID_168 4.391E-03 0.03162305 4.391E-03 0.04713624 BROCKE_APOPTOSIS_REVERSED_BY_IL6 scleroderma DOID_419 4.391E-03 0.03202847 0.09375579 0.31380616 BROCKE_APOPTOSIS_REVERSED_BY_IL6 uterine cancer DOID_363 4.579E-03 0.03257066 4.579E-03 0.04825283 BROCKE_APOPTOSIS_REVERSED_BY_IL6 learning disability DOID_8927 4.772E-03 0.03352088 4.772E-03 0.04936711 BROCKE_APOPTOSIS_REVERSED_BY_IL6 brain cancer DOID_1319 5.168E-03 0.03586036 5.168E-03 0.05250982 BROCKE_APOPTOSIS_REVERSED_BY_IL6 heart valve disease DOID_4079 5.168E-03 0.03542831 0.10148573 0.31903524 BROCKE_APOPTOSIS_REVERSED_BY_IL6 central nervous system cancer DOID_3620 5.371E-03 0.03638514 5.371E-03 0.05362021 BROCKE_APOPTOSIS_REVERSED_BY_IL6 glaucoma DOID_1686 5.579E-03 0.03734381 5.579E-03 0.054728 BROCKE_APOPTOSIS_REVERSED_BY_IL6 calcium metabolism disease DOID_10575 5.789E-03 0.03830414 0.10724041 0.33344148 BROCKE_APOPTOSIS_REVERSED_BY_IL6 B-cell lymphocytic neoplasm DOID_707 6.004E-03 0.03926597 6.004E-03 0.05693566 BROCKE_APOPTOSIS_REVERSED_BY_IL6 neuroectodermal tumor DOID_171 8.342E-03 0.05394103 8.342E-03 0.07781657 BROCKE_APOPTOSIS_REVERSED_BY_IL6 carotid artery disease DOID_3407 8.342E-03 0.05333495 0.12803116 0.36607905 BROCKE_APOPTOSIS_REVERSED_BY_IL6 collagen disease DOID_854 8.342E-03 0.05274234 0.12803116 0.36424865 BROCKE_APOPTOSIS_REVERSED_BY_IL6 mineral metabolism disease DOID_0050032 9.112E-03 0.05697249 0.13361789 0.37452502 BROCKE_APOPTOSIS_REVERSED_BY_IL6 endocrine organ benign neoplasm DOID_0060089 0.01018455 0.06298924 0.01018455 0.09054704 BROCKE_APOPTOSIS_REVERSED_BY_IL6 pancreatic ductal carcinoma DOID_3587 0.01074104 0.06571671 0.01074104 0.09402544 BROCKE_APOPTOSIS_REVERSED_BY_IL6 pancreatic carcinoma DOID_4905 0.01160046 0.07021978 0.01160046 0.10000999 BROCKE_APOPTOSIS_REVERSED_BY_IL6 syndrome DOID_225 0.01218967 0.07300972 0.01218967 0.10199888 BROCKE_APOPTOSIS_REVERSED_BY_IL6 aneurysm disease DOID_2403 0.01248912 0.07402405 0.01248912 0.10298998 BROCKE_APOPTOSIS_REVERSED_BY_IL6 alcohol abuse DOID_1574 0.01435261 0.0841921 0.01435261 0.115023 BROCKE_APOPTOSIS_REVERSED_BY_IL6 transitional cell carcinoma DOID_2671 0.0159914 0.09284802 0.0159914 0.12637647 BROCKE_APOPTOSIS_REVERSED_BY_IL6 primary immunodeficiency disease DOID_612 0.01632835 0.0938468 0.01632835 0.12727169 BROCKE_APOPTOSIS_REVERSED_BY_IL6 amino acid metabolic disorder DOID_9252 0.01632835 0.09290833 0.1770573 0.4600256 BROCKE_APOPTOSIS_REVERSED_BY_IL6 carbohydrate metabolic disorder DOID_2978 0.01770635 0.09975164 0.18408503 0.47611083 BARIS_THYROID_CANCER_DN invasive lobular carcinoma DOID_3457 8.606E-13 4.897E-10 7.526E-05 0.02141091 BARIS_THYROID_CANCER_DN transitional cell carcinoma DOID_2671 1.412E-11 4.018E-09 5.163E-03 0.15462905 BARIS_THYROID_CANCER_DN cervix uteri carcinoma in situ DOID_8991 2.27E-07 4.306E-05 1.263E-03 0.10262998 BARIS_THYROID_CANCER_DN oral submucous fibrosis DOID_5773 7.04E-07 1.001E-04 1.000 1.000 BARIS_THYROID_CANCER_DN hypertrophic cardiomyopathy DOID_11984 8.6E-07 9.787E-05 5.36E-05 0.03049631 BARIS_THYROID_CANCER_DN carotid artery disease DOID_3407 1.044E-06 9.905E-05 0.07325403 0.5083115 BARIS_THYROID_CANCER_DN urinary system benign neoplasm DOID_731 1.05E-06 8.538E-05 0.01999253 0.27085125 BARIS_THYROID_CANCER_DN pre-malignant neoplasm DOID_0060071 1.183E-06 8.412E-05 2.816E-03 0.12324404 BARIS_THYROID_CANCER_DN in situ carcinoma DOID_8719 1.183E-06 8.412E-05 2.816E-03 0.12324404 BARIS_THYROID_CANCER_DN bone resorption disease DOID_0080011 2.438E-06 1.541E-04 1.16E-04 0.02200502 BARIS_THYROID_CANCER_DN osteoporosis DOID_11476 2.438E-06 1.541E-04 1.16E-04 0.02200502 BARIS_THYROID_CANCER_DN mouth disease DOID_403 5.312E-06 3.022E-04 1.000 1.000 BARIS_THYROID_CANCER_DN papilloma DOID_2615 1.086E-05 5.615E-04 0.04187478 0.36101139 BARIS_THYROID_CANCER_DN nephroblastoma DOID_2154 1.18E-05 5.597E-04 0.04301315 0.35991886 BARIS_THYROID_CANCER_DN calcinosis DOID_182 1.497E-05 6.553E-04 1.000 1.000 BARIS_THYROID_CANCER_DN myeloma DOID_0070004 2.946E-05 1.197E-03 0.05769211 0.42632224 BARIS_THYROID_CANCER_DN pre-eclampsia DOID_10591 2.946E-05 1.117E-03 1.000 1.000 BARIS_THYROID_CANCER_DN integumentary system benign neoplasm DOID_0060121 3.316E-05 1.179E-03 1.759E-03 0.12511674 BARIS_THYROID_CANCER_DN skin benign neoplasm DOID_3165 3.316E-05 1.179E-03 1.759E-03 0.12511674 BARIS_THYROID_CANCER_DN calcium metabolism disease DOID_10575 3.512E-05 1.175E-03 1.000 1.000 BARIS_THYROID_CANCER_DN giant cell tumor DOID_200 4.145E-05 1.31E-03 2.037E-03 0.11589736 BARIS_THYROID_CANCER_DN malignant giant cell tumor DOID_2705 4.145E-05 1.31E-03 2.037E-03 0.11589736 BARIS_THYROID_CANCER_DN giant cell glioblastoma DOID_3074 4.145E-05 1.31E-03 2.037E-03 0.11589736 BARIS_THYROID_CANCER_DN bile duct adenocarcinoma DOID_4896 4.372E-05 1.309E-03 1.000 1.000 BARIS_THYROID_CANCER_DN cholangiocarcinoma DOID_4947 4.372E-05 1.309E-03 1.000 1.000 BARIS_THYROID_CANCER_DN bone marrow cancer DOID_4960 4.372E-05 1.244E-03 0.06550475 0.46015062 BARIS_THYROID_CANCER_DN integumentary system cancer DOID_0060122 4.607E-05 1.248E-03 2.183E-03 0.11292202 BARIS_THYROID_CANCER_DN skin cancer DOID_4159 4.607E-05 1.248E-03 2.183E-03 0.11292202 BARIS_THYROID_CANCER_DN glioblastoma DOID_3068 5.36E-05 1.386E-03 2.411E-03 0.11433704 BARIS_THYROID_CANCER_DN bile duct cancer DOID_4606 5.36E-05 1.326E-03 1.000 1.000 BARIS_THYROID_CANCER_DN bile duct carcinoma DOID_4897 5.36E-05 1.326E-03 1.000 1.000 BARIS_THYROID_CANCER_DN mineral metabolism disease DOID_0050032 7.099E-05 1.683E-03 1.000 1.000 BARIS_THYROID_CANCER_DN cholestasis DOID_13580 7.42E-05 1.689E-03 0.07765395 0.52601303 BARIS_THYROID_CANCER_DN astrocytoma DOID_3069 8.801E-05 1.926E-03 3.34E-03 0.12670398 BARIS_THYROID_CANCER_DN aortic valve insufficiency DOID_57 9.024E-05 1.902E-03 1.000 1.000 BARIS_THYROID_CANCER_DN pancreatic ductal carcinoma DOID_3587 9.17E-05 1.864E-03 0.08312512 0.54365742 BARIS_THYROID_CANCER_DN nephrosis DOID_2527 9.55E-05 1.874E-03 3.524E-03 0.12533481 BARIS_THYROID_CANCER_DN bile duct disease DOID_4138 9.55E-05 1.811E-03 0.08421555 0.54453006 BARIS_THYROID_CANCER_DN biliary tract disease DOID_9741 9.94E-05 1.824E-03 0.0853047 0.54537499 BARIS_THYROID_CANCER_DN pancreatic carcinoma DOID_4905 1.034E-04 1.839E-03 0.08639259 0.54619313 BARIS_THYROID_CANCER_DN parathyroid gland disease DOID_11201 1.066E-04 1.837E-03 0.01532386 0.27247747 BARIS_THYROID_CANCER_DN biliary tract cancer DOID_4607 1.442E-04 2.413E-03 1.000 1.000 BARIS_THYROID_CANCER_DN nervous system cancer DOID_3093 1.823E-04 2.963E-03 5.389E-03 0.15330585 BARIS_THYROID_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.067E-04 3.267E-03 5.852E-03 0.15857329 BARIS_THYROID_CANCER_DN ureteral obstruction DOID_5199 2.082E-04 3.203E-03 0.02115632 0.27995219 BARIS_THYROID_CANCER_DN dilated cardiomyopathy DOID_12930 2.131E-04 3.191E-03 0.10894816 0.63256638 BARIS_THYROID_CANCER_DN IgA glomerulonephritis DOID_2986 3.431E-04 5.005E-03 0.02695498 0.31952888 BARIS_THYROID_CANCER_DN urinary tract obstruction DOID_5200 3.431E-04 4.88E-03 0.02695498 0.31300788 BARIS_THYROID_CANCER_DN pulmonary embolism DOID_9477 3.431E-04 4.761E-03 0.02695498 0.30674772 BARIS_THYROID_CANCER_DN ureteral disease DOID_1426 3.74E-04 5.066E-03 0.02811068 0.30759572 BARIS_THYROID_CANCER_DN aortic valve disease DOID_62 3.74E-04 4.949E-03 1.000 1.000 BARIS_THYROID_CANCER_DN intracranial aneurysm DOID_10941 5.106E-04 6.603E-03 1.000 1.000 BARIS_THYROID_CANCER_DN seminoma DOID_4440 5.106E-04 6.457E-03 5.106E-04 0.07263673 BARIS_THYROID_CANCER_DN invasive ductal carcinoma DOID_3008 5.867E-04 7.258E-03 0.03501673 0.34352617 BARIS_THYROID_CANCER_DN focal glomerulosclerosis DOID_3945 6.267E-04 7.587E-03 1.000 1.000 BARIS_THYROID_CANCER_DN germinoma DOID_3304 7.544E-04 8.943E-03 7.544E-04 0.08585199 BARIS_THYROID_CANCER_DN leiomyoma DOID_127 7.995E-04 9.284E-03 1.000 1.000 BARIS_THYROID_CANCER_DN periodontal disease DOID_3388 8.936E-04 0.01016901 1.000 1.000 BARIS_THYROID_CANCER_DN adenoma DOID_657 9.927E-04 0.01107559 0.04528592 0.36292517 BARIS_THYROID_CANCER_DN embryonal cancer DOID_688 1.044E-03 0.0114257 1.044E-03 0.0990227 BARIS_THYROID_CANCER_DN multiple myeloma DOID_9538 1.044E-03 0.01121012 0.04642032 0.36684948 BARIS_THYROID_CANCER_DN respiratory syncytial virus infectious disease DOID_1273 1.151E-03 0.01212678 0.04868518 0.37434952 BARIS_THYROID_CANCER_DN pulmonary emphysema DOID_9675 1.263E-03 0.013062 1.000 1.000 BARIS_THYROID_CANCER_DN nephrotic syndrome DOID_1184 1.379E-03 0.01401453 0.05319912 0.40360397 BARIS_THYROID_CANCER_DN diabetic autonomic neuropathy DOID_11503 1.44E-03 0.01436976 1.000 1.000 BARIS_THYROID_CANCER_DN autonomic neuropathy DOID_11504 1.44E-03 0.01436976 1.000 1.000 BARIS_THYROID_CANCER_DN diabetic polyneuropathy DOID_12785 1.44E-03 0.01436976 1.000 1.000 BARIS_THYROID_CANCER_DN gallbladder cancer DOID_3121 1.44E-03 0.01412201 1.000 1.000 BARIS_THYROID_CANCER_DN diabetic neuropathy DOID_9743 1.44E-03 0.01436976 1.000 1.000 BARIS_THYROID_CANCER_DN autonomic nervous system disease DOID_11465 1.628E-03 0.01569642 1.000 1.000 BARIS_THYROID_CANCER_DN heart valve disease DOID_4079 1.628E-03 0.01543481 1.000 1.000 BARIS_THYROID_CANCER_DN glaucoma DOID_1686 1.759E-03 0.01640875 0.05993079 0.43165339 BARIS_THYROID_CANCER_DN lung small cell carcinoma DOID_5409 1.759E-03 0.0161441 1.759E-03 0.11121488 BARIS_THYROID_CANCER_DN vasculitis DOID_865 2.109E-03 0.01905101 1.000 1.000 BARIS_THYROID_CANCER_DN reproductive organ benign neoplasm DOID_0050622 2.183E-03 0.01940847 1.000 1.000 BARIS_THYROID_CANCER_DN familial hyperlipidemia DOID_1168 2.258E-03 0.01976551 1.000 1.000 BARIS_THYROID_CANCER_DN uterine disease DOID_345 2.986E-03 0.02574174 1.000 1.000 BARIS_THYROID_CANCER_DN tooth disease DOID_1091 3.161E-03 0.02684211 1.000 1.000 BARIS_THYROID_CANCER_DN tuberculosis DOID_399 3.25E-03 0.02719349 3.25E-03 0.13208267 BARIS_THYROID_CANCER_DN peripheral vascular disease DOID_341 3.618E-03 0.02983694 1.000 1.000 BARIS_THYROID_CANCER_DN cystic fibrosis DOID_1485 3.907E-03 0.0317554 0.08856457 0.55377184 BARIS_THYROID_CANCER_DN aneurysm disease DOID_2403 4.005E-03 0.03209719 1.000 1.000 BARIS_THYROID_CANCER_DN mixed glioma DOID_5076 4.105E-03 0.03243856 4.105E-03 0.13738685 BARIS_THYROID_CANCER_DN metabolic syndrome X DOID_14221 4.307E-03 0.03357375 1.000 1.000 BARIS_THYROID_CANCER_DN lipid metabolism disorder DOID_3146 4.307E-03 0.03312005 1.000 1.000 BARIS_THYROID_CANCER_DN female reproductive system disease DOID_229 4.41E-03 0.03346016 1.000 1.000 BARIS_THYROID_CANCER_DN chronic kidney failure DOID_784 4.62E-03 0.03458827 0.09612681 0.57574899 BARIS_THYROID_CANCER_DN primary bacterial infectious disease DOID_0050338 5.052E-03 0.03733537 5.052E-03 0.15971243 BARIS_THYROID_CANCER_DN encephalomyelitis DOID_640 5.735E-03 0.04183479 1.000 1.000 BARIS_THYROID_CANCER_DN hypersensitivity reaction type I disease DOID_1205 5.971E-03 0.0430075 1.000 1.000 BARIS_THYROID_CANCER_DN ulcerative colitis DOID_8577 6.334E-03 0.04505003 6.334E-03 0.16381829 BARIS_THYROID_CANCER_DN hyperparathyroidism DOID_13543 0.0118081 0.08294824 1.000 1.000 BARIS_THYROID_CANCER_DN bilirubin metabolic disorder DOID_2741 0.0118081 0.08193668 0.0118081 0.29212207 BARIS_THYROID_CANCER_DN Noonan syndrome DOID_3490 0.0118081 0.08094949 0.0118081 0.27995032 BARIS_THYROID_CANCER_DN insulinoma DOID_3892 0.0118081 0.0799858 1.000 1.000 BARIS_THYROID_CANCER_DN conjunctival disease DOID_4251 0.0118081 0.0790448 0.0118081 0.2687523 BARIS_THYROID_CANCER_DN conjunctivitis DOID_6195 0.0118081 0.0790448 0.0118081 0.2687523 BARIS_THYROID_CANCER_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.0118081 0.07812567 0.0118081 0.25841568 BARIS_THYROID_CANCER_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.0118081 0.07812567 0.0118081 0.25841568 BARIS_THYROID_CANCER_DN Hodgkin's granuloma DOID_8651 0.0118081 0.07812567 0.0118081 0.25841568 BARIS_THYROID_CANCER_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 0.0118081 0.07812567 0.0118081 0.25841568 BARIS_THYROID_CANCER_DN cutaneous leishmaniasis DOID_9111 0.0118081 0.07722767 1.000 1.000 BARIS_THYROID_CANCER_DN cannabis abuse DOID_9505 0.0118081 0.07635009 0.0118081 0.24884473 BARIS_THYROID_CANCER_DN familial adenomatous polyposis DOID_0050424 0.01298138 0.08299333 0.01298138 0.26380022 BARIS_THYROID_CANCER_DN breast benign neoplasm DOID_0060082 0.01298138 0.08207118 0.01298138 0.25470366 BARIS_THYROID_CANCER_DN thoracic benign neoplasm DOID_0060097 0.01298138 0.08207118 0.01298138 0.25470366 BARIS_THYROID_CANCER_DN benign breast phyllodes tumor DOID_1631 0.01298138 0.08207118 0.01298138 0.25470366 BARIS_THYROID_CANCER_DN eosinophilic pneumonia DOID_5870 0.01298138 0.0811693 1.000 1.000 BARIS_THYROID_CANCER_DN chronic monocytic leukemia DOID_8593 0.01298138 0.08028702 0.01298138 0.24621354 BARIS_THYROID_CANCER_DN pulmonary eosinophilia DOID_9498 0.01298138 0.0811693 1.000 1.000 BARIS_THYROID_CANCER_DN Loeffler syndrome DOID_9503 0.01298138 0.0811693 1.000 1.000 BARIS_THYROID_CANCER_DN intracranial arteriosclerosis DOID_13097 0.0141533 0.08659387 1.000 1.000 BARIS_THYROID_CANCER_DN islet cell tumor DOID_1799 0.0141533 0.08567266 1.000 1.000 BARIS_THYROID_CANCER_DN Hodgkin's lymphoma DOID_8567 0.0141533 0.08477084 0.0141533 0.2597816 BARIS_THYROID_CANCER_DN vascular dementia DOID_8725 0.0141533 0.08659387 1.000 1.000 BARIS_THYROID_CANCER_DN ocular hypertension DOID_9282 0.0141533 0.08388781 1.000 1.000 BARIS_THYROID_CANCER_DN borderline glaucoma DOID_9283 0.0141533 0.08388781 1.000 1.000 BARIS_THYROID_CANCER_DN berylliosis DOID_10322 0.01532386 0.08988947 1.000 1.000 BARIS_THYROID_CANCER_DN carotid stenosis DOID_13001 0.01532386 0.08897224 1.000 1.000 BARIS_THYROID_CANCER_DN cannabis dependence DOID_1849 0.01532386 0.08807353 0.01532386 0.26422058 BARIS_THYROID_CANCER_DN larynx cancer DOID_2596 0.01532386 0.08719279 1.000 1.000 BARIS_THYROID_CANCER_DN laryngeal benign neoplasm DOID_2598 0.01532386 0.08719279 1.000 1.000 BARIS_THYROID_CANCER_DN monocytic leukemia DOID_8527 0.01532386 0.0863295 0.01532386 0.25644938 BARIS_THYROID_CANCER_DN hallucinogen dependence DOID_9977 0.01532386 0.08807353 0.01532386 0.26422058 BARIS_THYROID_CANCER_DN eyelid disease DOID_530 0.01649307 0.09200544 0.01649307 0.26813015 BARIS_THYROID_CANCER_DN polycystic kidney disease DOID_898 0.01649307 0.09111219 0.01649307 0.26068209 BARIS_THYROID_CANCER_DN skeletal system cancer DOID_0060124 0.01766091 0.09662557 1.000 1.000 BARIS_THYROID_CANCER_DN Ehlers-Danlos syndrome DOID_13359 0.01766091 0.09570532 0.01766091 0.27159618 BARIS_THYROID_CANCER_DN thoracic aortic aneurysm DOID_14004 0.01766091 0.09480244 1.000 1.000 BARIS_THYROID_CANCER_DN bone cancer DOID_184 0.01766091 0.09662557 1.000 1.000 BARIS_THYROID_CANCER_DN hemangioma DOID_255 0.01766091 0.09391644 1.000 1.000 BARIS_THYROID_CANCER_DN lung oat cell carcinoma DOID_5411 0.01766091 0.09304684 0.01766091 0.26444892 BARIS_THYROID_CANCER_DN varicose veins DOID_799 0.01766091 0.0921932 1.000 1.000 BARIS_THYROID_CANCER_DN angiosarcoma DOID_0001816 0.0188274 0.09738901 1.000 1.000 BARIS_THYROID_CANCER_DN spastic diplegia DOID_10965 0.0188274 0.09651163 1.000 1.000 BARIS_THYROID_CANCER_DN vein disease DOID_866 0.0188274 0.09564992 1.000 1.000 BARIS_THYROID_CANCER_DN Graves' disease DOID_12361 0.01999253 0.0997873 0.01999253 0.28439381 BARIS_THYROID_CANCER_DN methylmalonic acidemia DOID_14749 0.01999253 0.09891959 0.01999253 0.27745737 BARIS_THYROID_CANCER_DN penile disease DOID_1529 0.01999253 0.09806683 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB cystic fibrosis DOID_1485 3.984E-14 2.267E-11 1.334E-09 7.591E-07 TIAN_TNF_SIGNALING_VIA_NFKB pustulosis of palm and sole DOID_4398 2.92E-10 8.307E-08 5.121E-08 1.457E-05 TIAN_TNF_SIGNALING_VIA_NFKB bacterial pneumonia DOID_874 1.518E-09 2.879E-07 1.891E-07 3.587E-05 TIAN_TNF_SIGNALING_VIA_NFKB pleurisy DOID_10247 3.347E-09 4.761E-07 1.653E-04 5.225E-03 TIAN_TNF_SIGNALING_VIA_NFKB ulcerative colitis DOID_8577 4.714E-09 5.364E-07 3.462E-05 1.791E-03 TIAN_TNF_SIGNALING_VIA_NFKB pleural disease DOID_1532 6.381E-09 6.052E-07 2.256E-04 6.757E-03 TIAN_TNF_SIGNALING_VIA_NFKB influenza DOID_8469 2.163E-08 1.758E-06 4.08E-04 0.01009421 TIAN_TNF_SIGNALING_VIA_NFKB cholestasis DOID_13580 9.788E-08 6.962E-06 1.087E-05 1.237E-03 TIAN_TNF_SIGNALING_VIA_NFKB bile duct disease DOID_4138 1.379E-07 8.721E-06 1.403E-05 1.33E-03 TIAN_TNF_SIGNALING_VIA_NFKB biliary tract disease DOID_9741 1.456E-07 8.287E-06 1.461E-05 1.187E-03 TIAN_TNF_SIGNALING_VIA_NFKB primary bacterial infectious disease DOID_0050338 2.909E-07 1.505E-05 2.442E-05 1.544E-03 TIAN_TNF_SIGNALING_VIA_NFKB urinary tract obstruction DOID_5200 3.915E-07 1.856E-05 9.639E-05 3.656E-03 TIAN_TNF_SIGNALING_VIA_NFKB respiratory syncytial virus infectious disease DOID_1273 2.518E-06 1.102E-04 3.256E-04 9.264E-03 TIAN_TNF_SIGNALING_VIA_NFKB pulmonary emphysema DOID_9675 2.902E-06 1.18E-04 3.575E-04 9.246E-03 TIAN_TNF_SIGNALING_VIA_NFKB autoimmune disease of urogenital tract DOID_0060049 3.108E-06 1.179E-04 3.108E-06 4.421E-04 TIAN_TNF_SIGNALING_VIA_NFKB primary biliary cirrhosis DOID_12236 3.108E-06 1.179E-04 3.108E-06 4.421E-04 TIAN_TNF_SIGNALING_VIA_NFKB pulmonary tuberculosis DOID_2957 4.827E-06 1.716E-04 4.995E-04 0.01184316 TIAN_TNF_SIGNALING_VIA_NFKB tuberculosis DOID_399 1.238E-05 4.145E-04 9.293E-04 0.02115116 TIAN_TNF_SIGNALING_VIA_NFKB aneurysm disease DOID_2403 1.708E-05 5.399E-04 0.04884597 0.28652943 TIAN_TNF_SIGNALING_VIA_NFKB hyperparathyroidism DOID_13543 1.723E-05 5.16E-04 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.723E-05 4.902E-04 1.723E-05 1.225E-03 TIAN_TNF_SIGNALING_VIA_NFKB Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.723E-05 4.902E-04 1.723E-05 1.225E-03 TIAN_TNF_SIGNALING_VIA_NFKB Hodgkin's granuloma DOID_8651 1.723E-05 4.902E-04 1.723E-05 1.225E-03 TIAN_TNF_SIGNALING_VIA_NFKB Hodgkin's lymphoma, mixed cellularity DOID_8654 1.723E-05 4.902E-04 1.723E-05 1.225E-03 TIAN_TNF_SIGNALING_VIA_NFKB pancreatitis DOID_4989 1.774E-05 4.806E-04 1.178E-03 0.02577224 TIAN_TNF_SIGNALING_VIA_NFKB Hodgkin's lymphoma DOID_8567 2.525E-05 6.531E-04 2.525E-05 1.437E-03 TIAN_TNF_SIGNALING_VIA_NFKB lymphoma DOID_0060058 2.877E-05 7.117E-04 1.62E-03 0.03292411 TIAN_TNF_SIGNALING_VIA_NFKB parathyroid gland disease DOID_11201 2.983E-05 7.072E-04 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB mouth disease DOID_403 3.064E-05 6.974E-04 0.05905396 0.32001623 TIAN_TNF_SIGNALING_VIA_NFKB hypersensitivity reaction type I disease DOID_1205 3.161E-05 6.917E-04 1.724E-03 0.03382233 TIAN_TNF_SIGNALING_VIA_NFKB Legionnaires' disease DOID_10457 3.479E-05 7.332E-04 3.479E-05 1.65E-03 TIAN_TNF_SIGNALING_VIA_NFKB legionellosis DOID_10458 3.479E-05 7.332E-04 3.479E-05 1.65E-03 TIAN_TNF_SIGNALING_VIA_NFKB viral pneumonia DOID_10533 3.479E-05 7.07E-04 3.479E-05 1.523E-03 TIAN_TNF_SIGNALING_VIA_NFKB Barrett's esophagus DOID_9206 4.584E-05 8.994E-04 0.01008302 0.13342417 TIAN_TNF_SIGNALING_VIA_NFKB ureteral obstruction DOID_5199 5.84E-05 1.108E-03 5.84E-05 2.374E-03 TIAN_TNF_SIGNALING_VIA_NFKB leishmaniasis DOID_9065 6.525E-05 1.198E-03 0.01196271 0.14482514 TIAN_TNF_SIGNALING_VIA_NFKB amnestic disorder DOID_10914 7.247E-05 1.289E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB esophagitis DOID_11963 7.247E-05 1.25E-03 0.01258851 0.14922631 TIAN_TNF_SIGNALING_VIA_NFKB autoimmune hepatitis DOID_2048 8.007E-05 1.34E-03 0.01321393 0.15037457 TIAN_TNF_SIGNALING_VIA_NFKB ureteral disease DOID_1426 1.051E-04 1.709E-03 1.051E-04 3.738E-03 TIAN_TNF_SIGNALING_VIA_NFKB meningitis DOID_9471 1.051E-04 1.661E-03 0.01508792 0.15898201 TIAN_TNF_SIGNALING_VIA_NFKB acute pancreatitis DOID_2913 1.142E-04 1.756E-03 1.142E-04 3.822E-03 TIAN_TNF_SIGNALING_VIA_NFKB middle cerebral artery infarction DOID_3525 1.437E-04 2.152E-03 0.01758127 0.16955498 TIAN_TNF_SIGNALING_VIA_NFKB periodontitis DOID_824 1.543E-04 2.251E-03 0.01820366 0.16441086 TIAN_TNF_SIGNALING_VIA_NFKB spastic cerebral palsy DOID_0050669 2.004E-04 2.85E-03 0.02068945 0.17312203 TIAN_TNF_SIGNALING_VIA_NFKB abdominal aortic aneurysm DOID_7693 2.004E-04 2.781E-03 0.02068945 0.17061302 TIAN_TNF_SIGNALING_VIA_NFKB chronic leukemia DOID_1036 2.256E-04 3.057E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB chronic lymphocytic leukemia DOID_1040 2.256E-04 3.057E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB periodontal disease DOID_3388 2.524E-04 3.339E-03 0.02316921 0.18833256 TIAN_TNF_SIGNALING_VIA_NFKB esophageal disease DOID_6050 2.524E-04 3.263E-03 0.02316921 0.18567999 TIAN_TNF_SIGNALING_VIA_NFKB multiple myeloma DOID_9538 2.952E-04 3.733E-03 0.02502508 0.19776761 TIAN_TNF_SIGNALING_VIA_NFKB hepatitis DOID_2237 3.256E-04 4.028E-03 3.256E-04 8.823E-03 TIAN_TNF_SIGNALING_VIA_NFKB systemic scleroderma DOID_418 3.256E-04 3.942E-03 0.02626044 0.20468756 TIAN_TNF_SIGNALING_VIA_NFKB peptic ulcer DOID_750 3.256E-04 3.86E-03 0.02626044 0.20192151 TIAN_TNF_SIGNALING_VIA_NFKB intracranial arterial disease DOID_13089 3.414E-04 3.964E-03 0.02687756 0.20391111 TIAN_TNF_SIGNALING_VIA_NFKB cerebral arterial disease DOID_3527 3.414E-04 3.964E-03 0.02687756 0.20391111 TIAN_TNF_SIGNALING_VIA_NFKB rheumatic disease DOID_1575 3.908E-04 4.447E-03 0.02872668 0.2150721 TIAN_TNF_SIGNALING_VIA_NFKB scleroderma DOID_419 3.908E-04 4.447E-03 0.02872668 0.2150721 TIAN_TNF_SIGNALING_VIA_NFKB cerebral infarction DOID_3526 4.256E-04 4.748E-03 0.02995755 0.22137462 TIAN_TNF_SIGNALING_VIA_NFKB proteinuria DOID_576 4.435E-04 4.853E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB myeloma DOID_0070004 4.618E-04 4.958E-03 0.03118693 0.22750463 TIAN_TNF_SIGNALING_VIA_NFKB neuritis DOID_1803 4.618E-04 4.866E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB autoimmune disease of gastrointestinal tract DOID_0060031 4.995E-04 5.168E-03 0.03241481 0.23055034 TIAN_TNF_SIGNALING_VIA_NFKB aortic aneurysm DOID_3627 5.189E-04 5.273E-03 0.03302819 0.23201286 TIAN_TNF_SIGNALING_VIA_NFKB B-cell lymphocytic neoplasm DOID_707 5.387E-04 5.377E-03 0.0336412 0.23062463 TIAN_TNF_SIGNALING_VIA_NFKB giant cell tumor DOID_200 5.793E-04 5.683E-03 0.0348661 0.23617635 TIAN_TNF_SIGNALING_VIA_NFKB malignant giant cell tumor DOID_2705 5.793E-04 5.683E-03 0.0348661 0.23617635 TIAN_TNF_SIGNALING_VIA_NFKB giant cell glioblastoma DOID_3074 5.793E-04 5.683E-03 0.0348661 0.23617635 TIAN_TNF_SIGNALING_VIA_NFKB bile duct adenocarcinoma DOID_4896 6.001E-04 5.787E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB cholangiocarcinoma DOID_4947 6.001E-04 5.787E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB bone marrow cancer DOID_4960 6.001E-04 5.691E-03 0.035478 0.23749389 TIAN_TNF_SIGNALING_VIA_NFKB integumentary system cancer DOID_0060122 6.213E-04 5.795E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB parasitic protozoa infectious disease DOID_2789 6.213E-04 5.702E-03 0.03608952 0.23877833 TIAN_TNF_SIGNALING_VIA_NFKB skin cancer DOID_4159 6.213E-04 5.795E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB glioblastoma DOID_3068 6.87E-04 6.205E-03 0.03792185 0.24801765 TIAN_TNF_SIGNALING_VIA_NFKB bile duct cancer DOID_4606 6.87E-04 6.108E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB bile duct carcinoma DOID_4897 6.87E-04 6.108E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB melancholia DOID_2848 7.096E-04 6.212E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB neurotic disorder DOID_4964 7.326E-04 6.316E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB collagen disease DOID_854 7.56E-04 6.42E-03 0.03975085 0.25702539 TIAN_TNF_SIGNALING_VIA_NFKB parasitic infectious disease DOID_1398 8.529E-04 7.137E-03 0.04218433 0.26669872 TIAN_TNF_SIGNALING_VIA_NFKB uterine disease DOID_345 8.529E-04 7.033E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB hyperglycemia DOID_4195 8.78E-04 7.137E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB tooth disease DOID_1091 9.035E-04 7.241E-03 0.04339885 0.27136207 TIAN_TNF_SIGNALING_VIA_NFKB brain infarction DOID_3454 9.293E-04 7.344E-03 0.04400556 0.27216483 TIAN_TNF_SIGNALING_VIA_NFKB astrocytoma DOID_3069 9.555E-04 7.448E-03 0.0446119 0.27294808 TIAN_TNF_SIGNALING_VIA_NFKB male reproductive system disease DOID_48 1.009E-03 7.758E-03 0.04582347 0.27737826 TIAN_TNF_SIGNALING_VIA_NFKB diabetic retinopathy DOID_8947 1.064E-03 8.07E-03 0.04703357 0.28170635 TIAN_TNF_SIGNALING_VIA_NFKB endogenous depression DOID_1595 1.12E-03 8.385E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB metabolic syndrome X DOID_14221 1.237E-03 9.139E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB female reproductive system disease DOID_229 1.267E-03 9.241E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB mental depression DOID_1596 1.328E-03 9.564E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB biliary tract cancer DOID_4607 1.328E-03 9.444E-03 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB chronic kidney failure DOID_784 1.328E-03 9.328E-03 0.05246085 0.29850222 TIAN_TNF_SIGNALING_VIA_NFKB retinal vascular disease DOID_2462 1.39E-03 9.648E-03 0.05366288 0.30231859 TIAN_TNF_SIGNALING_VIA_NFKB transitional cell carcinoma DOID_2671 1.487E-03 0.01019263 0.05546319 0.30939758 TIAN_TNF_SIGNALING_VIA_NFKB primary immunodeficiency disease DOID_612 1.52E-03 0.01029364 1.52E-03 0.03202465 TIAN_TNF_SIGNALING_VIA_NFKB lymphoblastic leukemia DOID_1037 1.654E-03 0.01107455 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB carbohydrate metabolic disorder DOID_2978 1.654E-03 0.01094578 0.05845641 0.319824 TIAN_TNF_SIGNALING_VIA_NFKB encephalomyelitis DOID_640 1.654E-03 0.01081997 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB Crohn's disease DOID_8778 1.689E-03 0.01092039 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB T cell deficiency DOID_11200 6.313E-03 0.04036294 6.313E-03 0.11974339 TIAN_TNF_SIGNALING_VIA_NFKB retinal vascular occlusion DOID_1729 6.313E-03 0.03991446 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB conjunctival disease DOID_4251 6.313E-03 0.03947584 6.313E-03 0.1158807 TIAN_TNF_SIGNALING_VIA_NFKB conjunctivitis DOID_6195 6.313E-03 0.03947584 6.313E-03 0.1158807 TIAN_TNF_SIGNALING_VIA_NFKB cutaneous leishmaniasis DOID_9111 6.313E-03 0.03904676 6.313E-03 0.11225943 TIAN_TNF_SIGNALING_VIA_NFKB visceral leishmaniasis DOID_9146 6.313E-03 0.0386269 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB familial adenomatous polyposis DOID_0050424 6.943E-03 0.04202483 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB prediabetes syndrome DOID_11716 6.943E-03 0.04158246 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB common cold DOID_10459 7.571E-03 0.04487655 7.571E-03 0.13054997 TIAN_TNF_SIGNALING_VIA_NFKB aortic valve insufficiency DOID_57 7.571E-03 0.04441391 7.571E-03 0.12671027 TIAN_TNF_SIGNALING_VIA_NFKB stomach disease DOID_76 7.571E-03 0.0439607 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB encephalitis DOID_9588 7.571E-03 0.04351666 7.571E-03 0.12308997 TIAN_TNF_SIGNALING_VIA_NFKB berylliosis DOID_10322 8.2E-03 0.04665747 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB polyneuropathy DOID_1389 8.2E-03 0.04619552 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB larynx cancer DOID_2596 8.2E-03 0.04574262 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB laryngeal benign neoplasm DOID_2598 8.2E-03 0.04574262 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB open-angle glaucoma DOID_1067 8.828E-03 0.04876823 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB hypercalcemia DOID_12678 8.828E-03 0.04829931 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB eyelid disease DOID_530 8.828E-03 0.04783931 8.828E-03 0.13953133 TIAN_TNF_SIGNALING_VIA_NFKB polycystic kidney disease DOID_898 8.828E-03 0.047388 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB bacterial meningitis DOID_9470 8.828E-03 0.04694512 8.828E-03 0.13576021 TIAN_TNF_SIGNALING_VIA_NFKB idiopathic pulmonary fibrosis DOID_0050156 9.456E-03 0.04981752 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB skeletal system cancer DOID_0060124 9.456E-03 0.04936048 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB bone cancer DOID_184 9.456E-03 0.04936048 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB membranoproliferative glomerulonephritis DOID_2920 9.456E-03 0.04891175 9.456E-03 0.14158663 TIAN_TNF_SIGNALING_VIA_NFKB lung oat cell carcinoma DOID_5411 9.456E-03 0.0484711 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB oral submucous fibrosis DOID_5773 9.456E-03 0.04803832 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB intermediate coronary syndrome DOID_8805 9.456E-03 0.0476132 9.456E-03 0.1379562 TIAN_TNF_SIGNALING_VIA_NFKB hyperhomocysteinemia DOID_9279 9.456E-03 0.04719554 9.456E-03 0.1345073 TIAN_TNF_SIGNALING_VIA_NFKB spastic diplegia DOID_10965 0.01008302 0.04988904 0.01008302 0.13993266 TIAN_TNF_SIGNALING_VIA_NFKB hemolytic-uremic syndrome DOID_12554 0.01008302 0.04945896 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB restrictive cardiomyopathy DOID_397 0.01008302 0.04903623 0.01008302 0.13660093 TIAN_TNF_SIGNALING_VIA_NFKB thyroiditis DOID_7166 0.01008302 0.04862067 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB autoimmune thyroiditis DOID_7188 0.01008302 0.04862067 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB tongue cancer DOID_8649 0.01008302 0.04821209 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB basal cell carcinoma DOID_2513 0.01070996 0.05078308 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB urinary system benign neoplasm DOID_731 0.01070996 0.05036339 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB skin carcinoma DOID_3451 0.01133653 0.05287282 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB prion disease DOID_649 0.01133653 0.05244296 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB dissociative disorder DOID_10935 0.01196271 0.0548934 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB dissociative amnesia DOID_11037 0.01196271 0.0548934 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB Down syndrome DOID_14250 0.01196271 0.05445425 0.01196271 0.15469958 TIAN_TNF_SIGNALING_VIA_NFKB granulosa cell tumor DOID_2999 0.01196271 0.05402208 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB MHC class II deficiency DOID_5812 0.01196271 0.05359671 0.01196271 0.15126181 TIAN_TNF_SIGNALING_VIA_NFKB psoriasis DOID_8893 0.01196271 0.05317798 0.01196271 0.14797351 TIAN_TNF_SIGNALING_VIA_NFKB sex cord-gonadal stromal tumor DOID_192 0.01258851 0.05552607 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB brain edema DOID_4724 0.01258851 0.05509895 0.01258851 0.14618088 TIAN_TNF_SIGNALING_VIA_NFKB mitochondrial myopathy DOID_699 0.01321393 0.05739487 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB gastric ulcer DOID_10808 0.01383898 0.05965438 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB hepatitis B DOID_2043 0.01383898 0.05920585 0.01383898 0.15439956 TIAN_TNF_SIGNALING_VIA_NFKB placenta disease DOID_780 0.01383898 0.05876401 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB muscle cancer DOID_4045 0.01446364 0.06096156 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB pulmonary embolism DOID_9477 0.01446364 0.06051332 0.01446364 0.15826559 TIAN_TNF_SIGNALING_VIA_NFKB aortic valve disease DOID_62 0.01508792 0.06266444 0.01508792 0.16198167 TIAN_TNF_SIGNALING_VIA_NFKB Goodpasture syndrome DOID_9808 0.01508792 0.06221035 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB spastic quadriplegia DOID_10970 0.01571183 0.06431677 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB severe combined immunodeficiency DOID_627 0.01571183 0.06385736 0.01571183 0.16254601 TIAN_TNF_SIGNALING_VIA_NFKB commensal bacterial infectious disease DOID_0050339 0.01633535 0.06592069 0.01633535 0.16597887 TIAN_TNF_SIGNALING_VIA_NFKB portal hypertension DOID_10762 0.01633535 0.06545646 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB hypogonadism DOID_1924 0.01633535 0.06499872 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB bronchiolitis DOID_2942 0.01633535 0.06454734 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB combined T cell and B cell immunodeficiency DOID_628 0.01633535 0.06410219 0.01633535 0.16306696 TIAN_TNF_SIGNALING_VIA_NFKB cystitis DOID_1679 0.0169585 0.0660917 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB myositis DOID_633 0.0169585 0.0656421 0.0169585 0.16636876 TIAN_TNF_SIGNALING_VIA_NFKB intracranial aneurysm DOID_10941 0.01758127 0.06759286 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB fragments of torsion dystonia DOID_531 0.01758127 0.06713922 0.01758127 0.16672906 TIAN_TNF_SIGNALING_VIA_NFKB dystonia DOID_543 0.01758127 0.06669163 0.01758127 0.1639958 TIAN_TNF_SIGNALING_VIA_NFKB diffuse large B-cell lymphoma DOID_0050745 0.01820366 0.06859526 0.01820366 0.16706265 TIAN_TNF_SIGNALING_VIA_NFKB Sciatic Neuropathy DOID_11446 0.01820366 0.06814398 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB lesion of sciatic nerve DOID_12528 0.01820366 0.06814398 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB mononeuritis of lower limb DOID_9473 0.01820366 0.06814398 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB mononeuritis DOID_1802 0.01882568 0.07001183 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB hepatic vascular disease DOID_272 0.01882568 0.06955721 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB central nervous system hereditary degenerative disease DOID_481 0.01882568 0.06910845 0.01882568 0.16737203 TIAN_TNF_SIGNALING_VIA_NFKB autoimmune disease of endocrine system DOID_0060005 0.01944731 0.07093283 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB polycystic ovary syndrome DOID_11612 0.01944731 0.07048102 0.01944731 0.17023878 TIAN_TNF_SIGNALING_VIA_NFKB mononeuropathy DOID_1188 0.01944731 0.07003494 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB focal glomerulosclerosis DOID_3945 0.01944731 0.06959447 0.01944731 0.16765941 TIAN_TNF_SIGNALING_VIA_NFKB dystonic disease DOID_544 0.01944731 0.06915951 0.01944731 0.16515703 TIAN_TNF_SIGNALING_VIA_NFKB gonadal disease DOID_2277 0.02068945 0.07311986 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB bronchiolitis obliterans DOID_2799 0.02068945 0.07266851 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB celiac disease DOID_10608 0.02130996 0.07438874 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB allergic rhinitis DOID_4481 0.02130996 0.07393515 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB bladder disease DOID_365 0.02193008 0.07562556 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB papilloma DOID_2615 0.02254983 0.07729431 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB myocarditis DOID_820 0.02254983 0.07683147 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB pneumoconiosis DOID_10316 0.02316921 0.0784719 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB nephroblastoma DOID_2154 0.02316921 0.07800757 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB thyroid carcinoma DOID_3963 0.02316921 0.0775487 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB spindle cell carcinoma DOID_4015 0.02316921 0.0770952 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB thyroid cancer DOID_1781 0.02440683 0.0807412 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB congenital diaphragmatic hernia DOID_3827 0.02626044 0.08637105 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB cervix uteri carcinoma in situ DOID_8991 0.02749431 0.08990955 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB endometriosis of uterus DOID_288 0.02811068 0.09139987 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB nephrotic syndrome DOID_1184 0.02872668 0.09287204 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB Huntington's disease DOID_12858 0.02872668 0.09234734 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB hyperinsulinism DOID_2018 0.02872668 0.09182854 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB endometriosis DOID_289 0.02872668 0.09131553 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB diabetic autonomic neuropathy DOID_11503 0.0293423 0.09275427 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB autonomic neuropathy DOID_11504 0.0293423 0.09275427 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB diabetic polyneuropathy DOID_12785 0.0293423 0.09275427 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB gallbladder cancer DOID_3121 0.0293423 0.09224182 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB diabetic neuropathy DOID_9743 0.0293423 0.09275427 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB autonomic nervous system disease DOID_11465 0.03118693 0.09750198 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB thyroid adenoma DOID_2891 0.03118693 0.09696919 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB heart valve disease DOID_4079 0.03118693 0.09644218 0.03118693 0.22462482 TIAN_TNF_SIGNALING_VIA_NFKB hemolytic anemia DOID_583 0.03180105 0.09780973 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB normocytic anemia DOID_720 0.03180105 0.09780973 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB integumentary system benign neoplasm DOID_0060121 0.03241481 0.09916144 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB glaucoma DOID_1686 0.03241481 0.09863116 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB skin benign neoplasm DOID_3165 0.03241481 0.09916144 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB lung small cell carcinoma DOID_5409 0.03241481 0.09810653 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB calcium metabolism disease DOID_10575 0.03302819 0.09943408 1.000 1.000 TIAN_TNF_SIGNALING_VIA_NFKB movement disease DOID_480 0.03302819 0.09891074 0.03302819 0.22918343 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS aneurysm disease DOID_2403 5.788E-13 3.293E-10 3.088E-09 1.757E-06 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS aortic aneurysm DOID_3627 2.267E-08 6.449E-06 1.566E-06 4.455E-04 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS parasitic infectious disease DOID_1398 8.086E-08 1.534E-05 5.247E-03 0.0609265 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pleurisy DOID_10247 1.506E-07 2.142E-05 0.04642332 0.24233822 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bacterial pneumonia DOID_874 1.838E-07 2.092E-05 2.839E-04 0.01346191 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pleural disease DOID_1532 2.86E-07 2.712E-05 0.05395171 0.26694369 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS alcohol-related neurodevelopmental disorder DOID_0050667 4.584E-07 3.726E-05 4.849E-04 0.0153293 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS parasitic protozoa infectious disease DOID_2789 2.256E-06 1.604E-04 0.08783633 0.3309859 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pustulosis of palm and sole DOID_4398 2.256E-06 1.426E-04 3.846E-03 0.05210447 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS melancholia DOID_2848 2.952E-06 1.679E-04 4.382E-03 0.05666678 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS neurotic disorder DOID_4964 3.148E-06 1.628E-04 4.521E-03 0.05716617 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS cholestasis DOID_13580 4.279E-06 2.029E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS brain infarction DOID_3454 5.087E-06 2.226E-04 0.1064576 0.37391589 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bile duct disease DOID_4138 6.003E-06 2.44E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS biliary tract disease DOID_9741 6.333E-06 2.402E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS diabetic retinopathy DOID_8947 6.677E-06 2.375E-04 6.511E-03 0.07264481 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS cystic fibrosis DOID_1485 7.406E-06 2.479E-04 0.11632908 0.39166417 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS endogenous depression DOID_1595 7.406E-06 2.341E-04 6.847E-03 0.07492085 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS sphingolipidosis DOID_1927 8.455E-06 2.532E-04 7.218E-04 0.02053555 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS mental depression DOID_1596 1.043E-05 2.966E-04 8.082E-03 0.08516273 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS morbid obesity DOID_11981 1.073E-05 2.907E-04 8.428E-04 0.02283593 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS retinal vascular disease DOID_2462 1.144E-05 2.958E-04 8.452E-03 0.08744235 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS intracranial aneurysm DOID_10941 1.2E-05 2.969E-04 9.067E-04 0.02345082 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS middle cerebral artery infarction DOID_3525 1.2E-05 2.846E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Human immunodeficiency virus infectious disease DOID_526 1.427E-05 3.248E-04 4.281E-04 0.01522559 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS spastic cerebral palsy DOID_0050669 1.988E-05 4.35E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS abdominal aortic aneurysm DOID_7693 1.988E-05 4.189E-04 1.26E-03 0.02655521 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS respiratory syncytial virus infectious disease DOID_1273 4.14E-05 8.413E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS intracranial arterial disease DOID_13089 4.446E-05 8.723E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS cerebral arterial disease DOID_3527 4.446E-05 8.723E-04 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS lymphatic system disease DOID_75 4.446E-05 8.432E-04 2.133E-03 0.03915532 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pulmonary emphysema DOID_9675 4.766E-05 8.747E-04 2.233E-03 0.03849467 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS diabetic autonomic neuropathy DOID_11503 5.815E-05 1.034E-03 2.543E-03 0.0413483 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS autonomic neuropathy DOID_11504 5.815E-05 1.034E-03 2.543E-03 0.0413483 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS diabetic polyneuropathy DOID_12785 5.815E-05 1.034E-03 2.543E-03 0.0413483 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS influenza DOID_8469 5.815E-05 1.003E-03 0.07178223 0.29813202 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS diabetic neuropathy DOID_9743 5.815E-05 1.034E-03 2.543E-03 0.0413483 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS cerebral infarction DOID_3526 6.196E-05 1.037E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS proteinuria DOID_576 6.592E-05 1.072E-03 0.07472168 0.30369025 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS autonomic nervous system disease DOID_11465 7.005E-05 1.107E-03 2.873E-03 0.04302586 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS heart valve disease DOID_4079 7.005E-05 1.077E-03 7.005E-05 0.0132866 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pulmonary tuberculosis DOID_2957 7.881E-05 1.18E-03 3.104E-03 0.04528708 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS atrophic muscular disease DOID_913 9.841E-05 1.436E-03 9.841E-05 0.01399845 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS muscular dystrophy DOID_9884 9.841E-05 1.436E-03 9.841E-05 0.01399845 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS insulinoma DOID_3892 1.099E-04 1.564E-03 1.099E-04 0.01251108 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS leukocyte disease DOID_9500 1.334E-04 1.851E-03 0.09360623 0.34362544 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS respiratory failure DOID_11162 1.535E-04 2.08E-03 4.805E-03 0.0594394 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pre-malignant neoplasm DOID_0060071 1.606E-04 2.126E-03 1.606E-04 0.01523339 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS in situ carcinoma DOID_8719 1.606E-04 2.126E-03 1.606E-04 0.01523339 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS islet cell tumor DOID_1799 1.609E-04 2.081E-03 1.609E-04 0.01308014 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS aortic valve insufficiency DOID_57 1.609E-04 2.035E-03 1.609E-04 0.01144513 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS mineral metabolism disease DOID_0050032 1.68E-04 2.078E-03 5.098E-03 0.06042771 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS temporal lobe epilepsy DOID_3328 1.833E-04 2.219E-03 0.10361731 0.37080661 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hyperglycemia DOID_4195 1.833E-04 2.173E-03 0.10361731 0.36848907 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS polyneuropathy DOID_1389 1.9E-04 2.206E-03 0.02038345 0.15464247 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS tuberculosis DOID_399 1.995E-04 2.27E-03 5.706E-03 0.06493594 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Legionnaires' disease DOID_10457 2.214E-04 2.47E-03 2.214E-04 0.01399846 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS legionellosis DOID_10458 2.214E-04 2.47E-03 2.214E-04 0.01399846 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS thoracic aortic aneurysm DOID_14004 2.552E-04 2.793E-03 2.552E-04 0.01452205 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS intermediate coronary syndrome DOID_8805 2.552E-04 2.74E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hyperhomocysteinemia DOID_9279 2.552E-04 2.689E-03 0.02348289 0.16294836 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS electroclinical syndrome DOID_0050701 2.839E-04 2.937E-03 7.19E-03 0.07719389 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS mixed glioma DOID_5076 2.839E-04 2.885E-03 2.839E-04 0.01468572 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS metabolic syndrome X DOID_14221 3.053E-04 3.048E-03 0.12192169 0.40333397 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bronchitis DOID_6132 3.299E-04 3.236E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS focal epilepsy DOID_2234 3.394E-04 3.273E-03 0.1260933 0.40998336 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS biliary tract cancer DOID_4607 3.394E-04 3.219E-03 0.1260933 0.40765391 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS chronic kidney failure DOID_784 3.394E-04 3.166E-03 0.1260933 0.40535078 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bone development disease DOID_0080006 3.513E-04 3.224E-03 3.513E-04 0.01537454 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS primary bacterial infectious disease DOID_0050338 3.885E-04 3.509E-03 8.83E-03 0.08971672 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS transitional cell carcinoma DOID_2671 4.014E-04 3.569E-03 4.014E-04 0.01631492 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS psoriasis DOID_8893 4.14E-04 3.624E-03 4.14E-04 0.01570267 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS leishmaniasis DOID_9065 4.14E-04 3.569E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS amino acid metabolic disorder DOID_9252 4.146E-04 3.521E-03 9.215E-03 0.0919856 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pulmonary edema DOID_11396 4.595E-04 3.845E-03 4.595E-04 0.0153791 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS brain edema DOID_4724 4.595E-04 3.789E-03 0.03118936 0.20635751 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS encephalomyelitis DOID_640 4.703E-04 3.823E-03 0.1398584 0.43966535 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hypersensitivity reaction type I disease DOID_1205 4.998E-04 4.006E-03 0.14258572 0.44577624 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS dilated cardiomyopathy DOID_12930 4.998E-04 3.95E-03 0.01041379 0.10216291 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS autoimmune hepatitis DOID_2048 5.073E-04 3.954E-03 0.03272346 0.21158692 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS ulcerative colitis DOID_8577 5.464E-04 4.201E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS acquired immunodeficiency syndrome DOID_635 5.575E-04 4.23E-03 0.03425517 0.21656882 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS aortic valve disease DOID_62 6.647E-04 4.977E-03 6.647E-04 0.01990731 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS meningitis DOID_9471 6.647E-04 4.912E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS spastic quadriplegia DOID_10970 7.218E-04 5.266E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS acute pancreatitis DOID_2913 7.218E-04 5.199E-03 0.03883602 0.22781127 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bronchiolitis DOID_2942 7.812E-04 5.556E-03 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS gestational diabetes DOID_11714 9.729E-04 6.834E-03 0.04491058 0.23661223 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS migraine DOID_6364 9.729E-04 6.751E-03 9.729E-04 0.02406828 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS renal hypertension DOID_1073 1.041E-03 7.139E-03 1.041E-03 0.02468784 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS secondary hypertension DOID_11130 1.041E-03 7.139E-03 1.041E-03 0.02468784 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS multiple epiphyseal dysplasia DOID_12721 1.112E-03 7.532E-03 1.112E-03 0.02530907 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS endometrial carcinoma DOID_2871 1.185E-03 7.932E-03 1.185E-03 0.02593162 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS endometrial cancer DOID_1380 1.337E-03 8.849E-03 1.337E-03 0.02717958 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS adenoma DOID_657 1.758E-03 0.01149553 1.758E-03 0.03448659 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS adolescence-adult electroclinical syndrome DOID_0050705 1.848E-03 0.0119509 0.06142166 0.27959138 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pulmonary sarcoidosis DOID_13406 1.848E-03 0.01181662 0.06142166 0.2773724 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS congenital diaphragmatic hernia DOID_3827 2.036E-03 0.01287261 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS peptic ulcer DOID_750 2.036E-03 0.01273115 0.06439337 0.27969333 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS adenoid cystic carcinoma DOID_4866 2.133E-03 0.01319364 2.133E-03 0.04046049 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS cervix uteri carcinoma in situ DOID_8991 2.233E-03 0.0136594 2.233E-03 0.03969763 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS salivary gland cancer DOID_8850 2.334E-03 0.01412829 2.334E-03 0.03906057 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS idiopathic generalized epilepsy DOID_1827 2.438E-03 0.01460017 0.07030906 0.30079591 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hyperinsulinism DOID_2018 2.438E-03 0.01444808 0.07030906 0.29855116 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS gallbladder cancer DOID_3121 2.543E-03 0.01491949 0.07178223 0.30032417 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS uterine cancer DOID_363 2.543E-03 0.01476725 2.543E-03 0.04019974 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pre-eclampsia DOID_10591 2.873E-03 0.01651498 2.873E-03 0.04418873 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS vascular skin disease DOID_9540 2.873E-03 0.01634983 0.07618797 0.30315352 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS autoimmune disease of gastrointestinal tract DOID_0060031 3.104E-03 0.01748709 0.0791137 0.31260899 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS lung small cell carcinoma DOID_5409 3.104E-03 0.01731565 0.0791137 0.30832667 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS calcium metabolism disease DOID_10575 3.222E-03 0.01780191 0.08057314 0.31187836 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS movement disease DOID_480 3.222E-03 0.01763074 3.222E-03 0.04583992 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS atopic dermatitis DOID_3310 3.466E-03 0.01878064 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS sarcoidosis DOID_11335 3.59E-03 0.01927291 0.08493785 0.32435998 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS giant cell tumor DOID_200 3.59E-03 0.01909279 0.08493785 0.32219758 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS malignant giant cell tumor DOID_2705 3.59E-03 0.01909279 0.08493785 0.32219758 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS giant cell glioblastoma DOID_3074 3.59E-03 0.01909279 0.08493785 0.32219758 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS osteochondrodysplasia DOID_2256 3.846E-03 0.02026285 3.846E-03 0.05337531 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hypertrophic cardiomyopathy DOID_11984 4.245E-03 0.02215923 0.09216713 0.34502036 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hypersensitivity reaction type IV disease DOID_2916 4.245E-03 0.02195778 0.09216713 0.34276532 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS glioblastoma DOID_3068 4.245E-03 0.02175996 0.09216713 0.34053958 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bile duct cancer DOID_4606 4.245E-03 0.02156568 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bile duct carcinoma DOID_4897 4.245E-03 0.02156568 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS oral cavity cancer DOID_8618 4.245E-03 0.02137483 4.245E-03 0.05617107 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS carotid artery disease DOID_3407 4.662E-03 0.02326992 0.0964777 0.35189623 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS congenital heart defect DOID_1682 4.95E-03 0.02449392 4.95E-03 0.05993192 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS endocrine pancreas disease DOID_1428 5.098E-03 0.02500457 0.10076815 0.36520432 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS uterine disease DOID_345 5.247E-03 0.02551623 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS astrocytoma DOID_3069 5.863E-03 0.02827273 0.10787442 0.37656776 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS nephrosis DOID_2527 6.183E-03 0.02956561 0.11070144 0.38175224 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS male reproductive system disease DOID_48 6.183E-03 0.02931923 0.11070144 0.37945253 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS peripheral vascular disease DOID_341 6.346E-03 0.02984332 0.11211164 0.38198519 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pancreatitis DOID_4989 7.19E-03 0.03353505 0.11912975 0.3964025 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS contact dermatitis DOID_2773 7.541E-03 0.03488644 0.12192169 0.40100256 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS female reproductive system disease DOID_229 7.72E-03 0.0354237 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS lymphoblastic leukemia DOID_1037 0.01000679 0.04555091 0.1398584 0.44210793 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Crohn's disease DOID_8778 0.01020938 0.04610428 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS gallbladder disease DOID_0000000 0.01571615 0.07041331 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS facioscapulohumeral muscular dystrophy DOID_11727 0.01571615 0.06986321 0.01571615 0.15156764 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hyperparathyroidism DOID_13543 0.01571615 0.06932163 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS familial combined hyperlipidemia DOID_13809 0.01571615 0.06878839 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS retinal vascular occlusion DOID_1729 0.01571615 0.06826329 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS conjunctival disease DOID_4251 0.01571615 0.06774614 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hypokalemia DOID_4500 0.01571615 0.06723677 0.01571615 0.14904151 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS conjunctivitis DOID_6195 0.01571615 0.06774614 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS cutaneous leishmaniasis DOID_9111 0.01571615 0.066735 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS visceral leishmaniasis DOID_9146 0.01571615 0.06624067 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS breast benign neoplasm DOID_0060082 0.01727434 0.07227281 0.01727434 0.16113282 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS thoracic benign neoplasm DOID_0060097 0.01727434 0.07227281 0.01727434 0.16113282 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS trypanosomiasis DOID_10113 0.01727434 0.07174527 0.01727434 0.1585339 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS sickle cell anemia DOID_10923 0.01727434 0.07122537 0.01727434 0.15601749 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS obsessive-compulsive disorder DOID_10933 0.01727434 0.07071296 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS prediabetes syndrome DOID_11716 0.01727434 0.07020787 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS migraine without aura DOID_12783 0.01727434 0.06970994 0.01727434 0.15357971 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS benign breast phyllodes tumor DOID_1631 0.01727434 0.07227281 0.01727434 0.16113282 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS craniosynostosis DOID_2340 0.01727434 0.06921903 0.01727434 0.15121695 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS eosinophilic pneumonia DOID_5870 0.01727434 0.06873498 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS pulmonary eosinophilia DOID_9498 0.01727434 0.06873498 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Loeffler syndrome DOID_9503 0.01727434 0.06873498 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bronchiectasis DOID_9563 0.01727434 0.06825765 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS heroin dependence DOID_9976 0.01727434 0.06778691 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS common cold DOID_10459 0.01883011 0.07338584 0.01883011 0.16233837 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS otitis media DOID_10754 0.01883011 0.07288662 0.01883011 0.15991541 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS relapsing-remitting multiple sclerosis DOID_2378 0.01883011 0.07239414 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS epidermolysis bullosa DOID_2730 0.01883011 0.07190827 0.01883011 0.15756372 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS middle ear disease DOID_5100 0.01883011 0.07288662 0.01883011 0.15991541 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS retinal detachment DOID_5327 0.01883011 0.07142888 0.01883011 0.15528018 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS peritonitis DOID_8283 0.01883011 0.07095585 0.01883011 0.1530619 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS progressive myoclonus epilepsy DOID_891 0.01883011 0.07048903 0.01883011 0.15090609 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS infancy electroclinical syndrome DOID_0050703 0.02038345 0.07580513 0.02038345 0.16108591 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS variable age at onset electroclinical syndrome DOID_0050706 0.02038345 0.07531289 0.02038345 0.15887925 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS nicotine dependence DOID_0050742 0.02038345 0.074827 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS berylliosis DOID_10322 0.02038345 0.07434734 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS parathyroid gland disease DOID_11201 0.02038345 0.07387379 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hepatic coma DOID_12550 0.02038345 0.07340624 0.02038345 0.15673224 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS newborn respiratory distress syndrome DOID_12716 0.02038345 0.07294456 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS carotid stenosis DOID_13001 0.02038345 0.07248866 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hepatic encephalopathy DOID_13413 0.02038345 0.07340624 0.02038345 0.15673224 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS vesiculobullous skin disease DOID_2731 0.02038345 0.07203842 0.02038345 0.1526077 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS epilepsy with generalized tonic-clonic seizures DOID_7725 0.02038345 0.07159374 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS psoriatic arthritis DOID_9008 0.02038345 0.07115451 0.02038345 0.15062579 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS viral pneumonia DOID_10533 0.02193438 0.0761016 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hypercalcemia DOID_12678 0.02193438 0.07564038 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS eyelid disease DOID_530 0.02193438 0.07518471 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS eating disorder DOID_8670 0.02193438 0.07473451 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS parasitic helminthiasis infectious disease DOID_883 0.02193438 0.07428966 0.02193438 0.16000849 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS polycystic kidney disease DOID_898 0.02193438 0.07385007 0.02193438 0.15798307 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS bacterial meningitis DOID_9470 0.02193438 0.07341566 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS renovascular hypertension DOID_1591 0.02348289 0.07813898 0.02348289 0.16702207 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS communication disorder DOID_2033 0.02348289 0.07768468 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS corneal dystrophy DOID_2566 0.02348289 0.07723564 0.02348289 0.16496007 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS lung oat cell carcinoma DOID_5411 0.02348289 0.07679176 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS spastic diplegia DOID_10965 0.02502899 0.08137998 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS hemolytic-uremic syndrome DOID_12554 0.02502899 0.08091759 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Fanconi's anemia DOID_13636 0.02502899 0.08046043 0.02502899 0.1715843 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS thyroiditis DOID_7166 0.02502899 0.08000841 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS autoimmune thyroiditis DOID_7188 0.02502899 0.08000841 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Barrett's esophagus DOID_9206 0.02502899 0.07956143 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS schizophreniform disorder DOID_11328 0.02657269 0.08399921 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS basal cell carcinoma DOID_2513 0.02657269 0.08353513 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS schizoaffective disorder DOID_5418 0.02657269 0.08399921 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS congenital muscular dystrophy DOID_0050557 0.02811398 0.08789479 0.02811398 0.19043872 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS skin carcinoma DOID_3451 0.02811398 0.08741449 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS ureteral obstruction DOID_5199 0.02811398 0.08693941 0.02811398 0.18819826 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS eosinophilia DOID_999 0.02811398 0.08646947 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS dissociative disorder DOID_10935 0.02965287 0.09071226 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS dissociative amnesia DOID_11037 0.02965287 0.09071226 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Down syndrome DOID_14250 0.02965287 0.09022717 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS amnestic disorder DOID_10914 0.03118936 0.09439758 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS membranous glomerulonephritis DOID_10976 0.03118936 0.09389813 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS esophagitis DOID_11963 0.03118936 0.09340392 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS amyloidosis DOID_9120 0.03118936 0.0929149 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS Kawasaki disease DOID_13378 0.03272346 0.09697734 0.03272346 0.21401896 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS lymphadenitis DOID_1602 0.03272346 0.09697734 0.03272346 0.21401896 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS mitochondrial myopathy DOID_699 0.03272346 0.09647487 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS lymph node disease DOID_9942 0.03272346 0.09697734 0.03272346 0.21401896 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS familial hypercholesterolemia DOID_13810 0.03425517 0.09995484 1.000 1.000 HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS placenta disease DOID_780 0.03425517 0.09944487 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS pre-malignant neoplasm DOID_0060071 1.031E-07 5.865E-05 8.726E-04 0.08275359 HWANG_PROSTATE_CANCER_MARKERS in situ carcinoma DOID_8719 1.031E-07 5.865E-05 8.726E-04 0.08275359 HWANG_PROSTATE_CANCER_MARKERS pancreatic ductal carcinoma DOID_3587 1.552E-07 4.415E-05 1.528E-05 8.695E-03 HWANG_PROSTATE_CANCER_MARKERS pancreatic carcinoma DOID_4905 1.827E-07 3.465E-05 1.725E-05 4.907E-03 HWANG_PROSTATE_CANCER_MARKERS B-cell lymphocytic neoplasm DOID_707 6.145E-06 8.741E-04 5.85E-04 0.08321374 HWANG_PROSTATE_CANCER_MARKERS lymphoma DOID_0060058 3.263E-05 3.714E-03 1.758E-03 0.10004236 HWANG_PROSTATE_CANCER_MARKERS hemangioma DOID_255 4.361E-05 4.135E-03 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS supratentorial cancer DOID_1659 1.919E-04 0.01559575 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS cerebrum cancer DOID_368 1.919E-04 0.01559575 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS endometrial carcinoma DOID_2871 2.046E-04 0.01455015 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS endometrial cancer DOID_1380 2.312E-04 0.01461656 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS myocarditis DOID_820 2.594E-04 0.01476095 2.594E-04 0.04920317 HWANG_PROSTATE_CANCER_MARKERS cervix uteri carcinoma in situ DOID_8991 3.883E-04 0.02008484 0.02862373 0.36193113 HWANG_PROSTATE_CANCER_MARKERS uterine cancer DOID_363 4.432E-04 0.02101299 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS brain cancer DOID_1319 5.016E-04 0.02195381 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS central nervous system cancer DOID_3620 5.218E-04 0.02120918 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS lung small cell carcinoma DOID_5409 5.425E-04 0.02057873 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS giant cell tumor DOID_200 6.29E-04 0.02236997 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS malignant giant cell tumor DOID_2705 6.29E-04 0.02236997 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS giant cell glioblastoma DOID_3074 6.29E-04 0.02236997 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS glioblastoma DOID_3068 7.46E-04 0.02496835 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS respiratory failure DOID_11162 8.465E-04 0.02675944 8.465E-04 0.09633398 HWANG_PROSTATE_CANCER_MARKERS astrocytoma DOID_3069 1.037E-03 0.03106462 1.000 1.000 HWANG_PROSTATE_CANCER_MARKERS cystic fibrosis DOID_1485 1.216E-03 0.03458855 1.216E-03 0.09882442 HWANG_PROSTATE_CANCER_MARKERS endogenous depression DOID_1595 1.216E-03 0.03294147 1.216E-03 0.08647137 HWANG_PROSTATE_CANCER_MARKERS mental depression DOID_1596 1.441E-03 0.03727569 1.441E-03 0.09111835 HWANG_PROSTATE_CANCER_MARKERS transitional cell carcinoma DOID_2671 1.614E-03 0.03991891 0.05770692 0.42096458 HWANG_PROSTATE_CANCER_MARKERS nervous system cancer DOID_3093 1.685E-03 0.03995227 1.000 1.000 JI_RESPONSE_TO_FSH_UP prostatic adenoma DOID_2883 3.543E-05 0.0201579 3.543E-05 0.0201579 JI_RESPONSE_TO_FSH_UP intermediate coronary syndrome DOID_8805 6.75E-05 0.01920243 6.75E-05 0.01920243 JI_RESPONSE_TO_FSH_UP male reproductive organ benign neoplasm DOID_0060087 9.82E-05 0.01862528 9.82E-05 0.01862528 JI_RESPONSE_TO_FSH_UP Huntington's disease DOID_12858 6.549E-04 0.09315751 6.549E-04 0.09315751 JI_RESPONSE_TO_FSH_UP uterine cancer DOID_363 6.836E-04 0.07779866 0.03774058 0.36397267 JI_RESPONSE_TO_FSH_UP cataract DOID_83 7.13E-04 0.06761657 7.13E-04 0.08113989 JI_RESPONSE_TO_FSH_UP lens disease DOID_110 7.735E-04 0.06287691 7.735E-04 0.07335639 JI_RESPONSE_TO_FSH_UP neuritis DOID_1803 7.735E-04 0.0550173 7.735E-04 0.06287691 JI_RESPONSE_TO_FSH_UP reproductive organ benign neoplasm DOID_0050622 1.04E-03 0.06572267 1.04E-03 0.073938 JI_RESPONSE_TO_FSH_UP pre-malignant neoplasm DOID_0060071 1.343E-03 0.07644418 0.05260289 0.42758635 JI_RESPONSE_TO_FSH_UP in situ carcinoma DOID_8719 1.343E-03 0.07644418 0.05260289 0.42758635 LOPEZ_MBD_TARGETS endocrine organ benign neoplasm DOID_0060089 8.041E-21 4.576E-18 1.616E-07 1.15E-05 LOPEZ_MBD_TARGETS transitional cell carcinoma DOID_2671 2.497E-17 7.103E-15 1.184E-07 9.621E-06 LOPEZ_MBD_TARGETS thyroid adenoma DOID_2891 1.759E-14 3.336E-12 3.082E-04 6.048E-03 LOPEZ_MBD_TARGETS mixed glioma DOID_5076 1.133E-11 1.612E-09 3.784E-04 6.525E-03 LOPEZ_MBD_TARGETS bone marrow disease DOID_4961 1.371E-11 1.56E-09 6.769E-09 1.926E-06 LOPEZ_MBD_TARGETS oral cavity cancer DOID_8618 1.366E-10 1.295E-08 2.531E-09 1.44E-06 LOPEZ_MBD_TARGETS pre-malignant neoplasm DOID_0060071 3.328E-10 2.705E-08 1.311E-05 5.74E-04 LOPEZ_MBD_TARGETS in situ carcinoma DOID_8719 3.328E-10 2.705E-08 1.311E-05 5.74E-04 LOPEZ_MBD_TARGETS thyroid carcinoma DOID_3963 3.85E-10 2.738E-08 7.193E-05 2.154E-03 LOPEZ_MBD_TARGETS bone development disease DOID_0080006 4.448E-10 2.812E-08 7.64E-08 7.246E-06 LOPEZ_MBD_TARGETS thyroid cancer DOID_1781 6.423E-10 3.654E-08 9.318E-05 2.525E-03 LOPEZ_MBD_TARGETS osteochondrodysplasia DOID_2256 1.511E-09 7.818E-08 4.084E-07 2.324E-05 LOPEZ_MBD_TARGETS uterine cancer DOID_363 3.799E-09 1.801E-07 0.0181025 0.09537333 LOPEZ_MBD_TARGETS carotid artery disease DOID_3407 4.119E-09 1.803E-07 6.996E-03 0.05768847 LOPEZ_MBD_TARGETS papilloma DOID_2615 8.092E-09 3.289E-07 0.06745803 0.23989761 LOPEZ_MBD_TARGETS aplastic anemia DOID_12449 1.281E-08 4.859E-07 2.825E-07 1.786E-05 LOPEZ_MBD_TARGETS adenoma DOID_657 1.595E-08 5.672E-07 0.0109325 0.0758609 LOPEZ_MBD_TARGETS papillary adenoma DOID_3172 2.224E-08 7.442E-07 0.04026151 0.1648115 LOPEZ_MBD_TARGETS microcystic adenoma DOID_5403 2.224E-08 7.442E-07 0.04026151 0.1648115 LOPEZ_MBD_TARGETS follicular adenoma DOID_6204 2.224E-08 7.442E-07 0.04026151 0.1648115 LOPEZ_MBD_TARGETS vasculitis DOID_865 2.259E-08 7.142E-07 0.02997874 0.1353802 LOPEZ_MBD_TARGETS congenital hypoplastic anemia DOID_1342 2.935E-08 8.788E-07 2.935E-08 5.566E-06 LOPEZ_MBD_TARGETS lung adenocarcinoma DOID_3910 3.829E-08 1.089E-06 3.616E-04 6.43E-03 LOPEZ_MBD_TARGETS salivary gland cancer DOID_8850 5.252E-08 1.423E-06 5.252E-08 7.471E-06 LOPEZ_MBD_TARGETS Diamond-Blackfan anemia DOID_1339 5.409E-08 1.399E-06 5.409E-08 6.155E-06 LOPEZ_MBD_TARGETS testicular cancer DOID_2998 6.273E-08 1.552E-06 1.38E-03 0.01706693 LOPEZ_MBD_TARGETS focal glomerulosclerosis DOID_3945 6.321E-08 1.499E-06 0.05172693 0.1962175 LOPEZ_MBD_TARGETS neuroectodermal tumor DOID_171 6.429E-08 1.463E-06 1.106E-04 2.737E-03 LOPEZ_MBD_TARGETS endometrial carcinoma DOID_2871 8.009E-08 1.753E-06 6.305E-03 0.05354438 LOPEZ_MBD_TARGETS endometrial cancer DOID_1380 1.254E-07 2.643E-06 7.475E-03 0.06076499 LOPEZ_MBD_TARGETS lymphoma DOID_0060058 1.794E-07 3.645E-06 0.02553153 0.12106203 LOPEZ_MBD_TARGETS pancreatic ductal carcinoma DOID_3587 2.063E-07 4.048E-06 0.05561117 0.20681538 LOPEZ_MBD_TARGETS uremia DOID_4676 2.242E-07 4.253E-06 1.000 1.000 LOPEZ_MBD_TARGETS pancreatic carcinoma DOID_4905 2.935E-07 5.387E-06 0.06128267 0.21930716 LOPEZ_MBD_TARGETS integumentary system cancer DOID_0060122 4.084E-07 7.262E-06 6.34E-05 2.004E-03 LOPEZ_MBD_TARGETS skin cancer DOID_4159 4.084E-07 7.262E-06 6.34E-05 2.004E-03 LOPEZ_MBD_TARGETS pustulosis of palm and sole DOID_4398 4.084E-07 7.042E-06 0.03134469 0.13933692 LOPEZ_MBD_TARGETS bone resorption disease DOID_0080011 4.109E-07 6.877E-06 4.477E-06 2.123E-04 LOPEZ_MBD_TARGETS osteoporosis DOID_11476 4.109E-07 6.877E-06 4.477E-06 2.123E-04 LOPEZ_MBD_TARGETS intracranial arterial disease DOID_13089 6.855E-07 1.114E-05 0.01426108 0.08725328 LOPEZ_MBD_TARGETS cerebral arterial disease DOID_3527 6.855E-07 1.114E-05 0.01426108 0.08725328 LOPEZ_MBD_TARGETS adenoid cystic carcinoma DOID_4866 6.855E-07 1.083E-05 6.855E-07 3.546E-05 LOPEZ_MBD_TARGETS spinal cord disease DOID_319 7.96E-07 1.224E-05 1.77E-05 6.294E-04 LOPEZ_MBD_TARGETS cervix uteri carcinoma in situ DOID_8991 8.069E-07 1.208E-05 1.674E-04 3.811E-03 LOPEZ_MBD_TARGETS pulmonary emphysema DOID_9675 8.069E-07 1.177E-05 1.000 1.000 LOPEZ_MBD_TARGETS hypothyroidism DOID_1459 1.001E-06 1.423E-05 1.04E-03 0.01344643 LOPEZ_MBD_TARGETS parasitic infectious disease DOID_1398 1.421E-06 1.972E-05 0.19199605 0.45142872 LOPEZ_MBD_TARGETS nervous system cancer DOID_3093 1.515E-06 2.053E-05 0.09570483 0.31117742 LOPEZ_MBD_TARGETS proteinuria DOID_576 1.719E-06 2.275E-05 0.11413732 0.34361976 LOPEZ_MBD_TARGETS encephalomyelitis DOID_640 1.986E-06 2.569E-05 0.30956172 0.59506967 LOPEZ_MBD_TARGETS hypersensitivity reaction type I disease DOID_1205 2.366E-06 2.992E-05 5.971E-03 0.05147916 LOPEZ_MBD_TARGETS lung small cell carcinoma DOID_5409 2.597E-06 3.212E-05 3.329E-03 0.0357423 LOPEZ_MBD_TARGETS germinoma DOID_3304 2.676E-06 3.24E-05 6.739E-04 9.586E-03 LOPEZ_MBD_TARGETS nephrosis DOID_2527 2.723E-06 3.228E-05 0.05747255 0.21234986 LOPEZ_MBD_TARGETS membranous glomerulonephritis DOID_10976 3.018E-06 3.505E-05 8.023E-05 2.283E-03 LOPEZ_MBD_TARGETS nephroblastoma DOID_2154 4.489E-06 5.109E-05 0.07077236 0.24857698 LOPEZ_MBD_TARGETS chronic monocytic leukemia DOID_8593 5.946E-06 6.634E-05 2.52E-04 5.122E-03 LOPEZ_MBD_TARGETS embryonal cancer DOID_688 7.193E-06 7.871E-05 0.01171708 0.0775235 LOPEZ_MBD_TARGETS hypertrophic cardiomyopathy DOID_11984 7.728E-06 8.297E-05 0.03563497 0.15597154 LOPEZ_MBD_TARGETS biliary tract cancer DOID_4607 7.765E-06 8.182E-05 0.07981666 0.27033144 LOPEZ_MBD_TARGETS aortic valve disease DOID_62 7.958E-06 8.233E-05 0.2482773 0.51184704 LOPEZ_MBD_TARGETS primary bacterial infectious disease DOID_0050338 1.094E-05 1.111E-04 0.0887458 0.29020896 LOPEZ_MBD_TARGETS respiratory failure DOID_11162 1.184E-05 1.182E-04 0.53853367 0.89598146 LOPEZ_MBD_TARGETS osteosarcoma DOID_3347 1.208E-05 1.185E-04 3.482E-03 0.03669306 LOPEZ_MBD_TARGETS osteogenesis imperfecta DOID_12347 1.264E-05 1.219E-04 4.293E-04 7.184E-03 LOPEZ_MBD_TARGETS larynx cancer DOID_2596 1.264E-05 1.199E-04 1.000 1.000 LOPEZ_MBD_TARGETS laryngeal benign neoplasm DOID_2598 1.264E-05 1.199E-04 1.000 1.000 LOPEZ_MBD_TARGETS monocytic leukemia DOID_8527 1.264E-05 1.179E-04 4.293E-04 6.979E-03 LOPEZ_MBD_TARGETS benign mesothelioma DOID_2645 1.271E-05 1.167E-04 0.01517304 0.08809651 LOPEZ_MBD_TARGETS endocrine pancreas disease DOID_1428 1.45E-05 1.309E-04 0.04506952 0.176859 LOPEZ_MBD_TARGETS ankylosing spondylitis DOID_7147 1.468E-05 1.305E-04 0.04026151 0.16363428 LOPEZ_MBD_TARGETS cerebral degeneration DOID_1443 1.6E-05 1.4E-04 8.643E-03 0.0673693 LOPEZ_MBD_TARGETS tethered spinal cord syndrome DOID_1089 1.753E-05 1.512E-04 1.753E-05 7.127E-04 LOPEZ_MBD_TARGETS congenital structural myopathy DOID_422 1.753E-05 1.489E-04 1.753E-05 6.652E-04 LOPEZ_MBD_TARGETS seminoma DOID_4440 1.77E-05 1.481E-04 4.312E-03 0.0438112 LOPEZ_MBD_TARGETS diabetic autonomic neuropathy DOID_11503 1.877E-05 1.548E-04 0.10650553 0.34045868 LOPEZ_MBD_TARGETS autonomic neuropathy DOID_11504 1.877E-05 1.548E-04 0.10650553 0.34045868 LOPEZ_MBD_TARGETS diabetic polyneuropathy DOID_12785 1.877E-05 1.548E-04 0.10650553 0.34045868 LOPEZ_MBD_TARGETS diabetic neuropathy DOID_9743 1.877E-05 1.548E-04 0.10650553 0.34045868 LOPEZ_MBD_TARGETS tuberculosis DOID_399 2.129E-05 1.73E-04 0.20488423 0.46445866 LOPEZ_MBD_TARGETS nutritional deficiency disease DOID_5113 2.369E-05 1.898E-04 6.71E-04 9.79E-03 LOPEZ_MBD_TARGETS leukodystrophy DOID_10579 2.396E-05 1.893E-04 0.0202176 0.10091064 LOPEZ_MBD_TARGETS autoimmune disease of cardiovascular system DOID_0060051 2.517E-05 1.962E-04 0.30006173 0.59283029 LOPEZ_MBD_TARGETS Behcet's disease DOID_13241 2.517E-05 1.962E-04 0.30006173 0.59283029 LOPEZ_MBD_TARGETS autonomic nervous system disease DOID_11465 2.695E-05 2.073E-04 0.11800455 0.35154234 LOPEZ_MBD_TARGETS brain cancer DOID_1319 2.695E-05 2.045E-04 0.11800455 0.34971139 LOPEZ_MBD_TARGETS neuritis DOID_1803 2.695E-05 2.018E-04 2.885E-03 0.03283082 LOPEZ_MBD_TARGETS heart valve disease DOID_4079 2.695E-05 1.992E-04 0.44830679 0.77533909 LOPEZ_MBD_TARGETS central nervous system cancer DOID_3620 3.025E-05 2.206E-04 0.12190421 0.35754378 LOPEZ_MBD_TARGETS peripheral vascular disease DOID_341 3.051E-05 2.197E-04 0.22220533 0.48442465 LOPEZ_MBD_TARGETS pituitary adenoma DOID_3829 3.129E-05 2.225E-04 0.01498566 0.08975621 LOPEZ_MBD_TARGETS integumentary system benign neoplasm DOID_0060121 3.385E-05 2.378E-04 3.329E-03 0.03642966 LOPEZ_MBD_TARGETS skin benign neoplasm DOID_3165 3.385E-05 2.378E-04 3.329E-03 0.03642966 LOPEZ_MBD_TARGETS basal cell carcinoma DOID_2513 4.054E-05 2.813E-04 9.854E-04 0.01303906 LOPEZ_MBD_TARGETS B-cell lymphocytic neoplasm DOID_707 4.21E-05 2.886E-04 0.02607474 0.12261593 LOPEZ_MBD_TARGETS aneurysm disease DOID_2403 4.279E-05 2.898E-04 0.23963562 0.50129658 LOPEZ_MBD_TARGETS neuroendocrine tumor DOID_169 5.163E-05 3.456E-04 0.01881239 0.0964347 LOPEZ_MBD_TARGETS skin carcinoma DOID_3451 5.163E-05 3.416E-04 1.172E-03 0.01482089 LOPEZ_MBD_TARGETS osteosclerosis DOID_4254 5.163E-05 3.377E-04 5.163E-05 1.728E-03 LOPEZ_MBD_TARGETS bile duct adenocarcinoma DOID_4896 5.741E-05 3.712E-04 0.14591225 0.37738215 LOPEZ_MBD_TARGETS cholangiocarcinoma DOID_4947 5.741E-05 3.712E-04 0.14591225 0.37738215 LOPEZ_MBD_TARGETS bone marrow cancer DOID_4960 5.741E-05 3.671E-04 0.14591225 0.37567454 LOPEZ_MBD_TARGETS chromosomal disease DOID_0080014 5.885E-05 3.721E-04 0.01700316 0.09214093 LOPEZ_MBD_TARGETS reproductive organ benign neoplasm DOID_0050622 6.34E-05 3.964E-04 0.15000395 0.38446959 LOPEZ_MBD_TARGETS Down syndrome DOID_14250 6.479E-05 4.007E-04 0.02086329 0.10322794 LOPEZ_MBD_TARGETS granulosa cell tumor DOID_2999 6.479E-05 3.964E-04 0.20221568 0.46024289 LOPEZ_MBD_TARGETS chronic kidney failure DOID_784 6.856E-05 4.15E-04 0.07981666 0.26873184 LOPEZ_MBD_TARGETS retinal vascular disease DOID_2462 7.955E-05 4.764E-04 0.08423024 0.28027488 LOPEZ_MBD_TARGETS sex cord-gonadal stromal tumor DOID_192 8.023E-05 4.755E-04 0.21164794 0.47042063 LOPEZ_MBD_TARGETS bile duct cancer DOID_4606 8.442E-05 4.952E-04 0.16241102 0.40179075 LOPEZ_MBD_TARGETS bile duct carcinoma DOID_4897 8.442E-05 4.952E-04 0.16241102 0.40179075 LOPEZ_MBD_TARGETS Leigh disease DOID_3652 9.819E-05 5.701E-04 9.819E-05 2.539E-03 LOPEZ_MBD_TARGETS neurotic disorder DOID_4964 1.013E-04 5.821E-04 6.619E-03 0.0553851 LOPEZ_MBD_TARGETS multiple myeloma DOID_9538 1.055E-04 6.001E-04 0.37857953 0.68168276 LOPEZ_MBD_TARGETS congenital heart defect DOID_1682 1.315E-04 7.406E-04 0.04341908 0.17156567 LOPEZ_MBD_TARGETS glycogen metabolism disorder DOID_0050728 1.426E-04 7.954E-04 1.426E-04 3.38E-03 LOPEZ_MBD_TARGETS glycogen storage disease DOID_2747 1.426E-04 7.954E-04 1.426E-04 3.38E-03 LOPEZ_MBD_TARGETS mineral metabolism disease DOID_0050032 1.43E-04 7.897E-04 0.18772412 0.44321588 LOPEZ_MBD_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 1.482E-04 8.106E-04 0.31390737 0.60139155 LOPEZ_MBD_TARGETS adult respiratory distress syndrome DOID_11394 1.499E-04 8.121E-04 0.40037377 0.7096968 LOPEZ_MBD_TARGETS cholestasis DOID_13580 1.552E-04 8.333E-04 0.04675073 0.18096032 LOPEZ_MBD_TARGETS dilated cardiomyopathy DOID_12930 1.581E-04 8.406E-04 0.02823102 0.12954396 LOPEZ_MBD_TARGETS Lewy body dementia DOID_12217 1.695E-04 8.93E-04 0.2482773 0.5137083 LOPEZ_MBD_TARGETS transient cerebral ischemia DOID_224 1.849E-04 9.654E-04 1.000 1.000 LOPEZ_MBD_TARGETS Noonan syndrome DOID_3490 1.849E-04 9.566E-04 1.849E-04 4.047E-03 LOPEZ_MBD_TARGETS Huntington's disease DOID_12858 2.073E-04 1.063E-03 2.121E-03 0.0251462 LOPEZ_MBD_TARGETS primitive neuroectodermal tumor DOID_168 2.073E-04 1.053E-03 2.121E-03 0.02463301 LOPEZ_MBD_TARGETS astrocytoma DOID_3069 2.13E-04 1.072E-03 0.57544313 0.95459807 LOPEZ_MBD_TARGETS gallbladder cancer DOID_3121 2.297E-04 1.147E-03 0.42825094 0.74746867 LOPEZ_MBD_TARGETS blood coagulation disease DOID_1247 2.298E-04 1.137E-03 0.213528 0.47092028 LOPEZ_MBD_TARGETS hypogonadism DOID_1924 2.341E-04 1.148E-03 2.341E-04 4.933E-03 LOPEZ_MBD_TARGETS bile duct disease DOID_4138 2.476E-04 1.204E-03 0.05747255 0.21097986 LOPEZ_MBD_TARGETS breast benign neoplasm DOID_0060082 2.52E-04 1.215E-03 1.000 1.000 LOPEZ_MBD_TARGETS thoracic benign neoplasm DOID_0060097 2.52E-04 1.215E-03 1.000 1.000 LOPEZ_MBD_TARGETS benign breast phyllodes tumor DOID_1631 2.52E-04 1.215E-03 1.000 1.000 LOPEZ_MBD_TARGETS biliary tract disease DOID_9741 2.665E-04 1.274E-03 0.05936313 0.21514409 LOPEZ_MBD_TARGETS myositis DOID_633 2.722E-04 1.291E-03 0.27463045 0.55217218 LOPEZ_MBD_TARGETS diabetic retinopathy DOID_8947 2.864E-04 1.347E-03 0.22655459 0.49202123 LOPEZ_MBD_TARGETS myeloma DOID_0070004 3.082E-04 1.438E-03 0.44830679 0.77770293 LOPEZ_MBD_TARGETS pre-eclampsia DOID_10591 3.082E-04 1.426E-03 0.11800455 0.35339256 LOPEZ_MBD_TARGETS middle cerebral artery infarction DOID_3525 3.146E-04 1.444E-03 4.312E-03 0.04460777 LOPEZ_MBD_TARGETS dystonia DOID_543 3.146E-04 1.432E-03 4.312E-03 0.04304259 LOPEZ_MBD_TARGETS endogenous depression DOID_1595 3.299E-04 1.49E-03 0.01381448 0.08637845 LOPEZ_MBD_TARGETS mucopolysaccharidosis DOID_12798 3.331E-04 1.492E-03 3.331E-04 6.318E-03 LOPEZ_MBD_TARGETS intracranial arteriosclerosis DOID_13097 3.331E-04 1.481E-03 1.000 1.000 LOPEZ_MBD_TARGETS osteopetrosis DOID_13533 3.331E-04 1.469E-03 3.331E-04 6.114E-03 LOPEZ_MBD_TARGETS epidermolysis bullosa DOID_2730 3.331E-04 1.458E-03 8.503E-03 0.06719594 LOPEZ_MBD_TARGETS aortic valve insufficiency DOID_57 3.331E-04 1.447E-03 1.000 1.000 LOPEZ_MBD_TARGETS peritonitis DOID_8283 3.331E-04 1.436E-03 0.13296086 0.36725597 LOPEZ_MBD_TARGETS Hodgkin's lymphoma DOID_8567 3.331E-04 1.425E-03 1.000 1.000 LOPEZ_MBD_TARGETS vascular dementia DOID_8725 3.331E-04 1.481E-03 1.000 1.000 LOPEZ_MBD_TARGETS ocular hypertension DOID_9282 3.331E-04 1.415E-03 1.000 1.000 LOPEZ_MBD_TARGETS borderline glaucoma DOID_9283 3.331E-04 1.415E-03 1.000 1.000 LOPEZ_MBD_TARGETS diffuse large B-cell lymphoma DOID_0050745 3.616E-04 1.524E-03 4.768E-03 0.04597924 LOPEZ_MBD_TARGETS glaucoma DOID_1686 3.709E-04 1.552E-03 1.000 1.000 LOPEZ_MBD_TARGETS pancreatitis DOID_4989 3.784E-04 1.572E-03 0.01503996 0.0882241 LOPEZ_MBD_TARGETS bacterial pneumonia DOID_874 3.784E-04 1.56E-03 0.24400461 0.50856639 LOPEZ_MBD_TARGETS calcium metabolism disease DOID_10575 4.056E-04 1.66E-03 0.12979566 0.37299864 LOPEZ_MBD_TARGETS aortic aneurysm DOID_3627 4.056E-04 1.648E-03 0.46766062 0.8015027 LOPEZ_MBD_TARGETS movement disease DOID_480 4.056E-04 1.637E-03 0.02483825 0.11876441 LOPEZ_MBD_TARGETS sarcoma DOID_1115 4.134E-04 1.656E-03 1.000 1.000 LOPEZ_MBD_TARGETS invasive ductal carcinoma DOID_3008 4.134E-04 1.645E-03 0.04876156 0.18746845 LOPEZ_MBD_TARGETS carotid stenosis DOID_13001 4.293E-04 1.696E-03 0.14321004 0.37551388 LOPEZ_MBD_TARGETS vesiculobullous skin disease DOID_2731 4.293E-04 1.684E-03 9.971E-03 0.07181461 LOPEZ_MBD_TARGETS hemorrhagic disease DOID_2213 4.427E-04 1.725E-03 0.47396017 0.80743513 LOPEZ_MBD_TARGETS polycystic ovary syndrome DOID_11612 4.702E-04 1.82E-03 5.764E-03 0.05289591 LOPEZ_MBD_TARGETS multiple epiphyseal dysplasia DOID_12721 4.702E-04 1.808E-03 5.764E-03 0.05124292 LOPEZ_MBD_TARGETS dystonic disease DOID_544 4.702E-04 1.796E-03 0.05172693 0.19491805 LOPEZ_MBD_TARGETS mental depression DOID_1596 5.242E-04 1.989E-03 0.01839674 0.09603434 LOPEZ_MBD_TARGETS giant cell tumor DOID_200 5.244E-04 1.976E-03 0.48633698 0.82604699 LOPEZ_MBD_TARGETS malignant giant cell tumor DOID_2705 5.244E-04 1.976E-03 0.48633698 0.82604699 LOPEZ_MBD_TARGETS giant cell glioblastoma DOID_3074 5.244E-04 1.976E-03 0.48633698 0.82604699 LOPEZ_MBD_TARGETS female reproductive organ benign neoplasm DOID_0060086 5.324E-04 1.993E-03 0.3165197 0.60234017 LOPEZ_MBD_TARGETS uterine benign neoplasm DOID_0060095 5.324E-04 1.993E-03 0.3165197 0.60234017 LOPEZ_MBD_TARGETS uterine fibroid DOID_13223 5.324E-04 1.993E-03 0.3165197 0.60234017 LOPEZ_MBD_TARGETS parasitic helminthiasis infectious disease DOID_883 5.415E-04 2.014E-03 0.15333833 0.38605977 LOPEZ_MBD_TARGETS polycystic kidney disease DOID_898 5.415E-04 2.001E-03 5.415E-04 8.559E-03 LOPEZ_MBD_TARGETS gonadal disease DOID_2277 6.002E-04 2.203E-03 6.002E-04 9.23E-03 LOPEZ_MBD_TARGETS abdominal aortic aneurysm DOID_7693 6.002E-04 2.189E-03 0.32460331 0.6095686 LOPEZ_MBD_TARGETS parasitic protozoa infectious disease DOID_2789 6.171E-04 2.236E-03 0.49842322 0.84155137 LOPEZ_MBD_TARGETS mitochondrial metabolism disease DOID_700 6.677E-04 2.405E-03 6.677E-04 9.998E-03 LOPEZ_MBD_TARGETS thoracic aortic aneurysm DOID_14004 6.71E-04 2.401E-03 1.000 1.000 LOPEZ_MBD_TARGETS membranoproliferative glomerulonephritis DOID_2920 6.71E-04 2.386E-03 0.01321478 0.08448552 LOPEZ_MBD_TARGETS arthropathy DOID_381 6.71E-04 2.371E-03 0.01321478 0.08354679 LOPEZ_MBD_TARGETS allergic rhinitis DOID_4481 6.739E-04 2.367E-03 0.33259153 0.62251507 LOPEZ_MBD_TARGETS congenital nervous system abnormality DOID_2490 7.214E-04 2.518E-03 7.214E-04 0.01001223 LOPEZ_MBD_TARGETS amino acid metabolic disorder DOID_9252 7.53E-04 2.613E-03 4.563E-03 0.04476112 LOPEZ_MBD_TARGETS leiomyoma DOID_127 7.538E-04 2.6E-03 0.34048548 0.63312496 LOPEZ_MBD_TARGETS glioblastoma DOID_3068 7.783E-04 2.668E-03 0.51602261 0.86357901 LOPEZ_MBD_TARGETS Human immunodeficiency virus infectious disease DOID_526 7.976E-04 2.718E-03 0.29649331 0.58782123 LOPEZ_MBD_TARGETS chronic myeloid leukemia DOID_8552 8.186E-04 2.773E-03 0.17323792 0.41243672 LOPEZ_MBD_TARGETS tongue cancer DOID_8649 8.186E-04 2.756E-03 0.01498566 0.08882125 LOPEZ_MBD_TARGETS melancholia DOID_2848 8.385E-04 2.806E-03 0.03712882 0.16126946 LOPEZ_MBD_TARGETS myocarditis DOID_820 8.402E-04 2.796E-03 8.766E-03 0.06740446 LOPEZ_MBD_TARGETS macular degeneration DOID_4448 9.333E-04 3.088E-03 0.07077236 0.24705197 LOPEZ_MBD_TARGETS carbohydrate metabolic disorder DOID_2978 9.438E-04 3.104E-03 9.438E-04 0.01278636 LOPEZ_MBD_TARGETS lymphatic system cancer DOID_0060073 9.854E-04 3.222E-03 0.01685236 0.09588995 LOPEZ_MBD_TARGETS drug-induced mental disorder DOID_1203 9.854E-04 3.204E-03 0.01685236 0.09400975 LOPEZ_MBD_TARGETS drug psychosis DOID_1742 9.854E-04 3.204E-03 0.01685236 0.09400975 LOPEZ_MBD_TARGETS urinary system benign neoplasm DOID_731 9.854E-04 3.186E-03 0.01685236 0.09220187 LOPEZ_MBD_TARGETS reticulosarcoma DOID_8538 9.854E-04 3.222E-03 0.01685236 0.09588995 LOPEZ_MBD_TARGETS substance-induced psychosis DOID_8646 9.854E-04 3.204E-03 0.01685236 0.09400975 LOPEZ_MBD_TARGETS lymphosarcoma DOID_8675 9.854E-04 3.222E-03 0.01685236 0.09588995 LOPEZ_MBD_TARGETS Crohn's disease DOID_8778 9.969E-04 3.205E-03 0.02731309 0.12738647 LOPEZ_MBD_TARGETS medullomyoblastoma DOID_3861 1.033E-03 3.304E-03 0.0101793 0.07150647 LOPEZ_MBD_TARGETS adult medulloblastoma DOID_3864 1.033E-03 3.304E-03 0.0101793 0.07150647 LOPEZ_MBD_TARGETS childhood medulloblastoma DOID_3869 1.033E-03 3.304E-03 0.0101793 0.07150647 LOPEZ_MBD_TARGETS prion disease DOID_649 1.172E-03 3.726E-03 1.000 1.000 LOPEZ_MBD_TARGETS ulcerative colitis DOID_8577 1.232E-03 3.895E-03 0.03109404 0.13931111 LOPEZ_MBD_TARGETS medulloblastoma DOID_3858 1.256E-03 3.948E-03 0.01171708 0.07843554 LOPEZ_MBD_TARGETS hyperglycemia DOID_4195 1.361E-03 4.256E-03 9.091E-03 0.06806492 LOPEZ_MBD_TARGETS blood platelet disease DOID_2218 1.379E-03 4.287E-03 0.38593071 0.69054897 LOPEZ_MBD_TARGETS infertility DOID_5223 1.38E-03 4.267E-03 0.02086329 0.10233805 LOPEZ_MBD_TARGETS psoriasis DOID_8893 1.38E-03 4.244E-03 0.02086329 0.10146336 LOPEZ_MBD_TARGETS allergic contact dermatitis DOID_3042 1.452E-03 4.442E-03 1.452E-03 0.01757908 LOPEZ_MBD_TARGETS brain infarction DOID_3454 1.547E-03 4.708E-03 0.01003229 0.07135469 LOPEZ_MBD_TARGETS male reproductive system disease DOID_48 1.86E-03 5.629E-03 0.0115585 0.07829506 LOPEZ_MBD_TARGETS rheumatic disease DOID_1575 2.121E-03 6.386E-03 0.42140529 0.74006053 LOPEZ_MBD_TARGETS scleroderma DOID_419 2.121E-03 6.386E-03 0.42140529 0.74006053 LOPEZ_MBD_TARGETS muscular atrophy DOID_767 2.136E-03 6.397E-03 0.23017997 0.49237745 LOPEZ_MBD_TARGETS syndrome DOID_225 2.346E-03 6.988E-03 0.01381448 0.08543956 LOPEZ_MBD_TARGETS pulmonary embolism DOID_9477 2.435E-03 7.216E-03 0.23928233 0.50426535 LOPEZ_MBD_TARGETS hypoglycemia DOID_9993 2.435E-03 7.179E-03 1.000 1.000 LOPEZ_MBD_TARGETS cerebral infarction DOID_3526 2.483E-03 7.283E-03 0.01914379 0.09725731 LOPEZ_MBD_TARGETS learning disability DOID_8927 2.483E-03 7.245E-03 0.01914379 0.09639663 LOPEZ_MBD_TARGETS diabetic angiopathy DOID_11713 2.759E-03 8.008E-03 1.000 1.000 LOPEZ_MBD_TARGETS vascular skin disease DOID_9540 2.885E-03 8.333E-03 0.11800455 0.34789941 LOPEZ_MBD_TARGETS contact dermatitis DOID_2773 2.918E-03 8.384E-03 2.918E-03 0.0325511 LOPEZ_MBD_TARGETS lipid metabolism disorder DOID_3146 2.918E-03 8.342E-03 0.07339295 0.25309446 LOPEZ_MBD_TARGETS spinal muscular atrophy DOID_12377 3.884E-03 0.01104871 0.04026151 0.16721751 LOPEZ_MBD_TARGETS cleft lip DOID_9296 3.884E-03 0.01099374 0.04026151 0.16247375 LOPEZ_MBD_TARGETS orofacial cleft DOID_0050567 4.08E-03 0.01149144 0.13780158 0.37516315 LOPEZ_MBD_TARGETS atopic dermatitis DOID_3310 4.08E-03 0.01143483 0.13780158 0.37337666 LOPEZ_MBD_TARGETS intracranial aneurysm DOID_10941 4.312E-03 0.0120266 0.04302687 0.17241049 LOPEZ_MBD_TARGETS fragments of torsion dystonia DOID_531 4.312E-03 0.01196794 0.04302687 0.17120482 LOPEZ_MBD_TARGETS sarcoidosis DOID_11335 4.353E-03 0.01202367 0.14184441 0.38250934 LOPEZ_MBD_TARGETS primary immunodeficiency disease DOID_612 4.563E-03 0.01254176 0.29212834 0.5811924 LOPEZ_MBD_TARGETS periodontitis DOID_824 4.768E-03 0.01304219 0.29168506 0.58234666 LOPEZ_MBD_TARGETS perinatal necrotizing enterocolitis DOID_8677 4.768E-03 0.01297979 4.768E-03 0.04521292 LOPEZ_MBD_TARGETS malaria DOID_12365 5.251E-03 0.01422887 0.30006173 0.59077898 LOPEZ_MBD_TARGETS thrombocytopenia DOID_1588 5.251E-03 0.01416143 0.30006173 0.58874181 LOPEZ_MBD_TARGETS mononeuritis DOID_1802 5.251E-03 0.01409463 5.251E-03 0.04898462 LOPEZ_MBD_TARGETS central nervous system hereditary degenerative disease DOID_481 5.251E-03 0.01402846 0.04876156 0.18621027 LOPEZ_MBD_TARGETS lymphoblastic leukemia DOID_1037 5.472E-03 0.01454881 0.67720117 1.000 LOPEZ_MBD_TARGETS mouth disease DOID_403 5.718E-03 0.01513185 0.31390737 0.59937346 LOPEZ_MBD_TARGETS autoimmune disease of endocrine system DOID_0060005 5.764E-03 0.01518309 0.30833956 0.60083975 LOPEZ_MBD_TARGETS mononeuropathy DOID_1188 5.764E-03 0.01511312 5.764E-03 0.0520563 LOPEZ_MBD_TARGETS supratentorial cancer DOID_1659 5.764E-03 0.01504379 0.30833956 0.5987891 LOPEZ_MBD_TARGETS toxic encephalopathy DOID_3602 5.764E-03 0.0149751 0.30833956 0.59675241 LOPEZ_MBD_TARGETS cerebrum cancer DOID_368 5.764E-03 0.01504379 0.30833956 0.5987891 LOPEZ_MBD_TARGETS gout DOID_13189 5.889E-03 0.01523014 5.889E-03 0.05154818 LOPEZ_MBD_TARGETS hyperparathyroidism DOID_13543 5.889E-03 0.01516123 0.11209407 0.35434182 LOPEZ_MBD_TARGETS familial combined hyperlipidemia DOID_13809 5.889E-03 0.01509294 1.000 1.000 LOPEZ_MBD_TARGETS childhood type dermatomyositis DOID_14203 5.889E-03 0.01502525 1.000 1.000 LOPEZ_MBD_TARGETS acute kidney failure DOID_3021 5.889E-03 0.01495818 0.11209407 0.34853294 LOPEZ_MBD_TARGETS teratoma DOID_3307 5.889E-03 0.0148917 1.000 1.000 LOPEZ_MBD_TARGETS insulinoma DOID_3892 5.889E-03 0.0148258 1.000 1.000 LOPEZ_MBD_TARGETS malignant teratoma DOID_5563 5.889E-03 0.0148917 1.000 1.000 LOPEZ_MBD_TARGETS mature teratoma DOID_5566 5.889E-03 0.0148917 1.000 1.000 LOPEZ_MBD_TARGETS polycythemia DOID_8432 5.889E-03 0.01476049 0.11209407 0.34107769 LOPEZ_MBD_TARGETS Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 5.889E-03 0.01469575 1.000 1.000 LOPEZ_MBD_TARGETS Hodgkin's lymphoma, lymphocytic depletion DOID_8628 5.889E-03 0.01469575 1.000 1.000 LOPEZ_MBD_TARGETS Hodgkin's granuloma DOID_8651 5.889E-03 0.01469575 1.000 1.000 LOPEZ_MBD_TARGETS Hodgkin's lymphoma, mixed cellularity DOID_8654 5.889E-03 0.01469575 1.000 1.000 LOPEZ_MBD_TARGETS hypersensitivity reaction type IV disease DOID_2916 5.906E-03 0.01467588 0.16241102 0.40354529 LOPEZ_MBD_TARGETS leukocyte disease DOID_9500 6.256E-03 0.01547674 0.03712882 0.16004772 LOPEZ_MBD_TARGETS age related macular degeneration DOID_10871 6.875E-03 0.01693537 0.05784409 0.2109826 LOPEZ_MBD_TARGETS degeneration of macula and posterior pole DOID_2007 6.875E-03 0.01693537 0.05784409 0.2109826 LOPEZ_MBD_TARGETS collagen disease DOID_854 6.996E-03 0.01715735 0.5330058 0.88938504 LOPEZ_MBD_TARGETS dermatomyositis DOID_10223 7.141E-03 0.01743926 1.000 1.000 LOPEZ_MBD_TARGETS invasive lobular carcinoma DOID_3457 7.141E-03 0.01736473 0.12258936 0.35407789 LOPEZ_MBD_TARGETS pleural disease DOID_1532 8.106E-03 0.01962599 1.000 1.000 LOPEZ_MBD_TARGETS diarrhea DOID_13250 8.503E-03 0.02050046 8.503E-03 0.06814236 LOPEZ_MBD_TARGETS porphyria DOID_13268 8.503E-03 0.02041396 0.13296086 0.37639169 LOPEZ_MBD_TARGETS aortic valve stenosis DOID_1712 8.503E-03 0.02032818 0.13296086 0.37452837 LOPEZ_MBD_TARGETS pituitary cancer DOID_1785 8.503E-03 0.02024313 0.13296086 0.3726834 LOPEZ_MBD_TARGETS islet cell tumor DOID_1799 8.503E-03 0.02015878 1.000 1.000 LOPEZ_MBD_TARGETS pituitary carcinoma DOID_4916 8.503E-03 0.02024313 0.13296086 0.3726834 LOPEZ_MBD_TARGETS temporal lobe epilepsy DOID_3328 9.091E-03 0.02146446 9.091E-03 0.06897245 LOPEZ_MBD_TARGETS male infertility DOID_12336 9.457E-03 0.02223629 9.457E-03 0.0698855 LOPEZ_MBD_TARGETS periodontal disease DOID_3388 9.457E-03 0.02214479 0.35599498 0.65342305 LOPEZ_MBD_TARGETS leukopenia DOID_615 9.457E-03 0.02205403 0.07077236 0.24554555 LOPEZ_MBD_TARGETS hyperthyroidism DOID_7998 9.457E-03 0.02196401 1.000 1.000 LOPEZ_MBD_TARGETS tooth disease DOID_1091 9.554E-03 0.02209907 0.20057698 0.4620579 LOPEZ_MBD_TARGETS nicotine dependence DOID_0050742 9.971E-03 0.02296905 0.14321004 0.38077809 LOPEZ_MBD_TARGETS parathyroid gland disease DOID_11201 9.971E-03 0.02287643 0.14321004 0.37725237 LOPEZ_MBD_TARGETS vulva cancer DOID_1245 9.971E-03 0.02278456 9.971E-03 0.07273531 LOPEZ_MBD_TARGETS hypercalcemia DOID_12678 0.01154228 0.02627023 0.01154228 0.07912719 LOPEZ_MBD_TARGETS pulmonary sarcoidosis DOID_13406 0.01171708 0.02656184 0.37857953 0.68384683 LOPEZ_MBD_TARGETS calcinosis DOID_182 0.01171708 0.02645643 1.000 1.000 LOPEZ_MBD_TARGETS cleft palate DOID_674 0.01171708 0.02635186 0.08102035 0.27117987 LOPEZ_MBD_TARGETS microcephaly DOID_10907 0.01253326 0.02807647 0.01253326 0.08197038 LOPEZ_MBD_TARGETS peripheral nervous system neoplasm DOID_1192 0.01253326 0.02796636 0.08453251 0.27964532 LOPEZ_MBD_TARGETS uveitis DOID_13141 0.01253326 0.02785712 0.38593071 0.69272735 LOPEZ_MBD_TARGETS idiopathic pulmonary fibrosis DOID_0050156 0.01321478 0.02925763 1.000 1.000 LOPEZ_MBD_TARGETS peripheral neuropathy DOID_0060053 0.01321478 0.02914423 0.01321478 0.08544558 LOPEZ_MBD_TARGETS skeletal system cancer DOID_0060124 0.01321478 0.0290317 1.000 1.000 LOPEZ_MBD_TARGETS bone cancer DOID_184 0.01321478 0.0290317 1.000 1.000 LOPEZ_MBD_TARGETS lung oat cell carcinoma DOID_5411 0.01321478 0.02892004 1.000 1.000 LOPEZ_MBD_TARGETS oral submucous fibrosis DOID_5773 0.01321478 0.02880924 1.000 1.000 LOPEZ_MBD_TARGETS varicose veins DOID_799 0.01321478 0.02869928 1.000 1.000 LOPEZ_MBD_TARGETS intermediate coronary syndrome DOID_8805 0.01321478 0.02859016 1.000 1.000 LOPEZ_MBD_TARGETS respiratory syncytial virus infectious disease DOID_1273 0.0133812 0.02884054 1.000 1.000 LOPEZ_MBD_TARGETS hepatitis DOID_2237 0.0133812 0.02873171 0.39319511 0.70134175 LOPEZ_MBD_TARGETS congenital diaphragmatic hernia DOID_3827 0.0133812 0.0286237 0.08809007 0.28972977 LOPEZ_MBD_TARGETS systemic scleroderma DOID_418 0.0133812 0.02851649 0.39319511 0.69915006 LOPEZ_MBD_TARGETS cystic fibrosis DOID_1485 0.01381448 0.02933 0.60472587 1.000 LOPEZ_MBD_TARGETS lymphatic system disease DOID_75 0.01426108 0.03016563 0.40037377 0.70749278 LOPEZ_MBD_TARGETS angiosarcoma DOID_0001816 0.01498566 0.03158089 1.000 1.000 LOPEZ_MBD_TARGETS hemolytic-uremic syndrome DOID_12554 0.01498566 0.03146435 1.000 1.000 LOPEZ_MBD_TARGETS Fanconi's anemia DOID_13636 0.01498566 0.03134868 0.01498566 0.09071107 LOPEZ_MBD_TARGETS thyroiditis DOID_7166 0.01498566 0.03123385 0.17323792 0.41416965 LOPEZ_MBD_TARGETS autoimmune thyroiditis DOID_7188 0.01498566 0.03123385 0.17323792 0.41416965 LOPEZ_MBD_TARGETS vein disease DOID_866 0.01498566 0.03111985 1.000 1.000 LOPEZ_MBD_TARGETS autoimmune disease of urogenital tract DOID_0060049 0.01611719 0.03334794 0.01611719 0.09263316 LOPEZ_MBD_TARGETS primary biliary cirrhosis DOID_12236 0.01611719 0.03334794 0.01611719 0.09263316 LOPEZ_MBD_TARGETS spinocerebellar ataxia DOID_1441 0.01611719 0.03322711 0.09901978 0.32012645 LOPEZ_MBD_TARGETS metabolic syndrome X DOID_14221 0.01633192 0.03354825 0.25275134 0.51918958 LOPEZ_MBD_TARGETS schizophreniform disorder DOID_11328 0.01685236 0.03449279 0.01685236 0.09494054 LOPEZ_MBD_TARGETS hyperostosis DOID_205 0.01685236 0.03436916 0.01685236 0.09309704 LOPEZ_MBD_TARGETS schizoaffective disorder DOID_5418 0.01685236 0.03449279 0.01685236 0.09494054 LOPEZ_MBD_TARGETS nephrotic syndrome DOID_1184 0.01709365 0.03473674 0.42140529 0.74235174 LOPEZ_MBD_TARGETS idiopathic generalized epilepsy DOID_1827 0.01709365 0.03461312 0.01709365 0.09175743 LOPEZ_MBD_TARGETS hyperinsulinism DOID_2018 0.01709365 0.03449038 0.01709365 0.09089988 LOPEZ_MBD_TARGETS uveal disease DOID_3480 0.01709365 0.03436851 0.42140529 0.73778342 LOPEZ_MBD_TARGETS auditory system disease DOID_2742 0.01769139 0.03544508 0.0776489 0.26456422 LOPEZ_MBD_TARGETS alcohol abuse DOID_1574 0.01839674 0.03672892 0.2658833 0.54031285 LOPEZ_MBD_TARGETS focal epilepsy DOID_2234 0.01839674 0.0366005 0.01839674 0.0951613 LOPEZ_MBD_TARGETS male reproductive organ benign neoplasm DOID_0060087 0.01881239 0.03729704 0.19267082 0.45115101 LOPEZ_MBD_TARGETS spinocerebellar degeneration DOID_2478 0.0202176 0.03994379 0.11413732 0.34544753 LOPEZ_MBD_TARGETS microphthalmia DOID_10629 0.02300265 0.04528895 0.21164794 0.47788762 LOPEZ_MBD_TARGETS pulmonary edema DOID_11396 0.02300265 0.04513278 1.000 1.000 LOPEZ_MBD_TARGETS colon carcinoma DOID_1520 0.02300265 0.04497769 0.21164794 0.47226541 LOPEZ_MBD_TARGETS amyloidosis DOID_9120 0.02300265 0.04482366 0.02300265 0.11091956 LOPEZ_MBD_TARGETS pulmonary tuberculosis DOID_2957 0.02363427 0.04589727 0.46128581 0.79296564 LOPEZ_MBD_TARGETS Kawasaki disease DOID_13378 0.0252281 0.04882581 1.000 1.000 LOPEZ_MBD_TARGETS lymphadenitis DOID_1602 0.0252281 0.04882581 1.000 1.000 LOPEZ_MBD_TARGETS autoimmune hepatitis DOID_2048 0.0252281 0.0486603 0.22096894 0.48544913 LOPEZ_MBD_TARGETS lymph node disease DOID_9942 0.0252281 0.04882581 1.000 1.000 LOPEZ_MBD_TARGETS funisitis DOID_0050698 0.02753731 0.0529349 0.02753731 0.12738805 LOPEZ_MBD_TARGETS hepatitis B DOID_2043 0.02753731 0.05275667 0.23017997 0.49610758 LOPEZ_MBD_TARGETS acquired immunodeficiency syndrome DOID_635 0.02753731 0.05257963 0.23017997 0.49423547 LOPEZ_MBD_TARGETS placenta disease DOID_780 0.02753731 0.05240378 1.000 1.000 LOPEZ_MBD_TARGETS agranulocytosis DOID_12987 0.02992801 0.05676346 0.02992801 0.13623232 LOPEZ_MBD_TARGETS muscle cancer DOID_4045 0.02992801 0.05657488 0.23928233 0.50613994 LOPEZ_MBD_TARGETS polyarteritis nodosa DOID_9810 0.02992801 0.05638755 1.000 1.000 LOPEZ_MBD_TARGETS lingual-facial-buccal dyskinesia DOID_9854 0.02992801 0.05620145 0.23928233 0.50240459 LOPEZ_MBD_TARGETS smallpox DOID_8736 0.03134469 0.05866818 0.15000395 0.38274551 LOPEZ_MBD_TARGETS Goodpasture syndrome DOID_9808 0.03239796 0.06044079 1.000 1.000 LOPEZ_MBD_TARGETS familial hyperlipidemia DOID_1168 0.03274278 0.06088445 0.50435951 0.84905491 LOPEZ_MBD_TARGETS spastic quadriplegia DOID_10970 0.03494496 0.06476769 0.25716615 0.52635805 LOPEZ_MBD_TARGETS toxic shock syndrome DOID_14115 0.03494496 0.06455741 1.000 1.000 LOPEZ_MBD_TARGETS sphingolipidosis DOID_1927 0.03494496 0.06434848 0.03494496 0.15413706 LOPEZ_MBD_TARGETS severe combined immunodeficiency DOID_627 0.03494496 0.06414091 1.000 1.000 LOPEZ_MBD_TARGETS commensal bacterial infectious disease DOID_0050339 0.03756685 0.06873163 1.000 1.000 LOPEZ_MBD_TARGETS X-linked disease DOID_0050735 0.03756685 0.06851133 0.03756685 0.16071831 LOPEZ_MBD_TARGETS organic acidemia DOID_0060159 0.03756685 0.06829245 0.26595012 0.53852533 LOPEZ_MBD_TARGETS reading disorder DOID_13365 0.03756685 0.06807495 0.03756685 0.15951892 LOPEZ_MBD_TARGETS urticaria DOID_1555 0.03756685 0.06785884 0.03756685 0.1583373 LOPEZ_MBD_TARGETS dyslexia DOID_4428 0.03756685 0.06807495 0.03756685 0.15951892 LOPEZ_MBD_TARGETS combined T cell and B cell immunodeficiency DOID_628 0.03756685 0.0676441 1.000 1.000 LOPEZ_MBD_TARGETS autosomal dominant nonsyndromic deafness DOID_0050564 0.04026151 0.0722675 0.04026151 0.16844705 LOPEZ_MBD_TARGETS morbid obesity DOID_11981 0.04026151 0.07204025 0.27463045 0.55413024 LOPEZ_MBD_TARGETS infantile epileptic encephalopathy DOID_2481 0.04026151 0.07181442 0.04026151 0.16600579 LOPEZ_MBD_TARGETS extrinsic allergic alveolitis DOID_841 0.04302687 0.07650715 1.000 1.000 LOPEZ_MBD_TARGETS Sciatic Neuropathy DOID_11446 0.04586089 0.08129235 0.04586089 0.17873182 LOPEZ_MBD_TARGETS lesion of sciatic nerve DOID_12528 0.04586089 0.08129235 0.04586089 0.17873182 LOPEZ_MBD_TARGETS mononeuritis of lower limb DOID_9473 0.04586089 0.08129235 0.04586089 0.17873182 LOPEZ_MBD_TARGETS uterine disease DOID_345 0.04675073 0.08261232 1.000 1.000 LOPEZ_MBD_TARGETS pleurisy DOID_10247 0.04876156 0.08589886 1.000 1.000 LOPEZ_MBD_TARGETS renal hypertension DOID_1073 0.04876156 0.08563374 1.000 1.000 LOPEZ_MBD_TARGETS secondary hypertension DOID_11130 0.04876156 0.08563374 1.000 1.000 LOPEZ_MBD_TARGETS coronary stenosis DOID_4248 0.04876156 0.08537025 0.30006173 0.58671864 LOPEZ_MBD_TARGETS corneal disease DOID_10124 0.05475507 0.09556943 0.3165197 0.60033236 LOPEZ_MBD_TARGETS dysostosis DOID_1934 0.05475507 0.09527717 0.05475507 0.20497129 DAIRKEE_CANCER_PRONE_RESPONSE_E2 dilated cardiomyopathy DOID_12930 1.076E-05 6.121E-03 1.076E-05 6.121E-03 DAIRKEE_CANCER_PRONE_RESPONSE_E2 familial hypertrophic cardiomyopathy DOID_11986 2.564E-05 7.294E-03 2.564E-05 7.294E-03 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP multiple myeloma DOID_9538 6.863E-14 3.905E-11 2.474E-04 0.04692515 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP myeloma DOID_0070004 2.831E-13 8.054E-11 3.872E-04 0.05507851 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP bone marrow cancer DOID_4960 6.449E-13 1.223E-10 5.032E-04 0.05726653 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP medullomyoblastoma DOID_3861 6.194E-09 8.811E-07 0.02182709 0.73056546 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP adult medulloblastoma DOID_3864 6.194E-09 8.811E-07 0.02182709 0.73056546 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP childhood medulloblastoma DOID_3869 6.194E-09 8.811E-07 0.02182709 0.73056546 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP medulloblastoma DOID_3858 7.663E-09 8.72E-07 0.02296319 0.725892 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP embryonal cancer DOID_688 7.663E-09 7.267E-07 0.02296319 0.68768716 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP cervix uteri carcinoma in situ DOID_8991 1.137E-08 9.238E-07 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP primitive neuroectodermal tumor DOID_168 1.365E-08 9.71E-07 0.02636395 0.65222125 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP vulva cancer DOID_1245 4.832E-08 3.055E-06 4.832E-08 2.75E-05 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP neuroectodermal tumor DOID_171 5.279E-08 3.004E-06 0.03649857 0.71612714 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP pre-malignant neoplasm DOID_0060071 5.984E-08 3.095E-06 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP in situ carcinoma DOID_8719 5.984E-08 3.095E-06 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP lymphoma DOID_0060058 2.505E-07 1.188E-05 0.0531662 0.94536148 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP nephroblastoma DOID_2154 1.301E-06 5.694E-05 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP B-cell lymphocytic neoplasm DOID_707 4.127E-06 1.677E-04 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP reproductive organ benign neoplasm DOID_0050622 5.126E-06 1.944E-04 0.03313161 0.69821792 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP transitional cell carcinoma DOID_2671 1.928E-05 6.857E-04 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP diffuse large B-cell lymphoma DOID_0050745 1.293E-04 4.327E-03 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP sarcoma DOID_1115 1.385E-04 4.377E-03 0.01727005 0.70190408 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP invasive ductal carcinoma DOID_3008 1.385E-04 4.147E-03 1.385E-04 0.03939292 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP primary immunodeficiency disease DOID_612 1.276E-03 0.03629749 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP nervous system cancer DOID_3093 1.304E-03 0.03532484 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP lymphoblastic leukemia DOID_1037 1.389E-03 0.03592872 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.418E-03 0.03508549 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS Lynch syndrome DOID_3883 2.643E-09 1.504E-06 3.902E-06 2.22E-03 TURJANSKI_MAPK1_AND_MAPK2_TARGETS angiosarcoma DOID_0001816 6.001E-06 1.707E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS tongue cancer DOID_8649 6.001E-06 1.138E-03 3.792E-03 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS sarcoma DOID_1115 2.172E-05 3.089E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS autonomic nervous system neoplasm DOID_2621 2.969E-05 3.378E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS neuroblastoma DOID_769 2.969E-05 3.378E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS peripheral nervous system neoplasm DOID_1192 4.088E-05 3.877E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS intracranial arterial disease DOID_13089 4.501E-05 3.659E-03 0.010163 0.64252714 TURJANSKI_MAPK1_AND_MAPK2_TARGETS cerebral arterial disease DOID_3527 4.501E-05 3.659E-03 0.010163 0.64252714 TURJANSKI_MAPK1_AND_MAPK2_TARGETS integumentary system benign neoplasm DOID_0060121 6.602E-05 4.696E-03 0.01227848 0.58220446 TURJANSKI_MAPK1_AND_MAPK2_TARGETS skin benign neoplasm DOID_3165 6.602E-05 4.696E-03 0.01227848 0.58220446 TURJANSKI_MAPK1_AND_MAPK2_TARGETS bile duct adenocarcinoma DOID_4896 7.942E-05 5.021E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS cholangiocarcinoma DOID_4947 7.942E-05 5.021E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS integumentary system cancer DOID_0060122 8.224E-05 4.68E-03 0.01368656 0.51917703 TURJANSKI_MAPK1_AND_MAPK2_TARGETS skin cancer DOID_4159 8.224E-05 4.68E-03 0.01368656 0.51917703 TURJANSKI_MAPK1_AND_MAPK2_TARGETS hypertrophic cardiomyopathy DOID_11984 9.101E-05 4.708E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS bile duct cancer DOID_4606 9.101E-05 4.316E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS bile duct carcinoma DOID_4897 9.101E-05 4.316E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS oral cavity cancer DOID_8618 9.101E-05 3.984E-03 0.01438994 0.51174222 TURJANSKI_MAPK1_AND_MAPK2_TARGETS astrocytoma DOID_3069 1.269E-04 5.16E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS biliary tract cancer DOID_4607 1.77E-04 6.715E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS transitional cell carcinoma DOID_2671 1.985E-04 7.058E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS nervous system cancer DOID_3093 2.074E-04 6.942E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS lymphoma DOID_0060058 2.165E-04 6.844E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS lymphoblastic leukemia DOID_1037 2.211E-04 6.622E-03 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS brachydactyly DOID_0050581 2.372E-03 0.06747566 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS familial adenomatous polyposis DOID_0050424 2.609E-03 0.07068133 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS breast benign neoplasm DOID_0060082 2.609E-03 0.06746854 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS thoracic benign neoplasm DOID_0060097 2.609E-03 0.06746854 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS benign breast phyllodes tumor DOID_1631 2.609E-03 0.06746854 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS intracranial arteriosclerosis DOID_13097 2.845E-03 0.07039453 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS vascular dementia DOID_8725 2.845E-03 0.07039453 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS vulva cancer DOID_1245 3.082E-03 0.0730755 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS mesenchymal cell neoplasm DOID_3350 3.556E-03 0.08092809 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS spindle cell sarcoma DOID_4235 3.556E-03 0.08092809 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS lung oat cell carcinoma DOID_5411 3.556E-03 0.07781547 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS epithelioid sarcoma DOID_6193 3.556E-03 0.08092809 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS basal cell carcinoma DOID_2513 4.029E-03 0.08490662 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS male reproductive organ benign neoplasm DOID_0060087 4.266E-03 0.08668123 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS keratosis DOID_161 4.266E-03 0.08369222 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS skin carcinoma DOID_3451 4.266E-03 0.08090248 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS testicular cancer DOID_2998 4.502E-03 0.0826336 4.502E-03 0.85388058 TURJANSKI_MAPK1_AND_MAPK2_TARGETS granulosa cell tumor DOID_2999 4.502E-03 0.0800513 4.502E-03 0.64041043 TURJANSKI_MAPK1_AND_MAPK2_TARGETS infertility DOID_5223 4.502E-03 0.07762551 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS colon carcinoma DOID_1520 4.738E-03 0.07929943 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS sex cord-gonadal stromal tumor DOID_192 4.738E-03 0.07703373 4.738E-03 0.53923611 TURJANSKI_MAPK1_AND_MAPK2_TARGETS subependymal glioma DOID_4843 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS pilocytic astrocytoma DOID_4851 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS subependymal giant cell astrocytoma DOID_5077 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS fibrillary astrocytoma DOID_6726 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS juvenile pilocytic astrocytoma DOID_6811 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS childhood pilocytic astrocytoma DOID_6812 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS gemistocytic astrocytoma DOID_7005 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS childhood cerebral astrocytoma DOID_7007 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS protoplasmic astrocytoma DOID_7008 4.738E-03 0.0748939 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS coronary restenosis DOID_4247 4.975E-03 0.07650516 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS benign glioma DOID_0060101 5.211E-03 0.07803087 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS benign ependymoma DOID_4844 5.211E-03 0.07803087 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS osteosarcoma DOID_3347 6.156E-03 0.08981583 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS papillary adenoma DOID_3172 6.392E-03 0.09092893 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS microcystic adenoma DOID_5403 6.392E-03 0.09092893 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS follicular adenoma DOID_6204 6.392E-03 0.09092893 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS middle cerebral artery infarction DOID_3525 6.628E-03 0.09198705 6.628E-03 0.62857817 TURJANSKI_MAPK1_AND_MAPK2_TARGETS seminoma DOID_4440 6.628E-03 0.08979688 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS coronary stenosis DOID_4248 7.1E-03 0.09395366 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS supratentorial cancer DOID_1659 7.336E-03 0.09486896 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS toxic encephalopathy DOID_3602 7.336E-03 0.09276076 7.336E-03 0.59631915 TURJANSKI_MAPK1_AND_MAPK2_TARGETS cerebrum cancer DOID_368 7.336E-03 0.09486896 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS germinoma DOID_3304 8.043E-03 0.09949443 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS thyroid carcinoma DOID_3963 8.75E-03 0.09957998 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS spindle cell carcinoma DOID_4015 8.75E-03 0.09762743 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS medullomyoblastoma DOID_3861 8.986E-03 0.09832745 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS adult medulloblastoma DOID_3864 8.986E-03 0.09832745 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS childhood medulloblastoma DOID_3869 8.986E-03 0.09832745 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS thyroid cancer DOID_1781 9.221E-03 0.09900051 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS adenoma DOID_657 9.221E-03 0.09716717 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS medulloblastoma DOID_3858 9.457E-03 0.09783634 1.000 1.000 TURJANSKI_MAPK1_AND_MAPK2_TARGETS multiple myeloma DOID_9538 9.457E-03 0.09608927 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 sarcoma DOID_1115 3.412E-06 1.941E-03 0.0288794 0.22822746 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 congenital diaphragmatic hernia DOID_3827 9.569E-06 2.722E-03 7.786E-04 0.04922371 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 endocrine pancreas disease DOID_1428 3.926E-05 7.447E-03 1.969E-03 0.08617757 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 parasitic infectious disease DOID_1398 4.105E-05 5.839E-03 0.06429698 0.30743683 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 visceral leishmaniasis DOID_9146 4.15E-05 4.723E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 brain infarction DOID_3454 4.672E-05 4.431E-03 2.207E-03 0.08373721 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 peritonitis DOID_8283 6.079E-05 4.942E-03 0.01165066 0.24552686 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 rhabdomyosarcoma DOID_3247 8.372E-05 5.954E-03 8.372E-05 0.04763554 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 transitional cell carcinoma DOID_2671 9.481E-05 5.994E-03 9.481E-05 0.02697482 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 mesenchymal cell neoplasm DOID_3350 9.654E-05 5.493E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 skeletal muscle cancer DOID_4043 9.654E-05 4.994E-03 9.654E-05 0.01831009 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 spindle cell sarcoma DOID_4235 9.654E-05 5.493E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 epithelioid sarcoma DOID_6193 9.654E-05 5.493E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 alcohol-related neurodevelopmental disorder DOID_0050667 1.149E-04 5.446E-03 1.149E-04 0.01633753 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 ulcerative colitis DOID_8577 1.296E-04 5.674E-03 4.32E-03 0.12289703 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 dissociative disorder DOID_10935 1.568E-04 6.374E-03 0.01838577 0.25515867 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 dissociative amnesia DOID_11037 1.568E-04 6.374E-03 0.01838577 0.25515867 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 leishmaniasis DOID_9065 1.568E-04 5.949E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 amnestic disorder DOID_10914 1.742E-04 6.193E-03 0.01934428 0.25015672 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 gastric ulcer DOID_10808 2.115E-04 7.078E-03 0.02125856 0.24685963 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 neutropenia DOID_1227 2.115E-04 6.685E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 placenta disease DOID_780 2.115E-04 6.333E-03 0.02125856 0.23261773 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 agranulocytosis DOID_12987 2.315E-04 6.585E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 muscle cancer DOID_4045 2.315E-04 6.272E-03 2.315E-04 0.02634122 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hypoglycemia DOID_9993 2.315E-04 5.987E-03 0.02221434 0.21793033 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 diabetic angiopathy DOID_11713 2.524E-04 6.243E-03 0.02316921 0.22344542 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 urticaria DOID_1555 2.968E-04 7.036E-03 0.02507622 0.22648209 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 bronchiolitis DOID_2942 2.968E-04 6.755E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 cystitis DOID_1679 3.203E-04 7.011E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 toxic encephalopathy DOID_3602 4.233E-04 8.922E-03 4.233E-04 0.0401468 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 female reproductive organ benign neoplasm DOID_0060086 4.513E-04 9.171E-03 4.513E-04 0.03668309 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 uterine benign neoplasm DOID_0060095 4.513E-04 9.171E-03 4.513E-04 0.03668309 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 uterine fibroid DOID_13223 4.513E-04 9.171E-03 4.513E-04 0.03668309 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 leiomyoma DOID_127 5.404E-04 0.01060231 5.404E-04 0.03843338 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 bladder disease DOID_365 5.404E-04 0.0102489 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 esophageal disease DOID_6050 6.041E-04 0.01108818 0.03550024 0.22444042 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 leukopenia DOID_615 6.041E-04 0.01074168 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 multiple myeloma DOID_9538 7.062E-04 0.01217665 0.03832428 0.23198422 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 peptic ulcer DOID_750 7.786E-04 0.0130298 0.04020251 0.2382836 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 uterine cancer DOID_363 9.745E-04 0.01584301 9.745E-04 0.05545052 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 influenza DOID_8469 9.745E-04 0.01540292 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 cerebral infarction DOID_3526 1.016E-03 0.01562862 0.04581578 0.25309885 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 myeloma DOID_0070004 1.102E-03 0.01650564 0.04767977 0.25594141 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 vascular skin disease DOID_9540 1.102E-03 0.01608242 0.04767977 0.24889715 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 bone marrow cancer DOID_4960 1.43E-03 0.02034167 0.05417586 0.27040407 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 reproductive organ benign neoplasm DOID_0050622 1.48E-03 0.02054168 1.48E-03 0.07656446 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 parasitic protozoa infectious disease DOID_2789 1.48E-03 0.0200526 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 leukocyte disease DOID_9500 1.689E-03 0.02235137 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 pre-malignant neoplasm DOID_0060071 1.911E-03 0.02471666 1.911E-03 0.09062777 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 in situ carcinoma DOID_8719 1.911E-03 0.02471666 1.911E-03 0.09062777 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 cholestasis DOID_13580 2.027E-03 0.02563443 0.06429698 0.31004222 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 cerebral degeneration DOID_1443 2.027E-03 0.02507716 2.027E-03 0.08239638 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 uterine disease DOID_345 2.027E-03 0.0245436 0.06429698 0.30487485 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 allergic contact dermatitis DOID_3042 2.147E-03 0.02544636 0.06612583 0.30840653 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 blood coagulation disease DOID_1247 2.332E-03 0.02707572 0.06886258 0.31599039 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 bile duct disease DOID_4138 2.395E-03 0.02725455 0.0697731 0.31508644 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 peripheral vascular disease DOID_341 2.459E-03 0.02743538 0.07068275 0.31420689 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 biliary tract disease DOID_9741 2.459E-03 0.02690778 0.07068275 0.31177118 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 mixed glioma DOID_5076 2.792E-03 0.02997079 2.792E-03 0.09927824 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 metabolic syndrome X DOID_14221 2.93E-03 0.03087662 2.93E-03 0.09807867 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 contact dermatitis DOID_2773 2.93E-03 0.03031523 0.0770261 0.33202918 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 chromosomal disease DOID_0080014 3.001E-03 0.03049035 3.001E-03 0.09485886 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 female reproductive system disease DOID_229 3.001E-03 0.02995543 0.07792885 0.33339485 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 Human immunodeficiency virus infectious disease DOID_526 3.671E-03 0.03601347 3.671E-03 0.10993586 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hypersensitivity reaction type I disease DOID_1205 4.071E-03 0.0392577 0.09047747 0.36511828 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 facioscapulohumeral muscular dystrophy DOID_11727 9.718E-03 0.09215995 9.718E-03 0.26331415 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 childhood type dermatomyositis DOID_14203 9.718E-03 0.09064913 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 angioedema DOID_1558 9.718E-03 0.08918705 9.718E-03 0.25134533 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 bilirubin metabolic disorder DOID_2741 9.718E-03 0.08777138 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 acute kidney failure DOID_3021 9.718E-03 0.08639996 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 keratitis DOID_4677 9.718E-03 0.08507073 9.718E-03 0.24041727 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 Paget's disease of bone DOID_5408 9.718E-03 0.08378178 9.718E-03 0.23039988 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 cutaneous leishmaniasis DOID_9111 9.718E-03 0.0825313 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 breast benign neoplasm DOID_0060082 0.01068484 0.08940695 0.01068484 0.2431869 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 thoracic benign neoplasm DOID_0060097 0.01068484 0.08940695 0.01068484 0.2431869 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 dermatomyositis DOID_10223 0.01068484 0.0881112 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 sickle cell anemia DOID_10923 0.01068484 0.08685246 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 pneumocystosis DOID_11339 0.01068484 0.08562919 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 migraine without aura DOID_12783 0.01068484 0.0844399 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 benign breast phyllodes tumor DOID_1631 0.01068484 0.08940695 0.01068484 0.2431869 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hemochromatosis DOID_2352 0.01068484 0.08328318 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 bronchiectasis DOID_9563 0.01068484 0.08215774 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 otitis media DOID_10754 0.01165066 0.08838967 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 osteopetrosis DOID_13533 0.01165066 0.08722665 0.01165066 0.2549702 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 middle ear disease DOID_5100 0.01165066 0.08838967 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 encephalitis DOID_9588 0.01165066 0.08609384 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 berylliosis DOID_10322 0.01261556 0.09202892 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 vulva cancer DOID_1245 0.01261556 0.090864 0.01261556 0.25636629 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hepatic coma DOID_12550 0.01261556 0.0897282 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hepatic encephalopathy DOID_13413 0.01261556 0.0897282 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 impotence DOID_1875 0.01261556 0.08862045 0.01261556 0.24752607 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 intracranial thrombosis DOID_4193 0.01261556 0.08753971 0.01261556 0.2392752 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 psoriatic arthritis DOID_9008 0.01261556 0.08648501 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hypercalcemia DOID_12678 0.01357955 0.0919853 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 eyelid disease DOID_530 0.01357955 0.09090312 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 parasitic helminthiasis infectious disease DOID_883 0.01357955 0.08984611 0.01357955 0.2492505 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 polycystic kidney disease DOID_898 0.01357955 0.0888134 0.01357955 0.24146142 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 communication disorder DOID_2033 0.01454262 0.09403129 0.01454262 0.25075011 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 membranoproliferative glomerulonephritis DOID_2920 0.01454262 0.09297476 0.01454262 0.24337511 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 lung oat cell carcinoma DOID_5411 0.01454262 0.09194171 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 oral submucous fibrosis DOID_5773 0.01454262 0.09093136 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hyperhomocysteinemia DOID_9279 0.01454262 0.08994297 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 angiosarcoma DOID_0001816 0.01550478 0.09486259 0.01550478 0.25206347 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 silicosis DOID_10325 0.01550478 0.09385342 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hemolytic-uremic syndrome DOID_12554 0.01550478 0.09286549 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 thyroiditis DOID_7166 0.01550478 0.09189814 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 autoimmune thyroiditis DOID_7188 0.01550478 0.09189814 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 Barrett's esophagus DOID_9206 0.01550478 0.09095073 0.01550478 0.2450617 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 lymphatic system cancer DOID_0060073 0.01646603 0.09560376 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 penile disease DOID_1529 0.01646603 0.09463807 0.01646603 0.25322078 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 hyperostosis DOID_205 0.01646603 0.09369169 0.01646603 0.24655707 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 reticulosarcoma DOID_8538 0.01646603 0.09560376 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 lymphosarcoma DOID_8675 0.01646603 0.09560376 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 sexual dysfunction DOID_1876 0.01742636 0.09817423 0.01742636 0.25424607 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 osteosclerosis DOID_4254 0.01742636 0.09721173 0.01742636 0.24788992 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP oral cavity cancer DOID_8618 2.713E-07 1.543E-04 2.289E-05 4.341E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP adenoid cystic carcinoma DOID_4866 7.936E-06 2.258E-03 7.936E-06 4.515E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP salivary gland cancer DOID_8850 9.113E-06 1.728E-03 9.113E-06 2.593E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP mixed glioma DOID_5076 5.165E-05 7.347E-03 0.06933333 0.74435221 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP Graves' disease DOID_12361 1.053E-04 0.0119809 0.01514051 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP lung adenocarcinoma DOID_3910 3.122E-04 0.02960497 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP invasive ductal carcinoma DOID_3008 3.343E-04 0.02717296 0.02656818 0.83984983 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP autoimmune disease of endocrine system DOID_0060005 3.571E-04 0.0254018 0.02744189 0.74354443 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP nephroblastoma DOID_2154 5.098E-04 0.03223063 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP hyperthyroidism DOID_7998 5.098E-04 0.02900757 0.03266813 0.74352669 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP medullomyoblastoma DOID_3861 5.378E-04 0.02781991 0.03353652 0.70675109 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP adult medulloblastoma DOID_3864 5.378E-04 0.02781991 0.03353652 0.70675109 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP childhood medulloblastoma DOID_3869 5.378E-04 0.02781991 0.03353652 0.70675109 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP medulloblastoma DOID_3858 5.961E-04 0.02826301 0.03527102 0.71675759 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP primitive neuroectodermal tumor DOID_168 7.883E-04 0.03450152 0.04045643 0.74257121 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP gallbladder cancer DOID_3121 8.228E-04 0.03344221 0.04131803 0.73468619 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP myeloma DOID_0070004 9.309E-04 0.03531104 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP atrophic muscular disease DOID_913 1.166E-03 0.04147662 1.166E-03 0.16590647 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP muscular dystrophy DOID_9884 1.166E-03 0.04147662 1.166E-03 0.16590647 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP bone marrow cancer DOID_4960 1.208E-03 0.04043363 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP hypertrophic cardiomyopathy DOID_11984 1.382E-03 0.04368802 0.05330187 0.75821908 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP neuroectodermal tumor DOID_171 1.52E-03 0.04551866 0.05585085 0.706203 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP pre-malignant neoplasm DOID_0060071 1.615E-03 0.04595815 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP in situ carcinoma DOID_8719 1.615E-03 0.04595815 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP allergic contact dermatitis DOID_3042 1.815E-03 0.04916867 0.06092885 0.73762801 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP diabetic retinopathy DOID_8947 2.134E-03 0.05520155 0.06598034 0.73613358 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP contact dermatitis DOID_2773 2.479E-03 0.06132097 0.07100545 0.74818703 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP biliary tract cancer DOID_4607 2.66E-03 0.0630659 0.07350815 0.72114032 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP retinal vascular disease DOID_2462 2.784E-03 0.06337216 0.07517298 0.72497336 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP transitional cell carcinoma DOID_2671 2.976E-03 0.06512531 1.000 1.000 SHEN_SMARCA2_TARGETS_DN alcohol abuse DOID_1574 5.091E-15 2.897E-12 2.598E-06 1.478E-03 SHEN_SMARCA2_TARGETS_DN temporal lobe epilepsy DOID_3328 2.959E-11 8.42E-09 1.611E-05 3.056E-03 SHEN_SMARCA2_TARGETS_DN lung oat cell carcinoma DOID_5411 3.865E-11 7.331E-09 0.06594654 0.39918701 SHEN_SMARCA2_TARGETS_DN lung small cell carcinoma DOID_5409 9.674E-11 1.376E-08 1.723E-03 0.06534384 SHEN_SMARCA2_TARGETS_DN focal epilepsy DOID_2234 2.021E-10 2.3E-08 4.436E-05 6.31E-03 SHEN_SMARCA2_TARGETS_DN hepatic coma DOID_12550 2.266E-09 2.149E-07 1.000 1.000 SHEN_SMARCA2_TARGETS_DN hepatic encephalopathy DOID_13413 2.266E-09 2.149E-07 1.000 1.000 SHEN_SMARCA2_TARGETS_DN electroclinical syndrome DOID_0050701 3.346E-09 2.72E-07 4.946E-04 0.03518188 SHEN_SMARCA2_TARGETS_DN movement disease DOID_480 4.525E-09 3.218E-07 1.007E-04 0.01146218 SHEN_SMARCA2_TARGETS_DN metal metabolism disorder DOID_896 1.39E-08 8.789E-07 0.0116519 0.15068022 SHEN_SMARCA2_TARGETS_DN parasitic infectious disease DOID_1398 2.688E-08 1.529E-06 0.26617757 0.78474113 SHEN_SMARCA2_TARGETS_DN adolescence-adult electroclinical syndrome DOID_0050705 2.699E-08 1.396E-06 0.0142566 0.17259584 SHEN_SMARCA2_TARGETS_DN juvenile myoclonic epilepsy DOID_4890 1.638E-07 7.765E-06 7.159E-03 0.13139861 SHEN_SMARCA2_TARGETS_DN bone marrow cancer DOID_4960 2.394E-07 1.048E-05 0.02774702 0.2722078 SHEN_SMARCA2_TARGETS_DN childhood absence epilepsy DOID_1825 5.272E-07 2.143E-05 0.01103718 0.14605007 SHEN_SMARCA2_TARGETS_DN bladder disease DOID_365 5.272E-07 2E-05 0.14719627 0.5583645 SHEN_SMARCA2_TARGETS_DN hyperglycemia DOID_4195 7.559E-07 2.688E-05 3.86E-03 0.11561064 SHEN_SMARCA2_TARGETS_DN childhood electroclinical syndrome DOID_0050704 8.062E-07 2.699E-05 0.01292537 0.16343416 SHEN_SMARCA2_TARGETS_DN bone resorption disease DOID_0080011 1.688E-06 5.337E-05 5.638E-03 0.13365622 SHEN_SMARCA2_TARGETS_DN osteoporosis DOID_11476 1.688E-06 5.337E-05 5.638E-03 0.13365622 SHEN_SMARCA2_TARGETS_DN idiopathic generalized epilepsy DOID_1827 2.138E-06 6.403E-05 1.207E-03 0.06243495 SHEN_SMARCA2_TARGETS_DN myeloma DOID_0070004 3.257E-06 9.266E-05 0.20348606 0.66542279 SHEN_SMARCA2_TARGETS_DN transitional cell carcinoma DOID_2671 3.629E-06 9.833E-05 8.077E-03 0.13927144 SHEN_SMARCA2_TARGETS_DN bronchiolitis DOID_2942 5.657E-06 1.463E-04 1.000 1.000 SHEN_SMARCA2_TARGETS_DN cystitis DOID_1679 6.618E-06 1.637E-04 0.11557571 0.5178156 SHEN_SMARCA2_TARGETS_DN parasitic protozoa infectious disease DOID_2789 6.84E-06 1.622E-04 0.2319806 0.70586611 SHEN_SMARCA2_TARGETS_DN fragments of torsion dystonia DOID_531 7.694E-06 1.751E-04 7.159E-03 0.12729241 SHEN_SMARCA2_TARGETS_DN retinitis pigmentosa DOID_10584 8.783E-06 1.922E-04 8.783E-06 2.499E-03 SHEN_SMARCA2_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 8.783E-06 1.851E-04 1.000 1.000 SHEN_SMARCA2_TARGETS_DN migraine DOID_6364 8.893E-06 1.807E-04 0.12358847 0.52090252 SHEN_SMARCA2_TARGETS_DN central nervous system hereditary degenerative disease DOID_481 1.022E-05 2.006E-04 8.19E-03 0.13705507 SHEN_SMARCA2_TARGETS_DN dystonic disease DOID_544 1.17E-05 2.219E-04 8.728E-03 0.13795835 SHEN_SMARCA2_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 1.332E-05 2.445E-04 0.13547248 0.54284395 SHEN_SMARCA2_TARGETS_DN uterine benign neoplasm DOID_0060095 1.332E-05 2.445E-04 0.13547248 0.54284395 SHEN_SMARCA2_TARGETS_DN uterine fibroid DOID_13223 1.332E-05 2.445E-04 0.13547248 0.54284395 SHEN_SMARCA2_TARGETS_DN endocrine pancreas disease DOID_1428 1.395E-05 2.48E-04 0.0373293 0.34258665 SHEN_SMARCA2_TARGETS_DN heroin dependence DOID_9976 1.474E-05 2.542E-04 1.000 1.000 SHEN_SMARCA2_TARGETS_DN cholestasis DOID_13580 1.5E-05 2.51E-04 3.705E-03 0.11711393 SHEN_SMARCA2_TARGETS_DN gonadal disease DOID_2277 1.511E-05 2.456E-04 4.53E-04 0.03682084 SHEN_SMARCA2_TARGETS_DN allergic contact dermatitis DOID_3042 1.729E-05 2.733E-04 4.02E-03 0.11436949 SHEN_SMARCA2_TARGETS_DN leiomyoma DOID_127 1.919E-05 2.952E-04 0.14719627 0.5697597 SHEN_SMARCA2_TARGETS_DN bile duct disease DOID_4138 2.268E-05 3.396E-04 4.698E-03 0.1272967 SHEN_SMARCA2_TARGETS_DN hepatitis C DOID_1883 2.404E-05 3.507E-04 0.15492417 0.57615591 SHEN_SMARCA2_TARGETS_DN biliary tract disease DOID_9741 2.421E-05 3.444E-04 4.878E-03 0.12067143 SHEN_SMARCA2_TARGETS_DN nicotine dependence DOID_0050742 2.538E-05 3.523E-04 1.545E-03 0.07324081 SHEN_SMARCA2_TARGETS_DN pulmonary sarcoidosis DOID_13406 3.291E-05 4.459E-04 1.000 1.000 SHEN_SMARCA2_TARGETS_DN multiple myeloma DOID_9538 3.291E-05 4.355E-04 0.16638568 0.58440404 SHEN_SMARCA2_TARGETS_DN contact dermatitis DOID_2773 3.731E-05 4.824E-04 6.251E-03 0.1270357 SHEN_SMARCA2_TARGETS_DN hepatitis DOID_2237 4.003E-05 5.061E-04 1.000 1.000 SHEN_SMARCA2_TARGETS_DN congenital diaphragmatic hernia DOID_3827 4.003E-05 4.951E-04 0.01564444 0.18166703 SHEN_SMARCA2_TARGETS_DN auditory system disease DOID_2742 4.19E-05 5.073E-04 5.95E-04 0.0376195 SHEN_SMARCA2_TARGETS_DN chronic kidney failure DOID_784 4.436E-05 5.258E-04 0.32087314 0.89498441 SHEN_SMARCA2_TARGETS_DN hyperinsulinism DOID_2018 5.753E-05 6.681E-04 0.01858548 0.19583586 SHEN_SMARCA2_TARGETS_DN drug-induced mental disorder DOID_1203 5.955E-05 6.777E-04 0.07440625 0.41917978 SHEN_SMARCA2_TARGETS_DN drug psychosis DOID_1742 5.955E-05 6.777E-04 0.07440625 0.41917978 SHEN_SMARCA2_TARGETS_DN substance-induced psychosis DOID_8646 5.955E-05 6.777E-04 0.07440625 0.41917978 SHEN_SMARCA2_TARGETS_DN lymphoblastic leukemia DOID_1037 7.555E-05 8.429E-04 9.362E-03 0.14396519 SHEN_SMARCA2_TARGETS_DN pre-eclampsia DOID_10591 8.006E-05 8.76E-04 0.20348606 0.66162038 SHEN_SMARCA2_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 8.342E-05 8.956E-04 0.0720441 0.40993091 SHEN_SMARCA2_TARGETS_DN integumentary system benign neoplasm DOID_0060121 9.345E-05 9.847E-04 1.723E-03 0.07001126 SHEN_SMARCA2_TARGETS_DN pulmonary tuberculosis DOID_2957 9.345E-05 9.668E-04 1.000 1.000 SHEN_SMARCA2_TARGETS_DN skin benign neoplasm DOID_3165 9.345E-05 9.847E-04 1.723E-03 0.07001126 SHEN_SMARCA2_TARGETS_DN juvenile absence epilepsy DOID_0060172 1.149E-04 1.168E-03 0.09109783 0.46280953 SHEN_SMARCA2_TARGETS_DN sarcoidosis DOID_11335 1.25E-04 1.248E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 1.434E-04 1.407E-03 0.2319806 0.70966109 SHEN_SMARCA2_TARGETS_DN integumentary system cancer DOID_0060122 1.434E-04 1.383E-03 2.358E-03 0.08384735 SHEN_SMARCA2_TARGETS_DN osteochondrodysplasia DOID_2256 1.434E-04 1.36E-03 1.434E-04 0.01359749 SHEN_SMARCA2_TARGETS_DN skin cancer DOID_4159 1.434E-04 1.383E-03 2.358E-03 0.08384735 SHEN_SMARCA2_TARGETS_DN opiate dependence DOID_2559 1.52E-04 1.418E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN lingual-facial-buccal dyskinesia DOID_9854 1.52E-04 1.395E-03 0.09933106 0.47897772 SHEN_SMARCA2_TARGETS_DN familial hyperlipidemia DOID_1168 1.533E-04 1.384E-03 0.2354704 0.71267372 SHEN_SMARCA2_TARGETS_DN carotid artery disease DOID_3407 2.102E-04 1.869E-03 0.25268432 0.75672305 SHEN_SMARCA2_TARGETS_DN urticaria DOID_1555 2.21E-04 1.934E-03 6.192E-03 0.14092298 SHEN_SMARCA2_TARGETS_DN hypogonadism DOID_1924 2.21E-04 1.905E-03 6.192E-03 0.13550286 SHEN_SMARCA2_TARGETS_DN dystonia DOID_543 2.766E-04 2.349E-03 0.11959116 0.51551036 SHEN_SMARCA2_TARGETS_DN Sciatic Neuropathy DOID_11446 3.074E-04 2.573E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN lesion of sciatic nerve DOID_12528 3.074E-04 2.573E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN mononeuritis of lower limb DOID_9473 3.074E-04 2.573E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN tuberculosis DOID_399 3.137E-04 2.587E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN mononeuritis DOID_1802 3.405E-04 2.767E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN nephrosis DOID_2527 3.675E-04 2.946E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN male reproductive system disease DOID_48 3.675E-04 2.905E-03 0.2859646 0.82178716 SHEN_SMARCA2_TARGETS_DN mononeuropathy DOID_1188 3.757E-04 2.928E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN toxic encephalopathy DOID_3602 3.757E-04 2.889E-03 8.728E-03 0.14190001 SHEN_SMARCA2_TARGETS_DN peripheral vascular disease DOID_341 3.869E-04 2.935E-03 0.04577001 0.36680476 SHEN_SMARCA2_TARGETS_DN cystic fibrosis DOID_1485 4.493E-04 3.364E-03 0.29886034 0.85025766 SHEN_SMARCA2_TARGETS_DN syndrome DOID_225 4.493E-04 3.32E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN opportunistic mycosis DOID_2473 4.53E-04 3.304E-03 0.1393981 0.54701739 SHEN_SMARCA2_TARGETS_DN pancreatitis DOID_4989 4.946E-04 3.563E-03 0.05136668 0.38970189 SHEN_SMARCA2_TARGETS_DN bacterial pneumonia DOID_874 4.946E-04 3.518E-03 0.3052211 0.86403387 SHEN_SMARCA2_TARGETS_DN Charcot-Marie-Tooth disease DOID_10595 4.952E-04 3.478E-03 0.01043733 0.1522779 SHEN_SMARCA2_TARGETS_DN germinoma DOID_3304 4.952E-04 3.436E-03 0.01043733 0.14484971 SHEN_SMARCA2_TARGETS_DN chronic leukemia DOID_1036 5.398E-04 3.7E-03 0.01103718 0.14952745 SHEN_SMARCA2_TARGETS_DN chronic lymphocytic leukemia DOID_1040 5.398E-04 3.7E-03 0.01103718 0.14952745 SHEN_SMARCA2_TARGETS_DN lipid metabolism disorder DOID_3146 5.432E-04 3.68E-03 0.3115245 0.87751208 SHEN_SMARCA2_TARGETS_DN female reproductive system disease DOID_229 5.687E-04 3.807E-03 0.31465484 0.88196358 SHEN_SMARCA2_TARGETS_DN systemic mycosis DOID_0050136 5.869E-04 3.883E-03 0.15106896 0.56925986 SHEN_SMARCA2_TARGETS_DN fungal infectious disease DOID_1564 5.869E-04 3.883E-03 0.15106896 0.56925986 SHEN_SMARCA2_TARGETS_DN bone development disease DOID_0080006 6.503E-04 4.253E-03 6.503E-04 0.0370017 SHEN_SMARCA2_TARGETS_DN primary bacterial infectious disease DOID_0050338 7.399E-04 4.784E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN gallbladder disease DOID_0000000 8.991E-04 5.748E-03 0.04445943 0.40154631 SHEN_SMARCA2_TARGETS_DN interstitial nephritis DOID_1063 8.991E-04 5.685E-03 0.04445943 0.38919104 SHEN_SMARCA2_TARGETS_DN familial combined hyperlipidemia DOID_13809 8.991E-04 5.622E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN bilirubin metabolic disorder DOID_2741 8.991E-04 5.561E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN acute T cell leukemia DOID_5603 8.991E-04 5.501E-03 0.04445943 0.36139168 SHEN_SMARCA2_TARGETS_DN visceral leishmaniasis DOID_9146 8.991E-04 5.443E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN lymphoma DOID_0060058 9.08E-04 5.438E-03 0.0682235 0.40862286 SHEN_SMARCA2_TARGETS_DN Crohn's disease DOID_8778 9.822E-04 5.821E-03 9.632E-03 0.14422405 SHEN_SMARCA2_TARGETS_DN adult respiratory distress syndrome DOID_11394 9.911E-04 5.814E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN migraine without aura DOID_12783 1.096E-03 6.362E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN hemochromatosis DOID_2352 1.096E-03 6.297E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN nephrotic syndrome DOID_1184 1.207E-03 6.868E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN Huntington's disease DOID_12858 1.207E-03 6.8E-03 0.01858548 0.19953088 SHEN_SMARCA2_TARGETS_DN influenza DOID_8469 1.285E-03 7.168E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN neonatoal period electroclinical syndrome DOID_0050702 1.311E-03 7.242E-03 0.05311262 0.38744975 SHEN_SMARCA2_TARGETS_DN pituitary gland disease DOID_53 1.311E-03 7.172E-03 0.05311262 0.36854976 SHEN_SMARCA2_TARGETS_DN peritonitis DOID_8283 1.311E-03 7.104E-03 0.05311262 0.3641094 SHEN_SMARCA2_TARGETS_DN neuritis DOID_1803 1.538E-03 8.255E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN vascular skin disease DOID_9540 1.538E-03 8.178E-03 0.02173971 0.22490715 SHEN_SMARCA2_TARGETS_DN infancy electroclinical syndrome DOID_0050703 1.545E-03 8.138E-03 0.05740995 0.38430898 SHEN_SMARCA2_TARGETS_DN epilepsy with generalized tonic-clonic seizures DOID_7725 1.545E-03 8.063E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN psoriatic arthritis DOID_9008 1.545E-03 7.99E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN hemolytic anemia DOID_583 1.629E-03 8.348E-03 0.20710457 0.65106353 SHEN_SMARCA2_TARGETS_DN normocytic anemia DOID_720 1.629E-03 8.348E-03 0.20710457 0.65106353 SHEN_SMARCA2_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.723E-03 8.751E-03 1.723E-03 0.07539674 SHEN_SMARCA2_TARGETS_DN T-cell leukemia DOID_715 1.797E-03 9.047E-03 0.0616879 0.39438666 SHEN_SMARCA2_TARGETS_DN parasitic helminthiasis infectious disease DOID_883 1.797E-03 8.968E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN bacterial meningitis DOID_9470 1.797E-03 8.89E-03 0.0616879 0.39000459 SHEN_SMARCA2_TARGETS_DN withdrawal disorder DOID_0060001 1.921E-03 9.421E-03 0.02509858 0.25501947 SHEN_SMARCA2_TARGETS_DN mesenchymal cell neoplasm DOID_3350 2.067E-03 0.01005202 1.000 1.000 SHEN_SMARCA2_TARGETS_DN spindle cell sarcoma DOID_4235 2.067E-03 0.01005202 1.000 1.000 SHEN_SMARCA2_TARGETS_DN nutritional deficiency disease DOID_5113 2.067E-03 9.967E-03 1.000 1.000 SHEN_SMARCA2_TARGETS_DN epithelioid sarcoma DOID_6193 2.067E-03 0.01005202 1.000 1.000 SHEN_SMARCA2_TARGETS_DN silicosis DOID_10325 2.355E-03 0.01126133 1.000 1.000 SHEN_SMARCA2_TARGETS_DN hemolytic-uremic syndrome DOID_12554 2.355E-03 0.01116749 1.000 1.000 SHEN_SMARCA2_TARGETS_DN thyroiditis DOID_7166 2.355E-03 0.0110752 0.07018596 0.41170939 SHEN_SMARCA2_TARGETS_DN autoimmune thyroiditis DOID_7188 2.355E-03 0.0110752 0.07018596 0.41170939 SHEN_SMARCA2_TARGETS_DN adrenal gland disease DOID_9553 2.661E-03 0.01241197 0.07440625 0.40708806 SHEN_SMARCA2_TARGETS_DN nonsyndromic deafness DOID_0050563 2.723E-03 0.01259603 2.723E-03 0.09113598 SHEN_SMARCA2_TARGETS_DN respiratory failure DOID_11162 3.261E-03 0.01496483 1.000 1.000 SHEN_SMARCA2_TARGETS_DN hypothyroidism DOID_1459 3.261E-03 0.01484511 0.03532361 0.32949398 SHEN_SMARCA2_TARGETS_DN leishmaniasis DOID_9065 3.326E-03 0.01502108 1.000 1.000 SHEN_SMARCA2_TARGETS_DN alopecia DOID_987 3.685E-03 0.01650946 1.000 1.000 SHEN_SMARCA2_TARGETS_DN uterine disease DOID_345 3.705E-03 0.01646915 1.000 1.000 SHEN_SMARCA2_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 4.184E-03 0.01845295 0.2761383 0.80991079 SHEN_SMARCA2_TARGETS_DN brain infarction DOID_3454 4.184E-03 0.018311 0.2761383 0.8057574 SHEN_SMARCA2_TARGETS_DN neutropenia DOID_1227 4.453E-03 0.01934374 1.000 1.000 SHEN_SMARCA2_TARGETS_DN familial hypercholesterolemia DOID_13810 4.453E-03 0.01919719 1.000 1.000 SHEN_SMARCA2_TARGETS_DN placenta disease DOID_780 4.453E-03 0.01905285 1.000 1.000 SHEN_SMARCA2_TARGETS_DN blood coagulation disease DOID_1247 4.523E-03 0.01920399 0.28270399 0.820707 SHEN_SMARCA2_TARGETS_DN sinusitis DOID_0050127 4.863E-03 0.02049724 1.000 1.000 SHEN_SMARCA2_TARGETS_DN sexual disorder DOID_0060043 4.863E-03 0.02034653 1.000 1.000 SHEN_SMARCA2_TARGETS_DN agranulocytosis DOID_12987 4.863E-03 0.02019801 1.000 1.000 SHEN_SMARCA2_TARGETS_DN paranasal sinus disease DOID_1352 4.863E-03 0.02049724 1.000 1.000 SHEN_SMARCA2_TARGETS_DN uremia DOID_4676 4.863E-03 0.02005165 0.09933106 0.48723596 SHEN_SMARCA2_TARGETS_DN pulmonary embolism DOID_9477 4.863E-03 0.01990739 4.863E-03 0.12577853 SHEN_SMARCA2_TARGETS_DN hypoglycemia DOID_9993 4.863E-03 0.0197652 0.09933106 0.4749527 SHEN_SMARCA2_TARGETS_DN diabetic angiopathy DOID_11713 5.29E-03 0.02134559 1.000 1.000 SHEN_SMARCA2_TARGETS_DN aortic valve disease DOID_62 5.29E-03 0.02119527 1.000 1.000 SHEN_SMARCA2_TARGETS_DN meningitis DOID_9471 5.29E-03 0.02104705 0.10341982 0.48234326 SHEN_SMARCA2_TARGETS_DN spastic quadriplegia DOID_10970 5.732E-03 0.02265097 1.000 1.000 SHEN_SMARCA2_TARGETS_DN osteosarcoma DOID_3347 6.192E-03 0.02429707 6.192E-03 0.13048424 SHEN_SMARCA2_TARGETS_DN metabolic syndrome X DOID_14221 6.251E-03 0.02436301 0.0536707 0.36355509 SHEN_SMARCA2_TARGETS_DN autosomal dominant nonsyndromic deafness DOID_0050564 6.667E-03 0.02580709 6.667E-03 0.13081527 SHEN_SMARCA2_TARGETS_DN morbid obesity DOID_11981 6.667E-03 0.02563272 0.11557571 0.52192525 SHEN_SMARCA2_TARGETS_DN infantile epileptic encephalopathy DOID_2481 6.667E-03 0.02546069 6.667E-03 0.12645476 SHEN_SMARCA2_TARGETS_DN myositis DOID_633 6.667E-03 0.02529095 1.000 1.000 SHEN_SMARCA2_TARGETS_DN biliary tract cancer DOID_4607 6.903E-03 0.02601382 1.000 1.000 SHEN_SMARCA2_TARGETS_DN seminoma DOID_4440 7.159E-03 0.0267984 0.11959116 0.51944555 SHEN_SMARCA2_TARGETS_DN hypotrichosis DOID_4535 7.159E-03 0.02662325 1.000 1.000 SHEN_SMARCA2_TARGETS_DN extrinsic allergic alveolitis DOID_841 7.159E-03 0.02645037 0.11959116 0.51163434 SHEN_SMARCA2_TARGETS_DN retinal vascular disease DOID_2462 7.36E-03 0.02701787 0.32703535 0.90772251 SHEN_SMARCA2_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 7.666E-03 0.02796237 0.12358847 0.51707235 SHEN_SMARCA2_TARGETS_DN pleurisy DOID_10247 8.19E-03 0.02968072 1.000 1.000 SHEN_SMARCA2_TARGETS_DN sarcoma DOID_1115 8.19E-03 0.02949286 1.000 1.000 SHEN_SMARCA2_TARGETS_DN malaria DOID_12365 8.19E-03 0.02930737 0.12756774 0.52982515 SHEN_SMARCA2_TARGETS_DN coronary stenosis DOID_4248 8.19E-03 0.0291242 1.000 1.000 SHEN_SMARCA2_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 8.578E-03 0.03031456 0.34219874 0.94063324 SHEN_SMARCA2_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 8.728E-03 0.03065741 0.13152905 0.53457165 SHEN_SMARCA2_TARGETS_DN polycystic ovary syndrome DOID_11612 8.728E-03 0.03046933 1.000 1.000 SHEN_SMARCA2_TARGETS_DN endometrial carcinoma DOID_2871 9.283E-03 0.03220687 0.13547248 0.53530445 SHEN_SMARCA2_TARGETS_DN spastic cerebral palsy DOID_0050669 9.852E-03 0.03397617 1.000 1.000 SHEN_SMARCA2_TARGETS_DN bronchiolitis obliterans DOID_2799 9.852E-03 0.03377149 1.000 1.000 SHEN_SMARCA2_TARGETS_DN dilated cardiomyopathy DOID_12930 9.907E-03 0.03375381 0.3570224 0.97198921 SHEN_SMARCA2_TARGETS_DN celiac disease DOID_10608 0.01043733 0.03535023 0.01043733 0.14847095 SHEN_SMARCA2_TARGETS_DN endometrial cancer DOID_1380 0.01043733 0.03514105 0.14330601 0.5585008 SHEN_SMARCA2_TARGETS_DN ulcerative colitis DOID_8577 0.01075835 0.03600885 0.36575669 0.99102645 SHEN_SMARCA2_TARGETS_DN pleural disease DOID_1532 0.01103718 0.03672604 1.000 1.000 SHEN_SMARCA2_TARGETS_DN hair disease DOID_421 0.0116519 0.0385461 1.000 1.000 SHEN_SMARCA2_TARGETS_DN pneumoconiosis DOID_10316 0.01228135 0.04039356 1.000 1.000 SHEN_SMARCA2_TARGETS_DN male infertility DOID_12336 0.01228135 0.04016141 0.15492417 0.57994641 SHEN_SMARCA2_TARGETS_DN leukopenia DOID_615 0.01228135 0.03993192 1.000 1.000 SHEN_SMARCA2_TARGETS_DN lymphoid leukemia DOID_10747 0.01292537 0.04178714 0.15876198 0.57538577 SHEN_SMARCA2_TARGETS_DN aplastic anemia DOID_12449 0.01292537 0.04155106 0.15876198 0.57174409 SHEN_SMARCA2_TARGETS_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.01358384 0.0434225 0.01358384 0.16802618 SHEN_SMARCA2_TARGETS_DN refractive error DOID_9835 0.01358384 0.04317991 0.16258246 0.58182024 SHEN_SMARCA2_TARGETS_DN microcephaly DOID_10907 0.01494351 0.0472381 0.01494351 0.17714287 SHEN_SMARCA2_TARGETS_DN blood platelet disease DOID_2218 0.01494351 0.04697712 1.000 1.000 SHEN_SMARCA2_TARGETS_DN respiratory syncytial virus infectious disease DOID_1273 0.01564444 0.04891035 0.1739407 0.59983186 SHEN_SMARCA2_TARGETS_DN peptic ulcer DOID_750 0.01564444 0.04864308 0.1739407 0.59621841 SHEN_SMARCA2_TARGETS_DN adenoid cystic carcinoma DOID_4866 0.01635923 0.05058915 0.01635923 0.18616808 SHEN_SMARCA2_TARGETS_DN lymphatic system disease DOID_75 0.01635923 0.0503157 0.17769264 0.6054318 SHEN_SMARCA2_TARGETS_DN benign mesothelioma DOID_2645 0.01708776 0.05227386 0.01708776 0.19064584 SHEN_SMARCA2_TARGETS_DN pulmonary emphysema DOID_9675 0.01708776 0.05199432 1.000 1.000 SHEN_SMARCA2_TARGETS_DN salivary gland cancer DOID_8850 0.01782989 0.05396387 0.01782989 0.19510016 SHEN_SMARCA2_TARGETS_DN rheumatic disease DOID_1575 0.01858548 0.0559531 1.000 1.000 SHEN_SMARCA2_TARGETS_DN scleroderma DOID_419 0.01858548 0.0559531 1.000 1.000 SHEN_SMARCA2_TARGETS_DN diabetic autonomic neuropathy DOID_11503 0.01935439 0.05796129 0.19253173 0.64441502 SHEN_SMARCA2_TARGETS_DN autonomic neuropathy DOID_11504 0.01935439 0.05796129 0.19253173 0.64441502 SHEN_SMARCA2_TARGETS_DN diabetic polyneuropathy DOID_12785 0.01935439 0.05796129 0.19253173 0.64441502 SHEN_SMARCA2_TARGETS_DN gallbladder cancer DOID_3121 0.01935439 0.05765783 1.000 1.000 SHEN_SMARCA2_TARGETS_DN uterine cancer DOID_363 0.01935439 0.05735753 0.19253173 0.64064651 SHEN_SMARCA2_TARGETS_DN diabetic neuropathy DOID_9743 0.01935439 0.05796129 0.19253173 0.64441502 SHEN_SMARCA2_TARGETS_DN cerebral infarction DOID_3526 0.02013648 0.05936611 1.000 1.000 SHEN_SMARCA2_TARGETS_DN autonomic nervous system disease DOID_11465 0.02173971 0.06376234 0.20348606 0.65414444 SHEN_SMARCA2_TARGETS_DN heart valve disease DOID_4079 0.02173971 0.06343535 1.000 1.000 SHEN_SMARCA2_TARGETS_DN bone marrow disease DOID_4961 0.02173971 0.0631117 0.20348606 0.64683557 SHEN_SMARCA2_TARGETS_DN calcium metabolism disease DOID_10575 0.02424013 0.07001338 0.21429263 0.66995882 SHEN_SMARCA2_TARGETS_DN hemorrhagic disease DOID_2213 0.02509858 0.07212672 1.000 1.000 SHEN_SMARCA2_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 0.02509858 0.07176427 0.02509858 0.25054545 SHEN_SMARCA2_TARGETS_DN orofacial cleft DOID_0050567 0.02596929 0.07388263 0.2214159 0.68844617 SHEN_SMARCA2_TARGETS_DN bile duct adenocarcinoma DOID_4896 0.02774702 0.07854752 1.000 1.000 SHEN_SMARCA2_TARGETS_DN cholangiocarcinoma DOID_4947 0.02774702 0.07854752 1.000 1.000 SHEN_SMARCA2_TARGETS_DN vasculitis DOID_865 0.02774702 0.07815868 0.22847497 0.7027149 SHEN_SMARCA2_TARGETS_DN congenital nervous system abnormality DOID_2490 0.03050246 0.08549706 0.03050246 0.29416783 SHEN_SMARCA2_TARGETS_DN bile duct cancer DOID_4606 0.03144415 0.0877045 1.000 1.000 SHEN_SMARCA2_TARGETS_DN bile duct carcinoma DOID_4897 0.03144415 0.0877045 1.000 1.000 SHEN_SMARCA2_TARGETS_DN oral cavity cancer DOID_8618 0.03144415 0.08727668 0.03144415 0.29819531 SHEN_SMARCA2_TARGETS_DN melancholia DOID_2848 0.03239722 0.08948553 1.000 1.000 SHEN_SMARCA2_TARGETS_DN leukocyte disease DOID_9500 0.03239722 0.08905323 1.000 1.000 SHEN_SMARCA2_TARGETS_DN neurotic disorder DOID_4964 0.03336157 0.09126314 1.000 1.000 SHEN_SMARCA2_TARGETS_DN collagen disease DOID_854 0.03433707 0.09348227 1.000 1.000 SHEN_SMARCA2_TARGETS_DN congenital heart defect DOID_1682 0.03632106 0.09841277 0.2594615 0.77295075 BROWNE_HCMV_INFECTION_48HR_DN amino acid metabolic disorder DOID_9252 4.568E-11 2.599E-08 1.654E-08 4.705E-06 BROWNE_HCMV_INFECTION_48HR_DN dilated cardiomyopathy DOID_12930 1.733E-09 4.929E-07 1.733E-09 9.859E-07 BROWNE_HCMV_INFECTION_48HR_DN coronary restenosis DOID_4247 5.477E-09 1.039E-06 4.091E-04 4.084E-03 BROWNE_HCMV_INFECTION_48HR_DN mental depression DOID_1596 9.011E-09 1.282E-06 1.55E-07 2.941E-05 BROWNE_HCMV_INFECTION_48HR_DN primary bacterial infectious disease DOID_0050338 1.358E-08 1.545E-06 3.942E-05 9.346E-04 BROWNE_HCMV_INFECTION_48HR_DN cerebral degeneration DOID_1443 2.638E-08 2.502E-06 8.392E-06 3.673E-04 BROWNE_HCMV_INFECTION_48HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.654E-08 2.157E-06 5.285E-06 3.007E-04 BROWNE_HCMV_INFECTION_48HR_DN leukodystrophy DOID_10579 5.036E-08 3.582E-06 2.383E-05 7.137E-04 BROWNE_HCMV_INFECTION_48HR_DN coronary stenosis DOID_4248 5.686E-08 3.595E-06 1.192E-03 8.811E-03 BROWNE_HCMV_INFECTION_48HR_DN atrophic muscular disease DOID_913 1.304E-07 7.421E-06 2.67E-06 2.17E-04 BROWNE_HCMV_INFECTION_48HR_DN muscular dystrophy DOID_9884 1.304E-07 7.421E-06 2.67E-06 2.17E-04 BROWNE_HCMV_INFECTION_48HR_DN reproductive organ benign neoplasm DOID_0050622 1.671E-07 8.643E-06 1.671E-07 2.377E-05 BROWNE_HCMV_INFECTION_48HR_DN Lewy body dementia DOID_12217 6.127E-07 2.905E-05 2.221E-05 7.899E-04 BROWNE_HCMV_INFECTION_48HR_DN meningitis DOID_9471 6.127E-07 2.682E-05 2.221E-05 7.022E-04 BROWNE_HCMV_INFECTION_48HR_DN endocrine organ benign neoplasm DOID_0060089 6.84E-07 2.78E-05 1.436E-04 1.816E-03 BROWNE_HCMV_INFECTION_48HR_DN tuberculosis DOID_399 6.84E-07 2.595E-05 1.436E-04 1.776E-03 BROWNE_HCMV_INFECTION_48HR_DN male reproductive system disease DOID_48 9.092E-07 3.234E-05 9.092E-07 1.035E-04 BROWNE_HCMV_INFECTION_48HR_DN endogenous depression DOID_1595 1.303E-06 4.363E-05 1.858E-05 7.047E-04 BROWNE_HCMV_INFECTION_48HR_DN pre-eclampsia DOID_10591 1.353E-06 4.278E-05 2.633E-05 7.491E-04 BROWNE_HCMV_INFECTION_48HR_DN thyroid adenoma DOID_2891 1.353E-06 4.053E-05 4.174E-04 4.095E-03 BROWNE_HCMV_INFECTION_48HR_DN bacterial meningitis DOID_9470 2.211E-06 6.29E-05 1.161E-04 1.611E-03 BROWNE_HCMV_INFECTION_48HR_DN bone development disease DOID_0080006 2.528E-06 6.85E-05 2.528E-06 2.397E-04 BROWNE_HCMV_INFECTION_48HR_DN endometrial carcinoma DOID_2871 2.773E-06 7.172E-05 7.194E-05 1.279E-03 BROWNE_HCMV_INFECTION_48HR_DN hyperhomocysteinemia DOID_9279 2.998E-06 7.418E-05 4.813E-03 0.02423647 BROWNE_HCMV_INFECTION_48HR_DN endometrial cancer DOID_1380 3.788E-06 8.981E-05 9.176E-05 1.492E-03 BROWNE_HCMV_INFECTION_48HR_DN nervous system cancer DOID_3093 3.978E-06 9.053E-05 4.03E-03 0.02163117 BROWNE_HCMV_INFECTION_48HR_DN leiomyoma DOID_127 4.394E-06 9.617E-05 4.394E-06 3.126E-04 BROWNE_HCMV_INFECTION_48HR_DN hereditary spastic paraplegia DOID_2476 4.394E-06 9.261E-05 4.394E-06 2.778E-04 BROWNE_HCMV_INFECTION_48HR_DN melancholia DOID_2848 4.881E-06 9.92E-05 7.511E-05 1.295E-03 BROWNE_HCMV_INFECTION_48HR_DN neurotic disorder DOID_4964 5.364E-06 1.052E-04 8.112E-05 1.358E-03 BROWNE_HCMV_INFECTION_48HR_DN male infertility DOID_12336 5.834E-06 1.106E-04 5.834E-06 3.018E-04 BROWNE_HCMV_INFECTION_48HR_DN hepatitis C DOID_1883 5.834E-06 1.071E-04 2.201E-03 0.01391602 BROWNE_HCMV_INFECTION_48HR_DN paraplegia DOID_607 5.834E-06 1.037E-04 5.834E-06 2.766E-04 BROWNE_HCMV_INFECTION_48HR_DN hyperglycemia DOID_4195 9.138E-06 1.576E-04 9.138E-06 3.714E-04 BROWNE_HCMV_INFECTION_48HR_DN benign mesothelioma DOID_2645 1.397E-05 2.337E-04 3.619E-03 0.01980244 BROWNE_HCMV_INFECTION_48HR_DN hepatitis B DOID_2043 1.546E-05 2.513E-04 4.713E-04 4.396E-03 BROWNE_HCMV_INFECTION_48HR_DN uterine cancer DOID_363 1.939E-05 3.065E-04 3.287E-04 3.528E-03 BROWNE_HCMV_INFECTION_48HR_DN electroclinical syndrome DOID_0050701 2.148E-05 3.304E-04 2.434E-03 0.01505581 BROWNE_HCMV_INFECTION_48HR_DN congenital hemolytic anemia DOID_589 2.221E-05 3.326E-04 2.221E-05 7.435E-04 BROWNE_HCMV_INFECTION_48HR_DN proteinuria DOID_576 2.383E-05 3.477E-04 4.908E-03 0.0244957 BROWNE_HCMV_INFECTION_48HR_DN heart valve disease DOID_4079 2.633E-05 3.745E-04 4.174E-04 4.026E-03 BROWNE_HCMV_INFECTION_48HR_DN focal epilepsy DOID_2234 3.037E-05 4.215E-04 3.037E-05 8.228E-04 BROWNE_HCMV_INFECTION_48HR_DN biliary tract cancer DOID_4607 3.037E-05 4.114E-04 3.037E-05 7.854E-04 BROWNE_HCMV_INFECTION_48HR_DN chronic kidney failure DOID_784 3.037E-05 4.018E-04 3.341E-04 3.521E-03 BROWNE_HCMV_INFECTION_48HR_DN osteosarcoma DOID_3347 3.091E-05 3.997E-04 3.091E-05 7.647E-04 BROWNE_HCMV_INFECTION_48HR_DN calcium metabolism disease DOID_10575 3.506E-05 4.433E-04 5.221E-04 4.642E-03 BROWNE_HCMV_INFECTION_48HR_DN seminoma DOID_4440 4.187E-05 5.179E-04 4.187E-05 9.53E-04 BROWNE_HCMV_INFECTION_48HR_DN transitional cell carcinoma DOID_2671 4.199E-05 5.084E-04 4.199E-05 9.19E-04 BROWNE_HCMV_INFECTION_48HR_DN Human immunodeficiency virus infectious disease DOID_526 4.754E-05 5.635E-04 4.815E-04 4.419E-03 BROWNE_HCMV_INFECTION_48HR_DN invasive lobular carcinoma DOID_3457 5.346E-05 6.207E-04 5.346E-05 1.127E-03 BROWNE_HCMV_INFECTION_48HR_DN lymphoma DOID_0060058 5.365E-05 6.105E-04 5.314E-04 4.652E-03 BROWNE_HCMV_INFECTION_48HR_DN osteochondrodysplasia DOID_2256 5.441E-05 6.07E-04 5.441E-05 1.106E-03 BROWNE_HCMV_INFECTION_48HR_DN parasitic protozoa infectious disease DOID_2789 5.441E-05 5.953E-04 0.0623209 0.17468271 BROWNE_HCMV_INFECTION_48HR_DN sarcoma DOID_1115 5.543E-05 5.951E-04 1.192E-03 9.046E-03 BROWNE_HCMV_INFECTION_48HR_DN familial hyperlipidemia DOID_1168 5.911E-05 6.228E-04 8.228E-03 0.03574026 BROWNE_HCMV_INFECTION_48HR_DN Crohn's disease DOID_8778 6.038E-05 6.246E-04 4.688E-03 0.02447369 BROWNE_HCMV_INFECTION_48HR_DN multiple epiphyseal dysplasia DOID_12721 6.329E-05 6.431E-04 6.329E-05 1.242E-03 BROWNE_HCMV_INFECTION_48HR_DN bile duct cancer DOID_4606 6.944E-05 6.932E-04 6.944E-05 1.317E-03 BROWNE_HCMV_INFECTION_48HR_DN bile duct carcinoma DOID_4897 6.944E-05 6.932E-04 6.944E-05 1.317E-03 BROWNE_HCMV_INFECTION_48HR_DN lipodystrophy DOID_811 7.091E-05 6.956E-04 3.068E-03 0.01763071 BROWNE_HCMV_INFECTION_48HR_DN female reproductive organ benign neoplasm DOID_0060086 7.194E-05 6.938E-04 7.194E-05 1.32E-03 BROWNE_HCMV_INFECTION_48HR_DN uterine benign neoplasm DOID_0060095 7.194E-05 6.938E-04 7.194E-05 1.32E-03 BROWNE_HCMV_INFECTION_48HR_DN uterine fibroid DOID_13223 7.194E-05 6.938E-04 7.194E-05 1.32E-03 BROWNE_HCMV_INFECTION_48HR_DN germinoma DOID_3304 9.176E-05 8.702E-04 9.176E-05 1.45E-03 BROWNE_HCMV_INFECTION_48HR_DN pre-malignant neoplasm DOID_0060071 1.014E-04 9.458E-04 1.014E-04 1.559E-03 BROWNE_HCMV_INFECTION_48HR_DN in situ carcinoma DOID_8719 1.014E-04 9.458E-04 1.014E-04 1.559E-03 BROWNE_HCMV_INFECTION_48HR_DN chronic leukemia DOID_1036 1.03E-04 9.456E-04 1.03E-04 1.543E-03 BROWNE_HCMV_INFECTION_48HR_DN chronic lymphocytic leukemia DOID_1040 1.03E-04 9.456E-04 1.03E-04 1.543E-03 BROWNE_HCMV_INFECTION_48HR_DN mineral metabolism disease DOID_0050032 1.09E-04 9.841E-04 1.266E-03 9.237E-03 BROWNE_HCMV_INFECTION_48HR_DN papilloma DOID_2615 1.153E-04 1.025E-03 1.153E-04 1.682E-03 BROWNE_HCMV_INFECTION_48HR_DN metal metabolism disorder DOID_896 1.153E-04 1.009E-03 1.153E-04 1.64E-03 BROWNE_HCMV_INFECTION_48HR_DN Legionnaires' disease DOID_10457 1.161E-04 1.001E-03 4.191E-03 0.02207882 BROWNE_HCMV_INFECTION_48HR_DN legionellosis DOID_10458 1.161E-04 1.001E-03 4.191E-03 0.02207882 BROWNE_HCMV_INFECTION_48HR_DN parasitic infectious disease DOID_1398 1.169E-04 9.931E-04 0.08212722 0.19885272 BROWNE_HCMV_INFECTION_48HR_DN temporal lobe epilepsy DOID_3328 1.254E-04 1.049E-03 1.254E-04 1.698E-03 BROWNE_HCMV_INFECTION_48HR_DN nephroblastoma DOID_2154 1.285E-04 1.06E-03 1.285E-04 1.701E-03 BROWNE_HCMV_INFECTION_48HR_DN thyroid carcinoma DOID_3963 1.285E-04 1.045E-03 0.02760706 0.09132802 BROWNE_HCMV_INFECTION_48HR_DN childhood electroclinical syndrome DOID_0050704 1.429E-04 1.145E-03 1.429E-04 1.848E-03 BROWNE_HCMV_INFECTION_48HR_DN thyroid cancer DOID_1781 1.583E-04 1.251E-03 0.03043823 0.09840541 BROWNE_HCMV_INFECTION_48HR_DN adenoma DOID_657 1.583E-04 1.234E-03 1.583E-04 1.917E-03 BROWNE_HCMV_INFECTION_48HR_DN adolescence-adult electroclinical syndrome DOID_0050705 1.75E-04 1.345E-03 0.03189518 0.10195708 BROWNE_HCMV_INFECTION_48HR_DN calcinosis DOID_182 1.75E-04 1.327E-03 2.756E-03 0.01668298 BROWNE_HCMV_INFECTION_48HR_DN angiosarcoma DOID_0001816 1.768E-04 1.324E-03 1.768E-04 2.096E-03 BROWNE_HCMV_INFECTION_48HR_DN diabetic retinopathy DOID_8947 1.98E-04 1.463E-03 2.018E-03 0.01350952 BROWNE_HCMV_INFECTION_48HR_DN syndrome DOID_225 2.238E-04 1.632E-03 2.238E-04 2.598E-03 BROWNE_HCMV_INFECTION_48HR_DN bone resorption disease DOID_0080011 2.375E-04 1.711E-03 2.375E-04 2.703E-03 BROWNE_HCMV_INFECTION_48HR_DN osteoporosis DOID_11476 2.375E-04 1.711E-03 2.375E-04 2.703E-03 BROWNE_HCMV_INFECTION_48HR_DN aneurysm disease DOID_2403 2.375E-04 1.689E-03 0.01808184 0.06553226 BROWNE_HCMV_INFECTION_48HR_DN mixed glioma DOID_5076 2.519E-04 1.77E-03 0.01869148 0.06647158 BROWNE_HCMV_INFECTION_48HR_DN congenital muscular dystrophy DOID_0050557 2.55E-04 1.769E-03 2.55E-04 2.844E-03 BROWNE_HCMV_INFECTION_48HR_DN prion disease DOID_649 2.55E-04 1.748E-03 6.917E-03 0.0307502 BROWNE_HCMV_INFECTION_48HR_DN lipid metabolism disorder DOID_3146 2.827E-04 1.915E-03 0.01994468 0.07005261 BROWNE_HCMV_INFECTION_48HR_DN Huntington's disease DOID_12858 3.023E-04 2.024E-03 4.106E-03 0.02183583 BROWNE_HCMV_INFECTION_48HR_DN diabetic autonomic neuropathy DOID_11503 3.287E-04 2.174E-03 0.04282473 0.12625529 BROWNE_HCMV_INFECTION_48HR_DN autonomic neuropathy DOID_11504 3.287E-04 2.174E-03 0.04282473 0.12625529 BROWNE_HCMV_INFECTION_48HR_DN diabetic polyneuropathy DOID_12785 3.287E-04 2.174E-03 0.04282473 0.12625529 BROWNE_HCMV_INFECTION_48HR_DN gallbladder cancer DOID_3121 3.287E-04 2.149E-03 3.287E-04 3.596E-03 BROWNE_HCMV_INFECTION_48HR_DN diabetic neuropathy DOID_9743 3.287E-04 2.174E-03 0.04282473 0.12625529 BROWNE_HCMV_INFECTION_48HR_DN colonic disease DOID_5353 3.525E-04 2.279E-03 3.525E-04 3.647E-03 BROWNE_HCMV_INFECTION_48HR_DN cerebral infarction DOID_3526 3.566E-04 2.28E-03 3.566E-04 3.623E-03 BROWNE_HCMV_INFECTION_48HR_DN retinal vascular disease DOID_2462 3.722E-04 2.353E-03 3.298E-03 0.01876754 BROWNE_HCMV_INFECTION_48HR_DN autonomic nervous system disease DOID_11465 4.174E-04 2.61E-03 0.04787678 0.13898922 BROWNE_HCMV_INFECTION_48HR_DN brain cancer DOID_1319 4.174E-04 2.582E-03 0.04787678 0.13828369 BROWNE_HCMV_INFECTION_48HR_DN central nervous system cancer DOID_3620 4.505E-04 2.756E-03 0.04960682 0.1418406 BROWNE_HCMV_INFECTION_48HR_DN hemolytic anemia DOID_583 4.505E-04 2.727E-03 4.505E-04 4.272E-03 BROWNE_HCMV_INFECTION_48HR_DN normocytic anemia DOID_720 4.505E-04 2.727E-03 4.505E-04 4.272E-03 BROWNE_HCMV_INFECTION_48HR_DN glaucoma DOID_1686 4.854E-04 2.907E-03 5.797E-03 0.02795485 BROWNE_HCMV_INFECTION_48HR_DN pulmonary tuberculosis DOID_2957 4.854E-04 2.877E-03 4.854E-04 4.384E-03 BROWNE_HCMV_INFECTION_48HR_DN movement disease DOID_480 5.221E-04 3.063E-03 6.114E-03 0.02898972 BROWNE_HCMV_INFECTION_48HR_DN lymphoblastic leukemia DOID_1037 5.578E-04 3.238E-03 5.578E-04 4.809E-03 BROWNE_HCMV_INFECTION_48HR_DN withdrawal disorder DOID_0060001 5.608E-04 3.223E-03 5.608E-04 4.763E-03 BROWNE_HCMV_INFECTION_48HR_DN diabetic angiopathy DOID_11713 6.131E-04 3.488E-03 6.131E-04 5.13E-03 BROWNE_HCMV_INFECTION_48HR_DN aortic valve disease DOID_62 6.131E-04 3.454E-03 6.131E-04 5.056E-03 BROWNE_HCMV_INFECTION_48HR_DN hypersensitivity reaction type I disease DOID_1205 6.134E-04 3.422E-03 0.03078619 0.09896802 BROWNE_HCMV_INFECTION_48HR_DN bile duct adenocarcinoma DOID_4896 6.891E-04 3.807E-03 6.891E-04 5.602E-03 BROWNE_HCMV_INFECTION_48HR_DN cholangiocarcinoma DOID_4947 6.891E-04 3.807E-03 6.891E-04 5.602E-03 BROWNE_HCMV_INFECTION_48HR_DN bone marrow cancer DOID_4960 6.891E-04 3.77E-03 7.482E-03 0.03300204 BROWNE_HCMV_INFECTION_48HR_DN organic acidemia DOID_0060159 7.795E-04 4.224E-03 7.795E-04 6.247E-03 BROWNE_HCMV_INFECTION_48HR_DN morbid obesity DOID_11981 8.724E-04 4.683E-03 8.724E-04 6.894E-03 BROWNE_HCMV_INFECTION_48HR_DN cleft lip DOID_9296 8.724E-04 4.639E-03 8.724E-04 6.8E-03 BROWNE_HCMV_INFECTION_48HR_DN spinal cord disease DOID_319 9.72E-04 5.121E-03 9.72E-04 7.474E-03 BROWNE_HCMV_INFECTION_48HR_DN dystonia DOID_543 9.72E-04 5.074E-03 0.01632478 0.06031688 BROWNE_HCMV_INFECTION_48HR_DN collagen disease DOID_854 1.067E-03 5.519E-03 0.01028043 0.04238814 BROWNE_HCMV_INFECTION_48HR_DN hypothyroidism DOID_1459 1.131E-03 5.796E-03 0.07599979 0.19567366 BROWNE_HCMV_INFECTION_48HR_DN invasive ductal carcinoma DOID_3008 1.192E-03 6.057E-03 1.192E-03 8.927E-03 BROWNE_HCMV_INFECTION_48HR_DN central nervous system hereditary degenerative disease DOID_481 1.192E-03 6.004E-03 0.01861568 0.06661838 BROWNE_HCMV_INFECTION_48HR_DN focal glomerulosclerosis DOID_3945 1.313E-03 6.555E-03 0.01980895 0.07000803 BROWNE_HCMV_INFECTION_48HR_DN brain infarction DOID_3454 1.571E-03 7.771E-03 1.571E-03 0.01131172 BROWNE_HCMV_INFECTION_48HR_DN spastic cerebral palsy DOID_0050669 1.578E-03 7.739E-03 1.578E-03 0.01122158 BROWNE_HCMV_INFECTION_48HR_DN gonadal disease DOID_2277 1.578E-03 7.673E-03 1.578E-03 0.01108304 BROWNE_HCMV_INFECTION_48HR_DN nephrosis DOID_2527 1.83E-03 8.823E-03 1.83E-03 0.0126965 BROWNE_HCMV_INFECTION_48HR_DN childhood absence epilepsy DOID_1825 1.873E-03 8.957E-03 1.873E-03 0.01284201 BROWNE_HCMV_INFECTION_48HR_DN autonomic nervous system neoplasm DOID_2621 1.873E-03 8.882E-03 0.02488929 0.08429764 BROWNE_HCMV_INFECTION_48HR_DN neuroblastoma DOID_769 1.873E-03 8.882E-03 0.02488929 0.08429764 BROWNE_HCMV_INFECTION_48HR_DN peripheral vascular disease DOID_341 1.922E-03 9.04E-03 1.922E-03 0.01302146 BROWNE_HCMV_INFECTION_48HR_DN hair disease DOID_421 2.033E-03 9.482E-03 2.033E-03 0.01345143 BROWNE_HCMV_INFECTION_48HR_DN familial combined hyperlipidemia DOID_13809 2.111E-03 9.765E-03 0.0677501 0.1853356 BROWNE_HCMV_INFECTION_48HR_DN progressive muscular atrophy DOID_318 2.111E-03 9.686E-03 2.111E-03 0.0138058 BROWNE_HCMV_INFECTION_48HR_DN phagocyte bactericidal dysfunction DOID_3262 2.111E-03 9.609E-03 0.0677501 0.1835705 BROWNE_HCMV_INFECTION_48HR_DN Noonan syndrome DOID_3490 2.111E-03 9.533E-03 2.111E-03 0.01364891 BROWNE_HCMV_INFECTION_48HR_DN polycythemia DOID_8432 2.111E-03 9.458E-03 2.111E-03 0.01349556 BROWNE_HCMV_INFECTION_48HR_DN cystic fibrosis DOID_1485 2.22E-03 9.866E-03 2.22E-03 0.01387801 BROWNE_HCMV_INFECTION_48HR_DN pancreatitis DOID_4989 2.434E-03 0.01073748 0.1080107 0.23104545 BROWNE_HCMV_INFECTION_48HR_DN maturity-onset diabetes of the young DOID_0050524 2.568E-03 0.01124044 2.568E-03 0.01571244 BROWNE_HCMV_INFECTION_48HR_DN trypanosomiasis DOID_10113 2.568E-03 0.01115464 0.07426829 0.19747037 BROWNE_HCMV_INFECTION_48HR_DN metabolic syndrome X DOID_14221 2.663E-03 0.01147929 0.11251402 0.23450724 BROWNE_HCMV_INFECTION_48HR_DN multiple myeloma DOID_9538 2.756E-03 0.01179098 0.03189518 0.10026718 BROWNE_HCMV_INFECTION_48HR_DN auditory system disease DOID_2742 2.906E-03 0.01233986 2.906E-03 0.0174057 BROWNE_HCMV_INFECTION_48HR_DN peripheral nervous system neoplasm DOID_1192 2.958E-03 0.01246921 0.03337912 0.1043556 BROWNE_HCMV_INFECTION_48HR_DN alcohol abuse DOID_1574 3.033E-03 0.01268977 0.02190937 0.07601484 BROWNE_HCMV_INFECTION_48HR_DN mucopolysaccharidosis DOID_12798 3.068E-03 0.01274044 3.068E-03 0.01818166 BROWNE_HCMV_INFECTION_48HR_DN epidermolysis bullosa DOID_2730 3.068E-03 0.01264811 3.068E-03 0.01799422 BROWNE_HCMV_INFECTION_48HR_DN aortic valve insufficiency DOID_57 3.068E-03 0.01255712 3.068E-03 0.01781061 BROWNE_HCMV_INFECTION_48HR_DN peritonitis DOID_8283 3.068E-03 0.01246743 0.08074109 0.19717459 BROWNE_HCMV_INFECTION_48HR_DN hepatitis DOID_2237 3.17E-03 0.01279116 0.25529954 0.41035435 BROWNE_HCMV_INFECTION_48HR_DN cone-rod dystrophy DOID_0050572 3.609E-03 0.0144599 3.609E-03 0.02032976 BROWNE_HCMV_INFECTION_48HR_DN vulva cancer DOID_1245 3.609E-03 0.01435878 3.609E-03 0.02013045 BROWNE_HCMV_INFECTION_48HR_DN vesiculobullous skin disease DOID_2731 3.609E-03 0.01425907 3.609E-03 0.01993501 BROWNE_HCMV_INFECTION_48HR_DN epilepsy with generalized tonic-clonic seizures DOID_7725 3.609E-03 0.01416073 1.000 1.000 BROWNE_HCMV_INFECTION_48HR_DN cervix uteri carcinoma in situ DOID_8991 3.619E-03 0.01410585 3.619E-03 0.01961384 BROWNE_HCMV_INFECTION_48HR_DN primary immunodeficiency disease DOID_612 3.875E-03 0.01500085 0.02614451 0.08802502 BROWNE_HCMV_INFECTION_48HR_DN encephalomyelitis DOID_640 4.517E-03 0.01736725 0.14285841 0.27933482 BROWNE_HCMV_INFECTION_48HR_DN mouth disease DOID_403 4.688E-03 0.01790357 0.14525998 0.28017942 BROWNE_HCMV_INFECTION_48HR_DN thalassemia DOID_10241 4.813E-03 0.01825814 4.813E-03 0.02489747 BROWNE_HCMV_INFECTION_48HR_DN Ehlers-Danlos syndrome DOID_13359 4.813E-03 0.01813723 4.813E-03 0.02467316 BROWNE_HCMV_INFECTION_48HR_DN renovascular hypertension DOID_1591 4.813E-03 0.0180179 4.813E-03 0.02445287 BROWNE_HCMV_INFECTION_48HR_DN oral submucous fibrosis DOID_5773 4.813E-03 0.01790014 0.09989019 0.21776826 BROWNE_HCMV_INFECTION_48HR_DN myeloma DOID_0070004 5.194E-03 0.01919217 0.04787678 0.13970199 BROWNE_HCMV_INFECTION_48HR_DN bone marrow disease DOID_4961 5.194E-03 0.01906835 0.04787678 0.13758529 BROWNE_HCMV_INFECTION_48HR_DN ulcerative colitis DOID_8577 5.416E-03 0.01975305 5.416E-03 0.02679544 BROWNE_HCMV_INFECTION_48HR_DN restrictive cardiomyopathy DOID_397 5.476E-03 0.01984457 5.476E-03 0.0268586 BROWNE_HCMV_INFECTION_48HR_DN chronic myeloid leukemia DOID_8552 5.476E-03 0.01971897 5.476E-03 0.02662903 BROWNE_HCMV_INFECTION_48HR_DN autoimmune disease of gastrointestinal tract DOID_0060031 5.797E-03 0.02074637 0.0513592 0.14611691 BROWNE_HCMV_INFECTION_48HR_DN lung small cell carcinoma DOID_5409 5.797E-03 0.0206167 5.797E-03 0.02771993 BROWNE_HCMV_INFECTION_48HR_DN aortic aneurysm DOID_3627 6.114E-03 0.02160725 0.05313352 0.1496682 BROWNE_HCMV_INFECTION_48HR_DN familial hypertrophic cardiomyopathy DOID_11986 6.177E-03 0.02169634 6.177E-03 0.029048 BROWNE_HCMV_INFECTION_48HR_DN methylmalonic acidemia DOID_14749 6.177E-03 0.02156324 6.177E-03 0.0288099 BROWNE_HCMV_INFECTION_48HR_DN urinary system benign neoplasm DOID_731 6.177E-03 0.02143175 6.177E-03 0.02857567 BROWNE_HCMV_INFECTION_48HR_DN B-cell lymphocytic neoplasm DOID_707 6.44E-03 0.02220987 6.44E-03 0.02955346 BROWNE_HCMV_INFECTION_48HR_DN orofacial cleft DOID_0050567 6.777E-03 0.02323074 6.777E-03 0.03085043 BROWNE_HCMV_INFECTION_48HR_DN male reproductive organ benign neoplasm DOID_0060087 6.917E-03 0.02356901 6.917E-03 0.0312383 BROWNE_HCMV_INFECTION_48HR_DN glucose intolerance DOID_10603 6.917E-03 0.02342872 6.917E-03 0.03099233 BROWNE_HCMV_INFECTION_48HR_DN dissociative disorder DOID_10935 7.696E-03 0.0259108 1.000 1.000 BROWNE_HCMV_INFECTION_48HR_DN dissociative amnesia DOID_11037 7.696E-03 0.0259108 1.000 1.000 BROWNE_HCMV_INFECTION_48HR_DN integumentary system cancer DOID_0060122 7.85E-03 0.0262743 7.85E-03 0.0343587 BROWNE_HCMV_INFECTION_48HR_DN skin cancer DOID_4159 7.85E-03 0.0262743 7.85E-03 0.0343587 BROWNE_HCMV_INFECTION_48HR_DN amnestic disorder DOID_10914 8.512E-03 0.02832272 1.000 1.000 BROWNE_HCMV_INFECTION_48HR_DN colon carcinoma DOID_1520 8.512E-03 0.02815805 8.512E-03 0.0366908 BROWNE_HCMV_INFECTION_48HR_DN brain edema DOID_4724 8.512E-03 0.02799529 8.512E-03 0.03641493 BROWNE_HCMV_INFECTION_48HR_DN alopecia DOID_987 8.512E-03 0.0278344 8.512E-03 0.03614317 BROWNE_HCMV_INFECTION_48HR_DN retinitis pigmentosa DOID_10584 9.017E-03 0.02931849 0.06807241 0.18184601 BROWNE_HCMV_INFECTION_48HR_DN hypertrophic cardiomyopathy DOID_11984 9.017E-03 0.02915191 9.017E-03 0.03800545 BROWNE_HCMV_INFECTION_48HR_DN oral cavity cancer DOID_8618 9.017E-03 0.02898721 9.017E-03 0.037726 BROWNE_HCMV_INFECTION_48HR_DN acquired immunodeficiency syndrome DOID_635 0.01025399 0.0327782 0.14304007 0.27778089 BROWNE_HCMV_INFECTION_48HR_DN neuroectodermal tumor DOID_171 0.01028043 0.03267912 0.01028043 0.04269754 BROWNE_HCMV_INFECTION_48HR_DN carotid artery disease DOID_3407 0.01028043 0.03249757 0.36193121 0.54625692 BROWNE_HCMV_INFECTION_48HR_DN congenital heart defect DOID_1682 0.01117678 0.03513583 0.01117678 0.04575242 BROWNE_HCMV_INFECTION_48HR_DN sinusitis DOID_0050127 0.01117921 0.03495037 0.01117921 0.04543548 BROWNE_HCMV_INFECTION_48HR_DN heart conduction disease DOID_10273 0.01117921 0.03475939 0.01117921 0.04511325 BROWNE_HCMV_INFECTION_48HR_DN paranasal sinus disease DOID_1352 0.01117921 0.03495037 0.01117921 0.04543548 BROWNE_HCMV_INFECTION_48HR_DN uremia DOID_4676 0.01117921 0.03457048 0.14903375 0.28266734 BROWNE_HCMV_INFECTION_48HR_DN sleep disorder DOID_535 0.01117921 0.03438361 0.01117921 0.04479555 BROWNE_HCMV_INFECTION_48HR_DN hypoglycemia DOID_9993 0.01117921 0.03419875 0.01117921 0.04448229 BROWNE_HCMV_INFECTION_48HR_DN endocrine pancreas disease DOID_1428 0.01164134 0.03542203 0.01164134 0.04599944 BROWNE_HCMV_INFECTION_48HR_DN cholestasis DOID_13580 0.01211687 0.03667287 0.08212722 0.19970252 BROWNE_HCMV_INFECTION_48HR_DN synostosis DOID_11971 0.01213976 0.03654775 0.01213976 0.0476381 BROWNE_HCMV_INFECTION_48HR_DN ureteral disease DOID_1426 0.01213976 0.03635539 0.15498566 0.29104568 BROWNE_HCMV_INFECTION_48HR_DN Goodpasture syndrome DOID_9808 0.01213976 0.03616505 0.15498566 0.29008829 BROWNE_HCMV_INFECTION_48HR_DN allergic contact dermatitis DOID_3042 0.01310104 0.03882547 0.38827412 0.5813894 BROWNE_HCMV_INFECTION_48HR_DN spastic quadriplegia DOID_10970 0.01313513 0.0387248 0.01313513 0.051191 BROWNE_HCMV_INFECTION_48HR_DN astrocytoma DOID_3069 0.01412956 0.04144185 0.39681205 0.59261432 BROWNE_HCMV_INFECTION_48HR_DN bronchiolitis DOID_2942 0.01416476 0.04133206 0.01416476 0.05482824 BROWNE_HCMV_INFECTION_48HR_DN pancreatic ductal carcinoma DOID_3587 0.01466053 0.04256041 0.09265955 0.21519709 BROWNE_HCMV_INFECTION_48HR_DN bile duct disease DOID_4138 0.01520267 0.04391026 0.09481113 0.21493042 BROWNE_HCMV_INFECTION_48HR_DN autosomal dominant nonsyndromic deafness DOID_0050564 0.01522816 0.04376172 0.01522816 0.05854608 BROWNE_HCMV_INFECTION_48HR_DN spinal muscular atrophy DOID_12377 0.01522816 0.04354181 0.01522816 0.05815316 BROWNE_HCMV_INFECTION_48HR_DN cystitis DOID_1679 0.01522816 0.0433241 0.17259371 0.31275738 BROWNE_HCMV_INFECTION_48HR_DN papillary adenoma DOID_3172 0.01522816 0.04310856 0.01522816 0.05776547 BROWNE_HCMV_INFECTION_48HR_DN microcystic adenoma DOID_5403 0.01522816 0.04310856 0.01522816 0.05776547 BROWNE_HCMV_INFECTION_48HR_DN follicular adenoma DOID_6204 0.01522816 0.04310856 0.01522816 0.05776547 BROWNE_HCMV_INFECTION_48HR_DN biliary tract disease DOID_9741 0.01575602 0.04438206 0.09697703 0.21896797 BROWNE_HCMV_INFECTION_48HR_DN pancreatic carcinoma DOID_4905 0.01632059 0.0457459 0.09915693 0.22300511 BROWNE_HCMV_INFECTION_48HR_DN middle cerebral artery infarction DOID_3525 0.01632478 0.04553333 0.01632478 0.06151523 BROWNE_HCMV_INFECTION_48HR_DN hypotrichosis DOID_4535 0.01632478 0.04531122 0.01632478 0.06111052 BROWNE_HCMV_INFECTION_48HR_DN juvenile myoclonic epilepsy DOID_4890 0.01632478 0.04509126 0.01632478 0.06071111 BROWNE_HCMV_INFECTION_48HR_DN fragments of torsion dystonia DOID_531 0.01632478 0.04487343 0.17838144 0.31917938 BROWNE_HCMV_INFECTION_48HR_DN gestational diabetes DOID_11714 0.01745412 0.0477471 0.01745412 0.06407353 BROWNE_HCMV_INFECTION_48HR_DN periodontitis DOID_824 0.01745412 0.04751864 0.18412885 0.32537054 BROWNE_HCMV_INFECTION_48HR_DN perinatal necrotizing enterocolitis DOID_8677 0.01745412 0.04729236 0.01745412 0.0636628 BROWNE_HCMV_INFECTION_48HR_DN renal hypertension DOID_1073 0.01861568 0.05020058 0.01861568 0.06704002 BROWNE_HCMV_INFECTION_48HR_DN secondary hypertension DOID_11130 0.01861568 0.05020058 0.01861568 0.06704002 BROWNE_HCMV_INFECTION_48HR_DN malaria DOID_12365 0.01861568 0.04996379 0.1898362 0.33338518 BROWNE_HCMV_INFECTION_48HR_DN supratentorial cancer DOID_1659 0.01980895 0.05291687 0.19550377 0.3350652 BROWNE_HCMV_INFECTION_48HR_DN toxic encephalopathy DOID_3602 0.01980895 0.05266959 0.19550377 0.334059 BROWNE_HCMV_INFECTION_48HR_DN cerebrum cancer DOID_368 0.01980895 0.05291687 0.19550377 0.3350652 BROWNE_HCMV_INFECTION_48HR_DN dystonic disease DOID_544 0.01980895 0.05242462 0.19550377 0.33305882 BROWNE_HCMV_INFECTION_48HR_DN contact dermatitis DOID_2773 0.01994468 0.05253946 0.43775342 0.65034385 BROWNE_HCMV_INFECTION_48HR_DN dysostosis DOID_1934 0.02103343 0.05515218 0.02103343 0.07342346 BROWNE_HCMV_INFECTION_48HR_DN age related macular degeneration DOID_10871 0.02228864 0.0581754 0.02228864 0.07686204 BROWNE_HCMV_INFECTION_48HR_DN degeneration of macula and posterior pole DOID_2007 0.02228864 0.0581754 0.02228864 0.07686204 BROWNE_HCMV_INFECTION_48HR_DN opportunistic mycosis DOID_2473 0.02228864 0.05790976 0.02228864 0.07639902 BROWNE_HCMV_INFECTION_48HR_DN bronchiolitis obliterans DOID_2799 0.02228864 0.05764653 0.2067207 0.34800023 BROWNE_HCMV_INFECTION_48HR_DN abdominal aortic aneurysm DOID_7693 0.02228864 0.05738569 0.2067207 0.34697368 BROWNE_HCMV_INFECTION_48HR_DN celiac disease DOID_10608 0.02357409 0.06042187 0.02357409 0.08032128 BROWNE_HCMV_INFECTION_48HR_DN bladder disease DOID_365 0.02488929 0.06350674 0.21778181 0.3623329 BROWNE_HCMV_INFECTION_48HR_DN systemic mycosis DOID_0050136 0.02623377 0.06663846 0.02623377 0.08780597 BROWNE_HCMV_INFECTION_48HR_DN fungal infectious disease DOID_1564 0.02623377 0.06663846 0.02623377 0.08780597 BROWNE_HCMV_INFECTION_48HR_DN myocarditis DOID_820 0.02623377 0.06634229 0.02623377 0.08729248 BROWNE_HCMV_INFECTION_48HR_DN periodontal disease DOID_3388 0.02760706 0.06950628 0.22868927 0.378268 BROWNE_HCMV_INFECTION_48HR_DN macular degeneration DOID_4448 0.02760706 0.06920008 0.02760706 0.09080011 BROWNE_HCMV_INFECTION_48HR_DN esophageal disease DOID_6050 0.02760706 0.06889657 0.22868927 0.37608148 BROWNE_HCMV_INFECTION_48HR_DN hyperthyroidism DOID_7998 0.02760706 0.06859572 0.02760706 0.09027827 BROWNE_HCMV_INFECTION_48HR_DN carbohydrate metabolic disorder DOID_2978 0.02919395 0.07222329 0.02919395 0.09492204 BROWNE_HCMV_INFECTION_48HR_DN pulmonary sarcoidosis DOID_13406 0.03189518 0.07856433 0.24476699 0.39792119 BROWNE_HCMV_INFECTION_48HR_DN cleft palate DOID_674 0.03189518 0.07822569 0.03189518 0.10138748 BROWNE_HCMV_INFECTION_48HR_DN embryonal cancer DOID_688 0.03189518 0.07788996 0.03189518 0.10082422 BROWNE_HCMV_INFECTION_48HR_DN congenital diaphragmatic hernia DOID_3827 0.03488959 0.08483837 0.03488959 0.10848185 BROWNE_HCMV_INFECTION_48HR_DN systemic scleroderma DOID_418 0.03488959 0.08447735 0.25529954 0.40919842 BROWNE_HCMV_INFECTION_48HR_DN peptic ulcer DOID_750 0.03488959 0.0841194 0.03488959 0.10789227 BROWNE_HCMV_INFECTION_48HR_DN adult respiratory distress syndrome DOID_11394 0.03642616 0.08745352 0.03642616 0.11203505 BROWNE_HCMV_INFECTION_48HR_DN intracranial arterial disease DOID_13089 0.03642616 0.08708607 0.03642616 0.11143271 BROWNE_HCMV_INFECTION_48HR_DN cerebral arterial disease DOID_3527 0.03642616 0.08708607 0.03642616 0.11143271 BROWNE_HCMV_INFECTION_48HR_DN adenoid cystic carcinoma DOID_4866 0.03642616 0.08672169 0.03642616 0.11083681 BROWNE_HCMV_INFECTION_48HR_DN lymphatic system disease DOID_75 0.03642616 0.08636035 0.03642616 0.11024726 BROWNE_HCMV_INFECTION_48HR_DN autoimmune disease of urogenital tract DOID_0060049 0.03957584 0.09343839 0.03957584 0.1191463 BROWNE_HCMV_INFECTION_48HR_DN primary biliary cirrhosis DOID_12236 0.03957584 0.09343839 0.03957584 0.1191463 BROWNE_HCMV_INFECTION_48HR_DN salivary gland cancer DOID_8850 0.03957584 0.09305228 0.03957584 0.11851922 BROWNE_HCMV_INFECTION_48HR_DN nephrotic syndrome DOID_1184 0.04118809 0.09644455 0.04118809 0.1227017 BROWNE_HCMV_INFECTION_48HR_DN rheumatic disease DOID_1575 0.04118809 0.09604928 0.27592765 0.43733379 BROWNE_HCMV_INFECTION_48HR_DN primitive neuroectodermal tumor DOID_168 0.04118809 0.09565724 0.04118809 0.12206263 BROWNE_HCMV_INFECTION_48HR_DN scleroderma DOID_419 0.04118809 0.09604928 0.27592765 0.43733379 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN multiple myeloma DOID_9538 3.585E-14 2.04E-11 4.98E-04 0.02361143 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN myeloma DOID_0070004 3.179E-13 9.045E-11 9.604E-04 0.03415589 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN bone marrow cancer DOID_4960 1.116E-12 2.117E-10 1.406E-03 0.0421028 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN oral cavity cancer DOID_8618 9.88E-11 1.405E-08 3.954E-06 2.25E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN transitional cell carcinoma DOID_2671 2.368E-09 2.694E-07 0.29367473 0.7919475 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lymphoma DOID_0060058 3.356E-09 3.183E-07 5.807E-03 0.10013019 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN germinoma DOID_3304 3.62E-09 2.942E-07 7.622E-03 0.11120849 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN pre-malignant neoplasm DOID_0060071 7E-09 4.978E-07 0.02690437 0.26857171 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN in situ carcinoma DOID_8719 7E-09 4.978E-07 0.02690437 0.26857171 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN cervix uteri carcinoma in situ DOID_8991 1.841E-08 1.164E-06 0.15622817 0.53229839 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN glaucoma DOID_1686 5.176E-08 2.945E-06 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN B-cell lymphocytic neoplasm DOID_707 6.525E-08 3.375E-06 0.0184935 0.21045601 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN nervous system cancer DOID_3093 7.244E-08 3.435E-06 0.04923024 0.32572099 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN reproductive organ benign neoplasm DOID_0050622 1.01E-07 4.419E-06 0.02115041 0.23597228 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN papilloma DOID_2615 2.708E-07 1.1E-05 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN spindle cell carcinoma DOID_4015 3.121E-07 1.184E-05 8.981E-03 0.12464053 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN adenoma DOID_657 4.097E-07 1.457E-05 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN peripheral nervous system neoplasm DOID_1192 5.299E-07 1.774E-05 0.01094748 0.14157082 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN adenoid cystic carcinoma DOID_4866 6.765E-07 2.138E-05 2.318E-05 6.594E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN granulosa cell tumor DOID_2999 7.821E-07 2.342E-05 0.07070596 0.39059894 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN salivary gland cancer DOID_8850 8.533E-07 2.428E-05 2.781E-05 5.275E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN sex cord-gonadal stromal tumor DOID_192 9.747E-07 2.641E-05 0.07428658 0.39138023 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN Human immunodeficiency virus infectious disease DOID_526 1.597E-06 4.132E-05 2.97E-05 4.225E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN encephalomyelitis DOID_640 1.929E-06 4.771E-05 0.05212459 0.34090682 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN papillary adenoma DOID_3172 3.457E-06 8.197E-05 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN microcystic adenoma DOID_5403 3.457E-06 8.197E-05 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN follicular adenoma DOID_6204 3.457E-06 8.197E-05 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN B cell deficiency DOID_2115 4.022E-06 9.153E-05 1.708E-04 0.01943611 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN seminoma DOID_4440 4.022E-06 8.801E-05 0.10244263 0.4553895 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN diffuse large B-cell lymphoma DOID_0050745 4.651E-06 9.802E-05 0.10590179 0.46352398 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN neuroectodermal tumor DOID_171 5.021E-06 1.02E-04 1.963E-03 0.05076915 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN allergic contact dermatitis DOID_3042 7.824E-06 1.535E-04 2.536E-03 0.06012476 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN endocrine organ benign neoplasm DOID_0060089 8.391E-06 1.591E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN autonomic nervous system neoplasm DOID_2621 1.007E-05 1.849E-04 0.12638046 0.47309526 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN neuroblastoma DOID_769 1.007E-05 1.849E-04 0.12638046 0.47309526 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN male reproductive system disease DOID_48 1.029E-05 1.829E-04 0.03321173 0.30979464 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN peripheral vascular disease DOID_341 1.099E-05 1.894E-04 0.03403712 0.31237294 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN ocular hypertension DOID_9282 1.2E-05 2.008E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN borderline glaucoma DOID_9283 1.2E-05 2.008E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN nephroblastoma DOID_2154 1.263E-05 2.053E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN medullomyoblastoma DOID_3861 1.407E-05 2.224E-04 4.276E-04 0.0304116 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN adult medulloblastoma DOID_3864 1.407E-05 2.224E-04 4.276E-04 0.0304116 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN childhood medulloblastoma DOID_3869 1.407E-05 2.224E-04 4.276E-04 0.0304116 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN contact dermatitis DOID_2773 1.7E-05 2.614E-04 3.967E-03 0.08062309 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN medulloblastoma DOID_3858 1.732E-05 2.593E-04 4.98E-04 0.02575793 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN uveitis DOID_13141 1.913E-05 2.791E-04 0.14639321 0.51102907 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN bone development disease DOID_0080006 2.143E-05 3.048E-04 4.534E-03 0.08895581 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN varicose veins DOID_799 2.461E-05 3.415E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN primary immunodeficiency disease DOID_612 2.818E-05 3.817E-04 4.35E-04 0.02750169 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN angiosarcoma DOID_0001816 3.02E-05 3.996E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN tongue cancer DOID_8649 3.02E-05 3.906E-04 0.05988136 0.36247332 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN vein disease DOID_866 3.02E-05 3.819E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN primitive neuroectodermal tumor DOID_168 3.037E-05 3.757E-04 7.523E-04 0.03292625 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN uveal disease DOID_3480 3.037E-05 3.677E-04 0.16272221 0.54464081 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lymphoblastic leukemia DOID_1037 3.467E-05 4.11E-04 5.98E-03 0.10007485 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.647E-05 4.235E-04 0.30987844 0.83170204 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lymphatic system cancer DOID_0060073 3.657E-05 4.162E-04 0.0635034 0.38035194 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN reticulosarcoma DOID_8538 3.657E-05 4.162E-04 0.0635034 0.38035194 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lymphosarcoma DOID_8675 3.657E-05 4.162E-04 0.0635034 0.38035194 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN thyroid adenoma DOID_2891 4.235E-05 4.725E-04 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN agammaglobulinemia DOID_2583 5.182E-05 5.67E-04 2.413E-03 0.05969072 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN testicular cancer DOID_2998 5.182E-05 5.563E-04 0.07070596 0.39442834 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN blood protein disease DOID_620 6.079E-05 6.406E-04 2.674E-03 0.05852255 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN hypertrophic cardiomyopathy DOID_11984 9.288E-05 9.608E-04 0.02324078 0.2361429 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN hypersensitivity reaction type IV disease DOID_2916 9.288E-05 9.437E-04 0.20987092 0.6385912 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN diabetic angiopathy DOID_11713 1.067E-04 1.065E-03 0.08847257 0.43774688 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN carotid artery disease DOID_3407 1.121E-04 1.099E-03 0.21897931 0.6489543 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN middle cerebral artery infarction DOID_3525 1.708E-04 1.647E-03 5.214E-03 0.09271117 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN sarcoma DOID_1115 2.105E-04 1.996E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN female reproductive organ benign neoplasm DOID_0060086 2.557E-04 2.385E-03 0.11620003 0.46892068 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN uterine benign neoplasm DOID_0060095 2.557E-04 2.385E-03 0.11620003 0.46892068 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN uterine fibroid DOID_13223 2.557E-04 2.385E-03 0.11620003 0.46892068 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN metabolic syndrome X DOID_14221 2.924E-04 2.683E-03 3.967E-03 0.08360913 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN celiac disease DOID_10608 3.067E-04 2.77E-03 3.067E-04 0.02908892 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN allergic rhinitis DOID_4481 3.067E-04 2.727E-03 0.12299999 0.46971136 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN chronic leukemia DOID_1036 3.345E-04 2.929E-03 3.345E-04 0.02719411 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN chronic lymphocytic leukemia DOID_1040 3.345E-04 2.929E-03 3.345E-04 0.02719411 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN leiomyoma DOID_127 3.345E-04 2.884E-03 0.12638046 0.47940319 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN systemic mycosis DOID_0050136 3.639E-04 3.091E-03 8.517E-03 0.12115446 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN fungal infectious disease DOID_1564 3.639E-04 3.091E-03 8.517E-03 0.12115446 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN myocarditis DOID_820 3.639E-04 3.045E-03 0.12974798 0.48252681 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN amino acid metabolic disorder DOID_9252 4.35E-04 3.587E-03 4.35E-04 0.02475153 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN refractive error DOID_9835 4.619E-04 3.755E-03 9.943E-03 0.13469733 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN mouth disease DOID_403 5.327E-04 4.269E-03 6.156E-03 0.09729241 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN Crohn's disease DOID_8778 5.327E-04 4.21E-03 0.05310266 0.33203749 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN hypersensitivity reaction type I disease DOID_1205 5.54E-04 4.318E-03 6.334E-03 0.09741216 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN intracranial arterial disease DOID_13089 6.168E-04 4.742E-03 0.01199532 0.15167419 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN cerebral arterial disease DOID_3527 6.168E-04 4.742E-03 0.01199532 0.15167419 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lymphatic system disease DOID_75 6.168E-04 4.679E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN rectal neoplasm DOID_1984 6.496E-04 4.863E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN rectum cancer DOID_1993 6.496E-04 4.863E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN invasive lobular carcinoma DOID_3457 7.919E-04 5.852E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN uterine cancer DOID_363 8.013E-04 5.845E-03 0.16595059 0.5489877 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN cerebral infarction DOID_3526 8.523E-04 6.139E-03 0.01479786 0.17914851 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN cataract DOID_83 8.523E-04 6.062E-03 0.1691666 0.55639189 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN leukodystrophy DOID_10579 9.054E-04 6.36E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN esophageal carcinoma DOID_1107 9.479E-04 6.577E-03 9.479E-04 0.03852413 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN beta thalassemia DOID_12241 9.479E-04 6.498E-03 9.479E-04 0.03595586 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN esophagus squamous cell carcinoma DOID_3748 9.479E-04 6.577E-03 9.479E-04 0.03852413 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lens disease DOID_110 9.604E-04 6.506E-03 0.17556173 0.57082644 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN brain cancer DOID_1319 9.604E-04 6.429E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN neuritis DOID_1803 9.604E-04 6.355E-03 0.01599022 0.18955069 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN vascular skin disease DOID_9540 9.604E-04 6.282E-03 0.17556173 0.56437642 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN central nervous system cancer DOID_3620 1.018E-03 6.58E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.077E-03 6.885E-03 1.077E-03 0.03604392 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN pulmonary tuberculosis DOID_2957 1.077E-03 6.808E-03 1.077E-03 0.03404148 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN berylliosis DOID_10322 1.117E-03 6.987E-03 0.04893154 0.35243097 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN viral pneumonia DOID_10533 1.3E-03 8.042E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN aspergillosis DOID_13564 1.3E-03 7.956E-03 0.05259548 0.3362565 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN sarcoidosis DOID_11335 1.336E-03 8.085E-03 0.19445526 0.60461773 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN giant cell tumor DOID_200 1.336E-03 8E-03 0.19445526 0.60133177 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN malignant giant cell tumor DOID_2705 1.336E-03 8E-03 0.19445526 0.60133177 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN giant cell glioblastoma DOID_3074 1.336E-03 8E-03 0.19445526 0.60133177 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN osteochondrodysplasia DOID_2256 1.478E-03 8.763E-03 0.02115041 0.23143435 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN parasitic protozoa infectious disease DOID_2789 1.478E-03 8.672E-03 0.20065705 0.61383796 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN thalassemia DOID_10241 1.497E-03 8.689E-03 1.497E-03 0.04257783 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN glioblastoma DOID_3068 1.71E-03 9.828E-03 0.20987092 0.63519444 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN congenital disorder of glycosylation type I DOID_0050570 1.929E-03 0.01097412 1.929E-03 0.05225771 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN congenital heart defect DOID_1682 2.144E-03 0.0120779 0.22499355 0.65990377 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN male reproductive organ benign neoplasm DOID_0060087 2.164E-03 0.01207329 0.06711158 0.38572213 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN parasitic infectious disease DOID_1398 2.335E-03 0.01289829 0.2309618 0.67049625 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN cerebral degeneration DOID_1443 2.335E-03 0.01277427 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN brain infarction DOID_3454 2.64E-03 0.01430898 0.0307841 0.30200264 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN tuberculosis DOID_399 2.64E-03 0.01417399 2.64E-03 0.0600977 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN colon carcinoma DOID_1520 2.674E-03 0.01422043 0.07428658 0.39503799 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN amyloidosis DOID_9120 2.674E-03 0.01408876 0.07428658 0.38426423 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN astrocytoma DOID_3069 2.748E-03 0.01434296 0.2427617 0.69412767 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN pancreatic ductal carcinoma DOID_3587 2.857E-03 0.01478024 0.03239438 0.31241357 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN Kawasaki disease DOID_13378 2.948E-03 0.01511277 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lymphadenitis DOID_1602 2.948E-03 0.01511277 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN lymph node disease DOID_9942 2.948E-03 0.01511277 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN pancreatic carcinoma DOID_4905 3.203E-03 0.01627059 0.03487049 0.31002042 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN diabetic retinopathy DOID_8947 3.203E-03 0.0161266 0.25438176 0.71655061 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN endogenous depression DOID_1595 3.446E-03 0.01720201 0.03656083 0.32004792 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN syndrome DOID_225 3.446E-03 0.01705243 0.26012521 0.72554531 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN muscle cancer DOID_4045 3.534E-03 0.01733488 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN polyarteritis nodosa DOID_9810 3.534E-03 0.01718672 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN aneurysm disease DOID_2403 3.572E-03 0.01722666 0.26298043 0.7263877 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN toxic shock syndrome DOID_14115 4.169E-03 0.01993629 0.0919852 0.44734681 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN mental depression DOID_1596 4.388E-03 0.02080576 0.04271757 0.32408394 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN commensal bacterial infectious disease DOID_0050339 4.506E-03 0.02118724 0.09548438 0.45655978 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN portal hypertension DOID_10762 4.506E-03 0.02101358 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN retinal vascular disease DOID_2462 4.683E-03 0.0216618 0.28543175 0.77338413 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN cleft lip DOID_9296 4.854E-03 0.02227248 0.09897018 0.45051224 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN primary bacterial infectious disease DOID_0050338 4.989E-03 0.02271016 4.989E-03 0.09462566 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN myopia DOID_11830 5.214E-03 0.02354569 0.10244263 0.45897524 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN vitiligo DOID_12306 5.214E-03 0.0233603 5.214E-03 0.09570185 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN periodontitis DOID_824 5.586E-03 0.02483212 0.10590179 0.44968745 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN malaria DOID_12365 5.97E-03 0.02633328 0.10934771 0.45749152 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN hepatic vascular disease DOID_272 5.97E-03 0.02613072 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN invasive ductal carcinoma DOID_3008 5.97E-03 0.02593124 0.10934771 0.4476176 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN carbohydrate metabolic disorder DOID_2978 5.98E-03 0.02577686 5.98E-03 0.09721557 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN dilated cardiomyopathy DOID_12930 6.334E-03 0.02709962 0.31254293 0.83491516 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN corneal disease DOID_10124 6.773E-03 0.02876065 0.11620003 0.46561842 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN dysostosis DOID_1934 6.773E-03 0.02854761 0.11620003 0.46236235 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN endometrial carcinoma DOID_2871 6.773E-03 0.0283377 0.11620003 0.4591515 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN congenital disorder of glycosylation DOID_5212 6.773E-03 0.02813086 6.773E-03 0.10141915 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN opportunistic mycosis DOID_2473 7.192E-03 0.02965415 0.11960653 0.46935251 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN bronchiolitis obliterans DOID_2799 7.192E-03 0.02944081 0.11960653 0.46613777 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN endometrial cancer DOID_1380 7.622E-03 0.03097951 0.12299999 0.47288508 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN pneumoconiosis DOID_10316 8.981E-03 0.03624299 0.13310262 0.49178824 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN periodontal disease DOID_3388 8.981E-03 0.03598776 0.13310262 0.48548326 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN esophageal disease DOID_6050 8.981E-03 0.0357361 0.13310262 0.48239101 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN pulmonary sarcoidosis DOID_13406 0.01043959 0.04125089 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN cleft palate DOID_674 0.01043959 0.0409664 0.14308966 0.50258034 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN embryonal cancer DOID_688 0.01043959 0.0406858 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN microcephaly DOID_10907 0.01094748 0.04237494 0.01094748 0.14486317 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN hepatitis DOID_2237 0.01146609 0.04408246 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN systemic scleroderma DOID_418 0.01146609 0.0437866 0.14968412 0.51307387 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN peptic ulcer DOID_750 0.01146609 0.04349469 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN benign mesothelioma DOID_2645 0.0125351 0.04723491 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN autoimmune disease of urogenital tract DOID_0060049 0.01308533 0.04898389 0.15948142 0.54014838 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN primary biliary cirrhosis DOID_12236 0.01308533 0.04898389 0.15948142 0.54014838 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN endometriosis of uterus DOID_288 0.01308533 0.04866373 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN rheumatic disease DOID_1575 0.01364592 0.05041902 0.16272221 0.54786353 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN endometriosis DOID_289 0.01364592 0.05009373 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN scleroderma DOID_419 0.01364592 0.05041902 0.16272221 0.54786353 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN diabetic autonomic neuropathy DOID_11503 0.01421679 0.05185484 0.16595059 0.55219816 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN autonomic neuropathy DOID_11504 0.01421679 0.05185484 0.16595059 0.55219816 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN diabetic polyneuropathy DOID_12785 0.01421679 0.05185484 0.16595059 0.55219816 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN gallbladder cancer DOID_3121 0.01421679 0.05152455 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN influenza DOID_8469 0.01421679 0.05119845 0.01421679 0.17585553 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN diabetic neuropathy DOID_9743 0.01421679 0.05185484 0.16595059 0.55219816 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN learning disability DOID_8927 0.01479786 0.05295585 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN proteinuria DOID_576 0.01538903 0.05472722 0.1723703 0.5636707 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN autonomic nervous system disease DOID_11465 0.01599022 0.05651201 0.17556173 0.5675831 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN bone marrow disease DOID_4961 0.01599022 0.05616317 0.01599022 0.18568231 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN hemolytic anemia DOID_583 0.01660134 0.05795193 0.17874094 0.57136851 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN normocytic anemia DOID_720 0.01660134 0.05795193 0.17874094 0.57136851 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN orofacial cleft DOID_0050567 0.01914353 0.06641871 0.19133647 0.59818931 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN smallpox DOID_8736 0.02115041 0.07293689 0.02115041 0.22706766 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN familial hyperlipidemia DOID_1168 0.02183803 0.07485447 0.02183803 0.23010818 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN congenital nervous system abnormality DOID_2490 0.02253485 0.07678041 0.02253485 0.23313325 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN melancholia DOID_2848 0.02395574 0.08113581 0.21291871 0.64100924 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN leukocyte disease DOID_9500 0.02395574 0.08065572 0.21291871 0.63763551 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN neurotic disorder DOID_4964 0.02467966 0.08260427 0.21595482 0.64334186 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN collagen disease DOID_854 0.02541246 0.08455958 0.21897931 0.64559184 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN respiratory failure DOID_11162 0.02615405 0.08652126 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN mineral metabolism disease DOID_0050032 0.02766333 0.09098518 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN uterine disease DOID_345 0.02843086 0.09297219 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN temporal lobe epilepsy DOID_3328 0.02920689 0.0949641 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN hyperglycemia DOID_4195 0.02920689 0.09442453 0.23392878 0.67566233 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN tooth disease DOID_1091 0.02999132 0.09641278 0.2368844 0.68074355 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP sarcoidosis DOID_11335 6.486E-14 3.69E-11 0.14901249 0.84788108 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hypersensitivity reaction type IV disease DOID_2916 1.467E-13 4.174E-11 0.16119448 0.86527981 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pulmonary sarcoidosis DOID_13406 2.561E-13 4.857E-11 0.10883993 0.75524292 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP respiratory failure DOID_11162 2.679E-13 3.81E-11 0.17081553 0.8999448 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bacterial pneumonia DOID_874 1.875E-12 2.134E-10 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hypersensitivity reaction type I disease DOID_1205 1.11E-11 1.053E-09 2.801E-03 0.22771002 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP peptic ulcer DOID_750 3.316E-11 2.696E-09 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP adult respiratory distress syndrome DOID_11394 3.952E-11 2.811E-09 0.11651279 0.77995034 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP neuritis DOID_1803 1.205E-10 7.618E-09 0.13416252 0.83888436 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP transitional cell carcinoma DOID_2671 2.293E-10 1.305E-08 0.02783799 0.63359257 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP vasculitis DOID_865 3.137E-10 1.623E-08 0.15146283 0.84492502 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Crohn's disease DOID_8778 3.867E-10 1.833E-08 0.24176343 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP ulcerative colitis DOID_8577 5.375E-10 2.353E-08 3.053E-03 0.21716087 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP peripheral vascular disease DOID_341 2.257E-09 9.175E-08 0.19439244 0.92174415 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP aneurysm disease DOID_2403 3.266E-09 1.239E-07 0.20363612 0.94974549 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pancreatitis DOID_4989 3.571E-09 1.27E-07 0.0223745 0.70728286 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP vascular skin disease DOID_9540 7.046E-09 2.358E-07 0.13416252 0.81211145 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP primary bacterial infectious disease DOID_0050338 7.583E-09 2.397E-07 0.22628808 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP portal hypertension DOID_10762 1.123E-08 3.362E-07 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Sciatic Neuropathy DOID_11446 2.013E-08 5.727E-07 0.08013695 0.72377662 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lesion of sciatic nerve DOID_12528 2.013E-08 5.727E-07 0.08013695 0.72377662 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP mononeuritis of lower limb DOID_9473 2.013E-08 5.727E-07 0.08013695 0.72377662 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP mononeuritis DOID_1802 2.41E-08 6.53E-07 0.08278373 0.71369608 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hepatic vascular disease DOID_272 2.41E-08 6.233E-07 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP mononeuropathy DOID_1188 2.867E-08 7.092E-07 0.08542296 0.72545764 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP allergic contact dermatitis DOID_3042 5.549E-08 1.316E-06 5.122E-05 0.02914343 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP tuberculosis DOID_399 6.047E-08 1.376E-06 0.18504246 0.90766518 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP papilloma DOID_2615 6.289E-08 1.376E-06 0.09850665 0.73750371 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pneumoconiosis DOID_10316 7.255E-08 1.529E-06 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cystic fibrosis DOID_1485 1.067E-07 2.168E-06 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP silicosis DOID_10325 1.146E-07 2.248E-06 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP contact dermatitis DOID_2773 1.441E-07 2.733E-06 9.515E-05 0.02707039 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lipid metabolism disorder DOID_3146 1.441E-07 2.645E-06 0.02342758 0.66651475 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pulmonary emphysema DOID_9675 1.779E-07 3.163E-06 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP biliary tract cancer DOID_4607 1.788E-07 3.082E-06 0.02504475 0.64774832 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP chronic kidney failure DOID_784 1.788E-07 2.991E-06 0.02504475 0.61958535 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP gallbladder cancer DOID_3121 2.495E-07 4.057E-06 8.138E-03 0.3561992 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pre-eclampsia DOID_10591 3.423E-07 5.41E-06 9.171E-03 0.34787735 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP encephalomyelitis DOID_640 3.47E-07 5.337E-06 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP familial hyperlipidemia DOID_1168 7.924E-07 1.186E-05 0.15634256 0.8553742 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP carotid artery disease DOID_3407 1.193E-06 1.741E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cholestasis DOID_13580 1.616E-06 2.299E-05 1.011E-03 0.1438688 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP parasitic infectious disease DOID_1398 1.616E-06 2.243E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP uterine disease DOID_345 1.616E-06 2.19E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP brain infarction DOID_3454 2.005E-06 2.653E-05 0.18504246 0.91555792 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bile duct disease DOID_4138 2.464E-06 3.186E-05 1.292E-03 0.14702477 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP biliary tract disease DOID_9741 2.634E-06 3.33E-05 1.343E-03 0.12736033 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP diabetic retinopathy DOID_8947 2.813E-06 3.479E-05 0.02032959 0.68044344 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP temporal arteritis DOID_13375 3.751E-06 4.541E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP central nervous system vasculitis DOID_525 3.751E-06 4.541E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP metabolic syndrome X DOID_14221 4.098E-06 4.857E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP female reproductive system disease DOID_229 4.35E-06 5.052E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP adenoma DOID_657 4.92E-06 5.6E-05 0.10626766 0.76539621 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP embryonal cancer DOID_688 5.455E-06 6.086E-05 5.949E-03 0.30774226 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP retinal vascular disease DOID_2462 5.486E-06 6.003E-05 0.02614751 0.61991393 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP uveitis DOID_13141 6.032E-06 6.475E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP intracranial thrombosis DOID_4193 6.475E-06 6.823E-05 0.03674469 0.63356755 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Legionnaires' disease DOID_10457 8.223E-06 8.507E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP legionellosis DOID_10458 8.223E-06 8.507E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP aspergillosis DOID_13564 8.223E-06 8.356E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP endometriosis of uterus DOID_288 8.796E-06 8.78E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.891E-06 8.722E-05 1.752E-04 0.0332344 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP endometriosis DOID_289 9.612E-06 9.27E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP uveal disease DOID_3480 9.612E-06 9.116E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP influenza DOID_8469 1.048E-05 9.779E-05 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP learning disability DOID_8927 1.141E-05 1.047E-04 8.476E-03 0.34449405 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP proteinuria DOID_576 1.24E-05 1.12E-04 0.13166269 0.8417536 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP spastic diplegia DOID_10965 1.26E-05 1.12E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP heart valve disease DOID_4079 1.345E-05 1.177E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bronchitis DOID_6132 1.527E-05 1.316E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pulmonary tuberculosis DOID_2957 1.574E-05 1.336E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lung small cell carcinoma DOID_5409 1.574E-05 1.317E-04 0.13914082 0.82469925 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP aortic aneurysm DOID_3627 1.698E-05 1.401E-04 0.14161933 0.83073605 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP giant cell tumor DOID_200 2.116E-05 1.72E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP malignant giant cell tumor DOID_2705 2.116E-05 1.72E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP giant cell glioblastoma DOID_3074 2.116E-05 1.72E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bone marrow cancer DOID_4960 2.271E-05 1.82E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP parasitic protozoa infectious disease DOID_2789 2.434E-05 1.923E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP brain edema DOID_4724 2.543E-05 1.982E-04 0.05597288 0.79621415 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP blood protein disease DOID_620 2.543E-05 1.956E-04 0.05597288 0.77679429 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Kawasaki disease DOID_13378 2.961E-05 2.246E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lymphadenitis DOID_1602 2.961E-05 2.246E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lymph node disease DOID_9942 2.961E-05 2.246E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP glioblastoma DOID_3068 2.974E-05 2.226E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bile duct cancer DOID_4606 2.974E-05 2.197E-04 0.16119448 0.85719309 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bile duct carcinoma DOID_4897 2.974E-05 2.197E-04 0.16119448 0.85719309 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP gastric ulcer DOID_10808 3.421E-05 2.496E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP urinary tract obstruction DOID_5200 3.926E-05 2.828E-04 0.06409665 0.79284764 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pulmonary embolism DOID_9477 3.926E-05 2.793E-04 0.06409665 0.77597855 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP polyarteritis nodosa DOID_9810 3.926E-05 2.758E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pre-malignant neoplasm DOID_0060071 4.062E-05 2.818E-04 0.17320366 0.9041549 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP in situ carcinoma DOID_8719 4.062E-05 2.818E-04 0.17320366 0.9041549 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP aortic valve disease DOID_62 4.478E-05 3.07E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP toxic shock syndrome DOID_14115 5.078E-05 3.44E-04 0.06947397 0.80674878 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP acute pancreatitis DOID_2913 5.078E-05 3.399E-04 0.06947397 0.77511157 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP endocrine organ benign neoplasm DOID_0060089 5.416E-05 3.583E-04 0.18504246 0.92358913 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP astrocytoma DOID_3069 5.722E-05 3.742E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP commensal bacterial infectious disease DOID_0050339 5.728E-05 3.704E-04 0.07215114 0.78950002 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP urticaria DOID_1555 5.728E-05 3.662E-04 0.07215114 0.74643638 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP blood coagulation disease DOID_1247 6.04E-05 3.819E-04 0.18973081 0.92270797 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP ankylosing spondylitis DOID_7147 6.431E-05 4.021E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP intracranial aneurysm DOID_10941 7.187E-05 4.445E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP extrinsic allergic alveolitis DOID_841 7.187E-05 4.397E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP mixed glioma DOID_5076 8.642E-05 5.231E-04 0.0223745 0.67005744 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP autoimmune disease of cardiovascular system DOID_0060051 8.87E-05 5.313E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP renal hypertension DOID_1073 8.87E-05 5.257E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP secondary hypertension DOID_11130 8.87E-05 5.257E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Behcet's disease DOID_13241 8.87E-05 5.313E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP spastic cerebral palsy DOID_0050669 1.185E-04 6.948E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP opportunistic mycosis DOID_2473 1.185E-04 6.877E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bronchiolitis obliterans DOID_2799 1.185E-04 6.808E-04 0.09067886 0.72670803 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP endometrial cancer DOID_1380 1.296E-04 7.377E-04 0.09329557 0.72719427 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP allergic rhinitis DOID_4481 1.296E-04 7.304E-04 0.09329557 0.71736732 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pleural disease DOID_1532 1.415E-04 7.894E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP systemic mycosis DOID_0050136 1.54E-04 8.51E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP fungal infectious disease DOID_1564 1.54E-04 8.51E-04 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hepatitis DOID_2237 2.446E-04 1.338E-03 0.11396247 0.77196008 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP systemic scleroderma DOID_418 2.446E-04 1.325E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP intracranial arterial disease DOID_13089 2.624E-04 1.408E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cerebral arterial disease DOID_3527 2.624E-04 1.408E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lymphatic system disease DOID_75 2.624E-04 1.395E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP rheumatic disease DOID_1575 3.207E-04 1.69E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP scleroderma DOID_419 3.207E-04 1.69E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP uterine cancer DOID_363 3.419E-04 1.785E-03 0.12664155 0.82826482 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP familial combined hyperlipidemia DOID_13809 3.631E-04 1.878E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hypolipoproteinemia DOID_1387 3.631E-04 1.861E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP insulinoma DOID_3892 3.631E-04 1.845E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cutaneous leishmaniasis DOID_9111 3.631E-04 1.828E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cerebral infarction DOID_3526 3.639E-04 1.816E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP myeloma DOID_0070004 4.107E-04 2.032E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP thyroid adenoma DOID_2891 4.107E-04 2.014E-03 0.13416252 0.82976605 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP breast benign neoplasm DOID_0060082 4.429E-04 2.154E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP thoracic benign neoplasm DOID_0060097 4.429E-04 2.154E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP common variable immunodeficiency DOID_12177 4.429E-04 2.136E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP benign breast phyllodes tumor DOID_1631 4.429E-04 2.154E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP aortic valve stenosis DOID_1712 5.305E-04 2.537E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP islet cell tumor DOID_1799 5.305E-04 2.516E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP atopic dermatitis DOID_3310 5.44E-04 2.558E-03 0.14655514 0.84232197 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP atrophic muscular disease DOID_913 5.736E-04 2.675E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP muscular dystrophy DOID_9884 5.736E-04 2.675E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bile duct adenocarcinoma DOID_4896 6.042E-04 2.795E-03 0.15146283 0.85329061 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cholangiocarcinoma DOID_4947 6.042E-04 2.795E-03 0.15146283 0.85329061 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP leprosy DOID_1024 6.258E-04 2.872E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP berylliosis DOID_10322 6.258E-04 2.849E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP polyneuropathy DOID_1389 6.258E-04 2.826E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP psoriatic arthritis DOID_9008 6.258E-04 2.804E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pustulosis of palm and sole DOID_4398 6.358E-04 2.826E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP viral pneumonia DOID_10533 7.287E-04 3.214E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hypertrophic cardiomyopathy DOID_11984 7.37E-04 3.226E-03 0.16119448 0.87352057 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP idiopathic pulmonary fibrosis DOID_0050156 8.393E-04 3.645E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lung oat cell carcinoma DOID_5411 8.393E-04 3.618E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP intermediate coronary syndrome DOID_8805 8.393E-04 3.591E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP collagen disease DOID_854 8.478E-04 3.6E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP chronic myeloid leukemia DOID_8552 9.574E-04 4.035E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP vein disease DOID_866 9.574E-04 4.005E-03 0.0450324 0.69252532 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Barrett's esophagus DOID_9206 9.574E-04 3.976E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cerebral degeneration DOID_1443 1.011E-03 4.17E-03 0.17795949 0.92053592 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP ureteral obstruction DOID_5199 1.216E-03 4.978E-03 0.05051825 0.75644435 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP prion disease DOID_649 1.216E-03 4.942E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pancreatic ductal carcinoma DOID_3587 1.242E-03 5.013E-03 0.18973081 0.91488841 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP nephrosis DOID_2527 1.292E-03 5.177E-03 0.19206496 0.91836101 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP male reproductive system disease DOID_48 1.292E-03 5.141E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Down syndrome DOID_14250 1.357E-03 5.36E-03 0.05324946 0.77689591 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP agammaglobulinemia DOID_2583 1.357E-03 5.323E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP granulosa cell tumor DOID_2999 1.357E-03 5.287E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP leishmaniasis DOID_9065 1.357E-03 5.251E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pancreatic carcinoma DOID_4905 1.395E-03 5.364E-03 0.19671328 0.92504012 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP syndrome DOID_225 1.504E-03 5.742E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP membranous glomerulonephritis DOID_10976 1.504E-03 5.707E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pulmonary edema DOID_11396 1.504E-03 5.669E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP esophagitis DOID_11963 1.504E-03 5.632E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP sex cord-gonadal stromal tumor DOID_192 1.504E-03 5.595E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP chromosomal disease DOID_0080014 1.797E-03 6.64E-03 0.02396167 0.64924704 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP familial hypercholesterolemia DOID_13810 1.822E-03 6.69E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hepatitis B DOID_2043 1.822E-03 6.647E-03 0.06139645 0.81243207 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP thrombophilia DOID_2452 1.822E-03 6.604E-03 0.06139645 0.79396771 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP IgA glomerulonephritis DOID_2986 1.992E-03 7.174E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP muscle cancer DOID_4045 1.992E-03 7.129E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP uremia DOID_4676 1.992E-03 7.084E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP diabetic angiopathy DOID_11713 2.169E-03 7.666E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP ureteral disease DOID_1426 2.169E-03 7.619E-03 0.06678915 0.79172968 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP meningitis DOID_9471 2.169E-03 7.572E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP primary immunodeficiency disease DOID_612 2.337E-03 8.109E-03 0.23074126 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP spastic quadriplegia DOID_10970 2.353E-03 8.115E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Human immunodeficiency virus infectious disease DOID_526 2.411E-03 8.264E-03 0.23295832 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP osteosarcoma DOID_3347 2.545E-03 8.67E-03 0.07215114 0.73310716 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lymphoblastic leukemia DOID_1037 2.641E-03 8.944E-03 0.03075022 0.62488832 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP mouth disease DOID_403 2.72E-03 9.159E-03 0.24176343 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP papillary adenoma DOID_3172 2.743E-03 9.181E-03 0.07482068 0.72157575 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP microcystic adenoma DOID_5403 2.743E-03 9.181E-03 0.07482068 0.72157575 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP follicular adenoma DOID_6204 2.743E-03 9.181E-03 0.07482068 0.72157575 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP myositis DOID_633 2.743E-03 9.128E-03 0.07482068 0.70954949 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP B cell deficiency DOID_2115 2.949E-03 9.754E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP middle cerebral artery infarction DOID_3525 2.949E-03 9.698E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP seminoma DOID_4440 2.949E-03 9.642E-03 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP periodontitis DOID_824 3.161E-03 0.01027799 0.08013695 0.71246761 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP perinatal necrotizing enterocolitis DOID_8677 3.161E-03 0.01021959 0.08013695 0.70150657 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP malaria DOID_12365 3.381E-03 0.01086734 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP autoimmune disease of the nervous system DOID_438 3.381E-03 0.01080628 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP toxic encephalopathy DOID_3602 3.607E-03 0.01146553 3.607E-03 0.22803661 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP corneal disease DOID_10124 3.84E-03 0.01213921 0.08805466 0.72613189 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP endometrial carcinoma DOID_2871 3.84E-03 0.01207214 0.08805466 0.71575858 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP abdominal aortic aneurysm DOID_7693 4.08E-03 0.01275649 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Charcot-Marie-Tooth disease DOID_10595 4.327E-03 0.01345451 0.09329557 0.73729419 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP germinoma DOID_3304 4.327E-03 0.01338139 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP myocarditis DOID_820 4.841E-03 0.0148902 0.09850665 0.72792574 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP periodontal disease DOID_3388 5.108E-03 0.0156272 0.10110104 0.73751915 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP spindle cell carcinoma DOID_4015 5.108E-03 0.01554363 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP esophageal disease DOID_6050 5.108E-03 0.01546095 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP lymphoid leukemia DOID_10747 5.382E-03 0.01620323 5.382E-03 0.30624111 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP thyroid cancer DOID_1781 5.662E-03 0.01695748 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP refractive error DOID_9835 5.662E-03 0.01686869 0.10626766 0.75582875 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP multiple myeloma DOID_9538 5.949E-03 0.01763107 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP respiratory syncytial virus infectious disease DOID_1273 6.543E-03 0.01928896 0.11396247 0.7812608 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP cervix uteri carcinoma in situ DOID_8991 7.162E-03 0.0210054 0.11905584 0.78770666 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP nephrotic syndrome DOID_1184 7.806E-03 0.02277857 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP idiopathic generalized epilepsy DOID_1827 7.806E-03 0.02266235 7.806E-03 0.37015176 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hyperinsulinism DOID_2018 7.806E-03 0.02254732 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP leukodystrophy DOID_10579 8.82E-03 0.02534738 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hemolytic anemia DOID_583 9.527E-03 0.02724138 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP normocytic anemia DOID_720 9.527E-03 0.02724138 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP autoimmune disease of gastrointestinal tract DOID_0060031 9.89E-03 0.0281369 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP integumentary system benign neoplasm DOID_0060121 9.89E-03 0.02799692 0.13914082 0.8333803 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP glaucoma DOID_1686 9.89E-03 0.02785832 9.89E-03 0.35171125 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP skin benign neoplasm DOID_3165 9.89E-03 0.02799692 0.13914082 0.8333803 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP movement disease DOID_480 0.01025866 0.02875457 0.14161933 0.82225915 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hemorrhagic disease DOID_2213 0.0106334 0.02965885 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP integumentary system cancer DOID_0060122 0.01219191 0.03383999 0.15390618 0.85021959 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP osteochondrodysplasia DOID_2256 0.01219191 0.03367572 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP skin cancer DOID_4159 0.01219191 0.03383999 0.15390618 0.85021959 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP leukocyte disease DOID_9500 0.01384394 0.03805412 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP endocrine pancreas disease DOID_1428 0.01603699 0.04387041 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP temporal lobe epilepsy DOID_3328 0.01695312 0.04615466 0.18032723 0.92438014 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP tooth disease DOID_1091 0.01741938 0.04719823 0.18268822 0.91990792 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bone resorption disease DOID_0080011 0.02185557 0.05893753 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP osteoporosis DOID_11476 0.02185557 0.05893753 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP electroclinical syndrome DOID_0050701 0.0223745 0.06005232 0.20593057 0.95263815 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP focal epilepsy DOID_2234 0.02504475 0.06690358 0.21730494 0.99714927 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bone development disease DOID_0080006 0.02559369 0.06805051 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP facioscapulohumeral muscular dystrophy DOID_11727 0.02838572 0.07512314 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Sjogren's syndrome DOID_12894 0.02838572 0.07477535 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP childhood type dermatomyositis DOID_14203 0.02838572 0.07443076 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP retinal vascular occlusion DOID_1729 0.02838572 0.07408933 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP acute kidney failure DOID_3021 0.02838572 0.07375103 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP phagocyte bactericidal dysfunction DOID_3262 0.02838572 0.07341579 0.02838572 0.62121057 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP chondrosarcoma DOID_3371 0.02838572 0.0730836 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP keratitis DOID_4677 0.02838572 0.07275439 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP polycythemia DOID_8432 0.02838572 0.07242814 0.02838572 0.59820277 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.03118 0.07920277 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP dermatomyositis DOID_10223 0.03118 0.07885075 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP adrenoleukodystrophy DOID_10588 0.03118 0.07850186 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP pneumocystosis DOID_11339 0.03118 0.07815603 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP neuronal ceroid lipofuscinosis DOID_14503 0.03118 0.07781324 0.03118 0.61177308 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP neonatoal period electroclinical syndrome DOID_0050702 0.03396632 0.08439665 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP common cold DOID_10459 0.03396632 0.08402971 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP otitis media DOID_10754 0.03396632 0.08366594 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP mucopolysaccharidosis DOID_12798 0.03396632 0.08330532 0.03396632 0.64422778 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP diarrhea DOID_13250 0.03396632 0.08294778 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP epidermolysis bullosa DOID_2730 0.03396632 0.0825933 0.03396632 0.62344623 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP middle ear disease DOID_5100 0.03396632 0.08366594 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP retinal detachment DOID_5327 0.03396632 0.08224184 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP aortic valve insufficiency DOID_57 0.03396632 0.08189336 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP stomach disease DOID_76 0.03396632 0.08154782 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP peritonitis DOID_8283 0.03396632 0.08120518 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP encephalitis DOID_9588 0.03396632 0.08086541 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP Hirschsprung's disease DOID_10487 0.03674469 0.08711554 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP osteogenesis imperfecta DOID_12347 0.03674469 0.08675406 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP newborn respiratory distress syndrome DOID_12716 0.03674469 0.08639558 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP larynx cancer DOID_2596 0.03674469 0.08604004 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP laryngeal benign neoplasm DOID_2598 0.03674469 0.08604004 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP vesiculobullous skin disease DOID_2731 0.03674469 0.08568741 0.03674469 0.65336654 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.03674469 0.08533767 0.03674469 0.61493321 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP tethered spinal cord syndrome DOID_1089 0.03951515 0.09139886 0.03951515 0.64240343 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP megacolon DOID_11372 0.03951515 0.09102883 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP rhabdomyosarcoma DOID_3247 0.03951515 0.09066177 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP parasitic helminthiasis infectious disease DOID_883 0.03951515 0.09029767 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP polycystic kidney disease DOID_898 0.03951515 0.08993648 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bacterial meningitis DOID_9470 0.03951515 0.08957817 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP peripheral neuropathy DOID_0060053 0.04227771 0.09546039 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP skeletal system cancer DOID_0060124 0.04227771 0.09508308 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP renovascular hypertension DOID_1591 0.04227771 0.09470873 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP bone cancer DOID_184 0.04227771 0.09508308 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP corneal dystrophy DOID_2566 0.04227771 0.09433733 0.04227771 0.66822273 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP membranoproliferative glomerulonephritis DOID_2920 0.04227771 0.09396882 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP skeletal muscle cancer DOID_4043 0.04227771 0.09360318 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP oral submucous fibrosis DOID_5773 0.04227771 0.09324038 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP varicose veins DOID_799 0.04227771 0.09288038 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP angiosarcoma DOID_0001816 0.0450324 0.09855168 1.000 1.000 SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP hemolytic-uremic syndrome DOID_12554 0.0450324 0.09817409 1.000 1.000 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP integumentary system cancer DOID_0060122 4.923E-05 0.02800939 2.28E-03 0.14414779 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP skin cancer DOID_4159 4.923E-05 0.02800939 2.28E-03 0.14414779 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP skin carcinoma DOID_3451 2.177E-04 0.06192261 0.02162162 0.38445943 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP alopecia DOID_987 2.699E-04 0.0511857 2.699E-04 0.15355711 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP hypotrichosis DOID_4535 5.336E-04 0.07590374 5.336E-04 0.15180748 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP Sciatic Neuropathy DOID_11446 5.727E-04 0.06517062 5.727E-04 0.10861771 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP lesion of sciatic nerve DOID_12528 5.727E-04 0.06517062 5.727E-04 0.10861771 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP mononeuritis of lower limb DOID_9473 5.727E-04 0.06517062 5.727E-04 0.10861771 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP mononeuritis DOID_1802 6.131E-04 0.05814313 6.131E-04 0.08721469 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP mononeuropathy DOID_1188 6.549E-04 0.05323286 6.549E-04 0.07452601 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP hair disease DOID_421 8.838E-04 0.06286351 8.838E-04 0.08381801 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP aortic aneurysm DOID_3627 1.908E-03 0.09869795 0.0623624 0.52182654 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP movement disease DOID_480 1.908E-03 0.09047312 1.908E-03 0.13570969 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP reproductive organ benign neoplasm DOID_0050622 2.28E-03 0.09979462 0.06804533 0.54532105 LINDGREN_BLADDER_CANCER_CLUSTER_1_UP smallpox DOID_8736 2.28E-03 0.09266643 2.28E-03 0.12973301 MULLIGHAN_MLL_SIGNATURE_1_UP bone resorption disease DOID_0080011 6.298E-08 3.584E-05 1.422E-06 8.093E-04 MULLIGHAN_MLL_SIGNATURE_1_UP osteoporosis DOID_11476 6.298E-08 3.584E-05 1.422E-06 8.093E-04 MULLIGHAN_MLL_SIGNATURE_1_UP lymphoma DOID_0060058 2.104E-07 5.987E-05 3.946E-06 1.123E-03 MULLIGHAN_MLL_SIGNATURE_1_UP ulcerative colitis DOID_8577 3.219E-07 6.105E-05 5.652E-06 1.072E-03 MULLIGHAN_MLL_SIGNATURE_1_UP syndrome DOID_225 1.319E-06 1.876E-04 4.019E-04 0.01633632 MULLIGHAN_MLL_SIGNATURE_1_UP primary immunodeficiency disease DOID_612 3.265E-06 3.716E-04 5.35E-05 5.073E-03 MULLIGHAN_MLL_SIGNATURE_1_UP bronchiolitis DOID_2942 5.034E-06 4.774E-04 5.848E-03 0.06655234 MULLIGHAN_MLL_SIGNATURE_1_UP polycystic ovary syndrome DOID_11612 1.041E-05 8.466E-04 3.446E-04 0.0150845 MULLIGHAN_MLL_SIGNATURE_1_UP cerebral degeneration DOID_1443 1.301E-05 9.254E-04 1.301E-05 1.851E-03 MULLIGHAN_MLL_SIGNATURE_1_UP relapsing-remitting multiple sclerosis DOID_2378 1.794E-05 1.134E-03 1.794E-05 2.041E-03 MULLIGHAN_MLL_SIGNATURE_1_UP primary bacterial infectious disease DOID_0050338 4.809E-05 2.736E-03 7.227E-03 0.0775851 MULLIGHAN_MLL_SIGNATURE_1_UP influenza DOID_8469 5.588E-05 2.891E-03 0.01831366 0.1447288 MULLIGHAN_MLL_SIGNATURE_1_UP lymphoblastic leukemia DOID_1037 6.572E-05 3.116E-03 6.572E-05 5.342E-03 MULLIGHAN_MLL_SIGNATURE_1_UP leukodystrophy DOID_10579 6.593E-05 2.886E-03 6.593E-05 4.689E-03 MULLIGHAN_MLL_SIGNATURE_1_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.908E-05 2.808E-03 8.804E-04 0.02636445 MULLIGHAN_MLL_SIGNATURE_1_UP Crohn's disease DOID_8778 6.908E-05 2.62E-03 8.804E-04 0.02504623 MULLIGHAN_MLL_SIGNATURE_1_UP hypersensitivity reaction type I disease DOID_1205 7.258E-05 2.581E-03 7.258E-05 4.589E-03 MULLIGHAN_MLL_SIGNATURE_1_UP agammaglobulinemia DOID_2583 7.724E-05 2.585E-03 3.14E-03 0.04962682 MULLIGHAN_MLL_SIGNATURE_1_UP integumentary system benign neoplasm DOID_0060121 8.338E-05 2.636E-03 8.338E-05 4.744E-03 MULLIGHAN_MLL_SIGNATURE_1_UP pulmonary tuberculosis DOID_2957 8.338E-05 2.497E-03 0.02214556 0.16801102 MULLIGHAN_MLL_SIGNATURE_1_UP skin benign neoplasm DOID_3165 8.338E-05 2.636E-03 8.338E-05 4.744E-03 MULLIGHAN_MLL_SIGNATURE_1_UP pulmonary edema DOID_11396 9.057E-05 2.577E-03 3.479E-03 0.05075248 MULLIGHAN_MLL_SIGNATURE_1_UP blood protein disease DOID_620 9.057E-05 2.454E-03 3.479E-03 0.04948367 MULLIGHAN_MLL_SIGNATURE_1_UP alopecia DOID_987 9.057E-05 2.343E-03 0.08453018 0.32719504 MULLIGHAN_MLL_SIGNATURE_1_UP B-cell lymphocytic neoplasm DOID_707 9.674E-05 2.393E-03 1.766E-03 0.03464638 MULLIGHAN_MLL_SIGNATURE_1_UP funisitis DOID_0050698 1.216E-04 2.882E-03 4.205E-03 0.05696697 MULLIGHAN_MLL_SIGNATURE_1_UP integumentary system cancer DOID_0060122 1.28E-04 2.914E-03 1.28E-04 6.622E-03 MULLIGHAN_MLL_SIGNATURE_1_UP skin cancer DOID_4159 1.28E-04 2.914E-03 1.28E-04 6.622E-03 MULLIGHAN_MLL_SIGNATURE_1_UP pustulosis of palm and sole DOID_4398 1.28E-04 2.802E-03 2.169E-03 0.03856005 MULLIGHAN_MLL_SIGNATURE_1_UP Lewy body dementia DOID_12217 1.587E-04 3.345E-03 1.587E-04 7.527E-03 MULLIGHAN_MLL_SIGNATURE_1_UP collagen disease DOID_854 1.878E-04 3.817E-03 0.03253753 0.21781008 MULLIGHAN_MLL_SIGNATURE_1_UP respiratory failure DOID_11162 1.994E-04 3.913E-03 0.03347518 0.22148115 MULLIGHAN_MLL_SIGNATURE_1_UP B cell deficiency DOID_2115 2.536E-04 4.81E-03 6.763E-03 0.07545171 MULLIGHAN_MLL_SIGNATURE_1_UP spinal cord disease DOID_319 2.536E-04 4.655E-03 6.763E-03 0.07400071 MULLIGHAN_MLL_SIGNATURE_1_UP hypotrichosis DOID_4535 2.536E-04 4.51E-03 0.11631809 0.38932349 MULLIGHAN_MLL_SIGNATURE_1_UP tuberculosis DOID_399 2.804E-04 4.835E-03 0.03931775 0.24584393 MULLIGHAN_MLL_SIGNATURE_1_UP periodontitis DOID_824 2.82E-04 4.719E-03 0.12021363 0.39086604 MULLIGHAN_MLL_SIGNATURE_1_UP nephrosis DOID_2527 3.287E-04 5.344E-03 4.328E-03 0.05726866 MULLIGHAN_MLL_SIGNATURE_1_UP male reproductive system disease DOID_48 3.287E-04 5.195E-03 0.04237349 0.25925287 MULLIGHAN_MLL_SIGNATURE_1_UP peripheral vascular disease DOID_341 3.46E-04 5.321E-03 4.494E-03 0.05811261 MULLIGHAN_MLL_SIGNATURE_1_UP hair disease DOID_421 5.387E-04 8.066E-03 0.14700861 0.43117474 MULLIGHAN_MLL_SIGNATURE_1_UP biliary tract cancer DOID_4607 5.571E-04 8.128E-03 5.571E-04 0.02113233 MULLIGHAN_MLL_SIGNATURE_1_UP periodontal disease DOID_3388 5.843E-04 8.312E-03 0.15076965 0.43547174 MULLIGHAN_MLL_SIGNATURE_1_UP lymphoid leukemia DOID_10747 6.323E-04 8.776E-03 6.323E-04 0.02248754 MULLIGHAN_MLL_SIGNATURE_1_UP encephalomyelitis DOID_640 8.466E-04 0.01146882 8.466E-04 0.02833473 MULLIGHAN_MLL_SIGNATURE_1_UP progressive muscular atrophy DOID_318 8.481E-04 0.0112222 0.04319254 0.25600579 MULLIGHAN_MLL_SIGNATURE_1_UP phagocyte bactericidal dysfunction DOID_3262 8.481E-04 0.01096715 8.481E-04 0.02680858 MULLIGHAN_MLL_SIGNATURE_1_UP alopecia areata DOID_986 8.481E-04 0.01072343 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP mouth disease DOID_403 8.804E-04 0.01088966 0.34580671 0.7777234 MULLIGHAN_MLL_SIGNATURE_1_UP lymphatic system disease DOID_75 9.102E-04 0.01101977 9.102E-04 0.0246633 MULLIGHAN_MLL_SIGNATURE_1_UP dilated cardiomyopathy DOID_12930 9.151E-04 0.01084778 9.146E-03 0.08820468 MULLIGHAN_MLL_SIGNATURE_1_UP nervous system benign neoplasm DOID_0060115 1.034E-03 0.01200168 0.04740844 0.25937888 MULLIGHAN_MLL_SIGNATURE_1_UP common variable immunodeficiency DOID_12177 1.034E-03 0.01176164 0.04740844 0.2569086 MULLIGHAN_MLL_SIGNATURE_1_UP neuronal ceroid lipofuscinosis DOID_14503 1.034E-03 0.01153102 1.034E-03 0.02673101 MULLIGHAN_MLL_SIGNATURE_1_UP Huntington's disease DOID_12858 1.109E-03 0.01213358 0.0175846 0.14500922 MULLIGHAN_MLL_SIGNATURE_1_UP gallbladder cancer DOID_3121 1.181E-03 0.01267542 1.181E-03 0.02920857 MULLIGHAN_MLL_SIGNATURE_1_UP Seckel syndrome DOID_0050569 1.237E-03 0.01303069 1.237E-03 0.02931905 MULLIGHAN_MLL_SIGNATURE_1_UP common cold DOID_10459 1.237E-03 0.01279377 0.05160588 0.26217629 MULLIGHAN_MLL_SIGNATURE_1_UP neuritis DOID_1803 1.413E-03 0.01436128 1.413E-03 0.03216926 MULLIGHAN_MLL_SIGNATURE_1_UP vascular skin disease DOID_9540 1.413E-03 0.01410933 1.413E-03 0.03093198 MULLIGHAN_MLL_SIGNATURE_1_UP monocytic leukemia DOID_8527 1.457E-03 0.01429638 1.457E-03 0.03071075 MULLIGHAN_MLL_SIGNATURE_1_UP psoriatic arthritis DOID_9008 1.457E-03 0.01405407 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP withdrawal disorder DOID_0060001 1.766E-03 0.01674575 1.766E-03 0.03588375 MULLIGHAN_MLL_SIGNATURE_1_UP communication disorder DOID_2033 1.95E-03 0.01819303 1.95E-03 0.03699249 MULLIGHAN_MLL_SIGNATURE_1_UP skeletal muscle cancer DOID_4043 1.95E-03 0.01789959 1.95E-03 0.03579919 MULLIGHAN_MLL_SIGNATURE_1_UP vasculitis DOID_865 2.063E-03 0.01863279 0.22262249 0.53903061 MULLIGHAN_MLL_SIGNATURE_1_UP congenital nervous system abnormality DOID_2490 2.39E-03 0.02124499 2.39E-03 0.04120241 MULLIGHAN_MLL_SIGNATURE_1_UP juvenile rheumatoid arthritis DOID_676 2.512E-03 0.02198664 0.07231887 0.30036087 MULLIGHAN_MLL_SIGNATURE_1_UP ureteral obstruction DOID_5199 2.817E-03 0.02428988 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP hypothyroidism DOID_1459 3.002E-03 0.02549124 0.03347518 0.21893539 MULLIGHAN_MLL_SIGNATURE_1_UP pre-malignant neoplasm DOID_0060071 3.134E-03 0.02622808 3.134E-03 0.05245616 MULLIGHAN_MLL_SIGNATURE_1_UP congenital heart defect DOID_1682 3.134E-03 0.02584796 3.134E-03 0.05095741 MULLIGHAN_MLL_SIGNATURE_1_UP in situ carcinoma DOID_8719 3.134E-03 0.02622808 3.134E-03 0.05245616 MULLIGHAN_MLL_SIGNATURE_1_UP mineral metabolism disease DOID_0050032 3.271E-03 0.02658757 3.271E-03 0.05030081 MULLIGHAN_MLL_SIGNATURE_1_UP cholestasis DOID_13580 3.411E-03 0.0273351 0.03635069 0.23239933 MULLIGHAN_MLL_SIGNATURE_1_UP parasitic infectious disease DOID_1398 3.411E-03 0.02695545 3.411E-03 0.05107349 MULLIGHAN_MLL_SIGNATURE_1_UP amyloidosis DOID_9120 3.479E-03 0.02711434 3.479E-03 0.04827675 MULLIGHAN_MLL_SIGNATURE_1_UP tooth disease DOID_1091 3.702E-03 0.02846363 0.26605203 0.62555208 MULLIGHAN_MLL_SIGNATURE_1_UP bile duct disease DOID_4138 4.328E-03 0.03283403 0.04237349 0.26207084 MULLIGHAN_MLL_SIGNATURE_1_UP biliary tract disease DOID_9741 4.494E-03 0.03364414 0.04341129 0.24456461 MULLIGHAN_MLL_SIGNATURE_1_UP IgA glomerulonephritis DOID_2986 4.592E-03 0.03393415 0.09658169 0.35003173 MULLIGHAN_MLL_SIGNATURE_1_UP muscle cancer DOID_4045 4.592E-03 0.03349909 4.592E-03 0.0580651 MULLIGHAN_MLL_SIGNATURE_1_UP urinary tract obstruction DOID_5200 4.592E-03 0.03307505 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP diabetic retinopathy DOID_8947 4.663E-03 0.03316904 0.04445853 0.24800886 MULLIGHAN_MLL_SIGNATURE_1_UP ureteral disease DOID_1426 4.995E-03 0.0350896 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP Goodpasture syndrome DOID_9808 4.995E-03 0.03466167 0.10056371 0.3554084 MULLIGHAN_MLL_SIGNATURE_1_UP cystic fibrosis DOID_1485 5.014E-03 0.03437608 0.04658091 0.25732561 MULLIGHAN_MLL_SIGNATURE_1_UP pancreatitis DOID_4989 5.381E-03 0.03644923 0.04873982 0.25211782 MULLIGHAN_MLL_SIGNATURE_1_UP bacterial pneumonia DOID_874 5.381E-03 0.03602041 0.29781059 0.68883832 MULLIGHAN_MLL_SIGNATURE_1_UP sphingolipidosis DOID_1927 5.414E-03 0.03581993 5.414E-03 0.0669677 MULLIGHAN_MLL_SIGNATURE_1_UP metabolic syndrome X DOID_14221 5.763E-03 0.03769182 5.763E-03 0.06976996 MULLIGHAN_MLL_SIGNATURE_1_UP X-linked disease DOID_0050735 5.848E-03 0.03781383 5.848E-03 0.06932536 MULLIGHAN_MLL_SIGNATURE_1_UP urticaria DOID_1555 5.848E-03 0.03738896 5.848E-03 0.06791055 MULLIGHAN_MLL_SIGNATURE_1_UP spinal muscular atrophy DOID_12377 6.298E-03 0.0398165 0.1124054 0.38529321 MULLIGHAN_MLL_SIGNATURE_1_UP chronic kidney failure DOID_784 6.366E-03 0.03980585 0.31317378 0.71278353 MULLIGHAN_MLL_SIGNATURE_1_UP vitiligo DOID_12306 6.763E-03 0.04182649 0.11631809 0.39395829 MULLIGHAN_MLL_SIGNATURE_1_UP extrinsic allergic alveolitis DOID_841 6.763E-03 0.04137674 0.11631809 0.38479647 MULLIGHAN_MLL_SIGNATURE_1_UP retinal vascular disease DOID_2462 6.788E-03 0.04109087 0.0565723 0.26824697 MULLIGHAN_MLL_SIGNATURE_1_UP diffuse large B-cell lymphoma DOID_0050745 7.243E-03 0.04338097 0.12021363 0.39538472 MULLIGHAN_MLL_SIGNATURE_1_UP Sciatic Neuropathy DOID_11446 7.243E-03 0.04292908 7.243E-03 0.07631837 MULLIGHAN_MLL_SIGNATURE_1_UP lesion of sciatic nerve DOID_12528 7.243E-03 0.04292908 7.243E-03 0.07631837 MULLIGHAN_MLL_SIGNATURE_1_UP lung adenocarcinoma DOID_3910 7.243E-03 0.04248652 7.243E-03 0.07493077 MULLIGHAN_MLL_SIGNATURE_1_UP perinatal necrotizing enterocolitis DOID_8677 7.243E-03 0.04205298 7.243E-03 0.07359272 MULLIGHAN_MLL_SIGNATURE_1_UP mononeuritis of lower limb DOID_9473 7.243E-03 0.04292908 7.243E-03 0.07631837 MULLIGHAN_MLL_SIGNATURE_1_UP autoimmune disease of cardiovascular system DOID_0060051 7.738E-03 0.04447344 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP pleurisy DOID_10247 7.738E-03 0.0440287 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP Behcet's disease DOID_13241 7.738E-03 0.04447344 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP thrombocytopenia DOID_1588 7.738E-03 0.04359278 0.12409211 0.39891756 MULLIGHAN_MLL_SIGNATURE_1_UP mononeuritis DOID_1802 7.738E-03 0.0431654 7.738E-03 0.07724334 MULLIGHAN_MLL_SIGNATURE_1_UP coronary stenosis DOID_4248 7.738E-03 0.04274632 0.12409211 0.39226894 MULLIGHAN_MLL_SIGNATURE_1_UP mononeuropathy DOID_1188 8.248E-03 0.04512493 8.248E-03 0.08091367 MULLIGHAN_MLL_SIGNATURE_1_UP opportunistic mycosis DOID_2473 9.312E-03 0.05045956 9.312E-03 0.08830422 MULLIGHAN_MLL_SIGNATURE_1_UP chronic leukemia DOID_1036 0.01043295 0.05600329 0.01043295 0.09731719 MULLIGHAN_MLL_SIGNATURE_1_UP chronic lymphocytic leukemia DOID_1040 0.01043295 0.05600329 0.01043295 0.09731719 MULLIGHAN_MLL_SIGNATURE_1_UP pleural disease DOID_1532 0.01043295 0.0554799 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP systemic mycosis DOID_0050136 0.01101497 0.05803256 0.01101497 0.10108898 MULLIGHAN_MLL_SIGNATURE_1_UP fungal infectious disease DOID_1564 0.01101497 0.05803256 0.01101497 0.10108898 MULLIGHAN_MLL_SIGNATURE_1_UP myocarditis DOID_820 0.01101497 0.05750015 0.01101497 0.09948439 MULLIGHAN_MLL_SIGNATURE_1_UP pneumoconiosis DOID_10316 0.01161101 0.06006057 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_UP medullomyoblastoma DOID_3861 0.01222093 0.06264604 0.01222093 0.10865172 MULLIGHAN_MLL_SIGNATURE_1_UP adult medulloblastoma DOID_3864 0.01222093 0.06264604 0.01222093 0.10865172 MULLIGHAN_MLL_SIGNATURE_1_UP childhood medulloblastoma DOID_3869 0.01222093 0.06264604 0.01222093 0.10865172 MULLIGHAN_MLL_SIGNATURE_1_UP pulmonary sarcoidosis DOID_13406 0.01348192 0.06849296 0.16195417 0.45846727 MULLIGHAN_MLL_SIGNATURE_1_UP calcinosis DOID_182 0.01348192 0.06788683 0.01348192 0.11801864 MULLIGHAN_MLL_SIGNATURE_1_UP medulloblastoma DOID_3858 0.01348192 0.06729133 0.01348192 0.11623048 MULLIGHAN_MLL_SIGNATURE_1_UP microcephaly DOID_10907 0.01413272 0.06992623 0.01413272 0.12002263 MULLIGHAN_MLL_SIGNATURE_1_UP blood platelet disease DOID_2218 0.01413272 0.06932341 0.1656497 0.45977893 MULLIGHAN_MLL_SIGNATURE_1_UP hepatitis DOID_2237 0.01479688 0.07196089 0.16932904 0.46770983 MULLIGHAN_MLL_SIGNATURE_1_UP congenital diaphragmatic hernia DOID_3827 0.01479688 0.07135105 0.01479688 0.12381506 MULLIGHAN_MLL_SIGNATURE_1_UP systemic scleroderma DOID_418 0.01479688 0.07075146 0.16932904 0.46545036 MULLIGHAN_MLL_SIGNATURE_1_UP benign mesothelioma DOID_2645 0.01616478 0.07664799 0.1766394 0.48089865 MULLIGHAN_MLL_SIGNATURE_1_UP nephrotic syndrome DOID_1184 0.0175846 0.08269121 0.18388581 0.49122546 MULLIGHAN_MLL_SIGNATURE_1_UP rheumatic disease DOID_1575 0.0175846 0.08201341 0.18388581 0.48893002 MULLIGHAN_MLL_SIGNATURE_1_UP primitive neuroectodermal tumor DOID_168 0.0175846 0.08134664 0.0175846 0.14293766 MULLIGHAN_MLL_SIGNATURE_1_UP hyperinsulinism DOID_2018 0.0175846 0.08069062 0.0175846 0.14092446 MULLIGHAN_MLL_SIGNATURE_1_UP scleroderma DOID_419 0.0175846 0.08201341 0.18388581 0.48893002 MULLIGHAN_MLL_SIGNATURE_1_UP diabetic autonomic neuropathy DOID_11503 0.01831366 0.08336379 0.1874852 0.49160866 MULLIGHAN_MLL_SIGNATURE_1_UP autonomic neuropathy DOID_11504 0.01831366 0.08336379 0.1874852 0.49160866 MULLIGHAN_MLL_SIGNATURE_1_UP diabetic polyneuropathy DOID_12785 0.01831366 0.08336379 0.1874852 0.49160866 MULLIGHAN_MLL_SIGNATURE_1_UP diabetic neuropathy DOID_9743 0.01831366 0.08336379 0.1874852 0.49160866 MULLIGHAN_MLL_SIGNATURE_1_UP proteinuria DOID_576 0.01980948 0.08945707 0.19463672 0.50569997 MULLIGHAN_MLL_SIGNATURE_1_UP autonomic nervous system disease DOID_11465 0.02057598 0.09218686 0.19818898 0.50797085 MULLIGHAN_MLL_SIGNATURE_1_UP heart valve disease DOID_4079 0.02057598 0.09146665 0.02057598 0.16037988 MULLIGHAN_MLL_SIGNATURE_1_UP hemolytic anemia DOID_583 0.02135471 0.0941925 0.20172566 0.51014179 MULLIGHAN_MLL_SIGNATURE_1_UP normocytic anemia DOID_720 0.02135471 0.0941925 0.20172566 0.51014179 MULLIGHAN_MLL_SIGNATURE_1_UP glaucoma DOID_1686 0.02214556 0.09692943 0.02214556 0.17028144 MULLIGHAN_MLL_SIGNATURE_1_UP calcium metabolism disease DOID_10575 0.02294841 0.09967667 0.02294841 0.1718111 LEE_LIVER_CANCER_HEPATOBLAST brain infarction DOID_3454 2.02E-08 1.15E-05 0.02955345 0.52549729 LEE_LIVER_CANCER_HEPATOBLAST nephrosis DOID_2527 2.391E-08 6.801E-06 0.03078397 0.50045944 LEE_LIVER_CANCER_HEPATOBLAST oral submucous fibrosis DOID_5773 2.797E-08 5.306E-06 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST varicose veins DOID_799 2.797E-08 3.979E-06 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST aneurysm disease DOID_2403 3.118E-08 3.548E-06 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST vein disease DOID_866 3.442E-08 3.264E-06 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST transitional cell carcinoma DOID_2671 5.287E-08 4.298E-06 0.03732209 0.50562549 LEE_LIVER_CANCER_HEPATOBLAST mouth disease DOID_403 6.864E-08 4.882E-06 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pleural disease DOID_1532 4.003E-07 2.531E-05 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST nephroblastoma DOID_2154 4.75E-07 2.703E-05 0.01550478 0.58814809 LEE_LIVER_CANCER_HEPATOBLAST nephrotic syndrome DOID_1184 9.259E-07 4.789E-05 0.01924199 0.54743455 LEE_LIVER_CANCER_HEPATOBLAST cerebral infarction DOID_3526 1.054E-06 5E-05 0.02007067 0.54381957 LEE_LIVER_CANCER_HEPATOBLAST glaucoma DOID_1686 1.346E-06 5.891E-05 0.02172606 0.53748395 LEE_LIVER_CANCER_HEPATOBLAST bile duct adenocarcinoma DOID_4896 1.78E-06 7.233E-05 0.02379162 0.52067049 LEE_LIVER_CANCER_HEPATOBLAST cholangiocarcinoma DOID_4947 1.78E-06 7.233E-05 0.02379162 0.52067049 LEE_LIVER_CANCER_HEPATOBLAST bile duct cancer DOID_4606 2.187E-06 8.295E-05 0.02544112 0.51699995 LEE_LIVER_CANCER_HEPATOBLAST bile duct carcinoma DOID_4897 2.187E-06 8.295E-05 0.02544112 0.51699995 LEE_LIVER_CANCER_HEPATOBLAST cholestasis DOID_13580 3.039E-06 1.081E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST tuberculosis DOID_399 3.464E-06 1.159E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST bile duct disease DOID_4138 3.925E-06 1.241E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST biliary tract disease DOID_9741 4.088E-06 1.224E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST metabolic syndrome X DOID_14221 5.352E-06 1.523E-04 0.03405822 0.49690068 LEE_LIVER_CANCER_HEPATOBLAST biliary tract cancer DOID_4607 5.964E-06 1.616E-04 0.03528339 0.50190615 LEE_LIVER_CANCER_HEPATOBLAST primary bacterial infectious disease DOID_0050338 6.85E-06 1.772E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hyperparathyroidism DOID_13543 7.5E-06 1.855E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST Crohn's disease DOID_8778 8.603E-06 2.04E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST invasive lobular carcinoma DOID_3457 9.164E-06 2.086E-04 4.633E-03 1.000 LEE_LIVER_CANCER_HEPATOBLAST epidermolysis bullosa DOID_2730 1.099E-05 2.406E-04 5.053E-03 1.000 LEE_LIVER_CANCER_HEPATOBLAST parathyroid gland disease DOID_11201 1.299E-05 2.738E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST vesiculobullous skin disease DOID_2731 1.299E-05 2.64E-04 5.474E-03 1.000 LEE_LIVER_CANCER_HEPATOBLAST tongue cancer DOID_8649 1.997E-05 3.918E-04 6.733E-03 0.76617593 LEE_LIVER_CANCER_HEPATOBLAST prion disease DOID_649 2.545E-05 4.827E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST granulosa cell tumor DOID_2999 2.844E-05 5.219E-04 7.99E-03 0.64949603 LEE_LIVER_CANCER_HEPATOBLAST amnestic disorder DOID_10914 3.159E-05 5.617E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST sex cord-gonadal stromal tumor DOID_192 3.159E-05 5.447E-04 8.409E-03 0.59810178 LEE_LIVER_CANCER_HEPATOBLAST aortic valve disease DOID_62 4.584E-05 7.672E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST meningitis DOID_9471 4.584E-05 7.452E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST intracranial aneurysm DOID_10941 6.272E-05 9.913E-04 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST middle cerebral artery infarction DOID_3525 6.272E-05 9.645E-04 0.01175423 0.60801425 LEE_LIVER_CANCER_HEPATOBLAST pleurisy DOID_10247 7.214E-05 1.08E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST abdominal aortic aneurysm DOID_7693 8.75E-05 1.277E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST chronic leukemia DOID_1036 9.856E-05 1.402E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST chronic lymphocytic leukemia DOID_1040 9.856E-05 1.402E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pneumoconiosis DOID_10316 1.103E-04 1.53E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST spindle cell carcinoma DOID_4015 1.103E-04 1.494E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST multiple myeloma DOID_9538 1.29E-04 1.708E-03 0.016752 0.56069924 LEE_LIVER_CANCER_HEPATOBLAST intracranial arterial disease DOID_13089 1.493E-04 1.93E-03 0.01799773 0.56892834 LEE_LIVER_CANCER_HEPATOBLAST cerebral arterial disease DOID_3527 1.493E-04 1.93E-03 0.01799773 0.56892834 LEE_LIVER_CANCER_HEPATOBLAST pulmonary emphysema DOID_9675 1.563E-04 1.977E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST rheumatic disease DOID_1575 1.71E-04 2.115E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST scleroderma DOID_419 1.71E-04 2.115E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST influenza DOID_8469 1.785E-04 2.161E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST proteinuria DOID_576 1.941E-04 2.301E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST myeloma DOID_0070004 2.022E-04 2.348E-03 0.0208987 0.54051625 LEE_LIVER_CANCER_HEPATOBLAST pre-eclampsia DOID_10591 2.022E-04 2.301E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST neuritis DOID_1803 2.022E-04 2.255E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST heart valve disease DOID_4079 2.022E-04 2.212E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pulmonary tuberculosis DOID_2957 2.187E-04 2.348E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST calcium metabolism disease DOID_10575 2.272E-04 2.394E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST aortic aneurysm DOID_3627 2.272E-04 2.351E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST withdrawal disorder DOID_0060001 2.359E-04 2.397E-03 0.02255278 0.53468879 LEE_LIVER_CANCER_HEPATOBLAST sarcoidosis DOID_11335 2.538E-04 2.533E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST giant cell tumor DOID_200 2.538E-04 2.49E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST malignant giant cell tumor DOID_2705 2.538E-04 2.49E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST giant cell glioblastoma DOID_3074 2.538E-04 2.49E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST bone marrow cancer DOID_4960 2.629E-04 2.536E-03 0.02379162 0.50138639 LEE_LIVER_CANCER_HEPATOBLAST integumentary system cancer DOID_0060122 2.723E-04 2.582E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST parasitic protozoa infectious disease DOID_2789 2.723E-04 2.54E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST skin cancer DOID_4159 2.723E-04 2.582E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hypersensitivity reaction type IV disease DOID_2916 3.012E-04 2.764E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST glioblastoma DOID_3068 3.012E-04 2.72E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST oral cavity cancer DOID_8618 3.012E-04 2.678E-03 0.02544112 0.49917237 LEE_LIVER_CANCER_HEPATOBLAST melancholia DOID_2848 3.111E-04 2.724E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST neurotic disorder DOID_4964 3.213E-04 2.77E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST carotid artery disease DOID_3407 3.316E-04 2.816E-03 0.02667653 0.50596491 LEE_LIVER_CANCER_HEPATOBLAST collagen disease DOID_854 3.316E-04 2.774E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mineral metabolism disease DOID_0050032 3.634E-04 2.996E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST parasitic infectious disease DOID_1398 3.743E-04 3.042E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST uterine disease DOID_345 3.743E-04 2.999E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hyperglycemia DOID_4195 3.854E-04 3.045E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST endocrine organ benign neoplasm DOID_0060089 4.08E-04 3.18E-03 0.02955345 0.54244881 LEE_LIVER_CANCER_HEPATOBLAST astrocytoma DOID_3069 4.195E-04 3.226E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pancreatic ductal carcinoma DOID_3587 4.312E-04 3.272E-03 0.03037396 0.50831718 LEE_LIVER_CANCER_HEPATOBLAST pancreatic carcinoma DOID_4905 4.673E-04 3.499E-03 0.03160351 0.48601071 LEE_LIVER_CANCER_HEPATOBLAST diabetic retinopathy DOID_8947 4.673E-04 3.453E-03 0.03160351 0.47322095 LEE_LIVER_CANCER_HEPATOBLAST cystic fibrosis DOID_1485 4.922E-04 3.59E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST endogenous depression DOID_1595 4.922E-04 3.545E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST female reproductive system disease DOID_229 5.571E-04 3.962E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mental depression DOID_1596 5.841E-04 4.103E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST chronic kidney failure DOID_784 5.841E-04 4.053E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST retinal vascular disease DOID_2462 6.118E-04 4.194E-03 0.03609935 0.50098858 LEE_LIVER_CANCER_HEPATOBLAST Human immunodeficiency virus infectious disease DOID_526 6.837E-04 4.631E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST lymphoblastic leukemia DOID_1037 7.287E-04 4.878E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST encephalomyelitis DOID_640 7.287E-04 4.822E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST ulcerative colitis DOID_8577 8.069E-04 5.277E-03 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST Sjogren's syndrome DOID_12894 4.213E-03 0.02724025 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST retinal vascular occlusion DOID_1729 4.213E-03 0.02693418 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST lateral sclerosis DOID_230 4.213E-03 0.02663491 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST conjunctival disease DOID_4251 4.213E-03 0.02634222 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST conjunctivitis DOID_6195 4.213E-03 0.02634222 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST visceral leishmaniasis DOID_9146 4.213E-03 0.02605589 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST familial adenomatous polyposis DOID_0050424 4.633E-03 0.02834769 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST trypanosomiasis DOID_10113 4.633E-03 0.02804612 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST prediabetes syndrome DOID_11716 4.633E-03 0.0277509 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST eosinophilic pneumonia DOID_5870 4.633E-03 0.02746182 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pulmonary eosinophilia DOID_9498 4.633E-03 0.02746182 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST Loeffler syndrome DOID_9503 4.633E-03 0.02746182 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST aortic valve stenosis DOID_1712 5.053E-03 0.02964364 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST aortic valve insufficiency DOID_57 5.053E-03 0.02934115 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST stomach disease DOID_76 5.053E-03 0.02904478 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST peritonitis DOID_8283 5.053E-03 0.02875433 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST ocular hypertension DOID_9282 5.053E-03 0.02846964 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST borderline glaucoma DOID_9283 5.053E-03 0.02846964 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST berylliosis DOID_10322 5.474E-03 0.03053369 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST carotid stenosis DOID_13001 5.474E-03 0.03023725 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST polyneuropathy DOID_1389 5.474E-03 0.02994651 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST larynx cancer DOID_2596 5.474E-03 0.0296613 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST laryngeal benign neoplasm DOID_2598 5.474E-03 0.0296613 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST intracranial thrombosis DOID_4193 5.474E-03 0.02938148 5.474E-03 0.77860916 LEE_LIVER_CANCER_HEPATOBLAST open-angle glaucoma DOID_1067 5.893E-03 0.03133968 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hypercalcemia DOID_12678 5.893E-03 0.0310495 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST eyelid disease DOID_530 5.893E-03 0.03076464 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST polycystic kidney disease DOID_898 5.893E-03 0.03048496 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST idiopathic pulmonary fibrosis DOID_0050156 6.313E-03 0.0323618 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST skeletal system cancer DOID_0060124 6.313E-03 0.03207286 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST thoracic aortic aneurysm DOID_14004 6.313E-03 0.03178903 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST bone cancer DOID_184 6.313E-03 0.03207286 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST lung oat cell carcinoma DOID_5411 6.313E-03 0.03151017 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST intermediate coronary syndrome DOID_8805 6.313E-03 0.03123617 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hemolytic-uremic syndrome DOID_12554 6.733E-03 0.03302482 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST thyroiditis DOID_7166 6.733E-03 0.03274256 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autoimmune thyroiditis DOID_7188 6.733E-03 0.03274256 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST Barrett's esophagus DOID_9206 6.733E-03 0.03246508 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST basal cell carcinoma DOID_2513 7.152E-03 0.03419752 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST urinary system benign neoplasm DOID_731 7.152E-03 0.03391254 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST skin carcinoma DOID_3451 7.571E-03 0.0356036 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST eosinophilia DOID_999 7.571E-03 0.03531177 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST dissociative disorder DOID_10935 7.99E-03 0.03696319 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST dissociative amnesia DOID_11037 7.99E-03 0.03696319 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST testicular cancer DOID_2998 7.99E-03 0.0366651 7.99E-03 0.75774537 LEE_LIVER_CANCER_HEPATOBLAST leishmaniasis DOID_9065 7.99E-03 0.03637178 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST esophagitis DOID_11963 8.409E-03 0.03797472 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autoimmune hepatitis DOID_2048 8.828E-03 0.03955167 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mitochondrial myopathy DOID_699 8.828E-03 0.03924267 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST gastric ulcer DOID_10808 9.246E-03 0.04078461 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hepatitis B DOID_2043 9.246E-03 0.04047089 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST thrombophilia DOID_2452 9.246E-03 0.04016195 9.246E-03 0.58457948 LEE_LIVER_CANCER_HEPATOBLAST placenta disease DOID_780 9.246E-03 0.03985769 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST sinusitis DOID_0050127 9.665E-03 0.04134793 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST paranasal sinus disease DOID_1352 9.665E-03 0.04134793 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST muscle cancer DOID_4045 9.665E-03 0.04103936 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST urinary tract obstruction DOID_5200 9.665E-03 0.04073537 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST diabetic angiopathy DOID_11713 0.01008302 0.04218558 0.01008302 0.57372392 LEE_LIVER_CANCER_HEPATOBLAST Goodpasture syndrome DOID_9808 0.01008302 0.04187766 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST spastic quadriplegia DOID_10970 0.01050107 0.0432979 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST toxic shock syndrome DOID_14115 0.01050107 0.0429864 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST commensal bacterial infectious disease DOID_0050339 0.01091896 0.04437776 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST portal hypertension DOID_10762 0.01091896 0.04406302 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hypogonadism DOID_1924 0.01091896 0.04375272 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST bronchiolitis DOID_2942 0.01091896 0.04344676 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST spinal muscular atrophy DOID_12377 0.01133668 0.04479562 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST cystitis DOID_1679 0.01133668 0.04448668 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST vitiligo DOID_12306 0.01175423 0.04580929 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST seminoma DOID_4440 0.01175423 0.04549767 0.01175423 0.5573464 LEE_LIVER_CANCER_HEPATOBLAST extrinsic allergic alveolitis DOID_841 0.01175423 0.04519025 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST Sciatic Neuropathy DOID_11446 0.01217162 0.04648088 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST lesion of sciatic nerve DOID_12528 0.01217162 0.04648088 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST periodontitis DOID_824 0.01217162 0.04617101 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST perinatal necrotizing enterocolitis DOID_8677 0.01217162 0.04586524 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mononeuritis of lower limb DOID_9473 0.01217162 0.04648088 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autoimmune disease of cardiovascular system DOID_0060051 0.01258884 0.04712534 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST Behcet's disease DOID_13241 0.01258884 0.04712534 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mononeuritis DOID_1802 0.01258884 0.04681733 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hepatic vascular disease DOID_272 0.01258884 0.04651332 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST invasive ductal carcinoma DOID_3008 0.01258884 0.04621323 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autoimmune disease of endocrine system DOID_0060005 0.0130059 0.04743819 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mononeuropathy DOID_1188 0.0130059 0.04713603 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST toxic encephalopathy DOID_3602 0.0130059 0.0468377 0.0130059 0.56925823 LEE_LIVER_CANCER_HEPATOBLAST spastic cerebral palsy DOID_0050669 0.01383952 0.04952634 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST gonadal disease DOID_2277 0.01383952 0.0492168 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST bronchiolitis obliterans DOID_2799 0.01383952 0.0489111 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST celiac disease DOID_10608 0.01425608 0.05007229 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST germinoma DOID_3304 0.01425608 0.0497651 0.01425608 0.57940797 LEE_LIVER_CANCER_HEPATOBLAST allergic rhinitis DOID_4481 0.01425608 0.04946166 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST leiomyoma DOID_127 0.01467248 0.05059783 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST bladder disease DOID_365 0.01467248 0.05029302 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST papilloma DOID_2615 0.01508871 0.05141005 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST myocarditis DOID_820 0.01508871 0.05110404 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST periodontal disease DOID_3388 0.01550478 0.05220249 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST thyroid carcinoma DOID_3963 0.01550478 0.05189542 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST esophageal disease DOID_6050 0.01550478 0.05159194 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hyperthyroidism DOID_7998 0.01550478 0.05129198 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST thyroid cancer DOID_1781 0.01633642 0.05373078 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pulmonary sarcoidosis DOID_13406 0.016752 0.05478096 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST calcinosis DOID_182 0.016752 0.05446793 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST embryonal cancer DOID_688 0.016752 0.05415845 0.016752 0.59574295 LEE_LIVER_CANCER_HEPATOBLAST respiratory syncytial virus infectious disease DOID_1273 0.01758265 0.05652276 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST congenital diaphragmatic hernia DOID_3827 0.01758265 0.05620522 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST systemic scleroderma DOID_418 0.01758265 0.05589123 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST peptic ulcer DOID_750 0.01758265 0.05558072 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST benign mesothelioma DOID_2645 0.01841265 0.05788286 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST cervix uteri carcinoma in situ DOID_8991 0.01841265 0.05756482 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autoimmune disease of urogenital tract DOID_0060049 0.0188274 0.05853984 0.0188274 0.5638311 LEE_LIVER_CANCER_HEPATOBLAST primary biliary cirrhosis DOID_12236 0.0188274 0.05853984 0.0188274 0.5638311 LEE_LIVER_CANCER_HEPATOBLAST endometriosis of uterus DOID_288 0.0188274 0.05822169 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST Huntington's disease DOID_12858 0.01924199 0.05918211 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hyperinsulinism DOID_2018 0.01924199 0.05886393 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST endometriosis DOID_289 0.01924199 0.05854915 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST diabetic autonomic neuropathy DOID_11503 0.01965641 0.05949201 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autonomic neuropathy DOID_11504 0.01965641 0.05949201 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST diabetic polyneuropathy DOID_12785 0.01965641 0.05949201 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST gallbladder cancer DOID_3121 0.01965641 0.05917724 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST diabetic neuropathy DOID_9743 0.01965641 0.05949201 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST cataract DOID_83 0.02007067 0.06010637 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST lens disease DOID_110 0.0208987 0.06225842 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autonomic nervous system disease DOID_11465 0.0208987 0.06193415 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST thyroid adenoma DOID_2891 0.0208987 0.06161325 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hemolytic anemia DOID_583 0.02131246 0.06250923 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST normocytic anemia DOID_720 0.02131246 0.06250923 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST autoimmune disease of gastrointestinal tract DOID_0060031 0.02172606 0.06339554 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST integumentary system benign neoplasm DOID_0060121 0.02172606 0.0630721 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST skin benign neoplasm DOID_3165 0.02172606 0.0630721 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST lung small cell carcinoma DOID_5409 0.02172606 0.06275193 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hemorrhagic disease DOID_2213 0.02255278 0.06481076 0.02255278 0.51330124 LEE_LIVER_CANCER_HEPATOBLAST B-cell lymphocytic neoplasm DOID_707 0.02255278 0.06448508 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST atopic dermatitis DOID_3310 0.02296589 0.06533796 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST vasculitis DOID_865 0.02379162 0.06735041 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pustulosis of palm and sole DOID_4398 0.02420424 0.06817928 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mitochondrial metabolism disease DOID_700 0.0246167 0.06899952 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST hypertrophic cardiomyopathy DOID_11984 0.02544112 0.07096078 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST leukocyte disease DOID_9500 0.02585309 0.07175809 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pre-malignant neoplasm DOID_0060071 0.02749932 0.07595687 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST in situ carcinoma DOID_8719 0.02749932 0.07595687 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST endocrine pancreas disease DOID_1428 0.02791048 0.0767201 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST tooth disease DOID_1091 0.02914295 0.07972278 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST blood coagulation disease DOID_1247 0.03037396 0.08269275 0.03037396 0.52372073 LEE_LIVER_CANCER_HEPATOBLAST male reproductive system disease DOID_48 0.03078397 0.08340991 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST peripheral vascular disease DOID_341 0.03119382 0.08411983 0.03119382 0.49303568 LEE_LIVER_CANCER_HEPATOBLAST bone resorption disease DOID_0080011 0.03283159 0.08811876 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST osteoporosis DOID_11476 0.03283159 0.08811876 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST pancreatitis DOID_4989 0.03324063 0.08879774 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST mixed glioma DOID_5076 0.03324063 0.0883828 1.000 1.000 LEE_LIVER_CANCER_HEPATOBLAST bacterial pneumonia DOID_874 0.03324063 0.08797172 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN integumentary system cancer DOID_0060122 1.005E-10 5.717E-08 5.252E-05 7.472E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN skin cancer DOID_4159 1.005E-10 5.717E-08 5.252E-05 7.472E-03 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN integumentary system benign neoplasm DOID_0060121 5.851E-09 1.665E-06 1.917E-03 0.13637817 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN skin benign neoplasm DOID_3165 5.851E-09 1.665E-06 1.917E-03 0.13637817 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN transitional cell carcinoma DOID_2671 9.553E-08 1.812E-05 4.899E-06 9.291E-04 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN mouth disease DOID_403 1.321E-07 1.879E-05 2.353E-04 0.02677971 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN pustulosis of palm and sole DOID_4398 8.373E-07 9.529E-05 8.373E-07 4.764E-04 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN keratosis DOID_161 1.438E-06 1.364E-04 1.438E-06 4.092E-04 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN thyroid cancer DOID_1781 1.582E-05 1.286E-03 0.04725154 0.38408753 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN glaucoma DOID_1686 3.782E-05 2.69E-03 0.06251097 0.45023727 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN giant cell tumor DOID_200 4.727E-05 2.988E-03 0.06715787 0.46601012 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN malignant giant cell tumor DOID_2705 4.727E-05 2.988E-03 0.06715787 0.46601012 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN giant cell glioblastoma DOID_3074 4.727E-05 2.988E-03 0.06715787 0.46601012 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN glioblastoma DOID_3068 6.11E-05 3.477E-03 0.07293481 0.47158982 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN oral cavity cancer DOID_8618 6.11E-05 3.161E-03 2.628E-03 0.16611882 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN tooth disease DOID_1091 9.221E-05 4.373E-03 3.443E-03 0.17809671 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN common cold DOID_10459 9.85E-05 4.311E-03 0.01477806 0.46715078 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN epidermolysis bullosa DOID_2730 9.85E-05 4.003E-03 0.01477806 0.4204357 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN astrocytoma DOID_3069 1.003E-04 3.805E-03 0.08552108 0.52892929 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN nephrosis DOID_2527 1.088E-04 3.87E-03 0.08779146 0.53713268 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN vesiculobullous skin disease DOID_2731 1.163E-04 3.893E-03 0.01599987 0.37933019 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN polycystic kidney disease DOID_898 1.356E-04 4.286E-03 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN bacterial pneumonia DOID_874 1.372E-04 4.109E-03 4.47E-03 0.21194297 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN varicose veins DOID_799 1.563E-04 4.448E-03 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN tongue cancer DOID_8649 1.785E-04 4.837E-03 0.01965641 0.38567234 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN vein disease DOID_866 1.785E-04 4.617E-03 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN psoriasis DOID_8893 2.538E-04 6.279E-03 2.538E-04 0.02406869 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN esophagitis DOID_11963 2.818E-04 6.68E-03 0.02451112 0.41020083 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN mitochondrial myopathy DOID_699 3.112E-04 7.083E-03 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN gastric ulcer DOID_10808 3.42E-04 7.485E-03 0.02692965 0.40323601 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN placenta disease DOID_780 3.42E-04 7.208E-03 0.02692965 0.39289662 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN morbid obesity DOID_11981 5.177E-04 0.01051988 0.03295031 0.42610741 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN myositis DOID_633 5.177E-04 0.01015712 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN extrinsic allergic alveolitis DOID_841 5.571E-04 0.01056547 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN lung adenocarcinoma DOID_3910 5.978E-04 0.01097336 0.03534835 0.40226426 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN renal hypertension DOID_1073 6.4E-04 0.01138077 0.03654519 0.40772968 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN secondary hypertension DOID_11130 6.4E-04 0.01138077 0.03654519 0.40772968 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN abdominal aortic aneurysm DOID_7693 7.75E-04 0.01336359 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN allergic rhinitis DOID_4481 8.228E-04 0.01377032 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN papilloma DOID_2615 9.226E-04 0.01499846 0.04369576 0.38848262 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN periodontal disease DOID_3388 9.745E-04 0.01540292 0.04488246 0.38116598 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN thyroid carcinoma DOID_3963 9.745E-04 0.01498663 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN spindle cell carcinoma DOID_4015 9.745E-04 0.01459224 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN esophageal disease DOID_6050 9.745E-04 0.01421808 0.04488246 0.3755606 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN peptic ulcer DOID_750 1.255E-03 0.01785092 0.05079438 0.39591785 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN uterine cancer DOID_363 1.569E-03 0.0217794 1.569E-03 0.12756503 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN brain cancer DOID_1319 1.774E-03 0.02403605 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN neuritis DOID_1803 1.774E-03 0.02347707 0.06017904 0.43899835 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN thyroid adenoma DOID_2891 1.774E-03 0.0229435 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN central nervous system cancer DOID_3620 1.845E-03 0.0233309 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN aortic aneurysm DOID_3627 1.991E-03 0.02462863 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN sarcoidosis DOID_11335 2.22E-03 0.02687476 0.06715787 0.47176333 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN mitochondrial metabolism disease DOID_700 2.461E-03 0.02916779 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN hypersensitivity reaction type IV disease DOID_2916 2.628E-03 0.03051162 0.07293481 0.47701039 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN carotid artery disease DOID_3407 2.888E-03 0.03286278 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN pre-malignant neoplasm DOID_0060071 3.068E-03 0.03422604 3.068E-03 0.1745528 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN in situ carcinoma DOID_8719 3.068E-03 0.03422604 3.068E-03 0.1745528 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN uterine disease DOID_345 3.253E-03 0.0355931 0.08096372 0.51187066 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN endocrine organ benign neoplasm DOID_0060089 3.54E-03 0.03800494 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN male reproductive system disease DOID_48 3.839E-03 0.04044777 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN diabetic retinopathy DOID_8947 4.044E-03 0.04183717 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN cystic fibrosis DOID_1485 4.254E-03 0.04322788 0.09231567 0.55880444 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN bone resorption disease DOID_0080011 4.361E-03 0.04353833 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN osteoporosis DOID_11476 4.361E-03 0.04353833 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN aneurysm disease DOID_2403 4.361E-03 0.04278767 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN mixed glioma DOID_5076 4.47E-03 0.04310705 0.09456954 0.56052152 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN female reproductive system disease DOID_229 4.802E-03 0.04554062 0.09794007 0.56865201 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN auditory system disease DOID_2742 4.915E-03 0.04585051 0.09906084 0.5693497 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN chronic kidney failure DOID_784 5.03E-03 0.04616168 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN retinal vascular disease DOID_2462 5.263E-03 0.04753015 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN nervous system cancer DOID_3093 5.865E-03 0.05214759 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN dilated cardiomyopathy DOID_12930 6.498E-03 0.05688636 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN ulcerative colitis DOID_8577 6.893E-03 0.05942187 0.11680904 0.63908024 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN leber hereditary optic neuropathy DOID_705 0.01110371 0.09429864 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN acute kidney failure DOID_3021 0.01232998 0.09881348 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN chondrosarcoma DOID_3371 0.01232998 0.09744107 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN keratitis DOID_4677 0.01232998 0.09610626 0.01232998 0.5011255 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN neuronal ceroid lipofuscinosis DOID_14503 0.01355476 0.09888024 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN craniosynostosis DOID_2340 0.01355476 0.09762859 0.01355476 0.48204115 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN mitochondrial encephalomyopathy DOID_890 0.01477806 0.09892605 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN ocular hypertension DOID_9282 0.01477806 0.09777574 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN borderline glaucoma DOID_9283 0.01477806 0.09777574 1.000 1.000 RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN psoriatic arthritis DOID_9008 0.01599987 0.0989557 0.01599987 0.36415699 LIANG_SILENCED_BY_METHYLATION_UP nephroblastoma DOID_2154 1.124E-06 6.398E-04 1.124E-06 6.398E-04 LIANG_SILENCED_BY_METHYLATION_UP opportunistic mycosis DOID_2473 1.527E-04 0.04344589 0.01812615 0.27141527 LIANG_SILENCED_BY_METHYLATION_UP systemic mycosis DOID_0050136 1.82E-04 0.03452463 0.01975838 0.27420771 LIANG_SILENCED_BY_METHYLATION_UP fungal infectious disease DOID_1564 1.82E-04 0.03452463 0.01975838 0.27420771 LIANG_SILENCED_BY_METHYLATION_UP pulmonary sarcoidosis DOID_13406 2.251E-04 0.03201579 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_UP embryonal cancer DOID_688 2.251E-04 0.02561263 2.251E-04 0.06403158 LIANG_SILENCED_BY_METHYLATION_UP multiple myeloma DOID_9538 2.251E-04 0.02134386 0.02193066 0.27127268 LIANG_SILENCED_BY_METHYLATION_UP uveitis DOID_13141 2.365E-04 0.01922651 0.02247301 0.27206686 LIANG_SILENCED_BY_METHYLATION_UP uveal disease DOID_3480 2.98E-04 0.02119873 0.02518048 0.27033385 LIANG_SILENCED_BY_METHYLATION_UP myeloma DOID_0070004 3.523E-04 0.02227272 0.02734132 0.28285834 LIANG_SILENCED_BY_METHYLATION_UP glaucoma DOID_1686 3.811E-04 0.02168369 0.02842002 0.27881021 LIANG_SILENCED_BY_METHYLATION_UP sarcoidosis DOID_11335 4.42E-04 0.02286324 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_UP bone marrow cancer DOID_4960 4.579E-04 0.02171283 0.0311118 0.29020682 LIANG_SILENCED_BY_METHYLATION_UP hypersensitivity reaction type IV disease DOID_2916 5.244E-04 0.02295053 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_UP carotid artery disease DOID_3407 5.771E-04 0.02345377 5.771E-04 0.10945092 LIANG_SILENCED_BY_METHYLATION_UP endocrine organ benign neoplasm DOID_0060089 7.097E-04 0.02691973 0.03861106 0.31840133 LIANG_SILENCED_BY_METHYLATION_UP astrocytoma DOID_3069 7.297E-04 0.02594966 0.0391446 0.31818967 LIANG_SILENCED_BY_METHYLATION_UP bacterial pneumonia DOID_874 8.997E-04 0.03011409 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_UP encephalomyelitis DOID_640 1.265E-03 0.03998596 1.265E-03 0.17993683 XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN intermediate coronary syndrome DOID_8805 5.252E-06 2.988E-03 5.252E-06 2.988E-03 XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN diabetic retinopathy DOID_8947 1.415E-04 0.04025163 1.415E-04 0.04025163 XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN retinal vascular disease DOID_2462 1.855E-04 0.03517603 1.855E-04 0.03517603 SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP cerebral degeneration DOID_1443 3.039E-06 1.729E-03 3.039E-06 1.729E-03 SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP gallbladder cancer DOID_3121 1.785E-04 0.05079128 1.785E-04 0.05079128 SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP leukodystrophy DOID_10579 1.941E-04 0.03681847 1.941E-04 0.03681847 SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP biliary tract cancer DOID_4607 5.841E-04 0.08308849 5.841E-04 0.08308849 SIMBULAN_UV_RESPONSE_NORMAL_DN epidermolysis bullosa DOID_2730 3.212E-08 1.828E-05 3.212E-08 1.828E-05 SIMBULAN_UV_RESPONSE_NORMAL_DN vesiculobullous skin disease DOID_2731 4.174E-08 1.188E-05 4.174E-08 1.188E-05 SIMBULAN_UV_RESPONSE_NORMAL_DN sarcoma DOID_1115 5.89E-07 1.117E-04 0.01649134 0.34753971 SIMBULAN_UV_RESPONSE_NORMAL_DN adenoid cystic carcinoma DOID_4866 1.782E-06 2.535E-04 1.782E-06 3.38E-04 SIMBULAN_UV_RESPONSE_NORMAL_DN cervix uteri carcinoma in situ DOID_8991 1.912E-06 2.176E-04 2.726E-04 0.02215862 SIMBULAN_UV_RESPONSE_NORMAL_DN salivary gland cancer DOID_8850 2.048E-06 1.942E-04 2.048E-06 2.913E-04 SIMBULAN_UV_RESPONSE_NORMAL_DN giant cell tumor DOID_200 3.984E-06 3.239E-04 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN malignant giant cell tumor DOID_2705 3.984E-06 3.239E-04 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN giant cell glioblastoma DOID_3074 3.984E-06 3.239E-04 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN bile duct adenocarcinoma DOID_4896 4.204E-06 2.99E-04 4.579E-04 0.02895044 SIMBULAN_UV_RESPONSE_NORMAL_DN cholangiocarcinoma DOID_4947 4.204E-06 2.99E-04 4.579E-04 0.02895044 SIMBULAN_UV_RESPONSE_NORMAL_DN glioblastoma DOID_3068 5.164E-06 3.265E-04 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN bile duct cancer DOID_4606 5.164E-06 2.938E-04 5.244E-04 0.02983569 SIMBULAN_UV_RESPONSE_NORMAL_DN bile duct carcinoma DOID_4897 5.164E-06 2.938E-04 5.244E-04 0.02983569 SIMBULAN_UV_RESPONSE_NORMAL_DN oral cavity cancer DOID_8618 5.164E-06 2.671E-04 5.164E-06 5.876E-04 SIMBULAN_UV_RESPONSE_NORMAL_DN pre-malignant neoplasm DOID_0060071 6.554E-06 3.108E-04 6.136E-04 0.03173912 SIMBULAN_UV_RESPONSE_NORMAL_DN in situ carcinoma DOID_8719 6.554E-06 3.108E-04 6.136E-04 0.03173912 SIMBULAN_UV_RESPONSE_NORMAL_DN astrocytoma DOID_3069 8.523E-06 3.731E-04 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN diabetic retinopathy DOID_8947 1.003E-05 4.077E-04 0.04127594 0.45165405 SIMBULAN_UV_RESPONSE_NORMAL_DN biliary tract cancer DOID_4607 1.405E-05 5.33E-04 1.015E-03 0.04811651 SIMBULAN_UV_RESPONSE_NORMAL_DN retinal vascular disease DOID_2462 1.507E-05 5.358E-04 0.04711394 0.46220402 SIMBULAN_UV_RESPONSE_NORMAL_DN nervous system cancer DOID_3093 1.782E-05 5.964E-04 0.04975637 0.47185627 SIMBULAN_UV_RESPONSE_NORMAL_DN angiosarcoma DOID_0001816 3.49E-05 1.103E-03 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN pulmonary edema DOID_11396 5.519E-05 1.653E-03 0.01102322 0.28510058 SIMBULAN_UV_RESPONSE_NORMAL_DN cleft lip DOID_9296 1.017E-04 2.894E-03 1.017E-04 9.647E-03 SIMBULAN_UV_RESPONSE_NORMAL_DN lung adenocarcinoma DOID_3910 1.176E-04 3.186E-03 0.01594583 0.34896827 SIMBULAN_UV_RESPONSE_NORMAL_DN endometrial carcinoma DOID_2871 1.435E-04 3.711E-03 0.0175815 0.32270564 SIMBULAN_UV_RESPONSE_NORMAL_DN endometrial cancer DOID_1380 1.622E-04 4.013E-03 0.01867051 0.33198508 SIMBULAN_UV_RESPONSE_NORMAL_DN spindle cell carcinoma DOID_4015 1.924E-04 4.561E-03 0.02030188 0.33975788 SIMBULAN_UV_RESPONSE_NORMAL_DN multiple myeloma DOID_9538 2.251E-04 5.123E-03 0.02193066 0.33725793 SIMBULAN_UV_RESPONSE_NORMAL_DN benign mesothelioma DOID_2645 2.726E-04 5.966E-03 0.02409835 0.36084109 SIMBULAN_UV_RESPONSE_NORMAL_DN uterine cancer DOID_363 3.112E-04 6.558E-03 0.02572112 0.36588291 SIMBULAN_UV_RESPONSE_NORMAL_DN myeloma DOID_0070004 3.523E-04 7.159E-03 0.02734132 0.37944411 SIMBULAN_UV_RESPONSE_NORMAL_DN brain cancer DOID_1319 3.523E-04 6.912E-03 0.02734132 0.37040973 SIMBULAN_UV_RESPONSE_NORMAL_DN central nervous system cancer DOID_3620 3.665E-04 6.952E-03 0.02788081 0.36893445 SIMBULAN_UV_RESPONSE_NORMAL_DN orofacial cleft DOID_0050567 4.264E-04 7.826E-03 4.264E-04 0.03032433 SIMBULAN_UV_RESPONSE_NORMAL_DN bone marrow cancer DOID_4960 4.579E-04 8.142E-03 0.0311118 0.39339146 SIMBULAN_UV_RESPONSE_NORMAL_DN respiratory failure DOID_11162 5.952E-04 0.01026253 0.03540389 0.428613 SIMBULAN_UV_RESPONSE_NORMAL_DN pancreatic ductal carcinoma DOID_3587 7.5E-04 0.0125514 0.03967786 0.45153401 SIMBULAN_UV_RESPONSE_NORMAL_DN pancreatic carcinoma DOID_4905 8.125E-04 0.01320955 0.04127594 0.46051001 SIMBULAN_UV_RESPONSE_NORMAL_DN syndrome DOID_225 8.556E-04 0.01352303 0.04233992 0.44613734 SIMBULAN_UV_RESPONSE_NORMAL_DN transitional cell carcinoma DOID_2671 1.137E-03 0.01747767 0.04870024 0.46966841 SIMBULAN_UV_RESPONSE_NORMAL_DN lymphoma DOID_0060058 1.239E-03 0.01854815 0.05081139 0.47396198 SIMBULAN_UV_RESPONSE_NORMAL_DN lymphoblastic leukemia DOID_1037 1.265E-03 0.01845506 0.05133848 0.47115476 SIMBULAN_UV_RESPONSE_NORMAL_DN dilated cardiomyopathy DOID_12930 1.318E-03 0.01875089 0.05239182 0.47318964 SIMBULAN_UV_RESPONSE_NORMAL_DN ulcerative colitis DOID_8577 1.4E-03 0.01942924 0.05396975 0.47982481 SIMBULAN_UV_RESPONSE_NORMAL_DN retinal vascular occlusion DOID_1729 5.526E-03 0.07486626 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN rectal neoplasm DOID_1984 5.526E-03 0.07312519 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN rectum cancer DOID_1993 5.526E-03 0.07312519 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN hypokalemia DOID_4500 5.526E-03 0.07146325 5.526E-03 0.24187562 SIMBULAN_UV_RESPONSE_NORMAL_DN keratitis DOID_4677 5.526E-03 0.06987518 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN breast benign neoplasm DOID_0060082 6.077E-03 0.07517195 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN thoracic benign neoplasm DOID_0060097 6.077E-03 0.07517195 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN nervous system benign neoplasm DOID_0060115 6.077E-03 0.07357254 6.077E-03 0.24699354 SIMBULAN_UV_RESPONSE_NORMAL_DN benign breast phyllodes tumor DOID_1631 6.077E-03 0.07517195 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN invasive lobular carcinoma DOID_3457 6.077E-03 0.07203978 6.077E-03 0.2305273 SIMBULAN_UV_RESPONSE_NORMAL_DN chronic monocytic leukemia DOID_8593 6.077E-03 0.07056958 6.077E-03 0.21611934 SIMBULAN_UV_RESPONSE_NORMAL_DN aortic valve stenosis DOID_1712 6.628E-03 0.07542541 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN aortic valve insufficiency DOID_57 6.628E-03 0.07394648 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN larynx cancer DOID_2596 7.178E-03 0.07854743 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN laryngeal benign neoplasm DOID_2598 7.178E-03 0.07854743 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN monocytic leukemia DOID_8527 7.178E-03 0.0770654 7.178E-03 0.24026272 SIMBULAN_UV_RESPONSE_NORMAL_DN rhabdomyosarcoma DOID_3247 7.728E-03 0.08143512 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN skeletal system cancer DOID_0060124 8.278E-03 0.08564294 8.278E-03 0.26168677 SIMBULAN_UV_RESPONSE_NORMAL_DN bone cancer DOID_184 8.278E-03 0.08564294 8.278E-03 0.26168677 SIMBULAN_UV_RESPONSE_NORMAL_DN mesenchymal cell neoplasm DOID_3350 8.278E-03 0.0841136 8.278E-03 0.24791378 SIMBULAN_UV_RESPONSE_NORMAL_DN skeletal muscle cancer DOID_4043 8.278E-03 0.08263793 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN spindle cell sarcoma DOID_4235 8.278E-03 0.0841136 8.278E-03 0.24791378 SIMBULAN_UV_RESPONSE_NORMAL_DN epithelioid sarcoma DOID_6193 8.278E-03 0.0841136 8.278E-03 0.24791378 SIMBULAN_UV_RESPONSE_NORMAL_DN Barrett's esophagus DOID_9206 8.828E-03 0.08660452 8.828E-03 0.2511531 SIMBULAN_UV_RESPONSE_NORMAL_DN bronchitis DOID_6132 9.377E-03 0.09043385 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN urinary system benign neoplasm DOID_731 9.377E-03 0.08892662 9.377E-03 0.25407605 SIMBULAN_UV_RESPONSE_NORMAL_DN granulosa cell tumor DOID_2999 0.01047482 0.09770774 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN sex cord-gonadal stromal tumor DOID_192 0.01102322 0.09955893 1.000 1.000 SIMBULAN_UV_RESPONSE_NORMAL_DN brain edema DOID_4724 0.01102322 0.09800332 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN collagen disease DOID_854 5.852E-12 3.33E-09 7.035E-07 4.003E-04 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN Ehlers-Danlos syndrome DOID_13359 3.063E-10 8.713E-08 7.451E-06 2.12E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN intracranial aneurysm DOID_10941 9.76E-09 1.851E-06 5.235E-05 5.958E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN oral submucous fibrosis DOID_5773 5.606E-08 7.974E-06 0.0380881 0.30960181 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN aneurysm disease DOID_2403 6.098E-08 6.94E-06 1.149E-03 0.03440164 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN mouth disease DOID_403 1.963E-07 1.862E-05 0.02576847 0.26658654 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN brain edema DOID_4724 1.97E-07 1.601E-05 1.849E-05 3.508E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN heart valve disease DOID_4079 2.012E-07 1.431E-05 0.12146651 0.56190604 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN aortic valve disease DOID_62 4.287E-07 2.71E-05 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN allergic contact dermatitis DOID_3042 1.103E-06 6.276E-05 3.377E-05 4.804E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN diabetic retinopathy DOID_8947 1.663E-06 8.604E-05 1.027E-03 0.03437239 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN bone resorption disease DOID_0080011 2.017E-06 9.562E-05 1.149E-03 0.03631284 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN osteoporosis DOID_11476 2.017E-06 9.562E-05 1.149E-03 0.03631284 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN contact dermatitis DOID_2773 2.427E-06 1.062E-04 6.291E-05 5.113E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN retinal vascular disease DOID_2462 3.253E-06 1.322E-04 1.517E-03 0.04110143 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN pulmonary sarcoidosis DOID_13406 3.572E-06 1.355E-04 4.839E-03 0.09834267 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN aortic valve insufficiency DOID_57 3.623E-06 1.288E-04 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN systemic scleroderma DOID_418 4.357E-06 1.458E-04 5.324E-03 0.10446093 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN nephrotic syndrome DOID_1184 6.302E-06 1.992E-04 6.357E-03 0.11303877 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN rheumatic disease DOID_1575 6.302E-06 1.887E-04 6.357E-03 0.10961335 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN scleroderma DOID_419 6.302E-06 1.887E-04 6.357E-03 0.10961335 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN ulcerative colitis DOID_8577 6.454E-06 1.836E-04 0.02778745 0.27738698 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN varicose veins DOID_799 7.451E-06 2.019E-04 0.0380881 0.30524122 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN pre-eclampsia DOID_10591 8.824E-06 2.282E-04 0.12146651 0.56651183 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN vein disease DOID_866 9.153E-06 2.264E-04 0.04057562 0.31199365 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN ureteral obstruction DOID_5199 1.329E-05 3.15E-04 0.0455316 0.33214715 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN sarcoidosis DOID_11335 1.391E-05 3.165E-04 9.302E-03 0.15122394 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN atrophic muscular disease DOID_913 1.391E-05 3.044E-04 4.204E-04 0.01839862 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN muscular dystrophy DOID_9884 1.391E-05 3.044E-04 4.204E-04 0.01839862 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN pustulosis of palm and sole DOID_4398 1.6E-05 3.372E-04 4.662E-04 0.0189462 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN hypersensitivity reaction type IV disease DOID_2916 1.956E-05 3.976E-04 0.01096169 0.16413688 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN carotid artery disease DOID_3407 2.368E-05 4.646E-04 6.224E-04 0.02361066 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN mineral metabolism disease DOID_0050032 2.84E-05 5.386E-04 0.15934227 0.65699821 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN urinary tract obstruction DOID_5200 2.857E-05 5.244E-04 0.05781094 0.37809682 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN ureteral disease DOID_1426 3.259E-05 5.795E-04 0.06024798 0.38518088 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN meningitis DOID_9471 3.259E-05 5.619E-04 0.06024798 0.38090109 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN nephrosis DOID_2527 4.204E-05 7.036E-04 0.01583186 0.21971539 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN fragments of torsion dystonia DOID_531 5.235E-05 8.511E-04 5.235E-05 4.965E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN periodontitis DOID_824 5.829E-05 9.212E-04 0.07233989 0.41577172 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN renal hypertension DOID_1073 6.464E-05 9.941E-04 0.07473973 0.4210585 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN secondary hypertension DOID_11130 6.464E-05 9.941E-04 0.07473973 0.4210585 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN central nervous system hereditary degenerative disease DOID_481 6.464E-05 9.679E-04 6.464E-05 4.598E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN dystonic disease DOID_544 7.143E-05 1.042E-03 7.143E-05 4.516E-03 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN periodontal disease DOID_3388 1.221E-04 1.737E-03 0.09136741 0.48137089 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN calcinosis DOID_182 1.544E-04 2.142E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN adult respiratory distress syndrome DOID_11394 1.918E-04 2.598E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN endometriosis of uterus DOID_288 2.197E-04 2.907E-03 0.11000855 0.53499883 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN endometriosis DOID_289 2.345E-04 3.033E-03 0.11231191 0.53254564 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN influenza DOID_8469 2.501E-04 3.162E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN facioscapulohumeral muscular dystrophy DOID_11727 2.936E-04 3.632E-03 0.02555438 0.30937109 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN hyperparathyroidism DOID_13543 2.936E-04 3.555E-03 0.02555438 0.2967437 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN pulmonary tuberculosis DOID_2957 3.376E-04 4.003E-03 0.1260087 0.56455867 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN calcium metabolism disease DOID_10575 3.572E-04 4.148E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN movement disease DOID_480 3.572E-04 4.065E-03 3.572E-04 0.02032691 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 3.583E-04 3.997E-03 0.02807399 0.27074743 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN hemochromatosis DOID_2352 3.583E-04 3.921E-03 3.583E-04 0.01853368 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN atopic dermatitis DOID_3310 3.986E-04 4.279E-03 3.986E-04 0.01889939 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN vasculitis DOID_865 4.429E-04 4.667E-03 0.13726274 0.60544574 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN parathyroid gland disease DOID_11201 5.064E-04 5.239E-03 0.03309387 0.30371636 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN osteogenesis imperfecta DOID_12347 5.064E-04 5.146E-03 0.03309387 0.29889546 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN bacterial meningitis DOID_9470 5.898E-04 5.888E-03 0.03559418 0.30686502 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN respiratory failure DOID_11162 6.513E-04 6.39E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN peripheral neuropathy DOID_0060053 6.794E-04 6.552E-03 0.0380881 0.32346458 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN nutritional deficiency disease DOID_5113 6.794E-04 6.443E-03 0.0380881 0.3140888 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN cholestasis DOID_13580 7.431E-04 6.932E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN uterine disease DOID_345 7.431E-04 6.82E-03 0.16151922 0.661183 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN tooth disease DOID_1091 8.087E-04 7.304E-03 0.16585639 0.669307 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN tuberculosis DOID_399 8.428E-04 7.493E-03 0.16801664 0.67324979 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN bile duct disease DOID_4138 9.505E-04 8.32E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN peripheral vascular disease DOID_341 9.882E-04 8.52E-03 9.882E-04 0.03514461 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN biliary tract disease DOID_9741 9.882E-04 8.393E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN bacterial pneumonia DOID_874 1.191E-03 9.968E-03 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN metabolic syndrome X DOID_14221 1.279E-03 0.01054943 0.01920845 0.26022875 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN female reproductive system disease DOID_229 1.325E-03 0.01076857 0.19351172 0.74903515 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN chronic kidney failure DOID_784 1.419E-03 0.01137044 0.19768506 0.74491918 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN bone development disease DOID_0080006 1.467E-03 0.01159614 0.1997637 0.74779965 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN thrombophilia DOID_2452 1.477E-03 0.01151412 1.477E-03 0.04202652 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN opiate dependence DOID_2559 1.615E-03 0.01241936 0.05781094 0.38699321 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN lingual-facial-buccal dyskinesia DOID_9854 1.615E-03 0.01225377 1.615E-03 0.04177422 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN primary bacterial infectious disease DOID_0050338 1.619E-03 0.01212268 0.20596771 0.76598449 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN transitional cell carcinoma DOID_2671 1.672E-03 0.01235479 0.20802512 0.76861228 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN primary immunodeficiency disease DOID_612 1.726E-03 0.0125887 1.726E-03 0.0426921 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN diabetic angiopathy DOID_11713 1.759E-03 0.01266956 1.759E-03 0.04170398 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN Human immunodeficiency virus infectious disease DOID_526 1.781E-03 0.01266409 0.02381254 0.30109632 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.011E-03 0.01412516 0.2202592 0.79826424 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN osteosarcoma DOID_3347 2.064E-03 0.01432478 0.06510335 0.39408305 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN cleft lip DOID_9296 2.226E-03 0.01525868 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN lung adenocarcinoma DOID_3910 2.566E-03 0.01738098 0.07233989 0.42001428 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN autoimmune disease of cardiovascular system DOID_0060051 2.745E-03 0.01837248 0.07473973 0.42526908 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN Behcet's disease DOID_13241 2.745E-03 0.01837248 0.07473973 0.42526908 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN invasive ductal carcinoma DOID_3008 2.745E-03 0.01815885 0.07473973 0.4128826 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN focal glomerulosclerosis DOID_3945 2.929E-03 0.01915585 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN endometrial carcinoma DOID_2871 3.119E-03 0.0201668 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN abdominal aortic aneurysm DOID_7693 3.315E-03 0.02119104 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN Charcot-Marie-Tooth disease DOID_10595 3.516E-03 0.02222795 0.08427779 0.45239683 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN endometrial cancer DOID_1380 3.516E-03 0.02198368 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN allergic rhinitis DOID_4481 3.516E-03 0.02174473 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN myocarditis DOID_820 3.935E-03 0.02407566 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN metal metabolism disorder DOID_896 3.935E-03 0.02381953 3.935E-03 0.08956145 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN thyroid carcinoma DOID_3963 4.153E-03 0.0248738 4.153E-03 0.09088505 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN spindle cell carcinoma DOID_4015 4.153E-03 0.0246147 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN thyroid cancer DOID_1781 4.605E-03 0.02701348 4.605E-03 0.09704841 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN hepatitis DOID_2237 5.324E-03 0.03091191 0.1030629 0.51896276 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN intracranial arterial disease DOID_13089 5.574E-03 0.03203857 0.10538406 0.52142199 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN cerebral arterial disease DOID_3527 5.574E-03 0.03203857 0.10538406 0.52142199 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN adenoid cystic carcinoma DOID_4866 5.574E-03 0.03171819 0.10538406 0.51692697 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN lymphatic system disease DOID_75 5.574E-03 0.03140414 5.574E-03 0.10572729 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN benign mesothelioma DOID_2645 5.83E-03 0.03252247 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN pulmonary emphysema DOID_9675 5.83E-03 0.03220672 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN autoimmune disease of urogenital tract DOID_0060049 6.091E-03 0.03332473 6.091E-03 0.11179908 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN primary biliary cirrhosis DOID_12236 6.091E-03 0.03332473 6.091E-03 0.11179908 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN salivary gland cancer DOID_8850 6.091E-03 0.03300735 0.11000855 0.53046494 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN uterine cancer DOID_363 6.629E-03 0.03558191 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN thyroid adenoma DOID_2891 7.474E-03 0.03974477 7.474E-03 0.12507912 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN glaucoma DOID_1686 8.063E-03 0.04248089 0.1260087 0.56903929 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN aortic aneurysm DOID_3627 8.365E-03 0.04366866 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN withdrawal disorder DOID_0060001 8.673E-03 0.04486085 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN orofacial cleft DOID_0050567 8.985E-03 0.04605721 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN osteochondrodysplasia DOID_2256 9.951E-03 0.05055575 0.13949628 0.61056447 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN smallpox DOID_8736 9.951E-03 0.05010836 9.951E-03 0.15728457 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN retinitis pigmentosa DOID_10584 0.01096169 0.05471229 0.01096169 0.16857302 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN hypertrophic cardiomyopathy DOID_11984 0.01096169 0.05423654 0.1461626 0.63004939 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN oral cavity cancer DOID_8618 0.01096169 0.05376898 0.1461626 0.62531218 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN melancholia DOID_2848 0.01130818 0.05499446 0.14837333 0.63003302 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN neurotic disorder DOID_4964 0.01165945 0.05622226 0.15057839 0.63466003 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN endocrine organ benign neoplasm DOID_0060089 0.01463879 0.06999558 0.01463879 0.21357625 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN blood coagulation disease DOID_1247 0.01542967 0.07316233 0.01542967 0.21948699 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN endogenous depression DOID_1595 0.01748516 0.08222361 0.18298413 0.72809771 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN lipid metabolism disorder DOID_3146 0.01920845 0.08958695 0.191417 0.74600186 CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN mental depression DOID_1596 0.02054589 0.09504563 0.19768506 0.7549181 VERHAAK_AML_WITH_NPM1_MUTATED_UP bacterial pneumonia DOID_874 5.827E-17 3.316E-14 0.23564776 0.70943691 VERHAAK_AML_WITH_NPM1_MUTATED_UP contact dermatitis DOID_2773 7.968E-17 2.267E-14 3.674E-10 1.045E-07 VERHAAK_AML_WITH_NPM1_MUTATED_UP allergic contact dermatitis DOID_3042 7.011E-16 1.33E-13 1.006E-10 5.726E-08 VERHAAK_AML_WITH_NPM1_MUTATED_UP primary bacterial infectious disease DOID_0050338 1.122E-14 1.596E-12 0.25843607 0.76191773 VERHAAK_AML_WITH_NPM1_MUTATED_UP bronchiolitis DOID_2942 1.883E-14 2.143E-12 0.08357383 0.47082684 VERHAAK_AML_WITH_NPM1_MUTATED_UP hypersensitivity reaction type I disease DOID_1205 2.987E-14 2.833E-12 9.662E-07 1.833E-04 VERHAAK_AML_WITH_NPM1_MUTATED_UP influenza DOID_8469 4.874E-14 3.962E-12 0.01090729 0.17239578 VERHAAK_AML_WITH_NPM1_MUTATED_UP pulmonary tuberculosis DOID_2957 1.298E-13 9.229E-12 0.16021348 0.57334258 VERHAAK_AML_WITH_NPM1_MUTATED_UP pleural disease DOID_1532 2.766E-13 1.749E-11 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP respiratory syncytial virus infectious disease DOID_1273 1.36E-12 7.741E-11 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP tuberculosis DOID_399 2.49E-12 1.288E-10 0.21216485 0.67067666 VERHAAK_AML_WITH_NPM1_MUTATED_UP myositis DOID_633 3.363E-12 1.595E-10 3.699E-03 0.08420054 VERHAAK_AML_WITH_NPM1_MUTATED_UP viral pneumonia DOID_10533 3.685E-12 1.613E-10 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP diabetic retinopathy DOID_8947 4.698E-12 1.909E-10 2.159E-03 0.05850666 VERHAAK_AML_WITH_NPM1_MUTATED_UP cystic fibrosis DOID_1485 5.98E-12 2.268E-10 0.23049009 0.71276556 VERHAAK_AML_WITH_NPM1_MUTATED_UP pleurisy DOID_10247 7.647E-12 2.719E-10 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP retinal vascular disease DOID_2462 1.64E-11 5.489E-10 3.17E-03 0.08198459 VERHAAK_AML_WITH_NPM1_MUTATED_UP parasitic protozoa infectious disease DOID_2789 2.113E-11 6.679E-10 0.17697611 0.59940122 VERHAAK_AML_WITH_NPM1_MUTATED_UP pustulosis of palm and sole DOID_4398 2.113E-11 6.327E-10 4.429E-05 3.15E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP leishmaniasis DOID_9065 3.284E-11 9.342E-10 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP mouth disease DOID_403 4.042E-11 1.095E-09 0.04138742 0.34129623 VERHAAK_AML_WITH_NPM1_MUTATED_UP carotid artery disease DOID_3407 4.798E-11 1.241E-09 6.531E-05 3.716E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP mitochondrial myopathy DOID_699 6.532E-11 1.616E-09 0.06805893 0.44006286 VERHAAK_AML_WITH_NPM1_MUTATED_UP parasitic infectious disease DOID_1398 7.923E-11 1.878E-09 0.20417924 0.66010221 VERHAAK_AML_WITH_NPM1_MUTATED_UP hepatitis DOID_2237 9.802E-11 2.231E-09 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP brain infarction DOID_3454 1.131E-10 2.475E-09 0.02380218 0.27086885 VERHAAK_AML_WITH_NPM1_MUTATED_UP rheumatic disease DOID_1575 1.923E-10 4.053E-09 0.14311219 0.56549192 VERHAAK_AML_WITH_NPM1_MUTATED_UP scleroderma DOID_419 1.923E-10 4.053E-09 0.14311219 0.56549192 VERHAAK_AML_WITH_NPM1_MUTATED_UP pancreatitis DOID_4989 3.005E-10 6.106E-09 1.56E-04 7.397E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP encephalitis DOID_9588 3.029E-10 5.943E-09 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP extrinsic allergic alveolitis DOID_841 4.449E-10 8.438E-09 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP periodontitis DOID_824 5.594E-10 1.027E-08 0.09275948 0.46708093 VERHAAK_AML_WITH_NPM1_MUTATED_UP collagen disease DOID_854 2.124E-09 3.776E-08 0.19340672 0.63981642 VERHAAK_AML_WITH_NPM1_MUTATED_UP respiratory failure DOID_11162 2.373E-09 4.092E-08 0.19611334 0.64502017 VERHAAK_AML_WITH_NPM1_MUTATED_UP pneumoconiosis DOID_10316 2.678E-09 4.482E-08 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP periodontal disease DOID_3388 2.678E-09 4.354E-08 0.11681038 0.51523338 VERHAAK_AML_WITH_NPM1_MUTATED_UP endocrine pancreas disease DOID_1428 2.948E-09 4.66E-08 0.20149957 0.65892676 VERHAAK_AML_WITH_NPM1_MUTATED_UP cholestasis DOID_13580 3.277E-09 5.04E-08 0.20417924 0.66387423 VERHAAK_AML_WITH_NPM1_MUTATED_UP bile duct disease DOID_4138 5.983E-09 8.959E-08 0.22007095 0.69182524 VERHAAK_AML_WITH_NPM1_MUTATED_UP biliary tract disease DOID_9741 6.581E-09 9.602E-08 0.22268878 0.69240392 VERHAAK_AML_WITH_NPM1_MUTATED_UP pulmonary emphysema DOID_9675 7.978E-09 1.135E-07 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP cerebral infarction DOID_3526 1.372E-08 1.904E-07 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP pre-eclampsia DOID_10591 1.767E-08 2.394E-07 0.15455101 0.57476814 VERHAAK_AML_WITH_NPM1_MUTATED_UP acute pancreatitis DOID_2913 1.962E-08 2.596E-07 3.176E-03 0.07856717 VERHAAK_AML_WITH_NPM1_MUTATED_UP childhood type dermatomyositis DOID_14203 2.483E-08 3.211E-07 0.03300286 0.32944958 VERHAAK_AML_WITH_NPM1_MUTATED_UP acute kidney failure DOID_3021 2.483E-08 3.14E-07 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP cutaneous leishmaniasis DOID_9111 2.483E-08 3.071E-07 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP atopic dermatitis DOID_3310 3.179E-08 3.849E-07 8.481E-04 0.02838574 VERHAAK_AML_WITH_NPM1_MUTATED_UP encephalomyelitis DOID_640 3.466E-08 4.109E-07 0.27325247 0.78130983 VERHAAK_AML_WITH_NPM1_MUTATED_UP sarcoidosis DOID_11335 3.551E-08 4.124E-07 0.01523771 0.21146962 VERHAAK_AML_WITH_NPM1_MUTATED_UP dermatomyositis DOID_10223 3.892E-08 4.429E-07 0.03624311 0.34953097 VERHAAK_AML_WITH_NPM1_MUTATED_UP vasculitis DOID_865 3.958E-08 4.416E-07 9.413E-04 0.02975451 VERHAAK_AML_WITH_NPM1_MUTATED_UP perinatal necrotizing enterocolitis DOID_8677 4.339E-08 4.748E-07 0.09275948 0.46298373 VERHAAK_AML_WITH_NPM1_MUTATED_UP mitochondrial metabolism disease DOID_700 4.888E-08 5.247E-07 0.17973742 0.60515143 VERHAAK_AML_WITH_NPM1_MUTATED_UP hypersensitivity reaction type IV disease DOID_2916 5.99E-08 6.312E-07 0.01791187 0.22648559 VERHAAK_AML_WITH_NPM1_MUTATED_UP uterine disease DOID_345 1.158E-07 1.198E-06 0.02196146 0.25502188 VERHAAK_AML_WITH_NPM1_MUTATED_UP tooth disease DOID_1091 1.38E-07 1.402E-06 0.20951185 0.66599019 VERHAAK_AML_WITH_NPM1_MUTATED_UP blood coagulation disease DOID_1247 1.777E-07 1.774E-06 1.093E-04 5.654E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP male reproductive system disease DOID_48 1.929E-07 1.892E-06 0.22007095 0.68802401 VERHAAK_AML_WITH_NPM1_MUTATED_UP multiple myeloma DOID_9538 2.334E-07 2.251E-06 0.12566545 0.51814233 VERHAAK_AML_WITH_NPM1_MUTATED_UP uveitis DOID_13141 2.651E-07 2.514E-06 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP blood platelet disease DOID_2218 2.651E-07 2.473E-06 1.105E-05 1.572E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP bone resorption disease DOID_0080011 2.855E-07 2.62E-06 0.23307323 0.71300358 VERHAAK_AML_WITH_NPM1_MUTATED_UP osteoporosis DOID_11476 2.855E-07 2.62E-06 0.23307323 0.71300358 VERHAAK_AML_WITH_NPM1_MUTATED_UP aneurysm disease DOID_2403 2.855E-07 2.578E-06 0.23307323 0.70919073 VERHAAK_AML_WITH_NPM1_MUTATED_UP systemic scleroderma DOID_418 3.002E-07 2.669E-06 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP peptic ulcer DOID_750 3.002E-07 2.628E-06 0.13151984 0.5345342 VERHAAK_AML_WITH_NPM1_MUTATED_UP adult respiratory distress syndrome DOID_11394 3.387E-07 2.92E-06 0.13443243 0.54249683 VERHAAK_AML_WITH_NPM1_MUTATED_UP intracranial arterial disease DOID_13089 3.387E-07 2.877E-06 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP cerebral arterial disease DOID_3527 3.387E-07 2.877E-06 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP metabolic syndrome X DOID_14221 3.567E-07 2.985E-06 1.716E-04 7.512E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP female reproductive system disease DOID_229 3.834E-07 3.162E-06 0.03176192 0.32859146 VERHAAK_AML_WITH_NPM1_MUTATED_UP uveal disease DOID_3480 4.785E-07 3.89E-06 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP pulmonary edema DOID_11396 5.582E-07 4.473E-06 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Kawasaki disease DOID_13378 6.877E-07 5.435E-06 0.06805893 0.44512106 VERHAAK_AML_WITH_NPM1_MUTATED_UP lymphadenitis DOID_1602 6.877E-07 5.435E-06 0.06805893 0.44512106 VERHAAK_AML_WITH_NPM1_MUTATED_UP lymph node disease DOID_9942 6.877E-07 5.435E-06 0.06805893 0.44512106 VERHAAK_AML_WITH_NPM1_MUTATED_UP myeloma DOID_0070004 7.317E-07 5.704E-06 0.15455101 0.57854951 VERHAAK_AML_WITH_NPM1_MUTATED_UP neuritis DOID_1803 7.317E-07 5.627E-06 0.15455101 0.56735178 VERHAAK_AML_WITH_NPM1_MUTATED_UP vascular skin disease DOID_9540 7.317E-07 5.551E-06 0.01227988 0.18884469 VERHAAK_AML_WITH_NPM1_MUTATED_UP hemolytic anemia DOID_583 8.091E-07 6.058E-06 0.15738697 0.57040244 VERHAAK_AML_WITH_NPM1_MUTATED_UP normocytic anemia DOID_720 8.091E-07 6.058E-06 0.15738697 0.57040244 VERHAAK_AML_WITH_NPM1_MUTATED_UP dilated cardiomyopathy DOID_12930 9.662E-07 7.14E-06 0.27812571 0.79126764 VERHAAK_AML_WITH_NPM1_MUTATED_UP polyarteritis nodosa DOID_9810 1.012E-06 7.384E-06 0.07429592 0.44972742 VERHAAK_AML_WITH_NPM1_MUTATED_UP hypoglycemia DOID_9993 1.012E-06 7.29E-06 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hemorrhagic disease DOID_2213 1.081E-06 7.686E-06 3.336E-05 2.712E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP ulcerative colitis DOID_8577 1.156E-06 8.121E-06 4.686E-03 0.09193863 VERHAAK_AML_WITH_NPM1_MUTATED_UP bone marrow cancer DOID_4960 1.419E-06 9.848E-06 0.17420557 0.60074527 VERHAAK_AML_WITH_NPM1_MUTATED_UP commensal bacterial infectious disease DOID_0050339 1.696E-06 1.162E-05 0.08357383 0.49024238 VERHAAK_AML_WITH_NPM1_MUTATED_UP cystitis DOID_1679 1.985E-06 1.345E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP oral cavity cancer DOID_8618 1.995E-06 1.335E-05 5.406E-05 3.418E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP diffuse large B-cell lymphoma DOID_0050745 2.673E-06 1.769E-05 0.09275948 0.48422152 VERHAAK_AML_WITH_NPM1_MUTATED_UP malaria DOID_12365 3.076E-06 2.012E-05 0.09580102 0.47400679 VERHAAK_AML_WITH_NPM1_MUTATED_UP mineral metabolism disease DOID_0050032 3.187E-06 2.061E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP endocrine organ benign neoplasm DOID_0060089 4.251E-06 2.718E-05 1.777E-03 0.05055598 VERHAAK_AML_WITH_NPM1_MUTATED_UP visceral leishmaniasis DOID_9146 4.331E-06 2.738E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP bronchiolitis obliterans DOID_2799 4.558E-06 2.85E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP pancreatic ductal carcinoma DOID_3587 4.878E-06 3.017E-05 0.02506334 0.27425078 VERHAAK_AML_WITH_NPM1_MUTATED_UP allergic rhinitis DOID_4481 5.152E-06 3.152E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP peripheral vascular disease DOID_341 5.575E-06 3.375E-05 0.02635122 0.28290275 VERHAAK_AML_WITH_NPM1_MUTATED_UP bladder disease DOID_365 5.802E-06 3.475E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP bronchiectasis DOID_9563 5.94E-06 3.521E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP pancreatic carcinoma DOID_4905 5.952E-06 3.491E-05 0.02700506 0.2845533 VERHAAK_AML_WITH_NPM1_MUTATED_UP papilloma DOID_2615 6.51E-06 3.78E-05 2.418E-04 9.826E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP spindle cell carcinoma DOID_4015 7.28E-06 4.184E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP macular degeneration DOID_4448 7.28E-06 4.143E-05 0.11681038 0.50736722 VERHAAK_AML_WITH_NPM1_MUTATED_UP mitochondrial encephalomyopathy DOID_890 7.9E-06 4.451E-05 0.03947258 0.3403015 VERHAAK_AML_WITH_NPM1_MUTATED_UP pulmonary sarcoidosis DOID_13406 9.996E-06 5.576E-05 0.12566545 0.52576207 VERHAAK_AML_WITH_NPM1_MUTATED_UP berylliosis DOID_10322 1.025E-05 5.66E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP biliary tract cancer DOID_4607 1.032E-05 5.644E-05 0.24839236 0.73997516 VERHAAK_AML_WITH_NPM1_MUTATED_UP congenital diaphragmatic hernia DOID_3827 1.218E-05 6.6E-05 8.783E-03 0.1514326 VERHAAK_AML_WITH_NPM1_MUTATED_UP adenoid cystic carcinoma DOID_4866 1.339E-05 7.19E-05 1.339E-05 1.524E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP lymphatic system disease DOID_75 1.339E-05 7.123E-05 0.13443243 0.53867643 VERHAAK_AML_WITH_NPM1_MUTATED_UP endometriosis of uterus DOID_288 1.609E-05 8.476E-05 0.01003266 0.1678996 VERHAAK_AML_WITH_NPM1_MUTATED_UP salivary gland cancer DOID_8850 1.609E-05 8.398E-05 1.609E-05 1.526E-03 VERHAAK_AML_WITH_NPM1_MUTATED_UP lung oat cell carcinoma DOID_5411 1.622E-05 8.39E-05 0.04909673 0.37751404 VERHAAK_AML_WITH_NPM1_MUTATED_UP endometriosis DOID_289 1.757E-05 9.009E-05 0.01046589 0.17014555 VERHAAK_AML_WITH_NPM1_MUTATED_UP lymphoblastic leukemia DOID_1037 1.774E-05 9.013E-05 4.06E-03 0.08884959 VERHAAK_AML_WITH_NPM1_MUTATED_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.867E-05 9.399E-05 4.181E-03 0.0881051 VERHAAK_AML_WITH_NPM1_MUTATED_UP diabetic autonomic neuropathy DOID_11503 1.916E-05 9.563E-05 0.14598621 0.56507588 VERHAAK_AML_WITH_NPM1_MUTATED_UP autonomic neuropathy DOID_11504 1.916E-05 9.563E-05 0.14598621 0.56507588 VERHAAK_AML_WITH_NPM1_MUTATED_UP diabetic polyneuropathy DOID_12785 1.916E-05 9.563E-05 0.14598621 0.56507588 VERHAAK_AML_WITH_NPM1_MUTATED_UP gallbladder cancer DOID_3121 1.916E-05 9.48E-05 0.14598621 0.5612578 VERHAAK_AML_WITH_NPM1_MUTATED_UP diabetic neuropathy DOID_9743 1.916E-05 9.563E-05 0.14598621 0.56507588 VERHAAK_AML_WITH_NPM1_MUTATED_UP hemolytic-uremic syndrome DOID_12554 1.991E-05 9.768E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP leukodystrophy DOID_10579 2.264E-05 1.101E-04 0.15170559 0.57933208 VERHAAK_AML_WITH_NPM1_MUTATED_UP proteinuria DOID_576 2.264E-05 1.092E-04 0.15170559 0.57165881 VERHAAK_AML_WITH_NPM1_MUTATED_UP autonomic nervous system disease DOID_11465 2.455E-05 1.174E-04 0.15455101 0.57103588 VERHAAK_AML_WITH_NPM1_MUTATED_UP thyroid adenoma DOID_2891 2.455E-05 1.164E-04 6.414E-04 0.02432925 VERHAAK_AML_WITH_NPM1_MUTATED_UP prion disease DOID_649 2.888E-05 1.358E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP calcium metabolism disease DOID_10575 3.097E-05 1.444E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP aortic aneurysm DOID_3627 3.097E-05 1.433E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP B-cell lymphocytic neoplasm DOID_707 3.336E-05 1.531E-04 0.16583832 0.58609941 VERHAAK_AML_WITH_NPM1_MUTATED_UP giant cell tumor DOID_200 3.854E-05 1.755E-04 0.01523771 0.20643463 VERHAAK_AML_WITH_NPM1_MUTATED_UP malignant giant cell tumor DOID_2705 3.854E-05 1.755E-04 0.01523771 0.20643463 VERHAAK_AML_WITH_NPM1_MUTATED_UP giant cell glioblastoma DOID_3074 3.854E-05 1.755E-04 0.01523771 0.20643463 VERHAAK_AML_WITH_NPM1_MUTATED_UP coronary restenosis DOID_4247 4.672E-05 2.11E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hypertrophic cardiomyopathy DOID_11984 5.406E-05 2.422E-04 0.01791187 0.23163299 VERHAAK_AML_WITH_NPM1_MUTATED_UP glioblastoma DOID_3068 5.406E-05 2.403E-04 0.01791187 0.22156199 VERHAAK_AML_WITH_NPM1_MUTATED_UP leukocyte disease DOID_9500 5.764E-05 2.542E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP sinusitis DOID_0050127 6.191E-05 2.71E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP paranasal sinus disease DOID_1352 6.191E-05 2.71E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP pulmonary embolism DOID_9477 6.191E-05 2.689E-04 0.07429592 0.4545632 VERHAAK_AML_WITH_NPM1_MUTATED_UP Lewy body dementia DOID_12217 7.058E-05 3.042E-04 0.07739886 0.46357846 VERHAAK_AML_WITH_NPM1_MUTATED_UP meningitis DOID_9471 7.058E-05 3.019E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Goodpasture syndrome DOID_9808 7.058E-05 2.997E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP toxic shock syndrome DOID_14115 8.001E-05 3.372E-04 0.08049149 0.47707977 VERHAAK_AML_WITH_NPM1_MUTATED_UP cerebral degeneration DOID_1443 8.285E-05 3.466E-04 0.20417924 0.65637282 VERHAAK_AML_WITH_NPM1_MUTATED_UP hyperglycemia DOID_4195 8.772E-05 3.643E-04 0.20684999 0.66122274 VERHAAK_AML_WITH_NPM1_MUTATED_UP portal hypertension DOID_10762 9.022E-05 3.72E-04 0.08357383 0.48033849 VERHAAK_AML_WITH_NPM1_MUTATED_UP urticaria DOID_1555 9.022E-05 3.693E-04 0.08357383 0.4755351 VERHAAK_AML_WITH_NPM1_MUTATED_UP astrocytoma DOID_3069 1.036E-04 4.21E-04 0.0244294 0.27255541 VERHAAK_AML_WITH_NPM1_MUTATED_UP intracranial aneurysm DOID_10941 1.131E-04 4.565E-04 0.08970779 0.48613081 VERHAAK_AML_WITH_NPM1_MUTATED_UP middle cerebral artery infarction DOID_3525 1.131E-04 4.533E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP renal hypertension DOID_1073 1.395E-04 5.551E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP secondary hypertension DOID_11130 1.395E-04 5.551E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hepatic vascular disease DOID_272 1.395E-04 5.513E-04 0.09580102 0.46590411 VERHAAK_AML_WITH_NPM1_MUTATED_UP coronary stenosis DOID_4248 1.395E-04 5.474E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP age related macular degeneration DOID_10871 1.861E-04 7.253E-04 0.10486507 0.48510751 VERHAAK_AML_WITH_NPM1_MUTATED_UP degeneration of macula and posterior pole DOID_2007 1.861E-04 7.253E-04 0.10486507 0.48510751 VERHAAK_AML_WITH_NPM1_MUTATED_UP abdominal aortic aneurysm DOID_7693 1.861E-04 7.204E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP chronic kidney failure DOID_784 1.971E-04 7.579E-04 0.24839236 0.73612112 VERHAAK_AML_WITH_NPM1_MUTATED_UP celiac disease DOID_10608 2.036E-04 7.776E-04 5.823E-03 0.11044537 VERHAAK_AML_WITH_NPM1_MUTATED_UP myocarditis DOID_820 2.418E-04 9.171E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Human immunodeficiency virus infectious disease DOID_526 2.672E-04 1.007E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP lymphoid leukemia DOID_10747 2.843E-04 1.064E-03 7.234E-03 0.13277297 VERHAAK_AML_WITH_NPM1_MUTATED_UP lymphoma DOID_0060058 2.901E-04 1.079E-03 0.27080363 0.77821851 VERHAAK_AML_WITH_NPM1_MUTATED_UP Crohn's disease DOID_8778 3.144E-04 1.162E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP retinal vascular occlusion DOID_1729 4.923E-04 1.807E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hyperinsulinism DOID_2018 5.016E-04 1.83E-03 0.14311219 0.55774546 VERHAAK_AML_WITH_NPM1_MUTATED_UP adrenoleukodystrophy DOID_10588 6.004E-04 2.176E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP sickle cell anemia DOID_10923 6.004E-04 2.162E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP neuronal ceroid lipofuscinosis DOID_14503 6.004E-04 2.149E-03 0.03624311 0.33807094 VERHAAK_AML_WITH_NPM1_MUTATED_UP intracranial arteriosclerosis DOID_13097 7.189E-04 2.556E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP osteopetrosis DOID_13533 7.189E-04 2.541E-03 7.189E-04 0.02556496 VERHAAK_AML_WITH_NPM1_MUTATED_UP peritonitis DOID_8283 7.189E-04 2.525E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP vascular dementia DOID_8725 7.189E-04 2.556E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP ocular hypertension DOID_9282 7.189E-04 2.509E-03 0.03947258 0.33522237 VERHAAK_AML_WITH_NPM1_MUTATED_UP borderline glaucoma DOID_9283 7.189E-04 2.509E-03 0.03947258 0.33522237 VERHAAK_AML_WITH_NPM1_MUTATED_UP autoimmune disease of gastrointestinal tract DOID_0060031 7.197E-04 2.497E-03 0.0132347 0.19817228 VERHAAK_AML_WITH_NPM1_MUTATED_UP glaucoma DOID_1686 7.197E-04 2.482E-03 0.0132347 0.19309094 VERHAAK_AML_WITH_NPM1_MUTATED_UP lung small cell carcinoma DOID_5409 7.197E-04 2.467E-03 0.16021348 0.56975919 VERHAAK_AML_WITH_NPM1_MUTATED_UP psoriatic arthritis DOID_9008 8.477E-04 2.888E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP bile duct adenocarcinoma DOID_4896 9.413E-04 3.188E-03 0.17420557 0.60440835 VERHAAK_AML_WITH_NPM1_MUTATED_UP cholangiocarcinoma DOID_4947 9.413E-04 3.188E-03 0.17420557 0.60440835 VERHAAK_AML_WITH_NPM1_MUTATED_UP Legionnaires' disease DOID_10457 9.868E-04 3.323E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP legionellosis DOID_10458 9.868E-04 3.323E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hypercalcemia DOID_12678 9.868E-04 3.303E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP integumentary system cancer DOID_0060122 9.902E-04 3.295E-03 0.17697611 0.60299044 VERHAAK_AML_WITH_NPM1_MUTATED_UP skin cancer DOID_4159 9.902E-04 3.295E-03 0.17697611 0.60299044 VERHAAK_AML_WITH_NPM1_MUTATED_UP thoracic aortic aneurysm DOID_14004 1.136E-03 3.759E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP oral submucous fibrosis DOID_5773 1.136E-03 3.737E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP varicose veins DOID_799 1.136E-03 3.715E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP bile duct cancer DOID_4606 1.147E-03 3.728E-03 0.1852325 0.61998409 VERHAAK_AML_WITH_NPM1_MUTATED_UP bile duct carcinoma DOID_4897 1.147E-03 3.728E-03 0.1852325 0.61998409 VERHAAK_AML_WITH_NPM1_MUTATED_UP silicosis DOID_10325 1.296E-03 4.189E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP restrictive cardiomyopathy DOID_397 1.296E-03 4.165E-03 0.05228347 0.39143808 VERHAAK_AML_WITH_NPM1_MUTATED_UP thyroiditis DOID_7166 1.296E-03 4.142E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP autoimmune thyroiditis DOID_7188 1.296E-03 4.142E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP vein disease DOID_866 1.296E-03 4.118E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP pre-malignant neoplasm DOID_0060071 1.44E-03 4.552E-03 0.02076893 0.25143666 VERHAAK_AML_WITH_NPM1_MUTATED_UP in situ carcinoma DOID_8719 1.44E-03 4.552E-03 0.02076893 0.25143666 VERHAAK_AML_WITH_NPM1_MUTATED_UP osteosclerosis DOID_4254 1.645E-03 5.17E-03 1.645E-03 0.04925417 VERHAAK_AML_WITH_NPM1_MUTATED_UP esophagitis DOID_11963 2.033E-03 6.357E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP syndrome DOID_225 2.325E-03 7.23E-03 0.23049009 0.70891277 VERHAAK_AML_WITH_NPM1_MUTATED_UP gastric ulcer DOID_10808 2.461E-03 7.612E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP neutropenia DOID_1227 2.461E-03 7.571E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP acquired immunodeficiency syndrome DOID_635 2.461E-03 7.53E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP placenta disease DOID_780 2.461E-03 7.49E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP agranulocytosis DOID_12987 2.69E-03 8.142E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP IgA glomerulonephritis DOID_2986 2.69E-03 8.099E-03 0.07429592 0.4645536 VERHAAK_AML_WITH_NPM1_MUTATED_UP urinary tract obstruction DOID_5200 2.69E-03 8.056E-03 0.07429592 0.4595041 VERHAAK_AML_WITH_NPM1_MUTATED_UP diabetic angiopathy DOID_11713 2.928E-03 8.723E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP alcohol abuse DOID_1574 2.968E-03 8.796E-03 0.03317739 0.32548167 VERHAAK_AML_WITH_NPM1_MUTATED_UP spastic quadriplegia DOID_10970 3.176E-03 9.363E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP transitional cell carcinoma DOID_2671 3.488E-03 0.0102299 0.26092611 0.7652936 VERHAAK_AML_WITH_NPM1_MUTATED_UP primary immunodeficiency disease DOID_612 3.598E-03 0.01049891 0.26340787 0.76861065 VERHAAK_AML_WITH_NPM1_MUTATED_UP amino acid metabolic disorder DOID_9252 3.598E-03 0.01044535 0.26340787 0.76468917 VERHAAK_AML_WITH_NPM1_MUTATED_UP papillary adenoma DOID_3172 3.699E-03 0.01068535 3.699E-03 0.0877089 VERHAAK_AML_WITH_NPM1_MUTATED_UP microcystic adenoma DOID_5403 3.699E-03 0.01068535 3.699E-03 0.0877089 VERHAAK_AML_WITH_NPM1_MUTATED_UP follicular adenoma DOID_6204 3.699E-03 0.01068535 3.699E-03 0.0877089 VERHAAK_AML_WITH_NPM1_MUTATED_UP carbohydrate metabolic disorder DOID_2978 4.06E-03 0.01166712 0.04061228 0.3398292 VERHAAK_AML_WITH_NPM1_MUTATED_UP Sciatic Neuropathy DOID_11446 4.261E-03 0.01218209 0.09275948 0.47981951 VERHAAK_AML_WITH_NPM1_MUTATED_UP lesion of sciatic nerve DOID_12528 4.261E-03 0.01218209 0.09275948 0.47981951 VERHAAK_AML_WITH_NPM1_MUTATED_UP lung adenocarcinoma DOID_3910 4.261E-03 0.01212118 0.09275948 0.4712513 VERHAAK_AML_WITH_NPM1_MUTATED_UP mononeuritis of lower limb DOID_9473 4.261E-03 0.01218209 0.09275948 0.47981951 VERHAAK_AML_WITH_NPM1_MUTATED_UP thrombocytopenia DOID_1588 4.555E-03 0.01289416 4.555E-03 0.09256163 VERHAAK_AML_WITH_NPM1_MUTATED_UP mononeuritis DOID_1802 4.555E-03 0.01283033 0.09580102 0.46992052 VERHAAK_AML_WITH_NPM1_MUTATED_UP autoimmune disease of endocrine system DOID_0060005 4.858E-03 0.01361783 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP mononeuropathy DOID_1188 4.858E-03 0.01355107 0.09883244 0.4686305 VERHAAK_AML_WITH_NPM1_MUTATED_UP focal glomerulosclerosis DOID_3945 4.858E-03 0.01348497 0.09883244 0.46475752 VERHAAK_AML_WITH_NPM1_MUTATED_UP corneal disease DOID_10124 5.171E-03 0.01428291 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP spastic cerebral palsy DOID_0050669 5.493E-03 0.01509794 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP opportunistic mycosis DOID_2473 5.493E-03 0.01502535 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP leiomyoma DOID_127 6.163E-03 0.01677756 0.11085763 0.50462391 VERHAAK_AML_WITH_NPM1_MUTATED_UP systemic mycosis DOID_0050136 6.511E-03 0.01764135 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP fungal infectious disease DOID_1564 6.511E-03 0.01764135 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP metal metabolism disorder DOID_896 6.511E-03 0.01755774 0.11383896 0.5100344 VERHAAK_AML_WITH_NPM1_MUTATED_UP thyroid carcinoma DOID_3963 6.868E-03 0.01843323 0.11681038 0.51127004 VERHAAK_AML_WITH_NPM1_MUTATED_UP esophageal disease DOID_6050 6.868E-03 0.01834669 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP leukopenia DOID_615 6.868E-03 0.01826096 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP aplastic anemia DOID_12449 7.234E-03 0.01914401 0.11977191 0.51628953 VERHAAK_AML_WITH_NPM1_MUTATED_UP thyroid cancer DOID_1781 7.608E-03 0.02004166 0.12272359 0.52111734 VERHAAK_AML_WITH_NPM1_MUTATED_UP adenoma DOID_657 7.608E-03 0.0199493 7.608E-03 0.13528119 VERHAAK_AML_WITH_NPM1_MUTATED_UP calcinosis DOID_182 7.991E-03 0.02085743 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP benign mesothelioma DOID_2645 9.608E-03 0.02496237 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP learning disability DOID_8927 0.01135679 0.02937279 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP bone marrow disease DOID_4961 0.01227988 0.03161653 0.15455101 0.56371491 VERHAAK_AML_WITH_NPM1_MUTATED_UP integumentary system benign neoplasm DOID_0060121 0.0132347 0.03392138 0.16021348 0.57697133 VERHAAK_AML_WITH_NPM1_MUTATED_UP skin benign neoplasm DOID_3165 0.0132347 0.03392138 0.16021348 0.57697133 VERHAAK_AML_WITH_NPM1_MUTATED_UP movement disease DOID_480 0.01372387 0.03501741 0.01372387 0.19522205 VERHAAK_AML_WITH_NPM1_MUTATED_UP reproductive organ benign neoplasm DOID_0050622 0.01628498 0.04136676 0.17697611 0.60662292 VERHAAK_AML_WITH_NPM1_MUTATED_UP smallpox DOID_8736 0.01628498 0.04118291 0.01628498 0.21549198 VERHAAK_AML_WITH_NPM1_MUTATED_UP melancholia DOID_2848 0.01846886 0.04649904 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP neurotic disorder DOID_4964 0.01903312 0.04770858 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP congenital heart defect DOID_1682 0.02076893 0.05183124 0.02076893 0.2461984 VERHAAK_AML_WITH_NPM1_MUTATED_UP nephrosis DOID_2527 0.02570397 0.06386706 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP endogenous depression DOID_1595 0.02833227 0.07009156 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP leber hereditary optic neuropathy DOID_705 0.0297518 0.07328474 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP interstitial nephritis DOID_1063 0.03300286 0.08094235 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP T cell deficiency DOID_11200 0.03300286 0.08059496 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Sjogren's syndrome DOID_12894 0.03300286 0.08025054 0.03300286 0.33533261 VERHAAK_AML_WITH_NPM1_MUTATED_UP hyperparathyroidism DOID_13543 0.03300286 0.07990905 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hypolipoproteinemia DOID_1387 0.03300286 0.07957045 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP transient cerebral ischemia DOID_224 0.03300286 0.07923471 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP bilirubin metabolic disorder DOID_2741 0.03300286 0.07890179 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP teratoma DOID_3307 0.03300286 0.07857166 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP adrenal gland hyperfunction DOID_3947 0.03300286 0.07824428 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP keratitis DOID_4677 0.03300286 0.07791961 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP malignant teratoma DOID_5563 0.03300286 0.07857166 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP mature teratoma DOID_5566 0.03300286 0.07857166 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP acute T cell leukemia DOID_5603 0.03300286 0.07759763 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.03300286 0.0772783 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.03300286 0.0772783 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Hodgkin's granuloma DOID_8651 0.03300286 0.0772783 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.03300286 0.0772783 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP mental depression DOID_1596 0.03317739 0.07736859 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP familial adenomatous polyposis DOID_0050424 0.03624311 0.08417276 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP prediabetes syndrome DOID_11716 0.03624311 0.0838306 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP migraine without aura DOID_12783 0.03624311 0.0834912 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP temporal arteritis DOID_13375 0.03624311 0.08315455 0.03624311 0.34370545 VERHAAK_AML_WITH_NPM1_MUTATED_UP hemochromatosis DOID_2352 0.03624311 0.08282059 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP prostatic adenoma DOID_2883 0.03624311 0.08248931 0.03624311 0.33261818 VERHAAK_AML_WITH_NPM1_MUTATED_UP central nervous system vasculitis DOID_525 0.03624311 0.08315455 0.03624311 0.34370545 VERHAAK_AML_WITH_NPM1_MUTATED_UP eosinophilic pneumonia DOID_5870 0.03624311 0.08216067 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP pulmonary eosinophilia DOID_9498 0.03624311 0.08216067 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Loeffler syndrome DOID_9503 0.03624311 0.08216067 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP nervous system cancer DOID_3093 0.03832074 0.08652579 0.26588135 0.76795172 VERHAAK_AML_WITH_NPM1_MUTATED_UP common cold DOID_10459 0.03947258 0.0887743 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP otitis media DOID_10754 0.03947258 0.0884248 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP mucopolysaccharidosis DOID_12798 0.03947258 0.08807803 0.03947258 0.35650633 VERHAAK_AML_WITH_NPM1_MUTATED_UP diarrhea DOID_13250 0.03947258 0.08773398 0.03947258 0.35093592 VERHAAK_AML_WITH_NPM1_MUTATED_UP relapsing-remitting multiple sclerosis DOID_2378 0.03947258 0.0873926 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP middle ear disease DOID_5100 0.03947258 0.0884248 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP stomach disease DOID_76 0.03947258 0.08705387 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP lipodystrophy DOID_811 0.03947258 0.08671776 0.03947258 0.3455369 VERHAAK_AML_WITH_NPM1_MUTATED_UP Hodgkin's lymphoma DOID_8567 0.03947258 0.08638423 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 0.04269132 0.09307035 0.04269132 0.34701945 VERHAAK_AML_WITH_NPM1_MUTATED_UP parathyroid gland disease DOID_11201 0.04269132 0.09271512 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hepatic coma DOID_12550 0.04269132 0.09236259 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP newborn respiratory distress syndrome DOID_12716 0.04269132 0.09201273 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP carotid stenosis DOID_13001 0.04269132 0.09166551 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP hepatic encephalopathy DOID_13413 0.04269132 0.09236259 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP polyneuropathy DOID_1389 0.04269132 0.09132091 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP larynx cancer DOID_2596 0.04269132 0.09097888 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP laryngeal benign neoplasm DOID_2598 0.04269132 0.09097888 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP intracranial thrombosis DOID_4193 0.04269132 0.09063941 0.04269132 0.34213185 VERHAAK_AML_WITH_NPM1_MUTATED_UP aspergillosis DOID_13564 0.04589936 0.09708823 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP T-cell leukemia DOID_715 0.04589936 0.09672865 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_UP polycystic kidney disease DOID_898 0.04589936 0.09637171 0.04589936 0.36273242 VERHAAK_AML_WITH_NPM1_MUTATED_UP bacterial meningitis DOID_9470 0.04589936 0.09601741 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP carotid artery disease DOID_3407 3.477E-16 1.978E-13 9.648E-08 1.83E-05 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP retinal vascular disease DOID_2462 1.225E-14 3.485E-12 6.09E-07 8.663E-05 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pulmonary emphysema DOID_9675 3.4E-14 6.448E-12 0.14134682 0.40619364 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP diabetic retinopathy DOID_8947 1.346E-13 1.915E-11 6.924E-06 4.377E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pulmonary sarcoidosis DOID_13406 1.147E-12 1.305E-10 3.628E-04 7.118E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP collagen disease DOID_854 1.246E-12 1.182E-10 0.02077455 0.11940121 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP heart valve disease DOID_4079 7.779E-12 6.323E-10 8.532E-07 9.709E-05 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP aneurysm disease DOID_2403 8.917E-12 6.343E-10 8.376E-06 4.766E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bacterial pneumonia DOID_874 1.002E-11 6.334E-10 0.24210093 0.6015521 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bone development disease DOID_0080006 1.952E-11 1.111E-09 6.929E-10 3.943E-07 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP sarcoidosis DOID_11335 2.023E-11 1.046E-09 9.777E-04 0.01324532 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hypersensitivity reaction type IV disease DOID_2916 4.133E-11 1.96E-09 1.254E-03 0.01426494 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP systemic scleroderma DOID_418 1.22E-10 5.341E-09 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP peripheral vascular disease DOID_341 2.274E-10 9.243E-09 8.168E-09 2.324E-06 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP rheumatic disease DOID_1575 2.393E-10 9.079E-09 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP scleroderma DOID_419 2.393E-10 9.079E-09 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pre-eclampsia DOID_10591 4.415E-10 1.57E-08 7.018E-04 0.0105087 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP glaucoma DOID_1686 5.88E-10 1.968E-08 1.041E-06 9.87E-05 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP aortic aneurysm DOID_3627 6.756E-10 2.136E-08 8.325E-04 0.01184227 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP primary bacterial infectious disease DOID_0050338 9.144E-10 2.738E-08 0.26539869 0.63988075 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP thoracic aortic aneurysm DOID_14004 1.332E-09 3.791E-08 1.208E-03 0.01494298 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP respiratory failure DOID_11162 2.948E-09 7.988E-08 0.02138625 0.12168775 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP tuberculosis DOID_399 5.536E-09 1.432E-07 0.2180701 0.55642103 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP intracranial arterial disease DOID_13089 8.325E-09 2.06E-07 4.498E-04 8.53E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP cerebral arterial disease DOID_3527 8.325E-09 2.06E-07 4.498E-04 8.53E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP urticaria DOID_1555 2.831E-08 6.711E-07 1.919E-06 1.365E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP middle cerebral artery infarction DOID_3525 4.206E-08 9.573E-07 4.223E-03 0.03482496 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP giant cell tumor DOID_200 4.274E-08 9.353E-07 9.777E-04 0.01293729 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP malignant giant cell tumor DOID_2705 4.274E-08 9.353E-07 9.777E-04 0.01293729 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP giant cell glioblastoma DOID_3074 4.274E-08 9.353E-07 9.777E-04 0.01293729 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP mouth disease DOID_403 4.619E-08 9.734E-07 2.168E-05 8.222E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP osteochondrodysplasia DOID_2256 5.298E-08 1.077E-06 1.805E-06 1.467E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP aortic valve insufficiency DOID_57 6.596E-08 1.294E-06 8.671E-06 4.485E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP glioblastoma DOID_3068 7.206E-08 1.367E-06 1.254E-03 0.01398524 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP osteogenesis imperfecta DOID_12347 9.503E-08 1.744E-06 1.124E-05 4.921E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP age related macular degeneration DOID_10871 1.002E-07 1.781E-06 5.833E-03 0.04366901 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP degeneration of macula and posterior pole DOID_2007 1.002E-07 1.781E-06 5.833E-03 0.04366901 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pleural disease DOID_1532 1.363E-07 2.35E-06 0.1141477 0.35298934 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP brain infarction DOID_3454 1.807E-07 3.024E-06 1.941E-03 0.01872202 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP macular degeneration DOID_4448 1.82E-07 2.958E-06 7.291E-03 0.05059437 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP astrocytoma DOID_3069 1.966E-07 3.107E-06 2.021E-03 0.01916228 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP respiratory syncytial virus infectious disease DOID_1273 3.502E-07 5.386E-06 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP adult respiratory distress syndrome DOID_11394 3.952E-07 5.918E-06 9.753E-03 0.06378985 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP uveal disease DOID_3480 5.581E-07 8.143E-06 0.01110415 0.07099171 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP diabetic autonomic neuropathy DOID_11503 6.228E-07 8.86E-06 0.01157167 0.07315866 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP autonomic neuropathy DOID_11504 6.228E-07 8.86E-06 0.01157167 0.07315866 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP diabetic polyneuropathy DOID_12785 6.228E-07 8.86E-06 0.01157167 0.07315866 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP diabetic neuropathy DOID_9743 6.228E-07 8.86E-06 0.01157167 0.07315866 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP membranous glomerulonephritis DOID_10976 6.319E-07 8.77E-06 2.161E-03 0.02016124 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP brain edema DOID_4724 6.319E-07 8.561E-06 4.403E-05 1.474E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP cerebral infarction DOID_3526 6.933E-07 9.175E-06 0.01204772 0.07533136 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP autonomic nervous system disease DOID_11465 8.532E-07 1.103E-05 0.01302518 0.07969171 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP vascular skin disease DOID_9540 8.532E-07 1.079E-05 2.772E-05 9.858E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pulmonary tuberculosis DOID_2957 1.041E-06 1.287E-05 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hypersensitivity reaction type I disease DOID_1205 1.159E-06 1.403E-05 4.692E-03 0.03760348 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP aortic valve disease DOID_62 1.371E-06 1.625E-05 7.739E-05 2.202E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP spastic quadriplegia DOID_10970 1.628E-06 1.89E-05 8.772E-05 2.377E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP vasculitis DOID_865 1.654E-06 1.882E-05 0.17917759 0.48780885 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP cystitis DOID_1679 2.247E-06 2.506E-05 0.08925392 0.31349061 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP autoimmune disease of the nervous system DOID_438 3.48E-06 3.808E-05 4.838E-03 0.03770991 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP mineral metabolism disease DOID_0050032 3.71E-06 3.983E-05 0.20714847 0.54067651 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP focal glomerulosclerosis DOID_3945 3.985E-06 4.199E-05 1.688E-04 3.695E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP cholestasis DOID_13580 3.994E-06 4.132E-05 9.343E-05 2.416E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP spastic cerebral palsy DOID_0050669 5.155E-06 5.237E-05 2.039E-04 4.144E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bronchiolitis obliterans DOID_2799 5.155E-06 5.146E-05 0.10798829 0.33761174 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP nephrosis DOID_2527 6.07E-06 5.955E-05 1.299E-04 3.214E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bile duct disease DOID_4138 6.07E-06 5.854E-05 1.299E-04 3.08E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP biliary tract disease DOID_9741 6.486E-06 6.151E-05 1.369E-04 3.115E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP temporal arteritis DOID_13375 6.52E-06 6.081E-05 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP central nervous system vasculitis DOID_525 6.52E-06 6.081E-05 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bladder disease DOID_365 6.561E-06 6.021E-05 0.1141477 0.34919376 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP cystic fibrosis DOID_1485 7.868E-06 7.106E-05 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP ocular hypertension DOID_9282 8.671E-06 7.709E-05 0.04069228 0.19135462 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP borderline glaucoma DOID_9283 8.671E-06 7.709E-05 0.04069228 0.19135462 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP metabolic syndrome X DOID_14221 1.006E-05 8.804E-05 0.03287711 0.17987574 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP adenoma DOID_657 1.02E-05 8.79E-05 1.02E-05 4.835E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP calcinosis DOID_182 1.13E-05 9.595E-05 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP multiple myeloma DOID_9538 1.13E-05 9.454E-05 8.482E-03 0.05745483 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP uveitis DOID_13141 1.249E-05 1.03E-04 0.13237381 0.38625999 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP congenital diaphragmatic hernia DOID_3827 1.376E-05 1.119E-04 1.376E-05 5.594E-04 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP Ehlers-Danlos syndrome DOID_13359 1.78E-05 1.426E-04 1.208E-03 0.01527504 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP oral submucous fibrosis DOID_5773 1.78E-05 1.406E-04 0.0506059 0.21650193 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP varicose veins DOID_799 1.78E-05 1.387E-04 1.208E-03 0.0140281 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP nephrotic syndrome DOID_1184 1.985E-05 1.527E-04 5.49E-04 8.926E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP vein disease DOID_866 2.185E-05 1.658E-04 1.378E-03 0.01451477 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP dilated cardiomyopathy DOID_12930 2.279E-05 1.706E-04 4.692E-03 0.03708121 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP ulcerative colitis DOID_8577 2.641E-05 1.951E-04 5.108E-03 0.03927299 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP myeloma DOID_0070004 2.772E-05 2.022E-04 0.01302518 0.08055793 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP thyroid adenoma DOID_2891 2.772E-05 1.997E-04 7.018E-04 0.01023924 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP ureteral obstruction DOID_5199 3.168E-05 2.253E-04 1.748E-03 0.01776483 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP calcium metabolism disease DOID_10575 3.497E-05 2.456E-04 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP atopic dermatitis DOID_3310 4.051E-05 2.811E-04 9.276E-04 0.01287385 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP atrophic muscular disease DOID_913 4.351E-05 2.983E-04 9.777E-04 0.01264326 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP muscular dystrophy DOID_9884 4.351E-05 2.983E-04 9.777E-04 0.01264326 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bone marrow cancer DOID_4960 4.667E-05 3.161E-04 0.01670593 0.09901746 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP autoimmune hepatitis DOID_2048 5.124E-05 3.43E-04 0.07012914 0.26426148 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP familial hyperlipidemia DOID_1168 5.348E-05 3.538E-04 0.01782972 0.10458879 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP familial hypercholesterolemia DOID_13810 5.918E-05 3.87E-04 0.07334406 0.27455769 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP myasthenia gravis DOID_437 6.788E-05 4.389E-04 0.07654794 0.27566948 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP urinary tract obstruction DOID_5200 6.788E-05 4.34E-04 2.859E-03 0.02502399 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP diabetic angiopathy DOID_11713 7.739E-05 4.893E-04 7.739E-05 2.446E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP synostosis DOID_11971 7.739E-05 4.839E-04 7.739E-05 2.318E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP ureteral disease DOID_1426 7.739E-05 4.786E-04 3.111E-03 0.02682463 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP temporal lobe epilepsy DOID_3328 9.891E-05 6.052E-04 0.21262808 0.54744514 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP tooth disease DOID_1091 1.046E-04 6.333E-04 1.864E-03 0.01860675 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP endocrine organ benign neoplasm DOID_0060089 1.106E-04 6.623E-04 1.941E-03 0.01904481 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP neuromuscular junction disease DOID_439 1.11E-04 6.578E-04 0.08925392 0.31156735 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP myositis DOID_633 1.11E-04 6.511E-04 3.93E-03 0.03288712 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP extrinsic allergic alveolitis DOID_841 1.24E-04 7.199E-04 0.09240321 0.31110902 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP periodontitis DOID_824 1.38E-04 7.929E-04 4.526E-03 0.03678717 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP perinatal necrotizing enterocolitis DOID_8677 1.38E-04 7.85E-04 0.09554169 0.31791358 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pleurisy DOID_10247 1.529E-04 8.614E-04 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP renal hypertension DOID_1073 1.529E-04 8.529E-04 0.0986694 0.32452538 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP secondary hypertension DOID_11130 1.529E-04 8.529E-04 0.0986694 0.32452538 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP mixed glioma DOID_5076 1.757E-04 9.708E-04 2.728E-03 0.02464156 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP dysostosis DOID_1934 1.858E-04 1.017E-03 1.858E-04 3.917E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP contact dermatitis DOID_2773 1.933E-04 1.048E-03 0.03287711 0.17816264 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP lipid metabolism disorder DOID_3146 1.933E-04 1.038E-03 0.03287711 0.17648186 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP focal epilepsy DOID_2234 2.22E-04 1.18E-03 0.2551332 0.6230506 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP chronic kidney failure DOID_784 2.22E-04 1.17E-03 0.2551332 0.61774804 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP myocarditis DOID_820 2.648E-04 1.383E-03 0.11721155 0.35664906 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP metal metabolism disorder DOID_896 2.648E-04 1.37E-03 6.913E-03 0.04978892 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pneumoconiosis DOID_10316 2.875E-04 1.474E-03 7.291E-03 0.05185923 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP periodontal disease DOID_3388 2.875E-04 1.461E-03 7.291E-03 0.05121899 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP encephalomyelitis DOID_640 3.399E-04 1.711E-03 0.042946 0.19866891 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP Crohn's disease DOID_8778 3.537E-04 1.765E-03 0.28302659 0.66822461 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP microcephaly DOID_10907 3.905E-04 1.932E-03 8.897E-03 0.05955659 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hepatitis DOID_2237 4.194E-04 2.057E-03 9.321E-03 0.06166852 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP adenoid cystic carcinoma DOID_4866 4.498E-04 2.187E-03 4.498E-04 8.255E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP autoimmune disease of urogenital tract DOID_0060049 5.145E-04 2.481E-03 0.14431731 0.41264598 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP primary biliary cirrhosis DOID_12236 5.145E-04 2.481E-03 0.14431731 0.41264598 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP salivary gland cancer DOID_8850 5.145E-04 2.46E-03 5.145E-04 9.149E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP facioscapulohumeral muscular dystrophy DOID_11727 5.236E-04 2.483E-03 5.236E-04 9.029E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP childhood type dermatomyositis DOID_14203 5.236E-04 2.462E-03 0.0340262 0.17926768 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP angioedema DOID_1558 5.236E-04 2.442E-03 5.236E-04 8.763E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP chondrosarcoma DOID_3371 5.236E-04 2.422E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP influenza DOID_8469 5.85E-04 2.684E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP dermatomyositis DOID_10223 6.385E-04 2.907E-03 0.03736497 0.18649708 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP sickle cell anemia DOID_10923 6.385E-04 2.884E-03 0.03736497 0.18487537 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pneumocystosis DOID_11339 6.385E-04 2.861E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP craniosynostosis DOID_2340 6.385E-04 2.839E-03 6.385E-04 0.01009254 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hemochromatosis DOID_2352 6.385E-04 2.817E-03 6.385E-04 9.82E-03 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP proteinuria DOID_576 6.614E-04 2.895E-03 0.15609764 0.43970077 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP neuritis DOID_1803 7.018E-04 3.048E-03 0.15901748 0.44571896 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hemolytic anemia DOID_583 7.438E-04 3.206E-03 0.01352646 0.08187828 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP normocytic anemia DOID_720 7.438E-04 3.206E-03 0.01352646 0.08187828 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP lipodystrophy DOID_811 7.645E-04 3.271E-03 0.04069228 0.19457066 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP encephalitis DOID_9588 7.645E-04 3.246E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP autoimmune disease of gastrointestinal tract DOID_0060031 7.874E-04 3.319E-03 0.16482713 0.45973842 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP viral pneumonia DOID_10533 1.049E-03 4.39E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP tethered spinal cord syndrome DOID_1089 1.049E-03 4.358E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bacterial meningitis DOID_9470 1.049E-03 4.327E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP parasitic protozoa infectious disease DOID_2789 1.083E-03 4.433E-03 0.18201818 0.49084525 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP congenital nervous system abnormality DOID_2490 1.195E-03 4.856E-03 0.01840334 0.10685204 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hemangioma DOID_255 1.208E-03 4.875E-03 1.208E-03 0.01462504 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP membranoproliferative glomerulonephritis DOID_2920 1.208E-03 4.841E-03 1.208E-03 0.01432035 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bile duct cancer DOID_4606 1.254E-03 4.988E-03 0.19048156 0.50411166 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bile duct carcinoma DOID_4897 1.254E-03 4.988E-03 0.19048156 0.50411166 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP oral cavity cancer DOID_8618 1.254E-03 4.953E-03 1.254E-03 0.01371629 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP spastic diplegia DOID_10965 1.378E-03 5.406E-03 1.378E-03 0.01478864 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hemolytic-uremic syndrome DOID_12554 1.378E-03 5.368E-03 0.05388779 0.22712707 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP familial hypertrophic cardiomyopathy DOID_11986 1.558E-03 6.029E-03 1.558E-03 0.01611448 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP parasitic infectious disease DOID_1398 1.715E-03 6.594E-03 0.20989299 0.5453384 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP uterine disease DOID_345 1.715E-03 6.55E-03 0.20989299 0.54285959 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP allergic contact dermatitis DOID_3042 1.864E-03 7.071E-03 0.02455518 0.1383356 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP leishmaniasis DOID_9065 1.95E-03 7.347E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pulmonary edema DOID_11396 2.161E-03 8.091E-03 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP amyloidosis DOID_9120 2.161E-03 8.038E-03 0.06690316 0.25548926 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP syndrome DOID_225 2.539E-03 9.381E-03 2.539E-03 0.02330136 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP acquired immunodeficiency syndrome DOID_635 2.616E-03 9.603E-03 0.07334406 0.27276319 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP placenta disease DOID_780 2.616E-03 9.542E-03 0.07334406 0.27099201 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bone resorption disease DOID_0080011 2.633E-03 9.541E-03 0.23946745 0.60025102 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP osteoporosis DOID_11476 2.633E-03 9.541E-03 0.23946745 0.60025102 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pancreatitis DOID_4989 2.728E-03 9.825E-03 0.24210093 0.60419048 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP IgA glomerulonephritis DOID_2986 2.859E-03 0.01022993 0.07654794 0.27742534 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP uremia DOID_4676 2.859E-03 0.010166 2.859E-03 0.02541499 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP female reproductive system disease DOID_229 3.028E-03 0.01070246 0.24994719 0.61567079 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP meningitis DOID_9471 3.111E-03 0.01092855 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP biliary tract cancer DOID_4607 3.239E-03 0.01130696 0.2551332 0.62038799 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bronchiolitis DOID_2942 3.647E-03 0.01265457 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP papillary adenoma DOID_3172 3.93E-03 0.01355348 3.93E-03 0.03337798 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP microcystic adenoma DOID_5403 3.93E-03 0.01355348 3.93E-03 0.03337798 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP follicular adenoma DOID_6204 3.93E-03 0.01355348 3.93E-03 0.03337798 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP intracranial aneurysm DOID_10941 4.223E-03 0.01447544 0.09240321 0.32059406 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP spinal cord disease DOID_319 4.223E-03 0.01438876 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP seminoma DOID_4440 4.223E-03 0.01430311 0.09240321 0.31483488 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP Sciatic Neuropathy DOID_11446 4.526E-03 0.01523729 0.09554169 0.31978366 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP lesion of sciatic nerve DOID_12528 4.526E-03 0.01523729 0.09554169 0.31978366 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP mononeuritis of lower limb DOID_9473 4.526E-03 0.01523729 0.09554169 0.31978366 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP autoimmune disease of cardiovascular system DOID_0060051 4.838E-03 0.01619308 0.0986694 0.32641216 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP Behcet's disease DOID_13241 4.838E-03 0.01619308 0.0986694 0.32641216 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP mononeuritis DOID_1802 4.838E-03 0.01609838 0.0986694 0.32081652 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP mononeuropathy DOID_1188 5.16E-03 0.01707004 0.10178638 0.32537333 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP multiple epiphyseal dysplasia DOID_12721 5.16E-03 0.01697137 5.16E-03 0.0391473 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP opportunistic mycosis DOID_2473 5.833E-03 0.01907382 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP abdominal aortic aneurysm DOID_7693 5.833E-03 0.01896483 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP Charcot-Marie-Tooth disease DOID_10595 6.183E-03 0.01999056 6.183E-03 0.04569271 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP germinoma DOID_3304 6.183E-03 0.01987762 0.11107329 0.34535902 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP allergic rhinitis DOID_4481 6.183E-03 0.01976595 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP systemic mycosis DOID_0050136 6.913E-03 0.02197388 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP fungal infectious disease DOID_1564 6.913E-03 0.02197388 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP papilloma DOID_2615 6.913E-03 0.0218518 6.913E-03 0.05042724 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP thyroid carcinoma DOID_3963 7.291E-03 0.02292121 0.12026489 0.36399321 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP esophageal disease DOID_6050 7.291E-03 0.02279527 7.291E-03 0.0499848 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP thyroid cancer DOID_1781 8.076E-03 0.02511048 0.12634017 0.37441436 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP embryonal cancer DOID_688 8.482E-03 0.02622938 0.12936218 0.37941793 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP peptic ulcer DOID_750 9.321E-03 0.02866753 0.1353751 0.39100728 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP lymphatic system disease DOID_75 9.753E-03 0.02983719 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP benign mesothelioma DOID_2645 0.01019498 0.03102109 0.01019498 0.06591982 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP gallbladder cancer DOID_3121 0.01157167 0.03502276 0.15022773 0.4273979 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP integumentary system benign neoplasm DOID_0060121 0.01403603 0.04225662 0.16482713 0.4574958 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP skin benign neoplasm DOID_3165 0.01403603 0.04225662 0.16482713 0.4574958 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP lung small cell carcinoma DOID_5409 0.01403603 0.04203421 0.16482713 0.45527494 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP movement disease DOID_480 0.01455381 0.04335665 0.01455381 0.08716969 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP integumentary system cancer DOID_0060122 0.0172639 0.05116229 0.18201818 0.4931826 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP skin cancer DOID_4159 0.0172639 0.05116229 0.18201818 0.4931826 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pustulosis of palm and sole DOID_4398 0.0172639 0.0508972 0.18201818 0.48852994 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hypertrophic cardiomyopathy DOID_11984 0.01898469 0.0556819 0.19048156 0.50646732 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pre-malignant neoplasm DOID_0060071 0.02200538 0.06421058 0.20439449 0.53842808 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP in situ carcinoma DOID_8719 0.02200538 0.06421058 0.20439449 0.53842808 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP hyperglycemia DOID_4195 0.02390686 0.06940306 0.21262808 0.54497918 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pancreatic ductal carcinoma DOID_3587 0.02654284 0.07666433 0.2234748 0.56514294 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP pancreatic carcinoma DOID_4905 0.02859337 0.08216983 0.23151241 0.58287859 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP leber hereditary optic neuropathy DOID_705 0.03067595 0.08771162 0.03067595 0.17112366 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP electroclinical syndrome DOID_0050701 0.03142264 0.08939741 0.03142264 0.17358721 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP gallbladder disease DOID_0000000 0.0340262 0.09632293 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP interstitial nephritis DOID_1063 0.0340262 0.09584609 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP Gilles de la Tourette syndrome DOID_11119 0.0340262 0.09537394 0.0340262 0.18094308 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP familial combined hyperlipidemia DOID_13809 0.0340262 0.09490642 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP retinal vascular occlusion DOID_1729 0.0340262 0.09444346 0.0340262 0.17762302 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP bilirubin metabolic disorder DOID_2741 0.0340262 0.093985 0.0340262 0.17600827 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP acute kidney failure DOID_3021 0.0340262 0.09353096 1.000 1.000 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP insulinoma DOID_3892 0.0340262 0.0930813 0.0340262 0.17442261 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP conjunctival disease DOID_4251 0.0340262 0.09263593 0.0340262 0.17286526 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP conjunctivitis DOID_6195 0.0340262 0.09263593 0.0340262 0.17286526 PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP cutaneous leishmaniasis DOID_9111 0.0340262 0.09219481 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP contact dermatitis DOID_2773 5.114E-09 2.91E-06 1.215E-07 3.457E-05 MITSIADES_RESPONSE_TO_APLIDIN_UP allergic contact dermatitis DOID_3042 4.016E-08 1.143E-05 4.016E-08 2.285E-05 MITSIADES_RESPONSE_TO_APLIDIN_UP diabetic retinopathy DOID_8947 7.154E-08 1.357E-05 0.04932906 0.30844216 MITSIADES_RESPONSE_TO_APLIDIN_UP retinal vascular disease DOID_2462 1.831E-07 2.605E-05 0.06265555 0.30470945 MITSIADES_RESPONSE_TO_APLIDIN_UP myeloma DOID_0070004 3.746E-06 4.263E-04 1.669E-03 0.04522368 MITSIADES_RESPONSE_TO_APLIDIN_UP amino acid metabolic disorder DOID_9252 4.565E-06 4.329E-04 7.046E-05 8.018E-03 MITSIADES_RESPONSE_TO_APLIDIN_UP nervous system cancer DOID_3093 4.864E-06 3.954E-04 9.319E-04 0.03534943 MITSIADES_RESPONSE_TO_APLIDIN_UP giant cell tumor DOID_200 6.603E-06 4.696E-04 2.313E-03 0.0469974 MITSIADES_RESPONSE_TO_APLIDIN_UP malignant giant cell tumor DOID_2705 6.603E-06 4.696E-04 2.313E-03 0.0469974 MITSIADES_RESPONSE_TO_APLIDIN_UP giant cell glioblastoma DOID_3074 6.603E-06 4.696E-04 2.313E-03 0.0469974 MITSIADES_RESPONSE_TO_APLIDIN_UP bone marrow cancer DOID_4960 7.21E-06 4.559E-04 2.433E-03 0.04773471 MITSIADES_RESPONSE_TO_APLIDIN_UP glioblastoma DOID_3068 1.009E-05 5.742E-04 2.952E-03 0.05089871 MITSIADES_RESPONSE_TO_APLIDIN_UP toxic encephalopathy DOID_3602 1.309E-05 6.773E-04 1.309E-05 2.484E-03 MITSIADES_RESPONSE_TO_APLIDIN_UP mineral metabolism disease DOID_0050032 1.602E-05 7.594E-04 3.85E-03 0.05920375 MITSIADES_RESPONSE_TO_APLIDIN_UP autonomic nervous system neoplasm DOID_2621 2.148E-05 9.399E-04 5.867E-04 0.02781861 MITSIADES_RESPONSE_TO_APLIDIN_UP neuroblastoma DOID_769 2.148E-05 9.399E-04 5.867E-04 0.02781861 MITSIADES_RESPONSE_TO_APLIDIN_UP astrocytoma DOID_3069 2.277E-05 9.254E-04 4.712E-03 0.06874825 MITSIADES_RESPONSE_TO_APLIDIN_UP multiple myeloma DOID_9538 3.681E-05 1.396E-03 8.706E-04 0.03538359 MITSIADES_RESPONSE_TO_APLIDIN_UP pancreatitis DOID_4989 3.796E-05 1.35E-03 0.31255438 0.73489025 MITSIADES_RESPONSE_TO_APLIDIN_UP peripheral nervous system neoplasm DOID_1192 4.064E-05 1.36E-03 9.361E-04 0.03329081 MITSIADES_RESPONSE_TO_APLIDIN_UP chronic kidney failure DOID_784 5.083E-05 1.607E-03 7.467E-03 0.09656247 MITSIADES_RESPONSE_TO_APLIDIN_UP primary bacterial infectious disease DOID_0050338 6.336E-05 1.898E-03 8.232E-04 0.03603035 MITSIADES_RESPONSE_TO_APLIDIN_UP Huntington's disease DOID_12858 6.43E-05 1.829E-03 6.43E-05 9.147E-03 MITSIADES_RESPONSE_TO_APLIDIN_UP ureteral obstruction DOID_5199 7.754E-05 2.101E-03 3.157E-03 0.05132674 MITSIADES_RESPONSE_TO_APLIDIN_UP proteinuria DOID_576 8.258E-05 2.136E-03 1.574E-03 0.04478845 MITSIADES_RESPONSE_TO_APLIDIN_UP lymphoblastic leukemia DOID_1037 8.648E-05 2.139E-03 0.0101161 0.10860488 MITSIADES_RESPONSE_TO_APLIDIN_UP pre-eclampsia DOID_10591 8.944E-05 2.12E-03 1.669E-03 0.04316806 MITSIADES_RESPONSE_TO_APLIDIN_UP alcohol-related neurodevelopmental disorder DOID_0050667 9.089E-05 2.069E-03 0.0104072 0.10766717 MITSIADES_RESPONSE_TO_APLIDIN_UP psoriasis DOID_8893 9.176E-05 2.008E-03 9.176E-05 8.702E-03 MITSIADES_RESPONSE_TO_APLIDIN_UP pulmonary tuberculosis DOID_2957 1.044E-04 2.2E-03 1.869E-03 0.04624116 MITSIADES_RESPONSE_TO_APLIDIN_UP calcium metabolism disease DOID_10575 1.125E-04 2.286E-03 1.975E-03 0.04321228 MITSIADES_RESPONSE_TO_APLIDIN_UP movement disease DOID_480 1.125E-04 2.207E-03 1.125E-04 9.144E-03 MITSIADES_RESPONSE_TO_APLIDIN_UP osteochondrodysplasia DOID_2256 1.6E-04 3.036E-03 0.0302025 0.23868363 MITSIADES_RESPONSE_TO_APLIDIN_UP uremia DOID_4676 1.654E-04 3.036E-03 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP urinary tract obstruction DOID_5200 1.654E-04 2.941E-03 5.141E-03 0.07313617 MITSIADES_RESPONSE_TO_APLIDIN_UP lingual-facial-buccal dyskinesia DOID_9854 1.654E-04 2.852E-03 1.654E-04 0.0117655 MITSIADES_RESPONSE_TO_APLIDIN_UP ureteral disease DOID_1426 1.884E-04 3.153E-03 5.592E-03 0.07760124 MITSIADES_RESPONSE_TO_APLIDIN_UP aortic valve disease DOID_62 1.884E-04 3.063E-03 0.10626723 0.38028966 MITSIADES_RESPONSE_TO_APLIDIN_UP intracranial aneurysm DOID_10941 3.008E-04 4.754E-03 7.565E-03 0.09565656 MITSIADES_RESPONSE_TO_APLIDIN_UP fragments of torsion dystonia DOID_531 3.008E-04 4.626E-03 3.008E-04 0.01901646 MITSIADES_RESPONSE_TO_APLIDIN_UP hyperglycemia DOID_4195 3.134E-04 4.692E-03 0.04146769 0.30250145 MITSIADES_RESPONSE_TO_APLIDIN_UP tuberculosis DOID_399 3.496E-04 5.101E-03 4.531E-03 0.06784766 MITSIADES_RESPONSE_TO_APLIDIN_UP sarcoma DOID_1115 3.702E-04 5.266E-03 8.653E-03 0.10257287 MITSIADES_RESPONSE_TO_APLIDIN_UP central nervous system hereditary degenerative disease DOID_481 3.702E-04 5.138E-03 3.702E-04 0.02106567 MITSIADES_RESPONSE_TO_APLIDIN_UP pancreatic ductal carcinoma DOID_3587 3.888E-04 5.268E-03 0.04589765 0.30367167 MITSIADES_RESPONSE_TO_APLIDIN_UP multiple epiphyseal dysplasia DOID_12721 4.085E-04 5.405E-03 9.221E-03 0.10708204 MITSIADES_RESPONSE_TO_APLIDIN_UP dystonic disease DOID_544 4.085E-04 5.282E-03 4.085E-04 0.02112988 MITSIADES_RESPONSE_TO_APLIDIN_UP nephrosis DOID_2527 4.096E-04 5.179E-03 0.04703128 0.30759539 MITSIADES_RESPONSE_TO_APLIDIN_UP bile duct disease DOID_4138 4.096E-04 5.066E-03 0.04703128 0.30409998 MITSIADES_RESPONSE_TO_APLIDIN_UP biliary tract disease DOID_9741 4.311E-04 5.219E-03 0.04817512 0.30799602 MITSIADES_RESPONSE_TO_APLIDIN_UP pancreatic carcinoma DOID_4905 4.534E-04 5.375E-03 0.04932906 0.3118693 MITSIADES_RESPONSE_TO_APLIDIN_UP aneurysm disease DOID_2403 5.252E-04 6.099E-03 6.101E-03 0.0807349 MITSIADES_RESPONSE_TO_APLIDIN_UP allergic rhinitis DOID_4481 5.382E-04 6.125E-03 0.011024 0.10814923 MITSIADES_RESPONSE_TO_APLIDIN_UP chronic leukemia DOID_1036 5.867E-04 6.546E-03 0.15114369 0.45745086 MITSIADES_RESPONSE_TO_APLIDIN_UP chronic lymphocytic leukemia DOID_1040 5.867E-04 6.546E-03 0.15114369 0.45745086 MITSIADES_RESPONSE_TO_APLIDIN_UP bone development disease DOID_0080006 7.238E-04 7.92E-03 0.06139816 0.30116855 MITSIADES_RESPONSE_TO_APLIDIN_UP transitional cell carcinoma DOID_2671 8.584E-04 9.215E-03 0.06647969 0.31005693 MITSIADES_RESPONSE_TO_APLIDIN_UP adolescence-adult electroclinical syndrome DOID_0050705 8.706E-04 9.174E-03 0.01505019 0.14038621 MITSIADES_RESPONSE_TO_APLIDIN_UP calcinosis DOID_182 8.706E-04 9.007E-03 0.01505019 0.13812192 MITSIADES_RESPONSE_TO_APLIDIN_UP Human immunodeficiency virus infectious disease DOID_526 9.319E-04 9.469E-03 9.272E-03 0.10551085 MITSIADES_RESPONSE_TO_APLIDIN_UP brachydactyly DOID_0050581 9.517E-04 9.5E-03 0.04572482 0.32521775 MITSIADES_RESPONSE_TO_APLIDIN_UP chondrosarcoma DOID_3371 9.517E-04 9.336E-03 9.517E-04 0.0318528 MITSIADES_RESPONSE_TO_APLIDIN_UP conjunctival disease DOID_4251 9.517E-04 9.178E-03 9.517E-04 0.0300832 MITSIADES_RESPONSE_TO_APLIDIN_UP conjunctivitis DOID_6195 9.517E-04 9.178E-03 9.517E-04 0.0300832 MITSIADES_RESPONSE_TO_APLIDIN_UP hepatitis DOID_2237 1.005E-03 9.528E-03 0.17852736 0.50040426 MITSIADES_RESPONSE_TO_APLIDIN_UP congenital diaphragmatic hernia DOID_3827 1.005E-03 9.372E-03 0.17852736 0.4979513 MITSIADES_RESPONSE_TO_APLIDIN_UP lymphoma DOID_0060058 1.01E-03 9.267E-03 9.83E-03 0.10756078 MITSIADES_RESPONSE_TO_APLIDIN_UP encephalomyelitis DOID_640 1.05E-03 9.486E-03 1.05E-03 0.0314538 MITSIADES_RESPONSE_TO_APLIDIN_UP mouth disease DOID_403 1.092E-03 9.709E-03 0.0104072 0.10574454 MITSIADES_RESPONSE_TO_APLIDIN_UP Crohn's disease DOID_8778 1.092E-03 9.559E-03 0.07435236 0.3157201 MITSIADES_RESPONSE_TO_APLIDIN_UP bronchiectasis DOID_9563 1.16E-03 9.997E-03 0.05018134 0.2943627 MITSIADES_RESPONSE_TO_APLIDIN_UP pituitary cancer DOID_1785 1.387E-03 0.01178106 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP pituitary carcinoma DOID_4916 1.387E-03 0.01178106 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP aortic valve insufficiency DOID_57 1.387E-03 0.01160781 0.05461717 0.28511164 MITSIADES_RESPONSE_TO_APLIDIN_UP diabetic autonomic neuropathy DOID_11503 1.395E-03 0.01150394 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP autonomic neuropathy DOID_11504 1.395E-03 0.01150394 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP diabetic polyneuropathy DOID_12785 1.395E-03 0.01150394 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP uterine cancer DOID_363 1.395E-03 0.0113396 0.02041953 0.17874941 MITSIADES_RESPONSE_TO_APLIDIN_UP diabetic neuropathy DOID_9743 1.395E-03 0.01150394 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP Leydig cell tumor DOID_2696 1.634E-03 0.01309838 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP sex cord-stromal neoplasm DOID_4757 1.634E-03 0.01309838 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP epilepsy with generalized tonic-clonic seizures DOID_7725 1.634E-03 0.01291646 0.0590324 0.29464415 MITSIADES_RESPONSE_TO_APLIDIN_UP autonomic nervous system disease DOID_11465 1.669E-03 0.01300955 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP heart valve disease DOID_4079 1.669E-03 0.01283375 0.20874884 0.54736446 MITSIADES_RESPONSE_TO_APLIDIN_UP integumentary system benign neoplasm DOID_0060121 1.869E-03 0.01418062 0.02467106 0.20344682 MITSIADES_RESPONSE_TO_APLIDIN_UP skin benign neoplasm DOID_3165 1.869E-03 0.01418062 0.02467106 0.20344682 MITSIADES_RESPONSE_TO_APLIDIN_UP eyelid disease DOID_530 1.901E-03 0.01423233 1.901E-03 0.04506904 MITSIADES_RESPONSE_TO_APLIDIN_UP primary ciliary dyskinesia DOID_9562 1.901E-03 0.01404749 1.901E-03 0.04326628 MITSIADES_RESPONSE_TO_APLIDIN_UP B-cell lymphocytic neoplasm DOID_707 2.084E-03 0.01519945 0.0264641 0.21208551 MITSIADES_RESPONSE_TO_APLIDIN_UP oral submucous fibrosis DOID_5773 2.187E-03 0.0157499 0.06780144 0.29906215 MITSIADES_RESPONSE_TO_APLIDIN_UP panic disorder DOID_594 2.187E-03 0.01555302 0.06780144 0.29676167 MITSIADES_RESPONSE_TO_APLIDIN_UP varicose veins DOID_799 2.187E-03 0.01536101 2.187E-03 0.04608303 MITSIADES_RESPONSE_TO_APLIDIN_UP hyperhomocysteinemia DOID_9279 2.187E-03 0.01517368 0.06780144 0.29449631 MITSIADES_RESPONSE_TO_APLIDIN_UP angiosarcoma DOID_0001816 2.491E-03 0.01707994 0.07215543 0.31103365 MITSIADES_RESPONSE_TO_APLIDIN_UP pituitary adenoma DOID_3829 2.491E-03 0.01687661 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP vein disease DOID_866 2.491E-03 0.01667806 2.491E-03 0.04725451 MITSIADES_RESPONSE_TO_APLIDIN_UP Barrett's esophagus DOID_9206 2.491E-03 0.01648413 2.491E-03 0.04573017 MITSIADES_RESPONSE_TO_APLIDIN_UP pustulosis of palm and sole DOID_4398 2.557E-03 0.01672238 0.0302025 0.235414 MITSIADES_RESPONSE_TO_APLIDIN_UP hyperostosis DOID_205 2.815E-03 0.01820153 2.815E-03 0.0500542 MITSIADES_RESPONSE_TO_APLIDIN_UP hypertrophic cardiomyopathy DOID_11984 2.952E-03 0.01887255 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP glucose intolerance DOID_10603 3.157E-03 0.0199604 0.08080286 0.32840591 MITSIADES_RESPONSE_TO_APLIDIN_UP dental caries DOID_216 3.157E-03 0.01974106 3.157E-03 0.05283635 MITSIADES_RESPONSE_TO_APLIDIN_UP neuroectodermal tumor DOID_171 3.383E-03 0.0209207 3.383E-03 0.053464 MITSIADES_RESPONSE_TO_APLIDIN_UP carotid artery disease DOID_3407 3.383E-03 0.02069574 0.03617468 0.26731681 MITSIADES_RESPONSE_TO_APLIDIN_UP brain edema DOID_4724 3.897E-03 0.02358767 0.08937014 0.34359197 MITSIADES_RESPONSE_TO_APLIDIN_UP cholestasis DOID_13580 4.014E-03 0.02404063 0.27276532 0.66610931 MITSIADES_RESPONSE_TO_APLIDIN_UP parasitic infectious disease DOID_1398 4.014E-03 0.02379021 0.27276532 0.66326269 MITSIADES_RESPONSE_TO_APLIDIN_UP tooth disease DOID_1091 4.354E-03 0.02554308 0.04255925 0.30653435 MITSIADES_RESPONSE_TO_APLIDIN_UP endocrine organ benign neoplasm DOID_0060089 4.531E-03 0.02630828 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP brain infarction DOID_3454 4.531E-03 0.02604254 0.28292225 0.67925214 MITSIADES_RESPONSE_TO_APLIDIN_UP muscular atrophy DOID_767 4.709E-03 0.02679245 0.09785802 0.36156634 MITSIADES_RESPONSE_TO_APLIDIN_UP sinusitis DOID_0050127 5.141E-03 0.02896482 0.10207242 0.37470455 MITSIADES_RESPONSE_TO_APLIDIN_UP paranasal sinus disease DOID_1352 5.141E-03 0.02896482 0.10207242 0.37470455 MITSIADES_RESPONSE_TO_APLIDIN_UP muscle cancer DOID_4045 5.141E-03 0.02868085 0.10207242 0.36993125 MITSIADES_RESPONSE_TO_APLIDIN_UP syndrome DOID_225 5.889E-03 0.03253511 0.05166675 0.29695337 MITSIADES_RESPONSE_TO_APLIDIN_UP spastic quadriplegia DOID_10970 6.059E-03 0.03315153 6.059E-03 0.08208951 MITSIADES_RESPONSE_TO_APLIDIN_UP acute pancreatitis DOID_2913 6.059E-03 0.0328358 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP bone resorption disease DOID_0080011 6.101E-03 0.03275095 0.30932299 0.7303103 MITSIADES_RESPONSE_TO_APLIDIN_UP osteoporosis DOID_11476 6.101E-03 0.03275095 0.30932299 0.7303103 MITSIADES_RESPONSE_TO_APLIDIN_UP electroclinical syndrome DOID_0050701 6.317E-03 0.03359482 0.05404342 0.30750708 MITSIADES_RESPONSE_TO_APLIDIN_UP mixed glioma DOID_5076 6.317E-03 0.03328376 0.05404342 0.30446245 MITSIADES_RESPONSE_TO_APLIDIN_UP bacterial pneumonia DOID_874 6.317E-03 0.0329784 0.05404342 0.30147753 MITSIADES_RESPONSE_TO_APLIDIN_UP metabolic syndrome X DOID_14221 6.764E-03 0.03498611 0.31897212 0.74689357 MITSIADES_RESPONSE_TO_APLIDIN_UP papillary adenoma DOID_3172 7.046E-03 0.03611984 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP microcystic adenoma DOID_5403 7.046E-03 0.03611984 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP follicular adenoma DOID_6204 7.046E-03 0.03611984 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP auditory system disease DOID_2742 7.228E-03 0.03672055 0.05891002 0.29928396 MITSIADES_RESPONSE_TO_APLIDIN_UP mental depression DOID_1596 7.467E-03 0.03759954 0.06014961 0.29760983 MITSIADES_RESPONSE_TO_APLIDIN_UP myopia DOID_11830 7.565E-03 0.03775917 7.565E-03 0.09357707 MITSIADES_RESPONSE_TO_APLIDIN_UP teeth hard tissue disease DOID_214 7.565E-03 0.03743083 7.565E-03 0.09158607 MITSIADES_RESPONSE_TO_APLIDIN_UP gestational diabetes DOID_11714 8.101E-03 0.03973542 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP pleurisy DOID_10247 8.653E-03 0.04208118 0.13103005 0.42603484 MITSIADES_RESPONSE_TO_APLIDIN_UP invasive ductal carcinoma DOID_3008 8.653E-03 0.04172456 0.13103005 0.41885447 MITSIADES_RESPONSE_TO_APLIDIN_UP renal tubular transport disease DOID_447 8.653E-03 0.04137393 0.13103005 0.41420054 MITSIADES_RESPONSE_TO_APLIDIN_UP polycystic ovary syndrome DOID_11612 9.221E-03 0.04372517 0.13509033 0.42234285 MITSIADES_RESPONSE_TO_APLIDIN_UP supratentorial cancer DOID_1659 9.221E-03 0.0433638 0.13509033 0.41775217 MITSIADES_RESPONSE_TO_APLIDIN_UP cerebrum cancer DOID_368 9.221E-03 0.0433638 0.13509033 0.41775217 MITSIADES_RESPONSE_TO_APLIDIN_UP endometrial carcinoma DOID_2871 9.806E-03 0.04573591 9.806E-03 0.10940748 MITSIADES_RESPONSE_TO_APLIDIN_UP spastic cerebral palsy DOID_0050669 0.01040719 0.04814383 0.01040719 0.10966093 MITSIADES_RESPONSE_TO_APLIDIN_UP endometrial cancer DOID_1380 0.011024 0.05058593 0.011024 0.11004658 MITSIADES_RESPONSE_TO_APLIDIN_UP pleural disease DOID_1532 0.01165656 0.05306067 0.15114369 0.45503048 MITSIADES_RESPONSE_TO_APLIDIN_UP bladder disease DOID_365 0.01165656 0.05263956 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP papilloma DOID_2615 0.01230472 0.05512904 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP metal metabolism disorder DOID_896 0.01230472 0.05469834 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP nephroblastoma DOID_2154 0.01296832 0.05720136 0.15905892 0.47384567 MITSIADES_RESPONSE_TO_APLIDIN_UP esophageal disease DOID_6050 0.01296832 0.05676135 0.01296832 0.12506738 MITSIADES_RESPONSE_TO_APLIDIN_UP adenoma DOID_657 0.01434121 0.06229122 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP refractive error DOID_9835 0.01434121 0.06181931 0.01434121 0.13600249 MITSIADES_RESPONSE_TO_APLIDIN_UP embryonal cancer DOID_688 0.01505019 0.06438766 0.01505019 0.1359295 MITSIADES_RESPONSE_TO_APLIDIN_UP respiratory syncytial virus infectious disease DOID_1273 0.01651245 0.07011632 0.17852736 0.50288151 MITSIADES_RESPONSE_TO_APLIDIN_UP intracranial arterial disease DOID_13089 0.01726544 0.07277061 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP cerebral arterial disease DOID_3527 0.01726544 0.07277061 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP nephrotic syndrome DOID_1184 0.01960998 0.08204468 0.19377889 0.52756071 MITSIADES_RESPONSE_TO_APLIDIN_UP primitive neuroectodermal tumor DOID_168 0.01960998 0.08144581 0.01960998 0.17434494 MITSIADES_RESPONSE_TO_APLIDIN_UP cataract DOID_83 0.02124286 0.0875883 0.02124286 0.18313918 MITSIADES_RESPONSE_TO_APLIDIN_UP leukodystrophy DOID_10579 0.02207982 0.09038429 0.20503246 0.54515641 MITSIADES_RESPONSE_TO_APLIDIN_UP lens disease DOID_110 0.02293027 0.09319515 0.02293027 0.19473614 MITSIADES_RESPONSE_TO_APLIDIN_UP brain cancer DOID_1319 0.02293027 0.0925342 0.20874884 0.55245622 MITSIADES_RESPONSE_TO_APLIDIN_UP thyroid adenoma DOID_2891 0.02293027 0.09188255 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP vascular skin disease DOID_9540 0.02293027 0.09124001 1.000 1.000 MITSIADES_RESPONSE_TO_APLIDIN_UP central nervous system cancer DOID_3620 0.02379406 0.09401958 0.21244793 0.55450859 MITSIADES_RESPONSE_TO_APLIDIN_UP hemolytic anemia DOID_583 0.02379406 0.09337117 0.02379406 0.19910029 MITSIADES_RESPONSE_TO_APLIDIN_UP normocytic anemia DOID_720 0.02379406 0.09337117 0.02379406 0.19910029 MITSIADES_RESPONSE_TO_APLIDIN_UP lung small cell carcinoma DOID_5409 0.02467106 0.09614953 0.02467106 0.20054044 NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON nicotine dependence DOID_0050742 2.271E-05 0.01292233 2.271E-05 0.01292233 NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON hypogonadism DOID_1924 9.422E-05 0.02680486 9.422E-05 0.02680486 NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON gonadal disease DOID_2277 1.527E-04 0.02896393 1.527E-04 0.02896393 NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON hereditary spastic paraplegia DOID_2476 1.72E-04 0.02446311 1.72E-04 0.02446311 NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON paraplegia DOID_607 1.924E-04 0.02189117 1.924E-04 0.02189117 NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON pre-malignant neoplasm DOID_0060071 6.136E-04 0.05818839 6.136E-04 0.05818839 NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON in situ carcinoma DOID_8719 6.136E-04 0.05818839 6.136E-04 0.05818839 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP multiple myeloma DOID_9538 3.758E-13 2.138E-10 4.752E-05 1.931E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP myeloma DOID_0070004 3.299E-12 9.385E-10 1.152E-04 3.641E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bone marrow cancer DOID_4960 1.15E-11 2.18E-09 1.923E-04 4.972E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP retinal vascular disease DOID_2462 2.141E-11 3.046E-09 5.121E-06 4.162E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hypersensitivity reaction type I disease DOID_1205 6.447E-11 7.337E-09 9.616E-06 6.079E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP diabetic retinopathy DOID_8947 1.678E-10 1.592E-08 4.05E-05 1.773E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bronchiolitis obliterans DOID_2799 2.621E-10 2.13E-08 0.01179372 0.09192636 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bacterial pneumonia DOID_874 2.685E-10 1.91E-08 0.06066335 0.26349196 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP oral cavity cancer DOID_8618 7.725E-10 4.884E-08 2.379E-08 1.354E-05 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP encephalomyelitis DOID_640 1.276E-09 7.261E-08 1.177E-04 3.524E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP adenoid cystic carcinoma DOID_4866 1.895E-09 9.804E-08 7.414E-08 2.109E-05 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP salivary gland cancer DOID_8850 2.647E-09 1.255E-07 9.824E-08 1.863E-05 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP tuberculosis DOID_399 2.675E-09 1.171E-07 5.435E-03 0.05835182 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pancreatic ductal carcinoma DOID_3587 3.351E-09 1.362E-07 3.333E-05 1.724E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP influenza DOID_8469 3.638E-09 1.38E-07 0.02307354 0.1491914 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pancreatic carcinoma DOID_4905 4.641E-09 1.651E-07 4.05E-05 1.92E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP aneurysm disease DOID_2403 6.34E-09 2.122E-07 0.32647908 0.74306639 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP autoimmune disease of gastrointestinal tract DOID_0060031 7.577E-09 2.395E-07 2.385E-07 3.393E-05 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP contact dermatitis DOID_2773 8.552E-09 2.561E-07 5.839E-05 2.215E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP lipid metabolism disorder DOID_3146 8.552E-09 2.433E-07 3.625E-06 3.437E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP aortic aneurysm DOID_3627 8.694E-09 2.356E-07 0.23284561 0.58109278 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP biliary tract cancer DOID_4607 1.14E-08 2.949E-07 8.842E-04 0.01796818 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP giant cell tumor DOID_200 1.292E-08 3.195E-07 2.784E-03 0.03771396 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP malignant giant cell tumor DOID_2705 1.292E-08 3.195E-07 2.784E-03 0.03771396 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP giant cell glioblastoma DOID_3074 1.292E-08 3.195E-07 2.784E-03 0.03771396 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP abdominal aortic aneurysm DOID_7693 1.404E-08 3.328E-07 0.15210475 0.44612165 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP primary bacterial infectious disease DOID_0050338 1.645E-08 3.744E-07 0.01011813 0.08592863 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hypertrophic cardiomyopathy DOID_11984 2.379E-08 5.207E-07 1.385E-05 7.883E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP glioblastoma DOID_3068 2.379E-08 5.014E-07 3.549E-03 0.04121358 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP myocarditis DOID_820 2.438E-08 4.955E-07 7.714E-04 0.01625556 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP allergic contact dermatitis DOID_3042 6.295E-08 1.235E-06 4.243E-04 9.658E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP intracranial arterial disease DOID_13089 7.414E-08 1.406E-06 0.19347959 0.52423754 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cerebral arterial disease DOID_3527 7.414E-08 1.406E-06 0.19347959 0.52423754 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP astrocytoma DOID_3069 7.671E-08 1.408E-06 5.651E-03 0.05954484 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pulmonary emphysema DOID_9675 8.549E-08 1.52E-06 0.19750495 0.53009582 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP Goodpasture syndrome DOID_9808 1.149E-07 1.982E-06 6.348E-03 0.06567764 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP chondrosarcoma DOID_3371 1.227E-07 2.054E-06 1.084E-03 0.02126173 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP gallbladder cancer DOID_3121 1.284E-07 2.088E-06 1.683E-03 0.02519661 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP mixed glioma DOID_5076 1.6E-07 2.528E-06 7.562E-03 0.0694028 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP temporal arteritis DOID_13375 1.921E-07 2.955E-06 1.32E-03 0.02209235 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP central nervous system vasculitis DOID_525 1.921E-07 2.955E-06 1.32E-03 0.02209235 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP glaucoma DOID_1686 2.385E-07 3.572E-06 1.343E-04 3.64E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP middle cerebral artery infarction DOID_3525 2.615E-07 3.815E-06 0.13063236 0.4223285 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP transitional cell carcinoma DOID_2671 3.608E-07 5.132E-06 1.094E-03 0.02008882 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP larynx cancer DOID_2596 4.131E-07 5.732E-06 0.06291575 0.26130702 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP laryngeal benign neoplasm DOID_2598 4.131E-07 5.732E-06 0.06291575 0.26130702 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP vasculitis DOID_865 4.165E-07 5.643E-06 0.03298371 0.18957304 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP Human immunodeficiency virus infectious disease DOID_526 4.195E-07 5.551E-06 7.083E-06 5.038E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP lymphoblastic leukemia DOID_1037 5.225E-07 6.757E-06 1.338E-03 0.02174464 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP alcohol-related neurodevelopmental disorder DOID_0050667 5.612E-07 7.096E-06 0.01241247 0.09544184 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bile duct cancer DOID_4606 6.268E-07 7.754E-06 3.549E-03 0.04038931 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bile duct carcinoma DOID_4897 6.268E-07 7.754E-06 3.549E-03 0.04038931 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP celiac disease DOID_10608 7.226E-07 8.748E-06 7.226E-07 8.223E-05 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP allergic rhinitis DOID_4481 7.226E-07 8.566E-06 0.15633549 0.4538515 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP mineral metabolism disease DOID_0050032 1.099E-06 1.276E-05 0.04424784 0.23978115 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cholestasis DOID_13580 1.2E-06 1.366E-05 0.28833912 0.68360401 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP parasitic infectious disease DOID_1398 1.2E-06 1.339E-05 0.04544268 0.24393289 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP uterine disease DOID_345 1.2E-06 1.314E-05 4.818E-03 0.05272039 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bile duct disease DOID_4138 1.982E-06 2.128E-05 0.30940157 0.71275098 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP respiratory syncytial virus infectious disease DOID_1273 2.139E-06 2.254E-05 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP biliary tract disease DOID_9741 2.146E-06 2.22E-05 0.31285118 0.71779162 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bone resorption disease DOID_0080011 2.913E-06 2.96E-05 6.715E-04 0.01469608 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP osteoporosis DOID_11476 2.913E-06 2.96E-05 6.715E-04 0.01469608 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP endometriosis of uterus DOID_288 3.035E-06 3.03E-05 1.483E-03 0.0234455 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP endometriosis DOID_289 3.391E-06 3.327E-05 1.581E-03 0.02431443 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP uveal disease DOID_3480 3.391E-06 3.271E-05 8.289E-05 2.948E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP female reproductive system disease DOID_229 3.891E-06 3.69E-05 8.366E-03 0.07437696 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cerebral infarction DOID_3526 4.202E-06 3.92E-05 0.21340752 0.55701322 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pre-eclampsia DOID_10591 5.158E-06 4.734E-05 0.22124087 0.56705429 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP brain cancer DOID_1319 5.158E-06 4.658E-05 0.22124087 0.56451145 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP central nervous system cancer DOID_3620 5.695E-06 5.064E-05 0.22512839 0.56932468 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pulmonary tuberculosis DOID_2957 6.276E-06 5.494E-05 0.02784927 0.17038961 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP calcium metabolism disease DOID_10575 6.902E-06 5.95E-05 0.02884812 0.17462322 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP sphingolipidosis DOID_1927 6.973E-06 5.922E-05 6.878E-03 0.06988537 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP sarcoidosis DOID_11335 9.076E-06 7.595E-05 0.03192912 0.18538436 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP dilated cardiomyopathy DOID_12930 9.616E-06 7.929E-05 0.01276251 0.09555091 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bile duct adenocarcinoma DOID_4896 9.909E-06 8.055E-05 2.928E-03 0.03786155 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cholangiocarcinoma DOID_4947 9.909E-06 8.055E-05 2.928E-03 0.03786155 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP parasitic protozoa infectious disease DOID_2789 1.08E-05 8.655E-05 0.25180583 0.61229709 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP intracranial aneurysm DOID_10941 1.116E-05 8.816E-05 0.13063236 0.4247418 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP familial hyperlipidemia DOID_1168 1.175E-05 9.161E-05 3.229E-03 0.03909495 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hypersensitivity reaction type IV disease DOID_2916 1.385E-05 1.065E-04 0.03733579 0.21033727 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP focal glomerulosclerosis DOID_3945 1.694E-05 1.286E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP carotid artery disease DOID_3407 1.754E-05 1.313E-04 0.27394374 0.65493273 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP eosinophilic pneumonia DOID_5870 1.954E-05 1.444E-04 0.05349913 0.25367503 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pulmonary eosinophilia DOID_9498 1.954E-05 1.444E-04 0.05349913 0.25367503 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP Loeffler syndrome DOID_9503 1.954E-05 1.444E-04 0.05349913 0.25367503 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP opportunistic mycosis DOID_2473 2.186E-05 1.595E-04 0.01179372 0.09320312 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP brain infarction DOID_3454 2.912E-05 2.098E-04 0.29894902 0.69713932 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP systemic mycosis DOID_0050136 3.111E-05 2.213E-04 0.01393543 0.10037035 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP fungal infectious disease DOID_1564 3.111E-05 2.213E-04 0.01393543 0.10037035 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP carotid stenosis DOID_13001 3.362E-05 2.362E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hepatitis C DOID_1883 3.474E-05 2.411E-04 0.01468395 0.10066464 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP periodontal disease DOID_3388 3.474E-05 2.382E-04 0.16890215 0.48052662 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP aspergillosis DOID_13564 4.263E-05 2.888E-04 2.163E-03 0.03076556 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pulmonary sarcoidosis DOID_13406 4.752E-05 3.181E-04 0.01703072 0.11536286 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP calcinosis DOID_182 4.752E-05 3.144E-04 0.1812826 0.50072718 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pancreatitis DOID_4989 5.186E-05 3.392E-04 7.562E-03 0.07054055 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP uveitis DOID_13141 5.245E-05 3.392E-04 1.131E-03 0.02010635 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP thoracic aortic aneurysm DOID_14004 5.309E-05 3.394E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP nutritional deficiency disease DOID_5113 5.309E-05 3.357E-04 2.487E-03 0.03451954 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP systemic scleroderma DOID_418 5.775E-05 3.611E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP rheumatic disease DOID_1575 8.289E-05 5.127E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP scleroderma DOID_419 8.289E-05 5.127E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP diabetic autonomic neuropathy DOID_11503 9.025E-05 5.522E-04 0.02307354 0.15090624 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP autonomic neuropathy DOID_11504 9.025E-05 5.522E-04 0.02307354 0.15090624 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP diabetic polyneuropathy DOID_12785 9.025E-05 5.522E-04 0.02307354 0.15090624 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP diabetic neuropathy DOID_9743 9.025E-05 5.522E-04 0.02307354 0.15090624 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP eosinophilia DOID_999 9.417E-05 5.7E-04 0.08605158 0.3200219 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP nervous system cancer DOID_3093 1.011E-04 6.054E-04 0.36894002 0.80741105 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP agammaglobulinemia DOID_2583 1.114E-04 6.604E-04 1.114E-04 3.729E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP autonomic nervous system disease DOID_11465 1.152E-04 6.756E-04 0.02589476 0.16371243 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP heart valve disease DOID_4079 1.152E-04 6.688E-04 0.02589476 0.16191339 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP mouth disease DOID_403 1.236E-04 7.106E-04 0.38146112 0.82844038 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP blood protein disease DOID_620 1.306E-04 7.431E-04 1.306E-04 3.715E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP ulcerative colitis DOID_8577 1.499E-04 8.443E-04 0.01384635 0.10100734 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP atopic dermatitis DOID_3310 1.673E-04 9.332E-04 0.03088821 0.18118961 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP familial hypercholesterolemia DOID_13810 1.751E-04 9.675E-04 0.10415043 0.36581232 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP congenital nervous system abnormality DOID_2490 2.346E-04 1.283E-03 3.387E-03 0.04014887 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP acute pancreatitis DOID_2913 2.587E-04 1.402E-03 6.878E-03 0.06865931 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP leukocyte disease DOID_9500 2.663E-04 1.429E-03 0.03845645 0.21452665 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP collagen disease DOID_854 3.01E-04 1.6E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pre-malignant neoplasm DOID_0060071 3.388E-04 1.785E-03 0.04306498 0.23561516 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP congenital heart defect DOID_1682 3.388E-04 1.768E-03 3.388E-04 8.38E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP in situ carcinoma DOID_8719 3.388E-04 1.785E-03 0.04306498 0.23561516 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP B cell deficiency DOID_2115 3.644E-04 1.885E-03 3.644E-04 8.64E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP extrinsic allergic alveolitis DOID_841 3.644E-04 1.868E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP periodontitis DOID_824 4.05E-04 2.058E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP tooth disease DOID_1091 4.243E-04 2.137E-03 0.29542999 0.69176816 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP endocrine organ benign neoplasm DOID_0060089 4.479E-04 2.236E-03 0.04909767 0.24083254 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP autoimmune disease of cardiovascular system DOID_0060051 4.484E-04 2.218E-03 0.13928547 0.43545842 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP renal hypertension DOID_1073 4.484E-04 2.199E-03 0.13928547 0.43307886 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP secondary hypertension DOID_11130 4.484E-04 2.199E-03 0.13928547 0.43307886 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP Behcet's disease DOID_13241 4.484E-04 2.218E-03 0.13928547 0.43545842 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP spastic cerebral palsy DOID_0050669 5.959E-04 2.898E-03 0.01179372 0.09586606 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cystic fibrosis DOID_1485 6.4E-04 3.086E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP Charcot-Marie-Tooth disease DOID_10595 6.512E-04 3.114E-03 0.01249012 0.0947584 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP chronic leukemia DOID_1036 7.097E-04 3.365E-03 0.01320409 0.09757308 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP chronic lymphocytic leukemia DOID_1040 7.097E-04 3.365E-03 0.01320409 0.09757308 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP papilloma DOID_2615 7.714E-04 3.627E-03 0.01393543 0.09911572 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP metal metabolism disorder DOID_896 7.714E-04 3.598E-03 0.01393543 0.09669827 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP chronic kidney failure DOID_784 8.842E-04 4.09E-03 0.34641845 0.76697315 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP lymphoid leukemia DOID_10747 9.047E-04 4.151E-03 0.17304952 0.48505013 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP gallbladder disease DOID_0000000 1.084E-03 4.933E-03 0.04875558 0.25686968 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hyperparathyroidism DOID_13543 1.084E-03 4.894E-03 0.04875558 0.25219932 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP Paget's disease of bone DOID_5408 1.084E-03 4.855E-03 1.084E-03 0.02055301 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP acute T cell leukemia DOID_5603 1.084E-03 4.817E-03 0.04875558 0.24335022 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cutaneous leishmaniasis DOID_9111 1.084E-03 4.78E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP microcephaly DOID_10907 1.131E-03 4.949E-03 0.0178461 0.11946392 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP lymphatic system disease DOID_75 1.3E-03 5.645E-03 0.01952546 0.1291859 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP breast benign neoplasm DOID_0060082 1.32E-03 5.69E-03 0.05349913 0.26017952 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP thoracic benign neoplasm DOID_0060097 1.32E-03 5.69E-03 0.05349913 0.26017952 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP common variable immunodeficiency DOID_12177 1.32E-03 5.648E-03 1.32E-03 0.02276181 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP benign breast phyllodes tumor DOID_1631 1.32E-03 5.69E-03 0.05349913 0.26017952 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cervix uteri carcinoma in situ DOID_8991 1.39E-03 5.9E-03 0.19750495 0.53260813 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP common cold DOID_10459 1.579E-03 6.655E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP relapsing-remitting multiple sclerosis DOID_2378 1.579E-03 6.606E-03 0.05821915 0.26291027 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP mitochondrial encephalomyopathy DOID_890 1.579E-03 6.558E-03 0.05821915 0.25679608 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP ocular hypertension DOID_9282 1.579E-03 6.51E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP borderline glaucoma DOID_9283 1.579E-03 6.51E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP parathyroid gland disease DOID_11201 1.86E-03 7.614E-03 0.06291575 0.26517823 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP proteinuria DOID_576 1.898E-03 7.714E-03 0.21733394 0.55956115 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP neuritis DOID_1803 2.012E-03 8.119E-03 2.012E-03 0.0293526 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP thyroid adenoma DOID_2891 2.012E-03 8.062E-03 0.22124087 0.5619913 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP viral pneumonia DOID_10533 2.163E-03 8.606E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP T-cell leukemia DOID_715 2.163E-03 8.546E-03 0.06758905 0.27275299 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bacterial meningitis DOID_9470 2.163E-03 8.487E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP integumentary system benign neoplasm DOID_0060121 2.252E-03 8.777E-03 0.22899661 0.57400471 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP skin benign neoplasm DOID_3165 2.252E-03 8.777E-03 0.22899661 0.57400471 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP lung small cell carcinoma DOID_5409 2.252E-03 8.717E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP skeletal system cancer DOID_0060124 2.487E-03 9.563E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bone cancer DOID_184 2.487E-03 9.563E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hemangioma DOID_255 2.487E-03 9.499E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP lung oat cell carcinoma DOID_5411 2.487E-03 9.435E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP oral submucous fibrosis DOID_5773 2.487E-03 9.373E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP varicose veins DOID_799 2.487E-03 9.311E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP atrophic muscular disease DOID_913 2.784E-03 0.01035285 2.784E-03 0.0368369 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP muscular dystrophy DOID_9884 2.784E-03 0.01035285 2.784E-03 0.0368369 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP vein disease DOID_866 2.833E-03 0.0104688 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP reproductive organ benign neoplasm DOID_0050622 3.076E-03 0.01129285 0.25180583 0.620249 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP integumentary system cancer DOID_0060122 3.076E-03 0.01122046 0.25180583 0.61757552 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP skin cancer DOID_4159 3.076E-03 0.01122046 0.25180583 0.61757552 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP smallpox DOID_8736 3.076E-03 0.01114899 3.076E-03 0.0388976 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hyperostosis DOID_205 3.201E-03 0.01152645 3.201E-03 0.03959085 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP urinary system benign neoplasm DOID_731 3.201E-03 0.01145396 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP leishmaniasis DOID_9065 3.998E-03 0.01421825 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP respiratory failure DOID_11162 4.245E-03 0.01500359 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP limb-girdle muscular dystrophy DOID_11724 4.428E-03 0.01555205 4.428E-03 0.04940064 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP subependymal glioma DOID_4843 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pilocytic astrocytoma DOID_4851 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP subependymal giant cell astrocytoma DOID_5077 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP fibrillary astrocytoma DOID_6726 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP juvenile pilocytic astrocytoma DOID_6811 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP childhood pilocytic astrocytoma DOID_6812 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP gemistocytic astrocytoma DOID_7005 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP childhood cerebral astrocytoma DOID_7007 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP protoplasmic astrocytoma DOID_7008 4.428E-03 0.01545664 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP autoimmune hepatitis DOID_2048 4.878E-03 0.01692405 0.09965942 0.36118606 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP mitochondrial myopathy DOID_699 4.878E-03 0.01682148 0.09965942 0.35664284 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP temporal lobe epilepsy DOID_3328 5.019E-03 0.01720292 0.29189339 0.68915907 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hyperglycemia DOID_4195 5.019E-03 0.01709991 0.29189339 0.68631131 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP benign glioma DOID_0060101 5.348E-03 0.01811389 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP benign ependymoma DOID_4844 5.348E-03 0.01811389 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP acquired immunodeficiency syndrome DOID_635 5.348E-03 0.01800671 0.10415043 0.36356808 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP muscular atrophy DOID_767 5.348E-03 0.01790078 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP IgA glomerulonephritis DOID_2986 5.838E-03 0.01942738 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP uremia DOID_4676 5.838E-03 0.01931443 0.10861916 0.37457153 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pulmonary embolism DOID_9477 5.838E-03 0.01920278 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP male reproductive system disease DOID_48 6.098E-03 0.01994052 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP meningitis DOID_9471 6.348E-03 0.02064154 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP spastic quadriplegia DOID_10970 6.878E-03 0.02223625 0.1174902 0.39792812 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP toxic shock syndrome DOID_14115 6.878E-03 0.02211063 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP commensal bacterial infectious disease DOID_0050339 7.427E-03 0.02374099 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP reading disorder DOID_13365 7.427E-03 0.02360836 7.427E-03 0.07286029 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP urticaria DOID_1555 7.427E-03 0.02347721 7.427E-03 0.07162537 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP bronchiolitis DOID_2942 7.427E-03 0.0233475 0.12189273 0.40559629 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP osteosarcoma DOID_3347 7.427E-03 0.02321921 7.427E-03 0.07043162 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP dyslexia DOID_4428 7.427E-03 0.02360836 7.427E-03 0.07286029 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP ankylosing spondylitis DOID_7147 7.995E-03 0.02485848 7.995E-03 0.07220798 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP vitiligo DOID_12306 8.582E-03 0.02653849 8.582E-03 0.07512434 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP auditory system disease DOID_2742 8.644E-03 0.02658703 0.06607372 0.27243438 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP focal epilepsy DOID_2234 8.928E-03 0.0273126 0.34641845 0.76996914 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP gestational diabetes DOID_11714 9.188E-03 0.02795573 0.13496968 0.42665415 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP migraine DOID_6364 9.188E-03 0.02780703 9.188E-03 0.07920791 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pleurisy DOID_10247 9.812E-03 0.0295392 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP supratentorial cancer DOID_1659 0.01045436 0.03130804 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP toxic encephalopathy DOID_3602 0.01045436 0.03114413 0.14357984 0.43455813 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cerebrum cancer DOID_368 0.01045436 0.03130804 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP cranial nerve disease DOID_5656 0.01045436 0.03098192 0.14357984 0.43225888 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP primary immunodeficiency disease DOID_612 0.01074596 0.0316811 0.01074596 0.08991842 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP female reproductive organ benign neoplasm DOID_0060086 0.01111506 0.03260036 0.1478529 0.44278052 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP uterine benign neoplasm DOID_0060095 0.01111506 0.03260036 0.1478529 0.44278052 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP corneal disease DOID_10124 0.01111506 0.03243318 0.1478529 0.44046229 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP uterine fibroid DOID_13223 0.01111506 0.03260036 0.1478529 0.44278052 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP endometrial carcinoma DOID_2871 0.01111506 0.03226771 0.1478529 0.43816822 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP lymphoma DOID_0060058 0.01172917 0.03387766 0.01172917 0.09672317 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP gonadal disease DOID_2277 0.01179372 0.03389204 0.01179372 0.09451584 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP Crohn's disease DOID_8778 0.01241247 0.03549094 0.0831974 0.31144288 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP endometrial cancer DOID_1380 0.01249012 0.0355344 0.15633549 0.45617895 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP leiomyoma DOID_127 0.01320409 0.03737874 0.16054524 0.46370681 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pleural disease DOID_1532 0.01320409 0.0371937 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hair disease DOID_421 0.01393543 0.03906038 0.01393543 0.09789207 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP pneumoconiosis DOID_10316 0.01468395 0.04095669 0.16890215 0.48538042 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP thyroid carcinoma DOID_3963 0.01468395 0.0407569 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP thyroid cancer DOID_1781 0.01623178 0.04483438 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP adult respiratory distress syndrome DOID_11394 0.01952546 0.05367144 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP autoimmune disease of urogenital tract DOID_0060049 0.02126841 0.05818138 0.20151032 0.53830692 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP primary biliary cirrhosis DOID_12236 0.02126841 0.05818138 0.20151032 0.53830692 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP uterine cancer DOID_363 0.02307354 0.06281743 0.20946151 0.54923318 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP learning disability DOID_8927 0.02399898 0.06502581 0.02399898 0.15343168 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP vascular skin disease DOID_9540 0.02589476 0.06982995 0.02589476 0.16015346 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP hemolytic anemia DOID_583 0.02686476 0.07210399 0.22512839 0.56680554 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP normocytic anemia DOID_720 0.02686476 0.07210399 0.22512839 0.56680554 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP movement disease DOID_480 0.02884812 0.07706377 0.02884812 0.17278508 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP withdrawal disorder DOID_0060001 0.02986116 0.0793972 0.23667551 0.58807146 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP B-cell lymphocytic neoplasm DOID_707 0.02986116 0.07902791 0.02986116 0.17698958 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP mitochondrial metabolism disease DOID_700 0.03513333 0.09255029 0.25554157 0.61873682 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP nonsyndromic deafness DOID_0050563 0.03733579 0.09789891 0.03733579 0.21244064 JISON_SICKLE_CELL_DISEASE_UP peripheral vascular disease DOID_341 7.975E-11 4.538E-08 8.27E-05 3.361E-03 JISON_SICKLE_CELL_DISEASE_UP vascular skin disease DOID_9540 9.732E-09 2.769E-06 0.01016197 0.09969247 JISON_SICKLE_CELL_DISEASE_UP pleural disease DOID_1532 7.102E-08 1.347E-05 0.10091604 0.36342547 JISON_SICKLE_CELL_DISEASE_UP blood coagulation disease DOID_1247 9.851E-08 1.401E-05 2.998E-06 5.686E-04 JISON_SICKLE_CELL_DISEASE_UP hemorrhagic disease DOID_2213 6.608E-07 7.52E-05 6.608E-07 3.76E-04 JISON_SICKLE_CELL_DISEASE_UP sarcoidosis DOID_11335 7.943E-07 7.533E-05 0.15654896 0.45216427 JISON_SICKLE_CELL_DISEASE_UP urticaria DOID_1555 1.141E-06 9.272E-05 2.827E-03 0.03922987 JISON_SICKLE_CELL_DISEASE_UP hypersensitivity reaction type IV disease DOID_2916 1.222E-06 8.693E-05 0.16928366 0.47216864 JISON_SICKLE_CELL_DISEASE_UP ankylosing spondylitis DOID_7147 1.336E-06 8.446E-05 7.541E-05 3.301E-03 JISON_SICKLE_CELL_DISEASE_UP mineral metabolism disease DOID_0050032 1.956E-06 1.113E-04 5.314E-05 2.52E-03 JISON_SICKLE_CELL_DISEASE_UP pleurisy DOID_10247 2.071E-06 1.072E-04 0.08714283 0.34196047 JISON_SICKLE_CELL_DISEASE_UP renal hypertension DOID_1073 2.071E-06 9.822E-05 3.754E-03 0.04643159 JISON_SICKLE_CELL_DISEASE_UP secondary hypertension DOID_11130 2.071E-06 9.822E-05 3.754E-03 0.04643159 JISON_SICKLE_CELL_DISEASE_UP allergic contact dermatitis DOID_3042 2.433E-06 1.065E-04 2.433E-06 6.922E-04 JISON_SICKLE_CELL_DISEASE_UP myocarditis DOID_820 4.39E-06 1.784E-04 5.372E-03 0.06368462 JISON_SICKLE_CELL_DISEASE_UP bacterial pneumonia DOID_874 4.718E-06 1.79E-04 0.02471666 0.1875171 JISON_SICKLE_CELL_DISEASE_UP contact dermatitis DOID_2773 5.329E-06 1.895E-04 5.329E-06 7.58E-04 JISON_SICKLE_CELL_DISEASE_UP calcinosis DOID_182 6.748E-06 2.259E-04 6.748E-06 7.679E-04 JISON_SICKLE_CELL_DISEASE_UP blood platelet disease DOID_2218 7.46E-06 2.358E-04 7.46E-06 7.075E-04 JISON_SICKLE_CELL_DISEASE_UP primary bacterial infectious disease DOID_0050338 7.971E-06 2.387E-04 0.03009676 0.20884215 JISON_SICKLE_CELL_DISEASE_UP systemic scleroderma DOID_418 8.226E-06 2.34E-04 7.256E-03 0.08257125 JISON_SICKLE_CELL_DISEASE_UP transitional cell carcinoma DOID_2671 8.419E-06 2.281E-04 8.419E-06 6.843E-04 JISON_SICKLE_CELL_DISEASE_UP adult respiratory distress syndrome DOID_11394 9.049E-06 2.34E-04 0.1225259 0.39838421 JISON_SICKLE_CELL_DISEASE_UP Human immunodeficiency virus infectious disease DOID_526 9.375E-06 2.319E-04 0.03198439 0.21926649 JISON_SICKLE_CELL_DISEASE_UP viral pneumonia DOID_10533 9.659E-06 2.29E-04 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP encephalomyelitis DOID_640 1.097E-05 2.496E-04 3.072E-03 0.04065703 JISON_SICKLE_CELL_DISEASE_UP rheumatic disease DOID_1575 1.188E-05 2.6E-04 8.654E-03 0.09469137 JISON_SICKLE_CELL_DISEASE_UP scleroderma DOID_419 1.188E-05 2.6E-04 8.654E-03 0.09469137 JISON_SICKLE_CELL_DISEASE_UP heart valve disease DOID_4079 1.661E-05 3.501E-04 1.661E-05 1.182E-03 JISON_SICKLE_CELL_DISEASE_UP glaucoma DOID_1686 1.944E-05 3.95E-04 5.392E-04 0.01333935 JISON_SICKLE_CELL_DISEASE_UP pulmonary tuberculosis DOID_2957 1.944E-05 3.814E-04 0.01095664 0.10390542 JISON_SICKLE_CELL_DISEASE_UP calcium metabolism disease DOID_10575 2.097E-05 3.978E-04 2.097E-05 1.326E-03 JISON_SICKLE_CELL_DISEASE_UP inherited blood coagulation disease DOID_2214 2.146E-05 3.939E-04 2.146E-05 1.221E-03 JISON_SICKLE_CELL_DISEASE_UP prion disease DOID_649 2.146E-05 3.816E-04 1.352E-03 0.02404025 JISON_SICKLE_CELL_DISEASE_UP hypertrophic cardiomyopathy DOID_11984 3.669E-05 6.326E-04 3.669E-05 1.898E-03 JISON_SICKLE_CELL_DISEASE_UP collagen disease DOID_854 4.436E-05 7.423E-04 0.01627014 0.14465173 JISON_SICKLE_CELL_DISEASE_UP myasthenia gravis DOID_437 4.607E-05 7.489E-04 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP respiratory failure DOID_11162 4.716E-05 7.453E-04 0.17933403 0.49534497 JISON_SICKLE_CELL_DISEASE_UP diabetic angiopathy DOID_11713 5.253E-05 8.079E-04 2.41E-03 0.0360879 JISON_SICKLE_CELL_DISEASE_UP tuberculosis DOID_399 6.673E-05 9.992E-04 0.01978206 0.15853513 JISON_SICKLE_CELL_DISEASE_UP neuromuscular junction disease DOID_439 7.541E-05 1.1E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP vitiligo DOID_12306 8.428E-05 1.199E-03 3.275E-03 0.04140746 JISON_SICKLE_CELL_DISEASE_UP bone resorption disease DOID_0080011 1.013E-04 1.406E-03 1.013E-04 3.842E-03 JISON_SICKLE_CELL_DISEASE_UP osteoporosis DOID_11476 1.013E-04 1.406E-03 1.013E-04 3.842E-03 JISON_SICKLE_CELL_DISEASE_UP aneurysm disease DOID_2403 1.013E-04 1.372E-03 0.02414587 0.18566215 JISON_SICKLE_CELL_DISEASE_UP thrombocytopenia DOID_1588 1.04E-04 1.376E-03 1.04E-04 3.698E-03 JISON_SICKLE_CELL_DISEASE_UP hepatic vascular disease DOID_272 1.04E-04 1.345E-03 3.754E-03 0.04544368 JISON_SICKLE_CELL_DISEASE_UP autoimmune disease of the nervous system DOID_438 1.04E-04 1.315E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP pancreatitis DOID_4989 1.064E-04 1.316E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP focal glomerulosclerosis DOID_3945 1.149E-04 1.391E-03 1.149E-04 3.845E-03 JISON_SICKLE_CELL_DISEASE_UP opportunistic mycosis DOID_2473 1.388E-04 1.646E-03 0.09543165 0.35960667 JISON_SICKLE_CELL_DISEASE_UP bronchiolitis obliterans DOID_2799 1.388E-04 1.612E-03 0.09543165 0.35724084 JISON_SICKLE_CELL_DISEASE_UP systemic mycosis DOID_0050136 1.805E-04 2.054E-03 0.10364585 0.36859057 JISON_SICKLE_CELL_DISEASE_UP fungal infectious disease DOID_1564 1.805E-04 2.054E-03 0.10364585 0.36859057 JISON_SICKLE_CELL_DISEASE_UP papilloma DOID_2615 1.805E-04 2.013E-03 1.805E-04 5.705E-03 JISON_SICKLE_CELL_DISEASE_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.152E-04 2.355E-03 3.165E-03 0.04092493 JISON_SICKLE_CELL_DISEASE_UP hypersensitivity reaction type I disease DOID_1205 2.24E-04 2.405E-03 0.03523106 0.21789643 JISON_SICKLE_CELL_DISEASE_UP dilated cardiomyopathy DOID_12930 2.24E-04 2.36E-03 2.24E-04 6.708E-03 JISON_SICKLE_CELL_DISEASE_UP adenoma DOID_657 2.295E-04 2.374E-03 2.295E-04 6.528E-03 JISON_SICKLE_CELL_DISEASE_UP pulmonary sarcoidosis DOID_13406 2.475E-04 2.515E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP respiratory syncytial virus infectious disease DOID_1273 2.863E-04 2.858E-03 0.11985308 0.39419887 JISON_SICKLE_CELL_DISEASE_UP lymphatic system disease DOID_75 3.071E-04 3.013E-03 0.1225259 0.39388269 JISON_SICKLE_CELL_DISEASE_UP hyperinsulinism DOID_2018 3.753E-04 3.619E-03 8.654E-03 0.09290474 JISON_SICKLE_CELL_DISEASE_UP Sjogren's syndrome DOID_12894 4.04E-04 3.831E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP angioedema DOID_1558 4.04E-04 3.769E-03 0.02992697 0.21554992 JISON_SICKLE_CELL_DISEASE_UP polycythemia DOID_8432 4.04E-04 3.708E-03 4.04E-04 0.01094671 JISON_SICKLE_CELL_DISEASE_UP bone marrow disease DOID_4961 4.803E-04 4.338E-03 4.803E-04 0.01242277 JISON_SICKLE_CELL_DISEASE_UP prediabetes syndrome DOID_11716 4.928E-04 4.381E-03 0.03287038 0.21747962 JISON_SICKLE_CELL_DISEASE_UP hemolytic anemia DOID_583 5.092E-04 4.458E-03 0.01055596 0.10180244 JISON_SICKLE_CELL_DISEASE_UP normocytic anemia DOID_720 5.092E-04 4.458E-03 0.01055596 0.10180244 JISON_SICKLE_CELL_DISEASE_UP aortic aneurysm DOID_3627 5.703E-04 4.917E-03 0.14881545 0.43873571 JISON_SICKLE_CELL_DISEASE_UP aortic valve insufficiency DOID_57 5.902E-04 5.012E-03 5.902E-04 0.01399261 JISON_SICKLE_CELL_DISEASE_UP mitochondrial encephalomyopathy DOID_890 5.902E-04 4.939E-03 5.902E-04 0.0134329 JISON_SICKLE_CELL_DISEASE_UP encephalitis DOID_9588 5.902E-04 4.867E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP atopic dermatitis DOID_3310 6.359E-04 5.169E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP giant cell tumor DOID_200 6.704E-04 5.373E-03 6.704E-04 0.01467106 JISON_SICKLE_CELL_DISEASE_UP malignant giant cell tumor DOID_2705 6.704E-04 5.373E-03 6.704E-04 0.01467106 JISON_SICKLE_CELL_DISEASE_UP giant cell glioblastoma DOID_3074 6.704E-04 5.373E-03 6.704E-04 0.01467106 JISON_SICKLE_CELL_DISEASE_UP intracranial thrombosis DOID_4193 6.961E-04 5.501E-03 6.961E-04 0.01467016 JISON_SICKLE_CELL_DISEASE_UP parasitic helminthiasis infectious disease DOID_883 8.105E-04 6.318E-03 8.105E-04 0.01647122 JISON_SICKLE_CELL_DISEASE_UP glioblastoma DOID_3068 8.609E-04 6.619E-03 8.609E-04 0.01689051 JISON_SICKLE_CELL_DISEASE_UP renovascular hypertension DOID_1591 9.334E-04 7.081E-03 0.04455577 0.25101222 JISON_SICKLE_CELL_DISEASE_UP varicose veins DOID_799 9.334E-04 6.988E-03 0.04455577 0.24377149 JISON_SICKLE_CELL_DISEASE_UP intermediate coronary syndrome DOID_8805 9.334E-04 6.897E-03 0.04455577 0.24144985 JISON_SICKLE_CELL_DISEASE_UP carotid artery disease DOID_3407 9.9E-04 7.222E-03 0.01627014 0.14694779 JISON_SICKLE_CELL_DISEASE_UP thyroiditis DOID_7166 1.065E-03 7.668E-03 0.04745518 0.25235514 JISON_SICKLE_CELL_DISEASE_UP autoimmune thyroiditis DOID_7188 1.065E-03 7.668E-03 0.04745518 0.25235514 JISON_SICKLE_CELL_DISEASE_UP vein disease DOID_866 1.065E-03 7.572E-03 0.04745518 0.25001851 JISON_SICKLE_CELL_DISEASE_UP endocrine pancreas disease DOID_1428 1.131E-03 7.944E-03 0.01773928 0.1552869 JISON_SICKLE_CELL_DISEASE_UP parasitic infectious disease DOID_1398 1.18E-03 8.191E-03 1.18E-03 0.02238842 JISON_SICKLE_CELL_DISEASE_UP cerebral degeneration DOID_1443 1.18E-03 8.092E-03 0.01824106 0.15491289 JISON_SICKLE_CELL_DISEASE_UP familial hypertrophic cardiomyopathy DOID_11986 1.204E-03 8.157E-03 1.204E-03 0.0221022 JISON_SICKLE_CELL_DISEASE_UP juvenile rheumatoid arthritis DOID_676 1.204E-03 8.061E-03 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP astrocytoma DOID_3069 1.392E-03 9.213E-03 1.392E-03 0.02400887 JISON_SICKLE_CELL_DISEASE_UP pancreatic ductal carcinoma DOID_3587 1.449E-03 9.476E-03 1.449E-03 0.02424805 JISON_SICKLE_CELL_DISEASE_UP nephrosis DOID_2527 1.507E-03 9.743E-03 1.507E-03 0.02449663 JISON_SICKLE_CELL_DISEASE_UP pancreatic carcinoma DOID_4905 1.627E-03 0.01040148 1.627E-03 0.02571476 JISON_SICKLE_CELL_DISEASE_UP Kawasaki disease DOID_13378 1.845E-03 0.01166253 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP lymphadenitis DOID_1602 1.845E-03 0.01166253 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP coronary restenosis DOID_4247 1.845E-03 0.01153437 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP mitochondrial myopathy DOID_699 1.845E-03 0.01140899 1.845E-03 0.02836831 JISON_SICKLE_CELL_DISEASE_UP lymph node disease DOID_9942 1.845E-03 0.01166253 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP funisitis DOID_0050698 2.025E-03 0.01239039 0.06466939 0.31450327 JISON_SICKLE_CELL_DISEASE_UP hepatitis B DOID_2043 2.025E-03 0.01225857 0.06466939 0.30664069 JISON_SICKLE_CELL_DISEASE_UP polyarteritis nodosa DOID_9810 2.214E-03 0.01325845 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP aortic valve disease DOID_62 2.41E-03 0.0142848 2.41E-03 0.03516257 JISON_SICKLE_CELL_DISEASE_UP toxic shock syndrome DOID_14115 2.614E-03 0.0153365 0.07316048 0.32522122 JISON_SICKLE_CELL_DISEASE_UP sphingolipidosis DOID_1927 2.614E-03 0.01518 2.614E-03 0.03719101 JISON_SICKLE_CELL_DISEASE_UP commensal bacterial infectious disease DOID_0050339 2.827E-03 0.01624671 0.07597383 0.33253163 JISON_SICKLE_CELL_DISEASE_UP portal hypertension DOID_10762 2.827E-03 0.01608425 0.07597383 0.32999322 JISON_SICKLE_CELL_DISEASE_UP lymphoma DOID_0060058 2.982E-03 0.0167996 0.03326815 0.2151088 JISON_SICKLE_CELL_DISEASE_UP cystitis DOID_1679 3.047E-03 0.01699672 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP papillary adenoma DOID_3172 3.047E-03 0.01683171 3.047E-03 0.04127775 JISON_SICKLE_CELL_DISEASE_UP microcystic adenoma DOID_5403 3.047E-03 0.01683171 3.047E-03 0.04127775 JISON_SICKLE_CELL_DISEASE_UP follicular adenoma DOID_6204 3.047E-03 0.01683171 3.047E-03 0.04127775 JISON_SICKLE_CELL_DISEASE_UP extrinsic allergic alveolitis DOID_841 3.275E-03 0.01791669 0.08157516 0.32687511 JISON_SICKLE_CELL_DISEASE_UP ulcerative colitis DOID_8577 3.55E-03 0.01923907 0.03723786 0.22071189 JISON_SICKLE_CELL_DISEASE_UP coronary stenosis DOID_4248 3.754E-03 0.02014956 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP autoimmune disease of endocrine system DOID_0060005 4.005E-03 0.02129575 0.0899141 0.34568326 JISON_SICKLE_CELL_DISEASE_UP abdominal aortic aneurysm DOID_7693 4.529E-03 0.02386261 0.09543165 0.35490593 JISON_SICKLE_CELL_DISEASE_UP celiac disease DOID_10608 4.803E-03 0.02507185 0.09817797 0.36274849 JISON_SICKLE_CELL_DISEASE_UP allergic rhinitis DOID_4481 4.803E-03 0.02484393 0.09817797 0.35809787 JISON_SICKLE_CELL_DISEASE_UP bladder disease DOID_365 5.084E-03 0.02606073 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP embryonal cancer DOID_688 6.599E-03 0.03352623 6.599E-03 0.07663137 JISON_SICKLE_CELL_DISEASE_UP uveitis DOID_13141 6.924E-03 0.0348648 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP peptic ulcer DOID_750 7.256E-03 0.03621546 0.11985308 0.39193336 JISON_SICKLE_CELL_DISEASE_UP pulmonary emphysema DOID_9675 7.941E-03 0.03928958 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP nephrotic syndrome DOID_1184 8.654E-03 0.04244785 8.654E-03 0.09654806 JISON_SICKLE_CELL_DISEASE_UP uveal disease DOID_3480 8.654E-03 0.04208505 1.000 1.000 JISON_SICKLE_CELL_DISEASE_UP influenza DOID_8469 9.021E-03 0.04349727 0.13313694 0.40948606 JISON_SICKLE_CELL_DISEASE_UP cataract DOID_83 9.394E-03 0.04491853 9.394E-03 0.09898714 JISON_SICKLE_CELL_DISEASE_UP learning disability DOID_8927 9.394E-03 0.04454421 0.13576977 0.41311763 JISON_SICKLE_CELL_DISEASE_UP leukodystrophy DOID_10579 9.775E-03 0.04596536 0.13839466 0.4188647 JISON_SICKLE_CELL_DISEASE_UP proteinuria DOID_576 9.775E-03 0.0455886 0.13839466 0.4144556 JISON_SICKLE_CELL_DISEASE_UP myeloma DOID_0070004 0.01016197 0.04700946 0.01016197 0.10513025 JISON_SICKLE_CELL_DISEASE_UP lens disease DOID_110 0.01016197 0.04663035 0.01016197 0.10325292 JISON_SICKLE_CELL_DISEASE_UP thyroid adenoma DOID_2891 0.01016197 0.04625731 0.01016197 0.10144146 JISON_SICKLE_CELL_DISEASE_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.01095664 0.04947877 0.14622203 0.43333507 JISON_SICKLE_CELL_DISEASE_UP B-cell lymphocytic neoplasm DOID_707 0.01177784 0.05276845 0.15140107 0.44178055 JISON_SICKLE_CELL_DISEASE_UP bone marrow cancer DOID_4960 0.01305868 0.05804992 0.01305868 0.12180966 JISON_SICKLE_CELL_DISEASE_UP pustulosis of palm and sole DOID_4398 0.01349853 0.05954002 0.1616659 0.45538563 JISON_SICKLE_CELL_DISEASE_UP mitochondrial metabolism disease DOID_700 0.01394476 0.06103513 0.01394476 0.12797688 JISON_SICKLE_CELL_DISEASE_UP leukocyte disease DOID_9500 0.01532131 0.06654827 0.17180763 0.47687094 JISON_SICKLE_CELL_DISEASE_UP hypothyroidism DOID_1459 0.01675378 0.07221893 0.17933403 0.492952 JISON_SICKLE_CELL_DISEASE_UP cholestasis DOID_13580 0.01824106 0.07803882 0.01824106 0.15726006 JISON_SICKLE_CELL_DISEASE_UP uterine disease DOID_345 0.01824106 0.07745645 0.01824106 0.15263476 JISON_SICKLE_CELL_DISEASE_UP hyperglycemia DOID_4195 0.01874881 0.07902278 0.01874881 0.15460978 JISON_SICKLE_CELL_DISEASE_UP endocrine organ benign neoplasm DOID_0060089 0.01978206 0.08276466 0.01978206 0.16079992 JISON_SICKLE_CELL_DISEASE_UP brain infarction DOID_3454 0.01978206 0.08216054 0.194184 0.52866363 JISON_SICKLE_CELL_DISEASE_UP bile duct disease DOID_4138 0.02137571 0.08813606 0.02137571 0.16892745 JISON_SICKLE_CELL_DISEASE_UP male reproductive system disease DOID_48 0.02137571 0.08750199 0.20150879 0.54599286 JISON_SICKLE_CELL_DISEASE_UP biliary tract disease DOID_9741 0.02191843 0.08908277 0.02191843 0.17084368 JISON_SICKLE_CELL_DISEASE_UP diabetic retinopathy DOID_8947 0.02246685 0.0906641 0.20635527 0.55647463 JISON_SICKLE_CELL_DISEASE_UP cystic fibrosis DOID_1485 0.02358061 0.09448849 0.21117259 0.56677926 WILLERT_WNT_SIGNALING heart septal defect DOID_1681 2.158E-05 0.01227729 2.158E-05 0.01227729 WILLERT_WNT_SIGNALING synostosis DOID_11971 3.479E-05 9.898E-03 3.479E-05 9.898E-03 WILLERT_WNT_SIGNALING osteosarcoma DOID_3347 4.095E-05 7.767E-03 9.56E-03 0.27199289 WILLERT_WNT_SIGNALING dysostosis DOID_1934 6.241E-05 8.878E-03 6.241E-05 0.01183792 WILLERT_WNT_SIGNALING papilloma DOID_2615 7.921E-05 9.014E-03 0.0132148 0.27848968 WILLERT_WNT_SIGNALING myocarditis DOID_820 7.921E-05 7.512E-03 7.921E-05 0.01126754 WILLERT_WNT_SIGNALING congenital diaphragmatic hernia DOID_3827 1.081E-04 8.788E-03 1.081E-04 0.01230359 WILLERT_WNT_SIGNALING adenoid cystic carcinoma DOID_4866 1.134E-04 8.063E-03 0.01576544 0.29901782 WILLERT_WNT_SIGNALING salivary gland cancer DOID_8850 1.242E-04 7.854E-03 0.01649307 0.30272758 WILLERT_WNT_SIGNALING brain cancer DOID_1319 1.536E-04 8.738E-03 1.000 1.000 WILLERT_WNT_SIGNALING central nervous system cancer DOID_3620 1.598E-04 8.266E-03 1.000 1.000 WILLERT_WNT_SIGNALING oral cavity cancer DOID_8618 2.289E-04 0.01085245 0.02229614 0.32529495 WILLERT_WNT_SIGNALING congenital heart defect DOID_1682 2.68E-04 0.01172961 2.68E-04 0.02541416 WILLERT_WNT_SIGNALING aneurysm disease DOID_2403 3.839E-04 0.01560171 3.839E-04 0.03120343 WILLERT_WNT_SIGNALING bone development disease DOID_0080006 4.547E-04 0.01724898 4.547E-04 0.03234184 WILLERT_WNT_SIGNALING nervous system cancer DOID_3093 5.201E-04 0.01849682 1.000 1.000 OLSSON_E2F3_TARGETS_DN embryonal cancer DOID_688 3.901E-06 2.22E-03 3.901E-06 2.22E-03 OLSSON_E2F3_TARGETS_DN pustulosis of palm and sole DOID_4398 1.207E-05 3.434E-03 1.207E-05 3.434E-03 OLSSON_E2F3_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 2.221E-05 4.212E-03 2.221E-05 4.212E-03 OLSSON_E2F3_TARGETS_DN brain infarction DOID_3454 2.221E-05 3.159E-03 1.359E-03 0.05522489 OLSSON_E2F3_TARGETS_DN familial combined hyperlipidemia DOID_13809 2.533E-05 2.882E-03 7.624E-03 0.18861407 OLSSON_E2F3_TARGETS_DN rhabdomyosarcoma DOID_3247 5.112E-05 4.848E-03 5.112E-05 7.272E-03 OLSSON_E2F3_TARGETS_DN arthropathy DOID_381 5.896E-05 4.792E-03 0.0114151 0.19103508 OLSSON_E2F3_TARGETS_DN skeletal muscle cancer DOID_4043 5.896E-05 4.193E-03 5.896E-05 6.709E-03 OLSSON_E2F3_TARGETS_DN muscle cancer DOID_4045 1.415E-04 8.947E-03 1.415E-04 0.01342112 OLSSON_E2F3_TARGETS_DN pulmonary embolism DOID_9477 1.415E-04 8.053E-03 1.000 1.000 OLSSON_E2F3_TARGETS_DN Lewy body dementia DOID_12217 1.543E-04 7.982E-03 0.01820366 0.23017521 OLSSON_E2F3_TARGETS_DN diffuse large B-cell lymphoma DOID_0050745 2.265E-04 0.01073811 2.265E-04 0.01840819 OLSSON_E2F3_TARGETS_DN focal glomerulosclerosis DOID_3945 2.591E-04 0.01134176 0.02345252 0.23411371 OLSSON_E2F3_TARGETS_DN nephroblastoma DOID_2154 3.701E-04 0.01504116 3.701E-04 0.02632202 OLSSON_E2F3_TARGETS_DN congenital diaphragmatic hernia DOID_3827 4.773E-04 0.01810577 0.03164602 0.25361384 OLSSON_E2F3_TARGETS_DN adult respiratory distress syndrome DOID_11394 5.004E-04 0.01779373 1.000 1.000 OLSSON_E2F3_TARGETS_DN gallbladder cancer DOID_3121 5.978E-04 0.02001025 5.978E-04 0.03779713 OLSSON_E2F3_TARGETS_DN leukodystrophy DOID_10579 6.498E-04 0.02053992 0.03682546 0.268637 OLSSON_E2F3_TARGETS_DN thyroid adenoma DOID_2891 6.765E-04 0.02026005 6.765E-04 0.03849409 OLSSON_E2F3_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 7.888E-04 0.0224411 7.888E-04 0.04080201 OLSSON_E2F3_TARGETS_DN vasculitis DOID_865 8.785E-04 0.02380294 0.04271207 0.2730693 OLSSON_E2F3_TARGETS_DN familial hyperlipidemia DOID_1168 9.409E-04 0.02433508 0.04417829 0.2732331 OLSSON_E2F3_TARGETS_DN respiratory failure DOID_11162 1.141E-03 0.02821671 1.000 1.000 OLSSON_E2F3_TARGETS_DN parasitic infectious disease DOID_1398 1.247E-03 0.02957305 1.247E-03 0.0591461 OLSSON_E2F3_TARGETS_DN cerebral degeneration DOID_1443 1.247E-03 0.02839013 0.05074947 0.30079635 OLSSON_E2F3_TARGETS_DN uterine disease DOID_345 1.247E-03 0.0272982 1.247E-03 0.0545964 OLSSON_E2F3_TARGETS_DN nephrosis DOID_2527 1.475E-03 0.03107995 0.05510601 0.31995223 OLSSON_E2F3_TARGETS_DN diabetic retinopathy DOID_8947 1.555E-03 0.0315933 0.05655389 0.32179164 OLSSON_E2F3_TARGETS_DN cystic fibrosis DOID_1485 1.637E-03 0.03211103 0.05799963 0.32675041 OLSSON_E2F3_TARGETS_DN bacterial pneumonia DOID_874 1.721E-03 0.03263258 0.05944324 0.32212572 OLSSON_E2F3_TARGETS_DN metabolic syndrome X DOID_14221 1.806E-03 0.03315748 0.0608847 0.32682448 OLSSON_E2F3_TARGETS_DN lipid metabolism disorder DOID_3146 1.806E-03 0.03212131 0.0608847 0.32377005 OLSSON_E2F3_TARGETS_DN female reproductive system disease DOID_229 1.85E-03 0.03190192 1.85E-03 0.07018422 OLSSON_E2F3_TARGETS_DN alcohol abuse DOID_1574 1.939E-03 0.03245241 1.939E-03 0.06896136 OLSSON_E2F3_TARGETS_DN biliary tract cancer DOID_4607 1.939E-03 0.03152519 1.939E-03 0.06490481 OLSSON_E2F3_TARGETS_DN chronic kidney failure DOID_784 1.939E-03 0.03064949 1.000 1.000 OLSSON_E2F3_TARGETS_DN retinal vascular disease DOID_2462 2.03E-03 0.03121997 0.06447904 0.33659242 OLSSON_E2F3_TARGETS_DN transitional cell carcinoma DOID_2671 2.17E-03 0.03249741 2.17E-03 0.06860564 OLSSON_E2F3_TARGETS_DN lymphoma DOID_0060058 2.364E-03 0.03449244 2.364E-03 0.07080027 OLSSON_E2F3_TARGETS_DN encephalomyelitis DOID_640 2.414E-03 0.03433711 2.414E-03 0.06867421 OLSSON_E2F3_TARGETS_DN ulcerative colitis DOID_8577 2.67E-03 0.03705068 0.07376227 0.35872421 OLSSON_E2F3_TARGETS_DN childhood type dermatomyositis DOID_14203 7.624E-03 0.09859372 1.000 1.000 OLSSON_E2F3_TARGETS_DN lateral sclerosis DOID_230 7.624E-03 0.09640275 7.624E-03 0.18075515 OLSSON_E2F3_TARGETS_DN acute kidney failure DOID_3021 7.624E-03 0.09430703 1.000 1.000 OLSSON_E2F3_TARGETS_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.624E-03 0.0923005 7.624E-03 0.17352494 OLSSON_E2F3_TARGETS_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.624E-03 0.0923005 7.624E-03 0.17352494 OLSSON_E2F3_TARGETS_DN Hodgkin's granuloma DOID_8651 7.624E-03 0.0923005 7.624E-03 0.17352494 OLSSON_E2F3_TARGETS_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 7.624E-03 0.0923005 7.624E-03 0.17352494 OLSSON_E2F3_TARGETS_DN breast benign neoplasm DOID_0060082 8.383E-03 0.09937865 8.383E-03 0.18346828 OLSSON_E2F3_TARGETS_DN thoracic benign neoplasm DOID_0060097 8.383E-03 0.09937865 8.383E-03 0.18346828 OLSSON_E2F3_TARGETS_DN trypanosomiasis DOID_10113 8.383E-03 0.09735052 8.383E-03 0.17667316 OLSSON_E2F3_TARGETS_DN dermatomyositis DOID_10223 8.383E-03 0.09540351 1.000 1.000 OLSSON_E2F3_TARGETS_DN benign breast phyllodes tumor DOID_1631 8.383E-03 0.09937865 8.383E-03 0.18346828 OLSSON_E2F3_TARGETS_DN Hodgkin's lymphoma DOID_8567 9.142E-03 0.09814921 9.142E-03 0.17339693 OLSSON_E2F3_TARGETS_DN encephalitis DOID_9588 9.142E-03 0.09633163 9.142E-03 0.16780348 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP nervous system cancer DOID_3093 1.802E-06 1.025E-03 3.478E-03 0.39579746 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP autonomic nervous system neoplasm DOID_2621 5.04E-06 1.434E-03 5.115E-04 0.14550787 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP neuroblastoma DOID_769 5.04E-06 1.434E-03 5.115E-04 0.14550787 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP peripheral nervous system neoplasm DOID_1192 8.177E-06 1.551E-03 7.023E-04 0.13320995 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP neuroectodermal tumor DOID_171 3.148E-05 4.478E-03 0.05903882 0.69985599 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP amino acid metabolic disorder DOID_9252 9.019E-05 0.01026401 9.019E-05 0.05132007 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP sarcoma DOID_1115 3.75E-04 0.03556593 1.000 1.000 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP spindle cell carcinoma DOID_4015 5.718E-04 0.04647904 0.0345571 0.72825895 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP medullomyoblastoma DOID_3861 6.032E-04 0.04290294 0.03547478 0.69603957 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP adult medulloblastoma DOID_3864 6.032E-04 0.04290294 0.03547478 0.69603957 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP childhood medulloblastoma DOID_3869 6.032E-04 0.04290294 0.03547478 0.69603957 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP medulloblastoma DOID_3858 6.685E-04 0.04226252 0.03730758 0.7076004 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP cervix uteri carcinoma in situ DOID_8991 8.088E-04 0.04602117 0.04096303 0.66594184 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP primitive neuroectodermal tumor DOID_168 8.838E-04 0.04571892 0.04278569 0.67625165 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP neurotic disorder DOID_4964 1.651E-03 0.07828277 0.05814295 0.70390081 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP hypothyroidism DOID_1459 1.756E-03 0.07686833 1.756E-03 0.24982207 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP pre-malignant neoplasm DOID_0060071 1.81E-03 0.07356443 0.06082807 0.70635047 DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP in situ carcinoma DOID_8719 1.81E-03 0.07356443 0.06082807 0.70635047 GENTILE_UV_RESPONSE_CLUSTER_D2 pancreatic ductal carcinoma DOID_3587 6.492E-06 3.694E-03 6.122E-04 0.34836186 GENTILE_UV_RESPONSE_CLUSTER_D2 pancreatic carcinoma DOID_4905 7.33E-06 2.086E-03 6.634E-04 0.18872569 GENTILE_UV_RESPONSE_CLUSTER_D2 epilepsy with generalized tonic-clonic seizures DOID_7725 1.85E-05 3.509E-03 6.497E-03 0.61610646 GENTILE_UV_RESPONSE_CLUSTER_D2 adolescence-adult electroclinical syndrome DOID_0050705 1.835E-04 0.02610484 0.01986239 0.59482638 GENTILE_UV_RESPONSE_CLUSTER_D2 pulmonary sarcoidosis DOID_13406 1.835E-04 0.02088387 0.01986239 0.56508506 GENTILE_UV_RESPONSE_CLUSTER_D2 endometriosis of uterus DOID_288 2.326E-04 0.02205573 0.02231875 0.50797467 GENTILE_UV_RESPONSE_CLUSTER_D2 endometriosis DOID_289 2.431E-04 0.01975833 0.02280932 0.49917313 GENTILE_UV_RESPONSE_CLUSTER_D2 diabetic autonomic neuropathy DOID_11503 2.538E-04 0.01805152 0.02329965 0.49101864 GENTILE_UV_RESPONSE_CLUSTER_D2 autonomic neuropathy DOID_11504 2.538E-04 0.01805152 0.02329965 0.49101864 GENTILE_UV_RESPONSE_CLUSTER_D2 diabetic polyneuropathy DOID_12785 2.538E-04 0.01805152 0.02329965 0.49101864 GENTILE_UV_RESPONSE_CLUSTER_D2 diabetic neuropathy DOID_9743 2.538E-04 0.01805152 0.02329965 0.49101864 GENTILE_UV_RESPONSE_CLUSTER_D2 autonomic nervous system disease DOID_11465 2.874E-04 0.01816697 0.02476927 0.44042855 GENTILE_UV_RESPONSE_CLUSTER_D2 sarcoidosis DOID_11335 3.606E-04 0.02051781 0.02770221 0.40416819 GENTILE_UV_RESPONSE_CLUSTER_D2 pustulosis of palm and sole DOID_4398 3.868E-04 0.02000926 0.028678 0.37948335 GENTILE_UV_RESPONSE_CLUSTER_D2 hypersensitivity reaction type IV disease DOID_2916 4.279E-04 0.02028764 0.03013995 0.37281807 GENTILE_UV_RESPONSE_CLUSTER_D2 hypothyroidism DOID_1459 4.857E-04 0.02125998 0.03208597 0.38035241 GENTILE_UV_RESPONSE_CLUSTER_D2 uterine disease DOID_345 5.315E-04 0.02160128 0.03354305 0.38171995 GENTILE_UV_RESPONSE_CLUSTER_D2 temporal lobe epilepsy DOID_3328 5.472E-04 0.02075682 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D2 diabetic retinopathy DOID_8947 6.634E-04 0.02359071 0.03741846 0.40944433 GENTILE_UV_RESPONSE_CLUSTER_D2 electroclinical syndrome DOID_0050701 7.346E-04 0.0245887 0.03935064 0.42246255 GENTILE_UV_RESPONSE_CLUSTER_D2 female reproductive system disease DOID_229 7.904E-04 0.02498606 0.04079736 0.42206728 GENTILE_UV_RESPONSE_CLUSTER_D2 alcohol abuse DOID_1574 8.287E-04 0.02481782 8.287E-04 0.15717955 GENTILE_UV_RESPONSE_CLUSTER_D2 focal epilepsy DOID_2234 8.287E-04 0.02357693 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D2 retinal vascular disease DOID_2462 8.679E-04 0.02351571 0.04272312 0.42648165 GENTILE_UV_RESPONSE_CLUSTER_D2 encephalomyelitis DOID_640 1.033E-03 0.02672707 0.04656364 0.44157852 GENTILE_UV_RESPONSE_CLUSTER_D2 alcohol-related neurodevelopmental disorder DOID_0050667 1.055E-03 0.02610117 0.04704268 0.43880793 GENTILE_UV_RESPONSE_CLUSTER_D2 ulcerative colitis DOID_8577 1.144E-03 0.02712054 0.04895655 0.44929479 DORSEY_GAB2_TARGETS nephrosis DOID_2527 1.592E-05 9.058E-03 0.04768715 0.45223313 DORSEY_GAB2_TARGETS bone resorption disease DOID_0080011 1.938E-05 5.513E-03 1.247E-03 0.08868158 DORSEY_GAB2_TARGETS osteoporosis DOID_11476 1.938E-05 5.513E-03 1.247E-03 0.08868158 DORSEY_GAB2_TARGETS osteogenesis imperfecta DOID_12347 3.242E-05 6.149E-03 8.54E-03 0.40494871 DORSEY_GAB2_TARGETS intracranial thrombosis DOID_4193 3.242E-05 4.612E-03 3.242E-05 0.01844619 DORSEY_GAB2_TARGETS inherited blood coagulation disease DOID_2214 6.346E-05 7.222E-03 6.346E-05 0.01805491 DORSEY_GAB2_TARGETS thrombocytopenia DOID_1588 1.796E-04 0.01702805 1.796E-04 0.03405611 DORSEY_GAB2_TARGETS focal glomerulosclerosis DOID_3945 1.919E-04 0.01559575 0.02024962 0.36006361 DORSEY_GAB2_TARGETS blood platelet disease DOID_2218 3.37E-04 0.02396736 3.37E-04 0.04793472 DORSEY_GAB2_TARGETS nephrotic syndrome DOID_1184 4.245E-04 0.02683594 1.000 1.000 DORSEY_GAB2_TARGETS hemorrhagic disease DOID_2213 5.85E-04 0.0332855 5.85E-04 0.06657099 DORSEY_GAB2_TARGETS osteochondrodysplasia DOID_2256 6.746E-04 0.03489747 0.03756514 0.41104931 DORSEY_GAB2_TARGETS carotid artery disease DOID_3407 8.208E-04 0.03891982 8.208E-04 0.07783964 DORSEY_GAB2_TARGETS cholestasis DOID_13580 9.26E-04 0.04052943 0.04390343 0.43070778 DORSEY_GAB2_TARGETS blood coagulation disease DOID_1247 1.066E-03 0.04332921 1.066E-03 0.08665843 DORSEY_GAB2_TARGETS bile duct disease DOID_4138 1.095E-03 0.04154717 0.04768715 0.44481947 DORSEY_GAB2_TARGETS biliary tract disease DOID_9741 1.125E-03 0.04000146 0.04831637 0.43638118 DORSEY_GAB2_TARGETS chronic kidney failure DOID_784 1.441E-03 0.04823912 0.05458666 0.4437116 DORSEY_GAB2_TARGETS bone development disease DOID_0080006 1.475E-03 0.0466251 0.05521151 0.44246969 DORSEY_GAB2_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 1.833E-03 0.0548863 0.06143818 0.46611097 CERVERA_SDHB_TARGETS_2 hyperglycemia DOID_4195 5.176E-06 2.945E-03 2.021E-04 0.03832376 CERVERA_SDHB_TARGETS_2 metabolic syndrome X DOID_14221 1.031E-05 2.932E-03 3.364E-04 0.02734517 CERVERA_SDHB_TARGETS_2 hepatic vascular disease DOID_272 1.639E-05 3.108E-03 1.639E-05 9.323E-03 CERVERA_SDHB_TARGETS_2 nephrotic syndrome DOID_1184 6.013E-05 8.554E-03 6.013E-05 0.01710724 CERVERA_SDHB_TARGETS_2 hyperinsulinism DOID_2018 6.013E-05 6.843E-03 2.6E-03 0.07397764 CERVERA_SDHB_TARGETS_2 giant cell tumor DOID_200 1.085E-04 0.01029252 3.829E-03 0.09076948 CERVERA_SDHB_TARGETS_2 malignant giant cell tumor DOID_2705 1.085E-04 0.01029252 3.829E-03 0.09076948 CERVERA_SDHB_TARGETS_2 giant cell glioblastoma DOID_3074 1.085E-04 0.01029252 3.829E-03 0.09076948 CERVERA_SDHB_TARGETS_2 glioblastoma DOID_3068 1.401E-04 0.01138768 4.526E-03 0.09196986 CERVERA_SDHB_TARGETS_2 congenital heart defect DOID_1682 1.771E-04 0.01259563 5.277E-03 0.10008798 CERVERA_SDHB_TARGETS_2 endocrine pancreas disease DOID_1428 1.852E-04 0.0117073 5.434E-03 0.09973504 CERVERA_SDHB_TARGETS_2 astrocytoma DOID_3069 2.292E-04 0.01304156 6.249E-03 0.11111088 CERVERA_SDHB_TARGETS_2 polycystic kidney disease DOID_898 2.365E-04 0.01223108 2.365E-04 0.03363548 CERVERA_SDHB_TARGETS_2 nephrosis DOID_2527 2.485E-04 0.01178518 2.485E-04 0.02828443 CERVERA_SDHB_TARGETS_2 bile duct disease DOID_4138 2.485E-04 0.01087863 6.589E-03 0.11361789 CERVERA_SDHB_TARGETS_2 biliary tract disease DOID_9741 2.586E-04 0.01051025 6.763E-03 0.11317889 CERVERA_SDHB_TARGETS_2 idiopathic pulmonary fibrosis DOID_0050156 2.725E-04 0.01033847 2.725E-04 0.02584619 CERVERA_SDHB_TARGETS_2 aneurysm disease DOID_2403 3.014E-04 0.01072006 7.477E-03 0.12155885 CERVERA_SDHB_TARGETS_2 auditory system disease DOID_2742 3.611E-04 0.01208655 3.611E-04 0.02568391 CERVERA_SDHB_TARGETS_2 bone development disease DOID_0080006 3.869E-04 0.01223191 3.869E-04 0.02446383 CERVERA_SDHB_TARGETS_2 glucose intolerance DOID_10603 3.959E-04 0.01185558 0.02903813 0.28004566 CERVERA_SDHB_TARGETS_2 infertility DOID_5223 4.42E-04 0.01257458 4.42E-04 0.02514916 CERVERA_SDHB_TARGETS_2 amyloidosis DOID_9120 4.906E-04 0.01329242 4.906E-04 0.02537644 CERVERA_SDHB_TARGETS_2 dilated cardiomyopathy DOID_12930 5.504E-04 0.01423518 5.504E-04 0.02609783 CERVERA_SDHB_TARGETS_2 ureteral disease DOID_1426 7.096E-04 0.01755582 0.03853189 0.296279 CERVERA_SDHB_TARGETS_2 Goodpasture syndrome DOID_9808 7.096E-04 0.01682433 0.03853189 0.28848218 CERVERA_SDHB_TARGETS_2 portal hypertension DOID_10762 8.339E-04 0.01897879 8.339E-04 0.03649768 CERVERA_SDHB_TARGETS_2 morbid obesity DOID_11981 8.996E-04 0.01968801 8.996E-04 0.03656344 CERVERA_SDHB_TARGETS_2 lung adenocarcinoma DOID_3910 1.038E-03 0.02188346 1.038E-03 0.03939022 CERVERA_SDHB_TARGETS_2 renal hypertension DOID_1073 1.111E-03 0.0225854 0.04793431 0.31714678 CERVERA_SDHB_TARGETS_2 secondary hypertension DOID_11130 1.111E-03 0.0225854 0.04793431 0.31714678 CERVERA_SDHB_TARGETS_2 multiple epiphyseal dysplasia DOID_12721 1.187E-03 0.02328598 1.187E-03 0.04220583 CERVERA_SDHB_TARGETS_2 spastic cerebral palsy DOID_0050669 1.345E-03 0.02550576 0.05260154 0.31840718 CERVERA_SDHB_TARGETS_2 age related macular degeneration DOID_10871 1.345E-03 0.02468299 1.345E-03 0.04501016 CERVERA_SDHB_TARGETS_2 degeneration of macula and posterior pole DOID_2007 1.345E-03 0.02468299 1.345E-03 0.04501016 CERVERA_SDHB_TARGETS_2 macular degeneration DOID_4448 1.689E-03 0.03003465 1.689E-03 0.05339493 CERVERA_SDHB_TARGETS_2 adenoma DOID_657 1.875E-03 0.03233622 1.875E-03 0.05616291 CERVERA_SDHB_TARGETS_2 congenital diaphragmatic hernia DOID_3827 2.172E-03 0.03635295 0.06646857 0.35346369 CERVERA_SDHB_TARGETS_2 pre-eclampsia DOID_10591 3.065E-03 0.04982343 3.065E-03 0.08303905 CERVERA_SDHB_TARGETS_2 hemolytic anemia DOID_583 3.186E-03 0.05036366 3.186E-03 0.08241326 CERVERA_SDHB_TARGETS_2 normocytic anemia DOID_720 3.186E-03 0.05036366 3.186E-03 0.08241326 CERVERA_SDHB_TARGETS_2 glaucoma DOID_1686 3.31E-03 0.0509091 3.31E-03 0.08189725 CERVERA_SDHB_TARGETS_2 aortic aneurysm DOID_3627 3.437E-03 0.05145924 0.08314619 0.38778837 CERVERA_SDHB_TARGETS_2 sarcoidosis DOID_11335 3.829E-03 0.05585814 0.08764353 0.40217069 CERVERA_SDHB_TARGETS_2 bile duct adenocarcinoma DOID_4896 3.964E-03 0.05638292 3.964E-03 0.09021268 CERVERA_SDHB_TARGETS_2 cholangiocarcinoma DOID_4947 3.964E-03 0.05638292 3.964E-03 0.09021268 CERVERA_SDHB_TARGETS_2 osteochondrodysplasia DOID_2256 4.101E-03 0.05691255 4.101E-03 0.08974671 CERVERA_SDHB_TARGETS_2 parasitic protozoa infectious disease DOID_2789 4.101E-03 0.05555749 0.09062968 0.40287727 CERVERA_SDHB_TARGETS_2 nonsyndromic deafness DOID_0050563 4.526E-03 0.05988735 4.526E-03 0.09537615 CERVERA_SDHB_TARGETS_2 hypersensitivity reaction type IV disease DOID_2916 4.526E-03 0.05852628 0.0950909 0.41302842 CERVERA_SDHB_TARGETS_2 bile duct cancer DOID_4606 4.526E-03 0.05722569 4.526E-03 0.08879849 CERVERA_SDHB_TARGETS_2 bile duct carcinoma DOID_4897 4.526E-03 0.05722569 4.526E-03 0.08879849 CERVERA_SDHB_TARGETS_2 cholestasis DOID_13580 5.593E-03 0.06917697 0.10541684 0.43782614 CERVERA_SDHB_TARGETS_2 parasitic infectious disease DOID_1398 5.593E-03 0.06770512 0.10541684 0.43465348 CERVERA_SDHB_TARGETS_2 uterine disease DOID_345 5.593E-03 0.06629459 0.10541684 0.43152648 CERVERA_SDHB_TARGETS_2 endocrine organ benign neoplasm DOID_0060089 6.082E-03 0.07062052 0.10980667 0.44312053 CERVERA_SDHB_TARGETS_2 pancreatic ductal carcinoma DOID_3587 6.418E-03 0.07303756 0.11272144 0.44852098 CERVERA_SDHB_TARGETS_2 pancreatic carcinoma DOID_4905 6.938E-03 0.07741076 0.117076 0.46261282 CERVERA_SDHB_TARGETS_2 female reproductive system disease DOID_229 8.224E-03 0.08999201 0.12715504 0.48234146 CERVERA_SDHB_TARGETS_2 biliary tract cancer DOID_4607 8.61E-03 0.09243346 8.61E-03 0.1360826 CERVERA_SDHB_TARGETS_2 chronic kidney failure DOID_784 8.61E-03 0.09072173 8.61E-03 0.13240469 CERVERA_SDHB_TARGETS_2 retinal vascular disease DOID_2462 9.003E-03 0.09314373 0.13286358 0.49411357 CERVERA_SDHB_TARGETS_2 transitional cell carcinoma DOID_2671 9.609E-03 0.09762951 9.609E-03 0.14387507 CERVERA_SDHB_TARGETS_2 amino acid metabolic disorder DOID_9252 9.814E-03 0.0979697 9.814E-03 0.14318649 MAINA_VHL_TARGETS_DN nervous system cancer DOID_3093 2.221E-10 1.264E-07 6.161E-06 3.506E-03 MAINA_VHL_TARGETS_DN multiple myeloma DOID_9538 4.907E-07 1.396E-04 1.13E-04 0.01607217 MAINA_VHL_TARGETS_DN myeloma DOID_0070004 9.712E-07 1.842E-04 1.77E-04 0.01678928 MAINA_VHL_TARGETS_DN bone marrow cancer DOID_4960 1.447E-06 2.059E-04 2.303E-04 0.0187192 MAINA_VHL_TARGETS_DN peripheral vascular disease DOID_341 3.326E-06 3.785E-04 3.988E-04 0.02836214 MAINA_VHL_TARGETS_DN diabetic retinopathy DOID_8947 3.462E-06 3.283E-04 4.094E-04 0.02588625 MAINA_VHL_TARGETS_DN retinal vascular disease DOID_2462 5.206E-06 4.232E-04 5.361E-04 0.03050444 MAINA_VHL_TARGETS_DN membranoproliferative glomerulonephritis DOID_2920 1.53E-05 1.088E-03 1.53E-05 4.352E-03 MAINA_VHL_TARGETS_DN angiosarcoma DOID_0001816 1.748E-05 1.105E-03 1.000 1.000 MAINA_VHL_TARGETS_DN urinary system benign neoplasm DOID_731 1.98E-05 1.127E-03 6.706E-03 0.21199809 MAINA_VHL_TARGETS_DN diabetic angiopathy DOID_11713 4.013E-05 2.076E-03 4.013E-05 7.611E-03 MAINA_VHL_TARGETS_DN sarcoma DOID_1115 6.316E-05 2.995E-03 1.000 1.000 MAINA_VHL_TARGETS_DN peripheral nervous system neoplasm DOID_1192 1.188E-04 5.198E-03 1.188E-04 0.01351401 MAINA_VHL_TARGETS_DN peptic ulcer DOID_750 1.247E-04 5.067E-03 0.01649264 0.21823975 MAINA_VHL_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 1.369E-04 5.193E-03 1.000 1.000 MAINA_VHL_TARGETS_DN brain cancer DOID_1319 1.77E-04 6.296E-03 1.000 1.000 MAINA_VHL_TARGETS_DN central nervous system cancer DOID_3620 1.842E-04 6.166E-03 1.000 1.000 MAINA_VHL_TARGETS_DN giant cell tumor DOID_200 2.223E-04 7.026E-03 0.02193352 0.24000333 MAINA_VHL_TARGETS_DN malignant giant cell tumor DOID_2705 2.223E-04 7.026E-03 0.02193352 0.24000333 MAINA_VHL_TARGETS_DN giant cell glioblastoma DOID_3074 2.223E-04 7.026E-03 0.02193352 0.24000333 MAINA_VHL_TARGETS_DN glioblastoma DOID_3068 2.638E-04 7.9E-03 0.02386988 0.25151777 MAINA_VHL_TARGETS_DN pre-malignant neoplasm DOID_0060071 3.089E-04 8.787E-03 1.000 1.000 MAINA_VHL_TARGETS_DN in situ carcinoma DOID_8719 3.089E-04 8.787E-03 1.000 1.000 MAINA_VHL_TARGETS_DN astrocytoma DOID_3069 3.675E-04 9.959E-03 0.02811727 0.28569156 MAINA_VHL_TARGETS_DN pancreatic ductal carcinoma DOID_3587 3.778E-04 9.772E-03 0.02850254 0.27961976 MAINA_VHL_TARGETS_DN pancreatic carcinoma DOID_4905 4.094E-04 0.0101294 0.0296575 0.28125193 MAINA_VHL_TARGETS_DN syndrome DOID_225 4.312E-04 0.0102238 0.03042676 0.28381679 MAINA_VHL_TARGETS_DN hyperparathyroidism DOID_13543 3.95E-03 0.0899035 1.000 1.000 MAINA_VHL_TARGETS_DN retinal vascular occlusion DOID_1729 3.95E-03 0.08644568 1.000 1.000 MAINA_VHL_TARGETS_DN keratitis DOID_4677 3.95E-03 0.08324398 1.000 1.000 MAINA_VHL_TARGETS_DN migraine without aura DOID_12783 4.344E-03 0.08828179 4.344E-03 0.22471727 MAINA_VHL_TARGETS_DN invasive lobular carcinoma DOID_3457 4.344E-03 0.08523759 1.000 1.000 MAINA_VHL_TARGETS_DN aortic valve insufficiency DOID_57 4.738E-03 0.08987032 4.738E-03 0.2246758 MAINA_VHL_TARGETS_DN parathyroid gland disease DOID_11201 5.132E-03 0.09420149 1.000 1.000 MAINA_VHL_TARGETS_DN osteogenesis imperfecta DOID_12347 5.132E-03 0.0912577 5.132E-03 0.22463433 MAINA_VHL_TARGETS_DN intracranial thrombosis DOID_4193 5.132E-03 0.08849231 5.132E-03 0.20858902 MAINA_VHL_TARGETS_DN rhabdomyosarcoma DOID_3247 5.526E-03 0.09247942 1.000 1.000 MAINA_VHL_TARGETS_DN hemangioma DOID_255 5.92E-03 0.09623633 1.000 1.000 MAINA_VHL_TARGETS_DN skeletal muscle cancer DOID_4043 5.92E-03 0.09356309 1.000 1.000 MAINA_VHL_TARGETS_DN lung oat cell carcinoma DOID_5411 5.92E-03 0.09103436 5.92E-03 0.22455143 MAINA_VHL_TARGETS_DN spastic diplegia DOID_10965 6.313E-03 0.09453052 6.313E-03 0.22450999 MAINA_VHL_TARGETS_DN restrictive cardiomyopathy DOID_397 6.313E-03 0.09210666 6.313E-03 0.21130352 MAINA_VHL_TARGETS_DN bronchitis DOID_6132 6.706E-03 0.09539914 1.000 1.000 MAINA_VHL_TARGETS_DN male reproductive organ benign neoplasm DOID_0060087 7.1E-03 0.09852899 1.000 1.000 MAINA_VHL_TARGETS_DN ureteral obstruction DOID_5199 7.1E-03 0.09618306 7.1E-03 0.21261519 MAINA_VHL_TARGETS_DN granulosa cell tumor DOID_2999 7.493E-03 0.09914719 1.000 1.000 MAINA_VHL_TARGETS_DN pulmonary edema DOID_11396 7.886E-03 0.09970859 1.000 1.000 MAINA_VHL_TARGETS_DN esophagitis DOID_11963 7.886E-03 0.09754102 7.886E-03 0.21366127 MAINA_VHL_TARGETS_DN colon carcinoma DOID_1520 7.886E-03 0.09546567 1.000 1.000 MAINA_VHL_TARGETS_DN sex cord-gonadal stromal tumor DOID_192 7.886E-03 0.09347681 1.000 1.000 MAINA_VHL_TARGETS_DN brain edema DOID_4724 7.886E-03 0.09156912 1.000 1.000 MAINA_VHL_TARGETS_DN Kawasaki disease DOID_13378 8.278E-03 0.09420724 1.000 1.000 MAINA_VHL_TARGETS_DN lymphadenitis DOID_1602 8.278E-03 0.09420724 1.000 1.000 MAINA_VHL_TARGETS_DN lymph node disease DOID_9942 8.278E-03 0.09420724 1.000 1.000 MAINA_VHL_TARGETS_DN gastric ulcer DOID_10808 8.671E-03 0.09674028 1.000 1.000 MAINA_VHL_TARGETS_DN hepatitis B DOID_2043 8.671E-03 0.09487989 8.671E-03 0.22426157 MAINA_VHL_TARGETS_DN thrombophilia DOID_2452 8.671E-03 0.09308971 8.671E-03 0.21451106 MAINA_VHL_TARGETS_DN glycogen metabolism disorder DOID_0050728 9.063E-03 0.09550119 9.063E-03 0.21487769 MAINA_VHL_TARGETS_DN glycogen storage disease DOID_2747 9.063E-03 0.09550119 9.063E-03 0.21487769 MAINA_VHL_TARGETS_DN muscle cancer DOID_4045 9.063E-03 0.09376481 1.000 1.000 MAINA_VHL_TARGETS_DN uremia DOID_4676 9.063E-03 0.09209044 9.063E-03 0.20628258 MAINA_VHL_TARGETS_DN urinary tract obstruction DOID_5200 9.063E-03 0.09047482 9.063E-03 0.19834863 MAINA_VHL_TARGETS_DN pulmonary embolism DOID_9477 9.063E-03 0.0889149 9.063E-03 0.19100239 MAINA_VHL_TARGETS_DN polyarteritis nodosa DOID_9810 9.063E-03 0.08740787 1.000 1.000 MAINA_VHL_TARGETS_DN ureteral disease DOID_1426 9.456E-03 0.08967153 9.456E-03 0.19215328 MAINA_VHL_TARGETS_DN aortic valve disease DOID_62 9.456E-03 0.08820151 9.456E-03 0.18552731 MAINA_VHL_TARGETS_DN spastic quadriplegia DOID_10970 9.848E-03 0.09037802 9.848E-03 0.18678123 MAINA_VHL_TARGETS_DN toxic shock syndrome DOID_14115 9.848E-03 0.08894344 9.848E-03 0.18075603 MAINA_VHL_TARGETS_DN commensal bacterial infectious disease DOID_0050339 0.01023989 0.09103906 0.01023989 0.18207811 MAINA_VHL_TARGETS_DN portal hypertension DOID_10762 0.01023989 0.08963845 1.000 1.000 MAINA_VHL_TARGETS_DN myositis DOID_633 0.01063177 0.09165878 0.01063177 0.18331757 MAINA_VHL_TARGETS_DN seminoma DOID_4440 0.01102351 0.09361757 1.000 1.000 MAINA_VHL_TARGETS_DN extrinsic allergic alveolitis DOID_841 0.01102351 0.09224084 1.000 1.000 MAINA_VHL_TARGETS_DN migraine DOID_6364 0.0114151 0.09413323 0.0114151 0.19103508 MAINA_VHL_TARGETS_DN hepatic vascular disease DOID_272 0.01180655 0.09597037 1.000 1.000 MAINA_VHL_TARGETS_DN invasive ductal carcinoma DOID_3008 0.01180655 0.09461867 0.01180655 0.19194074 MAINA_VHL_TARGETS_DN polycystic ovary syndrome DOID_11612 0.01219785 0.0963969 0.01219785 0.19279379 MAINA_VHL_TARGETS_DN focal glomerulosclerosis DOID_3945 0.01219785 0.09507639 0.01219785 0.18758315 MAINA_VHL_TARGETS_DN corneal disease DOID_10124 0.01258901 0.09679926 1.000 1.000 MAINA_VHL_TARGETS_DN endometrial carcinoma DOID_2871 0.01258901 0.0955086 0.01258901 0.18850381 MAINA_VHL_TARGETS_DN spastic cerebral palsy DOID_0050669 0.01298002 0.09717936 0.01298002 0.18937516 MAINA_VHL_TARGETS_DN age related macular degeneration DOID_10871 0.01298002 0.09591729 1.000 1.000 MAINA_VHL_TARGETS_DN degeneration of macula and posterior pole DOID_2007 0.01298002 0.09591729 1.000 1.000 MAINA_VHL_TARGETS_DN endometrial cancer DOID_1380 0.01337089 0.09753891 0.01337089 0.19020087 MAINA_VHL_TARGETS_DN germinoma DOID_3304 0.01337089 0.09630424 1.000 1.000 MAINA_VHL_TARGETS_DN autonomic nervous system neoplasm DOID_2621 0.01376161 0.09787946 0.01376161 0.19098431 MAINA_VHL_TARGETS_DN neuroblastoma DOID_769 0.01376161 0.09787946 0.01376161 0.19098431 MAINA_VHL_TARGETS_DN papilloma DOID_2615 0.01415219 0.09941477 1.000 1.000 MAINA_VHL_TARGETS_DN esophageal disease DOID_6050 0.01454262 0.09969583 0.01454262 0.19701794 WANG_CISPLATIN_RESPONSE_AND_XPC_DN papilloma DOID_2615 3.419E-06 1.946E-03 1.499E-04 0.0426467 WANG_CISPLATIN_RESPONSE_AND_XPC_DN adenoma DOID_657 4.743E-06 1.35E-03 1.907E-04 0.03616564 WANG_CISPLATIN_RESPONSE_AND_XPC_DN thyroid adenoma DOID_2891 1.297E-05 2.459E-03 3.997E-04 0.05686289 WANG_CISPLATIN_RESPONSE_AND_XPC_DN hypertrophic cardiomyopathy DOID_11984 2.868E-05 4.08E-03 0.01318954 0.22073077 WANG_CISPLATIN_RESPONSE_AND_XPC_DN endocrine organ benign neoplasm DOID_0060089 5.224E-05 5.945E-03 1.116E-03 0.07056809 WANG_CISPLATIN_RESPONSE_AND_XPC_DN papillary adenoma DOID_3172 6.257E-05 5.933E-03 6.257E-05 0.03559953 WANG_CISPLATIN_RESPONSE_AND_XPC_DN microcystic adenoma DOID_5403 6.257E-05 5.933E-03 6.257E-05 0.03559953 WANG_CISPLATIN_RESPONSE_AND_XPC_DN follicular adenoma DOID_6204 6.257E-05 5.933E-03 6.257E-05 0.03559953 WANG_CISPLATIN_RESPONSE_AND_XPC_DN renal hypertension DOID_1073 8.63E-05 7.015E-03 1.000 1.000 WANG_CISPLATIN_RESPONSE_AND_XPC_DN secondary hypertension DOID_11130 8.63E-05 7.015E-03 1.000 1.000 WANG_CISPLATIN_RESPONSE_AND_XPC_DN allergic rhinitis DOID_4481 1.262E-04 8.973E-03 4.25E-03 0.12091759 WANG_CISPLATIN_RESPONSE_AND_XPC_DN nephroblastoma DOID_2154 1.628E-04 0.01029191 5.018E-03 0.12977603 WANG_CISPLATIN_RESPONSE_AND_XPC_DN movement disease DOID_480 4.748E-04 0.027017 4.748E-04 0.054034 WANG_CISPLATIN_RESPONSE_AND_XPC_DN bone marrow cancer DOID_4960 5.882E-04 0.03042498 5.882E-04 0.05577914 WANG_CISPLATIN_RESPONSE_AND_XPC_DN renovascular hypertension DOID_1591 8.241E-04 0.03907402 1.000 1.000 WANG_CISPLATIN_RESPONSE_AND_XPC_DN angiosarcoma DOID_0001816 9.4E-04 0.04114432 9.4E-04 0.07641087 WANG_CISPLATIN_RESPONSE_AND_XPC_DN uterine disease DOID_345 9.848E-04 0.04002515 0.01620825 0.2634999 WANG_CISPLATIN_RESPONSE_AND_XPC_DN hyperostosis DOID_205 1.063E-03 0.04033775 1.063E-03 0.07563329 WANG_CISPLATIN_RESPONSE_AND_XPC_DN tuberculosis DOID_399 1.116E-03 0.03969455 1.116E-03 0.06351128 WANG_CISPLATIN_RESPONSE_AND_XPC_DN prion disease DOID_649 1.194E-03 0.03996675 0.05006594 0.39565998 WANG_CISPLATIN_RESPONSE_AND_XPC_DN blood coagulation disease DOID_1247 1.21E-03 0.03823801 1.21E-03 0.06257128 WANG_CISPLATIN_RESPONSE_AND_XPC_DN diabetic retinopathy DOID_8947 1.359E-03 0.0406931 0.19509508 0.66472514 WANG_CISPLATIN_RESPONSE_AND_XPC_DN lipid metabolism disorder DOID_3146 1.691E-03 0.04810134 1.691E-03 0.08016891 WANG_CISPLATIN_RESPONSE_AND_XPC_DN female reproductive system disease DOID_229 1.751E-03 0.04743091 0.02355498 0.35270482 WANG_CISPLATIN_RESPONSE_AND_XPC_DN gastric ulcer DOID_10808 1.789E-03 0.04628247 0.0608499 0.42745174 WANG_CISPLATIN_RESPONSE_AND_XPC_DN chronic kidney failure DOID_784 1.874E-03 0.04636215 0.02462052 0.35920702 WANG_CISPLATIN_RESPONSE_AND_XPC_DN retinal vascular disease DOID_2462 2.003E-03 0.04748454 0.22001429 0.71129619 WANG_CISPLATIN_RESPONSE_AND_XPC_DN primary bacterial infectious disease DOID_0050338 2.137E-03 0.04863971 2.137E-03 0.09353791 WANG_CISPLATIN_RESPONSE_AND_XPC_DN primary immunodeficiency disease DOID_612 2.277E-03 0.04982557 2.277E-03 0.0925332 WANG_CISPLATIN_RESPONSE_AND_XPC_DN acute pancreatitis DOID_2913 2.311E-03 0.04870401 0.06885819 0.42587291 WANG_CISPLATIN_RESPONSE_AND_XPC_DN lymphoma DOID_0060058 2.497E-03 0.05073552 2.497E-03 0.09470631 WANG_CISPLATIN_RESPONSE_AND_XPC_DN osteosarcoma DOID_3347 2.499E-03 0.04903275 2.499E-03 0.08887186 WANG_CISPLATIN_RESPONSE_AND_XPC_DN combined T cell and B cell immunodeficiency DOID_628 2.499E-03 0.04739832 2.499E-03 0.0836441 WANG_CISPLATIN_RESPONSE_AND_XPC_DN encephalomyelitis DOID_640 2.573E-03 0.04722273 0.23765579 0.75125637 WANG_CISPLATIN_RESPONSE_AND_XPC_DN ulcerative colitis DOID_8577 2.975E-03 0.05289633 0.03321379 0.37797288 WANG_CISPLATIN_RESPONSE_AND_XPC_DN sarcoma DOID_1115 3.32E-03 0.05724699 3.32E-03 0.10495282 WANG_CISPLATIN_RESPONSE_AND_XPC_DN opportunistic mycosis DOID_2473 4.008E-03 0.06706818 4.008E-03 0.12001675 WANG_CISPLATIN_RESPONSE_AND_XPC_DN systemic mycosis DOID_0050136 4.755E-03 0.07730718 4.755E-03 0.1288453 WANG_CISPLATIN_RESPONSE_AND_XPC_DN fungal infectious disease DOID_1564 4.755E-03 0.07730718 4.755E-03 0.1288453 WANG_CISPLATIN_RESPONSE_AND_XPC_DN hyperthyroidism DOID_7998 5.018E-03 0.07930757 5.018E-03 0.12413359 WANG_CISPLATIN_RESPONSE_AND_XPC_DN medullomyoblastoma DOID_3861 5.287E-03 0.08130033 0.10278615 0.48737767 WANG_CISPLATIN_RESPONSE_AND_XPC_DN adult medulloblastoma DOID_3864 5.287E-03 0.08130033 0.10278615 0.48737767 WANG_CISPLATIN_RESPONSE_AND_XPC_DN childhood medulloblastoma DOID_3869 5.287E-03 0.08130033 0.10278615 0.48737767 WANG_CISPLATIN_RESPONSE_AND_XPC_DN thyroid cancer DOID_1781 5.562E-03 0.08328548 0.10534468 0.49538118 WANG_CISPLATIN_RESPONSE_AND_XPC_DN refractive error DOID_9835 5.562E-03 0.08114996 0.10534468 0.49132068 WANG_CISPLATIN_RESPONSE_AND_XPC_DN medulloblastoma DOID_3858 5.844E-03 0.08313147 0.10789598 0.49510332 WANG_CISPLATIN_RESPONSE_AND_XPC_DN multiple myeloma DOID_9538 5.844E-03 0.08110387 5.844E-03 0.13855244 WANG_CISPLATIN_RESPONSE_AND_XPC_DN blood platelet disease DOID_2218 6.132E-03 0.08307909 6.132E-03 0.13957286 WANG_CISPLATIN_RESPONSE_AND_XPC_DN peptic ulcer DOID_750 6.427E-03 0.08504687 0.11297697 0.51018965 WANG_CISPLATIN_RESPONSE_AND_XPC_DN endometriosis of uterus DOID_288 7.349E-03 0.09503787 7.349E-03 0.16083332 WANG_CISPLATIN_RESPONSE_AND_XPC_DN primitive neuroectodermal tumor DOID_168 7.669E-03 0.09697041 0.1230531 0.53043342 WANG_CISPLATIN_RESPONSE_AND_XPC_DN endometriosis DOID_289 7.669E-03 0.09486236 7.669E-03 0.16161735 WANG_CISPLATIN_RESPONSE_AND_XPC_DN uterine cancer DOID_363 7.995E-03 0.09679136 0.12555436 0.53313753 CROONQUIST_STROMAL_STIMULATION_UP bacterial pneumonia DOID_874 6.058E-12 3.447E-09 4.105E-03 0.1015468 CROONQUIST_STROMAL_STIMULATION_UP cystic fibrosis DOID_1485 4.763E-10 1.355E-07 3.907E-03 0.10585133 CROONQUIST_STROMAL_STIMULATION_UP aneurysm disease DOID_2403 5.15E-10 9.768E-08 2.438E-06 6.936E-04 CROONQUIST_STROMAL_STIMULATION_UP intracranial arterial disease DOID_13089 2.066E-07 2.939E-05 1.206E-03 0.06862722 CROONQUIST_STROMAL_STIMULATION_UP cerebral arterial disease DOID_3527 2.066E-07 2.939E-05 1.206E-03 0.06862722 CROONQUIST_STROMAL_STIMULATION_UP viral pneumonia DOID_10533 5.636E-07 6.414E-05 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP atrophic muscular disease DOID_913 6.079E-07 5.765E-05 6.079E-07 3.459E-04 CROONQUIST_STROMAL_STIMULATION_UP muscular dystrophy DOID_9884 6.079E-07 5.765E-05 6.079E-07 3.459E-04 CROONQUIST_STROMAL_STIMULATION_UP collagen disease DOID_854 1.044E-06 8.49E-05 6.189E-05 8.804E-03 CROONQUIST_STROMAL_STIMULATION_UP cholestasis DOID_13580 1.334E-06 9.488E-05 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP bile duct disease DOID_4138 1.875E-06 1.185E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP biliary tract disease DOID_9741 1.979E-06 1.126E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP pancreatitis DOID_4989 2.564E-06 1.326E-04 4.105E-03 0.10616256 CROONQUIST_STROMAL_STIMULATION_UP Goodpasture syndrome DOID_9808 3.108E-06 1.474E-04 0.02811068 0.30759572 CROONQUIST_STROMAL_STIMULATION_UP spastic quadriplegia DOID_10970 3.529E-06 1.545E-04 0.02926504 0.314185 CROONQUIST_STROMAL_STIMULATION_UP commensal bacterial infectious disease DOID_0050339 3.986E-06 1.62E-04 0.03041805 0.31468854 CROONQUIST_STROMAL_STIMULATION_UP intracranial aneurysm DOID_10941 5.014E-06 1.902E-04 5.106E-04 0.03228299 CROONQUIST_STROMAL_STIMULATION_UP middle cerebral artery infarction DOID_3525 5.014E-06 1.783E-04 0.03272006 0.31555448 CROONQUIST_STROMAL_STIMULATION_UP mouth disease DOID_403 5.312E-06 1.778E-04 5.852E-03 0.13320156 CROONQUIST_STROMAL_STIMULATION_UP hypersensitivity reaction type I disease DOID_1205 5.535E-06 1.75E-04 5.971E-03 0.13067663 CROONQUIST_STROMAL_STIMULATION_UP pleurisy DOID_10247 6.204E-06 1.858E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP focal glomerulosclerosis DOID_3945 6.863E-06 1.952E-04 0.03616306 0.31176941 CROONQUIST_STROMAL_STIMULATION_UP spastic cerebral palsy DOID_0050669 8.316E-06 2.253E-04 0.03845173 0.31255766 CROONQUIST_STROMAL_STIMULATION_UP pleural disease DOID_1532 9.959E-06 2.576E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP multiple myeloma DOID_9538 1.497E-05 3.704E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP respiratory syncytial virus infectious disease DOID_1273 1.737E-05 4.118E-04 0.04868518 0.33375741 CROONQUIST_STROMAL_STIMULATION_UP influenza DOID_8469 2.443E-05 5.56E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP cerebral infarction DOID_3526 2.604E-05 5.698E-04 0.05544823 0.32864626 CROONQUIST_STROMAL_STIMULATION_UP myeloma DOID_0070004 2.946E-05 6.208E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP heart valve disease DOID_4079 2.946E-05 5.986E-04 1.628E-03 0.08418989 CROONQUIST_STROMAL_STIMULATION_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.316E-05 6.506E-04 1.759E-03 0.08341116 CROONQUIST_STROMAL_STIMULATION_UP aortic aneurysm DOID_3627 3.512E-05 6.661E-04 1.827E-03 0.07995405 CROONQUIST_STROMAL_STIMULATION_UP bone marrow cancer DOID_4960 4.372E-05 8.025E-04 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP facioscapulohumeral muscular dystrophy DOID_11727 6.162E-05 1.096E-03 6.162E-05 0.01168751 CROONQUIST_STROMAL_STIMULATION_UP visceral leishmaniasis DOID_9146 6.162E-05 1.063E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP brain infarction DOID_3454 8.441E-05 1.413E-03 0.08094047 0.40047937 CROONQUIST_STROMAL_STIMULATION_UP aortic valve insufficiency DOID_57 9.024E-05 1.467E-03 0.0141533 0.27769758 CROONQUIST_STROMAL_STIMULATION_UP osteogenesis imperfecta DOID_12347 1.066E-04 1.684E-03 0.01532386 0.28126707 CROONQUIST_STROMAL_STIMULATION_UP newborn respiratory distress syndrome DOID_12716 1.066E-04 1.639E-03 0.01532386 0.27247747 CROONQUIST_STROMAL_STIMULATION_UP Legionnaires' disease DOID_10457 1.242E-04 1.86E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP legionellosis DOID_10458 1.242E-04 1.86E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP Ehlers-Danlos syndrome DOID_13359 1.432E-04 2.09E-03 1.432E-04 0.01630079 CROONQUIST_STROMAL_STIMULATION_UP membranoproliferative glomerulonephritis DOID_2920 1.432E-04 2.038E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP oral submucous fibrosis DOID_5773 1.432E-04 1.988E-03 1.432E-04 0.01358399 CROONQUIST_STROMAL_STIMULATION_UP spastic diplegia DOID_10965 1.636E-04 2.216E-03 0.0188274 0.28191555 CROONQUIST_STROMAL_STIMULATION_UP primary bacterial infectious disease DOID_0050338 1.652E-04 2.187E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP familial hypertrophic cardiomyopathy DOID_11986 1.853E-04 2.396E-03 1.853E-04 0.01505823 CROONQUIST_STROMAL_STIMULATION_UP congenital muscular dystrophy DOID_0050557 2.082E-04 2.633E-03 2.082E-04 0.01481175 CROONQUIST_STROMAL_STIMULATION_UP ureteral obstruction DOID_5199 2.082E-04 2.576E-03 0.02115632 0.28661771 CROONQUIST_STROMAL_STIMULATION_UP leishmaniasis DOID_9065 2.326E-04 2.816E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP autoimmune hepatitis DOID_2048 2.852E-04 3.381E-03 0.02463956 0.3260444 CROONQUIST_STROMAL_STIMULATION_UP mitochondrial myopathy DOID_699 2.852E-04 3.312E-03 0.02463956 0.31155353 CROONQUIST_STROMAL_STIMULATION_UP hepatitis B DOID_2043 3.135E-04 3.567E-03 0.02579794 0.31910935 CROONQUIST_STROMAL_STIMULATION_UP acquired immunodeficiency syndrome DOID_635 3.135E-04 3.497E-03 0.02579794 0.31231979 CROONQUIST_STROMAL_STIMULATION_UP urinary tract obstruction DOID_5200 3.431E-04 3.754E-03 0.02695498 0.31952888 CROONQUIST_STROMAL_STIMULATION_UP ureteral disease DOID_1426 3.74E-04 4.015E-03 0.02811068 0.31989955 CROONQUIST_STROMAL_STIMULATION_UP aortic valve disease DOID_62 3.74E-04 3.941E-03 0.02811068 0.31362701 CROONQUIST_STROMAL_STIMULATION_UP meningitis DOID_9471 3.74E-04 3.869E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP toxic shock syndrome DOID_14115 4.062E-04 4.127E-03 0.02926504 0.30836676 CROONQUIST_STROMAL_STIMULATION_UP acute pancreatitis DOID_2913 4.062E-04 4.055E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP periodontitis DOID_824 5.48E-04 5.376E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP abdominal aortic aneurysm DOID_7693 7.106E-04 6.853E-03 0.03845173 0.3038755 CROONQUIST_STROMAL_STIMULATION_UP celiac disease DOID_10608 7.544E-04 7.154E-03 0.03959408 0.30861684 CROONQUIST_STROMAL_STIMULATION_UP periodontal disease DOID_3388 8.936E-04 8.335E-03 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP hepatitis DOID_2237 1.151E-03 0.01056204 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP congenital diaphragmatic hernia DOID_3827 1.151E-03 0.01039439 0.04868518 0.32978411 CROONQUIST_STROMAL_STIMULATION_UP systemic scleroderma DOID_418 1.151E-03 0.01023197 0.04868518 0.32590429 CROONQUIST_STROMAL_STIMULATION_UP adult respiratory distress syndrome DOID_11394 1.206E-03 0.01055803 0.04981563 0.32959411 CROONQUIST_STROMAL_STIMULATION_UP pulmonary emphysema DOID_9675 1.263E-03 0.010885 0.05094477 0.32570308 CROONQUIST_STROMAL_STIMULATION_UP autoimmune disease of urogenital tract DOID_0060049 1.32E-03 0.0112128 0.0520726 0.32921454 CROONQUIST_STROMAL_STIMULATION_UP primary biliary cirrhosis DOID_12236 1.32E-03 0.0112128 0.0520726 0.32921454 CROONQUIST_STROMAL_STIMULATION_UP rheumatic disease DOID_1575 1.379E-03 0.01154138 0.05319912 0.32902497 CROONQUIST_STROMAL_STIMULATION_UP scleroderma DOID_419 1.379E-03 0.01154138 0.05319912 0.32902497 CROONQUIST_STROMAL_STIMULATION_UP pulmonary tuberculosis DOID_2957 1.759E-03 0.01450629 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP giant cell tumor DOID_200 2.037E-03 0.01655677 2.037E-03 0.08278383 CROONQUIST_STROMAL_STIMULATION_UP malignant giant cell tumor DOID_2705 2.037E-03 0.01655677 2.037E-03 0.08278383 CROONQUIST_STROMAL_STIMULATION_UP giant cell glioblastoma DOID_3074 2.037E-03 0.01655677 2.037E-03 0.08278383 CROONQUIST_STROMAL_STIMULATION_UP bile duct adenocarcinoma DOID_4896 2.109E-03 0.01690442 0.06550475 0.36541373 CROONQUIST_STROMAL_STIMULATION_UP cholangiocarcinoma DOID_4947 2.109E-03 0.01690442 0.06550475 0.36541373 CROONQUIST_STROMAL_STIMULATION_UP osteochondrodysplasia DOID_2256 2.183E-03 0.01725198 0.06661565 0.36800297 CROONQUIST_STROMAL_STIMULATION_UP parasitic protozoa infectious disease DOID_2789 2.183E-03 0.01701565 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP pustulosis of palm and sole DOID_4398 2.183E-03 0.01678571 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP mitochondrial metabolism disease DOID_700 2.258E-03 0.01713011 0.06772527 0.36700646 CROONQUIST_STROMAL_STIMULATION_UP glioblastoma DOID_3068 2.411E-03 0.01805322 2.411E-03 0.09146963 CROONQUIST_STROMAL_STIMULATION_UP bile duct cancer DOID_4606 2.411E-03 0.01781876 0.06994063 0.37192729 CROONQUIST_STROMAL_STIMULATION_UP bile duct carcinoma DOID_4897 2.411E-03 0.01781876 0.06994063 0.37192729 CROONQUIST_STROMAL_STIMULATION_UP oral cavity cancer DOID_8618 2.411E-03 0.01759031 2.411E-03 0.08575278 CROONQUIST_STROMAL_STIMULATION_UP melancholia DOID_2848 2.49E-03 0.01793306 0.07104638 0.37430919 CROONQUIST_STROMAL_STIMULATION_UP neurotic disorder DOID_4964 2.57E-03 0.01827575 0.07215085 0.37664067 CROONQUIST_STROMAL_STIMULATION_UP respiratory failure DOID_11162 2.732E-03 0.01919496 0.07435593 0.38115787 CROONQUIST_STROMAL_STIMULATION_UP parasitic infectious disease DOID_1398 2.986E-03 0.02071896 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP temporal lobe epilepsy DOID_3328 3.073E-03 0.0210645 3.073E-03 0.10284432 CROONQUIST_STROMAL_STIMULATION_UP hyperglycemia DOID_4195 3.073E-03 0.02081373 0.07875073 0.39654128 CROONQUIST_STROMAL_STIMULATION_UP tooth disease DOID_1091 3.161E-03 0.0211579 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP tuberculosis DOID_399 3.25E-03 0.02150183 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP astrocytoma DOID_3069 3.34E-03 0.02184551 3.34E-03 0.10558665 CROONQUIST_STROMAL_STIMULATION_UP pancreatic ductal carcinoma DOID_3587 3.432E-03 0.02218894 3.432E-03 0.10276983 CROONQUIST_STROMAL_STIMULATION_UP pancreatic carcinoma DOID_4905 3.713E-03 0.02373933 3.713E-03 0.10564003 CROONQUIST_STROMAL_STIMULATION_UP diabetic retinopathy DOID_8947 3.713E-03 0.02347556 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP endogenous depression DOID_1595 3.907E-03 0.02442723 0.08856457 0.43442446 CROONQUIST_STROMAL_STIMULATION_UP bone resorption disease DOID_0080011 4.005E-03 0.02477066 0.08964866 0.43598366 CROONQUIST_STROMAL_STIMULATION_UP osteoporosis DOID_11476 4.005E-03 0.02477066 0.08964866 0.43598366 CROONQUIST_STROMAL_STIMULATION_UP mental depression DOID_1596 4.62E-03 0.02826569 0.09612681 0.45580128 CROONQUIST_STROMAL_STIMULATION_UP focal epilepsy DOID_2234 4.62E-03 0.02796499 4.62E-03 0.10952954 CROONQUIST_STROMAL_STIMULATION_UP biliary tract cancer DOID_4607 4.62E-03 0.02767062 0.09612681 0.45203433 CROONQUIST_STROMAL_STIMULATION_UP bone development disease DOID_0080006 4.726E-03 0.02801328 0.09720211 0.45334426 CROONQUIST_STROMAL_STIMULATION_UP retinal vascular disease DOID_2462 4.834E-03 0.0283555 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP Human immunodeficiency virus infectious disease DOID_526 5.389E-03 0.03128691 0.10362769 0.46796949 CROONQUIST_STROMAL_STIMULATION_UP dilated cardiomyopathy DOID_12930 5.971E-03 0.03431911 0.10894816 0.48812209 CROONQUIST_STROMAL_STIMULATION_UP T cell deficiency DOID_11200 0.0118081 0.06718808 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP hyperparathyroidism DOID_13543 0.0118081 0.06652285 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP retinal vascular occlusion DOID_1729 0.0118081 0.06587066 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.0118081 0.06523114 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.0118081 0.06523114 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP Hodgkin's granuloma DOID_8651 0.0118081 0.06523114 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.0118081 0.06523114 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP pneumocystosis DOID_11339 0.01298138 0.07102314 0.01298138 0.2735706 CROONQUIST_STROMAL_STIMULATION_UP prediabetes syndrome DOID_11716 0.01298138 0.07034673 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP common cold DOID_10459 0.0141533 0.07597387 0.0141533 0.28761535 CROONQUIST_STROMAL_STIMULATION_UP Hodgkin's lymphoma DOID_8567 0.0141533 0.07526383 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP encephalitis DOID_9588 0.0141533 0.07456694 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP nicotine dependence DOID_0050742 0.01532386 0.07999339 0.01532386 0.29064264 CROONQUIST_STROMAL_STIMULATION_UP berylliosis DOID_10322 0.01532386 0.07926617 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP parathyroid gland disease DOID_11201 0.01532386 0.07855206 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP polyneuropathy DOID_1389 0.01532386 0.07785071 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP psoriatic arthritis DOID_9008 0.01532386 0.07716176 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP hypercalcemia DOID_12678 0.01649307 0.08232066 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP congenital structural myopathy DOID_422 0.01649307 0.08160483 0.01649307 0.28438046 CROONQUIST_STROMAL_STIMULATION_UP bacterial meningitis DOID_9470 0.01649307 0.08090134 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP thoracic aortic aneurysm DOID_14004 0.01766091 0.08588939 0.01766091 0.29556055 CROONQUIST_STROMAL_STIMULATION_UP corneal dystrophy DOID_2566 0.01766091 0.08516152 0.01766091 0.28711597 CROONQUIST_STROMAL_STIMULATION_UP lung oat cell carcinoma DOID_5411 0.01766091 0.08444587 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP varicose veins DOID_799 0.01766091 0.08374216 0.01766091 0.27914052 CROONQUIST_STROMAL_STIMULATION_UP hyperhomocysteinemia DOID_9279 0.01766091 0.08305007 0.01766091 0.27159618 CROONQUIST_STROMAL_STIMULATION_UP hemolytic-uremic syndrome DOID_12554 0.0188274 0.08780976 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP restrictive cardiomyopathy DOID_397 0.0188274 0.08709586 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP thyroiditis DOID_7166 0.0188274 0.08639347 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP autoimmune thyroiditis DOID_7188 0.0188274 0.08639347 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP tongue cancer DOID_8649 0.0188274 0.08570233 0.0188274 0.27468695 CROONQUIST_STROMAL_STIMULATION_UP vein disease DOID_866 0.0188274 0.08502215 0.0188274 0.26781977 CROONQUIST_STROMAL_STIMULATION_UP basal cell carcinoma DOID_2513 0.01999253 0.08957285 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP glucose intolerance DOID_10603 0.02115632 0.09404644 0.02115632 0.29360839 CROONQUIST_STROMAL_STIMULATION_UP skin carcinoma DOID_3451 0.02115632 0.0933174 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP dissociative disorder DOID_10935 0.02231875 0.09768744 1.000 1.000 CROONQUIST_STROMAL_STIMULATION_UP dissociative amnesia DOID_11037 0.02231875 0.09768744 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pancreatitis DOID_4989 4.579E-09 2.606E-06 1.105E-07 6.287E-05 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP mouth disease DOID_403 3.891E-07 1.107E-04 9.582E-05 4.956E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pleural disease DOID_1532 6.421E-07 1.218E-04 2.244E-05 3.192E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP endocrine organ benign neoplasm DOID_0060089 1.131E-06 1.609E-04 3.648E-04 8.649E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP brain infarction DOID_3454 1.131E-06 1.287E-04 2.245E-05 2.554E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP male reproductive system disease DOID_48 1.446E-06 1.371E-04 2.746E-05 2.604E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP thyroid adenoma DOID_2891 3.957E-06 3.217E-04 1.723E-03 0.02086448 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP movement disease DOID_480 5.299E-06 3.769E-04 5.299E-06 1.508E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP sarcoidosis DOID_11335 6.973E-06 4.409E-04 1.457E-04 5.922E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hypersensitivity reaction type IV disease DOID_2916 1.066E-05 6.063E-04 2.033E-04 6.803E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP oral cavity cancer DOID_8618 1.066E-05 5.512E-04 2.033E-04 6.426E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pleurisy DOID_10247 1.196E-05 5.673E-04 3.826E-04 8.373E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP carotid artery disease DOID_3407 1.35E-05 5.909E-04 2.448E-04 7.33E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP familial adenomatous polyposis DOID_0050424 1.661E-05 6.751E-04 1.186E-03 0.01823307 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP mineral metabolism disease DOID_0050032 1.691E-05 6.413E-04 1.691E-05 3.207E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hyperglycemia DOID_4195 1.952E-05 6.943E-04 4.315E-03 0.03410096 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP chronic leukemia DOID_1036 2.244E-05 7.511E-04 0.01190853 0.06392409 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP chronic lymphocytic leukemia DOID_1040 2.244E-05 7.511E-04 0.01190853 0.06392409 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP astrocytoma DOID_3069 2.403E-05 7.596E-04 4.861E-03 0.03639683 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP myocarditis DOID_820 2.515E-05 7.533E-04 6.59E-04 0.01249838 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP blood coagulation disease DOID_1247 2.57E-05 7.311E-04 4.057E-04 8.55E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP thyroid carcinoma DOID_3963 2.81E-05 7.614E-04 0.01324773 0.06730322 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP thyroid cancer DOID_1781 3.474E-05 8.984E-04 0.0146492 0.07185684 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hypercalcemia DOID_12678 3.626E-05 8.971E-04 3.626E-05 2.948E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pulmonary sarcoidosis DOID_13406 3.845E-05 9.117E-04 3.845E-05 2.735E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP varicose veins DOID_799 4.517E-05 1.028E-03 2.236E-03 0.02544038 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP intermediate coronary syndrome DOID_8805 4.517E-05 9.885E-04 2.236E-03 0.02494155 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP peptic ulcer DOID_750 4.675E-05 9.853E-04 1.038E-03 0.01687062 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP adenoid cystic carcinoma DOID_4866 5.136E-05 1.044E-03 5.136E-05 3.247E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP biliary tract cancer DOID_4607 5.362E-05 1.052E-03 7.7E-03 0.04922725 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP vein disease DOID_866 5.54E-05 1.051E-03 2.547E-03 0.02786986 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP salivary gland cancer DOID_8850 6.155E-05 1.13E-03 6.155E-05 3.502E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP diabetic autonomic neuropathy DOID_11503 7.314E-05 1.301E-03 1.441E-03 0.0195172 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP autonomic neuropathy DOID_11504 7.314E-05 1.301E-03 1.441E-03 0.0195172 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP diabetic polyneuropathy DOID_12785 7.314E-05 1.301E-03 1.441E-03 0.0195172 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP diabetic neuropathy DOID_9743 7.314E-05 1.301E-03 1.441E-03 0.0195172 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP Human immunodeficiency virus infectious disease DOID_526 7.827E-05 1.35E-03 9.558E-03 0.05384736 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP lymphoblastic leukemia DOID_1037 9.117E-05 1.526E-03 0.01042754 0.05816934 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP autonomic nervous system disease DOID_11465 9.34E-05 1.518E-03 1.723E-03 0.02131806 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP granulosa cell tumor DOID_2999 9.487E-05 1.499E-03 3.596E-03 0.03100059 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP lung small cell carcinoma DOID_5409 1.09E-04 1.676E-03 1.09E-04 5.168E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP sex cord-gonadal stromal tumor DOID_192 1.112E-04 1.665E-03 3.983E-03 0.03382605 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP ulcerative colitis DOID_8577 1.162E-04 1.696E-03 1.324E-03 0.01931863 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP calcium metabolism disease DOID_10575 1.175E-04 1.671E-03 1.175E-04 5.141E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP aortic aneurysm DOID_3627 1.175E-04 1.63E-03 0.22198481 0.42103119 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP atrophic muscular disease DOID_913 1.457E-04 1.974E-03 1.457E-04 5.527E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP muscular dystrophy DOID_9884 1.457E-04 1.974E-03 1.457E-04 5.527E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP thrombophilia DOID_2452 1.492E-04 1.974E-03 1.492E-04 5.306E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bile duct adenocarcinoma DOID_4896 1.561E-04 2.019E-03 0.02985905 0.13273279 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP cholangiocarcinoma DOID_4947 1.561E-04 2.019E-03 0.02985905 0.13273279 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP muscle cancer DOID_4045 1.71E-04 2.162E-03 5.255E-03 0.03883017 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hypertrophic cardiomyopathy DOID_11984 2.033E-04 2.514E-03 3.047E-03 0.02889379 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP glioblastoma DOID_3068 2.033E-04 2.461E-03 3.047E-03 0.02842012 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bile duct cancer DOID_4606 2.033E-04 2.41E-03 0.03382161 0.14690454 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bile duct carcinoma DOID_4897 2.033E-04 2.41E-03 0.03382161 0.14690454 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP respiratory failure DOID_11162 2.599E-04 3.018E-03 2.599E-04 7.393E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP autosomal dominant nonsyndromic deafness DOID_0050564 2.785E-04 3.169E-03 2.785E-04 7.546E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP middle cerebral artery infarction DOID_3525 3.109E-04 3.468E-03 3.109E-04 8.04E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP tooth disease DOID_1091 3.455E-04 3.781E-03 3.455E-04 8.548E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP tuberculosis DOID_399 3.648E-04 3.917E-03 3.648E-04 8.303E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hepatic vascular disease DOID_272 3.826E-04 4.031E-03 8.841E-03 0.05409453 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bile duct disease DOID_4138 4.273E-04 4.421E-03 4.273E-04 8.684E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP biliary tract disease DOID_9741 4.497E-04 4.57E-03 4.497E-04 8.824E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP abdominal aortic aneurysm DOID_7693 5.088E-04 5.079E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP cystic fibrosis DOID_1485 5.22E-04 5.121E-03 6.075E-03 0.04320664 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP aneurysm disease DOID_2403 5.479E-04 5.284E-03 0.31221201 0.56575998 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP metabolic syndrome X DOID_14221 6.308E-04 5.982E-03 6.975E-03 0.04724909 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP papilloma DOID_2615 6.59E-04 6.147E-03 0.1567219 0.33398787 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP chromosomal disease DOID_0080014 6.603E-04 6.06E-03 6.603E-04 0.01211995 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP esophageal disease DOID_6050 7.146E-04 6.454E-03 0.1607073 0.33618548 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP primary bacterial infectious disease DOID_0050338 8.583E-04 7.631E-03 8.583E-04 0.01526171 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP transitional cell carcinoma DOID_2671 8.949E-04 7.834E-03 0.06779123 0.20850385 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP Paget's disease of bone DOID_5408 9.731E-04 8.389E-03 9.731E-04 0.01677828 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hepatitis DOID_2237 1.038E-03 8.813E-03 1.038E-03 0.01736681 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP lymphoma DOID_0060058 1.053E-03 8.808E-03 0.3594499 0.64115044 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP encephalomyelitis DOID_640 1.095E-03 9.028E-03 0.07444854 0.20867597 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP intracranial arterial disease DOID_13089 1.112E-03 9.037E-03 1.112E-03 0.01757126 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP cerebral arterial disease DOID_3527 1.112E-03 9.037E-03 1.112E-03 0.01757126 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hypersensitivity reaction type I disease DOID_1205 1.183E-03 9.48E-03 0.0110318 0.05978187 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP dilated cardiomyopathy DOID_12930 1.183E-03 9.348E-03 0.07716795 0.21418811 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP trypanosomiasis DOID_10113 1.186E-03 9.241E-03 1.186E-03 0.01775325 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP endometriosis of uterus DOID_288 1.269E-03 9.761E-03 0.01921445 0.09035556 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP Huntington's disease DOID_12858 1.353E-03 0.01026741 0.02002632 0.09340144 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP endometriosis DOID_289 1.353E-03 0.01013232 0.02002632 0.09264208 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP osteopetrosis DOID_13533 1.418E-03 0.010481 1.418E-03 0.02017592 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP stomach disease DOID_76 1.418E-03 0.01034663 0.05521837 0.19041972 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP peritonitis DOID_8283 1.418E-03 0.01021566 1.418E-03 0.01968383 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP cerebral infarction DOID_3526 1.531E-03 0.01089193 1.531E-03 0.02026406 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP intracranial thrombosis DOID_4193 1.671E-03 0.01173843 1.671E-03 0.02160939 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pre-eclampsia DOID_10591 1.723E-03 0.01195891 1.723E-03 0.02179179 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP neuritis DOID_1803 1.723E-03 0.01181483 0.02341392 0.10743966 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP glaucoma DOID_1686 1.93E-03 0.01307266 0.21828882 0.41540582 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP aspergillosis DOID_13564 1.943E-03 0.01300992 1.943E-03 0.0230384 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP polycystic kidney disease DOID_898 1.943E-03 0.01285864 0.06412197 0.19829023 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP skeletal system cancer DOID_0060124 2.236E-03 0.01462091 0.06854243 0.20855959 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP thoracic aortic aneurysm DOID_14004 2.236E-03 0.01445476 0.06854243 0.20635261 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bone cancer DOID_184 2.236E-03 0.01462091 0.06854243 0.20855959 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP communication disorder DOID_2033 2.236E-03 0.01429235 2.236E-03 0.02595957 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP oral submucous fibrosis DOID_5773 2.236E-03 0.01413354 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP giant cell tumor DOID_200 2.387E-03 0.01492827 0.02889948 0.12947878 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP malignant giant cell tumor DOID_2705 2.387E-03 0.01492827 0.02889948 0.12947878 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP giant cell glioblastoma DOID_3074 2.387E-03 0.01492827 0.02889948 0.12947878 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP Barrett's esophagus DOID_9206 2.547E-03 0.01575253 0.07294213 0.2054657 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP reproductive organ benign neoplasm DOID_0050622 2.639E-03 0.01614804 0.03083118 0.1359918 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP parasitic protozoa infectious disease DOID_2789 2.639E-03 0.01597625 2.639E-03 0.02833524 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP familial hyperlipidemia DOID_1168 2.771E-03 0.01659764 2.771E-03 0.02919956 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP penile disease DOID_1529 2.878E-03 0.01705602 2.878E-03 0.02977051 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hyperostosis DOID_205 2.878E-03 0.01688019 2.878E-03 0.02923889 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bronchitis DOID_6132 2.878E-03 0.01670794 2.878E-03 0.02872593 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP congenital nervous system abnormality DOID_2490 2.907E-03 0.01670763 2.907E-03 0.0285182 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP nonsyndromic deafness DOID_0050563 3.047E-03 0.01733628 3.047E-03 0.02938352 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP leukocyte disease DOID_9500 3.191E-03 0.01797539 0.03484264 0.15019289 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP male reproductive organ benign neoplasm DOID_0060087 3.227E-03 0.01800342 0.08167962 0.22344088 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP neuroendocrine tumor DOID_169 3.227E-03 0.01782863 3.227E-03 0.02961852 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP osteosclerosis DOID_4254 3.227E-03 0.0176572 3.227E-03 0.02914839 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP neuroectodermal tumor DOID_171 3.491E-03 0.01891731 3.491E-03 0.03103621 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP Down syndrome DOID_14250 3.596E-03 0.01930226 3.596E-03 0.03147752 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP membranous glomerulonephritis DOID_10976 3.983E-03 0.0211808 0.09033522 0.23470657 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP esophagitis DOID_11963 3.983E-03 0.02098468 0.09033522 0.23258253 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP brain edema DOID_4724 3.983E-03 0.02079216 3.983E-03 0.03332861 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP colonic disease DOID_5353 3.983E-03 0.02060314 3.983E-03 0.03284558 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP cholestasis DOID_13580 4.142E-03 0.0212307 4.142E-03 0.03366583 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP parasitic infectious disease DOID_1398 4.142E-03 0.02104114 4.142E-03 0.03319166 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP uterine disease DOID_345 4.142E-03 0.02085494 0.04121376 0.17632053 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP allergic contact dermatitis DOID_3042 4.493E-03 0.02242459 4.493E-03 0.03501922 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP familial hypercholesterolemia DOID_13810 4.813E-03 0.02381209 4.813E-03 0.03700527 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP muscular atrophy DOID_767 4.813E-03 0.02360681 4.813E-03 0.03651186 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP myasthenia gravis DOID_437 5.255E-03 0.0255549 0.10316673 0.25859853 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP urinary tract obstruction DOID_5200 5.255E-03 0.02533833 0.10316673 0.25634003 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pulmonary embolism DOID_9477 5.255E-03 0.0251254 5.255E-03 0.03833234 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP lingual-facial-buccal dyskinesia DOID_9854 5.255E-03 0.02491602 5.255E-03 0.03784713 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pancreatic carcinoma DOID_4905 5.652E-03 0.0265793 0.30235673 0.54965168 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP aortic valve disease DOID_62 5.715E-03 0.02665296 0.10740377 0.26341701 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP syndrome DOID_225 6.075E-03 0.02810188 0.05270693 0.18861789 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bone resorption disease DOID_0080011 6.293E-03 0.02887635 6.293E-03 0.04420577 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP osteoporosis DOID_11476 6.293E-03 0.02887635 6.293E-03 0.04420577 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP mixed glioma DOID_5076 6.516E-03 0.02965949 0.05512779 0.19604822 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP portal hypertension DOID_10762 6.688E-03 0.03020118 0.11581823 0.27923973 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP urticaria DOID_1555 6.688E-03 0.02996337 6.688E-03 0.04640669 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP osteosarcoma DOID_3347 6.688E-03 0.02972928 6.688E-03 0.04584757 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP contact dermatitis DOID_2773 6.975E-03 0.03076685 6.975E-03 0.04669322 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP lipid metabolism disorder DOID_3146 6.975E-03 0.03053018 6.975E-03 0.04615028 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP papillary adenoma DOID_3172 7.201E-03 0.03127556 0.11999584 0.28568047 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP neuromuscular junction disease DOID_439 7.201E-03 0.03103862 0.11999584 0.28449013 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP microcystic adenoma DOID_5403 7.201E-03 0.03127556 0.11999584 0.28568047 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP follicular adenoma DOID_6204 7.201E-03 0.03127556 0.11999584 0.28568047 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP female reproductive system disease DOID_229 7.212E-03 0.03085465 0.05883099 0.2004481 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP auditory system disease DOID_2742 7.454E-03 0.03164999 7.454E-03 0.04874826 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP alcohol abuse DOID_1574 7.7E-03 0.03245352 7.7E-03 0.04978665 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP chronic kidney failure DOID_784 7.7E-03 0.03221489 0.33150915 0.59504323 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP teeth hard tissue disease DOID_214 7.73E-03 0.03210696 7.73E-03 0.04887393 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP seminoma DOID_4440 7.73E-03 0.0318743 0.12415381 0.29071407 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP fragments of torsion dystonia DOID_531 7.73E-03 0.03164499 7.73E-03 0.04833686 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP gestational diabetes DOID_11714 8.278E-03 0.03364227 8.278E-03 0.05119475 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP sarcoma DOID_1115 8.841E-03 0.03567937 0.13241125 0.30257831 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP coronary stenosis DOID_4248 8.841E-03 0.0354281 8.841E-03 0.05351905 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP autoimmune disease of the nervous system DOID_438 8.841E-03 0.03518036 0.13241125 0.29779446 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP central nervous system hereditary degenerative disease DOID_481 8.841E-03 0.03493605 8.841E-03 0.05295569 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP primary immunodeficiency disease DOID_612 9.278E-03 0.03640872 9.278E-03 0.05499234 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP polycystic ovary syndrome DOID_11612 9.422E-03 0.0367204 9.422E-03 0.05526988 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP multiple epiphyseal dysplasia DOID_12721 9.422E-03 0.0364706 9.422E-03 0.0547059 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP supratentorial cancer DOID_1659 9.422E-03 0.03622418 0.13651088 0.30341677 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP toxic encephalopathy DOID_3602 9.422E-03 0.03598106 9.422E-03 0.05415331 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP cerebrum cancer DOID_368 9.422E-03 0.03622418 0.13651088 0.30341677 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP dystonic disease DOID_544 9.422E-03 0.03574119 9.422E-03 0.05361178 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP nervous system cancer DOID_3093 9.558E-03 0.03601711 0.07042942 0.20239566 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP spastic cerebral palsy DOID_0050669 0.01063288 0.03980336 0.01063288 0.05873893 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP opportunistic mycosis DOID_2473 0.01063288 0.0395432 0.01063288 0.05817413 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP Crohn's disease DOID_8778 0.0107272 0.03963491 0.07580432 0.21143459 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP celiac disease DOID_10608 0.01126268 0.04134494 0.14869457 0.32541235 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP endometrial cancer DOID_1380 0.01126268 0.0410799 0.14869457 0.32416556 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP germinoma DOID_3304 0.01126268 0.04081825 0.14869457 0.32292829 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP allergic rhinitis DOID_4481 0.01126268 0.0405599 0.14869457 0.32170042 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hereditary spastic paraplegia DOID_2476 0.01190853 0.04261606 0.01190853 0.06332667 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bladder disease DOID_365 0.01190853 0.04234971 0.15271769 0.32667807 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP systemic mycosis DOID_0050136 0.01257027 0.04442536 0.01257027 0.0662267 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP fungal infectious disease DOID_1564 0.01257027 0.04442536 0.01257027 0.0662267 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP male infertility DOID_12336 0.01324773 0.04653062 0.01324773 0.06915561 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hepatitis C DOID_1883 0.01324773 0.04624516 0.01324773 0.06852692 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP nephroblastoma DOID_2154 0.01324773 0.04596318 0.1607073 0.33867574 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP periodontal disease DOID_3388 0.01324773 0.04568461 0.01324773 0.06790956 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP spindle cell carcinoma DOID_4015 0.01324773 0.0454094 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP paraplegia DOID_607 0.01324773 0.04513749 0.01324773 0.06670762 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hyperthyroidism DOID_7998 0.01324773 0.04486882 0.01324773 0.06612247 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP autosomal recessive nonsyndromic deafness DOID_0050565 0.0146492 0.04932186 0.0146492 0.07248168 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP adenoma DOID_657 0.0146492 0.04903173 0.16862198 0.34637511 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP calcinosis DOID_182 0.01537288 0.05115302 0.01537288 0.07476211 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP multiple myeloma DOID_9538 0.01537288 0.05085562 0.17255144 0.34940132 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP microcephaly DOID_10907 0.01611164 0.05299147 0.01611164 0.07769088 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP adult respiratory distress syndrome DOID_11394 0.01763381 0.05766457 0.01763381 0.08431627 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP cervix uteri carcinoma in situ DOID_8991 0.0184169 0.05988122 0.18808547 0.37419801 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pulmonary emphysema DOID_9675 0.0184169 0.05954099 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP autoimmune disease of urogenital tract DOID_0060049 0.01921445 0.06176849 0.01921445 0.09110852 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP primary biliary cirrhosis DOID_12236 0.01921445 0.06176849 0.01921445 0.09110852 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP nephrotic syndrome DOID_1184 0.02002632 0.06401671 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP rheumatic disease DOID_1575 0.02002632 0.06365908 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP scleroderma DOID_419 0.02002632 0.06365908 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP uterine cancer DOID_363 0.02085235 0.06591659 0.19954536 0.39424066 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP influenza DOID_8469 0.02085235 0.06555241 0.19954536 0.39287651 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP proteinuria DOID_576 0.0225463 0.07048814 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP myeloma DOID_0070004 0.02341392 0.07280064 0.21084439 0.41085774 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP brain cancer DOID_1319 0.02341392 0.07240499 0.21084439 0.40945549 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP heart valve disease DOID_4079 0.02341392 0.07201361 0.21084439 0.40806279 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP vascular skin disease DOID_9540 0.02341392 0.07162644 0.02341392 0.10658014 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP central nervous system cancer DOID_3620 0.0242951 0.07392467 0.21457538 0.41247767 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.02518971 0.07623907 0.21828882 0.4167998 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pulmonary tuberculosis DOID_2957 0.02518971 0.07583569 0.02518971 0.11375354 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP withdrawal disorder DOID_0060001 0.02701862 0.08091364 0.22566342 0.42658632 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP hemorrhagic disease DOID_2213 0.02701862 0.08049001 0.22566342 0.42517379 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP B-cell lymphocytic neoplasm DOID_707 0.02701862 0.08007079 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP bone marrow cancer DOID_4960 0.02985905 0.08803004 0.23659578 0.44283882 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP osteochondrodysplasia DOID_2256 0.03083118 0.09042753 0.03083118 0.13494571 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP pustulosis of palm and sole DOID_4398 0.03083118 0.0899638 0.24020569 0.44665698 RAGHAVACHARI_PLATELET_SPECIFIC_GENES hemorrhagic disease DOID_2213 3.072E-09 1.748E-06 3.072E-09 1.748E-06 RAGHAVACHARI_PLATELET_SPECIFIC_GENES blood coagulation disease DOID_1247 1.438E-08 4.09E-06 1.438E-08 4.09E-06 RAGHAVACHARI_PLATELET_SPECIFIC_GENES inherited blood coagulation disease DOID_2214 8.781E-07 1.666E-04 8.781E-07 1.666E-04 RAGHAVACHARI_PLATELET_SPECIFIC_GENES sphingolipidosis DOID_1927 2.463E-06 3.503E-04 2.463E-06 3.503E-04 RAGHAVACHARI_PLATELET_SPECIFIC_GENES hypersensitivity reaction type I disease DOID_1205 3.429E-06 3.902E-04 3.429E-06 3.902E-04 RAGHAVACHARI_PLATELET_SPECIFIC_GENES thrombocytopenia DOID_1588 4.331E-06 4.107E-04 4.331E-06 4.107E-04 RAGHAVACHARI_PLATELET_SPECIFIC_GENES blood platelet disease DOID_2218 1.128E-05 9.169E-04 1.128E-05 9.169E-04 RAGHAVACHARI_PLATELET_SPECIFIC_GENES intracranial thrombosis DOID_4193 8.404E-05 5.978E-03 8.404E-05 5.978E-03 RAGHAVACHARI_PLATELET_SPECIFIC_GENES chronic kidney failure DOID_784 1.012E-04 6.399E-03 3.666E-03 0.09070371 RAGHAVACHARI_PLATELET_SPECIFIC_GENES familial hypertrophic cardiomyopathy DOID_11986 1.461E-04 8.316E-03 1.461E-04 9.24E-03 RAGHAVACHARI_PLATELET_SPECIFIC_GENES dilated cardiomyopathy DOID_12930 1.498E-04 7.747E-03 1.498E-04 8.522E-03 RAGHAVACHARI_PLATELET_SPECIFIC_GENES colon carcinoma DOID_1520 2.038E-04 9.662E-03 2.038E-04 0.01054037 RAGHAVACHARI_PLATELET_SPECIFIC_GENES X-linked disease DOID_0050735 3.472E-04 0.01519481 3.472E-04 0.01646104 RAGHAVACHARI_PLATELET_SPECIFIC_GENES pulmonary sarcoidosis DOID_13406 8.254E-04 0.03354789 0.04136812 0.28359591 RAGHAVACHARI_PLATELET_SPECIFIC_GENES adult respiratory distress syndrome DOID_11394 9.537E-04 0.03617649 9.537E-04 0.0417421 RAGHAVACHARI_PLATELET_SPECIFIC_GENES neuritis DOID_1803 1.288E-03 0.04579515 0.05144656 0.31141586 RAGHAVACHARI_PLATELET_SPECIFIC_GENES integumentary system benign neoplasm DOID_0060121 1.392E-03 0.04659284 1.392E-03 0.05657702 RAGHAVACHARI_PLATELET_SPECIFIC_GENES glaucoma DOID_1686 1.392E-03 0.04400435 1.392E-03 0.05280522 RAGHAVACHARI_PLATELET_SPECIFIC_GENES skin benign neoplasm DOID_3165 1.392E-03 0.04659284 1.392E-03 0.05657702 RAGHAVACHARI_PLATELET_SPECIFIC_GENES sarcoidosis DOID_11335 1.612E-03 0.04828745 0.05744395 0.33015766 RAGHAVACHARI_PLATELET_SPECIFIC_GENES bile duct adenocarcinoma DOID_4896 1.67E-03 0.04750953 1.67E-03 0.05938691 RAGHAVACHARI_PLATELET_SPECIFIC_GENES cholangiocarcinoma DOID_4947 1.67E-03 0.04750953 1.67E-03 0.05938691 RAGHAVACHARI_PLATELET_SPECIFIC_GENES parasitic protozoa infectious disease DOID_2789 1.728E-03 0.04683193 0.05943485 0.31904181 RAGHAVACHARI_PLATELET_SPECIFIC_GENES hypertrophic cardiomyopathy DOID_11984 1.91E-03 0.04939115 1.91E-03 0.06391796 RAGHAVACHARI_PLATELET_SPECIFIC_GENES hypersensitivity reaction type IV disease DOID_2916 1.91E-03 0.04724371 0.06241352 0.33189995 RAGHAVACHARI_PLATELET_SPECIFIC_GENES bile duct cancer DOID_4606 1.91E-03 0.04527522 1.91E-03 0.06036696 RAGHAVACHARI_PLATELET_SPECIFIC_GENES bile duct carcinoma DOID_4897 1.91E-03 0.04527522 1.91E-03 0.06036696 RAGHAVACHARI_PLATELET_SPECIFIC_GENES carotid artery disease DOID_3407 2.1E-03 0.04778633 2.1E-03 0.06287675 RAGHAVACHARI_PLATELET_SPECIFIC_GENES respiratory failure DOID_11162 2.165E-03 0.04737552 2.165E-03 0.06158817 RAGHAVACHARI_PLATELET_SPECIFIC_GENES parasitic infectious disease DOID_1398 2.366E-03 0.04986394 0.06932803 0.35221115 RAGHAVACHARI_PLATELET_SPECIFIC_GENES hyperglycemia DOID_4195 2.435E-03 0.04948545 0.07031175 0.35094197 RAGHAVACHARI_PLATELET_SPECIFIC_GENES allergic contact dermatitis DOID_3042 2.505E-03 0.04915159 0.07129445 0.35275256 RAGHAVACHARI_PLATELET_SPECIFIC_GENES diabetic retinopathy DOID_8947 2.945E-03 0.05584805 0.07716945 0.36288775 RAGHAVACHARI_PLATELET_SPECIFIC_GENES bone resorption disease DOID_0080011 3.177E-03 0.05831062 3.177E-03 0.08607759 RAGHAVACHARI_PLATELET_SPECIFIC_GENES osteoporosis DOID_11476 3.177E-03 0.05831062 3.177E-03 0.08607759 RAGHAVACHARI_PLATELET_SPECIFIC_GENES contact dermatitis DOID_2773 3.417E-03 0.06076731 0.08300821 0.37485452 RAGHAVACHARI_PLATELET_SPECIFIC_GENES biliary tract cancer DOID_4607 3.666E-03 0.06321774 3.666E-03 0.09482661 RAGHAVACHARI_PLATELET_SPECIFIC_GENES retinal vascular disease DOID_2462 3.837E-03 0.06421197 0.08784631 0.38156145 RAGHAVACHARI_PLATELET_SPECIFIC_GENES encephalomyelitis DOID_640 4.555E-03 0.07405448 0.09553555 0.39970389 RAGHAVACHARI_PLATELET_SPECIFIC_GENES alcohol-related neurodevelopmental disorder DOID_0050667 4.649E-03 0.07348042 4.649E-03 0.11022064 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN embryonal cancer DOID_688 2.503E-09 1.424E-06 1.461E-04 0.02771932 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN germinoma DOID_3304 4.443E-07 1.264E-04 0.01514051 0.45341839 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN vulva cancer DOID_1245 1.472E-05 2.792E-03 5.815E-03 0.66171309 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN granulosa cell tumor DOID_2999 3.222E-05 4.583E-03 8.488E-03 0.4829481 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN sex cord-gonadal stromal tumor DOID_192 3.579E-05 4.073E-03 8.932E-03 0.46205386 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN spastic quadriplegia DOID_10970 5.643E-05 5.352E-03 5.643E-05 0.03211061 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN seminoma DOID_4440 7.105E-05 5.775E-03 0.01248443 0.47357599 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN invasive ductal carcinoma DOID_3008 8.172E-05 5.812E-03 0.01337054 0.44751973 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN spastic cerebral palsy DOID_0050669 9.911E-05 6.266E-03 9.911E-05 0.02819778 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN benign mesothelioma DOID_2645 1.771E-04 0.01007494 0.01955237 0.48370871 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN cervix uteri carcinoma in situ DOID_8991 1.771E-04 9.159E-03 1.000 1.000 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN pre-malignant neoplasm DOID_0060071 3.992E-04 0.01892685 1.000 1.000 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN in situ carcinoma DOID_8719 3.992E-04 0.01892685 1.000 1.000 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN mixed glioma DOID_5076 5.859E-04 0.02564327 0.03528155 0.66917346 TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN nervous system cancer DOID_3093 7.736E-04 0.03144325 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP pre-eclampsia DOID_10591 1.371E-09 7.804E-07 1.625E-05 4.623E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP chromosomal disease DOID_0080014 1.335E-06 3.798E-04 1.335E-06 7.595E-04 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP transitional cell carcinoma DOID_2671 1.847E-06 3.503E-04 9.481E-05 0.01078993 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP reproductive organ benign neoplasm DOID_0050622 2.544E-05 3.619E-03 2.544E-05 4.826E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP mixed glioma DOID_5076 6.676E-05 7.597E-03 6.676E-05 9.496E-03 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP biliary tract cancer DOID_4607 7.998E-05 7.585E-03 3.144E-03 0.13761984 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP urinary system benign neoplasm DOID_731 1.249E-04 0.01015147 0.01646603 0.29278653 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP female reproductive organ benign neoplasm DOID_0060086 4.513E-04 0.03209771 4.513E-04 0.04279694 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP uterine benign neoplasm DOID_0060095 4.513E-04 0.03209771 4.513E-04 0.04279694 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP uterine fibroid DOID_13223 4.513E-04 0.03209771 4.513E-04 0.04279694 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP leiomyoma DOID_127 5.404E-04 0.034163 5.404E-04 0.04392386 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP nephroblastoma DOID_2154 6.041E-04 0.03437336 0.03550024 0.31561934 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP calcinosis DOID_182 7.062E-04 0.03652996 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP systemic scleroderma DOID_418 7.786E-04 0.03691778 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP pulmonary emphysema DOID_9675 8.544E-04 0.03739624 0.04207716 0.32797128 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP rheumatic disease DOID_1575 9.336E-04 0.03794538 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP scleroderma DOID_419 9.336E-04 0.03794538 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP gallbladder cancer DOID_3121 9.745E-04 0.03696701 9.745E-04 0.06931315 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP thyroid adenoma DOID_2891 1.102E-03 0.03920089 1.102E-03 0.06969048 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP glaucoma DOID_1686 1.192E-03 0.0398879 1.192E-03 0.06780943 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP calcium metabolism disease DOID_10575 1.238E-03 0.03912521 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP bile duct adenocarcinoma DOID_4896 1.43E-03 0.04282456 0.05417586 0.37592761 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP cholangiocarcinoma DOID_4947 1.43E-03 0.04282456 0.05417586 0.37592761 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP osteochondrodysplasia DOID_2256 1.48E-03 0.04211045 0.05510034 0.36884819 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP bile duct cancer DOID_4606 1.636E-03 0.04431791 0.05786853 0.37417266 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP bile duct carcinoma DOID_4897 1.636E-03 0.04431791 0.05786853 0.37417266 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP collagen disease DOID_854 1.799E-03 0.04651746 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP pre-malignant neoplasm DOID_0060071 1.911E-03 0.04728405 1.911E-03 0.09886666 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP in situ carcinoma DOID_8719 1.911E-03 0.04728405 1.911E-03 0.09886666 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP mineral metabolism disease DOID_0050032 1.969E-03 0.04667952 1.000 1.000 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP temporal lobe epilepsy DOID_3328 2.087E-03 0.04749021 0.06521184 0.40775315 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP tooth disease DOID_1091 2.147E-03 0.04697789 0.06612583 0.40897388 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP endocrine organ benign neoplasm DOID_0060089 2.207E-03 0.04652067 2.207E-03 0.10467152 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP diabetic retinopathy DOID_8947 2.524E-03 0.05129071 0.07159153 0.41995444 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP focal epilepsy DOID_2234 3.144E-03 0.06169165 0.07973177 0.44918193 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP bone development disease DOID_0080006 3.217E-03 0.06101775 0.08063194 0.44979974 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP retinal vascular disease DOID_2462 3.291E-03 0.06040182 0.08153125 0.45040081 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP lymphoma DOID_0060058 3.829E-03 0.06807577 3.829E-03 0.15560177 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP lymphoblastic leukemia DOID_1037 3.908E-03 0.06739122 3.908E-03 0.14826068 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP carbohydrate metabolic disorder DOID_2978 3.908E-03 0.06540912 3.908E-03 0.13899439 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP mouth disease DOID_403 3.989E-03 0.06485249 0.08958667 0.47640016 DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP dilated cardiomyopathy DOID_12930 4.071E-03 0.06433901 1.000 1.000 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR cerebral infarction DOID_3526 1.534E-06 8.726E-04 2.371E-04 0.04496582 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR brain infarction DOID_3454 5.033E-06 1.432E-03 5.189E-04 0.0492109 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR chronic kidney failure DOID_784 8.662E-06 1.643E-03 7.426E-04 0.04694646 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR peritonitis DOID_8283 1.401E-05 1.993E-03 5.684E-03 0.23099458 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR prion disease DOID_649 3.243E-05 3.69E-03 8.514E-03 0.26913162 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR hepatitis B DOID_2043 4.891E-05 4.638E-03 0.01039647 0.29577964 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR sinusitis DOID_0050127 5.355E-05 4.353E-03 0.01086661 0.29443325 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR paranasal sinus disease DOID_1352 5.355E-05 4.353E-03 0.01086661 0.29443325 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR meningitis DOID_9471 5.84E-05 4.154E-03 0.01133653 0.28045582 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR osteosarcoma DOID_3347 6.873E-05 4.345E-03 6.873E-05 0.03910798 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR middle cerebral artery infarction DOID_3525 7.989E-05 4.546E-03 0.01321411 0.27847507 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR perinatal necrotizing enterocolitis DOID_8677 8.579E-05 4.438E-03 8.579E-05 0.02440684 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR intracranial arterial disease DOID_13089 1.901E-04 9.012E-03 0.02022508 0.31966866 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR cerebral arterial disease DOID_3527 1.901E-04 9.012E-03 0.02022508 0.31966866 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR pulmonary tuberculosis DOID_2957 2.784E-04 0.01218446 2.784E-04 0.0395995 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR allergic contact dermatitis DOID_3042 5.044E-04 0.02050205 5.044E-04 0.05740574 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR tuberculosis DOID_399 5.189E-04 0.01968436 5.189E-04 0.04218077 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR contact dermatitis DOID_2773 6.914E-04 0.02458624 6.914E-04 0.04917249 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR primary bacterial infectious disease DOID_0050338 8.136E-04 0.02723219 8.136E-04 0.04629473 XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR transitional cell carcinoma DOID_2671 8.319E-04 0.02629643 0.04188941 0.46735441 CHANG_CORE_SERUM_RESPONSE_DN breast benign neoplasm DOID_0060082 2.105E-06 1.198E-03 3.023E-04 0.02866737 CHANG_CORE_SERUM_RESPONSE_DN thoracic benign neoplasm DOID_0060097 2.105E-06 1.198E-03 3.023E-04 0.02866737 CHANG_CORE_SERUM_RESPONSE_DN benign breast phyllodes tumor DOID_1631 2.105E-06 1.198E-03 3.023E-04 0.02866737 CHANG_CORE_SERUM_RESPONSE_DN amyloidosis DOID_9120 1.432E-05 4.075E-03 1.432E-05 8.15E-03 CHANG_CORE_SERUM_RESPONSE_DN transitional cell carcinoma DOID_2671 6.492E-05 0.01231304 1.309E-03 0.05730098 CHANG_CORE_SERUM_RESPONSE_DN age related macular degeneration DOID_10871 6.704E-05 9.536E-03 6.704E-05 0.01907198 CHANG_CORE_SERUM_RESPONSE_DN degeneration of macula and posterior pole DOID_2007 6.704E-05 9.536E-03 6.704E-05 0.01907198 CHANG_CORE_SERUM_RESPONSE_DN spindle cell carcinoma DOID_4015 9.481E-05 0.01078993 0.08422407 0.39936246 CHANG_CORE_SERUM_RESPONSE_DN macular degeneration DOID_4448 9.481E-05 8.992E-03 9.481E-05 0.01798321 CHANG_CORE_SERUM_RESPONSE_DN benign mesothelioma DOID_2645 1.597E-04 0.01297985 0.0993502 0.4348482 CHANG_CORE_SERUM_RESPONSE_DN facioscapulohumeral muscular dystrophy DOID_11727 2.477E-04 0.01761857 2.477E-04 0.03523714 CHANG_CORE_SERUM_RESPONSE_DN angioedema DOID_1558 2.477E-04 0.01566095 2.477E-04 0.02818971 CHANG_CORE_SERUM_RESPONSE_DN B-cell lymphocytic neoplasm DOID_707 2.94E-04 0.01672711 7.361E-03 0.14442674 CHANG_CORE_SERUM_RESPONSE_DN migraine without aura DOID_12783 3.023E-04 0.01563675 3.023E-04 0.02457203 CHANG_CORE_SERUM_RESPONSE_DN temporal arteritis DOID_13375 3.023E-04 0.01433368 3.023E-04 0.02150053 CHANG_CORE_SERUM_RESPONSE_DN central nervous system vasculitis DOID_525 3.023E-04 0.01433368 3.023E-04 0.02150053 CHANG_CORE_SERUM_RESPONSE_DN atrophic muscular disease DOID_913 3.274E-04 0.01433046 3.274E-04 0.02069955 CHANG_CORE_SERUM_RESPONSE_DN muscular dystrophy DOID_9884 3.274E-04 0.01433046 3.274E-04 0.02069955 CHANG_CORE_SERUM_RESPONSE_DN vasculitis DOID_865 3.45E-04 0.01402207 3.45E-04 0.0196309 CHANG_CORE_SERUM_RESPONSE_DN glioblastoma DOID_3068 4.215E-04 0.01598746 9.313E-03 0.17093565 CHANG_CORE_SERUM_RESPONSE_DN endocrine pancreas disease DOID_1428 5.553E-04 0.01974634 0.01114879 0.1922322 CHANG_CORE_SERUM_RESPONSE_DN hemolytic-uremic syndrome DOID_12554 6.545E-04 0.02190545 6.545E-04 0.03385387 CHANG_CORE_SERUM_RESPONSE_DN endocrine organ benign neoplasm DOID_0060089 6.58E-04 0.02079857 0.01245393 0.20842026 CHANG_CORE_SERUM_RESPONSE_DN astrocytoma DOID_3069 6.854E-04 0.02052544 0.01279018 0.20793176 CHANG_CORE_SERUM_RESPONSE_DN methylmalonic acidemia DOID_14749 7.406E-04 0.02106967 0.03960844 0.32196001 CHANG_CORE_SERUM_RESPONSE_DN aneurysm disease DOID_2403 8.98E-04 0.0243304 0.01525316 0.22839605 CHANG_CORE_SERUM_RESPONSE_DN pancreatitis DOID_4989 9.313E-04 0.02408809 9.313E-04 0.0441615 CHANG_CORE_SERUM_RESPONSE_DN mixed glioma DOID_5076 9.313E-04 0.02304078 0.01562039 0.22789747 CHANG_CORE_SERUM_RESPONSE_DN mitochondrial myopathy DOID_699 1.137E-03 0.02694475 0.04870024 0.32221437 CHANG_CORE_SERUM_RESPONSE_DN amino acid metabolic disorder DOID_9252 1.351E-03 0.03075971 0.0199053 0.26339803 CHANG_CORE_SERUM_RESPONSE_DN lymphoma DOID_0060058 1.484E-03 0.03246746 0.02114998 0.26742977 CHANG_CORE_SERUM_RESPONSE_DN lymphoblastic leukemia DOID_1037 1.529E-03 0.03222939 1.529E-03 0.06215668 CHANG_CORE_SERUM_RESPONSE_DN sphingolipidosis DOID_1927 1.614E-03 0.03279053 1.614E-03 0.06120899 CHANG_CORE_SERUM_RESPONSE_DN dilated cardiomyopathy DOID_12930 1.624E-03 0.03185422 0.20613566 0.67798377 CHANG_CORE_SERUM_RESPONSE_DN organic acidemia DOID_0060159 1.745E-03 0.03310377 0.05994538 0.34805023 CHANG_CORE_SERUM_RESPONSE_DN urticaria DOID_1555 1.745E-03 0.0320359 1.745E-03 0.06206956 CHANG_CORE_SERUM_RESPONSE_DN intracranial aneurysm DOID_10941 2.024E-03 0.03598468 2.024E-03 0.06773587 CHANG_CORE_SERUM_RESPONSE_DN diffuse large B-cell lymphoma DOID_0050745 2.17E-03 0.03742126 0.06662927 0.36453896 CHANG_CORE_SERUM_RESPONSE_DN lung adenocarcinoma DOID_3910 2.17E-03 0.03632063 1.000 1.000 CHANG_CORE_SERUM_RESPONSE_DN migraine DOID_6364 2.17E-03 0.0352829 2.17E-03 0.06860564 CHANG_CORE_SERUM_RESPONSE_DN autoimmune disease of the nervous system DOID_438 2.322E-03 0.03669641 2.322E-03 0.06953004 CHANG_CORE_SERUM_RESPONSE_DN autoimmune disease of endocrine system DOID_0060005 2.478E-03 0.03810823 2.478E-03 0.07050022 CHANG_CORE_SERUM_RESPONSE_DN endometrial cancer DOID_1380 2.976E-03 0.04455942 0.07766479 0.39456487 CHANG_CORE_SERUM_RESPONSE_DN papilloma DOID_2615 3.332E-03 0.04860698 0.08204278 0.40243401 CHANG_CORE_SERUM_RESPONSE_DN hyperthyroidism DOID_7998 3.517E-03 0.05002284 0.08422407 0.39606195 CHANG_CORE_SERUM_RESPONSE_DN intracranial arterial disease DOID_13089 4.724E-03 0.06556149 4.724E-03 0.12800101 CHANG_CORE_SERUM_RESPONSE_DN cerebral arterial disease DOID_3527 4.724E-03 0.06556149 4.724E-03 0.12800101 CHANG_CORE_SERUM_RESPONSE_DN hyperinsulinism DOID_2018 5.39E-03 0.07301852 5.39E-03 0.13939899 CHANG_CORE_SERUM_RESPONSE_DN uterine cancer DOID_363 5.621E-03 0.07437582 0.10575695 0.44907243 CHANG_CORE_SERUM_RESPONSE_DN cataract DOID_83 5.856E-03 0.07572925 5.856E-03 0.14487335 CHANG_CORE_SERUM_RESPONSE_DN learning disability DOID_8927 5.856E-03 0.07404638 5.856E-03 0.13883696 CHANG_CORE_SERUM_RESPONSE_DN pre-eclampsia DOID_10591 6.34E-03 0.07842441 6.34E-03 0.14430092 CHANG_CORE_SERUM_RESPONSE_DN lens disease DOID_110 6.34E-03 0.07675581 6.34E-03 0.13875088 CHANG_CORE_SERUM_RESPONSE_DN vascular skin disease DOID_9540 6.34E-03 0.07515673 6.34E-03 0.13361196 CHANG_CORE_SERUM_RESPONSE_DN hemolytic anemia DOID_583 6.589E-03 0.07651035 6.589E-03 0.13389311 CHANG_CORE_SERUM_RESPONSE_DN normocytic anemia DOID_720 6.589E-03 0.07651035 6.589E-03 0.13389311 CHANG_CORE_SERUM_RESPONSE_DN lung small cell carcinoma DOID_5409 6.842E-03 0.07785971 0.11633486 0.48672453 CHANG_CORE_SERUM_RESPONSE_DN sarcoidosis DOID_11335 7.897E-03 0.0881097 0.12470802 0.51794791 CHANG_CORE_SERUM_RESPONSE_DN giant cell tumor DOID_200 7.897E-03 0.08641528 0.12470802 0.51419466 CHANG_CORE_SERUM_RESPONSE_DN malignant giant cell tumor DOID_2705 7.897E-03 0.08641528 0.12470802 0.51419466 CHANG_CORE_SERUM_RESPONSE_DN giant cell glioblastoma DOID_3074 7.897E-03 0.08641528 0.12470802 0.51419466 CHANG_CORE_SERUM_RESPONSE_DN familial hyperlipidemia DOID_1168 8.734E-03 0.09376678 8.734E-03 0.16565464 CHANG_CORE_SERUM_RESPONSE_DN mitochondrial metabolism disease DOID_700 8.734E-03 0.09203036 0.13093635 0.52838855 CHANG_CORE_SERUM_RESPONSE_DN hypersensitivity reaction type IV disease DOID_2916 9.313E-03 0.09634555 0.13506421 0.53742332 CHANG_CORE_SERUM_RESPONSE_DN oral cavity cancer DOID_8618 9.313E-03 0.09462509 0.13506421 0.53369121 AMIT_SERUM_RESPONSE_40_MCF10A influenza DOID_8469 2.572E-08 1.464E-05 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A cholestasis DOID_13580 1.164E-07 3.311E-05 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A bile duct disease DOID_4138 1.64E-07 3.11E-05 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A biliary tract disease DOID_9741 1.731E-07 2.463E-05 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A pancreatitis DOID_4989 2.248E-07 2.558E-05 0.05145649 0.47223779 AMIT_SERUM_RESPONSE_40_MCF10A primary bacterial infectious disease DOID_0050338 3.456E-07 3.278E-05 0.05708366 0.46400861 AMIT_SERUM_RESPONSE_40_MCF10A osteosarcoma DOID_3347 6.52E-07 5.3E-05 1.344E-04 0.07645618 AMIT_SERUM_RESPONSE_40_MCF10A middle cerebral artery infarction DOID_3525 8.208E-07 5.838E-05 1.562E-04 0.04442628 AMIT_SERUM_RESPONSE_40_MCF10A intracranial arterial disease DOID_13089 3.072E-06 1.942E-04 3.708E-04 0.052744 AMIT_SERUM_RESPONSE_40_MCF10A cerebral arterial disease DOID_3527 3.072E-06 1.942E-04 3.708E-04 0.052744 AMIT_SERUM_RESPONSE_40_MCF10A cerebral infarction DOID_3526 4.296E-06 2.444E-04 4.622E-04 0.05260259 AMIT_SERUM_RESPONSE_40_MCF10A pulmonary tuberculosis DOID_2957 5.48E-06 2.834E-04 0.03374282 0.50525438 AMIT_SERUM_RESPONSE_40_MCF10A brain infarction DOID_3454 1.405E-05 6.664E-04 1.009E-03 0.09567738 AMIT_SERUM_RESPONSE_40_MCF10A tuberculosis DOID_399 1.405E-05 6.152E-04 0.04579709 0.45716744 AMIT_SERUM_RESPONSE_40_MCF10A diabetic retinopathy DOID_8947 1.725E-05 7.011E-04 0.04894519 0.46416356 AMIT_SERUM_RESPONSE_40_MCF10A cystic fibrosis DOID_1485 1.865E-05 7.075E-04 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A bacterial pneumonia DOID_874 2.012E-05 7.157E-04 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A retinal vascular disease DOID_2462 2.588E-05 8.663E-04 0.05583595 0.46044432 AMIT_SERUM_RESPONSE_40_MCF10A Legionnaires' disease DOID_10457 3.781E-05 1.195E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A legionellosis DOID_10458 3.781E-05 1.195E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A viral pneumonia DOID_10533 3.781E-05 1.132E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A sphingolipidosis DOID_1927 1.241E-04 3.53E-03 0.01636132 0.44331381 AMIT_SERUM_RESPONSE_40_MCF10A acute pancreatitis DOID_2913 1.241E-04 3.362E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A commensal bacterial infectious disease DOID_0050339 1.344E-04 3.475E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A portal hypertension DOID_10762 1.344E-04 3.324E-03 0.0170104 0.4399507 AMIT_SERUM_RESPONSE_40_MCF10A lung adenocarcinoma DOID_3910 1.677E-04 3.975E-03 0.01895516 0.41482647 AMIT_SERUM_RESPONSE_40_MCF10A periodontitis DOID_824 1.677E-04 3.816E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A pleurisy DOID_10247 1.796E-04 3.93E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A sarcoma DOID_1115 1.796E-04 3.784E-03 1.796E-04 0.03405611 AMIT_SERUM_RESPONSE_40_MCF10A hepatic vascular disease DOID_272 1.796E-04 3.649E-03 0.0196026 0.41310661 AMIT_SERUM_RESPONSE_40_MCF10A allergic rhinitis DOID_4481 2.312E-04 4.536E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A pleural disease DOID_1532 2.451E-04 4.649E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A pneumoconiosis DOID_10316 2.741E-04 5.032E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A periodontal disease DOID_3388 2.741E-04 4.874E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A hepatitis DOID_2237 3.537E-04 6.098E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A pulmonary emphysema DOID_9675 3.883E-04 6.498E-03 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A bone marrow cancer DOID_4960 6.516E-04 0.01059386 0.0369291 0.47756035 AMIT_SERUM_RESPONSE_40_MCF10A temporal lobe epilepsy DOID_3328 9.532E-04 0.01506643 0.04453505 0.46926747 AMIT_SERUM_RESPONSE_40_MCF10A hyperglycemia DOID_4195 9.532E-04 0.01465923 0.04453505 0.46073534 AMIT_SERUM_RESPONSE_40_MCF10A tooth disease DOID_1091 9.809E-04 0.01468733 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A male reproductive system disease DOID_48 1.095E-03 0.01597968 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A focal epilepsy DOID_2234 1.441E-03 0.02050163 0.05458666 0.46357928 AMIT_SERUM_RESPONSE_40_MCF10A mouth disease DOID_403 1.833E-03 0.02543512 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A leber hereditary optic neuropathy DOID_705 5.92E-03 0.08020116 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A facioscapulohumeral muscular dystrophy DOID_11727 6.576E-03 0.08701249 6.576E-03 0.53450527 AMIT_SERUM_RESPONSE_40_MCF10A childhood type dermatomyositis DOID_14203 6.576E-03 0.08503493 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A ventricular septal defect DOID_1657 6.576E-03 0.08314526 6.576E-03 0.46769211 AMIT_SERUM_RESPONSE_40_MCF10A chondrosarcoma DOID_3371 6.576E-03 0.08133776 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A insulinoma DOID_3892 6.576E-03 0.07960717 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A dermatomyositis DOID_10223 7.231E-03 0.08571643 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A common cold DOID_10459 7.886E-03 0.09157152 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A otitis media DOID_10754 7.886E-03 0.08974009 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A aortic valve stenosis DOID_1712 7.886E-03 0.08798048 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A islet cell tumor DOID_1799 7.886E-03 0.08628855 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A middle ear disease DOID_5100 7.886E-03 0.08974009 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A mitochondrial encephalomyopathy DOID_890 7.886E-03 0.08466047 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A bacterial meningitis DOID_9470 9.194E-03 0.09688016 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A corneal dystrophy DOID_2566 9.848E-03 0.09830591 9.848E-03 0.5603437 AMIT_SERUM_RESPONSE_40_MCF10A mesenchymal cell neoplasm DOID_3350 9.848E-03 0.09661098 9.848E-03 0.50940336 AMIT_SERUM_RESPONSE_40_MCF10A spindle cell sarcoma DOID_4235 9.848E-03 0.09661098 9.848E-03 0.50940336 AMIT_SERUM_RESPONSE_40_MCF10A epithelioid sarcoma DOID_6193 9.848E-03 0.09661098 9.848E-03 0.50940336 AMIT_SERUM_RESPONSE_40_MCF10A varicose veins DOID_799 9.848E-03 0.09497351 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A angiosarcoma DOID_0001816 0.01050107 0.09958516 0.01050107 0.49792582 AMIT_SERUM_RESPONSE_40_MCF10A silicosis DOID_10325 0.01050107 0.09795262 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A tongue cancer DOID_8649 0.01050107 0.09637274 0.01050107 0.45962383 AMIT_SERUM_RESPONSE_40_MCF10A vein disease DOID_866 0.01050107 0.09484301 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A Barrett's esophagus DOID_9206 0.01050107 0.09336109 0.01050107 0.42679356 AMIT_SERUM_RESPONSE_40_MCF10A bronchitis DOID_6132 0.01115386 0.09763919 1.000 1.000 AMIT_SERUM_RESPONSE_40_MCF10A urinary system benign neoplasm DOID_731 0.01115386 0.09615981 0.01115386 0.42310315 ZHU_CMV_24_HR_UP combined T cell and B cell immunodeficiency DOID_628 4.248E-08 2.417E-05 4.248E-08 2.417E-05 ZHU_CMV_24_HR_UP primary immunodeficiency disease DOID_612 1.535E-07 4.367E-05 7.12E-06 1.35E-03 ZHU_CMV_24_HR_UP severe combined immunodeficiency DOID_627 5.166E-06 9.798E-04 5.166E-06 1.47E-03 ZHU_CMV_24_HR_UP nervous system cancer DOID_3093 7.436E-06 1.058E-03 7.436E-06 1.058E-03 ZHU_CMV_24_HR_UP bone marrow cancer DOID_4960 6.375E-05 7.255E-03 0.07391382 0.3858437 ZHU_CMV_24_HR_UP bone resorption disease DOID_0080011 1.687E-04 0.01600248 1.687E-04 0.01920298 ZHU_CMV_24_HR_UP osteoporosis DOID_11476 1.687E-04 0.01600248 1.687E-04 0.01920298 ZHU_CMV_24_HR_UP lymphoma DOID_0060058 2.82E-04 0.02292237 7.166E-03 0.25485252 ZHU_CMV_24_HR_UP osteosarcoma DOID_3347 5.648E-04 0.04017449 0.03440594 0.39953015 ZHU_CMV_24_HR_UP lung adenocarcinoma DOID_3910 7.038E-04 0.04449588 0.03830038 0.36937145 ZHU_CMV_24_HR_UP multiple myeloma DOID_9538 1.339E-03 0.07621214 0.0524487 0.36394281 ZHU_CMV_24_HR_UP adult respiratory distress syndrome DOID_11394 1.547E-03 0.08000282 0.05627178 0.35976006 ZHU_CMV_24_HR_UP autoimmune disease of urogenital tract DOID_0060049 1.693E-03 0.08026351 1.693E-03 0.16052702 ZHU_CMV_24_HR_UP primary biliary cirrhosis DOID_12236 1.693E-03 0.08026351 1.693E-03 0.16052702 ZHU_CMV_24_HR_UP influenza DOID_8469 1.845E-03 0.0807608 0.06134571 0.36742854 ZHU_CMV_24_HR_UP myeloma DOID_0070004 2.086E-03 0.08476327 0.0651336 0.38207236 ZHU_CMV_24_HR_UP pulmonary tuberculosis DOID_2957 2.254E-03 0.08548824 2.254E-03 0.18318908 ZHU_CMV_24_HR_UP lung small cell carcinoma DOID_5409 2.254E-03 0.08014522 2.254E-03 0.16029045 ZHU_CMV_24_HR_UP B-cell lymphocytic neoplasm DOID_707 2.428E-03 0.08126422 0.07016081 0.37309815 BROWNE_HCMV_INFECTION_2HR_DN nephrotic syndrome DOID_1184 9.743E-06 5.544E-03 7.883E-04 0.44851976 BROWNE_HCMV_INFECTION_2HR_DN astrocytoma DOID_3069 3.767E-05 0.01071838 1.918E-03 0.15594311 BROWNE_HCMV_INFECTION_2HR_DN nephrosis DOID_2527 4.09E-05 7.757E-03 2.025E-03 0.11522342 BROWNE_HCMV_INFECTION_2HR_DN bacterial pneumonia DOID_874 5.165E-05 7.347E-03 2.361E-03 0.1033472 BROWNE_HCMV_INFECTION_2HR_DN toxic shock syndrome DOID_14115 2.312E-04 0.02630981 0.02218824 0.30059779 BROWNE_HCMV_INFECTION_2HR_DN commensal bacterial infectious disease DOID_0050339 2.503E-04 0.02373856 0.02306575 0.30521894 BROWNE_HCMV_INFECTION_2HR_DN autoimmune disease of cardiovascular system DOID_0060051 3.343E-04 0.02717296 0.02656818 0.33593993 BROWNE_HCMV_INFECTION_2HR_DN Behcet's disease DOID_13241 3.343E-04 0.02717296 0.02656818 0.33593993 BROWNE_HCMV_INFECTION_2HR_DN endometrial carcinoma DOID_2871 3.807E-04 0.02708003 0.02831483 0.32879869 BROWNE_HCMV_INFECTION_2HR_DN abdominal aortic aneurysm DOID_7693 4.051E-04 0.02560972 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_DN endometrial cancer DOID_1380 4.301E-04 0.02447553 0.03005843 0.32890854 BROWNE_HCMV_INFECTION_2HR_DN uterine cancer DOID_363 8.228E-04 0.04256281 0.04131803 0.35621148 BROWNE_HCMV_INFECTION_2HR_DN pre-eclampsia DOID_10591 9.309E-04 0.04413879 0.04389832 0.35180488 BROWNE_HCMV_INFECTION_2HR_DN aortic aneurysm DOID_3627 1.045E-03 0.04575514 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_DN hemorrhagic disease DOID_2213 1.085E-03 0.04409627 1.085E-03 0.30867386 BROWNE_HCMV_INFECTION_2HR_DN giant cell tumor DOID_200 1.166E-03 0.04424173 1.166E-03 0.22120863 BROWNE_HCMV_INFECTION_2HR_DN malignant giant cell tumor DOID_2705 1.166E-03 0.04424173 1.166E-03 0.22120863 BROWNE_HCMV_INFECTION_2HR_DN giant cell glioblastoma DOID_3074 1.166E-03 0.04424173 1.166E-03 0.22120863 BROWNE_HCMV_INFECTION_2HR_DN bile duct adenocarcinoma DOID_4896 1.208E-03 0.04296073 1.208E-03 0.17184294 BROWNE_HCMV_INFECTION_2HR_DN cholangiocarcinoma DOID_4947 1.208E-03 0.04296073 1.208E-03 0.17184294 BROWNE_HCMV_INFECTION_2HR_DN vasculitis DOID_865 1.208E-03 0.04043363 0.04989283 0.36396181 BROWNE_HCMV_INFECTION_2HR_DN glioblastoma DOID_3068 1.382E-03 0.04368802 1.382E-03 0.15727686 BROWNE_HCMV_INFECTION_2HR_DN bile duct cancer DOID_4606 1.382E-03 0.04138865 1.382E-03 0.13106405 BROWNE_HCMV_INFECTION_2HR_DN bile duct carcinoma DOID_4897 1.382E-03 0.04138865 1.382E-03 0.13106405 BROWNE_HCMV_INFECTION_2HR_DN carotid artery disease DOID_3407 1.52E-03 0.04324273 0.05585085 0.38288115 BROWNE_HCMV_INFECTION_2HR_DN allergic contact dermatitis DOID_3042 1.815E-03 0.04916867 0.06092885 0.41272044 BROWNE_HCMV_INFECTION_2HR_DN blood coagulation disease DOID_1247 1.971E-03 0.05098735 1.971E-03 0.14021522 BROWNE_HCMV_INFECTION_2HR_DN pancreatic ductal carcinoma DOID_3587 1.971E-03 0.04877051 1.971E-03 0.12463575 BROWNE_HCMV_INFECTION_2HR_DN pancreatic carcinoma DOID_4905 2.134E-03 0.05060142 2.134E-03 0.11040309 BROWNE_HCMV_INFECTION_2HR_DN diabetic retinopathy DOID_8947 2.134E-03 0.04857736 2.134E-03 0.10120284 BROWNE_HCMV_INFECTION_2HR_DN aneurysm disease DOID_2403 2.303E-03 0.05041002 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_DN contact dermatitis DOID_2773 2.479E-03 0.05223638 0.07100545 0.44891222 BROWNE_HCMV_INFECTION_2HR_DN biliary tract cancer DOID_4607 2.66E-03 0.05405649 2.66E-03 0.10811297 BROWNE_HCMV_INFECTION_2HR_DN chronic kidney failure DOID_784 2.66E-03 0.05219247 0.07350815 0.44974342 BROWNE_HCMV_INFECTION_2HR_DN retinal vascular disease DOID_2462 2.784E-03 0.05281013 2.784E-03 0.10562026 BROWNE_HCMV_INFECTION_2HR_DN transitional cell carcinoma DOID_2671 2.976E-03 0.05462122 0.07766479 0.46517122 BROWNE_HCMV_INFECTION_2HR_DN nervous system cancer DOID_3093 3.107E-03 0.05524375 0.07932237 0.46530341 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN membranous glomerulonephritis DOID_10976 1.921E-07 1.093E-04 0.01154525 0.36495806 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN glaucoma DOID_1686 3.68E-06 1.047E-03 4.188E-04 0.2383112 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN carotid artery disease DOID_3407 6.906E-06 1.31E-03 6.341E-04 0.18039755 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN temporal lobe epilepsy DOID_3328 8.668E-06 1.233E-03 0.03929582 0.33372125 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN focal epilepsy DOID_2234 1.624E-05 1.848E-03 0.04819503 0.31162469 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.34E-05 2.219E-03 1.418E-03 0.26898873 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN age related macular degeneration DOID_10871 1.679E-04 0.01364699 1.000 1.000 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN degeneration of macula and posterior pole DOID_2007 1.679E-04 0.01364699 1.000 1.000 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN macular degeneration DOID_4448 2.115E-04 0.01504092 1.000 1.000 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN intracranial arterial disease DOID_13089 2.861E-04 0.01808921 0.02466499 0.31187505 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN cerebral arterial disease DOID_3527 2.861E-04 0.01808921 0.02466499 0.31187505 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN influenza DOID_8469 3.42E-04 0.0194621 0.02692965 0.31271364 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN cerebral infarction DOID_3526 3.568E-04 0.01845558 0.02749503 0.31289339 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN pulmonary tuberculosis DOID_2957 4.188E-04 0.01985927 0.02975341 0.30231591 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN aortic aneurysm DOID_3627 4.351E-04 0.01904383 0.03031723 0.30264037 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN sarcoidosis DOID_11335 4.857E-04 0.01974164 0.03200679 0.30867566 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN hypersensitivity reaction type IV disease DOID_2916 5.762E-04 0.02185685 0.03481649 0.32476365 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN cholestasis DOID_13580 7.155E-04 0.02544449 0.03873699 0.34439609 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN brain infarction DOID_3454 7.797E-04 0.02609635 0.04041255 0.33325713 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN tuberculosis DOID_399 7.797E-04 0.02464656 0.04041255 0.32849632 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN bile duct disease DOID_4138 8.466E-04 0.02535221 0.04208532 0.33259095 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN biliary tract disease DOID_9741 8.694E-04 0.02473576 0.04264229 0.32351287 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN aneurysm disease DOID_2403 9.64E-04 0.02611889 0.04486709 0.31911717 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN bacterial pneumonia DOID_874 9.883E-04 0.02556196 0.04542252 0.31139051 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN metabolic syndrome X DOID_14221 1.038E-03 0.02567828 0.04653245 0.31520193 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN chronic kidney failure DOID_784 1.115E-03 0.02642557 0.04819503 0.30812329 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN primary bacterial infectious disease DOID_0050338 1.221E-03 0.02778819 0.05040751 0.3151854 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN primary immunodeficiency disease DOID_612 1.276E-03 0.02792115 0.0515119 0.31858992 BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN dilated cardiomyopathy DOID_12930 1.448E-03 0.03050614 0.05481774 0.31827851 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP primary bacterial infectious disease DOID_0050338 2.939E-14 1.672E-11 2.168E-06 4.113E-04 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP tuberculosis DOID_399 4.214E-11 1.199E-08 1.269E-03 0.01145831 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pancreatic ductal carcinoma DOID_3587 5.605E-11 1.063E-08 1.249E-04 5.075E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP peripheral vascular disease DOID_341 7.392E-11 1.051E-08 1.419E-04 5.048E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pancreatic carcinoma DOID_4905 8.463E-11 9.631E-09 1.511E-04 4.777E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP familial hyperlipidemia DOID_1168 1.925E-10 1.825E-08 2.604E-06 3.705E-04 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lymphatic system disease DOID_75 3.798E-10 3.087E-08 1.861E-04 4.814E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cholestasis DOID_13580 7.17E-10 5.099E-08 0.36256507 0.56059653 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP vascular skin disease DOID_9540 1.351E-09 8.543E-08 3.35E-04 5.295E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bile duct disease DOID_4138 1.554E-09 8.84E-08 0.38741935 0.59578813 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP biliary tract disease DOID_9741 1.755E-09 9.08E-08 0.39146684 0.5987759 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP diabetic retinopathy DOID_8947 1.98E-09 9.388E-08 1.511E-04 4.526E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cystic fibrosis DOID_1485 2.506E-09 1.097E-07 1.797E-03 0.01481704 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP sarcoidosis DOID_11335 3.456E-09 1.404E-07 0.05285637 0.15664206 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lipid metabolism disorder DOID_3146 3.935E-09 1.493E-07 1.784E-05 1.269E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP retinal vascular disease DOID_2462 6.693E-09 2.38E-07 2.85E-04 5.231E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hypersensitivity reaction type IV disease DOID_2916 6.963E-09 2.331E-07 0.06149293 0.17851774 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bile duct cancer DOID_4606 6.963E-09 2.201E-07 7.173E-04 7.849E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bile duct carcinoma DOID_4897 6.963E-09 2.201E-07 7.173E-04 7.849E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP carotid artery disease DOID_3407 1.029E-08 3.081E-07 8.6E-04 8.738E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP peptic ulcer DOID_750 1.105E-08 3.143E-07 0.031368 0.0986099 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP idiopathic generalized epilepsy DOID_1827 2.143E-08 5.807E-07 5.816E-07 3.309E-04 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP ulcerative colitis DOID_8577 2.304E-08 5.96E-07 4.414E-03 0.02589111 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP proteinuria DOID_576 3.382E-08 8.367E-07 3.098E-04 5.185E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pre-eclampsia DOID_10591 3.911E-08 9.272E-07 4.419E-03 0.02565653 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP aneurysm disease DOID_2403 5.57E-08 1.268E-06 1.883E-03 0.01467666 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pancreatitis DOID_4989 6.154E-08 1.347E-06 0.01603774 0.0616586 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP alcohol abuse DOID_1574 9.931E-08 2.093E-06 2.557E-04 5.018E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP biliary tract cancer DOID_4607 9.931E-08 2.018E-06 2.461E-03 0.01772314 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP amyloidosis DOID_9120 1.713E-07 3.361E-06 8.231E-06 9.367E-04 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Human immunodeficiency virus infectious disease DOID_526 1.846E-07 3.501E-06 0.02315013 0.07935193 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pulmonary sarcoidosis DOID_13406 2.463E-07 4.522E-06 0.02866131 0.09372578 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mouth disease DOID_403 2.571E-07 4.571E-06 3.816E-03 0.02285795 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP endocrine pancreas disease DOID_1428 3.095E-07 5.337E-06 1.022E-03 0.01002199 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cerebral degeneration DOID_1443 3.431E-07 5.742E-06 1.08E-03 0.01041424 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP insulinoma DOID_3892 3.758E-07 6.109E-06 1.882E-03 0.01487493 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hyperglycemia DOID_4195 3.797E-07 6.002E-06 9.545E-05 4.178E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP brain infarction DOID_3454 4.629E-07 7.118E-06 1.269E-03 0.01164313 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP sphingolipidosis DOID_1927 5.715E-07 8.557E-06 5.853E-04 7.086E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP nephrotic syndrome DOID_1184 5.816E-07 8.485E-06 1.317E-05 1.249E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hyperinsulinism DOID_2018 5.816E-07 8.273E-06 2.423E-04 5.303E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP uveal disease DOID_3480 5.816E-07 8.071E-06 1.317E-05 1.07E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP diabetic autonomic neuropathy DOID_11503 6.63E-07 8.983E-06 3.709E-03 0.02319185 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autonomic neuropathy DOID_11504 6.63E-07 8.983E-06 3.709E-03 0.02319185 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP diabetic polyneuropathy DOID_12785 6.63E-07 8.983E-06 3.709E-03 0.02319185 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP gallbladder cancer DOID_3121 6.63E-07 8.774E-06 3.709E-03 0.02293976 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP diabetic neuropathy DOID_9743 6.63E-07 8.983E-06 3.709E-03 0.02319185 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP islet cell tumor DOID_1799 8.767E-07 1.134E-05 2.737E-03 0.01789865 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autonomic nervous system disease DOID_11465 9.652E-07 1.22E-05 4.419E-03 0.02539737 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bacterial pneumonia DOID_874 1.051E-06 1.3E-05 0.09802437 0.22673117 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP aortic aneurysm DOID_3627 1.372E-06 1.66E-05 0.0479027 0.14345599 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bone development disease DOID_0080006 1.72E-06 2.038E-05 2.701E-04 5.122E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP toxic encephalopathy DOID_3602 1.77E-06 2.055E-05 1.77E-06 5.034E-04 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bile duct adenocarcinoma DOID_4896 2.121E-06 2.413E-05 6.378E-03 0.03299079 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cholangiocarcinoma DOID_4947 2.121E-06 2.413E-05 6.378E-03 0.03299079 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP oral submucous fibrosis DOID_5773 2.38E-06 2.655E-05 0.09449444 0.22217907 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP spastic cerebral palsy DOID_0050669 2.445E-06 2.676E-05 1.336E-03 0.01187403 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP age related macular degeneration DOID_10871 2.445E-06 2.625E-05 1.336E-03 0.01169135 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP degeneration of macula and posterior pole DOID_2007 2.445E-06 2.625E-05 1.336E-03 0.01169135 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP opportunistic mycosis DOID_2473 2.445E-06 2.577E-05 0.0199931 0.07065885 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP abdominal aortic aneurysm DOID_7693 2.445E-06 2.53E-05 0.19621876 0.34459405 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP primary immunodeficiency disease DOID_612 2.519E-06 2.559E-05 3.511E-04 5.4E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP nervous system cancer DOID_3093 2.711E-06 2.706E-05 3.438E-05 1.778E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP allergic rhinitis DOID_4481 2.851E-06 2.797E-05 0.20152383 0.35173944 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP tongue cancer DOID_8649 3.157E-06 3.045E-05 1.489E-04 4.984E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hypertrophic cardiomyopathy DOID_11984 3.174E-06 3.01E-05 7.173E-04 8.003E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP encephalomyelitis DOID_640 3.363E-06 3.137E-05 4.282E-04 5.943E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP systemic mycosis DOID_0050136 3.822E-06 3.508E-05 0.02354995 0.08023904 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP fungal infectious disease DOID_1564 3.822E-06 3.508E-05 0.02354995 0.08023904 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hypersensitivity reaction type I disease DOID_1205 3.866E-06 3.492E-05 4.713E-04 6.095E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bronchitis DOID_6132 4.107E-06 3.651E-05 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pneumoconiosis DOID_10316 4.395E-06 3.848E-05 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP macular degeneration DOID_4448 4.395E-06 3.789E-05 1.865E-03 0.01516354 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP adenoma DOID_657 5.744E-06 4.878E-05 2.173E-03 0.01605745 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP parasitic infectious disease DOID_1398 6.021E-06 5.038E-05 0.01036125 0.04679009 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP uveitis DOID_13141 7.396E-06 6.099E-05 1.543E-04 4.391E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hepatitis DOID_2237 8.35E-06 6.788E-05 0.031368 0.09915774 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP intracranial arterial disease DOID_13089 9.398E-06 7.532E-05 0.24772714 0.40857027 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cerebral arterial disease DOID_3527 9.398E-06 7.532E-05 0.24772714 0.40857027 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP nephrosis DOID_2527 9.86E-06 7.792E-05 1.332E-04 5.053E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Kawasaki disease DOID_13378 1.012E-05 7.885E-05 0.12975251 0.26749703 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lymphadenitis DOID_1602 1.012E-05 7.885E-05 0.12975251 0.26749703 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lymph node disease DOID_9942 1.012E-05 7.885E-05 0.12975251 0.26749703 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pulmonary emphysema DOID_9675 1.055E-05 8.109E-05 0.25269355 0.41435917 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autoimmune disease of urogenital tract DOID_0060049 1.18E-05 8.953E-05 3.277E-03 0.02072038 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP primary biliary cirrhosis DOID_12236 1.18E-05 8.953E-05 3.277E-03 0.02072038 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP familial hypercholesterolemia DOID_13810 1.23E-05 9.208E-05 9.172E-03 0.0434901 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP influenza DOID_8469 1.466E-05 1.083E-04 0.26739771 0.43471228 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP uremia DOID_4676 1.481E-05 1.081E-04 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pulmonary embolism DOID_9477 1.481E-05 1.067E-04 0.01000207 0.04589661 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP polyarteritis nodosa DOID_9810 1.481E-05 1.053E-04 0.14119864 0.27896538 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Lewy body dementia DOID_12217 1.768E-05 1.242E-04 0.14686536 0.28716972 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP metabolic syndrome X DOID_14221 1.784E-05 1.238E-04 2.159E-03 0.01616036 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP contact dermatitis DOID_2773 1.784E-05 1.223E-04 2.162E-04 5.125E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP leukodystrophy DOID_10579 1.803E-05 1.221E-04 0.04158261 0.12720703 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP chromosomal disease DOID_0080014 1.912E-05 1.28E-04 2.288E-04 5.207E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP neuritis DOID_1803 1.992E-05 1.318E-04 4.419E-03 0.02489445 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP heart valve disease DOID_4079 1.992E-05 1.303E-04 4.419E-03 0.02441107 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP spastic quadriplegia DOID_10970 2.094E-05 1.354E-04 5.853E-04 7.24E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP toxic shock syndrome DOID_14115 2.094E-05 1.339E-04 0.15249482 0.29513454 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hemolytic anemia DOID_583 2.197E-05 1.389E-04 3.617E-04 5.415E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP normocytic anemia DOID_720 2.197E-05 1.389E-04 3.617E-04 5.415E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP arrhythmogenic right ventricular dysplasia DOID_0050431 2.311E-05 1.445E-04 2.311E-05 1.461E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pulmonary tuberculosis DOID_2957 2.418E-05 1.495E-04 4.935E-03 0.02674113 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP commensal bacterial infectious disease DOID_0050339 2.462E-05 1.506E-04 0.15808729 0.30492091 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP urticaria DOID_1555 2.462E-05 1.49E-04 6.585E-04 7.646E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bronchiolitis DOID_2942 2.462E-05 1.475E-04 0.15808729 0.29884276 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP movement disease DOID_480 2.655E-05 1.574E-04 4.194E-04 5.967E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP infantile epileptic encephalopathy DOID_2481 2.875E-05 1.687E-04 2.875E-05 1.636E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP myositis DOID_633 2.875E-05 1.669E-04 7.372E-04 7.627E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP withdrawal disorder DOID_0060001 2.911E-05 1.673E-04 5.485E-03 0.02916932 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP middle cerebral artery infarction DOID_3525 3.337E-05 1.899E-04 0.1691622 0.31455325 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP vasculitis DOID_865 3.792E-05 2.136E-04 6.378E-03 0.03269357 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP periodontitis DOID_824 3.851E-05 2.148E-04 0.01564045 0.0609549 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP perinatal necrotizing enterocolitis DOID_8677 3.851E-05 2.128E-04 0.01564045 0.06054024 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pustulosis of palm and sole DOID_4398 4.128E-05 2.258E-04 0.31888978 0.50262683 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.373E-05 2.37E-04 4.494E-04 6.088E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP renal hypertension DOID_1073 4.421E-05 2.373E-04 0.180092 0.32843702 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP secondary hypertension DOID_11130 4.421E-05 2.373E-04 0.180092 0.32843702 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bronchiectasis DOID_9563 4.496E-05 2.391E-04 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP oral cavity cancer DOID_8618 5.274E-05 2.778E-04 7.173E-04 7.701E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP dysostosis DOID_1934 5.741E-05 2.997E-04 5.741E-05 2.722E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP respiratory failure DOID_11162 7.167E-05 3.707E-04 0.34976383 0.5422769 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hypothyroidism DOID_1459 7.167E-05 3.674E-04 9.162E-03 0.04380643 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hepatic coma DOID_12550 7.717E-05 3.921E-04 0.0824284 0.20845227 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hepatic encephalopathy DOID_13413 7.717E-05 3.921E-04 0.0824284 0.20845227 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mineral metabolism disease DOID_0050032 8.29E-05 4.174E-04 9.952E-03 0.04641443 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP myocarditis DOID_820 9.212E-05 4.598E-04 1.723E-03 0.0144136 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP aspergillosis DOID_13564 9.774E-05 4.836E-04 3.741E-03 0.02288646 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP parasitic helminthiasis infectious disease DOID_883 9.774E-05 4.794E-04 3.741E-03 0.02264299 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP tooth disease DOID_1091 1.022E-04 4.972E-04 0.0112092 0.04868728 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP allergic contact dermatitis DOID_3042 1.022E-04 4.93E-04 1.203E-03 0.01141186 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hepatitis C DOID_1883 1.027E-04 4.913E-04 0.02478906 0.0834614 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP periodontal disease DOID_3388 1.027E-04 4.872E-04 0.02478906 0.08297045 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP endocrine organ benign neoplasm DOID_0060089 1.094E-04 5.144E-04 1.269E-03 0.011834 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP calcinosis DOID_182 1.4E-04 6.529E-04 0.02866131 0.0931902 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP silicosis DOID_10325 1.489E-04 6.888E-04 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP congenital diaphragmatic hernia DOID_3827 1.697E-04 7.787E-04 2.69E-03 0.01866759 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP familial hypertrophic cardiomyopathy DOID_11986 1.799E-04 8.191E-04 1.799E-04 4.875E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP adult respiratory distress syndrome DOID_11394 1.861E-04 8.405E-04 0.24772714 0.40975797 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP electroclinical syndrome DOID_0050701 1.925E-04 8.625E-04 1.972E-03 0.01516244 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP keratosis DOID_161 2.149E-04 9.552E-04 2.149E-04 5.316E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP granulosa cell tumor DOID_2999 2.539E-04 1.12E-03 2.539E-04 5.351E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP MHC class II deficiency DOID_5812 2.539E-04 1.111E-03 2.539E-04 5.16E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP chronic kidney failure DOID_784 2.557E-04 1.111E-03 2.461E-03 0.0175016 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cerebral infarction DOID_3526 2.86E-04 1.233E-03 0.27223477 0.44131506 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cataract DOID_83 2.86E-04 1.224E-03 2.86E-04 5.085E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP membranous glomerulonephritis DOID_10976 2.973E-04 1.262E-03 7.61E-03 0.03798109 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP esophagitis DOID_11963 2.973E-04 1.253E-03 0.12397259 0.25838977 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP sex cord-gonadal stromal tumor DOID_192 2.973E-04 1.244E-03 2.973E-04 5.126E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP alopecia DOID_987 2.973E-04 1.235E-03 7.61E-03 0.03765082 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lens disease DOID_110 3.35E-04 1.381E-03 3.35E-04 5.446E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP brain cancer DOID_1319 3.35E-04 1.371E-03 4.419E-03 0.0251434 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP central nervous system cancer DOID_3620 3.617E-04 1.47E-03 4.672E-03 0.0255637 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP funisitis DOID_0050698 3.977E-04 1.605E-03 3.977E-04 5.802E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP gastric ulcer DOID_10808 3.977E-04 1.594E-03 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP calcium metabolism disease DOID_10575 4.194E-04 1.669E-03 0.0479027 0.14421502 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP heart conduction disease DOID_10273 4.551E-04 1.798E-03 4.551E-04 6.022E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP opiate dependence DOID_2559 4.551E-04 1.786E-03 0.14119864 0.28091619 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP urinary tract obstruction DOID_5200 4.551E-04 1.774E-03 0.01000207 0.04626975 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lingual-facial-buccal dyskinesia DOID_9854 4.551E-04 1.762E-03 0.01000207 0.04552943 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP dilated cardiomyopathy DOID_12930 4.713E-04 1.812E-03 0.02654147 0.08780287 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP orofacial cleft DOID_0050567 4.835E-04 1.846E-03 4.835E-04 6.114E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP diabetic angiopathy DOID_11713 5.176E-04 1.963E-03 0.14686536 0.28815996 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP aortic valve disease DOID_62 5.176E-04 1.95E-03 0.14686536 0.28520951 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP giant cell tumor DOID_200 5.18E-04 1.939E-03 0.30980345 0.49377636 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP malignant giant cell tumor DOID_2705 5.18E-04 1.939E-03 0.30980345 0.49377636 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP giant cell glioblastoma DOID_3074 5.18E-04 1.939E-03 0.30980345 0.49377636 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bone marrow cancer DOID_4960 5.543E-04 2.061E-03 0.0545465 0.16081326 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP acute pancreatitis DOID_2913 5.853E-04 2.163E-03 0.01175812 0.05068462 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP severe combined immunodeficiency DOID_627 5.853E-04 2.149E-03 5.853E-04 6.939E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP osteochondrodysplasia DOID_2256 5.923E-04 2.16E-03 0.05625554 0.16499692 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP parasitic protozoa infectious disease DOID_2789 5.923E-04 2.146E-03 0.31888978 0.50402302 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP osteosarcoma DOID_3347 6.585E-04 2.371E-03 0.01268309 0.05385581 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP combined T cell and B cell immunodeficiency DOID_628 6.585E-04 2.356E-03 6.585E-04 7.493E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP glioblastoma DOID_3068 7.173E-04 2.551E-03 0.33229637 0.51801818 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP morbid obesity DOID_11981 7.372E-04 2.605E-03 7.372E-04 7.768E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP neuromuscular junction disease DOID_439 7.372E-04 2.589E-03 0.01363876 0.05706217 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP melancholia DOID_2848 7.629E-04 2.663E-03 8.048E-03 0.03947538 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP neurotic disorder DOID_4964 8.104E-04 2.812E-03 8.41E-03 0.04089782 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP intracranial aneurysm DOID_10941 8.216E-04 2.833E-03 0.01462469 0.06030037 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hypotrichosis DOID_4535 8.216E-04 2.816E-03 0.01462469 0.05943894 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP fragments of torsion dystonia DOID_531 8.216E-04 2.799E-03 0.01462469 0.05901738 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP diffuse large B-cell lymphoma DOID_0050745 9.12E-04 3.089E-03 0.17464512 0.32055831 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lung adenocarcinoma DOID_3910 9.12E-04 3.071E-03 0.01564045 0.0618015 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP congenital heart defect DOID_1682 9.655E-04 3.232E-03 9.655E-04 9.638E-03 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP malaria DOID_12365 1.008E-03 3.356E-03 0.180092 0.32634506 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP invasive ductal carcinoma DOID_3008 1.008E-03 3.336E-03 0.01668559 0.06329402 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autoimmune disease of the nervous system DOID_438 1.008E-03 3.317E-03 0.01668559 0.0624612 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP central nervous system hereditary degenerative disease DOID_481 1.008E-03 3.298E-03 0.01668559 0.06205296 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP uterine disease DOID_345 1.08E-03 3.511E-03 0.0743171 0.19852785 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP multiple epiphyseal dysplasia DOID_12721 1.111E-03 3.592E-03 0.0177597 0.06519528 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP focal glomerulosclerosis DOID_3945 1.111E-03 3.572E-03 0.18550308 0.32984766 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP dystonic disease DOID_544 1.111E-03 3.552E-03 0.0177597 0.06477737 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP temporal lobe epilepsy DOID_3328 1.14E-03 3.625E-03 0.01078038 0.04829948 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bronchiolitis obliterans DOID_2799 1.336E-03 4.222E-03 0.19621876 0.34566091 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP astrocytoma DOID_3069 1.336E-03 4.201E-03 0.37924374 0.5847959 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Charcot-Marie-Tooth disease DOID_10595 1.458E-03 4.557E-03 1.458E-03 0.01256735 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pleural disease DOID_1532 1.587E-03 4.933E-03 0.20679402 0.35983424 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP childhood absence epilepsy DOID_1825 1.587E-03 4.907E-03 0.02233731 0.07749958 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP papilloma DOID_2615 1.723E-03 5.298E-03 1.723E-03 0.01462872 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hair disease DOID_421 1.723E-03 5.269E-03 0.02354995 0.07976143 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP metal metabolism disorder DOID_896 1.723E-03 5.241E-03 0.21202956 0.36670158 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP endogenous depression DOID_1595 1.797E-03 5.438E-03 0.01499278 0.06007669 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP esophageal disease DOID_6050 1.865E-03 5.616E-03 0.21723069 0.37007264 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP gout DOID_13189 1.882E-03 5.637E-03 0.06402844 0.18307631 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP familial combined hyperlipidemia DOID_13809 1.882E-03 5.607E-03 0.06402844 0.18216093 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP angioedema DOID_1558 1.882E-03 5.578E-03 1.882E-03 0.01508443 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP conjunctival disease DOID_4251 1.882E-03 5.549E-03 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP conjunctivitis DOID_6195 1.882E-03 5.549E-03 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP alopecia areata DOID_986 1.882E-03 5.521E-03 0.06402844 0.17600089 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bone resorption disease DOID_0080011 1.883E-03 5.494E-03 0.40739221 0.62146425 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP osteoporosis DOID_11476 1.883E-03 5.494E-03 0.40739221 0.62146425 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mixed glioma DOID_5076 1.972E-03 5.725E-03 1.972E-03 0.01496028 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP childhood electroclinical syndrome DOID_0050704 2.016E-03 5.822E-03 0.02605426 0.08669515 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP female reproductive system disease DOID_229 2.256E-03 6.484E-03 0.1042464 0.23261256 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP nervous system benign neoplasm DOID_0060115 2.291E-03 6.549E-03 0.07020224 0.19112475 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP sickle cell anemia DOID_10923 2.291E-03 6.517E-03 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP migraine without aura DOID_12783 2.291E-03 6.484E-03 2.291E-03 0.01670909 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP eosinophilic pneumonia DOID_5870 2.291E-03 6.452E-03 0.07020224 0.18842015 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pulmonary eosinophilia DOID_9498 2.291E-03 6.452E-03 0.07020224 0.18842015 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Loeffler syndrome DOID_9503 2.291E-03 6.452E-03 0.07020224 0.18842015 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP multiple myeloma DOID_9538 2.338E-03 6.553E-03 0.02866131 0.09161958 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mental depression DOID_1596 2.461E-03 6.863E-03 0.01882526 0.06779477 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP focal epilepsy DOID_2234 2.461E-03 6.83E-03 0.01882526 0.06736839 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP blood platelet disease DOID_2218 2.51E-03 6.933E-03 2.51E-03 0.01763333 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP respiratory syncytial virus infectious disease DOID_1273 2.69E-03 7.395E-03 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP systemic scleroderma DOID_418 2.69E-03 7.359E-03 0.24272785 0.40265932 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP familial atrial fibrillation DOID_0050650 2.737E-03 7.451E-03 2.737E-03 0.01876123 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP common cold DOID_10459 2.737E-03 7.415E-03 2.737E-03 0.01853788 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mucopolysaccharidosis DOID_12798 2.737E-03 7.38E-03 2.737E-03 0.01831979 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP porphyria DOID_13268 2.737E-03 7.345E-03 2.737E-03 0.01810677 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP relapsing-remitting multiple sclerosis DOID_2378 2.737E-03 7.311E-03 0.07633547 0.19833279 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP aortic valve insufficiency DOID_57 2.737E-03 7.277E-03 0.07633547 0.19743128 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP encephalitis DOID_9588 2.737E-03 7.243E-03 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 3.22E-03 8.483E-03 3.22E-03 0.02082185 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP leprosy DOID_1024 3.22E-03 8.444E-03 3.22E-03 0.02058789 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP essential hypertension DOID_10825 3.22E-03 8.405E-03 0.0824284 0.20938286 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP endometriosis of uterus DOID_288 3.277E-03 8.515E-03 0.03560821 0.11132456 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP rheumatic disease DOID_1575 3.489E-03 9.024E-03 0.26252863 0.42801945 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP endometriosis DOID_289 3.489E-03 8.983E-03 0.03706816 0.11462927 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP scleroderma DOID_419 3.489E-03 9.024E-03 0.26252863 0.42801945 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP uterine cancer DOID_363 3.709E-03 9.507E-03 0.03855079 0.11856973 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP eyelid disease DOID_530 3.741E-03 9.545E-03 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP skeletal system cancer DOID_0060124 4.297E-03 0.0109163 0.09449444 0.22977493 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP thoracic aortic aneurysm DOID_14004 4.297E-03 0.01086778 0.09449444 0.22782769 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bone cancer DOID_184 4.297E-03 0.0109163 0.09449444 0.22977493 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hemangioma DOID_255 4.297E-03 0.01081969 4.297E-03 0.02547136 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP varicose veins DOID_799 4.297E-03 0.01077203 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP intermediate coronary syndrome DOID_8805 4.297E-03 0.01072478 0.09449444 0.22126475 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP myeloma DOID_0070004 4.419E-03 0.01097965 0.0431311 0.13123849 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP thyroid adenoma DOID_2891 4.419E-03 0.01093191 4.419E-03 0.02465039 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP angiosarcoma DOID_0001816 4.89E-03 0.01204532 0.10046806 0.23144261 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP spastic diplegia DOID_10965 4.89E-03 0.0119934 0.10046806 0.23050938 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hemolytic-uremic syndrome DOID_12554 4.89E-03 0.01194192 0.10046806 0.22958364 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP thyroiditis DOID_7166 4.89E-03 0.01189089 0.10046806 0.22595386 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autoimmune thyroiditis DOID_7188 4.89E-03 0.01189089 0.10046806 0.22595386 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP vein disease DOID_866 4.89E-03 0.01184029 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP integumentary system benign neoplasm DOID_0060121 4.935E-03 0.01189754 0.291267 0.46684768 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP glaucoma DOID_1686 4.935E-03 0.01184734 0.04629149 0.14010563 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP skin benign neoplasm DOID_3165 4.935E-03 0.01189754 0.291267 0.46684768 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lung small cell carcinoma DOID_5409 4.935E-03 0.01179756 4.935E-03 0.02648885 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hemorrhagic disease DOID_2213 5.485E-03 0.01305907 5.485E-03 0.02889924 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP B-cell lymphocytic neoplasm DOID_707 5.485E-03 0.01300466 0.30059639 0.4804476 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP drug-induced mental disorder DOID_1203 5.518E-03 0.01302827 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP drug psychosis DOID_1742 5.518E-03 0.01302827 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP substance-induced psychosis DOID_8646 5.518E-03 0.01302827 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP atopic dermatitis DOID_3310 5.774E-03 0.01357566 0.05118548 0.15248448 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP glucose intolerance DOID_10603 6.181E-03 0.01447328 6.181E-03 0.03226612 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP ureteral obstruction DOID_5199 6.181E-03 0.01441396 0.11229781 0.2420358 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP eosinophilia DOID_999 6.181E-03 0.01435513 0.11229781 0.24021598 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP integumentary system cancer DOID_0060122 6.693E-03 0.01548191 0.31888978 0.50542698 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP skin cancer DOID_4159 6.693E-03 0.01548191 0.31888978 0.50542698 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP smallpox DOID_8736 6.693E-03 0.01541923 6.693E-03 0.03400491 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP conduct disorder DOID_12995 6.878E-03 0.01578135 6.878E-03 0.03463518 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP psoriasis DOID_8893 6.878E-03 0.01571797 0.11815444 0.24899955 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP congenital nervous system abnormality DOID_2490 7.352E-03 0.01673324 0.05972907 0.17428636 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP brain edema DOID_4724 7.61E-03 0.01725038 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP leukocyte disease DOID_9500 8.048E-03 0.01817121 0.06327444 0.18275713 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP neuroectodermal tumor DOID_171 8.781E-03 0.01974826 8.781E-03 0.0423416 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP collagen disease DOID_854 8.781E-03 0.01967051 0.34544011 0.53703667 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hepatitis B DOID_2043 9.172E-03 0.02046593 0.13549445 0.2743642 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP acquired immunodeficiency syndrome DOID_635 9.172E-03 0.02038599 0.13549445 0.27339128 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP muscular atrophy DOID_767 9.172E-03 0.02030666 9.172E-03 0.04313068 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP sinusitis DOID_0050127 0.01000207 0.02205883 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP paranasal sinus disease DOID_1352 0.01000207 0.02205883 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP myasthenia gravis DOID_437 0.01000207 0.02197366 0.14119864 0.27993738 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hypoglycemia DOID_9993 0.01000207 0.02188915 0.14119864 0.2780001 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP synostosis DOID_11971 0.0108643 0.023685 0.0108643 0.04829519 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP ureteral disease DOID_1426 0.0108643 0.0235946 0.14686536 0.28618626 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP congenital hemolytic anemia DOID_589 0.0108643 0.02350488 0.0108643 0.04792081 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Goodpasture syndrome DOID_9808 0.0108643 0.02341585 0.0108643 0.04755219 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP blood coagulation disease DOID_1247 0.01255419 0.02695597 0.01255419 0.05370927 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP portal hypertension DOID_10762 0.01268309 0.02713037 0.15808729 0.30185124 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP male reproductive system disease DOID_48 0.01302214 0.02775129 0.38741935 0.59418223 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cystitis DOID_1679 0.01363876 0.02895692 0.16364301 0.3073032 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP papillary adenoma DOID_3172 0.01363876 0.02884928 0.01363876 0.05748486 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP microcystic adenoma DOID_5403 0.01363876 0.02884928 0.01363876 0.05748486 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP follicular adenoma DOID_6204 0.01363876 0.02884928 0.01363876 0.05748486 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cleft lip DOID_9296 0.01363876 0.02874243 0.01363876 0.05664566 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP B cell deficiency DOID_2115 0.01462469 0.03070646 0.1691622 0.31558457 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP spinal cord disease DOID_319 0.01462469 0.03059357 0.01462469 0.05986656 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP juvenile myoclonic epilepsy DOID_4890 0.01462469 0.03048151 0.1691622 0.31251069 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP extrinsic allergic alveolitis DOID_841 0.01462469 0.03037026 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP syndrome DOID_225 0.01499278 0.03102142 0.09393763 0.22940134 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP Sciatic Neuropathy DOID_11446 0.01564045 0.03224426 0.01564045 0.06223368 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lesion of sciatic nerve DOID_12528 0.01564045 0.03224426 0.01564045 0.06223368 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP migraine DOID_6364 0.01564045 0.03212785 0.01564045 0.06137528 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mononeuritis of lower limb DOID_9473 0.01564045 0.03224426 0.01564045 0.06223368 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP pleurisy DOID_10247 0.01668559 0.03415145 0.180092 0.32949309 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP sarcoma DOID_1115 0.01668559 0.03402904 0.180092 0.3273877 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mononeuritis DOID_1802 0.01668559 0.03390751 0.01668559 0.06371881 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP hepatic vascular disease DOID_272 0.01668559 0.03378684 0.180092 0.32427959 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP coronary stenosis DOID_4248 0.01668559 0.03366703 0.01668559 0.06287485 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autoimmune disease of endocrine system DOID_0060005 0.0177597 0.03570766 0.18550308 0.33192218 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP mononeuropathy DOID_1188 0.0177597 0.03558193 0.0177597 0.06561863 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP supratentorial cancer DOID_1659 0.0177597 0.03545708 0.18550308 0.33088167 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cerebrum cancer DOID_368 0.0177597 0.03545708 0.18550308 0.33088167 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cranial nerve disease DOID_5656 0.0177597 0.03533311 0.0177597 0.06436477 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP endometrial carcinoma DOID_2871 0.01886234 0.03739607 0.01886234 0.0670792 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP endometrial cancer DOID_1380 0.02115156 0.04178903 0.02115156 0.0742916 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP transitional cell carcinoma DOID_2671 0.02186408 0.04304727 0.02186408 0.07632308 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autonomic nervous system neoplasm DOID_2621 0.02233731 0.04382735 0.02233731 0.07702989 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP bladder disease DOID_365 0.02233731 0.04367674 0.20679402 0.35873718 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP neuroblastoma DOID_769 0.02233731 0.04382735 0.02233731 0.07702989 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP lymphoma DOID_0060058 0.02447647 0.04769558 0.46350195 0.70328696 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP male infertility DOID_12336 0.02478906 0.04813985 0.21723069 0.37455837 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP nephroblastoma DOID_2154 0.02478906 0.04797611 0.21723069 0.37342677 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP spindle cell carcinoma DOID_4015 0.02478906 0.04781348 0.21723069 0.37118397 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP refractive error DOID_9835 0.02734514 0.05256548 0.02734514 0.08993862 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP adolescence-adult electroclinical syndrome DOID_0050705 0.02866131 0.05491005 0.23262979 0.38931279 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP cleft palate DOID_674 0.02866131 0.05472579 0.02866131 0.09266071 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP embryonal cancer DOID_688 0.02866131 0.05454276 0.02866131 0.09213721 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP microcephaly DOID_10907 0.03000239 0.05690454 0.23769547 0.39546411 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP peripheral nervous system neoplasm DOID_1192 0.03000239 0.05671549 0.03000239 0.09537074 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP benign mesothelioma DOID_2645 0.03417128 0.06438231 1.000 1.000 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP primitive neuroectodermal tumor DOID_168 0.03706816 0.06960985 0.03706816 0.11525566 TARTE_PLASMA_CELL_VS_PLASMABLAST_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.04629149 0.08664427 0.291267 0.46816645 ENGELMANN_CANCER_PROGENITORS_DN endometriosis of uterus DOID_288 9.959E-06 5.667E-03 9.959E-06 5.667E-03 ENGELMANN_CANCER_PROGENITORS_DN endometriosis DOID_289 1.065E-05 3.029E-03 1.065E-05 3.029E-03 ENGELMANN_CANCER_PROGENITORS_DN orofacial cleft DOID_0050567 1.83E-05 3.47E-03 1.83E-05 3.47E-03 ENGELMANN_CANCER_PROGENITORS_DN uterine disease DOID_345 3.467E-05 4.931E-03 3.467E-05 4.931E-03 ENGELMANN_CANCER_PROGENITORS_DN aortic valve insufficiency DOID_57 5.433E-05 6.183E-03 0.01102409 0.26136278 ENGELMANN_CANCER_PROGENITORS_DN female reproductive system disease DOID_229 6.296E-05 5.97E-03 6.296E-05 7.164E-03 ENGELMANN_CANCER_PROGENITORS_DN granulosa cell tumor DOID_2999 1.402E-04 0.01139605 1.402E-04 0.01329539 ENGELMANN_CANCER_PROGENITORS_DN sex cord-gonadal stromal tumor DOID_192 1.557E-04 0.01107307 1.557E-04 0.01265493 ENGELMANN_CANCER_PROGENITORS_DN aortic valve disease DOID_62 2.256E-04 0.01426473 0.02193008 0.28359585 ENGELMANN_CANCER_PROGENITORS_DN cleft lip DOID_9296 2.864E-04 0.01629853 2.864E-04 0.02037317 ENGELMANN_CANCER_PROGENITORS_DN focal glomerulosclerosis DOID_3945 3.786E-04 0.0195837 0.02823786 0.29754343 ENGELMANN_CANCER_PROGENITORS_DN nephroblastoma DOID_2154 5.404E-04 0.02562225 5.404E-04 0.034163 ENGELMANN_CANCER_PROGENITORS_DN heart valve disease DOID_4079 9.865E-04 0.04317643 0.04516044 0.35689291 ENGELMANN_CANCER_PROGENITORS_DN osteochondrodysplasia DOID_2256 1.325E-03 0.05385022 1.325E-03 0.0753903 ENGELMANN_CANCER_PROGENITORS_DN hypothyroidism DOID_1459 1.66E-03 0.06298766 1.66E-03 0.08589226 ENGELMANN_CANCER_PROGENITORS_DN cholestasis DOID_13580 1.815E-03 0.06455998 1.815E-03 0.08607997 ENGELMANN_CANCER_PROGENITORS_DN bile duct disease DOID_4138 2.145E-03 0.07179566 2.145E-03 0.09388663 ENGELMANN_CANCER_PROGENITORS_DN biliary tract disease DOID_9741 2.203E-03 0.06962446 2.203E-03 0.08951717 ENGELMANN_CANCER_PROGENITORS_DN bone development disease DOID_0080006 2.883E-03 0.08632637 2.883E-03 0.10934674 ENGELMANN_CANCER_PROGENITORS_DN transitional cell carcinoma DOID_2671 3.151E-03 0.0896558 3.151E-03 0.11206975 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN medullomyoblastoma DOID_3861 1.038E-05 5.907E-03 1.038E-05 5.907E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN adult medulloblastoma DOID_3864 1.038E-05 5.907E-03 1.038E-05 5.907E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN childhood medulloblastoma DOID_3869 1.038E-05 5.907E-03 1.038E-05 5.907E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN medulloblastoma DOID_3858 1.214E-05 3.454E-03 1.214E-05 3.454E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN adult respiratory distress syndrome DOID_11394 1.513E-05 2.869E-03 1.513E-05 2.869E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN primitive neuroectodermal tumor DOID_168 1.857E-05 2.641E-03 1.857E-05 2.641E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN withdrawal disorder DOID_0060001 3.015E-05 3.431E-03 1.653E-03 0.05878713 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN neuroectodermal tumor DOID_171 5.025E-05 4.766E-03 5.025E-05 5.719E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN respiratory failure DOID_11162 5.264E-05 4.279E-03 5.264E-05 4.992E-03 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN neutropenia DOID_1227 2.729E-04 0.01941066 2.729E-04 0.02218361 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN agranulocytosis DOID_12987 2.987E-04 0.01888387 2.987E-04 0.02124436 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN lingual-facial-buccal dyskinesia DOID_9854 2.987E-04 0.01699548 0.02517982 0.22386438 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN fragments of torsion dystonia DOID_531 4.447E-04 0.02300311 0.03057123 0.23193375 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN central nervous system hereditary degenerative disease DOID_481 5.11E-04 0.02423178 0.03271963 0.2327184 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN dystonic disease DOID_544 5.459E-04 0.02389362 0.03379209 0.23448416 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN endometrial carcinoma DOID_2871 5.819E-04 0.02364944 5.819E-04 0.03678802 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN endometrial cancer DOID_1380 6.572E-04 0.02493038 6.572E-04 0.03739557 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN leukopenia DOID_615 7.786E-04 0.02768833 7.786E-04 0.04027394 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN peptic ulcer DOID_750 1.003E-03 0.03357165 1.003E-03 0.04755983 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN hyperinsulinism DOID_2018 1.202E-03 0.03800733 1.202E-03 0.05262553 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN uterine cancer DOID_363 1.255E-03 0.03758088 1.255E-03 0.05100262 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN cerebral infarction DOID_3526 1.309E-03 0.03722796 1.309E-03 0.04963728 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN movement disease DOID_480 1.593E-03 0.04316155 0.05709464 0.29804452 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN parasitic protozoa infectious disease DOID_2789 1.904E-03 0.04924871 1.904E-03 0.06373362 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN leukocyte disease DOID_9500 2.172E-03 0.05373915 2.172E-03 0.06866669 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN endocrine pancreas disease DOID_1428 2.531E-03 0.0600044 2.531E-03 0.07579503 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN parasitic infectious disease DOID_1398 2.606E-03 0.05930824 2.606E-03 0.0741353 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN hyperglycemia DOID_4195 2.682E-03 0.05868833 2.682E-03 0.07266174 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN brain infarction DOID_3454 2.837E-03 0.05977937 2.837E-03 0.0733656 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN pancreatic ductal carcinoma DOID_3587 2.996E-03 0.06087623 2.996E-03 0.0741102 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN pancreatic carcinoma DOID_4905 3.242E-03 0.06360848 3.242E-03 0.07686025 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN cystic fibrosis DOID_1485 3.411E-03 0.0646985 3.411E-03 0.0776382 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN syndrome DOID_225 3.411E-03 0.06261145 3.411E-03 0.07465211 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN bone resorption disease DOID_0080011 3.497E-03 0.06218674 3.497E-03 0.07370281 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN osteoporosis DOID_11476 3.497E-03 0.06218674 3.497E-03 0.07370281 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN mixed glioma DOID_5076 3.584E-03 0.06180523 3.584E-03 0.07284188 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN alcohol abuse DOID_1574 4.035E-03 0.0675339 0.09001277 0.37113962 JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN ulcerative colitis DOID_8577 5.537E-03 0.09001483 5.537E-03 0.10863859 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN uterine cancer DOID_363 1.706E-06 9.709E-04 1.706E-06 9.709E-04 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN transitional cell carcinoma DOID_2671 1.22E-05 3.47E-03 9.283E-04 0.05868955 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN urinary system benign neoplasm DOID_731 3.222E-05 6.111E-03 3.222E-05 9.166E-03 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN colon carcinoma DOID_1520 4.497E-05 6.397E-03 4.497E-05 8.529E-03 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN nephroblastoma DOID_2154 1.568E-04 0.01784761 1.568E-04 0.02230951 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN embryonal cancer DOID_688 1.835E-04 0.01740323 1.835E-04 0.02088387 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN gallbladder cancer DOID_3121 2.538E-04 0.02063031 2.538E-04 0.02406869 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN pre-malignant neoplasm DOID_0060071 5.008E-04 0.03561644 5.008E-04 0.0407045 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN in situ carcinoma DOID_8719 5.008E-04 0.03561644 5.008E-04 0.0407045 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN mixed glioma DOID_5076 7.346E-04 0.04644533 0.03935064 0.43902971 ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN biliary tract cancer DOID_4607 8.287E-04 0.04715386 8.287E-04 0.05894233 DASU_IL6_SIGNALING_SCAR_DN aortic aneurysm DOID_3627 9.289E-07 5.285E-04 0.01939859 0.64928219 DASU_IL6_SIGNALING_SCAR_DN aneurysm disease DOID_2403 3.118E-06 8.871E-04 0.02878658 0.65518261 DASU_IL6_SIGNALING_SCAR_DN newborn respiratory distress syndrome DOID_12716 9.855E-06 1.869E-03 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN hepatitis B DOID_2043 2.913E-05 4.144E-03 8.095E-03 0.658016 DASU_IL6_SIGNALING_SCAR_DN toxic shock syndrome DOID_14115 3.781E-05 4.302E-03 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN commensal bacterial infectious disease DOID_0050339 4.095E-05 3.883E-03 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN focal glomerulosclerosis DOID_3945 5.853E-05 4.757E-03 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN abdominal aortic aneurysm DOID_7693 6.643E-05 4.725E-03 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN adult respiratory distress syndrome DOID_11394 1.134E-04 7.167E-03 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN autoimmune disease of urogenital tract DOID_0060049 1.242E-04 7.069E-03 0.01649307 0.72188886 DASU_IL6_SIGNALING_SCAR_DN primary biliary cirrhosis DOID_12236 1.242E-04 7.069E-03 0.01649307 0.72188886 DASU_IL6_SIGNALING_SCAR_DN leukocyte disease DOID_9500 2.365E-04 0.01223108 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN respiratory failure DOID_11162 2.599E-04 0.01232461 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN diabetic retinopathy DOID_8947 3.553E-04 0.01555195 0.02770763 0.65690167 DASU_IL6_SIGNALING_SCAR_DN bacterial pneumonia DOID_874 3.936E-04 0.01599838 1.000 1.000 DASU_IL6_SIGNALING_SCAR_DN retinal vascular disease DOID_2462 4.653E-04 0.01765112 0.03165836 0.62115889 KIM_WT1_TARGETS_8HR_UP toxic shock syndrome DOID_14115 2.737E-07 1.558E-04 2.33E-05 6.628E-03 KIM_WT1_TARGETS_8HR_UP commensal bacterial infectious disease DOID_0050339 3.23E-07 9.189E-05 2.63E-05 4.987E-03 KIM_WT1_TARGETS_8HR_UP congenital heart defect DOID_1682 1.455E-05 2.761E-03 1.455E-05 8.282E-03 KIM_WT1_TARGETS_8HR_UP portal hypertension DOID_10762 2.63E-05 3.741E-03 1.523E-03 0.03610848 KIM_WT1_TARGETS_8HR_UP osteosarcoma DOID_3347 2.63E-05 2.992E-03 2.63E-05 3.741E-03 KIM_WT1_TARGETS_8HR_UP hepatic vascular disease DOID_272 4.08E-05 3.869E-03 2.027E-03 0.03844223 KIM_WT1_TARGETS_8HR_UP bone development disease DOID_0080006 4.146E-05 3.37E-03 4.146E-05 4.719E-03 KIM_WT1_TARGETS_8HR_UP primary bacterial infectious disease DOID_0050338 4.743E-05 3.374E-03 1.039E-03 0.03110491 KIM_WT1_TARGETS_8HR_UP hypersensitivity reaction type I disease DOID_1205 6.641E-05 4.199E-03 1.331E-03 0.03293828 KIM_WT1_TARGETS_8HR_UP uterine cancer DOID_363 1.586E-04 9.023E-03 1.586E-04 0.01503824 KIM_WT1_TARGETS_8HR_UP cerebral infarction DOID_3526 1.689E-04 8.736E-03 1.689E-04 0.0137273 KIM_WT1_TARGETS_8HR_UP osteochondrodysplasia DOID_2256 2.965E-04 0.0140592 2.965E-04 0.02108879 KIM_WT1_TARGETS_8HR_UP epidermolysis bullosa DOID_2730 3.156E-04 0.01381301 3.156E-04 0.01995213 KIM_WT1_TARGETS_8HR_UP vesiculobullous skin disease DOID_2731 3.724E-04 0.01513661 3.724E-04 0.02119126 KIM_WT1_TARGETS_8HR_UP epilepsy with generalized tonic-clonic seizures DOID_7725 3.724E-04 0.01412751 3.724E-04 0.01926478 KIM_WT1_TARGETS_8HR_UP brain infarction DOID_3454 5.379E-04 0.01913064 5.379E-04 0.02550753 KIM_WT1_TARGETS_8HR_UP tuberculosis DOID_399 5.379E-04 0.01800531 0.01091841 0.10711336 KIM_WT1_TARGETS_8HR_UP nephrosis DOID_2527 6.072E-04 0.01919472 6.072E-04 0.0265773 KIM_WT1_TARGETS_8HR_UP endogenous depression DOID_1595 7.081E-04 0.02120528 7.081E-04 0.02877859 KIM_WT1_TARGETS_8HR_UP prion disease DOID_649 7.253E-04 0.02063462 7.253E-04 0.02751283 KIM_WT1_TARGETS_8HR_UP electroclinical syndrome DOID_0050701 7.623E-04 0.02065414 7.623E-04 0.02710856 KIM_WT1_TARGETS_8HR_UP mental depression DOID_1596 9.091E-04 0.0235131 9.091E-04 0.03042872 KIM_WT1_TARGETS_8HR_UP chronic kidney failure DOID_784 9.091E-04 0.02249079 9.091E-04 0.02873823 KIM_WT1_TARGETS_8HR_UP transitional cell carcinoma DOID_2671 1.073E-03 0.02543333 1.073E-03 0.03052 KIM_WT1_TARGETS_8HR_UP Human immunodeficiency virus infectious disease DOID_526 1.143E-03 0.02601649 0.01785011 0.16381798 KIM_WT1_TARGETS_8HR_UP lingual-facial-buccal dyskinesia DOID_9854 1.191E-03 0.026059 1.191E-03 0.03226353 KIM_WT1_TARGETS_8HR_UP encephalomyelitis DOID_640 1.254E-03 0.02642497 1.254E-03 0.03243065 KIM_WT1_TARGETS_8HR_UP cystitis DOID_1679 1.643E-03 0.03337812 1.643E-03 0.0373835 KIM_WT1_TARGETS_8HR_UP middle cerebral artery infarction DOID_3525 1.766E-03 0.03465632 1.766E-03 0.03865512 KIM_WT1_TARGETS_8HR_UP fragments of torsion dystonia DOID_531 1.766E-03 0.03350111 1.766E-03 0.03722345 KIM_WT1_TARGETS_8HR_UP migraine DOID_6364 1.894E-03 0.03477194 1.894E-03 0.0384975 KIM_WT1_TARGETS_8HR_UP perinatal necrotizing enterocolitis DOID_8677 1.894E-03 0.03368531 1.894E-03 0.03717 KIM_WT1_TARGETS_8HR_UP central nervous system hereditary degenerative disease DOID_481 2.027E-03 0.03494748 2.027E-03 0.03720215 KIM_WT1_TARGETS_8HR_UP dystonic disease DOID_544 2.164E-03 0.03620684 2.164E-03 0.03846977 KIM_WT1_TARGETS_8HR_UP endometrial carcinoma DOID_2871 2.304E-03 0.03746334 2.304E-03 0.03973385 KIM_WT1_TARGETS_8HR_UP gonadal disease DOID_2277 2.45E-03 0.0387169 2.45E-03 0.04099437 KIM_WT1_TARGETS_8HR_UP abdominal aortic aneurysm DOID_7693 2.45E-03 0.0376705 0.07061359 0.33482613 KIM_WT1_TARGETS_8HR_UP celiac disease DOID_10608 2.599E-03 0.0389157 2.599E-03 0.04225133 KIM_WT1_TARGETS_8HR_UP endometrial cancer DOID_1380 2.599E-03 0.03791786 2.599E-03 0.04107768 KIM_WT1_TARGETS_8HR_UP bladder disease DOID_365 2.752E-03 0.03915427 2.752E-03 0.04232894 KIM_WT1_TARGETS_8HR_UP adolescence-adult electroclinical syndrome DOID_0050705 3.583E-03 0.04971838 3.583E-03 0.05364352 KIM_WT1_TARGETS_8HR_UP cleft palate DOID_674 3.583E-03 0.04853461 3.583E-03 0.05226804 KIM_WT1_TARGETS_8HR_UP systemic scleroderma DOID_418 3.943E-03 0.05217895 3.943E-03 0.05609237 KIM_WT1_TARGETS_8HR_UP intracranial arterial disease DOID_13089 4.13E-03 0.05340391 4.13E-03 0.05731151 KIM_WT1_TARGETS_8HR_UP cerebral arterial disease DOID_3527 4.13E-03 0.05340391 4.13E-03 0.05731151 KIM_WT1_TARGETS_8HR_UP benign mesothelioma DOID_2645 4.32E-03 0.05462532 4.32E-03 0.05852713 KIM_WT1_TARGETS_8HR_UP nephrotic syndrome DOID_1184 4.713E-03 0.05829793 4.713E-03 0.06236523 KIM_WT1_TARGETS_8HR_UP rheumatic disease DOID_1575 4.713E-03 0.05705755 4.713E-03 0.06094783 KIM_WT1_TARGETS_8HR_UP hyperinsulinism DOID_2018 4.713E-03 0.05586885 0.09705775 0.40018739 KIM_WT1_TARGETS_8HR_UP scleroderma DOID_419 4.713E-03 0.05705755 4.713E-03 0.06094783 KIM_WT1_TARGETS_8HR_UP pre-eclampsia DOID_10591 5.546E-03 0.06440539 5.546E-03 0.07013032 KIM_WT1_TARGETS_8HR_UP autoimmune disease of gastrointestinal tract DOID_0060031 5.986E-03 0.06812589 5.986E-03 0.07404988 KIM_WT1_TARGETS_8HR_UP pulmonary tuberculosis DOID_2957 5.986E-03 0.06679008 5.986E-03 0.07247435 KIM_WT1_TARGETS_8HR_UP lung small cell carcinoma DOID_5409 5.986E-03 0.06550566 5.986E-03 0.07096446 KIM_WT1_TARGETS_8HR_UP aortic aneurysm DOID_3627 6.212E-03 0.06669455 0.11098753 0.4210127 KIM_WT1_TARGETS_8HR_UP movement disease DOID_480 6.212E-03 0.06545947 6.212E-03 0.07213901 KIM_WT1_TARGETS_8HR_UP orofacial cleft DOID_0050567 6.676E-03 0.06906179 6.676E-03 0.07596797 KIM_WT1_TARGETS_8HR_UP giant cell tumor DOID_200 6.913E-03 0.07024015 6.913E-03 0.07712644 KIM_WT1_TARGETS_8HR_UP malignant giant cell tumor DOID_2705 6.913E-03 0.07024015 6.913E-03 0.07712644 KIM_WT1_TARGETS_8HR_UP giant cell glioblastoma DOID_3074 6.913E-03 0.07024015 6.913E-03 0.07712644 KIM_WT1_TARGETS_8HR_UP atrophic muscular disease DOID_913 6.913E-03 0.06900787 6.913E-03 0.07564324 KIM_WT1_TARGETS_8HR_UP muscular dystrophy DOID_9884 6.913E-03 0.06900787 6.913E-03 0.07564324 KIM_WT1_TARGETS_8HR_UP bile duct adenocarcinoma DOID_4896 7.154E-03 0.07018372 0.11885185 0.4449125 KIM_WT1_TARGETS_8HR_UP cholangiocarcinoma DOID_4947 7.154E-03 0.07018372 0.11885185 0.4449125 KIM_WT1_TARGETS_8HR_UP hypertrophic cardiomyopathy DOID_11984 8.156E-03 0.07865869 0.12664741 0.456091 KIM_WT1_TARGETS_8HR_UP glioblastoma DOID_3068 8.156E-03 0.07734772 8.156E-03 0.08756345 KIM_WT1_TARGETS_8HR_UP bile duct cancer DOID_4606 8.156E-03 0.07607972 0.12664741 0.45322251 KIM_WT1_TARGETS_8HR_UP bile duct carcinoma DOID_4897 8.156E-03 0.07607972 0.12664741 0.45322251 KIM_WT1_TARGETS_8HR_UP oral cavity cancer DOID_8618 8.156E-03 0.07485263 8.156E-03 0.08594191 KIM_WT1_TARGETS_8HR_UP melancholia DOID_2848 8.416E-03 0.07601126 8.416E-03 0.08706744 KIM_WT1_TARGETS_8HR_UP neurotic disorder DOID_4964 8.68E-03 0.07716647 8.68E-03 0.08819025 KIM_WT1_TARGETS_8HR_UP collagen disease DOID_854 8.947E-03 0.07831826 8.947E-03 0.08931029 KIM_WT1_TARGETS_8HR_UP endocrine pancreas disease DOID_1428 9.77E-03 0.08423058 0.13821316 0.47662599 KIM_WT1_TARGETS_8HR_UP astrocytoma DOID_3069 0.01121435 0.0952383 0.01121435 0.10815197 KIM_WT1_TARGETS_8HR_UP pancreatic ductal carcinoma DOID_3587 0.01151381 0.09634351 0.14962754 0.49788346 ROZANOV_MMP14_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 1.618E-09 9.205E-07 2.116E-05 4.014E-03 ROZANOV_MMP14_TARGETS_UP salivary gland cancer DOID_8850 4.622E-07 1.315E-04 1.711E-05 4.867E-03 ROZANOV_MMP14_TARGETS_UP nervous system cancer DOID_3093 7.747E-07 1.469E-04 1.637E-05 9.315E-03 ROZANOV_MMP14_TARGETS_UP encephalomyelitis DOID_640 9.364E-07 1.332E-04 0.04177294 0.33477183 ROZANOV_MMP14_TARGETS_UP glaucoma DOID_1686 9.645E-07 1.098E-04 0.01363278 0.17237891 ROZANOV_MMP14_TARGETS_UP oral cavity cancer DOID_8618 2.154E-06 2.043E-04 5.745E-05 8.173E-03 ROZANOV_MMP14_TARGETS_UP spinal cord disease DOID_319 2.459E-06 1.999E-04 1.185E-04 0.01348267 ROZANOV_MMP14_TARGETS_UP autoimmune disease of the nervous system DOID_438 3.274E-06 2.328E-04 4.695E-03 0.0742141 ROZANOV_MMP14_TARGETS_UP pancreatitis DOID_4989 8.268E-06 5.227E-04 0.03054895 0.30495354 ROZANOV_MMP14_TARGETS_UP retinal vascular disease DOID_2462 1.247E-05 7.094E-04 3.312E-03 0.06079731 ROZANOV_MMP14_TARGETS_UP adenoid cystic carcinoma DOID_4866 1.425E-05 7.369E-04 4.3E-04 0.02446635 ROZANOV_MMP14_TARGETS_UP ulcerative colitis DOID_8577 2.452E-05 1.163E-03 3.897E-04 0.02463864 ROZANOV_MMP14_TARGETS_UP integumentary system benign neoplasm DOID_0060121 3.052E-05 1.336E-03 7.53E-04 0.03060488 ROZANOV_MMP14_TARGETS_UP skin benign neoplasm DOID_3165 3.052E-05 1.336E-03 7.53E-04 0.03060488 ROZANOV_MMP14_TARGETS_UP sarcoidosis DOID_11335 4.097E-05 1.665E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_UP giant cell tumor DOID_200 4.097E-05 1.554E-03 0.17388007 0.60327901 ROZANOV_MMP14_TARGETS_UP malignant giant cell tumor DOID_2705 4.097E-05 1.554E-03 0.17388007 0.60327901 ROZANOV_MMP14_TARGETS_UP giant cell glioblastoma DOID_3074 4.097E-05 1.554E-03 0.17388007 0.60327901 ROZANOV_MMP14_TARGETS_UP vasculitis DOID_865 4.395E-05 1.563E-03 0.01622876 0.19237837 ROZANOV_MMP14_TARGETS_UP integumentary system cancer DOID_0060122 4.708E-05 1.576E-03 1.036E-03 0.03102118 ROZANOV_MMP14_TARGETS_UP skin cancer DOID_4159 4.708E-05 1.576E-03 1.036E-03 0.03102118 ROZANOV_MMP14_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 5.745E-05 1.816E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_UP glioblastoma DOID_3068 5.745E-05 1.721E-03 0.1878612 0.6251054 ROZANOV_MMP14_TARGETS_UP myasthenia gravis DOID_437 6.485E-05 1.845E-03 0.07542259 0.4334894 ROZANOV_MMP14_TARGETS_UP respiratory failure DOID_11162 7.376E-05 1.998E-03 0.02078105 0.23648838 ROZANOV_MMP14_TARGETS_UP hypothyroidism DOID_1459 7.376E-05 1.908E-03 1.441E-03 0.03904929 ROZANOV_MMP14_TARGETS_UP mineral metabolism disease DOID_0050032 8.306E-05 2.055E-03 0.02199295 0.24065365 ROZANOV_MMP14_TARGETS_UP neuromuscular junction disease DOID_439 1.06E-04 2.514E-03 0.08795082 0.46770107 ROZANOV_MMP14_TARGETS_UP astrocytoma DOID_3069 1.1E-04 2.504E-03 0.21779867 0.68092001 ROZANOV_MMP14_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 1.318E-04 2.885E-03 1.318E-04 0.01250085 ROZANOV_MMP14_TARGETS_UP diabetic retinopathy DOID_8947 1.358E-04 2.862E-03 0.02779459 0.28241289 ROZANOV_MMP14_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 1.461E-04 2.969E-03 4.695E-03 0.0763345 ROZANOV_MMP14_TARGETS_UP Behcet's disease DOID_13241 1.461E-04 2.969E-03 4.695E-03 0.0763345 ROZANOV_MMP14_TARGETS_UP focal glomerulosclerosis DOID_3945 1.614E-04 3.166E-03 5.008E-03 0.07306747 ROZANOV_MMP14_TARGETS_UP contact dermatitis DOID_2773 1.822E-04 3.456E-03 1.822E-04 0.01481256 ROZANOV_MMP14_TARGETS_UP allergic rhinitis DOID_4481 2.132E-04 3.913E-03 0.10947121 0.49046552 ROZANOV_MMP14_TARGETS_UP nephroblastoma DOID_2154 2.748E-04 4.886E-03 0.11853928 0.51883732 ROZANOV_MMP14_TARGETS_UP lymphoma DOID_0060058 3.079E-04 5.309E-03 4.117E-03 0.07099135 ROZANOV_MMP14_TARGETS_UP pulmonary sarcoidosis DOID_13406 3.468E-04 5.804E-03 1.000 1.000 ROZANOV_MMP14_TARGETS_UP peripheral nervous system neoplasm DOID_1192 3.733E-04 6.068E-03 3.733E-04 0.02654861 ROZANOV_MMP14_TARGETS_UP progressive muscular atrophy DOID_318 5.078E-04 8.027E-03 5.078E-04 0.02626948 ROZANOV_MMP14_TARGETS_UP nephrotic syndrome DOID_1184 5.25E-04 8.073E-03 5.25E-04 0.024893 ROZANOV_MMP14_TARGETS_UP thyroid adenoma DOID_2891 6.712E-04 0.01004967 1.000 1.000 ROZANOV_MMP14_TARGETS_UP heart valve disease DOID_4079 6.712E-04 9.792E-03 0.01265011 0.16358888 ROZANOV_MMP14_TARGETS_UP osteopetrosis DOID_13533 7.415E-04 0.01054819 7.415E-04 0.03245596 ROZANOV_MMP14_TARGETS_UP aortic valve insufficiency DOID_57 7.415E-04 0.01029091 0.04008261 0.32581435 ROZANOV_MMP14_TARGETS_UP pulmonary tuberculosis DOID_2957 7.53E-04 0.01020163 1.000 1.000 ROZANOV_MMP14_TARGETS_UP calcium metabolism disease DOID_10575 7.962E-04 0.0105361 0.01413617 0.17485831 ROZANOV_MMP14_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 8.41E-04 0.01087536 8.41E-04 0.03190104 ROZANOV_MMP14_TARGETS_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 8.744E-04 0.01105624 8.744E-04 0.03109567 ROZANOV_MMP14_TARGETS_UP osteogenesis imperfecta DOID_12347 8.744E-04 0.01081589 8.744E-04 0.02926652 ROZANOV_MMP14_TARGETS_UP congenital structural myopathy DOID_422 1.018E-03 0.01232255 1.018E-03 0.03217555 ROZANOV_MMP14_TARGETS_UP osteochondrodysplasia DOID_2256 1.036E-03 0.01227922 1.036E-03 0.02947012 ROZANOV_MMP14_TARGETS_UP carotid artery disease DOID_3407 1.378E-03 0.01600254 1.000 1.000 ROZANOV_MMP14_TARGETS_UP congenital heart defect DOID_1682 1.506E-03 0.01713925 0.0213834 0.23857161 ROZANOV_MMP14_TARGETS_UP schizophreniform disorder DOID_11328 1.511E-03 0.01685864 0.05630938 0.38602455 ROZANOV_MMP14_TARGETS_UP familial hypertrophic cardiomyopathy DOID_11986 1.511E-03 0.01653444 1.511E-03 0.0390814 ROZANOV_MMP14_TARGETS_UP hyperostosis DOID_205 1.511E-03 0.01622247 0.05630938 0.37255857 ROZANOV_MMP14_TARGETS_UP schizoaffective disorder DOID_5418 1.511E-03 0.01685864 0.05630938 0.38602455 ROZANOV_MMP14_TARGETS_UP urinary system benign neoplasm DOID_731 1.511E-03 0.01592205 0.05630938 0.36827629 ROZANOV_MMP14_TARGETS_UP congenital muscular dystrophy DOID_0050557 1.696E-03 0.0175475 1.696E-03 0.04196142 ROZANOV_MMP14_TARGETS_UP osteosclerosis DOID_4254 1.696E-03 0.01723416 1.696E-03 0.04021303 ROZANOV_MMP14_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 1.858E-03 0.0185476 1.000 1.000 ROZANOV_MMP14_TARGETS_UP tuberculosis DOID_399 1.858E-03 0.01822782 1.000 1.000 ROZANOV_MMP14_TARGETS_UP Down syndrome DOID_14250 1.891E-03 0.01824163 1.891E-03 0.04305025 ROZANOV_MMP14_TARGETS_UP testicular cancer DOID_2998 1.891E-03 0.01793761 0.06272361 0.3921949 ROZANOV_MMP14_TARGETS_UP nephrosis DOID_2527 2.092E-03 0.01951174 2.092E-03 0.04577754 ROZANOV_MMP14_TARGETS_UP pulmonary edema DOID_11396 2.097E-03 0.01924486 1.000 1.000 ROZANOV_MMP14_TARGETS_UP colon carcinoma DOID_1520 2.097E-03 0.01893939 0.06591449 0.40766679 ROZANOV_MMP14_TARGETS_UP peripheral vascular disease DOID_341 2.174E-03 0.01932423 0.22577163 0.69440032 ROZANOV_MMP14_TARGETS_UP syndrome DOID_225 2.431E-03 0.02127822 2.431E-03 0.05122535 ROZANOV_MMP14_TARGETS_UP funisitis DOID_0050698 2.538E-03 0.02188206 0.07226394 0.43742746 ROZANOV_MMP14_TARGETS_UP hepatitis B DOID_2043 2.538E-03 0.02155546 1.000 1.000 ROZANOV_MMP14_TARGETS_UP mixed glioma DOID_5076 2.612E-03 0.02185793 0.03054895 0.29969573 ROZANOV_MMP14_TARGETS_UP metabolic syndrome X DOID_14221 2.802E-03 0.02310486 0.03196513 0.30827393 ROZANOV_MMP14_TARGETS_UP chromosomal disease DOID_0080014 2.9E-03 0.02357063 2.9E-03 0.05892659 ROZANOV_MMP14_TARGETS_UP diabetic angiopathy DOID_11713 3.019E-03 0.02419576 0.07857056 0.44706649 ROZANOV_MMP14_TARGETS_UP aortic valve disease DOID_62 3.019E-03 0.02385971 0.07857056 0.44264009 ROZANOV_MMP14_TARGETS_UP mental depression DOID_1596 3.102E-03 0.02417709 0.03413702 0.30831687 ROZANOV_MMP14_TARGETS_UP chronic kidney failure DOID_784 3.102E-03 0.02385037 0.25177028 0.73465277 ROZANOV_MMP14_TARGETS_UP bone development disease DOID_0080006 3.206E-03 0.0243229 3.206E-03 0.06290404 ROZANOV_MMP14_TARGETS_UP spastic quadriplegia DOID_10970 3.274E-03 0.02451493 3.274E-03 0.0621045 ROZANOV_MMP14_TARGETS_UP acute pancreatitis DOID_2913 3.274E-03 0.02419656 0.0817079 0.45137665 ROZANOV_MMP14_TARGETS_UP primary bacterial infectious disease DOID_0050338 3.531E-03 0.02576121 1.000 1.000 ROZANOV_MMP14_TARGETS_UP transitional cell carcinoma DOID_2671 3.644E-03 0.02624745 0.26444286 0.76769381 ROZANOV_MMP14_TARGETS_UP morbid obesity DOID_11981 3.814E-03 0.02712752 0.08795082 0.47211335 ROZANOV_MMP14_TARGETS_UP spinal muscular atrophy DOID_12377 3.814E-03 0.02679261 3.814E-03 0.0678188 ROZANOV_MMP14_TARGETS_UP myositis DOID_633 3.814E-03 0.02646587 1.000 1.000 ROZANOV_MMP14_TARGETS_UP ankylosing spondylitis DOID_7147 3.814E-03 0.02614701 0.08795082 0.46337051 ROZANOV_MMP14_TARGETS_UP seminoma DOID_4440 4.098E-03 0.02776136 0.09105646 0.45053155 ROZANOV_MMP14_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.367E-03 0.02923388 0.0425688 0.3364118 ROZANOV_MMP14_TARGETS_UP mouth disease DOID_403 4.367E-03 0.02889395 4.367E-03 0.07308469 ROZANOV_MMP14_TARGETS_UP dilated cardiomyopathy DOID_12930 4.495E-03 0.02940094 0.04337035 0.32903638 ROZANOV_MMP14_TARGETS_UP coronary stenosis DOID_4248 4.695E-03 0.03036031 0.09723631 0.46493666 ROZANOV_MMP14_TARGETS_UP polycystic ovary syndrome DOID_11612 5.008E-03 0.03201833 5.008E-03 0.07701707 ROZANOV_MMP14_TARGETS_UP toxic encephalopathy DOID_3602 5.008E-03 0.03166257 5.008E-03 0.0749903 ROZANOV_MMP14_TARGETS_UP spastic cerebral palsy DOID_0050669 5.661E-03 0.03539983 5.661E-03 0.08053462 ROZANOV_MMP14_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 6.002E-03 0.03712108 6.002E-03 0.08329608 ROZANOV_MMP14_TARGETS_UP germinoma DOID_3304 6.002E-03 0.03672193 0.10947121 0.4943581 ROZANOV_MMP14_TARGETS_UP autonomic nervous system neoplasm DOID_2621 6.352E-03 0.03844783 6.352E-03 0.08604989 ROZANOV_MMP14_TARGETS_UP neuroblastoma DOID_769 6.352E-03 0.03844783 6.352E-03 0.08604989 ROZANOV_MMP14_TARGETS_UP thyroid carcinoma DOID_3963 7.078E-03 0.04239438 1.000 1.000 ROZANOV_MMP14_TARGETS_UP thyroid cancer DOID_1781 7.84E-03 0.04647086 1.000 1.000 ROZANOV_MMP14_TARGETS_UP calcinosis DOID_182 8.235E-03 0.04830532 8.235E-03 0.10896782 ROZANOV_MMP14_TARGETS_UP embryonal cancer DOID_688 8.235E-03 0.04781241 0.12751572 0.52577135 ROZANOV_MMP14_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 0.01033691 0.05941116 1.000 1.000 ROZANOV_MMP14_TARGETS_UP primary biliary cirrhosis DOID_12236 0.01033691 0.05941116 1.000 1.000 ROZANOV_MMP14_TARGETS_UP endometriosis of uterus DOID_288 0.01033691 0.05881704 0.14227533 0.558308 ROZANOV_MMP14_TARGETS_UP endometriosis DOID_289 0.01078291 0.06074729 0.14519738 0.55822506 ROZANOV_MMP14_TARGETS_UP gallbladder cancer DOID_3121 0.01123729 0.06268645 0.14810955 0.56559957 ROZANOV_MMP14_TARGETS_UP influenza DOID_8469 0.01123729 0.06207785 0.14810955 0.55810819 ROZANOV_MMP14_TARGETS_UP proteinuria DOID_576 0.01217095 0.06658913 0.15390441 0.5686468 ROZANOV_MMP14_TARGETS_UP pre-eclampsia DOID_10591 0.01265011 0.06855153 0.15678715 0.57556056 ROZANOV_MMP14_TARGETS_UP brain cancer DOID_1319 0.01265011 0.06790482 0.15678715 0.57187107 ROZANOV_MMP14_TARGETS_UP neuritis DOID_1803 0.01265011 0.06727019 1.000 1.000 ROZANOV_MMP14_TARGETS_UP central nervous system cancer DOID_3620 0.0131374 0.06921465 0.15966014 0.57497861 ROZANOV_MMP14_TARGETS_UP aortic aneurysm DOID_3627 0.01413617 0.07379342 0.16537702 0.58812204 ROZANOV_MMP14_TARGETS_UP atrophic muscular disease DOID_913 0.01569388 0.08118014 0.01569388 0.18999608 ROZANOV_MMP14_TARGETS_UP muscular dystrophy DOID_9884 0.01569388 0.08118014 0.01569388 0.18999608 ROZANOV_MMP14_TARGETS_UP bile duct adenocarcinoma DOID_4896 0.01622876 0.08319065 0.17669527 0.60933096 ROZANOV_MMP14_TARGETS_UP cholangiocarcinoma DOID_4947 0.01622876 0.08319065 0.17669527 0.60933096 ROZANOV_MMP14_TARGETS_UP pustulosis of palm and sole DOID_4398 0.01677136 0.08520449 0.17950095 0.61527736 ROZANOV_MMP14_TARGETS_UP familial hyperlipidemia DOID_1168 0.01732163 0.0872213 0.18229715 0.61742307 ROZANOV_MMP14_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 0.01844494 0.09206291 0.01844494 0.21418717 ROZANOV_MMP14_TARGETS_UP bile duct cancer DOID_4606 0.01844494 0.09126236 0.1878612 0.62147107 ROZANOV_MMP14_TARGETS_UP bile duct carcinoma DOID_4897 0.01844494 0.09126236 0.1878612 0.62147107 ROZANOV_MMP14_TARGETS_UP melancholia DOID_2848 0.01901787 0.09328592 0.19062913 0.6269825 ROZANOV_MMP14_TARGETS_UP leukocyte disease DOID_9500 0.01901787 0.0924886 1.000 1.000 ROZANOV_MMP14_TARGETS_UP neurotic disorder DOID_4964 0.01959823 0.09450334 0.19338769 0.63239997 GU_PDEF_TARGETS_UP nephrosis DOID_2527 2.887E-15 1.642E-12 1.139E-07 3.24E-05 GU_PDEF_TARGETS_UP nephrotic syndrome DOID_1184 5.228E-15 1.487E-12 1.002E-08 5.701E-06 GU_PDEF_TARGETS_UP focal glomerulosclerosis DOID_3945 1.264E-09 2.398E-07 0.04715333 0.81303774 GU_PDEF_TARGETS_UP aortic valve insufficiency DOID_57 2.594E-09 3.69E-07 1.000 1.000 GU_PDEF_TARGETS_UP giant cell tumor DOID_200 2.759E-08 3.14E-06 1.000 1.000 GU_PDEF_TARGETS_UP malignant giant cell tumor DOID_2705 2.759E-08 3.14E-06 1.000 1.000 GU_PDEF_TARGETS_UP giant cell glioblastoma DOID_3074 2.759E-08 3.14E-06 1.000 1.000 GU_PDEF_TARGETS_UP glioblastoma DOID_3068 4.271E-08 4.051E-06 1.000 1.000 GU_PDEF_TARGETS_UP aortic valve disease DOID_62 5.491E-08 4.463E-06 1.000 1.000 GU_PDEF_TARGETS_UP astrocytoma DOID_3069 9.915E-08 7.052E-06 1.000 1.000 GU_PDEF_TARGETS_UP corneal disease DOID_10124 1.841E-07 1.164E-05 1.72E-05 1.957E-03 GU_PDEF_TARGETS_UP Lynch syndrome DOID_3883 1.013E-06 5.762E-05 1.837E-04 0.0116128 GU_PDEF_TARGETS_UP proteinuria DOID_576 1.064E-06 5.501E-05 0.07352234 0.97288861 GU_PDEF_TARGETS_UP heart valve disease DOID_4079 1.155E-06 5.475E-05 1.000 1.000 GU_PDEF_TARGETS_UP Ehlers-Danlos syndrome DOID_13359 1.607E-06 7.036E-05 2.468E-04 0.01404119 GU_PDEF_TARGETS_UP corneal dystrophy DOID_2566 1.607E-06 6.533E-05 1.607E-06 3.049E-04 GU_PDEF_TARGETS_UP atrophic muscular disease DOID_913 1.829E-06 6.937E-05 9.358E-05 8.875E-03 GU_PDEF_TARGETS_UP muscular dystrophy DOID_9884 1.829E-06 6.937E-05 9.358E-05 8.875E-03 GU_PDEF_TARGETS_UP vasculitis DOID_865 1.964E-06 6.986E-05 1.000 1.000 GU_PDEF_TARGETS_UP congenital muscular dystrophy DOID_0050557 2.873E-06 9.617E-05 2.873E-06 4.087E-04 GU_PDEF_TARGETS_UP ureteral obstruction DOID_5199 2.873E-06 9.082E-05 1.000 1.000 GU_PDEF_TARGETS_UP collagen disease DOID_854 3.134E-06 9.386E-05 4.512E-03 0.16044531 GU_PDEF_TARGETS_UP uremia DOID_4676 6.201E-06 1.764E-04 0.03519826 0.74177072 GU_PDEF_TARGETS_UP urinary tract obstruction DOID_5200 6.201E-06 1.68E-04 1.000 1.000 GU_PDEF_TARGETS_UP ureteral disease DOID_1426 7.079E-06 1.831E-04 1.000 1.000 GU_PDEF_TARGETS_UP female reproductive system disease DOID_229 8.867E-06 2.194E-04 0.12138782 1.000 GU_PDEF_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 1.411E-05 3.344E-04 1.000 1.000 GU_PDEF_TARGETS_UP Behcet's disease DOID_13241 1.411E-05 3.344E-04 1.000 1.000 GU_PDEF_TARGETS_UP leiomyoma DOID_127 2.262E-05 5.147E-04 1.371E-03 0.06499202 GU_PDEF_TARGETS_UP pneumoconiosis DOID_10316 2.679E-05 5.863E-04 1.000 1.000 GU_PDEF_TARGETS_UP spindle cell carcinoma DOID_4015 2.679E-05 5.646E-04 0.05602395 0.83888496 GU_PDEF_TARGETS_UP pre-eclampsia DOID_10591 6.661E-05 1.354E-03 1.000 1.000 GU_PDEF_TARGETS_UP integumentary system benign neoplasm DOID_0060121 7.494E-05 1.47E-03 0.07784687 1.000 GU_PDEF_TARGETS_UP skin benign neoplasm DOID_3165 7.494E-05 1.47E-03 0.07784687 1.000 GU_PDEF_TARGETS_UP brachydactyly DOID_0050581 1.063E-04 2.016E-03 0.01545605 0.51732304 GU_PDEF_TARGETS_UP epidermolysis bullosa DOID_2730 1.556E-04 2.856E-03 1.556E-04 0.01264636 GU_PDEF_TARGETS_UP uterine disease DOID_345 1.67E-04 2.969E-03 1.000 1.000 GU_PDEF_TARGETS_UP vesiculobullous skin disease DOID_2731 1.837E-04 3.167E-03 1.837E-04 0.01306439 GU_PDEF_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 1.898E-04 3.176E-03 0.10477841 1.000 GU_PDEF_TARGETS_UP pancreatic ductal carcinoma DOID_3587 2.061E-04 3.35E-03 1.000 1.000 GU_PDEF_TARGETS_UP bile duct disease DOID_4138 2.145E-04 3.391E-03 0.10895947 1.000 GU_PDEF_TARGETS_UP male reproductive system disease DOID_48 2.145E-04 3.299E-03 0.10895947 1.000 GU_PDEF_TARGETS_UP peripheral vascular disease DOID_341 2.232E-04 3.343E-03 1.000 1.000 GU_PDEF_TARGETS_UP biliary tract disease DOID_9741 2.232E-04 3.257E-03 0.11034889 1.000 GU_PDEF_TARGETS_UP pancreatic carcinoma DOID_4905 2.322E-04 3.302E-03 1.000 1.000 GU_PDEF_TARGETS_UP oral submucous fibrosis DOID_5773 2.468E-04 3.425E-03 1.000 1.000 GU_PDEF_TARGETS_UP bone resorption disease DOID_0080011 2.603E-04 3.526E-03 0.11588529 1.000 GU_PDEF_TARGETS_UP osteoporosis DOID_11476 2.603E-04 3.526E-03 0.11588529 1.000 GU_PDEF_TARGETS_UP bone development disease DOID_0080006 3.342E-04 4.423E-03 0.12549261 1.000 GU_PDEF_TARGETS_UP retinal vascular disease DOID_2462 3.458E-04 4.472E-03 0.12685668 1.000 GU_PDEF_TARGETS_UP granulosa cell tumor DOID_2999 4.003E-04 5.061E-03 0.02916555 0.69146659 GU_PDEF_TARGETS_UP lymphoma DOID_0060058 4.339E-04 5.368E-03 4.339E-04 0.02244683 GU_PDEF_TARGETS_UP sex cord-gonadal stromal tumor DOID_192 4.443E-04 5.379E-03 0.03067719 0.69821296 GU_PDEF_TARGETS_UP Crohn's disease DOID_8778 4.615E-04 5.471E-03 0.13903956 1.000 GU_PDEF_TARGETS_UP ulcerative colitis DOID_8577 5.2E-04 6.039E-03 0.14440039 1.000 GU_PDEF_TARGETS_UP spastic quadriplegia DOID_10970 6.98E-04 7.944E-03 0.03820078 0.74952562 GU_PDEF_TARGETS_UP myositis DOID_633 8.151E-04 9.094E-03 1.000 1.000 GU_PDEF_TARGETS_UP seminoma DOID_4440 8.769E-04 9.595E-03 1.000 1.000 GU_PDEF_TARGETS_UP extrinsic allergic alveolitis DOID_841 8.769E-04 9.414E-03 1.000 1.000 GU_PDEF_TARGETS_UP spastic cerebral palsy DOID_0050669 1.219E-03 0.012842 0.05011927 0.81479616 GU_PDEF_TARGETS_UP germinoma DOID_3304 1.294E-03 0.01338316 1.000 1.000 GU_PDEF_TARGETS_UP pulmonary sarcoidosis DOID_13406 1.788E-03 0.01816608 1.000 1.000 GU_PDEF_TARGETS_UP microcephaly DOID_10907 1.878E-03 0.0187439 1.878E-03 0.08218477 GU_PDEF_TARGETS_UP systemic scleroderma DOID_418 1.97E-03 0.01932245 1.000 1.000 GU_PDEF_TARGETS_UP peptic ulcer DOID_750 1.97E-03 0.01899495 1.000 1.000 GU_PDEF_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 2.16E-03 0.0204814 0.06627044 0.91970438 GU_PDEF_TARGETS_UP pulmonary emphysema DOID_9675 2.16E-03 0.02014564 1.000 1.000 GU_PDEF_TARGETS_UP endometriosis of uterus DOID_288 2.258E-03 0.0207219 1.000 1.000 GU_PDEF_TARGETS_UP rheumatic disease DOID_1575 2.358E-03 0.02129866 1.000 1.000 GU_PDEF_TARGETS_UP endometriosis DOID_289 2.358E-03 0.02096587 1.000 1.000 GU_PDEF_TARGETS_UP scleroderma DOID_419 2.358E-03 0.02129866 1.000 1.000 GU_PDEF_TARGETS_UP learning disability DOID_8927 2.565E-03 0.02245336 0.0720764 0.97646363 GU_PDEF_TARGETS_UP brain cancer DOID_1319 2.78E-03 0.02396685 1.000 1.000 GU_PDEF_TARGETS_UP vascular skin disease DOID_9540 2.78E-03 0.02360914 1.000 1.000 GU_PDEF_TARGETS_UP central nervous system cancer DOID_3620 2.891E-03 0.02418726 1.000 1.000 GU_PDEF_TARGETS_UP aortic aneurysm DOID_3627 3.118E-03 0.02571101 0.07928397 0.9807082 GU_PDEF_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 3.235E-03 0.02629223 3.235E-03 0.13146113 GU_PDEF_TARGETS_UP sarcoidosis DOID_11335 3.474E-03 0.02784081 1.000 1.000 GU_PDEF_TARGETS_UP bile duct adenocarcinoma DOID_4896 3.597E-03 0.02842411 1.000 1.000 GU_PDEF_TARGETS_UP cholangiocarcinoma DOID_4947 3.597E-03 0.02842411 1.000 1.000 GU_PDEF_TARGETS_UP integumentary system cancer DOID_0060122 3.721E-03 0.02900704 1.000 1.000 GU_PDEF_TARGETS_UP osteochondrodysplasia DOID_2256 3.721E-03 0.02861506 1.000 1.000 GU_PDEF_TARGETS_UP skin cancer DOID_4159 3.721E-03 0.02900704 1.000 1.000 GU_PDEF_TARGETS_UP familial hyperlipidemia DOID_1168 3.848E-03 0.02919505 0.08786043 1.000 GU_PDEF_TARGETS_UP congenital nervous system abnormality DOID_2490 3.977E-03 0.02977469 3.977E-03 0.15085845 GU_PDEF_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 4.108E-03 0.03035394 1.000 1.000 GU_PDEF_TARGETS_UP bile duct cancer DOID_4606 4.108E-03 0.02996479 1.000 1.000 GU_PDEF_TARGETS_UP bile duct carcinoma DOID_4897 4.108E-03 0.02996479 1.000 1.000 GU_PDEF_TARGETS_UP carotid artery disease DOID_3407 4.512E-03 0.03249525 0.09494744 1.000 GU_PDEF_TARGETS_UP respiratory failure DOID_11162 4.65E-03 0.03307479 1.000 1.000 GU_PDEF_TARGETS_UP pre-malignant neoplasm DOID_0060071 4.791E-03 0.03365375 0.09776707 1.000 GU_PDEF_TARGETS_UP in situ carcinoma DOID_8719 4.791E-03 0.03365375 0.09776707 1.000 GU_PDEF_TARGETS_UP cholestasis DOID_13580 5.078E-03 0.03523432 1.000 1.000 GU_PDEF_TARGETS_UP diabetic retinopathy DOID_8947 6.302E-03 0.04320503 1.000 1.000 GU_PDEF_TARGETS_UP syndrome DOID_225 6.627E-03 0.04489308 0.11450438 1.000 GU_PDEF_TARGETS_UP aneurysm disease DOID_2403 6.793E-03 0.04547201 0.11588529 1.000 GU_PDEF_TARGETS_UP lipid metabolism disorder DOID_3146 7.3E-03 0.04829988 0.12001535 1.000 GU_PDEF_TARGETS_UP biliary tract cancer DOID_4607 7.824E-03 0.05117163 1.000 1.000 GU_PDEF_TARGETS_UP chronic kidney failure DOID_784 7.824E-03 0.05059013 1.000 1.000 GU_PDEF_TARGETS_UP nervous system cancer DOID_3093 9.111E-03 0.05824635 1.000 1.000 GU_PDEF_TARGETS_UP encephalomyelitis DOID_640 9.689E-03 0.06125542 1.000 1.000 GU_PDEF_TARGETS_UP mouth disease DOID_403 9.885E-03 0.06180987 1.000 1.000 GU_PDEF_TARGETS_UP Sjogren's syndrome DOID_12894 0.01545605 0.0955923 1.000 1.000 GU_PDEF_TARGETS_UP retinal vascular occlusion DOID_1729 0.01545605 0.09456443 1.000 1.000 GU_PDEF_TARGETS_UP lateral sclerosis DOID_230 0.01545605 0.09355842 1.000 1.000 GU_PDEF_TARGETS_UP insulinoma DOID_3892 0.01545605 0.0925736 1.000 1.000 GU_PDEF_TARGETS_UP adrenal gland hyperfunction DOID_3947 0.01545605 0.09160929 1.000 1.000 GU_PDEF_TARGETS_UP conjunctival disease DOID_4251 0.01545605 0.09066486 1.000 1.000 GU_PDEF_TARGETS_UP keratitis DOID_4677 0.01545605 0.08973971 1.000 1.000 GU_PDEF_TARGETS_UP conjunctivitis DOID_6195 0.01545605 0.09066486 1.000 1.000 GU_PDEF_TARGETS_UP familial adenomatous polyposis DOID_0050424 0.01698868 0.09764198 1.000 1.000 GU_PDEF_TARGETS_UP trypanosomiasis DOID_10113 0.01698868 0.09666556 1.000 1.000 GU_PDEF_TARGETS_UP hemochromatosis DOID_2352 0.01698868 0.09570848 0.01698868 0.53703091 GU_PDEF_TARGETS_UP bronchiectasis DOID_9563 0.01698868 0.09477016 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS myeloma DOID_0070004 7.372E-22 4.195E-19 5.396E-05 3.411E-03 TENEDINI_MEGAKARYOCYTE_MARKERS bone marrow cancer DOID_4960 3.614E-21 1.028E-18 7.997E-05 4.55E-03 TENEDINI_MEGAKARYOCYTE_MARKERS blood platelet disease DOID_2218 1.879E-20 3.563E-18 4.83E-18 2.748E-15 TENEDINI_MEGAKARYOCYTE_MARKERS hemorrhagic disease DOID_2213 3.954E-19 5.625E-17 7.228E-17 2.056E-14 TENEDINI_MEGAKARYOCYTE_MARKERS blood coagulation disease DOID_1247 1.006E-17 1.145E-15 1.292E-15 2.451E-13 TENEDINI_MEGAKARYOCYTE_MARKERS encephalomyelitis DOID_640 1.527E-14 1.448E-12 8.464E-03 0.15049704 TENEDINI_MEGAKARYOCYTE_MARKERS thrombocytopenia DOID_1588 1.804E-14 1.467E-12 1.804E-14 2.567E-12 TENEDINI_MEGAKARYOCYTE_MARKERS uterine disease DOID_345 7.966E-14 5.666E-12 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS female reproductive system disease DOID_229 4.181E-13 2.643E-11 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pre-malignant neoplasm DOID_0060071 6.632E-12 3.774E-10 4.177E-03 0.09902091 TENEDINI_MEGAKARYOCYTE_MARKERS in situ carcinoma DOID_8719 6.632E-12 3.774E-10 4.177E-03 0.09902091 TENEDINI_MEGAKARYOCYTE_MARKERS diabetic retinopathy DOID_8947 1.841E-11 9.524E-10 5.498E-03 0.11586957 TENEDINI_MEGAKARYOCYTE_MARKERS multiple myeloma DOID_9538 2.6E-11 1.233E-09 1.556E-03 0.04659393 TENEDINI_MEGAKARYOCYTE_MARKERS cervix uteri carcinoma in situ DOID_8991 4.76E-11 2.083E-09 0.06191653 0.35586369 TENEDINI_MEGAKARYOCYTE_MARKERS retinal vascular disease DOID_2462 4.862E-11 1.976E-09 7.144E-03 0.14517699 TENEDINI_MEGAKARYOCYTE_MARKERS placenta disease DOID_780 1.378E-10 5.228E-09 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS reproductive organ benign neoplasm DOID_0050622 2.687E-10 9.557E-09 3.243E-03 0.08386524 TENEDINI_MEGAKARYOCYTE_MARKERS male reproductive system disease DOID_48 1.208E-09 4.044E-08 5.22E-03 0.11424672 TENEDINI_MEGAKARYOCYTE_MARKERS medullomyoblastoma DOID_3861 2.581E-09 8.159E-08 2.351E-05 2.23E-03 TENEDINI_MEGAKARYOCYTE_MARKERS adult medulloblastoma DOID_3864 2.581E-09 8.159E-08 2.351E-05 2.23E-03 TENEDINI_MEGAKARYOCYTE_MARKERS childhood medulloblastoma DOID_3869 2.581E-09 8.159E-08 2.351E-05 2.23E-03 TENEDINI_MEGAKARYOCYTE_MARKERS medulloblastoma DOID_3858 3.376E-09 1.011E-07 2.748E-05 2.234E-03 TENEDINI_MEGAKARYOCYTE_MARKERS transitional cell carcinoma DOID_2671 3.99E-09 1.135E-07 7.627E-03 0.14465875 TENEDINI_MEGAKARYOCYTE_MARKERS peptic ulcer DOID_750 4.355E-09 1.18E-07 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hypersensitivity reaction type I disease DOID_1205 6.283E-09 1.625E-07 3.868E-04 0.01571967 TENEDINI_MEGAKARYOCYTE_MARKERS primitive neuroectodermal tumor DOID_168 6.987E-09 1.728E-07 4.196E-05 2.984E-03 TENEDINI_MEGAKARYOCYTE_MARKERS ulcerative colitis DOID_8577 7.554E-09 1.791E-07 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS inherited blood coagulation disease DOID_2214 1.195E-08 2.719E-07 1.195E-08 1.359E-06 TENEDINI_MEGAKARYOCYTE_MARKERS pulmonary tuberculosis DOID_2957 1.316E-08 2.88E-07 2.616E-03 0.0708718 TENEDINI_MEGAKARYOCYTE_MARKERS autoimmune hepatitis DOID_2048 2.329E-08 4.908E-07 0.03003594 0.29983249 TENEDINI_MEGAKARYOCYTE_MARKERS neuroectodermal tumor DOID_171 3.81E-08 7.743E-07 1.131E-04 5.361E-03 TENEDINI_MEGAKARYOCYTE_MARKERS tuberculosis DOID_399 6.456E-08 1.267E-06 4.816E-03 0.10961891 TENEDINI_MEGAKARYOCYTE_MARKERS cystic fibrosis DOID_1485 1.039E-07 1.97E-06 0.10716829 0.49576227 TENEDINI_MEGAKARYOCYTE_MARKERS sarcoma DOID_1115 1.056E-07 1.939E-06 8.758E-04 0.03322181 TENEDINI_MEGAKARYOCYTE_MARKERS bacterial pneumonia DOID_874 1.18E-07 2.099E-06 0.10976236 0.49176995 TENEDINI_MEGAKARYOCYTE_MARKERS female reproductive organ benign neoplasm DOID_0060086 1.383E-07 2.384E-06 0.04541372 0.32709376 TENEDINI_MEGAKARYOCYTE_MARKERS uterine benign neoplasm DOID_0060095 1.383E-07 2.384E-06 0.04541372 0.32709376 TENEDINI_MEGAKARYOCYTE_MARKERS uterine fibroid DOID_13223 1.383E-07 2.384E-06 0.04541372 0.32709376 TENEDINI_MEGAKARYOCYTE_MARKERS biliary tract cancer DOID_4607 1.602E-07 2.681E-06 0.1162152 0.50478206 TENEDINI_MEGAKARYOCYTE_MARKERS endometrial cancer DOID_1380 1.78E-07 2.893E-06 1.125E-03 0.03766378 TENEDINI_MEGAKARYOCYTE_MARKERS leiomyoma DOID_127 2.007E-07 3.172E-06 0.04956595 0.3357503 TENEDINI_MEGAKARYOCYTE_MARKERS primary bacterial infectious disease DOID_0050338 2.018E-07 3.103E-06 7.464E-03 0.14645683 TENEDINI_MEGAKARYOCYTE_MARKERS nephroblastoma DOID_2154 2.526E-07 3.783E-06 0.05232425 0.3422126 TENEDINI_MEGAKARYOCYTE_MARKERS lymphoma DOID_0060058 2.654E-07 3.872E-06 8.293E-03 0.15222181 TENEDINI_MEGAKARYOCYTE_MARKERS lymphoblastic leukemia DOID_1037 2.798E-07 3.981E-06 0.12898342 0.53182294 TENEDINI_MEGAKARYOCYTE_MARKERS adenoma DOID_657 3.139E-07 4.357E-06 0.05507468 0.3369623 TENEDINI_MEGAKARYOCYTE_MARKERS retinal vascular occlusion DOID_1729 3.442E-07 4.663E-06 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS embryonal cancer DOID_688 3.484E-07 4.611E-06 1.556E-03 0.04918248 TENEDINI_MEGAKARYOCYTE_MARKERS benign mesothelioma DOID_2645 5.153E-07 6.664E-06 0.06191653 0.35949495 TENEDINI_MEGAKARYOCYTE_MARKERS diabetic autonomic neuropathy DOID_11503 6.749E-07 8.534E-06 0.06599827 0.37181202 TENEDINI_MEGAKARYOCYTE_MARKERS autonomic neuropathy DOID_11504 6.749E-07 8.534E-06 0.06599827 0.37181202 TENEDINI_MEGAKARYOCYTE_MARKERS diabetic polyneuropathy DOID_12785 6.749E-07 8.534E-06 0.06599827 0.37181202 TENEDINI_MEGAKARYOCYTE_MARKERS gallbladder cancer DOID_3121 6.749E-07 8.348E-06 0.06599827 0.3681668 TENEDINI_MEGAKARYOCYTE_MARKERS uterine cancer DOID_363 6.749E-07 8.171E-06 2.142E-03 0.06094815 TENEDINI_MEGAKARYOCYTE_MARKERS diabetic neuropathy DOID_9743 6.749E-07 8.534E-06 0.06599827 0.37181202 TENEDINI_MEGAKARYOCYTE_MARKERS Leydig cell tumor DOID_2696 8.178E-07 9.695E-06 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS sex cord-stromal neoplasm DOID_4757 8.178E-07 9.695E-06 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS autonomic nervous system disease DOID_11465 8.686E-07 1.009E-05 0.07006257 0.38332307 TENEDINI_MEGAKARYOCYTE_MARKERS heart valve disease DOID_4079 8.686E-07 9.885E-06 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS autoimmune disease of gastrointestinal tract DOID_0060031 1.019E-06 1.137E-05 0.07276245 0.386933 TENEDINI_MEGAKARYOCYTE_MARKERS calcium metabolism disease DOID_10575 1.101E-06 1.205E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS B-cell lymphocytic neoplasm DOID_707 1.188E-06 1.275E-05 0.07545463 0.39030622 TENEDINI_MEGAKARYOCYTE_MARKERS giant cell tumor DOID_200 1.376E-06 1.45E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS malignant giant cell tumor DOID_2705 1.376E-06 1.45E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS giant cell glioblastoma DOID_3074 1.376E-06 1.45E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS parasitic protozoa infectious disease DOID_2789 1.587E-06 1.641E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS angiosarcoma DOID_0001816 1.596E-06 1.622E-05 0.02296589 0.29039092 TENEDINI_MEGAKARYOCYTE_MARKERS glioblastoma DOID_3068 1.945E-06 1.942E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS prion disease DOID_649 2.321E-06 2.277E-05 0.02579996 0.2769845 TENEDINI_MEGAKARYOCYTE_MARKERS granulosa cell tumor DOID_2999 2.754E-06 2.656E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS leishmaniasis DOID_9065 2.754E-06 2.612E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mineral metabolism disease DOID_0050032 2.839E-06 2.648E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS parasitic infectious disease DOID_1398 3.013E-06 2.765E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS sex cord-gonadal stromal tumor DOID_192 3.237E-06 2.923E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS endocrine organ benign neoplasm DOID_0060089 3.583E-06 3.185E-05 0.09803048 0.47270628 TENEDINI_MEGAKARYOCYTE_MARKERS astrocytoma DOID_3069 3.79E-06 3.317E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS peripheral vascular disease DOID_341 4.463E-06 3.847E-05 0.10326327 0.48559339 TENEDINI_MEGAKARYOCYTE_MARKERS muscle cancer DOID_4045 5.012E-06 4.257E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS bone resorption disease DOID_0080011 5.493E-06 4.596E-05 0.10846625 0.49373839 TENEDINI_MEGAKARYOCYTE_MARKERS osteoporosis DOID_11476 5.493E-06 4.596E-05 0.10846625 0.49373839 TENEDINI_MEGAKARYOCYTE_MARKERS pancreatitis DOID_4989 5.776E-06 4.763E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS metabolic syndrome X DOID_14221 6.374E-06 5.181E-05 0.11234903 0.49942655 TENEDINI_MEGAKARYOCYTE_MARKERS bronchiolitis DOID_2942 7.336E-06 5.879E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS chronic kidney failure DOID_784 7.355E-06 5.812E-05 0.1162152 0.50095796 TENEDINI_MEGAKARYOCYTE_MARKERS extrinsic allergic alveolitis DOID_841 9.225E-06 7.19E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS nervous system cancer DOID_3093 1.007E-05 7.746E-05 0.12517209 0.52369794 TENEDINI_MEGAKARYOCYTE_MARKERS diffuse large B-cell lymphoma DOID_0050745 1.028E-05 7.798E-05 0.04124368 0.33525222 TENEDINI_MEGAKARYOCYTE_MARKERS Sciatic Neuropathy DOID_11446 1.028E-05 7.695E-05 0.04124368 0.33053036 TENEDINI_MEGAKARYOCYTE_MARKERS lesion of sciatic nerve DOID_12528 1.028E-05 7.695E-05 0.04124368 0.33053036 TENEDINI_MEGAKARYOCYTE_MARKERS periodontitis DOID_824 1.028E-05 7.595E-05 0.04124368 0.32593966 TENEDINI_MEGAKARYOCYTE_MARKERS mononeuritis of lower limb DOID_9473 1.028E-05 7.695E-05 0.04124368 0.33053036 TENEDINI_MEGAKARYOCYTE_MARKERS pleurisy DOID_10247 1.141E-05 8.322E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mononeuritis DOID_1802 1.141E-05 8.217E-05 0.04263568 0.33232467 TENEDINI_MEGAKARYOCYTE_MARKERS hepatic vascular disease DOID_272 1.141E-05 8.114E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS invasive ductal carcinoma DOID_3008 1.141E-05 8.014E-05 0.04263568 0.3278338 TENEDINI_MEGAKARYOCYTE_MARKERS alcohol-related neurodevelopmental disorder DOID_0050667 1.192E-05 8.275E-05 8.636E-03 0.14890391 TENEDINI_MEGAKARYOCYTE_MARKERS mouth disease DOID_403 1.192E-05 8.175E-05 0.13025023 0.53318262 TENEDINI_MEGAKARYOCYTE_MARKERS Crohn's disease DOID_8778 1.192E-05 8.078E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mononeuropathy DOID_1188 1.262E-05 8.447E-05 0.04402569 0.33400824 TENEDINI_MEGAKARYOCYTE_MARKERS endometrial carcinoma DOID_2871 1.391E-05 9.203E-05 9.968E-04 0.03544698 TENEDINI_MEGAKARYOCYTE_MARKERS spastic cerebral palsy DOID_0050669 1.528E-05 9.996E-05 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS germinoma DOID_3304 1.675E-05 1.083E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS chronic leukemia DOID_1036 1.83E-05 1.17E-04 0.04956595 0.33979549 TENEDINI_MEGAKARYOCYTE_MARKERS chronic lymphocytic leukemia DOID_1040 1.83E-05 1.17E-04 0.04956595 0.33979549 TENEDINI_MEGAKARYOCYTE_MARKERS pleural disease DOID_1532 1.83E-05 1.157E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pneumoconiosis DOID_10316 2.168E-05 1.355E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS periodontal disease DOID_3388 2.168E-05 1.341E-04 0.05232425 0.33832382 TENEDINI_MEGAKARYOCYTE_MARKERS esophageal disease DOID_6050 2.168E-05 1.326E-04 0.05232425 0.33080551 TENEDINI_MEGAKARYOCYTE_MARKERS calcinosis DOID_182 2.748E-05 1.663E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS peripheral nervous system neoplasm DOID_1192 2.962E-05 1.774E-04 0.05781728 0.34629508 TENEDINI_MEGAKARYOCYTE_MARKERS systemic scleroderma DOID_418 3.186E-05 1.889E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS intracranial arterial disease DOID_13089 3.422E-05 2.007E-04 0.06055206 0.35889712 TENEDINI_MEGAKARYOCYTE_MARKERS cerebral arterial disease DOID_3527 3.422E-05 2.007E-04 0.06055206 0.35889712 TENEDINI_MEGAKARYOCYTE_MARKERS lymphatic system disease DOID_75 3.422E-05 1.987E-04 0.06055206 0.35519715 TENEDINI_MEGAKARYOCYTE_MARKERS endometriosis of uterus DOID_288 3.926E-05 2.257E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS rheumatic disease DOID_1575 4.196E-05 2.388E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS endometriosis DOID_289 4.196E-05 2.364E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS scleroderma DOID_419 4.196E-05 2.388E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS influenza DOID_8469 4.478E-05 2.498E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS proteinuria DOID_576 5.077E-05 2.805E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS neuritis DOID_1803 5.396E-05 2.952E-04 0.07006257 0.37967238 TENEDINI_MEGAKARYOCYTE_MARKERS vascular skin disease DOID_9540 5.396E-05 2.924E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS glaucoma DOID_1686 6.071E-05 3.259E-04 0.07276245 0.38335029 TENEDINI_MEGAKARYOCYTE_MARKERS atopic dermatitis DOID_3310 7.185E-05 3.821E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS integumentary system cancer DOID_0060122 8.425E-05 4.439E-04 0.08081599 0.41427298 TENEDINI_MEGAKARYOCYTE_MARKERS skin cancer DOID_4159 8.425E-05 4.439E-04 0.08081599 0.41427298 TENEDINI_MEGAKARYOCYTE_MARKERS transient cerebral ischemia DOID_224 9.23E-05 4.818E-04 9.23E-05 4.775E-03 TENEDINI_MEGAKARYOCYTE_MARKERS insulinoma DOID_3892 9.23E-05 4.775E-04 0.01441502 0.24123953 TENEDINI_MEGAKARYOCYTE_MARKERS cutaneous leishmaniasis DOID_9111 9.23E-05 4.732E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS melancholia DOID_2848 1.028E-04 5.225E-04 0.08614683 0.4337836 TENEDINI_MEGAKARYOCYTE_MARKERS leukocyte disease DOID_9500 1.028E-04 5.178E-04 0.08614683 0.42997848 TENEDINI_MEGAKARYOCYTE_MARKERS neurotic disorder DOID_4964 1.079E-04 5.384E-04 0.08747479 0.43281004 TENEDINI_MEGAKARYOCYTE_MARKERS carotid artery disease DOID_3407 1.131E-04 5.594E-04 3.933E-03 0.09729232 TENEDINI_MEGAKARYOCYTE_MARKERS collagen disease DOID_854 1.131E-04 5.546E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS islet cell tumor DOID_1799 1.351E-04 6.571E-04 0.01727344 0.25201505 TENEDINI_MEGAKARYOCYTE_MARKERS retinal detachment DOID_5327 1.351E-04 6.516E-04 0.01727344 0.24571467 TENEDINI_MEGAKARYOCYTE_MARKERS cholestasis DOID_13580 1.354E-04 6.476E-04 0.09408622 0.46150912 TENEDINI_MEGAKARYOCYTE_MARKERS hyperglycemia DOID_4195 1.414E-04 6.707E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS tooth disease DOID_1091 1.476E-04 6.942E-04 0.0967176 0.47036166 TENEDINI_MEGAKARYOCYTE_MARKERS berylliosis DOID_10322 1.595E-04 7.441E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS polyneuropathy DOID_1389 1.595E-04 7.381E-04 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS intracranial thrombosis DOID_4193 1.595E-04 7.321E-04 1.595E-04 6.983E-03 TENEDINI_MEGAKARYOCYTE_MARKERS bile duct disease DOID_4138 1.741E-04 7.925E-04 0.10195787 0.48345025 TENEDINI_MEGAKARYOCYTE_MARKERS biliary tract disease DOID_9741 1.812E-04 8.182E-04 0.10326327 0.48161312 TENEDINI_MEGAKARYOCYTE_MARKERS endogenous depression DOID_1595 2.035E-04 9.117E-04 0.10716829 0.49176419 TENEDINI_MEGAKARYOCYTE_MARKERS membranoproliferative glomerulonephritis DOID_2920 2.144E-04 9.529E-04 0.02154582 0.29901394 TENEDINI_MEGAKARYOCYTE_MARKERS varicose veins DOID_799 2.144E-04 9.456E-04 0.02154582 0.28510631 TENEDINI_MEGAKARYOCYTE_MARKERS spastic diplegia DOID_10965 2.448E-04 1.071E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS tongue cancer DOID_8649 2.448E-04 1.063E-03 0.02296589 0.27803386 TENEDINI_MEGAKARYOCYTE_MARKERS vein disease DOID_866 2.448E-04 1.055E-03 0.02296589 0.27224149 TENEDINI_MEGAKARYOCYTE_MARKERS Barrett's esophagus DOID_9206 2.448E-04 1.047E-03 0.02296589 0.26668554 TENEDINI_MEGAKARYOCYTE_MARKERS mental depression DOID_1596 2.623E-04 1.114E-03 0.1162152 0.508665 TENEDINI_MEGAKARYOCYTE_MARKERS bone development disease DOID_0080006 2.715E-04 1.144E-03 0.11750025 0.50268904 TENEDINI_MEGAKARYOCYTE_MARKERS basal cell carcinoma DOID_2513 2.771E-04 1.16E-03 0.02438394 0.2774892 TENEDINI_MEGAKARYOCYTE_MARKERS skin carcinoma DOID_3451 3.115E-04 1.294E-03 0.02579996 0.28231113 TENEDINI_MEGAKARYOCYTE_MARKERS Down syndrome DOID_14250 3.478E-04 1.434E-03 0.02721397 0.28675461 TENEDINI_MEGAKARYOCYTE_MARKERS testicular cancer DOID_2998 3.478E-04 1.424E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pulmonary edema DOID_11396 3.861E-04 1.569E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS esophagitis DOID_11963 3.861E-04 1.558E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS Kawasaki disease DOID_13378 4.264E-04 1.708E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS lymphadenitis DOID_1602 4.264E-04 1.708E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mitochondrial myopathy DOID_699 4.264E-04 1.696E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS lymph node disease DOID_9942 4.264E-04 1.708E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS neutropenia DOID_1227 4.686E-04 1.851E-03 0.03144391 0.30847565 TENEDINI_MEGAKARYOCYTE_MARKERS sinusitis DOID_0050127 5.127E-04 2.012E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS agranulocytosis DOID_12987 5.127E-04 1.998E-03 0.03284988 0.31152635 TENEDINI_MEGAKARYOCYTE_MARKERS paranasal sinus disease DOID_1352 5.127E-04 2.012E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS optic nerve disease DOID_1891 5.127E-04 1.985E-03 0.03284988 0.30641936 TENEDINI_MEGAKARYOCYTE_MARKERS IgA glomerulonephritis DOID_2986 5.127E-04 1.971E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS polyarteritis nodosa DOID_9810 5.127E-04 1.958E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS Goodpasture syndrome DOID_9808 5.588E-04 2.12E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS spastic quadriplegia DOID_10970 6.068E-04 2.287E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS portal hypertension DOID_10762 6.568E-04 2.459E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS urticaria DOID_1555 6.568E-04 2.442E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS cystitis DOID_1679 7.087E-04 2.618E-03 0.03845373 0.33151773 TENEDINI_MEGAKARYOCYTE_MARKERS B cell deficiency DOID_2115 7.625E-04 2.799E-03 0.0398497 0.33344822 TENEDINI_MEGAKARYOCYTE_MARKERS middle cerebral artery infarction DOID_3525 7.625E-04 2.781E-03 0.0398497 0.32861563 TENEDINI_MEGAKARYOCYTE_MARKERS seminoma DOID_4440 7.625E-04 2.763E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS autoimmune disease of cardiovascular system DOID_0060051 8.758E-04 3.154E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS Behcet's disease DOID_13241 8.758E-04 3.154E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS multiple epiphyseal dysplasia DOID_12721 9.353E-04 3.347E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS focal glomerulosclerosis DOID_3945 9.353E-04 3.326E-03 0.04402569 0.3253327 TENEDINI_MEGAKARYOCYTE_MARKERS cranial nerve disease DOID_5656 9.353E-04 3.306E-03 0.04402569 0.32116177 TENEDINI_MEGAKARYOCYTE_MARKERS bronchiolitis obliterans DOID_2799 1.06E-03 3.723E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS autonomic nervous system neoplasm DOID_2621 1.192E-03 4.162E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS bladder disease DOID_365 1.192E-03 4.137E-03 0.04956595 0.3318003 TENEDINI_MEGAKARYOCYTE_MARKERS neuroblastoma DOID_769 1.192E-03 4.162E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS papilloma DOID_2615 1.261E-03 4.35E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS spindle cell carcinoma DOID_4015 1.332E-03 4.566E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS leukopenia DOID_615 1.332E-03 4.539E-03 0.05232425 0.32717028 TENEDINI_MEGAKARYOCYTE_MARKERS pulmonary sarcoidosis DOID_13406 1.556E-03 5.27E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS respiratory syncytial virus infectious disease DOID_1273 1.714E-03 5.772E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS congenital diaphragmatic hernia DOID_3827 1.714E-03 5.738E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pulmonary emphysema DOID_9675 1.88E-03 6.256E-03 0.06191653 0.35230505 TENEDINI_MEGAKARYOCYTE_MARKERS nephrotic syndrome DOID_1184 2.053E-03 6.792E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS cerebral infarction DOID_3526 2.233E-03 7.346E-03 0.06735497 0.37208715 TENEDINI_MEGAKARYOCYTE_MARKERS learning disability DOID_8927 2.233E-03 7.303E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pre-eclampsia DOID_10591 2.421E-03 7.871E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS brain cancer DOID_1319 2.421E-03 7.827E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS thyroid adenoma DOID_2891 2.421E-03 7.782E-03 0.07006257 0.37609056 TENEDINI_MEGAKARYOCYTE_MARKERS central nervous system cancer DOID_3620 2.517E-03 8.047E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS lung small cell carcinoma DOID_5409 2.616E-03 8.315E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS sarcoidosis DOID_11335 3.027E-03 9.567E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS bile duct adenocarcinoma DOID_4896 3.134E-03 9.851E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS cholangiocarcinoma DOID_4947 3.134E-03 9.851E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS vasculitis DOID_865 3.134E-03 9.797E-03 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS osteochondrodysplasia DOID_2256 3.243E-03 0.01008216 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pustulosis of palm and sole DOID_4398 3.243E-03 0.01002737 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mitochondrial metabolism disease DOID_700 3.353E-03 0.01031353 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hypertrophic cardiomyopathy DOID_11984 3.58E-03 0.0109512 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hypersensitivity reaction type IV disease DOID_2916 3.58E-03 0.01089264 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS bile duct cancer DOID_4606 3.58E-03 0.0108347 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS bile duct carcinoma DOID_4897 3.58E-03 0.0108347 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS oral cavity cancer DOID_8618 3.58E-03 0.01077737 0.08481697 0.43090052 TENEDINI_MEGAKARYOCYTE_MARKERS respiratory failure DOID_11162 4.054E-03 0.01214012 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS endocrine pancreas disease DOID_1428 4.301E-03 0.01281338 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS temporal lobe epilepsy DOID_3328 4.555E-03 0.0134999 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS allergic contact dermatitis DOID_3042 4.685E-03 0.01381215 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS brain infarction DOID_3454 4.816E-03 0.01412615 0.09803048 0.46873396 TENEDINI_MEGAKARYOCYTE_MARKERS pancreatic ductal carcinoma DOID_3587 5.084E-03 0.01483493 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS nephrosis DOID_2527 5.22E-03 0.01515518 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pancreatic carcinoma DOID_4905 5.498E-03 0.0158806 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mixed glioma DOID_5076 6.074E-03 0.01745429 0.10976236 0.49567289 TENEDINI_MEGAKARYOCYTE_MARKERS contact dermatitis DOID_2773 6.371E-03 0.01821766 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS lipid metabolism disorder DOID_3146 6.371E-03 0.01812657 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS chromosomal disease DOID_0080014 6.523E-03 0.01846464 0.1136396 0.50124752 TENEDINI_MEGAKARYOCYTE_MARKERS focal epilepsy DOID_2234 6.83E-03 0.01923926 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS primary immunodeficiency disease DOID_612 7.791E-03 0.02183835 0.12389801 0.52610425 TENEDINI_MEGAKARYOCYTE_MARKERS carbohydrate metabolic disorder DOID_2978 8.464E-03 0.02360738 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS leber hereditary optic neuropathy DOID_705 0.01298274 0.03603503 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hyperparathyroidism DOID_13543 0.01441502 0.03981623 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hypolipoproteinemia DOID_1387 0.01441502 0.03962388 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS childhood type dermatomyositis DOID_14203 0.01441502 0.03943338 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS rectal neoplasm DOID_1984 0.01441502 0.03924471 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS rectum cancer DOID_1993 0.01441502 0.03924471 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS chondrosarcoma DOID_3371 0.01441502 0.03905783 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS Hermansky-Pudlak syndrome DOID_3753 0.01441502 0.03887272 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS conjunctival disease DOID_4251 0.01441502 0.03868936 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS keratitis DOID_4677 0.01441502 0.03850772 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS conjunctivitis DOID_6195 0.01441502 0.03868936 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS polycythemia DOID_8432 0.01441502 0.03832778 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS visceral leishmaniasis DOID_9146 0.01441502 0.03814951 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS breast benign neoplasm DOID_0060082 0.01584525 0.04174049 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS thoracic benign neoplasm DOID_0060097 0.01584525 0.04174049 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS trypanosomiasis DOID_10113 0.01584525 0.04154813 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS dermatomyositis DOID_10223 0.01584525 0.04135755 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS prediabetes syndrome DOID_11716 0.01584525 0.0411687 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS benign breast phyllodes tumor DOID_1631 0.01584525 0.04174049 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS craniosynostosis DOID_2340 0.01584525 0.04098157 0.01584525 0.25759843 TENEDINI_MEGAKARYOCYTE_MARKERS prostatic adenoma DOID_2883 0.01584525 0.04079613 0.01584525 0.25044292 TENEDINI_MEGAKARYOCYTE_MARKERS invasive lobular carcinoma DOID_3457 0.01584525 0.04061237 0.01584525 0.24367419 TENEDINI_MEGAKARYOCYTE_MARKERS bronchiectasis DOID_9563 0.01584525 0.04043025 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS common cold DOID_10459 0.01727344 0.04387762 0.01727344 0.25864702 TENEDINI_MEGAKARYOCYTE_MARKERS intracranial arteriosclerosis DOID_13097 0.01727344 0.04368261 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pituitary cancer DOID_1785 0.01727344 0.04348932 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pituitary carcinoma DOID_4916 0.01727344 0.04348932 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS aortic valve insufficiency DOID_57 0.01727344 0.04329774 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS stomach disease DOID_76 0.01727344 0.04310784 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS vascular dementia DOID_8725 0.01727344 0.04368261 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mitochondrial encephalomyopathy DOID_890 0.01727344 0.04291959 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS encephalitis DOID_9588 0.01727344 0.04273299 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS parathyroid gland disease DOID_11201 0.0186996 0.04606091 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS vulva cancer DOID_1245 0.0186996 0.04586237 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hypercalcemia DOID_12678 0.02012372 0.04914334 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS rhabdomyosarcoma DOID_3247 0.02012372 0.04893333 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS eyelid disease DOID_530 0.02012372 0.0487251 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS idiopathic pulmonary fibrosis DOID_0050156 0.02154582 0.05194734 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS renovascular hypertension DOID_1591 0.02154582 0.05172815 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS mesenchymal cell neoplasm DOID_3350 0.02154582 0.0515108 0.02154582 0.29189456 TENEDINI_MEGAKARYOCYTE_MARKERS skeletal muscle cancer DOID_4043 0.02154582 0.05129528 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS spindle cell sarcoma DOID_4235 0.02154582 0.0515108 0.02154582 0.29189456 TENEDINI_MEGAKARYOCYTE_MARKERS lung oat cell carcinoma DOID_5411 0.02154582 0.05108155 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS oral submucous fibrosis DOID_5773 0.02154582 0.05086959 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS epithelioid sarcoma DOID_6193 0.02154582 0.0515108 0.02154582 0.29189456 TENEDINI_MEGAKARYOCYTE_MARKERS intermediate coronary syndrome DOID_8805 0.02154582 0.05065939 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hyperhomocysteinemia DOID_9279 0.02154582 0.05045091 0.02154582 0.27862662 TENEDINI_MEGAKARYOCYTE_MARKERS hemolytic-uremic syndrome DOID_12554 0.02296589 0.0535557 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pituitary adenoma DOID_3829 0.02296589 0.05333711 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS thyroiditis DOID_7166 0.02296589 0.05312029 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS autoimmune thyroiditis DOID_7188 0.02296589 0.05312029 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS chronic myeloid leukemia DOID_8552 0.02296589 0.05290523 0.02296589 0.28407807 TENEDINI_MEGAKARYOCYTE_MARKERS lymphatic system cancer DOID_0060073 0.02438394 0.0559454 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS penile disease DOID_1529 0.02438394 0.05572072 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS bronchitis DOID_6132 0.02438394 0.05549784 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS reticulosarcoma DOID_8538 0.02438394 0.0559454 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS lymphosarcoma DOID_8675 0.02438394 0.0559454 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS male reproductive organ benign neoplasm DOID_0060087 0.02579996 0.05848677 0.02579996 0.28784664 TENEDINI_MEGAKARYOCYTE_MARKERS glucose intolerance DOID_10603 0.02579996 0.05825468 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS osteosclerosis DOID_4254 0.02579996 0.05802442 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS ureteral obstruction DOID_5199 0.02579996 0.05779598 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS dissociative disorder DOID_10935 0.02721397 0.06072451 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS dissociative amnesia DOID_11037 0.02721397 0.06072451 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS agammaglobulinemia DOID_2583 0.02721397 0.0604873 0.02721397 0.28154089 TENEDINI_MEGAKARYOCYTE_MARKERS amnestic disorder DOID_10914 0.02862596 0.0633781 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS brain edema DOID_4724 0.02862596 0.06313245 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS blood protein disease DOID_620 0.02862596 0.0628887 0.02862596 0.29086023 TENEDINI_MEGAKARYOCYTE_MARKERS gastric ulcer DOID_10808 0.03144391 0.0688138 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS acquired immunodeficiency syndrome DOID_635 0.03144391 0.06855014 0.03144391 0.30324724 TENEDINI_MEGAKARYOCYTE_MARKERS uremia DOID_4676 0.03284988 0.07134191 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS urinary tract obstruction DOID_5200 0.03284988 0.07107065 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS sleep disorder DOID_535 0.03284988 0.07080144 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS pulmonary embolism DOID_9477 0.03284988 0.07053427 0.03284988 0.30147712 TENEDINI_MEGAKARYOCYTE_MARKERS hypoglycemia DOID_9993 0.03284988 0.0702691 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS diabetic angiopathy DOID_11713 0.03425384 0.07299788 0.03425384 0.30937198 TENEDINI_MEGAKARYOCYTE_MARKERS synostosis DOID_11971 0.03425384 0.0727255 0.03425384 0.30453804 TENEDINI_MEGAKARYOCYTE_MARKERS ureteral disease DOID_1426 0.03425384 0.07245515 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS aortic valve disease DOID_62 0.03425384 0.0721868 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS meningitis DOID_9471 0.03425384 0.07192042 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS acute pancreatitis DOID_2913 0.0356558 0.07458879 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS hypogonadism DOID_1924 0.03705576 0.07723343 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS osteosarcoma DOID_3347 0.03705576 0.07695156 0.03705576 0.32438042 TENEDINI_MEGAKARYOCYTE_MARKERS papillary adenoma DOID_3172 0.03845373 0.07956425 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS microcystic adenoma DOID_5403 0.03845373 0.07956425 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS follicular adenoma DOID_6204 0.03845373 0.07956425 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS myositis DOID_633 0.03845373 0.07927598 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS ankylosing spondylitis DOID_7147 0.03845373 0.07898978 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS intracranial aneurysm DOID_10941 0.0398497 0.08156287 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS myopia DOID_11830 0.0398497 0.08127053 0.0398497 0.33842506 TENEDINI_MEGAKARYOCYTE_MARKERS renal hypertension DOID_1073 0.04263568 0.08664179 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS secondary hypertension DOID_11130 0.04263568 0.08664179 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS autoimmune disease of endocrine system DOID_0060005 0.04402569 0.08914811 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS toxic encephalopathy DOID_3602 0.04402569 0.08883198 0.04402569 0.32961339 TENEDINI_MEGAKARYOCYTE_MARKERS corneal disease DOID_10124 0.04541372 0.09130886 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS dysostosis DOID_1934 0.04541372 0.09098735 0.04541372 0.32300509 TENEDINI_MEGAKARYOCYTE_MARKERS age related macular degeneration DOID_10871 0.04679977 0.09343533 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS degeneration of macula and posterior pole DOID_2007 0.04679977 0.09343533 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS gonadal disease DOID_2277 0.04679977 0.09310864 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS opportunistic mycosis DOID_2473 0.04679977 0.09278422 0.04679977 0.32875395 TENEDINI_MEGAKARYOCYTE_MARKERS celiac disease DOID_10608 0.04818385 0.09519656 1.000 1.000 TENEDINI_MEGAKARYOCYTE_MARKERS allergic rhinitis DOID_4481 0.04818385 0.09486716 0.04818385 0.33434889 TENEDINI_MEGAKARYOCYTE_MARKERS systemic mycosis DOID_0050136 0.05094608 0.09995973 0.05094608 0.33707349 TENEDINI_MEGAKARYOCYTE_MARKERS fungal infectious disease DOID_1564 0.05094608 0.09995973 0.05094608 0.33707349 BROWNE_HCMV_INFECTION_14HR_DN biliary tract cancer DOID_4607 2.859E-15 1.627E-12 3.746E-09 1.066E-06 BROWNE_HCMV_INFECTION_14HR_DN gallbladder cancer DOID_3121 5.031E-13 1.431E-10 1.355E-09 7.711E-07 BROWNE_HCMV_INFECTION_14HR_DN bile duct cancer DOID_4606 6.081E-12 1.153E-09 6.97E-06 5.666E-04 BROWNE_HCMV_INFECTION_14HR_DN bile duct carcinoma DOID_4897 6.081E-12 1.153E-09 6.97E-06 5.666E-04 BROWNE_HCMV_INFECTION_14HR_DN atrophic muscular disease DOID_913 1.229E-10 1.749E-08 1.623E-07 3.078E-05 BROWNE_HCMV_INFECTION_14HR_DN muscular dystrophy DOID_9884 1.229E-10 1.749E-08 1.623E-07 3.078E-05 BROWNE_HCMV_INFECTION_14HR_DN bile duct adenocarcinoma DOID_4896 1.425E-10 1.622E-08 1.115E-04 3.733E-03 BROWNE_HCMV_INFECTION_14HR_DN cholangiocarcinoma DOID_4947 1.425E-10 1.622E-08 1.115E-04 3.733E-03 BROWNE_HCMV_INFECTION_14HR_DN seminoma DOID_4440 2.081E-09 1.974E-07 6.374E-06 6.044E-04 BROWNE_HCMV_INFECTION_14HR_DN germinoma DOID_3304 7.272E-09 5.911E-07 1.415E-05 8.944E-04 BROWNE_HCMV_INFECTION_14HR_DN pancreatic ductal carcinoma DOID_3587 3.195E-08 2.273E-06 1.688E-05 9.604E-04 BROWNE_HCMV_INFECTION_14HR_DN pancreatic carcinoma DOID_4905 4.241E-08 2.681E-06 2.054E-05 1.063E-03 BROWNE_HCMV_INFECTION_14HR_DN pre-eclampsia DOID_10591 8.115E-08 4.617E-06 2.58E-06 2.936E-04 BROWNE_HCMV_INFECTION_14HR_DN transitional cell carcinoma DOID_2671 1.378E-07 7.126E-06 0.32337439 0.65480437 BROWNE_HCMV_INFECTION_14HR_DN dilated cardiomyopathy DOID_12930 2.309E-07 1.095E-05 8.555E-04 0.02318015 BROWNE_HCMV_INFECTION_14HR_DN neuroectodermal tumor DOID_171 3.642E-07 1.594E-05 0.0314764 0.215784 BROWNE_HCMV_INFECTION_14HR_DN embryonal cancer DOID_688 8.296E-07 3.372E-05 2.732E-05 1.196E-03 BROWNE_HCMV_INFECTION_14HR_DN mixed glioma DOID_5076 1.379E-06 5.23E-05 0.04718821 0.2355271 BROWNE_HCMV_INFECTION_14HR_DN limb-girdle muscular dystrophy DOID_11724 1.55E-06 5.51E-05 1.55E-06 2.204E-04 BROWNE_HCMV_INFECTION_14HR_DN uterine cancer DOID_363 1.887E-06 6.317E-05 0.18444248 0.42661696 BROWNE_HCMV_INFECTION_14HR_DN myeloma DOID_0070004 2.58E-06 8.154E-05 0.19499418 0.44380674 BROWNE_HCMV_INFECTION_14HR_DN heart valve disease DOID_4079 2.58E-06 7.725E-05 0.01989078 0.15719243 BROWNE_HCMV_INFECTION_14HR_DN Crohn's disease DOID_8778 4.018E-06 1.143E-04 6.34E-05 2.405E-03 BROWNE_HCMV_INFECTION_14HR_DN bone marrow cancer DOID_4960 4.975E-06 1.348E-04 0.21909008 0.47220552 BROWNE_HCMV_INFECTION_14HR_DN reproductive organ benign neoplasm DOID_0050622 5.425E-06 1.403E-04 2.06E-03 0.03780681 BROWNE_HCMV_INFECTION_14HR_DN parasitic protozoa infectious disease DOID_2789 5.425E-06 1.342E-04 2.06E-03 0.03662535 BROWNE_HCMV_INFECTION_14HR_DN invasive ductal carcinoma DOID_3008 8.474E-06 2.009E-04 8.474E-06 6.027E-04 BROWNE_HCMV_INFECTION_14HR_DN respiratory failure DOID_11162 9.544E-06 2.172E-04 1.861E-04 5.882E-03 BROWNE_HCMV_INFECTION_14HR_DN pre-malignant neoplasm DOID_0060071 1.029E-05 2.252E-04 2.979E-03 0.04580571 BROWNE_HCMV_INFECTION_14HR_DN in situ carcinoma DOID_8719 1.029E-05 2.252E-04 2.979E-03 0.04580571 BROWNE_HCMV_INFECTION_14HR_DN endometrial carcinoma DOID_2871 1.104E-05 2.327E-04 0.12958628 0.35111711 BROWNE_HCMV_INFECTION_14HR_DN parasitic infectious disease DOID_1398 1.192E-05 2.422E-04 3.242E-03 0.04729451 BROWNE_HCMV_INFECTION_14HR_DN endometrial cancer DOID_1380 1.415E-05 2.776E-04 0.13710711 0.36117566 BROWNE_HCMV_INFECTION_14HR_DN brain infarction DOID_3454 1.473E-05 2.794E-04 0.03804892 0.23791027 BROWNE_HCMV_INFECTION_14HR_DN astrocytoma DOID_3069 1.578E-05 2.896E-04 0.03902719 0.23877926 BROWNE_HCMV_INFECTION_14HR_DN peritonitis DOID_8283 1.699E-05 3.021E-04 1.193E-03 0.02514394 BROWNE_HCMV_INFECTION_14HR_DN spindle cell carcinoma DOID_4015 1.995E-05 3.439E-04 0.01121686 0.10462939 BROWNE_HCMV_INFECTION_14HR_DN vulva cancer DOID_1245 2.202E-05 3.685E-04 2.202E-05 1.044E-03 BROWNE_HCMV_INFECTION_14HR_DN adult respiratory distress syndrome DOID_11394 3.652E-05 5.938E-04 8.638E-04 0.02234147 BROWNE_HCMV_INFECTION_14HR_DN retinal vascular disease DOID_2462 3.955E-05 6.25E-04 0.05479043 0.24547836 BROWNE_HCMV_INFECTION_14HR_DN primitive neuroectodermal tumor DOID_168 4.781E-05 7.352E-04 0.18089479 0.42532701 BROWNE_HCMV_INFECTION_14HR_DN cerebral infarction DOID_3526 5.663E-05 8.479E-04 0.01841889 0.14971924 BROWNE_HCMV_INFECTION_14HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 6.34E-05 9.25E-04 6.34E-05 2.577E-03 BROWNE_HCMV_INFECTION_14HR_DN psoriasis DOID_8893 7.319E-05 1.041E-03 7.319E-05 2.603E-03 BROWNE_HCMV_INFECTION_14HR_DN giant cell tumor DOID_200 1.04E-04 1.444E-03 0.02458846 0.18408989 BROWNE_HCMV_INFECTION_14HR_DN malignant giant cell tumor DOID_2705 1.04E-04 1.444E-03 0.02458846 0.18408989 BROWNE_HCMV_INFECTION_14HR_DN giant cell glioblastoma DOID_3074 1.04E-04 1.444E-03 0.02458846 0.18408989 BROWNE_HCMV_INFECTION_14HR_DN sinusitis DOID_0050127 1.321E-04 1.789E-03 0.09492822 0.30516473 BROWNE_HCMV_INFECTION_14HR_DN paranasal sinus disease DOID_1352 1.321E-04 1.789E-03 0.09492822 0.30516473 BROWNE_HCMV_INFECTION_14HR_DN glioblastoma DOID_3068 1.454E-04 1.924E-03 0.02881283 0.20493123 BROWNE_HCMV_INFECTION_14HR_DN spinal cord disease DOID_319 2.405E-04 3.11E-03 0.11434862 0.33366341 BROWNE_HCMV_INFECTION_14HR_DN middle cerebral artery infarction DOID_3525 2.405E-04 3.041E-03 0.11434862 0.33196105 BROWNE_HCMV_INFECTION_14HR_DN gestational diabetes DOID_11714 2.674E-04 3.307E-03 0.11818271 0.33455703 BROWNE_HCMV_INFECTION_14HR_DN lung adenocarcinoma DOID_3910 2.674E-04 3.237E-03 0.11818271 0.33290081 BROWNE_HCMV_INFECTION_14HR_DN periodontitis DOID_824 2.674E-04 3.169E-03 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN sarcoma DOID_1115 2.961E-04 3.439E-03 7.473E-03 0.08022397 BROWNE_HCMV_INFECTION_14HR_DN coronary stenosis DOID_4248 2.961E-04 3.37E-03 7.473E-03 0.07873834 BROWNE_HCMV_INFECTION_14HR_DN nephrosis DOID_2527 3.068E-04 3.423E-03 0.04101223 0.24564167 BROWNE_HCMV_INFECTION_14HR_DN diabetic retinopathy DOID_8947 3.399E-04 3.719E-03 0.0430346 0.22672858 BROWNE_HCMV_INFECTION_14HR_DN female reproductive organ benign neoplasm DOID_0060086 3.595E-04 3.859E-03 8.472E-03 0.08457531 BROWNE_HCMV_INFECTION_14HR_DN uterine benign neoplasm DOID_0060095 3.595E-04 3.859E-03 8.472E-03 0.08457531 BROWNE_HCMV_INFECTION_14HR_DN uterine fibroid DOID_13223 3.595E-04 3.859E-03 8.472E-03 0.08457531 BROWNE_HCMV_INFECTION_14HR_DN aneurysm disease DOID_2403 3.94E-04 4.152E-03 0.04613644 0.23865121 BROWNE_HCMV_INFECTION_14HR_DN bacterial pneumonia DOID_874 4.134E-04 4.277E-03 4.134E-04 0.01237945 BROWNE_HCMV_INFECTION_14HR_DN metabolic syndrome X DOID_14221 4.541E-04 4.614E-03 5.482E-03 0.07426159 BROWNE_HCMV_INFECTION_14HR_DN leiomyoma DOID_127 4.699E-04 4.691E-03 0.01007775 0.09719053 BROWNE_HCMV_INFECTION_14HR_DN pleural disease DOID_1532 4.699E-04 4.61E-03 0.14084326 0.36930791 BROWNE_HCMV_INFECTION_14HR_DN female reproductive system disease DOID_229 4.755E-04 4.586E-03 5.669E-03 0.07012615 BROWNE_HCMV_INFECTION_14HR_DN chronic kidney failure DOID_784 5.204E-04 4.935E-03 0.05257646 0.23742864 BROWNE_HCMV_INFECTION_14HR_DN nephroblastoma DOID_2154 5.543E-04 5.17E-03 0.14826741 0.38173827 BROWNE_HCMV_INFECTION_14HR_DN periodontal disease DOID_3388 5.543E-04 5.087E-03 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN esophageal disease DOID_6050 5.543E-04 5.006E-03 5.543E-04 0.01576992 BROWNE_HCMV_INFECTION_14HR_DN medullomyoblastoma DOID_3861 5.999E-04 5.334E-03 0.15195554 0.3859942 BROWNE_HCMV_INFECTION_14HR_DN adult medulloblastoma DOID_3864 5.999E-04 5.334E-03 0.15195554 0.3859942 BROWNE_HCMV_INFECTION_14HR_DN childhood medulloblastoma DOID_3869 5.999E-04 5.334E-03 0.15195554 0.3859942 BROWNE_HCMV_INFECTION_14HR_DN primary bacterial infectious disease DOID_0050338 6.192E-04 5.421E-03 6.876E-03 0.07985092 BROWNE_HCMV_INFECTION_14HR_DN calcinosis DOID_182 6.982E-04 6.019E-03 0.15928424 0.39751199 BROWNE_HCMV_INFECTION_14HR_DN medulloblastoma DOID_3858 6.982E-04 5.929E-03 0.15928424 0.39577613 BROWNE_HCMV_INFECTION_14HR_DN cleft palate DOID_674 6.982E-04 5.842E-03 0.15928424 0.39405536 BROWNE_HCMV_INFECTION_14HR_DN multiple myeloma DOID_9538 6.982E-04 5.757E-03 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN nervous system cancer DOID_3093 7.015E-04 5.703E-03 0.32922973 0.66194953 BROWNE_HCMV_INFECTION_14HR_DN Human immunodeficiency virus infectious disease DOID_526 7.015E-04 5.622E-03 7.533E-03 0.0779307 BROWNE_HCMV_INFECTION_14HR_DN blood platelet disease DOID_2218 7.509E-04 5.934E-03 0.01365578 0.1177294 BROWNE_HCMV_INFECTION_14HR_DN interstitial nephritis DOID_1063 8.181E-04 6.377E-03 0.04243168 0.24636354 BROWNE_HCMV_INFECTION_14HR_DN retinal vascular occlusion DOID_1729 8.181E-04 6.291E-03 0.04243168 0.23904581 BROWNE_HCMV_INFECTION_14HR_DN teratoma DOID_3307 8.181E-04 6.207E-03 0.04243168 0.23440414 BROWNE_HCMV_INFECTION_14HR_DN chondrosarcoma DOID_3371 8.181E-04 6.125E-03 0.04243168 0.23215025 BROWNE_HCMV_INFECTION_14HR_DN malignant teratoma DOID_5563 8.181E-04 6.207E-03 0.04243168 0.23440414 BROWNE_HCMV_INFECTION_14HR_DN mature teratoma DOID_5566 8.181E-04 6.207E-03 0.04243168 0.23440414 BROWNE_HCMV_INFECTION_14HR_DN intracranial arterial disease DOID_13089 8.638E-04 6.383E-03 0.17015943 0.41733068 BROWNE_HCMV_INFECTION_14HR_DN cerebral arterial disease DOID_3527 8.638E-04 6.383E-03 0.17015943 0.41733068 BROWNE_HCMV_INFECTION_14HR_DN benign mesothelioma DOID_2645 9.241E-04 6.741E-03 0.17375333 0.42070488 BROWNE_HCMV_INFECTION_14HR_DN autoimmune disease of urogenital tract DOID_0060049 9.87E-04 7.109E-03 0.01630236 0.13641241 BROWNE_HCMV_INFECTION_14HR_DN primary biliary cirrhosis DOID_12236 9.87E-04 7.109E-03 0.01630236 0.13641241 BROWNE_HCMV_INFECTION_14HR_DN maturity-onset diabetes of the young DOID_0050524 9.971E-04 7.092E-03 9.971E-04 0.02466739 BROWNE_HCMV_INFECTION_14HR_DN trypanosomiasis DOID_10113 9.971E-04 7.004E-03 9.971E-04 0.02363959 BROWNE_HCMV_INFECTION_14HR_DN prostatic adenoma DOID_2883 9.971E-04 6.919E-03 9.971E-04 0.022694 BROWNE_HCMV_INFECTION_14HR_DN epidermolysis bullosa DOID_2730 1.193E-03 8.179E-03 1.193E-03 0.02611102 BROWNE_HCMV_INFECTION_14HR_DN lipodystrophy DOID_811 1.193E-03 8.082E-03 0.05070078 0.2364651 BROWNE_HCMV_INFECTION_14HR_DN brain cancer DOID_1319 1.342E-03 8.983E-03 0.19499418 0.44028447 BROWNE_HCMV_INFECTION_14HR_DN thyroid adenoma DOID_2891 1.342E-03 8.878E-03 0.01989078 0.1594064 BROWNE_HCMV_INFECTION_14HR_DN vesiculobullous skin disease DOID_2731 1.406E-03 9.196E-03 1.406E-03 0.02857294 BROWNE_HCMV_INFECTION_14HR_DN Lynch syndrome DOID_3883 1.406E-03 9.091E-03 1.406E-03 0.02758766 BROWNE_HCMV_INFECTION_14HR_DN psoriatic arthritis DOID_9008 1.406E-03 8.989E-03 1.406E-03 0.02666808 BROWNE_HCMV_INFECTION_14HR_DN central nervous system cancer DOID_3620 1.421E-03 8.985E-03 0.19848117 0.44288543 BROWNE_HCMV_INFECTION_14HR_DN pulmonary tuberculosis DOID_2957 1.503E-03 9.401E-03 0.02141029 0.16688292 BROWNE_HCMV_INFECTION_14HR_DN calcium metabolism disease DOID_10575 1.589E-03 9.826E-03 0.20541017 0.45126791 BROWNE_HCMV_INFECTION_14HR_DN aortic aneurysm DOID_3627 1.589E-03 9.72E-03 0.0221876 0.17060469 BROWNE_HCMV_INFECTION_14HR_DN tethered spinal cord syndrome DOID_1089 1.636E-03 9.901E-03 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN hemorrhagic disease DOID_2213 1.677E-03 0.01004327 0.02297648 0.1743149 BROWNE_HCMV_INFECTION_14HR_DN orofacial cleft DOID_0050567 1.768E-03 0.01047889 0.21227964 0.46101953 BROWNE_HCMV_INFECTION_14HR_DN idiopathic pulmonary fibrosis DOID_0050156 1.882E-03 0.01103996 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN intermediate coronary syndrome DOID_8805 1.882E-03 0.01092731 0.06297153 0.25411915 BROWNE_HCMV_INFECTION_14HR_DN vasculitis DOID_865 1.959E-03 0.01126165 0.02541133 0.18777983 BROWNE_HCMV_INFECTION_14HR_DN angiosarcoma DOID_0001816 2.145E-03 0.01220387 2.145E-03 0.03698143 BROWNE_HCMV_INFECTION_14HR_DN familial hyperlipidemia DOID_1168 2.163E-03 0.01218719 2.163E-03 0.03620314 BROWNE_HCMV_INFECTION_14HR_DN congenital nervous system abnormality DOID_2490 2.27E-03 0.01266284 2.27E-03 0.03690313 BROWNE_HCMV_INFECTION_14HR_DN urinary system benign neoplasm DOID_731 2.424E-03 0.01339013 0.07106432 0.26428495 BROWNE_HCMV_INFECTION_14HR_DN leukocyte disease DOID_9500 2.493E-03 0.01363954 0.02969015 0.2060207 BROWNE_HCMV_INFECTION_14HR_DN congenital muscular dystrophy DOID_0050557 2.719E-03 0.01473508 0.07508462 0.27563323 BROWNE_HCMV_INFECTION_14HR_DN male reproductive organ benign neoplasm DOID_0060087 2.719E-03 0.01459607 2.719E-03 0.04297733 BROWNE_HCMV_INFECTION_14HR_DN neuroendocrine tumor DOID_169 2.719E-03 0.01445966 0.07508462 0.27039969 BROWNE_HCMV_INFECTION_14HR_DN prion disease DOID_649 2.719E-03 0.01432578 0.07508462 0.26536119 BROWNE_HCMV_INFECTION_14HR_DN carotid artery disease DOID_3407 2.729E-03 0.01424647 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN testicular cancer DOID_2998 3.03E-03 0.01567551 0.07908764 0.27607893 BROWNE_HCMV_INFECTION_14HR_DN infertility DOID_5223 3.03E-03 0.01553429 3.03E-03 0.04537647 BROWNE_HCMV_INFECTION_14HR_DN mineral metabolism disease DOID_0050032 3.108E-03 0.01579173 0.25227434 0.52773565 BROWNE_HCMV_INFECTION_14HR_DN uterine disease DOID_345 3.242E-03 0.01632288 0.0351723 0.23270972 BROWNE_HCMV_INFECTION_14HR_DN esophagitis DOID_11963 3.358E-03 0.0167585 3.358E-03 0.04776171 BROWNE_HCMV_INFECTION_14HR_DN brain edema DOID_4724 3.358E-03 0.01661277 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN subependymal glioma DOID_4843 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN pilocytic astrocytoma DOID_4851 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN subependymal giant cell astrocytoma DOID_5077 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN fibrillary astrocytoma DOID_6726 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN juvenile pilocytic astrocytoma DOID_6811 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN childhood pilocytic astrocytoma DOID_6812 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN gemistocytic astrocytoma DOID_7005 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN childhood cerebral astrocytoma DOID_7007 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN protoplasmic astrocytoma DOID_7008 3.358E-03 0.01646956 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN temporal lobe epilepsy DOID_3328 3.378E-03 0.0164296 0.03612137 0.23624206 BROWNE_HCMV_INFECTION_14HR_DN tooth disease DOID_1091 3.518E-03 0.01696627 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN allergic contact dermatitis DOID_3042 3.518E-03 0.0168237 0.03708028 0.2370638 BROWNE_HCMV_INFECTION_14HR_DN endocrine organ benign neoplasm DOID_0060089 3.662E-03 0.01736479 0.03804892 0.24055372 BROWNE_HCMV_INFECTION_14HR_DN tuberculosis DOID_399 3.662E-03 0.01722128 0.03804892 0.23532429 BROWNE_HCMV_INFECTION_14HR_DN coronary restenosis DOID_4247 3.701E-03 0.01725895 0.08704207 0.29305882 BROWNE_HCMV_INFECTION_14HR_DN blood coagulation disease DOID_1247 3.96E-03 0.01831978 0.04001499 0.24221842 BROWNE_HCMV_INFECTION_14HR_DN benign glioma DOID_0060101 4.059E-03 0.01862576 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN hepatitis B DOID_2043 4.059E-03 0.01847676 0.09099365 0.29755968 BROWNE_HCMV_INFECTION_14HR_DN benign ependymoma DOID_4844 4.059E-03 0.01862576 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN placenta disease DOID_780 4.059E-03 0.01833012 0.09099365 0.29417832 BROWNE_HCMV_INFECTION_14HR_DN biliary tract disease DOID_9741 4.273E-03 0.01914218 0.0420188 0.2464814 BROWNE_HCMV_INFECTION_14HR_DN muscle cancer DOID_4045 4.433E-03 0.01970624 0.09492822 0.30007865 BROWNE_HCMV_INFECTION_14HR_DN aortic valve disease DOID_62 4.822E-03 0.02127073 0.09884587 0.3056701 BROWNE_HCMV_INFECTION_14HR_DN meningitis DOID_9471 4.822E-03 0.02110711 0.09884587 0.30401783 BROWNE_HCMV_INFECTION_14HR_DN toxic shock syndrome DOID_14115 5.227E-03 0.022703 5.227E-03 0.07253884 BROWNE_HCMV_INFECTION_14HR_DN contact dermatitis DOID_2773 5.482E-03 0.02362869 0.04931791 0.24401644 BROWNE_HCMV_INFECTION_14HR_DN lipid metabolism disorder DOID_3146 5.482E-03 0.02345103 5.482E-03 0.07253457 BROWNE_HCMV_INFECTION_14HR_DN commensal bacterial infectious disease DOID_0050339 5.646E-03 0.02397632 5.646E-03 0.07301878 BROWNE_HCMV_INFECTION_14HR_DN osteosarcoma DOID_3347 5.646E-03 0.02379871 5.646E-03 0.07139614 BROWNE_HCMV_INFECTION_14HR_DN alcohol abuse DOID_1574 6.056E-03 0.02533795 6.056E-03 0.07331833 BROWNE_HCMV_INFECTION_14HR_DN mental depression DOID_1596 6.056E-03 0.025153 0.05257646 0.24125813 BROWNE_HCMV_INFECTION_14HR_DN focal epilepsy DOID_2234 6.056E-03 0.02497074 0.05257646 0.23932807 BROWNE_HCMV_INFECTION_14HR_DN cleft lip DOID_9296 6.081E-03 0.02489243 0.11049796 0.32408939 BROWNE_HCMV_INFECTION_14HR_DN dystonia DOID_543 6.53E-03 0.02654057 6.53E-03 0.07741 BROWNE_HCMV_INFECTION_14HR_DN perinatal necrotizing enterocolitis DOID_8677 6.994E-03 0.02822444 6.994E-03 0.07959292 BROWNE_HCMV_INFECTION_14HR_DN amino acid metabolic disorder DOID_9252 7.31E-03 0.02929182 7.31E-03 0.08155761 BROWNE_HCMV_INFECTION_14HR_DN autoimmune disease of cardiovascular system DOID_0060051 7.473E-03 0.02973336 7.473E-03 0.08176674 BROWNE_HCMV_INFECTION_14HR_DN Behcet's disease DOID_13241 7.473E-03 0.02973336 7.473E-03 0.08176674 BROWNE_HCMV_INFECTION_14HR_DN supratentorial cancer DOID_1659 7.965E-03 0.03147415 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN cerebrum cancer DOID_368 7.965E-03 0.03147415 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN lymphoma DOID_0060058 7.99E-03 0.03135513 7.99E-03 0.08118739 BROWNE_HCMV_INFECTION_14HR_DN carbohydrate metabolic disorder DOID_2978 8.225E-03 0.03205525 0.06396337 0.25451159 BROWNE_HCMV_INFECTION_14HR_DN encephalomyelitis DOID_640 8.225E-03 0.03183719 0.06396337 0.25274415 BROWNE_HCMV_INFECTION_14HR_DN mouth disease DOID_403 8.464E-03 0.03254007 1.000 1.000 BROWNE_HCMV_INFECTION_14HR_DN abdominal aortic aneurysm DOID_7693 8.994E-03 0.03434457 0.1333548 0.35457421 BROWNE_HCMV_INFECTION_14HR_DN ulcerative colitis DOID_8577 9.46E-03 0.03588312 9.46E-03 0.09280116 BROWNE_HCMV_INFECTION_14HR_DN hereditary spastic paraplegia DOID_2476 0.01007775 0.03797511 0.01007775 0.09557069 BROWNE_HCMV_INFECTION_14HR_DN thyroid carcinoma DOID_3963 0.01121686 0.04198943 0.14826741 0.38001872 BROWNE_HCMV_INFECTION_14HR_DN paraplegia DOID_607 0.01121686 0.04171499 0.01121686 0.10294182 BROWNE_HCMV_INFECTION_14HR_DN leukopenia DOID_615 0.01121686 0.04144411 0.01121686 0.10130782 BROWNE_HCMV_INFECTION_14HR_DN lymphoid leukemia DOID_10747 0.01180669 0.04334198 0.01180669 0.10496885 BROWNE_HCMV_INFECTION_14HR_DN thyroid cancer DOID_1781 0.01240987 0.04526421 0.15562779 0.3935654 BROWNE_HCMV_INFECTION_14HR_DN microcephaly DOID_10907 0.01365578 0.04949134 0.01365578 0.11954062 BROWNE_HCMV_INFECTION_14HR_DN uveitis DOID_13141 0.01365578 0.0491781 0.16292495 0.40131731 BROWNE_HCMV_INFECTION_14HR_DN peptic ulcer DOID_750 0.01429827 0.05116801 0.01429827 0.12142857 BROWNE_HCMV_INFECTION_14HR_DN lymphatic system disease DOID_75 0.01495361 0.05317876 0.17015943 0.41376375 BROWNE_HCMV_INFECTION_14HR_DN cervix uteri carcinoma in situ DOID_8991 0.01562168 0.05520953 0.17375333 0.41892223 BROWNE_HCMV_INFECTION_14HR_DN nephrotic syndrome DOID_1184 0.01699554 0.0596942 0.18089479 0.4288714 BROWNE_HCMV_INFECTION_14HR_DN rheumatic disease DOID_1575 0.01699554 0.05932798 0.18089479 0.42709185 BROWNE_HCMV_INFECTION_14HR_DN uveal disease DOID_3480 0.01699554 0.05896622 0.18089479 0.42011893 BROWNE_HCMV_INFECTION_14HR_DN scleroderma DOID_419 0.01699554 0.05932798 0.18089479 0.42709185 BROWNE_HCMV_INFECTION_14HR_DN influenza DOID_8469 0.01770109 0.06104193 0.01770109 0.14596982 BROWNE_HCMV_INFECTION_14HR_DN cataract DOID_83 0.01841889 0.06313462 0.1879749 0.43302719 BROWNE_HCMV_INFECTION_14HR_DN lens disease DOID_110 0.01989078 0.06777159 0.19499418 0.44203859 BROWNE_HCMV_INFECTION_14HR_DN bone marrow disease DOID_4961 0.01989078 0.06736818 0.19499418 0.43854421 BROWNE_HCMV_INFECTION_14HR_DN glaucoma DOID_1686 0.02141029 0.07208552 0.20195314 0.44539279 BROWNE_HCMV_INFECTION_14HR_DN integumentary system cancer DOID_0060122 0.02624531 0.08784461 0.22247333 0.47768801 BROWNE_HCMV_INFECTION_14HR_DN skin cancer DOID_4159 0.02624531 0.08784461 0.22247333 0.47768801 BROWNE_HCMV_INFECTION_14HR_DN pustulosis of palm and sole DOID_4398 0.02624531 0.0873309 0.02624531 0.1914562 BROWNE_HCMV_INFECTION_14HR_DN smallpox DOID_8736 0.02624531 0.08682316 0.02624531 0.18903271 BROWNE_HCMV_INFECTION_14HR_DN hypersensitivity reaction type IV disease DOID_2916 0.02881283 0.09476589 0.23253589 0.49186959 BROWNE_HCMV_INFECTION_14HR_DN oral cavity cancer DOID_8618 0.02881283 0.09422125 0.02881283 0.20240121 ONDER_CDH1_TARGETS_2_DN transitional cell carcinoma DOID_2671 1.011E-22 5.752E-20 2.65E-12 5.027E-10 ONDER_CDH1_TARGETS_2_DN vesiculobullous skin disease DOID_2731 1.769E-22 5.033E-20 9.253E-20 5.265E-17 ONDER_CDH1_TARGETS_2_DN epidermolysis bullosa DOID_2730 2.149E-20 4.076E-18 1.018E-17 2.897E-15 ONDER_CDH1_TARGETS_2_DN cystic fibrosis DOID_1485 4.108E-19 5.844E-17 2.504E-03 0.02543854 ONDER_CDH1_TARGETS_2_DN influenza DOID_8469 1.246E-17 1.418E-15 0.04547071 0.21741878 ONDER_CDH1_TARGETS_2_DN bacterial pneumonia DOID_874 2.275E-17 2.157E-15 0.02039382 0.11157771 ONDER_CDH1_TARGETS_2_DN respiratory failure DOID_11162 3.336E-17 2.711E-15 1.279E-03 0.01484633 ONDER_CDH1_TARGETS_2_DN giant cell tumor DOID_200 6.716E-15 4.777E-13 3.236E-06 1.674E-04 ONDER_CDH1_TARGETS_2_DN malignant giant cell tumor DOID_2705 6.716E-15 4.777E-13 3.236E-06 1.674E-04 ONDER_CDH1_TARGETS_2_DN giant cell glioblastoma DOID_3074 6.716E-15 4.777E-13 3.236E-06 1.674E-04 ONDER_CDH1_TARGETS_2_DN adult respiratory distress syndrome DOID_11394 1.077E-14 6.811E-13 3.722E-03 0.03472081 ONDER_CDH1_TARGETS_2_DN glioblastoma DOID_3068 2.029E-14 1.155E-12 5.369E-06 2.036E-04 ONDER_CDH1_TARGETS_2_DN astrocytoma DOID_3069 1.668E-13 8.628E-12 1.414E-05 4.731E-04 ONDER_CDH1_TARGETS_2_DN intracranial arterial disease DOID_13089 5.127E-13 2.431E-11 3.722E-03 0.0341608 ONDER_CDH1_TARGETS_2_DN cerebral arterial disease DOID_3527 5.127E-13 2.431E-11 3.722E-03 0.0341608 ONDER_CDH1_TARGETS_2_DN pulmonary emphysema DOID_9675 6.594E-13 2.886E-11 3.974E-03 0.0358877 ONDER_CDH1_TARGETS_2_DN uterine cancer DOID_363 1.35E-12 5.487E-11 1.13E-06 7.144E-05 ONDER_CDH1_TARGETS_2_DN primary bacterial infectious disease DOID_0050338 2.312E-12 8.769E-11 0.47603601 0.92130779 ONDER_CDH1_TARGETS_2_DN pleural disease DOID_1532 2.826E-12 1.005E-10 0.22430337 0.51881551 ONDER_CDH1_TARGETS_2_DN tuberculosis DOID_399 4.012E-12 1.343E-10 0.40279233 0.79579457 ONDER_CDH1_TARGETS_2_DN pancreatic ductal carcinoma DOID_3587 5.504E-12 1.74E-10 1.912E-04 4.03E-03 ONDER_CDH1_TARGETS_2_DN pancreatic carcinoma DOID_4905 8.691E-12 2.603E-10 2.311E-04 4.242E-03 ONDER_CDH1_TARGETS_2_DN bronchiolitis DOID_2942 9.382E-12 2.669E-10 0.17193083 0.45082325 ONDER_CDH1_TARGETS_2_DN ulcerative colitis DOID_8577 9.535E-12 2.584E-10 6.084E-03 0.047424 ONDER_CDH1_TARGETS_2_DN peptic ulcer DOID_750 1.708E-11 4.417E-10 2.407E-04 4.28E-03 ONDER_CDH1_TARGETS_2_DN middle cerebral artery infarction DOID_3525 1.843E-11 4.56E-10 1.07E-03 0.01323698 ONDER_CDH1_TARGETS_2_DN pleurisy DOID_10247 3.428E-11 8.127E-10 0.19562888 0.48821418 ONDER_CDH1_TARGETS_2_DN mineral metabolism disease DOID_0050032 5.695E-11 1.296E-09 1.274E-04 3.151E-03 ONDER_CDH1_TARGETS_2_DN uterine disease DOID_345 6.635E-11 1.452E-09 1.367E-04 2.991E-03 ONDER_CDH1_TARGETS_2_DN pulmonary tuberculosis DOID_2957 1.323E-10 2.788E-09 1.000 1.000 ONDER_CDH1_TARGETS_2_DN nephrosis DOID_2527 1.578E-10 3.207E-09 2.039E-04 4E-03 ONDER_CDH1_TARGETS_2_DN diabetic retinopathy DOID_8947 2.071E-10 4.063E-09 0.01781905 0.10345961 ONDER_CDH1_TARGETS_2_DN pancreatitis DOID_4989 3.482E-10 6.604E-09 0.11412856 0.36688787 ONDER_CDH1_TARGETS_2_DN integumentary system cancer DOID_0060122 3.687E-10 6.768E-09 6.371E-05 1.812E-03 ONDER_CDH1_TARGETS_2_DN skin cancer DOID_4159 3.687E-10 6.768E-09 6.371E-05 1.812E-03 ONDER_CDH1_TARGETS_2_DN contact dermatitis DOID_2773 4.467E-10 7.944E-09 2.284E-06 1.3E-04 ONDER_CDH1_TARGETS_2_DN female reproductive system disease DOID_229 5.047E-10 8.703E-09 3.486E-04 5.219E-03 ONDER_CDH1_TARGETS_2_DN oral cavity cancer DOID_8618 5.893E-10 9.861E-09 2.983E-07 4.243E-05 ONDER_CDH1_TARGETS_2_DN chronic kidney failure DOID_784 6.411E-10 1.042E-08 0.12602842 0.38553857 ONDER_CDH1_TARGETS_2_DN retinal vascular disease DOID_2462 8.094E-10 1.279E-08 0.02536574 0.13121007 ONDER_CDH1_TARGETS_2_DN endometriosis of uterus DOID_288 1.15E-09 1.768E-08 3.15E-04 5.121E-03 ONDER_CDH1_TARGETS_2_DN pre-malignant neoplasm DOID_0060071 1.219E-09 1.825E-08 5.163E-07 4.197E-05 ONDER_CDH1_TARGETS_2_DN in situ carcinoma DOID_8719 1.219E-09 1.825E-08 5.163E-07 4.197E-05 ONDER_CDH1_TARGETS_2_DN endometriosis DOID_289 1.383E-09 2.018E-08 3.431E-04 5.276E-03 ONDER_CDH1_TARGETS_2_DN hyperglycemia DOID_4195 1.831E-09 2.605E-08 0.01377698 0.08614396 ONDER_CDH1_TARGETS_2_DN cerebral infarction DOID_3526 1.975E-09 2.741E-08 5.08E-03 0.04251117 ONDER_CDH1_TARGETS_2_DN allergic contact dermatitis DOID_3042 2.088E-09 2.829E-08 7.755E-07 5.516E-05 ONDER_CDH1_TARGETS_2_DN endometrial carcinoma DOID_2871 2.752E-09 3.641E-08 3.264E-06 1.547E-04 ONDER_CDH1_TARGETS_2_DN bile duct disease DOID_4138 3.46E-09 4.475E-08 0.10026823 0.35217668 ONDER_CDH1_TARGETS_2_DN biliary tract disease DOID_9741 3.908E-09 4.941E-08 0.10254392 0.35796006 ONDER_CDH1_TARGETS_2_DN endometrial cancer DOID_1380 4.344E-09 5.374E-08 4.457E-06 1.951E-04 ONDER_CDH1_TARGETS_2_DN calcium metabolism disease DOID_10575 4.496E-09 5.443E-08 4.109E-05 1.299E-03 ONDER_CDH1_TARGETS_2_DN vasculitis DOID_865 8.176E-09 9.692E-08 8.196E-03 0.05618368 ONDER_CDH1_TARGETS_2_DN bronchiectasis DOID_9563 8.478E-09 9.845E-08 0.07670016 0.30307217 ONDER_CDH1_TARGETS_2_DN IgA glomerulonephritis DOID_2986 1.229E-08 1.398E-07 0.15370194 0.42454565 ONDER_CDH1_TARGETS_2_DN cholestasis DOID_13580 3.415E-08 3.81E-07 0.3896297 0.78616773 ONDER_CDH1_TARGETS_2_DN myositis DOID_633 3.516E-08 3.848E-07 1.000 1.000 ONDER_CDH1_TARGETS_2_DN mouth disease DOID_403 3.535E-08 3.795E-07 0.50203833 0.96833834 ONDER_CDH1_TARGETS_2_DN brain infarction DOID_3454 4.824E-08 5.083E-07 0.01487192 0.09197961 ONDER_CDH1_TARGETS_2_DN proteinuria DOID_576 6.324E-08 6.542E-07 4.379E-04 6.23E-03 ONDER_CDH1_TARGETS_2_DN integumentary system benign neoplasm DOID_0060121 9.669E-08 9.824E-07 6.356E-03 0.04886969 ONDER_CDH1_TARGETS_2_DN skin benign neoplasm DOID_3165 9.669E-08 9.824E-07 6.356E-03 0.04886969 ONDER_CDH1_TARGETS_2_DN hemorrhagic disease DOID_2213 1.264E-07 1.262E-06 6.354E-04 8.409E-03 ONDER_CDH1_TARGETS_2_DN metabolic syndrome X DOID_14221 1.509E-07 1.48E-06 0.1188528 0.37363119 ONDER_CDH1_TARGETS_2_DN germinoma DOID_3304 1.531E-07 1.477E-06 4.457E-06 1.811E-04 ONDER_CDH1_TARGETS_2_DN hair disease DOID_421 2.191E-07 2.078E-06 1.311E-04 2.983E-03 ONDER_CDH1_TARGETS_2_DN myocarditis DOID_820 2.191E-07 2.044E-06 2.235E-03 0.02445701 ONDER_CDH1_TARGETS_2_DN esophagitis DOID_11963 2.697E-07 2.476E-06 9.075E-03 0.05867879 ONDER_CDH1_TARGETS_2_DN arrhythmogenic right ventricular dysplasia DOID_0050431 3.269E-07 2.953E-06 3.269E-07 3.72E-05 ONDER_CDH1_TARGETS_2_DN leukocyte disease DOID_9500 3.342E-07 2.971E-06 0.07418796 0.31502201 ONDER_CDH1_TARGETS_2_DN calcinosis DOID_182 4.214E-07 3.689E-06 3.028E-03 0.03022479 ONDER_CDH1_TARGETS_2_DN embryonal cancer DOID_688 4.214E-07 3.633E-06 4.214E-07 3.996E-05 ONDER_CDH1_TARGETS_2_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.145E-07 4.37E-06 7.258E-05 1.967E-03 ONDER_CDH1_TARGETS_2_DN childhood type dermatomyositis DOID_14203 5.417E-07 4.533E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hypersensitivity reaction type I disease DOID_1205 5.573E-07 4.596E-06 5.467E-03 0.04443926 ONDER_CDH1_TARGETS_2_DN dilated cardiomyopathy DOID_12930 5.573E-07 4.53E-06 5.467E-03 0.04381335 ONDER_CDH1_TARGETS_2_DN respiratory syncytial virus infectious disease DOID_1273 5.69E-07 4.56E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_DN pulmonary embolism DOID_9477 5.751E-07 4.545E-06 0.15370194 0.41845169 ONDER_CDH1_TARGETS_2_DN dermatomyositis DOID_10223 8.465E-07 6.598E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_DN acute pancreatitis DOID_2913 8.974E-07 6.9E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_DN nephrotic syndrome DOID_1184 9.917E-07 7.523E-06 4.506E-03 0.03885016 ONDER_CDH1_TARGETS_2_DN rheumatic disease DOID_1575 9.917E-07 7.424E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_DN scleroderma DOID_419 9.917E-07 7.424E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_DN blood coagulation disease DOID_1247 1.035E-06 7.646E-06 1.965E-03 0.02192143 ONDER_CDH1_TARGETS_2_DN cystitis DOID_1679 1.348E-06 9.83E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_DN cleft lip DOID_9296 1.348E-06 9.706E-06 9.606E-04 0.01214596 ONDER_CDH1_TARGETS_2_DN endogenous depression DOID_1595 1.627E-06 1.157E-05 0.10945473 0.35792956 ONDER_CDH1_TARGETS_2_DN hypotrichosis DOID_4535 1.631E-06 1.146E-05 1.07E-03 0.01295535 ONDER_CDH1_TARGETS_2_DN pre-eclampsia DOID_10591 1.642E-06 1.139E-05 5.697E-03 0.04501887 ONDER_CDH1_TARGETS_2_DN neuritis DOID_1803 1.642E-06 1.126E-05 0.05081201 0.23698387 ONDER_CDH1_TARGETS_2_DN heart valve disease DOID_4079 1.642E-06 1.112E-05 0.30435817 0.65350867 ONDER_CDH1_TARGETS_2_DN bone resorption disease DOID_0080011 1.774E-06 1.188E-05 0.01973198 0.11340908 ONDER_CDH1_TARGETS_2_DN osteoporosis DOID_11476 1.774E-06 1.188E-05 0.01973198 0.11340908 ONDER_CDH1_TARGETS_2_DN periodontitis DOID_824 1.959E-06 1.296E-05 0.18976849 0.47777996 ONDER_CDH1_TARGETS_2_DN mental depression DOID_1596 2.912E-06 1.904E-05 0.12602842 0.38762256 ONDER_CDH1_TARGETS_2_DN biliary tract cancer DOID_4607 2.912E-06 1.883E-05 0.46057468 0.8944266 ONDER_CDH1_TARGETS_2_DN skeletal system cancer DOID_0060124 3.422E-06 2.188E-05 0.10311322 0.35775257 ONDER_CDH1_TARGETS_2_DN bone cancer DOID_184 3.422E-06 2.188E-05 0.10311322 0.35775257 ONDER_CDH1_TARGETS_2_DN varicose veins DOID_799 3.422E-06 2.164E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN intermediate coronary syndrome DOID_8805 3.422E-06 2.14E-05 0.10311322 0.34111291 ONDER_CDH1_TARGETS_2_DN parasitic protozoa infectious disease DOID_2789 3.985E-06 2.465E-05 0.34363107 0.71621274 ONDER_CDH1_TARGETS_2_DN allergic rhinitis DOID_4481 4.457E-06 2.727E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN tongue cancer DOID_8649 4.537E-06 2.746E-05 1.95E-04 3.963E-03 ONDER_CDH1_TARGETS_2_DN vein disease DOID_866 4.537E-06 2.718E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN nervous system cancer DOID_3093 4.95E-06 2.934E-05 5.601E-04 7.588E-03 ONDER_CDH1_TARGETS_2_DN Human immunodeficiency virus infectious disease DOID_526 4.95E-06 2.904E-05 0.02927988 0.15009233 ONDER_CDH1_TARGETS_2_DN bladder disease DOID_365 5.169E-06 3.001E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hypertrophic cardiomyopathy DOID_11984 5.369E-06 3.086E-05 0.07212763 0.30857609 ONDER_CDH1_TARGETS_2_DN melancholia DOID_2848 5.908E-06 3.362E-05 0.36243103 0.74718571 ONDER_CDH1_TARGETS_2_DN papilloma DOID_2615 5.967E-06 3.362E-05 1.311E-04 3.107E-03 ONDER_CDH1_TARGETS_2_DN encephalomyelitis DOID_640 6.13E-06 3.42E-05 5.08E-03 0.04313958 ONDER_CDH1_TARGETS_2_DN neurotic disorder DOID_4964 6.491E-06 3.586E-05 0.36704658 0.75396933 ONDER_CDH1_TARGETS_2_DN pneumoconiosis DOID_10316 6.859E-06 3.753E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN periodontal disease DOID_3388 6.859E-06 3.717E-05 0.2354859 0.54028822 ONDER_CDH1_TARGETS_2_DN esophageal disease DOID_6050 6.859E-06 3.682E-05 0.02935724 0.14782538 ONDER_CDH1_TARGETS_2_DN collagen disease DOID_854 7.119E-06 3.786E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN testicular cancer DOID_2998 9.499E-06 5.005E-05 9.499E-06 3.378E-04 ONDER_CDH1_TARGETS_2_DN leishmaniasis DOID_9065 9.499E-06 4.959E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN parasitic infectious disease DOID_1398 1.014E-05 5.248E-05 0.3896297 0.78338975 ONDER_CDH1_TARGETS_2_DN temporal lobe epilepsy DOID_3328 1.104E-05 5.661E-05 0.39404905 0.78671547 ONDER_CDH1_TARGETS_2_DN blood platelet disease DOID_2218 1.152E-05 5.851E-05 3.25E-03 0.03133874 ONDER_CDH1_TARGETS_2_DN pulmonary edema DOID_11396 1.181E-05 5.945E-05 0.13507326 0.40450886 ONDER_CDH1_TARGETS_2_DN brain edema DOID_4724 1.181E-05 5.893E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN adenoid cystic carcinoma DOID_4866 1.462E-05 7.234E-05 2.639E-04 4.55E-03 ONDER_CDH1_TARGETS_2_DN male reproductive system disease DOID_48 1.656E-05 8.123E-05 1.000 1.000 ONDER_CDH1_TARGETS_2_DN funisitis DOID_0050698 1.762E-05 8.571E-05 5.194E-04 7.209E-03 ONDER_CDH1_TARGETS_2_DN peripheral vascular disease DOID_341 1.789E-05 8.627E-05 0.01720556 0.10305227 ONDER_CDH1_TARGETS_2_DN salivary gland cancer DOID_8850 1.834E-05 8.768E-05 3.15E-04 4.979E-03 ONDER_CDH1_TARGETS_2_DN urinary tract obstruction DOID_5200 2.121E-05 1.006E-04 0.01191355 0.0753201 ONDER_CDH1_TARGETS_2_DN gallbladder cancer DOID_3121 2.275E-05 1.07E-04 0.28903465 0.6325412 ONDER_CDH1_TARGETS_2_DN synostosis DOID_11971 2.531E-05 1.18E-04 6.754E-04 8.734E-03 ONDER_CDH1_TARGETS_2_DN vascular skin disease DOID_9540 3.088E-05 1.428E-04 0.05081201 0.23505717 ONDER_CDH1_TARGETS_2_DN portal hypertension DOID_10762 3.521E-05 1.616E-04 0.17193083 0.45291039 ONDER_CDH1_TARGETS_2_DN focal epilepsy DOID_2234 3.659E-05 1.665E-04 0.46057468 0.89748971 ONDER_CDH1_TARGETS_2_DN glaucoma DOID_1686 3.743E-05 1.69E-04 0.31439058 0.66501205 ONDER_CDH1_TARGETS_2_DN lung small cell carcinoma DOID_5409 3.743E-05 1.677E-04 6.356E-03 0.0482181 ONDER_CDH1_TARGETS_2_DN bone development disease DOID_0080006 3.909E-05 1.738E-04 4.108E-04 5.994E-03 ONDER_CDH1_TARGETS_2_DN seminoma DOID_4440 4.767E-05 2.103E-04 4.767E-05 1.428E-03 ONDER_CDH1_TARGETS_2_DN orofacial cleft DOID_0050567 4.923E-05 2.155E-04 7.426E-03 0.05153054 ONDER_CDH1_TARGETS_2_DN sarcoidosis DOID_11335 5.374E-05 2.334E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN pneumocystosis DOID_11339 5.903E-05 2.544E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN invasive lobular carcinoma DOID_3457 5.903E-05 2.525E-04 0.07670016 0.30952051 ONDER_CDH1_TARGETS_2_DN autoimmune disease of cardiovascular system DOID_0060051 6.309E-05 2.679E-04 0.01981707 0.11275914 ONDER_CDH1_TARGETS_2_DN Behcet's disease DOID_13241 6.309E-05 2.679E-04 0.01981707 0.11275914 ONDER_CDH1_TARGETS_2_DN hepatic vascular disease DOID_272 6.309E-05 2.659E-04 0.19562888 0.4797967 ONDER_CDH1_TARGETS_2_DN invasive ductal carcinoma DOID_3008 6.309E-05 2.639E-04 0.01981707 0.11164271 ONDER_CDH1_TARGETS_2_DN lymphoblastic leukemia DOID_1037 6.845E-05 2.843E-04 0.15062822 0.42013459 ONDER_CDH1_TARGETS_2_DN common cold DOID_10459 7.828E-05 3.228E-04 0.08337521 0.32493488 ONDER_CDH1_TARGETS_2_DN diarrhea DOID_13250 7.828E-05 3.204E-04 0.08337521 0.31626995 ONDER_CDH1_TARGETS_2_DN ocular hypertension DOID_9282 7.828E-05 3.182E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN borderline glaucoma DOID_9283 7.828E-05 3.182E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hypersensitivity reaction type IV disease DOID_2916 8.127E-05 3.279E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN dysostosis DOID_1934 8.185E-05 3.28E-04 1.586E-03 0.01804932 ONDER_CDH1_TARGETS_2_DN opportunistic mycosis DOID_2473 9.261E-05 3.685E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN bronchiolitis obliterans DOID_2799 9.261E-05 3.659E-04 0.21295787 0.49865443 ONDER_CDH1_TARGETS_2_DN intracranial thrombosis DOID_4193 1.012E-04 3.972E-04 0.09000217 0.32412173 ONDER_CDH1_TARGETS_2_DN carotid artery disease DOID_3407 1.023E-04 3.988E-04 0.37162884 0.760636 ONDER_CDH1_TARGETS_2_DN chronic leukemia DOID_1036 1.172E-04 4.535E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN chronic lymphocytic leukemia DOID_1040 1.172E-04 4.535E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN autonomic nervous system neoplasm DOID_2621 1.172E-04 4.504E-04 1.172E-04 3.03E-03 ONDER_CDH1_TARGETS_2_DN neuroblastoma DOID_769 1.172E-04 4.504E-04 1.172E-04 3.03E-03 ONDER_CDH1_TARGETS_2_DN Legionnaires' disease DOID_10457 1.281E-04 4.893E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN legionellosis DOID_10458 1.281E-04 4.893E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN polycystic kidney disease DOID_898 1.281E-04 4.861E-04 4.472E-03 0.0391495 ONDER_CDH1_TARGETS_2_DN systemic mycosis DOID_0050136 1.311E-04 4.939E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN fungal infectious disease DOID_1564 1.311E-04 4.939E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN nephroblastoma DOID_2154 1.461E-04 5.47E-04 0.02935724 0.14914525 ONDER_CDH1_TARGETS_2_DN spindle cell carcinoma DOID_4015 1.461E-04 5.434E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN tooth disease DOID_1091 1.568E-04 5.794E-04 0.39843652 0.79269363 ONDER_CDH1_TARGETS_2_DN idiopathic pulmonary fibrosis DOID_0050156 1.593E-04 5.849E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN arthropathy DOID_381 1.593E-04 5.811E-04 0.10311322 0.34512601 ONDER_CDH1_TARGETS_2_DN oral submucous fibrosis DOID_5773 1.593E-04 5.774E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hemolytic-uremic syndrome DOID_12554 1.95E-04 7.024E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN Barrett's esophagus DOID_9206 1.95E-04 6.98E-04 0.10959799 0.35432533 ONDER_CDH1_TARGETS_2_DN pulmonary sarcoidosis DOID_13406 1.988E-04 7.069E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN cleft palate DOID_674 1.988E-04 7.025E-04 3.028E-03 0.02970367 ONDER_CDH1_TARGETS_2_DN multiple myeloma DOID_9538 1.988E-04 6.982E-04 0.03390173 0.16629383 ONDER_CDH1_TARGETS_2_DN peripheral nervous system neoplasm DOID_1192 2.19E-04 7.645E-04 2.19E-04 4.154E-03 ONDER_CDH1_TARGETS_2_DN lymphatic system cancer DOID_0060073 2.356E-04 8.173E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN bronchitis DOID_6132 2.356E-04 8.123E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN reticulosarcoma DOID_8538 2.356E-04 8.173E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN lymphosarcoma DOID_8675 2.356E-04 8.173E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hepatitis DOID_2237 2.407E-04 8.251E-04 0.03707327 0.1802965 ONDER_CDH1_TARGETS_2_DN systemic scleroderma DOID_418 2.407E-04 8.201E-04 1.000 1.000 ONDER_CDH1_TARGETS_2_DN keratosis DOID_161 2.812E-04 9.523E-04 2.812E-04 4.706E-03 ONDER_CDH1_TARGETS_2_DN eosinophilia DOID_999 2.812E-04 9.467E-04 7.378E-03 0.05182521 ONDER_CDH1_TARGETS_2_DN cervix uteri carcinoma in situ DOID_8991 2.886E-04 9.661E-04 0.0403538 0.19458737 ONDER_CDH1_TARGETS_2_DN mixed glioma DOID_5076 2.937E-04 9.774E-04 0.02039382 0.11266099 ONDER_CDH1_TARGETS_2_DN lipid metabolism disorder DOID_3146 3.295E-04 1.09E-03 0.44868113 0.88034331 ONDER_CDH1_TARGETS_2_DN granulosa cell tumor DOID_2999 3.321E-04 1.092E-03 8.206E-03 0.05558897 ONDER_CDH1_TARGETS_2_DN amnestic disorder DOID_10914 3.886E-04 1.271E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN sex cord-gonadal stromal tumor DOID_192 3.886E-04 1.264E-03 9.075E-03 0.05801948 ONDER_CDH1_TARGETS_2_DN alopecia DOID_987 3.886E-04 1.256E-03 0.13507326 0.39616847 ONDER_CDH1_TARGETS_2_DN myeloma DOID_0070004 4.733E-04 1.522E-03 0.05081201 0.23894241 ONDER_CDH1_TARGETS_2_DN hemolytic anemia DOID_583 5.107E-04 1.633E-03 0.30939253 0.6568819 ONDER_CDH1_TARGETS_2_DN normocytic anemia DOID_720 5.107E-04 1.633E-03 0.30939253 0.6568819 ONDER_CDH1_TARGETS_2_DN gastric ulcer DOID_10808 5.194E-04 1.651E-03 0.14753723 0.41974341 ONDER_CDH1_TARGETS_2_DN neutropenia DOID_1227 5.194E-04 1.642E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN sinusitis DOID_0050127 5.941E-04 1.868E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN agranulocytosis DOID_12987 5.941E-04 1.858E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN paranasal sinus disease DOID_1352 5.941E-04 1.868E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN uremia DOID_4676 5.941E-04 1.847E-03 0.15370194 0.42046348 ONDER_CDH1_TARGETS_2_DN meningitis DOID_9471 6.754E-04 2.089E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN sphingolipidosis DOID_1927 7.634E-04 2.348E-03 0.16589843 0.43905211 ONDER_CDH1_TARGETS_2_DN bile duct adenocarcinoma DOID_4896 7.804E-04 2.387E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN cholangiocarcinoma DOID_4947 7.804E-04 2.387E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN bone marrow cancer DOID_4960 7.804E-04 2.374E-03 0.06408124 0.29169779 ONDER_CDH1_TARGETS_2_DN pustulosis of palm and sole DOID_4398 8.334E-04 2.523E-03 8.597E-03 0.05622686 ONDER_CDH1_TARGETS_2_DN urticaria DOID_1555 8.584E-04 2.584E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN familial hyperlipidemia DOID_1168 8.89E-04 2.662E-03 0.34838221 0.72083447 ONDER_CDH1_TARGETS_2_DN ankylosing spondylitis DOID_7147 9.606E-04 2.862E-03 0.17791977 0.46016523 ONDER_CDH1_TARGETS_2_DN bile duct cancer DOID_4606 1.008E-03 2.987E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN bile duct carcinoma DOID_4897 1.008E-03 2.987E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN Sciatic Neuropathy DOID_11446 1.187E-03 3.5E-03 0.18976849 0.48420749 ONDER_CDH1_TARGETS_2_DN lesion of sciatic nerve DOID_12528 1.187E-03 3.5E-03 0.18976849 0.48420749 ONDER_CDH1_TARGETS_2_DN lung adenocarcinoma DOID_3910 1.187E-03 3.482E-03 1.187E-03 0.01407394 ONDER_CDH1_TARGETS_2_DN perinatal necrotizing enterocolitis DOID_8677 1.187E-03 3.464E-03 0.18976849 0.4756752 ONDER_CDH1_TARGETS_2_DN mononeuritis of lower limb DOID_9473 1.187E-03 3.5E-03 0.18976849 0.48420749 ONDER_CDH1_TARGETS_2_DN thrombocytopenia DOID_1588 1.312E-03 3.809E-03 0.19562888 0.48396884 ONDER_CDH1_TARGETS_2_DN mononeuritis DOID_1802 1.312E-03 3.79E-03 0.19562888 0.48187374 ONDER_CDH1_TARGETS_2_DN polycystic ovary syndrome DOID_11612 1.445E-03 4.153E-03 0.02108411 0.11425579 ONDER_CDH1_TARGETS_2_DN mononeuropathy DOID_1188 1.445E-03 4.132E-03 0.20144704 0.4836429 ONDER_CDH1_TARGETS_2_DN supratentorial cancer DOID_1659 1.445E-03 4.111E-03 0.20144704 0.47959568 ONDER_CDH1_TARGETS_2_DN cerebrum cancer DOID_368 1.445E-03 4.111E-03 0.20144704 0.47959568 ONDER_CDH1_TARGETS_2_DN cerebral degeneration DOID_1443 1.512E-03 4.28E-03 0.3896297 0.78063133 ONDER_CDH1_TARGETS_2_DN abdominal aortic aneurysm DOID_7693 1.735E-03 4.888E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN leber hereditary optic neuropathy DOID_705 1.812E-03 5.079E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN brachydactyly DOID_0050581 2.254E-03 6.287E-03 2.254E-03 0.02420015 ONDER_CDH1_TARGETS_2_DN gout DOID_13189 2.254E-03 6.257E-03 2.254E-03 0.023752 ONDER_CDH1_TARGETS_2_DN retinal vascular occlusion DOID_1729 2.254E-03 6.226E-03 0.06997669 0.3135176 ONDER_CDH1_TARGETS_2_DN cutaneous leishmaniasis DOID_9111 2.254E-03 6.196E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hepatitis C DOID_1883 2.419E-03 6.618E-03 2.419E-03 0.02502988 ONDER_CDH1_TARGETS_2_DN leukopenia DOID_615 2.419E-03 6.587E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hyperthyroidism DOID_7998 2.419E-03 6.555E-03 0.02935724 0.14652867 ONDER_CDH1_TARGETS_2_DN syndrome DOID_225 2.504E-03 6.751E-03 0.10945473 0.35588425 ONDER_CDH1_TARGETS_2_DN aneurysm disease DOID_2403 2.622E-03 7.038E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN familial adenomatous polyposis DOID_0050424 2.742E-03 7.325E-03 0.07670016 0.32327698 ONDER_CDH1_TARGETS_2_DN breast benign neoplasm DOID_0060082 2.742E-03 7.291E-03 0.07670016 0.32089994 ONDER_CDH1_TARGETS_2_DN thoracic benign neoplasm DOID_0060097 2.742E-03 7.291E-03 0.07670016 0.32089994 ONDER_CDH1_TARGETS_2_DN nervous system benign neoplasm DOID_0060115 2.742E-03 7.257E-03 0.07670016 0.31855761 ONDER_CDH1_TARGETS_2_DN benign breast phyllodes tumor DOID_1631 2.742E-03 7.291E-03 0.07670016 0.32089994 ONDER_CDH1_TARGETS_2_DN eosinophilic pneumonia DOID_5870 2.742E-03 7.223E-03 0.07670016 0.30734079 ONDER_CDH1_TARGETS_2_DN pulmonary eosinophilia DOID_9498 2.742E-03 7.223E-03 0.07670016 0.30734079 ONDER_CDH1_TARGETS_2_DN Loeffler syndrome DOID_9503 2.742E-03 7.223E-03 0.07670016 0.30734079 ONDER_CDH1_TARGETS_2_DN auditory system disease DOID_2742 3.274E-03 8.586E-03 0.02316226 0.12203077 ONDER_CDH1_TARGETS_2_DN otitis media DOID_10754 3.275E-03 8.547E-03 0.08337521 0.32272443 ONDER_CDH1_TARGETS_2_DN beta thalassemia DOID_12241 3.275E-03 8.508E-03 0.08337521 0.31839256 ONDER_CDH1_TARGETS_2_DN intracranial arteriosclerosis DOID_13097 3.275E-03 8.47E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN osteopetrosis DOID_13533 3.275E-03 8.431E-03 3.275E-03 0.03105489 ONDER_CDH1_TARGETS_2_DN aortic valve stenosis DOID_1712 3.275E-03 8.393E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN middle ear disease DOID_5100 3.275E-03 8.547E-03 0.08337521 0.32272443 ONDER_CDH1_TARGETS_2_DN stomach disease DOID_76 3.275E-03 8.356E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN vascular dementia DOID_8725 3.275E-03 8.47E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN mitochondrial encephalomyopathy DOID_890 3.275E-03 8.318E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN encephalitis DOID_9588 3.275E-03 8.281E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN alcohol abuse DOID_1574 3.417E-03 8.603E-03 0.02388465 0.12468224 ONDER_CDH1_TARGETS_2_DN larynx cancer DOID_2596 3.852E-03 9.655E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN laryngeal benign neoplasm DOID_2598 3.852E-03 9.655E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_DN viral pneumonia DOID_10533 4.472E-03 0.01116104 1.000 1.000 ONDER_CDH1_TARGETS_2_DN hypercalcemia DOID_12678 4.472E-03 0.0111123 4.472E-03 0.03976121 ONDER_CDH1_TARGETS_2_DN eyelid disease DOID_530 4.472E-03 0.01106399 1.000 1.000 ONDER_CDH1_TARGETS_2_DN bacterial meningitis DOID_9470 4.472E-03 0.01101609 1.000 1.000 ONDER_CDH1_TARGETS_2_DN Huntington's disease DOID_12858 4.506E-03 0.0110522 0.28385243 0.63090639 ONDER_CDH1_TARGETS_2_DN learning disability DOID_8927 5.08E-03 0.01240669 0.04722681 0.2239338 ONDER_CDH1_TARGETS_2_DN thalassemia DOID_10241 5.136E-03 0.01248832 0.10311322 0.35558437 ONDER_CDH1_TARGETS_2_DN thoracic aortic aneurysm DOID_14004 5.136E-03 0.01243518 1.000 1.000 ONDER_CDH1_TARGETS_2_DN communication disorder DOID_2033 5.136E-03 0.01238248 0.10311322 0.34923465 ONDER_CDH1_TARGETS_2_DN panic disorder DOID_594 5.136E-03 0.01233024 5.136E-03 0.04235168 ONDER_CDH1_TARGETS_2_DN hyperhomocysteinemia DOID_9279 5.136E-03 0.01227843 0.10311322 0.33914116 ONDER_CDH1_TARGETS_2_DN brain cancer DOID_1319 5.697E-03 0.01356217 0.30435817 0.65847832 ONDER_CDH1_TARGETS_2_DN bone marrow disease DOID_4961 5.697E-03 0.01350566 0.30435817 0.65105187 ONDER_CDH1_TARGETS_2_DN silicosis DOID_10325 5.842E-03 0.01379203 1.000 1.000 ONDER_CDH1_TARGETS_2_DN central nervous system cancer DOID_3620 6.021E-03 0.01415612 0.30939253 0.65934213 ONDER_CDH1_TARGETS_2_DN autoimmune disease of gastrointestinal tract DOID_0060031 6.356E-03 0.01488213 0.05449161 0.25004617 ONDER_CDH1_TARGETS_2_DN drug-induced mental disorder DOID_1203 6.589E-03 0.01536554 0.11603605 0.37092422 ONDER_CDH1_TARGETS_2_DN Graves' disease DOID_12361 6.589E-03 0.01530282 0.11603605 0.36885202 ONDER_CDH1_TARGETS_2_DN drug psychosis DOID_1742 6.589E-03 0.01536554 0.11603605 0.37092422 ONDER_CDH1_TARGETS_2_DN basal cell carcinoma DOID_2513 6.589E-03 0.01524061 6.589E-03 0.04933146 ONDER_CDH1_TARGETS_2_DN urinary system benign neoplasm DOID_731 6.589E-03 0.01517891 0.11603605 0.36680284 ONDER_CDH1_TARGETS_2_DN substance-induced psychosis DOID_8646 6.589E-03 0.01536554 0.11603605 0.37092422 ONDER_CDH1_TARGETS_2_DN aortic aneurysm DOID_3627 6.701E-03 0.01537555 1.000 1.000 ONDER_CDH1_TARGETS_2_DN movement disease DOID_480 6.701E-03 0.01531381 6.701E-03 0.04952127 ONDER_CDH1_TARGETS_2_DN withdrawal disorder DOID_0060001 7.058E-03 0.01606468 0.32427884 0.68338762 ONDER_CDH1_TARGETS_2_DN male reproductive organ benign neoplasm DOID_0060087 7.378E-03 0.01672447 7.378E-03 0.05381848 ONDER_CDH1_TARGETS_2_DN skin carcinoma DOID_3451 7.378E-03 0.0166581 7.378E-03 0.05313724 ONDER_CDH1_TARGETS_2_DN osteosclerosis DOID_4254 7.378E-03 0.01659226 7.378E-03 0.05247302 ONDER_CDH1_TARGETS_2_DN ureteral obstruction DOID_5199 7.378E-03 0.01652694 0.12242772 0.37859443 ONDER_CDH1_TARGETS_2_DN prion disease DOID_649 7.378E-03 0.01646212 1.000 1.000 ONDER_CDH1_TARGETS_2_DN dissociative disorder DOID_10935 8.206E-03 0.01824013 1.000 1.000 ONDER_CDH1_TARGETS_2_DN dissociative amnesia DOID_11037 8.206E-03 0.01824013 1.000 1.000 ONDER_CDH1_TARGETS_2_DN reproductive organ benign neoplasm DOID_0050622 8.597E-03 0.019034 8.597E-03 0.05754985 ONDER_CDH1_TARGETS_2_DN osteochondrodysplasia DOID_2256 8.597E-03 0.01896022 8.597E-03 0.05688066 ONDER_CDH1_TARGETS_2_DN colon carcinoma DOID_1520 9.075E-03 0.01993719 0.13507326 0.40239101 ONDER_CDH1_TARGETS_2_DN subependymal glioma DOID_4843 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN pilocytic astrocytoma DOID_4851 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN subependymal giant cell astrocytoma DOID_5077 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN fibrillary astrocytoma DOID_6726 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN juvenile pilocytic astrocytoma DOID_6811 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN childhood pilocytic astrocytoma DOID_6812 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN gemistocytic astrocytoma DOID_7005 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN childhood cerebral astrocytoma DOID_7007 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN protoplasmic astrocytoma DOID_7008 9.075E-03 0.01986051 1.000 1.000 ONDER_CDH1_TARGETS_2_DN Kawasaki disease DOID_13378 9.983E-03 0.0217635 0.14132777 0.40820053 ONDER_CDH1_TARGETS_2_DN lymphadenitis DOID_1602 9.983E-03 0.0217635 0.14132777 0.40820053 ONDER_CDH1_TARGETS_2_DN autoimmune hepatitis DOID_2048 9.983E-03 0.02168043 0.14132777 0.40613891 ONDER_CDH1_TARGETS_2_DN mitochondrial myopathy DOID_699 9.983E-03 0.02159799 1.000 1.000 ONDER_CDH1_TARGETS_2_DN lymph node disease DOID_9942 9.983E-03 0.0217635 0.14132777 0.40820053 ONDER_CDH1_TARGETS_2_DN benign glioma DOID_0060101 0.01092925 0.02355585 1.000 1.000 ONDER_CDH1_TARGETS_2_DN familial hypercholesterolemia DOID_13810 0.01092925 0.02346696 1.000 1.000 ONDER_CDH1_TARGETS_2_DN thrombophilia DOID_2452 0.01092925 0.02337874 0.14753723 0.41765514 ONDER_CDH1_TARGETS_2_DN benign ependymoma DOID_4844 0.01092925 0.02355585 1.000 1.000 ONDER_CDH1_TARGETS_2_DN muscular atrophy DOID_767 0.01092925 0.02329118 0.14753723 0.41558754 ONDER_CDH1_TARGETS_2_DN placenta disease DOID_780 0.01092925 0.02320427 0.14753723 0.41354031 ONDER_CDH1_TARGETS_2_DN optic nerve disease DOID_1891 0.01191355 0.02520003 1.000 1.000 ONDER_CDH1_TARGETS_2_DN opiate dependence DOID_2559 0.01191355 0.0251067 0.15370194 0.42661661 ONDER_CDH1_TARGETS_2_DN muscle cancer DOID_4045 0.01191355 0.02501405 1.000 1.000 ONDER_CDH1_TARGETS_2_DN myasthenia gravis DOID_437 0.01191355 0.02492209 0.15370194 0.42249471 ONDER_CDH1_TARGETS_2_DN polyarteritis nodosa DOID_9810 0.01191355 0.0248308 0.15370194 0.41645907 ONDER_CDH1_TARGETS_2_DN hypoglycemia DOID_9993 0.01191355 0.02474018 1.000 1.000 ONDER_CDH1_TARGETS_2_DN endocrine pancreas disease DOID_1428 0.01272964 0.02633879 0.38517824 0.77995166 ONDER_CDH1_TARGETS_2_DN diabetic angiopathy DOID_11713 0.0129352 0.02666713 0.15982223 0.42895684 ONDER_CDH1_TARGETS_2_DN Lewy body dementia DOID_12217 0.0129352 0.02657086 1.000 1.000 ONDER_CDH1_TARGETS_2_DN ureteral disease DOID_1426 0.0129352 0.02647528 0.15982223 0.42694296 ONDER_CDH1_TARGETS_2_DN aortic valve disease DOID_62 0.0129352 0.02638038 1.000 1.000 ONDER_CDH1_TARGETS_2_DN Goodpasture syndrome DOID_9808 0.0129352 0.02628617 1.000 1.000 ONDER_CDH1_TARGETS_2_DN endocrine organ benign neoplasm DOID_0060089 0.01487192 0.03011432 0.40279233 0.79856738 ONDER_CDH1_TARGETS_2_DN reading disorder DOID_13365 0.01508821 0.03044394 0.01508821 0.0923139 ONDER_CDH1_TARGETS_2_DN dyslexia DOID_4428 0.01508821 0.03044394 0.01508821 0.0923139 ONDER_CDH1_TARGETS_2_DN autosomal dominant nonsyndromic deafness DOID_0050564 0.01621842 0.03260877 0.01621842 0.09817322 ONDER_CDH1_TARGETS_2_DN neuromuscular junction disease DOID_439 0.01621842 0.03249395 0.17791977 0.46226644 ONDER_CDH1_TARGETS_2_DN intracranial aneurysm DOID_10941 0.01738368 0.03470636 1.000 1.000 ONDER_CDH1_TARGETS_2_DN vitiligo DOID_12306 0.01738368 0.03458501 0.18386555 0.47339141 ONDER_CDH1_TARGETS_2_DN fragments of torsion dystonia DOID_531 0.01738368 0.0344645 0.01738368 0.1030345 ONDER_CDH1_TARGETS_2_DN dystonia DOID_543 0.01738368 0.03434483 0.01738368 0.10197229 ONDER_CDH1_TARGETS_2_DN extrinsic allergic alveolitis DOID_841 0.01738368 0.03422599 1.000 1.000 ONDER_CDH1_TARGETS_2_DN gestational diabetes DOID_11714 0.01858341 0.03646193 0.18976849 0.48204585 ONDER_CDH1_TARGETS_2_DN sarcoma DOID_1115 0.01981707 0.03874884 1.000 1.000 ONDER_CDH1_TARGETS_2_DN malaria DOID_12365 0.01981707 0.03861614 0.19562888 0.48608224 ONDER_CDH1_TARGETS_2_DN autoimmune disease of the nervous system DOID_438 0.01981707 0.03848435 0.19562888 0.47569587 ONDER_CDH1_TARGETS_2_DN central nervous system hereditary degenerative disease DOID_481 0.01981707 0.03835345 0.01981707 0.11054817 ONDER_CDH1_TARGETS_2_DN autoimmune disease of endocrine system DOID_0060005 0.02108411 0.04066731 0.20144704 0.48569223 ONDER_CDH1_TARGETS_2_DN toxic encephalopathy DOID_3602 0.02108411 0.04052992 0.02108411 0.1131779 ONDER_CDH1_TARGETS_2_DN focal glomerulosclerosis DOID_3945 0.02108411 0.04039346 1.000 1.000 ONDER_CDH1_TARGETS_2_DN dystonic disease DOID_544 0.02108411 0.04025791 0.02108411 0.11212016 ONDER_CDH1_TARGETS_2_DN cranial nerve disease DOID_5656 0.02108411 0.04012327 1.000 1.000 ONDER_CDH1_TARGETS_2_DN spastic cerebral palsy DOID_0050669 0.02371614 0.04498162 0.21295787 0.50071498 ONDER_CDH1_TARGETS_2_DN leiomyoma DOID_127 0.02647525 0.05004789 0.22430337 0.52093312 ONDER_CDH1_TARGETS_2_DN metal metabolism disorder DOID_896 0.02790114 0.0525687 0.22991486 0.52964192 ONDER_CDH1_TARGETS_2_DN primary immunodeficiency disease DOID_612 0.02847294 0.05346899 0.14067248 0.41047507 ONDER_CDH1_TARGETS_2_DN amino acid metabolic disorder DOID_9252 0.02847294 0.0532931 0.14067248 0.40838081 ONDER_CDH1_TARGETS_2_DN aplastic anemia DOID_12449 0.03084304 0.05753996 1.000 1.000 ONDER_CDH1_TARGETS_2_DN lymphoma DOID_0060058 0.03092979 0.05751323 1.000 1.000 ONDER_CDH1_TARGETS_2_DN thyroid cancer DOID_1781 0.03235803 0.05997303 0.24650781 0.55881651 ONDER_CDH1_TARGETS_2_DN adenoma DOID_657 0.03235803 0.05977831 0.03235803 0.16010191 ONDER_CDH1_TARGETS_2_DN Crohn's disease DOID_8778 0.03262762 0.06008128 1.000 1.000 ONDER_CDH1_TARGETS_2_DN uveitis DOID_13141 0.03547364 0.06511129 0.25737139 0.57883131 ONDER_CDH1_TARGETS_2_DN congenital diaphragmatic hernia DOID_3827 0.03707327 0.06782859 1.000 1.000 ONDER_CDH1_TARGETS_2_DN lymphatic system disease DOID_75 0.03870015 0.07057815 0.2680789 0.60053896 ONDER_CDH1_TARGETS_2_DN benign mesothelioma DOID_2645 0.0403538 0.07335882 0.27337484 0.61000111 ONDER_CDH1_TARGETS_2_DN uveal disease DOID_3480 0.04373954 0.0792605 0.28385243 0.62359859 ONDER_CDH1_TARGETS_2_DN diabetic autonomic neuropathy DOID_11503 0.04547071 0.08213598 1.000 1.000 ONDER_CDH1_TARGETS_2_DN autonomic neuropathy DOID_11504 0.04547071 0.08213598 1.000 1.000 ONDER_CDH1_TARGETS_2_DN diabetic polyneuropathy DOID_12785 0.04547071 0.08213598 1.000 1.000 ONDER_CDH1_TARGETS_2_DN diabetic neuropathy DOID_9743 0.04547071 0.08213598 1.000 1.000 ONDER_CDH1_TARGETS_2_DN leukodystrophy DOID_10579 0.04900739 0.08824432 1.000 1.000 ONDER_CDH1_TARGETS_2_DN autonomic nervous system disease DOID_11465 0.05081201 0.09120515 1.000 1.000 ONDER_CDH1_TARGETS_2_DN thyroid adenoma DOID_2891 0.05081201 0.09091834 0.30435817 0.65598408 LEE_EARLY_T_LYMPHOCYTE_DN mixed glioma DOID_5076 2.652E-07 1.509E-04 2.271E-05 6.462E-03 LEE_EARLY_T_LYMPHOCYTE_DN psoriasis DOID_8893 2.754E-07 7.836E-05 2.754E-07 1.567E-04 LEE_EARLY_T_LYMPHOCYTE_DN tuberculosis DOID_399 1.587E-05 3.009E-03 1.092E-03 0.07764383 LEE_EARLY_T_LYMPHOCYTE_DN primary bacterial infectious disease DOID_0050338 3.127E-05 4.448E-03 1.707E-03 0.08831388 LEE_EARLY_T_LYMPHOCYTE_DN Human immunodeficiency virus infectious disease DOID_526 3.453E-05 3.93E-03 0.06123743 0.49777285 LEE_EARLY_T_LYMPHOCYTE_DN acquired immunodeficiency syndrome DOID_635 1.036E-04 9.824E-03 0.01498394 0.35524413 LEE_EARLY_T_LYMPHOCYTE_DN myasthenia gravis DOID_437 1.134E-04 9.219E-03 1.000 1.000 LEE_EARLY_T_LYMPHOCYTE_DN reading disorder DOID_13365 1.455E-04 0.01034907 1.455E-04 0.02759753 LEE_EARLY_T_LYMPHOCYTE_DN dyslexia DOID_4428 1.455E-04 0.01034907 1.455E-04 0.02759753 LEE_EARLY_T_LYMPHOCYTE_DN neuromuscular junction disease DOID_439 1.571E-04 9.931E-03 1.000 1.000 LEE_EARLY_T_LYMPHOCYTE_DN autoimmune disease of the nervous system DOID_438 1.944E-04 0.01106279 1.000 1.000 LEE_EARLY_T_LYMPHOCYTE_DN opportunistic mycosis DOID_2473 2.357E-04 0.01219178 0.02239471 0.39820598 LEE_EARLY_T_LYMPHOCYTE_DN systemic mycosis DOID_0050136 2.809E-04 0.0133179 0.02440651 0.39678013 LEE_EARLY_T_LYMPHOCYTE_DN fungal infectious disease DOID_1564 2.809E-04 0.0133179 0.02440651 0.39678013 LEE_EARLY_T_LYMPHOCYTE_DN cataract DOID_83 5.004E-04 0.02190005 5.004E-04 0.07117516 LEE_EARLY_T_LYMPHOCYTE_DN learning disability DOID_8927 5.004E-04 0.02033576 5.004E-04 0.05694012 LEE_EARLY_T_LYMPHOCYTE_DN lens disease DOID_110 5.429E-04 0.02059482 5.429E-04 0.05148705 LEE_EARLY_T_LYMPHOCYTE_DN pulmonary tuberculosis DOID_2957 5.872E-04 0.02088193 5.872E-04 0.04773013 LEE_EARLY_T_LYMPHOCYTE_DN syndrome DOID_225 1.315E-03 0.04402472 1.315E-03 0.08315781 LEE_EARLY_T_LYMPHOCYTE_DN metabolic syndrome X DOID_14221 1.452E-03 0.04590449 1.452E-03 0.08262808 LEE_EARLY_T_LYMPHOCYTE_DN lymphoblastic leukemia DOID_1037 1.942E-03 0.05815005 1.942E-03 0.09207091 LEE_EARLY_T_LYMPHOCYTE_DN hypersensitivity reaction type I disease DOID_1205 2.023E-03 0.0575572 1.000 1.000 COLLIS_PRKDC_SUBSTRATES angiosarcoma DOID_0001816 1.099E-05 6.256E-03 5.053E-03 1.000 COLLIS_PRKDC_SUBSTRATES sarcoma DOID_1115 3.976E-05 0.01131066 9.456E-03 0.5380504 COLLIS_PRKDC_SUBSTRATES multiple myeloma DOID_9538 7.116E-05 0.01349703 1.000 1.000 COLLIS_PRKDC_SUBSTRATES myeloma DOID_0070004 1.116E-04 0.01587001 1.000 1.000 COLLIS_PRKDC_SUBSTRATES bone marrow cancer DOID_4960 1.452E-04 0.01652073 1.000 1.000 COLLIS_PRKDC_SUBSTRATES lymphoma DOID_0060058 3.95E-04 0.03746022 0.02935567 0.61864364 COLLIS_PRKDC_SUBSTRATES lymphoblastic leukemia DOID_1037 4.034E-04 0.03279351 0.02966368 0.60280827 ABE_VEGFA_TARGETS chronic kidney failure DOID_784 2.315E-08 1.317E-05 3.889E-06 2.213E-03 ABE_VEGFA_TARGETS nephrosis DOID_2527 2.559E-06 7.279E-04 3.369E-04 0.0479216 ABE_VEGFA_TARGETS male reproductive system disease DOID_48 2.559E-06 4.853E-04 3.369E-04 0.03833728 ABE_VEGFA_TARGETS Crohn's disease DOID_8778 5.613E-06 7.984E-04 5.661E-04 0.05368648 ABE_VEGFA_TARGETS polycystic kidney disease DOID_898 1.149E-05 1.308E-03 5.158E-03 0.16306574 ABE_VEGFA_TARGETS idiopathic pulmonary fibrosis DOID_0050156 1.326E-05 1.258E-03 5.526E-03 0.16548949 ABE_VEGFA_TARGETS gastric ulcer DOID_10808 2.913E-05 2.368E-03 8.095E-03 0.13547388 ABE_VEGFA_TARGETS muscle cancer DOID_4045 3.19E-05 2.269E-03 8.462E-03 0.12345271 ABE_VEGFA_TARGETS portal hypertension DOID_10762 4.095E-05 2.589E-03 9.56E-03 0.12650832 ABE_VEGFA_TARGETS hepatic vascular disease DOID_272 5.476E-05 3.116E-03 0.01102366 0.1254492 ABE_VEGFA_TARGETS chronic leukemia DOID_1036 7.482E-05 3.87E-03 0.01284992 0.13056439 ABE_VEGFA_TARGETS chronic lymphocytic leukemia DOID_1040 7.482E-05 3.87E-03 0.01284992 0.13056439 ABE_VEGFA_TARGETS peptic ulcer DOID_750 1.081E-04 5.126E-03 0.01540144 0.14366258 ABE_VEGFA_TARGETS nephrotic syndrome DOID_1184 1.299E-04 5.684E-03 0.01685669 0.15224538 ABE_VEGFA_TARGETS Huntington's disease DOID_12858 1.299E-04 5.278E-03 0.01685669 0.14986654 ABE_VEGFA_TARGETS gallbladder cancer DOID_3121 1.356E-04 5.144E-03 0.0172202 0.15074295 ABE_VEGFA_TARGETS hemolytic anemia DOID_583 1.598E-04 5.683E-03 1.598E-04 0.04546259 ABE_VEGFA_TARGETS normocytic anemia DOID_720 1.598E-04 5.683E-03 1.598E-04 0.04546259 ABE_VEGFA_TARGETS carotid artery disease DOID_3407 2.52E-04 8.434E-03 2.52E-04 0.04779167 ABE_VEGFA_TARGETS pre-malignant neoplasm DOID_0060071 2.68E-04 8.471E-03 0.02410307 0.18533305 ABE_VEGFA_TARGETS in situ carcinoma DOID_8719 2.68E-04 8.471E-03 0.02410307 0.18533305 ABE_VEGFA_TARGETS astrocytoma DOID_3069 3.189E-04 9.551E-03 0.02626729 0.19665905 ABE_VEGFA_TARGETS pancreatic ductal carcinoma DOID_3587 3.278E-04 9.327E-03 0.02662756 0.19424464 ABE_VEGFA_TARGETS pancreatic carcinoma DOID_4905 3.553E-04 9.627E-03 0.02770763 0.19956506 ABE_VEGFA_TARGETS mixed glioma DOID_5076 3.936E-04 0.01018079 0.02914599 0.19980803 ABE_VEGFA_TARGETS metabolic syndrome X DOID_14221 4.135E-04 0.01022998 0.02986442 0.19991597 ABE_VEGFA_TARGETS biliary tract cancer DOID_4607 4.442E-04 0.01053212 0.03094116 0.20006271 ABE_VEGFA_TARGETS transitional cell carcinoma DOID_2671 4.978E-04 0.01133087 0.03273324 0.20694685 ABE_VEGFA_TARGETS lymphoblastic leukemia DOID_1037 5.544E-04 0.01213364 0.03452225 0.21351264 ABE_VEGFA_TARGETS ulcerative colitis DOID_8577 6.14E-04 0.01293976 0.03630819 0.21520167 ABE_VEGFA_TARGETS hyperparathyroidism DOID_13543 3.687E-03 0.07492848 1.000 1.000 ABE_VEGFA_TARGETS familial combined hyperlipidemia DOID_13809 3.687E-03 0.07234474 3.687E-03 0.29971391 ABE_VEGFA_TARGETS childhood type dermatomyositis DOID_14203 3.687E-03 0.06993325 3.687E-03 0.26224967 ABE_VEGFA_TARGETS familial adenomatous polyposis DOID_0050424 4.055E-03 0.07443231 1.000 1.000 ABE_VEGFA_TARGETS Charcot-Marie-Tooth disease type 4 DOID_0050541 4.055E-03 0.0721063 4.055E-03 0.25637795 ABE_VEGFA_TARGETS dermatomyositis DOID_10223 4.055E-03 0.06992126 4.055E-03 0.23074016 ABE_VEGFA_TARGETS stomach disease DOID_76 4.423E-03 0.07402159 1.000 1.000 ABE_VEGFA_TARGETS peritonitis DOID_8283 4.423E-03 0.07190668 4.423E-03 0.22879399 ABE_VEGFA_TARGETS berylliosis DOID_10322 4.791E-03 0.07572207 4.791E-03 0.22716621 ABE_VEGFA_TARGETS parathyroid gland disease DOID_11201 4.791E-03 0.07367553 1.000 1.000 ABE_VEGFA_TARGETS impotence DOID_1875 4.791E-03 0.0717367 4.791E-03 0.20969188 ABE_VEGFA_TARGETS larynx cancer DOID_2596 4.791E-03 0.06989729 1.000 1.000 ABE_VEGFA_TARGETS laryngeal benign neoplasm DOID_2598 4.791E-03 0.06989729 1.000 1.000 ABE_VEGFA_TARGETS intracranial thrombosis DOID_4193 4.791E-03 0.06814986 4.791E-03 0.19471389 ABE_VEGFA_TARGETS epilepsy with generalized tonic-clonic seizures DOID_7725 4.791E-03 0.06648767 4.791E-03 0.18173296 ABE_VEGFA_TARGETS viral pneumonia DOID_10533 5.158E-03 0.06988532 5.158E-03 0.18344895 ABE_VEGFA_TARGETS open-angle glaucoma DOID_1067 5.158E-03 0.06826008 1.000 1.000 ABE_VEGFA_TARGETS rhabdomyosarcoma DOID_3247 5.158E-03 0.06670871 5.158E-03 0.17265784 ABE_VEGFA_TARGETS peripheral neuropathy DOID_0060053 5.526E-03 0.06987334 5.526E-03 0.15721501 ABE_VEGFA_TARGETS skeletal system cancer DOID_0060124 5.526E-03 0.06835435 1.000 1.000 ABE_VEGFA_TARGETS renovascular hypertension DOID_1591 5.526E-03 0.06690001 5.526E-03 0.14972858 ABE_VEGFA_TARGETS bone cancer DOID_184 5.526E-03 0.06835435 1.000 1.000 ABE_VEGFA_TARGETS membranoproliferative glomerulonephritis DOID_2920 5.526E-03 0.06550626 5.526E-03 0.14292274 ABE_VEGFA_TARGETS skeletal muscle cancer DOID_4043 5.526E-03 0.06416939 5.526E-03 0.13670871 ABE_VEGFA_TARGETS oral submucous fibrosis DOID_5773 5.526E-03 0.062886 1.000 1.000 ABE_VEGFA_TARGETS angiosarcoma DOID_0001816 5.893E-03 0.06575187 5.893E-03 0.13972273 ABE_VEGFA_TARGETS hemolytic-uremic syndrome DOID_12554 5.893E-03 0.06448741 5.893E-03 0.13413382 ABE_VEGFA_TARGETS tongue cancer DOID_8649 5.893E-03 0.06327067 1.000 1.000 ABE_VEGFA_TARGETS Barrett's esophagus DOID_9206 5.893E-03 0.06209899 1.000 1.000 ABE_VEGFA_TARGETS drug-induced mental disorder DOID_1203 6.261E-03 0.06476944 6.261E-03 0.13701227 ABE_VEGFA_TARGETS penile disease DOID_1529 6.261E-03 0.06361284 6.261E-03 0.13193774 ABE_VEGFA_TARGETS drug psychosis DOID_1742 6.261E-03 0.06476944 6.261E-03 0.13701227 ABE_VEGFA_TARGETS juvenile rheumatoid arthritis DOID_676 6.261E-03 0.06249683 6.261E-03 0.12722568 ABE_VEGFA_TARGETS urinary system benign neoplasm DOID_731 6.261E-03 0.06141929 1.000 1.000 ABE_VEGFA_TARGETS substance-induced psychosis DOID_8646 6.261E-03 0.06476944 6.261E-03 0.13701227 ABE_VEGFA_TARGETS sexual dysfunction DOID_1876 6.628E-03 0.063919 6.628E-03 0.1300421 ABE_VEGFA_TARGETS prion disease DOID_649 6.628E-03 0.06285368 1.000 1.000 ABE_VEGFA_TARGETS Down syndrome DOID_14250 6.995E-03 0.06524674 6.995E-03 0.13266837 ABE_VEGFA_TARGETS granulosa cell tumor DOID_2999 6.995E-03 0.06419437 1.000 1.000 ABE_VEGFA_TARGETS amnestic disorder DOID_10914 7.362E-03 0.06648904 1.000 1.000 ABE_VEGFA_TARGETS esophagitis DOID_11963 7.362E-03 0.06545015 1.000 1.000 ABE_VEGFA_TARGETS sex cord-gonadal stromal tumor DOID_192 7.362E-03 0.06444323 1.000 1.000 ABE_VEGFA_TARGETS subependymal glioma DOID_4843 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS pilocytic astrocytoma DOID_4851 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS subependymal giant cell astrocytoma DOID_5077 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS fibrillary astrocytoma DOID_6726 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS juvenile pilocytic astrocytoma DOID_6811 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS childhood pilocytic astrocytoma DOID_6812 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS gemistocytic astrocytoma DOID_7005 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS childhood cerebral astrocytoma DOID_7007 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS protoplasmic astrocytoma DOID_7008 7.362E-03 0.06346681 7.362E-03 0.13512289 ABE_VEGFA_TARGETS coronary restenosis DOID_4247 7.728E-03 0.06563428 7.728E-03 0.13742177 ABE_VEGFA_TARGETS benign glioma DOID_0060101 8.095E-03 0.06773694 8.095E-03 0.13957915 ABE_VEGFA_TARGETS thrombophilia DOID_2452 8.095E-03 0.06675525 8.095E-03 0.1316032 ABE_VEGFA_TARGETS benign ependymoma DOID_4844 8.095E-03 0.06773694 8.095E-03 0.13957915 ABE_VEGFA_TARGETS glycogen metabolism disorder DOID_0050728 8.462E-03 0.0687808 8.462E-03 0.13374044 ABE_VEGFA_TARGETS sexual disorder DOID_0060043 8.462E-03 0.06781205 8.462E-03 0.13012583 ABE_VEGFA_TARGETS glycogen storage disease DOID_2747 8.462E-03 0.0687808 8.462E-03 0.13374044 ABE_VEGFA_TARGETS IgA glomerulonephritis DOID_2986 8.462E-03 0.06687022 8.462E-03 0.12670147 ABE_VEGFA_TARGETS uremia DOID_4676 8.462E-03 0.06595419 8.462E-03 0.12036639 ABE_VEGFA_TARGETS urinary tract obstruction DOID_5200 8.462E-03 0.06506292 1.000 1.000 ABE_VEGFA_TARGETS pulmonary embolism DOID_9477 8.462E-03 0.06419541 8.462E-03 0.11743063 ABE_VEGFA_TARGETS sphingolipidosis DOID_1927 9.194E-03 0.0688359 9.194E-03 0.12456021 ABE_VEGFA_TARGETS cystitis DOID_1679 9.926E-03 0.07335215 1.000 1.000 ABE_VEGFA_TARGETS myositis DOID_633 9.926E-03 0.07241174 9.926E-03 0.12836626 ABE_VEGFA_TARGETS ankylosing spondylitis DOID_7147 9.926E-03 0.07149513 9.926E-03 0.12551368 ABE_VEGFA_TARGETS extrinsic allergic alveolitis DOID_841 0.01029227 0.07320377 0.01029227 0.12731091 ABE_VEGFA_TARGETS perinatal necrotizing enterocolitis DOID_8677 0.01065803 0.07486934 0.01065803 0.12903014 ABE_VEGFA_TARGETS pleurisy DOID_10247 0.01102366 0.07649341 1.000 1.000 ABE_VEGFA_TARGETS renal hypertension DOID_1073 0.01102366 0.0755718 0.01102366 0.13067625 ABE_VEGFA_TARGETS secondary hypertension DOID_11130 0.01102366 0.0755718 0.01102366 0.13067625 ABE_VEGFA_TARGETS sarcoma DOID_1115 0.01102366 0.07467214 0.01102366 0.12800938 ABE_VEGFA_TARGETS coronary stenosis DOID_4248 0.01102366 0.07379364 0.01102366 0.12298941 ABE_VEGFA_TARGETS supratentorial cancer DOID_1659 0.01138916 0.07535386 0.01138916 0.12462369 ABE_VEGFA_TARGETS cerebrum cancer DOID_368 0.01138916 0.07535386 0.01138916 0.12462369 ABE_VEGFA_TARGETS focal glomerulosclerosis DOID_3945 0.01138916 0.07448772 0.01138916 0.1222723 ABE_VEGFA_TARGETS bronchiolitis obliterans DOID_2799 0.01211979 0.07836547 0.01211979 0.1277067 ABE_VEGFA_TARGETS abdominal aortic aneurysm DOID_7693 0.01211979 0.07748496 1.000 1.000 ABE_VEGFA_TARGETS Charcot-Marie-Tooth disease DOID_10595 0.01248492 0.07893244 0.01248492 0.12916217 ABE_VEGFA_TARGETS allergic rhinitis DOID_4481 0.01248492 0.07806505 1.000 1.000 ABE_VEGFA_TARGETS pleural disease DOID_1532 0.01284992 0.07947398 1.000 1.000 ABE_VEGFA_TARGETS bladder disease DOID_365 0.01284992 0.07861942 1.000 1.000 ABE_VEGFA_TARGETS papilloma DOID_2615 0.0132148 0.07999172 1.000 1.000 ABE_VEGFA_TARGETS myocarditis DOID_820 0.0132148 0.0791497 1.000 1.000 ABE_VEGFA_TARGETS pneumoconiosis DOID_10316 0.01357955 0.08048714 0.01357955 0.13555729 ABE_VEGFA_TARGETS male infertility DOID_12336 0.01357955 0.07965738 0.01357955 0.13322009 ABE_VEGFA_TARGETS nephroblastoma DOID_2154 0.01357955 0.07884454 1.000 1.000 ABE_VEGFA_TARGETS thyroid carcinoma DOID_3963 0.01357955 0.07804814 1.000 1.000 ABE_VEGFA_TARGETS spindle cell carcinoma DOID_4015 0.01357955 0.07726765 1.000 1.000 ABE_VEGFA_TARGETS esophageal disease DOID_6050 0.01357955 0.07650263 1.000 1.000 ABE_VEGFA_TARGETS thyroid cancer DOID_1781 0.01430868 0.07982 1.000 1.000 ABE_VEGFA_TARGETS adenoma DOID_657 0.01430868 0.07904505 0.01430868 0.1379939 ABE_VEGFA_TARGETS adolescence-adult electroclinical syndrome DOID_0050705 0.01467306 0.08027856 0.01467306 0.1391495 ABE_VEGFA_TARGETS systemic scleroderma DOID_418 0.01540144 0.08346112 1.000 1.000 ABE_VEGFA_TARGETS adult respiratory distress syndrome DOID_11394 0.01576544 0.08462768 0.01576544 0.14468604 ABE_VEGFA_TARGETS cervix uteri carcinoma in situ DOID_8991 0.01612932 0.08577178 1.000 1.000 ABE_VEGFA_TARGETS pulmonary emphysema DOID_9675 0.01612932 0.0849776 1.000 1.000 ABE_VEGFA_TARGETS endometriosis of uterus DOID_288 0.01649307 0.08609684 1.000 1.000 ABE_VEGFA_TARGETS rheumatic disease DOID_1575 0.01685669 0.08719508 1.000 1.000 ABE_VEGFA_TARGETS endometriosis DOID_289 0.01685669 0.08640954 1.000 1.000 ABE_VEGFA_TARGETS scleroderma DOID_419 0.01685669 0.08719508 1.000 1.000 ABE_VEGFA_TARGETS diabetic autonomic neuropathy DOID_11503 0.0172202 0.08748475 1.000 1.000 ABE_VEGFA_TARGETS autonomic neuropathy DOID_11504 0.0172202 0.08748475 1.000 1.000 ABE_VEGFA_TARGETS diabetic polyneuropathy DOID_12785 0.0172202 0.08748475 1.000 1.000 ABE_VEGFA_TARGETS influenza DOID_8469 0.0172202 0.08671054 1.000 1.000 ABE_VEGFA_TARGETS diabetic neuropathy DOID_9743 0.0172202 0.08748475 1.000 1.000 ABE_VEGFA_TARGETS proteinuria DOID_576 0.01794683 0.0895767 1.000 1.000 ABE_VEGFA_TARGETS pre-eclampsia DOID_10591 0.01830995 0.09059447 0.01830995 0.15785399 ABE_VEGFA_TARGETS autonomic nervous system disease DOID_11465 0.01830995 0.08981348 1.000 1.000 ABE_VEGFA_TARGETS brain cancer DOID_1319 0.01830995 0.08904584 0.01830995 0.15549796 ABE_VEGFA_TARGETS neuritis DOID_1803 0.01830995 0.08829122 1.000 1.000 ABE_VEGFA_TARGETS thyroid adenoma DOID_2891 0.01830995 0.08754927 1.000 1.000 ABE_VEGFA_TARGETS central nervous system cancer DOID_3620 0.01867296 0.08854094 0.01867296 0.15624871 ABE_VEGFA_TARGETS integumentary system benign neoplasm DOID_0060121 0.01903584 0.08951562 1.000 1.000 ABE_VEGFA_TARGETS glaucoma DOID_1686 0.01903584 0.08878189 1.000 1.000 ABE_VEGFA_TARGETS skin benign neoplasm DOID_3165 0.01903584 0.08951562 1.000 1.000 ABE_VEGFA_TARGETS aortic aneurysm DOID_3627 0.01939859 0.08973819 1.000 1.000 ABE_VEGFA_TARGETS withdrawal disorder DOID_0060001 0.01976122 0.09067849 1.000 1.000 ABE_VEGFA_TARGETS hemorrhagic disease DOID_2213 0.01976122 0.08995307 0.01976122 0.16295845 ABE_VEGFA_TARGETS B-cell lymphocytic neoplasm DOID_707 0.01976122 0.08923915 1.000 1.000 ABE_VEGFA_TARGETS sarcoidosis DOID_11335 0.0204861 0.0917842 1.000 1.000 ABE_VEGFA_TARGETS giant cell tumor DOID_200 0.0204861 0.09106713 1.000 1.000 ABE_VEGFA_TARGETS malignant giant cell tumor DOID_2705 0.0204861 0.09106713 1.000 1.000 ABE_VEGFA_TARGETS giant cell glioblastoma DOID_3074 0.0204861 0.09106713 1.000 1.000 ABE_VEGFA_TARGETS bile duct adenocarcinoma DOID_4896 0.02084836 0.09195904 1.000 1.000 ABE_VEGFA_TARGETS cholangiocarcinoma DOID_4947 0.02084836 0.09195904 1.000 1.000 ABE_VEGFA_TARGETS vasculitis DOID_865 0.02084836 0.09125166 0.02084836 0.16946738 ABE_VEGFA_TARGETS integumentary system cancer DOID_0060122 0.02121049 0.09212801 1.000 1.000 ABE_VEGFA_TARGETS skin cancer DOID_4159 0.02121049 0.09212801 1.000 1.000 ABE_VEGFA_TARGETS familial hyperlipidemia DOID_1168 0.0215725 0.09299054 0.0215725 0.17288382 ABE_VEGFA_TARGETS hypertrophic cardiomyopathy DOID_11984 0.02229614 0.09538724 0.02229614 0.17620143 ABE_VEGFA_TARGETS hypersensitivity reaction type IV disease DOID_2916 0.02229614 0.0946754 1.000 1.000 ABE_VEGFA_TARGETS glioblastoma DOID_3068 0.02229614 0.0939741 1.000 1.000 ABE_VEGFA_TARGETS bile duct cancer DOID_4606 0.02229614 0.09328311 1.000 1.000 ABE_VEGFA_TARGETS bile duct carcinoma DOID_4897 0.02229614 0.09328311 1.000 1.000 ABE_VEGFA_TARGETS oral cavity cancer DOID_8618 0.02229614 0.09260221 1.000 1.000 ABE_VEGFA_TARGETS melancholia DOID_2848 0.02265777 0.09342227 1.000 1.000 ABE_VEGFA_TARGETS neurotic disorder DOID_4964 0.02301928 0.09423001 1.000 1.000 ABE_VEGFA_TARGETS collagen disease DOID_854 0.02338067 0.09502572 1.000 1.000 ABE_VEGFA_TARGETS respiratory failure DOID_11162 0.02374193 0.09580963 0.02374193 0.18505697 ABE_VEGFA_TARGETS congenital heart defect DOID_1682 0.02410307 0.09658201 0.02410307 0.18286194 ABE_VEGFA_TARGETS uterine disease DOID_345 0.02482497 0.09877908 1.000 1.000 ABE_VEGFA_TARGETS hyperglycemia DOID_4195 0.02518574 0.09951864 1.000 1.000 DE_YY1_TARGETS_DN giant cell tumor DOID_200 9.886E-13 5.625E-10 5.696E-05 0.01620432 DE_YY1_TARGETS_DN malignant giant cell tumor DOID_2705 9.886E-13 5.625E-10 5.696E-05 0.01620432 DE_YY1_TARGETS_DN giant cell glioblastoma DOID_3074 9.886E-13 5.625E-10 5.696E-05 0.01620432 DE_YY1_TARGETS_DN glioblastoma DOID_3068 1.85E-12 5.264E-10 7.361E-05 0.01396087 DE_YY1_TARGETS_DN astrocytoma DOID_3069 6.18E-12 1.172E-09 1.207E-04 0.01145001 DE_YY1_TARGETS_DN transitional cell carcinoma DOID_2671 2.208E-09 3.141E-07 6.291E-06 3.579E-03 DE_YY1_TARGETS_DN mixed glioma DOID_5076 7.249E-08 8.249E-06 5.045E-03 0.09897759 DE_YY1_TARGETS_DN biliary tract cancer DOID_4607 9.842E-08 9.333E-06 5.675E-03 0.10764001 DE_YY1_TARGETS_DN nervous system cancer DOID_3093 1.465E-07 1.191E-05 6.616E-03 0.11763267 DE_YY1_TARGETS_DN spindle cell carcinoma DOID_4015 1.712E-07 1.217E-05 1.000 1.000 DE_YY1_TARGETS_DN gallbladder cancer DOID_3121 4.578E-07 2.894E-05 1.774E-03 0.05608412 DE_YY1_TARGETS_DN aortic valve insufficiency DOID_57 4.709E-07 2.679E-05 1.116E-04 0.01269601 DE_YY1_TARGETS_DN integumentary system cancer DOID_0060122 1.077E-06 5.573E-05 2.688E-03 0.06649896 DE_YY1_TARGETS_DN skin cancer DOID_4159 1.077E-06 5.573E-05 2.688E-03 0.06649896 DE_YY1_TARGETS_DN pre-malignant neoplasm DOID_0060071 1.816E-06 8.611E-05 9.316E-05 0.01325144 DE_YY1_TARGETS_DN in situ carcinoma DOID_8719 1.816E-06 8.611E-05 9.316E-05 0.01325144 DE_YY1_TARGETS_DN pancreatitis DOID_4989 3.932E-06 1.721E-04 5.045E-03 0.10251251 DE_YY1_TARGETS_DN aortic valve disease DOID_62 4.284E-06 1.741E-04 4.618E-04 0.02919877 DE_YY1_TARGETS_DN encephalomyelitis DOID_640 7.8E-06 2.959E-04 2.743E-04 0.02229681 DE_YY1_TARGETS_DN endometrial carcinoma DOID_2871 1.042E-05 3.706E-04 0.04136919 0.33627242 DE_YY1_TARGETS_DN endometrial cancer DOID_1380 1.255E-05 4.2E-04 0.04389832 0.34691871 DE_YY1_TARGETS_DN thyroid carcinoma DOID_3963 1.625E-05 5.137E-04 0.04767977 0.35233492 DE_YY1_TARGETS_DN thyroid cancer DOID_1781 1.908E-05 5.713E-04 0.05019259 0.36151369 DE_YY1_TARGETS_DN peptic ulcer DOID_750 2.39E-05 6.799E-04 1.419E-03 0.05383016 DE_YY1_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 2.752E-05 7.456E-04 1.557E-03 0.05535464 DE_YY1_TARGETS_DN uterine cancer DOID_363 3.36E-05 8.689E-04 0.06017904 0.40764133 DE_YY1_TARGETS_DN thyroid adenoma DOID_2891 4.05E-05 1.002E-03 0.06389736 0.4227628 DE_YY1_TARGETS_DN heart valve disease DOID_4079 4.05E-05 9.601E-04 2.005E-03 0.05433849 DE_YY1_TARGETS_DN lung small cell carcinoma DOID_5409 4.558E-05 1.037E-03 0.06636824 0.41959474 DE_YY1_TARGETS_DN bile duct adenocarcinoma DOID_4896 6.007E-05 1.315E-03 1.000 1.000 DE_YY1_TARGETS_DN cholangiocarcinoma DOID_4947 6.007E-05 1.315E-03 1.000 1.000 DE_YY1_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 6.328E-05 1.334E-03 0.07374257 0.44167916 DE_YY1_TARGETS_DN bile duct cancer DOID_4606 7.361E-05 1.496E-03 1.000 1.000 DE_YY1_TARGETS_DN bile duct carcinoma DOID_4897 7.361E-05 1.496E-03 1.000 1.000 DE_YY1_TARGETS_DN rectal neoplasm DOID_1984 7.619E-05 1.495E-03 1.000 1.000 DE_YY1_TARGETS_DN rectum cancer DOID_1993 7.619E-05 1.495E-03 1.000 1.000 DE_YY1_TARGETS_DN breast benign neoplasm DOID_0060082 9.305E-05 1.765E-03 0.01441426 0.22166794 DE_YY1_TARGETS_DN thoracic benign neoplasm DOID_0060097 9.305E-05 1.765E-03 0.01441426 0.22166794 DE_YY1_TARGETS_DN benign breast phyllodes tumor DOID_1631 9.305E-05 1.765E-03 0.01441426 0.22166794 DE_YY1_TARGETS_DN stomach disease DOID_76 1.116E-04 2.048E-03 0.0157145 0.22927059 DE_YY1_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 1.158E-04 2.059E-03 0.08952501 0.47607223 DE_YY1_TARGETS_DN peripheral vascular disease DOID_341 1.363E-04 2.351E-03 0.0943279 0.48793251 DE_YY1_TARGETS_DN diabetic retinopathy DOID_8947 1.418E-04 2.373E-03 4.565E-03 0.10389869 DE_YY1_TARGETS_DN hemangioma DOID_255 1.77E-04 2.878E-03 1.000 1.000 DE_YY1_TARGETS_DN retinal vascular disease DOID_2462 2.116E-04 3.345E-03 5.937E-03 0.10897443 DE_YY1_TARGETS_DN gastric ulcer DOID_10808 3.872E-04 5.954E-03 3.872E-04 0.02753926 DE_YY1_TARGETS_DN sinusitis DOID_0050127 4.237E-04 6.345E-03 1.000 1.000 DE_YY1_TARGETS_DN paranasal sinus disease DOID_1352 4.237E-04 6.345E-03 1.000 1.000 DE_YY1_TARGETS_DN diabetic angiopathy DOID_11713 4.618E-04 6.738E-03 0.03118693 0.34794826 DE_YY1_TARGETS_DN portal hypertension DOID_10762 5.429E-04 7.723E-03 0.03374238 0.36225315 DE_YY1_TARGETS_DN seminoma DOID_4440 6.304E-04 8.749E-03 0.03629124 0.36874489 DE_YY1_TARGETS_DN lung adenocarcinoma DOID_3910 6.765E-04 9.165E-03 0.03756319 0.35622427 DE_YY1_TARGETS_DN pleurisy DOID_10247 7.242E-04 9.583E-03 7.242E-04 0.04120894 DE_YY1_TARGETS_DN malaria DOID_12365 7.242E-04 9.366E-03 1.000 1.000 DE_YY1_TARGETS_DN hepatic vascular disease DOID_272 7.242E-04 9.158E-03 0.0388335 0.34525409 DE_YY1_TARGETS_DN coronary stenosis DOID_4248 7.242E-04 8.958E-03 7.242E-04 0.03746267 DE_YY1_TARGETS_DN supratentorial cancer DOID_1659 7.735E-04 9.365E-03 1.000 1.000 DE_YY1_TARGETS_DN cerebrum cancer DOID_368 7.735E-04 9.365E-03 1.000 1.000 DE_YY1_TARGETS_DN focal glomerulosclerosis DOID_3945 7.735E-04 9.17E-03 7.735E-04 0.0366782 DE_YY1_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 8.244E-04 9.573E-03 0.04136919 0.34616279 DE_YY1_TARGETS_DN uterine benign neoplasm DOID_0060095 8.244E-04 9.573E-03 0.04136919 0.34616279 DE_YY1_TARGETS_DN uterine fibroid DOID_13223 8.244E-04 9.573E-03 0.04136919 0.34616279 DE_YY1_TARGETS_DN germinoma DOID_3304 9.309E-04 0.01059331 0.04389832 0.34216639 DE_YY1_TARGETS_DN chronic leukemia DOID_1036 9.865E-04 0.01100576 9.865E-04 0.04317643 DE_YY1_TARGETS_DN chronic lymphocytic leukemia DOID_1040 9.865E-04 0.01100576 9.865E-04 0.04317643 DE_YY1_TARGETS_DN leiomyoma DOID_127 9.865E-04 0.01079411 0.04516044 0.34724716 DE_YY1_TARGETS_DN pleural disease DOID_1532 9.865E-04 0.01059044 9.865E-04 0.0400924 DE_YY1_TARGETS_DN autonomic nervous system neoplasm DOID_2621 9.865E-04 0.01039433 0.04516044 0.34261719 DE_YY1_TARGETS_DN neuroblastoma DOID_769 9.865E-04 0.01039433 0.04516044 0.34261719 DE_YY1_TARGETS_DN peripheral nervous system neoplasm DOID_1192 1.353E-03 0.01399363 0.05269891 0.36567899 DE_YY1_TARGETS_DN hepatitis DOID_2237 1.419E-03 0.01441879 1.000 1.000 DE_YY1_TARGETS_DN lymphatic system disease DOID_75 1.487E-03 0.01484435 1.000 1.000 DE_YY1_TARGETS_DN benign mesothelioma DOID_2645 1.557E-03 0.01527025 1.000 1.000 DE_YY1_TARGETS_DN Huntington's disease DOID_12858 1.7E-03 0.01639609 1.7E-03 0.05690409 DE_YY1_TARGETS_DN pre-eclampsia DOID_10591 2.005E-03 0.01901847 2.005E-03 0.06005834 DE_YY1_TARGETS_DN brain cancer DOID_1319 2.005E-03 0.01870669 1.000 1.000 DE_YY1_TARGETS_DN neuritis DOID_1803 2.005E-03 0.01840497 2.005E-03 0.05705542 DE_YY1_TARGETS_DN central nervous system cancer DOID_3620 2.086E-03 0.01883628 1.000 1.000 DE_YY1_TARGETS_DN integumentary system benign neoplasm DOID_0060121 2.167E-03 0.01926744 0.06636824 0.42913098 DE_YY1_TARGETS_DN glaucoma DOID_1686 2.167E-03 0.01897101 0.06636824 0.42430929 DE_YY1_TARGETS_DN skin benign neoplasm DOID_3165 2.167E-03 0.01926744 0.06636824 0.42913098 DE_YY1_TARGETS_DN aortic aneurysm DOID_3627 2.25E-03 0.01939994 2.25E-03 0.05819983 DE_YY1_TARGETS_DN parasitic protozoa infectious disease DOID_2789 2.688E-03 0.022828 1.000 1.000 DE_YY1_TARGETS_DN pustulosis of palm and sole DOID_4398 2.688E-03 0.0224923 0.07374257 0.43257237 DE_YY1_TARGETS_DN neuroectodermal tumor DOID_171 3.262E-03 0.02689812 1.000 1.000 DE_YY1_TARGETS_DN hypothyroidism DOID_1459 3.363E-03 0.0273326 3.363E-03 0.07972009 DE_YY1_TARGETS_DN parasitic infectious disease DOID_1398 3.673E-03 0.02943858 1.000 1.000 DE_YY1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 4.22E-03 0.03334966 0.09192957 0.48433262 DE_YY1_TARGETS_DN nephrosis DOID_2527 4.334E-03 0.03377815 0.09312951 0.48615314 DE_YY1_TARGETS_DN pancreatic carcinoma DOID_4905 4.565E-03 0.03510091 0.09552474 0.48967187 DE_YY1_TARGETS_DN syndrome DOID_225 4.802E-03 0.03643095 0.09791377 0.49743693 DE_YY1_TARGETS_DN bone resorption disease DOID_0080011 4.923E-03 0.03685447 4.923E-03 0.10772846 DE_YY1_TARGETS_DN osteoporosis DOID_11476 4.923E-03 0.03685447 4.923E-03 0.10772846 DE_YY1_TARGETS_DN aneurysm disease DOID_2403 4.923E-03 0.03637584 4.923E-03 0.10373852 DE_YY1_TARGETS_DN lymphoma DOID_0060058 6.896E-03 0.05030802 0.11680469 0.56805015 DE_YY1_TARGETS_DN lymphoblastic leukemia DOID_1037 7.039E-03 0.05069692 7.039E-03 0.12136534 DE_YY1_TARGETS_DN dilated cardiomyopathy DOID_12930 7.328E-03 0.05211739 1.000 1.000 DE_YY1_TARGETS_DN keratitis DOID_4677 0.01311233 0.09211008 0.01311233 0.21943872 DE_YY1_TARGETS_DN Paget's disease of bone DOID_5408 0.01311233 0.09098679 0.01311233 0.21316904 DE_YY1_TARGETS_DN polycythemia DOID_8432 0.01311233 0.08989056 0.01311233 0.20724768 DE_YY1_TARGETS_DN familial adenomatous polyposis DOID_0050424 0.01441426 0.09763945 1.000 1.000 DE_YY1_TARGETS_DN nervous system benign neoplasm DOID_0060115 0.01441426 0.09649075 1.000 1.000 DE_YY1_TARGETS_DN polydactyly DOID_1148 0.01441426 0.09536876 1.000 1.000 DE_YY1_TARGETS_DN prostatic adenoma DOID_2883 0.01441426 0.09427257 1.000 1.000 DE_YY1_TARGETS_DN retinal detachment DOID_5327 0.0157145 0.09935059 1.000 1.000 DE_YY1_TARGETS_DN Hodgkin's lymphoma DOID_8567 0.0157145 0.09825883 1.000 1.000 DE_YY1_TARGETS_DN ocular hypertension DOID_9282 0.0157145 0.0971908 1.000 1.000 DE_YY1_TARGETS_DN borderline glaucoma DOID_9283 0.0157145 0.0971908 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN pancreatitis DOID_4989 1.07E-07 6.09E-05 1.07E-07 6.09E-05 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN mixed glioma DOID_5076 1.07E-07 3.045E-05 8.997E-04 0.05119395 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN pulmonary embolism DOID_9477 7.342E-05 0.01392498 7.342E-05 0.02088747 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN thyroid carcinoma DOID_3963 1.924E-04 0.02736396 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN thyroid cancer DOID_1781 2.139E-04 0.02434013 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN multiple myeloma DOID_9538 2.251E-04 0.02134386 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN hepatitis DOID_2237 2.483E-04 0.02018109 0.02301508 0.45157166 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN endometriosis of uterus DOID_288 2.852E-04 0.02028382 2.852E-04 0.05409019 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN endometriosis DOID_289 2.98E-04 0.01884332 2.98E-04 0.04239747 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN proteinuria DOID_576 3.383E-04 0.01925005 0.02680154 0.46212344 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN myeloma DOID_0070004 3.523E-04 0.01822313 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN thyroid adenoma DOID_2891 3.523E-04 0.01670454 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN sarcoidosis DOID_11335 4.42E-04 0.01934582 0.03057402 0.4832393 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN bone marrow cancer DOID_4960 4.579E-04 0.018611 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN hypersensitivity reaction type IV disease DOID_2916 5.244E-04 0.01989046 0.03326011 0.49802643 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN carotid artery disease DOID_3407 5.771E-04 0.02052205 5.771E-04 0.06567055 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN cholestasis DOID_13580 6.512E-04 0.02179592 0.03700874 0.50138036 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN parasitic infectious disease DOID_1398 6.512E-04 0.02058504 0.03700874 0.48972035 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN uterine disease DOID_345 6.512E-04 0.01950161 6.512E-04 0.06175511 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN temporal lobe epilepsy DOID_3328 6.704E-04 0.0190732 6.704E-04 0.05449485 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN endocrine organ benign neoplasm DOID_0060089 7.097E-04 0.01922838 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN tuberculosis DOID_399 7.097E-04 0.01835436 0.03861106 0.49931118 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN bile duct disease DOID_4138 7.706E-04 0.01906328 0.04021083 0.49739053 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN biliary tract disease DOID_9741 7.914E-04 0.01876324 0.04074353 0.49325676 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN syndrome DOID_225 8.556E-04 0.01947317 8.556E-04 0.06085365 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN bone resorption disease DOID_0080011 8.775E-04 0.01920414 8.775E-04 0.05547862 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN osteoporosis DOID_11476 8.775E-04 0.01920414 8.775E-04 0.05547862 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN bacterial pneumonia DOID_874 8.997E-04 0.01896072 0.04340278 0.49392365 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN female reproductive system disease DOID_229 9.679E-04 0.01966984 9.679E-04 0.05006868 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN focal epilepsy DOID_2234 1.015E-03 0.01991028 1.015E-03 0.04811651 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN primary bacterial infectious disease DOID_0050338 1.112E-03 0.02108381 0.04817175 0.49835869 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN alcohol-related neurodevelopmental disorder DOID_0050667 1.291E-03 0.02370374 0.05186529 0.50881639 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN hypersensitivity reaction type I disease DOID_1205 1.318E-03 0.02343861 0.05239182 0.5052703 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN acute kidney failure DOID_3021 5.526E-03 0.09528433 5.526E-03 0.24187562 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN chondrosarcoma DOID_3371 5.526E-03 0.09248185 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN temporal arteritis DOID_13375 6.077E-03 0.09879741 1.000 1.000 CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN central nervous system vasculitis DOID_525 6.077E-03 0.09879741 1.000 1.000 LU_TUMOR_VASCULATURE_UP aneurysm disease DOID_2403 1.89E-06 1.075E-03 2.792E-04 0.03176932 LU_TUMOR_VASCULATURE_UP larynx cancer DOID_2596 7.15E-06 2.034E-03 4.108E-03 0.23373062 LU_TUMOR_VASCULATURE_UP laryngeal benign neoplasm DOID_2598 7.15E-06 2.034E-03 4.108E-03 0.23373062 LU_TUMOR_VASCULATURE_UP intracranial aneurysm DOID_10941 3.456E-05 6.555E-03 8.828E-03 0.27907 LU_TUMOR_VASCULATURE_UP middle cerebral artery infarction DOID_3525 3.456E-05 4.916E-03 8.828E-03 0.2643821 LU_TUMOR_VASCULATURE_UP focal glomerulosclerosis DOID_3945 4.249E-05 4.835E-03 9.77E-03 0.25268401 LU_TUMOR_VASCULATURE_UP bronchiolitis obliterans DOID_2799 4.823E-05 4.574E-03 0.01039715 0.21911041 LU_TUMOR_VASCULATURE_UP calcinosis DOID_182 7.116E-05 5.784E-03 0.01258983 0.20467471 LU_TUMOR_VASCULATURE_UP multiple myeloma DOID_9538 7.116E-05 5.061E-03 7.116E-05 0.04049108 LU_TUMOR_VASCULATURE_UP systemic scleroderma DOID_418 7.852E-05 4.964E-03 0.01321549 0.20323286 LU_TUMOR_VASCULATURE_UP adult respiratory distress syndrome DOID_11394 8.234E-05 4.685E-03 0.01352819 0.20256681 LU_TUMOR_VASCULATURE_UP intracranial arterial disease DOID_13089 8.234E-05 4.259E-03 0.01352819 0.19737279 LU_TUMOR_VASCULATURE_UP cerebral arterial disease DOID_3527 8.234E-05 4.259E-03 0.01352819 0.19737279 LU_TUMOR_VASCULATURE_UP benign mesothelioma DOID_2645 8.625E-05 4.089E-03 8.625E-05 0.02453694 LU_TUMOR_VASCULATURE_UP rheumatic disease DOID_1575 9.433E-05 4.129E-03 0.01446573 0.19597613 LU_TUMOR_VASCULATURE_UP scleroderma DOID_419 9.433E-05 4.129E-03 0.01446573 0.19597613 LU_TUMOR_VASCULATURE_UP cerebral infarction DOID_3526 1.028E-04 4.177E-03 0.0150903 0.19080841 LU_TUMOR_VASCULATURE_UP myeloma DOID_0070004 1.116E-04 4.232E-03 1.116E-04 0.02116001 LU_TUMOR_VASCULATURE_UP brain cancer DOID_1319 1.116E-04 3.968E-03 0.0157145 0.19024581 LU_TUMOR_VASCULATURE_UP central nervous system cancer DOID_3620 1.161E-04 3.886E-03 0.01602647 0.18238126 LU_TUMOR_VASCULATURE_UP calcium metabolism disease DOID_10575 1.254E-04 3.965E-03 0.01665014 0.1857633 LU_TUMOR_VASCULATURE_UP bile duct adenocarcinoma DOID_4896 1.452E-04 4.348E-03 0.01789638 0.18857481 LU_TUMOR_VASCULATURE_UP cholangiocarcinoma DOID_4947 1.452E-04 4.348E-03 0.01789638 0.18857481 LU_TUMOR_VASCULATURE_UP bone marrow cancer DOID_4960 1.452E-04 4.13E-03 1.452E-04 0.02065092 LU_TUMOR_VASCULATURE_UP bile duct cancer DOID_4606 1.663E-04 4.507E-03 0.01914117 0.19107592 LU_TUMOR_VASCULATURE_UP bile duct carcinoma DOID_4897 1.663E-04 4.507E-03 0.01914117 0.19107592 LU_TUMOR_VASCULATURE_UP collagen disease DOID_854 1.832E-04 4.737E-03 0.02007382 0.19359327 LU_TUMOR_VASCULATURE_UP respiratory failure DOID_11162 1.889E-04 4.674E-03 0.02038452 0.1933132 LU_TUMOR_VASCULATURE_UP mineral metabolism disease DOID_0050032 2.008E-04 4.76E-03 0.02100565 0.19593797 LU_TUMOR_VASCULATURE_UP allergic contact dermatitis DOID_3042 2.192E-04 4.988E-03 0.02193667 0.19503073 LU_TUMOR_VASCULATURE_UP brain infarction DOID_3454 2.255E-04 4.935E-03 0.02224683 0.19179467 LU_TUMOR_VASCULATURE_UP tuberculosis DOID_399 2.255E-04 4.752E-03 0.02224683 0.18893206 LU_TUMOR_VASCULATURE_UP pancreatic ductal carcinoma DOID_3587 2.384E-04 4.844E-03 0.02286688 0.191342 LU_TUMOR_VASCULATURE_UP pancreatic carcinoma DOID_4905 2.584E-04 5.069E-03 0.02379628 0.1907054 LU_TUMOR_VASCULATURE_UP cystic fibrosis DOID_1485 2.721E-04 5.162E-03 0.02441543 0.19294971 LU_TUMOR_VASCULATURE_UP contact dermatitis DOID_2773 3.008E-04 5.52E-03 0.02565265 0.19724805 LU_TUMOR_VASCULATURE_UP biliary tract cancer DOID_4607 3.231E-04 5.746E-03 0.02657962 0.19899738 LU_TUMOR_VASCULATURE_UP primary bacterial infectious disease DOID_0050338 3.542E-04 6.107E-03 0.02781432 0.20290187 LU_TUMOR_VASCULATURE_UP nervous system cancer DOID_3093 3.784E-04 6.333E-03 0.0287394 0.20699643 LU_TUMOR_VASCULATURE_UP hypersensitivity reaction type I disease DOID_1205 4.205E-04 6.837E-03 4.205E-04 0.03988168 LU_TUMOR_VASCULATURE_UP pneumocystosis DOID_11339 3.477E-03 0.05495262 3.477E-03 0.28261349 LU_TUMOR_VASCULATURE_UP temporal arteritis DOID_13375 3.477E-03 0.05346742 1.000 1.000 LU_TUMOR_VASCULATURE_UP craniosynostosis DOID_2340 3.477E-03 0.05206038 3.477E-03 0.2472868 LU_TUMOR_VASCULATURE_UP central nervous system vasculitis DOID_525 3.477E-03 0.05346742 1.000 1.000 LU_TUMOR_VASCULATURE_UP bronchiectasis DOID_9563 3.477E-03 0.0507255 1.000 1.000 LU_TUMOR_VASCULATURE_UP otitis media DOID_10754 3.792E-03 0.05394566 3.792E-03 0.23975848 LU_TUMOR_VASCULATURE_UP middle ear disease DOID_5100 3.792E-03 0.05394566 3.792E-03 0.23975848 LU_TUMOR_VASCULATURE_UP ocular hypertension DOID_9282 3.792E-03 0.05262991 1.000 1.000 LU_TUMOR_VASCULATURE_UP borderline glaucoma DOID_9283 3.792E-03 0.05262991 1.000 1.000 LU_TUMOR_VASCULATURE_UP encephalitis DOID_9588 3.792E-03 0.05137682 1.000 1.000 LU_TUMOR_VASCULATURE_UP bacterial meningitis DOID_9470 4.423E-03 0.0585287 1.000 1.000 LU_TUMOR_VASCULATURE_UP skeletal system cancer DOID_0060124 4.738E-03 0.06127522 1.000 1.000 LU_TUMOR_VASCULATURE_UP thoracic aortic aneurysm DOID_14004 4.738E-03 0.05991355 1.000 1.000 LU_TUMOR_VASCULATURE_UP bone cancer DOID_184 4.738E-03 0.06127522 1.000 1.000 LU_TUMOR_VASCULATURE_UP oral submucous fibrosis DOID_5773 4.738E-03 0.05861108 1.000 1.000 LU_TUMOR_VASCULATURE_UP panic disorder DOID_594 4.738E-03 0.05736403 4.738E-03 0.24510087 LU_TUMOR_VASCULATURE_UP varicose veins DOID_799 4.738E-03 0.05616895 1.000 1.000 LU_TUMOR_VASCULATURE_UP vein disease DOID_866 5.053E-03 0.05868231 1.000 1.000 LU_TUMOR_VASCULATURE_UP prion disease DOID_649 5.684E-03 0.06467848 5.684E-03 0.26949368 LU_TUMOR_VASCULATURE_UP brain edema DOID_4724 6.313E-03 0.07043543 1.000 1.000 LU_TUMOR_VASCULATURE_UP subependymal glioma DOID_4843 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP pilocytic astrocytoma DOID_4851 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP subependymal giant cell astrocytoma DOID_5077 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP fibrillary astrocytoma DOID_6726 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP juvenile pilocytic astrocytoma DOID_6811 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP childhood pilocytic astrocytoma DOID_6812 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP gemistocytic astrocytoma DOID_7005 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP childhood cerebral astrocytoma DOID_7007 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP protoplasmic astrocytoma DOID_7008 6.313E-03 0.06908091 1.000 1.000 LU_TUMOR_VASCULATURE_UP coronary restenosis DOID_4247 6.628E-03 0.07115605 6.628E-03 0.29009774 LU_TUMOR_VASCULATURE_UP benign glioma DOID_0060101 6.942E-03 0.07315337 1.000 1.000 LU_TUMOR_VASCULATURE_UP gastric ulcer DOID_10808 6.942E-03 0.07182331 1.000 1.000 LU_TUMOR_VASCULATURE_UP familial hypercholesterolemia DOID_13810 6.942E-03 0.07054075 1.000 1.000 LU_TUMOR_VASCULATURE_UP benign ependymoma DOID_4844 6.942E-03 0.07315337 1.000 1.000 LU_TUMOR_VASCULATURE_UP sinusitis DOID_0050127 7.257E-03 0.07244283 1.000 1.000 LU_TUMOR_VASCULATURE_UP paranasal sinus disease DOID_1352 7.257E-03 0.07244283 1.000 1.000 LU_TUMOR_VASCULATURE_UP opiate dependence DOID_2559 7.257E-03 0.07119382 1.000 1.000 LU_TUMOR_VASCULATURE_UP uremia DOID_4676 7.257E-03 0.06998714 7.257E-03 0.29494582 LU_TUMOR_VASCULATURE_UP pulmonary embolism DOID_9477 7.257E-03 0.06882069 1.000 1.000 LU_TUMOR_VASCULATURE_UP synostosis DOID_11971 7.571E-03 0.07062539 7.571E-03 0.28720994 LU_TUMOR_VASCULATURE_UP meningitis DOID_9471 7.571E-03 0.06948628 1.000 1.000 LU_TUMOR_VASCULATURE_UP Goodpasture syndrome DOID_9808 7.571E-03 0.06838332 7.571E-03 0.26925932 LU_TUMOR_VASCULATURE_UP bronchiolitis DOID_2942 8.2E-03 0.07290326 8.2E-03 0.27445932 LU_TUMOR_VASCULATURE_UP renal hypertension DOID_1073 9.456E-03 0.08277699 1.000 1.000 LU_TUMOR_VASCULATURE_UP secondary hypertension DOID_11130 9.456E-03 0.08277699 1.000 1.000 LU_TUMOR_VASCULATURE_UP malaria DOID_12365 9.456E-03 0.08152279 9.456E-03 0.2690252 LU_TUMOR_VASCULATURE_UP coronary stenosis DOID_4248 9.456E-03 0.08030603 9.456E-03 0.25621448 LU_TUMOR_VASCULATURE_UP supratentorial cancer DOID_1659 9.77E-03 0.08175071 1.000 1.000 LU_TUMOR_VASCULATURE_UP cerebrum cancer DOID_368 9.77E-03 0.08175071 1.000 1.000 LU_TUMOR_VASCULATURE_UP cranial nerve disease DOID_5656 9.77E-03 0.08056592 9.77E-03 0.24169775 LU_TUMOR_VASCULATURE_UP dysostosis DOID_1934 0.01008355 0.08196487 0.01008355 0.23906419 LU_TUMOR_VASCULATURE_UP endometrial carcinoma DOID_2871 0.01008355 0.08081043 0.01008355 0.22950163 LU_TUMOR_VASCULATURE_UP opportunistic mycosis DOID_2473 0.01039715 0.08216641 0.01039715 0.22753774 LU_TUMOR_VASCULATURE_UP abdominal aortic aneurysm DOID_7693 0.01039715 0.08104084 1.000 1.000 LU_TUMOR_VASCULATURE_UP endometrial cancer DOID_1380 0.01071067 0.08235635 0.01071067 0.21765607 LU_TUMOR_VASCULATURE_UP allergic rhinitis DOID_4481 0.01071067 0.08125827 1.000 1.000 LU_TUMOR_VASCULATURE_UP systemic mycosis DOID_0050136 0.01133742 0.08488147 0.01133742 0.222448 LU_TUMOR_VASCULATURE_UP fungal infectious disease DOID_1564 0.01133742 0.08488147 0.01133742 0.222448 LU_TUMOR_VASCULATURE_UP myocarditis DOID_820 0.01133742 0.08377912 1.000 1.000 LU_TUMOR_VASCULATURE_UP hepatitis C DOID_1883 0.01165066 0.08499007 0.01165066 0.22097418 LU_TUMOR_VASCULATURE_UP thyroid carcinoma DOID_3963 0.01165066 0.08391424 0.01165066 0.21384598 LU_TUMOR_VASCULATURE_UP thyroid cancer DOID_1781 0.01227687 0.08731921 0.01227687 0.21829802 LU_TUMOR_VASCULATURE_UP refractive error DOID_9835 0.01227687 0.08624119 0.01227687 0.21168293 LU_TUMOR_VASCULATURE_UP pulmonary sarcoidosis DOID_13406 0.01258983 0.08736116 0.01258983 0.21069455 LU_TUMOR_VASCULATURE_UP respiratory syncytial virus infectious disease DOID_1273 0.01321549 0.09059778 1.000 1.000 LU_TUMOR_VASCULATURE_UP hepatitis DOID_2237 0.01321549 0.08951924 0.01321549 0.20887822 LU_TUMOR_VASCULATURE_UP peptic ulcer DOID_750 0.01321549 0.08846607 1.000 1.000 LU_TUMOR_VASCULATURE_UP adenoid cystic carcinoma DOID_4866 0.01352819 0.08950627 0.01352819 0.19243847 LU_TUMOR_VASCULATURE_UP pulmonary emphysema DOID_9675 0.01384079 0.09052196 1.000 1.000 LU_TUMOR_VASCULATURE_UP endometriosis of uterus DOID_288 0.0141533 0.09151397 1.000 1.000 LU_TUMOR_VASCULATURE_UP salivary gland cancer DOID_8850 0.0141533 0.09048573 0.0141533 0.19642024 LU_TUMOR_VASCULATURE_UP endometriosis DOID_289 0.01446573 0.09145553 1.000 1.000 LU_TUMOR_VASCULATURE_UP diabetic autonomic neuropathy DOID_11503 0.01477806 0.09240345 1.000 1.000 LU_TUMOR_VASCULATURE_UP autonomic neuropathy DOID_11504 0.01477806 0.09240345 1.000 1.000 LU_TUMOR_VASCULATURE_UP diabetic polyneuropathy DOID_12785 0.01477806 0.09240345 1.000 1.000 LU_TUMOR_VASCULATURE_UP gallbladder cancer DOID_3121 0.01477806 0.09139906 0.01477806 0.19555149 LU_TUMOR_VASCULATURE_UP uterine cancer DOID_363 0.01477806 0.09041628 0.01477806 0.19110714 LU_TUMOR_VASCULATURE_UP influenza DOID_8469 0.01477806 0.0894544 1.000 1.000 LU_TUMOR_VASCULATURE_UP diabetic neuropathy DOID_9743 0.01477806 0.09240345 1.000 1.000 LU_TUMOR_VASCULATURE_UP proteinuria DOID_576 0.01540245 0.09225254 0.01540245 0.19052156 LU_TUMOR_VASCULATURE_UP pre-eclampsia DOID_10591 0.0157145 0.09314118 1.000 1.000 LU_TUMOR_VASCULATURE_UP autonomic nervous system disease DOID_11465 0.0157145 0.09218096 1.000 1.000 LU_TUMOR_VASCULATURE_UP thyroid adenoma DOID_2891 0.0157145 0.09124034 0.0157145 0.18628236 LU_TUMOR_VASCULATURE_UP heart valve disease DOID_4079 0.0157145 0.09031872 0.0157145 0.18248068 LU_TUMOR_VASCULATURE_UP integumentary system benign neoplasm DOID_0060121 0.01633835 0.09296521 1.000 1.000 LU_TUMOR_VASCULATURE_UP glaucoma DOID_1686 0.01633835 0.09204477 1.000 1.000 LU_TUMOR_VASCULATURE_UP pulmonary tuberculosis DOID_2957 0.01633835 0.09114237 1.000 1.000 LU_TUMOR_VASCULATURE_UP skin benign neoplasm DOID_3165 0.01633835 0.09296521 1.000 1.000 LU_TUMOR_VASCULATURE_UP aortic aneurysm DOID_3627 0.01665014 0.09197988 1.000 1.000 LU_TUMOR_VASCULATURE_UP withdrawal disorder DOID_0060001 0.01696183 0.0928008 1.000 1.000 LU_TUMOR_VASCULATURE_UP sarcoidosis DOID_11335 0.01758495 0.09529371 0.01758495 0.19241998 LU_TUMOR_VASCULATURE_UP giant cell tumor DOID_200 0.01758495 0.09439471 1.000 1.000 LU_TUMOR_VASCULATURE_UP malignant giant cell tumor DOID_2705 0.01758495 0.09439471 1.000 1.000 LU_TUMOR_VASCULATURE_UP giant cell glioblastoma DOID_3074 0.01758495 0.09439471 1.000 1.000 LU_TUMOR_VASCULATURE_UP atrophic muscular disease DOID_913 0.01758495 0.09351251 0.01758495 0.18878942 LU_TUMOR_VASCULATURE_UP muscular dystrophy DOID_9884 0.01758495 0.09351251 0.01758495 0.18878942 LU_TUMOR_VASCULATURE_UP vasculitis DOID_865 0.01789638 0.0942874 1.000 1.000 LU_TUMOR_VASCULATURE_UP integumentary system cancer DOID_0060122 0.01820771 0.0950476 1.000 1.000 LU_TUMOR_VASCULATURE_UP parasitic protozoa infectious disease DOID_2789 0.01820771 0.09418353 0.01820771 0.18836707 LU_TUMOR_VASCULATURE_UP skin cancer DOID_4159 0.01820771 0.0950476 1.000 1.000 LU_TUMOR_VASCULATURE_UP familial hyperlipidemia DOID_1168 0.01851896 0.09493051 1.000 1.000 LU_TUMOR_VASCULATURE_UP hypertrophic cardiomyopathy DOID_11984 0.01914117 0.09724399 1.000 1.000 LU_TUMOR_VASCULATURE_UP hypersensitivity reaction type IV disease DOID_2916 0.01914117 0.09638343 0.01914117 0.19448799 LU_TUMOR_VASCULATURE_UP glioblastoma DOID_3068 0.01914117 0.09553796 1.000 1.000 LU_TUMOR_VASCULATURE_UP oral cavity cancer DOID_8618 0.01914117 0.0947072 0.01914117 0.18778151 LU_TUMOR_VASCULATURE_UP carotid artery disease DOID_3407 0.02007382 0.09846554 1.000 1.000 GARY_CD5_TARGETS_UP chronic kidney failure DOID_784 1.578E-09 8.977E-07 6.177E-07 7.029E-05 GARY_CD5_TARGETS_UP amino acid metabolic disorder DOID_9252 2.915E-09 8.295E-07 2.915E-09 1.659E-06 GARY_CD5_TARGETS_UP pre-malignant neoplasm DOID_0060071 4.373E-09 8.293E-07 1.068E-07 3.04E-05 GARY_CD5_TARGETS_UP in situ carcinoma DOID_8719 4.373E-09 8.293E-07 1.068E-07 3.04E-05 GARY_CD5_TARGETS_UP encephalomyelitis DOID_640 8.028E-08 1.142E-05 1.866E-05 1.062E-03 GARY_CD5_TARGETS_UP Crohn's disease DOID_8778 8.715E-08 9.918E-06 1.981E-05 1.025E-03 GARY_CD5_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 1.932E-07 1.832E-05 5.313E-06 5.038E-04 GARY_CD5_TARGETS_UP X-linked disease DOID_0050735 3.499E-07 2.844E-05 3.499E-07 6.637E-05 GARY_CD5_TARGETS_UP bacterial pneumonia DOID_874 4.073E-07 2.897E-05 4.073E-07 5.793E-05 GARY_CD5_TARGETS_UP contact dermatitis DOID_2773 4.827E-07 3.052E-05 7.997E-06 6.501E-04 GARY_CD5_TARGETS_UP biliary tract cancer DOID_4607 6.177E-07 3.514E-05 1.471E-03 0.02146851 GARY_CD5_TARGETS_UP nervous system cancer DOID_3093 1.06E-06 5.482E-05 1.926E-04 7.304E-03 GARY_CD5_TARGETS_UP papilloma DOID_2615 1.914E-06 9.076E-05 1.149E-03 0.02178865 GARY_CD5_TARGETS_UP spindle cell carcinoma DOID_4015 2.203E-06 9.642E-05 1.245E-03 0.02213594 GARY_CD5_TARGETS_UP allergic contact dermatitis DOID_3042 3.17E-06 1.289E-04 5.247E-05 2.488E-03 GARY_CD5_TARGETS_UP intracranial arterial disease DOID_13089 4.731E-06 1.795E-04 1.082E-04 4.396E-03 GARY_CD5_TARGETS_UP cerebral arterial disease DOID_3527 4.731E-06 1.795E-04 1.082E-04 4.396E-03 GARY_CD5_TARGETS_UP cystic fibrosis DOID_1485 5.979E-06 2.126E-04 1.069E-03 0.02173157 GARY_CD5_TARGETS_UP bone resorption disease DOID_0080011 6.439E-06 2.155E-04 9.372E-05 4.102E-03 GARY_CD5_TARGETS_UP osteoporosis DOID_11476 6.439E-06 2.155E-04 9.372E-05 4.102E-03 GARY_CD5_TARGETS_UP gallbladder cancer DOID_3121 7.4E-06 2.339E-04 2.491E-03 0.02892754 GARY_CD5_TARGETS_UP lipid metabolism disorder DOID_3146 7.997E-06 2.395E-04 1.288E-03 0.02221096 GARY_CD5_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.225E-05 3.485E-04 3.325E-03 0.03101373 GARY_CD5_TARGETS_UP portal hypertension DOID_10762 1.414E-05 3.831E-04 9.683E-03 0.06332787 GARY_CD5_TARGETS_UP primary immunodeficiency disease DOID_612 1.459E-05 3.773E-04 1.459E-05 1.037E-03 GARY_CD5_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 1.477E-05 3.653E-04 1.477E-05 9.337E-04 GARY_CD5_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 1.553E-05 3.682E-04 1.926E-04 6.848E-03 GARY_CD5_TARGETS_UP lymphoma DOID_0060058 1.757E-05 3.998E-04 2.13E-04 7.128E-03 GARY_CD5_TARGETS_UP familial hyperlipidemia DOID_1168 2.284E-05 4.999E-04 4.75E-03 0.03974376 GARY_CD5_TARGETS_UP ulcerative colitis DOID_8577 2.499E-05 5.267E-04 2.666E-03 0.02862445 GARY_CD5_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 2.546E-05 5.174E-04 0.01276745 0.0741294 GARY_CD5_TARGETS_UP sarcoma DOID_1115 2.546E-05 4.995E-04 0.01276745 0.07264682 GARY_CD5_TARGETS_UP Behcet's disease DOID_13241 2.546E-05 5.174E-04 0.01276745 0.0741294 GARY_CD5_TARGETS_UP hepatic vascular disease DOID_272 2.546E-05 4.829E-04 0.01276745 0.07122237 GARY_CD5_TARGETS_UP breast benign neoplasm DOID_0060082 2.95E-05 5.415E-04 0.0611997 0.21901026 GARY_CD5_TARGETS_UP thoracic benign neoplasm DOID_0060097 2.95E-05 5.415E-04 0.0611997 0.21901026 GARY_CD5_TARGETS_UP benign breast phyllodes tumor DOID_1631 2.95E-05 5.415E-04 0.0611997 0.21901026 GARY_CD5_TARGETS_UP carotid artery disease DOID_3407 3.399E-05 6.044E-04 0.05215861 0.20609896 GARY_CD5_TARGETS_UP respiratory failure DOID_11162 3.665E-05 6.32E-04 6.224E-03 0.04785691 GARY_CD5_TARGETS_UP parasitic infectious disease DOID_1398 4.562E-05 7.634E-04 6.383E-04 0.01729595 GARY_CD5_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 5.619E-05 9.134E-04 7.515E-04 0.01859112 GARY_CD5_TARGETS_UP hepatitis C DOID_1883 5.946E-05 9.398E-04 1.245E-03 0.02285 GARY_CD5_TARGETS_UP astrocytoma DOID_3069 6.01E-05 9.243E-04 8.254E-03 0.05797972 GARY_CD5_TARGETS_UP nephrosis DOID_2527 6.856E-05 1.027E-03 8.781E-04 0.02081864 GARY_CD5_TARGETS_UP peripheral vascular disease DOID_341 7.311E-05 1.067E-03 0.06895561 0.22420424 GARY_CD5_TARGETS_UP adenoma DOID_657 7.339E-05 1.044E-03 0.0210303 0.10684144 GARY_CD5_TARGETS_UP mesenchymal cell neoplasm DOID_3350 7.999E-05 1.11E-03 3.26E-03 0.03144238 GARY_CD5_TARGETS_UP spindle cell sarcoma DOID_4235 7.999E-05 1.11E-03 3.26E-03 0.03144238 GARY_CD5_TARGETS_UP epithelioid sarcoma DOID_6193 7.999E-05 1.11E-03 3.26E-03 0.03144238 GARY_CD5_TARGETS_UP syndrome DOID_225 8.82E-05 1.195E-03 0.01026878 0.06420811 GARY_CD5_TARGETS_UP bronchitis DOID_6132 1.185E-04 1.569E-03 0.09299477 0.26195062 GARY_CD5_TARGETS_UP learning disability DOID_8927 1.668E-04 2.157E-03 2.646E-03 0.02895424 GARY_CD5_TARGETS_UP transitional cell carcinoma DOID_2671 1.737E-04 2.196E-03 1.816E-03 0.02403262 GARY_CD5_TARGETS_UP proteinuria DOID_576 1.808E-04 2.236E-03 0.03215877 0.14876698 GARY_CD5_TARGETS_UP brain cancer DOID_1319 1.956E-04 2.368E-03 0.03337482 0.15192217 GARY_CD5_TARGETS_UP thyroid adenoma DOID_2891 1.956E-04 2.319E-03 2.974E-03 0.02917143 GARY_CD5_TARGETS_UP heart valve disease DOID_4079 1.956E-04 2.272E-03 0.03337482 0.15071644 GARY_CD5_TARGETS_UP vascular skin disease DOID_9540 1.956E-04 2.226E-03 0.03337482 0.1495297 GARY_CD5_TARGETS_UP pulmonary edema DOID_11396 1.962E-04 2.189E-03 0.10848802 0.28578556 GARY_CD5_TARGETS_UP subependymal glioma DOID_4843 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP pilocytic astrocytoma DOID_4851 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP subependymal giant cell astrocytoma DOID_5077 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP fibrillary astrocytoma DOID_6726 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP juvenile pilocytic astrocytoma DOID_6811 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP childhood pilocytic astrocytoma DOID_6812 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP gemistocytic astrocytoma DOID_7005 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP childhood cerebral astrocytoma DOID_7007 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP protoplasmic astrocytoma DOID_7008 1.962E-04 2.147E-03 5.79E-03 0.04639851 GARY_CD5_TARGETS_UP central nervous system cancer DOID_3620 2.113E-04 2.269E-03 0.03460864 0.15384622 GARY_CD5_TARGETS_UP mouth disease DOID_403 2.35E-04 2.476E-03 2.299E-03 0.02907173 GARY_CD5_TARGETS_UP benign glioma DOID_0060101 2.628E-04 2.719E-03 6.986E-03 0.05300259 GARY_CD5_TARGETS_UP benign ependymoma DOID_4844 2.628E-04 2.719E-03 6.986E-03 0.05300259 GARY_CD5_TARGETS_UP atopic dermatitis DOID_3310 2.833E-04 2.878E-03 3.898E-03 0.03520292 GARY_CD5_TARGETS_UP sinusitis DOID_0050127 3.01E-04 3.005E-03 3.01E-04 9.515E-03 GARY_CD5_TARGETS_UP paranasal sinus disease DOID_1352 3.01E-04 3.005E-03 3.01E-04 9.515E-03 GARY_CD5_TARGETS_UP uremia DOID_4676 3.01E-04 2.953E-03 0.12371781 0.30740363 GARY_CD5_TARGETS_UP bile duct adenocarcinoma DOID_4896 3.252E-04 3.136E-03 0.0423714 0.18264643 GARY_CD5_TARGETS_UP cholangiocarcinoma DOID_4947 3.252E-04 3.136E-03 0.0423714 0.18264643 GARY_CD5_TARGETS_UP bone marrow cancer DOID_4960 3.252E-04 3.084E-03 4.311E-03 0.03773689 GARY_CD5_TARGETS_UP vasculitis DOID_865 3.252E-04 3.033E-03 0.0423714 0.18127314 GARY_CD5_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 3.477E-04 3.191E-03 0.04372299 0.18565955 GARY_CD5_TARGETS_UP parasitic protozoa infectious disease DOID_2789 3.477E-04 3.141E-03 4.527E-03 0.0390288 GARY_CD5_TARGETS_UP pustulosis of palm and sole DOID_4398 3.477E-04 3.091E-03 0.04372299 0.18428429 GARY_CD5_TARGETS_UP bile duct cancer DOID_4606 4.22E-04 3.694E-03 0.04787224 0.19596624 GARY_CD5_TARGETS_UP bile duct carcinoma DOID_4897 4.22E-04 3.694E-03 0.04787224 0.19596624 GARY_CD5_TARGETS_UP urticaria DOID_1555 4.363E-04 3.762E-03 9.683E-03 0.06190477 GARY_CD5_TARGETS_UP osteosarcoma DOID_3347 4.363E-04 3.705E-03 9.683E-03 0.06121694 GARY_CD5_TARGETS_UP leukocyte disease DOID_9500 4.491E-04 3.758E-03 0.04928609 0.1988921 GARY_CD5_TARGETS_UP papillary adenoma DOID_3172 4.888E-04 4.031E-03 0.01041834 0.06374233 GARY_CD5_TARGETS_UP microcystic adenoma DOID_5403 4.888E-04 4.031E-03 0.01041834 0.06374233 GARY_CD5_TARGETS_UP follicular adenoma DOID_6204 4.888E-04 4.031E-03 0.01041834 0.06374233 GARY_CD5_TARGETS_UP middle cerebral artery infarction DOID_3525 5.451E-04 4.431E-03 5.451E-04 0.01632574 GARY_CD5_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 6.055E-04 4.852E-03 6.055E-04 0.01722625 GARY_CD5_TARGETS_UP gestational diabetes DOID_11714 6.055E-04 4.785E-03 0.01196095 0.07089357 GARY_CD5_TARGETS_UP uterine disease DOID_345 6.383E-04 4.976E-03 0.32341146 0.59361652 GARY_CD5_TARGETS_UP pleurisy DOID_10247 6.699E-04 5.151E-03 0.01276745 0.07338062 GARY_CD5_TARGETS_UP invasive ductal carcinoma DOID_3008 6.699E-04 5.083E-03 6.699E-04 0.01732709 GARY_CD5_TARGETS_UP hyperglycemia DOID_4195 6.746E-04 5.051E-03 7.342E-03 0.05496908 GARY_CD5_TARGETS_UP supratentorial cancer DOID_1659 7.386E-04 5.458E-03 0.01359703 0.07439145 GARY_CD5_TARGETS_UP cerebrum cancer DOID_368 7.386E-04 5.458E-03 0.01359703 0.07439145 GARY_CD5_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 8.116E-04 5.92E-03 0.01444939 0.07830195 GARY_CD5_TARGETS_UP uterine benign neoplasm DOID_0060095 8.116E-04 5.92E-03 0.01444939 0.07830195 GARY_CD5_TARGETS_UP uterine fibroid DOID_13223 8.116E-04 5.92E-03 0.01444939 0.07830195 GARY_CD5_TARGETS_UP opportunistic mycosis DOID_2473 8.89E-04 6.403E-03 8.89E-04 0.02023345 GARY_CD5_TARGETS_UP pancreatic carcinoma DOID_4905 9.704E-04 6.902E-03 0.35383604 0.64323548 GARY_CD5_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 9.709E-04 6.82E-03 9.709E-04 0.02124838 GARY_CD5_TARGETS_UP celiac disease DOID_10608 9.709E-04 6.737E-03 9.709E-04 0.0204614 GARY_CD5_TARGETS_UP leiomyoma DOID_127 1.057E-03 7.25E-03 0.01714036 0.09114828 GARY_CD5_TARGETS_UP pleural disease DOID_1532 1.057E-03 7.163E-03 0.01714036 0.09030432 GARY_CD5_TARGETS_UP systemic mycosis DOID_0050136 1.149E-03 7.69E-03 1.149E-03 0.02253998 GARY_CD5_TARGETS_UP fungal infectious disease DOID_1564 1.149E-03 7.69E-03 1.149E-03 0.02253998 GARY_CD5_TARGETS_UP mixed glioma DOID_5076 1.175E-03 7.776E-03 0.36853368 0.66150052 GARY_CD5_TARGETS_UP female reproductive system disease DOID_229 1.347E-03 8.812E-03 0.3793381 0.67662501 GARY_CD5_TARGETS_UP gallbladder disease DOID_0000000 1.424E-03 9.207E-03 1.424E-03 0.02382868 GARY_CD5_TARGETS_UP chondrosarcoma DOID_3371 1.424E-03 9.103E-03 1.424E-03 0.02314786 GARY_CD5_TARGETS_UP Noonan syndrome DOID_3490 1.424E-03 9.002E-03 1.424E-03 0.02250486 GARY_CD5_TARGETS_UP conjunctival disease DOID_4251 1.424E-03 8.903E-03 1.424E-03 0.02189662 GARY_CD5_TARGETS_UP conjunctivitis DOID_6195 1.424E-03 8.903E-03 1.424E-03 0.02189662 GARY_CD5_TARGETS_UP visceral leishmaniasis DOID_9146 1.424E-03 8.806E-03 0.0557937 0.20749423 GARY_CD5_TARGETS_UP cannabis abuse DOID_9505 1.424E-03 8.712E-03 1.424E-03 0.0213204 GARY_CD5_TARGETS_UP peripheral nervous system neoplasm DOID_1192 1.679E-03 0.01016613 0.02309978 0.11330842 GARY_CD5_TARGETS_UP polydactyly DOID_1148 1.734E-03 0.01038404 1.734E-03 0.02466209 GARY_CD5_TARGETS_UP migraine without aura DOID_12783 1.734E-03 0.01027587 1.734E-03 0.02406058 GARY_CD5_TARGETS_UP eosinophilic pneumonia DOID_5870 1.734E-03 0.01016993 1.000 1.000 GARY_CD5_TARGETS_UP chronic monocytic leukemia DOID_8593 1.734E-03 0.01006616 1.734E-03 0.02348771 GARY_CD5_TARGETS_UP pulmonary eosinophilia DOID_9498 1.734E-03 0.01016993 1.000 1.000 GARY_CD5_TARGETS_UP Loeffler syndrome DOID_9503 1.734E-03 0.01016993 1.000 1.000 GARY_CD5_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 1.801E-03 0.01035164 0.02416472 0.11652309 GARY_CD5_TARGETS_UP congenital diaphragmatic hernia DOID_3827 1.801E-03 0.01024812 0.21433648 0.43247325 GARY_CD5_TARGETS_UP common cold DOID_10459 2.073E-03 0.01167646 0.06657489 0.22683302 GARY_CD5_TARGETS_UP mucopolysaccharidosis DOID_12798 2.073E-03 0.01156199 2.073E-03 0.02680279 GARY_CD5_TARGETS_UP intracranial arteriosclerosis DOID_13097 2.073E-03 0.01144974 0.06657489 0.2241486 GARY_CD5_TARGETS_UP vascular dementia DOID_8725 2.073E-03 0.01144974 0.06657489 0.2241486 GARY_CD5_TARGETS_UP nephrotic syndrome DOID_1184 2.342E-03 0.01281299 0.02861968 0.135705 GARY_CD5_TARGETS_UP dilated cardiomyopathy DOID_12930 2.387E-03 0.01293772 0.0183944 0.09514921 GARY_CD5_TARGETS_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 2.44E-03 0.01309905 2.44E-03 0.03018477 GARY_CD5_TARGETS_UP vulva cancer DOID_1245 2.44E-03 0.01297663 1.000 1.000 GARY_CD5_TARGETS_UP cannabis dependence DOID_1849 2.44E-03 0.01285648 2.44E-03 0.02954254 GARY_CD5_TARGETS_UP monocytic leukemia DOID_8527 2.44E-03 0.01273853 2.44E-03 0.02892707 GARY_CD5_TARGETS_UP hallucinogen dependence DOID_9977 2.44E-03 0.01285648 2.44E-03 0.02954254 GARY_CD5_TARGETS_UP cerebral infarction DOID_3526 2.646E-03 0.01368746 2.646E-03 0.03011241 GARY_CD5_TARGETS_UP cataract DOID_83 2.646E-03 0.01356415 2.646E-03 0.02952197 GARY_CD5_TARGETS_UP viral pneumonia DOID_10533 2.836E-03 0.01440913 2.836E-03 0.02988559 GARY_CD5_TARGETS_UP aspergillosis DOID_13564 2.836E-03 0.01428161 2.836E-03 0.02934222 GARY_CD5_TARGETS_UP eyelid disease DOID_530 2.836E-03 0.01415633 2.836E-03 0.02881825 GARY_CD5_TARGETS_UP myeloma DOID_0070004 2.974E-03 0.01471255 0.03337482 0.15314735 GARY_CD5_TARGETS_UP pre-eclampsia DOID_10591 2.974E-03 0.01458571 0.24964213 0.48151312 GARY_CD5_TARGETS_UP lens disease DOID_110 2.974E-03 0.01446105 2.974E-03 0.02968321 GARY_CD5_TARGETS_UP hyperhomocysteinemia DOID_9279 3.26E-03 0.01572119 3.26E-03 0.03091834 GARY_CD5_TARGETS_UP integumentary system benign neoplasm DOID_0060121 3.325E-03 0.01589779 0.25821893 0.49304219 GARY_CD5_TARGETS_UP pulmonary tuberculosis DOID_2957 3.325E-03 0.01576531 3.325E-03 0.03051351 GARY_CD5_TARGETS_UP skin benign neoplasm DOID_3165 3.325E-03 0.01589779 0.25821893 0.49304219 GARY_CD5_TARGETS_UP angiosarcoma DOID_0001816 3.712E-03 0.01745575 1.000 1.000 GARY_CD5_TARGETS_UP tongue cancer DOID_8649 3.712E-03 0.01731267 0.08777103 0.25223089 GARY_CD5_TARGETS_UP giant cell tumor DOID_200 4.101E-03 0.01897184 0.04103595 0.1782401 GARY_CD5_TARGETS_UP malignant giant cell tumor DOID_2705 4.101E-03 0.01897184 0.04103595 0.1782401 GARY_CD5_TARGETS_UP giant cell glioblastoma DOID_3074 4.101E-03 0.01897184 0.04103595 0.1782401 GARY_CD5_TARGETS_UP lymphatic system cancer DOID_0060073 4.191E-03 0.01923204 4.191E-03 0.03726208 GARY_CD5_TARGETS_UP reticulosarcoma DOID_8538 4.191E-03 0.01923204 4.191E-03 0.03726208 GARY_CD5_TARGETS_UP lymphosarcoma DOID_8675 4.191E-03 0.01923204 4.191E-03 0.03726208 GARY_CD5_TARGETS_UP neuroendocrine tumor DOID_169 4.697E-03 0.02138236 4.697E-03 0.03989247 GARY_CD5_TARGETS_UP ureteral obstruction DOID_5199 4.697E-03 0.02121266 0.09818874 0.27253362 GARY_CD5_TARGETS_UP eosinophilia DOID_999 4.697E-03 0.02104563 1.000 1.000 GARY_CD5_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 5.215E-03 0.0231802 0.04787224 0.19882706 GARY_CD5_TARGETS_UP glioblastoma DOID_3068 5.215E-03 0.02300051 0.04787224 0.19738628 GARY_CD5_TARGETS_UP agammaglobulinemia DOID_2583 5.23E-03 0.02289254 5.23E-03 0.04313087 GARY_CD5_TARGETS_UP infertility DOID_5223 5.23E-03 0.02271778 0.1033531 0.27871048 GARY_CD5_TARGETS_UP psoriasis DOID_8893 5.23E-03 0.02254568 5.23E-03 0.04251471 GARY_CD5_TARGETS_UP leishmaniasis DOID_9065 5.23E-03 0.02237616 0.1033531 0.27609348 GARY_CD5_TARGETS_UP brain edema DOID_4724 5.79E-03 0.02458429 0.10848802 0.28446858 GARY_CD5_TARGETS_UP blood protein disease DOID_620 5.79E-03 0.02440218 5.79E-03 0.04575409 GARY_CD5_TARGETS_UP neuroectodermal tumor DOID_171 5.961E-03 0.02494181 5.961E-03 0.04646693 GARY_CD5_TARGETS_UP autoimmune hepatitis DOID_2048 6.375E-03 0.02647744 1.000 1.000 GARY_CD5_TARGETS_UP congenital heart defect DOID_1682 6.493E-03 0.02677251 0.05508947 0.21617869 GARY_CD5_TARGETS_UP endocrine pancreas disease DOID_1428 6.769E-03 0.02771004 0.05657625 0.20635824 GARY_CD5_TARGETS_UP acquired immunodeficiency syndrome DOID_635 6.986E-03 0.02839425 0.11867021 0.30144351 GARY_CD5_TARGETS_UP placenta disease DOID_780 6.986E-03 0.02819287 1.000 1.000 GARY_CD5_TARGETS_UP temporal lobe epilepsy DOID_3328 7.342E-03 0.02942007 0.05959145 0.21460466 GARY_CD5_TARGETS_UP glycogen metabolism disorder DOID_0050728 7.623E-03 0.03033199 7.623E-03 0.05633083 GARY_CD5_TARGETS_UP glycogen storage disease DOID_2747 7.623E-03 0.03033199 7.623E-03 0.05633083 GARY_CD5_TARGETS_UP muscle cancer DOID_4045 7.623E-03 0.03012135 0.12371781 0.30875189 GARY_CD5_TARGETS_UP urinary tract obstruction DOID_5200 7.623E-03 0.02991361 0.12371781 0.3060671 GARY_CD5_TARGETS_UP tooth disease DOID_1091 7.639E-03 0.02977096 7.639E-03 0.05572514 GARY_CD5_TARGETS_UP brain infarction DOID_3454 7.943E-03 0.0307446 7.943E-03 0.05720831 GARY_CD5_TARGETS_UP tuberculosis DOID_399 7.943E-03 0.03053687 7.943E-03 0.0564932 GARY_CD5_TARGETS_UP diabetic angiopathy DOID_11713 8.285E-03 0.03163806 0.12873663 0.31573769 GARY_CD5_TARGETS_UP ureteral disease DOID_1426 8.285E-03 0.03142714 0.12873663 0.31438259 GARY_CD5_TARGETS_UP Goodpasture syndrome DOID_9808 8.285E-03 0.03121901 8.285E-03 0.05748867 GARY_CD5_TARGETS_UP pancreatic ductal carcinoma DOID_3587 8.572E-03 0.03208739 0.34258979 0.62478715 GARY_CD5_TARGETS_UP bile duct disease DOID_4138 8.897E-03 0.03308663 8.897E-03 0.06099101 GARY_CD5_TARGETS_UP toxic shock syndrome DOID_14115 8.972E-03 0.03314813 0.13372684 0.32378968 GARY_CD5_TARGETS_UP sphingolipidosis DOID_1927 8.972E-03 0.03293427 8.972E-03 0.06077158 GARY_CD5_TARGETS_UP acute pancreatitis DOID_2913 8.972E-03 0.03272316 8.972E-03 0.06005662 GARY_CD5_TARGETS_UP biliary tract disease DOID_9741 9.229E-03 0.03344769 9.229E-03 0.06106148 GARY_CD5_TARGETS_UP diabetic retinopathy DOID_8947 9.568E-03 0.03445823 0.35383604 0.64118696 GARY_CD5_TARGETS_UP commensal bacterial infectious disease DOID_0050339 9.683E-03 0.0346511 0.1386886 0.33296969 GARY_CD5_TARGETS_UP reading disorder DOID_13365 9.683E-03 0.03443453 9.683E-03 0.06260823 GARY_CD5_TARGETS_UP dyslexia DOID_4428 9.683E-03 0.03443453 9.683E-03 0.06260823 GARY_CD5_TARGETS_UP endogenous depression DOID_1595 0.01026878 0.03629154 0.07380708 0.23331237 GARY_CD5_TARGETS_UP morbid obesity DOID_11981 0.01041834 0.03659282 0.01041834 0.06443518 GARY_CD5_TARGETS_UP ankylosing spondylitis DOID_7147 0.01041834 0.03636832 0.01041834 0.06306422 GARY_CD5_TARGETS_UP pancreatitis DOID_4989 0.01099823 0.03815848 0.0771006 0.24237704 GARY_CD5_TARGETS_UP B cell deficiency DOID_2115 0.01117782 0.03854654 0.01117782 0.06694925 GARY_CD5_TARGETS_UP metabolic syndrome X DOID_14221 0.0117569 0.04029925 0.08043976 0.24607648 GARY_CD5_TARGETS_UP migraine DOID_6364 0.01196095 0.04075319 0.01196095 0.07016271 GARY_CD5_TARGETS_UP renal hypertension DOID_1073 0.01276745 0.04324215 0.15825436 0.36309165 GARY_CD5_TARGETS_UP secondary hypertension DOID_11130 0.01276745 0.04324215 0.15825436 0.36309165 GARY_CD5_TARGETS_UP malaria DOID_12365 0.01276745 0.04298628 0.01276745 0.07192754 GARY_CD5_TARGETS_UP renal tubular transport disease DOID_447 0.01276745 0.04273342 0.01276745 0.07053089 GARY_CD5_TARGETS_UP mental depression DOID_1596 0.01295012 0.04309133 0.08553088 0.25086118 GARY_CD5_TARGETS_UP focal epilepsy DOID_2234 0.01295012 0.0428408 0.08553088 0.24957471 GARY_CD5_TARGETS_UP multiple epiphyseal dysplasia DOID_12721 0.01359703 0.04472087 0.16307627 0.36968285 GARY_CD5_TARGETS_UP focal glomerulosclerosis DOID_3945 0.01359703 0.04446385 0.16307627 0.36821586 GARY_CD5_TARGETS_UP retinal vascular disease DOID_2462 0.01378264 0.04481326 0.39345826 0.69527252 GARY_CD5_TARGETS_UP corneal disease DOID_10124 0.01444939 0.04671423 0.16787068 0.37754315 GARY_CD5_TARGETS_UP primary bacterial infectious disease DOID_0050338 0.01464495 0.04707898 0.01464495 0.07861301 GARY_CD5_TARGETS_UP bronchiolitis obliterans DOID_2799 0.01532426 0.04898597 0.17263776 0.38371439 GARY_CD5_TARGETS_UP germinoma DOID_3304 0.01622134 0.05156393 0.17737765 0.39119334 GARY_CD5_TARGETS_UP chronic leukemia DOID_1036 0.01714036 0.05418259 0.18209051 0.39849808 GARY_CD5_TARGETS_UP chronic lymphocytic leukemia DOID_1040 0.01714036 0.05418259 0.18209051 0.39849808 GARY_CD5_TARGETS_UP autonomic nervous system neoplasm DOID_2621 0.01714036 0.05388324 0.18209051 0.39395247 GARY_CD5_TARGETS_UP neuroblastoma DOID_769 0.01714036 0.05388324 0.18209051 0.39395247 GARY_CD5_TARGETS_UP lymphoblastic leukemia DOID_1037 0.01741183 0.0544359 0.10315834 0.28356084 GARY_CD5_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.01789934 0.05565423 0.10497236 0.27910875 GARY_CD5_TARGETS_UP myocarditis DOID_820 0.01808104 0.05591366 0.1867765 0.40104085 GARY_CD5_TARGETS_UP metal metabolism disorder DOID_896 0.01808104 0.05561143 0.01808104 0.09438636 GARY_CD5_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 0.0183944 0.05627104 0.42737532 0.7528686 GARY_CD5_TARGETS_UP thyroid carcinoma DOID_3963 0.01904311 0.057944 0.19143576 0.40644383 GARY_CD5_TARGETS_UP esophageal disease DOID_6050 0.01904311 0.05763579 0.01904311 0.09761738 GARY_CD5_TARGETS_UP thyroid cancer DOID_1781 0.0210303 0.06331345 0.20067471 0.41825608 GARY_CD5_TARGETS_UP pulmonary sarcoidosis DOID_13406 0.02205489 0.06604859 0.20525471 0.42315191 GARY_CD5_TARGETS_UP calcinosis DOID_182 0.02205489 0.06570278 0.02205489 0.11105515 GARY_CD5_TARGETS_UP cleft palate DOID_674 0.02205489 0.06536058 0.20525471 0.42010766 GARY_CD5_TARGETS_UP multiple myeloma DOID_9538 0.02205489 0.06502193 0.02205489 0.11008098 GARY_CD5_TARGETS_UP microcephaly DOID_10907 0.02309978 0.06775142 0.02309978 0.11429371 GARY_CD5_TARGETS_UP uveitis DOID_13141 0.02309978 0.06740398 0.02309978 0.11233997 GARY_CD5_TARGETS_UP systemic scleroderma DOID_418 0.02416472 0.07015165 0.21433648 0.43094508 GARY_CD5_TARGETS_UP peptic ulcer DOID_750 0.02416472 0.06979556 1.000 1.000 GARY_CD5_TARGETS_UP adult respiratory distress syndrome DOID_11394 0.02524943 0.07256024 0.02524943 0.12073048 GARY_CD5_TARGETS_UP lymphatic system disease DOID_75 0.02524943 0.07219562 0.21883855 0.43844766 GARY_CD5_TARGETS_UP benign mesothelioma DOID_2645 0.02635367 0.07497619 0.22331494 0.44584633 GARY_CD5_TARGETS_UP pulmonary emphysema DOID_9675 0.02635367 0.07460318 1.000 1.000 GARY_CD5_TARGETS_UP endometriosis of uterus DOID_288 0.02747717 0.07739857 0.2277658 0.45156356 GARY_CD5_TARGETS_UP rheumatic disease DOID_1575 0.02861968 0.0802197 0.23219127 0.45715167 GARY_CD5_TARGETS_UP hyperinsulinism DOID_2018 0.02861968 0.07982647 0.23219127 0.45245491 GARY_CD5_TARGETS_UP endometriosis DOID_289 0.02861968 0.07943707 0.23219127 0.4509107 GARY_CD5_TARGETS_UP uveal disease DOID_3480 0.02861968 0.07905146 0.02861968 0.13458347 GARY_CD5_TARGETS_UP scleroderma DOID_419 0.02861968 0.0802197 0.23219127 0.45715167 GARY_CD5_TARGETS_UP diabetic autonomic neuropathy DOID_11503 0.02978095 0.08186165 0.2365915 0.45789307 GARY_CD5_TARGETS_UP autonomic neuropathy DOID_11504 0.02978095 0.08186165 0.2365915 0.45789307 GARY_CD5_TARGETS_UP diabetic polyneuropathy DOID_12785 0.02978095 0.08186165 0.2365915 0.45789307 GARY_CD5_TARGETS_UP uterine cancer DOID_363 0.02978095 0.08146809 0.02978095 0.13889641 GARY_CD5_TARGETS_UP diabetic neuropathy DOID_9743 0.02978095 0.08186165 0.2365915 0.45789307 GARY_CD5_TARGETS_UP autonomic nervous system disease DOID_11465 0.03337482 0.09086254 0.24964213 0.47988639 GARY_CD5_TARGETS_UP hemolytic anemia DOID_583 0.03460864 0.09377293 0.03460864 0.15265361 GARY_CD5_TARGETS_UP normocytic anemia DOID_720 0.03460864 0.09377293 0.03460864 0.15265361 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP hypothyroidism DOID_1459 2.079E-09 1.183E-06 2.079E-09 1.183E-06 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP collagen disease DOID_854 1.994E-05 5.673E-03 0.05104896 0.72617144 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP diabetic retinopathy DOID_8947 3.342E-05 6.339E-03 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP retinal vascular disease DOID_2462 5.008E-05 7.125E-03 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP ulcerative colitis DOID_8577 7.586E-05 8.633E-03 0.078646 0.89499151 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP bronchitis DOID_6132 8.733E-05 8.282E-03 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP bronchiolitis DOID_2942 2.077E-04 0.01688679 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP chronic leukemia DOID_1036 3.786E-04 0.02692758 0.02823786 0.6426938 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP chronic lymphocytic leukemia DOID_1040 3.786E-04 0.02692758 0.02823786 0.6426938 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP hepatitis C DOID_1883 4.233E-04 0.02676453 0.02982793 0.65277282 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP multiple myeloma DOID_9538 4.95E-04 0.02816819 0.03220831 0.67876038 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP systemic scleroderma DOID_418 5.459E-04 0.02823791 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP rheumatic disease DOID_1575 6.549E-04 0.0310525 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP scleroderma DOID_419 6.549E-04 0.0310525 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP gallbladder cancer DOID_3121 6.836E-04 0.02992256 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP proteinuria DOID_576 7.43E-04 0.03019628 0.03931559 0.74568575 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP myeloma DOID_0070004 7.735E-04 0.02934256 0.04010217 0.73606879 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP heart valve disease DOID_4079 7.735E-04 0.02750865 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP hemolytic anemia DOID_583 8.047E-04 0.02693353 8.047E-04 0.22893503 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP normocytic anemia DOID_720 8.047E-04 0.02693353 8.047E-04 0.22893503 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP bone marrow cancer DOID_4960 1.004E-03 0.03174433 0.04559075 0.76297462 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP parasitic protozoa infectious disease DOID_2789 1.04E-03 0.03113179 0.04637235 0.73294076 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP carotid artery disease DOID_3407 1.264E-03 0.03595999 0.05104896 0.74479122 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP respiratory failure DOID_11162 1.303E-03 0.03531686 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP parasitic infectious disease DOID_1398 1.425E-03 0.03686433 0.05415436 0.75155684 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP temporal lobe epilepsy DOID_3328 1.467E-03 0.03629565 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP pancreatic ductal carcinoma DOID_3587 1.64E-03 0.03888527 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP pancreatic carcinoma DOID_4905 1.776E-03 0.04042158 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP syndrome DOID_225 1.869E-03 0.04091182 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP focal epilepsy DOID_2234 2.215E-03 0.04666872 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP biliary tract cancer DOID_4607 2.215E-03 0.04500198 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP Human immunodeficiency virus infectious disease DOID_526 2.587E-03 0.05076657 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP lymphoblastic leukemia DOID_1037 2.756E-03 0.05226547 0.07486006 0.90628451 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP Crohn's disease DOID_8778 2.813E-03 0.05162941 1.000 1.000 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP hypersensitivity reaction type I disease DOID_1205 2.871E-03 0.05104303 0.07637624 0.88689958 BRUECKNER_TARGETS_OF_MIRLET7A3_DN osteochondrodysplasia DOID_2256 5.284E-07 3.007E-04 5.284E-07 3.007E-04 BRUECKNER_TARGETS_OF_MIRLET7A3_DN bone development disease DOID_0080006 2.586E-06 7.358E-04 2.586E-06 7.358E-04 BRUECKNER_TARGETS_OF_MIRLET7A3_DN multiple epiphyseal dysplasia DOID_12721 5.561E-06 1.055E-03 5.561E-06 1.055E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN diabetic autonomic neuropathy DOID_11503 1.982E-05 2.819E-03 1.982E-05 2.819E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN autonomic neuropathy DOID_11504 1.982E-05 2.819E-03 1.982E-05 2.819E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN diabetic polyneuropathy DOID_12785 1.982E-05 2.819E-03 1.982E-05 2.819E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN diabetic neuropathy DOID_9743 1.982E-05 2.819E-03 1.982E-05 2.819E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN autonomic nervous system disease DOID_11465 2.39E-05 2.719E-03 2.39E-05 2.719E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN common cold DOID_10459 7.852E-05 7.447E-03 7.852E-05 7.447E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN aortic valve insufficiency DOID_57 7.852E-05 6.383E-03 7.852E-05 6.383E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN hyperhomocysteinemia DOID_9279 1.247E-04 8.867E-03 1.247E-04 8.867E-03 BRUECKNER_TARGETS_OF_MIRLET7A3_DN Barrett's esophagus DOID_9206 1.424E-04 9.001E-03 0.01758265 0.23266347 BRUECKNER_TARGETS_OF_MIRLET7A3_DN hypersensitivity reaction type I disease DOID_1205 1.734E-04 9.865E-03 1.734E-04 0.010961 BRUECKNER_TARGETS_OF_MIRLET7A3_DN urinary tract obstruction DOID_5200 2.987E-04 0.01545044 2.987E-04 0.01699548 BRUECKNER_TARGETS_OF_MIRLET7A3_DN diabetic angiopathy DOID_11713 3.256E-04 0.01543959 3.256E-04 0.01684319 BRUECKNER_TARGETS_OF_MIRLET7A3_DN aortic valve disease DOID_62 3.256E-04 0.01425193 3.256E-04 0.01543959 BRUECKNER_TARGETS_OF_MIRLET7A3_DN leiomyoma DOID_127 6.966E-04 0.0283101 6.966E-04 0.03048779 BRUECKNER_TARGETS_OF_MIRLET7A3_DN esophageal disease DOID_6050 7.786E-04 0.02953422 0.04020251 0.29327213 BRUECKNER_TARGETS_OF_MIRLET7A3_DN cataract DOID_83 1.309E-03 0.04653495 1.309E-03 0.0531828 BRUECKNER_TARGETS_OF_MIRLET7A3_DN lens disease DOID_110 1.419E-03 0.0474972 1.419E-03 0.05383016 BRUECKNER_TARGETS_OF_MIRLET7A3_DN heart valve disease DOID_4079 1.419E-03 0.04485847 1.419E-03 0.05046578 BRUECKNER_TARGETS_OF_MIRLET7A3_DN glaucoma DOID_1686 1.534E-03 0.04593689 1.534E-03 0.05134123 BRUECKNER_TARGETS_OF_MIRLET7A3_DN vasculitis DOID_865 1.84E-03 0.05234221 1.84E-03 0.05815801 BRUECKNER_TARGETS_OF_MIRLET7A3_DN reproductive organ benign neoplasm DOID_0050622 1.904E-03 0.05159388 1.904E-03 0.05702482 BRUECKNER_TARGETS_OF_MIRLET7A3_DN carotid artery disease DOID_3407 2.313E-03 0.05981172 0.06853927 0.35453497 BRUECKNER_TARGETS_OF_MIRLET7A3_DN collagen disease DOID_854 2.313E-03 0.05721121 2.313E-03 0.06579289 BRUECKNER_TARGETS_OF_MIRLET7A3_DN pre-malignant neoplasm DOID_0060071 2.457E-03 0.05825402 2.457E-03 0.06657602 BRUECKNER_TARGETS_OF_MIRLET7A3_DN in situ carcinoma DOID_8719 2.457E-03 0.05825402 2.457E-03 0.06657602 BRUECKNER_TARGETS_OF_MIRLET7A3_DN nephrosis DOID_2527 3.077E-03 0.07002626 3.077E-03 0.07957529 BRUECKNER_TARGETS_OF_MIRLET7A3_DN peripheral vascular disease DOID_341 3.159E-03 0.06912926 3.159E-03 0.07814612 BRUECKNER_TARGETS_OF_MIRLET7A3_DN diabetic retinopathy DOID_8947 3.242E-03 0.06832022 0.08086968 0.36811878 BRUECKNER_TARGETS_OF_MIRLET7A3_DN cystic fibrosis DOID_1485 3.411E-03 0.06931982 3.411E-03 0.08087312 BRUECKNER_TARGETS_OF_MIRLET7A3_DN pancreatitis DOID_4989 3.584E-03 0.07033009 0.0849443 0.3805772 BRUECKNER_TARGETS_OF_MIRLET7A3_DN bacterial pneumonia DOID_874 3.584E-03 0.06798576 3.584E-03 0.08158291 BRUECKNER_TARGETS_OF_MIRLET7A3_DN metabolic syndrome X DOID_14221 3.762E-03 0.06904805 0.08697498 0.38663099 BRUECKNER_TARGETS_OF_MIRLET7A3_DN retinal vascular disease DOID_2462 4.223E-03 0.07508662 0.09203248 0.39974414 BRUECKNER_TARGETS_OF_MIRLET7A3_DN amino acid metabolic disorder DOID_9252 4.609E-03 0.0794785 4.609E-03 0.10087656 BRUECKNER_TARGETS_OF_MIRLET7A3_DN lymphoma DOID_0060058 4.91E-03 0.08216758 0.09906706 0.41754931 BRUECKNER_TARGETS_OF_MIRLET7A3_DN Crohn's disease DOID_8778 5.115E-03 0.08315495 0.10106715 0.41076577 RIZKI_TUMOR_INVASIVENESS_3D_UP glioblastoma DOID_3068 3.67E-08 2.088E-05 0.17196296 0.61154329 RIZKI_TUMOR_INVASIVENESS_3D_UP astrocytoma DOID_3069 1.004E-07 2.858E-05 0.19969086 0.66446843 RIZKI_TUMOR_INVASIVENESS_3D_UP giant cell tumor DOID_200 8.652E-07 1.641E-04 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP malignant giant cell tumor DOID_2705 8.652E-07 1.641E-04 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP giant cell glioblastoma DOID_3074 8.652E-07 1.641E-04 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP spinal muscular atrophy DOID_12377 1.431E-06 2.036E-04 1.431E-06 8.144E-04 RIZKI_TUMOR_INVASIVENESS_3D_UP neuroectodermal tumor DOID_171 1.693E-06 1.927E-04 0.01680729 0.26564858 RIZKI_TUMOR_INVASIVENESS_3D_UP lateral sclerosis DOID_230 3.384E-06 3.209E-04 3.384E-06 9.627E-04 RIZKI_TUMOR_INVASIVENESS_3D_UP lymphoma DOID_0060058 1.132E-05 9.205E-04 2.121E-04 0.03016765 RIZKI_TUMOR_INVASIVENESS_3D_UP lung small cell carcinoma DOID_5409 2.08E-05 1.48E-03 5.67E-04 0.0537692 RIZKI_TUMOR_INVASIVENESS_3D_UP neuroendocrine tumor DOID_169 2.26E-05 1.429E-03 0.05412945 0.41621155 RIZKI_TUMOR_INVASIVENESS_3D_UP orofacial cleft DOID_0050567 2.602E-05 1.481E-03 0.0126049 0.23907296 RIZKI_TUMOR_INVASIVENESS_3D_UP collagen disease DOID_854 4.745E-05 2.454E-03 0.17961821 0.63088125 RIZKI_TUMOR_INVASIVENESS_3D_UP cleft lip DOID_9296 7.938E-05 3.764E-03 3.151E-03 0.14943243 RIZKI_TUMOR_INVASIVENESS_3D_UP diffuse large B-cell lymphoma DOID_0050745 9.872E-05 4.321E-03 9.872E-05 0.0187234 RIZKI_TUMOR_INVASIVENESS_3D_UP lymphoblastic leukemia DOID_1037 2.209E-04 8.977E-03 3.225E-03 0.14117486 RIZKI_TUMOR_INVASIVENESS_3D_UP lymphoid leukemia DOID_10747 2.233E-04 8.472E-03 6.174E-03 0.14051784 RIZKI_TUMOR_INVASIVENESS_3D_UP dilated cardiomyopathy DOID_12930 2.393E-04 8.508E-03 2.393E-04 0.02722688 RIZKI_TUMOR_INVASIVENESS_3D_UP adenoma DOID_657 2.414E-04 8.08E-03 0.11361821 0.5130854 RIZKI_TUMOR_INVASIVENESS_3D_UP cleft palate DOID_674 2.604E-04 8.231E-03 6.823E-03 0.1493118 RIZKI_TUMOR_INVASIVENESS_3D_UP ulcerative colitis DOID_8577 2.688E-04 8.051E-03 0.0384204 0.40483716 RIZKI_TUMOR_INVASIVENESS_3D_UP peptic ulcer DOID_750 3.012E-04 8.569E-03 0.12180811 0.51722996 RIZKI_TUMOR_INVASIVENESS_3D_UP rectal neoplasm DOID_1984 4.181E-04 0.01132928 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP rectum cancer DOID_1993 4.181E-04 0.01132928 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP thyroid adenoma DOID_2891 5.051E-04 0.01306396 0.01050251 0.20606645 RIZKI_TUMOR_INVASIVENESS_3D_UP movement disease DOID_480 5.997E-04 0.01483503 5.997E-04 0.04874368 RIZKI_TUMOR_INVASIVENESS_3D_UP B-cell lymphocytic neoplasm DOID_707 6.335E-04 0.01501947 6.335E-04 0.0450584 RIZKI_TUMOR_INVASIVENESS_3D_UP atrophic muscular disease DOID_913 7.048E-04 0.01604166 0.01304564 0.23945071 RIZKI_TUMOR_INVASIVENESS_3D_UP muscular dystrophy DOID_9884 7.048E-04 0.01604166 0.01304564 0.23945071 RIZKI_TUMOR_INVASIVENESS_3D_UP monocytic leukemia DOID_8527 7.204E-04 0.01576516 0.03939183 0.40024917 RIZKI_TUMOR_INVASIVENESS_3D_UP reproductive organ benign neoplasm DOID_0050622 7.81E-04 0.0164598 0.01394704 0.24048076 RIZKI_TUMOR_INVASIVENESS_3D_UP Ehlers-Danlos syndrome DOID_13359 9.658E-04 0.01962704 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP lung oat cell carcinoma DOID_5411 9.658E-04 0.01895025 0.045314 0.40286979 RIZKI_TUMOR_INVASIVENESS_3D_UP varicose veins DOID_799 9.658E-04 0.01831857 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP intermediate coronary syndrome DOID_8805 9.658E-04 0.01772765 0.045314 0.39066162 RIZKI_TUMOR_INVASIVENESS_3D_UP hypothyroidism DOID_1459 1.088E-03 0.01935395 1.088E-03 0.06881403 RIZKI_TUMOR_INVASIVENESS_3D_UP spastic diplegia DOID_10965 1.102E-03 0.01899391 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP vein disease DOID_866 1.102E-03 0.01843526 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP Barrett's esophagus DOID_9206 1.102E-03 0.01790854 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP schizophreniform disorder DOID_11328 1.246E-03 0.01969278 1.246E-03 0.07089402 RIZKI_TUMOR_INVASIVENESS_3D_UP schizoaffective disorder DOID_5418 1.246E-03 0.01969278 1.246E-03 0.07089402 RIZKI_TUMOR_INVASIVENESS_3D_UP endocrine organ benign neoplasm DOID_0060089 1.405E-03 0.02161006 0.02043028 0.31418456 RIZKI_TUMOR_INVASIVENESS_3D_UP tuberculosis DOID_399 1.405E-03 0.02104137 0.19720866 0.66006899 RIZKI_TUMOR_INVASIVENESS_3D_UP dissociative disorder DOID_10935 1.56E-03 0.02276409 0.05704995 0.427124 RIZKI_TUMOR_INVASIVENESS_3D_UP dissociative amnesia DOID_11037 1.56E-03 0.02276409 0.05704995 0.427124 RIZKI_TUMOR_INVASIVENESS_3D_UP diabetic retinopathy DOID_8947 1.709E-03 0.02431315 0.0231991 0.34737596 RIZKI_TUMOR_INVASIVENESS_3D_UP amnestic disorder DOID_10914 1.73E-03 0.02401114 0.05996152 0.42647633 RIZKI_TUMOR_INVASIVENESS_3D_UP pancreatitis DOID_4989 1.98E-03 0.0268209 0.21927649 0.69315734 RIZKI_TUMOR_INVASIVENESS_3D_UP mixed glioma DOID_5076 1.98E-03 0.02619715 0.21927649 0.68932774 RIZKI_TUMOR_INVASIVENESS_3D_UP gastric ulcer DOID_10808 2.095E-03 0.02709265 0.06575795 0.43507293 RIZKI_TUMOR_INVASIVENESS_3D_UP contact dermatitis DOID_2773 2.124E-03 0.02686249 0.22409817 0.69299924 RIZKI_TUMOR_INVASIVENESS_3D_UP bone development disease DOID_0080006 2.433E-03 0.03009735 0.02916663 0.40477593 RIZKI_TUMOR_INVASIVENESS_3D_UP Lewy body dementia DOID_12217 2.493E-03 0.03018238 0.07151893 0.43757282 RIZKI_TUMOR_INVASIVENESS_3D_UP retinal vascular disease DOID_2462 2.514E-03 0.02980678 0.02979374 0.40363425 RIZKI_TUMOR_INVASIVENESS_3D_UP primary bacterial infectious disease DOID_0050338 2.682E-03 0.03114414 0.24074273 0.72863094 RIZKI_TUMOR_INVASIVENESS_3D_UP amino acid metabolic disorder DOID_9252 2.856E-03 0.03250467 2.856E-03 0.14774852 RIZKI_TUMOR_INVASIVENESS_3D_UP papillary adenoma DOID_3172 3.151E-03 0.03516057 0.08009443 0.45122508 RIZKI_TUMOR_INVASIVENESS_3D_UP microcystic adenoma DOID_5403 3.151E-03 0.03516057 0.08009443 0.45122508 RIZKI_TUMOR_INVASIVENESS_3D_UP follicular adenoma DOID_6204 3.151E-03 0.03516057 0.08009443 0.45122508 RIZKI_TUMOR_INVASIVENESS_3D_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.322E-03 0.03635106 0.0356745 0.39036131 RIZKI_TUMOR_INVASIVENESS_3D_UP fragments of torsion dystonia DOID_531 3.387E-03 0.0363631 3.387E-03 0.1376603 RIZKI_TUMOR_INVASIVENESS_3D_UP migraine DOID_6364 3.631E-03 0.03825634 0.08576776 0.46924862 RIZKI_TUMOR_INVASIVENESS_3D_UP sarcoma DOID_1115 3.882E-03 0.04016281 3.882E-03 0.14726364 RIZKI_TUMOR_INVASIVENESS_3D_UP invasive ductal carcinoma DOID_3008 3.882E-03 0.03944562 3.882E-03 0.13805966 RIZKI_TUMOR_INVASIVENESS_3D_UP central nervous system hereditary degenerative disease DOID_481 3.882E-03 0.03875359 3.882E-03 0.1299385 RIZKI_TUMOR_INVASIVENESS_3D_UP polycystic ovary syndrome DOID_11612 4.142E-03 0.04063021 0.0914064 0.49066264 RIZKI_TUMOR_INVASIVENESS_3D_UP toxic encephalopathy DOID_3602 4.142E-03 0.03994156 0.0914064 0.48607701 RIZKI_TUMOR_INVASIVENESS_3D_UP dystonic disease DOID_544 4.142E-03 0.03927587 4.142E-03 0.13091957 RIZKI_TUMOR_INVASIVENESS_3D_UP female reproductive organ benign neoplasm DOID_0060086 4.409E-03 0.0411247 0.09421277 0.49636173 RIZKI_TUMOR_INVASIVENESS_3D_UP uterine benign neoplasm DOID_0060095 4.409E-03 0.0411247 0.09421277 0.49636173 RIZKI_TUMOR_INVASIVENESS_3D_UP uterine fibroid DOID_13223 4.409E-03 0.0411247 0.09421277 0.49636173 RIZKI_TUMOR_INVASIVENESS_3D_UP endometrial carcinoma DOID_2871 4.409E-03 0.0404614 4.409E-03 0.13203194 RIZKI_TUMOR_INVASIVENESS_3D_UP spastic cerebral palsy DOID_0050669 4.684E-03 0.04230301 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP age related macular degeneration DOID_10871 4.684E-03 0.04164203 4.684E-03 0.13325449 RIZKI_TUMOR_INVASIVENESS_3D_UP degeneration of macula and posterior pole DOID_2007 4.684E-03 0.04164203 4.684E-03 0.13325449 RIZKI_TUMOR_INVASIVENESS_3D_UP Charcot-Marie-Tooth disease DOID_10595 4.967E-03 0.04347651 4.967E-03 0.13457015 RIZKI_TUMOR_INVASIVENESS_3D_UP endometrial cancer DOID_1380 4.967E-03 0.04281777 4.967E-03 0.12845332 RIZKI_TUMOR_INVASIVENESS_3D_UP leiomyoma DOID_127 5.257E-03 0.0446452 0.10258043 0.50755014 RIZKI_TUMOR_INVASIVENESS_3D_UP papilloma DOID_2615 5.555E-03 0.04648276 0.10535259 0.50801374 RIZKI_TUMOR_INVASIVENESS_3D_UP nephroblastoma DOID_2154 5.861E-03 0.0483296 5.861E-03 0.14498881 RIZKI_TUMOR_INVASIVENESS_3D_UP macular degeneration DOID_4448 5.861E-03 0.04763918 5.861E-03 0.13894761 RIZKI_TUMOR_INVASIVENESS_3D_UP esophageal disease DOID_6050 5.861E-03 0.0469682 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP medullomyoblastoma DOID_3861 6.174E-03 0.04879092 0.11087145 0.50875689 RIZKI_TUMOR_INVASIVENESS_3D_UP adult medulloblastoma DOID_3864 6.174E-03 0.04879092 0.11087145 0.50875689 RIZKI_TUMOR_INVASIVENESS_3D_UP childhood medulloblastoma DOID_3869 6.174E-03 0.04879092 0.11087145 0.50875689 RIZKI_TUMOR_INVASIVENESS_3D_UP medulloblastoma DOID_3858 6.823E-03 0.05317955 0.11635656 0.51323163 RIZKI_TUMOR_INVASIVENESS_3D_UP systemic scleroderma DOID_418 7.501E-03 0.0576769 0.12180811 0.52111891 RIZKI_TUMOR_INVASIVENESS_3D_UP benign mesothelioma DOID_2645 8.209E-03 0.06227572 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP endometriosis of uterus DOID_288 8.573E-03 0.06418596 0.12992298 0.53569694 RIZKI_TUMOR_INVASIVENESS_3D_UP rheumatic disease DOID_1575 8.945E-03 0.06609944 0.13261138 0.53897055 RIZKI_TUMOR_INVASIVENESS_3D_UP primitive neuroectodermal tumor DOID_168 8.945E-03 0.06525201 0.13261138 0.53514807 RIZKI_TUMOR_INVASIVENESS_3D_UP endometriosis DOID_289 8.945E-03 0.06442604 0.13261138 0.52399915 RIZKI_TUMOR_INVASIVENESS_3D_UP scleroderma DOID_419 8.945E-03 0.06609944 0.13261138 0.53897055 RIZKI_TUMOR_INVASIVENESS_3D_UP gallbladder cancer DOID_3121 9.324E-03 0.06631531 0.13529155 0.5309027 RIZKI_TUMOR_INVASIVENESS_3D_UP uterine cancer DOID_363 9.324E-03 0.0654966 9.324E-03 0.19648981 RIZKI_TUMOR_INVASIVENESS_3D_UP leukodystrophy DOID_10579 0.01010261 0.07010227 0.14062727 0.54065485 RIZKI_TUMOR_INVASIVENESS_3D_UP myeloma DOID_0070004 0.01050251 0.07199912 0.01050251 0.21342597 RIZKI_TUMOR_INVASIVENESS_3D_UP heart valve disease DOID_4079 0.01050251 0.07114199 1.000 1.000 RIZKI_TUMOR_INVASIVENESS_3D_UP pulmonary tuberculosis DOID_2957 0.01132302 0.07579762 0.14856971 0.55984216 RIZKI_TUMOR_INVASIVENESS_3D_UP bone marrow cancer DOID_4960 0.01349304 0.08927371 0.01349304 0.2399231 RIZKI_TUMOR_INVASIVENESS_3D_UP osteochondrodysplasia DOID_2256 0.01394704 0.09121684 0.1642369 0.59904356 RIZKI_TUMOR_INVASIVENESS_3D_UP smallpox DOID_8736 0.01394704 0.09018028 0.1642369 0.59522799 RIZKI_TUMOR_INVASIVENESS_3D_UP hypertrophic cardiomyopathy DOID_11984 0.01534823 0.0981252 0.17196296 0.61538947 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bone resorption disease DOID_0080011 1.06E-10 6.03E-08 4.068E-06 2.315E-03 RODWELL_AGING_KIDNEY_NO_BLOOD_UP osteoporosis DOID_11476 1.06E-10 6.03E-08 4.068E-06 2.315E-03 RODWELL_AGING_KIDNEY_NO_BLOOD_UP heart valve disease DOID_4079 1.556E-10 4.426E-08 0.13873453 0.6366125 RODWELL_AGING_KIDNEY_NO_BLOOD_UP atrophic muscular disease DOID_913 1.763E-08 3.344E-06 6.37E-04 0.09061904 RODWELL_AGING_KIDNEY_NO_BLOOD_UP muscular dystrophy DOID_9884 1.763E-08 3.344E-06 6.37E-04 0.09061904 RODWELL_AGING_KIDNEY_NO_BLOOD_UP aortic valve insufficiency DOID_57 3.636E-08 5.172E-06 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP carotid artery disease DOID_3407 3.994E-08 4.545E-06 0.17403807 0.72814457 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pleural disease DOID_1532 6.504E-08 6.168E-06 0.09924864 0.54827646 RODWELL_AGING_KIDNEY_NO_BLOOD_UP Ehlers-Danlos syndrome DOID_13359 9.958E-08 8.094E-06 0.04379698 0.48863691 RODWELL_AGING_KIDNEY_NO_BLOOD_UP intracranial arterial disease DOID_13089 1.892E-07 1.346E-05 2.917E-04 0.08299188 RODWELL_AGING_KIDNEY_NO_BLOOD_UP cerebral arterial disease DOID_3527 1.892E-07 1.346E-05 2.917E-04 0.08299188 RODWELL_AGING_KIDNEY_NO_BLOOD_UP aortic valve disease DOID_62 7.593E-07 4.8E-05 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP collagen disease DOID_854 1.426E-06 8.114E-05 0.17403807 0.72282965 RODWELL_AGING_KIDNEY_NO_BLOOD_UP peripheral vascular disease DOID_341 3.145E-06 1.627E-04 0.20076706 0.76668764 RODWELL_AGING_KIDNEY_NO_BLOOD_UP osteogenesis imperfecta DOID_12347 7.216E-06 3.421E-04 0.0380691 0.45127749 RODWELL_AGING_KIDNEY_NO_BLOOD_UP primary bacterial infectious disease DOID_0050338 7.317E-06 3.202E-04 0.2335491 0.8573512 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pulmonary emphysema DOID_9675 9.264E-06 3.765E-04 7.677E-03 0.36401921 RODWELL_AGING_KIDNEY_NO_BLOOD_UP mouth disease DOID_403 1.06E-05 4.02E-04 0.03348285 0.52921502 RODWELL_AGING_KIDNEY_NO_BLOOD_UP oral submucous fibrosis DOID_5773 1.143E-05 4.065E-04 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP varicose veins DOID_799 1.143E-05 3.825E-04 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP vein disease DOID_866 1.404E-05 4.437E-04 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP Barrett's esophagus DOID_9206 1.404E-05 4.204E-04 1.028E-03 0.09751173 RODWELL_AGING_KIDNEY_NO_BLOOD_UP vascular skin disease DOID_9540 1.55E-05 4.41E-04 0.13873453 0.6315196 RODWELL_AGING_KIDNEY_NO_BLOOD_UP calcium metabolism disease DOID_10575 1.958E-05 5.304E-04 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP ureteral obstruction DOID_5199 2.036E-05 5.267E-04 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP urinary tract obstruction DOID_5200 4.372E-05 1.082E-03 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP mineral metabolism disease DOID_0050032 4.962E-05 1.176E-03 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP ureteral disease DOID_1426 4.986E-05 1.135E-03 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP cholestasis DOID_13580 5.26E-05 1.151E-03 0.18385868 0.74725422 RODWELL_AGING_KIDNEY_NO_BLOOD_UP tuberculosis DOID_399 6.233E-05 1.313E-03 0.19114811 0.76058235 RODWELL_AGING_KIDNEY_NO_BLOOD_UP urticaria DOID_1555 6.377E-05 1.296E-03 0.07470129 0.5380384 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bile duct disease DOID_4138 7.33E-05 1.438E-03 0.19837301 0.76785198 RODWELL_AGING_KIDNEY_NO_BLOOD_UP biliary tract disease DOID_9741 7.726E-05 1.465E-03 0.20076706 0.76157639 RODWELL_AGING_KIDNEY_NO_BLOOD_UP intracranial aneurysm DOID_10941 8E-05 1.468E-03 0.08021293 0.53695477 RODWELL_AGING_KIDNEY_NO_BLOOD_UP middle cerebral artery infarction DOID_3525 8E-05 1.422E-03 0.08021293 0.51864949 RODWELL_AGING_KIDNEY_NO_BLOOD_UP aneurysm disease DOID_2403 9.463E-05 1.632E-03 0.02337187 0.53194376 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pleurisy DOID_10247 9.871E-05 1.652E-03 0.08569202 0.52998653 RODWELL_AGING_KIDNEY_NO_BLOOD_UP metabolic syndrome X DOID_14221 1.094E-04 1.779E-03 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bone development disease DOID_0080006 1.316E-04 2.08E-03 0.02735635 0.53675038 RODWELL_AGING_KIDNEY_NO_BLOOD_UP opportunistic mycosis DOID_2473 1.318E-04 2.027E-03 0.09385007 0.52871968 RODWELL_AGING_KIDNEY_NO_BLOOD_UP transitional cell carcinoma DOID_2671 1.569E-04 2.35E-03 2.509E-03 0.20392309 RODWELL_AGING_KIDNEY_NO_BLOOD_UP systemic mycosis DOID_0050136 1.714E-04 2.5E-03 0.10193596 0.55770731 RODWELL_AGING_KIDNEY_NO_BLOOD_UP fungal infectious disease DOID_1564 1.714E-04 2.5E-03 0.10193596 0.55770731 RODWELL_AGING_KIDNEY_NO_BLOOD_UP esophageal disease DOID_6050 1.861E-04 2.647E-03 5.479E-03 0.3463658 RODWELL_AGING_KIDNEY_NO_BLOOD_UP calcinosis DOID_182 2.351E-04 3.262E-03 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP benign mesothelioma DOID_2645 3.124E-04 4.232E-03 7.677E-03 0.39711187 RODWELL_AGING_KIDNEY_NO_BLOOD_UP facioscapulohumeral muscular dystrophy DOID_11727 3.901E-04 5.162E-03 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP Diamond-Blackfan anemia DOID_1339 3.901E-04 5.045E-03 3.901E-04 0.07399419 RODWELL_AGING_KIDNEY_NO_BLOOD_UP angioedema DOID_1558 3.901E-04 4.933E-03 0.02941346 0.55787533 RODWELL_AGING_KIDNEY_NO_BLOOD_UP cerebral infarction DOID_3526 4.044E-04 5.003E-03 0.13357056 0.62811281 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pre-eclampsia DOID_10591 4.563E-04 5.524E-03 9.826E-03 0.39937647 RODWELL_AGING_KIDNEY_NO_BLOOD_UP neuritis DOID_1803 4.563E-04 5.409E-03 0.13873453 0.64178821 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pneumocystosis DOID_11339 4.759E-04 5.526E-03 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP temporal arteritis DOID_13375 4.759E-04 5.416E-03 0.03230722 0.55705477 RODWELL_AGING_KIDNEY_NO_BLOOD_UP central nervous system vasculitis DOID_525 4.759E-04 5.416E-03 0.03230722 0.55705477 RODWELL_AGING_KIDNEY_NO_BLOOD_UP hemolytic anemia DOID_583 4.838E-04 5.398E-03 0.01020782 0.36301561 RODWELL_AGING_KIDNEY_NO_BLOOD_UP normocytic anemia DOID_720 4.838E-04 5.398E-03 0.01020782 0.36301561 RODWELL_AGING_KIDNEY_NO_BLOOD_UP glaucoma DOID_1686 5.123E-04 5.606E-03 0.01059564 0.35464234 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pulmonary tuberculosis DOID_2957 5.123E-04 5.5E-03 0.143868 0.64968961 RODWELL_AGING_KIDNEY_NO_BLOOD_UP lipodystrophy DOID_811 5.7E-04 6.006E-03 0.03519242 0.50061224 RODWELL_AGING_KIDNEY_NO_BLOOD_UP ocular hypertension DOID_9282 5.7E-04 5.896E-03 0.03519242 0.4656858 RODWELL_AGING_KIDNEY_NO_BLOOD_UP borderline glaucoma DOID_9283 5.7E-04 5.896E-03 0.03519242 0.4656858 RODWELL_AGING_KIDNEY_NO_BLOOD_UP giant cell tumor DOID_200 6.37E-04 6.473E-03 0.15404412 0.68477425 RODWELL_AGING_KIDNEY_NO_BLOOD_UP malignant giant cell tumor DOID_2705 6.37E-04 6.473E-03 0.15404412 0.68477425 RODWELL_AGING_KIDNEY_NO_BLOOD_UP giant cell glioblastoma DOID_3074 6.37E-04 6.473E-03 0.15404412 0.68477425 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bile duct adenocarcinoma DOID_4896 6.71E-04 6.698E-03 0.0126306 0.39926726 RODWELL_AGING_KIDNEY_NO_BLOOD_UP cholangiocarcinoma DOID_4947 6.71E-04 6.698E-03 0.0126306 0.39926726 RODWELL_AGING_KIDNEY_NO_BLOOD_UP vasculitis DOID_865 6.71E-04 6.583E-03 0.15656936 0.69060439 RODWELL_AGING_KIDNEY_NO_BLOOD_UP Hirschsprung's disease DOID_10487 6.723E-04 6.483E-03 0.0380691 0.46087914 RODWELL_AGING_KIDNEY_NO_BLOOD_UP osteochondrodysplasia DOID_2256 7.06E-04 6.696E-03 0.15908713 0.69631213 RODWELL_AGING_KIDNEY_NO_BLOOD_UP Legionnaires' disease DOID_10457 7.828E-04 7.302E-03 0.04093728 0.47537373 RODWELL_AGING_KIDNEY_NO_BLOOD_UP legionellosis DOID_10458 7.828E-04 7.302E-03 0.04093728 0.47537373 RODWELL_AGING_KIDNEY_NO_BLOOD_UP megacolon DOID_11372 7.828E-04 7.184E-03 0.04093728 0.46586626 RODWELL_AGING_KIDNEY_NO_BLOOD_UP glioblastoma DOID_3068 8.182E-04 7.39E-03 0.16659583 0.70741065 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bile duct cancer DOID_4606 8.182E-04 7.274E-03 0.01437115 0.40885923 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bile duct carcinoma DOID_4897 8.182E-04 7.274E-03 0.01437115 0.40885923 RODWELL_AGING_KIDNEY_NO_BLOOD_UP hypothyroidism DOID_1459 9.845E-04 8.618E-03 9.845E-04 0.11203266 RODWELL_AGING_KIDNEY_NO_BLOOD_UP hemolytic-uremic syndrome DOID_12554 1.028E-03 8.865E-03 0.04664823 0.45763523 RODWELL_AGING_KIDNEY_NO_BLOOD_UP tooth disease DOID_1091 1.22E-03 0.01036501 0.01863933 0.50503702 RODWELL_AGING_KIDNEY_NO_BLOOD_UP brain infarction DOID_3454 1.272E-03 0.01064013 0.19114811 0.76593857 RODWELL_AGING_KIDNEY_NO_BLOOD_UP astrocytoma DOID_3069 1.324E-03 0.01091822 0.19356355 0.76484487 RODWELL_AGING_KIDNEY_NO_BLOOD_UP membranous glomerulonephritis DOID_10976 1.615E-03 0.01313106 0.0579692 0.5074535 RODWELL_AGING_KIDNEY_NO_BLOOD_UP colonic disease DOID_5353 1.615E-03 0.01294612 0.0579692 0.49230563 RODWELL_AGING_KIDNEY_NO_BLOOD_UP autoimmune hepatitis DOID_2048 1.782E-03 0.0140827 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bacterial pneumonia DOID_874 1.793E-03 0.01397338 0.21263145 0.79076663 RODWELL_AGING_KIDNEY_NO_BLOOD_UP biliary tract cancer DOID_4607 2.132E-03 0.01639359 0.02677142 0.5641828 RODWELL_AGING_KIDNEY_NO_BLOOD_UP chronic kidney failure DOID_784 2.132E-03 0.016175 0.02677142 0.54403341 RODWELL_AGING_KIDNEY_NO_BLOOD_UP uremia DOID_4676 2.139E-03 0.01601093 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP Crohn's disease DOID_8778 3.012E-03 0.02225713 0.24943675 0.87073321 RODWELL_AGING_KIDNEY_NO_BLOOD_UP dilated cardiomyopathy DOID_12930 3.101E-03 0.02262426 0.03412246 0.52474807 RODWELL_AGING_KIDNEY_NO_BLOOD_UP congenital hypoplastic anemia DOID_1342 3.164E-03 0.02279047 3.164E-03 0.22505594 RODWELL_AGING_KIDNEY_NO_BLOOD_UP spinal cord disease DOID_319 3.164E-03 0.02250559 0.08021293 0.52461098 RODWELL_AGING_KIDNEY_NO_BLOOD_UP ulcerative colitis DOID_8577 3.379E-03 0.02373967 0.2583684 0.89641232 RODWELL_AGING_KIDNEY_NO_BLOOD_UP Sciatic Neuropathy DOID_11446 3.392E-03 0.02353733 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP gestational diabetes DOID_11714 3.392E-03 0.02325375 0.08295653 0.53036254 RODWELL_AGING_KIDNEY_NO_BLOOD_UP lesion of sciatic nerve DOID_12528 3.392E-03 0.02353733 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP mononeuritis of lower limb DOID_9473 3.392E-03 0.02353733 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP mononeuritis DOID_1802 3.627E-03 0.02457037 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP mononeuropathy DOID_1188 3.87E-03 0.02590553 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP age related macular degeneration DOID_10871 4.377E-03 0.02896064 0.09385007 0.53400688 RODWELL_AGING_KIDNEY_NO_BLOOD_UP degeneration of macula and posterior pole DOID_2007 4.377E-03 0.02896064 0.09385007 0.53400688 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pneumoconiosis DOID_10316 5.479E-03 0.03583094 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP periodontal disease DOID_3388 5.479E-03 0.03542377 0.10461533 0.55116781 RODWELL_AGING_KIDNEY_NO_BLOOD_UP macular degeneration DOID_4448 5.479E-03 0.03502575 0.10461533 0.54611122 RODWELL_AGING_KIDNEY_NO_BLOOD_UP aplastic anemia DOID_12449 5.772E-03 0.03649003 5.772E-03 0.32841029 RODWELL_AGING_KIDNEY_NO_BLOOD_UP pulmonary sarcoidosis DOID_13406 6.379E-03 0.03988701 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP hepatitis DOID_2237 7.014E-03 0.04338217 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP systemic scleroderma DOID_418 7.014E-03 0.0429157 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP adult respiratory distress syndrome DOID_11394 7.342E-03 0.04444419 0.12052599 0.60157268 RODWELL_AGING_KIDNEY_NO_BLOOD_UP nephrotic syndrome DOID_1184 8.367E-03 0.050113 0.12837591 0.62432385 RODWELL_AGING_KIDNEY_NO_BLOOD_UP rheumatic disease DOID_1575 8.367E-03 0.04959099 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP uveal disease DOID_3480 8.367E-03 0.04907974 0.12837591 0.61383101 RODWELL_AGING_KIDNEY_NO_BLOOD_UP scleroderma DOID_419 8.367E-03 0.04959099 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP diabetic autonomic neuropathy DOID_11503 8.722E-03 0.05063994 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP autonomic neuropathy DOID_11504 8.722E-03 0.05063994 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP diabetic polyneuropathy DOID_12785 8.722E-03 0.05063994 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP gallbladder cancer DOID_3121 8.722E-03 0.05012842 0.13097708 0.62104966 RODWELL_AGING_KIDNEY_NO_BLOOD_UP uterine cancer DOID_363 8.722E-03 0.04962714 8.722E-03 0.38174722 RODWELL_AGING_KIDNEY_NO_BLOOD_UP influenza DOID_8469 8.722E-03 0.04913578 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP diabetic neuropathy DOID_9743 8.722E-03 0.05063994 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP autonomic nervous system disease DOID_11465 9.826E-03 0.05481638 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP bone marrow disease DOID_4961 9.826E-03 0.05428418 9.826E-03 0.37275137 RODWELL_AGING_KIDNEY_NO_BLOOD_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.01059564 0.05797038 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP sarcoidosis DOID_11335 0.01221096 0.06617179 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP smallpox DOID_8736 0.01305648 0.07008618 0.15908713 0.69099677 RODWELL_AGING_KIDNEY_NO_BLOOD_UP hypertrophic cardiomyopathy DOID_11984 0.01437115 0.07642229 0.01437115 0.43037814 RODWELL_AGING_KIDNEY_NO_BLOOD_UP hypersensitivity reaction type IV disease DOID_2916 0.01437115 0.07571467 1.000 1.000 RODWELL_AGING_KIDNEY_NO_BLOOD_UP respiratory failure DOID_11162 0.016209 0.08461398 0.17650415 0.72775986 RODWELL_AGING_KIDNEY_NO_BLOOD_UP allergic contact dermatitis DOID_3042 0.01863933 0.09641616 0.01863933 0.4820808 RIGGI_EWING_SARCOMA_PROGENITOR_DN endometrial carcinoma DOID_2871 7.329E-07 4.17E-04 4.794E-05 5.455E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN mixed glioma DOID_5076 9.407E-07 2.676E-04 7.362E-04 0.01745335 RIGGI_EWING_SARCOMA_PROGENITOR_DN endometrial cancer DOID_1380 9.42E-07 1.787E-04 5.765E-05 5.467E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN allergic rhinitis DOID_4481 9.42E-07 1.34E-04 9.42E-07 5.36E-04 RIGGI_EWING_SARCOMA_PROGENITOR_DN uterine cancer DOID_363 3.545E-06 4.035E-04 1.53E-04 6.699E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN leukocyte disease DOID_9500 1.081E-05 1.026E-03 1.081E-05 3.077E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN peripheral vascular disease DOID_341 2.306E-05 1.874E-03 2.306E-05 4.374E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN diabetic retinopathy DOID_8947 2.43E-05 1.728E-03 6.339E-04 0.01639443 RIGGI_EWING_SARCOMA_PROGENITOR_DN urticaria DOID_1555 2.537E-05 1.604E-03 2.537E-05 3.609E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN biliary tract cancer DOID_4607 3.778E-05 2.15E-03 8.781E-04 0.01921609 RIGGI_EWING_SARCOMA_PROGENITOR_DN retinal vascular disease DOID_2462 4.14E-05 2.141E-03 9.393E-04 0.01908863 RIGGI_EWING_SARCOMA_PROGENITOR_DN embryonal cancer DOID_688 9.429E-05 4.471E-03 9.429E-05 7.664E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN congenital diaphragmatic hernia DOID_3827 1.092E-04 4.78E-03 1.092E-04 7.768E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN adenoid cystic carcinoma DOID_4866 1.172E-04 4.764E-03 1.172E-04 7.411E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN pulmonary emphysema DOID_9675 1.256E-04 4.764E-03 4.22E-03 0.06490204 RIGGI_EWING_SARCOMA_PROGENITOR_DN salivary gland cancer DOID_8850 1.344E-04 4.778E-03 1.344E-04 7.645E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN diabetic autonomic neuropathy DOID_11503 1.53E-04 5.123E-03 1.53E-04 7.917E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN autonomic neuropathy DOID_11504 1.53E-04 5.123E-03 1.53E-04 7.917E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN diabetic polyneuropathy DOID_12785 1.53E-04 5.123E-03 1.53E-04 7.917E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN gallbladder cancer DOID_3121 1.53E-04 4.838E-03 1.53E-04 7.257E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN diabetic neuropathy DOID_9743 1.53E-04 5.123E-03 1.53E-04 7.917E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN autonomic nervous system disease DOID_11465 1.841E-04 5.514E-03 1.841E-04 7.483E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN vascular skin disease DOID_9540 1.841E-04 5.238E-03 1.841E-04 6.984E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN lung small cell carcinoma DOID_5409 2.07E-04 5.607E-03 0.10778416 0.35656505 RIGGI_EWING_SARCOMA_PROGENITOR_DN angioedema DOID_1558 2.107E-04 5.449E-03 2.107E-04 7.493E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN chondrosarcoma DOID_3371 2.107E-04 5.212E-03 0.02168149 0.19582172 RIGGI_EWING_SARCOMA_PROGENITOR_DN orofacial cleft DOID_0050567 2.445E-04 5.797E-03 2.445E-04 8.184E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN giant cell tumor DOID_200 2.579E-04 5.871E-03 0.11558296 0.37367445 RIGGI_EWING_SARCOMA_PROGENITOR_DN malignant giant cell tumor DOID_2705 2.579E-04 5.871E-03 0.11558296 0.37367445 RIGGI_EWING_SARCOMA_PROGENITOR_DN giant cell glioblastoma DOID_3074 2.579E-04 5.871E-03 0.11558296 0.37367445 RIGGI_EWING_SARCOMA_PROGENITOR_DN reproductive organ benign neoplasm DOID_0050622 2.862E-04 6.264E-03 2.862E-04 9.048E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN osteochondrodysplasia DOID_2256 2.862E-04 6.032E-03 2.862E-04 8.572E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN aortic valve stenosis DOID_1712 3.081E-04 6.262E-03 0.02596173 0.21723856 RIGGI_EWING_SARCOMA_PROGENITOR_DN glioblastoma DOID_3068 3.323E-04 6.519E-03 0.1252368 0.39588745 RIGGI_EWING_SARCOMA_PROGENITOR_DN oral cavity cancer DOID_8618 3.323E-04 6.302E-03 3.323E-04 9.453E-03 RIGGI_EWING_SARCOMA_PROGENITOR_DN pre-malignant neoplasm DOID_0060071 4.192E-04 7.694E-03 4.192E-04 0.01135716 RIGGI_EWING_SARCOMA_PROGENITOR_DN in situ carcinoma DOID_8719 4.192E-04 7.694E-03 4.192E-04 0.01135716 RIGGI_EWING_SARCOMA_PROGENITOR_DN lung oat cell carcinoma DOID_5411 4.881E-04 8.679E-03 0.03234741 0.22445948 RIGGI_EWING_SARCOMA_PROGENITOR_DN astrocytoma DOID_3069 5.412E-04 9.331E-03 0.14611032 0.43300402 RIGGI_EWING_SARCOMA_PROGENITOR_DN eosinophilia DOID_999 7.082E-04 0.01185234 7.082E-04 0.01752086 RIGGI_EWING_SARCOMA_PROGENITOR_DN microphthalmia DOID_10629 8.77E-04 0.01425747 8.77E-04 0.01996046 RIGGI_EWING_SARCOMA_PROGENITOR_DN bone development disease DOID_0080006 9.084E-04 0.01435731 9.084E-04 0.01914309 RIGGI_EWING_SARCOMA_PROGENITOR_DN transitional cell carcinoma DOID_2671 1.036E-03 0.01593533 0.01674469 0.170138 RIGGI_EWING_SARCOMA_PROGENITOR_DN aortic valve disease DOID_62 1.267E-03 0.01896766 0.05125735 0.25361246 RIGGI_EWING_SARCOMA_PROGENITOR_DN hypersensitivity reaction type I disease DOID_1205 1.286E-03 0.01876599 1.286E-03 0.02523702 RIGGI_EWING_SARCOMA_PROGENITOR_DN ulcerative colitis DOID_8577 1.404E-03 0.01997211 1.404E-03 0.02662948 RIGGI_EWING_SARCOMA_PROGENITOR_DN lung adenocarcinoma DOID_3910 1.85E-03 0.02567715 0.06160463 0.27172897 RIGGI_EWING_SARCOMA_PROGENITOR_DN leiomyoma DOID_127 2.689E-03 0.03642297 2.689E-03 0.04934725 RIGGI_EWING_SARCOMA_PROGENITOR_DN nephroblastoma DOID_2154 3.001E-03 0.03970836 3.001E-03 0.05335811 RIGGI_EWING_SARCOMA_PROGENITOR_DN spindle cell carcinoma DOID_4015 3.001E-03 0.0388059 0.07792885 0.29759406 RIGGI_EWING_SARCOMA_PROGENITOR_DN autosomal recessive nonsyndromic deafness DOID_0050565 3.329E-03 0.04209696 3.329E-03 0.05740495 RIGGI_EWING_SARCOMA_PROGENITOR_DN refractive error DOID_9835 3.329E-03 0.04118181 3.329E-03 0.05571656 RIGGI_EWING_SARCOMA_PROGENITOR_DN pulmonary sarcoidosis DOID_13406 3.5E-03 0.04236687 0.08397783 0.30827989 RIGGI_EWING_SARCOMA_PROGENITOR_DN cleft palate DOID_674 3.5E-03 0.04148423 3.5E-03 0.05689265 RIGGI_EWING_SARCOMA_PROGENITOR_DN microcephaly DOID_10907 3.674E-03 0.0426611 3.674E-03 0.0580665 RIGGI_EWING_SARCOMA_PROGENITOR_DN benign mesothelioma DOID_2645 4.22E-03 0.04802751 0.09198218 0.32916894 RIGGI_EWING_SARCOMA_PROGENITOR_DN pre-eclampsia DOID_10591 5.419E-03 0.06045704 0.10385932 0.353868 RIGGI_EWING_SARCOMA_PROGENITOR_DN neuritis DOID_1803 5.419E-03 0.0592944 5.419E-03 0.08113971 RIGGI_EWING_SARCOMA_PROGENITOR_DN heart valve disease DOID_4079 5.419E-03 0.05817564 0.10385932 0.35176164 RIGGI_EWING_SARCOMA_PROGENITOR_DN sarcoidosis DOID_11335 6.755E-03 0.07117435 0.11558296 0.37580973 RIGGI_EWING_SARCOMA_PROGENITOR_DN atrophic muscular disease DOID_913 6.755E-03 0.06988027 6.755E-03 0.0985491 RIGGI_EWING_SARCOMA_PROGENITOR_DN muscular dystrophy DOID_9884 6.755E-03 0.06988027 6.755E-03 0.0985491 RIGGI_EWING_SARCOMA_PROGENITOR_DN bile duct adenocarcinoma DOID_4896 6.99E-03 0.07102769 0.11752211 0.37779707 RIGGI_EWING_SARCOMA_PROGENITOR_DN cholangiocarcinoma DOID_4947 6.99E-03 0.07102769 0.11752211 0.37779707 RIGGI_EWING_SARCOMA_PROGENITOR_DN bone marrow cancer DOID_4960 6.99E-03 0.06978159 0.11752211 0.37567461 RIGGI_EWING_SARCOMA_PROGENITOR_DN congenital nervous system abnormality DOID_2490 7.72E-03 0.07573342 7.72E-03 0.10981346 RIGGI_EWING_SARCOMA_PROGENITOR_DN nonsyndromic deafness DOID_0050563 7.97E-03 0.0768649 7.97E-03 0.11061047 RIGGI_EWING_SARCOMA_PROGENITOR_DN hypersensitivity reaction type IV disease DOID_2916 7.97E-03 0.07558382 0.1252368 0.39809911 RIGGI_EWING_SARCOMA_PROGENITOR_DN bile duct cancer DOID_4606 7.97E-03 0.07434474 0.1252368 0.39370023 RIGGI_EWING_SARCOMA_PROGENITOR_DN bile duct carcinoma DOID_4897 7.97E-03 0.07434474 0.1252368 0.39370023 RIGGI_EWING_SARCOMA_PROGENITOR_DN neuroectodermal tumor DOID_171 8.743E-03 0.08023955 8.743E-03 0.11844886 RIGGI_EWING_SARCOMA_PROGENITOR_DN carotid artery disease DOID_3407 8.743E-03 0.07896591 8.743E-03 0.11569424 RIGGI_EWING_SARCOMA_PROGENITOR_DN collagen disease DOID_854 8.743E-03 0.07773207 0.13097906 0.40503851 RIGGI_EWING_SARCOMA_PROGENITOR_DN congenital heart defect DOID_1682 9.276E-03 0.08120408 9.276E-03 0.11996058 RIGGI_EWING_SARCOMA_PROGENITOR_DN cholestasis DOID_13580 9.824E-03 0.08469317 9.824E-03 0.12421665 RIGGI_EWING_SARCOMA_PROGENITOR_DN uterine disease DOID_345 9.824E-03 0.0834291 9.824E-03 0.12151629 RIGGI_EWING_SARCOMA_PROGENITOR_DN tooth disease DOID_1091 0.01038529 0.08690043 0.01038529 0.12572828 RIGGI_EWING_SARCOMA_PROGENITOR_DN allergic contact dermatitis DOID_3042 0.01038529 0.085641 0.01038529 0.12310894 RIGGI_EWING_SARCOMA_PROGENITOR_DN endocrine organ benign neoplasm DOID_0060089 0.01067126 0.08674206 0.14423324 0.43422601 RIGGI_EWING_SARCOMA_PROGENITOR_DN bile duct disease DOID_4138 0.01154988 0.0925617 0.01154988 0.13412002 RIGGI_EWING_SARCOMA_PROGENITOR_DN biliary tract disease DOID_9741 0.01184961 0.0936448 0.01184961 0.13484852 FRIDMAN_SENESCENCE_DN aortic valve disease DOID_62 1.379E-05 7.846E-03 5.684E-03 0.3593391 FRIDMAN_SENESCENCE_DN osteosarcoma DOID_3347 1.623E-05 4.618E-03 6.156E-03 0.35028172 FRIDMAN_SENESCENCE_DN heart valve disease DOID_4079 6.101E-05 0.01157108 0.01180872 0.51685849 SHEPARD_CRUSH_AND_BURN_MUTANT_DN congenital nervous system abnormality DOID_2490 5.027E-11 2.86E-08 5.027E-11 2.86E-08 SHEPARD_CRUSH_AND_BURN_MUTANT_DN primitive neuroectodermal tumor DOID_168 4.721E-08 1.343E-05 4.285E-03 0.1060179 SHEPARD_CRUSH_AND_BURN_MUTANT_DN neuroectodermal tumor DOID_171 2.549E-07 4.835E-05 8.145E-03 0.12525978 SHEPARD_CRUSH_AND_BURN_MUTANT_DN pre-malignant neoplasm DOID_0060071 2.978E-07 4.236E-05 1.199E-05 2.275E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_DN in situ carcinoma DOID_8719 2.978E-07 4.236E-05 1.199E-05 2.275E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_DN supratentorial cancer DOID_1659 5.538E-07 6.302E-05 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN cerebrum cancer DOID_368 5.538E-07 6.302E-05 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN microcephaly DOID_10907 1.754E-06 1.663E-04 1.754E-06 4.99E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_DN brain cancer DOID_1319 3.932E-06 3.196E-04 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN central nervous system cancer DOID_3620 4.259E-06 3.029E-04 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN giant cell tumor DOID_200 6.21E-06 3.926E-04 0.11164368 0.59929483 SHEPARD_CRUSH_AND_BURN_MUTANT_DN malignant giant cell tumor DOID_2705 6.21E-06 3.926E-04 0.11164368 0.59929483 SHEPARD_CRUSH_AND_BURN_MUTANT_DN giant cell glioblastoma DOID_3074 6.21E-06 3.926E-04 0.11164368 0.59929483 SHEPARD_CRUSH_AND_BURN_MUTANT_DN glioblastoma DOID_3068 8.753E-06 4.981E-04 0.12099151 0.6146801 SHEPARD_CRUSH_AND_BURN_MUTANT_DN astrocytoma DOID_3069 1.696E-05 8.77E-04 0.1412162 0.66406628 SHEPARD_CRUSH_AND_BURN_MUTANT_DN mixed glioma DOID_5076 2.573E-05 1.22E-03 0.01249286 0.17337646 SHEPARD_CRUSH_AND_BURN_MUTANT_DN female reproductive organ benign neoplasm DOID_0060086 4.294E-05 1.879E-03 2.093E-03 0.09162294 SHEPARD_CRUSH_AND_BURN_MUTANT_DN uterine benign neoplasm DOID_0060095 4.294E-05 1.879E-03 2.093E-03 0.09162294 SHEPARD_CRUSH_AND_BURN_MUTANT_DN uterine fibroid DOID_13223 4.294E-05 1.879E-03 2.093E-03 0.09162294 SHEPARD_CRUSH_AND_BURN_MUTANT_DN nervous system cancer DOID_3093 4.46E-05 1.813E-03 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN leiomyoma DOID_127 5.64E-05 2.14E-03 2.501E-03 0.09486624 SHEPARD_CRUSH_AND_BURN_MUTANT_DN adenoid cystic carcinoma DOID_4866 1.051E-04 3.736E-03 1.051E-04 0.01494549 SHEPARD_CRUSH_AND_BURN_MUTANT_DN salivary gland cancer DOID_8850 1.204E-04 4.031E-03 1.204E-04 0.01370605 SHEPARD_CRUSH_AND_BURN_MUTANT_DN uterine cancer DOID_363 1.372E-04 4.337E-03 4.47E-03 0.09419688 SHEPARD_CRUSH_AND_BURN_MUTANT_DN lung small cell carcinoma DOID_5409 1.856E-04 5.558E-03 5.446E-03 0.09682978 SHEPARD_CRUSH_AND_BURN_MUTANT_DN holoprosencephaly DOID_4621 1.957E-04 5.568E-03 1.957E-04 0.01856116 SHEPARD_CRUSH_AND_BURN_MUTANT_DN reproductive organ benign neoplasm DOID_0050622 2.568E-04 6.957E-03 6.733E-03 0.10946424 SHEPARD_CRUSH_AND_BURN_MUTANT_DN oral cavity cancer DOID_8618 2.981E-04 7.711E-03 2.981E-04 0.02423442 SHEPARD_CRUSH_AND_BURN_MUTANT_DN long QT syndrome DOID_2843 5.177E-04 0.01280637 0.03324063 0.29552998 SHEPARD_CRUSH_AND_BURN_MUTANT_DN biliary tract cancer DOID_4607 7.89E-04 0.01870521 7.89E-04 0.05611563 SHEPARD_CRUSH_AND_BURN_MUTANT_DN subependymal glioma DOID_4843 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN pilocytic astrocytoma DOID_4851 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN subependymal giant cell astrocytoma DOID_5077 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN fibrillary astrocytoma DOID_6726 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN juvenile pilocytic astrocytoma DOID_6811 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN childhood pilocytic astrocytoma DOID_6812 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN gemistocytic astrocytoma DOID_7005 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN childhood cerebral astrocytoma DOID_7007 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN protoplasmic astrocytoma DOID_7008 8.151E-04 0.01855271 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN transitional cell carcinoma DOID_2671 9.313E-04 0.02038223 9.313E-04 0.05888201 SHEPARD_CRUSH_AND_BURN_MUTANT_DN benign glioma DOID_0060101 9.883E-04 0.02082827 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN benign ependymoma DOID_4844 9.883E-04 0.02082827 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_DN muscle cancer DOID_4045 1.081E-03 0.02196712 1.081E-03 0.06150793 SHEPARD_CRUSH_AND_BURN_MUTANT_DN Crohn's disease DOID_8778 1.122E-03 0.02202375 0.01764117 0.21821365 SHEPARD_CRUSH_AND_BURN_MUTANT_DN spastic quadriplegia DOID_10970 1.278E-03 0.024245 1.278E-03 0.06612274 SHEPARD_CRUSH_AND_BURN_MUTANT_DN diffuse large B-cell lymphoma DOID_0050745 1.721E-03 0.03157992 1.721E-03 0.08158145 SHEPARD_CRUSH_AND_BURN_MUTANT_DN endometrial carcinoma DOID_2871 2.093E-03 0.03722182 0.06538968 0.43263636 SHEPARD_CRUSH_AND_BURN_MUTANT_DN spastic cerebral palsy DOID_0050669 2.225E-03 0.03837006 2.225E-03 0.09044371 SHEPARD_CRUSH_AND_BURN_MUTANT_DN endometrial cancer DOID_1380 2.361E-03 0.0395151 0.06933333 0.44830303 SHEPARD_CRUSH_AND_BURN_MUTANT_DN hereditary spastic paraplegia DOID_2476 2.501E-03 0.04065696 2.501E-03 0.0889371 SHEPARD_CRUSH_AND_BURN_MUTANT_DN thyroid carcinoma DOID_3963 2.792E-03 0.04412366 0.07521803 0.47554507 SHEPARD_CRUSH_AND_BURN_MUTANT_DN paraplegia DOID_607 2.792E-03 0.04293113 2.792E-03 0.09343834 SHEPARD_CRUSH_AND_BURN_MUTANT_DN hyperthyroidism DOID_7998 2.792E-03 0.04180136 0.07521803 0.46020491 SHEPARD_CRUSH_AND_BURN_MUTANT_DN lymphoid leukemia DOID_10747 2.943E-03 0.04293363 2.943E-03 0.09302286 SHEPARD_CRUSH_AND_BURN_MUTANT_DN medullomyoblastoma DOID_3861 2.943E-03 0.04186029 2.943E-03 0.08812692 SHEPARD_CRUSH_AND_BURN_MUTANT_DN adult medulloblastoma DOID_3864 2.943E-03 0.04186029 2.943E-03 0.08812692 SHEPARD_CRUSH_AND_BURN_MUTANT_DN childhood medulloblastoma DOID_3869 2.943E-03 0.04186029 2.943E-03 0.08812692 SHEPARD_CRUSH_AND_BURN_MUTANT_DN thyroid cancer DOID_1781 3.098E-03 0.04298811 0.07912072 0.47893289 SHEPARD_CRUSH_AND_BURN_MUTANT_DN medulloblastoma DOID_3858 3.256E-03 0.044113 3.256E-03 0.0926373 SHEPARD_CRUSH_AND_BURN_MUTANT_DN congenital diaphragmatic hernia DOID_3827 3.584E-03 0.04743192 3.584E-03 0.09712251 SHEPARD_CRUSH_AND_BURN_MUTANT_DN benign mesothelioma DOID_2645 3.928E-03 0.05079134 3.928E-03 0.10158267 SHEPARD_CRUSH_AND_BURN_MUTANT_DN cervix uteri carcinoma in situ DOID_8991 3.928E-03 0.04966264 0.08880646 0.52093684 SHEPARD_CRUSH_AND_BURN_MUTANT_DN endometriosis DOID_289 4.285E-03 0.05300895 4.285E-03 0.10160049 SHEPARD_CRUSH_AND_BURN_MUTANT_DN diabetic autonomic neuropathy DOID_11503 4.47E-03 0.0541131 4.47E-03 0.10173263 SHEPARD_CRUSH_AND_BURN_MUTANT_DN autonomic neuropathy DOID_11504 4.47E-03 0.0541131 4.47E-03 0.10173263 SHEPARD_CRUSH_AND_BURN_MUTANT_DN diabetic polyneuropathy DOID_12785 4.47E-03 0.0541131 4.47E-03 0.10173263 SHEPARD_CRUSH_AND_BURN_MUTANT_DN gallbladder cancer DOID_3121 4.47E-03 0.05298574 4.47E-03 0.09781983 SHEPARD_CRUSH_AND_BURN_MUTANT_DN diabetic neuropathy DOID_9743 4.47E-03 0.0541131 4.47E-03 0.10173263 SHEPARD_CRUSH_AND_BURN_MUTANT_DN cataract DOID_83 4.658E-03 0.05408733 4.658E-03 0.09465283 SHEPARD_CRUSH_AND_BURN_MUTANT_DN leukodystrophy DOID_10579 4.849E-03 0.05518588 4.849E-03 0.09514806 SHEPARD_CRUSH_AND_BURN_MUTANT_DN lens disease DOID_110 5.045E-03 0.05628138 5.045E-03 0.09567834 SHEPARD_CRUSH_AND_BURN_MUTANT_DN autonomic nervous system disease DOID_11465 5.045E-03 0.05519904 5.045E-03 0.09259194 SHEPARD_CRUSH_AND_BURN_MUTANT_DN aortic aneurysm DOID_3627 5.651E-03 0.06067324 5.651E-03 0.0974449 SHEPARD_CRUSH_AND_BURN_MUTANT_DN B-cell lymphocytic neoplasm DOID_707 5.861E-03 0.06175587 5.861E-03 0.09808286 SHEPARD_CRUSH_AND_BURN_MUTANT_DN hypertrophic cardiomyopathy DOID_11984 7.424E-03 0.07680388 7.424E-03 0.11733925 SHEPARD_CRUSH_AND_BURN_MUTANT_DN carotid artery disease DOID_3407 8.145E-03 0.08276093 8.145E-03 0.12196347 SHEPARD_CRUSH_AND_BURN_MUTANT_DN cerebral degeneration DOID_1443 9.154E-03 0.09137776 9.154E-03 0.13355211 JEON_SMAD6_TARGETS_DN endometrial carcinoma DOID_2871 1.553E-07 8.838E-05 1.000 1.000 JEON_SMAD6_TARGETS_DN endometrial cancer DOID_1380 1.873E-07 5.329E-05 1.000 1.000 JEON_SMAD6_TARGETS_DN uterine cancer DOID_363 5.063E-07 9.602E-05 1.000 1.000 JEON_SMAD6_TARGETS_DN breast benign neoplasm DOID_0060082 5.96E-06 8.477E-04 1.000 1.000 JEON_SMAD6_TARGETS_DN thoracic benign neoplasm DOID_0060097 5.96E-06 8.477E-04 1.000 1.000 JEON_SMAD6_TARGETS_DN benign breast phyllodes tumor DOID_1631 5.96E-06 8.477E-04 1.000 1.000 JEON_SMAD6_TARGETS_DN spindle cell carcinoma DOID_4015 7.18E-05 8.171E-03 1.000 1.000 JEON_SMAD6_TARGETS_DN adenoid cystic carcinoma DOID_4866 9.724E-05 9.222E-03 1.000 1.000 JEON_SMAD6_TARGETS_DN benign mesothelioma DOID_2645 1.019E-04 8.279E-03 1.000 1.000 JEON_SMAD6_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 1.019E-04 7.244E-03 1.000 1.000 JEON_SMAD6_TARGETS_DN salivary gland cancer DOID_8850 1.066E-04 6.737E-03 1.000 1.000 JEON_SMAD6_TARGETS_DN giant cell tumor DOID_200 1.654E-04 9.412E-03 0.01903658 0.83321656 JEON_SMAD6_TARGETS_DN malignant giant cell tumor DOID_2705 1.654E-04 9.412E-03 0.01903658 0.83321656 JEON_SMAD6_TARGETS_DN giant cell glioblastoma DOID_3074 1.654E-04 9.412E-03 0.01903658 0.83321656 JEON_SMAD6_TARGETS_DN glioblastoma DOID_3068 1.964E-04 0.01015827 0.02071991 0.73685164 JEON_SMAD6_TARGETS_DN oral cavity cancer DOID_8618 1.964E-04 9.312E-03 1.000 1.000 JEON_SMAD6_TARGETS_DN pre-malignant neoplasm DOID_0060071 2.3E-04 0.01006527 1.000 1.000 JEON_SMAD6_TARGETS_DN in situ carcinoma DOID_8719 2.3E-04 0.01006527 1.000 1.000 JEON_SMAD6_TARGETS_DN astrocytoma DOID_3069 2.737E-04 0.01112423 0.02441384 0.77174847 JEON_SMAD6_TARGETS_DN mixed glioma DOID_5076 3.379E-04 0.01281626 1.000 1.000 JEON_SMAD6_TARGETS_DN transitional cell carcinoma DOID_2671 4.274E-04 0.01519875 1.000 1.000 JEON_SMAD6_TARGETS_DN amino acid metabolic disorder DOID_9252 4.369E-04 0.01462334 4.369E-04 0.24859672 MUELLER_METHYLATED_IN_GLIOBLASTOMA invasive ductal carcinoma DOID_3008 8.949E-07 5.092E-04 8.949E-07 5.092E-04 MUELLER_METHYLATED_IN_GLIOBLASTOMA vulva cancer DOID_1245 2.983E-05 8.487E-03 2.983E-05 8.487E-03 MUELLER_METHYLATED_IN_GLIOBLASTOMA acute pancreatitis DOID_2913 1.142E-04 0.02166049 1.000 1.000 MUELLER_METHYLATED_IN_GLIOBLASTOMA respiratory syncytial virus infectious disease DOID_1273 3.256E-04 0.04631876 1.000 1.000 MUELLER_METHYLATED_IN_GLIOBLASTOMA hepatitis DOID_2237 3.256E-04 0.03705501 0.02626044 0.41506088 MUELLER_METHYLATED_IN_GLIOBLASTOMA pulmonary emphysema DOID_9675 3.575E-04 0.03390142 1.000 1.000 MUELLER_METHYLATED_IN_GLIOBLASTOMA influenza DOID_8469 4.08E-04 0.03316669 1.000 1.000 MUELLER_METHYLATED_IN_GLIOBLASTOMA giant cell tumor DOID_200 5.793E-04 0.04119978 5.793E-04 0.10986607 MUELLER_METHYLATED_IN_GLIOBLASTOMA malignant giant cell tumor DOID_2705 5.793E-04 0.04119978 5.793E-04 0.10986607 MUELLER_METHYLATED_IN_GLIOBLASTOMA giant cell glioblastoma DOID_3074 5.793E-04 0.04119978 5.793E-04 0.10986607 MUELLER_METHYLATED_IN_GLIOBLASTOMA osteochondrodysplasia DOID_2256 6.213E-04 0.03927886 6.213E-04 0.08837744 MUELLER_METHYLATED_IN_GLIOBLASTOMA glioblastoma DOID_3068 6.87E-04 0.03909096 6.87E-04 0.07818191 MUELLER_METHYLATED_IN_GLIOBLASTOMA pre-malignant neoplasm DOID_0060071 8.037E-04 0.04157392 8.037E-04 0.07621886 MUELLER_METHYLATED_IN_GLIOBLASTOMA in situ carcinoma DOID_8719 8.037E-04 0.04157392 8.037E-04 0.07621886 MUELLER_METHYLATED_IN_GLIOBLASTOMA astrocytoma DOID_3069 9.555E-04 0.0453064 9.555E-04 0.07766812 MUELLER_METHYLATED_IN_GLIOBLASTOMA pancreatitis DOID_4989 1.178E-03 0.05154447 1.000 1.000 MUELLER_METHYLATED_IN_GLIOBLASTOMA bacterial pneumonia DOID_874 1.178E-03 0.04786273 1.000 1.000 MUELLER_METHYLATED_IN_GLIOBLASTOMA bone development disease DOID_0080006 1.359E-03 0.05154998 1.359E-03 0.09665621 MUELLER_METHYLATED_IN_GLIOBLASTOMA primary bacterial infectious disease DOID_0050338 1.454E-03 0.05171924 1.000 1.000 MUELLER_METHYLATED_IN_GLIOBLASTOMA transitional cell carcinoma DOID_2671 1.487E-03 0.04976402 1.487E-03 0.0939987 MUELLER_METHYLATED_IN_GLIOBLASTOMA dilated cardiomyopathy DOID_12930 1.724E-03 0.05449153 0.05965115 0.49913977 DORN_ADENOVIRUS_INFECTION_12HR_DN multiple myeloma DOID_9538 1.546E-11 8.795E-09 1.225E-06 6.97E-04 DORN_ADENOVIRUS_INFECTION_12HR_DN myeloma DOID_0070004 4.961E-11 1.411E-08 2.422E-06 6.891E-04 DORN_ADENOVIRUS_INFECTION_12HR_DN bone marrow cancer DOID_4960 9.781E-11 1.855E-08 3.607E-06 6.842E-04 DORN_ADENOVIRUS_INFECTION_12HR_DN nervous system cancer DOID_3093 1.527E-07 2.172E-05 1.53E-05 2.177E-03 DORN_ADENOVIRUS_INFECTION_12HR_DN sarcoma DOID_1115 5.051E-07 5.748E-05 1.14E-04 0.010811 DORN_ADENOVIRUS_INFECTION_12HR_DN brain cancer DOID_1319 2.422E-06 2.297E-04 3.19E-04 0.0165015 DORN_ADENOVIRUS_INFECTION_12HR_DN central nervous system cancer DOID_3620 2.573E-06 2.091E-04 3.319E-04 0.0157388 DORN_ADENOVIRUS_INFECTION_12HR_DN hyperparathyroidism DOID_13543 1.187E-05 8.441E-04 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN lymphoma DOID_0060058 1.632E-05 1.032E-03 1.632E-05 1.857E-03 DORN_ADENOVIRUS_INFECTION_12HR_DN parathyroid gland disease DOID_11201 2.055E-05 1.169E-03 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN angiosarcoma DOID_0001816 3.159E-05 1.634E-03 8.409E-03 0.17721534 DORN_ADENOVIRUS_INFECTION_12HR_DN male reproductive organ benign neoplasm DOID_0060087 4.025E-05 1.908E-03 9.456E-03 0.18552487 DORN_ADENOVIRUS_INFECTION_12HR_DN pleurisy DOID_10247 1.14E-04 4.99E-03 0.01571203 0.23526704 DORN_ADENOVIRUS_INFECTION_12HR_DN supratentorial cancer DOID_1659 1.218E-04 4.951E-03 1.218E-04 9.903E-03 DORN_ADENOVIRUS_INFECTION_12HR_DN toxic encephalopathy DOID_3602 1.218E-04 4.621E-03 1.218E-04 8.665E-03 DORN_ADENOVIRUS_INFECTION_12HR_DN cerebrum cancer DOID_368 1.218E-04 4.951E-03 1.218E-04 9.903E-03 DORN_ADENOVIRUS_INFECTION_12HR_DN pleural disease DOID_1532 1.557E-04 5.537E-03 0.0183078 0.26710607 DORN_ADENOVIRUS_INFECTION_12HR_DN papilloma DOID_2615 1.648E-04 5.516E-03 0.01882617 0.26127049 DORN_ADENOVIRUS_INFECTION_12HR_DN peripheral nervous system neoplasm DOID_1192 2.142E-04 6.77E-03 2.142E-04 0.01353904 DORN_ADENOVIRUS_INFECTION_12HR_DN adenoid cystic carcinoma DOID_4866 2.357E-04 7.058E-03 0.0224475 0.27175799 DORN_ADENOVIRUS_INFECTION_12HR_DN cervix uteri carcinoma in situ DOID_8991 2.468E-04 7.022E-03 0.02296379 0.26666117 DORN_ADENOVIRUS_INFECTION_12HR_DN salivary gland cancer DOID_8850 2.582E-04 6.997E-03 0.02347983 0.26196121 DORN_ADENOVIRUS_INFECTION_12HR_DN primitive neuroectodermal tumor DOID_168 2.699E-04 6.98E-03 2.699E-04 0.01535571 DORN_ADENOVIRUS_INFECTION_12HR_DN B-cell lymphocytic neoplasm DOID_707 3.722E-04 9.208E-03 3.722E-04 0.01629022 DORN_ADENOVIRUS_INFECTION_12HR_DN giant cell tumor DOID_200 4.003E-04 9.49E-03 4.003E-04 0.01626854 DORN_ADENOVIRUS_INFECTION_12HR_DN malignant giant cell tumor DOID_2705 4.003E-04 9.49E-03 4.003E-04 0.01626854 DORN_ADENOVIRUS_INFECTION_12HR_DN giant cell glioblastoma DOID_3074 4.003E-04 9.49E-03 4.003E-04 0.01626854 DORN_ADENOVIRUS_INFECTION_12HR_DN reproductive organ benign neoplasm DOID_0050622 4.294E-04 9.773E-03 0.03016477 0.29592683 DORN_ADENOVIRUS_INFECTION_12HR_DN integumentary system cancer DOID_0060122 4.294E-04 9.397E-03 0.03016477 0.29091112 DORN_ADENOVIRUS_INFECTION_12HR_DN skin cancer DOID_4159 4.294E-04 9.397E-03 0.03016477 0.29091112 DORN_ADENOVIRUS_INFECTION_12HR_DN pustulosis of palm and sole DOID_4398 4.294E-04 9.049E-03 0.03016477 0.2860626 DORN_ADENOVIRUS_INFECTION_12HR_DN glioblastoma DOID_3068 4.749E-04 9.651E-03 4.749E-04 0.01801478 DORN_ADENOVIRUS_INFECTION_12HR_DN oral cavity cancer DOID_8618 4.749E-04 9.318E-03 0.03170127 0.28631779 DORN_ADENOVIRUS_INFECTION_12HR_DN neuroectodermal tumor DOID_171 5.227E-04 9.913E-03 5.227E-04 0.01858779 DORN_ADENOVIRUS_INFECTION_12HR_DN pre-malignant neoplasm DOID_0060071 5.558E-04 0.01020113 0.03425695 0.30456572 DORN_ADENOVIRUS_INFECTION_12HR_DN in situ carcinoma DOID_8719 5.558E-04 0.01020113 0.03425695 0.30456572 DORN_ADENOVIRUS_INFECTION_12HR_DN astrocytoma DOID_3069 6.61E-04 0.01175356 6.61E-04 0.02212436 DORN_ADENOVIRUS_INFECTION_12HR_DN alcohol abuse DOID_1574 9.195E-04 0.01585361 9.195E-04 0.02906496 DORN_ADENOVIRUS_INFECTION_12HR_DN lymphoblastic leukemia DOID_1037 1.146E-03 0.01918421 0.04895402 0.39792629 DORN_ADENOVIRUS_INFECTION_12HR_DN encephalomyelitis DOID_640 1.146E-03 0.01863609 0.04895402 0.39232169 DORN_ADENOVIRUS_INFECTION_12HR_DN T cell deficiency DOID_11200 5.264E-03 0.08319461 5.264E-03 0.15763189 DORN_ADENOVIRUS_INFECTION_12HR_DN retinal vascular occlusion DOID_1729 5.264E-03 0.0809461 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN transient cerebral ischemia DOID_224 5.264E-03 0.07881594 5.264E-03 0.14975029 DORN_ADENOVIRUS_INFECTION_12HR_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 5.264E-03 0.07679502 5.264E-03 0.14261933 DORN_ADENOVIRUS_INFECTION_12HR_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 5.264E-03 0.07679502 5.264E-03 0.14261933 DORN_ADENOVIRUS_INFECTION_12HR_DN Hodgkin's granuloma DOID_8651 5.264E-03 0.07679502 5.264E-03 0.14261933 DORN_ADENOVIRUS_INFECTION_12HR_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 5.264E-03 0.07679502 5.264E-03 0.14261933 DORN_ADENOVIRUS_INFECTION_12HR_DN visceral leishmaniasis DOID_9146 5.264E-03 0.07487515 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN prediabetes syndrome DOID_11716 5.789E-03 0.08033369 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN invasive lobular carcinoma DOID_3457 5.789E-03 0.07842098 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN epidermolysis bullosa DOID_2730 6.313E-03 0.0835397 6.313E-03 0.16328214 DORN_ADENOVIRUS_INFECTION_12HR_DN Hodgkin's lymphoma DOID_8567 6.313E-03 0.08164107 6.313E-03 0.15618292 DORN_ADENOVIRUS_INFECTION_12HR_DN encephalitis DOID_9588 6.313E-03 0.07982682 6.313E-03 0.1496753 DORN_ADENOVIRUS_INFECTION_12HR_DN berylliosis DOID_10322 6.838E-03 0.0845779 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN polyneuropathy DOID_1389 6.838E-03 0.08277837 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN vesiculobullous skin disease DOID_2731 6.838E-03 0.08105382 6.838E-03 0.15562333 DORN_ADENOVIRUS_INFECTION_12HR_DN hypercalcemia DOID_12678 7.362E-03 0.08548591 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN hemangioma DOID_255 7.886E-03 0.08973773 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN mesenchymal cell neoplasm DOID_3350 7.886E-03 0.08797817 7.886E-03 0.17257257 DORN_ADENOVIRUS_INFECTION_12HR_DN spindle cell sarcoma DOID_4235 7.886E-03 0.08797817 7.886E-03 0.17257257 DORN_ADENOVIRUS_INFECTION_12HR_DN lung oat cell carcinoma DOID_5411 7.886E-03 0.08628628 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN epithelioid sarcoma DOID_6193 7.886E-03 0.08797817 7.886E-03 0.17257257 DORN_ADENOVIRUS_INFECTION_12HR_DN hemolytic-uremic syndrome DOID_12554 8.409E-03 0.09027951 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN thyroiditis DOID_7166 8.409E-03 0.08860767 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN autoimmune thyroiditis DOID_7188 8.409E-03 0.08860767 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN Barrett's esophagus DOID_9206 8.409E-03 0.08699662 8.409E-03 0.17088622 DORN_ADENOVIRUS_INFECTION_12HR_DN basal cell carcinoma DOID_2513 8.932E-03 0.09076058 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN urinary system benign neoplasm DOID_731 8.932E-03 0.08916829 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN keratosis DOID_161 9.456E-03 0.09276244 9.456E-03 0.17934071 DORN_ADENOVIRUS_INFECTION_12HR_DN skin carcinoma DOID_3451 9.456E-03 0.09119019 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN dissociative disorder DOID_10935 9.978E-03 0.09462835 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN dissociative amnesia DOID_11037 9.978E-03 0.09462835 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN granulosa cell tumor DOID_2999 9.978E-03 0.09307706 9.978E-03 0.18315164 DORN_ADENOVIRUS_INFECTION_12HR_DN leishmaniasis DOID_9065 9.978E-03 0.09157582 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN amnestic disorder DOID_10914 0.01050093 0.09484177 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN colon carcinoma DOID_1520 0.01050093 0.09335987 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN sex cord-gonadal stromal tumor DOID_192 0.01050093 0.09192356 0.01050093 0.18671973 DORN_ADENOVIRUS_INFECTION_12HR_DN subependymal glioma DOID_4843 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN pilocytic astrocytoma DOID_4851 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN subependymal giant cell astrocytoma DOID_5077 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN fibrillary astrocytoma DOID_6726 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN juvenile pilocytic astrocytoma DOID_6811 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN childhood pilocytic astrocytoma DOID_6812 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN gemistocytic astrocytoma DOID_7005 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN childhood cerebral astrocytoma DOID_7007 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN protoplasmic astrocytoma DOID_7008 0.01050093 0.09053078 0.01050093 0.18106156 DORN_ADENOVIRUS_INFECTION_12HR_DN autoimmune hepatitis DOID_2048 0.01102322 0.09361512 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN mitochondrial myopathy DOID_699 0.01102322 0.09223842 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN benign glioma DOID_0060101 0.01154525 0.09520645 0.01154525 0.19321309 DORN_ADENOVIRUS_INFECTION_12HR_DN benign ependymoma DOID_4844 0.01154525 0.09520645 0.01154525 0.19321309 DORN_ADENOVIRUS_INFECTION_12HR_DN placenta disease DOID_780 0.01154525 0.09384636 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN uremia DOID_4676 0.01206701 0.09670604 0.01206701 0.1961751 DORN_ADENOVIRUS_INFECTION_12HR_DN meningitis DOID_9471 0.01258851 0.09948421 1.000 1.000 DORN_ADENOVIRUS_INFECTION_12HR_DN Goodpasture syndrome DOID_9808 0.01258851 0.09812141 1.000 1.000 POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN congenital hypoplastic anemia DOID_1342 6.341E-12 3.608E-09 6.341E-12 3.608E-09 POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN Diamond-Blackfan anemia DOID_1339 2.586E-11 7.359E-09 2.586E-11 7.359E-09 POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN aplastic anemia DOID_12449 3.225E-11 6.117E-09 3.225E-11 6.117E-09 POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN bone marrow disease DOID_4961 1.355E-10 1.927E-08 1.355E-10 1.927E-08 POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN lung adenocarcinoma DOID_3910 1.543E-04 0.01756113 1.543E-04 0.01756113 MAHADEVAN_RESPONSE_TO_MP470_UP sarcoidosis DOID_11335 2.526E-11 1.437E-08 2.538E-04 0.01110731 MAHADEVAN_RESPONSE_TO_MP470_UP hypersensitivity reaction type IV disease DOID_2916 3.929E-11 1.118E-08 3.012E-04 0.01224109 MAHADEVAN_RESPONSE_TO_MP470_UP bacterial pneumonia DOID_874 1.581E-10 2.998E-08 4.967E-06 5.653E-04 MAHADEVAN_RESPONSE_TO_MP470_UP pulmonary sarcoidosis DOID_13406 1.915E-09 2.724E-07 1.29E-04 7.342E-03 MAHADEVAN_RESPONSE_TO_MP470_UP common cold DOID_10459 1.354E-08 1.54E-06 1.099E-05 8.937E-04 MAHADEVAN_RESPONSE_TO_MP470_UP primary bacterial infectious disease DOID_0050338 5.054E-08 4.793E-06 6.401E-04 0.02142393 MAHADEVAN_RESPONSE_TO_MP470_UP amino acid metabolic disorder DOID_9252 5.529E-08 4.494E-06 7.324E-06 6.946E-04 MAHADEVAN_RESPONSE_TO_MP470_UP esophagitis DOID_11963 7E-08 4.979E-06 8.409E-03 0.1649936 MAHADEVAN_RESPONSE_TO_MP470_UP extrinsic allergic alveolitis DOID_841 2.007E-07 1.269E-05 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP pleurisy DOID_10247 2.486E-07 1.415E-05 0.01258884 0.18366797 MAHADEVAN_RESPONSE_TO_MP470_UP bronchiolitis obliterans DOID_2799 3.339E-07 1.727E-05 0.01383952 0.19206554 MAHADEVAN_RESPONSE_TO_MP470_UP pleural disease DOID_1532 4.003E-07 1.898E-05 0.01467248 0.19877719 MAHADEVAN_RESPONSE_TO_MP470_UP esophageal disease DOID_6050 4.75E-07 2.079E-05 0.01550478 0.19604936 MAHADEVAN_RESPONSE_TO_MP470_UP uveitis DOID_13141 6.51E-07 2.646E-05 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP hepatitis DOID_2237 7.009E-07 2.659E-05 0.01758265 0.21748977 MAHADEVAN_RESPONSE_TO_MP470_UP pulmonary emphysema DOID_9675 8.082E-07 2.874E-05 1.563E-04 8.087E-03 MAHADEVAN_RESPONSE_TO_MP470_UP uveal disease DOID_3480 9.259E-07 3.099E-05 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP pulmonary tuberculosis DOID_2957 1.346E-06 4.254E-05 2.187E-04 0.01037102 MAHADEVAN_RESPONSE_TO_MP470_UP cholestasis DOID_13580 3.039E-06 9.102E-05 3.039E-06 1.729E-03 MAHADEVAN_RESPONSE_TO_MP470_UP tuberculosis DOID_399 3.464E-06 9.854E-05 4.08E-04 0.01547618 MAHADEVAN_RESPONSE_TO_MP470_UP bile duct disease DOID_4138 3.925E-06 1.064E-04 3.925E-06 1.117E-03 MAHADEVAN_RESPONSE_TO_MP470_UP biliary tract disease DOID_9741 4.088E-06 1.057E-04 4.088E-06 7.753E-04 MAHADEVAN_RESPONSE_TO_MP470_UP diabetic retinopathy DOID_8947 4.255E-06 1.053E-04 0.03160351 0.26061444 MAHADEVAN_RESPONSE_TO_MP470_UP cystic fibrosis DOID_1485 4.602E-06 1.091E-04 4.602E-06 6.546E-04 MAHADEVAN_RESPONSE_TO_MP470_UP pancreatitis DOID_4989 4.967E-06 1.131E-04 5.177E-04 0.01840916 MAHADEVAN_RESPONSE_TO_MP470_UP retinal vascular disease DOID_2462 6.397E-06 1.4E-04 0.03609935 0.28137715 MAHADEVAN_RESPONSE_TO_MP470_UP Legionnaires' disease DOID_10457 1.515E-05 3.193E-04 1.515E-05 1.078E-03 MAHADEVAN_RESPONSE_TO_MP470_UP legionellosis DOID_10458 1.515E-05 3.193E-04 1.515E-05 1.078E-03 MAHADEVAN_RESPONSE_TO_MP470_UP viral pneumonia DOID_10533 1.515E-05 3.079E-04 5.893E-03 0.1524248 MAHADEVAN_RESPONSE_TO_MP470_UP hyperhomocysteinemia DOID_9279 1.748E-05 3.429E-04 1.748E-05 1.105E-03 MAHADEVAN_RESPONSE_TO_MP470_UP autoimmune hepatitis DOID_2048 3.49E-05 6.62E-04 8.828E-03 0.16203426 MAHADEVAN_RESPONSE_TO_MP470_UP cystitis DOID_1679 5.825E-05 1.069E-03 0.01133668 0.17433969 MAHADEVAN_RESPONSE_TO_MP470_UP bladder disease DOID_365 9.856E-05 1.752E-03 0.01467248 0.19415446 MAHADEVAN_RESPONSE_TO_MP470_UP respiratory syncytial virus infectious disease DOID_1273 1.424E-04 2.455E-03 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP systemic scleroderma DOID_418 1.424E-04 2.383E-03 0.01758265 0.2084277 MAHADEVAN_RESPONSE_TO_MP470_UP peptic ulcer DOID_750 1.424E-04 2.315E-03 0.01758265 0.20417407 MAHADEVAN_RESPONSE_TO_MP470_UP adult respiratory distress syndrome DOID_11394 1.493E-04 2.359E-03 0.01799773 0.2048142 MAHADEVAN_RESPONSE_TO_MP470_UP autoimmune disease of urogenital tract DOID_0060049 1.636E-04 2.516E-03 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP primary biliary cirrhosis DOID_12236 1.636E-04 2.516E-03 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP rheumatic disease DOID_1575 1.71E-04 2.56E-03 0.01924199 0.21468022 MAHADEVAN_RESPONSE_TO_MP470_UP scleroderma DOID_419 1.71E-04 2.56E-03 0.01924199 0.21468022 MAHADEVAN_RESPONSE_TO_MP470_UP diabetic autonomic neuropathy DOID_11503 1.785E-04 2.605E-03 0.01965641 0.2150865 MAHADEVAN_RESPONSE_TO_MP470_UP autonomic neuropathy DOID_11504 1.785E-04 2.605E-03 0.01965641 0.2150865 MAHADEVAN_RESPONSE_TO_MP470_UP diabetic polyneuropathy DOID_12785 1.785E-04 2.605E-03 0.01965641 0.2150865 MAHADEVAN_RESPONSE_TO_MP470_UP influenza DOID_8469 1.785E-04 2.54E-03 0.01965641 0.21102826 MAHADEVAN_RESPONSE_TO_MP470_UP diabetic neuropathy DOID_9743 1.785E-04 2.605E-03 0.01965641 0.2150865 MAHADEVAN_RESPONSE_TO_MP470_UP autonomic nervous system disease DOID_11465 2.022E-04 2.806E-03 0.0208987 0.22021032 MAHADEVAN_RESPONSE_TO_MP470_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.187E-04 2.963E-03 0.02172606 0.22075233 MAHADEVAN_RESPONSE_TO_MP470_UP aortic aneurysm DOID_3627 2.272E-04 3.007E-03 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP atopic dermatitis DOID_3310 2.448E-04 3.165E-03 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP parasitic protozoa infectious disease DOID_2789 2.723E-04 3.443E-03 0.02420424 0.23745196 MAHADEVAN_RESPONSE_TO_MP470_UP carotid artery disease DOID_3407 3.316E-04 4.101E-03 0.02667653 0.2488352 MAHADEVAN_RESPONSE_TO_MP470_UP collagen disease DOID_854 3.316E-04 4.014E-03 0.02667653 0.24482173 MAHADEVAN_RESPONSE_TO_MP470_UP respiratory failure DOID_11162 3.42E-04 4.054E-03 0.02708801 0.24465203 MAHADEVAN_RESPONSE_TO_MP470_UP parasitic infectious disease DOID_1398 3.743E-04 4.346E-03 0.02832146 0.25179551 MAHADEVAN_RESPONSE_TO_MP470_UP male reproductive system disease DOID_48 4.431E-04 5.043E-03 0.03078397 0.26143404 MAHADEVAN_RESPONSE_TO_MP470_UP aneurysm disease DOID_2403 5.048E-04 5.632E-03 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP metabolic syndrome X DOID_14221 5.438E-04 5.95E-03 0.03405822 0.27684466 MAHADEVAN_RESPONSE_TO_MP470_UP encephalomyelitis DOID_640 7.287E-04 7.824E-03 0.03935676 0.30262157 MAHADEVAN_RESPONSE_TO_MP470_UP hypersensitivity reaction type I disease DOID_1205 7.595E-04 8.003E-03 7.595E-04 0.02400994 MAHADEVAN_RESPONSE_TO_MP470_UP ulcerative colitis DOID_8577 8.069E-04 8.348E-03 8.069E-04 0.02416472 MAHADEVAN_RESPONSE_TO_MP470_UP transient cerebral ischemia DOID_224 4.213E-03 0.04280611 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP acute kidney failure DOID_3021 4.213E-03 0.04205513 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP Hermansky-Pudlak syndrome DOID_3753 4.213E-03 0.04133004 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP conjunctival disease DOID_4251 4.213E-03 0.04062953 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP conjunctivitis DOID_6195 4.213E-03 0.04062953 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP cutaneous leishmaniasis DOID_9111 4.213E-03 0.03995237 4.213E-03 0.11985711 MAHADEVAN_RESPONSE_TO_MP470_UP familial adenomatous polyposis DOID_0050424 4.633E-03 0.04321861 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP trypanosomiasis DOID_10113 4.633E-03 0.04252153 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP adrenoleukodystrophy DOID_10588 4.633E-03 0.04184659 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP sickle cell anemia DOID_10923 4.633E-03 0.04119273 4.633E-03 0.12553976 MAHADEVAN_RESPONSE_TO_MP470_UP neuronal ceroid lipofuscinosis DOID_14503 4.633E-03 0.040559 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP encephalitis DOID_9588 5.053E-03 0.04356717 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP polyneuropathy DOID_1389 5.474E-03 0.04648413 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP eyelid disease DOID_530 5.893E-03 0.0493139 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP idiopathic pulmonary fibrosis DOID_0050156 6.313E-03 0.05206029 6.313E-03 0.15618086 MAHADEVAN_RESPONSE_TO_MP470_UP thoracic aortic aneurysm DOID_14004 6.313E-03 0.05131657 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP renovascular hypertension DOID_1591 6.313E-03 0.0505938 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP intermediate coronary syndrome DOID_8805 6.313E-03 0.04989111 6.313E-03 0.14967333 MAHADEVAN_RESPONSE_TO_MP470_UP spastic diplegia DOID_10965 6.733E-03 0.0524778 6.733E-03 0.15323519 MAHADEVAN_RESPONSE_TO_MP470_UP restrictive cardiomyopathy DOID_397 6.733E-03 0.05176864 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP tongue cancer DOID_8649 6.733E-03 0.0510784 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP Barrett's esophagus DOID_9206 6.733E-03 0.05040631 6.733E-03 0.14734152 MAHADEVAN_RESPONSE_TO_MP470_UP drug-induced mental disorder DOID_1203 7.152E-03 0.05285071 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP methylmalonic acidemia DOID_14749 7.152E-03 0.05217314 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP drug psychosis DOID_1742 7.152E-03 0.05285071 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP substance-induced psychosis DOID_8646 7.152E-03 0.05285071 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP glucose intolerance DOID_10603 7.571E-03 0.0545321 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP Down syndrome DOID_14250 7.99E-03 0.0568309 7.99E-03 0.16838786 MAHADEVAN_RESPONSE_TO_MP470_UP leishmaniasis DOID_9065 7.99E-03 0.05612929 7.99E-03 0.16237401 MAHADEVAN_RESPONSE_TO_MP470_UP brain edema DOID_4724 8.409E-03 0.05835139 8.409E-03 0.15949381 MAHADEVAN_RESPONSE_TO_MP470_UP coronary restenosis DOID_4247 8.828E-03 0.06051882 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP mitochondrial myopathy DOID_699 8.828E-03 0.05979836 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP sinusitis DOID_0050127 9.665E-03 0.06469735 9.665E-03 0.17185232 MAHADEVAN_RESPONSE_TO_MP470_UP paranasal sinus disease DOID_1352 9.665E-03 0.06469735 9.665E-03 0.17185232 MAHADEVAN_RESPONSE_TO_MP470_UP myasthenia gravis DOID_437 9.665E-03 0.06394505 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP uremia DOID_4676 9.665E-03 0.06321005 9.665E-03 0.16664468 MAHADEVAN_RESPONSE_TO_MP470_UP hypoglycemia DOID_9993 9.665E-03 0.06249175 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP Lewy body dementia DOID_12217 0.01008302 0.06446336 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP Goodpasture syndrome DOID_9808 0.01008302 0.0637471 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP acute pancreatitis DOID_2913 0.01050107 0.06566055 0.01050107 0.17573852 MAHADEVAN_RESPONSE_TO_MP470_UP commensal bacterial infectious disease DOID_0050339 0.01091896 0.06753137 0.01091896 0.17751104 MAHADEVAN_RESPONSE_TO_MP470_UP organic acidemia DOID_0060159 0.01091896 0.06680523 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP urticaria DOID_1555 0.01091896 0.06609453 0.01091896 0.17258017 MAHADEVAN_RESPONSE_TO_MP470_UP bronchiolitis DOID_2942 0.01091896 0.0653988 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP neuromuscular junction disease DOID_439 0.01133668 0.06719342 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP myositis DOID_633 0.01133668 0.06650071 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP diffuse large B-cell lymphoma DOID_0050745 0.01217162 0.07066991 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP Sciatic Neuropathy DOID_11446 0.01217162 0.06995607 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP lesion of sciatic nerve DOID_12528 0.01217162 0.06995607 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP lung adenocarcinoma DOID_3910 0.01217162 0.06925651 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP periodontitis DOID_824 0.01217162 0.0685708 0.01217162 0.18225397 MAHADEVAN_RESPONSE_TO_MP470_UP perinatal necrotizing enterocolitis DOID_8677 0.01217162 0.06789854 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP mononeuritis of lower limb DOID_9473 0.01217162 0.06995607 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP renal hypertension DOID_1073 0.01258884 0.06954418 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP secondary hypertension DOID_11130 0.01258884 0.06954418 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP mononeuritis DOID_1802 0.01258884 0.06887549 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP coronary stenosis DOID_4248 0.01258884 0.06821953 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP autoimmune disease of the nervous system DOID_438 0.01258884 0.06757595 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP mononeuropathy DOID_1188 0.0130059 0.06916222 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP spastic cerebral palsy DOID_0050669 0.01383952 0.07291377 0.01383952 0.19686718 MAHADEVAN_RESPONSE_TO_MP470_UP abdominal aortic aneurysm DOID_7693 0.01383952 0.07224484 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP papilloma DOID_2615 0.01508871 0.0780498 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP myocarditis DOID_820 0.01508871 0.07734665 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP periodontal disease DOID_3388 0.01550478 0.07876983 0.01550478 0.20050503 MAHADEVAN_RESPONSE_TO_MP470_UP thyroid carcinoma DOID_3963 0.01550478 0.07807275 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP spindle cell carcinoma DOID_4015 0.01550478 0.07738791 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP hyperthyroidism DOID_7998 0.01550478 0.07671497 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP aplastic anemia DOID_12449 0.01592069 0.07809371 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP thyroid cancer DOID_1781 0.01633642 0.07944808 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP multiple myeloma DOID_9538 0.016752 0.0807787 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP congenital diaphragmatic hernia DOID_3827 0.01758265 0.08407168 0.01758265 0.21286233 MAHADEVAN_RESPONSE_TO_MP470_UP benign mesothelioma DOID_2645 0.01841265 0.08730664 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP endometriosis of uterus DOID_288 0.0188274 0.08853546 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP endometriosis DOID_289 0.01924199 0.08974337 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP leukodystrophy DOID_10579 0.02048476 0.09476285 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP proteinuria DOID_576 0.02048476 0.09399864 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP myeloma DOID_0070004 0.0208987 0.09513086 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP pre-eclampsia DOID_10591 0.0208987 0.09437585 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP brain cancer DOID_1319 0.0208987 0.09363274 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP neuritis DOID_1803 0.0208987 0.09290123 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP thyroid adenoma DOID_2891 0.0208987 0.09218107 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP bone marrow disease DOID_4961 0.0208987 0.09147198 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP vascular skin disease DOID_9540 0.0208987 0.09077372 0.0208987 0.2162065 MAHADEVAN_RESPONSE_TO_MP470_UP central nervous system cancer DOID_3620 0.02131246 0.09186963 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP integumentary system benign neoplasm DOID_0060121 0.02172606 0.09294835 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP skin benign neoplasm DOID_3165 0.02172606 0.09294835 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP B-cell lymphocytic neoplasm DOID_707 0.02255278 0.09576516 1.000 1.000 MAHADEVAN_RESPONSE_TO_MP470_UP giant cell tumor DOID_200 0.02337884 0.09853747 0.02337884 0.23337822 MAHADEVAN_RESPONSE_TO_MP470_UP malignant giant cell tumor DOID_2705 0.02337884 0.09853747 0.02337884 0.23337822 MAHADEVAN_RESPONSE_TO_MP470_UP giant cell glioblastoma DOID_3074 0.02337884 0.09853747 0.02337884 0.23337822 MAHADEVAN_RESPONSE_TO_MP470_UP bone marrow cancer DOID_4960 0.02379162 0.09953995 1.000 1.000 LEE_NEURAL_CREST_STEM_CELL_DN leiomyoma DOID_127 6.33E-07 3.602E-04 4.289E-05 8.134E-03 LEE_NEURAL_CREST_STEM_CELL_DN withdrawal disorder DOID_0060001 3.719E-06 1.058E-03 1.583E-04 0.01286908 LEE_NEURAL_CREST_STEM_CELL_DN oral cavity cancer DOID_8618 6.075E-06 1.152E-03 6.075E-06 3.457E-03 LEE_NEURAL_CREST_STEM_CELL_DN mixed glioma DOID_5076 1.791E-05 2.548E-03 1.791E-05 5.095E-03 LEE_NEURAL_CREST_STEM_CELL_DN transitional cell carcinoma DOID_2671 2.852E-05 3.245E-03 7.135E-04 0.02255564 LEE_NEURAL_CREST_STEM_CELL_DN cervix uteri carcinoma in situ DOID_8991 8.571E-05 8.128E-03 3.283E-03 0.06026331 LEE_NEURAL_CREST_STEM_CELL_DN salivary gland cancer DOID_8850 9.17E-05 7.454E-03 9.17E-05 0.01304503 LEE_NEURAL_CREST_STEM_CELL_DN uterine cancer DOID_363 1.045E-04 7.433E-03 1.045E-04 0.0118924 LEE_NEURAL_CREST_STEM_CELL_DN lung small cell carcinoma DOID_5409 1.415E-04 8.943E-03 1.415E-04 0.01341418 LEE_NEURAL_CREST_STEM_CELL_DN Gilles de la Tourette syndrome DOID_11119 1.629E-04 9.271E-03 1.629E-04 0.01158864 LEE_NEURAL_CREST_STEM_CELL_DN giant cell tumor DOID_200 1.764E-04 9.127E-03 1.764E-04 0.01115514 LEE_NEURAL_CREST_STEM_CELL_DN malignant giant cell tumor DOID_2705 1.764E-04 9.127E-03 1.764E-04 0.01115514 LEE_NEURAL_CREST_STEM_CELL_DN giant cell glioblastoma DOID_3074 1.764E-04 9.127E-03 1.764E-04 0.01115514 LEE_NEURAL_CREST_STEM_CELL_DN reproductive organ benign neoplasm DOID_0050622 1.959E-04 9.287E-03 5.638E-03 0.08911447 LEE_NEURAL_CREST_STEM_CELL_DN speech disorder DOID_92 1.989E-04 8.705E-03 1.989E-04 0.01131698 LEE_NEURAL_CREST_STEM_CELL_DN glioblastoma DOID_3068 2.275E-04 9.247E-03 2.275E-04 0.01176837 LEE_NEURAL_CREST_STEM_CELL_DN tic disorder DOID_2769 2.384E-04 9.042E-03 2.384E-04 0.01130287 LEE_NEURAL_CREST_STEM_CELL_DN psoriatic arthritis DOID_9008 2.814E-04 0.01000596 0.02474901 0.20408965 LEE_NEURAL_CREST_STEM_CELL_DN pre-malignant neoplasm DOID_0060071 2.873E-04 9.615E-03 7.244E-03 0.1084717 LEE_NEURAL_CREST_STEM_CELL_DN in situ carcinoma DOID_8719 2.873E-04 9.615E-03 7.244E-03 0.1084717 LEE_NEURAL_CREST_STEM_CELL_DN temporal lobe epilepsy DOID_3328 3.276E-04 0.01035482 3.276E-04 0.01433744 LEE_NEURAL_CREST_STEM_CELL_DN astrocytoma DOID_3069 3.713E-04 0.0111204 3.713E-04 0.01509198 LEE_NEURAL_CREST_STEM_CELL_DN communication disorder DOID_2033 3.778E-04 0.0107488 3.778E-04 0.01433173 LEE_NEURAL_CREST_STEM_CELL_DN pancreatic ductal carcinoma DOID_3587 3.867E-04 0.01047806 8.799E-03 0.12211001 LEE_NEURAL_CREST_STEM_CELL_DN bile duct disease DOID_4138 4.025E-04 0.01041003 9.032E-03 0.12236234 LEE_NEURAL_CREST_STEM_CELL_DN biliary tract disease DOID_9741 4.187E-04 0.01035802 9.268E-03 0.12263935 LEE_NEURAL_CREST_STEM_CELL_DN pancreatic carcinoma DOID_4905 4.353E-04 0.01032014 9.507E-03 0.12293919 LEE_NEURAL_CREST_STEM_CELL_DN syndrome DOID_225 4.698E-04 0.01069182 9.992E-03 0.1263476 LEE_NEURAL_CREST_STEM_CELL_DN contact dermatitis DOID_2773 5.438E-04 0.01190184 0.01099597 0.13312147 LEE_NEURAL_CREST_STEM_CELL_DN dental caries DOID_216 5.485E-04 0.01155856 5.485E-04 0.01950506 LEE_NEURAL_CREST_STEM_CELL_DN focal epilepsy DOID_2234 6.04E-04 0.01227501 6.04E-04 0.02021766 LEE_NEURAL_CREST_STEM_CELL_DN biliary tract cancer DOID_4607 6.04E-04 0.01185173 0.15126862 0.55530224 LEE_NEURAL_CREST_STEM_CELL_DN psoriasis DOID_8893 6.122E-04 0.01161206 0.03596691 0.25265646 LEE_NEURAL_CREST_STEM_CELL_DN mouth disease DOID_403 8.607E-04 0.01579741 8.607E-04 0.02577472 LEE_NEURAL_CREST_STEM_CELL_DN diabetic angiopathy DOID_11713 9.82E-04 0.01746175 0.04521787 0.28587743 LEE_NEURAL_CREST_STEM_CELL_DN acute pancreatitis DOID_2913 1.066E-03 0.01838209 0.04705753 0.28791112 LEE_NEURAL_CREST_STEM_CELL_DN morbid obesity DOID_11981 1.244E-03 0.02082256 1.244E-03 0.03539835 LEE_NEURAL_CREST_STEM_CELL_DN cleft lip DOID_9296 1.244E-03 0.02022763 1.244E-03 0.03371271 LEE_NEURAL_CREST_STEM_CELL_DN teeth hard tissue disease DOID_214 1.338E-03 0.02115215 1.338E-03 0.0346126 LEE_NEURAL_CREST_STEM_CELL_DN middle cerebral artery infarction DOID_3525 1.338E-03 0.02058047 0.05255555 0.29904108 LEE_NEURAL_CREST_STEM_CELL_DN multiple epiphyseal dysplasia DOID_12721 1.64E-03 0.02455912 0.05802228 0.32053086 LEE_NEURAL_CREST_STEM_CELL_DN female reproductive organ benign neoplasm DOID_0060086 1.747E-03 0.02549294 0.0598376 0.32120374 LEE_NEURAL_CREST_STEM_CELL_DN uterine benign neoplasm DOID_0060095 1.747E-03 0.02549294 0.0598376 0.32120374 LEE_NEURAL_CREST_STEM_CELL_DN uterine fibroid DOID_13223 1.747E-03 0.02549294 0.0598376 0.32120374 LEE_NEURAL_CREST_STEM_CELL_DN endometrial carcinoma DOID_2871 1.747E-03 0.02485562 1.747E-03 0.04322717 LEE_NEURAL_CREST_STEM_CELL_DN endometrial cancer DOID_1380 1.971E-03 0.02735907 1.971E-03 0.04673841 LEE_NEURAL_CREST_STEM_CELL_DN nephroblastoma DOID_2154 2.332E-03 0.03158834 2.332E-03 0.05306841 LEE_NEURAL_CREST_STEM_CELL_DN spindle cell carcinoma DOID_4015 2.332E-03 0.03085373 0.06886258 0.35299828 LEE_NEURAL_CREST_STEM_CELL_DN paraplegia DOID_607 2.332E-03 0.03015251 0.06886258 0.34675052 LEE_NEURAL_CREST_STEM_CELL_DN lymphoid leukemia DOID_10747 2.458E-03 0.03108169 2.458E-03 0.05379524 LEE_NEURAL_CREST_STEM_CELL_DN calcinosis DOID_182 2.721E-03 0.03365262 2.721E-03 0.05733409 LEE_NEURAL_CREST_STEM_CELL_DN cleft palate DOID_674 2.721E-03 0.03293661 2.721E-03 0.05528645 LEE_NEURAL_CREST_STEM_CELL_DN embryonal cancer DOID_688 2.721E-03 0.03225043 2.721E-03 0.05338002 LEE_NEURAL_CREST_STEM_CELL_DN intracranial arterial disease DOID_13089 3.138E-03 0.03643802 0.07957982 0.38701639 LEE_NEURAL_CREST_STEM_CELL_DN cerebral arterial disease DOID_3527 3.138E-03 0.03643802 0.07957982 0.38701639 LEE_NEURAL_CREST_STEM_CELL_DN adenoid cystic carcinoma DOID_4866 3.138E-03 0.03570926 3.138E-03 0.05951543 LEE_NEURAL_CREST_STEM_CELL_DN gallbladder cancer DOID_3121 3.738E-03 0.04170238 1.000 1.000 LEE_NEURAL_CREST_STEM_CELL_DN cerebral infarction DOID_3526 3.895E-03 0.04262573 0.08841784 0.41924793 LEE_NEURAL_CREST_STEM_CELL_DN calcium metabolism disease DOID_10575 4.729E-03 0.05077435 4.729E-03 0.08409502 LEE_NEURAL_CREST_STEM_CELL_DN movement disease DOID_480 4.729E-03 0.04983409 4.729E-03 0.08154669 LEE_NEURAL_CREST_STEM_CELL_DN orofacial cleft DOID_0050567 5.084E-03 0.05259656 5.084E-03 0.08508267 LEE_NEURAL_CREST_STEM_CELL_DN atrophic muscular disease DOID_913 5.266E-03 0.05350417 5.266E-03 0.08560667 LEE_NEURAL_CREST_STEM_CELL_DN muscular dystrophy DOID_9884 5.266E-03 0.05350417 5.266E-03 0.08560667 LEE_NEURAL_CREST_STEM_CELL_DN bile duct adenocarcinoma DOID_4896 5.451E-03 0.05440946 0.10411585 0.44880241 LEE_NEURAL_CREST_STEM_CELL_DN cholangiocarcinoma DOID_4947 5.451E-03 0.05440946 0.10411585 0.44880241 LEE_NEURAL_CREST_STEM_CELL_DN osteochondrodysplasia DOID_2256 5.638E-03 0.05531243 0.10584353 0.44944006 LEE_NEURAL_CREST_STEM_CELL_DN pustulosis of palm and sole DOID_4398 5.638E-03 0.05437493 0.10584353 0.44611087 LEE_NEURAL_CREST_STEM_CELL_DN congenital nervous system abnormality DOID_2490 6.022E-03 0.05711145 6.022E-03 0.09261316 LEE_NEURAL_CREST_STEM_CELL_DN bile duct cancer DOID_4606 6.219E-03 0.0580075 0.11100687 0.45116364 LEE_NEURAL_CREST_STEM_CELL_DN bile duct carcinoma DOID_4897 6.219E-03 0.0580075 0.11100687 0.45116364 LEE_NEURAL_CREST_STEM_CELL_DN mineral metabolism disease DOID_0050032 7.458E-03 0.06844347 7.458E-03 0.10880756 LEE_NEURAL_CREST_STEM_CELL_DN cholestasis DOID_13580 7.674E-03 0.06931231 0.12294059 0.48918317 LEE_NEURAL_CREST_STEM_CELL_DN tooth disease DOID_1091 8.116E-03 0.07215379 8.116E-03 0.11544607 LEE_NEURAL_CREST_STEM_CELL_DN allergic contact dermatitis DOID_3042 8.116E-03 0.07104374 0.1263211 0.4991438 LEE_NEURAL_CREST_STEM_CELL_DN brain infarction DOID_3454 8.341E-03 0.0719063 0.12800654 0.50231531 LEE_NEURAL_CREST_STEM_CELL_DN peripheral vascular disease DOID_341 9.268E-03 0.07870883 0.13471627 0.51792944 LEE_NEURAL_CREST_STEM_CELL_DN pancreatitis DOID_4989 0.01048879 0.08776647 0.14303186 0.53897437 LEE_NEURAL_CREST_STEM_CELL_DN bacterial pneumonia DOID_874 0.01048879 0.0864945 0.14303186 0.53542848 LEE_NEURAL_CREST_STEM_CELL_DN metabolic syndrome X DOID_14221 0.01099597 0.08938156 0.01099597 0.13601541 LEE_NEURAL_CREST_STEM_CELL_DN auditory system disease DOID_2742 0.01151381 0.09227266 0.14962754 0.55284462 LEE_NEURAL_CREST_STEM_CELL_DN alcohol abuse DOID_1574 0.0117767 0.09306862 0.0117767 0.13960293 LEE_NEURAL_CREST_STEM_CELL_DN bone development disease DOID_0080006 0.01204221 0.09386328 0.15290658 0.55771695 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP primitive neuroectodermal tumor DOID_168 2.962E-05 0.01685267 2.962E-05 0.01685267 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP pre-eclampsia DOID_10591 3.81E-05 0.01084037 1.927E-03 0.06852411 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP oral cavity cancer DOID_8618 6.927E-05 0.01313826 6.927E-05 0.01970739 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP neuroectodermal tumor DOID_171 7.997E-05 0.01137614 7.997E-05 0.01516818 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP pancreatic ductal carcinoma DOID_3587 1.184E-04 0.01347524 1.184E-04 0.01684406 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP pancreatic carcinoma DOID_4905 1.335E-04 0.01265801 1.335E-04 0.01518961 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP lipid metabolism disorder DOID_3146 1.672E-04 0.01359363 1.672E-04 0.01585924 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP chronic kidney failure DOID_784 1.86E-04 0.01322966 5.456E-03 0.11498255 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP tongue cancer DOID_8649 1.941E-04 0.01227282 1.941E-04 0.01577934 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP autoimmune hepatitis DOID_2048 3.383E-04 0.01925005 0.02680154 0.2629323 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP toxic shock syndrome DOID_14115 4.817E-04 0.02491766 4.817E-04 0.03426178 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP commensal bacterial infectious disease DOID_0050339 5.214E-04 0.0247242 5.214E-04 0.03296561 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP bronchiolitis obliterans DOID_2799 8.422E-04 0.03686402 0.04179942 0.29362804 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP metal metabolism disorder DOID_896 1.002E-03 0.04074274 1.002E-03 0.05703984 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP esophageal disease DOID_6050 1.059E-03 0.04016637 0.04674822 0.29555264 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP lymphoid leukemia DOID_10747 1.117E-03 0.03971521 1.117E-03 0.05776759 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP medullomyoblastoma DOID_3861 1.117E-03 0.03737903 1.117E-03 0.05295362 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP adult medulloblastoma DOID_3864 1.117E-03 0.03737903 1.117E-03 0.05295362 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP childhood medulloblastoma DOID_3869 1.117E-03 0.03737903 1.117E-03 0.05295362 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP refractive error DOID_9835 1.176E-03 0.03717999 1.176E-03 0.05147998 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP medulloblastoma DOID_3858 1.237E-03 0.03704645 1.237E-03 0.05027732 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP hepatitis DOID_2237 1.363E-03 0.03878491 0.05289902 0.30099543 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP peptic ulcer DOID_750 1.363E-03 0.03693801 0.05289902 0.29801528 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP uterine cancer DOID_363 1.705E-03 0.04408628 1.705E-03 0.06465988 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.082E-03 0.05151429 0.06508422 0.32485016 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP giant cell tumor DOID_200 2.41E-03 0.05714672 2.41E-03 0.08067772 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP malignant giant cell tumor DOID_2705 2.41E-03 0.05714672 2.41E-03 0.08067772 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP giant cell glioblastoma DOID_3074 2.41E-03 0.05714672 2.41E-03 0.08067772 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP atrophic muscular disease DOID_913 2.41E-03 0.05486085 2.41E-03 0.07619562 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP muscular dystrophy DOID_9884 2.41E-03 0.05486085 2.41E-03 0.07619562 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP reproductive organ benign neoplasm DOID_0050622 2.583E-03 0.05652836 2.583E-03 0.0773546 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP familial hyperlipidemia DOID_1168 2.671E-03 0.05629836 2.671E-03 0.07600278 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP glioblastoma DOID_3068 2.853E-03 0.05796793 2.853E-03 0.07729058 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP leukocyte disease DOID_9500 2.945E-03 0.05778711 2.945E-03 0.07617391 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP pre-malignant neoplasm DOID_0060071 3.33E-03 0.06315598 3.33E-03 0.08237737 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP in situ carcinoma DOID_8719 3.33E-03 0.06315598 3.33E-03 0.08237737 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP mineral metabolism disease DOID_0050032 3.429E-03 0.06294748 3.429E-03 0.08130716 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP uterine disease DOID_345 3.53E-03 0.06277661 0.0842618 0.3775194 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP astrocytoma DOID_3069 3.948E-03 0.06807894 3.948E-03 0.0898642 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP diabetic retinopathy DOID_8947 4.388E-03 0.07343517 0.09370555 0.40089064 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP mixed glioma DOID_5076 4.849E-03 0.07883697 4.849E-03 0.10612669 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP metabolic syndrome X DOID_14221 5.088E-03 0.08041995 0.10072568 0.41834243 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP female reproductive system disease DOID_229 5.209E-03 0.08011263 0.10189051 0.41709139 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP retinal vascular disease DOID_2462 5.708E-03 0.08547094 0.10653508 0.42991817 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP nervous system cancer DOID_3093 6.361E-03 0.09280399 6.361E-03 0.1292627 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP lymphoblastic leukemia DOID_1037 6.768E-03 0.09627743 6.768E-03 0.13279646 GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.907E-03 0.09584903 6.907E-03 0.13099368 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP neuroectodermal tumor DOID_171 5.22E-07 2.97E-04 3.711E-05 5.278E-03 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP nervous system cancer DOID_3093 2.25E-06 6.401E-04 1.097E-04 0.01248374 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP autonomic nervous system neoplasm DOID_2621 5.947E-06 1.128E-03 5.701E-04 0.03243605 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP neuroblastoma DOID_769 5.947E-06 1.128E-03 5.701E-04 0.03243605 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP medullomyoblastoma DOID_3861 7.65E-06 1.088E-03 7.65E-06 4.353E-03 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP adult medulloblastoma DOID_3864 7.65E-06 1.088E-03 7.65E-06 4.353E-03 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP childhood medulloblastoma DOID_3869 7.65E-06 1.088E-03 7.65E-06 4.353E-03 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP medulloblastoma DOID_3858 8.947E-06 1.018E-03 8.947E-06 2.545E-03 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP peripheral nervous system neoplasm DOID_1192 9.646E-06 9.148E-04 7.826E-04 0.04048419 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP primitive neuroectodermal tumor DOID_168 1.369E-05 1.113E-03 1.369E-05 2.596E-03 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP dilated cardiomyopathy DOID_12930 1.284E-04 9.129E-03 1.284E-04 0.01217187 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP granulosa cell tumor DOID_2999 1.655E-04 0.01046306 1.655E-04 0.01345251 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP sex cord-gonadal stromal tumor DOID_192 1.838E-04 0.01045644 1.838E-04 0.01307055 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP heart conduction disease DOID_10273 2.442E-04 0.0126338 2.442E-04 0.01544131 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP sarcoma DOID_1115 4.181E-04 0.01982402 0.02964862 0.31830313 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP spindle cell carcinoma DOID_4015 6.373E-04 0.02789285 0.03644248 0.34559623 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP cervix uteri carcinoma in situ DOID_8991 9.012E-04 0.03662724 9.012E-04 0.04273179 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP gallbladder cancer DOID_3121 1.028E-03 0.03898994 0.04606772 0.36406296 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP bile duct adenocarcinoma DOID_4896 1.508E-03 0.05362766 0.05559931 0.39545013 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP cholangiocarcinoma DOID_4947 1.508E-03 0.05362766 0.05559931 0.39545013 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP bile duct cancer DOID_4606 1.725E-03 0.05772736 0.05938593 0.39753641 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP bile duct carcinoma DOID_4897 1.725E-03 0.05772736 0.05938593 0.39753641 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP pre-malignant neoplasm DOID_0060071 2.015E-03 0.06370362 2.015E-03 0.08820502 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP in situ carcinoma DOID_8719 2.015E-03 0.06370362 2.015E-03 0.08820502 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP pancreatic ductal carcinoma DOID_3587 2.458E-03 0.07361454 0.0706573 0.44671113 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP pancreatic carcinoma DOID_4905 2.661E-03 0.07569813 0.07345452 0.45430026 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP electroclinical syndrome DOID_0050701 2.943E-03 0.07973388 2.943E-03 0.11960082 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP biliary tract cancer DOID_4607 3.314E-03 0.08571406 0.08179711 0.47492403 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP transitional cell carcinoma DOID_2671 3.706E-03 0.09168812 3.706E-03 0.14058846 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP amino acid metabolic disorder DOID_9252 3.787E-03 0.08978576 3.787E-03 0.13467865 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP Human immunodeficiency virus infectious disease DOID_526 3.869E-03 0.08805428 3.869E-03 0.12949159 DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP lymphoma DOID_0060058 4.035E-03 0.08829816 4.035E-03 0.12754178 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP microphthalmia DOID_10629 2.765E-05 0.01573182 2.765E-05 0.01573182 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP embryonal cancer DOID_688 1.13E-04 0.03214433 1.13E-04 0.03214433 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP adenoid cystic carcinoma DOID_4866 1.307E-04 0.02479183 1.307E-04 0.02479183 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP salivary gland cancer DOID_8850 1.432E-04 0.02037599 1.432E-04 0.02037599 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP lung small cell carcinoma DOID_5409 1.915E-04 0.02179828 1.915E-04 0.02179828 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP oral cavity cancer DOID_8618 2.638E-04 0.02501815 2.638E-04 0.02501815 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP aneurysm disease DOID_2403 4.423E-04 0.03595529 0.03081117 0.60453643 SMID_BREAST_CANCER_ERBB2_UP cholestasis DOID_13580 1.416E-07 8.057E-05 6.662E-06 3.791E-03 SMID_BREAST_CANCER_ERBB2_UP bile duct disease DOID_4138 2.17E-07 6.175E-05 9.338E-06 2.657E-03 SMID_BREAST_CANCER_ERBB2_UP biliary tract disease DOID_9741 2.322E-07 4.405E-05 9.851E-06 1.868E-03 SMID_BREAST_CANCER_ERBB2_UP bile duct adenocarcinoma DOID_4896 3.279E-06 4.664E-04 4.612E-03 0.16402 SMID_BREAST_CANCER_ERBB2_UP cholangiocarcinoma DOID_4947 3.279E-06 4.664E-04 4.612E-03 0.16402 SMID_BREAST_CANCER_ERBB2_UP bile duct cancer DOID_4606 4.309E-06 4.904E-04 5.264E-03 0.1664139 SMID_BREAST_CANCER_ERBB2_UP bile duct carcinoma DOID_4897 4.309E-06 4.904E-04 5.264E-03 0.1664139 SMID_BREAST_CANCER_ERBB2_UP biliary tract cancer DOID_4607 1.619E-05 1.536E-03 9.994E-03 0.22746937 SMID_BREAST_CANCER_ERBB2_UP chronic kidney failure DOID_784 1.619E-05 1.316E-03 1.619E-05 2.304E-03 SMID_BREAST_CANCER_ERBB2_UP gestational diabetes DOID_11714 1.865E-05 1.327E-03 1.211E-03 0.07657828 SMID_BREAST_CANCER_ERBB2_UP pre-eclampsia DOID_10591 9.743E-05 6.16E-03 0.08469715 0.62587895 SMID_BREAST_CANCER_ERBB2_UP hemolytic anemia DOID_583 1.034E-04 5.883E-03 0.0863169 0.62967072 SMID_BREAST_CANCER_ERBB2_UP normocytic anemia DOID_720 1.034E-04 5.883E-03 0.0863169 0.62967072 SMID_BREAST_CANCER_ERBB2_UP bilirubin metabolic disorder DOID_2741 1.372E-04 7.097E-03 1.372E-04 0.01561286 SMID_BREAST_CANCER_ERBB2_UP parasitic protozoa infectious disease DOID_2789 1.518E-04 7.2E-03 4.771E-03 0.15970353 SMID_BREAST_CANCER_ERBB2_UP migraine without aura DOID_12783 1.675E-04 7.331E-03 0.01927191 0.36552392 SMID_BREAST_CANCER_ERBB2_UP parasitic infectious disease DOID_1398 2.435E-04 9.898E-03 6.501E-03 0.18496288 SMID_BREAST_CANCER_ERBB2_UP bacterial meningitis DOID_9470 2.762E-04 0.01047624 0.02446408 0.3866684 SMID_BREAST_CANCER_ERBB2_UP hemolytic-uremic syndrome DOID_12554 3.634E-04 0.01292185 1.000 1.000 SMID_BREAST_CANCER_ERBB2_UP bone resorption disease DOID_0080011 3.79E-04 0.01268458 8.684E-03 0.22460241 SMID_BREAST_CANCER_ERBB2_UP osteoporosis DOID_11476 3.79E-04 0.01268458 8.684E-03 0.22460241 SMID_BREAST_CANCER_ERBB2_UP pancreatitis DOID_4989 3.932E-04 0.01243095 8.897E-03 0.22009628 SMID_BREAST_CANCER_ERBB2_UP urinary system benign neoplasm DOID_731 4.113E-04 0.01231836 1.000 1.000 SMID_BREAST_CANCER_ERBB2_UP primary immunodeficiency disease DOID_612 5.735E-04 0.01631504 5.735E-04 0.05438347 SMID_BREAST_CANCER_ERBB2_UP pulmonary embolism DOID_9477 7.6E-04 0.02059183 7.6E-04 0.06177549 SMID_BREAST_CANCER_ERBB2_UP meningitis DOID_9471 8.281E-04 0.02141829 0.04157652 0.4463592 SMID_BREAST_CANCER_ERBB2_UP B cell deficiency DOID_2115 1.129E-03 0.02793066 1.129E-03 0.08030064 SMID_BREAST_CANCER_ERBB2_UP migraine DOID_6364 1.211E-03 0.02871686 0.0500215 0.49933744 SMID_BREAST_CANCER_ERBB2_UP malaria DOID_12365 1.296E-03 0.02950369 1.296E-03 0.07375921 SMID_BREAST_CANCER_ERBB2_UP renal tubular transport disease DOID_447 1.296E-03 0.02836893 1.296E-03 0.06705383 SMID_BREAST_CANCER_ERBB2_UP bronchiolitis obliterans DOID_2799 1.568E-03 0.0330455 0.05672467 0.537939 SMID_BREAST_CANCER_ERBB2_UP myocarditis DOID_820 1.865E-03 0.03789139 1.865E-03 0.08841323 SMID_BREAST_CANCER_ERBB2_UP hepatitis C DOID_1883 1.969E-03 0.03863132 0.06338125 0.56349893 SMID_BREAST_CANCER_ERBB2_UP multiple myeloma DOID_9538 2.298E-03 0.04358662 1.000 1.000 SMID_BREAST_CANCER_ERBB2_UP pulmonary emphysema DOID_9675 2.774E-03 0.05092513 0.07491909 0.60040794 SMID_BREAST_CANCER_ERBB2_UP nephrotic syndrome DOID_1184 3.029E-03 0.05385238 3.029E-03 0.1325597 SMID_BREAST_CANCER_ERBB2_UP diabetic autonomic neuropathy DOID_11503 3.16E-03 0.05447939 3.16E-03 0.12841572 SMID_BREAST_CANCER_ERBB2_UP autonomic neuropathy DOID_11504 3.16E-03 0.05447939 3.16E-03 0.12841572 SMID_BREAST_CANCER_ERBB2_UP diabetic polyneuropathy DOID_12785 3.16E-03 0.05447939 3.16E-03 0.12841572 SMID_BREAST_CANCER_ERBB2_UP diabetic neuropathy DOID_9743 3.16E-03 0.05447939 3.16E-03 0.12841572 SMID_BREAST_CANCER_ERBB2_UP myeloma DOID_0070004 3.568E-03 0.05971673 1.000 1.000 SMID_BREAST_CANCER_ERBB2_UP autonomic nervous system disease DOID_11465 3.568E-03 0.05801054 3.568E-03 0.13535793 SMID_BREAST_CANCER_ERBB2_UP bone marrow cancer DOID_4960 4.612E-03 0.07289778 1.000 1.000 SMID_BREAST_CANCER_ERBB2_UP reproductive organ benign neoplasm DOID_0050622 4.771E-03 0.0733773 0.09757635 0.66892701 SMID_BREAST_CANCER_ERBB2_UP carotid artery disease DOID_3407 5.78E-03 0.08654439 5.78E-03 0.17308878 SMID_BREAST_CANCER_ERBB2_UP pre-malignant neoplasm DOID_0060071 6.136E-03 0.08951772 0.11027699 0.70502928 SMID_BREAST_CANCER_ERBB2_UP in situ carcinoma DOID_8719 6.136E-03 0.08951772 0.11027699 0.70502928 TAVOR_CEBPA_TARGETS_UP silicosis DOID_10325 4.75E-07 2.703E-04 1.103E-04 0.01254777 TAVOR_CEBPA_TARGETS_UP acute pancreatitis DOID_2913 1.939E-06 5.517E-04 1.939E-06 1.103E-03 TAVOR_CEBPA_TARGETS_UP pleural disease DOID_1532 5.481E-06 1.04E-03 5.404E-04 0.0204978 TAVOR_CEBPA_TARGETS_UP pneumoconiosis DOID_10316 6.498E-06 9.244E-04 6.041E-04 0.02021963 TAVOR_CEBPA_TARGETS_UP nephroblastoma DOID_2154 6.498E-06 7.395E-04 6.498E-06 1.849E-03 TAVOR_CEBPA_TARGETS_UP multiple myeloma DOID_9538 8.246E-06 7.82E-04 7.062E-04 0.02232386 TAVOR_CEBPA_TARGETS_UP uveitis DOID_13141 8.891E-06 7.227E-04 7.42E-04 0.02221983 TAVOR_CEBPA_TARGETS_UP uveal disease DOID_3480 1.262E-05 8.975E-04 9.336E-04 0.02414706 TAVOR_CEBPA_TARGETS_UP myeloma DOID_0070004 1.625E-05 1.027E-03 1.102E-03 0.02727019 TAVOR_CEBPA_TARGETS_UP sarcoidosis DOID_11335 2.289E-05 1.302E-03 0.05325049 0.3029953 TAVOR_CEBPA_TARGETS_UP bone marrow cancer DOID_4960 2.414E-05 1.249E-03 1.43E-03 0.03254666 TAVOR_CEBPA_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 2.962E-05 1.404E-03 0.05786853 0.31063391 TAVOR_CEBPA_TARGETS_UP oral cavity cancer DOID_8618 2.962E-05 1.296E-03 1.636E-03 0.03579524 TAVOR_CEBPA_TARGETS_UP acute kidney failure DOID_3021 4.15E-05 1.687E-03 1.000 1.000 TAVOR_CEBPA_TARGETS_UP familial adenomatous polyposis DOID_0050424 5.069E-05 1.923E-03 0.01068484 0.17370493 TAVOR_CEBPA_TARGETS_UP adrenoleukodystrophy DOID_10588 5.069E-05 1.803E-03 1.000 1.000 TAVOR_CEBPA_TARGETS_UP diarrhea DOID_13250 6.079E-05 2.035E-03 6.079E-05 0.01153047 TAVOR_CEBPA_TARGETS_UP bone resorption disease DOID_0080011 6.43E-05 2.032E-03 2.724E-03 0.05343759 TAVOR_CEBPA_TARGETS_UP osteoporosis DOID_11476 6.43E-05 2.032E-03 2.724E-03 0.05343759 TAVOR_CEBPA_TARGETS_UP pancreatitis DOID_4989 6.676E-05 1.999E-03 6.676E-05 9.496E-03 TAVOR_CEBPA_TARGETS_UP ureteral obstruction DOID_5199 1.404E-04 3.995E-03 1.404E-04 0.01331561 TAVOR_CEBPA_TARGETS_UP coronary restenosis DOID_4247 1.924E-04 5.212E-03 0.02030188 0.21003214 TAVOR_CEBPA_TARGETS_UP funisitis DOID_0050698 2.115E-04 5.469E-03 2.115E-04 0.01718963 TAVOR_CEBPA_TARGETS_UP urinary tract obstruction DOID_5200 2.315E-04 5.726E-03 2.315E-04 0.01646326 TAVOR_CEBPA_TARGETS_UP ureteral disease DOID_1426 2.524E-04 5.983E-03 2.524E-04 0.01595456 TAVOR_CEBPA_TARGETS_UP myositis DOID_633 3.203E-04 7.291E-03 0.02602837 0.22439614 TAVOR_CEBPA_TARGETS_UP fragments of torsion dystonia DOID_531 3.448E-04 7.545E-03 3.448E-04 0.01961742 TAVOR_CEBPA_TARGETS_UP lung adenocarcinoma DOID_3910 3.701E-04 7.799E-03 0.02792996 0.22072426 TAVOR_CEBPA_TARGETS_UP pleurisy DOID_10247 3.963E-04 8.053E-03 3.963E-04 0.02049806 TAVOR_CEBPA_TARGETS_UP coronary stenosis DOID_4248 3.963E-04 7.775E-03 0.0288794 0.22205915 TAVOR_CEBPA_TARGETS_UP central nervous system hereditary degenerative disease DOID_481 3.963E-04 7.516E-03 3.963E-04 0.01878989 TAVOR_CEBPA_TARGETS_UP dystonic disease DOID_544 4.233E-04 7.77E-03 4.233E-04 0.01852929 TAVOR_CEBPA_TARGETS_UP bronchiolitis obliterans DOID_2799 4.801E-04 8.537E-03 0.0317223 0.23441543 TAVOR_CEBPA_TARGETS_UP abdominal aortic aneurysm DOID_7693 4.801E-04 8.278E-03 1.000 1.000 TAVOR_CEBPA_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 5.098E-04 8.532E-03 5.098E-04 0.02071969 TAVOR_CEBPA_TARGETS_UP papilloma DOID_2615 5.718E-04 9.296E-03 0.0345571 0.24889863 TAVOR_CEBPA_TARGETS_UP hair disease DOID_421 5.718E-04 9.038E-03 5.718E-04 0.02033458 TAVOR_CEBPA_TARGETS_UP hyperthyroidism DOID_7998 6.041E-04 9.29E-03 0.03550024 0.24047188 TAVOR_CEBPA_TARGETS_UP pulmonary sarcoidosis DOID_13406 7.062E-04 0.01057446 0.03832428 0.25356415 TAVOR_CEBPA_TARGETS_UP hepatitis DOID_2237 7.786E-04 0.01135932 1.000 1.000 TAVOR_CEBPA_TARGETS_UP adult respiratory distress syndrome DOID_11394 8.161E-04 0.01160846 0.04114028 0.26302043 TAVOR_CEBPA_TARGETS_UP adenoid cystic carcinoma DOID_4866 8.161E-04 0.01132533 8.161E-04 0.02321692 TAVOR_CEBPA_TARGETS_UP salivary gland cancer DOID_8850 8.936E-04 0.01210596 8.936E-04 0.02421192 TAVOR_CEBPA_TARGETS_UP leukodystrophy DOID_10579 1.059E-03 0.01401152 1.000 1.000 TAVOR_CEBPA_TARGETS_UP thyroid adenoma DOID_2891 1.102E-03 0.01425487 0.04767977 0.28557673 TAVOR_CEBPA_TARGETS_UP hemolytic anemia DOID_583 1.147E-03 0.01449809 0.04861043 0.28811809 TAVOR_CEBPA_TARGETS_UP normocytic anemia DOID_720 1.147E-03 0.01449809 0.04861043 0.28811809 TAVOR_CEBPA_TARGETS_UP integumentary system benign neoplasm DOID_0060121 1.192E-03 0.01474118 0.04954021 0.29060186 TAVOR_CEBPA_TARGETS_UP skin benign neoplasm DOID_3165 1.192E-03 0.01474118 0.04954021 0.29060186 TAVOR_CEBPA_TARGETS_UP aortic aneurysm DOID_3627 1.238E-03 0.01498412 1.000 1.000 TAVOR_CEBPA_TARGETS_UP movement disease DOID_480 1.238E-03 0.01467195 1.238E-03 0.02934391 TAVOR_CEBPA_TARGETS_UP integumentary system cancer DOID_0060122 1.48E-03 0.01718794 0.05510034 0.31041679 TAVOR_CEBPA_TARGETS_UP skin cancer DOID_4159 1.48E-03 0.01718794 0.05510034 0.31041679 TAVOR_CEBPA_TARGETS_UP leukocyte disease DOID_9500 1.689E-03 0.01922218 0.0587895 0.3126283 TAVOR_CEBPA_TARGETS_UP carotid artery disease DOID_3407 1.799E-03 0.02006635 1.000 1.000 TAVOR_CEBPA_TARGETS_UP respiratory failure DOID_11162 1.855E-03 0.02029279 0.06154717 0.32426243 TAVOR_CEBPA_TARGETS_UP endocrine pancreas disease DOID_1428 1.969E-03 0.02113789 1.000 1.000 TAVOR_CEBPA_TARGETS_UP cerebral degeneration DOID_1443 2.027E-03 0.02136202 1.000 1.000 TAVOR_CEBPA_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 2.207E-03 0.02283742 0.06703895 0.33169706 TAVOR_CEBPA_TARGETS_UP bile duct disease DOID_4138 2.395E-03 0.02433442 2.395E-03 0.05047139 TAVOR_CEBPA_TARGETS_UP male reproductive system disease DOID_48 2.395E-03 0.0239075 0.0697731 0.33644824 TAVOR_CEBPA_TARGETS_UP biliary tract disease DOID_9741 2.459E-03 0.02412421 2.459E-03 0.04997158 TAVOR_CEBPA_TARGETS_UP cystic fibrosis DOID_1485 2.656E-03 0.02561667 0.0734065 0.34806917 TAVOR_CEBPA_TARGETS_UP aneurysm disease DOID_2403 2.724E-03 0.02582817 1.000 1.000 TAVOR_CEBPA_TARGETS_UP bacterial pneumonia DOID_874 2.792E-03 0.02604019 0.07521803 0.35371121 TAVOR_CEBPA_TARGETS_UP transitional cell carcinoma DOID_2671 3.517E-03 0.0322728 3.517E-03 0.06669712 TAVOR_CEBPA_TARGETS_UP primary immunodeficiency disease DOID_612 3.593E-03 0.03245437 3.593E-03 0.06595565 TAVOR_CEBPA_TARGETS_UP amino acid metabolic disorder DOID_9252 3.593E-03 0.03194727 0.08511997 0.38136426 TAVOR_CEBPA_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.989E-03 0.03492057 0.08958667 0.39515362 TAVOR_CEBPA_TARGETS_UP dilated cardiomyopathy DOID_12930 4.071E-03 0.03509401 0.09047747 0.39298991 TAVOR_CEBPA_TARGETS_UP retinal vascular occlusion DOID_1729 9.718E-03 0.0825313 9.718E-03 0.17279991 TAVOR_CEBPA_TARGETS_UP transient cerebral ischemia DOID_224 9.718E-03 0.08131761 1.000 1.000 TAVOR_CEBPA_TARGETS_UP keratitis DOID_4677 9.718E-03 0.08013909 9.718E-03 0.16756355 TAVOR_CEBPA_TARGETS_UP alopecia areata DOID_986 9.718E-03 0.07899425 9.718E-03 0.16263521 TAVOR_CEBPA_TARGETS_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.01068484 0.08562919 0.01068484 0.16887979 TAVOR_CEBPA_TARGETS_UP neuronal ceroid lipofuscinosis DOID_14503 0.01068484 0.0844399 1.000 1.000 TAVOR_CEBPA_TARGETS_UP invasive lobular carcinoma DOID_3457 0.01068484 0.08328318 0.01068484 0.16431547 TAVOR_CEBPA_TARGETS_UP common cold DOID_10459 0.01165066 0.08958413 0.01165066 0.1744533 TAVOR_CEBPA_TARGETS_UP osteopetrosis DOID_13533 0.01165066 0.08838967 0.01165066 0.16998014 TAVOR_CEBPA_TARGETS_UP stomach disease DOID_76 0.01165066 0.08722665 0.01165066 0.16573063 TAVOR_CEBPA_TARGETS_UP berylliosis DOID_10322 0.01261556 0.09322411 1.000 1.000 TAVOR_CEBPA_TARGETS_UP osteogenesis imperfecta DOID_12347 0.01261556 0.09202892 0.01261556 0.17507942 TAVOR_CEBPA_TARGETS_UP newborn respiratory distress syndrome DOID_12716 0.01261556 0.090864 1.000 1.000 TAVOR_CEBPA_TARGETS_UP viral pneumonia DOID_10533 0.01357955 0.09658457 1.000 1.000 CAIRO_HEPATOBLASTOMA_CLASSES_DN diabetic retinopathy DOID_8947 1.784E-07 1.015E-04 1.095E-04 5.192E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN bronchitis DOID_6132 2.352E-07 6.691E-05 2.352E-07 1.338E-04 CAIRO_HEPATOBLASTOMA_CLASSES_DN lipid metabolism disorder DOID_3146 2.813E-07 5.336E-05 2.813E-07 8.004E-05 CAIRO_HEPATOBLASTOMA_CLASSES_DN alcohol abuse DOID_1574 3.486E-07 4.959E-05 3.486E-07 6.612E-05 CAIRO_HEPATOBLASTOMA_CLASSES_DN retinal vascular disease DOID_2462 4.004E-07 4.557E-05 1.848E-04 7.012E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN alcohol-related neurodevelopmental disorder DOID_0050667 7.18E-07 6.809E-05 2.698E-04 7.676E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN hypersensitivity reaction type I disease DOID_1205 7.633E-07 6.205E-05 7.633E-07 1.086E-04 CAIRO_HEPATOBLASTOMA_CLASSES_DN diffuse large B-cell lymphoma DOID_0050745 2.278E-06 1.62E-04 1.118E-04 4.891E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN contact dermatitis DOID_2773 7.112E-06 4.497E-04 7.112E-06 8.094E-04 CAIRO_HEPATOBLASTOMA_CLASSES_DN uveitis DOID_13141 9.427E-06 5.364E-04 9.427E-06 8.94E-04 CAIRO_HEPATOBLASTOMA_CLASSES_DN peptic ulcer DOID_750 1.039E-05 5.376E-04 3.406E-04 8.425E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN uveal disease DOID_3480 1.5E-05 7.114E-04 1.5E-05 1.219E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN dilated cardiomyopathy DOID_12930 1.617E-05 7.075E-04 0.03921929 0.17710935 CAIRO_HEPATOBLASTOMA_CLASSES_DN diabetic autonomic neuropathy DOID_11503 1.636E-05 6.648E-04 0.0101016 0.08211154 CAIRO_HEPATOBLASTOMA_CLASSES_DN autonomic neuropathy DOID_11504 1.636E-05 6.648E-04 0.0101016 0.08211154 CAIRO_HEPATOBLASTOMA_CLASSES_DN diabetic polyneuropathy DOID_12785 1.636E-05 6.648E-04 0.0101016 0.08211154 CAIRO_HEPATOBLASTOMA_CLASSES_DN diabetic neuropathy DOID_9743 1.636E-05 6.648E-04 0.0101016 0.08211154 CAIRO_HEPATOBLASTOMA_CLASSES_DN autonomic nervous system disease DOID_11465 2.096E-05 7.952E-04 0.01137573 0.08630389 CAIRO_HEPATOBLASTOMA_CLASSES_DN neuritis DOID_1803 2.096E-05 7.455E-04 2.096E-05 1.491E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN B-cell lymphocytic neoplasm DOID_707 2.85E-05 9.54E-04 7.154E-04 0.01356904 CAIRO_HEPATOBLASTOMA_CLASSES_DN familial hyperlipidemia DOID_1168 4.051E-05 1.281E-03 4.051E-05 2.561E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN familial hypercholesterolemia DOID_13810 4.788E-05 1.434E-03 4.788E-05 2.724E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN cholestasis DOID_13580 7.089E-05 2.017E-03 0.02037579 0.12601986 CAIRO_HEPATOBLASTOMA_CLASSES_DN allergic contact dermatitis DOID_3042 7.942E-05 2.152E-03 7.942E-05 4.108E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN bile duct disease DOID_4138 9.868E-05 2.552E-03 0.02386023 0.13996362 CAIRO_HEPATOBLASTOMA_CLASSES_DN peripheral vascular disease DOID_341 1.04E-04 2.572E-03 1.854E-03 0.02573443 CAIRO_HEPATOBLASTOMA_CLASSES_DN biliary tract disease DOID_9741 1.04E-04 2.465E-03 0.02446313 0.14203594 CAIRO_HEPATOBLASTOMA_CLASSES_DN autoimmune disease of endocrine system DOID_0060005 1.368E-04 3.114E-03 1.368E-04 5.561E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN corneal disease DOID_10124 1.506E-04 3.297E-03 4.783E-03 0.0469209 CAIRO_HEPATOBLASTOMA_CLASSES_DN allergic rhinitis DOID_4481 1.809E-04 3.812E-03 5.387E-03 0.05108615 CAIRO_HEPATOBLASTOMA_CLASSES_DN primary immunodeficiency disease DOID_612 2.198E-04 4.466E-03 2.198E-04 7.815E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN amino acid metabolic disorder DOID_9252 2.198E-04 4.312E-03 2.198E-04 7.356E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN Human immunodeficiency virus infectious disease DOID_526 2.292E-04 4.347E-03 2.292E-04 7.245E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN pneumoconiosis DOID_10316 2.332E-04 4.281E-03 6.355E-03 0.05927969 CAIRO_HEPATOBLASTOMA_CLASSES_DN hyperthyroidism DOID_7998 2.332E-04 4.147E-03 2.332E-04 6.984E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN lymphoma DOID_0060058 2.489E-04 4.292E-03 3.522E-03 0.04089365 CAIRO_HEPATOBLASTOMA_CLASSES_DN Crohn's disease DOID_8778 2.698E-04 4.515E-03 3.736E-03 0.04088384 CAIRO_HEPATOBLASTOMA_CLASSES_DN refractive error DOID_9835 2.73E-04 4.439E-03 2.73E-04 7.398E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN ulcerative colitis DOID_8577 3.153E-04 4.984E-03 3.153E-04 8.156E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN endometriosis of uterus DOID_288 4.18E-04 6.428E-03 4.18E-04 9.91E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN endometriosis DOID_289 4.461E-04 6.68E-03 4.461E-04 0.01015354 CAIRO_HEPATOBLASTOMA_CLASSES_DN angioedema DOID_1558 4.545E-04 6.631E-03 4.545E-04 9.946E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN bilirubin metabolic disorder DOID_2741 4.545E-04 6.465E-03 4.545E-04 9.578E-03 CAIRO_HEPATOBLASTOMA_CLASSES_DN cataract DOID_83 5.059E-04 7.021E-03 0.0105188 0.08198899 CAIRO_HEPATOBLASTOMA_CLASSES_DN lens disease DOID_110 5.706E-04 7.731E-03 0.01137573 0.08747016 CAIRO_HEPATOBLASTOMA_CLASSES_DN brain cancer DOID_1319 5.706E-04 7.551E-03 5.706E-04 0.01159615 CAIRO_HEPATOBLASTOMA_CLASSES_DN central nervous system cancer DOID_3620 6.049E-04 7.822E-03 6.049E-04 0.01186823 CAIRO_HEPATOBLASTOMA_CLASSES_DN glaucoma DOID_1686 6.404E-04 8.098E-03 0.01226236 0.08832001 CAIRO_HEPATOBLASTOMA_CLASSES_DN pituitary cancer DOID_1785 6.638E-04 8.21E-03 0.03794596 0.17844007 CAIRO_HEPATOBLASTOMA_CLASSES_DN pituitary carcinoma DOID_4916 6.638E-04 8.21E-03 0.03794596 0.17844007 CAIRO_HEPATOBLASTOMA_CLASSES_DN atrophic muscular disease DOID_913 7.958E-04 9.634E-03 7.958E-04 0.01460654 CAIRO_HEPATOBLASTOMA_CLASSES_DN muscular dystrophy DOID_9884 7.958E-04 9.634E-03 7.958E-04 0.01460654 CAIRO_HEPATOBLASTOMA_CLASSES_DN pustulosis of palm and sole DOID_4398 8.817E-04 0.01045159 0.01509629 0.10225939 CAIRO_HEPATOBLASTOMA_CLASSES_DN alcohol dependence DOID_0050741 9.113E-04 0.01058252 9.113E-04 0.01620448 CAIRO_HEPATOBLASTOMA_CLASSES_DN hypersensitivity reaction type IV disease DOID_2916 1.021E-03 0.01162113 0.01660868 0.11118044 CAIRO_HEPATOBLASTOMA_CLASSES_DN corneal dystrophy DOID_2566 1.049E-03 0.01170707 1.049E-03 0.01809274 CAIRO_HEPATOBLASTOMA_CLASSES_DN varicose veins DOID_799 1.049E-03 0.01148193 0.04720712 0.19186321 CAIRO_HEPATOBLASTOMA_CLASSES_DN pituitary adenoma DOID_3829 1.197E-03 0.01284753 0.05027448 0.19593273 CAIRO_HEPATOBLASTOMA_CLASSES_DN vein disease DOID_866 1.197E-03 0.01260962 0.05027448 0.19328499 CAIRO_HEPATOBLASTOMA_CLASSES_DN respiratory failure DOID_11162 1.228E-03 0.01270269 0.01872116 0.11968919 CAIRO_HEPATOBLASTOMA_CLASSES_DN Graves' disease DOID_12361 1.353E-03 0.01375153 1.353E-03 0.02264958 CAIRO_HEPATOBLASTOMA_CLASSES_DN uterine disease DOID_345 1.399E-03 0.01396475 1.399E-03 0.02274259 CAIRO_HEPATOBLASTOMA_CLASSES_DN hyperglycemia DOID_4195 1.459E-03 0.01431432 1.459E-03 0.02306196 CAIRO_HEPATOBLASTOMA_CLASSES_DN ureteral obstruction DOID_5199 1.519E-03 0.01465296 0.05637985 0.20967408 CAIRO_HEPATOBLASTOMA_CLASSES_DN endocrine organ benign neoplasm DOID_0060089 1.584E-03 0.01502421 0.02208924 0.13230292 CAIRO_HEPATOBLASTOMA_CLASSES_DN brain infarction DOID_3454 1.584E-03 0.01477792 1.584E-03 0.02436359 CAIRO_HEPATOBLASTOMA_CLASSES_DN conduct disorder DOID_12995 1.695E-03 0.01555165 1.695E-03 0.02537375 CAIRO_HEPATOBLASTOMA_CLASSES_DN Down syndrome DOID_14250 1.695E-03 0.0153048 1.695E-03 0.02472314 CAIRO_HEPATOBLASTOMA_CLASSES_DN agammaglobulinemia DOID_2583 1.695E-03 0.01506566 1.695E-03 0.02410506 CAIRO_HEPATOBLASTOMA_CLASSES_DN nephrosis DOID_2527 1.784E-03 0.01561959 0.02386023 0.14142157 CAIRO_HEPATOBLASTOMA_CLASSES_DN blood protein disease DOID_620 1.879E-03 0.01619825 1.879E-03 0.0254544 CAIRO_HEPATOBLASTOMA_CLASSES_DN syndrome DOID_225 2.075E-03 0.01761842 2.075E-03 0.02745195 CAIRO_HEPATOBLASTOMA_CLASSES_DN bone resorption disease DOID_0080011 2.151E-03 0.01800252 0.02693638 0.15326799 CAIRO_HEPATOBLASTOMA_CLASSES_DN osteoporosis DOID_11476 2.151E-03 0.01800252 0.02693638 0.15326799 CAIRO_HEPATOBLASTOMA_CLASSES_DN aneurysm disease DOID_2403 2.151E-03 0.01774162 2.151E-03 0.02782208 CAIRO_HEPATOBLASTOMA_CLASSES_DN gastric ulcer DOID_10808 2.275E-03 0.01849038 0.06847405 0.23902905 CAIRO_HEPATOBLASTOMA_CLASSES_DN muscular atrophy DOID_767 2.275E-03 0.01822995 0.06847405 0.23613173 CAIRO_HEPATOBLASTOMA_CLASSES_DN female reproductive system disease DOID_229 2.477E-03 0.01957149 2.477E-03 0.03131439 CAIRO_HEPATOBLASTOMA_CLASSES_DN myasthenia gravis DOID_437 2.486E-03 0.01937834 0.0714735 0.24352349 CAIRO_HEPATOBLASTOMA_CLASSES_DN urinary tract obstruction DOID_5200 2.486E-03 0.01911647 0.0714735 0.24207394 CAIRO_HEPATOBLASTOMA_CLASSES_DN chronic kidney failure DOID_784 2.65E-03 0.02010344 0.23988149 0.5526015 CAIRO_HEPATOBLASTOMA_CLASSES_DN diabetic angiopathy DOID_11713 2.706E-03 0.02026291 0.07446337 0.24923329 CAIRO_HEPATOBLASTOMA_CLASSES_DN ureteral disease DOID_1426 2.706E-03 0.01999975 0.07446337 0.24777579 CAIRO_HEPATOBLASTOMA_CLASSES_DN urticaria DOID_1555 3.174E-03 0.02315103 3.174E-03 0.03925609 CAIRO_HEPATOBLASTOMA_CLASSES_DN bronchiolitis DOID_2942 3.174E-03 0.02285797 0.0804145 0.25561927 CAIRO_HEPATOBLASTOMA_CLASSES_DN nervous system cancer DOID_3093 3.315E-03 0.02357527 3.315E-03 0.04012812 CAIRO_HEPATOBLASTOMA_CLASSES_DN morbid obesity DOID_11981 3.42E-03 0.02402656 3.42E-03 0.04054481 CAIRO_HEPATOBLASTOMA_CLASSES_DN neuromuscular junction disease DOID_439 3.42E-03 0.02373355 0.08337581 0.25923955 CAIRO_HEPATOBLASTOMA_CLASSES_DN myopia DOID_11830 3.676E-03 0.0251983 3.676E-03 0.04182919 CAIRO_HEPATOBLASTOMA_CLASSES_DN B cell deficiency DOID_2115 3.676E-03 0.02489833 3.676E-03 0.04100901 CAIRO_HEPATOBLASTOMA_CLASSES_DN extrinsic allergic alveolitis DOID_841 3.676E-03 0.0246054 0.08632767 0.26127896 CAIRO_HEPATOBLASTOMA_CLASSES_DN Sciatic Neuropathy DOID_11446 3.94E-03 0.02606595 3.94E-03 0.0422957 CAIRO_HEPATOBLASTOMA_CLASSES_DN gestational diabetes DOID_11714 3.94E-03 0.02576634 3.94E-03 0.04151244 CAIRO_HEPATOBLASTOMA_CLASSES_DN lesion of sciatic nerve DOID_12528 3.94E-03 0.02606595 3.94E-03 0.0422957 CAIRO_HEPATOBLASTOMA_CLASSES_DN perinatal necrotizing enterocolitis DOID_8677 3.94E-03 0.02547355 3.94E-03 0.04075767 CAIRO_HEPATOBLASTOMA_CLASSES_DN mononeuritis of lower limb DOID_9473 3.94E-03 0.02606595 3.94E-03 0.0422957 CAIRO_HEPATOBLASTOMA_CLASSES_DN mononeuritis DOID_1802 4.212E-03 0.02692985 4.212E-03 0.04279923 CAIRO_HEPATOBLASTOMA_CLASSES_DN autoimmune disease of the nervous system DOID_438 4.212E-03 0.02663063 0.09220313 0.27183203 CAIRO_HEPATOBLASTOMA_CLASSES_DN mononeuropathy DOID_1188 4.493E-03 0.02809539 4.493E-03 0.04485405 CAIRO_HEPATOBLASTOMA_CLASSES_DN gonadal disease DOID_2277 5.081E-03 0.03142303 5.081E-03 0.04899862 CAIRO_HEPATOBLASTOMA_CLASSES_DN hepatitis C DOID_1883 6.355E-03 0.03888238 6.355E-03 0.05832357 CAIRO_HEPATOBLASTOMA_CLASSES_DN macular degeneration DOID_4448 6.355E-03 0.03846874 6.355E-03 0.0573978 CAIRO_HEPATOBLASTOMA_CLASSES_DN pulmonary sarcoidosis DOID_13406 7.396E-03 0.04430009 7.396E-03 0.06575795 CAIRO_HEPATOBLASTOMA_CLASSES_DN hepatitis DOID_2237 8.13E-03 0.04818902 0.12667715 0.32912922 CAIRO_HEPATOBLASTOMA_CLASSES_DN adult respiratory distress syndrome DOID_11394 8.509E-03 0.04991417 8.509E-03 0.07448729 CAIRO_HEPATOBLASTOMA_CLASSES_DN adenoid cystic carcinoma DOID_4866 8.509E-03 0.04940484 8.509E-03 0.0733587 CAIRO_HEPATOBLASTOMA_CLASSES_DN benign mesothelioma DOID_2645 8.896E-03 0.05112762 0.13229521 0.34061528 CAIRO_HEPATOBLASTOMA_CLASSES_DN salivary gland cancer DOID_8850 9.29E-03 0.05285997 9.29E-03 0.07889548 CAIRO_HEPATOBLASTOMA_CLASSES_DN Huntington's disease DOID_12858 9.692E-03 0.0546013 0.13787743 0.35180384 CAIRO_HEPATOBLASTOMA_CLASSES_DN primitive neuroectodermal tumor DOID_168 9.692E-03 0.054066 9.692E-03 0.08109899 CAIRO_HEPATOBLASTOMA_CLASSES_DN hyperinsulinism DOID_2018 9.692E-03 0.05354108 9.692E-03 0.07992365 CAIRO_HEPATOBLASTOMA_CLASSES_DN gallbladder cancer DOID_3121 0.0101016 0.05526738 0.0101016 0.08095504 CAIRO_HEPATOBLASTOMA_CLASSES_DN influenza DOID_8469 0.0101016 0.05474103 0.14065516 0.35570128 CAIRO_HEPATOBLASTOMA_CLASSES_DN cerebral infarction DOID_3526 0.0105188 0.05646412 0.0105188 0.08312773 CAIRO_HEPATOBLASTOMA_CLASSES_DN thyroid adenoma DOID_2891 0.01137573 0.06049338 0.14893522 0.36845279 CAIRO_HEPATOBLASTOMA_CLASSES_DN heart valve disease DOID_4079 0.01137573 0.05993326 0.01137573 0.08516831 CAIRO_HEPATOBLASTOMA_CLASSES_DN vascular skin disease DOID_9540 0.01137573 0.05938341 0.01137573 0.08406223 CAIRO_HEPATOBLASTOMA_CLASSES_DN autoimmune disease of gastrointestinal tract DOID_0060031 0.01226236 0.06342983 0.01226236 0.08945232 CAIRO_HEPATOBLASTOMA_CLASSES_DN aortic aneurysm DOID_3627 0.01271667 0.06518728 0.01271667 0.09044735 CAIRO_HEPATOBLASTOMA_CLASSES_DN withdrawal disorder DOID_0060001 0.01317826 0.06695027 0.01317826 0.09257322 CAIRO_HEPATOBLASTOMA_CLASSES_DN sarcoidosis DOID_11335 0.01412304 0.07111513 0.01412304 0.09800012 CAIRO_HEPATOBLASTOMA_CLASSES_DN bone marrow cancer DOID_4960 0.01460613 0.07290253 0.01460613 0.10013119 CAIRO_HEPATOBLASTOMA_CLASSES_DN vasculitis DOID_865 0.01460613 0.0722686 0.16794891 0.4083886 CAIRO_HEPATOBLASTOMA_CLASSES_DN oral cavity cancer DOID_8618 0.01660868 0.08146843 0.01660868 0.10988765 CAIRO_HEPATOBLASTOMA_CLASSES_DN neuroectodermal tumor DOID_171 0.0181829 0.08842796 0.0181829 0.11892036 CAIRO_HEPATOBLASTOMA_CLASSES_DN carotid artery disease DOID_3407 0.0181829 0.08767857 0.18654123 0.43860313 CAIRO_HEPATOBLASTOMA_CLASSES_DN collagen disease DOID_854 0.0181829 0.08694177 0.0181829 0.11756899 CAIRO_HEPATOBLASTOMA_CLASSES_DN congenital heart defect DOID_1682 0.01926609 0.09135337 0.01926609 0.1218045 CAIRO_HEPATOBLASTOMA_CLASSES_DN endocrine pancreas disease DOID_1428 0.01981765 0.09319209 0.01981765 0.12391476 CAIRO_HEPATOBLASTOMA_CLASSES_DN cerebral degeneration DOID_1443 0.02037579 0.09503137 0.02037579 0.1246648 CAIRO_HEPATOBLASTOMA_CLASSES_DN temporal lobe epilepsy DOID_3328 0.02094047 0.09687096 0.02094047 0.12675668 HAN_SATB1_TARGETS_DN metabolic syndrome X DOID_14221 8.616E-14 4.902E-11 1.628E-09 9.266E-07 HAN_SATB1_TARGETS_DN ulcerative colitis DOID_8577 2.354E-11 6.697E-09 1.637E-07 2.328E-05 HAN_SATB1_TARGETS_DN retinal vascular disease DOID_2462 2.778E-09 5.268E-07 9.503E-07 1.081E-04 HAN_SATB1_TARGETS_DN mouth disease DOID_403 6.703E-09 9.535E-07 2.489E-05 9.443E-04 HAN_SATB1_TARGETS_DN influenza DOID_8469 1.252E-08 1.425E-06 1.794E-04 3.002E-03 HAN_SATB1_TARGETS_DN diabetic retinopathy DOID_8947 1.875E-08 1.778E-06 6.482E-06 5.269E-04 HAN_SATB1_TARGETS_DN cystic fibrosis DOID_1485 2.308E-08 1.876E-06 1.242E-03 0.0119792 HAN_SATB1_TARGETS_DN bone development disease DOID_0080006 5.013E-08 3.565E-06 5.013E-08 1.426E-05 HAN_SATB1_TARGETS_DN leishmaniasis DOID_9065 7.823E-08 4.946E-06 5.659E-03 0.02981446 HAN_SATB1_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 8.09E-08 4.603E-06 8.09E-08 1.534E-05 HAN_SATB1_TARGETS_DN encephalomyelitis DOID_640 1.097E-07 5.673E-06 2.345E-05 9.532E-04 HAN_SATB1_TARGETS_DN lymphatic system disease DOID_75 2.129E-07 1.01E-05 5.764E-06 5.466E-04 HAN_SATB1_TARGETS_DN pulmonary emphysema DOID_9675 2.453E-07 1.074E-05 1.385E-04 2.717E-03 HAN_SATB1_TARGETS_DN diabetic autonomic neuropathy DOID_11503 3.676E-07 1.494E-05 1.794E-04 3.093E-03 HAN_SATB1_TARGETS_DN autonomic neuropathy DOID_11504 3.676E-07 1.494E-05 1.794E-04 3.093E-03 HAN_SATB1_TARGETS_DN diabetic polyneuropathy DOID_12785 3.676E-07 1.494E-05 1.794E-04 3.093E-03 HAN_SATB1_TARGETS_DN diabetic neuropathy DOID_9743 3.676E-07 1.494E-05 1.794E-04 3.093E-03 HAN_SATB1_TARGETS_DN cystitis DOID_1679 5.224E-07 1.982E-05 0.01125825 0.04641989 HAN_SATB1_TARGETS_DN autonomic nervous system disease DOID_11465 5.36E-07 1.906E-05 2.284E-04 3.17E-03 HAN_SATB1_TARGETS_DN neuritis DOID_1803 5.36E-07 1.794E-05 2.284E-04 3.094E-03 HAN_SATB1_TARGETS_DN heart valve disease DOID_4079 5.36E-07 1.694E-05 2.284E-04 3.022E-03 HAN_SATB1_TARGETS_DN glaucoma DOID_1686 6.799E-07 2.036E-05 1.49E-05 7.707E-04 HAN_SATB1_TARGETS_DN gestational diabetes DOID_11714 7.611E-07 2.165E-05 2.598E-05 8.696E-04 HAN_SATB1_TARGETS_DN primary bacterial infectious disease DOID_0050338 1.109E-06 3.006E-05 2.021E-03 0.01619354 HAN_SATB1_TARGETS_DN parasitic protozoa infectious disease DOID_2789 1.312E-06 3.394E-05 5.068E-03 0.02799456 HAN_SATB1_TARGETS_DN intermediate coronary syndrome DOID_8805 1.594E-06 3.944E-05 9.022E-05 1.974E-03 HAN_SATB1_TARGETS_DN bladder disease DOID_365 2.021E-06 4.791E-05 0.01849931 0.06191828 HAN_SATB1_TARGETS_DN pre-malignant neoplasm DOID_0060071 2.831E-06 6.443E-05 4.788E-05 1.297E-03 HAN_SATB1_TARGETS_DN in situ carcinoma DOID_8719 2.831E-06 6.443E-05 4.788E-05 1.297E-03 HAN_SATB1_TARGETS_DN parasitic infectious disease DOID_1398 3.376E-06 7.389E-05 7.881E-03 0.03616159 HAN_SATB1_TARGETS_DN astrocytoma DOID_3069 4.725E-06 9.957E-05 9.211E-04 9.706E-03 HAN_SATB1_TARGETS_DN peptic ulcer DOID_750 5.119E-06 1.04E-04 2.022E-03 0.01575841 HAN_SATB1_TARGETS_DN amnestic disorder DOID_10914 5.528E-06 1.085E-04 6.263E-03 0.03181925 HAN_SATB1_TARGETS_DN intracranial arterial disease DOID_13089 5.764E-06 1.093E-04 0.02721791 0.08603883 HAN_SATB1_TARGETS_DN cerebral arterial disease DOID_3527 5.764E-06 1.093E-04 0.02721791 0.08603883 HAN_SATB1_TARGETS_DN peripheral vascular disease DOID_341 6E-06 1.101E-04 8.852E-05 2.099E-03 HAN_SATB1_TARGETS_DN autoimmune hepatitis DOID_2048 6.797E-06 1.209E-04 6.895E-03 0.03325005 HAN_SATB1_TARGETS_DN mitochondrial myopathy DOID_699 6.797E-06 1.172E-04 6.895E-03 0.03269588 HAN_SATB1_TARGETS_DN nephrotic syndrome DOID_1184 8.09E-06 1.354E-04 1.649E-04 3.026E-03 HAN_SATB1_TARGETS_DN Huntington's disease DOID_12858 8.09E-06 1.315E-04 1.649E-04 2.932E-03 HAN_SATB1_TARGETS_DN rheumatic disease DOID_1575 8.09E-06 1.279E-04 0.03083681 0.09694002 HAN_SATB1_TARGETS_DN scleroderma DOID_419 8.09E-06 1.279E-04 0.03083681 0.09694002 HAN_SATB1_TARGETS_DN electroclinical syndrome DOID_0050701 8.734E-06 1.343E-04 1.204E-04 2.537E-03 HAN_SATB1_TARGETS_DN bacterial pneumonia DOID_874 8.734E-06 1.308E-04 1.365E-03 0.01272825 HAN_SATB1_TARGETS_DN uterine cancer DOID_363 9.009E-06 1.314E-04 9.009E-06 6.408E-04 HAN_SATB1_TARGETS_DN spinocerebellar degeneration DOID_2478 1.109E-05 1.578E-04 1.109E-05 7.012E-04 HAN_SATB1_TARGETS_DN vascular skin disease DOID_9540 1.226E-05 1.702E-04 2.284E-04 2.954E-03 HAN_SATB1_TARGETS_DN biliary tract cancer DOID_4607 1.24E-05 1.68E-04 0.01442922 0.05163663 HAN_SATB1_TARGETS_DN severe combined immunodeficiency DOID_627 1.41E-05 1.866E-04 1.41E-05 8.022E-04 HAN_SATB1_TARGETS_DN pulmonary tuberculosis DOID_2957 1.49E-05 1.927E-04 0.03860287 0.11746007 HAN_SATB1_TARGETS_DN portal hypertension DOID_10762 1.658E-05 2.097E-04 0.01046506 0.04443744 HAN_SATB1_TARGETS_DN bronchiolitis DOID_2942 1.658E-05 2.051E-04 0.01046506 0.04378395 HAN_SATB1_TARGETS_DN combined T cell and B cell immunodeficiency DOID_628 1.658E-05 2.008E-04 1.658E-05 7.864E-04 HAN_SATB1_TARGETS_DN transitional cell carcinoma DOID_2671 1.722E-05 2.042E-04 2.097E-04 3.225E-03 HAN_SATB1_TARGETS_DN withdrawal disorder DOID_0060001 1.795E-05 2.085E-04 4.145E-03 0.02431579 HAN_SATB1_TARGETS_DN nervous system cancer DOID_3093 1.953E-05 2.222E-04 1.953E-05 8.548E-04 HAN_SATB1_TARGETS_DN sarcoidosis DOID_11335 2.148E-05 2.396E-04 4.592E-03 0.02613045 HAN_SATB1_TARGETS_DN giant cell tumor DOID_200 2.148E-05 2.35E-04 4.592E-03 0.02587173 HAN_SATB1_TARGETS_DN malignant giant cell tumor DOID_2705 2.148E-05 2.35E-04 4.592E-03 0.02587173 HAN_SATB1_TARGETS_DN giant cell glioblastoma DOID_3074 2.148E-05 2.35E-04 4.592E-03 0.02587173 HAN_SATB1_TARGETS_DN atrophic muscular disease DOID_913 2.148E-05 2.306E-04 3.542E-04 4.288E-03 HAN_SATB1_TARGETS_DN muscular dystrophy DOID_9884 2.148E-05 2.306E-04 3.542E-04 4.288E-03 HAN_SATB1_TARGETS_DN middle cerebral artery infarction DOID_3525 2.25E-05 2.371E-04 0.01207708 0.04739213 HAN_SATB1_TARGETS_DN bile duct adenocarcinoma DOID_4896 2.343E-05 2.424E-04 4.826E-03 0.0269238 HAN_SATB1_TARGETS_DN cholangiocarcinoma DOID_4947 2.343E-05 2.424E-04 4.826E-03 0.0269238 HAN_SATB1_TARGETS_DN lymphoblastic leukemia DOID_1037 2.345E-05 2.383E-04 2.563E-03 0.01800143 HAN_SATB1_TARGETS_DN cutaneous leishmaniasis DOID_9111 2.432E-05 2.428E-04 0.05804598 0.161113 HAN_SATB1_TARGETS_DN osteochondrodysplasia DOID_2256 2.552E-05 2.503E-04 2.552E-05 9.074E-04 HAN_SATB1_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 2.64E-05 2.546E-04 0.02045368 0.06688589 HAN_SATB1_TARGETS_DN mitochondrial metabolism disease DOID_700 2.774E-05 2.631E-04 5.316E-03 0.02880681 HAN_SATB1_TARGETS_DN hepatic vascular disease DOID_272 2.984E-05 2.783E-04 0.01379033 0.05062387 HAN_SATB1_TARGETS_DN invasive ductal carcinoma DOID_3008 2.984E-05 2.738E-04 2.984E-05 9.432E-04 HAN_SATB1_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 3.265E-05 2.949E-04 5.834E-03 0.0304549 HAN_SATB1_TARGETS_DN glioblastoma DOID_3068 3.265E-05 2.903E-04 5.834E-03 0.03017803 HAN_SATB1_TARGETS_DN bile duct cancer DOID_4606 3.265E-05 2.858E-04 5.834E-03 0.02990616 HAN_SATB1_TARGETS_DN bile duct carcinoma DOID_4897 3.265E-05 2.858E-04 5.834E-03 0.02990616 HAN_SATB1_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 3.41E-05 2.94E-04 3.41E-05 1.021E-03 HAN_SATB1_TARGETS_DN melancholia DOID_2848 3.534E-05 3.001E-04 0.30996158 0.49962646 HAN_SATB1_TARGETS_DN neurotic disorder DOID_4964 3.82E-05 3.197E-04 0.31408187 0.50483781 HAN_SATB1_TARGETS_DN endometrial carcinoma DOID_2871 3.879E-05 3.199E-04 3.879E-05 1.104E-03 HAN_SATB1_TARGETS_DN collagen disease DOID_854 4.124E-05 3.352E-04 0.05604704 0.16523712 HAN_SATB1_TARGETS_DN mitochondrial encephalomyopathy DOID_890 4.42E-05 3.542E-04 2.245E-03 0.01658947 HAN_SATB1_TARGETS_DN endometrial cancer DOID_1380 4.956E-05 3.916E-04 4.956E-05 1.282E-03 HAN_SATB1_TARGETS_DN allergic rhinitis DOID_4481 4.956E-05 3.863E-04 1.091E-03 0.01089492 HAN_SATB1_TARGETS_DN mineral metabolism disease DOID_0050032 5.149E-05 3.959E-04 0.06076684 0.16703543 HAN_SATB1_TARGETS_DN chronic leukemia DOID_1036 5.569E-05 4.225E-04 0.01849931 0.0626554 HAN_SATB1_TARGETS_DN chronic lymphocytic leukemia DOID_1040 5.569E-05 4.225E-04 0.01849931 0.0626554 HAN_SATB1_TARGETS_DN pleural disease DOID_1532 5.569E-05 4.17E-04 1.000 1.000 HAN_SATB1_TARGETS_DN temporal lobe epilepsy DOID_3328 5.934E-05 4.385E-04 8.203E-03 0.03734045 HAN_SATB1_TARGETS_DN tooth disease DOID_1091 6.359E-05 4.639E-04 8.533E-03 0.03823182 HAN_SATB1_TARGETS_DN tuberculosis DOID_399 6.808E-05 4.904E-04 0.06726215 0.17162405 HAN_SATB1_TARGETS_DN open-angle glaucoma DOID_1067 7.249E-05 5.156E-04 3.071E-03 0.02055846 HAN_SATB1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 7.779E-05 5.464E-04 9.7E-04 0.01003539 HAN_SATB1_TARGETS_DN nephrosis DOID_2527 8.302E-05 5.761E-04 1.021E-03 0.01037119 HAN_SATB1_TARGETS_DN adenoma DOID_657 8.587E-05 5.887E-04 8.587E-05 2.124E-03 HAN_SATB1_TARGETS_DN skeletal system cancer DOID_0060124 9.022E-05 6.111E-04 3.53E-03 0.02256644 HAN_SATB1_TARGETS_DN bone cancer DOID_184 9.022E-05 6.111E-04 3.53E-03 0.02256644 HAN_SATB1_TARGETS_DN hemangioma DOID_255 9.022E-05 6.039E-04 9.022E-05 2.053E-03 HAN_SATB1_TARGETS_DN pancreatic carcinoma DOID_4905 9.43E-05 6.239E-04 1.128E-03 0.01106231 HAN_SATB1_TARGETS_DN pulmonary sarcoidosis DOID_13406 9.496E-05 6.211E-04 1.755E-03 0.0149065 HAN_SATB1_TARGETS_DN endogenous depression DOID_1595 1.067E-04 6.901E-04 0.37302647 0.59288286 HAN_SATB1_TARGETS_DN aneurysm disease DOID_2403 1.134E-04 7.249E-04 0.01185607 0.04750779 HAN_SATB1_TARGETS_DN systemic scleroderma DOID_418 1.152E-04 7.285E-04 0.22218101 0.37513649 HAN_SATB1_TARGETS_DN familial hypertrophic cardiomyopathy DOID_11986 1.336E-04 8.356E-04 1.336E-04 2.716E-03 HAN_SATB1_TARGETS_DN spinocerebellar ataxia DOID_1441 1.513E-04 9.355E-04 1.513E-04 2.869E-03 HAN_SATB1_TARGETS_DN mental depression DOID_1596 1.603E-04 9.809E-04 0.39878041 0.63029459 HAN_SATB1_TARGETS_DN focal epilepsy DOID_2234 1.603E-04 9.704E-04 0.01442922 0.05196344 HAN_SATB1_TARGETS_DN dissociative disorder DOID_10935 1.888E-04 1.131E-03 5.659E-03 0.030377 HAN_SATB1_TARGETS_DN dissociative amnesia DOID_11037 1.888E-04 1.131E-03 5.659E-03 0.030377 HAN_SATB1_TARGETS_DN MHC class II deficiency DOID_5812 1.888E-04 1.119E-03 1.888E-04 3.069E-03 HAN_SATB1_TARGETS_DN cerebral infarction DOID_3526 1.948E-04 1.143E-03 0.03334907 0.10369193 HAN_SATB1_TARGETS_DN cataract DOID_83 1.948E-04 1.131E-03 1.948E-04 3.079E-03 HAN_SATB1_TARGETS_DN primary immunodeficiency disease DOID_612 2.208E-04 1.269E-03 2.208E-04 3.306E-03 HAN_SATB1_TARGETS_DN pre-eclampsia DOID_10591 2.284E-04 1.3E-03 2.284E-04 3.332E-03 HAN_SATB1_TARGETS_DN lens disease DOID_110 2.284E-04 1.287E-03 2.284E-04 3.249E-03 HAN_SATB1_TARGETS_DN Kawasaki disease DOID_13378 2.568E-04 1.433E-03 6.895E-03 0.03353423 HAN_SATB1_TARGETS_DN lymphadenitis DOID_1602 2.568E-04 1.433E-03 6.895E-03 0.03353423 HAN_SATB1_TARGETS_DN lymph node disease DOID_9942 2.568E-04 1.433E-03 6.895E-03 0.03353423 HAN_SATB1_TARGETS_DN lymphoma DOID_0060058 2.569E-04 1.419E-03 2.466E-03 0.01776186 HAN_SATB1_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 2.66E-04 1.455E-03 0.03860287 0.11809158 HAN_SATB1_TARGETS_DN integumentary system benign neoplasm DOID_0060121 2.66E-04 1.442E-03 3.726E-03 0.02304251 HAN_SATB1_TARGETS_DN skin benign neoplasm DOID_3165 2.66E-04 1.442E-03 3.726E-03 0.02304251 HAN_SATB1_TARGETS_DN carbohydrate metabolic disorder DOID_2978 2.699E-04 1.449E-03 0.01936766 0.06444559 HAN_SATB1_TARGETS_DN Crohn's disease DOID_8778 2.833E-04 1.507E-03 0.11227011 0.2314554 HAN_SATB1_TARGETS_DN calcium metabolism disease DOID_10575 2.864E-04 1.509E-03 0.27175242 0.44689921 HAN_SATB1_TARGETS_DN aortic aneurysm DOID_3627 2.864E-04 1.495E-03 3.932E-03 0.02405729 HAN_SATB1_TARGETS_DN gastric ulcer DOID_10808 2.961E-04 1.532E-03 7.555E-03 0.03523778 HAN_SATB1_TARGETS_DN muscular atrophy DOID_767 2.961E-04 1.518E-03 2.961E-04 3.744E-03 HAN_SATB1_TARGETS_DN dilated cardiomyopathy DOID_12930 2.973E-04 1.51E-03 2.973E-04 3.677E-03 HAN_SATB1_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 3.079E-04 1.55E-03 4.145E-03 0.02406767 HAN_SATB1_TARGETS_DN polyarteritis nodosa DOID_9810 3.39E-04 1.692E-03 8.243E-03 0.03722277 HAN_SATB1_TARGETS_DN aortic valve disease DOID_62 3.857E-04 1.908E-03 3.857E-04 4.572E-03 HAN_SATB1_TARGETS_DN meningitis DOID_9471 3.857E-04 1.892E-03 0.13371711 0.25704404 HAN_SATB1_TARGETS_DN Goodpasture syndrome DOID_9808 3.857E-04 1.876E-03 8.957E-03 0.03920374 HAN_SATB1_TARGETS_DN sphingolipidosis DOID_1927 4.364E-04 2.104E-03 4.364E-04 5.068E-03 HAN_SATB1_TARGETS_DN urticaria DOID_1555 4.912E-04 2.348E-03 0.01046506 0.04410827 HAN_SATB1_TARGETS_DN carotid artery disease DOID_3407 5.904E-04 2.8E-03 6.666E-03 0.03269944 HAN_SATB1_TARGETS_DN congenital heart defect DOID_1682 6.635E-04 3.12E-03 6.635E-04 7.551E-03 HAN_SATB1_TARGETS_DN Sciatic Neuropathy DOID_11446 6.812E-04 3.177E-03 0.01292122 0.04934345 HAN_SATB1_TARGETS_DN lesion of sciatic nerve DOID_12528 6.812E-04 3.177E-03 0.01292122 0.04934345 HAN_SATB1_TARGETS_DN periodontitis DOID_824 6.812E-04 3.151E-03 0.15924938 0.28949807 HAN_SATB1_TARGETS_DN mononeuritis of lower limb DOID_9473 6.812E-04 3.177E-03 0.01292122 0.04934345 HAN_SATB1_TARGETS_DN endocrine pancreas disease DOID_1428 7.024E-04 3.223E-03 0.06076684 0.16623237 HAN_SATB1_TARGETS_DN pleurisy DOID_10247 7.536E-04 3.43E-03 1.000 1.000 HAN_SATB1_TARGETS_DN mononeuritis DOID_1802 7.536E-04 3.403E-03 0.01379033 0.0509526 HAN_SATB1_TARGETS_DN hyperglycemia DOID_4195 7.849E-04 3.517E-03 0.33829424 0.53918606 HAN_SATB1_TARGETS_DN allergic contact dermatitis DOID_3042 8.286E-04 3.683E-03 8.286E-04 9.245E-03 HAN_SATB1_TARGETS_DN mononeuropathy DOID_1188 8.307E-04 3.664E-03 0.0146841 0.05189599 HAN_SATB1_TARGETS_DN supratentorial cancer DOID_1659 8.307E-04 3.636E-03 8.307E-04 9.09E-03 HAN_SATB1_TARGETS_DN cerebrum cancer DOID_368 8.307E-04 3.636E-03 8.307E-04 9.09E-03 HAN_SATB1_TARGETS_DN brain infarction DOID_3454 8.74E-04 3.796E-03 0.06726215 0.17239714 HAN_SATB1_TARGETS_DN dysostosis DOID_1934 9.126E-04 3.934E-03 9.126E-04 9.798E-03 HAN_SATB1_TARGETS_DN spastic cerebral palsy DOID_0050669 9.995E-04 4.276E-03 0.01654431 0.0574007 HAN_SATB1_TARGETS_DN abdominal aortic aneurysm DOID_7693 9.995E-04 4.244E-03 0.01654431 0.05705282 HAN_SATB1_TARGETS_DN papilloma DOID_2615 1.291E-03 5.441E-03 0.01951157 0.064547 HAN_SATB1_TARGETS_DN hair disease DOID_421 1.291E-03 5.401E-03 1.291E-03 0.01224187 HAN_SATB1_TARGETS_DN pancreatitis DOID_4989 1.365E-03 5.667E-03 0.01226484 0.04747409 HAN_SATB1_TARGETS_DN nephroblastoma DOID_2154 1.399E-03 5.767E-03 0.02054659 0.06680578 HAN_SATB1_TARGETS_DN periodontal disease DOID_3388 1.399E-03 5.725E-03 0.19855162 0.34549197 HAN_SATB1_TARGETS_DN contact dermatitis DOID_2773 1.495E-03 6.077E-03 1.495E-03 0.0137214 HAN_SATB1_TARGETS_DN lipid metabolism disorder DOID_3146 1.495E-03 6.034E-03 0.01310641 0.04938773 HAN_SATB1_TARGETS_DN hyperparathyroidism DOID_13543 1.543E-03 6.182E-03 1.000 1.000 HAN_SATB1_TARGETS_DN childhood type dermatomyositis DOID_14203 1.543E-03 6.139E-03 0.05804598 0.16851105 HAN_SATB1_TARGETS_DN ventricular septal defect DOID_1657 1.543E-03 6.096E-03 1.543E-03 0.01393367 HAN_SATB1_TARGETS_DN retinal vascular occlusion DOID_1729 1.543E-03 6.054E-03 1.000 1.000 HAN_SATB1_TARGETS_DN teratoma DOID_3307 1.543E-03 6.012E-03 1.543E-03 0.01371596 HAN_SATB1_TARGETS_DN insulinoma DOID_3892 1.543E-03 5.972E-03 1.543E-03 0.01350494 HAN_SATB1_TARGETS_DN malignant teratoma DOID_5563 1.543E-03 6.012E-03 1.543E-03 0.01371596 HAN_SATB1_TARGETS_DN mature teratoma DOID_5566 1.543E-03 6.012E-03 1.543E-03 0.01371596 HAN_SATB1_TARGETS_DN alcohol abuse DOID_1574 1.707E-03 6.563E-03 1.707E-03 0.01471602 HAN_SATB1_TARGETS_DN chronic kidney failure DOID_784 1.707E-03 6.519E-03 0.39878041 0.62854863 HAN_SATB1_TARGETS_DN adolescence-adult electroclinical syndrome DOID_0050705 1.755E-03 6.658E-03 0.02378522 0.07646208 HAN_SATB1_TARGETS_DN calcinosis DOID_182 1.755E-03 6.614E-03 0.21281365 0.36363654 HAN_SATB1_TARGETS_DN multiple myeloma DOID_9538 1.755E-03 6.571E-03 0.21281365 0.36146558 HAN_SATB1_TARGETS_DN familial adenomatous polyposis DOID_0050424 1.878E-03 6.985E-03 0.06366277 0.17249578 HAN_SATB1_TARGETS_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 1.878E-03 6.939E-03 1.878E-03 0.01571592 HAN_SATB1_TARGETS_DN dermatomyositis DOID_10223 1.878E-03 6.895E-03 0.06366277 0.16927156 HAN_SATB1_TARGETS_DN invasive lobular carcinoma DOID_3457 1.878E-03 6.851E-03 1.878E-03 0.01548815 HAN_SATB1_TARGETS_DN bronchiectasis DOID_9563 1.878E-03 6.807E-03 0.06366277 0.16540691 HAN_SATB1_TARGETS_DN heroin dependence DOID_9976 1.878E-03 6.764E-03 0.06366277 0.16465506 HAN_SATB1_TARGETS_DN uveitis DOID_13141 1.886E-03 6.748E-03 1.886E-03 0.01532683 HAN_SATB1_TARGETS_DN hepatitis DOID_2237 2.022E-03 7.19E-03 2.022E-03 0.01597728 HAN_SATB1_TARGETS_DN neonatoal period electroclinical syndrome DOID_0050702 2.245E-03 7.934E-03 2.245E-03 0.01726201 HAN_SATB1_TARGETS_DN islet cell tumor DOID_1799 2.245E-03 7.885E-03 2.245E-03 0.01703185 HAN_SATB1_TARGETS_DN aortic valve insufficiency DOID_57 2.245E-03 7.837E-03 2.245E-03 0.01680775 HAN_SATB1_TARGETS_DN stomach disease DOID_76 2.245E-03 7.789E-03 1.000 1.000 HAN_SATB1_TARGETS_DN ocular hypertension DOID_9282 2.245E-03 7.742E-03 2.245E-03 0.01637678 HAN_SATB1_TARGETS_DN borderline glaucoma DOID_9283 2.245E-03 7.742E-03 2.245E-03 0.01637678 HAN_SATB1_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 2.281E-03 7.817E-03 0.10462731 0.21967873 HAN_SATB1_TARGETS_DN autoimmune disease of urogenital tract DOID_0060049 2.466E-03 8.404E-03 2.466E-03 0.01754242 HAN_SATB1_TARGETS_DN primary biliary cirrhosis DOID_12236 2.466E-03 8.404E-03 2.466E-03 0.01754242 HAN_SATB1_TARGETS_DN idiopathic generalized epilepsy DOID_1827 2.627E-03 8.897E-03 2.627E-03 0.01822877 HAN_SATB1_TARGETS_DN hyperinsulinism DOID_2018 2.627E-03 8.845E-03 0.03083681 0.09640738 HAN_SATB1_TARGETS_DN uveal disease DOID_3480 2.627E-03 8.793E-03 2.627E-03 0.01800915 HAN_SATB1_TARGETS_DN parathyroid gland disease DOID_11201 2.643E-03 8.794E-03 1.000 1.000 HAN_SATB1_TARGETS_DN polyneuropathy DOID_1389 2.643E-03 8.743E-03 0.07479649 0.17882018 HAN_SATB1_TARGETS_DN larynx cancer DOID_2596 2.643E-03 8.692E-03 0.07479649 0.17733001 HAN_SATB1_TARGETS_DN laryngeal benign neoplasm DOID_2598 2.643E-03 8.692E-03 0.07479649 0.17733001 HAN_SATB1_TARGETS_DN intracranial thrombosis DOID_4193 2.643E-03 8.642E-03 2.643E-03 0.01790146 HAN_SATB1_TARGETS_DN epilepsy with generalized tonic-clonic seizures DOID_7725 2.643E-03 8.593E-03 0.07479649 0.17514075 HAN_SATB1_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.662E-03 8.605E-03 0.01990656 0.06547302 HAN_SATB1_TARGETS_DN gallbladder cancer DOID_3121 2.794E-03 8.981E-03 0.24511672 0.40781115 HAN_SATB1_TARGETS_DN bacterial meningitis DOID_9470 3.071E-03 9.817E-03 0.08031382 0.18426841 HAN_SATB1_TARGETS_DN myeloma DOID_0070004 3.333E-03 0.0105954 0.25855364 0.42642615 HAN_SATB1_TARGETS_DN brain cancer DOID_1319 3.333E-03 0.01053654 3.333E-03 0.02205322 HAN_SATB1_TARGETS_DN thyroid adenoma DOID_2891 3.333E-03 0.01047833 0.03593849 0.11113586 HAN_SATB1_TARGETS_DN central nervous system cancer DOID_3620 3.526E-03 0.01102385 3.526E-03 0.02306138 HAN_SATB1_TARGETS_DN peripheral neuropathy DOID_0060053 3.53E-03 0.01097493 3.53E-03 0.02282287 HAN_SATB1_TARGETS_DN thoracic aortic aneurysm DOID_14004 3.53E-03 0.01091529 3.53E-03 0.0223157 HAN_SATB1_TARGETS_DN communication disorder DOID_2033 3.53E-03 0.01085629 0.0857984 0.19527717 HAN_SATB1_TARGETS_DN oral submucous fibrosis DOID_5773 3.53E-03 0.01079792 0.0857984 0.19296163 HAN_SATB1_TARGETS_DN varicose veins DOID_799 3.53E-03 0.01074018 0.0857984 0.1914482 HAN_SATB1_TARGETS_DN hyperhomocysteinemia DOID_9279 3.53E-03 0.01068305 3.53E-03 0.02207047 HAN_SATB1_TARGETS_DN lung small cell carcinoma DOID_5409 3.726E-03 0.01121646 0.03860287 0.11683529 HAN_SATB1_TARGETS_DN movement disease DOID_480 3.932E-03 0.01177541 3.932E-03 0.02380136 HAN_SATB1_TARGETS_DN angiosarcoma DOID_0001816 4.018E-03 0.01197038 4.018E-03 0.02406677 HAN_SATB1_TARGETS_DN spastic diplegia DOID_10965 4.018E-03 0.01190804 4.018E-03 0.02381608 HAN_SATB1_TARGETS_DN vein disease DOID_866 4.018E-03 0.01184634 0.09125042 0.20124608 HAN_SATB1_TARGETS_DN Barrett's esophagus DOID_9206 4.018E-03 0.01178527 0.09125042 0.20046907 HAN_SATB1_TARGETS_DN orofacial cleft DOID_0050567 4.365E-03 0.01273774 4.365E-03 0.02508948 HAN_SATB1_TARGETS_DN atopic dermatitis DOID_3310 4.365E-03 0.01267275 0.28042138 0.45850508 HAN_SATB1_TARGETS_DN schizophreniform disorder DOID_11328 4.536E-03 0.01310178 0.09667006 0.21074814 HAN_SATB1_TARGETS_DN schizoaffective disorder DOID_5418 4.536E-03 0.01310178 0.09667006 0.21074814 HAN_SATB1_TARGETS_DN urinary system benign neoplasm DOID_731 4.536E-03 0.01303561 0.09667006 0.20835328 HAN_SATB1_TARGETS_DN bone marrow cancer DOID_4960 4.826E-03 0.01380014 0.28898761 0.47115745 HAN_SATB1_TARGETS_DN integumentary system cancer DOID_0060122 5.068E-03 0.0144172 0.29323257 0.47535422 HAN_SATB1_TARGETS_DN skin cancer DOID_4159 5.068E-03 0.0144172 0.29323257 0.47535422 HAN_SATB1_TARGETS_DN pustulosis of palm and sole DOID_4398 5.068E-03 0.01434547 0.04702476 0.14082678 HAN_SATB1_TARGETS_DN dental caries DOID_216 5.083E-03 0.01431844 5.083E-03 0.02781081 HAN_SATB1_TARGETS_DN heart septal defect DOID_1681 5.659E-03 0.01586188 5.659E-03 0.0300931 HAN_SATB1_TARGETS_DN granulosa cell tumor DOID_2999 5.659E-03 0.01578412 0.107413 0.22305838 HAN_SATB1_TARGETS_DN pulmonary edema DOID_11396 6.263E-03 0.01738418 0.11273667 0.23157822 HAN_SATB1_TARGETS_DN esophagitis DOID_11963 6.263E-03 0.01729979 0.11273667 0.22991816 HAN_SATB1_TARGETS_DN colon carcinoma DOID_1520 6.263E-03 0.01721621 6.263E-03 0.03153766 HAN_SATB1_TARGETS_DN sex cord-gonadal stromal tumor DOID_192 6.263E-03 0.01713344 0.11273667 0.22909703 HAN_SATB1_TARGETS_DN brain edema DOID_4724 6.263E-03 0.01705146 6.263E-03 0.03126102 HAN_SATB1_TARGETS_DN subependymal glioma DOID_4843 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN pilocytic astrocytoma DOID_4851 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN subependymal giant cell astrocytoma DOID_5077 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN fibrillary astrocytoma DOID_6726 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN juvenile pilocytic astrocytoma DOID_6811 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN childhood pilocytic astrocytoma DOID_6812 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN gemistocytic astrocytoma DOID_7005 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN childhood cerebral astrocytoma DOID_7007 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN protoplasmic astrocytoma DOID_7008 6.263E-03 0.01697027 6.263E-03 0.03098918 HAN_SATB1_TARGETS_DN coronary restenosis DOID_4247 6.895E-03 0.01859481 6.895E-03 0.03297063 HAN_SATB1_TARGETS_DN hypothyroidism DOID_1459 6.959E-03 0.01867657 0.0576054 0.16895605 HAN_SATB1_TARGETS_DN benign glioma DOID_0060101 7.555E-03 0.02018314 7.555E-03 0.035529 HAN_SATB1_TARGETS_DN thrombophilia DOID_2452 7.555E-03 0.02008883 7.555E-03 0.03495129 HAN_SATB1_TARGETS_DN benign ependymoma DOID_4844 7.555E-03 0.02018314 7.555E-03 0.035529 HAN_SATB1_TARGETS_DN sinusitis DOID_0050127 8.243E-03 0.02181427 0.12851877 0.2565866 HAN_SATB1_TARGETS_DN paranasal sinus disease DOID_1352 8.243E-03 0.02181427 0.12851877 0.2565866 HAN_SATB1_TARGETS_DN opiate dependence DOID_2559 8.243E-03 0.02171328 0.12851877 0.25391382 HAN_SATB1_TARGETS_DN IgA glomerulonephritis DOID_2986 8.243E-03 0.02161322 0.12851877 0.25303522 HAN_SATB1_TARGETS_DN muscle cancer DOID_4045 8.243E-03 0.02151408 0.12851877 0.25216269 HAN_SATB1_TARGETS_DN urinary tract obstruction DOID_5200 8.243E-03 0.02141584 0.12851877 0.25043555 HAN_SATB1_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 8.871E-03 0.02294414 0.06726215 0.17317721 HAN_SATB1_TARGETS_DN diabetic angiopathy DOID_11713 8.957E-03 0.02306102 8.957E-03 0.0398163 HAN_SATB1_TARGETS_DN synostosis DOID_11971 8.957E-03 0.02295714 8.957E-03 0.03950764 HAN_SATB1_TARGETS_DN blood coagulation disease DOID_1247 9.57E-03 0.02441925 9.57E-03 0.04156865 HAN_SATB1_TARGETS_DN spastic quadriplegia DOID_10970 9.698E-03 0.02463423 0.13888458 0.26607854 HAN_SATB1_TARGETS_DN toxic shock syndrome DOID_14115 9.698E-03 0.02452474 9.698E-03 0.04180354 HAN_SATB1_TARGETS_DN bile duct disease DOID_4138 9.932E-03 0.02500462 0.07227745 0.17803407 HAN_SATB1_TARGETS_DN biliary tract disease DOID_9741 0.01030063 0.02581965 0.07397545 0.18143116 HAN_SATB1_TARGETS_DN commensal bacterial infectious disease DOID_0050339 0.01046506 0.02611674 0.01046506 0.04477155 HAN_SATB1_TARGETS_DN osteosarcoma DOID_3347 0.01046506 0.02600269 0.01046506 0.04346436 HAN_SATB1_TARGETS_DN infantile epileptic encephalopathy DOID_2481 0.01125825 0.02785193 0.01125825 0.04608593 HAN_SATB1_TARGETS_DN papillary adenoma DOID_3172 0.01125825 0.02773136 0.01125825 0.04575674 HAN_SATB1_TARGETS_DN microcystic adenoma DOID_5403 0.01125825 0.02773136 0.01125825 0.04575674 HAN_SATB1_TARGETS_DN follicular adenoma DOID_6204 0.01125825 0.02773136 0.01125825 0.04575674 HAN_SATB1_TARGETS_DN myositis DOID_633 0.01125825 0.02761183 0.14912764 0.28284541 HAN_SATB1_TARGETS_DN syndrome DOID_225 0.0114553 0.02797453 0.0114553 0.04622741 HAN_SATB1_TARGETS_DN vitiligo DOID_12306 0.01207708 0.02936692 0.01207708 0.04805496 HAN_SATB1_TARGETS_DN teeth hard tissue disease DOID_214 0.01207708 0.02924195 0.01207708 0.04772125 HAN_SATB1_TARGETS_DN spinal cord disease DOID_319 0.01207708 0.02911805 0.15420358 0.28673803 HAN_SATB1_TARGETS_DN dystonia DOID_543 0.01207708 0.02899519 0.01207708 0.04706753 HAN_SATB1_TARGETS_DN extrinsic allergic alveolitis DOID_841 0.01207708 0.02887336 0.15420358 0.28303819 HAN_SATB1_TARGETS_DN diffuse large B-cell lymphoma DOID_0050745 0.01292122 0.03076223 0.01292122 0.04967685 HAN_SATB1_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 0.01292122 0.03063406 0.01292122 0.04901449 HAN_SATB1_TARGETS_DN chromosomal disease DOID_0080014 0.01353927 0.03196615 0.01353927 0.05068317 HAN_SATB1_TARGETS_DN sarcoma DOID_1115 0.01379033 0.03242438 0.01379033 0.05128562 HAN_SATB1_TARGETS_DN coronary stenosis DOID_4248 0.01379033 0.03229095 0.01379033 0.05029936 HAN_SATB1_TARGETS_DN autoimmune disease of the nervous system DOID_438 0.01379033 0.03215861 0.01379033 0.04997898 HAN_SATB1_TARGETS_DN polycystic ovary syndrome DOID_11612 0.0146841 0.03410308 0.0146841 0.05222034 HAN_SATB1_TARGETS_DN toxic encephalopathy DOID_3602 0.0146841 0.03396445 0.0146841 0.05157565 HAN_SATB1_TARGETS_DN dystonic disease DOID_544 0.0146841 0.03382694 0.0146841 0.05125923 HAN_SATB1_TARGETS_DN cranial nerve disease DOID_5656 0.0146841 0.03369054 0.16925125 0.30284264 HAN_SATB1_TARGETS_DN bronchiolitis obliterans DOID_2799 0.01654431 0.03780608 0.17913465 0.31654539 HAN_SATB1_TARGETS_DN amino acid metabolic disorder DOID_9252 0.01729415 0.03936147 0.01729415 0.05927933 HAN_SATB1_TARGETS_DN Charcot-Marie-Tooth disease DOID_10595 0.01751012 0.03969426 0.01751012 0.05966023 HAN_SATB1_TARGETS_DN autonomic nervous system neoplasm DOID_2621 0.01849931 0.04177027 0.01849931 0.06228466 HAN_SATB1_TARGETS_DN neuroblastoma DOID_769 0.01849931 0.04177027 0.01849931 0.06228466 HAN_SATB1_TARGETS_DN pneumoconiosis DOID_10316 0.02054659 0.04620953 1.000 1.000 HAN_SATB1_TARGETS_DN spindle cell carcinoma DOID_4015 0.02054659 0.04602761 0.19855162 0.34443864 HAN_SATB1_TARGETS_DN esophageal disease DOID_6050 0.02054659 0.04584711 0.19855162 0.34235113 HAN_SATB1_TARGETS_DN refractive error DOID_9835 0.02268372 0.05041811 0.02268372 0.07333543 HAN_SATB1_TARGETS_DN cleft palate DOID_674 0.02378522 0.05266066 0.02378522 0.07603252 HAN_SATB1_TARGETS_DN peripheral nervous system neoplasm DOID_1192 0.02490828 0.05493337 0.02490828 0.07917771 HAN_SATB1_TARGETS_DN respiratory syncytial virus infectious disease DOID_1273 0.0260526 0.05723526 0.22218101 0.37625297 HAN_SATB1_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 0.0284039 0.06216084 0.23143739 0.38731728 HAN_SATB1_TARGETS_DN learning disability DOID_8927 0.03334907 0.07270354 0.24962242 0.41409666 HAN_SATB1_TARGETS_DN proteinuria DOID_576 0.03463427 0.07521718 1.000 1.000 HAN_SATB1_TARGETS_DN bone marrow disease DOID_4961 0.03593849 0.07775285 0.03593849 0.11053513 HAN_SATB1_TARGETS_DN vasculitis DOID_865 0.04557796 0.09823431 0.28898761 0.46981128 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP thyroid cancer DOID_1781 2.001E-06 1.139E-03 1.005E-04 0.02858857 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP giant cell tumor DOID_200 8.673E-06 2.468E-03 2.963E-04 0.04215276 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP malignant giant cell tumor DOID_2705 8.673E-06 2.468E-03 2.963E-04 0.04215276 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP giant cell glioblastoma DOID_3074 8.673E-06 2.468E-03 2.963E-04 0.04215276 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP granulosa cell tumor DOID_2999 1.101E-05 2.089E-03 0.04272312 0.31165966 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP glioblastoma DOID_3068 1.222E-05 1.738E-03 3.816E-04 0.03618509 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP sex cord-gonadal stromal tumor DOID_192 1.294E-05 1.472E-03 0.04492102 0.31170808 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP endocrine organ benign neoplasm DOID_0060089 2.235E-05 2.12E-03 0.01167496 0.22143508 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP astrocytoma DOID_3069 2.362E-05 1.92E-03 6.209E-04 0.03532943 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP allergic rhinitis DOID_4481 6.634E-05 4.719E-03 2.784E-03 0.09901899 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP hypersensitivity reaction type I disease DOID_1205 7.617E-05 4.815E-03 7.617E-05 0.04333901 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP nephroblastoma DOID_2154 8.572E-05 4.877E-03 3.291E-03 0.10402535 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP thyroid carcinoma DOID_3963 8.572E-05 4.434E-03 3.291E-03 0.09855033 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP ulcerative colitis DOID_8577 8.575E-05 4.066E-03 1.607E-03 0.07035471 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP congenital diaphragmatic hernia DOID_3827 1.256E-04 5.497E-03 1.256E-04 0.02382235 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP withdrawal disorder DOID_0060001 2.66E-04 0.01081246 6.894E-03 0.15691806 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP sarcoidosis DOID_11335 2.963E-04 0.01124074 7.398E-03 0.16189479 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP beta thalassemia DOID_12241 3.385E-04 0.01203769 3.385E-04 0.0385206 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP hypersensitivity reaction type IV disease DOID_2916 3.816E-04 0.01277121 8.726E-03 0.17732135 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP congenital heart defect DOID_1682 4.812E-04 0.0152097 4.812E-04 0.03911066 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP thalassemia DOID_10241 5.361E-04 0.01605497 5.361E-04 0.03813055 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP membranoproliferative glomerulonephritis DOID_2920 5.361E-04 0.01525222 5.361E-04 0.03389382 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP pancreatic ductal carcinoma DOID_3587 6.464E-04 0.01751557 0.01231035 0.22595448 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP nephrosis DOID_2527 6.726E-04 0.01739709 0.01263362 0.22464154 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP male reproductive system disease DOID_48 6.726E-04 0.01664069 0.15648536 0.52686492 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP urinary system benign neoplasm DOID_731 6.923E-04 0.01641364 0.03831229 0.30703795 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP pancreatic carcinoma DOID_4905 7.271E-04 0.01654792 0.01329122 0.21007506 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP prion disease DOID_649 7.777E-04 0.01701952 0.04052021 0.30741333 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP syndrome DOID_225 7.842E-04 0.01652636 7.842E-04 0.0405647 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP testicular cancer DOID_2998 8.679E-04 0.01763679 0.04272312 0.31570719 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP amnestic disorder DOID_10914 9.629E-04 0.01889249 0.04492102 0.31950079 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP esophagitis DOID_11963 9.629E-04 0.01826274 0.04492102 0.31555633 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP gastric ulcer DOID_10808 1.167E-03 0.02142341 0.04930188 0.32619502 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP primary immunodeficiency disease DOID_612 1.226E-03 0.02179442 1.226E-03 0.05811844 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP muscle cancer DOID_4045 1.276E-03 0.02200885 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP urinary tract obstruction DOID_5200 1.276E-03 0.02136153 0.05148486 0.33289642 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP lymphoma DOID_0060058 1.346E-03 0.02187775 0.01985048 0.28237307 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP lymphoblastic leukemia DOID_1037 1.387E-03 0.02192742 0.02024754 0.2809963 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP encephalomyelitis DOID_640 1.387E-03 0.02133479 0.02024754 0.27430591 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP portal hypertension DOID_10762 1.632E-03 0.02444267 0.0580041 0.34379512 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP vitiligo DOID_12306 1.893E-03 0.02761736 1.893E-03 0.07693407 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP hepatic vascular disease DOID_272 2.172E-03 0.03089518 0.06662756 0.35765173 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP dysostosis DOID_1934 2.469E-03 0.03426621 2.469E-03 0.09366098 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP chronic leukemia DOID_1036 2.949E-03 0.03994819 0.07729723 0.37272985 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP chronic lymphocytic leukemia DOID_1040 2.949E-03 0.03994819 0.07729723 0.37272985 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP pneumoconiosis DOID_10316 3.291E-03 0.0435455 3.291E-03 0.11014449 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP male infertility DOID_12336 3.291E-03 0.04255583 0.08153125 0.37716491 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP esophageal disease DOID_6050 3.291E-03 0.04161014 0.08153125 0.37113027 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP peptic ulcer DOID_750 4.223E-03 0.05223417 0.09203248 0.39373295 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP autoimmune disease of urogenital tract DOID_0060049 4.834E-03 0.05852093 4.834E-03 0.13752418 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP primary biliary cirrhosis DOID_12236 4.834E-03 0.05852093 4.834E-03 0.13752418 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP nephrotic syndrome DOID_1184 5.046E-03 0.05981747 0.10034794 0.41375345 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP gallbladder cancer DOID_3121 5.263E-03 0.0611102 0.10241501 0.41923842 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP influenza DOID_8469 5.263E-03 0.05988799 0.10241501 0.41624386 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP proteinuria DOID_576 5.708E-03 0.06368423 0.10653508 0.42390532 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP thyroid adenoma DOID_2891 5.937E-03 0.06496553 0.1085881 0.4231961 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP heart valve disease DOID_4079 5.937E-03 0.06373976 5.937E-03 0.16086702 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP bone marrow disease DOID_4961 5.937E-03 0.0625594 5.937E-03 0.15355488 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP hemolytic anemia DOID_583 6.17E-03 0.06383419 6.17E-03 0.15264697 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP normocytic anemia DOID_720 6.17E-03 0.06383419 6.17E-03 0.15264697 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP lung small cell carcinoma DOID_5409 6.408E-03 0.0651054 0.11268016 0.4303021 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP movement disease DOID_480 6.649E-03 0.06637304 6.649E-03 0.15763598 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP atrophic muscular disease DOID_913 7.398E-03 0.07257353 7.398E-03 0.15589869 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP muscular dystrophy DOID_9884 7.398E-03 0.07257353 7.398E-03 0.15589869 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP bile duct adenocarcinoma DOID_4896 7.655E-03 0.07382826 0.12282925 0.45980161 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP cholangiocarcinoma DOID_4947 7.655E-03 0.07382826 0.12282925 0.45980161 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP bile duct cancer DOID_4606 8.726E-03 0.08274996 0.13086583 0.47128265 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP bile duct carcinoma DOID_4897 8.726E-03 0.08274996 0.13086583 0.47128265 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP oral cavity cancer DOID_8618 8.726E-03 0.08139341 0.13086583 0.46831861 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP melancholia DOID_2848 9.003E-03 0.08262751 0.13286358 0.4724961 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP neurotic disorder DOID_4964 9.285E-03 0.0838578 0.13485678 0.47660566 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP hyperglycemia DOID_4195 0.01105456 0.09828195 0.14672127 0.50291808 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP allergic contact dermatitis DOID_3042 0.01136288 0.09946888 0.01136288 0.22294749 CHENG_RESPONSE_TO_NICKEL_ACETATE hepatitis DOID_2237 1.658E-06 9.435E-04 2.483E-04 0.14126765 CHENG_RESPONSE_TO_NICKEL_ACETATE nutritional deficiency disease DOID_5113 3.055E-05 8.692E-03 8.278E-03 0.52337354 CHENG_RESPONSE_TO_NICKEL_ACETATE metal metabolism disorder DOID_896 1.82E-04 0.03452463 0.01975838 0.48880505 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER nervous system cancer DOID_3093 6.961E-08 3.961E-05 5.922E-05 4.212E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER lymphoma DOID_0060058 7.92E-08 2.253E-05 7.92E-08 4.507E-05 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER B-cell lymphocytic neoplasm DOID_707 1.547E-07 2.934E-05 1.547E-07 4.401E-05 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER giant cell tumor DOID_200 1.862E-07 2.649E-05 2.864E-04 9.586E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER malignant giant cell tumor DOID_2705 1.862E-07 2.649E-05 2.864E-04 9.586E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER giant cell glioblastoma DOID_3074 1.862E-07 2.649E-05 2.864E-04 9.586E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER glioblastoma DOID_3068 2.874E-07 3.271E-05 3.688E-04 9.994E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER sarcoma DOID_1115 6.465E-07 6.131E-05 4.377E-05 4.151E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER astrocytoma DOID_3069 6.629E-07 5.388E-05 6.003E-04 0.01313751 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER brain cancer DOID_1319 5.248E-06 3.733E-04 5.805E-03 0.06477089 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER central nervous system cancer DOID_3620 5.685E-06 3.594E-04 6.034E-03 0.06602128 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER neuroectodermal tumor DOID_171 1.413E-05 8.042E-04 1.413E-05 2.681E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER muscular atrophy DOID_767 1.682E-05 8.702E-04 1.141E-03 0.02093826 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER mixed glioma DOID_5076 3.422E-05 1.623E-03 3.422E-05 4.868E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER diffuse large B-cell lymphoma DOID_0050745 3.946E-05 1.727E-03 3.946E-05 4.491E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER transitional cell carcinoma DOID_2671 5.434E-05 2.209E-03 5.434E-05 4.417E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER lymphoblastic leukemia DOID_1037 6.713E-05 2.546E-03 6.713E-05 4.244E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER paraplegia DOID_607 8.282E-05 2.945E-03 3.217E-03 0.04160301 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER multiple myeloma DOID_9538 1.048E-04 3.507E-03 1.048E-04 5.963E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER hepatitis DOID_2237 1.214E-04 3.836E-03 1.214E-04 6.278E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER benign mesothelioma DOID_2645 1.396E-04 4.179E-03 1.396E-04 6.617E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER myeloma DOID_0070004 2.045E-04 5.818E-03 2.045E-04 8.951E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER T cell deficiency DOID_11200 2.262E-04 6.129E-03 2.262E-04 9.193E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER rectal neoplasm DOID_1984 2.262E-04 5.85E-03 2.262E-04 8.58E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER rectum cancer DOID_1993 2.262E-04 5.85E-03 2.262E-04 8.58E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER cannabis abuse DOID_9505 2.262E-04 5.596E-03 0.02245717 0.16382221 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER breast benign neoplasm DOID_0060082 2.76E-04 6.545E-03 2.76E-04 9.817E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER thoracic benign neoplasm DOID_0060097 2.76E-04 6.545E-03 2.76E-04 9.817E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER benign breast phyllodes tumor DOID_1631 2.76E-04 6.545E-03 2.76E-04 9.817E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER bone marrow cancer DOID_4960 3.018E-04 6.87E-03 3.018E-04 9.541E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER reproductive organ benign neoplasm DOID_0050622 3.178E-04 6.954E-03 3.178E-04 9.516E-03 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER pustulosis of palm and sole DOID_4398 3.178E-04 6.697E-03 7.743E-03 0.08009993 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER hypertrophic cardiomyopathy DOID_11984 3.688E-04 7.495E-03 3.688E-04 0.01049318 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER cannabis dependence DOID_1849 3.903E-04 7.659E-03 0.0290966 0.17802113 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER hallucinogen dependence DOID_9977 3.903E-04 7.659E-03 0.0290966 0.17802113 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER tethered spinal cord syndrome DOID_1089 4.547E-04 8.624E-03 4.547E-04 0.01176067 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER congenital structural myopathy DOID_422 4.547E-04 8.346E-03 4.547E-04 0.01124934 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER pre-malignant neoplasm DOID_0060071 4.651E-04 8.271E-03 0.13930747 0.4307932 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER in situ carcinoma DOID_8719 4.651E-04 8.271E-03 0.13930747 0.4307932 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER mesenchymal cell neoplasm DOID_3350 5.239E-04 9.033E-03 5.239E-04 0.01242083 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER spindle cell sarcoma DOID_4235 5.239E-04 9.033E-03 5.239E-04 0.01242083 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER nutritional deficiency disease DOID_5113 5.239E-04 8.768E-03 5.239E-04 0.011924 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER epithelioid sarcoma DOID_6193 5.239E-04 9.033E-03 5.239E-04 0.01242083 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER angiosarcoma DOID_0001816 5.979E-04 9.72E-03 0.03569145 0.20107361 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER pancreatic ductal carcinoma DOID_3587 6.25E-04 9.879E-03 0.01204221 0.11051645 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER pancreatic carcinoma DOID_4905 7.03E-04 0.01081099 0.01300239 0.11382088 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER diabetic retinopathy DOID_8947 7.03E-04 0.01052649 0.01300239 0.11209632 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER male reproductive organ benign neoplasm DOID_0060087 7.6E-04 0.01108863 7.6E-04 0.01601691 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER keratosis DOID_161 7.6E-04 0.01081141 7.6E-04 0.01544488 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER neuroendocrine tumor DOID_169 7.6E-04 0.01054772 7.6E-04 0.01491229 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER pulmonary edema DOID_11396 9.41E-04 0.01274896 0.04441576 0.22564791 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER colon carcinoma DOID_1520 9.41E-04 0.01245247 0.04441576 0.22365103 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER Leigh disease DOID_3652 1.039E-03 0.01343065 1.039E-03 0.01969828 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER retinal vascular disease DOID_2462 1.041E-03 0.01316403 0.01679567 0.13460193 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER gastric ulcer DOID_10808 1.141E-03 0.01411057 0.04874861 0.23707658 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER amino acid metabolic disorder DOID_9252 1.185E-03 0.01435185 1.185E-03 0.02107929 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER alcohol-related neurodevelopmental disorder DOID_0050667 1.383E-03 0.01639358 0.02020612 0.15536867 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER mouth disease DOID_403 1.383E-03 0.01605902 1.383E-03 0.02384521 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER dilated cardiomyopathy DOID_12930 1.425E-03 0.01621367 1.425E-03 0.02384363 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER ulcerative colitis DOID_8577 1.555E-03 0.01734814 0.02180703 0.16326578 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER spinal cord disease DOID_319 1.85E-03 0.02024609 1.85E-03 0.0300799 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER extrinsic allergic alveolitis DOID_841 1.85E-03 0.01986408 0.061631 0.26170179 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER lung adenocarcinoma DOID_3910 1.984E-03 0.0209096 1.984E-03 0.03136439 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER supratentorial cancer DOID_1659 2.266E-03 0.02344366 0.06800738 0.27640142 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER cerebrum cancer DOID_368 2.266E-03 0.02344366 0.06800738 0.27640142 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER endometrial carcinoma DOID_2871 2.414E-03 0.02452392 2.414E-03 0.03711729 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER endometrial cancer DOID_1380 2.722E-03 0.02717107 2.722E-03 0.0407566 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER childhood absence epilepsy DOID_1825 2.883E-03 0.02827933 2.883E-03 0.04205644 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER hereditary spastic paraplegia DOID_2476 2.883E-03 0.02780002 2.883E-03 0.04100503 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER autonomic nervous system neoplasm DOID_2621 2.883E-03 0.02733668 2.883E-03 0.0400049 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER neuroblastoma DOID_769 2.883E-03 0.02733668 2.883E-03 0.0400049 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER nephroblastoma DOID_2154 3.217E-03 0.03000873 3.217E-03 0.04358411 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER spindle cell carcinoma DOID_4015 3.217E-03 0.02952472 3.217E-03 0.04257052 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER childhood electroclinical syndrome DOID_0050704 3.391E-03 0.03062526 3.391E-03 0.04287536 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER medullomyoblastoma DOID_3861 3.391E-03 0.03014674 3.391E-03 0.04194328 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER adult medulloblastoma DOID_3864 3.391E-03 0.03014674 3.391E-03 0.04194328 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER childhood medulloblastoma DOID_3869 3.391E-03 0.03014674 3.391E-03 0.04194328 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER medulloblastoma DOID_3858 3.751E-03 0.03283749 3.751E-03 0.04541355 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER peripheral nervous system neoplasm DOID_1192 3.938E-03 0.03394851 3.938E-03 0.0466792 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER peptic ulcer DOID_750 4.129E-03 0.03506237 0.09102318 0.32573702 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER cervix uteri carcinoma in situ DOID_8991 4.523E-03 0.03784598 0.09514709 0.33626518 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER endometriosis of uterus DOID_288 4.726E-03 0.038975 0.09720211 0.33931288 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER primitive neuroectodermal tumor DOID_168 4.934E-03 0.04010559 4.934E-03 0.0572937 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER endometriosis DOID_289 4.934E-03 0.03954072 0.09925251 0.34227079 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER uterine cancer DOID_363 5.146E-03 0.04066478 5.146E-03 0.05855729 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER glaucoma DOID_1686 6.266E-03 0.04883835 6.266E-03 0.06726792 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER bile duct adenocarcinoma DOID_4896 7.486E-03 0.0575651 7.486E-03 0.07888551 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER cholangiocarcinoma DOID_4947 7.486E-03 0.0575651 7.486E-03 0.07888551 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER integumentary system cancer DOID_0060122 7.743E-03 0.05873995 0.12350125 0.39927394 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER skin cancer DOID_4159 7.743E-03 0.05873995 0.12350125 0.39927394 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER mitochondrial metabolism disease DOID_700 8.002E-03 0.05991318 8.002E-03 0.08131075 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER bile duct cancer DOID_4606 8.534E-03 0.063063 8.534E-03 0.08519037 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER bile duct carcinoma DOID_4897 8.534E-03 0.063063 8.534E-03 0.08519037 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER leukocyte disease DOID_9500 8.806E-03 0.06423556 8.806E-03 0.08638575 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER respiratory failure DOID_11162 9.643E-03 0.06945579 0.1373472 0.42939867 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER cholestasis DOID_13580 0.01051497 0.07478775 0.01051497 0.10140712 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER uterine disease DOID_345 0.01051497 0.07386445 0.1432148 0.43811408 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER tooth disease DOID_1091 0.01111481 0.07712591 0.01111481 0.10540541 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER endocrine organ benign neoplasm DOID_0060089 0.01142027 0.07829078 0.01142027 0.1065268 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER bile duct disease DOID_4138 0.01235865 0.08371517 0.01235865 0.11162023 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER biliary tract disease DOID_9741 0.01267872 0.08487282 0.01267872 0.11272172 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER electroclinical syndrome DOID_0050701 0.01433276 0.09482952 0.01433276 0.12172147 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER lipid metabolism disorder DOID_3146 0.01501912 0.09822848 0.01501912 0.12567467 LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER female reproductive system disease DOID_229 0.01536753 0.09936505 0.17196624 0.48924395 SINGH_NFE2L2_TARGETS hemolytic anemia DOID_583 1.07E-11 6.09E-09 3.921E-09 2.231E-06 SINGH_NFE2L2_TARGETS normocytic anemia DOID_720 1.07E-11 6.09E-09 3.921E-09 2.231E-06 SINGH_NFE2L2_TARGETS pulmonary emphysema DOID_9675 6.572E-07 1.87E-04 1.369E-04 0.01298323 SINGH_NFE2L2_TARGETS cholestasis DOID_13580 2.473E-06 4.69E-04 2.473E-06 7.035E-04 SINGH_NFE2L2_TARGETS bile duct disease DOID_4138 3.194E-06 4.543E-04 3.194E-06 6.058E-04 SINGH_NFE2L2_TARGETS biliary tract disease DOID_9741 3.326E-06 3.785E-04 3.326E-06 4.731E-04 SINGH_NFE2L2_TARGETS berylliosis DOID_10322 1.137E-05 1.078E-03 5.132E-03 0.26547694 SINGH_NFE2L2_TARGETS diabetic angiopathy DOID_11713 4.013E-05 3.262E-03 9.456E-03 0.25620438 SINGH_NFE2L2_TARGETS congenital hemolytic anemia DOID_589 4.013E-05 2.854E-03 4.013E-05 4.566E-03 SINGH_NFE2L2_TARGETS pneumoconiosis DOID_10316 9.654E-05 6.103E-03 0.01454262 0.28533633 SINGH_NFE2L2_TARGETS endocrine pancreas disease DOID_1428 3.183E-04 0.01811126 0.02618878 0.3170514 SINGH_NFE2L2_TARGETS parasitic infectious disease DOID_1398 3.279E-04 0.01695984 3.279E-04 0.02665118 SINGH_NFE2L2_TARGETS peripheral vascular disease DOID_341 3.988E-04 0.0189081 0.02927265 0.33312281 SINGH_NFE2L2_TARGETS cystic fibrosis DOID_1485 4.312E-04 0.01887471 0.03042676 0.33946714 SINGH_NFE2L2_TARGETS bacterial pneumonia DOID_874 4.536E-04 0.0184344 0.03119544 0.34135016 YAMASHITA_LIVER_CANCER_STEM_CELL_UP invasive ductal carcinoma DOID_3008 2.877E-06 1.637E-03 3.544E-04 0.06721314 YAMASHITA_LIVER_CANCER_STEM_CELL_UP reproductive organ benign neoplasm DOID_0050622 2.148E-05 6.111E-03 0.05219977 0.8250464 YAMASHITA_LIVER_CANCER_STEM_CELL_UP Leydig cell tumor DOID_2696 6.417E-05 0.01217141 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP sex cord-stromal neoplasm DOID_4757 6.417E-05 0.01217141 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP testicular cancer DOID_2998 1.402E-04 0.01994308 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP granulosa cell tumor DOID_2999 1.402E-04 0.01595447 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP sex cord-gonadal stromal tumor DOID_192 1.557E-04 0.01476409 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP portal hypertension DOID_10762 2.654E-04 0.02157141 2.654E-04 0.15099988 YAMASHITA_LIVER_CANCER_STEM_CELL_UP hepatic vascular disease DOID_272 3.544E-04 0.02520493 3.544E-04 0.1008197 YAMASHITA_LIVER_CANCER_STEM_CELL_UP female reproductive organ benign neoplasm DOID_0060086 4.036E-04 0.02551654 0.02913574 0.92101325 YAMASHITA_LIVER_CANCER_STEM_CELL_UP uterine benign neoplasm DOID_0060095 4.036E-04 0.02551654 0.02913574 0.92101325 YAMASHITA_LIVER_CANCER_STEM_CELL_UP uterine fibroid DOID_13223 4.036E-04 0.02551654 0.02913574 0.92101325 YAMASHITA_LIVER_CANCER_STEM_CELL_UP germinoma DOID_3304 4.56E-04 0.02594431 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP leiomyoma DOID_127 4.833E-04 0.02500068 0.03182455 0.90540845 YAMASHITA_LIVER_CANCER_STEM_CELL_UP cleft palate DOID_674 6.318E-04 0.02995593 0.03628983 0.86037128 YAMASHITA_LIVER_CANCER_STEM_CELL_UP benign mesothelioma DOID_2645 7.644E-04 0.03345884 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP glaucoma DOID_1686 1.067E-03 0.04334775 0.04692502 0.86130115 YAMASHITA_LIVER_CANCER_STEM_CELL_UP orofacial cleft DOID_0050567 1.192E-03 0.04523056 0.04956595 0.82950075 YAMASHITA_LIVER_CANCER_STEM_CELL_UP bile duct adenocarcinoma DOID_4896 1.28E-03 0.04552049 0.05132262 0.83435917 YAMASHITA_LIVER_CANCER_STEM_CELL_UP cholangiocarcinoma DOID_4947 1.28E-03 0.04552049 0.05132262 0.83435917 YAMASHITA_LIVER_CANCER_STEM_CELL_UP osteochondrodysplasia DOID_2256 1.325E-03 0.04434724 0.05219977 0.80274785 YAMASHITA_LIVER_CANCER_STEM_CELL_UP bile duct cancer DOID_4606 1.464E-03 0.04628787 0.0548265 0.79990462 YAMASHITA_LIVER_CANCER_STEM_CELL_UP bile duct carcinoma DOID_4897 1.464E-03 0.04628787 0.0548265 0.79990462 YAMASHITA_LIVER_CANCER_STEM_CELL_UP pre-malignant neoplasm DOID_0060071 1.711E-03 0.05125141 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP in situ carcinoma DOID_8719 1.711E-03 0.05125141 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP endocrine pancreas disease DOID_1428 1.763E-03 0.05015793 1.763E-03 0.25078967 YAMASHITA_LIVER_CANCER_STEM_CELL_UP cholestasis DOID_13580 1.815E-03 0.04918856 0.06092807 0.84556275 YAMASHITA_LIVER_CANCER_STEM_CELL_UP uterine disease DOID_345 1.815E-03 0.04695271 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP pancreatic ductal carcinoma DOID_3587 2.088E-03 0.051662 0.06526289 0.86359499 YAMASHITA_LIVER_CANCER_STEM_CELL_UP bile duct disease DOID_4138 2.145E-03 0.05085526 0.06612752 0.85514904 YAMASHITA_LIVER_CANCER_STEM_CELL_UP biliary tract disease DOID_9741 2.203E-03 0.05012961 0.06699137 0.84706865 YAMASHITA_LIVER_CANCER_STEM_CELL_UP pancreatic carcinoma DOID_4905 2.261E-03 0.04947568 0.06785444 0.83932997 YAMASHITA_LIVER_CANCER_STEM_CELL_UP mixed glioma DOID_5076 2.501E-03 0.05270347 0.07129899 0.82794139 YAMASHITA_LIVER_CANCER_STEM_CELL_UP female reproductive system disease DOID_229 2.689E-03 0.05463446 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP biliary tract cancer DOID_4607 2.817E-03 0.05527528 0.0755873 0.82709947 YAMASHITA_LIVER_CANCER_STEM_CELL_UP bone development disease DOID_0080006 2.883E-03 0.05467337 0.07644265 0.82067672 YAMASHITA_LIVER_CANCER_STEM_CELL_UP transitional cell carcinoma DOID_2671 3.151E-03 0.05784245 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_UP lymphoblastic leukemia DOID_1037 3.503E-03 0.06229065 0.08410627 0.87011763 YAMASHITA_LIVER_CANCER_STEM_CELL_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.576E-03 0.0616526 0.08495396 0.84804922 RUIZ_TNC_TARGETS_UP mouth disease DOID_403 2.245E-09 1.278E-06 8.375E-08 4.766E-05 RUIZ_TNC_TARGETS_UP cholestasis DOID_13580 4.691E-07 1.335E-04 0.01028225 0.13296816 RUIZ_TNC_TARGETS_UP allergic contact dermatitis DOID_3042 5.428E-07 1.029E-04 5.428E-07 1.544E-04 RUIZ_TNC_TARGETS_UP bile duct disease DOID_4138 7.173E-07 1.02E-04 0.01208637 0.14327382 RUIZ_TNC_TARGETS_UP biliary tract disease DOID_9741 7.672E-07 8.731E-05 0.01239959 0.14110736 RUIZ_TNC_TARGETS_UP aneurysm disease DOID_2403 9.948E-07 9.434E-05 7.606E-04 0.02704924 RUIZ_TNC_TARGETS_UP contact dermatitis DOID_2773 1.198E-06 9.739E-05 1.198E-06 2.272E-04 RUIZ_TNC_TARGETS_UP Ehlers-Danlos syndrome DOID_13359 4.854E-06 3.452E-04 4.854E-06 6.904E-04 RUIZ_TNC_TARGETS_UP heart valve disease DOID_4079 5.009E-06 3.167E-04 1.976E-04 0.01873515 RUIZ_TNC_TARGETS_UP pustulosis of palm and sole DOID_4398 9.103E-06 5.179E-04 7.57E-03 0.10768119 RUIZ_TNC_TARGETS_UP urinary tract obstruction DOID_5200 1.865E-05 9.646E-04 1.219E-03 0.03302878 RUIZ_TNC_TARGETS_UP pulmonary embolism DOID_9477 1.865E-05 8.842E-04 1.219E-03 0.03152748 RUIZ_TNC_TARGETS_UP mixed glioma DOID_5076 3.268E-05 1.431E-03 7.89E-04 0.02640736 RUIZ_TNC_TARGETS_UP endometrial carcinoma DOID_2871 5.147E-05 2.092E-03 0.06933599 0.30583082 RUIZ_TNC_TARGETS_UP endometrial cancer DOID_1380 6.19E-05 2.348E-03 0.07350815 0.31686469 RUIZ_TNC_TARGETS_UP encephalomyelitis DOID_640 6.413E-05 2.281E-03 1.297E-03 0.03209748 RUIZ_TNC_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 6.956E-05 2.328E-03 1.378E-03 0.03266037 RUIZ_TNC_TARGETS_UP adenoma DOID_657 9.377E-05 2.964E-03 9.377E-05 0.01067111 RUIZ_TNC_TARGETS_UP hepatitis DOID_2237 1.172E-04 3.51E-03 0.09001277 0.34606262 RUIZ_TNC_TARGETS_UP benign mesothelioma DOID_2645 1.348E-04 3.835E-03 0.09409332 0.35456357 RUIZ_TNC_TARGETS_UP uterine cancer DOID_363 1.642E-04 4.45E-03 0.10018026 0.36077575 RUIZ_TNC_TARGETS_UP thyroid adenoma DOID_2891 1.976E-04 5.11E-03 5.675E-03 0.08970001 RUIZ_TNC_TARGETS_UP relapsing-remitting multiple sclerosis DOID_2378 3.231E-04 7.994E-03 0.02657962 0.22240884 RUIZ_TNC_TARGETS_UP glioblastoma DOID_3068 3.564E-04 8.449E-03 3.564E-04 0.02896778 RUIZ_TNC_TARGETS_UP Leydig cell tumor DOID_2696 3.813E-04 8.679E-03 0.02876281 0.22116265 RUIZ_TNC_TARGETS_UP sex cord-stromal neoplasm DOID_4757 3.813E-04 8.679E-03 0.02876281 0.22116265 RUIZ_TNC_TARGETS_UP collagen disease DOID_854 4.106E-04 8.985E-03 4.106E-04 0.02920102 RUIZ_TNC_TARGETS_UP communication disorder DOID_2033 5.118E-04 0.01078644 5.118E-04 0.03235932 RUIZ_TNC_TARGETS_UP tooth disease DOID_1091 5.342E-04 0.01085592 5.342E-04 0.03039659 RUIZ_TNC_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 5.569E-04 0.01092635 0.01116809 0.14121423 RUIZ_TNC_TARGETS_UP brain infarction DOID_3454 5.569E-04 0.01056214 0.01116809 0.13814436 RUIZ_TNC_TARGETS_UP astrocytoma DOID_3069 5.802E-04 0.01064864 5.802E-04 0.0300098 RUIZ_TNC_TARGETS_UP peripheral vascular disease DOID_341 6.537E-04 0.01162333 6.537E-04 0.03099554 RUIZ_TNC_TARGETS_UP schizophreniform disorder DOID_11328 6.61E-04 0.01139755 6.61E-04 0.02893225 RUIZ_TNC_TARGETS_UP Graves' disease DOID_12361 6.61E-04 0.01106233 6.61E-04 0.02686566 RUIZ_TNC_TARGETS_UP schizoaffective disorder DOID_5418 6.61E-04 0.01139755 6.61E-04 0.02893225 RUIZ_TNC_TARGETS_UP diabetic retinopathy DOID_8947 6.795E-04 0.01104594 0.01271635 0.14187461 RUIZ_TNC_TARGETS_UP syndrome DOID_225 7.329E-04 0.01158402 7.329E-04 0.02780165 RUIZ_TNC_TARGETS_UP keratosis DOID_161 7.426E-04 0.01141941 0.03960638 0.25321385 RUIZ_TNC_TARGETS_UP ureteral obstruction DOID_5199 7.426E-04 0.0111189 0.03960638 0.24495688 RUIZ_TNC_TARGETS_UP bone resorption disease DOID_0080011 7.606E-04 0.01109712 0.01368768 0.1469489 RUIZ_TNC_TARGETS_UP osteoporosis DOID_11476 7.606E-04 0.01109712 0.01368768 0.1469489 RUIZ_TNC_TARGETS_UP Down syndrome DOID_14250 8.287E-04 0.01178847 8.287E-04 0.02619659 RUIZ_TNC_TARGETS_UP chromosomal disease DOID_0080014 8.781E-04 0.01218581 8.781E-04 0.02629571 RUIZ_TNC_TARGETS_UP membranous glomerulonephritis DOID_10976 9.195E-04 0.01245641 0.04391024 0.26579708 RUIZ_TNC_TARGETS_UP amyloidosis DOID_9120 9.195E-04 0.01216673 0.04391024 0.25757655 RUIZ_TNC_TARGETS_UP retinal vascular disease DOID_2462 1.006E-03 0.01301504 0.01642929 0.16693328 RUIZ_TNC_TARGETS_UP gastric ulcer DOID_10808 1.115E-03 0.01409364 0.04819503 0.27422973 RUIZ_TNC_TARGETS_UP acquired immunodeficiency syndrome DOID_635 1.115E-03 0.01378726 1.115E-03 0.03171069 RUIZ_TNC_TARGETS_UP placenta disease DOID_780 1.115E-03 0.01349391 0.04819503 0.26885268 RUIZ_TNC_TARGETS_UP nervous system cancer DOID_3093 1.183E-03 0.01402146 0.01825173 0.18219714 RUIZ_TNC_TARGETS_UP uremia DOID_4676 1.219E-03 0.01415519 0.05033031 0.27274233 RUIZ_TNC_TARGETS_UP lymphoma DOID_0060058 1.258E-03 0.01432163 0.01900361 0.18327208 RUIZ_TNC_TARGETS_UP ureteral disease DOID_1426 1.328E-03 0.01481488 0.05246085 0.27897404 RUIZ_TNC_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.337E-03 0.01463135 1.000 1.000 RUIZ_TNC_TARGETS_UP spastic quadriplegia DOID_10970 1.441E-03 0.01547293 0.05458666 0.2849524 RUIZ_TNC_TARGETS_UP sphingolipidosis DOID_1927 1.441E-03 0.01518639 0.05458666 0.28236192 RUIZ_TNC_TARGETS_UP ulcerative colitis DOID_8577 1.504E-03 0.01555489 1.504E-03 0.03422075 RUIZ_TNC_TARGETS_UP reading disorder DOID_13365 1.559E-03 0.01584129 1.559E-03 0.03411969 RUIZ_TNC_TARGETS_UP urticaria DOID_1555 1.559E-03 0.01556337 1.559E-03 0.032856 RUIZ_TNC_TARGETS_UP dyslexia DOID_4428 1.559E-03 0.01584129 1.559E-03 0.03411969 RUIZ_TNC_TARGETS_UP intracranial aneurysm DOID_10941 1.808E-03 0.01773762 1.808E-03 0.0367422 RUIZ_TNC_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 1.939E-03 0.01870139 0.0630429 0.30144043 RUIZ_TNC_TARGETS_UP periodontitis DOID_824 1.939E-03 0.0183897 1.939E-03 0.03804765 RUIZ_TNC_TARGETS_UP pleurisy DOID_10247 2.075E-03 0.01935208 0.06514526 0.30634422 RUIZ_TNC_TARGETS_UP malaria DOID_12365 2.075E-03 0.01903995 0.06514526 0.29893266 RUIZ_TNC_TARGETS_UP autoimmune disease of endocrine system DOID_0060005 2.215E-03 0.02000088 2.215E-03 0.04200185 RUIZ_TNC_TARGETS_UP spastic cerebral palsy DOID_0050669 2.507E-03 0.02229092 0.07142438 0.31261904 RUIZ_TNC_TARGETS_UP abdominal aortic aneurysm DOID_7693 2.507E-03 0.02194799 0.07142438 0.31023263 RUIZ_TNC_TARGETS_UP allergic rhinitis DOID_4481 2.66E-03 0.02293306 0.07350815 0.31448224 RUIZ_TNC_TARGETS_UP pleural disease DOID_1532 2.817E-03 0.02392512 0.0755873 0.31858646 RUIZ_TNC_TARGETS_UP periodontal disease DOID_3388 3.144E-03 0.02630968 3.144E-03 0.05771155 RUIZ_TNC_TARGETS_UP thyroid carcinoma DOID_3963 3.144E-03 0.02592838 0.07973177 0.32405268 RUIZ_TNC_TARGETS_UP hyperthyroidism DOID_7998 3.144E-03 0.02555797 3.144E-03 0.05590806 RUIZ_TNC_TARGETS_UP thyroid cancer DOID_1781 3.488E-03 0.0279543 0.08385787 0.33367223 RUIZ_TNC_TARGETS_UP calcinosis DOID_182 3.666E-03 0.0289748 0.08591406 0.33947987 RUIZ_TNC_TARGETS_UP embryonal cancer DOID_688 3.666E-03 0.02857788 0.08591406 0.33713863 RUIZ_TNC_TARGETS_UP multiple myeloma DOID_9538 3.666E-03 0.02819169 0.08591406 0.33482946 RUIZ_TNC_TARGETS_UP congenital diaphragmatic hernia DOID_3827 4.035E-03 0.03061537 4.035E-03 0.06958038 RUIZ_TNC_TARGETS_UP peptic ulcer DOID_750 4.035E-03 0.03021253 0.09001277 0.34374005 RUIZ_TNC_TARGETS_UP primitive neuroectodermal tumor DOID_168 4.823E-03 0.03563912 0.09815578 0.35801693 RUIZ_TNC_TARGETS_UP diabetic autonomic neuropathy DOID_11503 5.03E-03 0.03669262 0.10018026 0.36307368 RUIZ_TNC_TARGETS_UP autonomic neuropathy DOID_11504 5.03E-03 0.03669262 0.10018026 0.36307368 RUIZ_TNC_TARGETS_UP diabetic polyneuropathy DOID_12785 5.03E-03 0.03669262 0.10018026 0.36307368 RUIZ_TNC_TARGETS_UP diabetic neuropathy DOID_9743 5.03E-03 0.03669262 0.10018026 0.36307368 RUIZ_TNC_TARGETS_UP learning disability DOID_8927 5.241E-03 0.03774852 5.241E-03 0.0877098 RUIZ_TNC_TARGETS_UP proteinuria DOID_576 5.456E-03 0.03880661 1.000 1.000 RUIZ_TNC_TARGETS_UP myeloma DOID_0070004 5.675E-03 0.03986667 0.10622678 0.37542259 RUIZ_TNC_TARGETS_UP pre-eclampsia DOID_10591 5.675E-03 0.03938049 5.675E-03 0.09226287 RUIZ_TNC_TARGETS_UP autonomic nervous system disease DOID_11465 5.675E-03 0.03890603 0.10622678 0.37081618 RUIZ_TNC_TARGETS_UP brain cancer DOID_1319 5.675E-03 0.03844286 0.10622678 0.3685551 RUIZ_TNC_TARGETS_UP vascular skin disease DOID_9540 5.675E-03 0.03799059 5.675E-03 0.08727569 RUIZ_TNC_TARGETS_UP central nervous system cancer DOID_3620 5.898E-03 0.03902485 0.10823335 0.37099262 RUIZ_TNC_TARGETS_UP calcium metabolism disease DOID_10575 6.356E-03 0.04157202 0.11223314 0.37565092 RUIZ_TNC_TARGETS_UP aortic aneurysm DOID_3627 6.356E-03 0.04109961 0.11223314 0.37345413 RUIZ_TNC_TARGETS_UP movement disease DOID_480 6.356E-03 0.04063782 6.356E-03 0.09517804 RUIZ_TNC_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 6.591E-03 0.04167151 0.11422638 0.37569255 RUIZ_TNC_TARGETS_UP orofacial cleft DOID_0050567 6.83E-03 0.04270692 0.1162152 0.38003707 RUIZ_TNC_TARGETS_UP giant cell tumor DOID_200 7.073E-03 0.04374387 7.073E-03 0.10319067 RUIZ_TNC_TARGETS_UP malignant giant cell tumor DOID_2705 7.073E-03 0.04374387 7.073E-03 0.10319067 RUIZ_TNC_TARGETS_UP giant cell glioblastoma DOID_3074 7.073E-03 0.04374387 7.073E-03 0.10319067 RUIZ_TNC_TARGETS_UP bone marrow cancer DOID_4960 7.319E-03 0.04478221 0.12017961 0.38634011 RUIZ_TNC_TARGETS_UP vasculitis DOID_865 7.319E-03 0.04430581 0.12017961 0.38416966 RUIZ_TNC_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 7.57E-03 0.04533945 0.12215522 0.38830347 RUIZ_TNC_TARGETS_UP parasitic protozoa infectious disease DOID_2789 7.57E-03 0.04486716 0.12215522 0.38401283 RUIZ_TNC_TARGETS_UP familial hyperlipidemia DOID_1168 7.824E-03 0.0458962 0.12412645 0.38594508 RUIZ_TNC_TARGETS_UP melancholia DOID_2848 8.61E-03 0.04998953 8.61E-03 0.11948716 RUIZ_TNC_TARGETS_UP leukocyte disease DOID_9500 8.61E-03 0.04948458 0.13001392 0.39988064 RUIZ_TNC_TARGETS_UP neurotic disorder DOID_4964 8.879E-03 0.05052284 8.879E-03 0.12029247 RUIZ_TNC_TARGETS_UP neuroectodermal tumor DOID_171 9.152E-03 0.05156163 0.13391715 0.40967129 RUIZ_TNC_TARGETS_UP carotid artery disease DOID_3407 9.152E-03 0.05105613 0.13391715 0.40748053 RUIZ_TNC_TARGETS_UP congenital heart defect DOID_1682 9.71E-03 0.05364039 9.71E-03 0.12848744 RUIZ_TNC_TARGETS_UP mineral metabolism disease DOID_0050032 9.994E-03 0.05468014 0.13973958 0.42069745 RUIZ_TNC_TARGETS_UP parasitic infectious disease DOID_1398 0.01028225 0.05571999 0.14167177 0.42426968 RUIZ_TNC_TARGETS_UP uterine disease DOID_345 0.01028225 0.05519433 0.14167177 0.41985021 RUIZ_TNC_TARGETS_UP blood coagulation disease DOID_1247 0.0117767 0.06262562 0.0117767 0.14257321 RUIZ_TNC_TARGETS_UP male reproductive system disease DOID_48 0.01208637 0.06367725 0.01208637 0.14034987 RUIZ_TNC_TARGETS_UP endogenous depression DOID_1595 0.01336042 0.06974382 0.01336042 0.14619377 RUIZ_TNC_TARGETS_UP pancreatitis DOID_4989 0.01401842 0.07251346 0.01401842 0.1477126 RUIZ_TNC_TARGETS_UP lipid metabolism disorder DOID_3146 0.01469023 0.07530397 0.16827648 0.48603714 RUIZ_TNC_TARGETS_UP female reproductive system disease DOID_229 0.01503127 0.07636422 0.17014532 0.48895297 RUIZ_TNC_TARGETS_UP mental depression DOID_1596 0.01572354 0.07917429 0.01572354 0.16266718 RUIZ_TNC_TARGETS_UP chronic kidney failure DOID_784 0.01572354 0.07847978 1.000 1.000 RUIZ_TNC_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 0.01825173 0.09030641 0.01825173 0.17905581 RUIZ_TNC_TARGETS_UP lymphoblastic leukemia DOID_1037 0.01938439 0.09508375 0.01938439 0.18382859 RUIZ_TNC_TARGETS_UP dilated cardiomyopathy DOID_12930 0.02015554 0.09802141 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bone development disease DOID_0080006 1.044E-07 5.94E-05 1.044E-07 5.94E-05 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP peptic ulcer DOID_750 2.887E-07 8.213E-05 0.05394963 0.40929788 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP leukodystrophy DOID_10579 5.428E-07 1.029E-04 1.927E-03 0.12182064 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP parasitic protozoa infectious disease DOID_2789 1.077E-06 1.533E-04 0.07374257 0.43707834 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP endocrine pancreas disease DOID_1428 1.93E-06 2.196E-04 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP parasitic infectious disease DOID_1398 2.048E-06 1.942E-04 0.08590646 0.4484475 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP cerebral degeneration DOID_1443 2.048E-06 1.665E-04 3.673E-03 0.19001268 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hyperglycemia DOID_4195 2.172E-06 1.545E-04 3.78E-03 0.16544039 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP brain infarction DOID_3454 2.437E-06 1.54E-04 3.997E-03 0.16245236 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bone resorption disease DOID_0080011 3.739E-06 2.127E-04 4.923E-03 0.18672933 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP osteoporosis DOID_11476 3.739E-06 2.127E-04 4.923E-03 0.18672933 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP aneurysm disease DOID_2403 3.739E-06 1.934E-04 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP uremia DOID_4676 3.752E-06 1.779E-04 4.237E-04 0.0482186 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP middle cerebral artery infarction DOID_3525 6.909E-06 3.024E-04 0.03629124 0.41299428 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP multiple epiphyseal dysplasia DOID_12721 9.453E-06 3.842E-04 9.453E-06 2.689E-03 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP ulcerative colitis DOID_8577 9.56E-06 3.627E-04 0.12378837 0.54601225 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP spastic cerebral palsy DOID_0050669 1.145E-05 4.073E-04 0.04263458 0.41117074 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP abdominal aortic aneurysm DOID_7693 1.145E-05 3.833E-04 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP pleural disease DOID_1532 1.371E-05 4.335E-04 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP multiple myeloma DOID_9538 2.06E-05 6.171E-04 0.05144656 0.41229706 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hepatitis DOID_2237 2.39E-05 6.799E-04 0.05394963 0.41482893 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP adult respiratory distress syndrome DOID_11394 2.567E-05 6.954E-04 0.05519874 0.41326427 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP intracranial arterial disease DOID_13089 2.567E-05 6.638E-04 0.05519874 0.4078972 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP cerebral arterial disease DOID_3527 2.567E-05 6.638E-04 0.05519874 0.4078972 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hyperinsulinism DOID_2018 3.148E-05 7.788E-04 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP cerebral infarction DOID_3526 3.58E-05 8.488E-04 0.06142008 0.42619546 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP myeloma DOID_0070004 4.05E-05 9.217E-04 0.06389736 0.42773648 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP vascular skin disease DOID_9540 4.05E-05 8.863E-04 0.06389736 0.41315455 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP aortic aneurysm DOID_3627 4.827E-05 1.017E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bone marrow cancer DOID_4960 6.007E-05 1.221E-03 0.07251749 0.44368226 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP osteochondrodysplasia DOID_2256 6.328E-05 1.242E-03 6.328E-05 0.01200272 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hypertrophic cardiomyopathy DOID_11984 7.361E-05 1.396E-03 0.0774083 0.44490222 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP acute kidney failure DOID_3021 7.619E-05 1.399E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP melancholia DOID_2848 7.728E-05 1.374E-03 0.07862704 0.44295829 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP neurotic disorder DOID_4964 8.107E-05 1.398E-03 0.07984421 0.44540546 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP carotid artery disease DOID_3407 8.498E-05 1.422E-03 0.08105981 0.44349067 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP respiratory failure DOID_11162 8.9E-05 1.447E-03 0.08227383 0.44163969 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hypothyroidism DOID_1459 8.9E-05 1.407E-03 8.9E-05 0.01266084 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP adrenoleukodystrophy DOID_10588 9.305E-05 1.431E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP mineral metabolism disease DOID_0050032 9.743E-05 1.459E-03 0.08469715 0.44622851 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP cholestasis DOID_13580 1.018E-04 1.486E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP relapsing-remitting multiple sclerosis DOID_2378 1.116E-04 1.587E-03 0.0157145 0.31934118 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bile duct disease DOID_4138 1.31E-04 1.818E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP berylliosis DOID_10322 1.317E-04 1.785E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP newborn respiratory distress syndrome DOID_12716 1.317E-04 1.743E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP peripheral vascular disease DOID_341 1.363E-04 1.763E-03 0.0943279 0.46671806 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP biliary tract disease DOID_9741 1.363E-04 1.724E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP diabetic retinopathy DOID_8947 1.418E-04 1.754E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP cystic fibrosis DOID_1485 1.532E-04 1.854E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP endogenous depression DOID_1595 1.532E-04 1.816E-03 0.09791377 0.48028393 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hypercalcemia DOID_12678 1.536E-04 1.783E-03 0.01830995 0.34727879 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bacterial pneumonia DOID_874 1.651E-04 1.879E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP metabolic syndrome X DOID_14221 1.776E-04 1.982E-03 0.10267329 0.49093365 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP female reproductive system disease DOID_229 1.841E-04 2.015E-03 5.419E-03 0.19270681 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP mental depression DOID_1596 1.976E-04 2.121E-03 0.10622678 0.49543473 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP spastic diplegia DOID_10965 2.022E-04 2.13E-03 0.0208987 0.32138804 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP retinal vascular disease DOID_2462 2.116E-04 2.189E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP prion disease DOID_649 2.573E-04 2.615E-03 0.02348075 0.32586694 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP lymphoblastic leukemia DOID_1037 2.743E-04 2.738E-03 7.039E-03 0.22250313 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP dissociative disorder DOID_10935 2.874E-04 2.819E-03 0.02476927 0.33556461 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP dissociative amnesia DOID_11037 2.874E-04 2.819E-03 0.02476927 0.33556461 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Down syndrome DOID_14250 2.874E-04 2.771E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP leishmaniasis DOID_9065 2.874E-04 2.725E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP amnestic disorder DOID_10914 3.19E-04 2.976E-03 0.02605612 0.34478917 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP esophagitis DOID_11963 3.19E-04 2.928E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP brain edema DOID_4724 3.19E-04 2.881E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP mitochondrial myopathy DOID_699 3.523E-04 3.132E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP diabetic angiopathy DOID_11713 4.618E-04 4.043E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP meningitis DOID_9471 4.618E-04 3.982E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP spastic quadriplegia DOID_10970 5.016E-04 4.26E-03 0.03246548 0.4015839 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP toxic shock syndrome DOID_14115 5.016E-04 4.197E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP commensal bacterial infectious disease DOID_0050339 5.429E-04 4.477E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP X-linked disease DOID_0050735 5.429E-04 4.413E-03 5.429E-04 0.05148705 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP portal hypertension DOID_10762 5.429E-04 4.351E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP gestational diabetes DOID_11714 6.765E-04 5.346E-03 0.03756319 0.411028 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP autoimmune disease of cardiovascular system DOID_0060051 7.242E-04 5.645E-03 0.0388335 0.4169106 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP pleurisy DOID_10247 7.242E-04 5.569E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP renal hypertension DOID_1073 7.242E-04 5.495E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP secondary hypertension DOID_11130 7.242E-04 5.495E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Behcet's disease DOID_13241 7.242E-04 5.645E-03 0.0388335 0.4169106 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP mononeuritis DOID_1802 7.242E-04 5.422E-03 0.0388335 0.40175021 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hepatic vascular disease DOID_272 7.242E-04 5.352E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP coronary stenosis DOID_4248 7.242E-04 5.283E-03 0.0388335 0.3945761 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP mononeuropathy DOID_1188 7.735E-04 5.571E-03 0.04010217 0.40031811 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP dysostosis DOID_1934 8.244E-04 5.864E-03 8.244E-04 0.06701223 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bronchiolitis obliterans DOID_2799 8.769E-04 6.16E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP allergic rhinitis DOID_4481 9.309E-04 6.459E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP papilloma DOID_2615 1.044E-03 7.154E-03 0.04642092 0.42602425 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP metal metabolism disorder DOID_896 1.044E-03 7.069E-03 1.044E-03 0.07422633 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP pneumoconiosis DOID_10316 1.102E-03 7.379E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP esophageal disease DOID_6050 1.102E-03 7.293E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hyperthyroidism DOID_7998 1.102E-03 7.209E-03 0.04767977 0.42390295 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP respiratory syncytial virus infectious disease DOID_1273 1.419E-03 9.176E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP congenital diaphragmatic hernia DOID_3827 1.419E-03 9.072E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP spinocerebellar ataxia DOID_1441 1.628E-03 0.01028988 0.05769211 0.42085657 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP learning disability DOID_8927 1.85E-03 0.01156616 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP spinocerebellar degeneration DOID_2478 1.927E-03 0.01191724 0.06265953 0.4244437 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP neuritis DOID_1803 2.005E-03 0.01226998 0.06389736 0.41790345 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hemolytic anemia DOID_583 2.086E-03 0.01262432 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP normocytic anemia DOID_720 2.086E-03 0.01262432 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP calcium metabolism disease DOID_10575 2.25E-03 0.01347786 0.06760127 0.43219242 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP withdrawal disorder DOID_0060001 2.335E-03 0.0138388 2.335E-03 0.13285249 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP B-cell lymphocytic neoplasm DOID_707 2.335E-03 0.01369613 0.06883272 0.43039358 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP sarcoidosis DOID_11335 2.508E-03 0.01456447 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP giant cell tumor DOID_200 2.508E-03 0.01441735 0.07129082 0.44091823 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP malignant giant cell tumor DOID_2705 2.508E-03 0.01441735 0.07129082 0.44091823 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP giant cell glioblastoma DOID_3074 2.508E-03 0.01441735 0.07129082 0.44091823 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP vasculitis DOID_865 2.597E-03 0.01477977 0.07251749 0.43896224 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP integumentary system cancer DOID_0060122 2.688E-03 0.01514333 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP skin cancer DOID_4159 2.688E-03 0.01514333 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP mitochondrial metabolism disease DOID_700 2.78E-03 0.01550796 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hypersensitivity reaction type IV disease DOID_2916 2.968E-03 0.01639792 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP glioblastoma DOID_3068 2.968E-03 0.01624025 0.0774083 0.4404532 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP leukocyte disease DOID_9500 3.065E-03 0.01660781 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP uterine disease DOID_345 3.673E-03 0.0197183 0.08590646 0.4443707 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP temporal lobe epilepsy DOID_3328 3.78E-03 0.02010023 3.78E-03 0.17922709 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP astrocytoma DOID_3069 4.108E-03 0.02164214 0.09072807 0.46093097 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP blood coagulation disease DOID_1247 4.22E-03 0.02202914 0.09192957 0.46290198 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP nephrosis DOID_2527 4.334E-03 0.02241641 0.09312951 0.46483063 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP contact dermatitis DOID_2773 5.293E-03 0.02713096 0.10267329 0.48684254 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP chromosomal disease DOID_0080014 5.419E-03 0.02752954 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP focal epilepsy DOID_2234 5.675E-03 0.02857699 5.675E-03 0.18995297 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP amino acid metabolic disorder DOID_9252 6.477E-03 0.03232896 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP nervous system cancer DOID_3093 6.616E-03 0.03273257 0.1144647 0.52524526 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP lymphoma DOID_0060058 6.896E-03 0.0338278 0.11680469 0.53169494 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP encephalomyelitis DOID_640 7.039E-03 0.03423125 0.11797241 0.53274843 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP alcohol-related neurodevelopmental disorder DOID_0050667 7.183E-03 0.03463428 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP mouth disease DOID_403 7.183E-03 0.03434324 0.11913862 0.53377854 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Crohn's disease DOID_8778 7.183E-03 0.03405705 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hypersensitivity reaction type I disease DOID_1205 7.328E-03 0.03445778 0.12030332 0.53478585 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP dilated cardiomyopathy DOID_12930 7.328E-03 0.03417533 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP brachydactyly DOID_0050581 0.01311233 0.06065786 0.01311233 0.39267982 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Sjogren's syndrome DOID_12894 0.01311233 0.06016868 0.01311233 0.37304583 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hyperparathyroidism DOID_13543 0.01311233 0.05968733 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP retinal vascular occlusion DOID_1729 0.01311233 0.05921362 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP transient cerebral ischemia DOID_224 0.01311233 0.05874737 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP lateral sclerosis DOID_230 0.01311233 0.05828841 0.01311233 0.35528174 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP insulinoma DOID_3892 0.01311233 0.05783656 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Paget's disease of bone DOID_5408 0.01311233 0.05739167 0.01311233 0.33913257 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP cutaneous leishmaniasis DOID_9111 0.01311233 0.05695356 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP visceral leishmaniasis DOID_9146 0.01311233 0.0565221 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP familial adenomatous polyposis DOID_0050424 0.01441426 0.06166702 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP trypanosomiasis DOID_10113 0.01441426 0.06120682 0.01441426 0.35659625 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP prediabetes syndrome DOID_11716 0.01441426 0.06075344 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP migraine without aura DOID_12783 0.01441426 0.06030672 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP neuronal ceroid lipofuscinosis DOID_14503 0.01441426 0.05986652 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP craniosynostosis DOID_2340 0.01441426 0.05943271 0.01441426 0.34173807 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hemochromatosis DOID_2352 0.01441426 0.05900513 0.01441426 0.32806855 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP prostatic adenoma DOID_2883 0.01441426 0.05858367 0.01441426 0.31545053 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bronchiectasis DOID_9563 0.01441426 0.05816818 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP ovarian disease DOID_1100 0.0157145 0.06296868 0.0157145 0.33116864 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP islet cell tumor DOID_1799 0.0157145 0.06252834 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP parathyroid gland disease DOID_11201 0.01701307 0.06722525 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP polyneuropathy DOID_1389 0.01701307 0.06676163 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP vesiculobullous skin disease DOID_2731 0.01701307 0.06630436 0.01701307 0.33380814 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP viral pneumonia DOID_10533 0.01830995 0.07087322 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP eyelid disease DOID_530 0.01830995 0.07039435 0.01830995 0.33607624 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP polycystic kidney disease DOID_898 0.01830995 0.0699219 0.01830995 0.32557386 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bacterial meningitis DOID_9470 0.01830995 0.06945576 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP skeletal system cancer DOID_0060124 0.01960516 0.0738764 0.01960516 0.33804052 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Ehlers-Danlos syndrome DOID_13359 0.01960516 0.07339038 0.01960516 0.32809815 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP renovascular hypertension DOID_1591 0.01960516 0.0729107 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bone cancer DOID_184 0.01960516 0.0738764 0.01960516 0.33804052 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP arthropathy DOID_381 0.01960516 0.07243725 0.01960516 0.31872391 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP lung oat cell carcinoma DOID_5411 0.01960516 0.07196992 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP varicose veins DOID_799 0.01960516 0.07150857 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP intermediate coronary syndrome DOID_8805 0.01960516 0.0710531 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hyperhomocysteinemia DOID_9279 0.01960516 0.0706034 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP angiosarcoma DOID_0001816 0.0208987 0.07478841 0.0208987 0.33031549 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP silicosis DOID_10325 0.0208987 0.07432098 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hemolytic-uremic syndrome DOID_12554 0.0208987 0.07385936 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP restrictive cardiomyopathy DOID_397 0.0208987 0.07340344 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP thyroiditis DOID_7166 0.0208987 0.07295311 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP autoimmune thyroiditis DOID_7188 0.0208987 0.07295311 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP tongue cancer DOID_8649 0.0208987 0.07250828 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP vein disease DOID_866 0.0208987 0.07206883 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Barrett's esophagus DOID_9206 0.0208987 0.07163468 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP drug-induced mental disorder DOID_1203 0.02219056 0.07560734 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP methylmalonic acidemia DOID_14749 0.02219056 0.0751573 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP drug psychosis DOID_1742 0.02219056 0.07560734 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hyperostosis DOID_205 0.02219056 0.07471258 0.02219056 0.33227438 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP basal cell carcinoma DOID_2513 0.02219056 0.0742731 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP bronchitis DOID_6132 0.02219056 0.07383875 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP substance-induced psychosis DOID_8646 0.02219056 0.07560734 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP male reproductive organ benign neoplasm DOID_0060087 0.02348075 0.07767758 0.02348075 0.34257807 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP skin carcinoma DOID_3451 0.02348075 0.07722858 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP osteosclerosis DOID_4254 0.02348075 0.07678474 0.02348075 0.33401362 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Kawasaki disease DOID_13378 0.02734132 0.08889833 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP lymphadenitis DOID_1602 0.02734132 0.08889833 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP autoimmune hepatitis DOID_2048 0.02734132 0.08839323 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP coronary restenosis DOID_4247 0.02734132 0.08789383 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP lymph node disease DOID_9942 0.02734132 0.08889833 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP gastric ulcer DOID_10808 0.02862485 0.09150302 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP placenta disease DOID_780 0.02862485 0.09099183 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP optic nerve disease DOID_1891 0.02990671 0.09453845 0.02990671 0.3867482 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP polyarteritis nodosa DOID_9810 0.02990671 0.09401614 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP hypoglycemia DOID_9993 0.02990671 0.09349956 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP synostosis DOID_11971 0.03118693 0.09696919 0.03118693 0.39434136 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Lewy body dementia DOID_12217 0.03118693 0.09644218 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP Goodpasture syndrome DOID_9808 0.03118693 0.09592087 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP acute pancreatitis DOID_2913 0.03246548 0.09931645 1.000 1.000 ROPERO_HDAC2_TARGETS cerebral degeneration DOID_1443 2.401E-06 1.366E-03 3.967E-03 0.16123233 ROPERO_HDAC2_TARGETS polycystic ovary syndrome DOID_11612 1.065E-05 3.029E-03 8.365E-04 0.47594254 ROPERO_HDAC2_TARGETS hyperinsulinism DOID_2018 3.544E-05 6.721E-03 1.837E-03 0.2613786 ROPERO_HDAC2_TARGETS leukodystrophy DOID_10579 4.289E-05 6.1E-03 0.06508422 0.38982019 ROPERO_HDAC2_TARGETS maturity-onset diabetes of the young DOID_0050524 1.007E-04 0.01145836 0.01498688 0.35531397 ROPERO_HDAC2_TARGETS mineral metabolism disease DOID_0050032 1.096E-04 0.01039208 3.854E-03 0.18273162 ROPERO_HDAC2_TARGETS endocrine pancreas disease DOID_1428 1.096E-04 8.907E-03 3.854E-03 0.16867534 ROPERO_HDAC2_TARGETS hyperglycemia DOID_4195 1.196E-04 8.508E-03 4.082E-03 0.1548401 ROPERO_HDAC2_TARGETS hydrocephalus DOID_10908 1.662E-04 0.01050469 0.01903584 0.32822395 ROPERO_HDAC2_TARGETS syndrome DOID_225 1.722E-04 9.797E-03 5.184E-03 0.18435968 ROPERO_HDAC2_TARGETS intracranial hypertension DOID_9428 1.915E-04 9.908E-03 0.02038186 0.27612562 ROPERO_HDAC2_TARGETS Lewy body dementia DOID_12217 4.995E-04 0.02368632 0.03241481 0.34155605 ROPERO_HDAC2_TARGETS multiple myeloma DOID_9538 1.392E-03 0.0609291 1.392E-03 0.39603912 ROPERO_HDAC2_TARGETS hepatitis DOID_2237 1.534E-03 0.06234293 0.05604744 0.35832579 ROPERO_HDAC2_TARGETS spinocerebellar ataxia DOID_1441 1.759E-03 0.06672893 1.759E-03 0.33364464 ROPERO_HDAC2_TARGETS spinocerebellar degeneration DOID_2478 2.082E-03 0.07405179 2.082E-03 0.23696573 ROPERO_HDAC2_TARGETS myeloma DOID_0070004 2.167E-03 0.07253623 2.167E-03 0.20551932 ROPERO_HDAC2_TARGETS autonomic nervous system disease DOID_11465 2.167E-03 0.06850644 0.06636824 0.38931471 ROPERO_HDAC2_TARGETS glaucoma DOID_1686 2.342E-03 0.0701289 2.342E-03 0.19034987 ROPERO_HDAC2_TARGETS calcium metabolism disease DOID_10575 2.431E-03 0.0691745 2.431E-03 0.17293624 ROPERO_HDAC2_TARGETS B-cell lymphocytic neoplasm DOID_707 2.523E-03 0.06835446 2.523E-03 0.15949374 ROPERO_HDAC2_TARGETS bone marrow cancer DOID_4960 2.806E-03 0.07257986 2.806E-03 0.15967569 ROPERO_HDAC2_TARGETS smallpox DOID_8736 2.904E-03 0.07184074 2.904E-03 0.15021246 ROPERO_HDAC2_TARGETS temporal lobe epilepsy DOID_3328 4.082E-03 0.09677506 0.09043861 0.44361696 CLAUS_PGR_POSITIVE_MENINGIOMA_DN reproductive organ benign neoplasm DOID_0050622 2.294E-05 0.01305006 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN uterine disease DOID_345 3.159E-05 8.987E-03 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN female reproductive system disease DOID_229 4.715E-05 8.943E-03 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN lymphoma DOID_0060058 6.053E-05 8.611E-03 0.01233678 0.36945404 CLAUS_PGR_POSITIVE_MENINGIOMA_DN salivary gland cancer DOID_8850 5.921E-03 0.09909289 5.921E-03 0.25916601 CLAUS_PGR_POSITIVE_MENINGIOMA_DN endometriosis DOID_289 6.052E-03 0.09839562 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN gallbladder cancer DOID_3121 6.184E-03 0.09773687 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN uterine cancer DOID_363 6.184E-03 0.09509533 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN myeloma DOID_0070004 6.577E-03 0.09848741 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN thyroid adenoma DOID_2891 6.577E-03 0.09596209 1.000 1.000 CLAUS_PGR_POSITIVE_MENINGIOMA_DN heart valve disease DOID_4079 6.577E-03 0.09356304 6.577E-03 0.26732298 CLAUS_PGR_POSITIVE_MENINGIOMA_DN B-cell lymphocytic neoplasm DOID_707 7.102E-03 0.0985627 1.000 1.000 KORKOLA_TERATOMA heart valve disease DOID_4079 1.737E-06 9.883E-04 1.737E-06 9.883E-04 KORKOLA_TERATOMA pre-malignant neoplasm DOID_0060071 4.036E-06 1.148E-03 4.036E-06 1.148E-03 KORKOLA_TERATOMA in situ carcinoma DOID_8719 4.036E-06 1.148E-03 4.036E-06 1.148E-03 KORKOLA_TERATOMA facioscapulohumeral muscular dystrophy DOID_11727 9.56E-06 1.813E-03 9.56E-06 1.813E-03 KORKOLA_TERATOMA aortic valve stenosis DOID_1712 1.401E-05 1.993E-03 1.401E-05 1.993E-03 KORKOLA_TERATOMA aortic valve disease DOID_62 5.84E-05 6.646E-03 5.84E-05 6.646E-03 KORKOLA_TERATOMA osteosarcoma DOID_3347 6.873E-05 6.518E-03 6.873E-05 6.518E-03 KORKOLA_TERATOMA gestational diabetes DOID_11714 8.579E-05 6.973E-03 0.01368298 0.31142452 KORKOLA_TERATOMA spindle cell carcinoma DOID_4015 1.404E-04 9.987E-03 1.404E-04 0.01141338 KORKOLA_TERATOMA calcinosis DOID_182 1.643E-04 0.01038781 1.643E-04 0.01168628 KORKOLA_TERATOMA calcium metabolism disease DOID_10575 2.892E-04 0.01645634 2.892E-04 0.01828482 KORKOLA_TERATOMA atrophic muscular disease DOID_913 3.229E-04 0.01670497 3.229E-04 0.01837547 KORKOLA_TERATOMA muscular dystrophy DOID_9884 3.229E-04 0.01670497 3.229E-04 0.01837547 KORKOLA_TERATOMA mineral metabolism disease DOID_0050032 4.622E-04 0.02191704 4.622E-04 0.0239095 PODAR_RESPONSE_TO_ADAPHOSTIN_DN cystitis DOID_1679 4.421E-05 0.02515825 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN bladder disease DOID_365 7.482E-05 0.02128762 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN uveitis DOID_13141 1.03E-04 0.01953363 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN respiratory syncytial virus infectious disease DOID_1273 1.081E-04 0.01537949 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN systemic scleroderma DOID_418 1.081E-04 0.01230359 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN rheumatic disease DOID_1575 1.299E-04 0.01231463 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN uveal disease DOID_3480 1.299E-04 0.0105554 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN scleroderma DOID_419 1.299E-04 0.01231463 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN proteinuria DOID_576 1.475E-04 0.01048756 0.01794683 0.44398886 PODAR_RESPONSE_TO_ADAPHOSTIN_DN collagen disease DOID_854 2.52E-04 0.01593056 1.000 1.000 PODAR_RESPONSE_TO_ADAPHOSTIN_DN lipid metabolism disorder DOID_3146 4.135E-04 0.02352896 4.135E-04 0.23528957 ZHAN_MULTIPLE_MYELOMA_SPIKED transitional cell carcinoma DOID_2671 7.085E-06 4.031E-03 6.545E-04 0.37239257 ZHAN_MULTIPLE_MYELOMA_SPIKED colon carcinoma DOID_1520 3.159E-05 8.987E-03 8.409E-03 0.39873452 BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION hypokalemia DOID_4500 2.815E-06 1.602E-03 1.000 1.000 BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION bronchiectasis DOID_9563 3.44E-06 9.786E-04 1.000 1.000 BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION renal tubular transport disease DOID_447 2.713E-05 5.146E-03 1.000 1.000 BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION mineral metabolism disease DOID_0050032 1.372E-04 0.01951607 1.000 1.000 BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION cystic fibrosis DOID_1485 1.861E-04 0.02117273 1.000 1.000 BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION Human immunodeficiency virus infectious disease DOID_526 2.588E-04 0.02454617 1.000 1.000 BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION carbohydrate metabolic disorder DOID_2978 2.76E-04 0.02243241 2.76E-04 0.15702686 MURAKAMI_UV_RESPONSE_24HR integumentary system cancer DOID_0060122 5.927E-11 3.372E-08 2.728E-06 1.552E-03 MURAKAMI_UV_RESPONSE_24HR skin cancer DOID_4159 5.927E-11 3.372E-08 2.728E-06 1.552E-03 MURAKAMI_UV_RESPONSE_24HR autoimmune hepatitis DOID_2048 1.189E-07 3.382E-05 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pneumoconiosis DOID_10316 6.912E-07 1.311E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pulmonary emphysema DOID_9675 1.176E-06 1.673E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR influenza DOID_8469 1.438E-06 1.637E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR autoimmune disease of gastrointestinal tract DOID_0060031 1.957E-06 1.856E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR integumentary system benign neoplasm DOID_0060121 1.957E-06 1.591E-04 2.784E-04 0.0316796 MURAKAMI_UV_RESPONSE_24HR skin benign neoplasm DOID_3165 1.957E-06 1.591E-04 2.784E-04 0.0316796 MURAKAMI_UV_RESPONSE_24HR bone marrow cancer DOID_4960 2.588E-06 1.84E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pancreatic ductal carcinoma DOID_3587 5.474E-06 3.461E-04 5.485E-04 0.0520135 MURAKAMI_UV_RESPONSE_24HR pancreatic carcinoma DOID_4905 6.182E-06 3.518E-04 5.943E-04 0.04830839 MURAKAMI_UV_RESPONSE_24HR cystic fibrosis DOID_1485 6.686E-06 3.458E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pancreatitis DOID_4989 7.216E-06 3.422E-04 0.03731822 0.55879125 MURAKAMI_UV_RESPONSE_24HR encephalomyelitis DOID_640 1.21E-05 5.298E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hypersensitivity reaction type I disease DOID_1205 1.288E-05 5.237E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR epidermolysis bullosa DOID_2730 1.401E-05 5.316E-04 1.401E-05 3.987E-03 MURAKAMI_UV_RESPONSE_24HR berylliosis DOID_10322 1.656E-05 5.888E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR vesiculobullous skin disease DOID_2731 1.656E-05 5.541E-04 1.656E-05 3.14E-03 MURAKAMI_UV_RESPONSE_24HR basal cell carcinoma DOID_2513 2.883E-05 9.115E-04 8.043E-03 0.28601641 MURAKAMI_UV_RESPONSE_24HR bronchitis DOID_6132 2.883E-05 8.635E-04 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR keratosis DOID_161 3.243E-05 9.226E-04 3.243E-05 4.613E-03 MURAKAMI_UV_RESPONSE_24HR skin carcinoma DOID_3451 3.243E-05 8.787E-04 8.514E-03 0.28496289 MURAKAMI_UV_RESPONSE_24HR esophagitis DOID_11963 4.025E-05 1.041E-03 9.456E-03 0.29890118 MURAKAMI_UV_RESPONSE_24HR placenta disease DOID_780 4.891E-05 1.21E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR aortic valve disease DOID_62 5.84E-05 1.385E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR spastic quadriplegia DOID_10970 6.346E-05 1.444E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR spastic cerebral palsy DOID_0050669 1.114E-04 2.439E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR bronchiolitis obliterans DOID_2799 1.114E-04 2.349E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR allergic rhinitis DOID_4481 1.184E-04 2.406E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR spindle cell carcinoma DOID_4015 1.404E-04 2.755E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR esophageal disease DOID_6050 1.404E-04 2.663E-03 0.01742636 0.41314987 MURAKAMI_UV_RESPONSE_24HR pulmonary sarcoidosis DOID_13406 1.643E-04 3.016E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR respiratory syncytial virus infectious disease DOID_1273 1.813E-04 3.223E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR congenital diaphragmatic hernia DOID_3827 1.813E-04 3.125E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR systemic scleroderma DOID_418 1.813E-04 3.034E-03 0.01975915 0.43242143 MURAKAMI_UV_RESPONSE_24HR peptic ulcer DOID_750 1.813E-04 2.947E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR rheumatic disease DOID_1575 2.177E-04 3.44E-03 0.02162162 0.45565562 MURAKAMI_UV_RESPONSE_24HR scleroderma DOID_419 2.177E-04 3.44E-03 0.02162162 0.45565562 MURAKAMI_UV_RESPONSE_24HR proteinuria DOID_576 2.471E-04 3.8E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR myeloma DOID_0070004 2.573E-04 3.853E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR heart valve disease DOID_4079 2.573E-04 3.754E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR vascular skin disease DOID_9540 2.573E-04 3.66E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pulmonary tuberculosis DOID_2957 2.784E-04 3.863E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR atopic dermatitis DOID_3310 3.115E-04 4.22E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR sarcoidosis DOID_11335 3.229E-04 4.273E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR bile duct adenocarcinoma DOID_4896 3.346E-04 4.327E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR cholangiocarcinoma DOID_4947 3.346E-04 4.327E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR vasculitis DOID_865 3.346E-04 4.231E-03 0.02672619 0.47522509 MURAKAMI_UV_RESPONSE_24HR parasitic protozoa infectious disease DOID_2789 3.464E-04 4.285E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pustulosis of palm and sole DOID_4398 3.464E-04 4.194E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hypersensitivity reaction type IV disease DOID_2916 3.832E-04 4.543E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR bile duct cancer DOID_4606 3.832E-04 4.45E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR bile duct carcinoma DOID_4897 3.832E-04 4.45E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR collagen disease DOID_854 4.218E-04 4.8E-03 0.02996145 0.48708753 MURAKAMI_UV_RESPONSE_24HR respiratory failure DOID_11162 4.351E-04 4.854E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR cholestasis DOID_13580 4.761E-04 5.21E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR parasitic infectious disease DOID_1398 4.761E-04 5.111E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR uterine disease DOID_345 4.761E-04 5.017E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR tuberculosis DOID_399 5.189E-04 5.368E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR bile duct disease DOID_4138 5.635E-04 5.726E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR peripheral vascular disease DOID_341 5.788E-04 5.778E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR biliary tract disease DOID_9741 5.788E-04 5.678E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR diabetic retinopathy DOID_8947 5.943E-04 5.732E-03 0.03548398 0.56084407 MURAKAMI_UV_RESPONSE_24HR bone resorption disease DOID_0080011 6.419E-04 6.088E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR osteoporosis DOID_11476 6.419E-04 6.088E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR aneurysm disease DOID_2403 6.419E-04 5.988E-03 0.03685997 0.56684657 MURAKAMI_UV_RESPONSE_24HR bacterial pneumonia DOID_874 6.582E-04 6.041E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR metabolic syndrome X DOID_14221 6.914E-04 6.244E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR chromosomal disease DOID_0080014 7.082E-04 6.297E-03 7.082E-04 0.05037246 MURAKAMI_UV_RESPONSE_24HR female reproductive system disease DOID_229 7.082E-04 6.2E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR biliary tract cancer DOID_4607 7.426E-04 6.402E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR retinal vascular disease DOID_2462 7.777E-04 6.605E-03 0.04052021 0.59117948 MURAKAMI_UV_RESPONSE_24HR primary bacterial infectious disease DOID_0050338 8.136E-04 6.808E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR mouth disease DOID_403 9.456E-04 7.797E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR Crohn's disease DOID_8778 9.456E-04 7.686E-03 0.04462228 0.61927014 MURAKAMI_UV_RESPONSE_24HR arrhythmogenic right ventricular dysplasia DOID_0050431 4.266E-03 0.03418415 4.266E-03 0.26967494 MURAKAMI_UV_RESPONSE_24HR DiGeorge syndrome DOID_11198 4.266E-03 0.03370937 4.266E-03 0.24270745 MURAKAMI_UV_RESPONSE_24HR velocardiofacial syndrome DOID_12583 4.266E-03 0.03370937 4.266E-03 0.24270745 MURAKAMI_UV_RESPONSE_24HR T cell deficiency DOID_11200 4.738E-03 0.03693349 4.738E-03 0.2451041 MURAKAMI_UV_RESPONSE_24HR hyperparathyroidism DOID_13543 4.738E-03 0.03643439 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR retinal vascular occlusion DOID_1729 4.738E-03 0.0359486 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR insulinoma DOID_3892 4.738E-03 0.03547559 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR visceral leishmaniasis DOID_9146 4.738E-03 0.03501487 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR alopecia areata DOID_986 4.738E-03 0.03456596 4.738E-03 0.22467875 MURAKAMI_UV_RESPONSE_24HR prediabetes syndrome DOID_11716 5.211E-03 0.03753285 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR prostatic adenoma DOID_2883 5.211E-03 0.03706369 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR aortic valve stenosis DOID_1712 5.684E-03 0.03992499 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR islet cell tumor DOID_1799 5.684E-03 0.0394381 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR aortic valve insufficiency DOID_57 5.684E-03 0.03896294 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR Hodgkin's lymphoma DOID_8567 5.684E-03 0.0384991 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR ocular hypertension DOID_9282 5.684E-03 0.03804617 5.684E-03 0.2487634 MURAKAMI_UV_RESPONSE_24HR borderline glaucoma DOID_9283 5.684E-03 0.03804617 5.684E-03 0.2487634 MURAKAMI_UV_RESPONSE_24HR parathyroid gland disease DOID_11201 6.156E-03 0.04072829 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR polyneuropathy DOID_1389 6.156E-03 0.04026015 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hypercalcemia DOID_12678 6.628E-03 0.04285478 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR Williams-Beuren syndrome DOID_1928 7.1E-03 0.04538976 7.1E-03 0.28854919 MURAKAMI_UV_RESPONSE_24HR lung oat cell carcinoma DOID_5411 7.1E-03 0.04488543 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR oral submucous fibrosis DOID_5773 7.1E-03 0.04439218 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR silicosis DOID_10325 7.571E-03 0.04682648 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR spastic diplegia DOID_10965 7.571E-03 0.04632297 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hemolytic-uremic syndrome DOID_12554 7.571E-03 0.04583017 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR thyroiditis DOID_7166 7.571E-03 0.04534775 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR autoimmune thyroiditis DOID_7188 7.571E-03 0.04534775 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR tongue cancer DOID_8649 7.571E-03 0.04487537 7.571E-03 0.28720239 MURAKAMI_UV_RESPONSE_24HR penile disease DOID_1529 8.043E-03 0.04717797 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR male reproductive organ benign neoplasm DOID_0060087 8.514E-03 0.04943234 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR osteosclerosis DOID_4254 8.514E-03 0.04893302 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR ureteral obstruction DOID_5199 8.514E-03 0.04844369 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR dissociative disorder DOID_10935 8.985E-03 0.05061738 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR dissociative amnesia DOID_11037 8.985E-03 0.05061738 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR psoriasis DOID_8893 8.985E-03 0.05012113 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR leishmaniasis DOID_9065 8.985E-03 0.04963452 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR amnestic disorder DOID_10914 9.456E-03 0.0517329 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pulmonary edema DOID_11396 9.456E-03 0.0512402 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR alopecia DOID_987 9.456E-03 0.0507568 9.456E-03 0.28316954 MURAKAMI_UV_RESPONSE_24HR Kawasaki disease DOID_13378 9.926E-03 0.05278474 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR lymphadenitis DOID_1602 9.926E-03 0.05278474 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR mitochondrial myopathy DOID_699 9.926E-03 0.05229599 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR lymph node disease DOID_9942 9.926E-03 0.05278474 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR sinusitis DOID_0050127 0.01086661 0.05672567 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR paranasal sinus disease DOID_1352 0.01086661 0.05672567 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR IgA glomerulonephritis DOID_2986 0.01086661 0.05620998 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR uremia DOID_4676 0.01086661 0.05570359 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR urinary tract obstruction DOID_5200 0.01086661 0.05520624 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR polyarteritis nodosa DOID_9810 0.01086661 0.05471768 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR ureteral disease DOID_1426 0.01133653 0.05658319 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR meningitis DOID_9471 0.01133653 0.05609116 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR Goodpasture syndrome DOID_9808 0.01133653 0.05560762 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR urticaria DOID_1555 0.01227574 0.05969996 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hypogonadism DOID_1924 0.01227574 0.05919403 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR bronchiolitis DOID_2942 0.01227574 0.0586966 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR osteosarcoma DOID_3347 0.01227574 0.05820746 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR intracranial aneurysm DOID_10941 0.01321411 0.06213907 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR middle cerebral artery infarction DOID_3525 0.01321411 0.06162973 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hypotrichosis DOID_4535 0.01321411 0.06112867 0.01321411 0.37594135 MURAKAMI_UV_RESPONSE_24HR extrinsic allergic alveolitis DOID_841 0.01321411 0.0606357 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR Sciatic Neuropathy DOID_11446 0.01368298 0.0622849 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR lesion of sciatic nerve DOID_12528 0.01368298 0.0622849 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR lung adenocarcinoma DOID_3910 0.01368298 0.06179058 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR periodontitis DOID_824 0.01368298 0.06130404 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR mononeuritis of lower limb DOID_9473 0.01368298 0.0622849 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR autoimmune disease of cardiovascular system DOID_0060051 0.01415163 0.06290843 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pleurisy DOID_10247 0.01415163 0.06242077 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR malaria DOID_12365 0.01415163 0.06194061 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR Behcet's disease DOID_13241 0.01415163 0.06290843 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR mononeuritis DOID_1802 0.01415163 0.06146778 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR autoimmune disease of endocrine system DOID_0060005 0.01462008 0.06302141 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR mononeuropathy DOID_1188 0.01462008 0.06254757 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR multiple epiphyseal dysplasia DOID_12721 0.01462008 0.06208079 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR focal glomerulosclerosis DOID_3945 0.01462008 0.06162094 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR age related macular degeneration DOID_10871 0.01555635 0.06508501 0.01555635 0.42150291 MURAKAMI_UV_RESPONSE_24HR degeneration of macula and posterior pole DOID_2007 0.01555635 0.06508501 0.01555635 0.42150291 MURAKAMI_UV_RESPONSE_24HR gonadal disease DOID_2277 0.01555635 0.06460994 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR celiac disease DOID_10608 0.01602416 0.06607065 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR chronic leukemia DOID_1036 0.01649177 0.06750948 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR chronic lymphocytic leukemia DOID_1040 0.01649177 0.06750948 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pleural disease DOID_1532 0.01649177 0.06702727 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR papilloma DOID_2615 0.01695917 0.06843806 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hair disease DOID_421 0.01695917 0.06795611 0.01695917 0.43862577 MURAKAMI_UV_RESPONSE_24HR periodontal disease DOID_3388 0.01742636 0.06933984 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR macular degeneration DOID_4448 0.01742636 0.06885831 0.01742636 0.4311129 MURAKAMI_UV_RESPONSE_24HR adenoma DOID_657 0.0183601 0.07204758 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR cleft palate DOID_674 0.01882666 0.0733724 0.01882666 0.42849482 MURAKAMI_UV_RESPONSE_24HR multiple myeloma DOID_9538 0.01882666 0.07287327 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR uveitis DOID_13141 0.01929301 0.07417381 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hepatitis DOID_2237 0.01975915 0.07545609 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR adult respiratory distress syndrome DOID_11394 0.02022508 0.07672048 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR intracranial arterial disease DOID_13089 0.02022508 0.0762124 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR cerebral arterial disease DOID_3527 0.02022508 0.0762124 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR lymphatic system disease DOID_75 0.02022508 0.075711 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR benign mesothelioma DOID_2645 0.0206908 0.07694815 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR nephrotic syndrome DOID_1184 0.02162162 0.07988767 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hyperinsulinism DOID_2018 0.02162162 0.07937227 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR uveal disease DOID_3480 0.02162162 0.07886347 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR diabetic autonomic neuropathy DOID_11503 0.02208671 0.08004676 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR autonomic neuropathy DOID_11504 0.02208671 0.08004676 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR diabetic polyneuropathy DOID_12785 0.02208671 0.08004676 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR gallbladder cancer DOID_3121 0.02208671 0.07954013 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR diabetic neuropathy DOID_9743 0.02208671 0.08004676 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR cerebral infarction DOID_3526 0.0225516 0.08070353 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR pre-eclampsia DOID_10591 0.02348075 0.0835034 0.02348075 0.47716231 MURAKAMI_UV_RESPONSE_24HR autonomic nervous system disease DOID_11465 0.02348075 0.08298475 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR neuritis DOID_1803 0.02348075 0.0824725 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hemolytic anemia DOID_583 0.02394501 0.08358717 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR normocytic anemia DOID_720 0.02394501 0.08358717 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR glaucoma DOID_1686 0.02440906 0.08468752 0.02440906 0.47892255 MURAKAMI_UV_RESPONSE_24HR lung small cell carcinoma DOID_5409 0.02440906 0.08417427 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR calcium metabolism disease DOID_10575 0.0248729 0.08525711 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR aortic aneurysm DOID_3627 0.0248729 0.08474659 0.0248729 0.47175602 MURAKAMI_UV_RESPONSE_24HR orofacial cleft DOID_0050567 0.02579996 0.08738202 0.02579996 0.47355415 MURAKAMI_UV_RESPONSE_24HR atrophic muscular disease DOID_913 0.02626318 0.08842456 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR muscular dystrophy DOID_9884 0.02626318 0.08842456 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR reproductive organ benign neoplasm DOID_0050622 0.02718899 0.09100316 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR osteochondrodysplasia DOID_2256 0.02718899 0.09047098 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR familial hyperlipidemia DOID_1168 0.02765159 0.09147531 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR mitochondrial metabolism disease DOID_700 0.02765159 0.09094655 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR hypertrophic cardiomyopathy DOID_11984 0.02857615 0.09344731 0.02857615 0.49272219 MURAKAMI_UV_RESPONSE_24HR oral cavity cancer DOID_8618 0.02857615 0.09291333 0.02857615 0.47823036 MURAKAMI_UV_RESPONSE_24HR melancholia DOID_2848 0.02903813 0.09387894 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR neurotic disorder DOID_4964 0.02949989 0.09483298 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR carotid artery disease DOID_3407 0.02996145 0.09577564 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR mineral metabolism disease DOID_0050032 0.03134487 0.09963818 1.000 1.000 MURAKAMI_UV_RESPONSE_24HR endocrine pancreas disease DOID_1428 0.03134487 0.09908463 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN glioblastoma DOID_3068 2.131E-08 1.213E-05 1.282E-05 7.297E-03 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN astrocytoma DOID_3069 6.877E-08 1.956E-05 2.888E-05 8.215E-03 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN bone marrow cancer DOID_4960 3.792E-07 7.192E-05 1.808E-04 0.01715047 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN multiple myeloma DOID_9538 1.542E-06 2.193E-04 1.004E-03 0.04082561 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN aneurysm disease DOID_2403 2.656E-06 3.023E-04 6.325E-04 0.03599154 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN myeloma DOID_0070004 4.771E-06 4.525E-04 1.922E-03 0.06076906 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN lymphoma DOID_0060058 7.321E-06 5.951E-04 1.038E-04 0.01477067 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN giant cell tumor DOID_200 8.399E-06 5.974E-04 2.661E-03 0.06308637 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN malignant giant cell tumor DOID_2705 8.399E-06 5.974E-04 2.661E-03 0.06308637 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN giant cell glioblastoma DOID_3074 8.399E-06 5.974E-04 2.661E-03 0.06308637 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN cholestasis DOID_13580 2.186E-05 1.382E-03 4.609E-03 0.0874093 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN cerebral degeneration DOID_1443 2.186E-05 1.244E-03 4.609E-03 0.08458964 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN brain infarction DOID_3454 2.698E-05 1.395E-03 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN bile duct disease DOID_4138 3.298E-05 1.564E-03 5.835E-03 0.10060483 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN biliary tract disease DOID_9741 3.52E-05 1.541E-03 6.056E-03 0.10135216 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN lymphatic system disease DOID_75 5.961E-05 2.423E-03 5.961E-05 0.01130564 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN leukodystrophy DOID_10579 1E-04 3.794E-03 0.02421096 0.22583664 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hemolytic anemia DOID_583 1.171E-04 4.163E-03 2.035E-03 0.06094975 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN normocytic anemia DOID_720 1.171E-04 4.163E-03 2.035E-03 0.06094975 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hemorrhagic disease DOID_2213 1.465E-04 4.902E-03 1.465E-04 0.01666704 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN vasculitis DOID_865 1.808E-04 5.717E-03 0.03203325 0.27204355 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN congenital hemolytic anemia DOID_589 2.18E-04 6.528E-03 2.18E-04 0.01771981 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN spastic quadriplegia DOID_10970 2.468E-04 7.022E-03 0.11573333 0.43610773 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN autoimmune disease of cardiovascular system DOID_0060051 4.279E-04 0.01159449 9.516E-03 0.1259197 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN Behcet's disease DOID_13241 4.279E-04 0.01159449 9.516E-03 0.1259197 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN blood coagulation disease DOID_1247 4.688E-04 0.01212517 4.688E-04 0.03334423 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN spastic cerebral palsy DOID_0050669 5.689E-04 0.01407328 0.1498757 0.50164277 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN bone resorption disease DOID_0080011 6.325E-04 0.01499647 6.325E-04 0.0399906 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN osteoporosis DOID_11476 6.325E-04 0.01499647 6.325E-04 0.0399906 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hereditary spastic paraplegia DOID_2476 6.775E-04 0.01542018 0.01280921 0.14576877 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN metabolic syndrome X DOID_14221 7.28E-04 0.01593155 7.28E-04 0.0376564 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN auditory system disease DOID_2742 7.97E-04 0.0167959 8.276E-03 0.1239236 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hepatitis C DOID_1883 7.985E-04 0.01622764 0.01424627 0.1558871 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN nephroblastoma DOID_2154 7.985E-04 0.01566806 0.01424627 0.15294584 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN paraplegia DOID_607 7.985E-04 0.0151458 0.01424627 0.15011351 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN alcohol abuse DOID_1574 8.332E-04 0.01529281 8.548E-03 0.12160092 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN bone development disease DOID_0080006 8.705E-04 0.01547861 8.705E-04 0.0412763 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN cleft palate DOID_674 1.004E-03 0.01731996 1.004E-03 0.04396605 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN teratoma DOID_3307 1.05E-03 0.01756977 0.0479987 0.35014438 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN malignant teratoma DOID_5563 1.05E-03 0.01756977 0.0479987 0.35014438 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN mature teratoma DOID_5566 1.05E-03 0.01756977 0.0479987 0.35014438 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN intracranial arterial disease DOID_13089 1.241E-03 0.02017906 0.19071533 0.57416414 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN cerebral arterial disease DOID_3527 1.241E-03 0.02017906 0.19071533 0.57416414 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN carbohydrate metabolic disorder DOID_2978 1.261E-03 0.01993303 1.261E-03 0.04783926 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN Crohn's disease DOID_8778 1.311E-03 0.02016082 0.01189191 0.14396796 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN primitive neuroectodermal tumor DOID_168 1.51E-03 0.02261647 0.02151261 0.20746903 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN otitis media DOID_10754 1.53E-03 0.02232061 0.05731983 0.37062483 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN porphyria DOID_13268 1.53E-03 0.02176259 1.53E-03 0.05440648 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN osteopetrosis DOID_13533 1.53E-03 0.0212318 1.53E-03 0.0512061 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN middle ear disease DOID_5100 1.53E-03 0.02232061 0.05731983 0.37062483 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN parasitic helminthiasis infectious disease DOID_883 2.096E-03 0.02839325 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN pulmonary tuberculosis DOID_2957 2.152E-03 0.02847778 0.02703991 0.24040169 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN lung small cell carcinoma DOID_5409 2.152E-03 0.02783056 0.02703991 0.2367032 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN peripheral neuropathy DOID_0060053 2.41E-03 0.03047886 2.41E-03 0.06857744 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hemangioma DOID_255 2.41E-03 0.02981628 2.41E-03 0.06531185 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN nutritional deficiency disease DOID_5113 2.41E-03 0.02918189 2.41E-03 0.06234313 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN orofacial cleft DOID_0050567 2.527E-03 0.02996057 2.527E-03 0.0625264 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN spastic diplegia DOID_10965 2.746E-03 0.03188649 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN osteochondrodysplasia DOID_2256 2.941E-03 0.03346655 2.941E-03 0.06693311 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN urinary system benign neoplasm DOID_731 3.102E-03 0.0346091 0.08022742 0.36229686 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN inherited blood coagulation disease DOID_2214 3.479E-03 0.03806364 3.479E-03 0.07612728 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN osteosclerosis DOID_4254 3.479E-03 0.03734546 3.479E-03 0.07330775 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN ureteral obstruction DOID_5199 3.479E-03 0.03665388 0.08474206 0.36528965 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN neuroectodermal tumor DOID_171 3.887E-03 0.04020794 0.03957595 0.30847555 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hypothyroidism DOID_1459 4.06E-03 0.04125294 4.06E-03 0.08250587 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN amyloidosis DOID_9120 4.292E-03 0.04284537 4.292E-03 0.08421331 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN parasitic infectious disease DOID_1398 4.609E-03 0.0452117 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN tuberculosis DOID_399 5.2E-03 0.05014761 0.04771642 0.35724528 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN urinary tract obstruction DOID_5200 5.66E-03 0.05367882 0.10698677 0.41411885 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN pulmonary embolism DOID_9477 5.66E-03 0.05279883 5.66E-03 0.10064778 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN ureteral disease DOID_1426 6.155E-03 0.05648784 0.11137075 0.42246639 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hypogonadism DOID_1924 7.201E-03 0.06504141 7.201E-03 0.11707454 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN osteosarcoma DOID_3347 7.201E-03 0.06402514 7.201E-03 0.11382247 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN mixed glioma DOID_5076 7.239E-03 0.06336536 0.05898311 0.34246314 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN cleft lip DOID_9296 7.753E-03 0.06683684 7.753E-03 0.11922247 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN intracranial aneurysm DOID_10941 8.322E-03 0.07067664 0.12869367 0.46641208 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN myopia DOID_11830 8.322E-03 0.06963728 8.322E-03 0.12141884 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN vitiligo DOID_12306 8.322E-03 0.06862804 0.12869367 0.46346011 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN middle cerebral artery infarction DOID_3525 8.322E-03 0.06764764 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN migraine DOID_6364 8.91E-03 0.07140577 8.91E-03 0.12365389 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN perinatal necrotizing enterocolitis DOID_8677 8.91E-03 0.07041402 8.91E-03 0.12070975 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN sarcoma DOID_1115 9.516E-03 0.07417188 9.516E-03 0.12305788 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN renal tubular transport disease DOID_447 9.516E-03 0.07316955 0.13722875 0.47611682 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN primary bacterial infectious disease DOID_0050338 9.69E-03 0.07351425 0.07106062 0.36101333 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN transitional cell carcinoma DOID_2671 9.988E-03 0.07478224 0.35800126 0.86682007 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN toxic encephalopathy DOID_3602 0.01013961 0.07492779 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN amino acid metabolic disorder DOID_9252 0.01029236 0.07508144 0.01029236 0.13014117 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN Human immunodeficiency virus infectious disease DOID_526 0.01060155 0.07635803 0.36430039 0.87833441 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN gonadal disease DOID_2277 0.01143983 0.08136581 0.01143983 0.14150575 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN lymphoblastic leukemia DOID_1037 0.01156125 0.08121423 0.373634 0.89703691 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN Charcot-Marie-Tooth disease DOID_10595 0.01211597 0.08407299 0.01211597 0.14362469 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN celiac disease DOID_10608 0.01211597 0.08306006 0.01211597 0.14069358 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN hypersensitivity reaction type I disease DOID_1205 0.01222796 0.08282988 0.08240356 0.36346996 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN ulcerative colitis DOID_8577 0.01326866 0.08882197 0.38888809 0.92584653 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN metal metabolism disorder DOID_896 0.01351937 0.08944792 0.01351937 0.15083374 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN pneumoconiosis DOID_10316 0.01424627 0.0931739 0.1664519 0.54431686 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN lymphoid leukemia DOID_10747 0.01498974 0.09692229 1.000 1.000 GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN refractive error DOID_9835 0.01574959 0.09957241 0.01574959 0.16002708 ZHU_CMV_8_HR_DN hypersensitivity reaction type I disease DOID_1205 4.183E-06 2.38E-03 1.734E-04 0.02466224 ZHU_CMV_8_HR_DN dilated cardiomyopathy DOID_12930 4.183E-06 1.19E-03 5.219E-03 0.14848092 ZHU_CMV_8_HR_DN abdominal aortic aneurysm DOID_7693 6.74E-06 1.278E-03 1.000 1.000 ZHU_CMV_8_HR_DN endometriosis of uterus DOID_288 1.737E-05 2.471E-03 1.151E-03 0.0727607 ZHU_CMV_8_HR_DN endometriosis DOID_289 1.857E-05 2.113E-03 1.202E-03 0.06219381 ZHU_CMV_8_HR_DN aortic aneurysm DOID_3627 2.85E-05 2.702E-03 1.000 1.000 ZHU_CMV_8_HR_DN hypertrophic cardiomyopathy DOID_11984 4.351E-05 3.537E-03 0.06543153 0.3650053 ZHU_CMV_8_HR_DN uterine disease DOID_345 6.026E-05 4.286E-03 2.606E-03 0.09884707 ZHU_CMV_8_HR_DN brain infarction DOID_3454 6.857E-05 4.335E-03 2.837E-03 0.09494371 ZHU_CMV_8_HR_DN blood coagulation disease DOID_1247 7.45E-05 4.239E-03 7.45E-05 0.04239016 ZHU_CMV_8_HR_DN ocular hypertension DOID_9282 7.852E-05 4.062E-03 1.000 1.000 ZHU_CMV_8_HR_DN borderline glaucoma DOID_9283 7.852E-05 4.062E-03 1.000 1.000 ZHU_CMV_8_HR_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 9.274E-05 4.397E-03 9.274E-05 0.02638338 ZHU_CMV_8_HR_DN carotid stenosis DOID_13001 9.274E-05 4.059E-03 1.000 1.000 ZHU_CMV_8_HR_DN aneurysm disease DOID_2403 9.429E-05 3.832E-03 1.000 1.000 ZHU_CMV_8_HR_DN metabolic syndrome X DOID_14221 1.053E-04 3.996E-03 3.762E-03 0.11891608 ZHU_CMV_8_HR_DN female reproductive system disease DOID_229 1.092E-04 3.884E-03 3.852E-03 0.11535825 ZHU_CMV_8_HR_DN silicosis DOID_10325 1.424E-04 4.765E-03 0.01758265 0.2858437 ZHU_CMV_8_HR_DN pituitary adenoma DOID_3829 1.424E-04 4.5E-03 1.424E-04 0.02700286 ZHU_CMV_8_HR_DN familial hypercholesterolemia DOID_13810 2.729E-04 8.173E-03 0.02409804 0.28566214 ZHU_CMV_8_HR_DN Sciatic Neuropathy DOID_11446 4.773E-04 0.01357933 0.03164602 0.33345523 ZHU_CMV_8_HR_DN gestational diabetes DOID_11714 4.773E-04 0.0129327 0.03164602 0.32739241 ZHU_CMV_8_HR_DN lesion of sciatic nerve DOID_12528 4.773E-04 0.01357933 0.03164602 0.33345523 ZHU_CMV_8_HR_DN mononeuritis of lower limb DOID_9473 4.773E-04 0.01357933 0.03164602 0.33345523 ZHU_CMV_8_HR_DN renal hypertension DOID_1073 5.11E-04 0.01321733 0.03271963 0.3209909 ZHU_CMV_8_HR_DN secondary hypertension DOID_11130 5.11E-04 0.01321733 0.03271963 0.3209909 ZHU_CMV_8_HR_DN mononeuritis DOID_1802 5.11E-04 0.01264267 0.03271963 0.3102912 ZHU_CMV_8_HR_DN mononeuropathy DOID_1188 5.459E-04 0.01294238 0.03379209 0.31012421 ZHU_CMV_8_HR_DN female reproductive organ benign neoplasm DOID_0060086 5.819E-04 0.01324369 0.03486339 0.30056468 ZHU_CMV_8_HR_DN uterine benign neoplasm DOID_0060095 5.819E-04 0.01324369 0.03486339 0.30056468 ZHU_CMV_8_HR_DN uterine fibroid DOID_13223 5.819E-04 0.01324369 0.03486339 0.30056468 ZHU_CMV_8_HR_DN gonadal disease DOID_2277 6.19E-04 0.01354637 0.03593353 0.30067907 ZHU_CMV_8_HR_DN Charcot-Marie-Tooth disease DOID_10595 6.572E-04 0.01385021 6.572E-04 0.07479115 ZHU_CMV_8_HR_DN leiomyoma DOID_127 6.966E-04 0.01415505 0.03807033 0.30945738 ZHU_CMV_8_HR_DN pneumoconiosis DOID_10316 7.786E-04 0.01527632 0.04020251 0.32218628 ZHU_CMV_8_HR_DN male infertility DOID_12336 7.786E-04 0.01476711 0.04020251 0.31771147 ZHU_CMV_8_HR_DN uveitis DOID_13141 9.559E-04 0.01754589 1.000 1.000 ZHU_CMV_8_HR_DN blood platelet disease DOID_2218 9.559E-04 0.01699758 9.559E-04 0.09065376 ZHU_CMV_8_HR_DN congenital diaphragmatic hernia DOID_3827 1.003E-03 0.01729449 1.003E-03 0.08153114 ZHU_CMV_8_HR_DN adenoid cystic carcinoma DOID_4866 1.051E-03 0.01759229 1.051E-03 0.07476725 ZHU_CMV_8_HR_DN lymphatic system disease DOID_75 1.051E-03 0.01708966 0.04657139 0.34414446 ZHU_CMV_8_HR_DN autoimmune disease of urogenital tract DOID_0060049 1.151E-03 0.01819018 1.000 1.000 ZHU_CMV_8_HR_DN primary biliary cirrhosis DOID_12236 1.151E-03 0.01819018 1.000 1.000 ZHU_CMV_8_HR_DN salivary gland cancer DOID_8850 1.151E-03 0.01769855 1.151E-03 0.06548463 ZHU_CMV_8_HR_DN rheumatic disease DOID_1575 1.202E-03 0.01800347 0.04974035 0.36284947 ZHU_CMV_8_HR_DN uveal disease DOID_3480 1.202E-03 0.01754184 1.000 1.000 ZHU_CMV_8_HR_DN scleroderma DOID_419 1.202E-03 0.01800347 0.04974035 0.36284947 ZHU_CMV_8_HR_DN cerebral infarction DOID_3526 1.309E-03 0.01861398 0.05184727 0.36421108 ZHU_CMV_8_HR_DN proteinuria DOID_576 1.363E-03 0.01891947 0.05289902 0.3626451 ZHU_CMV_8_HR_DN neuritis DOID_1803 1.419E-03 0.01922506 0.05394963 0.352843 ZHU_CMV_8_HR_DN glaucoma DOID_1686 1.534E-03 0.0202977 1.000 1.000 ZHU_CMV_8_HR_DN hemorrhagic disease DOID_2213 1.653E-03 0.02137714 1.653E-03 0.07838284 ZHU_CMV_8_HR_DN orofacial cleft DOID_0050567 1.714E-03 0.02167564 1.714E-03 0.07503108 ZHU_CMV_8_HR_DN reproductive organ benign neoplasm DOID_0050622 1.904E-03 0.02355373 0.06231367 0.37322606 ZHU_CMV_8_HR_DN familial hyperlipidemia DOID_1168 1.97E-03 0.02384473 0.06335408 0.36412598 ZHU_CMV_8_HR_DN congenital nervous system abnormality DOID_2490 2.036E-03 0.02413614 0.06439337 0.36639826 ZHU_CMV_8_HR_DN oral cavity cancer DOID_8618 2.104E-03 0.02442792 2.104E-03 0.08549771 ZHU_CMV_8_HR_DN carotid artery disease DOID_3407 2.313E-03 0.02631715 1.000 1.000 ZHU_CMV_8_HR_DN collagen disease DOID_854 2.313E-03 0.02580113 0.06853927 0.37498892 ZHU_CMV_8_HR_DN cholestasis DOID_13580 2.606E-03 0.02851358 0.07266724 0.38642675 ZHU_CMV_8_HR_DN temporal lobe epilepsy DOID_3328 2.682E-03 0.0287905 1.000 1.000 ZHU_CMV_8_HR_DN endocrine organ benign neoplasm DOID_0060089 2.837E-03 0.02988969 2.837E-03 0.10087769 ZHU_CMV_8_HR_DN bile duct disease DOID_4138 3.077E-03 0.03183012 0.07882574 0.40407066 ZHU_CMV_8_HR_DN male reproductive system disease DOID_48 3.077E-03 0.03126172 0.07882574 0.40046289 ZHU_CMV_8_HR_DN biliary tract disease DOID_9741 3.159E-03 0.03153264 0.07984826 0.39854089 ZHU_CMV_8_HR_DN diabetic retinopathy DOID_8947 3.242E-03 0.03180424 0.08086968 0.39667972 ZHU_CMV_8_HR_DN lipid metabolism disorder DOID_3146 3.762E-03 0.03627948 0.08697498 0.41939633 ZHU_CMV_8_HR_DN focal epilepsy DOID_2234 4.035E-03 0.03826921 1.000 1.000 ZHU_CMV_8_HR_DN chronic kidney failure DOID_784 4.035E-03 0.03764184 0.09001277 0.41981367 ZHU_CMV_8_HR_DN retinal vascular disease DOID_2462 4.223E-03 0.03875438 0.09203248 0.42574376 ZHU_CMV_8_HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.115E-03 0.04619719 0.10106715 0.45640641 ZHU_CMV_8_HR_DN mouth disease DOID_403 5.115E-03 0.04547536 0.10106715 0.45281266 ZHU_CMV_8_HR_DN ulcerative colitis DOID_8577 5.537E-03 0.04846953 5.537E-03 0.15002472 ZHU_CMV_8_HR_DN gallbladder disease DOID_0000000 0.01102481 0.09504725 1.000 1.000 ZHU_CMV_8_HR_DN familial combined hyperlipidemia DOID_13809 0.01102481 0.09362864 1.000 1.000 ZHU_CMV_8_HR_DN progressive muscular atrophy DOID_318 0.01102481 0.09225174 1.000 1.000 ZHU_CMV_8_HR_DN insulinoma DOID_3892 0.01102481 0.09091476 1.000 1.000 ZHU_CMV_8_HR_DN hypokalemia DOID_4500 0.01102481 0.08961598 1.000 1.000 ZHU_CMV_8_HR_DN holoprosencephaly DOID_4621 0.01102481 0.08835378 0.01102481 0.28514176 ZHU_CMV_8_HR_DN nervous system benign neoplasm DOID_0060115 0.01212075 0.09578756 0.01212075 0.29985672 ZHU_CMV_8_HR_DN migraine without aura DOID_12783 0.01212075 0.0944754 0.01212075 0.28736269 ZHU_CMV_8_HR_DN prostatic adenoma DOID_2883 0.01212075 0.09319871 0.01212075 0.27586818 ZHU_CMV_8_HR_DN chronic monocytic leukemia DOID_8593 0.01212075 0.09195606 0.01212075 0.26525787 ZHU_CMV_8_HR_DN aortic valve stenosis DOID_1712 0.01321549 0.09894231 1.000 1.000 ZHU_CMV_8_HR_DN pituitary cancer DOID_1785 0.01321549 0.09765735 0.01321549 0.27850429 ZHU_CMV_8_HR_DN islet cell tumor DOID_1799 0.01321549 0.09640533 1.000 1.000 ZHU_CMV_8_HR_DN relapsing-remitting multiple sclerosis DOID_2378 0.01321549 0.09518501 1.000 1.000 ZHU_CMV_8_HR_DN epidermolysis bullosa DOID_2730 0.01321549 0.0939952 1.000 1.000 ZHU_CMV_8_HR_DN pituitary carcinoma DOID_4916 0.01321549 0.09765735 0.01321549 0.27850429 ZHU_CMV_8_HR_DN lipodystrophy DOID_811 0.01321549 0.09283476 0.01321549 0.26855771 ZHU_CMV_8_HR_DN vulva cancer DOID_1245 0.01430906 0.09929089 0.01430906 0.28075356 ZHU_CMV_8_HR_DN larynx cancer DOID_2596 0.01430906 0.09809462 0.01430906 0.27139511 ZHU_CMV_8_HR_DN laryngeal benign neoplasm DOID_2598 0.01430906 0.09809462 0.01430906 0.27139511 ZHU_CMV_8_HR_DN vesiculobullous skin disease DOID_2731 0.01430906 0.09692682 1.000 1.000 ZHU_CMV_8_HR_DN monocytic leukemia DOID_8527 0.01430906 0.09578651 0.01430906 0.26264043 ZHU_CMV_8_HR_DN aspergillosis DOID_13564 0.01540144 0.09958429 1.000 1.000 ZHU_CMV_8_HR_DN varicose veins DOID_799 0.01649264 0.09983308 1.000 1.000 ZHU_CMV_8_HR_DN intermediate coronary syndrome DOID_8805 0.01649264 0.0987822 1.000 1.000 LEE_RECENT_THYMIC_EMIGRANT oral cavity cancer DOID_8618 4.62E-09 2.629E-06 2.405E-07 3.421E-05 LEE_RECENT_THYMIC_EMIGRANT adenoid cystic carcinoma DOID_4866 4.013E-08 1.142E-05 4.013E-08 2.284E-05 LEE_RECENT_THYMIC_EMIGRANT salivary gland cancer DOID_8850 5.077E-08 9.629E-06 5.077E-08 1.444E-05 LEE_RECENT_THYMIC_EMIGRANT lymphoma DOID_0060058 6.397E-08 9.099E-06 2.097E-06 2.387E-04 LEE_RECENT_THYMIC_EMIGRANT smallpox DOID_8736 1.862E-07 2.119E-05 1.862E-07 3.532E-05 LEE_RECENT_THYMIC_EMIGRANT osteosarcoma DOID_3347 2.537E-05 2.406E-03 2.537E-05 2.406E-03 LEE_RECENT_THYMIC_EMIGRANT celiac disease DOID_10608 5.765E-05 4.686E-03 5.765E-05 4.686E-03 LEE_RECENT_THYMIC_EMIGRANT cervix uteri carcinoma in situ DOID_8991 1.256E-04 8.933E-03 1.256E-04 8.933E-03 LEE_RECENT_THYMIC_EMIGRANT leukodystrophy DOID_10579 1.733E-04 0.01095935 1.733E-04 0.01095935 LEE_RECENT_THYMIC_EMIGRANT autoimmune disease of gastrointestinal tract DOID_0060031 2.07E-04 0.01177553 2.07E-04 0.01177553 LEE_RECENT_THYMIC_EMIGRANT rectal neoplasm DOID_1984 2.107E-04 0.01089821 0.02168149 0.45691734 LEE_RECENT_THYMIC_EMIGRANT rectum cancer DOID_1993 2.107E-04 0.01089821 0.02168149 0.45691734 LEE_RECENT_THYMIC_EMIGRANT pre-malignant neoplasm DOID_0060071 4.192E-04 0.01987502 4.192E-04 0.02168184 LEE_RECENT_THYMIC_EMIGRANT in situ carcinoma DOID_8719 4.192E-04 0.01987502 4.192E-04 0.02168184 LEE_RECENT_THYMIC_EMIGRANT cerebral degeneration DOID_1443 4.576E-04 0.02002938 4.576E-04 0.0216985 LEE_RECENT_THYMIC_EMIGRANT transitional cell carcinoma DOID_2671 1.036E-03 0.04211479 1.036E-03 0.04535439 LEE_RECENT_THYMIC_EMIGRANT nervous system cancer DOID_3093 1.104E-03 0.04188538 1.104E-03 0.0448772 LEE_RECENT_THYMIC_EMIGRANT hypersensitivity reaction type I disease DOID_1205 1.286E-03 0.0457421 0.01927604 0.4570027 LEE_RECENT_THYMIC_EMIGRANT ulcerative colitis DOID_8577 1.404E-03 0.04699321 1.404E-03 0.05325897 LEE_RECENT_THYMIC_EMIGRANT cystitis DOID_1679 1.604E-03 0.05070752 0.05747917 0.49554011 LEE_RECENT_THYMIC_EMIGRANT cleft lip DOID_9296 1.604E-03 0.04803871 0.05747917 0.4809654 LEE_RECENT_THYMIC_EMIGRANT Charcot-Marie-Tooth disease DOID_10595 2.538E-03 0.07221983 2.538E-03 0.09027479 LEE_RECENT_THYMIC_EMIGRANT autonomic nervous system neoplasm DOID_2621 2.689E-03 0.07284594 2.689E-03 0.08998617 LEE_RECENT_THYMIC_EMIGRANT bladder disease DOID_365 2.689E-03 0.06953476 0.07387429 0.50041037 LEE_RECENT_THYMIC_EMIGRANT neuroblastoma DOID_769 2.689E-03 0.07284594 2.689E-03 0.08998617 LEE_RECENT_THYMIC_EMIGRANT myocarditis DOID_820 2.843E-03 0.07032417 0.07590377 0.5022005 LEE_RECENT_THYMIC_EMIGRANT nephroblastoma DOID_2154 3.001E-03 0.07114414 3.001E-03 0.09485886 LEE_RECENT_THYMIC_EMIGRANT cleft palate DOID_674 3.5E-03 0.07964971 0.08397783 0.51938459 LEE_RECENT_THYMIC_EMIGRANT peripheral nervous system neoplasm DOID_1192 3.674E-03 0.08039977 3.674E-03 0.11002074 RODRIGUES_NTN1_AND_DCC_TARGETS tongue cancer DOID_8649 1.748E-05 9.945E-03 1.748E-05 9.945E-03 RODRIGUES_NTN1_AND_DCC_TARGETS learning disability DOID_8927 1.631E-04 0.04640073 0.01882789 0.24914119 RODRIGUES_NTN1_AND_DCC_TARGETS bone marrow cancer DOID_4960 2.303E-04 0.04367813 1.000 1.000 RODRIGUES_NTN1_AND_DCC_TARGETS oral cavity cancer DOID_8618 2.638E-04 0.03752723 2.638E-04 0.07505446 RODRIGUES_NTN1_AND_DCC_TARGETS endocrine pancreas disease DOID_1428 3.183E-04 0.03622252 3.183E-04 0.06037087 RODRIGUES_NTN1_AND_DCC_TARGETS chromosomal disease DOID_0080014 4.881E-04 0.04628954 4.881E-04 0.06943432 RODRIGUES_NTN1_AND_DCC_TARGETS encephalomyelitis DOID_640 6.387E-04 0.05191645 6.387E-04 0.07268302 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP atrophic muscular disease DOID_913 3.006E-08 1.711E-05 3.006E-08 1.711E-05 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP muscular dystrophy DOID_9884 3.006E-08 1.711E-05 3.006E-08 1.711E-05 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP lingual-facial-buccal dyskinesia DOID_9854 6.525E-06 1.856E-03 6.525E-06 1.856E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP fragments of torsion dystonia DOID_531 1.2E-05 2.276E-03 1.2E-05 2.276E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP diffuse large B-cell lymphoma DOID_0050745 1.337E-05 1.902E-03 9.729E-04 0.0369047 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP renal hypertension DOID_1073 1.484E-05 1.689E-03 1.041E-03 0.03703176 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP secondary hypertension DOID_11130 1.484E-05 1.689E-03 1.041E-03 0.03703176 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP central nervous system hereditary degenerative disease DOID_481 1.484E-05 1.407E-03 1.484E-05 2.111E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP lymphoma DOID_0060058 1.554E-05 1.263E-03 4.56E-04 0.02594454 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP focal glomerulosclerosis DOID_3945 1.641E-05 1.167E-03 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP dystonic disease DOID_544 1.641E-05 1.038E-03 1.641E-05 1.868E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP abdominal aortic aneurysm DOID_7693 1.988E-05 1.131E-03 0.05094739 0.4201314 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP hyperinsulinism DOID_2018 5.45E-05 2.819E-03 2.438E-03 0.07300085 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP aortic aneurysm DOID_3627 8.344E-05 3.957E-03 0.08057314 0.51512494 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP movement disease DOID_480 8.344E-05 3.652E-03 8.344E-05 7.913E-03 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP B-cell lymphocytic neoplasm DOID_707 8.825E-05 3.587E-03 3.343E-03 0.08270384 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP hypertrophic cardiomyopathy DOID_11984 1.27E-04 4.819E-03 1.27E-04 0.01032732 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP carotid artery disease DOID_3407 1.466E-04 5.213E-03 4.662E-03 0.1105321 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP endocrine pancreas disease DOID_1428 1.68E-04 5.622E-03 5.098E-03 0.11602121 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP congenital structural myopathy DOID_422 2.214E-04 6.999E-03 2.214E-04 0.01574826 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP aneurysm disease DOID_2403 2.736E-04 8.193E-03 0.11773051 0.63196848 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP alcohol abuse DOID_1574 3.394E-04 9.656E-03 8.082E-03 0.15857888 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP glucose intolerance DOID_10603 3.708E-04 0.01004577 0.02811398 0.32646637 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP primary bacterial infectious disease DOID_0050338 3.885E-04 0.01004743 3.885E-04 0.02456037 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP limb-girdle muscular dystrophy DOID_11724 4.595E-04 0.01136716 4.595E-04 0.0237677 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP encephalomyelitis DOID_640 4.703E-04 0.01115021 4.703E-04 0.02230041 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP dilated cardiomyopathy DOID_12930 4.998E-04 0.01137657 4.998E-04 0.02187801 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP ureteral disease DOID_1426 6.647E-04 0.01454765 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP myositis DOID_633 8.428E-04 0.01776128 0.04187803 0.40387459 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP spinal cord disease DOID_319 9.067E-04 0.01842564 9.067E-04 0.03685129 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP sarcoma DOID_1115 1.041E-03 0.02043131 1.041E-03 0.03485342 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP polycystic ovary syndrome DOID_11612 1.112E-03 0.02109089 1.112E-03 0.03515148 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP multiple myeloma DOID_9538 1.848E-03 0.03392513 0.06142166 0.44806311 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP diabetic autonomic neuropathy DOID_11503 2.543E-03 0.04522471 2.543E-03 0.07235953 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP autonomic neuropathy DOID_11504 2.543E-03 0.04522471 2.543E-03 0.07235953 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP diabetic polyneuropathy DOID_12785 2.543E-03 0.04522471 2.543E-03 0.07235953 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP diabetic neuropathy DOID_9743 2.543E-03 0.04522471 2.543E-03 0.07235953 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP learning disability DOID_8927 2.651E-03 0.04571452 2.651E-03 0.07183711 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP proteinuria DOID_576 2.761E-03 0.04621112 0.07472168 0.50615041 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP myeloma DOID_0070004 2.873E-03 0.0467138 0.07618797 0.51001122 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP pre-eclampsia DOID_10591 2.873E-03 0.04541619 0.07618797 0.50408086 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP autonomic nervous system disease DOID_11465 2.873E-03 0.04418873 2.873E-03 0.0743174 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP bone marrow cancer DOID_4960 3.717E-03 0.05565975 0.08638822 0.5401637 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP pustulosis of palm and sole DOID_4398 3.846E-03 0.0561125 0.08783633 0.53740721 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP hyperglycemia DOID_4195 5.398E-03 0.07678504 0.10361731 0.58374506 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP brain infarction DOID_3454 5.706E-03 0.07919017 5.706E-03 0.1248768 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP nephrosis DOID_2527 6.183E-03 0.08376924 0.11070144 0.61154485 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP diabetic retinopathy DOID_8947 6.511E-03 0.08616012 1.000 1.000 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP endogenous depression DOID_1595 6.847E-03 0.08854283 6.847E-03 0.14429201 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP syndrome DOID_225 6.847E-03 0.08657521 6.847E-03 0.13913873 CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP mental depression DOID_1596 8.082E-03 0.09997364 8.082E-03 0.15329292 BROWNE_HCMV_INFECTION_1HR_UP parasitic protozoa infectious disease DOID_2789 2.21E-07 1.257E-04 1.25E-03 0.10164589 BROWNE_HCMV_INFECTION_1HR_UP parasitic infectious disease DOID_1398 4.214E-07 1.199E-04 1.714E-03 0.12188257 BROWNE_HCMV_INFECTION_1HR_UP bile duct disease DOID_4138 5.932E-07 1.125E-04 0.06429945 0.37717923 BROWNE_HCMV_INFECTION_1HR_UP biliary tract disease DOID_9741 6.262E-07 8.908E-05 0.06514026 0.37064808 BROWNE_HCMV_INFECTION_1HR_UP cystic fibrosis DOID_1485 7.335E-07 8.347E-05 0.0676583 0.37742718 BROWNE_HCMV_INFECTION_1HR_UP dilated cardiomyopathy DOID_12930 1.76E-06 1.669E-04 9.172E-05 0.01739664 BROWNE_HCMV_INFECTION_1HR_UP cerebral infarction DOID_3526 1.109E-05 9.013E-04 0.04217888 0.35293796 BROWNE_HCMV_INFECTION_1HR_UP cholestasis DOID_13580 3.174E-05 2.257E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP endocrine organ benign neoplasm DOID_0060089 3.613E-05 2.284E-03 3.613E-05 0.02055615 BROWNE_HCMV_INFECTION_1HR_UP brain infarction DOID_3454 3.613E-05 2.056E-03 0.0617726 0.36998538 BROWNE_HCMV_INFECTION_1HR_UP pituitary cancer DOID_1785 5.124E-05 2.65E-03 5.124E-05 0.01457659 BROWNE_HCMV_INFECTION_1HR_UP pituitary carcinoma DOID_4916 5.124E-05 2.65E-03 5.124E-05 0.01457659 BROWNE_HCMV_INFECTION_1HR_UP bacterial pneumonia DOID_874 5.165E-05 2.449E-03 0.06933333 0.36869782 BROWNE_HCMV_INFECTION_1HR_UP transitional cell carcinoma DOID_2671 7.34E-05 3.213E-03 2.976E-03 0.1693258 BROWNE_HCMV_INFECTION_1HR_UP mouth disease DOID_403 8.894E-05 3.615E-03 3.377E-03 0.16011949 BROWNE_HCMV_INFECTION_1HR_UP hypersensitivity reaction type I disease DOID_1205 9.172E-05 3.479E-03 3.446E-03 0.15082972 BROWNE_HCMV_INFECTION_1HR_UP pituitary adenoma DOID_3829 9.295E-05 3.305E-03 9.295E-05 0.01322166 BROWNE_HCMV_INFECTION_1HR_UP ulcerative colitis DOID_8577 1.004E-04 3.361E-03 0.08592384 0.42513621 BROWNE_HCMV_INFECTION_1HR_UP dissociative disorder DOID_10935 1.322E-04 4.18E-03 0.01690705 0.34357539 BROWNE_HCMV_INFECTION_1HR_UP dissociative amnesia DOID_11037 1.322E-04 4.18E-03 0.01690705 0.34357539 BROWNE_HCMV_INFECTION_1HR_UP leishmaniasis DOID_9065 1.322E-04 3.96E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP amnestic disorder DOID_10914 1.468E-04 4.177E-03 0.01778917 0.32651727 BROWNE_HCMV_INFECTION_1HR_UP autoimmune hepatitis DOID_2048 1.622E-04 4.395E-03 0.01867051 0.30352921 BROWNE_HCMV_INFECTION_1HR_UP meningitis DOID_9471 2.128E-04 5.504E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP Goodpasture syndrome DOID_9808 2.128E-04 5.265E-03 0.02130996 0.28198523 BROWNE_HCMV_INFECTION_1HR_UP intracranial aneurysm DOID_10941 2.908E-04 6.895E-03 0.0248185 0.306994 BROWNE_HCMV_INFECTION_1HR_UP middle cerebral artery infarction DOID_3525 2.908E-04 6.619E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP migraine DOID_6364 3.122E-04 6.832E-03 3.122E-04 0.03552596 BROWNE_HCMV_INFECTION_1HR_UP pleurisy DOID_10247 3.343E-04 7.045E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP autoimmune disease of endocrine system DOID_0060005 3.571E-04 7.258E-03 0.02744189 0.31228866 BROWNE_HCMV_INFECTION_1HR_UP spastic cerebral palsy DOID_0050669 4.051E-04 7.948E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP gonadal disease DOID_2277 4.051E-04 7.683E-03 0.02918701 0.3193732 BROWNE_HCMV_INFECTION_1HR_UP chronic leukemia DOID_1036 4.56E-04 8.369E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP chronic lymphocytic leukemia DOID_1040 4.56E-04 8.369E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP pleural disease DOID_1532 4.56E-04 8.108E-03 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP periodontal disease DOID_3388 5.098E-04 8.79E-03 0.03266813 0.32048564 BROWNE_HCMV_INFECTION_1HR_UP respiratory syncytial virus infectious disease DOID_1273 6.572E-04 0.0109987 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP intracranial arterial disease DOID_13089 6.889E-04 0.01119935 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP cerebral arterial disease DOID_3527 6.889E-04 0.01119935 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP pulmonary emphysema DOID_9675 7.213E-04 0.01140034 0.03873097 0.33390793 BROWNE_HCMV_INFECTION_1HR_UP influenza DOID_8469 8.228E-04 0.01265381 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP hemolytic anemia DOID_583 9.683E-04 0.01449934 0.04475692 0.34414446 BROWNE_HCMV_INFECTION_1HR_UP normocytic anemia DOID_720 9.683E-04 0.01449934 0.04475692 0.34414446 BROWNE_HCMV_INFECTION_1HR_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.006E-03 0.01468442 0.04561478 0.3460641 BROWNE_HCMV_INFECTION_1HR_UP withdrawal disorder DOID_0060001 1.085E-03 0.01543369 1.085E-03 0.10289129 BROWNE_HCMV_INFECTION_1HR_UP bone marrow cancer DOID_4960 1.208E-03 0.01676516 0.04989283 0.35486276 BROWNE_HCMV_INFECTION_1HR_UP integumentary system cancer DOID_0060122 1.25E-03 0.01694098 0.05074621 0.35647643 BROWNE_HCMV_INFECTION_1HR_UP skin cancer DOID_4159 1.25E-03 0.01694098 0.05074621 0.35647643 BROWNE_HCMV_INFECTION_1HR_UP melancholia DOID_2848 1.427E-03 0.018887 0.05415227 0.3541683 BROWNE_HCMV_INFECTION_1HR_UP neurotic disorder DOID_4964 1.473E-03 0.01905223 0.05500193 0.35563749 BROWNE_HCMV_INFECTION_1HR_UP mineral metabolism disease DOID_0050032 1.664E-03 0.02104252 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP tooth disease DOID_1091 1.815E-03 0.02244657 0.06092885 0.36881401 BROWNE_HCMV_INFECTION_1HR_UP male reproductive system disease DOID_48 2.025E-03 0.02451562 0.06429945 0.37333046 BROWNE_HCMV_INFECTION_1HR_UP endogenous depression DOID_1595 2.246E-03 0.02662908 0.0676583 0.37376284 BROWNE_HCMV_INFECTION_1HR_UP syndrome DOID_225 2.246E-03 0.02608563 2.246E-03 0.14202174 BROWNE_HCMV_INFECTION_1HR_UP aneurysm disease DOID_2403 2.303E-03 0.02621321 0.06849618 0.37475315 BROWNE_HCMV_INFECTION_1HR_UP mixed glioma DOID_5076 2.361E-03 0.0263434 0.06933333 0.3721761 BROWNE_HCMV_INFECTION_1HR_UP mental depression DOID_1596 2.66E-03 0.02910734 0.07350815 0.38023762 BROWNE_HCMV_INFECTION_1HR_UP primary bacterial infectious disease DOID_0050338 2.911E-03 0.03125581 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP lymphoblastic leukemia DOID_1037 3.308E-03 0.03486034 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.377E-03 0.03493516 3.377E-03 0.17467581 BROWNE_HCMV_INFECTION_1HR_UP hyperparathyroidism DOID_13543 8.933E-03 0.09076893 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP retinal vascular occlusion DOID_1729 8.933E-03 0.08917649 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP Noonan syndrome DOID_3490 8.933E-03 0.08763897 8.933E-03 0.36307571 BROWNE_HCMV_INFECTION_1HR_UP cutaneous leishmaniasis DOID_9111 8.933E-03 0.08615356 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP visceral leishmaniasis DOID_9146 8.933E-03 0.08471767 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP breast benign neoplasm DOID_0060082 9.822E-03 0.09162189 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP thoracic benign neoplasm DOID_0060097 9.822E-03 0.09162189 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP obsessive-compulsive disorder DOID_10933 9.822E-03 0.09014412 9.822E-03 0.37259568 BROWNE_HCMV_INFECTION_1HR_UP prediabetes syndrome DOID_11716 9.822E-03 0.08871326 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP migraine without aura DOID_12783 9.822E-03 0.08732711 9.822E-03 0.34930845 BROWNE_HCMV_INFECTION_1HR_UP benign breast phyllodes tumor DOID_1631 9.822E-03 0.09162189 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP common cold DOID_10459 0.01071067 0.09375954 0.01071067 0.35849235 BROWNE_HCMV_INFECTION_1HR_UP beta thalassemia DOID_12241 0.01071067 0.09233894 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP pituitary gland disease DOID_53 0.01071067 0.09096075 0.01071067 0.33857611 BROWNE_HCMV_INFECTION_1HR_UP berylliosis DOID_10322 0.01159818 0.09704948 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP Hirschsprung's disease DOID_10487 0.01159818 0.09564296 0.01159818 0.34733498 BROWNE_HCMV_INFECTION_1HR_UP parathyroid gland disease DOID_11201 0.01159818 0.09427664 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP hepatic coma DOID_12550 0.01159818 0.0929488 0.01159818 0.32996823 BROWNE_HCMV_INFECTION_1HR_UP carotid stenosis DOID_13001 0.01159818 0.09165784 0.01159818 0.31425545 BROWNE_HCMV_INFECTION_1HR_UP hepatic encephalopathy DOID_13413 0.01159818 0.0929488 0.01159818 0.32996823 BROWNE_HCMV_INFECTION_1HR_UP polyneuropathy DOID_1389 0.01159818 0.09040225 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP Legionnaires' disease DOID_10457 0.01248492 0.09599891 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP legionellosis DOID_10458 0.01248492 0.09599891 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP viral pneumonia DOID_10533 0.01248492 0.09471893 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP megacolon DOID_11372 0.01248492 0.09347262 0.01248492 0.32290543 BROWNE_HCMV_INFECTION_1HR_UP hypercalcemia DOID_12678 0.01248492 0.09225869 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP bacterial meningitis DOID_9470 0.01248492 0.09107589 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP thalassemia DOID_10241 0.01337089 0.09630424 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP thoracic aortic aneurysm DOID_14004 0.01337089 0.09510044 0.01337089 0.33078413 BROWNE_HCMV_INFECTION_1HR_UP nutritional deficiency disease DOID_5113 0.01337089 0.09392636 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP lung oat cell carcinoma DOID_5411 0.01337089 0.09278091 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP intermediate coronary syndrome DOID_8805 0.01337089 0.09166307 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP hyperhomocysteinemia DOID_9279 0.01337089 0.09057185 0.01337089 0.31700146 BROWNE_HCMV_INFECTION_1HR_UP spastic diplegia DOID_10965 0.01425608 0.0954319 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP hemolytic-uremic syndrome DOID_12554 0.01425608 0.09432223 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP thyroiditis DOID_7166 0.01425608 0.09323806 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP autoimmune thyroiditis DOID_7188 0.01425608 0.09323806 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP night blindness DOID_8499 0.01425608 0.09217854 0.01425608 0.32446846 BROWNE_HCMV_INFECTION_1HR_UP Barrett's esophagus DOID_9206 0.01425608 0.09114283 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP lymphatic system cancer DOID_0060073 0.01514051 0.09572166 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP Graves' disease DOID_12361 0.01514051 0.09466977 0.01514051 0.33134421 BROWNE_HCMV_INFECTION_1HR_UP hyperostosis DOID_205 0.01514051 0.09364076 0.01514051 0.3190722 BROWNE_HCMV_INFECTION_1HR_UP basal cell carcinoma DOID_2513 0.01514051 0.09263387 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP reticulosarcoma DOID_8538 0.01514051 0.09572166 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP lymphosarcoma DOID_8675 0.01514051 0.09572166 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP skin carcinoma DOID_3451 0.01602416 0.09699733 1.000 1.000 BROWNE_HCMV_INFECTION_1HR_UP testicular cancer DOID_2998 0.01690705 0.0991764 0.01690705 0.32067037 KORKOLA_YOLK_SAC_TUMOR atrophic muscular disease DOID_913 2.106E-05 0.01198035 2.106E-05 0.01198035 KORKOLA_YOLK_SAC_TUMOR muscular dystrophy DOID_9884 2.106E-05 0.01198035 2.106E-05 0.01198035 KORKOLA_YOLK_SAC_TUMOR brachydactyly DOID_0050581 3.926E-05 0.0111704 3.926E-05 0.0111704 KORKOLA_YOLK_SAC_TUMOR facioscapulohumeral muscular dystrophy DOID_11727 3.926E-05 7.447E-03 3.926E-05 7.447E-03 KORKOLA_YOLK_SAC_TUMOR varicose veins DOID_799 9.134E-05 0.01299324 9.134E-05 0.01299324 KORKOLA_YOLK_SAC_TUMOR vein disease DOID_866 1.043E-04 0.01187243 1.043E-04 0.01187243 KORKOLA_YOLK_SAC_TUMOR familial hypercholesterolemia DOID_13810 2.001E-04 0.0189772 0.02068972 0.34624859 KORKOLA_YOLK_SAC_TUMOR uremia DOID_4676 2.19E-04 0.01780469 2.19E-04 0.02077214 KORKOLA_YOLK_SAC_TUMOR ureteral disease DOID_1426 2.388E-04 0.01698524 2.388E-04 0.0194117 KORKOLA_YOLK_SAC_TUMOR leiomyoma DOID_127 5.115E-04 0.03233508 5.115E-04 0.03637697 KORKOLA_YOLK_SAC_TUMOR hyperthyroidism DOID_7998 5.718E-04 0.03253533 5.718E-04 0.03615037 KORKOLA_YOLK_SAC_TUMOR bile duct adenocarcinoma DOID_4896 1.354E-03 0.07003884 0.05275029 0.35732045 KORKOLA_YOLK_SAC_TUMOR cholangiocarcinoma DOID_4947 1.354E-03 0.07003884 0.05275029 0.35732045 KORKOLA_YOLK_SAC_TUMOR vasculitis DOID_865 1.354E-03 0.06420227 0.05275029 0.35311668 KORKOLA_YOLK_SAC_TUMOR familial hyperlipidemia DOID_1168 1.45E-03 0.06345816 0.05455117 0.35272293 KORKOLA_YOLK_SAC_TUMOR bile duct cancer DOID_4606 1.549E-03 0.06294859 0.05634872 0.35233432 KORKOLA_YOLK_SAC_TUMOR bile duct carcinoma DOID_4897 1.549E-03 0.06294859 0.05634872 0.35233432 KORKOLA_YOLK_SAC_TUMOR metabolic syndrome X DOID_14221 2.776E-03 0.09871382 0.07502351 0.37445945 KORKOLA_YOLK_SAC_TUMOR lipid metabolism disorder DOID_3146 2.776E-03 0.09290713 0.07502351 0.37120329 KORKOLA_YOLK_SAC_TUMOR auditory system disease DOID_2742 2.91E-03 0.09199554 2.91E-03 0.15053816 KORKOLA_YOLK_SAC_TUMOR biliary tract cancer DOID_4607 2.979E-03 0.08920064 0.07766183 0.37768874 GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP allergic contact dermatitis DOID_3042 7.829E-06 4.454E-03 7.829E-06 4.454E-03 GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP contact dermatitis DOID_2773 1.261E-05 3.588E-03 1.261E-05 3.588E-03 GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP celiac disease DOID_10608 1.622E-04 0.0307639 0.01867051 0.55913276 GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.811E-04 0.05420922 0.02842002 0.46202834 GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP pustulosis of palm and sole DOID_4398 4.741E-04 0.05395388 0.03164931 0.46175526 GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP lymphoblastic leukemia DOID_1037 1.265E-03 0.08996842 0.05133848 0.50364819 ROZANOV_MMP14_CORRELATED salivary gland cancer DOID_8850 3.118E-08 1.774E-05 2.06E-05 0.01172292 ROZANOV_MMP14_CORRELATED oral cavity cancer DOID_8618 7.9E-08 2.247E-05 3.804E-05 5.411E-03 ROZANOV_MMP14_CORRELATED adenoid cystic carcinoma DOID_4866 1.879E-05 3.565E-03 6.787E-03 0.55165288 ROZANOV_MMP14_CORRELATED integumentary system benign neoplasm DOID_0060121 2.758E-05 3.923E-03 2.758E-05 7.847E-03 ROZANOV_MMP14_CORRELATED skin benign neoplasm DOID_3165 2.758E-05 3.923E-03 2.758E-05 7.847E-03 ROZANOV_MMP14_CORRELATED integumentary system cancer DOID_0060122 3.437E-05 3.911E-03 3.437E-05 6.519E-03 ROZANOV_MMP14_CORRELATED skin cancer DOID_4159 3.437E-05 3.911E-03 3.437E-05 6.519E-03 ROZANOV_MMP14_CORRELATED encephalomyelitis DOID_640 9.259E-05 8.781E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP retinal vascular disease DOID_2462 2.374E-33 1.351E-30 3.459E-03 0.17890671 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP diabetic retinopathy DOID_8947 1.197E-32 3.405E-30 0.02859337 0.54232089 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pulmonary emphysema DOID_9675 1.103E-26 2.091E-24 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP astrocytoma DOID_3069 5.596E-25 7.96E-23 0.2207771 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP giant cell tumor DOID_200 7.531E-25 8.57E-23 0.17632721 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP malignant giant cell tumor DOID_2705 7.531E-25 8.57E-23 0.17632721 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP giant cell glioblastoma DOID_3074 7.531E-25 8.57E-23 0.17632721 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP aneurysm disease DOID_2403 2.874E-24 2.725E-22 0.23946745 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP glioblastoma DOID_3068 3.222E-24 2.619E-22 0.19048156 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pleural disease DOID_1532 7.512E-24 5.343E-22 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP uterine disease DOID_345 1.986E-23 1.256E-21 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP encephalomyelitis DOID_640 7.024E-23 3.997E-21 4.427E-03 0.20991535 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP peptic ulcer DOID_750 1.272E-22 6.582E-21 4.194E-04 0.03977594 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP female reproductive system disease DOID_229 5.216E-22 2.473E-20 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP respiratory syncytial virus infectious disease DOID_1273 1.751E-20 7.662E-19 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bacterial pneumonia DOID_874 2.105E-20 8.555E-19 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pleurisy DOID_10247 2.82E-20 1.07E-18 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hepatic vascular disease DOID_272 2.82E-20 1.003E-18 0.0986694 0.9055305 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP carotid artery disease DOID_3407 6.146E-20 2.057E-18 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP influenza DOID_8469 8.153E-20 2.577E-18 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP primary bacterial infectious disease DOID_0050338 1.038E-19 3.108E-18 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pre-eclampsia DOID_10591 1.878E-19 5.342E-18 0.15901748 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mouth disease DOID_403 3.189E-19 8.64E-18 0.28302659 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP peripheral vascular disease DOID_341 5.737E-19 1.484E-17 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP portal hypertension DOID_10762 8.663E-19 2.143E-17 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cystic fibrosis DOID_1485 9.906E-19 2.348E-17 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mixed glioma DOID_5076 1.408E-18 3.204E-17 8.91E-06 5.07E-03 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bone development disease DOID_0080006 3.821E-18 8.361E-17 3.348E-03 0.19048755 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP collagen disease DOID_854 4.877E-18 1.028E-16 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP rheumatic disease DOID_1575 6.573E-18 1.336E-16 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP scleroderma DOID_419 6.573E-18 1.336E-16 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP tuberculosis DOID_399 1.863E-17 3.656E-16 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hypersensitivity reaction type I disease DOID_1205 1.982E-17 3.759E-16 0.28551036 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP gastric ulcer DOID_10808 2.543E-17 4.667E-16 5.918E-05 0.01122431 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sarcoidosis DOID_11335 7.126E-17 1.267E-15 0.17632721 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP reproductive organ benign neoplasm DOID_0050622 1.083E-16 1.868E-15 0.0172639 0.42709389 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pulmonary sarcoidosis DOID_13406 1.327E-16 2.221E-15 0.12936218 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP chronic kidney failure DOID_784 1.838E-16 2.989E-15 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hypersensitivity reaction type IV disease DOID_2916 1.972E-16 3.117E-15 0.19048156 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP transitional cell carcinoma DOID_2671 3.772E-16 5.801E-15 0.03895068 0.6332268 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP respiratory failure DOID_11162 4.173E-16 6.249E-15 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP nervous system cancer DOID_3093 4.968E-16 7.248E-15 0.04053092 0.64061368 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mineral metabolism disease DOID_0050032 5.957E-16 8.473E-15 0.20714847 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP renal hypertension DOID_1073 7.146E-16 9.917E-15 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP secondary hypertension DOID_11130 7.146E-16 9.917E-15 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sarcoma DOID_1115 7.146E-16 9.681E-15 1.529E-04 0.02174934 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP diabetic autonomic neuropathy DOID_11503 7.945E-16 1.051E-14 0.15022773 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autonomic neuropathy DOID_11504 7.945E-16 1.051E-14 0.15022773 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP diabetic polyneuropathy DOID_12785 7.945E-16 1.051E-14 0.15022773 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP diabetic neuropathy DOID_9743 7.945E-16 1.051E-14 0.15022773 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autonomic nervous system disease DOID_11465 1.563E-15 2.021E-14 0.15901748 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pancreatic ductal carcinoma DOID_3587 1.621E-15 2.05E-14 0.02654284 0.58087976 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP male reproductive system disease DOID_48 1.898E-15 2.348E-14 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pulmonary tuberculosis DOID_2957 2.392E-15 2.896E-14 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pancreatic carcinoma DOID_4905 2.586E-15 3.066E-14 0.02859337 0.56102161 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP calcium metabolism disease DOID_10575 2.94E-15 3.414E-14 0.167717 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP aortic aneurysm DOID_3627 2.94E-15 3.346E-14 0.167717 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP uremia DOID_4676 7.68E-15 8.569E-14 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP diabetic angiopathy DOID_11713 1.149E-14 1.257E-13 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP systemic scleroderma DOID_418 2.151E-14 2.309E-13 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP intracranial arterial disease DOID_13089 2.712E-14 2.858E-13 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cerebral arterial disease DOID_3527 2.712E-14 2.858E-13 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP oral submucous fibrosis DOID_5773 3.145E-14 3.253E-13 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP angiosarcoma DOID_0001816 5.574E-14 5.664E-13 2.185E-05 6.216E-03 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP ulcerative colitis DOID_8577 5.964E-14 5.954E-13 0.04708712 0.68698896 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP brain cancer DOID_1319 1.181E-13 1.158E-12 0.15901748 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP heart valve disease DOID_4079 1.181E-13 1.139E-12 0.15901748 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP central nervous system cancer DOID_3620 1.43E-13 1.356E-12 0.1619273 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP female reproductive organ benign neoplasm DOID_0060086 1.605E-13 1.497E-12 5.492E-03 0.20831563 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP uterine benign neoplasm DOID_0060095 1.605E-13 1.497E-12 5.492E-03 0.20831563 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP uterine fibroid DOID_13223 1.605E-13 1.497E-12 5.492E-03 0.20831563 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bronchiolitis obliterans DOID_2799 2.113E-13 1.939E-12 0.10798829 0.94531287 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pancreatitis DOID_4989 2.295E-13 2.073E-12 0.24210093 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP metabolic syndrome X DOID_14221 2.965E-13 2.636E-12 0.24734077 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP leiomyoma DOID_127 3.561E-13 3.117E-12 6.543E-03 0.23269864 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bladder disease DOID_365 3.561E-13 3.07E-12 0.1141477 0.95514763 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP vasculitis DOID_865 4.155E-13 3.529E-12 0.01670593 0.43207617 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP biliary tract cancer DOID_4607 4.299E-13 3.598E-12 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP integumentary system cancer DOID_0060122 4.904E-13 4.044E-12 0.18201818 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP parasitic protozoa infectious disease DOID_2789 4.904E-13 3.986E-12 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP skin cancer DOID_4159 4.904E-13 4.044E-12 0.18201818 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP placenta disease DOID_780 8.169E-13 6.546E-12 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP calcinosis DOID_182 1.147E-12 9.064E-12 0.12936218 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP endocrine pancreas disease DOID_1428 1.918E-12 1.495E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP adult respiratory distress syndrome DOID_11394 2.144E-12 1.649E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cholestasis DOID_13580 2.204E-12 1.672E-11 0.02326574 0.52952835 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP parasitic infectious disease DOID_1398 2.204E-12 1.65E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP endometriosis of uterus DOID_288 3.169E-12 2.341E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP endometriosis DOID_289 3.825E-12 2.79E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cystitis DOID_1679 4.193E-12 3.02E-11 0.08925392 0.89097331 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP viral pneumonia DOID_10533 4.451E-12 3.166E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP uterine cancer DOID_363 4.596E-12 3.228E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP nephrosis DOID_2527 4.859E-12 3.372E-11 2.185E-03 0.15542733 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bile duct disease DOID_4138 4.859E-12 3.331E-11 0.02721944 0.5736244 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP biliary tract disease DOID_9741 5.505E-12 3.729E-11 0.02790296 0.5670281 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP intracranial aneurysm DOID_10941 5.575E-12 3.732E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thoracic aortic aneurysm DOID_14004 7.398E-12 4.895E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP renovascular hypertension DOID_1591 7.398E-12 4.838E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP myeloma DOID_0070004 7.779E-12 5.03E-11 0.15901748 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP vascular skin disease DOID_9540 7.779E-12 4.973E-11 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP coronary stenosis DOID_4248 9.53E-12 6.025E-11 4.838E-03 0.21175567 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP abdominal aortic aneurysm DOID_7693 1.983E-11 1.24E-10 0.10798829 0.93098994 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bone marrow cancer DOID_4960 2.346E-11 1.451E-10 0.17917759 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP allergic rhinitis DOID_4481 2.49E-11 1.523E-10 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP osteochondrodysplasia DOID_2256 2.714E-11 1.643E-10 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP leishmaniasis DOID_9065 3.965E-11 2.375E-10 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hypertrophic cardiomyopathy DOID_11984 4.133E-11 2.45E-10 0.01898469 0.45009533 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP nephroblastoma DOID_2154 4.724E-11 2.771E-10 7.291E-03 0.24404343 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP leukocyte disease DOID_9500 4.732E-11 2.748E-10 0.19328333 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Crohn's disease DOID_8778 5.347E-11 3.073E-10 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP brain edema DOID_4724 5.649E-11 3.214E-10 0.06690316 0.79308123 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cleft palate DOID_674 8.481E-11 4.778E-10 8.482E-03 0.25401084 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hepatitis DOID_2237 1.22E-10 6.807E-10 0.1353751 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP tooth disease DOID_1091 1.291E-10 7.132E-10 0.21535377 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lymphatic system disease DOID_75 1.453E-10 7.951E-10 0.1383661 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sinusitis DOID_0050127 1.459E-10 7.905E-10 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP paranasal sinus disease DOID_1352 1.459E-10 7.905E-10 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP blood coagulation disease DOID_1247 1.823E-10 9.783E-10 0.2234748 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP gallbladder cancer DOID_3121 2.804E-10 1.491E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cerebral infarction DOID_3526 3.273E-10 1.725E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP commensal bacterial infectious disease DOID_0050339 3.299E-10 1.722E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP contact dermatitis DOID_2773 4.708E-10 2.436E-09 0.24734077 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP extrinsic allergic alveolitis DOID_841 5.368E-10 2.751E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP berylliosis DOID_10322 5.742E-10 2.917E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Leydig cell tumor DOID_2696 5.742E-10 2.891E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP intracranial thrombosis DOID_4193 5.742E-10 2.866E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sex cord-stromal neoplasm DOID_4757 5.742E-10 2.891E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP integumentary system benign neoplasm DOID_0060121 5.88E-10 2.909E-09 0.16482713 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP skin benign neoplasm DOID_3165 5.88E-10 2.909E-09 0.16482713 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP periodontitis DOID_824 6.749E-10 3.31E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP orofacial cleft DOID_0050567 8.843E-10 4.301E-09 0.0156138 0.42305966 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP atopic dermatitis DOID_3310 8.843E-10 4.264E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP supratentorial cancer DOID_1659 1.04E-09 4.973E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cerebrum cancer DOID_368 1.04E-09 4.973E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP focal glomerulosclerosis DOID_3945 1.04E-09 4.932E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bile duct adenocarcinoma DOID_4896 1.146E-09 5.387E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cholangiocarcinoma DOID_4947 1.146E-09 5.387E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Human immunodeficiency virus infectious disease DOID_526 1.195E-09 5.572E-09 0.27300556 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP dysostosis DOID_1934 1.277E-09 5.905E-09 1.858E-04 0.02114941 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP endometrial carcinoma DOID_2871 1.277E-09 5.858E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP skeletal system cancer DOID_0060124 1.332E-09 6.065E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bone cancer DOID_184 1.332E-09 6.065E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP varicose veins DOID_799 1.332E-09 6.017E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP dilated cardiomyopathy DOID_12930 1.828E-09 8.192E-09 0.28551036 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bile duct cancer DOID_4606 1.869E-09 8.307E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bile duct carcinoma DOID_4897 1.869E-09 8.307E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP endometrial cancer DOID_1380 1.884E-09 8.31E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP vein disease DOID_866 1.933E-09 8.459E-09 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP myocarditis DOID_820 2.713E-09 1.178E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pneumoconiosis DOID_10316 3.229E-09 1.392E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP periodontal disease DOID_3388 3.229E-09 1.381E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP prion disease DOID_649 3.77E-09 1.601E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hyperglycemia DOID_4195 4.517E-09 1.904E-08 0.21262808 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP allergic contact dermatitis DOID_3042 5.004E-09 2.094E-08 0.21535377 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP brain infarction DOID_3454 5.536E-09 2.299E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pulmonary edema DOID_11396 6.784E-09 2.797E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP subependymal glioma DOID_4843 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pilocytic astrocytoma DOID_4851 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP subependymal giant cell astrocytoma DOID_5077 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP fibrillary astrocytoma DOID_6726 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP juvenile pilocytic astrocytoma DOID_6811 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP childhood pilocytic astrocytoma DOID_6812 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP gemistocytic astrocytoma DOID_7005 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP childhood cerebral astrocytoma DOID_7007 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP protoplasmic astrocytoma DOID_7008 6.784E-09 2.777E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Kawasaki disease DOID_13378 8.879E-09 3.609E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lymphadenitis DOID_1602 8.879E-09 3.609E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autoimmune hepatitis DOID_2048 8.879E-09 3.583E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP coronary restenosis DOID_4247 8.879E-09 3.558E-08 0.07012914 0.78242123 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lymph node disease DOID_9942 8.879E-09 3.609E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP benign glioma DOID_0060101 1.146E-08 4.56E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP benign ependymoma DOID_4844 1.146E-08 4.56E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP acquired immunodeficiency syndrome DOID_635 1.146E-08 4.528E-08 0.07334406 0.77282905 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP nephrotic syndrome DOID_1184 1.268E-08 4.977E-08 0.1472776 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pulmonary embolism DOID_9477 1.46E-08 5.691E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP polyarteritis nodosa DOID_9810 1.46E-08 5.652E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP meningitis DOID_9471 1.839E-08 7.071E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP proteinuria DOID_576 1.877E-08 7.17E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP neuritis DOID_1803 2.127E-08 8.07E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP toxic shock syndrome DOID_14115 2.293E-08 8.64E-08 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lung small cell carcinoma DOID_5409 2.71E-08 1.015E-07 0.01403603 0.39932501 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP retinal vascular occlusion DOID_1729 2.814E-08 1.046E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP keratitis DOID_4677 2.814E-08 1.04E-07 0.0340262 0.58669422 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cutaneous leishmaniasis DOID_9111 2.814E-08 1.033E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP urticaria DOID_1555 2.831E-08 1.033E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bronchiolitis DOID_2942 2.831E-08 1.026E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hemorrhagic disease DOID_2213 3.419E-08 1.231E-07 0.17059695 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP middle cerebral artery infarction DOID_3525 4.206E-08 1.505E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autoimmune disease of cardiovascular system DOID_0060051 6.065E-08 2.157E-07 0.0986694 0.93571485 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Behcet's disease DOID_13241 6.065E-08 2.157E-07 0.0986694 0.93571485 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP peritonitis DOID_8283 6.596E-08 2.331E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP encephalitis DOID_9588 6.596E-08 2.317E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP multiple epiphyseal dysplasia DOID_12721 7.212E-08 2.517E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP corneal disease DOID_10124 8.523E-08 2.957E-07 0.10489267 0.93256137 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP larynx cancer DOID_2596 9.503E-08 3.277E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP laryngeal benign neoplasm DOID_2598 9.503E-08 3.277E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP neuroectodermal tumor DOID_171 9.648E-08 3.307E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pre-malignant neoplasm DOID_0060071 1.163E-07 3.961E-07 0.20439449 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP in situ carcinoma DOID_8719 1.163E-07 3.961E-07 0.20439449 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Legionnaires' disease DOID_10457 1.327E-07 4.494E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP legionellosis DOID_10458 1.327E-07 4.494E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hemangioma DOID_255 1.804E-07 6.075E-07 0.0506059 0.70231114 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP endocrine organ benign neoplasm DOID_0060089 1.807E-07 6.048E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP spindle cell carcinoma DOID_4015 1.82E-07 6.055E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP esophageal disease DOID_6050 1.82E-07 6.019E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP adenoma DOID_657 2.39E-07 7.861E-07 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP multiple myeloma DOID_9538 2.724E-07 8.908E-07 0.12936218 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP urinary system benign neoplasm DOID_731 3.129E-07 1.017E-06 0.05715843 0.72273656 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP congenital diaphragmatic hernia DOID_3827 3.502E-07 1.132E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP eosinophilia DOID_999 4.013E-07 1.29E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hyperinsulinism DOID_2018 5.581E-07 1.784E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP esophagitis DOID_11963 6.319E-07 2.009E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thyroid adenoma DOID_2891 8.532E-07 2.697E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hepatitis B DOID_2043 9.49E-07 2.983E-06 0.07334406 0.78741073 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lymphoblastic leukemia DOID_1037 1.025E-06 3.204E-06 0.042946 0.64305989 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.041E-06 3.236E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP glaucoma DOID_1686 1.041E-06 3.219E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP IgA glomerulonephritis DOID_2986 1.146E-06 3.524E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP muscle cancer DOID_4045 1.146E-06 3.505E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP synostosis DOID_11971 1.371E-06 4.172E-06 3.111E-03 0.19671397 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Goodpasture syndrome DOID_9808 1.371E-06 4.15E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP spastic quadriplegia DOID_10970 1.628E-06 4.901E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pustulosis of palm and sole DOID_4398 1.805E-06 5.405E-06 0.18201818 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cleft lip DOID_9296 2.247E-06 6.693E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Sciatic Neuropathy DOID_11446 3.024E-06 8.962E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lesion of sciatic nerve DOID_12528 3.024E-06 8.962E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mononeuritis of lower limb DOID_9473 3.024E-06 8.962E-06 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thrombocytopenia DOID_1588 3.48E-06 1.026E-05 0.0986694 0.92037527 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mononeuritis DOID_1802 3.48E-06 1.021E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mononeuropathy DOID_1188 3.985E-06 1.163E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP temporal lobe epilepsy DOID_3328 4.294E-06 1.247E-05 0.21262808 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP childhood type dermatomyositis DOID_14203 4.754E-06 1.373E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP insulinoma DOID_3892 4.754E-06 1.366E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP visceral leishmaniasis DOID_9146 4.754E-06 1.359E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP spastic cerebral palsy DOID_0050669 5.155E-06 1.466E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP age related macular degeneration DOID_10871 5.155E-06 1.459E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP degeneration of macula and posterior pole DOID_2007 5.155E-06 1.459E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP gonadal disease DOID_2277 5.155E-06 1.452E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP germinoma DOID_3304 5.826E-06 1.633E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP dermatomyositis DOID_10223 6.52E-06 1.818E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP temporal arteritis DOID_13375 6.52E-06 1.81E-05 0.03736497 0.62531374 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP central nervous system vasculitis DOID_525 6.52E-06 1.81E-05 0.03736497 0.62531374 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP eosinophilic pneumonia DOID_5870 6.52E-06 1.801E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pulmonary eosinophilia DOID_9498 6.52E-06 1.801E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Loeffler syndrome DOID_9503 6.52E-06 1.801E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bronchiectasis DOID_9563 6.52E-06 1.792E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP papilloma DOID_2615 7.361E-06 2.014E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP endogenous depression DOID_1595 7.868E-06 2.142E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP syndrome DOID_225 7.868E-06 2.132E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thyroid carcinoma DOID_3963 8.231E-06 2.22E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP macular degeneration DOID_4448 8.231E-06 2.209E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bone resorption disease DOID_0080011 8.376E-06 2.238E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP osteoporosis DOID_11476 8.376E-06 2.238E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP common cold DOID_10459 8.671E-06 2.305E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP intracranial arteriosclerosis DOID_13097 8.671E-06 2.295E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pituitary cancer DOID_1785 8.671E-06 2.284E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP islet cell tumor DOID_1799 8.671E-06 2.274E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pituitary carcinoma DOID_4916 8.671E-06 2.284E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP stomach disease DOID_76 8.671E-06 2.263E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP vascular dementia DOID_8725 8.671E-06 2.295E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP ocular hypertension DOID_9282 8.671E-06 2.253E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP borderline glaucoma DOID_9283 8.671E-06 2.253E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lymphoid leukemia DOID_10747 9.175E-06 2.373E-05 7.679E-03 0.24274345 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thyroid cancer DOID_1781 1.02E-05 2.625E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP carotid stenosis DOID_13001 1.124E-05 2.882E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mental depression DOID_1596 1.199E-05 3.06E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP focal epilepsy DOID_2234 1.199E-05 3.046E-05 0.2551332 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP uveitis DOID_13141 1.249E-05 3.158E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP blood platelet disease DOID_2218 1.249E-05 3.144E-05 0.13237381 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP polycystic kidney disease DOID_898 1.427E-05 3.578E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cervix uteri carcinoma in situ DOID_8991 1.66E-05 4.144E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP idiopathic pulmonary fibrosis DOID_0050156 1.78E-05 4.422E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mesenchymal cell neoplasm DOID_3350 1.78E-05 4.403E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP spindle cell sarcoma DOID_4235 1.78E-05 4.403E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP epithelioid sarcoma DOID_6193 1.78E-05 4.403E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autoimmune disease of urogenital tract DOID_0060049 1.818E-05 4.477E-05 0.14431731 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP primary biliary cirrhosis DOID_12236 1.818E-05 4.477E-05 0.14431731 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP primitive neuroectodermal tumor DOID_168 1.985E-05 4.869E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP uveal disease DOID_3480 1.985E-05 4.848E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.168E-05 5.271E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pituitary adenoma DOID_3829 2.185E-05 5.29E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP learning disability DOID_8927 2.355E-05 5.677E-05 0.15316773 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bronchitis DOID_6132 2.646E-05 6.354E-05 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mitochondrial myopathy DOID_699 5.124E-05 1.225E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP neutropenia DOID_1227 5.918E-05 1.409E-04 0.07334406 0.80255325 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thrombophilia DOID_2452 5.918E-05 1.403E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP oral cavity cancer DOID_8618 6.1E-05 1.44E-04 0.19048156 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP melancholia DOID_2848 6.503E-05 1.529E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP agranulocytosis DOID_12987 6.788E-05 1.59E-04 0.07654794 0.79192324 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hypoglycemia DOID_9993 6.788E-05 1.583E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP neurotic disorder DOID_4964 6.925E-05 1.608E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP aortic valve disease DOID_62 7.739E-05 1.79E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hypogonadism DOID_1924 9.891E-05 2.278E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP myositis DOID_633 1.11E-04 2.547E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP spinal cord disease DOID_319 1.24E-04 2.833E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP seminoma DOID_4440 1.24E-04 2.822E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP perinatal necrotizing enterocolitis DOID_8677 1.38E-04 3.127E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP malaria DOID_12365 1.529E-04 3.452E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP invasive ductal carcinoma DOID_3008 1.529E-04 3.439E-04 0.0986694 0.891157 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP toxic encephalopathy DOID_3602 1.688E-04 3.783E-04 5.16E-03 0.20971769 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lipid metabolism disorder DOID_3146 1.933E-04 4.313E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autonomic nervous system neoplasm DOID_2621 2.434E-04 5.41E-04 0.1141477 0.96940356 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP neuroblastoma DOID_769 2.434E-04 5.41E-04 0.1141477 0.96940356 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hepatitis C DOID_1883 2.875E-04 6.365E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP leukopenia DOID_615 2.875E-04 6.34E-04 0.12026489 0.99174963 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP refractive error DOID_9835 3.364E-04 7.391E-04 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP peripheral nervous system neoplasm DOID_1192 3.905E-04 8.545E-04 0.13237381 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP adenoid cystic carcinoma DOID_4866 4.498E-04 9.805E-04 0.1383661 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP benign mesothelioma DOID_2645 4.814E-04 1.046E-03 0.14134682 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP salivary gland cancer DOID_8850 5.145E-04 1.113E-03 0.14431731 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Sjogren's syndrome DOID_12894 5.236E-04 1.129E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hyperparathyroidism DOID_13543 5.236E-04 1.124E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP acute kidney failure DOID_3021 5.236E-04 1.12E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP conjunctival disease DOID_4251 5.236E-04 1.116E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP conjunctivitis DOID_6195 5.236E-04 1.116E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP nervous system benign neoplasm DOID_0060115 6.385E-04 1.356E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sickle cell anemia DOID_10923 6.385E-04 1.351E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hemolytic anemia DOID_583 7.438E-04 1.567E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP normocytic anemia DOID_720 7.438E-04 1.567E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP aortic valve insufficiency DOID_57 7.645E-04 1.605E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP withdrawal disorder DOID_0060001 8.793E-04 1.839E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP parathyroid gland disease DOID_11201 9.015E-04 1.879E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP osteogenesis imperfecta DOID_12347 9.015E-04 1.872E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hepatic coma DOID_12550 9.015E-04 1.865E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hepatic encephalopathy DOID_13413 9.015E-04 1.865E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP polyneuropathy DOID_1389 9.015E-04 1.858E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP psoriatic arthritis DOID_9008 9.015E-04 1.852E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP tethered spinal cord syndrome DOID_1089 1.049E-03 2.148E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hypercalcemia DOID_12678 1.049E-03 2.14E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP rhabdomyosarcoma DOID_3247 1.049E-03 2.132E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP eyelid disease DOID_530 1.049E-03 2.125E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bacterial meningitis DOID_9470 1.049E-03 2.117E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP familial hyperlipidemia DOID_1168 1.138E-03 2.288E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mitochondrial metabolism disease DOID_700 1.138E-03 2.28E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP membranoproliferative glomerulonephritis DOID_2920 1.208E-03 2.412E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP skeletal muscle cancer DOID_4043 1.208E-03 2.403E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP nutritional deficiency disease DOID_5113 1.208E-03 2.395E-03 1.208E-03 0.09819671 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lung oat cell carcinoma DOID_5411 1.208E-03 2.387E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP intermediate coronary syndrome DOID_8805 1.208E-03 2.378E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hyperhomocysteinemia DOID_9279 1.208E-03 2.37E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP silicosis DOID_10325 1.378E-03 2.693E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP spastic diplegia DOID_10965 1.378E-03 2.684E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hemolytic-uremic syndrome DOID_12554 1.378E-03 2.675E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thyroiditis DOID_7166 1.378E-03 2.666E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autoimmune thyroiditis DOID_7188 1.378E-03 2.666E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Barrett's esophagus DOID_9206 1.378E-03 2.657E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP penile disease DOID_1529 1.558E-03 2.994E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP juvenile rheumatoid arthritis DOID_676 1.558E-03 2.984E-03 0.05715843 0.73916239 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP neuroendocrine tumor DOID_169 1.748E-03 3.338E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sexual dysfunction DOID_1876 1.748E-03 3.327E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP inherited blood coagulation disease DOID_2214 1.748E-03 3.316E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP skin carcinoma DOID_3451 1.748E-03 3.305E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP agammaglobulinemia DOID_2583 1.95E-03 3.673E-03 0.06366607 0.77076587 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP granulosa cell tumor DOID_2999 1.95E-03 3.661E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP amnestic disorder DOID_10914 2.161E-03 4.046E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sex cord-gonadal stromal tumor DOID_192 2.161E-03 4.032E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP blood protein disease DOID_620 2.161E-03 4.019E-03 0.06690316 0.7768959 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sexual disorder DOID_0060043 2.859E-03 5.298E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP myasthenia gravis DOID_437 2.859E-03 5.281E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP urinary tract obstruction DOID_5200 2.859E-03 5.264E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP sleep disorder DOID_535 2.859E-03 5.247E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP auditory system disease DOID_2742 3.133E-03 5.731E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP acute pancreatitis DOID_2913 3.374E-03 6.154E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP amino acid metabolic disorder DOID_9252 3.925E-03 7.135E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP papillary adenoma DOID_3172 3.93E-03 7.122E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP neuromuscular junction disease DOID_439 3.93E-03 7.099E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP microcystic adenoma DOID_5403 3.93E-03 7.122E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP follicular adenoma DOID_6204 3.93E-03 7.122E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP ankylosing spondylitis DOID_7147 3.93E-03 7.077E-03 0.08925392 0.8756117 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP B cell deficiency DOID_2115 4.223E-03 7.58E-03 0.09240321 0.8911428 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP gestational diabetes DOID_11714 4.526E-03 8.098E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autoimmune disease of the nervous system DOID_438 4.838E-03 8.63E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP autoimmune disease of endocrine system DOID_0060005 5.16E-03 9.175E-03 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP chronic leukemia DOID_1036 6.543E-03 0.01159869 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP chronic lymphocytic leukemia DOID_1040 6.543E-03 0.01159869 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP medullomyoblastoma DOID_3861 7.679E-03 0.01356951 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP adult medulloblastoma DOID_3864 7.679E-03 0.01356951 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP childhood medulloblastoma DOID_3869 7.679E-03 0.01356951 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP medulloblastoma DOID_3858 8.482E-03 0.01494181 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Huntington's disease DOID_12858 0.01110415 0.01950081 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP B-cell lymphocytic neoplasm DOID_707 0.01507976 0.02640118 0.17059695 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP atrophic muscular disease DOID_913 0.01615588 0.02819845 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP muscular dystrophy DOID_9884 0.01615588 0.02819845 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP congenital heart defect DOID_1682 0.02200538 0.03829071 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP arrhythmogenic right ventricular dysplasia DOID_0050431 0.03067595 0.05321528 0.03067595 0.56305203 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP leber hereditary optic neuropathy DOID_705 0.03067595 0.05305354 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hypolipoproteinemia DOID_1387 0.0340262 0.05866942 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP angioedema DOID_1558 0.0340262 0.05849217 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP transient cerebral ischemia DOID_224 0.0340262 0.05831599 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP bilirubin metabolic disorder DOID_2741 0.0340262 0.05814087 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP progressive muscular atrophy DOID_318 0.0340262 0.05796679 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP teratoma DOID_3307 0.0340262 0.05779376 0.0340262 0.60502842 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP chondrosarcoma DOID_3371 0.0340262 0.05762175 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP Hermansky-Pudlak syndrome DOID_3753 0.0340262 0.05745077 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP labyrinthine disease DOID_4539 0.0340262 0.0572808 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP malignant teratoma DOID_5563 0.0340262 0.05779376 0.0340262 0.60502842 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mature teratoma DOID_5566 0.0340262 0.05779376 0.0340262 0.60502842 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP acute T cell leukemia DOID_5603 0.0340262 0.05711183 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP alopecia areata DOID_986 0.0340262 0.05694385 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP familial adenomatous polyposis DOID_0050424 0.03736497 0.062348 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP breast benign neoplasm DOID_0060082 0.03736497 0.06216569 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP thoracic benign neoplasm DOID_0060097 0.03736497 0.06216569 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP trypanosomiasis DOID_10113 0.03736497 0.06198445 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP adrenoleukodystrophy DOID_10588 0.03736497 0.06180427 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP polydactyly DOID_1148 0.03736497 0.06162512 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP prediabetes syndrome DOID_11716 0.03736497 0.06144702 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP common variable immunodeficiency DOID_12177 0.03736497 0.06126993 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP migraine without aura DOID_12783 0.03736497 0.06109387 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP benign breast phyllodes tumor DOID_1631 0.03736497 0.06216569 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP craniosynostosis DOID_2340 0.03736497 0.06091882 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP hemochromatosis DOID_2352 0.03736497 0.06074476 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP prostatic adenoma DOID_2883 0.03736497 0.0605717 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP inner ear disease DOID_2952 0.03736497 0.06039962 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP invasive lobular carcinoma DOID_3457 0.03736497 0.06022852 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP primary immunodeficiency disease DOID_612 0.03973778 0.06387231 0.27047867 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP otitis media DOID_10754 0.04069228 0.06522228 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP aortic valve stenosis DOID_1712 0.04069228 0.06503907 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP relapsing-remitting multiple sclerosis DOID_2378 0.04069228 0.06485689 0.04069228 0.62578132 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP epidermolysis bullosa DOID_2730 0.04069228 0.06467572 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP middle ear disease DOID_5100 0.04069228 0.06522228 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP pituitary gland disease DOID_53 0.04069228 0.06449557 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP mitochondrial encephalomyopathy DOID_890 0.04069228 0.06431641 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP lymphoma DOID_0060058 0.04213508 0.06641235 0.27803333 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP carbohydrate metabolic disorder DOID_2978 0.042946 0.06750352 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP cone-rod dystrophy DOID_0050572 0.04400818 0.06898252 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP essential hypertension DOID_10825 0.04400818 0.06879301 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP vulva cancer DOID_1245 0.04400818 0.06860454 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP newborn respiratory distress syndrome DOID_12716 0.04400818 0.06841709 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP impotence DOID_1875 0.04400818 0.06823067 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP vesiculobullous skin disease DOID_2731 0.04400818 0.06804526 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP open-angle glaucoma DOID_1067 0.04731271 0.07295645 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP congenital structural myopathy DOID_422 0.04731271 0.07275927 0.04731271 0.67302328 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP T-cell leukemia DOID_715 0.04731271 0.07256316 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP communication disorder DOID_2033 0.0506059 0.07740526 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP arthropathy DOID_381 0.0506059 0.07719774 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP long QT syndrome DOID_2843 0.05388779 0.08198437 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP restrictive cardiomyopathy DOID_397 0.05388779 0.08176574 0.05388779 0.73005129 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP tongue cancer DOID_8649 0.05388779 0.08154828 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP familial hypertrophic cardiomyopathy DOID_11986 0.05715843 0.08626829 0.05715843 0.75635221 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP basal cell carcinoma DOID_2513 0.05715843 0.08604007 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP male reproductive organ benign neoplasm DOID_0060087 0.06041784 0.09070647 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP glucose intolerance DOID_10603 0.06041784 0.09046777 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP keratosis DOID_161 0.06041784 0.09023032 0.06041784 0.74734243 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP dental caries DOID_216 0.06041784 0.08999411 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP osteosclerosis DOID_4254 0.06041784 0.08975914 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP ureteral obstruction DOID_5199 0.06041784 0.0895254 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP dissociative disorder DOID_10935 0.06366607 0.0940935 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP dissociative amnesia DOID_11037 0.06366607 0.0940935 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP testicular cancer DOID_2998 0.06366607 0.09384973 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP membranous glomerulonephritis DOID_10976 0.06690316 0.09836666 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP colon carcinoma DOID_1520 0.06690316 0.09811314 1.000 1.000 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP amyloidosis DOID_9120 0.06690316 0.09786092 0.06690316 0.76135798 VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP alopecia DOID_987 0.06690316 0.09761 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN pre-malignant neoplasm DOID_0060071 2.174E-12 1.237E-09 8.705E-06 2.477E-03 LOPES_METHYLATED_IN_COLON_CANCER_DN in situ carcinoma DOID_8719 2.174E-12 1.237E-09 8.705E-06 2.477E-03 LOPES_METHYLATED_IN_COLON_CANCER_DN cervix uteri carcinoma in situ DOID_8991 5.515E-11 1.569E-08 3.279E-04 0.02332443 LOPES_METHYLATED_IN_COLON_CANCER_DN vulva cancer DOID_1245 7.331E-11 1.39E-08 2.735E-05 5.187E-03 LOPES_METHYLATED_IN_COLON_CANCER_DN lung adenocarcinoma DOID_3910 2.42E-09 3.442E-07 1.415E-04 0.01610534 LOPES_METHYLATED_IN_COLON_CANCER_DN gallbladder cancer DOID_3121 1.804E-08 2.053E-06 3.743E-04 0.02366532 LOPES_METHYLATED_IN_COLON_CANCER_DN bile duct adenocarcinoma DOID_4896 3.979E-08 3.773E-06 5.506E-04 0.03132997 LOPES_METHYLATED_IN_COLON_CANCER_DN cholangiocarcinoma DOID_4947 3.979E-08 3.773E-06 5.506E-04 0.03132997 LOPES_METHYLATED_IN_COLON_CANCER_DN bile duct cancer DOID_4606 5.248E-08 4.266E-06 6.304E-04 0.03260955 LOPES_METHYLATED_IN_COLON_CANCER_DN bile duct carcinoma DOID_4897 5.248E-08 4.266E-06 6.304E-04 0.03260955 LOPES_METHYLATED_IN_COLON_CANCER_DN Lynch syndrome DOID_3883 5.556E-08 3.952E-06 2.735E-05 3.891E-03 LOPES_METHYLATED_IN_COLON_CANCER_DN hypothyroidism DOID_1459 6.798E-08 4.298E-06 8.313E-06 4.73E-03 LOPES_METHYLATED_IN_COLON_CANCER_DN biliary tract cancer DOID_4607 2.017E-07 1.148E-05 1.219E-03 0.05335419 LOPES_METHYLATED_IN_COLON_CANCER_DN lymphoma DOID_0060058 3.027E-07 1.566E-05 1.488E-03 0.06045832 LOPES_METHYLATED_IN_COLON_CANCER_DN muscle cancer DOID_4045 3.427E-07 1.625E-05 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN nephroblastoma DOID_2154 1.495E-06 6.544E-05 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN embryonal cancer DOID_688 1.899E-06 7.718E-05 2.708E-04 0.02201139 LOPES_METHYLATED_IN_COLON_CANCER_DN benign mesothelioma DOID_2645 2.541E-06 9.641E-05 0.02636361 0.32610637 LOPES_METHYLATED_IN_COLON_CANCER_DN thyroid adenoma DOID_2891 3.752E-06 1.334E-04 0.02990671 0.33366511 LOPES_METHYLATED_IN_COLON_CANCER_DN endocrine organ benign neoplasm DOID_0060089 1.085E-05 3.632E-04 0.04221072 0.40029831 LOPES_METHYLATED_IN_COLON_CANCER_DN astrocytoma DOID_3069 1.132E-05 3.578E-04 0.04279288 0.39916641 LOPES_METHYLATED_IN_COLON_CANCER_DN mixed glioma DOID_5076 1.554E-05 4.655E-04 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.58E-05 4.494E-04 6.051E-03 0.21518943 LOPES_METHYLATED_IN_COLON_CANCER_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.58E-05 4.494E-04 6.051E-03 0.21518943 LOPES_METHYLATED_IN_COLON_CANCER_DN Hodgkin's granuloma DOID_8651 1.58E-05 4.494E-04 6.051E-03 0.21518943 LOPES_METHYLATED_IN_COLON_CANCER_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 1.58E-05 4.494E-04 6.051E-03 0.21518943 LOPES_METHYLATED_IN_COLON_CANCER_DN transitional cell carcinoma DOID_2671 2.214E-05 5.998E-04 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN Hodgkin's lymphoma DOID_8567 2.315E-05 5.988E-04 7.257E-03 0.24289656 LOPES_METHYLATED_IN_COLON_CANCER_DN nervous system cancer DOID_3093 2.364E-05 5.85E-04 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.686E-05 6.368E-04 1.551E-03 0.05882431 LOPES_METHYLATED_IN_COLON_CANCER_DN schizophreniform disorder DOID_11328 4.762E-05 1.084E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN schizoaffective disorder DOID_5418 4.762E-05 1.084E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN testicular cancer DOID_2998 5.983E-05 1.309E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN granulosa cell tumor DOID_2999 5.983E-05 1.261E-03 0.01146698 0.3107006 LOPES_METHYLATED_IN_COLON_CANCER_DN sex cord-gonadal stromal tumor DOID_192 6.645E-05 1.35E-03 0.01206701 0.31209675 LOPES_METHYLATED_IN_COLON_CANCER_DN lingual-facial-buccal dyskinesia DOID_9854 8.839E-05 1.734E-03 0.013865 0.34300814 LOPES_METHYLATED_IN_COLON_CANCER_DN meningitis DOID_9471 9.639E-05 1.828E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN papillary adenoma DOID_3172 1.224E-04 2.247E-03 0.01625746 0.35578829 LOPES_METHYLATED_IN_COLON_CANCER_DN microcystic adenoma DOID_5403 1.224E-04 2.247E-03 0.01625746 0.35578829 LOPES_METHYLATED_IN_COLON_CANCER_DN follicular adenoma DOID_6204 1.224E-04 2.247E-03 0.01625746 0.35578829 LOPES_METHYLATED_IN_COLON_CANCER_DN fragments of torsion dystonia DOID_531 1.318E-04 2.344E-03 0.01685471 0.31967762 LOPES_METHYLATED_IN_COLON_CANCER_DN invasive ductal carcinoma DOID_3008 1.516E-04 2.614E-03 0.01804816 0.33127107 LOPES_METHYLATED_IN_COLON_CANCER_DN central nervous system hereditary degenerative disease DOID_481 1.516E-04 2.537E-03 0.01804816 0.32091884 LOPES_METHYLATED_IN_COLON_CANCER_DN dystonic disease DOID_544 1.62E-04 2.633E-03 0.01864437 0.31201895 LOPES_METHYLATED_IN_COLON_CANCER_DN germinoma DOID_3304 1.952E-04 3.085E-03 0.02043091 0.30592597 LOPES_METHYLATED_IN_COLON_CANCER_DN allergic rhinitis DOID_4481 1.952E-04 3.002E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN autonomic nervous system neoplasm DOID_2621 2.069E-04 3.099E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN neuroblastoma DOID_769 2.069E-04 3.099E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN papilloma DOID_2615 2.19E-04 3.196E-03 0.02162021 0.31543329 LOPES_METHYLATED_IN_COLON_CANCER_DN thyroid carcinoma DOID_3963 2.315E-04 3.293E-03 0.02221434 0.31599898 LOPES_METHYLATED_IN_COLON_CANCER_DN spindle cell carcinoma DOID_4015 2.315E-04 3.212E-03 2.315E-04 0.02195102 LOPES_METHYLATED_IN_COLON_CANCER_DN thyroid cancer DOID_1781 2.573E-04 3.486E-03 0.02340157 0.31703552 LOPES_METHYLATED_IN_COLON_CANCER_DN adenoma DOID_657 2.573E-04 3.405E-03 0.02340157 0.3096626 LOPES_METHYLATED_IN_COLON_CANCER_DN pulmonary sarcoidosis DOID_13406 2.708E-04 3.502E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN peripheral nervous system neoplasm DOID_1192 2.846E-04 3.598E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN uterine cancer DOID_363 3.743E-04 4.63E-03 0.02813671 0.32673032 LOPES_METHYLATED_IN_COLON_CANCER_DN brain cancer DOID_1319 4.237E-04 5.13E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN central nervous system cancer DOID_3620 4.408E-04 5.226E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN glaucoma DOID_1686 4.583E-04 5.322E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN movement disease DOID_480 4.761E-04 5.418E-03 0.03167364 0.33374631 LOPES_METHYLATED_IN_COLON_CANCER_DN sarcoidosis DOID_11335 5.315E-04 5.93E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN giant cell tumor DOID_200 5.315E-04 5.816E-03 0.03343749 0.33974874 LOPES_METHYLATED_IN_COLON_CANCER_DN malignant giant cell tumor DOID_2705 5.315E-04 5.816E-03 0.03343749 0.33974874 LOPES_METHYLATED_IN_COLON_CANCER_DN giant cell glioblastoma DOID_3074 5.315E-04 5.816E-03 0.03343749 0.33974874 LOPES_METHYLATED_IN_COLON_CANCER_DN hypersensitivity reaction type IV disease DOID_2916 6.304E-04 6.768E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN glioblastoma DOID_3068 6.304E-04 6.643E-03 0.0363704 0.35680619 LOPES_METHYLATED_IN_COLON_CANCER_DN melancholia DOID_2848 6.512E-04 6.737E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN neurotic disorder DOID_4964 6.723E-04 6.831E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN endocrine pancreas disease DOID_1428 7.6E-04 7.586E-03 7.6E-04 0.0360357 LOPES_METHYLATED_IN_COLON_CANCER_DN temporal lobe epilepsy DOID_3328 8.058E-04 7.905E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN pancreatic ductal carcinoma DOID_3587 9.013E-04 8.692E-03 0.04337471 0.39806792 LOPES_METHYLATED_IN_COLON_CANCER_DN pancreatic carcinoma DOID_4905 9.764E-04 9.259E-03 0.04511816 0.40112868 LOPES_METHYLATED_IN_COLON_CANCER_DN endogenous depression DOID_1595 1.028E-03 9.589E-03 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN chromosomal disease DOID_0080014 1.163E-03 0.01067171 0.04917441 0.42394302 LOPES_METHYLATED_IN_COLON_CANCER_DN mental depression DOID_1596 1.219E-03 0.01100959 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN focal epilepsy DOID_2234 1.219E-03 0.01083757 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN hypersensitivity reaction type I disease DOID_1205 1.583E-03 0.01385552 0.05723751 0.46525919 LOPES_METHYLATED_IN_COLON_CANCER_DN rectal neoplasm DOID_1984 6.051E-03 0.05216713 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN rectum cancer DOID_1993 6.051E-03 0.05216713 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN teratoma DOID_3307 6.051E-03 0.05138852 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN hypokalemia DOID_4500 6.051E-03 0.05063281 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN labyrinthine disease DOID_4539 6.051E-03 0.049899 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN malignant teratoma DOID_5563 6.051E-03 0.05138852 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN mature teratoma DOID_5566 6.051E-03 0.05138852 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN familial adenomatous polyposis DOID_0050424 6.654E-03 0.05408908 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN obsessive-compulsive disorder DOID_10933 6.654E-03 0.05332727 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN prostatic adenoma DOID_2883 6.654E-03 0.05258661 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN inner ear disease DOID_2952 6.654E-03 0.05186624 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN heroin dependence DOID_9976 6.654E-03 0.05116535 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN peritonitis DOID_8283 7.257E-03 0.05505655 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN ocular hypertension DOID_9282 7.257E-03 0.05433213 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN borderline glaucoma DOID_9283 7.257E-03 0.05433213 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN nicotine dependence DOID_0050742 7.859E-03 0.05807855 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN parathyroid gland disease DOID_11201 7.859E-03 0.05733395 7.859E-03 0.24844712 LOPES_METHYLATED_IN_COLON_CANCER_DN larynx cancer DOID_2596 7.859E-03 0.0566082 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN laryngeal benign neoplasm DOID_2598 7.859E-03 0.0566082 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN epilepsy with generalized tonic-clonic seizures DOID_7725 7.859E-03 0.0559006 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN rhabdomyosarcoma DOID_3247 8.462E-03 0.05944019 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN eating disorder DOID_8670 8.462E-03 0.05871531 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN bacterial meningitis DOID_9470 8.462E-03 0.0580079 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN idiopathic pulmonary fibrosis DOID_0050156 9.063E-03 0.06139362 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN communication disorder DOID_2033 9.063E-03 0.06067135 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN mesenchymal cell neoplasm DOID_3350 9.063E-03 0.05996587 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN skeletal muscle cancer DOID_4043 9.063E-03 0.0592766 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN spindle cell sarcoma DOID_4235 9.063E-03 0.05996587 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN epithelioid sarcoma DOID_6193 9.063E-03 0.05996587 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN intermediate coronary syndrome DOID_8805 9.063E-03 0.05860301 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN thyroiditis DOID_7166 9.665E-03 0.0617896 9.665E-03 0.28943549 LOPES_METHYLATED_IN_COLON_CANCER_DN autoimmune thyroiditis DOID_7188 9.665E-03 0.0617896 9.665E-03 0.28943549 LOPES_METHYLATED_IN_COLON_CANCER_DN chronic myeloid leukemia DOID_8552 9.665E-03 0.06110305 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN tongue cancer DOID_8649 9.665E-03 0.06043159 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN drug-induced mental disorder DOID_1203 0.01026588 0.06349224 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN Graves' disease DOID_12361 0.01026588 0.06280952 0.01026588 0.29206428 LOPES_METHYLATED_IN_COLON_CANCER_DN drug psychosis DOID_1742 0.01026588 0.06349224 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN basal cell carcinoma DOID_2513 0.01026588 0.06214134 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN substance-induced psychosis DOID_8646 0.01026588 0.06349224 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN male reproductive organ benign neoplasm DOID_0060087 0.01086661 0.06508525 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN skin carcinoma DOID_3451 0.01086661 0.06440727 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN colon carcinoma DOID_1520 0.01206701 0.07078483 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN subependymal glioma DOID_4843 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN pilocytic astrocytoma DOID_4851 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN subependymal giant cell astrocytoma DOID_5077 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN fibrillary astrocytoma DOID_6726 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN juvenile pilocytic astrocytoma DOID_6811 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN childhood pilocytic astrocytoma DOID_6812 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN gemistocytic astrocytoma DOID_7005 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN childhood cerebral astrocytoma DOID_7007 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN protoplasmic astrocytoma DOID_7008 0.01206701 0.07006254 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN benign glioma DOID_0060101 0.01326602 0.07624612 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN benign ependymoma DOID_4844 0.01326602 0.07624612 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN muscular atrophy DOID_767 0.01326602 0.07548366 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN sinusitis DOID_0050127 0.013865 0.07811077 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN paranasal sinus disease DOID_1352 0.013865 0.07811077 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN opiate dependence DOID_2559 0.013865 0.07734497 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN hypoglycemia DOID_9993 0.013865 0.07659405 0.013865 0.32871614 LOPES_METHYLATED_IN_COLON_CANCER_DN X-linked disease DOID_0050735 0.01565987 0.08567755 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN reading disorder DOID_13365 0.01565987 0.08486157 0.01565987 0.3564186 LOPES_METHYLATED_IN_COLON_CANCER_DN osteosarcoma DOID_3347 0.01565987 0.08406099 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN dyslexia DOID_4428 0.01565987 0.08486157 0.01565987 0.3564186 LOPES_METHYLATED_IN_COLON_CANCER_DN morbid obesity DOID_11981 0.01625746 0.08645323 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN cystitis DOID_1679 0.01625746 0.08565274 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN ankylosing spondylitis DOID_7147 0.01625746 0.08486693 0.01625746 0.34261095 LOPES_METHYLATED_IN_COLON_CANCER_DN myopia DOID_11830 0.01685471 0.08718481 0.01685471 0.34251174 LOPES_METHYLATED_IN_COLON_CANCER_DN seminoma DOID_4440 0.01685471 0.08639936 0.01685471 0.33070099 LOPES_METHYLATED_IN_COLON_CANCER_DN diffuse large B-cell lymphoma DOID_0050745 0.01745161 0.0886604 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN sarcoma DOID_1115 0.01804816 0.09087967 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN autoimmune disease of endocrine system DOID_0060005 0.01864437 0.09305828 0.01864437 0.32147407 LOPES_METHYLATED_IN_COLON_CANCER_DN supratentorial cancer DOID_1659 0.01864437 0.09224908 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN toxic encephalopathy DOID_3602 0.01864437 0.09145383 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN cerebrum cancer DOID_368 0.01864437 0.09224908 1.000 1.000 LOPES_METHYLATED_IN_COLON_CANCER_DN endometrial carcinoma DOID_2871 0.01924023 0.09356999 0.01924023 0.31279111 LOPES_METHYLATED_IN_COLON_CANCER_DN celiac disease DOID_10608 0.02043091 0.09851853 0.02043091 0.32292186 LOPES_METHYLATED_IN_COLON_CANCER_DN endometrial cancer DOID_1380 0.02043091 0.09769065 0.02043091 0.31419424 LOPES_METHYLATED_IN_COLON_CANCER_DN bladder disease DOID_365 0.02102573 0.09969701 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN amino acid metabolic disorder DOID_9252 1.889E-29 1.075E-26 1.889E-29 1.075E-26 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN carbohydrate metabolic disorder DOID_2978 1.132E-16 3.219E-14 1.132E-16 3.219E-14 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN oral cavity cancer DOID_8618 3.273E-12 6.208E-10 3.273E-12 6.208E-10 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hypertrophic cardiomyopathy DOID_11984 2.055E-09 2.924E-07 2.055E-09 2.924E-07 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN bone resorption disease DOID_0080011 2.139E-08 2.434E-06 3.329E-07 1.722E-05 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN osteoporosis DOID_11476 2.139E-08 2.434E-06 3.329E-07 1.722E-05 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN glycogen metabolism disorder DOID_0050728 2.865E-08 2.717E-06 2.865E-08 3.261E-06 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN glycogen storage disease DOID_2747 2.865E-08 2.717E-06 2.865E-08 3.261E-06 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN mitochondrial metabolism disease DOID_700 3.269E-08 2.658E-06 3.269E-08 3.101E-06 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN chronic kidney failure DOID_784 4.096E-08 2.913E-06 8.048E-05 1.477E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN organic acidemia DOID_0060159 6.399E-08 4.045E-06 6.399E-08 5.201E-06 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN salivary gland cancer DOID_8850 9.048E-08 5.148E-06 9.048E-08 6.435E-06 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hemangioma DOID_255 1.093E-07 5.655E-06 2.423E-04 3.83E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN perinatal necrotizing enterocolitis DOID_8677 1.293E-07 6.13E-06 1.293E-07 8.173E-06 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN renal tubular transport disease DOID_447 1.605E-07 7.023E-06 1.605E-07 9.13E-06 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN nephrosis DOID_2527 1.994E-07 8.105E-06 3.68E-05 9.972E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN syndrome DOID_225 3.014E-07 1.143E-05 4.164E-06 1.823E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN mixed glioma DOID_5076 3.673E-07 1.306E-05 5.725E-05 1.253E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN membranous glomerulonephritis DOID_10976 5.454E-07 1.826E-05 2.065E-05 6.528E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN transitional cell carcinoma DOID_2671 9.138E-07 2.889E-05 1.081E-05 3.62E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN adenoid cystic carcinoma DOID_4866 1.504E-06 4.504E-05 1.504E-06 7.132E-05 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN ulcerative colitis DOID_8577 2.041E-06 5.808E-05 1.538E-03 0.01716229 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN nephrotic syndrome DOID_1184 2.263E-06 6.131E-05 4.038E-05 9.573E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN bile duct disease DOID_4138 2.918E-06 7.548E-05 3.68E-05 9.518E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cataract DOID_83 2.923E-06 7.232E-05 4.976E-05 1.132E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN biliary tract disease DOID_9741 3.196E-06 7.577E-05 3.972E-05 9.828E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN proteinuria DOID_576 3.308E-06 7.529E-05 7.963E-03 0.04820211 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN lens disease DOID_110 3.733E-06 8.169E-05 6.074E-05 1.28E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hypercalcemia DOID_12678 4.439E-06 9.354E-05 4.439E-06 1.804E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN lipid metabolism disorder DOID_3146 5.825E-06 1.184E-04 6.579E-05 1.337E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN chromosomal disease DOID_0080014 6.316E-06 1.239E-04 7.043E-05 1.382E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN alcohol abuse DOID_1574 7.403E-06 1.404E-04 7.403E-06 2.808E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN focal epilepsy DOID_2234 7.403E-06 1.359E-04 7.416E-04 9.377E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN age related macular degeneration DOID_10871 7.639E-06 1.358E-04 0.03085519 0.13004891 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN degeneration of macula and posterior pole DOID_2007 7.639E-06 1.358E-04 0.03085519 0.13004891 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN tongue cancer DOID_8649 7.965E-06 1.373E-04 7.965E-06 2.832E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN peroxisomal disease DOID_906 1.035E-05 1.732E-04 3.577E-04 5.088E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN macular degeneration DOID_4448 1.365E-05 2.22E-04 0.03808594 0.15479213 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Down syndrome DOID_14250 1.663E-05 2.629E-04 5.034E-04 6.987E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cholestasis DOID_13580 2.267E-05 3.487E-04 2.644E-04 3.959E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN temporal lobe epilepsy DOID_3328 2.466E-05 3.693E-04 2.675E-03 0.0253683 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Leigh disease DOID_3652 2.534E-05 3.698E-04 2.534E-05 7.59E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN brain infarction DOID_3454 2.905E-05 4.133E-04 2.905E-05 8.266E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN peripheral vascular disease DOID_341 3.972E-05 5.513E-04 0.02492972 0.111693 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Huntington's disease DOID_12858 4.038E-05 5.47E-04 5.865E-04 7.946E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN uveal disease DOID_3480 4.038E-05 5.343E-04 5.865E-04 7.762E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN vascular skin disease DOID_9540 6.074E-05 7.854E-04 8.42E-03 0.04990544 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN urticaria DOID_1555 6.126E-05 7.746E-04 1.294E-03 0.0156631 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN angioedema DOID_1558 6.592E-05 8.153E-04 2.982E-03 0.02651127 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN acute kidney failure DOID_3021 6.592E-05 7.98E-04 2.982E-03 0.0257079 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN integumentary system benign neoplasm DOID_0060121 7.349E-05 8.712E-04 7.349E-05 1.394E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN skin benign neoplasm DOID_3165 7.349E-05 8.712E-04 7.349E-05 1.394E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN biliary tract cancer DOID_4607 8.048E-05 9.345E-04 7.416E-04 9.173E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN calcium metabolism disease DOID_10575 8.06E-05 9.172E-04 8.06E-05 1.433E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN retinal vascular disease DOID_2462 9.164E-05 1.022E-03 0.03640968 0.14904393 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN bile duct adenocarcinoma DOID_4896 1.144E-04 1.252E-03 1.321E-03 0.01566514 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cholangiocarcinoma DOID_4947 1.144E-04 1.252E-03 1.321E-03 0.01566514 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN integumentary system cancer DOID_0060122 1.244E-04 1.335E-03 1.244E-04 2.145E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN skin cancer DOID_4159 1.244E-04 1.335E-03 1.244E-04 2.145E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN polycystic ovary syndrome DOID_11612 1.248E-04 1.315E-03 1.248E-04 2.088E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN toxic encephalopathy DOID_3602 1.248E-04 1.291E-03 2.169E-03 0.02243965 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN familial hyperlipidemia DOID_1168 1.35E-04 1.372E-03 1.503E-03 0.01710301 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN endometrial carcinoma DOID_2871 1.417E-04 1.414E-03 2.379E-03 0.0237459 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN bile duct cancer DOID_4606 1.582E-04 1.552E-03 1.701E-03 0.0182613 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN bile duct carcinoma DOID_4897 1.582E-04 1.552E-03 1.701E-03 0.0182613 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN dilated cardiomyopathy DOID_12930 1.673E-04 1.613E-03 1.344E-03 0.01560286 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN endometrial cancer DOID_1380 1.803E-04 1.71E-03 2.835E-03 0.0260166 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Zellweger syndrome DOID_905 1.951E-04 1.819E-03 1.951E-04 3.171E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN nutritional deficiency disease DOID_5113 2.423E-04 2.224E-03 6.769E-03 0.04427165 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN mineral metabolism disease DOID_0050032 2.466E-04 2.228E-03 2.466E-04 3.793E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN angiosarcoma DOID_0001816 2.964E-04 2.635E-03 0.12536667 0.34460692 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN lymphatic system cancer DOID_0060073 3.577E-04 3.131E-03 3.577E-04 5.219E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN reticulosarcoma DOID_8538 3.577E-04 3.131E-03 3.577E-04 5.219E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN lymphosarcoma DOID_8675 3.577E-04 3.131E-03 3.577E-04 5.219E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN uveitis DOID_13141 3.761E-04 3.242E-03 4.838E-03 0.03622182 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN diabetic retinopathy DOID_8947 4.439E-04 3.77E-03 0.13239876 0.35368495 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN benign mesothelioma DOID_2645 4.944E-04 4.137E-03 5.902E-03 0.03950592 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cervix uteri carcinoma in situ DOID_8991 4.944E-04 4.077E-03 5.902E-03 0.03904655 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN brain edema DOID_4724 5.886E-04 4.785E-03 0.0119178 0.06583714 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN diabetic autonomic neuropathy DOID_11503 6.369E-04 5.104E-03 7.094E-03 0.044852 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN autonomic neuropathy DOID_11504 6.369E-04 5.104E-03 7.094E-03 0.044852 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN diabetic polyneuropathy DOID_12785 6.369E-04 5.104E-03 7.094E-03 0.044852 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN uterine cancer DOID_363 6.369E-04 5.034E-03 7.094E-03 0.04435912 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN diabetic neuropathy DOID_9743 6.369E-04 5.104E-03 7.094E-03 0.044852 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN female reproductive system disease DOID_229 6.654E-04 5.186E-03 5.193E-03 0.03560115 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN mitochondrial myopathy DOID_699 6.825E-04 5.248E-03 6.825E-04 8.826E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN gastric ulcer DOID_10808 7.854E-04 5.959E-03 0.16822775 0.41259307 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN autonomic nervous system disease DOID_11465 8.064E-04 6.038E-03 8.42E-03 0.05043076 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hemolytic anemia DOID_583 8.694E-04 6.424E-03 8.892E-03 0.05162691 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN normocytic anemia DOID_720 8.694E-04 6.424E-03 8.892E-03 0.05162691 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN uremia DOID_4676 8.977E-04 6.549E-03 0.01561141 0.08301768 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN glaucoma DOID_1686 9.357E-04 6.739E-03 9.379E-03 0.05336602 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.283E-03 9.125E-03 0.04650779 0.18001994 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN portal hypertension DOID_10762 1.294E-03 9.088E-03 0.01972873 0.09594571 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hypersensitivity reaction type I disease DOID_1205 1.344E-03 9.324E-03 8.946E-03 0.05141694 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN spinal muscular atrophy DOID_12377 1.447E-03 9.917E-03 0.0211913 0.10218519 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN seminoma DOID_4440 1.61E-03 0.01090742 0.02269754 0.10499919 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN dystonia DOID_543 1.61E-03 0.0107791 1.61E-03 0.01761968 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN diffuse large B-cell lymphoma DOID_0050745 1.785E-03 0.01181019 0.21559292 0.49068948 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN lung adenocarcinoma DOID_3910 1.785E-03 0.01167445 0.02424662 0.10949464 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN sarcoma DOID_1115 1.971E-03 0.01274562 0.2221362 0.49762007 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hepatic vascular disease DOID_272 1.971E-03 0.01260241 0.02583772 0.11485672 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN central nervous system hereditary degenerative disease DOID_481 1.971E-03 0.01246238 1.971E-03 0.02077063 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN respiratory failure DOID_11162 2.15E-03 0.01344417 0.41988423 0.7990439 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN focal glomerulosclerosis DOID_3945 2.169E-03 0.01341501 2.169E-03 0.02203894 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN pre-malignant neoplasm DOID_0060071 2.274E-03 0.01391305 0.01783783 0.09143898 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN congenital heart defect DOID_1682 2.274E-03 0.01376504 0.01783783 0.09062256 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN in situ carcinoma DOID_8719 2.274E-03 0.01391305 0.01783783 0.09143898 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN corneal disease DOID_10124 2.379E-03 0.01424754 0.23505998 0.51244878 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cerebral degeneration DOID_1443 2.536E-03 0.01503334 2.536E-03 0.02488277 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN uterine disease DOID_345 2.536E-03 0.01487836 0.01930097 0.09549782 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN spastic cerebral palsy DOID_0050669 2.601E-03 0.01509955 2.601E-03 0.02508061 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hyperglycemia DOID_4195 2.675E-03 0.01537473 2.675E-03 0.02495243 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Charcot-Marie-Tooth disease DOID_10595 2.835E-03 0.01613029 0.03260646 0.13641967 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN germinoma DOID_3304 2.835E-03 0.01597059 0.03260646 0.13542391 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN facioscapulohumeral muscular dystrophy DOID_11727 2.982E-03 0.01663452 2.982E-03 0.02693208 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN retinal vascular occlusion DOID_1729 2.982E-03 0.01647302 0.0803043 0.27525992 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN transient cerebral ischemia DOID_224 2.982E-03 0.01631463 0.0803043 0.27361166 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN lateral sclerosis DOID_230 2.982E-03 0.01615925 0.0803043 0.27198302 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN bilirubin metabolic disorder DOID_2741 2.982E-03 0.0160068 2.982E-03 0.0261034 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cannabis abuse DOID_9505 2.982E-03 0.01585721 0.0803043 0.26412224 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN leiomyoma DOID_127 3.082E-03 0.01623576 3.082E-03 0.02617107 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN blood coagulation disease DOID_1247 3.282E-03 0.0171309 0.02324086 0.10579239 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN pancreatic ductal carcinoma DOID_3587 3.282E-03 0.01697517 0.45752391 0.86777035 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN myocarditis DOID_820 3.341E-03 0.0171277 3.341E-03 0.02795846 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN thyroid carcinoma DOID_3963 3.614E-03 0.01835968 3.614E-03 0.02980123 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hyperthyroidism DOID_7998 3.614E-03 0.01819721 0.03808594 0.15369432 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN breast benign neoplasm DOID_0060082 3.625E-03 0.01809106 3.625E-03 0.02946259 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN thoracic benign neoplasm DOID_0060097 3.625E-03 0.01809106 3.625E-03 0.02946259 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN benign breast phyllodes tumor DOID_1631 3.625E-03 0.01809106 3.625E-03 0.02946259 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN invasive lobular carcinoma DOID_3457 3.625E-03 0.01793375 3.625E-03 0.02904762 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN chronic monocytic leukemia DOID_8593 3.625E-03 0.01777915 3.625E-03 0.02864418 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN pancreatic carcinoma DOID_4905 3.794E-03 0.0184499 0.47100236 0.8903666 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN thyroid cancer DOID_1781 4.199E-03 0.02024692 4.199E-03 0.03272789 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN refractive error DOID_9835 4.199E-03 0.02007677 4.199E-03 0.03228562 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN epidermolysis bullosa DOID_2730 4.326E-03 0.02051062 4.326E-03 0.03281699 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN ocular hypertension DOID_9282 4.326E-03 0.02034111 0.09557652 0.28324498 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN borderline glaucoma DOID_9283 4.326E-03 0.02034111 0.09557652 0.28324498 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN metabolic syndrome X DOID_14221 4.975E-03 0.02320275 4.975E-03 0.0367628 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN polyneuropathy DOID_1389 5.084E-03 0.02351891 5.084E-03 0.03708751 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN obstructive hydrocephalus DOID_14159 5.084E-03 0.02332924 5.084E-03 0.03661805 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN communicating hydrocephalus DOID_1573 5.084E-03 0.02332924 5.084E-03 0.03661805 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cannabis dependence DOID_1849 5.084E-03 0.0231426 0.10311755 0.29633277 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN vesiculobullous skin disease DOID_2731 5.084E-03 0.02295893 5.084E-03 0.03616032 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Lynch syndrome DOID_3883 5.084E-03 0.02277815 5.084E-03 0.0357139 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN monocytic leukemia DOID_8527 5.084E-03 0.0226002 5.084E-03 0.03527836 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hallucinogen dependence DOID_9977 5.084E-03 0.0231426 0.10311755 0.29633277 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hepatitis DOID_2237 5.178E-03 0.02284141 0.04792662 0.18425844 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN peptic ulcer DOID_750 5.178E-03 0.0226657 0.29653792 0.6047673 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hydrocephalus DOID_10908 5.899E-03 0.02562188 5.899E-03 0.03995793 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN panic disorder DOID_594 6.769E-03 0.02917904 6.769E-03 0.04376856 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN intracranial hypertension DOID_9428 6.769E-03 0.02895965 6.769E-03 0.04327678 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN nervous system cancer DOID_3093 7.451E-03 0.03163698 0.53744606 0.99287924 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Human immunodeficiency virus infectious disease DOID_526 7.451E-03 0.03140264 0.04186513 0.16775535 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cerebral infarction DOID_3526 7.521E-03 0.03146769 7.521E-03 0.04651746 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN leukodystrophy DOID_10579 7.963E-03 0.03307298 7.963E-03 0.04872041 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN lymphoma DOID_0060058 8.027E-03 0.03309787 0.18486818 0.42934693 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Crohn's disease DOID_8778 8.633E-03 0.03533738 0.55271361 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN methylmalonic acidemia DOID_14749 8.672E-03 0.03524529 8.672E-03 0.0508695 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN keratosis DOID_161 9.703E-03 0.03915456 0.13989288 0.36181385 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN ureteral obstruction DOID_5199 9.703E-03 0.03887882 0.13989288 0.35855427 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN prion disease DOID_649 9.703E-03 0.03860694 0.13989288 0.3569464 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN movement disease DOID_480 9.881E-03 0.03904493 9.881E-03 0.05566802 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hemorrhagic disease DOID_2213 0.01039911 0.04080753 0.07469079 0.27242988 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN B-cell lymphocytic neoplasm DOID_707 0.01039911 0.04052803 0.36384357 0.71388617 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN testicular cancer DOID_2998 0.01078488 0.04174556 0.01078488 0.06016271 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN granulosa cell tumor DOID_2999 0.01078488 0.04146349 0.14706554 0.37191242 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN pulmonary edema DOID_11396 0.0119178 0.04551158 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN sex cord-gonadal stromal tumor DOID_192 0.0119178 0.04520817 0.15417858 0.38646526 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN vasculitis DOID_865 0.0120456 0.04539038 0.37964175 0.73978136 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN pustulosis of palm and sole DOID_4398 0.01262572 0.04726337 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN congenital nervous system abnormality DOID_2490 0.01383325 0.05144523 0.01383325 0.07568385 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN placenta disease DOID_780 0.01433196 0.05295379 0.01433196 0.07766555 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN heart conduction disease DOID_10273 0.01561141 0.05730898 0.01561141 0.08380086 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN agranulocytosis DOID_12987 0.01561141 0.05694161 0.17516486 0.42054348 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN urinary tract obstruction DOID_5200 0.01561141 0.05657893 0.17516486 0.41702429 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN carotid artery disease DOID_3407 0.01643899 0.05920117 0.01643899 0.08660912 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN ureteral disease DOID_1426 0.01693793 0.06061436 0.18204429 0.42452132 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN congenital hemolytic anemia DOID_589 0.01693793 0.06023552 0.01693793 0.08841911 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN hypothyroidism DOID_1459 0.01713039 0.06054155 0.01713039 0.08861081 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN spastic quadriplegia DOID_10970 0.01831066 0.06431336 0.01831066 0.09220146 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN endocrine pancreas disease DOID_1428 0.01856135 0.06479392 0.01856135 0.09264394 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN parasitic infectious disease DOID_1398 0.01930097 0.06696494 0.11038014 0.31560954 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN X-linked disease DOID_0050735 0.01972873 0.06803423 0.01972873 0.09677283 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cleft lip DOID_9296 0.0211913 0.07263766 0.0211913 0.10132649 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN endocrine organ benign neoplasm DOID_0060089 0.02161651 0.07365146 0.02161651 0.10249829 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN myopia DOID_11830 0.02269754 0.07687441 0.02269754 0.10673471 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN middle cerebral artery infarction DOID_3525 0.02269754 0.07641953 0.02269754 0.10585984 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN fragments of torsion dystonia DOID_531 0.02269754 0.07597 0.02269754 0.10415242 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN extrinsic allergic alveolitis DOID_841 0.02269754 0.07552573 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN autoimmune disease of cardiovascular system DOID_0060051 0.02583772 0.08547477 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN Behcet's disease DOID_13241 0.02583772 0.08547477 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN thrombocytopenia DOID_1588 0.02583772 0.0849807 0.2221362 0.49373241 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN invasive ductal carcinoma DOID_3008 0.02583772 0.0844923 0.2221362 0.48990503 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN coronary stenosis DOID_4248 0.02583772 0.08400949 0.02583772 0.11396636 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN autoimmune disease of endocrine system DOID_0060005 0.02747004 0.08880939 0.02747004 0.12023425 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN multiple epiphyseal dysplasia DOID_12721 0.02747004 0.08830764 0.22862507 0.50033718 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN dystonic disease DOID_544 0.02747004 0.08781153 0.02747004 0.11931643 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN cranial nerve disease DOID_5656 0.02747004 0.08732096 0.02747004 0.11841252 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN endogenous depression DOID_1595 0.0275838 0.08719544 0.47980201 0.90101434 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN female reproductive organ benign neoplasm DOID_0060086 0.02914279 0.09161463 0.02914279 0.12467856 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN uterine benign neoplasm DOID_0060095 0.02914279 0.09161463 0.02914279 0.12467856 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN uterine fibroid DOID_13223 0.02914279 0.09161463 0.02914279 0.12467856 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN congenital disorder of glycosylation DOID_5212 0.02914279 0.09111125 0.02914279 0.12374812 ROSS_AML_WITH_MLL_FUSIONS funisitis DOID_0050698 1.652E-06 9.402E-04 1.652E-06 9.402E-04 ROSS_AML_WITH_MLL_FUSIONS proteinuria DOID_576 1.938E-05 5.514E-03 1.938E-05 5.514E-03 ROSS_AML_WITH_MLL_FUSIONS carbohydrate metabolic disorder DOID_2978 1.408E-04 0.02670541 4.555E-03 0.23562788 ROSS_AML_WITH_MLL_FUSIONS lung adenocarcinoma DOID_3910 4.328E-04 0.06156753 4.328E-04 0.08209004 ROSS_AML_WITH_MLL_FUSIONS calcinosis DOID_182 8.254E-04 0.0939341 8.254E-04 0.11741763 ROSS_AML_WITH_MLL_FUSIONS heart valve disease DOID_4079 1.288E-03 0.0915903 1.288E-03 0.1221204 ROSS_AML_WITH_MLL_FUSIONS lung small cell carcinoma DOID_5409 1.392E-03 0.08800869 1.392E-03 0.11315404 ROSS_AML_WITH_MLL_FUSIONS calcium metabolism disease DOID_10575 1.446E-03 0.08225918 1.446E-03 0.10282398 GAJATE_RESPONSE_TO_TRABECTEDIN_UP middle cerebral artery infarction DOID_3525 5.014E-06 2.853E-03 5.106E-04 0.03631837 GAJATE_RESPONSE_TO_TRABECTEDIN_UP encephalomyelitis DOID_640 5.095E-06 1.449E-03 5.735E-03 0.15538635 GAJATE_RESPONSE_TO_TRABECTEDIN_UP intracranial arterial disease DOID_13089 1.865E-05 3.538E-03 1.206E-03 0.06862722 GAJATE_RESPONSE_TO_TRABECTEDIN_UP cerebral arterial disease DOID_3527 1.865E-05 3.538E-03 1.206E-03 0.06862722 GAJATE_RESPONSE_TO_TRABECTEDIN_UP cerebral infarction DOID_3526 2.604E-05 3.704E-03 1.501E-03 0.0776404 GAJATE_RESPONSE_TO_TRABECTEDIN_UP pustulosis of palm and sole DOID_4398 4.607E-05 5.242E-03 2.183E-03 0.10351185 GAJATE_RESPONSE_TO_TRABECTEDIN_UP brain infarction DOID_3454 8.441E-05 8.005E-03 3.25E-03 0.12327716 GAJATE_RESPONSE_TO_TRABECTEDIN_UP diabetic retinopathy DOID_8947 1.034E-04 8.405E-03 0.08639259 0.47725613 GAJATE_RESPONSE_TO_TRABECTEDIN_UP bone resorption disease DOID_0080011 1.16E-04 8.252E-03 4.005E-03 0.13405296 GAJATE_RESPONSE_TO_TRABECTEDIN_UP osteoporosis DOID_11476 1.16E-04 8.252E-03 4.005E-03 0.13405296 GAJATE_RESPONSE_TO_TRABECTEDIN_UP pancreatitis DOID_4989 1.204E-04 7.614E-03 4.105E-03 0.12975425 GAJATE_RESPONSE_TO_TRABECTEDIN_UP retinal vascular disease DOID_2462 1.545E-04 8.79E-03 0.09827616 0.527539 GAJATE_RESPONSE_TO_TRABECTEDIN_UP vein disease DOID_866 1.636E-04 8.462E-03 1.636E-04 0.09307701 GAJATE_RESPONSE_TO_TRABECTEDIN_UP transitional cell carcinoma DOID_2671 1.708E-04 8.098E-03 1.708E-04 0.048591 GAJATE_RESPONSE_TO_TRABECTEDIN_UP Human immunodeficiency virus infectious disease DOID_526 1.823E-04 7.978E-03 1.823E-04 0.03457015 GAJATE_RESPONSE_TO_TRABECTEDIN_UP psoriasis DOID_8893 2.326E-04 9.452E-03 2.326E-04 0.0330836 GAJATE_RESPONSE_TO_TRABECTEDIN_UP leishmaniasis DOID_9065 2.326E-04 8.822E-03 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP blood protein disease DOID_620 2.582E-04 9.183E-03 2.582E-04 0.02938544 GAJATE_RESPONSE_TO_TRABECTEDIN_UP autoimmune hepatitis DOID_2048 2.852E-04 9.545E-03 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP pulmonary embolism DOID_9477 3.431E-04 0.01084457 3.431E-04 0.03253371 GAJATE_RESPONSE_TO_TRABECTEDIN_UP Goodpasture syndrome DOID_9808 3.74E-04 0.01119932 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP urticaria DOID_1555 4.397E-04 0.01250932 0.03041805 0.35322183 GAJATE_RESPONSE_TO_TRABECTEDIN_UP hypogonadism DOID_1924 4.397E-04 0.01191364 0.03041805 0.34615739 GAJATE_RESPONSE_TO_TRABECTEDIN_UP osteosarcoma DOID_3347 4.397E-04 0.01137211 4.397E-04 0.03574092 GAJATE_RESPONSE_TO_TRABECTEDIN_UP myositis DOID_633 4.745E-04 0.01173902 0.03156972 0.34544562 GAJATE_RESPONSE_TO_TRABECTEDIN_UP pleurisy DOID_10247 5.867E-04 0.01391063 0.03501673 0.33770369 GAJATE_RESPONSE_TO_TRABECTEDIN_UP focal glomerulosclerosis DOID_3945 6.267E-04 0.01426441 6.267E-04 0.03962336 GAJATE_RESPONSE_TO_TRABECTEDIN_UP gonadal disease DOID_2277 7.106E-04 0.01555055 0.03845173 0.32655278 GAJATE_RESPONSE_TO_TRABECTEDIN_UP pleural disease DOID_1532 7.995E-04 0.01684934 0.04073509 0.33111811 GAJATE_RESPONSE_TO_TRABECTEDIN_UP respiratory syncytial virus infectious disease DOID_1273 1.151E-03 0.02338737 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP hyperinsulinism DOID_2018 1.379E-03 0.02706254 0.05319912 0.37837872 GAJATE_RESPONSE_TO_TRABECTEDIN_UP influenza DOID_8469 1.44E-03 0.02730255 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP neuritis DOID_1803 1.628E-03 0.02987383 0.05769211 0.40032698 GAJATE_RESPONSE_TO_TRABECTEDIN_UP vascular skin disease DOID_9540 1.628E-03 0.02894028 0.05769211 0.39550377 GAJATE_RESPONSE_TO_TRABECTEDIN_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.759E-03 0.03033133 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP pulmonary tuberculosis DOID_2957 1.759E-03 0.02943923 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP calcium metabolism disease DOID_10575 1.827E-03 0.02969722 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP vasculitis DOID_865 2.109E-03 0.03333927 0.06550475 0.41878876 GAJATE_RESPONSE_TO_TRABECTEDIN_UP parasitic protozoa infectious disease DOID_2789 2.183E-03 0.03357141 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP leukocyte disease DOID_9500 2.49E-03 0.03728189 2.49E-03 0.10897784 GAJATE_RESPONSE_TO_TRABECTEDIN_UP hypothyroidism DOID_1459 2.732E-03 0.03986646 2.732E-03 0.11105657 GAJATE_RESPONSE_TO_TRABECTEDIN_UP mineral metabolism disease DOID_0050032 2.9E-03 0.04125568 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP endocrine pancreas disease DOID_1428 2.9E-03 0.04024945 0.07655589 0.45852946 GAJATE_RESPONSE_TO_TRABECTEDIN_UP cholestasis DOID_13580 2.986E-03 0.04045131 0.07765395 0.46026141 GAJATE_RESPONSE_TO_TRABECTEDIN_UP parasitic infectious disease DOID_1398 2.986E-03 0.03951058 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP tuberculosis DOID_399 3.25E-03 0.04202631 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP bile duct disease DOID_4138 3.524E-03 0.04456349 0.08421555 0.48402672 GAJATE_RESPONSE_TO_TRABECTEDIN_UP peripheral vascular disease DOID_341 3.618E-03 0.04475541 0.0853047 0.48057796 GAJATE_RESPONSE_TO_TRABECTEDIN_UP biliary tract disease DOID_9741 3.618E-03 0.04380316 0.0853047 0.47586641 GAJATE_RESPONSE_TO_TRABECTEDIN_UP cystic fibrosis DOID_1485 3.907E-03 0.04630996 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP syndrome DOID_225 3.907E-03 0.04536485 3.907E-03 0.13892987 GAJATE_RESPONSE_TO_TRABECTEDIN_UP bacterial pneumonia DOID_874 4.105E-03 0.04671153 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP metabolic syndrome X DOID_14221 4.307E-03 0.04805654 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP lipid metabolism disorder DOID_3146 4.307E-03 0.04713238 4.307E-03 0.12899388 GAJATE_RESPONSE_TO_TRABECTEDIN_UP female reproductive system disease DOID_229 4.41E-03 0.04734928 0.09397245 0.50924118 GAJATE_RESPONSE_TO_TRABECTEDIN_UP primary bacterial infectious disease DOID_0050338 5.052E-03 0.05323748 1.000 1.000 GAJATE_RESPONSE_TO_TRABECTEDIN_UP primary immunodeficiency disease DOID_612 5.275E-03 0.05457667 5.275E-03 0.15008585 GAJATE_RESPONSE_TO_TRABECTEDIN_UP hypersensitivity reaction type I disease DOID_1205 5.971E-03 0.06067129 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bone resorption disease DOID_0080011 1.72E-10 9.787E-08 2.041E-07 1.161E-04 SENESE_HDAC1_AND_HDAC2_TARGETS_UP osteoporosis DOID_11476 1.72E-10 9.787E-08 2.041E-07 1.161E-04 SENESE_HDAC1_AND_HDAC2_TARGETS_UP mouth disease DOID_403 8.36E-10 2.378E-07 1.419E-05 1.346E-03 SENESE_HDAC1_AND_HDAC2_TARGETS_UP spindle cell carcinoma DOID_4015 1.902E-09 3.607E-07 6.155E-03 0.0875568 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pulmonary tuberculosis DOID_2957 1.602E-08 2.279E-06 6.104E-04 0.0315721 SENESE_HDAC1_AND_HDAC2_TARGETS_UP transitional cell carcinoma DOID_2671 1.603E-08 1.825E-06 2.973E-03 0.05834147 SENESE_HDAC1_AND_HDAC2_TARGETS_UP giant cell tumor DOID_200 2.529E-08 2.399E-06 7.586E-04 0.03320133 SENESE_HDAC1_AND_HDAC2_TARGETS_UP malignant giant cell tumor DOID_2705 2.529E-08 2.399E-06 7.586E-04 0.03320133 SENESE_HDAC1_AND_HDAC2_TARGETS_UP giant cell glioblastoma DOID_3074 2.529E-08 2.399E-06 7.586E-04 0.03320133 SENESE_HDAC1_AND_HDAC2_TARGETS_UP glioblastoma DOID_3068 4.27E-08 3.471E-06 9.736E-04 0.03462365 SENESE_HDAC1_AND_HDAC2_TARGETS_UP epidermolysis bullosa DOID_2730 4.633E-08 3.295E-06 6.664E-06 9.479E-04 SENESE_HDAC1_AND_HDAC2_TARGETS_UP ocular hypertension DOID_9282 4.633E-08 2.929E-06 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP borderline glaucoma DOID_9283 4.633E-08 2.929E-06 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP carotid artery disease DOID_3407 5.721E-08 3.255E-06 1.119E-03 0.03538379 SENESE_HDAC1_AND_HDAC2_TARGETS_UP vesiculobullous skin disease DOID_2731 6.676E-08 3.453E-06 8.643E-06 9.836E-04 SENESE_HDAC1_AND_HDAC2_TARGETS_UP tooth disease DOID_1091 9.852E-08 4.671E-06 3E-06 8.534E-04 SENESE_HDAC1_AND_HDAC2_TARGETS_UP tuberculosis DOID_399 1.073E-07 4.698E-06 1.511E-03 0.04094182 SENESE_HDAC1_AND_HDAC2_TARGETS_UP astrocytoma DOID_3069 1.168E-07 4.747E-06 1.573E-03 0.04068647 SENESE_HDAC1_AND_HDAC2_TARGETS_UP periodontal disease DOID_3388 1.174E-07 4.454E-06 5.815E-06 1.103E-03 SENESE_HDAC1_AND_HDAC2_TARGETS_UP influenza DOID_8469 4.029E-07 1.433E-05 0.13851364 0.45822244 SENESE_HDAC1_AND_HDAC2_TARGETS_UP primary bacterial infectious disease DOID_0050338 4.158E-07 1.392E-05 2.881E-03 0.05854484 SENESE_HDAC1_AND_HDAC2_TARGETS_UP myeloma DOID_0070004 5.523E-07 1.746E-05 5.438E-04 0.03438091 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pre-eclampsia DOID_10591 5.523E-07 1.654E-05 5.438E-04 0.03094282 SENESE_HDAC1_AND_HDAC2_TARGETS_UP glaucoma DOID_1686 6.741E-07 1.918E-05 0.15207937 0.48073978 SENESE_HDAC1_AND_HDAC2_TARGETS_UP sinusitis DOID_0050127 8.068E-07 2.186E-05 2.407E-03 0.05705991 SENESE_HDAC1_AND_HDAC2_TARGETS_UP paranasal sinus disease DOID_1352 8.068E-07 2.186E-05 2.407E-03 0.05705991 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bone marrow cancer DOID_4960 1.072E-06 2.774E-05 7.989E-04 0.03246779 SENESE_HDAC1_AND_HDAC2_TARGETS_UP respiratory failure DOID_11162 2.073E-06 5.129E-05 0.0181495 0.17503502 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bile duct disease DOID_4138 3.953E-06 9.371E-05 0.02313874 0.21235388 SENESE_HDAC1_AND_HDAC2_TARGETS_UP biliary tract disease DOID_9741 4.224E-06 9.614E-05 0.02372421 0.21427105 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cystic fibrosis DOID_1485 5.128E-06 1.122E-04 0.02551683 0.22686058 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bacterial pneumonia DOID_874 5.81E-06 1.224E-04 0.02674164 0.2340922 SENESE_HDAC1_AND_HDAC2_TARGETS_UP chronic kidney failure DOID_784 7.828E-06 1.591E-04 2.529E-03 0.05329014 SENESE_HDAC1_AND_HDAC2_TARGETS_UP multiple myeloma DOID_9538 7.988E-06 1.567E-04 7.164E-03 0.09264772 SENESE_HDAC1_AND_HDAC2_TARGETS_UP adult respiratory distress syndrome DOID_11394 1.071E-05 2.031E-04 0.12750627 0.44238456 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pulmonary emphysema DOID_9675 1.175E-05 2.157E-04 0.13027112 0.44385788 SENESE_HDAC1_AND_HDAC2_TARGETS_UP skeletal system cancer DOID_0060124 1.369E-05 2.434E-04 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP thoracic aortic aneurysm DOID_14004 1.369E-05 2.36E-04 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bone cancer DOID_184 1.369E-05 2.434E-04 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP varicose veins DOID_799 1.369E-05 2.29E-04 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP intermediate coronary syndrome DOID_8805 1.369E-05 2.225E-04 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP rheumatic disease DOID_1575 1.406E-05 2.222E-04 9.39E-03 0.11367779 SENESE_HDAC1_AND_HDAC2_TARGETS_UP scleroderma DOID_419 1.406E-05 2.222E-04 9.39E-03 0.11367779 SENESE_HDAC1_AND_HDAC2_TARGETS_UP Crohn's disease DOID_8778 1.419E-05 2.182E-04 1.419E-05 1.153E-03 SENESE_HDAC1_AND_HDAC2_TARGETS_UP dilated cardiomyopathy DOID_12930 1.492E-05 2.234E-04 3.672E-03 0.05970365 SENESE_HDAC1_AND_HDAC2_TARGETS_UP uterine cancer DOID_363 1.533E-05 2.236E-04 9.787E-03 0.11365021 SENESE_HDAC1_AND_HDAC2_TARGETS_UP vein disease DOID_866 1.681E-05 2.391E-04 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP ulcerative colitis DOID_8577 1.73E-05 2.401E-04 4E-03 0.06151515 SENESE_HDAC1_AND_HDAC2_TARGETS_UP heart valve disease DOID_4079 1.964E-05 2.661E-04 0.14667868 0.47152639 SENESE_HDAC1_AND_HDAC2_TARGETS_UP brain edema DOID_4724 3.39E-05 4.485E-04 0.06145313 0.32679284 SENESE_HDAC1_AND_HDAC2_TARGETS_UP opiate dependence DOID_2559 5.23E-05 6.763E-04 2.407E-03 0.05477751 SENESE_HDAC1_AND_HDAC2_TARGETS_UP collagen disease DOID_854 5.237E-05 6.622E-04 0.01762708 0.17292773 SENESE_HDAC1_AND_HDAC2_TARGETS_UP aortic valve disease DOID_62 5.963E-05 7.376E-04 0.07328667 0.36902758 SENESE_HDAC1_AND_HDAC2_TARGETS_UP meningitis DOID_9471 5.963E-05 7.219E-04 0.07328667 0.3657905 SENESE_HDAC1_AND_HDAC2_TARGETS_UP mineral metabolism disease DOID_0050032 6.272E-05 7.435E-04 0.01921382 0.18221109 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cholestasis DOID_13580 6.648E-05 7.72E-04 0.19408207 0.57219013 SENESE_HDAC1_AND_HDAC2_TARGETS_UP allergic contact dermatitis DOID_3042 7.448E-05 8.476E-04 1.451E-03 0.04126713 SENESE_HDAC1_AND_HDAC2_TARGETS_UP male reproductive system disease DOID_48 9.256E-05 1.033E-03 0.2092954 0.60146 SENESE_HDAC1_AND_HDAC2_TARGETS_UP diabetic retinopathy DOID_8947 1.027E-04 1.124E-03 0.21430295 0.60969188 SENESE_HDAC1_AND_HDAC2_TARGETS_UP Sciatic Neuropathy DOID_11446 1.064E-04 1.142E-03 0.08787072 0.39368851 SENESE_HDAC1_AND_HDAC2_TARGETS_UP lesion of sciatic nerve DOID_12528 1.064E-04 1.142E-03 0.08787072 0.39368851 SENESE_HDAC1_AND_HDAC2_TARGETS_UP periodontitis DOID_824 1.064E-04 1.121E-03 3.815E-03 0.06029248 SENESE_HDAC1_AND_HDAC2_TARGETS_UP mononeuritis of lower limb DOID_9473 1.064E-04 1.142E-03 0.08787072 0.39368851 SENESE_HDAC1_AND_HDAC2_TARGETS_UP mononeuritis DOID_1802 1.18E-04 1.22E-03 0.0907601 0.39123105 SENESE_HDAC1_AND_HDAC2_TARGETS_UP aneurysm disease DOID_2403 1.194E-04 1.213E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP mononeuropathy DOID_1188 1.303E-04 1.301E-03 0.09364041 0.38891526 SENESE_HDAC1_AND_HDAC2_TARGETS_UP contact dermatitis DOID_2773 1.38E-04 1.354E-03 2.283E-03 0.0564783 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bronchiolitis obliterans DOID_2799 1.574E-04 1.518E-03 0.0993739 0.38995688 SENESE_HDAC1_AND_HDAC2_TARGETS_UP biliary tract cancer DOID_4607 1.586E-04 1.504E-03 0.23645054 0.65310853 SENESE_HDAC1_AND_HDAC2_TARGETS_UP retinal vascular disease DOID_2462 1.735E-04 1.618E-03 0.24128752 0.66006057 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pleural disease DOID_1532 1.88E-04 1.725E-03 0.10507142 0.40124589 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pneumoconiosis DOID_10316 2.221E-04 2.006E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP lymphoma DOID_0060058 2.337E-04 2.077E-03 3.362E-03 0.0579653 SENESE_HDAC1_AND_HDAC2_TARGETS_UP systemic scleroderma DOID_418 3.244E-04 2.84E-03 7.876E-03 0.09958548 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cerebral infarction DOID_3526 4.821E-04 4.156E-03 0.14124389 0.46455361 SENESE_HDAC1_AND_HDAC2_TARGETS_UP proteinuria DOID_576 5.124E-04 4.351E-03 0.01060355 0.11830237 SENESE_HDAC1_AND_HDAC2_TARGETS_UP breast benign neoplasm DOID_0060082 5.364E-04 4.488E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP thoracic benign neoplasm DOID_0060097 5.364E-04 4.488E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pneumocystosis DOID_11339 5.364E-04 4.423E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP benign breast phyllodes tumor DOID_1631 5.364E-04 4.488E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP invasive lobular carcinoma DOID_3457 5.364E-04 4.36E-03 5.364E-04 0.03814894 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bronchiectasis DOID_9563 5.364E-04 4.298E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP neuritis DOID_1803 5.438E-04 4.298E-03 0.14667868 0.47420552 SENESE_HDAC1_AND_HDAC2_TARGETS_UP common cold DOID_10459 6.423E-04 5.006E-03 0.03733468 0.27235173 SENESE_HDAC1_AND_HDAC2_TARGETS_UP aortic valve stenosis DOID_1712 6.423E-04 4.939E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP aortic valve insufficiency DOID_57 6.423E-04 4.873E-03 0.03733468 0.26226463 SENESE_HDAC1_AND_HDAC2_TARGETS_UP peritonitis DOID_8283 6.423E-04 4.809E-03 0.03733468 0.25906628 SENESE_HDAC1_AND_HDAC2_TARGETS_UP calcium metabolism disease DOID_10575 6.455E-04 4.77E-03 0.01232331 0.13230115 SENESE_HDAC1_AND_HDAC2_TARGETS_UP aortic aneurysm DOID_3627 6.455E-04 4.709E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP obstructive hydrocephalus DOID_14159 7.575E-04 5.456E-03 7.575E-04 0.0359189 SENESE_HDAC1_AND_HDAC2_TARGETS_UP communicating hydrocephalus DOID_1573 7.575E-04 5.456E-03 7.575E-04 0.0359189 SENESE_HDAC1_AND_HDAC2_TARGETS_UP larynx cancer DOID_2596 7.575E-04 5.388E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP laryngeal benign neoplasm DOID_2598 7.575E-04 5.388E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bile duct adenocarcinoma DOID_4896 7.989E-04 5.612E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cholangiocarcinoma DOID_4947 7.989E-04 5.612E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP hydrocephalus DOID_10908 8.819E-04 6.12E-03 8.819E-04 0.03345492 SENESE_HDAC1_AND_HDAC2_TARGETS_UP familial hyperlipidemia DOID_1168 8.835E-04 6.057E-03 0.01511422 0.15357125 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bile duct cancer DOID_4606 9.736E-04 6.595E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bile duct carcinoma DOID_4897 9.736E-04 6.595E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP idiopathic pulmonary fibrosis DOID_0050156 1.016E-03 6.798E-03 0.04645029 0.30034336 SENESE_HDAC1_AND_HDAC2_TARGETS_UP mesenchymal cell neoplasm DOID_3350 1.016E-03 6.719E-03 0.04645029 0.29696872 SENESE_HDAC1_AND_HDAC2_TARGETS_UP spindle cell sarcoma DOID_4235 1.016E-03 6.719E-03 0.04645029 0.29696872 SENESE_HDAC1_AND_HDAC2_TARGETS_UP oral submucous fibrosis DOID_5773 1.016E-03 6.642E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP epithelioid sarcoma DOID_6193 1.016E-03 6.719E-03 0.04645029 0.29696872 SENESE_HDAC1_AND_HDAC2_TARGETS_UP intracranial hypertension DOID_9428 1.016E-03 6.566E-03 1.016E-03 0.03398996 SENESE_HDAC1_AND_HDAC2_TARGETS_UP Barrett's esophagus DOID_9206 1.158E-03 7.405E-03 0.04946977 0.30266985 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pre-malignant neoplasm DOID_0060071 1.224E-03 7.737E-03 1.224E-03 0.03664816 SENESE_HDAC1_AND_HDAC2_TARGETS_UP in situ carcinoma DOID_8719 1.224E-03 7.737E-03 1.224E-03 0.03664816 SENESE_HDAC1_AND_HDAC2_TARGETS_UP lymphatic system cancer DOID_0060073 1.31E-03 8.19E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP reticulosarcoma DOID_8538 1.31E-03 8.19E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP lymphosarcoma DOID_8675 1.31E-03 8.19E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP temporal lobe epilepsy DOID_3328 1.392E-03 8.606E-03 0.19663763 0.57673614 SENESE_HDAC1_AND_HDAC2_TARGETS_UP prion disease DOID_649 1.471E-03 8.997E-03 0.0554803 0.31568288 SENESE_HDAC1_AND_HDAC2_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 1.511E-03 9.147E-03 0.20172467 0.58862224 SENESE_HDAC1_AND_HDAC2_TARGETS_UP brain infarction DOID_3454 1.511E-03 9.05E-03 0.20172467 0.58561907 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pancreatic ductal carcinoma DOID_3587 1.637E-03 9.701E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP dissociative disorder DOID_10935 1.64E-03 9.621E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP dissociative amnesia DOID_11037 1.64E-03 9.621E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP leishmaniasis DOID_9065 1.64E-03 9.523E-03 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP amnestic disorder DOID_10914 1.819E-03 0.01045284 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pancreatic carcinoma DOID_4905 1.837E-03 0.0104545 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP mixed glioma DOID_5076 2.128E-03 0.01198678 0.22422389 0.62848963 SENESE_HDAC1_AND_HDAC2_TARGETS_UP hepatitis B DOID_2043 2.202E-03 0.01228376 0.06738852 0.35178042 SENESE_HDAC1_AND_HDAC2_TARGETS_UP metabolic syndrome X DOID_14221 2.283E-03 0.01261166 0.02798983 0.24130627 SENESE_HDAC1_AND_HDAC2_TARGETS_UP lipid metabolism disorder DOID_3146 2.283E-03 0.01249039 0.02798983 0.23770468 SENESE_HDAC1_AND_HDAC2_TARGETS_UP IgA glomerulonephritis DOID_2986 2.407E-03 0.01304226 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP uremia DOID_4676 2.407E-03 0.01291922 2.407E-03 0.05267068 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pulmonary embolism DOID_9477 2.407E-03 0.01279848 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP hypoglycemia DOID_9993 2.407E-03 0.01267998 0.07034223 0.36058316 SENESE_HDAC1_AND_HDAC2_TARGETS_UP focal epilepsy DOID_2234 2.529E-03 0.01320031 0.23645054 0.65629443 SENESE_HDAC1_AND_HDAC2_TARGETS_UP commensal bacterial infectious disease DOID_0050339 3.073E-03 0.01589353 3.073E-03 0.05827628 SENESE_HDAC1_AND_HDAC2_TARGETS_UP reading disorder DOID_13365 3.073E-03 0.01575035 3.073E-03 0.0563964 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bronchiolitis DOID_2942 3.073E-03 0.01560972 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP dyslexia DOID_4428 3.073E-03 0.01575035 3.073E-03 0.0563964 SENESE_HDAC1_AND_HDAC2_TARGETS_UP nervous system cancer DOID_3093 3.164E-03 0.0159318 0.03456977 0.25881837 SENESE_HDAC1_AND_HDAC2_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 3.164E-03 0.01579205 0.03456977 0.2554571 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cystitis DOID_1679 3.312E-03 0.01638483 0.08206462 0.38912306 SENESE_HDAC1_AND_HDAC2_TARGETS_UP myositis DOID_633 3.312E-03 0.01624359 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP ankylosing spondylitis DOID_7147 3.312E-03 0.01610475 3.312E-03 0.058883 SENESE_HDAC1_AND_HDAC2_TARGETS_UP intracranial aneurysm DOID_10941 3.559E-03 0.01716113 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP middle cerebral artery infarction DOID_3525 3.559E-03 0.01701692 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 3.672E-03 0.01741356 3.672E-03 0.06145964 SENESE_HDAC1_AND_HDAC2_TARGETS_UP migraine DOID_6364 3.815E-03 0.01793826 0.08787072 0.39061282 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pleurisy DOID_10247 4.079E-03 0.01902273 0.0907601 0.39724999 SENESE_HDAC1_AND_HDAC2_TARGETS_UP sarcoma DOID_1115 4.079E-03 0.01886807 0.0907601 0.39421754 SENESE_HDAC1_AND_HDAC2_TARGETS_UP toxic encephalopathy DOID_3602 4.351E-03 0.01996542 0.09364041 0.38609704 SENESE_HDAC1_AND_HDAC2_TARGETS_UP focal glomerulosclerosis DOID_3945 4.351E-03 0.0198057 0.09364041 0.38331936 SENESE_HDAC1_AND_HDAC2_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 4.631E-03 0.02091523 0.09651166 0.38946905 SENESE_HDAC1_AND_HDAC2_TARGETS_UP uterine benign neoplasm DOID_0060095 4.631E-03 0.02091523 0.09651166 0.38946905 SENESE_HDAC1_AND_HDAC2_TARGETS_UP uterine fibroid DOID_13223 4.631E-03 0.02091523 0.09651166 0.38946905 SENESE_HDAC1_AND_HDAC2_TARGETS_UP endometrial carcinoma DOID_2871 4.631E-03 0.02075054 0.09651166 0.38402193 SENESE_HDAC1_AND_HDAC2_TARGETS_UP opportunistic mycosis DOID_2473 4.92E-03 0.02187156 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP abdominal aortic aneurysm DOID_7693 4.92E-03 0.02170202 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP celiac disease DOID_10608 5.217E-03 0.02283389 5.217E-03 0.07811596 SENESE_HDAC1_AND_HDAC2_TARGETS_UP endometrial cancer DOID_1380 5.217E-03 0.02265959 0.10222714 0.39840577 SENESE_HDAC1_AND_HDAC2_TARGETS_UP allergic rhinitis DOID_4481 5.217E-03 0.02248793 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP leiomyoma DOID_127 5.522E-03 0.02362276 0.10507142 0.40395701 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bladder disease DOID_365 5.522E-03 0.02344647 0.10507142 0.39593137 SENESE_HDAC1_AND_HDAC2_TARGETS_UP systemic mycosis DOID_0050136 5.834E-03 0.02459106 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP fungal infectious disease DOID_1564 5.834E-03 0.02459106 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP myocarditis DOID_820 5.834E-03 0.02441024 0.10790676 0.40394044 SENESE_HDAC1_AND_HDAC2_TARGETS_UP metal metabolism disorder DOID_896 5.834E-03 0.02423206 5.834E-03 0.08512288 SENESE_HDAC1_AND_HDAC2_TARGETS_UP nephroblastoma DOID_2154 6.155E-03 0.02537878 0.11073319 0.40913758 SENESE_HDAC1_AND_HDAC2_TARGETS_UP esophageal disease DOID_6050 6.155E-03 0.0251962 0.11073319 0.40649799 SENESE_HDAC1_AND_HDAC2_TARGETS_UP medullomyoblastoma DOID_3861 6.484E-03 0.02635169 6.484E-03 0.08998138 SENESE_HDAC1_AND_HDAC2_TARGETS_UP adult medulloblastoma DOID_3864 6.484E-03 0.02635169 6.484E-03 0.08998138 SENESE_HDAC1_AND_HDAC2_TARGETS_UP childhood medulloblastoma DOID_3869 6.484E-03 0.02635169 6.484E-03 0.08998138 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pulmonary sarcoidosis DOID_13406 7.164E-03 0.02891135 0.11915932 0.4264255 SENESE_HDAC1_AND_HDAC2_TARGETS_UP calcinosis DOID_182 7.164E-03 0.02870775 0.11915932 0.42376034 SENESE_HDAC1_AND_HDAC2_TARGETS_UP medulloblastoma DOID_3858 7.164E-03 0.02850699 7.164E-03 0.09705952 SENESE_HDAC1_AND_HDAC2_TARGETS_UP embryonal cancer DOID_688 7.164E-03 0.02830903 7.164E-03 0.09480232 SENESE_HDAC1_AND_HDAC2_TARGETS_UP peptic ulcer DOID_750 7.876E-03 0.03090584 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP intracranial arterial disease DOID_13089 8.243E-03 0.03212528 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cerebral arterial disease DOID_3527 8.243E-03 0.03212528 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 8.618E-03 0.03335743 8.618E-03 0.10659875 SENESE_HDAC1_AND_HDAC2_TARGETS_UP primitive neuroectodermal tumor DOID_168 9.39E-03 0.03610038 9.39E-03 0.11130951 SENESE_HDAC1_AND_HDAC2_TARGETS_UP diabetic autonomic neuropathy DOID_11503 9.787E-03 0.0373749 0.13851364 0.4609021 SENESE_HDAC1_AND_HDAC2_TARGETS_UP autonomic neuropathy DOID_11504 9.787E-03 0.0373749 0.13851364 0.4609021 SENESE_HDAC1_AND_HDAC2_TARGETS_UP diabetic polyneuropathy DOID_12785 9.787E-03 0.0373749 0.13851364 0.4609021 SENESE_HDAC1_AND_HDAC2_TARGETS_UP diabetic neuropathy DOID_9743 9.787E-03 0.0373749 0.13851364 0.4609021 SENESE_HDAC1_AND_HDAC2_TARGETS_UP learning disability DOID_8927 0.01019167 0.03866039 0.01019167 0.11598116 SENESE_HDAC1_AND_HDAC2_TARGETS_UP autonomic nervous system disease DOID_11465 0.01102271 0.0415359 0.14667868 0.47965616 SENESE_HDAC1_AND_HDAC2_TARGETS_UP brain cancer DOID_1319 0.01102271 0.04126263 0.14667868 0.47691527 SENESE_HDAC1_AND_HDAC2_TARGETS_UP bone marrow disease DOID_4961 0.01102271 0.04099294 0.14667868 0.46887737 SENESE_HDAC1_AND_HDAC2_TARGETS_UP central nervous system cancer DOID_3620 0.01144908 0.04230214 0.14938328 0.47485522 SENESE_HDAC1_AND_HDAC2_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.01188263 0.04362076 0.01188263 0.13002343 SENESE_HDAC1_AND_HDAC2_TARGETS_UP integumentary system benign neoplasm DOID_0060121 0.01188263 0.04334114 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP skin benign neoplasm DOID_3165 0.01188263 0.04334114 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP sarcoidosis DOID_11335 0.01368758 0.04960657 0.16277925 0.50337714 SENESE_HDAC1_AND_HDAC2_TARGETS_UP atrophic muscular disease DOID_913 0.01368758 0.0492926 0.01368758 0.1442265 SENESE_HDAC1_AND_HDAC2_TARGETS_UP muscular dystrophy DOID_9884 0.01368758 0.0492926 0.01368758 0.1442265 SENESE_HDAC1_AND_HDAC2_TARGETS_UP vasculitis DOID_865 0.01415626 0.05065981 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 0.01463182 0.05203441 0.16807887 0.5169561 SENESE_HDAC1_AND_HDAC2_TARGETS_UP integumentary system cancer DOID_0060122 0.01463182 0.05171121 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP parasitic protozoa infectious disease DOID_2789 0.01463182 0.05139201 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP skin cancer DOID_4159 0.01463182 0.05171121 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP smallpox DOID_8736 0.01463182 0.05107672 0.01463182 0.15137283 SENESE_HDAC1_AND_HDAC2_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 0.01609933 0.05585682 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 0.01609933 0.05551829 0.17596599 0.53257791 SENESE_HDAC1_AND_HDAC2_TARGETS_UP neuroectodermal tumor DOID_171 0.01762708 0.06042053 0.01762708 0.17596155 SENESE_HDAC1_AND_HDAC2_TARGETS_UP endocrine pancreas disease DOID_1428 0.01921382 0.06546506 0.19151844 0.56757288 SENESE_HDAC1_AND_HDAC2_TARGETS_UP parasitic infectious disease DOID_1398 0.01975563 0.06691045 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cerebral degeneration DOID_1443 0.01975563 0.06651453 0.01975563 0.18427795 SENESE_HDAC1_AND_HDAC2_TARGETS_UP uterine disease DOID_345 0.01975563 0.06612327 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP hyperglycemia DOID_4195 0.02030381 0.06756065 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP blood coagulation disease DOID_1247 0.02255937 0.07462953 0.20677976 0.59724714 SENESE_HDAC1_AND_HDAC2_TARGETS_UP pancreatitis DOID_4989 0.02674164 0.08795372 0.22422389 0.63160096 SENESE_HDAC1_AND_HDAC2_TARGETS_UP leber hereditary optic neuropathy DOID_705 0.02813267 0.09199705 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP chromosomal disease DOID_0080014 0.02862259 0.0930643 0.23158298 0.64593489 SENESE_HDAC1_AND_HDAC2_TARGETS_UP female reproductive system disease DOID_229 0.02862259 0.09253553 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP alcohol abuse DOID_1574 0.02990522 0.09613598 0.02990522 0.25023631 SENESE_HDAC1_AND_HDAC2_TARGETS_UP brachydactyly DOID_0050581 0.03120966 0.0997657 0.03120966 0.25736658 SENESE_HDAC1_AND_HDAC2_TARGETS_UP childhood type dermatomyositis DOID_14203 0.03120966 0.09920835 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP rectal neoplasm DOID_1984 0.03120966 0.09865719 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP rectum cancer DOID_1993 0.03120966 0.09865719 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP acute kidney failure DOID_3021 0.03120966 0.09811212 0.03120966 0.25368992 SENESE_HDAC1_AND_HDAC2_TARGETS_UP chondrosarcoma DOID_3371 0.03120966 0.09757305 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP adrenal gland hyperfunction DOID_3947 0.03120966 0.09703986 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP Paget's disease of bone DOID_5408 0.03120966 0.09651247 0.03120966 0.25011682 SENESE_HDAC1_AND_HDAC2_TARGETS_UP polycythemia DOID_8432 0.03120966 0.09599078 0.03120966 0.24664298 SENESE_HDAC1_AND_HDAC2_TARGETS_UP cutaneous leishmaniasis DOID_9111 0.03120966 0.0954747 1.000 1.000 SENESE_HDAC1_AND_HDAC2_TARGETS_UP visceral leishmaniasis DOID_9146 0.03120966 0.09496414 1.000 1.000 DORSAM_HOXA9_TARGETS_DN parasitic infectious disease DOID_1398 5.239E-06 2.981E-03 5.315E-04 0.04320255 DORSAM_HOXA9_TARGETS_DN uterine disease DOID_345 5.239E-06 1.491E-03 5.315E-04 0.03780223 DORSAM_HOXA9_TARGETS_DN brain infarction DOID_3454 5.969E-06 1.132E-03 5.793E-04 0.03662254 DORSAM_HOXA9_TARGETS_DN female reproductive system disease DOID_229 9.56E-06 1.36E-03 7.904E-04 0.0374791 DORSAM_HOXA9_TARGETS_DN angiosarcoma DOID_0001816 2.844E-05 3.236E-03 2.844E-05 0.01618016 DORSAM_HOXA9_TARGETS_DN osteosarcoma DOID_3347 7.678E-05 7.282E-03 7.678E-05 0.02184524 DORSAM_HOXA9_TARGETS_DN sarcoma DOID_1115 1.027E-04 8.344E-03 1.027E-04 0.01946938 DORSAM_HOXA9_TARGETS_DN malaria DOID_12365 1.027E-04 7.301E-03 0.01493213 0.26551199 DORSAM_HOXA9_TARGETS_DN nephroblastoma DOID_2154 1.568E-04 9.915E-03 1.568E-04 0.02230951 DORSAM_HOXA9_TARGETS_DN endometriosis of uterus DOID_288 2.326E-04 0.01323344 0.02231875 0.28862197 DORSAM_HOXA9_TARGETS_DN endometriosis DOID_289 2.431E-04 0.01257348 0.02280932 0.28214134 DORSAM_HOXA9_TARGETS_DN cerebral infarction DOID_3526 2.648E-04 0.01255383 0.02378976 0.28800793 DORSAM_HOXA9_TARGETS_DN giant cell tumor DOID_200 3.606E-04 0.01578293 3.606E-04 0.04103563 DORSAM_HOXA9_TARGETS_DN malignant giant cell tumor DOID_2705 3.606E-04 0.01578293 3.606E-04 0.04103563 DORSAM_HOXA9_TARGETS_DN giant cell glioblastoma DOID_3074 3.606E-04 0.01578293 3.606E-04 0.04103563 DORSAM_HOXA9_TARGETS_DN parasitic protozoa infectious disease DOID_2789 3.868E-04 0.01572156 0.028678 0.29668698 DORSAM_HOXA9_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 4.279E-04 0.01623011 0.03013995 0.30624341 DORSAM_HOXA9_TARGETS_DN glioblastoma DOID_3068 4.279E-04 0.01521573 4.279E-04 0.04057528 DORSAM_HOXA9_TARGETS_DN allergic contact dermatitis DOID_3042 5.631E-04 0.01884788 0.03451329 0.31171526 DORSAM_HOXA9_TARGETS_DN tuberculosis DOID_399 5.793E-04 0.01831127 5.793E-04 0.03296029 DORSAM_HOXA9_TARGETS_DN astrocytoma DOID_3069 5.956E-04 0.01783784 5.956E-04 0.03081081 DORSAM_HOXA9_TARGETS_DN metabolic syndrome X DOID_14221 7.716E-04 0.02195214 0.04031535 0.33734465 DORSAM_HOXA9_TARGETS_DN contact dermatitis DOID_2773 7.716E-04 0.0209068 0.04031535 0.33245559 DORSAM_HOXA9_TARGETS_DN primary bacterial infectious disease DOID_0050338 9.079E-04 0.02348283 9.079E-04 0.03974017 WIELAND_UP_BY_HBV_INFECTION sarcoidosis DOID_11335 6.774E-12 3.855E-09 0.09168731 0.59284182 WIELAND_UP_BY_HBV_INFECTION autoimmune disease of the nervous system DOID_438 1.152E-11 3.279E-09 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION hypersensitivity reaction type IV disease DOID_2916 1.266E-11 2.401E-09 0.09945921 0.62189328 WIELAND_UP_BY_HBV_INFECTION contact dermatitis DOID_2773 1.072E-10 1.526E-08 6.34E-09 3.608E-06 WIELAND_UP_BY_HBV_INFECTION lymphoma DOID_0060058 2.841E-10 3.234E-08 2.137E-05 1.52E-03 WIELAND_UP_BY_HBV_INFECTION encephalomyelitis DOID_640 3.063E-10 2.905E-08 2.228E-05 1.409E-03 WIELAND_UP_BY_HBV_INFECTION myasthenia gravis DOID_437 4.16E-10 3.382E-08 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION neuromuscular junction disease DOID_439 9.928E-10 7.061E-08 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION allergic contact dermatitis DOID_3042 2.412E-09 1.525E-07 1.406E-07 4.001E-05 WIELAND_UP_BY_HBV_INFECTION primary bacterial infectious disease DOID_0050338 1.042E-08 5.931E-07 0.14178693 0.79877986 WIELAND_UP_BY_HBV_INFECTION primary immunodeficiency disease DOID_612 1.192E-08 6.168E-07 5.256E-07 9.969E-05 WIELAND_UP_BY_HBV_INFECTION funisitis DOID_0050698 5.623E-08 2.666E-06 0.03705864 0.51430165 WIELAND_UP_BY_HBV_INFECTION tuberculosis DOID_399 1.511E-07 6.613E-06 0.11480708 0.65985082 WIELAND_UP_BY_HBV_INFECTION extrinsic allergic alveolitis DOID_841 1.562E-07 6.348E-06 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION autoimmune disease of endocrine system DOID_0060005 2.391E-07 9.069E-06 1.303E-03 0.05297529 WIELAND_UP_BY_HBV_INFECTION bronchiolitis obliterans DOID_2799 3.101E-07 1.103E-05 0.05507751 0.53117126 WIELAND_UP_BY_HBV_INFECTION pulmonary sarcoidosis DOID_13406 6.864E-07 2.298E-05 0.06637078 0.53949962 WIELAND_UP_BY_HBV_INFECTION hypersensitivity reaction type I disease DOID_1205 7.227E-07 2.284E-05 0.15351652 0.82406511 WIELAND_UP_BY_HBV_INFECTION uveitis DOID_13141 7.597E-07 2.275E-05 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION neuronal ceroid lipofuscinosis DOID_14503 7.859E-07 2.236E-05 1.576E-04 8.153E-03 WIELAND_UP_BY_HBV_INFECTION systemic scleroderma DOID_418 8.386E-07 2.272E-05 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION autoimmune disease of urogenital tract DOID_0060049 1.112E-06 2.876E-05 0.07435593 0.5566911 WIELAND_UP_BY_HBV_INFECTION primary biliary cirrhosis DOID_12236 1.112E-06 2.876E-05 0.07435593 0.5566911 WIELAND_UP_BY_HBV_INFECTION rheumatic disease DOID_1575 1.216E-06 3.009E-05 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION uveal disease DOID_3480 1.216E-06 2.884E-05 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION scleroderma DOID_419 1.216E-06 3.009E-05 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION proteinuria DOID_576 1.573E-06 3.58E-05 0.0806956 0.56686168 WIELAND_UP_BY_HBV_INFECTION autoimmune disease of gastrointestinal tract DOID_0060031 2.002E-06 4.382E-05 0.08542228 0.57182678 WIELAND_UP_BY_HBV_INFECTION B-cell lymphocytic neoplasm DOID_707 2.333E-06 4.917E-05 3.911E-03 0.13907476 WIELAND_UP_BY_HBV_INFECTION thyroiditis DOID_7166 2.651E-06 5.388E-05 0.02708801 0.51376926 WIELAND_UP_BY_HBV_INFECTION autoimmune thyroiditis DOID_7188 2.651E-06 5.388E-05 0.02708801 0.51376926 WIELAND_UP_BY_HBV_INFECTION pustulosis of palm and sole DOID_4398 3.114E-06 6.109E-05 1.388E-04 7.895E-03 WIELAND_UP_BY_HBV_INFECTION MHC class II deficiency DOID_5812 4.571E-06 8.669E-05 4.571E-06 6.502E-04 WIELAND_UP_BY_HBV_INFECTION psoriasis DOID_8893 4.571E-06 8.389E-05 4.571E-06 5.201E-04 WIELAND_UP_BY_HBV_INFECTION collagen disease DOID_854 4.627E-06 8.228E-05 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION parasitic infectious disease DOID_1398 5.901E-06 1.017E-04 6.13E-03 0.18358456 WIELAND_UP_BY_HBV_INFECTION hepatitis B DOID_2043 7.237E-06 1.211E-04 0.03705864 0.49038065 WIELAND_UP_BY_HBV_INFECTION aneurysm disease DOID_2403 1.073E-05 1.745E-04 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION severe combined immunodeficiency DOID_627 1.077E-05 1.702E-04 1.077E-05 1.021E-03 WIELAND_UP_BY_HBV_INFECTION mixed glioma DOID_5076 1.128E-05 1.735E-04 8.392E-03 0.22739266 WIELAND_UP_BY_HBV_INFECTION combined T cell and B cell immunodeficiency DOID_628 1.216E-05 1.821E-04 1.216E-05 9.883E-04 WIELAND_UP_BY_HBV_INFECTION cystitis DOID_1679 1.366E-05 1.993E-04 0.04529059 0.52592548 WIELAND_UP_BY_HBV_INFECTION myositis DOID_633 1.366E-05 1.943E-04 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION ankylosing spondylitis DOID_7147 1.366E-05 1.896E-04 0.04529059 0.51540697 WIELAND_UP_BY_HBV_INFECTION diffuse large B-cell lymphoma DOID_0050745 1.703E-05 2.307E-04 1.141E-03 0.05408202 WIELAND_UP_BY_HBV_INFECTION autoimmune disease of cardiovascular system DOID_0060051 1.889E-05 2.5E-04 1.221E-03 0.05342865 WIELAND_UP_BY_HBV_INFECTION pleurisy DOID_10247 1.889E-05 2.443E-04 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION Behcet's disease DOID_13241 1.889E-05 2.5E-04 1.221E-03 0.05342865 WIELAND_UP_BY_HBV_INFECTION Human immunodeficiency virus infectious disease DOID_526 1.963E-05 2.482E-04 0.14620417 0.80767155 WIELAND_UP_BY_HBV_INFECTION celiac disease DOID_10608 2.771E-05 3.428E-04 0.05669903 0.53769583 WIELAND_UP_BY_HBV_INFECTION pleural disease DOID_1532 3.027E-05 3.665E-04 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION bladder disease DOID_365 3.027E-05 3.588E-04 0.05831781 0.54398092 WIELAND_UP_BY_HBV_INFECTION esophageal disease DOID_6050 3.585E-05 4.163E-04 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION respiratory syncytial virus infectious disease DOID_1273 5.264E-05 5.991E-04 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION pulmonary tuberculosis DOID_2957 1.001E-04 1.117E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION aortic aneurysm DOID_3627 1.06E-04 1.16E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION angioedema DOID_1558 1.291E-04 1.386E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION vasculitis DOID_865 1.317E-04 1.388E-03 4.347E-03 0.14550487 WIELAND_UP_BY_HBV_INFECTION carotid artery disease DOID_3407 1.86E-04 1.924E-03 5.449E-03 0.17225232 WIELAND_UP_BY_HBV_INFECTION encephalitis DOID_9588 1.889E-04 1.92E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION polyneuropathy DOID_1389 2.23E-04 2.226E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION viral pneumonia DOID_10533 2.599E-04 2.55E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION parasitic helminthiasis infectious disease DOID_883 2.599E-04 2.507E-03 0.02374193 0.48246994 WIELAND_UP_BY_HBV_INFECTION thoracic aortic aneurysm DOID_14004 2.996E-04 2.841E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION tongue cancer DOID_8649 3.42E-04 3.19E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION pancreatitis DOID_4989 3.597E-04 3.301E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION bacterial pneumonia DOID_874 3.597E-04 3.248E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION prion disease DOID_649 4.351E-04 3.868E-03 0.0304228 0.49458776 WIELAND_UP_BY_HBV_INFECTION agammaglobulinemia DOID_2583 4.857E-04 4.252E-03 0.03208597 0.50713654 WIELAND_UP_BY_HBV_INFECTION esophagitis DOID_11963 5.391E-04 4.648E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION blood protein disease DOID_620 5.391E-04 4.578E-03 0.03374633 0.49235029 WIELAND_UP_BY_HBV_INFECTION autoimmune hepatitis DOID_2048 5.952E-04 4.98E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION urticaria DOID_1555 9.161E-04 7.554E-03 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION vitiligo DOID_12306 1.063E-03 8.641E-03 0.04692865 0.52357651 WIELAND_UP_BY_HBV_INFECTION B cell deficiency DOID_2115 1.063E-03 8.52E-03 0.04692865 0.51350773 WIELAND_UP_BY_HBV_INFECTION opportunistic mycosis DOID_2473 1.477E-03 0.01167053 0.05507751 0.54032938 WIELAND_UP_BY_HBV_INFECTION systemic mycosis DOID_0050136 1.756E-03 0.01368888 0.05993386 0.55003816 WIELAND_UP_BY_HBV_INFECTION fungal infectious disease DOID_1564 1.756E-03 0.01368888 0.05993386 0.55003816 WIELAND_UP_BY_HBV_INFECTION myocarditis DOID_820 1.756E-03 0.0135039 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION thyroid carcinoma DOID_3963 1.855E-03 0.01406966 0.06154717 0.53877449 WIELAND_UP_BY_HBV_INFECTION hyperthyroidism DOID_7998 1.855E-03 0.01388454 0.06154717 0.52269167 WIELAND_UP_BY_HBV_INFECTION thyroid cancer DOID_1781 2.059E-03 0.01521386 0.06476563 0.53408178 WIELAND_UP_BY_HBV_INFECTION multiple myeloma DOID_9538 2.165E-03 0.01579184 0.06637078 0.52451352 WIELAND_UP_BY_HBV_INFECTION hepatitis DOID_2237 2.384E-03 0.01717317 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION adult respiratory distress syndrome DOID_11394 2.498E-03 0.01776613 0.07116997 0.54723937 WIELAND_UP_BY_HBV_INFECTION pulmonary emphysema DOID_9675 2.614E-03 0.01836209 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION endometriosis of uterus DOID_288 2.732E-03 0.01896088 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION endometriosis DOID_289 2.854E-03 0.01956232 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION diabetic autonomic neuropathy DOID_11503 2.977E-03 0.02016627 0.07753113 0.5584204 WIELAND_UP_BY_HBV_INFECTION autonomic neuropathy DOID_11504 2.977E-03 0.02016627 0.07753113 0.5584204 WIELAND_UP_BY_HBV_INFECTION diabetic polyneuropathy DOID_12785 2.977E-03 0.02016627 0.07753113 0.5584204 WIELAND_UP_BY_HBV_INFECTION uterine cancer DOID_363 2.977E-03 0.01992902 2.977E-03 0.11293114 WIELAND_UP_BY_HBV_INFECTION diabetic neuropathy DOID_9743 2.977E-03 0.02016627 0.07753113 0.5584204 WIELAND_UP_BY_HBV_INFECTION myeloma DOID_0070004 3.363E-03 0.02224747 0.08227383 0.57090008 WIELAND_UP_BY_HBV_INFECTION autonomic nervous system disease DOID_11465 3.363E-03 0.02199175 0.08227383 0.55730722 WIELAND_UP_BY_HBV_INFECTION vascular skin disease DOID_9540 3.363E-03 0.02174184 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION atopic dermatitis DOID_3310 4.054E-03 0.02591712 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION bone marrow cancer DOID_4960 4.347E-03 0.02748425 0.09324696 0.59615188 WIELAND_UP_BY_HBV_INFECTION parasitic protozoa infectious disease DOID_2789 4.498E-03 0.02812204 0.09480396 0.59937172 WIELAND_UP_BY_HBV_INFECTION oral cavity cancer DOID_8618 4.963E-03 0.03069334 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION neuroectodermal tumor DOID_171 5.449E-03 0.03333916 0.10409088 0.63685708 WIELAND_UP_BY_HBV_INFECTION respiratory failure DOID_11162 5.616E-03 0.03399419 0.10562955 0.63939587 WIELAND_UP_BY_HBV_INFECTION hypothyroidism DOID_1459 5.616E-03 0.03363636 0.10562955 0.63266539 WIELAND_UP_BY_HBV_INFECTION cerebral degeneration DOID_1443 6.13E-03 0.03633445 0.11022997 0.6533422 WIELAND_UP_BY_HBV_INFECTION uterine disease DOID_345 6.13E-03 0.03595986 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION endocrine organ benign neoplasm DOID_0060089 6.665E-03 0.03869935 0.11480708 0.66658399 WIELAND_UP_BY_HBV_INFECTION male reproductive system disease DOID_48 7.221E-03 0.0415012 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION peripheral vascular disease DOID_341 7.41E-03 0.04216548 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION diabetic retinopathy DOID_8947 7.602E-03 0.04282924 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION syndrome DOID_225 7.993E-03 0.04458798 7.993E-03 0.2273987 WIELAND_UP_BY_HBV_INFECTION female reproductive system disease DOID_229 9.008E-03 0.04976258 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION retinal vascular disease DOID_2462 9.859E-03 0.05394186 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION amino acid metabolic disorder DOID_9252 0.01074503 0.05822783 0.14473425 0.80739007 WIELAND_UP_BY_HBV_INFECTION carbohydrate metabolic disorder DOID_2978 0.01166462 0.06261479 0.15059901 0.82395035 WIELAND_UP_BY_HBV_INFECTION Crohn's disease DOID_8778 0.01189975 0.06327999 0.01189975 0.30777085 WIELAND_UP_BY_HBV_INFECTION Sjogren's syndrome DOID_12894 0.01701574 0.08964775 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION childhood type dermatomyositis DOID_14203 0.01701574 0.0888253 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION rectal neoplasm DOID_1984 0.01701574 0.08801779 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION rectum cancer DOID_1993 0.01701574 0.08801779 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION transient cerebral ischemia DOID_224 0.01701574 0.08722484 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION acute kidney failure DOID_3021 0.01701574 0.08644605 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION Hermansky-Pudlak syndrome DOID_3753 0.01701574 0.08568104 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION conjunctival disease DOID_4251 0.01701574 0.08492945 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION conjunctivitis DOID_6195 0.01701574 0.08492945 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION visceral leishmaniasis DOID_9146 0.01701574 0.08419093 0.01701574 0.42095467 WIELAND_UP_BY_HBV_INFECTION familial adenomatous polyposis DOID_0050424 0.01870155 0.09173435 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION trypanosomiasis DOID_10113 0.01870155 0.0909503 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION dermatomyositis DOID_10223 0.01870155 0.09017953 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION adrenoleukodystrophy DOID_10588 0.01870155 0.08942172 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION pneumocystosis DOID_11339 0.01870155 0.08867654 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION prediabetes syndrome DOID_11716 0.01870155 0.08794368 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION common variable immunodeficiency DOID_12177 0.01870155 0.08722283 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION common cold DOID_10459 0.02038452 0.09429912 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION otitis media DOID_10754 0.02038452 0.09353865 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION pituitary cancer DOID_1785 0.02038452 0.09279034 0.02038452 0.48328301 WIELAND_UP_BY_HBV_INFECTION pituitary carcinoma DOID_4916 0.02038452 0.09279034 0.02038452 0.48328301 WIELAND_UP_BY_HBV_INFECTION middle ear disease DOID_5100 0.02038452 0.09353865 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION stomach disease DOID_76 0.02038452 0.09205391 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION ocular hypertension DOID_9282 0.02038452 0.09132907 0.02038452 0.46395169 WIELAND_UP_BY_HBV_INFECTION borderline glaucoma DOID_9283 0.02038452 0.09132907 0.02038452 0.46395169 WIELAND_UP_BY_HBV_INFECTION berylliosis DOID_10322 0.02206464 0.09808424 1.000 1.000 WIELAND_UP_BY_HBV_INFECTION psoriatic arthritis DOID_9008 0.02206464 0.0973239 0.02206464 0.48287625 MATHEW_FANCONI_ANEMIA_GENES Fanconi's anemia DOID_13636 7.51E-40 4.273E-37 5.218E-35 2.969E-32 MATHEW_FANCONI_ANEMIA_GENES congenital hypoplastic anemia DOID_1342 3.692E-36 1.05E-33 8.548E-32 2.432E-29 MATHEW_FANCONI_ANEMIA_GENES aplastic anemia DOID_12449 2.069E-34 3.924E-32 3.079E-30 5.839E-28 MATHEW_FANCONI_ANEMIA_GENES bone marrow disease DOID_4961 6.422E-33 9.136E-31 6.688E-29 9.513E-27 POOLA_INVASIVE_BREAST_CANCER_UP aneurysm disease DOID_2403 2.609E-19 1.485E-16 3.422E-04 0.01390735 POOLA_INVASIVE_BREAST_CANCER_UP contact dermatitis DOID_2773 4.562E-19 1.298E-16 1.96E-12 5.576E-10 POOLA_INVASIVE_BREAST_CANCER_UP primary immunodeficiency disease DOID_612 2.147E-18 4.071E-16 5.703E-12 1.082E-09 POOLA_INVASIVE_BREAST_CANCER_UP allergic contact dermatitis DOID_3042 2.676E-18 3.806E-16 3.793E-13 2.158E-10 POOLA_INVASIVE_BREAST_CANCER_UP aortic aneurysm DOID_3627 4.132E-18 4.703E-16 0.02069849 0.26766912 POOLA_INVASIVE_BREAST_CANCER_UP collagen disease DOID_854 4.892E-17 4.639E-15 0.02939673 0.3484737 POOLA_INVASIVE_BREAST_CANCER_UP B cell deficiency DOID_2115 1.944E-15 1.58E-13 1.663E-09 1.577E-07 POOLA_INVASIVE_BREAST_CANCER_UP agammaglobulinemia DOID_2583 5.531E-15 3.934E-13 1.236E-10 1.758E-08 POOLA_INVASIVE_BREAST_CANCER_UP encephalomyelitis DOID_640 7.29E-15 4.609E-13 7.429E-03 0.13636211 POOLA_INVASIVE_BREAST_CANCER_UP blood protein disease DOID_620 9.186E-15 5.227E-13 1.759E-10 2.002E-08 POOLA_INVASIVE_BREAST_CANCER_UP abdominal aortic aneurysm DOID_7693 1.066E-14 5.516E-13 8.373E-03 0.13233569 POOLA_INVASIVE_BREAST_CANCER_UP bacterial pneumonia DOID_874 3.787E-14 1.796E-12 0.28427446 1.000 POOLA_INVASIVE_BREAST_CANCER_UP rheumatic disease DOID_1575 2.909E-13 1.273E-11 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP scleroderma DOID_419 2.909E-13 1.273E-11 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP hypersensitivity reaction type I disease DOID_1205 3.384E-13 1.375E-11 7.866E-03 0.13986761 POOLA_INVASIVE_BREAST_CANCER_UP pulmonary sarcoidosis DOID_13406 5.227E-12 1.983E-10 6.266E-04 0.0222834 POOLA_INVASIVE_BREAST_CANCER_UP carotid artery disease DOID_3407 6.823E-12 2.427E-10 2.456E-03 0.06076548 POOLA_INVASIVE_BREAST_CANCER_UP systemic scleroderma DOID_418 7.966E-12 2.666E-10 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP pulmonary emphysema DOID_9675 1.188E-11 3.755E-10 0.16795151 0.80306226 POOLA_INVASIVE_BREAST_CANCER_UP bronchiolitis obliterans DOID_2799 7.45E-11 2.231E-09 8.373E-03 0.13611671 POOLA_INVASIVE_BREAST_CANCER_UP sarcoidosis DOID_11335 9.126E-11 2.596E-09 1.674E-03 0.05014418 POOLA_INVASIVE_BREAST_CANCER_UP hypersensitivity reaction type IV disease DOID_2916 1.859E-10 5.036E-09 2.141E-03 0.05537834 POOLA_INVASIVE_BREAST_CANCER_UP viral pneumonia DOID_10533 2.292E-09 5.927E-08 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP thoracic aortic aneurysm DOID_14004 3.426E-09 8.475E-08 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP vasculitis DOID_865 4.241E-09 1.005E-07 0.02371552 0.29335072 POOLA_INVASIVE_BREAST_CANCER_UP lymphoblastic leukemia DOID_1037 6.807E-09 1.549E-07 6.886E-04 0.02304732 POOLA_INVASIVE_BREAST_CANCER_UP oral cavity cancer DOID_8618 6.901E-09 1.51E-07 2.189E-07 1.384E-05 POOLA_INVASIVE_BREAST_CANCER_UP chronic leukemia DOID_1036 6.996E-09 1.474E-07 4.215E-04 0.01598784 POOLA_INVASIVE_BREAST_CANCER_UP chronic lymphocytic leukemia DOID_1040 6.996E-09 1.474E-07 4.215E-04 0.01598784 POOLA_INVASIVE_BREAST_CANCER_UP brain infarction DOID_3454 2.031E-08 4.128E-07 0.25680481 0.99402678 POOLA_INVASIVE_BREAST_CANCER_UP respiratory syncytial virus infectious disease DOID_1273 2.207E-08 4.331E-07 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP adenoid cystic carcinoma DOID_4866 2.556E-08 4.848E-07 2.556E-08 2.078E-06 POOLA_INVASIVE_BREAST_CANCER_UP salivary gland cancer DOID_8850 3.392E-08 6.226E-07 3.392E-08 2.412E-06 POOLA_INVASIVE_BREAST_CANCER_UP primary bacterial infectious disease DOID_0050338 9.886E-08 1.758E-06 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP extrinsic allergic alveolitis DOID_841 1.073E-07 1.85E-06 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP ulcerative colitis DOID_8577 2.21E-07 3.699E-06 0.06555415 0.50405822 POOLA_INVASIVE_BREAST_CANCER_UP opportunistic mycosis DOID_2473 2.548E-07 4.143E-06 8.373E-03 0.14012014 POOLA_INVASIVE_BREAST_CANCER_UP aspergillosis DOID_13564 2.814E-07 4.448E-06 1.52E-03 0.0480427 POOLA_INVASIVE_BREAST_CANCER_UP systemic mycosis DOID_0050136 4.007E-07 6.162E-06 9.909E-03 0.15238516 POOLA_INVASIVE_BREAST_CANCER_UP fungal infectious disease DOID_1564 4.007E-07 6.162E-06 9.909E-03 0.15238516 POOLA_INVASIVE_BREAST_CANCER_UP tuberculosis DOID_399 5.455E-07 8.168E-06 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP peripheral vascular disease DOID_341 7.564E-07 1.104E-05 0.26914054 1.000 POOLA_INVASIVE_BREAST_CANCER_UP cystic fibrosis DOID_1485 9.55E-07 1.359E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP influenza DOID_8469 1.571E-06 2.181E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP coronary restenosis DOID_4247 1.645E-06 2.228E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP cerebral infarction DOID_3526 1.748E-06 2.313E-05 0.18175226 0.82733631 POOLA_INVASIVE_BREAST_CANCER_UP pre-eclampsia DOID_10591 2.149E-06 2.779E-05 0.1885671 0.84484001 POOLA_INVASIVE_BREAST_CANCER_UP heart valve disease DOID_4079 2.149E-06 2.717E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP vascular skin disease DOID_9540 2.149E-06 2.658E-05 0.1885671 0.83174171 POOLA_INVASIVE_BREAST_CANCER_UP myasthenia gravis DOID_437 2.418E-06 2.927E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP Human immunodeficiency virus infectious disease DOID_526 2.527E-06 2.996E-05 0.3193373 1.000 POOLA_INVASIVE_BREAST_CANCER_UP lymphoma DOID_0060058 2.866E-06 3.328E-05 7.216E-03 0.14664668 POOLA_INVASIVE_BREAST_CANCER_UP mouth disease DOID_403 3.241E-06 3.688E-05 0.06103509 0.49612811 POOLA_INVASIVE_BREAST_CANCER_UP Crohn's disease DOID_8778 3.241E-06 3.616E-05 0.33064134 1.000 POOLA_INVASIVE_BREAST_CANCER_UP atopic dermatitis DOID_3310 3.469E-06 3.796E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP pustulosis of palm and sole DOID_4398 4.524E-06 4.857E-05 0.21526706 0.89406536 POOLA_INVASIVE_BREAST_CANCER_UP cystitis DOID_1679 4.73E-06 4.984E-05 0.10667124 0.6669883 POOLA_INVASIVE_BREAST_CANCER_UP neuromuscular junction disease DOID_439 4.73E-06 4.893E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP intracranial aneurysm DOID_10941 5.5E-06 5.588E-05 2.155E-04 9.433E-03 POOLA_INVASIVE_BREAST_CANCER_UP perinatal necrotizing enterocolitis DOID_8677 6.359E-06 6.348E-05 0.11410728 0.66252084 POOLA_INVASIVE_BREAST_CANCER_UP autoimmune disease of cardiovascular system DOID_0060051 7.314E-06 7.175E-05 0.1178022 0.67706518 POOLA_INVASIVE_BREAST_CANCER_UP Behcet's disease DOID_13241 7.314E-06 7.175E-05 0.1178022 0.67706518 POOLA_INVASIVE_BREAST_CANCER_UP coronary stenosis DOID_4248 7.314E-06 7.054E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP autoimmune disease of the nervous system DOID_438 7.314E-06 6.936E-05 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP conjunctival disease DOID_4251 8.342E-06 7.781E-05 0.04090833 0.41565781 POOLA_INVASIVE_BREAST_CANCER_UP conjunctivitis DOID_6195 8.342E-06 7.781E-05 0.04090833 0.41565781 POOLA_INVASIVE_BREAST_CANCER_UP common variable immunodeficiency DOID_12177 1.144E-05 1.049E-04 0.04490654 0.43308176 POOLA_INVASIVE_BREAST_CANCER_UP allergic rhinitis DOID_4481 1.222E-05 1.103E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP pleural disease DOID_1532 1.375E-05 1.222E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP bladder disease DOID_365 1.375E-05 1.204E-04 0.13604836 0.75156815 POOLA_INVASIVE_BREAST_CANCER_UP encephalitis DOID_9588 1.52E-05 1.31E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP myocarditis DOID_820 1.542E-05 1.309E-04 0.13965234 0.76405946 POOLA_INVASIVE_BREAST_CANCER_UP diabetic retinopathy DOID_8947 1.717E-05 1.437E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP carotid stenosis DOID_13001 1.97E-05 1.625E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP eyelid disease DOID_530 2.5E-05 2.032E-04 0.0568021 0.47529991 POOLA_INVASIVE_BREAST_CANCER_UP Ehlers-Danlos syndrome DOID_13359 3.115E-05 2.496E-04 1.749E-03 0.04975417 POOLA_INVASIVE_BREAST_CANCER_UP varicose veins DOID_799 3.115E-05 2.462E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP retinal vascular disease DOID_2462 3.31E-05 2.58E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP autoimmune disease of urogenital tract DOID_0060049 3.788E-05 2.912E-04 0.17142323 0.81283182 POOLA_INVASIVE_BREAST_CANCER_UP primary biliary cirrhosis DOID_12236 3.788E-05 2.912E-04 0.17142323 0.81283182 POOLA_INVASIVE_BREAST_CANCER_UP vein disease DOID_866 3.822E-05 2.9E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP uveal disease DOID_3480 4.135E-05 3.096E-04 0.17488056 0.8090003 POOLA_INVASIVE_BREAST_CANCER_UP prion disease DOID_649 5.535E-05 4.09E-04 0.07243412 0.52170906 POOLA_INVASIVE_BREAST_CANCER_UP dilated cardiomyopathy DOID_12930 5.583E-05 4.073E-04 7.866E-03 0.1356292 POOLA_INVASIVE_BREAST_CANCER_UP MHC class II deficiency DOID_5812 6.553E-05 4.72E-04 6.553E-05 3.729E-03 POOLA_INVASIVE_BREAST_CANCER_UP leishmaniasis DOID_9065 6.553E-05 4.661E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP autoimmune disease of gastrointestinal tract DOID_0060031 6.728E-05 4.726E-04 0.19532554 0.85492486 POOLA_INVASIVE_BREAST_CANCER_UP glaucoma DOID_1686 6.728E-05 4.668E-04 0.0199713 0.26427143 POOLA_INVASIVE_BREAST_CANCER_UP pulmonary tuberculosis DOID_2957 6.728E-05 4.612E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP amyloidosis DOID_9120 7.686E-05 5.206E-04 0.08015332 0.54294333 POOLA_INVASIVE_BREAST_CANCER_UP B-cell lymphocytic neoplasm DOID_707 7.808E-05 5.227E-04 0.02143661 0.27105402 POOLA_INVASIVE_BREAST_CANCER_UP Kawasaki disease DOID_13378 8.939E-05 5.914E-04 0.08398895 0.5622319 POOLA_INVASIVE_BREAST_CANCER_UP lymphadenitis DOID_1602 8.939E-05 5.914E-04 0.08398895 0.5622319 POOLA_INVASIVE_BREAST_CANCER_UP lymph node disease DOID_9942 8.939E-05 5.914E-04 0.08398895 0.5622319 POOLA_INVASIVE_BREAST_CANCER_UP parasitic protozoa infectious disease DOID_2789 1.034E-04 6.763E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP sinusitis DOID_0050127 1.183E-04 7.65E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP paranasal sinus disease DOID_1352 1.183E-04 7.65E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP polyarteritis nodosa DOID_9810 1.183E-04 7.564E-04 0.09161259 0.58570297 POOLA_INVASIVE_BREAST_CANCER_UP leukocyte disease DOID_9500 1.342E-04 8.485E-04 0.2282878 0.92782683 POOLA_INVASIVE_BREAST_CANCER_UP aortic valve disease DOID_62 1.348E-04 8.428E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP toxic shock syndrome DOID_14115 1.527E-04 9.445E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP severe combined immunodeficiency DOID_627 1.527E-04 9.343E-04 1.527E-04 7.899E-03 POOLA_INVASIVE_BREAST_CANCER_UP respiratory failure DOID_11162 1.613E-04 9.765E-04 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP commensal bacterial infectious disease DOID_0050339 1.721E-04 1.031E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP bronchiolitis DOID_2942 1.721E-04 1.02E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP combined T cell and B cell immunodeficiency DOID_628 1.721E-04 1.01E-03 1.721E-04 8.16E-03 POOLA_INVASIVE_BREAST_CANCER_UP parasitic infectious disease DOID_1398 1.922E-04 1.116E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP myositis DOID_633 1.93E-04 1.109E-03 0.10667124 0.65973843 POOLA_INVASIVE_BREAST_CANCER_UP middle cerebral artery infarction DOID_3525 2.155E-04 1.226E-03 0.11039698 0.66121981 POOLA_INVASIVE_BREAST_CANCER_UP astrocytoma DOID_3069 2.397E-04 1.35E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP diffuse large B-cell lymphoma DOID_0050745 2.397E-04 1.337E-03 6.509E-03 0.14243805 POOLA_INVASIVE_BREAST_CANCER_UP periodontitis DOID_824 2.397E-04 1.324E-03 0.11410728 0.66935095 POOLA_INVASIVE_BREAST_CANCER_UP pleurisy DOID_10247 2.655E-04 1.452E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP renal hypertension DOID_1073 2.655E-04 1.439E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP secondary hypertension DOID_11130 2.655E-04 1.439E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP nephrosis DOID_2527 2.663E-04 1.43E-03 0.26607581 1.000 POOLA_INVASIVE_BREAST_CANCER_UP bile duct disease DOID_4138 2.663E-04 1.416E-03 0.03834117 0.42776713 POOLA_INVASIVE_BREAST_CANCER_UP biliary tract disease DOID_9741 2.804E-04 1.477E-03 0.03928612 0.42988085 POOLA_INVASIVE_BREAST_CANCER_UP focal glomerulosclerosis DOID_3945 2.93E-04 1.53E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP pancreatitis DOID_4989 3.59E-04 1.857E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP celiac disease DOID_10608 3.865E-04 1.981E-03 0.13242938 0.74606256 POOLA_INVASIVE_BREAST_CANCER_UP periodontal disease DOID_3388 4.973E-04 2.527E-03 0.14324139 0.76172288 POOLA_INVASIVE_BREAST_CANCER_UP calcinosis DOID_182 6.266E-04 3.155E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP microcephaly DOID_10907 6.74E-04 3.364E-03 0.01272362 0.18099343 POOLA_INVASIVE_BREAST_CANCER_UP uveitis DOID_13141 6.74E-04 3.335E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP hepatitis DOID_2237 7.236E-04 3.55E-03 0.16096465 0.80341126 POOLA_INVASIVE_BREAST_CANCER_UP Gilles de la Tourette syndrome DOID_11119 7.598E-04 3.695E-03 0.04090833 0.43105255 POOLA_INVASIVE_BREAST_CANCER_UP phagocyte bactericidal dysfunction DOID_3262 7.598E-04 3.664E-03 0.04090833 0.42321523 POOLA_INVASIVE_BREAST_CANCER_UP adult respiratory distress syndrome DOID_11394 7.755E-04 3.708E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP intracranial arterial disease DOID_13089 7.755E-04 3.677E-03 0.16446534 0.80673082 POOLA_INVASIVE_BREAST_CANCER_UP cerebral arterial disease DOID_3527 7.755E-04 3.677E-03 0.16446534 0.80673082 POOLA_INVASIVE_BREAST_CANCER_UP lymphatic system disease DOID_75 7.755E-04 3.647E-03 0.16446534 0.79983569 POOLA_INVASIVE_BREAST_CANCER_UP endometriosis of uterus DOID_288 8.863E-04 4.134E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP dermatomyositis DOID_10223 9.261E-04 4.284E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP temporal arteritis DOID_13375 9.261E-04 4.25E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP central nervous system vasculitis DOID_525 9.261E-04 4.25E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP nephrotic syndrome DOID_1184 9.453E-04 4.303E-03 0.17488056 0.81563145 POOLA_INVASIVE_BREAST_CANCER_UP endometriosis DOID_289 9.453E-04 4.269E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP uterine cancer DOID_363 1.007E-03 4.51E-03 0.01650295 0.22902875 POOLA_INVASIVE_BREAST_CANCER_UP tic disorder DOID_2769 1.108E-03 4.927E-03 0.0488882 0.43464666 POOLA_INVASIVE_BREAST_CANCER_UP aortic valve insufficiency DOID_57 1.108E-03 4.889E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP ocular hypertension DOID_9282 1.108E-03 4.851E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP borderline glaucoma DOID_9283 1.108E-03 4.851E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP neuritis DOID_1803 1.206E-03 5.237E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP calcium metabolism disease DOID_10575 1.428E-03 6.156E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP movement disease DOID_480 1.428E-03 6.109E-03 0.19868375 0.85644738 POOLA_INVASIVE_BREAST_CANCER_UP giant cell tumor DOID_200 1.674E-03 7.11E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP malignant giant cell tumor DOID_2705 1.674E-03 7.11E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP giant cell glioblastoma DOID_3074 1.674E-03 7.11E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP renovascular hypertension DOID_1591 1.749E-03 7.371E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP oral submucous fibrosis DOID_5773 1.749E-03 7.317E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP osteochondrodysplasia DOID_2256 1.853E-03 7.694E-03 1.853E-03 0.050195 POOLA_INVASIVE_BREAST_CANCER_UP restrictive cardiomyopathy DOID_397 1.993E-03 8.218E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP congenital nervous system abnormality DOID_2490 2.042E-03 8.359E-03 0.02608916 0.31584537 POOLA_INVASIVE_BREAST_CANCER_UP glioblastoma DOID_3068 2.141E-03 8.702E-03 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP urinary system benign neoplasm DOID_731 2.253E-03 9.091E-03 0.06855042 0.52006918 POOLA_INVASIVE_BREAST_CANCER_UP eosinophilia DOID_999 2.527E-03 0.01012769 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP mineral metabolism disease DOID_0050032 2.799E-03 0.01113561 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP cholestasis DOID_13580 2.919E-03 0.01153361 0.24741744 0.97764252 POOLA_INVASIVE_BREAST_CANCER_UP uterine disease DOID_345 2.919E-03 0.01145407 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP hyperglycemia DOID_4195 3.042E-03 0.01185667 0.25055958 0.98323036 POOLA_INVASIVE_BREAST_CANCER_UP colon carcinoma DOID_1520 3.122E-03 0.01208287 0.08015332 0.54948481 POOLA_INVASIVE_BREAST_CANCER_UP subependymal glioma DOID_4843 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP pilocytic astrocytoma DOID_4851 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP subependymal giant cell astrocytoma DOID_5077 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP fibrillary astrocytoma DOID_6726 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP juvenile pilocytic astrocytoma DOID_6811 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP childhood pilocytic astrocytoma DOID_6812 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP gemistocytic astrocytoma DOID_7005 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP childhood cerebral astrocytoma DOID_7007 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP protoplasmic astrocytoma DOID_7008 3.122E-03 0.01200123 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP tooth disease DOID_1091 3.169E-03 0.01210139 0.25368869 0.98869084 POOLA_INVASIVE_BREAST_CANCER_UP endocrine organ benign neoplasm DOID_0060089 3.299E-03 0.01251304 0.03556012 0.4129328 POOLA_INVASIVE_BREAST_CANCER_UP pancreatic ductal carcinoma DOID_3587 3.568E-03 0.01344474 0.26299832 1.000 POOLA_INVASIVE_BREAST_CANCER_UP benign glioma DOID_0060101 3.775E-03 0.01412962 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP benign ependymoma DOID_4844 3.775E-03 0.01412962 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP acquired immunodeficiency syndrome DOID_635 3.775E-03 0.01403727 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP pancreatic carcinoma DOID_4905 3.996E-03 0.01476569 0.27219255 1.000 POOLA_INVASIVE_BREAST_CANCER_UP Lewy body dementia DOID_12217 4.485E-03 0.01646529 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP meningitis DOID_9471 4.485E-03 0.01635974 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP Goodpasture syndrome DOID_9808 4.485E-03 0.01625554 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP mixed glioma DOID_5076 4.614E-03 0.01661738 0.04414145 0.44064012 POOLA_INVASIVE_BREAST_CANCER_UP metabolic syndrome X DOID_14221 4.944E-03 0.01769177 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP lipid metabolism disorder DOID_3146 4.944E-03 0.0175812 0.29024046 1.000 POOLA_INVASIVE_BREAST_CANCER_UP female reproductive system disease DOID_229 5.114E-03 0.01807245 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP urticaria DOID_1555 5.253E-03 0.0184498 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP biliary tract cancer DOID_4607 5.464E-03 0.01907339 0.29909694 1.000 POOLA_INVASIVE_BREAST_CANCER_UP bone development disease DOID_0080006 5.644E-03 0.01958299 5.644E-03 0.13381707 POOLA_INVASIVE_BREAST_CANCER_UP cleft lip DOID_9296 5.658E-03 0.01951025 0.10667124 0.65264447 POOLA_INVASIVE_BREAST_CANCER_UP vitiligo DOID_12306 6.076E-03 0.02082764 6.076E-03 0.13829551 POOLA_INVASIVE_BREAST_CANCER_UP gestational diabetes DOID_11714 6.509E-03 0.02217598 0.11410728 0.67632335 POOLA_INVASIVE_BREAST_CANCER_UP malaria DOID_12365 6.955E-03 0.02355433 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP invasive ductal carcinoma DOID_3008 6.955E-03 0.02341496 6.955E-03 0.14656028 POOLA_INVASIVE_BREAST_CANCER_UP multiple epiphyseal dysplasia DOID_12721 7.414E-03 0.02481491 7.414E-03 0.14546671 POOLA_INVASIVE_BREAST_CANCER_UP supratentorial cancer DOID_1659 7.414E-03 0.02466979 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP toxic encephalopathy DOID_3602 7.414E-03 0.02452636 7.414E-03 0.14061782 POOLA_INVASIVE_BREAST_CANCER_UP cerebrum cancer DOID_368 7.414E-03 0.02466979 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP endometrial carcinoma DOID_2871 7.887E-03 0.02593955 0.12514617 0.7120817 POOLA_INVASIVE_BREAST_CANCER_UP endometrial cancer DOID_1380 8.872E-03 0.02901204 0.13242938 0.73874822 POOLA_INVASIVE_BREAST_CANCER_UP pneumoconiosis DOID_10316 0.01044687 0.03396724 0.14324139 0.77623189 POOLA_INVASIVE_BREAST_CANCER_UP nephroblastoma DOID_2154 0.01044687 0.03377424 0.01044687 0.15642808 POOLA_INVASIVE_BREAST_CANCER_UP thyroid carcinoma DOID_3963 0.01044687 0.03358343 0.14324139 0.75466989 POOLA_INVASIVE_BREAST_CANCER_UP spindle cell carcinoma DOID_4015 0.01044687 0.03339476 0.14324139 0.74774631 POOLA_INVASIVE_BREAST_CANCER_UP lymphoid leukemia DOID_10747 0.01099734 0.03495803 0.14681555 0.75259502 POOLA_INVASIVE_BREAST_CANCER_UP aplastic anemia DOID_12449 0.01099734 0.03476382 0.01099734 0.16044841 POOLA_INVASIVE_BREAST_CANCER_UP thyroid cancer DOID_1781 0.01156037 0.03634171 0.1503749 0.76395817 POOLA_INVASIVE_BREAST_CANCER_UP embryonal cancer DOID_688 0.01213583 0.03794114 0.15391949 0.77504591 POOLA_INVASIVE_BREAST_CANCER_UP peptic ulcer DOID_750 0.01332361 0.04142697 0.16096465 0.79642508 POOLA_INVASIVE_BREAST_CANCER_UP diabetic autonomic neuropathy DOID_11503 0.01650295 0.05103358 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP autonomic neuropathy DOID_11504 0.01650295 0.05103358 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP diabetic polyneuropathy DOID_12785 0.01650295 0.05103358 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP gallbladder cancer DOID_3121 0.01650295 0.05075772 0.17832355 0.818275 POOLA_INVASIVE_BREAST_CANCER_UP diabetic neuropathy DOID_9743 0.01650295 0.05103358 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP leukodystrophy DOID_10579 0.01785636 0.05462509 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP proteinuria DOID_576 0.01785636 0.05433297 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP autonomic nervous system disease DOID_11465 0.01855013 0.05614375 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP brain cancer DOID_1319 0.01855013 0.05584669 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP thyroid adenoma DOID_2891 0.01855013 0.05555276 0.1885671 0.8382397 POOLA_INVASIVE_BREAST_CANCER_UP bone marrow disease DOID_4961 0.01855013 0.05526191 0.01855013 0.2513101 POOLA_INVASIVE_BREAST_CANCER_UP central nervous system cancer DOID_3620 0.01925515 0.05706343 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP integumentary system benign neoplasm DOID_0060121 0.0199713 0.05887913 0.19532554 0.84839871 POOLA_INVASIVE_BREAST_CANCER_UP skin benign neoplasm DOID_3165 0.0199713 0.05887913 0.19532554 0.84839871 POOLA_INVASIVE_BREAST_CANCER_UP lung small cell carcinoma DOID_5409 0.0199713 0.05857563 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP hemorrhagic disease DOID_2213 0.02143661 0.06255093 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP orofacial cleft DOID_0050567 0.02218556 0.06440603 0.20535845 0.87856361 POOLA_INVASIVE_BREAST_CANCER_UP atrophic muscular disease DOID_913 0.02294523 0.06627327 0.20867506 0.88609035 POOLA_INVASIVE_BREAST_CANCER_UP muscular dystrophy DOID_9884 0.02294523 0.06627327 0.20867506 0.88609035 POOLA_INVASIVE_BREAST_CANCER_UP integumentary system cancer DOID_0060122 0.02449635 0.07039606 0.21526706 0.90063937 POOLA_INVASIVE_BREAST_CANCER_UP skin cancer DOID_4159 0.02449635 0.07039606 0.21526706 0.90063937 POOLA_INVASIVE_BREAST_CANCER_UP familial hyperlipidemia DOID_1168 0.02528759 0.07230472 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP hypertrophic cardiomyopathy DOID_11984 0.02690096 0.07653322 1.000 1.000 POOLA_INVASIVE_BREAST_CANCER_UP cerebral degeneration DOID_1443 0.03286172 0.09302645 1.000 1.000 KYNG_DNA_DAMAGE_UP encephalomyelitis DOID_640 4.764E-07 2.711E-04 3.072E-03 0.09201328 KYNG_DNA_DAMAGE_UP syndrome DOID_225 4.163E-06 1.184E-03 4.163E-06 2.369E-03 KYNG_DNA_DAMAGE_UP pancreatitis DOID_4989 4.718E-06 8.948E-04 0.02471666 0.3057344 KYNG_DNA_DAMAGE_UP primary immunodeficiency disease DOID_612 8.887E-06 1.264E-03 1.752E-04 0.01993773 KYNG_DNA_DAMAGE_UP lymphoblastic leukemia DOID_1037 1.097E-05 1.248E-03 1.097E-05 3.12E-03 KYNG_DNA_DAMAGE_UP bile duct adenocarcinoma DOID_4896 2.803E-05 2.658E-03 0.15911129 0.53889479 KYNG_DNA_DAMAGE_UP cholangiocarcinoma DOID_4947 2.803E-05 2.658E-03 0.15911129 0.53889479 KYNG_DNA_DAMAGE_UP bile duct cancer DOID_4606 3.669E-05 2.982E-03 0.16928366 0.54113709 KYNG_DNA_DAMAGE_UP bile duct carcinoma DOID_4897 3.669E-05 2.982E-03 0.16928366 0.54113709 KYNG_DNA_DAMAGE_UP hypothyroidism DOID_1459 4.716E-05 3.354E-03 1.036E-03 0.0736593 KYNG_DNA_DAMAGE_UP tooth disease DOID_1091 6.312E-05 3.991E-03 0.19172764 0.58338517 KYNG_DNA_DAMAGE_UP urticaria DOID_1555 6.718E-05 3.823E-03 2.827E-03 0.08935692 KYNG_DNA_DAMAGE_UP peripheral vascular disease DOID_341 8.27E-05 4.278E-03 1.566E-03 0.08101324 KYNG_DNA_DAMAGE_UP B cell deficiency DOID_2115 8.428E-05 3.996E-03 3.275E-03 0.08873028 KYNG_DNA_DAMAGE_UP polycystic ovary syndrome DOID_11612 1.149E-04 5.028E-03 1.149E-04 0.0217877 KYNG_DNA_DAMAGE_UP biliary tract cancer DOID_4607 1.346E-04 5.47E-03 0.22780606 0.64488382 KYNG_DNA_DAMAGE_UP chronic leukemia DOID_1036 1.658E-04 6.289E-03 1.658E-04 0.02358379 KYNG_DNA_DAMAGE_UP chronic lymphocytic leukemia DOID_1040 1.658E-04 6.289E-03 1.658E-04 0.02358379 KYNG_DNA_DAMAGE_UP transitional cell carcinoma DOID_2671 1.679E-04 5.971E-03 0.03072086 0.29627402 KYNG_DNA_DAMAGE_UP amino acid metabolic disorder DOID_9252 1.752E-04 5.864E-03 1.752E-04 0.01661477 KYNG_DNA_DAMAGE_UP periodontal disease DOID_3388 1.96E-04 6.194E-03 1.000 1.000 KYNG_DNA_DAMAGE_UP spindle cell carcinoma DOID_4015 1.96E-04 5.868E-03 0.10636746 0.43230774 KYNG_DNA_DAMAGE_UP mouth disease DOID_403 2.152E-04 6.124E-03 0.25324455 0.69949587 KYNG_DNA_DAMAGE_UP dilated cardiomyopathy DOID_12930 2.24E-04 6.069E-03 0.03523106 0.29920107 KYNG_DNA_DAMAGE_UP benign mesothelioma DOID_2645 3.289E-04 8.506E-03 7.941E-03 0.17378085 KYNG_DNA_DAMAGE_UP vascular skin disease DOID_9540 4.803E-04 0.01188265 0.01016197 0.1865214 KYNG_DNA_DAMAGE_UP aortic aneurysm DOID_3627 5.703E-04 0.01352072 0.01136394 0.19594192 KYNG_DNA_DAMAGE_UP giant cell tumor DOID_200 6.704E-04 0.0152579 0.15654896 0.53339138 KYNG_DNA_DAMAGE_UP malignant giant cell tumor DOID_2705 6.704E-04 0.0152579 0.15654896 0.53339138 KYNG_DNA_DAMAGE_UP giant cell glioblastoma DOID_3074 6.704E-04 0.0152579 0.15654896 0.53339138 KYNG_DNA_DAMAGE_UP glioblastoma DOID_3068 8.609E-04 0.01883941 0.16928366 0.54419436 KYNG_DNA_DAMAGE_UP adrenal cortex disease DOID_3952 9.334E-04 0.01967009 0.04455577 0.28809358 KYNG_DNA_DAMAGE_UP nutritional deficiency disease DOID_5113 9.334E-04 0.01896759 9.334E-04 0.07587034 KYNG_DNA_DAMAGE_UP neuroectodermal tumor DOID_171 9.9E-04 0.01942467 0.1768328 0.55589978 KYNG_DNA_DAMAGE_UP adrenal gland disease DOID_9553 1.204E-03 0.02283894 0.05034587 0.31137828 KYNG_DNA_DAMAGE_UP brain infarction DOID_3454 1.337E-03 0.02454683 1.337E-03 0.08455019 KYNG_DNA_DAMAGE_UP prion disease DOID_649 1.352E-03 0.02404025 0.05322787 0.3188069 KYNG_DNA_DAMAGE_UP astrocytoma DOID_3069 1.392E-03 0.02400887 0.19663297 0.59197968 KYNG_DNA_DAMAGE_UP agammaglobulinemia DOID_2583 1.508E-03 0.02523794 0.05610119 0.32244016 KYNG_DNA_DAMAGE_UP infertility DOID_5223 1.508E-03 0.02451686 1.508E-03 0.085809 KYNG_DNA_DAMAGE_UP blood protein disease DOID_620 1.672E-03 0.02643184 0.05896586 0.33219383 KYNG_DNA_DAMAGE_UP aneurysm disease DOID_2403 1.818E-03 0.02795933 0.02414587 0.30531108 KYNG_DNA_DAMAGE_UP bacterial pneumonia DOID_874 1.885E-03 0.02822216 0.02471666 0.29922941 KYNG_DNA_DAMAGE_UP funisitis DOID_0050698 2.025E-03 0.0295463 1.000 1.000 KYNG_DNA_DAMAGE_UP uremia DOID_4676 2.214E-03 0.03148882 2.214E-03 0.10496274 KYNG_DNA_DAMAGE_UP alcohol abuse DOID_1574 2.241E-03 0.03110192 2.241E-03 0.09809068 KYNG_DNA_DAMAGE_UP focal epilepsy DOID_2234 2.241E-03 0.0303614 2.241E-03 0.0910842 KYNG_DNA_DAMAGE_UP chronic kidney failure DOID_784 2.241E-03 0.02965532 2.241E-03 0.08501192 KYNG_DNA_DAMAGE_UP sphingolipidosis DOID_1927 2.614E-03 0.03381001 2.614E-03 0.09297751 KYNG_DNA_DAMAGE_UP nervous system cancer DOID_3093 2.806E-03 0.03548012 0.24409178 0.68417843 KYNG_DNA_DAMAGE_UP organic acidemia DOID_0060159 2.827E-03 0.03496575 2.827E-03 0.09461321 KYNG_DNA_DAMAGE_UP Crohn's disease DOID_8778 3.165E-03 0.0383127 3.165E-03 0.09003484 KYNG_DNA_DAMAGE_UP hypersensitivity reaction type I disease DOID_1205 3.259E-03 0.03862705 0.03523106 0.30373442 KYNG_DNA_DAMAGE_UP vitiligo DOID_12306 3.275E-03 0.03802726 0.08157516 0.39335819 KYNG_DNA_DAMAGE_UP periodontitis DOID_824 3.51E-03 0.03994815 1.000 1.000 KYNG_DNA_DAMAGE_UP ulcerative colitis DOID_8577 3.55E-03 0.03960984 3.55E-03 0.09182282 KYNG_DNA_DAMAGE_UP renal hypertension DOID_1073 3.754E-03 0.0410741 3.754E-03 0.09286318 KYNG_DNA_DAMAGE_UP secondary hypertension DOID_11130 3.754E-03 0.0410741 3.754E-03 0.09286318 KYNG_DNA_DAMAGE_UP endometrial carcinoma DOID_2871 4.263E-03 0.04576901 1.000 1.000 KYNG_DNA_DAMAGE_UP abdominal aortic aneurysm DOID_7693 4.529E-03 0.04772522 0.09543165 0.40522841 KYNG_DNA_DAMAGE_UP Charcot-Marie-Tooth disease DOID_10595 4.803E-03 0.04968786 4.803E-03 0.113868 KYNG_DNA_DAMAGE_UP endometrial cancer DOID_1380 4.803E-03 0.04880057 1.000 1.000 KYNG_DNA_DAMAGE_UP nephroblastoma DOID_2154 5.668E-03 0.0565819 0.10636746 0.43541787 KYNG_DNA_DAMAGE_UP leukopenia DOID_615 5.668E-03 0.05560635 5.668E-03 0.12900674 KYNG_DNA_DAMAGE_UP medullomyoblastoma DOID_3861 5.971E-03 0.05758702 0.10908087 0.43709165 KYNG_DNA_DAMAGE_UP adult medulloblastoma DOID_3864 5.971E-03 0.05758702 0.10908087 0.43709165 KYNG_DNA_DAMAGE_UP childhood medulloblastoma DOID_3869 5.971E-03 0.05758702 0.10908087 0.43709165 KYNG_DNA_DAMAGE_UP medulloblastoma DOID_3858 6.599E-03 0.06258229 0.11448321 0.44617088 KYNG_DNA_DAMAGE_UP multiple myeloma DOID_9538 6.599E-03 0.06155635 0.11448321 0.44313571 KYNG_DNA_DAMAGE_UP uveitis DOID_13141 6.924E-03 0.06354391 1.000 1.000 KYNG_DNA_DAMAGE_UP hepatitis DOID_2237 7.256E-03 0.06553274 0.11985308 0.45769399 KYNG_DNA_DAMAGE_UP autoimmune disease of urogenital tract DOID_0060049 8.294E-03 0.07373673 8.294E-03 0.17478336 KYNG_DNA_DAMAGE_UP primary biliary cirrhosis DOID_12236 8.294E-03 0.07373673 8.294E-03 0.17478336 KYNG_DNA_DAMAGE_UP Huntington's disease DOID_12858 8.654E-03 0.07575309 8.654E-03 0.17585539 KYNG_DNA_DAMAGE_UP primitive neuroectodermal tumor DOID_168 8.654E-03 0.07460532 0.13049617 0.47904722 KYNG_DNA_DAMAGE_UP idiopathic generalized epilepsy DOID_1827 8.654E-03 0.07349181 8.654E-03 0.16979141 KYNG_DNA_DAMAGE_UP hyperinsulinism DOID_2018 8.654E-03 0.07241104 8.654E-03 0.1641317 KYNG_DNA_DAMAGE_UP uveal disease DOID_3480 8.654E-03 0.07136161 1.000 1.000 KYNG_DNA_DAMAGE_UP uterine cancer DOID_363 9.021E-03 0.07332397 1.000 1.000 KYNG_DNA_DAMAGE_UP influenza DOID_8469 9.021E-03 0.07229123 0.13313694 0.48251542 KYNG_DNA_DAMAGE_UP myeloma DOID_0070004 0.01016197 0.08030783 0.14101166 0.49835797 KYNG_DNA_DAMAGE_UP hemolytic anemia DOID_583 0.01055596 0.08227868 0.01055596 0.18769825 KYNG_DNA_DAMAGE_UP normocytic anemia DOID_720 0.01055596 0.08227868 0.01055596 0.18769825 KYNG_DNA_DAMAGE_UP calcium metabolism disease DOID_10575 0.01136394 0.08737951 0.14881545 0.51948462 KYNG_DNA_DAMAGE_UP withdrawal disorder DOID_0060001 0.01177784 0.08935458 0.01177784 0.19710568 KYNG_DNA_DAMAGE_UP B-cell lymphocytic neoplasm DOID_707 0.01177784 0.08817886 0.15140107 0.52210429 KYNG_DNA_DAMAGE_UP atopic dermatitis DOID_3310 0.0121983 0.09014065 0.0121983 0.19830944 KYNG_DNA_DAMAGE_UP sarcoidosis DOID_11335 0.01262526 0.09209962 0.15654896 0.53660458 KYNG_DNA_DAMAGE_UP bone marrow cancer DOID_4960 0.01305868 0.09405556 0.15911129 0.53570606 KYNG_DNA_DAMAGE_UP parasitic protozoa infectious disease DOID_2789 0.01349853 0.09600828 0.1616659 0.53481336 KYNG_DNA_DAMAGE_UP familial hyperlipidemia DOID_1168 0.01394476 0.09795761 0.01394476 0.22040463 CAIRO_HEPATOBLASTOMA_DN amino acid metabolic disorder DOID_9252 1.499E-28 8.53E-26 1.047E-26 5.956E-24 CAIRO_HEPATOBLASTOMA_DN lipid metabolism disorder DOID_3146 3.843E-12 1.093E-09 3.554E-09 6.741E-07 CAIRO_HEPATOBLASTOMA_DN carbohydrate metabolic disorder DOID_2978 4.746E-10 9.002E-08 4.746E-10 1.35E-07 CAIRO_HEPATOBLASTOMA_DN metabolic syndrome X DOID_14221 3.554E-09 5.056E-07 3.43E-05 2.169E-03 CAIRO_HEPATOBLASTOMA_DN chronic kidney failure DOID_784 4.745E-09 5.4E-07 4.08E-05 2.11E-03 CAIRO_HEPATOBLASTOMA_DN familial hyperlipidemia DOID_1168 8.666E-09 8.218E-07 2.66E-07 3.783E-05 CAIRO_HEPATOBLASTOMA_DN meningitis DOID_9471 6.583E-08 5.351E-06 3.777E-06 3.582E-04 CAIRO_HEPATOBLASTOMA_DN bacterial pneumonia DOID_874 7.461E-08 5.306E-06 4.629E-04 0.01317086 CAIRO_HEPATOBLASTOMA_DN retinal vascular disease DOID_2462 1.337E-07 8.452E-06 0.32235989 0.80448585 CAIRO_HEPATOBLASTOMA_DN bile duct disease DOID_4138 1.035E-06 5.888E-05 4.474E-03 0.06527082 CAIRO_HEPATOBLASTOMA_DN biliary tract disease DOID_9741 1.121E-06 5.797E-05 4.645E-03 0.06607613 CAIRO_HEPATOBLASTOMA_DN diabetic retinopathy DOID_8947 1.212E-06 5.748E-05 0.28814992 0.74526047 CAIRO_HEPATOBLASTOMA_DN contact dermatitis DOID_2773 1.899E-06 8.313E-05 3.43E-05 1.952E-03 CAIRO_HEPATOBLASTOMA_DN familial hypercholesterolemia DOID_13810 2.618E-06 1.064E-04 1.259E-04 5.118E-03 CAIRO_HEPATOBLASTOMA_DN pre-eclampsia DOID_10591 2.988E-06 1.134E-04 0.20031194 0.58151782 CAIRO_HEPATOBLASTOMA_DN glycogen metabolism disorder DOID_0050728 3.158E-06 1.123E-04 3.158E-06 3.594E-04 CAIRO_HEPATOBLASTOMA_DN glycogen storage disease DOID_2747 3.158E-06 1.123E-04 3.158E-06 3.594E-04 CAIRO_HEPATOBLASTOMA_DN carotid artery disease DOID_3407 1.023E-05 3.422E-04 2.97E-03 0.04567749 CAIRO_HEPATOBLASTOMA_DN cholestasis DOID_13580 1.378E-05 4.356E-04 0.0371447 0.31081376 CAIRO_HEPATOBLASTOMA_DN hemochromatosis DOID_2352 1.399E-05 4.189E-04 0.04796361 0.31369303 CAIRO_HEPATOBLASTOMA_DN prostatic adenoma DOID_2883 1.399E-05 3.979E-04 1.399E-05 1.137E-03 CAIRO_HEPATOBLASTOMA_DN allergic contact dermatitis DOID_3042 1.589E-05 4.304E-04 1.589E-05 1.13E-03 CAIRO_HEPATOBLASTOMA_DN tuberculosis DOID_399 1.703E-05 4.404E-04 0.2720376 0.71331518 CAIRO_HEPATOBLASTOMA_DN esophageal disease DOID_6050 2.244E-05 5.551E-04 0.01187713 0.13792019 CAIRO_HEPATOBLASTOMA_DN female reproductive system disease DOID_229 3.637E-05 8.623E-04 5.323E-04 0.01442413 CAIRO_HEPATOBLASTOMA_DN hyperhomocysteinemia DOID_9279 3.807E-05 8.664E-04 1.997E-03 0.03664766 CAIRO_HEPATOBLASTOMA_DN primary bacterial infectious disease DOID_0050338 5.089E-05 1.114E-03 0.32840191 0.81598554 CAIRO_HEPATOBLASTOMA_DN hyperinsulinism DOID_2018 5.373E-05 1.132E-03 0.0179821 0.18603295 CAIRO_HEPATOBLASTOMA_DN primary immunodeficiency disease DOID_612 5.661E-05 1.15E-03 5.661E-05 2.684E-03 CAIRO_HEPATOBLASTOMA_DN male reproductive organ benign neoplasm DOID_0060087 6.76E-05 1.326E-03 6.76E-05 2.959E-03 CAIRO_HEPATOBLASTOMA_DN Crohn's disease DOID_8778 7.308E-05 1.386E-03 0.06863763 0.33380179 CAIRO_HEPATOBLASTOMA_DN thrombophilia DOID_2452 1.259E-04 2.311E-03 1.259E-04 4.776E-03 CAIRO_HEPATOBLASTOMA_DN muscular atrophy DOID_767 1.259E-04 2.239E-03 0.09363967 0.40364374 CAIRO_HEPATOBLASTOMA_DN pustulosis of palm and sole DOID_4398 1.34E-04 2.311E-03 0.02774049 0.25875962 CAIRO_HEPATOBLASTOMA_DN toxic shock syndrome DOID_14115 1.862E-04 3.116E-03 0.10571415 0.42063884 CAIRO_HEPATOBLASTOMA_DN commensal bacterial infectious disease DOID_0050339 2.098E-04 3.411E-03 0.10970334 0.43348056 CAIRO_HEPATOBLASTOMA_DN organic acidemia DOID_0060159 2.098E-04 3.316E-03 2.098E-04 7.462E-03 CAIRO_HEPATOBLASTOMA_DN endocrine pancreas disease DOID_1428 2.347E-04 3.609E-03 0.03615594 0.30705565 CAIRO_HEPATOBLASTOMA_DN parasitic infectious disease DOID_1398 2.485E-04 3.721E-03 0.0371447 0.30630922 CAIRO_HEPATOBLASTOMA_DN uterine disease DOID_345 2.485E-04 3.625E-03 3.527E-03 0.05280732 CAIRO_HEPATOBLASTOMA_DN dystonia DOID_543 2.626E-04 3.736E-03 2.626E-04 8.791E-03 CAIRO_HEPATOBLASTOMA_DN hyperglycemia DOID_4195 2.629E-04 3.648E-03 0.0381438 0.30568762 CAIRO_HEPATOBLASTOMA_DN brain infarction DOID_3454 2.934E-04 3.975E-03 0.04017253 0.3174746 CAIRO_HEPATOBLASTOMA_DN renal hypertension DOID_1073 3.234E-04 4.279E-03 0.12548396 0.45477946 CAIRO_HEPATOBLASTOMA_DN secondary hypertension DOID_11130 3.234E-04 4.279E-03 0.12548396 0.45477946 CAIRO_HEPATOBLASTOMA_DN malaria DOID_12365 3.234E-04 4.182E-03 0.12548396 0.44905897 CAIRO_HEPATOBLASTOMA_DN central nervous system hereditary degenerative disease DOID_481 3.234E-04 4.089E-03 3.234E-04 0.01022216 CAIRO_HEPATOBLASTOMA_DN blood coagulation disease DOID_1247 3.264E-04 4.037E-03 3.264E-04 9.775E-03 CAIRO_HEPATOBLASTOMA_DN metal metabolism disorder DOID_896 5.576E-04 6.751E-03 0.14863501 0.48605357 CAIRO_HEPATOBLASTOMA_DN hepatitis C DOID_1883 6.049E-04 7.17E-03 0.15243384 0.49562775 CAIRO_HEPATOBLASTOMA_DN leukopenia DOID_615 6.049E-04 7.024E-03 0.01187713 0.13516178 CAIRO_HEPATOBLASTOMA_DN thyroid cancer DOID_1781 7.068E-04 8.043E-03 0.01313811 0.14658012 CAIRO_HEPATOBLASTOMA_DN interstitial nephritis DOID_1063 8.683E-04 9.688E-03 0.04369948 0.33601357 CAIRO_HEPATOBLASTOMA_DN gout DOID_13189 8.683E-04 9.502E-03 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN hyperparathyroidism DOID_13543 8.683E-04 9.322E-03 0.04369948 0.32292213 CAIRO_HEPATOBLASTOMA_DN hypolipoproteinemia DOID_1387 8.683E-04 9.15E-03 0.04369948 0.31474688 CAIRO_HEPATOBLASTOMA_DN intracranial arterial disease DOID_13089 9.421E-04 9.746E-03 0.17487554 0.53496874 CAIRO_HEPATOBLASTOMA_DN cerebral arterial disease DOID_3527 9.421E-04 9.746E-03 0.17487554 0.53496874 CAIRO_HEPATOBLASTOMA_DN lymphatic system disease DOID_75 9.421E-04 9.572E-03 0.01582569 0.1731696 CAIRO_HEPATOBLASTOMA_DN hypersensitivity reaction type I disease DOID_1205 9.564E-04 9.547E-03 0.35203916 0.85602685 CAIRO_HEPATOBLASTOMA_DN dilated cardiomyopathy DOID_12930 9.564E-04 9.383E-03 0.06988377 0.33136553 CAIRO_HEPATOBLASTOMA_DN sickle cell anemia DOID_10923 1.058E-03 0.01020516 0.04796361 0.31734063 CAIRO_HEPATOBLASTOMA_DN ulcerative colitis DOID_8577 1.071E-03 0.0101592 0.01025984 0.12162182 CAIRO_HEPATOBLASTOMA_DN endometriosis of uterus DOID_288 1.076E-03 0.01003827 0.01725016 0.18519507 CAIRO_HEPATOBLASTOMA_DN endometriosis DOID_289 1.147E-03 0.010531 0.0179821 0.18271094 CAIRO_HEPATOBLASTOMA_DN beta thalassemia DOID_12241 1.266E-03 0.01143508 1.266E-03 0.03274592 CAIRO_HEPATOBLASTOMA_DN intracranial arteriosclerosis DOID_13097 1.266E-03 0.01125641 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN porphyria DOID_13268 1.266E-03 0.01108323 1.266E-03 0.03132218 CAIRO_HEPATOBLASTOMA_DN osteopetrosis DOID_13533 1.266E-03 0.01091531 1.266E-03 0.03001709 CAIRO_HEPATOBLASTOMA_DN vascular dementia DOID_8725 1.266E-03 0.01125641 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN cerebral infarction DOID_3526 1.299E-03 0.01103134 0.19312501 0.56936855 CAIRO_HEPATOBLASTOMA_DN cataract DOID_83 1.299E-03 0.01086912 1.299E-03 0.029564 CAIRO_HEPATOBLASTOMA_DN lens disease DOID_110 1.462E-03 0.01205962 1.462E-03 0.03200437 CAIRO_HEPATOBLASTOMA_DN thyroid adenoma DOID_2891 1.462E-03 0.01188734 0.20031194 0.57856596 CAIRO_HEPATOBLASTOMA_DN nicotine dependence DOID_0050742 1.492E-03 0.01195637 1.492E-03 0.03144082 CAIRO_HEPATOBLASTOMA_DN parathyroid gland disease DOID_11201 1.492E-03 0.01179031 0.05643525 0.31482016 CAIRO_HEPATOBLASTOMA_DN hemolytic anemia DOID_583 1.549E-03 0.01207185 0.02183371 0.21419625 CAIRO_HEPATOBLASTOMA_DN normocytic anemia DOID_720 1.549E-03 0.01207185 0.02183371 0.21419625 CAIRO_HEPATOBLASTOMA_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.638E-03 0.01259672 0.02264153 0.21835647 CAIRO_HEPATOBLASTOMA_DN pulmonary tuberculosis DOID_2957 1.638E-03 0.01242876 0.20743523 0.58721714 CAIRO_HEPATOBLASTOMA_DN movement disease DOID_480 1.731E-03 0.01295886 1.731E-03 0.03517405 CAIRO_HEPATOBLASTOMA_DN bacterial meningitis DOID_9470 1.735E-03 0.01282453 1.735E-03 0.03405133 CAIRO_HEPATOBLASTOMA_DN thalassemia DOID_10241 1.997E-03 0.0145651 1.997E-03 0.03786925 CAIRO_HEPATOBLASTOMA_DN nutritional deficiency disease DOID_5113 1.997E-03 0.01438073 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN sarcoidosis DOID_11335 2.028E-03 0.01442594 0.22149313 0.61179412 CAIRO_HEPATOBLASTOMA_DN reproductive organ benign neoplasm DOID_0050622 2.243E-03 0.01575684 2.243E-03 0.0398845 CAIRO_HEPATOBLASTOMA_DN parasitic protozoa infectious disease DOID_2789 2.243E-03 0.01556468 0.22842884 0.61600004 CAIRO_HEPATOBLASTOMA_DN smallpox DOID_8736 2.243E-03 0.01537716 2.243E-03 0.03867588 CAIRO_HEPATOBLASTOMA_DN lymphatic system cancer DOID_0060073 2.571E-03 0.01741549 2.571E-03 0.04302651 CAIRO_HEPATOBLASTOMA_DN methylmalonic acidemia DOID_14749 2.571E-03 0.0172106 2.571E-03 0.04179718 CAIRO_HEPATOBLASTOMA_DN juvenile rheumatoid arthritis DOID_676 2.571E-03 0.01701048 0.07315436 0.34118712 CAIRO_HEPATOBLASTOMA_DN reticulosarcoma DOID_8538 2.571E-03 0.01741549 2.571E-03 0.04302651 CAIRO_HEPATOBLASTOMA_DN lymphosarcoma DOID_8675 2.571E-03 0.01741549 2.571E-03 0.04302651 CAIRO_HEPATOBLASTOMA_DN hypersensitivity reaction type IV disease DOID_2916 2.591E-03 0.01694494 0.2387174 0.64070849 CAIRO_HEPATOBLASTOMA_DN glioblastoma DOID_3068 2.591E-03 0.01675238 0.03044655 0.27942071 CAIRO_HEPATOBLASTOMA_DN melancholia DOID_2848 2.714E-03 0.01734991 0.24211652 0.64375841 CAIRO_HEPATOBLASTOMA_DN leukocyte disease DOID_9500 2.714E-03 0.01715713 0.03137097 0.28333464 CAIRO_HEPATOBLASTOMA_DN neurotic disorder DOID_4964 2.84E-03 0.01775921 0.24550056 0.64972007 CAIRO_HEPATOBLASTOMA_DN osteosclerosis DOID_4254 2.884E-03 0.01783648 2.884E-03 0.04558211 CAIRO_HEPATOBLASTOMA_DN mineral metabolism disease DOID_0050032 3.382E-03 0.02069232 0.03615594 0.31170801 CAIRO_HEPATOBLASTOMA_DN esophagitis DOID_11963 3.56E-03 0.02155219 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN colonic disease DOID_5353 3.56E-03 0.02132532 0.08550012 0.38610769 CAIRO_HEPATOBLASTOMA_DN endocrine organ benign neoplasm DOID_0060089 3.983E-03 0.02360784 0.2720376 0.71661757 CAIRO_HEPATOBLASTOMA_DN astrocytoma DOID_3069 4.143E-03 0.02430135 0.04120196 0.32114949 CAIRO_HEPATOBLASTOMA_DN gastric ulcer DOID_10808 4.304E-03 0.02498696 0.09363967 0.4130308 CAIRO_HEPATOBLASTOMA_DN hepatitis B DOID_2043 4.304E-03 0.02473457 0.09363967 0.40672499 CAIRO_HEPATOBLASTOMA_DN peripheral vascular disease DOID_341 4.645E-03 0.02643045 0.28495607 0.74036532 CAIRO_HEPATOBLASTOMA_DN agranulocytosis DOID_12987 4.7E-03 0.02647636 4.7E-03 0.06522226 CAIRO_HEPATOBLASTOMA_DN myasthenia gravis DOID_437 4.7E-03 0.02621679 0.0976824 0.40276293 CAIRO_HEPATOBLASTOMA_DN uremia DOID_4676 4.7E-03 0.02596226 4.7E-03 0.06366935 CAIRO_HEPATOBLASTOMA_DN pulmonary embolism DOID_9477 4.7E-03 0.02571262 0.0976824 0.39700918 CAIRO_HEPATOBLASTOMA_DN diabetic angiopathy DOID_11713 5.112E-03 0.02770199 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN congenital hemolytic anemia DOID_589 5.112E-03 0.02744065 5.112E-03 0.0676444 CAIRO_HEPATOBLASTOMA_DN endogenous depression DOID_1595 5.183E-03 0.02756018 0.29449513 0.75480959 CAIRO_HEPATOBLASTOMA_DN bone resorption disease DOID_0080011 5.37E-03 0.02829105 5.37E-03 0.06944166 CAIRO_HEPATOBLASTOMA_DN osteoporosis DOID_11476 5.37E-03 0.02829105 5.37E-03 0.06944166 CAIRO_HEPATOBLASTOMA_DN bronchiolitis DOID_2942 5.985E-03 0.03124019 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN neuromuscular junction disease DOID_439 6.444E-03 0.03333532 0.11367484 0.43120655 CAIRO_HEPATOBLASTOMA_DN myositis DOID_633 6.444E-03 0.033035 6.444E-03 0.08148634 CAIRO_HEPATOBLASTOMA_DN mental depression DOID_1596 6.578E-03 0.03341836 0.31626382 0.79625715 CAIRO_HEPATOBLASTOMA_DN fragments of torsion dystonia DOID_531 6.92E-03 0.03484476 6.92E-03 0.08559691 CAIRO_HEPATOBLASTOMA_DN autoimmune disease of the nervous system DOID_438 7.917E-03 0.03951643 0.12548396 0.44074306 CAIRO_HEPATOBLASTOMA_DN Human immunodeficiency virus infectious disease DOID_526 8.176E-03 0.04045532 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN supratentorial cancer DOID_1659 8.439E-03 0.04139268 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN toxic encephalopathy DOID_3602 8.439E-03 0.04103889 0.12938548 0.44890449 CAIRO_HEPATOBLASTOMA_DN cerebrum cancer DOID_368 8.439E-03 0.04139268 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN dystonic disease DOID_544 8.439E-03 0.04069111 8.439E-03 0.10216065 CAIRO_HEPATOBLASTOMA_DN alcohol-related neurodevelopmental disorder DOID_0050667 9.183E-03 0.04391065 0.34913034 0.85259728 CAIRO_HEPATOBLASTOMA_DN spastic cerebral palsy DOID_0050669 9.526E-03 0.04517032 0.13713667 0.47006485 CAIRO_HEPATOBLASTOMA_DN abdominal aortic aneurysm DOID_7693 9.526E-03 0.04479701 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN celiac disease DOID_10608 0.01009224 0.04706956 0.1409865 0.47189011 CAIRO_HEPATOBLASTOMA_DN thyroid carcinoma DOID_3963 0.01187713 0.05494381 0.15243384 0.49281168 CAIRO_HEPATOBLASTOMA_DN hyperthyroidism DOID_7998 0.01187713 0.05450072 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN adenoma DOID_657 0.01313811 0.05980469 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN hepatitis DOID_2237 0.01513343 0.06834065 0.17117671 0.52934537 CAIRO_HEPATOBLASTOMA_DN peptic ulcer DOID_750 0.01513343 0.06780254 0.17117671 0.52648405 CAIRO_HEPATOBLASTOMA_DN nephrotic syndrome DOID_1184 0.0179821 0.07993603 0.18587388 0.55958855 CAIRO_HEPATOBLASTOMA_DN Huntington's disease DOID_12858 0.0179821 0.07931638 0.0179821 0.18947801 CAIRO_HEPATOBLASTOMA_DN influenza DOID_8469 0.018727 0.08196664 0.1895075 0.56161339 CAIRO_HEPATOBLASTOMA_DN brain cancer DOID_1319 0.02103822 0.09137977 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN heart valve disease DOID_4079 0.02103822 0.0906875 0.02103822 0.21001316 CAIRO_HEPATOBLASTOMA_DN vascular skin disease DOID_9540 0.02103822 0.09000564 0.20031194 0.57275122 CAIRO_HEPATOBLASTOMA_DN central nervous system cancer DOID_3620 0.02183371 0.09271181 1.000 1.000 CAIRO_HEPATOBLASTOMA_DN calcium metabolism disease DOID_10575 0.02346156 0.09888612 0.02346156 0.22249377 CAIRO_HEPATOBLASTOMA_DN aortic aneurysm DOID_3627 0.02346156 0.09815902 1.000 1.000 KAYO_AGING_MUSCLE_UP hypersensitivity reaction type I disease DOID_1205 3.662E-09 2.084E-06 0.05213344 0.40635519 KAYO_AGING_MUSCLE_UP carotid artery disease DOID_3407 4.863E-09 1.384E-06 1.034E-04 0.01177149 KAYO_AGING_MUSCLE_UP bone development disease DOID_0080006 3.926E-08 7.446E-06 1.939E-05 0.01103294 KAYO_AGING_MUSCLE_UP encephalomyelitis DOID_640 1.709E-06 2.431E-04 0.05023668 0.42663689 KAYO_AGING_MUSCLE_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.818E-06 2.068E-04 5.813E-03 0.13781418 KAYO_AGING_MUSCLE_UP vasculitis DOID_865 2.545E-06 2.413E-04 0.19391786 0.77703707 KAYO_AGING_MUSCLE_UP osteochondrodysplasia DOID_2256 2.777E-06 2.257E-04 7.029E-05 0.01999832 KAYO_AGING_MUSCLE_UP melancholia DOID_2848 3.874E-06 2.755E-04 9.135E-05 0.01732604 KAYO_AGING_MUSCLE_UP neurotic disorder DOID_4964 4.195E-06 2.652E-04 9.726E-05 0.01383506 KAYO_AGING_MUSCLE_UP gestational diabetes DOID_11714 4.284E-06 2.437E-04 0.10383898 0.53713072 KAYO_AGING_MUSCLE_UP hypothyroidism DOID_1459 4.9E-06 2.535E-04 1.934E-03 0.11007073 KAYO_AGING_MUSCLE_UP focal glomerulosclerosis DOID_3945 5.642E-06 2.675E-04 6.115E-03 0.13383108 KAYO_AGING_MUSCLE_UP endocrine pancreas disease DOID_1428 5.695E-06 2.493E-04 1.000 1.000 KAYO_AGING_MUSCLE_UP cystic fibrosis DOID_1485 1.204E-05 4.894E-04 0.03520664 0.47696615 KAYO_AGING_MUSCLE_UP endogenous depression DOID_1595 1.204E-05 4.568E-04 2.229E-04 0.02114119 KAYO_AGING_MUSCLE_UP mental depression DOID_1596 1.832E-05 6.514E-04 3.101E-04 0.02520306 KAYO_AGING_MUSCLE_UP chronic kidney failure DOID_784 1.832E-05 6.131E-04 1.000 1.000 KAYO_AGING_MUSCLE_UP hyperinsulinism DOID_2018 2.8E-05 8.852E-04 1.000 1.000 KAYO_AGING_MUSCLE_UP integumentary system benign neoplasm DOID_0060121 4.565E-05 1.367E-03 1.014E-03 0.07214508 KAYO_AGING_MUSCLE_UP skin benign neoplasm DOID_3165 4.565E-05 1.367E-03 1.014E-03 0.07214508 KAYO_AGING_MUSCLE_UP lung small cell carcinoma DOID_5409 4.565E-05 1.299E-03 0.01656252 0.29450224 KAYO_AGING_MUSCLE_UP calcium metabolism disease DOID_10575 4.923E-05 1.334E-03 0.18162232 0.74347553 KAYO_AGING_MUSCLE_UP colonic disease DOID_5353 5.715E-05 1.478E-03 2.567E-03 0.10434782 KAYO_AGING_MUSCLE_UP atrophic muscular disease DOID_913 6.121E-05 1.514E-03 0.01904831 0.30967102 KAYO_AGING_MUSCLE_UP muscular dystrophy DOID_9884 6.121E-05 1.514E-03 0.01904831 0.30967102 KAYO_AGING_MUSCLE_UP respiratory failure DOID_11162 1.099E-04 2.606E-03 0.21796129 0.83234884 KAYO_AGING_MUSCLE_UP severe combined immunodeficiency DOID_627 1.137E-04 2.588E-03 4.004E-03 0.11391727 KAYO_AGING_MUSCLE_UP mineral metabolism disease DOID_0050032 1.237E-04 2.707E-03 0.22386003 0.83800234 KAYO_AGING_MUSCLE_UP combined T cell and B cell immunodeficiency DOID_628 1.282E-04 2.702E-03 4.327E-03 0.11724421 KAYO_AGING_MUSCLE_UP parasitic infectious disease DOID_1398 1.31E-04 2.663E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP temporal lobe epilepsy DOID_3328 1.387E-04 2.721E-03 0.02811229 0.42094454 KAYO_AGING_MUSCLE_UP morbid obesity DOID_11981 1.438E-04 2.728E-03 4.662E-03 0.12057053 KAYO_AGING_MUSCLE_UP spinal cord disease DOID_319 1.606E-04 2.949E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP blood coagulation disease DOID_1247 1.726E-04 3.069E-03 2.695E-03 0.10221862 KAYO_AGING_MUSCLE_UP peripheral vascular disease DOID_341 1.916E-04 3.304E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP diabetic retinopathy DOID_8947 2.017E-04 3.375E-03 0.24986227 0.91723635 KAYO_AGING_MUSCLE_UP polycystic ovary syndrome DOID_11612 2.186E-04 3.554E-03 0.1105921 0.55199038 KAYO_AGING_MUSCLE_UP multiple epiphyseal dysplasia DOID_12721 2.186E-04 3.455E-03 6.115E-03 0.13918433 KAYO_AGING_MUSCLE_UP syndrome DOID_225 2.229E-04 3.428E-03 0.03520664 0.46587391 KAYO_AGING_MUSCLE_UP dysostosis DOID_1934 2.406E-04 3.602E-03 6.507E-03 0.13712804 KAYO_AGING_MUSCLE_UP pancreatitis DOID_4989 2.457E-04 3.585E-03 0.26113938 0.94043231 KAYO_AGING_MUSCLE_UP abdominal aortic aneurysm DOID_7693 2.639E-04 3.754E-03 6.91E-03 0.14041565 KAYO_AGING_MUSCLE_UP metabolic syndrome X DOID_14221 2.702E-04 3.75E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP lipid metabolism disorder DOID_3146 2.702E-04 3.66E-03 0.03855892 0.41396278 KAYO_AGING_MUSCLE_UP focal epilepsy DOID_2234 3.101E-04 4.103E-03 0.0411498 0.41811141 KAYO_AGING_MUSCLE_UP retinal vascular disease DOID_2462 3.389E-04 4.382E-03 0.28047068 0.97906635 KAYO_AGING_MUSCLE_UP papilloma DOID_2615 3.425E-04 4.33E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP primary immunodeficiency disease DOID_612 4.022E-04 4.975E-03 5.01E-03 0.12395363 KAYO_AGING_MUSCLE_UP nervous system cancer DOID_3093 4.192E-04 5.075E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP Human immunodeficiency virus infectious disease DOID_526 4.192E-04 4.97E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP uveitis DOID_13141 5.043E-04 5.856E-03 0.01052211 0.19956944 KAYO_AGING_MUSCLE_UP peptic ulcer DOID_750 5.416E-04 6.164E-03 0.14684093 0.66311501 KAYO_AGING_MUSCLE_UP ulcerative colitis DOID_8577 5.748E-04 6.413E-03 0.31504878 1.000 KAYO_AGING_MUSCLE_UP adult respiratory distress syndrome DOID_11394 5.806E-04 6.354E-03 0.15006261 0.67232777 KAYO_AGING_MUSCLE_UP pulmonary emphysema DOID_9675 6.214E-04 6.671E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP brachydactyly DOID_0050581 6.233E-04 6.568E-03 0.03709039 0.43967569 KAYO_AGING_MUSCLE_UP interstitial nephritis DOID_1063 6.233E-04 6.448E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP insulinoma DOID_3892 6.233E-04 6.333E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP labyrinthine disease DOID_4539 6.233E-04 6.222E-03 0.03709039 0.42208867 KAYO_AGING_MUSCLE_UP uveal disease DOID_3480 7.083E-04 6.949E-03 0.01311909 0.24079872 KAYO_AGING_MUSCLE_UP uterine cancer DOID_363 7.545E-04 7.277E-03 0.16282897 0.69661415 KAYO_AGING_MUSCLE_UP breast benign neoplasm DOID_0060082 7.599E-04 7.207E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP thoracic benign neoplasm DOID_0060097 7.599E-04 7.207E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP benign breast phyllodes tumor DOID_1631 7.599E-04 7.207E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP inner ear disease DOID_2952 7.599E-04 7.089E-03 0.04072344 0.42130248 KAYO_AGING_MUSCLE_UP pre-eclampsia DOID_10591 9.046E-04 8.302E-03 0.17227861 0.72078328 KAYO_AGING_MUSCLE_UP brain cancer DOID_1319 9.046E-04 8.17E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP neuritis DOID_1803 9.046E-04 8.042E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP heart valve disease DOID_4079 9.046E-04 7.918E-03 0.17227861 0.71552209 KAYO_AGING_MUSCLE_UP vascular skin disease DOID_9540 9.046E-04 7.798E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP common cold DOID_10459 9.097E-04 7.725E-03 0.04434287 0.43501887 KAYO_AGING_MUSCLE_UP islet cell tumor DOID_1799 9.097E-04 7.612E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP central nervous system cancer DOID_3620 9.585E-04 7.904E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP aortic aneurysm DOID_3627 1.072E-03 8.716E-03 0.01716998 0.29605204 KAYO_AGING_MUSCLE_UP Hirschsprung's disease DOID_10487 1.072E-03 8.594E-03 0.04794875 0.42629431 KAYO_AGING_MUSCLE_UP essential hypertension DOID_10825 1.072E-03 8.475E-03 1.072E-03 0.06779951 KAYO_AGING_MUSCLE_UP hemorrhagic disease DOID_2213 1.132E-03 8.825E-03 0.01778682 0.29766758 KAYO_AGING_MUSCLE_UP Legionnaires' disease DOID_10457 1.248E-03 9.596E-03 0.05154111 0.43127779 KAYO_AGING_MUSCLE_UP legionellosis DOID_10458 1.248E-03 9.596E-03 0.05154111 0.43127779 KAYO_AGING_MUSCLE_UP tethered spinal cord syndrome DOID_1089 1.248E-03 9.468E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP megacolon DOID_11372 1.248E-03 9.344E-03 0.05154111 0.42502739 KAYO_AGING_MUSCLE_UP hypercalcemia DOID_12678 1.248E-03 9.223E-03 0.05154111 0.41895557 KAYO_AGING_MUSCLE_UP parasitic helminthiasis infectious disease DOID_883 1.248E-03 9.104E-03 1.000 1.000 KAYO_AGING_MUSCLE_UP integumentary system cancer DOID_0060122 1.393E-03 0.01003348 0.02034637 0.3215856 KAYO_AGING_MUSCLE_UP skin cancer DOID_4159 1.393E-03 0.01003348 0.02034637 0.3215856 KAYO_AGING_MUSCLE_UP hyperhomocysteinemia DOID_9279 1.436E-03 0.01021703 0.05512001 0.40731539 KAYO_AGING_MUSCLE_UP familial hyperlipidemia DOID_1168 1.464E-03 0.01028169 0.19999667 0.79026461 KAYO_AGING_MUSCLE_UP spastic diplegia DOID_10965 1.638E-03 0.01136367 0.0586855 0.42810319 KAYO_AGING_MUSCLE_UP neuroectodermal tumor DOID_171 1.85E-03 0.01268424 1.000 1.000 KAYO_AGING_MUSCLE_UP pre-malignant neoplasm DOID_0060071 2.021E-03 0.01369001 0.22091621 0.8380088 KAYO_AGING_MUSCLE_UP in situ carcinoma DOID_8719 2.021E-03 0.01369001 0.22091621 0.8380088 KAYO_AGING_MUSCLE_UP keratosis DOID_161 2.078E-03 0.01390837 2.078E-03 0.1074738 KAYO_AGING_MUSCLE_UP neuroendocrine tumor DOID_169 2.078E-03 0.01374665 1.000 1.000 KAYO_AGING_MUSCLE_UP inherited blood coagulation disease DOID_2214 2.078E-03 0.01358864 0.06577645 0.44031528 KAYO_AGING_MUSCLE_UP hyperglycemia DOID_4195 2.295E-03 0.01483957 0.02811229 0.41015109 KAYO_AGING_MUSCLE_UP granulosa cell tumor DOID_2999 2.316E-03 0.01480938 0.06930201 0.43332793 KAYO_AGING_MUSCLE_UP MHC class II deficiency DOID_5812 2.316E-03 0.01464483 2.316E-03 0.10983621 KAYO_AGING_MUSCLE_UP leishmaniasis DOID_9065 2.316E-03 0.0144839 1.000 1.000 KAYO_AGING_MUSCLE_UP limb-girdle muscular dystrophy DOID_11724 2.567E-03 0.01587902 2.567E-03 0.11237458 KAYO_AGING_MUSCLE_UP sex cord-gonadal stromal tumor DOID_192 2.567E-03 0.01570827 0.07281435 0.44075922 KAYO_AGING_MUSCLE_UP nephrosis DOID_2527 2.801E-03 0.01695417 0.03197513 0.44375241 KAYO_AGING_MUSCLE_UP Kawasaki disease DOID_13378 2.831E-03 0.01695434 1.000 1.000 KAYO_AGING_MUSCLE_UP lymphadenitis DOID_1602 2.831E-03 0.01695434 1.000 1.000 KAYO_AGING_MUSCLE_UP autoimmune hepatitis DOID_2048 2.831E-03 0.01677774 1.000 1.000 KAYO_AGING_MUSCLE_UP lymph node disease DOID_9942 2.831E-03 0.01695434 1.000 1.000 KAYO_AGING_MUSCLE_UP gastric ulcer DOID_10808 3.106E-03 0.01822021 0.0797996 0.47297891 KAYO_AGING_MUSCLE_UP neutropenia DOID_1227 3.106E-03 0.01803429 3.106E-03 0.11046 KAYO_AGING_MUSCLE_UP thrombophilia DOID_2452 3.106E-03 0.01785212 3.106E-03 0.10396236 KAYO_AGING_MUSCLE_UP muscular atrophy DOID_767 3.106E-03 0.0176736 0.0797996 0.46810284 KAYO_AGING_MUSCLE_UP aneurysm disease DOID_2403 3.37E-03 0.01898714 0.03603356 0.46597942 KAYO_AGING_MUSCLE_UP agranulocytosis DOID_12987 3.394E-03 0.01893047 3.394E-03 0.10727269 KAYO_AGING_MUSCLE_UP muscle cancer DOID_4045 3.394E-03 0.01874668 0.08327261 0.47860722 KAYO_AGING_MUSCLE_UP sleep disorder DOID_535 3.394E-03 0.01856643 3.394E-03 0.10162676 KAYO_AGING_MUSCLE_UP polyarteritis nodosa DOID_9810 3.394E-03 0.0183896 1.000 1.000 KAYO_AGING_MUSCLE_UP hypoglycemia DOID_9993 3.394E-03 0.01821612 1.000 1.000 KAYO_AGING_MUSCLE_UP bacterial pneumonia DOID_874 3.492E-03 0.0185698 0.26113938 0.93451764 KAYO_AGING_MUSCLE_UP synostosis DOID_11971 3.693E-03 0.01945606 0.0867326 0.48862225 KAYO_AGING_MUSCLE_UP Goodpasture syndrome DOID_9808 3.693E-03 0.01927756 1.000 1.000 KAYO_AGING_MUSCLE_UP female reproductive system disease DOID_229 3.873E-03 0.02003538 1.000 1.000 KAYO_AGING_MUSCLE_UP spastic quadriplegia DOID_10970 4.004E-03 0.02052563 0.09017962 0.49817672 KAYO_AGING_MUSCLE_UP acute pancreatitis DOID_2913 4.004E-03 0.02034237 1.000 1.000 KAYO_AGING_MUSCLE_UP biliary tract cancer DOID_4607 4.141E-03 0.02085139 0.0411498 0.41077612 KAYO_AGING_MUSCLE_UP spinal muscular atrophy DOID_12377 4.662E-03 0.023268 1.000 1.000 KAYO_AGING_MUSCLE_UP papillary adenoma DOID_3172 4.662E-03 0.02306567 1.000 1.000 KAYO_AGING_MUSCLE_UP microcystic adenoma DOID_5403 4.662E-03 0.02306567 1.000 1.000 KAYO_AGING_MUSCLE_UP follicular adenoma DOID_6204 4.662E-03 0.02306567 1.000 1.000 KAYO_AGING_MUSCLE_UP primary bacterial infectious disease DOID_0050338 4.709E-03 0.02310047 0.28590107 0.99193724 KAYO_AGING_MUSCLE_UP transitional cell carcinoma DOID_2671 4.859E-03 0.02362813 0.28860098 0.99523611 KAYO_AGING_MUSCLE_UP B cell deficiency DOID_2115 5.008E-03 0.02414884 0.10044335 0.53413333 KAYO_AGING_MUSCLE_UP amino acid metabolic disorder DOID_9252 5.01E-03 0.02395742 0.04652104 0.42016625 KAYO_AGING_MUSCLE_UP perinatal necrotizing enterocolitis DOID_8677 5.366E-03 0.02544258 1.000 1.000 KAYO_AGING_MUSCLE_UP carbohydrate metabolic disorder DOID_2978 5.647E-03 0.02655322 0.30194925 1.000 KAYO_AGING_MUSCLE_UP autoimmune disease of cardiovascular system DOID_0060051 5.735E-03 0.02674707 1.000 1.000 KAYO_AGING_MUSCLE_UP renal hypertension DOID_1073 5.735E-03 0.02652961 1.000 1.000 KAYO_AGING_MUSCLE_UP secondary hypertension DOID_11130 5.735E-03 0.02652961 1.000 1.000 KAYO_AGING_MUSCLE_UP Behcet's disease DOID_13241 5.735E-03 0.02674707 1.000 1.000 KAYO_AGING_MUSCLE_UP thrombocytopenia DOID_1588 5.735E-03 0.02631566 0.10722188 0.54472544 KAYO_AGING_MUSCLE_UP invasive ductal carcinoma DOID_3008 5.735E-03 0.02610514 1.000 1.000 KAYO_AGING_MUSCLE_UP endometrial carcinoma DOID_2871 6.507E-03 0.02938458 0.11394968 0.55894284 KAYO_AGING_MUSCLE_UP spastic cerebral palsy DOID_0050669 6.91E-03 0.03095778 0.11729468 0.56559893 KAYO_AGING_MUSCLE_UP endometrial cancer DOID_1380 7.324E-03 0.03255548 0.12062714 0.57678019 KAYO_AGING_MUSCLE_UP germinoma DOID_3304 7.324E-03 0.03230311 1.000 1.000 KAYO_AGING_MUSCLE_UP pleural disease DOID_1532 7.748E-03 0.03391383 1.000 1.000 KAYO_AGING_MUSCLE_UP bladder disease DOID_365 7.748E-03 0.03365494 0.1239471 0.58771586 KAYO_AGING_MUSCLE_UP esophageal disease DOID_6050 8.63E-03 0.03720217 1.000 1.000 KAYO_AGING_MUSCLE_UP leukopenia DOID_615 8.63E-03 0.03692245 8.63E-03 0.16933402 KAYO_AGING_MUSCLE_UP adenoma DOID_657 9.555E-03 0.04057397 1.000 1.000 KAYO_AGING_MUSCLE_UP pulmonary sarcoidosis DOID_13406 0.01003344 0.0422891 1.000 1.000 KAYO_AGING_MUSCLE_UP calcinosis DOID_182 0.01003344 0.04197815 1.000 1.000 KAYO_AGING_MUSCLE_UP multiple myeloma DOID_9538 0.01003344 0.04167174 1.000 1.000 KAYO_AGING_MUSCLE_UP blood platelet disease DOID_2218 0.01052211 0.04338466 0.14360713 0.65897142 KAYO_AGING_MUSCLE_UP systemic scleroderma DOID_418 0.01102114 0.04511531 1.000 1.000 KAYO_AGING_MUSCLE_UP lymphatic system disease DOID_75 0.01153043 0.04686297 1.000 1.000 KAYO_AGING_MUSCLE_UP cervix uteri carcinoma in situ DOID_8991 0.01204991 0.04862694 1.000 1.000 KAYO_AGING_MUSCLE_UP endometriosis of uterus DOID_288 0.01257949 0.05040654 1.000 1.000 KAYO_AGING_MUSCLE_UP rheumatic disease DOID_1575 0.01311909 0.05220112 1.000 1.000 KAYO_AGING_MUSCLE_UP idiopathic generalized epilepsy DOID_1827 0.01311909 0.05183861 0.15965534 0.69346481 KAYO_AGING_MUSCLE_UP endometriosis DOID_289 0.01311909 0.05148111 1.000 1.000 KAYO_AGING_MUSCLE_UP scleroderma DOID_419 0.01311909 0.05220112 1.000 1.000 KAYO_AGING_MUSCLE_UP gallbladder cancer DOID_3121 0.01366862 0.05327018 0.16282897 0.70189153 KAYO_AGING_MUSCLE_UP leukodystrophy DOID_10579 0.01479718 0.05727615 1.000 1.000 KAYO_AGING_MUSCLE_UP myeloma DOID_0070004 0.01537604 0.05911463 1.000 1.000 KAYO_AGING_MUSCLE_UP thyroid adenoma DOID_2891 0.01537604 0.05871789 1.000 1.000 KAYO_AGING_MUSCLE_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.01656252 0.06282715 1.000 1.000 KAYO_AGING_MUSCLE_UP pulmonary tuberculosis DOID_2957 0.01656252 0.06241107 1.000 1.000 KAYO_AGING_MUSCLE_UP sarcoidosis DOID_11335 0.01904831 0.07130583 1.000 1.000 KAYO_AGING_MUSCLE_UP bile duct adenocarcinoma DOID_4896 0.0196928 0.07323663 0.19391786 0.78254797 KAYO_AGING_MUSCLE_UP cholangiocarcinoma DOID_4947 0.0196928 0.07323663 0.19391786 0.78254797 KAYO_AGING_MUSCLE_UP bone marrow cancer DOID_4960 0.0196928 0.07276107 1.000 1.000 KAYO_AGING_MUSCLE_UP reproductive organ benign neoplasm DOID_0050622 0.02034637 0.07469085 1.000 1.000 KAYO_AGING_MUSCLE_UP parasitic protozoa infectious disease DOID_2789 0.02034637 0.07421206 1.000 1.000 KAYO_AGING_MUSCLE_UP hypersensitivity reaction type IV disease DOID_2916 0.02236068 0.08103967 1.000 1.000 KAYO_AGING_MUSCLE_UP bile duct cancer DOID_4606 0.02236068 0.08052676 0.20602995 0.79749008 KAYO_AGING_MUSCLE_UP bile duct carcinoma DOID_4897 0.02236068 0.08052676 0.20602995 0.79749008 KAYO_AGING_MUSCLE_UP leukocyte disease DOID_9500 0.02304974 0.08248619 0.02304974 0.3544677 KAYO_AGING_MUSCLE_UP collagen disease DOID_854 0.02445386 0.08696403 1.000 1.000 KAYO_AGING_MUSCLE_UP cholestasis DOID_13580 0.02736396 0.09670867 1.000 1.000 KAYO_AGING_MUSCLE_UP cerebral degeneration DOID_1443 0.02736396 0.0961117 1.000 1.000 KAYO_AGING_MUSCLE_UP uterine disease DOID_345 0.02736396 0.09552206 1.000 1.000 CHANG_IMMORTALIZED_BY_HPV31_UP neuroectodermal tumor DOID_171 7.135E-07 4.06E-04 7.135E-07 4.06E-04 CHANG_IMMORTALIZED_BY_HPV31_UP endocrine organ benign neoplasm DOID_0060089 1.085E-06 3.087E-04 1.085E-06 3.087E-04 CHANG_IMMORTALIZED_BY_HPV31_UP pancreatic ductal carcinoma DOID_3587 1.214E-06 2.302E-04 1.214E-06 2.302E-04 CHANG_IMMORTALIZED_BY_HPV31_UP pancreatic carcinoma DOID_4905 1.427E-06 2.03E-04 1.427E-06 2.03E-04 CHANG_IMMORTALIZED_BY_HPV31_UP biliary tract cancer DOID_4607 2.237E-06 2.545E-04 2.237E-06 2.545E-04 CHANG_IMMORTALIZED_BY_HPV31_UP primitive neuroectodermal tumor DOID_168 1.725E-05 1.636E-03 1.725E-05 1.636E-03 CHANG_IMMORTALIZED_BY_HPV31_UP thyroid adenoma DOID_2891 2.221E-05 1.805E-03 2.221E-05 1.805E-03 CHANG_IMMORTALIZED_BY_HPV31_UP giant cell tumor DOID_200 3.127E-05 2.224E-03 3.127E-05 2.224E-03 CHANG_IMMORTALIZED_BY_HPV31_UP malignant giant cell tumor DOID_2705 3.127E-05 2.224E-03 3.127E-05 2.224E-03 CHANG_IMMORTALIZED_BY_HPV31_UP giant cell glioblastoma DOID_3074 3.127E-05 2.224E-03 3.127E-05 2.224E-03 CHANG_IMMORTALIZED_BY_HPV31_UP bile duct adenocarcinoma DOID_4896 3.298E-05 2.085E-03 3.298E-05 2.085E-03 CHANG_IMMORTALIZED_BY_HPV31_UP cholangiocarcinoma DOID_4947 3.298E-05 2.085E-03 3.298E-05 2.085E-03 CHANG_IMMORTALIZED_BY_HPV31_UP glioblastoma DOID_3068 4.045E-05 2.302E-03 4.045E-05 2.302E-03 CHANG_IMMORTALIZED_BY_HPV31_UP bile duct cancer DOID_4606 4.045E-05 2.092E-03 4.045E-05 2.092E-03 CHANG_IMMORTALIZED_BY_HPV31_UP bile duct carcinoma DOID_4897 4.045E-05 2.092E-03 4.045E-05 2.092E-03 CHANG_IMMORTALIZED_BY_HPV31_UP adrenal gland hyperfunction DOID_3947 5.107E-05 2.422E-03 0.01076359 0.16117066 CHANG_IMMORTALIZED_BY_HPV31_UP cholestasis DOID_13580 5.603E-05 2.452E-03 2.485E-03 0.05437438 CHANG_IMMORTALIZED_BY_HPV31_UP astrocytoma DOID_3069 6.648E-05 2.702E-03 6.648E-05 3.152E-03 CHANG_IMMORTALIZED_BY_HPV31_UP bile duct disease DOID_4138 7.215E-05 2.737E-03 2.934E-03 0.05962122 CHANG_IMMORTALIZED_BY_HPV31_UP pituitary gland disease DOID_53 7.48E-05 2.66E-03 0.01290271 0.17073584 CHANG_IMMORTALIZED_BY_HPV31_UP biliary tract disease DOID_9741 7.51E-05 2.514E-03 3.012E-03 0.05910208 CHANG_IMMORTALIZED_BY_HPV31_UP adrenal cortex disease DOID_3952 1.188E-04 3.754E-03 0.01610292 0.18325125 CHANG_IMMORTALIZED_BY_HPV31_UP adrenal gland disease DOID_9553 1.536E-04 4.6E-03 0.01823077 0.18860561 CHANG_IMMORTALIZED_BY_HPV31_UP mouth disease DOID_403 1.564E-04 4.45E-03 1.564E-04 6.846E-03 CHANG_IMMORTALIZED_BY_HPV31_UP funisitis DOID_0050698 2.6E-04 7.045E-03 2.6E-04 0.01056734 CHANG_IMMORTALIZED_BY_HPV31_UP middle cerebral artery infarction DOID_3525 4.237E-04 0.01095886 0.02985393 0.2326971 CHANG_IMMORTALIZED_BY_HPV31_UP thyroid carcinoma DOID_3963 7.42E-04 0.01835551 7.42E-04 0.02814512 CHANG_IMMORTALIZED_BY_HPV31_UP medullomyoblastoma DOID_3861 7.826E-04 0.01855525 7.826E-04 0.02783288 CHANG_IMMORTALIZED_BY_HPV31_UP adult medulloblastoma DOID_3864 7.826E-04 0.01855525 7.826E-04 0.02783288 CHANG_IMMORTALIZED_BY_HPV31_UP childhood medulloblastoma DOID_3869 7.826E-04 0.01855525 7.826E-04 0.02783288 CHANG_IMMORTALIZED_BY_HPV31_UP thyroid cancer DOID_1781 8.244E-04 0.01876306 8.244E-04 0.02759274 CHANG_IMMORTALIZED_BY_HPV31_UP adenoma DOID_657 8.244E-04 0.01804141 8.244E-04 0.02605981 CHANG_IMMORTALIZED_BY_HPV31_UP medulloblastoma DOID_3858 8.672E-04 0.01827507 8.672E-04 0.02596984 CHANG_IMMORTALIZED_BY_HPV31_UP intracranial arterial disease DOID_13089 1.002E-03 0.02035947 0.04548758 0.26410646 CHANG_IMMORTALIZED_BY_HPV31_UP cerebral arterial disease DOID_3527 1.002E-03 0.02035947 0.04548758 0.26410646 CHANG_IMMORTALIZED_BY_HPV31_UP gallbladder cancer DOID_3121 1.196E-03 0.02346799 1.196E-03 0.03402859 CHANG_IMMORTALIZED_BY_HPV31_UP cerebral infarction DOID_3526 1.247E-03 0.02365588 0.05064397 0.26931232 CHANG_IMMORTALIZED_BY_HPV31_UP pre-eclampsia DOID_10591 1.353E-03 0.02482741 1.353E-03 0.03664999 CHANG_IMMORTALIZED_BY_HPV31_UP central nervous system cancer DOID_3620 1.407E-03 0.02501614 1.407E-03 0.03638711 CHANG_IMMORTALIZED_BY_HPV31_UP pulmonary tuberculosis DOID_2957 1.462E-03 0.02521115 1.462E-03 0.03617252 CHANG_IMMORTALIZED_BY_HPV31_UP pustulosis of palm and sole DOID_4398 1.815E-03 0.03037914 1.815E-03 0.04303712 CHANG_IMMORTALIZED_BY_HPV31_UP familial hyperlipidemia DOID_1168 1.878E-03 0.03052577 1.878E-03 0.04273608 CHANG_IMMORTALIZED_BY_HPV31_UP collagen disease DOID_854 2.205E-03 0.03484887 0.06696245 0.31230847 CHANG_IMMORTALIZED_BY_HPV31_UP brain infarction DOID_3454 2.705E-03 0.04159572 0.07401543 0.32647116 CHANG_IMMORTALIZED_BY_HPV31_UP tuberculosis DOID_399 2.705E-03 0.0405011 2.705E-03 0.05700155 CHANG_IMMORTALIZED_BY_HPV31_UP lipid metabolism disorder DOID_3146 3.588E-03 0.05234399 3.588E-03 0.06804719 CHANG_IMMORTALIZED_BY_HPV31_UP alcohol abuse DOID_1574 3.849E-03 0.0547497 0.08796569 0.36008978 CHANG_IMMORTALIZED_BY_HPV31_UP primary bacterial infectious disease DOID_0050338 4.21E-03 0.05843153 4.21E-03 0.07728041 CHANG_IMMORTALIZED_BY_HPV31_UP nervous system cancer DOID_3093 4.491E-03 0.06084848 4.491E-03 0.07986362 CHANG_IMMORTALIZED_BY_HPV31_UP lymphoma DOID_0060058 4.684E-03 0.06197547 4.684E-03 0.08075591 ROVERSI_GLIOMA_COPY_NUMBER_UP carotid artery disease DOID_3407 6.189E-05 0.03521645 0.07325403 0.54844136 ROVERSI_GLIOMA_COPY_NUMBER_UP chronic monocytic leukemia DOID_8593 7.526E-05 0.02141091 7.526E-05 0.04282183 ROVERSI_GLIOMA_COPY_NUMBER_UP carotid stenosis DOID_13001 1.066E-04 0.02021246 1.000 1.000 ROVERSI_GLIOMA_COPY_NUMBER_UP monocytic leukemia DOID_8527 1.066E-04 0.01515935 1.066E-04 0.03031869 ROVERSI_GLIOMA_COPY_NUMBER_UP biliary tract cancer DOID_4607 1.442E-04 0.0164088 4.62E-03 0.43811814 ROVERSI_GLIOMA_COPY_NUMBER_UP familial hypertrophic cardiomyopathy DOID_11986 1.853E-04 0.01756793 1.853E-04 0.03513586 ROVERSI_GLIOMA_COPY_NUMBER_UP amyloidosis DOID_9120 2.582E-04 0.0209896 0.02347983 0.49481561 ROVERSI_GLIOMA_COPY_NUMBER_UP spastic quadriplegia DOID_10970 4.062E-04 0.02888947 1.000 1.000 ROVERSI_GLIOMA_COPY_NUMBER_UP spastic cerebral palsy DOID_0050669 7.106E-04 0.04492382 1.000 1.000 ROVERSI_GLIOMA_COPY_NUMBER_UP age related macular degeneration DOID_10871 7.106E-04 0.04043144 0.03845173 0.49725083 ROVERSI_GLIOMA_COPY_NUMBER_UP degeneration of macula and posterior pole DOID_2007 7.106E-04 0.04043144 0.03845173 0.49725083 ROVERSI_GLIOMA_COPY_NUMBER_UP macular degeneration DOID_4448 8.936E-04 0.04622276 0.04301315 0.50988505 ROVERSI_GLIOMA_COPY_NUMBER_UP lymphatic system disease DOID_75 1.206E-03 0.05718935 0.04981563 0.52490913 ROVERSI_GLIOMA_COPY_NUMBER_UP gallbladder cancer DOID_3121 1.44E-03 0.06300588 0.05432433 0.52390748 ROVERSI_GLIOMA_COPY_NUMBER_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.759E-03 0.07149528 0.05993079 0.56834363 ROVERSI_GLIOMA_COPY_NUMBER_UP familial hyperlipidemia DOID_1168 2.258E-03 0.08565053 0.06772527 0.57515937 ROVERSI_GLIOMA_COPY_NUMBER_UP congenital nervous system abnormality DOID_2490 2.334E-03 0.08300371 0.06883359 0.57597523 ROVERSI_GLIOMA_COPY_NUMBER_UP hypertrophic cardiomyopathy DOID_11984 2.411E-03 0.0807085 2.411E-03 0.34301112 ROVERSI_GLIOMA_COPY_NUMBER_UP bile duct cancer DOID_4606 2.411E-03 0.07622469 0.06994063 0.56051014 ROVERSI_GLIOMA_COPY_NUMBER_UP bile duct carcinoma DOID_4897 2.411E-03 0.07622469 0.06994063 0.56051014 ROVERSI_GLIOMA_COPY_NUMBER_UP temporal lobe epilepsy DOID_3328 3.073E-03 0.0920186 0.07875073 0.55319956 ROVERSI_GLIOMA_COPY_NUMBER_UP brain infarction DOID_3454 3.25E-03 0.09245787 0.08094047 0.55488106 ROVERSI_GLIOMA_COPY_NUMBER_UP nephrosis DOID_2527 3.524E-03 0.09549319 0.08421555 0.56374877 WINTER_HYPOXIA_UP carbohydrate metabolic disorder DOID_2978 1.822E-09 1.037E-06 1.822E-09 1.037E-06 WINTER_HYPOXIA_UP giant cell tumor DOID_200 6.651E-07 1.892E-04 4.43E-05 6.301E-03 WINTER_HYPOXIA_UP malignant giant cell tumor DOID_2705 6.651E-07 1.892E-04 4.43E-05 6.301E-03 WINTER_HYPOXIA_UP giant cell glioblastoma DOID_3074 6.651E-07 1.892E-04 4.43E-05 6.301E-03 WINTER_HYPOXIA_UP glioblastoma DOID_3068 9.408E-07 1.784E-04 5.727E-05 6.517E-03 WINTER_HYPOXIA_UP astrocytoma DOID_3069 1.837E-06 2.613E-04 9.402E-05 8.916E-03 WINTER_HYPOXIA_UP glycogen metabolism disorder DOID_0050728 2.911E-06 3.312E-04 2.911E-06 8.281E-04 WINTER_HYPOXIA_UP glycogen storage disease DOID_2747 2.911E-06 3.312E-04 2.911E-06 8.281E-04 WINTER_HYPOXIA_UP hemolytic anemia DOID_583 3.342E-05 3.169E-03 3.342E-05 6.339E-03 WINTER_HYPOXIA_UP normocytic anemia DOID_720 3.342E-05 3.169E-03 3.342E-05 6.339E-03 WINTER_HYPOXIA_UP respiratory failure DOID_11162 6.927E-05 5.631E-03 2.854E-03 0.1248979 WINTER_HYPOXIA_UP pancreatic ductal carcinoma DOID_3587 9.797E-05 6.968E-03 3.583E-03 0.13592325 WINTER_HYPOXIA_UP pancreatic carcinoma DOID_4905 1.105E-04 6.983E-03 3.877E-03 0.13787377 WINTER_HYPOXIA_UP intermediate coronary syndrome DOID_8805 1.497E-04 8.519E-03 1.497E-04 0.01216989 WINTER_HYPOXIA_UP nervous system cancer DOID_3093 1.946E-04 0.01006832 5.625E-03 0.14547508 WINTER_HYPOXIA_UP pulmonary edema DOID_11396 2.699E-04 0.01279643 0.0239956 0.27864283 WINTER_HYPOXIA_UP brain edema DOID_4724 2.699E-04 0.01181209 0.0239956 0.26771566 WINTER_HYPOXIA_UP funisitis DOID_0050698 3.276E-04 0.01331462 3.276E-04 0.02330059 WINTER_HYPOXIA_UP systemic scleroderma DOID_418 1.202E-03 0.04560879 0.04974035 0.27747313 WINTER_HYPOXIA_UP peptic ulcer DOID_750 1.202E-03 0.04275824 0.04974035 0.27477921 WINTER_HYPOXIA_UP lymphatic system disease DOID_75 1.26E-03 0.04217357 0.05089464 0.2731986 WINTER_HYPOXIA_UP rheumatic disease DOID_1575 1.441E-03 0.04554746 0.0543493 0.28634029 WINTER_HYPOXIA_UP scleroderma DOID_419 1.441E-03 0.04554746 0.0543493 0.28634029 WINTER_HYPOXIA_UP pre-eclampsia DOID_10591 1.7E-03 0.05091419 0.05893638 0.29160696 WINTER_HYPOXIA_UP brain cancer DOID_1319 1.7E-03 0.04836848 0.05893638 0.28662222 WINTER_HYPOXIA_UP central nervous system cancer DOID_3620 1.768E-03 0.04790847 0.06007974 0.28487812 WINTER_HYPOXIA_UP integumentary system cancer DOID_0060122 2.28E-03 0.05896955 2.28E-03 0.14414779 WINTER_HYPOXIA_UP parasitic protozoa infectious disease DOID_2789 2.28E-03 0.05640566 2.28E-03 0.12973301 WINTER_HYPOXIA_UP skin cancer DOID_4159 2.28E-03 0.05896955 2.28E-03 0.14414779 WINTER_HYPOXIA_UP familial hyperlipidemia DOID_1168 2.358E-03 0.05590899 2.358E-03 0.12198326 WINTER_HYPOXIA_UP carotid artery disease DOID_3407 2.768E-03 0.06299705 2.768E-03 0.13124386 WINTER_HYPOXIA_UP collagen disease DOID_854 2.768E-03 0.06057409 0.07482039 0.32498322 WINTER_HYPOXIA_UP parasitic infectious disease DOID_1398 3.118E-03 0.06570851 3.118E-03 0.12672355 WINTER_HYPOXIA_UP temporal lobe epilepsy DOID_3328 3.209E-03 0.06520294 0.08042944 0.34409288 WINTER_HYPOXIA_UP diabetic retinopathy DOID_8947 3.877E-03 0.07606828 0.08822627 0.35857676 WINTER_HYPOXIA_UP cystic fibrosis DOID_1485 4.079E-03 0.07736105 4.079E-03 0.13651951 WINTER_HYPOXIA_UP bone resorption disease DOID_0080011 4.182E-03 0.07675101 4.182E-03 0.1321823 WINTER_HYPOXIA_UP osteoporosis DOID_11476 4.182E-03 0.07675101 4.182E-03 0.1321823 WINTER_HYPOXIA_UP lipid metabolism disorder DOID_3146 4.497E-03 0.0799596 4.497E-03 0.1346688 WINTER_HYPOXIA_UP focal epilepsy DOID_2234 4.823E-03 0.08315796 0.09815578 0.37993634 WINTER_HYPOXIA_UP chronic kidney failure DOID_784 4.823E-03 0.08071214 4.823E-03 0.13721063 WINTER_HYPOXIA_UP retinal vascular disease DOID_2462 5.046E-03 0.08203539 0.10034794 0.38320789 WINTER_HYPOXIA_UP transitional cell carcinoma DOID_2671 5.39E-03 0.08518827 5.39E-03 0.14603704 WINTER_HYPOXIA_UP Crohn's disease DOID_8778 6.108E-03 0.09393774 0.11014828 0.40963642 WINTER_HYPOXIA_UP ulcerative colitis DOID_8577 6.611E-03 0.09898375 0.11447039 0.41752342 SANCHEZ_MDM2_TARGETS transitional cell carcinoma DOID_2671 4.497E-07 2.559E-04 0.01650128 0.44710612 SANCHEZ_MDM2_TARGETS bronchiolitis obliterans DOID_2799 1.539E-05 4.378E-03 6.078E-03 0.43228419 SANCHEZ_MDM2_TARGETS papilloma DOID_2615 1.836E-05 3.481E-03 1.000 1.000 SANCHEZ_MDM2_TARGETS pre-eclampsia DOID_10591 3.565E-05 5.071E-03 9.196E-03 0.47570603 SANCHEZ_MDM2_TARGETS reproductive organ benign neoplasm DOID_0050622 4.807E-05 5.47E-03 0.01066111 0.43329778 SANCHEZ_MDM2_TARGETS pre-malignant neoplasm DOID_0060071 6.233E-05 5.911E-03 0.01212393 0.45990103 SANCHEZ_MDM2_TARGETS in situ carcinoma DOID_8719 6.233E-05 5.911E-03 0.01212393 0.45990103 SANCHEZ_MDM2_TARGETS mouth disease DOID_403 1.322E-04 0.01074281 0.01759302 0.45501939 SANCHEZ_MDM2_TARGETS invasive lobular carcinoma DOID_3457 2.029E-03 0.09623052 1.000 1.000 SANCHEZ_MDM2_TARGETS common cold DOID_10459 2.214E-03 0.09689579 1.000 1.000 SANCHEZ_MDM2_TARGETS diarrhea DOID_13250 2.214E-03 0.08997466 1.000 1.000 SANCHEZ_MDM2_TARGETS aortic valve insufficiency DOID_57 2.214E-03 0.08397635 2.214E-03 1.000 SANCHEZ_MDM2_TARGETS parathyroid gland disease DOID_11201 2.398E-03 0.08528173 1.000 1.000 SANCHEZ_MDM2_TARGETS hemangioma DOID_255 2.767E-03 0.09259899 1.000 1.000 SANCHEZ_MDM2_TARGETS oral submucous fibrosis DOID_5773 2.767E-03 0.0874546 2.767E-03 0.78709144 SANCHEZ_MDM2_TARGETS varicose veins DOID_799 2.767E-03 0.08285173 2.767E-03 0.52472763 SANCHEZ_MDM2_TARGETS angiosarcoma DOID_0001816 2.951E-03 0.08394978 1.000 1.000 SANCHEZ_MDM2_TARGETS silicosis DOID_10325 2.951E-03 0.07995217 1.000 1.000 SANCHEZ_MDM2_TARGETS hemolytic-uremic syndrome DOID_12554 2.951E-03 0.07631798 1.000 1.000 SANCHEZ_MDM2_TARGETS vein disease DOID_866 2.951E-03 0.07299981 2.951E-03 0.41974889 SANCHEZ_MDM2_TARGETS urinary system benign neoplasm DOID_731 3.135E-03 0.07432465 1.000 1.000 SANCHEZ_MDM2_TARGETS male reproductive organ benign neoplasm DOID_0060087 3.319E-03 0.07554284 1.000 1.000 SANCHEZ_MDM2_TARGETS ureteral obstruction DOID_5199 3.319E-03 0.07263735 1.000 1.000 SANCHEZ_MDM2_TARGETS colon carcinoma DOID_1520 3.687E-03 0.07770668 1.000 1.000 SANCHEZ_MDM2_TARGETS alopecia DOID_987 3.687E-03 0.07493144 1.000 1.000 SANCHEZ_MDM2_TARGETS funisitis DOID_0050698 4.055E-03 0.07956976 1.000 1.000 SANCHEZ_MDM2_TARGETS IgA glomerulonephritis DOID_2986 4.239E-03 0.08040732 1.000 1.000 SANCHEZ_MDM2_TARGETS urinary tract obstruction DOID_5200 4.239E-03 0.07781354 1.000 1.000 SANCHEZ_MDM2_TARGETS ureteral disease DOID_1426 4.423E-03 0.07865311 1.000 1.000 SANCHEZ_MDM2_TARGETS aortic valve disease DOID_62 4.423E-03 0.07626969 4.423E-03 0.50337992 SANCHEZ_MDM2_TARGETS Goodpasture syndrome DOID_9808 4.423E-03 0.07402646 1.000 1.000 SANCHEZ_MDM2_TARGETS acute pancreatitis DOID_2913 4.607E-03 0.0749018 1.000 1.000 SANCHEZ_MDM2_TARGETS bronchiolitis DOID_2942 4.791E-03 0.07572805 1.000 1.000 SANCHEZ_MDM2_TARGETS morbid obesity DOID_11981 4.975E-03 0.07650919 1.000 1.000 SANCHEZ_MDM2_TARGETS myositis DOID_633 4.975E-03 0.07449579 1.000 1.000 SANCHEZ_MDM2_TARGETS intracranial aneurysm DOID_10941 5.159E-03 0.07526804 5.159E-03 0.48924229 SANCHEZ_MDM2_TARGETS hypotrichosis DOID_4535 5.159E-03 0.07338634 1.000 1.000 SANCHEZ_MDM2_TARGETS periodontitis DOID_824 5.343E-03 0.07414758 1.000 1.000 SANCHEZ_MDM2_TARGETS pleurisy DOID_10247 5.527E-03 0.07487217 1.000 1.000 SANCHEZ_MDM2_TARGETS renal hypertension DOID_1073 5.527E-03 0.07313096 1.000 1.000 SANCHEZ_MDM2_TARGETS secondary hypertension DOID_11130 5.527E-03 0.07313096 1.000 1.000 SANCHEZ_MDM2_TARGETS sarcoma DOID_1115 5.527E-03 0.07146889 1.000 1.000 SANCHEZ_MDM2_TARGETS female reproductive organ benign neoplasm DOID_0060086 5.894E-03 0.07452762 5.894E-03 0.4791061 SANCHEZ_MDM2_TARGETS uterine benign neoplasm DOID_0060095 5.894E-03 0.07452762 5.894E-03 0.4791061 SANCHEZ_MDM2_TARGETS uterine fibroid DOID_13223 5.894E-03 0.07452762 5.894E-03 0.4791061 SANCHEZ_MDM2_TARGETS leiomyoma DOID_127 6.445E-03 0.0797236 6.445E-03 0.40747617 SANCHEZ_MDM2_TARGETS pleural disease DOID_1532 6.445E-03 0.07802735 1.000 1.000 SANCHEZ_MDM2_TARGETS hair disease DOID_421 6.629E-03 0.07857847 1.000 1.000 SANCHEZ_MDM2_TARGETS pneumoconiosis DOID_10316 6.812E-03 0.07910676 1.000 1.000 SANCHEZ_MDM2_TARGETS periodontal disease DOID_3388 6.812E-03 0.07752463 1.000 1.000 SANCHEZ_MDM2_TARGETS pulmonary sarcoidosis DOID_13406 7.363E-03 0.08214757 1.000 1.000 SANCHEZ_MDM2_TARGETS calcinosis DOID_182 7.363E-03 0.08056781 7.363E-03 0.41895259 SANCHEZ_MDM2_TARGETS multiple myeloma DOID_9538 7.363E-03 0.07904766 1.000 1.000 SANCHEZ_MDM2_TARGETS adult respiratory distress syndrome DOID_11394 7.913E-03 0.08338281 1.000 1.000 SANCHEZ_MDM2_TARGETS adenoid cystic carcinoma DOID_4866 7.913E-03 0.08186676 1.000 1.000 SANCHEZ_MDM2_TARGETS cervix uteri carcinoma in situ DOID_8991 8.097E-03 0.08226822 1.000 1.000 SANCHEZ_MDM2_TARGETS salivary gland cancer DOID_8850 8.28E-03 0.08265531 1.000 1.000 SANCHEZ_MDM2_TARGETS nephrotic syndrome DOID_1184 8.463E-03 0.08302877 1.000 1.000 SANCHEZ_MDM2_TARGETS influenza DOID_8469 8.647E-03 0.08338928 1.000 1.000 SANCHEZ_MDM2_TARGETS proteinuria DOID_576 9.013E-03 0.08547528 1.000 1.000 SANCHEZ_MDM2_TARGETS myeloma DOID_0070004 9.196E-03 0.08578305 1.000 1.000 SANCHEZ_MDM2_TARGETS brain cancer DOID_1319 9.196E-03 0.08439946 1.000 1.000 SANCHEZ_MDM2_TARGETS heart valve disease DOID_4079 9.196E-03 0.08305978 9.196E-03 0.43606386 SANCHEZ_MDM2_TARGETS central nervous system cancer DOID_3620 9.38E-03 0.08339062 1.000 1.000 SANCHEZ_MDM2_TARGETS hemolytic anemia DOID_583 9.38E-03 0.08210768 1.000 1.000 SANCHEZ_MDM2_TARGETS normocytic anemia DOID_720 9.38E-03 0.08210768 1.000 1.000 SANCHEZ_MDM2_TARGETS pulmonary tuberculosis DOID_2957 9.563E-03 0.08244267 1.000 1.000 SANCHEZ_MDM2_TARGETS calcium metabolism disease DOID_10575 9.746E-03 0.0827674 9.746E-03 0.42657047 SANCHEZ_MDM2_TARGETS sarcoidosis DOID_11335 0.01029511 0.08614584 1.000 1.000 SANCHEZ_MDM2_TARGETS atrophic muscular disease DOID_913 0.01029511 0.08489735 1.000 1.000 SANCHEZ_MDM2_TARGETS muscular dystrophy DOID_9884 0.01029511 0.08489735 1.000 1.000 SANCHEZ_MDM2_TARGETS bone marrow cancer DOID_4960 0.01047812 0.08517216 1.000 1.000 SANCHEZ_MDM2_TARGETS hypersensitivity reaction type IV disease DOID_2916 0.01120988 0.08983694 1.000 1.000 SANCHEZ_MDM2_TARGETS oral cavity cancer DOID_8618 0.01120988 0.0885892 1.000 1.000 SANCHEZ_MDM2_TARGETS respiratory failure DOID_11162 0.01194118 0.09307575 1.000 1.000 SANCHEZ_MDM2_TARGETS mineral metabolism disease DOID_0050032 0.01230665 0.09462817 0.01230665 0.43765528 SANCHEZ_MDM2_TARGETS cholestasis DOID_13580 0.01248934 0.09475249 0.01248934 0.41802571 SANCHEZ_MDM2_TARGETS temporal lobe epilepsy DOID_3328 0.01267201 0.09487333 1.000 1.000 SANCHEZ_MDM2_TARGETS hyperglycemia DOID_4195 0.01267201 0.09364121 1.000 1.000 SANCHEZ_MDM2_TARGETS tooth disease DOID_1091 0.01285464 0.09377299 1.000 1.000 SANCHEZ_MDM2_TARGETS tuberculosis DOID_399 0.01303725 0.09390122 1.000 1.000 SANCHEZ_MDM2_TARGETS nephrosis DOID_2527 0.0135849 0.09662258 1.000 1.000 SANCHEZ_MDM2_TARGETS bile duct disease DOID_4138 0.0135849 0.09542971 0.0135849 0.42943371 SANCHEZ_MDM2_TARGETS male reproductive system disease DOID_48 0.0135849 0.09426594 1.000 1.000 SANCHEZ_MDM2_TARGETS biliary tract disease DOID_9741 0.01376739 0.09438125 0.01376739 0.41229705 SANCHEZ_MDM2_TARGETS cystic fibrosis DOID_1485 0.01431469 0.09696497 1.000 1.000 SANCHEZ_MDM2_TARGETS aneurysm disease DOID_2403 0.01449706 0.09704504 0.01449706 0.41244142 SANCHEZ_MDM2_TARGETS pancreatitis DOID_4989 0.01467941 0.09712306 1.000 1.000 SANCHEZ_MDM2_TARGETS bacterial pneumonia DOID_874 0.01467941 0.09600671 1.000 1.000 SANCHEZ_MDM2_TARGETS chronic kidney failure DOID_784 0.01559071 0.09967541 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP mesenchymal cell neoplasm DOID_3350 3.746E-10 2.131E-07 5.896E-05 0.03354732 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP spindle cell sarcoma DOID_4235 3.746E-10 2.131E-07 5.896E-05 0.03354732 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP epithelioid sarcoma DOID_6193 3.746E-10 2.131E-07 5.896E-05 0.03354732 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP sarcoma DOID_1115 7.461E-09 2.123E-06 2.425E-04 0.06899797 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP neuroectodermal tumor DOID_171 1.699E-07 3.222E-05 1.106E-03 0.0786642 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP transitional cell carcinoma DOID_2671 6.739E-07 9.587E-05 0.06662927 0.67700093 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP nephroblastoma DOID_2154 3.072E-06 3.496E-04 0.02792996 0.54800507 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP medullomyoblastoma DOID_3861 3.334E-06 3.162E-04 3.905E-04 0.07405649 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP adult medulloblastoma DOID_3864 3.334E-06 3.162E-04 3.905E-04 0.07405649 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP childhood medulloblastoma DOID_3869 3.334E-06 3.162E-04 3.905E-04 0.07405649 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP medulloblastoma DOID_3858 3.901E-06 3.171E-04 4.328E-04 0.06156753 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP embryonal cancer DOID_688 3.901E-06 2.774E-04 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP primitive neuroectodermal tumor DOID_168 5.975E-06 3.777E-04 5.727E-04 0.06517062 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP giant cell tumor DOID_200 1.085E-05 6.176E-04 8.481E-04 0.08042524 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP malignant giant cell tumor DOID_2705 1.085E-05 6.176E-04 8.481E-04 0.08042524 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP giant cell glioblastoma DOID_3074 1.085E-05 6.176E-04 8.481E-04 0.08042524 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP bile duct adenocarcinoma DOID_4896 1.145E-05 5.924E-04 0.04271207 0.5927602 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP cholangiocarcinoma DOID_4947 1.145E-05 5.924E-04 0.04271207 0.5927602 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP reproductive organ benign neoplasm DOID_0050622 1.207E-05 5.723E-04 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP glioblastoma DOID_3068 1.406E-05 6.153E-04 1.005E-03 0.0817235 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP bile duct cancer DOID_4606 1.406E-05 5.713E-04 0.04564234 0.59023838 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP bile duct carcinoma DOID_4897 1.406E-05 5.713E-04 0.04564234 0.59023838 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP astrocytoma DOID_3069 2.316E-05 8.786E-04 1.397E-03 0.08831799 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP rectal neoplasm DOID_1984 2.533E-05 9.007E-04 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP rectum cancer DOID_1993 2.533E-05 9.007E-04 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP mixed glioma DOID_5076 3.178E-05 1.064E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP biliary tract cancer DOID_4607 3.81E-05 1.205E-03 0.0630429 0.66428539 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP Leydig cell tumor DOID_2696 4.384E-05 1.313E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP sex cord-stromal neoplasm DOID_4757 4.384E-05 1.313E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP nervous system cancer DOID_3093 4.827E-05 1.373E-03 0.0680601 0.67940693 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP seminoma DOID_4440 2.109E-04 5.716E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP endometrial carcinoma DOID_2871 2.763E-04 7.145E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP endometrial cancer DOID_1380 3.122E-04 7.723E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP germinoma DOID_3304 3.122E-04 7.401E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP autonomic nervous system neoplasm DOID_2621 3.309E-04 7.532E-03 0.02643969 0.53729217 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP neuroblastoma DOID_769 3.309E-04 7.532E-03 0.02643969 0.53729217 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP spindle cell carcinoma DOID_4015 3.701E-04 8.099E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP multiple myeloma DOID_9538 4.328E-04 9.121E-03 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP peripheral nervous system neoplasm DOID_1192 4.548E-04 9.242E-03 0.0309039 0.58614403 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP uterine cancer DOID_363 5.978E-04 0.01173014 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP myeloma DOID_0070004 6.765E-04 0.01283136 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP lung small cell carcinoma DOID_5409 7.316E-04 0.01342852 0.03903702 0.60032609 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP bone marrow cancer DOID_4960 8.785E-04 0.01562068 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP pre-malignant neoplasm DOID_0060071 1.176E-03 0.02027115 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP in situ carcinoma DOID_8719 1.176E-03 0.02027115 1.000 1.000 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP pancreatic ductal carcinoma DOID_3587 1.436E-03 0.02402545 0.05438126 0.64464454 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP nephrosis DOID_2527 1.475E-03 0.02397596 1.475E-03 0.08391586 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP pancreatic carcinoma DOID_4905 1.555E-03 0.02457257 0.05655389 0.65671764 TCGA_GLIOBLASTOMA_COPY_NUMBER_UP pancreatitis DOID_4989 1.721E-03 0.02645885 0.05944324 0.65044617 STOSSI_RESPONSE_TO_ESTRADIOL peptic ulcer DOID_750 3.543E-10 2.016E-07 6.572E-04 0.09348893 STOSSI_RESPONSE_TO_ESTRADIOL papilloma DOID_2615 3.111E-08 8.85E-06 4.825E-04 0.13727507 STOSSI_RESPONSE_TO_ESTRADIOL thyroid adenoma DOID_2891 1.205E-07 2.286E-05 9.309E-04 0.10593311 STOSSI_RESPONSE_TO_ESTRADIOL endocrine organ benign neoplasm DOID_0060089 5.019E-07 7.139E-05 1.866E-03 0.13273437 STOSSI_RESPONSE_TO_ESTRADIOL urinary tract obstruction DOID_5200 1.153E-06 1.312E-04 0.02043091 0.38750623 STOSSI_RESPONSE_TO_ESTRADIOL lymphoblastic leukemia DOID_1037 1.62E-06 1.536E-04 8.621E-05 0.04905534 STOSSI_RESPONSE_TO_ESTRADIOL aneurysm disease DOID_2403 4.974E-05 4.043E-03 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL metabolic syndrome X DOID_14221 5.56E-05 3.955E-03 0.07100545 0.57717285 STOSSI_RESPONSE_TO_ESTRADIOL polycystic kidney disease DOID_898 7.056E-05 4.461E-03 0.01248492 0.32290543 STOSSI_RESPONSE_TO_ESTRADIOL transitional cell carcinoma DOID_2671 7.34E-05 4.176E-03 2.976E-03 0.15393254 STOSSI_RESPONSE_TO_ESTRADIOL Barrett's esophagus DOID_9206 9.295E-05 4.808E-03 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL esophagitis DOID_11963 1.468E-04 6.962E-03 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL gastric ulcer DOID_10808 1.783E-04 7.805E-03 0.01955109 0.39730618 STOSSI_RESPONSE_TO_ESTRADIOL papillary adenoma DOID_3172 2.702E-04 0.01098139 0.02394251 0.37842462 STOSSI_RESPONSE_TO_ESTRADIOL microcystic adenoma DOID_5403 2.702E-04 0.01098139 0.02394251 0.37842462 STOSSI_RESPONSE_TO_ESTRADIOL follicular adenoma DOID_6204 2.702E-04 0.01098139 0.02394251 0.37842462 STOSSI_RESPONSE_TO_ESTRADIOL abdominal aortic aneurysm DOID_7693 4.051E-04 0.01536583 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL chronic leukemia DOID_1036 4.56E-04 0.01621519 0.03092909 0.45124744 STOSSI_RESPONSE_TO_ESTRADIOL chronic lymphocytic leukemia DOID_1040 4.56E-04 0.01621519 0.03092909 0.45124744 STOSSI_RESPONSE_TO_ESTRADIOL myocarditis DOID_820 4.825E-04 0.01615001 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL thyroid carcinoma DOID_3963 5.098E-04 0.01611532 0.03266813 0.42245835 STOSSI_RESPONSE_TO_ESTRADIOL esophageal disease DOID_6050 5.098E-04 0.01526714 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL thyroid cancer DOID_1781 5.666E-04 0.01611897 0.03440415 0.42556437 STOSSI_RESPONSE_TO_ESTRADIOL adenoma DOID_657 5.666E-04 0.0153514 0.03440415 0.41650981 STOSSI_RESPONSE_TO_ESTRADIOL refractive error DOID_9835 5.666E-04 0.01465361 5.666E-04 0.10745979 STOSSI_RESPONSE_TO_ESTRADIOL congenital diaphragmatic hernia DOID_3827 6.572E-04 0.01625894 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL endometriosis DOID_289 7.883E-04 0.01868832 0.04045643 0.41854014 STOSSI_RESPONSE_TO_ESTRADIOL proteinuria DOID_576 8.941E-04 0.02035058 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL integumentary system benign neoplasm DOID_0060121 1.006E-03 0.02202663 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL skin benign neoplasm DOID_3165 1.006E-03 0.02202663 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL aortic aneurysm DOID_3627 1.045E-03 0.02203025 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL hemorrhagic disease DOID_2213 1.085E-03 0.02204813 1.085E-03 0.10289129 STOSSI_RESPONSE_TO_ESTRADIOL sarcoidosis DOID_11335 1.166E-03 0.02288365 0.04903871 0.47293266 STOSSI_RESPONSE_TO_ESTRADIOL giant cell tumor DOID_200 1.166E-03 0.02212086 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL malignant giant cell tumor DOID_2705 1.166E-03 0.02212086 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL giant cell glioblastoma DOID_3074 1.166E-03 0.02212086 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL integumentary system cancer DOID_0060122 1.25E-03 0.0229523 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL skin cancer DOID_4159 1.25E-03 0.0229523 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL hypersensitivity reaction type IV disease DOID_2916 1.382E-03 0.02457451 0.05330187 0.49719284 STOSSI_RESPONSE_TO_ESTRADIOL glioblastoma DOID_3068 1.382E-03 0.02382983 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL oral cavity cancer DOID_8618 1.382E-03 0.02312895 0.05330187 0.4891736 STOSSI_RESPONSE_TO_ESTRADIOL respiratory failure DOID_11162 1.567E-03 0.02548028 0.05669903 0.50408984 STOSSI_RESPONSE_TO_ESTRADIOL mineral metabolism disease DOID_0050032 1.664E-03 0.02630315 0.05839317 0.51116487 STOSSI_RESPONSE_TO_ESTRADIOL hyperglycemia DOID_4195 1.764E-03 0.02712442 0.06008436 0.51800004 STOSSI_RESPONSE_TO_ESTRADIOL allergic contact dermatitis DOID_3042 1.815E-03 0.02717216 1.815E-03 0.147506 STOSSI_RESPONSE_TO_ESTRADIOL astrocytoma DOID_3069 1.918E-03 0.02798979 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL blood coagulation disease DOID_1247 1.971E-03 0.02804304 1.971E-03 0.12463575 STOSSI_RESPONSE_TO_ESTRADIOL nephrosis DOID_2527 2.025E-03 0.02810327 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL male reproductive system disease DOID_48 2.025E-03 0.02743415 0.06429945 0.53023747 STOSSI_RESPONSE_TO_ESTRADIOL cystic fibrosis DOID_1485 2.246E-03 0.02972548 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL contact dermatitis DOID_2773 2.479E-03 0.03205415 2.479E-03 0.14103824 STOSSI_RESPONSE_TO_ESTRADIOL female reproductive system disease DOID_229 2.538E-03 0.0320977 0.07184041 0.57573512 STOSSI_RESPONSE_TO_ESTRADIOL Human immunodeficiency virus infectious disease DOID_526 3.107E-03 0.03843043 0.07932237 0.60179241 STOSSI_RESPONSE_TO_ESTRADIOL mouth disease DOID_403 3.377E-03 0.04088157 0.08262887 0.6186293 STOSSI_RESPONSE_TO_ESTRADIOL dilated cardiomyopathy DOID_12930 3.446E-03 0.04084972 0.08345369 0.61669026 STOSSI_RESPONSE_TO_ESTRADIOL ulcerative colitis DOID_8577 3.657E-03 0.04247141 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL hyperparathyroidism DOID_13543 8.933E-03 0.09966784 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL chondrosarcoma DOID_3371 8.933E-03 0.09775115 8.933E-03 0.39100461 STOSSI_RESPONSE_TO_ESTRADIOL hypokalemia DOID_4500 8.933E-03 0.09590679 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL acute T cell leukemia DOID_5603 8.933E-03 0.09413074 8.933E-03 0.36307571 STOSSI_RESPONSE_TO_ESTRADIOL cutaneous leishmaniasis DOID_9111 8.933E-03 0.09241927 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL familial adenomatous polyposis DOID_0050424 9.822E-03 0.09980241 1.000 1.000 STOSSI_RESPONSE_TO_ESTRADIOL hemochromatosis DOID_2352 9.822E-03 0.09805149 9.822E-03 0.37259568 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN viral pneumonia DOID_10533 1.166E-07 6.637E-05 4.421E-05 3.145E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN leishmaniasis DOID_9065 3.098E-07 8.813E-05 3.098E-07 1.763E-04 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN bacterial pneumonia DOID_874 3.109E-07 5.896E-05 2.552E-05 2.42E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN neuritis DOID_1803 6.174E-06 8.783E-04 6.174E-06 1.757E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN parasitic protozoa infectious disease DOID_2789 9.683E-06 1.102E-03 9.683E-06 1.837E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN parasitic infectious disease DOID_1398 1.565E-05 1.484E-03 1.565E-05 2.227E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN cerebral degeneration DOID_1443 1.565E-05 1.272E-03 1.081E-03 0.01983957 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN cutaneous leishmaniasis DOID_9111 2.19E-05 1.558E-03 2.19E-05 2.493E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN cystic fibrosis DOID_1485 2.365E-05 1.495E-03 1.419E-03 0.02306336 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN newborn respiratory distress syndrome DOID_12716 3.792E-05 2.157E-03 9.221E-03 0.10089376 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN Human immunodeficiency virus infectious disease DOID_526 3.878E-05 2.006E-03 3.878E-05 3.152E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN hypersensitivity reaction type I disease DOID_1205 4.542E-05 2.154E-03 4.542E-05 2.872E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN acquired immunodeficiency syndrome DOID_635 1.118E-04 4.895E-03 1.118E-04 6.364E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN Goodpasture syndrome DOID_9808 1.335E-04 5.426E-03 1.335E-04 6.906E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN toxic shock syndrome DOID_14115 1.451E-04 5.503E-03 0.01765906 0.13955565 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN commensal bacterial infectious disease DOID_0050339 1.571E-04 5.586E-03 0.01835914 0.14116692 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN Sciatic Neuropathy DOID_11446 1.96E-04 6.559E-03 1.96E-04 9.292E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN gestational diabetes DOID_11714 1.96E-04 6.195E-03 1.96E-04 8.577E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN lesion of sciatic nerve DOID_12528 1.96E-04 6.559E-03 1.96E-04 9.292E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN mononeuritis of lower limb DOID_9473 1.96E-04 6.559E-03 1.96E-04 9.292E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN renal hypertension DOID_1073 2.099E-04 6.285E-03 0.02115466 0.1450241 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN secondary hypertension DOID_11130 2.099E-04 6.285E-03 0.02115466 0.1450241 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN mononeuritis DOID_1802 2.099E-04 5.971E-03 2.099E-04 8.53E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN mononeuropathy DOID_1188 2.243E-04 6.076E-03 2.243E-04 8.507E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN opportunistic mycosis DOID_2473 2.544E-04 6.58E-03 2.544E-04 9.047E-03 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN abdominal aortic aneurysm DOID_7693 2.544E-04 6.294E-03 0.02324626 0.15030822 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN pleural disease DOID_1532 2.864E-04 6.791E-03 0.02463827 0.15238237 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN systemic mycosis DOID_0050136 3.032E-04 6.9E-03 3.032E-04 0.01014688 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN fungal infectious disease DOID_1564 3.032E-04 6.9E-03 3.032E-04 0.01014688 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN periodontal disease DOID_3388 3.203E-04 7.011E-03 3.203E-04 0.01012632 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN uveitis DOID_13141 3.937E-04 8.297E-03 3.937E-04 0.01179091 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN hepatitis DOID_2237 4.132E-04 8.397E-03 0.02949528 0.1661665 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN systemic scleroderma DOID_418 4.132E-04 8.108E-03 4.132E-04 0.01175627 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN adult respiratory distress syndrome DOID_11394 4.332E-04 8.216E-03 0.03018724 0.16839744 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN pulmonary emphysema DOID_9675 4.536E-04 8.326E-03 0.03087872 0.16575463 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN autoimmune disease of urogenital tract DOID_0060049 4.745E-04 8.437E-03 4.745E-04 0.01285702 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN primary biliary cirrhosis DOID_12236 4.745E-04 8.437E-03 4.745E-04 0.01285702 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN rheumatic disease DOID_1575 4.959E-04 8.55E-03 4.959E-04 0.01282482 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN uveal disease DOID_3480 4.959E-04 8.298E-03 4.959E-04 0.01226722 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN scleroderma DOID_419 4.959E-04 8.55E-03 4.959E-04 0.01282482 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN leukodystrophy DOID_10579 5.627E-04 9.147E-03 0.034329 0.17286019 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN myeloma DOID_0070004 5.859E-04 9.26E-03 5.859E-04 0.01388979 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN pre-eclampsia DOID_10591 5.859E-04 9.01E-03 5.859E-04 0.0133342 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN autoimmune disease of gastrointestinal tract DOID_0060031 6.336E-04 9.487E-03 6.336E-04 0.01386628 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN pulmonary tuberculosis DOID_2957 6.336E-04 9.244E-03 6.336E-04 0.01335271 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN aortic aneurysm DOID_3627 6.582E-04 9.362E-03 0.03708071 0.18188726 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN bone marrow cancer DOID_4960 7.61E-04 0.01056053 7.61E-04 0.01546363 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN vasculitis DOID_865 7.61E-04 0.01030909 7.61E-04 0.0149304 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN carotid artery disease DOID_3407 9.583E-04 0.01268015 0.04460902 0.2115211 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN collagen disease DOID_854 9.583E-04 0.01239197 9.583E-04 0.01817489 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN respiratory failure DOID_11162 9.882E-04 0.01249576 0.04529059 0.21297809 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN mineral metabolism disease DOID_0050032 1.05E-03 0.0129826 0.04665234 0.21581448 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN tooth disease DOID_1091 1.145E-03 0.01386049 1.145E-03 0.02035759 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN allergic contact dermatitis DOID_3042 1.145E-03 0.01357173 1.145E-03 0.01974069 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN tuberculosis DOID_399 1.178E-03 0.01367411 1.178E-03 0.0197068 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN male reproductive system disease DOID_48 1.278E-03 0.01454627 0.05140373 0.22673429 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN aneurysm disease DOID_2403 1.455E-03 0.01623178 0.05478362 0.23437502 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN metabolic syndrome X DOID_14221 1.566E-03 0.01713716 1.566E-03 0.02475368 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN contact dermatitis DOID_2773 1.566E-03 0.01681382 1.566E-03 0.02408466 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN chronic kidney failure DOID_784 1.681E-03 0.01771644 1.681E-03 0.025176 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN primary bacterial infectious disease DOID_0050338 1.841E-03 0.01904673 1.841E-03 0.02686078 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN encephalomyelitis DOID_640 2.094E-03 0.02127315 2.094E-03 0.0297824 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.137E-03 0.02133526 2.137E-03 0.02966121 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN mouth disease DOID_403 2.137E-03 0.02096741 2.137E-03 0.02895499 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN interstitial nephritis DOID_1063 7.1E-03 0.0684729 7.1E-03 0.09395119 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN retinal vascular occlusion DOID_1729 7.1E-03 0.06733169 7.1E-03 0.09181593 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN acute kidney failure DOID_3021 7.1E-03 0.06622789 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN acute T cell leukemia DOID_5603 7.1E-03 0.0651597 7.1E-03 0.08977558 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN visceral leishmaniasis DOID_9146 7.1E-03 0.06412541 7.1E-03 0.08782394 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN adrenoleukodystrophy DOID_10588 7.807E-03 0.06941201 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN pneumocystosis DOID_11339 7.807E-03 0.06834413 7.807E-03 0.09451848 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN temporal arteritis DOID_13375 7.807E-03 0.06730862 7.807E-03 0.09254935 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN central nervous system vasculitis DOID_525 7.807E-03 0.06730862 7.807E-03 0.09254935 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN relapsing-remitting multiple sclerosis DOID_2378 8.514E-03 0.07230687 8.514E-03 0.09886857 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN lipodystrophy DOID_811 8.514E-03 0.07124353 8.514E-03 0.0968912 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN encephalitis DOID_9588 8.514E-03 0.07021102 8.514E-03 0.09499137 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN berylliosis DOID_10322 9.221E-03 0.07494965 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN obstructive hydrocephalus DOID_14159 9.221E-03 0.07389402 9.221E-03 0.09899011 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN communicating hydrocephalus DOID_1573 9.221E-03 0.07389402 9.221E-03 0.09899011 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN Leydig cell tumor DOID_2696 9.221E-03 0.07286772 9.221E-03 0.09715696 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN sex cord-stromal neoplasm DOID_4757 9.221E-03 0.07286772 9.221E-03 0.09715696 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN psoriatic arthritis DOID_9008 9.221E-03 0.07186953 9.221E-03 0.09539047 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN tethered spinal cord syndrome DOID_1089 9.926E-03 0.07632588 9.926E-03 0.1008592 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN hydrocephalus DOID_10908 9.926E-03 0.07530821 9.926E-03 0.09908974 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN aspergillosis DOID_13564 9.926E-03 0.07431731 9.926E-03 0.0973813 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN T-cell leukemia DOID_715 9.926E-03 0.07335215 9.926E-03 0.09573077 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN renovascular hypertension DOID_1591 0.01063177 0.07755743 0.01063177 0.10082466 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN varicose veins DOID_799 0.01063177 0.07657569 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN intracranial hypertension DOID_9428 0.01063177 0.0756185 0.01063177 0.0991718 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN silicosis DOID_10325 0.01133668 0.07963665 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN vein disease DOID_866 0.01133668 0.07866547 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN prion disease DOID_649 0.01274503 0.08737254 0.01274503 0.11696647 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN MHC class II deficiency DOID_5812 0.01344848 0.09109744 0.01344848 0.12146325 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN brain edema DOID_4724 0.01415145 0.09473146 0.01415145 0.12581522 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN amyloidosis DOID_9120 0.01415145 0.09362993 0.01415145 0.1238796 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN juvenile absence epilepsy DOID_0060172 0.01485393 0.09714815 0.01485393 0.12805892 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN Kawasaki disease DOID_13378 0.01485393 0.09604419 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN lymphadenitis DOID_1602 0.01485393 0.09604419 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN autoimmune hepatitis DOID_2048 0.01485393 0.09496504 0.01485393 0.12614759 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN coronary restenosis DOID_4247 0.01485393 0.09390987 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN lymph node disease DOID_9942 0.01485393 0.09604419 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN muscular atrophy DOID_767 0.01555594 0.09726735 0.01555594 0.13016661 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN placenta disease DOID_780 0.01555594 0.0962101 0.01555594 0.12828013 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN sinusitis DOID_0050127 0.01625746 0.09946769 0.01625746 0.13214994 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN paranasal sinus disease DOID_1352 0.01625746 0.09946769 0.01625746 0.13214994 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN polyarteritis nodosa DOID_9810 0.01625746 0.09840953 1.000 1.000 ROSS_AML_WITH_CBFB_MYH11_FUSION sarcoidosis DOID_11335 1.469E-05 8.357E-03 1.033E-03 0.09797463 ROSS_AML_WITH_CBFB_MYH11_FUSION giant cell tumor DOID_200 1.469E-05 4.179E-03 1.033E-03 0.08397825 ROSS_AML_WITH_CBFB_MYH11_FUSION malignant giant cell tumor DOID_2705 1.469E-05 4.179E-03 1.033E-03 0.08397825 ROSS_AML_WITH_CBFB_MYH11_FUSION giant cell glioblastoma DOID_3074 1.469E-05 4.179E-03 1.033E-03 0.08397825 ROSS_AML_WITH_CBFB_MYH11_FUSION hypersensitivity reaction type IV disease DOID_2916 1.902E-05 3.607E-03 1.224E-03 0.0870888 ROSS_AML_WITH_CBFB_MYH11_FUSION glioblastoma DOID_3068 1.902E-05 2.705E-03 1.224E-03 0.07741227 ROSS_AML_WITH_CBFB_MYH11_FUSION allergic contact dermatitis DOID_3042 2.877E-05 3.274E-03 2.877E-05 0.01637187 ROSS_AML_WITH_CBFB_MYH11_FUSION astrocytoma DOID_3069 3.131E-05 2.969E-03 1.7E-03 0.08795405 ROSS_AML_WITH_CBFB_MYH11_FUSION contact dermatitis DOID_2773 4.623E-05 3.758E-03 4.623E-05 0.01315267 ROSS_AML_WITH_CBFB_MYH11_FUSION bacterial meningitis DOID_9470 6.241E-05 4.439E-03 0.01175454 0.29079706 ROSS_AML_WITH_CBFB_MYH11_FUSION encephalomyelitis DOID_640 7.172E-05 4.534E-03 7.172E-05 0.01360294 ROSS_AML_WITH_CBFB_MYH11_FUSION meningitis DOID_9471 1.883E-04 0.01071456 0.02006857 0.31719491 ROSS_AML_WITH_CBFB_MYH11_FUSION bronchiolitis obliterans DOID_2799 3.585E-04 0.01854583 3.585E-04 0.05100104 ROSS_AML_WITH_CBFB_MYH11_FUSION myocarditis DOID_820 4.271E-04 0.02025246 4.271E-04 0.04860591 ROSS_AML_WITH_CBFB_MYH11_FUSION multiple myeloma DOID_9538 5.277E-04 0.02309695 1.000 1.000 ROSS_AML_WITH_CBFB_MYH11_FUSION myeloma DOID_0070004 8.244E-04 0.03350611 1.000 1.000 ROSS_AML_WITH_CBFB_MYH11_FUSION bone marrow cancer DOID_4960 1.07E-03 0.04059356 1.000 1.000 ROSS_AML_WITH_CBFB_MYH11_FUSION congenital heart defect DOID_1682 1.431E-03 0.05090563 1.431E-03 0.08144901 ROSS_AML_WITH_CBFB_MYH11_FUSION endocrine organ benign neoplasm DOID_0060089 1.654E-03 0.05535968 0.05824544 0.58143251 ROSS_AML_WITH_CBFB_MYH11_FUSION aneurysm disease DOID_2403 2.042E-03 0.06455175 2.042E-03 0.09682763 ROSS_AML_WITH_CBFB_MYH11_FUSION bacterial pneumonia DOID_874 2.093E-03 0.06268938 0.06538968 0.62011212 ROSS_AML_WITH_CBFB_MYH11_FUSION carbohydrate metabolic disorder DOID_2978 2.935E-03 0.08348873 2.935E-03 0.1284442 STREICHER_LSM1_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 3.952E-08 2.249E-05 5.779E-04 0.32883094 STREICHER_LSM1_TARGETS_DN congenital diaphragmatic hernia DOID_3827 4.563E-07 1.298E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN myeloma DOID_0070004 7.777E-07 1.475E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 8.765E-07 1.247E-04 0.01903584 0.47093001 STREICHER_LSM1_TARGETS_DN bile duct adenocarcinoma DOID_4896 1.159E-06 1.319E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN cholangiocarcinoma DOID_4947 1.159E-06 1.319E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN bone marrow cancer DOID_4960 1.159E-06 1.099E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN bile duct cancer DOID_4606 1.425E-06 1.158E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN bile duct carcinoma DOID_4897 1.425E-06 1.158E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN biliary tract cancer DOID_4607 3.889E-06 2.766E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN mouth disease DOID_403 5.613E-06 3.548E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN berylliosis DOID_10322 9.855E-06 5.607E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN oral submucous fibrosis DOID_5773 1.326E-05 6.859E-04 1.000 1.000 STREICHER_LSM1_TARGETS_DN autoimmune hepatitis DOID_2048 2.649E-05 1.256E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN placenta disease DOID_780 2.913E-05 1.275E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN spastic quadriplegia DOID_10970 3.781E-05 1.537E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN periodontitis DOID_824 5.112E-05 1.939E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 6.241E-05 2.22E-03 0.01175454 0.66883323 STREICHER_LSM1_TARGETS_DN uterine benign neoplasm DOID_0060095 6.241E-05 2.22E-03 0.01175454 0.66883323 STREICHER_LSM1_TARGETS_DN uterine fibroid DOID_13223 6.241E-05 2.22E-03 0.01175454 0.66883323 STREICHER_LSM1_TARGETS_DN spastic cerebral palsy DOID_0050669 6.643E-05 2.223E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN celiac disease DOID_10608 7.056E-05 2.231E-03 0.01248492 0.59199329 STREICHER_LSM1_TARGETS_DN leiomyoma DOID_127 7.482E-05 2.241E-03 0.01284992 0.56243123 STREICHER_LSM1_TARGETS_DN pneumoconiosis DOID_10316 8.372E-05 2.382E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN periodontal disease DOID_3388 8.372E-05 2.268E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN pulmonary emphysema DOID_9675 1.187E-04 3.071E-03 0.01612932 0.43702764 STREICHER_LSM1_TARGETS_DN nephrotic syndrome DOID_1184 1.299E-04 3.213E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN diabetic autonomic neuropathy DOID_11503 1.356E-04 3.215E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN autonomic neuropathy DOID_11504 1.356E-04 3.215E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN diabetic polyneuropathy DOID_12785 1.356E-04 3.215E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN gallbladder cancer DOID_3121 1.356E-04 3.086E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN influenza DOID_8469 1.356E-04 2.968E-03 0.0172202 0.44537689 STREICHER_LSM1_TARGETS_DN diabetic neuropathy DOID_9743 1.356E-04 3.215E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN proteinuria DOID_576 1.475E-04 3.107E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN autonomic nervous system disease DOID_11465 1.536E-04 3.121E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 2.069E-04 4.059E-03 0.02121049 0.48275077 STREICHER_LSM1_TARGETS_DN integumentary system cancer DOID_0060122 2.069E-04 3.924E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN skin cancer DOID_4159 2.069E-04 3.924E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN melancholia DOID_2848 2.365E-04 4.34E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN neurotic disorder DOID_4964 2.442E-04 4.341E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN uterine disease DOID_345 2.845E-04 4.905E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN tooth disease DOID_1091 3.015E-04 5.045E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN brain infarction DOID_3454 3.101E-04 5.042E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 3.278E-04 5.182E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN nephrosis DOID_2527 3.369E-04 5.181E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN biliary tract disease DOID_9741 3.46E-04 5.181E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN pancreatic carcinoma DOID_4905 3.553E-04 5.184E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN diabetic retinopathy DOID_8947 3.553E-04 5.054E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN cystic fibrosis DOID_1485 3.742E-04 5.194E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN endogenous depression DOID_1595 3.742E-04 5.07E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN bone resorption disease DOID_0080011 3.839E-04 5.08E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN osteoporosis DOID_11476 3.839E-04 5.08E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN bacterial pneumonia DOID_874 3.936E-04 5.09E-03 0.02914599 0.55280221 STREICHER_LSM1_TARGETS_DN metabolic syndrome X DOID_14221 4.135E-04 5.229E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN female reproductive system disease DOID_229 4.236E-04 5.24E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN mental depression DOID_1596 4.442E-04 5.378E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN retinal vascular disease DOID_2462 4.653E-04 5.516E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN lymphoblastic leukemia DOID_1037 5.544E-04 6.438E-03 0.03452225 0.63365041 STREICHER_LSM1_TARGETS_DN encephalomyelitis DOID_640 5.544E-04 6.309E-03 1.000 1.000 STREICHER_LSM1_TARGETS_DN ulcerative colitis DOID_8577 6.14E-04 6.85E-03 0.03630819 0.64560502 STREICHER_LSM1_TARGETS_DN hyperparathyroidism DOID_13543 3.687E-03 0.0403461 1.000 1.000 STREICHER_LSM1_TARGETS_DN retinal vascular occlusion DOID_1729 3.687E-03 0.03958486 1.000 1.000 STREICHER_LSM1_TARGETS_DN insulinoma DOID_3892 3.687E-03 0.0388518 1.000 1.000 STREICHER_LSM1_TARGETS_DN keratitis DOID_4677 3.687E-03 0.03814541 1.000 1.000 STREICHER_LSM1_TARGETS_DN visceral leishmaniasis DOID_9146 3.687E-03 0.03746424 1.000 1.000 STREICHER_LSM1_TARGETS_DN prediabetes syndrome DOID_11716 4.055E-03 0.04048073 1.000 1.000 STREICHER_LSM1_TARGETS_DN islet cell tumor DOID_1799 4.423E-03 0.04339196 1.000 1.000 STREICHER_LSM1_TARGETS_DN aortic valve insufficiency DOID_57 4.423E-03 0.04265651 1.000 1.000 STREICHER_LSM1_TARGETS_DN parathyroid gland disease DOID_11201 4.791E-03 0.04543324 1.000 1.000 STREICHER_LSM1_TARGETS_DN polyneuropathy DOID_1389 4.791E-03 0.04468843 1.000 1.000 STREICHER_LSM1_TARGETS_DN epilepsy with generalized tonic-clonic seizures DOID_7725 4.791E-03 0.04396765 1.000 1.000 STREICHER_LSM1_TARGETS_DN hypercalcemia DOID_12678 5.158E-03 0.04659021 1.000 1.000 STREICHER_LSM1_TARGETS_DN eyelid disease DOID_530 5.158E-03 0.04586224 5.158E-03 1.000 STREICHER_LSM1_TARGETS_DN lung oat cell carcinoma DOID_5411 5.526E-03 0.04837385 1.000 1.000 STREICHER_LSM1_TARGETS_DN spastic diplegia DOID_10965 5.893E-03 0.05080827 1.000 1.000 STREICHER_LSM1_TARGETS_DN hemolytic-uremic syndrome DOID_12554 5.893E-03 0.05004993 1.000 1.000 STREICHER_LSM1_TARGETS_DN thyroiditis DOID_7166 5.893E-03 0.0493139 1.000 1.000 STREICHER_LSM1_TARGETS_DN autoimmune thyroiditis DOID_7188 5.893E-03 0.0493139 1.000 1.000 STREICHER_LSM1_TARGETS_DN penile disease DOID_1529 6.261E-03 0.05162781 1.000 1.000 STREICHER_LSM1_TARGETS_DN basal cell carcinoma DOID_2513 6.261E-03 0.05089027 1.000 1.000 STREICHER_LSM1_TARGETS_DN skin carcinoma DOID_3451 6.628E-03 0.05311579 1.000 1.000 STREICHER_LSM1_TARGETS_DN osteosclerosis DOID_4254 6.628E-03 0.05237807 1.000 1.000 STREICHER_LSM1_TARGETS_DN ureteral obstruction DOID_5199 6.628E-03 0.05166056 1.000 1.000 STREICHER_LSM1_TARGETS_DN dissociative disorder DOID_10935 6.995E-03 0.05378448 1.000 1.000 STREICHER_LSM1_TARGETS_DN dissociative amnesia DOID_11037 6.995E-03 0.05378448 1.000 1.000 STREICHER_LSM1_TARGETS_DN leishmaniasis DOID_9065 6.995E-03 0.05306735 1.000 1.000 STREICHER_LSM1_TARGETS_DN amnestic disorder DOID_10914 7.362E-03 0.05511592 1.000 1.000 STREICHER_LSM1_TARGETS_DN alopecia DOID_987 7.362E-03 0.05440013 7.362E-03 1.000 STREICHER_LSM1_TARGETS_DN mitochondrial myopathy DOID_699 7.728E-03 0.05637816 1.000 1.000 STREICHER_LSM1_TARGETS_DN neutropenia DOID_1227 8.095E-03 0.05830522 8.095E-03 1.000 STREICHER_LSM1_TARGETS_DN agranulocytosis DOID_12987 8.462E-03 0.0601832 8.462E-03 0.96293115 STREICHER_LSM1_TARGETS_DN IgA glomerulonephritis DOID_2986 8.462E-03 0.05944019 1.000 1.000 STREICHER_LSM1_TARGETS_DN uremia DOID_4676 8.462E-03 0.05871531 1.000 1.000 STREICHER_LSM1_TARGETS_DN urinary tract obstruction DOID_5200 8.462E-03 0.0580079 1.000 1.000 STREICHER_LSM1_TARGETS_DN ureteral disease DOID_1426 8.828E-03 0.05979914 1.000 1.000 STREICHER_LSM1_TARGETS_DN aortic valve disease DOID_62 8.828E-03 0.05909562 1.000 1.000 STREICHER_LSM1_TARGETS_DN meningitis DOID_9471 8.828E-03 0.05840846 1.000 1.000 STREICHER_LSM1_TARGETS_DN Goodpasture syndrome DOID_9808 8.828E-03 0.0577371 1.000 1.000 STREICHER_LSM1_TARGETS_DN urticaria DOID_1555 9.56E-03 0.06181657 1.000 1.000 STREICHER_LSM1_TARGETS_DN hypogonadism DOID_1924 9.56E-03 0.061122 1.000 1.000 STREICHER_LSM1_TARGETS_DN bronchiolitis DOID_2942 9.56E-03 0.06044286 1.000 1.000 STREICHER_LSM1_TARGETS_DN ankylosing spondylitis DOID_7147 9.926E-03 0.0620672 9.926E-03 0.94135258 STREICHER_LSM1_TARGETS_DN cleft lip DOID_9296 9.926E-03 0.06139256 1.000 1.000 STREICHER_LSM1_TARGETS_DN intracranial aneurysm DOID_10941 0.01029227 0.06297099 1.000 1.000 STREICHER_LSM1_TARGETS_DN middle cerebral artery infarction DOID_3525 0.01029227 0.06230108 1.000 1.000 STREICHER_LSM1_TARGETS_DN hypotrichosis DOID_4535 0.01029227 0.06164528 0.01029227 0.83661452 STREICHER_LSM1_TARGETS_DN Sciatic Neuropathy DOID_11446 0.01065803 0.063171 1.000 1.000 STREICHER_LSM1_TARGETS_DN gestational diabetes DOID_11714 0.01065803 0.06251976 1.000 1.000 STREICHER_LSM1_TARGETS_DN lesion of sciatic nerve DOID_12528 0.01065803 0.063171 1.000 1.000 STREICHER_LSM1_TARGETS_DN mononeuritis of lower limb DOID_9473 0.01065803 0.063171 1.000 1.000 STREICHER_LSM1_TARGETS_DN autoimmune disease of cardiovascular system DOID_0060051 0.01102366 0.06400469 1.000 1.000 STREICHER_LSM1_TARGETS_DN pleurisy DOID_10247 0.01102366 0.06335818 1.000 1.000 STREICHER_LSM1_TARGETS_DN Behcet's disease DOID_13241 0.01102366 0.06400469 1.000 1.000 STREICHER_LSM1_TARGETS_DN thrombocytopenia DOID_1588 0.01102366 0.0627246 0.01102366 0.78405747 STREICHER_LSM1_TARGETS_DN mononeuritis DOID_1802 0.01102366 0.06210356 1.000 1.000 STREICHER_LSM1_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 0.01138916 0.06353364 1.000 1.000 STREICHER_LSM1_TARGETS_DN polycystic ovary syndrome DOID_11612 0.01138916 0.06291681 0.01138916 0.72004797 STREICHER_LSM1_TARGETS_DN mononeuropathy DOID_1188 0.01138916 0.06231184 1.000 1.000 STREICHER_LSM1_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 0.01138916 0.0617184 1.000 1.000 STREICHER_LSM1_TARGETS_DN focal glomerulosclerosis DOID_3945 0.01138916 0.06113615 1.000 1.000 STREICHER_LSM1_TARGETS_DN corneal disease DOID_10124 0.01175454 0.06250778 1.000 1.000 STREICHER_LSM1_TARGETS_DN age related macular degeneration DOID_10871 0.01211979 0.06385335 0.01211979 0.62692378 STREICHER_LSM1_TARGETS_DN degeneration of macula and posterior pole DOID_2007 0.01211979 0.06385335 0.01211979 0.62692378 STREICHER_LSM1_TARGETS_DN gonadal disease DOID_2277 0.01211979 0.06326754 1.000 1.000 STREICHER_LSM1_TARGETS_DN bronchiolitis obliterans DOID_2799 0.01211979 0.06269238 1.000 1.000 STREICHER_LSM1_TARGETS_DN chronic leukemia DOID_1036 0.01284992 0.06587032 1.000 1.000 STREICHER_LSM1_TARGETS_DN chronic lymphocytic leukemia DOID_1040 0.01284992 0.06587032 1.000 1.000 STREICHER_LSM1_TARGETS_DN pleural disease DOID_1532 0.01284992 0.0652822 1.000 1.000 STREICHER_LSM1_TARGETS_DN bladder disease DOID_365 0.01284992 0.06470448 1.000 1.000 STREICHER_LSM1_TARGETS_DN papilloma DOID_2615 0.0132148 0.06595808 1.000 1.000 STREICHER_LSM1_TARGETS_DN hair disease DOID_421 0.0132148 0.06538453 0.0132148 0.53708724 STREICHER_LSM1_TARGETS_DN hepatitis C DOID_1883 0.01357955 0.06661005 0.01357955 0.51511769 STREICHER_LSM1_TARGETS_DN spindle cell carcinoma DOID_4015 0.01357955 0.06604073 1.000 1.000 STREICHER_LSM1_TARGETS_DN macular degeneration DOID_4448 0.01357955 0.06548106 0.01357955 0.48292284 STREICHER_LSM1_TARGETS_DN leukopenia DOID_615 0.01357955 0.0649308 0.01357955 0.45451561 STREICHER_LSM1_TARGETS_DN lymphoid leukemia DOID_10747 0.01394418 0.06611865 0.01394418 0.44079101 STREICHER_LSM1_TARGETS_DN adenoma DOID_657 0.01430868 0.06728628 1.000 1.000 STREICHER_LSM1_TARGETS_DN adolescence-adult electroclinical syndrome DOID_0050705 0.01467306 0.06843418 1.000 1.000 STREICHER_LSM1_TARGETS_DN pulmonary sarcoidosis DOID_13406 0.01467306 0.06787781 1.000 1.000 STREICHER_LSM1_TARGETS_DN cleft palate DOID_674 0.01467306 0.0673304 1.000 1.000 STREICHER_LSM1_TARGETS_DN multiple myeloma DOID_9538 0.01467306 0.06679176 1.000 1.000 STREICHER_LSM1_TARGETS_DN blood platelet disease DOID_2218 0.01503731 0.06790658 0.01503731 0.45032787 STREICHER_LSM1_TARGETS_DN respiratory syncytial virus infectious disease DOID_1273 0.01540144 0.06900329 1.000 1.000 STREICHER_LSM1_TARGETS_DN peptic ulcer DOID_750 0.01540144 0.0684642 1.000 1.000 STREICHER_LSM1_TARGETS_DN intracranial arterial disease DOID_13089 0.01576544 0.06953903 1.000 1.000 STREICHER_LSM1_TARGETS_DN cerebral arterial disease DOID_3527 0.01576544 0.06953903 1.000 1.000 STREICHER_LSM1_TARGETS_DN lymphatic system disease DOID_75 0.01576544 0.06900411 0.01576544 0.44852672 STREICHER_LSM1_TARGETS_DN benign mesothelioma DOID_2645 0.01612932 0.07005787 1.000 1.000 STREICHER_LSM1_TARGETS_DN hyperinsulinism DOID_2018 0.01685669 0.07266257 1.000 1.000 STREICHER_LSM1_TARGETS_DN cerebral infarction DOID_3526 0.01758357 0.07522596 1.000 1.000 STREICHER_LSM1_TARGETS_DN neuritis DOID_1803 0.01830995 0.07774898 1.000 1.000 STREICHER_LSM1_TARGETS_DN heart valve disease DOID_4079 0.01830995 0.07717306 1.000 1.000 STREICHER_LSM1_TARGETS_DN vascular skin disease DOID_9540 0.01830995 0.07660561 1.000 1.000 STREICHER_LSM1_TARGETS_DN hemolytic anemia DOID_583 0.01867296 0.0775541 1.000 1.000 STREICHER_LSM1_TARGETS_DN normocytic anemia DOID_720 0.01867296 0.0775541 1.000 1.000 STREICHER_LSM1_TARGETS_DN integumentary system benign neoplasm DOID_0060121 0.01903584 0.07848833 1.000 1.000 STREICHER_LSM1_TARGETS_DN pulmonary tuberculosis DOID_2957 0.01903584 0.07792367 1.000 1.000 STREICHER_LSM1_TARGETS_DN skin benign neoplasm DOID_3165 0.01903584 0.07848833 1.000 1.000 STREICHER_LSM1_TARGETS_DN lung small cell carcinoma DOID_5409 0.01903584 0.07736707 1.000 1.000 STREICHER_LSM1_TARGETS_DN calcium metabolism disease DOID_10575 0.01939859 0.07828225 1.000 1.000 STREICHER_LSM1_TARGETS_DN hemorrhagic disease DOID_2213 0.01976122 0.07918404 0.01976122 0.46850555 STREICHER_LSM1_TARGETS_DN orofacial cleft DOID_0050567 0.02012372 0.08007272 1.000 1.000 STREICHER_LSM1_TARGETS_DN atopic dermatitis DOID_3310 0.02012372 0.07951666 1.000 1.000 STREICHER_LSM1_TARGETS_DN sarcoidosis DOID_11335 0.0204861 0.0803903 1.000 1.000 STREICHER_LSM1_TARGETS_DN atrophic muscular disease DOID_913 0.0204861 0.07983968 1.000 1.000 STREICHER_LSM1_TARGETS_DN muscular dystrophy DOID_9884 0.0204861 0.07983968 1.000 1.000 STREICHER_LSM1_TARGETS_DN vasculitis DOID_865 0.02084836 0.08069875 1.000 1.000 STREICHER_LSM1_TARGETS_DN osteochondrodysplasia DOID_2256 0.02121049 0.08154574 1.000 1.000 STREICHER_LSM1_TARGETS_DN parasitic protozoa infectious disease DOID_2789 0.02121049 0.08099845 1.000 1.000 STREICHER_LSM1_TARGETS_DN pustulosis of palm and sole DOID_4398 0.02121049 0.08045846 1.000 1.000 STREICHER_LSM1_TARGETS_DN familial hyperlipidemia DOID_1168 0.0215725 0.08128974 1.000 1.000 STREICHER_LSM1_TARGETS_DN mitochondrial metabolism disease DOID_700 0.0215725 0.08075494 1.000 1.000 STREICHER_LSM1_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 0.02229614 0.08291832 1.000 1.000 STREICHER_LSM1_TARGETS_DN leukocyte disease DOID_9500 0.02265777 0.08371606 0.02265777 0.49585665 STREICHER_LSM1_TARGETS_DN carotid artery disease DOID_3407 0.02338067 0.08582968 1.000 1.000 STREICHER_LSM1_TARGETS_DN pre-malignant neoplasm DOID_0060071 0.02410307 0.0879144 0.02410307 0.50794984 STREICHER_LSM1_TARGETS_DN in situ carcinoma DOID_8719 0.02410307 0.0879144 0.02410307 0.50794984 STREICHER_LSM1_TARGETS_DN mineral metabolism disease DOID_0050032 0.02446408 0.08866282 1.000 1.000 STREICHER_LSM1_TARGETS_DN endocrine pancreas disease DOID_1428 0.02446408 0.08810166 1.000 1.000 STREICHER_LSM1_TARGETS_DN cholestasis DOID_13580 0.02482497 0.08883905 1.000 1.000 STREICHER_LSM1_TARGETS_DN parasitic infectious disease DOID_1398 0.02482497 0.0882838 1.000 1.000 STREICHER_LSM1_TARGETS_DN hyperglycemia DOID_4195 0.02518574 0.08901046 1.000 1.000 STREICHER_LSM1_TARGETS_DN tuberculosis DOID_399 0.0259069 0.09099397 1.000 1.000 STREICHER_LSM1_TARGETS_DN blood coagulation disease DOID_1247 0.02662756 0.09295142 0.02662756 0.54111006 STREICHER_LSM1_TARGETS_DN bile duct disease DOID_4138 0.02698771 0.09363418 1.000 1.000 STREICHER_LSM1_TARGETS_DN male reproductive system disease DOID_48 0.02698771 0.0930667 1.000 1.000 STREICHER_LSM1_TARGETS_DN peripheral vascular disease DOID_341 0.02734773 0.09374011 1.000 1.000 STREICHER_LSM1_TARGETS_DN syndrome DOID_225 0.02842705 0.09685625 0.02842705 0.55775841 STREICHER_LSM1_TARGETS_DN aneurysm disease DOID_2403 0.02878658 0.09749741 1.000 1.000 STREICHER_LSM1_TARGETS_DN electroclinical syndrome DOID_0050701 0.02914599 0.09813057 1.000 1.000 STREICHER_LSM1_TARGETS_DN mixed glioma DOID_5076 0.02914599 0.09755333 1.000 1.000 STREICHER_LSM1_TARGETS_DN lipid metabolism disorder DOID_3146 0.02986442 0.09937344 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP primary immunodeficiency disease DOID_612 7.054E-29 4.014E-26 1.517E-25 8.631E-23 SMID_BREAST_CANCER_NORMAL_LIKE_UP B cell deficiency DOID_2115 6.011E-21 1.71E-18 6.585E-17 1.873E-14 SMID_BREAST_CANCER_NORMAL_LIKE_UP blood protein disease DOID_620 5.431E-19 1.03E-16 1.023E-14 1.939E-12 SMID_BREAST_CANCER_NORMAL_LIKE_UP hypersensitivity reaction type I disease DOID_1205 1.005E-18 1.43E-16 4.727E-13 4.483E-11 SMID_BREAST_CANCER_NORMAL_LIKE_UP agammaglobulinemia DOID_2583 4.133E-17 4.703E-15 6.323E-13 5.14E-11 SMID_BREAST_CANCER_NORMAL_LIKE_UP tuberculosis DOID_399 2.088E-16 1.98E-14 3.248E-09 1.087E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP primary bacterial infectious disease DOID_0050338 2.105E-16 1.711E-14 1.435E-09 5.103E-08 SMID_BREAST_CANCER_NORMAL_LIKE_UP Crohn's disease DOID_8778 6.885E-16 4.897E-14 4.121E-13 4.689E-11 SMID_BREAST_CANCER_NORMAL_LIKE_UP Human immunodeficiency virus infectious disease DOID_526 9.501E-15 6.007E-13 1.079E-10 6.141E-09 SMID_BREAST_CANCER_NORMAL_LIKE_UP lymphoblastic leukemia DOID_1037 1.511E-14 8.596E-13 3.586E-13 5.102E-11 SMID_BREAST_CANCER_NORMAL_LIKE_UP hypersensitivity reaction type IV disease DOID_2916 3.11E-14 1.609E-12 8.074E-10 3.063E-08 SMID_BREAST_CANCER_NORMAL_LIKE_UP encephalomyelitis DOID_640 3.586E-13 1.701E-11 4.381E-08 9.588E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP sarcoidosis DOID_11335 3.794E-13 1.66E-11 9.35E-09 2.418E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP peripheral vascular disease DOID_341 4.25E-13 1.727E-11 5.336E-09 1.518E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP ulcerative colitis DOID_8577 7.068E-13 2.681E-11 1.447E-11 1.029E-09 SMID_BREAST_CANCER_NORMAL_LIKE_UP metabolic syndrome X DOID_14221 1.286E-12 4.575E-11 1.189E-08 2.82E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP contact dermatitis DOID_2773 1.286E-12 4.306E-11 3.004E-11 1.899E-09 SMID_BREAST_CANCER_NORMAL_LIKE_UP collagen disease DOID_854 1.797E-12 5.68E-11 5.303E-07 9.144E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP allergic contact dermatitis DOID_3042 5.025E-12 1.505E-10 1.268E-10 6.561E-09 SMID_BREAST_CANCER_NORMAL_LIKE_UP autoimmune disease of gastrointestinal tract DOID_0060031 5.695E-12 1.62E-10 4.438E-05 3.607E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP lymphoma DOID_0060058 6.847E-12 1.855E-10 1.368E-10 6.487E-09 SMID_BREAST_CANCER_NORMAL_LIKE_UP urticaria DOID_1555 1.249E-11 3.23E-10 3.403E-08 7.745E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP common variable immunodeficiency DOID_12177 7.505E-11 1.857E-09 9.763E-07 1.587E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP parasitic infectious disease DOID_1398 9.42E-11 2.233E-09 1.243E-05 1.387E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP neuritis DOID_1803 1.253E-10 2.853E-09 9.325E-08 1.965E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP vascular skin disease DOID_9540 1.253E-10 2.743E-09 9.325E-08 1.895E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP chronic leukemia DOID_1036 1.775E-10 3.741E-09 6.91E-09 1.872E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP chronic lymphocytic leukemia DOID_1040 1.775E-10 3.741E-09 6.91E-09 1.872E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP pulmonary tuberculosis DOID_2957 1.817E-10 3.692E-09 4.438E-05 3.557E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP atopic dermatitis DOID_3310 3.079E-10 6.041E-09 1.835E-07 3.48E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP bacterial pneumonia DOID_874 4.929E-10 9.349E-09 1.634E-07 3.205E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP parasitic protozoa infectious disease DOID_2789 5.056E-10 9.28E-09 7.543E-05 5.574E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP severe combined immunodeficiency DOID_627 5.266E-10 9.364E-09 5.266E-10 2.305E-08 SMID_BREAST_CANCER_NORMAL_LIKE_UP combined T cell and B cell immunodeficiency DOID_628 7.161E-10 1.235E-08 7.161E-10 2.91E-08 SMID_BREAST_CANCER_NORMAL_LIKE_UP ankylosing spondylitis DOID_7147 9.605E-10 1.607E-08 1.606E-06 2.539E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP thyroiditis DOID_7166 1.261E-09 2.049E-08 2.167E-04 1.326E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP autoimmune thyroiditis DOID_7188 1.261E-09 2.049E-08 2.167E-04 1.326E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP uterine disease DOID_345 2.192E-09 3.464E-08 1.243E-05 1.36E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP dilated cardiomyopathy DOID_12930 3.367E-09 5.178E-08 3.367E-09 1.064E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP MHC class II deficiency DOID_5812 4.191E-09 6.275E-08 4.191E-09 1.255E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP celiac disease DOID_10608 5.564E-09 8.117E-08 1.198E-04 8.019E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP autoimmune hepatitis DOID_2048 8.277E-09 1.177E-07 0.14610739 0.24237641 SMID_BREAST_CANCER_NORMAL_LIKE_UP atrophic muscular disease DOID_913 9.35E-09 1.298E-07 2.084E-07 3.825E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP muscular dystrophy DOID_9884 9.35E-09 1.298E-07 2.084E-07 3.825E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP mixed glioma DOID_5076 9.536E-09 1.292E-07 9.536E-09 2.359E-07 SMID_BREAST_CANCER_NORMAL_LIKE_UP vasculitis DOID_865 1.081E-08 1.43E-07 4.415E-06 5.461E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP female reproductive system disease DOID_229 1.325E-08 1.714E-07 3.902E-05 3.218E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP pulmonary sarcoidosis DOID_13406 1.855E-08 2.346E-07 5.195E-07 9.238E-06 SMID_BREAST_CANCER_NORMAL_LIKE_UP retinal vascular disease DOID_2462 2.015E-08 2.492E-07 4.308E-06 5.447E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP hepatitis DOID_2237 2.651E-08 3.209E-07 7.011E-07 1.173E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP systemic scleroderma DOID_418 2.651E-08 3.142E-07 1.544E-05 1.627E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP myositis DOID_633 4.348E-08 5.049E-07 4.724E-05 3.733E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP endometriosis of uterus DOID_288 4.374E-08 4.978E-07 2.177E-05 1.998E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP rheumatic disease DOID_1575 5.126E-08 5.72E-07 2.428E-05 2.159E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP endometriosis DOID_289 5.126E-08 5.61E-07 2.428E-05 2.125E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP scleroderma DOID_419 5.126E-08 5.72E-07 2.428E-05 2.159E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP vitiligo DOID_12306 5.499E-08 5.903E-07 5.479E-05 4.27E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP influenza DOID_8469 5.985E-08 6.307E-07 4.268E-04 2.249E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP Sciatic Neuropathy DOID_11446 6.89E-08 7.128E-07 6.318E-05 4.858E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP lesion of sciatic nerve DOID_12528 6.89E-08 7.128E-07 6.318E-05 4.858E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP mononeuritis of lower limb DOID_9473 6.89E-08 7.128E-07 6.318E-05 4.858E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP mononeuritis DOID_1802 8.558E-08 8.696E-07 7.247E-05 5.426E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP male reproductive system disease DOID_48 8.829E-08 8.814E-07 2.026E-05 1.988E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP hemolytic-uremic syndrome DOID_12554 9.299E-08 9.122E-07 5.227E-06 6.329E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP autoimmune disease of endocrine system DOID_0060005 1.055E-07 1.017E-06 1.601E-03 6.953E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP mononeuropathy DOID_1188 1.055E-07 1E-06 8.272E-05 6.034E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP hemolytic anemia DOID_583 1.074E-07 1.002E-06 2.275E-06 3.498E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP normocytic anemia DOID_720 1.074E-07 1.002E-06 2.275E-06 3.498E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP diabetic retinopathy DOID_8947 1.09E-07 1.001E-06 2.361E-05 2.133E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP juvenile rheumatoid arthritis DOID_676 1.309E-07 1.182E-06 2.617E-04 1.504E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP aortic aneurysm DOID_3627 1.412E-07 1.255E-06 2.864E-06 3.974E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP aneurysm disease DOID_2403 1.48E-07 1.295E-06 2.946E-05 2.502E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP B-cell lymphocytic neoplasm DOID_707 1.612E-07 1.389E-06 3.202E-06 4.237E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP myocarditis DOID_820 2.703E-07 2.296E-06 7.099E-06 8.415E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP periodontal disease DOID_3388 3.206E-07 2.683E-06 1.676E-04 1.084E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP membranous glomerulonephritis DOID_10976 3.22E-07 2.656E-06 1.359E-05 1.459E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP multiple myeloma DOID_9538 5.195E-07 4.223E-06 2.279E-04 1.379E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP carotid artery disease DOID_3407 5.303E-07 4.25E-06 8.729E-06 1.014E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP funisitis DOID_0050698 5.403E-07 4.27E-06 2.028E-05 1.956E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP uveitis DOID_13141 6.048E-07 4.714E-06 2.51E-04 1.472E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP angioedema DOID_1558 6.25E-07 4.805E-06 2.419E-03 9.76E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP meningitis DOID_9471 8.615E-07 6.536E-06 2.911E-05 2.51E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP temporal arteritis DOID_13375 9.763E-07 7.309E-06 2.941E-03 0.01108406 SMID_BREAST_CANCER_NORMAL_LIKE_UP central nervous system vasculitis DOID_525 9.763E-07 7.309E-06 2.941E-03 0.01108406 SMID_BREAST_CANCER_NORMAL_LIKE_UP autoimmune disease of urogenital tract DOID_0060049 1.068E-06 7.895E-06 2.177E-05 2.031E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP primary biliary cirrhosis DOID_12236 1.068E-06 7.895E-06 2.177E-05 2.031E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP uveal disease DOID_3480 1.221E-06 8.906E-06 3.928E-04 2.108E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP blood coagulation disease DOID_1247 1.313E-06 9.459E-06 1.873E-05 1.87E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP bronchiolitis DOID_2942 1.317E-06 9.367E-06 9.519E-04 4.44E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP myeloma DOID_0070004 2.02E-06 1.419E-05 5.415E-04 2.703E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP diffuse large B-cell lymphoma DOID_0050745 2.334E-06 1.62E-05 2.334E-06 3.495E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP periodontitis DOID_824 2.334E-06 1.6E-05 1.316E-03 5.804E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP pancreatitis DOID_4989 2.449E-06 1.659E-05 3.461E-04 1.912E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP glaucoma DOID_1686 2.556E-06 1.711E-05 2.556E-06 3.728E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP sarcoma DOID_1115 2.784E-06 1.842E-05 7.247E-05 5.498E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP malaria DOID_12365 2.784E-06 1.821E-05 2.784E-06 3.96E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP bacterial meningitis DOID_9470 2.909E-06 1.881E-05 2.909E-06 3.941E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP corneal disease DOID_10124 3.886E-06 2.485E-05 9.398E-05 6.602E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP membranoproliferative glomerulonephritis DOID_2920 3.944E-06 2.493E-05 3.944E-06 5.1E-05 SMID_BREAST_CANCER_NORMAL_LIKE_UP adrenal cortex disease DOID_3952 3.944E-06 2.466E-05 5.506E-03 0.01810818 SMID_BREAST_CANCER_NORMAL_LIKE_UP bone marrow cancer DOID_4960 4.415E-06 2.73E-05 8.914E-04 4.227E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP pleural disease DOID_1532 6.151E-06 3.763E-05 0.02828451 0.07089818 SMID_BREAST_CANCER_NORMAL_LIKE_UP adrenal gland disease DOID_9553 6.796E-06 4.114E-05 7.061E-03 0.02244578 SMID_BREAST_CANCER_NORMAL_LIKE_UP systemic mycosis DOID_0050136 7.099E-06 4.252E-05 0.02980279 0.07437627 SMID_BREAST_CANCER_NORMAL_LIKE_UP fungal infectious disease DOID_1564 7.099E-06 4.252E-05 0.02980279 0.07437627 SMID_BREAST_CANCER_NORMAL_LIKE_UP pneumoconiosis DOID_10316 8.158E-06 4.835E-05 2.677E-03 0.0104337 SMID_BREAST_CANCER_NORMAL_LIKE_UP esophageal disease DOID_6050 8.158E-06 4.786E-05 0.03135283 0.07656549 SMID_BREAST_CANCER_NORMAL_LIKE_UP pre-malignant neoplasm DOID_0060071 1.045E-05 6.066E-05 1.401E-04 9.164E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP in situ carcinoma DOID_8719 1.045E-05 6.066E-05 1.401E-04 9.164E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP adenoma DOID_657 1.064E-05 6.118E-05 1.064E-05 1.211E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP peripheral nervous system neoplasm DOID_1192 1.369E-05 7.788E-05 2.51E-04 1.488E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP tooth disease DOID_1091 1.47E-05 8.283E-05 1.918E-03 8.083E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP congenital diaphragmatic hernia DOID_3827 1.544E-05 8.614E-05 2.758E-04 1.569E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP peptic ulcer DOID_750 1.544E-05 8.53E-05 3.848E-03 0.01394646 SMID_BREAST_CANCER_NORMAL_LIKE_UP endocrine organ benign neoplasm DOID_0060089 1.596E-05 8.732E-05 1.596E-05 1.651E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP adult respiratory distress syndrome DOID_11394 1.737E-05 9.411E-05 1.737E-05 1.765E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP intracranial arterial disease DOID_13089 1.737E-05 9.322E-05 4.114E-03 0.0148159 SMID_BREAST_CANCER_NORMAL_LIKE_UP cerebral arterial disease DOID_3527 1.737E-05 9.322E-05 4.114E-03 0.0148159 SMID_BREAST_CANCER_NORMAL_LIKE_UP bile duct disease DOID_4138 2.026E-05 1.077E-04 2.405E-04 1.441E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP thrombophilia DOID_2452 2.028E-05 1.068E-04 2.028E-05 1.923E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP biliary tract disease DOID_9741 2.188E-05 1.142E-04 2.562E-04 1.487E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP hyperinsulinism DOID_2018 2.428E-05 1.256E-04 3.928E-04 2.129E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP diabetic autonomic neuropathy DOID_11503 2.701E-05 1.384E-04 4.268E-04 2.27E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP autonomic neuropathy DOID_11504 2.701E-05 1.384E-04 4.268E-04 2.27E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP diabetic polyneuropathy DOID_12785 2.701E-05 1.384E-04 4.268E-04 2.27E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP diabetic neuropathy DOID_9743 2.701E-05 1.384E-04 4.268E-04 2.27E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP endogenous depression DOID_1595 2.74E-05 1.392E-04 3.077E-04 1.733E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP syndrome DOID_225 2.74E-05 1.379E-04 3.077E-04 1.716E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP Goodpasture syndrome DOID_9808 2.911E-05 1.453E-04 0.16516509 0.26398577 SMID_BREAST_CANCER_NORMAL_LIKE_UP pre-eclampsia DOID_10591 3.662E-05 1.812E-04 5.415E-04 2.679E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP autonomic nervous system disease DOID_11465 3.662E-05 1.796E-04 5.415E-04 2.656E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP thyroid adenoma DOID_2891 3.662E-05 1.781E-04 3.662E-05 3.065E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP lung small cell carcinoma DOID_5409 4.438E-05 2.14E-04 6.291E-04 3.034E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP mental depression DOID_1596 4.465E-05 2.135E-04 4.581E-04 2.328E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP conjunctival disease DOID_4251 4.801E-05 2.277E-04 2.419E-03 9.557E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP conjunctivitis DOID_6195 4.801E-05 2.277E-04 2.419E-03 9.557E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP trypanosomiasis DOID_10113 6.565E-05 3.087E-04 0.07939543 0.16794051 SMID_BREAST_CANCER_NORMAL_LIKE_UP pneumocystosis DOID_11339 6.565E-05 3.062E-04 0.07939543 0.1667011 SMID_BREAST_CANCER_NORMAL_LIKE_UP prediabetes syndrome DOID_11716 6.565E-05 3.037E-04 2.941E-03 0.01115795 SMID_BREAST_CANCER_NORMAL_LIKE_UP pleurisy DOID_10247 7.247E-05 3.326E-04 0.02118935 0.05633991 SMID_BREAST_CANCER_NORMAL_LIKE_UP toxic encephalopathy DOID_3602 8.272E-05 3.765E-04 8.272E-05 5.958E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP epidermolysis bullosa DOID_2730 8.705E-05 3.931E-04 8.705E-05 6.191E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP mouth disease DOID_403 8.836E-05 3.959E-04 5.973E-03 0.01942164 SMID_BREAST_CANCER_NORMAL_LIKE_UP oral cavity cancer DOID_8618 9.616E-05 4.274E-04 9.616E-05 6.672E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP melancholia DOID_2848 1.04E-04 4.585E-04 1.223E-03 5.478E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP age related macular degeneration DOID_10871 1.063E-04 4.653E-04 1.063E-04 7.288E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP degeneration of macula and posterior pole DOID_2007 1.063E-04 4.653E-04 1.063E-04 7.288E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP opportunistic mycosis DOID_2473 1.063E-04 4.618E-04 0.02534547 0.06496203 SMID_BREAST_CANCER_NORMAL_LIKE_UP bronchiolitis obliterans DOID_2799 1.063E-04 4.583E-04 0.02534547 0.06467072 SMID_BREAST_CANCER_NORMAL_LIKE_UP neurotic disorder DOID_4964 1.122E-04 4.802E-04 1.298E-03 5.769E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP polyneuropathy DOID_1389 1.125E-04 4.779E-04 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP vesiculobullous skin disease DOID_2731 1.125E-04 4.743E-04 1.125E-04 7.623E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP respiratory failure DOID_11162 1.303E-04 5.451E-04 1.303E-04 8.62E-04 SMID_BREAST_CANCER_NORMAL_LIKE_UP autonomic nervous system neoplasm DOID_2621 1.344E-04 5.584E-04 2.28E-03 9.401E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP neuroblastoma DOID_769 1.344E-04 5.584E-04 2.28E-03 9.401E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP eyelid disease DOID_530 1.424E-04 5.873E-04 4.795E-03 0.01653607 SMID_BREAST_CANCER_NORMAL_LIKE_UP endocrine pancreas disease DOID_1428 1.505E-04 6.16E-04 1.631E-03 7.033E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP cholestasis DOID_13580 1.615E-04 6.562E-04 1.723E-03 7.373E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP macular degeneration DOID_4448 1.676E-04 6.764E-04 1.676E-04 1.072E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP hyperglycemia DOID_4195 1.73E-04 6.932E-04 0.01515171 0.04289216 SMID_BREAST_CANCER_NORMAL_LIKE_UP idiopathic pulmonary fibrosis DOID_0050156 1.771E-04 7.045E-04 5.506E-03 0.01853677 SMID_BREAST_CANCER_NORMAL_LIKE_UP corneal dystrophy DOID_2566 1.771E-04 6.996E-04 1.771E-04 1.119E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP lung oat cell carcinoma DOID_5411 1.771E-04 6.948E-04 5.506E-03 0.01800411 SMID_BREAST_CANCER_NORMAL_LIKE_UP brain infarction DOID_3454 1.98E-04 7.717E-04 0.01634974 0.04560295 SMID_BREAST_CANCER_NORMAL_LIKE_UP angiosarcoma DOID_0001816 2.167E-04 8.388E-04 2.167E-04 1.355E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP silicosis DOID_10325 2.167E-04 8.331E-04 2.167E-04 1.34E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP nephrosis DOID_2527 2.405E-04 9.186E-04 2.351E-03 9.625E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP lipid metabolism disorder DOID_3146 3.881E-04 1.472E-03 3.881E-04 2.123E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP esophagitis DOID_11963 4.315E-04 1.626E-03 0.13965898 0.23441286 SMID_BREAST_CANCER_NORMAL_LIKE_UP brain edema DOID_4724 4.315E-04 1.615E-03 4.315E-04 2.252E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP amyloidosis DOID_9120 4.315E-04 1.605E-03 4.315E-04 2.232E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP alcohol abuse DOID_1574 4.581E-04 1.693E-03 4.581E-04 2.348E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP focal epilepsy DOID_2234 4.581E-04 1.682E-03 4.581E-04 2.307E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP cerebral infarction DOID_3526 4.629E-04 1.688E-03 0.05034403 0.11597472 SMID_BREAST_CANCER_NORMAL_LIKE_UP gastric ulcer DOID_10808 5.764E-04 2.089E-03 5.764E-04 2.803E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP nervous system cancer DOID_3093 6.583E-04 2.371E-03 5.142E-03 0.01762563 SMID_BREAST_CANCER_NORMAL_LIKE_UP sleep disorder DOID_535 6.593E-04 2.359E-03 0.15886009 0.25534291 SMID_BREAST_CANCER_NORMAL_LIKE_UP pulmonary embolism DOID_9477 6.593E-04 2.344E-03 6.593E-04 3.152E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP calcium metabolism disease DOID_10575 6.765E-04 2.391E-03 0.06003629 0.13609821 SMID_BREAST_CANCER_NORMAL_LIKE_UP hemorrhagic disease DOID_2213 7.263E-04 2.551E-03 7.785E-03 0.02460858 SMID_BREAST_CANCER_NORMAL_LIKE_UP diabetic angiopathy DOID_11713 7.493E-04 2.616E-03 0.01384515 0.04019333 SMID_BREAST_CANCER_NORMAL_LIKE_UP toxic shock syndrome DOID_14115 8.467E-04 2.938E-03 0.01497545 0.04260516 SMID_BREAST_CANCER_NORMAL_LIKE_UP bile duct adenocarcinoma DOID_4896 8.914E-04 3.074E-03 9.034E-03 0.02778525 SMID_BREAST_CANCER_NORMAL_LIKE_UP cholangiocarcinoma DOID_4947 8.914E-04 3.074E-03 9.034E-03 0.02778525 SMID_BREAST_CANCER_NORMAL_LIKE_UP reproductive organ benign neoplasm DOID_0050622 9.519E-04 3.263E-03 9.519E-04 4.476E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP integumentary system cancer DOID_0060122 9.519E-04 3.243E-03 9.475E-03 0.02898445 SMID_BREAST_CANCER_NORMAL_LIKE_UP skin cancer DOID_4159 9.519E-04 3.243E-03 9.475E-03 0.02898445 SMID_BREAST_CANCER_NORMAL_LIKE_UP pustulosis of palm and sole DOID_4398 9.519E-04 3.224E-03 0.07030685 0.15749841 SMID_BREAST_CANCER_NORMAL_LIKE_UP commensal bacterial infectious disease DOID_0050339 9.519E-04 3.205E-03 0.01614408 0.04547515 SMID_BREAST_CANCER_NORMAL_LIKE_UP familial hyperlipidemia DOID_1168 1.015E-03 3.398E-03 1.015E-03 4.696E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP morbid obesity DOID_11981 1.065E-03 3.544E-03 1.065E-03 4.887E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP papillary adenoma DOID_3172 1.065E-03 3.523E-03 1.065E-03 4.848E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP microcystic adenoma DOID_5403 1.065E-03 3.523E-03 1.065E-03 4.848E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP follicular adenoma DOID_6204 1.065E-03 3.523E-03 1.065E-03 4.848E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP hypertrophic cardiomyopathy DOID_11984 1.15E-03 3.784E-03 1.15E-03 5.195E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP bile duct cancer DOID_4606 1.15E-03 3.762E-03 0.0108716 0.03272984 SMID_BREAST_CANCER_NORMAL_LIKE_UP bile duct carcinoma DOID_4897 1.15E-03 3.762E-03 0.0108716 0.03272984 SMID_BREAST_CANCER_NORMAL_LIKE_UP spinal cord disease DOID_319 1.186E-03 3.857E-03 0.18991761 0.29525443 SMID_BREAST_CANCER_NORMAL_LIKE_UP middle cerebral artery infarction DOID_3525 1.186E-03 3.835E-03 0.18991761 0.29444992 SMID_BREAST_CANCER_NORMAL_LIKE_UP leukocyte disease DOID_9500 1.223E-03 3.93E-03 0.01136223 0.03402688 SMID_BREAST_CANCER_NORMAL_LIKE_UP gestational diabetes DOID_11714 1.316E-03 4.206E-03 0.01987366 0.05384815 SMID_BREAST_CANCER_NORMAL_LIKE_UP perinatal necrotizing enterocolitis DOID_8677 1.316E-03 4.183E-03 1.316E-03 5.759E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP hypothyroidism DOID_1459 1.458E-03 4.609E-03 0.08555203 0.17701494 SMID_BREAST_CANCER_NORMAL_LIKE_UP mineral metabolism disease DOID_0050032 1.631E-03 5.129E-03 0.09007596 0.17920706 SMID_BREAST_CANCER_NORMAL_LIKE_UP temporal lobe epilepsy DOID_3328 1.819E-03 5.686E-03 1.819E-03 7.723E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP endometrial cancer DOID_1380 2.096E-03 6.518E-03 2.096E-03 8.77E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP allergic rhinitis DOID_4481 2.096E-03 6.482E-03 2.096E-03 8.706E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP Sjogren's syndrome DOID_12894 2.419E-03 7.439E-03 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP familial combined hyperlipidemia DOID_13809 2.419E-03 7.399E-03 2.419E-03 9.83E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP retinal vascular occlusion DOID_1729 2.419E-03 7.359E-03 0.07244506 0.15793579 SMID_BREAST_CANCER_NORMAL_LIKE_UP chondrosarcoma DOID_3371 2.419E-03 7.32E-03 2.419E-03 9.691E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP insulinoma DOID_3892 2.419E-03 7.281E-03 2.419E-03 9.624E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP papilloma DOID_2615 2.474E-03 7.408E-03 2.474E-03 9.707E-03 SMID_BREAST_CANCER_NORMAL_LIKE_UP male infertility DOID_12336 2.677E-03 7.975E-03 2.677E-03 0.01036272 SMID_BREAST_CANCER_NORMAL_LIKE_UP hepatitis C DOID_1883 2.677E-03 7.934E-03 0.03135283 0.07756417 SMID_BREAST_CANCER_NORMAL_LIKE_UP nephroblastoma DOID_2154 2.677E-03 7.893E-03 2.677E-03 0.0102927 SMID_BREAST_CANCER_NORMAL_LIKE_UP cystic fibrosis DOID_1485 2.848E-03 8.352E-03 0.11610947 0.20645716 SMID_BREAST_CANCER_NORMAL_LIKE_UP sickle cell anemia DOID_10923 2.941E-03 8.583E-03 2.941E-03 0.01123284 SMID_BREAST_CANCER_NORMAL_LIKE_UP bone resorption disease DOID_0080011 2.982E-03 8.657E-03 0.02166013 0.05679546 SMID_BREAST_CANCER_NORMAL_LIKE_UP osteoporosis DOID_11476 2.982E-03 8.657E-03 0.02166013 0.05679546 SMID_BREAST_CANCER_NORMAL_LIKE_UP refractive error DOID_9835 3.114E-03 8.995E-03 3.114E-03 0.01165851 SMID_BREAST_CANCER_NORMAL_LIKE_UP calcinosis DOID_182 3.348E-03 9.623E-03 0.03618791 0.08615447 SMID_BREAST_CANCER_NORMAL_LIKE_UP cleft palate DOID_674 3.348E-03 9.574E-03 3.348E-03 0.01245271 SMID_BREAST_CANCER_NORMAL_LIKE_UP embryonal cancer DOID_688 3.348E-03 9.526E-03 0.03618791 0.08543949 SMID_BREAST_CANCER_NORMAL_LIKE_UP esophageal carcinoma DOID_1107 3.512E-03 9.943E-03 3.512E-03 0.01297743 SMID_BREAST_CANCER_NORMAL_LIKE_UP beta thalassemia DOID_12241 3.512E-03 9.894E-03 3.512E-03 0.01289371 SMID_BREAST_CANCER_NORMAL_LIKE_UP islet cell tumor DOID_1799 3.512E-03 9.845E-03 3.512E-03 0.01281106 SMID_BREAST_CANCER_NORMAL_LIKE_UP esophagus squamous cell carcinoma DOID_3748 3.512E-03 9.943E-03 3.512E-03 0.01297743 SMID_BREAST_CANCER_NORMAL_LIKE_UP stomach disease DOID_76 3.512E-03 9.797E-03 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP lipodystrophy DOID_811 3.512E-03 9.749E-03 0.08629389 0.17350255 SMID_BREAST_CANCER_NORMAL_LIKE_UP encephalitis DOID_9588 3.512E-03 9.702E-03 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP respiratory syncytial virus infectious disease DOID_1273 3.848E-03 0.01057775 0.2709315 0.39834632 SMID_BREAST_CANCER_NORMAL_LIKE_UP biliary tract cancer DOID_4607 3.881E-03 0.01061624 0.02618919 0.06652523 SMID_BREAST_CANCER_NORMAL_LIKE_UP chronic kidney failure DOID_784 3.881E-03 0.01056545 0.13354224 0.22480927 SMID_BREAST_CANCER_NORMAL_LIKE_UP adenoid cystic carcinoma DOID_4866 4.114E-03 0.0111472 4.114E-03 0.01472271 SMID_BREAST_CANCER_NORMAL_LIKE_UP berylliosis DOID_10322 4.13E-03 0.01113863 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP essential hypertension DOID_10825 4.13E-03 0.01108609 4.13E-03 0.01468907 SMID_BREAST_CANCER_NORMAL_LIKE_UP intracranial thrombosis DOID_4193 4.13E-03 0.01103404 4.13E-03 0.01459783 SMID_BREAST_CANCER_NORMAL_LIKE_UP psoriatic arthritis DOID_9008 4.13E-03 0.01098248 0.09314084 0.17965131 SMID_BREAST_CANCER_NORMAL_LIKE_UP pulmonary emphysema DOID_9675 4.391E-03 0.01162062 0.04304613 0.10079526 SMID_BREAST_CANCER_NORMAL_LIKE_UP salivary gland cancer DOID_8850 4.679E-03 0.01232514 4.679E-03 0.01643353 SMID_BREAST_CANCER_NORMAL_LIKE_UP alcohol dependence DOID_0050741 4.795E-03 0.01257351 4.795E-03 0.01673897 SMID_BREAST_CANCER_NORMAL_LIKE_UP Legionnaires' disease DOID_10457 4.795E-03 0.01251584 4.795E-03 0.0166369 SMID_BREAST_CANCER_NORMAL_LIKE_UP legionellosis DOID_10458 4.795E-03 0.01251584 4.795E-03 0.0166369 SMID_BREAST_CANCER_NORMAL_LIKE_UP tethered spinal cord syndrome DOID_1089 4.795E-03 0.01245869 0.09993666 0.19081865 SMID_BREAST_CANCER_NORMAL_LIKE_UP narcolepsy DOID_8986 4.795E-03 0.01240206 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP nephrotic syndrome DOID_1184 4.978E-03 0.01281618 0.04664215 0.10832401 SMID_BREAST_CANCER_NORMAL_LIKE_UP gallbladder cancer DOID_3121 5.288E-03 0.01355376 5.288E-03 0.01801757 SMID_BREAST_CANCER_NORMAL_LIKE_UP uterine cancer DOID_363 5.288E-03 0.01349298 5.288E-03 0.01791032 SMID_BREAST_CANCER_NORMAL_LIKE_UP thalassemia DOID_10241 5.506E-03 0.01398533 5.506E-03 0.01842774 SMID_BREAST_CANCER_NORMAL_LIKE_UP Ehlers-Danlos syndrome DOID_13359 5.506E-03 0.01392318 5.506E-03 0.01831997 SMID_BREAST_CANCER_NORMAL_LIKE_UP thoracic aortic aneurysm DOID_14004 5.506E-03 0.01386157 5.506E-03 0.01821346 SMID_BREAST_CANCER_NORMAL_LIKE_UP mesenchymal cell neoplasm DOID_3350 5.506E-03 0.01380051 0.10668173 0.19644629 SMID_BREAST_CANCER_NORMAL_LIKE_UP spindle cell sarcoma DOID_4235 5.506E-03 0.01380051 0.10668173 0.19644629 SMID_BREAST_CANCER_NORMAL_LIKE_UP epithelioid sarcoma DOID_6193 5.506E-03 0.01380051 0.10668173 0.19644629 SMID_BREAST_CANCER_NORMAL_LIKE_UP proteinuria DOID_576 5.943E-03 0.01483135 0.30835771 0.449886 SMID_BREAST_CANCER_NORMAL_LIKE_UP tongue cancer DOID_8649 6.261E-03 0.01555734 6.261E-03 0.02024222 SMID_BREAST_CANCER_NORMAL_LIKE_UP vein disease DOID_866 6.261E-03 0.0154897 6.261E-03 0.02012786 SMID_BREAST_CANCER_NORMAL_LIKE_UP integumentary system benign neoplasm DOID_0060121 7.012E-03 0.01727319 7.012E-03 0.02241633 SMID_BREAST_CANCER_NORMAL_LIKE_UP skin benign neoplasm DOID_3165 7.012E-03 0.01727319 7.012E-03 0.02241633 SMID_BREAST_CANCER_NORMAL_LIKE_UP basal cell carcinoma DOID_2513 7.061E-03 0.01731808 0.12002113 0.21143042 SMID_BREAST_CANCER_NORMAL_LIKE_UP congenital muscular dystrophy DOID_0050557 7.905E-03 0.01930389 7.905E-03 0.02484976 SMID_BREAST_CANCER_NORMAL_LIKE_UP inherited blood coagulation disease DOID_2214 7.905E-03 0.0192214 7.905E-03 0.02471323 SMID_BREAST_CANCER_NORMAL_LIKE_UP skin carcinoma DOID_3451 7.905E-03 0.01913961 0.12661622 0.21898063 SMID_BREAST_CANCER_NORMAL_LIKE_UP prion disease DOID_649 7.905E-03 0.01905851 0.12661622 0.21831705 SMID_BREAST_CANCER_NORMAL_LIKE_UP eosinophilia DOID_999 7.905E-03 0.01897809 0.12661622 0.21765748 SMID_BREAST_CANCER_NORMAL_LIKE_UP orofacial cleft DOID_0050567 8.189E-03 0.01957787 8.189E-03 0.02546192 SMID_BREAST_CANCER_NORMAL_LIKE_UP giant cell tumor DOID_200 8.605E-03 0.02048714 0.06613286 0.14873359 SMID_BREAST_CANCER_NORMAL_LIKE_UP malignant giant cell tumor DOID_2705 8.605E-03 0.02048714 0.06613286 0.14873359 SMID_BREAST_CANCER_NORMAL_LIKE_UP giant cell glioblastoma DOID_3074 8.605E-03 0.02048714 0.06613286 0.14873359 SMID_BREAST_CANCER_NORMAL_LIKE_UP granulosa cell tumor DOID_2999 8.791E-03 0.02084281 8.791E-03 0.02718627 SMID_BREAST_CANCER_NORMAL_LIKE_UP leishmaniasis DOID_9065 8.791E-03 0.02075632 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP sex cord-gonadal stromal tumor DOID_192 9.72E-03 0.02285456 9.72E-03 0.02957649 SMID_BREAST_CANCER_NORMAL_LIKE_UP colonic disease DOID_5353 9.72E-03 0.02276051 9.72E-03 0.02941917 SMID_BREAST_CANCER_NORMAL_LIKE_UP glioblastoma DOID_3068 0.0108716 0.02535221 0.07672352 0.16350442 SMID_BREAST_CANCER_NORMAL_LIKE_UP hepatitis B DOID_2043 0.01170213 0.0271776 0.15250764 0.2515271 SMID_BREAST_CANCER_NORMAL_LIKE_UP acquired immunodeficiency syndrome DOID_635 0.01170213 0.02706712 0.15250764 0.25080014 SMID_BREAST_CANCER_NORMAL_LIKE_UP placenta disease DOID_780 0.01170213 0.02695753 0.15250764 0.24935876 SMID_BREAST_CANCER_NORMAL_LIKE_UP neuroectodermal tumor DOID_171 0.0123813 0.0284071 0.0123813 0.03688461 SMID_BREAST_CANCER_NORMAL_LIKE_UP heart conduction disease DOID_10273 0.01275383 0.0291443 0.01275383 0.03779651 SMID_BREAST_CANCER_NORMAL_LIKE_UP muscle cancer DOID_4045 0.01275383 0.02902772 0.01275383 0.03760067 SMID_BREAST_CANCER_NORMAL_LIKE_UP myasthenia gravis DOID_437 0.01275383 0.02891207 0.15886009 0.25606626 SMID_BREAST_CANCER_NORMAL_LIKE_UP uremia DOID_4676 0.01275383 0.02879734 0.01275383 0.03740685 SMID_BREAST_CANCER_NORMAL_LIKE_UP congenital heart defect DOID_1682 0.01345112 0.03025173 0.01345112 0.03924968 SMID_BREAST_CANCER_NORMAL_LIKE_UP Lewy body dementia DOID_12217 0.01384515 0.03101533 0.01384515 0.0399893 SMID_BREAST_CANCER_NORMAL_LIKE_UP congenital hemolytic anemia DOID_589 0.01384515 0.0308937 0.01384515 0.03978734 SMID_BREAST_CANCER_NORMAL_LIKE_UP cerebral degeneration DOID_1443 0.01457202 0.03238859 0.01457202 0.04166573 SMID_BREAST_CANCER_NORMAL_LIKE_UP spastic quadriplegia DOID_10970 0.01497545 0.03315577 0.17142299 0.27322039 SMID_BREAST_CANCER_NORMAL_LIKE_UP portal hypertension DOID_10762 0.01614408 0.03560458 0.01614408 0.04525114 SMID_BREAST_CANCER_NORMAL_LIKE_UP hypogonadism DOID_1924 0.01614408 0.03546711 0.17763415 0.27998291 SMID_BREAST_CANCER_NORMAL_LIKE_UP astrocytoma DOID_3069 0.01696813 0.03713409 0.10168064 0.18907282 SMID_BREAST_CANCER_NORMAL_LIKE_UP spinal muscular atrophy DOID_12377 0.01735041 0.03782522 0.1837989 0.28889938 SMID_BREAST_CANCER_NORMAL_LIKE_UP neuromuscular junction disease DOID_439 0.01735041 0.03768084 0.1837989 0.28731202 SMID_BREAST_CANCER_NORMAL_LIKE_UP cleft lip DOID_9296 0.01735041 0.03753757 0.01735041 0.04815796 SMID_BREAST_CANCER_NORMAL_LIKE_UP pancreatic ductal carcinoma DOID_3587 0.01759946 0.03793216 0.01759946 0.04861209 SMID_BREAST_CANCER_NORMAL_LIKE_UP intracranial aneurysm DOID_10941 0.01859381 0.03992406 0.18991761 0.29606335 SMID_BREAST_CANCER_NORMAL_LIKE_UP myopia DOID_11830 0.01859381 0.03977397 0.01859381 0.05111051 SMID_BREAST_CANCER_NORMAL_LIKE_UP seminoma DOID_4440 0.01859381 0.039625 0.01859381 0.05086478 SMID_BREAST_CANCER_NORMAL_LIKE_UP extrinsic allergic alveolitis DOID_841 0.01859381 0.03947715 0.18991761 0.29285399 SMID_BREAST_CANCER_NORMAL_LIKE_UP pancreatic carcinoma DOID_4905 0.01957129 0.04139801 0.01957129 0.05328261 SMID_BREAST_CANCER_NORMAL_LIKE_UP lung adenocarcinoma DOID_3910 0.01987366 0.04188189 0.01987366 0.05359294 SMID_BREAST_CANCER_NORMAL_LIKE_UP migraine DOID_6364 0.01987366 0.04172735 0.01987366 0.05334015 SMID_BREAST_CANCER_NORMAL_LIKE_UP autoimmune disease of cardiovascular system DOID_0060051 0.02118935 0.04432625 0.02118935 0.05660442 SMID_BREAST_CANCER_NORMAL_LIKE_UP renal hypertension DOID_1073 0.02118935 0.04416388 0.02118935 0.05607786 SMID_BREAST_CANCER_NORMAL_LIKE_UP secondary hypertension DOID_11130 0.02118935 0.04416388 0.02118935 0.05607786 SMID_BREAST_CANCER_NORMAL_LIKE_UP Behcet's disease DOID_13241 0.02118935 0.04432625 0.02118935 0.05660442 SMID_BREAST_CANCER_NORMAL_LIKE_UP thrombocytopenia DOID_1588 0.02118935 0.0440027 0.20201824 0.31067129 SMID_BREAST_CANCER_NORMAL_LIKE_UP hepatic vascular disease DOID_272 0.02118935 0.04384269 0.02118935 0.05581824 SMID_BREAST_CANCER_NORMAL_LIKE_UP autoimmune disease of the nervous system DOID_438 0.02118935 0.04368384 0.20201824 0.30900102 SMID_BREAST_CANCER_NORMAL_LIKE_UP electroclinical syndrome DOID_0050701 0.02238245 0.04597694 0.02238245 0.05842023 SMID_BREAST_CANCER_NORMAL_LIKE_UP focal glomerulosclerosis DOID_3945 0.02254028 0.0461346 0.02254028 0.05856356 SMID_BREAST_CANCER_NORMAL_LIKE_UP female reproductive organ benign neoplasm DOID_0060086 0.02392585 0.04879501 0.02392585 0.06188095 SMID_BREAST_CANCER_NORMAL_LIKE_UP uterine benign neoplasm DOID_0060095 0.02392585 0.04879501 0.02392585 0.06188095 SMID_BREAST_CANCER_NORMAL_LIKE_UP uterine fibroid DOID_13223 0.02392585 0.04879501 0.02392585 0.06188095 SMID_BREAST_CANCER_NORMAL_LIKE_UP endometrial carcinoma DOID_2871 0.02392585 0.04862074 0.02392585 0.06160094 SMID_BREAST_CANCER_NORMAL_LIKE_UP spastic cerebral palsy DOID_0050669 0.02534547 0.05132231 0.21983228 0.33445072 SMID_BREAST_CANCER_NORMAL_LIKE_UP gonadal disease DOID_2277 0.02534547 0.05114032 0.21983228 0.33355885 SMID_BREAST_CANCER_NORMAL_LIKE_UP abdominal aortic aneurysm DOID_7693 0.02534547 0.05095961 0.21983228 0.33267172 SMID_BREAST_CANCER_NORMAL_LIKE_UP germinoma DOID_3304 0.02679855 0.05369145 0.02679855 0.06777054 SMID_BREAST_CANCER_NORMAL_LIKE_UP leiomyoma DOID_127 0.02828451 0.05646978 0.02828451 0.07121189 SMID_BREAST_CANCER_NORMAL_LIKE_UP transitional cell carcinoma DOID_2671 0.03032039 0.06032274 0.03032039 0.07533757 SMID_BREAST_CANCER_NORMAL_LIKE_UP thyroid carcinoma DOID_3963 0.03135283 0.06215944 0.03135283 0.0772284 SMID_BREAST_CANCER_NORMAL_LIKE_UP spindle cell carcinoma DOID_4015 0.03135283 0.06194361 0.03135283 0.07689552 SMID_BREAST_CANCER_NORMAL_LIKE_UP hyperthyroidism DOID_7998 0.03135283 0.06172927 0.03135283 0.07623829 SMID_BREAST_CANCER_NORMAL_LIKE_UP lymphoid leukemia DOID_10747 0.03293406 0.0646189 0.03293406 0.07974247 SMID_BREAST_CANCER_NORMAL_LIKE_UP medullomyoblastoma DOID_3861 0.03293406 0.06439684 0.03293406 0.07940457 SMID_BREAST_CANCER_NORMAL_LIKE_UP adult medulloblastoma DOID_3864 0.03293406 0.06439684 0.03293406 0.07940457 SMID_BREAST_CANCER_NORMAL_LIKE_UP childhood medulloblastoma DOID_3869 0.03293406 0.06439684 0.03293406 0.07940457 SMID_BREAST_CANCER_NORMAL_LIKE_UP thyroid cancer DOID_1781 0.03454593 0.06731725 0.03454593 0.08293939 SMID_BREAST_CANCER_NORMAL_LIKE_UP carbohydrate metabolic disorder DOID_2978 0.03477377 0.06752995 1.000 1.000 SMID_BREAST_CANCER_NORMAL_LIKE_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.03570282 0.06909832 0.03570282 0.08535674 SMID_BREAST_CANCER_NORMAL_LIKE_UP medulloblastoma DOID_3858 0.03618791 0.06979972 0.03618791 0.08579549 SMID_BREAST_CANCER_NORMAL_LIKE_UP blood platelet disease DOID_2218 0.03785944 0.0727771 0.26542266 0.39125775 SMID_BREAST_CANCER_NORMAL_LIKE_UP lymphatic system disease DOID_75 0.04128907 0.07910264 0.04128907 0.09708051 SMID_BREAST_CANCER_NORMAL_LIKE_UP cervix uteri carcinoma in situ DOID_8991 0.04304613 0.08219211 0.28182599 0.41329637 SMID_BREAST_CANCER_NORMAL_LIKE_UP spinocerebellar ataxia DOID_1441 0.04483066 0.08531319 0.04483066 0.10454362 SMID_BREAST_CANCER_NORMAL_LIKE_UP primitive neuroectodermal tumor DOID_168 0.04664215 0.08846461 0.04664215 0.10788367 SMID_BREAST_CANCER_NORMAL_LIKE_UP learning disability DOID_8927 0.05034403 0.09516862 0.05034403 0.11550708 SMID_BREAST_CANCER_NORMAL_LIKE_UP leukodystrophy DOID_10579 0.05223344 0.09841334 0.05223344 0.11936076 SMID_BREAST_CANCER_NORMAL_LIKE_UP spinocerebellar degeneration DOID_2478 0.05223344 0.09808854 0.05223344 0.11888331 JIANG_HYPOXIA_NORMAL aneurysm disease DOID_2403 7.818E-10 4.448E-07 6.232E-07 1.182E-04 JIANG_HYPOXIA_NORMAL multiple myeloma DOID_9538 9.727E-09 2.767E-06 4.511E-07 1.283E-04 JIANG_HYPOXIA_NORMAL myeloma DOID_0070004 3.902E-08 7.401E-06 1.409E-06 1.603E-04 JIANG_HYPOXIA_NORMAL aortic aneurysm DOID_3627 5.585E-08 7.944E-06 5.196E-05 3.696E-03 JIANG_HYPOXIA_NORMAL bone marrow cancer DOID_4960 8.718E-08 9.921E-06 2.724E-06 2.584E-04 JIANG_HYPOXIA_NORMAL abdominal aortic aneurysm DOID_7693 1.663E-07 1.577E-05 2.749E-04 0.01203047 JIANG_HYPOXIA_NORMAL embryonal cancer DOID_688 4.511E-07 3.667E-05 4.511E-07 2.567E-04 JIANG_HYPOXIA_NORMAL transitional cell carcinoma DOID_2671 1.349E-06 9.592E-05 1.349E-06 1.918E-04 JIANG_HYPOXIA_NORMAL nervous system cancer DOID_3093 1.535E-06 9.703E-05 4.418E-04 0.01571202 JIANG_HYPOXIA_NORMAL alcohol-related neurodevelopmental disorder DOID_0050667 1.97E-06 1.121E-04 3.529E-05 2.868E-03 JIANG_HYPOXIA_NORMAL acute kidney failure DOID_3021 6.448E-06 3.335E-04 0.03760024 0.23254931 JIANG_HYPOXIA_NORMAL adrenoleukodystrophy DOID_10588 8.841E-06 4.192E-04 0.04128215 0.2396892 JIANG_HYPOXIA_NORMAL lymphoma DOID_0060058 3.188E-05 1.396E-03 4.794E-04 0.01604417 JIANG_HYPOXIA_NORMAL methylmalonic acidemia DOID_14749 3.583E-05 1.456E-03 1.903E-03 0.04164092 JIANG_HYPOXIA_NORMAL brain cancer DOID_1319 4.123E-05 1.564E-03 0.01578433 0.13608005 JIANG_HYPOXIA_NORMAL central nervous system cancer DOID_3620 4.461E-05 1.586E-03 0.01638787 0.13712789 JIANG_HYPOXIA_NORMAL B-cell lymphocytic neoplasm DOID_707 5.596E-05 1.873E-03 1.178E-03 0.02793687 JIANG_HYPOXIA_NORMAL toxic shock syndrome DOID_14115 1.185E-04 3.746E-03 4.114E-03 0.05852155 JIANG_HYPOXIA_NORMAL commensal bacterial infectious disease DOID_0050339 1.336E-04 4E-03 4.446E-03 0.06022858 JIANG_HYPOXIA_NORMAL organic acidemia DOID_0060159 1.336E-04 3.8E-03 4.446E-03 0.05882791 JIANG_HYPOXIA_NORMAL cerebral degeneration DOID_1443 1.382E-04 3.746E-03 0.02807338 0.1948019 JIANG_HYPOXIA_NORMAL allergic contact dermatitis DOID_3042 1.547E-04 4.002E-03 1.547E-04 9.782E-03 JIANG_HYPOXIA_NORMAL diffuse large B-cell lymphoma DOID_0050745 1.862E-04 4.605E-03 5.512E-03 0.062729 JIANG_HYPOXIA_NORMAL migraine DOID_6364 1.862E-04 4.413E-03 1.862E-04 0.01059217 JIANG_HYPOXIA_NORMAL nephrosis DOID_2527 1.919E-04 4.367E-03 1.919E-04 9.925E-03 JIANG_HYPOXIA_NORMAL coronary stenosis DOID_4248 2.063E-04 4.514E-03 5.891E-03 0.06446345 JIANG_HYPOXIA_NORMAL mixed glioma DOID_5076 2.591E-04 5.46E-03 2.591E-04 0.01228593 JIANG_HYPOXIA_NORMAL contact dermatitis DOID_2773 2.849E-04 5.789E-03 2.849E-04 0.0115773 JIANG_HYPOXIA_NORMAL lipid metabolism disorder DOID_3146 2.849E-04 5.589E-03 2.849E-04 0.01080548 JIANG_HYPOXIA_NORMAL spindle cell carcinoma DOID_4015 3.871E-04 7.342E-03 0.13225247 0.39606134 JIANG_HYPOXIA_NORMAL amino acid metabolic disorder DOID_9252 4.239E-04 7.78E-03 5.207E-03 0.06046744 JIANG_HYPOXIA_NORMAL adult respiratory distress syndrome DOID_11394 6.046E-04 0.01074992 0.01183945 0.11418047 JIANG_HYPOXIA_NORMAL nephrotic syndrome DOID_1184 7.374E-04 0.01271518 7.374E-04 0.02331116 JIANG_HYPOXIA_NORMAL migraine without aura DOID_12783 7.812E-04 0.01307306 7.812E-04 0.0233939 JIANG_HYPOXIA_NORMAL neuronal ceroid lipofuscinosis DOID_14503 7.812E-04 0.01269955 0.04128215 0.23489541 JIANG_HYPOXIA_NORMAL leukodystrophy DOID_10579 8.876E-04 0.0140284 0.17129509 0.45974955 JIANG_HYPOXIA_NORMAL proteinuria DOID_576 8.876E-04 0.01364925 8.876E-04 0.02525111 JIANG_HYPOXIA_NORMAL aortic valve insufficiency DOID_57 9.35E-04 0.01400114 9.35E-04 0.02533539 JIANG_HYPOXIA_NORMAL lipodystrophy DOID_811 9.35E-04 0.01364213 9.35E-04 0.02418378 JIANG_HYPOXIA_NORMAL glaucoma DOID_1686 1.056E-03 0.01501836 1.056E-03 0.02611889 JIANG_HYPOXIA_NORMAL newborn respiratory distress syndrome DOID_12716 1.102E-03 0.0152976 0.04860405 0.24474073 JIANG_HYPOXIA_NORMAL giant cell tumor DOID_200 1.31E-03 0.01774144 0.0195501 0.15891441 JIANG_HYPOXIA_NORMAL malignant giant cell tumor DOID_2705 1.31E-03 0.01774144 0.0195501 0.15891441 JIANG_HYPOXIA_NORMAL giant cell glioblastoma DOID_3074 1.31E-03 0.01774144 0.0195501 0.15891441 JIANG_HYPOXIA_NORMAL hemangioma DOID_255 1.476E-03 0.01953682 0.05587041 0.25845742 JIANG_HYPOXIA_NORMAL oral submucous fibrosis DOID_5773 1.476E-03 0.0190928 1.476E-03 0.03360333 JIANG_HYPOXIA_NORMAL varicose veins DOID_799 1.476E-03 0.01866852 0.05587041 0.25031703 JIANG_HYPOXIA_NORMAL glioblastoma DOID_3068 1.677E-03 0.0207404 0.02294583 0.17643486 JIANG_HYPOXIA_NORMAL oral cavity cancer DOID_8618 1.677E-03 0.02029912 0.02294583 0.1740824 JIANG_HYPOXIA_NORMAL restrictive cardiomyopathy DOID_397 1.683E-03 0.01995188 0.0594829 0.25836464 JIANG_HYPOXIA_NORMAL vein disease DOID_866 1.683E-03 0.01954469 0.0594829 0.25447946 JIANG_HYPOXIA_NORMAL urinary system benign neoplasm DOID_731 1.903E-03 0.02165328 0.06308165 0.26392251 JIANG_HYPOXIA_NORMAL peroxisomal disease DOID_906 1.903E-03 0.0212287 1.903E-03 0.04009866 JIANG_HYPOXIA_NORMAL respiratory failure DOID_11162 2.012E-03 0.02202089 0.02582389 0.18599739 JIANG_HYPOXIA_NORMAL endocrine pancreas disease DOID_1428 2.195E-03 0.02356367 0.22661135 0.56061677 JIANG_HYPOXIA_NORMAL cholestasis DOID_13580 2.29E-03 0.0241275 2.29E-03 0.0465316 JIANG_HYPOXIA_NORMAL heart septal defect DOID_1681 2.38E-03 0.02462698 2.38E-03 0.04670634 JIANG_HYPOXIA_NORMAL testicular cancer DOID_2998 2.38E-03 0.02418721 2.38E-03 0.04514946 JIANG_HYPOXIA_NORMAL granulosa cell tumor DOID_2999 2.38E-03 0.02376288 2.38E-03 0.04369303 JIANG_HYPOXIA_NORMAL tuberculosis DOID_399 2.59E-03 0.02540574 2.59E-03 0.0460479 JIANG_HYPOXIA_NORMAL sex cord-gonadal stromal tumor DOID_192 2.638E-03 0.02544435 2.638E-03 0.04549141 JIANG_HYPOXIA_NORMAL subependymal glioma DOID_4843 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL pilocytic astrocytoma DOID_4851 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL subependymal giant cell astrocytoma DOID_5077 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL fibrillary astrocytoma DOID_6726 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL juvenile pilocytic astrocytoma DOID_6811 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL childhood pilocytic astrocytoma DOID_6812 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL gemistocytic astrocytoma DOID_7005 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL childhood cerebral astrocytoma DOID_7007 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL protoplasmic astrocytoma DOID_7008 2.638E-03 0.02502027 0.07379609 0.29363617 JIANG_HYPOXIA_NORMAL astrocytoma DOID_3069 2.695E-03 0.02513656 0.03119011 0.21127585 JIANG_HYPOXIA_NORMAL coronary restenosis DOID_4247 2.909E-03 0.02669498 0.07734045 0.3056022 JIANG_HYPOXIA_NORMAL bile duct disease DOID_4138 2.913E-03 0.02630745 2.913E-03 0.04874615 JIANG_HYPOXIA_NORMAL biliary tract disease DOID_9741 3.026E-03 0.02690055 3.026E-03 0.04918957 JIANG_HYPOXIA_NORMAL benign glioma DOID_0060101 3.192E-03 0.02793916 0.08087135 0.31517669 JIANG_HYPOXIA_NORMAL hepatitis B DOID_2043 3.192E-03 0.02751584 3.192E-03 0.0504457 JIANG_HYPOXIA_NORMAL benign ependymoma DOID_4844 3.192E-03 0.02793916 0.08087135 0.31517669 JIANG_HYPOXIA_NORMAL muscular atrophy DOID_767 3.192E-03 0.02710515 3.192E-03 0.0490823 JIANG_HYPOXIA_NORMAL syndrome DOID_225 3.381E-03 0.02828758 3.381E-03 0.05061987 JIANG_HYPOXIA_NORMAL bone resorption disease DOID_0080011 3.504E-03 0.02889768 0.03695404 0.24449826 JIANG_HYPOXIA_NORMAL osteoporosis DOID_11476 3.504E-03 0.02889768 0.03695404 0.24449826 JIANG_HYPOXIA_NORMAL aortic valve disease DOID_62 3.794E-03 0.03084267 3.794E-03 0.05535864 JIANG_HYPOXIA_NORMAL chronic kidney failure DOID_784 4.305E-03 0.03449735 4.305E-03 0.05973931 JIANG_HYPOXIA_NORMAL portal hypertension DOID_10762 4.446E-03 0.03513334 0.09486124 0.35278461 JIANG_HYPOXIA_NORMAL osteosarcoma DOID_3347 4.446E-03 0.03465206 4.446E-03 0.05749091 JIANG_HYPOXIA_NORMAL morbid obesity DOID_11981 4.789E-03 0.03682631 0.09832554 0.35409642 JIANG_HYPOXIA_NORMAL primary bacterial infectious disease DOID_0050338 4.895E-03 0.03713484 4.895E-03 0.0618914 JIANG_HYPOXIA_NORMAL intracranial aneurysm DOID_10941 5.145E-03 0.03851906 5.145E-03 0.06364018 JIANG_HYPOXIA_NORMAL dystonia DOID_543 5.145E-03 0.03801881 5.145E-03 0.06228613 JIANG_HYPOXIA_NORMAL primary immunodeficiency disease DOID_612 5.207E-03 0.03798595 5.207E-03 0.06172718 JIANG_HYPOXIA_NORMAL lung adenocarcinoma DOID_3910 5.512E-03 0.0397019 0.1052147 0.36283128 JIANG_HYPOXIA_NORMAL renal hypertension DOID_1073 5.891E-03 0.04190124 0.10863964 0.36795212 JIANG_HYPOXIA_NORMAL secondary hypertension DOID_11130 5.891E-03 0.04190124 0.10863964 0.36795212 JIANG_HYPOXIA_NORMAL sarcoma DOID_1115 5.891E-03 0.04138394 5.891E-03 0.06572744 JIANG_HYPOXIA_NORMAL hepatic vascular disease DOID_272 5.891E-03 0.04087926 0.10863964 0.36149682 JIANG_HYPOXIA_NORMAL mouth disease DOID_403 6.04E-03 0.04140705 6.04E-03 0.06484501 JIANG_HYPOXIA_NORMAL polycystic ovary syndrome DOID_11612 6.282E-03 0.0425517 6.282E-03 0.06619153 JIANG_HYPOXIA_NORMAL supratentorial cancer DOID_1659 6.282E-03 0.04205109 0.11205157 0.36642152 JIANG_HYPOXIA_NORMAL cerebrum cancer DOID_368 6.282E-03 0.04205109 0.11205157 0.36642152 JIANG_HYPOXIA_NORMAL focal glomerulosclerosis DOID_3945 6.282E-03 0.04156212 6.282E-03 0.06498805 JIANG_HYPOXIA_NORMAL endometrial carcinoma DOID_2871 6.684E-03 0.0437141 6.684E-03 0.06791298 JIANG_HYPOXIA_NORMAL Charcot-Marie-Tooth disease DOID_10595 7.522E-03 0.0486376 7.522E-03 0.07508963 JIANG_HYPOXIA_NORMAL endometrial cancer DOID_1380 7.522E-03 0.04809111 7.522E-03 0.07379499 JIANG_HYPOXIA_NORMAL allergic rhinitis DOID_4481 7.522E-03 0.04755677 0.12220973 0.38418418 JIANG_HYPOXIA_NORMAL nephroblastoma DOID_2154 8.864E-03 0.05542128 0.13225247 0.40027476 JIANG_HYPOXIA_NORMAL thyroid carcinoma DOID_3963 8.864E-03 0.05481887 1.000 1.000 JIANG_HYPOXIA_NORMAL esophageal disease DOID_6050 8.864E-03 0.05422942 0.13225247 0.39398772 JIANG_HYPOXIA_NORMAL thyroid cancer DOID_1781 9.813E-03 0.05939778 1.000 1.000 JIANG_HYPOXIA_NORMAL hepatitis DOID_2237 0.0113169 0.06778227 1.000 1.000 JIANG_HYPOXIA_NORMAL adenoid cystic carcinoma DOID_4866 0.01183945 0.07017342 0.01183945 0.11227747 JIANG_HYPOXIA_NORMAL lymphatic system disease DOID_75 0.01183945 0.06944998 0.15199689 0.42814967 JIANG_HYPOXIA_NORMAL benign mesothelioma DOID_2645 0.01237243 0.07183582 0.15524397 0.43514198 JIANG_HYPOXIA_NORMAL salivary gland cancer DOID_8850 0.01291574 0.07423286 0.01291574 0.12047629 JIANG_HYPOXIA_NORMAL hyperinsulinism DOID_2018 0.01346929 0.07664029 0.16170114 0.4423459 JIANG_HYPOXIA_NORMAL uterine cancer DOID_363 0.01403302 0.0790573 0.01403302 0.12878689 JIANG_HYPOXIA_NORMAL cataract DOID_83 0.01460682 0.08148315 0.01460682 0.1319251 JIANG_HYPOXIA_NORMAL learning disability DOID_8927 0.01460682 0.08069205 0.16810928 0.45333736 JIANG_HYPOXIA_NORMAL pre-eclampsia DOID_10591 0.01578433 0.08635849 0.01578433 0.14033255 JIANG_HYPOXIA_NORMAL lens disease DOID_110 0.01578433 0.08553603 0.01578433 0.13817359 JIANG_HYPOXIA_NORMAL thyroid adenoma DOID_2891 0.01578433 0.08472909 1.000 1.000 JIANG_HYPOXIA_NORMAL heart valve disease DOID_4079 0.01578433 0.08393723 0.01578433 0.134049 JIANG_HYPOXIA_NORMAL vascular skin disease DOID_9540 0.01578433 0.08316003 0.17446878 0.46389128 JIANG_HYPOXIA_NORMAL hemolytic anemia DOID_583 0.01638787 0.08554767 0.1776304 0.47010091 JIANG_HYPOXIA_NORMAL normocytic anemia DOID_720 0.01638787 0.08554767 0.1776304 0.47010091 JIANG_HYPOXIA_NORMAL integumentary system benign neoplasm DOID_0060121 0.01700115 0.08794232 1.000 1.000 JIANG_HYPOXIA_NORMAL skin benign neoplasm DOID_3165 0.01700115 0.08794232 1.000 1.000 JIANG_HYPOXIA_NORMAL lung small cell carcinoma DOID_5409 0.01700115 0.08715004 0.01700115 0.1401979 JIANG_HYPOXIA_NORMAL sarcoidosis DOID_11335 0.0195501 0.09932151 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP urinary system benign neoplasm DOID_731 1.068E-10 6.074E-08 8.488E-03 0.8049135 CHIN_BREAST_CANCER_COPY_NUMBER_UP nephroblastoma DOID_2154 2.944E-09 8.375E-07 0.01838577 0.95104596 CHIN_BREAST_CANCER_COPY_NUMBER_UP transitional cell carcinoma DOID_2671 1.12E-07 2.124E-05 0.04416503 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP cervix uteri carcinoma in situ DOID_8991 1.395E-06 1.984E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP giant cell tumor DOID_200 2.909E-06 3.31E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP malignant giant cell tumor DOID_2705 2.909E-06 3.31E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP giant cell glioblastoma DOID_3074 2.909E-06 3.31E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP reproductive organ benign neoplasm DOID_0050622 3.236E-06 3.069E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP glioblastoma DOID_3068 3.771E-06 3.065E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP oral cavity cancer DOID_8618 3.771E-06 2.682E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP pre-malignant neoplasm DOID_0060071 4.787E-06 3.026E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP in situ carcinoma DOID_8719 4.787E-06 3.026E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP astrocytoma DOID_3069 6.227E-06 3.543E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP hyperparathyroidism DOID_13543 1.068E-05 5.526E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP nervous system cancer DOID_3093 1.303E-05 6.178E-04 0.04512516 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP invasive lobular carcinoma DOID_3457 1.305E-05 5.713E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP lymphoblastic leukemia DOID_1037 1.435E-05 5.831E-04 0.04656364 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP parathyroid gland disease DOID_11201 1.85E-05 7.018E-04 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP angiosarcoma DOID_0001816 2.844E-05 1.011E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP male reproductive organ benign neoplasm DOID_0060087 3.623E-05 1.213E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP colon carcinoma DOID_1520 4.497E-05 1.422E-03 9.978E-03 0.81110013 CHIN_BREAST_CANCER_COPY_NUMBER_UP urinary tract obstruction DOID_5200 5.983E-05 1.792E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP sarcoma DOID_1115 1.027E-04 2.92E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP autonomic nervous system neoplasm DOID_2621 1.402E-04 3.799E-03 0.01740019 0.99007092 CHIN_BREAST_CANCER_COPY_NUMBER_UP neuroblastoma DOID_769 1.402E-04 3.799E-03 0.01740019 0.99007092 CHIN_BREAST_CANCER_COPY_NUMBER_UP papilloma DOID_2615 1.484E-04 3.838E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP medullomyoblastoma DOID_3861 1.655E-04 4.094E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP adult medulloblastoma DOID_3864 1.655E-04 4.094E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP childhood medulloblastoma DOID_3869 1.655E-04 4.094E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP medulloblastoma DOID_3858 1.835E-04 4.351E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP multiple myeloma DOID_9538 1.835E-04 4.177E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP peripheral nervous system neoplasm DOID_1192 1.929E-04 4.221E-03 0.02035413 0.89088463 CHIN_BREAST_CANCER_COPY_NUMBER_UP adenoid cystic carcinoma DOID_4866 2.123E-04 4.473E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP endometriosis of uterus DOID_288 2.326E-04 4.726E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP salivary gland cancer DOID_8850 2.326E-04 4.563E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP primitive neuroectodermal tumor DOID_168 2.431E-04 4.61E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP endometriosis DOID_289 2.431E-04 4.462E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP diabetic autonomic neuropathy DOID_11503 2.538E-04 4.513E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP autonomic neuropathy DOID_11504 2.538E-04 4.513E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP diabetic polyneuropathy DOID_12785 2.538E-04 4.513E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP uterine cancer DOID_363 2.538E-04 4.376E-03 0.02329965 0.88383356 CHIN_BREAST_CANCER_COPY_NUMBER_UP diabetic neuropathy DOID_9743 2.538E-04 4.513E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP proteinuria DOID_576 2.759E-04 4.618E-03 0.02427963 0.86344434 CHIN_BREAST_CANCER_COPY_NUMBER_UP myeloma DOID_0070004 2.874E-04 4.672E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP autonomic nervous system disease DOID_11465 2.874E-04 4.542E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP glaucoma DOID_1686 3.109E-04 4.78E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP calcium metabolism disease DOID_10575 3.23E-04 4.836E-03 0.02623679 0.87816069 CHIN_BREAST_CANCER_COPY_NUMBER_UP aortic aneurysm DOID_3627 3.23E-04 4.712E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP B-cell lymphocytic neoplasm DOID_707 3.353E-04 4.769E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP bile duct adenocarcinoma DOID_4896 3.736E-04 5.185E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP cholangiocarcinoma DOID_4947 3.736E-04 5.185E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP bone marrow cancer DOID_4960 3.736E-04 5.061E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP bile duct cancer DOID_4606 4.279E-04 5.662E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP bile duct carcinoma DOID_4897 4.279E-04 5.662E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP neuroectodermal tumor DOID_171 4.709E-04 6.09E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP mineral metabolism disease DOID_0050032 5.16E-04 6.525E-03 0.03305759 0.94048841 CHIN_BREAST_CANCER_COPY_NUMBER_UP uterine disease DOID_345 5.315E-04 6.574E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP aneurysm disease DOID_2403 7.165E-04 8.674E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP mixed glioma DOID_5076 7.346E-04 8.708E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP female reproductive system disease DOID_229 7.904E-04 9.179E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP biliary tract cancer DOID_4607 8.287E-04 9.431E-03 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP lymphoma DOID_0060058 1.012E-03 0.01128997 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP encephalomyelitis DOID_640 1.033E-03 0.01130761 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP chondrosarcoma DOID_3371 5.001E-03 0.05369044 5.001E-03 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP familial adenomatous polyposis DOID_0050424 5.5E-03 0.05795203 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP epidermolysis bullosa DOID_2730 5.998E-03 0.06205621 5.998E-03 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP aortic valve insufficiency DOID_57 5.998E-03 0.06094807 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP stomach disease DOID_76 5.998E-03 0.0598788 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP larynx cancer DOID_2596 6.497E-03 0.06373515 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP laryngeal benign neoplasm DOID_2598 6.497E-03 0.06373515 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP vesiculobullous skin disease DOID_2731 6.497E-03 0.06265489 6.497E-03 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP open-angle glaucoma DOID_1067 6.995E-03 0.06633419 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP hypercalcemia DOID_12678 6.995E-03 0.06524674 6.995E-03 0.99501279 CHIN_BREAST_CANCER_COPY_NUMBER_UP polycystic kidney disease DOID_898 6.995E-03 0.06419437 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP idiopathic pulmonary fibrosis DOID_0050156 7.493E-03 0.06767189 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP skeletal system cancer DOID_0060124 7.493E-03 0.06661452 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP thoracic aortic aneurysm DOID_14004 7.493E-03 0.06558968 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP bone cancer DOID_184 7.493E-03 0.06661452 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP hemangioma DOID_255 7.493E-03 0.06459589 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP oral submucous fibrosis DOID_5773 7.493E-03 0.06363178 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP tongue cancer DOID_8649 7.99E-03 0.06685989 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP Barrett's esophagus DOID_9206 7.99E-03 0.0658909 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP hyperostosis DOID_205 8.488E-03 0.06899259 8.488E-03 0.9658962 CHIN_BREAST_CANCER_COPY_NUMBER_UP ureteral obstruction DOID_5199 8.985E-03 0.072005 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP prion disease DOID_649 8.985E-03 0.07100493 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP granulosa cell tumor DOID_2999 9.482E-03 0.07390541 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP amnestic disorder DOID_10914 9.978E-03 0.07672569 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP esophagitis DOID_11963 9.978E-03 0.07570268 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP sex cord-gonadal stromal tumor DOID_192 9.978E-03 0.07470659 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP gastric ulcer DOID_10808 0.01097102 0.08107155 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP muscle cancer DOID_4045 0.01146698 0.08365016 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP uremia DOID_4676 0.01146698 0.0825913 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP ureteral disease DOID_1426 0.01196271 0.08508477 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP aortic valve disease DOID_62 0.01196271 0.08403434 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP portal hypertension DOID_10762 0.01295346 0.08988436 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP cystitis DOID_1679 0.01344848 0.092195 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP cleft lip DOID_9296 0.01344848 0.09109744 0.01344848 0.9565231 CHIN_BREAST_CANCER_COPY_NUMBER_UP pleurisy DOID_10247 0.01493213 0.09995745 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP thrombocytopenia DOID_1588 0.01493213 0.09879516 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP hepatic vascular disease DOID_272 0.01493213 0.09765958 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP invasive ductal carcinoma DOID_3008 0.01493213 0.09654981 0.01493213 0.94404261 CHIN_BREAST_CANCER_COPY_NUMBER_UP multiple epiphyseal dysplasia DOID_12721 0.01542621 0.09862377 1.000 1.000 CHIN_BREAST_CANCER_COPY_NUMBER_UP endometrial carcinoma DOID_2871 0.01592006 0.09954411 1.000 1.000 BROWNE_HCMV_INFECTION_18HR_DN lymphoma DOID_0060058 5.797E-06 3.298E-03 5.797E-06 3.298E-03 BROWNE_HCMV_INFECTION_18HR_DN salivary gland cancer DOID_8850 6.76E-06 1.923E-03 6.76E-06 1.923E-03 BROWNE_HCMV_INFECTION_18HR_DN ureteral obstruction DOID_5199 1.498E-05 2.842E-03 1.066E-03 0.04667137 BROWNE_HCMV_INFECTION_18HR_DN atrophic muscular disease DOID_913 1.629E-05 2.317E-03 1.629E-05 3.089E-03 BROWNE_HCMV_INFECTION_18HR_DN muscular dystrophy DOID_9884 1.629E-05 2.317E-03 1.629E-05 3.089E-03 BROWNE_HCMV_INFECTION_18HR_DN oral cavity cancer DOID_8618 2.291E-05 2.607E-03 2.291E-05 3.258E-03 BROWNE_HCMV_INFECTION_18HR_DN urinary tract obstruction DOID_5200 3.22E-05 3.054E-03 1.748E-03 0.04972614 BROWNE_HCMV_INFECTION_18HR_DN ureteral disease DOID_1426 3.673E-05 2.986E-03 1.903E-03 0.05157305 BROWNE_HCMV_INFECTION_18HR_DN allergic contact dermatitis DOID_3042 3.951E-05 2.81E-03 9.081E-04 0.0516699 BROWNE_HCMV_INFECTION_18HR_DN bone resorption disease DOID_0080011 6.355E-05 4.018E-03 6.355E-05 7.232E-03 BROWNE_HCMV_INFECTION_18HR_DN osteoporosis DOID_11476 6.355E-05 4.018E-03 6.355E-05 7.232E-03 BROWNE_HCMV_INFECTION_18HR_DN mixed glioma DOID_5076 6.676E-05 3.798E-03 0.01976655 0.20449395 BROWNE_HCMV_INFECTION_18HR_DN contact dermatitis DOID_2773 7.352E-05 3.803E-03 1.435E-03 0.05444332 BROWNE_HCMV_INFECTION_18HR_DN focal epilepsy DOID_2234 8.459E-05 4.011E-03 8.459E-05 8.022E-03 BROWNE_HCMV_INFECTION_18HR_DN adenoid cystic carcinoma DOID_4866 2.158E-04 9.445E-03 2.158E-04 0.01754038 BROWNE_HCMV_INFECTION_18HR_DN polydactyly DOID_1148 3.881E-04 0.01577158 0.02920449 0.22455886 BROWNE_HCMV_INFECTION_18HR_DN peritonitis DOID_8283 4.648E-04 0.01763316 0.03181719 0.22629974 BROWNE_HCMV_INFECTION_18HR_DN giant cell tumor DOID_200 4.726E-04 0.01680535 0.01004305 0.15444588 BROWNE_HCMV_INFECTION_18HR_DN malignant giant cell tumor DOID_2705 4.726E-04 0.01680535 0.01004305 0.15444588 BROWNE_HCMV_INFECTION_18HR_DN giant cell glioblastoma DOID_3074 4.726E-04 0.01680535 0.01004305 0.15444588 BROWNE_HCMV_INFECTION_18HR_DN reproductive organ benign neoplasm DOID_0050622 5.24E-04 0.01753768 0.01074252 0.15281229 BROWNE_HCMV_INFECTION_18HR_DN glioblastoma DOID_3068 6.076E-04 0.01920668 0.01183089 0.16418972 BROWNE_HCMV_INFECTION_18HR_DN pre-malignant neoplasm DOID_0060071 7.65E-04 0.02291113 0.01374735 0.15963764 BROWNE_HCMV_INFECTION_18HR_DN in situ carcinoma DOID_8719 7.65E-04 0.02291113 0.01374735 0.15963764 BROWNE_HCMV_INFECTION_18HR_DN uterine disease DOID_345 8.346E-04 0.02374486 8.346E-04 0.05936216 BROWNE_HCMV_INFECTION_18HR_DN temporal lobe epilepsy DOID_3328 8.709E-04 0.0235961 8.709E-04 0.05505757 BROWNE_HCMV_INFECTION_18HR_DN hyperostosis DOID_205 9.495E-04 0.02455731 9.495E-04 0.04911462 BROWNE_HCMV_INFECTION_18HR_DN astrocytoma DOID_3069 9.855E-04 0.02438106 0.01621169 0.1808716 BROWNE_HCMV_INFECTION_18HR_DN congenital muscular dystrophy DOID_0050557 1.066E-03 0.02528033 1.066E-03 0.05056065 BROWNE_HCMV_INFECTION_18HR_DN diabetic retinopathy DOID_8947 1.153E-03 0.02623488 1.153E-03 0.046848 BROWNE_HCMV_INFECTION_18HR_DN autoimmune hepatitis DOID_2048 1.456E-03 0.03186127 0.05502031 0.29534488 BROWNE_HCMV_INFECTION_18HR_DN female reproductive system disease DOID_229 1.486E-03 0.03131961 1.486E-03 0.05285184 BROWNE_HCMV_INFECTION_18HR_DN placenta disease DOID_780 1.599E-03 0.03248699 1.599E-03 0.05350799 BROWNE_HCMV_INFECTION_18HR_DN retinal vascular disease DOID_2462 1.701E-03 0.03337852 1.701E-03 0.05377651 BROWNE_HCMV_INFECTION_18HR_DN uremia DOID_4676 1.748E-03 0.03315076 1.748E-03 0.05234331 BROWNE_HCMV_INFECTION_18HR_DN transitional cell carcinoma DOID_2671 1.875E-03 0.03440741 0.02462244 0.22597047 BROWNE_HCMV_INFECTION_18HR_DN aortic valve disease DOID_62 1.903E-03 0.03384482 1.903E-03 0.04922882 BROWNE_HCMV_INFECTION_18HR_DN amino acid metabolic disorder DOID_9252 1.935E-03 0.03335918 1.935E-03 0.04786317 BROWNE_HCMV_INFECTION_18HR_DN Human immunodeficiency virus infectious disease DOID_526 1.996E-03 0.03340452 0.02564642 0.23163192 BROWNE_HCMV_INFECTION_18HR_DN lymphoblastic leukemia DOID_1037 2.187E-03 0.03555906 2.187E-03 0.05185696 BROWNE_HCMV_INFECTION_18HR_DN portal hypertension DOID_10762 2.233E-03 0.03530141 0.06767212 0.33776698 BROWNE_HCMV_INFECTION_18HR_DN Crohn's disease DOID_8778 2.253E-03 0.03465471 0.02774546 0.21926623 BROWNE_HCMV_INFECTION_18HR_DN dilated cardiomyopathy DOID_12930 2.321E-03 0.03475215 2.321E-03 0.05282327 BROWNE_HCMV_INFECTION_18HR_DN sarcoma DOID_1115 2.969E-03 0.04331057 0.07767268 0.34260276 BROWNE_HCMV_INFECTION_18HR_DN hepatic vascular disease DOID_272 2.969E-03 0.0422278 0.07767268 0.33481633 BROWNE_HCMV_INFECTION_18HR_DN invasive ductal carcinoma DOID_3008 2.969E-03 0.04119785 0.07767268 0.33229891 BROWNE_HCMV_INFECTION_18HR_DN toxic encephalopathy DOID_3602 3.168E-03 0.04291536 3.168E-03 0.06932481 BROWNE_HCMV_INFECTION_18HR_DN cranial nerve disease DOID_5656 3.168E-03 0.04191733 3.168E-03 0.06675723 BROWNE_HCMV_INFECTION_18HR_DN endometrial carcinoma DOID_2871 3.373E-03 0.04361925 0.08263306 0.34572212 BROWNE_HCMV_INFECTION_18HR_DN endometrial cancer DOID_1380 3.802E-03 0.04807066 0.08756701 0.36105529 BROWNE_HCMV_INFECTION_18HR_DN leiomyoma DOID_127 4.025E-03 0.04978854 1.000 1.000 BROWNE_HCMV_INFECTION_18HR_DN pneumoconiosis DOID_10316 4.49E-03 0.05435358 4.49E-03 0.09123636 BROWNE_HCMV_INFECTION_18HR_DN refractive error DOID_9835 4.978E-03 0.059008 0.09978724 0.37601947 BROWNE_HCMV_INFECTION_18HR_DN embryonal cancer DOID_688 5.231E-03 0.06073985 5.231E-03 0.10262941 BROWNE_HCMV_INFECTION_18HR_DN multiple myeloma DOID_9538 5.231E-03 0.05952506 5.231E-03 0.09920843 BROWNE_HCMV_INFECTION_18HR_DN adult respiratory distress syndrome DOID_11394 6.024E-03 0.06720748 6.024E-03 0.11056715 BROWNE_HCMV_INFECTION_18HR_DN benign mesothelioma DOID_2645 6.3E-03 0.06893341 0.11184539 0.40278497 BROWNE_HCMV_INFECTION_18HR_DN hyperinsulinism DOID_2018 6.868E-03 0.0737379 0.11662374 0.39975246 BROWNE_HCMV_INFECTION_18HR_DN gallbladder cancer DOID_3121 7.161E-03 0.07545719 7.161E-03 0.12733401 BROWNE_HCMV_INFECTION_18HR_DN uterine cancer DOID_363 7.161E-03 0.07408524 0.11900336 0.40066813 BROWNE_HCMV_INFECTION_18HR_DN proteinuria DOID_576 7.763E-03 0.07888115 0.12374358 0.40699478 BROWNE_HCMV_INFECTION_18HR_DN myeloma DOID_0070004 8.073E-03 0.08058571 8.073E-03 0.13919351 BROWNE_HCMV_INFECTION_18HR_DN heart valve disease DOID_4079 8.073E-03 0.07919631 8.073E-03 0.13509958 BROWNE_HCMV_INFECTION_18HR_DN autoimmune disease of gastrointestinal tract DOID_0060031 8.708E-03 0.08397974 0.13080659 0.42289177 BROWNE_HCMV_INFECTION_18HR_DN glaucoma DOID_1686 8.708E-03 0.08258008 8.708E-03 0.14156585 BROWNE_HCMV_INFECTION_18HR_DN B-cell lymphocytic neoplasm DOID_707 9.365E-03 0.08735337 9.365E-03 0.14801543 BROWNE_HCMV_INFECTION_18HR_DN bile duct adenocarcinoma DOID_4896 0.01039015 0.09535478 0.01039015 0.15557886 BROWNE_HCMV_INFECTION_18HR_DN cholangiocarcinoma DOID_4947 0.01039015 0.09535478 0.01039015 0.15557886 BROWNE_HCMV_INFECTION_18HR_DN bone marrow cancer DOID_4960 0.01039015 0.09384122 0.01039015 0.15158966 BROWNE_HCMV_INFECTION_18HR_DN parasitic protozoa infectious disease DOID_2789 0.01074252 0.09550768 0.14476393 0.450113 KANG_IMMORTALIZED_BY_TERT_UP diabetic autonomic neuropathy DOID_11503 1.005E-10 5.717E-08 5.252E-05 0.02988663 KANG_IMMORTALIZED_BY_TERT_UP autonomic neuropathy DOID_11504 1.005E-10 5.717E-08 5.252E-05 0.02988663 KANG_IMMORTALIZED_BY_TERT_UP diabetic polyneuropathy DOID_12785 1.005E-10 5.717E-08 5.252E-05 0.02988663 KANG_IMMORTALIZED_BY_TERT_UP diabetic neuropathy DOID_9743 1.005E-10 5.717E-08 5.252E-05 0.02988663 KANG_IMMORTALIZED_BY_TERT_UP autonomic nervous system disease DOID_11465 1.482E-10 4.215E-08 6.328E-05 0.01800408 KANG_IMMORTALIZED_BY_TERT_UP metabolic syndrome X DOID_14221 3.144E-09 5.964E-07 0.11810493 0.58436264 KANG_IMMORTALIZED_BY_TERT_UP pulmonary sarcoidosis DOID_13406 4.437E-09 6.311E-07 0.05943485 0.42808142 KANG_IMMORTALIZED_BY_TERT_UP congenital diaphragmatic hernia DOID_3827 5.722E-09 6.512E-07 1.904E-03 0.09849742 KANG_IMMORTALIZED_BY_TERT_UP myeloma DOID_0070004 1.412E-08 1.339E-06 2.688E-03 0.12745634 KANG_IMMORTALIZED_BY_TERT_UP sarcoidosis DOID_11335 2.528E-08 2.055E-06 0.0822243 0.50307123 KANG_IMMORTALIZED_BY_TERT_UP bone marrow cancer DOID_4960 2.768E-08 1.969E-06 3.478E-03 0.13193767 KANG_IMMORTALIZED_BY_TERT_UP hypersensitivity reaction type IV disease DOID_2916 3.914E-08 2.475E-06 0.08923406 0.51810387 KANG_IMMORTALIZED_BY_TERT_UP uremia DOID_4676 4.272E-08 2.431E-06 5.701E-04 0.04054617 KANG_IMMORTALIZED_BY_TERT_UP leiomyoma DOID_127 2.492E-07 1.289E-05 1.325E-03 0.0753903 KANG_IMMORTALIZED_BY_TERT_UP encephalomyelitis DOID_640 3.664E-07 1.737E-05 4.256E-04 0.03459626 KANG_IMMORTALIZED_BY_TERT_UP epilepsy with generalized tonic-clonic seizures DOID_7725 9.613E-07 4.208E-05 0.01971023 0.31153116 KANG_IMMORTALIZED_BY_TERT_UP atrophic muscular disease DOID_913 1.707E-06 6.936E-05 8.892E-05 0.01686503 KANG_IMMORTALIZED_BY_TERT_UP muscular dystrophy DOID_9884 1.707E-06 6.936E-05 8.892E-05 0.01686503 KANG_IMMORTALIZED_BY_TERT_UP vasculitis DOID_865 1.833E-06 6.954E-05 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP carotid artery disease DOID_3407 2.926E-06 1.04E-04 4.363E-03 0.15517456 KANG_IMMORTALIZED_BY_TERT_UP pancreatic ductal carcinoma DOID_3587 4.96E-06 1.66E-04 0.10584353 0.56285017 KANG_IMMORTALIZED_BY_TERT_UP nephrosis DOID_2527 5.238E-06 1.656E-04 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP pancreatic carcinoma DOID_4905 5.827E-06 1.745E-04 0.10994916 0.56361327 KANG_IMMORTALIZED_BY_TERT_UP diabetic retinopathy DOID_8947 5.827E-06 1.658E-04 0.10994916 0.55858101 KANG_IMMORTALIZED_BY_TERT_UP aortic valve disease DOID_62 6.722E-06 1.821E-04 6.213E-04 0.03927886 KANG_IMMORTALIZED_BY_TERT_UP pancreatitis DOID_4989 7.151E-06 1.849E-04 6.733E-03 0.19156242 KANG_IMMORTALIZED_BY_TERT_UP urticaria DOID_1555 8.617E-06 2.132E-04 0.03903854 0.39665944 KANG_IMMORTALIZED_BY_TERT_UP retinal vascular disease DOID_2462 9.984E-06 2.367E-04 0.12484526 0.5822701 KANG_IMMORTALIZED_BY_TERT_UP primary immunodeficiency disease DOID_612 1.193E-05 2.716E-04 0.13020105 0.60231216 KANG_IMMORTALIZED_BY_TERT_UP gestational diabetes DOID_11714 1.207E-05 2.642E-04 0.04344545 0.40525346 KANG_IMMORTALIZED_BY_TERT_UP autoimmune disease of cardiovascular system DOID_0060051 1.34E-05 2.823E-04 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP Behcet's disease DOID_13241 1.34E-05 2.823E-04 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.475E-05 2.997E-04 9.566E-03 0.25918727 KANG_IMMORTALIZED_BY_TERT_UP female reproductive organ benign neoplasm DOID_0060086 1.633E-05 3.204E-04 0.0478325 0.40621928 KANG_IMMORTALIZED_BY_TERT_UP uterine benign neoplasm DOID_0060095 1.633E-05 3.204E-04 0.0478325 0.40621928 KANG_IMMORTALIZED_BY_TERT_UP uterine fibroid DOID_13223 1.633E-05 3.204E-04 0.0478325 0.40621928 KANG_IMMORTALIZED_BY_TERT_UP age related macular degeneration DOID_10871 1.794E-05 3.403E-04 0.04929045 0.40646762 KANG_IMMORTALIZED_BY_TERT_UP degeneration of macula and posterior pole DOID_2007 1.794E-05 3.403E-04 0.04929045 0.40646762 KANG_IMMORTALIZED_BY_TERT_UP pleural disease DOID_1532 2.148E-05 3.942E-04 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP pneumoconiosis DOID_10316 2.544E-05 4.524E-04 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP macular degeneration DOID_4448 2.544E-05 4.387E-04 0.05510034 0.42367698 KANG_IMMORTALIZED_BY_TERT_UP adolescence-adult electroclinical syndrome DOID_0050705 3.225E-05 5.397E-04 0.05943485 0.43356964 KANG_IMMORTALIZED_BY_TERT_UP benign mesothelioma DOID_2645 4.304E-05 6.997E-04 0.06518382 0.44154276 KANG_IMMORTALIZED_BY_TERT_UP heart valve disease DOID_4079 6.328E-05 1E-03 2.688E-03 0.11765201 KANG_IMMORTALIZED_BY_TERT_UP vascular skin disease DOID_9540 6.328E-05 9.732E-04 0.07374257 0.46621689 KANG_IMMORTALIZED_BY_TERT_UP glaucoma DOID_1686 7.12E-05 1.066E-03 0.07657833 0.47882497 KANG_IMMORTALIZED_BY_TERT_UP reproductive organ benign neoplasm DOID_0050622 9.876E-05 1.441E-03 0.08503454 0.51473036 KANG_IMMORTALIZED_BY_TERT_UP keratitis DOID_4677 1.027E-04 1.461E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP familial hyperlipidemia DOID_1168 1.039E-04 1.443E-03 0.08643649 0.51231628 KANG_IMMORTALIZED_BY_TERT_UP sickle cell anemia DOID_10923 1.254E-04 1.699E-03 0.01670293 0.35199881 KANG_IMMORTALIZED_BY_TERT_UP relapsing-remitting multiple sclerosis DOID_2378 1.503E-04 1.989E-03 0.01820771 0.34533963 KANG_IMMORTALIZED_BY_TERT_UP epidermolysis bullosa DOID_2730 1.503E-04 1.944E-03 1.503E-04 0.02138469 KANG_IMMORTALIZED_BY_TERT_UP pituitary gland disease DOID_53 1.503E-04 1.901E-03 0.01820771 0.33419964 KANG_IMMORTALIZED_BY_TERT_UP aortic valve insufficiency DOID_57 1.503E-04 1.86E-03 0.01820771 0.3237559 KANG_IMMORTALIZED_BY_TERT_UP ocular hypertension DOID_9282 1.503E-04 1.82E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP borderline glaucoma DOID_9283 1.503E-04 1.82E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP uterine disease DOID_345 1.587E-04 1.881E-03 0.09895941 0.54142215 KANG_IMMORTALIZED_BY_TERT_UP hyperglycemia DOID_4195 1.657E-04 1.924E-03 0.10034039 0.54374933 KANG_IMMORTALIZED_BY_TERT_UP nicotine dependence DOID_0050742 1.775E-04 2.02E-03 0.01971023 0.33985218 KANG_IMMORTALIZED_BY_TERT_UP vesiculobullous skin disease DOID_2731 1.775E-04 1.98E-03 1.775E-04 0.02019836 KANG_IMMORTALIZED_BY_TERT_UP brain infarction DOID_3454 1.804E-04 1.974E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP peripheral vascular disease DOID_341 2.122E-04 2.278E-03 0.10858268 0.56682151 KANG_IMMORTALIZED_BY_TERT_UP biliary tract disease DOID_9741 2.122E-04 2.236E-03 0.10858268 0.56166859 KANG_IMMORTALIZED_BY_TERT_UP oral submucous fibrosis DOID_5773 2.385E-04 2.467E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bone resorption disease DOID_0080011 2.474E-04 2.514E-03 6.571E-03 0.20772888 KANG_IMMORTALIZED_BY_TERT_UP osteoporosis DOID_11476 2.474E-04 2.514E-03 6.571E-03 0.20772888 KANG_IMMORTALIZED_BY_TERT_UP electroclinical syndrome DOID_0050701 2.568E-04 2.563E-03 0.11539453 0.58105743 KANG_IMMORTALIZED_BY_TERT_UP bacterial pneumonia DOID_874 2.568E-04 2.519E-03 0.11539453 0.57596043 KANG_IMMORTALIZED_BY_TERT_UP hemolytic-uremic syndrome DOID_12554 2.723E-04 2.626E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP contact dermatitis DOID_2773 2.762E-04 2.619E-03 0.11810493 0.57932503 KANG_IMMORTALIZED_BY_TERT_UP lipid metabolism disorder DOID_3146 2.762E-04 2.576E-03 0.11810493 0.57437354 KANG_IMMORTALIZED_BY_TERT_UP female reproductive system disease DOID_229 2.862E-04 2.627E-03 0.11945706 0.57118545 KANG_IMMORTALIZED_BY_TERT_UP chronic kidney failure DOID_784 3.07E-04 2.773E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP ureteral obstruction DOID_5199 3.464E-04 3.08E-03 0.02718899 0.34378972 KANG_IMMORTALIZED_BY_TERT_UP infertility DOID_5223 3.868E-04 3.386E-03 3.868E-04 0.03668365 KANG_IMMORTALIZED_BY_TERT_UP Crohn's disease DOID_8778 4.389E-04 3.784E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP dilated cardiomyopathy DOID_12930 4.524E-04 3.842E-03 9.758E-03 0.25236826 KANG_IMMORTALIZED_BY_TERT_UP ulcerative colitis DOID_8577 4.945E-04 4.138E-03 0.01034348 0.25588865 KANG_IMMORTALIZED_BY_TERT_UP placenta disease DOID_780 5.21E-04 4.296E-03 0.03313161 0.38473232 KANG_IMMORTALIZED_BY_TERT_UP urinary tract obstruction DOID_5200 5.701E-04 4.634E-03 0.03461168 0.37158573 KANG_IMMORTALIZED_BY_TERT_UP ureteral disease DOID_1426 6.213E-04 4.979E-03 0.03608952 0.3802766 KANG_IMMORTALIZED_BY_TERT_UP spastic quadriplegia DOID_10970 6.746E-04 5.332E-03 0.03756514 0.38862844 KANG_IMMORTALIZED_BY_TERT_UP morbid obesity DOID_11981 7.878E-04 6.14E-03 0.04050972 0.39741434 KANG_IMMORTALIZED_BY_TERT_UP pleurisy DOID_10247 9.734E-04 7.485E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP malaria DOID_12365 9.734E-04 7.385E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP multiple epiphyseal dysplasia DOID_12721 1.04E-03 7.783E-03 0.04637235 0.40593642 KANG_IMMORTALIZED_BY_TERT_UP corneal disease DOID_10124 1.108E-03 8.186E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP spastic cerebral palsy DOID_0050669 1.178E-03 8.594E-03 0.04929045 0.41244508 KANG_IMMORTALIZED_BY_TERT_UP bladder disease DOID_365 1.325E-03 9.543E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP papilloma DOID_2615 1.402E-03 9.968E-03 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP myocarditis DOID_820 1.402E-03 9.845E-03 0.05365115 0.418185 KANG_IMMORTALIZED_BY_TERT_UP spindle cell carcinoma DOID_4015 1.48E-03 0.01027084 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP adenoma DOID_657 1.644E-03 0.01126764 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP multiple myeloma DOID_9538 1.728E-03 0.01170798 0.05943485 0.4227304 KANG_IMMORTALIZED_BY_TERT_UP uveitis DOID_13141 1.815E-03 0.01215166 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP peptic ulcer DOID_750 1.904E-03 0.01259851 0.06231367 0.43239604 KANG_IMMORTALIZED_BY_TERT_UP adult respiratory distress syndrome DOID_11394 1.995E-03 0.01304838 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP nephrotic syndrome DOID_1184 2.28E-03 0.01474239 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP uveal disease DOID_3480 2.28E-03 0.01457674 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP gallbladder cancer DOID_3121 2.379E-03 0.01504068 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP cerebral infarction DOID_3526 2.48E-03 0.01550694 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP pre-eclampsia DOID_10591 2.688E-03 0.01662474 0.07374257 0.47681273 KANG_IMMORTALIZED_BY_TERT_UP thyroid adenoma DOID_2891 2.688E-03 0.01644598 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP hemolytic anemia DOID_583 2.795E-03 0.01691855 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP normocytic anemia DOID_720 2.795E-03 0.01691855 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP aortic aneurysm DOID_3627 3.015E-03 0.01805739 3.015E-03 0.12253231 KANG_IMMORTALIZED_BY_TERT_UP bile duct adenocarcinoma DOID_4896 3.478E-03 0.02061526 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP cholangiocarcinoma DOID_4947 3.478E-03 0.02061526 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP osteochondrodysplasia DOID_2256 3.599E-03 0.02111071 0.08503454 0.50931214 KANG_IMMORTALIZED_BY_TERT_UP parasitic protozoa infectious disease DOID_2789 3.599E-03 0.0208953 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP hypertrophic cardiomyopathy DOID_11984 3.973E-03 0.02283187 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bile duct cancer DOID_4606 3.973E-03 0.02260355 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bile duct carcinoma DOID_4897 3.973E-03 0.02260355 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP melancholia DOID_2848 4.101E-03 0.02310311 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP leukocyte disease DOID_9500 4.101E-03 0.02287661 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP neurotic disorder DOID_4964 4.231E-03 0.02337438 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP respiratory failure DOID_11162 4.498E-03 0.02460678 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP cholestasis DOID_13580 4.911E-03 0.02661424 0.09895941 0.54667867 KANG_IMMORTALIZED_BY_TERT_UP parasitic infectious disease DOID_1398 4.911E-03 0.02636317 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP cerebral degeneration DOID_1443 4.911E-03 0.02611678 4.911E-03 0.16438209 KANG_IMMORTALIZED_BY_TERT_UP temporal lobe epilepsy DOID_3328 5.053E-03 0.02662128 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP allergic contact dermatitis DOID_3042 5.196E-03 0.02712629 0.10171928 0.54602144 KANG_IMMORTALIZED_BY_TERT_UP endocrine organ benign neoplasm DOID_0060089 5.342E-03 0.02763177 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP tuberculosis DOID_399 5.342E-03 0.02738283 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bile duct disease DOID_4138 5.789E-03 0.02941083 0.10721414 0.56485967 KANG_IMMORTALIZED_BY_TERT_UP endogenous depression DOID_1595 6.411E-03 0.03228339 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP aneurysm disease DOID_2403 6.571E-03 0.0327993 6.571E-03 0.19679578 KANG_IMMORTALIZED_BY_TERT_UP alcohol abuse DOID_1574 7.57E-03 0.03745433 0.12215522 0.57921935 KANG_IMMORTALIZED_BY_TERT_UP mental depression DOID_1596 7.57E-03 0.03713145 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP focal epilepsy DOID_2234 7.57E-03 0.03681408 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP biliary tract cancer DOID_4607 7.57E-03 0.0365021 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bone development disease DOID_0080006 7.743E-03 0.03702098 0.12350125 0.5807621 KANG_IMMORTALIZED_BY_TERT_UP primary bacterial infectious disease DOID_0050338 8.271E-03 0.03921901 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP transitional cell carcinoma DOID_2671 8.451E-03 0.03974004 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP amino acid metabolic disorder DOID_9252 8.632E-03 0.0402607 0.13020105 0.59745481 KANG_IMMORTALIZED_BY_TERT_UP lymphoma DOID_0060058 9.187E-03 0.04250023 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP mouth disease DOID_403 9.566E-03 0.04389462 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP hypersensitivity reaction type I disease DOID_1205 9.758E-03 0.04441681 0.13817439 0.62397799 KANG_IMMORTALIZED_BY_TERT_UP facioscapulohumeral muscular dystrophy DOID_11727 0.01519588 0.06862268 0.01519588 0.36026906 KANG_IMMORTALIZED_BY_TERT_UP Diamond-Blackfan anemia DOID_1339 0.01519588 0.06808234 0.01519588 0.3458583 KANG_IMMORTALIZED_BY_TERT_UP familial combined hyperlipidemia DOID_13809 0.01519588 0.06755045 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP childhood type dermatomyositis DOID_14203 0.01519588 0.0670268 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP insulinoma DOID_3892 0.01519588 0.06651121 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP adrenal gland hyperfunction DOID_3947 0.01519588 0.06600349 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP conjunctival disease DOID_4251 0.01519588 0.06550347 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP Paget's disease of bone DOID_5408 0.01519588 0.06501096 0.01519588 0.33255606 KANG_IMMORTALIZED_BY_TERT_UP conjunctivitis DOID_6195 0.01519588 0.06550347 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP dermatomyositis DOID_10223 0.01670293 0.07092513 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP obsessive-compulsive disorder DOID_10933 0.01670293 0.07039976 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP pneumocystosis DOID_11339 0.01670293 0.06988212 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP common variable immunodeficiency DOID_12177 0.01670293 0.06937203 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP temporal arteritis DOID_13375 0.01670293 0.06886933 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP neuronal ceroid lipofuscinosis DOID_14503 0.01670293 0.06837387 0.01670293 0.33942743 KANG_IMMORTALIZED_BY_TERT_UP central nervous system vasculitis DOID_525 0.01670293 0.06886933 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bronchiectasis DOID_9563 0.01670293 0.06788549 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP heroin dependence DOID_9976 0.01670293 0.06740403 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP aortic valve stenosis DOID_1712 0.01820771 0.07295908 0.01820771 0.35724789 KANG_IMMORTALIZED_BY_TERT_UP islet cell tumor DOID_1799 0.01820771 0.07244887 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP lipodystrophy DOID_811 0.01820771 0.07194576 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP berylliosis DOID_10322 0.01971023 0.07734567 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP newborn respiratory distress syndrome DOID_12716 0.01971023 0.0768159 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP obstructive hydrocephalus DOID_14159 0.01971023 0.07629335 0.01971023 0.32985653 KANG_IMMORTALIZED_BY_TERT_UP communicating hydrocephalus DOID_1573 0.01971023 0.07629335 0.01971023 0.32985653 KANG_IMMORTALIZED_BY_TERT_UP Leydig cell tumor DOID_2696 0.01971023 0.07577785 0.01971023 0.32043206 KANG_IMMORTALIZED_BY_TERT_UP sex cord-stromal neoplasm DOID_4757 0.01971023 0.07577785 0.01971023 0.32043206 KANG_IMMORTALIZED_BY_TERT_UP hydrocephalus DOID_10908 0.02121049 0.08099845 0.02121049 0.32618295 KANG_IMMORTALIZED_BY_TERT_UP hypercalcemia DOID_12678 0.02121049 0.08045846 0.02121049 0.31759919 KANG_IMMORTALIZED_BY_TERT_UP eyelid disease DOID_530 0.02121049 0.07992562 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP eating disorder DOID_8670 0.02121049 0.0793998 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bacterial meningitis DOID_9470 0.02121049 0.07888084 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP Ehlers-Danlos syndrome DOID_13359 0.02270849 0.08390346 0.02270849 0.33131109 KANG_IMMORTALIZED_BY_TERT_UP thoracic aortic aneurysm DOID_14004 0.02270849 0.08336214 0.02270849 0.32302831 KANG_IMMORTALIZED_BY_TERT_UP communication disorder DOID_2033 0.02270849 0.08282777 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP adrenal cortex disease DOID_3952 0.02270849 0.08230021 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP varicose veins DOID_799 0.02270849 0.08177932 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP intermediate coronary syndrome DOID_8805 0.02270849 0.08126498 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP hyperhomocysteinemia DOID_9279 0.02270849 0.08075708 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP intracranial hypertension DOID_9428 0.02270849 0.08025548 0.02270849 0.31514957 KANG_IMMORTALIZED_BY_TERT_UP silicosis DOID_10325 0.02420424 0.08501366 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP spastic diplegia DOID_10965 0.02420424 0.08449211 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP restrictive cardiomyopathy DOID_397 0.02420424 0.08397691 0.02420424 0.32790985 KANG_IMMORTALIZED_BY_TERT_UP vein disease DOID_866 0.02420424 0.08346796 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP Barrett's esophagus DOID_9206 0.02420424 0.08296514 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP schizophreniform disorder DOID_11328 0.02569774 0.08755697 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP penile disease DOID_1529 0.02569774 0.0870358 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP hyperostosis DOID_205 0.02569774 0.0865208 0.02569774 0.34004685 KANG_IMMORTALIZED_BY_TERT_UP schizoaffective disorder DOID_5418 0.02569774 0.08755697 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP bronchitis DOID_6132 0.02569774 0.08601185 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP adrenal gland disease DOID_9553 0.02569774 0.08550886 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP congenital muscular dystrophy DOID_0050557 0.02718899 0.08994499 0.02718899 0.35160313 KANG_IMMORTALIZED_BY_TERT_UP glucose intolerance DOID_10603 0.02718899 0.08942507 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP osteosclerosis DOID_4254 0.02718899 0.08891114 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP Down syndrome DOID_14250 0.028678 0.09324448 0.028678 0.35473443 KANG_IMMORTALIZED_BY_TERT_UP agammaglobulinemia DOID_2583 0.028678 0.09271468 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP membranous glomerulonephritis DOID_10976 0.03016477 0.09697037 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP brain edema DOID_4724 0.03016477 0.0964256 1.000 1.000 KANG_IMMORTALIZED_BY_TERT_UP blood protein disease DOID_620 0.03016477 0.0958869 1.000 1.000 SMITH_TERT_TARGETS_DN giant cell tumor DOID_200 5.018E-10 2.855E-07 3.95E-03 0.2497521 SMITH_TERT_TARGETS_DN malignant giant cell tumor DOID_2705 5.018E-10 2.855E-07 3.95E-03 0.2497521 SMITH_TERT_TARGETS_DN giant cell glioblastoma DOID_3074 5.018E-10 2.855E-07 3.95E-03 0.2497521 SMITH_TERT_TARGETS_DN glioblastoma DOID_3068 8.526E-10 2.426E-07 4.669E-03 0.24153149 SMITH_TERT_TARGETS_DN astrocytoma DOID_3069 2.365E-09 4.486E-07 6.446E-03 0.28212615 SMITH_TERT_TARGETS_DN diabetic autonomic neuropathy DOID_11503 1.17E-06 1.665E-04 0.07523576 0.528508 SMITH_TERT_TARGETS_DN autonomic neuropathy DOID_11504 1.17E-06 1.665E-04 0.07523576 0.528508 SMITH_TERT_TARGETS_DN diabetic polyneuropathy DOID_12785 1.17E-06 1.665E-04 0.07523576 0.528508 SMITH_TERT_TARGETS_DN diabetic neuropathy DOID_9743 1.17E-06 1.665E-04 0.07523576 0.528508 SMITH_TERT_TARGETS_DN autonomic nervous system disease DOID_11465 1.505E-06 1.713E-04 0.07984421 0.55404094 SMITH_TERT_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 2.746E-06 2.604E-04 4.231E-03 0.24075615 SMITH_TERT_TARGETS_DN bone resorption disease DOID_0080011 9.473E-06 7.7E-04 3.16E-04 0.0599425 SMITH_TERT_TARGETS_DN osteoporosis DOID_11476 9.473E-06 7.7E-04 3.16E-04 0.0599425 SMITH_TERT_TARGETS_DN sphingolipidosis DOID_1927 9.799E-06 6.97E-04 9.799E-06 5.576E-03 SMITH_TERT_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 2.096E-05 1.325E-03 0.05185061 0.5268392 SMITH_TERT_TARGETS_DN uterine benign neoplasm DOID_0060095 2.096E-05 1.325E-03 0.05185061 0.5268392 SMITH_TERT_TARGETS_DN uterine fibroid DOID_13223 2.096E-05 1.325E-03 0.05185061 0.5268392 SMITH_TERT_TARGETS_DN leiomyoma DOID_127 2.756E-05 1.568E-03 0.05657373 0.52771231 SMITH_TERT_TARGETS_DN lymphatic system disease DOID_75 5.147E-05 2.662E-03 0.06905581 0.53825693 SMITH_TERT_TARGETS_DN pulmonary emphysema DOID_9675 5.517E-05 2.616E-03 1.000 1.000 SMITH_TERT_TARGETS_DN endometriosis of uterus DOID_288 5.904E-05 2.584E-03 2.57E-03 0.20886573 SMITH_TERT_TARGETS_DN Huntington's disease DOID_12858 6.308E-05 2.564E-03 1.000 1.000 SMITH_TERT_TARGETS_DN endometriosis DOID_289 6.308E-05 2.393E-03 2.683E-03 0.19086072 SMITH_TERT_TARGETS_DN pre-eclampsia DOID_10591 8.107E-05 2.883E-03 1.000 1.000 SMITH_TERT_TARGETS_DN intracranial arteriosclerosis DOID_13097 1.775E-04 5.94E-03 0.01976303 0.48892011 SMITH_TERT_TARGETS_DN vascular dementia DOID_8725 1.775E-04 5.94E-03 0.01976303 0.48892011 SMITH_TERT_TARGETS_DN hypothyroidism DOID_1459 1.775E-04 5.61E-03 1.775E-04 0.05049405 SMITH_TERT_TARGETS_DN pre-malignant neoplasm DOID_0060071 1.857E-04 5.562E-03 0.10404353 0.62316599 SMITH_TERT_TARGETS_DN in situ carcinoma DOID_8719 1.857E-04 5.562E-03 0.10404353 0.62316599 SMITH_TERT_TARGETS_DN uterine disease DOID_345 2.029E-04 5.773E-03 5.769E-03 0.27355729 SMITH_TERT_TARGETS_DN tuberculosis DOID_399 2.306E-04 6.248E-03 0.11147656 0.64724656 SMITH_TERT_TARGETS_DN bile duct disease DOID_4138 2.606E-04 6.74E-03 0.11590721 0.65951205 SMITH_TERT_TARGETS_DN peripheral vascular disease DOID_341 2.711E-04 6.708E-03 6.976E-03 0.2835136 SMITH_TERT_TARGETS_DN biliary tract disease DOID_9741 2.711E-04 6.428E-03 0.11737926 0.66127524 SMITH_TERT_TARGETS_DN diabetic retinopathy DOID_8947 2.82E-04 6.417E-03 1.000 1.000 SMITH_TERT_TARGETS_DN bacterial pneumonia DOID_874 3.28E-04 7.177E-03 1.000 1.000 SMITH_TERT_TARGETS_DN female reproductive system disease DOID_229 3.655E-04 7.702E-03 8.482E-03 0.25401029 SMITH_TERT_TARGETS_DN chronic kidney failure DOID_784 3.919E-04 7.965E-03 1.000 1.000 SMITH_TERT_TARGETS_DN ureteral obstruction DOID_5199 4.087E-04 8.02E-03 1.000 1.000 SMITH_TERT_TARGETS_DN retinal vascular disease DOID_2462 4.196E-04 7.959E-03 1.000 1.000 SMITH_TERT_TARGETS_DN primary bacterial infectious disease DOID_0050338 4.485E-04 8.233E-03 0.1377364 0.75357705 SMITH_TERT_TARGETS_DN amino acid metabolic disorder DOID_9252 4.787E-04 8.512E-03 4.787E-04 0.06809219 SMITH_TERT_TARGETS_DN nervous system cancer DOID_3093 4.942E-04 8.522E-03 0.14203815 0.76245009 SMITH_TERT_TARGETS_DN alopecia DOID_987 5.065E-04 8.477E-03 0.03272431 0.47743931 SMITH_TERT_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 5.597E-04 9.099E-03 1.000 1.000 SMITH_TERT_TARGETS_DN mouth disease DOID_403 5.597E-04 8.846E-03 1.000 1.000 SMITH_TERT_TARGETS_DN dilated cardiomyopathy DOID_12930 5.768E-04 8.871E-03 1.000 1.000 SMITH_TERT_TARGETS_DN ulcerative colitis DOID_8577 6.304E-04 9.439E-03 0.1534065 0.80081009 SMITH_TERT_TARGETS_DN urinary tract obstruction DOID_5200 6.723E-04 9.809E-03 1.000 1.000 SMITH_TERT_TARGETS_DN pulmonary embolism DOID_9477 6.723E-04 9.563E-03 1.000 1.000 SMITH_TERT_TARGETS_DN ureteral disease DOID_1426 7.326E-04 0.01016736 1.000 1.000 SMITH_TERT_TARGETS_DN bronchiolitis DOID_2942 8.608E-04 0.01166238 1.000 1.000 SMITH_TERT_TARGETS_DN ankylosing spondylitis DOID_7147 9.287E-04 0.01228929 1.000 1.000 SMITH_TERT_TARGETS_DN hypotrichosis DOID_4535 9.991E-04 0.01292 0.0455169 0.51798231 SMITH_TERT_TARGETS_DN periodontitis DOID_824 1.072E-03 0.01355414 1.000 1.000 SMITH_TERT_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 1.072E-03 0.01325949 1.072E-03 0.1219873 SMITH_TERT_TARGETS_DN autoimmune disease of cardiovascular system DOID_0060051 1.147E-03 0.01388946 0.04868894 0.52271711 SMITH_TERT_TARGETS_DN pleurisy DOID_10247 1.147E-03 0.01360009 1.000 1.000 SMITH_TERT_TARGETS_DN Behcet's disease DOID_13241 1.147E-03 0.01388946 0.04868894 0.52271711 SMITH_TERT_TARGETS_DN polycystic ovary syndrome DOID_11612 1.225E-03 0.01422611 1.225E-03 0.11617989 SMITH_TERT_TARGETS_DN focal glomerulosclerosis DOID_3945 1.225E-03 0.01394159 1.000 1.000 SMITH_TERT_TARGETS_DN allergic rhinitis DOID_4481 1.473E-03 0.01643722 1.000 1.000 SMITH_TERT_TARGETS_DN pleural disease DOID_1532 1.561E-03 0.01707988 1.000 1.000 SMITH_TERT_TARGETS_DN hair disease DOID_421 1.651E-03 0.0177244 0.05814295 0.52513235 SMITH_TERT_TARGETS_DN myocarditis DOID_820 1.651E-03 0.01739617 1.000 1.000 SMITH_TERT_TARGETS_DN pneumoconiosis DOID_10316 1.743E-03 0.01803658 1.000 1.000 SMITH_TERT_TARGETS_DN periodontal disease DOID_3388 1.743E-03 0.01771449 1.000 1.000 SMITH_TERT_TARGETS_DN hepatitis DOID_2237 2.242E-03 0.02237949 1.000 1.000 SMITH_TERT_TARGETS_DN systemic scleroderma DOID_418 2.242E-03 0.02199363 0.06750448 0.54098663 SMITH_TERT_TARGETS_DN intracranial arterial disease DOID_13089 2.349E-03 0.02265132 0.06905581 0.54573272 SMITH_TERT_TARGETS_DN cerebral arterial disease DOID_3527 2.349E-03 0.02265132 0.06905581 0.54573272 SMITH_TERT_TARGETS_DN benign mesothelioma DOID_2645 2.458E-03 0.02330954 0.0706046 0.54289211 SMITH_TERT_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 2.458E-03 0.02292742 0.0706046 0.53565354 SMITH_TERT_TARGETS_DN nephrotic syndrome DOID_1184 2.683E-03 0.02462719 0.07369457 0.54457415 SMITH_TERT_TARGETS_DN rheumatic disease DOID_1575 2.683E-03 0.02423628 0.07369457 0.53759243 SMITH_TERT_TARGETS_DN scleroderma DOID_419 2.683E-03 0.02423628 0.07369457 0.53759243 SMITH_TERT_TARGETS_DN influenza DOID_8469 2.8E-03 0.02489133 1.000 1.000 SMITH_TERT_TARGETS_DN brain cancer DOID_1319 3.163E-03 0.02768434 1.000 1.000 SMITH_TERT_TARGETS_DN vascular skin disease DOID_9540 3.163E-03 0.02726488 0.07984421 0.54736574 SMITH_TERT_TARGETS_DN central nervous system cancer DOID_3620 3.288E-03 0.02792436 1.000 1.000 SMITH_TERT_TARGETS_DN hemolytic anemia DOID_583 3.288E-03 0.02751371 0.08137533 0.55122101 SMITH_TERT_TARGETS_DN normocytic anemia DOID_720 3.288E-03 0.02751371 0.08137533 0.55122101 SMITH_TERT_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 3.416E-03 0.02816948 0.08290395 0.55496879 SMITH_TERT_TARGETS_DN pulmonary tuberculosis DOID_2957 3.416E-03 0.02776706 1.000 1.000 SMITH_TERT_TARGETS_DN vasculitis DOID_865 4.09E-03 0.03277497 0.09050955 0.58522654 SMITH_TERT_TARGETS_DN pustulosis of palm and sole DOID_4398 4.231E-03 0.03343835 1.000 1.000 SMITH_TERT_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 4.669E-03 0.03639516 0.09654931 0.59071569 SMITH_TERT_TARGETS_DN carotid artery disease DOID_3407 5.127E-03 0.03942625 1.000 1.000 SMITH_TERT_TARGETS_DN collagen disease DOID_854 5.127E-03 0.03890057 0.10105321 0.61169445 SMITH_TERT_TARGETS_DN respiratory failure DOID_11162 5.285E-03 0.03956522 1.000 1.000 SMITH_TERT_TARGETS_DN cholestasis DOID_13580 5.769E-03 0.0426323 1.000 1.000 SMITH_TERT_TARGETS_DN cerebral degeneration DOID_1443 5.769E-03 0.04208574 0.10702406 0.63434051 SMITH_TERT_TARGETS_DN temporal lobe epilepsy DOID_3328 5.935E-03 0.04274784 1.000 1.000 SMITH_TERT_TARGETS_DN tooth disease DOID_1091 6.103E-03 0.04340881 1.000 1.000 SMITH_TERT_TARGETS_DN pancreatic ductal carcinoma DOID_3587 6.62E-03 0.04650545 1.000 1.000 SMITH_TERT_TARGETS_DN nephrosis DOID_2527 6.797E-03 0.04716414 0.11590721 0.66617379 SMITH_TERT_TARGETS_DN pancreatic carcinoma DOID_4905 7.157E-03 0.04906181 1.000 1.000 SMITH_TERT_TARGETS_DN syndrome DOID_225 7.525E-03 0.05097164 7.525E-03 0.28544117 SMITH_TERT_TARGETS_DN electroclinical syndrome DOID_0050701 7.901E-03 0.05289282 7.901E-03 0.28099309 SMITH_TERT_TARGETS_DN contact dermatitis DOID_2773 8.286E-03 0.05482456 8.286E-03 0.2773478 SMITH_TERT_TARGETS_DN lipid metabolism disorder DOID_3146 8.286E-03 0.0541944 8.286E-03 0.26193959 SMITH_TERT_TARGETS_DN focal epilepsy DOID_2234 8.879E-03 0.05741231 1.000 1.000 SMITH_TERT_TARGETS_DN encephalomyelitis DOID_640 0.0109879 0.07024849 0.14631878 0.77088322 SMITH_TERT_TARGETS_DN Crohn's disease DOID_8778 0.01120978 0.07087071 1.000 1.000 SMITH_TERT_TARGETS_DN cannabis abuse DOID_9505 0.01649609 0.099854 1.000 1.000 SMITH_TERT_TARGETS_DN alopecia areata DOID_986 0.01649609 0.09880291 1.000 1.000 JIANG_TIP30_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 1.966E-06 1.119E-03 1.966E-06 1.119E-03 JIANG_TIP30_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 1.316E-05 3.743E-03 1.316E-05 3.743E-03 JIANG_TIP30_TARGETS_UP allergic contact dermatitis DOID_3042 2.877E-05 5.457E-03 1.608E-03 0.15251427 JIANG_TIP30_TARGETS_UP contact dermatitis DOID_2773 4.623E-05 6.576E-03 2.198E-03 0.13894092 JIANG_TIP30_TARGETS_UP biliary tract cancer DOID_4607 5.147E-05 5.858E-03 5.147E-05 9.763E-03 JIANG_TIP30_TARGETS_UP lymphoma DOID_0060058 6.95E-05 6.59E-03 6.95E-05 9.886E-03 JIANG_TIP30_TARGETS_UP adenoid cystic carcinoma DOID_4866 6.099E-04 0.04958003 0.03567895 0.5342453 JIANG_TIP30_TARGETS_UP salivary gland cancer DOID_8850 6.68E-04 0.04751216 0.03730806 0.5177631 JIANG_TIP30_TARGETS_UP familial hyperlipidemia DOID_1168 1.146E-03 0.07245458 1.146E-03 0.13041824 JIANG_TIP30_TARGETS_UP oral cavity cancer DOID_8618 1.224E-03 0.06967104 0.05024534 0.52943699 JIANG_TIP30_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 1.654E-03 0.08555588 1.654E-03 0.13444495 JIANG_TIP30_TARGETS_UP astrocytoma DOID_3069 1.7E-03 0.08062455 1.000 1.000 JIANG_TIP30_TARGETS_UP pancreatic ductal carcinoma DOID_3587 1.747E-03 0.07647883 0.0598376 0.55815732 JIANG_TIP30_TARGETS_UP peripheral vascular disease DOID_341 1.843E-03 0.07490958 1.843E-03 0.13109176 JIANG_TIP30_TARGETS_UP pancreatic carcinoma DOID_4905 1.892E-03 0.07176746 0.06222097 0.57102789 JIANG_TIP30_TARGETS_UP aneurysm disease DOID_2403 2.042E-03 0.07262072 0.06459847 0.57432081 JIANG_TIP30_TARGETS_UP pancreatitis DOID_4989 2.093E-03 0.0700646 0.06538968 0.57241119 JIANG_TIP30_TARGETS_UP lipid metabolism disorder DOID_3146 2.198E-03 0.06947046 2.198E-03 0.12504683 JIANG_TIP30_TARGETS_UP chronic kidney failure DOID_784 2.359E-03 0.0706372 2.359E-03 0.12200971 JIANG_TIP30_TARGETS_UP transitional cell carcinoma DOID_2671 2.639E-03 0.07508445 2.639E-03 0.12514075 JIANG_TIP30_TARGETS_UP ulcerative colitis DOID_8577 3.245E-03 0.08791874 3.245E-03 0.14202258 MARKS_HDAC_TARGETS_UP retinal detachment DOID_5327 2.224E-11 1.265E-08 5.998E-03 1.000 MARKS_HDAC_TARGETS_UP transitional cell carcinoma DOID_2671 7.631E-10 2.171E-07 0.04416503 0.81064196 MARKS_HDAC_TARGETS_UP glaucoma DOID_1686 1.201E-08 2.278E-06 3.109E-04 0.1768776 MARKS_HDAC_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 1.879E-08 2.672E-06 0.028678 0.8158892 MARKS_HDAC_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.453E-07 1.654E-05 0.04704268 0.76477954 MARKS_HDAC_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 3.771E-06 3.576E-04 0.03013995 0.77952868 MARKS_HDAC_TARGETS_UP male reproductive system disease DOID_48 6.764E-06 5.498E-04 1.000 1.000 MARKS_HDAC_TARGETS_UP mixed glioma DOID_5076 8.556E-06 6.086E-04 1.000 1.000 MARKS_HDAC_TARGETS_UP transient cerebral ischemia DOID_224 1.068E-05 6.754E-04 1.000 1.000 MARKS_HDAC_TARGETS_UP encephalomyelitis DOID_640 1.435E-05 8.163E-04 0.04656364 0.77925622 MARKS_HDAC_TARGETS_UP dilated cardiomyopathy DOID_12930 1.527E-05 7.9E-04 0.04752149 0.75110352 MARKS_HDAC_TARGETS_UP parasitic helminthiasis infectious disease DOID_883 2.158E-05 1.023E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP lung oat cell carcinoma DOID_5411 2.489E-05 1.089E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP varicose veins DOID_799 2.489E-05 1.012E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP vein disease DOID_866 2.844E-05 1.079E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP male reproductive organ benign neoplasm DOID_0060087 3.623E-05 1.289E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP diabetic angiopathy DOID_11713 6.525E-05 2.184E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP seminoma DOID_4440 8.925E-05 2.821E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 1.17E-04 3.503E-03 0.01592006 0.8235013 MARKS_HDAC_TARGETS_UP uterine benign neoplasm DOID_0060095 1.17E-04 3.503E-03 0.01592006 0.8235013 MARKS_HDAC_TARGETS_UP uterine fibroid DOID_13223 1.17E-04 3.503E-03 0.01592006 0.8235013 MARKS_HDAC_TARGETS_UP germinoma DOID_3304 1.322E-04 3.762E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP chronic leukemia DOID_1036 1.402E-04 3.799E-03 0.01740019 0.8250591 MARKS_HDAC_TARGETS_UP chronic lymphocytic leukemia DOID_1040 1.402E-04 3.799E-03 0.01740019 0.8250591 MARKS_HDAC_TARGETS_UP leiomyoma DOID_127 1.402E-04 3.626E-03 0.01740019 0.76159302 MARKS_HDAC_TARGETS_UP autonomic nervous system neoplasm DOID_2621 1.402E-04 3.468E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP neuroblastoma DOID_769 1.402E-04 3.468E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP peripheral nervous system neoplasm DOID_1192 1.929E-04 4.573E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP benign mesothelioma DOID_2645 2.223E-04 5.06E-03 0.02182794 0.82800663 MARKS_HDAC_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 2.223E-04 4.865E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP integumentary system benign neoplasm DOID_0060121 3.109E-04 6.551E-03 0.02574785 0.81391804 MARKS_HDAC_TARGETS_UP skin benign neoplasm DOID_3165 3.109E-04 6.551E-03 0.02574785 0.81391804 MARKS_HDAC_TARGETS_UP lung small cell carcinoma DOID_5409 3.109E-04 6.317E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP bile duct adenocarcinoma DOID_4896 3.736E-04 7.33E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP cholangiocarcinoma DOID_4947 3.736E-04 7.33E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP integumentary system cancer DOID_0060122 3.868E-04 7.337E-03 0.028678 0.77703733 MARKS_HDAC_TARGETS_UP skin cancer DOID_4159 3.868E-04 7.337E-03 0.028678 0.77703733 MARKS_HDAC_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 4.279E-04 7.853E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP bile duct cancer DOID_4606 4.279E-04 7.608E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP bile duct carcinoma DOID_4897 4.279E-04 7.608E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP carotid artery disease DOID_3407 4.709E-04 8.12E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP pre-malignant neoplasm DOID_0060071 5.008E-04 8.38E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP in situ carcinoma DOID_8719 5.008E-04 8.38E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP parasitic infectious disease DOID_1398 5.315E-04 8.641E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP astrocytoma DOID_3069 5.956E-04 9.414E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP peripheral vascular disease DOID_341 6.461E-04 9.936E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP pancreatic carcinoma DOID_4905 6.634E-04 9.933E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP diabetic retinopathy DOID_8947 6.634E-04 9.678E-03 1.000 1.000 MARKS_HDAC_TARGETS_UP biliary tract cancer DOID_4607 8.287E-04 0.01178847 1.000 1.000 MARKS_HDAC_TARGETS_UP retinal vascular disease DOID_2462 8.679E-04 0.01204463 1.000 1.000 MARKS_HDAC_TARGETS_UP nervous system cancer DOID_3093 9.697E-04 0.01313685 1.000 1.000 MARKS_HDAC_TARGETS_UP lymphoma DOID_0060058 1.012E-03 0.01339043 0.04608437 0.81943778 MARKS_HDAC_TARGETS_UP lymphoblastic leukemia DOID_1037 1.033E-03 0.01336353 0.04656364 0.80287004 MARKS_HDAC_TARGETS_UP familial combined hyperlipidemia DOID_13809 5.001E-03 0.0632354 1.000 1.000 MARKS_HDAC_TARGETS_UP breast benign neoplasm DOID_0060082 5.5E-03 0.06803065 1.000 1.000 MARKS_HDAC_TARGETS_UP thoracic benign neoplasm DOID_0060097 5.5E-03 0.06803065 1.000 1.000 MARKS_HDAC_TARGETS_UP benign breast phyllodes tumor DOID_1631 5.5E-03 0.06803065 1.000 1.000 MARKS_HDAC_TARGETS_UP prostatic adenoma DOID_2883 5.5E-03 0.06658319 1.000 1.000 MARKS_HDAC_TARGETS_UP invasive lobular carcinoma DOID_3457 5.5E-03 0.06519604 1.000 1.000 MARKS_HDAC_TARGETS_UP intracranial arteriosclerosis DOID_13097 5.998E-03 0.06965493 1.000 1.000 MARKS_HDAC_TARGETS_UP vascular dementia DOID_8725 5.998E-03 0.06965493 1.000 1.000 MARKS_HDAC_TARGETS_UP ocular hypertension DOID_9282 5.998E-03 0.06826183 1.000 1.000 MARKS_HDAC_TARGETS_UP borderline glaucoma DOID_9283 5.998E-03 0.06826183 1.000 1.000 MARKS_HDAC_TARGETS_UP vulva cancer DOID_1245 6.497E-03 0.07248311 1.000 1.000 MARKS_HDAC_TARGETS_UP mesenchymal cell neoplasm DOID_3350 7.493E-03 0.0819871 1.000 1.000 MARKS_HDAC_TARGETS_UP spindle cell sarcoma DOID_4235 7.493E-03 0.0819871 1.000 1.000 MARKS_HDAC_TARGETS_UP epithelioid sarcoma DOID_6193 7.493E-03 0.0819871 1.000 1.000 MARKS_HDAC_TARGETS_UP intermediate coronary syndrome DOID_8805 7.493E-03 0.08044017 7.493E-03 1.000 MARKS_HDAC_TARGETS_UP angiosarcoma DOID_0001816 7.99E-03 0.08419393 1.000 1.000 MARKS_HDAC_TARGETS_UP tongue cancer DOID_8649 7.99E-03 0.08266313 1.000 1.000 MARKS_HDAC_TARGETS_UP basal cell carcinoma DOID_2513 8.488E-03 0.08624073 1.000 1.000 MARKS_HDAC_TARGETS_UP keratosis DOID_161 8.985E-03 0.08969044 1.000 1.000 MARKS_HDAC_TARGETS_UP skin carcinoma DOID_3451 8.985E-03 0.08814406 1.000 1.000 MARKS_HDAC_TARGETS_UP infertility DOID_5223 9.482E-03 0.09144229 1.000 1.000 MARKS_HDAC_TARGETS_UP colon carcinoma DOID_1520 9.978E-03 0.09462835 1.000 1.000 MARKS_HDAC_TARGETS_UP subependymal glioma DOID_4843 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP pilocytic astrocytoma DOID_4851 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP subependymal giant cell astrocytoma DOID_5077 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP fibrillary astrocytoma DOID_6726 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP juvenile pilocytic astrocytoma DOID_6811 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP childhood pilocytic astrocytoma DOID_6812 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP gemistocytic astrocytoma DOID_7005 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP childhood cerebral astrocytoma DOID_7007 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP protoplasmic astrocytoma DOID_7008 9.978E-03 0.09307706 1.000 1.000 MARKS_HDAC_TARGETS_UP amyloidosis DOID_9120 9.978E-03 0.09157582 9.978E-03 1.000 MARKS_HDAC_TARGETS_UP coronary restenosis DOID_4247 0.01047482 0.09460591 1.000 1.000 MARKS_HDAC_TARGETS_UP benign glioma DOID_0060101 0.01097102 0.09753921 1.000 1.000 MARKS_HDAC_TARGETS_UP benign ependymoma DOID_4844 0.01097102 0.09753921 1.000 1.000 MARKS_HDAC_TARGETS_UP muscular atrophy DOID_767 0.01097102 0.09603861 0.01097102 1.000 MARKS_HDAC_TARGETS_UP myasthenia gravis DOID_437 0.01146698 0.09885928 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC placenta disease DOID_780 2.24E-07 1.275E-04 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC atrophic muscular disease DOID_913 3.984E-06 1.133E-03 3.984E-06 2.267E-03 LIEN_BREAST_CARCINOMA_METAPLASTIC muscular dystrophy DOID_9884 3.984E-06 1.133E-03 3.984E-06 2.267E-03 LIEN_BREAST_CARCINOMA_METAPLASTIC uterine disease DOID_345 7.172E-06 1.36E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC female reproductive system disease DOID_229 1.308E-05 1.861E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC facioscapulohumeral muscular dystrophy DOID_11727 1.312E-05 1.493E-03 1.312E-05 3.731E-03 LIEN_BREAST_CARCINOMA_METAPLASTIC lymphoblastic leukemia DOID_1037 1.962E-05 1.861E-03 1.962E-05 3.721E-03 LIEN_BREAST_CARCINOMA_METAPLASTIC Leydig cell tumor DOID_2696 2.271E-05 1.846E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC sex cord-stromal neoplasm DOID_4757 2.271E-05 1.846E-03 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC lymphoid leukemia DOID_10747 2.03E-04 0.01443727 2.03E-04 0.02887453 LIEN_BREAST_CARCINOMA_METAPLASTIC cleft palate DOID_674 2.251E-04 0.01422924 0.02193066 0.62392716 LIEN_BREAST_CARCINOMA_METAPLASTIC myeloma DOID_0070004 3.523E-04 0.02004544 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC orofacial cleft DOID_0050567 4.264E-04 0.02205406 0.03003594 0.6329797 LIEN_BREAST_CARCINOMA_METAPLASTIC bone marrow cancer DOID_4960 4.579E-04 0.02171283 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC reproductive organ benign neoplasm DOID_0050622 4.741E-04 0.02075149 1.000 1.000 LIEN_BREAST_CARCINOMA_METAPLASTIC osteochondrodysplasia DOID_2256 4.741E-04 0.01926924 0.03164931 0.62098122 LIEN_BREAST_CARCINOMA_METAPLASTIC bone resorption disease DOID_0080011 8.775E-04 0.03328717 8.775E-04 0.09986151 LIEN_BREAST_CARCINOMA_METAPLASTIC osteoporosis DOID_11476 8.775E-04 0.03328717 8.775E-04 0.09986151 LIEN_BREAST_CARCINOMA_METAPLASTIC chromosomal disease DOID_0080014 9.679E-04 0.03442222 0.04499496 0.65646495 LIEN_BREAST_CARCINOMA_METAPLASTIC bone development disease DOID_0080006 1.039E-03 0.03476168 0.04658462 0.64650359 LIEN_BREAST_CARCINOMA_METAPLASTIC ulcerative colitis DOID_8577 1.4E-03 0.04425549 0.05396975 0.66758235 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN adenoid cystic carcinoma DOID_4866 4.441E-10 2.527E-07 4.441E-10 2.527E-07 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN salivary gland cancer DOID_8850 6.526E-10 1.857E-07 6.526E-10 1.857E-07 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.079E-09 2.047E-07 4.108E-06 1.558E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN oral cavity cancer DOID_8618 8.126E-09 1.156E-06 8.126E-09 1.541E-06 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN carbohydrate metabolic disorder DOID_2978 1.738E-08 1.977E-06 2.755E-07 1.959E-05 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN Crohn's disease DOID_8778 1.906E-08 1.808E-06 4.108E-06 1.461E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN uterine cancer DOID_363 2.868E-08 2.331E-06 2.868E-08 4.08E-06 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN myeloma DOID_0070004 4.477E-08 3.185E-06 2.191E-05 4.986E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN heart valve disease DOID_4079 4.477E-08 2.831E-06 2.191E-05 4.616E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN Fanconi's anemia DOID_13636 5.443E-08 3.097E-06 5.443E-08 6.194E-06 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN focal glomerulosclerosis DOID_3945 5.583E-08 2.888E-06 5.583E-08 5.295E-06 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bone marrow cancer DOID_4960 1.139E-07 5.399E-06 4.166E-05 7.184E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN aplastic anemia DOID_12449 2.013E-07 8.809E-06 2.013E-07 1.636E-05 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lymphoma DOID_0060058 2.538E-07 1.031E-05 3.568E-06 1.45E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN multiple myeloma DOID_9538 2.767E-07 1.05E-05 1.51E-04 2.203E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN respiratory failure DOID_11162 2.864E-07 1.019E-05 7.867E-05 1.21E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pre-malignant neoplasm DOID_0060071 3.186E-07 1.066E-05 5.659E-06 1.789E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN in situ carcinoma DOID_8719 3.186E-07 1.066E-05 5.659E-06 1.789E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cervix uteri carcinoma in situ DOID_8991 4.975E-07 1.573E-05 1.16E-05 3.301E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN diabetic autonomic neuropathy DOID_11503 7.441E-07 2.228E-05 2.841E-04 3.849E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN autonomic neuropathy DOID_11504 7.441E-07 2.228E-05 2.841E-04 3.849E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN diabetic polyneuropathy DOID_12785 7.441E-07 2.228E-05 2.841E-04 3.849E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN diabetic neuropathy DOID_9743 7.441E-07 2.228E-05 2.841E-04 3.849E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN peripheral vascular disease DOID_341 7.712E-07 2.194E-05 1.192E-05 3.231E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN autonomic nervous system disease DOID_11465 1.083E-06 2.934E-05 3.611E-04 4.466E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bone marrow disease DOID_4961 1.083E-06 2.801E-05 1.083E-06 6.846E-05 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN aneurysm disease DOID_2403 1.101E-06 2.723E-05 1.61E-05 3.816E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital hypoplastic anemia DOID_1342 1.146E-06 2.718E-05 1.146E-06 6.523E-05 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN diffuse large B-cell lymphoma DOID_0050745 1.378E-06 3.136E-05 4.16E-05 7.396E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN biliary tract cancer DOID_4607 1.811E-06 3.964E-05 2.449E-05 4.805E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital disorder of glycosylation DOID_5212 2.298E-06 4.843E-05 2.298E-06 1.189E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN skeletal system cancer DOID_0060124 2.574E-06 5.232E-05 1.289E-04 1.93E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN thoracic aortic aneurysm DOID_14004 2.574E-06 5.051E-05 2.574E-06 1.221E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bone cancer DOID_184 2.574E-06 5.232E-05 1.289E-04 1.93E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN membranoproliferative glomerulonephritis DOID_2920 2.574E-06 4.883E-05 2.574E-06 1.127E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN reproductive organ benign neoplasm DOID_0050622 2.637E-06 4.84E-05 4.534E-05 7.589E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN transitional cell carcinoma DOID_2671 2.665E-06 4.738E-05 3.652E-04 4.422E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital disorder of glycosylation type I DOID_0050570 4.441E-06 7.658E-05 4.441E-06 1.487E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pancreatic ductal carcinoma DOID_3587 1.019E-05 1.706E-04 1.019E-05 3.053E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN adult respiratory distress syndrome DOID_11394 1.034E-05 1.681E-04 3.043E-03 0.02111513 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN intracranial arterial disease DOID_13089 1.034E-05 1.635E-04 0.03396339 0.12630829 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cerebral arterial disease DOID_3527 1.034E-05 1.635E-04 0.03396339 0.12630829 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pancreatic carcinoma DOID_4905 1.287E-05 1.98E-04 1.287E-05 3.33E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN diabetic retinopathy DOID_8947 1.287E-05 1.928E-04 1.657E-04 2.357E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN autoimmune disease of urogenital tract DOID_0060049 1.298E-05 1.894E-04 1.298E-05 3.212E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN primary biliary cirrhosis DOID_12236 1.298E-05 1.894E-04 1.298E-05 3.212E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hepatitis B DOID_2043 1.329E-05 1.891E-04 4.213E-04 4.893E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pancreatitis DOID_4989 1.73E-05 2.401E-04 2.119E-03 0.01629043 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN diabetic angiopathy DOID_11713 1.911E-05 2.589E-04 5.483E-04 6.117E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN brain cancer DOID_1319 2.191E-05 2.899E-04 2.191E-05 4.794E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN central nervous system cancer DOID_3620 2.415E-05 3.124E-04 2.415E-05 4.908E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN chronic kidney failure DOID_784 2.449E-05 3.096E-04 0.01982443 0.08057216 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bone development disease DOID_0080006 2.618E-05 3.238E-04 2.958E-04 3.914E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN glaucoma DOID_1686 2.658E-05 3.218E-04 4.2E-04 4.979E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN retinal vascular disease DOID_2462 2.796E-05 3.314E-04 3.121E-04 4.036E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN aortic aneurysm DOID_3627 2.919E-05 3.389E-04 2.919E-05 5.536E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN B-cell lymphocytic neoplasm DOID_707 3.199E-05 3.64E-04 4.855E-04 5.525E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN middle cerebral artery infarction DOID_3525 3.605E-05 4.022E-04 0.17224631 0.33795914 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN amino acid metabolic disorder DOID_9252 3.609E-05 3.949E-04 3.38E-03 0.02262882 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN nervous system cancer DOID_3093 3.839E-05 4.121E-04 3.839E-05 7.046E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN osteochondrodysplasia DOID_2256 4.534E-05 4.778E-04 6.378E-04 6.48E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN female reproductive organ benign neoplasm DOID_0060086 6.199E-05 6.413E-04 1.291E-03 0.01148091 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN uterine benign neoplasm DOID_0060095 6.199E-05 6.413E-04 1.291E-03 0.01148091 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN uterine fibroid DOID_13223 6.199E-05 6.413E-04 1.291E-03 0.01148091 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN porphyria DOID_13268 6.326E-05 6.428E-04 6.326E-05 1.028E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN aortic valve insufficiency DOID_57 6.326E-05 6.315E-04 6.326E-05 9.999E-04 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lipodystrophy DOID_811 6.326E-05 6.206E-04 2.845E-03 0.01998514 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN carotid artery disease DOID_3407 7.302E-05 7.042E-04 9.265E-03 0.04624522 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN leiomyoma DOID_127 8.884E-05 8.425E-04 1.679E-03 0.01384477 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cerebral degeneration DOID_1443 9.767E-05 9.111E-04 1.162E-03 0.01049151 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN spindle cell carcinoma DOID_4015 1.109E-04 1.018E-03 1.974E-03 0.0153825 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN nephrosis DOID_2527 1.461E-04 1.319E-03 1.59E-03 0.01330844 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN urinary system benign neoplasm DOID_731 1.907E-04 1.696E-03 1.907E-04 2.647E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bacterial pneumonia DOID_874 2.11E-04 1.847E-03 2.119E-03 0.01607323 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN metabolic syndrome X DOID_14221 2.368E-04 2.042E-03 0.01803655 0.07834198 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN gallbladder cancer DOID_3121 2.841E-04 2.413E-03 3.92E-03 0.02534689 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cerebral infarction DOID_3526 3.083E-04 2.58E-03 0.276861 0.46745967 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN colon carcinoma DOID_1520 3.15E-04 2.598E-03 3.15E-04 3.983E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN brain edema DOID_4724 3.15E-04 2.561E-03 0.12629634 0.28630524 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN leukodystrophy DOID_10579 3.339E-04 2.676E-03 4.41E-03 0.02727768 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN vascular skin disease DOID_9540 3.611E-04 2.853E-03 4.669E-03 0.02738781 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN encephalomyelitis DOID_640 4.686E-04 3.652E-03 3.943E-03 0.02521179 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN opiate dependence DOID_2559 4.821E-04 3.707E-03 0.14381798 0.31353422 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pulmonary embolism DOID_9477 4.821E-04 3.658E-03 0.0103879 0.05051895 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN Lewy body dementia DOID_12217 5.483E-04 4.105E-03 0.01128241 0.05394701 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN aortic valve disease DOID_62 5.483E-04 4.052E-03 5.483E-04 5.999E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN giant cell tumor DOID_200 5.579E-04 4.07E-03 5.579E-04 5.99E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN malignant giant cell tumor DOID_2705 5.579E-04 4.07E-03 5.579E-04 5.99E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN giant cell glioblastoma DOID_3074 5.579E-04 4.07E-03 5.579E-04 5.99E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN atrophic muscular disease DOID_913 5.579E-04 4.019E-03 6.411E-03 0.03541713 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN muscular dystrophy DOID_9884 5.579E-04 4.019E-03 6.411E-03 0.03541713 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bile duct adenocarcinoma DOID_4896 5.969E-04 4.246E-03 5.969E-04 6.29E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cholangiocarcinoma DOID_4947 5.969E-04 4.246E-03 5.969E-04 6.29E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN vasculitis DOID_865 5.969E-04 4.193E-03 0.05648791 0.19840507 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN spastic quadriplegia DOID_10970 6.2E-04 4.302E-03 6.2E-04 6.414E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN mitochondrial metabolism disease DOID_700 6.806E-04 4.666E-03 6.806E-04 6.794E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bronchiolitis DOID_2942 6.974E-04 4.724E-03 6.974E-04 6.841E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN glioblastoma DOID_3068 7.722E-04 5.169E-03 7.722E-04 7.447E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bile duct cancer DOID_4606 7.722E-04 5.109E-03 7.722E-04 7.323E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bile duct carcinoma DOID_4897 7.722E-04 5.109E-03 7.722E-04 7.323E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN perinatal necrotizing enterocolitis DOID_8677 9.656E-04 6.315E-03 9.656E-04 9.007E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hypothyroidism DOID_1459 9.81E-04 6.343E-03 0.07112079 0.22993029 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital heart defect DOID_1682 1.039E-03 6.642E-03 1.039E-03 9.534E-03 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN mineral metabolism disease DOID_0050032 1.099E-03 6.948E-03 0.01049781 0.05062082 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN multiple epiphyseal dysplasia DOID_12721 1.176E-03 7.354E-03 0.01843211 0.07885617 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN brain infarction DOID_3454 1.364E-03 8.438E-03 0.3809837 0.61410687 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN spastic cerebral palsy DOID_0050669 1.413E-03 8.648E-03 1.413E-03 0.01237329 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN astrocytoma DOID_3069 1.437E-03 8.699E-03 1.437E-03 0.01238887 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN endometrial cancer DOID_1380 1.543E-03 9.239E-03 1.543E-03 0.0131006 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pleural disease DOID_1532 1.679E-03 9.951E-03 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN papilloma DOID_2615 1.822E-03 0.01069062 0.02443117 0.09587127 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cystic fibrosis DOID_1485 1.931E-03 0.01121081 0.01579894 0.07078421 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN muscular dystrophy-dystroglycanopathy DOID_0050588 1.957E-03 0.01124815 1.957E-03 0.0159081 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN interstitial nephritis DOID_1063 1.957E-03 0.01113567 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN acute kidney failure DOID_3021 1.957E-03 0.01102541 1.957E-03 0.01568404 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN chondrosarcoma DOID_3371 1.957E-03 0.01091732 0.06527048 0.21592385 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN nephroblastoma DOID_2154 1.974E-03 0.01090216 1.974E-03 0.01559615 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN electroclinical syndrome DOID_0050701 2.119E-03 0.01159127 0.10132273 0.25510014 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN adenoma DOID_657 2.298E-03 0.01245503 0.02836115 0.10687081 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN contact dermatitis DOID_2773 2.319E-03 0.0124461 0.10558103 0.25894657 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lipid metabolism disorder DOID_3146 2.319E-03 0.01232978 2.319E-03 0.01735903 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN nervous system benign neoplasm DOID_0060115 2.381E-03 0.01254626 2.381E-03 0.01759736 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN temporal arteritis DOID_13375 2.381E-03 0.01243116 0.07155939 0.22495742 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN neuronal ceroid lipofuscinosis DOID_14503 2.381E-03 0.01231815 2.381E-03 0.01737175 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN central nervous system vasculitis DOID_525 2.381E-03 0.01243116 0.07155939 0.22495742 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN heroin dependence DOID_9976 2.381E-03 0.01220718 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN female reproductive system disease DOID_229 2.423E-03 0.01231129 0.01862205 0.07734268 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN adolescence-adult electroclinical syndrome DOID_0050705 2.472E-03 0.01244997 0.2366965 0.42219533 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN embryonal cancer DOID_688 2.472E-03 0.01234076 2.472E-03 0.01780819 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN microcephaly DOID_10907 2.655E-03 0.01313422 2.655E-03 0.01888044 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN respiratory syncytial virus infectious disease DOID_1273 2.845E-03 0.01395355 0.24694126 0.43367154 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN systemic scleroderma DOID_418 2.845E-03 0.01383429 0.24694126 0.4296929 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lymphatic system disease DOID_75 3.043E-03 0.01467323 3.043E-03 0.02086073 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN nicotine dependence DOID_0050742 3.347E-03 0.01600552 0.08401105 0.23901144 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN newborn respiratory distress syndrome DOID_12716 3.347E-03 0.01587215 0.08401105 0.23547925 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN Lynch syndrome DOID_3883 3.347E-03 0.01574097 3.347E-03 0.02267449 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN intracranial thrombosis DOID_4193 3.347E-03 0.01561195 0.08401105 0.23092893 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN epilepsy with generalized tonic-clonic seizures DOID_7725 3.347E-03 0.01548502 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN Human immunodeficiency virus infectious disease DOID_526 3.516E-03 0.01613245 0.02436288 0.09626722 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN nephrotic syndrome DOID_1184 3.688E-03 0.01678776 3.688E-03 0.02440082 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN rheumatic disease DOID_1575 3.688E-03 0.01665453 0.2670217 0.45763658 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN primitive neuroectodermal tumor DOID_168 3.688E-03 0.01652339 3.688E-03 0.02412035 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN scleroderma DOID_419 3.688E-03 0.01665453 0.2670217 0.45763658 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN tethered spinal cord syndrome DOID_1089 3.888E-03 0.01728338 0.09017436 0.24202459 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN learning disability DOID_8927 4.161E-03 0.01835298 4.161E-03 0.02630593 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN dilated cardiomyopathy DOID_12930 4.247E-03 0.01859085 4.247E-03 0.02655836 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hemangioma DOID_255 4.466E-03 0.01939953 4.466E-03 0.02732622 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN corneal dystrophy DOID_2566 4.466E-03 0.01925257 4.466E-03 0.02703552 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lung oat cell carcinoma DOID_5411 4.466E-03 0.01910781 4.466E-03 0.02675093 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN intermediate coronary syndrome DOID_8805 4.466E-03 0.01896522 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hyperhomocysteinemia DOID_9279 4.466E-03 0.01882473 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pre-eclampsia DOID_10591 4.669E-03 0.01953395 4.669E-03 0.0276731 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN neuritis DOID_1803 4.669E-03 0.01939137 0.04469225 0.16197383 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN thyroid adenoma DOID_2891 4.669E-03 0.01925085 0.04469225 0.16094868 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hemolytic anemia DOID_583 4.936E-03 0.02020717 4.936E-03 0.02866118 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN normocytic anemia DOID_720 4.936E-03 0.02020717 4.936E-03 0.02866118 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN chronic myeloid leukemia DOID_8552 5.082E-03 0.02065397 5.082E-03 0.02920764 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lung small cell carcinoma DOID_5409 5.213E-03 0.0210364 5.213E-03 0.02966132 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN calcium metabolism disease DOID_10575 5.499E-03 0.0220329 0.04962414 0.17647584 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN movement disease DOID_480 5.499E-03 0.02187882 5.499E-03 0.03097695 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lymphatic system cancer DOID_0060073 5.734E-03 0.02265713 0.10841755 0.26476216 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN familial hypertrophic cardiomyopathy DOID_11986 5.734E-03 0.02250087 5.734E-03 0.03198654 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bronchitis DOID_6132 5.734E-03 0.02234676 0.10841755 0.25919993 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN reticulosarcoma DOID_8538 5.734E-03 0.02265713 0.10841755 0.26476216 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN lymphosarcoma DOID_8675 5.734E-03 0.02265713 0.10841755 0.26476216 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital muscular dystrophy DOID_0050557 6.422E-03 0.02485889 6.422E-03 0.03513709 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN male reproductive organ benign neoplasm DOID_0060087 6.422E-03 0.02469093 6.422E-03 0.03480245 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN keratosis DOID_161 6.422E-03 0.02452522 6.422E-03 0.03447413 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN inherited blood coagulation disease DOID_2214 6.422E-03 0.02436172 6.422E-03 0.03415194 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN ureteral obstruction DOID_5199 6.422E-03 0.02420038 6.422E-03 0.03383572 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pustulosis of palm and sole DOID_4398 7.067E-03 0.02645376 7.067E-03 0.03688964 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN familial hyperlipidemia DOID_1168 7.409E-03 0.02755317 7.409E-03 0.03832396 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital nervous system abnormality DOID_2490 7.761E-03 0.02867395 7.761E-03 0.03978187 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pulmonary edema DOID_11396 7.905E-03 0.02901958 7.905E-03 0.04016103 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hypertrophic cardiomyopathy DOID_11984 8.122E-03 0.02962477 0.06366052 0.21953235 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN melancholia DOID_2848 8.493E-03 0.03078151 0.34214869 0.56104498 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN neurotic disorder DOID_4964 8.874E-03 0.03195897 0.34658084 0.56667958 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN neuroectodermal tumor DOID_171 9.265E-03 0.03315695 9.265E-03 0.04665447 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN collagen disease DOID_854 9.265E-03 0.03294972 0.35098323 0.57223341 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN familial hypercholesterolemia DOID_13810 9.527E-03 0.0336683 9.527E-03 0.04713563 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN sinusitis DOID_0050127 0.0103879 0.03648591 0.14381798 0.31717997 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN paranasal sinus disease DOID_1352 0.0103879 0.03648591 0.14381798 0.31717997 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN uremia DOID_4676 0.0103879 0.03626207 0.14381798 0.31114993 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN urinary tract obstruction DOID_5200 0.0103879 0.03604096 0.0103879 0.05095446 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cholestasis DOID_13580 0.01092872 0.03768751 0.07689254 0.23649653 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN parasitic infectious disease DOID_1398 0.01092872 0.03746048 0.36829933 0.59874948 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN uterine disease DOID_345 0.01092872 0.03723616 0.07689254 0.23522504 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN ureteral disease DOID_1426 0.01128241 0.03821247 0.01128241 0.05349745 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital hemolytic anemia DOID_589 0.01128241 0.03798636 0.01128241 0.05305532 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN meningitis DOID_9471 0.01128241 0.03776291 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN sphingolipidosis DOID_1927 0.01220958 0.04062722 0.01220958 0.0569447 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN acute pancreatitis DOID_2913 0.01220958 0.04039101 0.15530418 0.32728918 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN endocrine organ benign neoplasm DOID_0060089 0.01228218 0.0403963 0.08280645 0.23917193 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN tuberculosis DOID_399 0.01228218 0.04016413 0.08280645 0.23796399 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN X-linked disease DOID_0050735 0.01316894 0.04281786 0.16098959 0.33554241 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN reading disorder DOID_13365 0.01316894 0.04257458 0.01316894 0.06091972 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN urticaria DOID_1555 0.01316894 0.04233404 0.16098959 0.33189521 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN dyslexia DOID_4428 0.01316894 0.04257458 0.01316894 0.06091972 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bile duct disease DOID_4138 0.01372752 0.04388179 0.08885454 0.24190543 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cystitis DOID_1679 0.01416 0.0450114 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN papillary adenoma DOID_3172 0.01416 0.04476134 0.16663688 0.33622832 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN microcystic adenoma DOID_5403 0.01416 0.04476134 0.16663688 0.33622832 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN follicular adenoma DOID_6204 0.01416 0.04476134 0.16663688 0.33622832 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN myositis DOID_633 0.01416 0.04451404 0.01416 0.06497613 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN biliary tract disease DOID_9741 0.01422986 0.04448787 0.09089905 0.23617151 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN intracranial aneurysm DOID_10941 0.01518231 0.0472062 0.17224631 0.34509912 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN spinal cord disease DOID_319 0.01518231 0.04694964 0.17224631 0.33912855 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN fragments of torsion dystonia DOID_531 0.01518231 0.04669586 0.01518231 0.06910987 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN dystonia DOID_543 0.01518231 0.04644481 0.01518231 0.06856138 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN endogenous depression DOID_1595 0.01579894 0.0480727 0.4096026 0.65651797 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN gestational diabetes DOID_11714 0.0162354 0.04913799 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN mixed glioma DOID_5076 0.0168969 0.0508695 0.0168969 0.07511199 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN autoimmune disease of cardiovascular system DOID_0060051 0.01731882 0.0518653 0.18335259 0.35365296 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN Behcet's disease DOID_13241 0.01731882 0.0518653 0.18335259 0.35365296 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN invasive ductal carcinoma DOID_3008 0.01731882 0.05159376 0.01731882 0.07639075 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN central nervous system hereditary degenerative disease DOID_481 0.01731882 0.05132504 0.01731882 0.07580313 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN autoimmune disease of endocrine system DOID_0060005 0.01843211 0.0543413 0.01843211 0.07945356 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN supratentorial cancer DOID_1659 0.01843211 0.05406119 0.01843211 0.07826769 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN cerebrum cancer DOID_368 0.01843211 0.05406119 0.01843211 0.07826769 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN dystonic disease DOID_544 0.01843211 0.05378395 0.01843211 0.07768793 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN chromosomal disease DOID_0080014 0.01862205 0.05406096 0.01862205 0.07791138 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN corneal disease DOID_10124 0.01957483 0.05653846 0.01957483 0.0807107 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN endometrial carcinoma DOID_2871 0.01957483 0.05625291 0.01957483 0.08013004 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN mental depression DOID_1596 0.01982443 0.05668393 0.43690331 0.6963529 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN allergic rhinitis DOID_4481 0.02194677 0.06243857 0.2051218 0.37894254 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN primary bacterial infectious disease DOID_0050338 0.02235493 0.06328335 0.12084687 0.27838814 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN chronic leukemia DOID_1036 0.02317513 0.06528044 0.02317513 0.09352233 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN chronic lymphocytic leukemia DOID_1040 0.02317513 0.06528044 0.02317513 0.09352233 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hereditary spastic paraplegia DOID_2476 0.02317513 0.06495886 0.02317513 0.09286372 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN bladder disease DOID_365 0.02317513 0.06464043 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN primary immunodeficiency disease DOID_612 0.02368308 0.06573499 0.02368308 0.09423548 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN thyroid carcinoma DOID_3963 0.02571446 0.07102684 0.02571446 0.10021595 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN paraplegia DOID_607 0.02571446 0.07068371 0.02571446 0.09953421 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN hyperthyroidism DOID_7998 0.02571446 0.07034389 0.02571446 0.09886168 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN medullomyoblastoma DOID_3861 0.02702459 0.07357413 0.02702459 0.1032013 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN adult medulloblastoma DOID_3864 0.02702459 0.07357413 0.02702459 0.1032013 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN childhood medulloblastoma DOID_3869 0.02702459 0.07357413 0.02702459 0.1032013 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN thyroid cancer DOID_1781 0.02836115 0.0768452 0.02836115 0.10758328 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pulmonary sarcoidosis DOID_13406 0.02972371 0.0801554 1.000 1.000 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN calcinosis DOID_182 0.02972371 0.07977731 0.2366965 0.42087597 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN medulloblastoma DOID_3858 0.02972371 0.07940276 0.02972371 0.11126835 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN ulcerative colitis DOID_8577 0.03017773 0.08023892 0.1458144 0.31074305 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN congenital diaphragmatic hernia DOID_3827 0.03252523 0.0860784 0.24694126 0.43101098 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN benign mesothelioma DOID_2645 0.03542595 0.09332114 0.03542595 0.130892 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN pulmonary emphysema DOID_9675 0.03542595 0.09289109 0.25704905 0.44456204 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN endometriosis of uterus DOID_288 0.03691253 0.09634509 0.26205216 0.45047636 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN Huntington's disease DOID_12858 0.03842274 0.09982894 0.03842274 0.14104863 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN endometriosis DOID_289 0.03842274 0.09937517 0.2670217 0.45353835 BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN uveal disease DOID_3480 0.03842274 0.09892551 0.03842274 0.14014447 SABATES_COLORECTAL_ADENOMA_DN hyperglycemia DOID_4195 1.007E-08 5.73E-06 7.534E-06 8.574E-04 SABATES_COLORECTAL_ADENOMA_DN hypokalemia DOID_4500 4.475E-08 1.273E-05 4.475E-08 2.546E-05 SABATES_COLORECTAL_ADENOMA_DN uveitis DOID_13141 5.482E-07 1.04E-04 1.965E-05 1.118E-03 SABATES_COLORECTAL_ADENOMA_DN glucose intolerance DOID_10603 6.365E-07 9.054E-05 2.194E-03 0.02773581 SABATES_COLORECTAL_ADENOMA_DN uveal disease DOID_3480 9.872E-07 1.123E-04 3.119E-05 1.614E-03 SABATES_COLORECTAL_ADENOMA_DN muscular atrophy DOID_767 1.503E-06 1.426E-04 1.503E-06 4.277E-04 SABATES_COLORECTAL_ADENOMA_DN parasitic protozoa infectious disease DOID_2789 3.179E-06 2.584E-04 0.02142135 0.11949753 SABATES_COLORECTAL_ADENOMA_DN renal tubular transport disease DOID_447 5.497E-06 3.91E-04 5.497E-06 1.043E-03 SABATES_COLORECTAL_ADENOMA_DN mineral metabolism disease DOID_0050032 6.515E-06 4.119E-04 6.515E-06 9.267E-04 SABATES_COLORECTAL_ADENOMA_DN parasitic infectious disease DOID_1398 7.01E-06 3.989E-04 0.02879018 0.15309918 SABATES_COLORECTAL_ADENOMA_DN tooth disease DOID_1091 8.088E-06 4.184E-04 8.088E-06 7.67E-04 SABATES_COLORECTAL_ADENOMA_DN allergic contact dermatitis DOID_3042 8.088E-06 3.835E-04 2.585E-03 0.02942247 SABATES_COLORECTAL_ADENOMA_DN trypanosomiasis DOID_10113 9.212E-06 4.032E-04 0.04184056 0.19045822 SABATES_COLORECTAL_ADENOMA_DN peripheral vascular disease DOID_341 1.136E-05 4.615E-04 1.136E-05 9.231E-04 SABATES_COLORECTAL_ADENOMA_DN aneurysm disease DOID_2403 1.465E-05 5.555E-04 1.465E-05 1.042E-03 SABATES_COLORECTAL_ADENOMA_DN electroclinical syndrome DOID_0050701 1.557E-05 5.538E-04 2.73E-04 6.753E-03 SABATES_COLORECTAL_ADENOMA_DN infancy electroclinical syndrome DOID_0050703 1.588E-05 5.314E-04 1.588E-05 1.004E-03 SABATES_COLORECTAL_ADENOMA_DN metabolic syndrome X DOID_14221 1.757E-05 5.553E-04 0.04053042 0.19059346 SABATES_COLORECTAL_ADENOMA_DN contact dermatitis DOID_2773 1.757E-05 5.261E-04 4.044E-03 0.03539876 SABATES_COLORECTAL_ADENOMA_DN pulmonary sarcoidosis DOID_13406 1.779E-05 5.061E-04 5.08E-04 0.01070479 SABATES_COLORECTAL_ADENOMA_DN endometriosis of uterus DOID_288 2.857E-05 7.74E-04 0.01325589 0.08474835 SABATES_COLORECTAL_ADENOMA_DN endometriosis DOID_289 3.119E-05 8.068E-04 0.01382356 0.0864352 SABATES_COLORECTAL_ADENOMA_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.768E-05 9.32E-04 3.768E-05 1.786E-03 SABATES_COLORECTAL_ADENOMA_DN mouth disease DOID_403 3.768E-05 8.932E-04 3.768E-05 1.649E-03 SABATES_COLORECTAL_ADENOMA_DN glaucoma DOID_1686 5.083E-05 1.157E-03 5.083E-05 2.066E-03 SABATES_COLORECTAL_ADENOMA_DN aortic aneurysm DOID_3627 5.481E-05 1.199E-03 5.481E-05 2.079E-03 SABATES_COLORECTAL_ADENOMA_DN colonic disease DOID_5353 6.204E-05 1.307E-03 6.204E-05 2.206E-03 SABATES_COLORECTAL_ADENOMA_DN sarcoidosis DOID_11335 6.813E-05 1.385E-03 1.362E-03 0.01937516 SABATES_COLORECTAL_ADENOMA_DN smallpox DOID_8736 7.823E-05 1.535E-03 7.823E-05 2.618E-03 SABATES_COLORECTAL_ADENOMA_DN hypersensitivity reaction type IV disease DOID_2916 9.536E-05 1.809E-03 1.744E-03 0.02307221 SABATES_COLORECTAL_ADENOMA_DN melancholia DOID_2848 1.016E-04 1.865E-03 1.016E-04 3.213E-03 SABATES_COLORECTAL_ADENOMA_DN neurotic disorder DOID_4964 1.082E-04 1.924E-03 1.082E-04 3.24E-03 SABATES_COLORECTAL_ADENOMA_DN Goodpasture syndrome DOID_9808 1.089E-04 1.878E-03 3.897E-03 0.03464775 SABATES_COLORECTAL_ADENOMA_DN uterine disease DOID_345 1.457E-04 2.439E-03 0.02879018 0.1516816 SABATES_COLORECTAL_ADENOMA_DN intracranial aneurysm DOID_10941 1.743E-04 2.833E-03 1.743E-04 4.958E-03 SABATES_COLORECTAL_ADENOMA_DN Sciatic Neuropathy DOID_11446 1.938E-04 3.063E-03 5.661E-03 0.04352474 SABATES_COLORECTAL_ADENOMA_DN lesion of sciatic nerve DOID_12528 1.938E-04 3.063E-03 5.661E-03 0.04352474 SABATES_COLORECTAL_ADENOMA_DN periodontitis DOID_824 1.938E-04 2.981E-03 1.938E-04 5.252E-03 SABATES_COLORECTAL_ADENOMA_DN mononeuritis of lower limb DOID_9473 1.938E-04 3.063E-03 5.661E-03 0.04352474 SABATES_COLORECTAL_ADENOMA_DN nephrosis DOID_2527 2.022E-04 3.028E-03 3.027E-03 0.03076062 SABATES_COLORECTAL_ADENOMA_DN mononeuritis DOID_1802 2.147E-04 3.133E-03 6.049E-03 0.0458955 SABATES_COLORECTAL_ADENOMA_DN diabetic retinopathy DOID_8947 2.241E-04 3.188E-03 3.265E-03 0.03148498 SABATES_COLORECTAL_ADENOMA_DN mononeuropathy DOID_1188 2.371E-04 3.29E-03 6.45E-03 0.04766558 SABATES_COLORECTAL_ADENOMA_DN endogenous depression DOID_1595 2.477E-04 3.356E-03 2.477E-04 6.406E-03 SABATES_COLORECTAL_ADENOMA_DN corneal disease DOID_10124 2.609E-04 3.452E-03 6.863E-03 0.04943086 SABATES_COLORECTAL_ADENOMA_DN pancreatitis DOID_4989 2.73E-04 3.53E-03 3.773E-03 0.03519159 SABATES_COLORECTAL_ADENOMA_DN female reproductive system disease DOID_229 3.143E-04 3.975E-03 0.04142787 0.19164601 SABATES_COLORECTAL_ADENOMA_DN mental depression DOID_1596 3.443E-04 4.259E-03 3.443E-04 8.162E-03 SABATES_COLORECTAL_ADENOMA_DN focal epilepsy DOID_2234 3.443E-04 4.168E-03 3.443E-04 7.836E-03 SABATES_COLORECTAL_ADENOMA_DN chronic kidney failure DOID_784 3.443E-04 4.081E-03 4.472E-03 0.03797947 SABATES_COLORECTAL_ADENOMA_DN retinal vascular disease DOID_2462 3.762E-04 4.369E-03 4.772E-03 0.03935434 SABATES_COLORECTAL_ADENOMA_DN periodontal disease DOID_3388 4.029E-04 4.585E-03 4.029E-04 8.817E-03 SABATES_COLORECTAL_ADENOMA_DN primary immunodeficiency disease DOID_612 4.464E-04 4.98E-03 5.409E-03 0.04215744 SABATES_COLORECTAL_ADENOMA_DN encephalomyelitis DOID_640 5.253E-04 5.748E-03 6.094E-03 0.0456211 SABATES_COLORECTAL_ADENOMA_DN Crohn's disease DOID_8778 5.465E-04 5.868E-03 5.465E-04 0.01110664 SABATES_COLORECTAL_ADENOMA_DN hypersensitivity reaction type I disease DOID_1205 5.684E-04 5.989E-03 5.684E-04 0.01115147 SABATES_COLORECTAL_ADENOMA_DN hepatitis DOID_2237 5.869E-04 6.072E-03 0.01161614 0.07868555 SABATES_COLORECTAL_ADENOMA_DN Gilles de la Tourette syndrome DOID_11119 6.584E-04 6.69E-03 6.584E-04 0.01248801 SABATES_COLORECTAL_ADENOMA_DN angioedema DOID_1558 6.584E-04 6.573E-03 6.584E-04 0.01208517 SABATES_COLORECTAL_ADENOMA_DN keratitis DOID_4677 6.584E-04 6.459E-03 0.03810984 0.18070417 SABATES_COLORECTAL_ADENOMA_DN autoimmune disease of urogenital tract DOID_0060049 7.193E-04 6.937E-03 0.01325589 0.0857114 SABATES_COLORECTAL_ADENOMA_DN primary biliary cirrhosis DOID_12236 7.193E-04 6.937E-03 0.01325589 0.0857114 SABATES_COLORECTAL_ADENOMA_DN nephrotic syndrome DOID_1184 7.673E-04 7.276E-03 7.673E-04 0.0136434 SABATES_COLORECTAL_ADENOMA_DN bronchiectasis DOID_9563 8.027E-04 7.487E-03 8.027E-04 0.01384027 SABATES_COLORECTAL_ADENOMA_DN cerebral infarction DOID_3526 8.693E-04 7.978E-03 0.01498997 0.09270973 SABATES_COLORECTAL_ADENOMA_DN cataract DOID_83 8.693E-04 7.851E-03 8.693E-04 0.01454816 SABATES_COLORECTAL_ADENOMA_DN intracranial arteriosclerosis DOID_13097 9.608E-04 8.542E-03 9.608E-04 0.01561945 SABATES_COLORECTAL_ADENOMA_DN diarrhea DOID_13250 9.608E-04 8.41E-03 9.608E-04 0.01518558 SABATES_COLORECTAL_ADENOMA_DN osteopetrosis DOID_13533 9.608E-04 8.283E-03 9.608E-04 0.01477516 SABATES_COLORECTAL_ADENOMA_DN tic disorder DOID_2769 9.608E-04 8.159E-03 9.608E-04 0.01438634 SABATES_COLORECTAL_ADENOMA_DN vascular dementia DOID_8725 9.608E-04 8.542E-03 9.608E-04 0.01561945 SABATES_COLORECTAL_ADENOMA_DN pre-eclampsia DOID_10591 9.795E-04 8.197E-03 0.01619726 0.09804512 SABATES_COLORECTAL_ADENOMA_DN lens disease DOID_110 9.795E-04 8.078E-03 9.795E-04 0.01429138 SABATES_COLORECTAL_ADENOMA_DN neuritis DOID_1803 9.795E-04 7.962E-03 0.01619726 0.09701306 SABATES_COLORECTAL_ADENOMA_DN epilepsy with generalized tonic-clonic seizures DOID_7725 1.133E-03 9.077E-03 0.04925893 0.20164267 SABATES_COLORECTAL_ADENOMA_DN movement disease DOID_480 1.161E-03 9.174E-03 0.0180833 0.10499388 SABATES_COLORECTAL_ADENOMA_DN giant cell tumor DOID_200 1.362E-03 0.01061652 0.02005744 0.11527963 SABATES_COLORECTAL_ADENOMA_DN malignant giant cell tumor DOID_2705 1.362E-03 0.01061652 0.02005744 0.11527963 SABATES_COLORECTAL_ADENOMA_DN giant cell glioblastoma DOID_3074 1.362E-03 0.01061652 0.02005744 0.11527963 SABATES_COLORECTAL_ADENOMA_DN atrophic muscular disease DOID_913 1.362E-03 0.01047306 0.02005744 0.11412684 SABATES_COLORECTAL_ADENOMA_DN muscular dystrophy DOID_9884 1.362E-03 0.01047306 0.02005744 0.11412684 SABATES_COLORECTAL_ADENOMA_DN varicose veins DOID_799 1.517E-03 0.01150807 1.517E-03 0.02105134 SABATES_COLORECTAL_ADENOMA_DN hemolytic-uremic syndrome DOID_12554 1.729E-03 0.01294606 0.06027966 0.2227216 SABATES_COLORECTAL_ADENOMA_DN vein disease DOID_866 1.729E-03 0.01277793 1.729E-03 0.0234262 SABATES_COLORECTAL_ADENOMA_DN glioblastoma DOID_3068 1.744E-03 0.01271929 0.02353729 0.12877613 SABATES_COLORECTAL_ADENOMA_DN pre-malignant neoplasm DOID_0060071 2.186E-03 0.01574359 2.186E-03 0.02826691 SABATES_COLORECTAL_ADENOMA_DN in situ carcinoma DOID_8719 2.186E-03 0.01574359 2.186E-03 0.02826691 SABATES_COLORECTAL_ADENOMA_DN dental caries DOID_216 2.194E-03 0.01560139 2.194E-03 0.02713285 SABATES_COLORECTAL_ADENOMA_DN osteosclerosis DOID_4254 2.194E-03 0.01540878 2.194E-03 0.02655556 SABATES_COLORECTAL_ADENOMA_DN cerebral degeneration DOID_1443 2.38E-03 0.01651797 2.38E-03 0.0282182 SABATES_COLORECTAL_ADENOMA_DN agammaglobulinemia DOID_2583 2.445E-03 0.01676395 2.445E-03 0.02839608 SABATES_COLORECTAL_ADENOMA_DN brain infarction DOID_3454 2.692E-03 0.01823453 0.03117158 0.15978944 SABATES_COLORECTAL_ADENOMA_DN membranous glomerulonephritis DOID_10976 2.71E-03 0.0181422 2.71E-03 0.030237 SABATES_COLORECTAL_ADENOMA_DN limb-girdle muscular dystrophy DOID_11724 2.71E-03 0.01793124 2.71E-03 0.02965552 SABATES_COLORECTAL_ADENOMA_DN brain edema DOID_4724 2.71E-03 0.01772514 2.71E-03 0.02909598 SABATES_COLORECTAL_ADENOMA_DN blood protein disease DOID_620 2.71E-03 0.01752371 2.71E-03 0.02855716 SABATES_COLORECTAL_ADENOMA_DN amyloidosis DOID_9120 2.71E-03 0.01732682 2.71E-03 0.02803794 SABATES_COLORECTAL_ADENOMA_DN astrocytoma DOID_3069 2.801E-03 0.01770885 0.03198217 0.16248082 SABATES_COLORECTAL_ADENOMA_DN bile duct disease DOID_4138 3.027E-03 0.01892961 3.027E-03 0.03022096 SABATES_COLORECTAL_ADENOMA_DN biliary tract disease DOID_9741 3.145E-03 0.01944914 3.145E-03 0.03085035 SABATES_COLORECTAL_ADENOMA_DN IgA glomerulonephritis DOID_2986 3.581E-03 0.02191217 3.581E-03 0.03396386 SABATES_COLORECTAL_ADENOMA_DN mixed glioma DOID_5076 3.773E-03 0.0228371 3.773E-03 0.03462398 SABATES_COLORECTAL_ADENOMA_DN diabetic angiopathy DOID_11713 3.897E-03 0.02334164 3.897E-03 0.03519771 SABATES_COLORECTAL_ADENOMA_DN alcohol abuse DOID_1574 4.472E-03 0.02650651 4.472E-03 0.03855492 SABATES_COLORECTAL_ADENOMA_DN urticaria DOID_1555 4.566E-03 0.02678274 4.566E-03 0.03820479 SABATES_COLORECTAL_ADENOMA_DN infantile epileptic encephalopathy DOID_2481 4.919E-03 0.02855772 4.919E-03 0.03998081 SABATES_COLORECTAL_ADENOMA_DN myositis DOID_633 4.919E-03 0.02826926 0.09961437 0.30638148 SABATES_COLORECTAL_ADENOMA_DN primary bacterial infectious disease DOID_0050338 5.084E-03 0.02893048 0.29260865 0.64283523 SABATES_COLORECTAL_ADENOMA_DN B cell deficiency DOID_2115 5.283E-03 0.02976545 5.283E-03 0.0423424 SABATES_COLORECTAL_ADENOMA_DN teeth hard tissue disease DOID_214 5.283E-03 0.02947363 5.283E-03 0.04175431 SABATES_COLORECTAL_ADENOMA_DN malaria DOID_12365 6.049E-03 0.03341905 0.11005523 0.32786087 SABATES_COLORECTAL_ADENOMA_DN multiple epiphyseal dysplasia DOID_12721 6.45E-03 0.03529086 6.45E-03 0.04705449 SABATES_COLORECTAL_ADENOMA_DN dilated cardiomyopathy DOID_12930 6.454E-03 0.03497715 0.05474426 0.21335262 SABATES_COLORECTAL_ADENOMA_DN ulcerative colitis DOID_8577 7.019E-03 0.03767971 7.019E-03 0.04992562 SABATES_COLORECTAL_ADENOMA_DN age related macular degeneration DOID_10871 7.287E-03 0.03875207 0.12037584 0.34419021 SABATES_COLORECTAL_ADENOMA_DN degeneration of macula and posterior pole DOID_2007 7.287E-03 0.03875207 0.12037584 0.34419021 SABATES_COLORECTAL_ADENOMA_DN bronchiolitis obliterans DOID_2799 7.287E-03 0.03839326 0.12037584 0.34246926 SABATES_COLORECTAL_ADENOMA_DN metal metabolism disorder DOID_896 8.629E-03 0.04504686 8.629E-03 0.06061862 SABATES_COLORECTAL_ADENOMA_DN macular degeneration DOID_4448 9.099E-03 0.04706896 0.13395195 0.35616197 SABATES_COLORECTAL_ADENOMA_DN esophageal disease DOID_6050 9.099E-03 0.04664492 0.13395195 0.3545054 SABATES_COLORECTAL_ADENOMA_DN hyperthyroidism DOID_7998 9.099E-03 0.04622845 9.099E-03 0.06314129 SABATES_COLORECTAL_ADENOMA_DN adenoma DOID_657 0.01007315 0.05072231 0.01007315 0.06905568 SABATES_COLORECTAL_ADENOMA_DN adolescence-adult electroclinical syndrome DOID_0050705 0.01057658 0.05279012 0.14399728 0.37074413 SABATES_COLORECTAL_ADENOMA_DN respiratory syncytial virus infectious disease DOID_1273 0.01161614 0.05747466 0.15062979 0.38434238 SABATES_COLORECTAL_ADENOMA_DN congenital diaphragmatic hernia DOID_3827 0.01161614 0.05697919 0.01161614 0.07775984 SABATES_COLORECTAL_ADENOMA_DN peptic ulcer DOID_750 0.01161614 0.05649219 0.15062979 0.38262656 SABATES_COLORECTAL_ADENOMA_DN intracranial arterial disease DOID_13089 0.0121521 0.05859783 0.0121521 0.08040167 SABATES_COLORECTAL_ADENOMA_DN cerebral arterial disease DOID_3527 0.0121521 0.05859783 0.0121521 0.08040167 SABATES_COLORECTAL_ADENOMA_DN cervix uteri carcinoma in situ DOID_8991 0.01269871 0.06071904 0.01269871 0.08305248 SABATES_COLORECTAL_ADENOMA_DN Huntington's disease DOID_12858 0.01382356 0.0655467 0.16374206 0.40863699 SABATES_COLORECTAL_ADENOMA_DN idiopathic generalized epilepsy DOID_1827 0.01382356 0.06500499 0.01382356 0.08739559 SABATES_COLORECTAL_ADENOMA_DN diabetic autonomic neuropathy DOID_11503 0.01440161 0.06716818 0.16698859 0.41311526 SABATES_COLORECTAL_ADENOMA_DN autonomic neuropathy DOID_11504 0.01440161 0.06716818 0.16698859 0.41311526 SABATES_COLORECTAL_ADENOMA_DN diabetic polyneuropathy DOID_12785 0.01440161 0.06716818 0.16698859 0.41311526 SABATES_COLORECTAL_ADENOMA_DN influenza DOID_8469 0.01440161 0.06662209 0.16698859 0.40955392 SABATES_COLORECTAL_ADENOMA_DN diabetic neuropathy DOID_9743 0.01440161 0.06716818 0.16698859 0.41311526 SABATES_COLORECTAL_ADENOMA_DN leukodystrophy DOID_10579 0.01558855 0.07153134 0.01558855 0.09537512 SABATES_COLORECTAL_ADENOMA_DN autonomic nervous system disease DOID_11465 0.01619726 0.07372993 0.17665327 0.42955432 SABATES_COLORECTAL_ADENOMA_DN thyroid adenoma DOID_2891 0.01619726 0.07314477 0.01619726 0.09600251 SABATES_COLORECTAL_ADENOMA_DN vascular skin disease DOID_9540 0.01619726 0.07256883 0.01619726 0.09501279 SABATES_COLORECTAL_ADENOMA_DN hemolytic anemia DOID_583 0.01681601 0.07475243 0.17985002 0.43362144 SABATES_COLORECTAL_ADENOMA_DN normocytic anemia DOID_720 0.01681601 0.07475243 0.17985002 0.43362144 SABATES_COLORECTAL_ADENOMA_DN pulmonary tuberculosis DOID_2957 0.01744472 0.0769461 0.18303443 0.4394371 SABATES_COLORECTAL_ADENOMA_DN hemorrhagic disease DOID_2213 0.01873167 0.0819871 0.18936647 0.44895635 SABATES_COLORECTAL_ADENOMA_DN osteochondrodysplasia DOID_2256 0.02142135 0.09304388 0.02142135 0.12068068 SABATES_COLORECTAL_ADENOMA_DN familial hyperlipidemia DOID_1168 0.0221174 0.09533941 0.20498413 0.47801626 SABATES_COLORECTAL_ADENOMA_DN hypertrophic cardiomyopathy DOID_11984 0.02353729 0.09994566 0.21114718 0.49037855 SHEPARD_BMYB_MORPHOLINO_DN oral cavity cancer DOID_8618 5.47E-10 3.112E-07 5.47E-10 3.112E-07 SHEPARD_BMYB_MORPHOLINO_DN adenoid cystic carcinoma DOID_4866 2.904E-09 8.261E-07 2.904E-09 8.261E-07 SHEPARD_BMYB_MORPHOLINO_DN salivary gland cancer DOID_8850 3.861E-09 7.324E-07 3.861E-09 7.324E-07 SHEPARD_BMYB_MORPHOLINO_DN autoimmune disease of the nervous system DOID_438 1.735E-06 2.467E-04 9.114E-05 5.186E-03 SHEPARD_BMYB_MORPHOLINO_DN age related macular degeneration DOID_10871 2.573E-06 2.928E-04 4.154E-03 0.04005751 SHEPARD_BMYB_MORPHOLINO_DN degeneration of macula and posterior pole DOID_2007 2.573E-06 2.928E-04 4.154E-03 0.04005751 SHEPARD_BMYB_MORPHOLINO_DN macular degeneration DOID_4448 4.115E-06 3.903E-04 5.2E-03 0.04850288 SHEPARD_BMYB_MORPHOLINO_DN Ehlers-Danlos syndrome DOID_13359 1.054E-05 8.57E-04 1.054E-05 1.5E-03 SHEPARD_BMYB_MORPHOLINO_DN microphthalmia DOID_10629 2.614E-05 1.859E-03 2.614E-05 2.974E-03 SHEPARD_BMYB_MORPHOLINO_DN congenital nervous system abnormality DOID_2490 2.886E-05 1.825E-03 7.211E-04 0.01641165 SHEPARD_BMYB_MORPHOLINO_DN thrombophilia DOID_2452 3.516E-05 2.001E-03 3.516E-05 3.334E-03 SHEPARD_BMYB_MORPHOLINO_DN collagen disease DOID_854 3.728E-05 1.928E-03 8.706E-04 0.01597926 SHEPARD_BMYB_MORPHOLINO_DN hypothyroidism DOID_1459 3.963E-05 1.879E-03 9.108E-04 0.01619484 SHEPARD_BMYB_MORPHOLINO_DN pre-malignant neoplasm DOID_0060071 4.21E-05 1.842E-03 4.21E-05 3.422E-03 SHEPARD_BMYB_MORPHOLINO_DN in situ carcinoma DOID_8719 4.21E-05 1.842E-03 4.21E-05 3.422E-03 SHEPARD_BMYB_MORPHOLINO_DN spastic quadriplegia DOID_10970 5.218E-05 2.121E-03 2.396E-03 0.02900628 SHEPARD_BMYB_MORPHOLINO_DN blood coagulation disease DOID_1247 6.259E-05 2.374E-03 6.259E-05 4.452E-03 SHEPARD_BMYB_MORPHOLINO_DN diffuse large B-cell lymphoma DOID_0050745 8.22E-05 2.923E-03 8.22E-05 5.197E-03 SHEPARD_BMYB_MORPHOLINO_DN metabolic syndrome X DOID_14221 9.858E-05 3.3E-03 1.782E-03 0.02304187 SHEPARD_BMYB_MORPHOLINO_DN spastic cerebral palsy DOID_0050669 1.217E-04 3.847E-03 4.154E-03 0.04074815 SHEPARD_BMYB_MORPHOLINO_DN retinal vascular disease DOID_2462 1.241E-04 3.715E-03 1.241E-04 6.418E-03 SHEPARD_BMYB_MORPHOLINO_DN leiomyoma DOID_127 1.454E-04 4.136E-03 1.454E-04 6.893E-03 SHEPARD_BMYB_MORPHOLINO_DN hyperthyroidism DOID_7998 1.719E-04 4.657E-03 5.2E-03 0.04772057 SHEPARD_BMYB_MORPHOLINO_DN Crohn's disease DOID_8778 1.815E-04 4.694E-03 2.792E-03 0.03054586 SHEPARD_BMYB_MORPHOLINO_DN microcephaly DOID_10907 2.338E-04 5.784E-03 6.354E-03 0.05562213 SHEPARD_BMYB_MORPHOLINO_DN primitive neuroectodermal tumor DOID_168 3.294E-04 7.811E-03 3.294E-04 0.01441942 SHEPARD_BMYB_MORPHOLINO_DN diabetic autonomic neuropathy DOID_11503 3.512E-04 7.992E-03 3.512E-04 0.01427226 SHEPARD_BMYB_MORPHOLINO_DN autonomic neuropathy DOID_11504 3.512E-04 7.992E-03 3.512E-04 0.01427226 SHEPARD_BMYB_MORPHOLINO_DN diabetic polyneuropathy DOID_12785 3.512E-04 7.992E-03 3.512E-04 0.01427226 SHEPARD_BMYB_MORPHOLINO_DN uterine cancer DOID_363 3.512E-04 7.685E-03 3.512E-04 0.01332078 SHEPARD_BMYB_MORPHOLINO_DN diabetic neuropathy DOID_9743 3.512E-04 7.992E-03 3.512E-04 0.01427226 SHEPARD_BMYB_MORPHOLINO_DN proteinuria DOID_576 3.973E-04 8.373E-03 8.976E-03 0.07402224 SHEPARD_BMYB_MORPHOLINO_DN autonomic nervous system disease DOID_11465 4.218E-04 8.571E-03 4.218E-04 0.01500009 SHEPARD_BMYB_MORPHOLINO_DN brain cancer DOID_1319 4.218E-04 8.276E-03 4.218E-04 0.01411774 SHEPARD_BMYB_MORPHOLINO_DN central nervous system cancer DOID_3620 4.472E-04 8.482E-03 4.472E-04 0.01413694 SHEPARD_BMYB_MORPHOLINO_DN glaucoma DOID_1686 4.736E-04 8.693E-03 0.01006432 0.07844658 SHEPARD_BMYB_MORPHOLINO_DN hemorrhagic disease DOID_2213 5.293E-04 9.412E-03 5.293E-04 0.01585136 SHEPARD_BMYB_MORPHOLINO_DN B-cell lymphocytic neoplasm DOID_707 5.293E-04 9.127E-03 5.293E-04 0.01505879 SHEPARD_BMYB_MORPHOLINO_DN relapsing-remitting multiple sclerosis DOID_2378 5.403E-04 9.041E-03 0.03427298 0.18572689 SHEPARD_BMYB_MORPHOLINO_DN giant cell tumor DOID_200 5.89E-04 9.576E-03 5.89E-04 0.01596038 SHEPARD_BMYB_MORPHOLINO_DN malignant giant cell tumor DOID_2705 5.89E-04 9.576E-03 5.89E-04 0.01596038 SHEPARD_BMYB_MORPHOLINO_DN giant cell glioblastoma DOID_3074 5.89E-04 9.576E-03 5.89E-04 0.01596038 SHEPARD_BMYB_MORPHOLINO_DN osteogenesis imperfecta DOID_12347 6.373E-04 0.01007239 6.373E-04 0.01648209 SHEPARD_BMYB_MORPHOLINO_DN carotid stenosis DOID_13001 6.373E-04 9.8E-03 0.03707595 0.19178379 SHEPARD_BMYB_MORPHOLINO_DN polyneuropathy DOID_1389 6.373E-04 9.542E-03 6.373E-04 0.01576548 SHEPARD_BMYB_MORPHOLINO_DN integumentary system cancer DOID_0060122 6.529E-04 9.526E-03 6.529E-04 0.01547993 SHEPARD_BMYB_MORPHOLINO_DN skin cancer DOID_4159 6.529E-04 9.526E-03 6.529E-04 0.01547993 SHEPARD_BMYB_MORPHOLINO_DN familial hyperlipidemia DOID_1168 6.865E-04 9.765E-03 0.01281679 0.09471112 SHEPARD_BMYB_MORPHOLINO_DN hypertrophic cardiomyopathy DOID_11984 7.568E-04 0.01050259 7.568E-04 0.01656178 SHEPARD_BMYB_MORPHOLINO_DN glioblastoma DOID_3068 7.568E-04 0.01025253 7.568E-04 0.01594838 SHEPARD_BMYB_MORPHOLINO_DN oral submucous fibrosis DOID_5773 8.546E-04 0.01130874 8.546E-04 0.01736699 SHEPARD_BMYB_MORPHOLINO_DN intermediate coronary syndrome DOID_8805 8.546E-04 0.01105172 8.546E-04 0.01676813 SHEPARD_BMYB_MORPHOLINO_DN neuroectodermal tumor DOID_171 8.706E-04 0.01100793 8.706E-04 0.0165119 SHEPARD_BMYB_MORPHOLINO_DN carotid artery disease DOID_3407 8.706E-04 0.01076863 0.01496049 0.10913483 SHEPARD_BMYB_MORPHOLINO_DN silicosis DOID_10325 9.749E-04 0.01180194 0.0454366 0.21366467 SHEPARD_BMYB_MORPHOLINO_DN hemolytic-uremic syndrome DOID_12554 9.749E-04 0.01155607 0.0454366 0.21019045 SHEPARD_BMYB_MORPHOLINO_DN cholestasis DOID_13580 1.038E-03 0.01205826 0.01677849 0.12084761 SHEPARD_BMYB_MORPHOLINO_DN cerebral degeneration DOID_1443 1.038E-03 0.01181709 1.038E-03 0.01790468 SHEPARD_BMYB_MORPHOLINO_DN hyperglycemia DOID_4195 1.083E-03 0.01208656 1.083E-03 0.01812983 SHEPARD_BMYB_MORPHOLINO_DN schizophreniform disorder DOID_11328 1.103E-03 0.01206653 1.103E-03 0.01792742 SHEPARD_BMYB_MORPHOLINO_DN Graves' disease DOID_12361 1.103E-03 0.01183886 0.04820747 0.21598463 SHEPARD_BMYB_MORPHOLINO_DN schizoaffective disorder DOID_5418 1.103E-03 0.01206653 1.103E-03 0.01792742 SHEPARD_BMYB_MORPHOLINO_DN endocrine organ benign neoplasm DOID_0060089 1.177E-03 0.01240012 1.177E-03 0.01860019 SHEPARD_BMYB_MORPHOLINO_DN brain infarction DOID_3454 1.177E-03 0.01217467 0.01820059 0.12785354 SHEPARD_BMYB_MORPHOLINO_DN astrocytoma DOID_3069 1.225E-03 0.01245095 1.225E-03 0.01884468 SHEPARD_BMYB_MORPHOLINO_DN inherited blood coagulation disease DOID_2214 1.238E-03 0.01236063 1.238E-03 0.01854094 SHEPARD_BMYB_MORPHOLINO_DN bile duct disease DOID_4138 1.326E-03 0.01301175 0.01967185 0.13485886 SHEPARD_BMYB_MORPHOLINO_DN biliary tract disease DOID_9741 1.379E-03 0.01329622 0.02017304 0.13664831 SHEPARD_BMYB_MORPHOLINO_DN diabetic retinopathy DOID_8947 1.432E-03 0.01358337 1.432E-03 0.02089749 SHEPARD_BMYB_MORPHOLINO_DN membranous glomerulonephritis DOID_10976 1.532E-03 0.01428902 1.000 1.000 SHEPARD_BMYB_MORPHOLINO_DN subependymal glioma DOID_4843 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN pilocytic astrocytoma DOID_4851 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN subependymal giant cell astrocytoma DOID_5077 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN fibrillary astrocytoma DOID_6726 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN juvenile pilocytic astrocytoma DOID_6811 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN childhood pilocytic astrocytoma DOID_6812 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN gemistocytic astrocytoma DOID_7005 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN childhood cerebral astrocytoma DOID_7007 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN protoplasmic astrocytoma DOID_7008 1.532E-03 0.01405855 1.532E-03 0.02179076 SHEPARD_BMYB_MORPHOLINO_DN amyloidosis DOID_9120 1.532E-03 0.0138354 0.05647233 0.23627028 SHEPARD_BMYB_MORPHOLINO_DN bone resorption disease DOID_0080011 1.601E-03 0.01423472 1.601E-03 0.02222004 SHEPARD_BMYB_MORPHOLINO_DN osteoporosis DOID_11476 1.601E-03 0.01423472 1.601E-03 0.02222004 SHEPARD_BMYB_MORPHOLINO_DN pancreatitis DOID_4989 1.66E-03 0.01453125 1.66E-03 0.02248884 SHEPARD_BMYB_MORPHOLINO_DN mixed glioma DOID_5076 1.66E-03 0.01431108 1.66E-03 0.02196584 SHEPARD_BMYB_MORPHOLINO_DN lipid metabolism disorder DOID_3146 1.782E-03 0.01513197 0.02382843 0.15584342 SHEPARD_BMYB_MORPHOLINO_DN benign glioma DOID_0060101 1.855E-03 0.0155252 1.855E-03 0.0234603 SHEPARD_BMYB_MORPHOLINO_DN familial hypercholesterolemia DOID_13810 1.855E-03 0.0153002 0.0619427 0.25726565 SHEPARD_BMYB_MORPHOLINO_DN benign ependymoma DOID_4844 1.855E-03 0.0155252 1.855E-03 0.0234603 SHEPARD_BMYB_MORPHOLINO_DN biliary tract cancer DOID_4607 1.975E-03 0.01605188 0.02547197 0.16103947 SHEPARD_BMYB_MORPHOLINO_DN myasthenia gravis DOID_437 2.028E-03 0.01625452 0.06466608 0.25911972 SHEPARD_BMYB_MORPHOLINO_DN pulmonary embolism DOID_9477 2.028E-03 0.01602877 2.028E-03 0.02508851 SHEPARD_BMYB_MORPHOLINO_DN sphingolipidosis DOID_1927 2.396E-03 0.01867528 0.07008937 0.2694652 SHEPARD_BMYB_MORPHOLINO_DN nervous system cancer DOID_3093 2.474E-03 0.01902449 2.474E-03 0.02932942 SHEPARD_BMYB_MORPHOLINO_DN osteosarcoma DOID_3347 2.591E-03 0.01965483 2.591E-03 0.03008392 SHEPARD_BMYB_MORPHOLINO_DN lymphoma DOID_0060058 2.63E-03 0.01968964 2.63E-03 0.02992825 SHEPARD_BMYB_MORPHOLINO_DN lymphoblastic leukemia DOID_1037 2.71E-03 0.02002564 2.71E-03 0.0302348 SHEPARD_BMYB_MORPHOLINO_DN neuromuscular junction disease DOID_439 2.793E-03 0.02037222 0.07548149 0.28443026 SHEPARD_BMYB_MORPHOLINO_DN cleft lip DOID_9296 2.793E-03 0.02011435 2.793E-03 0.02998176 SHEPARD_BMYB_MORPHOLINO_DN dilated cardiomyopathy DOID_12930 2.875E-03 0.0204456 0.03248594 0.17946114 SHEPARD_BMYB_MORPHOLINO_DN ulcerative colitis DOID_8577 3.133E-03 0.02200751 3.133E-03 0.03301127 SHEPARD_BMYB_MORPHOLINO_DN Sciatic Neuropathy DOID_11446 3.218E-03 0.02233038 0.08084263 0.2967707 SHEPARD_BMYB_MORPHOLINO_DN lesion of sciatic nerve DOID_12528 3.218E-03 0.02233038 0.08084263 0.2967707 SHEPARD_BMYB_MORPHOLINO_DN mononeuritis of lower limb DOID_9473 3.218E-03 0.02233038 0.08084263 0.2967707 SHEPARD_BMYB_MORPHOLINO_DN mononeuritis DOID_1802 3.441E-03 0.02359252 0.08351164 0.29885612 SHEPARD_BMYB_MORPHOLINO_DN autoimmune disease of endocrine system DOID_0060005 3.672E-03 0.02487232 0.08617297 0.30081238 SHEPARD_BMYB_MORPHOLINO_DN mononeuropathy DOID_1188 3.672E-03 0.0245797 0.08617297 0.29716617 SHEPARD_BMYB_MORPHOLINO_DN supratentorial cancer DOID_1659 3.672E-03 0.02429389 3.672E-03 0.03798681 SHEPARD_BMYB_MORPHOLINO_DN cerebrum cancer DOID_368 3.672E-03 0.02429389 3.672E-03 0.03798681 SHEPARD_BMYB_MORPHOLINO_DN female reproductive organ benign neoplasm DOID_0060086 3.909E-03 0.02556729 3.909E-03 0.0397206 SHEPARD_BMYB_MORPHOLINO_DN uterine benign neoplasm DOID_0060095 3.909E-03 0.02556729 3.909E-03 0.0397206 SHEPARD_BMYB_MORPHOLINO_DN uterine fibroid DOID_13223 3.909E-03 0.02556729 3.909E-03 0.0397206 SHEPARD_BMYB_MORPHOLINO_DN endometrial carcinoma DOID_2871 3.909E-03 0.02527675 3.909E-03 0.03902375 SHEPARD_BMYB_MORPHOLINO_DN endometrial cancer DOID_1380 4.405E-03 0.02816144 4.405E-03 0.0417728 SHEPARD_BMYB_MORPHOLINO_DN pneumoconiosis DOID_10316 5.2E-03 0.03287417 0.10198087 0.33541685 SHEPARD_BMYB_MORPHOLINO_DN lymphoid leukemia DOID_10747 5.478E-03 0.03425451 5.478E-03 0.04947874 SHEPARD_BMYB_MORPHOLINO_DN embryonal cancer DOID_688 6.055E-03 0.03745179 6.055E-03 0.05383695 SHEPARD_BMYB_MORPHOLINO_DN uveitis DOID_13141 6.354E-03 0.03887568 0.11236863 0.34375134 SHEPARD_BMYB_MORPHOLINO_DN systemic scleroderma DOID_418 6.659E-03 0.04030917 0.11494691 0.34605709 SHEPARD_BMYB_MORPHOLINO_DN adult respiratory distress syndrome DOID_11394 6.971E-03 0.04175172 0.11751776 0.35193478 SHEPARD_BMYB_MORPHOLINO_DN autoimmune disease of urogenital tract DOID_0060049 7.614E-03 0.04512716 7.614E-03 0.06563951 SHEPARD_BMYB_MORPHOLINO_DN primary biliary cirrhosis DOID_12236 7.614E-03 0.04512716 7.614E-03 0.06563951 SHEPARD_BMYB_MORPHOLINO_DN endometriosis of uterus DOID_288 7.614E-03 0.04466194 0.1226373 0.36344076 SHEPARD_BMYB_MORPHOLINO_DN nephrotic syndrome DOID_1184 7.945E-03 0.04612863 7.945E-03 0.06747173 SHEPARD_BMYB_MORPHOLINO_DN rheumatic disease DOID_1575 7.945E-03 0.04566268 0.12518602 0.36716932 SHEPARD_BMYB_MORPHOLINO_DN endometriosis DOID_289 7.945E-03 0.04520606 0.12518602 0.36342269 SHEPARD_BMYB_MORPHOLINO_DN uveal disease DOID_3480 7.945E-03 0.04475847 0.12518602 0.36157791 SHEPARD_BMYB_MORPHOLINO_DN scleroderma DOID_419 7.945E-03 0.04566268 0.12518602 0.36716932 SHEPARD_BMYB_MORPHOLINO_DN gallbladder cancer DOID_3121 8.282E-03 0.04620236 0.12772741 0.36705503 SHEPARD_BMYB_MORPHOLINO_DN cerebral infarction DOID_3526 8.626E-03 0.04765331 0.13026148 0.37245619 SHEPARD_BMYB_MORPHOLINO_DN leukodystrophy DOID_10579 8.976E-03 0.04911091 8.976E-03 0.0751108 SHEPARD_BMYB_MORPHOLINO_DN neuritis DOID_1803 9.333E-03 0.05057475 0.13530775 0.38303538 SHEPARD_BMYB_MORPHOLINO_DN thyroid adenoma DOID_2891 9.333E-03 0.05009763 9.333E-03 0.07586212 SHEPARD_BMYB_MORPHOLINO_DN heart valve disease DOID_4079 9.333E-03 0.04962942 9.333E-03 0.07479364 SHEPARD_BMYB_MORPHOLINO_DN hemolytic anemia DOID_583 9.695E-03 0.05108066 0.13782 0.38821574 SHEPARD_BMYB_MORPHOLINO_DN normocytic anemia DOID_720 9.695E-03 0.05108066 0.13782 0.38821574 SHEPARD_BMYB_MORPHOLINO_DN integumentary system benign neoplasm DOID_0060121 0.01006432 0.05253762 0.01006432 0.07953612 SHEPARD_BMYB_MORPHOLINO_DN pulmonary tuberculosis DOID_2957 0.01006432 0.05206 1.000 1.000 SHEPARD_BMYB_MORPHOLINO_DN skin benign neoplasm DOID_3165 0.01006432 0.05253762 0.01006432 0.07953612 SHEPARD_BMYB_MORPHOLINO_DN orofacial cleft DOID_0050567 0.01120775 0.05745236 0.01120775 0.08617854 SHEPARD_BMYB_MORPHOLINO_DN vasculitis DOID_865 0.01200033 0.06096597 0.1527423 0.4158391 SHEPARD_BMYB_MORPHOLINO_DN reproductive organ benign neoplasm DOID_0050622 0.0124056 0.06246712 0.0124056 0.09411713 SHEPARD_BMYB_MORPHOLINO_DN osteochondrodysplasia DOID_2256 0.0124056 0.06191916 0.0124056 0.09287874 SHEPARD_BMYB_MORPHOLINO_DN pustulosis of palm and sole DOID_4398 0.0124056 0.06138074 0.15520435 0.42052989 SHEPARD_BMYB_MORPHOLINO_DN bile duct cancer DOID_4606 0.01365684 0.06698916 0.16254804 0.4362728 SHEPARD_BMYB_MORPHOLINO_DN bile duct carcinoma DOID_4897 0.01365684 0.06698916 0.16254804 0.4362728 SHEPARD_BMYB_MORPHOLINO_DN respiratory failure DOID_11162 0.01540651 0.07492567 0.1722413 0.46011879 SHEPARD_BMYB_MORPHOLINO_DN uterine disease DOID_345 0.01677849 0.08090645 0.17943822 0.47268679 SHEPARD_BMYB_MORPHOLINO_DN temporal lobe epilepsy DOID_3328 0.017247 0.08246676 1.000 1.000 SHEPARD_BMYB_MORPHOLINO_DN allergic contact dermatitis DOID_3042 0.01772105 0.0840273 0.01772105 0.12604096 SHEPARD_BMYB_MORPHOLINO_DN tuberculosis DOID_399 0.01820059 0.08558791 1.000 1.000 SHEPARD_BMYB_MORPHOLINO_DN nephrosis DOID_2527 0.01967185 0.09174824 0.01967185 0.13650348 SHEPARD_BMYB_MORPHOLINO_DN pancreatic carcinoma DOID_4905 0.02067954 0.0956639 0.02067954 0.13843129 SHEPARD_BMYB_MORPHOLINO_DN syndrome DOID_225 0.02170838 0.09961347 0.20298305 0.52498797 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN neuroectodermal tumor DOID_171 1.458E-05 8.299E-03 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN hyperglycemia DOID_4195 1.83E-05 5.205E-03 0.04974612 0.61533783 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN peripheral vascular disease DOID_341 2.351E-05 4.459E-03 1.412E-03 0.11476259 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN angioedema DOID_1558 2.358E-05 3.355E-03 2.358E-05 0.01341958 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN diabetic retinopathy DOID_8947 2.446E-05 2.784E-03 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN islet cell tumor DOID_1799 3.456E-05 3.277E-03 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN retinal vascular disease DOID_2462 3.668E-05 2.982E-03 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN amino acid metabolic disorder DOID_9252 4.196E-05 2.985E-03 2.068E-03 0.14710623 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN nutritional deficiency disease DOID_5113 5.49E-05 3.471E-03 5.49E-05 0.01562043 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN neuroendocrine tumor DOID_169 7.989E-05 4.546E-03 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN urticaria DOID_1555 1.691E-04 8.747E-03 1.691E-04 0.03207099 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN hepatic vascular disease DOID_272 2.259E-04 0.01071185 0.0219298 0.56718429 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN nephrotic syndrome DOID_1184 5.336E-04 0.023355 5.336E-04 0.07590374 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN brain cancer DOID_1319 6.304E-04 0.0256211 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN vascular skin disease DOID_9540 6.304E-04 0.02391302 6.304E-04 0.07173907 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN central nervous system cancer DOID_3620 6.558E-04 0.02332285 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN hemorrhagic disease DOID_2213 7.351E-04 0.02460296 0.03913902 0.57102829 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN familial hyperlipidemia DOID_1168 8.769E-04 0.02771935 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN hypothyroidism DOID_1459 1.063E-03 0.03183657 0.04692865 0.6209861 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN blood coagulation disease DOID_1247 1.338E-03 0.03807386 0.05255555 0.63625761 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN pancreatic ductal carcinoma DOID_3587 1.338E-03 0.03626082 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN nephrosis DOID_2527 1.375E-03 0.03555784 1.375E-03 0.13037875 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN pancreatic carcinoma DOID_4905 1.449E-03 0.03585538 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN metabolic syndrome X DOID_14221 1.684E-03 0.03993068 0.05884752 0.65655371 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN lipid metabolism disorder DOID_3146 1.684E-03 0.03833345 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN nervous system cancer DOID_3093 2.113E-03 0.04624823 1.000 1.000 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN carbohydrate metabolic disorder DOID_2978 2.251E-03 0.04743873 0.06786484 0.68955523 BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN ulcerative colitis DOID_8577 2.49E-03 0.05059796 0.0713108 0.69958359 LI_CISPLATIN_RESISTANCE_DN hemolytic-uremic syndrome DOID_12554 2.263E-05 0.01287477 2.263E-05 0.01287477 LI_CISPLATIN_RESISTANCE_DN portal hypertension DOID_10762 6.112E-05 0.01738866 0.01159757 0.23567922 LI_CISPLATIN_RESISTANCE_DN hepatic vascular disease DOID_272 8.172E-05 0.01549967 0.01337054 0.26233915 LI_CISPLATIN_RESISTANCE_DN age related macular degeneration DOID_10871 9.911E-05 0.01409889 9.911E-05 0.02819778 LI_CISPLATIN_RESISTANCE_DN degeneration of macula and posterior pole DOID_2007 9.911E-05 0.01409889 9.911E-05 0.02819778 LI_CISPLATIN_RESISTANCE_DN macular degeneration DOID_4448 1.249E-04 0.01421206 1.249E-04 0.02368677 LI_CISPLATIN_RESISTANCE_DN adenoid cystic carcinoma DOID_4866 1.691E-04 0.01603254 1.691E-04 0.0240488 LI_CISPLATIN_RESISTANCE_DN endometriosis of uterus DOID_288 1.853E-04 0.01505823 1.853E-04 0.02108152 LI_CISPLATIN_RESISTANCE_DN salivary gland cancer DOID_8850 1.853E-04 0.01317595 1.853E-04 0.01756793 LI_CISPLATIN_RESISTANCE_DN endometriosis DOID_289 1.936E-04 0.01224109 1.936E-04 0.01573854 LI_CISPLATIN_RESISTANCE_DN hemolytic anemia DOID_583 2.382E-04 0.01355376 2.382E-04 0.0169422 LI_CISPLATIN_RESISTANCE_DN normocytic anemia DOID_720 2.382E-04 0.01355376 2.382E-04 0.0169422 LI_CISPLATIN_RESISTANCE_DN giant cell tumor DOID_200 2.873E-04 0.01486296 2.873E-04 0.01816583 LI_CISPLATIN_RESISTANCE_DN malignant giant cell tumor DOID_2705 2.873E-04 0.01486296 2.873E-04 0.01816583 LI_CISPLATIN_RESISTANCE_DN giant cell glioblastoma DOID_3074 2.873E-04 0.01486296 2.873E-04 0.01816583 LI_CISPLATIN_RESISTANCE_DN glioblastoma DOID_3068 3.41E-04 0.01616868 3.41E-04 0.01940241 LI_CISPLATIN_RESISTANCE_DN oral cavity cancer DOID_8618 3.41E-04 0.01492493 3.41E-04 0.01763856 LI_CISPLATIN_RESISTANCE_DN uterine disease DOID_345 4.237E-04 0.01721983 4.237E-04 0.02008981 LI_CISPLATIN_RESISTANCE_DN astrocytoma DOID_3069 4.749E-04 0.0180142 4.749E-04 0.02078562 LI_CISPLATIN_RESISTANCE_DN syndrome DOID_225 5.571E-04 0.01981043 5.571E-04 0.02264049 LI_CISPLATIN_RESISTANCE_DN female reproductive system disease DOID_229 6.304E-04 0.02110082 6.304E-04 0.02391426 MAHADEVAN_IMATINIB_RESISTANCE_DN leukocyte disease DOID_9500 2.725E-04 0.07753856 2.725E-04 0.15507711 MAHADEVAN_IMATINIB_RESISTANCE_DN bile duct disease DOID_4138 3.882E-04 0.07363234 3.882E-04 0.11044851 MAHADEVAN_IMATINIB_RESISTANCE_DN peripheral vascular disease DOID_341 3.988E-04 0.05672429 3.988E-04 0.07563238 MAHADEVAN_IMATINIB_RESISTANCE_DN biliary tract disease DOID_9741 3.988E-04 0.04537943 3.988E-04 0.05672429 MAHADEVAN_IMATINIB_RESISTANCE_DN diabetic retinopathy DOID_8947 4.094E-04 0.03882938 4.094E-04 0.04659525 MAHADEVAN_IMATINIB_RESISTANCE_DN metabolic syndrome X DOID_14221 4.765E-04 0.03872953 0.03196357 0.30825879 MAHADEVAN_IMATINIB_RESISTANCE_DN lipid metabolism disorder DOID_3146 4.765E-04 0.03388834 0.03196357 0.29815194 MAHADEVAN_IMATINIB_RESISTANCE_DN retinal vascular disease DOID_2462 5.361E-04 0.03389382 5.361E-04 0.05084073 MAHADEVAN_IMATINIB_RESISTANCE_DN primary immunodeficiency disease DOID_612 5.863E-04 0.03336048 5.863E-04 0.04765783 DAZARD_RESPONSE_TO_UV_NHEK_UP biliary tract cancer DOID_4607 4.957E-11 2.821E-08 1.042E-06 6.591E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP peptic ulcer DOID_750 2.748E-10 7.817E-08 6.203E-07 7.059E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP bile duct disease DOID_4138 5.119E-10 9.709E-08 1.653E-08 9.404E-06 DAZARD_RESPONSE_TO_UV_NHEK_UP biliary tract disease DOID_9741 5.712E-10 8.125E-08 1.817E-08 5.169E-06 DAZARD_RESPONSE_TO_UV_NHEK_UP cystic fibrosis DOID_1485 7.861E-10 8.945E-08 1.376E-05 4.35E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP middle cerebral artery infarction DOID_3525 1.077E-09 1.021E-07 7.487E-08 1.42E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP cholestasis DOID_13580 9.078E-09 7.379E-07 2.754E-07 3.918E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP intracranial arterial disease DOID_13089 1.661E-08 1.181E-06 6.997E-07 6.636E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP cerebral arterial disease DOID_3527 1.661E-08 1.181E-06 6.997E-07 6.636E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP pancreatitis DOID_4989 2.861E-08 1.809E-06 7.278E-07 5.916E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP bacterial pneumonia DOID_874 2.861E-08 1.628E-06 7.278E-07 5.176E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP gallbladder cancer DOID_3121 2.889E-08 1.494E-06 3.399E-05 8.41E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP cerebral infarction DOID_3526 3.291E-08 1.56E-06 1.225E-06 6.973E-05 DAZARD_RESPONSE_TO_UV_NHEK_UP integumentary system cancer DOID_0060122 1.051E-07 4.602E-06 1.508E-03 0.0182515 DAZARD_RESPONSE_TO_UV_NHEK_UP skin cancer DOID_4159 1.051E-07 4.602E-06 1.508E-03 0.0182515 DAZARD_RESPONSE_TO_UV_NHEK_UP bile duct cancer DOID_4606 1.429E-07 5.806E-06 1.744E-03 0.01837231 DAZARD_RESPONSE_TO_UV_NHEK_UP bile duct carcinoma DOID_4897 1.429E-07 5.806E-06 1.744E-03 0.01837231 DAZARD_RESPONSE_TO_UV_NHEK_UP uterine disease DOID_345 2.754E-07 1.045E-05 2.38E-03 0.02418703 DAZARD_RESPONSE_TO_UV_NHEK_UP myocarditis DOID_820 2.801E-07 9.961E-06 1.16E-05 4.402E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP esophageal disease DOID_6050 3.229E-07 1.081E-05 1.297E-05 4.342E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP endocrine organ benign neoplasm DOID_0060089 3.569E-07 1.128E-05 8.674E-06 3.796E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP brain infarction DOID_3454 3.569E-07 1.069E-05 8.674E-06 3.525E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP tongue cancer DOID_8649 3.808E-07 1.083E-05 3.082E-05 7.972E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP diabetic retinopathy DOID_8947 5.362E-07 1.453E-05 1.212E-05 4.309E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP pulmonary emphysema DOID_9675 7.87E-07 2.035E-05 6.732E-04 0.01094492 DAZARD_RESPONSE_TO_UV_NHEK_UP metabolic syndrome X DOID_14221 8.426E-07 2.085E-05 4.044E-03 0.03486241 DAZARD_RESPONSE_TO_UV_NHEK_UP female reproductive system disease DOID_229 9.054E-07 2.147E-05 4.184E-03 0.0350073 DAZARD_RESPONSE_TO_UV_NHEK_UP esophagitis DOID_11963 1.002E-06 2.28E-05 6.204E-05 1.412E-03 DAZARD_RESPONSE_TO_UV_NHEK_UP retinal vascular disease DOID_2462 1.196E-06 2.617E-05 2.342E-05 7.014E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP transitional cell carcinoma DOID_2671 1.461E-06 3.078E-05 2.76E-05 7.478E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP integumentary system benign neoplasm DOID_0060121 1.837E-06 3.733E-05 1.098E-03 0.01562274 DAZARD_RESPONSE_TO_UV_NHEK_UP skin benign neoplasm DOID_3165 1.837E-06 3.733E-05 1.098E-03 0.01562274 DAZARD_RESPONSE_TO_UV_NHEK_UP hypersensitivity reaction type I disease DOID_1205 2.267E-06 4.448E-05 5.684E-04 0.01010602 DAZARD_RESPONSE_TO_UV_NHEK_UP sphingolipidosis DOID_1927 2.576E-06 4.886E-05 2.576E-06 1.333E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP bile duct adenocarcinoma DOID_4896 2.914E-06 5.348E-05 0.02073467 0.10924099 DAZARD_RESPONSE_TO_UV_NHEK_UP cholangiocarcinoma DOID_4947 2.914E-06 5.348E-05 0.02073467 0.10924099 DAZARD_RESPONSE_TO_UV_NHEK_UP oral cavity cancer DOID_8618 4.089E-06 7.27E-05 9.536E-05 2.087E-03 DAZARD_RESPONSE_TO_UV_NHEK_UP pleurisy DOID_10247 5.497E-06 9.479E-05 6.049E-03 0.0458955 DAZARD_RESPONSE_TO_UV_NHEK_UP renal hypertension DOID_1073 5.497E-06 9.2E-05 5.497E-06 2.607E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP secondary hypertension DOID_11130 5.497E-06 9.2E-05 5.497E-06 2.607E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP spastic cerebral palsy DOID_0050669 8.135E-06 1.322E-04 7.287E-03 0.04936276 DAZARD_RESPONSE_TO_UV_NHEK_UP pancreatic ductal carcinoma DOID_3587 9.944E-06 1.572E-04 2.913E-03 0.02762374 DAZARD_RESPONSE_TO_UV_NHEK_UP pleural disease DOID_1532 1.035E-05 1.591E-04 8.171E-03 0.05283024 DAZARD_RESPONSE_TO_UV_NHEK_UP papilloma DOID_2615 1.16E-05 1.738E-04 8.629E-03 0.05516976 DAZARD_RESPONSE_TO_UV_NHEK_UP pancreatic carcinoma DOID_4905 1.212E-05 1.768E-04 3.265E-03 0.03045268 DAZARD_RESPONSE_TO_UV_NHEK_UP spindle cell carcinoma DOID_4015 1.297E-05 1.845E-04 9.099E-03 0.05689655 DAZARD_RESPONSE_TO_UV_NHEK_UP aneurysm disease DOID_2403 1.465E-05 2.032E-04 3.641E-03 0.03187709 DAZARD_RESPONSE_TO_UV_NHEK_UP adenoma DOID_657 1.606E-05 2.175E-04 4.712E-04 8.937E-03 DAZARD_RESPONSE_TO_UV_NHEK_UP chronic kidney failure DOID_784 2.092E-05 2.768E-04 4.472E-03 0.03635178 DAZARD_RESPONSE_TO_UV_NHEK_UP respiratory syncytial virus infectious disease DOID_1273 2.166E-05 2.8E-04 5.869E-04 0.0101193 DAZARD_RESPONSE_TO_UV_NHEK_UP renovascular hypertension DOID_1591 2.512E-05 3.176E-04 2.512E-05 7.145E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP primary bacterial infectious disease DOID_0050338 2.615E-05 3.234E-04 4.102E-04 8.049E-03 DAZARD_RESPONSE_TO_UV_NHEK_UP endometriosis of uterus DOID_288 2.857E-05 3.459E-04 7.193E-04 0.0113687 DAZARD_RESPONSE_TO_UV_NHEK_UP Barrett's esophagus DOID_9206 3.082E-05 3.654E-04 1.729E-03 0.01856416 DAZARD_RESPONSE_TO_UV_NHEK_UP endometriosis DOID_289 3.119E-05 3.622E-04 7.673E-04 0.0117997 DAZARD_RESPONSE_TO_UV_NHEK_UP influenza DOID_8469 3.399E-05 3.868E-04 0.01440161 0.08194517 DAZARD_RESPONSE_TO_UV_NHEK_UP encephalomyelitis DOID_640 3.582E-05 3.997E-04 0.0527595 0.20013439 DAZARD_RESPONSE_TO_UV_NHEK_UP dilated cardiomyopathy DOID_12930 3.96E-05 4.333E-04 3.96E-05 9.388E-04 DAZARD_RESPONSE_TO_UV_NHEK_UP proteinuria DOID_576 4.014E-05 4.309E-04 0.17344415 0.37812154 DAZARD_RESPONSE_TO_UV_NHEK_UP myeloma DOID_0070004 4.35E-05 4.583E-04 0.01619726 0.08947807 DAZARD_RESPONSE_TO_UV_NHEK_UP thyroid adenoma DOID_2891 4.35E-05 4.5E-04 9.795E-04 0.01429138 DAZARD_RESPONSE_TO_UV_NHEK_UP ulcerative colitis DOID_8577 4.583E-05 4.657E-04 7.019E-03 0.04812108 DAZARD_RESPONSE_TO_UV_NHEK_UP pulmonary tuberculosis DOID_2957 5.083E-05 5.074E-04 1.098E-03 0.0152417 DAZARD_RESPONSE_TO_UV_NHEK_UP aortic aneurysm DOID_3627 5.481E-05 5.377E-04 1.161E-03 0.01572698 DAZARD_RESPONSE_TO_UV_NHEK_UP withdrawal disorder DOID_0060001 5.902E-05 5.692E-04 1.226E-03 0.0162189 DAZARD_RESPONSE_TO_UV_NHEK_UP sarcoidosis DOID_11335 6.813E-05 6.461E-04 0.02005744 0.1066606 DAZARD_RESPONSE_TO_UV_NHEK_UP autoimmune hepatitis DOID_2048 7.217E-05 6.732E-04 0.07836628 0.2397334 DAZARD_RESPONSE_TO_UV_NHEK_UP bone marrow cancer DOID_4960 7.305E-05 6.704E-04 0.02073467 0.10823878 DAZARD_RESPONSE_TO_UV_NHEK_UP pustulosis of palm and sole DOID_4398 7.823E-05 7.065E-04 1.508E-03 0.01787126 DAZARD_RESPONSE_TO_UV_NHEK_UP gastric ulcer DOID_10808 8.333E-05 7.408E-04 3.278E-03 0.0300864 DAZARD_RESPONSE_TO_UV_NHEK_UP hypersensitivity reaction type IV disease DOID_2916 9.536E-05 8.348E-04 0.02353729 0.11851963 DAZARD_RESPONSE_TO_UV_NHEK_UP urinary tract obstruction DOID_5200 9.556E-05 8.238E-04 0.08550374 0.24696257 DAZARD_RESPONSE_TO_UV_NHEK_UP spastic quadriplegia DOID_10970 1.234E-04 1.048E-03 0.09258629 0.25698342 DAZARD_RESPONSE_TO_UV_NHEK_UP pre-malignant neoplasm DOID_0060071 1.297E-04 1.086E-03 2.186E-03 0.02261353 DAZARD_RESPONSE_TO_UV_NHEK_UP in situ carcinoma DOID_8719 1.297E-04 1.086E-03 2.186E-03 0.02261353 DAZARD_RESPONSE_TO_UV_NHEK_UP portal hypertension DOID_10762 1.391E-04 1.147E-03 4.566E-03 0.0360823 DAZARD_RESPONSE_TO_UV_NHEK_UP osteosarcoma DOID_3347 1.391E-04 1.131E-03 1.391E-04 2.931E-03 DAZARD_RESPONSE_TO_UV_NHEK_UP tuberculosis DOID_399 1.723E-04 1.381E-03 2.692E-03 0.02596103 DAZARD_RESPONSE_TO_UV_NHEK_UP hepatic vascular disease DOID_272 2.147E-04 1.697E-03 6.049E-03 0.04470341 DAZARD_RESPONSE_TO_UV_NHEK_UP multiple epiphyseal dysplasia DOID_12721 2.371E-04 1.848E-03 6.45E-03 0.04587812 DAZARD_RESPONSE_TO_UV_NHEK_UP bone resorption disease DOID_0080011 2.601E-04 2E-03 0.03788355 0.18267578 DAZARD_RESPONSE_TO_UV_NHEK_UP osteoporosis DOID_11476 2.601E-04 2E-03 0.03788355 0.18267578 DAZARD_RESPONSE_TO_UV_NHEK_UP abdominal aortic aneurysm DOID_7693 2.861E-04 2.171E-03 7.287E-03 0.04878202 DAZARD_RESPONSE_TO_UV_NHEK_UP chromosomal disease DOID_0080014 3.143E-04 2.353E-03 3.143E-04 6.388E-03 DAZARD_RESPONSE_TO_UV_NHEK_UP thyroid carcinoma DOID_3963 4.029E-04 2.977E-03 9.099E-03 0.05752873 DAZARD_RESPONSE_TO_UV_NHEK_UP thyroid cancer DOID_1781 4.712E-04 3.437E-03 0.01007315 0.06230023 DAZARD_RESPONSE_TO_UV_NHEK_UP pulmonary sarcoidosis DOID_13406 5.08E-04 3.659E-03 0.01057658 0.06402206 DAZARD_RESPONSE_TO_UV_NHEK_UP multiple myeloma DOID_9538 5.08E-04 3.613E-03 0.01057658 0.06334814 DAZARD_RESPONSE_TO_UV_NHEK_UP alcohol-related neurodevelopmental disorder DOID_0050667 5.465E-04 3.839E-03 5.465E-04 0.01003181 DAZARD_RESPONSE_TO_UV_NHEK_UP mouth disease DOID_403 5.465E-04 3.793E-03 0.31163275 0.58328631 DAZARD_RESPONSE_TO_UV_NHEK_UP congenital diaphragmatic hernia DOID_3827 5.869E-04 4.023E-03 0.15062979 0.34559818 DAZARD_RESPONSE_TO_UV_NHEK_UP lymphatic system disease DOID_75 6.291E-04 4.262E-03 6.291E-04 0.01052842 DAZARD_RESPONSE_TO_UV_NHEK_UP hyperparathyroidism DOID_13543 6.584E-04 4.408E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP insulinoma DOID_3892 6.584E-04 4.356E-03 0.03810984 0.16680385 DAZARD_RESPONSE_TO_UV_NHEK_UP hyperinsulinism DOID_2018 7.673E-04 5.018E-03 0.01382356 0.07945054 DAZARD_RESPONSE_TO_UV_NHEK_UP nervous system benign neoplasm DOID_0060115 8.027E-04 5.19E-03 8.027E-04 0.01201918 DAZARD_RESPONSE_TO_UV_NHEK_UP diabetic autonomic neuropathy DOID_11503 8.173E-04 5.225E-03 0.16698859 0.36828105 DAZARD_RESPONSE_TO_UV_NHEK_UP autonomic neuropathy DOID_11504 8.173E-04 5.225E-03 0.16698859 0.36828105 DAZARD_RESPONSE_TO_UV_NHEK_UP diabetic polyneuropathy DOID_12785 8.173E-04 5.225E-03 0.16698859 0.36828105 DAZARD_RESPONSE_TO_UV_NHEK_UP diabetic neuropathy DOID_9743 8.173E-04 5.225E-03 0.16698859 0.36828105 DAZARD_RESPONSE_TO_UV_NHEK_UP islet cell tumor DOID_1799 9.608E-04 6.074E-03 0.0455569 0.18648833 DAZARD_RESPONSE_TO_UV_NHEK_UP aortic valve insufficiency DOID_57 9.608E-04 6.007E-03 0.0455569 0.1838431 DAZARD_RESPONSE_TO_UV_NHEK_UP autonomic nervous system disease DOID_11465 9.795E-04 6.058E-03 0.17665327 0.38364775 DAZARD_RESPONSE_TO_UV_NHEK_UP hemolytic anemia DOID_583 1.038E-03 6.35E-03 0.01681601 0.09112677 DAZARD_RESPONSE_TO_UV_NHEK_UP normocytic anemia DOID_720 1.038E-03 6.35E-03 0.01681601 0.09112677 DAZARD_RESPONSE_TO_UV_NHEK_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.098E-03 6.648E-03 0.18303443 0.38860669 DAZARD_RESPONSE_TO_UV_NHEK_UP glaucoma DOID_1686 1.098E-03 6.578E-03 0.01744472 0.09364195 DAZARD_RESPONSE_TO_UV_NHEK_UP berylliosis DOID_10322 1.133E-03 6.713E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP parathyroid gland disease DOID_11201 1.133E-03 6.644E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP polyneuropathy DOID_1389 1.133E-03 6.576E-03 0.04925893 0.19197487 DAZARD_RESPONSE_TO_UV_NHEK_UP Legionnaires' disease DOID_10457 1.318E-03 7.575E-03 1.318E-03 0.01704386 DAZARD_RESPONSE_TO_UV_NHEK_UP legionellosis DOID_10458 1.318E-03 7.575E-03 1.318E-03 0.01704386 DAZARD_RESPONSE_TO_UV_NHEK_UP viral pneumonia DOID_10533 1.318E-03 7.499E-03 1.318E-03 0.01666511 DAZARD_RESPONSE_TO_UV_NHEK_UP open-angle glaucoma DOID_1067 1.318E-03 7.425E-03 0.0529467 0.19951437 DAZARD_RESPONSE_TO_UV_NHEK_UP reproductive organ benign neoplasm DOID_0050622 1.508E-03 8.41E-03 1.508E-03 0.01864827 DAZARD_RESPONSE_TO_UV_NHEK_UP osteochondrodysplasia DOID_2256 1.508E-03 8.328E-03 0.02142135 0.1108068 DAZARD_RESPONSE_TO_UV_NHEK_UP idiopathic pulmonary fibrosis DOID_0050156 1.517E-03 8.299E-03 0.05662025 0.20520334 DAZARD_RESPONSE_TO_UV_NHEK_UP skeletal system cancer DOID_0060124 1.517E-03 8.22E-03 0.05662025 0.20390459 DAZARD_RESPONSE_TO_UV_NHEK_UP bone cancer DOID_184 1.517E-03 8.22E-03 0.05662025 0.20390459 DAZARD_RESPONSE_TO_UV_NHEK_UP membranoproliferative glomerulonephritis DOID_2920 1.517E-03 8.143E-03 1.517E-03 0.01761439 DAZARD_RESPONSE_TO_UV_NHEK_UP nutritional deficiency disease DOID_5113 1.517E-03 8.066E-03 1.517E-03 0.0172621 DAZARD_RESPONSE_TO_UV_NHEK_UP oral submucous fibrosis DOID_5773 1.517E-03 7.992E-03 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP intermediate coronary syndrome DOID_8805 1.517E-03 7.918E-03 1.517E-03 0.01692363 DAZARD_RESPONSE_TO_UV_NHEK_UP mitochondrial metabolism disease DOID_700 1.584E-03 8.193E-03 0.0221174 0.1123643 DAZARD_RESPONSE_TO_UV_NHEK_UP angiosarcoma DOID_0001816 1.729E-03 8.864E-03 1.729E-03 0.01892116 DAZARD_RESPONSE_TO_UV_NHEK_UP spastic diplegia DOID_10965 1.729E-03 8.785E-03 0.06027966 0.20787349 DAZARD_RESPONSE_TO_UV_NHEK_UP melancholia DOID_2848 1.827E-03 9.2E-03 0.21421089 0.43530712 DAZARD_RESPONSE_TO_UV_NHEK_UP neurotic disorder DOID_4964 1.913E-03 9.548E-03 0.21726278 0.43837773 DAZARD_RESPONSE_TO_UV_NHEK_UP ureteral obstruction DOID_5199 2.194E-03 0.01085314 0.06755623 0.22091663 DAZARD_RESPONSE_TO_UV_NHEK_UP endocrine pancreas disease DOID_1428 2.282E-03 0.01119289 0.02801342 0.13860555 DAZARD_RESPONSE_TO_UV_NHEK_UP Down syndrome DOID_14250 2.445E-03 0.01189238 2.445E-03 0.02441067 DAZARD_RESPONSE_TO_UV_NHEK_UP granulosa cell tumor DOID_2999 2.445E-03 0.01179159 0.0711735 0.22751528 DAZARD_RESPONSE_TO_UV_NHEK_UP leishmaniasis DOID_9065 2.445E-03 0.0116925 0.0711735 0.22498734 DAZARD_RESPONSE_TO_UV_NHEK_UP hyperglycemia DOID_4195 2.482E-03 0.0117671 0.23532846 0.46332836 DAZARD_RESPONSE_TO_UV_NHEK_UP allergic contact dermatitis DOID_3042 2.585E-03 0.01215805 2.585E-03 0.0253642 DAZARD_RESPONSE_TO_UV_NHEK_UP amnestic disorder DOID_10914 2.71E-03 0.01264006 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP sex cord-gonadal stromal tumor DOID_192 2.71E-03 0.01253729 0.07477683 0.23250282 DAZARD_RESPONSE_TO_UV_NHEK_UP mitochondrial myopathy DOID_699 2.988E-03 0.0137104 0.07836628 0.23592811 DAZARD_RESPONSE_TO_UV_NHEK_UP nephrosis DOID_2527 3.027E-03 0.01378076 0.25006641 0.48728694 DAZARD_RESPONSE_TO_UV_NHEK_UP male reproductive system disease DOID_48 3.027E-03 0.01367139 0.25006641 0.48562384 DAZARD_RESPONSE_TO_UV_NHEK_UP muscular atrophy DOID_767 3.278E-03 0.01468785 3.278E-03 0.02960884 DAZARD_RESPONSE_TO_UV_NHEK_UP placenta disease DOID_780 3.278E-03 0.0145731 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP endogenous depression DOID_1595 3.513E-03 0.01549572 0.26165335 0.50468053 DAZARD_RESPONSE_TO_UV_NHEK_UP uremia DOID_4676 3.581E-03 0.01567563 0.08550374 0.24822258 DAZARD_RESPONSE_TO_UV_NHEK_UP sleep disorder DOID_535 3.581E-03 0.01555597 3.581E-03 0.03184112 DAZARD_RESPONSE_TO_UV_NHEK_UP ureteral disease DOID_1426 3.897E-03 0.01679891 0.08905185 0.25335252 DAZARD_RESPONSE_TO_UV_NHEK_UP aortic valve disease DOID_62 3.897E-03 0.0166726 0.08905185 0.25084408 DAZARD_RESPONSE_TO_UV_NHEK_UP meningitis DOID_9471 3.897E-03 0.01654818 0.08905185 0.24960839 DAZARD_RESPONSE_TO_UV_NHEK_UP Goodpasture syndrome DOID_9808 3.897E-03 0.0164256 0.08905185 0.24838482 DAZARD_RESPONSE_TO_UV_NHEK_UP contact dermatitis DOID_2773 4.044E-03 0.01691852 4.044E-03 0.03434208 DAZARD_RESPONSE_TO_UV_NHEK_UP acute pancreatitis DOID_2913 4.225E-03 0.01754871 4.225E-03 0.03484309 DAZARD_RESPONSE_TO_UV_NHEK_UP mental depression DOID_1596 4.472E-03 0.01843931 0.28150424 0.53570538 DAZARD_RESPONSE_TO_UV_NHEK_UP commensal bacterial infectious disease DOID_0050339 4.566E-03 0.01869011 4.566E-03 0.0365905 DAZARD_RESPONSE_TO_UV_NHEK_UP urticaria DOID_1555 4.566E-03 0.01855661 0.09610711 0.26417849 DAZARD_RESPONSE_TO_UV_NHEK_UP bone development disease DOID_0080006 4.621E-03 0.01864677 0.04416472 0.18614611 DAZARD_RESPONSE_TO_UV_NHEK_UP seminoma DOID_4440 5.283E-03 0.0211712 5.283E-03 0.04118234 DAZARD_RESPONSE_TO_UV_NHEK_UP Human immunodeficiency virus infectious disease DOID_526 5.575E-03 0.02218396 0.04983238 0.19029947 DAZARD_RESPONSE_TO_UV_NHEK_UP lung adenocarcinoma DOID_3910 5.661E-03 0.02236688 5.661E-03 0.04352474 DAZARD_RESPONSE_TO_UV_NHEK_UP periodontitis DOID_824 5.661E-03 0.02221263 0.10658837 0.27319272 DAZARD_RESPONSE_TO_UV_NHEK_UP sarcoma DOID_1115 6.049E-03 0.02357646 6.049E-03 0.04529161 DAZARD_RESPONSE_TO_UV_NHEK_UP invasive ductal carcinoma DOID_3008 6.049E-03 0.02341607 6.049E-03 0.04413029 DAZARD_RESPONSE_TO_UV_NHEK_UP autoimmune disease of the nervous system DOID_438 6.049E-03 0.02325786 6.049E-03 0.04357168 DAZARD_RESPONSE_TO_UV_NHEK_UP toxic encephalopathy DOID_3602 6.45E-03 0.02463255 6.45E-03 0.04531173 DAZARD_RESPONSE_TO_UV_NHEK_UP focal glomerulosclerosis DOID_3945 6.45E-03 0.02446833 0.11350873 0.28452187 DAZARD_RESPONSE_TO_UV_NHEK_UP female reproductive organ benign neoplasm DOID_0060086 6.863E-03 0.02586118 6.863E-03 0.04762241 DAZARD_RESPONSE_TO_UV_NHEK_UP uterine benign neoplasm DOID_0060095 6.863E-03 0.02586118 6.863E-03 0.04762241 DAZARD_RESPONSE_TO_UV_NHEK_UP uterine fibroid DOID_13223 6.863E-03 0.02586118 6.863E-03 0.04762241 DAZARD_RESPONSE_TO_UV_NHEK_UP bronchiolitis obliterans DOID_2799 7.287E-03 0.02727942 0.12037584 0.29523212 DAZARD_RESPONSE_TO_UV_NHEK_UP germinoma DOID_3304 7.723E-03 0.02872221 7.723E-03 0.05109881 DAZARD_RESPONSE_TO_UV_NHEK_UP chronic leukemia DOID_1036 8.171E-03 0.03018871 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP chronic lymphocytic leukemia DOID_1040 8.171E-03 0.03018871 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP leiomyoma DOID_127 8.171E-03 0.02999394 8.171E-03 0.05343748 DAZARD_RESPONSE_TO_UV_NHEK_UP pneumoconiosis DOID_10316 9.099E-03 0.03318965 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP periodontal disease DOID_3388 9.099E-03 0.03297826 0.13395195 0.32024648 DAZARD_RESPONSE_TO_UV_NHEK_UP adolescence-adult electroclinical syndrome DOID_0050705 0.01057658 0.03808907 0.01057658 0.06471047 DAZARD_RESPONSE_TO_UV_NHEK_UP hepatitis DOID_2237 0.01161614 0.04156973 0.01161614 0.06884986 DAZARD_RESPONSE_TO_UV_NHEK_UP systemic scleroderma DOID_418 0.01161614 0.04130992 0.15062979 0.34421024 DAZARD_RESPONSE_TO_UV_NHEK_UP cervix uteri carcinoma in situ DOID_8991 0.01269871 0.04487929 0.15721125 0.35497303 DAZARD_RESPONSE_TO_UV_NHEK_UP spinocerebellar ataxia DOID_1441 0.01325589 0.04655928 0.01325589 0.07775879 DAZARD_RESPONSE_TO_UV_NHEK_UP nephrotic syndrome DOID_1184 0.01382356 0.04825524 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP Huntington's disease DOID_12858 0.01382356 0.047961 0.16374206 0.36536954 DAZARD_RESPONSE_TO_UV_NHEK_UP rheumatic disease DOID_1575 0.01382356 0.04767032 0.16374206 0.36394232 DAZARD_RESPONSE_TO_UV_NHEK_UP idiopathic generalized epilepsy DOID_1827 0.01382356 0.04738315 0.01382356 0.08026126 DAZARD_RESPONSE_TO_UV_NHEK_UP scleroderma DOID_419 0.01382356 0.04767032 0.16374206 0.36394232 DAZARD_RESPONSE_TO_UV_NHEK_UP cataract DOID_83 0.01498997 0.05107362 0.01498997 0.08444846 DAZARD_RESPONSE_TO_UV_NHEK_UP spinocerebellar degeneration DOID_2478 0.01558855 0.05279694 0.01558855 0.08695966 DAZARD_RESPONSE_TO_UV_NHEK_UP lens disease DOID_110 0.01619726 0.05453397 0.01619726 0.0886177 DAZARD_RESPONSE_TO_UV_NHEK_UP neuritis DOID_1803 0.01619726 0.05421318 1.000 1.000 DAZARD_RESPONSE_TO_UV_NHEK_UP heart valve disease DOID_4079 0.01619726 0.05389615 0.17665327 0.38074133 DAZARD_RESPONSE_TO_UV_NHEK_UP vascular skin disease DOID_9540 0.01619726 0.0535828 0.17665327 0.37787861 DAZARD_RESPONSE_TO_UV_NHEK_UP B-cell lymphocytic neoplasm DOID_707 0.01873167 0.0616088 0.18936647 0.40055585 DAZARD_RESPONSE_TO_UV_NHEK_UP atopic dermatitis DOID_3310 0.01938975 0.06340671 0.19251419 0.40420876 DAZARD_RESPONSE_TO_UV_NHEK_UP giant cell tumor DOID_200 0.02005744 0.06521534 0.19564977 0.40928205 DAZARD_RESPONSE_TO_UV_NHEK_UP malignant giant cell tumor DOID_2705 0.02005744 0.06521534 0.19564977 0.40928205 DAZARD_RESPONSE_TO_UV_NHEK_UP giant cell glioblastoma DOID_3074 0.02005744 0.06521534 0.19564977 0.40928205 DAZARD_RESPONSE_TO_UV_NHEK_UP atrophic muscular disease DOID_913 0.02005744 0.06484479 0.19564977 0.40778285 DAZARD_RESPONSE_TO_UV_NHEK_UP muscular dystrophy DOID_9884 0.02005744 0.06484479 0.19564977 0.40778285 DAZARD_RESPONSE_TO_UV_NHEK_UP vasculitis DOID_865 0.02073467 0.06665552 0.19877325 0.41278095 DAZARD_RESPONSE_TO_UV_NHEK_UP parasitic protozoa infectious disease DOID_2789 0.02142135 0.06847611 0.20188469 0.41771778 DAZARD_RESPONSE_TO_UV_NHEK_UP smallpox DOID_8736 0.02142135 0.06809357 0.02142135 0.10980854 DAZARD_RESPONSE_TO_UV_NHEK_UP familial hyperlipidemia DOID_1168 0.0221174 0.06991557 0.20498413 0.42259409 DAZARD_RESPONSE_TO_UV_NHEK_UP glioblastoma DOID_3068 0.02353729 0.07399292 0.21114718 0.43061916 DAZARD_RESPONSE_TO_UV_NHEK_UP carotid artery disease DOID_3407 0.02573537 0.08045837 0.2203029 0.4413815 DAZARD_RESPONSE_TO_UV_NHEK_UP collagen disease DOID_854 0.02573537 0.08001871 0.2203029 0.4398328 DAZARD_RESPONSE_TO_UV_NHEK_UP hypothyroidism DOID_1459 0.02648594 0.08190489 0.02648594 0.13219736 DAZARD_RESPONSE_TO_UV_NHEK_UP parasitic infectious disease DOID_1398 0.02879018 0.08854926 0.23234654 0.46064523 DAZARD_RESPONSE_TO_UV_NHEK_UP cerebral degeneration DOID_1443 0.02879018 0.08807318 0.02879018 0.1412208 DAZARD_RESPONSE_TO_UV_NHEK_UP tooth disease DOID_1091 0.03036933 0.09240723 0.23829889 0.46755885 DAZARD_RESPONSE_TO_UV_NHEK_UP astrocytoma DOID_3069 0.03198217 0.09679709 0.24420539 0.47750127 JI_RESPONSE_TO_FSH_DN cervix uteri carcinoma in situ DOID_8991 7.766E-06 4.419E-03 7.766E-06 4.419E-03 JI_RESPONSE_TO_FSH_DN nephrotic syndrome DOID_1184 8.891E-06 2.53E-03 0.03928972 0.49679665 JI_RESPONSE_TO_FSH_DN pre-malignant neoplasm DOID_0060071 2.649E-05 5.023E-03 2.649E-05 7.535E-03 JI_RESPONSE_TO_FSH_DN in situ carcinoma DOID_8719 2.649E-05 5.023E-03 2.649E-05 7.535E-03 JI_RESPONSE_TO_FSH_DN Noonan syndrome DOID_3490 3.292E-05 4.683E-03 3.292E-05 6.244E-03 JI_RESPONSE_TO_FSH_DN nephrosis DOID_2527 3.734E-05 4.25E-03 0.06246785 0.54683392 JI_RESPONSE_TO_FSH_DN epidermolysis bullosa DOID_2730 4.823E-05 4.574E-03 4.823E-05 6.861E-03 JI_RESPONSE_TO_FSH_DN aortic valve insufficiency DOID_57 4.823E-05 3.92E-03 0.01039715 0.32866562 JI_RESPONSE_TO_FSH_DN vesiculobullous skin disease DOID_2731 5.697E-05 4.052E-03 5.697E-05 6.483E-03 JI_RESPONSE_TO_FSH_DN oral submucous fibrosis DOID_5773 7.66E-05 4.843E-03 1.000 1.000 JI_RESPONSE_TO_FSH_DN mouth disease DOID_403 8.124E-05 4.623E-03 0.08029793 0.58576309 JI_RESPONSE_TO_FSH_DN aortic valve disease DOID_62 2.004E-04 0.01036492 0.02068945 0.42043922 JI_RESPONSE_TO_FSH_DN periodontitis DOID_824 2.94E-04 0.01393836 1.000 1.000 JI_RESPONSE_TO_FSH_DN focal glomerulosclerosis DOID_3945 3.363E-04 0.01471985 3.363E-04 0.03189301 JI_RESPONSE_TO_FSH_DN periodontal disease DOID_3388 4.801E-04 0.01951287 1.000 1.000 JI_RESPONSE_TO_FSH_DN adenoid cystic carcinoma DOID_4866 6.488E-04 0.02461236 6.488E-04 0.05274076 JI_RESPONSE_TO_FSH_DN salivary gland cancer DOID_8850 7.106E-04 0.02526965 7.106E-04 0.0505393 JI_RESPONSE_TO_FSH_DN pre-eclampsia DOID_10591 8.769E-04 0.02934875 8.769E-04 0.05543653 JI_RESPONSE_TO_FSH_DN heart valve disease DOID_4079 8.769E-04 0.02771827 0.04263458 0.51615051 JI_RESPONSE_TO_FSH_DN bile duct adenocarcinoma DOID_4896 1.138E-03 0.03408224 0.04846093 0.53027436 JI_RESPONSE_TO_FSH_DN cholangiocarcinoma DOID_4947 1.138E-03 0.03408224 0.04846093 0.53027436 JI_RESPONSE_TO_FSH_DN reproductive organ benign neoplasm DOID_0050622 1.178E-03 0.03351625 0.04929045 0.51937529 JI_RESPONSE_TO_FSH_DN bile duct cancer DOID_4606 1.302E-03 0.03528059 0.05177482 0.49931983 JI_RESPONSE_TO_FSH_DN bile duct carcinoma DOID_4897 1.302E-03 0.03528059 0.05177482 0.49931983 JI_RESPONSE_TO_FSH_DN oral cavity cancer DOID_8618 1.302E-03 0.03367693 1.302E-03 0.07408925 JI_RESPONSE_TO_FSH_DN tooth disease DOID_1091 1.71E-03 0.04230274 1.000 1.000 JI_RESPONSE_TO_FSH_DN biliary tract disease DOID_9741 1.96E-03 0.04645697 0.06328553 0.52955095 JI_RESPONSE_TO_FSH_DN aneurysm disease DOID_2403 2.171E-03 0.0494091 2.171E-03 0.11229341 JI_RESPONSE_TO_FSH_DN mixed glioma DOID_5076 2.225E-03 0.04870046 0.06736356 0.54756955 JI_RESPONSE_TO_FSH_DN biliary tract cancer DOID_4607 2.507E-03 0.05283775 0.07142438 0.541873 JI_RESPONSE_TO_FSH_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.183E-03 0.06469233 3.183E-03 0.15094877 AMIT_EGF_RESPONSE_480_MCF10A diabetic retinopathy DOID_8947 1.725E-05 9.815E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_MCF10A retinal vascular occlusion DOID_1729 1.873E-05 5.327E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_MCF10A retinal vascular disease DOID_2462 2.588E-05 4.909E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_MCF10A hypercalcemia DOID_12678 3.781E-05 5.378E-03 3.781E-05 0.02151186 AMIT_EGF_RESPONSE_480_MCF10A rhabdomyosarcoma DOID_3247 3.781E-05 4.302E-03 9.194E-03 0.58128096 AMIT_EGF_RESPONSE_480_MCF10A skeletal muscle cancer DOID_4043 4.361E-05 4.135E-03 9.848E-03 0.5603437 AMIT_EGF_RESPONSE_480_MCF10A intermediate coronary syndrome DOID_8805 4.361E-05 3.544E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_MCF10A angiosarcoma DOID_0001816 4.981E-05 3.543E-03 0.01050107 0.5431918 AMIT_EGF_RESPONSE_480_MCF10A muscle cancer DOID_4045 1.047E-04 6.621E-03 0.01506193 0.50413158 AMIT_EGF_RESPONSE_480_MCF10A osteosarcoma DOID_3347 1.344E-04 7.646E-03 1.344E-04 0.03822809 AMIT_EGF_RESPONSE_480_MCF10A sarcoma DOID_1115 1.796E-04 9.288E-03 0.0196026 0.61965992 AMIT_EGF_RESPONSE_480_MCF10A systemic scleroderma DOID_418 3.537E-04 0.01677037 0.02733989 0.62225592 AMIT_EGF_RESPONSE_480_MCF10A rheumatic disease DOID_1575 4.245E-04 0.01857873 0.02990594 0.65447992 AMIT_EGF_RESPONSE_480_MCF10A scleroderma DOID_419 4.245E-04 0.01857873 0.02990594 0.65447992 AMIT_EGF_RESPONSE_480_MCF10A calcium metabolism disease DOID_10575 5.635E-04 0.02290404 5.635E-04 0.1068855 AMIT_EGF_RESPONSE_480_MCF10A neuroectodermal tumor DOID_171 8.208E-04 0.03113585 8.208E-04 0.11675945 AMIT_EGF_RESPONSE_480_MCF10A collagen disease DOID_854 8.208E-04 0.02918986 0.04137294 0.63624868 AMIT_EGF_RESPONSE_480_MCF10A mineral metabolism disease DOID_0050032 8.991E-04 0.03009368 8.991E-04 0.10231851 AMIT_EGF_RESPONSE_480_MCF10A temporal lobe epilepsy DOID_3328 9.532E-04 0.03013285 1.000 1.000 AMIT_EGF_RESPONSE_480_MCF10A syndrome DOID_225 1.216E-03 0.036409 0.05020164 0.73242902 AMIT_EGF_RESPONSE_480_MCF10A focal epilepsy DOID_2234 1.441E-03 0.04100326 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN esophagitis DOID_11963 1.187E-05 6.753E-03 5.264E-03 0.27227326 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN esophageal disease DOID_6050 4.15E-05 0.01180705 9.718E-03 0.32527042 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pustulosis of palm and sole DOID_4398 1.027E-04 0.01947894 0.01519588 0.3930208 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hypersensitivity reaction type IV disease DOID_2916 1.136E-04 0.0161667 0.01597619 0.39523714 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN Human immunodeficiency virus infectious disease DOID_526 2.588E-04 0.02945541 2.588E-04 0.14727705 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN lymphoma DOID_0060058 2.702E-04 0.02562378 2.702E-04 0.07687133 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN visceral leishmaniasis DOID_9146 2.635E-03 0.09995208 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN dermatomyositis DOID_10223 2.898E-03 0.09700079 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN sickle cell anemia DOID_10923 2.898E-03 0.09161186 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN migraine without aura DOID_12783 2.898E-03 0.08679018 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hemochromatosis DOID_2352 2.898E-03 0.08245068 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN bronchiectasis DOID_9563 2.898E-03 0.07852445 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN otitis media DOID_10754 3.161E-03 0.08175956 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN middle ear disease DOID_5100 3.161E-03 0.08175956 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN peritonitis DOID_8283 3.161E-03 0.0782048 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN encephalitis DOID_9588 3.161E-03 0.07494626 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN berylliosis DOID_10322 3.424E-03 0.07793487 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hepatic coma DOID_12550 3.424E-03 0.07493737 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hepatic encephalopathy DOID_13413 3.424E-03 0.07493737 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN psoriatic arthritis DOID_9008 3.424E-03 0.07216191 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hypercalcemia DOID_12678 3.687E-03 0.07492848 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN T-cell leukemia DOID_715 3.687E-03 0.07234474 3.687E-03 0.26224967 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN mesenchymal cell neoplasm DOID_3350 3.95E-03 0.07491959 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN spindle cell sarcoma DOID_4235 3.95E-03 0.07491959 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN lung oat cell carcinoma DOID_5411 3.95E-03 0.07250282 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN oral submucous fibrosis DOID_5773 3.95E-03 0.07023711 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN epithelioid sarcoma DOID_6193 3.95E-03 0.07491959 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hyperhomocysteinemia DOID_9279 3.95E-03 0.06810871 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN silicosis DOID_10325 4.213E-03 0.07050418 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hemolytic-uremic syndrome DOID_12554 4.213E-03 0.06848978 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN thyroiditis DOID_7166 4.213E-03 0.06658728 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN autoimmune thyroiditis DOID_7188 4.213E-03 0.06658728 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN prion disease DOID_649 4.738E-03 0.07286879 4.738E-03 0.29957167 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN psoriasis DOID_8893 5.001E-03 0.07488403 5.001E-03 0.28455932 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN leishmaniasis DOID_9065 5.001E-03 0.07296393 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pulmonary edema DOID_11396 5.264E-03 0.07487515 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN Kawasaki disease DOID_13378 5.526E-03 0.07669227 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN lymphadenitis DOID_1602 5.526E-03 0.07669227 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN coronary restenosis DOID_4247 5.526E-03 0.07486626 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN mitochondrial myopathy DOID_699 5.526E-03 0.07312519 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN lymph node disease DOID_9942 5.526E-03 0.07669227 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN gastric ulcer DOID_10808 5.789E-03 0.07485738 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN neutropenia DOID_1227 5.789E-03 0.07319388 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN placenta disease DOID_780 5.789E-03 0.07160271 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN agranulocytosis DOID_12987 6.051E-03 0.07325598 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN polyarteritis nodosa DOID_9810 6.051E-03 0.07172981 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hypoglycemia DOID_9993 6.051E-03 0.07026594 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN diabetic angiopathy DOID_11713 6.313E-03 0.07184603 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN spastic quadriplegia DOID_10970 6.576E-03 0.07336347 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN urticaria DOID_1555 6.838E-03 0.07482186 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN bronchiolitis DOID_2942 6.838E-03 0.07341013 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN cystitis DOID_1679 7.1E-03 0.07481298 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN myositis DOID_633 7.1E-03 0.07345275 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN extrinsic allergic alveolitis DOID_841 7.362E-03 0.07480411 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN migraine DOID_6364 7.624E-03 0.07610743 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN perinatal necrotizing enterocolitis DOID_8677 7.624E-03 0.07479523 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pleurisy DOID_10247 7.886E-03 0.07605393 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN renal hypertension DOID_1073 7.886E-03 0.07478636 7.886E-03 0.37393181 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN secondary hypertension DOID_11130 7.886E-03 0.07478636 7.886E-03 0.37393181 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN sarcoma DOID_1115 7.886E-03 0.07356036 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN malaria DOID_12365 7.886E-03 0.0723739 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN coronary stenosis DOID_4248 7.886E-03 0.07122511 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN autoimmune disease of endocrine system DOID_0060005 8.148E-03 0.07244069 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN spastic cerebral palsy DOID_0050669 8.672E-03 0.0759099 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN opportunistic mycosis DOID_2473 8.672E-03 0.07475975 8.672E-03 0.3795495 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pleural disease DOID_1532 9.195E-03 0.07808867 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN bladder disease DOID_365 9.195E-03 0.07694031 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN systemic mycosis DOID_0050136 9.457E-03 0.07798242 9.457E-03 0.38434192 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN fungal infectious disease DOID_1564 9.457E-03 0.07798242 9.457E-03 0.38434192 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN papilloma DOID_2615 9.457E-03 0.07686838 9.457E-03 0.35871912 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN myocarditis DOID_820 9.457E-03 0.07578573 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN metal metabolism disorder DOID_896 9.457E-03 0.07473315 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pneumoconiosis DOID_10316 9.718E-03 0.07574791 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN nephroblastoma DOID_2154 9.718E-03 0.07472429 9.718E-03 0.34559982 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN leukopenia DOID_615 9.718E-03 0.07372796 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN lymphoid leukemia DOID_10747 9.98E-03 0.07471542 9.98E-03 0.31546512 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pulmonary sarcoidosis DOID_13406 0.01050231 0.077608 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN respiratory syncytial virus infectious disease DOID_1273 0.01102481 0.0804246 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hepatitis DOID_2237 0.01102481 0.07940657 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN congenital diaphragmatic hernia DOID_3827 0.01102481 0.07841398 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN peptic ulcer DOID_750 0.01102481 0.07744591 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN adult respiratory distress syndrome DOID_11394 0.01128597 0.07831362 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN lymphatic system disease DOID_75 0.01128597 0.07737008 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN rheumatic disease DOID_1575 0.01206907 0.08175357 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN scleroderma DOID_419 0.01206907 0.08175357 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN influenza DOID_8469 0.01232998 0.08253832 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN cerebral infarction DOID_3526 0.01259082 0.0833044 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pre-eclampsia DOID_10591 0.01311233 0.08575766 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN vascular skin disease DOID_9540 0.01311233 0.08478314 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN hemolytic anemia DOID_583 0.01337299 0.08549699 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN normocytic anemia DOID_720 0.01337299 0.08549699 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN integumentary system benign neoplasm DOID_0060121 0.01363359 0.08619459 0.01363359 0.40829017 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN pulmonary tuberculosis DOID_2957 0.01363359 0.0852474 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN skin benign neoplasm DOID_3165 0.01363359 0.08619459 0.01363359 0.40829017 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN lung small cell carcinoma DOID_5409 0.01363359 0.0843208 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN calcium metabolism disease DOID_10575 0.01389413 0.08500816 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN sarcoidosis DOID_11335 0.01467537 0.0888328 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN atrophic muscular disease DOID_913 0.01467537 0.08789772 0.01467537 0.41751418 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN muscular dystrophy DOID_9884 0.01467537 0.08789772 0.01467537 0.41751418 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN integumentary system cancer DOID_0060122 0.01519588 0.09006727 0.01519588 0.41173607 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN parasitic protozoa infectious disease DOID_2789 0.01519588 0.08913874 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN skin cancer DOID_4159 0.01519588 0.09006727 0.01519588 0.41173607 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN mitochondrial metabolism disease DOID_700 0.01545605 0.08973971 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN leukocyte disease DOID_9500 0.01623617 0.093317 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN collagen disease DOID_854 0.01675595 0.09534134 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN respiratory failure DOID_11162 0.01701574 0.09586096 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN mineral metabolism disease DOID_0050032 0.01753515 0.09781861 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN endocrine pancreas disease DOID_1428 0.01753515 0.09686891 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN cholestasis DOID_13580 0.01779476 0.09735784 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN parasitic infectious disease DOID_1398 0.01779476 0.09643063 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN uterine disease DOID_345 0.01779476 0.0955209 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN temporal lobe epilepsy DOID_3328 0.0180543 0.09600839 0.0180543 0.42803742 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN allergic contact dermatitis DOID_3042 0.01831379 0.09648653 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN brain infarction DOID_3454 0.01857321 0.09695558 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN tuberculosis DOID_399 0.01857321 0.09607416 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN bile duct disease DOID_4138 0.01935111 0.09919625 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN peripheral vascular disease DOID_341 0.01961029 0.09962728 1.000 1.000 NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN biliary tract disease DOID_9741 0.01961029 0.09874563 1.000 1.000 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN bone development disease DOID_0080006 6.802E-08 3.87E-05 3.745E-06 2.131E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN cleft palate DOID_674 1.6E-05 4.553E-03 1.091E-03 0.0413819 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN adenoid cystic carcinoma DOID_4866 1.994E-05 3.782E-03 1.994E-05 5.673E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN salivary gland cancer DOID_8850 2.289E-05 3.256E-03 2.289E-05 4.341E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN orofacial cleft DOID_0050567 4.196E-05 4.775E-03 2.053E-03 0.06871625 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN osteochondrodysplasia DOID_2256 4.923E-05 4.668E-03 4.923E-05 7.002E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN oral cavity cancer DOID_8618 5.727E-05 4.655E-03 5.727E-05 6.517E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN craniosynostosis DOID_2340 7.867E-05 5.595E-03 0.01326811 0.29036746 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN Hirschsprung's disease DOID_10487 1.114E-04 7.042E-03 1.114E-04 0.01056356 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN megacolon DOID_11372 1.299E-04 7.389E-03 1.299E-04 0.0105554 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN metabolic syndrome X DOID_14221 1.384E-04 7.161E-03 4.497E-03 0.12793536 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN colonic disease DOID_5353 2.699E-04 0.01279643 2.699E-04 0.01919464 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN familial hypercholesterolemia DOID_13810 3.276E-04 0.01433882 3.276E-04 0.02071164 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN synostosis DOID_11971 3.908E-04 0.01588381 0.02872668 0.36323288 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN cleft lip DOID_9296 4.959E-04 0.01880974 0.03226025 0.35992322 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN multiple epiphyseal dysplasia DOID_12721 6.549E-04 0.02328938 6.549E-04 0.037263 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN corneal disease DOID_10124 6.98E-04 0.02336266 6.98E-04 0.03610593 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN dysostosis DOID_1934 6.98E-04 0.02206473 0.03812162 0.34430478 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN endometrial carcinoma DOID_2871 6.98E-04 0.02090343 0.03812162 0.33892502 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN endometrial cancer DOID_1380 7.883E-04 0.02242599 0.04045643 0.34878345 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN germinoma DOID_3304 7.883E-04 0.02135808 0.04045643 0.34357773 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN leiomyoma DOID_127 8.354E-04 0.02160616 8.354E-04 0.0396113 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN autonomic nervous system neoplasm DOID_2621 8.354E-04 0.02066677 8.354E-04 0.03656428 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN neuroblastoma DOID_769 8.354E-04 0.02066677 8.354E-04 0.03656428 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN lymphoid leukemia DOID_10747 9.847E-04 0.02334649 9.847E-04 0.04002255 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN peripheral nervous system neoplasm DOID_1192 1.146E-03 0.02608229 1.146E-03 0.04075358 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN uterine cancer DOID_363 1.504E-03 0.03290892 0.05549812 0.38046299 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN familial hyperlipidemia DOID_1168 2.358E-03 0.04969688 2.358E-03 0.07454533 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN cholestasis DOID_13580 3.118E-03 0.06336178 0.0793103 0.43391885 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN uterine disease DOID_345 3.118E-03 0.06117689 0.0793103 0.42573171 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN brain infarction DOID_3454 3.393E-03 0.06436259 0.08266374 0.42759697 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN bile duct disease DOID_4138 3.68E-03 0.06754422 0.08600523 0.43693727 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN biliary tract disease DOID_9741 3.778E-03 0.06717444 0.08711641 0.4386658 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN pancreatitis DOID_4989 4.285E-03 0.07389126 4.285E-03 0.12833746 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN lipid metabolism disorder DOID_3146 4.497E-03 0.07525609 4.497E-03 0.1218432 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN female reproductive system disease DOID_229 4.604E-03 0.0748534 0.09595841 0.45882634 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN transitional cell carcinoma DOID_2671 5.39E-03 0.08518827 0.10362639 0.47170734 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN nervous system cancer DOID_3093 5.625E-03 0.0864987 5.625E-03 0.14547508 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN lymphoblastic leukemia DOID_1037 5.986E-03 0.089629 5.986E-03 0.1480827 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN alcohol-related neurodevelopmental disorder DOID_0050667 6.108E-03 0.08912042 0.11014828 0.49349899 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN Crohn's disease DOID_8778 6.108E-03 0.08689241 0.11014828 0.48964353 KIM_WT1_TARGETS_12HR_UP brain edema DOID_4724 9.058E-10 5.154E-07 1.339E-05 1.088E-03 KIM_WT1_TARGETS_12HR_UP aneurysm disease DOID_2403 3.192E-08 9.081E-06 1.182E-06 2.243E-04 KIM_WT1_TARGETS_12HR_UP cleft palate DOID_674 3.707E-08 7.03E-06 3.707E-08 2.109E-05 KIM_WT1_TARGETS_12HR_UP cerebral infarction DOID_3526 9.506E-08 1.352E-05 1.938E-04 6.892E-03 KIM_WT1_TARGETS_12HR_UP orofacial cleft DOID_0050567 1.907E-07 2.17E-05 1.907E-07 5.425E-05 KIM_WT1_TARGETS_12HR_UP middle cerebral artery infarction DOID_3525 5.317E-07 5.042E-05 1.936E-03 0.03338251 KIM_WT1_TARGETS_12HR_UP brain infarction DOID_3454 6.931E-07 5.634E-05 6.162E-04 0.01669684 KIM_WT1_TARGETS_12HR_UP bone development disease DOID_0080006 1.804E-06 1.283E-04 1.804E-06 2.566E-04 KIM_WT1_TARGETS_12HR_UP intracranial arterial disease DOID_13089 3.121E-06 1.973E-04 4.522E-03 0.04947905 KIM_WT1_TARGETS_12HR_UP cerebral arterial disease DOID_3527 3.121E-06 1.973E-04 4.522E-03 0.04947905 KIM_WT1_TARGETS_12HR_UP neuritis DOID_1803 5.752E-06 3.273E-04 6.07E-03 0.05756457 KIM_WT1_TARGETS_12HR_UP aortic aneurysm DOID_3627 7.275E-06 3.763E-04 7.275E-06 8.279E-04 KIM_WT1_TARGETS_12HR_UP hyperostosis DOID_205 8.026E-06 3.806E-04 8.026E-06 7.612E-04 KIM_WT1_TARGETS_12HR_UP toxic shock syndrome DOID_14115 2.679E-05 1.172E-03 2.679E-05 1.905E-03 KIM_WT1_TARGETS_12HR_UP commensal bacterial infectious disease DOID_0050339 3.023E-05 1.229E-03 3.023E-05 1.911E-03 KIM_WT1_TARGETS_12HR_UP cleft lip DOID_9296 3.395E-05 1.288E-03 3.395E-05 1.932E-03 KIM_WT1_TARGETS_12HR_UP chronic kidney failure DOID_784 4.754E-05 1.69E-03 1.04E-03 0.02367674 KIM_WT1_TARGETS_12HR_UP toxic encephalopathy DOID_3602 5.182E-05 1.735E-03 2.371E-03 0.03646108 KIM_WT1_TARGETS_12HR_UP endometrial carcinoma DOID_2871 5.709E-05 1.805E-03 5.709E-05 2.953E-03 KIM_WT1_TARGETS_12HR_UP transitional cell carcinoma DOID_2671 5.946E-05 1.781E-03 1.227E-03 0.02585895 KIM_WT1_TARGETS_12HR_UP endometrial cancer DOID_1380 6.864E-05 1.953E-03 6.864E-05 3.255E-03 KIM_WT1_TARGETS_12HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 7.649E-05 2.072E-03 1.477E-03 0.02711886 KIM_WT1_TARGETS_12HR_UP mouth disease DOID_403 7.649E-05 1.978E-03 7.649E-05 3.348E-03 KIM_WT1_TARGETS_12HR_UP hypersensitivity reaction type I disease DOID_1205 7.964E-05 1.97E-03 7.964E-05 3.237E-03 KIM_WT1_TARGETS_12HR_UP adult respiratory distress syndrome DOID_11394 1.394E-04 3.306E-03 4.522E-03 0.05044923 KIM_WT1_TARGETS_12HR_UP uterine cancer DOID_363 1.82E-04 4.142E-03 1.82E-04 6.904E-03 KIM_WT1_TARGETS_12HR_UP Paget's disease of bone DOID_5408 2.368E-04 5.183E-03 2.368E-04 7.927E-03 KIM_WT1_TARGETS_12HR_UP reproductive organ benign neoplasm DOID_0050622 3.4E-04 7.165E-03 3.4E-04 0.01074769 KIM_WT1_TARGETS_12HR_UP osteochondrodysplasia DOID_2256 3.4E-04 6.909E-03 3.4E-04 0.01018202 KIM_WT1_TARGETS_12HR_UP peritonitis DOID_8283 3.463E-04 6.795E-03 1.000 1.000 KIM_WT1_TARGETS_12HR_UP oral cavity cancer DOID_8618 3.946E-04 7.484E-03 3.946E-04 0.01122583 KIM_WT1_TARGETS_12HR_UP intracranial thrombosis DOID_4193 4.087E-04 7.501E-03 1.000 1.000 KIM_WT1_TARGETS_12HR_UP carotid artery disease DOID_3407 4.545E-04 8.082E-03 9.782E-03 0.08563103 KIM_WT1_TARGETS_12HR_UP respiratory failure DOID_11162 4.757E-04 8.202E-03 0.01007755 0.08558393 KIM_WT1_TARGETS_12HR_UP skeletal system cancer DOID_0060124 5.484E-04 9.178E-03 0.03426452 0.17886707 KIM_WT1_TARGETS_12HR_UP bone cancer DOID_184 5.484E-04 9.178E-03 0.03426452 0.17886707 KIM_WT1_TARGETS_12HR_UP nephrosis DOID_2527 6.954E-04 0.01130546 6.954E-04 0.01798596 KIM_WT1_TARGETS_12HR_UP prion disease DOID_649 7.956E-04 0.0125742 0.04097682 0.19111318 KIM_WT1_TARGETS_12HR_UP mixed glioma DOID_5076 8.726E-04 0.0134191 8.726E-04 0.02158725 KIM_WT1_TARGETS_12HR_UP alcohol abuse DOID_1574 1.04E-03 0.0155768 1.04E-03 0.02466327 KIM_WT1_TARGETS_12HR_UP retinal vascular disease DOID_2462 1.113E-03 0.01623331 1.113E-03 0.02434996 KIM_WT1_TARGETS_12HR_UP hepatitis B DOID_2043 1.194E-03 0.0169833 0.04985485 0.2199024 KIM_WT1_TARGETS_12HR_UP pulmonary embolism DOID_9477 1.306E-03 0.01811972 1.000 1.000 KIM_WT1_TARGETS_12HR_UP nervous system cancer DOID_3093 1.307E-03 0.01771055 1.307E-03 0.02656582 KIM_WT1_TARGETS_12HR_UP synostosis DOID_11971 1.422E-03 0.01881917 1.422E-03 0.02790429 KIM_WT1_TARGETS_12HR_UP encephalomyelitis DOID_640 1.434E-03 0.0185403 1.434E-03 0.02719244 KIM_WT1_TARGETS_12HR_UP cystitis DOID_1679 1.8E-03 0.02276619 1.8E-03 0.03201495 KIM_WT1_TARGETS_12HR_UP seminoma DOID_4440 1.936E-03 0.02394833 1.936E-03 0.03240068 KIM_WT1_TARGETS_12HR_UP Sciatic Neuropathy DOID_11446 2.076E-03 0.02513709 1.000 1.000 KIM_WT1_TARGETS_12HR_UP gestational diabetes DOID_11714 2.076E-03 0.0246134 0.06519631 0.25235852 KIM_WT1_TARGETS_12HR_UP lesion of sciatic nerve DOID_12528 2.076E-03 0.02513709 1.000 1.000 KIM_WT1_TARGETS_12HR_UP migraine DOID_6364 2.076E-03 0.02411108 2.076E-03 0.03375552 KIM_WT1_TARGETS_12HR_UP perinatal necrotizing enterocolitis DOID_8677 2.076E-03 0.02362886 2.076E-03 0.03281786 KIM_WT1_TARGETS_12HR_UP mononeuritis of lower limb DOID_9473 2.076E-03 0.02513709 1.000 1.000 KIM_WT1_TARGETS_12HR_UP mononeuritis DOID_1802 2.221E-03 0.02478287 1.000 1.000 KIM_WT1_TARGETS_12HR_UP mononeuropathy DOID_1188 2.371E-03 0.02594346 1.000 1.000 KIM_WT1_TARGETS_12HR_UP cranial nerve disease DOID_5656 2.371E-03 0.02545396 2.371E-03 0.03550158 KIM_WT1_TARGETS_12HR_UP female reproductive organ benign neoplasm DOID_0060086 2.525E-03 0.026608 2.525E-03 0.03684184 KIM_WT1_TARGETS_12HR_UP uterine benign neoplasm DOID_0060095 2.525E-03 0.026608 2.525E-03 0.03684184 KIM_WT1_TARGETS_12HR_UP uterine fibroid DOID_13223 2.525E-03 0.026608 2.525E-03 0.03684184 KIM_WT1_TARGETS_12HR_UP dysostosis DOID_1934 2.525E-03 0.02612421 2.525E-03 0.03592079 KIM_WT1_TARGETS_12HR_UP abdominal aortic aneurysm DOID_7693 2.684E-03 0.02727195 2.684E-03 0.03724949 KIM_WT1_TARGETS_12HR_UP germinoma DOID_3304 2.848E-03 0.02842526 2.848E-03 0.03857714 KIM_WT1_TARGETS_12HR_UP leiomyoma DOID_127 3.016E-03 0.02958365 3.016E-03 0.03990352 KIM_WT1_TARGETS_12HR_UP bladder disease DOID_365 3.016E-03 0.02908223 3.016E-03 0.03899662 KIM_WT1_TARGETS_12HR_UP myocarditis DOID_820 3.188E-03 0.03023419 3.188E-03 0.04031226 KIM_WT1_TARGETS_12HR_UP nephroblastoma DOID_2154 3.365E-03 0.03139063 3.365E-03 0.0416267 KIM_WT1_TARGETS_12HR_UP medullomyoblastoma DOID_3861 3.547E-03 0.03255111 3.547E-03 0.04293977 KIM_WT1_TARGETS_12HR_UP adult medulloblastoma DOID_3864 3.547E-03 0.03255111 3.547E-03 0.04293977 KIM_WT1_TARGETS_12HR_UP childhood medulloblastoma DOID_3869 3.547E-03 0.03255111 3.547E-03 0.04293977 KIM_WT1_TARGETS_12HR_UP medulloblastoma DOID_3858 3.924E-03 0.03543642 3.924E-03 0.0465103 KIM_WT1_TARGETS_12HR_UP uveitis DOID_13141 4.119E-03 0.03661648 4.119E-03 0.04782561 KIM_WT1_TARGETS_12HR_UP systemic scleroderma DOID_418 4.318E-03 0.03779894 4.318E-03 0.04913862 KIM_WT1_TARGETS_12HR_UP adenoid cystic carcinoma DOID_4866 4.522E-03 0.0389835 4.522E-03 0.04854549 KIM_WT1_TARGETS_12HR_UP salivary gland cancer DOID_8850 4.943E-03 0.04197513 4.943E-03 0.05208026 KIM_WT1_TARGETS_12HR_UP nephrotic syndrome DOID_1184 5.159E-03 0.04317284 5.159E-03 0.05337733 KIM_WT1_TARGETS_12HR_UP rheumatic disease DOID_1575 5.159E-03 0.04254715 5.159E-03 0.05242416 KIM_WT1_TARGETS_12HR_UP primitive neuroectodermal tumor DOID_168 5.159E-03 0.04193933 5.159E-03 0.05150444 KIM_WT1_TARGETS_12HR_UP hyperinsulinism DOID_2018 5.159E-03 0.04134864 5.159E-03 0.05061643 KIM_WT1_TARGETS_12HR_UP uveal disease DOID_3480 5.159E-03 0.04077435 5.159E-03 0.04975853 KIM_WT1_TARGETS_12HR_UP scleroderma DOID_419 5.159E-03 0.04254715 5.159E-03 0.05242416 KIM_WT1_TARGETS_12HR_UP diabetic autonomic neuropathy DOID_11503 5.381E-03 0.04194012 0.10353035 0.32367454 KIM_WT1_TARGETS_12HR_UP autonomic neuropathy DOID_11504 5.381E-03 0.04194012 0.10353035 0.32367454 KIM_WT1_TARGETS_12HR_UP diabetic polyneuropathy DOID_12785 5.381E-03 0.04194012 0.10353035 0.32367454 KIM_WT1_TARGETS_12HR_UP diabetic neuropathy DOID_9743 5.381E-03 0.04194012 0.10353035 0.32367454 KIM_WT1_TARGETS_12HR_UP autonomic nervous system disease DOID_11465 6.07E-03 0.04667397 0.10976647 0.33579098 KIM_WT1_TARGETS_12HR_UP heart valve disease DOID_4079 6.07E-03 0.04605165 0.10976647 0.33046096 KIM_WT1_TARGETS_12HR_UP bone marrow disease DOID_4961 6.07E-03 0.04544571 6.07E-03 0.05662089 KIM_WT1_TARGETS_12HR_UP vascular skin disease DOID_9540 6.07E-03 0.04485551 0.10976647 0.32872169 KIM_WT1_TARGETS_12HR_UP congenital nervous system abnormality DOID_2490 8.64E-03 0.06302822 8.64E-03 0.07929357 KIM_WT1_TARGETS_12HR_UP hypertrophic cardiomyopathy DOID_11984 8.92E-03 0.06424357 8.92E-03 0.08055939 KIM_WT1_TARGETS_12HR_UP neuroectodermal tumor DOID_171 9.782E-03 0.06957521 9.782E-03 0.08696902 KIM_WT1_TARGETS_12HR_UP collagen disease DOID_854 9.782E-03 0.06871626 9.782E-03 0.08433359 KIM_WT1_TARGETS_12HR_UP mineral metabolism disease DOID_0050032 0.01068021 0.07411025 0.01068021 0.08936825 KIM_WT1_TARGETS_12HR_UP endocrine pancreas disease DOID_1428 0.01068021 0.07321736 0.01068021 0.08807306 KIM_WT1_TARGETS_12HR_UP cerebral degeneration DOID_1443 0.0109874 0.07442655 0.0109874 0.08931186 KIM_WT1_TARGETS_12HR_UP tooth disease DOID_1091 0.01161338 0.07774135 0.01161338 0.09307062 KIM_WT1_TARGETS_12HR_UP pancreatic ductal carcinoma DOID_3587 0.01258109 0.08324003 0.01258109 0.09942559 KIM_WT1_TARGETS_12HR_UP male reproductive system disease DOID_48 0.01291125 0.08444255 0.01291125 0.10063702 KIM_WT1_TARGETS_12HR_UP peripheral vascular disease DOID_341 0.01324517 0.08564207 0.16009362 0.41978465 KIM_WT1_TARGETS_12HR_UP pancreatic carcinoma DOID_4905 0.01358283 0.08683857 0.01358283 0.10444098 KIM_WT1_TARGETS_12HR_UP diabetic retinopathy DOID_8947 0.01358283 0.0858737 0.01358283 0.10304844 KIM_WT1_TARGETS_12HR_UP electroclinical syndrome DOID_0050701 0.01497054 0.09360703 0.01497054 0.1120821 KIM_WT1_TARGETS_12HR_UP metabolic syndrome X DOID_14221 0.01568637 0.09701681 0.17367399 0.44116294 DER_IFN_ALPHA_RESPONSE_UP thyroiditis DOID_7166 8.082E-07 4.599E-04 1.563E-04 0.02224054 DER_IFN_ALPHA_RESPONSE_UP autoimmune thyroiditis DOID_7188 8.082E-07 4.599E-04 1.563E-04 0.02224054 DER_IFN_ALPHA_RESPONSE_UP psoriasis DOID_8893 1.395E-06 3.969E-04 1.395E-06 7.938E-04 DER_IFN_ALPHA_RESPONSE_UP tuberculosis DOID_399 1.448E-06 2.747E-04 7.889E-05 0.02244435 DER_IFN_ALPHA_RESPONSE_UP primary bacterial infectious disease DOID_0050338 3.585E-06 5.1E-04 1.545E-04 0.02930048 DER_IFN_ALPHA_RESPONSE_UP encephalomyelitis DOID_640 4.651E-06 5.292E-04 1.874E-04 0.01776965 DER_IFN_ALPHA_RESPONSE_UP autoimmune disease of endocrine system DOID_0060005 6.409E-06 6.078E-04 5.992E-04 0.02622573 DER_IFN_ALPHA_RESPONSE_UP multiple myeloma DOID_9538 1.398E-05 1.137E-03 9.984E-04 0.0355068 DER_IFN_ALPHA_RESPONSE_UP myeloma DOID_0070004 2.752E-05 1.957E-03 1.557E-03 0.04217496 DER_IFN_ALPHA_RESPONSE_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.098E-05 1.958E-03 1.682E-03 0.04162115 DER_IFN_ALPHA_RESPONSE_UP pulmonary tuberculosis DOID_2957 3.098E-05 1.763E-03 1.682E-03 0.03829146 DER_IFN_ALPHA_RESPONSE_UP bile duct adenocarcinoma DOID_4896 4.085E-05 2.113E-03 2.018E-03 0.04099915 DER_IFN_ALPHA_RESPONSE_UP cholangiocarcinoma DOID_4947 4.085E-05 2.113E-03 2.018E-03 0.04099915 DER_IFN_ALPHA_RESPONSE_UP bone marrow cancer DOID_4960 4.085E-05 1.937E-03 2.018E-03 0.03958539 DER_IFN_ALPHA_RESPONSE_UP pustulosis of palm and sole DOID_4398 4.304E-05 1.884E-03 2.088E-03 0.03960336 DER_IFN_ALPHA_RESPONSE_UP bile duct cancer DOID_4606 5.008E-05 2.035E-03 2.307E-03 0.04101313 DER_IFN_ALPHA_RESPONSE_UP bile duct carcinoma DOID_4897 5.008E-05 2.035E-03 2.307E-03 0.04101313 DER_IFN_ALPHA_RESPONSE_UP biliary tract cancer DOID_4607 1.348E-04 5.113E-03 4.421E-03 0.06135424 DER_IFN_ALPHA_RESPONSE_UP lymphoma DOID_0060058 1.816E-04 6.458E-03 1.816E-04 0.02066692 DER_IFN_ALPHA_RESPONSE_UP ureteral obstruction DOID_5199 1.99E-04 6.662E-03 1.99E-04 0.01617992 DER_IFN_ALPHA_RESPONSE_UP autoimmune hepatitis DOID_2048 2.726E-04 8.617E-03 0.02409835 0.19588516 DER_IFN_ALPHA_RESPONSE_UP urinary tract obstruction DOID_5200 3.279E-04 9.821E-03 3.279E-04 0.02332443 DER_IFN_ALPHA_RESPONSE_UP ureteral disease DOID_1426 3.575E-04 0.01017043 3.575E-04 0.02260095 DER_IFN_ALPHA_RESPONSE_UP spastic quadriplegia DOID_10970 3.883E-04 0.01052063 0.02862373 0.21715868 DER_IFN_ALPHA_RESPONSE_UP ankylosing spondylitis DOID_7147 4.536E-04 0.01173231 4.536E-04 0.02581108 DER_IFN_ALPHA_RESPONSE_UP seminoma DOID_4440 4.882E-04 0.01207655 4.882E-04 0.02525096 DER_IFN_ALPHA_RESPONSE_UP thrombocytopenia DOID_1588 5.609E-04 0.01329892 5.609E-04 0.02659783 DER_IFN_ALPHA_RESPONSE_UP spastic cerebral palsy DOID_0050669 6.794E-04 0.01546221 0.03761304 0.23262848 DER_IFN_ALPHA_RESPONSE_UP celiac disease DOID_10608 7.213E-04 0.01578508 0.03873097 0.234446 DER_IFN_ALPHA_RESPONSE_UP germinoma DOID_3304 7.213E-04 0.01520045 7.213E-04 0.02931516 DER_IFN_ALPHA_RESPONSE_UP nephroblastoma DOID_2154 8.544E-04 0.01736254 8.544E-04 0.03241007 DER_IFN_ALPHA_RESPONSE_UP blood platelet disease DOID_2218 1.049E-03 0.0205794 1.049E-03 0.03510604 DER_IFN_ALPHA_RESPONSE_UP respiratory syncytial virus infectious disease DOID_1273 1.1E-03 0.02087271 0.04762886 0.26311476 DER_IFN_ALPHA_RESPONSE_UP lymphatic system disease DOID_75 1.153E-03 0.02116913 1.153E-03 0.03645795 DER_IFN_ALPHA_RESPONSE_UP Huntington's disease DOID_12858 1.319E-03 0.0234535 1.319E-03 0.03950063 DER_IFN_ALPHA_RESPONSE_UP influenza DOID_8469 1.377E-03 0.02373609 0.05314911 0.28001706 DER_IFN_ALPHA_RESPONSE_UP cataract DOID_83 1.435E-03 0.02402192 1.435E-03 0.04083726 DER_IFN_ALPHA_RESPONSE_UP proteinuria DOID_576 1.495E-03 0.02431067 0.05534844 0.28892902 DER_IFN_ALPHA_RESPONSE_UP lens disease DOID_110 1.557E-03 0.02460206 1.557E-03 0.04025792 DER_IFN_ALPHA_RESPONSE_UP glaucoma DOID_1686 1.682E-03 0.02587261 1.682E-03 0.03988694 DER_IFN_ALPHA_RESPONSE_UP hemorrhagic disease DOID_2213 1.813E-03 0.02714657 1.813E-03 0.03967576 DER_IFN_ALPHA_RESPONSE_UP B-cell lymphocytic neoplasm DOID_707 1.813E-03 0.02645051 1.813E-03 0.03820629 DER_IFN_ALPHA_RESPONSE_UP integumentary system cancer DOID_0060122 2.088E-03 0.02970252 0.06518382 0.32822647 DER_IFN_ALPHA_RESPONSE_UP parasitic protozoa infectious disease DOID_2789 2.088E-03 0.02897807 0.06518382 0.32534729 DER_IFN_ALPHA_RESPONSE_UP skin cancer DOID_4159 2.088E-03 0.02970252 0.06518382 0.32822647 DER_IFN_ALPHA_RESPONSE_UP hypersensitivity reaction type IV disease DOID_2916 2.307E-03 0.0312481 2.307E-03 0.04233613 DER_IFN_ALPHA_RESPONSE_UP hypothyroidism DOID_1459 2.614E-03 0.03458906 2.614E-03 0.0450706 DER_IFN_ALPHA_RESPONSE_UP parasitic infectious disease DOID_1398 2.856E-03 0.03693914 0.07599465 0.3633694 DER_IFN_ALPHA_RESPONSE_UP hyperglycemia DOID_4195 2.94E-03 0.03716909 0.07706899 0.36543548 DER_IFN_ALPHA_RESPONSE_UP allergic contact dermatitis DOID_3042 3.024E-03 0.037403 3.024E-03 0.05060405 DER_IFN_ALPHA_RESPONSE_UP blood coagulation disease DOID_1247 3.283E-03 0.03974814 3.283E-03 0.05337607 DER_IFN_ALPHA_RESPONSE_UP male reproductive system disease DOID_48 3.372E-03 0.03997177 3.372E-03 0.0532957 DER_IFN_ALPHA_RESPONSE_UP peripheral vascular disease DOID_341 3.462E-03 0.04019923 3.462E-03 0.05323682 DER_IFN_ALPHA_RESPONSE_UP cystic fibrosis DOID_1485 3.738E-03 0.04253816 0.08668328 0.40428513 DER_IFN_ALPHA_RESPONSE_UP electroclinical syndrome DOID_0050701 3.928E-03 0.04381998 3.928E-03 0.05881102 DER_IFN_ALPHA_RESPONSE_UP mixed glioma DOID_5076 3.928E-03 0.04297728 3.928E-03 0.05730305 DER_IFN_ALPHA_RESPONSE_UP bacterial pneumonia DOID_874 3.928E-03 0.04216639 0.08880646 0.40424699 DER_IFN_ALPHA_RESPONSE_UP contact dermatitis DOID_2773 4.122E-03 0.04343024 4.122E-03 0.05863083 DER_IFN_ALPHA_RESPONSE_UP transitional cell carcinoma DOID_2671 4.941E-03 0.05112174 4.941E-03 0.06694513 DER_IFN_ALPHA_RESPONSE_UP Crohn's disease DOID_8778 5.602E-03 0.05691543 0.10561912 0.46587038 DER_IFN_ALPHA_RESPONSE_UP hypersensitivity reaction type I disease DOID_1205 5.715E-03 0.05705224 0.10665979 0.46684168 DER_IFN_ALPHA_RESPONSE_UP dilated cardiomyopathy DOID_12930 5.715E-03 0.05606858 5.715E-03 0.07562738 DER_IFN_ALPHA_RESPONSE_UP visceral leishmaniasis DOID_9146 0.01154706 0.0995497 1.000 1.000 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN congenital heart defect DOID_1682 7.234E-08 4.116E-05 7.234E-08 4.116E-05 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN aneurysm disease DOID_2403 1.5E-07 4.268E-05 1.5E-07 4.268E-05 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN dilated cardiomyopathy DOID_12930 3.435E-07 6.514E-05 2.771E-05 5.255E-03 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN rectal neoplasm DOID_1984 1.58E-05 2.247E-03 6.051E-03 0.43037886 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN rectum cancer DOID_1993 1.58E-05 2.247E-03 6.051E-03 0.43037886 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN familial hypertrophic cardiomyopathy DOID_11986 4.762E-05 5.419E-03 4.762E-05 6.774E-03 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN heart septal defect DOID_1681 5.983E-05 5.674E-03 5.983E-05 6.808E-03 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN lung adenocarcinoma DOID_3910 1.415E-04 0.01150382 0.01745161 0.45136202 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN benign mesothelioma DOID_2645 3.279E-04 0.02332443 0.02636361 0.44120274 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN aortic aneurysm DOID_3627 4.761E-04 0.03010056 4.761E-04 0.04515085 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN hypothyroidism DOID_1459 7.155E-04 0.04071075 7.155E-04 0.05815822 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN diabetic retinopathy DOID_8947 9.764E-04 0.05050526 0.04511816 0.53483824 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN mixed glioma DOID_5076 1.081E-03 0.05125661 0.04743804 0.53984491 PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN retinal vascular disease DOID_2462 1.276E-03 0.05586862 0.05148486 0.54249786 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH coronary restenosis DOID_4247 3.212E-08 1.828E-05 3.212E-08 1.828E-05 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH coronary stenosis DOID_4248 9.789E-08 2.785E-05 9.789E-08 2.785E-05 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH focal glomerulosclerosis DOID_3945 1.084E-07 2.055E-05 4.249E-05 8.059E-03 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH aneurysm disease DOID_2403 1.89E-06 2.689E-04 2.792E-04 0.02269237 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH carotid stenosis DOID_13001 7.15E-06 8.137E-04 4.108E-03 0.23373062 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH larynx cancer DOID_2596 7.15E-06 6.781E-04 4.108E-03 0.21248238 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH laryngeal benign neoplasm DOID_2598 7.15E-06 6.781E-04 4.108E-03 0.21248238 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH pulmonary embolism DOID_9477 2.315E-05 1.882E-03 7.257E-03 0.17205173 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH periodontitis DOID_824 3.711E-05 2.64E-03 9.142E-03 0.17937614 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH abdominal aortic aneurysm DOID_7693 4.823E-05 3.049E-03 0.01039715 0.17927216 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH periodontal disease DOID_3388 6.079E-05 3.459E-03 0.01165066 0.17916825 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH calcinosis DOID_182 7.116E-05 3.681E-03 0.01258983 0.17472231 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH gallbladder cancer DOID_3121 9.85E-05 4.671E-03 0.01477806 0.17890881 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH brain cancer DOID_1319 1.116E-04 4.883E-03 1.116E-04 0.01587001 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH heart valve disease DOID_4079 1.116E-04 4.534E-03 1.116E-04 0.01269601 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH central nervous system cancer DOID_3620 1.161E-04 4.404E-03 1.161E-04 0.01100991 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH calcium metabolism disease DOID_10575 1.254E-04 4.461E-03 0.01665014 0.17875336 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH aortic aneurysm DOID_3627 1.254E-04 4.198E-03 0.01665014 0.17544311 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH bile duct adenocarcinoma DOID_4896 1.452E-04 4.589E-03 0.01789638 0.18514618 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH cholangiocarcinoma DOID_4947 1.452E-04 4.589E-03 0.01789638 0.18514618 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH parasitic protozoa infectious disease DOID_2789 1.503E-04 4.502E-03 0.01820771 0.1817577 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH bile duct cancer DOID_4606 1.663E-04 4.732E-03 0.01914117 0.18778151 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH bile duct carcinoma DOID_4897 1.663E-04 4.732E-03 0.01914117 0.18778151 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH carotid artery disease DOID_3407 1.832E-04 4.963E-03 0.02007382 0.19359327 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH mineral metabolism disease DOID_0050032 2.008E-04 5.192E-03 0.02100565 0.1992036 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH parasitic infectious disease DOID_1398 2.068E-04 5.116E-03 0.02131608 0.19562663 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH tooth disease DOID_1091 2.192E-04 5.196E-03 0.02193667 0.19812646 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH astrocytoma DOID_3069 2.319E-04 5.278E-03 0.0225569 0.19156534 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH pancreatic ductal carcinoma DOID_3587 2.384E-04 5.217E-03 0.02286688 0.191342 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH pancreatic carcinoma DOID_4905 2.584E-04 5.445E-03 0.02379628 0.1907054 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH diabetic retinopathy DOID_8947 2.584E-04 5.251E-03 0.02379628 0.18805672 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH biliary tract cancer DOID_4607 3.231E-04 6.34E-03 0.02657962 0.19899738 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH retinal vascular disease DOID_2462 3.385E-04 6.42E-03 0.02719715 0.20097631 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH nervous system cancer DOID_3093 3.784E-04 6.946E-03 3.784E-04 0.02691552 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH encephalomyelitis DOID_640 4.034E-04 7.174E-03 0.02966368 0.20837817 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH mouth disease DOID_403 4.119E-04 7.103E-03 0.02997159 0.20546788 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH cutaneous leishmaniasis DOID_9111 3.161E-03 0.05290325 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH intracranial arteriosclerosis DOID_13097 3.792E-03 0.06165218 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH aortic valve insufficiency DOID_57 3.792E-03 0.05993962 3.792E-03 0.23975848 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH vascular dementia DOID_8725 3.792E-03 0.06165218 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH ocular hypertension DOID_9282 3.792E-03 0.05831963 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH borderline glaucoma DOID_9283 3.792E-03 0.05831963 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH congenital structural myopathy DOID_422 4.423E-03 0.06622984 4.423E-03 0.20972783 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH skeletal system cancer DOID_0060124 4.738E-03 0.06913101 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH thoracic aortic aneurysm DOID_14004 4.738E-03 0.06740274 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH bone cancer DOID_184 4.738E-03 0.06913101 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH membranoproliferative glomerulonephritis DOID_2920 4.738E-03 0.06575877 4.738E-03 0.20739304 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH arthropathy DOID_381 4.738E-03 0.06419308 4.738E-03 0.19257925 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH oral submucous fibrosis DOID_5773 4.738E-03 0.06270022 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH restrictive cardiomyopathy DOID_397 5.053E-03 0.06535075 5.053E-03 0.19169554 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH Barrett's esophagus DOID_9206 5.053E-03 0.06389851 5.053E-03 0.17971457 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH ureteral obstruction DOID_5199 5.684E-03 0.0703027 5.684E-03 0.19023083 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH prion disease DOID_649 5.684E-03 0.0688069 5.684E-03 0.17966245 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH leishmaniasis DOID_9065 5.998E-03 0.07110608 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH subependymal glioma DOID_4843 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH pilocytic astrocytoma DOID_4851 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH subependymal giant cell astrocytoma DOID_5077 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH fibrillary astrocytoma DOID_6726 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH juvenile pilocytic astrocytoma DOID_6811 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH childhood pilocytic astrocytoma DOID_6812 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH gemistocytic astrocytoma DOID_7005 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH childhood cerebral astrocytoma DOID_7007 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH protoplasmic astrocytoma DOID_7008 6.313E-03 0.07331035 6.313E-03 0.18906353 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH benign glioma DOID_0060101 6.942E-03 0.07900564 6.942E-03 0.1975141 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH hepatitis B DOID_2043 6.942E-03 0.07745651 6.942E-03 0.18810867 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH benign ependymoma DOID_4844 6.942E-03 0.07900564 6.942E-03 0.1975141 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH uremia DOID_4676 7.257E-03 0.07940849 7.257E-03 0.1876928 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH urinary tract obstruction DOID_5200 7.257E-03 0.07791022 7.257E-03 0.17953224 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH ureteral disease DOID_1426 7.571E-03 0.07978054 7.571E-03 0.17232596 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH aortic valve disease DOID_62 7.571E-03 0.07832998 7.571E-03 0.16569804 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH Goodpasture syndrome DOID_9808 7.571E-03 0.07693123 7.571E-03 0.15956108 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH myositis DOID_633 8.514E-03 0.08499228 8.514E-03 0.17302 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH intracranial aneurysm DOID_10941 8.828E-03 0.08660793 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH renal hypertension DOID_1073 9.456E-03 0.09119498 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH secondary hypertension DOID_11130 9.456E-03 0.09119498 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH malaria DOID_12365 9.456E-03 0.08967507 9.456E-03 0.17935013 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH supratentorial cancer DOID_1659 9.77E-03 0.09113194 9.77E-03 0.17932414 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH cerebrum cancer DOID_368 9.77E-03 0.09113194 9.77E-03 0.17932414 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH female reproductive organ benign neoplasm DOID_0060086 0.01008355 0.09254098 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH uterine benign neoplasm DOID_0060095 0.01008355 0.09254098 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH uterine fibroid DOID_13223 0.01008355 0.09254098 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH endometrial carcinoma DOID_2871 0.01008355 0.09107207 0.01008355 0.17929815 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH celiac disease DOID_10608 0.01071067 0.09522453 0.01071067 0.17924617 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH endometrial cancer DOID_1380 0.01071067 0.09375954 0.01071067 0.17412485 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH allergic rhinitis DOID_4481 0.01071067 0.09233894 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH leiomyoma DOID_127 0.01102409 0.09362249 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH myocarditis DOID_820 0.01133742 0.09486753 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH hepatitis C DOID_1883 0.01165066 0.09607573 0.01165066 0.18414515 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH thyroid carcinoma DOID_3963 0.01165066 0.09470322 0.01165066 0.1744533 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH esophageal disease DOID_6050 0.01165066 0.09336937 0.01165066 0.16998014 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH thyroid cancer DOID_1781 0.01227687 0.09702134 0.01227687 0.17463842 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH embryonal cancer DOID_688 0.01258983 0.09813171 0.01258983 0.17056226 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH multiple myeloma DOID_9538 0.01258983 0.09680561 0.01258983 0.16659569 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH hepatitis DOID_2237 0.01321549 0.09894231 0.01321549 0.17090036 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH intracranial arterial disease DOID_13089 0.01352819 0.09996804 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH cerebral arterial disease DOID_3527 0.01352819 0.09996804 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH cervix uteri carcinoma in situ DOID_8991 0.01384079 0.09968874 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH pulmonary emphysema DOID_9675 0.01384079 0.09844263 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH autoimmune disease of urogenital tract DOID_0060049 0.0141533 0.09942259 0.0141533 0.17507021 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH primary biliary cirrhosis DOID_12236 0.0141533 0.09942259 0.0141533 0.17507021 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH endometriosis of uterus DOID_288 0.0141533 0.09821012 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH endometriosis DOID_289 0.01446573 0.09916865 1.000 1.000 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH uterine cancer DOID_363 0.01477806 0.09892605 0.01477806 0.17518154 MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH thyroid adenoma DOID_2891 0.0157145 0.09935059 0.0157145 0.17532457 ZHAN_MULTIPLE_MYELOMA_PR_UP oral cavity cancer DOID_8618 1.425E-06 8.106E-04 0.02229614 0.66771068 ZHAN_MULTIPLE_MYELOMA_PR_UP lymphoma DOID_0060058 5.268E-06 1.499E-03 0.0341647 0.92570064 ZHAN_MULTIPLE_MYELOMA_PR_UP urinary system benign neoplasm DOID_731 1.717E-05 3.256E-03 6.261E-03 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP colon carcinoma DOID_1520 2.397E-05 3.41E-03 7.362E-03 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP cleft lip DOID_9296 4.421E-05 5.032E-03 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP diffuse large B-cell lymphoma DOID_0050745 5.112E-05 4.848E-03 0.01065803 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP cleft palate DOID_674 9.799E-05 7.965E-03 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP microcephaly DOID_10907 1.03E-04 7.325E-03 0.01503731 0.85562294 ZHAN_MULTIPLE_MYELOMA_PR_UP adenoid cystic carcinoma DOID_4866 1.134E-04 7.167E-03 0.01576544 0.81550314 ZHAN_MULTIPLE_MYELOMA_PR_UP salivary gland cancer DOID_8850 1.242E-04 7.069E-03 0.01649307 0.78204626 ZHAN_MULTIPLE_MYELOMA_PR_UP gallbladder cancer DOID_3121 1.356E-04 7.014E-03 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP uterine cancer DOID_363 1.356E-04 6.43E-03 0.0172202 0.75371473 ZHAN_MULTIPLE_MYELOMA_PR_UP thyroid adenoma DOID_2891 1.536E-04 6.721E-03 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP B-cell lymphocytic neoplasm DOID_707 1.792E-04 7.285E-03 0.01976122 0.70275833 ZHAN_MULTIPLE_MYELOMA_PR_UP orofacial cleft DOID_0050567 1.86E-04 7.054E-03 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP congenital nervous system abnormality DOID_2490 2.214E-04 7.874E-03 0.02193438 0.69337014 ZHAN_MULTIPLE_MYELOMA_PR_UP pre-malignant neoplasm DOID_0060071 2.68E-04 8.97E-03 0.02410307 0.68573229 ZHAN_MULTIPLE_MYELOMA_PR_UP in situ carcinoma DOID_8719 2.68E-04 8.97E-03 0.02410307 0.68573229 ZHAN_MULTIPLE_MYELOMA_PR_UP endocrine organ benign neoplasm DOID_0060089 3.101E-04 9.804E-03 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP biliary tract cancer DOID_4607 4.442E-04 0.01330373 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP transitional cell carcinoma DOID_2671 4.978E-04 0.01416359 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP rectal neoplasm DOID_1984 3.687E-03 0.09990464 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_PR_UP rectum cancer DOID_1993 3.687E-03 0.09990464 1.000 1.000 MASSARWEH_RESPONSE_TO_ESTRADIOL adenoid cystic carcinoma DOID_4866 6.588E-06 3.749E-03 6.588E-06 3.749E-03 MASSARWEH_RESPONSE_TO_ESTRADIOL salivary gland cancer DOID_8850 7.566E-06 2.153E-03 7.566E-06 2.153E-03 MASSARWEH_RESPONSE_TO_ESTRADIOL oral cavity cancer DOID_8618 1.902E-05 3.607E-03 1.902E-05 3.607E-03 MASSARWEH_RESPONSE_TO_ESTRADIOL pancreatic ductal carcinoma DOID_3587 3.264E-05 4.642E-03 3.264E-05 4.642E-03 MASSARWEH_RESPONSE_TO_ESTRADIOL pancreatic carcinoma DOID_4905 3.683E-05 4.191E-03 3.683E-05 4.191E-03 MASSARWEH_RESPONSE_TO_ESTRADIOL alcohol-related neurodevelopmental disorder DOID_0050667 7.399E-05 7.017E-03 7.399E-05 7.017E-03 MASSARWEH_RESPONSE_TO_ESTRADIOL Lewy body dementia DOID_12217 1.883E-04 0.01530652 1.883E-04 0.01530652 MASSARWEH_RESPONSE_TO_ESTRADIOL Sciatic Neuropathy DOID_11446 2.763E-04 0.01964973 2.763E-04 0.01964973 MASSARWEH_RESPONSE_TO_ESTRADIOL lesion of sciatic nerve DOID_12528 2.763E-04 0.01964973 2.763E-04 0.01964973 MASSARWEH_RESPONSE_TO_ESTRADIOL mononeuritis of lower limb DOID_9473 2.763E-04 0.01964973 2.763E-04 0.01964973 MASSARWEH_RESPONSE_TO_ESTRADIOL mononeuritis DOID_1802 2.958E-04 0.01870417 2.958E-04 0.01870417 MASSARWEH_RESPONSE_TO_ESTRADIOL mononeuropathy DOID_1188 3.161E-04 0.01798522 3.161E-04 0.01798522 MASSARWEH_RESPONSE_TO_ESTRADIOL multiple epiphyseal dysplasia DOID_12721 3.161E-04 0.0163502 3.161E-04 0.0163502 MASSARWEH_RESPONSE_TO_ESTRADIOL toxic encephalopathy DOID_3602 3.161E-04 0.01498769 3.161E-04 0.01498769 MASSARWEH_RESPONSE_TO_ESTRADIOL endometriosis DOID_289 6.98E-04 0.03055117 0.03812162 0.40168891 MASSARWEH_RESPONSE_TO_ESTRADIOL leukodystrophy DOID_10579 7.918E-04 0.03218281 7.918E-04 0.03465841 MASSARWEH_RESPONSE_TO_ESTRADIOL neuritis DOID_1803 8.244E-04 0.03127237 8.244E-04 0.03350611 MASSARWEH_RESPONSE_TO_ESTRADIOL integumentary system benign neoplasm DOID_0060121 8.914E-04 0.03170168 8.914E-04 0.03381512 MASSARWEH_RESPONSE_TO_ESTRADIOL skin benign neoplasm DOID_3165 8.914E-04 0.03170168 8.914E-04 0.03381512 MASSARWEH_RESPONSE_TO_ESTRADIOL reproductive organ benign neoplasm DOID_0050622 1.108E-03 0.03707754 0.0478325 0.45361153 MASSARWEH_RESPONSE_TO_ESTRADIOL osteochondrodysplasia DOID_2256 1.108E-03 0.03501767 1.108E-03 0.03939488 MASSARWEH_RESPONSE_TO_ESTRADIOL cerebral degeneration DOID_1443 1.519E-03 0.04547803 1.519E-03 0.05082839 MASSARWEH_RESPONSE_TO_ESTRADIOL mixed glioma DOID_5076 2.093E-03 0.05955491 2.093E-03 0.06617212 MASSARWEH_RESPONSE_TO_ESTRADIOL female reproductive system disease DOID_229 2.251E-03 0.06098431 0.0677594 0.49429617 MASSARWEH_RESPONSE_TO_ESTRADIOL auditory system disease DOID_2742 2.304E-03 0.05960077 2.304E-03 0.06901142 MASSARWEH_RESPONSE_TO_ESTRADIOL bone development disease DOID_0080006 2.414E-03 0.05971042 2.414E-03 0.06866698 MASSARWEH_RESPONSE_TO_ESTRADIOL ulcerative colitis DOID_8577 3.245E-03 0.0769289 3.245E-03 0.08791874 ONDER_CDH1_TARGETS_3_DN cystic fibrosis DOID_1485 4.846E-13 2.757E-10 4.372E-05 0.01243853 ONDER_CDH1_TARGETS_3_DN bacterial pneumonia DOID_874 7.718E-11 2.196E-08 4.716E-05 8.945E-03 ONDER_CDH1_TARGETS_3_DN influenza DOID_8469 5.438E-10 1.031E-07 7.75E-04 0.04409984 ONDER_CDH1_TARGETS_3_DN cystitis DOID_1679 8.228E-09 1.17E-06 1.000 1.000 ONDER_CDH1_TARGETS_3_DN pleurisy DOID_10247 1.283E-08 1.46E-06 3.148E-04 0.02558713 ONDER_CDH1_TARGETS_3_DN pleural disease DOID_1532 2.443E-08 2.317E-06 4.294E-04 0.03054041 ONDER_CDH1_TARGETS_3_DN bladder disease DOID_365 2.443E-08 1.986E-06 1.000 1.000 ONDER_CDH1_TARGETS_3_DN peptic ulcer DOID_750 5.2E-08 3.698E-06 1.000 1.000 ONDER_CDH1_TARGETS_3_DN rheumatic disease DOID_1575 7.563E-08 4.781E-06 1.000 1.000 ONDER_CDH1_TARGETS_3_DN scleroderma DOID_419 7.563E-08 4.781E-06 1.000 1.000 ONDER_CDH1_TARGETS_3_DN giant cell tumor DOID_200 1.692E-07 9.626E-06 0.0476307 0.3927807 ONDER_CDH1_TARGETS_3_DN malignant giant cell tumor DOID_2705 1.692E-07 9.626E-06 0.0476307 0.3927807 ONDER_CDH1_TARGETS_3_DN giant cell glioblastoma DOID_3074 1.692E-07 9.626E-06 0.0476307 0.3927807 ONDER_CDH1_TARGETS_3_DN glioblastoma DOID_3068 2.396E-07 1.24E-05 0.05177482 0.40355986 ONDER_CDH1_TARGETS_3_DN collagen disease DOID_854 2.912E-07 1.381E-05 1.000 1.000 ONDER_CDH1_TARGETS_3_DN astrocytoma DOID_3069 4.692E-07 2.054E-05 0.06083041 0.42731485 ONDER_CDH1_TARGETS_3_DN leishmaniasis DOID_9065 5.767E-07 2.344E-05 1.000 1.000 ONDER_CDH1_TARGETS_3_DN neutropenia DOID_1227 9.149E-07 3.471E-05 1.000 1.000 ONDER_CDH1_TARGETS_3_DN chronic kidney failure DOID_784 9.162E-07 3.258E-05 0.07142438 0.4671319 ONDER_CDH1_TARGETS_3_DN agranulocytosis DOID_12987 1.052E-06 3.52E-05 1.000 1.000 ONDER_CDH1_TARGETS_3_DN mouth disease DOID_403 1.493E-06 4.72E-05 0.08029793 0.49662523 ONDER_CDH1_TARGETS_3_DN portal hypertension DOID_10762 1.541E-06 4.615E-05 1.000 1.000 ONDER_CDH1_TARGETS_3_DN ulcerative colitis DOID_8577 1.758E-06 5.002E-05 0.08350424 0.50546715 ONDER_CDH1_TARGETS_3_DN hepatic vascular disease DOID_272 2.401E-06 6.505E-05 1.000 1.000 ONDER_CDH1_TARGETS_3_DN spindle cell carcinoma DOID_4015 4.575E-06 1.183E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN leukopenia DOID_615 4.575E-06 1.132E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN multiple myeloma DOID_9538 5.807E-06 1.377E-04 0.03425117 0.36090586 ONDER_CDH1_TARGETS_3_DN hepatitis DOID_2237 6.74E-06 1.534E-04 6.74E-06 3.835E-03 ONDER_CDH1_TARGETS_3_DN systemic scleroderma DOID_418 6.74E-06 1.475E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN intracranial arterial disease DOID_13089 7.241E-06 1.526E-04 0.03677364 0.37364644 ONDER_CDH1_TARGETS_3_DN cerebral arterial disease DOID_3527 7.241E-06 1.526E-04 0.03677364 0.37364644 ONDER_CDH1_TARGETS_3_DN pulmonary emphysema DOID_9675 7.766E-06 1.578E-04 6.794E-04 0.04295057 ONDER_CDH1_TARGETS_3_DN gallbladder cancer DOID_3121 9.492E-06 1.862E-04 0.04012699 0.38053765 ONDER_CDH1_TARGETS_3_DN myeloma DOID_0070004 1.145E-05 2.172E-04 0.04263458 0.38506466 ONDER_CDH1_TARGETS_3_DN integumentary system benign neoplasm DOID_0060121 1.29E-05 2.367E-04 0.04430277 0.38194356 ONDER_CDH1_TARGETS_3_DN skin benign neoplasm DOID_3165 1.29E-05 2.367E-04 0.04430277 0.38194356 ONDER_CDH1_TARGETS_3_DN calcium metabolism disease DOID_10575 1.366E-05 2.43E-04 9.848E-04 0.05093898 ONDER_CDH1_TARGETS_3_DN bone marrow cancer DOID_4960 1.703E-05 2.936E-04 0.04846093 0.39391809 ONDER_CDH1_TARGETS_3_DN integumentary system cancer DOID_0060122 1.794E-05 3.003E-04 0.04929045 0.39501783 ONDER_CDH1_TARGETS_3_DN parasitic protozoa infectious disease DOID_2789 1.794E-05 2.917E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN skin cancer DOID_4159 1.794E-05 3.003E-04 0.04929045 0.39501783 ONDER_CDH1_TARGETS_3_DN melancholia DOID_2848 2.194E-05 3.468E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN leukocyte disease DOID_9500 2.194E-05 3.374E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN neurotic disorder DOID_4964 2.303E-05 3.448E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN respiratory failure DOID_11162 2.53E-05 3.691E-04 0.05507751 0.41235664 ONDER_CDH1_TARGETS_3_DN mineral metabolism disease DOID_0050032 2.771E-05 3.942E-04 1.568E-03 0.07435238 ONDER_CDH1_TARGETS_3_DN cholestasis DOID_13580 2.897E-05 4.021E-04 1.615E-03 0.07067433 ONDER_CDH1_TARGETS_3_DN parasitic infectious disease DOID_1398 2.897E-05 3.925E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN cutaneous leishmaniasis DOID_9111 3.292E-05 4.356E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN bile duct disease DOID_4138 3.734E-05 4.829E-04 1.908E-03 0.07755891 ONDER_CDH1_TARGETS_3_DN male reproductive system disease DOID_48 3.734E-05 4.722E-04 0.06246785 0.43346591 ONDER_CDH1_TARGETS_3_DN biliary tract disease DOID_9741 3.888E-05 4.809E-04 1.96E-03 0.07433115 ONDER_CDH1_TARGETS_3_DN endogenous depression DOID_1595 4.372E-05 5.293E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN pancreatitis DOID_4989 4.716E-05 5.591E-04 2.225E-03 0.07913825 ONDER_CDH1_TARGETS_3_DN stomach disease DOID_76 4.823E-05 5.601E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN mental depression DOID_1596 5.653E-05 6.433E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN biliary tract cancer DOID_4607 5.653E-05 6.307E-04 0.07142438 0.47256366 ONDER_CDH1_TARGETS_3_DN primary bacterial infectious disease DOID_0050338 6.484E-05 7.095E-04 2.744E-03 0.09185234 ONDER_CDH1_TARGETS_3_DN Legionnaires' disease DOID_10457 6.643E-05 7.132E-04 6.643E-05 9.449E-03 ONDER_CDH1_TARGETS_3_DN legionellosis DOID_10458 6.643E-05 7.132E-04 6.643E-05 9.449E-03 ONDER_CDH1_TARGETS_3_DN viral pneumonia DOID_10533 6.643E-05 6.999E-04 6.643E-05 7.559E-03 ONDER_CDH1_TARGETS_3_DN transitional cell carcinoma DOID_2671 6.704E-05 6.935E-04 0.07546806 0.48248679 ONDER_CDH1_TARGETS_3_DN lymphoma DOID_0060058 7.631E-05 7.753E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN hypersensitivity reaction type I disease DOID_1205 8.378E-05 8.364E-04 3.249E-03 0.09729032 ONDER_CDH1_TARGETS_3_DN Barrett's esophagus DOID_9206 8.75E-05 8.584E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN lymphatic system cancer DOID_0060073 9.911E-05 9.559E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN urinary system benign neoplasm DOID_731 9.911E-05 9.399E-04 0.0146983 0.26978486 ONDER_CDH1_TARGETS_3_DN reticulosarcoma DOID_8538 9.911E-05 9.559E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN lymphosarcoma DOID_8675 9.911E-05 9.559E-04 1.000 1.000 ONDER_CDH1_TARGETS_3_DN amnestic disorder DOID_10914 1.382E-04 1.289E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN pulmonary edema DOID_11396 1.382E-04 1.269E-03 0.01727027 0.28902311 ONDER_CDH1_TARGETS_3_DN esophagitis DOID_11963 1.382E-04 1.249E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN muscle cancer DOID_4045 1.838E-04 1.634E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN acute pancreatitis DOID_2913 2.177E-04 1.906E-03 2.177E-04 0.02064349 ONDER_CDH1_TARGETS_3_DN bronchiolitis DOID_2942 2.357E-04 2.032E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN middle cerebral artery infarction DOID_3525 2.738E-04 2.326E-03 0.02409709 0.32645824 ONDER_CDH1_TARGETS_3_DN periodontitis DOID_824 2.94E-04 2.46E-03 0.02494721 0.32261272 ONDER_CDH1_TARGETS_3_DN sarcoma DOID_1115 3.148E-04 2.596E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN thrombocytopenia DOID_1588 3.148E-04 2.559E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN myocarditis DOID_820 4.544E-04 3.642E-03 0.03087792 0.37381987 ONDER_CDH1_TARGETS_3_DN periodontal disease DOID_3388 4.801E-04 3.794E-03 0.0317223 0.36836711 ONDER_CDH1_TARGETS_3_DN esophageal disease DOID_6050 4.801E-04 3.742E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN aplastic anemia DOID_12449 5.065E-04 3.895E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN calcinosis DOID_182 5.614E-04 4.259E-03 0.03425117 0.37478686 ONDER_CDH1_TARGETS_3_DN blood platelet disease DOID_2218 5.898E-04 4.416E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN adult respiratory distress syndrome DOID_11394 6.488E-04 4.795E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN cervix uteri carcinoma in situ DOID_8991 6.794E-04 4.956E-03 0.03761304 0.3689969 ONDER_CDH1_TARGETS_3_DN uterine cancer DOID_363 7.75E-04 5.582E-03 0.04012699 0.37429933 ONDER_CDH1_TARGETS_3_DN cerebral infarction DOID_3526 8.083E-04 5.749E-03 0.04096356 0.37593978 ONDER_CDH1_TARGETS_3_DN heart valve disease DOID_4079 8.769E-04 6.16E-03 0.04263458 0.37904803 ONDER_CDH1_TARGETS_3_DN bone marrow disease DOID_4961 8.769E-04 6.084E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN pulmonary tuberculosis DOID_2957 9.481E-04 6.5E-03 0.04430277 0.37624291 ONDER_CDH1_TARGETS_3_DN hemorrhagic disease DOID_2213 1.022E-03 6.923E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN B-cell lymphocytic neoplasm DOID_707 1.022E-03 6.842E-03 1.000 1.000 ONDER_CDH1_TARGETS_3_DN oral cavity cancer DOID_8618 1.302E-03 8.615E-03 0.05177482 0.39810635 ONDER_CDH1_TARGETS_3_DN pre-malignant neoplasm DOID_0060071 1.522E-03 9.955E-03 0.05590144 0.41308987 ONDER_CDH1_TARGETS_3_DN in situ carcinoma DOID_8719 1.522E-03 9.955E-03 0.05590144 0.41308987 ONDER_CDH1_TARGETS_3_DN hyperglycemia DOID_4195 1.662E-03 0.01074634 1.000 1.000 ONDER_CDH1_TARGETS_3_DN tooth disease DOID_1091 1.71E-03 0.01093217 0.0591902 0.43178491 ONDER_CDH1_TARGETS_3_DN brain infarction DOID_3454 1.759E-03 0.01111801 0.06001065 0.43222861 ONDER_CDH1_TARGETS_3_DN tuberculosis DOID_399 1.759E-03 0.01099583 0.06001065 0.42682576 ONDER_CDH1_TARGETS_3_DN blood coagulation disease DOID_1247 1.858E-03 0.0114897 1.000 1.000 ONDER_CDH1_TARGETS_3_DN nephrosis DOID_2527 1.908E-03 0.01167553 1.000 1.000 ONDER_CDH1_TARGETS_3_DN diabetic retinopathy DOID_8947 2.011E-03 0.01217531 1.000 1.000 ONDER_CDH1_TARGETS_3_DN retinal vascular disease DOID_2462 2.624E-03 0.01571926 1.000 1.000 ONDER_CDH1_TARGETS_3_DN lymphoblastic leukemia DOID_1037 3.119E-03 0.01848553 0.07949465 0.49705997 ONDER_CDH1_TARGETS_3_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.183E-03 0.01867407 3.183E-03 0.10063251 ONDER_CDH1_TARGETS_3_DN dilated cardiomyopathy DOID_12930 3.249E-03 0.01886241 0.08110052 0.49619568 ONDER_CDH1_TARGETS_3_DN arrhythmogenic right ventricular dysplasia DOID_0050431 7.808E-03 0.04487477 7.808E-03 0.22213012 ONDER_CDH1_TARGETS_3_DN leber hereditary optic neuropathy DOID_705 7.808E-03 0.04442602 1.000 1.000 ONDER_CDH1_TARGETS_3_DN brachydactyly DOID_0050581 8.672E-03 0.04885291 8.672E-03 0.23495921 ONDER_CDH1_TARGETS_3_DN hyperparathyroidism DOID_13543 8.672E-03 0.04837396 1.000 1.000 ONDER_CDH1_TARGETS_3_DN hypolipoproteinemia DOID_1387 8.672E-03 0.04790431 1.000 1.000 ONDER_CDH1_TARGETS_3_DN childhood type dermatomyositis DOID_14203 8.672E-03 0.04744369 1.000 1.000 ONDER_CDH1_TARGETS_3_DN retinal vascular occlusion DOID_1729 8.672E-03 0.04699184 1.000 1.000 ONDER_CDH1_TARGETS_3_DN bilirubin metabolic disorder DOID_2741 8.672E-03 0.04654852 1.000 1.000 ONDER_CDH1_TARGETS_3_DN acute kidney failure DOID_3021 8.672E-03 0.04611349 1.000 1.000 ONDER_CDH1_TARGETS_3_DN insulinoma DOID_3892 8.672E-03 0.04568651 8.672E-03 0.22427925 ONDER_CDH1_TARGETS_3_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 8.672E-03 0.04526737 1.000 1.000 ONDER_CDH1_TARGETS_3_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 8.672E-03 0.04526737 1.000 1.000 ONDER_CDH1_TARGETS_3_DN Hodgkin's granuloma DOID_8651 8.672E-03 0.04526737 1.000 1.000 ONDER_CDH1_TARGETS_3_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 8.672E-03 0.04526737 1.000 1.000 ONDER_CDH1_TARGETS_3_DN visceral leishmaniasis DOID_9146 8.672E-03 0.04485585 1.000 1.000 ONDER_CDH1_TARGETS_3_DN familial adenomatous polyposis DOID_0050424 9.535E-03 0.0488763 1.000 1.000 ONDER_CDH1_TARGETS_3_DN dermatomyositis DOID_10223 9.535E-03 0.04843991 1.000 1.000 ONDER_CDH1_TARGETS_3_DN pneumocystosis DOID_11339 9.535E-03 0.04801124 1.000 1.000 ONDER_CDH1_TARGETS_3_DN bronchiectasis DOID_9563 9.535E-03 0.04759008 1.000 1.000 ONDER_CDH1_TARGETS_3_DN common cold DOID_10459 0.01039715 0.05144331 0.01039715 0.25721657 ONDER_CDH1_TARGETS_3_DN beta thalassemia DOID_12241 0.01039715 0.05099984 0.01039715 0.24649922 ONDER_CDH1_TARGETS_3_DN intracranial arteriosclerosis DOID_13097 0.01039715 0.05056394 1.000 1.000 ONDER_CDH1_TARGETS_3_DN diarrhea DOID_13250 0.01039715 0.05013543 1.000 1.000 ONDER_CDH1_TARGETS_3_DN islet cell tumor DOID_1799 0.01039715 0.04971413 0.01039715 0.23663925 ONDER_CDH1_TARGETS_3_DN Hodgkin's lymphoma DOID_8567 0.01039715 0.04929984 1.000 1.000 ONDER_CDH1_TARGETS_3_DN vascular dementia DOID_8725 0.01039715 0.05056394 1.000 1.000 ONDER_CDH1_TARGETS_3_DN mitochondrial encephalomyopathy DOID_890 0.01039715 0.04889241 1.000 1.000 ONDER_CDH1_TARGETS_3_DN encephalitis DOID_9588 0.01039715 0.04849165 1.000 1.000 ONDER_CDH1_TARGETS_3_DN parathyroid gland disease DOID_11201 0.01125884 0.05208356 1.000 1.000 ONDER_CDH1_TARGETS_3_DN larynx cancer DOID_2596 0.01125884 0.05166354 1.000 1.000 ONDER_CDH1_TARGETS_3_DN laryngeal benign neoplasm DOID_2598 0.01125884 0.05166354 1.000 1.000 ONDER_CDH1_TARGETS_3_DN epilepsy with generalized tonic-clonic seizures DOID_7725 0.01125884 0.05125023 0.01125884 0.24639532 ONDER_CDH1_TARGETS_3_DN open-angle glaucoma DOID_1067 0.01211979 0.05473144 1.000 1.000 ONDER_CDH1_TARGETS_3_DN hypercalcemia DOID_12678 0.01211979 0.05430048 0.01211979 0.25541339 ONDER_CDH1_TARGETS_3_DN eyelid disease DOID_530 0.01211979 0.05387626 1.000 1.000 ONDER_CDH1_TARGETS_3_DN polycystic kidney disease DOID_898 0.01211979 0.05345862 1.000 1.000 ONDER_CDH1_TARGETS_3_DN bacterial meningitis DOID_9470 0.01211979 0.0530474 0.01211979 0.24629148 ONDER_CDH1_TARGETS_3_DN idiopathic pulmonary fibrosis DOID_0050156 0.01298002 0.05637886 1.000 1.000 ONDER_CDH1_TARGETS_3_DN skeletal system cancer DOID_0060124 0.01298002 0.05595175 1.000 1.000 ONDER_CDH1_TARGETS_3_DN thalassemia DOID_10241 0.01298002 0.05553106 0.01298002 0.25467693 ONDER_CDH1_TARGETS_3_DN bone cancer DOID_184 0.01298002 0.05595175 1.000 1.000 ONDER_CDH1_TARGETS_3_DN membranoproliferative glomerulonephritis DOID_2920 0.01298002 0.05511665 1.000 1.000 ONDER_CDH1_TARGETS_3_DN mesenchymal cell neoplasm DOID_3350 0.01298002 0.05470838 1.000 1.000 ONDER_CDH1_TARGETS_3_DN arthropathy DOID_381 0.01298002 0.05430611 1.000 1.000 ONDER_CDH1_TARGETS_3_DN spindle cell sarcoma DOID_4235 0.01298002 0.05470838 1.000 1.000 ONDER_CDH1_TARGETS_3_DN oral submucous fibrosis DOID_5773 0.01298002 0.05390972 1.000 1.000 ONDER_CDH1_TARGETS_3_DN epithelioid sarcoma DOID_6193 0.01298002 0.05470838 1.000 1.000 ONDER_CDH1_TARGETS_3_DN varicose veins DOID_799 0.01298002 0.05351907 1.000 1.000 ONDER_CDH1_TARGETS_3_DN intermediate coronary syndrome DOID_8805 0.01298002 0.05313404 1.000 1.000 ONDER_CDH1_TARGETS_3_DN hyperhomocysteinemia DOID_9279 0.01298002 0.05275451 0.01298002 0.2461877 ONDER_CDH1_TARGETS_3_DN angiosarcoma DOID_0001816 0.01383952 0.05584885 1.000 1.000 ONDER_CDH1_TARGETS_3_DN spastic diplegia DOID_10965 0.01383952 0.05545554 1.000 1.000 ONDER_CDH1_TARGETS_3_DN tongue cancer DOID_8649 0.01383952 0.05506774 1.000 1.000 ONDER_CDH1_TARGETS_3_DN vein disease DOID_866 0.01383952 0.05468533 1.000 1.000 ONDER_CDH1_TARGETS_3_DN bronchitis DOID_6132 0.0146983 0.05767814 1.000 1.000 ONDER_CDH1_TARGETS_3_DN neuroendocrine tumor DOID_169 0.01555635 0.06062713 0.01555635 0.27661128 ONDER_CDH1_TARGETS_3_DN prion disease DOID_649 0.01555635 0.0602147 1.000 1.000 ONDER_CDH1_TARGETS_3_DN dissociative disorder DOID_10935 0.01641367 0.06310391 1.000 1.000 ONDER_CDH1_TARGETS_3_DN dissociative amnesia DOID_11037 0.01641367 0.06310391 1.000 1.000 ONDER_CDH1_TARGETS_3_DN Down syndrome DOID_14250 0.01641367 0.0626804 1.000 1.000 ONDER_CDH1_TARGETS_3_DN testicular cancer DOID_2998 0.01641367 0.06226253 0.01641367 0.2830115 ONDER_CDH1_TARGETS_3_DN granulosa cell tumor DOID_2999 0.01641367 0.06185019 1.000 1.000 ONDER_CDH1_TARGETS_3_DN sex cord-gonadal stromal tumor DOID_192 0.01727027 0.06464991 1.000 1.000 ONDER_CDH1_TARGETS_3_DN brain edema DOID_4724 0.01727027 0.06422736 0.01727027 0.28076531 ONDER_CDH1_TARGETS_3_DN Kawasaki disease DOID_13378 0.01812615 0.0669726 1.000 1.000 ONDER_CDH1_TARGETS_3_DN lymphadenitis DOID_1602 0.01812615 0.0669726 1.000 1.000 ONDER_CDH1_TARGETS_3_DN autoimmune hepatitis DOID_2048 0.01812615 0.06654052 0.01812615 0.2864939 ONDER_CDH1_TARGETS_3_DN mitochondrial myopathy DOID_699 0.01812615 0.06611398 1.000 1.000 ONDER_CDH1_TARGETS_3_DN lymph node disease DOID_9942 0.01812615 0.0669726 1.000 1.000 ONDER_CDH1_TARGETS_3_DN gastric ulcer DOID_10808 0.01898131 0.06879213 1.000 1.000 ONDER_CDH1_TARGETS_3_DN sinusitis DOID_0050127 0.01983574 0.07143377 1.000 1.000 ONDER_CDH1_TARGETS_3_DN paranasal sinus disease DOID_1352 0.01983574 0.07143377 1.000 1.000 ONDER_CDH1_TARGETS_3_DN optic nerve disease DOID_1891 0.01983574 0.0709845 1.000 1.000 ONDER_CDH1_TARGETS_3_DN opiate dependence DOID_2559 0.01983574 0.07054085 0.01983574 0.30504152 ONDER_CDH1_TARGETS_3_DN IgA glomerulonephritis DOID_2986 0.01983574 0.07010271 1.000 1.000 ONDER_CDH1_TARGETS_3_DN urinary tract obstruction DOID_5200 0.01983574 0.06966998 1.000 1.000 ONDER_CDH1_TARGETS_3_DN sleep disorder DOID_535 0.01983574 0.06924255 1.000 1.000 ONDER_CDH1_TARGETS_3_DN pulmonary embolism DOID_9477 0.01983574 0.06882034 1.000 1.000 ONDER_CDH1_TARGETS_3_DN polyarteritis nodosa DOID_9810 0.01983574 0.06840325 1.000 1.000 ONDER_CDH1_TARGETS_3_DN hypoglycemia DOID_9993 0.01983574 0.06799118 1.000 1.000 ONDER_CDH1_TARGETS_3_DN Lewy body dementia DOID_12217 0.02068945 0.0704928 1.000 1.000 ONDER_CDH1_TARGETS_3_DN meningitis DOID_9471 0.02068945 0.0700732 0.02068945 0.30979732 ONDER_CDH1_TARGETS_3_DN commensal bacterial infectious disease DOID_0050339 0.02239471 0.07539995 0.02239471 0.32673311 ONDER_CDH1_TARGETS_3_DN urticaria DOID_1555 0.02239471 0.07495642 1.000 1.000 ONDER_CDH1_TARGETS_3_DN hypogonadism DOID_1924 0.02239471 0.07451808 1.000 1.000 ONDER_CDH1_TARGETS_3_DN myositis DOID_633 0.02324626 0.07690188 1.000 1.000 ONDER_CDH1_TARGETS_3_DN ankylosing spondylitis DOID_7147 0.02324626 0.07645736 0.02324626 0.33067808 ONDER_CDH1_TARGETS_3_DN cleft lip DOID_9296 0.02324626 0.07601795 0.02324626 0.32261276 ONDER_CDH1_TARGETS_3_DN extrinsic allergic alveolitis DOID_841 0.02409709 0.07834998 1.000 1.000 ONDER_CDH1_TARGETS_3_DN lung adenocarcinoma DOID_3910 0.02494721 0.08065318 0.02494721 0.33011534 ONDER_CDH1_TARGETS_3_DN perinatal necrotizing enterocolitis DOID_8677 0.02494721 0.08019751 0.02494721 0.31544355 ONDER_CDH1_TARGETS_3_DN polycystic ovary syndrome DOID_11612 0.02664528 0.08517507 0.02664528 0.32959047 ONDER_CDH1_TARGETS_3_DN focal glomerulosclerosis DOID_3945 0.02664528 0.08469923 1.000 1.000 ONDER_CDH1_TARGETS_3_DN cranial nerve disease DOID_5656 0.02664528 0.08422868 1.000 1.000 ONDER_CDH1_TARGETS_3_DN spastic cerebral palsy DOID_0050669 0.02834048 0.08909244 1.000 1.000 ONDER_CDH1_TARGETS_3_DN gonadal disease DOID_2277 0.02834048 0.08860292 1.000 1.000 ONDER_CDH1_TARGETS_3_DN opportunistic mycosis DOID_2473 0.02834048 0.08811875 1.000 1.000 ONDER_CDH1_TARGETS_3_DN bronchiolitis obliterans DOID_2799 0.02834048 0.08763985 1.000 1.000 ONDER_CDH1_TARGETS_3_DN abdominal aortic aneurysm DOID_7693 0.02834048 0.08716612 1.000 1.000 ONDER_CDH1_TARGETS_3_DN allergic rhinitis DOID_4481 0.02918701 0.08928713 1.000 1.000 ONDER_CDH1_TARGETS_3_DN chronic leukemia DOID_1036 0.03003282 0.09138328 1.000 1.000 ONDER_CDH1_TARGETS_3_DN chronic lymphocytic leukemia DOID_1040 0.03003282 0.09138328 1.000 1.000 ONDER_CDH1_TARGETS_3_DN systemic mycosis DOID_0050136 0.03087792 0.09345497 1.000 1.000 ONDER_CDH1_TARGETS_3_DN fungal infectious disease DOID_1564 0.03087792 0.09345497 1.000 1.000 ONDER_CDH1_TARGETS_3_DN papilloma DOID_2615 0.03087792 0.0929605 1.000 1.000 ONDER_CDH1_TARGETS_3_DN pneumoconiosis DOID_10316 0.0317223 0.09499994 1.000 1.000 ONDER_CDH1_TARGETS_3_DN hepatitis C DOID_1883 0.0317223 0.09450256 0.0317223 0.37604142 ONDER_CDH1_TARGETS_3_DN nephroblastoma DOID_2154 0.0317223 0.09401035 1.000 1.000 ONDER_CDH1_TARGETS_3_DN thyroid carcinoma DOID_3963 0.0317223 0.09352325 1.000 1.000 ONDER_CDH1_TARGETS_3_DN thyroid cancer DOID_1781 0.03340893 0.09798804 1.000 1.000 ONDER_CDH1_TARGETS_3_DN adenoma DOID_657 0.03340893 0.09748553 0.03340893 0.38019358 ONDER_CDH1_TARGETS_3_DN adolescence-adult electroclinical syndrome DOID_0050705 0.03425117 0.09943325 0.03425117 0.38213562 ONDER_CDH1_TARGETS_3_DN cleft palate DOID_674 0.03425117 0.09892851 0.03425117 0.36771541 GRABARCZYK_BCL11B_TARGETS_UP cholestasis DOID_13580 6.672E-07 3.796E-04 4.451E-05 0.02532658 GRABARCZYK_BCL11B_TARGETS_UP bile duct disease DOID_4138 9.386E-07 2.67E-04 5.734E-05 0.01631188 GRABARCZYK_BCL11B_TARGETS_UP biliary tract disease DOID_9741 9.908E-07 1.879E-04 5.968E-05 0.01131986 GRABARCZYK_BCL11B_TARGETS_UP peripheral neuropathy DOID_0060053 1.019E-04 0.01449218 1.019E-04 0.01449218 GRABARCZYK_BCL11B_TARGETS_UP lung oat cell carcinoma DOID_5411 1.019E-04 0.01159374 0.01493292 0.25747966 GRABARCZYK_BCL11B_TARGETS_UP lymphoma DOID_0060058 1.169E-04 0.01108894 1.169E-04 0.01330672 GRABARCZYK_BCL11B_TARGETS_UP autoimmune disease of the nervous system DOID_438 4.181E-04 0.03398404 4.181E-04 0.03964804 GRABARCZYK_BCL11B_TARGETS_UP autonomic nervous system neoplasm DOID_2621 5.701E-04 0.04054506 5.701E-04 0.04633722 GRABARCZYK_BCL11B_TARGETS_UP neuroblastoma DOID_769 5.701E-04 0.04054506 5.701E-04 0.04633722 GRABARCZYK_BCL11B_TARGETS_UP medullomyoblastoma DOID_3861 6.722E-04 0.04250112 6.722E-04 0.04781376 GRABARCZYK_BCL11B_TARGETS_UP adult medulloblastoma DOID_3864 6.722E-04 0.04250112 6.722E-04 0.04781376 GRABARCZYK_BCL11B_TARGETS_UP childhood medulloblastoma DOID_3869 6.722E-04 0.04250112 6.722E-04 0.04781376 GRABARCZYK_BCL11B_TARGETS_UP medulloblastoma DOID_3858 7.449E-04 0.04238706 7.449E-04 0.04709673 GRABARCZYK_BCL11B_TARGETS_UP multiple myeloma DOID_9538 7.449E-04 0.03853369 0.03933994 0.35530836 GRABARCZYK_BCL11B_TARGETS_UP peripheral nervous system neoplasm DOID_1192 7.826E-04 0.03711051 7.826E-04 0.04453261 GRABARCZYK_BCL11B_TARGETS_UP lymphatic system disease DOID_75 8.608E-04 0.03767558 8.608E-04 0.04452568 GRABARCZYK_BCL11B_TARGETS_UP primitive neuroectodermal tumor DOID_168 9.847E-04 0.04002255 9.847E-04 0.04669298 GRABARCZYK_BCL11B_TARGETS_UP myeloma DOID_0070004 1.163E-03 0.04410016 0.04893699 0.40948747 GRABARCZYK_BCL11B_TARGETS_UP lung small cell carcinoma DOID_5409 1.257E-03 0.04469618 0.05084517 0.40181806 GRABARCZYK_BCL11B_TARGETS_UP bone marrow cancer DOID_4960 1.508E-03 0.05047309 0.05559931 0.40558987 GRABARCZYK_BCL11B_TARGETS_UP neuroectodermal tumor DOID_171 1.896E-03 0.0599481 1.896E-03 0.08300505 GRABARCZYK_BCL11B_TARGETS_UP syndrome DOID_225 2.8E-03 0.08385412 2.8E-03 0.11380202 GRABARCZYK_BCL11B_TARGETS_UP bone resorption disease DOID_0080011 2.871E-03 0.08167903 2.871E-03 0.10890538 GRABARCZYK_BCL11B_TARGETS_UP osteoporosis DOID_11476 2.871E-03 0.08167903 2.871E-03 0.10890538 GRABARCZYK_BCL11B_TARGETS_UP electroclinical syndrome DOID_0050701 2.943E-03 0.07973388 2.943E-03 0.10465072 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN thyroid adenoma DOID_2891 3.317E-08 1.887E-05 5.016E-04 0.0570799 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN breast benign neoplasm DOID_0060082 4.165E-08 1.185E-05 7.231E-03 0.27429259 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN thoracic benign neoplasm DOID_0060097 4.165E-08 1.185E-05 7.231E-03 0.27429259 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN benign breast phyllodes tumor DOID_1631 4.165E-08 1.185E-05 7.231E-03 0.27429259 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN endocrine organ benign neoplasm DOID_0060089 1.386E-07 2.63E-05 1.009E-03 0.06378492 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN mixed glioma DOID_5076 2.248E-07 3.198E-05 1.278E-03 0.06061251 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN endometrial carcinoma DOID_2871 1.241E-06 1.412E-04 1.000 1.000 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN endometrial cancer DOID_1380 1.495E-06 1.418E-04 1.000 1.000 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN thyroid carcinoma DOID_3963 1.939E-06 1.576E-04 2.741E-04 0.07799065 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN thyroid cancer DOID_1781 2.279E-06 1.621E-04 3.048E-04 0.05780218 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN adenoma DOID_657 2.279E-06 1.441E-04 3.048E-04 0.04335164 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN benign mesothelioma DOID_2645 3.295E-06 1.875E-04 0.02862373 0.32573801 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN uterine cancer DOID_363 4.029E-06 2.084E-04 1.000 1.000 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN heart valve disease DOID_4079 4.864E-06 2.306E-04 0.03246548 0.31849758 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN giant cell tumor DOID_200 6.861E-06 3.003E-04 6.29E-04 0.05113135 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN malignant giant cell tumor DOID_2705 6.861E-06 3.003E-04 6.29E-04 0.05113135 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN giant cell glioblastoma DOID_3074 6.861E-06 3.003E-04 6.29E-04 0.05113135 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN glioblastoma DOID_3068 8.889E-06 3.613E-04 7.46E-04 0.05305774 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN astrocytoma DOID_3069 1.466E-05 5.561E-04 1.037E-03 0.05902278 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN aortic valve insufficiency DOID_57 2.744E-05 9.759E-04 7.886E-03 0.24927804 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN transitional cell carcinoma DOID_2671 2.865E-05 9.59E-04 0.05770692 0.43204259 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN larynx cancer DOID_2596 3.242E-05 1.025E-03 1.000 1.000 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN laryngeal benign neoplasm DOID_2598 3.242E-05 1.025E-03 1.000 1.000 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN nutritional deficiency disease DOID_5113 4.361E-05 1.306E-03 4.361E-05 0.02481134 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN muscular atrophy DOID_767 9.566E-05 2.722E-03 0.01441161 0.28276582 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN aortic valve disease DOID_62 1.142E-04 3.094E-03 0.01571183 0.28838808 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN papillary adenoma DOID_3172 1.451E-04 3.752E-03 0.01765906 0.28708591 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN microcystic adenoma DOID_5403 1.451E-04 3.752E-03 0.01765906 0.28708591 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN follicular adenoma DOID_6204 1.451E-04 3.752E-03 0.01765906 0.28708591 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN focal glomerulosclerosis DOID_3945 1.919E-04 4.747E-03 0.02024962 0.28805089 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN papilloma DOID_2615 2.594E-04 6.15E-03 0.0234786 0.31068196 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN multiple myeloma DOID_9538 3.207E-04 7.298E-03 0.02605443 0.32228192 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN myeloma DOID_0070004 5.016E-04 0.0109769 0.03246548 0.33587017 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN hemolytic anemia DOID_583 5.218E-04 0.01099735 5.218E-04 0.04948808 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN normocytic anemia DOID_720 5.218E-04 0.01099735 5.218E-04 0.04948808 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN lung small cell carcinoma DOID_5409 5.425E-04 0.01102432 0.03374282 0.32541807 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN bile duct adenocarcinoma DOID_4896 6.516E-04 0.01278569 0.0369291 0.34446976 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN cholangiocarcinoma DOID_4947 6.516E-04 0.01278569 0.0369291 0.34446976 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN bone marrow cancer DOID_4960 6.516E-04 0.0123595 0.0369291 0.3389138 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN bile duct cancer DOID_4606 7.46E-04 0.01369232 0.03947085 0.34028656 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN bile duct carcinoma DOID_4897 7.46E-04 0.01369232 0.03947085 0.34028656 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN mineral metabolism disease DOID_0050032 8.991E-04 0.01598727 0.04327141 0.36207987 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN nephrosis DOID_2527 1.095E-03 0.01888508 1.095E-03 0.05665524 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN biliary tract cancer DOID_4607 1.441E-03 0.02411956 0.05458666 0.41413082 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN encephalomyelitis DOID_640 1.795E-03 0.02918646 0.06081729 0.44365432 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN chondrosarcoma DOID_3371 6.576E-03 0.0984615 6.576E-03 0.28781053 COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN Paget's disease of bone DOID_5408 6.576E-03 0.09593684 6.576E-03 0.26725264 MURAKAMI_UV_RESPONSE_1HR_UP integumentary system benign neoplasm DOID_0060121 4.247E-09 2.416E-06 1.095E-06 6.228E-04 MURAKAMI_UV_RESPONSE_1HR_UP skin benign neoplasm DOID_3165 4.247E-09 2.416E-06 1.095E-06 6.228E-04 MURAKAMI_UV_RESPONSE_1HR_UP integumentary system cancer DOID_0060122 6.646E-09 1.891E-06 1.526E-06 4.342E-04 MURAKAMI_UV_RESPONSE_1HR_UP skin cancer DOID_4159 6.646E-09 1.891E-06 1.526E-06 4.342E-04 MURAKAMI_UV_RESPONSE_1HR_UP teratoma DOID_3307 6.563E-06 1.245E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_1HR_UP malignant teratoma DOID_5563 6.563E-06 1.245E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_1HR_UP mature teratoma DOID_5566 6.563E-06 1.245E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_1HR_UP keratosis DOID_161 2.227E-05 3.169E-03 2.227E-05 4.225E-03 MURAKAMI_UV_RESPONSE_1HR_UP embryonal cancer DOID_688 1.13E-04 0.01285773 0.01571306 0.68774871 MURAKAMI_UV_RESPONSE_1HR_UP oral cavity cancer DOID_8618 2.638E-04 0.02501815 2.638E-04 0.03752723 MURAKAMI_UV_RESPONSE_1HR_UP transitional cell carcinoma DOID_2671 5.735E-04 0.04662106 5.735E-04 0.06526948 MURAKAMI_UV_RESPONSE_1HR_UP nervous system cancer DOID_3093 5.992E-04 0.04261754 0.03579565 0.92580562 CROMER_TUMORIGENESIS_UP aneurysm disease DOID_2403 4.787E-16 2.724E-13 0.09154793 0.89811678 CROMER_TUMORIGENESIS_UP heart valve disease DOID_4079 1.276E-15 3.63E-13 1.000 1.000 CROMER_TUMORIGENESIS_UP collagen disease DOID_854 1.039E-14 1.97E-12 2.768E-03 0.17499182 CROMER_TUMORIGENESIS_UP astrocytoma DOID_3069 3.332E-12 4.739E-10 1.000 1.000 CROMER_TUMORIGENESIS_UP varicose veins DOID_799 6.253E-12 7.116E-10 1.000 1.000 CROMER_TUMORIGENESIS_UP bacterial pneumonia DOID_874 7.133E-12 6.765E-10 4.285E-03 0.20320098 CROMER_TUMORIGENESIS_UP vein disease DOID_866 9.087E-12 7.386E-10 1.000 1.000 CROMER_TUMORIGENESIS_UP mouth disease DOID_403 2.638E-11 1.876E-09 1.000 1.000 CROMER_TUMORIGENESIS_UP giant cell tumor DOID_200 7.052E-11 4.458E-09 1.000 1.000 CROMER_TUMORIGENESIS_UP malignant giant cell tumor DOID_2705 7.052E-11 4.458E-09 1.000 1.000 CROMER_TUMORIGENESIS_UP giant cell glioblastoma DOID_3074 7.052E-11 4.458E-09 1.000 1.000 CROMER_TUMORIGENESIS_UP glioblastoma DOID_3068 1.201E-10 6.831E-09 1.000 1.000 CROMER_TUMORIGENESIS_UP intracranial aneurysm DOID_10941 2.022E-10 1.046E-08 0.03343531 0.65602394 CROMER_TUMORIGENESIS_UP tuberculosis DOID_399 3.069E-10 1.455E-08 1.000 1.000 CROMER_TUMORIGENESIS_UP focal glomerulosclerosis DOID_3945 3.487E-10 1.526E-08 0.03695213 0.6782504 CROMER_TUMORIGENESIS_UP nephrosis DOID_2527 3.959E-10 1.609E-08 3.68E-03 0.20938709 CROMER_TUMORIGENESIS_UP spastic cerebral palsy DOID_0050669 4.862E-10 1.844E-08 0.03928972 0.69862028 CROMER_TUMORIGENESIS_UP abdominal aortic aneurysm DOID_7693 4.862E-10 1.729E-08 0.03928972 0.67744997 CROMER_TUMORIGENESIS_UP cystic fibrosis DOID_1485 5.469E-10 1.83E-08 4.079E-03 0.21098469 CROMER_TUMORIGENESIS_UP epidermolysis bullosa DOID_2730 9.32E-10 2.946E-08 3.65E-07 2.077E-04 CROMER_TUMORIGENESIS_UP primary bacterial infectious disease DOID_0050338 1.225E-09 3.669E-08 1.000 1.000 CROMER_TUMORIGENESIS_UP osteogenesis imperfecta DOID_12347 1.345E-09 3.827E-08 0.01566192 0.59410882 CROMER_TUMORIGENESIS_UP vesiculobullous skin disease DOID_2731 1.345E-09 3.644E-08 4.741E-07 1.349E-04 CROMER_TUMORIGENESIS_UP adult respiratory distress syndrome DOID_11394 1.954E-09 5.055E-08 1.000 1.000 CROMER_TUMORIGENESIS_UP hypersensitivity reaction type I disease DOID_1205 2.068E-09 5.116E-08 2.276E-04 0.03236998 CROMER_TUMORIGENESIS_UP Ehlers-Danlos syndrome DOID_13359 2.563E-09 6.077E-08 0.01805005 0.60414577 CROMER_TUMORIGENESIS_UP oral submucous fibrosis DOID_5773 2.563E-09 5.834E-08 1.000 1.000 CROMER_TUMORIGENESIS_UP nephrotic syndrome DOID_1184 2.775E-09 6.074E-08 1.441E-03 0.13664237 CROMER_TUMORIGENESIS_UP rheumatic disease DOID_1575 2.775E-09 5.849E-08 0.0543493 0.77311879 CROMER_TUMORIGENESIS_UP scleroderma DOID_419 2.775E-09 5.849E-08 0.0543493 0.77311879 CROMER_TUMORIGENESIS_UP calcium metabolism disease DOID_10575 5.774E-09 1.173E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP aortic aneurysm DOID_3627 5.774E-09 1.133E-07 0.0623624 0.72416744 CROMER_TUMORIGENESIS_UP osteochondrodysplasia DOID_2256 9.178E-09 1.741E-07 2.28E-03 0.16216626 CROMER_TUMORIGENESIS_UP carotid artery disease DOID_3407 1.519E-08 2.788E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP respiratory failure DOID_11162 1.644E-08 2.923E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP sinusitis DOID_0050127 1.651E-08 2.847E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP paranasal sinus disease DOID_1352 1.651E-08 2.847E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP mineral metabolism disease DOID_0050032 1.919E-08 3.211E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP aortic valve disease DOID_62 1.98E-08 3.218E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP meningitis DOID_9471 1.98E-08 3.129E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP spastic quadriplegia DOID_10970 2.355E-08 3.621E-07 0.02990594 0.63023992 CROMER_TUMORIGENESIS_UP periodontitis DOID_824 4.405E-08 6.596E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP bone resorption disease DOID_0080011 4.43E-08 6.463E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP osteoporosis DOID_11476 4.43E-08 6.463E-07 1.000 1.000 CROMER_TUMORIGENESIS_UP bone development disease DOID_0080006 6.802E-08 9.675E-07 4.934E-03 0.21595316 CROMER_TUMORIGENESIS_UP pleural disease DOID_1532 9.66E-08 1.341E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP periodontal disease DOID_3388 1.216E-07 1.648E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP ulcerative colitis DOID_8577 1.452E-07 1.921E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP calcinosis DOID_182 1.679E-07 2.171E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP systemic scleroderma DOID_418 2.052E-07 2.595E-06 0.04974035 0.72569895 CROMER_TUMORIGENESIS_UP intracranial arterial disease DOID_13089 2.261E-07 2.796E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP cerebral arterial disease DOID_3527 2.261E-07 2.796E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP pulmonary emphysema DOID_9675 2.485E-07 3.008E-06 1.319E-03 0.15010238 CROMER_TUMORIGENESIS_UP cerebral infarction DOID_3526 3.549E-07 4.207E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP aortic valve insufficiency DOID_57 3.65E-07 4.238E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP pulmonary tuberculosis DOID_2957 4.92E-07 5.599E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP intermediate coronary syndrome DOID_8805 7.529E-07 8.4E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP integumentary system cancer DOID_0060122 7.669E-07 8.392E-06 2.28E-03 0.18533287 CROMER_TUMORIGENESIS_UP parasitic protozoa infectious disease DOID_2789 7.669E-07 8.234E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP skin cancer DOID_4159 7.669E-07 8.392E-06 2.28E-03 0.18533287 CROMER_TUMORIGENESIS_UP spastic diplegia DOID_10965 9.259E-07 9.756E-06 1.000 1.000 CROMER_TUMORIGENESIS_UP ureteral obstruction DOID_5199 1.347E-06 1.393E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP prion disease DOID_649 1.347E-06 1.368E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP cholestasis DOID_13580 1.459E-06 1.457E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP parasitic infectious disease DOID_1398 1.459E-06 1.431E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP leishmaniasis DOID_9065 1.598E-06 1.541E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP tooth disease DOID_1091 1.64E-06 1.555E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP brain infarction DOID_3454 1.736E-06 1.62E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP bile duct disease DOID_4138 2.051E-06 1.882E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP biliary tract disease DOID_9741 2.164E-06 1.955E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP urinary tract obstruction DOID_5200 2.911E-06 2.588E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP ureteral disease DOID_1426 3.324E-06 2.909E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP biliary tract cancer DOID_4607 3.574E-06 3.081E-05 0.09815578 0.93084403 CROMER_TUMORIGENESIS_UP chronic kidney failure DOID_784 3.574E-06 3.035E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP middle cerebral artery infarction DOID_3525 5.361E-06 4.486E-05 1.000 1.000 CROMER_TUMORIGENESIS_UP pneumoconiosis DOID_10316 1.262E-05 1.041E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP multiple myeloma DOID_9538 1.6E-05 1.301E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP peptic ulcer DOID_750 1.857E-05 1.488E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP influenza DOID_8469 2.611E-05 2.064E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP myeloma DOID_0070004 3.148E-05 2.454E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP pre-eclampsia DOID_10591 3.148E-05 2.421E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP brain cancer DOID_1319 3.148E-05 2.388E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP central nervous system cancer DOID_3620 3.342E-05 2.502E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP glaucoma DOID_1686 3.544E-05 2.619E-04 0.06122175 0.74117395 CROMER_TUMORIGENESIS_UP atrophic muscular disease DOID_913 4.43E-05 3.231E-04 0.06577621 0.73385619 CROMER_TUMORIGENESIS_UP muscular dystrophy DOID_9884 4.43E-05 3.231E-04 0.06577621 0.73385619 CROMER_TUMORIGENESIS_UP bone marrow cancer DOID_4960 4.672E-05 3.365E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP facioscapulohumeral muscular dystrophy DOID_11727 6.441E-05 4.581E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP retinal vascular occlusion DOID_1729 6.441E-05 4.525E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP cutaneous leishmaniasis DOID_9111 6.441E-05 4.47E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP bronchiectasis DOID_9563 7.867E-05 5.393E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP uterine disease DOID_345 7.928E-05 5.37E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP hyperglycemia DOID_4195 8.281E-05 5.543E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP allergic contact dermatitis DOID_3042 8.644E-05 5.719E-04 0.08154726 0.8140419 CROMER_TUMORIGENESIS_UP common cold DOID_10459 9.433E-05 6.169E-04 9.433E-05 0.01789063 CROMER_TUMORIGENESIS_UP peritonitis DOID_8283 9.433E-05 6.099E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP ocular hypertension DOID_9282 9.433E-05 6.031E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP borderline glaucoma DOID_9283 9.433E-05 6.031E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP encephalitis DOID_9588 9.433E-05 5.964E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP peripheral vascular disease DOID_341 1.062E-04 6.639E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP diabetic retinopathy DOID_8947 1.105E-04 6.831E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP carotid stenosis DOID_13001 1.114E-04 6.815E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP larynx cancer DOID_2596 1.114E-04 6.743E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP laryngeal benign neoplasm DOID_2598 1.114E-04 6.743E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP contact dermatitis DOID_2773 1.384E-04 8.291E-04 0.09485776 0.91481464 CROMER_TUMORIGENESIS_UP female reproductive system disease DOID_229 1.435E-04 8.506E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP skeletal system cancer DOID_0060124 1.497E-04 8.782E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP thoracic aortic aneurysm DOID_14004 1.497E-04 8.693E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP bone cancer DOID_184 1.497E-04 8.782E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP retinal vascular disease DOID_2462 1.65E-04 9.482E-04 1.000 1.000 CROMER_TUMORIGENESIS_UP basal cell carcinoma DOID_2513 1.936E-04 1.102E-03 0.02043251 0.61189993 CROMER_TUMORIGENESIS_UP nervous system cancer DOID_3093 1.946E-04 1.097E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP Human immunodeficiency virus infectious disease DOID_526 1.946E-04 1.086E-03 5.625E-03 0.2286037 CROMER_TUMORIGENESIS_UP skin carcinoma DOID_3451 2.177E-04 1.202E-03 0.02162162 0.58584294 CROMER_TUMORIGENESIS_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.207E-04 1.208E-03 0.11014828 1.000 CROMER_TUMORIGENESIS_UP Crohn's disease DOID_8778 2.207E-04 1.196E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP brain edema DOID_4724 2.699E-04 1.449E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP subependymal glioma DOID_4843 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP pilocytic astrocytoma DOID_4851 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP subependymal giant cell astrocytoma DOID_5077 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP fibrillary astrocytoma DOID_6726 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP juvenile pilocytic astrocytoma DOID_6811 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP childhood pilocytic astrocytoma DOID_6812 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP gemistocytic astrocytoma DOID_7005 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP childhood cerebral astrocytoma DOID_7007 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP protoplasmic astrocytoma DOID_7008 2.699E-04 1.435E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP autoimmune hepatitis DOID_2048 2.98E-04 1.57E-03 0.02518048 0.59698725 CROMER_TUMORIGENESIS_UP coronary restenosis DOID_4247 2.98E-04 1.556E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP mitochondrial myopathy DOID_699 2.98E-04 1.542E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP benign glioma DOID_0060101 3.276E-04 1.679E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP hepatitis B DOID_2043 3.276E-04 1.664E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP benign ependymoma DOID_4844 3.276E-04 1.679E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP placenta disease DOID_780 3.276E-04 1.65E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP IgA glomerulonephritis DOID_2986 3.585E-04 1.789E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP uremia DOID_4676 3.585E-04 1.774E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP pulmonary embolism DOID_9477 3.585E-04 1.759E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP diabetic angiopathy DOID_11713 3.908E-04 1.901E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP Goodpasture syndrome DOID_9808 3.908E-04 1.885E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP toxic shock syndrome DOID_14115 4.245E-04 2.03E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP commensal bacterial infectious disease DOID_0050339 4.595E-04 2.179E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP bronchiolitis DOID_2942 4.595E-04 2.161E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP extrinsic allergic alveolitis DOID_841 5.336E-04 2.489E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP Sciatic Neuropathy DOID_11446 5.727E-04 2.649E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP lesion of sciatic nerve DOID_12528 5.727E-04 2.649E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP mononeuritis of lower limb DOID_9473 5.727E-04 2.649E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP pleurisy DOID_10247 6.131E-04 2.813E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP mononeuritis DOID_1802 6.131E-04 2.791E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP coronary stenosis DOID_4248 6.131E-04 2.769E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP mononeuropathy DOID_1188 6.549E-04 2.934E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP supratentorial cancer DOID_1659 6.549E-04 2.911E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP cerebrum cancer DOID_368 6.549E-04 2.911E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP bronchiolitis obliterans DOID_2799 7.425E-04 3.275E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP myocarditis DOID_820 8.838E-04 3.869E-03 0.04278569 0.71603116 CROMER_TUMORIGENESIS_UP pulmonary sarcoidosis DOID_13406 1.091E-03 4.738E-03 0.04742764 0.77103793 CROMER_TUMORIGENESIS_UP embryonal cancer DOID_688 1.091E-03 4.702E-03 0.04742764 0.74962021 CROMER_TUMORIGENESIS_UP respiratory syncytial virus infectious disease DOID_1273 1.202E-03 5.144E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP hepatitis DOID_2237 1.202E-03 5.105E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP congenital diaphragmatic hernia DOID_3827 1.202E-03 5.068E-03 0.04974035 0.74479629 CROMER_TUMORIGENESIS_UP benign mesothelioma DOID_2645 1.319E-03 5.518E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP gallbladder cancer DOID_3121 1.504E-03 6.245E-03 0.05549812 0.77020557 CROMER_TUMORIGENESIS_UP learning disability DOID_8927 1.568E-03 6.465E-03 0.05664557 0.74956577 CROMER_TUMORIGENESIS_UP proteinuria DOID_576 1.633E-03 6.686E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP neuritis DOID_1803 1.7E-03 6.91E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.837E-03 7.415E-03 0.06122175 0.77411502 CROMER_TUMORIGENESIS_UP integumentary system benign neoplasm DOID_0060121 1.837E-03 7.363E-03 0.06122175 0.75728643 CROMER_TUMORIGENESIS_UP skin benign neoplasm DOID_3165 1.837E-03 7.363E-03 0.06122175 0.75728643 CROMER_TUMORIGENESIS_UP lung small cell carcinoma DOID_5409 1.837E-03 7.311E-03 0.06122175 0.72573283 CROMER_TUMORIGENESIS_UP atopic dermatitis DOID_3310 2.053E-03 8.112E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP sarcoidosis DOID_11335 2.127E-03 8.348E-03 0.06577621 0.74853332 CROMER_TUMORIGENESIS_UP bile duct adenocarcinoma DOID_4896 2.203E-03 8.586E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP cholangiocarcinoma DOID_4947 2.203E-03 8.586E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP vasculitis DOID_865 2.203E-03 8.528E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP pustulosis of palm and sole DOID_4398 2.28E-03 8.766E-03 0.06804533 0.74457297 CROMER_TUMORIGENESIS_UP mitochondrial metabolism disease DOID_700 2.358E-03 9.005E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP hypertrophic cardiomyopathy DOID_11984 2.518E-03 9.553E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP hypersensitivity reaction type IV disease DOID_2916 2.518E-03 9.49E-03 0.07143891 0.7527544 CROMER_TUMORIGENESIS_UP bile duct cancer DOID_4606 2.518E-03 9.427E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP bile duct carcinoma DOID_4897 2.518E-03 9.427E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP melancholia DOID_2848 2.6E-03 9.67E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP neurotic disorder DOID_4964 2.683E-03 9.915E-03 1.000 1.000 CROMER_TUMORIGENESIS_UP endocrine pancreas disease DOID_1428 3.029E-03 0.01111791 1.000 1.000 CROMER_TUMORIGENESIS_UP endogenous depression DOID_1595 4.079E-03 0.01487713 1.000 1.000 CROMER_TUMORIGENESIS_UP lipid metabolism disorder DOID_3146 4.497E-03 0.0162975 1.000 1.000 CROMER_TUMORIGENESIS_UP mental depression DOID_1596 4.823E-03 0.01736843 1.000 1.000 CROMER_TUMORIGENESIS_UP encephalomyelitis DOID_640 5.986E-03 0.02142077 1.000 1.000 CROMER_TUMORIGENESIS_UP leber hereditary optic neuropathy DOID_705 0.0108686 0.03865147 1.000 1.000 CROMER_TUMORIGENESIS_UP hyperparathyroidism DOID_13543 0.01206907 0.04265404 1.000 1.000 CROMER_TUMORIGENESIS_UP hypolipoproteinemia DOID_1387 0.01206907 0.04239074 1.000 1.000 CROMER_TUMORIGENESIS_UP childhood type dermatomyositis DOID_14203 0.01206907 0.04213067 1.000 1.000 CROMER_TUMORIGENESIS_UP conjunctival disease DOID_4251 0.01206907 0.04187378 1.000 1.000 CROMER_TUMORIGENESIS_UP conjunctivitis DOID_6195 0.01206907 0.04187378 1.000 1.000 CROMER_TUMORIGENESIS_UP visceral leishmaniasis DOID_9146 0.01206907 0.04162 1.000 1.000 CROMER_TUMORIGENESIS_UP dermatomyositis DOID_10223 0.01326811 0.04547924 1.000 1.000 CROMER_TUMORIGENESIS_UP prediabetes syndrome DOID_11716 0.01326811 0.04520691 1.000 1.000 CROMER_TUMORIGENESIS_UP temporal arteritis DOID_13375 0.01326811 0.04493782 1.000 1.000 CROMER_TUMORIGENESIS_UP central nervous system vasculitis DOID_525 0.01326811 0.04493782 1.000 1.000 CROMER_TUMORIGENESIS_UP intracranial arteriosclerosis DOID_13097 0.01446573 0.04870413 1.000 1.000 CROMER_TUMORIGENESIS_UP aortic valve stenosis DOID_1712 0.01446573 0.04841763 1.000 1.000 CROMER_TUMORIGENESIS_UP stomach disease DOID_76 0.01446573 0.04813449 1.000 1.000 CROMER_TUMORIGENESIS_UP vascular dementia DOID_8725 0.01446573 0.04870413 1.000 1.000 CROMER_TUMORIGENESIS_UP mitochondrial encephalomyopathy DOID_890 0.01446573 0.04785464 1.000 1.000 CROMER_TUMORIGENESIS_UP berylliosis DOID_10322 0.01566192 0.05151233 1.000 1.000 CROMER_TUMORIGENESIS_UP parathyroid gland disease DOID_11201 0.01566192 0.05121628 1.000 1.000 CROMER_TUMORIGENESIS_UP newborn respiratory distress syndrome DOID_12716 0.01566192 0.05092361 1.000 1.000 CROMER_TUMORIGENESIS_UP polyneuropathy DOID_1389 0.01566192 0.05063427 1.000 1.000 CROMER_TUMORIGENESIS_UP intracranial thrombosis DOID_4193 0.01566192 0.05034821 1.000 1.000 CROMER_TUMORIGENESIS_UP open-angle glaucoma DOID_1067 0.01685669 0.0538846 0.01685669 0.59946618 CROMER_TUMORIGENESIS_UP hypercalcemia DOID_12678 0.01685669 0.05358357 1.000 1.000 CROMER_TUMORIGENESIS_UP eyelid disease DOID_530 0.01685669 0.05328588 1.000 1.000 CROMER_TUMORIGENESIS_UP bacterial meningitis DOID_9470 0.01685669 0.05299149 1.000 1.000 CROMER_TUMORIGENESIS_UP idiopathic pulmonary fibrosis DOID_0050156 0.01805005 0.0564312 1.000 1.000 CROMER_TUMORIGENESIS_UP membranoproliferative glomerulonephritis DOID_2920 0.01805005 0.05612283 1.000 1.000 CROMER_TUMORIGENESIS_UP arthropathy DOID_381 0.01805005 0.05581782 1.000 1.000 CROMER_TUMORIGENESIS_UP lung oat cell carcinoma DOID_5411 0.01805005 0.0555161 1.000 1.000 CROMER_TUMORIGENESIS_UP hyperhomocysteinemia DOID_9279 0.01805005 0.05521762 0.01805005 0.57058212 CROMER_TUMORIGENESIS_UP hemolytic-uremic syndrome DOID_12554 0.01924199 0.05854915 1.000 1.000 CROMER_TUMORIGENESIS_UP restrictive cardiomyopathy DOID_397 0.01924199 0.05823772 1.000 1.000 CROMER_TUMORIGENESIS_UP thyroiditis DOID_7166 0.01924199 0.05792958 1.000 1.000 CROMER_TUMORIGENESIS_UP autoimmune thyroiditis DOID_7188 0.01924199 0.05792958 1.000 1.000 CROMER_TUMORIGENESIS_UP Barrett's esophagus DOID_9206 0.01924199 0.05762469 1.000 1.000 CROMER_TUMORIGENESIS_UP keratosis DOID_161 0.02162162 0.06441205 0.02162162 0.61513509 CROMER_TUMORIGENESIS_UP dissociative disorder DOID_10935 0.02280932 0.06759636 1.000 1.000 CROMER_TUMORIGENESIS_UP dissociative amnesia DOID_11037 0.02280932 0.06759636 1.000 1.000 CROMER_TUMORIGENESIS_UP Down syndrome DOID_14250 0.02280932 0.06724612 1.000 1.000 CROMER_TUMORIGENESIS_UP psoriasis DOID_8893 0.02280932 0.06689949 0.02280932 0.58993188 CROMER_TUMORIGENESIS_UP amnestic disorder DOID_10914 0.0239956 0.07001794 1.000 1.000 CROMER_TUMORIGENESIS_UP membranous glomerulonephritis DOID_10976 0.0239956 0.06966071 1.000 1.000 CROMER_TUMORIGENESIS_UP pulmonary edema DOID_11396 0.0239956 0.0693071 1.000 1.000 CROMER_TUMORIGENESIS_UP esophagitis DOID_11963 0.0239956 0.06895706 1.000 1.000 CROMER_TUMORIGENESIS_UP colon carcinoma DOID_1520 0.0239956 0.06861055 0.0239956 0.59363037 CROMER_TUMORIGENESIS_UP Kawasaki disease DOID_13378 0.02518048 0.07163847 1.000 1.000 CROMER_TUMORIGENESIS_UP lymphadenitis DOID_1602 0.02518048 0.07163847 1.000 1.000 CROMER_TUMORIGENESIS_UP lymph node disease DOID_9942 0.02518048 0.07163847 1.000 1.000 CROMER_TUMORIGENESIS_UP funisitis DOID_0050698 0.02636395 0.07463228 0.02636395 0.60004355 CROMER_TUMORIGENESIS_UP gastric ulcer DOID_10808 0.02636395 0.07426282 1.000 1.000 CROMER_TUMORIGENESIS_UP neutropenia DOID_1227 0.02636395 0.07389699 1.000 1.000 CROMER_TUMORIGENESIS_UP familial hypercholesterolemia DOID_13810 0.02636395 0.07353475 1.000 1.000 CROMER_TUMORIGENESIS_UP acquired immunodeficiency syndrome DOID_635 0.02636395 0.07317604 0.02636395 0.57696495 CROMER_TUMORIGENESIS_UP muscular atrophy DOID_767 0.02636395 0.07282082 1.000 1.000 CROMER_TUMORIGENESIS_UP agranulocytosis DOID_12987 0.02754602 0.07571828 1.000 1.000 CROMER_TUMORIGENESIS_UP optic nerve disease DOID_1891 0.02754602 0.07535425 1.000 1.000 CROMER_TUMORIGENESIS_UP opiate dependence DOID_2559 0.02754602 0.0749937 1.000 1.000 CROMER_TUMORIGENESIS_UP sleep disorder DOID_535 0.02754602 0.07463659 1.000 1.000 CROMER_TUMORIGENESIS_UP polyarteritis nodosa DOID_9810 0.02754602 0.07428286 1.000 1.000 CROMER_TUMORIGENESIS_UP hypoglycemia DOID_9993 0.02754602 0.07393247 1.000 1.000 CROMER_TUMORIGENESIS_UP portal hypertension DOID_10762 0.03108379 0.08303605 1.000 1.000 CROMER_TUMORIGENESIS_UP reading disorder DOID_13365 0.03108379 0.08264803 0.03108379 0.63166711 CROMER_TUMORIGENESIS_UP urticaria DOID_1555 0.03108379 0.08226362 1.000 1.000 CROMER_TUMORIGENESIS_UP hypogonadism DOID_1924 0.03108379 0.08188277 1.000 1.000 CROMER_TUMORIGENESIS_UP dyslexia DOID_4428 0.03108379 0.08264803 0.03108379 0.63166711 CROMER_TUMORIGENESIS_UP cystitis DOID_1679 0.03226025 0.08459025 1.000 1.000 CROMER_TUMORIGENESIS_UP myositis DOID_633 0.03226025 0.08420222 1.000 1.000 CROMER_TUMORIGENESIS_UP seminoma DOID_4440 0.03343531 0.08687075 1.000 1.000 CROMER_TUMORIGENESIS_UP perinatal necrotizing enterocolitis DOID_8677 0.03460898 0.08951141 1.000 1.000 CROMER_TUMORIGENESIS_UP autoimmune disease of cardiovascular system DOID_0060051 0.03578125 0.09212458 1.000 1.000 CROMER_TUMORIGENESIS_UP renal hypertension DOID_1073 0.03578125 0.09170961 1.000 1.000 CROMER_TUMORIGENESIS_UP secondary hypertension DOID_11130 0.03578125 0.09170961 1.000 1.000 CROMER_TUMORIGENESIS_UP malaria DOID_12365 0.03578125 0.09129835 1.000 1.000 CROMER_TUMORIGENESIS_UP Behcet's disease DOID_13241 0.03578125 0.09212458 1.000 1.000 CROMER_TUMORIGENESIS_UP hepatic vascular disease DOID_272 0.03578125 0.09089077 1.000 1.000 CROMER_TUMORIGENESIS_UP autoimmune disease of endocrine system DOID_0060005 0.03695213 0.09344783 1.000 1.000 CROMER_TUMORIGENESIS_UP multiple epiphyseal dysplasia DOID_12721 0.03695213 0.09303435 0.03695213 0.70085875 CROMER_TUMORIGENESIS_UP cranial nerve disease DOID_5656 0.03695213 0.0926245 1.000 1.000 CROMER_TUMORIGENESIS_UP endometrial carcinoma DOID_2871 0.03812162 0.09513685 1.000 1.000 CROMER_TUMORIGENESIS_UP gonadal disease DOID_2277 0.03928972 0.0976238 1.000 1.000 CROMER_TUMORIGENESIS_UP endometrial cancer DOID_1380 0.04045643 0.09965241 1.000 1.000 CROMER_TUMORIGENESIS_UP germinoma DOID_3304 0.04045643 0.09922288 1.000 1.000 CROMER_TUMORIGENESIS_UP allergic rhinitis DOID_4481 0.04045643 0.09879703 1.000 1.000 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP intracranial arterial disease DOID_13089 2.424E-12 1.379E-09 1.617E-10 9.202E-08 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP cerebral arterial disease DOID_3527 2.424E-12 1.379E-09 1.617E-10 9.202E-08 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP brain infarction DOID_3454 3.79E-12 1.078E-09 1.638E-10 4.661E-08 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP middle cerebral artery infarction DOID_3525 6.208E-12 1.177E-09 5.883E-10 8.368E-08 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP cerebral infarction DOID_3526 6.217E-12 8.843E-10 3.642E-10 6.908E-08 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP atrophic muscular disease DOID_913 4.678E-08 5.324E-06 4.678E-08 5.324E-06 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP muscular dystrophy DOID_9884 4.678E-08 5.324E-06 4.678E-08 5.324E-06 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP allergic contact dermatitis DOID_3042 1.815E-07 1.721E-05 4.966E-06 3.14E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pancreatic ductal carcinoma DOID_3587 2.336E-07 1.899E-05 2.336E-07 2.215E-05 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pancreatic carcinoma DOID_4905 2.974E-07 2.116E-05 2.974E-07 2.418E-05 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pancreatitis DOID_4989 4.042E-07 2.555E-05 4.042E-07 2.875E-05 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP contact dermatitis DOID_2773 4.683E-07 2.664E-05 1.082E-05 4.738E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.191E-06 6.161E-05 3.746E-04 7.895E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP diabetic angiopathy DOID_11713 1.457E-06 6.907E-05 3.205E-03 0.02941454 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP facioscapulohumeral muscular dystrophy DOID_11727 4.975E-06 2.178E-04 4.975E-06 2.831E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP Charcot-Marie-Tooth disease DOID_10595 6.187E-06 2.515E-04 6.187E-06 3.2E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP nephrosis DOID_2527 6.536E-06 2.479E-04 6.536E-06 3.099E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bile duct disease DOID_4138 6.536E-06 2.324E-04 1.377E-04 3.562E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP peripheral vascular disease DOID_341 6.983E-06 2.337E-04 2.37E-03 0.02408437 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP biliary tract disease DOID_9741 6.983E-06 2.207E-04 1.451E-04 3.44E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP aneurysm disease DOID_2403 9.017E-06 2.7E-04 2.748E-03 0.02695685 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 1.177E-05 3.347E-04 1.177E-05 4.782E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP adult respiratory distress syndrome DOID_11394 1.607E-05 4.353E-04 4.701E-04 9.223E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP Human immunodeficiency virus infectious disease DOID_526 1.897E-05 4.907E-04 1.897E-05 7.196E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP tongue cancer DOID_8649 2.286E-05 5.656E-04 2.286E-05 8.13E-04 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP aortic aneurysm DOID_3627 3.71E-05 8.796E-04 8.698E-04 0.01269019 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP parasitic protozoa infectious disease DOID_2789 5.303E-05 1.207E-03 1.131E-03 0.01532419 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP oral cavity cancer DOID_8618 6.47E-05 1.416E-03 6.47E-05 2.165E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP leukocyte disease DOID_9500 6.897E-05 1.454E-03 1.372E-03 0.01735247 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP myasthenia gravis DOID_437 7.101E-05 1.443E-03 7.101E-05 2.245E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP respiratory failure DOID_11162 8.303E-05 1.629E-03 1.573E-03 0.01945597 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hypothyroidism DOID_1459 8.303E-05 1.575E-03 8.303E-05 2.487E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP toxic shock syndrome DOID_14115 9.175E-05 1.684E-03 3.476E-03 0.02996583 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP cholestasis DOID_13580 9.907E-05 1.762E-03 1.791E-03 0.02168123 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP parasitic infectious disease DOID_1398 9.907E-05 1.708E-03 1.791E-03 0.02122954 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP commensal bacterial infectious disease DOID_0050339 1.034E-04 1.731E-03 3.757E-03 0.03190525 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hyperglycemia DOID_4195 1.049E-04 1.705E-03 1.049E-04 2.984E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP neuromuscular junction disease DOID_439 1.161E-04 1.835E-03 1.161E-04 3.145E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP tuberculosis DOID_399 1.172E-04 1.803E-03 2.027E-03 0.02176019 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP male reproductive system disease DOID_48 1.377E-04 2.062E-03 2.281E-03 0.02360141 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP Sciatic Neuropathy DOID_11446 1.443E-04 2.105E-03 4.661E-03 0.03583961 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP lesion of sciatic nerve DOID_12528 1.443E-04 2.105E-03 4.661E-03 0.03583961 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP migraine DOID_6364 1.443E-04 2.052E-03 1.443E-04 3.569E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP mononeuritis of lower limb DOID_9473 1.443E-04 2.105E-03 4.661E-03 0.03583961 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP malaria DOID_12365 1.599E-04 2.219E-03 4.983E-03 0.03634706 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP mononeuritis DOID_1802 1.599E-04 2.166E-03 4.983E-03 0.03588697 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP autoimmune disease of the nervous system DOID_438 1.599E-04 2.116E-03 1.599E-04 3.639E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP mononeuropathy DOID_1188 1.766E-04 2.283E-03 5.314E-03 0.0377958 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP toxic encephalopathy DOID_3602 1.766E-04 2.233E-03 5.314E-03 0.03732918 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP focal glomerulosclerosis DOID_3945 1.766E-04 2.184E-03 5.314E-03 0.03687395 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bacterial pneumonia DOID_874 1.862E-04 2.255E-03 2.848E-03 0.02746244 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP primary bacterial infectious disease DOID_0050338 2.806E-04 3.326E-03 3.847E-03 0.03172365 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP lymphoblastic leukemia DOID_1037 3.6E-04 4.18E-03 3.6E-04 7.878E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP multiple myeloma DOID_9538 3.792E-04 4.316E-03 8.732E-03 0.05711126 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP DiGeorge syndrome DOID_11198 4.327E-04 4.828E-03 4.327E-04 8.793E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP velocardiofacial syndrome DOID_12583 4.327E-04 4.828E-03 4.327E-04 8.793E-03 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP lymphatic system disease DOID_75 4.701E-04 5.144E-03 0.01004035 0.06491998 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pulmonary emphysema DOID_9675 5.032E-04 5.402E-03 0.0104945 0.06709404 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP T cell deficiency DOID_11200 5.397E-04 5.686E-03 5.397E-04 0.01023539 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP angioedema DOID_1558 5.397E-04 5.583E-03 0.03453751 0.18716041 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP nephrotic syndrome DOID_1184 5.738E-04 5.83E-03 5.738E-04 0.01053219 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP cataract DOID_83 6.505E-04 6.493E-03 6.505E-04 0.01156597 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP prediabetes syndrome DOID_11716 6.581E-04 6.456E-03 6.581E-04 0.01134651 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP migraine without aura DOID_12783 6.581E-04 6.346E-03 6.581E-04 0.01101279 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP myeloma DOID_0070004 7.333E-04 6.955E-03 0.01340509 0.08201606 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pre-eclampsia DOID_10591 7.333E-04 6.841E-03 7.333E-04 0.01192211 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP lens disease DOID_110 7.333E-04 6.73E-03 7.333E-04 0.01159094 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP neuritis DOID_1803 7.333E-04 6.623E-03 0.01340509 0.08114355 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP vascular skin disease DOID_9540 7.333E-04 6.52E-03 0.16124204 0.37447641 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hemolytic anemia DOID_583 7.772E-04 6.803E-03 0.01392051 0.08250802 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP normocytic anemia DOID_720 7.772E-04 6.803E-03 0.01392051 0.08250802 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP lipodystrophy DOID_811 7.879E-04 6.792E-03 7.879E-04 0.01211592 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pulmonary tuberculosis DOID_2957 8.227E-04 6.987E-03 8.227E-04 0.01231837 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP berylliosis DOID_10322 9.29E-04 7.773E-03 0.04466599 0.20331957 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP newborn respiratory distress syndrome DOID_12716 9.29E-04 7.661E-03 0.04466599 0.19855427 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP Lynch syndrome DOID_3883 9.29E-04 7.551E-03 9.29E-04 0.01321448 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bile duct adenocarcinoma DOID_4896 1.075E-03 8.618E-03 1.075E-03 0.01492405 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP cholangiocarcinoma DOID_4947 1.075E-03 8.618E-03 1.075E-03 0.01492405 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bone marrow cancer DOID_4960 1.075E-03 8.498E-03 0.01718907 0.09879375 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP viral pneumonia DOID_10533 1.081E-03 8.428E-03 0.04801866 0.20543319 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP thoracic aortic aneurysm DOID_14004 1.245E-03 9.571E-03 1.245E-03 0.01647172 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP varicose veins DOID_799 1.245E-03 9.444E-03 0.05135965 0.19745702 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hypersensitivity reaction type IV disease DOID_2916 1.309E-03 9.802E-03 0.01953106 0.11113174 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bile duct cancer DOID_4606 1.309E-03 9.675E-03 1.309E-03 0.01693129 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bile duct carcinoma DOID_4897 1.309E-03 9.675E-03 1.309E-03 0.01693129 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP vein disease DOID_866 1.419E-03 0.01035397 0.054689 0.20472395 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP mineral metabolism disease DOID_0050032 1.716E-03 0.01236137 0.20995814 0.44743888 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP congenital muscular dystrophy DOID_0050557 1.801E-03 0.01281227 1.801E-03 0.02091799 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP glucose intolerance DOID_10603 1.801E-03 0.01265409 1.801E-03 0.02049963 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP ureteral obstruction DOID_5199 1.801E-03 0.01249977 1.801E-03 0.02009768 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP testicular cancer DOID_2998 2.009E-03 0.01377036 2.009E-03 0.02197961 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP limb-girdle muscular dystrophy DOID_11724 2.227E-03 0.01508358 2.227E-03 0.02346335 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP coronary restenosis DOID_4247 2.456E-03 0.01643743 1.000 1.000 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bone resorption disease DOID_0080011 2.748E-03 0.0181802 2.748E-03 0.02742978 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP osteoporosis DOID_11476 2.748E-03 0.0181802 2.748E-03 0.02742978 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP urinary tract obstruction DOID_5200 2.945E-03 0.01925936 2.945E-03 0.02792608 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP metabolic syndrome X DOID_14221 3.054E-03 0.01974584 0.03379926 0.18492094 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP chromosomal disease DOID_0080014 3.16E-03 0.02020467 3.16E-03 0.02947895 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP ureteral disease DOID_1426 3.205E-03 0.02026335 3.205E-03 0.02894764 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP Goodpasture syndrome DOID_9808 3.205E-03 0.02004068 0.08090968 0.26009947 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP biliary tract cancer DOID_4607 3.38E-03 0.02090472 3.38E-03 0.03005054 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP chronic kidney failure DOID_784 3.38E-03 0.02067994 3.38E-03 0.02958822 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP portal hypertension DOID_10762 3.757E-03 0.02274098 0.08735126 0.27612703 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP urticaria DOID_1555 3.757E-03 0.0225016 0.08735126 0.27309266 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP osteosarcoma DOID_3347 3.757E-03 0.02226721 3.757E-03 0.03143605 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP transitional cell carcinoma DOID_2671 3.97E-03 0.02328522 3.97E-03 0.03226666 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP spinal muscular atrophy DOID_12377 4.048E-03 0.02350388 4.048E-03 0.03244197 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP vitiligo DOID_12306 4.35E-03 0.02499886 4.35E-03 0.03437343 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP seminoma DOID_4440 4.35E-03 0.02474887 4.35E-03 0.03390256 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP lung adenocarcinoma DOID_3910 4.661E-03 0.02625872 4.661E-03 0.03536175 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hypersensitivity reaction type I disease DOID_1205 4.894E-03 0.02730135 0.04581281 0.197481 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP dilated cardiomyopathy DOID_12930 4.894E-03 0.02703629 4.894E-03 0.03664129 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP renal hypertension DOID_1073 4.983E-03 0.02726029 0.1001003 0.29359314 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP secondary hypertension DOID_11130 4.983E-03 0.02726029 0.1001003 0.29359314 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP sarcoma DOID_1115 4.983E-03 0.02700067 4.983E-03 0.0368191 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hepatic vascular disease DOID_272 4.983E-03 0.02674595 0.1001003 0.29208753 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP coronary stenosis DOID_4248 4.983E-03 0.02649599 1.000 1.000 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP abdominal aortic aneurysm DOID_7693 6.006E-03 0.03164488 0.10954593 0.30111902 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP germinoma DOID_3304 6.367E-03 0.03323812 6.367E-03 0.04365006 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP allergic rhinitis DOID_4481 6.367E-03 0.03293595 0.11267256 0.30822446 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP leiomyoma DOID_127 6.738E-03 0.03453831 6.738E-03 0.04563991 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pleural disease DOID_1532 6.738E-03 0.03422993 0.11578829 0.31373114 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pneumoconiosis DOID_10316 7.507E-03 0.03780226 0.12198722 0.3198651 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP thyroid carcinoma DOID_3963 7.507E-03 0.03747066 0.12198722 0.3155033 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hyperthyroidism DOID_7998 7.507E-03 0.03714483 7.507E-03 0.05025477 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP lymphoid leukemia DOID_10747 7.906E-03 0.03878173 7.906E-03 0.05231024 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP thyroid cancer DOID_1781 8.315E-03 0.0404362 0.12814301 0.32262554 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP pulmonary sarcoidosis DOID_13406 8.732E-03 0.04210746 0.13120482 0.32887904 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP hepatitis DOID_2237 9.595E-03 0.04587967 1.000 1.000 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP Huntington's disease DOID_12858 0.01142959 0.05419532 0.01142959 0.07226043 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP rheumatic disease DOID_1575 0.01142959 0.05374743 0.01142959 0.07146636 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP uveal disease DOID_3480 0.01142959 0.05330687 0.01142959 0.07068955 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP scleroderma DOID_419 0.01142959 0.05374743 0.01142959 0.07146636 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP diabetic autonomic neuropathy DOID_11503 0.0119104 0.05509772 0.15234075 0.36420962 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP autonomic neuropathy DOID_11504 0.0119104 0.05509772 0.15234075 0.36420962 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP diabetic polyneuropathy DOID_12785 0.0119104 0.05509772 0.15234075 0.36420962 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP diabetic neuropathy DOID_9743 0.0119104 0.05509772 0.15234075 0.36420962 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP learning disability DOID_8927 0.01239997 0.05689985 0.15531822 0.36823361 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP leukodystrophy DOID_10579 0.01289822 0.05871268 0.1582853 0.37371094 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP autonomic nervous system disease DOID_11465 0.01340509 0.06053566 0.16124204 0.37755852 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP thyroid adenoma DOID_2891 0.01340509 0.060059 0.16124204 0.37601115 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP bone marrow disease DOID_4961 0.01340509 0.05958979 0.01340509 0.0802894 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP integumentary system benign neoplasm DOID_0060121 0.01444442 0.06371222 0.01444442 0.08473069 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP skin benign neoplasm DOID_3165 0.01444442 0.06371222 0.01444442 0.08473069 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP calcium metabolism disease DOID_10575 0.01497676 0.06555213 0.17005055 0.38858941 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP movement disease DOID_480 0.01497676 0.06505173 0.01497676 0.08695691 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP sarcoidosis DOID_11335 0.01662368 0.07165812 0.17876724 0.40364508 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP carotid artery disease DOID_3407 0.02137025 0.09142612 0.20157006 0.43280514 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP collagen disease DOID_854 0.02137025 0.09074384 0.02137025 0.12039281 CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP endocrine pancreas disease DOID_1428 0.02327849 0.09811452 0.20995814 0.44576933 CROONQUIST_NRAS_SIGNALING_UP systemic scleroderma DOID_418 2.612E-08 1.486E-05 4.063E-06 4.623E-04 CROONQUIST_NRAS_SIGNALING_UP rheumatic disease DOID_1575 3.801E-08 1.081E-05 5.361E-06 5.084E-04 CROONQUIST_NRAS_SIGNALING_UP scleroderma DOID_419 3.801E-08 1.081E-05 5.361E-06 5.084E-04 CROONQUIST_NRAS_SIGNALING_UP phagocyte bactericidal dysfunction DOID_3262 4.314E-08 8.183E-06 4.314E-08 2.455E-05 CROONQUIST_NRAS_SIGNALING_UP collagen disease DOID_854 1.466E-07 2.086E-05 1.458E-05 1.186E-03 CROONQUIST_NRAS_SIGNALING_UP bacterial pneumonia DOID_874 3.621E-07 4.121E-05 1.604E-03 0.07020836 CROONQUIST_NRAS_SIGNALING_UP chronic kidney failure DOID_784 4.624E-07 4.385E-05 3.422E-05 2.434E-03 CROONQUIST_NRAS_SIGNALING_UP acquired immunodeficiency syndrome DOID_635 5.504E-07 4.474E-05 5.504E-07 1.566E-04 CROONQUIST_NRAS_SIGNALING_UP primary immunodeficiency disease DOID_612 6.085E-07 4.328E-05 6.085E-07 1.154E-04 CROONQUIST_NRAS_SIGNALING_UP Human immunodeficiency virus infectious disease DOID_526 6.358E-07 4.02E-05 6.358E-07 9.044E-05 CROONQUIST_NRAS_SIGNALING_UP Goodpasture syndrome DOID_9808 7.227E-07 4.112E-05 1.437E-04 8.178E-03 CROONQUIST_NRAS_SIGNALING_UP encephalomyelitis DOID_640 7.233E-07 3.742E-05 2.251E-03 0.08538972 CROONQUIST_NRAS_SIGNALING_UP bronchiolitis DOID_2942 9.274E-07 4.397E-05 0.01903285 0.30941972 CROONQUIST_NRAS_SIGNALING_UP bronchiolitis obliterans DOID_2799 1.939E-06 8.489E-05 0.02409709 0.32645824 CROONQUIST_NRAS_SIGNALING_UP pulmonary tuberculosis DOID_2957 7.782E-06 3.163E-04 0.03771615 0.36373706 CROONQUIST_NRAS_SIGNALING_UP hypersensitivity reaction type IV disease DOID_2916 1.262E-05 4.786E-04 9.37E-04 0.04443028 CROONQUIST_NRAS_SIGNALING_UP tuberculosis DOID_399 1.994E-05 7.09E-04 0.05115184 0.39331614 CROONQUIST_NRAS_SIGNALING_UP primary bacterial infectious disease DOID_0050338 3.927E-05 1.314E-03 0.0637134 0.43678222 CROONQUIST_NRAS_SIGNALING_UP hypersensitivity reaction type I disease DOID_1205 5.078E-05 1.605E-03 5.078E-05 3.21E-03 CROONQUIST_NRAS_SIGNALING_UP extrinsic allergic alveolitis DOID_841 1.965E-04 5.884E-03 1.000 1.000 CROONQUIST_NRAS_SIGNALING_UP allergic rhinitis DOID_4481 2.908E-04 8.274E-03 0.0248185 0.32094827 CROONQUIST_NRAS_SIGNALING_UP esophageal disease DOID_6050 3.448E-04 9.342E-03 0.02697962 0.3198209 CROONQUIST_NRAS_SIGNALING_UP uveitis DOID_13141 4.237E-04 0.01095886 0.02985393 0.32667093 CROONQUIST_NRAS_SIGNALING_UP respiratory syncytial virus infectious disease DOID_1273 4.447E-04 0.01100149 0.03057123 0.32820813 CROONQUIST_NRAS_SIGNALING_UP uveal disease DOID_3480 5.336E-04 0.01265062 0.03343531 0.33972668 CROONQUIST_NRAS_SIGNALING_UP influenza DOID_8469 5.571E-04 0.01267857 1.000 1.000 CROONQUIST_NRAS_SIGNALING_UP neuritis DOID_1803 6.304E-04 0.01379598 0.03629124 0.36227568 CROONQUIST_NRAS_SIGNALING_UP B-cell lymphocytic neoplasm DOID_707 7.351E-04 0.01549075 7.351E-04 0.03802276 CROONQUIST_NRAS_SIGNALING_UP sarcoidosis DOID_11335 7.903E-04 0.01606064 0.04055987 0.37223493 CROONQUIST_NRAS_SIGNALING_UP bone marrow cancer DOID_4960 8.187E-04 0.01606338 0.04126953 0.36691194 CROONQUIST_NRAS_SIGNALING_UP parasitic protozoa infectious disease DOID_2789 8.475E-04 0.01607516 0.04197869 0.367475 CROONQUIST_NRAS_SIGNALING_UP parasitic infectious disease DOID_1398 1.163E-03 0.02134097 0.0490425 0.39864549 CROONQUIST_NRAS_SIGNALING_UP allergic contact dermatitis DOID_3042 1.231E-03 0.02189742 0.05044923 0.40430437 CROONQUIST_NRAS_SIGNALING_UP brain infarction DOID_3454 1.267E-03 0.02183938 0.05115184 0.39870403 CROONQUIST_NRAS_SIGNALING_UP male reproductive system disease DOID_48 1.375E-03 0.02300802 1.000 1.000 CROONQUIST_NRAS_SIGNALING_UP contact dermatitis DOID_2773 1.684E-03 0.02738104 0.05884752 0.41338567 CROONQUIST_NRAS_SIGNALING_UP lymphoma DOID_0060058 2.205E-03 0.0348459 2.205E-03 0.08960373 CROONQUIST_NRAS_SIGNALING_UP acute T cell leukemia DOID_5603 7.362E-03 0.09973881 1.000 1.000 CROONQUIST_NRAS_SIGNALING_UP visceral leishmaniasis DOID_9146 7.362E-03 0.0974193 7.362E-03 0.22047527 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP sinusitis DOID_0050127 3.985E-06 2.268E-03 3.985E-06 2.268E-03 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP paranasal sinus disease DOID_1352 3.985E-06 2.268E-03 3.985E-06 2.268E-03 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP dilated cardiomyopathy DOID_12930 9.175E-06 2.61E-03 3.093E-04 0.02514169 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP congenital heart defect DOID_1682 9.886E-05 0.01874954 3.602E-03 0.18632599 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP pancreatitis DOID_4989 1.752E-04 0.02491533 1.752E-04 0.04983066 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP arthropathy DOID_381 1.842E-04 0.02096467 1.842E-04 0.03494112 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP long QT syndrome DOID_2843 2.104E-04 0.01994917 2.104E-04 0.02992376 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP carbohydrate metabolic disorder DOID_2978 2.909E-04 0.02364745 2.909E-04 0.03310643 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP alcohol-related neurodevelopmental disorder DOID_0050667 3E-04 0.02133878 3E-04 0.02845171 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP coronary stenosis DOID_4248 7.534E-04 0.04763317 0.0395951 0.41721505 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP Charcot-Marie-Tooth disease DOID_10595 9.683E-04 0.05509751 9.683E-04 0.06887188 MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP autosomal recessive nonsyndromic deafness DOID_0050565 1.274E-03 0.06587616 1.274E-03 0.0805153 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bacterial pneumonia DOID_874 1.848E-21 1.052E-18 2.091E-16 1.19E-13 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cystic fibrosis DOID_1485 1.476E-16 4.199E-14 2.339E-10 2.218E-08 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cholestasis DOID_13580 1.073E-15 2.036E-13 1.875E-12 5.336E-10 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bile duct disease DOID_4138 3.151E-15 4.483E-13 4.515E-12 8.563E-10 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP biliary tract disease DOID_9741 3.735E-15 4.25E-13 5.187E-12 7.378E-10 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP respiratory syncytial virus infectious disease DOID_1273 1.063E-14 1.008E-12 3.651E-11 4.155E-09 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pleurisy DOID_10247 2.258E-14 1.836E-12 3.962E-07 9.394E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP influenza DOID_8469 3.659E-14 2.603E-12 1.367E-07 4.575E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hypersensitivity reaction type I disease DOID_1205 9.258E-14 5.853E-12 1.688E-09 1.067E-07 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pleural disease DOID_1532 1.091E-13 6.206E-12 8.843E-07 1.735E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cystitis DOID_1679 7.326E-13 3.789E-11 2.272E-07 6.805E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP rheumatic disease DOID_1575 1.623E-12 7.694E-11 1.197E-07 4.258E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP scleroderma DOID_419 1.623E-12 7.694E-11 1.197E-07 4.258E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP encephalomyelitis DOID_640 2.146E-12 9.392E-11 1.4E-09 9.958E-08 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bladder disease DOID_365 7.504E-12 3.05E-10 8.843E-07 1.623E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pancreatitis DOID_4989 1.008E-11 3.824E-10 2.948E-10 2.397E-08 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP retinal vascular disease DOID_2462 2.376E-11 8.45E-10 1.49E-08 7.066E-07 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP primary bacterial infectious disease DOID_0050338 2.994E-11 1.002E-09 3.587E-07 9.278E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP collagen disease DOID_854 3.752E-11 1.186E-09 8.889E-07 1.581E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP aneurysm disease DOID_2403 2.628E-10 7.87E-09 1.575E-07 4.977E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP sarcoidosis DOID_11335 4.138E-10 1.177E-08 3.98E-07 9.059E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP chronic kidney failure DOID_784 5.123E-10 1.388E-08 2.614E-07 7.436E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hypersensitivity reaction type IV disease DOID_2916 8.396E-10 2.172E-08 6.666E-07 1.355E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pulmonary sarcoidosis DOID_13406 1.195E-09 2.956E-08 5.031E-08 2.202E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP systemic scleroderma DOID_418 1.715E-09 4.065E-08 2.252E-06 3.661E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pulmonary emphysema DOID_9675 2.415E-09 5.496E-08 9.099E-08 3.698E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP acute pancreatitis DOID_2913 2.472E-09 5.409E-08 2.472E-09 1.406E-07 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP tuberculosis DOID_399 2.906E-09 6.124E-08 3.062E-05 3.788E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cerebral infarction DOID_3526 4.562E-09 9.27E-08 4.423E-06 6.623E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP diabetic retinopathy DOID_8947 5.041E-09 9.891E-08 2.465E-06 3.897E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP viral pneumonia DOID_10533 5.943E-09 1.127E-07 5.943E-09 3.074E-07 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pulmonary tuberculosis DOID_2957 8.149E-09 1.496E-07 1.399E-04 1.447E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP aortic aneurysm DOID_3627 9.35E-09 1.662E-07 2.85E-07 7.722E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP parasitic protozoa infectious disease DOID_2789 1.785E-08 3.078E-07 2.141E-04 2.138E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pustulosis of palm and sole DOID_4398 1.785E-08 2.988E-07 1.136E-05 1.617E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP transitional cell carcinoma DOID_2671 1.952E-08 3.173E-07 3.873E-07 9.582E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP nephroblastoma DOID_2154 3.086E-08 4.877E-07 1.178E-06 2.031E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP leishmaniasis DOID_9065 3.382E-08 5.201E-07 4.081E-03 0.02019189 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP respiratory failure DOID_11162 4.013E-08 6.009E-07 1.991E-05 2.697E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP ulcerative colitis DOID_8577 4.488E-08 6.548E-07 1.679E-03 9.953E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP parasitic infectious disease DOID_1398 5.517E-08 7.848E-07 3.952E-04 3.46E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP peptic ulcer DOID_750 6.818E-08 9.463E-07 1.251E-03 9.007E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP brain infarction DOID_3454 7.473E-08 1.012E-06 3.062E-05 3.872E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP adult respiratory distress syndrome DOID_11394 7.891E-08 1.044E-06 6.607E-05 7.229E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autoimmune disease of urogenital tract DOID_0060049 1.045E-07 1.352E-06 1.045E-07 3.966E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP primary biliary cirrhosis DOID_12236 1.045E-07 1.352E-06 1.045E-07 3.966E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bronchiectasis DOID_9563 2.004E-07 2.534E-06 1.348E-03 9.023E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP metabolic syndrome X DOID_14221 2.039E-07 2.522E-06 6.137E-05 6.984E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP extrinsic allergic alveolitis DOID_841 2.755E-07 3.335E-06 3.758E-04 3.341E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP encephalitis DOID_9588 2.994E-07 3.549E-06 1.612E-03 9.758E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP vasculitis DOID_865 4.43E-07 5.144E-06 4.43E-07 9.695E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP nervous system cancer DOID_3093 4.503E-07 5.125E-06 4.503E-07 9.49E-06 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP mouth disease DOID_403 6.024E-07 6.721E-06 0.01276669 0.04747873 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Crohn's disease DOID_8778 6.024E-07 6.591E-06 1.445E-03 9.343E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP leukocyte disease DOID_9500 7.35E-07 7.89E-06 2.772E-04 2.585E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP allergic rhinitis DOID_4481 7.611E-07 8.02E-06 2.572E-05 3.326E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autonomic nervous system neoplasm DOID_2621 8.843E-07 9.149E-06 8.843E-07 1.677E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP neuroblastoma DOID_769 8.843E-07 9.149E-06 8.843E-07 1.677E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP peripheral nervous system neoplasm DOID_1192 1.992E-06 2.024E-05 1.992E-06 3.334E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP intracranial arterial disease DOID_13089 2.538E-06 2.533E-05 1.339E-03 9.409E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cerebral arterial disease DOID_3527 2.538E-06 2.533E-05 1.339E-03 9.409E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP contact dermatitis DOID_2773 3.851E-06 3.778E-05 6.137E-05 6.847E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP uterine cancer DOID_363 3.979E-06 3.837E-05 3.979E-06 6.119E-05 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP mental depression DOID_1596 4.75E-06 4.505E-05 9.187E-03 0.03733785 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP sinusitis DOID_0050127 5.129E-06 4.784E-05 2.07E-04 2.103E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP paranasal sinus disease DOID_1352 5.129E-06 4.784E-05 2.07E-04 2.103E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Goodpasture syndrome DOID_9808 6.13E-06 5.626E-05 2.357E-04 2.312E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP commensal bacterial infectious disease DOID_0050339 8.557E-06 7.729E-05 8.557E-06 1.248E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP portal hypertension DOID_10762 8.557E-06 7.608E-05 7.579E-03 0.03266991 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP urticaria DOID_1555 8.557E-06 7.491E-05 7.579E-03 0.0321823 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lymphoblastic leukemia DOID_1037 9.054E-06 7.806E-05 1.39E-03 9.198E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP middle cerebral artery infarction DOID_3525 1.163E-05 9.875E-05 3.758E-04 3.394E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP perinatal necrotizing enterocolitis DOID_8677 1.343E-05 1.124E-04 4.176E-04 3.601E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP glioblastoma DOID_3068 1.457E-05 1.202E-04 3.655E-03 0.01873762 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP childhood type dermatomyositis DOID_14203 1.472E-05 1.196E-04 0.04925987 0.13807322 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP retinal vascular occlusion DOID_1729 1.472E-05 1.18E-04 0.04925987 0.13739639 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP visceral leishmaniasis DOID_9146 1.472E-05 1.163E-04 0.04925987 0.13283821 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autoimmune disease of cardiovascular system DOID_0060051 1.544E-05 1.204E-04 1.544E-05 2.143E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP malaria DOID_12365 1.544E-05 1.187E-04 4.623E-04 3.813E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Behcet's disease DOID_13241 1.544E-05 1.204E-04 1.544E-05 2.143E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hepatic vascular disease DOID_272 1.544E-05 1.171E-04 0.01001132 0.04040027 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autoimmune disease of endocrine system DOID_0060005 1.766E-05 1.322E-04 0.01066658 0.04185714 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP familial adenomatous polyposis DOID_0050424 2.016E-05 1.49E-04 1.348E-03 9.24E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP dermatomyositis DOID_10223 2.016E-05 1.471E-04 0.05405107 0.14438994 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP congenital heart defect DOID_1682 2.145E-05 1.545E-04 2.145E-05 2.839E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bronchiolitis obliterans DOID_2799 2.278E-05 1.621E-04 6.144E-04 4.994E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP abdominal aortic aneurysm DOID_7693 2.278E-05 1.601E-04 6.144E-04 4.924E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hyperglycemia DOID_4195 2.665E-05 1.849E-04 0.0475351 0.13729681 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP allergic contact dermatitis DOID_3042 2.858E-05 1.96E-04 4.415E-04 3.749E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP astrocytoma DOID_3069 3.278E-05 2.22E-04 5.818E-03 0.02735708 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP psoriatic arthritis DOID_9008 3.469E-05 2.322E-04 1.899E-03 0.01080443 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP periodontal disease DOID_3388 3.62E-05 2.395E-04 0.01497894 0.05394316 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP spindle cell carcinoma DOID_4015 3.62E-05 2.368E-04 8.622E-04 6.72E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP esophageal disease DOID_6050 3.62E-05 2.341E-04 0.01497894 0.05360389 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP male reproductive system disease DOID_48 3.743E-05 2.393E-04 6.277E-03 0.02812328 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Legionnaires' disease DOID_10457 4.399E-05 2.781E-04 4.399E-05 5.325E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP legionellosis DOID_10458 4.399E-05 2.781E-04 4.399E-05 5.325E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP thoracic aortic aneurysm DOID_14004 5.478E-05 3.425E-04 5.478E-05 6.493E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP renovascular hypertension DOID_1591 5.478E-05 3.388E-04 5.478E-05 6.361E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hyperhomocysteinemia DOID_9279 5.478E-05 3.351E-04 2.539E-03 0.01363051 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP congenital diaphragmatic hernia DOID_3827 6.016E-05 3.641E-04 0.01904972 0.06451958 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cervix uteri carcinoma in situ DOID_8991 7.239E-05 4.336E-04 1.432E-03 9.366E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP biliary tract cancer DOID_4607 7.288E-05 4.32E-04 0.06869505 0.15889221 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bronchitis DOID_6132 8.126E-05 4.767E-04 8.126E-05 8.724E-04 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP amino acid metabolic disorder DOID_9252 1.008E-04 5.855E-04 1.186E-03 8.648E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP learning disability DOID_8927 1.021E-04 5.87E-04 1.843E-03 0.01080979 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP proteinuria DOID_576 1.108E-04 6.303E-04 0.02543006 0.0841262 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lymphoma DOID_0060058 1.176E-04 6.624E-04 1.337E-03 9.509E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP thyroid adenoma DOID_2891 1.199E-04 6.691E-04 2.073E-03 0.0116782 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP vascular skin disease DOID_9540 1.199E-04 6.626E-04 0.02640328 0.08440149 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hemolytic anemia DOID_583 1.296E-04 7.093E-04 0.0273914 0.08658725 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP normocytic anemia DOID_720 1.296E-04 7.093E-04 0.0273914 0.08658725 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pulmonary edema DOID_11396 1.347E-04 7.301E-04 0.09610527 0.20328588 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP esophagitis DOID_11963 1.347E-04 7.232E-04 0.09610527 0.20253297 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP brain edema DOID_4724 1.347E-04 7.164E-04 1.347E-04 1.42E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.399E-04 7.37E-04 2.32E-03 0.01281726 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP calcium metabolism disease DOID_10575 1.507E-04 7.868E-04 0.23499986 0.39327917 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autoimmune hepatitis DOID_2048 1.566E-04 8.1E-04 4.979E-03 0.02421255 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP coronary restenosis DOID_4247 1.566E-04 8.027E-04 4.979E-03 0.02400736 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP mitochondrial myopathy DOID_699 1.566E-04 7.955E-04 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP atopic dermatitis DOID_3310 1.742E-04 8.77E-04 0.03148947 0.09633068 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP gastric ulcer DOID_10808 1.806E-04 9.016E-04 0.10519509 0.2176582 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP neutropenia DOID_1227 1.806E-04 8.938E-04 0.10519509 0.21686958 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP giant cell tumor DOID_200 1.868E-04 9.165E-04 0.03254953 0.09904109 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP malignant giant cell tumor DOID_2705 1.868E-04 9.165E-04 0.03254953 0.09904109 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP giant cell glioblastoma DOID_3074 1.868E-04 9.165E-04 0.03254953 0.09904109 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bile duct adenocarcinoma DOID_4896 2.001E-04 9.734E-04 0.03362349 0.1017647 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cholangiocarcinoma DOID_4947 2.001E-04 9.734E-04 0.03362349 0.1017647 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP agranulocytosis DOID_12987 2.07E-04 9.98E-04 0.10970583 0.22214456 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP muscle cancer DOID_4045 2.07E-04 9.896E-04 5.959E-03 0.0275647 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP meningitis DOID_9471 2.357E-04 1.117E-03 6.479E-03 0.02835763 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hypertrophic cardiomyopathy DOID_11984 2.603E-04 1.224E-03 2.603E-04 2.51E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bile duct cancer DOID_4606 2.603E-04 1.214E-03 0.03805486 0.11277717 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bile duct carcinoma DOID_4897 2.603E-04 1.214E-03 0.03805486 0.11277717 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP oral cavity cancer DOID_8618 2.603E-04 1.204E-03 3.655E-03 0.01857032 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP toxic shock syndrome DOID_14115 2.668E-04 1.224E-03 2.668E-04 2.53E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP melancholia DOID_2848 2.772E-04 1.262E-03 0.26904657 0.44244942 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP neurotic disorder DOID_4964 2.948E-04 1.331E-03 0.27273523 0.4472229 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bronchiolitis DOID_2942 3.005E-04 1.346E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP myositis DOID_633 3.368E-04 1.497E-03 0.12752375 0.24764851 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pre-malignant neoplasm DOID_0060071 3.525E-04 1.555E-03 4.563E-03 0.02238236 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP in situ carcinoma DOID_8719 3.525E-04 1.555E-03 4.563E-03 0.02238236 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP mineral metabolism disease DOID_0050032 3.734E-04 1.634E-03 0.28730562 0.46841518 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP endocrine pancreas disease DOID_1428 3.734E-04 1.622E-03 0.28730562 0.46707685 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP vitiligo DOID_12306 3.758E-04 1.62E-03 3.758E-04 3.449E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP periodontitis DOID_824 4.176E-04 1.787E-03 0.13629923 0.25595465 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP tooth disease DOID_1091 4.415E-04 1.875E-03 0.04877499 0.1401665 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP renal hypertension DOID_1073 4.623E-04 1.949E-03 4.623E-04 3.869E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP secondary hypertension DOID_11130 4.623E-04 1.949E-03 4.623E-04 3.869E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP coronary stenosis DOID_4248 4.623E-04 1.934E-03 0.01001132 0.03983524 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP endocrine organ benign neoplasm DOID_0060089 4.66E-04 1.936E-03 5.596E-03 0.02653279 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pancreatic ductal carcinoma DOID_3587 5.18E-04 2.136E-03 6.045E-03 0.02751553 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP nephrosis DOID_2527 5.454E-04 2.233E-03 6.277E-03 0.02834648 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP peripheral vascular disease DOID_341 5.739E-04 2.333E-03 0.05514679 0.14198427 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pancreatic carcinoma DOID_4905 6.034E-04 2.435E-03 6.758E-03 0.02935187 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP endogenous depression DOID_1595 6.657E-04 2.667E-03 0.32589401 0.52680026 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Charcot-Marie-Tooth disease DOID_10595 6.714E-04 2.672E-03 6.714E-04 5.306E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP chronic leukemia DOID_1036 7.316E-04 2.891E-03 0.1621023 0.29005097 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP chronic lymphocytic leukemia DOID_1040 7.316E-04 2.891E-03 0.1621023 0.29005097 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP papilloma DOID_2615 7.952E-04 3.12E-03 0.01421587 0.05185149 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP myocarditis DOID_820 7.952E-04 3.099E-03 0.16632762 0.29575131 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pneumoconiosis DOID_10316 8.622E-04 3.337E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP leukopenia DOID_615 8.622E-04 3.315E-03 0.17053175 0.30041043 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP auditory system disease DOID_2742 8.796E-04 3.359E-03 8.895E-03 0.03641201 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP leber hereditary optic neuropathy DOID_705 8.881E-04 3.369E-03 0.04444452 0.12968684 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lymphoid leukemia DOID_10747 9.326E-04 3.514E-03 9.326E-04 7.171E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP adenoma DOID_657 1.007E-03 3.768E-03 1.007E-03 7.637E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP multiple myeloma DOID_9538 1.084E-03 4.032E-03 0.01737108 0.05990391 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hyperparathyroidism DOID_13543 1.106E-03 4.088E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bilirubin metabolic disorder DOID_2741 1.106E-03 4.062E-03 0.04925987 0.13672616 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP acute kidney failure DOID_3021 1.106E-03 4.036E-03 0.04925987 0.13606244 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.106E-03 4.01E-03 1.106E-03 8.284E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.106E-03 4.01E-03 1.106E-03 8.284E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Hodgkin's granuloma DOID_8651 1.106E-03 4.01E-03 1.106E-03 8.284E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 1.106E-03 4.01E-03 1.106E-03 8.284E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cutaneous leishmaniasis DOID_9111 1.106E-03 3.985E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP uveitis DOID_13141 1.165E-03 4.171E-03 1.165E-03 8.613E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Human immunodeficiency virus infectious disease DOID_526 1.235E-03 4.39E-03 0.01138573 0.04347975 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hepatitis DOID_2237 1.251E-03 4.42E-03 0.01904972 0.06490593 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP adenoid cystic carcinoma DOID_4866 1.339E-03 4.704E-03 1.339E-03 9.294E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP invasive lobular carcinoma DOID_3457 1.348E-03 4.705E-03 1.348E-03 9.13E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP carbohydrate metabolic disorder DOID_2978 1.39E-03 4.823E-03 0.01241289 0.04677439 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP dilated cardiomyopathy DOID_12930 1.501E-03 5.177E-03 1.501E-03 9.598E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP salivary gland cancer DOID_8850 1.529E-03 5.24E-03 1.529E-03 9.665E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP common cold DOID_10459 1.612E-03 5.493E-03 1.612E-03 0.01007975 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP otitis media DOID_10754 1.612E-03 5.46E-03 0.05881825 0.15075489 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP diarrhea DOID_13250 1.612E-03 5.428E-03 1.612E-03 9.97E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP middle ear disease DOID_5100 1.612E-03 5.46E-03 0.05881825 0.15075489 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP stomach disease DOID_76 1.612E-03 5.396E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP peritonitis DOID_8283 1.612E-03 5.364E-03 0.05881825 0.14678765 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Hodgkin's lymphoma DOID_8567 1.612E-03 5.333E-03 1.612E-03 9.863E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP uveal disease DOID_3480 1.629E-03 5.359E-03 1.629E-03 9.759E-03 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP gallbladder cancer DOID_3121 1.734E-03 5.67E-03 0.21143027 0.35911589 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 1.899E-03 6.174E-03 1.899E-03 0.01102493 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP berylliosis DOID_10322 1.899E-03 6.139E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP parathyroid gland disease DOID_11201 1.899E-03 6.104E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hepatic coma DOID_12550 1.899E-03 6.07E-03 0.06356153 0.15455775 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP newborn respiratory distress syndrome DOID_12716 1.899E-03 6.036E-03 1.899E-03 0.01091356 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hepatic encephalopathy DOID_13413 1.899E-03 6.07E-03 0.06356153 0.15455775 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP larynx cancer DOID_2596 1.899E-03 6.002E-03 0.06356153 0.15324794 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP laryngeal benign neoplasm DOID_2598 1.899E-03 6.002E-03 0.06356153 0.15324794 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP myeloma DOID_0070004 2.073E-03 6.517E-03 0.02640328 0.08684084 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP pre-eclampsia DOID_10591 2.073E-03 6.481E-03 0.02640328 0.08634175 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP neuritis DOID_1803 2.073E-03 6.445E-03 0.22330399 0.37815468 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hypercalcemia DOID_12678 2.208E-03 6.828E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP aspergillosis DOID_13564 2.208E-03 6.791E-03 2.208E-03 0.01231711 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP integumentary system benign neoplasm DOID_0060121 2.32E-03 7.098E-03 0.02839424 0.08926147 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP skin benign neoplasm DOID_3165 2.32E-03 7.098E-03 0.02839424 0.08926147 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lung small cell carcinoma DOID_5409 2.32E-03 7.06E-03 0.23112083 0.38792848 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP congenital ichthyosiform erythroderma DOID_1699 2.539E-03 7.685E-03 2.539E-03 0.01389263 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP membranoproliferative glomerulonephritis DOID_2920 2.539E-03 7.645E-03 2.539E-03 0.01376032 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lung oat cell carcinoma DOID_5411 2.539E-03 7.604E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP oral submucous fibrosis DOID_5773 2.539E-03 7.565E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP B-cell lymphocytic neoplasm DOID_707 2.585E-03 7.661E-03 0.03044345 0.09414306 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hemolytic-uremic syndrome DOID_12554 2.892E-03 8.527E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Leber congenital amaurosis DOID_14791 2.892E-03 8.483E-03 2.892E-03 0.01538111 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP thyroiditis DOID_7166 2.892E-03 8.44E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autoimmune thyroiditis DOID_7188 2.892E-03 8.44E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP night blindness DOID_8499 2.892E-03 8.397E-03 2.892E-03 0.01523869 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Barrett's esophagus DOID_9206 2.892E-03 8.354E-03 0.07764918 0.17124954 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bone marrow cancer DOID_4960 3.016E-03 8.667E-03 0.03362349 0.10122626 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP integumentary system cancer DOID_0060122 3.169E-03 9.06E-03 0.25410489 0.4215326 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP skin cancer DOID_4159 3.169E-03 9.06E-03 0.25410489 0.4215326 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Graves' disease DOID_12361 3.267E-03 9.295E-03 3.267E-03 0.01705552 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP mitochondrial metabolism disease DOID_700 3.326E-03 9.416E-03 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP retinitis pigmentosa DOID_10584 3.655E-03 0.01029642 3.655E-03 0.01890796 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP prion disease DOID_649 3.663E-03 0.01026859 0.08692361 0.1859381 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP testicular cancer DOID_2998 4.081E-03 0.01138268 4.081E-03 0.02054926 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP psoriasis DOID_8893 4.081E-03 0.01132716 4.081E-03 0.02036901 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP amnestic disorder DOID_10914 4.519E-03 0.01248329 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP uterine disease DOID_345 4.961E-03 0.01363627 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Kawasaki disease DOID_13378 4.979E-03 0.01361956 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lymphadenitis DOID_1602 4.979E-03 0.01361956 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lymph node disease DOID_9942 4.979E-03 0.01361956 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hepatitis B DOID_2043 5.458E-03 0.01486065 5.458E-03 0.0260998 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP placenta disease DOID_780 5.458E-03 0.01478989 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP optic nerve disease DOID_1891 5.959E-03 0.01606852 0.10970583 0.22135681 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP opiate dependence DOID_2559 5.959E-03 0.01599273 5.959E-03 0.02779064 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP IgA glomerulonephritis DOID_2986 5.959E-03 0.01591765 0.10970583 0.22057463 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP myasthenia gravis DOID_437 5.959E-03 0.01584326 5.959E-03 0.02734241 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP sleep disorder DOID_535 5.959E-03 0.01576957 0.10970583 0.21902674 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP polyarteritis nodosa DOID_9810 5.959E-03 0.01569657 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hypoglycemia DOID_9993 5.959E-03 0.01562423 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP diabetic angiopathy DOID_11713 6.479E-03 0.01691051 0.11419396 0.22561238 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP synostosis DOID_11971 6.479E-03 0.0168333 6.479E-03 0.02880072 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP congenital hemolytic anemia DOID_589 6.479E-03 0.01675678 6.479E-03 0.02857746 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP spastic quadriplegia DOID_10970 7.019E-03 0.01807174 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP syndrome DOID_225 7.26E-03 0.01860656 0.05910254 0.14621456 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bone resorption disease DOID_0080011 7.518E-03 0.01918395 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP osteoporosis DOID_11476 7.518E-03 0.01918395 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP reading disorder DOID_13365 7.579E-03 0.01925191 7.579E-03 0.03242427 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hypogonadism DOID_1924 7.579E-03 0.01916635 0.12310281 0.2415362 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP dyslexia DOID_4428 7.579E-03 0.01925191 7.579E-03 0.03242427 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP mixed glioma DOID_5076 7.783E-03 0.01959496 0.06179263 0.15220783 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP papillary adenoma DOID_3172 8.158E-03 0.02044974 8.158E-03 0.03438586 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP neuromuscular junction disease DOID_439 8.158E-03 0.02036005 8.158E-03 0.03413302 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP microcystic adenoma DOID_5403 8.158E-03 0.02044974 8.158E-03 0.03438586 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP follicular adenoma DOID_6204 8.158E-03 0.02044974 8.158E-03 0.03438586 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP chromosomal disease DOID_0080014 8.609E-03 0.02139033 8.609E-03 0.03575463 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP female reproductive system disease DOID_229 8.609E-03 0.02129732 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP myopia DOID_11830 8.757E-03 0.02157024 8.757E-03 0.03610671 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP sarcoma DOID_1115 0.01001132 0.02455362 0.14065398 0.26326354 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP invasive ductal carcinoma DOID_3008 0.01001132 0.02444823 0.01001132 0.04011577 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autoimmune disease of the nervous system DOID_438 0.01001132 0.02434376 0.01001132 0.0395586 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP toxic encephalopathy DOID_3602 0.01066658 0.02582674 0.01066658 0.04157044 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP focal glomerulosclerosis DOID_3945 0.01066658 0.02571731 0.01066658 0.04128765 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cranial nerve disease DOID_5656 0.01066658 0.0256088 0.14498689 0.26612111 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP dysostosis DOID_1934 0.01134031 0.02711192 0.01134031 0.0435989 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP spastic cerebral palsy DOID_0050669 0.0120323 0.02864594 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP gonadal disease DOID_2277 0.0120323 0.02852658 0.15358763 0.27831644 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP opportunistic mycosis DOID_2473 0.0120323 0.02840822 0.0120323 0.04564253 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP celiac disease DOID_10608 0.01274236 0.02996034 0.15785567 0.28514246 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.01276669 0.02989402 0.01276669 0.04779109 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP leiomyoma DOID_127 0.01347028 0.03141225 0.01347028 0.04977007 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP systemic mycosis DOID_0050136 0.01421587 0.03301564 0.01421587 0.05218602 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP fungal infectious disease DOID_1564 0.01421587 0.03301564 0.01421587 0.05218602 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP male infertility DOID_12336 0.01497894 0.03464642 0.01497894 0.05428674 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP thyroid carcinoma DOID_3963 0.01497894 0.03450615 0.17053175 0.30134338 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hyperthyroidism DOID_7998 0.01497894 0.03436701 0.01497894 0.05326887 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP aplastic anemia DOID_12449 0.01575929 0.0360122 0.01575929 0.05569589 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP autosomal recessive nonsyndromic deafness DOID_0050565 0.01655674 0.03768313 0.01655674 0.05815299 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP thyroid cancer DOID_1781 0.01655674 0.037533 0.17887685 0.31317208 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP refractive error DOID_9835 0.01655674 0.03738406 0.01655674 0.05779622 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP calcinosis DOID_182 0.01737108 0.03906777 0.18301802 0.31846255 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cleft palate DOID_674 0.01737108 0.03891396 0.01737108 0.06026918 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP blood platelet disease DOID_2218 0.01820214 0.04061575 0.01820214 0.06239166 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lymphatic system disease DOID_75 0.01991364 0.04426117 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP nephrotic syndrome DOID_1184 0.0226016 0.05004012 0.20743237 0.35658313 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Huntington's disease DOID_12858 0.0226016 0.04984616 0.20743237 0.35550909 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP idiopathic generalized epilepsy DOID_1827 0.0226016 0.04965371 0.0226016 0.07609651 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hyperinsulinism DOID_2018 0.0226016 0.04946273 0.20743237 0.35338029 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cataract DOID_83 0.02447193 0.05335068 0.02447193 0.08190899 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP leukodystrophy DOID_10579 0.02543006 0.05522789 0.02543006 0.08461817 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP lens disease DOID_110 0.02640328 0.05712344 0.02640328 0.08584837 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP brain cancer DOID_1319 0.02640328 0.05690707 0.02640328 0.0853606 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP heart valve disease DOID_4079 0.02640328 0.05669232 0.22330399 0.37703256 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP bone marrow disease DOID_4961 0.02640328 0.05647919 0.02640328 0.08487833 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP central nervous system cancer DOID_3620 0.0273914 0.05837342 0.0273914 0.08707097 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP glaucoma DOID_1686 0.02839424 0.0602848 0.23112083 0.3890762 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP movement disease DOID_480 0.02941165 0.06221275 0.02941165 0.09195182 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP withdrawal disorder DOID_0060001 0.03044345 0.06415675 0.23885941 0.398566 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hemorrhagic disease DOID_2213 0.03044345 0.06392001 0.03044345 0.0946575 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP orofacial cleft DOID_0050567 0.03148947 0.06587318 0.03148947 0.09685138 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP reproductive organ benign neoplasm DOID_0050622 0.03471116 0.0723467 0.03471116 0.10395079 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP nonsyndromic deafness DOID_0050563 0.03805486 0.07902634 0.03805486 0.11336763 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP neuroectodermal tumor DOID_171 0.04151622 0.08590084 0.04151622 0.12239757 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP DiGeorge syndrome DOID_11198 0.04444452 0.09162657 0.04444452 0.13035533 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP velocardiofacial syndrome DOID_12583 0.04444452 0.09162657 0.04444452 0.13035533 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP cerebral degeneration DOID_1443 0.04630705 0.0951217 0.04630705 0.13443219 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP temporal lobe epilepsy DOID_3328 0.0475351 0.09729306 0.29448155 0.47737892 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP T cell deficiency DOID_11200 0.04925987 0.09974684 0.04925987 0.13944708 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Sjogren's syndrome DOID_12894 0.04925987 0.09939313 0.04925987 0.13875675 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP hypolipoproteinemia DOID_1387 0.04925987 0.09904192 1.000 1.000 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP Hermansky-Pudlak syndrome DOID_3753 0.04925987 0.09869318 0.04925987 0.13540514 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP insulinoma DOID_3892 0.04925987 0.09834689 0.04925987 0.13475415 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP holoprosencephaly DOID_4621 0.04925987 0.09800302 0.04925987 0.13410939 ZHOU_INFLAMMATORY_RESPONSE_LPS_UP acute T cell leukemia DOID_5603 0.04925987 0.09766154 0.04925987 0.13347078 SENESE_HDAC1_TARGETS_UP multiple myeloma DOID_9538 8.56E-17 4.871E-14 5.189E-08 1.476E-05 SENESE_HDAC1_TARGETS_UP bone marrow cancer DOID_4960 1.166E-16 3.316E-14 1.634E-08 9.3E-06 SENESE_HDAC1_TARGETS_UP myeloma DOID_0070004 1.324E-15 2.511E-13 2.06E-07 2.93E-05 SENESE_HDAC1_TARGETS_UP bone resorption disease DOID_0080011 9.33E-12 1.327E-09 1.631E-07 3.094E-05 SENESE_HDAC1_TARGETS_UP osteoporosis DOID_11476 9.33E-12 1.327E-09 1.631E-07 3.094E-05 SENESE_HDAC1_TARGETS_UP sarcoma DOID_1115 1.412E-10 1.607E-08 1.576E-05 8.968E-04 SENESE_HDAC1_TARGETS_UP spindle cell carcinoma DOID_4015 6.932E-10 6.574E-08 0.0151274 0.10247015 SENESE_HDAC1_TARGETS_UP transitional cell carcinoma DOID_2671 9.005E-10 7.32E-08 9.806E-05 2.325E-03 SENESE_HDAC1_TARGETS_UP nervous system cancer DOID_3093 1.098E-09 7.81E-08 1.259E-03 0.01627485 SENESE_HDAC1_TARGETS_UP carotid artery disease DOID_3407 1.298E-09 8.208E-08 0.04190854 0.23845956 SENESE_HDAC1_TARGETS_UP lymphoma DOID_0060058 1.333E-09 7.584E-08 5.404E-07 4.392E-05 SENESE_HDAC1_TARGETS_UP mouth disease DOID_403 1.611E-09 8.331E-08 1.473E-03 0.01862467 SENESE_HDAC1_TARGETS_UP dilated cardiomyopathy DOID_12930 1.768E-09 8.381E-08 1.052E-05 6.649E-04 SENESE_HDAC1_TARGETS_UP epidermolysis bullosa DOID_2730 2.433E-09 1.065E-07 3.057E-07 3.479E-05 SENESE_HDAC1_TARGETS_UP ocular hypertension DOID_9282 2.433E-09 9.89E-08 1.000 1.000 SENESE_HDAC1_TARGETS_UP borderline glaucoma DOID_9283 2.433E-09 9.89E-08 1.000 1.000 SENESE_HDAC1_TARGETS_UP vesiculobullous skin disease DOID_2731 3.938E-09 1.494E-07 4.399E-07 4.172E-05 SENESE_HDAC1_TARGETS_UP aneurysm disease DOID_2403 7.173E-09 2.551E-07 0.06099835 0.27115671 SENESE_HDAC1_TARGETS_UP thoracic aortic aneurysm DOID_14004 9.113E-09 3.05E-07 2.565E-03 0.02862175 SENESE_HDAC1_TARGETS_UP aortic aneurysm DOID_3627 9.693E-09 3.064E-07 0.02969507 0.17785786 SENESE_HDAC1_TARGETS_UP periodontal disease DOID_3388 3.183E-08 9.532E-07 8.753E-04 0.0124507 SENESE_HDAC1_TARGETS_UP tooth disease DOID_1091 7.011E-08 1.995E-06 4.503E-04 7.32E-03 SENESE_HDAC1_TARGETS_UP allergic contact dermatitis DOID_3042 7.011E-08 1.9E-06 2.931E-05 1.112E-03 SENESE_HDAC1_TARGETS_UP astrocytoma DOID_3069 8.542E-08 2.209E-06 5.902E-03 0.05330512 SENESE_HDAC1_TARGETS_UP contact dermatitis DOID_2773 2.112E-07 5.226E-06 6.29E-05 1.79E-03 SENESE_HDAC1_TARGETS_UP glaucoma DOID_1686 2.617E-07 6.204E-06 0.23218079 0.55046197 SENESE_HDAC1_TARGETS_UP pulmonary tuberculosis DOID_2957 2.617E-07 5.956E-06 0.02866835 0.17353498 SENESE_HDAC1_TARGETS_UP giant cell tumor DOID_200 4.104E-07 8.982E-06 2.91E-03 0.03124271 SENESE_HDAC1_TARGETS_UP malignant giant cell tumor DOID_2705 4.104E-07 8.982E-06 2.91E-03 0.03124271 SENESE_HDAC1_TARGETS_UP giant cell glioblastoma DOID_3074 4.104E-07 8.982E-06 2.91E-03 0.03124271 SENESE_HDAC1_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.239E-07 1.315E-05 1.331E-04 3.029E-03 SENESE_HDAC1_TARGETS_UP glioblastoma DOID_3068 6.873E-07 1.397E-05 3.709E-03 0.03768736 SENESE_HDAC1_TARGETS_UP mesenchymal cell neoplasm DOID_3350 8.331E-07 1.635E-05 2.565E-03 0.02807134 SENESE_HDAC1_TARGETS_UP spindle cell sarcoma DOID_4235 8.331E-07 1.635E-05 2.565E-03 0.02807134 SENESE_HDAC1_TARGETS_UP epithelioid sarcoma DOID_6193 8.331E-07 1.635E-05 2.565E-03 0.02807134 SENESE_HDAC1_TARGETS_UP varicose veins DOID_799 8.331E-07 1.58E-05 1.000 1.000 SENESE_HDAC1_TARGETS_UP intermediate coronary syndrome DOID_8805 8.331E-07 1.529E-05 0.07334553 0.29598301 SENESE_HDAC1_TARGETS_UP pleural disease DOID_1532 9.074E-07 1.613E-05 0.01360426 0.09440026 SENESE_HDAC1_TARGETS_UP neuroectodermal tumor DOID_171 9.164E-07 1.58E-05 1.892E-05 9.787E-04 SENESE_HDAC1_TARGETS_UP pre-malignant neoplasm DOID_0060071 1.101E-06 1.843E-05 2.2E-05 9.628E-04 SENESE_HDAC1_TARGETS_UP in situ carcinoma DOID_8719 1.101E-06 1.843E-05 2.2E-05 9.628E-04 SENESE_HDAC1_TARGETS_UP vein disease DOID_866 1.106E-06 1.799E-05 1.000 1.000 SENESE_HDAC1_TARGETS_UP mineral metabolism disease DOID_0050032 1.204E-06 1.904E-05 4.829E-03 0.04657023 SENESE_HDAC1_TARGETS_UP nephroblastoma DOID_2154 1.208E-06 1.858E-05 3.694E-05 1.314E-03 SENESE_HDAC1_TARGETS_UP uterine disease DOID_345 1.316E-06 1.97E-05 5.033E-03 0.04694872 SENESE_HDAC1_TARGETS_UP tuberculosis DOID_399 1.7E-06 2.48E-05 0.0504934 0.25883553 SENESE_HDAC1_TARGETS_UP bile duct disease DOID_4138 2.171E-06 3.088E-05 5.562E-04 8.554E-03 SENESE_HDAC1_TARGETS_UP biliary tract disease DOID_9741 2.35E-06 3.261E-05 5.853E-04 8.763E-03 SENESE_HDAC1_TARGETS_UP brain edema DOID_4724 2.899E-06 3.928E-05 0.09658454 0.32712264 SENESE_HDAC1_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 2.925E-06 3.871E-05 7.386E-05 2.001E-03 SENESE_HDAC1_TARGETS_UP cystic fibrosis DOID_1485 2.96E-06 3.828E-05 0.05964716 0.26723807 SENESE_HDAC1_TARGETS_UP endometriosis of uterus DOID_288 3.278E-06 4.144E-05 1.552E-03 0.01919355 SENESE_HDAC1_TARGETS_UP rheumatic disease DOID_1575 3.662E-06 4.53E-05 0.20839891 0.5270177 SENESE_HDAC1_TARGETS_UP endometriosis DOID_289 3.662E-06 4.434E-05 1.654E-03 0.02002136 SENESE_HDAC1_TARGETS_UP scleroderma DOID_419 3.662E-06 4.53E-05 0.20839891 0.5270177 SENESE_HDAC1_TARGETS_UP influenza DOID_8469 4.081E-06 4.838E-05 0.21241284 0.53010047 SENESE_HDAC1_TARGETS_UP female reproductive system disease DOID_229 4.26E-06 4.947E-05 8.732E-03 0.06900545 SENESE_HDAC1_TARGETS_UP biliary tract cancer DOID_4607 4.895E-06 5.57E-05 9.318E-03 0.07069074 SENESE_HDAC1_TARGETS_UP sinusitis DOID_0050127 5.236E-06 5.842E-05 0.1102487 0.36471807 SENESE_HDAC1_TARGETS_UP paranasal sinus disease DOID_1352 5.236E-06 5.842E-05 0.1102487 0.36471807 SENESE_HDAC1_TARGETS_UP uremia DOID_4676 5.236E-06 5.729E-05 5.236E-06 3.724E-04 SENESE_HDAC1_TARGETS_UP brain cancer DOID_1319 5.569E-06 5.978E-05 0.22433355 0.547836 SENESE_HDAC1_TARGETS_UP central nervous system cancer DOID_3620 6.149E-06 6.479E-05 0.22826709 0.54573099 SENESE_HDAC1_TARGETS_UP primary bacterial infectious disease DOID_0050338 6.395E-06 6.616E-05 0.07506234 0.29660052 SENESE_HDAC1_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 6.775E-06 6.884E-05 1.427E-04 3.008E-03 SENESE_HDAC1_TARGETS_UP integumentary system benign neoplasm DOID_0060121 6.775E-06 6.763E-05 0.02866835 0.17540095 SENESE_HDAC1_TARGETS_UP skin benign neoplasm DOID_3165 6.775E-06 6.763E-05 0.02866835 0.17540095 SENESE_HDAC1_TARGETS_UP sphingolipidosis DOID_1927 7.421E-06 7.28E-05 2.709E-04 4.973E-03 SENESE_HDAC1_TARGETS_UP calcium metabolism disease DOID_10575 7.45E-06 7.185E-05 2.487E-03 0.0282997 SENESE_HDAC1_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 8.177E-06 7.754E-05 1.654E-04 3.246E-03 SENESE_HDAC1_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 1.052E-05 9.81E-05 1.397E-04 3.058E-03 SENESE_HDAC1_TARGETS_UP integumentary system cancer DOID_0060122 1.165E-05 1.07E-04 0.03504269 0.20346216 SENESE_HDAC1_TARGETS_UP skin cancer DOID_4159 1.165E-05 1.07E-04 0.03504269 0.20346216 SENESE_HDAC1_TARGETS_UP pustulosis of palm and sole DOID_4398 1.165E-05 1.053E-04 2.184E-04 4.143E-03 SENESE_HDAC1_TARGETS_UP middle cerebral artery infarction DOID_3525 1.187E-05 1.055E-04 0.1325669 0.40554068 SENESE_HDAC1_TARGETS_UP seminoma DOID_4440 1.187E-05 1.039E-04 8.845E-03 0.06801202 SENESE_HDAC1_TARGETS_UP periodontitis DOID_824 1.371E-05 1.182E-04 0.13696326 0.40589632 SENESE_HDAC1_TARGETS_UP collagen disease DOID_854 1.892E-05 1.607E-04 0.27763311 0.61229937 SENESE_HDAC1_TARGETS_UP respiratory failure DOID_11162 2.041E-05 1.708E-04 0.28129771 0.6179861 SENESE_HDAC1_TARGETS_UP pneumocystosis DOID_11339 2.048E-05 1.689E-04 1.000 1.000 SENESE_HDAC1_TARGETS_UP invasive lobular carcinoma DOID_3457 2.048E-05 1.665E-04 2.048E-05 9.71E-04 SENESE_HDAC1_TARGETS_UP abdominal aortic aneurysm DOID_7693 2.326E-05 1.864E-04 1.000 1.000 SENESE_HDAC1_TARGETS_UP cholestasis DOID_13580 2.545E-05 2.011E-04 5.033E-03 0.0477312 SENESE_HDAC1_TARGETS_UP cerebral degeneration DOID_1443 2.545E-05 1.984E-04 4.031E-04 6.746E-03 SENESE_HDAC1_TARGETS_UP celiac disease DOID_10608 2.625E-05 2.019E-04 2.625E-05 1.067E-03 SENESE_HDAC1_TARGETS_UP germinoma DOID_3304 2.625E-05 1.992E-04 0.01286931 0.09269164 SENESE_HDAC1_TARGETS_UP pancreatic ductal carcinoma DOID_3587 3.593E-05 2.69E-04 0.30995652 0.66805024 SENESE_HDAC1_TARGETS_UP male reproductive system disease DOID_48 3.837E-05 2.836E-04 0.05434974 0.26431628 SENESE_HDAC1_TARGETS_UP peripheral vascular disease DOID_341 4.095E-05 2.987E-04 6.609E-03 0.05697609 SENESE_HDAC1_TARGETS_UP medullomyoblastoma DOID_3861 4.113E-05 2.962E-04 4.113E-05 1.377E-03 SENESE_HDAC1_TARGETS_UP adult medulloblastoma DOID_3864 4.113E-05 2.962E-04 4.113E-05 1.377E-03 SENESE_HDAC1_TARGETS_UP childhood medulloblastoma DOID_3869 4.113E-05 2.962E-04 4.113E-05 1.377E-03 SENESE_HDAC1_TARGETS_UP pancreatic carcinoma DOID_4905 4.365E-05 3.105E-04 0.32040798 0.68797033 SENESE_HDAC1_TARGETS_UP medulloblastoma DOID_3858 5.052E-05 3.549E-04 5.052E-05 1.597E-03 SENESE_HDAC1_TARGETS_UP embryonal cancer DOID_688 5.052E-05 3.506E-04 5.052E-05 1.513E-03 SENESE_HDAC1_TARGETS_UP skeletal system cancer DOID_0060124 5.563E-05 3.814E-04 1.000 1.000 SENESE_HDAC1_TARGETS_UP bone cancer DOID_184 5.563E-05 3.814E-04 1.000 1.000 SENESE_HDAC1_TARGETS_UP systemic scleroderma DOID_418 6.139E-05 4.158E-04 0.19213867 0.50149956 SENESE_HDAC1_TARGETS_UP metabolic syndrome X DOID_14221 6.29E-05 4.211E-04 8.447E-03 0.06866352 SENESE_HDAC1_TARGETS_UP adult respiratory distress syndrome DOID_11394 6.742E-05 4.46E-04 0.19623462 0.50985159 SENESE_HDAC1_TARGETS_UP intracranial arterial disease DOID_13089 6.742E-05 4.409E-04 0.19623462 0.50753408 SENESE_HDAC1_TARGETS_UP cerebral arterial disease DOID_3527 6.742E-05 4.409E-04 0.19623462 0.50753408 SENESE_HDAC1_TARGETS_UP angiosarcoma DOID_0001816 6.822E-05 4.411E-04 2.922E-03 0.03079064 SENESE_HDAC1_TARGETS_UP pulmonary emphysema DOID_9675 7.386E-05 4.722E-04 0.2003099 0.51340692 SENESE_HDAC1_TARGETS_UP hyperostosis DOID_205 8.253E-05 5.217E-04 8.253E-05 2.134E-03 SENESE_HDAC1_TARGETS_UP primitive neuroectodermal tumor DOID_168 8.809E-05 5.508E-04 8.809E-05 2.179E-03 SENESE_HDAC1_TARGETS_UP primary immunodeficiency disease DOID_612 1.033E-04 6.391E-04 1.209E-03 0.01599189 SENESE_HDAC1_TARGETS_UP cerebral infarction DOID_3526 1.042E-04 6.376E-04 0.21640652 0.53770879 SENESE_HDAC1_TARGETS_UP learning disability DOID_8927 1.042E-04 6.308E-04 1.87E-03 0.02217192 SENESE_HDAC1_TARGETS_UP leishmaniasis DOID_9065 1.167E-04 6.991E-04 1.000 1.000 SENESE_HDAC1_TARGETS_UP heart valve disease DOID_4079 1.224E-04 7.253E-04 0.22433355 0.54087199 SENESE_HDAC1_TARGETS_UP Crohn's disease DOID_8778 1.331E-04 7.807E-04 0.01294595 0.0920781 SENESE_HDAC1_TARGETS_UP lung small cell carcinoma DOID_5409 1.427E-04 8.287E-04 1.427E-04 2.9E-03 SENESE_HDAC1_TARGETS_UP ulcerative colitis DOID_8577 1.613E-04 9.269E-04 0.09158083 0.32366144 SENESE_HDAC1_TARGETS_UP muscular atrophy DOID_767 1.834E-04 1.044E-03 5.514E-03 0.05060437 SENESE_HDAC1_TARGETS_UP bile duct adenocarcinoma DOID_4896 2.042E-04 1.15E-03 0.2514551 0.58638505 SENESE_HDAC1_TARGETS_UP cholangiocarcinoma DOID_4947 2.042E-04 1.15E-03 0.2514551 0.58638505 SENESE_HDAC1_TARGETS_UP parasitic protozoa infectious disease DOID_2789 2.184E-04 1.219E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP diabetic angiopathy DOID_11713 2.393E-04 1.322E-03 6.545E-03 0.05729021 SENESE_HDAC1_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 2.655E-04 1.453E-03 0.26652738 0.5970633 SENESE_HDAC1_TARGETS_UP bile duct cancer DOID_4606 2.655E-04 1.439E-03 0.26652738 0.59472187 SENESE_HDAC1_TARGETS_UP bile duct carcinoma DOID_4897 2.655E-04 1.439E-03 0.26652738 0.59472187 SENESE_HDAC1_TARGETS_UP reading disorder DOID_13365 3.051E-04 1.638E-03 3.051E-04 5.425E-03 SENESE_HDAC1_TARGETS_UP dyslexia DOID_4428 3.051E-04 1.638E-03 3.051E-04 5.425E-03 SENESE_HDAC1_TARGETS_UP combined T cell and B cell immunodeficiency DOID_628 3.051E-04 1.623E-03 3.051E-04 5.261E-03 SENESE_HDAC1_TARGETS_UP extrinsic allergic alveolitis DOID_841 3.816E-04 2.01E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP parasitic infectious disease DOID_1398 4.031E-04 2.104E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 4.24E-04 2.193E-03 9.469E-03 0.07089241 SENESE_HDAC1_TARGETS_UP Sciatic Neuropathy DOID_11446 4.24E-04 2.174E-03 0.13696326 0.41233912 SENESE_HDAC1_TARGETS_UP lesion of sciatic nerve DOID_12528 4.24E-04 2.174E-03 0.13696326 0.41233912 SENESE_HDAC1_TARGETS_UP mononeuritis of lower limb DOID_9473 4.24E-04 2.174E-03 0.13696326 0.41233912 SENESE_HDAC1_TARGETS_UP temporal lobe epilepsy DOID_3328 4.262E-04 2.165E-03 0.29577213 0.64480591 SENESE_HDAC1_TARGETS_UP pleurisy DOID_10247 4.694E-04 2.364E-03 0.01011176 0.07472194 SENESE_HDAC1_TARGETS_UP mononeuritis DOID_1802 4.694E-04 2.343E-03 0.14133745 0.41454128 SENESE_HDAC1_TARGETS_UP invasive ductal carcinoma DOID_3008 4.694E-04 2.323E-03 4.694E-04 7.419E-03 SENESE_HDAC1_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 4.753E-04 2.331E-03 0.0504934 0.26118858 SENESE_HDAC1_TARGETS_UP brain infarction DOID_3454 4.753E-04 2.311E-03 0.30290022 0.65532404 SENESE_HDAC1_TARGETS_UP mononeuropathy DOID_1188 5.178E-04 2.497E-03 0.14568958 0.41656971 SENESE_HDAC1_TARGETS_UP blood coagulation disease DOID_1247 5.282E-04 2.526E-03 6.132E-03 0.05451977 SENESE_HDAC1_TARGETS_UP diabetic retinopathy DOID_8947 6.153E-04 2.918E-03 0.32040798 0.68538398 SENESE_HDAC1_TARGETS_UP opportunistic mycosis DOID_2473 6.238E-04 2.933E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP bronchiolitis obliterans DOID_2799 6.238E-04 2.909E-03 0.15432813 0.42627527 SENESE_HDAC1_TARGETS_UP syndrome DOID_225 6.788E-04 3.14E-03 7.364E-03 0.06161899 SENESE_HDAC1_TARGETS_UP leiomyoma DOID_127 7.428E-04 3.408E-03 0.01360426 0.09556569 SENESE_HDAC1_TARGETS_UP autonomic nervous system neoplasm DOID_2621 7.428E-04 3.381E-03 0.01360426 0.09326291 SENESE_HDAC1_TARGETS_UP neuroblastoma DOID_769 7.428E-04 3.381E-03 0.01360426 0.09326291 SENESE_HDAC1_TARGETS_UP bacterial pneumonia DOID_874 7.467E-04 3.372E-03 0.33409867 0.70933636 SENESE_HDAC1_TARGETS_UP systemic mycosis DOID_0050136 8.073E-04 3.617E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP fungal infectious disease DOID_1564 8.073E-04 3.617E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP metal metabolism disorder DOID_896 8.073E-04 3.589E-03 8.073E-04 0.01177825 SENESE_HDAC1_TARGETS_UP chromosomal disease DOID_0080014 8.574E-04 3.782E-03 8.732E-03 0.06997736 SENESE_HDAC1_TARGETS_UP esophageal disease DOID_6050 8.753E-04 3.831E-03 0.17134539 0.46206411 SENESE_HDAC1_TARGETS_UP hyperthyroidism DOID_7998 8.753E-04 3.802E-03 0.0151274 0.10126462 SENESE_HDAC1_TARGETS_UP focal epilepsy DOID_2234 9.374E-04 4.041E-03 0.35082682 0.73389875 SENESE_HDAC1_TARGETS_UP retinal vascular disease DOID_2462 1.022E-03 4.374E-03 0.35740042 0.74219285 SENESE_HDAC1_TARGETS_UP calcinosis DOID_182 1.101E-03 4.674E-03 0.18388439 0.48665216 SENESE_HDAC1_TARGETS_UP brachydactyly DOID_0050581 1.118E-03 4.712E-03 1.118E-03 0.01551474 SENESE_HDAC1_TARGETS_UP retinal vascular occlusion DOID_1729 1.118E-03 4.677E-03 0.04951192 0.26329234 SENESE_HDAC1_TARGETS_UP Paget's disease of bone DOID_5408 1.118E-03 4.643E-03 1.118E-03 0.01514534 SENESE_HDAC1_TARGETS_UP cutaneous leishmaniasis DOID_9111 1.118E-03 4.609E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP peripheral nervous system neoplasm DOID_1192 1.183E-03 4.843E-03 0.01838128 0.11885172 SENESE_HDAC1_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 1.259E-03 5.115E-03 0.01154648 0.08423011 SENESE_HDAC1_TARGETS_UP hepatitis DOID_2237 1.269E-03 5.123E-03 0.19213867 0.50381062 SENESE_HDAC1_TARGETS_UP peptic ulcer DOID_750 1.269E-03 5.087E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP lymphatic system disease DOID_75 1.36E-03 5.41E-03 0.19623462 0.50523755 SENESE_HDAC1_TARGETS_UP breast benign neoplasm DOID_0060082 1.362E-03 5.381E-03 0.05432693 0.27355771 SENESE_HDAC1_TARGETS_UP thoracic benign neoplasm DOID_0060097 1.362E-03 5.381E-03 0.05432693 0.27355771 SENESE_HDAC1_TARGETS_UP temporal arteritis DOID_13375 1.362E-03 5.344E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP neuronal ceroid lipofuscinosis DOID_14503 1.362E-03 5.307E-03 0.05432693 0.27115809 SENESE_HDAC1_TARGETS_UP benign breast phyllodes tumor DOID_1631 1.362E-03 5.381E-03 0.05432693 0.27355771 SENESE_HDAC1_TARGETS_UP central nervous system vasculitis DOID_525 1.362E-03 5.344E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP common cold DOID_10459 1.629E-03 6.304E-03 0.05911767 0.28506742 SENESE_HDAC1_TARGETS_UP esophageal carcinoma DOID_1107 1.629E-03 6.262E-03 0.05911767 0.2826719 SENESE_HDAC1_TARGETS_UP esophagus squamous cell carcinoma DOID_3748 1.629E-03 6.262E-03 0.05911767 0.2826719 SENESE_HDAC1_TARGETS_UP peritonitis DOID_8283 1.629E-03 6.22E-03 0.05911767 0.27127384 SENESE_HDAC1_TARGETS_UP encephalitis DOID_9588 1.629E-03 6.178E-03 0.05911767 0.2669679 SENESE_HDAC1_TARGETS_UP cataract DOID_83 1.87E-03 7.048E-03 0.02470984 0.1562211 SENESE_HDAC1_TARGETS_UP carotid stenosis DOID_13001 1.918E-03 7.182E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP impotence DOID_1875 1.918E-03 7.135E-03 0.06388427 0.27537994 SENESE_HDAC1_TARGETS_UP leukodystrophy DOID_10579 1.985E-03 7.334E-03 0.02567685 0.16055088 SENESE_HDAC1_TARGETS_UP pre-eclampsia DOID_10591 2.104E-03 7.723E-03 0.22433355 0.55019737 SENESE_HDAC1_TARGETS_UP lens disease DOID_110 2.104E-03 7.674E-03 0.02665906 0.1648805 SENESE_HDAC1_TARGETS_UP neuritis DOID_1803 2.104E-03 7.625E-03 0.22433355 0.54549482 SENESE_HDAC1_TARGETS_UP thyroid adenoma DOID_2891 2.104E-03 7.577E-03 0.22433355 0.54317357 SENESE_HDAC1_TARGETS_UP hypercalcemia DOID_12678 2.231E-03 7.983E-03 2.231E-03 0.02590413 SENESE_HDAC1_TARGETS_UP idiopathic pulmonary fibrosis DOID_0050156 2.565E-03 9.123E-03 0.07334553 0.30241743 SENESE_HDAC1_TARGETS_UP oral submucous fibrosis DOID_5773 2.565E-03 9.067E-03 1.000 1.000 SENESE_HDAC1_TARGETS_UP sarcoidosis DOID_11335 2.91E-03 0.01022138 0.24763914 0.57986284 SENESE_HDAC1_TARGETS_UP atrophic muscular disease DOID_913 2.91E-03 0.01015867 0.03286153 0.19276504 SENESE_HDAC1_TARGETS_UP muscular dystrophy DOID_9884 2.91E-03 0.01015867 0.03286153 0.19276504 SENESE_HDAC1_TARGETS_UP Barrett's esophagus DOID_9206 2.922E-03 0.01013838 0.07804042 0.30207482 SENESE_HDAC1_TARGETS_UP vasculitis DOID_865 3.06E-03 0.01055395 0.2514551 0.58399165 SENESE_HDAC1_TARGETS_UP lymphatic system cancer DOID_0060073 3.301E-03 0.01131401 1.000 1.000 SENESE_HDAC1_TARGETS_UP penile disease DOID_1529 3.301E-03 0.01124626 0.08271165 0.31585858 SENESE_HDAC1_TARGETS_UP bronchitis DOID_6132 3.301E-03 0.01117932 0.08271165 0.31375286 SENESE_HDAC1_TARGETS_UP reticulosarcoma DOID_8538 3.301E-03 0.01131401 1.000 1.000 SENESE_HDAC1_TARGETS_UP lymphosarcoma DOID_8675 3.301E-03 0.01131401 1.000 1.000 SENESE_HDAC1_TARGETS_UP neuroendocrine tumor DOID_169 3.701E-03 0.01246079 0.08735933 0.3206933 SENESE_HDAC1_TARGETS_UP sexual dysfunction DOID_1876 3.701E-03 0.0123875 0.08735933 0.31863757 SENESE_HDAC1_TARGETS_UP inherited blood coagulation disease DOID_2214 3.701E-03 0.01231505 3.701E-03 0.03828862 SENESE_HDAC1_TARGETS_UP prion disease DOID_649 3.701E-03 0.01224346 0.08735933 0.31262554 SENESE_HDAC1_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 3.709E-03 0.01219938 0.26652738 0.59942323 SENESE_HDAC1_TARGETS_UP leukocyte disease DOID_9500 3.883E-03 0.012699 0.0395675 0.2274132 SENESE_HDAC1_TARGETS_UP dissociative disorder DOID_10935 4.123E-03 0.01340463 1.000 1.000 SENESE_HDAC1_TARGETS_UP dissociative amnesia DOID_11037 4.123E-03 0.01340463 1.000 1.000 SENESE_HDAC1_TARGETS_UP Down syndrome DOID_14250 4.123E-03 0.01332847 0.09198359 0.32307817 SENESE_HDAC1_TARGETS_UP testicular cancer DOID_2998 4.123E-03 0.01325317 4.123E-03 0.04115457 SENESE_HDAC1_TARGETS_UP granulosa cell tumor DOID_2999 4.123E-03 0.01317871 0.09198359 0.3210961 SENESE_HDAC1_TARGETS_UP amnestic disorder DOID_10914 4.566E-03 0.01451289 1.000 1.000 SENESE_HDAC1_TARGETS_UP limb-girdle muscular dystrophy DOID_11724 4.566E-03 0.01443226 4.566E-03 0.04478977 SENESE_HDAC1_TARGETS_UP esophagitis DOID_11963 4.566E-03 0.01435252 1.000 1.000 SENESE_HDAC1_TARGETS_UP sex cord-gonadal stromal tumor DOID_192 4.566E-03 0.01427366 0.09658454 0.32908146 SENESE_HDAC1_TARGETS_UP subependymal glioma DOID_4843 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP pilocytic astrocytoma DOID_4851 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP subependymal giant cell astrocytoma DOID_5077 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP fibrillary astrocytoma DOID_6726 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP juvenile pilocytic astrocytoma DOID_6811 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP childhood pilocytic astrocytoma DOID_6812 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP gemistocytic astrocytoma DOID_7005 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP childhood cerebral astrocytoma DOID_7007 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP protoplasmic astrocytoma DOID_7008 4.566E-03 0.01419566 1.000 1.000 SENESE_HDAC1_TARGETS_UP congenital heart defect DOID_1682 4.63E-03 0.01431695 0.04430029 0.24957292 SENESE_HDAC1_TARGETS_UP mitochondrial myopathy DOID_699 5.029E-03 0.01546884 1.000 1.000 SENESE_HDAC1_TARGETS_UP hyperglycemia DOID_4195 5.243E-03 0.01603777 0.29577213 0.64234482 SENESE_HDAC1_TARGETS_UP benign glioma DOID_0060101 5.514E-03 0.01677792 1.000 1.000 SENESE_HDAC1_TARGETS_UP gastric ulcer DOID_10808 5.514E-03 0.01668868 1.000 1.000 SENESE_HDAC1_TARGETS_UP benign ependymoma DOID_4844 5.514E-03 0.01677792 1.000 1.000 SENESE_HDAC1_TARGETS_UP acquired immunodeficiency syndrome DOID_635 5.514E-03 0.01660038 0.10571698 0.3517717 SENESE_HDAC1_TARGETS_UP sexual disorder DOID_0060043 6.019E-03 0.01802573 0.1102487 0.36260988 SENESE_HDAC1_TARGETS_UP opiate dependence DOID_2559 6.019E-03 0.01793135 0.1102487 0.36052591 SENESE_HDAC1_TARGETS_UP IgA glomerulonephritis DOID_2986 6.019E-03 0.01783796 1.000 1.000 SENESE_HDAC1_TARGETS_UP muscle cancer DOID_4045 6.019E-03 0.01774554 0.1102487 0.35846576 SENESE_HDAC1_TARGETS_UP pulmonary embolism DOID_9477 6.019E-03 0.01765406 1.000 1.000 SENESE_HDAC1_TARGETS_UP hypoglycemia DOID_9993 6.019E-03 0.01756353 0.1102487 0.35642903 SENESE_HDAC1_TARGETS_UP aortic valve disease DOID_62 6.545E-03 0.0189993 0.11475757 0.36683741 SENESE_HDAC1_TARGETS_UP meningitis DOID_9471 6.545E-03 0.01890286 1.000 1.000 SENESE_HDAC1_TARGETS_UP severe combined immunodeficiency DOID_627 7.09E-03 0.02037512 7.09E-03 0.06021303 SENESE_HDAC1_TARGETS_UP bronchiolitis DOID_2942 7.656E-03 0.02188942 1.000 1.000 SENESE_HDAC1_TARGETS_UP pancreatitis DOID_4989 7.895E-03 0.02246005 0.06235998 0.2750607 SENESE_HDAC1_TARGETS_UP myositis DOID_633 8.241E-03 0.02332789 1.000 1.000 SENESE_HDAC1_TARGETS_UP ankylosing spondylitis DOID_7147 8.241E-03 0.02321241 8.241E-03 0.06795517 SENESE_HDAC1_TARGETS_UP intracranial aneurysm DOID_10941 8.845E-03 0.02479256 1.000 1.000 SENESE_HDAC1_TARGETS_UP myopia DOID_11830 8.845E-03 0.02467103 8.845E-03 0.06894369 SENESE_HDAC1_TARGETS_UP chronic kidney failure DOID_784 9.318E-03 0.02586247 1.000 1.000 SENESE_HDAC1_TARGETS_UP gestational diabetes DOID_11714 9.469E-03 0.02615448 0.13696326 0.41016892 SENESE_HDAC1_TARGETS_UP migraine DOID_6364 9.469E-03 0.02602813 0.13696326 0.40802143 SENESE_HDAC1_TARGETS_UP coronary stenosis DOID_4248 0.01011176 0.02766149 0.14133745 0.41241543 SENESE_HDAC1_TARGETS_UP supratentorial cancer DOID_1659 0.01077341 0.02933048 1.000 1.000 SENESE_HDAC1_TARGETS_UP toxic encephalopathy DOID_3602 0.01077341 0.02919081 0.14568958 0.41242474 SENESE_HDAC1_TARGETS_UP cerebrum cancer DOID_368 0.01077341 0.02933048 1.000 1.000 SENESE_HDAC1_TARGETS_UP focal glomerulosclerosis DOID_3945 0.01077341 0.02905247 0.14568958 0.41038303 SENESE_HDAC1_TARGETS_UP amino acid metabolic disorder DOID_9252 0.01121101 0.03008992 0.07798865 0.30603821 SENESE_HDAC1_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 0.01145369 0.03059695 0.15001977 0.4184375 SENESE_HDAC1_TARGETS_UP uterine benign neoplasm DOID_0060095 0.01145369 0.03059695 0.15001977 0.4184375 SENESE_HDAC1_TARGETS_UP uterine fibroid DOID_13223 0.01145369 0.03059695 0.15001977 0.4184375 SENESE_HDAC1_TARGETS_UP age related macular degeneration DOID_10871 0.01215239 0.03231173 1.000 1.000 SENESE_HDAC1_TARGETS_UP degeneration of macula and posterior pole DOID_2007 0.01215239 0.03231173 1.000 1.000 SENESE_HDAC1_TARGETS_UP lymphoblastic leukemia DOID_1037 0.01258742 0.03331276 0.08394647 0.31424699 SENESE_HDAC1_TARGETS_UP allergic rhinitis DOID_4481 0.01286931 0.03390111 1.000 1.000 SENESE_HDAC1_TARGETS_UP chronic leukemia DOID_1036 0.01360426 0.03567199 0.16287977 0.44557015 SENESE_HDAC1_TARGETS_UP chronic lymphocytic leukemia DOID_1040 0.01360426 0.03567199 0.16287977 0.44557015 SENESE_HDAC1_TARGETS_UP papilloma DOID_2615 0.01435702 0.03747313 1.000 1.000 SENESE_HDAC1_TARGETS_UP myocarditis DOID_820 0.01435702 0.03730202 0.16712328 0.45499113 SENESE_HDAC1_TARGETS_UP pneumoconiosis DOID_10316 0.0151274 0.03912497 1.000 1.000 SENESE_HDAC1_TARGETS_UP thyroid carcinoma DOID_3963 0.0151274 0.03894793 0.17134539 0.46426441 SENESE_HDAC1_TARGETS_UP macular degeneration DOID_4448 0.0151274 0.03877249 1.000 1.000 SENESE_HDAC1_TARGETS_UP aplastic anemia DOID_12449 0.01591522 0.04060878 1.000 1.000 SENESE_HDAC1_TARGETS_UP thyroid cancer DOID_1781 0.01672026 0.04247245 0.17972583 0.48011268 SENESE_HDAC1_TARGETS_UP refractive error DOID_9835 0.01672026 0.04228369 0.01672026 0.11062592 SENESE_HDAC1_TARGETS_UP pulmonary sarcoidosis DOID_13406 0.01754235 0.04416636 0.18388439 0.48892624 SENESE_HDAC1_TARGETS_UP cleft palate DOID_674 0.01754235 0.04397179 0.01754235 0.114731 SENESE_HDAC1_TARGETS_UP uveitis DOID_13141 0.01838128 0.04587259 1.000 1.000 SENESE_HDAC1_TARGETS_UP blood platelet disease DOID_2218 0.01838128 0.04567228 0.18802196 0.4952986 SENESE_HDAC1_TARGETS_UP Huntington's disease DOID_12858 0.0228221 0.0564599 0.0228221 0.1459076 SENESE_HDAC1_TARGETS_UP uveal disease DOID_3480 0.0228221 0.05621548 1.000 1.000 SENESE_HDAC1_TARGETS_UP gallbladder cancer DOID_3121 0.0237582 0.05826902 0.21241284 0.53479163 SENESE_HDAC1_TARGETS_UP uterine cancer DOID_363 0.0237582 0.05801894 0.21241284 0.53243572 SENESE_HDAC1_TARGETS_UP proteinuria DOID_576 0.02567685 0.06243645 0.22038006 0.54284092 SENESE_HDAC1_TARGETS_UP bone marrow disease DOID_4961 0.02665906 0.06454896 1.000 1.000 SENESE_HDAC1_TARGETS_UP vascular skin disease DOID_9540 0.02665906 0.06427545 0.22433355 0.53858983 SENESE_HDAC1_TARGETS_UP hemolytic anemia DOID_583 0.02765628 0.06639842 0.22826709 0.5434476 SENESE_HDAC1_TARGETS_UP normocytic anemia DOID_720 0.02765628 0.06639842 0.22826709 0.5434476 SENESE_HDAC1_TARGETS_UP hemorrhagic disease DOID_2213 0.03073629 0.07348299 0.23994906 0.56417775 SENESE_HDAC1_TARGETS_UP orofacial cleft DOID_0050567 0.03179183 0.07568851 0.03179183 0.18843285 SENESE_HDAC1_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 0.03504269 0.08308038 0.25525181 0.59039951 SENESE_HDAC1_TARGETS_UP familial hyperlipidemia DOID_1168 0.03615383 0.08535905 0.25902936 0.5919185 SENESE_HDAC1_TARGETS_UP mitochondrial metabolism disease DOID_700 0.03615383 0.08500632 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP adult respiratory distress syndrome DOID_11394 9.14E-07 5.201E-04 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP pulmonary emphysema DOID_9675 9.806E-07 2.79E-04 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP hypersensitivity reaction type IV disease DOID_2916 2.652E-06 5.03E-04 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP respiratory failure DOID_11162 3.215E-06 4.574E-04 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP nephrosis DOID_2527 4.76E-06 5.417E-04 0.03267662 0.50251348 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP cystic fibrosis DOID_1485 5.58E-06 5.292E-04 0.03441398 0.50209111 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP acute kidney failure DOID_3021 8.499E-06 6.908E-04 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP arthropathy DOID_381 1.98E-05 1.409E-03 6.706E-03 0.63599426 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP varicose veins DOID_799 1.98E-05 1.252E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP silicosis DOID_10325 2.263E-05 1.287E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP vein disease DOID_866 2.263E-05 1.17E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP bronchitis DOID_6132 2.564E-05 1.216E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP diabetic angiopathy DOID_11713 5.193E-05 2.273E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP toxic shock syndrome DOID_14115 5.643E-05 2.294E-03 0.01115386 0.70517192 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP commensal bacterial infectious disease DOID_0050339 6.112E-05 2.318E-03 0.01159757 0.65990181 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP portal hypertension DOID_10762 6.112E-05 2.174E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP osteosarcoma DOID_3347 6.112E-05 2.046E-03 0.01159757 0.59991074 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP middle cerebral artery infarction DOID_3525 7.105E-05 2.246E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP hepatic vascular disease DOID_272 8.172E-05 2.447E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP allergic rhinitis DOID_4481 1.053E-04 2.995E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP pneumoconiosis DOID_10316 1.249E-04 3.384E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP pulmonary sarcoidosis DOID_13406 1.461E-04 3.78E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP embryonal cancer DOID_688 1.461E-04 3.616E-03 1.461E-04 0.08315797 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP hepatitis DOID_2237 1.612E-04 3.823E-03 0.01867149 0.50590849 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP peptic ulcer DOID_750 1.612E-04 3.67E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP intracranial arterial disease DOID_13089 1.691E-04 3.7E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP cerebral arterial disease DOID_3527 1.691E-04 3.7E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP lymphatic system disease DOID_75 1.691E-04 3.563E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP cerebral infarction DOID_3526 2.109E-04 4.286E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP learning disability DOID_8927 2.109E-04 4.138E-03 0.0213119 0.52723799 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP leukodystrophy DOID_10579 2.198E-04 4.169E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP hemolytic anemia DOID_583 2.382E-04 4.372E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP normocytic anemia DOID_720 2.382E-04 4.372E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP glaucoma DOID_1686 2.477E-04 4.404E-03 0.02306846 0.50484447 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP sarcoidosis DOID_11335 2.873E-04 4.954E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP bone marrow cancer DOID_4960 2.977E-04 4.982E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP cholestasis DOID_13580 4.237E-04 6.888E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP cerebral degeneration DOID_1443 4.237E-04 6.697E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP brain infarction DOID_3454 4.618E-04 7.102E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP bile duct disease DOID_4138 5.016E-04 7.51E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP male reproductive system disease DOID_48 5.016E-04 7.318E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP peripheral vascular disease DOID_341 5.152E-04 7.328E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP biliary tract disease DOID_9741 5.152E-04 7.15E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP bacterial pneumonia DOID_874 5.859E-04 7.937E-03 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP primary bacterial infectious disease DOID_0050338 7.243E-04 9.585E-03 7.243E-04 0.20606883 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP facioscapulohumeral muscular dystrophy DOID_11727 4.476E-03 0.05787867 4.476E-03 0.84888714 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP teratoma DOID_3307 4.476E-03 0.05659248 4.476E-03 0.63666535 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP malignant teratoma DOID_5563 4.476E-03 0.05659248 4.476E-03 0.63666535 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP mature teratoma DOID_5566 4.476E-03 0.05659248 4.476E-03 0.63666535 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP adrenoleukodystrophy DOID_10588 4.922E-03 0.06088558 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP chronic monocytic leukemia DOID_8593 4.922E-03 0.05959014 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP aortic valve stenosis DOID_1712 5.369E-03 0.06363968 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP retinal detachment DOID_5327 5.369E-03 0.06234091 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP ocular hypertension DOID_9282 5.369E-03 0.06109409 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP borderline glaucoma DOID_9283 5.369E-03 0.06109409 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP berylliosis DOID_10322 5.815E-03 0.06487383 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP newborn respiratory distress syndrome DOID_12716 5.815E-03 0.06362626 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP monocytic leukemia DOID_8527 5.815E-03 0.06242576 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP alcohol dependence DOID_0050741 6.261E-03 0.06596887 6.261E-03 0.71246382 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP viral pneumonia DOID_10533 6.261E-03 0.06476944 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP parasitic helminthiasis infectious disease DOID_883 6.261E-03 0.06361284 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP membranoproliferative glomerulonephritis DOID_2920 6.706E-03 0.06694676 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP lung oat cell carcinoma DOID_5411 6.706E-03 0.06579251 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP angiosarcoma DOID_0001816 7.152E-03 0.06897466 7.152E-03 0.58135785 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP hemolytic-uremic syndrome DOID_12554 7.152E-03 0.06782508 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP urinary system benign neoplasm DOID_731 7.597E-03 0.07086782 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP ureteral obstruction DOID_5199 8.043E-03 0.07381069 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP Kawasaki disease DOID_13378 9.377E-03 0.08469202 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP lymphadenitis DOID_1602 9.377E-03 0.08469202 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP coronary restenosis DOID_4247 9.377E-03 0.0833687 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP lymph node disease DOID_9942 9.377E-03 0.08469202 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP myasthenia gravis DOID_437 0.01026588 0.08986593 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP urinary tract obstruction DOID_5200 0.01026588 0.08850433 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP pulmonary embolism DOID_9477 0.01026588 0.08718337 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP polyarteritis nodosa DOID_9810 0.01026588 0.08590126 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP lingual-facial-buccal dyskinesia DOID_9854 0.01026588 0.08465631 0.01026588 0.73016071 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP Lewy body dementia DOID_12217 0.01070996 0.08705671 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP ureteral disease DOID_1426 0.01070996 0.08583056 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP aortic valve disease DOID_62 0.01070996 0.08463847 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP hypogonadism DOID_1924 0.01159757 0.09039751 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP papillary adenoma DOID_3172 0.01204109 0.09258625 0.01204109 0.57094852 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP neuromuscular junction disease DOID_439 0.01204109 0.09135176 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP microcystic adenoma DOID_5403 0.01204109 0.09258625 0.01204109 0.57094852 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP follicular adenoma DOID_6204 0.01204109 0.09258625 0.01204109 0.57094852 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP seminoma DOID_4440 0.01248443 0.09346895 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP fragments of torsion dystonia DOID_531 0.01248443 0.09225506 0.01248443 0.54643384 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP lung adenocarcinoma DOID_3910 0.01292758 0.09430501 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP renal hypertension DOID_1073 0.01337054 0.09630171 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP secondary hypertension DOID_11130 0.01337054 0.09630171 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP sarcoma DOID_1115 0.01337054 0.09509794 0.01337054 0.54341682 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP malaria DOID_12365 0.01337054 0.09392389 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP coronary stenosis DOID_4248 0.01337054 0.09277848 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP autoimmune disease of the nervous system DOID_438 0.01337054 0.09166067 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP central nervous system hereditary degenerative disease DOID_481 0.01337054 0.09056947 0.01337054 0.50718903 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP toxic encephalopathy DOID_3602 0.01381331 0.09246792 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP focal glomerulosclerosis DOID_3945 0.01381331 0.09139272 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP dystonic disease DOID_544 0.01381331 0.09034222 0.01381331 0.49123585 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP gonadal disease DOID_2277 0.0146983 0.09503785 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP bronchiolitis obliterans DOID_2799 0.0146983 0.09397001 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP abdominal aortic aneurysm DOID_7693 0.0146983 0.09292589 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP germinoma DOID_3304 0.01514051 0.09466977 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP pleural disease DOID_1532 0.01558253 0.09637459 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP papilloma DOID_2615 0.01602437 0.0980416 0.01602437 0.53634521 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP nephroblastoma DOID_2154 0.01646603 0.09967201 0.01646603 0.52050938 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP spindle cell carcinoma DOID_4015 0.01646603 0.09862283 1.000 1.000 CHUANG_OXIDATIVE_STRESS_RESPONSE_UP aplastic anemia DOID_12449 0.01690749 0.099179 0.01690749 0.50633489 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 contact dermatitis DOID_2773 3.397E-12 1.933E-09 2.049E-09 5.829E-07 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 chronic kidney failure DOID_784 5.093E-12 1.449E-09 2.833E-09 5.373E-07 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 allergic contact dermatitis DOID_3042 1.745E-11 3.309E-09 1.187E-08 1.689E-06 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bacterial pneumonia DOID_874 6.866E-11 9.767E-09 6.381E-07 2.793E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 parasitic protozoa infectious disease DOID_2789 8.455E-11 9.621E-09 2.892E-05 3.657E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Human immunodeficiency virus infectious disease DOID_526 2.821E-10 2.675E-08 2.821E-10 1.605E-07 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 parasitic infectious disease DOID_1398 3.711E-10 3.016E-08 6.26E-05 5.937E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 influenza DOID_8469 4.462E-10 3.174E-08 1.983E-04 1.525E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hypersensitivity reaction type I disease DOID_1205 4.79E-10 3.028E-08 1.577E-07 1.496E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 metabolic syndrome X DOID_14221 2.049E-09 1.166E-07 4.208E-08 4.789E-06 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 primary bacterial infectious disease DOID_0050338 4.282E-09 2.215E-07 1.873E-05 2.732E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hypoglycemia DOID_9993 4.555E-09 2.16E-07 3.66E-04 2.45E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 respiratory syncytial virus infectious disease DOID_1273 6.6E-09 2.889E-07 5.813E-06 1.838E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lymphatic system disease DOID_75 7.843E-09 3.187E-07 6.546E-06 1.693E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 endocrine pancreas disease DOID_1428 8.332E-09 3.16E-07 5.829E-05 5.718E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cholestasis DOID_13580 9.393E-09 3.34E-07 2.072E-07 1.684E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bronchiolitis DOID_2942 1.023E-08 3.424E-07 0.01100168 0.03639509 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 rheumatic disease DOID_1575 1.283E-08 4.054E-07 9.183E-06 1.866E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 scleroderma DOID_419 1.283E-08 4.054E-07 9.183E-06 1.866E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 myositis DOID_633 1.309E-08 3.919E-07 5.936E-04 3.671E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 tuberculosis DOID_399 1.331E-08 3.786E-07 7.703E-05 7.185E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 eyelid disease DOID_530 1.573E-08 4.263E-07 7.834E-05 7.19E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bile duct disease DOID_4138 1.856E-08 4.8E-07 3.729E-07 2.357E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 peripheral vascular disease DOID_341 2.066E-08 5.112E-07 6.968E-06 1.724E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 biliary tract disease DOID_9741 2.066E-08 4.899E-07 4.091E-07 2.328E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 diabetic retinopathy DOID_8947 2.297E-08 5.229E-07 7.527E-06 1.647E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pre-eclampsia DOID_10591 2.344E-08 5.13E-07 1.391E-05 2.329E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pleurisy DOID_10247 2.585E-08 5.448E-07 8.129E-04 4.72E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 syndrome DOID_225 2.827E-08 5.745E-07 5.362E-07 2.773E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 sarcoidosis DOID_11335 5.276E-08 1.035E-06 3.911E-04 2.587E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 retinal vascular disease DOID_2462 6.72E-08 1.275E-06 1.644E-05 2.528E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pleural disease DOID_1532 6.888E-08 1.264E-06 1.281E-03 6.689E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bladder disease DOID_365 6.888E-08 1.225E-06 1.281E-03 6.568E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 amino acid metabolic disorder DOID_9252 9.571E-08 1.65E-06 2.126E-05 3.025E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hypersensitivity reaction type IV disease DOID_2916 9.67E-08 1.618E-06 5.425E-04 3.43E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 leukocyte disease DOID_9500 1.084E-07 1.763E-06 5.772E-04 3.609E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 collagen disease DOID_854 1.356E-07 2.143E-06 4.671E-05 4.746E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Crohn's disease DOID_8778 1.455E-07 2.237E-06 2.204E-06 7.836E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 ulcerative colitis DOID_8577 1.999E-07 2.993E-06 3.632E-05 4.218E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 systemic scleroderma DOID_418 2.148E-07 3.134E-06 5.813E-06 1.741E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 intracranial arterial disease DOID_13089 2.484E-07 3.533E-06 6.546E-06 1.774E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cerebral arterial disease DOID_3527 2.484E-07 3.533E-06 6.546E-06 1.774E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 brain infarction DOID_3454 2.799E-07 3.884E-06 5.058E-06 1.693E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 diabetic angiopathy DOID_11713 3.177E-07 4.305E-06 1.319E-05 2.345E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Goodpasture syndrome DOID_9808 3.177E-07 4.205E-06 1.319E-05 2.274E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 nephrosis DOID_2527 3.729E-07 4.822E-06 3.729E-07 2.652E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 uveal disease DOID_3480 3.758E-07 4.752E-06 1.823E-04 1.461E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bronchiectasis DOID_9563 4.36E-07 5.394E-06 1.978E-03 9.075E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 portal hypertension DOID_10762 4.869E-07 5.894E-06 1.838E-05 2.752E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 urticaria DOID_1555 4.869E-07 5.771E-06 5.301E-04 3.389E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cerebral infarction DOID_3526 4.873E-07 5.659E-06 1.136E-05 2.154E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cystitis DOID_1679 5.945E-07 6.766E-06 0.01183432 0.0386996 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 neuritis DOID_1803 6.246E-07 6.969E-06 1.391E-05 2.262E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 vascular skin disease DOID_9540 6.246E-07 6.835E-06 2.523E-04 1.841E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mixed glioma DOID_5076 6.381E-07 6.85E-06 6.381E-07 3.025E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 peritonitis DOID_8283 6.509E-07 6.859E-06 4.778E-05 4.77E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pulmonary tuberculosis DOID_2957 7.921E-07 8.195E-06 4.009E-03 0.01583954 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 malaria DOID_12365 1.034E-06 1.051E-05 3.305E-05 4.088E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hepatic vascular disease DOID_272 1.034E-06 1.032E-05 3.305E-05 4.001E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 atopic dermatitis DOID_3310 1.111E-06 1.09E-05 3.649E-04 2.472E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 giant cell tumor DOID_200 1.238E-06 1.194E-05 2.435E-05 3.299E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 malignant giant cell tumor DOID_2705 1.238E-06 1.194E-05 2.435E-05 3.299E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 giant cell glioblastoma DOID_3074 1.238E-06 1.194E-05 2.435E-05 3.299E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bone marrow cancer DOID_4960 1.376E-06 1.305E-05 4.186E-04 2.738E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 vasculitis DOID_865 1.376E-06 1.284E-05 1.376E-06 5.594E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 transitional cell carcinoma DOID_2671 1.425E-06 1.308E-05 1.425E-06 5.405E-05 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 glioblastoma DOID_3068 2.063E-06 1.864E-05 3.699E-05 4.209E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 oral cavity cancer DOID_8618 2.063E-06 1.835E-05 3.699E-05 4.127E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 alcohol-related neurodevelopmental disorder DOID_0050667 2.204E-06 1.929E-05 2.883E-05 3.728E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mouth disease DOID_403 2.204E-06 1.9E-05 3.195E-04 2.217E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 melancholia DOID_2848 2.273E-06 1.93E-05 4.004E-05 4.298E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 neurotic disorder DOID_4964 2.499E-06 2.091E-05 4.327E-05 4.477E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 respiratory failure DOID_11162 3.008E-06 2.48E-05 6.906E-04 4.18E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pneumoconiosis DOID_10316 3.054E-06 2.482E-05 1.507E-03 7.524E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pulmonary sarcoidosis DOID_13406 4.542E-06 3.64E-05 1.891E-03 8.893E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 multiple myeloma DOID_9538 4.542E-06 3.589E-05 1.891E-03 8.82E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 leishmaniasis DOID_9065 4.928E-06 3.841E-05 0.11010992 0.20407995 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 uveitis DOID_13141 5.147E-06 3.958E-05 2.031E-03 9.173E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 astrocytoma DOID_3069 5.49E-06 4.165E-05 8.237E-05 7.44E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 peptic ulcer DOID_750 5.813E-06 4.352E-05 0.0273436 0.07516189 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pancreatic ductal carcinoma DOID_3587 5.951E-06 4.397E-05 5.951E-06 1.693E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 male reproductive system disease DOID_48 6.443E-06 4.7E-05 1.124E-03 6.036E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 adult respiratory distress syndrome DOID_11394 6.546E-06 4.715E-05 2.331E-03 0.01044196 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pulmonary emphysema DOID_9675 7.348E-06 5.226E-05 7.348E-06 1.742E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pancreatic carcinoma DOID_4905 7.527E-06 5.287E-05 7.527E-06 1.713E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 endogenous depression DOID_1595 8.753E-06 6.074E-05 1.206E-04 1.056E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 acquired immunodeficiency syndrome DOID_635 9.167E-06 6.285E-05 9.167E-06 1.932E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 diabetic autonomic neuropathy DOID_11503 1.023E-05 6.926E-05 1.983E-04 1.545E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autonomic neuropathy DOID_11504 1.023E-05 6.926E-05 1.983E-04 1.545E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 diabetic polyneuropathy DOID_12785 1.023E-05 6.926E-05 1.983E-04 1.545E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 diabetic neuropathy DOID_9743 1.023E-05 6.926E-05 1.983E-04 1.545E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 uremia DOID_4676 1.104E-05 7.393E-05 1.104E-05 2.167E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 proteinuria DOID_576 1.259E-05 8.327E-05 1.259E-05 2.31E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 myeloma DOID_0070004 1.391E-05 9.1E-05 3.587E-03 0.01468398 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autonomic nervous system disease DOID_11465 1.391E-05 8.997E-05 2.523E-04 1.865E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 alcohol abuse DOID_1574 1.438E-05 9.195E-05 1.438E-05 2.273E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mental depression DOID_1596 1.438E-05 9.093E-05 1.811E-04 1.472E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lung small cell carcinoma DOID_5409 1.69E-05 1.057E-04 2.938E-04 2.09E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 ankylosing spondylitis DOID_7147 2.147E-05 1.328E-04 2.147E-05 2.98E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 nervous system cancer DOID_3093 2.263E-05 1.385E-04 2.622E-04 1.889E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 middle cerebral artery infarction DOID_3525 2.493E-05 1.509E-04 2.493E-05 3.299E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 extrinsic allergic alveolitis DOID_841 2.493E-05 1.493E-04 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 childhood type dermatomyositis DOID_14203 2.63E-05 1.559E-04 0.05954482 0.14860088 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 conjunctival disease DOID_4251 2.63E-05 1.543E-04 1.625E-03 8.038E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 conjunctivitis DOID_6195 2.63E-05 1.543E-04 1.625E-03 8.038E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 visceral leishmaniasis DOID_9146 2.63E-05 1.527E-04 0.05954482 0.14356356 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 encephalomyelitis DOID_640 2.716E-05 1.561E-04 3.044E-04 2.138E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Sciatic Neuropathy DOID_11446 2.878E-05 1.638E-04 7.349E-04 4.356E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lesion of sciatic nerve DOID_12528 2.878E-05 1.638E-04 7.349E-04 4.356E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 perinatal necrotizing enterocolitis DOID_8677 2.878E-05 1.621E-04 0.01357958 0.0426894 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mononeuritis of lower limb DOID_9473 2.878E-05 1.638E-04 7.349E-04 4.356E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pustulosis of palm and sole DOID_4398 2.892E-05 1.613E-04 4.475E-04 2.893E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mononeuritis DOID_1802 3.305E-05 1.826E-04 8.129E-04 4.672E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 dermatomyositis DOID_10223 3.6E-05 1.97E-04 0.06530154 0.15417667 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 eosinophilic pneumonia DOID_5870 3.6E-05 1.951E-04 3.6E-05 4.267E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pulmonary eosinophilia DOID_9498 3.6E-05 1.951E-04 3.6E-05 4.267E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Loeffler syndrome DOID_9503 3.6E-05 1.951E-04 3.6E-05 4.267E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mononeuropathy DOID_1188 3.776E-05 2.027E-04 8.96E-04 4.998E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 toxic encephalopathy DOID_3602 3.776E-05 2.008E-04 3.776E-05 4.132E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 corneal disease DOID_10124 4.295E-05 2.263E-04 4.295E-05 4.526E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 carotid artery disease DOID_3407 4.671E-05 2.438E-04 6.512E-04 3.984E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 opportunistic mycosis DOID_2473 4.864E-05 2.516E-04 1.078E-03 5.84E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bronchiolitis obliterans DOID_2799 4.864E-05 2.493E-04 0.01738012 0.05177639 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 newborn respiratory distress syndrome DOID_12716 6.184E-05 3.141E-04 6.184E-05 5.963E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 psoriatic arthritis DOID_9008 6.184E-05 3.114E-04 2.782E-03 0.01199221 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 temporal lobe epilepsy DOID_3328 6.716E-05 3.352E-04 8.651E-04 4.923E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hyperglycemia DOID_4195 6.716E-05 3.323E-04 8.809E-03 0.03037689 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 systemic mycosis DOID_0050136 6.902E-05 3.386E-04 1.391E-03 7.069E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 fungal infectious disease DOID_1564 6.902E-05 3.386E-04 1.391E-03 7.069E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 spindle cell carcinoma DOID_4015 7.702E-05 3.746E-04 0.02157575 0.06169147 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 esophageal disease DOID_6050 7.702E-05 3.714E-04 0.20326164 0.31090289 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 endocrine organ benign neoplasm DOID_0060089 7.703E-05 3.683E-04 9.631E-04 5.269E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 aplastic anemia DOID_12449 8.567E-05 4.062E-04 0.02268388 0.06421458 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lung oat cell carcinoma DOID_5411 9.749E-05 4.584E-04 3.715E-03 0.01488604 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 panic disorder DOID_594 9.749E-05 4.547E-04 9.749E-05 8.667E-04 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 silicosis DOID_10325 1.194E-04 5.525E-04 4.229E-03 0.01659367 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cystic fibrosis DOID_1485 1.206E-04 5.536E-04 0.01228848 0.03972809 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hepatitis DOID_2237 1.274E-04 5.801E-04 0.22736817 0.34045392 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 electroclinical syndrome DOID_0050701 1.36E-04 6.143E-04 1.36E-04 1.173E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pancreatitis DOID_4989 1.36E-04 6.094E-04 1.502E-03 7.563E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 adenoid cystic carcinoma DOID_4866 1.398E-04 6.216E-04 1.398E-04 1.188E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 salivary gland cancer DOID_8850 1.672E-04 7.376E-04 1.672E-04 1.399E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 eosinophilia DOID_999 1.725E-04 7.549E-04 1.725E-04 1.422E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 focal epilepsy DOID_2234 1.811E-04 7.864E-04 1.878E-03 8.978E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bone development disease DOID_0080006 1.913E-04 8.246E-04 1.913E-04 1.512E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 dissociative disorder DOID_10935 2.039E-04 8.723E-04 5.953E-03 0.02171497 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 dissociative amnesia DOID_11037 2.039E-04 8.723E-04 5.953E-03 0.02171497 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 testicular cancer DOID_2998 2.039E-04 8.658E-04 2.039E-04 1.547E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 learning disability DOID_8927 2.153E-04 9.073E-04 3.194E-03 0.01346191 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 amnestic disorder DOID_10914 2.388E-04 9.991E-04 6.588E-03 0.02372677 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 esophagitis DOID_11963 2.388E-04 9.918E-04 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 primary immunodeficiency disease DOID_612 2.492E-04 1.027E-03 2.492E-04 1.866E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bone marrow disease DOID_4961 2.523E-04 1.033E-03 0.03768882 0.10068047 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Kawasaki disease DOID_13378 2.773E-04 1.127E-03 0.1209737 0.21645923 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lymphadenitis DOID_1602 2.773E-04 1.127E-03 0.1209737 0.21645923 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mitochondrial myopathy DOID_699 2.773E-04 1.119E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lymph node disease DOID_9942 2.773E-04 1.127E-03 0.1209737 0.21645923 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 gastric ulcer DOID_10808 3.197E-04 1.281E-03 7.946E-03 0.02790942 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 neutropenia DOID_1227 3.197E-04 1.272E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 withdrawal disorder DOID_0060001 3.4E-04 1.343E-03 3.4E-04 2.331E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 sinusitis DOID_0050127 3.66E-04 1.436E-03 8.668E-03 0.03007376 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 agranulocytosis DOID_12987 3.66E-04 1.426E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 paranasal sinus disease DOID_1352 3.66E-04 1.436E-03 8.668E-03 0.03007376 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 polyarteritis nodosa DOID_9810 3.66E-04 1.417E-03 0.13170542 0.22572405 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pre-malignant neoplasm DOID_0060071 7.316E-04 2.813E-03 7.316E-04 4.382E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 in situ carcinoma DOID_8719 7.316E-04 2.813E-03 7.316E-04 4.382E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 migraine DOID_6364 7.349E-04 2.807E-03 0.01357958 0.04292656 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autoimmune disease of cardiovascular system DOID_0060051 8.129E-04 3.084E-03 8.129E-04 4.769E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 sarcoma DOID_1115 8.129E-04 3.063E-03 0.16824937 0.27043472 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Behcet's disease DOID_13241 8.129E-04 3.084E-03 8.129E-04 4.769E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 polycystic ovary syndrome DOID_11612 8.96E-04 3.354E-03 8.96E-04 5.048E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 focal glomerulosclerosis DOID_3945 8.96E-04 3.332E-03 8.96E-04 4.95E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cranial nerve disease DOID_5656 8.96E-04 3.31E-03 0.01542911 0.0471998 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 tooth disease DOID_1091 9.132E-04 3.352E-03 9.162E-03 0.03140571 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 allergic rhinitis DOID_4481 1.177E-03 4.292E-03 1.177E-03 6.258E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 leiomyoma DOID_127 1.281E-03 4.644E-03 1.281E-03 6.751E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autonomic nervous system neoplasm DOID_2621 1.281E-03 4.614E-03 1.281E-03 6.628E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 neuroblastoma DOID_769 1.281E-03 4.614E-03 1.281E-03 6.628E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 papilloma DOID_2615 1.391E-03 4.98E-03 0.02049098 0.05979163 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 myocarditis DOID_820 1.391E-03 4.949E-03 0.02049098 0.05948657 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 metal metabolism disorder DOID_896 1.391E-03 4.918E-03 0.02049098 0.05918461 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 leukopenia DOID_615 1.507E-03 5.295E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hyperthyroidism DOID_7998 1.507E-03 5.262E-03 0.02157575 0.06138301 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hypolipoproteinemia DOID_1387 1.625E-03 5.636E-03 0.05954482 0.14925551 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 retinal vascular occlusion DOID_1729 1.625E-03 5.602E-03 0.05954482 0.1473087 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bilirubin metabolic disorder DOID_2741 1.625E-03 5.569E-03 0.05954482 0.146671 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 acute kidney failure DOID_3021 1.625E-03 5.535E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 keratitis DOID_4677 1.625E-03 5.502E-03 1.625E-03 7.969E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 Paget's disease of bone DOID_5408 1.625E-03 5.47E-03 1.625E-03 7.901E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cutaneous leishmaniasis DOID_9111 1.625E-03 5.438E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 childhood electroclinical syndrome DOID_0050704 1.629E-03 5.422E-03 1.629E-03 7.857E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lipid metabolism disorder DOID_3146 1.645E-03 5.443E-03 0.01405329 0.04393584 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 female reproductive system disease DOID_229 1.72E-03 5.659E-03 0.09198625 0.18494761 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 biliary tract cancer DOID_4607 1.878E-03 6.14E-03 0.0154664 0.04706088 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 adolescence-adult electroclinical syndrome DOID_0050705 1.891E-03 6.149E-03 1.891E-03 8.967E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 trypanosomiasis DOID_10113 1.978E-03 6.393E-03 0.06530154 0.15481907 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 sickle cell anemia DOID_10923 1.978E-03 6.357E-03 0.06530154 0.15353957 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pneumocystosis DOID_11339 1.978E-03 6.322E-03 0.06530154 0.15290772 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 craniosynostosis DOID_2340 1.978E-03 6.286E-03 1.978E-03 9.148E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 peripheral nervous system neoplasm DOID_1192 2.031E-03 6.421E-03 2.031E-03 9.247E-03 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 congenital diaphragmatic hernia DOID_3827 2.178E-03 6.846E-03 0.0273436 0.07552675 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 intracranial arteriosclerosis DOID_13097 2.364E-03 7.389E-03 0.07102318 0.16100473 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 vascular dementia DOID_8725 2.364E-03 7.389E-03 0.07102318 0.16100473 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 encephalitis DOID_9588 2.364E-03 7.349E-03 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 spinocerebellar ataxia DOID_1441 2.656E-03 8.213E-03 2.656E-03 0.01180619 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lymphoma DOID_0060058 2.71E-03 8.334E-03 0.11322045 0.20916376 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 osteogenesis imperfecta DOID_12347 2.782E-03 8.511E-03 2.782E-03 0.0122711 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 vulva cancer DOID_1245 2.782E-03 8.465E-03 2.782E-03 0.01217671 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 epilepsy with generalized tonic-clonic seizures DOID_7725 2.782E-03 8.42E-03 2.782E-03 0.01208376 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 nephrotic syndrome DOID_1184 2.828E-03 8.515E-03 2.828E-03 0.01210067 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 gallbladder cancer DOID_3121 3.008E-03 9.008E-03 0.03365592 0.09119153 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 uterine cancer DOID_363 3.008E-03 8.96E-03 3.008E-03 0.01277185 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 viral pneumonia DOID_10533 3.233E-03 9.58E-03 3.233E-03 0.01352479 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 eating disorder DOID_8670 3.233E-03 9.53E-03 3.233E-03 0.01342607 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 spinocerebellar degeneration DOID_2478 3.387E-03 9.934E-03 3.387E-03 0.0139654 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 brain cancer DOID_1319 3.587E-03 0.01046705 0.03768882 0.10163478 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 thyroid adenoma DOID_2891 3.587E-03 0.01041364 0.03768882 0.10115537 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 membranoproliferative glomerulonephritis DOID_2920 3.715E-03 0.01073004 3.715E-03 0.0150987 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mesenchymal cell neoplasm DOID_3350 3.715E-03 0.01067585 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 adrenal cortex disease DOID_3952 3.715E-03 0.0106222 3.715E-03 0.01499161 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 spindle cell sarcoma DOID_4235 3.715E-03 0.01067585 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 epithelioid sarcoma DOID_6193 3.715E-03 0.01067585 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hyperhomocysteinemia DOID_9279 3.715E-03 0.01056909 0.08797969 0.1775193 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 central nervous system cancer DOID_3620 3.794E-03 0.01074104 0.03907227 0.10388842 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hemolytic anemia DOID_583 3.794E-03 0.01068787 0.03907227 0.10340522 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 normocytic anemia DOID_720 3.794E-03 0.01068787 0.03907227 0.10340522 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 glaucoma DOID_1686 4.009E-03 0.01123593 4.009E-03 0.01595031 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hemolytic-uremic syndrome DOID_12554 4.229E-03 0.01179452 0.09356309 0.18614476 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 tongue cancer DOID_8649 4.229E-03 0.01173699 0.09356309 0.18357724 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 calcium metabolism disease DOID_10575 4.23E-03 0.01168422 0.27787648 0.40541466 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 aortic aneurysm DOID_3627 4.23E-03 0.01162778 0.04189618 0.1103654 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 movement disease DOID_480 4.23E-03 0.01157187 4.23E-03 0.01648596 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lymphatic system cancer DOID_0060073 4.773E-03 0.01299492 0.09911246 0.19313353 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 schizophreniform disorder DOID_11328 4.773E-03 0.01293304 4.773E-03 0.01847578 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 drug-induced mental disorder DOID_1203 4.773E-03 0.01287175 0.09911246 0.19247437 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 methylmalonic acidemia DOID_14749 4.773E-03 0.01281103 0.09911246 0.19116946 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 drug psychosis DOID_1742 4.773E-03 0.01287175 0.09911246 0.19247437 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hyperostosis DOID_205 4.773E-03 0.01275089 4.773E-03 0.01835094 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 schizoaffective disorder DOID_5418 4.773E-03 0.01293304 4.773E-03 0.01847578 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bronchitis DOID_6132 4.773E-03 0.01269131 4.773E-03 0.01822778 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 reticulosarcoma DOID_8538 4.773E-03 0.01299492 0.09911246 0.19313353 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 substance-induced psychosis DOID_8646 4.773E-03 0.01287175 0.09911246 0.19247437 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lymphosarcoma DOID_8675 4.773E-03 0.01299492 0.09911246 0.19313353 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 adrenal gland disease DOID_9553 4.773E-03 0.01263228 4.773E-03 0.01810626 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 atrophic muscular disease DOID_913 4.939E-03 0.01301008 4.939E-03 0.01861044 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 muscular dystrophy DOID_9884 4.939E-03 0.01301008 4.939E-03 0.01861044 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 congenital muscular dystrophy DOID_0050557 5.348E-03 0.0140238 5.348E-03 0.02002082 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 prion disease DOID_649 5.348E-03 0.01395947 5.348E-03 0.01988996 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 osteochondrodysplasia DOID_2256 5.449E-03 0.01415641 5.449E-03 0.02013153 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 familial hyperlipidemia DOID_1168 5.715E-03 0.01478081 5.715E-03 0.02097922 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mitochondrial metabolism disease DOID_700 5.715E-03 0.01471393 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 psoriasis DOID_8893 5.953E-03 0.01525917 5.953E-03 0.02157665 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 membranous glomerulonephritis DOID_10976 6.588E-03 0.0168109 6.588E-03 0.02357755 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 pulmonary edema DOID_11396 6.588E-03 0.01673585 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 brain edema DOID_4724 6.588E-03 0.01666147 6.588E-03 0.02343019 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autoimmune hepatitis DOID_2048 7.253E-03 0.01826032 0.1209737 0.21578068 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hypothyroidism DOID_1459 7.476E-03 0.01873889 7.476E-03 0.02642068 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 familial hypercholesterolemia DOID_13810 7.946E-03 0.01983038 7.946E-03 0.0277382 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 mineral metabolism disease DOID_0050032 8.126E-03 0.02019113 0.33743204 0.48362426 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 uterine disease DOID_345 8.463E-03 0.02093769 0.34149386 0.4869925 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 optic nerve disease DOID_1891 8.668E-03 0.02135107 0.13170542 0.22987848 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 IgA glomerulonephritis DOID_2986 8.668E-03 0.02125904 0.13170542 0.22847678 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 synostosis DOID_11971 9.418E-03 0.02299971 9.418E-03 0.03208941 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 meningitis DOID_9471 9.418E-03 0.02290142 9.418E-03 0.0318984 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 spastic quadriplegia DOID_10970 0.01019617 0.02468775 0.14230668 0.24098959 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 toxic shock syndrome DOID_14115 0.01019617 0.02458314 0.01019617 0.03432912 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 severe combined immunodeficiency DOID_627 0.01019617 0.02447941 0.01019617 0.03412718 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 blood coagulation disease DOID_1247 0.01027221 0.02455836 0.07386123 0.16226657 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 commensal bacterial infectious disease DOID_0050339 0.01100168 0.02619228 0.01100168 0.03660793 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 organic acidemia DOID_0060159 0.01100168 0.02608315 0.14755888 0.24767257 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 combined T cell and B cell immunodeficiency DOID_628 0.01100168 0.02597492 0.01100168 0.03618471 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cleft lip DOID_9296 0.01183432 0.02782533 0.01183432 0.03847846 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 myopia DOID_11830 0.01269374 0.02972321 0.01269374 0.04080644 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 B cell deficiency DOID_2115 0.01269374 0.02960139 0.01269374 0.04057719 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bone resorption disease DOID_0080011 0.01271696 0.02953448 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 osteoporosis DOID_11476 0.01271696 0.02953448 1.000 1.000 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 aneurysm disease DOID_2403 0.01271696 0.02941442 0.08458897 0.17502227 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 gestational diabetes DOID_11714 0.01357958 0.03128252 0.01357958 0.04316638 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 lung adenocarcinoma DOID_3910 0.01357958 0.03115638 0.16312411 0.26368641 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 periodontitis DOID_824 0.01357958 0.03103125 0.16312411 0.26293943 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 renal hypertension DOID_1073 0.01449149 0.03298262 0.01449149 0.04505823 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 secondary hypertension DOID_11130 0.01449149 0.03298262 0.01449149 0.04505823 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 thrombocytopenia DOID_1588 0.01449149 0.03285122 0.16824937 0.26967294 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 chromosomal disease DOID_0080014 0.01451577 0.03277569 0.01451577 0.04488845 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autoimmune disease of endocrine system DOID_0060005 0.01542911 0.03470025 0.17334338 0.27474201 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 dystonic disease DOID_544 0.01542911 0.03456363 0.01542911 0.04745493 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 female reproductive organ benign neoplasm DOID_0060086 0.0163921 0.03657689 0.0163921 0.04961227 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 uterine benign neoplasm DOID_0060095 0.0163921 0.03657689 0.0163921 0.04961227 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 uterine fibroid DOID_13223 0.0163921 0.03657689 0.0163921 0.04961227 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 dysostosis DOID_1934 0.0163921 0.03643401 0.0163921 0.04934977 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 endometrial carcinoma DOID_2871 0.0163921 0.03629224 0.0163921 0.04909003 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 spastic cerebral palsy DOID_0050669 0.01738012 0.03833058 0.18343839 0.28913143 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 abdominal aortic aneurysm DOID_7693 0.01738012 0.03818259 0.18343839 0.28753842 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 endometrial cancer DOID_1380 0.01839283 0.04025201 0.01839283 0.05450793 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 germinoma DOID_3304 0.01839283 0.04009779 0.01839283 0.05422551 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 childhood absence epilepsy DOID_1825 0.0194299 0.04219699 0.0194299 0.05698769 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hepatitis C DOID_1883 0.02157575 0.0466791 0.02157575 0.06200304 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 periodontal disease DOID_3388 0.02157575 0.04650228 0.20326164 0.31343056 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 thyroid carcinoma DOID_3963 0.02157575 0.0463268 0.20326164 0.31258345 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 dilated cardiomyopathy DOID_12930 0.02189427 0.04683398 0.11921378 0.21466026 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 thyroid cancer DOID_1781 0.02381506 0.05075194 0.21299284 0.32232161 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 adenoma DOID_657 0.02381506 0.05056256 0.02381506 0.067083 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 refractive error DOID_9835 0.02381506 0.0503746 0.02381506 0.06675255 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 calcinosis DOID_182 0.02496894 0.05261974 0.21781396 0.32874309 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cleft palate DOID_674 0.02496894 0.05242557 0.02496894 0.06964377 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 microcephaly DOID_10907 0.02614523 0.05469352 0.02614523 0.07256896 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 blood platelet disease DOID_2218 0.02614523 0.05449318 0.22260568 0.33420219 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cervix uteri carcinoma in situ DOID_8991 0.02980536 0.06189507 0.02980536 0.08153485 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autoimmune disease of urogenital tract DOID_0060049 0.03106813 0.06428278 0.24148204 0.36063853 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 primary biliary cirrhosis DOID_12236 0.03106813 0.06428278 0.24148204 0.36063853 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 endometriosis of uterus DOID_288 0.03106813 0.06404987 0.24148204 0.35969445 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hyperinsulinism DOID_2018 0.03235175 0.06645539 0.03235175 0.08807724 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 endometriosis DOID_289 0.03235175 0.06621635 0.24612938 0.36470733 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 heart valve disease DOID_4079 0.03768882 0.07686358 0.26443694 0.38879746 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 autoimmune disease of gastrointestinal tract DOID_0060031 0.04047482 0.08225061 0.27342402 0.40097492 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 integumentary system benign neoplasm DOID_0060121 0.04047482 0.08195791 0.27342402 0.39994413 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 skin benign neoplasm DOID_3165 0.04047482 0.08195791 0.27342402 0.39994413 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 hemorrhagic disease DOID_2213 0.04333607 0.08744051 0.28230177 0.41081767 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 B-cell lymphocytic neoplasm DOID_707 0.04333607 0.08713154 0.28230177 0.40976966 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 orofacial cleft DOID_0050567 0.04479422 0.08974616 0.04479422 0.11745581 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 bile duct adenocarcinoma DOID_4896 0.04776418 0.09536076 0.04776418 0.12466889 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 cholangiocarcinoma DOID_4947 0.04776418 0.09536076 0.04776418 0.12466889 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 reproductive organ benign neoplasm DOID_0050622 0.04927545 0.09803402 0.04927545 0.12802617 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 integumentary system cancer DOID_0060122 0.04927545 0.09769244 0.29973454 0.43396681 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 skin cancer DOID_4159 0.04927545 0.09769244 0.29973454 0.43396681 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 smallpox DOID_8736 0.04927545 0.09735323 0.04927545 0.12744423 APPIERTO_RESPONSE_TO_FENRETINIDE_UP trypanosomiasis DOID_10113 1.45E-05 8.251E-03 5.789E-03 0.65873627 APPIERTO_RESPONSE_TO_FENRETINIDE_UP mouth disease DOID_403 1.739E-05 4.946E-03 0.04945701 0.48519033 APPIERTO_RESPONSE_TO_FENRETINIDE_UP periodontitis DOID_824 1.064E-04 0.02018692 1.000 1.000 APPIERTO_RESPONSE_TO_FENRETINIDE_UP abdominal aortic aneurysm DOID_7693 1.382E-04 0.01966481 1.000 1.000 APPIERTO_RESPONSE_TO_FENRETINIDE_UP periodontal disease DOID_3388 1.742E-04 0.01981848 1.000 1.000 APPIERTO_RESPONSE_TO_FENRETINIDE_UP idiopathic generalized epilepsy DOID_1827 2.699E-04 0.02559285 2.699E-04 0.15355711 APPIERTO_RESPONSE_TO_FENRETINIDE_UP aortic aneurysm DOID_3627 3.585E-04 0.02914199 1.000 1.000 APPIERTO_RESPONSE_TO_FENRETINIDE_UP parasitic protozoa infectious disease DOID_2789 4.294E-04 0.03053965 0.03016477 0.3814168 APPIERTO_RESPONSE_TO_FENRETINIDE_UP respiratory failure DOID_11162 5.391E-04 0.03408323 0.03374633 0.41742742 APPIERTO_RESPONSE_TO_FENRETINIDE_UP mineral metabolism disease DOID_0050032 5.727E-04 0.03258622 5.727E-04 0.1629311 APPIERTO_RESPONSE_TO_FENRETINIDE_UP parasitic infectious disease DOID_1398 5.899E-04 0.03051188 0.03527743 0.40965018 APPIERTO_RESPONSE_TO_FENRETINIDE_UP tooth disease DOID_1091 6.249E-04 0.02963256 1.000 1.000 APPIERTO_RESPONSE_TO_FENRETINIDE_UP aneurysm disease DOID_2403 7.95E-04 0.03479733 1.000 1.000 GNATENKO_PLATELET_SIGNATURE hemorrhagic disease DOID_2213 1.458E-07 8.299E-05 1.446E-05 8.227E-03 GNATENKO_PLATELET_SIGNATURE blood coagulation disease DOID_1247 4.961E-07 1.412E-04 3.585E-05 0.01019932 GNATENKO_PLATELET_SIGNATURE bone resorption disease DOID_0080011 4.542E-05 8.615E-03 2.171E-03 0.12352276 GNATENKO_PLATELET_SIGNATURE osteoporosis DOID_11476 4.542E-05 8.615E-03 2.171E-03 0.12352276 GNATENKO_PLATELET_SIGNATURE mixed glioma DOID_5076 4.716E-05 6.709E-03 4.716E-05 8.945E-03 GNATENKO_PLATELET_SIGNATURE bone development disease DOID_0080006 5.854E-05 6.661E-03 2.566E-03 0.13270848 GNATENKO_PLATELET_SIGNATURE inherited blood coagulation disease DOID_2214 1.114E-04 0.01056841 1.114E-04 0.01585261 GNATENKO_PLATELET_SIGNATURE psoriasis DOID_8893 1.245E-04 0.01011884 1.245E-04 0.01416638 GNATENKO_PLATELET_SIGNATURE diabetic angiopathy DOID_11713 2.004E-04 0.01425177 1.000 1.000 GNATENKO_PLATELET_SIGNATURE thrombocytopenia DOID_1588 3.148E-04 0.0199011 3.148E-04 0.02985165 GNATENKO_PLATELET_SIGNATURE blood platelet disease DOID_2218 5.898E-04 0.03356165 5.898E-04 0.04794521 GNATENKO_PLATELET_SIGNATURE pre-eclampsia DOID_10591 8.769E-04 0.04535716 0.04263458 0.53909053 GNATENKO_PLATELET_SIGNATURE hemolytic anemia DOID_583 9.121E-04 0.0432509 1.000 1.000 GNATENKO_PLATELET_SIGNATURE normocytic anemia DOID_720 9.121E-04 0.0432509 1.000 1.000 GNATENKO_PLATELET_SIGNATURE osteochondrodysplasia DOID_2256 1.178E-03 0.05156347 0.04929045 0.56092531 GNATENKO_PLATELET_SIGNATURE parasitic protozoa infectious disease DOID_2789 1.178E-03 0.04788036 1.000 1.000 GNATENKO_PLATELET_SIGNATURE carotid artery disease DOID_3407 1.432E-03 0.0543244 1.432E-03 0.10185826 GNATENKO_PLATELET_SIGNATURE parasitic infectious disease DOID_1398 1.615E-03 0.05742289 1.000 1.000 GNATENKO_PLATELET_SIGNATURE hyperglycemia DOID_4195 1.662E-03 0.05562812 1.000 1.000 GNATENKO_PLATELET_SIGNATURE allergic contact dermatitis DOID_3042 1.71E-03 0.0540535 0.0591902 0.59086357 GNATENKO_PLATELET_SIGNATURE endocrine organ benign neoplasm DOID_0060089 1.759E-03 0.05266426 0.06001065 0.58872518 GNATENKO_PLATELET_SIGNATURE peripheral vascular disease DOID_341 1.96E-03 0.05574836 1.000 1.000 GNATENKO_PLATELET_SIGNATURE syndrome DOID_225 2.117E-03 0.05736239 2.117E-03 0.13384558 GNATENKO_PLATELET_SIGNATURE contact dermatitis DOID_2773 2.336E-03 0.06042181 0.06898996 0.64352925 GNATENKO_PLATELET_SIGNATURE encephalomyelitis DOID_640 3.119E-03 0.077157 0.07949465 0.68534026 GNATENKO_PLATELET_SIGNATURE alcohol-related neurodevelopmental disorder DOID_0050667 3.183E-03 0.07547438 0.08029793 0.68193315 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP Ehlers-Danlos syndrome DOID_13359 6.441E-18 3.665E-15 6.441E-18 3.665E-15 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP collagen disease DOID_854 5.983E-13 1.702E-10 5.983E-13 1.702E-10 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP heart valve disease DOID_4079 1.674E-11 3.175E-09 1.674E-11 3.175E-09 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP bone development disease DOID_0080006 4.814E-10 6.848E-08 4.814E-10 6.848E-08 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP aortic valve insufficiency DOID_57 5.789E-10 6.588E-08 5.789E-10 6.588E-08 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP osteochondrodysplasia DOID_2256 5.047E-09 4.786E-07 5.047E-09 4.786E-07 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP aortic valve disease DOID_62 1.231E-08 1.001E-06 1.231E-08 1.001E-06 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP aneurysm disease DOID_2403 2.441E-08 1.736E-06 2.441E-08 1.736E-06 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP osteogenesis imperfecta DOID_12347 3.332E-07 2.107E-05 3.332E-07 2.107E-05 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP atrophic muscular disease DOID_913 4.15E-07 2.361E-05 4.15E-07 2.361E-05 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP muscular dystrophy DOID_9884 4.15E-07 2.361E-05 4.15E-07 2.361E-05 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP oral submucous fibrosis DOID_5773 5.293E-07 2.738E-05 5.293E-07 2.738E-05 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP intracranial aneurysm DOID_10941 3.774E-06 1.79E-04 3.774E-06 1.79E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP spastic diplegia DOID_10965 1.356E-04 5.936E-03 1.356E-04 5.936E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP mouth disease DOID_403 1.564E-04 6.357E-03 1.564E-04 6.357E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP Crohn's disease DOID_8778 1.564E-04 5.933E-03 4.879E-03 0.10678413 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP ureteral obstruction DOID_5199 1.727E-04 6.141E-03 1.727E-04 6.55E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP urinary tract obstruction DOID_5200 2.846E-04 9.525E-03 2.846E-04 0.01012009 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP diabetic angiopathy DOID_11713 3.102E-04 9.807E-03 3.102E-04 0.01038357 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP ureteral disease DOID_1426 3.102E-04 9.291E-03 3.102E-04 9.807E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP spastic quadriplegia DOID_10970 3.37E-04 9.587E-03 3.37E-04 0.01009152 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP multiple epiphyseal dysplasia DOID_12721 5.202E-04 0.01409411 5.202E-04 0.01479882 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP focal glomerulosclerosis DOID_3945 5.202E-04 0.01345347 5.202E-04 0.01409411 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP corneal disease DOID_10124 5.545E-04 0.01371705 0.03404716 0.31758748 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP spastic cerebral palsy DOID_0050669 5.898E-04 0.01398402 5.898E-04 0.0152553 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP congenital diaphragmatic hernia DOID_3827 9.559E-04 0.0217569 0.04445303 0.31617217 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP aortic aneurysm DOID_3627 1.518E-03 0.03323089 1.518E-03 0.03756535 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP peripheral vascular disease DOID_341 3.012E-03 0.06348001 3.012E-03 0.07141501 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP bone resorption disease DOID_0080011 3.335E-03 0.06777749 3.335E-03 0.07591079 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP osteoporosis DOID_11476 3.335E-03 0.06777749 3.335E-03 0.07591079 SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP osteochondrodysplasia DOID_2256 7.631E-06 4.342E-03 7.631E-06 4.342E-03 SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP bone development disease DOID_0080006 2.5E-05 7.113E-03 2.5E-05 7.113E-03 SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP multiple epiphyseal dysplasia DOID_12721 1.919E-04 0.03639009 1.919E-04 0.03639009 SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP adenoid cystic carcinoma DOID_4866 3.708E-04 0.052744 3.708E-04 0.052744 SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP salivary gland cancer DOID_8850 4.062E-04 0.04622315 4.062E-04 0.04622315 SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP oral cavity cancer DOID_8618 7.46E-04 0.07074365 7.46E-04 0.07074365 WEINMANN_ADAPTATION_TO_HYPOXIA_UP atrophic muscular disease DOID_913 4.608E-06 2.622E-03 4.608E-06 2.622E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_UP muscular dystrophy DOID_9884 4.608E-06 2.622E-03 4.608E-06 2.622E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_UP facioscapulohumeral muscular dystrophy DOID_11727 1.442E-05 4.104E-03 1.442E-05 4.104E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_UP restrictive cardiomyopathy DOID_397 3.839E-05 7.28E-03 3.839E-05 7.28E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_UP ureteral obstruction DOID_5199 4.891E-05 6.957E-03 4.891E-05 6.957E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_UP urinary tract obstruction DOID_5200 8.073E-05 9.187E-03 8.073E-05 9.187E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_UP ureteral disease DOID_1426 8.804E-05 8.349E-03 8.804E-05 8.349E-03 WEINMANN_ADAPTATION_TO_HYPOXIA_UP toxic shock syndrome DOID_14115 9.566E-05 7.776E-03 0.01441161 0.35653081 WEINMANN_ADAPTATION_TO_HYPOXIA_UP commensal bacterial infectious disease DOID_0050339 1.036E-04 7.368E-03 0.01498394 0.35524413 WEINMANN_ADAPTATION_TO_HYPOXIA_UP pulmonary emphysema DOID_9675 2.996E-04 0.01894394 0.02523162 0.39879981 WEINMANN_ADAPTATION_TO_HYPOXIA_UP hemolytic anemia DOID_583 4.029E-04 0.02292259 0.02918928 0.39544531 WEINMANN_ADAPTATION_TO_HYPOXIA_UP normocytic anemia DOID_720 4.029E-04 0.02292259 0.02918928 0.39544531 WEINMANN_ADAPTATION_TO_HYPOXIA_UP familial hyperlipidemia DOID_1168 5.391E-04 0.02788626 5.391E-04 0.04382126 WEINMANN_ADAPTATION_TO_HYPOXIA_UP mineral metabolism disease DOID_0050032 6.947E-04 0.03293972 0.03817785 0.42594508 WEINMANN_ADAPTATION_TO_HYPOXIA_UP cystic fibrosis DOID_1485 9.399E-04 0.04113834 0.04431135 0.4273417 WEINMANN_ADAPTATION_TO_HYPOXIA_UP lipid metabolism disorder DOID_3146 1.038E-03 0.04218574 1.038E-03 0.07382505 WEINMANN_ADAPTATION_TO_HYPOXIA_UP dilated cardiomyopathy DOID_12930 1.448E-03 0.05491106 1.448E-03 0.09151843 LIANG_SILENCED_BY_METHYLATION_2 influenza DOID_8469 1.479E-14 8.413E-12 0.04131803 0.78366526 LIANG_SILENCED_BY_METHYLATION_2 pleurisy DOID_10247 1.908E-13 5.429E-11 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pleural disease DOID_1532 5.2E-13 9.862E-11 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bacterial pneumonia DOID_874 9.356E-11 1.331E-08 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 metabolic syndrome X DOID_14221 1.089E-10 1.239E-08 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hepatitis DOID_2237 3.543E-10 3.36E-08 0.03700251 0.80978562 LIANG_SILENCED_BY_METHYLATION_2 sarcoidosis DOID_11335 1.577E-09 1.282E-07 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hypersensitivity reaction type IV disease DOID_2916 2.448E-09 1.741E-07 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bronchiolitis DOID_2942 7.945E-09 5.023E-07 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 chronic kidney failure DOID_784 1.329E-08 7.564E-07 0.07350815 1.000 LIANG_SILENCED_BY_METHYLATION_2 primary bacterial infectious disease DOID_0050338 1.678E-08 8.679E-07 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bronchiolitis obliterans DOID_2799 2.165E-08 1.027E-06 0.02918701 0.97690625 LIANG_SILENCED_BY_METHYLATION_2 ulcerative colitis DOID_8577 3.022E-08 1.323E-06 0.08592384 1.000 LIANG_SILENCED_BY_METHYLATION_2 respiratory syncytial virus infectious disease DOID_1273 5.889E-08 2.393E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 adult respiratory distress syndrome DOID_11394 6.488E-08 2.461E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pulmonary emphysema DOID_9675 7.133E-08 2.537E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 neuritis DOID_1803 1.205E-07 4.035E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pulmonary tuberculosis DOID_2957 1.415E-07 4.474E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 integumentary system cancer DOID_0060122 2.21E-07 6.617E-06 0.05074621 0.82498832 LIANG_SILENCED_BY_METHYLATION_2 parasitic protozoa infectious disease DOID_2789 2.21E-07 6.286E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 skin cancer DOID_4159 2.21E-07 6.617E-06 0.05074621 0.82498832 LIANG_SILENCED_BY_METHYLATION_2 idiopathic pulmonary fibrosis DOID_0050156 2.976E-07 8.065E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 respiratory failure DOID_11162 3.51E-07 9.079E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hemolytic-uremic syndrome DOID_12554 3.661E-07 9.057E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 parasitic infectious disease DOID_1398 4.214E-07 9.992E-06 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hyperglycemia DOID_4195 4.471E-07 1.018E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 tuberculosis DOID_399 5.019E-07 1.098E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 male reproductive system disease DOID_48 5.932E-07 1.25E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 amnestic disorder DOID_10914 7.435E-07 1.511E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 esophagitis DOID_11963 7.435E-07 1.459E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 aneurysm disease DOID_2403 7.722E-07 1.465E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pancreatitis DOID_4989 8.123E-07 1.491E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 autoimmune hepatitis DOID_2048 8.668E-07 1.541E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 encephalomyelitis DOID_640 1.62E-06 2.793E-05 0.08180333 1.000 LIANG_SILENCED_BY_METHYLATION_2 Crohn's disease DOID_8778 1.689E-06 2.826E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 dilated cardiomyopathy DOID_12930 1.76E-06 2.862E-05 0.08345369 1.000 LIANG_SILENCED_BY_METHYLATION_2 middle cerebral artery infarction DOID_3525 2.126E-06 3.36E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Sciatic Neuropathy DOID_11446 2.37E-06 3.644E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lesion of sciatic nerve DOID_12528 2.37E-06 3.644E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mononeuritis of lower limb DOID_9473 2.37E-06 3.644E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mononeuritis DOID_1802 2.632E-06 3.94E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mononeuropathy DOID_1188 2.912E-06 4.248E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 opportunistic mycosis DOID_2473 3.53E-06 5.021E-05 0.02918701 1.000 LIANG_SILENCED_BY_METHYLATION_2 abdominal aortic aneurysm DOID_7693 3.53E-06 4.899E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 chronic leukemia DOID_1036 4.229E-06 5.73E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 chronic lymphocytic leukemia DOID_1040 4.229E-06 5.73E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 systemic mycosis DOID_0050136 4.611E-06 6.101E-05 0.03179899 1.000 LIANG_SILENCED_BY_METHYLATION_2 fungal infectious disease DOID_1564 4.611E-06 6.101E-05 0.03179899 1.000 LIANG_SILENCED_BY_METHYLATION_2 nephroblastoma DOID_2154 5.015E-06 6.485E-05 0.03266813 0.92940837 LIANG_SILENCED_BY_METHYLATION_2 spindle cell carcinoma DOID_4015 5.015E-06 6.341E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 esophageal disease DOID_6050 5.015E-06 6.203E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 aplastic anemia DOID_12449 5.441E-06 6.587E-05 0.03353652 0.90867997 LIANG_SILENCED_BY_METHYLATION_2 pulmonary sarcoidosis DOID_13406 6.365E-06 7.545E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 multiple myeloma DOID_9538 6.365E-06 7.391E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 uveitis DOID_13141 6.863E-06 7.81E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 congenital diaphragmatic hernia DOID_3827 7.386E-06 8.241E-05 0.03700251 0.77979356 LIANG_SILENCED_BY_METHYLATION_2 intracranial arterial disease DOID_13089 7.936E-06 8.683E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 cerebral arterial disease DOID_3527 7.936E-06 8.683E-05 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 rheumatic disease DOID_1575 9.743E-06 1.046E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 uveal disease DOID_3480 9.743E-06 1.027E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 scleroderma DOID_419 9.743E-06 1.046E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 uterine cancer DOID_363 1.04E-05 1.076E-04 8.228E-04 0.15606365 LIANG_SILENCED_BY_METHYLATION_2 cerebral infarction DOID_3526 1.109E-05 1.127E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 myeloma DOID_0070004 1.255E-05 1.253E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bone marrow disease DOID_4961 1.255E-05 1.231E-04 0.04389832 0.75691354 LIANG_SILENCED_BY_METHYLATION_2 hemolytic anemia DOID_583 1.333E-05 1.285E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 normocytic anemia DOID_720 1.333E-05 1.285E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 autoimmune disease of gastrointestinal tract DOID_0060031 1.413E-05 1.34E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 glaucoma DOID_1686 1.413E-05 1.318E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 aortic aneurysm DOID_3627 1.497E-05 1.374E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bone marrow cancer DOID_4960 1.865E-05 1.685E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pustulosis of palm and sole DOID_4398 1.966E-05 1.748E-04 1.25E-03 0.17788031 LIANG_SILENCED_BY_METHYLATION_2 carotid artery disease DOID_3407 2.645E-05 2.315E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 collagen disease DOID_854 2.645E-05 2.28E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 cholestasis DOID_13580 3.174E-05 2.695E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 uterine disease DOID_345 3.174E-05 2.656E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hyperparathyroidism DOID_13543 3.497E-05 2.884E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 visceral leishmaniasis DOID_9146 3.497E-05 2.843E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 brain infarction DOID_3454 3.613E-05 2.895E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 nephrosis DOID_2527 4.09E-05 3.232E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bile duct disease DOID_4138 4.09E-05 3.188E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 biliary tract disease DOID_9741 4.258E-05 3.274E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 familial adenomatous polyposis DOID_0050424 4.272E-05 3.241E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pneumocystosis DOID_11339 4.272E-05 3.198E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 diabetic retinopathy DOID_8947 4.43E-05 3.274E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 cystic fibrosis DOID_1485 4.788E-05 3.493E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 ocular hypertension DOID_9282 5.124E-05 3.69E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 borderline glaucoma DOID_9283 5.124E-05 3.69E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 female reproductive system disease DOID_229 5.765E-05 4.1E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 parathyroid gland disease DOID_11201 6.052E-05 4.251E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 polyneuropathy DOID_1389 6.052E-05 4.199E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 biliary tract cancer DOID_4607 6.19E-05 4.243E-04 0.07350815 1.000 LIANG_SILENCED_BY_METHYLATION_2 retinal vascular disease DOID_2462 6.634E-05 4.494E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Legionnaires' disease DOID_10457 7.056E-05 4.724E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 legionellosis DOID_10458 7.056E-05 4.724E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 eyelid disease DOID_530 7.056E-05 4.669E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 amino acid metabolic disorder DOID_9252 7.585E-05 4.961E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lung oat cell carcinoma DOID_5411 8.137E-05 5.262E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 oral submucous fibrosis DOID_5773 8.137E-05 5.202E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hyperhomocysteinemia DOID_9279 8.137E-05 5.145E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lymphoma DOID_0060058 8.354E-05 5.224E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lymphoblastic leukemia DOID_1037 8.621E-05 5.332E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mouth disease DOID_403 8.894E-05 5.442E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hypersensitivity reaction type I disease DOID_1205 9.172E-05 5.552E-04 0.08345369 1.000 LIANG_SILENCED_BY_METHYLATION_2 thyroiditis DOID_7166 9.295E-05 5.567E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 autoimmune thyroiditis DOID_7188 9.295E-05 5.567E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 tongue cancer DOID_8649 9.295E-05 5.509E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 basal cell carcinoma DOID_2513 1.053E-04 6.176E-04 0.01514051 0.95721661 LIANG_SILENCED_BY_METHYLATION_2 skin carcinoma DOID_3451 1.184E-04 6.873E-04 0.01602416 0.91177492 LIANG_SILENCED_BY_METHYLATION_2 prion disease DOID_649 1.184E-04 6.803E-04 0.01602416 0.82888629 LIANG_SILENCED_BY_METHYLATION_2 dissociative disorder DOID_10935 1.322E-04 7.524E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 dissociative amnesia DOID_11037 1.322E-04 7.524E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 leishmaniasis DOID_9065 1.322E-04 7.449E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mitochondrial myopathy DOID_699 1.622E-04 9.048E-04 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 meningitis DOID_9471 2.128E-04 1.176E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Goodpasture syndrome DOID_9808 2.128E-04 1.164E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 acute pancreatitis DOID_2913 2.312E-04 1.253E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 urticaria DOID_1555 2.503E-04 1.344E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 cystitis DOID_1679 2.702E-04 1.437E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 myositis DOID_633 2.702E-04 1.424E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 extrinsic allergic alveolitis DOID_841 2.908E-04 1.518E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 gestational diabetes DOID_11714 3.122E-04 1.615E-03 0.02569372 1.000 LIANG_SILENCED_BY_METHYLATION_2 perinatal necrotizing enterocolitis DOID_8677 3.122E-04 1.6E-03 0.02569372 0.97464849 LIANG_SILENCED_BY_METHYLATION_2 autoimmune disease of endocrine system DOID_0060005 3.571E-04 1.814E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 endometrial carcinoma DOID_2871 3.807E-04 1.917E-03 3.807E-04 0.21664023 LIANG_SILENCED_BY_METHYLATION_2 endometrial cancer DOID_1380 4.301E-04 2.147E-03 4.301E-04 0.12237765 LIANG_SILENCED_BY_METHYLATION_2 allergic rhinitis DOID_4481 4.301E-04 2.128E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bladder disease DOID_365 4.56E-04 2.237E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 papilloma DOID_2615 4.825E-04 2.347E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 myocarditis DOID_820 4.825E-04 2.327E-03 0.03179899 0.95229602 LIANG_SILENCED_BY_METHYLATION_2 pneumoconiosis DOID_10316 5.098E-04 2.438E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 thyroid carcinoma DOID_3963 5.098E-04 2.417E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 thyroid cancer DOID_1781 5.666E-04 2.664E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 systemic scleroderma DOID_418 6.572E-04 3.065E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 peptic ulcer DOID_750 6.572E-04 3.04E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 endometriosis of uterus DOID_288 7.544E-04 3.462E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 nephrotic syndrome DOID_1184 7.883E-04 3.588E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 endometriosis DOID_289 7.883E-04 3.56E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 diabetic autonomic neuropathy DOID_11503 8.228E-04 3.687E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 autonomic neuropathy DOID_11504 8.228E-04 3.687E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 diabetic polyneuropathy DOID_12785 8.228E-04 3.687E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 gallbladder cancer DOID_3121 8.228E-04 3.658E-03 0.04131803 0.8106882 LIANG_SILENCED_BY_METHYLATION_2 diabetic neuropathy DOID_9743 8.228E-04 3.687E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 proteinuria DOID_576 8.941E-04 3.944E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pre-eclampsia DOID_10591 9.309E-04 4.074E-03 0.04389832 0.80574667 LIANG_SILENCED_BY_METHYLATION_2 autonomic nervous system disease DOID_11465 9.309E-04 4.043E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 thyroid adenoma DOID_2891 9.309E-04 4.013E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 heart valve disease DOID_4079 9.309E-04 3.982E-03 0.04389832 0.78056709 LIANG_SILENCED_BY_METHYLATION_2 vascular skin disease DOID_9540 9.309E-04 3.953E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 integumentary system benign neoplasm DOID_0060121 1.006E-03 4.242E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 skin benign neoplasm DOID_3165 1.006E-03 4.242E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lung small cell carcinoma DOID_5409 1.006E-03 4.211E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 calcium metabolism disease DOID_10575 1.045E-03 4.342E-03 0.04647188 0.77772059 LIANG_SILENCED_BY_METHYLATION_2 hemorrhagic disease DOID_2213 1.085E-03 4.474E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 B-cell lymphocytic neoplasm DOID_707 1.085E-03 4.441E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 atopic dermatitis DOID_3310 1.125E-03 4.573E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 giant cell tumor DOID_200 1.166E-03 4.707E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 malignant giant cell tumor DOID_2705 1.166E-03 4.707E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 giant cell glioblastoma DOID_3074 1.166E-03 4.707E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bile duct adenocarcinoma DOID_4896 1.208E-03 4.841E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 cholangiocarcinoma DOID_4947 1.208E-03 4.841E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 vasculitis DOID_865 1.208E-03 4.807E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mitochondrial metabolism disease DOID_700 1.294E-03 5.112E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hypertrophic cardiomyopathy DOID_11984 1.382E-03 5.423E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 glioblastoma DOID_3068 1.382E-03 5.386E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bile duct cancer DOID_4606 1.382E-03 5.35E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bile duct carcinoma DOID_4897 1.382E-03 5.35E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 oral cavity cancer DOID_8618 1.382E-03 5.313E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 melancholia DOID_2848 1.427E-03 5.451E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 leukocyte disease DOID_9500 1.427E-03 5.414E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 neurotic disorder DOID_4964 1.473E-03 5.552E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mineral metabolism disease DOID_0050032 1.664E-03 6.23E-03 0.05839317 0.89799233 LIANG_SILENCED_BY_METHYLATION_2 endocrine pancreas disease DOID_1428 1.664E-03 6.189E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 cerebral degeneration DOID_1443 1.714E-03 6.332E-03 0.05923914 0.88702814 LIANG_SILENCED_BY_METHYLATION_2 endocrine organ benign neoplasm DOID_0060089 1.866E-03 6.851E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 astrocytoma DOID_3069 1.918E-03 6.997E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 blood coagulation disease DOID_1247 1.971E-03 7.145E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 peripheral vascular disease DOID_341 2.079E-03 7.488E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 endogenous depression DOID_1595 2.246E-03 8.039E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bone resorption disease DOID_0080011 2.303E-03 8.192E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 osteoporosis DOID_11476 2.303E-03 8.192E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mixed glioma DOID_5076 2.361E-03 8.345E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 contact dermatitis DOID_2773 2.479E-03 8.706E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mental depression DOID_1596 2.66E-03 9.286E-03 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 transitional cell carcinoma DOID_2671 2.976E-03 0.01032474 0.07766479 1.000 LIANG_SILENCED_BY_METHYLATION_2 nervous system cancer DOID_3093 3.107E-03 0.01071394 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 carbohydrate metabolic disorder DOID_2978 3.308E-03 0.01134011 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 alcohol-related neurodevelopmental disorder DOID_0050667 3.377E-03 0.01150559 0.08262887 1.000 LIANG_SILENCED_BY_METHYLATION_2 familial combined hyperlipidemia DOID_13809 8.933E-03 0.03025631 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 childhood type dermatomyositis DOID_14203 8.933E-03 0.03007728 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 angioedema DOID_1558 8.933E-03 0.02990035 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 retinal vascular occlusion DOID_1729 8.933E-03 0.0297255 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 transient cerebral ischemia DOID_224 8.933E-03 0.02955267 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 acute kidney failure DOID_3021 8.933E-03 0.02938185 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 teratoma DOID_3307 8.933E-03 0.02921299 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Hermansky-Pudlak syndrome DOID_3753 8.933E-03 0.02904606 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 conjunctival disease DOID_4251 8.933E-03 0.02888102 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 malignant teratoma DOID_5563 8.933E-03 0.02921299 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mature teratoma DOID_5566 8.933E-03 0.02921299 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 conjunctivitis DOID_6195 8.933E-03 0.02888102 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 trypanosomiasis DOID_10113 9.822E-03 0.03157591 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 dermatomyositis DOID_10223 9.822E-03 0.03139851 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 adrenoleukodystrophy DOID_10588 9.822E-03 0.0312231 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 prediabetes syndrome DOID_11716 9.822E-03 0.03104964 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 neuronal ceroid lipofuscinosis DOID_14503 9.822E-03 0.03087809 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bronchiectasis DOID_9563 9.822E-03 0.03070844 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 common cold DOID_10459 0.01071067 0.03330257 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 beta thalassemia DOID_12241 0.01071067 0.03312158 0.01071067 1.000 LIANG_SILENCED_BY_METHYLATION_2 aortic valve stenosis DOID_1712 0.01071067 0.03294254 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 epidermolysis bullosa DOID_2730 0.01071067 0.03276543 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 stomach disease DOID_76 0.01071067 0.03259021 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 berylliosis DOID_10322 0.01159818 0.035103 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 newborn respiratory distress syndrome DOID_12716 0.01159818 0.03491727 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 carotid stenosis DOID_13001 0.01159818 0.0347335 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 larynx cancer DOID_2596 0.01159818 0.03455165 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 laryngeal benign neoplasm DOID_2598 0.01159818 0.03455165 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 vesiculobullous skin disease DOID_2731 0.01159818 0.03437169 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 intracranial thrombosis DOID_4193 0.01159818 0.0341936 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 epilepsy with generalized tonic-clonic seizures DOID_7725 0.01159818 0.03401734 0.01159818 1.000 LIANG_SILENCED_BY_METHYLATION_2 viral pneumonia DOID_10533 0.01248492 0.03643036 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 open-angle glaucoma DOID_1067 0.01248492 0.03624449 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hypercalcemia DOID_12678 0.01248492 0.0360605 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 polycystic kidney disease DOID_898 0.01248492 0.03587838 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bacterial meningitis DOID_9470 0.01248492 0.03569809 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 skeletal system cancer DOID_0060124 0.01337089 0.03804017 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 thalassemia DOID_10241 0.01337089 0.03785092 0.01337089 1.000 LIANG_SILENCED_BY_METHYLATION_2 thoracic aortic aneurysm DOID_14004 0.01337089 0.03766354 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bone cancer DOID_184 0.01337089 0.03804017 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 mesenchymal cell neoplasm DOID_3350 0.01337089 0.037478 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 spindle cell sarcoma DOID_4235 0.01337089 0.037478 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 epithelioid sarcoma DOID_6193 0.01337089 0.037478 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 varicose veins DOID_799 0.01337089 0.03729429 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 intermediate coronary syndrome DOID_8805 0.01337089 0.03711237 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 silicosis DOID_10325 0.01425608 0.03937724 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Fanconi's anemia DOID_13636 0.01425608 0.03918701 0.01425608 1.000 LIANG_SILENCED_BY_METHYLATION_2 restrictive cardiomyopathy DOID_397 0.01425608 0.03899861 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 vein disease DOID_866 0.01425608 0.03881202 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Barrett's esophagus DOID_9206 0.01425608 0.0386272 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lymphatic system cancer DOID_0060073 0.01514051 0.04082914 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 drug-induced mental disorder DOID_1203 0.01514051 0.04063655 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 methylmalonic acidemia DOID_14749 0.01514051 0.04044577 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 drug psychosis DOID_1742 0.01514051 0.04063655 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 bronchitis DOID_6132 0.01514051 0.04025677 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 juvenile rheumatoid arthritis DOID_676 0.01514051 0.04006953 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 urinary system benign neoplasm DOID_731 0.01514051 0.03988403 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 reticulosarcoma DOID_8538 0.01514051 0.04082914 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 substance-induced psychosis DOID_8646 0.01514051 0.04063655 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lymphosarcoma DOID_8675 0.01514051 0.04082914 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 glucose intolerance DOID_10603 0.01602416 0.04201728 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 granulosa cell tumor DOID_2999 0.01690705 0.04412895 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 psoriasis DOID_8893 0.01690705 0.04392745 0.01690705 0.80167592 LIANG_SILENCED_BY_METHYLATION_2 membranous glomerulonephritis DOID_10976 0.01778917 0.04600925 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 sex cord-gonadal stromal tumor DOID_192 0.01778917 0.04580106 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 brain edema DOID_4724 0.01778917 0.04559475 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 gastric ulcer DOID_10808 0.01955109 0.04988598 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 neutropenia DOID_1227 0.01955109 0.04966327 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 thrombophilia DOID_2452 0.01955109 0.04944255 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 placenta disease DOID_780 0.01955109 0.04922377 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 sinusitis DOID_0050127 0.02043091 0.05121228 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 agranulocytosis DOID_12987 0.02043091 0.05098766 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 paranasal sinus disease DOID_1352 0.02043091 0.05121228 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 muscle cancer DOID_4045 0.02043091 0.05076501 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 uremia DOID_4676 0.02043091 0.05054429 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 urinary tract obstruction DOID_5200 0.02043091 0.05032548 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 pulmonary embolism DOID_9477 0.02043091 0.05010856 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hypoglycemia DOID_9993 0.02043091 0.04989351 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 diabetic angiopathy DOID_11713 0.02130996 0.0518178 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Lewy body dementia DOID_12217 0.02130996 0.0515973 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 aortic valve disease DOID_62 0.02130996 0.05137866 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 spastic quadriplegia DOID_10970 0.02218824 0.05327049 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 organic acidemia DOID_0060159 0.02306575 0.0551446 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 portal hypertension DOID_10762 0.02306575 0.05491387 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hypogonadism DOID_1924 0.02306575 0.05468506 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 ankylosing spondylitis DOID_7147 0.02394251 0.05652816 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 intracranial aneurysm DOID_10941 0.0248185 0.05835423 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 congenital hypoplastic anemia DOID_1342 0.0248185 0.05811409 0.0248185 1.000 LIANG_SILENCED_BY_METHYLATION_2 diffuse large B-cell lymphoma DOID_0050745 0.02569372 0.05991692 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 lung adenocarcinoma DOID_3910 0.02569372 0.05967236 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 periodontitis DOID_824 0.02569372 0.05942979 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 autoimmune disease of cardiovascular system DOID_0060051 0.02656818 0.06120363 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 sarcoma DOID_1115 0.02656818 0.06095684 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 malaria DOID_12365 0.02656818 0.06071204 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Behcet's disease DOID_13241 0.02656818 0.06120363 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 thrombocytopenia DOID_1588 0.02656818 0.06046919 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hepatic vascular disease DOID_272 0.02656818 0.06022827 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 polycystic ovary syndrome DOID_11612 0.02744189 0.06196204 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 spastic cerebral palsy DOID_0050669 0.02918701 0.06564192 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 age related macular degeneration DOID_10871 0.02918701 0.06538349 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 degeneration of macula and posterior pole DOID_2007 0.02918701 0.06538349 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 gonadal disease DOID_2277 0.02918701 0.06512708 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 celiac disease DOID_10608 0.03005843 0.06680955 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 autonomic nervous system neoplasm DOID_2621 0.03092909 0.06847724 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 neuroblastoma DOID_769 0.03092909 0.06847724 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 periodontal disease DOID_3388 0.03266813 0.07204716 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 macular degeneration DOID_4448 0.03266813 0.07176899 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 leukopenia DOID_615 0.03266813 0.07149295 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 hyperthyroidism DOID_7998 0.03266813 0.07121903 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 medullomyoblastoma DOID_3861 0.03353652 0.07283313 0.03353652 0.86737634 LIANG_SILENCED_BY_METHYLATION_2 adult medulloblastoma DOID_3864 0.03353652 0.07283313 0.03353652 0.86737634 LIANG_SILENCED_BY_METHYLATION_2 childhood medulloblastoma DOID_3869 0.03353652 0.07283313 0.03353652 0.86737634 LIANG_SILENCED_BY_METHYLATION_2 adolescence-adult electroclinical syndrome DOID_0050705 0.03527102 0.07630879 0.03527102 0.87257445 LIANG_SILENCED_BY_METHYLATION_2 calcinosis DOID_182 0.03527102 0.07601974 0.03527102 0.83621718 LIANG_SILENCED_BY_METHYLATION_2 medulloblastoma DOID_3858 0.03527102 0.07573288 0.03527102 0.8027685 LIANG_SILENCED_BY_METHYLATION_2 embryonal cancer DOID_688 0.03527102 0.07544817 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 peripheral nervous system neoplasm DOID_1192 0.03613714 0.07701136 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 blood platelet disease DOID_2218 0.03613714 0.07672401 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 benign mesothelioma DOID_2645 0.03873097 0.08192537 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 cervix uteri carcinoma in situ DOID_8991 0.03873097 0.08162194 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 autoimmune disease of urogenital tract DOID_0060049 0.03959408 0.08313295 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 primary biliary cirrhosis DOID_12236 0.03959408 0.08313295 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 Huntington's disease DOID_12858 0.04045643 0.08463128 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 primitive neuroectodermal tumor DOID_168 0.04045643 0.08432127 0.04045643 0.82213241 LIANG_SILENCED_BY_METHYLATION_2 hyperinsulinism DOID_2018 0.04045643 0.08401353 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 leukodystrophy DOID_10579 0.04303898 0.08905155 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 brain cancer DOID_1319 0.04389832 0.09050053 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 central nervous system cancer DOID_3620 0.04475692 0.09193751 1.000 1.000 LIANG_SILENCED_BY_METHYLATION_2 withdrawal disorder DOID_0060001 0.04732824 0.09686967 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bacterial pneumonia DOID_874 8.812E-26 5.014E-23 6.374E-04 0.18135394 HINATA_NFKB_TARGETS_KERATINOCYTE_UP primary bacterial infectious disease DOID_0050338 4.996E-25 1.421E-22 0.01493416 0.3694581 HINATA_NFKB_TARGETS_KERATINOCYTE_UP tuberculosis DOID_399 1.886E-24 3.577E-22 9.708E-03 0.30688245 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pleural disease DOID_1532 2.241E-24 3.187E-22 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pulmonary tuberculosis DOID_2957 2.938E-24 3.344E-22 5.314E-03 0.25197744 HINATA_NFKB_TARGETS_KERATINOCYTE_UP respiratory failure DOID_11162 1.272E-18 1.207E-16 0.1268997 0.76814817 HINATA_NFKB_TARGETS_KERATINOCYTE_UP adult respiratory distress syndrome DOID_11394 1.549E-18 1.259E-16 0.08583835 0.62617978 HINATA_NFKB_TARGETS_KERATINOCYTE_UP ulcerative colitis DOID_8577 2.536E-18 1.804E-16 1.218E-03 0.09897605 HINATA_NFKB_TARGETS_KERATINOCYTE_UP extrinsic allergic alveolitis DOID_841 3.093E-18 1.955E-16 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP influenza DOID_8469 4.157E-18 2.365E-16 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pleurisy DOID_10247 6.385E-18 3.303E-16 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP chronic kidney failure DOID_784 2.935E-17 1.392E-15 0.01368768 0.35401325 HINATA_NFKB_TARGETS_KERATINOCYTE_UP parasitic infectious disease DOID_1398 2.254E-16 9.866E-15 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP brain infarction DOID_3454 3.562E-16 1.448E-14 0.1377786 0.78396023 HINATA_NFKB_TARGETS_KERATINOCYTE_UP rheumatic disease DOID_1575 4.787E-16 1.816E-14 0.09154793 0.65113466 HINATA_NFKB_TARGETS_KERATINOCYTE_UP scleroderma DOID_419 4.787E-16 1.816E-14 0.09154793 0.65113466 HINATA_NFKB_TARGETS_KERATINOCYTE_UP diabetic retinopathy DOID_8947 7.303E-16 2.597E-14 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cystic fibrosis DOID_1485 9.595E-16 3.212E-14 0.15030159 0.81449145 HINATA_NFKB_TARGETS_KERATINOCYTE_UP retinal vascular disease DOID_2462 3.006E-15 9.501E-14 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP giant cell tumor DOID_200 3.238E-15 9.696E-14 6.139E-03 0.24949191 HINATA_NFKB_TARGETS_KERATINOCYTE_UP malignant giant cell tumor DOID_2705 3.238E-15 9.696E-14 6.139E-03 0.24949191 HINATA_NFKB_TARGETS_KERATINOCYTE_UP giant cell glioblastoma DOID_3074 3.238E-15 9.696E-14 6.139E-03 0.24949191 HINATA_NFKB_TARGETS_KERATINOCYTE_UP parasitic protozoa infectious disease DOID_2789 4.536E-15 1.29E-13 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP glioblastoma DOID_3068 7.35E-15 1.991E-13 7.246E-03 0.25767805 HINATA_NFKB_TARGETS_KERATINOCYTE_UP collagen disease DOID_854 1.161E-14 3.004E-13 0.12507342 0.76523414 HINATA_NFKB_TARGETS_KERATINOCYTE_UP intracranial arterial disease DOID_13089 3.375E-14 8.349E-13 0.08583835 0.61825345 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cerebral arterial disease DOID_3527 3.375E-14 8.349E-13 0.08583835 0.61825345 HINATA_NFKB_TARGETS_KERATINOCYTE_UP astrocytoma DOID_3069 3.542E-14 8.397E-13 9.972E-03 0.29863665 HINATA_NFKB_TARGETS_KERATINOCYTE_UP encephalitis DOID_9588 6.17E-14 1.404E-12 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP aneurysm disease DOID_2403 8.465E-14 1.853E-12 0.01190808 0.32265216 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cerebral infarction DOID_3526 8.709E-14 1.835E-12 0.09533474 0.66969714 HINATA_NFKB_TARGETS_KERATINOCYTE_UP middle cerebral artery infarction DOID_3525 1.485E-13 3.018E-12 0.05675469 0.52086157 HINATA_NFKB_TARGETS_KERATINOCYTE_UP sarcoidosis DOID_11335 3.235E-13 6.347E-12 0.11032676 0.73854029 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mouth disease DOID_403 5.184E-13 9.832E-12 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bronchiolitis obliterans DOID_2799 5.313E-13 9.753E-12 0.06654934 0.56517273 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypersensitivity reaction type IV disease DOID_2916 6.651E-13 1.183E-11 0.11957192 0.76445418 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cholestasis DOID_13580 1.65E-12 2.845E-11 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP leishmaniasis DOID_9065 1.791E-12 2.997E-11 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pulmonary sarcoidosis DOID_13406 2.292E-12 3.726E-11 0.08009335 0.60764152 HINATA_NFKB_TARGETS_KERATINOCYTE_UP brain edema DOID_4724 2.554E-12 4.037E-11 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP respiratory syncytial virus infectious disease DOID_1273 3.306E-12 5.084E-11 0.0839273 0.62835042 HINATA_NFKB_TARGETS_KERATINOCYTE_UP systemic scleroderma DOID_418 3.306E-12 4.95E-11 0.0839273 0.62019003 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bile duct disease DOID_4138 3.331E-12 4.86E-11 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP peripheral vascular disease DOID_341 3.722E-12 5.295E-11 0.01078301 0.30677674 HINATA_NFKB_TARGETS_KERATINOCYTE_UP biliary tract disease DOID_9741 3.722E-12 5.166E-11 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP contact dermatitis DOID_2773 7.773E-12 1.053E-10 6.851E-04 0.12993139 HINATA_NFKB_TARGETS_KERATINOCYTE_UP diabetic angiopathy DOID_11713 8.811E-12 1.166E-10 1.149E-03 0.10892975 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bronchiolitis DOID_2942 1.502E-11 1.943E-10 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bronchiectasis DOID_9563 1.58E-11 1.998E-10 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP aortic aneurysm DOID_3627 1.854E-11 2.294E-10 5.515E-03 0.24139108 HINATA_NFKB_TARGETS_KERATINOCYTE_UP abdominal aortic aneurysm DOID_7693 7.143E-11 8.648E-10 2.171E-03 0.13724751 HINATA_NFKB_TARGETS_KERATINOCYTE_UP varicose veins DOID_799 1.021E-10 1.21E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP uterine disease DOID_345 1.138E-10 1.321E-09 0.13235598 0.76847504 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hyperglycemia DOID_4195 1.264E-10 1.438E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP vein disease DOID_866 1.482E-10 1.654E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pneumoconiosis DOID_10316 1.49E-10 1.63E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP periodontal disease DOID_3388 1.49E-10 1.599E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP nephrosis DOID_2527 2.091E-10 2.203E-09 0.14316775 0.79865148 HINATA_NFKB_TARGETS_KERATINOCYTE_UP peptic ulcer DOID_750 3.333E-10 3.449E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bone resorption disease DOID_0080011 3.34E-10 3.394E-09 0.15207586 0.80870248 HINATA_NFKB_TARGETS_KERATINOCYTE_UP osteoporosis DOID_11476 3.34E-10 3.394E-09 0.15207586 0.80870248 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pulmonary emphysema DOID_9675 4.471E-10 4.463E-09 3.832E-03 0.1982318 HINATA_NFKB_TARGETS_KERATINOCYTE_UP female reproductive system disease DOID_229 4.752E-10 4.662E-09 0.15913646 0.83841337 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mitochondrial myopathy DOID_699 6.849E-10 6.605E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pre-eclampsia DOID_10591 9.965E-10 9.45E-09 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP heart valve disease DOID_4079 9.965E-10 9.295E-09 0.09910597 0.68769872 HINATA_NFKB_TARGETS_KERATINOCYTE_UP IgA glomerulonephritis DOID_2986 1.129E-09 1.036E-08 0.04685858 0.52279472 HINATA_NFKB_TARGETS_KERATINOCYTE_UP calcium metabolism disease DOID_10575 1.433E-09 1.294E-08 0.10473372 0.70944626 HINATA_NFKB_TARGETS_KERATINOCYTE_UP vasculitis DOID_865 2.249E-09 2E-08 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pustulosis of palm and sole DOID_4398 2.505E-09 2.193E-08 6.571E-03 0.24927466 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cystitis DOID_1679 2.691E-09 2.32E-08 0.05478362 0.51953129 HINATA_NFKB_TARGETS_KERATINOCYTE_UP myositis DOID_633 2.691E-09 2.285E-08 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cutaneous leishmaniasis DOID_9111 3.632E-09 3.039E-08 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP periodontitis DOID_824 3.945E-09 3.253E-08 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP carotid artery disease DOID_3407 4.594E-09 3.734E-08 0.12507342 0.7735519 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mineral metabolism disease DOID_0050032 6.085E-09 4.877E-08 0.13054097 0.76575065 HINATA_NFKB_TARGETS_KERATINOCYTE_UP tooth disease DOID_1091 7.955E-09 6.287E-08 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP allergic contact dermatitis DOID_3042 7.955E-09 6.201E-08 9.447E-03 0.31620504 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bladder disease DOID_365 1.068E-08 8.212E-08 0.07043902 0.57256859 HINATA_NFKB_TARGETS_KERATINOCYTE_UP esophageal disease DOID_6050 1.429E-08 1.084E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP eyelid disease DOID_530 1.72E-08 1.288E-07 0.02878658 0.39950159 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pancreatitis DOID_4989 1.793E-08 1.325E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP multiple myeloma DOID_9538 2.147E-08 1.566E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP thoracic aortic aneurysm DOID_14004 2.342E-08 1.687E-07 0.03081117 0.41741801 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autoimmune disease of urogenital tract DOID_0060049 3.954E-08 2.813E-07 1.16E-04 0.06601507 HINATA_NFKB_TARGETS_KERATINOCYTE_UP primary biliary cirrhosis DOID_12236 3.954E-08 2.813E-07 1.16E-04 0.06601507 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lymphoma DOID_0060058 4.748E-08 3.335E-07 0.01655832 0.39257028 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Crohn's disease DOID_8778 5.388E-08 3.739E-07 0.18168489 0.89894523 HINATA_NFKB_TARGETS_KERATINOCYTE_UP proteinuria DOID_576 6.132E-08 4.204E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP myeloma DOID_0070004 6.802E-08 4.608E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP brain cancer DOID_1319 6.802E-08 4.554E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP vascular skin disease DOID_9540 6.802E-08 4.501E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP central nervous system cancer DOID_3620 7.529E-08 4.924E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP esophagitis DOID_11963 8.248E-08 5.333E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP placenta disease DOID_780 1.241E-07 7.936E-07 0.04486709 0.51058748 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bone marrow cancer DOID_4960 1.329E-07 8.403E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP integumentary system cancer DOID_0060122 1.452E-07 9.079E-07 0.11403627 0.73734814 HINATA_NFKB_TARGETS_KERATINOCYTE_UP skin cancer DOID_4159 1.452E-07 9.079E-07 0.11403627 0.73734814 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mitochondrial metabolism disease DOID_700 1.584E-07 9.796E-07 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Goodpasture syndrome DOID_9808 1.797E-07 1.1E-06 0.04884597 0.49630991 HINATA_NFKB_TARGETS_KERATINOCYTE_UP acute pancreatitis DOID_2913 2.136E-07 1.293E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP urticaria DOID_1555 2.521E-07 1.51E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP intracranial aneurysm DOID_10941 3.442E-07 2.04E-06 0.05675469 0.52940028 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Sciatic Neuropathy DOID_11446 3.986E-07 2.338E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lesion of sciatic nerve DOID_12528 3.986E-07 2.338E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lung adenocarcinoma DOID_3910 3.986E-07 2.314E-06 1.678E-03 0.11936938 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mononeuritis of lower limb DOID_9473 3.986E-07 2.338E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autoimmune disease of cardiovascular system DOID_0060051 4.592E-07 2.639E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP renal hypertension DOID_1073 4.592E-07 2.613E-06 0.06068466 0.53122422 HINATA_NFKB_TARGETS_KERATINOCYTE_UP secondary hypertension DOID_11130 4.592E-07 2.613E-06 0.06068466 0.53122422 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Behcet's disease DOID_13241 4.592E-07 2.639E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mononeuritis DOID_1802 4.592E-07 2.587E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP male reproductive system disease DOID_48 4.974E-07 2.775E-06 0.14316775 0.79089758 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mononeuropathy DOID_1188 5.264E-07 2.908E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP metabolic syndrome X DOID_14221 8.316E-07 4.55E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP biliary tract cancer DOID_4607 9.948E-07 5.391E-06 0.16264496 0.84903651 HINATA_NFKB_TARGETS_KERATINOCYTE_UP childhood type dermatomyositis DOID_14203 1.034E-06 5.551E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP retinal vascular occlusion DOID_1729 1.034E-06 5.499E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lateral sclerosis DOID_230 1.034E-06 5.448E-06 0.02064638 0.41956401 HINATA_NFKB_TARGETS_KERATINOCYTE_UP acute kidney failure DOID_3021 1.034E-06 5.398E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP conjunctival disease DOID_4251 1.034E-06 5.349E-06 0.02064638 0.40509629 HINATA_NFKB_TARGETS_KERATINOCYTE_UP conjunctivitis DOID_6195 1.034E-06 5.349E-06 0.02064638 0.40509629 HINATA_NFKB_TARGETS_KERATINOCYTE_UP visceral leishmaniasis DOID_9146 1.034E-06 5.301E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP transitional cell carcinoma DOID_2671 1.322E-06 6.717E-06 8.98E-04 0.12773461 HINATA_NFKB_TARGETS_KERATINOCYTE_UP dermatomyositis DOID_10223 1.42E-06 7.149E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP nervous system cancer DOID_3093 1.475E-06 7.36E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Human immunodeficiency virus infectious disease DOID_526 1.475E-06 7.296E-06 9.57E-04 0.10890739 HINATA_NFKB_TARGETS_KERATINOCYTE_UP uveitis DOID_13141 1.668E-06 8.18E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.821E-06 8.856E-06 0.18168489 0.90683072 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hepatitis DOID_2237 1.84E-06 8.873E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP common cold DOID_10459 1.89E-06 9.038E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP peritonitis DOID_8283 1.89E-06 8.962E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP ocular hypertension DOID_9282 1.89E-06 8.888E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP borderline glaucoma DOID_9283 1.89E-06 8.888E-06 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypersensitivity reaction type I disease DOID_1205 1.917E-06 8.94E-06 0.18339445 0.89958137 HINATA_NFKB_TARGETS_KERATINOCYTE_UP dilated cardiomyopathy DOID_12930 1.917E-06 8.867E-06 0.01756743 0.39983464 HINATA_NFKB_TARGETS_KERATINOCYTE_UP uveal disease DOID_3480 2.666E-06 1.223E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP viral pneumonia DOID_10533 3.118E-06 1.419E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypercalcemia DOID_12678 3.118E-06 1.408E-05 0.02878658 0.40948913 HINATA_NFKB_TARGETS_KERATINOCYTE_UP neuritis DOID_1803 3.739E-06 1.675E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP oral submucous fibrosis DOID_5773 3.892E-06 1.73E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP intermediate coronary syndrome DOID_8805 3.892E-06 1.717E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP integumentary system benign neoplasm DOID_0060121 4.381E-06 1.918E-05 0.10286167 0.70516011 HINATA_NFKB_TARGETS_KERATINOCYTE_UP glaucoma DOID_1686 4.381E-06 1.903E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP skin benign neoplasm DOID_3165 4.381E-06 1.918E-05 0.10286167 0.70516011 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hemolytic-uremic syndrome DOID_12554 4.782E-06 2.062E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP atopic dermatitis DOID_3310 5.493E-06 2.35E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bronchitis DOID_6132 5.798E-06 2.462E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bile duct adenocarcinoma DOID_4896 6.342E-06 2.673E-05 0.11218342 0.73370539 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cholangiocarcinoma DOID_4947 6.342E-06 2.673E-05 0.11218342 0.73370539 HINATA_NFKB_TARGETS_KERATINOCYTE_UP dissociative disorder DOID_10935 8.238E-06 3.447E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP dissociative amnesia DOID_11037 8.238E-06 3.447E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bile duct cancer DOID_4606 8.326E-06 3.458E-05 0.11957192 0.75596024 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bile duct carcinoma DOID_4897 8.326E-06 3.458E-05 0.11957192 0.75596024 HINATA_NFKB_TARGETS_KERATINOCYTE_UP leukocyte disease DOID_9500 8.886E-06 3.664E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP amnestic disorder DOID_10914 9.677E-06 3.961E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pulmonary edema DOID_11396 9.677E-06 3.933E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Kawasaki disease DOID_13378 1.127E-05 4.549E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lymphadenitis DOID_1602 1.127E-05 4.549E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autoimmune hepatitis DOID_2048 1.127E-05 4.517E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lymph node disease DOID_9942 1.127E-05 4.549E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP endocrine pancreas disease DOID_1428 1.211E-05 4.82E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP gastric ulcer DOID_10808 1.303E-05 5.15E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP neutropenia DOID_1227 1.303E-05 5.115E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hepatitis B DOID_2043 1.303E-05 5.08E-05 0.04486709 0.52100763 HINATA_NFKB_TARGETS_KERATINOCYTE_UP temporal lobe epilepsy DOID_3328 1.362E-05 5.272E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP sinusitis DOID_0050127 1.497E-05 5.754E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP agranulocytosis DOID_12987 1.497E-05 5.715E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP paranasal sinus disease DOID_1352 1.497E-05 5.754E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pulmonary embolism DOID_9477 1.497E-05 5.677E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP polyarteritis nodosa DOID_9810 1.497E-05 5.64E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypoglycemia DOID_9993 1.497E-05 5.602E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP aortic valve disease DOID_62 1.708E-05 6.351E-05 0.04884597 0.50533372 HINATA_NFKB_TARGETS_KERATINOCYTE_UP meningitis DOID_9471 1.708E-05 6.31E-05 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP spinal muscular atrophy DOID_12377 2.457E-05 9.02E-05 0.05478362 0.5283369 HINATA_NFKB_TARGETS_KERATINOCYTE_UP gestational diabetes DOID_11714 3.06E-05 1.116E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP focal epilepsy DOID_2234 3.11E-05 1.127E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP sarcoma DOID_1115 3.395E-05 1.223E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP focal glomerulosclerosis DOID_3945 3.753E-05 1.343E-04 0.06264359 0.54006365 HINATA_NFKB_TARGETS_KERATINOCYTE_UP amino acid metabolic disorder DOID_9252 4.067E-05 1.446E-04 0.17308396 0.88725019 HINATA_NFKB_TARGETS_KERATINOCYTE_UP spastic cerebral palsy DOID_0050669 4.542E-05 1.605E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP opportunistic mycosis DOID_2473 4.542E-05 1.595E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP carbohydrate metabolic disorder DOID_2978 4.814E-05 1.68E-04 0.1799718 0.91432101 HINATA_NFKB_TARGETS_KERATINOCYTE_UP encephalomyelitis DOID_640 4.814E-05 1.67E-04 0.1799718 0.90622967 HINATA_NFKB_TARGETS_KERATINOCYTE_UP allergic rhinitis DOID_4481 4.974E-05 1.715E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP systemic mycosis DOID_0050136 5.917E-05 2.028E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP fungal infectious disease DOID_1564 5.917E-05 2.028E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP myocarditis DOID_820 5.917E-05 2.016E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP spindle cell carcinoma DOID_4015 6.43E-05 2.178E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP leukopenia DOID_615 6.43E-05 2.165E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hyperthyroidism DOID_7998 6.43E-05 2.152E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP calcinosis DOID_182 8.139E-05 2.708E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP congenital diaphragmatic hernia DOID_3827 9.429E-05 3.119E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lymphatic system disease DOID_75 1.012E-04 3.329E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP benign mesothelioma DOID_2645 1.084E-04 3.546E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP endometriosis of uterus DOID_288 1.16E-04 3.772E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP nephrotic syndrome DOID_1184 1.239E-04 4.007E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP endometriosis DOID_289 1.239E-04 3.984E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP diabetic autonomic neuropathy DOID_11503 1.322E-04 4.225E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autonomic neuropathy DOID_11504 1.322E-04 4.225E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP diabetic polyneuropathy DOID_12785 1.322E-04 4.225E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP diabetic neuropathy DOID_9743 1.322E-04 4.225E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP leber hereditary optic neuropathy DOID_705 1.529E-04 4.86E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autonomic nervous system disease DOID_11465 1.591E-04 5.028E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hemolytic anemia DOID_583 1.687E-04 5.305E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP normocytic anemia DOID_720 1.687E-04 5.305E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.788E-04 5.59E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lung small cell carcinoma DOID_5409 1.788E-04 5.56E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP transient cerebral ischemia DOID_224 1.909E-04 5.902E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.909E-04 5.87E-04 0.02064638 0.39159308 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.909E-04 5.87E-04 0.02064638 0.39159308 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Hodgkin's granuloma DOID_8651 1.909E-04 5.87E-04 0.02064638 0.39159308 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 1.909E-04 5.87E-04 0.02064638 0.39159308 HINATA_NFKB_TARGETS_KERATINOCYTE_UP breast benign neoplasm DOID_0060082 2.33E-04 7.126E-04 0.02268773 0.41642956 HINATA_NFKB_TARGETS_KERATINOCYTE_UP thoracic benign neoplasm DOID_0060097 2.33E-04 7.126E-04 0.02268773 0.41642956 HINATA_NFKB_TARGETS_KERATINOCYTE_UP trypanosomiasis DOID_10113 2.33E-04 7.088E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pneumocystosis DOID_11339 2.33E-04 7.051E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP prediabetes syndrome DOID_11716 2.33E-04 7.013E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP temporal arteritis DOID_13375 2.33E-04 6.976E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP benign breast phyllodes tumor DOID_1631 2.33E-04 7.126E-04 0.02268773 0.41642956 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hemochromatosis DOID_2352 2.33E-04 6.94E-04 0.02268773 0.40341614 HINATA_NFKB_TARGETS_KERATINOCYTE_UP central nervous system vasculitis DOID_525 2.33E-04 6.976E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP otitis media DOID_10754 2.792E-04 8.273E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP aortic valve stenosis DOID_1712 2.792E-04 8.23E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP epidermolysis bullosa DOID_2730 2.792E-04 8.188E-04 0.02472487 0.41377794 HINATA_NFKB_TARGETS_KERATINOCYTE_UP middle ear disease DOID_5100 2.792E-04 8.273E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP aortic valve insufficiency DOID_57 2.792E-04 8.146E-04 0.02472487 0.40195571 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Hodgkin's lymphoma DOID_8567 2.792E-04 8.104E-04 0.02472487 0.39079028 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mitochondrial encephalomyopathy DOID_890 2.792E-04 8.063E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypertrophic cardiomyopathy DOID_11984 2.873E-04 8.256E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP melancholia DOID_2848 3.014E-04 8.619E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP neurotic disorder DOID_4964 3.16E-04 8.991E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP berylliosis DOID_10322 3.295E-04 9.327E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP newborn respiratory distress syndrome DOID_12716 3.295E-04 9.281E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP carotid stenosis DOID_13001 3.295E-04 9.235E-04 0.02675782 0.41149184 HINATA_NFKB_TARGETS_KERATINOCYTE_UP polyneuropathy DOID_1389 3.295E-04 9.19E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP larynx cancer DOID_2596 3.295E-04 9.145E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP laryngeal benign neoplasm DOID_2598 3.295E-04 9.145E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP vesiculobullous skin disease DOID_2731 3.295E-04 9.101E-04 0.02675782 0.40066311 HINATA_NFKB_TARGETS_KERATINOCYTE_UP intracranial thrombosis DOID_4193 3.295E-04 9.057E-04 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pre-malignant neoplasm DOID_0060071 3.626E-04 9.918E-04 0.12872221 0.77097831 HINATA_NFKB_TARGETS_KERATINOCYTE_UP in situ carcinoma DOID_8719 3.626E-04 9.918E-04 0.12872221 0.77097831 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Legionnaires' disease DOID_10457 3.839E-04 1.045E-03 0.02878658 0.41998885 HINATA_NFKB_TARGETS_KERATINOCYTE_UP legionellosis DOID_10458 3.839E-04 1.045E-03 0.02878658 0.41998885 HINATA_NFKB_TARGETS_KERATINOCYTE_UP skeletal system cancer DOID_0060124 4.423E-04 1.199E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP renovascular hypertension DOID_1591 4.423E-04 1.193E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bone cancer DOID_184 4.423E-04 1.199E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mesenchymal cell neoplasm DOID_3350 4.423E-04 1.187E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP spindle cell sarcoma DOID_4235 4.423E-04 1.187E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lung oat cell carcinoma DOID_5411 4.423E-04 1.182E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP epithelioid sarcoma DOID_6193 4.423E-04 1.187E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hyperhomocysteinemia DOID_9279 4.423E-04 1.176E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pancreatic ductal carcinoma DOID_3587 4.876E-04 1.291E-03 0.14137507 0.79645957 HINATA_NFKB_TARGETS_KERATINOCYTE_UP silicosis DOID_10325 5.048E-04 1.33E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP thyroiditis DOID_7166 5.048E-04 1.324E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autoimmune thyroiditis DOID_7188 5.048E-04 1.324E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP tongue cancer DOID_8649 5.048E-04 1.318E-03 0.03283159 0.43444597 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Barrett's esophagus DOID_9206 5.048E-04 1.312E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pancreatic carcinoma DOID_4905 5.487E-04 1.419E-03 0.14674203 0.80284822 HINATA_NFKB_TARGETS_KERATINOCYTE_UP endogenous depression DOID_1595 5.92E-04 1.524E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP syndrome DOID_225 5.92E-04 1.517E-03 0.15030159 0.80680757 HINATA_NFKB_TARGETS_KERATINOCYTE_UP ureteral obstruction DOID_5199 6.419E-04 1.638E-03 0.03685997 0.46607385 HINATA_NFKB_TARGETS_KERATINOCYTE_UP prion disease DOID_649 6.419E-04 1.631E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Down syndrome DOID_14250 7.165E-04 1.812E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mental depression DOID_1596 7.606E-04 1.915E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP subependymal glioma DOID_4843 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP pilocytic astrocytoma DOID_4851 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP subependymal giant cell astrocytoma DOID_5077 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP fibrillary astrocytoma DOID_6726 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP juvenile pilocytic astrocytoma DOID_6811 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP childhood pilocytic astrocytoma DOID_6812 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP gemistocytic astrocytoma DOID_7005 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP childhood cerebral astrocytoma DOID_7007 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP protoplasmic astrocytoma DOID_7008 7.95E-04 1.993E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP coronary restenosis DOID_4247 8.775E-04 2.19E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP primary immunodeficiency disease DOID_612 9.272E-04 2.304E-03 0.17308396 0.8953161 HINATA_NFKB_TARGETS_KERATINOCYTE_UP benign glioma DOID_0060101 9.64E-04 2.385E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP benign ependymoma DOID_4844 9.64E-04 2.385E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP optic nerve disease DOID_1891 1.054E-03 2.597E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP myasthenia gravis DOID_437 1.054E-03 2.586E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP uremia DOID_4676 1.054E-03 2.575E-03 0.04685858 0.51274098 HINATA_NFKB_TARGETS_KERATINOCYTE_UP urinary tract obstruction DOID_5200 1.054E-03 2.564E-03 0.04685858 0.50306662 HINATA_NFKB_TARGETS_KERATINOCYTE_UP ureteral disease DOID_1426 1.149E-03 2.781E-03 0.04884597 0.51469175 HINATA_NFKB_TARGETS_KERATINOCYTE_UP spastic quadriplegia DOID_10970 1.247E-03 3.006E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP severe combined immunodeficiency DOID_627 1.247E-03 2.993E-03 0.05082926 0.50740089 HINATA_NFKB_TARGETS_KERATINOCYTE_UP commensal bacterial infectious disease DOID_0050339 1.349E-03 3.225E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP portal hypertension DOID_10762 1.349E-03 3.211E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP combined T cell and B cell immunodeficiency DOID_628 1.349E-03 3.198E-03 0.05280848 0.51806937 HINATA_NFKB_TARGETS_KERATINOCYTE_UP neuromuscular junction disease DOID_439 1.455E-03 3.435E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP seminoma DOID_4440 1.565E-03 3.679E-03 0.05675469 0.51259392 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypotrichosis DOID_4535 1.565E-03 3.664E-03 0.05675469 0.50458464 HINATA_NFKB_TARGETS_KERATINOCYTE_UP diffuse large B-cell lymphoma DOID_0050745 1.678E-03 3.914E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP perinatal necrotizing enterocolitis DOID_8677 1.678E-03 3.898E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP malaria DOID_12365 1.796E-03 4.154E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hepatic vascular disease DOID_272 1.796E-03 4.137E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP coronary stenosis DOID_4248 1.796E-03 4.12E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autoimmune disease of the nervous system DOID_438 1.796E-03 4.104E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP autoimmune disease of endocrine system DOID_0060005 1.917E-03 4.363E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP supratentorial cancer DOID_1659 1.917E-03 4.346E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cerebrum cancer DOID_368 1.917E-03 4.346E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cranial nerve disease DOID_5656 1.917E-03 4.328E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP corneal disease DOID_10124 2.042E-03 4.593E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP age related macular degeneration DOID_10871 2.171E-03 4.863E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP degeneration of macula and posterior pole DOID_2007 2.171E-03 4.863E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP germinoma DOID_3304 2.303E-03 5.14E-03 0.06849618 0.56484533 HINATA_NFKB_TARGETS_KERATINOCYTE_UP papilloma DOID_2615 2.58E-03 5.734E-03 0.07237785 0.58004223 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hair disease DOID_421 2.58E-03 5.712E-03 0.07237785 0.57198609 HINATA_NFKB_TARGETS_KERATINOCYTE_UP metal metabolism disorder DOID_896 2.58E-03 5.69E-03 0.07237785 0.56415066 HINATA_NFKB_TARGETS_KERATINOCYTE_UP macular degeneration DOID_4448 2.724E-03 5.983E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP aplastic anemia DOID_12449 2.871E-03 6.283E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP embryonal cancer DOID_688 3.177E-03 6.926E-03 3.177E-03 0.18076293 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cervix uteri carcinoma in situ DOID_8991 3.832E-03 8.323E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP cataract DOID_83 4.545E-03 9.833E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP learning disability DOID_8927 4.545E-03 9.796E-03 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lens disease DOID_110 4.923E-03 0.01056958 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bone marrow disease DOID_4961 4.923E-03 0.01052985 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP B-cell lymphocytic neoplasm DOID_707 5.72E-03 0.01218877 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP atrophic muscular disease DOID_913 6.139E-03 0.01303316 0.11032676 0.72995261 HINATA_NFKB_TARGETS_KERATINOCYTE_UP muscular dystrophy DOID_9884 6.139E-03 0.01303316 0.11032676 0.72995261 HINATA_NFKB_TARGETS_KERATINOCYTE_UP oral cavity cancer DOID_8618 7.246E-03 0.01532658 0.11957192 0.74765299 HINATA_NFKB_TARGETS_KERATINOCYTE_UP congenital heart defect DOID_1682 8.436E-03 0.01777848 0.12872221 0.76294728 HINATA_NFKB_TARGETS_KERATINOCYTE_UP endocrine organ benign neoplasm DOID_0060089 9.708E-03 0.02038334 0.1377786 0.79187902 HINATA_NFKB_TARGETS_KERATINOCYTE_UP blood coagulation disease DOID_1247 0.01023922 0.02141954 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP mixed glioma DOID_5076 0.01219707 0.02542172 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lipid metabolism disorder DOID_3146 0.01278422 0.02654825 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP chromosomal disease DOID_0080014 0.01308236 0.02706859 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP auditory system disease DOID_2742 0.01338352 0.02759138 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP brachydactyly DOID_0050581 0.02064638 0.0424108 0.02064638 0.45183817 HINATA_NFKB_TARGETS_KERATINOCYTE_UP interstitial nephritis DOID_1063 0.02064638 0.04225825 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP T cell deficiency DOID_11200 0.02064638 0.04210678 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP facioscapulohumeral muscular dystrophy DOID_11727 0.02064638 0.0419564 0.02064638 0.43510342 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Sjogren's syndrome DOID_12894 0.02064638 0.04180709 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hyperparathyroidism DOID_13543 0.02064638 0.04165884 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypolipoproteinemia DOID_1387 0.02064638 0.04151163 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP angioedema DOID_1558 0.02064638 0.04136547 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP rectal neoplasm DOID_1984 0.02064638 0.04122032 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP rectum cancer DOID_1993 0.02064638 0.04122032 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bilirubin metabolic disorder DOID_2741 0.02064638 0.0410762 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP chondrosarcoma DOID_3371 0.02064638 0.04093307 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Hermansky-Pudlak syndrome DOID_3753 0.02064638 0.04079095 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP keratitis DOID_4677 0.02064638 0.0406498 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP alopecia areata DOID_986 0.02064638 0.04050963 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP familial adenomatous polyposis DOID_0050424 0.02268773 0.04436191 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP adrenoleukodystrophy DOID_10588 0.02268773 0.04420999 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP sickle cell anemia DOID_10923 0.02268773 0.0440591 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP migraine without aura DOID_12783 0.02268773 0.04390924 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP neuronal ceroid lipofuscinosis DOID_14503 0.02268773 0.04376039 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP invasive lobular carcinoma DOID_3457 0.02268773 0.04361256 0.02268773 0.39119141 HINATA_NFKB_TARGETS_KERATINOCYTE_UP intracranial arteriosclerosis DOID_13097 0.02472487 0.04736852 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP diarrhea DOID_13250 0.02472487 0.04720956 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP stomach disease DOID_76 0.02472487 0.04705167 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lipodystrophy DOID_811 0.02472487 0.04689483 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP vascular dementia DOID_8725 0.02472487 0.04736852 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP parathyroid gland disease DOID_11201 0.02675782 0.05058205 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hepatic coma DOID_12550 0.02675782 0.05041456 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hepatic encephalopathy DOID_13413 0.02675782 0.05041456 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP psoriatic arthritis DOID_9008 0.02675782 0.05024818 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP open-angle glaucoma DOID_1067 0.02878658 0.05388015 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP tethered spinal cord syndrome DOID_1089 0.02878658 0.05370349 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP aspergillosis DOID_13564 0.02878658 0.05352799 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP rhabdomyosarcoma DOID_3247 0.02878658 0.05335363 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP parasitic helminthiasis infectious disease DOID_883 0.02878658 0.05318041 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP bacterial meningitis DOID_9470 0.02878658 0.0530083 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP idiopathic pulmonary fibrosis DOID_0050156 0.03081117 0.05655341 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP communication disorder DOID_2033 0.03081117 0.05637156 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP skeletal muscle cancer DOID_4043 0.03081117 0.05619089 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP nutritional deficiency disease DOID_5113 0.03081117 0.05601136 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP angiosarcoma DOID_0001816 0.03283159 0.05949419 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP spastic diplegia DOID_10965 0.03283159 0.05930532 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP restrictive cardiomyopathy DOID_397 0.03283159 0.05911765 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lymphatic system cancer DOID_0060073 0.03484786 0.06255025 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP schizophreniform disorder DOID_11328 0.03484786 0.06235356 0.03484786 0.45064615 HINATA_NFKB_TARGETS_KERATINOCYTE_UP drug-induced mental disorder DOID_1203 0.03484786 0.06215809 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP methylmalonic acidemia DOID_14749 0.03484786 0.06196385 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP drug psychosis DOID_1742 0.03484786 0.06215809 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP basal cell carcinoma DOID_2513 0.03484786 0.06177081 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP schizoaffective disorder DOID_5418 0.03484786 0.06235356 0.03484786 0.45064615 HINATA_NFKB_TARGETS_KERATINOCYTE_UP reticulosarcoma DOID_8538 0.03484786 0.06255025 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP substance-induced psychosis DOID_8646 0.03484786 0.06215809 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP lymphosarcoma DOID_8675 0.03484786 0.06255025 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP glucose intolerance DOID_10603 0.03685997 0.06513454 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP skin carcinoma DOID_3451 0.03685997 0.06493289 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP granulosa cell tumor DOID_2999 0.03886794 0.06825882 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP MHC class II deficiency DOID_5812 0.03886794 0.0680488 0.03886794 0.48077954 HINATA_NFKB_TARGETS_KERATINOCYTE_UP psoriasis DOID_8893 0.03886794 0.06784006 0.03886794 0.47055019 HINATA_NFKB_TARGETS_KERATINOCYTE_UP sex cord-gonadal stromal tumor DOID_192 0.04087178 0.0711194 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP amyloidosis DOID_9120 0.04087178 0.07090257 0.04087178 0.48450089 HINATA_NFKB_TARGETS_KERATINOCYTE_UP alopecia DOID_987 0.04087178 0.07068706 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP juvenile absence epilepsy DOID_0060172 0.04287149 0.07392085 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP funisitis DOID_0050698 0.04486709 0.07712802 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP familial hypercholesterolemia DOID_13810 0.04486709 0.0768957 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP thrombophilia DOID_2452 0.04486709 0.07666479 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP acquired immunodeficiency syndrome DOID_635 0.04486709 0.07643525 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP muscular atrophy DOID_767 0.04486709 0.07620709 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP opiate dependence DOID_2559 0.04685858 0.07935277 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP muscle cancer DOID_4045 0.04685858 0.0791173 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP sleep disorder DOID_535 0.04685858 0.07888323 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP Lewy body dementia DOID_12217 0.04884597 0.0819863 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP toxic shock syndrome DOID_14115 0.05082926 0.08506427 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP sphingolipidosis DOID_1927 0.05082926 0.08481481 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP organic acidemia DOID_0060159 0.05280848 0.08785972 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP hypogonadism DOID_1924 0.05280848 0.08760357 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP morbid obesity DOID_11981 0.05478362 0.09061592 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP ankylosing spondylitis DOID_7147 0.05478362 0.09035327 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP spinal cord disease DOID_319 0.05675469 0.09333358 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP juvenile myoclonic epilepsy DOID_4890 0.05675469 0.0930646 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP migraine DOID_6364 0.0587217 0.09601336 1.000 1.000 HINATA_NFKB_TARGETS_KERATINOCYTE_UP thrombocytopenia DOID_1588 0.06068466 0.09893861 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI abdominal aortic aneurysm DOID_7693 4.052E-07 2.306E-04 0.0146983 0.3484721 MURATA_VIRULENCE_OF_H_PILORI multiple myeloma DOID_9538 7.323E-07 2.083E-04 0.01778986 0.32653009 MURATA_VIRULENCE_OF_H_PILORI myeloma DOID_0070004 1.449E-06 2.748E-04 0.02219056 0.34125477 MURATA_VIRULENCE_OF_H_PILORI aortic aneurysm DOID_3627 1.73E-06 2.461E-04 0.02350714 0.34296315 MURATA_VIRULENCE_OF_H_PILORI atrophic muscular disease DOID_913 2.046E-06 2.328E-04 2.046E-06 1.164E-03 MURATA_VIRULENCE_OF_H_PILORI muscular dystrophy DOID_9884 2.046E-06 2.328E-04 2.046E-06 1.164E-03 MURATA_VIRULENCE_OF_H_PILORI bone marrow cancer DOID_4960 2.159E-06 2.047E-04 0.02525999 0.34221274 MURATA_VIRULENCE_OF_H_PILORI aneurysm disease DOID_2403 5.798E-06 4.713E-04 0.03484786 0.38131597 MURATA_VIRULENCE_OF_H_PILORI alcohol-related neurodevelopmental disorder DOID_0050667 1.043E-05 7.417E-04 8.419E-04 0.07983846 MURATA_VIRULENCE_OF_H_PILORI dilated cardiomyopathy DOID_12930 1.076E-05 6.801E-04 0.04262638 0.42551597 MURATA_VIRULENCE_OF_H_PILORI congenital muscular dystrophy DOID_0050557 2.883E-05 1.641E-03 2.883E-05 8.203E-03 MURATA_VIRULENCE_OF_H_PILORI diffuse large B-cell lymphoma DOID_0050745 7.629E-05 3.946E-03 0.01292758 0.35027576 MURATA_VIRULENCE_OF_H_PILORI papilloma DOID_2615 1.182E-04 5.603E-03 0.01602437 0.33769884 MURATA_VIRULENCE_OF_H_PILORI benign mesothelioma DOID_2645 1.771E-04 7.75E-03 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI rheumatic disease DOID_1575 1.936E-04 7.869E-03 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI scleroderma DOID_419 1.936E-04 7.869E-03 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI glaucoma DOID_1686 2.477E-04 9.395E-03 0.02306846 0.3454199 MURATA_VIRULENCE_OF_H_PILORI B-cell lymphocytic neoplasm DOID_707 2.671E-04 9.5E-03 0.02394563 0.3406266 MURATA_VIRULENCE_OF_H_PILORI sarcoidosis DOID_11335 2.873E-04 9.617E-03 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI osteochondrodysplasia DOID_2256 3.083E-04 9.744E-03 3.083E-04 0.05846551 MURATA_VIRULENCE_OF_H_PILORI hypersensitivity reaction type IV disease DOID_2916 3.41E-04 0.0102118 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI oral cavity cancer DOID_8618 3.41E-04 9.701E-03 0.02700988 0.34928687 MURATA_VIRULENCE_OF_H_PILORI carotid artery disease DOID_3407 3.754E-04 0.01017027 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI collagen disease DOID_854 3.754E-04 9.708E-03 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI cerebral degeneration DOID_1443 4.237E-04 0.01048164 0.03006507 0.3639793 MURATA_VIRULENCE_OF_H_PILORI pancreatic ductal carcinoma DOID_3587 4.881E-04 0.01157298 0.03224183 0.37439997 MURATA_VIRULENCE_OF_H_PILORI pancreatic carcinoma DOID_4905 5.29E-04 0.01203905 0.03354567 0.3817497 MURATA_VIRULENCE_OF_H_PILORI bone development disease DOID_0080006 6.766E-04 0.01480666 6.766E-04 0.09624326 MURATA_VIRULENCE_OF_H_PILORI transitional cell carcinoma DOID_2671 7.406E-04 0.01560716 7.406E-04 0.08427867 MURATA_VIRULENCE_OF_H_PILORI lymphoma DOID_0060058 8.074E-04 0.01640779 0.04133407 0.41998368 MURATA_VIRULENCE_OF_H_PILORI facioscapulohumeral muscular dystrophy DOID_11727 4.476E-03 0.08781591 4.476E-03 0.36380877 MURATA_VIRULENCE_OF_H_PILORI transient cerebral ischemia DOID_224 4.476E-03 0.08488871 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI acute kidney failure DOID_3021 4.476E-03 0.08215037 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI familial adenomatous polyposis DOID_0050424 4.922E-03 0.08752302 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI breast benign neoplasm DOID_0060082 4.922E-03 0.08487081 4.922E-03 0.35009208 MURATA_VIRULENCE_OF_H_PILORI thoracic benign neoplasm DOID_0060097 4.922E-03 0.08487081 4.922E-03 0.35009208 MURATA_VIRULENCE_OF_H_PILORI adrenoleukodystrophy DOID_10588 4.922E-03 0.08237461 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI pneumocystosis DOID_11339 4.922E-03 0.08002105 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI neuronal ceroid lipofuscinosis DOID_14503 4.922E-03 0.07779824 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI benign breast phyllodes tumor DOID_1631 4.922E-03 0.08487081 4.922E-03 0.35009208 MURATA_VIRULENCE_OF_H_PILORI invasive lobular carcinoma DOID_3457 4.922E-03 0.07569559 4.922E-03 0.31119296 MURATA_VIRULENCE_OF_H_PILORI otitis media DOID_10754 5.369E-03 0.08038697 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI aortic valve stenosis DOID_1712 5.369E-03 0.07832576 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI epidermolysis bullosa DOID_2730 5.369E-03 0.07636762 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI middle ear disease DOID_5100 5.369E-03 0.08038697 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI ocular hypertension DOID_9282 5.369E-03 0.07450499 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI borderline glaucoma DOID_9283 5.369E-03 0.07450499 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI vulva cancer DOID_1245 5.815E-03 0.07877537 5.815E-03 0.33085655 MURATA_VIRULENCE_OF_H_PILORI carotid stenosis DOID_13001 5.815E-03 0.07694338 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI obstructive hydrocephalus DOID_14159 5.815E-03 0.07519467 5.815E-03 0.30077868 MURATA_VIRULENCE_OF_H_PILORI communicating hydrocephalus DOID_1573 5.815E-03 0.07519467 5.815E-03 0.30077868 MURATA_VIRULENCE_OF_H_PILORI vesiculobullous skin disease DOID_2731 5.815E-03 0.07352368 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI hydrocephalus DOID_10908 6.261E-03 0.07744172 6.261E-03 0.29685992 MURATA_VIRULENCE_OF_H_PILORI thoracic aortic aneurysm DOID_14004 6.706E-03 0.08119076 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI communication disorder DOID_2033 6.706E-03 0.07949928 6.706E-03 0.29353581 MURATA_VIRULENCE_OF_H_PILORI oral submucous fibrosis DOID_5773 6.706E-03 0.07787685 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI varicose veins DOID_799 6.706E-03 0.07631931 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI intermediate coronary syndrome DOID_8805 6.706E-03 0.07482285 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI intracranial hypertension DOID_9428 6.706E-03 0.07338395 6.706E-03 0.27256897 MURATA_VIRULENCE_OF_H_PILORI restrictive cardiomyopathy DOID_397 7.152E-03 0.07678311 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI tongue cancer DOID_8649 7.152E-03 0.0753612 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI vein disease DOID_866 7.152E-03 0.073991 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI drug-induced mental disorder DOID_1203 7.597E-03 0.07719531 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI methylmalonic acidemia DOID_14749 7.597E-03 0.07584101 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI drug psychosis DOID_1742 7.597E-03 0.07719531 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI substance-induced psychosis DOID_8646 7.597E-03 0.07719531 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI testicular cancer DOID_2998 8.488E-03 0.08326691 8.488E-03 0.3219654 MURATA_VIRULENCE_OF_H_PILORI granulosa cell tumor DOID_2999 8.488E-03 0.08185561 8.488E-03 0.30184256 MURATA_VIRULENCE_OF_H_PILORI esophagitis DOID_11963 8.932E-03 0.08470987 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI sex cord-gonadal stromal tumor DOID_192 8.932E-03 0.08332119 8.932E-03 0.29897603 MURATA_VIRULENCE_OF_H_PILORI mitochondrial myopathy DOID_699 9.377E-03 0.08605802 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI funisitis DOID_0050698 9.822E-03 0.08870627 9.822E-03 0.31047193 MURATA_VIRULENCE_OF_H_PILORI hypoglycemia DOID_9993 0.01026588 0.09127009 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI Lewy body dementia DOID_12217 0.01070996 0.09375338 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI aortic valve disease DOID_62 0.01070996 0.09233288 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI organic acidemia DOID_0060159 0.01159757 0.09849281 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI bronchiolitis DOID_2942 0.01159757 0.09704438 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI cystitis DOID_1679 0.01204109 0.0992954 0.01204109 0.36059907 MURATA_VIRULENCE_OF_H_PILORI myositis DOID_633 0.01204109 0.09787689 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI extrinsic allergic alveolitis DOID_841 0.01248443 0.09866166 1.000 1.000 MURATA_VIRULENCE_OF_H_PILORI perinatal necrotizing enterocolitis DOID_8677 0.01292758 0.09940258 1.000 1.000 WHITESIDE_CISPLATIN_RESISTANCE_UP transitional cell carcinoma DOID_2671 1.534E-06 8.728E-04 1.000 1.000 WHITESIDE_CISPLATIN_RESISTANCE_UP breast benign neoplasm DOID_0060082 3.44E-06 9.786E-04 1.000 1.000 WHITESIDE_CISPLATIN_RESISTANCE_UP thoracic benign neoplasm DOID_0060097 3.44E-06 9.786E-04 1.000 1.000 WHITESIDE_CISPLATIN_RESISTANCE_UP benign breast phyllodes tumor DOID_1631 3.44E-06 9.786E-04 1.000 1.000 WHITESIDE_CISPLATIN_RESISTANCE_UP papilloma DOID_2615 3.926E-05 7.447E-03 1.000 1.000 WHITESIDE_CISPLATIN_RESISTANCE_UP aplastic anemia DOID_12449 4.38E-05 6.231E-03 4.38E-05 0.02492248 WHITESIDE_CISPLATIN_RESISTANCE_UP bone marrow disease DOID_4961 7.619E-05 8.671E-03 7.619E-05 0.02167747 WHITESIDE_CISPLATIN_RESISTANCE_UP atrophic muscular disease DOID_913 9.571E-05 9.076E-03 0.01467537 0.75911669 WHITESIDE_CISPLATIN_RESISTANCE_UP muscular dystrophy DOID_9884 9.571E-05 9.076E-03 0.01467537 0.75911669 RUTELLA_RESPONSE_TO_HGF_DN funisitis DOID_0050698 1.103E-08 6.274E-06 1.103E-08 6.274E-06 RUTELLA_RESPONSE_TO_HGF_DN peripheral vascular disease DOID_341 2.401E-07 6.83E-05 1.329E-04 4.725E-03 RUTELLA_RESPONSE_TO_HGF_DN vascular skin disease DOID_9540 8.214E-07 1.558E-04 2.69E-05 1.531E-03 RUTELLA_RESPONSE_TO_HGF_DN bone marrow cancer DOID_4960 1.592E-06 2.265E-04 1.592E-06 4.531E-04 RUTELLA_RESPONSE_TO_HGF_DN urticaria DOID_1555 1.861E-06 2.118E-04 9.669E-05 4.232E-03 RUTELLA_RESPONSE_TO_HGF_DN celiac disease DOID_10608 5.652E-06 5.36E-04 2.181E-04 6.895E-03 RUTELLA_RESPONSE_TO_HGF_DN aneurysm disease DOID_2403 8.07E-06 6.56E-04 2.576E-03 0.04188082 RUTELLA_RESPONSE_TO_HGF_DN contact dermatitis DOID_2773 9.69E-06 6.892E-04 9.69E-06 1.838E-03 RUTELLA_RESPONSE_TO_HGF_DN multiple myeloma DOID_9538 1.096E-05 6.93E-04 1.096E-05 1.559E-03 RUTELLA_RESPONSE_TO_HGF_DN adenoid cystic carcinoma DOID_4866 1.469E-05 8.356E-04 1.469E-05 1.671E-03 RUTELLA_RESPONSE_TO_HGF_DN Human immunodeficiency virus infectious disease DOID_526 1.699E-05 8.79E-04 2.92E-04 8.309E-03 RUTELLA_RESPONSE_TO_HGF_DN salivary gland cancer DOID_8850 1.764E-05 8.362E-04 1.764E-05 1.672E-03 RUTELLA_RESPONSE_TO_HGF_DN encephalomyelitis DOID_640 1.986E-05 8.691E-04 3.301E-04 8.945E-03 RUTELLA_RESPONSE_TO_HGF_DN influenza DOID_8469 2.1E-05 8.535E-04 2.1E-05 1.707E-03 RUTELLA_RESPONSE_TO_HGF_DN hypersensitivity reaction type I disease DOID_1205 2.197E-05 8.332E-04 3.574E-04 8.842E-03 RUTELLA_RESPONSE_TO_HGF_DN myeloma DOID_0070004 2.69E-05 9.567E-04 2.69E-05 1.913E-03 RUTELLA_RESPONSE_TO_HGF_DN neuritis DOID_1803 2.69E-05 9.004E-04 2.69E-05 1.701E-03 RUTELLA_RESPONSE_TO_HGF_DN autoimmune disease of gastrointestinal tract DOID_0060031 3.146E-05 9.943E-04 7.701E-04 0.01685257 RUTELLA_RESPONSE_TO_HGF_DN aortic aneurysm DOID_3627 3.393E-05 1.016E-03 0.01434433 0.13833768 RUTELLA_RESPONSE_TO_HGF_DN giant cell tumor DOID_200 4.223E-05 1.201E-03 9.563E-04 0.02015298 RUTELLA_RESPONSE_TO_HGF_DN malignant giant cell tumor DOID_2705 4.223E-05 1.201E-03 9.563E-04 0.02015298 RUTELLA_RESPONSE_TO_HGF_DN giant cell glioblastoma DOID_3074 4.223E-05 1.201E-03 9.563E-04 0.02015298 RUTELLA_RESPONSE_TO_HGF_DN glioblastoma DOID_3068 5.92E-05 1.604E-03 1.226E-03 0.02325694 RUTELLA_RESPONSE_TO_HGF_DN oral cavity cancer DOID_8618 5.92E-05 1.531E-03 5.92E-05 3.063E-03 RUTELLA_RESPONSE_TO_HGF_DN carotid artery disease DOID_3407 7.151E-05 1.769E-03 7.151E-05 3.391E-03 RUTELLA_RESPONSE_TO_HGF_DN bronchiolitis DOID_2942 9.669E-05 2.292E-03 9.669E-05 3.93E-03 RUTELLA_RESPONSE_TO_HGF_DN allergic contact dermatitis DOID_3042 1.016E-04 2.312E-03 1.016E-04 3.853E-03 RUTELLA_RESPONSE_TO_HGF_DN brain infarction DOID_3454 1.074E-04 2.349E-03 0.02485539 0.19111782 RUTELLA_RESPONSE_TO_HGF_DN tuberculosis DOID_399 1.074E-04 2.262E-03 1.899E-03 0.03274982 RUTELLA_RESPONSE_TO_HGF_DN astrocytoma DOID_3069 1.134E-04 2.304E-03 1.977E-03 0.03308613 RUTELLA_RESPONSE_TO_HGF_DN pancreatitis DOID_4989 1.706E-04 3.348E-03 1.706E-04 5.711E-03 RUTELLA_RESPONSE_TO_HGF_DN allergic rhinitis DOID_4481 2.181E-04 4.137E-03 2.181E-04 6.532E-03 RUTELLA_RESPONSE_TO_HGF_DN primary bacterial infectious disease DOID_0050338 2.572E-04 4.721E-03 3.609E-03 0.05133457 RUTELLA_RESPONSE_TO_HGF_DN primary immunodeficiency disease DOID_612 2.801E-04 4.98E-03 3.841E-03 0.05331034 RUTELLA_RESPONSE_TO_HGF_DN esophageal disease DOID_6050 2.811E-04 4.847E-03 0.1194025 0.40440489 RUTELLA_RESPONSE_TO_HGF_DN lymphoblastic leukemia DOID_1037 3.301E-04 5.525E-03 4.333E-03 0.05603923 RUTELLA_RESPONSE_TO_HGF_DN Crohn's disease DOID_8778 3.436E-04 5.585E-03 3.436E-04 8.886E-03 RUTELLA_RESPONSE_TO_HGF_DN leukodystrophy DOID_10579 6.468E-04 0.01022312 6.468E-04 0.01533468 RUTELLA_RESPONSE_TO_HGF_DN diarrhea DOID_13250 7.53E-04 0.01157959 7.53E-04 0.01713779 RUTELLA_RESPONSE_TO_HGF_DN pulmonary tuberculosis DOID_2957 7.701E-04 0.01153071 0.01383376 0.13571394 RUTELLA_RESPONSE_TO_HGF_DN hemorrhagic disease DOID_2213 8.6E-04 0.01254687 0.1694098 0.48439284 RUTELLA_RESPONSE_TO_HGF_DN T-cell leukemia DOID_715 1.034E-03 0.01470213 1.034E-03 0.02100304 RUTELLA_RESPONSE_TO_HGF_DN smallpox DOID_8736 1.059E-03 0.01469935 1.059E-03 0.02078183 RUTELLA_RESPONSE_TO_HGF_DN mesenchymal cell neoplasm DOID_3350 1.19E-03 0.01611994 0.05022882 0.28868885 RUTELLA_RESPONSE_TO_HGF_DN spindle cell sarcoma DOID_4235 1.19E-03 0.01611994 0.05022882 0.28868885 RUTELLA_RESPONSE_TO_HGF_DN epithelioid sarcoma DOID_6193 1.19E-03 0.01611994 0.05022882 0.28868885 RUTELLA_RESPONSE_TO_HGF_DN leukocyte disease DOID_9500 1.285E-03 0.01700834 0.01929494 0.16386298 RUTELLA_RESPONSE_TO_HGF_DN silicosis DOID_10325 1.357E-03 0.01754593 1.357E-03 0.02490391 RUTELLA_RESPONSE_TO_HGF_DN collagen disease DOID_854 1.409E-03 0.01781524 0.02047937 0.16888061 RUTELLA_RESPONSE_TO_HGF_DN respiratory failure DOID_11162 1.473E-03 0.01822575 0.02108273 0.17137251 RUTELLA_RESPONSE_TO_HGF_DN pre-malignant neoplasm DOID_0060071 1.54E-03 0.01864088 0.02169345 0.17143853 RUTELLA_RESPONSE_TO_HGF_DN in situ carcinoma DOID_8719 1.54E-03 0.01864088 0.02169345 0.17143853 RUTELLA_RESPONSE_TO_HGF_DN cerebral degeneration DOID_1443 1.678E-03 0.01989065 1.678E-03 0.02983598 RUTELLA_RESPONSE_TO_HGF_DN eosinophilia DOID_999 1.722E-03 0.01999831 0.05996998 0.31305432 RUTELLA_RESPONSE_TO_HGF_DN agammaglobulinemia DOID_2583 1.92E-03 0.02185494 0.06319496 0.32689027 RUTELLA_RESPONSE_TO_HGF_DN blood coagulation disease DOID_1247 2.057E-03 0.02294554 0.2219715 0.59858666 RUTELLA_RESPONSE_TO_HGF_DN blood protein disease DOID_620 2.129E-03 0.02329697 0.06640895 0.32296318 RUTELLA_RESPONSE_TO_HGF_DN male reproductive system disease DOID_48 2.138E-03 0.0229554 0.02683723 0.20360515 RUTELLA_RESPONSE_TO_HGF_DN bacterial pneumonia DOID_874 2.67E-03 0.02813252 0.03098456 0.23197651 RUTELLA_RESPONSE_TO_HGF_DN lingual-facial-buccal dyskinesia DOID_9854 2.816E-03 0.02913302 2.816E-03 0.04450879 RUTELLA_RESPONSE_TO_HGF_DN toxic shock syndrome DOID_14115 3.324E-03 0.0337765 3.324E-03 0.05112119 RUTELLA_RESPONSE_TO_HGF_DN commensal bacterial infectious disease DOID_0050339 3.593E-03 0.03586883 3.593E-03 0.05380324 RUTELLA_RESPONSE_TO_HGF_DN osteosarcoma DOID_3347 3.593E-03 0.0352504 3.593E-03 0.05242367 RUTELLA_RESPONSE_TO_HGF_DN spinal muscular atrophy DOID_12377 3.872E-03 0.03734146 0.08860259 0.3706976 RUTELLA_RESPONSE_TO_HGF_DN ankylosing spondylitis DOID_7147 3.872E-03 0.0367191 0.08860259 0.36532518 RUTELLA_RESPONSE_TO_HGF_DN nervous system cancer DOID_3093 3.961E-03 0.03694752 0.03997391 0.26759005 RUTELLA_RESPONSE_TO_HGF_DN vitiligo DOID_12306 4.16E-03 0.03818248 4.16E-03 0.05636461 RUTELLA_RESPONSE_TO_HGF_DN B cell deficiency DOID_2115 4.16E-03 0.03757641 0.09173008 0.37017315 RUTELLA_RESPONSE_TO_HGF_DN middle cerebral artery infarction DOID_3525 4.16E-03 0.03698927 0.09173008 0.36756629 RUTELLA_RESPONSE_TO_HGF_DN fragments of torsion dystonia DOID_531 4.16E-03 0.03642021 4.16E-03 0.0550538 RUTELLA_RESPONSE_TO_HGF_DN lymphoma DOID_0060058 4.207E-03 0.03626959 0.04155741 0.26568727 RUTELLA_RESPONSE_TO_HGF_DN mouth disease DOID_403 4.462E-03 0.03789492 0.04316422 0.27289379 RUTELLA_RESPONSE_TO_HGF_DN dilated cardiomyopathy DOID_12930 4.593E-03 0.03843383 4.593E-03 0.05807778 RUTELLA_RESPONSE_TO_HGF_DN sarcoma DOID_1115 4.766E-03 0.03930615 0.09795313 0.37406264 RUTELLA_RESPONSE_TO_HGF_DN thrombocytopenia DOID_1588 4.766E-03 0.03874463 0.09795313 0.37156889 RUTELLA_RESPONSE_TO_HGF_DN central nervous system hereditary degenerative disease DOID_481 4.766E-03 0.03819893 4.766E-03 0.05895922 RUTELLA_RESPONSE_TO_HGF_DN autoimmune disease of endocrine system DOID_0060005 5.084E-03 0.04017624 0.10104878 0.37826812 RUTELLA_RESPONSE_TO_HGF_DN dystonic disease DOID_544 5.084E-03 0.03962588 5.084E-03 0.06154658 RUTELLA_RESPONSE_TO_HGF_DN corneal disease DOID_10124 5.411E-03 0.04160328 0.10413388 0.38227212 RUTELLA_RESPONSE_TO_HGF_DN bronchiolitis obliterans DOID_2799 5.747E-03 0.04359929 5.747E-03 0.06812389 RUTELLA_RESPONSE_TO_HGF_DN abdominal aortic aneurysm DOID_7693 5.747E-03 0.04302561 0.10720848 0.38608622 RUTELLA_RESPONSE_TO_HGF_DN chronic leukemia DOID_1036 6.447E-03 0.04764221 0.11332629 0.40555131 RUTELLA_RESPONSE_TO_HGF_DN chronic lymphocytic leukemia DOID_1040 6.447E-03 0.04764221 0.11332629 0.40555131 RUTELLA_RESPONSE_TO_HGF_DN autonomic nervous system neoplasm DOID_2621 6.447E-03 0.04703141 0.11332629 0.4005134 RUTELLA_RESPONSE_TO_HGF_DN neuroblastoma DOID_769 6.447E-03 0.04703141 0.11332629 0.4005134 RUTELLA_RESPONSE_TO_HGF_DN papilloma DOID_2615 6.811E-03 0.0490579 0.11636958 0.40374566 RUTELLA_RESPONSE_TO_HGF_DN pneumoconiosis DOID_10316 7.184E-03 0.0510987 7.184E-03 0.08342645 RUTELLA_RESPONSE_TO_HGF_DN lymphoid leukemia DOID_10747 7.567E-03 0.05315282 7.567E-03 0.08610757 RUTELLA_RESPONSE_TO_HGF_DN peripheral nervous system neoplasm DOID_1192 8.767E-03 0.06083433 0.13143124 0.42251059 RUTELLA_RESPONSE_TO_HGF_DN uveitis DOID_13141 8.767E-03 0.06010139 0.13143124 0.42013693 RUTELLA_RESPONSE_TO_HGF_DN blood platelet disease DOID_2218 8.767E-03 0.05938589 0.13143124 0.4177898 RUTELLA_RESPONSE_TO_HGF_DN systemic scleroderma DOID_418 9.185E-03 0.06148432 9.185E-03 0.10247387 RUTELLA_RESPONSE_TO_HGF_DN adult respiratory distress syndrome DOID_11394 9.611E-03 0.06359181 9.611E-03 0.10517106 RUTELLA_RESPONSE_TO_HGF_DN intracranial arterial disease DOID_13089 9.611E-03 0.06286087 0.13738432 0.42951471 RUTELLA_RESPONSE_TO_HGF_DN cerebral arterial disease DOID_3527 9.611E-03 0.06286087 0.13738432 0.42951471 RUTELLA_RESPONSE_TO_HGF_DN autoimmune disease of urogenital tract DOID_0060049 0.01049057 0.06783105 0.01049057 0.11262514 RUTELLA_RESPONSE_TO_HGF_DN primary biliary cirrhosis DOID_12236 0.01049057 0.06783105 0.01049057 0.11262514 RUTELLA_RESPONSE_TO_HGF_DN endometriosis of uterus DOID_288 0.01049057 0.06706891 0.01049057 0.11053949 RUTELLA_RESPONSE_TO_HGF_DN rheumatic disease DOID_1575 0.010943 0.06918411 0.010943 0.11321036 RUTELLA_RESPONSE_TO_HGF_DN endometriosis DOID_289 0.010943 0.06842384 0.010943 0.11118875 RUTELLA_RESPONSE_TO_HGF_DN uveal disease DOID_3480 0.010943 0.06768011 0.14623811 0.44260364 RUTELLA_RESPONSE_TO_HGF_DN scleroderma DOID_419 0.010943 0.06918411 0.010943 0.11321036 RUTELLA_RESPONSE_TO_HGF_DN cerebral infarction DOID_3526 0.01187329 0.07264411 0.15209048 0.45547096 RUTELLA_RESPONSE_TO_HGF_DN proteinuria DOID_576 0.01235101 0.07476305 0.15500172 0.45697398 RUTELLA_RESPONSE_TO_HGF_DN heart valve disease DOID_4079 0.01283704 0.07688711 0.01283704 0.12814519 RUTELLA_RESPONSE_TO_HGF_DN movement disease DOID_480 0.01434433 0.08502003 0.01434433 0.13603205 RUTELLA_RESPONSE_TO_HGF_DN B-cell lymphocytic neoplasm DOID_707 0.01486296 0.0871858 0.1694098 0.48197088 RUTELLA_RESPONSE_TO_HGF_DN sarcoidosis DOID_11335 0.01592415 0.09245757 0.01592415 0.14853839 RUTELLA_RESPONSE_TO_HGF_DN atrophic muscular disease DOID_913 0.01592415 0.09152366 0.01592415 0.14614261 RUTELLA_RESPONSE_TO_HGF_DN muscular dystrophy DOID_9884 0.01592415 0.09152366 0.01592415 0.14614261 RUTELLA_RESPONSE_TO_HGF_DN bile duct adenocarcinoma DOID_4896 0.0164666 0.09369493 0.17793735 0.50121957 RUTELLA_RESPONSE_TO_HGF_DN cholangiocarcinoma DOID_4947 0.0164666 0.09369493 0.17793735 0.50121957 RUTELLA_RESPONSE_TO_HGF_DN reproductive organ benign neoplasm DOID_0050622 0.01701686 0.09586727 0.01701686 0.15369197 RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP allergic contact dermatitis DOID_3042 8.644E-05 0.04918616 8.644E-05 0.04918616 RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP contact dermatitis DOID_2773 1.384E-04 0.03938418 1.384E-04 0.03938418 RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP ulcerative colitis DOID_8577 2.489E-04 0.047214 6.611E-03 0.53734034 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 4.404E-05 0.02505683 4.404E-05 0.02505683 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN invasive ductal carcinoma DOID_3008 2.099E-04 0.05970968 2.099E-04 0.05970968 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN female reproductive organ benign neoplasm DOID_0060086 2.391E-04 0.04534865 0.02254954 0.3207672 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN uterine benign neoplasm DOID_0060095 2.391E-04 0.04534865 0.02254954 0.3207672 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN uterine fibroid DOID_13223 2.391E-04 0.04534865 0.02254954 0.3207672 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN leiomyoma DOID_127 2.864E-04 0.04074634 0.02463827 0.32602739 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN Huntington's disease DOID_12858 4.959E-04 0.05642921 4.959E-04 0.09404869 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN reproductive organ benign neoplasm DOID_0050622 7.878E-04 0.07470807 0.04050972 0.3906785 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN hypertrophic cardiomyopathy DOID_11984 8.71E-04 0.07079901 8.71E-04 0.12389827 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN pancreatic ductal carcinoma DOID_3587 1.244E-03 0.08849587 1.244E-03 0.14159339 SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN pancreatic carcinoma DOID_4905 1.348E-03 0.08519586 1.348E-03 0.1277938 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN contact dermatitis DOID_2773 2.61E-08 1.485E-05 1.002E-06 5.7E-04 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN allergic contact dermatitis DOID_3042 4.534E-07 1.29E-04 1.672E-05 4.756E-03 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN bacterial pneumonia DOID_874 8.855E-07 1.68E-04 0.15920314 0.60796365 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN sarcoidosis DOID_11335 6.853E-06 9.748E-04 0.11427177 0.53736066 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN hypersensitivity reaction type IV disease DOID_2916 9.657E-06 1.099E-03 0.12382395 0.53375628 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN funisitis DOID_0050698 1.458E-05 1.383E-03 1.038E-03 0.06562226 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN pancreatitis DOID_4989 2.837E-05 2.306E-03 7.106E-04 0.06739201 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN mixed glioma DOID_5076 2.837E-05 2.018E-03 0.0130938 0.26608473 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN encephalomyelitis DOID_640 5.571E-05 3.522E-03 0.18613398 0.69222377 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN aplastic anemia DOID_12449 7.79E-05 4.432E-03 3.089E-03 0.10338264 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN pulmonary sarcoidosis DOID_13406 9.095E-05 4.704E-03 0.08300821 0.49717547 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN bone marrow disease DOID_4961 1.776E-04 8.423E-03 5.293E-03 0.1673076 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN pulmonary tuberculosis DOID_2957 1.997E-04 8.739E-03 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN Diamond-Blackfan anemia DOID_1339 2.056E-04 8.358E-03 2.056E-04 0.03900269 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN orofacial cleft DOID_0050567 2.359E-04 8.949E-03 2.359E-04 0.03355918 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN vasculitis DOID_865 2.623E-04 9.328E-03 0.1161904 0.53316403 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN aspergillosis DOID_13564 4.135E-04 0.01384056 0.02986442 0.40459185 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN parasitic infectious disease DOID_1398 4.416E-04 0.01396067 0.13702626 0.55691389 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN hyperglycemia DOID_4195 4.61E-04 0.01380558 0.1388962 0.56051018 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN tuberculosis DOID_399 5.013E-04 0.01426264 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN endogenous depression DOID_1595 6.601E-04 0.01788453 6.601E-04 0.07511503 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN mental depression DOID_1596 8.477E-04 0.0219244 8.477E-04 0.06890527 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN limb-girdle muscular dystrophy DOID_11724 8.561E-04 0.02118004 8.561E-04 0.06089262 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN primary bacterial infectious disease DOID_0050338 9.686E-04 0.0229645 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN primary immunodeficiency disease DOID_612 1.033E-03 0.02351048 0.01671074 0.28813363 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN lymphoma DOID_0060058 1.134E-03 0.02482735 0.01776293 0.29726782 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN synostosis DOID_11971 1.237E-03 0.02606202 1.237E-03 0.07036746 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN hypersensitivity reaction type I disease DOID_1205 1.242E-03 0.02524013 0.18965977 0.68736566 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN acute pancreatitis DOID_2913 1.342E-03 0.02633763 0.05270975 0.46141306 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN severe combined immunodeficiency DOID_627 1.342E-03 0.02545971 0.05270975 0.45442195 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN ulcerative colitis DOID_8577 1.356E-03 0.02488635 0.01994921 0.31530831 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN combined T cell and B cell immunodeficiency DOID_628 1.452E-03 0.02582127 0.05476006 0.45157205 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN autosomal dominant nonsyndromic deafness DOID_0050564 1.566E-03 0.02700402 1.566E-03 0.08101205 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN cleft lip DOID_9296 1.566E-03 0.02620978 1.566E-03 0.07426104 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN congenital hypoplastic anemia DOID_1342 1.684E-03 0.02738104 1.684E-03 0.07371818 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN spinal cord disease DOID_319 1.684E-03 0.02662045 0.05884752 0.46505888 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN lung adenocarcinoma DOID_3910 1.806E-03 0.02778059 0.0608847 0.46815399 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN autoimmune disease of cardiovascular system DOID_0060051 1.933E-03 0.02894103 0.06291753 0.47733429 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN pleurisy DOID_10247 1.933E-03 0.02819896 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN Behcet's disease DOID_13241 1.933E-03 0.02894103 0.06291753 0.47733429 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN supratentorial cancer DOID_1659 2.063E-03 0.02934895 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN cerebrum cancer DOID_368 2.063E-03 0.02934895 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN dysostosis DOID_1934 2.198E-03 0.03049923 2.198E-03 0.08931916 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN opportunistic mycosis DOID_2473 2.336E-03 0.03164952 0.06898996 0.46732481 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN bronchiolitis obliterans DOID_2799 2.336E-03 0.03091348 0.06898996 0.46182688 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN pleural disease DOID_1532 2.625E-03 0.03394923 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN systemic mycosis DOID_0050136 2.776E-03 0.03509825 0.07502351 0.4796447 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN fungal infectious disease DOID_1564 2.776E-03 0.03509825 0.07502351 0.4796447 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN myocarditis DOID_820 2.776E-03 0.03433524 2.776E-03 0.10529475 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN metal metabolism disorder DOID_896 2.776E-03 0.03360471 2.776E-03 0.09871382 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN nephroblastoma DOID_2154 2.93E-03 0.0347362 0.0770261 0.48162474 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN leukopenia DOID_615 2.93E-03 0.03402729 0.0770261 0.47126722 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN cervix uteri carcinoma in situ DOID_8991 4.122E-03 0.04690466 0.09092481 0.51223978 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN uterine cancer DOID_363 4.69E-03 0.05232733 0.09681792 0.51008702 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN proteinuria DOID_576 5.088E-03 0.05567535 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN brain cancer DOID_1319 5.293E-03 0.05682145 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN central nervous system cancer DOID_3620 5.501E-03 0.05796445 1.000 1.000 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN aortic aneurysm DOID_3627 5.929E-03 0.06133643 5.929E-03 0.17755284 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN giant cell tumor DOID_200 6.598E-03 0.06704177 0.11427177 0.53295606 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN malignant giant cell tumor DOID_2705 6.598E-03 0.06704177 0.11427177 0.53295606 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN giant cell glioblastoma DOID_3074 6.598E-03 0.06704177 0.11427177 0.53295606 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN atrophic muscular disease DOID_913 6.598E-03 0.0658656 6.598E-03 0.18771696 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN muscular dystrophy DOID_9884 6.598E-03 0.0658656 6.598E-03 0.18771696 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN parasitic protozoa infectious disease DOID_2789 7.063E-03 0.06928598 0.11810493 0.52914727 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN nonsyndromic deafness DOID_0050563 7.786E-03 0.07508995 7.786E-03 0.210967 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN glioblastoma DOID_3068 7.786E-03 0.07383845 0.12382395 0.52974308 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN melancholia DOID_2848 8.034E-03 0.07494432 8.034E-03 0.20780015 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN leukocyte disease DOID_9500 8.034E-03 0.07373554 0.12572214 0.52989554 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN neurotic disorder DOID_4964 8.286E-03 0.07483988 8.286E-03 0.2049962 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN respiratory failure DOID_11162 8.801E-03 0.0782427 0.13139237 0.54972248 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN pre-malignant neoplasm DOID_0060071 9.063E-03 0.07933577 0.13327436 0.55352635 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN in situ carcinoma DOID_8719 9.063E-03 0.07933577 0.13327436 0.55352635 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN uterine disease DOID_345 9.598E-03 0.08274744 9.598E-03 0.22755545 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN temporal lobe epilepsy DOID_3328 9.871E-03 0.08382874 9.871E-03 0.22466103 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN tooth disease DOID_1091 0.01014705 0.08490691 0.14076213 0.56403979 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN astrocytoma DOID_3069 0.01070961 0.08831551 0.14448201 0.57489696 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN nephrosis DOID_2527 0.0112857 0.09173659 0.14818599 0.57751937 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN syndrome DOID_225 0.01247791 0.09999905 0.15554648 0.59801317 DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN aneurysm disease DOID_2403 0.01278422 0.09964687 0.01278422 0.26941562 SASAKI_ADULT_T_CELL_LEUKEMIA pre-malignant neoplasm DOID_0060071 1.309E-08 7.449E-06 5.676E-07 3.23E-04 SASAKI_ADULT_T_CELL_LEUKEMIA in situ carcinoma DOID_8719 1.309E-08 7.449E-06 5.676E-07 3.23E-04 SASAKI_ADULT_T_CELL_LEUKEMIA mixed glioma DOID_5076 4.215E-08 1.199E-05 9.616E-04 0.0287987 SASAKI_ADULT_T_CELL_LEUKEMIA autonomic nervous system neoplasm DOID_2621 1.536E-06 2.914E-04 1.536E-06 4.37E-04 SASAKI_ADULT_T_CELL_LEUKEMIA neuroblastoma DOID_769 1.536E-06 2.914E-04 1.536E-06 4.37E-04 SASAKI_ADULT_T_CELL_LEUKEMIA peripheral nervous system neoplasm DOID_1192 2.939E-06 4.18E-04 2.939E-06 5.574E-04 SASAKI_ADULT_T_CELL_LEUKEMIA nervous system cancer DOID_3093 2.974E-06 3.384E-04 7.385E-05 5.253E-03 SASAKI_ADULT_T_CELL_LEUKEMIA cervix uteri carcinoma in situ DOID_8991 3.918E-06 3.715E-04 3.918E-06 5.573E-04 SASAKI_ADULT_T_CELL_LEUKEMIA neuroendocrine tumor DOID_169 1.064E-05 8.645E-04 1.064E-05 1.21E-03 SASAKI_ADULT_T_CELL_LEUKEMIA reproductive organ benign neoplasm DOID_0050622 1.193E-05 8.488E-04 0.13020105 0.56987997 SASAKI_ADULT_T_CELL_LEUKEMIA neuroectodermal tumor DOID_171 1.768E-05 1.118E-03 1.768E-05 1.676E-03 SASAKI_ADULT_T_CELL_LEUKEMIA cleft lip DOID_9296 3.753E-05 2.136E-03 3.753E-05 3.051E-03 SASAKI_ADULT_T_CELL_LEUKEMIA contact dermatitis DOID_2773 4.708E-05 2.435E-03 1.033E-03 0.0293881 SASAKI_ADULT_T_CELL_LEUKEMIA female reproductive organ benign neoplasm DOID_0060086 6.309E-05 2.992E-03 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA uterine benign neoplasm DOID_0060095 6.309E-05 2.992E-03 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA uterine fibroid DOID_13223 6.309E-05 2.992E-03 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA leiomyoma DOID_127 8.282E-05 3.625E-03 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA nephroblastoma DOID_2154 9.798E-05 3.982E-03 3.593E-03 0.07572685 SASAKI_ADULT_T_CELL_LEUKEMIA cleft palate DOID_674 1.239E-04 4.702E-03 1.239E-04 7.836E-03 SASAKI_ADULT_T_CELL_LEUKEMIA multiple myeloma DOID_9538 1.239E-04 4.408E-03 1.239E-04 7.052E-03 SASAKI_ADULT_T_CELL_LEUKEMIA myeloma DOID_0070004 2.416E-04 8.088E-03 2.416E-04 0.01249965 SASAKI_ADULT_T_CELL_LEUKEMIA chondrosarcoma DOID_3371 2.532E-04 8.005E-03 0.02374875 0.22903457 SASAKI_ADULT_T_CELL_LEUKEMIA breast benign neoplasm DOID_0060082 3.09E-04 9.255E-03 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA thoracic benign neoplasm DOID_0060097 3.09E-04 9.255E-03 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA benign breast phyllodes tumor DOID_1631 3.09E-04 9.255E-03 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA orofacial cleft DOID_0050567 3.207E-04 9.123E-03 3.207E-04 0.01520436 SASAKI_ADULT_T_CELL_LEUKEMIA bone marrow cancer DOID_4960 3.564E-04 9.656E-03 3.564E-04 0.01559888 SASAKI_ADULT_T_CELL_LEUKEMIA integumentary system cancer DOID_0060122 3.752E-04 9.703E-03 3.752E-04 0.01524829 SASAKI_ADULT_T_CELL_LEUKEMIA skin cancer DOID_4159 3.752E-04 9.703E-03 3.752E-04 0.01524829 SASAKI_ADULT_T_CELL_LEUKEMIA pustulosis of palm and sole DOID_4398 3.752E-04 9.282E-03 0.13020105 0.56552974 SASAKI_ADULT_T_CELL_LEUKEMIA parasitic helminthiasis infectious disease DOID_883 5.089E-04 0.01206569 0.03309129 0.25793076 SASAKI_ADULT_T_CELL_LEUKEMIA allergic contact dermatitis DOID_3042 6.519E-04 0.014837 0.0123794 0.16008816 SASAKI_ADULT_T_CELL_LEUKEMIA pancreatic ductal carcinoma DOID_3587 7.368E-04 0.01612557 7.368E-04 0.02795099 SASAKI_ADULT_T_CELL_LEUKEMIA lymphatic system cancer DOID_0060073 7.57E-04 0.01595368 0.04004012 0.28478534 SASAKI_ADULT_T_CELL_LEUKEMIA reticulosarcoma DOID_8538 7.57E-04 0.01595368 0.04004012 0.28478534 SASAKI_ADULT_T_CELL_LEUKEMIA lymphosarcoma DOID_8675 7.57E-04 0.01595368 0.04004012 0.28478534 SASAKI_ADULT_T_CELL_LEUKEMIA pancreatic carcinoma DOID_4905 8.285E-04 0.01683715 8.285E-04 0.02946501 SASAKI_ADULT_T_CELL_LEUKEMIA syndrome DOID_225 8.935E-04 0.01753146 8.935E-04 0.02990661 SASAKI_ADULT_T_CELL_LEUKEMIA MHC class II deficiency DOID_5812 9.489E-04 0.01799715 9.489E-04 0.02999525 SASAKI_ADULT_T_CELL_LEUKEMIA colon carcinoma DOID_1520 1.053E-03 0.01932158 1.053E-03 0.02852233 SASAKI_ADULT_T_CELL_LEUKEMIA biliary tract cancer DOID_4607 1.146E-03 0.02037916 0.01788067 0.20763474 SASAKI_ADULT_T_CELL_LEUKEMIA bone development disease DOID_0080006 1.185E-03 0.02044052 1.185E-03 0.03066078 SASAKI_ADULT_T_CELL_LEUKEMIA transitional cell carcinoma DOID_2671 1.351E-03 0.02261743 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA myasthenia gravis DOID_437 1.395E-03 0.02268137 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA lymphoma DOID_0060058 1.531E-03 0.02420484 0.02159085 0.24088613 SASAKI_ADULT_T_CELL_LEUKEMIA lymphoblastic leukemia DOID_1037 1.579E-03 0.02427665 0.02202122 0.24096295 SASAKI_ADULT_T_CELL_LEUKEMIA Crohn's disease DOID_8778 1.627E-03 0.0243582 0.2062616 0.77212402 SASAKI_ADULT_T_CELL_LEUKEMIA severe combined immunodeficiency DOID_627 1.649E-03 0.02406124 1.649E-03 0.0407995 SASAKI_ADULT_T_CELL_LEUKEMIA dilated cardiomyopathy DOID_12930 1.676E-03 0.02383761 0.0228926 0.24122023 SASAKI_ADULT_T_CELL_LEUKEMIA combined T cell and B cell immunodeficiency DOID_628 1.784E-03 0.02475617 1.784E-03 0.04229178 SASAKI_ADULT_T_CELL_LEUKEMIA neuromuscular junction disease DOID_439 1.924E-03 0.0260594 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA middle cerebral artery infarction DOID_3525 2.068E-03 0.0273686 2.068E-03 0.04707399 SASAKI_ADULT_T_CELL_LEUKEMIA seminoma DOID_4440 2.068E-03 0.02674659 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA diffuse large B-cell lymphoma DOID_0050745 2.218E-03 0.02804566 0.06734495 0.38706337 SASAKI_ADULT_T_CELL_LEUKEMIA autoimmune disease of the nervous system DOID_438 2.373E-03 0.02934989 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA celiac disease DOID_10608 3.041E-03 0.03681572 3.041E-03 0.06655149 SASAKI_ADULT_T_CELL_LEUKEMIA germinoma DOID_3304 3.041E-03 0.03604873 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA chronic leukemia DOID_1036 3.22E-03 0.03739493 0.08070787 0.42130991 SASAKI_ADULT_T_CELL_LEUKEMIA chronic lymphocytic leukemia DOID_1040 3.22E-03 0.03739493 0.08070787 0.42130991 SASAKI_ADULT_T_CELL_LEUKEMIA embryonal cancer DOID_688 4.189E-03 0.04766903 0.09169886 0.45768995 SASAKI_ADULT_T_CELL_LEUKEMIA microcephaly DOID_10907 4.397E-03 0.04905459 4.397E-03 0.08934944 SASAKI_ADULT_T_CELL_LEUKEMIA intracranial arterial disease DOID_13089 4.827E-03 0.05281648 4.827E-03 0.09470541 SASAKI_ADULT_T_CELL_LEUKEMIA cerebral arterial disease DOID_3527 4.827E-03 0.05281648 4.827E-03 0.09470541 SASAKI_ADULT_T_CELL_LEUKEMIA endometriosis of uterus DOID_288 5.275E-03 0.05663617 5.275E-03 0.10005723 SASAKI_ADULT_T_CELL_LEUKEMIA endometriosis DOID_289 5.507E-03 0.05802379 5.507E-03 0.10107369 SASAKI_ADULT_T_CELL_LEUKEMIA cerebral infarction DOID_3526 5.983E-03 0.06189508 5.983E-03 0.10638217 SASAKI_ADULT_T_CELL_LEUKEMIA autoimmune disease of gastrointestinal tract DOID_0060031 6.989E-03 0.07101779 6.989E-03 0.12051504 SASAKI_ADULT_T_CELL_LEUKEMIA integumentary system benign neoplasm DOID_0060121 6.989E-03 0.06977187 6.989E-03 0.11697048 SASAKI_ADULT_T_CELL_LEUKEMIA glaucoma DOID_1686 6.989E-03 0.0685689 1.000 1.000 SASAKI_ADULT_T_CELL_LEUKEMIA skin benign neoplasm DOID_3165 6.989E-03 0.06977187 6.989E-03 0.11697048 SASAKI_ADULT_T_CELL_LEUKEMIA lung small cell carcinoma DOID_5409 6.989E-03 0.06740672 6.989E-03 0.11362847 SASAKI_ADULT_T_CELL_LEUKEMIA withdrawal disorder DOID_0060001 7.52E-03 0.07131022 7.52E-03 0.11885036 SASAKI_ADULT_T_CELL_LEUKEMIA B-cell lymphocytic neoplasm DOID_707 7.52E-03 0.0701412 0.12178698 0.54564403 SASAKI_ADULT_T_CELL_LEUKEMIA bile duct adenocarcinoma DOID_4896 8.348E-03 0.07660958 0.12810504 0.56505244 SASAKI_ADULT_T_CELL_LEUKEMIA cholangiocarcinoma DOID_4947 8.348E-03 0.07660958 0.12810504 0.56505244 SASAKI_ADULT_T_CELL_LEUKEMIA osteochondrodysplasia DOID_2256 8.632E-03 0.07796516 8.632E-03 0.13275149 SASAKI_ADULT_T_CELL_LEUKEMIA congenital nervous system abnormality DOID_2490 9.215E-03 0.08192468 9.215E-03 0.1379784 SASAKI_ADULT_T_CELL_LEUKEMIA bile duct cancer DOID_4606 9.512E-03 0.0832695 0.13645923 0.57944255 SASAKI_ADULT_T_CELL_LEUKEMIA bile duct carcinoma DOID_4897 9.512E-03 0.0832695 0.13645923 0.57944255 SASAKI_ADULT_T_CELL_LEUKEMIA oral cavity cancer DOID_8618 9.512E-03 0.08200784 9.512E-03 0.1387825 SASAKI_ADULT_T_CELL_LEUKEMIA melancholia DOID_2848 9.814E-03 0.08334736 9.814E-03 0.13960683 SASAKI_ADULT_T_CELL_LEUKEMIA neurotic disorder DOID_4964 0.01012027 0.08468285 0.01012027 0.14044961 SASAKI_ADULT_T_CELL_LEUKEMIA mineral metabolism disease DOID_0050032 0.01138644 0.09389687 0.1488423 0.61818444 SASAKI_ADULT_T_CELL_LEUKEMIA parasitic infectious disease DOID_1398 0.01171333 0.09521268 0.150889 0.62214377 SASAKI_ADULT_T_CELL_LEUKEMIA uterine disease DOID_345 0.01171333 0.09387166 0.01171333 0.1586878 SASAKI_ADULT_T_CELL_LEUKEMIA hyperglycemia DOID_4195 0.01204433 0.09518366 0.01204433 0.15937728 SASAKI_ADULT_T_CELL_LEUKEMIA brain infarction DOID_3454 0.01271853 0.09913484 0.01271853 0.16081873 AMIT_EGF_RESPONSE_120_HELA giant cell tumor DOID_200 5.401E-09 3.073E-06 5.046E-07 2.871E-04 AMIT_EGF_RESPONSE_120_HELA malignant giant cell tumor DOID_2705 5.401E-09 3.073E-06 5.046E-07 2.871E-04 AMIT_EGF_RESPONSE_120_HELA giant cell glioblastoma DOID_3074 5.401E-09 3.073E-06 5.046E-07 2.871E-04 AMIT_EGF_RESPONSE_120_HELA glioblastoma DOID_3068 8.376E-09 2.383E-06 7.141E-07 2.032E-04 AMIT_EGF_RESPONSE_120_HELA astrocytoma DOID_3069 1.952E-08 3.702E-06 1.395E-06 2.646E-04 AMIT_EGF_RESPONSE_120_HELA meningitis DOID_9471 2.705E-06 3.848E-04 0.02687756 0.27806061 AMIT_EGF_RESPONSE_120_HELA Human immunodeficiency virus infectious disease DOID_526 3.727E-06 4.241E-04 3.727E-06 5.302E-04 AMIT_EGF_RESPONSE_120_HELA cholestasis DOID_13580 6.47E-05 6.136E-03 0.07433242 0.38103737 AMIT_EGF_RESPONSE_120_HELA bile duct disease DOID_4138 8.329E-05 6.77E-03 0.08062581 0.39210328 AMIT_EGF_RESPONSE_120_HELA biliary tract disease DOID_9741 8.669E-05 6.166E-03 0.08167063 0.39050916 AMIT_EGF_RESPONSE_120_HELA epilepsy with generalized tonic-clonic seizures DOID_7725 9.724E-05 6.148E-03 0.01464743 0.22525377 AMIT_EGF_RESPONSE_120_HELA cystic fibrosis DOID_1485 9.744E-05 5.544E-03 0.08479816 0.39549305 AMIT_EGF_RESPONSE_120_HELA pancreatitis DOID_4989 1.051E-04 5.435E-03 3.754E-03 0.12565576 AMIT_EGF_RESPONSE_120_HELA bacterial meningitis DOID_9470 1.134E-04 5.375E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_HELA intermediate coronary syndrome DOID_8805 1.307E-04 5.721E-03 1.000 1.000 AMIT_EGF_RESPONSE_120_HELA primary bacterial infectious disease DOID_0050338 1.442E-04 5.861E-03 4.622E-03 0.12524629 AMIT_EGF_RESPONSE_120_HELA Barrett's esophagus DOID_9206 1.493E-04 5.663E-03 0.01799773 0.24382643 AMIT_EGF_RESPONSE_120_HELA alcohol-related neurodevelopmental disorder DOID_0050667 1.804E-04 6.416E-03 5.356E-03 0.12697447 AMIT_EGF_RESPONSE_120_HELA perinatal necrotizing enterocolitis DOID_8677 5.004E-04 0.01674704 5.004E-04 0.05693994 AMIT_EGF_RESPONSE_120_HELA papilloma DOID_2615 7.725E-04 0.02441974 7.725E-04 0.07325921 AMIT_EGF_RESPONSE_120_HELA esophageal disease DOID_6050 8.161E-04 0.02443887 0.04114028 0.32066875 AMIT_EGF_RESPONSE_120_HELA aplastic anemia DOID_12449 8.608E-04 0.02448912 8.608E-04 0.06996893 AMIT_EGF_RESPONSE_120_HELA adenoma DOID_657 9.067E-04 0.024566 9.067E-04 0.06448574 AMIT_EGF_RESPONSE_120_HELA adolescence-adult electroclinical syndrome DOID_0050705 9.537E-04 0.02466579 0.04440256 0.33686745 AMIT_EGF_RESPONSE_120_HELA pulmonary emphysema DOID_9675 1.153E-03 0.0285323 0.04873542 0.33817625 AMIT_EGF_RESPONSE_120_HELA gallbladder cancer DOID_3121 1.315E-03 0.03117821 1.315E-03 0.08314188 AMIT_EGF_RESPONSE_120_HELA cerebral infarction DOID_3526 1.371E-03 0.03120998 0.05304908 0.33915648 AMIT_EGF_RESPONSE_120_HELA bone marrow disease DOID_4961 1.487E-03 0.03254339 1.487E-03 0.0846128 AMIT_EGF_RESPONSE_120_HELA autoimmune disease of gastrointestinal tract DOID_0060031 1.607E-03 0.03387314 1.607E-03 0.08314315 AMIT_EGF_RESPONSE_120_HELA pulmonary tuberculosis DOID_2957 1.607E-03 0.03266338 1.607E-03 0.07621456 AMIT_EGF_RESPONSE_120_HELA atrophic muscular disease DOID_913 1.861E-03 0.03652161 1.861E-03 0.08147129 AMIT_EGF_RESPONSE_120_HELA muscular dystrophy DOID_9884 1.861E-03 0.03652161 1.861E-03 0.08147129 AMIT_EGF_RESPONSE_120_HELA neuroectodermal tumor DOID_171 2.423E-03 0.04595161 2.423E-03 0.09846773 AMIT_EGF_RESPONSE_120_HELA allergic contact dermatitis DOID_3042 2.89E-03 0.05304153 2.89E-03 0.10961915 AMIT_EGF_RESPONSE_120_HELA brain infarction DOID_3454 2.971E-03 0.05283543 0.07748436 0.39016459 AMIT_EGF_RESPONSE_120_HELA tuberculosis DOID_399 2.971E-03 0.05123436 2.971E-03 0.10567086 AMIT_EGF_RESPONSE_120_HELA electroclinical syndrome DOID_0050701 3.754E-03 0.06282788 0.08687739 0.40189623 AMIT_EGF_RESPONSE_120_HELA bacterial pneumonia DOID_874 3.754E-03 0.0610328 0.08687739 0.39865513 AMIT_EGF_RESPONSE_120_HELA contact dermatitis DOID_2773 3.94E-03 0.06227125 3.94E-03 0.12454251 AMIT_EGF_RESPONSE_120_HELA chromosomal disease DOID_0080014 4.034E-03 0.06203974 0.0899876 0.40637255 AMIT_EGF_RESPONSE_120_HELA biliary tract cancer DOID_4607 4.226E-03 0.06328074 4.226E-03 0.12656148 AMIT_EGF_RESPONSE_120_HELA chronic kidney failure DOID_784 4.226E-03 0.06165816 4.226E-03 0.1202334 AMIT_EGF_RESPONSE_120_HELA transitional cell carcinoma DOID_2671 4.724E-03 0.06720053 4.724E-03 0.12218278 AMIT_EGF_RESPONSE_120_HELA lymphoma DOID_0060058 5.141E-03 0.07134805 5.141E-03 0.12718566 AMIT_EGF_RESPONSE_120_HELA Crohn's disease DOID_8778 5.356E-03 0.07255684 5.356E-03 0.12189549 AMUNDSON_GAMMA_RADIATION_RESISTANCE ulcerative colitis DOID_8577 7.918E-06 4.505E-03 7.073E-04 0.10060757 AMUNDSON_GAMMA_RADIATION_RESISTANCE pleurisy DOID_10247 6.316E-05 0.01796767 6.316E-05 0.03593534 AMUNDSON_GAMMA_RADIATION_RESISTANCE pleural disease DOID_1532 8.629E-05 0.0163656 8.629E-05 0.0245484 AMUNDSON_GAMMA_RADIATION_RESISTANCE myocarditis DOID_820 9.134E-05 0.01299324 9.134E-05 0.01732432 AMUNDSON_GAMMA_RADIATION_RESISTANCE neuritis DOID_1803 1.77E-04 0.02014713 0.01960516 0.2187321 AMUNDSON_GAMMA_RADIATION_RESISTANCE pancreatic ductal carcinoma DOID_3587 3.778E-04 0.03582933 0.02850254 0.24572646 AMUNDSON_GAMMA_RADIATION_RESISTANCE pancreatic carcinoma DOID_4905 4.094E-04 0.03328232 0.0296575 0.2445669 AMUNDSON_GAMMA_RADIATION_RESISTANCE primary immunodeficiency disease DOID_612 5.863E-04 0.0417006 0.03541308 0.24876594 AMUNDSON_GAMMA_RADIATION_RESISTANCE lymphoblastic leukemia DOID_1037 6.387E-04 0.04037946 0.03694251 0.25325648 TRACEY_RESISTANCE_TO_IFNA2_DN neuritis DOID_1803 1.737E-06 9.883E-04 0.02348075 0.60729748 TRACEY_RESISTANCE_TO_IFNA2_DN angiosarcoma DOID_0001816 2.545E-05 7.24E-03 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN brain edema DOID_4724 4.025E-05 7.634E-03 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN Sciatic Neuropathy DOID_11446 8.579E-05 0.01220342 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN lesion of sciatic nerve DOID_12528 8.579E-05 0.01220342 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN perinatal necrotizing enterocolitis DOID_8677 8.579E-05 9.763E-03 8.579E-05 0.04881367 TRACEY_RESISTANCE_TO_IFNA2_DN mononeuritis of lower limb DOID_9473 8.579E-05 0.01220342 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN sarcoma DOID_1115 9.189E-05 8.714E-03 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN mononeuritis DOID_1802 9.189E-05 7.469E-03 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN mononeuropathy DOID_1188 9.82E-05 6.984E-03 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN endometriosis of uterus DOID_288 2.082E-04 0.013166 0.02115632 0.633576 TRACEY_RESISTANCE_TO_IFNA2_DN endometriosis DOID_289 2.177E-04 0.01238452 0.02162162 0.58584294 TRACEY_RESISTANCE_TO_IFNA2_DN vascular skin disease DOID_9540 2.573E-04 0.01331048 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN B-cell lymphocytic neoplasm DOID_707 3.003E-04 0.01423706 0.02533654 0.62680386 TRACEY_RESISTANCE_TO_IFNA2_DN giant cell tumor DOID_200 3.229E-04 0.01413497 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN malignant giant cell tumor DOID_2705 3.229E-04 0.01413497 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN giant cell glioblastoma DOID_3074 3.229E-04 0.01413497 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN pustulosis of palm and sole DOID_4398 3.464E-04 0.01408051 0.02718899 0.6188215 TRACEY_RESISTANCE_TO_IFNA2_DN glioblastoma DOID_3068 3.832E-04 0.01453674 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN congenital heart defect DOID_1682 4.486E-04 0.01595159 0.03088394 0.62760577 TRACEY_RESISTANCE_TO_IFNA2_DN uterine disease DOID_345 4.761E-04 0.01593519 0.0318056 0.62404786 TRACEY_RESISTANCE_TO_IFNA2_DN astrocytoma DOID_3069 5.336E-04 0.01686757 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN peripheral vascular disease DOID_341 5.788E-04 0.01733434 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN female reproductive system disease DOID_229 7.082E-04 0.02014899 0.03869174 0.68798743 TRACEY_RESISTANCE_TO_IFNA2_DN transitional cell carcinoma DOID_2671 8.319E-04 0.0225398 0.04188941 0.68100214 TRACEY_RESISTANCE_TO_IFNA2_DN nervous system cancer DOID_3093 8.69E-04 0.02247498 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN lymphoma DOID_0060058 9.069E-04 0.02243529 0.04371214 0.67222184 TRACEY_RESISTANCE_TO_IFNA2_DN encephalomyelitis DOID_640 9.261E-04 0.02195669 0.04416731 0.66134737 TRACEY_RESISTANCE_TO_IFNA2_DN alcohol-related neurodevelopmental disorder DOID_0050667 9.456E-04 0.02152085 0.04462228 0.65102758 TRACEY_RESISTANCE_TO_IFNA2_DN retinal vascular occlusion DOID_1729 4.738E-03 0.09985722 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN Noonan syndrome DOID_3490 4.738E-03 0.09629089 4.738E-03 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN keratitis DOID_4677 4.738E-03 0.09297052 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN stomach disease DOID_76 5.684E-03 0.0979977 5.684E-03 0.64678484 TRACEY_RESISTANCE_TO_IFNA2_DN lipodystrophy DOID_811 5.684E-03 0.09511542 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN peritonitis DOID_8283 5.684E-03 0.09239783 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN intracranial thrombosis DOID_4193 6.156E-03 0.09729536 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN epilepsy with generalized tonic-clonic seizures DOID_7725 6.156E-03 0.09466575 6.156E-03 0.58377214 TRACEY_RESISTANCE_TO_IFNA2_DN open-angle glaucoma DOID_1067 6.628E-03 0.09924266 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN rhabdomyosarcoma DOID_3247 6.628E-03 0.09669797 1.000 1.000 TRACEY_RESISTANCE_TO_IFNA2_DN skeletal muscle cancer DOID_4043 7.1E-03 0.09852899 1.000 1.000 LY_AGING_MIDDLE_UP myocarditis DOID_820 5.752E-05 0.03272735 5.752E-05 0.03272735 LY_AGING_MIDDLE_UP giant cell tumor DOID_200 1.401E-04 0.03985965 1.000 1.000 LY_AGING_MIDDLE_UP malignant giant cell tumor DOID_2705 1.401E-04 0.03985965 1.000 1.000 LY_AGING_MIDDLE_UP giant cell glioblastoma DOID_3074 1.401E-04 0.03985965 1.000 1.000 LY_AGING_MIDDLE_UP glioblastoma DOID_3068 1.663E-04 0.03154938 1.000 1.000 LY_AGING_MIDDLE_UP astrocytoma DOID_3069 2.319E-04 0.0329854 1.000 1.000 LY_AGING_MIDDLE_UP ulcerative colitis DOID_8577 4.469E-04 0.05085314 1.000 1.000 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON toxic shock syndrome DOID_14115 4.17E-06 2.373E-03 3.293E-03 0.46843264 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON commensal bacterial infectious disease DOID_0050339 4.517E-06 1.285E-03 3.425E-03 0.3897154 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON periodontal disease DOID_3388 9.251E-06 1.755E-03 9.251E-06 5.264E-03 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON tooth disease DOID_1091 3.349E-05 4.763E-03 3.349E-05 9.527E-03 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON mouth disease DOID_403 6.314E-05 7.186E-03 6.314E-05 0.011976 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON visceral leishmaniasis DOID_9146 1.318E-03 0.0937607 1.000 1.000 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON eosinophilic pneumonia DOID_5870 1.45E-03 0.09167229 1.000 1.000 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON pulmonary eosinophilia DOID_9498 1.45E-03 0.09167229 1.000 1.000 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON Loeffler syndrome DOID_9503 1.45E-03 0.09167229 1.000 1.000 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON common cold DOID_10459 1.582E-03 0.09000077 1.000 1.000 NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON carotid stenosis DOID_13001 1.713E-03 0.08863245 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP giant cell tumor DOID_200 5.294E-06 3.012E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP malignant giant cell tumor DOID_2705 5.294E-06 3.012E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP giant cell glioblastoma DOID_3074 5.294E-06 3.012E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP glioblastoma DOID_3068 6.86E-06 1.952E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP collagen disease DOID_854 7.932E-06 1.504E-03 6.937E-04 0.07894534 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP astrocytoma DOID_3069 1.132E-05 1.61E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP cannabis abuse DOID_9505 1.58E-05 1.798E-03 6.051E-03 0.49186156 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP cannabis dependence DOID_1849 2.735E-05 2.594E-03 7.859E-03 0.37267068 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP hallucinogen dependence DOID_9977 2.735E-05 2.594E-03 7.859E-03 0.37267068 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP subependymal glioma DOID_4843 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP pilocytic astrocytoma DOID_4851 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP subependymal giant cell astrocytoma DOID_5077 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP fibrillary astrocytoma DOID_6726 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP juvenile pilocytic astrocytoma DOID_6811 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP childhood pilocytic astrocytoma DOID_6812 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP gemistocytic astrocytoma DOID_7005 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP childhood cerebral astrocytoma DOID_7007 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP protoplasmic astrocytoma DOID_7008 6.645E-05 5.401E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP benign glioma DOID_0060101 8.073E-05 5.742E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP benign ependymoma DOID_4844 8.073E-05 5.742E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP sinusitis DOID_0050127 8.839E-05 5.588E-03 0.013865 0.31556749 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP paranasal sinus disease DOID_1352 8.839E-05 5.588E-03 0.013865 0.31556749 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP extrinsic allergic alveolitis DOID_841 1.318E-04 7.5E-03 0.01685471 0.35519736 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP supratentorial cancer DOID_1659 1.62E-04 8.378E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP cerebrum cancer DOID_368 1.62E-04 8.378E-03 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP pulmonary sarcoidosis DOID_13406 2.708E-04 0.01283998 2.708E-04 0.15407973 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP systemic scleroderma DOID_418 2.987E-04 0.01307345 0.02517982 0.32562091 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP adult respiratory distress syndrome DOID_11394 3.131E-04 0.01272711 0.02577189 0.32587121 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP rheumatic disease DOID_1575 3.585E-04 0.01359999 0.02754602 0.31987109 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP scleroderma DOID_419 3.585E-04 0.01359999 0.02754602 0.31987109 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP influenza DOID_8469 3.743E-04 0.01331174 0.02813671 0.31391737 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP brain cancer DOID_1319 4.237E-04 0.01418194 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP heart valve disease DOID_4079 4.237E-04 0.01339406 0.02990671 0.29854247 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP central nervous system cancer DOID_3620 4.408E-04 0.01320216 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP integumentary system benign neoplasm DOID_0060121 4.583E-04 0.01303892 0.03108501 0.30495464 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP skin benign neoplasm DOID_3165 4.583E-04 0.01303892 0.03108501 0.30495464 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP sarcoidosis DOID_11335 5.315E-04 0.01440087 5.315E-04 0.15120915 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP smallpox DOID_8736 5.701E-04 0.01474406 5.701E-04 0.10812312 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP hypersensitivity reaction type IV disease DOID_2916 6.304E-04 0.01559587 6.304E-04 0.08967627 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP respiratory failure DOID_11162 7.155E-04 0.01696281 0.0387106 0.33886668 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP nervous system cancer DOID_3093 1.426E-03 0.0324476 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.551E-03 0.0339371 0.05666375 0.41872304 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP mouth disease DOID_403 1.551E-03 0.03268017 0.05666375 0.4133548 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP hypersensitivity reaction type I disease DOID_1205 1.583E-03 0.0321646 0.05723751 0.41225498 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP bronchiectasis DOID_9563 6.654E-03 0.09963778 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP aortic valve insufficiency DOID_57 7.257E-03 0.09831527 7.257E-03 0.37538559 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP stomach disease DOID_76 7.257E-03 0.09602887 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP mitochondrial encephalomyopathy DOID_890 7.257E-03 0.0938464 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP encephalitis DOID_9588 7.257E-03 0.09176092 1.000 1.000 JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP hyperhomocysteinemia DOID_9279 9.063E-03 0.09917432 9.063E-03 0.30335673 HAMAI_APOPTOSIS_VIA_TRAIL_DN tuberculosis DOID_399 1.01E-08 5.746E-06 0.1410119 0.77898806 HAMAI_APOPTOSIS_VIA_TRAIL_DN primary bacterial infectious disease DOID_0050338 3.975E-08 1.131E-05 0.17352106 0.9141989 HAMAI_APOPTOSIS_VIA_TRAIL_DN brain infarction DOID_3454 4.579E-07 8.685E-05 0.01018455 0.41392931 HAMAI_APOPTOSIS_VIA_TRAIL_DN biliary tract cancer DOID_4607 1.127E-06 1.603E-04 0.16640348 0.8932413 HAMAI_APOPTOSIS_VIA_TRAIL_DN pulmonary sarcoidosis DOID_13406 1.666E-06 1.896E-04 0.08203759 0.65745617 HAMAI_APOPTOSIS_VIA_TRAIL_DN gallbladder cancer DOID_3121 3.216E-06 3.05E-04 0.09569441 0.67222372 HAMAI_APOPTOSIS_VIA_TRAIL_DN cerebral infarction DOID_3526 3.502E-06 2.847E-04 0.09762894 0.67744956 HAMAI_APOPTOSIS_VIA_TRAIL_DN panic disorder DOID_594 4.197E-06 2.985E-04 0.03157958 0.56152434 HAMAI_APOPTOSIS_VIA_TRAIL_DN pulmonary tuberculosis DOID_2957 4.841E-06 3.061E-04 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN sarcoidosis DOID_11335 6.526E-06 3.713E-04 0.11295868 0.73877574 HAMAI_APOPTOSIS_VIA_TRAIL_DN hypersensitivity reaction type IV disease DOID_2916 9.197E-06 4.757E-04 0.12240886 0.73316463 HAMAI_APOPTOSIS_VIA_TRAIL_DN urticaria DOID_1555 2.358E-05 1.118E-03 1.417E-03 0.20161677 HAMAI_APOPTOSIS_VIA_TRAIL_DN mixed glioma DOID_5076 2.703E-05 1.183E-03 0.01279177 0.45490739 HAMAI_APOPTOSIS_VIA_TRAIL_DN middle cerebral artery infarction DOID_3525 2.962E-05 1.204E-03 0.05815041 0.67525678 HAMAI_APOPTOSIS_VIA_TRAIL_DN lipid metabolism disorder DOID_3146 2.979E-05 1.13E-03 7.368E-04 0.13975069 HAMAI_APOPTOSIS_VIA_TRAIL_DN chronic kidney failure DOID_784 3.432E-05 1.221E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN autoimmune disease of the nervous system DOID_438 3.659E-05 1.225E-03 0.06217381 0.63173031 HAMAI_APOPTOSIS_VIA_TRAIL_DN transitional cell carcinoma DOID_2671 4.296E-05 1.358E-03 0.17529105 0.91505146 HAMAI_APOPTOSIS_VIA_TRAIL_DN primary immunodeficiency disease DOID_612 4.487E-05 1.344E-03 0.01632835 0.48899122 HAMAI_APOPTOSIS_VIA_TRAIL_DN hypersensitivity reaction type I disease DOID_1205 5.76E-05 1.639E-03 0.01841327 0.45552821 HAMAI_APOPTOSIS_VIA_TRAIL_DN dilated cardiomyopathy DOID_12930 5.76E-05 1.561E-03 0.18757663 0.93623775 HAMAI_APOPTOSIS_VIA_TRAIL_DN nephroblastoma DOID_2154 6.928E-05 1.792E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN spindle cell carcinoma DOID_4015 6.928E-05 1.714E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN respiratory syncytial virus infectious disease DOID_1273 1.016E-04 2.408E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN intracranial arterial disease DOID_13089 1.09E-04 2.481E-03 0.08791528 0.66698391 HAMAI_APOPTOSIS_VIA_TRAIL_DN cerebral arterial disease DOID_3527 1.09E-04 2.481E-03 0.08791528 0.66698391 HAMAI_APOPTOSIS_VIA_TRAIL_DN vascular skin disease DOID_9540 1.713E-04 3.749E-03 5.168E-03 0.32672776 HAMAI_APOPTOSIS_VIA_TRAIL_DN teratoma DOID_3307 2.007E-04 4.229E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN malignant teratoma DOID_5563 2.007E-04 4.229E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN mature teratoma DOID_5566 2.007E-04 4.229E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN parasitic protozoa infectious disease DOID_2789 2.664E-04 5.413E-03 0.11675075 0.73001294 HAMAI_APOPTOSIS_VIA_TRAIL_DN familial hyperlipidemia DOID_1168 2.802E-04 5.498E-03 7.129E-03 0.40565093 HAMAI_APOPTOSIS_VIA_TRAIL_DN peritonitis DOID_8283 2.935E-04 5.566E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN bile duct cancer DOID_4606 3.093E-04 5.676E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN bile duct carcinoma DOID_4897 3.093E-04 5.676E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN parasitic infectious disease DOID_1398 4.26E-04 7.575E-03 0.13547226 0.77862341 HAMAI_APOPTOSIS_VIA_TRAIL_DN cerebral degeneration DOID_1443 4.26E-04 7.346E-03 4.26E-04 0.2424086 HAMAI_APOPTOSIS_VIA_TRAIL_DN hyperglycemia DOID_4195 4.447E-04 7.442E-03 0.13732272 0.77362996 HAMAI_APOPTOSIS_VIA_TRAIL_DN pancreatic ductal carcinoma DOID_3587 5.247E-04 8.53E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN restrictive cardiomyopathy DOID_397 5.306E-04 8.387E-03 5.306E-04 0.15096457 HAMAI_APOPTOSIS_VIA_TRAIL_DN peripheral vascular disease DOID_341 5.679E-04 8.733E-03 0.01131072 0.42905312 HAMAI_APOPTOSIS_VIA_TRAIL_DN pancreatic carcinoma DOID_4905 5.903E-04 8.839E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN urinary system benign neoplasm DOID_731 6.005E-04 8.762E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN bacterial pneumonia DOID_874 6.857E-04 9.754E-03 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN contact dermatitis DOID_2773 7.368E-04 0.01022566 0.01340664 0.44872796 HAMAI_APOPTOSIS_VIA_TRAIL_DN myasthenia gravis DOID_437 1.108E-03 0.01500996 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.164E-03 0.01539635 0.18583268 0.93574155 HAMAI_APOPTOSIS_VIA_TRAIL_DN toxic shock syndrome DOID_14115 1.31E-03 0.01694234 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN sphingolipidosis DOID_1927 1.31E-03 0.01656585 0.05208332 0.67353202 HAMAI_APOPTOSIS_VIA_TRAIL_DN commensal bacterial infectious disease DOID_0050339 1.417E-03 0.01753189 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN osteosarcoma DOID_3347 1.417E-03 0.01715887 0.05410996 0.66931667 HAMAI_APOPTOSIS_VIA_TRAIL_DN neuromuscular junction disease DOID_439 1.529E-03 0.01812039 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN seminoma DOID_4440 1.644E-03 0.01908956 0.05815041 0.66175164 HAMAI_APOPTOSIS_VIA_TRAIL_DN pleurisy DOID_10247 1.887E-03 0.02146925 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN malaria DOID_12365 1.887E-03 0.02104829 0.06217381 0.65512773 HAMAI_APOPTOSIS_VIA_TRAIL_DN coronary stenosis DOID_4248 1.887E-03 0.02064351 0.06217381 0.64321632 HAMAI_APOPTOSIS_VIA_TRAIL_DN opportunistic mycosis DOID_2473 2.28E-03 0.02448232 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN germinoma DOID_3304 2.42E-03 0.02549545 0.07016976 0.62385298 HAMAI_APOPTOSIS_VIA_TRAIL_DN pleural disease DOID_1532 2.563E-03 0.02651228 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN systemic mycosis DOID_0050136 2.71E-03 0.02753244 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN fungal infectious disease DOID_1564 2.71E-03 0.02753244 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN metal metabolism disorder DOID_896 2.71E-03 0.02704941 0.07414244 0.62965745 HAMAI_APOPTOSIS_VIA_TRAIL_DN thyroid carcinoma DOID_3963 2.861E-03 0.02806324 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN aplastic anemia DOID_12449 3.015E-03 0.02908 0.07809836 0.63482812 HAMAI_APOPTOSIS_VIA_TRAIL_DN thyroid cancer DOID_1781 3.174E-03 0.03009938 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN congenital diaphragmatic hernia DOID_3827 3.673E-03 0.0342581 0.08596019 0.66096417 HAMAI_APOPTOSIS_VIA_TRAIL_DN adenoid cystic carcinoma DOID_4866 3.846E-03 0.03530092 3.846E-03 0.43773143 HAMAI_APOPTOSIS_VIA_TRAIL_DN salivary gland cancer DOID_8850 4.205E-03 0.03798262 4.205E-03 0.39881746 HAMAI_APOPTOSIS_VIA_TRAIL_DN idiopathic generalized epilepsy DOID_1827 4.391E-03 0.0390347 0.09375579 0.67527908 HAMAI_APOPTOSIS_VIA_TRAIL_DN hyperinsulinism DOID_2018 4.391E-03 0.03843417 4.391E-03 0.35688869 HAMAI_APOPTOSIS_VIA_TRAIL_DN uterine cancer DOID_363 4.579E-03 0.03947959 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN leukodystrophy DOID_10579 4.968E-03 0.04219144 4.968E-03 0.3533533 HAMAI_APOPTOSIS_VIA_TRAIL_DN pre-eclampsia DOID_10591 5.168E-03 0.04324338 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN thyroid adenoma DOID_2891 5.168E-03 0.04261666 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN bone marrow disease DOID_4961 5.168E-03 0.04200786 0.10148573 0.69572745 HAMAI_APOPTOSIS_VIA_TRAIL_DN aortic aneurysm DOID_3627 5.789E-03 0.04639656 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN bile duct adenocarcinoma DOID_4896 6.668E-03 0.05269871 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN cholangiocarcinoma DOID_4947 6.668E-03 0.05269871 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN integumentary system cancer DOID_0060122 6.897E-03 0.05375897 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN skin cancer DOID_4159 6.897E-03 0.05375897 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN mitochondrial metabolism disease DOID_700 7.129E-03 0.05481769 0.11864078 0.73376743 HAMAI_APOPTOSIS_VIA_TRAIL_DN hypertrophic cardiomyopathy DOID_11984 7.604E-03 0.05768934 0.12240886 0.74096425 HAMAI_APOPTOSIS_VIA_TRAIL_DN oral cavity cancer DOID_8618 7.604E-03 0.05693027 7.604E-03 0.39333641 HAMAI_APOPTOSIS_VIA_TRAIL_DN melancholia DOID_2848 7.847E-03 0.05798402 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN leukocyte disease DOID_9500 7.847E-03 0.05724064 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN neurotic disorder DOID_4964 8.093E-03 0.05828872 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN neuroectodermal tumor DOID_171 8.342E-03 0.05933513 0.12803116 0.75885136 HAMAI_APOPTOSIS_VIA_TRAIL_DN respiratory failure DOID_11162 8.595E-03 0.06037981 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN pre-malignant neoplasm DOID_0060071 8.852E-03 0.06142272 0.13175959 0.76501229 HAMAI_APOPTOSIS_VIA_TRAIL_DN in situ carcinoma DOID_8719 8.852E-03 0.06142272 0.13175959 0.76501229 HAMAI_APOPTOSIS_VIA_TRAIL_DN endocrine pancreas disease DOID_1428 9.112E-03 0.06246381 9.112E-03 0.43204138 HAMAI_APOPTOSIS_VIA_TRAIL_DN cholestasis DOID_13580 9.375E-03 0.06350306 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN allergic contact dermatitis DOID_3042 9.911E-03 0.06634732 9.911E-03 0.43380941 HAMAI_APOPTOSIS_VIA_TRAIL_DN endocrine organ benign neoplasm DOID_0060089 0.01018455 0.06738384 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN bile duct disease DOID_4138 0.01102424 0.07210106 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN biliary tract disease DOID_9741 0.01131072 0.07313406 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN diabetic retinopathy DOID_8947 0.01160046 0.07416471 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN endogenous depression DOID_1595 0.01218967 0.07706582 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN aneurysm disease DOID_2403 0.01248912 0.07809131 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN metabolic syndrome X DOID_14221 0.01340664 0.08291712 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN chromosomal disease DOID_0080014 0.01371882 0.08393556 0.16282202 0.8908243 HAMAI_APOPTOSIS_VIA_TRAIL_DN alcohol abuse DOID_1574 0.01435261 0.08687908 0.01435261 0.45370185 HAMAI_APOPTOSIS_VIA_TRAIL_DN mental depression DOID_1596 0.01435261 0.08596456 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN retinal vascular disease DOID_2462 0.01499887 0.08889955 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN nervous system cancer DOID_3093 0.01666834 0.09777614 0.17881982 0.92498616 HAMAI_APOPTOSIS_VIA_TRAIL_DN Human immunodeficiency virus infectious disease DOID_526 0.01666834 0.09677843 1.000 1.000 HAMAI_APOPTOSIS_VIA_TRAIL_DN lymphoma DOID_0060058 0.01735736 0.09976096 0.01735736 0.49381676 HAMAI_APOPTOSIS_VIA_TRAIL_DN encephalomyelitis DOID_640 0.01770635 0.09975164 0.18408503 0.9352177 HAMAI_APOPTOSIS_VIA_TRAIL_DN Crohn's disease DOID_8778 0.01805833 0.09975912 1.000 1.000 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN mouth disease DOID_403 2.727E-07 1.552E-04 2.34E-05 6.657E-03 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.34E-05 6.657E-03 2.34E-05 0.01331409 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN varicose veins DOID_799 3.36E-05 6.373E-03 8.671E-03 0.12650652 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN vein disease DOID_866 3.839E-05 5.46E-03 9.246E-03 0.12235384 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN neutropenia DOID_1227 7.374E-05 8.391E-03 7.374E-05 0.01398528 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN agranulocytosis DOID_12987 8.073E-05 7.656E-03 8.073E-05 0.01148387 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN cystitis DOID_1679 1.118E-04 9.091E-03 1.118E-04 0.01272782 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN bladder disease DOID_365 1.891E-04 0.01344691 1.891E-04 0.01792921 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN leukopenia DOID_615 2.115E-04 0.01336971 2.115E-04 0.01718963 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN rheumatic disease DOID_1575 3.276E-04 0.01864047 3.276E-04 0.02330059 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN scleroderma DOID_419 3.276E-04 0.01864047 3.276E-04 0.02330059 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN uterine cancer DOID_363 3.42E-04 0.01769282 3.42E-04 0.02162455 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN integumentary system benign neoplasm DOID_0060121 4.188E-04 0.01985927 0.02975341 0.22275909 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN skin benign neoplasm DOID_3165 4.188E-04 0.01985927 0.02975341 0.22275909 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN B-cell lymphocytic neoplasm DOID_707 4.517E-04 0.01976933 4.517E-04 0.02570013 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN integumentary system cancer DOID_0060122 5.21E-04 0.02117533 0.03313161 0.22442719 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN skin cancer DOID_4159 5.21E-04 0.02117533 0.03313161 0.22442719 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN melancholia DOID_2848 5.952E-04 0.02257748 5.952E-04 0.03078747 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN leukocyte disease DOID_9500 5.952E-04 0.02116639 5.952E-04 0.02822185 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN neurotic disorder DOID_4964 6.145E-04 0.02056724 6.145E-04 0.02689562 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN collagen disease DOID_854 6.341E-04 0.02004417 6.341E-04 0.02577108 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN endogenous depression DOID_1595 9.399E-04 0.02814729 9.399E-04 0.03565323 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN bacterial pneumonia DOID_874 9.883E-04 0.02811816 0.04542252 0.26372869 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN mental depression DOID_1596 1.115E-03 0.03020065 1.115E-03 0.03963836 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN transitional cell carcinoma DOID_2671 1.248E-03 0.03228382 1.248E-03 0.04177907 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN lymphoma DOID_0060058 1.36E-03 0.0336549 1.36E-03 0.04300349 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN dilated cardiomyopathy DOID_12930 1.448E-03 0.03431941 1.448E-03 0.04335083 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN Hodgkin's lymphoma DOID_8567 6.942E-03 0.09875705 6.942E-03 0.13621662 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN mitochondrial encephalomyopathy DOID_890 6.942E-03 0.09634834 1.000 1.000 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN ocular hypertension DOID_9282 6.942E-03 0.09405433 6.942E-03 0.13167607 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN borderline glaucoma DOID_9283 6.942E-03 0.09405433 6.942E-03 0.13167607 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN carotid stenosis DOID_13001 7.519E-03 0.09949507 7.519E-03 0.13800929 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN obstructive hydrocephalus DOID_14159 7.519E-03 0.09723382 7.519E-03 0.1336965 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN communicating hydrocephalus DOID_1573 7.519E-03 0.09723382 7.519E-03 0.1336965 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN vesiculobullous skin disease DOID_2731 7.519E-03 0.09507306 7.519E-03 0.12964509 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN oral submucous fibrosis DOID_5773 8.671E-03 0.09867509 8.671E-03 0.12983564 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN intermediate coronary syndrome DOID_8805 8.671E-03 0.09674028 8.671E-03 0.12334386 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN intracranial hypertension DOID_9428 8.671E-03 0.09487989 8.671E-03 0.12033547 SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN angiosarcoma DOID_0001816 9.246E-03 0.09926821 9.246E-03 0.12526703 RICKMAN_HEAD_AND_NECK_CANCER_C sarcoidosis DOID_11335 3.856E-08 2.194E-05 1.138E-04 0.02159169 RICKMAN_HEAD_AND_NECK_CANCER_C hypersensitivity reaction type IV disease DOID_2916 5.967E-08 1.698E-05 1.469E-04 0.01672074 RICKMAN_HEAD_AND_NECK_CANCER_C cystic fibrosis DOID_1485 2.072E-07 3.93E-05 9.005E-06 5.124E-03 RICKMAN_HEAD_AND_NECK_CANCER_C esophagitis DOID_11963 4.886E-06 6.95E-04 0.03272431 0.40478551 RICKMAN_HEAD_AND_NECK_CANCER_C aneurysm disease DOID_2403 9.473E-06 1.078E-03 7.712E-03 0.19946171 RICKMAN_HEAD_AND_NECK_CANCER_C chronic kidney failure DOID_784 1.267E-05 1.202E-03 3.919E-04 0.02787721 RICKMAN_HEAD_AND_NECK_CANCER_C mouth disease DOID_403 2.051E-05 1.667E-03 5.597E-04 0.02894996 RICKMAN_HEAD_AND_NECK_CANCER_C abdominal aortic aneurysm DOID_7693 2.303E-05 1.638E-03 0.05342756 0.39480885 RICKMAN_HEAD_AND_NECK_CANCER_C esophageal disease DOID_6050 3.264E-05 2.063E-03 0.0597096 0.39505539 RICKMAN_HEAD_AND_NECK_CANCER_C thyroid cancer DOID_1781 3.83E-05 2.179E-03 0.06283522 0.40628682 RICKMAN_HEAD_AND_NECK_CANCER_C pulmonary sarcoidosis DOID_13406 4.135E-05 2.139E-03 4.135E-05 0.0117645 RICKMAN_HEAD_AND_NECK_CANCER_C uveitis DOID_13141 4.456E-05 2.113E-03 2.137E-03 0.08107901 RICKMAN_HEAD_AND_NECK_CANCER_C uveal disease DOID_3480 6.308E-05 2.761E-03 2.683E-03 0.09543036 RICKMAN_HEAD_AND_NECK_CANCER_C integumentary system benign neoplasm DOID_0060121 9.119E-05 3.706E-03 0.08290395 0.44926045 RICKMAN_HEAD_AND_NECK_CANCER_C skin benign neoplasm DOID_3165 9.119E-05 3.706E-03 0.08290395 0.44926045 RICKMAN_HEAD_AND_NECK_CANCER_C aortic aneurysm DOID_3627 9.655E-05 3.662E-03 0.08443006 0.45321419 RICKMAN_HEAD_AND_NECK_CANCER_C bilirubin metabolic disorder DOID_2741 1.213E-04 4.312E-03 1.213E-04 0.01724846 RICKMAN_HEAD_AND_NECK_CANCER_C integumentary system cancer DOID_0060122 1.264E-04 4.231E-03 0.09202321 0.47172257 RICKMAN_HEAD_AND_NECK_CANCER_C skin cancer DOID_4159 1.264E-04 4.231E-03 0.09202321 0.47172257 RICKMAN_HEAD_AND_NECK_CANCER_C familial adenomatous polyposis DOID_0050424 1.48E-04 4.68E-03 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C hypercalcemia DOID_12678 2.442E-04 7.312E-03 2.442E-04 0.02315397 RICKMAN_HEAD_AND_NECK_CANCER_C idiopathic pulmonary fibrosis DOID_0050156 2.814E-04 8.006E-03 0.02464342 0.36900274 RICKMAN_HEAD_AND_NECK_CANCER_C congenital ichthyosiform erythroderma DOID_1699 2.814E-04 7.625E-03 2.814E-04 0.022875 RICKMAN_HEAD_AND_NECK_CANCER_C tongue cancer DOID_8649 3.213E-04 8.309E-03 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C keratosis DOID_161 4.087E-04 0.01011201 4.087E-04 0.02584179 RICKMAN_HEAD_AND_NECK_CANCER_C testicular cancer DOID_2998 4.563E-04 0.01081915 4.563E-04 0.02596597 RICKMAN_HEAD_AND_NECK_CANCER_C gastric ulcer DOID_10808 6.145E-04 0.01398572 0.03593819 0.40095744 RICKMAN_HEAD_AND_NECK_CANCER_C Lewy body dementia DOID_12217 7.326E-04 0.01603314 0.03914156 0.40493719 RICKMAN_HEAD_AND_NECK_CANCER_C cystitis DOID_1679 9.287E-04 0.01957183 0.04392698 0.42363474 RICKMAN_HEAD_AND_NECK_CANCER_C extrinsic allergic alveolitis DOID_841 9.991E-04 0.02030285 0.0455169 0.40467368 RICKMAN_HEAD_AND_NECK_CANCER_C lung adenocarcinoma DOID_3910 1.072E-03 0.02103229 0.04710422 0.41234308 RICKMAN_HEAD_AND_NECK_CANCER_C chronic leukemia DOID_1036 1.561E-03 0.02960513 0.05657373 0.40747406 RICKMAN_HEAD_AND_NECK_CANCER_C chronic lymphocytic leukemia DOID_1040 1.561E-03 0.02960513 0.05657373 0.40747406 RICKMAN_HEAD_AND_NECK_CANCER_C leiomyoma DOID_127 1.561E-03 0.02865012 1.561E-03 0.07401282 RICKMAN_HEAD_AND_NECK_CANCER_C pleural disease DOID_1532 1.561E-03 0.02775481 0.05657373 0.40238064 RICKMAN_HEAD_AND_NECK_CANCER_C bladder disease DOID_365 1.561E-03 0.02691375 0.05657373 0.39256647 RICKMAN_HEAD_AND_NECK_CANCER_C papilloma DOID_2615 1.651E-03 0.02762921 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C hepatitis C DOID_1883 1.743E-03 0.02834319 1.743E-03 0.07630859 RICKMAN_HEAD_AND_NECK_CANCER_C nephroblastoma DOID_2154 1.743E-03 0.02755588 0.0597096 0.3997031 RICKMAN_HEAD_AND_NECK_CANCER_C periodontal disease DOID_3388 1.743E-03 0.02681113 1.743E-03 0.07085798 RICKMAN_HEAD_AND_NECK_CANCER_C thyroid carcinoma DOID_3963 1.743E-03 0.02610557 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C spindle cell carcinoma DOID_4015 1.743E-03 0.0254362 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C multiple myeloma DOID_9538 2.035E-03 0.0289524 0.06439419 0.41168871 RICKMAN_HEAD_AND_NECK_CANCER_C hepatitis DOID_2237 2.242E-03 0.03111294 0.06750448 0.41750055 RICKMAN_HEAD_AND_NECK_CANCER_C peptic ulcer DOID_750 2.242E-03 0.03037216 0.06750448 0.4130113 RICKMAN_HEAD_AND_NECK_CANCER_C benign mesothelioma DOID_2645 2.458E-03 0.03252495 0.0706046 0.42288438 RICKMAN_HEAD_AND_NECK_CANCER_C endometriosis of uterus DOID_288 2.57E-03 0.03322864 0.07215085 0.42323539 RICKMAN_HEAD_AND_NECK_CANCER_C nephrotic syndrome DOID_1184 2.683E-03 0.0339308 0.07369457 0.42787969 RICKMAN_HEAD_AND_NECK_CANCER_C endometriosis DOID_289 2.683E-03 0.03319317 0.07369457 0.42355767 RICKMAN_HEAD_AND_NECK_CANCER_C influenza DOID_8469 2.8E-03 0.03389458 0.07523576 0.42385295 RICKMAN_HEAD_AND_NECK_CANCER_C leukodystrophy DOID_10579 3.039E-03 0.03602808 0.07831058 0.43685019 RICKMAN_HEAD_AND_NECK_CANCER_C myeloma DOID_0070004 3.163E-03 0.03672412 0.07984421 0.44108113 RICKMAN_HEAD_AND_NECK_CANCER_C neuritis DOID_1803 3.163E-03 0.03598964 0.07984421 0.43683997 RICKMAN_HEAD_AND_NECK_CANCER_C thyroid adenoma DOID_2891 3.163E-03 0.03528396 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C calcium metabolism disease DOID_10575 3.546E-03 0.03880314 3.546E-03 0.11869195 RICKMAN_HEAD_AND_NECK_CANCER_C movement disease DOID_480 3.546E-03 0.038071 3.546E-03 0.11209795 RICKMAN_HEAD_AND_NECK_CANCER_C B-cell lymphocytic neoplasm DOID_707 3.679E-03 0.03876176 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C giant cell tumor DOID_200 3.95E-03 0.04086853 0.08899341 0.47324536 RICKMAN_HEAD_AND_NECK_CANCER_C malignant giant cell tumor DOID_2705 3.95E-03 0.04086853 0.08899341 0.47324536 RICKMAN_HEAD_AND_NECK_CANCER_C giant cell glioblastoma DOID_3074 3.95E-03 0.04086853 0.08899341 0.47324536 RICKMAN_HEAD_AND_NECK_CANCER_C bone marrow cancer DOID_4960 4.09E-03 0.04155398 0.09050955 0.47685126 RICKMAN_HEAD_AND_NECK_CANCER_C retinitis pigmentosa DOID_10584 4.669E-03 0.04661134 4.669E-03 0.13983402 RICKMAN_HEAD_AND_NECK_CANCER_C glioblastoma DOID_3068 4.669E-03 0.0458077 0.09654931 0.47770921 RICKMAN_HEAD_AND_NECK_CANCER_C oral cavity cancer DOID_8618 4.669E-03 0.04503129 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C melancholia DOID_2848 4.82E-03 0.04570805 0.09805308 0.48096724 RICKMAN_HEAD_AND_NECK_CANCER_C neurotic disorder DOID_4964 4.973E-03 0.04638333 0.09955437 0.4841576 RICKMAN_HEAD_AND_NECK_CANCER_C mineral metabolism disease DOID_0050032 5.606E-03 0.05144409 5.606E-03 0.15947668 RICKMAN_HEAD_AND_NECK_CANCER_C cerebral degeneration DOID_1443 5.769E-03 0.05210615 0.10702406 0.50747241 RICKMAN_HEAD_AND_NECK_CANCER_C uterine disease DOID_345 5.769E-03 0.05129199 0.10702406 0.50327842 RICKMAN_HEAD_AND_NECK_CANCER_C tooth disease DOID_1091 6.103E-03 0.05342623 6.103E-03 0.16536689 RICKMAN_HEAD_AND_NECK_CANCER_C endocrine organ benign neoplasm DOID_0060089 6.273E-03 0.05408424 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C astrocytoma DOID_3069 6.446E-03 0.05474089 0.11295587 0.51832168 RICKMAN_HEAD_AND_NECK_CANCER_C nephrosis DOID_2527 6.797E-03 0.0568744 0.11590721 0.52760964 RICKMAN_HEAD_AND_NECK_CANCER_C endogenous depression DOID_1595 7.525E-03 0.06205243 0.12178095 0.54561699 RICKMAN_HEAD_AND_NECK_CANCER_C bacterial pneumonia DOID_874 7.901E-03 0.06422699 7.901E-03 0.19547346 RICKMAN_HEAD_AND_NECK_CANCER_C metabolic syndrome X DOID_14221 8.286E-03 0.06640722 0.12761627 0.56289656 RICKMAN_HEAD_AND_NECK_CANCER_C female reproductive system disease DOID_229 8.482E-03 0.06703049 0.12906913 0.56061323 RICKMAN_HEAD_AND_NECK_CANCER_C mental depression DOID_1596 8.879E-03 0.06920937 0.1319677 0.56886078 RICKMAN_HEAD_AND_NECK_CANCER_C amino acid metabolic disorder DOID_9252 0.01012027 0.07781668 0.14060659 0.58397919 RICKMAN_HEAD_AND_NECK_CANCER_C lymphoma DOID_0060058 0.01076801 0.08169327 1.000 1.000 RICKMAN_HEAD_AND_NECK_CANCER_C lymphoblastic leukemia DOID_1037 0.0109879 0.08226468 0.14631878 0.60329991 RICKMAN_HEAD_AND_NECK_CANCER_C encephalomyelitis DOID_640 0.0109879 0.08119631 0.14631878 0.59895962 RICKMAN_HEAD_AND_NECK_CANCER_C Crohn's disease DOID_8778 0.01120978 0.0817739 0.14774098 0.60046157 RICKMAN_HEAD_AND_NECK_CANCER_C dilated cardiomyopathy DOID_12930 0.01143363 0.08235108 0.14916085 0.6019328 ROSS_AML_OF_FAB_M7_TYPE blood coagulation disease DOID_1247 1.214E-06 6.906E-04 1.214E-06 6.906E-04 ROSS_AML_OF_FAB_M7_TYPE metal metabolism disorder DOID_896 8.177E-06 2.326E-03 7.023E-04 0.03632999 ROSS_AML_OF_FAB_M7_TYPE blood platelet disease DOID_2218 1.216E-05 2.307E-03 1.216E-05 3.46E-03 ROSS_AML_OF_FAB_M7_TYPE hemolytic anemia DOID_583 2.358E-05 3.354E-03 2.358E-05 4.473E-03 ROSS_AML_OF_FAB_M7_TYPE normocytic anemia DOID_720 2.358E-05 3.354E-03 2.358E-05 4.473E-03 ROSS_AML_OF_FAB_M7_TYPE hemorrhagic disease DOID_2213 2.802E-05 3.189E-03 2.802E-05 3.986E-03 ROSS_AML_OF_FAB_M7_TYPE gallbladder disease DOID_0000000 5.107E-05 4.843E-03 0.01076359 0.408299 ROSS_AML_OF_FAB_M7_TYPE cholestasis DOID_13580 5.603E-05 4.554E-03 2.485E-03 0.11781115 ROSS_AML_OF_FAB_M7_TYPE bile duct disease DOID_4138 7.215E-05 5.131E-03 2.934E-03 0.12841493 ROSS_AML_OF_FAB_M7_TYPE biliary tract disease DOID_9741 7.51E-05 4.748E-03 3.012E-03 0.12242573 ROSS_AML_OF_FAB_M7_TYPE intracranial thrombosis DOID_4193 8.834E-05 5.026E-03 8.834E-05 0.01005276 ROSS_AML_OF_FAB_M7_TYPE angiosarcoma DOID_0001816 1.356E-04 7.015E-03 1.356E-04 0.01286167 ROSS_AML_OF_FAB_M7_TYPE inherited blood coagulation disease DOID_2214 1.727E-04 8.188E-03 1.727E-04 0.01403671 ROSS_AML_OF_FAB_M7_TYPE prion disease DOID_649 1.727E-04 7.558E-03 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE Down syndrome DOID_14250 1.929E-04 7.839E-03 0.02035413 0.39936207 ROSS_AML_OF_FAB_M7_TYPE congenital hemolytic anemia DOID_589 3.102E-04 0.01176804 3.102E-04 0.02206508 ROSS_AML_OF_FAB_M7_TYPE spastic quadriplegia DOID_10970 3.37E-04 0.01198368 0.02669736 0.42196664 ROSS_AML_OF_FAB_M7_TYPE sarcoma DOID_1115 4.869E-04 0.01629828 4.869E-04 0.03078565 ROSS_AML_OF_FAB_M7_TYPE thrombocytopenia DOID_1588 4.869E-04 0.01539282 4.869E-04 0.02770708 ROSS_AML_OF_FAB_M7_TYPE spastic cerebral palsy DOID_0050669 5.898E-04 0.01766403 0.03509271 0.4754226 ROSS_AML_OF_FAB_M7_TYPE age related macular degeneration DOID_10871 5.898E-04 0.01678082 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE degeneration of macula and posterior pole DOID_2007 5.898E-04 0.01678082 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE macular degeneration DOID_4448 7.42E-04 0.02010365 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE lymphatic system disease DOID_75 1.002E-03 0.02591205 0.04548758 0.55069007 ROSS_AML_OF_FAB_M7_TYPE proteinuria DOID_576 1.299E-03 0.03214649 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE glaucoma DOID_1686 1.462E-03 0.03466533 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE vasculitis DOID_865 1.754E-03 0.03991823 0.05985707 0.70955565 ROSS_AML_OF_FAB_M7_TYPE carotid artery disease DOID_3407 2.205E-03 0.04825229 0.06696245 0.73272371 ROSS_AML_OF_FAB_M7_TYPE temporal lobe epilepsy DOID_3328 2.557E-03 0.05388669 0.07200562 0.75872585 ROSS_AML_OF_FAB_M7_TYPE mixed glioma DOID_5076 3.418E-03 0.06946794 0.08300716 0.81432883 ROSS_AML_OF_FAB_M7_TYPE chromosomal disease DOID_0080014 3.674E-03 0.07208255 0.08598543 0.82924928 ROSS_AML_OF_FAB_M7_TYPE focal epilepsy DOID_2234 3.849E-03 0.0729996 0.08796569 0.80729806 ROSS_AML_OF_FAB_M7_TYPE chronic kidney failure DOID_784 3.849E-03 0.07064478 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE encephalomyelitis DOID_640 4.781E-03 0.0850125 0.09780442 0.85616481 ROSS_AML_OF_FAB_M7_TYPE alcohol-related neurodevelopmental disorder DOID_0050667 4.879E-03 0.08413295 1.000 1.000 ROSS_AML_OF_FAB_M7_TYPE dilated cardiomyopathy DOID_12930 4.979E-03 0.08332075 0.0997597 0.84721294 WINTER_HYPOXIA_METAGENE chronic kidney failure DOID_784 1.948E-23 1.108E-20 0.32392895 1.000 WINTER_HYPOXIA_METAGENE aneurysm disease DOID_2403 3.216E-22 9.148E-20 0.05127135 0.63420435 WINTER_HYPOXIA_METAGENE diabetic retinopathy DOID_8947 1.017E-20 1.929E-18 0.04784818 0.61876401 WINTER_HYPOXIA_METAGENE retinal vascular disease DOID_2462 9.023E-20 1.283E-17 0.06080782 0.64073422 WINTER_HYPOXIA_METAGENE peptic ulcer DOID_750 5.832E-19 6.637E-17 1.000 1.000 WINTER_HYPOXIA_METAGENE biliary tract cancer DOID_4607 3.096E-18 2.936E-16 7.126E-03 0.21339752 WINTER_HYPOXIA_METAGENE transitional cell carcinoma DOID_2671 7.22E-18 5.869E-16 0.06452875 0.66757921 WINTER_HYPOXIA_METAGENE encephalomyelitis DOID_640 1.601E-17 1.139E-15 1.000 1.000 WINTER_HYPOXIA_METAGENE nephrosis DOID_2527 2.087E-17 1.32E-15 4.851E-03 0.18403069 WINTER_HYPOXIA_METAGENE pancreatic carcinoma DOID_4905 3.022E-17 1.72E-15 5.226E-03 0.18585838 WINTER_HYPOXIA_METAGENE cystic fibrosis DOID_1485 4.329E-17 2.239E-15 1.000 1.000 WINTER_HYPOXIA_METAGENE renal hypertension DOID_1073 8.861E-17 4.202E-15 0.12895426 0.87351161 WINTER_HYPOXIA_METAGENE secondary hypertension DOID_11130 8.861E-17 4.202E-15 0.12895426 0.87351161 WINTER_HYPOXIA_METAGENE sarcoma DOID_1115 8.861E-17 3.878E-15 0.12895426 0.863235 WINTER_HYPOXIA_METAGENE respiratory failure DOID_11162 1.94E-16 7.884E-15 1.000 1.000 WINTER_HYPOXIA_METAGENE gallbladder cancer DOID_3121 2.086E-16 7.914E-15 0.01977753 0.40190769 WINTER_HYPOXIA_METAGENE abdominal aortic aneurysm DOID_7693 2.698E-16 9.594E-15 0.14090253 0.87145153 WINTER_HYPOXIA_METAGENE pre-eclampsia DOID_10591 4.421E-16 1.48E-14 0.02221273 0.4213015 WINTER_HYPOXIA_METAGENE uremia DOID_4676 5.67E-16 1.792E-14 1.000 1.000 WINTER_HYPOXIA_METAGENE astrocytoma DOID_3069 7.197E-16 2.155E-14 0.28217546 1.000 WINTER_HYPOXIA_METAGENE pancreatic ductal carcinoma DOID_3587 8.579E-16 2.441E-14 4.67E-03 0.18981478 WINTER_HYPOXIA_METAGENE aortic aneurysm DOID_3627 8.916E-16 2.416E-14 0.02476504 0.42700934 WINTER_HYPOXIA_METAGENE spindle cell carcinoma DOID_4015 9.993E-16 2.585E-14 0.15658044 0.89994212 WINTER_HYPOXIA_METAGENE giant cell tumor DOID_200 1.721E-15 4.258E-14 0.2272519 1.000 WINTER_HYPOXIA_METAGENE malignant giant cell tumor DOID_2705 1.721E-15 4.258E-14 0.2272519 1.000 WINTER_HYPOXIA_METAGENE giant cell glioblastoma DOID_3074 1.721E-15 4.258E-14 0.2272519 1.000 WINTER_HYPOXIA_METAGENE angiosarcoma DOID_0001816 2.088E-15 4.95E-14 0.07097422 0.67307218 WINTER_HYPOXIA_METAGENE bile duct adenocarcinoma DOID_4896 2.124E-15 4.835E-14 0.02834402 0.47434555 WINTER_HYPOXIA_METAGENE cholangiocarcinoma DOID_4947 2.124E-15 4.835E-14 0.02834402 0.47434555 WINTER_HYPOXIA_METAGENE glioblastoma DOID_3068 4.738E-15 1.037E-13 0.24484993 1.000 WINTER_HYPOXIA_METAGENE bile duct cancer DOID_4606 4.738E-15 9.986E-14 0.03211636 0.50761692 WINTER_HYPOXIA_METAGENE bile duct carcinoma DOID_4897 4.738E-15 9.986E-14 0.03211636 0.50761692 WINTER_HYPOXIA_METAGENE intracranial arterial disease DOID_13089 5.372E-15 1.092E-13 1.000 1.000 WINTER_HYPOXIA_METAGENE cerebral arterial disease DOID_3527 5.372E-15 1.092E-13 1.000 1.000 WINTER_HYPOXIA_METAGENE focal glomerulosclerosis DOID_3945 1.356E-14 2.66E-13 0.13295526 0.86955799 WINTER_HYPOXIA_METAGENE endocrine pancreas disease DOID_1428 1.422E-14 2.698E-13 0.03811964 0.55615571 WINTER_HYPOXIA_METAGENE carbohydrate metabolic disorder DOID_2978 2.338E-14 4.291E-13 6.147E-10 3.497E-07 WINTER_HYPOXIA_METAGENE Crohn's disease DOID_8778 2.661E-14 4.732E-13 0.35736649 1.000 WINTER_HYPOXIA_METAGENE brain infarction DOID_3454 2.79E-14 4.81E-13 1.000 1.000 WINTER_HYPOXIA_METAGENE gastric ulcer DOID_10808 5.068E-14 8.481E-13 1.000 1.000 WINTER_HYPOXIA_METAGENE peripheral vascular disease DOID_341 5.253E-14 8.539E-13 0.29203286 1.000 WINTER_HYPOXIA_METAGENE bone marrow cancer DOID_4960 1.145E-13 1.81E-12 0.02834402 0.46079282 WINTER_HYPOXIA_METAGENE portal hypertension DOID_10762 2.438E-13 3.749E-12 1.000 1.000 WINTER_HYPOXIA_METAGENE middle cerebral artery infarction DOID_3525 4.812E-13 7.205E-12 1.000 1.000 WINTER_HYPOXIA_METAGENE nervous system cancer DOID_3093 5.39E-13 7.864E-12 0.06705098 0.65779321 WINTER_HYPOXIA_METAGENE hepatic vascular disease DOID_272 8.991E-13 1.279E-11 1.000 1.000 WINTER_HYPOXIA_METAGENE cerebral infarction DOID_3526 1.055E-12 1.464E-11 1.000 1.000 WINTER_HYPOXIA_METAGENE myeloma DOID_0070004 1.564E-12 2.118E-11 0.02221273 0.43582914 WINTER_HYPOXIA_METAGENE allergic rhinitis DOID_4481 2.746E-12 3.633E-11 1.000 1.000 WINTER_HYPOXIA_METAGENE pancreatitis DOID_4989 3.988E-12 5.157E-11 1.000 1.000 WINTER_HYPOXIA_METAGENE mixed glioma DOID_5076 3.988E-12 5.042E-11 0.30816364 1.000 WINTER_HYPOXIA_METAGENE metabolic syndrome X DOID_14221 5.14E-12 6.358E-11 0.31451315 1.000 WINTER_HYPOXIA_METAGENE nephroblastoma DOID_2154 5.771E-12 6.987E-11 0.15658044 0.91849762 WINTER_HYPOXIA_METAGENE diabetic angiopathy DOID_11713 1.231E-11 1.46E-10 0.10455983 0.79326055 WINTER_HYPOXIA_METAGENE carotid artery disease DOID_3407 1.627E-11 1.889E-10 1.000 1.000 WINTER_HYPOXIA_METAGENE collagen disease DOID_854 1.627E-11 1.851E-10 0.03506759 0.52509102 WINTER_HYPOXIA_METAGENE mineral metabolism disease DOID_0050032 2.496E-11 2.785E-10 0.26544233 1.000 WINTER_HYPOXIA_METAGENE pulmonary emphysema DOID_9675 2.578E-11 2.821E-10 1.000 1.000 WINTER_HYPOXIA_METAGENE cholestasis DOID_13580 2.866E-11 3.077E-10 0.2688197 1.000 WINTER_HYPOXIA_METAGENE uterine disease DOID_345 2.866E-11 3.02E-10 1.000 1.000 WINTER_HYPOXIA_METAGENE nephrotic syndrome DOID_1184 3.766E-11 3.896E-10 0.01899246 0.41564267 WINTER_HYPOXIA_METAGENE ulcerative colitis DOID_8577 3.875E-11 3.937E-10 1.000 1.000 WINTER_HYPOXIA_METAGENE endocrine organ benign neoplasm DOID_0060089 4.28E-11 4.273E-10 0.27885944 1.000 WINTER_HYPOXIA_METAGENE diabetic autonomic neuropathy DOID_11503 4.521E-11 4.435E-10 0.19454174 1.000 WINTER_HYPOXIA_METAGENE autonomic neuropathy DOID_11504 4.521E-11 4.435E-10 0.19454174 1.000 WINTER_HYPOXIA_METAGENE diabetic polyneuropathy DOID_12785 4.521E-11 4.435E-10 0.19454174 1.000 WINTER_HYPOXIA_METAGENE diabetic neuropathy DOID_9743 4.521E-11 4.435E-10 0.19454174 1.000 WINTER_HYPOXIA_METAGENE bile duct disease DOID_4138 6.278E-11 6.054E-10 0.2887621 1.000 WINTER_HYPOXIA_METAGENE biliary tract disease DOID_9741 7.106E-11 6.739E-10 0.29203286 1.000 WINTER_HYPOXIA_METAGENE autonomic nervous system disease DOID_11465 7.629E-11 7.116E-10 0.20559527 1.000 WINTER_HYPOXIA_METAGENE thyroid adenoma DOID_2891 7.629E-11 7.001E-10 0.20559527 1.000 WINTER_HYPOXIA_METAGENE hemolytic anemia DOID_583 9.013E-11 8.14E-10 9.052E-05 0.01287663 WINTER_HYPOXIA_METAGENE normocytic anemia DOID_720 9.013E-11 8.14E-10 9.052E-05 0.01287663 WINTER_HYPOXIA_METAGENE glaucoma DOID_1686 1.061E-10 9.433E-10 0.02390149 0.42499828 WINTER_HYPOXIA_METAGENE prion disease DOID_649 1.52E-10 1.331E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE female reproductive system disease DOID_229 1.802E-10 1.554E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE sarcoidosis DOID_11335 1.972E-10 1.675E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE pleural disease DOID_1532 2.293E-10 1.919E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE thyroid carcinoma DOID_3963 3.483E-10 2.873E-09 0.15658044 0.9091252 WINTER_HYPOXIA_METAGENE hypersensitivity reaction type IV disease DOID_2916 4.009E-10 3.259E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE thyroid cancer DOID_1781 5.164E-10 4.138E-09 0.16431238 0.92568065 WINTER_HYPOXIA_METAGENE adenoma DOID_657 5.164E-10 4.081E-09 0.16431238 0.91660535 WINTER_HYPOXIA_METAGENE placenta disease DOID_780 6.017E-10 4.69E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE multiple myeloma DOID_9538 6.235E-10 4.794E-09 0.01457178 0.33165367 WINTER_HYPOXIA_METAGENE hepatitis DOID_2237 8.953E-10 6.793E-09 0.17577835 0.95255126 WINTER_HYPOXIA_METAGENE parasitic infectious disease DOID_1398 9.792E-10 7.331E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE adult respiratory distress syndrome DOID_11394 1.065E-09 7.872E-09 1.000 1.000 WINTER_HYPOXIA_METAGENE cervix uteri carcinoma in situ DOID_8991 1.262E-09 9.206E-09 0.1833353 0.97493256 WINTER_HYPOXIA_METAGENE toxic shock syndrome DOID_14115 1.412E-09 1.017E-08 1.000 1.000 WINTER_HYPOXIA_METAGENE hyperinsulinism DOID_2018 1.749E-09 1.244E-08 0.01899246 0.4002485 WINTER_HYPOXIA_METAGENE commensal bacterial infectious disease DOID_0050339 1.829E-09 1.285E-08 1.000 1.000 WINTER_HYPOXIA_METAGENE uterine cancer DOID_363 2.047E-09 1.421E-08 0.19454174 0.99724548 WINTER_HYPOXIA_METAGENE brain cancer DOID_1319 3.214E-09 2.203E-08 0.20559527 1.000 WINTER_HYPOXIA_METAGENE heart valve disease DOID_4079 3.214E-09 2.177E-08 0.20559527 0.99986077 WINTER_HYPOXIA_METAGENE bone resorption disease DOID_0080011 3.311E-09 2.216E-08 3.292E-05 6.245E-03 WINTER_HYPOXIA_METAGENE osteoporosis DOID_11476 3.311E-09 2.216E-08 3.292E-05 6.245E-03 WINTER_HYPOXIA_METAGENE bacterial pneumonia DOID_874 3.665E-09 2.425E-08 1.000 1.000 WINTER_HYPOXIA_METAGENE central nervous system cancer DOID_3620 3.711E-09 2.427E-08 0.20924616 1.000 WINTER_HYPOXIA_METAGENE lung adenocarcinoma DOID_3910 3.73E-09 2.412E-08 3.18E-04 0.03015952 WINTER_HYPOXIA_METAGENE renovascular hypertension DOID_1591 5.562E-09 3.556E-08 1.000 1.000 WINTER_HYPOXIA_METAGENE nutritional deficiency disease DOID_5113 5.562E-09 3.517E-08 2.114E-03 0.10026062 WINTER_HYPOXIA_METAGENE reproductive organ benign neoplasm DOID_0050622 9.382E-09 5.866E-08 1.000 1.000 WINTER_HYPOXIA_METAGENE integumentary system cancer DOID_0060122 9.382E-09 5.802E-08 0.23433952 1.000 WINTER_HYPOXIA_METAGENE parasitic protozoa infectious disease DOID_2789 9.382E-09 5.74E-08 1.000 1.000 WINTER_HYPOXIA_METAGENE skin cancer DOID_4159 9.382E-09 5.802E-08 0.23433952 1.000 WINTER_HYPOXIA_METAGENE pustulosis of palm and sole DOID_4398 9.382E-09 5.679E-08 0.23433952 1.000 WINTER_HYPOXIA_METAGENE bronchitis DOID_6132 1.138E-08 6.814E-08 1.000 1.000 WINTER_HYPOXIA_METAGENE lymphoma DOID_0060058 1.333E-08 7.899E-08 9.385E-03 0.23218542 WINTER_HYPOXIA_METAGENE melancholia DOID_2848 1.511E-08 8.864E-08 0.24832143 1.000 WINTER_HYPOXIA_METAGENE mouth disease DOID_403 1.575E-08 9.146E-08 0.35736649 1.000 WINTER_HYPOXIA_METAGENE neurotic disorder DOID_4964 1.693E-08 9.732E-08 0.25177706 1.000 WINTER_HYPOXIA_METAGENE pre-malignant neoplasm DOID_0060071 2.356E-08 1.341E-07 0.26204946 1.000 WINTER_HYPOXIA_METAGENE in situ carcinoma DOID_8719 2.356E-08 1.341E-07 0.26204946 1.000 WINTER_HYPOXIA_METAGENE pulmonary edema DOID_11396 2.819E-08 1.588E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE brain edema DOID_4724 2.819E-08 1.572E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE pulmonary sarcoidosis DOID_13406 2.891E-08 1.597E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE hyperglycemia DOID_4195 3.227E-08 1.765E-07 0.27218162 1.000 WINTER_HYPOXIA_METAGENE congenital diaphragmatic hernia DOID_3827 3.921E-08 2.125E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE systemic scleroderma DOID_418 3.921E-08 2.105E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE tuberculosis DOID_399 3.947E-08 2.099E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE sinusitis DOID_0050127 6.05E-08 3.187E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE glycogen metabolism disorder DOID_0050728 6.05E-08 3.158E-07 3.546E-06 1.009E-03 WINTER_HYPOXIA_METAGENE paranasal sinus disease DOID_1352 6.05E-08 3.187E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE glycogen storage disease DOID_2747 6.05E-08 3.158E-07 3.546E-06 1.009E-03 WINTER_HYPOXIA_METAGENE muscle cancer DOID_4045 6.05E-08 3.129E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE rheumatic disease DOID_1575 6.896E-08 3.535E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE scleroderma DOID_419 6.896E-08 3.535E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE aortic valve disease DOID_62 7.614E-08 3.868E-07 0.10455983 0.77265638 WINTER_HYPOXIA_METAGENE endogenous depression DOID_1595 7.632E-08 3.843E-07 0.30175565 1.000 WINTER_HYPOXIA_METAGENE proteinuria DOID_576 1.018E-07 5.08E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE neuritis DOID_1803 1.152E-07 5.701E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE vascular skin disease DOID_9540 1.152E-07 5.652E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE breast benign neoplasm DOID_0060082 1.379E-07 6.709E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE thoracic benign neoplasm DOID_0060097 1.379E-07 6.709E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE benign breast phyllodes tumor DOID_1631 1.379E-07 6.709E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE mental depression DOID_1596 1.388E-07 6.693E-07 0.32392895 1.000 WINTER_HYPOXIA_METAGENE autoimmune disease of gastrointestinal tract DOID_0060031 1.465E-07 7.005E-07 0.02390149 0.43870791 WINTER_HYPOXIA_METAGENE integumentary system benign neoplasm DOID_0060121 1.465E-07 6.947E-07 0.21288037 1.000 WINTER_HYPOXIA_METAGENE pulmonary tuberculosis DOID_2957 1.465E-07 6.889E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE skin benign neoplasm DOID_3165 1.465E-07 6.947E-07 0.21288037 1.000 WINTER_HYPOXIA_METAGENE intracranial aneurysm DOID_10941 1.735E-07 8.09E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE B-cell lymphocytic neoplasm DOID_707 1.844E-07 8.533E-07 1.985E-03 0.12548281 WINTER_HYPOXIA_METAGENE primary bacterial infectious disease DOID_0050338 1.908E-07 8.755E-07 1.000 1.000 WINTER_HYPOXIA_METAGENE Human immunodeficiency virus infectious disease DOID_526 2.398E-07 1.092E-06 0.06705098 0.64664417 WINTER_HYPOXIA_METAGENE pleurisy DOID_10247 2.496E-07 1.127E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE newborn respiratory distress syndrome DOID_12716 2.968E-07 1.33E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE endometrial carcinoma DOID_2871 3.502E-07 1.557E-06 0.13693799 0.86575242 WINTER_HYPOXIA_METAGENE hypertrophic cardiomyopathy DOID_11984 3.861E-07 1.703E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE bronchiolitis obliterans DOID_2799 4.112E-07 1.8E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE leukocyte disease DOID_9500 4.259E-07 1.85E-06 0.24832143 1.000 WINTER_HYPOXIA_METAGENE endometrial cancer DOID_1380 4.803E-07 2.07E-06 0.14484896 0.88622646 WINTER_HYPOXIA_METAGENE leiomyoma DOID_127 5.582E-07 2.388E-06 0.14877737 0.90057792 WINTER_HYPOXIA_METAGENE skeletal system cancer DOID_0060124 5.625E-07 2.388E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE bone cancer DOID_184 5.625E-07 2.388E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE oral submucous fibrosis DOID_5773 5.625E-07 2.371E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE papilloma DOID_2615 6.459E-07 2.702E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE myocarditis DOID_820 6.459E-07 2.682E-06 0.15268784 0.91451978 WINTER_HYPOXIA_METAGENE cerebral degeneration DOID_1443 7.412E-07 3.056E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE pneumoconiosis DOID_10316 7.44E-07 3.046E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE esophageal disease DOID_6050 7.44E-07 3.024E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE tongue cancer DOID_8649 7.473E-07 3.016E-06 0.07097422 0.66203821 WINTER_HYPOXIA_METAGENE Barrett's esophagus DOID_9206 7.473E-07 2.994E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE temporal lobe epilepsy DOID_3328 8.088E-07 3.218E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE cleft palate DOID_674 1.111E-06 4.389E-06 8.286E-04 0.06735674 WINTER_HYPOXIA_METAGENE peripheral nervous system neoplasm DOID_1192 1.26E-06 4.945E-06 0.17197385 0.94089538 WINTER_HYPOXIA_METAGENE benign mesothelioma DOID_2645 1.806E-06 7.039E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE autoimmune disease of urogenital tract DOID_0060049 2.024E-06 7.836E-06 0.1870879 0.98567604 WINTER_HYPOXIA_METAGENE primary biliary cirrhosis DOID_12236 2.024E-06 7.836E-06 0.1870879 0.98567604 WINTER_HYPOXIA_METAGENE autoimmune hepatitis DOID_2048 2.414E-06 9.28E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE coronary restenosis DOID_4247 2.414E-06 9.217E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE influenza DOID_8469 2.523E-06 9.57E-06 1.000 1.000 WINTER_HYPOXIA_METAGENE focal epilepsy DOID_2234 2.777E-06 1.046E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE funisitis DOID_0050698 2.94E-06 1.1E-05 4.555E-03 0.19935853 WINTER_HYPOXIA_METAGENE benign glioma DOID_0060101 2.94E-06 1.093E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE hepatitis B DOID_2043 2.94E-06 1.086E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE benign ependymoma DOID_4844 2.94E-06 1.093E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE muscular atrophy DOID_767 2.94E-06 1.079E-05 0.09627834 0.75044353 WINTER_HYPOXIA_METAGENE leukodystrophy DOID_10579 3.113E-06 1.135E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE pulmonary embolism DOID_9477 3.546E-06 1.285E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE hypoglycemia DOID_9993 3.546E-06 1.277E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE congenital hemolytic anemia DOID_589 4.24E-06 1.517E-05 1.792E-04 0.02038785 WINTER_HYPOXIA_METAGENE meningitis DOID_9471 4.24E-06 1.508E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE Goodpasture syndrome DOID_9808 4.24E-06 1.498E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE acute pancreatitis DOID_2913 5.029E-06 1.766E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE orofacial cleft DOID_0050567 5.554E-06 1.939E-05 2.092E-03 0.11905019 WINTER_HYPOXIA_METAGENE osteosarcoma DOID_3347 5.922E-06 2.055E-05 0.11276585 0.80204713 WINTER_HYPOXIA_METAGENE hypersensitivity reaction type I disease DOID_1205 5.996E-06 2.068E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE oral cavity cancer DOID_8618 9.29E-06 3.184E-05 0.03211636 0.49389754 WINTER_HYPOXIA_METAGENE periodontitis DOID_824 9.308E-06 3.171E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE perinatal necrotizing enterocolitis DOID_8677 9.308E-06 3.152E-05 0.1249349 0.85648145 WINTER_HYPOXIA_METAGENE autoimmune disease of cardiovascular system DOID_0060051 1.07E-05 3.603E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE Behcet's disease DOID_13241 1.07E-05 3.603E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE invasive ductal carcinoma DOID_3008 1.07E-05 3.582E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE coronary stenosis DOID_4248 1.07E-05 3.561E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE acute kidney failure DOID_3021 1.114E-05 3.684E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE insulinoma DOID_3892 1.114E-05 3.663E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE hypothyroidism DOID_1459 1.271E-05 4.156E-05 0.258641 1.000 WINTER_HYPOXIA_METAGENE female reproductive organ benign neoplasm DOID_0060086 1.394E-05 4.533E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE uterine benign neoplasm DOID_0060095 1.394E-05 4.533E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE uterine fibroid DOID_13223 1.394E-05 4.533E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE pneumocystosis DOID_11339 1.526E-05 4.934E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE spastic cerebral palsy DOID_0050669 1.581E-05 5.082E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE celiac disease DOID_10608 1.785E-05 5.707E-05 0.01067027 0.25297431 WINTER_HYPOXIA_METAGENE chronic leukemia DOID_1036 2.008E-05 6.384E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE chronic lymphocytic leukemia DOID_1040 2.008E-05 6.384E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE autonomic nervous system neoplasm DOID_2621 2.008E-05 6.349E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE bladder disease DOID_365 2.008E-05 6.313E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE neuroblastoma DOID_769 2.008E-05 6.349E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE beta thalassemia DOID_12241 2.028E-05 6.34E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE islet cell tumor DOID_1799 2.028E-05 6.305E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE aortic valve insufficiency DOID_57 2.028E-05 6.271E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE stomach disease DOID_76 2.028E-05 6.237E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE ocular hypertension DOID_9282 2.028E-05 6.204E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE borderline glaucoma DOID_9283 2.028E-05 6.204E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE metal metabolism disorder DOID_896 2.251E-05 6.85E-05 0.15268784 0.90499353 WINTER_HYPOXIA_METAGENE male reproductive system disease DOID_48 2.397E-05 7.255E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE periodontal disease DOID_3388 2.515E-05 7.572E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE berylliosis DOID_10322 2.627E-05 7.868E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE vulva cancer DOID_1245 2.627E-05 7.827E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE hepatic coma DOID_12550 2.627E-05 7.786E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE hepatic encephalopathy DOID_13413 2.627E-05 7.786E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE larynx cancer DOID_2596 2.627E-05 7.746E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE laryngeal benign neoplasm DOID_2598 2.627E-05 7.746E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE Leydig cell tumor DOID_2696 2.627E-05 7.706E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE sex cord-stromal neoplasm DOID_4757 2.627E-05 7.706E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE rhabdomyosarcoma DOID_3247 3.333E-05 9.725E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE polycystic kidney disease DOID_898 3.333E-05 9.675E-05 1.000 1.000 WINTER_HYPOXIA_METAGENE uveitis DOID_13141 3.802E-05 1.098E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE contact dermatitis DOID_2773 3.942E-05 1.133E-04 0.05477961 0.62339197 WINTER_HYPOXIA_METAGENE thalassemia DOID_10241 4.152E-05 1.187E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE Ehlers-Danlos syndrome DOID_13359 4.152E-05 1.181E-04 2.114E-03 0.10937522 WINTER_HYPOXIA_METAGENE hemangioma DOID_255 4.152E-05 1.175E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE membranoproliferative glomerulonephritis DOID_2920 4.152E-05 1.169E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE mesenchymal cell neoplasm DOID_3350 4.152E-05 1.164E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE skeletal muscle cancer DOID_4043 4.152E-05 1.158E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE spindle cell sarcoma DOID_4235 4.152E-05 1.164E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE epithelioid sarcoma DOID_6193 4.152E-05 1.164E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE intermediate coronary syndrome DOID_8805 4.152E-05 1.152E-04 0.06668891 0.66571911 WINTER_HYPOXIA_METAGENE lymphatic system disease DOID_75 4.6E-05 1.271E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE bone development disease DOID_0080006 4.958E-05 1.363E-04 0.32703888 1.000 WINTER_HYPOXIA_METAGENE silicosis DOID_10325 5.093E-05 1.393E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE spastic diplegia DOID_10965 5.093E-05 1.386E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE uveal disease DOID_3480 6.018E-05 1.63E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE primary immunodeficiency disease DOID_612 6.499E-05 1.753E-04 8.591E-03 0.22220131 WINTER_HYPOXIA_METAGENE cataract DOID_83 7.124E-05 1.912E-04 0.19824314 1.000 WINTER_HYPOXIA_METAGENE learning disability DOID_8927 7.124E-05 1.903E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE lens disease DOID_110 8.372E-05 2.226E-04 0.20559527 1.000 WINTER_HYPOXIA_METAGENE alcohol-related neurodevelopmental disorder DOID_0050667 8.386E-05 2.219E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE leishmaniasis DOID_9065 8.723E-05 2.298E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE dilated cardiomyopathy DOID_12930 8.809E-05 2.31E-04 0.07349632 0.67450659 WINTER_HYPOXIA_METAGENE subependymal glioma DOID_4843 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE pilocytic astrocytoma DOID_4851 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE subependymal giant cell astrocytoma DOID_5077 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE fibrillary astrocytoma DOID_6726 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE juvenile pilocytic astrocytoma DOID_6811 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE childhood pilocytic astrocytoma DOID_6812 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE gemistocytic astrocytoma DOID_7005 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE childhood cerebral astrocytoma DOID_7007 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE protoplasmic astrocytoma DOID_7008 1.023E-04 2.67E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE calcium metabolism disease DOID_10575 1.053E-04 2.736E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE Kawasaki disease DOID_13378 1.189E-04 3.076E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE lymphadenitis DOID_1602 1.189E-04 3.076E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE lymph node disease DOID_9942 1.189E-04 3.076E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE vasculitis DOID_865 1.401E-04 3.606E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE osteochondrodysplasia DOID_2256 1.499E-04 3.842E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE polyarteritis nodosa DOID_9810 1.573E-04 4.013E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE familial hyperlipidemia DOID_1168 1.602E-04 4.07E-04 0.23785905 1.000 WINTER_HYPOXIA_METAGENE Lewy body dementia DOID_12217 1.792E-04 4.531E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE spastic quadriplegia DOID_10970 2.029E-04 5.108E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE urticaria DOID_1555 2.286E-04 5.73E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE hypogonadism DOID_1924 2.286E-04 5.705E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE bronchiolitis DOID_2942 2.286E-04 5.68E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE combined T cell and B cell immunodeficiency DOID_628 2.286E-04 5.655E-04 6.332E-03 0.2119235 WINTER_HYPOXIA_METAGENE congenital heart defect DOID_1682 2.475E-04 6.095E-04 0.26204946 1.000 WINTER_HYPOXIA_METAGENE cystitis DOID_1679 2.563E-04 6.286E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE cleft lip DOID_9296 2.563E-04 6.259E-04 6.818E-03 0.21551382 WINTER_HYPOXIA_METAGENE dystonia DOID_543 2.861E-04 6.957E-04 7.32E-03 0.20825653 WINTER_HYPOXIA_METAGENE tooth disease DOID_1091 3.104E-04 7.515E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE diffuse large B-cell lymphoma DOID_0050745 3.18E-04 7.668E-04 7.839E-03 0.21239307 WINTER_HYPOXIA_METAGENE malaria DOID_12365 3.522E-04 8.455E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE multiple epiphyseal dysplasia DOID_12721 3.886E-04 9.29E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE supratentorial cancer DOID_1659 3.886E-04 9.251E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE toxic encephalopathy DOID_3602 3.886E-04 9.213E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE cerebrum cancer DOID_368 3.886E-04 9.251E-04 1.000 1.000 WINTER_HYPOXIA_METAGENE age related macular degeneration DOID_10871 4.685E-04 1.106E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE degeneration of macula and posterior pole DOID_2007 4.685E-04 1.106E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE gonadal disease DOID_2277 4.685E-04 1.102E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE opportunistic mycosis DOID_2473 4.685E-04 1.097E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE lipid metabolism disorder DOID_3146 5.673E-04 1.323E-03 0.31451315 1.000 WINTER_HYPOXIA_METAGENE systemic mycosis DOID_0050136 6.069E-04 1.41E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE fungal infectious disease DOID_1564 6.069E-04 1.41E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE auditory system disease DOID_2742 6.214E-04 1.437E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE hepatitis C DOID_1883 6.583E-04 1.516E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE macular degeneration DOID_4448 6.583E-04 1.51E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE hyperthyroidism DOID_7998 6.583E-04 1.504E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE calcinosis DOID_182 8.286E-04 1.886E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE Sjogren's syndrome DOID_12894 9.2E-04 2.086E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE hyperparathyroidism DOID_13543 9.2E-04 2.077E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE ventricular septal defect DOID_1657 9.2E-04 2.069E-03 0.04496577 0.60917908 WINTER_HYPOXIA_METAGENE retinal vascular occlusion DOID_1729 9.2E-04 2.061E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE lateral sclerosis DOID_230 9.2E-04 2.053E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE cutaneous leishmaniasis DOID_9111 9.2E-04 2.045E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE respiratory syncytial virus infectious disease DOID_1273 9.564E-04 2.117E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE lymphoblastic leukemia DOID_1037 9.859E-04 2.174E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE trypanosomiasis DOID_10113 1.121E-03 2.463E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE sickle cell anemia DOID_10923 1.121E-03 2.453E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE neuronal ceroid lipofuscinosis DOID_14503 1.121E-03 2.444E-03 1.121E-03 0.07973291 WINTER_HYPOXIA_METAGENE eosinophilic pneumonia DOID_5870 1.121E-03 2.435E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE pulmonary eosinophilia DOID_9498 1.121E-03 2.435E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE Loeffler syndrome DOID_9503 1.121E-03 2.435E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE endometriosis of uterus DOID_288 1.17E-03 2.532E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE endometriosis DOID_289 1.248E-03 2.689E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE otitis media DOID_10754 1.341E-03 2.88E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE intracranial arteriosclerosis DOID_13097 1.341E-03 2.869E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE aortic valve stenosis DOID_1712 1.341E-03 2.858E-03 0.0537147 0.63674303 WINTER_HYPOXIA_METAGENE middle ear disease DOID_5100 1.341E-03 2.88E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE peritonitis DOID_8283 1.341E-03 2.847E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE vascular dementia DOID_8725 1.341E-03 2.869E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE encephalitis DOID_9588 1.341E-03 2.837E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE essential hypertension DOID_10825 1.58E-03 3.33E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE parathyroid gland disease DOID_11201 1.58E-03 3.318E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE polyneuropathy DOID_1389 1.58E-03 3.306E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE obstructive hydrocephalus DOID_14159 1.58E-03 3.294E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE communicating hydrocephalus DOID_1573 1.58E-03 3.294E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE intracranial thrombosis DOID_4193 1.58E-03 3.282E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE lung small cell carcinoma DOID_5409 1.78E-03 3.684E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE viral pneumonia DOID_10533 1.838E-03 3.789E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE hydrocephalus DOID_10908 1.838E-03 3.776E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE parasitic helminthiasis infectious disease DOID_883 1.838E-03 3.762E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE withdrawal disorder DOID_0060001 1.985E-03 4.048E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE idiopathic pulmonary fibrosis DOID_0050156 2.114E-03 4.297E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE lung oat cell carcinoma DOID_5411 2.114E-03 4.282E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE varicose veins DOID_799 2.114E-03 4.266E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE intracranial hypertension DOID_9428 2.114E-03 4.251E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE hemolytic-uremic syndrome DOID_12554 2.409E-03 4.827E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE thyroiditis DOID_7166 2.409E-03 4.81E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE autoimmune thyroiditis DOID_7188 2.409E-03 4.81E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE vein disease DOID_866 2.409E-03 4.793E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE penile disease DOID_1529 2.722E-03 5.397E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE basal cell carcinoma DOID_2513 2.722E-03 5.378E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE urinary system benign neoplasm DOID_731 2.722E-03 5.36E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE skin carcinoma DOID_3451 3.053E-03 5.991E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE eosinophilia DOID_999 3.053E-03 5.97E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE heart septal defect DOID_1681 3.402E-03 6.63E-03 0.08371312 0.744262 WINTER_HYPOXIA_METAGENE agammaglobulinemia DOID_2583 3.402E-03 6.607E-03 0.08371312 0.73281182 WINTER_HYPOXIA_METAGENE granulosa cell tumor DOID_2999 3.402E-03 6.585E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE infertility DOID_5223 3.402E-03 6.562E-03 0.08371312 0.72170861 WINTER_HYPOXIA_METAGENE MHC class II deficiency DOID_5812 3.402E-03 6.54E-03 0.08371312 0.71093684 WINTER_HYPOXIA_METAGENE psoriasis DOID_8893 3.402E-03 6.518E-03 0.08371312 0.70048188 WINTER_HYPOXIA_METAGENE amnestic disorder DOID_10914 3.769E-03 7.196E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE esophagitis DOID_11963 3.769E-03 7.172E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE colon carcinoma DOID_1520 3.769E-03 7.148E-03 0.08792071 0.71466979 WINTER_HYPOXIA_METAGENE sex cord-gonadal stromal tumor DOID_192 3.769E-03 7.125E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE blood protein disease DOID_620 3.769E-03 7.101E-03 0.08792071 0.70460402 WINTER_HYPOXIA_METAGENE allergic contact dermatitis DOID_3042 4.152E-03 7.797E-03 0.04126921 0.57273617 WINTER_HYPOXIA_METAGENE neutropenia DOID_1227 4.555E-03 8.525E-03 0.09627834 0.76086635 WINTER_HYPOXIA_METAGENE blood coagulation disease DOID_1247 4.67E-03 8.713E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE agranulocytosis DOID_12987 4.974E-03 9.248E-03 0.10042856 0.7722142 WINTER_HYPOXIA_METAGENE opiate dependence DOID_2559 4.974E-03 9.218E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE IgA glomerulonephritis DOID_2986 4.974E-03 9.188E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE urinary tract obstruction DOID_5200 4.974E-03 9.158E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE sleep disorder DOID_535 4.974E-03 9.129E-03 1.000 1.000 WINTER_HYPOXIA_METAGENE syndrome DOID_225 5.618E-03 0.01027866 1.000 1.000 WINTER_HYPOXIA_METAGENE severe combined immunodeficiency DOID_627 5.862E-03 0.01069094 0.10867223 0.79274998 WINTER_HYPOXIA_METAGENE morbid obesity DOID_11981 6.818E-03 0.01239377 1.000 1.000 WINTER_HYPOXIA_METAGENE spinal muscular atrophy DOID_12377 6.818E-03 0.0123543 1.000 1.000 WINTER_HYPOXIA_METAGENE papillary adenoma DOID_3172 6.818E-03 0.01231508 1.000 1.000 WINTER_HYPOXIA_METAGENE microcystic adenoma DOID_5403 6.818E-03 0.01231508 1.000 1.000 WINTER_HYPOXIA_METAGENE follicular adenoma DOID_6204 6.818E-03 0.01231508 1.000 1.000 WINTER_HYPOXIA_METAGENE ankylosing spondylitis DOID_7147 6.818E-03 0.0122761 1.000 1.000 WINTER_HYPOXIA_METAGENE alcohol abuse DOID_1574 7.126E-03 0.01279039 0.05837001 0.62665161 WINTER_HYPOXIA_METAGENE B cell deficiency DOID_2115 7.32E-03 0.01309789 0.12089711 0.84926485 WINTER_HYPOXIA_METAGENE extrinsic allergic alveolitis DOID_841 7.32E-03 0.01305684 1.000 1.000 WINTER_HYPOXIA_METAGENE Sciatic Neuropathy DOID_11446 7.839E-03 0.0139383 1.000 1.000 WINTER_HYPOXIA_METAGENE gestational diabetes DOID_11714 7.839E-03 0.01389487 1.000 1.000 WINTER_HYPOXIA_METAGENE lesion of sciatic nerve DOID_12528 7.839E-03 0.0139383 1.000 1.000 WINTER_HYPOXIA_METAGENE mononeuritis of lower limb DOID_9473 7.839E-03 0.0139383 1.000 1.000 WINTER_HYPOXIA_METAGENE mononeuritis DOID_1802 8.374E-03 0.01479668 1.000 1.000 WINTER_HYPOXIA_METAGENE autoimmune disease of the nervous system DOID_438 8.374E-03 0.01475087 0.12895426 0.85319738 WINTER_HYPOXIA_METAGENE autoimmune disease of endocrine system DOID_0060005 8.924E-03 0.01567244 1.000 1.000 WINTER_HYPOXIA_METAGENE mononeuropathy DOID_1188 8.924E-03 0.01562422 1.000 1.000 WINTER_HYPOXIA_METAGENE corneal disease DOID_10124 9.491E-03 0.01656498 0.13693799 0.88542861 WINTER_HYPOXIA_METAGENE congenital disorder of glycosylation DOID_5212 9.491E-03 0.01651432 0.13693799 0.85623866 WINTER_HYPOXIA_METAGENE paraplegia DOID_607 0.01255415 0.02177839 1.000 1.000 WINTER_HYPOXIA_METAGENE leukopenia DOID_615 0.01255415 0.02171219 0.15658044 0.89094269 WINTER_HYPOXIA_METAGENE embryonal cancer DOID_688 0.01457178 0.02512528 1.000 1.000 WINTER_HYPOXIA_METAGENE Huntington's disease DOID_12858 0.01899246 0.03264867 1.000 1.000 WINTER_HYPOXIA_METAGENE hemorrhagic disease DOID_2213 0.0256412 0.04394532 1.000 1.000 WINTER_HYPOXIA_METAGENE atopic dermatitis DOID_3310 0.02652984 0.04533177 1.000 1.000 WINTER_HYPOXIA_METAGENE atrophic muscular disease DOID_913 0.02743083 0.04673096 1.000 1.000 WINTER_HYPOXIA_METAGENE muscular dystrophy DOID_9884 0.02743083 0.04673096 1.000 1.000 WINTER_HYPOXIA_METAGENE mitochondrial metabolism disease DOID_700 0.03020654 0.05130603 1.000 1.000 WINTER_HYPOXIA_METAGENE arrhythmogenic right ventricular dysplasia DOID_0050431 0.04056119 0.06868844 0.04056119 0.5769829 WINTER_HYPOXIA_METAGENE facioscapulohumeral muscular dystrophy DOID_11727 0.04496577 0.07592143 1.000 1.000 WINTER_HYPOXIA_METAGENE angioedema DOID_1558 0.04496577 0.07569681 1.000 1.000 WINTER_HYPOXIA_METAGENE rectal neoplasm DOID_1984 0.04496577 0.07547351 1.000 1.000 WINTER_HYPOXIA_METAGENE rectum cancer DOID_1993 0.04496577 0.07547351 1.000 1.000 WINTER_HYPOXIA_METAGENE teratoma DOID_3307 0.04496577 0.07525153 1.000 1.000 WINTER_HYPOXIA_METAGENE chondrosarcoma DOID_3371 0.04496577 0.07503085 0.04496577 0.59501213 WINTER_HYPOXIA_METAGENE hypokalemia DOID_4500 0.04496577 0.07481147 1.000 1.000 WINTER_HYPOXIA_METAGENE labyrinthine disease DOID_4539 0.04496577 0.07459336 1.000 1.000 WINTER_HYPOXIA_METAGENE keratitis DOID_4677 0.04496577 0.07437652 1.000 1.000 WINTER_HYPOXIA_METAGENE malignant teratoma DOID_5563 0.04496577 0.07525153 1.000 1.000 WINTER_HYPOXIA_METAGENE mature teratoma DOID_5566 0.04496577 0.07525153 1.000 1.000 WINTER_HYPOXIA_METAGENE visceral leishmaniasis DOID_9146 0.04496577 0.07416093 1.000 1.000 WINTER_HYPOXIA_METAGENE cannabis abuse DOID_9505 0.04496577 0.07394659 1.000 1.000 WINTER_HYPOXIA_METAGENE familial adenomatous polyposis DOID_0050424 0.04935024 0.08092302 1.000 1.000 WINTER_HYPOXIA_METAGENE Charcot-Marie-Tooth disease type 4 DOID_0050541 0.04935024 0.08069048 1.000 1.000 WINTER_HYPOXIA_METAGENE adrenoleukodystrophy DOID_10588 0.04935024 0.08045928 1.000 1.000 WINTER_HYPOXIA_METAGENE prediabetes syndrome DOID_11716 0.04935024 0.08022939 1.000 1.000 WINTER_HYPOXIA_METAGENE common variable immunodeficiency DOID_12177 0.04935024 0.08000082 1.000 1.000 WINTER_HYPOXIA_METAGENE migraine without aura DOID_12783 0.04935024 0.07977354 0.04935024 0.62400638 WINTER_HYPOXIA_METAGENE hemochromatosis DOID_2352 0.04935024 0.07954756 1.000 1.000 WINTER_HYPOXIA_METAGENE inner ear disease DOID_2952 0.04935024 0.07932285 1.000 1.000 WINTER_HYPOXIA_METAGENE bronchiectasis DOID_9563 0.04935024 0.0790994 1.000 1.000 WINTER_HYPOXIA_METAGENE heroin dependence DOID_9976 0.04935024 0.07887721 1.000 1.000 WINTER_HYPOXIA_METAGENE esophageal carcinoma DOID_1107 0.0537147 0.08561251 0.0537147 0.65029075 WINTER_HYPOXIA_METAGENE porphyria DOID_13268 0.0537147 0.08537337 1.000 1.000 WINTER_HYPOXIA_METAGENE pituitary cancer DOID_1785 0.0537147 0.08513556 1.000 1.000 WINTER_HYPOXIA_METAGENE epidermolysis bullosa DOID_2730 0.0537147 0.08489907 0.0537147 0.62374827 WINTER_HYPOXIA_METAGENE esophagus squamous cell carcinoma DOID_3748 0.0537147 0.08561251 0.0537147 0.65029075 WINTER_HYPOXIA_METAGENE pituitary carcinoma DOID_4916 0.0537147 0.08513556 1.000 1.000 WINTER_HYPOXIA_METAGENE chromosomal disease DOID_0080014 0.05596743 0.08821459 1.000 1.000 WINTER_HYPOXIA_METAGENE infancy electroclinical syndrome DOID_0050703 0.05805924 0.09125886 1.000 1.000 WINTER_HYPOXIA_METAGENE carotid stenosis DOID_13001 0.05805924 0.09100746 1.000 1.000 WINTER_HYPOXIA_METAGENE cannabis dependence DOID_1849 0.05805924 0.09075744 1.000 1.000 WINTER_HYPOXIA_METAGENE impotence DOID_1875 0.05805924 0.09050879 1.000 1.000 WINTER_HYPOXIA_METAGENE vesiculobullous skin disease DOID_2731 0.05805924 0.0902615 0.05805924 0.64775897 WINTER_HYPOXIA_METAGENE Lynch syndrome DOID_3883 0.05805924 0.09001555 0.05805924 0.63530207 WINTER_HYPOXIA_METAGENE psoriatic arthritis DOID_9008 0.05805924 0.08977094 1.000 1.000 WINTER_HYPOXIA_METAGENE hallucinogen dependence DOID_9977 0.05805924 0.09075744 1.000 1.000 WINTER_HYPOXIA_METAGENE open-angle glaucoma DOID_1067 0.06238395 0.09619638 1.000 1.000 WINTER_HYPOXIA_METAGENE hypercalcemia DOID_12678 0.06238395 0.09593639 1.000 1.000 WINTER_HYPOXIA_METAGENE narcolepsy DOID_8986 0.06238395 0.0956778 1.000 1.000 DING_LUNG_CANCER_BY_MUTATION_RATE alcohol-related neurodevelopmental disorder DOID_0050667 8.603E-06 4.895E-03 0.03976321 0.58013503 DING_LUNG_CANCER_BY_MUTATION_RATE autonomic nervous system neoplasm DOID_2621 9.856E-05 0.02803904 1.000 1.000 DING_LUNG_CANCER_BY_MUTATION_RATE neuroblastoma DOID_769 9.856E-05 0.02803904 1.000 1.000 DING_LUNG_CANCER_BY_MUTATION_RATE medullomyoblastoma DOID_3861 1.164E-04 0.02206935 0.01592069 0.60392469 DING_LUNG_CANCER_BY_MUTATION_RATE adult medulloblastoma DOID_3864 1.164E-04 0.02206935 0.01592069 0.60392469 DING_LUNG_CANCER_BY_MUTATION_RATE childhood medulloblastoma DOID_3869 1.164E-04 0.02206935 0.01592069 0.60392469 DING_LUNG_CANCER_BY_MUTATION_RATE refractive error DOID_9835 1.226E-04 0.01744242 0.01633642 0.5809641 DING_LUNG_CANCER_BY_MUTATION_RATE medulloblastoma DOID_3858 1.29E-04 0.01468474 0.016752 0.56069924 DING_LUNG_CANCER_BY_MUTATION_RATE peripheral nervous system neoplasm DOID_1192 1.356E-04 0.01286167 1.000 1.000 DING_LUNG_CANCER_BY_MUTATION_RATE primitive neuroectodermal tumor DOID_168 1.71E-04 0.01389769 0.01924199 0.54743455 DING_LUNG_CANCER_BY_MUTATION_RATE bile duct adenocarcinoma DOID_4896 2.629E-04 0.01870112 0.02379162 0.58858403 DING_LUNG_CANCER_BY_MUTATION_RATE cholangiocarcinoma DOID_4947 2.629E-04 0.01870112 0.02379162 0.58858403 DING_LUNG_CANCER_BY_MUTATION_RATE reproductive organ benign neoplasm DOID_0050622 2.723E-04 0.01721267 1.000 1.000 DING_LUNG_CANCER_BY_MUTATION_RATE pustulosis of palm and sole DOID_4398 2.723E-04 0.0154914 0.02420424 0.57384224 DING_LUNG_CANCER_BY_MUTATION_RATE bile duct cancer DOID_4606 3.012E-04 0.01557957 0.02544112 0.55676918 DING_LUNG_CANCER_BY_MUTATION_RATE bile duct carcinoma DOID_4897 3.012E-04 0.01557957 0.02544112 0.55676918 DING_LUNG_CANCER_BY_MUTATION_RATE leukocyte disease DOID_9500 3.111E-04 0.01475369 0.02585309 0.54482992 DING_LUNG_CANCER_BY_MUTATION_RATE neuroectodermal tumor DOID_171 3.316E-04 0.01451188 0.02667653 0.54210526 DING_LUNG_CANCER_BY_MUTATION_RATE uterine disease DOID_345 3.743E-04 0.0152116 0.02832146 0.53716375 DING_LUNG_CANCER_BY_MUTATION_RATE female reproductive system disease DOID_229 5.571E-04 0.02113085 0.03446677 0.57681152 DING_LUNG_CANCER_BY_MUTATION_RATE focal epilepsy DOID_2234 5.841E-04 0.02077212 0.03528339 0.57360703 DING_LUNG_CANCER_BY_MUTATION_RATE biliary tract cancer DOID_4607 5.841E-04 0.01955023 0.03528339 0.5576735 DING_LUNG_CANCER_BY_MUTATION_RATE nervous system cancer DOID_3093 6.837E-04 0.02161282 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 ocular hypertension DOID_9282 5.551E-08 3.158E-05 7.886E-03 0.49855608 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 borderline glaucoma DOID_9283 5.551E-08 3.158E-05 7.886E-03 0.49855608 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 dilated cardiomyopathy DOID_12930 4.887E-07 1.39E-04 1.871E-03 0.26609122 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 glaucoma DOID_1686 5.48E-06 1.039E-03 0.03374282 0.68570237 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 giant cell tumor DOID_200 6.861E-06 9.76E-04 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 malignant giant cell tumor DOID_2705 6.861E-06 9.76E-04 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 giant cell glioblastoma DOID_3074 6.861E-06 9.76E-04 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 hypertrophic cardiomyopathy DOID_11984 8.889E-06 1.012E-03 0.03947085 0.70184104 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 glioblastoma DOID_3068 8.889E-06 8.429E-04 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 carotid artery disease DOID_3407 1.028E-05 8.353E-04 0.04137294 0.69238827 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 pre-malignant neoplasm DOID_0060071 1.128E-05 8.021E-04 0.04263899 0.69318808 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 in situ carcinoma DOID_8719 1.128E-05 8.021E-04 0.04263899 0.69318808 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 astrocytoma DOID_3069 1.466E-05 9.268E-04 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 pancreatic ductal carcinoma DOID_3587 1.528E-05 8.695E-04 1.066E-03 0.60660898 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 pancreatic carcinoma DOID_4905 1.725E-05 8.923E-04 1.155E-03 0.32852803 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 invasive lobular carcinoma DOID_3457 2.288E-05 1.085E-03 7.231E-03 0.58776984 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 epidermolysis bullosa DOID_2730 2.744E-05 1.201E-03 7.886E-03 0.56087559 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 transitional cell carcinoma DOID_2671 2.865E-05 1.164E-03 0.05770692 0.76361017 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 carotid stenosis DOID_13001 3.242E-05 1.23E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 vesiculobullous skin disease DOID_2731 3.242E-05 1.153E-03 8.54E-03 0.48593846 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 thoracic aortic aneurysm DOID_14004 4.361E-05 1.459E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 oral submucous fibrosis DOID_5773 4.361E-05 1.378E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 varicose veins DOID_799 4.361E-05 1.306E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 vein disease DOID_866 4.981E-05 1.417E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 extrinsic allergic alveolitis DOID_841 1.562E-04 4.231E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 focal glomerulosclerosis DOID_3945 1.919E-04 4.962E-03 0.02024962 0.67776679 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 abdominal aortic aneurysm DOID_7693 2.177E-04 5.385E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 pneumoconiosis DOID_10316 2.741E-04 6.499E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 cervix uteri carcinoma in situ DOID_8991 3.883E-04 8.837E-03 0.02862373 0.70812612 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 pulmonary emphysema DOID_9675 3.883E-04 8.497E-03 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 gallbladder cancer DOID_3121 4.432E-04 9.339E-03 0.03054643 0.72420499 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 aortic aneurysm DOID_3627 5.635E-04 0.01145202 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 bile duct adenocarcinoma DOID_4896 6.516E-04 0.01278569 0.0369291 0.70042185 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 cholangiocarcinoma DOID_4947 6.516E-04 0.01278569 0.0369291 0.70042185 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 bile duct cancer DOID_4606 7.46E-04 0.01414873 0.03947085 0.68057313 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 bile duct carcinoma DOID_4897 7.46E-04 0.01414873 0.03947085 0.68057313 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 diabetic retinopathy DOID_8947 1.155E-03 0.02119536 0.04894519 0.75269766 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 aneurysm disease DOID_2403 1.247E-03 0.02217039 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 biliary tract cancer DOID_4607 1.441E-03 0.02485046 0.05458666 0.77649529 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 retinal vascular disease DOID_2462 1.509E-03 0.02525448 0.05583595 0.75644424 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 primary bacterial infectious disease DOID_0050338 1.578E-03 0.02565983 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 lymphoma DOID_0060058 1.758E-03 0.02778954 0.060196 0.77844377 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 alcohol-related neurodevelopmental disorder DOID_0050667 1.833E-03 0.02818486 1.833E-03 0.34761326 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 mouth disease DOID_403 1.833E-03 0.02744315 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 arrhythmogenic right ventricular dysplasia DOID_0050431 5.92E-03 0.08637048 5.92E-03 0.67368974 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 transient cerebral ischemia DOID_224 6.576E-03 0.09353842 6.576E-03 0.62358948 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 teratoma DOID_3307 6.576E-03 0.091257 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 conjunctival disease DOID_4251 6.576E-03 0.08908421 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 malignant teratoma DOID_5563 6.576E-03 0.091257 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 mature teratoma DOID_5566 6.576E-03 0.091257 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 conjunctivitis DOID_6195 6.576E-03 0.08908421 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 cutaneous leishmaniasis DOID_9111 6.576E-03 0.08701249 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 breast benign neoplasm DOID_0060082 7.231E-03 0.09350884 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 thoracic benign neoplasm DOID_0060097 7.231E-03 0.09350884 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 benign breast phyllodes tumor DOID_1631 7.231E-03 0.09350884 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 intracranial arteriosclerosis DOID_13097 7.886E-03 0.09971122 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 aortic valve stenosis DOID_1712 7.886E-03 0.09754358 1.000 1.000 VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 vascular dementia DOID_8725 7.886E-03 0.09971122 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN glaucoma DOID_1686 1.683E-05 9.576E-03 0.0482335 0.49008677 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN bile duct adenocarcinoma DOID_4896 2.221E-05 6.319E-03 0.05275029 0.50024863 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN cholangiocarcinoma DOID_4947 2.221E-05 6.319E-03 0.05275029 0.50024863 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN bile duct cancer DOID_4606 2.725E-05 5.168E-03 0.05634872 0.50097536 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN bile duct carcinoma DOID_4897 2.725E-05 5.168E-03 0.05634872 0.50097536 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN melancholia DOID_2848 2.861E-05 4.07E-03 1.599E-03 0.3033712 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN neurotic disorder DOID_4964 3.003E-05 3.417E-03 1.651E-03 0.23484831 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN carotid artery disease DOID_3407 3.148E-05 2.986E-03 0.05903882 0.50898618 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN parasitic infectious disease DOID_1398 3.777E-05 3.07E-03 0.06261402 0.50179403 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 3.926E-05 2.793E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 3.926E-05 2.793E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN Hodgkin's granuloma DOID_8651 3.926E-05 2.793E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 3.926E-05 2.793E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN pancreatic ductal carcinoma DOID_3587 4.672E-05 2.954E-03 0.06706445 0.49558014 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN pancreatic carcinoma DOID_4905 5.271E-05 2.999E-03 0.06972484 0.50219536 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN diabetic retinopathy DOID_8947 5.271E-05 2.726E-03 0.06972484 0.49591792 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN endogenous depression DOID_1595 5.696E-05 2.701E-03 2.516E-03 0.17894887 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN Hodgkin's lymphoma DOID_8567 5.752E-05 2.517E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN ocular hypertension DOID_9282 5.752E-05 2.338E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN borderline glaucoma DOID_9283 5.752E-05 2.338E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN bone resorption disease DOID_0080011 5.917E-05 2.245E-03 5.917E-05 0.03366845 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN osteoporosis DOID_11476 5.917E-05 2.245E-03 5.917E-05 0.03366845 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN mixed glioma DOID_5076 6.144E-05 2.185E-03 0.07326056 0.51463279 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN larynx cancer DOID_2596 6.793E-05 2.274E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN laryngeal benign neoplasm DOID_2598 6.793E-05 2.274E-03 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN chromosomal disease DOID_0080014 6.857E-05 2.168E-03 2.843E-03 0.17971732 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN mental depression DOID_1596 7.362E-05 2.205E-03 2.979E-03 0.16948121 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN biliary tract cancer DOID_4607 7.362E-05 2.094E-03 0.07766183 0.51987744 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN retinal vascular disease DOID_2462 7.89E-05 2.138E-03 0.07941665 0.5254427 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN parasitic helminthiasis infectious disease DOID_883 7.921E-05 2.049E-03 0.0132148 0.50128142 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN nutritional deficiency disease DOID_5113 9.134E-05 2.26E-03 0.01415219 0.47368213 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN lymphoma DOID_0060058 9.932E-05 2.355E-03 0.08553297 0.54683441 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN Down syndrome DOID_14250 1.484E-04 3.378E-03 0.0178931 0.48481781 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN female reproductive organ benign neoplasm DOID_0060086 4.271E-04 9.347E-03 0.02995599 0.54983738 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN uterine benign neoplasm DOID_0060095 4.271E-04 9.347E-03 0.02995599 0.54983738 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN uterine fibroid DOID_13223 4.271E-04 9.347E-03 0.02995599 0.54983738 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN allergic rhinitis DOID_4481 4.825E-04 0.01016852 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN leiomyoma DOID_127 5.115E-04 0.01039342 0.03271921 0.5641585 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN myocarditis DOID_820 5.412E-04 0.01061898 0.03363858 0.53167646 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN hyperthyroidism DOID_7998 5.718E-04 0.01084511 0.0345571 0.49157479 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN respiratory syncytial virus infectious disease DOID_1273 7.37E-04 0.01352777 0.03913699 0.5061125 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN pulmonary emphysema DOID_9675 8.088E-04 0.01438162 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN diabetic autonomic neuropathy DOID_11503 9.226E-04 0.01590746 0.04369576 0.48750761 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN autonomic neuropathy DOID_11504 9.226E-04 0.01590746 0.04369576 0.48750761 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN diabetic polyneuropathy DOID_12785 9.226E-04 0.01590746 0.04369576 0.48750761 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN gallbladder cancer DOID_3121 9.226E-04 0.0154396 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN diabetic neuropathy DOID_9743 9.226E-04 0.01590746 0.04369576 0.48750761 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN cataract DOID_83 9.621E-04 0.01564124 0.04460499 0.4880815 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN lens disease DOID_110 1.044E-03 0.01649474 0.04642092 0.49836799 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN autonomic nervous system disease DOID_11465 1.044E-03 0.01604894 0.04642092 0.48913895 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN heart valve disease DOID_4079 1.044E-03 0.01562659 1.044E-03 0.2969053 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN B-cell lymphocytic neoplasm DOID_707 1.216E-03 0.01774397 0.05004272 0.49093637 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN reproductive organ benign neoplasm DOID_0050622 1.402E-03 0.01993667 0.05365115 0.5004509 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN pustulosis of palm and sole DOID_4398 1.402E-03 0.01945041 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN pre-malignant neoplasm DOID_0060071 1.81E-03 0.02452148 0.06082807 0.50898784 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN in situ carcinoma DOID_8719 1.81E-03 0.02452148 0.06082807 0.50898784 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN mineral metabolism disease DOID_0050032 1.865E-03 0.02467346 0.06172146 0.5089784 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN cholestasis DOID_13580 1.92E-03 0.02482859 1.92E-03 0.21849157 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN astrocytoma DOID_3069 2.149E-03 0.02717466 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN nephrosis DOID_2527 2.268E-03 0.02805854 0.06795207 0.49570161 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN bile duct disease DOID_4138 2.268E-03 0.02746155 2.268E-03 0.21511551 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN biliary tract disease DOID_9741 2.329E-03 0.02760968 2.329E-03 0.18932354 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN transitional cell carcinoma DOID_2671 3.332E-03 0.03868719 0.08204278 0.53048119 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN Human immunodeficiency virus infectious disease DOID_526 3.478E-03 0.03957975 3.478E-03 0.17990793 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.78E-03 0.04217011 0.08727323 0.54569743 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN hypersensitivity reaction type I disease DOID_1205 3.857E-03 0.04220475 0.08814215 0.53927829 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN dilated cardiomyopathy DOID_12930 3.857E-03 0.04140843 0.08814215 0.53354129 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN T cell deficiency DOID_11200 9.457E-03 0.0996442 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN transient cerebral ischemia DOID_224 9.457E-03 0.09783249 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN lateral sclerosis DOID_230 9.457E-03 0.09608548 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN acute kidney failure DOID_3021 9.457E-03 0.09439977 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN labyrinthine disease DOID_4539 9.457E-03 0.09277219 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN cutaneous leishmaniasis DOID_9111 9.457E-03 0.09119978 1.000 1.000 NATSUME_RESPONSE_TO_INTERFERON_BETA_DN inner ear disease DOID_2952 0.01039743 0.09860228 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN thyroiditis DOID_7166 4.991E-10 2.84E-07 0.01217162 0.28856879 BEIER_GLIOMA_STEM_CELL_DN autoimmune thyroiditis DOID_7188 4.991E-10 2.84E-07 0.01217162 0.28856879 BEIER_GLIOMA_STEM_CELL_DN autoimmune disease of endocrine system DOID_0060005 8.561E-09 2.436E-06 0.02345252 0.31772575 BEIER_GLIOMA_STEM_CELL_DN hypersensitivity reaction type I disease DOID_1205 1.117E-08 2.119E-06 2.515E-03 0.11006794 BEIER_GLIOMA_STEM_CELL_DN Sjogren's syndrome DOID_12894 4.811E-08 6.844E-06 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN narcolepsy DOID_8986 1.456E-07 1.657E-05 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN juvenile rheumatoid arthritis DOID_676 2.717E-07 2.576E-05 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN funisitis DOID_0050698 6.137E-07 4.988E-05 1.293E-04 0.02451977 BEIER_GLIOMA_STEM_CELL_DN sleep disorder DOID_535 7.054E-07 5.017E-05 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN Human immunodeficiency virus infectious disease DOID_526 7.362E-07 4.654E-05 0.0680601 0.4400704 BEIER_GLIOMA_STEM_CELL_DN encephalomyelitis DOID_640 8.374E-07 4.765E-05 0.07020237 0.44882191 BEIER_GLIOMA_STEM_CELL_DN urticaria DOID_1555 1.034E-06 5.348E-05 0.01970611 0.32036502 BEIER_GLIOMA_STEM_CELL_DN myositis DOID_633 1.163E-06 5.513E-05 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN ankylosing spondylitis DOID_7147 1.163E-06 5.089E-05 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN celiac disease DOID_10608 2.37E-06 9.632E-05 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN cervix uteri carcinoma in situ DOID_8991 5.218E-06 1.979E-04 5.239E-04 0.04968591 BEIER_GLIOMA_STEM_CELL_DN vascular skin disease DOID_9540 7.699E-06 2.738E-04 0.03756319 0.33926121 BEIER_GLIOMA_STEM_CELL_DN autoimmune disease of gastrointestinal tract DOID_0060031 8.672E-06 2.902E-04 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN vasculitis DOID_865 1.145E-05 3.62E-04 8.785E-04 0.07140883 BEIER_GLIOMA_STEM_CELL_DN collagen disease DOID_854 1.625E-05 4.866E-04 0.04783435 0.36780736 BEIER_GLIOMA_STEM_CELL_DN pre-malignant neoplasm DOID_0060071 1.783E-05 5.072E-04 1.176E-03 0.08361851 BEIER_GLIOMA_STEM_CELL_DN in situ carcinoma DOID_8719 1.783E-05 5.072E-04 1.176E-03 0.08361851 BEIER_GLIOMA_STEM_CELL_DN angioedema DOID_1558 2.533E-05 6.863E-04 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN peripheral vascular disease DOID_341 2.618E-05 6.772E-04 0.05583022 0.40727428 BEIER_GLIOMA_STEM_CELL_DN aneurysm disease DOID_2403 3.06E-05 7.571E-04 0.0587217 0.41250183 BEIER_GLIOMA_STEM_CELL_DN hemochromatosis DOID_2352 3.094E-05 7.336E-04 3.094E-05 0.01760581 BEIER_GLIOMA_STEM_CELL_DN stomach disease DOID_76 3.711E-05 8.447E-04 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN encephalitis DOID_9588 3.711E-05 8.122E-04 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN transitional cell carcinoma DOID_2671 4.521E-05 9.527E-04 4.521E-05 0.012861 BEIER_GLIOMA_STEM_CELL_DN adrenal cortex disease DOID_3952 5.896E-05 1.198E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN adrenal gland disease DOID_9553 7.629E-05 1.497E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN eosinophilia DOID_999 8.579E-05 1.627E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN membranous glomerulonephritis DOID_10976 1.064E-04 1.954E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN autoimmune hepatitis DOID_2048 1.176E-04 2.091E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN hepatitis B DOID_2043 1.293E-04 2.229E-03 0.01669899 0.3276458 BEIER_GLIOMA_STEM_CELL_DN myasthenia gravis DOID_437 1.415E-04 2.368E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN toxic shock syndrome DOID_14115 1.677E-04 2.726E-03 0.01895516 0.34791897 BEIER_GLIOMA_STEM_CELL_DN commensal bacterial infectious disease DOID_0050339 1.815E-04 2.869E-03 0.01970611 0.35039924 BEIER_GLIOMA_STEM_CELL_DN neuromuscular junction disease DOID_439 1.96E-04 3.014E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN vitiligo DOID_12306 2.109E-04 3.159E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN autoimmune disease of cardiovascular system DOID_0060051 2.425E-04 3.538E-03 2.425E-04 0.03449898 BEIER_GLIOMA_STEM_CELL_DN Behcet's disease DOID_13241 2.425E-04 3.538E-03 2.425E-04 0.03449898 BEIER_GLIOMA_STEM_CELL_DN autoimmune disease of the nervous system DOID_438 2.425E-04 3.45E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN abdominal aortic aneurysm DOID_7693 2.94E-04 4.08E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN systemic mycosis DOID_0050136 3.502E-04 4.745E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN fungal infectious disease DOID_1564 3.502E-04 4.745E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN metal metabolism disorder DOID_896 3.502E-04 4.635E-03 3.502E-04 0.03985764 BEIER_GLIOMA_STEM_CELL_DN esophageal disease DOID_6050 3.701E-04 4.786E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN uveitis DOID_13141 4.548E-04 5.751E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN systemic scleroderma DOID_418 4.773E-04 5.904E-03 0.03164602 0.34628043 BEIER_GLIOMA_STEM_CELL_DN rheumatic disease DOID_1575 5.727E-04 6.933E-03 0.03460898 0.33952603 BEIER_GLIOMA_STEM_CELL_DN uveal disease DOID_3480 5.727E-04 6.789E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN scleroderma DOID_419 5.727E-04 6.933E-03 0.03460898 0.33952603 BEIER_GLIOMA_STEM_CELL_DN proteinuria DOID_576 6.498E-04 7.545E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN aortic aneurysm DOID_3627 7.599E-04 8.648E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN B-cell lymphocytic neoplasm DOID_707 7.888E-04 8.8E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN sarcoidosis DOID_11335 8.481E-04 9.28E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN pustulosis of palm and sole DOID_4398 9.094E-04 9.764E-03 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN hypersensitivity reaction type IV disease DOID_2916 1.005E-03 0.01059379 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN leukocyte disease DOID_9500 1.038E-03 0.01074279 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN hypothyroidism DOID_1459 1.141E-03 0.01158901 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN parasitic infectious disease DOID_1398 1.247E-03 0.01245181 0.05074947 0.38501933 BEIER_GLIOMA_STEM_CELL_DN brain infarction DOID_3454 1.359E-03 0.01333015 0.05293016 0.39627974 BEIER_GLIOMA_STEM_CELL_DN tuberculosis DOID_399 1.359E-03 0.01310421 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN bone resorption disease DOID_0080011 1.678E-03 0.01591592 1.678E-03 0.10610611 BEIER_GLIOMA_STEM_CELL_DN osteoporosis DOID_11476 1.678E-03 0.01591592 1.678E-03 0.10610611 BEIER_GLIOMA_STEM_CELL_DN electroclinical syndrome DOID_0050701 1.721E-03 0.01604881 1.721E-03 0.09789774 BEIER_GLIOMA_STEM_CELL_DN chronic kidney failure DOID_784 1.939E-03 0.01779648 1.939E-03 0.10030743 BEIER_GLIOMA_STEM_CELL_DN primary bacterial infectious disease DOID_0050338 2.123E-03 0.01917509 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN lymphoma DOID_0060058 2.364E-03 0.02101883 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.464E-03 0.0215699 2.464E-03 0.11683698 BEIER_GLIOMA_STEM_CELL_DN brachydactyly DOID_0050581 7.624E-03 0.06572915 7.624E-03 0.30986597 BEIER_GLIOMA_STEM_CELL_DN hyperparathyroidism DOID_13543 7.624E-03 0.06474811 7.624E-03 0.28920824 BEIER_GLIOMA_STEM_CELL_DN trypanosomiasis DOID_10113 8.383E-03 0.07014964 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN dermatomyositis DOID_10223 8.383E-03 0.06913298 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN pneumocystosis DOID_11339 8.383E-03 0.06814536 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN prediabetes syndrome DOID_11716 8.383E-03 0.06718557 8.383E-03 0.29813596 BEIER_GLIOMA_STEM_CELL_DN common variable immunodeficiency DOID_12177 8.383E-03 0.06625244 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN temporal arteritis DOID_13375 8.383E-03 0.06534487 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN invasive lobular carcinoma DOID_3457 8.383E-03 0.06446183 8.383E-03 0.28059855 BEIER_GLIOMA_STEM_CELL_DN central nervous system vasculitis DOID_525 8.383E-03 0.06534487 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN leprosy DOID_1024 9.9E-03 0.07511095 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN berylliosis DOID_10322 9.9E-03 0.07412265 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN parathyroid gland disease DOID_11201 9.9E-03 0.07316002 9.9E-03 0.31296231 BEIER_GLIOMA_STEM_CELL_DN polyneuropathy DOID_1389 9.9E-03 0.07222207 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN epilepsy with generalized tonic-clonic seizures DOID_7725 9.9E-03 0.07130787 9.9E-03 0.29649061 BEIER_GLIOMA_STEM_CELL_DN parasitic helminthiasis infectious disease DOID_883 0.01065803 0.07580521 0.01065803 0.30322082 BEIER_GLIOMA_STEM_CELL_DN idiopathic pulmonary fibrosis DOID_0050156 0.0114151 0.08018757 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN hemangioma DOID_255 0.0114151 0.07920967 0.0114151 0.3092949 BEIER_GLIOMA_STEM_CELL_DN nutritional deficiency disease DOID_5113 0.0114151 0.07825533 0.0114151 0.29523604 BEIER_GLIOMA_STEM_CELL_DN angiosarcoma DOID_0001816 0.01217162 0.08244822 0.01217162 0.30111526 BEIER_GLIOMA_STEM_CELL_DN lymphatic system cancer DOID_0060073 0.01292758 0.08653872 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN urinary system benign neoplasm DOID_731 0.01292758 0.08553245 0.01292758 0.29423164 BEIER_GLIOMA_STEM_CELL_DN reticulosarcoma DOID_8538 0.01292758 0.08653872 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN lymphosarcoma DOID_8675 0.01292758 0.08653872 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN male reproductive organ benign neoplasm DOID_0060087 0.01368298 0.08948981 0.01368298 0.29944666 BEIER_GLIOMA_STEM_CELL_DN glucose intolerance DOID_10603 0.01368298 0.08847288 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN prion disease DOID_649 0.01368298 0.0874788 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN Down syndrome DOID_14250 0.01443782 0.09127909 0.01443782 0.30426362 BEIER_GLIOMA_STEM_CELL_DN agammaglobulinemia DOID_2583 0.01443782 0.09027602 1.000 1.000 BEIER_GLIOMA_STEM_CELL_DN colon carcinoma DOID_1520 0.0151921 0.09395984 0.0151921 0.30872517 BEIER_GLIOMA_STEM_CELL_DN blood protein disease DOID_620 0.0151921 0.09294951 1.000 1.000 FERNANDEZ_BOUND_BY_MYC lymphoma DOID_0060058 2.283E-14 1.299E-11 2.989E-04 0.0283452 FERNANDEZ_BOUND_BY_MYC pancreatic ductal carcinoma DOID_3587 6.984E-14 1.987E-11 0.02542994 0.42557744 FERNANDEZ_BOUND_BY_MYC pancreatic carcinoma DOID_4905 1.064E-13 2.018E-11 0.02739866 0.44542398 FERNANDEZ_BOUND_BY_MYC papilloma DOID_2615 3.781E-13 5.378E-11 0.11468328 0.63354162 FERNANDEZ_BOUND_BY_MYC thyroid adenoma DOID_2891 6.448E-12 7.338E-10 1.000 1.000 FERNANDEZ_BOUND_BY_MYC spindle cell carcinoma DOID_4015 4.009E-11 3.802E-09 1.000 1.000 FERNANDEZ_BOUND_BY_MYC adenoma DOID_657 5.956E-11 4.842E-09 1.000 1.000 FERNANDEZ_BOUND_BY_MYC endocrine organ benign neoplasm DOID_0060089 1.204E-10 8.567E-09 1.000 1.000 FERNANDEZ_BOUND_BY_MYC nephrosis DOID_2527 1.692E-10 1.07E-08 1.188E-04 0.01689946 FERNANDEZ_BOUND_BY_MYC nephrotic syndrome DOID_1184 2.033E-10 1.157E-08 1.812E-05 5.156E-03 FERNANDEZ_BOUND_BY_MYC diabetic autonomic neuropathy DOID_11503 2.382E-10 1.232E-08 5.469E-04 0.04445143 FERNANDEZ_BOUND_BY_MYC autonomic neuropathy DOID_11504 2.382E-10 1.232E-08 5.469E-04 0.04445143 FERNANDEZ_BOUND_BY_MYC diabetic polyneuropathy DOID_12785 2.382E-10 1.232E-08 5.469E-04 0.04445143 FERNANDEZ_BOUND_BY_MYC diabetic neuropathy DOID_9743 2.382E-10 1.232E-08 5.469E-04 0.04445143 FERNANDEZ_BOUND_BY_MYC papillary adenoma DOID_3172 3.676E-10 1.743E-08 1.000 1.000 FERNANDEZ_BOUND_BY_MYC microcystic adenoma DOID_5403 3.676E-10 1.743E-08 1.000 1.000 FERNANDEZ_BOUND_BY_MYC follicular adenoma DOID_6204 3.676E-10 1.743E-08 1.000 1.000 FERNANDEZ_BOUND_BY_MYC autonomic nervous system disease DOID_11465 3.751E-10 1.642E-08 6.562E-04 0.04148351 FERNANDEZ_BOUND_BY_MYC bone marrow cancer DOID_4960 9.736E-10 3.957E-08 1.000 1.000 FERNANDEZ_BOUND_BY_MYC integumentary system cancer DOID_0060122 1.104E-09 4.189E-08 0.0165274 0.31346964 FERNANDEZ_BOUND_BY_MYC skin cancer DOID_4159 1.104E-09 4.189E-08 0.0165274 0.31346964 FERNANDEZ_BOUND_BY_MYC astrocytoma DOID_3069 5.202E-09 1.85E-07 0.21630525 0.87912632 FERNANDEZ_BOUND_BY_MYC pulmonary emphysema DOID_9675 8.363E-09 2.799E-07 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bacterial pneumonia DOID_874 1.097E-08 3.468E-07 0.23726612 0.92468783 FERNANDEZ_BOUND_BY_MYC gallbladder cancer DOID_3121 1.262E-08 3.778E-07 1.000 1.000 FERNANDEZ_BOUND_BY_MYC biliary tract cancer DOID_4607 1.681E-08 4.782E-07 1.000 1.000 FERNANDEZ_BOUND_BY_MYC myeloma DOID_0070004 1.852E-08 5.017E-07 1.000 1.000 FERNANDEZ_BOUND_BY_MYC transitional cell carcinoma DOID_2671 2.509E-08 6.49E-07 3.566E-03 0.15605968 FERNANDEZ_BOUND_BY_MYC nervous system cancer DOID_3093 2.926E-08 7.238E-07 1.000 1.000 FERNANDEZ_BOUND_BY_MYC B-cell lymphocytic neoplasm DOID_707 2.977E-08 7.057E-07 3.44E-05 6.525E-03 FERNANDEZ_BOUND_BY_MYC alcohol-related neurodevelopmental disorder DOID_0050667 3.936E-08 8.959E-07 4.273E-03 0.16210043 FERNANDEZ_BOUND_BY_MYC bile duct adenocarcinoma DOID_4896 4.148E-08 9.078E-07 1.000 1.000 FERNANDEZ_BOUND_BY_MYC cholangiocarcinoma DOID_4947 4.148E-08 9.078E-07 1.000 1.000 FERNANDEZ_BOUND_BY_MYC gestational diabetes DOID_11714 4.513E-08 9.51E-07 4.326E-03 0.15384703 FERNANDEZ_BOUND_BY_MYC sarcoma DOID_1115 5.401E-08 1.098E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC glioblastoma DOID_3068 6.277E-08 1.232E-06 0.1865479 0.81027293 FERNANDEZ_BOUND_BY_MYC bile duct cancer DOID_4606 6.277E-08 1.191E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bile duct carcinoma DOID_4897 6.277E-08 1.191E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC respiratory failure DOID_11162 9.236E-08 1.695E-06 0.19749627 0.82628954 FERNANDEZ_BOUND_BY_MYC nephroblastoma DOID_2154 1.621E-07 2.882E-06 0.11767524 0.64381936 FERNANDEZ_BOUND_BY_MYC mesenchymal cell neoplasm DOID_3350 1.644E-07 2.835E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC spindle cell sarcoma DOID_4235 1.644E-07 2.835E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC epithelioid sarcoma DOID_6193 1.644E-07 2.835E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC multiple myeloma DOID_9538 2.427E-07 4.062E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC cystic fibrosis DOID_1485 2.771E-07 4.505E-06 1.000 1.000 FERNANDEZ_BOUND_BY_MYC lymphatic system cancer DOID_0060073 2.852E-07 4.507E-06 0.05588459 0.51287629 FERNANDEZ_BOUND_BY_MYC reticulosarcoma DOID_8538 2.852E-07 4.507E-06 0.05588459 0.51287629 FERNANDEZ_BOUND_BY_MYC lymphosarcoma DOID_8675 2.852E-07 4.507E-06 0.05588459 0.51287629 FERNANDEZ_BOUND_BY_MYC mixed glioma DOID_5076 3.224E-07 4.958E-06 0.23726612 0.93106499 FERNANDEZ_BOUND_BY_MYC adult respiratory distress syndrome DOID_11394 3.522E-07 5.274E-06 0.13541749 0.69416713 FERNANDEZ_BOUND_BY_MYC contact dermatitis DOID_2773 3.736E-07 5.451E-06 0.03151299 0.47186557 FERNANDEZ_BOUND_BY_MYC bone development disease DOID_0080006 4.961E-07 7.057E-06 0.0343825 0.46580103 FERNANDEZ_BOUND_BY_MYC vascular skin disease DOID_9540 7.607E-07 1.056E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC integumentary system benign neoplasm DOID_0060121 9.281E-07 1.257E-05 0.01343309 0.28308999 FERNANDEZ_BOUND_BY_MYC skin benign neoplasm DOID_3165 9.281E-07 1.257E-05 0.01343309 0.28308999 FERNANDEZ_BOUND_BY_MYC giant cell tumor DOID_200 1.349E-06 1.786E-05 0.17265382 0.78592018 FERNANDEZ_BOUND_BY_MYC malignant giant cell tumor DOID_2705 1.349E-06 1.786E-05 0.17265382 0.78592018 FERNANDEZ_BOUND_BY_MYC giant cell glioblastoma DOID_3074 1.349E-06 1.786E-05 0.17265382 0.78592018 FERNANDEZ_BOUND_BY_MYC vasculitis DOID_865 1.475E-06 1.908E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC reproductive organ benign neoplasm DOID_0050622 1.61E-06 2.036E-05 0.17823948 0.80490687 FERNANDEZ_BOUND_BY_MYC hypersensitivity reaction type IV disease DOID_2916 2.074E-06 2.565E-05 0.1865479 0.8165058 FERNANDEZ_BOUND_BY_MYC middle cerebral artery infarction DOID_3525 2.384E-06 2.886E-05 0.09038237 0.56513812 FERNANDEZ_BOUND_BY_MYC carotid artery disease DOID_3407 2.636E-06 3.125E-05 0.19477296 0.82093196 FERNANDEZ_BOUND_BY_MYC lung adenocarcinoma DOID_3910 2.758E-06 3.202E-05 0.09345581 0.55975111 FERNANDEZ_BOUND_BY_MYC perinatal necrotizing enterocolitis DOID_8677 2.758E-06 3.138E-05 1.288E-04 0.01465968 FERNANDEZ_BOUND_BY_MYC autoimmune disease of cardiovascular system DOID_0060051 3.174E-06 3.541E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Behcet's disease DOID_13241 3.174E-06 3.541E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC multiple epiphyseal dysplasia DOID_12721 3.634E-06 3.977E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hyperglycemia DOID_4195 3.833E-06 4.115E-05 0.02289982 0.40718738 FERNANDEZ_BOUND_BY_MYC brain infarction DOID_3454 4.417E-06 4.654E-05 0.21364527 0.8745623 FERNANDEZ_BOUND_BY_MYC teratoma DOID_3307 4.434E-06 4.587E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC malignant teratoma DOID_5563 4.434E-06 4.587E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC mature teratoma DOID_5566 4.434E-06 4.587E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC allergic rhinitis DOID_4481 5.315E-06 5.4E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC male reproductive system disease DOID_48 5.421E-06 5.412E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC peripheral vascular disease DOID_341 5.793E-06 5.683E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pleural disease DOID_1532 5.985E-06 5.772E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC aneurysm disease DOID_2403 7.483E-06 7.096E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC thyroid carcinoma DOID_3963 7.51E-06 7.005E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pancreatitis DOID_4989 7.96E-06 7.305E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC porphyria DOID_13268 8.089E-06 7.305E-05 8.089E-06 4.602E-03 FERNANDEZ_BOUND_BY_MYC thyroid cancer DOID_1781 9.304E-06 8.272E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC newborn respiratory distress syndrome DOID_12716 1.049E-05 9.182E-05 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hepatitis DOID_2237 1.256E-05 1.083E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC congenital diaphragmatic hernia DOID_3827 1.256E-05 1.067E-04 8.916E-03 0.22056772 FERNANDEZ_BOUND_BY_MYC peptic ulcer DOID_750 1.256E-05 1.051E-04 0.13248523 0.68530994 FERNANDEZ_BOUND_BY_MYC intracranial arterial disease DOID_13089 1.381E-05 1.139E-04 0.13541749 0.68796921 FERNANDEZ_BOUND_BY_MYC cerebral arterial disease DOID_3527 1.381E-05 1.139E-04 0.13541749 0.68796921 FERNANDEZ_BOUND_BY_MYC cervix uteri carcinoma in situ DOID_8991 1.516E-05 1.232E-04 0.13833992 0.69659658 FERNANDEZ_BOUND_BY_MYC hemangioma DOID_255 1.661E-05 1.331E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC varicose veins DOID_799 1.661E-05 1.312E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC encephalomyelitis DOID_640 1.843E-05 1.436E-04 0.27507973 1.000 FERNANDEZ_BOUND_BY_MYC vein disease DOID_866 2.039E-05 1.568E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC cerebral infarction DOID_3526 2.15E-05 1.631E-04 0.14993195 0.72297694 FERNANDEZ_BOUND_BY_MYC brain cancer DOID_1319 2.531E-05 1.895E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC central nervous system cancer DOID_3620 2.74E-05 2.024E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC ureteral obstruction DOID_5199 2.956E-05 2.156E-04 0.05907366 0.50168527 FERNANDEZ_BOUND_BY_MYC aortic aneurysm DOID_3627 3.193E-05 2.3E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC osteochondrodysplasia DOID_2256 4.567E-05 3.248E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC autoimmune hepatitis DOID_2048 4.782E-05 3.359E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC muscular atrophy DOID_767 5.524E-05 3.833E-04 0.07172343 0.5300082 FERNANDEZ_BOUND_BY_MYC uremia DOID_4676 6.337E-05 4.344E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC urinary tract obstruction DOID_5200 6.337E-05 4.292E-04 0.07485942 0.53917731 FERNANDEZ_BOUND_BY_MYC neuroectodermal tumor DOID_171 6.733E-05 4.507E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC ureteral disease DOID_1426 7.224E-05 4.78E-04 0.07798489 0.55466754 FERNANDEZ_BOUND_BY_MYC meningitis DOID_9471 7.224E-05 4.725E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pre-malignant neoplasm DOID_0060071 7.598E-05 4.913E-04 0.20021044 0.83153095 FERNANDEZ_BOUND_BY_MYC in situ carcinoma DOID_8719 7.598E-05 4.913E-04 0.20021044 0.83153095 FERNANDEZ_BOUND_BY_MYC mineral metabolism disease DOID_0050032 8.059E-05 5.153E-04 0.2029155 0.83665884 FERNANDEZ_BOUND_BY_MYC endocrine pancreas disease DOID_1428 8.059E-05 5.095E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC toxic shock syndrome DOID_14115 8.189E-05 5.12E-04 0.08109989 0.55597394 FERNANDEZ_BOUND_BY_MYC parasitic infectious disease DOID_1398 8.541E-05 5.282E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC cerebral degeneration DOID_1443 8.541E-05 5.226E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC uterine disease DOID_345 8.541E-05 5.17E-04 0.02228458 0.40902984 FERNANDEZ_BOUND_BY_MYC commensal bacterial infectious disease DOID_0050339 9.234E-05 5.531E-04 0.08420445 0.56367446 FERNANDEZ_BOUND_BY_MYC urticaria DOID_1555 9.234E-05 5.473E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC osteosarcoma DOID_3347 9.234E-05 5.417E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC allergic contact dermatitis DOID_3042 9.566E-05 5.554E-04 0.02352203 0.40557676 FERNANDEZ_BOUND_BY_MYC pleurisy DOID_10247 1.428E-04 8.206E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC supratentorial cancer DOID_1659 1.577E-04 8.972E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC cerebrum cancer DOID_368 1.577E-04 8.972E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC focal glomerulosclerosis DOID_3945 1.577E-04 8.884E-04 0.09957181 0.57812611 FERNANDEZ_BOUND_BY_MYC female reproductive organ benign neoplasm DOID_0060086 1.736E-04 9.683E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC uterine benign neoplasm DOID_0060095 1.736E-04 9.683E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC uterine fibroid DOID_13223 1.736E-04 9.683E-04 1.000 1.000 FERNANDEZ_BOUND_BY_MYC metabolic syndrome X DOID_14221 1.769E-04 9.771E-04 0.24241883 0.93834227 FERNANDEZ_BOUND_BY_MYC female reproductive system disease DOID_229 1.853E-04 1.014E-03 0.03222105 0.4700968 FERNANDEZ_BOUND_BY_MYC bronchiolitis obliterans DOID_2799 1.905E-04 1.032E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC leiomyoma DOID_127 2.274E-04 1.22E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pneumoconiosis DOID_10316 2.686E-04 1.428E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC esophageal disease DOID_6050 2.686E-04 1.415E-03 0.11767524 0.63167182 FERNANDEZ_BOUND_BY_MYC lymphoblastic leukemia DOID_1037 3.112E-04 1.625E-03 0.27507973 1.000 FERNANDEZ_BOUND_BY_MYC carbohydrate metabolic disorder DOID_2978 3.112E-04 1.61E-03 4.15E-03 0.16866296 FERNANDEZ_BOUND_BY_MYC hypersensitivity reaction type I disease DOID_1205 3.37E-04 1.727E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC dilated cardiomyopathy DOID_12930 3.37E-04 1.712E-03 0.27997892 1.000 FERNANDEZ_BOUND_BY_MYC pulmonary sarcoidosis DOID_13406 3.39E-04 1.707E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC cleft palate DOID_674 3.39E-04 1.692E-03 8.113E-03 0.20981957 FERNANDEZ_BOUND_BY_MYC peripheral nervous system neoplasm DOID_1192 3.649E-04 1.805E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC respiratory syncytial virus infectious disease DOID_1273 3.92E-04 1.923E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC benign mesothelioma DOID_2645 4.5E-04 2.188E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC rectal neoplasm DOID_1984 5E-04 2.411E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC rectum cancer DOID_1993 5E-04 2.411E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC insulinoma DOID_3892 5E-04 2.391E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Huntington's disease DOID_12858 5.132E-04 2.433E-03 0.01062387 0.25187434 FERNANDEZ_BOUND_BY_MYC rheumatic disease DOID_1575 5.132E-04 2.413E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hyperinsulinism DOID_2018 5.132E-04 2.394E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC scleroderma DOID_419 5.132E-04 2.413E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC uterine cancer DOID_363 5.469E-04 2.53E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC influenza DOID_8469 5.469E-04 2.509E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC polydactyly DOID_1148 6.098E-04 2.776E-03 0.03652368 0.47231763 FERNANDEZ_BOUND_BY_MYC prediabetes syndrome DOID_11716 6.098E-04 2.754E-03 6.098E-04 0.04337286 FERNANDEZ_BOUND_BY_MYC prostatic adenoma DOID_2883 6.098E-04 2.732E-03 0.03652368 0.45178208 FERNANDEZ_BOUND_BY_MYC leukodystrophy DOID_10579 6.183E-04 2.749E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bone marrow disease DOID_4961 6.562E-04 2.894E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC islet cell tumor DOID_1799 7.302E-04 3.196E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC aortic valve insufficiency DOID_57 7.302E-04 3.171E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC peritonitis DOID_8283 7.302E-04 3.147E-03 0.03977764 0.44379367 FERNANDEZ_BOUND_BY_MYC Hodgkin's lymphoma DOID_8567 7.302E-04 3.124E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC autoimmune disease of gastrointestinal tract DOID_0060031 7.362E-04 3.126E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC glaucoma DOID_1686 7.362E-04 3.103E-03 0.16136923 0.75883548 FERNANDEZ_BOUND_BY_MYC berylliosis DOID_10322 8.61E-04 3.602E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC obstructive hydrocephalus DOID_14159 8.61E-04 3.576E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC communicating hydrocephalus DOID_1573 8.61E-04 3.576E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC orofacial cleft DOID_0050567 8.675E-04 3.577E-03 0.01494539 0.29323893 FERNANDEZ_BOUND_BY_MYC sarcoidosis DOID_11335 9.144E-04 3.743E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC viral pneumonia DOID_10533 1.002E-03 4.074E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hydrocephalus DOID_10908 1.002E-03 4.045E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bacterial meningitis DOID_9470 1.002E-03 4.016E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC parasitic protozoa infectious disease DOID_2789 1.013E-03 4.03E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC thoracic aortic aneurysm DOID_14004 1.154E-03 4.56E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC panic disorder DOID_594 1.154E-03 4.528E-03 1.154E-03 0.06565859 FERNANDEZ_BOUND_BY_MYC intracranial hypertension DOID_9428 1.154E-03 4.497E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hypertrophic cardiomyopathy DOID_11984 1.173E-03 4.539E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC leukocyte disease DOID_9500 1.229E-03 4.726E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC chronic myeloid leukemia DOID_8552 1.316E-03 5.025E-03 0.05268479 0.49962742 FERNANDEZ_BOUND_BY_MYC collagen disease DOID_854 1.348E-03 5.112E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hypothyroidism DOID_1459 1.409E-03 5.311E-03 1.409E-03 0.07290368 FERNANDEZ_BOUND_BY_MYC drug-induced mental disorder DOID_1203 1.488E-03 5.57E-03 0.05588459 0.5047354 FERNANDEZ_BOUND_BY_MYC drug psychosis DOID_1742 1.488E-03 5.57E-03 0.05588459 0.5047354 FERNANDEZ_BOUND_BY_MYC bronchitis DOID_6132 1.488E-03 5.534E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC substance-induced psychosis DOID_8646 1.488E-03 5.57E-03 0.05588459 0.5047354 FERNANDEZ_BOUND_BY_MYC cholestasis DOID_13580 1.605E-03 5.931E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC male reproductive organ benign neoplasm DOID_0060087 1.67E-03 6.132E-03 0.05907366 0.51712174 FERNANDEZ_BOUND_BY_MYC neuroendocrine tumor DOID_169 1.67E-03 6.092E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC skin carcinoma DOID_3451 1.67E-03 6.054E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC osteosclerosis DOID_4254 1.67E-03 6.015E-03 0.05907366 0.50928656 FERNANDEZ_BOUND_BY_MYC dissociative disorder DOID_10935 1.863E-03 6.666E-03 0.06225205 0.52090316 FERNANDEZ_BOUND_BY_MYC dissociative amnesia DOID_11037 1.863E-03 6.666E-03 0.06225205 0.52090316 FERNANDEZ_BOUND_BY_MYC testicular cancer DOID_2998 1.863E-03 6.624E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC MHC class II deficiency DOID_5812 1.863E-03 6.583E-03 0.06225205 0.50602021 FERNANDEZ_BOUND_BY_MYC bile duct disease DOID_4138 2.046E-03 7.186E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC amnestic disorder DOID_10914 2.065E-03 7.209E-03 0.06541978 0.52427965 FERNANDEZ_BOUND_BY_MYC esophagitis DOID_11963 2.065E-03 7.165E-03 0.06541978 0.51699798 FERNANDEZ_BOUND_BY_MYC colon carcinoma DOID_1520 2.065E-03 7.122E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC subependymal glioma DOID_4843 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pilocytic astrocytoma DOID_4851 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC subependymal giant cell astrocytoma DOID_5077 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC fibrillary astrocytoma DOID_6726 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC juvenile pilocytic astrocytoma DOID_6811 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC childhood pilocytic astrocytoma DOID_6812 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC gemistocytic astrocytoma DOID_7005 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC childhood cerebral astrocytoma DOID_7007 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC protoplasmic astrocytoma DOID_7008 2.065E-03 7.079E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC biliary tract disease DOID_9741 2.126E-03 7.244E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Kawasaki disease DOID_13378 2.277E-03 7.714E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC lymphadenitis DOID_1602 2.277E-03 7.714E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC coronary restenosis DOID_4247 2.277E-03 7.668E-03 0.0685769 0.51342439 FERNANDEZ_BOUND_BY_MYC lymph node disease DOID_9942 2.277E-03 7.714E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC syndrome DOID_225 2.378E-03 7.958E-03 0.23207864 0.92344579 FERNANDEZ_BOUND_BY_MYC bone resorption disease DOID_0080011 2.466E-03 8.204E-03 0.02942681 0.46510705 FERNANDEZ_BOUND_BY_MYC osteoporosis DOID_11476 2.466E-03 8.204E-03 0.02942681 0.46510705 FERNANDEZ_BOUND_BY_MYC benign glioma DOID_0060101 2.5E-03 8.269E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC benign ependymoma DOID_4844 2.5E-03 8.269E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC placenta disease DOID_780 2.5E-03 8.222E-03 0.07172343 0.52321322 FERNANDEZ_BOUND_BY_MYC sinusitis DOID_0050127 2.732E-03 8.933E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC paranasal sinus disease DOID_1352 2.732E-03 8.933E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC muscle cancer DOID_4045 2.732E-03 8.882E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC polyarteritis nodosa DOID_9810 2.732E-03 8.832E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC lingual-facial-buccal dyskinesia DOID_9854 2.732E-03 8.782E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC auditory system disease DOID_2742 2.935E-03 9.381E-03 0.247537 0.95167941 FERNANDEZ_BOUND_BY_MYC diabetic angiopathy DOID_11713 2.973E-03 9.452E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC synostosis DOID_11971 2.973E-03 9.4E-03 2.973E-03 0.14099309 FERNANDEZ_BOUND_BY_MYC aortic valve disease DOID_62 2.973E-03 9.348E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC chronic kidney failure DOID_784 3.035E-03 9.487E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC spastic quadriplegia DOID_10970 3.225E-03 0.01002726 0.08109989 0.56275411 FERNANDEZ_BOUND_BY_MYC acute pancreatitis DOID_2913 3.225E-03 9.973E-03 1.000 1.000 FERNANDEZ_BOUND_BY_MYC severe combined immunodeficiency DOID_627 3.225E-03 9.919E-03 0.08109989 0.5493552 FERNANDEZ_BOUND_BY_MYC primary bacterial infectious disease DOID_0050338 3.455E-03 0.01056962 1.000 1.000 FERNANDEZ_BOUND_BY_MYC portal hypertension DOID_10762 3.486E-03 0.01060709 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bronchiolitis DOID_2942 3.486E-03 0.01055067 1.000 1.000 FERNANDEZ_BOUND_BY_MYC combined T cell and B cell immunodeficiency DOID_628 3.486E-03 0.01049484 0.08420445 0.55071643 FERNANDEZ_BOUND_BY_MYC primary immunodeficiency disease DOID_612 3.678E-03 0.01101483 0.03810628 0.46132919 FERNANDEZ_BOUND_BY_MYC Human immunodeficiency virus infectious disease DOID_526 3.793E-03 0.01129886 1.000 1.000 FERNANDEZ_BOUND_BY_MYC seminoma DOID_4440 4.037E-03 0.01196274 0.09038237 0.55899531 FERNANDEZ_BOUND_BY_MYC fragments of torsion dystonia DOID_531 4.037E-03 0.01190075 1.000 1.000 FERNANDEZ_BOUND_BY_MYC mouth disease DOID_403 4.273E-03 0.01253354 1.000 1.000 FERNANDEZ_BOUND_BY_MYC diffuse large B-cell lymphoma DOID_0050745 4.326E-03 0.01262335 0.09345581 0.57178876 FERNANDEZ_BOUND_BY_MYC periodontitis DOID_824 4.326E-03 0.01255894 1.000 1.000 FERNANDEZ_BOUND_BY_MYC malaria DOID_12365 4.625E-03 0.01335825 1.000 1.000 FERNANDEZ_BOUND_BY_MYC mononeuritis DOID_1802 4.625E-03 0.01329078 4.625E-03 0.15479851 FERNANDEZ_BOUND_BY_MYC hepatic vascular disease DOID_272 4.625E-03 0.01322399 1.000 1.000 FERNANDEZ_BOUND_BY_MYC invasive ductal carcinoma DOID_3008 4.625E-03 0.01315787 0.09651894 0.57207582 FERNANDEZ_BOUND_BY_MYC coronary stenosis DOID_4248 4.625E-03 0.01309241 0.09651894 0.56617813 FERNANDEZ_BOUND_BY_MYC central nervous system hereditary degenerative disease DOID_481 4.625E-03 0.0130276 1.000 1.000 FERNANDEZ_BOUND_BY_MYC mononeuropathy DOID_1188 4.933E-03 0.01382697 4.933E-03 0.15593748 FERNANDEZ_BOUND_BY_MYC toxic encephalopathy DOID_3602 4.933E-03 0.01375919 1.000 1.000 FERNANDEZ_BOUND_BY_MYC dystonic disease DOID_544 4.933E-03 0.01369207 1.000 1.000 FERNANDEZ_BOUND_BY_MYC dysostosis DOID_1934 5.25E-03 0.01450202 5.25E-03 0.15723239 FERNANDEZ_BOUND_BY_MYC spastic cerebral palsy DOID_0050669 5.577E-03 0.01532928 0.10564687 0.60720269 FERNANDEZ_BOUND_BY_MYC abdominal aortic aneurysm DOID_7693 5.577E-03 0.01525558 1.000 1.000 FERNANDEZ_BOUND_BY_MYC germinoma DOID_3304 5.912E-03 0.01609604 0.10866913 0.61220528 FERNANDEZ_BOUND_BY_MYC chronic leukemia DOID_1036 6.257E-03 0.01695293 0.11168125 0.62300621 FERNANDEZ_BOUND_BY_MYC chronic lymphocytic leukemia DOID_1040 6.257E-03 0.01695293 0.11168125 0.62300621 FERNANDEZ_BOUND_BY_MYC autonomic nervous system neoplasm DOID_2621 6.257E-03 0.01687258 1.000 1.000 FERNANDEZ_BOUND_BY_MYC neuroblastoma DOID_769 6.257E-03 0.01687258 1.000 1.000 FERNANDEZ_BOUND_BY_MYC myocarditis DOID_820 6.61E-03 0.01774176 6.61E-03 0.18806264 FERNANDEZ_BOUND_BY_MYC periodontal disease DOID_3388 6.973E-03 0.01862652 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hyperthyroidism DOID_7998 6.973E-03 0.01853948 6.973E-03 0.18892614 FERNANDEZ_BOUND_BY_MYC lymphoid leukemia DOID_10747 7.344E-03 0.01943566 1.000 1.000 FERNANDEZ_BOUND_BY_MYC aplastic anemia DOID_12449 7.344E-03 0.01934568 1.000 1.000 FERNANDEZ_BOUND_BY_MYC calcinosis DOID_182 8.113E-03 0.02127203 0.12659106 0.67318052 FERNANDEZ_BOUND_BY_MYC medulloblastoma DOID_3858 8.113E-03 0.02117445 1.000 1.000 FERNANDEZ_BOUND_BY_MYC systemic scleroderma DOID_418 8.916E-03 0.02316465 1.000 1.000 FERNANDEZ_BOUND_BY_MYC lymphatic system disease DOID_75 9.33E-03 0.02413117 1.000 1.000 FERNANDEZ_BOUND_BY_MYC endometriosis of uterus DOID_288 0.01018428 0.02622106 0.14125255 0.6928681 FERNANDEZ_BOUND_BY_MYC primitive neuroectodermal tumor DOID_168 0.01062387 0.02722966 1.000 1.000 FERNANDEZ_BOUND_BY_MYC endometriosis DOID_289 0.01062387 0.02710755 0.14415541 0.70106347 FERNANDEZ_BOUND_BY_MYC learning disability DOID_8927 0.01152782 0.02928273 0.14993195 0.7169015 FERNANDEZ_BOUND_BY_MYC spinocerebellar degeneration DOID_2478 0.01199206 0.03032658 0.01199206 0.27293922 FERNANDEZ_BOUND_BY_MYC proteinuria DOID_576 0.01199206 0.03019239 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pre-eclampsia DOID_10591 0.01246439 0.03124333 1.000 1.000 FERNANDEZ_BOUND_BY_MYC neuritis DOID_1803 0.01246439 0.0311063 0.01246439 0.27277831 FERNANDEZ_BOUND_BY_MYC heart valve disease DOID_4079 0.01246439 0.03097046 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hemolytic anemia DOID_583 0.01294475 0.03202419 0.15852431 0.75166942 FERNANDEZ_BOUND_BY_MYC normocytic anemia DOID_720 0.01294475 0.03202419 0.15852431 0.75166942 FERNANDEZ_BOUND_BY_MYC pulmonary tuberculosis DOID_2957 0.01343309 0.03308844 1.000 1.000 FERNANDEZ_BOUND_BY_MYC lung small cell carcinoma DOID_5409 0.01343309 0.03294582 0.16136923 0.75261551 FERNANDEZ_BOUND_BY_MYC calcium metabolism disease DOID_10575 0.01392935 0.03401632 0.16420461 0.75961321 FERNANDEZ_BOUND_BY_MYC movement disease DOID_480 0.01392935 0.03387095 1.000 1.000 FERNANDEZ_BOUND_BY_MYC withdrawal disorder DOID_0060001 0.01443347 0.03494743 0.01443347 0.29330877 FERNANDEZ_BOUND_BY_MYC atopic dermatitis DOID_3310 0.01494539 0.0360336 1.000 1.000 FERNANDEZ_BOUND_BY_MYC atrophic muscular disease DOID_913 0.01546506 0.03712919 1.000 1.000 FERNANDEZ_BOUND_BY_MYC muscular dystrophy DOID_9884 0.01546506 0.03712919 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pustulosis of palm and sole DOID_4398 0.0165274 0.03951298 1.000 1.000 FERNANDEZ_BOUND_BY_MYC familial hyperlipidemia DOID_1168 0.01706996 0.04063935 1.000 1.000 FERNANDEZ_BOUND_BY_MYC melancholia DOID_2848 0.01874251 0.04443536 0.18929881 0.8098573 FERNANDEZ_BOUND_BY_MYC neurotic disorder DOID_4964 0.0193148 0.04560216 0.19204048 0.81545548 FERNANDEZ_BOUND_BY_MYC tooth disease DOID_1091 0.02352203 0.05530592 1.000 1.000 FERNANDEZ_BOUND_BY_MYC tuberculosis DOID_399 0.02415115 0.05655146 1.000 1.000 FERNANDEZ_BOUND_BY_MYC blood coagulation disease DOID_1247 0.02542994 0.05930178 0.21895629 0.88358957 FERNANDEZ_BOUND_BY_MYC diabetic retinopathy DOID_8947 0.02739866 0.063632 1.000 1.000 FERNANDEZ_BOUND_BY_MYC endogenous depression DOID_1595 0.02874424 0.06648567 0.23207864 0.92994893 FERNANDEZ_BOUND_BY_MYC arrhythmogenic right ventricular dysplasia DOID_0050431 0.02998291 0.06906995 0.02998291 0.46108855 FERNANDEZ_BOUND_BY_MYC leber hereditary optic neuropathy DOID_705 0.02998291 0.06879144 1.000 1.000 FERNANDEZ_BOUND_BY_MYC electroclinical syndrome DOID_0050701 0.03011582 0.06881888 0.23726612 0.93753072 FERNANDEZ_BOUND_BY_MYC lipid metabolism disorder DOID_3146 0.03151299 0.07172357 1.000 1.000 FERNANDEZ_BOUND_BY_MYC chromosomal disease DOID_0080014 0.03222105 0.07304293 1.000 1.000 FERNANDEZ_BOUND_BY_MYC brachydactyly DOID_0050581 0.03325879 0.07509623 0.03325879 0.47310622 FERNANDEZ_BOUND_BY_MYC interstitial nephritis DOID_1063 0.03325879 0.0747994 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hyperparathyroidism DOID_13543 0.03325879 0.07450492 1.000 1.000 FERNANDEZ_BOUND_BY_MYC transient cerebral ischemia DOID_224 0.03325879 0.07421274 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bilirubin metabolic disorder DOID_2741 0.03325879 0.07392285 0.03325879 0.46156705 FERNANDEZ_BOUND_BY_MYC acute kidney failure DOID_3021 0.03325879 0.07363521 1.000 1.000 FERNANDEZ_BOUND_BY_MYC chondrosarcoma DOID_3371 0.03325879 0.0733498 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Noonan syndrome DOID_3490 0.03325879 0.0730666 1.000 1.000 FERNANDEZ_BOUND_BY_MYC labyrinthine disease DOID_4539 0.03325879 0.07278557 1.000 1.000 FERNANDEZ_BOUND_BY_MYC acute T cell leukemia DOID_5603 0.03325879 0.0725067 1.000 1.000 FERNANDEZ_BOUND_BY_MYC polycythemia DOID_8432 0.03325879 0.07222996 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.03325879 0.07195532 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.03325879 0.07195532 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Hodgkin's granuloma DOID_8651 0.03325879 0.07195532 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Hodgkin's lymphoma, mixed cellularity DOID_8654 0.03325879 0.07195532 1.000 1.000 FERNANDEZ_BOUND_BY_MYC mental depression DOID_1596 0.03365585 0.07253856 0.2500832 0.95501572 FERNANDEZ_BOUND_BY_MYC retinal vascular disease DOID_2462 0.03511525 0.07539841 1.000 1.000 FERNANDEZ_BOUND_BY_MYC familial adenomatous polyposis DOID_0050424 0.03652368 0.07812773 1.000 1.000 FERNANDEZ_BOUND_BY_MYC breast benign neoplasm DOID_0060082 0.03652368 0.07783511 1.000 1.000 FERNANDEZ_BOUND_BY_MYC thoracic benign neoplasm DOID_0060097 0.03652368 0.07783511 1.000 1.000 FERNANDEZ_BOUND_BY_MYC nervous system benign neoplasm DOID_0060115 0.03652368 0.07754468 1.000 1.000 FERNANDEZ_BOUND_BY_MYC adrenoleukodystrophy DOID_10588 0.03652368 0.07725641 1.000 1.000 FERNANDEZ_BOUND_BY_MYC obsessive-compulsive disorder DOID_10933 0.03652368 0.07697028 0.03652368 0.48330176 FERNANDEZ_BOUND_BY_MYC pneumocystosis DOID_11339 0.03652368 0.07668626 1.000 1.000 FERNANDEZ_BOUND_BY_MYC benign breast phyllodes tumor DOID_1631 0.03652368 0.07783511 1.000 1.000 FERNANDEZ_BOUND_BY_MYC craniosynostosis DOID_2340 0.03652368 0.07640432 0.03652368 0.46182168 FERNANDEZ_BOUND_BY_MYC inner ear disease DOID_2952 0.03652368 0.07612445 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bronchiectasis DOID_9563 0.03652368 0.07584663 1.000 1.000 FERNANDEZ_BOUND_BY_MYC amino acid metabolic disorder DOID_9252 0.03810628 0.07884535 0.2651819 1.000 FERNANDEZ_BOUND_BY_MYC neonatoal period electroclinical syndrome DOID_0050702 0.03977764 0.08200535 1.000 1.000 FERNANDEZ_BOUND_BY_MYC otitis media DOID_10754 0.03977764 0.0817093 1.000 1.000 FERNANDEZ_BOUND_BY_MYC beta thalassemia DOID_12241 0.03977764 0.08141539 1.000 1.000 FERNANDEZ_BOUND_BY_MYC osteopetrosis DOID_13533 0.03977764 0.08112357 0.03977764 0.47153077 FERNANDEZ_BOUND_BY_MYC pituitary cancer DOID_1785 0.03977764 0.08083385 1.000 1.000 FERNANDEZ_BOUND_BY_MYC relapsing-remitting multiple sclerosis DOID_2378 0.03977764 0.08054618 0.03977764 0.4619077 FERNANDEZ_BOUND_BY_MYC epidermolysis bullosa DOID_2730 0.03977764 0.08026056 0.03977764 0.45266954 FERNANDEZ_BOUND_BY_MYC pituitary carcinoma DOID_4916 0.03977764 0.08083385 1.000 1.000 FERNANDEZ_BOUND_BY_MYC middle ear disease DOID_5100 0.03977764 0.0817093 1.000 1.000 FERNANDEZ_BOUND_BY_MYC retinal detachment DOID_5327 0.03977764 0.07997695 1.000 1.000 FERNANDEZ_BOUND_BY_MYC stomach disease DOID_76 0.03977764 0.07969534 1.000 1.000 FERNANDEZ_BOUND_BY_MYC lipodystrophy DOID_811 0.03977764 0.07941571 1.000 1.000 FERNANDEZ_BOUND_BY_MYC progressive myoclonus epilepsy DOID_891 0.03977764 0.07913803 0.03977764 0.43525917 FERNANDEZ_BOUND_BY_MYC Charcot-Marie-Tooth disease type 2 DOID_0050539 0.04302069 0.0852919 1.000 1.000 FERNANDEZ_BOUND_BY_MYC variable age at onset electroclinical syndrome DOID_0050706 0.04302069 0.08499574 0.04302069 0.46186366 FERNANDEZ_BOUND_BY_MYC Hirschsprung's disease DOID_10487 0.04302069 0.08470164 1.000 1.000 FERNANDEZ_BOUND_BY_MYC parathyroid gland disease DOID_11201 0.04302069 0.08440957 1.000 1.000 FERNANDEZ_BOUND_BY_MYC hepatic coma DOID_12550 0.04302069 0.0841195 0.04302069 0.45331063 FERNANDEZ_BOUND_BY_MYC hepatic encephalopathy DOID_13413 0.04302069 0.0841195 0.04302069 0.45331063 FERNANDEZ_BOUND_BY_MYC larynx cancer DOID_2596 0.04302069 0.08383142 1.000 1.000 FERNANDEZ_BOUND_BY_MYC laryngeal benign neoplasm DOID_2598 0.04302069 0.08383142 1.000 1.000 FERNANDEZ_BOUND_BY_MYC vesiculobullous skin disease DOID_2731 0.04302069 0.0835453 0.04302069 0.44506862 FERNANDEZ_BOUND_BY_MYC Lynch syndrome DOID_3883 0.04302069 0.08326114 1.000 1.000 FERNANDEZ_BOUND_BY_MYC epilepsy with generalized tonic-clonic seizures DOID_7725 0.04302069 0.0829789 1.000 1.000 FERNANDEZ_BOUND_BY_MYC ulcerative colitis DOID_8577 0.04517424 0.08683832 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Legionnaires' disease DOID_10457 0.04625288 0.08861242 1.000 1.000 FERNANDEZ_BOUND_BY_MYC legionellosis DOID_10458 0.04625288 0.08861242 1.000 1.000 FERNANDEZ_BOUND_BY_MYC open-angle glaucoma DOID_1067 0.04625288 0.08831506 1.000 1.000 FERNANDEZ_BOUND_BY_MYC megacolon DOID_11372 0.04625288 0.08801969 1.000 1.000 FERNANDEZ_BOUND_BY_MYC rhabdomyosarcoma DOID_3247 0.04625288 0.08772629 1.000 1.000 FERNANDEZ_BOUND_BY_MYC congenital structural myopathy DOID_422 0.04625288 0.08743484 0.04625288 0.46996228 FERNANDEZ_BOUND_BY_MYC T-cell leukemia DOID_715 0.04625288 0.08714532 1.000 1.000 FERNANDEZ_BOUND_BY_MYC parasitic helminthiasis infectious disease DOID_883 0.04625288 0.08685771 1.000 1.000 FERNANDEZ_BOUND_BY_MYC polycystic kidney disease DOID_898 0.04625288 0.086572 0.04625288 0.46171732 FERNANDEZ_BOUND_BY_MYC Zellweger syndrome DOID_905 0.04625288 0.08628816 0.04625288 0.45375668 FERNANDEZ_BOUND_BY_MYC idiopathic pulmonary fibrosis DOID_0050156 0.04947423 0.0919962 1.000 1.000 FERNANDEZ_BOUND_BY_MYC skeletal system cancer DOID_0060124 0.04947423 0.09169654 1.000 1.000 FERNANDEZ_BOUND_BY_MYC thalassemia DOID_10241 0.04947423 0.09139882 1.000 1.000 FERNANDEZ_BOUND_BY_MYC bone cancer DOID_184 0.04947423 0.09169654 1.000 1.000 FERNANDEZ_BOUND_BY_MYC skeletal muscle cancer DOID_4043 0.04947423 0.09110303 1.000 1.000 FERNANDEZ_BOUND_BY_MYC nutritional deficiency disease DOID_5113 0.04947423 0.09080915 1.000 1.000 FERNANDEZ_BOUND_BY_MYC oral submucous fibrosis DOID_5773 0.04947423 0.09051716 1.000 1.000 FERNANDEZ_BOUND_BY_MYC intermediate coronary syndrome DOID_8805 0.04947423 0.09022704 0.04947423 0.47713284 FERNANDEZ_BOUND_BY_MYC hyperhomocysteinemia DOID_9279 0.04947423 0.08993878 1.000 1.000 FERNANDEZ_BOUND_BY_MYC angiosarcoma DOID_0001816 0.05268479 0.09547021 1.000 1.000 FERNANDEZ_BOUND_BY_MYC silicosis DOID_10325 0.05268479 0.09516713 1.000 1.000 FERNANDEZ_BOUND_BY_MYC spastic diplegia DOID_10965 0.05268479 0.09486597 1.000 1.000 FERNANDEZ_BOUND_BY_MYC Fanconi's anemia DOID_13636 0.05268479 0.0945667 1.000 1.000 FERNANDEZ_BOUND_BY_MYC long QT syndrome DOID_2843 0.05268479 0.09426932 1.000 1.000 FERNANDEZ_BOUND_BY_MYC pituitary adenoma DOID_3829 0.05268479 0.09397381 1.000 1.000 FERNANDEZ_BOUND_BY_MYC tongue cancer DOID_8649 0.05268479 0.09368014 0.05268479 0.4914368 FERNANDEZ_BOUND_BY_MYC Barrett's esophagus DOID_9206 0.05268479 0.0933883 1.000 1.000 FERNANDEZ_BOUND_BY_MYC penile disease DOID_1529 0.05588459 0.09875258 1.000 1.000 FERNANDEZ_BOUND_BY_MYC basal cell carcinoma DOID_2513 0.05588459 0.09844684 1.000 1.000 FERNANDEZ_BOUND_BY_MYC juvenile rheumatoid arthritis DOID_676 0.05588459 0.09814299 1.000 1.000 FERNANDEZ_BOUND_BY_MYC urinary system benign neoplasm DOID_731 0.05588459 0.09784102 1.000 1.000 FERNANDEZ_BOUND_BY_MYC peroxisomal disease DOID_906 0.05588459 0.09754089 0.05588459 0.49684891 HORIUCHI_WTAP_TARGETS_UP vascular skin disease DOID_9540 1.253E-09 7.128E-07 4.955E-05 4.699E-03 HORIUCHI_WTAP_TARGETS_UP pancreatitis DOID_4989 1.259E-09 3.583E-07 1.83E-05 2.603E-03 HORIUCHI_WTAP_TARGETS_UP pleural disease DOID_1532 5.546E-09 1.052E-06 0.13122747 0.35898285 HORIUCHI_WTAP_TARGETS_UP intracranial arterial disease DOID_13089 2.029E-08 2.886E-06 6.933E-04 0.01972309 HORIUCHI_WTAP_TARGETS_UP cerebral arterial disease DOID_3527 2.029E-08 2.886E-06 6.933E-04 0.01972309 HORIUCHI_WTAP_TARGETS_UP peripheral vascular disease DOID_341 2.289E-08 2.605E-06 2.42E-04 0.01059072 HORIUCHI_WTAP_TARGETS_UP bacterial pneumonia DOID_874 3.603E-08 3.417E-06 4.142E-03 0.04621704 HORIUCHI_WTAP_TARGETS_UP sarcoidosis DOID_11335 1.035E-07 8.414E-06 0.02134979 0.13204379 HORIUCHI_WTAP_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 1.377E-07 9.791E-06 2.752E-06 1.566E-03 HORIUCHI_WTAP_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 1.741E-07 1.101E-05 0.02504321 0.15159134 HORIUCHI_WTAP_TARGETS_UP viral pneumonia DOID_10533 2.41E-07 1.371E-05 0.05470096 0.23055442 HORIUCHI_WTAP_TARGETS_UP allergic rhinitis DOID_4481 2.457E-07 1.271E-05 8.236E-03 0.07438853 HORIUCHI_WTAP_TARGETS_UP respiratory failure DOID_11162 2.556E-07 1.212E-05 2.301E-03 0.03193025 HORIUCHI_WTAP_TARGETS_UP brain infarction DOID_3454 4.346E-07 1.902E-05 0.03313792 0.18855476 HORIUCHI_WTAP_TARGETS_UP pulmonary sarcoidosis DOID_13406 5.698E-07 2.316E-05 0.01127348 0.09296534 HORIUCHI_WTAP_TARGETS_UP adult respiratory distress syndrome DOID_11394 8.256E-07 3.132E-05 0.01294947 0.10093489 HORIUCHI_WTAP_TARGETS_UP pulmonary emphysema DOID_9675 9.284E-07 3.302E-05 0.01353078 0.10265355 HORIUCHI_WTAP_TARGETS_UP brain edema DOID_4724 1.145E-06 3.831E-05 6.852E-05 5.569E-03 HORIUCHI_WTAP_TARGETS_UP influenza DOID_8469 1.299E-06 4.105E-05 9.003E-04 0.02048996 HORIUCHI_WTAP_TARGETS_UP vasculitis DOID_865 3.432E-06 1.028E-04 1.578E-03 0.02720287 HORIUCHI_WTAP_TARGETS_UP urticaria DOID_1555 3.467E-06 9.862E-05 1.535E-04 7.942E-03 HORIUCHI_WTAP_TARGETS_UP middle cerebral artery infarction DOID_3525 4.718E-06 1.278E-04 0.10642834 0.31705615 HORIUCHI_WTAP_TARGETS_UP carotid artery disease DOID_3407 6.111E-06 1.58E-04 0.02737496 0.16396161 HORIUCHI_WTAP_TARGETS_UP collagen disease DOID_854 6.111E-06 1.512E-04 1.309E-04 8.275E-03 HORIUCHI_WTAP_TARGETS_UP pleurisy DOID_10247 6.276E-06 1.488E-04 0.1135847 0.32806951 HORIUCHI_WTAP_TARGETS_UP male reproductive system disease DOID_48 1.25E-05 2.845E-04 3.326E-03 0.03862263 HORIUCHI_WTAP_TARGETS_UP metal metabolism disorder DOID_896 1.324E-05 2.897E-04 1.324E-05 3.767E-03 HORIUCHI_WTAP_TARGETS_UP osteopetrosis DOID_13533 1.354E-05 2.853E-04 1.354E-05 2.568E-03 HORIUCHI_WTAP_TARGETS_UP cystic fibrosis DOID_1485 1.617E-05 3.287E-04 0.03932858 0.21111287 HORIUCHI_WTAP_TARGETS_UP Legionnaires' disease DOID_10457 2.227E-05 4.369E-04 1.408E-03 0.02670496 HORIUCHI_WTAP_TARGETS_UP legionellosis DOID_10458 2.227E-05 4.369E-04 1.408E-03 0.02670496 HORIUCHI_WTAP_TARGETS_UP hepatitis DOID_2237 2.469E-05 4.683E-04 0.15534276 0.40360746 HORIUCHI_WTAP_TARGETS_UP lymphatic system disease DOID_75 2.714E-05 4.981E-04 0.01294947 0.0995709 HORIUCHI_WTAP_TARGETS_UP hyperhomocysteinemia DOID_9279 2.775E-05 4.935E-04 1.62E-03 0.02634209 HORIUCHI_WTAP_TARGETS_UP primary bacterial infectious disease DOID_0050338 3.069E-05 5.292E-04 0.0498544 0.22693723 HORIUCHI_WTAP_TARGETS_UP amino acid metabolic disorder DOID_9252 3.417E-05 5.718E-04 5.932E-03 0.05921979 HORIUCHI_WTAP_TARGETS_UP cerebral infarction DOID_3526 4.213E-05 6.849E-04 0.17548295 0.44181326 HORIUCHI_WTAP_TARGETS_UP osteosclerosis DOID_4254 4.933E-05 7.797E-04 4.933E-05 5.614E-03 HORIUCHI_WTAP_TARGETS_UP ulcerative colitis DOID_8577 5.374E-05 8.264E-04 7.224E-04 0.01868461 HORIUCHI_WTAP_TARGETS_UP pulmonary tuberculosis DOID_2957 5.789E-05 8.668E-04 0.01857506 0.12148514 HORIUCHI_WTAP_TARGETS_UP aortic aneurysm DOID_3627 6.242E-05 9.107E-04 0.01925337 0.12449056 HORIUCHI_WTAP_TARGETS_UP Kawasaki disease DOID_13378 7.97E-05 1.134E-03 0.0809261 0.28249664 HORIUCHI_WTAP_TARGETS_UP lymphadenitis DOID_1602 7.97E-05 1.134E-03 0.0809261 0.28249664 HORIUCHI_WTAP_TARGETS_UP lymph node disease DOID_9942 7.97E-05 1.134E-03 0.0809261 0.28249664 HORIUCHI_WTAP_TARGETS_UP familial hyperlipidemia DOID_1168 9.522E-05 1.321E-03 9.522E-05 6.773E-03 HORIUCHI_WTAP_TARGETS_UP uremia DOID_4676 1.055E-04 1.429E-03 0.08828534 0.28705349 HORIUCHI_WTAP_TARGETS_UP polyarteritis nodosa DOID_9810 1.055E-04 1.396E-03 0.08828534 0.2854225 HORIUCHI_WTAP_TARGETS_UP sphingolipidosis DOID_1927 1.362E-04 1.762E-03 1.362E-04 7.751E-03 HORIUCHI_WTAP_TARGETS_UP acute pancreatitis DOID_2913 1.362E-04 1.722E-03 0.09558604 0.30215811 HORIUCHI_WTAP_TARGETS_UP endocrine pancreas disease DOID_1428 1.564E-04 1.935E-03 0.02979059 0.17475101 HORIUCHI_WTAP_TARGETS_UP cholestasis DOID_13580 1.657E-04 2.006E-03 0.03061404 0.17774888 HORIUCHI_WTAP_TARGETS_UP cerebral degeneration DOID_1443 1.657E-04 1.964E-03 0.03061404 0.17595344 HORIUCHI_WTAP_TARGETS_UP vitiligo DOID_12306 1.923E-04 2.233E-03 1.923E-04 9.119E-03 HORIUCHI_WTAP_TARGETS_UP tuberculosis DOID_399 1.958E-04 2.229E-03 0.03313792 0.18668789 HORIUCHI_WTAP_TARGETS_UP nephrosis DOID_2527 2.298E-04 2.564E-03 3.326E-03 0.03942727 HORIUCHI_WTAP_TARGETS_UP bile duct disease DOID_4138 2.298E-04 2.514E-03 0.03574034 0.19743935 HORIUCHI_WTAP_TARGETS_UP autoimmune disease of the nervous system DOID_438 2.369E-04 2.544E-03 6.454E-03 0.06331271 HORIUCHI_WTAP_TARGETS_UP biliary tract disease DOID_9741 2.42E-04 2.55E-03 0.03662488 0.20038037 HORIUCHI_WTAP_TARGETS_UP autoimmune disease of endocrine system DOID_0060005 2.616E-04 2.706E-03 2.616E-04 0.01063041 HORIUCHI_WTAP_TARGETS_UP focal glomerulosclerosis DOID_3945 2.616E-04 2.658E-03 2.616E-04 9.922E-03 HORIUCHI_WTAP_TARGETS_UP aneurysm disease DOID_2403 2.954E-04 2.949E-03 0.04024624 0.20818283 HORIUCHI_WTAP_TARGETS_UP age related macular degeneration DOID_10871 3.156E-04 3.096E-03 7.772E-03 0.07249761 HORIUCHI_WTAP_TARGETS_UP degeneration of macula and posterior pole DOID_2007 3.156E-04 3.096E-03 7.772E-03 0.07249761 HORIUCHI_WTAP_TARGETS_UP metabolic syndrome X DOID_14221 3.407E-04 3.286E-03 0.04304738 0.21869606 HORIUCHI_WTAP_TARGETS_UP contact dermatitis DOID_2773 3.407E-04 3.231E-03 4.439E-03 0.04857558 HORIUCHI_WTAP_TARGETS_UP lipid metabolism disorder DOID_3146 3.407E-04 3.178E-03 3.407E-04 0.01211673 HORIUCHI_WTAP_TARGETS_UP chronic kidney failure DOID_784 3.908E-04 3.586E-03 0.04591913 0.21593376 HORIUCHI_WTAP_TARGETS_UP macular degeneration DOID_4448 4.442E-04 4.012E-03 9.702E-03 0.08492564 HORIUCHI_WTAP_TARGETS_UP hyperthyroidism DOID_7998 4.442E-04 3.949E-03 9.702E-03 0.08363889 HORIUCHI_WTAP_TARGETS_UP primary immunodeficiency disease DOID_612 5.063E-04 4.432E-03 5.063E-04 0.01694661 HORIUCHI_WTAP_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 5.277E-04 4.549E-03 0.05288293 0.22455514 HORIUCHI_WTAP_TARGETS_UP embryonal cancer DOID_688 5.599E-04 4.755E-03 5.599E-04 0.01769943 HORIUCHI_WTAP_TARGETS_UP lymphoblastic leukemia DOID_1037 5.957E-04 4.984E-03 5.957E-04 0.01783872 HORIUCHI_WTAP_TARGETS_UP encephalomyelitis DOID_640 5.957E-04 4.912E-03 6.681E-03 0.06443258 HORIUCHI_WTAP_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.196E-04 5.037E-03 6.877E-03 0.06521297 HORIUCHI_WTAP_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 6.468E-04 5.183E-03 0.15534276 0.40545887 HORIUCHI_WTAP_TARGETS_UP congenital diaphragmatic hernia DOID_3827 6.468E-04 5.111E-03 0.01237941 0.09920965 HORIUCHI_WTAP_TARGETS_UP systemic scleroderma DOID_418 6.468E-04 5.041E-03 0.01237941 0.09783173 HORIUCHI_WTAP_TARGETS_UP acute kidney failure DOID_3021 7.036E-04 5.41E-03 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP Paget's disease of bone DOID_5408 7.036E-04 5.338E-03 7.036E-04 0.01906514 HORIUCHI_WTAP_TARGETS_UP rheumatic disease DOID_1575 8.453E-04 6.328E-03 0.01472681 0.10607031 HORIUCHI_WTAP_TARGETS_UP hyperinsulinism DOID_2018 8.453E-04 6.246E-03 0.01472681 0.10474444 HORIUCHI_WTAP_TARGETS_UP scleroderma DOID_419 8.453E-04 6.328E-03 0.01472681 0.10607031 HORIUCHI_WTAP_TARGETS_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 8.577E-04 6.257E-03 8.577E-04 0.0212196 HORIUCHI_WTAP_TARGETS_UP adrenoleukodystrophy DOID_10588 8.577E-04 6.178E-03 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP temporal arteritis DOID_13375 8.577E-04 6.101E-03 0.0432353 0.21579722 HORIUCHI_WTAP_TARGETS_UP neuronal ceroid lipofuscinosis DOID_14503 8.577E-04 6.025E-03 0.0432353 0.21392073 HORIUCHI_WTAP_TARGETS_UP hemochromatosis DOID_2352 8.577E-04 5.952E-03 8.577E-04 0.02033545 HORIUCHI_WTAP_TARGETS_UP central nervous system vasculitis DOID_525 8.577E-04 6.101E-03 0.0432353 0.21579722 HORIUCHI_WTAP_TARGETS_UP leukodystrophy DOID_10579 1.017E-03 6.971E-03 0.17879295 0.44424973 HORIUCHI_WTAP_TARGETS_UP common cold DOID_10459 1.027E-03 6.954E-03 1.027E-03 0.02246617 HORIUCHI_WTAP_TARGETS_UP progressive myoclonus epilepsy DOID_891 1.027E-03 6.872E-03 1.027E-03 0.02163409 HORIUCHI_WTAP_TARGETS_UP heart valve disease DOID_4079 1.079E-03 7.137E-03 0.01724971 0.11825404 HORIUCHI_WTAP_TARGETS_UP hemolytic anemia DOID_583 1.143E-03 7.474E-03 0.01790714 0.12129954 HORIUCHI_WTAP_TARGETS_UP normocytic anemia DOID_720 1.143E-03 7.474E-03 0.01790714 0.12129954 HORIUCHI_WTAP_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.209E-03 7.818E-03 0.01857506 0.12434361 HORIUCHI_WTAP_TARGETS_UP glaucoma DOID_1686 1.209E-03 7.731E-03 0.01857506 0.12289775 HORIUCHI_WTAP_TARGETS_UP variable age at onset electroclinical syndrome DOID_0050706 1.21E-03 7.65E-03 1.21E-03 0.0245896 HORIUCHI_WTAP_TARGETS_UP Hirschsprung's disease DOID_10487 1.21E-03 7.566E-03 1.21E-03 0.02374169 HORIUCHI_WTAP_TARGETS_UP newborn respiratory distress syndrome DOID_12716 1.21E-03 7.484E-03 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP megacolon DOID_11372 1.408E-03 8.615E-03 1.408E-03 0.02584351 HORIUCHI_WTAP_TARGETS_UP giant cell tumor DOID_200 1.499E-03 9.074E-03 1.499E-03 0.02665431 HORIUCHI_WTAP_TARGETS_UP malignant giant cell tumor DOID_2705 1.499E-03 9.074E-03 1.499E-03 0.02665431 HORIUCHI_WTAP_TARGETS_UP giant cell glioblastoma DOID_3074 1.499E-03 9.074E-03 1.499E-03 0.02665431 HORIUCHI_WTAP_TARGETS_UP bone marrow cancer DOID_4960 1.578E-03 9.449E-03 0.2048021 0.48963191 HORIUCHI_WTAP_TARGETS_UP thoracic aortic aneurysm DOID_14004 1.62E-03 9.604E-03 1.62E-03 0.02711685 HORIUCHI_WTAP_TARGETS_UP pustulosis of palm and sole DOID_4398 1.659E-03 9.731E-03 1.659E-03 0.02621934 HORIUCHI_WTAP_TARGETS_UP hemolytic-uremic syndrome DOID_12554 1.847E-03 0.01072362 1.847E-03 0.02840311 HORIUCHI_WTAP_TARGETS_UP glioblastoma DOID_3068 1.918E-03 0.01102361 1.918E-03 0.02871939 HORIUCHI_WTAP_TARGETS_UP Graves' disease DOID_12361 2.088E-03 0.01187909 2.088E-03 0.03045921 HORIUCHI_WTAP_TARGETS_UP hyperostosis DOID_205 2.088E-03 0.01176148 2.088E-03 0.02969773 HORIUCHI_WTAP_TARGETS_UP bronchitis DOID_6132 2.088E-03 0.01164617 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP prion disease DOID_649 2.343E-03 0.01294067 2.343E-03 0.03173545 HORIUCHI_WTAP_TARGETS_UP congenital heart defect DOID_1682 2.403E-03 0.01314887 2.403E-03 0.03180192 HORIUCHI_WTAP_TARGETS_UP mineral metabolism disease DOID_0050032 2.509E-03 0.01359439 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP MHC class II deficiency DOID_5812 2.611E-03 0.01401688 2.611E-03 0.03376794 HORIUCHI_WTAP_TARGETS_UP allergic contact dermatitis DOID_3042 2.842E-03 0.01511082 2.842E-03 0.03593017 HORIUCHI_WTAP_TARGETS_UP colonic disease DOID_5353 2.894E-03 0.01524579 2.894E-03 0.03579447 HORIUCHI_WTAP_TARGETS_UP astrocytoma DOID_3069 3.078E-03 0.01606738 3.078E-03 0.03726266 HORIUCHI_WTAP_TARGETS_UP autoimmune hepatitis DOID_2048 3.19E-03 0.01650084 0.0809261 0.28077409 HORIUCHI_WTAP_TARGETS_UP coronary restenosis DOID_4247 3.19E-03 0.01635218 0.0809261 0.27907243 HORIUCHI_WTAP_TARGETS_UP acquired immunodeficiency syndrome DOID_635 3.5E-03 0.01778005 0.08461307 0.28320492 HORIUCHI_WTAP_TARGETS_UP diabetic retinopathy DOID_8947 3.586E-03 0.0180571 0.26334027 0.60176954 HORIUCHI_WTAP_TARGETS_UP sinusitis DOID_0050127 3.823E-03 0.0190816 0.08828534 0.29376819 HORIUCHI_WTAP_TARGETS_UP paranasal sinus disease DOID_1352 3.823E-03 0.0190816 0.08828534 0.29376819 HORIUCHI_WTAP_TARGETS_UP myasthenia gravis DOID_437 3.823E-03 0.01891568 0.08828534 0.28870322 HORIUCHI_WTAP_TARGETS_UP electroclinical syndrome DOID_0050701 4.142E-03 0.02031956 4.142E-03 0.04714138 HORIUCHI_WTAP_TARGETS_UP diabetic angiopathy DOID_11713 4.16E-03 0.02022939 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP Lewy body dementia DOID_12217 4.16E-03 0.02005796 0.09194298 0.29390763 HORIUCHI_WTAP_TARGETS_UP severe combined immunodeficiency DOID_627 4.51E-03 0.02156228 4.51E-03 0.04841342 HORIUCHI_WTAP_TARGETS_UP commensal bacterial infectious disease DOID_0050339 4.873E-03 0.02310381 0.09921459 0.31189558 HORIUCHI_WTAP_TARGETS_UP portal hypertension DOID_10762 4.873E-03 0.02291287 0.09921459 0.31018187 HORIUCHI_WTAP_TARGETS_UP combined T cell and B cell immunodeficiency DOID_628 4.873E-03 0.02272506 4.873E-03 0.0513418 HORIUCHI_WTAP_TARGETS_UP mental depression DOID_1596 4.908E-03 0.02270457 0.04591913 0.2195629 HORIUCHI_WTAP_TARGETS_UP focal epilepsy DOID_2234 4.908E-03 0.02252147 0.04591913 0.21773321 HORIUCHI_WTAP_TARGETS_UP retinal vascular disease DOID_2462 5.236E-03 0.02383653 0.29525268 0.6614125 HORIUCHI_WTAP_TARGETS_UP spinal muscular atrophy DOID_12377 5.249E-03 0.0237017 5.249E-03 0.05429845 HORIUCHI_WTAP_TARGETS_UP neuromuscular junction disease DOID_439 5.249E-03 0.02351508 0.10282867 0.31288508 HORIUCHI_WTAP_TARGETS_UP cleft lip DOID_9296 5.249E-03 0.02333136 5.249E-03 0.05332883 HORIUCHI_WTAP_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 6.039E-03 0.02663811 0.11001366 0.32603008 HORIUCHI_WTAP_TARGETS_UP gestational diabetes DOID_11714 6.039E-03 0.0264332 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP perinatal necrotizing enterocolitis DOID_8677 6.039E-03 0.02623142 0.11001366 0.32101423 HORIUCHI_WTAP_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 6.454E-03 0.02781922 0.1135847 0.32974333 HORIUCHI_WTAP_TARGETS_UP renal hypertension DOID_1073 6.454E-03 0.02761006 0.1135847 0.32641259 HORIUCHI_WTAP_TARGETS_UP secondary hypertension DOID_11130 6.454E-03 0.02761006 0.1135847 0.32641259 HORIUCHI_WTAP_TARGETS_UP Behcet's disease DOID_13241 6.454E-03 0.02781922 0.1135847 0.32974333 HORIUCHI_WTAP_TARGETS_UP hepatic vascular disease DOID_272 6.454E-03 0.02740401 0.1135847 0.32314847 HORIUCHI_WTAP_TARGETS_UP coronary stenosis DOID_4248 6.454E-03 0.02720102 0.1135847 0.32154076 HORIUCHI_WTAP_TARGETS_UP Crohn's disease DOID_8778 6.877E-03 0.02877043 0.32033835 0.70648263 HORIUCHI_WTAP_TARGETS_UP dilated cardiomyopathy DOID_12930 7.075E-03 0.02938653 0.32307029 0.70975674 HORIUCHI_WTAP_TARGETS_UP opportunistic mycosis DOID_2473 7.772E-03 0.03204605 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP bronchiolitis obliterans DOID_2799 7.772E-03 0.0318155 0.12421262 0.34309214 HORIUCHI_WTAP_TARGETS_UP abdominal aortic aneurysm DOID_7693 7.772E-03 0.03158824 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 8.236E-03 0.03323743 8.236E-03 0.07558834 HORIUCHI_WTAP_TARGETS_UP chronic leukemia DOID_1036 8.713E-03 0.03491216 8.713E-03 0.07746135 HORIUCHI_WTAP_TARGETS_UP chronic lymphocytic leukemia DOID_1040 8.713E-03 0.03491216 8.713E-03 0.07746135 HORIUCHI_WTAP_TARGETS_UP systemic mycosis DOID_0050136 9.201E-03 0.03661148 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP fungal infectious disease DOID_1564 9.201E-03 0.03661148 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP papilloma DOID_2615 9.201E-03 0.03635724 0.13471394 0.36328072 HORIUCHI_WTAP_TARGETS_UP periodontal disease DOID_3388 9.702E-03 0.03807011 0.13818651 0.36742113 HORIUCHI_WTAP_TARGETS_UP esophageal disease DOID_6050 9.702E-03 0.03780936 0.13818651 0.3657122 HORIUCHI_WTAP_TARGETS_UP lymphoid leukemia DOID_10747 0.01021378 0.03953497 0.01021378 0.08674091 HORIUCHI_WTAP_TARGETS_UP adenoma DOID_657 0.0107378 0.04128248 0.0107378 0.08985011 HORIUCHI_WTAP_TARGETS_UP multiple myeloma DOID_9538 0.01127348 0.04305106 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP microcephaly DOID_10907 0.01182071 0.04483991 0.01182071 0.09608552 HORIUCHI_WTAP_TARGETS_UP uveitis DOID_13141 0.01182071 0.04454296 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 0.01412326 0.05286933 0.16547321 0.42603736 HORIUCHI_WTAP_TARGETS_UP primary biliary cirrhosis DOID_12236 0.01412326 0.05286933 0.16547321 0.42603736 HORIUCHI_WTAP_TARGETS_UP spinocerebellar ataxia DOID_1441 0.01412326 0.05252378 0.01412326 0.10573865 HORIUCHI_WTAP_TARGETS_UP nephrotic syndrome DOID_1184 0.01472681 0.05441269 0.01472681 0.10882539 HORIUCHI_WTAP_TARGETS_UP Huntington's disease DOID_12858 0.01472681 0.05406164 0.01472681 0.10743019 HORIUCHI_WTAP_TARGETS_UP uveal disease DOID_3480 0.01472681 0.0537151 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP cataract DOID_83 0.01596671 0.0578666 0.17548295 0.43986695 HORIUCHI_WTAP_TARGETS_UP learning disability DOID_8927 0.01596671 0.05750036 0.17548295 0.43793771 HORIUCHI_WTAP_TARGETS_UP spinocerebellar degeneration DOID_2478 0.01660287 0.0594153 0.01660287 0.11663003 HORIUCHI_WTAP_TARGETS_UP myeloma DOID_0070004 0.01724971 0.06134428 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP pre-eclampsia DOID_10591 0.01724971 0.06096326 0.18208975 0.45047421 HORIUCHI_WTAP_TARGETS_UP lens disease DOID_110 0.01724971 0.06058694 0.18208975 0.4485241 HORIUCHI_WTAP_TARGETS_UP brain cancer DOID_1319 0.01724971 0.06021525 0.18208975 0.44467411 HORIUCHI_WTAP_TARGETS_UP neuritis DOID_1803 0.01724971 0.05984808 0.01724971 0.11969616 HORIUCHI_WTAP_TARGETS_UP thyroid adenoma DOID_2891 0.01724971 0.05948536 0.18208975 0.44277379 HORIUCHI_WTAP_TARGETS_UP central nervous system cancer DOID_3620 0.01790714 0.06138049 0.1853734 0.44884028 HORIUCHI_WTAP_TARGETS_UP integumentary system benign neoplasm DOID_0060121 0.01857506 0.06328866 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP skin benign neoplasm DOID_3165 0.01857506 0.06328866 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP movement disease DOID_480 0.01925337 0.06520934 0.01925337 0.12309179 HORIUCHI_WTAP_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 0.019942 0.06714198 0.19514599 0.46851505 HORIUCHI_WTAP_TARGETS_UP orofacial cleft DOID_0050567 0.02064083 0.06908607 0.02064083 0.13049592 HORIUCHI_WTAP_TARGETS_UP atopic dermatitis DOID_3310 0.02064083 0.06868206 0.02064083 0.1290619 HORIUCHI_WTAP_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 0.0227977 0.07541797 0.20799516 0.49518513 HORIUCHI_WTAP_TARGETS_UP integumentary system cancer DOID_0060122 0.0227977 0.07498202 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP parasitic protozoa infectious disease DOID_2789 0.0227977 0.07455109 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP skin cancer DOID_4159 0.0227977 0.07498202 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP congenital nervous system abnormality DOID_2490 0.02428501 0.07896096 0.02428501 0.14858245 HORIUCHI_WTAP_TARGETS_UP oral cavity cancer DOID_8618 0.02504321 0.08096356 0.21749811 0.51351215 HORIUCHI_WTAP_TARGETS_UP leukocyte disease DOID_9500 0.025811 0.08297433 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP pre-malignant neoplasm DOID_0060071 0.02897621 0.09262619 0.02897621 0.17174439 HORIUCHI_WTAP_TARGETS_UP in situ carcinoma DOID_8719 0.02897621 0.09262619 0.02897621 0.17174439 HORIUCHI_WTAP_TARGETS_UP parasitic infectious disease DOID_1398 0.03061404 0.09731503 1.000 1.000 HORIUCHI_WTAP_TARGETS_UP temporal lobe epilepsy DOID_3328 0.03144647 0.09940578 0.24228915 0.56501035 HORIUCHI_WTAP_TARGETS_UP hyperglycemia DOID_4195 0.03144647 0.09885658 0.24228915 0.56270419 NOJIMA_SFRP2_TARGETS_UP pancreatic ductal carcinoma DOID_3587 1.18E-05 6.714E-03 9.013E-04 0.1709499 NOJIMA_SFRP2_TARGETS_UP pancreatic carcinoma DOID_4905 1.332E-05 3.79E-03 9.764E-04 0.13888946 NOJIMA_SFRP2_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 2.364E-05 4.485E-03 1.426E-03 0.11588428 NOJIMA_SFRP2_TARGETS_UP myositis DOID_633 1.224E-04 0.01741734 1.224E-04 0.06966934 NOJIMA_SFRP2_TARGETS_UP perinatal necrotizing enterocolitis DOID_8677 1.415E-04 0.01610534 0.01745161 0.32032144 NOJIMA_SFRP2_TARGETS_UP adenoma DOID_657 2.573E-04 0.02440496 0.02340157 0.34142287 NOJIMA_SFRP2_TARGETS_UP pustulosis of palm and sole DOID_4398 5.701E-04 0.04633848 0.03461168 0.38615772 NOJIMA_SFRP2_TARGETS_UP allergic contact dermatitis DOID_3042 8.292E-04 0.05897559 8.292E-04 0.23590234 NOJIMA_SFRP2_TARGETS_UP mixed glioma DOID_5076 1.081E-03 0.06834215 1.081E-03 0.12301586 NOJIMA_SFRP2_TARGETS_UP contact dermatitis DOID_2773 1.135E-03 0.06459409 1.135E-03 0.10765681 NOJIMA_SFRP2_TARGETS_UP lymphoblastic leukemia DOID_1037 1.519E-03 0.07857276 0.05608966 0.50658753 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY nervous system cancer DOID_3093 6.273E-16 3.569E-13 1.553E-03 0.11044239 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY endometrial carcinoma DOID_2871 2.928E-14 8.33E-12 1.883E-04 0.0357152 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY endometrial cancer DOID_1380 4.342E-14 8.235E-12 2.128E-04 0.0302733 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY transitional cell carcinoma DOID_2671 1.121E-13 1.595E-11 1.487E-03 0.12085547 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY peripheral nervous system neoplasm DOID_1192 1.448E-13 1.647E-11 0.02564295 0.54040136 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY uterine cancer DOID_363 3.448E-13 3.27E-11 4.08E-04 0.03869448 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY germinoma DOID_3304 1.791E-11 1.456E-09 2.128E-04 0.02421864 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY breast benign neoplasm DOID_0060082 4.063E-11 2.89E-09 2.105E-05 0.01197795 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY thoracic benign neoplasm DOID_0060097 4.063E-11 2.89E-09 2.105E-05 0.01197795 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY benign breast phyllodes tumor DOID_1631 4.063E-11 2.89E-09 2.105E-05 0.01197795 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY bile duct adenocarcinoma DOID_4896 2.669E-10 1.688E-08 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY cholangiocarcinoma DOID_4947 2.669E-10 1.688E-08 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY bile duct cancer DOID_4606 3.786E-10 2.154E-08 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY bile duct carcinoma DOID_4897 3.786E-10 2.154E-08 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY astrocytoma DOID_3069 8.863E-10 4.585E-08 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY biliary tract cancer DOID_4607 2.067E-09 9.799E-08 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY seminoma DOID_4440 2.503E-09 1.095E-07 1.437E-04 0.04089086 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY sarcoma DOID_1115 3.347E-09 1.36E-07 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY autonomic nervous system neoplasm DOID_2621 6.381E-09 2.421E-07 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY neuroblastoma DOID_769 6.381E-09 2.421E-07 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY benign mesothelioma DOID_2645 1.648E-08 5.861E-07 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY rectal neoplasm DOID_1984 2.667E-08 8.927E-07 6.313E-03 0.39914463 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY rectum cancer DOID_1993 2.667E-08 8.927E-07 6.313E-03 0.39914463 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY brain cancer DOID_1319 2.789E-08 8.816E-07 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY central nervous system cancer DOID_3620 3.025E-08 9.059E-07 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY bone marrow cancer DOID_4960 4.77E-08 1.357E-06 0.035478 0.56074946 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY mesenchymal cell neoplasm DOID_3350 1.009E-07 2.734E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY spindle cell sarcoma DOID_4235 1.009E-07 2.734E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY epithelioid sarcoma DOID_6193 1.009E-07 2.734E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY endocrine organ benign neoplasm DOID_0060089 1.166E-07 3.016E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY angiosarcoma DOID_0001816 1.241E-07 3.071E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY mixed glioma DOID_5076 1.891E-07 4.484E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY colon carcinoma DOID_1520 2.523E-07 5.743E-06 0.01258851 0.44767894 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY subependymal glioma DOID_4843 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY pilocytic astrocytoma DOID_4851 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY subependymal giant cell astrocytoma DOID_5077 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY fibrillary astrocytoma DOID_6726 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY juvenile pilocytic astrocytoma DOID_6811 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY childhood pilocytic astrocytoma DOID_6812 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY gemistocytic astrocytoma DOID_7005 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY childhood cerebral astrocytoma DOID_7007 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY protoplasmic astrocytoma DOID_7008 2.523E-07 5.522E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY benign glioma DOID_0060101 3.406E-07 7.177E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY benign ependymoma DOID_4844 3.406E-07 7.177E-06 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY lymphoma DOID_0060058 3.625E-07 7.367E-06 0.05785849 0.71568439 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY lymphoblastic leukemia DOID_1037 3.783E-07 7.422E-06 0.05845641 0.70769566 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY papillary adenoma DOID_3172 6.455E-07 1.224E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY microcystic adenoma DOID_5403 6.455E-07 1.224E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY follicular adenoma DOID_6204 6.455E-07 1.224E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY supratentorial cancer DOID_1659 9.903E-07 1.818E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY cerebrum cancer DOID_368 9.903E-07 1.818E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY chronic leukemia DOID_1036 1.44E-06 2.56E-05 0.02193008 0.5671917 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY chronic lymphocytic leukemia DOID_1040 1.44E-06 2.56E-05 0.02193008 0.5671917 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY papilloma DOID_2615 1.57E-06 2.707E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY thyroid carcinoma DOID_3963 1.708E-06 2.858E-05 0.02316921 0.57318607 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY spindle cell carcinoma DOID_4015 1.708E-06 2.776E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY thyroid cancer DOID_1781 2.007E-06 3.172E-05 0.02440683 0.57864523 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY adenoma DOID_657 2.007E-06 3.086E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY embryonal cancer DOID_688 2.169E-06 3.247E-05 0.02502508 0.54766415 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY thyroid adenoma DOID_2891 4.284E-06 6.251E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY lung small cell carcinoma DOID_5409 4.827E-06 6.866E-05 0.03241481 0.54247138 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY reproductive organ benign neoplasm DOID_0050622 6.722E-06 9.329E-05 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY pre-malignant neoplasm DOID_0060071 9.936E-06 1.346E-04 0.04096833 0.59771745 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY in situ carcinoma DOID_8719 9.936E-06 1.346E-04 0.04096833 0.59771745 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY pancreatic carcinoma DOID_4905 1.52E-05 2.012E-04 0.04703357 0.63719293 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY Noonan syndrome DOID_3490 1.723E-05 2.228E-04 6.313E-03 0.35923016 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY vulva cancer DOID_1245 2.983E-05 3.772E-04 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY alcohol-related neurodevelopmental disorder DOID_0050667 3.064E-05 3.79E-04 0.05905396 0.70003549 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY tongue cancer DOID_8649 4.584E-05 5.55E-04 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY male reproductive organ benign neoplasm DOID_0060087 5.84E-05 6.923E-04 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY osteosarcoma DOID_3347 1.237E-04 1.436E-03 0.01633535 0.48920089 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY medullomyoblastoma DOID_3861 2.663E-04 3.03E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY adult medulloblastoma DOID_3864 2.663E-04 3.03E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY childhood medulloblastoma DOID_3869 2.663E-04 3.03E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY refractive error DOID_9835 2.806E-04 3.13E-03 0.02440683 0.55549942 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY medulloblastoma DOID_3858 2.952E-04 3.23E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY multiple myeloma DOID_9538 2.952E-04 3.169E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY cervix uteri carcinoma in situ DOID_8991 3.575E-04 3.767E-03 0.02749431 0.55872364 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY primitive neuroectodermal tumor DOID_168 3.908E-04 4.043E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY myeloma DOID_0070004 4.618E-04 4.693E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY integumentary system benign neoplasm DOID_0060121 4.995E-04 4.987E-03 0.03241481 0.55890991 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY glaucoma DOID_1686 4.995E-04 4.901E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY skin benign neoplasm DOID_3165 4.995E-04 4.987E-03 0.03241481 0.55890991 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY B-cell lymphocytic neoplasm DOID_707 5.387E-04 5.195E-03 0.0336412 0.54690983 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY giant cell tumor DOID_200 5.793E-04 5.493E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY malignant giant cell tumor DOID_2705 5.793E-04 5.493E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY giant cell glioblastoma DOID_3074 5.793E-04 5.493E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY integumentary system cancer DOID_0060122 6.213E-04 5.795E-03 0.03608952 0.55499828 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY skin cancer DOID_4159 6.213E-04 5.795E-03 0.03608952 0.55499828 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY hypersensitivity reaction type IV disease DOID_2916 6.87E-04 6.305E-03 0.03792185 0.56782987 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY glioblastoma DOID_3068 6.87E-04 6.205E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY oral cavity cancer DOID_8618 6.87E-04 6.108E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY neuroectodermal tumor DOID_171 7.56E-04 6.618E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY uterine disease DOID_345 8.529E-04 7.353E-03 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY female reproductive system disease DOID_229 1.267E-03 0.01075778 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY focal epilepsy DOID_2234 1.328E-03 0.01111116 0.05246085 0.67841413 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY encephalomyelitis DOID_640 1.654E-03 0.01364257 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY dilated cardiomyopathy DOID_12930 1.724E-03 0.01401211 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY brachydactyly DOID_0050581 6.313E-03 0.0505958 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY chondrosarcoma DOID_3371 6.313E-03 0.04989308 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY familial adenomatous polyposis DOID_0050424 6.943E-03 0.05411416 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY intracranial arteriosclerosis DOID_13097 7.571E-03 0.05821823 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY aortic valve stenosis DOID_1712 7.571E-03 0.05744199 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY pituitary cancer DOID_1785 7.571E-03 0.05668617 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY pituitary carcinoma DOID_4916 7.571E-03 0.05668617 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY retinal detachment DOID_5327 7.571E-03 0.05594999 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY aortic valve insufficiency DOID_57 7.571E-03 0.05523268 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY vascular dementia DOID_8725 7.571E-03 0.05821823 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY Hirschsprung's disease DOID_10487 8.2E-03 0.05906009 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY polyneuropathy DOID_1389 8.2E-03 0.05832184 8.2E-03 0.42415882 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY impotence DOID_1875 8.2E-03 0.05760182 8.2E-03 0.38881225 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY larynx cancer DOID_2596 8.2E-03 0.05689935 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY laryngeal benign neoplasm DOID_2598 8.2E-03 0.05689935 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY Leydig cell tumor DOID_2696 8.2E-03 0.05621382 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY Lynch syndrome DOID_3883 8.2E-03 0.05554461 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY sex cord-stromal neoplasm DOID_4757 8.2E-03 0.05621382 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY tethered spinal cord syndrome DOID_1089 8.828E-03 0.05909562 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY megacolon DOID_11372 8.828E-03 0.05840846 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY peripheral neuropathy DOID_0060053 9.456E-03 0.06184244 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY hemangioma DOID_255 9.456E-03 0.06113968 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY lung oat cell carcinoma DOID_5411 9.456E-03 0.06045272 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY pituitary adenoma DOID_3829 0.01008302 0.0637471 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY schizophreniform disorder DOID_11328 0.01070996 0.0669667 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY penile disease DOID_1529 0.01070996 0.0662388 0.01070996 0.46876691 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY basal cell carcinoma DOID_2513 0.01070996 0.06552656 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY schizoaffective disorder DOID_5418 0.01070996 0.0669667 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY keratosis DOID_161 0.01133653 0.06862217 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY sexual dysfunction DOID_1876 0.01133653 0.06789983 0.01133653 0.46074885 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY skin carcinoma DOID_3451 0.01133653 0.06719254 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY eosinophilia DOID_999 0.01133653 0.06649983 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY testicular cancer DOID_2998 0.01196271 0.06945696 0.01196271 0.45378544 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY granulosa cell tumor DOID_2999 0.01196271 0.06875537 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY infertility DOID_5223 0.01196271 0.06806782 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY sex cord-gonadal stromal tumor DOID_192 0.01258851 0.07091944 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY colonic disease DOID_5353 0.01258851 0.07022415 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY coronary restenosis DOID_4247 0.01321393 0.07299736 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY placenta disease DOID_780 0.01383898 0.07571517 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY sexual disorder DOID_0060043 0.01446364 0.07837915 0.01446364 0.48410653 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY muscle cancer DOID_4045 0.01446364 0.07763973 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY uremia DOID_4676 0.01446364 0.07691412 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY Lewy body dementia DOID_12217 0.01508792 0.079491 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY aortic valve disease DOID_62 0.01508792 0.07876173 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY sphingolipidosis DOID_1927 0.01571183 0.081273 0.01571183 0.49666836 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY myopia DOID_11830 0.01758127 0.09012382 0.01758127 0.50018719 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY spinal cord disease DOID_319 0.01758127 0.08931914 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY diffuse large B-cell lymphoma DOID_0050745 0.01820366 0.09166269 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY gestational diabetes DOID_11714 0.01820366 0.09085864 0.01820366 0.49323259 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY lung adenocarcinoma DOID_3910 0.01820366 0.09006856 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY periodontitis DOID_824 0.01820366 0.08929211 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY invasive ductal carcinoma DOID_3008 0.01882568 0.09155393 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY coronary stenosis DOID_4248 0.01882568 0.09077805 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY multiple epiphyseal dysplasia DOID_12721 0.01944731 0.09298757 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY age related macular degeneration DOID_10871 0.02068945 0.09810248 1.000 1.000 DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY degeneration of macula and posterior pole DOID_2007 0.02068945 0.09810248 1.000 1.000 KARAKAS_TGFB1_SIGNALING mouth disease DOID_403 5.158E-08 2.935E-05 7.003E-06 3.985E-03 KARAKAS_TGFB1_SIGNALING aortic valve insufficiency DOID_57 9.622E-06 2.737E-03 9.622E-06 2.737E-03 KARAKAS_TGFB1_SIGNALING carotid stenosis DOID_13001 1.137E-05 2.156E-03 5.132E-03 0.48670772 KARAKAS_TGFB1_SIGNALING oral submucous fibrosis DOID_5773 1.53E-05 2.176E-03 5.92E-03 0.30620649 KARAKAS_TGFB1_SIGNALING aortic valve disease DOID_62 4.013E-05 4.566E-03 4.013E-05 7.611E-03 KARAKAS_TGFB1_SIGNALING focal glomerulosclerosis DOID_3945 6.75E-05 6.401E-03 0.01219785 0.27762306 KARAKAS_TGFB1_SIGNALING abdominal aortic aneurysm DOID_7693 7.66E-05 6.227E-03 0.01298002 0.26377254 KARAKAS_TGFB1_SIGNALING periodontal disease DOID_3388 9.654E-05 6.866E-03 0.01454262 0.23642153 KARAKAS_TGFB1_SIGNALING cervix uteri carcinoma in situ DOID_8991 1.369E-04 8.655E-03 0.01727163 0.25198866 KARAKAS_TGFB1_SIGNALING endometriosis of uterus DOID_288 1.432E-04 8.15E-03 0.01766091 0.24509899 KARAKAS_TGFB1_SIGNALING endometriosis DOID_289 1.497E-04 7.744E-03 0.01805005 0.24453519 KARAKAS_TGFB1_SIGNALING diabetic autonomic neuropathy DOID_11503 1.563E-04 7.413E-03 0.01843904 0.24399571 KARAKAS_TGFB1_SIGNALING autonomic neuropathy DOID_11504 1.563E-04 7.413E-03 0.01843904 0.24399571 KARAKAS_TGFB1_SIGNALING diabetic polyneuropathy DOID_12785 1.563E-04 7.413E-03 0.01843904 0.24399571 KARAKAS_TGFB1_SIGNALING diabetic neuropathy DOID_9743 1.563E-04 7.413E-03 0.01843904 0.24399571 KARAKAS_TGFB1_SIGNALING autonomic nervous system disease DOID_11465 1.77E-04 7.749E-03 0.01960516 0.24250733 KARAKAS_TGFB1_SIGNALING heart valve disease DOID_4079 1.77E-04 7.195E-03 1.77E-04 0.02518392 KARAKAS_TGFB1_SIGNALING aortic aneurysm DOID_3627 1.99E-04 7.549E-03 0.02076999 0.24118618 KARAKAS_TGFB1_SIGNALING giant cell tumor DOID_200 2.223E-04 7.904E-03 0.02193352 0.24470928 KARAKAS_TGFB1_SIGNALING malignant giant cell tumor DOID_2705 2.223E-04 7.904E-03 0.02193352 0.24470928 KARAKAS_TGFB1_SIGNALING giant cell glioblastoma DOID_3074 2.223E-04 7.904E-03 0.02193352 0.24470928 KARAKAS_TGFB1_SIGNALING glioblastoma DOID_3068 2.638E-04 8.83E-03 0.02386988 0.25626339 KARAKAS_TGFB1_SIGNALING carotid artery disease DOID_3407 2.904E-04 9.181E-03 0.02502997 0.26374174 KARAKAS_TGFB1_SIGNALING pre-malignant neoplasm DOID_0060071 3.089E-04 9.25E-03 0.02580265 0.25757386 KARAKAS_TGFB1_SIGNALING in situ carcinoma DOID_8719 3.089E-04 9.25E-03 0.02580265 0.25757386 KARAKAS_TGFB1_SIGNALING uterine disease DOID_345 3.279E-04 9.328E-03 0.02657476 0.2607076 KARAKAS_TGFB1_SIGNALING tooth disease DOID_1091 3.474E-04 9.414E-03 0.0273463 0.2637296 KARAKAS_TGFB1_SIGNALING astrocytoma DOID_3069 3.675E-04 9.506E-03 0.02811727 0.25804399 KARAKAS_TGFB1_SIGNALING aneurysm disease DOID_2403 4.423E-04 0.01094291 0.03081117 0.27393057 KARAKAS_TGFB1_SIGNALING female reproductive system disease DOID_229 4.881E-04 0.01157239 0.03234741 0.27067173 KARAKAS_TGFB1_SIGNALING transitional cell carcinoma DOID_2671 5.735E-04 0.0130539 0.03503037 0.28474683 KARAKAS_TGFB1_SIGNALING dilated cardiomyopathy DOID_12930 6.657E-04 0.01456876 0.03770638 0.29390312 KARAKAS_TGFB1_SIGNALING cutaneous leishmaniasis DOID_9111 3.95E-03 0.08324398 1.000 1.000 KARAKAS_TGFB1_SIGNALING prediabetes syndrome DOID_11716 4.344E-03 0.08828179 4.344E-03 0.494378 KARAKAS_TGFB1_SIGNALING intracranial arteriosclerosis DOID_13097 4.738E-03 0.0929693 1.000 1.000 KARAKAS_TGFB1_SIGNALING vascular dementia DOID_8725 4.738E-03 0.0929693 1.000 1.000 KARAKAS_TGFB1_SIGNALING ocular hypertension DOID_9282 4.738E-03 0.08987032 1.000 1.000 KARAKAS_TGFB1_SIGNALING borderline glaucoma DOID_9283 4.738E-03 0.08987032 1.000 1.000 KARAKAS_TGFB1_SIGNALING larynx cancer DOID_2596 5.132E-03 0.09420149 1.000 1.000 KARAKAS_TGFB1_SIGNALING laryngeal benign neoplasm DOID_2598 5.132E-03 0.09420149 1.000 1.000 KARAKAS_TGFB1_SIGNALING viral pneumonia DOID_10533 5.526E-03 0.09825938 5.526E-03 0.44918575 KARAKAS_TGFB1_SIGNALING aspergillosis DOID_13564 5.526E-03 0.09528183 5.526E-03 0.39303753 KARAKAS_TGFB1_SIGNALING skeletal system cancer DOID_0060124 5.92E-03 0.09906681 1.000 1.000 KARAKAS_TGFB1_SIGNALING Ehlers-Danlos syndrome DOID_13359 5.92E-03 0.09623633 5.92E-03 0.37425238 KARAKAS_TGFB1_SIGNALING thoracic aortic aneurysm DOID_14004 5.92E-03 0.09356309 1.000 1.000 KARAKAS_TGFB1_SIGNALING bone cancer DOID_184 5.92E-03 0.09906681 1.000 1.000 KARAKAS_TGFB1_SIGNALING lung oat cell carcinoma DOID_5411 5.92E-03 0.09103436 5.92E-03 0.33682714 KARAKAS_TGFB1_SIGNALING chronic myeloid leukemia DOID_8552 6.313E-03 0.09453052 6.313E-03 0.29934665 KARAKAS_TGFB1_SIGNALING schizophreniform disorder DOID_11328 6.706E-03 0.09784527 6.706E-03 0.29353581 KARAKAS_TGFB1_SIGNALING schizoaffective disorder DOID_5418 6.706E-03 0.09784527 6.706E-03 0.29353581 KARAKAS_TGFB1_SIGNALING bronchitis DOID_6132 6.706E-03 0.09539914 6.706E-03 0.27256897 KARAKAS_TGFB1_SIGNALING urinary system benign neoplasm DOID_731 6.706E-03 0.09307233 6.706E-03 0.2543977 TSAI_RESPONSE_TO_RADIATION_THERAPY aneurysm disease DOID_2403 2.196E-09 1.25E-06 0.05280848 0.50928853 TSAI_RESPONSE_TO_RADIATION_THERAPY focal glomerulosclerosis DOID_3945 5.398E-09 1.536E-06 2.077E-04 0.01970126 TSAI_RESPONSE_TO_RADIATION_THERAPY nephrotic syndrome DOID_1184 2.78E-08 5.273E-06 4.262E-06 1.213E-03 TSAI_RESPONSE_TO_RADIATION_THERAPY hemolytic anemia DOID_583 4.248E-08 6.042E-06 5.834E-06 1.107E-03 TSAI_RESPONSE_TO_RADIATION_THERAPY normocytic anemia DOID_720 4.248E-08 6.042E-06 5.834E-06 1.107E-03 TSAI_RESPONSE_TO_RADIATION_THERAPY aortic aneurysm DOID_3627 4.973E-08 5.659E-06 0.03573172 0.46207615 TSAI_RESPONSE_TO_RADIATION_THERAPY nephrosis DOID_2527 1.935E-07 1.835E-05 1.797E-05 2.045E-03 TSAI_RESPONSE_TO_RADIATION_THERAPY diabetic retinopathy DOID_8947 2.156E-07 1.752E-05 0.05085302 0.50763808 TSAI_RESPONSE_TO_RADIATION_THERAPY congenital muscular dystrophy DOID_0050557 2.321E-07 1.65E-05 2.321E-07 1.32E-04 TSAI_RESPONSE_TO_RADIATION_THERAPY retinal vascular disease DOID_2462 3.721E-07 2.352E-05 0.0580041 0.51569268 TSAI_RESPONSE_TO_RADIATION_THERAPY aortic valve disease DOID_62 5.74E-07 3.266E-05 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY heart valve disease DOID_4079 5.493E-06 2.842E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY atrophic muscular disease DOID_913 7.748E-06 3.674E-04 7.748E-06 1.102E-03 TSAI_RESPONSE_TO_RADIATION_THERAPY muscular dystrophy DOID_9884 7.748E-06 3.674E-04 7.748E-06 1.102E-03 TSAI_RESPONSE_TO_RADIATION_THERAPY bile duct adenocarcinoma DOID_4896 8.175E-06 3.578E-04 0.03837805 0.48526911 TSAI_RESPONSE_TO_RADIATION_THERAPY cholangiocarcinoma DOID_4947 8.175E-06 3.578E-04 0.03837805 0.48526911 TSAI_RESPONSE_TO_RADIATION_THERAPY bile duct cancer DOID_4606 1.004E-05 4.079E-04 0.04101739 0.46677791 TSAI_RESPONSE_TO_RADIATION_THERAPY bile duct carcinoma DOID_4897 1.004E-05 4.079E-04 0.04101739 0.46677791 TSAI_RESPONSE_TO_RADIATION_THERAPY respiratory failure DOID_11162 1.216E-05 4.612E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY cholestasis DOID_13580 1.393E-05 4.954E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pancreatic ductal carcinoma DOID_3587 1.725E-05 5.774E-04 0.04889369 0.50582745 TSAI_RESPONSE_TO_RADIATION_THERAPY bile duct disease DOID_4138 1.797E-05 5.681E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY biliary tract disease DOID_9741 1.871E-05 5.603E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pancreatic carcinoma DOID_4905 1.947E-05 5.54E-04 0.05085302 0.51670305 TSAI_RESPONSE_TO_RADIATION_THERAPY retinal vascular occlusion DOID_1729 2.028E-05 5.496E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY biliary tract cancer DOID_4607 2.724E-05 7.047E-04 0.05670777 0.52043096 TSAI_RESPONSE_TO_RADIATION_THERAPY aortic valve insufficiency DOID_57 2.972E-05 7.353E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY peritonitis DOID_8283 2.972E-05 7.047E-04 8.2E-03 0.35890834 TSAI_RESPONSE_TO_RADIATION_THERAPY Lynch syndrome DOID_3883 3.511E-05 7.992E-04 8.88E-03 0.36092577 TSAI_RESPONSE_TO_RADIATION_THERAPY encephalomyelitis DOID_640 3.801E-05 8.318E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY Crohn's disease DOID_8778 3.922E-05 8.264E-04 0.06381642 0.55863909 TSAI_RESPONSE_TO_RADIATION_THERAPY hypercalcemia DOID_12678 4.095E-05 8.321E-04 9.56E-03 0.36265719 TSAI_RESPONSE_TO_RADIATION_THERAPY thoracic aortic aneurysm DOID_14004 4.723E-05 9.266E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY membranoproliferative glomerulonephritis DOID_2920 4.723E-05 8.958E-04 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY angiosarcoma DOID_0001816 5.395E-05 9.903E-04 0.01091896 0.34516035 TSAI_RESPONSE_TO_RADIATION_THERAPY hemolytic-uremic syndrome DOID_12554 5.395E-05 9.593E-04 0.01091896 0.32699401 TSAI_RESPONSE_TO_RADIATION_THERAPY bronchitis DOID_6132 6.112E-05 1.054E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY ureteral obstruction DOID_5199 6.873E-05 1.15E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY brain edema DOID_4724 8.528E-05 1.386E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY urinary tract obstruction DOID_5200 1.134E-04 1.793E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pulmonary embolism DOID_9477 1.134E-04 1.744E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY ureteral disease DOID_1426 1.237E-04 1.852E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY spastic quadriplegia DOID_10970 1.344E-04 1.96E-03 0.0170104 0.38715661 TSAI_RESPONSE_TO_RADIATION_THERAPY middle cerebral artery infarction DOID_3525 1.691E-04 2.405E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY Sciatic Neuropathy DOID_11446 1.815E-04 2.519E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY lesion of sciatic nerve DOID_12528 1.815E-04 2.519E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY mononeuritis of lower limb DOID_9473 1.815E-04 2.519E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY sarcoma DOID_1115 1.944E-04 2.634E-03 0.02037893 0.42946698 TSAI_RESPONSE_TO_RADIATION_THERAPY mononeuritis DOID_1802 1.944E-04 2.573E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY mononeuropathy DOID_1188 2.077E-04 2.687E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY spastic cerebral palsy DOID_0050669 2.357E-04 2.98E-03 0.02239471 0.41105133 TSAI_RESPONSE_TO_RADIATION_THERAPY age related macular degeneration DOID_10871 2.357E-04 2.915E-03 0.02239471 0.39820598 TSAI_RESPONSE_TO_RADIATION_THERAPY degeneration of macula and posterior pole DOID_2007 2.357E-04 2.915E-03 0.02239471 0.39820598 TSAI_RESPONSE_TO_RADIATION_THERAPY pneumoconiosis DOID_10316 2.968E-04 3.593E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY spindle cell carcinoma DOID_4015 2.968E-04 3.518E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY macular degeneration DOID_4448 2.968E-04 3.446E-03 0.02507622 0.39634366 TSAI_RESPONSE_TO_RADIATION_THERAPY adult respiratory distress syndrome DOID_11394 4.014E-04 4.568E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY intracranial arterial disease DOID_13089 4.014E-04 4.478E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY cerebral arterial disease DOID_3527 4.014E-04 4.478E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY hyperinsulinism DOID_2018 4.595E-04 5.028E-03 0.03108379 0.44216698 TSAI_RESPONSE_TO_RADIATION_THERAPY diabetic autonomic neuropathy DOID_11503 4.797E-04 5.15E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY autonomic neuropathy DOID_11504 4.797E-04 5.15E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY diabetic polyneuropathy DOID_12785 4.797E-04 5.15E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY influenza DOID_8469 4.797E-04 5.055E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY diabetic neuropathy DOID_9743 4.797E-04 5.15E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY cerebral infarction DOID_3526 5.004E-04 5.176E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY proteinuria DOID_576 5.214E-04 5.298E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pre-eclampsia DOID_10591 5.429E-04 5.42E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY autonomic nervous system disease DOID_11465 5.429E-04 5.326E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY neuritis DOID_1803 5.429E-04 5.236E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY vascular skin disease DOID_9540 5.429E-04 5.149E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY calcium metabolism disease DOID_10575 6.1E-04 5.69E-03 0.03573172 0.47282211 TSAI_RESPONSE_TO_RADIATION_THERAPY bone marrow cancer DOID_4960 7.053E-04 6.473E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY vasculitis DOID_865 7.053E-04 6.37E-03 0.03837805 0.47471978 TSAI_RESPONSE_TO_RADIATION_THERAPY parasitic protozoa infectious disease DOID_2789 7.301E-04 6.491E-03 0.03903854 0.4726155 TSAI_RESPONSE_TO_RADIATION_THERAPY pustulosis of palm and sole DOID_4398 7.301E-04 6.392E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY carotid artery disease DOID_3407 8.882E-04 7.658E-03 8.882E-04 0.07220106 TSAI_RESPONSE_TO_RADIATION_THERAPY congenital heart defect DOID_1682 9.443E-04 8.019E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY mineral metabolism disease DOID_0050032 9.729E-04 8.141E-03 0.04496335 0.49200279 TSAI_RESPONSE_TO_RADIATION_THERAPY endocrine pancreas disease DOID_1428 9.729E-04 8.023E-03 0.04496335 0.48271971 TSAI_RESPONSE_TO_RADIATION_THERAPY parasitic infectious disease DOID_1398 1.002E-03 8.145E-03 0.04561949 0.48069423 TSAI_RESPONSE_TO_RADIATION_THERAPY uterine disease DOID_345 1.002E-03 8.03E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY brain infarction DOID_3454 1.092E-03 8.627E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY peripheral vascular disease DOID_341 1.217E-03 9.486E-03 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY bone resorption disease DOID_0080011 1.349E-03 0.01037212 0.05280848 0.51806937 TSAI_RESPONSE_TO_RADIATION_THERAPY osteoporosis DOID_11476 1.349E-03 0.01037212 0.05280848 0.51806937 TSAI_RESPONSE_TO_RADIATION_THERAPY bacterial pneumonia DOID_874 1.383E-03 0.01049181 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY metabolic syndrome X DOID_14221 1.452E-03 0.01087212 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY female reproductive system disease DOID_229 1.487E-03 0.01099125 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY chronic kidney failure DOID_784 1.559E-03 0.01137323 0.05670777 0.51217015 TSAI_RESPONSE_TO_RADIATION_THERAPY alcohol-related neurodevelopmental disorder DOID_0050667 1.982E-03 0.01427701 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY ulcerative colitis DOID_8577 2.148E-03 0.0152786 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY hyperparathyroidism DOID_13543 6.838E-03 0.04803379 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY familial combined hyperlipidemia DOID_13809 6.838E-03 0.04744801 6.838E-03 0.48634209 TSAI_RESPONSE_TO_RADIATION_THERAPY angioedema DOID_1558 6.838E-03 0.04687635 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY keratitis DOID_4677 6.838E-03 0.04631829 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY Paget's disease of bone DOID_5408 6.838E-03 0.04577337 6.838E-03 0.43230408 TSAI_RESPONSE_TO_RADIATION_THERAPY polycythemia DOID_8432 6.838E-03 0.04524112 6.838E-03 0.38907367 TSAI_RESPONSE_TO_RADIATION_THERAPY visceral leishmaniasis DOID_9146 6.838E-03 0.04472111 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY sickle cell anemia DOID_10923 7.519E-03 0.04861819 7.519E-03 0.38894549 TSAI_RESPONSE_TO_RADIATION_THERAPY prediabetes syndrome DOID_11716 7.519E-03 0.04807191 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY esophageal carcinoma DOID_1107 8.2E-03 0.05184232 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY beta thalassemia DOID_12241 8.2E-03 0.05127262 8.2E-03 0.38881736 TSAI_RESPONSE_TO_RADIATION_THERAPY aortic valve stenosis DOID_1712 8.2E-03 0.05071531 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY esophagus squamous cell carcinoma DOID_3748 8.2E-03 0.05184232 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY berylliosis DOID_10322 8.88E-03 0.05433291 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY parathyroid gland disease DOID_11201 8.88E-03 0.0537549 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY newborn respiratory distress syndrome DOID_12716 8.88E-03 0.05318906 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY polyneuropathy DOID_1389 8.88E-03 0.05263501 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY impotence DOID_1875 8.88E-03 0.05209238 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY intracranial thrombosis DOID_4193 8.88E-03 0.05156082 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY rhabdomyosarcoma DOID_3247 9.56E-03 0.05494806 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY skeletal system cancer DOID_0060124 0.01023989 0.058265 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY thalassemia DOID_10241 0.01023989 0.05768811 0.01023989 0.36415622 TSAI_RESPONSE_TO_RADIATION_THERAPY bone cancer DOID_184 0.01023989 0.058265 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY communication disorder DOID_2033 0.01023989 0.05712254 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY skeletal muscle cancer DOID_4043 0.01023989 0.05656796 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY nutritional deficiency disease DOID_5113 0.01023989 0.05602403 0.01023989 0.34273527 TSAI_RESPONSE_TO_RADIATION_THERAPY lung oat cell carcinoma DOID_5411 0.01023989 0.05549047 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY silicosis DOID_10325 0.01091896 0.05861213 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY restrictive cardiomyopathy DOID_397 0.01091896 0.05806436 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY thyroiditis DOID_7166 0.01091896 0.05752672 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY autoimmune thyroiditis DOID_7188 0.01091896 0.05752672 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY penile disease DOID_1529 0.01159757 0.06054145 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY hyperostosis DOID_205 0.01159757 0.05999107 0.01159757 0.3299509 TSAI_RESPONSE_TO_RADIATION_THERAPY basal cell carcinoma DOID_2513 0.01159757 0.05945061 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY sexual dysfunction DOID_1876 0.01227574 0.06236514 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY skin carcinoma DOID_3451 0.01227574 0.06181323 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY dissociative disorder DOID_10935 0.01295346 0.06465366 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY dissociative amnesia DOID_11037 0.01295346 0.06465366 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY granulosa cell tumor DOID_2999 0.01295346 0.06409146 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY leishmaniasis DOID_9065 0.01295346 0.06353895 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY amnestic disorder DOID_10914 0.01363073 0.06628962 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pulmonary edema DOID_11396 0.01363073 0.06572784 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY sex cord-gonadal stromal tumor DOID_192 0.01363073 0.06517551 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY Kawasaki disease DOID_13378 0.01430756 0.06784166 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY lymphadenitis DOID_1602 0.01430756 0.06784166 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY autoimmune hepatitis DOID_2048 0.01430756 0.06728099 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY mitochondrial myopathy DOID_699 0.01430756 0.0667295 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY lymph node disease DOID_9942 0.01430756 0.06784166 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY gastric ulcer DOID_10808 0.01498394 0.06931593 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY familial hypercholesterolemia DOID_13810 0.01498394 0.06875693 0.01498394 0.4059933 TSAI_RESPONSE_TO_RADIATION_THERAPY hepatitis B DOID_2043 0.01498394 0.06820687 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY thrombophilia DOID_2452 0.01498394 0.06766555 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY muscular atrophy DOID_767 0.01498394 0.06713275 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY placenta disease DOID_780 0.01498394 0.06660828 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY sexual disorder DOID_0060043 0.01565987 0.06907337 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY muscle cancer DOID_4045 0.01565987 0.06854204 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY myasthenia gravis DOID_437 0.01565987 0.06801882 0.01565987 0.40502113 TSAI_RESPONSE_TO_RADIATION_THERAPY uremia DOID_4676 0.01565987 0.06750352 0.01565987 0.38741152 TSAI_RESPONSE_TO_RADIATION_THERAPY polyarteritis nodosa DOID_9810 0.01565987 0.06699598 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY diabetic angiopathy DOID_11713 0.01633535 0.06936431 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY congenital hemolytic anemia DOID_589 0.01633535 0.0688505 0.01633535 0.38728404 TSAI_RESPONSE_TO_RADIATION_THERAPY meningitis DOID_9471 0.01633535 0.06834424 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY Goodpasture syndrome DOID_9808 0.01633535 0.06784538 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY toxic shock syndrome DOID_14115 0.0170104 0.07013707 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY commensal bacterial infectious disease DOID_0050339 0.01768499 0.07239396 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY portal hypertension DOID_10762 0.01768499 0.07187686 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY urticaria DOID_1555 0.01768499 0.07136709 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY hypogonadism DOID_1924 0.01768499 0.07086451 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY bronchiolitis DOID_2942 0.01768499 0.07036895 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY osteosarcoma DOID_3347 0.01768499 0.06988028 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY neuromuscular junction disease DOID_439 0.01835914 0.07204381 0.01835914 0.40178276 TSAI_RESPONSE_TO_RADIATION_THERAPY myositis DOID_633 0.01835914 0.07155036 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY intracranial aneurysm DOID_10941 0.01903285 0.07367136 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY seminoma DOID_4440 0.01903285 0.07317358 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY extrinsic allergic alveolitis DOID_841 0.01903285 0.07268249 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY gestational diabetes DOID_11714 0.01970611 0.07475184 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY lung adenocarcinoma DOID_3910 0.01970611 0.07425679 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY migraine DOID_6364 0.01970611 0.07376826 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY periodontitis DOID_824 0.01970611 0.07328612 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY autoimmune disease of cardiovascular system DOID_0060051 0.02037893 0.07529616 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pleurisy DOID_10247 0.02037893 0.07481038 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY malaria DOID_12365 0.02037893 0.07433082 0.02037893 0.41412887 TSAI_RESPONSE_TO_RADIATION_THERAPY Behcet's disease DOID_13241 0.02037893 0.07529616 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY hepatic vascular disease DOID_272 0.02037893 0.07385738 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY coronary stenosis DOID_4248 0.02037893 0.07338993 0.02037893 0.39984857 TSAI_RESPONSE_TO_RADIATION_THERAPY autoimmune disease of the nervous system DOID_438 0.02037893 0.07292836 0.02037893 0.38652028 TSAI_RESPONSE_TO_RADIATION_THERAPY autoimmune disease of endocrine system DOID_0060005 0.0210513 0.07486368 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY multiple epiphyseal dysplasia DOID_12721 0.0210513 0.07439869 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY toxic encephalopathy DOID_3602 0.0210513 0.07393944 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY corneal disease DOID_10124 0.02172323 0.07583139 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY gonadal disease DOID_2277 0.02239471 0.07769873 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY bronchiolitis obliterans DOID_2799 0.02239471 0.07722783 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY abdominal aortic aneurysm DOID_7693 0.02239471 0.0767626 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY Charcot-Marie-Tooth disease DOID_10595 0.02306575 0.07858931 0.02306575 0.39770952 TSAI_RESPONSE_TO_RADIATION_THERAPY celiac disease DOID_10608 0.02306575 0.07812151 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY germinoma DOID_3304 0.02306575 0.07765926 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY allergic rhinitis DOID_4481 0.02306575 0.07720244 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY chronic leukemia DOID_1036 0.02373635 0.07898237 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY chronic lymphocytic leukemia DOID_1040 0.02373635 0.07898237 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pleural disease DOID_1532 0.02373635 0.07852317 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY myocarditis DOID_820 0.02440651 0.08027344 0.02440651 0.40845013 TSAI_RESPONSE_TO_RADIATION_THERAPY nephroblastoma DOID_2154 0.02507622 0.08200214 0.02507622 0.40766777 TSAI_RESPONSE_TO_RADIATION_THERAPY periodontal disease DOID_3388 0.02507622 0.08153355 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY adenoma DOID_657 0.02641433 0.08539632 0.02641433 0.40620952 TSAI_RESPONSE_TO_RADIATION_THERAPY pulmonary sarcoidosis DOID_13406 0.02708272 0.08706252 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY multiple myeloma DOID_9538 0.02708272 0.0865734 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY microcephaly DOID_10907 0.02775066 0.08821301 0.02775066 0.41552968 TSAI_RESPONSE_TO_RADIATION_THERAPY respiratory syncytial virus infectious disease DOID_1273 0.02841817 0.089833 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY hepatitis DOID_2237 0.02841817 0.08933668 0.02841817 0.41461383 TSAI_RESPONSE_TO_RADIATION_THERAPY congenital diaphragmatic hernia DOID_3827 0.02841817 0.08884582 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY systemic scleroderma DOID_418 0.02841817 0.08836032 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY peptic ulcer DOID_750 0.02841817 0.08788011 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY lymphatic system disease DOID_75 0.02908524 0.08945676 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY benign mesothelioma DOID_2645 0.02975186 0.09101511 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY cervix uteri carcinoma in situ DOID_8991 0.02975186 0.0905284 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pulmonary emphysema DOID_9675 0.02975186 0.09004686 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY autoimmune disease of urogenital tract DOID_0060049 0.03041805 0.09157603 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY primary biliary cirrhosis DOID_12236 0.03041805 0.09157603 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY endometriosis of uterus DOID_288 0.03041805 0.09109405 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY rheumatic disease DOID_1575 0.03108379 0.09260041 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY endometriosis DOID_289 0.03108379 0.09211812 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY scleroderma DOID_419 0.03108379 0.09260041 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY gallbladder cancer DOID_3121 0.0317491 0.09360227 0.0317491 0.44061557 TSAI_RESPONSE_TO_RADIATION_THERAPY learning disability DOID_8927 0.03241397 0.09506983 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY myeloma DOID_0070004 0.03374238 0.09845855 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY brain cancer DOID_1319 0.03374238 0.09795621 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY bone marrow disease DOID_4961 0.03374238 0.09745897 0.03374238 0.45712898 TSAI_RESPONSE_TO_RADIATION_THERAPY central nervous system cancer DOID_3620 0.03440594 0.09887362 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY glaucoma DOID_1686 0.03506905 0.09977144 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY pulmonary tuberculosis DOID_2957 0.03506905 0.09927507 1.000 1.000 TSAI_RESPONSE_TO_RADIATION_THERAPY lung small cell carcinoma DOID_5409 0.03506905 0.09878361 1.000 1.000 SHIPP_DLBCL_CURED_VS_FATAL_DN granulosa cell tumor DOID_2999 7.678E-05 0.04369048 0.01295346 0.43355986 SHIPP_DLBCL_CURED_VS_FATAL_DN sex cord-gonadal stromal tumor DOID_192 8.528E-05 0.02426225 0.01363073 0.43088254 SHIPP_DLBCL_CURED_VS_FATAL_DN muscular atrophy DOID_767 1.036E-04 0.0196486 1.036E-04 0.05894581 SHIPP_DLBCL_CURED_VS_FATAL_DN muscle cancer DOID_4045 1.134E-04 0.01613312 0.01565987 0.42430786 SHIPP_DLBCL_CURED_VS_FATAL_DN germinoma DOID_3304 2.503E-04 0.02848627 0.02306575 0.45256601 SHIPP_DLBCL_CURED_VS_FATAL_DN nephroblastoma DOID_2154 2.968E-04 0.02814598 2.968E-04 0.08443793 SHIPP_DLBCL_CURED_VS_FATAL_DN cervix uteri carcinoma in situ DOID_8991 4.203E-04 0.03416683 0.02975186 0.40306691 SHIPP_DLBCL_CURED_VS_FATAL_DN pre-eclampsia DOID_10591 5.429E-04 0.03861529 0.03374238 0.42665371 SHIPP_DLBCL_CURED_VS_FATAL_DN brain cancer DOID_1319 5.429E-04 0.0343247 0.03374238 0.41737863 SHIPP_DLBCL_CURED_VS_FATAL_DN central nervous system cancer DOID_3620 5.648E-04 0.03213959 0.03440594 0.41653144 SHIPP_DLBCL_CURED_VS_FATAL_DN pre-malignant neoplasm DOID_0060071 9.443E-04 0.04884497 0.04430677 0.45018847 SHIPP_DLBCL_CURED_VS_FATAL_DN congenital heart defect DOID_1682 9.443E-04 0.04477455 0.04430677 0.44229043 SHIPP_DLBCL_CURED_VS_FATAL_DN in situ carcinoma DOID_8719 9.443E-04 0.04884497 0.04430677 0.45018847 SHIPP_DLBCL_CURED_VS_FATAL_DN chronic kidney failure DOID_784 1.559E-03 0.06823939 1.559E-03 0.295704 SHIPP_DLBCL_CURED_VS_FATAL_DN nervous system cancer DOID_3093 1.823E-03 0.07408013 0.06123743 0.49777285 SHIPP_DLBCL_CURED_VS_FATAL_DN lymphoblastic leukemia DOID_1037 1.942E-03 0.07365673 1.942E-03 0.27621273 SHIPP_DLBCL_CURED_VS_FATAL_DN encephalomyelitis DOID_640 1.942E-03 0.06905318 0.06317231 0.49923672 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN B cell deficiency DOID_2115 5.383E-16 3.063E-13 5.383E-16 3.063E-13 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN agammaglobulinemia DOID_2583 1.516E-14 4.314E-12 1.516E-14 4.314E-12 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN blood protein disease DOID_620 2.165E-14 4.106E-12 2.165E-14 4.106E-12 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN primary immunodeficiency disease DOID_612 3.522E-12 5.011E-10 3.522E-12 5.011E-10 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN common variable immunodeficiency DOID_12177 1.404E-07 1.598E-05 1.404E-07 1.598E-05 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN atopic dermatitis DOID_3310 2.526E-07 2.396E-05 2.168E-05 1.37E-03 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN pustulosis of palm and sole DOID_4398 3.136E-07 2.549E-05 2.544E-05 1.448E-03 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN funisitis DOID_0050698 1.301E-06 9.253E-05 1.301E-06 1.234E-04 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN lymphoma DOID_0060058 2.198E-06 1.39E-04 1.079E-04 5.116E-03 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN chronic leukemia DOID_1036 5.481E-06 3.119E-04 5.481E-06 4.455E-04 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN chronic lymphocytic leukemia DOID_1040 5.481E-06 3.119E-04 5.481E-06 4.455E-04 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN B-cell lymphocytic neoplasm DOID_707 2.051E-05 1.061E-03 2.051E-05 1.459E-03 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN Human immunodeficiency virus infectious disease DOID_526 1.012E-04 4.799E-03 1.012E-04 5.236E-03 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN lymphoblastic leukemia DOID_1037 1.113E-04 4.873E-03 1.113E-04 4.873E-03 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN fragments of torsion dystonia DOID_531 3.448E-04 0.01401245 0.02697962 0.26467936 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN diffuse large B-cell lymphoma DOID_0050745 3.701E-04 0.01403841 3.701E-04 0.01504116 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN lung adenocarcinoma DOID_3910 3.701E-04 0.01316101 0.02792996 0.26486912 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN autoimmune disease of cardiovascular system DOID_0060051 3.963E-04 0.01326345 3.963E-04 0.01503191 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN Behcet's disease DOID_13241 3.963E-04 0.01326345 3.963E-04 0.01503191 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN central nervous system hereditary degenerative disease DOID_481 3.963E-04 0.01252659 0.0288794 0.26083138 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN dystonic disease DOID_544 4.233E-04 0.01267794 0.02982793 0.26110913 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN celiac disease DOID_10608 5.098E-04 0.01450378 5.098E-04 0.01812973 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN allergic rhinitis DOID_4481 5.098E-04 0.01381313 0.03266813 0.27743533 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN autoimmune disease of urogenital tract DOID_0060049 8.936E-04 0.02311138 8.936E-04 0.02990885 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN primary biliary cirrhosis DOID_12236 8.936E-04 0.02311138 8.936E-04 0.02990885 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN vascular skin disease DOID_9540 1.102E-03 0.02727019 1.102E-03 0.03484524 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.192E-03 0.02825393 1.192E-03 0.03568917 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN movement disease DOID_480 1.238E-03 0.02817015 0.05046911 0.3190769 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN vasculitis DOID_865 1.43E-03 0.03129487 1.43E-03 0.04068333 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN astrocytoma DOID_3069 2.269E-03 0.0478205 0.0679512 0.38281418 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN pancreatic ductal carcinoma DOID_3587 2.332E-03 0.04738251 0.06886258 0.38414518 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN peripheral vascular disease DOID_341 2.459E-03 0.04824842 2.459E-03 0.06662878 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN pancreatic carcinoma DOID_4905 2.524E-03 0.04787133 0.07159153 0.39549107 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN pancreatitis DOID_4989 2.792E-03 0.05124038 2.792E-03 0.07220236 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN amino acid metabolic disorder DOID_9252 3.593E-03 0.06389453 3.593E-03 0.08889674 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN Crohn's disease DOID_8778 3.989E-03 0.06878294 3.989E-03 0.09457654 KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN hypersensitivity reaction type I disease DOID_1205 4.071E-03 0.06812366 0.09047747 0.46801525 KRASNOSELSKAYA_ILF3_TARGETS_UP intracranial thrombosis DOID_4193 1.85E-05 0.01052654 6.497E-03 0.61610646 KRASNOSELSKAYA_ILF3_TARGETS_UP prion disease DOID_649 3.623E-05 0.01030869 8.985E-03 0.42602961 KRASNOSELSKAYA_ILF3_TARGETS_UP blood protein disease DOID_620 4.497E-05 8.529E-03 4.497E-05 0.02558797 KRASNOSELSKAYA_ILF3_TARGETS_UP hepatitis B DOID_2043 5.464E-05 7.773E-03 0.01097102 0.36720644 KRASNOSELSKAYA_ILF3_TARGETS_UP pulmonary embolism DOID_9477 5.983E-05 6.808E-03 0.01146698 0.34340593 KRASNOSELSKAYA_ILF3_TARGETS_UP ankylosing spondylitis DOID_7147 8.29E-05 7.862E-03 8.29E-05 0.02358581 KRASNOSELSKAYA_ILF3_TARGETS_UP middle cerebral artery infarction DOID_3525 8.925E-05 7.255E-03 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP Sciatic Neuropathy DOID_11446 9.584E-05 6.816E-03 0.01443782 0.29339706 KRASNOSELSKAYA_ILF3_TARGETS_UP lesion of sciatic nerve DOID_12528 9.584E-05 6.816E-03 0.01443782 0.29339706 KRASNOSELSKAYA_ILF3_TARGETS_UP mononeuritis of lower limb DOID_9473 9.584E-05 6.816E-03 0.01443782 0.29339706 KRASNOSELSKAYA_ILF3_TARGETS_UP mononeuritis DOID_1802 1.027E-04 6.49E-03 0.01493213 0.27407689 KRASNOSELSKAYA_ILF3_TARGETS_UP mononeuropathy DOID_1188 1.097E-04 6.242E-03 0.01542621 0.25816223 KRASNOSELSKAYA_ILF3_TARGETS_UP pleural disease DOID_1532 1.402E-04 7.252E-03 0.01740019 0.26054498 KRASNOSELSKAYA_ILF3_TARGETS_UP adult respiratory distress syndrome DOID_11394 2.123E-04 0.01006476 0.02133691 0.26392824 KRASNOSELSKAYA_ILF3_TARGETS_UP intracranial arterial disease DOID_13089 2.123E-04 9.291E-03 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP cerebral arterial disease DOID_3527 2.123E-04 9.291E-03 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP cerebral infarction DOID_3526 2.648E-04 0.01076042 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP neuritis DOID_1803 2.874E-04 0.01090018 0.02476927 0.27634733 KRASNOSELSKAYA_ILF3_TARGETS_UP pustulosis of palm and sole DOID_4398 3.868E-04 0.01375637 0.028678 0.28627691 KRASNOSELSKAYA_ILF3_TARGETS_UP carotid artery disease DOID_3407 4.709E-04 0.0157621 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP respiratory failure DOID_11162 4.857E-04 0.01535443 0.03208597 0.30428193 KRASNOSELSKAYA_ILF3_TARGETS_UP temporal lobe epilepsy DOID_3328 5.472E-04 0.01638696 0.03402829 0.31229186 KRASNOSELSKAYA_ILF3_TARGETS_UP brain infarction DOID_3454 5.793E-04 0.01648014 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP aneurysm disease DOID_2403 7.165E-04 0.01941331 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP focal epilepsy DOID_2234 8.287E-04 0.02143357 0.0417607 0.33945483 KRASNOSELSKAYA_ILF3_TARGETS_UP chronic kidney failure DOID_784 8.287E-04 0.02050168 1.000 1.000 KRASNOSELSKAYA_ILF3_TARGETS_UP primary immunodeficiency disease DOID_612 9.489E-04 0.02249644 9.489E-04 0.17997151 KRASNOSELSKAYA_ILF3_TARGETS_UP dilated cardiomyopathy DOID_12930 1.077E-03 0.02451129 0.04752149 0.35578588 ENK_UV_RESPONSE_KERATINOCYTE_UP hypersensitivity reaction type I disease DOID_1205 5.645E-13 3.212E-10 5.926E-08 1.686E-05 ENK_UV_RESPONSE_KERATINOCYTE_UP bone resorption disease DOID_0080011 9.563E-13 2.721E-10 4.971E-10 2.829E-07 ENK_UV_RESPONSE_KERATINOCYTE_UP osteoporosis DOID_11476 9.563E-13 2.721E-10 4.971E-10 2.829E-07 ENK_UV_RESPONSE_KERATINOCYTE_UP biliary tract cancer DOID_4607 1.037E-09 1.968E-07 4.825E-05 9.152E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP intracranial arterial disease DOID_13089 1.159E-09 1.649E-07 8.783E-07 8.33E-05 ENK_UV_RESPONSE_KERATINOCYTE_UP cerebral arterial disease DOID_3527 1.159E-09 1.649E-07 8.783E-07 8.33E-05 ENK_UV_RESPONSE_KERATINOCYTE_UP middle cerebral artery infarction DOID_3525 1.402E-09 1.596E-07 5.973E-08 1.133E-05 ENK_UV_RESPONSE_KERATINOCYTE_UP bone marrow cancer DOID_4960 1.205E-08 1.142E-06 2.594E-07 3.69E-05 ENK_UV_RESPONSE_KERATINOCYTE_UP bile duct cancer DOID_4606 2.091E-08 1.7E-06 1.027E-04 1.537E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP bile duct carcinoma DOID_4897 2.091E-08 1.7E-06 1.027E-04 1.537E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP primary bacterial infectious disease DOID_0050338 2.779E-08 1.977E-06 5.495E-06 1.954E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP peptic ulcer DOID_750 2.917E-08 1.844E-06 2.908E-04 3.598E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP osteosarcoma DOID_3347 3.697E-08 2.103E-06 1.41E-06 1.003E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP gallbladder cancer DOID_3121 6.583E-08 3.405E-06 5.497E-03 0.03292149 ENK_UV_RESPONSE_KERATINOCYTE_UP brain infarction DOID_3454 7.075E-08 3.355E-06 1.192E-06 9.686E-05 ENK_UV_RESPONSE_KERATINOCYTE_UP lung adenocarcinoma DOID_3910 7.483E-08 3.275E-06 2.499E-06 1.094E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP cerebral infarction DOID_3526 7.657E-08 3.112E-06 1.713E-06 1.083E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP pancreatic ductal carcinoma DOID_3587 8.823E-08 3.347E-06 2.027E-05 5.242E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP myeloma DOID_0070004 1.025E-07 3.647E-06 2.19E-06 1.246E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP pancreatic carcinoma DOID_4905 1.213E-07 4.062E-06 2.554E-05 5.812E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP bile duct adenocarcinoma DOID_4896 2.594E-07 8.199E-06 7.407E-05 1.36E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP cholangiocarcinoma DOID_4947 2.594E-07 8.199E-06 7.407E-05 1.36E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP testicular cancer DOID_2998 2.604E-07 7.799E-06 1.156E-05 3.653E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP pustulosis of palm and sole DOID_4398 2.931E-07 8.338E-06 8.056E-05 1.348E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP adenoma DOID_657 4.822E-07 1.307E-05 2.176E-04 2.814E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP multiple myeloma DOID_9538 5.637E-07 1.458E-05 5.637E-07 6.415E-05 ENK_UV_RESPONSE_KERATINOCYTE_UP carotid artery disease DOID_3407 5.824E-07 1.441E-05 0.01285265 0.06250564 ENK_UV_RESPONSE_KERATINOCYTE_UP lymphatic system disease DOID_75 8.783E-07 2.082E-05 3.188E-04 3.859E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP cholestasis DOID_13580 8.857E-07 2.016E-05 1.345E-05 3.827E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP Goodpasture syndrome DOID_9808 9.228E-07 2.019E-05 3.074E-05 6.728E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP sphingolipidosis DOID_1927 1.146E-06 2.416E-05 3.638E-05 7.393E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP endocrine organ benign neoplasm DOID_0060089 1.192E-06 2.421E-05 1.727E-05 4.679E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP tuberculosis DOID_399 1.192E-06 2.338E-05 2.112E-04 2.795E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP influenza DOID_8469 1.508E-06 2.86E-05 4.499E-04 4.923E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP bile duct disease DOID_4138 1.581E-06 2.903E-05 2.191E-05 5.421E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP biliary tract disease DOID_9741 1.733E-06 3.081E-05 2.367E-05 5.612E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP neuritis DOID_1803 2.19E-06 3.775E-05 2.19E-06 1.133E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP cystic fibrosis DOID_1485 2.262E-06 3.786E-05 3.28E-04 3.888E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP syndrome DOID_225 2.262E-06 3.678E-05 2.262E-06 1.073E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP pancreatitis DOID_4989 2.685E-06 4.244E-05 2.685E-06 1.091E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP renal hypertension DOID_1073 2.981E-06 4.584E-05 7.65E-05 1.36E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP secondary hypertension DOID_11130 2.981E-06 4.584E-05 7.65E-05 1.36E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP Legionnaires' disease DOID_10457 3.075E-06 4.604E-05 3.075E-06 1.166E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP legionellosis DOID_10458 3.075E-06 4.604E-05 3.075E-06 1.166E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP chronic kidney failure DOID_784 4.04E-06 5.894E-05 4.078E-03 0.02607009 ENK_UV_RESPONSE_KERATINOCYTE_UP renovascular hypertension DOID_1591 4.168E-06 5.929E-05 1.845E-04 2.499E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP tongue cancer DOID_8649 5.524E-06 7.667E-05 5.524E-06 1.849E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP papilloma DOID_2615 7.596E-06 1.029E-04 2.573E-03 0.01901646 ENK_UV_RESPONSE_KERATINOCYTE_UP pneumoconiosis DOID_10316 8.729E-06 1.155E-04 0.03216583 0.11438974 ENK_UV_RESPONSE_KERATINOCYTE_UP psoriasis DOID_8893 1.156E-05 1.494E-04 1.156E-05 3.46E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP ulcerative colitis DOID_8577 1.189E-05 1.504E-04 1.196E-04 1.745E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP astrocytoma DOID_3069 1.872E-05 2.315E-04 2.237E-03 0.01674931 ENK_UV_RESPONSE_KERATINOCYTE_UP pulmonary emphysema DOID_9675 2.082E-05 2.521E-04 4.565E-03 0.02854415 ENK_UV_RESPONSE_KERATINOCYTE_UP diabetic retinopathy DOID_8947 2.554E-05 3.027E-04 2.906E-04 3.675E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP ureteral disease DOID_1426 3.074E-05 3.57E-04 7.802E-04 7.047E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP cataract DOID_83 3.203E-05 3.645E-04 3.203E-05 6.749E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP bacterial pneumonia DOID_874 3.422E-05 3.818E-04 3.69E-04 4.284E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP lens disease DOID_110 3.914E-05 4.283E-04 3.914E-05 7.68E-04 ENK_UV_RESPONSE_KERATINOCYTE_UP female reproductive system disease DOID_229 4.217E-05 4.528E-04 0.02552853 0.09683823 ENK_UV_RESPONSE_KERATINOCYTE_UP commensal bacterial infectious disease DOID_0050339 4.274E-05 4.504E-04 9.91E-04 8.417E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP portal hypertension DOID_10762 4.274E-05 4.422E-04 0.01657512 0.07605841 ENK_UV_RESPONSE_KERATINOCYTE_UP integumentary system benign neoplasm DOID_0060121 4.742E-05 4.818E-04 6.628E-04 6.502E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP pulmonary tuberculosis DOID_2957 4.742E-05 4.734E-04 6.628E-04 6.392E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP skin benign neoplasm DOID_3165 4.742E-05 4.818E-04 6.628E-04 6.502E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP mental depression DOID_1596 4.825E-05 4.734E-04 4.881E-04 5.241E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP myositis DOID_633 4.987E-05 4.81E-04 0.01781243 0.07796365 ENK_UV_RESPONSE_KERATINOCYTE_UP retinal vascular disease DOID_2462 5.501E-05 5.217E-04 5.432E-04 5.723E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP sarcoidosis DOID_11335 6.799E-05 6.342E-04 8.938E-03 0.04665988 ENK_UV_RESPONSE_KERATINOCYTE_UP giant cell tumor DOID_200 6.799E-05 6.24E-04 8.781E-04 7.807E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP malignant giant cell tumor DOID_2705 6.799E-05 6.24E-04 8.781E-04 7.807E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP giant cell glioblastoma DOID_3074 6.799E-05 6.24E-04 8.781E-04 7.807E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP atrophic muscular disease DOID_913 6.799E-05 6.141E-04 8.781E-04 7.687E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP muscular dystrophy DOID_9884 6.799E-05 6.141E-04 8.781E-04 7.687E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP nervous system cancer DOID_3093 7.526E-05 6.691E-04 7.01E-04 6.539E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP Human immunodeficiency virus infectious disease DOID_526 7.526E-05 6.588E-04 7.01E-04 6.433E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP mononeuritis DOID_1802 7.65E-05 6.595E-04 7.65E-05 1.319E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP hepatic vascular disease DOID_272 7.65E-05 6.496E-04 0.02174914 0.08839474 ENK_UV_RESPONSE_KERATINOCYTE_UP polycystic ovary syndrome DOID_11612 8.731E-05 7.305E-04 8.731E-05 1.419E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP mononeuropathy DOID_1188 8.731E-05 7.2E-04 8.731E-05 1.38E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP carbohydrate metabolic disorder DOID_2978 9E-05 7.316E-04 9E-05 1.384E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP islet cell tumor DOID_1799 9.073E-05 7.271E-04 3.61E-03 0.02445089 ENK_UV_RESPONSE_KERATINOCYTE_UP pituitary gland disease DOID_53 9.073E-05 7.17E-04 3.61E-03 0.02416323 ENK_UV_RESPONSE_KERATINOCYTE_UP mouth disease DOID_403 9.539E-05 7.435E-04 6.271E-03 0.036409 ENK_UV_RESPONSE_KERATINOCYTE_UP hypersensitivity reaction type IV disease DOID_2916 1.027E-04 7.894E-04 0.01128805 0.0558513 ENK_UV_RESPONSE_KERATINOCYTE_UP glioblastoma DOID_3068 1.027E-04 7.789E-04 1.211E-03 0.01013479 ENK_UV_RESPONSE_KERATINOCYTE_UP melancholia DOID_2848 1.11E-04 8.309E-04 1.287E-03 0.01046199 ENK_UV_RESPONSE_KERATINOCYTE_UP abdominal aortic aneurysm DOID_7693 1.122E-04 8.291E-04 0.02600974 0.09736542 ENK_UV_RESPONSE_KERATINOCYTE_UP neurotic disorder DOID_4964 1.198E-04 8.74E-04 1.366E-03 0.01094883 ENK_UV_RESPONSE_KERATINOCYTE_UP allergic rhinitis DOID_4481 1.264E-04 9.104E-04 2.181E-03 0.01654655 ENK_UV_RESPONSE_KERATINOCYTE_UP collagen disease DOID_854 1.292E-04 9.187E-04 0.01285265 0.06197593 ENK_UV_RESPONSE_KERATINOCYTE_UP viral pneumonia DOID_10533 1.484E-04 1.043E-03 1.484E-04 2.111E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP myocarditis DOID_820 1.586E-04 1.101E-03 1.586E-04 2.202E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP metal metabolism disorder DOID_896 1.586E-04 1.088E-03 2.573E-03 0.01877266 ENK_UV_RESPONSE_KERATINOCYTE_UP uterine disease DOID_345 1.723E-04 1.167E-03 0.09456494 0.22326744 ENK_UV_RESPONSE_KERATINOCYTE_UP chronic myeloid leukemia DOID_8552 2.258E-04 1.511E-03 6.433E-03 0.03660278 ENK_UV_RESPONSE_KERATINOCYTE_UP pulmonary sarcoidosis DOID_13406 2.403E-04 1.59E-03 3.482E-03 0.02446219 ENK_UV_RESPONSE_KERATINOCYTE_UP male reproductive system disease DOID_48 2.565E-04 1.678E-03 0.01892399 0.08157386 ENK_UV_RESPONSE_KERATINOCYTE_UP peripheral vascular disease DOID_341 2.732E-04 1.766E-03 0.11137394 0.241877 ENK_UV_RESPONSE_KERATINOCYTE_UP systemic scleroderma DOID_418 2.908E-04 1.859E-03 4.001E-03 0.02587252 ENK_UV_RESPONSE_KERATINOCYTE_UP ureteral obstruction DOID_5199 3.253E-04 2.057E-03 8.12E-03 0.04318173 ENK_UV_RESPONSE_KERATINOCYTE_UP endogenous depression DOID_1595 3.28E-04 2.051E-03 2.994E-03 0.02156296 ENK_UV_RESPONSE_KERATINOCYTE_UP endometriosis of uterus DOID_288 3.803E-04 2.352E-03 0.04596843 0.14861383 ENK_UV_RESPONSE_KERATINOCYTE_UP metabolic syndrome X DOID_14221 4.136E-04 2.531E-03 0.02474116 0.09448136 ENK_UV_RESPONSE_KERATINOCYTE_UP contact dermatitis DOID_2773 4.136E-04 2.504E-03 4.136E-04 4.707E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP rheumatic disease DOID_1575 4.14E-04 2.48E-03 5.174E-03 0.0316586 ENK_UV_RESPONSE_KERATINOCYTE_UP endometriosis DOID_289 4.14E-04 2.454E-03 0.0478227 0.1520174 ENK_UV_RESPONSE_KERATINOCYTE_UP scleroderma DOID_419 4.14E-04 2.48E-03 5.174E-03 0.0316586 ENK_UV_RESPONSE_KERATINOCYTE_UP uterine cancer DOID_363 4.499E-04 2.639E-03 4.499E-04 5.019E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP auditory system disease DOID_2742 4.623E-04 2.684E-03 3.909E-03 0.02556461 ENK_UV_RESPONSE_KERATINOCYTE_UP autoimmune hepatitis DOID_2048 5.214E-04 2.997E-03 0.14801214 0.28743654 ENK_UV_RESPONSE_KERATINOCYTE_UP proteinuria DOID_576 5.281E-04 3.005E-03 0.31195361 0.49033592 ENK_UV_RESPONSE_KERATINOCYTE_UP brain cancer DOID_1319 5.706E-04 3.215E-03 6.534E-03 0.03644997 ENK_UV_RESPONSE_KERATINOCYTE_UP thyroid adenoma DOID_2891 5.706E-04 3.183E-03 6.534E-03 0.03609608 ENK_UV_RESPONSE_KERATINOCYTE_UP funisitis DOID_0050698 6.003E-04 3.316E-03 6.003E-04 6.211E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP muscular atrophy DOID_767 6.003E-04 3.285E-03 6.003E-04 6.1E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP central nervous system cancer DOID_3620 6.155E-04 3.335E-03 6.904E-03 0.03777286 ENK_UV_RESPONSE_KERATINOCYTE_UP transitional cell carcinoma DOID_2671 6.342E-04 3.404E-03 6.342E-04 6.331E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP autoimmune disease of gastrointestinal tract DOID_0060031 6.628E-04 3.525E-03 0.05949529 0.18498808 ENK_UV_RESPONSE_KERATINOCYTE_UP primary immunodeficiency disease DOID_612 6.67E-04 3.514E-03 6.67E-04 6.325E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP IgA glomerulonephritis DOID_2986 6.865E-04 3.584E-03 0.16091492 0.304188 ENK_UV_RESPONSE_KERATINOCYTE_UP urinary tract obstruction DOID_5200 6.865E-04 3.551E-03 0.01309705 0.06210186 ENK_UV_RESPONSE_KERATINOCYTE_UP sleep disorder DOID_535 6.865E-04 3.519E-03 0.16091492 0.30118615 ENK_UV_RESPONSE_KERATINOCYTE_UP aortic aneurysm DOID_3627 7.127E-04 3.621E-03 0.06152724 0.18923784 ENK_UV_RESPONSE_KERATINOCYTE_UP withdrawal disorder DOID_0060001 7.651E-04 3.853E-03 8.087E-03 0.04382551 ENK_UV_RESPONSE_KERATINOCYTE_UP encephalomyelitis DOID_640 8.108E-04 4.047E-03 0.03601398 0.12270633 ENK_UV_RESPONSE_KERATINOCYTE_UP toxic shock syndrome DOID_14115 8.816E-04 4.362E-03 0.01537634 0.07113122 ENK_UV_RESPONSE_KERATINOCYTE_UP acute pancreatitis DOID_2913 8.816E-04 4.325E-03 8.816E-04 7.601E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP dilated cardiomyopathy DOID_12930 8.908E-04 4.332E-03 6.502E-03 0.03663115 ENK_UV_RESPONSE_KERATINOCYTE_UP urticaria DOID_1555 9.91E-04 4.779E-03 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP bronchiolitis DOID_2942 9.91E-04 4.739E-03 0.01657512 0.07544994 ENK_UV_RESPONSE_KERATINOCYTE_UP reproductive organ benign neoplasm DOID_0050622 1.002E-03 4.753E-03 9.84E-03 0.05089908 ENK_UV_RESPONSE_KERATINOCYTE_UP integumentary system cancer DOID_0060122 1.002E-03 4.714E-03 9.84E-03 0.05044053 ENK_UV_RESPONSE_KERATINOCYTE_UP skin cancer DOID_4159 1.002E-03 4.714E-03 9.84E-03 0.05044053 ENK_UV_RESPONSE_KERATINOCYTE_UP mitochondrial metabolism disease DOID_700 1.069E-03 4.985E-03 0.01030977 0.05191378 ENK_UV_RESPONSE_KERATINOCYTE_UP cystitis DOID_1679 1.109E-03 5.129E-03 0.01781243 0.07918183 ENK_UV_RESPONSE_KERATINOCYTE_UP papillary adenoma DOID_3172 1.109E-03 5.087E-03 0.01781243 0.07856802 ENK_UV_RESPONSE_KERATINOCYTE_UP microcystic adenoma DOID_5403 1.109E-03 5.087E-03 0.01781243 0.07856802 ENK_UV_RESPONSE_KERATINOCYTE_UP follicular adenoma DOID_6204 1.109E-03 5.087E-03 0.01781243 0.07856802 ENK_UV_RESPONSE_KERATINOCYTE_UP ankylosing spondylitis DOID_7147 1.109E-03 5.047E-03 0.01781243 0.07736851 ENK_UV_RESPONSE_KERATINOCYTE_UP oral cavity cancer DOID_8618 1.211E-03 5.47E-03 1.211E-03 9.988E-03 ENK_UV_RESPONSE_KERATINOCYTE_UP extrinsic allergic alveolitis DOID_841 1.235E-03 5.532E-03 0.01908764 0.08045085 ENK_UV_RESPONSE_KERATINOCYTE_UP Sciatic Neuropathy DOID_11446 1.37E-03 6.088E-03 1.37E-03 0.01082347 ENK_UV_RESPONSE_KERATINOCYTE_UP lesion of sciatic nerve DOID_12528 1.37E-03 6.088E-03 1.37E-03 0.01082347 ENK_UV_RESPONSE_KERATINOCYTE_UP periodontitis DOID_824 1.37E-03 6.041E-03 0.02040008 0.08535035 ENK_UV_RESPONSE_KERATINOCYTE_UP mononeuritis of lower limb DOID_9473 1.37E-03 6.088E-03 1.37E-03 0.01082347 ENK_UV_RESPONSE_KERATINOCYTE_UP pleurisy DOID_10247 1.513E-03 6.623E-03 0.02174914 0.08967582 ENK_UV_RESPONSE_KERATINOCYTE_UP sarcoma DOID_1115 1.513E-03 6.573E-03 0.02174914 0.08903067 ENK_UV_RESPONSE_KERATINOCYTE_UP invasive ductal carcinoma DOID_3008 1.513E-03 6.523E-03 1.513E-03 0.01179509 ENK_UV_RESPONSE_KERATINOCYTE_UP respiratory failure DOID_11162 1.535E-03 6.565E-03 0.0134003 0.06301465 ENK_UV_RESPONSE_KERATINOCYTE_UP toxic encephalopathy DOID_3602 1.666E-03 7.074E-03 0.02313419 0.09269966 ENK_UV_RESPONSE_KERATINOCYTE_UP focal glomerulosclerosis DOID_3945 1.666E-03 7.022E-03 0.02313419 0.09205141 ENK_UV_RESPONSE_KERATINOCYTE_UP mineral metabolism disease DOID_0050032 1.717E-03 7.183E-03 0.01453504 0.06779045 ENK_UV_RESPONSE_KERATINOCYTE_UP endocrine pancreas disease DOID_1428 1.717E-03 7.13E-03 0.09222839 0.22619808 ENK_UV_RESPONSE_KERATINOCYTE_UP allergic contact dermatitis DOID_3042 2.018E-03 8.319E-03 2.018E-03 0.01551348 ENK_UV_RESPONSE_KERATINOCYTE_UP pleural disease DOID_1532 2.372E-03 9.711E-03 0.02902188 0.10518121 ENK_UV_RESPONSE_KERATINOCYTE_UP bladder disease DOID_365 2.372E-03 9.641E-03 0.02902188 0.10385818 ENK_UV_RESPONSE_KERATINOCYTE_UP nephrosis DOID_2527 2.473E-03 9.978E-03 0.10892675 0.23746867 ENK_UV_RESPONSE_KERATINOCYTE_UP gallbladder disease DOID_0000000 2.486E-03 9.961E-03 0.07343076 0.21875447 ENK_UV_RESPONSE_KERATINOCYTE_UP insulinoma DOID_3892 2.486E-03 9.892E-03 0.07343076 0.2068421 ENK_UV_RESPONSE_KERATINOCYTE_UP periodontal disease DOID_3388 2.785E-03 0.0110041 0.03216583 0.11297753 ENK_UV_RESPONSE_KERATINOCYTE_UP prostatic adenoma DOID_2883 3.023E-03 0.01186321 0.08047153 0.21100598 ENK_UV_RESPONSE_KERATINOCYTE_UP aneurysm disease DOID_2403 3.135E-03 0.01221756 0.12130238 0.25754125 ENK_UV_RESPONSE_KERATINOCYTE_UP mixed glioma DOID_5076 3.28E-03 0.01269794 0.02320656 0.09106572 ENK_UV_RESPONSE_KERATINOCYTE_UP adolescence-adult electroclinical syndrome DOID_0050705 3.482E-03 0.01338809 3.482E-03 0.02476796 ENK_UV_RESPONSE_KERATINOCYTE_UP lipid metabolism disorder DOID_3146 3.585E-03 0.01369158 0.46526414 0.70408323 ENK_UV_RESPONSE_KERATINOCYTE_UP common cold DOID_10459 3.61E-03 0.0136925 3.61E-03 0.02504725 ENK_UV_RESPONSE_KERATINOCYTE_UP otitis media DOID_10754 3.61E-03 0.01360182 3.61E-03 0.02474547 ENK_UV_RESPONSE_KERATINOCYTE_UP pituitary cancer DOID_1785 3.61E-03 0.01351233 0.08745897 0.22117402 ENK_UV_RESPONSE_KERATINOCYTE_UP relapsing-remitting multiple sclerosis DOID_2378 3.61E-03 0.01342402 0.08745897 0.22019538 ENK_UV_RESPONSE_KERATINOCYTE_UP pituitary carcinoma DOID_4916 3.61E-03 0.01351233 0.08745897 0.22117402 ENK_UV_RESPONSE_KERATINOCYTE_UP middle ear disease DOID_5100 3.61E-03 0.01360182 3.61E-03 0.02474547 ENK_UV_RESPONSE_KERATINOCYTE_UP aortic valve insufficiency DOID_57 3.61E-03 0.01333685 0.08745897 0.21826384 ENK_UV_RESPONSE_KERATINOCYTE_UP stomach disease DOID_76 3.61E-03 0.0132508 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP encephalitis DOID_9588 3.61E-03 0.01316586 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP chromosomal disease DOID_0080014 3.745E-03 0.01357157 3.745E-03 0.024776 ENK_UV_RESPONSE_KERATINOCYTE_UP berylliosis DOID_10322 4.245E-03 0.0152859 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP carotid stenosis DOID_13001 4.245E-03 0.01518977 0.0943935 0.22662407 ENK_UV_RESPONSE_KERATINOCYTE_UP bone development disease DOID_0080006 4.252E-03 0.01511952 0.02797076 0.10334649 ENK_UV_RESPONSE_KERATINOCYTE_UP adult respiratory distress syndrome DOID_11394 4.278E-03 0.01511762 0.04234263 0.13926564 ENK_UV_RESPONSE_KERATINOCYTE_UP benign mesothelioma DOID_2645 4.565E-03 0.01603406 4.565E-03 0.02886131 ENK_UV_RESPONSE_KERATINOCYTE_UP tethered spinal cord syndrome DOID_1089 4.927E-03 0.01720016 4.927E-03 0.03047419 ENK_UV_RESPONSE_KERATINOCYTE_UP narcolepsy DOID_8986 4.927E-03 0.01709528 0.10127552 0.2314288 ENK_UV_RESPONSE_KERATINOCYTE_UP nephrotic syndrome DOID_1184 5.174E-03 0.01784394 0.29601152 0.47179427 ENK_UV_RESPONSE_KERATINOCYTE_UP idiopathic generalized epilepsy DOID_1827 5.174E-03 0.01773645 0.0478227 0.15373511 ENK_UV_RESPONSE_KERATINOCYTE_UP amino acid metabolic disorder DOID_9252 5.196E-03 0.01770263 5.196E-03 0.03145042 ENK_UV_RESPONSE_KERATINOCYTE_UP diabetic autonomic neuropathy DOID_11503 5.497E-03 0.01861632 0.04970386 0.15711942 ENK_UV_RESPONSE_KERATINOCYTE_UP autonomic neuropathy DOID_11504 5.497E-03 0.01861632 0.04970386 0.15711942 ENK_UV_RESPONSE_KERATINOCYTE_UP diabetic polyneuropathy DOID_12785 5.497E-03 0.01861632 0.04970386 0.15711942 ENK_UV_RESPONSE_KERATINOCYTE_UP diabetic neuropathy DOID_9743 5.497E-03 0.01861632 0.04970386 0.15711942 ENK_UV_RESPONSE_KERATINOCYTE_UP membranoproliferative glomerulonephritis DOID_2920 5.657E-03 0.01904617 5.657E-03 0.03352919 ENK_UV_RESPONSE_KERATINOCYTE_UP mesenchymal cell neoplasm DOID_3350 5.657E-03 0.01893413 0.10810542 0.23934624 ENK_UV_RESPONSE_KERATINOCYTE_UP adrenal cortex disease DOID_3952 5.657E-03 0.01882341 0.10810542 0.23841854 ENK_UV_RESPONSE_KERATINOCYTE_UP spindle cell sarcoma DOID_4235 5.657E-03 0.01893413 0.10810542 0.23934624 ENK_UV_RESPONSE_KERATINOCYTE_UP panic disorder DOID_594 5.657E-03 0.01871397 5.657E-03 0.03318353 ENK_UV_RESPONSE_KERATINOCYTE_UP epithelioid sarcoma DOID_6193 5.657E-03 0.01893413 0.10810542 0.23934624 ENK_UV_RESPONSE_KERATINOCYTE_UP lymphoma DOID_0060058 5.825E-03 0.01915704 0.03506759 0.12166744 ENK_UV_RESPONSE_KERATINOCYTE_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.271E-03 0.02050622 0.03697344 0.12522553 ENK_UV_RESPONSE_KERATINOCYTE_UP silicosis DOID_10325 6.433E-03 0.02091587 6.433E-03 0.0369725 ENK_UV_RESPONSE_KERATINOCYTE_UP pituitary adenoma DOID_3829 6.433E-03 0.02079703 0.11488359 0.24667458 ENK_UV_RESPONSE_KERATINOCYTE_UP autonomic nervous system disease DOID_11465 6.534E-03 0.02100507 0.05550359 0.17352495 ENK_UV_RESPONSE_KERATINOCYTE_UP heart valve disease DOID_4079 6.534E-03 0.02088706 0.31718728 0.49582298 ENK_UV_RESPONSE_KERATINOCYTE_UP vascular skin disease DOID_9540 6.534E-03 0.02077037 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP adrenal gland disease DOID_9553 7.254E-03 0.02293128 0.12161043 0.25439829 ENK_UV_RESPONSE_KERATINOCYTE_UP calcium metabolism disease DOID_10575 7.681E-03 0.02414484 0.06152724 0.1902663 ENK_UV_RESPONSE_KERATINOCYTE_UP male reproductive organ benign neoplasm DOID_0060087 8.12E-03 0.02538706 0.12828632 0.2664048 ENK_UV_RESPONSE_KERATINOCYTE_UP keratosis DOID_161 8.12E-03 0.02524833 8.12E-03 0.04358911 ENK_UV_RESPONSE_KERATINOCYTE_UP neuroendocrine tumor DOID_169 8.12E-03 0.02511112 0.12828632 0.26447433 ENK_UV_RESPONSE_KERATINOCYTE_UP osteosclerosis DOID_4254 8.12E-03 0.02497538 0.12828632 0.26351955 ENK_UV_RESPONSE_KERATINOCYTE_UP prion disease DOID_649 8.12E-03 0.0248411 8.12E-03 0.0427819 ENK_UV_RESPONSE_KERATINOCYTE_UP atopic dermatitis DOID_3310 8.507E-03 0.0258836 0.34276651 0.52854782 ENK_UV_RESPONSE_KERATINOCYTE_UP vasculitis DOID_865 9.383E-03 0.02839788 0.35272878 0.54243966 ENK_UV_RESPONSE_KERATINOCYTE_UP parasitic protozoa infectious disease DOID_2789 9.84E-03 0.0296238 0.35765333 0.54705577 ENK_UV_RESPONSE_KERATINOCYTE_UP smallpox DOID_8736 9.84E-03 0.02946789 9.84E-03 0.04999017 ENK_UV_RESPONSE_KERATINOCYTE_UP membranous glomerulonephritis DOID_10976 9.984E-03 0.02974252 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP pulmonary edema DOID_11396 9.984E-03 0.02958761 0.14148679 0.28247714 ENK_UV_RESPONSE_KERATINOCYTE_UP subependymal glioma DOID_4843 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP pilocytic astrocytoma DOID_4851 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP subependymal giant cell astrocytoma DOID_5077 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP fibrillary astrocytoma DOID_6726 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP juvenile pilocytic astrocytoma DOID_6811 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP childhood pilocytic astrocytoma DOID_6812 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP gemistocytic astrocytoma DOID_7005 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP childhood cerebral astrocytoma DOID_7007 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP protoplasmic astrocytoma DOID_7008 9.984E-03 0.0294343 0.14148679 0.27760685 ENK_UV_RESPONSE_KERATINOCYTE_UP amyloidosis DOID_9120 9.984E-03 0.02928258 0.14148679 0.27570543 ENK_UV_RESPONSE_KERATINOCYTE_UP Leigh disease DOID_3652 0.01097992 0.03203884 0.01097992 0.05480327 ENK_UV_RESPONSE_KERATINOCYTE_UP benign glioma DOID_0060101 0.01201788 0.03488863 0.15448806 0.29797866 ENK_UV_RESPONSE_KERATINOCYTE_UP gastric ulcer DOID_10808 0.01201788 0.03471153 0.01201788 0.05894975 ENK_UV_RESPONSE_KERATINOCYTE_UP benign ependymoma DOID_4844 0.01201788 0.03488863 0.15448806 0.29797866 ENK_UV_RESPONSE_KERATINOCYTE_UP neuroectodermal tumor DOID_171 0.01285265 0.03693515 0.08532442 0.22168766 ENK_UV_RESPONSE_KERATINOCYTE_UP sinusitis DOID_0050127 0.01309705 0.03744836 0.16091492 0.3072503 ENK_UV_RESPONSE_KERATINOCYTE_UP glycogen metabolism disorder DOID_0050728 0.01309705 0.03726112 0.01309705 0.06262372 ENK_UV_RESPONSE_KERATINOCYTE_UP sexual disorder DOID_0060043 0.01309705 0.03707574 0.16091492 0.30622271 ENK_UV_RESPONSE_KERATINOCYTE_UP paranasal sinus disease DOID_1352 0.01309705 0.03744836 0.16091492 0.3072503 ENK_UV_RESPONSE_KERATINOCYTE_UP optic nerve disease DOID_1891 0.01309705 0.03689219 0.16091492 0.30520196 ENK_UV_RESPONSE_KERATINOCYTE_UP glycogen storage disease DOID_2747 0.01309705 0.03726112 0.01309705 0.06262372 ENK_UV_RESPONSE_KERATINOCYTE_UP uremia DOID_4676 0.01309705 0.03671046 0.16091492 0.30218016 ENK_UV_RESPONSE_KERATINOCYTE_UP lingual-facial-buccal dyskinesia DOID_9854 0.01309705 0.03653051 0.16091492 0.29921761 ENK_UV_RESPONSE_KERATINOCYTE_UP hypoglycemia DOID_9993 0.01309705 0.03635231 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP hypothyroidism DOID_1459 0.0134003 0.03701346 0.08760773 0.21768034 ENK_UV_RESPONSE_KERATINOCYTE_UP pre-malignant neoplasm DOID_0060071 0.01396108 0.03837612 0.08990919 0.22242751 ENK_UV_RESPONSE_KERATINOCYTE_UP in situ carcinoma DOID_8719 0.01396108 0.03837612 0.08990919 0.22242751 ENK_UV_RESPONSE_KERATINOCYTE_UP aortic valve disease DOID_62 0.01421677 0.03889106 0.1672931 0.30706379 ENK_UV_RESPONSE_KERATINOCYTE_UP meningitis DOID_9471 0.01421677 0.03870498 0.1672931 0.30607644 ENK_UV_RESPONSE_KERATINOCYTE_UP parasitic infectious disease DOID_1398 0.01512219 0.04097393 0.40489116 0.61599752 ENK_UV_RESPONSE_KERATINOCYTE_UP spastic quadriplegia DOID_10970 0.01537634 0.04146512 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP hyperglycemia DOID_4195 0.01572258 0.04219882 0.09691845 0.22787849 ENK_UV_RESPONSE_KERATINOCYTE_UP tooth disease DOID_1091 0.01633624 0.04364 0.09928851 0.23249038 ENK_UV_RESPONSE_KERATINOCYTE_UP hypogonadism DOID_1924 0.01657512 0.04407123 0.17990488 0.32497103 ENK_UV_RESPONSE_KERATINOCYTE_UP combined T cell and B cell immunodeficiency DOID_628 0.01657512 0.04386625 0.01657512 0.07485113 ENK_UV_RESPONSE_KERATINOCYTE_UP spinal muscular atrophy DOID_12377 0.01781243 0.04692257 0.01781243 0.07980531 ENK_UV_RESPONSE_KERATINOCYTE_UP spinal cord disease DOID_319 0.01908764 0.05005007 0.01908764 0.08166064 ENK_UV_RESPONSE_KERATINOCYTE_UP juvenile myoclonic epilepsy DOID_4890 0.01908764 0.04982048 0.01908764 0.08105123 ENK_UV_RESPONSE_KERATINOCYTE_UP fragments of torsion dystonia DOID_531 0.01908764 0.04959299 0.1923263 0.3398561 ENK_UV_RESPONSE_KERATINOCYTE_UP perinatal necrotizing enterocolitis DOID_8677 0.02040008 0.05276204 0.02040008 0.08472736 ENK_UV_RESPONSE_KERATINOCYTE_UP renal tubular transport disease DOID_447 0.02174914 0.05599667 0.02174914 0.08776782 ENK_UV_RESPONSE_KERATINOCYTE_UP central nervous system hereditary degenerative disease DOID_481 0.02174914 0.05574443 0.20456022 0.35378348 ENK_UV_RESPONSE_KERATINOCYTE_UP multiple epiphyseal dysplasia DOID_12721 0.02313419 0.05902848 0.21060776 0.36313883 ENK_UV_RESPONSE_KERATINOCYTE_UP supratentorial cancer DOID_1659 0.02313419 0.05876496 0.21060776 0.36204173 ENK_UV_RESPONSE_KERATINOCYTE_UP cerebrum cancer DOID_368 0.02313419 0.05876496 0.21060776 0.36204173 ENK_UV_RESPONSE_KERATINOCYTE_UP dystonic disease DOID_544 0.02313419 0.05850379 0.21060776 0.36095125 ENK_UV_RESPONSE_KERATINOCYTE_UP cranial nerve disease DOID_5656 0.02313419 0.05824492 0.21060776 0.35986731 ENK_UV_RESPONSE_KERATINOCYTE_UP electroclinical syndrome DOID_0050701 0.02320656 0.05816974 0.02320656 0.09169813 ENK_UV_RESPONSE_KERATINOCYTE_UP female reproductive organ benign neoplasm DOID_0060086 0.02455459 0.06127878 0.02455459 0.09569563 ENK_UV_RESPONSE_KERATINOCYTE_UP uterine benign neoplasm DOID_0060095 0.02455459 0.06127878 0.02455459 0.09569563 ENK_UV_RESPONSE_KERATINOCYTE_UP uterine fibroid DOID_13223 0.02455459 0.06127878 0.02455459 0.09569563 ENK_UV_RESPONSE_KERATINOCYTE_UP dysostosis DOID_1934 0.02455459 0.06101119 0.02455459 0.09504464 ENK_UV_RESPONSE_KERATINOCYTE_UP congenital disorder of glycosylation DOID_5212 0.02455459 0.06074592 0.02455459 0.09440245 ENK_UV_RESPONSE_KERATINOCYTE_UP spastic cerebral palsy DOID_0050669 0.02600974 0.06406729 1.000 1.000 ENK_UV_RESPONSE_KERATINOCYTE_UP gonadal disease DOID_2277 0.02600974 0.06379114 0.22256571 0.37690444 ENK_UV_RESPONSE_KERATINOCYTE_UP bronchiolitis obliterans DOID_2799 0.02600974 0.06351736 0.02600974 0.09801023 ENK_UV_RESPONSE_KERATINOCYTE_UP celiac disease DOID_10608 0.02749904 0.06686732 0.22847682 0.3834906 ENK_UV_RESPONSE_KERATINOCYTE_UP endometrial cancer DOID_1380 0.02749904 0.06658278 0.02749904 0.10226767 ENK_UV_RESPONSE_KERATINOCYTE_UP chronic leukemia DOID_1036 0.02902188 0.06997225 0.02902188 0.10653839 ENK_UV_RESPONSE_KERATINOCYTE_UP chronic lymphocytic leukemia DOID_1040 0.02902188 0.06997225 0.02902188 0.10653839 ENK_UV_RESPONSE_KERATINOCYTE_UP leiomyoma DOID_127 0.02902188 0.069677 0.02902188 0.10585545 ENK_UV_RESPONSE_KERATINOCYTE_UP autonomic nervous system neoplasm DOID_2621 0.02902188 0.06938424 0.02902188 0.10451551 ENK_UV_RESPONSE_KERATINOCYTE_UP neuroblastoma DOID_769 0.02902188 0.06938424 0.02902188 0.10451551 ENK_UV_RESPONSE_KERATINOCYTE_UP systemic mycosis DOID_0050136 0.03057767 0.07279789 0.24016502 0.39957279 ENK_UV_RESPONSE_KERATINOCYTE_UP fungal infectious disease DOID_1564 0.03057767 0.07279789 0.24016502 0.39957279 ENK_UV_RESPONSE_KERATINOCYTE_UP male infertility DOID_12336 0.03216583 0.07625983 0.03216583 0.11367925 ENK_UV_RESPONSE_KERATINOCYTE_UP hepatitis C DOID_1883 0.03216583 0.0759434 0.24594277 0.40799253 ENK_UV_RESPONSE_KERATINOCYTE_UP esophageal disease DOID_6050 0.03216583 0.07562958 0.03216583 0.11228441 ENK_UV_RESPONSE_KERATINOCYTE_UP autosomal recessive nonsyndromic deafness DOID_0050565 0.03543695 0.08297788 0.03543695 0.12220379 ENK_UV_RESPONSE_KERATINOCYTE_UP lymphoblastic leukemia DOID_1037 0.03601398 0.08398343 0.03601398 0.12344553 ENK_UV_RESPONSE_KERATINOCYTE_UP calcinosis DOID_182 0.03711877 0.08620646 0.26301466 0.4263685 ENK_UV_RESPONSE_KERATINOCYTE_UP cleft palate DOID_674 0.03711877 0.08585603 0.03711877 0.12497386 ENK_UV_RESPONSE_KERATINOCYTE_UP embryonal cancer DOID_688 0.03711877 0.08550843 0.26301466 0.42395281 ENK_UV_RESPONSE_KERATINOCYTE_UP peripheral nervous system neoplasm DOID_1192 0.03883069 0.08909139 0.03883069 0.12996862 ENK_UV_RESPONSE_KERATINOCYTE_UP respiratory syncytial virus infectious disease DOID_1273 0.04057216 0.09271309 0.04057216 0.13500327 ENK_UV_RESPONSE_KERATINOCYTE_UP hepatitis DOID_2237 0.04057216 0.09234224 0.04057216 0.13421837 ENK_UV_RESPONSE_KERATINOCYTE_UP congenital diaphragmatic hernia DOID_3827 0.04057216 0.09197434 0.27418139 0.43822812 ONDER_CDH1_TARGETS_2_UP Ehlers-Danlos syndrome DOID_13359 3.125E-16 1.778E-13 1.686E-11 9.592E-09 ONDER_CDH1_TARGETS_2_UP aneurysm disease DOID_2403 1.839E-14 5.233E-12 7.602E-07 8.651E-05 ONDER_CDH1_TARGETS_2_UP collagen disease DOID_854 4.266E-12 8.09E-10 6.781E-09 1.286E-06 ONDER_CDH1_TARGETS_2_UP aortic aneurysm DOID_3627 3.792E-11 5.395E-09 1.23E-03 0.02800108 ONDER_CDH1_TARGETS_2_UP atrophic muscular disease DOID_913 6.017E-11 6.848E-09 6.017E-11 1.712E-08 ONDER_CDH1_TARGETS_2_UP muscular dystrophy DOID_9884 6.017E-11 6.848E-09 6.017E-11 1.712E-08 ONDER_CDH1_TARGETS_2_UP aortic valve insufficiency DOID_57 7.023E-10 6.66E-08 1E-03 0.02586363 ONDER_CDH1_TARGETS_2_UP heart valve disease DOID_4079 1.142E-09 9.282E-08 4.706E-05 2.434E-03 ONDER_CDH1_TARGETS_2_UP focal glomerulosclerosis DOID_3945 2.354E-09 1.674E-07 6.707E-03 0.0887512 ONDER_CDH1_TARGETS_2_UP aortic valve disease DOID_62 3.627E-08 2.293E-06 4.054E-03 0.06783931 ONDER_CDH1_TARGETS_2_UP bone development disease DOID_0080006 5.454E-08 3.104E-06 2.44E-05 1.736E-03 ONDER_CDH1_TARGETS_2_UP osteogenesis imperfecta DOID_12347 1.637E-07 8.469E-06 1.179E-03 0.02916128 ONDER_CDH1_TARGETS_2_UP abdominal aortic aneurysm DOID_7693 1.968E-07 9.333E-06 1.000 1.000 ONDER_CDH1_TARGETS_2_UP oral submucous fibrosis DOID_5773 3.106E-07 1.36E-05 0.05774398 0.32531014 ONDER_CDH1_TARGETS_2_UP diabetic retinopathy DOID_8947 6.037E-07 2.454E-05 0.03662697 0.27065903 ONDER_CDH1_TARGETS_2_UP congenital muscular dystrophy DOID_0050557 6.9E-07 2.617E-05 6.9E-07 9.815E-05 ONDER_CDH1_TARGETS_2_UP retinal vascular disease DOID_2462 1.346E-06 4.785E-05 0.04675231 0.28604371 ONDER_CDH1_TARGETS_2_UP ureteral disease DOID_1426 2.352E-06 7.873E-05 0.09078759 0.41998485 ONDER_CDH1_TARGETS_2_UP mouth disease DOID_403 2.399E-06 7.584E-05 6.631E-03 0.08983342 ONDER_CDH1_TARGETS_2_UP spastic quadriplegia DOID_10970 2.792E-06 8.36E-05 1.31E-04 5.324E-03 ONDER_CDH1_TARGETS_2_UP intracranial aneurysm DOID_10941 4.477E-06 1.274E-04 1.85E-04 7.016E-03 ONDER_CDH1_TARGETS_2_UP carotid artery disease DOID_3407 5.729E-06 1.552E-04 0.22426043 0.70112188 ONDER_CDH1_TARGETS_2_UP mineral metabolism disease DOID_0050032 7.188E-06 1.859E-04 0.02907441 0.23300477 ONDER_CDH1_TARGETS_2_UP spastic cerebral palsy DOID_0050669 8.81E-06 2.18E-04 3.036E-04 9.597E-03 ONDER_CDH1_TARGETS_2_UP endogenous depression DOID_1595 1.517E-05 3.597E-04 1.517E-05 1.439E-03 ONDER_CDH1_TARGETS_2_UP mental depression DOID_1596 2.306E-05 5.247E-04 2.306E-05 1.874E-03 ONDER_CDH1_TARGETS_2_UP adenoid cystic carcinoma DOID_4866 2.577E-05 5.639E-04 2.577E-05 1.629E-03 ONDER_CDH1_TARGETS_2_UP thoracic aortic aneurysm DOID_14004 2.668E-05 5.622E-04 1.579E-03 0.03454619 ONDER_CDH1_TARGETS_2_UP salivary gland cancer DOID_8850 3.092E-05 6.283E-04 3.092E-05 1.759E-03 ONDER_CDH1_TARGETS_2_UP spastic diplegia DOID_10965 3.274E-05 6.423E-04 1.799E-03 0.03530532 ONDER_CDH1_TARGETS_2_UP dilated cardiomyopathy DOID_12930 4.361E-05 8.27E-04 6.131E-04 0.01836099 ONDER_CDH1_TARGETS_2_UP pre-eclampsia DOID_10591 4.706E-05 8.638E-04 0.17991939 0.59519846 ONDER_CDH1_TARGETS_2_UP ureteral obstruction DOID_5199 4.743E-05 8.433E-04 0.06888896 0.35961301 ONDER_CDH1_TARGETS_2_UP osteochondrodysplasia DOID_2256 8.459E-05 1.459E-03 0.02224284 0.19775279 ONDER_CDH1_TARGETS_2_UP urinary tract obstruction DOID_5200 1.014E-04 1.698E-03 0.08717367 0.4099324 ONDER_CDH1_TARGETS_2_UP oral cavity cancer DOID_8618 1.031E-04 1.676E-03 1.031E-04 4.889E-03 ONDER_CDH1_TARGETS_2_UP diabetic angiopathy DOID_11713 1.156E-04 1.827E-03 0.09078759 0.42342735 ONDER_CDH1_TARGETS_2_UP synostosis DOID_11971 1.156E-04 1.778E-03 1.156E-04 5.06E-03 ONDER_CDH1_TARGETS_2_UP toxic shock syndrome DOID_14115 1.31E-04 1.961E-03 0.09438729 0.42965094 ONDER_CDH1_TARGETS_2_UP commensal bacterial infectious disease DOID_0050339 1.476E-04 2.154E-03 0.09797283 0.44243287 ONDER_CDH1_TARGETS_2_UP uterine disease DOID_345 1.575E-04 2.24E-03 0.02987907 0.23289303 ONDER_CDH1_TARGETS_2_UP tooth disease DOID_1091 1.762E-04 2.446E-03 0.03151476 0.23909199 ONDER_CDH1_TARGETS_2_UP endocrine organ benign neoplasm DOID_0060089 1.862E-04 2.522E-03 0.03234563 0.2421666 ONDER_CDH1_TARGETS_2_UP renal hypertension DOID_1073 2.279E-04 3.016E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_UP secondary hypertension DOID_11130 2.279E-04 3.016E-03 1.000 1.000 ONDER_CDH1_TARGETS_2_UP female reproductive organ benign neoplasm DOID_0060086 2.768E-04 3.58E-03 7.136E-03 0.09227777 ONDER_CDH1_TARGETS_2_UP uterine benign neoplasm DOID_0060095 2.768E-04 3.58E-03 7.136E-03 0.09227777 ONDER_CDH1_TARGETS_2_UP corneal disease DOID_10124 2.768E-04 3.5E-03 2.768E-04 9.844E-03 ONDER_CDH1_TARGETS_2_UP uterine fibroid DOID_13223 2.768E-04 3.58E-03 7.136E-03 0.09227777 ONDER_CDH1_TARGETS_2_UP dysostosis DOID_1934 2.768E-04 3.424E-03 2.768E-04 9.265E-03 ONDER_CDH1_TARGETS_2_UP female reproductive system disease DOID_229 3.394E-04 4.109E-03 0.04296225 0.27779001 ONDER_CDH1_TARGETS_2_UP leiomyoma DOID_127 3.621E-04 4.292E-03 8.494E-03 0.09863388 ONDER_CDH1_TARGETS_2_UP myocarditis DOID_820 3.939E-04 4.574E-03 8.97E-03 0.10208349 ONDER_CDH1_TARGETS_2_UP calcinosis DOID_182 5.387E-04 6.131E-03 0.14671453 0.53172337 ONDER_CDH1_TARGETS_2_UP hepatitis DOID_2237 6.224E-04 6.944E-03 0.15346065 0.54574442 ONDER_CDH1_TARGETS_2_UP congenital diaphragmatic hernia DOID_3827 6.224E-04 6.81E-03 0.01207152 0.12719802 ONDER_CDH1_TARGETS_2_UP intracranial arterial disease DOID_13089 6.671E-04 7.162E-03 0.01262783 0.13064063 ONDER_CDH1_TARGETS_2_UP cerebral arterial disease DOID_3527 6.671E-04 7.162E-03 0.01262783 0.13064063 ONDER_CDH1_TARGETS_2_UP facioscapulohumeral muscular dystrophy DOID_11727 6.854E-04 7.222E-03 6.854E-04 0.01949883 ONDER_CDH1_TARGETS_2_UP endometriosis of uterus DOID_288 7.626E-04 7.89E-03 0.01377342 0.13994776 ONDER_CDH1_TARGETS_2_UP hyperinsulinism DOID_2018 8.135E-04 8.266E-03 0.16679434 0.57172276 ONDER_CDH1_TARGETS_2_UP endometriosis DOID_289 8.135E-04 8.121E-03 0.0143625 0.14337307 ONDER_CDH1_TARGETS_2_UP craniosynostosis DOID_2340 8.355E-04 8.197E-03 8.355E-04 0.02263812 ONDER_CDH1_TARGETS_2_UP learning disability DOID_8927 9.216E-04 8.888E-03 0.0155728 0.15018511 ONDER_CDH1_TARGETS_2_UP pituitary cancer DOID_1785 1E-03 9.483E-03 0.0464665 0.29377153 ONDER_CDH1_TARGETS_2_UP pituitary carcinoma DOID_4916 1E-03 9.483E-03 0.0464665 0.29377153 ONDER_CDH1_TARGETS_2_UP pituitary gland disease DOID_53 1E-03 9.328E-03 0.0464665 0.28738519 ONDER_CDH1_TARGETS_2_UP glaucoma DOID_1686 1.164E-03 0.01068246 0.01811927 0.17183109 ONDER_CDH1_TARGETS_2_UP newborn respiratory distress syndrome DOID_12716 1.179E-03 0.01064618 1.000 1.000 ONDER_CDH1_TARGETS_2_UP major depressive disorder DOID_1470 1.179E-03 0.01047984 1.179E-03 0.02794623 ONDER_CDH1_TARGETS_2_UP calcium metabolism disease DOID_10575 1.23E-03 0.01076965 0.18962822 0.60959579 ONDER_CDH1_TARGETS_2_UP skeletal system cancer DOID_0060124 1.579E-03 0.01360911 0.05774398 0.33188206 ONDER_CDH1_TARGETS_2_UP bone cancer DOID_184 1.579E-03 0.01360911 0.05774398 0.33188206 ONDER_CDH1_TARGETS_2_UP corneal dystrophy DOID_2566 1.579E-03 0.01340598 1.579E-03 0.0332667 ONDER_CDH1_TARGETS_2_UP membranoproliferative glomerulonephritis DOID_2920 1.579E-03 0.01320884 1.000 1.000 ONDER_CDH1_TARGETS_2_UP reproductive organ benign neoplasm DOID_0050622 1.597E-03 0.01317167 0.02224284 0.20089172 ONDER_CDH1_TARGETS_2_UP parasitic protozoa infectious disease DOID_2789 1.597E-03 0.0129835 0.02224284 0.19471044 ONDER_CDH1_TARGETS_2_UP smallpox DOID_8736 1.597E-03 0.01280064 1.597E-03 0.03245876 ONDER_CDH1_TARGETS_2_UP pituitary adenoma DOID_3829 1.799E-03 0.0142202 0.06147362 0.33959698 ONDER_CDH1_TARGETS_2_UP restrictive cardiomyopathy DOID_397 1.799E-03 0.0140254 0.06147362 0.33633162 ONDER_CDH1_TARGETS_2_UP familial hypertrophic cardiomyopathy DOID_11986 2.034E-03 0.01564002 2.034E-03 0.03857871 ONDER_CDH1_TARGETS_2_UP glucose intolerance DOID_10603 2.282E-03 0.01731544 0.06888896 0.36294276 ONDER_CDH1_TARGETS_2_UP dental caries DOID_216 2.282E-03 0.01708761 2.282E-03 0.0418922 ONDER_CDH1_TARGETS_2_UP congenital heart defect DOID_1682 2.315E-03 0.01710533 0.02827865 0.22986499 ONDER_CDH1_TARGETS_2_UP endocrine pancreas disease DOID_1428 2.416E-03 0.01762673 0.23344769 0.7219116 ONDER_CDH1_TARGETS_2_UP parasitic infectious disease DOID_1398 2.521E-03 0.0181545 0.02987907 0.23612766 ONDER_CDH1_TARGETS_2_UP conduct disorder DOID_12995 2.544E-03 0.01809603 2.544E-03 0.04524007 ONDER_CDH1_TARGETS_2_UP infertility DOID_5223 2.544E-03 0.01787262 2.544E-03 0.04386916 ONDER_CDH1_TARGETS_2_UP hyperglycemia DOID_4195 2.628E-03 0.01823276 0.03069255 0.23600081 ONDER_CDH1_TARGETS_2_UP membranous glomerulonephritis DOID_10976 2.82E-03 0.01932977 0.0762461 0.38392948 ONDER_CDH1_TARGETS_2_UP pancreatic ductal carcinoma DOID_3587 3.083E-03 0.02088667 1.000 1.000 ONDER_CDH1_TARGETS_2_UP coronary restenosis DOID_4247 3.108E-03 0.0208078 1.000 1.000 ONDER_CDH1_TARGETS_2_UP peripheral vascular disease DOID_341 3.328E-03 0.02202187 0.25742203 0.77499015 ONDER_CDH1_TARGETS_2_UP hepatitis B DOID_2043 3.41E-03 0.02230454 1.000 1.000 ONDER_CDH1_TARGETS_2_UP muscular atrophy DOID_767 3.41E-03 0.02205108 0.08354549 0.39947382 ONDER_CDH1_TARGETS_2_UP pancreatic carcinoma DOID_4905 3.455E-03 0.02209046 1.000 1.000 ONDER_CDH1_TARGETS_2_UP pulmonary embolism DOID_9477 3.725E-03 0.02355341 1.000 1.000 ONDER_CDH1_TARGETS_2_UP pancreatitis DOID_4989 3.992E-03 0.02496124 0.04019974 0.28239079 ONDER_CDH1_TARGETS_2_UP bacterial pneumonia DOID_874 3.992E-03 0.02468992 0.27202622 0.80198404 ONDER_CDH1_TARGETS_2_UP Goodpasture syndrome DOID_9808 4.054E-03 0.02480147 0.09078759 0.41659788 ONDER_CDH1_TARGETS_2_UP chromosomal disease DOID_0080014 4.426E-03 0.02679189 4.426E-03 0.07195535 ONDER_CDH1_TARGETS_2_UP chronic kidney failure DOID_784 4.731E-03 0.02833437 0.28634507 0.83127726 ONDER_CDH1_TARGETS_2_UP portal hypertension DOID_10762 4.749E-03 0.02814592 0.09797283 0.43214373 ONDER_CDH1_TARGETS_2_UP reading disorder DOID_13365 4.749E-03 0.02785576 4.749E-03 0.07505579 ONDER_CDH1_TARGETS_2_UP hypogonadism DOID_1924 4.749E-03 0.02757151 4.749E-03 0.07302726 ONDER_CDH1_TARGETS_2_UP dyslexia DOID_4428 4.749E-03 0.02785576 4.749E-03 0.07505579 ONDER_CDH1_TARGETS_2_UP morbid obesity DOID_11981 5.115E-03 0.02940031 5.115E-03 0.07659553 ONDER_CDH1_TARGETS_2_UP teeth hard tissue disease DOID_214 5.495E-03 0.0312643 5.495E-03 0.08016486 ONDER_CDH1_TARGETS_2_UP gestational diabetes DOID_11714 5.886E-03 0.03316185 5.886E-03 0.08373368 ONDER_CDH1_TARGETS_2_UP periodontitis DOID_824 5.886E-03 0.03283674 1.000 1.000 ONDER_CDH1_TARGETS_2_UP malaria DOID_12365 6.291E-03 0.03475072 6.291E-03 0.08730059 ONDER_CDH1_TARGETS_2_UP hepatic vascular disease DOID_272 6.291E-03 0.03441658 0.11217454 0.45590937 ONDER_CDH1_TARGETS_2_UP coronary stenosis DOID_4248 6.291E-03 0.0340888 1.000 1.000 ONDER_CDH1_TARGETS_2_UP endometrial carcinoma DOID_2871 7.136E-03 0.03830398 7.136E-03 0.09022715 ONDER_CDH1_TARGETS_2_UP ulcerative colitis DOID_8577 7.419E-03 0.03945196 0.059859 0.33391935 ONDER_CDH1_TARGETS_2_UP age related macular degeneration DOID_10871 7.576E-03 0.03991691 7.576E-03 0.09371797 ONDER_CDH1_TARGETS_2_UP degeneration of macula and posterior pole DOID_2007 7.576E-03 0.03991691 7.576E-03 0.09371797 ONDER_CDH1_TARGETS_2_UP gonadal disease DOID_2277 7.576E-03 0.0395507 7.576E-03 0.09172397 ONDER_CDH1_TARGETS_2_UP endometrial cancer DOID_1380 8.029E-03 0.04153326 8.029E-03 0.09518038 ONDER_CDH1_TARGETS_2_UP allergic rhinitis DOID_4481 8.029E-03 0.04115908 1.000 1.000 ONDER_CDH1_TARGETS_2_UP metal metabolism disorder DOID_896 8.97E-03 0.04557299 0.13306169 0.50813491 ONDER_CDH1_TARGETS_2_UP periodontal disease DOID_3388 9.459E-03 0.04762784 1.000 1.000 ONDER_CDH1_TARGETS_2_UP macular degeneration DOID_4448 9.459E-03 0.04721005 9.459E-03 0.10552835 ONDER_CDH1_TARGETS_2_UP cleft palate DOID_674 0.01099233 0.05438815 0.01099233 0.12028149 ONDER_CDH1_TARGETS_2_UP microcephaly DOID_10907 0.01152632 0.05653859 0.01152632 0.12374483 ONDER_CDH1_TARGETS_2_UP systemic scleroderma DOID_418 0.01207152 0.05870678 0.15346065 0.5423547 ONDER_CDH1_TARGETS_2_UP adult respiratory distress syndrome DOID_11394 0.01262783 0.06089182 1.000 1.000 ONDER_CDH1_TARGETS_2_UP cervix uteri carcinoma in situ DOID_8991 0.01319516 0.06309283 0.16015378 0.56251543 ONDER_CDH1_TARGETS_2_UP pulmonary emphysema DOID_9675 0.01319516 0.06256705 1.000 1.000 ONDER_CDH1_TARGETS_2_UP autoimmune disease of urogenital tract DOID_0060049 0.01377342 0.06476921 1.000 1.000 ONDER_CDH1_TARGETS_2_UP primary biliary cirrhosis DOID_12236 0.01377342 0.06476921 1.000 1.000 ONDER_CDH1_TARGETS_2_UP nephrotic syndrome DOID_1184 0.0143625 0.06698578 1.000 1.000 ONDER_CDH1_TARGETS_2_UP rheumatic disease DOID_1575 0.0143625 0.06644118 0.16679434 0.57869499 ONDER_CDH1_TARGETS_2_UP scleroderma DOID_419 0.0143625 0.06644118 0.16679434 0.57869499 ONDER_CDH1_TARGETS_2_UP diabetic autonomic neuropathy DOID_11503 0.01496233 0.06865778 0.17009503 0.57609568 ONDER_CDH1_TARGETS_2_UP autonomic neuropathy DOID_11504 0.01496233 0.06865778 0.17009503 0.57609568 ONDER_CDH1_TARGETS_2_UP diabetic polyneuropathy DOID_12785 0.01496233 0.06865778 0.17009503 0.57609568 ONDER_CDH1_TARGETS_2_UP uterine cancer DOID_363 0.01496233 0.06810852 0.01496233 0.1467856 ONDER_CDH1_TARGETS_2_UP diabetic neuropathy DOID_9743 0.01496233 0.06865778 0.17009503 0.57609568 ONDER_CDH1_TARGETS_2_UP autonomic nervous system disease DOID_11465 0.0168253 0.0759809 0.17991939 0.58835709 ONDER_CDH1_TARGETS_2_UP thyroid adenoma DOID_2891 0.0168253 0.07538263 0.17991939 0.58167122 ONDER_CDH1_TARGETS_2_UP lung small cell carcinoma DOID_5409 0.01811927 0.08054582 0.01811927 0.16901418 ONDER_CDH1_TARGETS_2_UP orofacial cleft DOID_0050567 0.02013642 0.08881876 0.02013642 0.18480033 ONDER_CDH1_TARGETS_2_UP sarcoidosis DOID_11335 0.02082876 0.09116586 1.000 1.000 ONDER_CDH1_TARGETS_2_UP giant cell tumor DOID_200 0.02082876 0.09046994 0.19922286 0.63328383 ONDER_CDH1_TARGETS_2_UP malignant giant cell tumor DOID_2705 0.02082876 0.09046994 0.19922286 0.63328383 ONDER_CDH1_TARGETS_2_UP giant cell glioblastoma DOID_3074 0.02082876 0.09046994 0.19922286 0.63328383 BENPORATH_MYC_TARGETS_WITH_EBOX pancreatic ductal carcinoma DOID_3587 2.099E-16 1.194E-13 6.985E-10 3.974E-07 BENPORATH_MYC_TARGETS_WITH_EBOX pancreatic carcinoma DOID_4905 3.504E-16 9.969E-14 9.697E-10 2.759E-07 BENPORATH_MYC_TARGETS_WITH_EBOX papilloma DOID_2615 1.786E-12 3.388E-10 1.43E-05 6.779E-04 BENPORATH_MYC_TARGETS_WITH_EBOX nephroblastoma DOID_2154 2.271E-12 3.231E-10 4.199E-07 3.413E-05 BENPORATH_MYC_TARGETS_WITH_EBOX transitional cell carcinoma DOID_2671 4.206E-12 4.786E-10 1.988E-06 1.257E-04 BENPORATH_MYC_TARGETS_WITH_EBOX lymphoma DOID_0060058 6.555E-12 6.217E-10 1.266E-07 1.201E-05 BENPORATH_MYC_TARGETS_WITH_EBOX pre-malignant neoplasm DOID_0060071 7.659E-12 6.226E-10 2.54E-03 0.0222347 BENPORATH_MYC_TARGETS_WITH_EBOX in situ carcinoma DOID_8719 7.659E-12 6.226E-10 2.54E-03 0.0222347 BENPORATH_MYC_TARGETS_WITH_EBOX alcohol-related neurodevelopmental disorder DOID_0050667 8.122E-12 5.777E-10 6.365E-09 1.207E-06 BENPORATH_MYC_TARGETS_WITH_EBOX biliary tract cancer DOID_4607 7.976E-11 5.043E-09 0.04755222 0.17124817 BENPORATH_MYC_TARGETS_WITH_EBOX spindle cell carcinoma DOID_4015 1.547E-10 8.805E-09 0.01007109 0.06228753 BENPORATH_MYC_TARGETS_WITH_EBOX endocrine organ benign neoplasm DOID_0060089 5.566E-10 2.879E-08 2.11E-04 4.141E-03 BENPORATH_MYC_TARGETS_WITH_EBOX cervix uteri carcinoma in situ DOID_8991 5.623E-10 2.666E-08 0.01404116 0.07756718 BENPORATH_MYC_TARGETS_WITH_EBOX diabetic autonomic neuropathy DOID_11503 9.135E-10 3.998E-08 3.962E-08 5.636E-06 BENPORATH_MYC_TARGETS_WITH_EBOX autonomic neuropathy DOID_11504 9.135E-10 3.998E-08 3.962E-08 5.636E-06 BENPORATH_MYC_TARGETS_WITH_EBOX diabetic polyneuropathy DOID_12785 9.135E-10 3.998E-08 3.962E-08 5.636E-06 BENPORATH_MYC_TARGETS_WITH_EBOX gallbladder cancer DOID_3121 9.135E-10 3.713E-08 0.17524726 0.3548601 BENPORATH_MYC_TARGETS_WITH_EBOX diabetic neuropathy DOID_9743 9.135E-10 3.998E-08 3.962E-08 5.636E-06 BENPORATH_MYC_TARGETS_WITH_EBOX myeloma DOID_0070004 1.436E-09 5.447E-08 1.141E-03 0.01248617 BENPORATH_MYC_TARGETS_WITH_EBOX autonomic nervous system disease DOID_11465 1.436E-09 5.107E-08 5.804E-08 6.605E-06 BENPORATH_MYC_TARGETS_WITH_EBOX thyroid adenoma DOID_2891 1.436E-09 4.806E-08 1.141E-03 0.01225058 BENPORATH_MYC_TARGETS_WITH_EBOX mixed glioma DOID_5076 1.47E-09 4.648E-08 3.339E-04 5.937E-03 BENPORATH_MYC_TARGETS_WITH_EBOX hemangioma DOID_255 3.111E-09 9.316E-08 1.684E-03 0.01596987 BENPORATH_MYC_TARGETS_WITH_EBOX bile duct adenocarcinoma DOID_4896 3.711E-09 1.056E-07 0.02288595 0.11323572 BENPORATH_MYC_TARGETS_WITH_EBOX cholangiocarcinoma DOID_4947 3.711E-09 1.056E-07 0.02288595 0.11323572 BENPORATH_MYC_TARGETS_WITH_EBOX bone marrow cancer DOID_4960 3.711E-09 1.006E-07 1.668E-03 0.01608892 BENPORATH_MYC_TARGETS_WITH_EBOX nervous system cancer DOID_3093 4.53E-09 1.172E-07 6.453E-03 0.04370884 BENPORATH_MYC_TARGETS_WITH_EBOX bile duct cancer DOID_4606 6.041E-09 1.494E-07 0.02596524 0.12311853 BENPORATH_MYC_TARGETS_WITH_EBOX bile duct carcinoma DOID_4897 6.041E-09 1.494E-07 0.02596524 0.12311853 BENPORATH_MYC_TARGETS_WITH_EBOX lymphatic system cancer DOID_0060073 6.368E-09 1.51E-07 4.37E-05 1.381E-03 BENPORATH_MYC_TARGETS_WITH_EBOX reticulosarcoma DOID_8538 6.368E-09 1.51E-07 4.37E-05 1.381E-03 BENPORATH_MYC_TARGETS_WITH_EBOX lymphosarcoma DOID_8675 6.368E-09 1.51E-07 4.37E-05 1.381E-03 BENPORATH_MYC_TARGETS_WITH_EBOX adenoma DOID_657 1.237E-08 2.815E-07 5.498E-04 8.939E-03 BENPORATH_MYC_TARGETS_WITH_EBOX multiple myeloma DOID_9538 1.45E-08 3.173E-07 5.927E-04 9.114E-03 BENPORATH_MYC_TARGETS_WITH_EBOX astrocytoma DOID_3069 1.964E-08 4.14E-07 3.252E-03 0.02681602 BENPORATH_MYC_TARGETS_WITH_EBOX brain cancer DOID_1319 5.804E-08 1.18E-06 0.01789485 0.09427934 BENPORATH_MYC_TARGETS_WITH_EBOX central nervous system cancer DOID_3620 6.556E-08 1.286E-06 0.01857591 0.09608813 BENPORATH_MYC_TARGETS_WITH_EBOX papillary adenoma DOID_3172 8.038E-08 1.525E-06 1.824E-04 3.992E-03 BENPORATH_MYC_TARGETS_WITH_EBOX microcystic adenoma DOID_5403 8.038E-08 1.525E-06 1.824E-04 3.992E-03 BENPORATH_MYC_TARGETS_WITH_EBOX follicular adenoma DOID_6204 8.038E-08 1.525E-06 1.824E-04 3.992E-03 BENPORATH_MYC_TARGETS_WITH_EBOX B-cell lymphocytic neoplasm DOID_707 9.308E-08 1.708E-06 7.25E-05 1.964E-03 BENPORATH_MYC_TARGETS_WITH_EBOX sarcoma DOID_1115 1.405E-07 2.498E-06 6.702E-03 0.04486362 BENPORATH_MYC_TARGETS_WITH_EBOX reproductive organ benign neoplasm DOID_0050622 1.439E-07 2.481E-06 1.754E-03 0.01609746 BENPORATH_MYC_TARGETS_WITH_EBOX integumentary system cancer DOID_0060122 1.439E-07 2.408E-06 0.02364067 0.11497042 BENPORATH_MYC_TARGETS_WITH_EBOX skin cancer DOID_4159 1.439E-07 2.408E-06 0.02364067 0.11497042 BENPORATH_MYC_TARGETS_WITH_EBOX glioblastoma DOID_3068 1.954E-07 3.177E-06 2.028E-03 0.01831333 BENPORATH_MYC_TARGETS_WITH_EBOX neuroectodermal tumor DOID_171 2.612E-07 4.129E-06 1.411E-04 3.491E-03 BENPORATH_MYC_TARGETS_WITH_EBOX uterine disease DOID_345 3.763E-07 5.787E-06 1.786E-04 4.064E-03 BENPORATH_MYC_TARGETS_WITH_EBOX hyperglycemia DOID_4195 4.107E-07 6.15E-06 9.745E-06 5.041E-04 BENPORATH_MYC_TARGETS_WITH_EBOX brain infarction DOID_3454 4.874E-07 7.111E-06 2.11E-04 4.003E-03 BENPORATH_MYC_TARGETS_WITH_EBOX nephrosis DOID_2527 6.241E-07 8.879E-06 2.476E-04 4.544E-03 BENPORATH_MYC_TARGETS_WITH_EBOX adult respiratory distress syndrome DOID_11394 9.092E-07 1.262E-05 2.93E-05 1.191E-03 BENPORATH_MYC_TARGETS_WITH_EBOX intracranial arterial disease DOID_13089 9.092E-07 1.232E-05 2.93E-05 1.111E-03 BENPORATH_MYC_TARGETS_WITH_EBOX cerebral arterial disease DOID_3527 9.092E-07 1.232E-05 2.93E-05 1.111E-03 BENPORATH_MYC_TARGETS_WITH_EBOX female reproductive system disease DOID_229 1.234E-06 1.633E-05 3.843E-04 6.431E-03 BENPORATH_MYC_TARGETS_WITH_EBOX nephrotic syndrome DOID_1184 1.282E-06 1.658E-05 3.837E-05 1.284E-03 BENPORATH_MYC_TARGETS_WITH_EBOX chronic kidney failure DOID_784 1.42E-06 1.796E-05 0.04755222 0.17017113 BENPORATH_MYC_TARGETS_WITH_EBOX cerebral infarction DOID_3526 1.591E-06 1.968E-05 1.013E-03 0.01226361 BENPORATH_MYC_TARGETS_WITH_EBOX muscular atrophy DOID_767 1.856E-06 2.247E-05 1.856E-06 1.32E-04 BENPORATH_MYC_TARGETS_WITH_EBOX bone marrow disease DOID_4961 1.956E-06 2.318E-05 5.347E-05 1.601E-03 BENPORATH_MYC_TARGETS_WITH_EBOX integumentary system benign neoplasm DOID_0060121 2.383E-06 2.767E-05 1.279E-03 0.01323161 BENPORATH_MYC_TARGETS_WITH_EBOX skin benign neoplasm DOID_3165 2.383E-06 2.767E-05 1.279E-03 0.01323161 BENPORATH_MYC_TARGETS_WITH_EBOX giant cell tumor DOID_200 3.457E-06 3.934E-05 0.02214147 0.11051315 BENPORATH_MYC_TARGETS_WITH_EBOX malignant giant cell tumor DOID_2705 3.457E-06 3.934E-05 0.02214147 0.11051315 BENPORATH_MYC_TARGETS_WITH_EBOX giant cell glioblastoma DOID_3074 3.457E-06 3.934E-05 0.02214147 0.11051315 BENPORATH_MYC_TARGETS_WITH_EBOX osteosarcoma DOID_3347 3.746E-06 4.179E-05 5.061E-03 0.03691942 BENPORATH_MYC_TARGETS_WITH_EBOX middle cerebral artery infarction DOID_3525 5.098E-06 5.578E-05 2.037E-04 4.293E-03 BENPORATH_MYC_TARGETS_WITH_EBOX lung adenocarcinoma DOID_3910 5.895E-06 6.329E-05 6.272E-03 0.04299638 BENPORATH_MYC_TARGETS_WITH_EBOX perinatal necrotizing enterocolitis DOID_8677 5.895E-06 6.211E-05 5.895E-06 3.354E-04 BENPORATH_MYC_TARGETS_WITH_EBOX carotid artery disease DOID_3407 6.721E-06 6.953E-05 0.02837852 0.1312795 BENPORATH_MYC_TARGETS_WITH_EBOX respiratory failure DOID_11162 7.257E-06 7.373E-05 1.499E-04 3.553E-03 BENPORATH_MYC_TARGETS_WITH_EBOX supratentorial cancer DOID_1659 7.76E-06 7.746E-05 0.11931424 0.26833914 BENPORATH_MYC_TARGETS_WITH_EBOX cerebrum cancer DOID_368 7.76E-06 7.746E-05 0.11931424 0.26833914 BENPORATH_MYC_TARGETS_WITH_EBOX teratoma DOID_3307 7.876E-06 7.727E-05 7.315E-04 0.01015135 BENPORATH_MYC_TARGETS_WITH_EBOX malignant teratoma DOID_5563 7.876E-06 7.727E-05 7.315E-04 0.01015135 BENPORATH_MYC_TARGETS_WITH_EBOX mature teratoma DOID_5566 7.876E-06 7.727E-05 7.315E-04 0.01015135 BENPORATH_MYC_TARGETS_WITH_EBOX beta thalassemia DOID_12241 1.435E-05 1.384E-04 1.435E-05 6.282E-04 BENPORATH_MYC_TARGETS_WITH_EBOX peripheral vascular disease DOID_341 1.467E-05 1.391E-04 0.03794645 0.16482083 BENPORATH_MYC_TARGETS_WITH_EBOX bone resorption disease DOID_0080011 1.891E-05 1.764E-04 4.223E-03 0.03432695 BENPORATH_MYC_TARGETS_WITH_EBOX osteoporosis DOID_11476 1.891E-05 1.764E-04 4.223E-03 0.03432695 BENPORATH_MYC_TARGETS_WITH_EBOX bacterial pneumonia DOID_874 2.01E-05 1.845E-04 4.375E-03 0.03457089 BENPORATH_MYC_TARGETS_WITH_EBOX contact dermatitis DOID_2773 2.267E-05 2.047E-04 4.687E-03 0.03604211 BENPORATH_MYC_TARGETS_WITH_EBOX congenital diaphragmatic hernia DOID_3827 2.665E-05 2.37E-04 0.01284768 0.0723795 BENPORATH_MYC_TARGETS_WITH_EBOX thalassemia DOID_10241 2.942E-05 2.575E-04 2.942E-05 1.046E-03 BENPORATH_MYC_TARGETS_WITH_EBOX mesenchymal cell neoplasm DOID_3350 2.942E-05 2.536E-04 0.05961408 0.18535743 BENPORATH_MYC_TARGETS_WITH_EBOX spindle cell sarcoma DOID_4235 2.942E-05 2.536E-04 0.05961408 0.18535743 BENPORATH_MYC_TARGETS_WITH_EBOX epithelioid sarcoma DOID_6193 2.942E-05 2.536E-04 0.05961408 0.18535743 BENPORATH_MYC_TARGETS_WITH_EBOX hyperhomocysteinemia DOID_9279 2.942E-05 2.498E-04 0.05961408 0.17947307 BENPORATH_MYC_TARGETS_WITH_EBOX endometriosis of uterus DOID_288 3.514E-05 2.941E-04 8.386E-04 0.01109628 BENPORATH_MYC_TARGETS_WITH_EBOX amino acid metabolic disorder DOID_9252 3.751E-05 3.093E-04 6.261E-03 0.0439797 BENPORATH_MYC_TARGETS_WITH_EBOX primitive neuroectodermal tumor DOID_168 3.837E-05 3.119E-04 8.944E-04 0.01130902 BENPORATH_MYC_TARGETS_WITH_EBOX endometriosis DOID_289 3.837E-05 3.075E-04 8.944E-04 0.01106317 BENPORATH_MYC_TARGETS_WITH_EBOX uterine cancer DOID_363 4.181E-05 3.304E-04 0.01591754 0.08625789 BENPORATH_MYC_TARGETS_WITH_EBOX drug-induced mental disorder DOID_1203 4.37E-05 3.406E-04 0.06729107 0.19337686 BENPORATH_MYC_TARGETS_WITH_EBOX drug psychosis DOID_1742 4.37E-05 3.406E-04 0.06729107 0.19337686 BENPORATH_MYC_TARGETS_WITH_EBOX substance-induced psychosis DOID_8646 4.37E-05 3.406E-04 0.06729107 0.19337686 BENPORATH_MYC_TARGETS_WITH_EBOX lymphoblastic leukemia DOID_1037 4.613E-05 3.547E-04 6.409E-04 9.597E-03 BENPORATH_MYC_TARGETS_WITH_EBOX carbohydrate metabolic disorder DOID_2978 4.613E-05 3.5E-04 6.409E-04 9.351E-03 BENPORATH_MYC_TARGETS_WITH_EBOX vascular skin disease DOID_9540 5.347E-05 4.003E-04 0.01789485 0.09341439 BENPORATH_MYC_TARGETS_WITH_EBOX dissociative disorder DOID_10935 6.19E-05 4.574E-04 6.19E-05 1.761E-03 BENPORATH_MYC_TARGETS_WITH_EBOX dissociative amnesia DOID_11037 6.19E-05 4.574E-04 6.19E-05 1.761E-03 BENPORATH_MYC_TARGETS_WITH_EBOX testicular cancer DOID_2998 6.19E-05 4.516E-04 0.07490579 0.20295902 BENPORATH_MYC_TARGETS_WITH_EBOX lung small cell carcinoma DOID_5409 6.245E-05 4.498E-04 0.01926779 0.09702099 BENPORATH_MYC_TARGETS_WITH_EBOX amnestic disorder DOID_10914 7.261E-05 5.164E-04 7.261E-05 1.878E-03 BENPORATH_MYC_TARGETS_WITH_EBOX orofacial cleft DOID_0050567 7.793E-05 5.475E-04 1.505E-03 0.01476211 BENPORATH_MYC_TARGETS_WITH_EBOX coronary restenosis DOID_4247 8.446E-05 5.86E-04 0.08245874 0.21326829 BENPORATH_MYC_TARGETS_WITH_EBOX vasculitis DOID_865 8.969E-05 6.149E-04 0.02288595 0.11225955 BENPORATH_MYC_TARGETS_WITH_EBOX hypertrophic cardiomyopathy DOID_11984 1.17E-04 7.925E-04 0.02596524 0.12520528 BENPORATH_MYC_TARGETS_WITH_EBOX spastic quadriplegia DOID_10970 1.443E-04 9.66E-04 0.09738132 0.24091293 BENPORATH_MYC_TARGETS_WITH_EBOX portal hypertension DOID_10762 1.626E-04 1.076E-03 5.061E-03 0.03789099 BENPORATH_MYC_TARGETS_WITH_EBOX urticaria DOID_1555 1.626E-04 1.064E-03 0.10107414 0.24577429 BENPORATH_MYC_TARGETS_WITH_EBOX spinal cord disease DOID_319 2.037E-04 1.317E-03 5.855E-03 0.04164339 BENPORATH_MYC_TARGETS_WITH_EBOX seminoma DOID_4440 2.037E-04 1.302E-03 2.037E-04 4.14E-03 BENPORATH_MYC_TARGETS_WITH_EBOX diffuse large B-cell lymphoma DOID_0050745 2.265E-04 1.432E-03 0.11206275 0.26240208 BENPORATH_MYC_TARGETS_WITH_EBOX gestational diabetes DOID_11714 2.265E-04 1.416E-03 6.272E-03 0.04352073 BENPORATH_MYC_TARGETS_WITH_EBOX male reproductive system disease DOID_48 2.476E-04 1.531E-03 0.26174336 0.49315222 BENPORATH_MYC_TARGETS_WITH_EBOX autoimmune disease of cardiovascular system DOID_0060051 2.509E-04 1.535E-03 0.11569588 0.26869778 BENPORATH_MYC_TARGETS_WITH_EBOX Behcet's disease DOID_13241 2.509E-04 1.535E-03 0.11569588 0.26869778 BENPORATH_MYC_TARGETS_WITH_EBOX hepatic vascular disease DOID_272 2.509E-04 1.519E-03 6.702E-03 0.04434195 BENPORATH_MYC_TARGETS_WITH_EBOX coronary stenosis DOID_4248 2.509E-04 1.503E-03 0.11569588 0.26332382 BENPORATH_MYC_TARGETS_WITH_EBOX female reproductive organ benign neoplasm DOID_0060086 3.047E-04 1.806E-03 0.12291789 0.27427561 BENPORATH_MYC_TARGETS_WITH_EBOX uterine benign neoplasm DOID_0060095 3.047E-04 1.806E-03 0.12291789 0.27427561 BENPORATH_MYC_TARGETS_WITH_EBOX uterine fibroid DOID_13223 3.047E-04 1.806E-03 0.12291789 0.27427561 BENPORATH_MYC_TARGETS_WITH_EBOX pancreatitis DOID_4989 3.339E-04 1.959E-03 0.04264691 0.16969294 BENPORATH_MYC_TARGETS_WITH_EBOX spastic cerebral palsy DOID_0050669 3.342E-04 1.94E-03 0.12650689 0.28008724 BENPORATH_MYC_TARGETS_WITH_EBOX germinoma DOID_3304 3.655E-04 2.1E-03 3.655E-04 6.301E-03 BENPORATH_MYC_TARGETS_WITH_EBOX metabolic syndrome X DOID_14221 3.669E-04 2.088E-03 0.04458502 0.16473297 BENPORATH_MYC_TARGETS_WITH_EBOX chronic leukemia DOID_1036 3.985E-04 2.245E-03 9.046E-03 0.05783047 BENPORATH_MYC_TARGETS_WITH_EBOX chronic lymphocytic leukemia DOID_1040 3.985E-04 2.245E-03 9.046E-03 0.05783047 BENPORATH_MYC_TARGETS_WITH_EBOX leiomyoma DOID_127 3.985E-04 2.223E-03 0.13364118 0.28913243 BENPORATH_MYC_TARGETS_WITH_EBOX bone development disease DOID_0080006 4.399E-04 2.43E-03 0.04855696 0.16445781 BENPORATH_MYC_TARGETS_WITH_EBOX thyroid carcinoma DOID_3963 4.703E-04 2.573E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX hyperthyroidism DOID_7998 4.703E-04 2.549E-03 0.01007109 0.06032056 BENPORATH_MYC_TARGETS_WITH_EBOX lymphoid leukemia DOID_10747 5.091E-04 2.733E-03 0.01060232 0.06284082 BENPORATH_MYC_TARGETS_WITH_EBOX aplastic anemia DOID_12449 5.091E-04 2.707E-03 0.01060232 0.06219298 BENPORATH_MYC_TARGETS_WITH_EBOX thyroid cancer DOID_1781 5.498E-04 2.897E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX Human immunodeficiency virus infectious disease DOID_526 5.679E-04 2.965E-03 5.679E-04 8.976E-03 BENPORATH_MYC_TARGETS_WITH_EBOX medulloblastoma DOID_3858 5.927E-04 3.066E-03 0.01170112 0.06793813 BENPORATH_MYC_TARGETS_WITH_EBOX hypersensitivity reaction type I disease DOID_1205 6.932E-04 3.553E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX dilated cardiomyopathy DOID_12930 6.932E-04 3.522E-03 6.932E-04 9.86E-03 BENPORATH_MYC_TARGETS_WITH_EBOX rectal neoplasm DOID_1984 7.315E-04 3.683E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX rectum cancer DOID_1993 7.315E-04 3.683E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX polycythemia DOID_8432 7.315E-04 3.651E-03 7.315E-04 9.91E-03 BENPORATH_MYC_TARGETS_WITH_EBOX Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.315E-04 3.619E-03 0.04014583 0.16552883 BENPORATH_MYC_TARGETS_WITH_EBOX Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.315E-04 3.619E-03 0.04014583 0.16552883 BENPORATH_MYC_TARGETS_WITH_EBOX Hodgkin's granuloma DOID_8651 7.315E-04 3.619E-03 0.04014583 0.16552883 BENPORATH_MYC_TARGETS_WITH_EBOX Hodgkin's lymphoma, mixed cellularity DOID_8654 7.315E-04 3.619E-03 0.04014583 0.16552883 BENPORATH_MYC_TARGETS_WITH_EBOX nervous system benign neoplasm DOID_0060115 8.916E-04 4.374E-03 0.04407125 0.17175714 BENPORATH_MYC_TARGETS_WITH_EBOX invasive lobular carcinoma DOID_3457 8.916E-04 4.336E-03 0.04407125 0.16389897 BENPORATH_MYC_TARGETS_WITH_EBOX rheumatic disease DOID_1575 8.944E-04 4.313E-03 8.944E-04 0.01156604 BENPORATH_MYC_TARGETS_WITH_EBOX scleroderma DOID_419 8.944E-04 4.313E-03 8.944E-04 0.01156604 BENPORATH_MYC_TARGETS_WITH_EBOX learning disability DOID_8927 1.013E-03 4.844E-03 1.013E-03 0.01200812 BENPORATH_MYC_TARGETS_WITH_EBOX mucopolysaccharidosis DOID_12798 1.067E-03 5.06E-03 1.067E-03 0.01239108 BENPORATH_MYC_TARGETS_WITH_EBOX porphyria DOID_13268 1.067E-03 5.018E-03 1.067E-03 0.01214326 BENPORATH_MYC_TARGETS_WITH_EBOX lipodystrophy DOID_811 1.067E-03 4.977E-03 1.067E-03 0.01190516 BENPORATH_MYC_TARGETS_WITH_EBOX peritonitis DOID_8283 1.067E-03 4.936E-03 0.04798072 0.1654608 BENPORATH_MYC_TARGETS_WITH_EBOX Hodgkin's lymphoma DOID_8567 1.067E-03 4.896E-03 0.04798072 0.16446405 BENPORATH_MYC_TARGETS_WITH_EBOX berylliosis DOID_10322 1.258E-03 5.725E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX newborn respiratory distress syndrome DOID_12716 1.258E-03 5.68E-03 0.05187431 0.172611 BENPORATH_MYC_TARGETS_WITH_EBOX obstructive hydrocephalus DOID_14159 1.258E-03 5.635E-03 1.258E-03 0.01325244 BENPORATH_MYC_TARGETS_WITH_EBOX communicating hydrocephalus DOID_1573 1.258E-03 5.635E-03 1.258E-03 0.01325244 BENPORATH_MYC_TARGETS_WITH_EBOX withdrawal disorder DOID_0060001 1.427E-03 6.343E-03 1.427E-03 0.01449855 BENPORATH_MYC_TARGETS_WITH_EBOX hydrocephalus DOID_10908 1.463E-03 6.455E-03 1.463E-03 0.01460816 BENPORATH_MYC_TARGETS_WITH_EBOX skeletal system cancer DOID_0060124 1.684E-03 7.371E-03 0.05961408 0.18740558 BENPORATH_MYC_TARGETS_WITH_EBOX bone cancer DOID_184 1.684E-03 7.371E-03 0.05961408 0.18740558 BENPORATH_MYC_TARGETS_WITH_EBOX intracranial hypertension DOID_9428 1.684E-03 7.314E-03 1.684E-03 0.01570807 BENPORATH_MYC_TARGETS_WITH_EBOX angiosarcoma DOID_0001816 1.919E-03 8.274E-03 0.06346039 0.18905216 BENPORATH_MYC_TARGETS_WITH_EBOX spastic diplegia DOID_10965 1.919E-03 8.212E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX chronic myeloid leukemia DOID_8552 1.919E-03 8.15E-03 0.06346039 0.18612867 BENPORATH_MYC_TARGETS_WITH_EBOX hypersensitivity reaction type IV disease DOID_2916 2.028E-03 8.546E-03 0.02596524 0.12415314 BENPORATH_MYC_TARGETS_WITH_EBOX melancholia DOID_2848 2.124E-03 8.888E-03 0.02675994 0.12583805 BENPORATH_MYC_TARGETS_WITH_EBOX urinary system benign neoplasm DOID_731 2.17E-03 9.011E-03 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX neurotic disorder DOID_4964 2.224E-03 9.17E-03 0.02756439 0.12855853 BENPORATH_MYC_TARGETS_WITH_EBOX collagen disease DOID_854 2.326E-03 9.523E-03 2.326E-03 0.02068358 BENPORATH_MYC_TARGETS_WITH_EBOX hypothyroidism DOID_1459 2.432E-03 9.883E-03 0.02920223 0.13400055 BENPORATH_MYC_TARGETS_WITH_EBOX male reproductive organ benign neoplasm DOID_0060087 2.434E-03 9.823E-03 0.07110618 0.20029415 BENPORATH_MYC_TARGETS_WITH_EBOX neuroendocrine tumor DOID_169 2.434E-03 9.754E-03 0.07110618 0.19736302 BENPORATH_MYC_TARGETS_WITH_EBOX osteosclerosis DOID_4254 2.434E-03 9.686E-03 0.07110618 0.19640494 BENPORATH_MYC_TARGETS_WITH_EBOX ureteral obstruction DOID_5199 2.434E-03 9.618E-03 0.07110618 0.19545613 BENPORATH_MYC_TARGETS_WITH_EBOX Down syndrome DOID_14250 2.713E-03 0.01064713 0.07490579 0.20491055 BENPORATH_MYC_TARGETS_WITH_EBOX granulosa cell tumor DOID_2999 2.713E-03 0.01057421 2.713E-03 0.02339143 BENPORATH_MYC_TARGETS_WITH_EBOX infertility DOID_5223 2.713E-03 0.01050227 0.07490579 0.20199713 BENPORATH_MYC_TARGETS_WITH_EBOX parasitic infectious disease DOID_1398 2.765E-03 0.01063134 0.03172992 0.14328828 BENPORATH_MYC_TARGETS_WITH_EBOX cerebral degeneration DOID_1443 2.765E-03 0.01055999 2.765E-03 0.02348415 BENPORATH_MYC_TARGETS_WITH_EBOX allergic contact dermatitis DOID_3042 3.002E-03 0.01138944 0.03346129 0.14874589 BENPORATH_MYC_TARGETS_WITH_EBOX colon carcinoma DOID_1520 3.007E-03 0.01132967 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX sex cord-gonadal stromal tumor DOID_192 3.007E-03 0.01125514 3.007E-03 0.02515854 BENPORATH_MYC_TARGETS_WITH_EBOX subependymal glioma DOID_4843 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX pilocytic astrocytoma DOID_4851 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX subependymal giant cell astrocytoma DOID_5077 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX fibrillary astrocytoma DOID_6726 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX juvenile pilocytic astrocytoma DOID_6811 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX childhood pilocytic astrocytoma DOID_6812 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX gemistocytic astrocytoma DOID_7005 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX childhood cerebral astrocytoma DOID_7007 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX protoplasmic astrocytoma DOID_7008 3.007E-03 0.01118157 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX bile duct disease DOID_4138 3.514E-03 0.01298191 0.03703185 0.16208556 BENPORATH_MYC_TARGETS_WITH_EBOX benign glioma DOID_0060101 3.636E-03 0.01334734 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX benign ependymoma DOID_4844 3.636E-03 0.01334734 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX placenta disease DOID_780 3.636E-03 0.01326178 0.08621221 0.22096733 BENPORATH_MYC_TARGETS_WITH_EBOX biliary tract disease DOID_9741 3.649E-03 0.01322506 0.03794645 0.16357218 BENPORATH_MYC_TARGETS_WITH_EBOX IgA glomerulonephritis DOID_2986 3.972E-03 0.01430261 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX muscle cancer DOID_4045 3.972E-03 0.01421265 0.08995042 0.22951475 BENPORATH_MYC_TARGETS_WITH_EBOX uremia DOID_4676 3.972E-03 0.01412382 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX urinary tract obstruction DOID_5200 3.972E-03 0.0140361 0.08995042 0.22849013 BENPORATH_MYC_TARGETS_WITH_EBOX cystic fibrosis DOID_1485 4.075E-03 0.01431181 0.04074156 0.16558535 BENPORATH_MYC_TARGETS_WITH_EBOX endogenous depression DOID_1595 4.075E-03 0.01422401 0.04074156 0.16441099 BENPORATH_MYC_TARGETS_WITH_EBOX aneurysm disease DOID_2403 4.223E-03 0.01465175 0.0416901 0.16705398 BENPORATH_MYC_TARGETS_WITH_EBOX diabetic angiopathy DOID_11713 4.321E-03 0.01490097 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX ureteral disease DOID_1426 4.321E-03 0.01481121 0.09367344 0.23377275 BENPORATH_MYC_TARGETS_WITH_EBOX congenital hemolytic anemia DOID_589 4.321E-03 0.01472252 4.321E-03 0.03462902 BENPORATH_MYC_TARGETS_WITH_EBOX meningitis DOID_9471 4.321E-03 0.01463489 0.09367344 0.23275191 BENPORATH_MYC_TARGETS_WITH_EBOX toxic shock syndrome DOID_14115 4.684E-03 0.01577111 4.684E-03 0.0365112 BENPORATH_MYC_TARGETS_WITH_EBOX sphingolipidosis DOID_1927 4.684E-03 0.01567834 0.09738132 0.23987001 BENPORATH_MYC_TARGETS_WITH_EBOX chromosomal disease DOID_0080014 4.849E-03 0.01613412 0.28852292 0.53826079 BENPORATH_MYC_TARGETS_WITH_EBOX auditory system disease DOID_2742 5.013E-03 0.01658512 0.04655526 0.17090284 BENPORATH_MYC_TARGETS_WITH_EBOX commensal bacterial infectious disease DOID_0050339 5.061E-03 0.01664575 5.061E-03 0.0383962 BENPORATH_MYC_TARGETS_WITH_EBOX bronchiolitis DOID_2942 5.061E-03 0.01655009 5.061E-03 0.0373989 BENPORATH_MYC_TARGETS_WITH_EBOX mental depression DOID_1596 5.181E-03 0.01684713 0.04755222 0.17344366 BENPORATH_MYC_TARGETS_WITH_EBOX morbid obesity DOID_11981 5.451E-03 0.0176238 0.10475194 0.2525587 BENPORATH_MYC_TARGETS_WITH_EBOX cleft lip DOID_9296 5.451E-03 0.01752423 0.10475194 0.25043635 BENPORATH_MYC_TARGETS_WITH_EBOX congenital hypoplastic anemia DOID_1342 5.855E-03 0.01871613 5.855E-03 0.04217053 BENPORATH_MYC_TARGETS_WITH_EBOX pleurisy DOID_10247 6.702E-03 0.02130395 0.11569588 0.26760551 BENPORATH_MYC_TARGETS_WITH_EBOX renal hypertension DOID_1073 6.702E-03 0.0211856 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX secondary hypertension DOID_11130 6.702E-03 0.0211856 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX malaria DOID_12365 6.702E-03 0.02106855 0.11569588 0.26652209 BENPORATH_MYC_TARGETS_WITH_EBOX invasive ductal carcinoma DOID_3008 6.702E-03 0.02095279 0.11569588 0.26438135 BENPORATH_MYC_TARGETS_WITH_EBOX multiple epiphyseal dysplasia DOID_12721 7.145E-03 0.02221602 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX focal glomerulosclerosis DOID_3945 7.145E-03 0.02209528 0.11931424 0.26728269 BENPORATH_MYC_TARGETS_WITH_EBOX dysostosis DOID_1934 7.601E-03 0.02337842 7.601E-03 0.04971273 BENPORATH_MYC_TARGETS_WITH_EBOX endometrial carcinoma DOID_2871 7.601E-03 0.02325273 0.12291789 0.27320422 BENPORATH_MYC_TARGETS_WITH_EBOX age related macular degeneration DOID_10871 8.07E-03 0.02455493 8.07E-03 0.05217922 BENPORATH_MYC_TARGETS_WITH_EBOX degeneration of macula and posterior pole DOID_2007 8.07E-03 0.02455493 8.07E-03 0.05217922 BENPORATH_MYC_TARGETS_WITH_EBOX bronchiolitis obliterans DOID_2799 8.07E-03 0.02442431 0.12650689 0.27792441 BENPORATH_MYC_TARGETS_WITH_EBOX abdominal aortic aneurysm DOID_7693 8.07E-03 0.02429509 0.12650689 0.27685547 BENPORATH_MYC_TARGETS_WITH_EBOX ulcerative colitis DOID_8577 8.114E-03 0.02429975 0.06339761 0.18985915 BENPORATH_MYC_TARGETS_WITH_EBOX endometrial cancer DOID_1380 8.551E-03 0.02547518 0.1300813 0.28250481 BENPORATH_MYC_TARGETS_WITH_EBOX allergic rhinitis DOID_4481 8.551E-03 0.0253425 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX pleural disease DOID_1532 9.046E-03 0.02666794 0.13364118 0.28803723 BENPORATH_MYC_TARGETS_WITH_EBOX hereditary spastic paraplegia DOID_2476 9.046E-03 0.02653047 9.046E-03 0.05718791 BENPORATH_MYC_TARGETS_WITH_EBOX autonomic nervous system neoplasm DOID_2621 9.046E-03 0.02639442 0.13364118 0.2869503 BENPORATH_MYC_TARGETS_WITH_EBOX neuroblastoma DOID_769 9.046E-03 0.02639442 0.13364118 0.2869503 BENPORATH_MYC_TARGETS_WITH_EBOX myocarditis DOID_820 9.552E-03 0.02773043 9.552E-03 0.05972707 BENPORATH_MYC_TARGETS_WITH_EBOX pneumoconiosis DOID_10316 0.01007109 0.02908859 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX male infertility DOID_12336 0.01007109 0.02894168 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX macular degeneration DOID_4448 0.01007109 0.02879625 0.01007109 0.06161777 BENPORATH_MYC_TARGETS_WITH_EBOX paraplegia DOID_607 0.01007109 0.02865226 0.01007109 0.06096227 BENPORATH_MYC_TARGETS_WITH_EBOX medullomyoblastoma DOID_3861 0.01060232 0.03001353 0.14423419 0.30509017 BENPORATH_MYC_TARGETS_WITH_EBOX adult medulloblastoma DOID_3864 0.01060232 0.03001353 0.14423419 0.30509017 BENPORATH_MYC_TARGETS_WITH_EBOX childhood medulloblastoma DOID_3869 0.01060232 0.03001353 0.14423419 0.30509017 BENPORATH_MYC_TARGETS_WITH_EBOX pulmonary sarcoidosis DOID_13406 0.01170112 0.03296008 0.15122461 0.31869186 BENPORATH_MYC_TARGETS_WITH_EBOX cleft palate DOID_674 0.01170112 0.03279772 0.01170112 0.06725188 BENPORATH_MYC_TARGETS_WITH_EBOX embryonal cancer DOID_688 0.01170112 0.03263694 0.01170112 0.06657936 BENPORATH_MYC_TARGETS_WITH_EBOX peripheral nervous system neoplasm DOID_1192 0.01226848 0.03405252 0.15469851 0.32361563 BENPORATH_MYC_TARGETS_WITH_EBOX blood platelet disease DOID_2218 0.01226848 0.03388721 0.15469851 0.32243023 BENPORATH_MYC_TARGETS_WITH_EBOX systemic scleroderma DOID_418 0.01284768 0.0353156 0.01284768 0.0716699 BENPORATH_MYC_TARGETS_WITH_EBOX peptic ulcer DOID_750 0.01284768 0.03514582 0.15815829 0.32843819 BENPORATH_MYC_TARGETS_WITH_EBOX benign mesothelioma DOID_2645 0.01404116 0.03822689 0.16503569 0.34023662 BENPORATH_MYC_TARGETS_WITH_EBOX pulmonary emphysema DOID_9675 0.01404116 0.03804486 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX Huntington's disease DOID_12858 0.01528073 0.04120727 0.01528073 0.08360321 BENPORATH_MYC_TARGETS_WITH_EBOX idiopathic generalized epilepsy DOID_1827 0.01528073 0.0410129 0.17185726 0.35049026 BENPORATH_MYC_TARGETS_WITH_EBOX hyperinsulinism DOID_2018 0.01528073 0.04082035 0.17185726 0.34923851 BENPORATH_MYC_TARGETS_WITH_EBOX leukodystrophy DOID_10579 0.0172247 0.04579838 0.0172247 0.09246088 BENPORATH_MYC_TARGETS_WITH_EBOX spinocerebellar degeneration DOID_2478 0.0172247 0.04558536 0.0172247 0.09159676 BENPORATH_MYC_TARGETS_WITH_EBOX proteinuria DOID_576 0.0172247 0.04537432 0.18198594 0.36590105 BENPORATH_MYC_TARGETS_WITH_EBOX pre-eclampsia DOID_10591 0.01789485 0.04692244 0.18533473 0.37132206 BENPORATH_MYC_TARGETS_WITH_EBOX hemolytic anemia DOID_583 0.01857591 0.04848483 0.01857591 0.09522247 BENPORATH_MYC_TARGETS_WITH_EBOX normocytic anemia DOID_720 0.01857591 0.04848483 0.01857591 0.09522247 BENPORATH_MYC_TARGETS_WITH_EBOX glaucoma DOID_1686 0.01926779 0.05006106 0.01926779 0.09788725 BENPORATH_MYC_TARGETS_WITH_EBOX aortic aneurysm DOID_3627 0.01997038 0.05165067 0.19529962 0.38451725 BENPORATH_MYC_TARGETS_WITH_EBOX hemorrhagic disease DOID_2213 0.02068359 0.05325323 0.19859426 0.38965564 BENPORATH_MYC_TARGETS_WITH_EBOX sarcoidosis DOID_11335 0.02214147 0.05675 0.20514339 0.40112231 BENPORATH_MYC_TARGETS_WITH_EBOX atrophic muscular disease DOID_913 0.02214147 0.05649551 0.20514339 0.3997486 BENPORATH_MYC_TARGETS_WITH_EBOX muscular dystrophy DOID_9884 0.02214147 0.05649551 0.20514339 0.3997486 BENPORATH_MYC_TARGETS_WITH_EBOX osteochondrodysplasia DOID_2256 0.02364067 0.06005151 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX parasitic protozoa infectious disease DOID_2789 0.02364067 0.05978462 0.21163935 0.41099928 BENPORATH_MYC_TARGETS_WITH_EBOX familial hyperlipidemia DOID_1168 0.02440551 0.06144574 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX oral cavity cancer DOID_8618 0.02596524 0.06508469 0.22128451 0.42394237 BENPORATH_MYC_TARGETS_WITH_EBOX leukocyte disease DOID_9500 0.02675994 0.06678248 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX mineral metabolism disease DOID_0050032 0.03087802 0.0767231 0.03087802 0.14055673 BENPORATH_MYC_TARGETS_WITH_EBOX endocrine pancreas disease DOID_1428 0.03087802 0.07638953 0.24022449 0.45868368 BENPORATH_MYC_TARGETS_WITH_EBOX cholestasis DOID_13580 0.03172992 0.07815724 0.24333635 0.46307152 BENPORATH_MYC_TARGETS_WITH_EBOX temporal lobe epilepsy DOID_3328 0.03259104 0.07993233 0.03259104 0.14601811 BENPORATH_MYC_TARGETS_WITH_EBOX blood coagulation disease DOID_1247 0.03612595 0.08822174 0.25870671 0.48905024 BENPORATH_MYC_TARGETS_WITH_EBOX arrhythmogenic right ventricular dysplasia DOID_0050431 0.03620439 0.08803547 0.03620439 0.15969225 BENPORATH_MYC_TARGETS_WITH_EBOX diabetic retinopathy DOID_8947 0.03886965 0.09411418 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX interstitial nephritis DOID_1063 0.04014583 0.09679228 0.04014583 0.17175171 BENPORATH_MYC_TARGETS_WITH_EBOX Diamond-Blackfan anemia DOID_1339 0.04014583 0.09638387 0.04014583 0.17046998 BENPORATH_MYC_TARGETS_WITH_EBOX hyperparathyroidism DOID_13543 0.04014583 0.0959789 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX bilirubin metabolic disorder DOID_2741 0.04014583 0.09557731 0.04014583 0.16920724 BENPORATH_MYC_TARGETS_WITH_EBOX chondrosarcoma DOID_3371 0.04014583 0.09517907 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX insulinoma DOID_3892 0.04014583 0.09478414 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX labyrinthine disease DOID_4539 0.04014583 0.09439247 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX Paget's disease of bone DOID_5408 0.04014583 0.09400402 0.04014583 0.16796307 BENPORATH_MYC_TARGETS_WITH_EBOX acute T cell leukemia DOID_5603 0.04014583 0.09361876 0.04014583 0.16673707 BENPORATH_MYC_TARGETS_WITH_EBOX alopecia areata DOID_986 0.04014583 0.09323664 0.04014583 0.16433797 BENPORATH_MYC_TARGETS_WITH_EBOX syndrome DOID_225 0.04074156 0.09423557 0.27376683 0.51410339 BENPORATH_MYC_TARGETS_WITH_EBOX obsessive-compulsive disorder DOID_10933 0.04407125 0.09990654 0.04407125 0.1694361 BENPORATH_MYC_TARGETS_WITH_EBOX pneumocystosis DOID_11339 0.04407125 0.09951009 0.04407125 0.16829894 BENPORATH_MYC_TARGETS_WITH_EBOX polydactyly DOID_1148 0.04407125 0.09911677 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX prediabetes syndrome DOID_11716 0.04407125 0.09872655 0.04407125 0.16717695 BENPORATH_MYC_TARGETS_WITH_EBOX craniosynostosis DOID_2340 0.04407125 0.09833938 0.04407125 0.16606982 BENPORATH_MYC_TARGETS_WITH_EBOX prostatic adenoma DOID_2883 0.04407125 0.09795525 0.04407125 0.16497725 BENPORATH_MYC_TARGETS_WITH_EBOX inner ear disease DOID_2952 0.04407125 0.0975741 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX bronchiectasis DOID_9563 0.04407125 0.0971959 1.000 1.000 BENPORATH_MYC_TARGETS_WITH_EBOX lipid metabolism disorder DOID_3146 0.04458502 0.09794933 1.000 1.000 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN embryonal cancer DOID_688 1.36E-06 7.736E-04 7.54E-05 0.02145028 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN mixed glioma DOID_5076 2.213E-05 6.295E-03 2.213E-05 0.01258929 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN cataract DOID_83 1.305E-04 0.0247432 1.305E-04 0.0247432 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN myeloma DOID_0070004 1.474E-04 0.02096812 0.09672003 0.57326768 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN lens disease DOID_110 1.474E-04 0.0167745 1.474E-04 0.02096812 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN bone marrow cancer DOID_4960 2.178E-04 0.02065616 0.1095022 0.59910336 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN nutritional deficiency disease DOID_5113 4.203E-04 0.03416204 4.203E-04 0.04782686 AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN uremia DOID_4676 1.002E-03 0.07127031 0.04569864 0.48152826 RADMACHER_AML_PROGNOSIS urinary tract obstruction DOID_5200 2.205E-06 1.254E-03 0.02517982 0.57309281 RADMACHER_AML_PROGNOSIS hepatitis DOID_2237 1.408E-05 4.007E-03 1.000 1.000 RADMACHER_AML_PROGNOSIS congenital diaphragmatic hernia DOID_3827 1.408E-05 2.671E-03 0.04551279 0.69991284 RADMACHER_AML_PROGNOSIS adenoid cystic carcinoma DOID_4866 1.513E-05 2.152E-03 1.513E-05 8.608E-03 RADMACHER_AML_PROGNOSIS salivary gland cancer DOID_8850 1.737E-05 1.976E-03 1.737E-05 4.941E-03 RADMACHER_AML_PROGNOSIS oral cavity cancer DOID_8618 4.351E-05 4.126E-03 4.351E-05 8.252E-03 RADMACHER_AML_PROGNOSIS mineral metabolism disease DOID_0050032 5.765E-05 4.686E-03 1.000 1.000 RADMACHER_AML_PROGNOSIS nephrosis DOID_2527 7.759E-05 5.518E-03 0.07882574 0.8305897 RADMACHER_AML_PROGNOSIS beta thalassemia DOID_12241 7.852E-05 4.964E-03 0.01321549 0.53711542 RADMACHER_AML_PROGNOSIS thalassemia DOID_10241 1.247E-04 7.093E-03 0.01649264 0.5520182 RADMACHER_AML_PROGNOSIS corneal dystrophy DOID_2566 1.247E-04 6.448E-03 1.247E-04 0.01773309 RADMACHER_AML_PROGNOSIS corneal disease DOID_10124 5.819E-04 0.02759102 5.819E-04 0.06621844 RADMACHER_AML_PROGNOSIS gonadal disease DOID_2277 6.19E-04 0.02709274 1.000 1.000 RADMACHER_AML_PROGNOSIS abdominal aortic aneurysm DOID_7693 6.19E-04 0.02515754 0.03593353 0.58417649 RADMACHER_AML_PROGNOSIS calcinosis DOID_182 9.099E-04 0.03451687 1.000 1.000 RADMACHER_AML_PROGNOSIS microcephaly DOID_10907 9.559E-04 0.03399516 9.559E-04 0.09065376 RADMACHER_AML_PROGNOSIS peptic ulcer DOID_750 1.003E-03 0.03357165 0.04551279 0.68149408 RADMACHER_AML_PROGNOSIS autoimmune disease of urogenital tract DOID_0060049 1.151E-03 0.03638035 1.151E-03 0.09354947 RADMACHER_AML_PROGNOSIS primary biliary cirrhosis DOID_12236 1.151E-03 0.03638035 1.151E-03 0.09354947 RADMACHER_AML_PROGNOSIS brain cancer DOID_1319 1.419E-03 0.0424975 1.419E-03 0.10093156 RADMACHER_AML_PROGNOSIS heart valve disease DOID_4079 1.419E-03 0.04037262 1.000 1.000 RADMACHER_AML_PROGNOSIS central nervous system cancer DOID_3620 1.476E-03 0.03999145 1.476E-03 0.09331339 RADMACHER_AML_PROGNOSIS calcium metabolism disease DOID_10575 1.593E-03 0.04119966 1.000 1.000 RADMACHER_AML_PROGNOSIS aortic aneurysm DOID_3627 1.593E-03 0.03940837 0.05709464 0.7734965 RADMACHER_AML_PROGNOSIS congenital nervous system abnormality DOID_2490 2.036E-03 0.04827229 2.036E-03 0.11585348 RADMACHER_AML_PROGNOSIS respiratory failure DOID_11162 2.384E-03 0.0542672 1.000 1.000 RADMACHER_AML_PROGNOSIS diabetic retinopathy DOID_8947 3.242E-03 0.07094792 0.08086968 0.80727803 RADMACHER_AML_PROGNOSIS aneurysm disease DOID_2403 3.497E-03 0.07370281 0.0839273 0.82335573 RADMACHER_AML_PROGNOSIS bone development disease DOID_0080006 4.129E-03 0.08389924 1.000 1.000 RADMACHER_AML_PROGNOSIS retinal vascular disease DOID_2462 4.223E-03 0.0828542 0.09203248 0.81822629 RADMACHER_AML_PROGNOSIS transitional cell carcinoma DOID_2671 4.511E-03 0.08556472 4.511E-03 0.23335832 RADMACHER_AML_PROGNOSIS nervous system cancer DOID_3093 4.709E-03 0.08642582 4.709E-03 0.2232667 RADMACHER_AML_PROGNOSIS hypersensitivity reaction type I disease DOID_1205 5.219E-03 0.09280057 0.10206557 0.82964725 RADMACHER_AML_PROGNOSIS ulcerative colitis DOID_8577 5.537E-03 0.09547028 0.10505433 0.84191428 ELVIDGE_HYPOXIA_UP toxic shock syndrome DOID_14115 7.17E-09 4.08E-06 0.06639113 0.39350576 ELVIDGE_HYPOXIA_UP commensal bacterial infectious disease DOID_0050339 8.857E-09 2.52E-06 0.06895396 0.39631113 ELVIDGE_HYPOXIA_UP endometrial carcinoma DOID_2871 2.676E-08 5.076E-06 9.387E-05 6.677E-03 ELVIDGE_HYPOXIA_UP endometrial cancer DOID_1380 3.682E-08 5.238E-06 1.128E-04 7.132E-03 ELVIDGE_HYPOXIA_UP nephrosis DOID_2527 5.865E-08 6.675E-06 5.305E-05 4.312E-03 ELVIDGE_HYPOXIA_UP nephrotic syndrome DOID_1184 1.767E-07 1.676E-05 2.794E-04 0.01222883 ELVIDGE_HYPOXIA_UP uterine cancer DOID_363 1.973E-07 1.604E-05 2.978E-04 0.01129842 ELVIDGE_HYPOXIA_UP nervous system cancer DOID_3093 2.17E-07 1.543E-05 0.02658429 0.24797479 ELVIDGE_HYPOXIA_UP dilated cardiomyopathy DOID_12930 2.973E-07 1.88E-05 7.437E-06 4.232E-03 ELVIDGE_HYPOXIA_UP glaucoma DOID_1686 3.307E-07 1.882E-05 4.019E-04 0.01345286 ELVIDGE_HYPOXIA_UP sinusitis DOID_0050127 4.545E-07 2.351E-05 1.000 1.000 ELVIDGE_HYPOXIA_UP paranasal sinus disease DOID_1352 4.545E-07 2.351E-05 1.000 1.000 ELVIDGE_HYPOXIA_UP osteosarcoma DOID_3347 7.626E-07 3.616E-05 4.98E-05 4.723E-03 ELVIDGE_HYPOXIA_UP neuroectodermal tumor DOID_171 9.452E-07 4.137E-05 7.399E-04 0.0233884 ELVIDGE_HYPOXIA_UP sarcoma DOID_1115 1.386E-06 5.634E-05 3.084E-03 0.06266477 ELVIDGE_HYPOXIA_UP brain infarction DOID_3454 1.59E-06 6.03E-05 4.508E-05 5.13E-03 ELVIDGE_HYPOXIA_UP pancreatic ductal carcinoma DOID_3587 1.826E-06 6.494E-05 0.1818623 0.69449428 ELVIDGE_HYPOXIA_UP abdominal aortic aneurysm DOID_7693 2.057E-06 6.884E-05 1.000 1.000 ELVIDGE_HYPOXIA_UP pancreatic carcinoma DOID_4905 2.231E-06 7.054E-05 0.18859005 0.71538492 ELVIDGE_HYPOXIA_UP diabetic retinopathy DOID_8947 2.231E-06 6.682E-05 0.01861803 0.20372422 ELVIDGE_HYPOXIA_UP aneurysm disease DOID_2403 2.704E-06 7.694E-05 0.19526301 0.72617419 ELVIDGE_HYPOXIA_UP pancreatitis DOID_4989 2.878E-06 7.799E-05 0.02049775 0.21598557 ELVIDGE_HYPOXIA_UP hepatitis C DOID_1883 3.292E-06 8.513E-05 4.663E-03 0.08290741 ELVIDGE_HYPOXIA_UP spindle cell carcinoma DOID_4015 3.292E-06 8.143E-05 1.000 1.000 ELVIDGE_HYPOXIA_UP retinal vascular disease DOID_2462 4.357E-06 1.033E-04 0.02396852 0.23513944 ELVIDGE_HYPOXIA_UP cervix uteri carcinoma in situ DOID_8991 6.666E-06 1.517E-04 6.541E-03 0.1063352 ELVIDGE_HYPOXIA_UP autoimmune disease of urogenital tract DOID_0060049 7.301E-06 1.598E-04 6.833E-03 0.1079975 ELVIDGE_HYPOXIA_UP primary biliary cirrhosis DOID_12236 7.301E-06 1.598E-04 6.833E-03 0.1079975 ELVIDGE_HYPOXIA_UP primitive neuroectodermal tumor DOID_168 7.98E-06 1.682E-04 2.794E-04 0.01135534 ELVIDGE_HYPOXIA_UP cerebral infarction DOID_3526 9.475E-06 1.925E-04 3.171E-04 0.01127596 ELVIDGE_HYPOXIA_UP angiosarcoma DOID_0001816 1.094E-05 2.147E-04 8.722E-04 0.02481496 ELVIDGE_HYPOXIA_UP aortic aneurysm DOID_3627 1.411E-05 2.676E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP giant cell tumor DOID_200 1.759E-05 3.228E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP malignant giant cell tumor DOID_2705 1.759E-05 3.228E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP giant cell glioblastoma DOID_3074 1.759E-05 3.228E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP heart septal defect DOID_1681 1.882E-05 3.347E-04 1.882E-05 5.355E-03 ELVIDGE_HYPOXIA_UP bile duct adenocarcinoma DOID_4896 1.887E-05 3.254E-04 0.01078299 0.14268651 ELVIDGE_HYPOXIA_UP cholangiocarcinoma DOID_4947 1.887E-05 3.254E-04 0.01078299 0.14268651 ELVIDGE_HYPOXIA_UP bone marrow cancer DOID_4960 1.887E-05 3.159E-04 0.14503694 0.59801463 ELVIDGE_HYPOXIA_UP glioblastoma DOID_3068 2.473E-05 4.02E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP bile duct cancer DOID_4606 2.473E-05 3.908E-04 0.01227651 0.15185513 ELVIDGE_HYPOXIA_UP bile duct carcinoma DOID_4897 2.473E-05 3.908E-04 0.01227651 0.15185513 ELVIDGE_HYPOXIA_UP hepatitis B DOID_2043 2.973E-05 4.572E-04 0.05866065 0.36679021 ELVIDGE_HYPOXIA_UP muscular atrophy DOID_767 2.973E-05 4.452E-04 0.05866065 0.36280336 ELVIDGE_HYPOXIA_UP pre-malignant neoplasm DOID_0060071 3.379E-05 4.93E-04 0.01426271 0.15912711 ELVIDGE_HYPOXIA_UP congenital heart defect DOID_1682 3.379E-05 4.807E-04 8.094E-04 0.02423926 ELVIDGE_HYPOXIA_UP in situ carcinoma DOID_8719 3.379E-05 4.93E-04 0.01426271 0.15912711 ELVIDGE_HYPOXIA_UP glycogen metabolism disorder DOID_0050728 3.412E-05 4.736E-04 3.412E-05 6.472E-03 ELVIDGE_HYPOXIA_UP glycogen storage disease DOID_2747 3.412E-05 4.736E-04 3.412E-05 6.472E-03 ELVIDGE_HYPOXIA_UP uterine disease DOID_345 3.802E-05 5.151E-04 0.17052639 0.66916909 ELVIDGE_HYPOXIA_UP aortic valve disease DOID_62 3.892E-05 5.15E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP endocrine organ benign neoplasm DOID_0060089 4.508E-05 5.829E-04 4.508E-05 6.412E-03 ELVIDGE_HYPOXIA_UP astrocytoma DOID_3069 4.763E-05 6.022E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP portal hypertension DOID_10762 4.98E-05 6.16E-04 0.06895396 0.38846339 ELVIDGE_HYPOXIA_UP mixed glioma DOID_5076 7.2E-05 8.717E-04 1.000 1.000 ELVIDGE_HYPOXIA_UP hepatic vascular disease DOID_272 7.715E-05 9.145E-04 0.07913578 0.42479491 ELVIDGE_HYPOXIA_UP female reproductive system disease DOID_229 8.313E-05 9.653E-04 0.20407581 0.75402035 ELVIDGE_HYPOXIA_UP biliary tract cancer DOID_4607 9.121E-05 1.038E-03 0.02295376 0.22913495 ELVIDGE_HYPOXIA_UP transitional cell carcinoma DOID_2671 1.139E-04 1.271E-03 0.0255246 0.24205829 ELVIDGE_HYPOXIA_UP carbohydrate metabolic disorder DOID_2978 1.404E-04 1.537E-03 1.404E-04 7.991E-03 ELVIDGE_HYPOXIA_UP mouth disease DOID_403 1.462E-04 1.57E-03 0.02875621 0.24062181 ELVIDGE_HYPOXIA_UP medullomyoblastoma DOID_3861 1.578E-04 1.662E-03 1.578E-04 8.161E-03 ELVIDGE_HYPOXIA_UP adult medulloblastoma DOID_3864 1.578E-04 1.662E-03 1.578E-04 8.161E-03 ELVIDGE_HYPOXIA_UP childhood medulloblastoma DOID_3869 1.578E-04 1.662E-03 1.578E-04 8.161E-03 ELVIDGE_HYPOXIA_UP adenoma DOID_657 1.706E-04 1.765E-03 5.169E-03 0.0891303 ELVIDGE_HYPOXIA_UP medulloblastoma DOID_3858 1.84E-04 1.87E-03 1.84E-04 8.726E-03 ELVIDGE_HYPOXIA_UP peptic ulcer DOID_750 2.13E-04 2.126E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP endometriosis of uterus DOID_288 2.617E-04 2.567E-03 0.11634498 0.52539917 ELVIDGE_HYPOXIA_UP endometriosis DOID_289 2.794E-04 2.694E-03 0.11877197 0.51985576 ELVIDGE_HYPOXIA_UP uveal disease DOID_3480 2.794E-04 2.65E-03 7.131E-03 0.10677387 ELVIDGE_HYPOXIA_UP hypokalemia DOID_4500 3.306E-04 3.084E-03 0.02709967 0.23722631 ELVIDGE_HYPOXIA_UP myeloma DOID_0070004 3.579E-04 3.284E-03 0.12841406 0.55776792 ELVIDGE_HYPOXIA_UP pre-eclampsia DOID_10591 3.579E-04 3.232E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP brain cancer DOID_1319 3.579E-04 3.182E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP heart valve disease DOID_4079 3.579E-04 3.133E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP central nervous system cancer DOID_3620 3.795E-04 3.272E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP aortic valve stenosis DOID_1712 4.832E-04 4.103E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP aortic valve insufficiency DOID_57 4.832E-04 4.043E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP lipodystrophy DOID_811 4.832E-04 3.984E-03 0.03243167 0.25630028 ELVIDGE_HYPOXIA_UP sarcoidosis DOID_11335 5.001E-04 4.065E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP reproductive organ benign neoplasm DOID_0050622 5.545E-04 4.444E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP Leydig cell tumor DOID_2696 5.7E-04 4.505E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP sex cord-stromal neoplasm DOID_4757 5.7E-04 4.505E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP hypersensitivity reaction type IV disease DOID_2916 6.429E-04 5.011E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP melancholia DOID_2848 6.743E-04 5.185E-03 0.01266325 0.15011232 ELVIDGE_HYPOXIA_UP neurotic disorder DOID_4964 7.066E-04 5.361E-03 0.01305528 0.15160105 ELVIDGE_HYPOXIA_UP collagen disease DOID_854 7.399E-04 5.539E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP respiratory failure DOID_11162 7.741E-04 5.721E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP hypothyroidism DOID_1459 7.741E-04 5.647E-03 0.01385504 0.1576703 ELVIDGE_HYPOXIA_UP temporal lobe epilepsy DOID_3328 9.212E-04 6.635E-03 0.17280595 0.67346977 ELVIDGE_HYPOXIA_UP allergic contact dermatitis DOID_3042 9.606E-04 6.832E-03 9.606E-04 0.02602695 ELVIDGE_HYPOXIA_UP bronchitis DOID_6132 9.868E-04 6.932E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP urinary system benign neoplasm DOID_731 9.868E-04 6.847E-03 9.868E-04 0.02552119 ELVIDGE_HYPOXIA_UP tuberculosis DOID_399 1.001E-03 6.862E-03 0.17734647 0.68182527 ELVIDGE_HYPOXIA_UP endogenous depression DOID_1595 1.314E-03 8.9E-03 0.0195483 0.20986761 ELVIDGE_HYPOXIA_UP sex cord-gonadal stromal tumor DOID_192 1.371E-03 9.179E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP subependymal glioma DOID_4843 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP pilocytic astrocytoma DOID_4851 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP subependymal giant cell astrocytoma DOID_5077 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP fibrillary astrocytoma DOID_6726 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP juvenile pilocytic astrocytoma DOID_6811 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP childhood pilocytic astrocytoma DOID_6812 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP gemistocytic astrocytoma DOID_7005 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP childhood cerebral astrocytoma DOID_7007 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP protoplasmic astrocytoma DOID_7008 1.371E-03 9.072E-03 1.000 1.000 ELVIDGE_HYPOXIA_UP contact dermatitis DOID_2773 1.517E-03 9.925E-03 1.517E-03 0.03754137 ELVIDGE_HYPOXIA_UP benign glioma DOID_0060101 1.661E-03 0.01074061 1.000 1.000 ELVIDGE_HYPOXIA_UP gastric ulcer DOID_10808 1.661E-03 0.01061993 1.000 1.000 ELVIDGE_HYPOXIA_UP benign ependymoma DOID_4844 1.661E-03 0.01074061 1.000 1.000 ELVIDGE_HYPOXIA_UP mental depression DOID_1596 1.682E-03 0.01063655 0.02295376 0.23322664 ELVIDGE_HYPOXIA_UP focal epilepsy DOID_2234 1.682E-03 0.01051967 0.2084463 0.7602945 ELVIDGE_HYPOXIA_UP chronic kidney failure DOID_784 1.682E-03 0.01040532 0.2084463 0.75545186 ELVIDGE_HYPOXIA_UP bone development disease DOID_0080006 1.74E-03 0.01064438 1.74E-03 0.04124697 ELVIDGE_HYPOXIA_UP primary bacterial infectious disease DOID_0050338 1.919E-03 0.01161689 0.21711609 0.78189277 ELVIDGE_HYPOXIA_UP synostosis DOID_11971 1.978E-03 0.01184493 1.978E-03 0.04501073 ELVIDGE_HYPOXIA_UP Goodpasture syndrome DOID_9808 1.978E-03 0.01172154 0.06382131 0.38225608 ELVIDGE_HYPOXIA_UP encephalomyelitis DOID_640 2.311E-03 0.01355906 1.000 1.000 ELVIDGE_HYPOXIA_UP papillary adenoma DOID_3172 2.502E-03 0.01452446 2.502E-03 0.05474603 ELVIDGE_HYPOXIA_UP microcystic adenoma DOID_5403 2.502E-03 0.01452446 2.502E-03 0.05474603 ELVIDGE_HYPOXIA_UP follicular adenoma DOID_6204 2.502E-03 0.01452446 2.502E-03 0.05474603 ELVIDGE_HYPOXIA_UP middle cerebral artery infarction DOID_3525 2.689E-03 0.01545609 2.689E-03 0.05667235 ELVIDGE_HYPOXIA_UP seminoma DOID_4440 2.689E-03 0.01530153 1.000 1.000 ELVIDGE_HYPOXIA_UP lung adenocarcinoma DOID_3910 2.883E-03 0.01624323 1.000 1.000 ELVIDGE_HYPOXIA_UP supratentorial cancer DOID_1659 3.29E-03 0.01835565 1.000 1.000 ELVIDGE_HYPOXIA_UP cerebrum cancer DOID_368 3.29E-03 0.01835565 1.000 1.000 ELVIDGE_HYPOXIA_UP focal glomerulosclerosis DOID_3945 3.29E-03 0.01817744 0.08166396 0.41861976 ELVIDGE_HYPOXIA_UP female reproductive organ benign neoplasm DOID_0060086 3.504E-03 0.0191686 1.000 1.000 ELVIDGE_HYPOXIA_UP uterine benign neoplasm DOID_0060095 3.504E-03 0.0191686 1.000 1.000 ELVIDGE_HYPOXIA_UP corneal disease DOID_10124 3.504E-03 0.01898604 0.08418526 0.4276912 ELVIDGE_HYPOXIA_UP uterine fibroid DOID_13223 3.504E-03 0.0191686 1.000 1.000 ELVIDGE_HYPOXIA_UP dysostosis DOID_1934 3.504E-03 0.01880692 3.504E-03 0.06874255 ELVIDGE_HYPOXIA_UP congenital disorder of glycosylation DOID_5212 3.504E-03 0.01863116 3.504E-03 0.06645113 ELVIDGE_HYPOXIA_UP germinoma DOID_3304 3.949E-03 0.02080326 1.000 1.000 ELVIDGE_HYPOXIA_UP allergic rhinitis DOID_4481 3.949E-03 0.02061241 1.000 1.000 ELVIDGE_HYPOXIA_UP leiomyoma DOID_127 4.18E-03 0.0216243 1.000 1.000 ELVIDGE_HYPOXIA_UP papilloma DOID_2615 4.418E-03 0.02264962 4.418E-03 0.08110025 ELVIDGE_HYPOXIA_UP myocarditis DOID_820 4.418E-03 0.02244739 0.0942021 0.47434508 ELVIDGE_HYPOXIA_UP metal metabolism disorder DOID_896 4.418E-03 0.02224874 0.0942021 0.47018416 ELVIDGE_HYPOXIA_UP pneumoconiosis DOID_10316 4.663E-03 0.02327226 1.000 1.000 ELVIDGE_HYPOXIA_UP pulmonary sarcoidosis DOID_13406 5.432E-03 0.02687473 1.000 1.000 ELVIDGE_HYPOXIA_UP embryonal cancer DOID_688 5.432E-03 0.02664305 1.000 1.000 ELVIDGE_HYPOXIA_UP multiple myeloma DOID_9538 5.432E-03 0.02641533 0.10411042 0.49780527 ELVIDGE_HYPOXIA_UP peripheral nervous system neoplasm DOID_1192 5.7E-03 0.02748562 0.10657068 0.50114641 ELVIDGE_HYPOXIA_UP uveitis DOID_13141 5.7E-03 0.02725465 0.10657068 0.49703865 ELVIDGE_HYPOXIA_UP adult respiratory distress syndrome DOID_11394 6.255E-03 0.02965743 1.000 1.000 ELVIDGE_HYPOXIA_UP intracranial arterial disease DOID_13089 6.255E-03 0.02941233 6.255E-03 0.1046733 ELVIDGE_HYPOXIA_UP cerebral arterial disease DOID_3527 6.255E-03 0.02941233 6.255E-03 0.1046733 ELVIDGE_HYPOXIA_UP lymphatic system disease DOID_75 6.255E-03 0.02917125 0.11147114 0.50741664 ELVIDGE_HYPOXIA_UP benign mesothelioma DOID_2645 6.541E-03 0.03025798 1.000 1.000 ELVIDGE_HYPOXIA_UP spinocerebellar ataxia DOID_1441 6.833E-03 0.03135411 6.833E-03 0.10507865 ELVIDGE_HYPOXIA_UP hyperinsulinism DOID_2018 7.131E-03 0.03245926 0.11877197 0.52388565 ELVIDGE_HYPOXIA_UP influenza DOID_8469 7.434E-03 0.03357305 1.000 1.000 ELVIDGE_HYPOXIA_UP spinocerebellar degeneration DOID_2478 8.059E-03 0.03610726 8.059E-03 0.11758004 ELVIDGE_HYPOXIA_UP proteinuria DOID_576 8.059E-03 0.03582517 1.000 1.000 ELVIDGE_HYPOXIA_UP neuritis DOID_1803 8.38E-03 0.03696282 0.12841406 0.54938043 ELVIDGE_HYPOXIA_UP thyroid adenoma DOID_2891 8.38E-03 0.03667849 8.38E-03 0.11920511 ELVIDGE_HYPOXIA_UP bone marrow disease DOID_4961 8.38E-03 0.03639851 8.38E-03 0.11629767 ELVIDGE_HYPOXIA_UP vascular skin disease DOID_9540 8.38E-03 0.03612276 1.000 1.000 ELVIDGE_HYPOXIA_UP hemolytic anemia DOID_583 8.707E-03 0.03724821 8.707E-03 0.11795265 ELVIDGE_HYPOXIA_UP normocytic anemia DOID_720 8.707E-03 0.03724821 8.707E-03 0.11795265 ELVIDGE_HYPOXIA_UP pulmonary tuberculosis DOID_2957 9.039E-03 0.03838077 0.13319584 0.56139581 ELVIDGE_HYPOXIA_UP lung small cell carcinoma DOID_5409 9.039E-03 0.03809647 1.000 1.000 ELVIDGE_HYPOXIA_UP vasculitis DOID_865 0.01078299 0.04511412 1.000 1.000 ELVIDGE_HYPOXIA_UP osteochondrodysplasia DOID_2256 0.01114829 0.04630202 0.01114829 0.14416766 ELVIDGE_HYPOXIA_UP familial hyperlipidemia DOID_1168 0.011519 0.047495 0.011519 0.14565135 ELVIDGE_HYPOXIA_UP oral cavity cancer DOID_8618 0.01227651 0.05025422 0.01227651 0.14862417 ELVIDGE_HYPOXIA_UP leukocyte disease DOID_9500 0.01266325 0.05146708 0.15671782 0.62797491 ELVIDGE_HYPOXIA_UP mineral metabolism disease DOID_0050032 0.01467554 0.05922258 0.16824062 0.66943294 ELVIDGE_HYPOXIA_UP endocrine pancreas disease DOID_1428 0.01467554 0.05880552 0.16824062 0.6647841 ELVIDGE_HYPOXIA_UP cholestasis DOID_13580 0.0150935 0.06005736 1.000 1.000 ELVIDGE_HYPOXIA_UP bile duct disease DOID_4138 0.01770718 0.06996794 1.000 1.000 ELVIDGE_HYPOXIA_UP peripheral vascular disease DOID_341 0.01816016 0.07126298 1.000 1.000 ELVIDGE_HYPOXIA_UP biliary tract disease DOID_9741 0.01816016 0.07077488 1.000 1.000 ELVIDGE_HYPOXIA_UP syndrome DOID_225 0.0195483 0.07566655 0.19304475 0.72264778 ELVIDGE_HYPOXIA_UP lipid metabolism disorder DOID_3146 0.02146615 0.08252864 0.02146615 0.22207707 ELVIDGE_HYPOXIA_UP arrhythmogenic right ventricular dysplasia DOID_0050431 0.02442276 0.09326544 0.02442276 0.23553477 ELVIDGE_HYPOXIA_UP rectal neoplasm DOID_1984 0.02709967 0.099482 1.000 1.000 ELVIDGE_HYPOXIA_UP rectum cancer DOID_1993 0.02709967 0.099482 1.000 1.000 ELVIDGE_HYPOXIA_UP acute kidney failure DOID_3021 0.02709967 0.09884429 0.02709967 0.2447573 ELVIDGE_HYPOXIA_UP teratoma DOID_3307 0.02709967 0.09821471 0.02709967 0.24093297 ELVIDGE_HYPOXIA_UP insulinoma DOID_3892 0.02709967 0.0975931 1.000 1.000 ELVIDGE_HYPOXIA_UP keratitis DOID_4677 0.02709967 0.09697931 1.000 1.000 ELVIDGE_HYPOXIA_UP malignant teratoma DOID_5563 0.02709967 0.09821471 0.02709967 0.24093297 ELVIDGE_HYPOXIA_UP mature teratoma DOID_5566 0.02709967 0.09821471 0.02709967 0.24093297 ELVIDGE_HYPOXIA_UP polycythemia DOID_8432 0.02709967 0.09637319 0.02709967 0.23363197 ELVIDGE_HYPOXIA_UP cannabis abuse DOID_9505 0.02709967 0.0957746 0.02709967 0.23014492 SEMENZA_HIF1_TARGETS peptic ulcer DOID_750 2.569E-10 1.462E-07 1.000 1.000 SEMENZA_HIF1_TARGETS nutritional deficiency disease DOID_5113 5.667E-10 1.612E-07 2.468E-07 1.404E-04 SEMENZA_HIF1_TARGETS hemolytic anemia DOID_583 7.055E-10 1.338E-07 1.107E-05 2.099E-03 SEMENZA_HIF1_TARGETS normocytic anemia DOID_720 7.055E-10 1.338E-07 1.107E-05 2.099E-03 SEMENZA_HIF1_TARGETS respiratory failure DOID_11162 2.46E-09 3.5E-07 0.05345325 0.41101213 SEMENZA_HIF1_TARGETS endocrine pancreas disease DOID_1428 2.873E-09 3.27E-07 0.05505326 0.39652286 SEMENZA_HIF1_TARGETS peripheral vascular disease DOID_341 5.11E-09 4.846E-07 0.06142716 0.4160959 SEMENZA_HIF1_TARGETS toxic shock syndrome DOID_14115 5.221E-09 4.244E-07 0.02089624 0.38354707 SEMENZA_HIF1_TARGETS diabetic retinopathy DOID_8947 5.467E-09 3.888E-07 1.000 1.000 SEMENZA_HIF1_TARGETS commensal bacterial infectious disease DOID_0050339 6.166E-09 3.899E-07 0.02172323 0.38626613 SEMENZA_HIF1_TARGETS portal hypertension DOID_10762 6.166E-09 3.509E-07 1.000 1.000 SEMENZA_HIF1_TARGETS retinal vascular disease DOID_2462 1.086E-08 5.619E-07 1.000 1.000 SEMENZA_HIF1_TARGETS renal hypertension DOID_1073 1.128E-08 5.347E-07 0.02502442 0.3747078 SEMENZA_HIF1_TARGETS secondary hypertension DOID_11130 1.128E-08 5.347E-07 0.02502442 0.3747078 SEMENZA_HIF1_TARGETS hepatic vascular disease DOID_272 1.128E-08 4.936E-07 1.000 1.000 SEMENZA_HIF1_TARGETS abdominal aortic aneurysm DOID_7693 1.681E-08 6.831E-07 0.02749324 0.36380583 SEMENZA_HIF1_TARGETS hepatitis DOID_2237 4.573E-08 1.735E-06 5.819E-04 0.02364944 SEMENZA_HIF1_TARGETS leukodystrophy DOID_10579 8.621E-08 3.066E-06 1.000 1.000 SEMENZA_HIF1_TARGETS pre-eclampsia DOID_10591 9.365E-08 3.135E-06 8.244E-04 0.02759327 SEMENZA_HIF1_TARGETS aortic aneurysm DOID_3627 1.189E-07 3.758E-06 0.0437979 0.37759095 SEMENZA_HIF1_TARGETS congenital heart defect DOID_1682 2.903E-07 8.695E-06 0.05425358 0.40091283 SEMENZA_HIF1_TARGETS mineral metabolism disease DOID_0050032 3.086E-07 8.779E-06 0.05505326 0.40160649 SEMENZA_HIF1_TARGETS cerebral degeneration DOID_1443 3.277E-07 8.878E-06 1.000 1.000 SEMENZA_HIF1_TARGETS bronchitis DOID_6132 3.685E-07 9.53E-06 1.000 1.000 SEMENZA_HIF1_TARGETS aneurysm disease DOID_2403 6.006E-07 1.486E-05 0.06459847 0.42248887 SEMENZA_HIF1_TARGETS brain edema DOID_4724 6.167E-07 1.462E-05 0.01675112 0.32866855 SEMENZA_HIF1_TARGETS bacterial pneumonia DOID_874 6.319E-07 1.438E-05 0.06538968 0.42280372 SEMENZA_HIF1_TARGETS Kawasaki disease DOID_13378 7.19E-07 1.574E-05 1.000 1.000 SEMENZA_HIF1_TARGETS lymphadenitis DOID_1602 7.19E-07 1.574E-05 1.000 1.000 SEMENZA_HIF1_TARGETS lymph node disease DOID_9942 7.19E-07 1.574E-05 1.000 1.000 SEMENZA_HIF1_TARGETS gastric ulcer DOID_10808 8.321E-07 1.753E-05 1.000 1.000 SEMENZA_HIF1_TARGETS muscular atrophy DOID_767 8.321E-07 1.691E-05 1.578E-04 0.01122135 SEMENZA_HIF1_TARGETS muscle cancer DOID_4045 9.563E-07 1.876E-05 1.000 1.000 SEMENZA_HIF1_TARGETS polyarteritis nodosa DOID_9810 9.563E-07 1.814E-05 1.000 1.000 SEMENZA_HIF1_TARGETS transitional cell carcinoma DOID_2671 1.015E-06 1.863E-05 6.105E-05 6.947E-03 SEMENZA_HIF1_TARGETS diabetic angiopathy DOID_11713 1.092E-06 1.942E-05 0.02006857 0.38063389 SEMENZA_HIF1_TARGETS Lewy body dementia DOID_12217 1.092E-06 1.883E-05 1.000 1.000 SEMENZA_HIF1_TARGETS lung adenocarcinoma DOID_3910 1.966E-06 3.291E-05 1.966E-06 5.594E-04 SEMENZA_HIF1_TARGETS sarcoma DOID_1115 2.184E-06 3.55E-05 1.000 1.000 SEMENZA_HIF1_TARGETS focal glomerulosclerosis DOID_3945 2.416E-06 3.819E-05 0.02584803 0.35017932 SEMENZA_HIF1_TARGETS adult respiratory distress syndrome DOID_11394 6.588E-06 1.013E-04 0.03567895 0.3830438 SEMENZA_HIF1_TARGETS lymphatic system disease DOID_75 6.588E-06 9.865E-05 1.000 1.000 SEMENZA_HIF1_TARGETS hyperinsulinism DOID_2018 8.09E-06 1.18E-04 0.03812162 0.37398622 SEMENZA_HIF1_TARGETS diabetic autonomic neuropathy DOID_11503 8.636E-06 1.229E-04 0.03893451 0.37548705 SEMENZA_HIF1_TARGETS autonomic neuropathy DOID_11504 8.636E-06 1.229E-04 0.03893451 0.37548705 SEMENZA_HIF1_TARGETS diabetic polyneuropathy DOID_12785 8.636E-06 1.229E-04 0.03893451 0.37548705 SEMENZA_HIF1_TARGETS uterine cancer DOID_363 8.636E-06 1.199E-04 7.286E-04 0.02591241 SEMENZA_HIF1_TARGETS diabetic neuropathy DOID_9743 8.636E-06 1.229E-04 0.03893451 0.37548705 SEMENZA_HIF1_TARGETS learning disability DOID_8927 9.207E-06 1.247E-04 0.03974673 0.37075233 SEMENZA_HIF1_TARGETS autonomic nervous system disease DOID_11465 1.042E-05 1.379E-04 0.04136919 0.36779796 SEMENZA_HIF1_TARGETS vascular skin disease DOID_9540 1.042E-05 1.348E-04 1.000 1.000 SEMENZA_HIF1_TARGETS pustulosis of palm and sole DOID_4398 1.633E-05 2.065E-04 0.0478325 0.38333369 SEMENZA_HIF1_TARGETS uterine disease DOID_345 2.637E-05 3.262E-04 1.000 1.000 SEMENZA_HIF1_TARGETS brain infarction DOID_3454 3.003E-05 3.635E-04 1.000 1.000 SEMENZA_HIF1_TARGETS ventricular septal defect DOID_1657 3.093E-05 3.666E-04 8.41E-03 0.19938298 SEMENZA_HIF1_TARGETS acute kidney failure DOID_3021 3.093E-05 3.592E-04 1.000 1.000 SEMENZA_HIF1_TARGETS nephrosis DOID_2527 3.4E-05 3.869E-04 1.795E-03 0.05375289 SEMENZA_HIF1_TARGETS breast benign neoplasm DOID_0060082 3.778E-05 4.215E-04 9.247E-03 0.21046244 SEMENZA_HIF1_TARGETS thoracic benign neoplasm DOID_0060097 3.778E-05 4.215E-04 9.247E-03 0.21046244 SEMENZA_HIF1_TARGETS benign breast phyllodes tumor DOID_1631 3.778E-05 4.215E-04 9.247E-03 0.21046244 SEMENZA_HIF1_TARGETS cystic fibrosis DOID_1485 3.98E-05 4.356E-04 1.000 1.000 SEMENZA_HIF1_TARGETS syndrome DOID_225 3.98E-05 4.273E-04 0.06380662 0.42216241 SEMENZA_HIF1_TARGETS bone resorption disease DOID_0080011 4.135E-05 4.357E-04 4.135E-05 5.882E-03 SEMENZA_HIF1_TARGETS osteoporosis DOID_11476 4.135E-05 4.357E-04 4.135E-05 5.882E-03 SEMENZA_HIF1_TARGETS beta thalassemia DOID_12241 4.532E-05 4.688E-04 1.000 1.000 SEMENZA_HIF1_TARGETS metabolic syndrome X DOID_14221 4.623E-05 4.697E-04 2.198E-03 0.06252341 SEMENZA_HIF1_TARGETS female reproductive system disease DOID_229 4.794E-05 4.785E-04 1.000 1.000 SEMENZA_HIF1_TARGETS chronic kidney failure DOID_784 5.147E-05 5.05E-04 0.06933599 0.43835752 SEMENZA_HIF1_TARGETS newborn respiratory distress syndrome DOID_12716 5.353E-05 5.162E-04 0.01091939 0.23011596 SEMENZA_HIF1_TARGETS rhabdomyosarcoma DOID_3247 6.241E-05 5.919E-04 1.000 1.000 SEMENZA_HIF1_TARGETS parasitic helminthiasis infectious disease DOID_883 6.241E-05 5.822E-04 1.000 1.000 SEMENZA_HIF1_TARGETS carbohydrate metabolic disorder DOID_2978 7.172E-05 6.582E-04 7.172E-05 6.801E-03 SEMENZA_HIF1_TARGETS encephalomyelitis DOID_640 7.172E-05 6.478E-04 1.000 1.000 SEMENZA_HIF1_TARGETS thalassemia DOID_10241 7.198E-05 6.399E-04 1.000 1.000 SEMENZA_HIF1_TARGETS skeletal muscle cancer DOID_4043 7.198E-05 6.301E-04 1.000 1.000 SEMENZA_HIF1_TARGETS angiosarcoma DOID_0001816 8.222E-05 7.088E-04 1.000 1.000 SEMENZA_HIF1_TARGETS silicosis DOID_10325 8.222E-05 6.982E-04 1.000 1.000 SEMENZA_HIF1_TARGETS heart septal defect DOID_1681 1.17E-04 9.788E-04 0.01592006 0.32351837 SEMENZA_HIF1_TARGETS pulmonary edema DOID_11396 1.299E-04 1.071E-03 1.000 1.000 SEMENZA_HIF1_TARGETS funisitis DOID_0050698 1.578E-04 1.282E-03 1.578E-04 0.0128244 SEMENZA_HIF1_TARGETS placenta disease DOID_780 1.578E-04 1.264E-03 1.000 1.000 SEMENZA_HIF1_TARGETS glycogen metabolism disorder DOID_0050728 1.727E-04 1.365E-03 1.727E-04 0.01091873 SEMENZA_HIF1_TARGETS glycogen storage disease DOID_2747 1.727E-04 1.365E-03 1.727E-04 0.01091873 SEMENZA_HIF1_TARGETS uremia DOID_4676 1.727E-04 1.346E-03 1.000 1.000 SEMENZA_HIF1_TARGETS hypoglycemia DOID_9993 1.727E-04 1.328E-03 1.000 1.000 SEMENZA_HIF1_TARGETS congenital hemolytic anemia DOID_589 1.883E-04 1.429E-03 1.883E-04 0.01071456 SEMENZA_HIF1_TARGETS middle cerebral artery infarction DOID_3525 2.574E-04 1.927E-03 1.000 1.000 SEMENZA_HIF1_TARGETS extrinsic allergic alveolitis DOID_841 2.574E-04 1.902E-03 1.000 1.000 SEMENZA_HIF1_TARGETS perinatal necrotizing enterocolitis DOID_8677 2.763E-04 2.015E-03 0.02420014 0.38249661 SEMENZA_HIF1_TARGETS endometrial carcinoma DOID_2871 3.37E-04 2.427E-03 3.37E-04 0.01743103 SEMENZA_HIF1_TARGETS age related macular degeneration DOID_10871 3.585E-04 2.55E-03 1.000 1.000 SEMENZA_HIF1_TARGETS degeneration of macula and posterior pole DOID_2007 3.585E-04 2.55E-03 1.000 1.000 SEMENZA_HIF1_TARGETS bronchiolitis obliterans DOID_2799 3.585E-04 2.519E-03 1.000 1.000 SEMENZA_HIF1_TARGETS endometrial cancer DOID_1380 3.807E-04 2.642E-03 3.807E-04 0.01805335 SEMENZA_HIF1_TARGETS allergic rhinitis DOID_4481 3.807E-04 2.61E-03 1.000 1.000 SEMENZA_HIF1_TARGETS pleural disease DOID_1532 4.036E-04 2.734E-03 1.000 1.000 SEMENZA_HIF1_TARGETS metal metabolism disorder DOID_896 4.271E-04 2.859E-03 4.271E-04 0.01869458 SEMENZA_HIF1_TARGETS pneumoconiosis DOID_10316 4.513E-04 2.986E-03 1.000 1.000 SEMENZA_HIF1_TARGETS nephroblastoma DOID_2154 4.513E-04 2.952E-03 1.000 1.000 SEMENZA_HIF1_TARGETS thyroid carcinoma DOID_3963 4.513E-04 2.918E-03 0.03077557 0.38913993 SEMENZA_HIF1_TARGETS macular degeneration DOID_4448 4.513E-04 2.885E-03 1.000 1.000 SEMENZA_HIF1_TARGETS thyroid cancer DOID_1781 5.016E-04 3.171E-03 0.0324127 0.39240061 SEMENZA_HIF1_TARGETS adenoma DOID_657 5.016E-04 3.136E-03 0.0324127 0.3842256 SEMENZA_HIF1_TARGETS pulmonary sarcoidosis DOID_13406 5.277E-04 3.264E-03 1.000 1.000 SEMENZA_HIF1_TARGETS congenital diaphragmatic hernia DOID_3827 5.819E-04 3.56E-03 1.000 1.000 SEMENZA_HIF1_TARGETS systemic scleroderma DOID_418 5.819E-04 3.522E-03 1.000 1.000 SEMENZA_HIF1_TARGETS intracranial arterial disease DOID_13089 6.099E-04 3.653E-03 1.000 1.000 SEMENZA_HIF1_TARGETS cerebral arterial disease DOID_3527 6.099E-04 3.653E-03 1.000 1.000 SEMENZA_HIF1_TARGETS cervix uteri carcinoma in situ DOID_8991 6.387E-04 3.785E-03 0.03649384 0.37754535 SEMENZA_HIF1_TARGETS pulmonary emphysema DOID_9675 6.387E-04 3.746E-03 1.000 1.000 SEMENZA_HIF1_TARGETS autoimmune disease of urogenital tract DOID_0060049 6.68E-04 3.879E-03 0.03730806 0.37907656 SEMENZA_HIF1_TARGETS primary biliary cirrhosis DOID_12236 6.68E-04 3.879E-03 0.03730806 0.37907656 SEMENZA_HIF1_TARGETS nephrotic syndrome DOID_1184 6.98E-04 4.012E-03 6.98E-04 0.02647768 SEMENZA_HIF1_TARGETS rheumatic disease DOID_1575 6.98E-04 3.972E-03 1.000 1.000 SEMENZA_HIF1_TARGETS scleroderma DOID_419 6.98E-04 3.972E-03 1.000 1.000 SEMENZA_HIF1_TARGETS cerebral infarction DOID_3526 7.599E-04 4.281E-03 1.000 1.000 SEMENZA_HIF1_TARGETS thyroid adenoma DOID_2891 8.244E-04 4.599E-03 0.04136919 0.36213953 SEMENZA_HIF1_TARGETS sarcoidosis DOID_11335 1.033E-03 5.707E-03 1.000 1.000 SEMENZA_HIF1_TARGETS hypertrophic cardiomyopathy DOID_11984 1.224E-03 6.699E-03 1.000 1.000 SEMENZA_HIF1_TARGETS hypersensitivity reaction type IV disease DOID_2916 1.224E-03 6.635E-03 1.000 1.000 SEMENZA_HIF1_TARGETS leukocyte disease DOID_9500 1.265E-03 6.788E-03 1.000 1.000 SEMENZA_HIF1_TARGETS collagen disease DOID_854 1.347E-03 7.162E-03 1.000 1.000 SEMENZA_HIF1_TARGETS hypothyroidism DOID_1459 1.389E-03 7.317E-03 0.05345325 0.40553197 SEMENZA_HIF1_TARGETS pre-malignant neoplasm DOID_0060071 1.431E-03 7.472E-03 0.05425358 0.406188 SEMENZA_HIF1_TARGETS in situ carcinoma DOID_8719 1.431E-03 7.472E-03 0.05425358 0.406188 SEMENZA_HIF1_TARGETS cholestasis DOID_13580 1.519E-03 7.855E-03 0.05585229 0.39724939 SEMENZA_HIF1_TARGETS parasitic infectious disease DOID_1398 1.519E-03 7.785E-03 1.000 1.000 SEMENZA_HIF1_TARGETS hyperglycemia DOID_4195 1.563E-03 7.941E-03 1.563E-03 0.04941156 SEMENZA_HIF1_TARGETS endocrine organ benign neoplasm DOID_0060089 1.654E-03 8.328E-03 0.05824544 0.4041665 SEMENZA_HIF1_TARGETS blood coagulation disease DOID_1247 1.747E-03 8.721E-03 1.000 1.000 SEMENZA_HIF1_TARGETS pancreatic ductal carcinoma DOID_3587 1.747E-03 8.645E-03 1.000 1.000 SEMENZA_HIF1_TARGETS bile duct disease DOID_4138 1.795E-03 8.804E-03 0.06063271 0.41566279 SEMENZA_HIF1_TARGETS biliary tract disease DOID_9741 1.843E-03 8.964E-03 0.06142716 0.41120065 SEMENZA_HIF1_TARGETS pancreatic carcinoma DOID_4905 1.892E-03 9.123E-03 1.000 1.000 SEMENZA_HIF1_TARGETS alcohol abuse DOID_1574 2.359E-03 0.01127821 2.359E-03 0.06390985 SEMENZA_HIF1_TARGETS Human immunodeficiency virus infectious disease DOID_526 2.756E-03 0.01306589 0.07483371 0.46791627 SEMENZA_HIF1_TARGETS ulcerative colitis DOID_8577 3.245E-03 0.01525862 1.000 1.000 SEMENZA_HIF1_TARGETS arrhythmogenic right ventricular dysplasia DOID_0050431 7.572E-03 0.03531502 7.572E-03 0.19583783 SEMENZA_HIF1_TARGETS facioscapulohumeral muscular dystrophy DOID_11727 8.41E-03 0.038904 8.41E-03 0.20805181 SEMENZA_HIF1_TARGETS retinal vascular occlusion DOID_1729 8.41E-03 0.03859026 1.000 1.000 SEMENZA_HIF1_TARGETS insulinoma DOID_3892 8.41E-03 0.03828153 1.000 1.000 SEMENZA_HIF1_TARGETS keratitis DOID_4677 8.41E-03 0.03797771 1.000 1.000 SEMENZA_HIF1_TARGETS trypanosomiasis DOID_10113 9.247E-03 0.04142961 1.000 1.000 SEMENZA_HIF1_TARGETS adrenoleukodystrophy DOID_10588 9.247E-03 0.04110594 1.000 1.000 SEMENZA_HIF1_TARGETS pneumocystosis DOID_11339 9.247E-03 0.04078729 1.000 1.000 SEMENZA_HIF1_TARGETS hemochromatosis DOID_2352 9.247E-03 0.04047355 9.247E-03 0.20236773 SEMENZA_HIF1_TARGETS eosinophilic pneumonia DOID_5870 9.247E-03 0.04016459 1.000 1.000 SEMENZA_HIF1_TARGETS pulmonary eosinophilia DOID_9498 9.247E-03 0.04016459 1.000 1.000 SEMENZA_HIF1_TARGETS Loeffler syndrome DOID_9503 9.247E-03 0.04016459 1.000 1.000 SEMENZA_HIF1_TARGETS otitis media DOID_10754 0.01008355 0.04346622 1.000 1.000 SEMENZA_HIF1_TARGETS porphyria DOID_13268 0.01008355 0.0431394 1.000 1.000 SEMENZA_HIF1_TARGETS islet cell tumor DOID_1799 0.01008355 0.04281747 1.000 1.000 SEMENZA_HIF1_TARGETS middle ear disease DOID_5100 0.01008355 0.04346622 1.000 1.000 SEMENZA_HIF1_TARGETS berylliosis DOID_10322 0.01091939 0.04602319 1.000 1.000 SEMENZA_HIF1_TARGETS essential hypertension DOID_10825 0.01091939 0.04568479 1.000 1.000 SEMENZA_HIF1_TARGETS hepatic coma DOID_12550 0.01091939 0.04535132 1.000 1.000 SEMENZA_HIF1_TARGETS hepatic encephalopathy DOID_13413 0.01091939 0.04535132 1.000 1.000 SEMENZA_HIF1_TARGETS polyneuropathy DOID_1389 0.01091939 0.04502269 1.000 1.000 SEMENZA_HIF1_TARGETS Leydig cell tumor DOID_2696 0.01091939 0.04469878 1.000 1.000 SEMENZA_HIF1_TARGETS sex cord-stromal neoplasm DOID_4757 0.01091939 0.04469878 1.000 1.000 SEMENZA_HIF1_TARGETS psoriatic arthritis DOID_9008 0.01091939 0.04437951 1.000 1.000 SEMENZA_HIF1_TARGETS viral pneumonia DOID_10533 0.01175454 0.04743498 1.000 1.000 SEMENZA_HIF1_TARGETS renovascular hypertension DOID_1591 0.01258901 0.05044468 1.000 1.000 SEMENZA_HIF1_TARGETS membranoproliferative glomerulonephritis DOID_2920 0.01258901 0.05009192 1.000 1.000 SEMENZA_HIF1_TARGETS arthropathy DOID_381 0.01258901 0.04974406 1.000 1.000 SEMENZA_HIF1_TARGETS varicose veins DOID_799 0.01258901 0.049401 1.000 1.000 SEMENZA_HIF1_TARGETS hemolytic-uremic syndrome DOID_12554 0.01342279 0.05231212 1.000 1.000 SEMENZA_HIF1_TARGETS vein disease DOID_866 0.01342279 0.05195625 1.000 1.000 SEMENZA_HIF1_TARGETS lymphatic system cancer DOID_0060073 0.0142559 0.05480814 1.000 1.000 SEMENZA_HIF1_TARGETS reticulosarcoma DOID_8538 0.0142559 0.05480814 1.000 1.000 SEMENZA_HIF1_TARGETS lymphosarcoma DOID_8675 0.0142559 0.05480814 1.000 1.000 SEMENZA_HIF1_TARGETS eosinophilia DOID_999 0.01508832 0.05761915 1.000 1.000 SEMENZA_HIF1_TARGETS granulosa cell tumor DOID_2999 0.01592006 0.0603901 1.000 1.000 SEMENZA_HIF1_TARGETS MHC class II deficiency DOID_5812 0.01592006 0.05999016 1.000 1.000 SEMENZA_HIF1_TARGETS psoriasis DOID_8893 0.01592006 0.05959549 1.000 1.000 SEMENZA_HIF1_TARGETS sex cord-gonadal stromal tumor DOID_192 0.01675112 0.06229665 1.000 1.000 SEMENZA_HIF1_TARGETS coronary restenosis DOID_4247 0.0175815 0.06496023 1.000 1.000 SEMENZA_HIF1_TARGETS benign glioma DOID_0060101 0.0184112 0.06758693 1.000 1.000 SEMENZA_HIF1_TARGETS benign ependymoma DOID_4844 0.0184112 0.06758693 1.000 1.000 SEMENZA_HIF1_TARGETS acquired immunodeficiency syndrome DOID_635 0.0184112 0.06715369 1.000 1.000 SEMENZA_HIF1_TARGETS pulmonary embolism DOID_9477 0.01924023 0.0697305 1.000 1.000 SEMENZA_HIF1_TARGETS meningitis DOID_9471 0.02006857 0.07227226 1.000 1.000 SEMENZA_HIF1_TARGETS acute pancreatitis DOID_2913 0.02089624 0.07477962 1.000 1.000 SEMENZA_HIF1_TARGETS severe combined immunodeficiency DOID_627 0.02089624 0.07431224 1.000 1.000 SEMENZA_HIF1_TARGETS reading disorder DOID_13365 0.02172323 0.07677339 0.02172323 0.37456109 SEMENZA_HIF1_TARGETS hypogonadism DOID_1924 0.02172323 0.07629948 1.000 1.000 SEMENZA_HIF1_TARGETS bronchiolitis DOID_2942 0.02172323 0.07583139 1.000 1.000 SEMENZA_HIF1_TARGETS osteosarcoma DOID_3347 0.02172323 0.075369 0.02172323 0.36354459 SEMENZA_HIF1_TARGETS dyslexia DOID_4428 0.02172323 0.07677339 0.02172323 0.37456109 SEMENZA_HIF1_TARGETS combined T cell and B cell immunodeficiency DOID_628 0.02172323 0.07491222 1.000 1.000 SEMENZA_HIF1_TARGETS cystitis DOID_1679 0.02254954 0.0772933 1.000 1.000 SEMENZA_HIF1_TARGETS seminoma DOID_4440 0.02337518 0.07964356 1.000 1.000 SEMENZA_HIF1_TARGETS dystonia DOID_543 0.02337518 0.0791695 0.02337518 0.38001358 SEMENZA_HIF1_TARGETS autoimmune disease of cardiovascular system DOID_0060051 0.02502442 0.08425383 0.02502442 0.38483504 SEMENZA_HIF1_TARGETS pleurisy DOID_10247 0.02502442 0.08375822 1.000 1.000 SEMENZA_HIF1_TARGETS malaria DOID_12365 0.02502442 0.0832684 1.000 1.000 SEMENZA_HIF1_TARGETS Behcet's disease DOID_13241 0.02502442 0.08425383 0.02502442 0.38483504 SEMENZA_HIF1_TARGETS thrombocytopenia DOID_1588 0.02502442 0.08278428 1.000 1.000 SEMENZA_HIF1_TARGETS invasive ductal carcinoma DOID_3008 0.02502442 0.08230576 1.000 1.000 SEMENZA_HIF1_TARGETS coronary stenosis DOID_4248 0.02502442 0.08183274 1.000 1.000 SEMENZA_HIF1_TARGETS autoimmune disease of the nervous system DOID_438 0.02502442 0.08136512 0.02502442 0.36509991 SEMENZA_HIF1_TARGETS polycystic ovary syndrome DOID_11612 0.02584803 0.08356552 0.02584803 0.36768828 SEMENZA_HIF1_TARGETS multiple epiphyseal dysplasia DOID_12721 0.02584803 0.0830934 1.000 1.000 SEMENZA_HIF1_TARGETS toxic encephalopathy DOID_3602 0.02584803 0.08262658 0.02584803 0.35872028 SEMENZA_HIF1_TARGETS corneal disease DOID_10124 0.02667097 0.08478091 1.000 1.000 SEMENZA_HIF1_TARGETS gonadal disease DOID_2277 0.02749324 0.08690917 1.000 1.000 SEMENZA_HIF1_TARGETS opportunistic mycosis DOID_2473 0.02749324 0.08642901 1.000 1.000 SEMENZA_HIF1_TARGETS germinoma DOID_3304 0.02831483 0.08852272 1.000 1.000 SEMENZA_HIF1_TARGETS chronic leukemia DOID_1036 0.02913574 0.09059147 1.000 1.000 SEMENZA_HIF1_TARGETS chronic lymphocytic leukemia DOID_1040 0.02913574 0.09059147 1.000 1.000 SEMENZA_HIF1_TARGETS bladder disease DOID_365 0.02913574 0.09009912 1.000 1.000 SEMENZA_HIF1_TARGETS systemic mycosis DOID_0050136 0.02995599 0.09213491 1.000 1.000 SEMENZA_HIF1_TARGETS fungal infectious disease DOID_1564 0.02995599 0.09213491 1.000 1.000 SEMENZA_HIF1_TARGETS papilloma DOID_2615 0.02995599 0.09163956 0.02995599 0.38738543 SEMENZA_HIF1_TARGETS paraplegia DOID_607 0.03077557 0.0936433 1.000 1.000 SEMENZA_HIF1_TARGETS hyperthyroidism DOID_7998 0.03077557 0.0931452 0.03077557 0.38068037 SEMENZA_HIF1_TARGETS cleft palate DOID_674 0.03323027 0.09951591 0.03323027 0.38587802 SEMENZA_HIF1_TARGETS embryonal cancer DOID_688 0.03323027 0.09899488 0.03323027 0.37816046 SEMENZA_HIF1_TARGETS multiple myeloma DOID_9538 0.03323027 0.09847929 0.03323027 0.37074554 SEMENZA_HIF1_TARGETS uveitis DOID_13141 0.03404716 0.09985998 1.000 1.000 SEMENZA_HIF1_TARGETS blood platelet disease DOID_2218 0.03404716 0.09934788 1.000 1.000 LEE_LIVER_CANCER_DENA_UP pancreatic ductal carcinoma DOID_3587 3.317E-08 1.887E-05 2.119E-06 1.206E-03 LEE_LIVER_CANCER_DENA_UP pancreatic carcinoma DOID_4905 4.068E-08 1.157E-05 2.491E-06 7.087E-04 LEE_LIVER_CANCER_DENA_UP encephalomyelitis DOID_640 6.076E-06 1.152E-03 6.242E-03 0.17757528 LEE_LIVER_CANCER_DENA_UP myocarditis DOID_820 1.239E-05 1.762E-03 1.239E-05 2.35E-03 LEE_LIVER_CANCER_DENA_UP hepatitis DOID_2237 1.982E-05 2.255E-03 1.255E-03 0.08925458 LEE_LIVER_CANCER_DENA_UP diabetic autonomic neuropathy DOID_11503 2.787E-05 2.643E-03 0.05667048 0.49608467 LEE_LIVER_CANCER_DENA_UP autonomic neuropathy DOID_11504 2.787E-05 2.643E-03 0.05667048 0.49608467 LEE_LIVER_CANCER_DENA_UP diabetic polyneuropathy DOID_12785 2.787E-05 2.643E-03 0.05667048 0.49608467 LEE_LIVER_CANCER_DENA_UP diabetic neuropathy DOID_9743 2.787E-05 2.643E-03 0.05667048 0.49608467 LEE_LIVER_CANCER_DENA_UP autonomic nervous system disease DOID_11465 3.36E-05 2.731E-03 0.06017904 0.51107271 LEE_LIVER_CANCER_DENA_UP carotid artery disease DOID_3407 7.055E-05 5.018E-03 2.888E-03 0.11736706 LEE_LIVER_CANCER_DENA_UP peripheral vascular disease DOID_341 1.133E-04 7.161E-03 0.08892458 0.57497822 LEE_LIVER_CANCER_DENA_UP aneurysm disease DOID_2403 1.322E-04 7.521E-03 4.361E-03 0.14598145 LEE_LIVER_CANCER_DENA_UP metabolic syndrome X DOID_14221 1.476E-04 7.637E-03 0.09681792 0.5987978 LEE_LIVER_CANCER_DENA_UP prion disease DOID_649 2.273E-04 0.01077609 0.02208671 0.36962767 LEE_LIVER_CANCER_DENA_UP uremia DOID_4676 3.743E-04 0.01638368 1.000 1.000 LEE_LIVER_CANCER_DENA_UP diabetic angiopathy DOID_11713 4.08E-04 0.01658335 0.0293423 0.41739423 LEE_LIVER_CANCER_DENA_UP urticaria DOID_1555 4.797E-04 0.01819688 1.000 1.000 LEE_LIVER_CANCER_DENA_UP morbid obesity DOID_11981 5.177E-04 0.01840978 5.177E-04 0.07363913 LEE_LIVER_CANCER_DENA_UP intracranial aneurysm DOID_10941 5.571E-04 0.01864495 5.571E-04 0.06339284 LEE_LIVER_CANCER_DENA_UP gestational diabetes DOID_11714 5.978E-04 0.01889856 0.03534835 0.44696029 LEE_LIVER_CANCER_DENA_UP lung adenocarcinoma DOID_3910 5.978E-04 0.0179039 5.978E-04 0.05669569 LEE_LIVER_CANCER_DENA_UP focal glomerulosclerosis DOID_3945 6.836E-04 0.01944966 0.03774058 0.45690187 LEE_LIVER_CANCER_DENA_UP hepatitis C DOID_1883 9.745E-04 0.02640501 0.04488246 0.44803721 LEE_LIVER_CANCER_DENA_UP calcinosis DOID_182 1.139E-03 0.02944929 0.04843392 0.45931504 LEE_LIVER_CANCER_DENA_UP microcephaly DOID_10907 1.196E-03 0.02959008 1.196E-03 0.09722454 LEE_LIVER_CANCER_DENA_UP benign mesothelioma DOID_2645 1.377E-03 0.03263712 0.05314911 0.4957679 LEE_LIVER_CANCER_DENA_UP nephrotic syndrome DOID_1184 1.504E-03 0.03422527 1.504E-03 0.09507021 LEE_LIVER_CANCER_DENA_UP pre-eclampsia DOID_10591 1.774E-03 0.03882747 1.774E-03 0.10095141 LEE_LIVER_CANCER_DENA_UP brain cancer DOID_1319 1.774E-03 0.03738941 1.000 1.000 LEE_LIVER_CANCER_DENA_UP neuritis DOID_1803 1.774E-03 0.03605408 0.06017904 0.50355694 LEE_LIVER_CANCER_DENA_UP heart valve disease DOID_4079 1.774E-03 0.03481083 0.06017904 0.49625901 LEE_LIVER_CANCER_DENA_UP vascular skin disease DOID_9540 1.774E-03 0.03365047 1.000 1.000 LEE_LIVER_CANCER_DENA_UP central nervous system cancer DOID_3620 1.845E-03 0.03386743 1.000 1.000 LEE_LIVER_CANCER_DENA_UP lung small cell carcinoma DOID_5409 1.917E-03 0.03409454 0.06251097 0.49401034 LEE_LIVER_CANCER_DENA_UP calcium metabolism disease DOID_10575 1.991E-03 0.03433082 0.06367482 0.49631468 LEE_LIVER_CANCER_DENA_UP giant cell tumor DOID_200 2.22E-03 0.0371504 0.06715787 0.5095044 LEE_LIVER_CANCER_DENA_UP malignant giant cell tumor DOID_2705 2.22E-03 0.0371504 0.06715787 0.5095044 LEE_LIVER_CANCER_DENA_UP giant cell glioblastoma DOID_3074 2.22E-03 0.0371504 0.06715787 0.5095044 LEE_LIVER_CANCER_DENA_UP bile duct adenocarcinoma DOID_4896 2.299E-03 0.03737181 2.299E-03 0.11891032 LEE_LIVER_CANCER_DENA_UP cholangiocarcinoma DOID_4947 2.299E-03 0.03737181 2.299E-03 0.11891032 LEE_LIVER_CANCER_DENA_UP familial hyperlipidemia DOID_1168 2.461E-03 0.03889039 0.07062825 0.50870218 LEE_LIVER_CANCER_DENA_UP congenital nervous system abnormality DOID_2490 2.543E-03 0.03911326 2.543E-03 0.12059922 LEE_LIVER_CANCER_DENA_UP glioblastoma DOID_3068 2.628E-03 0.03934393 0.07293481 0.5123445 LEE_LIVER_CANCER_DENA_UP bile duct cancer DOID_4606 2.628E-03 0.03833511 2.628E-03 0.11500534 LEE_LIVER_CANCER_DENA_UP bile duct carcinoma DOID_4897 2.628E-03 0.03833511 2.628E-03 0.11500534 LEE_LIVER_CANCER_DENA_UP mineral metabolism disease DOID_0050032 3.16E-03 0.0449455 0.07982092 0.54720604 LEE_LIVER_CANCER_DENA_UP cholestasis DOID_13580 3.253E-03 0.04514247 1.000 1.000 LEE_LIVER_CANCER_DENA_UP tuberculosis DOID_399 3.54E-03 0.04795861 0.08438382 0.5583069 LEE_LIVER_CANCER_DENA_UP astrocytoma DOID_3069 3.638E-03 0.04814376 0.08552108 0.55932753 LEE_LIVER_CANCER_DENA_UP nephrosis DOID_2527 3.839E-03 0.04964045 3.839E-03 0.14561199 LEE_LIVER_CANCER_DENA_UP bile duct disease DOID_4138 3.839E-03 0.04853733 1.000 1.000 LEE_LIVER_CANCER_DENA_UP biliary tract disease DOID_9741 3.941E-03 0.04874467 1.000 1.000 LEE_LIVER_CANCER_DENA_UP diabetic retinopathy DOID_8947 4.044E-03 0.04895839 0.09005632 0.5757533 LEE_LIVER_CANCER_DENA_UP bone resorption disease DOID_0080011 4.361E-03 0.05170176 4.361E-03 0.15510529 LEE_LIVER_CANCER_DENA_UP osteoporosis DOID_11476 4.361E-03 0.05170176 4.361E-03 0.15510529 LEE_LIVER_CANCER_DENA_UP pancreatitis DOID_4989 4.47E-03 0.0519044 0.09456954 0.59788962 LEE_LIVER_CANCER_DENA_UP lipid metabolism disorder DOID_3146 4.69E-03 0.05337388 0.09681792 0.59235912 LEE_LIVER_CANCER_DENA_UP alcohol abuse DOID_1574 5.03E-03 0.05611812 5.03E-03 0.15900135 LEE_LIVER_CANCER_DENA_UP biliary tract cancer DOID_4607 5.03E-03 0.05503893 5.03E-03 0.15063286 LEE_LIVER_CANCER_DENA_UP retinal vascular disease DOID_2462 5.263E-03 0.05649811 0.10241501 0.60702229 LEE_LIVER_CANCER_DENA_UP primary bacterial infectious disease DOID_0050338 5.5E-03 0.05795462 0.10464433 0.61384146 LEE_LIVER_CANCER_DENA_UP nervous system cancer DOID_3093 5.865E-03 0.06068083 1.000 1.000 LEE_LIVER_CANCER_DENA_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.369E-03 0.06471822 1.000 1.000 LEE_LIVER_CANCER_DENA_UP dilated cardiomyopathy DOID_12930 6.498E-03 0.06487041 6.498E-03 0.17607684 TAVOR_CEBPA_TARGETS_DN lymphoblastic leukemia DOID_1037 1.393E-07 7.927E-05 1.033E-03 0.29399774 TAVOR_CEBPA_TARGETS_DN pulmonary embolism DOID_9477 5.983E-05 0.01702093 0.01146698 0.40779454 TAVOR_CEBPA_TARGETS_DN autonomic nervous system neoplasm DOID_2621 1.402E-04 0.02659078 1.000 1.000 TAVOR_CEBPA_TARGETS_DN neuroblastoma DOID_769 1.402E-04 0.02659078 1.000 1.000 TAVOR_CEBPA_TARGETS_DN adenoma DOID_657 1.744E-04 0.02480701 0.01937042 0.45924038 TAVOR_CEBPA_TARGETS_DN peripheral nervous system neoplasm DOID_1192 1.929E-04 0.02194828 1.000 1.000 TAVOR_CEBPA_TARGETS_DN hemolytic anemia DOID_583 2.99E-04 0.02835424 0.02525867 0.43552077 TAVOR_CEBPA_TARGETS_DN normocytic anemia DOID_720 2.99E-04 0.02835424 0.02525867 0.43552077 TAVOR_CEBPA_TARGETS_DN hemorrhagic disease DOID_2213 3.353E-04 0.02725282 0.02672549 0.44725902 TAVOR_CEBPA_TARGETS_DN giant cell tumor DOID_200 3.606E-04 0.02564727 1.000 1.000 TAVOR_CEBPA_TARGETS_DN malignant giant cell tumor DOID_2705 3.606E-04 0.02564727 1.000 1.000 TAVOR_CEBPA_TARGETS_DN giant cell glioblastoma DOID_3074 3.606E-04 0.02564727 1.000 1.000 TAVOR_CEBPA_TARGETS_DN integumentary system cancer DOID_0060122 3.868E-04 0.02445576 0.028678 0.45327178 TAVOR_CEBPA_TARGETS_DN skin cancer DOID_4159 3.868E-04 0.02445576 0.028678 0.45327178 TAVOR_CEBPA_TARGETS_DN glioblastoma DOID_3068 4.279E-04 0.02434517 1.000 1.000 TAVOR_CEBPA_TARGETS_DN hypothyroidism DOID_1459 4.857E-04 0.02512543 4.857E-04 0.27637974 TAVOR_CEBPA_TARGETS_DN astrocytoma DOID_3069 5.956E-04 0.02824324 1.000 1.000 TAVOR_CEBPA_TARGETS_DN blood coagulation disease DOID_1247 6.122E-04 0.02679707 0.03596691 0.49915057 TAVOR_CEBPA_TARGETS_DN syndrome DOID_225 6.986E-04 0.02839122 1.000 1.000 TAVOR_CEBPA_TARGETS_DN nervous system cancer DOID_3093 9.697E-04 0.03678319 1.000 1.000 TAVOR_CEBPA_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 1.077E-03 0.03829889 1.077E-03 0.20426077 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN seminoma DOID_4440 2.881E-05 0.01639421 8.095E-03 1.000 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN germinoma DOID_3304 4.272E-05 0.01215399 9.822E-03 0.6986169 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN embryonal cancer DOID_688 5.934E-05 0.01125504 0.01154661 0.46928723 KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN lung small cell carcinoma DOID_5409 1.007E-04 0.01432294 0.01498688 0.37076241 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE hypertrophic cardiomyopathy DOID_11984 6.306E-10 3.588E-07 4.654E-08 2.648E-05 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE Charcot-Marie-Tooth disease DOID_10595 2.536E-07 7.216E-05 2.178E-05 3.098E-03 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE multiple myeloma DOID_9538 4.963E-07 9.413E-05 1.848E-03 0.06186348 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE myeloma DOID_0070004 1.236E-06 1.758E-04 2.873E-03 0.08605173 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE bone marrow cancer DOID_4960 2.102E-06 2.393E-04 3.717E-03 0.09613956 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE astrocytoma DOID_3069 5.38E-06 5.102E-04 0.10787442 0.61380545 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE glycogen metabolism disorder DOID_0050728 6.525E-06 5.304E-04 6.525E-06 1.856E-03 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE glycogen storage disease DOID_2747 6.525E-06 5.304E-04 6.525E-06 1.856E-03 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE transitional cell carcinoma DOID_2671 1.308E-05 9.303E-04 9.021E-03 0.19011592 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE nervous system cancer DOID_3093 1.427E-05 9.022E-04 0.13575141 0.70220502 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE lymphoma DOID_0060058 1.554E-05 8.841E-04 9.806E-03 0.19927237 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE lymphoblastic leukemia DOID_1037 1.62E-05 8.38E-04 4.703E-04 0.02432772 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE carbohydrate metabolic disorder DOID_2978 1.62E-05 7.682E-04 1.62E-05 3.073E-03 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE giant cell tumor DOID_200 9.841E-05 4.307E-03 0.08493785 0.58228478 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE malignant giant cell tumor DOID_2705 9.841E-05 4.307E-03 0.08493785 0.58228478 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE giant cell glioblastoma DOID_3074 9.841E-05 4.307E-03 0.08493785 0.58228478 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE familial hyperlipidemia DOID_1168 1.15E-04 4.675E-03 1.15E-04 0.01308925 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE glioblastoma DOID_3068 1.27E-04 4.819E-03 0.09216713 0.59594426 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE Charcot-Marie-Tooth disease type 2 DOID_0050539 1.9E-04 6.756E-03 1.9E-04 0.01801637 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE nutritional deficiency disease DOID_5113 2.552E-04 8.542E-03 2.552E-04 0.02074579 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE angiosarcoma DOID_0001816 2.914E-04 9.211E-03 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE lipid metabolism disorder DOID_3146 3.053E-04 9.144E-03 3.053E-04 0.02171697 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE amino acid metabolic disorder DOID_9252 4.146E-04 0.01179652 4.146E-04 0.0262145 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE Human immunodeficiency virus infectious disease DOID_526 4.281E-04 0.01160045 4.281E-04 0.02436095 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE subependymal glioma DOID_4843 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE pilocytic astrocytoma DOID_4851 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE subependymal giant cell astrocytoma DOID_5077 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE fibrillary astrocytoma DOID_6726 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE juvenile pilocytic astrocytoma DOID_6811 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE childhood pilocytic astrocytoma DOID_6812 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE gemistocytic astrocytoma DOID_7005 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE childhood cerebral astrocytoma DOID_7007 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE protoplasmic astrocytoma DOID_7008 4.595E-04 0.01188385 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE benign glioma DOID_0060101 5.575E-04 0.01379195 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE familial hypercholesterolemia DOID_13810 5.575E-04 0.01321729 5.575E-04 0.02643457 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE benign ependymoma DOID_4844 5.575E-04 0.01379195 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE organic acidemia DOID_0060159 7.812E-04 0.01777937 7.812E-04 0.03419109 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE portal hypertension DOID_10762 7.812E-04 0.01709554 7.812E-04 0.03174887 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE seminoma DOID_4440 9.067E-04 0.01910807 0.04339549 0.43319357 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE sarcoma DOID_1115 1.041E-03 0.021161 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE hepatic vascular disease DOID_272 1.041E-03 0.02043131 1.041E-03 0.03950054 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE supratentorial cancer DOID_1659 1.112E-03 0.02109089 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE cerebrum cancer DOID_368 1.112E-03 0.02109089 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE germinoma DOID_3304 1.337E-03 0.0245493 0.05245072 0.48136229 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE chronic leukemia DOID_1036 1.417E-03 0.02519783 1.417E-03 0.05039567 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE chronic lymphocytic leukemia DOID_1040 1.417E-03 0.02519783 1.417E-03 0.05039567 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE peripheral nervous system neoplasm DOID_1192 1.941E-03 0.03346934 0.06290867 0.51876861 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE intracranial arterial disease DOID_13089 2.133E-03 0.03570043 2.133E-03 0.06743415 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE cerebral arterial disease DOID_3527 2.133E-03 0.03570043 2.133E-03 0.06743415 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE brain cancer DOID_1319 2.873E-03 0.0467138 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE central nervous system cancer DOID_3620 2.988E-03 0.04722195 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE orofacial cleft DOID_0050567 3.466E-03 0.0532964 3.466E-03 0.09859834 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE atrophic muscular disease DOID_913 3.59E-03 0.05376129 3.59E-03 0.09728233 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE muscular dystrophy DOID_9884 3.59E-03 0.05376129 3.59E-03 0.09728233 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE bile duct adenocarcinoma DOID_4896 3.717E-03 0.05423257 0.08638822 0.58517735 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE cholangiocarcinoma DOID_4947 3.717E-03 0.05423257 0.08638822 0.58517735 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE reproductive organ benign neoplasm DOID_0050622 3.846E-03 0.05470969 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE bile duct cancer DOID_4606 4.245E-03 0.05891112 0.09216713 0.58924825 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE bile duct carcinoma DOID_4897 4.245E-03 0.05891112 0.09216713 0.58924825 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE allergic contact dermatitis DOID_3042 5.551E-03 0.07520323 5.551E-03 0.13732763 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE pancreatic carcinoma DOID_4905 6.511E-03 0.08616012 1.000 1.000 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE diabetic retinopathy DOID_8947 6.511E-03 0.08420194 6.511E-03 0.15437022 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE contact dermatitis DOID_2773 7.541E-03 0.09535628 7.541E-03 0.17164131 SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE biliary tract cancer DOID_4607 8.082E-03 0.09997364 0.1260933 0.66432489 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN aortic aneurysm DOID_3627 3.41E-08 1.94E-05 1.06E-04 0.01507683 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN aneurysm disease DOID_2403 2.588E-07 7.363E-05 3.466E-04 0.01408637 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN abdominal aortic aneurysm DOID_7693 3.101E-07 5.882E-05 1.477E-03 0.02710574 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN pulmonary emphysema DOID_9675 1.014E-06 1.443E-04 6.058E-05 0.01723635 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN rheumatic disease DOID_1575 1.216E-06 1.384E-04 6.927E-05 0.01313843 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN scleroderma DOID_419 1.216E-06 1.384E-04 6.927E-05 0.01313843 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN thoracic aortic aneurysm DOID_14004 2.157E-06 2.045E-04 2.996E-04 0.01549634 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN carotid artery disease DOID_3407 4.627E-06 3.761E-04 5.449E-03 0.06327636 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN collagen disease DOID_854 4.627E-06 3.291E-04 1.86E-04 0.01322815 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bacterial pneumonia DOID_874 1.128E-05 7.134E-04 3.597E-04 0.01279016 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN mouth disease DOID_403 2.322E-05 1.321E-03 6.134E-04 0.01661895 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN hypersensitivity reaction type I disease DOID_1205 2.419E-05 1.251E-03 2.419E-05 0.01376186 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN spastic cerebral palsy DOID_0050669 2.53E-05 1.2E-03 1.477E-03 0.02800926 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN ulcerative colitis DOID_8577 2.727E-05 1.193E-03 6.908E-04 0.01786566 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN metal metabolism disorder DOID_896 3.298E-05 1.341E-03 1.756E-03 0.03122776 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN systemic scleroderma DOID_418 5.264E-05 1.997E-03 2.384E-03 0.03768556 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN lymphatic system disease DOID_75 5.652E-05 2.01E-03 2.498E-03 0.03841326 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN pre-eclampsia DOID_10591 8.9E-05 2.979E-03 3.363E-03 0.04666542 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN sarcoidosis DOID_11335 1.25E-04 3.95E-03 1.25E-04 0.01422005 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN temporal arteritis DOID_13375 1.576E-04 4.72E-03 0.01870155 0.16371053 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN hemochromatosis DOID_2352 1.576E-04 4.484E-03 1.576E-04 0.01494745 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN central nervous system vasculitis DOID_525 1.576E-04 4.72E-03 0.01870155 0.16371053 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN hypersensitivity reaction type IV disease DOID_2916 1.612E-04 4.369E-03 1.612E-04 0.01310706 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN common cold DOID_10459 1.889E-04 4.886E-03 1.889E-04 0.01194473 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN ocular hypertension DOID_9282 1.889E-04 4.674E-03 0.02038452 0.15888756 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN borderline glaucoma DOID_9283 1.889E-04 4.674E-03 0.02038452 0.15888756 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN cholestasis DOID_13580 2.226E-04 5.278E-03 6.13E-03 0.06976213 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN carotid stenosis DOID_13001 2.23E-04 5.076E-03 0.02206464 0.16519451 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bacterial meningitis DOID_9470 2.599E-04 5.688E-03 0.02374193 0.17100201 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bile duct disease DOID_4138 2.859E-04 6.024E-03 7.221E-03 0.07470216 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN peripheral vascular disease DOID_341 2.974E-04 6.044E-03 2.974E-04 0.01692206 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN biliary tract disease DOID_9741 2.974E-04 5.835E-03 7.41E-03 0.0752955 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN oral submucous fibrosis DOID_5773 2.996E-04 5.682E-03 0.02541638 0.16816189 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN varicose veins DOID_799 2.996E-04 5.499E-03 0.02541638 0.166229 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN hyperhomocysteinemia DOID_9279 2.996E-04 5.327E-03 2.996E-04 0.01420498 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN spastic diplegia DOID_10965 3.42E-04 5.897E-03 3.42E-04 0.01496889 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN vein disease DOID_866 3.42E-04 5.723E-03 0.02708801 0.16937448 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bone resorption disease DOID_0080011 3.466E-04 5.635E-03 8.192E-03 0.08177159 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN osteoporosis DOID_11476 3.466E-04 5.635E-03 8.192E-03 0.08177159 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN pancreatitis DOID_4989 3.597E-04 5.685E-03 3.597E-04 0.01364284 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN lipid metabolism disorder DOID_3146 3.867E-04 5.947E-03 0.13139237 0.42478555 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN dental caries DOID_216 4.351E-04 6.515E-03 4.351E-04 0.01456241 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bone development disease DOID_0080006 4.447E-04 6.488E-03 4.447E-04 0.01405807 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN amino acid metabolic disorder DOID_9252 5.247E-04 7.464E-03 5.247E-04 0.01571342 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN membranous glomerulonephritis DOID_10976 5.391E-04 7.482E-03 0.03374633 0.2000173 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN Kawasaki disease DOID_13378 5.952E-04 8.063E-03 5.952E-04 0.01693318 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN lymphadenitis DOID_1602 5.952E-04 8.063E-03 5.952E-04 0.01693318 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN lymph node disease DOID_9942 5.952E-04 8.063E-03 5.952E-04 0.01693318 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN dilated cardiomyopathy DOID_12930 6.322E-04 8.365E-03 0.01213696 0.11509888 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN familial hypercholesterolemia DOID_13810 6.54E-04 8.457E-03 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN sinusitis DOID_0050127 7.155E-04 9.047E-03 0.0387106 0.21808252 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN paranasal sinus disease DOID_1352 7.155E-04 9.047E-03 0.0387106 0.21808252 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN uremia DOID_4676 7.155E-04 8.85E-03 7.155E-04 0.01770033 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN pulmonary embolism DOID_9477 7.155E-04 8.662E-03 0.0387106 0.21384791 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN polyarteritis nodosa DOID_9810 7.155E-04 8.481E-03 7.155E-04 0.01696281 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN diabetic angiopathy DOID_11713 7.797E-04 9.054E-03 7.797E-04 0.01774506 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN meningitis DOID_9471 7.797E-04 8.873E-03 0.04035978 0.21462348 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN spastic quadriplegia DOID_10970 8.465E-04 9.445E-03 0.04200616 0.22131024 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN sphingolipidosis DOID_1927 8.465E-04 9.263E-03 0.04200616 0.21927987 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN acute pancreatitis DOID_2913 8.465E-04 9.088E-03 8.465E-04 0.01852576 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN reading disorder DOID_13365 9.161E-04 9.652E-03 9.161E-04 0.01930491 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN dyslexia DOID_4428 9.161E-04 9.652E-03 9.161E-04 0.01930491 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN ankylosing spondylitis DOID_7147 9.882E-04 0.0102238 9.882E-04 0.02008247 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN teeth hard tissue disease DOID_214 1.063E-03 0.01080169 1.063E-03 0.02085844 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN middle cerebral artery infarction DOID_3525 1.063E-03 0.01061219 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN pulmonary sarcoidosis DOID_13406 2.165E-03 0.0212373 2.165E-03 0.03732617 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN multiple myeloma DOID_9538 2.165E-03 0.02087735 2.165E-03 0.03622834 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN microcephaly DOID_10907 2.273E-03 0.02155838 0.06797322 0.28649452 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN uveitis DOID_13141 2.273E-03 0.02120496 2.273E-03 0.03695722 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN adult respiratory distress syndrome DOID_11394 2.498E-03 0.02292404 0.07116997 0.29558915 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN intracranial arterial disease DOID_13089 2.498E-03 0.02256017 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN cerebral arterial disease DOID_3527 2.498E-03 0.02256017 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN uveal disease DOID_3480 2.854E-03 0.02536989 2.854E-03 0.04272823 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN cerebral infarction DOID_3526 3.103E-03 0.02716415 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN learning disability DOID_8927 3.103E-03 0.02675258 3.103E-03 0.04527359 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN proteinuria DOID_576 3.232E-03 0.02744443 0.0806956 0.32335068 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN myeloma DOID_0070004 3.363E-03 0.0281365 3.363E-03 0.04783205 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN thyroid adenoma DOID_2891 3.363E-03 0.02772873 3.363E-03 0.04555434 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN vascular skin disease DOID_9540 3.363E-03 0.0273326 3.363E-03 0.04449493 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN integumentary system benign neoplasm DOID_0060121 3.632E-03 0.02910522 0.08542228 0.32841403 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN glaucoma DOID_1686 3.632E-03 0.02870098 0.08542228 0.32620991 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN skin benign neoplasm DOID_3165 3.632E-03 0.02910522 0.08542228 0.32841403 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN lung small cell carcinoma DOID_5409 3.632E-03 0.02830782 3.632E-03 0.04696524 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN giant cell tumor DOID_200 4.199E-03 0.03228947 0.09168731 0.34549722 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN malignant giant cell tumor DOID_2705 4.199E-03 0.03228947 0.09168731 0.34549722 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN giant cell glioblastoma DOID_3074 4.199E-03 0.03228947 0.09168731 0.34549722 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bone marrow cancer DOID_4960 4.347E-03 0.0329811 4.347E-03 0.05496851 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN vasculitis DOID_865 4.347E-03 0.03254714 0.09324696 0.34678116 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN integumentary system cancer DOID_0060122 4.498E-03 0.03323513 0.09480396 0.34802229 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN osteochondrodysplasia DOID_2256 4.498E-03 0.03280904 4.498E-03 0.05563273 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN parasitic protozoa infectious disease DOID_2789 4.498E-03 0.03239374 4.498E-03 0.05444905 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN skin cancer DOID_4159 4.498E-03 0.03323513 0.09480396 0.34802229 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN smallpox DOID_8736 4.498E-03 0.03198882 4.498E-03 0.0533147 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN familial hyperlipidemia DOID_1168 4.65E-03 0.03266646 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN congenital nervous system abnormality DOID_2490 4.805E-03 0.03334405 0.09791008 0.35712075 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN hypertrophic cardiomyopathy DOID_11984 4.963E-03 0.03402154 0.09945921 0.36046044 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN glioblastoma DOID_3068 4.963E-03 0.03361652 0.09945921 0.35817904 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bile duct cancer DOID_4606 4.963E-03 0.03322103 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bile duct carcinoma DOID_4897 4.963E-03 0.03322103 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN respiratory failure DOID_11162 5.616E-03 0.03715644 0.10562955 0.37100748 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN parasitic infectious disease DOID_1398 6.13E-03 0.04009318 6.13E-03 0.06839425 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN hyperglycemia DOID_4195 6.306E-03 0.04077592 0.11175826 0.38539665 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN tooth disease DOID_1091 6.485E-03 0.04145797 6.485E-03 0.07095691 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN endocrine organ benign neoplasm DOID_0060089 6.665E-03 0.0421393 6.665E-03 0.0715573 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN brain infarction DOID_3454 6.665E-03 0.04167623 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN tuberculosis DOID_399 6.665E-03 0.04122323 0.11480708 0.39352549 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN astrocytoma DOID_3069 6.848E-03 0.04189902 0.11632763 0.39634984 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN nephrosis DOID_2527 7.221E-03 0.04370871 7.221E-03 0.07608554 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN diabetic retinopathy DOID_8947 7.602E-03 0.04553424 0.12238415 0.40962695 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN cystic fibrosis DOID_1485 7.993E-03 0.04737473 0.12539706 0.41725689 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN chromosomal disease DOID_0080014 9.008E-03 0.05284067 9.008E-03 0.08837147 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN biliary tract cancer DOID_4607 9.429E-03 0.05474783 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN retinal vascular disease DOID_2462 9.859E-03 0.0566662 0.13882962 0.44378682 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN primary bacterial infectious disease DOID_0050338 0.01029791 0.05859511 0.14178693 0.45070819 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN nervous system cancer DOID_3093 0.01097177 0.06181126 0.14620417 0.46216761 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN lymphoma DOID_0060058 0.01143157 0.06377024 0.01143157 0.11024685 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.01189975 0.06573746 0.152059 0.47279547 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN gallbladder disease DOID_0000000 0.01701574 0.09309574 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN gout DOID_13189 0.01701574 0.09220912 0.01701574 0.15872061 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN familial combined hyperlipidemia DOID_13809 0.01701574 0.09133922 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN chondrosarcoma DOID_3371 0.01701574 0.09048558 0.01701574 0.1561606 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01701574 0.08964775 0.01701574 0.15368186 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01701574 0.08964775 0.01701574 0.15368186 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN Hodgkin's granuloma DOID_8651 0.01701574 0.08964775 0.01701574 0.15368186 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01701574 0.08964775 0.01701574 0.15368186 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN sickle cell anemia DOID_10923 0.01870155 0.09762555 0.01870155 0.16626851 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN chronic monocytic leukemia DOID_8593 0.01870155 0.09673804 0.01870155 0.16123007 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN bronchiectasis DOID_9563 0.01870155 0.09586653 1.000 1.000 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN retinal detachment DOID_5327 0.02038452 0.09998959 0.02038452 0.16569703 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN Hodgkin's lymphoma DOID_8567 0.02038452 0.09913498 0.02038452 0.16336327 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN progressive myoclonus epilepsy DOID_891 0.02038452 0.09829485 0.02038452 0.16109434 TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN encephalitis DOID_9588 0.02038452 0.09746884 1.000 1.000 HAN_SATB1_TARGETS_UP heart valve disease DOID_4079 1.029E-13 5.854E-11 0.23048285 0.75370541 HAN_SATB1_TARGETS_UP aortic valve insufficiency DOID_57 1.693E-11 4.817E-09 1.000 1.000 HAN_SATB1_TARGETS_UP aortic valve disease DOID_62 3.059E-11 5.802E-09 0.11813202 0.52106293 HAN_SATB1_TARGETS_UP uterine cancer DOID_363 1.268E-10 1.804E-08 1.921E-03 0.05205393 HAN_SATB1_TARGETS_UP astrocytoma DOID_3069 4.319E-09 4.915E-07 0.05466758 0.41474468 HAN_SATB1_TARGETS_UP endometrial carcinoma DOID_2871 1.522E-08 1.444E-06 0.0121445 0.16854198 HAN_SATB1_TARGETS_UP endometrial cancer DOID_1380 2.24E-08 1.821E-06 0.01364269 0.18482599 HAN_SATB1_TARGETS_UP transitional cell carcinoma DOID_2671 2.582E-08 1.836E-06 0.01181883 0.17697141 HAN_SATB1_TARGETS_UP glioblastoma DOID_3068 3.275E-08 2.071E-06 0.04061324 0.36680845 HAN_SATB1_TARGETS_UP intracranial arterial disease DOID_13089 9.764E-08 5.555E-06 0.20171713 0.68728772 HAN_SATB1_TARGETS_UP cerebral arterial disease DOID_3527 9.764E-08 5.555E-06 0.20171713 0.68728772 HAN_SATB1_TARGETS_UP aneurysm disease DOID_2403 2.01E-07 1.04E-05 1.000 1.000 HAN_SATB1_TARGETS_UP epidermolysis bullosa DOID_2730 3.458E-07 1.64E-05 3.458E-07 1.967E-04 HAN_SATB1_TARGETS_UP giant cell tumor DOID_200 4.915E-07 2.151E-05 0.25431677 0.79948199 HAN_SATB1_TARGETS_UP malignant giant cell tumor DOID_2705 4.915E-07 2.151E-05 0.25431677 0.79948199 HAN_SATB1_TARGETS_UP giant cell glioblastoma DOID_3074 4.915E-07 2.151E-05 0.25431677 0.79948199 HAN_SATB1_TARGETS_UP atrophic muscular disease DOID_913 4.915E-07 1.997E-05 3.173E-03 0.07222321 HAN_SATB1_TARGETS_UP muscular dystrophy DOID_9884 4.915E-07 1.997E-05 3.173E-03 0.07222321 HAN_SATB1_TARGETS_UP vesiculobullous skin disease DOID_2731 4.974E-07 1.887E-05 4.974E-07 1.415E-04 HAN_SATB1_TARGETS_UP pleural disease DOID_1532 1.056E-06 3.755E-05 1.000 1.000 HAN_SATB1_TARGETS_UP hypothyroidism DOID_1459 1.202E-06 4.025E-05 3.809E-04 0.03096495 HAN_SATB1_TARGETS_UP medullomyoblastoma DOID_3861 1.612E-06 5.095E-05 1.035E-03 0.0452809 HAN_SATB1_TARGETS_UP adult medulloblastoma DOID_3864 1.612E-06 5.095E-05 1.035E-03 0.0452809 HAN_SATB1_TARGETS_UP childhood medulloblastoma DOID_3869 1.612E-06 5.095E-05 1.035E-03 0.0452809 HAN_SATB1_TARGETS_UP allergic contact dermatitis DOID_3042 1.868E-06 5.594E-05 5.055E-04 0.03595522 HAN_SATB1_TARGETS_UP brain infarction DOID_3454 2.031E-06 5.779E-05 0.31073685 0.9020881 HAN_SATB1_TARGETS_UP medulloblastoma DOID_3858 2.095E-06 5.677E-05 1.202E-03 0.04560987 HAN_SATB1_TARGETS_UP peptic ulcer DOID_750 2.686E-06 6.946E-05 0.02037617 0.23188082 HAN_SATB1_TARGETS_UP autoimmune hepatitis DOID_2048 4.029E-06 9.968E-05 0.10416088 0.49389617 HAN_SATB1_TARGETS_UP primitive neuroectodermal tumor DOID_168 4.255E-06 1.009E-04 1.805E-03 0.051364 HAN_SATB1_TARGETS_UP metabolic syndrome X DOID_14221 4.736E-06 1.078E-04 0.34939271 0.97933227 HAN_SATB1_TARGETS_UP contact dermatitis DOID_2773 4.736E-06 1.036E-04 9.185E-04 0.04751179 HAN_SATB1_TARGETS_UP biliary tract cancer DOID_4607 5.839E-06 1.23E-04 0.35955559 0.97888578 HAN_SATB1_TARGETS_UP chronic kidney failure DOID_784 5.839E-06 1.187E-04 0.35955559 0.97422442 HAN_SATB1_TARGETS_UP calcium metabolism disease DOID_10575 8.648E-06 1.697E-04 0.24249307 0.77516042 HAN_SATB1_TARGETS_UP carbohydrate metabolic disorder DOID_2978 1.111E-05 2.107E-04 1.586E-03 0.05013837 HAN_SATB1_TARGETS_UP bile duct adenocarcinoma DOID_4896 1.241E-05 2.277E-04 0.25821705 0.80728298 HAN_SATB1_TARGETS_UP cholangiocarcinoma DOID_4947 1.241E-05 2.277E-04 0.25821705 0.80728298 HAN_SATB1_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 1.253E-05 2.227E-04 0.39865174 1.000 HAN_SATB1_TARGETS_UP middle cerebral artery infarction DOID_3525 1.34E-05 2.31E-04 1.000 1.000 HAN_SATB1_TARGETS_UP mitochondrial metabolism disease DOID_700 1.471E-05 2.462E-04 3.679E-03 0.08051633 HAN_SATB1_TARGETS_UP gestational diabetes DOID_11714 1.548E-05 2.516E-04 0.01004315 0.15873759 HAN_SATB1_TARGETS_UP bile duct cancer DOID_4606 1.733E-05 2.739E-04 0.27361626 0.83255429 HAN_SATB1_TARGETS_UP bile duct carcinoma DOID_4897 1.733E-05 2.739E-04 0.27361626 0.83255429 HAN_SATB1_TARGETS_UP neurotic disorder DOID_4964 2.03E-05 3.123E-04 0.04305218 0.38276082 HAN_SATB1_TARGETS_UP mononeuropathy DOID_1188 2.034E-05 3.045E-04 0.14989399 0.59228945 HAN_SATB1_TARGETS_UP focal glomerulosclerosis DOID_3945 2.034E-05 2.967E-04 1.000 1.000 HAN_SATB1_TARGETS_UP neuroectodermal tumor DOID_171 2.193E-05 3.12E-04 4.626E-03 0.09401171 HAN_SATB1_TARGETS_UP mineral metabolism disease DOID_0050032 2.743E-05 3.807E-04 0.29612068 0.88680351 HAN_SATB1_TARGETS_UP pneumoconiosis DOID_10316 4.165E-05 5.643E-04 1.000 1.000 HAN_SATB1_TARGETS_UP male reproductive system disease DOID_48 4.442E-05 5.878E-04 6.929E-03 0.1232104 HAN_SATB1_TARGETS_UP diabetic retinopathy DOID_8947 5.052E-05 6.533E-04 0.3285831 0.94426153 HAN_SATB1_TARGETS_UP calcinosis DOID_182 5.693E-05 7.199E-04 0.18906379 0.6640574 HAN_SATB1_TARGETS_UP cystic fibrosis DOID_1485 5.724E-05 7.081E-04 0.33559219 0.95955756 HAN_SATB1_TARGETS_UP communication disorder DOID_2033 6.096E-05 7.38E-04 0.07555453 0.43424778 HAN_SATB1_TARGETS_UP adult respiratory distress syndrome DOID_11394 7.594E-05 9.003E-04 1.000 1.000 HAN_SATB1_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 9.094E-05 1.056E-03 0.02319175 0.25377123 HAN_SATB1_TARGETS_UP primary biliary cirrhosis DOID_12236 9.094E-05 1.056E-03 0.02319175 0.25377123 HAN_SATB1_TARGETS_UP retinal vascular disease DOID_2462 9.646E-05 1.098E-03 0.36624293 0.98764089 HAN_SATB1_TARGETS_UP primary bacterial infectious disease DOID_0050338 1.074E-04 1.199E-03 0.3728608 1.000 HAN_SATB1_TARGETS_UP diabetic autonomic neuropathy DOID_11503 1.08E-04 1.182E-03 1.000 1.000 HAN_SATB1_TARGETS_UP autonomic neuropathy DOID_11504 1.08E-04 1.182E-03 1.000 1.000 HAN_SATB1_TARGETS_UP diabetic polyneuropathy DOID_12785 1.08E-04 1.182E-03 1.000 1.000 HAN_SATB1_TARGETS_UP diabetic neuropathy DOID_9743 1.08E-04 1.182E-03 1.000 1.000 HAN_SATB1_TARGETS_UP ureteral obstruction DOID_5199 1.081E-04 1.16E-03 1.000 1.000 HAN_SATB1_TARGETS_UP cerebral infarction DOID_3526 1.173E-04 1.236E-03 1.000 1.000 HAN_SATB1_TARGETS_UP amino acid metabolic disorder DOID_9252 1.194E-04 1.235E-03 1.194E-04 0.02264031 HAN_SATB1_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 1.257E-04 1.277E-03 1.409E-03 0.05011096 HAN_SATB1_TARGETS_UP conduct disorder DOID_12995 1.278E-04 1.276E-03 1.278E-04 0.01818403 HAN_SATB1_TARGETS_UP leishmaniasis DOID_9065 1.278E-04 1.254E-03 1.000 1.000 HAN_SATB1_TARGETS_UP pre-eclampsia DOID_10591 1.377E-04 1.328E-03 0.02821491 0.29189602 HAN_SATB1_TARGETS_UP autonomic nervous system disease DOID_11465 1.377E-04 1.306E-03 1.000 1.000 HAN_SATB1_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.536E-04 1.433E-03 0.09003186 0.44936953 HAN_SATB1_TARGETS_UP mouth disease DOID_403 1.536E-04 1.41E-03 1.000 1.000 HAN_SATB1_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.606E-04 1.45E-03 0.23851053 0.7710937 HAN_SATB1_TARGETS_UP integumentary system benign neoplasm DOID_0060121 1.606E-04 1.428E-03 2.569E-03 0.06643937 HAN_SATB1_TARGETS_UP skin benign neoplasm DOID_3165 1.606E-04 1.428E-03 2.569E-03 0.06643937 HAN_SATB1_TARGETS_UP dilated cardiomyopathy DOID_12930 1.613E-04 1.412E-03 0.09162314 0.45333538 HAN_SATB1_TARGETS_UP aortic aneurysm DOID_3627 1.73E-04 1.491E-03 1.000 1.000 HAN_SATB1_TARGETS_UP ulcerative colitis DOID_8577 1.861E-04 1.58E-03 0.01566445 0.19376248 HAN_SATB1_TARGETS_UP hepatitis B DOID_2043 2.008E-04 1.68E-03 1.000 1.000 HAN_SATB1_TARGETS_UP vasculitis DOID_865 2.296E-04 1.893E-03 0.25821705 0.8028716 HAN_SATB1_TARGETS_UP IgA glomerulonephritis DOID_2986 2.301E-04 1.87E-03 1.000 1.000 HAN_SATB1_TARGETS_UP urinary tract obstruction DOID_5200 2.301E-04 1.844E-03 1.000 1.000 HAN_SATB1_TARGETS_UP pulmonary embolism DOID_9477 2.301E-04 1.818E-03 1.000 1.000 HAN_SATB1_TARGETS_UP osteochondrodysplasia DOID_2256 2.456E-04 1.914E-03 0.0370578 0.35738793 HAN_SATB1_TARGETS_UP ureteral disease DOID_1426 2.619E-04 2.014E-03 1.000 1.000 HAN_SATB1_TARGETS_UP meningitis DOID_9471 2.619E-04 1.987E-03 1.000 1.000 HAN_SATB1_TARGETS_UP spastic quadriplegia DOID_10970 2.965E-04 2.22E-03 0.12274072 0.53312572 HAN_SATB1_TARGETS_UP oral cavity cancer DOID_8618 2.984E-04 2.205E-03 2.984E-04 0.03396226 HAN_SATB1_TARGETS_UP melancholia DOID_2848 3.177E-04 2.318E-03 0.2774161 0.83962639 HAN_SATB1_TARGETS_UP organic acidemia DOID_0060159 3.339E-04 2.405E-03 3.339E-04 0.0316629 HAN_SATB1_TARGETS_UP urticaria DOID_1555 3.339E-04 2.375E-03 1.000 1.000 HAN_SATB1_TARGETS_UP bronchiolitis DOID_2942 3.339E-04 2.345E-03 1.000 1.000 HAN_SATB1_TARGETS_UP carotid artery disease DOID_3407 3.59E-04 2.491E-03 1.000 1.000 HAN_SATB1_TARGETS_UP collagen disease DOID_854 3.59E-04 2.461E-03 1.000 1.000 HAN_SATB1_TARGETS_UP cystitis DOID_1679 3.742E-04 2.535E-03 0.13188635 0.54776157 HAN_SATB1_TARGETS_UP myositis DOID_633 3.742E-04 2.505E-03 0.13188635 0.53602382 HAN_SATB1_TARGETS_UP respiratory failure DOID_11162 3.809E-04 2.52E-03 1.000 1.000 HAN_SATB1_TARGETS_UP pre-malignant neoplasm DOID_0060071 4.039E-04 2.641E-03 0.04681012 0.40355994 HAN_SATB1_TARGETS_UP in situ carcinoma DOID_8719 4.039E-04 2.641E-03 0.04681012 0.40355994 HAN_SATB1_TARGETS_UP intracranial aneurysm DOID_10941 4.175E-04 2.699E-03 1.000 1.000 HAN_SATB1_TARGETS_UP parasitic infectious disease DOID_1398 4.527E-04 2.894E-03 1.000 1.000 HAN_SATB1_TARGETS_UP Sciatic Neuropathy DOID_11446 4.639E-04 2.933E-03 1.000 1.000 HAN_SATB1_TARGETS_UP lesion of sciatic nerve DOID_12528 4.639E-04 2.933E-03 1.000 1.000 HAN_SATB1_TARGETS_UP periodontitis DOID_824 4.639E-04 2.9E-03 1.000 1.000 HAN_SATB1_TARGETS_UP mononeuritis of lower limb DOID_9473 4.639E-04 2.933E-03 1.000 1.000 HAN_SATB1_TARGETS_UP mononeuritis DOID_1802 5.134E-04 3.175E-03 1.000 1.000 HAN_SATB1_TARGETS_UP invasive ductal carcinoma DOID_3008 5.134E-04 3.141E-03 0.01072385 0.16491538 HAN_SATB1_TARGETS_UP tuberculosis DOID_399 5.335E-04 3.23E-03 1.000 1.000 HAN_SATB1_TARGETS_UP polycystic ovary syndrome DOID_11612 5.662E-04 3.391E-03 5.662E-04 0.03579913 HAN_SATB1_TARGETS_UP bile duct disease DOID_4138 6.242E-04 3.7E-03 0.05738314 0.40309884 HAN_SATB1_TARGETS_UP peripheral vascular disease DOID_341 6.567E-04 3.852E-03 1.000 1.000 HAN_SATB1_TARGETS_UP biliary tract disease DOID_9741 6.567E-04 3.813E-03 0.05875828 0.40772511 HAN_SATB1_TARGETS_UP spastic cerebral palsy DOID_0050669 6.82E-04 3.92E-03 0.15875795 0.61872103 HAN_SATB1_TARGETS_UP abdominal aortic aneurysm DOID_7693 6.82E-04 3.881E-03 1.000 1.000 HAN_SATB1_TARGETS_UP endogenous depression DOID_1595 7.613E-04 4.289E-03 0.33559219 0.95475977 HAN_SATB1_TARGETS_UP syndrome DOID_225 7.613E-04 4.247E-03 7.613E-04 0.0433193 HAN_SATB1_TARGETS_UP bone resorption disease DOID_0080011 7.987E-04 4.412E-03 0.33906938 0.95985313 HAN_SATB1_TARGETS_UP osteoporosis DOID_11476 7.987E-04 4.412E-03 0.33906938 0.95985313 HAN_SATB1_TARGETS_UP bladder disease DOID_365 8.119E-04 4.442E-03 0.16752994 0.63128831 HAN_SATB1_TARGETS_UP bacterial pneumonia DOID_874 8.373E-04 4.537E-03 0.34252847 0.96484505 HAN_SATB1_TARGETS_UP papilloma DOID_2615 8.823E-04 4.736E-03 0.01521667 0.19240628 HAN_SATB1_TARGETS_UP male infertility DOID_12336 9.565E-04 5.087E-03 9.565E-04 0.04535515 HAN_SATB1_TARGETS_UP periodontal disease DOID_3388 9.565E-04 5.039E-03 1.000 1.000 HAN_SATB1_TARGETS_UP mental depression DOID_1596 1.05E-03 5.484E-03 0.35955559 0.98834362 HAN_SATB1_TARGETS_UP bone development disease DOID_0080006 1.097E-03 5.676E-03 0.07460134 0.4376099 HAN_SATB1_TARGETS_UP thyroid cancer DOID_1781 1.116E-03 5.723E-03 0.18480183 0.65720149 HAN_SATB1_TARGETS_UP adenoma DOID_657 1.116E-03 5.672E-03 0.01771595 0.21000785 HAN_SATB1_TARGETS_UP ventricular septal defect DOID_1657 1.188E-03 5.982E-03 1.188E-03 0.048287 HAN_SATB1_TARGETS_UP retinal vascular occlusion DOID_1729 1.188E-03 5.93E-03 1.000 1.000 HAN_SATB1_TARGETS_UP rectal neoplasm DOID_1984 1.188E-03 5.878E-03 0.05102297 0.40890237 HAN_SATB1_TARGETS_UP rectum cancer DOID_1993 1.188E-03 5.878E-03 0.05102297 0.40890237 HAN_SATB1_TARGETS_UP cutaneous leishmaniasis DOID_9111 1.188E-03 5.828E-03 1.000 1.000 HAN_SATB1_TARGETS_UP pulmonary sarcoidosis DOID_13406 1.202E-03 5.847E-03 1.000 1.000 HAN_SATB1_TARGETS_UP congenital diaphragmatic hernia DOID_3827 1.386E-03 6.685E-03 0.19752133 0.67704602 HAN_SATB1_TARGETS_UP breast benign neoplasm DOID_0060082 1.447E-03 6.919E-03 1.000 1.000 HAN_SATB1_TARGETS_UP thoracic benign neoplasm DOID_0060097 1.447E-03 6.919E-03 1.000 1.000 HAN_SATB1_TARGETS_UP benign breast phyllodes tumor DOID_1631 1.447E-03 6.919E-03 1.000 1.000 HAN_SATB1_TARGETS_UP adenoid cystic carcinoma DOID_4866 1.485E-03 7.04E-03 1.485E-03 0.04969408 HAN_SATB1_TARGETS_UP lymphatic system disease DOID_75 1.485E-03 6.982E-03 0.0212977 0.23761557 HAN_SATB1_TARGETS_UP lymphoblastic leukemia DOID_1037 1.586E-03 7.397E-03 0.01366424 0.18081288 HAN_SATB1_TARGETS_UP benign mesothelioma DOID_2645 1.587E-03 7.343E-03 0.20589111 0.69733357 HAN_SATB1_TARGETS_UP pulmonary emphysema DOID_9675 1.587E-03 7.283E-03 0.20589111 0.69320734 HAN_SATB1_TARGETS_UP Crohn's disease DOID_8778 1.648E-03 7.503E-03 0.3954865 1.000 HAN_SATB1_TARGETS_UP salivary gland cancer DOID_8850 1.694E-03 7.651E-03 1.694E-03 0.05073498 HAN_SATB1_TARGETS_UP intracranial arteriosclerosis DOID_13097 1.731E-03 7.753E-03 0.06091237 0.40301323 HAN_SATB1_TARGETS_UP lipodystrophy DOID_811 1.731E-03 7.693E-03 1.000 1.000 HAN_SATB1_TARGETS_UP peritonitis DOID_8283 1.731E-03 7.633E-03 1.000 1.000 HAN_SATB1_TARGETS_UP vascular dementia DOID_8725 1.731E-03 7.753E-03 0.06091237 0.40301323 HAN_SATB1_TARGETS_UP rheumatic disease DOID_1575 1.805E-03 7.902E-03 1.000 1.000 HAN_SATB1_TARGETS_UP scleroderma DOID_419 1.805E-03 7.902E-03 1.000 1.000 HAN_SATB1_TARGETS_UP influenza DOID_8469 1.921E-03 8.345E-03 1.000 1.000 HAN_SATB1_TARGETS_UP berylliosis DOID_10322 2.038E-03 8.786E-03 1.000 1.000 HAN_SATB1_TARGETS_UP polyneuropathy DOID_1389 2.038E-03 8.72E-03 1.000 1.000 HAN_SATB1_TARGETS_UP intracranial thrombosis DOID_4193 2.038E-03 8.655E-03 1.000 1.000 HAN_SATB1_TARGETS_UP epilepsy with generalized tonic-clonic seizures DOID_7725 2.038E-03 8.591E-03 0.06581855 0.40269629 HAN_SATB1_TARGETS_UP proteinuria DOID_576 2.166E-03 9.063E-03 1.000 1.000 HAN_SATB1_TARGETS_UP myeloma DOID_0070004 2.296E-03 9.535E-03 1.000 1.000 HAN_SATB1_TARGETS_UP neuritis DOID_1803 2.296E-03 9.466E-03 1.000 1.000 HAN_SATB1_TARGETS_UP vascular skin disease DOID_9540 2.296E-03 9.398E-03 1.000 1.000 HAN_SATB1_TARGETS_UP pulmonary tuberculosis DOID_2957 2.569E-03 0.01044047 1.000 1.000 HAN_SATB1_TARGETS_UP corneal dystrophy DOID_2566 2.725E-03 0.01099637 2.725E-03 0.06741254 HAN_SATB1_TARGETS_UP oral submucous fibrosis DOID_5773 2.725E-03 0.01091893 1.000 1.000 HAN_SATB1_TARGETS_UP varicose veins DOID_799 2.725E-03 0.01084258 1.000 1.000 HAN_SATB1_TARGETS_UP intermediate coronary syndrome DOID_8805 2.725E-03 0.01076728 1.000 1.000 HAN_SATB1_TARGETS_UP hemolytic-uremic syndrome DOID_12554 3.104E-03 0.0121787 0.0803846 0.44841998 HAN_SATB1_TARGETS_UP Fanconi's anemia DOID_13636 3.104E-03 0.01209529 3.104E-03 0.07357966 HAN_SATB1_TARGETS_UP thyroiditis DOID_7166 3.104E-03 0.01201301 1.000 1.000 HAN_SATB1_TARGETS_UP autoimmune thyroiditis DOID_7188 3.104E-03 0.01201301 1.000 1.000 HAN_SATB1_TARGETS_UP vein disease DOID_866 3.104E-03 0.01193184 1.000 1.000 HAN_SATB1_TARGETS_UP sarcoidosis DOID_11335 3.173E-03 0.01211799 1.000 1.000 HAN_SATB1_TARGETS_UP bone marrow cancer DOID_4960 3.337E-03 0.01265755 1.000 1.000 HAN_SATB1_TARGETS_UP schizophreniform disorder DOID_11328 3.505E-03 0.01320866 0.08518956 0.45301737 HAN_SATB1_TARGETS_UP schizoaffective disorder DOID_5418 3.505E-03 0.01320866 0.08518956 0.45301737 HAN_SATB1_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 3.505E-03 0.01312218 0.0370578 0.36354979 HAN_SATB1_TARGETS_UP integumentary system cancer DOID_0060122 3.505E-03 0.01303641 0.26209704 0.8105066 HAN_SATB1_TARGETS_UP parasitic protozoa infectious disease DOID_2789 3.505E-03 0.01295176 1.000 1.000 HAN_SATB1_TARGETS_UP skin cancer DOID_4159 3.505E-03 0.01303641 0.26209704 0.8105066 HAN_SATB1_TARGETS_UP pustulosis of palm and sole DOID_4398 3.505E-03 0.0128682 0.26209704 0.80612549 HAN_SATB1_TARGETS_UP congenital muscular dystrophy DOID_0050557 3.93E-03 0.0143342 0.08996954 0.46119518 HAN_SATB1_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 4.042E-03 0.01464957 1.000 1.000 HAN_SATB1_TARGETS_UP heart septal defect DOID_1681 4.377E-03 0.01576363 4.377E-03 0.09224643 HAN_SATB1_TARGETS_UP limb-girdle muscular dystrophy DOID_11724 4.847E-03 0.01734542 0.09945507 0.47957571 HAN_SATB1_TARGETS_UP brain edema DOID_4724 4.847E-03 0.01723701 1.000 1.000 HAN_SATB1_TARGETS_UP amyloidosis DOID_9120 4.847E-03 0.01712995 4.847E-03 0.09510074 HAN_SATB1_TARGETS_UP congenital heart defect DOID_1682 5.042E-03 0.017711 0.04681012 0.39753666 HAN_SATB1_TARGETS_UP endocrine pancreas disease DOID_1428 5.259E-03 0.01835746 0.29612068 0.88216056 HAN_SATB1_TARGETS_UP coronary restenosis DOID_4247 5.339E-03 0.01852317 1.000 1.000 HAN_SATB1_TARGETS_UP mitochondrial myopathy DOID_699 5.339E-03 0.01841091 1.000 1.000 HAN_SATB1_TARGETS_UP cholestasis DOID_13580 5.481E-03 0.01878604 0.29980338 0.88847981 HAN_SATB1_TARGETS_UP uterine disease DOID_345 5.481E-03 0.01867355 0.29980338 0.88387629 HAN_SATB1_TARGETS_UP temporal lobe epilepsy DOID_3328 5.708E-03 0.01933246 0.30346691 0.89006532 HAN_SATB1_TARGETS_UP hyperglycemia DOID_4195 5.708E-03 0.01921807 0.30346691 0.88550088 HAN_SATB1_TARGETS_UP gastric ulcer DOID_10808 5.853E-03 0.01958914 0.10884222 0.50763299 HAN_SATB1_TARGETS_UP placenta disease DOID_780 5.853E-03 0.01947458 1.000 1.000 HAN_SATB1_TARGETS_UP tooth disease DOID_1091 5.941E-03 0.01965349 1.000 1.000 HAN_SATB1_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 6.18E-03 0.02032453 6.18E-03 0.11720476 HAN_SATB1_TARGETS_UP sinusitis DOID_0050127 6.388E-03 0.02088991 1.000 1.000 HAN_SATB1_TARGETS_UP paranasal sinus disease DOID_1352 6.388E-03 0.02088991 1.000 1.000 HAN_SATB1_TARGETS_UP muscle cancer DOID_4045 6.388E-03 0.02077054 6.388E-03 0.11725303 HAN_SATB1_TARGETS_UP uremia DOID_4676 6.388E-03 0.02065252 0.11349923 0.51664849 HAN_SATB1_TARGETS_UP sleep disorder DOID_535 6.388E-03 0.02053584 0.11349923 0.5125481 HAN_SATB1_TARGETS_UP hypoglycemia DOID_9993 6.388E-03 0.02042047 0.11349923 0.50851229 HAN_SATB1_TARGETS_UP pancreatic ductal carcinoma DOID_3587 6.674E-03 0.02121391 0.05601952 0.39843883 HAN_SATB1_TARGETS_UP nephrosis DOID_2527 6.929E-03 0.02190407 0.32150045 0.92859774 HAN_SATB1_TARGETS_UP diabetic angiopathy DOID_11713 6.945E-03 0.0218328 1.000 1.000 HAN_SATB1_TARGETS_UP Goodpasture syndrome DOID_9808 6.945E-03 0.02171284 0.11813202 0.51705476 HAN_SATB1_TARGETS_UP pancreatic carcinoma DOID_4905 7.458E-03 0.02318822 0.06014478 0.41231782 HAN_SATB1_TARGETS_UP sphingolipidosis DOID_1927 7.523E-03 0.02326465 7.523E-03 0.12971804 HAN_SATB1_TARGETS_UP X-linked disease DOID_0050735 8.122E-03 0.02498156 0.12732546 0.54472319 HAN_SATB1_TARGETS_UP portal hypertension DOID_10762 8.122E-03 0.02484725 0.12732546 0.54065809 HAN_SATB1_TARGETS_UP electroclinical syndrome DOID_0050701 8.585E-03 0.02612103 0.06580134 0.42068496 HAN_SATB1_TARGETS_UP pancreatitis DOID_4989 8.585E-03 0.02598209 0.06580134 0.41601068 HAN_SATB1_TARGETS_UP papillary adenoma DOID_3172 8.742E-03 0.02631896 8.742E-03 0.14630245 HAN_SATB1_TARGETS_UP microcystic adenoma DOID_5403 8.742E-03 0.02631896 8.742E-03 0.14630245 HAN_SATB1_TARGETS_UP follicular adenoma DOID_6204 8.742E-03 0.02631896 8.742E-03 0.14630245 HAN_SATB1_TARGETS_UP congenital hypoplastic anemia DOID_1342 9.383E-03 0.02809815 9.383E-03 0.15253281 HAN_SATB1_TARGETS_UP extrinsic allergic alveolitis DOID_841 9.383E-03 0.02795104 1.000 1.000 HAN_SATB1_TARGETS_UP female reproductive system disease DOID_229 9.492E-03 0.02812917 0.35279804 0.97922967 HAN_SATB1_TARGETS_UP lung adenocarcinoma DOID_3910 0.01004315 0.02960908 1.000 1.000 HAN_SATB1_TARGETS_UP focal epilepsy DOID_2234 0.01012639 0.02970059 0.35955559 0.98359197 HAN_SATB1_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 0.01072385 0.03129164 1.000 1.000 HAN_SATB1_TARGETS_UP pleurisy DOID_10247 0.01072385 0.03113198 1.000 1.000 HAN_SATB1_TARGETS_UP Behcet's disease DOID_13241 0.01072385 0.03129164 1.000 1.000 HAN_SATB1_TARGETS_UP hepatic vascular disease DOID_272 0.01072385 0.03097395 0.14542723 0.58686591 HAN_SATB1_TARGETS_UP coronary stenosis DOID_4248 0.01072385 0.03081752 1.000 1.000 HAN_SATB1_TARGETS_UP autoimmune disease of the nervous system DOID_438 0.01072385 0.03066266 0.14542723 0.58273305 HAN_SATB1_TARGETS_UP renal tubular transport disease DOID_447 0.01072385 0.03050935 0.14542723 0.578658 HAN_SATB1_TARGETS_UP autoimmune disease of endocrine system DOID_0060005 0.01142437 0.03234063 1.000 1.000 HAN_SATB1_TARGETS_UP multiple epiphyseal dysplasia DOID_12721 0.01142437 0.03218053 1.000 1.000 HAN_SATB1_TARGETS_UP cranial nerve disease DOID_5656 0.01142437 0.03202201 0.14989399 0.5882047 HAN_SATB1_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 0.0121445 0.03387363 0.0121445 0.17718516 HAN_SATB1_TARGETS_UP uterine benign neoplasm DOID_0060095 0.0121445 0.03387363 0.0121445 0.17718516 HAN_SATB1_TARGETS_UP corneal disease DOID_10124 0.0121445 0.0337084 0.0121445 0.17275553 HAN_SATB1_TARGETS_UP uterine fibroid DOID_13223 0.0121445 0.03387363 0.0121445 0.17718516 HAN_SATB1_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 0.01364269 0.03768297 0.16315538 0.62726628 HAN_SATB1_TARGETS_UP encephalomyelitis DOID_640 0.01366424 0.03756016 1.000 1.000 HAN_SATB1_TARGETS_UP chronic leukemia DOID_1036 0.01442031 0.03944788 0.16752994 0.63976198 HAN_SATB1_TARGETS_UP chronic lymphocytic leukemia DOID_1040 0.01442031 0.03944788 0.16752994 0.63976198 HAN_SATB1_TARGETS_UP leiomyoma DOID_127 0.01442031 0.03925913 0.01442031 0.18648088 HAN_SATB1_TARGETS_UP hair disease DOID_421 0.01521667 0.04122992 0.17188175 0.64342575 HAN_SATB1_TARGETS_UP metal metabolism disorder DOID_896 0.01521667 0.04103451 0.17188175 0.63922035 HAN_SATB1_TARGETS_UP nephroblastoma DOID_2154 0.01603153 0.04302802 1.000 1.000 HAN_SATB1_TARGETS_UP thyroid carcinoma DOID_3963 0.01603153 0.04282601 0.17621092 0.65106502 HAN_SATB1_TARGETS_UP spindle cell carcinoma DOID_4015 0.01603153 0.04262589 1.000 1.000 HAN_SATB1_TARGETS_UP aplastic anemia DOID_12449 0.0168647 0.04463262 0.0168647 0.20417048 HAN_SATB1_TARGETS_UP adolescence-adult electroclinical syndrome DOID_0050705 0.01858509 0.04895794 0.18906379 0.66818198 HAN_SATB1_TARGETS_UP embryonal cancer DOID_688 0.01858509 0.04873233 1.000 1.000 HAN_SATB1_TARGETS_UP multiple myeloma DOID_9538 0.01858509 0.04850879 1.000 1.000 HAN_SATB1_TARGETS_UP microcephaly DOID_10907 0.0194719 0.05059137 0.0194719 0.22611243 HAN_SATB1_TARGETS_UP systemic scleroderma DOID_418 0.02037617 0.05270019 1.000 1.000 HAN_SATB1_TARGETS_UP nephrotic syndrome DOID_1184 0.02416385 0.06221372 1.000 1.000 HAN_SATB1_TARGETS_UP Huntington's disease DOID_12858 0.02416385 0.06193348 0.21417402 0.71266092 HAN_SATB1_TARGETS_UP idiopathic generalized epilepsy DOID_1827 0.02416385 0.06165575 0.02416385 0.25941948 HAN_SATB1_TARGETS_UP gallbladder cancer DOID_3121 0.02515242 0.06389163 1.000 1.000 HAN_SATB1_TARGETS_UP leukodystrophy DOID_10579 0.02717814 0.06873049 0.02717814 0.28637705 HAN_SATB1_TARGETS_UP thyroid adenoma DOID_2891 0.02821491 0.07103664 0.02821491 0.2866836 HAN_SATB1_TARGETS_UP bone marrow disease DOID_4961 0.02821491 0.07072371 0.02821491 0.28165406 HAN_SATB1_TARGETS_UP hemolytic anemia DOID_583 0.02926736 0.07304002 0.23450716 0.76248328 HAN_SATB1_TARGETS_UP normocytic anemia DOID_720 0.02926736 0.07304002 0.23450716 0.76248328 HAN_SATB1_TARGETS_UP glaucoma DOID_1686 0.0303353 0.0753746 0.23851053 0.76673724 HAN_SATB1_TARGETS_UP lung small cell carcinoma DOID_5409 0.0303353 0.07504688 1.000 1.000 HAN_SATB1_TARGETS_UP withdrawal disorder DOID_0060001 0.0325169 0.08009574 0.24645488 0.78342362 HAN_SATB1_TARGETS_UP atopic dermatitis DOID_3310 0.03363019 0.08248093 1.000 1.000 HAN_SATB1_TARGETS_UP smallpox DOID_8736 0.0370578 0.09049737 0.0370578 0.35143147 HAN_SATB1_TARGETS_UP congenital nervous system abnormality DOID_2490 0.03941419 0.09584048 0.03941419 0.36765036 HAN_SATB1_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 0.04061324 0.09833588 0.04061324 0.37272472 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP cystic fibrosis DOID_1485 5.047E-12 2.872E-09 4.763E-10 2.71E-07 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP influenza DOID_8469 2.768E-09 7.876E-07 2.975E-07 2.419E-05 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP cholestasis DOID_13580 1.847E-08 3.503E-06 1.847E-08 5.254E-06 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bile duct disease DOID_4138 2.839E-08 4.038E-06 2.839E-08 5.385E-06 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP biliary tract disease DOID_9741 3.039E-08 3.458E-06 3.039E-08 4.323E-06 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP pancreatitis DOID_4989 4.214E-08 3.997E-06 2.564E-06 1.459E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bacterial pneumonia DOID_874 4.214E-08 3.426E-06 4.214E-08 4.796E-06 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP pleurisy DOID_10247 4.639E-08 3.3E-06 6.204E-06 2.206E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP primary bacterial infectious disease DOID_0050338 7.219E-08 4.564E-06 7.219E-08 6.846E-06 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP pleural disease DOID_1532 8.825E-08 5.022E-06 9.959E-06 3.333E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP spindle cell carcinoma DOID_4015 1.111E-07 5.748E-06 1.18E-05 3.731E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP peptic ulcer DOID_750 1.875E-07 8.892E-06 1.737E-05 4.941E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP pulmonary emphysema DOID_9675 2.27E-07 9.937E-06 2E-05 4.949E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP viral pneumonia DOID_10533 5.636E-07 2.291E-05 5.636E-07 4.009E-05 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP leishmaniasis DOID_9065 1.494E-06 5.668E-05 1.494E-06 9.447E-05 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP esophagitis DOID_11963 1.756E-06 6.246E-05 2.582E-04 3.867E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP sinusitis DOID_0050127 2.722E-06 9.11E-05 2.722E-06 1.408E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP paranasal sinus disease DOID_1352 2.722E-06 9.11E-05 2.722E-06 1.408E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP chronic kidney failure DOID_784 3.268E-06 1.033E-04 1.442E-04 2.344E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP acute pancreatitis DOID_2913 3.529E-06 1.057E-04 3.529E-06 1.673E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP commensal bacterial infectious disease DOID_0050339 3.986E-06 1.134E-04 3.986E-06 1.745E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP portal hypertension DOID_10762 3.986E-06 1.08E-04 4.397E-04 5.818E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Human immunodeficiency virus infectious disease DOID_526 4.483E-06 1.159E-04 1.823E-04 2.803E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hypersensitivity reaction type I disease DOID_1205 5.535E-06 1.369E-04 5.535E-06 2.25E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP perinatal necrotizing enterocolitis DOID_8677 5.588E-06 1.325E-04 5.588E-06 2.12E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hepatic vascular disease DOID_272 6.204E-06 1.412E-04 5.867E-04 6.546E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP abdominal aortic aneurysm DOID_7693 8.316E-06 1.82E-04 7.106E-04 7.775E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP papilloma DOID_2615 1.086E-05 2.288E-04 8.459E-04 9.082E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP thyroid carcinoma DOID_3963 1.18E-05 2.399E-04 8.936E-04 9.079E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP esophageal disease DOID_6050 1.18E-05 2.316E-04 8.936E-04 8.92E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP thyroid cancer DOID_1781 1.386E-05 2.629E-04 9.927E-04 9.739E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hepatitis DOID_2237 1.737E-05 3.188E-04 1.737E-05 5.201E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP systemic scleroderma DOID_418 1.737E-05 3.088E-04 1.151E-03 0.01109909 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP adult respiratory distress syndrome DOID_11394 1.865E-05 3.217E-04 1.865E-05 5.055E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP intracranial arterial disease DOID_13089 1.865E-05 3.122E-04 1.865E-05 4.825E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP cerebral arterial disease DOID_3527 1.865E-05 3.122E-04 1.865E-05 4.825E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP rheumatic disease DOID_1575 2.289E-05 3.721E-04 1.379E-03 0.0128658 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP scleroderma DOID_419 2.289E-05 3.721E-04 1.379E-03 0.0128658 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP cerebral infarction DOID_3526 2.604E-05 4.115E-04 2.604E-05 6.173E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP pulmonary tuberculosis DOID_2957 3.316E-05 5.099E-04 3.316E-05 7.547E-04 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP aortic aneurysm DOID_3627 3.512E-05 5.259E-04 1.827E-03 0.01624067 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP sarcoidosis DOID_11335 4.145E-05 6.048E-04 2.037E-03 0.01756021 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP giant cell tumor DOID_200 4.145E-05 5.897E-04 2.037E-03 0.01729811 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP malignant giant cell tumor DOID_2705 4.145E-05 5.897E-04 2.037E-03 0.01729811 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP giant cell glioblastoma DOID_3074 4.145E-05 5.897E-04 2.037E-03 0.01729811 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP parasitic protozoa infectious disease DOID_2789 4.607E-05 6.393E-04 4.607E-05 1.008E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hypersensitivity reaction type IV disease DOID_2916 5.36E-05 7.261E-04 2.411E-03 0.01960064 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP glioblastoma DOID_3068 5.36E-05 7.092E-04 2.411E-03 0.01932457 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP cutaneous leishmaniasis DOID_9111 6.162E-05 7.969E-04 6.162E-05 1.299E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP collagen disease DOID_854 6.189E-05 7.826E-04 2.65E-03 0.02094566 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP respiratory failure DOID_11162 6.483E-05 8.02E-04 6.483E-05 1.317E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP endocrine pancreas disease DOID_1428 7.099E-05 8.594E-04 7.099E-05 1.393E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP parasitic infectious disease DOID_1398 7.42E-05 8.796E-04 7.42E-05 1.407E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP familial adenomatous polyposis DOID_0050424 7.526E-05 8.739E-04 0.01298138 0.07537149 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP brain infarction DOID_3454 8.441E-05 9.606E-04 8.441E-05 1.549E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP tuberculosis DOID_399 8.441E-05 9.418E-04 8.441E-05 1.501E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP astrocytoma DOID_3069 8.801E-05 9.63E-04 3.34E-03 0.02500736 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP stomach disease DOID_76 9.024E-05 9.688E-04 0.0141533 0.07388284 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP male reproductive system disease DOID_48 9.55E-05 1.006E-03 3.524E-03 0.0260436 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP diabetic retinopathy DOID_8947 1.034E-04 1.07E-03 1.034E-04 1.783E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP aneurysm disease DOID_2403 1.16E-04 1.179E-03 4.005E-03 0.02848625 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Legionnaires' disease DOID_10457 1.242E-04 1.24E-03 1.242E-04 2.079E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP legionellosis DOID_10458 1.242E-04 1.24E-03 1.242E-04 2.079E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP retinal vascular disease DOID_2462 1.545E-04 1.516E-03 1.545E-04 2.442E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP tongue cancer DOID_8649 1.636E-04 1.578E-03 0.0188274 0.08369368 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Barrett's esophagus DOID_9206 1.636E-04 1.551E-03 0.0188274 0.08240608 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP mouth disease DOID_403 2.067E-04 1.928E-03 5.852E-03 0.03964332 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Crohn's disease DOID_8778 2.067E-04 1.897E-03 5.852E-03 0.03917693 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP prion disease DOID_649 2.082E-04 1.881E-03 0.02115632 0.08916996 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP ulcerative colitis DOID_8577 2.331E-04 2.073E-03 6.334E-03 0.04142531 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP mitochondrial myopathy DOID_699 2.852E-04 2.496E-03 2.852E-04 4.161E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP gastric ulcer DOID_10808 3.135E-04 2.702E-03 0.02579794 0.1041066 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hypoglycemia DOID_9993 3.431E-04 2.913E-03 3.431E-04 4.88E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP meningitis DOID_9471 3.74E-04 3.129E-03 3.74E-04 5.19E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP toxic shock syndrome DOID_14115 4.062E-04 3.35E-03 4.062E-04 5.503E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP urticaria DOID_1555 4.397E-04 3.574E-03 4.397E-04 5.686E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP cystitis DOID_1679 4.745E-04 3.803E-03 0.03156972 0.11369096 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP myositis DOID_633 4.745E-04 3.75E-03 4.745E-04 6E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP middle cerebral artery infarction DOID_3525 5.106E-04 3.98E-03 5.106E-04 6.316E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP extrinsic allergic alveolitis DOID_841 5.106E-04 3.926E-03 5.106E-04 6.182E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP lung adenocarcinoma DOID_3910 5.48E-04 4.158E-03 5.48E-04 6.497E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP periodontitis DOID_824 5.48E-04 4.103E-03 5.48E-04 6.364E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP renal hypertension DOID_1073 5.867E-04 4.336E-03 5.867E-04 6.677E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP secondary hypertension DOID_11130 5.867E-04 4.336E-03 5.867E-04 6.677E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP allergic rhinitis DOID_4481 7.544E-04 5.503E-03 0.03959408 0.13571705 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bladder disease DOID_365 7.995E-04 5.759E-03 0.04073509 0.13879202 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP pneumoconiosis DOID_10316 8.936E-04 6.356E-03 8.936E-04 9.416E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP nephroblastoma DOID_2154 8.936E-04 6.277E-03 0.04301315 0.14568144 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP periodontal disease DOID_3388 8.936E-04 6.201E-03 8.936E-04 9.245E-03 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP benign mesothelioma DOID_2645 1.263E-03 8.656E-03 1.263E-03 0.0119735 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP diabetic autonomic neuropathy DOID_11503 1.44E-03 9.751E-03 0.05432433 0.16983814 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP autonomic neuropathy DOID_11504 1.44E-03 9.751E-03 0.05432433 0.16983814 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP diabetic polyneuropathy DOID_12785 1.44E-03 9.751E-03 0.05432433 0.16983814 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP gallbladder cancer DOID_3121 1.44E-03 9.636E-03 0.05432433 0.16891006 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP diabetic neuropathy DOID_9743 1.44E-03 9.751E-03 0.05432433 0.16983814 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP autonomic nervous system disease DOID_11465 1.628E-03 0.01076847 0.05769211 0.17461071 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP thyroid adenoma DOID_2891 1.628E-03 0.0106447 0.05769211 0.1727727 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP heart valve disease DOID_4079 1.628E-03 0.01052374 1.628E-03 0.01493692 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP vascular skin disease DOID_9540 1.628E-03 0.01040549 1.628E-03 0.01469982 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP integumentary system benign neoplasm DOID_0060121 1.759E-03 0.01112149 0.05993079 0.17577638 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP skin benign neoplasm DOID_3165 1.759E-03 0.01112149 0.05993079 0.17577638 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP B-cell lymphocytic neoplasm DOID_707 1.896E-03 0.01185238 0.06216426 0.18046665 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP atopic dermatitis DOID_3310 1.966E-03 0.01215678 1.966E-03 0.01720652 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bone marrow cancer DOID_4960 2.109E-03 0.01290552 2.109E-03 0.0176502 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP integumentary system cancer DOID_0060122 2.183E-03 0.01321428 0.06661565 0.19143589 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP skin cancer DOID_4159 2.183E-03 0.01321428 0.06661565 0.19143589 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP mitochondrial metabolism disease DOID_700 2.258E-03 0.01352377 2.258E-03 0.01861968 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP oral cavity cancer DOID_8618 2.411E-03 0.01429213 0.06994063 0.19799114 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP melancholia DOID_2848 2.49E-03 0.01460528 0.07104638 0.2001257 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP neurotic disorder DOID_4964 2.57E-03 0.01491898 0.07215085 0.20124428 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP cerebral degeneration DOID_1443 2.986E-03 0.01716116 2.986E-03 0.02327335 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP temporal lobe epilepsy DOID_3328 3.073E-03 0.01748353 3.073E-03 0.0236264 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hyperglycemia DOID_4195 3.073E-03 0.01731043 0.07875073 0.21542868 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP tooth disease DOID_1091 3.161E-03 0.01763158 3.161E-03 0.02397895 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP endocrine organ benign neoplasm DOID_0060089 3.25E-03 0.01795298 0.08094047 0.21931013 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP peripheral vascular disease DOID_341 3.618E-03 0.01979566 3.618E-03 0.02639421 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP endogenous depression DOID_1595 3.907E-03 0.02117027 0.08856457 0.23883051 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bone resorption disease DOID_0080011 4.005E-03 0.02149906 4.005E-03 0.02884684 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP osteoporosis DOID_11476 4.005E-03 0.02149906 4.005E-03 0.02884684 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP mental depression DOID_1596 4.62E-03 0.02456737 0.09612681 0.25205601 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP focal epilepsy DOID_2234 4.62E-03 0.0243399 4.62E-03 0.0324532 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP biliary tract cancer DOID_4607 4.62E-03 0.02411659 0.09612681 0.25089979 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP transitional cell carcinoma DOID_2671 5.163E-03 0.02670865 0.10149081 0.26249215 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP amino acid metabolic disorder DOID_9252 5.275E-03 0.02704249 5.275E-03 0.0366063 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP lymphoma DOID_0060058 5.618E-03 0.02854301 0.1057596 0.27106851 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP alcohol-related neurodevelopmental disorder DOID_0050667 5.852E-03 0.02946937 5.852E-03 0.04012095 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP dilated cardiomyopathy DOID_12930 5.971E-03 0.02980344 5.971E-03 0.03950689 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP leber hereditary optic neuropathy DOID_705 0.01063345 0.05261246 0.01063345 0.06875492 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP facioscapulohumeral muscular dystrophy DOID_11727 0.0118081 0.05792076 0.0118081 0.07549222 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hyperparathyroidism DOID_13543 0.0118081 0.05742571 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hypolipoproteinemia DOID_1387 0.0118081 0.05693905 0.0118081 0.07465342 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP childhood type dermatomyositis DOID_14203 0.0118081 0.05646057 0.0118081 0.07383305 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP retinal vascular occlusion DOID_1729 0.0118081 0.05599006 0.0118081 0.07303052 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP transient cerebral ischemia DOID_224 0.0118081 0.05552734 0.0118081 0.07224524 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP acute kidney failure DOID_3021 0.0118081 0.05507219 0.0118081 0.07147668 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP insulinoma DOID_3892 0.0118081 0.05462445 0.0118081 0.07072429 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP adrenal gland hyperfunction DOID_3947 0.0118081 0.05418393 0.0118081 0.06998758 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP visceral leishmaniasis DOID_9146 0.0118081 0.05375046 0.0118081 0.06926606 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.01298138 0.05862227 0.01298138 0.07461016 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP breast benign neoplasm DOID_0060082 0.01298138 0.05816068 0.01298138 0.07386406 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP thoracic benign neoplasm DOID_0060097 0.01298138 0.05816068 0.01298138 0.07386406 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP dermatomyositis DOID_10223 0.01298138 0.0577063 0.01298138 0.07313273 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP adrenoleukodystrophy DOID_10588 0.01298138 0.05725896 0.01298138 0.07241575 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP neuronal ceroid lipofuscinosis DOID_14503 0.01298138 0.05681851 0.01298138 0.07171268 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP benign breast phyllodes tumor DOID_1631 0.01298138 0.05816068 0.01298138 0.07386406 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bronchiectasis DOID_9563 0.01298138 0.05638478 0.01298138 0.07102314 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP common cold DOID_10459 0.0141533 0.06100932 0.0141533 0.07669743 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP intracranial arteriosclerosis DOID_13097 0.0141533 0.0605506 0.0141533 0.07597387 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP aortic valve stenosis DOID_1712 0.0141533 0.06009873 0.0141533 0.07526383 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP islet cell tumor DOID_1799 0.0141533 0.05965355 0.0141533 0.07456694 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP peritonitis DOID_8283 0.0141533 0.05921492 0.0141533 0.07321118 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP vascular dementia DOID_8725 0.0141533 0.0605506 0.0141533 0.07597387 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP mitochondrial encephalomyopathy DOID_890 0.0141533 0.0587827 0.0141533 0.07255162 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP encephalitis DOID_9588 0.0141533 0.05835674 0.0141533 0.07190384 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP leprosy DOID_1024 0.01532386 0.06272863 0.01532386 0.07716176 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP parathyroid gland disease DOID_11201 0.01532386 0.06228056 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP larynx cancer DOID_2596 0.01532386 0.06183886 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP laryngeal benign neoplasm DOID_2598 0.01532386 0.06183886 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.01532386 0.06140337 0.01532386 0.0764849 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP psoriatic arthritis DOID_9008 0.01532386 0.06097398 0.01532386 0.07581982 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP open-angle glaucoma DOID_1067 0.01649307 0.06517052 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP polycystic kidney disease DOID_898 0.01649307 0.06472107 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bacterial meningitis DOID_9470 0.01649307 0.06427777 0.01649307 0.08090134 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP idiopathic pulmonary fibrosis DOID_0050156 0.01766091 0.06836094 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP peripheral neuropathy DOID_0060053 0.01766091 0.06789905 0.01766091 0.08588939 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP skeletal system cancer DOID_0060124 0.01766091 0.06744335 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP renovascular hypertension DOID_1591 0.01766091 0.06699373 0.01766091 0.08516152 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP congenital ichthyosiform erythroderma DOID_1699 0.01766091 0.06655006 0.01766091 0.08444587 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bone cancer DOID_184 0.01766091 0.06744335 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP adrenal cortex disease DOID_3952 0.01766091 0.06611223 0.01766091 0.08374216 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP oral submucous fibrosis DOID_5773 0.01766091 0.06568012 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP varicose veins DOID_799 0.01766091 0.06525363 0.01766091 0.08305007 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP intermediate coronary syndrome DOID_8805 0.01766091 0.06483264 0.01766091 0.08236933 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hyperhomocysteinemia DOID_9279 0.01766091 0.06441704 0.01766091 0.08169966 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP silicosis DOID_10325 0.0188274 0.06823434 0.0188274 0.08639347 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP spastic diplegia DOID_10965 0.0188274 0.06780247 0.0188274 0.08570233 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP restrictive cardiomyopathy DOID_397 0.0188274 0.06737604 0.0188274 0.08502215 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP chronic myeloid leukemia DOID_8552 0.0188274 0.06695494 0.0188274 0.08435268 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP vein disease DOID_866 0.0188274 0.06653907 0.0188274 0.08304489 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP drug-induced mental disorder DOID_1203 0.01999253 0.07022069 0.01999253 0.0868378 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP methylmalonic acidemia DOID_14749 0.01999253 0.06978989 0.01999253 0.08617994 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP drug psychosis DOID_1742 0.01999253 0.07022069 0.01999253 0.0868378 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bronchitis DOID_6132 0.01999253 0.06936434 0.01999253 0.08553197 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP urinary system benign neoplasm DOID_731 0.01999253 0.06894395 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP substance-induced psychosis DOID_8646 0.01999253 0.07022069 0.01999253 0.0868378 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP adrenal gland disease DOID_9553 0.01999253 0.06852863 0.01999253 0.08489367 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Down syndrome DOID_14250 0.02231875 0.07604411 0.02231875 0.0933777 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP granulosa cell tumor DOID_2999 0.02231875 0.07559147 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP amnestic disorder DOID_10914 0.02347983 0.07905338 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP pulmonary edema DOID_11396 0.02347983 0.07858836 0.02347983 0.09751841 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP sex cord-gonadal stromal tumor DOID_192 0.02347983 0.07812878 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP brain edema DOID_4724 0.02347983 0.07767454 0.02347983 0.09681175 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Kawasaki disease DOID_13378 0.02463956 0.08103994 0.02463956 0.10086266 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP lymphadenitis DOID_1602 0.02463956 0.08103994 0.02463956 0.10086266 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP autoimmune hepatitis DOID_2048 0.02463956 0.08057419 0.02463956 0.10014221 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP lymph node disease DOID_9942 0.02463956 0.08103994 0.02463956 0.10086266 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP neutropenia DOID_1227 0.02579794 0.08388017 0.02579794 0.10337345 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP hepatitis B DOID_2043 0.02579794 0.08340358 0.02579794 0.10265056 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP acquired immunodeficiency syndrome DOID_635 0.02579794 0.08293237 0.02579794 0.10193771 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP agranulocytosis DOID_12987 0.02695498 0.08616509 0.02695498 0.10577508 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP optic nerve disease DOID_1891 0.02695498 0.08568372 0.02695498 0.10505059 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP IgA glomerulonephritis DOID_2986 0.02695498 0.0852077 0.02695498 0.10433596 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP muscle cancer DOID_4045 0.02695498 0.08473694 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP urinary tract obstruction DOID_5200 0.02695498 0.08427135 1.000 1.000 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP sleep disorder DOID_535 0.02695498 0.08381085 0.02695498 0.10363099 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP polyarteritis nodosa DOID_9810 0.02695498 0.08335536 0.02695498 0.10293548 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Lewy body dementia DOID_12217 0.02811068 0.08645934 0.02811068 0.10663318 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP aortic valve disease DOID_62 0.02811068 0.0859945 0.02811068 0.105927 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP Goodpasture syndrome DOID_9808 0.02811068 0.08553464 0.02811068 0.10523011 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP sphingolipidosis DOID_1927 0.02926504 0.08857343 0.02926504 0.10883533 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP organic acidemia DOID_0060159 0.03041805 0.09157603 0.03041805 0.11238876 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP bronchiolitis DOID_2942 0.03041805 0.09109405 0.03041805 0.11166368 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP osteosarcoma DOID_3347 0.03041805 0.09061712 0.03041805 0.11094788 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP morbid obesity DOID_11981 0.03156972 0.09355819 0.03156972 0.11441511 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP spinal cord disease DOID_319 0.03272006 0.09646484 0.03272006 0.11709254 HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP diffuse large B-cell lymphoma DOID_0050745 0.03386906 0.09933761 0.03386906 0.12044685 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN funisitis DOID_0050698 3.36E-05 0.01911783 3.36E-05 0.01911783 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN hepatitis B DOID_2043 3.36E-05 9.559E-03 3.36E-05 9.559E-03 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN spastic quadriplegia DOID_10970 4.361E-05 8.27E-03 9.848E-03 0.4002455 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN spastic cerebral palsy DOID_0050669 7.66E-05 0.01089704 0.01298002 0.30773463 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN microcephaly DOID_10907 1.188E-04 0.01351401 0.01610292 0.30541874 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN aortic aneurysm DOID_3627 1.99E-04 0.01887328 1.000 1.000 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN congenital nervous system abnormality DOID_2490 2.552E-04 0.02074579 0.02348289 0.32589672 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN bile duct cancer DOID_4606 2.638E-04 0.01876362 1.000 1.000 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN bile duct carcinoma DOID_4897 2.638E-04 0.01876362 1.000 1.000 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN temporal lobe epilepsy DOID_3328 3.376E-04 0.02134258 0.0269606 0.32639541 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN male reproductive system disease DOID_48 3.882E-04 0.0220897 0.02888767 0.32874168 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN aneurysm disease DOID_2403 4.423E-04 0.02288064 1.000 1.000 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN focal epilepsy DOID_2234 5.118E-04 0.02426949 0.03311468 0.34893061 WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN biliary tract cancer DOID_4607 5.118E-04 0.02240261 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP intracranial arterial disease DOID_13089 1.854E-15 1.055E-12 2.004E-13 1.14E-10 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cerebral arterial disease DOID_3527 1.854E-15 1.055E-12 2.004E-13 1.14E-10 SHEPARD_CRUSH_AND_BURN_MUTANT_UP middle cerebral artery infarction DOID_3525 7.022E-13 1.998E-10 9.19E-11 2.615E-08 SHEPARD_CRUSH_AND_BURN_MUTANT_UP brain infarction DOID_3454 1.386E-11 2.629E-09 7.205E-10 1.367E-07 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cerebral infarction DOID_3526 4.187E-11 5.956E-09 2.872E-09 4.085E-07 SHEPARD_CRUSH_AND_BURN_MUTANT_UP astrocytoma DOID_3069 7.965E-10 9.064E-08 1.27E-06 1.204E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pancreatic carcinoma DOID_4905 1.172E-09 1.112E-07 1.663E-06 1.352E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP giant cell tumor DOID_200 7.472E-09 6.074E-07 1.391E-05 7.913E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP malignant giant cell tumor DOID_2705 7.472E-09 6.074E-07 1.391E-05 7.913E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP giant cell glioblastoma DOID_3074 7.472E-09 6.074E-07 1.391E-05 7.913E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP integumentary system cancer DOID_0060122 9.276E-09 6.598E-07 1.6E-05 8.277E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP skin cancer DOID_4159 9.276E-09 6.598E-07 1.6E-05 8.277E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP glioblastoma DOID_3068 1.265E-08 7.995E-07 1.956E-05 9.277E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pancreatic ductal carcinoma DOID_3587 3.782E-08 2.152E-06 3.985E-05 1.62E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP skeletal system cancer DOID_0060124 5.606E-08 2.9E-06 6.794E-04 0.01288637 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bone cancer DOID_184 5.606E-08 2.9E-06 6.794E-04 0.01288637 SHEPARD_CRUSH_AND_BURN_MUTANT_UP tongue cancer DOID_8649 7.46E-08 3.537E-06 9.153E-06 6.51E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP integumentary system benign neoplasm DOID_0060121 2.457E-07 1.076E-05 3.376E-04 8.353E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP skin benign neoplasm DOID_3165 2.457E-07 1.076E-05 3.376E-04 8.353E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP calcium metabolism disease DOID_10575 2.708E-07 1.101E-05 1.115E-05 7.052E-04 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bile duct adenocarcinoma DOID_4896 3.919E-07 1.487E-05 4.429E-04 0.01007993 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cholangiocarcinoma DOID_4947 3.919E-07 1.487E-05 4.429E-04 0.01007993 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bile duct cancer DOID_4606 5.523E-07 1.964E-05 5.407E-04 0.01139442 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bile duct carcinoma DOID_4897 5.523E-07 1.964E-05 5.407E-04 0.01139442 SHEPARD_CRUSH_AND_BURN_MUTANT_UP osteosarcoma DOID_3347 6.007E-07 2.011E-05 6.007E-07 6.836E-05 SHEPARD_CRUSH_AND_BURN_MUTANT_UP mineral metabolism disease DOID_0050032 8.856E-07 2.799E-05 2.84E-05 1.243E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP allergic rhinitis DOID_4481 1.834E-06 5.493E-05 3.516E-03 0.03449164 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pancreatitis DOID_4989 2.147E-06 6.107E-05 5.711E-05 2.166E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP biliary tract cancer DOID_4607 2.899E-06 7.856E-05 1.419E-03 0.01755003 SHEPARD_CRUSH_AND_BURN_MUTANT_UP Human immunodeficiency virus infectious disease DOID_526 4.285E-06 1.108E-04 9.853E-05 3.298E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP larynx cancer DOID_2596 4.701E-06 1.163E-04 0.03309387 0.15692012 SHEPARD_CRUSH_AND_BURN_MUTANT_UP laryngeal benign neoplasm DOID_2598 4.701E-06 1.163E-04 0.03309387 0.15692012 SHEPARD_CRUSH_AND_BURN_MUTANT_UP lymphoma DOID_0060058 4.764E-06 1.129E-04 1.071E-04 3.386E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pulmonary emphysema DOID_9675 5.264E-06 1.198E-04 5.83E-03 0.04951182 SHEPARD_CRUSH_AND_BURN_MUTANT_UP diabetic autonomic neuropathy DOID_11503 6.875E-06 1.505E-04 6.629E-03 0.05312229 SHEPARD_CRUSH_AND_BURN_MUTANT_UP autonomic neuropathy DOID_11504 6.875E-06 1.505E-04 6.629E-03 0.05312229 SHEPARD_CRUSH_AND_BURN_MUTANT_UP diabetic polyneuropathy DOID_12785 6.875E-06 1.505E-04 6.629E-03 0.05312229 SHEPARD_CRUSH_AND_BURN_MUTANT_UP diabetic neuropathy DOID_9743 6.875E-06 1.505E-04 6.629E-03 0.05312229 SHEPARD_CRUSH_AND_BURN_MUTANT_UP thoracic aortic aneurysm DOID_14004 7.451E-06 1.57E-04 6.794E-04 0.01247068 SHEPARD_CRUSH_AND_BURN_MUTANT_UP oral submucous fibrosis DOID_5773 7.451E-06 1.514E-04 0.0380881 0.16800098 SHEPARD_CRUSH_AND_BURN_MUTANT_UP autonomic nervous system disease DOID_11465 8.824E-06 1.731E-04 7.474E-03 0.05746878 SHEPARD_CRUSH_AND_BURN_MUTANT_UP glaucoma DOID_1686 1.033E-05 1.96E-04 8.063E-03 0.05881969 SHEPARD_CRUSH_AND_BURN_MUTANT_UP aortic aneurysm DOID_3627 1.115E-05 2.047E-04 8.365E-03 0.06025169 SHEPARD_CRUSH_AND_BURN_MUTANT_UP oral cavity cancer DOID_8618 1.956E-05 3.479E-04 5.407E-04 0.01098748 SHEPARD_CRUSH_AND_BURN_MUTANT_UP benign glioma DOID_0060101 2.489E-05 4.292E-04 1.477E-03 0.01788363 SHEPARD_CRUSH_AND_BURN_MUTANT_UP benign ependymoma DOID_4844 2.489E-05 4.292E-04 1.477E-03 0.01788363 SHEPARD_CRUSH_AND_BURN_MUTANT_UP uterine disease DOID_345 3.011E-05 5.039E-04 0.01348669 0.08720371 SHEPARD_CRUSH_AND_BURN_MUTANT_UP allergic contact dermatitis DOID_3042 3.377E-05 5.49E-04 8.087E-04 0.0127812 SHEPARD_CRUSH_AND_BURN_MUTANT_UP aneurysm disease DOID_2403 5.436E-05 8.592E-04 0.01790948 0.11076626 SHEPARD_CRUSH_AND_BURN_MUTANT_UP mixed glioma DOID_5076 5.711E-05 8.782E-04 1.191E-03 0.01653247 SHEPARD_CRUSH_AND_BURN_MUTANT_UP contact dermatitis DOID_2773 6.291E-05 9.419E-04 1.279E-03 0.01692816 SHEPARD_CRUSH_AND_BURN_MUTANT_UP sarcoma DOID_1115 6.464E-05 9.431E-04 6.464E-05 2.299E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP female reproductive system disease DOID_229 6.596E-05 9.383E-04 0.01965002 0.12022432 SHEPARD_CRUSH_AND_BURN_MUTANT_UP supratentorial cancer DOID_1659 7.143E-05 9.913E-04 2.929E-03 0.03030107 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cerebrum cancer DOID_368 7.143E-05 9.913E-04 2.929E-03 0.03030107 SHEPARD_CRUSH_AND_BURN_MUTANT_UP focal glomerulosclerosis DOID_3945 7.143E-05 9.677E-04 2.929E-03 0.02975998 SHEPARD_CRUSH_AND_BURN_MUTANT_UP abdominal aortic aneurysm DOID_7693 8.638E-05 1.143E-03 0.08190244 0.2709447 SHEPARD_CRUSH_AND_BURN_MUTANT_UP encephalomyelitis DOID_640 1.116E-04 1.443E-03 1.952E-03 0.02177353 SHEPARD_CRUSH_AND_BURN_MUTANT_UP myocarditis DOID_820 1.124E-04 1.421E-03 0.08901026 0.28776613 SHEPARD_CRUSH_AND_BURN_MUTANT_UP thyroid carcinoma DOID_3963 1.221E-04 1.51E-03 4.153E-03 0.03938352 SHEPARD_CRUSH_AND_BURN_MUTANT_UP spindle cell carcinoma DOID_4015 1.221E-04 1.478E-03 4.153E-03 0.03873789 SHEPARD_CRUSH_AND_BURN_MUTANT_UP ulcerative colitis DOID_8577 1.361E-04 1.613E-03 0.02778745 0.14916092 SHEPARD_CRUSH_AND_BURN_MUTANT_UP thyroid cancer DOID_1781 1.431E-04 1.661E-03 4.605E-03 0.04226302 SHEPARD_CRUSH_AND_BURN_MUTANT_UP calcinosis DOID_182 1.544E-04 1.757E-03 4.839E-03 0.04370785 SHEPARD_CRUSH_AND_BURN_MUTANT_UP peptic ulcer DOID_750 1.787E-04 1.994E-03 0.1030629 0.31027932 SHEPARD_CRUSH_AND_BURN_MUTANT_UP adult respiratory distress syndrome DOID_11394 1.918E-04 2.098E-03 5.574E-03 0.04879721 SHEPARD_CRUSH_AND_BURN_MUTANT_UP benign mesothelioma DOID_2645 2.054E-04 2.205E-03 2.054E-04 6.151E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cervix uteri carcinoma in situ DOID_8991 2.054E-04 2.164E-03 5.83E-03 0.050262 SHEPARD_CRUSH_AND_BURN_MUTANT_UP endometriosis of uterus DOID_288 2.197E-04 2.272E-03 0.11000855 0.3277218 SHEPARD_CRUSH_AND_BURN_MUTANT_UP Huntington's disease DOID_12858 2.345E-04 2.383E-03 6.357E-03 0.05242378 SHEPARD_CRUSH_AND_BURN_MUTANT_UP endometriosis DOID_289 2.345E-04 2.341E-03 0.11231191 0.32940967 SHEPARD_CRUSH_AND_BURN_MUTANT_UP influenza DOID_8469 2.501E-04 2.453E-03 0.11460937 0.33271803 SHEPARD_CRUSH_AND_BURN_MUTANT_UP brachydactyly DOID_0050581 2.936E-04 2.832E-03 2.936E-04 8.354E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP transient cerebral ischemia DOID_224 2.936E-04 2.785E-03 2.936E-04 7.956E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP brain cancer DOID_1319 3.006E-04 2.804E-03 7.474E-03 0.05670253 SHEPARD_CRUSH_AND_BURN_MUTANT_UP thyroid adenoma DOID_2891 3.006E-04 2.759E-03 7.474E-03 0.05595645 SHEPARD_CRUSH_AND_BURN_MUTANT_UP heart valve disease DOID_4079 3.006E-04 2.715E-03 3.006E-04 7.774E-03 SHEPARD_CRUSH_AND_BURN_MUTANT_UP central nervous system cancer DOID_3620 3.188E-04 2.834E-03 7.766E-03 0.05738787 SHEPARD_CRUSH_AND_BURN_MUTANT_UP familial adenomatous polyposis DOID_0050424 3.583E-04 3.136E-03 0.02807399 0.14929064 SHEPARD_CRUSH_AND_BURN_MUTANT_UP withdrawal disorder DOID_0060001 3.775E-04 3.255E-03 0.13052765 0.36406976 SHEPARD_CRUSH_AND_BURN_MUTANT_UP B-cell lymphocytic neoplasm DOID_707 3.775E-04 3.206E-03 8.673E-03 0.06168367 SHEPARD_CRUSH_AND_BURN_MUTANT_UP intracranial arteriosclerosis DOID_13097 4.292E-04 3.592E-03 4.292E-04 0.01017635 SHEPARD_CRUSH_AND_BURN_MUTANT_UP vascular dementia DOID_8725 4.292E-04 3.592E-03 4.292E-04 0.01017635 SHEPARD_CRUSH_AND_BURN_MUTANT_UP ocular hypertension DOID_9282 4.292E-04 3.54E-03 0.03058715 0.15003523 SHEPARD_CRUSH_AND_BURN_MUTANT_UP borderline glaucoma DOID_9283 4.292E-04 3.54E-03 0.03058715 0.15003523 SHEPARD_CRUSH_AND_BURN_MUTANT_UP reproductive organ benign neoplasm DOID_0050622 4.662E-04 3.789E-03 4.662E-04 0.0102018 SHEPARD_CRUSH_AND_BURN_MUTANT_UP hypertrophic cardiomyopathy DOID_11984 5.407E-04 4.333E-03 0.01096169 0.07606343 SHEPARD_CRUSH_AND_BURN_MUTANT_UP hypersensitivity reaction type IV disease DOID_2916 5.407E-04 4.273E-03 0.01096169 0.07514701 SHEPARD_CRUSH_AND_BURN_MUTANT_UP hypercalcemia DOID_12678 5.898E-04 4.597E-03 5.898E-04 0.01157279 SHEPARD_CRUSH_AND_BURN_MUTANT_UP carotid artery disease DOID_3407 6.224E-04 4.786E-03 0.01201548 0.08139058 SHEPARD_CRUSH_AND_BURN_MUTANT_UP respiratory failure DOID_11162 6.513E-04 4.941E-03 0.01237625 0.08284806 SHEPARD_CRUSH_AND_BURN_MUTANT_UP mesenchymal cell neoplasm DOID_3350 6.794E-04 5.087E-03 6.794E-04 0.01208097 SHEPARD_CRUSH_AND_BURN_MUTANT_UP spindle cell sarcoma DOID_4235 6.794E-04 5.087E-03 6.794E-04 0.01208097 SHEPARD_CRUSH_AND_BURN_MUTANT_UP epithelioid sarcoma DOID_6193 6.794E-04 5.087E-03 6.794E-04 0.01208097 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pre-malignant neoplasm DOID_0060071 6.811E-04 5.033E-03 0.01274172 0.08430279 SHEPARD_CRUSH_AND_BURN_MUTANT_UP in situ carcinoma DOID_8719 6.811E-04 5.033E-03 0.01274172 0.08430279 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cholestasis DOID_13580 7.431E-04 5.421E-03 7.431E-04 0.01281311 SHEPARD_CRUSH_AND_BURN_MUTANT_UP parasitic infectious disease DOID_1398 7.431E-04 5.352E-03 7.431E-04 0.01243625 SHEPARD_CRUSH_AND_BURN_MUTANT_UP angiosarcoma DOID_0001816 7.752E-04 5.513E-03 7.752E-04 0.01260212 SHEPARD_CRUSH_AND_BURN_MUTANT_UP hyperglycemia DOID_4195 7.754E-04 5.447E-03 0.16369059 0.42724746 SHEPARD_CRUSH_AND_BURN_MUTANT_UP endocrine organ benign neoplasm DOID_0060089 8.428E-04 5.848E-03 0.01463879 0.09358959 SHEPARD_CRUSH_AND_BURN_MUTANT_UP basal cell carcinoma DOID_2513 8.771E-04 6.013E-03 8.771E-04 0.01348763 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bile duct disease DOID_4138 9.505E-04 6.438E-03 9.505E-04 0.01423237 SHEPARD_CRUSH_AND_BURN_MUTANT_UP skin carcinoma DOID_3451 9.85E-04 6.594E-03 9.85E-04 0.01437122 SHEPARD_CRUSH_AND_BURN_MUTANT_UP biliary tract disease DOID_9741 9.882E-04 6.539E-03 9.882E-04 0.01405784 SHEPARD_CRUSH_AND_BURN_MUTANT_UP granulosa cell tumor DOID_2999 1.099E-03 7.188E-03 0.04800007 0.19648949 SHEPARD_CRUSH_AND_BURN_MUTANT_UP esophagitis DOID_11963 1.219E-03 7.883E-03 0.05046222 0.20220427 SHEPARD_CRUSH_AND_BURN_MUTANT_UP colon carcinoma DOID_1520 1.219E-03 7.794E-03 1.219E-03 0.01651613 SHEPARD_CRUSH_AND_BURN_MUTANT_UP sex cord-gonadal stromal tumor DOID_192 1.219E-03 7.708E-03 0.05046222 0.20079025 SHEPARD_CRUSH_AND_BURN_MUTANT_UP subependymal glioma DOID_4843 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pilocytic astrocytoma DOID_4851 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP subependymal giant cell astrocytoma DOID_5077 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP fibrillary astrocytoma DOID_6726 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP juvenile pilocytic astrocytoma DOID_6811 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP childhood pilocytic astrocytoma DOID_6812 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP gemistocytic astrocytoma DOID_7005 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP childhood cerebral astrocytoma DOID_7007 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP protoplasmic astrocytoma DOID_7008 1.219E-03 7.623E-03 0.05046222 0.19939588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP chromosomal disease DOID_0080014 1.325E-03 8.193E-03 1.325E-03 0.01713182 SHEPARD_CRUSH_AND_BURN_MUTANT_UP alcohol abuse DOID_1574 1.419E-03 8.681E-03 1.419E-03 0.01794003 SHEPARD_CRUSH_AND_BURN_MUTANT_UP gastric ulcer DOID_10808 1.477E-03 8.942E-03 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP muscle cancer DOID_4045 1.615E-03 9.674E-03 0.05781094 0.22225961 SHEPARD_CRUSH_AND_BURN_MUTANT_UP uremia DOID_4676 1.615E-03 9.573E-03 1.615E-03 0.01914652 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pulmonary embolism DOID_9477 1.615E-03 9.475E-03 0.05781094 0.21929615 SHEPARD_CRUSH_AND_BURN_MUTANT_UP transitional cell carcinoma DOID_2671 1.672E-03 9.707E-03 0.02285868 0.13691148 SHEPARD_CRUSH_AND_BURN_MUTANT_UP diabetic angiopathy DOID_11713 1.759E-03 0.01011006 1.759E-03 0.02042644 SHEPARD_CRUSH_AND_BURN_MUTANT_UP aortic valve disease DOID_62 1.759E-03 0.01000895 1.759E-03 0.02001791 SHEPARD_CRUSH_AND_BURN_MUTANT_UP meningitis DOID_9471 1.759E-03 9.91E-03 0.06024798 0.22116837 SHEPARD_CRUSH_AND_BURN_MUTANT_UP nervous system cancer DOID_3093 1.781E-03 9.933E-03 0.02381254 0.1411389 SHEPARD_CRUSH_AND_BURN_MUTANT_UP lymphoblastic leukemia DOID_1037 1.952E-03 0.01078107 0.02527352 0.14825394 SHEPARD_CRUSH_AND_BURN_MUTANT_UP mouth disease DOID_403 2.011E-03 0.01100133 0.2202592 0.54254323 SHEPARD_CRUSH_AND_BURN_MUTANT_UP intracranial aneurysm DOID_10941 2.393E-03 0.01296762 0.06993389 0.25026658 SHEPARD_CRUSH_AND_BURN_MUTANT_UP spinal cord disease DOID_319 2.393E-03 0.01284528 2.393E-03 0.02618461 SHEPARD_CRUSH_AND_BURN_MUTANT_UP lung adenocarcinoma DOID_3910 2.566E-03 0.01364488 2.566E-03 0.02754722 SHEPARD_CRUSH_AND_BURN_MUTANT_UP renal hypertension DOID_1073 2.745E-03 0.01445983 0.07473973 0.26090128 SHEPARD_CRUSH_AND_BURN_MUTANT_UP secondary hypertension DOID_11130 2.745E-03 0.01445983 0.07473973 0.26090128 SHEPARD_CRUSH_AND_BURN_MUTANT_UP polycystic ovary syndrome DOID_11612 2.929E-03 0.01528953 2.929E-03 0.0308622 SHEPARD_CRUSH_AND_BURN_MUTANT_UP female reproductive organ benign neoplasm DOID_0060086 3.119E-03 0.01613344 3.119E-03 0.03113471 SHEPARD_CRUSH_AND_BURN_MUTANT_UP uterine benign neoplasm DOID_0060095 3.119E-03 0.01613344 3.119E-03 0.03113471 SHEPARD_CRUSH_AND_BURN_MUTANT_UP uterine fibroid DOID_13223 3.119E-03 0.01613344 3.119E-03 0.03113471 SHEPARD_CRUSH_AND_BURN_MUTANT_UP chronic leukemia DOID_1036 3.723E-03 0.01908287 0.08664706 0.28498368 SHEPARD_CRUSH_AND_BURN_MUTANT_UP chronic lymphocytic leukemia DOID_1040 3.723E-03 0.01908287 0.08664706 0.28498368 SHEPARD_CRUSH_AND_BURN_MUTANT_UP leiomyoma DOID_127 3.723E-03 0.01891249 3.723E-03 0.03590167 SHEPARD_CRUSH_AND_BURN_MUTANT_UP papilloma DOID_2615 3.935E-03 0.01981448 0.08901026 0.28941051 SHEPARD_CRUSH_AND_BURN_MUTANT_UP nephroblastoma DOID_2154 4.153E-03 0.02072817 0.09136741 0.29043607 SHEPARD_CRUSH_AND_BURN_MUTANT_UP esophageal disease DOID_6050 4.153E-03 0.02054792 0.09136741 0.28722683 SHEPARD_CRUSH_AND_BURN_MUTANT_UP uveitis DOID_13141 5.079E-03 0.02491339 5.079E-03 0.04515552 SHEPARD_CRUSH_AND_BURN_MUTANT_UP respiratory syncytial virus infectious disease DOID_1273 5.324E-03 0.02589202 0.1030629 0.31359782 SHEPARD_CRUSH_AND_BURN_MUTANT_UP systemic scleroderma DOID_418 5.324E-03 0.0256726 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP autoimmune disease of urogenital tract DOID_0060049 6.091E-03 0.02912413 6.091E-03 0.05096723 SHEPARD_CRUSH_AND_BURN_MUTANT_UP primary biliary cirrhosis DOID_12236 6.091E-03 0.02912413 6.091E-03 0.05096723 SHEPARD_CRUSH_AND_BURN_MUTANT_UP rheumatic disease DOID_1575 6.357E-03 0.03014367 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP uveal disease DOID_3480 6.357E-03 0.02989455 6.357E-03 0.05167486 SHEPARD_CRUSH_AND_BURN_MUTANT_UP scleroderma DOID_419 6.357E-03 0.03014367 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP gallbladder cancer DOID_3121 6.629E-03 0.03091543 0.11460937 0.33442427 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cataract DOID_83 6.905E-03 0.03194376 6.905E-03 0.05457059 SHEPARD_CRUSH_AND_BURN_MUTANT_UP proteinuria DOID_576 7.187E-03 0.03297922 0.11918666 0.34078999 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pre-eclampsia DOID_10591 7.474E-03 0.03402152 0.12146651 0.34557221 SHEPARD_CRUSH_AND_BURN_MUTANT_UP lens disease DOID_110 7.474E-03 0.03375151 7.474E-03 0.05825603 SHEPARD_CRUSH_AND_BURN_MUTANT_UP pulmonary tuberculosis DOID_2957 8.063E-03 0.03612548 0.1260087 0.3549453 SHEPARD_CRUSH_AND_BURN_MUTANT_UP sarcoidosis DOID_11335 9.302E-03 0.0413503 0.13502347 0.37477246 SHEPARD_CRUSH_AND_BURN_MUTANT_UP parasitic protozoa infectious disease DOID_2789 9.951E-03 0.04389337 9.951E-03 0.06990425 SHEPARD_CRUSH_AND_BURN_MUTANT_UP melancholia DOID_2848 0.01130818 0.04949502 0.14837333 0.3963588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP neurotic disorder DOID_4964 0.01165945 0.05064295 0.15057839 0.40036965 SHEPARD_CRUSH_AND_BURN_MUTANT_UP collagen disease DOID_854 0.01201548 0.05179401 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP endocrine pancreas disease DOID_1428 0.01311188 0.05609518 0.01311188 0.0857547 SHEPARD_CRUSH_AND_BURN_MUTANT_UP tuberculosis DOID_399 0.01463879 0.06216025 0.16801664 0.43455214 SHEPARD_CRUSH_AND_BURN_MUTANT_UP peripheral vascular disease DOID_341 0.01623854 0.06844244 0.01623854 0.10266365 SHEPARD_CRUSH_AND_BURN_MUTANT_UP diabetic retinopathy DOID_8947 0.01664966 0.06965925 0.17873512 0.46018227 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cystic fibrosis DOID_1485 0.01748516 0.07262085 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP endogenous depression DOID_1595 0.01748516 0.07209461 0.18298413 0.46899988 SHEPARD_CRUSH_AND_BURN_MUTANT_UP syndrome DOID_225 0.01748516 0.07157594 0.01748516 0.10933029 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bone resorption disease DOID_0080011 0.01790948 0.07278926 0.18510048 0.47229673 SHEPARD_CRUSH_AND_BURN_MUTANT_UP osteoporosis DOID_11476 0.01790948 0.07278926 0.18510048 0.47229673 SHEPARD_CRUSH_AND_BURN_MUTANT_UP metabolic syndrome X DOID_14221 0.01920845 0.07751495 0.191417 0.48623336 SHEPARD_CRUSH_AND_BURN_MUTANT_UP lipid metabolism disorder DOID_3146 0.01920845 0.07696907 0.191417 0.48407232 SHEPARD_CRUSH_AND_BURN_MUTANT_UP mental depression DOID_1596 0.02054589 0.08175254 0.19768506 0.49771149 SHEPARD_CRUSH_AND_BURN_MUTANT_UP chronic kidney failure DOID_784 0.02054589 0.08118481 0.19768506 0.49551893 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bone development disease DOID_0080006 0.02100014 0.08240746 0.02100014 0.12711789 SHEPARD_CRUSH_AND_BURN_MUTANT_UP retinal vascular disease DOID_2462 0.02145857 0.08362964 0.20183702 0.50370729 SHEPARD_CRUSH_AND_BURN_MUTANT_UP primary bacterial infectious disease DOID_0050338 0.02238787 0.0866578 0.20596771 0.5117713 SHEPARD_CRUSH_AND_BURN_MUTANT_UP interstitial nephritis DOID_1063 0.02555438 0.09824622 0.02555438 0.14837185 SHEPARD_CRUSH_AND_BURN_MUTANT_UP facioscapulohumeral muscular dystrophy DOID_11727 0.02555438 0.09758685 0.02555438 0.14687314 SHEPARD_CRUSH_AND_BURN_MUTANT_UP hyperparathyroidism DOID_13543 0.02555438 0.09693628 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP hypolipoproteinemia DOID_1387 0.02555438 0.09629431 0.02555438 0.14540441 SHEPARD_CRUSH_AND_BURN_MUTANT_UP acute kidney failure DOID_3021 0.02555438 0.0956608 0.02555438 0.14396476 SHEPARD_CRUSH_AND_BURN_MUTANT_UP teratoma DOID_3307 0.02555438 0.09503556 0.02555438 0.14255335 SHEPARD_CRUSH_AND_BURN_MUTANT_UP malignant teratoma DOID_5563 0.02555438 0.09503556 0.02555438 0.14255335 SHEPARD_CRUSH_AND_BURN_MUTANT_UP mature teratoma DOID_5566 0.02555438 0.09503556 0.02555438 0.14255335 SHEPARD_CRUSH_AND_BURN_MUTANT_UP acute T cell leukemia DOID_5603 0.02555438 0.09441845 0.02555438 0.14116933 SHEPARD_CRUSH_AND_BURN_MUTANT_UP cutaneous leishmaniasis DOID_9111 0.02555438 0.0938093 0.02555438 0.13981194 SHEPARD_CRUSH_AND_BURN_MUTANT_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.02576847 0.09398884 0.02576847 0.13964057 SHEPARD_CRUSH_AND_BURN_MUTANT_UP Crohn's disease DOID_8778 0.02576847 0.09339019 0.2202592 0.54020468 SHEPARD_CRUSH_AND_BURN_MUTANT_UP nervous system benign neoplasm DOID_0060115 0.02807399 0.09983811 0.02807399 0.14521908 SHEPARD_CRUSH_AND_BURN_MUTANT_UP trypanosomiasis DOID_10113 0.02807399 0.099218 0.02807399 0.1439108 SHEPARD_CRUSH_AND_BURN_MUTANT_UP temporal arteritis DOID_13375 0.02807399 0.09860555 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP hemochromatosis DOID_2352 0.02807399 0.0980006 0.02807399 0.14262588 SHEPARD_CRUSH_AND_BURN_MUTANT_UP central nervous system vasculitis DOID_525 0.02807399 0.09860555 1.000 1.000 SHEPARD_CRUSH_AND_BURN_MUTANT_UP bronchiectasis DOID_9563 0.02807399 0.09740304 1.000 1.000 FRIDMAN_SENESCENCE_UP transitional cell carcinoma DOID_2671 9.127E-11 5.193E-08 8.451E-03 0.32056967 FRIDMAN_SENESCENCE_UP glaucoma DOID_1686 1.894E-10 5.388E-08 2.904E-03 0.33046742 FRIDMAN_SENESCENCE_UP diabetic angiopathy DOID_11713 2.92E-10 5.538E-08 6.722E-06 3.825E-03 FRIDMAN_SENESCENCE_UP benign mesothelioma DOID_2645 7.288E-09 1.037E-06 0.06518382 0.63947572 FRIDMAN_SENESCENCE_UP oral cavity cancer DOID_8618 3.914E-08 4.454E-06 3.973E-03 0.28254443 FRIDMAN_SENESCENCE_UP pre-malignant neoplasm DOID_0060071 5.846E-08 5.544E-06 1.452E-04 0.04131017 FRIDMAN_SENESCENCE_UP in situ carcinoma DOID_8719 5.846E-08 5.544E-06 1.452E-04 0.04131017 FRIDMAN_SENESCENCE_UP nephrosis DOID_2527 1.044E-07 8.486E-06 0.10721414 0.73499812 FRIDMAN_SENESCENCE_UP peripheral vascular disease DOID_341 1.117E-07 7.946E-06 2.122E-04 0.04024423 FRIDMAN_SENESCENCE_UP sarcoma DOID_1115 1.312E-07 8.293E-06 1.000 1.000 FRIDMAN_SENESCENCE_UP mixed glioma DOID_5076 1.547E-07 8.803E-06 0.11539453 0.74613056 FRIDMAN_SENESCENCE_UP papilloma DOID_2615 2.8E-07 1.448E-05 0.05365115 0.59857852 FRIDMAN_SENESCENCE_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.861E-07 1.831E-05 0.1368505 0.82838231 FRIDMAN_SENESCENCE_UP cervix uteri carcinoma in situ DOID_8991 6.394E-07 2.799E-05 2.088E-03 0.29702521 FRIDMAN_SENESCENCE_UP brain cancer DOID_1319 1.077E-06 4.379E-05 1.000 1.000 FRIDMAN_SENESCENCE_UP heart valve disease DOID_4079 1.077E-06 4.087E-05 0.07374257 0.60810899 FRIDMAN_SENESCENCE_UP central nervous system cancer DOID_3620 1.168E-06 4.153E-05 1.000 1.000 FRIDMAN_SENESCENCE_UP mesenchymal cell neoplasm DOID_3350 1.526E-06 5.108E-05 1.000 1.000 FRIDMAN_SENESCENCE_UP spindle cell sarcoma DOID_4235 1.526E-06 5.108E-05 1.000 1.000 FRIDMAN_SENESCENCE_UP oral submucous fibrosis DOID_5773 1.526E-06 4.824E-05 1.000 1.000 FRIDMAN_SENESCENCE_UP epithelioid sarcoma DOID_6193 1.526E-06 5.108E-05 1.000 1.000 FRIDMAN_SENESCENCE_UP tongue cancer DOID_8649 1.876E-06 5.619E-05 0.02420424 0.5987919 FRIDMAN_SENESCENCE_UP astrocytoma DOID_3069 4.694E-06 1.335E-04 5.489E-03 0.31232806 FRIDMAN_SENESCENCE_UP diabetic retinopathy DOID_8947 5.827E-06 1.579E-04 6.097E-03 0.31535775 FRIDMAN_SENESCENCE_UP aortic valve disease DOID_62 6.722E-06 1.739E-04 0.03608952 0.55499828 FRIDMAN_SENESCENCE_UP retinal vascular disease DOID_2462 9.984E-06 2.47E-04 7.917E-03 0.3217681 FRIDMAN_SENESCENCE_UP nervous system cancer DOID_3093 1.246E-05 2.954E-04 1.000 1.000 FRIDMAN_SENESCENCE_UP autoimmune disease of cardiovascular system DOID_0060051 1.34E-05 3.049E-04 1.000 1.000 FRIDMAN_SENESCENCE_UP Behcet's disease DOID_13241 1.34E-05 3.049E-04 1.000 1.000 FRIDMAN_SENESCENCE_UP focal glomerulosclerosis DOID_3945 1.482E-05 3.242E-04 0.04637235 0.62823494 FRIDMAN_SENESCENCE_UP nephroblastoma DOID_2154 2.544E-05 5.362E-04 0.05510034 0.59154898 FRIDMAN_SENESCENCE_UP multiple myeloma DOID_9538 3.225E-05 6.553E-04 1.000 1.000 FRIDMAN_SENESCENCE_UP nephrotic syndrome DOID_1184 4.923E-05 9.658E-04 0.06804533 0.63471794 FRIDMAN_SENESCENCE_UP cataract DOID_83 5.597E-05 1.061E-03 0.07089824 0.61122878 FRIDMAN_SENESCENCE_UP myeloma DOID_0070004 6.328E-05 1.162E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP lens disease DOID_110 6.328E-05 1.125E-03 0.07374257 0.6262615 FRIDMAN_SENESCENCE_UP giant cell tumor DOID_200 8.892E-05 1.533E-03 3.359E-03 0.31858268 FRIDMAN_SENESCENCE_UP malignant giant cell tumor DOID_2705 8.892E-05 1.533E-03 3.359E-03 0.31858268 FRIDMAN_SENESCENCE_UP giant cell glioblastoma DOID_3074 8.892E-05 1.533E-03 3.359E-03 0.31858268 FRIDMAN_SENESCENCE_UP bile duct adenocarcinoma DOID_4896 9.376E-05 1.569E-03 0.08363048 0.66091307 FRIDMAN_SENESCENCE_UP cholangiocarcinoma DOID_4947 9.376E-05 1.569E-03 0.08363048 0.66091307 FRIDMAN_SENESCENCE_UP bone marrow cancer DOID_4960 9.376E-05 1.524E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP vasculitis DOID_865 9.376E-05 1.482E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP reproductive organ benign neoplasm DOID_0050622 9.876E-05 1.519E-03 0.08503454 0.66280347 FRIDMAN_SENESCENCE_UP lateral sclerosis DOID_230 1.027E-04 1.538E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP glioblastoma DOID_3068 1.148E-04 1.675E-03 3.973E-03 0.32290792 FRIDMAN_SENESCENCE_UP bile duct cancer DOID_4606 1.148E-04 1.633E-03 0.08923406 0.67698906 FRIDMAN_SENESCENCE_UP bile duct carcinoma DOID_4897 1.148E-04 1.633E-03 0.08923406 0.67698906 FRIDMAN_SENESCENCE_UP breast benign neoplasm DOID_0060082 1.254E-04 1.74E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP thoracic benign neoplasm DOID_0060097 1.254E-04 1.74E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP benign breast phyllodes tumor DOID_1631 1.254E-04 1.74E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP invasive lobular carcinoma DOID_3457 1.254E-04 1.699E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP carotid artery disease DOID_3407 1.325E-04 1.753E-03 0.09341463 0.69938061 FRIDMAN_SENESCENCE_UP collagen disease DOID_854 1.325E-04 1.713E-03 0.09341463 0.69029774 FRIDMAN_SENESCENCE_UP aortic valve insufficiency DOID_57 1.503E-04 1.901E-03 0.01820771 0.51800944 FRIDMAN_SENESCENCE_UP ocular hypertension DOID_9282 1.503E-04 1.86E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP borderline glaucoma DOID_9283 1.503E-04 1.86E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP parasitic infectious disease DOID_1398 1.587E-04 1.921E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP osteogenesis imperfecta DOID_12347 1.775E-04 2.104E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP vulva cancer DOID_1245 1.775E-04 2.061E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP parasitic helminthiasis infectious disease DOID_883 2.069E-04 2.354E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP pancreatic carcinoma DOID_4905 2.207E-04 2.462E-03 0.10994916 0.73601263 FRIDMAN_SENESCENCE_UP membranoproliferative glomerulonephritis DOID_2920 2.385E-04 2.609E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP aneurysm disease DOID_2403 2.474E-04 2.656E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP angiosarcoma DOID_0001816 2.723E-04 2.869E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP spastic diplegia DOID_10965 2.723E-04 2.817E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP chromosomal disease DOID_0080014 2.862E-04 2.908E-03 7.23E-03 0.31644536 FRIDMAN_SENESCENCE_UP biliary tract cancer DOID_4607 3.07E-04 3.065E-03 0.12215522 0.77229247 FRIDMAN_SENESCENCE_UP male reproductive organ benign neoplasm DOID_0060087 3.464E-04 3.399E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP ureteral obstruction DOID_5199 3.464E-04 3.341E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP prion disease DOID_649 3.464E-04 3.285E-03 0.02718899 0.59502068 FRIDMAN_SENESCENCE_UP granulosa cell tumor DOID_2999 3.868E-04 3.608E-03 0.028678 0.582778 FRIDMAN_SENESCENCE_UP Human immunodeficiency virus infectious disease DOID_526 3.874E-04 3.555E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP lymphoma DOID_0060058 4.126E-04 3.727E-03 0.13419674 0.83909829 FRIDMAN_SENESCENCE_UP lymphoblastic leukemia DOID_1037 4.256E-04 3.784E-03 0.13552462 0.83819033 FRIDMAN_SENESCENCE_UP colon carcinoma DOID_1520 4.294E-04 3.759E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP sex cord-gonadal stromal tumor DOID_192 4.294E-04 3.702E-03 0.03016477 0.55366955 FRIDMAN_SENESCENCE_UP subependymal glioma DOID_4843 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP pilocytic astrocytoma DOID_4851 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP subependymal giant cell astrocytoma DOID_5077 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP fibrillary astrocytoma DOID_6726 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP juvenile pilocytic astrocytoma DOID_6811 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP childhood pilocytic astrocytoma DOID_6812 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP gemistocytic astrocytoma DOID_7005 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP childhood cerebral astrocytoma DOID_7007 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP protoplasmic astrocytoma DOID_7008 4.294E-04 3.647E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP mouth disease DOID_403 4.389E-04 3.672E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP dilated cardiomyopathy DOID_12930 4.524E-04 3.731E-03 9.758E-03 0.34700635 FRIDMAN_SENESCENCE_UP benign glioma DOID_0060101 5.21E-04 4.235E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP hepatitis B DOID_2043 5.21E-04 4.175E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP benign ependymoma DOID_4844 5.21E-04 4.235E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP muscular atrophy DOID_767 5.21E-04 4.117E-03 0.03313161 0.55446717 FRIDMAN_SENESCENCE_UP urinary tract obstruction DOID_5200 5.701E-04 4.443E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP ureteral disease DOID_1426 6.213E-04 4.777E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP spastic quadriplegia DOID_10970 6.746E-04 5.118E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP osteosarcoma DOID_3347 7.301E-04 5.466E-03 0.03903854 0.56956227 FRIDMAN_SENESCENCE_UP spinal muscular atrophy DOID_12377 7.878E-04 5.821E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP papillary adenoma DOID_3172 7.878E-04 5.747E-03 0.04050972 0.57625079 FRIDMAN_SENESCENCE_UP microcystic adenoma DOID_5403 7.878E-04 5.747E-03 0.04050972 0.57625079 FRIDMAN_SENESCENCE_UP follicular adenoma DOID_6204 7.878E-04 5.747E-03 0.04050972 0.57625079 FRIDMAN_SENESCENCE_UP invasive ductal carcinoma DOID_3008 9.734E-04 7.011E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP supratentorial cancer DOID_1659 1.04E-03 7.394E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP cerebrum cancer DOID_368 1.04E-03 7.394E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP spastic cerebral palsy DOID_0050669 1.178E-03 8.276E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP abdominal aortic aneurysm DOID_7693 1.178E-03 8.175E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP chronic leukemia DOID_1036 1.325E-03 9.083E-03 0.05219977 0.6187848 FRIDMAN_SENESCENCE_UP chronic lymphocytic leukemia DOID_1040 1.325E-03 9.083E-03 0.05219977 0.6187848 FRIDMAN_SENESCENCE_UP leiomyoma DOID_127 1.325E-03 8.975E-03 0.05219977 0.60615654 FRIDMAN_SENESCENCE_UP autonomic nervous system neoplasm DOID_2621 1.325E-03 8.869E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP neuroblastoma DOID_769 1.325E-03 8.869E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP hyperthyroidism DOID_7998 1.48E-03 9.793E-03 1.000 1.000 FRIDMAN_SENESCENCE_UP thyroid cancer DOID_1781 1.644E-03 0.01074959 1.000 1.000 FRIDMAN_SENESCENCE_UP adenoma DOID_657 1.644E-03 0.01062744 0.05799219 0.61106589 FRIDMAN_SENESCENCE_UP embryonal cancer DOID_688 1.728E-03 0.01105023 1.000 1.000 FRIDMAN_SENESCENCE_UP peripheral nervous system neoplasm DOID_1192 1.815E-03 0.01147656 1.000 1.000 FRIDMAN_SENESCENCE_UP adenoid cystic carcinoma DOID_4866 1.995E-03 0.01247483 0.06374982 0.64774372 FRIDMAN_SENESCENCE_UP autoimmune disease of urogenital tract DOID_0060049 2.183E-03 0.01350155 0.06661565 0.64244587 FRIDMAN_SENESCENCE_UP primary biliary cirrhosis DOID_12236 2.183E-03 0.01350155 0.06661565 0.64244587 FRIDMAN_SENESCENCE_UP salivary gland cancer DOID_8850 2.183E-03 0.01335637 0.06661565 0.63173844 FRIDMAN_SENESCENCE_UP rheumatic disease DOID_1575 2.28E-03 0.01380138 0.06804533 0.62448056 FRIDMAN_SENESCENCE_UP scleroderma DOID_419 2.28E-03 0.01380138 0.06804533 0.62448056 FRIDMAN_SENESCENCE_UP proteinuria DOID_576 2.583E-03 0.01547092 1.000 1.000 FRIDMAN_SENESCENCE_UP thyroid adenoma DOID_2891 2.688E-03 0.01593204 0.07374257 0.61705177 FRIDMAN_SENESCENCE_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.904E-03 0.0170344 0.07657833 0.62247245 FRIDMAN_SENESCENCE_UP integumentary system benign neoplasm DOID_0060121 2.904E-03 0.01686058 1.000 1.000 FRIDMAN_SENESCENCE_UP skin benign neoplasm DOID_3165 2.904E-03 0.01686058 1.000 1.000 FRIDMAN_SENESCENCE_UP aortic aneurysm DOID_3627 3.015E-03 0.0173278 1.000 1.000 FRIDMAN_SENESCENCE_UP integumentary system cancer DOID_0060122 3.599E-03 0.02047739 1.000 1.000 FRIDMAN_SENESCENCE_UP osteochondrodysplasia DOID_2256 3.599E-03 0.02027464 1.000 1.000 FRIDMAN_SENESCENCE_UP parasitic protozoa infectious disease DOID_2789 3.599E-03 0.02007587 1.000 1.000 FRIDMAN_SENESCENCE_UP skin cancer DOID_4159 3.599E-03 0.02047739 1.000 1.000 FRIDMAN_SENESCENCE_UP pustulosis of palm and sole DOID_4398 3.599E-03 0.01988096 0.08503454 0.65384667 FRIDMAN_SENESCENCE_UP hypertrophic cardiomyopathy DOID_11984 3.973E-03 0.02173419 1.000 1.000 FRIDMAN_SENESCENCE_UP hypothyroidism DOID_1459 4.498E-03 0.02437243 4.498E-03 0.28434504 FRIDMAN_SENESCENCE_UP cholestasis DOID_13580 4.911E-03 0.02636317 1.000 1.000 FRIDMAN_SENESCENCE_UP endocrine organ benign neoplasm DOID_0060089 5.342E-03 0.02840649 0.10309611 0.73327105 FRIDMAN_SENESCENCE_UP pancreatic ductal carcinoma DOID_3587 5.638E-03 0.02970482 0.10584353 0.73445083 FRIDMAN_SENESCENCE_UP bile duct disease DOID_4138 5.789E-03 0.0302203 1.000 1.000 FRIDMAN_SENESCENCE_UP biliary tract disease DOID_9741 5.942E-03 0.03073592 1.000 1.000 FRIDMAN_SENESCENCE_UP bone resorption disease DOID_0080011 6.571E-03 0.03368576 0.11403627 0.74582341 FRIDMAN_SENESCENCE_UP osteoporosis DOID_11476 6.571E-03 0.03368576 0.11403627 0.74582341 FRIDMAN_SENESCENCE_UP metabolic syndrome X DOID_14221 7.063E-03 0.03588024 7.063E-03 0.33488222 FRIDMAN_SENESCENCE_UP bone development disease DOID_0080006 7.743E-03 0.03898669 1.000 1.000 FRIDMAN_SENESCENCE_UP Crohn's disease DOID_8778 9.566E-03 0.04774502 0.1368505 0.8196625 FRIDMAN_SENESCENCE_UP facioscapulohumeral muscular dystrophy DOID_11727 0.01519588 0.07518659 1.000 1.000 FRIDMAN_SENESCENCE_UP Sjogren's syndrome DOID_12894 0.01519588 0.07453843 1.000 1.000 FRIDMAN_SENESCENCE_UP hyperparathyroidism DOID_13543 0.01519588 0.07390135 1.000 1.000 FRIDMAN_SENESCENCE_UP ventricular septal defect DOID_1657 0.01519588 0.07327506 0.01519588 0.50861515 FRIDMAN_SENESCENCE_UP transient cerebral ischemia DOID_224 0.01519588 0.07265931 1.000 1.000 FRIDMAN_SENESCENCE_UP acute kidney failure DOID_3021 0.01519588 0.07205381 1.000 1.000 FRIDMAN_SENESCENCE_UP phagocyte bactericidal dysfunction DOID_3262 0.01519588 0.07145833 1.000 1.000 FRIDMAN_SENESCENCE_UP teratoma DOID_3307 0.01519588 0.0708726 1.000 1.000 FRIDMAN_SENESCENCE_UP Hermansky-Pudlak syndrome DOID_3753 0.01519588 0.0702964 0.01519588 0.48035875 FRIDMAN_SENESCENCE_UP Paget's disease of bone DOID_5408 0.01519588 0.0697295 1.000 1.000 FRIDMAN_SENESCENCE_UP malignant teratoma DOID_5563 0.01519588 0.0708726 1.000 1.000 FRIDMAN_SENESCENCE_UP mature teratoma DOID_5566 0.01519588 0.0708726 1.000 1.000 FRIDMAN_SENESCENCE_UP cutaneous leishmaniasis DOID_9111 0.01519588 0.06917166 1.000 1.000 FRIDMAN_SENESCENCE_UP visceral leishmaniasis DOID_9146 0.01519588 0.06862268 1.000 1.000 FRIDMAN_SENESCENCE_UP trypanosomiasis DOID_10113 0.01670293 0.07483439 1.000 1.000 FRIDMAN_SENESCENCE_UP adrenoleukodystrophy DOID_10588 0.01670293 0.07424975 1.000 1.000 FRIDMAN_SENESCENCE_UP eosinophilic pneumonia DOID_5870 0.01670293 0.07367417 1.000 1.000 FRIDMAN_SENESCENCE_UP pulmonary eosinophilia DOID_9498 0.01670293 0.07367417 1.000 1.000 FRIDMAN_SENESCENCE_UP Loeffler syndrome DOID_9503 0.01670293 0.07367417 1.000 1.000 FRIDMAN_SENESCENCE_UP familial atrial fibrillation DOID_0050650 0.01820771 0.07969376 0.01820771 0.5452731 FRIDMAN_SENESCENCE_UP intracranial arteriosclerosis DOID_13097 0.01820771 0.07908541 1.000 1.000 FRIDMAN_SENESCENCE_UP aortic valve stenosis DOID_1712 0.01820771 0.07848628 1.000 1.000 FRIDMAN_SENESCENCE_UP epidermolysis bullosa DOID_2730 0.01820771 0.07789616 1.000 1.000 FRIDMAN_SENESCENCE_UP peritonitis DOID_8283 0.01820771 0.07731484 1.000 1.000 FRIDMAN_SENESCENCE_UP vascular dementia DOID_8725 0.01820771 0.07908541 1.000 1.000 FRIDMAN_SENESCENCE_UP progressive myoclonus epilepsy DOID_891 0.01820771 0.07674214 1.000 1.000 FRIDMAN_SENESCENCE_UP variable age at onset electroclinical syndrome DOID_0050706 0.01971023 0.08246413 1.000 1.000 FRIDMAN_SENESCENCE_UP Hirschsprung's disease DOID_10487 0.01971023 0.0818622 1.000 1.000 FRIDMAN_SENESCENCE_UP parathyroid gland disease DOID_11201 0.01971023 0.081269 1.000 1.000 FRIDMAN_SENESCENCE_UP newborn respiratory distress syndrome DOID_12716 0.01971023 0.08068433 1.000 1.000 FRIDMAN_SENESCENCE_UP carotid stenosis DOID_13001 0.01971023 0.08010801 1.000 1.000 FRIDMAN_SENESCENCE_UP impotence DOID_1875 0.01971023 0.07953987 0.01971023 0.53405343 FRIDMAN_SENESCENCE_UP vesiculobullous skin disease DOID_2731 0.01971023 0.07897973 1.000 1.000 FRIDMAN_SENESCENCE_UP intracranial thrombosis DOID_4193 0.01971023 0.07842743 0.01971023 0.50977827 FRIDMAN_SENESCENCE_UP Legionnaires' disease DOID_10457 0.02121049 0.0838109 1.000 1.000 FRIDMAN_SENESCENCE_UP legionellosis DOID_10458 0.02121049 0.0838109 1.000 1.000 FRIDMAN_SENESCENCE_UP open-angle glaucoma DOID_1067 0.02121049 0.08323289 1.000 1.000 FRIDMAN_SENESCENCE_UP megacolon DOID_11372 0.02121049 0.0826628 1.000 1.000 FRIDMAN_SENESCENCE_UP eyelid disease DOID_530 0.02121049 0.08210047 1.000 1.000 FRIDMAN_SENESCENCE_UP Ehlers-Danlos syndrome DOID_13359 0.02270849 0.08730495 1.000 1.000 FRIDMAN_SENESCENCE_UP thoracic aortic aneurysm DOID_14004 0.02270849 0.08671901 1.000 1.000 FRIDMAN_SENESCENCE_UP hemangioma DOID_255 0.02270849 0.08614088 1.000 1.000 FRIDMAN_SENESCENCE_UP nutritional deficiency disease DOID_5113 0.02270849 0.08557041 1.000 1.000 FRIDMAN_SENESCENCE_UP lung oat cell carcinoma DOID_5411 0.02270849 0.08500745 1.000 1.000 FRIDMAN_SENESCENCE_UP varicose veins DOID_799 0.02270849 0.08445185 1.000 1.000 FRIDMAN_SENESCENCE_UP intermediate coronary syndrome DOID_8805 0.02270849 0.08390346 1.000 1.000 FRIDMAN_SENESCENCE_UP restrictive cardiomyopathy DOID_397 0.02420424 0.08885299 1.000 1.000 FRIDMAN_SENESCENCE_UP vein disease DOID_866 0.02420424 0.08828342 1.000 1.000 FRIDMAN_SENESCENCE_UP penile disease DOID_1529 0.02569774 0.09313385 0.02569774 0.60925061 FRIDMAN_SENESCENCE_UP hyperostosis DOID_205 0.02569774 0.0925444 1.000 1.000 FRIDMAN_SENESCENCE_UP basal cell carcinoma DOID_2513 0.02569774 0.09196236 1.000 1.000 FRIDMAN_SENESCENCE_UP bronchitis DOID_6132 0.02569774 0.09138759 1.000 1.000 FRIDMAN_SENESCENCE_UP urinary system benign neoplasm DOID_731 0.02569774 0.09081997 1.000 1.000 FRIDMAN_SENESCENCE_UP keratosis DOID_161 0.02718899 0.09549715 1.000 1.000 FRIDMAN_SENESCENCE_UP sexual dysfunction DOID_1876 0.02718899 0.09491127 0.02718899 0.6188215 FRIDMAN_SENESCENCE_UP skin carcinoma DOID_3451 0.02718899 0.09433255 1.000 1.000 FRIDMAN_SENESCENCE_UP eosinophilia DOID_999 0.02718899 0.09376083 1.000 1.000 FRIDMAN_SENESCENCE_UP Down syndrome DOID_14250 0.028678 0.0982999 1.000 1.000 FRIDMAN_SENESCENCE_UP heart septal defect DOID_1681 0.028678 0.09771128 0.028678 0.60436237 FRIDMAN_SENESCENCE_UP infertility DOID_5223 0.028678 0.09712967 1.000 1.000 FRIDMAN_SENESCENCE_UP psoriasis DOID_8893 0.028678 0.09655493 0.028678 0.56268221 FRIDMAN_SENESCENCE_UP leishmaniasis DOID_9065 0.028678 0.09598696 1.000 1.000 FRIDMAN_SENESCENCE_UP membranous glomerulonephritis DOID_10976 0.03016477 0.09978928 1.000 1.000 FRIDMAN_SENESCENCE_UP colonic disease DOID_5353 0.03016477 0.09921246 1.000 1.000 FRIDMAN_SENESCENCE_UP amyloidosis DOID_9120 0.03016477 0.09864228 0.03016477 0.53636737 RIGGI_EWING_SARCOMA_PROGENITOR_UP mouth disease DOID_403 5.435E-13 3.092E-10 1.746E-06 1.242E-04 RIGGI_EWING_SARCOMA_PROGENITOR_UP nephrosis DOID_2527 7.219E-13 2.054E-10 7.962E-05 2.665E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP giant cell tumor DOID_200 1.19E-12 2.257E-10 1.01E-06 9.574E-05 RIGGI_EWING_SARCOMA_PROGENITOR_UP malignant giant cell tumor DOID_2705 1.19E-12 2.257E-10 1.01E-06 9.574E-05 RIGGI_EWING_SARCOMA_PROGENITOR_UP giant cell glioblastoma DOID_3074 1.19E-12 2.257E-10 1.01E-06 9.574E-05 RIGGI_EWING_SARCOMA_PROGENITOR_UP pancreatitis DOID_4989 1.755E-12 2.496E-10 2.636E-08 7.499E-06 RIGGI_EWING_SARCOMA_PROGENITOR_UP glioblastoma DOID_3068 2.938E-12 3.343E-10 1.684E-06 1.369E-04 RIGGI_EWING_SARCOMA_PROGENITOR_UP oral cavity cancer DOID_8618 2.938E-12 2.786E-10 9.923E-11 5.646E-08 RIGGI_EWING_SARCOMA_PROGENITOR_UP carotid artery disease DOID_3407 4.859E-12 3.95E-10 3.954E-05 1.607E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP astrocytoma DOID_3069 1.651E-11 1.174E-09 4.49E-06 2.555E-04 RIGGI_EWING_SARCOMA_PROGENITOR_UP uterine disease DOID_345 2.721E-10 1.72E-08 7.692E-03 0.07059032 RIGGI_EWING_SARCOMA_PROGENITOR_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.07E-10 1.747E-08 2.368E-05 1.037E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP diabetic autonomic neuropathy DOID_11503 3.38E-10 1.748E-08 0.24323032 0.50144221 RIGGI_EWING_SARCOMA_PROGENITOR_UP autonomic neuropathy DOID_11504 3.38E-10 1.748E-08 0.24323032 0.50144221 RIGGI_EWING_SARCOMA_PROGENITOR_UP diabetic polyneuropathy DOID_12785 3.38E-10 1.748E-08 0.24323032 0.50144221 RIGGI_EWING_SARCOMA_PROGENITOR_UP diabetic neuropathy DOID_9743 3.38E-10 1.748E-08 0.24323032 0.50144221 RIGGI_EWING_SARCOMA_PROGENITOR_UP autonomic nervous system disease DOID_11465 5.683E-10 2.695E-08 0.25658231 0.52328077 RIGGI_EWING_SARCOMA_PROGENITOR_UP cystic fibrosis DOID_1485 9.567E-10 4.187E-08 1.024E-04 3.066E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP aneurysm disease DOID_2403 1.074E-09 4.366E-08 1.26E-03 0.01887408 RIGGI_EWING_SARCOMA_PROGENITOR_UP female reproductive system disease DOID_229 1.681E-09 6.376E-08 0.01322241 0.09523479 RIGGI_EWING_SARCOMA_PROGENITOR_UP retinal vascular disease DOID_2462 2.57E-09 9.139E-08 1.8E-03 0.02381947 RIGGI_EWING_SARCOMA_PROGENITOR_UP mineral metabolism disease DOID_0050032 6.335E-09 2.12E-07 2.939E-06 1.858E-04 RIGGI_EWING_SARCOMA_PROGENITOR_UP dilated cardiomyopathy DOID_12930 6.804E-09 2.151E-07 2.854E-04 6.495E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP endometriosis of uterus DOID_288 8.582E-09 2.57E-07 0.02913067 0.15206742 RIGGI_EWING_SARCOMA_PROGENITOR_UP nephrotic syndrome DOID_1184 1.007E-08 2.865E-07 2.562E-03 0.03101511 RIGGI_EWING_SARCOMA_PROGENITOR_UP endometriosis DOID_289 1.007E-08 2.729E-07 0.03033834 0.15551815 RIGGI_EWING_SARCOMA_PROGENITOR_UP diabetic retinopathy DOID_8947 1.75E-08 4.525E-07 0.01042495 0.08596806 RIGGI_EWING_SARCOMA_PROGENITOR_UP glaucoma DOID_1686 2.443E-08 6.043E-07 0.03798654 0.18011951 RIGGI_EWING_SARCOMA_PROGENITOR_UP calcium metabolism disease DOID_10575 2.8E-08 6.639E-07 1.569E-05 7.438E-04 RIGGI_EWING_SARCOMA_PROGENITOR_UP movement disease DOID_480 2.8E-08 6.374E-07 2.8E-08 5.312E-06 RIGGI_EWING_SARCOMA_PROGENITOR_UP chronic kidney failure DOID_784 4.267E-08 9.337E-07 0.09025821 0.28063891 RIGGI_EWING_SARCOMA_PROGENITOR_UP vasculitis DOID_865 4.708E-08 9.922E-07 0.04485777 0.20751278 RIGGI_EWING_SARCOMA_PROGENITOR_UP encephalomyelitis DOID_640 1.024E-07 2.082E-06 0.01892295 0.11100161 RIGGI_EWING_SARCOMA_PROGENITOR_UP calcinosis DOID_182 1.291E-07 2.534E-06 9.176E-05 2.901E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP congenital diaphragmatic hernia DOID_3827 1.747E-07 3.314E-06 1.971E-03 0.02492616 RIGGI_EWING_SARCOMA_PROGENITOR_UP adenoid cystic carcinoma DOID_4866 2.021E-07 3.709E-06 2.021E-07 2.875E-05 RIGGI_EWING_SARCOMA_PROGENITOR_UP pulmonary emphysema DOID_9675 2.328E-07 4.14E-06 0.22963961 0.48038579 RIGGI_EWING_SARCOMA_PROGENITOR_UP salivary gland cancer DOID_8850 2.673E-07 4.61E-06 2.673E-07 3.042E-05 RIGGI_EWING_SARCOMA_PROGENITOR_UP pancreatic ductal carcinoma DOID_3587 2.678E-07 4.482E-06 9.343E-03 0.08178513 RIGGI_EWING_SARCOMA_PROGENITOR_UP rheumatic disease DOID_1575 3.059E-07 4.974E-06 0.23872681 0.49756614 RIGGI_EWING_SARCOMA_PROGENITOR_UP scleroderma DOID_419 3.059E-07 4.974E-06 0.23872681 0.49756614 RIGGI_EWING_SARCOMA_PROGENITOR_UP pancreatic carcinoma DOID_4905 3.54E-07 5.595E-06 0.01042495 0.08723229 RIGGI_EWING_SARCOMA_PROGENITOR_UP myeloma DOID_0070004 5.089E-07 7.826E-06 2.208E-04 5.462E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP contact dermatitis DOID_2773 5.974E-07 8.945E-06 1.447E-03 0.0205873 RIGGI_EWING_SARCOMA_PROGENITOR_UP aortic aneurysm DOID_3627 7.244E-07 1.057E-05 3.836E-03 0.04117858 RIGGI_EWING_SARCOMA_PROGENITOR_UP withdrawal disorder DOID_0060001 8.11E-07 1.154E-05 2.977E-04 6.514E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP bone development disease DOID_0080006 8.276E-07 1.149E-05 1.261E-05 6.525E-04 RIGGI_EWING_SARCOMA_PROGENITOR_UP bone marrow cancer DOID_4960 1.123E-06 1.521E-05 3.667E-04 7.727E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP abdominal aortic aneurysm DOID_7693 1.428E-06 1.89E-05 0.01626968 0.10519829 RIGGI_EWING_SARCOMA_PROGENITOR_UP oral submucous fibrosis DOID_5773 1.539E-06 1.99E-05 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP hypertrophic cardiomyopathy DOID_11984 1.684E-06 2.13E-05 0.30356396 0.59767437 RIGGI_EWING_SARCOMA_PROGENITOR_UP Crohn's disease DOID_8778 1.746E-06 2.16E-05 0.11063695 0.31164567 RIGGI_EWING_SARCOMA_PROGENITOR_UP tongue cancer DOID_8649 2.042E-06 2.473E-05 1.077E-04 3.063E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP collagen disease DOID_854 2.241E-06 2.657E-05 0.31585598 0.61548648 RIGGI_EWING_SARCOMA_PROGENITOR_UP ulcerative colitis DOID_8577 2.299E-06 2.67E-05 2.988E-03 0.03400166 RIGGI_EWING_SARCOMA_PROGENITOR_UP hyperglycemia DOID_4195 3.496E-06 3.979E-05 0.06300037 0.25605149 RIGGI_EWING_SARCOMA_PROGENITOR_UP tooth disease DOID_1091 3.805E-06 4.246E-05 6.098E-05 2.313E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP allergic contact dermatitis DOID_3042 3.805E-06 4.164E-05 8.017E-04 0.01303306 RIGGI_EWING_SARCOMA_PROGENITOR_UP brain infarction DOID_3454 4.136E-06 4.441E-05 8.66E-03 0.07698957 RIGGI_EWING_SARCOMA_PROGENITOR_UP systemic scleroderma DOID_418 4.902E-06 5.165E-05 0.22044442 0.46629321 RIGGI_EWING_SARCOMA_PROGENITOR_UP brain edema DOID_4724 5.337E-06 5.521E-05 6.156E-03 0.05937336 RIGGI_EWING_SARCOMA_PROGENITOR_UP intracranial arterial disease DOID_13089 5.521E-06 5.609E-05 0.02677522 0.14372735 RIGGI_EWING_SARCOMA_PROGENITOR_UP cerebral arterial disease DOID_3527 5.521E-06 5.609E-05 0.02677522 0.14372735 RIGGI_EWING_SARCOMA_PROGENITOR_UP endogenous depression DOID_1595 7.167E-06 7.155E-05 0.01118509 0.08963826 RIGGI_EWING_SARCOMA_PROGENITOR_UP metabolic syndrome X DOID_14221 9.581E-06 9.399E-05 0.08491465 0.27928574 RIGGI_EWING_SARCOMA_PROGENITOR_UP cerebral infarction DOID_3526 9.587E-06 9.246E-05 0.03281221 0.16669774 RIGGI_EWING_SARCOMA_PROGENITOR_UP pre-eclampsia DOID_10591 1.175E-05 1.114E-04 3.251E-03 0.03557414 RIGGI_EWING_SARCOMA_PROGENITOR_UP mental depression DOID_1596 1.179E-05 1.1E-04 0.01409259 0.09546054 RIGGI_EWING_SARCOMA_PROGENITOR_UP acute pancreatitis DOID_2913 1.362E-05 1.25E-04 4.252E-04 8.343E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP integumentary system benign neoplasm DOID_0060121 1.427E-05 1.289E-04 0.03798654 0.18163312 RIGGI_EWING_SARCOMA_PROGENITOR_UP skin benign neoplasm DOID_3165 1.427E-05 1.289E-04 0.03798654 0.18163312 RIGGI_EWING_SARCOMA_PROGENITOR_UP primary bacterial infectious disease DOID_0050338 1.536E-05 1.366E-04 0.09753179 0.28903952 RIGGI_EWING_SARCOMA_PROGENITOR_UP nervous system cancer DOID_3093 1.858E-05 1.626E-04 0.01738954 0.10526223 RIGGI_EWING_SARCOMA_PROGENITOR_UP sarcoidosis DOID_11335 2.058E-05 1.774E-04 0.28258678 0.56616858 RIGGI_EWING_SARCOMA_PROGENITOR_UP lymphoma DOID_0060058 2.1E-05 1.784E-04 2.466E-04 5.846E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP middle cerebral artery infarction DOID_3525 2.173E-05 1.819E-04 0.01187457 0.09130579 RIGGI_EWING_SARCOMA_PROGENITOR_UP integumentary system cancer DOID_0060122 2.445E-05 2.016E-04 0.04628325 0.21238042 RIGGI_EWING_SARCOMA_PROGENITOR_UP skin cancer DOID_4159 2.445E-05 2.016E-04 0.04628325 0.21238042 RIGGI_EWING_SARCOMA_PROGENITOR_UP hypersensitivity reaction type I disease DOID_1205 2.512E-05 2.042E-04 2.677E-03 0.03108096 RIGGI_EWING_SARCOMA_PROGENITOR_UP autoimmune disease of cardiovascular system DOID_0060051 2.882E-05 2.31E-04 0.16293306 0.39450601 RIGGI_EWING_SARCOMA_PROGENITOR_UP renal hypertension DOID_1073 2.882E-05 2.278E-04 0.01356002 0.09644567 RIGGI_EWING_SARCOMA_PROGENITOR_UP secondary hypertension DOID_11130 2.882E-05 2.278E-04 0.01356002 0.09644567 RIGGI_EWING_SARCOMA_PROGENITOR_UP Behcet's disease DOID_13241 2.882E-05 2.31E-04 0.16293306 0.39450601 RIGGI_EWING_SARCOMA_PROGENITOR_UP hypersensitivity reaction type IV disease DOID_2916 3.129E-05 2.439E-04 0.30356396 0.59561342 RIGGI_EWING_SARCOMA_PROGENITOR_UP bronchiectasis DOID_9563 3.243E-05 2.493E-04 0.06311593 0.23941975 RIGGI_EWING_SARCOMA_PROGENITOR_UP focal glomerulosclerosis DOID_3945 3.294E-05 2.499E-04 0.16788285 0.39637071 RIGGI_EWING_SARCOMA_PROGENITOR_UP melancholia DOID_2848 3.388E-05 2.536E-04 0.05214779 0.23549278 RIGGI_EWING_SARCOMA_PROGENITOR_UP neurotic disorder DOID_4964 3.662E-05 2.706E-04 0.05365337 0.23850601 RIGGI_EWING_SARCOMA_PROGENITOR_UP hypothyroidism DOID_1459 4.263E-05 3.109E-04 6.057E-04 0.01077086 RIGGI_EWING_SARCOMA_PROGENITOR_UP pleural disease DOID_1532 5.38E-05 3.875E-04 0.18739232 0.42480569 RIGGI_EWING_SARCOMA_PROGENITOR_UP larynx cancer DOID_2596 5.572E-05 3.963E-04 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP laryngeal benign neoplasm DOID_2598 5.572E-05 3.963E-04 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP temporal lobe epilepsy DOID_3328 5.69E-05 3.997E-04 8.007E-03 0.07231581 RIGGI_EWING_SARCOMA_PROGENITOR_UP tuberculosis DOID_399 6.529E-05 4.53E-04 0.34370388 0.6651956 RIGGI_EWING_SARCOMA_PROGENITOR_UP pneumoconiosis DOID_10316 6.724E-05 4.61E-04 0.02020829 0.11614663 RIGGI_EWING_SARCOMA_PROGENITOR_UP nephroblastoma DOID_2154 6.724E-05 4.555E-04 1.363E-03 0.01989311 RIGGI_EWING_SARCOMA_PROGENITOR_UP eating disorder DOID_8670 7.061E-05 4.726E-04 7.061E-05 2.511E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP adenoma DOID_657 8.297E-05 5.49E-04 0.02231174 0.12569686 RIGGI_EWING_SARCOMA_PROGENITOR_UP skeletal system cancer DOID_0060124 8.787E-05 5.747E-04 0.08507023 0.27502818 RIGGI_EWING_SARCOMA_PROGENITOR_UP bone cancer DOID_184 8.787E-05 5.747E-04 0.08507023 0.27502818 RIGGI_EWING_SARCOMA_PROGENITOR_UP varicose veins DOID_799 8.787E-05 5.682E-04 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP vein disease DOID_866 1.077E-04 6.884E-04 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP bone resorption disease DOID_0080011 1.088E-04 6.876E-04 0.01157685 0.09148928 RIGGI_EWING_SARCOMA_PROGENITOR_UP osteoporosis DOID_11476 1.088E-04 6.876E-04 0.01157685 0.09148928 RIGGI_EWING_SARCOMA_PROGENITOR_UP bacterial pneumonia DOID_874 1.155E-04 7.22E-04 0.08140828 0.26930995 RIGGI_EWING_SARCOMA_PROGENITOR_UP benign mesothelioma DOID_2645 1.338E-04 8.276E-04 0.02794287 0.14859338 RIGGI_EWING_SARCOMA_PROGENITOR_UP focal epilepsy DOID_2234 1.538E-04 9.411E-04 0.01409259 0.09433748 RIGGI_EWING_SARCOMA_PROGENITOR_UP biliary tract cancer DOID_4607 1.538E-04 9.311E-04 0.09025821 0.28218088 RIGGI_EWING_SARCOMA_PROGENITOR_UP dental caries DOID_216 1.555E-04 9.316E-04 1.555E-04 4.214E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP Huntington's disease DOID_12858 1.594E-04 9.446E-04 2.562E-03 0.03036897 RIGGI_EWING_SARCOMA_PROGENITOR_UP influenza DOID_8469 1.734E-04 1.017E-03 0.24323032 0.49783471 RIGGI_EWING_SARCOMA_PROGENITOR_UP granulosa cell tumor DOID_2999 1.839E-04 1.068E-03 0.10651231 0.30455027 RIGGI_EWING_SARCOMA_PROGENITOR_UP learning disability DOID_8927 1.883E-04 1.082E-03 1.883E-04 4.87E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP sex cord-gonadal stromal tumor DOID_192 2.154E-04 1.226E-03 0.11179419 0.30879076 RIGGI_EWING_SARCOMA_PROGENITOR_UP brain cancer DOID_1319 2.208E-04 1.244E-03 0.03536232 0.17496659 RIGGI_EWING_SARCOMA_PROGENITOR_UP heart valve disease DOID_4079 2.208E-04 1.232E-03 0.25658231 0.52141191 RIGGI_EWING_SARCOMA_PROGENITOR_UP central nervous system cancer DOID_3620 2.385E-04 1.317E-03 0.03666529 0.17831242 RIGGI_EWING_SARCOMA_PROGENITOR_UP coronary restenosis DOID_4247 2.502E-04 1.369E-03 6.778E-03 0.06427968 RIGGI_EWING_SARCOMA_PROGENITOR_UP opiate dependence DOID_2559 3.303E-04 1.79E-03 0.12745407 0.33888488 RIGGI_EWING_SARCOMA_PROGENITOR_UP uremia DOID_4676 3.303E-04 1.773E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP bile duct adenocarcinoma DOID_4896 3.667E-04 1.95E-03 0.28683194 0.57065515 RIGGI_EWING_SARCOMA_PROGENITOR_UP cholangiocarcinoma DOID_4947 3.667E-04 1.95E-03 0.28683194 0.57065515 RIGGI_EWING_SARCOMA_PROGENITOR_UP synostosis DOID_11971 3.758E-04 1.98E-03 3.758E-04 7.638E-03 RIGGI_EWING_SARCOMA_PROGENITOR_UP osteochondrodysplasia DOID_2256 3.92E-04 2.046E-03 4.944E-03 0.05115044 RIGGI_EWING_SARCOMA_PROGENITOR_UP familial hyperlipidemia DOID_1168 4.186E-04 2.165E-03 0.04772524 0.21724529 RIGGI_EWING_SARCOMA_PROGENITOR_UP bile duct cancer DOID_4606 4.756E-04 2.438E-03 0.30356396 0.59356664 RIGGI_EWING_SARCOMA_PROGENITOR_UP bile duct carcinoma DOID_4897 4.756E-04 2.438E-03 0.30356396 0.59356664 RIGGI_EWING_SARCOMA_PROGENITOR_UP portal hypertension DOID_10762 4.786E-04 2.431E-03 0.01028886 0.08870247 RIGGI_EWING_SARCOMA_PROGENITOR_UP urticaria DOID_1555 4.786E-04 2.41E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP leukocyte disease DOID_9500 5.06E-04 2.526E-03 0.05214779 0.23363851 RIGGI_EWING_SARCOMA_PROGENITOR_UP cystitis DOID_1679 5.361E-04 2.652E-03 0.14790713 0.37571052 RIGGI_EWING_SARCOMA_PROGENITOR_UP intracranial aneurysm DOID_10941 5.978E-04 2.932E-03 0.15294537 0.38169262 RIGGI_EWING_SARCOMA_PROGENITOR_UP teeth hard tissue disease DOID_214 5.978E-04 2.907E-03 5.978E-04 0.01133859 RIGGI_EWING_SARCOMA_PROGENITOR_UP fragments of torsion dystonia DOID_531 5.978E-04 2.883E-03 5.978E-04 0.01097283 RIGGI_EWING_SARCOMA_PROGENITOR_UP respiratory failure DOID_11162 6.057E-04 2.896E-03 0.05671024 0.24821637 RIGGI_EWING_SARCOMA_PROGENITOR_UP pleurisy DOID_10247 7.345E-04 3.483E-03 0.16293306 0.39283437 RIGGI_EWING_SARCOMA_PROGENITOR_UP malaria DOID_12365 7.345E-04 3.454E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP hepatic vascular disease DOID_272 7.345E-04 3.425E-03 0.01356002 0.09525498 RIGGI_EWING_SARCOMA_PROGENITOR_UP coronary stenosis DOID_4248 7.345E-04 3.398E-03 0.01356002 0.09409333 RIGGI_EWING_SARCOMA_PROGENITOR_UP renal tubular transport disease DOID_447 7.345E-04 3.37E-03 7.345E-04 0.01266395 RIGGI_EWING_SARCOMA_PROGENITOR_UP central nervous system hereditary degenerative disease DOID_481 7.345E-04 3.343E-03 7.345E-04 0.01229148 RIGGI_EWING_SARCOMA_PROGENITOR_UP multiple epiphyseal dysplasia DOID_12721 8.096E-04 3.656E-03 0.01443936 0.09553484 RIGGI_EWING_SARCOMA_PROGENITOR_UP dystonic disease DOID_544 8.096E-04 3.627E-03 8.096E-04 0.01279662 RIGGI_EWING_SARCOMA_PROGENITOR_UP endocrine organ benign neoplasm DOID_0060089 8.456E-04 3.759E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP corneal disease DOID_10124 8.895E-04 3.923E-03 0.1728035 0.40463042 RIGGI_EWING_SARCOMA_PROGENITOR_UP dysostosis DOID_1934 8.895E-04 3.893E-03 8.895E-04 0.01367917 RIGGI_EWING_SARCOMA_PROGENITOR_UP bile duct disease DOID_4138 9.877E-04 4.29E-03 0.35529048 0.68297392 RIGGI_EWING_SARCOMA_PROGENITOR_UP biliary tract disease DOID_9741 1.039E-03 4.477E-03 0.35910724 0.6879866 RIGGI_EWING_SARCOMA_PROGENITOR_UP allergic rhinitis DOID_4481 1.064E-03 4.551E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP bladder disease DOID_365 1.159E-03 4.92E-03 0.18739232 0.42144755 RIGGI_EWING_SARCOMA_PROGENITOR_UP syndrome DOID_225 1.202E-03 5.067E-03 0.07794854 0.26718507 RIGGI_EWING_SARCOMA_PROGENITOR_UP papilloma DOID_2615 1.258E-03 5.265E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP myocarditis DOID_820 1.258E-03 5.226E-03 0.19219811 0.43055403 RIGGI_EWING_SARCOMA_PROGENITOR_UP mixed glioma DOID_5076 1.321E-03 5.446E-03 0.08140828 0.27088486 RIGGI_EWING_SARCOMA_PROGENITOR_UP lipid metabolism disorder DOID_3146 1.447E-03 5.924E-03 0.08491465 0.27768065 RIGGI_EWING_SARCOMA_PROGENITOR_UP Gilles de la Tourette syndrome DOID_11119 1.516E-03 6.161E-03 1.516E-03 0.0210381 RIGGI_EWING_SARCOMA_PROGENITOR_UP insulinoma DOID_3892 1.516E-03 6.117E-03 0.0575459 0.23900449 RIGGI_EWING_SARCOMA_PROGENITOR_UP labyrinthine disease DOID_4539 1.516E-03 6.074E-03 1.516E-03 0.02053719 RIGGI_EWING_SARCOMA_PROGENITOR_UP pulmonary sarcoidosis DOID_13406 1.711E-03 6.809E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP sickle cell anemia DOID_10923 1.846E-03 7.293E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP temporal arteritis DOID_13375 1.846E-03 7.242E-03 0.06311593 0.24430586 RIGGI_EWING_SARCOMA_PROGENITOR_UP inner ear disease DOID_2952 1.846E-03 7.193E-03 1.846E-03 0.02386687 RIGGI_EWING_SARCOMA_PROGENITOR_UP central nervous system vasculitis DOID_525 1.846E-03 7.242E-03 0.06311593 0.24430586 RIGGI_EWING_SARCOMA_PROGENITOR_UP respiratory syncytial virus infectious disease DOID_1273 1.971E-03 7.63E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP hepatitis DOID_2237 1.971E-03 7.579E-03 0.025628 0.13887935 RIGGI_EWING_SARCOMA_PROGENITOR_UP peptic ulcer DOID_750 1.971E-03 7.528E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP transitional cell carcinoma DOID_2671 2.038E-03 7.731E-03 0.0164075 0.10489742 RIGGI_EWING_SARCOMA_PROGENITOR_UP adult respiratory distress syndrome DOID_11394 2.11E-03 7.951E-03 0.22505559 0.47428382 RIGGI_EWING_SARCOMA_PROGENITOR_UP primary immunodeficiency disease DOID_612 2.122E-03 7.944E-03 0.01689451 0.10681083 RIGGI_EWING_SARCOMA_PROGENITOR_UP amino acid metabolic disorder DOID_9252 2.122E-03 7.892E-03 0.01689451 0.10563708 RIGGI_EWING_SARCOMA_PROGENITOR_UP islet cell tumor DOID_1799 2.206E-03 8.151E-03 0.06865318 0.25531805 RIGGI_EWING_SARCOMA_PROGENITOR_UP epidermolysis bullosa DOID_2730 2.206E-03 8.099E-03 0.06865318 0.25366014 RIGGI_EWING_SARCOMA_PROGENITOR_UP tic disorder DOID_2769 2.206E-03 8.047E-03 2.206E-03 0.02728852 RIGGI_EWING_SARCOMA_PROGENITOR_UP stomach disease DOID_76 2.206E-03 7.995E-03 0.06865318 0.25202362 RIGGI_EWING_SARCOMA_PROGENITOR_UP ocular hypertension DOID_9282 2.206E-03 7.945E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP borderline glaucoma DOID_9283 2.206E-03 7.945E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP encephalitis DOID_9588 2.206E-03 7.895E-03 0.06865318 0.24881313 RIGGI_EWING_SARCOMA_PROGENITOR_UP lymphoblastic leukemia DOID_1037 2.482E-03 8.826E-03 0.01892295 0.11215788 RIGGI_EWING_SARCOMA_PROGENITOR_UP Hirschsprung's disease DOID_10487 2.597E-03 9.179E-03 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP vesiculobullous skin disease DOID_2731 2.597E-03 9.122E-03 0.07415786 0.25729159 RIGGI_EWING_SARCOMA_PROGENITOR_UP gallbladder cancer DOID_3121 2.725E-03 9.511E-03 0.24323032 0.49963195 RIGGI_EWING_SARCOMA_PROGENITOR_UP open-angle glaucoma DOID_1067 3.018E-03 0.01047154 0.07963014 0.27131468 RIGGI_EWING_SARCOMA_PROGENITOR_UP megacolon DOID_11372 3.018E-03 0.01040808 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP congenital structural myopathy DOID_422 3.018E-03 0.01034538 3.018E-03 0.03367319 RIGGI_EWING_SARCOMA_PROGENITOR_UP polycystic kidney disease DOID_898 3.018E-03 0.01028343 0.07963014 0.26652677 RIGGI_EWING_SARCOMA_PROGENITOR_UP proteinuria DOID_576 3.069E-03 0.01039525 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP thyroid adenoma DOID_2891 3.251E-03 0.01094589 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP vascular skin disease DOID_9540 3.251E-03 0.0108815 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP peripheral neuropathy DOID_0060053 3.469E-03 0.01154296 0.08507023 0.27659976 RIGGI_EWING_SARCOMA_PROGENITOR_UP thoracic aortic aneurysm DOID_14004 3.469E-03 0.01147584 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP renovascular hypertension DOID_1591 3.469E-03 0.01140951 0.08507023 0.27347434 RIGGI_EWING_SARCOMA_PROGENITOR_UP hyperhomocysteinemia DOID_9279 3.469E-03 0.01134394 0.08507023 0.26743071 RIGGI_EWING_SARCOMA_PROGENITOR_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.634E-03 0.01181627 0.03798654 0.18317238 RIGGI_EWING_SARCOMA_PROGENITOR_UP pulmonary tuberculosis DOID_2957 3.634E-03 0.01174913 0.26535308 0.53541101 RIGGI_EWING_SARCOMA_PROGENITOR_UP lung small cell carcinoma DOID_5409 3.634E-03 0.01168275 0.03798654 0.17863092 RIGGI_EWING_SARCOMA_PROGENITOR_UP B-cell lymphocytic neoplasm DOID_707 4.044E-03 0.01292631 0.04068279 0.18974188 RIGGI_EWING_SARCOMA_PROGENITOR_UP orofacial cleft DOID_0050567 4.259E-03 0.01353707 4.259E-03 0.0448729 RIGGI_EWING_SARCOMA_PROGENITOR_UP Graves' disease DOID_12361 4.458E-03 0.01409335 0.09585454 0.29011296 RIGGI_EWING_SARCOMA_PROGENITOR_UP urinary system benign neoplasm DOID_731 4.458E-03 0.01401549 0.09585454 0.28555621 RIGGI_EWING_SARCOMA_PROGENITOR_UP parasitic protozoa infectious disease DOID_2789 4.944E-03 0.01545755 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP smallpox DOID_8736 4.944E-03 0.01537308 4.944E-03 0.05023704 RIGGI_EWING_SARCOMA_PROGENITOR_UP glucose intolerance DOID_10603 4.996E-03 0.01545022 0.10119915 0.29835398 RIGGI_EWING_SARCOMA_PROGENITOR_UP prion disease DOID_649 4.996E-03 0.01536671 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP congenital nervous system abnormality DOID_2490 5.436E-03 0.01663002 5.436E-03 0.05426637 RIGGI_EWING_SARCOMA_PROGENITOR_UP conduct disorder DOID_12995 5.562E-03 0.01692504 5.562E-03 0.05456866 RIGGI_EWING_SARCOMA_PROGENITOR_UP testicular cancer DOID_2998 5.562E-03 0.01683501 0.10651231 0.3060884 RIGGI_EWING_SARCOMA_PROGENITOR_UP amnestic disorder DOID_10914 6.156E-03 0.01853454 0.11179419 0.31181812 RIGGI_EWING_SARCOMA_PROGENITOR_UP colonic disease DOID_5353 6.156E-03 0.01843699 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP congenital heart defect DOID_1682 7.084E-03 0.02110333 7.084E-03 0.06607765 RIGGI_EWING_SARCOMA_PROGENITOR_UP gastric ulcer DOID_10808 7.427E-03 0.02201065 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP familial hypercholesterolemia DOID_13810 7.427E-03 0.02189661 0.12226489 0.33446502 RIGGI_EWING_SARCOMA_PROGENITOR_UP muscular atrophy DOID_767 7.427E-03 0.02178374 0.12226489 0.33286471 RIGGI_EWING_SARCOMA_PROGENITOR_UP placenta disease DOID_780 7.427E-03 0.02167203 0.12226489 0.33127964 RIGGI_EWING_SARCOMA_PROGENITOR_UP cholestasis DOID_13580 7.692E-03 0.02232959 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP parasitic infectious disease DOID_1398 7.692E-03 0.02221624 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP muscle cancer DOID_4045 8.103E-03 0.023286 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP urinary tract obstruction DOID_5200 8.103E-03 0.02316898 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP pulmonary embolism DOID_9477 8.103E-03 0.02305314 0.12745407 0.33730867 RIGGI_EWING_SARCOMA_PROGENITOR_UP aortic valve disease DOID_62 8.806E-03 0.02492703 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP Goodpasture syndrome DOID_9808 8.806E-03 0.02480363 0.1326127 0.34772639 RIGGI_EWING_SARCOMA_PROGENITOR_UP male reproductive system disease DOID_48 9.696E-03 0.02717689 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP peripheral vascular disease DOID_341 0.01005651 0.02804979 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP osteosarcoma DOID_3347 0.01028886 0.02855787 0.01028886 0.08737855 RIGGI_EWING_SARCOMA_PROGENITOR_UP spinal muscular atrophy DOID_12377 0.01106908 0.03057432 0.14790713 0.37739532 RIGGI_EWING_SARCOMA_PROGENITOR_UP myositis DOID_633 0.01106908 0.03042661 0.14790713 0.37238565 RIGGI_EWING_SARCOMA_PROGENITOR_UP ankylosing spondylitis DOID_7147 0.01106908 0.03028033 0.14790713 0.37074519 RIGGI_EWING_SARCOMA_PROGENITOR_UP cleft lip DOID_9296 0.01106908 0.03013545 0.01106908 0.08997584 RIGGI_EWING_SARCOMA_PROGENITOR_UP vitiligo DOID_12306 0.01187457 0.03217442 0.15294537 0.37837356 RIGGI_EWING_SARCOMA_PROGENITOR_UP spinal cord disease DOID_319 0.01187457 0.03202193 0.01187457 0.09255655 RIGGI_EWING_SARCOMA_PROGENITOR_UP seminoma DOID_4440 0.01187457 0.03187089 0.15294537 0.37673557 RIGGI_EWING_SARCOMA_PROGENITOR_UP dystonia DOID_543 0.01187457 0.03172126 0.01187457 0.09008838 RIGGI_EWING_SARCOMA_PROGENITOR_UP gestational diabetes DOID_11714 0.01270499 0.03378101 0.15795396 0.38573306 RIGGI_EWING_SARCOMA_PROGENITOR_UP migraine DOID_6364 0.01270499 0.03362389 0.01270499 0.09512022 RIGGI_EWING_SARCOMA_PROGENITOR_UP periodontitis DOID_824 0.01270499 0.03346823 0.15795396 0.38408463 RIGGI_EWING_SARCOMA_PROGENITOR_UP perinatal necrotizing enterocolitis DOID_8677 0.01270499 0.033314 0.01270499 0.0938849 RIGGI_EWING_SARCOMA_PROGENITOR_UP chromosomal disease DOID_0080014 0.01322241 0.03451169 0.01322241 0.09645575 RIGGI_EWING_SARCOMA_PROGENITOR_UP invasive ductal carcinoma DOID_3008 0.01356002 0.03523129 0.16293306 0.39117684 RIGGI_EWING_SARCOMA_PROGENITOR_UP auditory system disease DOID_2742 0.01365353 0.035313 0.01365353 0.09360072 RIGGI_EWING_SARCOMA_PROGENITOR_UP autoimmune disease of endocrine system DOID_0060005 0.01443936 0.03717645 0.16788285 0.40136698 RIGGI_EWING_SARCOMA_PROGENITOR_UP polycystic ovary syndrome DOID_11612 0.01443936 0.03700899 0.16788285 0.39968762 RIGGI_EWING_SARCOMA_PROGENITOR_UP supratentorial cancer DOID_1659 0.01443936 0.03684303 0.16788285 0.39802226 RIGGI_EWING_SARCOMA_PROGENITOR_UP toxic encephalopathy DOID_3602 0.01443936 0.03667856 0.01443936 0.09443674 RIGGI_EWING_SARCOMA_PROGENITOR_UP cerebrum cancer DOID_368 0.01443936 0.03684303 0.16788285 0.39802226 RIGGI_EWING_SARCOMA_PROGENITOR_UP age related macular degeneration DOID_10871 0.01626968 0.04114422 0.17769518 0.412688 RIGGI_EWING_SARCOMA_PROGENITOR_UP degeneration of macula and posterior pole DOID_2007 0.01626968 0.04114422 0.17769518 0.412688 RIGGI_EWING_SARCOMA_PROGENITOR_UP bronchiolitis obliterans DOID_2799 0.01626968 0.04096217 0.17769518 0.40934639 RIGGI_EWING_SARCOMA_PROGENITOR_UP Charcot-Marie-Tooth disease DOID_10595 0.01722005 0.04316391 0.01722005 0.10650225 RIGGI_EWING_SARCOMA_PROGENITOR_UP celiac disease DOID_10608 0.01722005 0.04297459 0.01722005 0.10535706 RIGGI_EWING_SARCOMA_PROGENITOR_UP endometrial cancer DOID_1380 0.01722005 0.04278693 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP germinoma DOID_3304 0.01722005 0.0426009 0.18255807 0.41885298 RIGGI_EWING_SARCOMA_PROGENITOR_UP chronic leukemia DOID_1036 0.01819347 0.04481422 0.18739232 0.42821779 RIGGI_EWING_SARCOMA_PROGENITOR_UP chronic lymphocytic leukemia DOID_1040 0.01819347 0.04481422 0.18739232 0.42821779 RIGGI_EWING_SARCOMA_PROGENITOR_UP hereditary spastic paraplegia DOID_2476 0.01819347 0.04462106 0.01819347 0.10896931 RIGGI_EWING_SARCOMA_PROGENITOR_UP autonomic nervous system neoplasm DOID_2621 0.01819347 0.04442955 0.18739232 0.42311996 RIGGI_EWING_SARCOMA_PROGENITOR_UP neuroblastoma DOID_769 0.01819347 0.04442955 0.18739232 0.42311996 RIGGI_EWING_SARCOMA_PROGENITOR_UP metal metabolism disorder DOID_896 0.01918965 0.04666202 0.01918965 0.11141747 RIGGI_EWING_SARCOMA_PROGENITOR_UP hepatitis C DOID_1883 0.02020829 0.04892986 0.1969756 0.43952596 RIGGI_EWING_SARCOMA_PROGENITOR_UP periodontal disease DOID_3388 0.02020829 0.04872253 0.1969756 0.43780906 RIGGI_EWING_SARCOMA_PROGENITOR_UP thyroid carcinoma DOID_3963 0.02020829 0.04851695 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP spindle cell carcinoma DOID_4015 0.02020829 0.04831309 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP macular degeneration DOID_4448 0.02020829 0.04811095 0.1969756 0.43610552 RIGGI_EWING_SARCOMA_PROGENITOR_UP paraplegia DOID_607 0.02020829 0.04791048 0.02020829 0.11498516 RIGGI_EWING_SARCOMA_PROGENITOR_UP hyperthyroidism DOID_7998 0.02020829 0.04771169 0.1969756 0.43273791 RIGGI_EWING_SARCOMA_PROGENITOR_UP thyroid cancer DOID_1781 0.02231174 0.05246026 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP refractive error DOID_9835 0.02231174 0.05224437 0.02231174 0.12446454 RIGGI_EWING_SARCOMA_PROGENITOR_UP cleft palate DOID_674 0.02339598 0.05455865 0.02339598 0.12924573 RIGGI_EWING_SARCOMA_PROGENITOR_UP embryonal cancer DOID_688 0.02339598 0.05433596 0.21113997 0.45335337 RIGGI_EWING_SARCOMA_PROGENITOR_UP multiple myeloma DOID_9538 0.02339598 0.05411508 0.21113997 0.45164903 RIGGI_EWING_SARCOMA_PROGENITOR_UP microcephaly DOID_10907 0.02450149 0.0564427 0.02450149 0.13405142 RIGGI_EWING_SARCOMA_PROGENITOR_UP peripheral nervous system neoplasm DOID_1192 0.02450149 0.05621511 0.21580593 0.45990103 RIGGI_EWING_SARCOMA_PROGENITOR_UP blood platelet disease DOID_2218 0.02450149 0.05598935 0.21580593 0.45818498 RIGGI_EWING_SARCOMA_PROGENITOR_UP lymphatic system disease DOID_75 0.02677522 0.0609404 0.22505559 0.47253369 RIGGI_EWING_SARCOMA_PROGENITOR_UP autoimmune disease of urogenital tract DOID_0060049 0.02913067 0.06603725 0.02913067 0.15347545 RIGGI_EWING_SARCOMA_PROGENITOR_UP primary biliary cirrhosis DOID_12236 0.02913067 0.06603725 0.02913067 0.15347545 RIGGI_EWING_SARCOMA_PROGENITOR_UP primitive neuroectodermal tumor DOID_168 0.03033834 0.06850204 0.03033834 0.15693195 RIGGI_EWING_SARCOMA_PROGENITOR_UP uterine cancer DOID_363 0.03156561 0.07099143 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP cataract DOID_83 0.03281221 0.07350451 0.03281221 0.16522254 RIGGI_EWING_SARCOMA_PROGENITOR_UP lens disease DOID_110 0.03536232 0.0789065 0.03536232 0.17650139 RIGGI_EWING_SARCOMA_PROGENITOR_UP neuritis DOID_1803 0.03536232 0.07859827 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP bone marrow disease DOID_4961 0.03536232 0.07829244 0.03536232 0.17345826 RIGGI_EWING_SARCOMA_PROGENITOR_UP hemolytic anemia DOID_583 0.03666529 0.08086261 0.26098065 0.5284626 RIGGI_EWING_SARCOMA_PROGENITOR_UP normocytic anemia DOID_720 0.03666529 0.08086261 0.26098065 0.5284626 RIGGI_EWING_SARCOMA_PROGENITOR_UP hemorrhagic disease DOID_2213 0.04068279 0.08937649 0.27402084 0.55094649 RIGGI_EWING_SARCOMA_PROGENITOR_UP atopic dermatitis DOID_3310 0.04205729 0.09204077 1.000 1.000 RIGGI_EWING_SARCOMA_PROGENITOR_UP atrophic muscular disease DOID_913 0.04344903 0.09472222 0.28258678 0.56418202 RIGGI_EWING_SARCOMA_PROGENITOR_UP muscular dystrophy DOID_9884 0.04344903 0.09472222 0.28258678 0.56418202 CHEN_LUNG_CANCER_SURVIVAL pancreatic ductal carcinoma DOID_3587 1.089E-07 6.199E-05 1.18E-05 6.714E-03 CHEN_LUNG_CANCER_SURVIVAL pancreatic carcinoma DOID_4905 1.283E-07 3.649E-05 1.332E-05 3.79E-03 CHEN_LUNG_CANCER_SURVIVAL bone resorption disease DOID_0080011 1.5E-07 2.845E-05 1.497E-05 2.839E-03 CHEN_LUNG_CANCER_SURVIVAL osteoporosis DOID_11476 1.5E-07 2.845E-05 1.497E-05 2.839E-03 CHEN_LUNG_CANCER_SURVIVAL lung adenocarcinoma DOID_3910 7.054E-07 1.003E-04 0.01745161 0.29205778 CHEN_LUNG_CANCER_SURVIVAL pulmonary emphysema DOID_9675 2.541E-06 2.892E-04 3.279E-04 0.03109924 CHEN_LUNG_CANCER_SURVIVAL bile duct adenocarcinoma DOID_4896 5.586E-06 5.297E-04 5.506E-04 0.03481108 CHEN_LUNG_CANCER_SURVIVAL cholangiocarcinoma DOID_4947 5.586E-06 5.297E-04 5.506E-04 0.03481108 CHEN_LUNG_CANCER_SURVIVAL bile duct cancer DOID_4606 6.86E-06 5.576E-04 6.304E-04 0.03587051 CHEN_LUNG_CANCER_SURVIVAL bile duct carcinoma DOID_4897 6.86E-06 5.576E-04 6.304E-04 0.03587051 CHEN_LUNG_CANCER_SURVIVAL endocrine organ benign neoplasm DOID_0060089 1.085E-05 7.718E-04 8.529E-04 0.04411829 CHEN_LUNG_CANCER_SURVIVAL biliary tract cancer DOID_4607 1.865E-05 1.179E-03 1.219E-03 0.05780037 CHEN_LUNG_CANCER_SURVIVAL neuronal ceroid lipofuscinosis DOID_14503 1.93E-05 1.098E-03 6.654E-03 0.22271975 CHEN_LUNG_CANCER_SURVIVAL nervous system cancer DOID_3093 2.364E-05 1.223E-03 0.05436537 0.41245193 CHEN_LUNG_CANCER_SURVIVAL lymphoma DOID_0060058 2.522E-05 1.196E-03 0.05551523 0.41023591 CHEN_LUNG_CANCER_SURVIVAL alcohol-related neurodevelopmental disorder DOID_0050667 2.686E-05 1.176E-03 1.551E-03 0.0678742 CHEN_LUNG_CANCER_SURVIVAL drug-induced mental disorder DOID_1203 4.762E-05 1.935E-03 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL drug psychosis DOID_1742 4.762E-05 1.935E-03 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL substance-induced psychosis DOID_8646 4.762E-05 1.935E-03 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL hypoglycemia DOID_9993 8.839E-05 3.353E-03 0.013865 0.27204094 CHEN_LUNG_CANCER_SURVIVAL Lewy body dementia DOID_12217 9.639E-05 3.428E-03 0.01446364 0.27432703 CHEN_LUNG_CANCER_SURVIVAL myositis DOID_633 1.224E-04 4.098E-03 0.01625746 0.28031805 CHEN_LUNG_CANCER_SURVIVAL dystonia DOID_543 1.318E-04 4.167E-03 1.318E-04 0.01875021 CHEN_LUNG_CANCER_SURVIVAL toxic encephalopathy DOID_3602 1.62E-04 4.851E-03 0.01864437 0.29468457 CHEN_LUNG_CANCER_SURVIVAL pneumoconiosis DOID_10316 2.315E-04 6.585E-03 2.315E-04 0.02634122 CHEN_LUNG_CANCER_SURVIVAL hyperthyroidism DOID_7998 2.315E-04 6.272E-03 0.02221434 0.30829169 CHEN_LUNG_CANCER_SURVIVAL multiple myeloma DOID_9538 2.708E-04 7.004E-03 0.02399466 0.3033992 CHEN_LUNG_CANCER_SURVIVAL benign mesothelioma DOID_2645 3.279E-04 8.113E-03 0.02636361 0.31916794 CHEN_LUNG_CANCER_SURVIVAL leukodystrophy DOID_10579 4.069E-04 9.647E-03 0.02931705 0.33362808 CHEN_LUNG_CANCER_SURVIVAL myeloma DOID_0070004 4.237E-04 9.644E-03 0.02990671 0.32724847 CHEN_LUNG_CANCER_SURVIVAL pre-eclampsia DOID_10591 4.237E-04 9.273E-03 4.237E-04 0.03444186 CHEN_LUNG_CANCER_SURVIVAL brain cancer DOID_1319 4.237E-04 8.929E-03 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL central nervous system cancer DOID_3620 4.408E-04 8.959E-03 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL hemolytic anemia DOID_583 4.408E-04 8.65E-03 4.408E-04 0.03135512 CHEN_LUNG_CANCER_SURVIVAL normocytic anemia DOID_720 4.408E-04 8.65E-03 4.408E-04 0.03135512 CHEN_LUNG_CANCER_SURVIVAL integumentary system benign neoplasm DOID_0060121 4.583E-04 8.693E-03 0.03108501 0.32754387 CHEN_LUNG_CANCER_SURVIVAL skin benign neoplasm DOID_3165 4.583E-04 8.693E-03 0.03108501 0.32754387 CHEN_LUNG_CANCER_SURVIVAL bone marrow cancer DOID_4960 5.506E-04 0.01010644 0.03402475 0.35200152 CHEN_LUNG_CANCER_SURVIVAL integumentary system cancer DOID_0060122 5.701E-04 0.01013654 0.03461168 0.34550954 CHEN_LUNG_CANCER_SURVIVAL skin cancer DOID_4159 5.701E-04 0.01013654 0.03461168 0.34550954 CHEN_LUNG_CANCER_SURVIVAL carotid artery disease DOID_3407 6.937E-04 0.01196141 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL endocrine pancreas disease DOID_1428 7.6E-04 0.01271848 0.03987867 0.36598325 CHEN_LUNG_CANCER_SURVIVAL cerebral degeneration DOID_1443 7.827E-04 0.0127248 0.04046219 0.35973414 CHEN_LUNG_CANCER_SURVIVAL mixed glioma DOID_5076 1.081E-03 0.01708554 0.04743804 0.3856035 CHEN_LUNG_CANCER_SURVIVAL auditory system disease DOID_2742 1.191E-03 0.01831173 0.04975253 0.39872095 CHEN_LUNG_CANCER_SURVIVAL leber hereditary optic neuropathy DOID_705 5.447E-03 0.08156912 5.447E-03 0.2214019 CHEN_LUNG_CANCER_SURVIVAL gout DOID_13189 6.051E-03 0.08828284 6.051E-03 0.22953539 CHEN_LUNG_CANCER_SURVIVAL transient cerebral ischemia DOID_224 6.051E-03 0.08607577 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL acute kidney failure DOID_3021 6.051E-03 0.08397636 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL adrenal gland hyperfunction DOID_3947 6.051E-03 0.08197693 6.051E-03 0.21518943 CHEN_LUNG_CANCER_SURVIVAL labyrinthine disease DOID_4539 6.051E-03 0.08007049 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 6.051E-03 0.0782507 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL Hodgkin's lymphoma, lymphocytic depletion DOID_8628 6.051E-03 0.0782507 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL Hodgkin's granuloma DOID_8651 6.051E-03 0.0782507 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL Hodgkin's lymphoma, mixed cellularity DOID_8654 6.051E-03 0.0782507 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL familial adenomatous polyposis DOID_0050424 6.654E-03 0.08413857 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL adrenoleukodystrophy DOID_10588 6.654E-03 0.08230947 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL inner ear disease DOID_2952 6.654E-03 0.08055821 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL bronchiectasis DOID_9563 6.654E-03 0.07887991 6.654E-03 0.21034643 CHEN_LUNG_CANCER_SURVIVAL stomach disease DOID_76 7.257E-03 0.08427024 7.257E-03 0.2173285 CHEN_LUNG_CANCER_SURVIVAL peritonitis DOID_8283 7.257E-03 0.08258483 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL Hodgkin's lymphoma DOID_8567 7.257E-03 0.08096552 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL larynx cancer DOID_2596 7.859E-03 0.08600093 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL laryngeal benign neoplasm DOID_2598 7.859E-03 0.08600093 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL mesenchymal cell neoplasm DOID_3350 9.063E-03 0.0973031 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL adrenal cortex disease DOID_3952 9.063E-03 0.09550119 9.063E-03 0.25785322 CHEN_LUNG_CANCER_SURVIVAL spindle cell sarcoma DOID_4235 9.063E-03 0.0973031 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL nutritional deficiency disease DOID_5113 9.063E-03 0.09376481 9.063E-03 0.2455745 CHEN_LUNG_CANCER_SURVIVAL epithelioid sarcoma DOID_6193 9.063E-03 0.0973031 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL restrictive cardiomyopathy DOID_397 9.665E-03 0.09820133 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL chronic myeloid leukemia DOID_8552 9.665E-03 0.0964785 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL tongue cancer DOID_8649 9.665E-03 0.09481508 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL lymphatic system cancer DOID_0060073 0.01026588 0.09900484 0.01026588 0.26551298 CHEN_LUNG_CANCER_SURVIVAL methylmalonic acidemia DOID_14749 0.01026588 0.09735476 1.000 1.000 CHEN_LUNG_CANCER_SURVIVAL reticulosarcoma DOID_8538 0.01026588 0.09900484 0.01026588 0.26551298 CHEN_LUNG_CANCER_SURVIVAL lymphosarcoma DOID_8675 0.01026588 0.09900484 0.01026588 0.26551298 CHEN_LUNG_CANCER_SURVIVAL adrenal gland disease DOID_9553 0.01026588 0.09575878 0.01026588 0.25396894 CHEN_LUNG_CANCER_SURVIVAL keratosis DOID_161 0.01086661 0.09972739 0.01086661 0.2576291 SCHLOSSER_SERUM_RESPONSE_UP bacterial pneumonia DOID_874 3.462E-07 1.97E-04 3.462E-07 1.97E-04 SCHLOSSER_SERUM_RESPONSE_UP primary immunodeficiency disease DOID_612 6.596E-07 1.877E-04 6.596E-07 1.877E-04 SCHLOSSER_SERUM_RESPONSE_UP respiratory failure DOID_11162 5.901E-06 1.119E-03 2.226E-04 0.0126672 SCHLOSSER_SERUM_RESPONSE_UP severe combined immunodeficiency DOID_627 1.234E-05 1.755E-03 1.234E-05 2.34E-03 SCHLOSSER_SERUM_RESPONSE_UP combined T cell and B cell immunodeficiency DOID_628 1.393E-05 1.585E-03 1.393E-05 1.982E-03 SCHLOSSER_SERUM_RESPONSE_UP female reproductive organ benign neoplasm DOID_0060086 2.637E-05 2.501E-03 1.519E-03 0.05760551 SCHLOSSER_SERUM_RESPONSE_UP uterine benign neoplasm DOID_0060095 2.637E-05 2.501E-03 1.519E-03 0.05760551 SCHLOSSER_SERUM_RESPONSE_UP uterine fibroid DOID_13223 2.637E-05 2.501E-03 1.519E-03 0.05760551 SCHLOSSER_SERUM_RESPONSE_UP pulmonary sarcoidosis DOID_13406 5.2E-05 4.227E-03 2.366E-03 0.06119665 SCHLOSSER_SERUM_RESPONSE_UP medulloblastoma DOID_3858 5.2E-05 3.698E-03 5.2E-05 5.917E-03 SCHLOSSER_SERUM_RESPONSE_UP congenital diaphragmatic hernia DOID_3827 6.026E-05 3.81E-03 6.026E-05 5.715E-03 SCHLOSSER_SERUM_RESPONSE_UP adult respiratory distress syndrome DOID_11394 6.47E-05 3.681E-03 2.73E-03 0.06471822 SCHLOSSER_SERUM_RESPONSE_UP cervix uteri carcinoma in situ DOID_8991 6.934E-05 3.587E-03 2.856E-03 0.06501289 SCHLOSSER_SERUM_RESPONSE_UP primitive neuroectodermal tumor DOID_168 7.928E-05 3.759E-03 7.928E-05 6.444E-03 SCHLOSSER_SERUM_RESPONSE_UP pulmonary tuberculosis DOID_2957 1.145E-04 5.013E-03 1.145E-04 8.146E-03 SCHLOSSER_SERUM_RESPONSE_UP chondrosarcoma DOID_3371 1.413E-04 5.744E-03 0.01779476 0.19853364 SCHLOSSER_SERUM_RESPONSE_UP sarcoidosis DOID_11335 1.429E-04 5.421E-03 4.586E-03 0.08698248 SCHLOSSER_SERUM_RESPONSE_UP reproductive organ benign neoplasm DOID_0050622 1.587E-04 5.643E-03 4.911E-03 0.09014502 SCHLOSSER_SERUM_RESPONSE_UP hypersensitivity reaction type IV disease DOID_2916 1.844E-04 6.171E-03 5.418E-03 0.09342553 SCHLOSSER_SERUM_RESPONSE_UP neuroectodermal tumor DOID_171 2.126E-04 6.721E-03 2.126E-04 0.01344229 SCHLOSSER_SERUM_RESPONSE_UP pre-malignant neoplasm DOID_0060071 2.329E-04 6.975E-03 6.315E-03 0.09710725 SCHLOSSER_SERUM_RESPONSE_UP in situ carcinoma DOID_8719 2.329E-04 6.975E-03 6.315E-03 0.09710725 SCHLOSSER_SERUM_RESPONSE_UP tuberculosis DOID_399 2.891E-04 8.224E-03 2.891E-04 0.01495274 SCHLOSSER_SERUM_RESPONSE_UP bone development disease DOID_0080006 5.078E-04 0.01375763 0.01051497 0.13914001 SCHLOSSER_SERUM_RESPONSE_UP MHC class II deficiency DOID_5812 5.315E-04 0.01374627 5.315E-04 0.02520149 SCHLOSSER_SERUM_RESPONSE_UP primary bacterial infectious disease DOID_0050338 5.613E-04 0.01388555 5.613E-04 0.02456675 SCHLOSSER_SERUM_RESPONSE_UP lymphoma DOID_0060058 6.583E-04 0.0156066 0.01245982 0.16112811 SCHLOSSER_SERUM_RESPONSE_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.999E-04 0.01592916 0.01296877 0.16041811 SCHLOSSER_SERUM_RESPONSE_UP osteosarcoma DOID_3347 1.002E-03 0.02192803 0.04561949 0.29497146 SCHLOSSER_SERUM_RESPONSE_UP spinal cord disease DOID_319 1.163E-03 0.0245026 1.163E-03 0.04725501 SCHLOSSER_SERUM_RESPONSE_UP diffuse large B-cell lymphoma DOID_0050745 1.247E-03 0.02534833 0.05074947 0.30079635 SCHLOSSER_SERUM_RESPONSE_UP lung adenocarcinoma DOID_3910 1.247E-03 0.02447425 0.05074947 0.29769536 SCHLOSSER_SERUM_RESPONSE_UP multiple epiphyseal dysplasia DOID_12721 1.425E-03 0.02703384 0.05415436 0.2991634 SCHLOSSER_SERUM_RESPONSE_UP leiomyoma DOID_127 1.815E-03 0.03332128 0.06092807 0.30953636 SCHLOSSER_SERUM_RESPONSE_UP hereditary spastic paraplegia DOID_2476 1.815E-03 0.03227999 1.815E-03 0.06455998 SCHLOSSER_SERUM_RESPONSE_UP nephroblastoma DOID_2154 2.027E-03 0.03495604 2.027E-03 0.06785584 SCHLOSSER_SERUM_RESPONSE_UP spindle cell carcinoma DOID_4015 2.027E-03 0.03392792 1.000 1.000 SCHLOSSER_SERUM_RESPONSE_UP esophageal disease DOID_6050 2.027E-03 0.03295855 2.027E-03 0.06408607 SCHLOSSER_SERUM_RESPONSE_UP paraplegia DOID_607 2.027E-03 0.03204304 2.027E-03 0.06071312 SCHLOSSER_SERUM_RESPONSE_UP leukopenia DOID_615 2.027E-03 0.03117701 2.027E-03 0.05767747 SCHLOSSER_SERUM_RESPONSE_UP medullomyoblastoma DOID_3861 2.137E-03 0.03200601 2.137E-03 0.05791564 SCHLOSSER_SERUM_RESPONSE_UP adult medulloblastoma DOID_3864 2.137E-03 0.03200601 2.137E-03 0.05791564 SCHLOSSER_SERUM_RESPONSE_UP childhood medulloblastoma DOID_3869 2.137E-03 0.03200601 2.137E-03 0.05791564 SCHLOSSER_SERUM_RESPONSE_UP respiratory syncytial virus infectious disease DOID_1273 2.606E-03 0.0380181 2.606E-03 0.06446548 SCHLOSSER_SERUM_RESPONSE_UP pulmonary emphysema DOID_9675 2.856E-03 0.04063305 0.07599465 0.34871741 SCHLOSSER_SERUM_RESPONSE_UP autoimmune disease of urogenital tract DOID_0060049 2.986E-03 0.04143792 2.986E-03 0.06534442 SCHLOSSER_SERUM_RESPONSE_UP primary biliary cirrhosis DOID_12236 2.986E-03 0.04143792 2.986E-03 0.06534442 SCHLOSSER_SERUM_RESPONSE_UP idiopathic generalized epilepsy DOID_1827 3.118E-03 0.04224118 3.118E-03 0.06570851 SCHLOSSER_SERUM_RESPONSE_UP gallbladder cancer DOID_3121 3.253E-03 0.04304282 0.08096372 0.35711906 SCHLOSSER_SERUM_RESPONSE_UP integumentary system benign neoplasm DOID_0060121 3.967E-03 0.05130119 3.967E-03 0.08061616 SCHLOSSER_SERUM_RESPONSE_UP skin benign neoplasm DOID_3165 3.967E-03 0.05130119 3.967E-03 0.08061616 SCHLOSSER_SERUM_RESPONSE_UP movement disease DOID_480 4.118E-03 0.05206815 4.118E-03 0.08079541 SCHLOSSER_SERUM_RESPONSE_UP B-cell lymphocytic neoplasm DOID_707 4.271E-03 0.05283432 0.09245606 0.37576783 SCHLOSSER_SERUM_RESPONSE_UP bone marrow cancer DOID_4960 4.747E-03 0.05747334 1.000 1.000 SCHLOSSER_SERUM_RESPONSE_UP integumentary system cancer DOID_0060122 4.911E-03 0.05821866 4.911E-03 0.08732799 SCHLOSSER_SERUM_RESPONSE_UP osteochondrodysplasia DOID_2256 4.911E-03 0.05703052 0.09895941 0.39376156 SCHLOSSER_SERUM_RESPONSE_UP skin cancer DOID_4159 4.911E-03 0.05821866 4.911E-03 0.08732799 SCHLOSSER_SERUM_RESPONSE_UP melancholia DOID_2848 5.593E-03 0.06364281 5.593E-03 0.09359237 SCHLOSSER_SERUM_RESPONSE_UP leukocyte disease DOID_9500 5.593E-03 0.06239491 5.593E-03 0.0909183 SCHLOSSER_SERUM_RESPONSE_UP neurotic disorder DOID_4964 5.769E-03 0.0631286 5.769E-03 0.09118576 SCHLOSSER_SERUM_RESPONSE_UP cholestasis DOID_13580 6.691E-03 0.07182961 0.11501758 0.43341061 SCHLOSSER_SERUM_RESPONSE_UP bile duct disease DOID_4138 7.878E-03 0.08301501 0.12451678 0.45709708 SCHLOSSER_SERUM_RESPONSE_UP biliary tract disease DOID_9741 8.085E-03 0.08364237 0.12609018 0.45990586 SCHLOSSER_SERUM_RESPONSE_UP cystic fibrosis DOID_1485 8.719E-03 0.08859199 8.719E-03 0.13055662 SCHLOSSER_SERUM_RESPONSE_UP endogenous depression DOID_1595 8.719E-03 0.08703775 8.719E-03 0.12720902 SCHLOSSER_SERUM_RESPONSE_UP electroclinical syndrome DOID_0050701 9.154E-03 0.08980228 9.154E-03 0.1302133 SCHLOSSER_SERUM_RESPONSE_UP pancreatitis DOID_4989 9.154E-03 0.08828021 0.1339155 0.47623701 SCHLOSSER_SERUM_RESPONSE_UP mental depression DOID_1596 0.01028225 0.09750999 0.01028225 0.14269754 SCHLOSSER_SERUM_RESPONSE_UP biliary tract cancer DOID_4607 0.01028225 0.09591146 0.14167177 0.49454748 SCHLOSSER_SERUM_RESPONSE_UP chronic kidney failure DOID_784 0.01028225 0.0943645 0.01028225 0.13929998 JEON_SMAD6_TARGETS_UP aneurysm disease DOID_2403 5.225E-08 2.973E-05 6.948E-06 3.953E-03 JEON_SMAD6_TARGETS_UP aortic aneurysm DOID_3627 2.074E-06 5.901E-04 2.892E-04 0.02742723 JEON_SMAD6_TARGETS_UP bone development disease DOID_0080006 8.973E-06 1.702E-03 8.973E-06 2.553E-03 JEON_SMAD6_TARGETS_UP thoracic aortic aneurysm DOID_14004 2.227E-05 3.169E-03 2.227E-05 4.225E-03 JEON_SMAD6_TARGETS_UP peptic ulcer DOID_750 1.813E-04 0.02062817 0.01975915 0.26146412 JEON_SMAD6_TARGETS_UP intracranial arterial disease DOID_13089 1.901E-04 0.01802361 1.901E-04 0.02703542 JEON_SMAD6_TARGETS_UP cerebral arterial disease DOID_3527 1.901E-04 0.01802361 1.901E-04 0.02703542 JEON_SMAD6_TARGETS_UP heart valve disease DOID_4079 2.573E-04 0.02091647 2.573E-04 0.02928306 JEON_SMAD6_TARGETS_UP glaucoma DOID_1686 2.784E-04 0.01979975 0.02440906 0.27777508 JEON_SMAD6_TARGETS_UP osteochondrodysplasia DOID_2256 3.464E-04 0.02190301 3.464E-04 0.02816101 JEON_SMAD6_TARGETS_UP parasitic protozoa infectious disease DOID_2789 3.464E-04 0.01971271 1.000 1.000 JEON_SMAD6_TARGETS_UP cholestasis DOID_13580 4.761E-04 0.02462711 1.000 1.000 JEON_SMAD6_TARGETS_UP parasitic infectious disease DOID_1398 4.761E-04 0.02257485 1.000 1.000 JEON_SMAD6_TARGETS_UP nephrosis DOID_2527 5.635E-04 0.02466614 1.000 1.000 JEON_SMAD6_TARGETS_UP bile duct disease DOID_4138 5.635E-04 0.02290427 1.000 1.000 JEON_SMAD6_TARGETS_UP biliary tract disease DOID_9741 5.788E-04 0.02195682 1.000 1.000 JEON_SMAD6_TARGETS_UP transitional cell carcinoma DOID_2671 8.319E-04 0.02958349 0.04188941 0.33570528 LEE_NEURAL_CREST_STEM_CELL_UP uterine cancer DOID_363 2.366E-09 1.346E-06 1.392E-07 3.96E-05 LEE_NEURAL_CREST_STEM_CELL_UP atrophic muscular disease DOID_913 7.023E-09 1.998E-06 3.403E-07 6.455E-05 LEE_NEURAL_CREST_STEM_CELL_UP muscular dystrophy DOID_9884 7.023E-09 1.998E-06 3.403E-07 6.455E-05 LEE_NEURAL_CREST_STEM_CELL_UP Ehlers-Danlos syndrome DOID_13359 5.378E-08 1.02E-05 5.378E-08 3.06E-05 LEE_NEURAL_CREST_STEM_CELL_UP hypothyroidism DOID_1459 7.227E-07 1.028E-04 2.419E-05 1.529E-03 LEE_NEURAL_CREST_STEM_CELL_UP endometrial carcinoma DOID_2871 1.37E-06 1.56E-04 7.631E-05 3.101E-03 LEE_NEURAL_CREST_STEM_CELL_UP endometrial cancer DOID_1380 1.76E-06 1.669E-04 9.172E-05 3.262E-03 LEE_NEURAL_CREST_STEM_CELL_UP facioscapulohumeral muscular dystrophy DOID_11727 1.923E-06 1.563E-04 1.923E-06 2.736E-04 LEE_NEURAL_CREST_STEM_CELL_UP electroclinical syndrome DOID_0050701 2.041E-06 1.451E-04 5.487E-05 2.401E-03 LEE_NEURAL_CREST_STEM_CELL_UP neonatoal period electroclinical syndrome DOID_0050702 3.513E-06 2.221E-04 3.513E-06 3.998E-04 LEE_NEURAL_CREST_STEM_CELL_UP alcohol-related neurodevelopmental disorder DOID_0050667 5.023E-06 2.858E-04 1.117E-04 3.738E-03 LEE_NEURAL_CREST_STEM_CELL_UP tethered spinal cord syndrome DOID_1089 5.791E-06 2.995E-04 5.791E-06 5.491E-04 LEE_NEURAL_CREST_STEM_CELL_UP colonic disease DOID_5353 1.793E-05 8.504E-04 1.793E-05 1.458E-03 LEE_NEURAL_CREST_STEM_CELL_UP collagen disease DOID_854 2.274E-05 9.954E-04 2.274E-05 1.618E-03 LEE_NEURAL_CREST_STEM_CELL_UP congenital heart defect DOID_1682 2.57E-05 1.044E-03 2.57E-05 1.462E-03 LEE_NEURAL_CREST_STEM_CELL_UP muscle cancer DOID_4045 2.771E-05 1.051E-03 2.771E-05 1.433E-03 LEE_NEURAL_CREST_STEM_CELL_UP spinal cord disease DOID_319 5.078E-05 1.806E-03 5.078E-05 2.408E-03 LEE_NEURAL_CREST_STEM_CELL_UP Charcot-Marie-Tooth disease DOID_10595 9.172E-05 3.07E-03 9.172E-05 3.479E-03 LEE_NEURAL_CREST_STEM_CELL_UP nervous system cancer DOID_3093 9.468E-05 2.993E-03 0.02336291 0.1641172 LEE_NEURAL_CREST_STEM_CELL_UP autonomic nervous system neoplasm DOID_2621 1.001E-04 2.999E-03 3.649E-03 0.03774852 LEE_NEURAL_CREST_STEM_CELL_UP neuroblastoma DOID_769 1.001E-04 2.999E-03 3.649E-03 0.03774852 LEE_NEURAL_CREST_STEM_CELL_UP encephalomyelitis DOID_640 1.072E-04 3.051E-03 1.895E-03 0.02507908 LEE_NEURAL_CREST_STEM_CELL_UP peripheral nervous system neoplasm DOID_1192 1.613E-04 4.37E-03 4.979E-03 0.04801535 LEE_NEURAL_CREST_STEM_CELL_UP congenital diaphragmatic hernia DOID_3827 1.734E-04 4.484E-03 1.734E-04 5.48E-03 LEE_NEURAL_CREST_STEM_CELL_UP benign mesothelioma DOID_2645 1.993E-04 4.93E-03 5.715E-03 0.05331111 LEE_NEURAL_CREST_STEM_CELL_UP Huntington's disease DOID_12858 2.276E-04 5.395E-03 6.232E-03 0.05628798 LEE_NEURAL_CREST_STEM_CELL_UP neuritis DOID_1803 2.916E-04 6.638E-03 2.916E-04 8.734E-03 LEE_NEURAL_CREST_STEM_CELL_UP heart valve disease DOID_4079 2.916E-04 6.383E-03 7.328E-03 0.06222971 LEE_NEURAL_CREST_STEM_CELL_UP movement disease DOID_480 3.466E-04 7.305E-03 8.202E-03 0.06863076 LEE_NEURAL_CREST_STEM_CELL_UP orofacial cleft DOID_0050567 3.868E-04 7.86E-03 3.868E-04 0.01100377 LEE_NEURAL_CREST_STEM_CELL_UP parasitic protozoa infectious disease DOID_2789 4.524E-04 8.876E-03 0.13817439 0.41162946 LEE_NEURAL_CREST_STEM_CELL_UP familial hyperlipidemia DOID_1168 4.757E-04 9.023E-03 0.01008333 0.08196306 LEE_NEURAL_CREST_STEM_CELL_UP infancy electroclinical syndrome DOID_0050703 4.962E-04 9.107E-03 4.962E-04 0.01344408 LEE_NEURAL_CREST_STEM_CELL_UP Hirschsprung's disease DOID_10487 4.962E-04 8.823E-03 4.962E-04 0.01283299 LEE_NEURAL_CREST_STEM_CELL_UP epilepsy with generalized tonic-clonic seizures DOID_7725 4.962E-04 8.555E-03 0.03276135 0.17753531 LEE_NEURAL_CREST_STEM_CELL_UP melancholia DOID_2848 5.504E-04 9.211E-03 5.504E-04 0.01361626 LEE_NEURAL_CREST_STEM_CELL_UP neurotic disorder DOID_4964 5.768E-04 9.378E-03 5.768E-04 0.01367604 LEE_NEURAL_CREST_STEM_CELL_UP megacolon DOID_11372 5.779E-04 9.134E-03 5.779E-04 0.01315324 LEE_NEURAL_CREST_STEM_CELL_UP rhabdomyosarcoma DOID_3247 5.779E-04 8.887E-03 5.779E-04 0.01264734 LEE_NEURAL_CREST_STEM_CELL_UP neuroectodermal tumor DOID_171 6.041E-04 9.046E-03 6.041E-04 0.01273077 LEE_NEURAL_CREST_STEM_CELL_UP pre-malignant neoplasm DOID_0060071 6.61E-04 9.644E-03 6.61E-04 0.01343318 LEE_NEURAL_CREST_STEM_CELL_UP in situ carcinoma DOID_8719 6.61E-04 9.644E-03 6.61E-04 0.01343318 LEE_NEURAL_CREST_STEM_CELL_UP communication disorder DOID_2033 6.657E-04 9.47E-03 6.657E-04 0.01306165 LEE_NEURAL_CREST_STEM_CELL_UP corneal dystrophy DOID_2566 6.657E-04 9.239E-03 6.657E-04 0.01262626 LEE_NEURAL_CREST_STEM_CELL_UP skeletal muscle cancer DOID_4043 6.657E-04 9.019E-03 6.657E-04 0.01221896 LEE_NEURAL_CREST_STEM_CELL_UP varicose veins DOID_799 6.657E-04 8.809E-03 6.657E-04 0.01183712 LEE_NEURAL_CREST_STEM_CELL_UP hyperhomocysteinemia DOID_9279 6.657E-04 8.609E-03 0.03770638 0.1950448 LEE_NEURAL_CREST_STEM_CELL_UP parasitic infectious disease DOID_1398 7.213E-04 9.12E-03 0.16000868 0.45982294 LEE_NEURAL_CREST_STEM_CELL_UP vein disease DOID_866 7.595E-04 9.395E-03 7.595E-04 0.01309633 LEE_NEURAL_CREST_STEM_CELL_UP ureteral obstruction DOID_5199 9.652E-04 0.01168497 9.652E-04 0.01615275 LEE_NEURAL_CREST_STEM_CELL_UP endogenous depression DOID_1595 1.075E-03 0.01274166 1.075E-03 0.01747428 LEE_NEURAL_CREST_STEM_CELL_UP syndrome DOID_225 1.075E-03 0.01248163 1.075E-03 0.01698888 LEE_NEURAL_CREST_STEM_CELL_UP aneurysm disease DOID_2403 1.115E-03 0.01269138 0.01756743 0.13152455 LEE_NEURAL_CREST_STEM_CELL_UP pancreatitis DOID_4989 1.157E-03 0.01290345 1.157E-03 0.01778584 LEE_NEURAL_CREST_STEM_CELL_UP lipid metabolism disorder DOID_3146 1.242E-03 0.01359084 0.01884255 0.13923909 LEE_NEURAL_CREST_STEM_CELL_UP chromosomal disease DOID_0080014 1.286E-03 0.01380894 1.286E-03 0.01925983 LEE_NEURAL_CREST_STEM_CELL_UP coronary restenosis DOID_4247 1.318E-03 0.01388955 1.000 1.000 LEE_NEURAL_CREST_STEM_CELL_UP mental depression DOID_1596 1.378E-03 0.0142518 1.378E-03 0.02009869 LEE_NEURAL_CREST_STEM_CELL_UP focal epilepsy DOID_2234 1.378E-03 0.0139973 1.378E-03 0.01959622 LEE_NEURAL_CREST_STEM_CELL_UP urinary tract obstruction DOID_5200 1.583E-03 0.01580015 1.583E-03 0.02196607 LEE_NEURAL_CREST_STEM_CELL_UP amino acid metabolic disorder DOID_9252 1.676E-03 0.01643973 0.0228926 0.16282365 LEE_NEURAL_CREST_STEM_CELL_UP ureteral disease DOID_1426 1.724E-03 0.01662453 1.724E-03 0.02335351 LEE_NEURAL_CREST_STEM_CELL_UP dilated cardiomyopathy DOID_12930 2.011E-03 0.0190748 2.011E-03 0.02601109 LEE_NEURAL_CREST_STEM_CELL_UP cleft lip DOID_9296 2.181E-03 0.02034702 2.181E-03 0.02758151 LEE_NEURAL_CREST_STEM_CELL_UP intracranial aneurysm DOID_10941 2.345E-03 0.0215229 2.345E-03 0.02900913 LEE_NEURAL_CREST_STEM_CELL_UP fragments of torsion dystonia DOID_531 2.345E-03 0.02118127 0.0692447 0.27552612 LEE_NEURAL_CREST_STEM_CELL_UP Sciatic Neuropathy DOID_11446 2.515E-03 0.02235755 2.515E-03 0.03044432 LEE_NEURAL_CREST_STEM_CELL_UP lesion of sciatic nerve DOID_12528 2.515E-03 0.02235755 2.515E-03 0.03044432 LEE_NEURAL_CREST_STEM_CELL_UP migraine DOID_6364 2.515E-03 0.02201359 2.515E-03 0.02981007 LEE_NEURAL_CREST_STEM_CELL_UP mononeuritis of lower limb DOID_9473 2.515E-03 0.02235755 2.515E-03 0.03044432 LEE_NEURAL_CREST_STEM_CELL_UP pleurisy DOID_10247 2.69E-03 0.02319002 2.69E-03 0.03123553 LEE_NEURAL_CREST_STEM_CELL_UP malaria DOID_12365 2.69E-03 0.0228439 0.07400509 0.28841709 LEE_NEURAL_CREST_STEM_CELL_UP mononeuritis DOID_1802 2.69E-03 0.02250796 2.69E-03 0.03061082 LEE_NEURAL_CREST_STEM_CELL_UP coronary stenosis DOID_4248 2.69E-03 0.02218176 1.000 1.000 LEE_NEURAL_CREST_STEM_CELL_UP central nervous system hereditary degenerative disease DOID_481 2.69E-03 0.02186487 0.07400509 0.28072597 LEE_NEURAL_CREST_STEM_CELL_UP polycystic ovary syndrome DOID_11612 2.871E-03 0.02300531 2.871E-03 0.032027 LEE_NEURAL_CREST_STEM_CELL_UP mononeuropathy DOID_1188 2.871E-03 0.02268579 2.871E-03 0.03141109 LEE_NEURAL_CREST_STEM_CELL_UP dystonic disease DOID_544 2.871E-03 0.02237503 0.07637624 0.28780185 LEE_NEURAL_CREST_STEM_CELL_UP corneal disease DOID_10124 3.057E-03 0.02350505 3.057E-03 0.03281838 LEE_NEURAL_CREST_STEM_CELL_UP pleural disease DOID_1532 3.649E-03 0.02768225 3.649E-03 0.03844757 LEE_NEURAL_CREST_STEM_CELL_UP medullomyoblastoma DOID_3861 4.29E-03 0.03211612 4.29E-03 0.04358616 LEE_NEURAL_CREST_STEM_CELL_UP adult medulloblastoma DOID_3864 4.29E-03 0.03211612 4.29E-03 0.04358616 LEE_NEURAL_CREST_STEM_CELL_UP childhood medulloblastoma DOID_3869 4.29E-03 0.03211612 4.29E-03 0.04358616 LEE_NEURAL_CREST_STEM_CELL_UP adolescence-adult electroclinical syndrome DOID_0050705 4.744E-03 0.03505444 0.09744797 0.33004698 LEE_NEURAL_CREST_STEM_CELL_UP medulloblastoma DOID_3858 4.744E-03 0.03460502 4.744E-03 0.04735424 LEE_NEURAL_CREST_STEM_CELL_UP cleft palate DOID_674 4.744E-03 0.03416698 4.744E-03 0.04653779 LEE_NEURAL_CREST_STEM_CELL_UP hepatitis DOID_2237 5.219E-03 0.03712023 0.10206557 0.33764714 LEE_NEURAL_CREST_STEM_CELL_UP peptic ulcer DOID_750 5.219E-03 0.03666195 5.219E-03 0.04949364 LEE_NEURAL_CREST_STEM_CELL_UP cervix uteri carcinoma in situ DOID_8991 5.715E-03 0.03965826 5.715E-03 0.05245125 LEE_NEURAL_CREST_STEM_CELL_UP primitive neuroectodermal tumor DOID_168 6.232E-03 0.04272461 6.232E-03 0.05540848 LEE_NEURAL_CREST_STEM_CELL_UP diabetic autonomic neuropathy DOID_11503 6.498E-03 0.04401921 6.498E-03 0.05688636 LEE_NEURAL_CREST_STEM_CELL_UP autonomic neuropathy DOID_11504 6.498E-03 0.04401921 6.498E-03 0.05688636 LEE_NEURAL_CREST_STEM_CELL_UP diabetic polyneuropathy DOID_12785 6.498E-03 0.04401921 6.498E-03 0.05688636 LEE_NEURAL_CREST_STEM_CELL_UP diabetic neuropathy DOID_9743 6.498E-03 0.04401921 6.498E-03 0.05688636 LEE_NEURAL_CREST_STEM_CELL_UP autonomic nervous system disease DOID_11465 7.328E-03 0.04905166 7.328E-03 0.06317259 LEE_NEURAL_CREST_STEM_CELL_UP withdrawal disorder DOID_0060001 8.503E-03 0.05626011 8.503E-03 0.0701213 LEE_NEURAL_CREST_STEM_CELL_UP giant cell tumor DOID_200 9.121E-03 0.05965175 0.1337406 0.40477872 LEE_NEURAL_CREST_STEM_CELL_UP malignant giant cell tumor DOID_2705 9.121E-03 0.05965175 0.1337406 0.40477872 LEE_NEURAL_CREST_STEM_CELL_UP giant cell glioblastoma DOID_3074 9.121E-03 0.05965175 0.1337406 0.40477872 LEE_NEURAL_CREST_STEM_CELL_UP congenital nervous system abnormality DOID_2490 0.01041379 0.06733464 0.01041379 0.08345702 LEE_NEURAL_CREST_STEM_CELL_UP glioblastoma DOID_3068 0.01074902 0.06872124 0.144783 0.42684729 LEE_NEURAL_CREST_STEM_CELL_UP leukocyte disease DOID_9500 0.01108897 0.07010694 0.01108897 0.08763367 LEE_NEURAL_CREST_STEM_CELL_UP carotid artery disease DOID_3407 0.01178297 0.07367593 0.01178297 0.0918426 LEE_NEURAL_CREST_STEM_CELL_UP mineral metabolism disease DOID_0050032 0.01285881 0.07952896 0.15785012 0.46059857 LEE_NEURAL_CREST_STEM_CELL_UP cholestasis DOID_13580 0.01322662 0.08092414 0.16000868 0.46215706 LEE_NEURAL_CREST_STEM_CELL_UP uterine disease DOID_345 0.01322662 0.08006324 0.01322662 0.10170196 LEE_NEURAL_CREST_STEM_CELL_UP astrocytoma DOID_3069 0.01474311 0.08830344 0.1685883 0.47022914 LEE_NEURAL_CREST_STEM_CELL_UP bile duct disease DOID_4138 0.01552816 0.09203672 0.17284553 0.47511646 LEE_NEURAL_CREST_STEM_CELL_UP biliary tract disease DOID_9741 0.01592731 0.09342926 0.17496605 0.47407467 MAHADEVAN_RESPONSE_TO_MP470_DN tongue cancer DOID_8649 9.164E-06 5.214E-03 4.633E-03 1.000 MAHADEVAN_RESPONSE_TO_MP470_DN aplastic anemia DOID_12449 5.35E-05 0.01522077 0.01097217 0.62431652 MAHADEVAN_RESPONSE_TO_MP470_DN multiple myeloma DOID_9538 5.934E-05 0.01125504 0.01154661 0.50538624 MAHADEVAN_RESPONSE_TO_MP470_DN myeloma DOID_0070004 9.305E-05 0.01323617 0.01441426 0.43166914 MAHADEVAN_RESPONSE_TO_MP470_DN bone marrow disease DOID_4961 9.305E-05 0.01058894 0.01441426 0.3905578 MAHADEVAN_RESPONSE_TO_MP470_DN B-cell lymphocytic neoplasm DOID_707 1.086E-04 0.01030148 0.0155592 0.4024175 MAHADEVAN_RESPONSE_TO_MP470_DN bone marrow cancer DOID_4960 1.211E-04 9.843E-03 0.01641711 0.38922236 MAHADEVAN_RESPONSE_TO_MP470_DN oral cavity cancer DOID_8618 1.388E-04 9.869E-03 0.01755994 0.37005941 MAHADEVAN_RESPONSE_TO_MP470_DN nervous system cancer DOID_3093 3.159E-04 0.01996898 0.02637599 0.4168871 MAHADEVAN_RESPONSE_TO_MP470_DN lymphoma DOID_0060058 3.297E-04 0.01876041 0.02694228 0.41432865 BROWNE_HCMV_INFECTION_24HR_DN transitional cell carcinoma DOID_2671 2.774E-12 1.578E-09 4.46E-06 2.538E-03 BROWNE_HCMV_INFECTION_24HR_DN reproductive organ benign neoplasm DOID_0050622 1.113E-08 3.166E-06 5.091E-04 0.03621066 BROWNE_HCMV_INFECTION_24HR_DN endometrial cancer DOID_1380 3.178E-08 6.027E-06 1.034E-04 9.808E-03 BROWNE_HCMV_INFECTION_24HR_DN leiomyoma DOID_127 3.699E-08 5.262E-06 3.948E-03 0.11824539 BROWNE_HCMV_INFECTION_24HR_DN thoracic aortic aneurysm DOID_14004 6.332E-08 7.206E-06 7.214E-04 0.04560738 BROWNE_HCMV_INFECTION_24HR_DN uterine cancer DOID_363 1.704E-07 1.616E-05 2.733E-04 0.02221403 BROWNE_HCMV_INFECTION_24HR_DN neuroectodermal tumor DOID_171 8.173E-07 6.643E-05 0.01272506 0.23356638 BROWNE_HCMV_INFECTION_24HR_DN female reproductive organ benign neoplasm DOID_0060086 1.611E-06 1.146E-04 3.309E-03 0.11074136 BROWNE_HCMV_INFECTION_24HR_DN uterine benign neoplasm DOID_0060095 1.611E-06 1.146E-04 3.309E-03 0.11074136 BROWNE_HCMV_INFECTION_24HR_DN uterine fibroid DOID_13223 1.611E-06 1.146E-04 3.309E-03 0.11074136 BROWNE_HCMV_INFECTION_24HR_DN endometrial carcinoma DOID_2871 1.611E-06 1.019E-04 8.605E-05 0.01224118 BROWNE_HCMV_INFECTION_24HR_DN mixed glioma DOID_5076 2.491E-06 1.418E-04 0.19235941 0.65935243 BROWNE_HCMV_INFECTION_24HR_DN spindle cell carcinoma DOID_4015 2.929E-06 1.515E-04 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN biliary tract cancer DOID_4607 3.364E-06 1.595E-04 0.20308363 0.6757578 BROWNE_HCMV_INFECTION_24HR_DN embryonal cancer DOID_688 4.028E-06 1.763E-04 5.132E-03 0.13271971 BROWNE_HCMV_INFECTION_24HR_DN gallbladder cancer DOID_3121 7.75E-06 3.15E-04 0.11790687 0.5160693 BROWNE_HCMV_INFECTION_24HR_DN aortic aneurysm DOID_3627 1.257E-05 4.767E-04 8.864E-03 0.18013722 BROWNE_HCMV_INFECTION_24HR_DN bile duct adenocarcinoma DOID_4896 1.682E-05 5.98E-04 0.14115848 0.55013135 BROWNE_HCMV_INFECTION_24HR_DN cholangiocarcinoma DOID_4947 1.682E-05 5.98E-04 0.14115848 0.55013135 BROWNE_HCMV_INFECTION_24HR_DN bile duct cancer DOID_4606 2.203E-05 7.375E-04 0.15028828 0.56259232 BROWNE_HCMV_INFECTION_24HR_DN bile duct carcinoma DOID_4897 2.203E-05 7.375E-04 0.15028828 0.56259232 BROWNE_HCMV_INFECTION_24HR_DN pre-malignant neoplasm DOID_0060071 3.012E-05 9.522E-04 7.435E-04 0.04230322 BROWNE_HCMV_INFECTION_24HR_DN in situ carcinoma DOID_8719 3.012E-05 9.522E-04 7.435E-04 0.04230322 BROWNE_HCMV_INFECTION_24HR_DN sexual disorder DOID_0060043 3.127E-05 9.363E-04 1.714E-03 0.0812818 BROWNE_HCMV_INFECTION_24HR_DN pancreatic ductal carcinoma DOID_3587 4.485E-05 1.276E-03 0.17710506 0.6220542 BROWNE_HCMV_INFECTION_24HR_DN pancreatic carcinoma DOID_4905 5.254E-05 1.424E-03 0.18367726 0.64118013 BROWNE_HCMV_INFECTION_24HR_DN diabetic retinopathy DOID_8947 5.254E-05 1.359E-03 5.254E-05 0.01494723 BROWNE_HCMV_INFECTION_24HR_DN dystonia DOID_543 5.728E-05 1.417E-03 5.728E-05 0.0108639 BROWNE_HCMV_INFECTION_24HR_DN aneurysm disease DOID_2403 6.115E-05 1.45E-03 0.01895254 0.28378928 BROWNE_HCMV_INFECTION_24HR_DN retinal vascular disease DOID_2462 8.913E-05 2.029E-03 8.913E-05 0.01014301 BROWNE_HCMV_INFECTION_24HR_DN medullomyoblastoma DOID_3861 1.447E-04 3.166E-03 4.641E-03 0.13203568 BROWNE_HCMV_INFECTION_24HR_DN adult medulloblastoma DOID_3864 1.447E-04 3.166E-03 4.641E-03 0.13203568 BROWNE_HCMV_INFECTION_24HR_DN childhood medulloblastoma DOID_3869 1.447E-04 3.166E-03 4.641E-03 0.13203568 BROWNE_HCMV_INFECTION_24HR_DN medulloblastoma DOID_3858 1.688E-04 3.557E-03 5.132E-03 0.1390397 BROWNE_HCMV_INFECTION_24HR_DN multiple myeloma DOID_9538 1.688E-04 3.43E-03 0.10126097 0.49245721 BROWNE_HCMV_INFECTION_24HR_DN cervix uteri carcinoma in situ DOID_8991 2.245E-04 4.405E-03 6.181E-03 0.14653462 BROWNE_HCMV_INFECTION_24HR_DN primitive neuroectodermal tumor DOID_168 2.563E-04 4.862E-03 6.739E-03 0.14747782 BROWNE_HCMV_INFECTION_24HR_DN hyperinsulinism DOID_2018 2.563E-04 4.705E-03 6.739E-03 0.14201568 BROWNE_HCMV_INFECTION_24HR_DN myeloma DOID_0070004 3.284E-04 5.84E-03 0.12494704 0.53454786 BROWNE_HCMV_INFECTION_24HR_DN lung small cell carcinoma DOID_5409 3.689E-04 6.361E-03 0.12960955 0.52677023 BROWNE_HCMV_INFECTION_24HR_DN breast benign neoplasm DOID_0060082 3.805E-04 6.368E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN thoracic benign neoplasm DOID_0060097 3.805E-04 6.368E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN nervous system benign neoplasm DOID_0060115 3.805E-04 6.186E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN benign breast phyllodes tumor DOID_1631 3.805E-04 6.368E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN giant cell tumor DOID_200 4.591E-04 7.257E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN malignant giant cell tumor DOID_2705 4.591E-04 7.257E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN giant cell glioblastoma DOID_3074 4.591E-04 7.257E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN atrophic muscular disease DOID_913 4.591E-04 7.061E-03 9.855E-03 0.19336968 BROWNE_HCMV_INFECTION_24HR_DN muscular dystrophy DOID_9884 4.591E-04 7.061E-03 9.855E-03 0.19336968 BROWNE_HCMV_INFECTION_24HR_DN bone marrow cancer DOID_4960 4.837E-04 7.243E-03 0.14115848 0.54638896 BROWNE_HCMV_INFECTION_24HR_DN glioblastoma DOID_3068 5.904E-04 8.614E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN leukocyte disease DOID_9500 6.192E-04 8.808E-03 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN skeletal system cancer DOID_0060124 7.214E-04 0.01001138 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN bone cancer DOID_184 7.214E-04 0.01001138 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN intermediate coronary syndrome DOID_8805 7.214E-04 9.773E-03 0.03923241 0.33823095 BROWNE_HCMV_INFECTION_24HR_DN endocrine pancreas disease DOID_1428 7.768E-04 0.01027928 0.01388406 0.24687593 BROWNE_HCMV_INFECTION_24HR_DN methylmalonic acidemia DOID_14749 9.311E-04 0.01204107 9.311E-04 0.04816428 BROWNE_HCMV_INFECTION_24HR_DN astrocytoma DOID_3069 9.578E-04 0.01211133 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN nephrosis DOID_2527 1.037E-03 0.01282839 0.01675821 0.27244055 BROWNE_HCMV_INFECTION_24HR_DN neuroendocrine tumor DOID_169 1.046E-03 0.01265954 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN peripheral vascular disease DOID_341 1.078E-03 0.01278148 0.01718779 0.27166264 BROWNE_HCMV_INFECTION_24HR_DN testicular cancer DOID_2998 1.167E-03 0.01354784 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN chromosomal disease DOID_0080014 1.445E-03 0.01644096 0.19881096 0.6733538 BROWNE_HCMV_INFECTION_24HR_DN amino acid metabolic disorder DOID_9252 1.881E-03 0.02098668 1.881E-03 0.08233235 BROWNE_HCMV_INFECTION_24HR_DN nervous system cancer DOID_3093 1.941E-03 0.02123605 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN organic acidemia DOID_0060159 2.191E-03 0.02351804 2.191E-03 0.0890326 BROWNE_HCMV_INFECTION_24HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.191E-03 0.02308856 2.191E-03 0.08311881 BROWNE_HCMV_INFECTION_24HR_DN mouth disease DOID_403 2.191E-03 0.02266877 0.22618313 0.74392025 BROWNE_HCMV_INFECTION_24HR_DN dilated cardiomyopathy DOID_12930 2.257E-03 0.02293044 0.0277717 0.32249179 BROWNE_HCMV_INFECTION_24HR_DN morbid obesity DOID_11981 2.362E-03 0.02357615 2.362E-03 0.08399002 BROWNE_HCMV_INFECTION_24HR_DN sarcoma DOID_1115 2.912E-03 0.0285656 0.07694029 0.43779024 BROWNE_HCMV_INFECTION_24HR_DN invasive ductal carcinoma DOID_3008 2.912E-03 0.02808143 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN dysostosis DOID_1934 3.309E-03 0.03137672 3.309E-03 0.10458906 BROWNE_HCMV_INFECTION_24HR_DN refractive error DOID_9835 4.883E-03 0.04555154 0.09885774 0.49342151 BROWNE_HCMV_INFECTION_24HR_DN cleft palate DOID_674 5.132E-03 0.04709409 0.10126097 0.49670253 BROWNE_HCMV_INFECTION_24HR_DN hepatitis DOID_2237 5.645E-03 0.05098286 0.10604843 0.49869053 BROWNE_HCMV_INFECTION_24HR_DN benign mesothelioma DOID_2645 6.181E-03 0.05495048 6.181E-03 0.15290569 BROWNE_HCMV_INFECTION_24HR_DN salivary gland cancer DOID_8850 6.457E-03 0.05652386 0.1131823 0.50709235 BROWNE_HCMV_INFECTION_24HR_DN Huntington's disease DOID_12858 6.739E-03 0.05809732 6.739E-03 0.15337693 BROWNE_HCMV_INFECTION_24HR_DN brain cancer DOID_1319 7.921E-03 0.06727002 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN neuritis DOID_1803 7.921E-03 0.06628075 0.12494704 0.52275636 BROWNE_HCMV_INFECTION_24HR_DN heart valve disease DOID_4079 7.921E-03 0.06532016 0.12494704 0.51894062 BROWNE_HCMV_INFECTION_24HR_DN central nervous system cancer DOID_3620 8.23E-03 0.06689951 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN glaucoma DOID_1686 8.545E-03 0.0684773 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN orofacial cleft DOID_0050567 9.52E-03 0.07523299 0.13655723 0.5358694 BROWNE_HCMV_INFECTION_24HR_DN integumentary system cancer DOID_0060122 0.01054215 0.08217102 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN skin cancer DOID_4159 0.01054215 0.08217102 1.000 1.000 BROWNE_HCMV_INFECTION_24HR_DN congenital nervous system abnormality DOID_2490 0.0112495 0.08649956 0.0112495 0.21336558 BROWNE_HCMV_INFECTION_24HR_DN hypertrophic cardiomyopathy DOID_11984 0.01161083 0.08808749 0.15028828 0.5663181 BROWNE_HCMV_INFECTION_24HR_DN oral cavity cancer DOID_8618 0.01161083 0.08692844 0.15028828 0.55891525 BROWNE_HCMV_INFECTION_24HR_DN carotid artery disease DOID_3407 0.01272506 0.09403322 0.15707251 0.58035233 BROWNE_HCMV_INFECTION_24HR_DN collagen disease DOID_854 0.01272506 0.09282766 0.15707251 0.57660812 LEE_DIFFERENTIATING_T_LYMPHOCYTE primary immunodeficiency disease DOID_612 1.672E-09 9.511E-07 1.672E-09 9.511E-07 LEE_DIFFERENTIATING_T_LYMPHOCYTE lymphoma DOID_0060058 2.102E-09 5.981E-07 7.92E-08 2.253E-05 LEE_DIFFERENTIATING_T_LYMPHOCYTE MHC class II deficiency DOID_5812 9.319E-08 1.768E-05 9.319E-08 1.768E-05 LEE_DIFFERENTIATING_T_LYMPHOCYTE severe combined immunodeficiency DOID_627 3.01E-07 4.282E-05 3.01E-07 4.282E-05 LEE_DIFFERENTIATING_T_LYMPHOCYTE combined T cell and B cell immunodeficiency DOID_628 3.551E-07 4.041E-05 3.551E-07 4.041E-05 LEE_DIFFERENTIATING_T_LYMPHOCYTE vitiligo DOID_12306 4.847E-07 4.596E-05 4.847E-07 4.596E-05 LEE_DIFFERENTIATING_T_LYMPHOCYTE contact dermatitis DOID_2773 3.772E-05 3.066E-03 3.772E-05 3.066E-03 LEE_DIFFERENTIATING_T_LYMPHOCYTE celiac disease DOID_10608 6.41E-05 4.559E-03 6.41E-05 4.559E-03 LEE_DIFFERENTIATING_T_LYMPHOCYTE ulcerative colitis DOID_8577 8.197E-05 5.182E-03 8.197E-05 5.182E-03 LEE_DIFFERENTIATING_T_LYMPHOCYTE autoimmune disease of gastrointestinal tract DOID_0060031 2.298E-04 0.01307799 2.298E-04 0.01307799 LEE_DIFFERENTIATING_T_LYMPHOCYTE integumentary system benign neoplasm DOID_0060121 2.298E-04 0.01188908 2.298E-04 0.01188908 LEE_DIFFERENTIATING_T_LYMPHOCYTE skin benign neoplasm DOID_3165 2.298E-04 0.01188908 2.298E-04 0.01188908 LEE_DIFFERENTIATING_T_LYMPHOCYTE leukocyte disease DOID_9500 3.869E-04 0.01834787 3.869E-04 0.01834787 LEE_DIFFERENTIATING_T_LYMPHOCYTE uterine disease DOID_345 5.078E-04 0.02222387 5.078E-04 0.02222387 LEE_DIFFERENTIATING_T_LYMPHOCYTE allergic contact dermatitis DOID_3042 5.528E-04 0.02246696 5.528E-04 0.02246696 LEE_DIFFERENTIATING_T_LYMPHOCYTE nephrosis DOID_2527 6.504E-04 0.02467032 0.01235865 0.1496186 LEE_DIFFERENTIATING_T_LYMPHOCYTE pancreatitis DOID_4989 8.163E-04 0.02902797 8.163E-04 0.03096316 LEE_DIFFERENTIATING_T_LYMPHOCYTE conduct disorder DOID_12995 8.482E-04 0.02838951 8.482E-04 0.03016385 LEE_DIFFERENTIATING_T_LYMPHOCYTE agammaglobulinemia DOID_2583 8.482E-04 0.02681231 8.482E-04 0.02838951 LEE_DIFFERENTIATING_T_LYMPHOCYTE female reproductive system disease DOID_229 9.084E-04 0.02720333 9.084E-04 0.02871463 LEE_DIFFERENTIATING_T_LYMPHOCYTE blood protein disease DOID_620 9.41E-04 0.02677282 9.41E-04 0.02818191 LEE_DIFFERENTIATING_T_LYMPHOCYTE dilated cardiomyopathy DOID_12930 1.425E-03 0.03860397 1.425E-03 0.04053417 LEE_DIFFERENTIATING_T_LYMPHOCYTE B cell deficiency DOID_2115 1.85E-03 0.04785438 1.85E-03 0.05013316 LEE_DIFFERENTIATING_T_LYMPHOCYTE autoimmune disease of endocrine system DOID_0060005 2.266E-03 0.05606093 2.266E-03 0.05860915 LEE_DIFFERENTIATING_T_LYMPHOCYTE leukopenia DOID_615 3.217E-03 0.07627219 3.217E-03 0.07958837 LEE_DIFFERENTIATING_T_LYMPHOCYTE lymphoid leukemia DOID_10747 3.391E-03 0.07717564 3.391E-03 0.0803913 LEE_DIFFERENTIATING_T_LYMPHOCYTE medullomyoblastoma DOID_3861 3.391E-03 0.07420735 3.391E-03 0.07717564 LEE_DIFFERENTIATING_T_LYMPHOCYTE adult medulloblastoma DOID_3864 3.391E-03 0.07420735 3.391E-03 0.07717564 LEE_DIFFERENTIATING_T_LYMPHOCYTE childhood medulloblastoma DOID_3869 3.391E-03 0.07420735 3.391E-03 0.07717564 LEE_DIFFERENTIATING_T_LYMPHOCYTE medulloblastoma DOID_3858 3.751E-03 0.07905322 3.751E-03 0.08209372 LEE_DIFFERENTIATING_T_LYMPHOCYTE multiple myeloma DOID_9538 3.751E-03 0.07622989 3.751E-03 0.07905322 LEE_DIFFERENTIATING_T_LYMPHOCYTE peripheral nervous system neoplasm DOID_1192 3.938E-03 0.07726212 3.938E-03 0.08002148 LEE_DIFFERENTIATING_T_LYMPHOCYTE autoimmune disease of urogenital tract DOID_0060049 4.726E-03 0.08964249 4.726E-03 0.09273361 LEE_DIFFERENTIATING_T_LYMPHOCYTE primary biliary cirrhosis DOID_12236 4.726E-03 0.08964249 4.726E-03 0.09273361 LEE_DIFFERENTIATING_T_LYMPHOCYTE endometriosis of uterus DOID_288 4.726E-03 0.0867508 4.726E-03 0.08964249 LEE_DIFFERENTIATING_T_LYMPHOCYTE primitive neuroectodermal tumor DOID_168 4.934E-03 0.08773097 4.934E-03 0.090561 LEE_DIFFERENTIATING_T_LYMPHOCYTE hyperinsulinism DOID_2018 4.934E-03 0.08507246 4.934E-03 0.08773097 LEE_DIFFERENTIATING_T_LYMPHOCYTE endometriosis DOID_289 4.934E-03 0.08257033 4.934E-03 0.08507246 LEE_DIFFERENTIATING_T_LYMPHOCYTE uterine cancer DOID_363 5.146E-03 0.08365327 5.146E-03 0.08611366 LEE_DIFFERENTIATING_T_LYMPHOCYTE leukodystrophy DOID_10579 5.581E-03 0.08821771 0.10537615 0.49146746 LEE_DIFFERENTIATING_T_LYMPHOCYTE myeloma DOID_0070004 5.805E-03 0.0892788 5.805E-03 0.09438044 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN bone development disease DOID_0080006 1.163E-07 6.617E-05 1.163E-07 6.617E-05 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN allergic rhinitis DOID_4481 7.435E-07 2.115E-04 0.01778917 0.59541384 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN intracranial arterial disease DOID_13089 1.529E-06 2.899E-04 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN cerebral arterial disease DOID_3527 1.529E-06 2.899E-04 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.187E-05 1.688E-03 5.264E-03 0.49916764 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.187E-05 1.688E-03 5.264E-03 0.49916764 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN Hodgkin's granuloma DOID_8651 1.187E-05 1.688E-03 5.264E-03 0.49916764 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 1.187E-05 1.688E-03 5.264E-03 0.49916764 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN Hodgkin's lymphoma DOID_8567 1.74E-05 1.98E-03 6.313E-03 0.39913412 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN hypersensitivity reaction type I disease DOID_1205 1.793E-05 1.701E-03 0.04995974 0.8122027 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN larynx cancer DOID_2596 2.055E-05 1.671E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN laryngeal benign neoplasm DOID_2598 2.055E-05 1.671E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN synostosis DOID_11971 7.247E-05 5.154E-03 7.247E-05 0.02061729 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN middle cerebral artery infarction DOID_3525 9.912E-05 6.267E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN lung adenocarcinoma DOID_3910 1.064E-04 6.056E-03 0.0151921 0.54026906 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN periodontitis DOID_824 1.064E-04 5.506E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN polycystic ovary syndrome DOID_11612 1.218E-04 5.776E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN multiple epiphyseal dysplasia DOID_12721 1.218E-04 5.332E-03 1.218E-04 0.02310587 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN dystonic disease DOID_544 1.218E-04 4.951E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN female reproductive organ benign neoplasm DOID_0060086 1.299E-04 4.928E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN uterine benign neoplasm DOID_0060095 1.299E-04 4.928E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN uterine fibroid DOID_13223 1.299E-04 4.928E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN dysostosis DOID_1934 1.299E-04 4.62E-03 1.299E-04 0.01847884 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN leiomyoma DOID_127 1.557E-04 5.211E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN myocarditis DOID_820 1.648E-04 5.209E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN periodontal disease DOID_3388 1.742E-04 5.215E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN pulmonary emphysema DOID_9675 2.468E-04 7.022E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN endometriosis of uterus DOID_288 2.582E-04 6.997E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN endometriosis DOID_289 2.699E-04 6.98E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN gallbladder cancer DOID_3121 2.818E-04 6.971E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN cerebral infarction DOID_3526 2.939E-04 6.969E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN learning disability DOID_8927 2.939E-04 6.69E-03 0.02502638 0.6191309 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN glaucoma DOID_1686 3.451E-04 7.552E-03 0.02708483 0.61645081 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN movement disease DOID_480 3.585E-04 7.555E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN bile duct adenocarcinoma DOID_4896 4.147E-04 8.427E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN cholangiocarcinoma DOID_4947 4.147E-04 8.427E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN reproductive organ benign neoplasm DOID_0050622 4.294E-04 8.425E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN osteochondrodysplasia DOID_2256 4.294E-04 8.144E-03 4.294E-04 0.04886345 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN bile duct cancer DOID_4606 4.749E-04 8.717E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN bile duct carcinoma DOID_4897 4.749E-04 8.717E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN carotid artery disease DOID_3407 5.227E-04 9.294E-03 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN uterine disease DOID_345 5.899E-04 0.01017063 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN tooth disease DOID_1091 6.249E-04 0.01045855 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN brain infarction DOID_3454 6.429E-04 0.01045092 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN astrocytoma DOID_3069 6.61E-04 0.01044761 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN pancreatic ductal carcinoma DOID_3587 6.794E-04 0.01044829 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN pancreatic carcinoma DOID_4905 7.361E-04 0.01102226 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN syndrome DOID_225 7.751E-04 0.01130904 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN female reproductive system disease DOID_229 8.77E-04 0.01247528 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN biliary tract cancer DOID_4607 9.195E-04 0.01276022 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN lymphoma DOID_0060058 1.123E-03 0.01520793 0.04845079 0.83540901 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN mouth disease DOID_403 1.17E-03 0.01548676 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN interstitial nephritis DOID_1063 5.264E-03 0.06806831 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN progressive muscular atrophy DOID_318 5.264E-03 0.06655569 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN conjunctival disease DOID_4251 5.264E-03 0.06510882 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN labyrinthine disease DOID_4539 5.264E-03 0.06372353 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN conjunctivitis DOID_6195 5.264E-03 0.06510882 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN cutaneous leishmaniasis DOID_9111 5.264E-03 0.06239596 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN polydactyly DOID_1148 5.789E-03 0.06721799 5.789E-03 0.47052591 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN craniosynostosis DOID_2340 5.789E-03 0.06587363 5.789E-03 0.41171017 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN inner ear disease DOID_2952 5.789E-03 0.06458199 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN intracranial arteriosclerosis DOID_13097 6.313E-03 0.06908091 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN peritonitis DOID_8283 6.313E-03 0.06777749 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN vascular dementia DOID_8725 6.313E-03 0.06908091 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN ocular hypertension DOID_9282 6.313E-03 0.06652235 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN borderline glaucoma DOID_9283 6.313E-03 0.06652235 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN carotid stenosis DOID_13001 6.838E-03 0.07073788 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN open-angle glaucoma DOID_1067 7.362E-03 0.07480017 7.362E-03 0.41888097 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN eyelid disease DOID_530 7.362E-03 0.07348789 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN skeletal system cancer DOID_0060124 7.886E-03 0.07736012 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN thoracic aortic aneurysm DOID_14004 7.886E-03 0.07604893 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN bone cancer DOID_184 7.886E-03 0.07736012 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN mesenchymal cell neoplasm DOID_3350 7.886E-03 0.07478145 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN spindle cell sarcoma DOID_4235 7.886E-03 0.07478145 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN oral submucous fibrosis DOID_5773 7.886E-03 0.07355552 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN epithelioid sarcoma DOID_6193 7.886E-03 0.07478145 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN silicosis DOID_10325 8.409E-03 0.07717442 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN chronic myeloid leukemia DOID_8552 8.409E-03 0.07594943 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN drug-induced mental disorder DOID_1203 8.932E-03 0.07941551 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN drug psychosis DOID_1742 8.932E-03 0.07941551 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN Bardet-Biedl syndrome DOID_1935 8.932E-03 0.07819373 8.932E-03 0.46205386 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN substance-induced psychosis DOID_8646 8.932E-03 0.07941551 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN dissociative disorder DOID_10935 9.978E-03 0.08602577 9.978E-03 0.47314174 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN dissociative amnesia DOID_11037 9.978E-03 0.08602577 9.978E-03 0.47314174 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN conduct disorder DOID_12995 9.978E-03 0.0847418 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN testicular cancer DOID_2998 9.978E-03 0.0834956 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN leishmaniasis DOID_9065 9.978E-03 0.08228552 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN amnestic disorder DOID_10914 0.01050093 0.08535759 0.01050093 0.4596178 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN subependymal glioma DOID_4843 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN pilocytic astrocytoma DOID_4851 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN subependymal giant cell astrocytoma DOID_5077 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN fibrillary astrocytoma DOID_6726 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN juvenile pilocytic astrocytoma DOID_6811 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN childhood pilocytic astrocytoma DOID_6812 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN gemistocytic astrocytoma DOID_7005 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN childhood cerebral astrocytoma DOID_7007 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN protoplasmic astrocytoma DOID_7008 0.01050093 0.08415537 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN alopecia DOID_987 0.01050093 0.08298655 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN benign glioma DOID_0060101 0.01154525 0.08998966 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN benign ependymoma DOID_4844 0.01154525 0.08998966 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN sinusitis DOID_0050127 0.01206701 0.09278552 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN paranasal sinus disease DOID_1352 0.01206701 0.09278552 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN uremia DOID_4676 0.01206701 0.09154838 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN pulmonary embolism DOID_9477 0.01206701 0.0903438 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN lingual-facial-buccal dyskinesia DOID_9854 0.01206701 0.0891705 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN hypoglycemia DOID_9993 0.01206701 0.08802729 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN meningitis DOID_9471 0.01258851 0.09066915 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN X-linked disease DOID_0050735 0.01363073 0.09694857 0.01363073 0.55399184 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN portal hypertension DOID_10762 0.01363073 0.09575168 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN osteosarcoma DOID_3347 0.01363073 0.09458397 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN morbid obesity DOID_11981 0.01415145 0.09701414 0.01415145 0.5368116 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN spinal muscular atrophy DOID_12377 0.01415145 0.09585921 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN intracranial aneurysm DOID_10941 0.0146719 0.09821546 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN spinal cord disease DOID_319 0.0146719 0.09707342 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN hypotrichosis DOID_4535 0.0146719 0.09595763 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN fragments of torsion dystonia DOID_531 0.0146719 0.0948672 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN dystonia DOID_543 0.0146719 0.09380128 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN extrinsic allergic alveolitis DOID_841 0.0146719 0.09275904 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN gestational diabetes DOID_11714 0.0151921 0.09499236 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN renal hypertension DOID_1073 0.01571203 0.09717552 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN secondary hypertension DOID_11130 0.01571203 0.09717552 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN sarcoma DOID_1115 0.01571203 0.09613062 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN hepatic vascular disease DOID_272 0.01571203 0.09510795 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN invasive ductal carcinoma DOID_3008 0.01571203 0.09410682 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN central nervous system hereditary degenerative disease DOID_481 0.01571203 0.09312654 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN supratentorial cancer DOID_1659 0.01623171 0.09521487 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN toxic encephalopathy DOID_3602 0.01623171 0.09424329 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN cerebrum cancer DOID_368 0.01623171 0.09521487 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN focal glomerulosclerosis DOID_3945 0.01623171 0.09329133 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN gonadal disease DOID_2277 0.01727027 0.09826786 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN bronchiolitis obliterans DOID_2799 0.01727027 0.09729491 1.000 1.000 OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN abdominal aortic aneurysm DOID_7693 0.01727027 0.09634104 1.000 1.000 HALMOS_CEBPA_TARGETS_UP cystic fibrosis DOID_1485 1.54E-08 8.765E-06 1.000 1.000 HALMOS_CEBPA_TARGETS_UP pleural disease DOID_1532 4.392E-08 1.25E-05 1.000 1.000 HALMOS_CEBPA_TARGETS_UP lymphatic system disease DOID_75 1.029E-07 1.952E-05 8.608E-04 0.16326083 HALMOS_CEBPA_TARGETS_UP viral pneumonia DOID_10533 3.356E-07 4.774E-05 1.000 1.000 HALMOS_CEBPA_TARGETS_UP male reproductive system disease DOID_48 9.386E-07 1.068E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP esophagitis DOID_11963 1.047E-06 9.926E-05 1.000 1.000 HALMOS_CEBPA_TARGETS_UP primary bacterial infectious disease DOID_0050338 1.97E-06 1.602E-04 0.08548141 0.79735934 HALMOS_CEBPA_TARGETS_UP ulcerative colitis DOID_8577 3.14E-06 2.233E-04 0.09553916 0.84940281 HALMOS_CEBPA_TARGETS_UP pleurisy DOID_10247 3.702E-06 2.34E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP hepatic vascular disease DOID_272 3.702E-06 2.106E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP allergic rhinitis DOID_4481 5.441E-06 2.815E-04 0.03353652 0.51573728 HALMOS_CEBPA_TARGETS_UP esophageal disease DOID_6050 7.051E-06 3.343E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP hepatitis DOID_2237 1.038E-05 4.544E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP peptic ulcer DOID_750 1.038E-05 4.219E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 1.196E-05 4.537E-04 9.012E-04 0.12819536 HALMOS_CEBPA_TARGETS_UP pulmonary emphysema DOID_9675 1.196E-05 4.253E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP influenza DOID_8469 1.461E-05 4.891E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP integumentary system benign neoplasm DOID_0060121 1.985E-05 6.274E-04 1.257E-03 0.14302777 HALMOS_CEBPA_TARGETS_UP skin benign neoplasm DOID_3165 1.985E-05 6.274E-04 1.257E-03 0.14302777 HALMOS_CEBPA_TARGETS_UP integumentary system cancer DOID_0060122 2.76E-05 8.264E-04 1.561E-03 0.14802102 HALMOS_CEBPA_TARGETS_UP skin cancer DOID_4159 2.76E-05 8.264E-04 1.561E-03 0.14802102 HALMOS_CEBPA_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 3.212E-05 9.138E-04 1.000 1.000 HALMOS_CEBPA_TARGETS_UP leukocyte disease DOID_9500 3.373E-05 9.139E-04 1.781E-03 0.14477679 HALMOS_CEBPA_TARGETS_UP pre-malignant neoplasm DOID_0060071 4.07E-05 1.053E-03 2.015E-03 0.14333316 HALMOS_CEBPA_TARGETS_UP in situ carcinoma DOID_8719 4.07E-05 1.053E-03 2.015E-03 0.14333316 HALMOS_CEBPA_TARGETS_UP cholestasis DOID_13580 4.451E-05 1.101E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP uterine disease DOID_345 4.451E-05 1.055E-03 0.06597697 0.65861218 HALMOS_CEBPA_TARGETS_UP familial adenomatous polyposis DOID_0050424 5.35E-05 1.218E-03 0.01097217 0.41621101 HALMOS_CEBPA_TARGETS_UP blood coagulation disease DOID_1247 5.505E-05 1.205E-03 0.0706573 0.68142375 HALMOS_CEBPA_TARGETS_UP nephrosis DOID_2527 5.734E-05 1.208E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bile duct disease DOID_4138 5.734E-05 1.165E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP biliary tract disease DOID_9741 5.968E-05 1.171E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP pancreatitis DOID_4989 7.237E-05 1.373E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bacterial pneumonia DOID_874 7.237E-05 1.328E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP female reproductive system disease DOID_229 8.076E-05 1.436E-03 0.07994955 0.75818819 HALMOS_CEBPA_TARGETS_UP Legionnaires' disease DOID_10457 8.835E-05 1.523E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP legionellosis DOID_10458 8.835E-05 1.523E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP polycystic kidney disease DOID_898 8.835E-05 1.479E-03 0.01394418 0.41759148 HALMOS_CEBPA_TARGETS_UP varicose veins DOID_799 1.019E-04 1.656E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP transitional cell carcinoma DOID_2671 1.028E-04 1.624E-03 0.08640023 0.79293113 HALMOS_CEBPA_TARGETS_UP vein disease DOID_866 1.164E-04 1.789E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP Barrett's esophagus DOID_9206 1.164E-04 1.742E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 1.284E-04 1.873E-03 4.29E-03 0.20340209 HALMOS_CEBPA_TARGETS_UP prion disease DOID_649 1.482E-04 2.108E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP coronary restenosis DOID_4247 2.03E-04 2.817E-03 0.02084509 0.56480267 HALMOS_CEBPA_TARGETS_UP agranulocytosis DOID_12987 2.442E-04 3.309E-03 2.442E-04 0.13897182 HALMOS_CEBPA_TARGETS_UP myasthenia gravis DOID_437 2.442E-04 3.232E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP diabetic angiopathy DOID_11713 2.663E-04 3.443E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP acute pancreatitis DOID_2913 2.892E-04 3.657E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP commensal bacterial infectious disease DOID_0050339 3.132E-04 3.874E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP portal hypertension DOID_10762 3.132E-04 3.791E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP neuromuscular junction disease DOID_439 3.38E-04 4.007E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP coronary stenosis DOID_4248 4.181E-04 4.855E-03 0.02964862 0.54419567 HALMOS_CEBPA_TARGETS_UP autoimmune disease of the nervous system DOID_438 4.181E-04 4.758E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP abdominal aortic aneurysm DOID_7693 5.065E-04 5.651E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP papilloma DOID_2615 6.032E-04 6.6E-03 0.03547478 0.53118809 HALMOS_CEBPA_TARGETS_UP leukopenia DOID_615 6.373E-04 6.842E-03 6.373E-04 0.18130353 HALMOS_CEBPA_TARGETS_UP blood platelet disease DOID_2218 7.826E-04 8.247E-03 0.04030387 0.53332335 HALMOS_CEBPA_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 8.213E-04 8.496E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP systemic scleroderma DOID_418 8.213E-04 8.345E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP endometriosis of uterus DOID_288 9.425E-04 9.409E-03 0.04415019 0.55825467 HALMOS_CEBPA_TARGETS_UP nephrotic syndrome DOID_1184 9.847E-04 9.661E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP rheumatic disease DOID_1575 9.847E-04 9.497E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP hyperinsulinism DOID_2018 9.847E-04 9.339E-03 0.04510943 0.55798399 HALMOS_CEBPA_TARGETS_UP endometriosis DOID_289 9.847E-04 9.186E-03 0.04510943 0.54611199 HALMOS_CEBPA_TARGETS_UP scleroderma DOID_419 9.847E-04 9.497E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP gallbladder cancer DOID_3121 1.028E-03 9.433E-03 1.000 1.000 HALMOS_CEBPA_TARGETS_UP myeloma DOID_0070004 1.163E-03 0.01050004 0.04893699 0.56826833 HALMOS_CEBPA_TARGETS_UP thyroid adenoma DOID_2891 1.163E-03 0.01033597 0.04893699 0.55690296 HALMOS_CEBPA_TARGETS_UP bone marrow disease DOID_4961 1.163E-03 0.01017696 0.04893699 0.5459833 HALMOS_CEBPA_TARGETS_UP glaucoma DOID_1686 1.257E-03 0.01083544 1.000 1.000 HALMOS_CEBPA_TARGETS_UP aortic aneurysm DOID_3627 1.305E-03 0.01108529 1.000 1.000 HALMOS_CEBPA_TARGETS_UP hemorrhagic disease DOID_2213 1.355E-03 0.0113352 0.05274962 0.56631192 HALMOS_CEBPA_TARGETS_UP sarcoidosis DOID_11335 1.456E-03 0.01200665 1.000 1.000 HALMOS_CEBPA_TARGETS_UP giant cell tumor DOID_200 1.456E-03 0.01183512 1.000 1.000 HALMOS_CEBPA_TARGETS_UP malignant giant cell tumor DOID_2705 1.456E-03 0.01183512 1.000 1.000 HALMOS_CEBPA_TARGETS_UP giant cell glioblastoma DOID_3074 1.456E-03 0.01183512 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bile duct adenocarcinoma DOID_4896 1.508E-03 0.01208511 1.000 1.000 HALMOS_CEBPA_TARGETS_UP cholangiocarcinoma DOID_4947 1.508E-03 0.01208511 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bone marrow cancer DOID_4960 1.508E-03 0.01191726 0.05559931 0.58585204 HALMOS_CEBPA_TARGETS_UP parasitic protozoa infectious disease DOID_2789 1.561E-03 0.01216611 1.000 1.000 HALMOS_CEBPA_TARGETS_UP glioblastoma DOID_3068 1.725E-03 0.01326169 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bile duct cancer DOID_4606 1.725E-03 0.01308487 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bile duct carcinoma DOID_4897 1.725E-03 0.01308487 1.000 1.000 HALMOS_CEBPA_TARGETS_UP collagen disease DOID_854 1.896E-03 0.01419823 1.000 1.000 HALMOS_CEBPA_TARGETS_UP mineral metabolism disease DOID_0050032 2.076E-03 0.01534028 1.000 1.000 HALMOS_CEBPA_TARGETS_UP endocrine pancreas disease DOID_1428 2.076E-03 0.01514361 0.06503815 0.66083408 HALMOS_CEBPA_TARGETS_UP parasitic infectious disease DOID_1398 2.137E-03 0.0153953 1.000 1.000 HALMOS_CEBPA_TARGETS_UP allergic contact dermatitis DOID_3042 2.263E-03 0.01609684 2.263E-03 0.14308304 HALMOS_CEBPA_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 2.327E-03 0.01634862 0.06878791 0.67483313 HALMOS_CEBPA_TARGETS_UP tuberculosis DOID_399 2.327E-03 0.01614924 1.000 1.000 HALMOS_CEBPA_TARGETS_UP astrocytoma DOID_3069 2.392E-03 0.01640017 1.000 1.000 HALMOS_CEBPA_TARGETS_UP pancreatic ductal carcinoma DOID_3587 2.458E-03 0.01665091 1.000 1.000 HALMOS_CEBPA_TARGETS_UP peripheral vascular disease DOID_341 2.592E-03 0.01735354 1.000 1.000 HALMOS_CEBPA_TARGETS_UP pancreatic carcinoma DOID_4905 2.661E-03 0.01760422 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bone resorption disease DOID_0080011 2.871E-03 0.01877679 2.871E-03 0.16335807 HALMOS_CEBPA_TARGETS_UP osteoporosis DOID_11476 2.871E-03 0.01877679 2.871E-03 0.16335807 HALMOS_CEBPA_TARGETS_UP aneurysm disease DOID_2403 2.871E-03 0.01856342 1.000 1.000 HALMOS_CEBPA_TARGETS_UP contact dermatitis DOID_2773 3.089E-03 0.01974725 3.089E-03 0.15977317 HALMOS_CEBPA_TARGETS_UP biliary tract cancer DOID_4607 3.314E-03 0.02095233 1.000 1.000 HALMOS_CEBPA_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 3.869E-03 0.02419074 1.000 1.000 HALMOS_CEBPA_TARGETS_UP lymphoblastic leukemia DOID_1037 4.119E-03 0.02547442 0.09098087 0.82171615 HALMOS_CEBPA_TARGETS_UP encephalomyelitis DOID_640 4.119E-03 0.0252005 1.000 1.000 HALMOS_CEBPA_TARGETS_UP mouth disease DOID_403 4.204E-03 0.02544686 1.000 1.000 HALMOS_CEBPA_TARGETS_UP Crohn's disease DOID_8778 4.204E-03 0.025179 1.000 1.000 HALMOS_CEBPA_TARGETS_UP dilated cardiomyopathy DOID_12930 4.29E-03 0.02542526 1.000 1.000 HALMOS_CEBPA_TARGETS_UP brachydactyly DOID_0050581 9.98E-03 0.05853992 9.98E-03 0.43679786 HALMOS_CEBPA_TARGETS_UP hyperparathyroidism DOID_13543 9.98E-03 0.05794257 1.000 1.000 HALMOS_CEBPA_TARGETS_UP acute kidney failure DOID_3021 9.98E-03 0.05735729 1.000 1.000 HALMOS_CEBPA_TARGETS_UP conjunctival disease DOID_4251 9.98E-03 0.05678372 1.000 1.000 HALMOS_CEBPA_TARGETS_UP acute T cell leukemia DOID_5603 9.98E-03 0.05622151 9.98E-03 0.40559801 HALMOS_CEBPA_TARGETS_UP conjunctivitis DOID_6195 9.98E-03 0.05678372 1.000 1.000 HALMOS_CEBPA_TARGETS_UP polycythemia DOID_8432 9.98E-03 0.05567032 1.000 1.000 HALMOS_CEBPA_TARGETS_UP cutaneous leishmaniasis DOID_9111 9.98E-03 0.05512983 1.000 1.000 HALMOS_CEBPA_TARGETS_UP adrenoleukodystrophy DOID_10588 0.01097217 0.06003043 1.000 1.000 HALMOS_CEBPA_TARGETS_UP hemochromatosis DOID_2352 0.01097217 0.05945872 0.01097217 0.39019783 HALMOS_CEBPA_TARGETS_UP retinal detachment DOID_5327 0.01196381 0.06422082 1.000 1.000 HALMOS_CEBPA_TARGETS_UP stomach disease DOID_76 0.01196381 0.06362063 1.000 1.000 HALMOS_CEBPA_TARGETS_UP ocular hypertension DOID_9282 0.01196381 0.06303155 1.000 1.000 HALMOS_CEBPA_TARGETS_UP borderline glaucoma DOID_9283 0.01196381 0.06303155 1.000 1.000 HALMOS_CEBPA_TARGETS_UP leprosy DOID_1024 0.01295448 0.06762475 0.01295448 0.43359398 HALMOS_CEBPA_TARGETS_UP berylliosis DOID_10322 0.01295448 0.06700998 1.000 1.000 HALMOS_CEBPA_TARGETS_UP parathyroid gland disease DOID_11201 0.01295448 0.06640629 1.000 1.000 HALMOS_CEBPA_TARGETS_UP newborn respiratory distress syndrome DOID_12716 0.01295448 0.06581337 1.000 1.000 HALMOS_CEBPA_TARGETS_UP larynx cancer DOID_2596 0.01295448 0.06523095 1.000 1.000 HALMOS_CEBPA_TARGETS_UP laryngeal benign neoplasm DOID_2598 0.01295448 0.06523095 1.000 1.000 HALMOS_CEBPA_TARGETS_UP open-angle glaucoma DOID_1067 0.01394418 0.06959858 1.000 1.000 HALMOS_CEBPA_TARGETS_UP eyelid disease DOID_530 0.01394418 0.06899338 1.000 1.000 HALMOS_CEBPA_TARGETS_UP T-cell leukemia DOID_715 0.01394418 0.06839861 0.01394418 0.44079101 HALMOS_CEBPA_TARGETS_UP parasitic helminthiasis infectious disease DOID_883 0.01394418 0.067814 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bacterial meningitis DOID_9470 0.01394418 0.06723931 1.000 1.000 HALMOS_CEBPA_TARGETS_UP idiopathic pulmonary fibrosis DOID_0050156 0.01493292 0.07140192 1.000 1.000 HALMOS_CEBPA_TARGETS_UP skeletal system cancer DOID_0060124 0.01493292 0.07080691 1.000 1.000 HALMOS_CEBPA_TARGETS_UP bone cancer DOID_184 0.01493292 0.07080691 1.000 1.000 HALMOS_CEBPA_TARGETS_UP nutritional deficiency disease DOID_5113 0.01493292 0.07022173 0.01493292 0.42484144 HALMOS_CEBPA_TARGETS_UP oral submucous fibrosis DOID_5773 0.01493292 0.06964614 1.000 1.000 HALMOS_CEBPA_TARGETS_UP intermediate coronary syndrome DOID_8805 0.01493292 0.06907991 1.000 1.000 HALMOS_CEBPA_TARGETS_UP silicosis DOID_10325 0.01592069 0.07305541 1.000 1.000 HALMOS_CEBPA_TARGETS_UP spastic diplegia DOID_10965 0.01592069 0.07247096 1.000 1.000 HALMOS_CEBPA_TARGETS_UP tongue cancer DOID_8649 0.01592069 0.0718958 1.000 1.000 HALMOS_CEBPA_TARGETS_UP urinary system benign neoplasm DOID_731 0.01690749 0.07575089 1.000 1.000 HALMOS_CEBPA_TARGETS_UP Down syndrome DOID_14250 0.01887821 0.08391956 1.000 1.000 HALMOS_CEBPA_TARGETS_UP granulosa cell tumor DOID_2999 0.01887821 0.08326902 1.000 1.000 HALMOS_CEBPA_TARGETS_UP leishmaniasis DOID_9065 0.01887821 0.08262849 1.000 1.000 HALMOS_CEBPA_TARGETS_UP amnestic disorder DOID_10914 0.01986213 0.0862714 1.000 1.000 HALMOS_CEBPA_TARGETS_UP sex cord-gonadal stromal tumor DOID_192 0.01986213 0.08561783 1.000 1.000 HALMOS_CEBPA_TARGETS_UP brain edema DOID_4724 0.01986213 0.08497409 1.000 1.000 HALMOS_CEBPA_TARGETS_UP Kawasaki disease DOID_13378 0.02084509 0.08851385 1.000 1.000 HALMOS_CEBPA_TARGETS_UP lymphadenitis DOID_1602 0.02084509 0.08851385 1.000 1.000 HALMOS_CEBPA_TARGETS_UP lymph node disease DOID_9942 0.02084509 0.08851385 1.000 1.000 HALMOS_CEBPA_TARGETS_UP gastric ulcer DOID_10808 0.02182709 0.09199713 1.000 1.000 HALMOS_CEBPA_TARGETS_UP neutropenia DOID_1227 0.02182709 0.09132068 0.02182709 0.56452785 HALMOS_CEBPA_TARGETS_UP acquired immunodeficiency syndrome DOID_635 0.02182709 0.09065411 1.000 1.000 HALMOS_CEBPA_TARGETS_UP placenta disease DOID_780 0.02182709 0.08999719 1.000 1.000 HALMOS_CEBPA_TARGETS_UP muscle cancer DOID_4045 0.02280813 0.09336564 1.000 1.000 HALMOS_CEBPA_TARGETS_UP uremia DOID_4676 0.02280813 0.09269874 0.02280813 0.5642532 HALMOS_CEBPA_TARGETS_UP urinary tract obstruction DOID_5200 0.02280813 0.0920413 1.000 1.000 HALMOS_CEBPA_TARGETS_UP polyarteritis nodosa DOID_9810 0.02280813 0.09139312 1.000 1.000 HALMOS_CEBPA_TARGETS_UP lingual-facial-buccal dyskinesia DOID_9854 0.02280813 0.09075401 0.02280813 0.54074265 HALMOS_CEBPA_TARGETS_UP meningitis DOID_9471 0.02378821 0.09399645 1.000 1.000 HALMOS_CEBPA_TARGETS_UP Goodpasture syndrome DOID_9808 0.02378821 0.0933482 0.02378821 0.54141958 HALMOS_CEBPA_TARGETS_UP toxic shock syndrome DOID_14115 0.02476733 0.09652473 1.000 1.000 HALMOS_CEBPA_TARGETS_UP X-linked disease DOID_0050735 0.0257455 0.09965434 0.0257455 0.5634303 HALMOS_CEBPA_TARGETS_UP bronchiolitis DOID_2942 0.0257455 0.098981 1.000 1.000 HALMOS_CEBPA_TARGETS_UP osteosarcoma DOID_3347 0.0257455 0.0983167 0.0257455 0.54256251 LINDSTEDT_DENDRITIC_CELL_MATURATION_D contact dermatitis DOID_2773 8.501E-10 4.837E-07 5.975E-08 3.4E-05 LINDSTEDT_DENDRITIC_CELL_MATURATION_D allergic contact dermatitis DOID_3042 2.68E-08 7.624E-06 1.79E-06 5.092E-04 LINDSTEDT_DENDRITIC_CELL_MATURATION_D primary immunodeficiency disease DOID_612 5.119E-06 9.709E-04 2.01E-04 0.0163348 LINDSTEDT_DENDRITIC_CELL_MATURATION_D periodontitis DOID_824 6.379E-06 9.074E-04 0.03534835 0.41047373 LINDSTEDT_DENDRITIC_CELL_MATURATION_D coronary stenosis DOID_4248 7.082E-06 8.059E-04 6.4E-04 0.03641845 LINDSTEDT_DENDRITIC_CELL_MATURATION_D corneal disease DOID_10124 8.636E-06 8.19E-04 7.286E-04 0.03769078 LINDSTEDT_DENDRITIC_CELL_MATURATION_D periodontal disease DOID_3388 1.347E-05 1.095E-03 0.04488246 0.41865772 LINDSTEDT_DENDRITIC_CELL_MATURATION_D spindle cell carcinoma DOID_4015 1.347E-05 9.581E-04 1.347E-05 2.555E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_D phagocyte bactericidal dysfunction DOID_3262 6.727E-05 4.253E-03 6.727E-05 9.569E-03 LINDSTEDT_DENDRITIC_CELL_MATURATION_D keratitis DOID_4677 6.727E-05 3.827E-03 0.01232998 0.31889805 LINDSTEDT_DENDRITIC_CELL_MATURATION_D tooth disease DOID_1091 9.221E-05 4.77E-03 0.08324517 0.50389898 LINDSTEDT_DENDRITIC_CELL_MATURATION_D tuberculosis DOID_399 9.62E-05 4.561E-03 9.62E-05 0.01094752 LINDSTEDT_DENDRITIC_CELL_MATURATION_D encephalitis DOID_9588 9.85E-05 4.311E-03 0.01477806 0.30031121 LINDSTEDT_DENDRITIC_CELL_MATURATION_D primary bacterial infectious disease DOID_0050338 1.882E-04 7.648E-03 1.882E-04 0.01784566 LINDSTEDT_DENDRITIC_CELL_MATURATION_D encephalomyelitis DOID_640 2.282E-04 8.655E-03 6.242E-03 0.20891209 LINDSTEDT_DENDRITIC_CELL_MATURATION_D mouth disease DOID_403 2.353E-04 8.369E-03 0.11240434 0.61498145 LINDSTEDT_DENDRITIC_CELL_MATURATION_D hypersensitivity reaction type I disease DOID_1205 2.426E-04 8.121E-03 6.498E-03 0.20542298 LINDSTEDT_DENDRITIC_CELL_MATURATION_D funisitis DOID_0050698 3.42E-04 0.01081228 3.42E-04 0.02432762 LINDSTEDT_DENDRITIC_CELL_MATURATION_D autoimmune disease of cardiovascular system DOID_0060051 6.4E-04 0.01916761 6.4E-04 0.04046495 LINDSTEDT_DENDRITIC_CELL_MATURATION_D Behcet's disease DOID_13241 6.4E-04 0.01916761 6.4E-04 0.04046495 LINDSTEDT_DENDRITIC_CELL_MATURATION_D neuritis DOID_1803 1.774E-03 0.05047571 0.06017904 0.45055094 LINDSTEDT_DENDRITIC_CELL_MATURATION_D integumentary system benign neoplasm DOID_0060121 1.917E-03 0.05195359 1.917E-03 0.09091878 LINDSTEDT_DENDRITIC_CELL_MATURATION_D skin benign neoplasm DOID_3165 1.917E-03 0.05195359 1.917E-03 0.09091878 LINDSTEDT_DENDRITIC_CELL_MATURATION_D hemorrhagic disease DOID_2213 2.066E-03 0.0534347 0.06483725 0.45546166 LINDSTEDT_DENDRITIC_CELL_MATURATION_D vasculitis DOID_865 2.299E-03 0.05687015 2.299E-03 0.10061642 LINDSTEDT_DENDRITIC_CELL_MATURATION_D oral cavity cancer DOID_8618 2.628E-03 0.06229456 2.628E-03 0.10679067 LINDSTEDT_DENDRITIC_CELL_MATURATION_D hypothyroidism DOID_1459 2.977E-03 0.06775868 2.977E-03 0.11293114 LINDSTEDT_DENDRITIC_CELL_MATURATION_D cerebral degeneration DOID_1443 3.253E-03 0.0711862 0.08096372 0.50074303 LINDSTEDT_DENDRITIC_CELL_MATURATION_D blood coagulation disease DOID_1247 3.738E-03 0.07877117 0.08665696 0.51902958 LINDSTEDT_DENDRITIC_CELL_MATURATION_D metabolic syndrome X DOID_14221 4.69E-03 0.09531049 4.69E-03 0.16679336 BAELDE_DIABETIC_NEPHROPATHY_DN aneurysm disease DOID_2403 8.771E-11 4.991E-08 1.53E-04 7.916E-03 BAELDE_DIABETIC_NEPHROPATHY_DN focal glomerulosclerosis DOID_3945 8.877E-10 2.526E-07 1.478E-06 2.804E-04 BAELDE_DIABETIC_NEPHROPATHY_DN glaucoma DOID_1686 4.032E-08 7.647E-06 4.457E-03 0.06854114 BAELDE_DIABETIC_NEPHROPATHY_DN aortic aneurysm DOID_3627 4.62E-08 6.573E-06 3.653E-04 0.01222554 BAELDE_DIABETIC_NEPHROPATHY_DN Human immunodeficiency virus infectious disease DOID_526 1.395E-07 1.588E-05 1.395E-07 7.94E-05 BAELDE_DIABETIC_NEPHROPATHY_DN respiratory failure DOID_11162 1.956E-07 1.855E-05 7.957E-04 0.01968524 BAELDE_DIABETIC_NEPHROPATHY_DN hypothyroidism DOID_1459 1.956E-07 1.59E-05 1.956E-07 5.565E-05 BAELDE_DIABETIC_NEPHROPATHY_DN nephrotic syndrome DOID_1184 4.695E-07 3.339E-05 1.104E-05 1.57E-03 BAELDE_DIABETIC_NEPHROPATHY_DN nephrosis DOID_2527 4.816E-07 3.045E-05 1.122E-04 6.386E-03 BAELDE_DIABETIC_NEPHROPATHY_DN aortic valve insufficiency DOID_57 7.575E-07 4.31E-05 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN bacterial meningitis DOID_9470 1.517E-06 7.845E-05 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN transitional cell carcinoma DOID_2671 1.834E-06 8.698E-05 2.654E-03 0.05593138 BAELDE_DIABETIC_NEPHROPATHY_DN thyroid carcinoma DOID_3963 3.677E-06 1.609E-04 8.921E-05 6.345E-03 BAELDE_DIABETIC_NEPHROPATHY_DN thyroid cancer DOID_1781 4.807E-06 1.954E-04 1.1E-04 6.954E-03 BAELDE_DIABETIC_NEPHROPATHY_DN brain edema DOID_4724 7.124E-06 2.702E-04 2.67E-04 0.01168623 BAELDE_DIABETIC_NEPHROPATHY_DN autoimmune disease of urogenital tract DOID_0060049 9.888E-06 3.516E-04 0.03330735 0.19741546 BAELDE_DIABETIC_NEPHROPATHY_DN primary biliary cirrhosis DOID_12236 9.888E-06 3.516E-04 0.03330735 0.19741546 BAELDE_DIABETIC_NEPHROPATHY_DN muscular atrophy DOID_767 1.065E-05 3.564E-04 8.549E-03 0.09008106 BAELDE_DIABETIC_NEPHROPATHY_DN proteinuria DOID_576 1.512E-05 4.778E-04 2.696E-04 0.01095708 BAELDE_DIABETIC_NEPHROPATHY_DN aortic valve disease DOID_62 1.531E-05 4.586E-04 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN meningitis DOID_9471 1.531E-05 4.357E-04 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN chromosomal disease DOID_0080014 1.555E-05 4.213E-04 1.555E-05 1.77E-03 BAELDE_DIABETIC_NEPHROPATHY_DN pre-eclampsia DOID_10591 1.671E-05 4.322E-04 0.2731762 0.60717678 BAELDE_DIABETIC_NEPHROPATHY_DN focal epilepsy DOID_2234 1.783E-05 4.411E-04 0.01709933 0.12161899 BAELDE_DIABETIC_NEPHROPATHY_DN portal hypertension DOID_10762 2.133E-05 5.058E-04 0.01182906 0.10516778 BAELDE_DIABETIC_NEPHROPATHY_DN spinal muscular atrophy DOID_12377 2.492E-05 5.671E-04 6.629E-04 0.01714561 BAELDE_DIABETIC_NEPHROPATHY_DN bone marrow cancer DOID_4960 3.185E-05 6.97E-04 0.05111418 0.2823686 BAELDE_DIABETIC_NEPHROPATHY_DN encephalomyelitis DOID_640 3.361E-05 7.082E-04 3.226E-03 0.05562826 BAELDE_DIABETIC_NEPHROPATHY_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.566E-05 7.246E-04 0.02351728 0.15206059 BAELDE_DIABETIC_NEPHROPATHY_DN renal hypertension DOID_1073 3.833E-05 7.521E-04 0.01557168 0.1213738 BAELDE_DIABETIC_NEPHROPATHY_DN secondary hypertension DOID_11130 3.833E-05 7.521E-04 0.01557168 0.1213738 BAELDE_DIABETIC_NEPHROPATHY_DN hepatic vascular disease DOID_272 3.833E-05 7.27E-04 0.01557168 0.11658273 BAELDE_DIABETIC_NEPHROPATHY_DN glioblastoma DOID_3068 4.432E-05 8.136E-04 0.05765787 0.30098469 BAELDE_DIABETIC_NEPHROPATHY_DN carotid artery disease DOID_3407 5.593E-05 9.946E-04 5.593E-05 5.304E-03 BAELDE_DIABETIC_NEPHROPATHY_DN collagen disease DOID_854 5.593E-05 9.644E-04 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN abdominal aortic aneurysm DOID_7693 5.638E-05 9.436E-04 0.18985301 0.48226056 BAELDE_DIABETIC_NEPHROPATHY_DN congenital heart defect DOID_1682 6.489E-05 1.055E-03 8.648E-03 0.0878713 BAELDE_DIABETIC_NEPHROPATHY_DN temporal lobe epilepsy DOID_3328 8.035E-05 1.27E-03 0.07154525 0.30380035 BAELDE_DIABETIC_NEPHROPATHY_DN nephroblastoma DOID_2154 8.921E-05 1.372E-03 8.921E-05 7.251E-03 BAELDE_DIABETIC_NEPHROPATHY_DN brain infarction DOID_3454 9.213E-05 1.379E-03 0.07517101 0.3012134 BAELDE_DIABETIC_NEPHROPATHY_DN astrocytoma DOID_3069 9.849E-05 1.437E-03 0.07700553 0.3064066 BAELDE_DIABETIC_NEPHROPATHY_DN restrictive cardiomyopathy DOID_397 1.336E-04 1.901E-03 0.09702176 0.34289058 BAELDE_DIABETIC_NEPHROPATHY_DN adult respiratory distress syndrome DOID_11394 1.618E-04 2.245E-03 0.03063179 0.18741384 BAELDE_DIABETIC_NEPHROPATHY_DN pancreatitis DOID_4989 1.624E-04 2.2E-03 0.01455503 0.11831162 BAELDE_DIABETIC_NEPHROPATHY_DN metabolic syndrome X DOID_14221 1.824E-04 2.414E-03 1.824E-04 8.65E-03 BAELDE_DIABETIC_NEPHROPATHY_DN spinocerebellar ataxia DOID_1441 1.934E-04 2.501E-03 2.957E-03 0.05800938 BAELDE_DIABETIC_NEPHROPATHY_DN Huntington's disease DOID_12858 2.108E-04 2.665E-03 3.148E-03 0.05597729 BAELDE_DIABETIC_NEPHROPATHY_DN bone development disease DOID_0080006 2.281E-04 2.821E-03 0.01763607 0.12388792 BAELDE_DIABETIC_NEPHROPATHY_DN learning disability DOID_8927 2.488E-04 3.012E-03 0.03748451 0.21763964 BAELDE_DIABETIC_NEPHROPATHY_DN leukodystrophy DOID_10579 2.696E-04 3.196E-03 3.768E-03 0.06305616 BAELDE_DIABETIC_NEPHROPATHY_DN spinocerebellar degeneration DOID_2478 2.696E-04 3.131E-03 3.768E-03 0.06125456 BAELDE_DIABETIC_NEPHROPATHY_DN myeloma DOID_0070004 2.916E-04 3.318E-03 0.2731762 0.60955787 BAELDE_DIABETIC_NEPHROPATHY_DN thyroid adenoma DOID_2891 2.916E-04 3.253E-03 0.04037465 0.22973178 BAELDE_DIABETIC_NEPHROPATHY_DN heart valve disease DOID_4079 2.916E-04 3.191E-03 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN nervous system cancer DOID_3093 3.123E-04 3.353E-03 0.11633504 0.36571624 BAELDE_DIABETIC_NEPHROPATHY_DN integumentary system benign neoplasm DOID_0060121 3.394E-04 3.576E-03 0.04334611 0.24419741 BAELDE_DIABETIC_NEPHROPATHY_DN skin benign neoplasm DOID_3165 3.394E-04 3.576E-03 0.04334611 0.24419741 BAELDE_DIABETIC_NEPHROPATHY_DN lymphoma DOID_0060058 3.45E-04 3.569E-03 3.45E-04 0.01308785 BAELDE_DIABETIC_NEPHROPATHY_DN hepatitis B DOID_2043 3.573E-04 3.631E-03 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN lymphoblastic leukemia DOID_1037 3.623E-04 3.617E-03 3.623E-04 0.01288513 BAELDE_DIABETIC_NEPHROPATHY_DN hypersensitivity reaction type I disease DOID_1205 3.989E-04 3.913E-03 3.989E-04 0.01260918 BAELDE_DIABETIC_NEPHROPATHY_DN giant cell tumor DOID_200 4.514E-04 4.353E-03 0.30049906 0.64522251 BAELDE_DIABETIC_NEPHROPATHY_DN malignant giant cell tumor DOID_2705 4.514E-04 4.353E-03 0.30049906 0.64522251 BAELDE_DIABETIC_NEPHROPATHY_DN giant cell glioblastoma DOID_3074 4.514E-04 4.353E-03 0.30049906 0.64522251 BAELDE_DIABETIC_NEPHROPATHY_DN Lewy body dementia DOID_12217 4.652E-04 4.412E-03 0.0101296 0.09606235 BAELDE_DIABETIC_NEPHROPATHY_DN vasculitis DOID_865 4.83E-04 4.506E-03 0.30495236 0.6523229 BAELDE_DIABETIC_NEPHROPATHY_DN integumentary system cancer DOID_0060122 5.162E-04 4.738E-03 0.05272355 0.28571142 BAELDE_DIABETIC_NEPHROPATHY_DN skin cancer DOID_4159 5.162E-04 4.738E-03 0.05272355 0.28571142 BAELDE_DIABETIC_NEPHROPATHY_DN spastic quadriplegia DOID_10970 5.262E-04 4.752E-03 5.262E-04 0.01575782 BAELDE_DIABETIC_NEPHROPATHY_DN congenital nervous system abnormality DOID_2490 5.875E-04 5.223E-03 5.875E-04 0.01671415 BAELDE_DIABETIC_NEPHROPATHY_DN hypertrophic cardiomyopathy DOID_11984 6.256E-04 5.476E-03 6.961E-03 0.08083434 BAELDE_DIABETIC_NEPHROPATHY_DN oral cavity cancer DOID_8618 6.256E-04 5.394E-03 6.256E-04 0.01695102 BAELDE_DIABETIC_NEPHROPATHY_DN ankylosing spondylitis DOID_7147 6.629E-04 5.63E-03 0.01272236 0.10968213 BAELDE_DIABETIC_NEPHROPATHY_DN spinal cord disease DOID_319 7.39E-04 6.184E-03 0.01364415 0.11416945 BAELDE_DIABETIC_NEPHROPATHY_DN pre-malignant neoplasm DOID_0060071 8.429E-04 6.951E-03 8.648E-03 0.08946896 BAELDE_DIABETIC_NEPHROPATHY_DN in situ carcinoma DOID_8719 8.429E-04 6.951E-03 8.648E-03 0.08946896 BAELDE_DIABETIC_NEPHROPATHY_DN coronary stenosis DOID_4248 9.073E-04 7.375E-03 0.01557168 0.11506866 BAELDE_DIABETIC_NEPHROPATHY_DN cholestasis DOID_13580 9.43E-04 7.557E-03 0.35211386 0.74204736 BAELDE_DIABETIC_NEPHROPATHY_DN cerebral degeneration DOID_1443 9.43E-04 7.452E-03 9.384E-03 0.09206141 BAELDE_DIABETIC_NEPHROPATHY_DN uterine disease DOID_345 9.43E-04 7.35E-03 0.35211386 0.73930918 BAELDE_DIABETIC_NEPHROPATHY_DN autoimmune disease of endocrine system DOID_0060005 9.998E-04 7.688E-03 9.998E-04 0.02370454 BAELDE_DIABETIC_NEPHROPATHY_DN dysostosis DOID_1934 1.098E-03 8.331E-03 0.18466556 0.47545114 BAELDE_DIABETIC_NEPHROPATHY_DN endocrine organ benign neoplasm DOID_0060089 1.109E-03 8.299E-03 0.07517101 0.30334966 BAELDE_DIABETIC_NEPHROPATHY_DN spastic cerebral palsy DOID_0050669 1.202E-03 8.884E-03 1.202E-03 0.02736421 BAELDE_DIABETIC_NEPHROPATHY_DN bile duct disease DOID_4138 1.293E-03 9.435E-03 0.37648069 0.78467953 BAELDE_DIABETIC_NEPHROPATHY_DN Charcot-Marie-Tooth disease DOID_10595 1.312E-03 9.453E-03 0.1950076 0.49315255 BAELDE_DIABETIC_NEPHROPATHY_DN biliary tract disease DOID_9741 1.36E-03 9.67E-03 0.38045215 0.79006304 BAELDE_DIABETIC_NEPHROPATHY_DN diabetic retinopathy DOID_8947 1.428E-03 0.01003098 0.38439842 0.79247355 BAELDE_DIABETIC_NEPHROPATHY_DN leiomyoma DOID_127 1.429E-03 9.915E-03 0.02086214 0.14301874 BAELDE_DIABETIC_NEPHROPATHY_DN autonomic nervous system neoplasm DOID_2621 1.429E-03 9.795E-03 0.02086214 0.14131614 BAELDE_DIABETIC_NEPHROPATHY_DN neuroblastoma DOID_769 1.429E-03 9.795E-03 0.02086214 0.14131614 BAELDE_DIABETIC_NEPHROPATHY_DN metal metabolism disorder DOID_896 1.551E-03 0.01050934 0.02199806 0.14725759 BAELDE_DIABETIC_NEPHROPATHY_DN syndrome DOID_225 1.572E-03 0.01052318 0.08829978 0.32001638 BAELDE_DIABETIC_NEPHROPATHY_DN hyperthyroidism DOID_7998 1.68E-03 0.01111858 0.02315906 0.15146559 BAELDE_DIABETIC_NEPHROPATHY_DN mixed glioma DOID_5076 1.726E-03 0.01128749 0.01455503 0.11664526 BAELDE_DIABETIC_NEPHROPATHY_DN Sjogren's syndrome DOID_12894 1.751E-03 0.01132254 0.06178904 0.3139104 BAELDE_DIABETIC_NEPHROPATHY_DN lateral sclerosis DOID_230 1.751E-03 0.01119532 0.06178904 0.30049542 BAELDE_DIABETIC_NEPHROPATHY_DN keratitis DOID_4677 1.751E-03 0.01107093 0.06178904 0.28583711 BAELDE_DIABETIC_NEPHROPATHY_DN adenoma DOID_657 1.958E-03 0.01224411 0.22029472 0.52228206 BAELDE_DIABETIC_NEPHROPATHY_DN female reproductive system disease DOID_229 1.976E-03 0.01221968 0.41133018 0.83887767 BAELDE_DIABETIC_NEPHROPATHY_DN multiple myeloma DOID_9538 2.107E-03 0.01289188 0.22525641 0.52745224 BAELDE_DIABETIC_NEPHROPATHY_DN peripheral nervous system neoplasm DOID_1192 2.263E-03 0.01369761 0.02804671 0.17536901 BAELDE_DIABETIC_NEPHROPATHY_DN retinal vascular disease DOID_2462 2.346E-03 0.01405404 0.42618953 0.85993562 BAELDE_DIABETIC_NEPHROPATHY_DN systemic scleroderma DOID_418 2.426E-03 0.01437671 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN adenoid cystic carcinoma DOID_4866 2.595E-03 0.01522446 2.595E-03 0.05679895 BAELDE_DIABETIC_NEPHROPATHY_DN primary immunodeficiency disease DOID_612 2.762E-03 0.01603891 0.02045975 0.14197068 BAELDE_DIABETIC_NEPHROPATHY_DN amino acid metabolic disorder DOID_9252 2.762E-03 0.0158769 2.762E-03 0.05613619 BAELDE_DIABETIC_NEPHROPATHY_DN benign mesothelioma DOID_2645 2.772E-03 0.01577457 0.03195843 0.19345049 BAELDE_DIABETIC_NEPHROPATHY_DN cervix uteri carcinoma in situ DOID_8991 2.772E-03 0.01561838 0.03195843 0.19141417 BAELDE_DIABETIC_NEPHROPATHY_DN endometriosis of uterus DOID_288 2.957E-03 0.01649286 0.24959713 0.57498286 BAELDE_DIABETIC_NEPHROPATHY_DN salivary gland cancer DOID_8850 2.957E-03 0.01633274 2.957E-03 0.05607574 BAELDE_DIABETIC_NEPHROPATHY_DN newborn respiratory distress syndrome DOID_12716 2.997E-03 0.01639883 0.07957327 0.31011775 BAELDE_DIABETIC_NEPHROPATHY_DN intracranial thrombosis DOID_4193 2.997E-03 0.01624265 2.997E-03 0.05501543 BAELDE_DIABETIC_NEPHROPATHY_DN rheumatic disease DOID_1575 3.148E-03 0.0168988 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN hyperinsulinism DOID_2018 3.148E-03 0.01674087 0.03467823 0.20342177 BAELDE_DIABETIC_NEPHROPATHY_DN endometriosis DOID_289 3.148E-03 0.01658586 0.25437311 0.58362217 BAELDE_DIABETIC_NEPHROPATHY_DN uveal disease DOID_3480 3.148E-03 0.0164337 0.25437311 0.5812783 BAELDE_DIABETIC_NEPHROPATHY_DN scleroderma DOID_419 3.148E-03 0.0168988 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN uterine cancer DOID_363 3.347E-03 0.01731375 0.25911881 0.58740479 BAELDE_DIABETIC_NEPHROPATHY_DN dilated cardiomyopathy DOID_12930 3.477E-03 0.01782308 0.12683072 0.38386532 BAELDE_DIABETIC_NEPHROPATHY_DN open-angle glaucoma DOID_1067 3.482E-03 0.01769115 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN tethered spinal cord syndrome DOID_1089 3.482E-03 0.01753459 0.08542643 0.315634 BAELDE_DIABETIC_NEPHROPATHY_DN cerebral infarction DOID_3526 3.554E-03 0.01773721 0.26383443 0.59336677 BAELDE_DIABETIC_NEPHROPATHY_DN cataract DOID_83 3.554E-03 0.01758297 0.26383443 0.59103068 BAELDE_DIABETIC_NEPHROPATHY_DN lens disease DOID_110 3.99E-03 0.01957039 0.2731762 0.60481423 BAELDE_DIABETIC_NEPHROPATHY_DN Ehlers-Danlos syndrome DOID_13359 4.001E-03 0.01945889 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN renovascular hypertension DOID_1591 4.001E-03 0.01929399 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN adrenal cortex disease DOID_3952 4.001E-03 0.01913185 4.001E-03 0.0632414 BAELDE_DIABETIC_NEPHROPATHY_DN oral submucous fibrosis DOID_5773 4.001E-03 0.01897242 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN spastic diplegia DOID_10965 4.554E-03 0.02141379 4.554E-03 0.06818602 BAELDE_DIABETIC_NEPHROPATHY_DN thyroiditis DOID_7166 4.554E-03 0.02123827 4.554E-03 0.06643766 BAELDE_DIABETIC_NEPHROPATHY_DN autoimmune thyroiditis DOID_7188 4.554E-03 0.02123827 4.554E-03 0.06643766 BAELDE_DIABETIC_NEPHROPATHY_DN hemorrhagic disease DOID_2213 4.956E-03 0.02292659 4.956E-03 0.07049925 BAELDE_DIABETIC_NEPHROPATHY_DN familial hypertrophic cardiomyopathy DOID_11986 5.139E-03 0.02358299 5.139E-03 0.07132415 BAELDE_DIABETIC_NEPHROPATHY_DN methylmalonic acidemia DOID_14749 5.139E-03 0.02339432 5.139E-03 0.06962596 BAELDE_DIABETIC_NEPHROPATHY_DN hyperostosis DOID_205 5.139E-03 0.02320865 0.10276442 0.35013744 BAELDE_DIABETIC_NEPHROPATHY_DN adrenal gland disease DOID_9553 5.139E-03 0.02302591 5.139E-03 0.06800675 BAELDE_DIABETIC_NEPHROPATHY_DN atrophic muscular disease DOID_913 5.487E-03 0.0243933 0.04952299 0.27626062 BAELDE_DIABETIC_NEPHROPATHY_DN muscular dystrophy DOID_9884 5.487E-03 0.0243933 0.04952299 0.27626062 BAELDE_DIABETIC_NEPHROPATHY_DN keratosis DOID_161 5.758E-03 0.02539617 5.758E-03 0.07445694 BAELDE_DIABETIC_NEPHROPATHY_DN ureteral obstruction DOID_5199 5.758E-03 0.02520081 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN reproductive organ benign neoplasm DOID_0050622 6.052E-03 0.0262859 0.05272355 0.28845864 BAELDE_DIABETIC_NEPHROPATHY_DN parasitic protozoa infectious disease DOID_2789 6.052E-03 0.02608677 0.05272355 0.28037102 BAELDE_DIABETIC_NEPHROPATHY_DN pustulosis of palm and sole DOID_4398 6.052E-03 0.02589063 0.05272355 0.27777499 BAELDE_DIABETIC_NEPHROPATHY_DN smallpox DOID_8736 6.052E-03 0.02569741 6.052E-03 0.07652118 BAELDE_DIABETIC_NEPHROPATHY_DN familial hyperlipidemia DOID_1168 6.346E-03 0.02674909 6.346E-03 0.07850275 BAELDE_DIABETIC_NEPHROPATHY_DN Down syndrome DOID_14250 6.408E-03 0.02681078 6.408E-03 0.07758012 BAELDE_DIABETIC_NEPHROPATHY_DN heart septal defect DOID_1681 6.408E-03 0.02661508 0.11414083 0.36692731 BAELDE_DIABETIC_NEPHROPATHY_DN granulosa cell tumor DOID_2999 6.408E-03 0.02642222 0.11414083 0.36486592 BAELDE_DIABETIC_NEPHROPATHY_DN nonsyndromic deafness DOID_0050563 6.961E-03 0.02849556 6.961E-03 0.08251839 BAELDE_DIABETIC_NEPHROPATHY_DN membranous glomerulonephritis DOID_10976 7.091E-03 0.02881805 7.091E-03 0.08069053 BAELDE_DIABETIC_NEPHROPATHY_DN pulmonary edema DOID_11396 7.091E-03 0.02861366 0.11977506 0.37446159 BAELDE_DIABETIC_NEPHROPATHY_DN sex cord-gonadal stromal tumor DOID_192 7.091E-03 0.02841216 0.11977506 0.37039135 BAELDE_DIABETIC_NEPHROPATHY_DN amyloidosis DOID_9120 7.091E-03 0.02821347 7.091E-03 0.07910836 BAELDE_DIABETIC_NEPHROPATHY_DN coronary restenosis DOID_4247 7.804E-03 0.0308378 0.1253736 0.38353536 BAELDE_DIABETIC_NEPHROPATHY_DN funisitis DOID_0050698 8.549E-03 0.03354743 8.549E-03 0.09354572 BAELDE_DIABETIC_NEPHROPATHY_DN gastric ulcer DOID_10808 8.549E-03 0.03331765 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN familial hypercholesterolemia DOID_13810 8.549E-03 0.033091 8.549E-03 0.09178071 BAELDE_DIABETIC_NEPHROPATHY_DN mineral metabolism disease DOID_0050032 9.012E-03 0.03464639 0.34796152 0.73602269 BAELDE_DIABETIC_NEPHROPATHY_DN endocrine pancreas disease DOID_1428 9.012E-03 0.03441386 0.06797893 0.29303038 BAELDE_DIABETIC_NEPHROPATHY_DN sexual disorder DOID_0060043 9.324E-03 0.03536992 9.324E-03 0.09307875 BAELDE_DIABETIC_NEPHROPATHY_DN urinary tract obstruction DOID_5200 9.324E-03 0.03513569 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN parasitic infectious disease DOID_1398 9.384E-03 0.0351287 0.06975453 0.29842351 BAELDE_DIABETIC_NEPHROPATHY_DN hyperglycemia DOID_4195 9.765E-03 0.03631703 9.765E-03 0.09417807 BAELDE_DIABETIC_NEPHROPATHY_DN synostosis DOID_11971 0.0101296 0.03742689 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN ureteral disease DOID_1426 0.0101296 0.03718543 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN toxic shock syndrome DOID_14115 0.01096468 0.03999296 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN severe combined immunodeficiency DOID_627 0.01096468 0.03973823 0.14741536 0.42150422 BAELDE_DIABETIC_NEPHROPATHY_DN blood coagulation disease DOID_1247 0.01137997 0.0409823 0.01137997 0.10615088 BAELDE_DIABETIC_NEPHROPATHY_DN pancreatic ductal carcinoma DOID_3587 0.01137997 0.04072455 0.37248388 0.77920341 BAELDE_DIABETIC_NEPHROPATHY_DN male reproductive system disease DOID_48 0.01180616 0.04198567 0.08071658 0.30215613 BAELDE_DIABETIC_NEPHROPATHY_DN commensal bacterial infectious disease DOID_0050339 0.01182906 0.04180582 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN X-linked disease DOID_0050735 0.01182906 0.04154776 0.01182906 0.10856028 BAELDE_DIABETIC_NEPHROPATHY_DN organic acidemia DOID_0060159 0.01182906 0.04129287 0.01182906 0.1068371 BAELDE_DIABETIC_NEPHROPATHY_DN reading disorder DOID_13365 0.01182906 0.04104108 0.15283881 0.43482642 BAELDE_DIABETIC_NEPHROPATHY_DN dyslexia DOID_4428 0.01182906 0.04104108 0.15283881 0.43482642 BAELDE_DIABETIC_NEPHROPATHY_DN combined T cell and B cell immunodeficiency DOID_628 0.01182906 0.04079235 0.15283881 0.42630042 BAELDE_DIABETIC_NEPHROPATHY_DN peripheral vascular disease DOID_341 0.01224144 0.04196012 0.08259261 0.30715813 BAELDE_DIABETIC_NEPHROPATHY_DN pancreatic carcinoma DOID_4905 0.01268583 0.04322298 0.38439842 0.79535527 BAELDE_DIABETIC_NEPHROPATHY_DN autosomal dominant nonsyndromic deafness DOID_0050564 0.01272236 0.04308941 0.01272236 0.11136954 BAELDE_DIABETIC_NEPHROPATHY_DN papillary adenoma DOID_3172 0.01272236 0.04283444 0.15822791 0.43704699 BAELDE_DIABETIC_NEPHROPATHY_DN microcystic adenoma DOID_5403 0.01272236 0.04283444 0.15822791 0.43704699 BAELDE_DIABETIC_NEPHROPATHY_DN follicular adenoma DOID_6204 0.01272236 0.04283444 0.15822791 0.43704699 BAELDE_DIABETIC_NEPHROPATHY_DN myositis DOID_633 0.01272236 0.04258247 0.15822791 0.43493565 BAELDE_DIABETIC_NEPHROPATHY_DN cleft lip DOID_9296 0.01272236 0.04233345 0.15822791 0.43284461 BAELDE_DIABETIC_NEPHROPATHY_DN endogenous depression DOID_1595 0.01360206 0.0449975 0.39221602 0.80567117 BAELDE_DIABETIC_NEPHROPATHY_DN intracranial aneurysm DOID_10941 0.01364415 0.04487585 0.16358286 0.44535238 BAELDE_DIABETIC_NEPHROPATHY_DN B cell deficiency DOID_2115 0.01364415 0.04461795 0.01364415 0.11587347 BAELDE_DIABETIC_NEPHROPATHY_DN middle cerebral artery infarction DOID_3525 0.01364415 0.04436299 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN extrinsic allergic alveolitis DOID_841 0.01364415 0.04411092 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN bone resorption disease DOID_0080011 0.01407394 0.04524334 0.01407394 0.116059 BAELDE_DIABETIC_NEPHROPATHY_DN osteoporosis DOID_11476 0.01407394 0.04524334 0.01407394 0.116059 BAELDE_DIABETIC_NEPHROPATHY_DN electroclinical syndrome DOID_0050701 0.01455503 0.04652704 0.39993475 0.81857148 BAELDE_DIABETIC_NEPHROPATHY_DN bacterial pneumonia DOID_874 0.01455503 0.04626712 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN lipid metabolism disorder DOID_3146 0.01554493 0.04913927 0.01554493 0.12284816 BAELDE_DIABETIC_NEPHROPATHY_DN autoimmune disease of cardiovascular system DOID_0060051 0.01557168 0.04895186 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN pleurisy DOID_10247 0.01557168 0.0486829 0.17419121 0.46099906 BAELDE_DIABETIC_NEPHROPATHY_DN sarcoma DOID_1115 0.01557168 0.04841687 0.17419121 0.4588648 BAELDE_DIABETIC_NEPHROPATHY_DN malaria DOID_12365 0.01557168 0.04815373 0.01557168 0.11973361 BAELDE_DIABETIC_NEPHROPATHY_DN Behcet's disease DOID_13241 0.01557168 0.04895186 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN thrombocytopenia DOID_1588 0.01557168 0.04789344 0.01557168 0.11813716 BAELDE_DIABETIC_NEPHROPATHY_DN auditory system disease DOID_2742 0.01657191 0.05069578 0.01657191 0.12088993 BAELDE_DIABETIC_NEPHROPATHY_DN multiple epiphyseal dysplasia DOID_12721 0.01657664 0.05043907 0.01657664 0.11939375 BAELDE_DIABETIC_NEPHROPATHY_DN mental depression DOID_1596 0.01709933 0.05175276 0.41880715 0.84804721 BAELDE_DIABETIC_NEPHROPATHY_DN chronic kidney failure DOID_784 0.01709933 0.05147894 0.1020473 0.35405435 BAELDE_DIABETIC_NEPHROPATHY_DN female reproductive organ benign neoplasm DOID_0060086 0.01760854 0.05273294 0.18466556 0.47979316 BAELDE_DIABETIC_NEPHROPATHY_DN uterine benign neoplasm DOID_0060095 0.01760854 0.05273294 0.18466556 0.47979316 BAELDE_DIABETIC_NEPHROPATHY_DN corneal disease DOID_10124 0.01760854 0.05245685 0.18466556 0.47761229 BAELDE_DIABETIC_NEPHROPATHY_DN uterine fibroid DOID_13223 0.01760854 0.05273294 0.18466556 0.47979316 BAELDE_DIABETIC_NEPHROPATHY_DN endometrial carcinoma DOID_2871 0.01760854 0.05218364 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN age related macular degeneration DOID_10871 0.01866701 0.05503381 0.18985301 0.48660525 BAELDE_DIABETIC_NEPHROPATHY_DN degeneration of macula and posterior pole DOID_2007 0.01866701 0.05503381 0.18985301 0.48660525 BAELDE_DIABETIC_NEPHROPATHY_DN endometrial cancer DOID_1380 0.01975166 0.05793142 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN germinoma DOID_3304 0.01975166 0.05763434 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN allergic rhinitis DOID_4481 0.01975166 0.05734029 0.1950076 0.49097046 BAELDE_DIABETIC_NEPHROPATHY_DN pleural disease DOID_1532 0.02086214 0.06025663 0.20012953 0.50164626 BAELDE_DIABETIC_NEPHROPATHY_DN papilloma DOID_2615 0.02199806 0.06321664 0.205219 0.50769395 BAELDE_DIABETIC_NEPHROPATHY_DN hair disease DOID_421 0.02199806 0.06289897 0.205219 0.50549614 BAELDE_DIABETIC_NEPHROPATHY_DN myocarditis DOID_820 0.02199806 0.06258448 0.205219 0.50331728 BAELDE_DIABETIC_NEPHROPATHY_DN carbohydrate metabolic disorder DOID_2978 0.02288705 0.06478971 0.02288705 0.15142712 BAELDE_DIABETIC_NEPHROPATHY_DN hepatitis C DOID_1883 0.02315906 0.06523518 0.21027622 0.51131268 BAELDE_DIABETIC_NEPHROPATHY_DN macular degeneration DOID_4448 0.02315906 0.06491382 0.21027622 0.50913688 BAELDE_DIABETIC_NEPHROPATHY_DN mouth disease DOID_403 0.02351728 0.06559476 0.45827146 0.92140092 BAELDE_DIABETIC_NEPHROPATHY_DN lymphoid leukemia DOID_10747 0.02434479 0.06757163 0.02434479 0.15564251 BAELDE_DIABETIC_NEPHROPATHY_DN pulmonary sarcoidosis DOID_13406 0.02678897 0.07399476 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN cleft palate DOID_674 0.02678897 0.0736373 0.22525641 0.5296318 BAELDE_DIABETIC_NEPHROPATHY_DN embryonal cancer DOID_688 0.02678897 0.07328327 0.02678897 0.16936579 BAELDE_DIABETIC_NEPHROPATHY_DN blood platelet disease DOID_2218 0.02804671 0.07635684 0.02804671 0.17346283 BAELDE_DIABETIC_NEPHROPATHY_DN hepatitis DOID_2237 0.02932777 0.07946429 0.23508564 0.54597442 BAELDE_DIABETIC_NEPHROPATHY_DN congenital diaphragmatic hernia DOID_3827 0.02932777 0.07908768 0.23508564 0.54375501 BAELDE_DIABETIC_NEPHROPATHY_DN peptic ulcer DOID_750 0.02932777 0.07871463 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN intracranial arterial disease DOID_13089 0.03063179 0.08182858 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN cerebral arterial disease DOID_3527 0.03063179 0.08182858 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN pulmonary emphysema DOID_9675 0.03195843 0.08497358 1.000 1.000 BAELDE_DIABETIC_NEPHROPATHY_DN diabetic autonomic neuropathy DOID_11503 0.03607072 0.09546159 0.25911881 0.58975441 BAELDE_DIABETIC_NEPHROPATHY_DN autonomic neuropathy DOID_11504 0.03607072 0.09546159 0.25911881 0.58975441 BAELDE_DIABETIC_NEPHROPATHY_DN diabetic polyneuropathy DOID_12785 0.03607072 0.09546159 0.25911881 0.58975441 BAELDE_DIABETIC_NEPHROPATHY_DN influenza DOID_8469 0.03607072 0.09501963 0.25911881 0.58507382 BAELDE_DIABETIC_NEPHROPATHY_DN diabetic neuropathy DOID_9743 0.03607072 0.09546159 0.25911881 0.58975441 LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP urinary system benign neoplasm DOID_731 1.135E-06 6.458E-04 1.793E-03 0.50997747 LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP uterine cancer DOID_363 9.012E-06 2.564E-03 4.95E-03 0.3520662 RODRIGUES_NTN1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 1.289E-08 7.333E-06 5.599E-07 3.186E-04 RODRIGUES_NTN1_TARGETS_DN pancreatic carcinoma DOID_4905 1.647E-08 4.685E-06 6.852E-07 1.949E-04 RODRIGUES_NTN1_TARGETS_DN giant cell tumor DOID_200 1.465E-07 2.779E-05 6.853E-06 1.3E-03 RODRIGUES_NTN1_TARGETS_DN malignant giant cell tumor DOID_2705 1.465E-07 2.779E-05 6.853E-06 1.3E-03 RODRIGUES_NTN1_TARGETS_DN giant cell glioblastoma DOID_3074 1.465E-07 2.779E-05 6.853E-06 1.3E-03 RODRIGUES_NTN1_TARGETS_DN glioblastoma DOID_3068 2.263E-07 3.219E-05 9.657E-06 1.374E-03 RODRIGUES_NTN1_TARGETS_DN astrocytoma DOID_3069 5.224E-07 5.945E-05 1.87E-05 1.773E-03 RODRIGUES_NTN1_TARGETS_DN primary bacterial infectious disease DOID_0050338 1.506E-06 1.428E-04 4.315E-05 3.069E-03 RODRIGUES_NTN1_TARGETS_DN Crohn's disease DOID_8778 2.191E-06 1.781E-04 5.804E-05 3.669E-03 RODRIGUES_NTN1_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 2.307E-06 1.641E-04 6.044E-05 3.439E-03 RODRIGUES_NTN1_TARGETS_DN bile duct cancer DOID_4606 9.657E-06 6.105E-04 9.657E-06 1.099E-03 RODRIGUES_NTN1_TARGETS_DN bile duct carcinoma DOID_4897 9.657E-06 6.105E-04 9.657E-06 1.099E-03 RODRIGUES_NTN1_TARGETS_DN tuberculosis DOID_399 1.769E-05 1.006E-03 5.013E-04 0.01677958 RODRIGUES_NTN1_TARGETS_DN ankylosing spondylitis DOID_7147 2.748E-05 1.421E-03 1.566E-03 0.02970442 RODRIGUES_NTN1_TARGETS_DN biliary tract cancer DOID_4607 3.602E-05 1.708E-03 3.602E-05 2.928E-03 RODRIGUES_NTN1_TARGETS_DN sarcoma DOID_1115 3.796E-05 1.662E-03 1.933E-03 0.03436748 RODRIGUES_NTN1_TARGETS_DN peptic ulcer DOID_750 1.053E-04 4.282E-03 0.08697498 0.31521507 RODRIGUES_NTN1_TARGETS_DN endometriosis of uterus DOID_288 1.296E-04 4.916E-03 0.09289339 0.32427202 RODRIGUES_NTN1_TARGETS_DN endometriosis DOID_289 1.384E-04 4.923E-03 0.09485776 0.31937316 RODRIGUES_NTN1_TARGETS_DN pre-eclampsia DOID_10591 1.776E-04 5.945E-03 5.293E-03 0.07345212 RODRIGUES_NTN1_TARGETS_DN aortic aneurysm DOID_3627 2.113E-04 6.68E-03 5.929E-03 0.07845358 RODRIGUES_NTN1_TARGETS_DN bile duct adenocarcinoma DOID_4896 2.623E-04 7.855E-03 2.623E-04 0.01356811 RODRIGUES_NTN1_TARGETS_DN cholangiocarcinoma DOID_4947 2.623E-04 7.855E-03 2.623E-04 0.01356811 RODRIGUES_NTN1_TARGETS_DN bone marrow cancer DOID_4960 2.623E-04 7.462E-03 2.623E-04 0.01243743 RODRIGUES_NTN1_TARGETS_DN osteochondrodysplasia DOID_2256 2.762E-04 7.483E-03 2.762E-04 0.01208809 RODRIGUES_NTN1_TARGETS_DN parasitic protozoa infectious disease DOID_2789 2.762E-04 7.143E-03 7.063E-03 0.09133151 RODRIGUES_NTN1_TARGETS_DN nonsyndromic deafness DOID_0050563 3.206E-04 7.932E-03 3.206E-04 0.01303128 RODRIGUES_NTN1_TARGETS_DN leprosy DOID_1024 3.549E-04 8.415E-03 0.02776079 0.21638204 RODRIGUES_NTN1_TARGETS_DN neuroectodermal tumor DOID_171 3.694E-04 8.409E-03 3.694E-04 0.01401442 RODRIGUES_NTN1_TARGETS_DN collagen disease DOID_854 3.694E-04 8.085E-03 0.12950634 0.38180885 RODRIGUES_NTN1_TARGETS_DN respiratory failure DOID_11162 3.867E-04 8.15E-03 8.801E-03 0.10654325 RODRIGUES_NTN1_TARGETS_DN parasitic infectious disease DOID_1398 4.416E-04 8.975E-03 9.598E-03 0.11377773 RODRIGUES_NTN1_TARGETS_DN uterine disease DOID_345 4.416E-04 8.665E-03 0.13702626 0.3937775 RODRIGUES_NTN1_TARGETS_DN temporal lobe epilepsy DOID_3328 4.61E-04 8.744E-03 9.871E-03 0.11462297 RODRIGUES_NTN1_TARGETS_DN mesenchymal cell neoplasm DOID_3350 4.765E-04 8.745E-03 4.765E-04 0.01694417 RODRIGUES_NTN1_TARGETS_DN spindle cell sarcoma DOID_4235 4.765E-04 8.745E-03 4.765E-04 0.01694417 RODRIGUES_NTN1_TARGETS_DN epithelioid sarcoma DOID_6193 4.765E-04 8.745E-03 4.765E-04 0.01694417 RODRIGUES_NTN1_TARGETS_DN peripheral vascular disease DOID_341 5.886E-04 0.0104662 0.15003203 0.4184717 RODRIGUES_NTN1_TARGETS_DN diabetic retinopathy DOID_8947 6.118E-04 0.01054972 0.01187517 0.12994177 RODRIGUES_NTN1_TARGETS_DN penile disease DOID_1529 6.154E-04 0.0102989 6.154E-04 0.01945347 RODRIGUES_NTN1_TARGETS_DN aneurysm disease DOID_2403 6.851E-04 0.01113698 0.01278422 0.13470781 RODRIGUES_NTN1_TARGETS_DN neuroendocrine tumor DOID_169 6.914E-04 0.01092722 6.914E-04 0.02070421 RODRIGUES_NTN1_TARGETS_DN mixed glioma DOID_5076 7.106E-04 0.01092843 7.106E-04 0.0202176 RODRIGUES_NTN1_TARGETS_DN female reproductive system disease DOID_229 7.91E-04 0.0118445 0.16465881 0.45261285 RODRIGUES_NTN1_TARGETS_DN auditory system disease DOID_2742 8.19E-04 0.01194966 8.19E-04 0.02219222 RODRIGUES_NTN1_TARGETS_DN focal epilepsy DOID_2234 8.477E-04 0.01205842 0.01469023 0.14926323 RODRIGUES_NTN1_TARGETS_DN chronic kidney failure DOID_784 8.477E-04 0.01176431 8.477E-04 0.0219244 RODRIGUES_NTN1_TARGETS_DN membranous glomerulonephritis DOID_10976 8.561E-04 0.01159859 0.04239215 0.25390669 RODRIGUES_NTN1_TARGETS_DN brain edema DOID_4724 8.561E-04 0.01132886 0.04239215 0.24613404 RODRIGUES_NTN1_TARGETS_DN bone development disease DOID_0080006 8.77E-04 0.0113408 8.77E-04 0.02169544 RODRIGUES_NTN1_TARGETS_DN retinal vascular disease DOID_2462 9.069E-04 0.01146698 0.01535117 0.15324238 RODRIGUES_NTN1_TARGETS_DN transitional cell carcinoma DOID_2671 1E-03 0.0123754 1E-03 0.02371952 RODRIGUES_NTN1_TARGETS_DN lymphoblastic leukemia DOID_1037 1.17E-03 0.01416014 1.17E-03 0.02662106 RODRIGUES_NTN1_TARGETS_DN encephalomyelitis DOID_640 1.17E-03 0.01386514 0.18613398 0.49723116 RODRIGUES_NTN1_TARGETS_DN aortic valve disease DOID_62 1.237E-03 0.01436071 1.237E-03 0.02706441 RODRIGUES_NTN1_TARGETS_DN portal hypertension DOID_10762 1.452E-03 0.01652562 0.05476006 0.27573869 RODRIGUES_NTN1_TARGETS_DN bronchiolitis DOID_2942 1.452E-03 0.01620158 1.452E-03 0.03060299 RODRIGUES_NTN1_TARGETS_DN osteosarcoma DOID_3347 1.452E-03 0.01589001 1.452E-03 0.02951003 RODRIGUES_NTN1_TARGETS_DN autosomal dominant nonsyndromic deafness DOID_0050564 1.566E-03 0.01681382 1.566E-03 0.03072871 RODRIGUES_NTN1_TARGETS_DN seminoma DOID_4440 1.684E-03 0.01774697 0.05884752 0.2911673 RODRIGUES_NTN1_TARGETS_DN extrinsic allergic alveolitis DOID_841 1.684E-03 0.0174243 0.05884752 0.28376474 RODRIGUES_NTN1_TARGETS_DN periodontitis DOID_824 1.806E-03 0.01835503 1.806E-03 0.03315748 RODRIGUES_NTN1_TARGETS_DN malaria DOID_12365 1.933E-03 0.01929402 1.933E-03 0.03332604 RODRIGUES_NTN1_TARGETS_DN hepatic vascular disease DOID_272 1.933E-03 0.01896137 0.06291753 0.2910575 RODRIGUES_NTN1_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 2.063E-03 0.01989759 0.064946 0.28870528 RODRIGUES_NTN1_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 2.063E-03 0.01956597 2.063E-03 0.03452818 RODRIGUES_NTN1_TARGETS_DN germinoma DOID_3304 2.479E-03 0.02312102 0.07100545 0.29707426 RODRIGUES_NTN1_TARGETS_DN chronic leukemia DOID_1036 2.625E-03 0.024093 2.625E-03 0.04267903 RODRIGUES_NTN1_TARGETS_DN chronic lymphocytic leukemia DOID_1040 2.625E-03 0.024093 2.625E-03 0.04267903 RODRIGUES_NTN1_TARGETS_DN pneumoconiosis DOID_10316 2.93E-03 0.02646567 0.0770261 0.30864684 RODRIGUES_NTN1_TARGETS_DN periodontal disease DOID_3388 2.93E-03 0.02605215 2.93E-03 0.04631493 RODRIGUES_NTN1_TARGETS_DN spindle cell carcinoma DOID_4015 2.93E-03 0.02565134 2.93E-03 0.04506317 RODRIGUES_NTN1_TARGETS_DN systemic scleroderma DOID_418 3.762E-03 0.03243166 0.08697498 0.31723568 RODRIGUES_NTN1_TARGETS_DN adult respiratory distress syndrome DOID_11394 3.94E-03 0.03345918 3.94E-03 0.05899382 RODRIGUES_NTN1_TARGETS_DN lymphatic system disease DOID_75 3.94E-03 0.03296713 0.08895201 0.31633559 RODRIGUES_NTN1_TARGETS_DN benign mesothelioma DOID_2645 4.122E-03 0.03398889 4.122E-03 0.06013418 RODRIGUES_NTN1_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 4.122E-03 0.03350333 1.000 1.000 RODRIGUES_NTN1_TARGETS_DN nephrotic syndrome DOID_1184 4.497E-03 0.03603813 0.09485776 0.32711554 RODRIGUES_NTN1_TARGETS_DN rheumatic disease DOID_1575 4.497E-03 0.0355376 0.09485776 0.32514496 RODRIGUES_NTN1_TARGETS_DN scleroderma DOID_419 4.497E-03 0.0355376 0.09485776 0.32514496 RODRIGUES_NTN1_TARGETS_DN gallbladder cancer DOID_3121 4.69E-03 0.03655745 4.69E-03 0.06671734 RODRIGUES_NTN1_TARGETS_DN proteinuria DOID_576 5.088E-03 0.03912322 1.000 1.000 RODRIGUES_NTN1_TARGETS_DN heart valve disease DOID_4079 5.293E-03 0.04015382 5.293E-03 0.07170326 RODRIGUES_NTN1_TARGETS_DN vascular skin disease DOID_9540 5.293E-03 0.03962548 1.000 1.000 RODRIGUES_NTN1_TARGETS_DN sarcoidosis DOID_11335 6.598E-03 0.04875765 0.11427177 0.35146292 RODRIGUES_NTN1_TARGETS_DN vasculitis DOID_865 6.829E-03 0.04981325 0.1161904 0.35544269 RODRIGUES_NTN1_TARGETS_DN pustulosis of palm and sole DOID_4398 7.063E-03 0.05086818 0.11810493 0.35556457 RODRIGUES_NTN1_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 7.786E-03 0.05537884 7.786E-03 0.09845127 RODRIGUES_NTN1_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 7.786E-03 0.05469515 0.12382395 0.36887869 RODRIGUES_NTN1_TARGETS_DN carotid artery disease DOID_3407 8.542E-03 0.05927104 8.542E-03 0.10565707 RODRIGUES_NTN1_TARGETS_DN hypothyroidism DOID_1459 8.801E-03 0.06033172 0.13139237 0.38537246 RODRIGUES_NTN1_TARGETS_DN pre-malignant neoplasm DOID_0060071 9.063E-03 0.06139078 1.000 1.000 RODRIGUES_NTN1_TARGETS_DN congenital heart defect DOID_1682 9.063E-03 0.06066853 0.13327436 0.38888774 RODRIGUES_NTN1_TARGETS_DN in situ carcinoma DOID_8719 9.063E-03 0.06139078 1.000 1.000 RODRIGUES_NTN1_TARGETS_DN tooth disease DOID_1091 0.01014705 0.0671357 0.01014705 0.1154734 RODRIGUES_NTN1_TARGETS_DN nephrosis DOID_2527 0.0112857 0.07381105 0.14818599 0.41535876 RODRIGUES_NTN1_TARGETS_DN male reproductive system disease DOID_48 0.0112857 0.07297229 0.0112857 0.12591297 RODRIGUES_NTN1_TARGETS_DN bone resorption disease DOID_0080011 0.01278422 0.08173283 0.01278422 0.13724947 RODRIGUES_NTN1_TARGETS_DN osteoporosis DOID_11476 0.01278422 0.08173283 0.01278422 0.13724947 RODRIGUES_NTN1_TARGETS_DN bacterial pneumonia DOID_874 0.0130938 0.08278191 0.0130938 0.13546132 VERRECCHIA_RESPONSE_TO_TGFB1_C5 pre-malignant neoplasm DOID_0060071 1.423E-06 8.099E-04 2.3E-04 0.06542422 VERRECCHIA_RESPONSE_TO_TGFB1_C5 in situ carcinoma DOID_8719 1.423E-06 8.099E-04 2.3E-04 0.06542422 VERRECCHIA_RESPONSE_TO_TGFB1_C5 transitional cell carcinoma DOID_2671 3.637E-06 1.035E-03 4.274E-04 0.08106003 VERRECCHIA_RESPONSE_TO_TGFB1_C5 invasive lobular carcinoma DOID_3457 5.96E-06 1.13E-03 5.96E-06 3.391E-03 VERRECCHIA_RESPONSE_TO_TGFB1_C5 ocular hypertension DOID_9282 7.15E-06 1.017E-03 4.108E-03 0.33390088 VERRECCHIA_RESPONSE_TO_TGFB1_C5 borderline glaucoma DOID_9283 7.15E-06 1.017E-03 4.108E-03 0.33390088 VERRECCHIA_RESPONSE_TO_TGFB1_C5 focal glomerulosclerosis DOID_3945 5.019E-05 5.712E-03 0.01057983 0.22296009 VERRECCHIA_RESPONSE_TO_TGFB1_C5 cervix uteri carcinoma in situ DOID_8991 1.019E-04 9.659E-03 0.0149857 0.20797231 VERRECCHIA_RESPONSE_TO_TGFB1_C5 glaucoma DOID_1686 1.425E-04 0.01158678 0.017688 0.1973426 VERRECCHIA_RESPONSE_TO_TGFB1_C5 carotid artery disease DOID_3407 2.162E-04 0.01537835 0.02172862 0.22479244 VERRECCHIA_RESPONSE_TO_TGFB1_C5 pancreatic ductal carcinoma DOID_3587 2.814E-04 0.01778837 0.02474901 0.23868112 VERRECCHIA_RESPONSE_TO_TGFB1_C5 pancreatic carcinoma DOID_4905 3.05E-04 0.01735187 0.02575389 0.24423273 HSIAO_HOUSEKEEPING_GENES Diamond-Blackfan anemia DOID_1339 1.957E-14 1.114E-11 1.957E-14 1.114E-11 HSIAO_HOUSEKEEPING_GENES lymphoma DOID_0060058 1.591E-10 4.527E-08 1.118E-06 1.06E-04 HSIAO_HOUSEKEEPING_GENES congenital hypoplastic anemia DOID_1342 1.772E-10 3.361E-08 1.772E-10 5.041E-08 HSIAO_HOUSEKEEPING_GENES aplastic anemia DOID_12449 1.8E-09 2.561E-07 1.8E-09 3.415E-07 HSIAO_HOUSEKEEPING_GENES bone marrow disease DOID_4961 1.345E-08 1.531E-06 1.345E-08 1.914E-06 HSIAO_HOUSEKEEPING_GENES parasitic infectious disease DOID_1398 1.198E-07 1.136E-05 4.27E-05 1.735E-03 HSIAO_HOUSEKEEPING_GENES bone resorption disease DOID_0080011 3.4E-07 2.764E-05 3.4E-07 3.869E-05 HSIAO_HOUSEKEEPING_GENES osteoporosis DOID_11476 3.4E-07 2.764E-05 3.4E-07 3.869E-05 HSIAO_HOUSEKEEPING_GENES glaucoma DOID_1686 4.944E-07 3.516E-05 2.161E-04 5.347E-03 HSIAO_HOUSEKEEPING_GENES lung adenocarcinoma DOID_3910 5.816E-07 3.677E-05 2.099E-05 9.952E-04 HSIAO_HOUSEKEEPING_GENES B-cell lymphocytic neoplasm DOID_707 6.213E-07 3.535E-05 2.503E-04 5.477E-03 HSIAO_HOUSEKEEPING_GENES parasitic helminthiasis infectious disease DOID_883 9.453E-07 4.89E-05 2.76E-03 0.02755087 HSIAO_HOUSEKEEPING_GENES nutritional deficiency disease DOID_5113 1.283E-06 6.085E-05 7.676E-05 2.569E-03 HSIAO_HOUSEKEEPING_GENES Charcot-Marie-Tooth disease DOID_10595 1.332E-06 5.829E-05 1.332E-06 1.083E-04 HSIAO_HOUSEKEEPING_GENES dilated cardiomyopathy DOID_12930 1.383E-06 5.62E-05 1.943E-05 1.005E-03 HSIAO_HOUSEKEEPING_GENES multiple myeloma DOID_9538 3.064E-06 1.162E-04 3.064E-06 2.179E-04 HSIAO_HOUSEKEEPING_GENES funisitis DOID_0050698 6.667E-06 2.371E-04 2.523E-04 5.317E-03 HSIAO_HOUSEKEEPING_GENES cataract DOID_83 7.686E-06 2.573E-04 2.544E-03 0.02731288 HSIAO_HOUSEKEEPING_GENES proteinuria DOID_576 8.52E-06 2.693E-04 1.714E-04 4.876E-03 HSIAO_HOUSEKEEPING_GENES myeloma DOID_0070004 9.424E-06 2.822E-04 9.424E-06 5.958E-04 HSIAO_HOUSEKEEPING_GENES lens disease DOID_110 9.424E-06 2.681E-04 2.859E-03 0.02805021 HSIAO_HOUSEKEEPING_GENES primary immunodeficiency disease DOID_612 1.348E-05 3.653E-04 1.715E-04 4.647E-03 HSIAO_HOUSEKEEPING_GENES encephalomyelitis DOID_640 1.725E-05 4.462E-04 2.098E-04 5.426E-03 HSIAO_HOUSEKEEPING_GENES bone marrow cancer DOID_4960 1.804E-05 4.462E-04 1.804E-05 1.026E-03 HSIAO_HOUSEKEEPING_GENES vasculitis DOID_865 1.804E-05 4.276E-04 3.085E-04 6.269E-03 HSIAO_HOUSEKEEPING_GENES alcohol-related neurodevelopmental disorder DOID_0050667 1.832E-05 4.169E-04 2.203E-04 5.223E-03 HSIAO_HOUSEKEEPING_GENES Sjogren's syndrome DOID_12894 2.067E-05 4.524E-04 1.385E-03 0.01876691 HSIAO_HOUSEKEEPING_GENES carotid artery disease DOID_3407 3.181E-05 6.703E-04 4.812E-04 8.831E-03 HSIAO_HOUSEKEEPING_GENES pre-malignant neoplasm DOID_0060071 3.694E-05 7.507E-04 5.41E-04 9.054E-03 HSIAO_HOUSEKEEPING_GENES in situ carcinoma DOID_8719 3.694E-05 7.507E-04 5.41E-04 9.054E-03 HSIAO_HOUSEKEEPING_GENES encephalitis DOID_9588 3.758E-05 7.373E-04 2.017E-03 0.02390564 HSIAO_HOUSEKEEPING_GENES mineral metabolism disease DOID_0050032 3.974E-05 7.537E-04 3.974E-05 1.739E-03 HSIAO_HOUSEKEEPING_GENES Charcot-Marie-Tooth disease type 2 DOID_0050539 4.865E-05 8.93E-04 4.865E-05 1.845E-03 HSIAO_HOUSEKEEPING_GENES brain infarction DOID_3454 5.26E-05 9.353E-04 5.26E-05 1.871E-03 HSIAO_HOUSEKEEPING_GENES varicose veins DOID_799 7.676E-05 1.323E-03 3.173E-03 0.02959476 HSIAO_HOUSEKEEPING_GENES calcinosis DOID_182 7.693E-05 1.287E-03 7.693E-05 2.432E-03 HSIAO_HOUSEKEEPING_GENES pancreatitis DOID_4989 9.321E-05 1.515E-03 1.116E-03 0.01628847 HSIAO_HOUSEKEEPING_GENES mixed glioma DOID_5076 9.321E-05 1.473E-03 0.01059376 0.06772868 HSIAO_HOUSEKEEPING_GENES vein disease DOID_866 9.408E-05 1.447E-03 3.613E-03 0.03162355 HSIAO_HOUSEKEEPING_GENES cervix uteri carcinoma in situ DOID_8991 1.123E-04 1.681E-03 1.123E-04 3.362E-03 HSIAO_HOUSEKEEPING_GENES mental depression DOID_1596 1.243E-04 1.814E-03 1.398E-03 0.01850326 HSIAO_HOUSEKEEPING_GENES prion disease DOID_649 1.359E-04 1.934E-03 0.09689565 0.28273653 HSIAO_HOUSEKEEPING_GENES Human immunodeficiency virus infectious disease DOID_526 1.805E-04 2.505E-03 1.871E-03 0.02265596 HSIAO_HOUSEKEEPING_GENES calcium metabolism disease DOID_10575 2.327E-04 3.153E-03 2.327E-04 5.297E-03 HSIAO_HOUSEKEEPING_GENES diabetic angiopathy DOID_11713 3.289E-04 4.352E-03 0.12707038 0.32865022 HSIAO_HOUSEKEEPING_GENES parasitic protozoa infectious disease DOID_2789 3.299E-04 4.266E-03 4.355E-03 0.03754609 HSIAO_HOUSEKEEPING_GENES pustulosis of palm and sole DOID_4398 3.299E-04 4.171E-03 0.04264264 0.19567472 HSIAO_HOUSEKEEPING_GENES mitochondrial metabolism disease DOID_700 3.523E-04 4.358E-03 3.523E-04 6.913E-03 HSIAO_HOUSEKEEPING_GENES oral cavity cancer DOID_8618 4.004E-04 4.848E-03 4.004E-04 7.595E-03 HSIAO_HOUSEKEEPING_GENES melancholia DOID_2848 4.262E-04 5.052E-03 5.251E-03 0.04268103 HSIAO_HOUSEKEEPING_GENES neurotic disorder DOID_4964 4.531E-04 5.261E-03 5.491E-03 0.04400234 HSIAO_HOUSEKEEPING_GENES spinal muscular atrophy DOID_12377 4.694E-04 5.342E-03 0.01014488 0.06712137 HSIAO_HOUSEKEEPING_GENES myositis DOID_633 4.694E-04 5.237E-03 0.01014488 0.06634986 HSIAO_HOUSEKEEPING_GENES B cell deficiency DOID_2115 5.235E-04 5.729E-03 0.01088499 0.06881731 HSIAO_HOUSEKEEPING_GENES spinal cord disease DOID_319 5.235E-04 5.62E-03 5.235E-04 9.309E-03 HSIAO_HOUSEKEEPING_GENES middle cerebral artery infarction DOID_3525 5.235E-04 5.516E-03 5.235E-04 9.027E-03 HSIAO_HOUSEKEEPING_GENES diffuse large B-cell lymphoma DOID_0050745 5.815E-04 6.016E-03 5.815E-04 9.454E-03 HSIAO_HOUSEKEEPING_GENES cerebral degeneration DOID_1443 6.06E-04 6.157E-03 6.06E-04 9.578E-03 HSIAO_HOUSEKEEPING_GENES hyperglycemia DOID_4195 6.404E-04 6.393E-03 6.404E-04 9.849E-03 HSIAO_HOUSEKEEPING_GENES autoimmune disease of cardiovascular system DOID_0060051 6.434E-04 6.312E-03 0.01243426 0.07526697 HSIAO_HOUSEKEEPING_GENES sarcoma DOID_1115 6.434E-04 6.205E-03 0.15624147 0.36888546 HSIAO_HOUSEKEEPING_GENES malaria DOID_12365 6.434E-04 6.102E-03 0.01243426 0.07447469 HSIAO_HOUSEKEEPING_GENES Behcet's disease DOID_13241 6.434E-04 6.312E-03 0.01243426 0.07526697 HSIAO_HOUSEKEEPING_GENES autoimmune disease of the nervous system DOID_438 6.434E-04 6.002E-03 0.15624147 0.36584936 HSIAO_HOUSEKEEPING_GENES cranial nerve disease DOID_5656 7.094E-04 6.511E-03 7.094E-04 0.01062272 HSIAO_HOUSEKEEPING_GENES nephrosis DOID_2527 8.339E-04 7.531E-03 0.06575074 0.24136884 HSIAO_HOUSEKEEPING_GENES male reproductive system disease DOID_48 8.339E-04 7.414E-03 8.567E-03 0.06170151 HSIAO_HOUSEKEEPING_GENES age related macular degeneration DOID_10871 8.54E-04 7.476E-03 0.01492665 0.08579053 HSIAO_HOUSEKEEPING_GENES degeneration of macula and posterior pole DOID_2007 8.54E-04 7.476E-03 0.01492665 0.08579053 HSIAO_HOUSEKEEPING_GENES peripheral vascular disease DOID_341 8.77E-04 7.561E-03 0.34621417 0.67234083 HSIAO_HOUSEKEEPING_GENES germinoma DOID_3304 9.327E-04 7.921E-03 0.01580127 0.08990921 HSIAO_HOUSEKEEPING_GENES endogenous depression DOID_1595 1.016E-03 8.5E-03 9.89E-03 0.06699311 HSIAO_HOUSEKEEPING_GENES myocarditis DOID_820 1.104E-03 9.102E-03 0.01761462 0.09730794 HSIAO_HOUSEKEEPING_GENES nephroblastoma DOID_2154 1.196E-03 9.723E-03 0.01855282 0.1005386 HSIAO_HOUSEKEEPING_GENES macular degeneration DOID_4448 1.196E-03 9.586E-03 0.01855282 0.09959012 HSIAO_HOUSEKEEPING_GENES hyperthyroidism DOID_7998 1.196E-03 9.453E-03 0.01855282 0.09865937 HSIAO_HOUSEKEEPING_GENES chromosomal disease DOID_0080014 1.28E-03 9.979E-03 0.01170254 0.07237765 HSIAO_HOUSEKEEPING_GENES medullomyoblastoma DOID_3861 1.293E-03 9.944E-03 1.293E-03 0.01839723 HSIAO_HOUSEKEEPING_GENES adult medulloblastoma DOID_3864 1.293E-03 9.944E-03 1.293E-03 0.01839723 HSIAO_HOUSEKEEPING_GENES childhood medulloblastoma DOID_3869 1.293E-03 9.944E-03 1.293E-03 0.01839723 HSIAO_HOUSEKEEPING_GENES auditory system disease DOID_2742 1.338E-03 0.01015369 0.0120864 0.07394795 HSIAO_HOUSEKEEPING_GENES T cell deficiency DOID_11200 1.385E-03 0.01037119 1.385E-03 0.01922464 HSIAO_HOUSEKEEPING_GENES transient cerebral ischemia DOID_224 1.385E-03 0.0102365 0.05504187 0.23726381 HSIAO_HOUSEKEEPING_GENES lateral sclerosis DOID_230 1.385E-03 0.01010526 0.05504187 0.23547987 HSIAO_HOUSEKEEPING_GENES Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.385E-03 9.977E-03 0.05504187 0.23028546 HSIAO_HOUSEKEEPING_GENES Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.385E-03 9.977E-03 0.05504187 0.23028546 HSIAO_HOUSEKEEPING_GENES Hodgkin's granuloma DOID_8651 1.385E-03 9.977E-03 0.05504187 0.23028546 HSIAO_HOUSEKEEPING_GENES Hodgkin's lymphoma, mixed cellularity DOID_8654 1.385E-03 9.977E-03 0.05504187 0.23028546 HSIAO_HOUSEKEEPING_GENES adenoma DOID_657 1.395E-03 9.924E-03 0.02049094 0.10795691 HSIAO_HOUSEKEEPING_GENES medulloblastoma DOID_3858 1.502E-03 0.01055233 1.502E-03 0.01942587 HSIAO_HOUSEKEEPING_GENES embryonal cancer DOID_688 1.502E-03 0.01042364 1.502E-03 0.01899419 HSIAO_HOUSEKEEPING_GENES common variable immunodeficiency DOID_12177 1.687E-03 0.01156373 0.06037737 0.24024284 HSIAO_HOUSEKEEPING_GENES invasive lobular carcinoma DOID_3457 1.687E-03 0.01142607 0.06037737 0.23857449 HSIAO_HOUSEKEEPING_GENES transitional cell carcinoma DOID_2671 1.726E-03 0.01155672 0.09204088 0.27563821 HSIAO_HOUSEKEEPING_GENES intracranial arterial disease DOID_13089 1.853E-03 0.01226119 1.853E-03 0.02292309 HSIAO_HOUSEKEEPING_GENES cerebral arterial disease DOID_3527 1.853E-03 0.01226119 1.853E-03 0.02292309 HSIAO_HOUSEKEEPING_GENES peritonitis DOID_8283 2.017E-03 0.01318932 0.0656829 0.24750707 HSIAO_HOUSEKEEPING_GENES Hodgkin's lymphoma DOID_8567 2.017E-03 0.01303944 0.0656829 0.24587873 HSIAO_HOUSEKEEPING_GENES ocular hypertension DOID_9282 2.017E-03 0.01289293 1.000 1.000 HSIAO_HOUSEKEEPING_GENES borderline glaucoma DOID_9283 2.017E-03 0.01289293 1.000 1.000 HSIAO_HOUSEKEEPING_GENES primitive neuroectodermal tumor DOID_168 2.251E-03 0.01423373 2.251E-03 0.02614358 HSIAO_HOUSEKEEPING_GENES uveal disease DOID_3480 2.251E-03 0.01407731 0.02789563 0.13683288 HSIAO_HOUSEKEEPING_GENES hypersensitivity reaction type I disease DOID_1205 2.27E-03 0.01404204 0.10435598 0.29107133 HSIAO_HOUSEKEEPING_GENES obstructive hydrocephalus DOID_14159 2.374E-03 0.01452762 2.374E-03 0.02702138 HSIAO_HOUSEKEEPING_GENES communicating hydrocephalus DOID_1573 2.374E-03 0.01452762 2.374E-03 0.02702138 HSIAO_HOUSEKEEPING_GENES diabetic autonomic neuropathy DOID_11503 2.395E-03 0.01449714 2.395E-03 0.02672022 HSIAO_HOUSEKEEPING_GENES autonomic neuropathy DOID_11504 2.395E-03 0.01449714 2.395E-03 0.02672022 HSIAO_HOUSEKEEPING_GENES diabetic polyneuropathy DOID_12785 2.395E-03 0.01449714 2.395E-03 0.02672022 HSIAO_HOUSEKEEPING_GENES diabetic neuropathy DOID_9743 2.395E-03 0.01449714 2.395E-03 0.02672022 HSIAO_HOUSEKEEPING_GENES cerebral infarction DOID_3526 2.544E-03 0.01523771 2.544E-03 0.02783813 HSIAO_HOUSEKEEPING_GENES leukodystrophy DOID_10579 2.699E-03 0.01599614 2.699E-03 0.02843759 HSIAO_HOUSEKEEPING_GENES tethered spinal cord syndrome DOID_1089 2.76E-03 0.01618968 2.76E-03 0.02855272 HSIAO_HOUSEKEEPING_GENES hydrocephalus DOID_10908 2.76E-03 0.01602448 2.76E-03 0.02804285 HSIAO_HOUSEKEEPING_GENES narcolepsy DOID_8986 2.76E-03 0.01586262 0.07620465 0.25964339 HSIAO_HOUSEKEEPING_GENES autonomic nervous system disease DOID_11465 2.859E-03 0.01626912 2.859E-03 0.02757478 HSIAO_HOUSEKEEPING_GENES hemolytic anemia DOID_583 3.025E-03 0.01704423 3.025E-03 0.02869113 HSIAO_HOUSEKEEPING_GENES normocytic anemia DOID_720 3.025E-03 0.01704423 3.025E-03 0.02869113 HSIAO_HOUSEKEEPING_GENES mesenchymal cell neoplasm DOID_3350 3.173E-03 0.01769883 0.08142122 0.26473527 HSIAO_HOUSEKEEPING_GENES spindle cell sarcoma DOID_4235 3.173E-03 0.01769883 0.08142122 0.26473527 HSIAO_HOUSEKEEPING_GENES epithelioid sarcoma DOID_6193 3.173E-03 0.01769883 0.08142122 0.26473527 HSIAO_HOUSEKEEPING_GENES intracranial hypertension DOID_9428 3.173E-03 0.01752699 3.173E-03 0.02911742 HSIAO_HOUSEKEEPING_GENES hemorrhagic disease DOID_2213 3.559E-03 0.01947255 3.559E-03 0.03214517 HSIAO_HOUSEKEEPING_GENES thyroiditis DOID_7166 3.613E-03 0.01957648 0.08660846 0.26782725 HSIAO_HOUSEKEEPING_GENES autoimmune thyroiditis DOID_7188 3.613E-03 0.01957648 0.08660846 0.26782725 HSIAO_HOUSEKEEPING_GENES chronic myeloid leukemia DOID_8552 3.613E-03 0.0193918 0.08660846 0.26637954 HSIAO_HOUSEKEEPING_GENES tongue cancer DOID_8649 3.613E-03 0.01921057 3.613E-03 0.03211766 HSIAO_HOUSEKEEPING_GENES bile duct adenocarcinoma DOID_4896 4.147E-03 0.02184792 0.04132238 0.19115802 HSIAO_HOUSEKEEPING_GENES cholangiocarcinoma DOID_4947 4.147E-03 0.02184792 0.04132238 0.19115802 HSIAO_HOUSEKEEPING_GENES nonsyndromic deafness DOID_0050563 5.017E-03 0.0261912 5.017E-03 0.04260957 HSIAO_HOUSEKEEPING_GENES hypertrophic cardiomyopathy DOID_11984 5.017E-03 0.0259531 5.017E-03 0.04198296 HSIAO_HOUSEKEEPING_GENES hypersensitivity reaction type IV disease DOID_2916 5.017E-03 0.02571929 0.29219215 0.5772824 HSIAO_HOUSEKEEPING_GENES bile duct cancer DOID_4606 5.017E-03 0.02548965 0.04669639 0.20921455 HSIAO_HOUSEKEEPING_GENES bile duct carcinoma DOID_4897 5.017E-03 0.02548965 0.04669639 0.20921455 HSIAO_HOUSEKEEPING_GENES Down syndrome DOID_14250 5.091E-03 0.02563461 0.10199591 0.29459733 HSIAO_HOUSEKEEPING_GENES agammaglobulinemia DOID_2583 5.091E-03 0.02540975 0.10199591 0.29310946 HSIAO_HOUSEKEEPING_GENES testicular cancer DOID_2998 5.091E-03 0.02518879 0.10199591 0.29163655 HSIAO_HOUSEKEEPING_GENES granulosa cell tumor DOID_2999 5.091E-03 0.02497165 0.10199591 0.29017837 HSIAO_HOUSEKEEPING_GENES psoriasis DOID_8893 5.091E-03 0.02475822 5.091E-03 0.04198132 HSIAO_HOUSEKEEPING_GENES sex cord-gonadal stromal tumor DOID_192 5.636E-03 0.02717509 0.10706751 0.295735 HSIAO_HOUSEKEEPING_GENES subependymal glioma DOID_4843 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES pilocytic astrocytoma DOID_4851 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES subependymal giant cell astrocytoma DOID_5077 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES blood protein disease DOID_620 5.636E-03 0.02672217 0.10706751 0.2928914 HSIAO_HOUSEKEEPING_GENES fibrillary astrocytoma DOID_6726 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES juvenile pilocytic astrocytoma DOID_6811 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES childhood pilocytic astrocytoma DOID_6812 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES gemistocytic astrocytoma DOID_7005 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES childhood cerebral astrocytoma DOID_7007 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES protoplasmic astrocytoma DOID_7008 5.636E-03 0.02694673 0.10706751 0.29430633 HSIAO_HOUSEKEEPING_GENES neuroectodermal tumor DOID_171 5.737E-03 0.02697809 5.737E-03 0.04533819 HSIAO_HOUSEKEEPING_GENES Leigh disease DOID_3652 6.206E-03 0.02894342 6.206E-03 0.0483712 HSIAO_HOUSEKEEPING_GENES congenital heart defect DOID_1682 6.249E-03 0.02890965 6.249E-03 0.04805252 HSIAO_HOUSEKEEPING_GENES benign glioma DOID_0060101 6.801E-03 0.03120847 0.11712533 0.31435996 HSIAO_HOUSEKEEPING_GENES hepatitis B DOID_2043 6.801E-03 0.0309588 0.11712533 0.31288409 HSIAO_HOUSEKEEPING_GENES benign ependymoma DOID_4844 6.801E-03 0.03120847 0.11712533 0.31435996 HSIAO_HOUSEKEEPING_GENES muscular atrophy DOID_767 6.801E-03 0.0307131 0.11712533 0.31142202 HSIAO_HOUSEKEEPING_GENES temporal lobe epilepsy DOID_3328 7.068E-03 0.03166525 7.068E-03 0.05361982 HSIAO_HOUSEKEEPING_GENES glycogen metabolism disorder DOID_0050728 7.421E-03 0.03299022 7.421E-03 0.05556248 HSIAO_HOUSEKEEPING_GENES optic nerve disease DOID_1891 7.421E-03 0.03273449 7.421E-03 0.05484089 HSIAO_HOUSEKEEPING_GENES glycogen storage disease DOID_2747 7.421E-03 0.03299022 7.421E-03 0.05556248 HSIAO_HOUSEKEEPING_GENES myasthenia gravis DOID_437 7.421E-03 0.03248268 1.000 1.000 HSIAO_HOUSEKEEPING_GENES sleep disorder DOID_535 7.421E-03 0.03223472 0.12211187 0.31726783 HSIAO_HOUSEKEEPING_GENES endocrine organ benign neoplasm DOID_0060089 7.647E-03 0.03296223 0.06115213 0.23996939 HSIAO_HOUSEKEEPING_GENES astrocytoma DOID_3069 7.947E-03 0.03399685 0.06267229 0.24425022 HSIAO_HOUSEKEEPING_GENES meningitis DOID_9471 8.066E-03 0.03425092 0.12707038 0.32278146 HSIAO_HOUSEKEEPING_GENES blood coagulation disease DOID_1247 8.253E-03 0.0347855 8.253E-03 0.06020568 HSIAO_HOUSEKEEPING_GENES pancreatic ductal carcinoma DOID_3587 8.253E-03 0.03452973 0.06420522 0.24852225 HSIAO_HOUSEKEEPING_GENES sphingolipidosis DOID_1927 8.735E-03 0.03627961 8.735E-03 0.06212884 HSIAO_HOUSEKEEPING_GENES acute pancreatitis DOID_2913 8.735E-03 0.03601672 8.735E-03 0.06136181 HSIAO_HOUSEKEEPING_GENES pancreatic carcinoma DOID_4905 9.214E-03 0.03771932 0.06887876 0.25123087 HSIAO_HOUSEKEEPING_GENES portal hypertension DOID_10762 9.428E-03 0.03831881 9.428E-03 0.06542236 HSIAO_HOUSEKEEPING_GENES reading disorder DOID_13365 9.428E-03 0.03804705 9.428E-03 0.06463414 HSIAO_HOUSEKEEPING_GENES dyslexia DOID_4428 9.428E-03 0.03804705 9.428E-03 0.06463414 HSIAO_HOUSEKEEPING_GENES autosomal dominant nonsyndromic deafness DOID_0050564 0.01014488 0.04065097 0.01014488 0.06791104 HSIAO_HOUSEKEEPING_GENES papillary adenoma DOID_3172 0.01014488 0.0403667 0.14177928 0.34623352 HSIAO_HOUSEKEEPING_GENES neuromuscular junction disease DOID_439 0.01014488 0.04008638 1.000 1.000 HSIAO_HOUSEKEEPING_GENES microcystic adenoma DOID_5403 0.01014488 0.0403667 0.14177928 0.34623352 HSIAO_HOUSEKEEPING_GENES follicular adenoma DOID_6204 0.01014488 0.0403667 0.14177928 0.34623352 HSIAO_HOUSEKEEPING_GENES electroclinical syndrome DOID_0050701 0.01059376 0.04157139 0.01059376 0.06849832 HSIAO_HOUSEKEEPING_GENES seminoma DOID_4440 0.01088499 0.04242163 0.14662721 0.3535207 HSIAO_HOUSEKEEPING_GENES perinatal necrotizing enterocolitis DOID_8677 0.01164821 0.04508728 0.01164821 0.0728333 HSIAO_HOUSEKEEPING_GENES thrombocytopenia DOID_1588 0.01243426 0.0478047 0.01243426 0.07369891 HSIAO_HOUSEKEEPING_GENES hepatic vascular disease DOID_272 0.01243426 0.04748386 0.01243426 0.07293913 HSIAO_HOUSEKEEPING_GENES focal epilepsy DOID_2234 0.01247742 0.04733103 0.01247742 0.07244545 HSIAO_HOUSEKEEPING_GENES biliary tract cancer DOID_4607 0.01247742 0.04701758 0.08352893 0.26258542 HSIAO_HOUSEKEEPING_GENES autoimmune disease of endocrine system DOID_0060005 0.01324287 0.04957365 0.16100809 0.37546558 HSIAO_HOUSEKEEPING_GENES supratentorial cancer DOID_1659 0.01324287 0.04924964 0.16100809 0.37090527 HSIAO_HOUSEKEEPING_GENES cerebrum cancer DOID_368 0.01324287 0.04924964 0.16100809 0.37090527 HSIAO_HOUSEKEEPING_GENES corneal disease DOID_10124 0.01407376 0.0519998 0.1657479 0.37724223 HSIAO_HOUSEKEEPING_GENES nervous system cancer DOID_3093 0.01541686 0.05659479 0.09551393 0.28305952 HSIAO_HOUSEKEEPING_GENES chronic leukemia DOID_1036 0.01669735 0.0609025 0.01669735 0.09406723 HSIAO_HOUSEKEEPING_GENES chronic lymphocytic leukemia DOID_1040 0.01669735 0.0609025 0.01669735 0.09406723 HSIAO_HOUSEKEEPING_GENES lymphoblastic leukemia DOID_1037 0.01678578 0.06083509 0.01678578 0.09363833 HSIAO_HOUSEKEEPING_GENES papilloma DOID_2615 0.01761462 0.06343492 0.18444213 0.40835632 HSIAO_HOUSEKEEPING_GENES male infertility DOID_12336 0.01855282 0.06639341 0.01855282 0.10150531 HSIAO_HOUSEKEEPING_GENES refractive error DOID_9835 0.02049094 0.07287092 0.02049094 0.10696648 HSIAO_HOUSEKEEPING_GENES uveitis DOID_13141 0.02250965 0.07955273 0.20722461 0.43670668 HSIAO_HOUSEKEEPING_GENES blood platelet disease DOID_2218 0.02250965 0.07906167 0.02250965 0.11643627 HSIAO_HOUSEKEEPING_GENES systemic scleroderma DOID_418 0.02354858 0.08220332 0.21170451 0.44450136 HSIAO_HOUSEKEEPING_GENES adult respiratory distress syndrome DOID_11394 0.02460689 0.08537391 0.02460689 0.12613803 HSIAO_HOUSEKEEPING_GENES adenoid cystic carcinoma DOID_4866 0.02460689 0.08485649 0.02460689 0.12501179 HSIAO_HOUSEKEEPING_GENES lymphatic system disease DOID_75 0.02460689 0.08434531 0.21615922 0.45218601 HSIAO_HOUSEKEEPING_GENES salivary gland cancer DOID_8850 0.02678066 0.09124669 0.02678066 0.1348513 HSIAO_HOUSEKEEPING_GENES rheumatic disease DOID_1575 0.02789563 0.09447984 0.22937355 0.47459473 HSIAO_HOUSEKEEPING_GENES idiopathic generalized epilepsy DOID_1827 0.02789563 0.09392079 0.02789563 0.13923345 HSIAO_HOUSEKEEPING_GENES hyperinsulinism DOID_2018 0.02789563 0.09336832 0.02789563 0.13802273 HSIAO_HOUSEKEEPING_GENES scleroderma DOID_419 0.02789563 0.09447984 0.22937355 0.47459473 YAMASHITA_LIVER_CANCER_STEM_CELL_DN cholestasis DOID_13580 1.756E-11 9.992E-09 1.756E-11 9.992E-09 YAMASHITA_LIVER_CANCER_STEM_CELL_DN bile duct disease DOID_4138 3.236E-11 9.205E-09 3.236E-11 9.205E-09 YAMASHITA_LIVER_CANCER_STEM_CELL_DN biliary tract disease DOID_9741 3.564E-11 6.76E-09 3.564E-11 6.76E-09 YAMASHITA_LIVER_CANCER_STEM_CELL_DN metabolic syndrome X DOID_14221 2.263E-07 3.219E-05 2.263E-07 3.219E-05 YAMASHITA_LIVER_CANCER_STEM_CELL_DN thrombophilia DOID_2452 5.972E-06 6.796E-04 5.972E-06 6.796E-04 YAMASHITA_LIVER_CANCER_STEM_CELL_DN meningitis DOID_9471 7.831E-06 7.426E-04 6.87E-04 0.02443185 YAMASHITA_LIVER_CANCER_STEM_CELL_DN mixed glioma DOID_5076 8.753E-06 7.115E-04 7.424E-03 0.10831316 YAMASHITA_LIVER_CANCER_STEM_CELL_DN osteosarcoma DOID_3347 1.004E-05 7.138E-04 8.073E-04 0.02702105 YAMASHITA_LIVER_CANCER_STEM_CELL_DN nervous system cancer DOID_3093 1.524E-05 9.637E-04 9.714E-03 0.13159791 YAMASHITA_LIVER_CANCER_STEM_CELL_DN toxic encephalopathy DOID_3602 1.725E-05 9.817E-04 0.04871344 0.28575201 YAMASHITA_LIVER_CANCER_STEM_CELL_DN hypersensitivity reaction type I disease DOID_1205 1.879E-05 9.719E-04 0.01074902 0.13296066 YAMASHITA_LIVER_CANCER_STEM_CELL_DN ulcerative colitis DOID_8577 2.119E-05 1.005E-03 5.735E-04 0.02330925 YAMASHITA_LIVER_CANCER_STEM_CELL_DN benign mesothelioma DOID_2645 5.008E-05 2.192E-03 2.307E-03 0.0504777 YAMASHITA_LIVER_CANCER_STEM_CELL_DN brain cancer DOID_1319 7.361E-05 2.992E-03 0.0774083 0.33116782 YAMASHITA_LIVER_CANCER_STEM_CELL_DN central nervous system cancer DOID_3620 7.812E-05 2.963E-03 0.07889474 0.32529786 YAMASHITA_LIVER_CANCER_STEM_CELL_DN larynx cancer DOID_2596 1.964E-04 6.984E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN laryngeal benign neoplasm DOID_2598 1.964E-04 6.984E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN blood coagulation disease DOID_1247 2.275E-04 7.615E-03 2.275E-04 0.02157534 YAMASHITA_LIVER_CANCER_STEM_CELL_DN peripheral vascular disease DOID_341 2.464E-04 7.79E-03 6.553E-03 0.09812361 YAMASHITA_LIVER_CANCER_STEM_CELL_DN diabetic retinopathy DOID_8947 2.563E-04 7.675E-03 2.563E-04 0.02083117 YAMASHITA_LIVER_CANCER_STEM_CELL_DN endogenous depression DOID_1595 2.767E-04 7.872E-03 2.767E-04 0.01967981 YAMASHITA_LIVER_CANCER_STEM_CELL_DN lipid metabolism disorder DOID_3146 3.206E-04 8.688E-03 3.206E-04 0.02027087 YAMASHITA_LIVER_CANCER_STEM_CELL_DN drug-induced mental disorder DOID_1203 3.41E-04 8.819E-03 0.02700988 0.21645947 YAMASHITA_LIVER_CANCER_STEM_CELL_DN drug psychosis DOID_1742 3.41E-04 8.819E-03 0.02700988 0.21645947 YAMASHITA_LIVER_CANCER_STEM_CELL_DN substance-induced psychosis DOID_8646 3.41E-04 8.819E-03 0.02700988 0.21645947 YAMASHITA_LIVER_CANCER_STEM_CELL_DN mental depression DOID_1596 3.564E-04 8.816E-03 3.564E-04 0.02027745 YAMASHITA_LIVER_CANCER_STEM_CELL_DN chronic kidney failure DOID_784 3.564E-04 8.449E-03 3.564E-04 0.01843404 YAMASHITA_LIVER_CANCER_STEM_CELL_DN retinal vascular disease DOID_2462 3.816E-04 8.684E-03 3.816E-04 0.01809255 YAMASHITA_LIVER_CANCER_STEM_CELL_DN inherited blood coagulation disease DOID_2214 3.832E-04 8.387E-03 3.832E-04 0.01677316 YAMASHITA_LIVER_CANCER_STEM_CELL_DN testicular cancer DOID_2998 4.279E-04 9.017E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN subependymal glioma DOID_4843 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN pilocytic astrocytoma DOID_4851 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN subependymal giant cell astrocytoma DOID_5077 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN fibrillary astrocytoma DOID_6726 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN juvenile pilocytic astrocytoma DOID_6811 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN childhood pilocytic astrocytoma DOID_6812 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN gemistocytic astrocytoma DOID_7005 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN childhood cerebral astrocytoma DOID_7007 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN protoplasmic astrocytoma DOID_7008 4.749E-04 9.651E-03 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN lymphoma DOID_0060058 4.787E-04 9.392E-03 0.0101222 0.13089848 YAMASHITA_LIVER_CANCER_STEM_CELL_DN benign glioma DOID_0060101 5.762E-04 0.01092843 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN benign ependymoma DOID_4844 5.762E-04 0.01092843 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN agranulocytosis DOID_12987 6.304E-04 0.01157113 6.304E-04 0.02391367 YAMASHITA_LIVER_CANCER_STEM_CELL_DN lingual-facial-buccal dyskinesia DOID_9854 6.304E-04 0.01120953 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN urticaria DOID_1555 8.073E-04 0.01391993 0.04101739 0.25932106 YAMASHITA_LIVER_CANCER_STEM_CELL_DN fragments of torsion dystonia DOID_531 9.37E-04 0.01568128 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN diffuse large B-cell lymphoma DOID_0050745 1.005E-03 0.0163447 1.005E-03 0.03178136 YAMASHITA_LIVER_CANCER_STEM_CELL_DN migraine DOID_6364 1.005E-03 0.01589068 1.005E-03 0.03010866 YAMASHITA_LIVER_CANCER_STEM_CELL_DN invasive ductal carcinoma DOID_3008 1.076E-03 0.01654844 1.076E-03 0.03061461 YAMASHITA_LIVER_CANCER_STEM_CELL_DN central nervous system hereditary degenerative disease DOID_481 1.076E-03 0.01611295 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN supratentorial cancer DOID_1659 1.149E-03 0.01676519 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN cerebrum cancer DOID_368 1.149E-03 0.01676519 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN dystonic disease DOID_544 1.149E-03 0.01634606 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN autonomic nervous system neoplasm DOID_2621 1.464E-03 0.0203215 1.464E-03 0.03967532 YAMASHITA_LIVER_CANCER_STEM_CELL_DN neuroblastoma DOID_769 1.464E-03 0.0203215 1.464E-03 0.03967532 YAMASHITA_LIVER_CANCER_STEM_CELL_DN nephroblastoma DOID_2154 1.636E-03 0.02215896 1.636E-03 0.04230346 YAMASHITA_LIVER_CANCER_STEM_CELL_DN leukopenia DOID_615 1.636E-03 0.02164363 1.636E-03 0.04046418 YAMASHITA_LIVER_CANCER_STEM_CELL_DN embryonal cancer DOID_688 1.91E-03 0.02469558 1.91E-03 0.04527522 YAMASHITA_LIVER_CANCER_STEM_CELL_DN peripheral nervous system neoplasm DOID_1192 2.006E-03 0.02535885 2.006E-03 0.04564594 YAMASHITA_LIVER_CANCER_STEM_CELL_DN pulmonary emphysema DOID_9675 2.307E-03 0.02853087 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN Huntington's disease DOID_12858 2.518E-03 0.03048785 2.518E-03 0.05307144 YAMASHITA_LIVER_CANCER_STEM_CELL_DN gallbladder cancer DOID_3121 2.628E-03 0.03114728 0.07293481 0.3267709 YAMASHITA_LIVER_CANCER_STEM_CELL_DN proteinuria DOID_576 2.853E-03 0.03312453 2.853E-03 0.05796793 YAMASHITA_LIVER_CANCER_STEM_CELL_DN vascular skin disease DOID_9540 2.968E-03 0.03377972 0.0774083 0.32149869 YAMASHITA_LIVER_CANCER_STEM_CELL_DN glaucoma DOID_1686 3.206E-03 0.03577392 3.206E-03 0.06291276 YAMASHITA_LIVER_CANCER_STEM_CELL_DN pulmonary tuberculosis DOID_2957 3.206E-03 0.03508596 0.08037882 0.32436559 YAMASHITA_LIVER_CANCER_STEM_CELL_DN movement disease DOID_480 3.329E-03 0.03573701 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN B-cell lymphocytic neoplasm DOID_707 3.453E-03 0.03638668 3.453E-03 0.06549602 YAMASHITA_LIVER_CANCER_STEM_CELL_DN atopic dermatitis DOID_3310 3.58E-03 0.03703498 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN bile duct adenocarcinoma DOID_4896 3.839E-03 0.03901188 0.08776403 0.34203928 YAMASHITA_LIVER_CANCER_STEM_CELL_DN cholangiocarcinoma DOID_4947 3.839E-03 0.03901188 0.08776403 0.34203928 YAMASHITA_LIVER_CANCER_STEM_CELL_DN familial hyperlipidemia DOID_1168 4.108E-03 0.04100445 4.108E-03 0.07539528 YAMASHITA_LIVER_CANCER_STEM_CELL_DN bile duct cancer DOID_4606 4.384E-03 0.04301134 0.09363017 0.35049716 YAMASHITA_LIVER_CANCER_STEM_CELL_DN bile duct carcinoma DOID_4897 4.384E-03 0.04301134 0.09363017 0.35049716 YAMASHITA_LIVER_CANCER_STEM_CELL_DN melancholia DOID_2848 4.526E-03 0.04364671 4.526E-03 0.08047363 YAMASHITA_LIVER_CANCER_STEM_CELL_DN leukocyte disease DOID_9500 4.526E-03 0.04291927 4.526E-03 0.07803503 YAMASHITA_LIVER_CANCER_STEM_CELL_DN neurotic disorder DOID_4964 4.669E-03 0.04355486 4.669E-03 0.07814254 YAMASHITA_LIVER_CANCER_STEM_CELL_DN carotid artery disease DOID_3407 4.815E-03 0.04418911 0.09800541 0.36211091 YAMASHITA_LIVER_CANCER_STEM_CELL_DN pre-malignant neoplasm DOID_0060071 5.113E-03 0.04617509 5.113E-03 0.08311516 YAMASHITA_LIVER_CANCER_STEM_CELL_DN in situ carcinoma DOID_8719 5.113E-03 0.04617509 5.113E-03 0.08311516 YAMASHITA_LIVER_CANCER_STEM_CELL_DN endocrine pancreas disease DOID_1428 5.264E-03 0.04680391 5.264E-03 0.08320695 YAMASHITA_LIVER_CANCER_STEM_CELL_DN tuberculosis DOID_399 5.892E-03 0.05158178 0.10813368 0.3821619 YAMASHITA_LIVER_CANCER_STEM_CELL_DN astrocytoma DOID_3069 6.055E-03 0.05219788 1.000 1.000 YAMASHITA_LIVER_CANCER_STEM_CELL_DN pancreatic ductal carcinoma DOID_3587 6.219E-03 0.0528128 0.11100687 0.38989451 YAMASHITA_LIVER_CANCER_STEM_CELL_DN nephrosis DOID_2527 6.385E-03 0.05342654 6.385E-03 0.09818931 YAMASHITA_LIVER_CANCER_STEM_CELL_DN pancreatic carcinoma DOID_4905 6.723E-03 0.05544249 0.11529959 0.40248753 YAMASHITA_LIVER_CANCER_STEM_CELL_DN bacterial pneumonia DOID_874 7.424E-03 0.0603459 7.424E-03 0.10560533 YAMASHITA_LIVER_CANCER_STEM_CELL_DN biliary tract cancer DOID_4607 8.344E-03 0.06687049 0.12805579 0.42861025 YAMASHITA_LIVER_CANCER_STEM_CELL_DN primary bacterial infectious disease DOID_0050338 9.115E-03 0.07203581 0.13366697 0.44477489 YAMASHITA_LIVER_CANCER_STEM_CELL_DN transitional cell carcinoma DOID_2671 9.313E-03 0.07258911 0.13506421 0.44681125 YAMASHITA_LIVER_CANCER_STEM_CELL_DN primary immunodeficiency disease DOID_612 9.512E-03 0.07314213 9.512E-03 0.13201262 YAMASHITA_LIVER_CANCER_STEM_CELL_DN Human immunodeficiency virus infectious disease DOID_526 9.714E-03 0.07369483 9.714E-03 0.12853749 YAMASHITA_LIVER_CANCER_STEM_CELL_DN encephalomyelitis DOID_640 0.01032927 0.07733359 0.01032927 0.13060783 YAMASHITA_LIVER_CANCER_STEM_CELL_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.01053821 0.07787324 0.14340121 0.46625878 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION nervous system cancer DOID_3093 5.347E-06 3.042E-03 5.865E-03 0.33374455 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION myeloma DOID_0070004 3.36E-05 9.558E-03 0.06017904 0.56134216 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION brain cancer DOID_1319 3.36E-05 6.372E-03 1.774E-03 0.25237853 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION central nervous system cancer DOID_3620 3.567E-05 5.073E-03 1.845E-03 0.20997809 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION giant cell tumor DOID_200 4.727E-05 5.379E-03 2.22E-03 0.21051893 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION malignant giant cell tumor DOID_2705 4.727E-05 5.379E-03 2.22E-03 0.21051893 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION giant cell glioblastoma DOID_3074 4.727E-05 5.379E-03 2.22E-03 0.21051893 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION bone marrow cancer DOID_4960 4.985E-05 4.728E-03 0.06831607 0.54749077 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION glioblastoma DOID_3068 6.11E-05 4.967E-03 2.628E-03 0.21358134 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION oral cavity cancer DOID_8618 6.11E-05 4.346E-03 2.628E-03 0.18688367 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION astrocytoma DOID_3069 1.003E-04 6.341E-03 3.638E-03 0.23002017 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION open-angle glaucoma DOID_1067 1.356E-04 7.716E-03 0.0172202 0.46658531 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION angiosarcoma DOID_0001816 1.785E-04 9.235E-03 1.000 1.000 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION transitional cell carcinoma DOID_2671 1.945E-04 9.223E-03 0.10575695 0.66861895 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION sarcoma DOID_1115 6.4E-04 0.02801419 1.000 1.000 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION toxic encephalopathy DOID_3602 6.836E-04 0.02778523 6.836E-04 0.38899329 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION spindle cell carcinoma DOID_4015 9.745E-04 0.03696701 9.745E-04 0.2772526 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION multiple myeloma DOID_9538 1.139E-03 0.04049277 1.000 1.000 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION adenoid cystic carcinoma DOID_4866 1.315E-03 0.04401629 0.05197246 0.54763573 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION salivary gland cancer DOID_8850 1.44E-03 0.04550425 0.05432433 0.56200984 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION primitive neuroectodermal tumor DOID_168 1.504E-03 0.04503326 0.05549812 0.56390051 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION learning disability DOID_8927 1.636E-03 0.04655223 1.636E-03 0.31034821 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION glaucoma DOID_1686 1.917E-03 0.05195359 0.06251097 0.53892037 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION reproductive organ benign neoplasm DOID_0050622 2.379E-03 0.06153004 1.000 1.000 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION neuroectodermal tumor DOID_171 2.888E-03 0.07144082 0.07638414 0.58733212 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION pre-malignant neoplasm DOID_0060071 3.068E-03 0.07273033 0.07867672 0.58904016 ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION in situ carcinoma DOID_8719 3.068E-03 0.07273033 0.07867672 0.58904016 TIEN_INTESTINE_PROBIOTICS_6HR_UP Diamond-Blackfan anemia DOID_1339 4.575E-14 2.603E-11 4.575E-14 2.603E-11 TIEN_INTESTINE_PROBIOTICS_6HR_UP congenital hypoplastic anemia DOID_1342 1.767E-11 5.028E-09 1.767E-11 5.028E-09 TIEN_INTESTINE_PROBIOTICS_6HR_UP aplastic anemia DOID_12449 8.979E-11 1.703E-08 8.979E-11 1.703E-08 TIEN_INTESTINE_PROBIOTICS_6HR_UP bone marrow disease DOID_4961 3.766E-10 5.357E-08 3.766E-10 5.357E-08 TIEN_INTESTINE_PROBIOTICS_6HR_UP myocarditis DOID_820 3.502E-04 0.03985764 3.502E-04 0.03985764 TIEN_INTESTINE_PROBIOTICS_6HR_UP cataract DOID_83 6.235E-04 0.05913268 6.235E-04 0.05913268 TIEN_INTESTINE_PROBIOTICS_6HR_UP lens disease DOID_110 6.765E-04 0.05499156 6.765E-04 0.05499156 TIEN_INTESTINE_PROBIOTICS_6HR_UP B-cell lymphocytic neoplasm DOID_707 7.888E-04 0.05610276 0.04050867 0.6229577 TIEN_INTESTINE_PROBIOTICS_6HR_UP temporal lobe epilepsy DOID_3328 1.284E-03 0.08117708 1.284E-03 0.09132422 ONKEN_UVEAL_MELANOMA_UP aneurysm disease DOID_2403 1.033E-12 5.88E-10 6.254E-09 1.779E-06 ONKEN_UVEAL_MELANOMA_UP astrocytoma DOID_3069 1.351E-10 3.843E-08 5.865E-07 3.708E-05 ONKEN_UVEAL_MELANOMA_UP lymphoma DOID_0060058 1.698E-10 3.22E-08 2.542E-09 1.446E-06 ONKEN_UVEAL_MELANOMA_UP giant cell tumor DOID_200 1.891E-10 2.69E-08 7.988E-08 1.515E-05 ONKEN_UVEAL_MELANOMA_UP malignant giant cell tumor DOID_2705 1.891E-10 2.69E-08 7.988E-08 1.515E-05 ONKEN_UVEAL_MELANOMA_UP giant cell glioblastoma DOID_3074 1.891E-10 2.69E-08 7.988E-08 1.515E-05 ONKEN_UVEAL_MELANOMA_UP encephalomyelitis DOID_640 1.926E-10 2.192E-08 4.579E-07 3.257E-05 ONKEN_UVEAL_MELANOMA_UP glioblastoma DOID_3068 4.583E-10 4.347E-08 1.586E-07 2.256E-05 ONKEN_UVEAL_MELANOMA_UP transitional cell carcinoma DOID_2671 1.587E-09 1.29E-07 2.874E-07 2.336E-05 ONKEN_UVEAL_MELANOMA_UP nervous system cancer DOID_3093 2.014E-09 1.433E-07 3.731E-05 1.117E-03 ONKEN_UVEAL_MELANOMA_UP spindle cell carcinoma DOID_4015 2.557E-09 1.617E-07 1.615E-06 8.353E-05 ONKEN_UVEAL_MELANOMA_UP intracranial aneurysm DOID_10941 8.675E-09 4.936E-07 2.821E-07 2.675E-05 ONKEN_UVEAL_MELANOMA_UP female reproductive system disease DOID_229 1.019E-08 5.273E-07 1.759E-06 8.338E-05 ONKEN_UVEAL_MELANOMA_UP endometriosis DOID_289 1.599E-08 7.583E-07 6.037E-06 2.453E-04 ONKEN_UVEAL_MELANOMA_UP polycystic kidney disease DOID_898 1.715E-07 7.509E-06 1.715E-07 1.952E-05 ONKEN_UVEAL_MELANOMA_UP endometriosis of uterus DOID_288 2.877E-07 1.169E-05 8.138E-05 2.205E-03 ONKEN_UVEAL_MELANOMA_UP uterine disease DOID_345 3.749E-07 1.422E-05 5.875E-05 1.671E-03 ONKEN_UVEAL_MELANOMA_UP proteinuria DOID_576 5.265E-07 1.872E-05 8.79E-06 3.126E-04 ONKEN_UVEAL_MELANOMA_UP ulcerative colitis DOID_8577 7.098E-07 2.376E-05 7.171E-06 2.72E-04 ONKEN_UVEAL_MELANOMA_UP aortic aneurysm DOID_3627 9.132E-07 2.887E-05 1.883E-03 0.01409513 ONKEN_UVEAL_MELANOMA_UP mixed glioma DOID_5076 1.326E-06 3.971E-05 1.46E-04 3.324E-03 ONKEN_UVEAL_MELANOMA_UP atrophic muscular disease DOID_913 1.339E-06 3.811E-05 1.339E-06 7.622E-05 ONKEN_UVEAL_MELANOMA_UP muscular dystrophy DOID_9884 1.339E-06 3.811E-05 1.339E-06 7.622E-05 ONKEN_UVEAL_MELANOMA_UP bone marrow cancer DOID_4960 1.514E-06 4.102E-05 0.01895098 0.0718874 ONKEN_UVEAL_MELANOMA_UP funisitis DOID_0050698 2.114E-06 5.468E-05 2.114E-06 9.254E-05 ONKEN_UVEAL_MELANOMA_UP bone development disease DOID_0080006 2.306E-06 5.704E-05 2.407E-05 7.61E-04 ONKEN_UVEAL_MELANOMA_UP peripheral nervous system neoplasm DOID_1192 3.021E-06 7.162E-05 7.146E-04 6.665E-03 ONKEN_UVEAL_MELANOMA_UP pre-malignant neoplasm DOID_0060071 4.132E-06 9.405E-05 5.024E-04 5.105E-03 ONKEN_UVEAL_MELANOMA_UP in situ carcinoma DOID_8719 4.132E-06 9.405E-05 5.024E-04 5.105E-03 ONKEN_UVEAL_MELANOMA_UP mouth disease DOID_403 5.288E-06 1.157E-04 3.947E-04 4.404E-03 ONKEN_UVEAL_MELANOMA_UP uterine cancer DOID_363 6.863E-06 1.446E-04 1.005E-04 2.487E-03 ONKEN_UVEAL_MELANOMA_UP pancreatic ductal carcinoma DOID_3587 8.148E-06 1.656E-04 5.998E-03 0.03159922 ONKEN_UVEAL_MELANOMA_UP diffuse large B-cell lymphoma DOID_0050745 9.006E-06 1.767E-04 1.84E-04 3.377E-03 ONKEN_UVEAL_MELANOMA_UP brain cancer DOID_1319 9.906E-06 1.879E-04 0.01335099 0.05312389 ONKEN_UVEAL_MELANOMA_UP pancreatic carcinoma DOID_4905 1.066E-05 1.956E-04 6.909E-03 0.03359901 ONKEN_UVEAL_MELANOMA_UP invasive ductal carcinoma DOID_3008 1.072E-05 1.906E-04 1.072E-05 3.588E-04 ONKEN_UVEAL_MELANOMA_UP central nervous system cancer DOID_3620 1.113E-05 1.92E-04 0.01408345 0.05488686 ONKEN_UVEAL_MELANOMA_UP hemangioma DOID_255 1.18E-05 1.974E-04 9.41E-03 0.04283516 ONKEN_UVEAL_MELANOMA_UP focal glomerulosclerosis DOID_3945 1.268E-05 2.061E-04 2.4E-04 3.793E-03 ONKEN_UVEAL_MELANOMA_UP B-cell lymphocytic neoplasm DOID_707 1.557E-05 2.461E-04 1.959E-04 3.483E-03 ONKEN_UVEAL_MELANOMA_UP contact dermatitis DOID_2773 1.762E-05 2.709E-04 1.674E-04 3.284E-03 ONKEN_UVEAL_MELANOMA_UP celiac disease DOID_10608 2.026E-05 3.034E-04 3.455E-04 4.469E-03 ONKEN_UVEAL_MELANOMA_UP allergic rhinitis DOID_4481 2.026E-05 2.956E-04 3.455E-04 4.274E-03 ONKEN_UVEAL_MELANOMA_UP autonomic nervous system neoplasm DOID_2621 2.345E-05 3.336E-04 3.871E-04 4.495E-03 ONKEN_UVEAL_MELANOMA_UP neuroblastoma DOID_769 2.345E-05 3.336E-04 3.871E-04 4.495E-03 ONKEN_UVEAL_MELANOMA_UP osteochondrodysplasia DOID_2256 2.361E-05 3.276E-04 2.748E-04 4.009E-03 ONKEN_UVEAL_MELANOMA_UP mitochondrial metabolism disease DOID_700 2.606E-05 3.531E-04 2.978E-04 3.941E-03 ONKEN_UVEAL_MELANOMA_UP oral cavity cancer DOID_8618 3.159E-05 4.18E-04 3.482E-04 4.216E-03 ONKEN_UVEAL_MELANOMA_UP amino acid metabolic disorder DOID_9252 3.476E-05 4.495E-04 2.958E-04 4.007E-03 ONKEN_UVEAL_MELANOMA_UP hypothyroidism DOID_1459 4.545E-05 5.747E-04 4.681E-04 4.933E-03 ONKEN_UVEAL_MELANOMA_UP embryonal cancer DOID_688 4.564E-05 5.646E-04 6.499E-04 6.376E-03 ONKEN_UVEAL_MELANOMA_UP multiple myeloma DOID_9538 4.564E-05 5.526E-04 0.05950034 0.17185632 ONKEN_UVEAL_MELANOMA_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.908E-05 5.817E-04 3.947E-04 4.492E-03 ONKEN_UVEAL_MELANOMA_UP mitochondrial myopathy DOID_699 4.936E-05 5.731E-04 1.119E-03 9.5E-03 ONKEN_UVEAL_MELANOMA_UP hypersensitivity reaction type I disease DOID_1205 5.245E-05 5.969E-04 4.173E-04 4.48E-03 ONKEN_UVEAL_MELANOMA_UP uremia DOID_4676 7.189E-05 8.021E-04 1.468E-03 0.01176391 ONKEN_UVEAL_MELANOMA_UP cervix uteri carcinoma in situ DOID_8991 7.293E-05 7.98E-04 9.421E-03 0.04254558 ONKEN_UVEAL_MELANOMA_UP Huntington's disease DOID_12858 9.057E-05 9.723E-04 9.057E-05 2.342E-03 ONKEN_UVEAL_MELANOMA_UP influenza DOID_8469 1.005E-04 1.059E-03 1.201E-03 0.01005213 ONKEN_UVEAL_MELANOMA_UP learning disability DOID_8927 1.113E-04 1.152E-03 1.3E-03 0.01057039 ONKEN_UVEAL_MELANOMA_UP myeloma DOID_0070004 1.355E-04 1.377E-03 0.08769795 0.24223366 ONKEN_UVEAL_MELANOMA_UP myositis DOID_633 1.381E-04 1.379E-03 0.02910297 0.10036116 ONKEN_UVEAL_MELANOMA_UP ankylosing spondylitis DOID_7147 1.381E-04 1.355E-03 2.355E-03 0.0163382 ONKEN_UVEAL_MELANOMA_UP cleft lip DOID_9296 1.381E-04 1.332E-03 1.381E-04 3.274E-03 ONKEN_UVEAL_MELANOMA_UP breast benign neoplasm DOID_0060082 1.494E-04 1.416E-03 1.494E-04 3.269E-03 ONKEN_UVEAL_MELANOMA_UP thoracic benign neoplasm DOID_0060097 1.494E-04 1.416E-03 1.494E-04 3.269E-03 ONKEN_UVEAL_MELANOMA_UP migraine without aura DOID_12783 1.494E-04 1.393E-03 1.494E-04 3.147E-03 ONKEN_UVEAL_MELANOMA_UP benign breast phyllodes tumor DOID_1631 1.494E-04 1.416E-03 1.494E-04 3.269E-03 ONKEN_UVEAL_MELANOMA_UP seminoma DOID_4440 1.599E-04 1.467E-03 1.599E-04 3.249E-03 ONKEN_UVEAL_MELANOMA_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.636E-04 1.477E-03 1.754E-03 0.01386217 ONKEN_UVEAL_MELANOMA_UP glaucoma DOID_1686 1.636E-04 1.454E-03 1.754E-03 0.01367228 ONKEN_UVEAL_MELANOMA_UP chromosomal disease DOID_0080014 1.789E-04 1.566E-03 1.789E-04 3.394E-03 ONKEN_UVEAL_MELANOMA_UP periodontitis DOID_824 1.84E-04 1.586E-03 0.03323225 0.10867328 ONKEN_UVEAL_MELANOMA_UP mucopolysaccharidosis DOID_12798 1.977E-04 1.679E-03 1.977E-04 3.408E-03 ONKEN_UVEAL_MELANOMA_UP mitochondrial encephalomyopathy DOID_890 1.977E-04 1.654E-03 1.977E-04 3.308E-03 ONKEN_UVEAL_MELANOMA_UP biliary tract cancer DOID_4607 2.039E-04 1.682E-03 0.01017676 0.04454289 ONKEN_UVEAL_MELANOMA_UP sarcoma DOID_1115 2.107E-04 1.712E-03 0.25795081 0.42297986 ONKEN_UVEAL_MELANOMA_UP orofacial cleft DOID_0050567 2.137E-04 1.713E-03 2.137E-04 3.474E-03 ONKEN_UVEAL_MELANOMA_UP sarcoidosis DOID_11335 2.328E-04 1.84E-03 0.01808316 0.06905581 ONKEN_UVEAL_MELANOMA_UP osteogenesis imperfecta DOID_12347 2.551E-04 1.988E-03 2.551E-04 3.923E-03 ONKEN_UVEAL_MELANOMA_UP primary bacterial infectious disease DOID_0050338 2.621E-04 2.016E-03 1.94E-03 0.01433459 ONKEN_UVEAL_MELANOMA_UP female reproductive organ benign neoplasm DOID_0060086 2.721E-04 2.065E-03 3.85E-03 0.02461192 ONKEN_UVEAL_MELANOMA_UP uterine benign neoplasm DOID_0060095 2.721E-04 2.065E-03 3.85E-03 0.02461192 ONKEN_UVEAL_MELANOMA_UP uterine fibroid DOID_13223 2.721E-04 2.065E-03 3.85E-03 0.02461192 ONKEN_UVEAL_MELANOMA_UP congenital disorder of glycosylation DOID_5212 2.721E-04 2.038E-03 2.721E-04 4.075E-03 ONKEN_UVEAL_MELANOMA_UP reproductive organ benign neoplasm DOID_0050622 2.748E-04 2.03E-03 2.624E-03 0.01756751 ONKEN_UVEAL_MELANOMA_UP smallpox DOID_8736 2.748E-04 2.004E-03 2.748E-04 3.909E-03 ONKEN_UVEAL_MELANOMA_UP primary immunodeficiency disease DOID_612 2.958E-04 2.13E-03 2.958E-04 4.104E-03 ONKEN_UVEAL_MELANOMA_UP age related macular degeneration DOID_10871 3.073E-04 2.186E-03 4.204E-03 0.02544705 ONKEN_UVEAL_MELANOMA_UP degeneration of macula and posterior pole DOID_2007 3.073E-04 2.186E-03 4.204E-03 0.02544705 ONKEN_UVEAL_MELANOMA_UP abdominal aortic aneurysm DOID_7693 3.073E-04 2.159E-03 0.27977151 0.44842251 ONKEN_UVEAL_MELANOMA_UP Human immunodeficiency virus infectious disease DOID_526 3.138E-04 2.177E-03 2.244E-03 0.01576135 ONKEN_UVEAL_MELANOMA_UP endometrial cancer DOID_1380 3.455E-04 2.369E-03 4.577E-03 0.02741559 ONKEN_UVEAL_MELANOMA_UP germinoma DOID_3304 3.455E-04 2.341E-03 3.455E-04 4.369E-03 ONKEN_UVEAL_MELANOMA_UP hypertrophic cardiomyopathy DOID_11984 3.482E-04 2.331E-03 3.154E-03 0.02062808 ONKEN_UVEAL_MELANOMA_UP hypersensitivity reaction type IV disease DOID_2916 3.482E-04 2.304E-03 0.02264966 0.08105443 ONKEN_UVEAL_MELANOMA_UP lymphoblastic leukemia DOID_1037 3.731E-04 2.44E-03 2.581E-03 0.01769273 ONKEN_UVEAL_MELANOMA_UP carbohydrate metabolic disorder DOID_2978 3.731E-04 2.412E-03 3.731E-04 4.423E-03 ONKEN_UVEAL_MELANOMA_UP leiomyoma DOID_127 3.871E-04 2.475E-03 4.97E-03 0.02915466 ONKEN_UVEAL_MELANOMA_UP membranoproliferative glomerulonephritis DOID_2920 3.999E-04 2.528E-03 3.999E-04 4.376E-03 ONKEN_UVEAL_MELANOMA_UP mesenchymal cell neoplasm DOID_3350 3.999E-04 2.501E-03 1.000 1.000 ONKEN_UVEAL_MELANOMA_UP spindle cell sarcoma DOID_4235 3.999E-04 2.501E-03 1.000 1.000 ONKEN_UVEAL_MELANOMA_UP epithelioid sarcoma DOID_6193 3.999E-04 2.501E-03 1.000 1.000 ONKEN_UVEAL_MELANOMA_UP carotid artery disease DOID_3407 4.356E-04 2.694E-03 0.02566257 0.09013582 ONKEN_UVEAL_MELANOMA_UP nephroblastoma DOID_2154 4.807E-04 2.941E-03 4.807E-04 4.974E-03 ONKEN_UVEAL_MELANOMA_UP periodontal disease DOID_3388 4.807E-04 2.91E-03 0.05178667 0.15347196 ONKEN_UVEAL_MELANOMA_UP thyroid carcinoma DOID_3963 4.807E-04 2.879E-03 5.815E-03 0.03151282 ONKEN_UVEAL_MELANOMA_UP macular degeneration DOID_4448 4.807E-04 2.849E-03 5.815E-03 0.03121553 ONKEN_UVEAL_MELANOMA_UP thyroiditis DOID_7166 4.886E-04 2.866E-03 0.0106847 0.04503401 ONKEN_UVEAL_MELANOMA_UP autoimmune thyroiditis DOID_7188 4.886E-04 2.866E-03 0.0106847 0.04503401 ONKEN_UVEAL_MELANOMA_UP tongue cancer DOID_8649 4.886E-04 2.837E-03 0.0106847 0.04470288 ONKEN_UVEAL_MELANOMA_UP congenital heart defect DOID_1682 5.024E-04 2.888E-03 4.191E-03 0.02592185 ONKEN_UVEAL_MELANOMA_UP lymphoid leukemia DOID_10747 5.331E-04 3.034E-03 6.268E-03 0.03184338 ONKEN_UVEAL_MELANOMA_UP cholestasis DOID_13580 5.767E-04 3.249E-03 4.664E-03 0.02764125 ONKEN_UVEAL_MELANOMA_UP parasitic infectious disease DOID_1398 5.767E-04 3.217E-03 0.02999751 0.10282278 ONKEN_UVEAL_MELANOMA_UP thyroid cancer DOID_1781 5.895E-04 3.256E-03 6.741E-03 0.03306649 ONKEN_UVEAL_MELANOMA_UP cleft palate DOID_674 6.499E-04 3.556E-03 6.499E-04 6.488E-03 ONKEN_UVEAL_MELANOMA_UP tooth disease DOID_1091 6.588E-04 3.57E-03 0.03230045 0.10623673 ONKEN_UVEAL_MELANOMA_UP allergic contact dermatitis DOID_3042 6.588E-04 3.537E-03 6.588E-04 6.354E-03 ONKEN_UVEAL_MELANOMA_UP prion disease DOID_649 7.016E-04 3.731E-03 7.016E-04 6.653E-03 ONKEN_UVEAL_MELANOMA_UP endocrine organ benign neoplasm DOID_0060089 7.031E-04 3.704E-03 5.437E-03 0.03003598 ONKEN_UVEAL_MELANOMA_UP testicular cancer DOID_2998 8.27E-04 4.317E-03 8.27E-04 7.59E-03 ONKEN_UVEAL_MELANOMA_UP granulosa cell tumor DOID_2999 8.27E-04 4.278E-03 8.27E-04 7.47E-03 ONKEN_UVEAL_MELANOMA_UP MHC class II deficiency DOID_5812 8.27E-04 4.24E-03 8.27E-04 7.353E-03 ONKEN_UVEAL_MELANOMA_UP bile duct disease DOID_4138 8.491E-04 4.314E-03 6.292E-03 0.03168247 ONKEN_UVEAL_MELANOMA_UP biliary tract disease DOID_9741 9.025E-04 4.544E-03 6.596E-03 0.03263378 ONKEN_UVEAL_MELANOMA_UP sex cord-gonadal stromal tumor DOID_192 9.659E-04 4.821E-03 9.659E-04 8.455E-03 ONKEN_UVEAL_MELANOMA_UP subependymal glioma DOID_4843 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP pilocytic astrocytoma DOID_4851 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP subependymal giant cell astrocytoma DOID_5077 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP fibrillary astrocytoma DOID_6726 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP juvenile pilocytic astrocytoma DOID_6811 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP childhood pilocytic astrocytoma DOID_6812 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP gemistocytic astrocytoma DOID_7005 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP childhood cerebral astrocytoma DOID_7007 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP protoplasmic astrocytoma DOID_7008 9.659E-04 4.779E-03 0.18034092 0.33866002 ONKEN_UVEAL_MELANOMA_UP syndrome DOID_225 1.078E-03 5.286E-03 1.078E-03 9.29E-03 ONKEN_UVEAL_MELANOMA_UP nephrotic syndrome DOID_1184 1.108E-03 5.387E-03 0.01064339 0.0462297 ONKEN_UVEAL_MELANOMA_UP diabetic autonomic neuropathy DOID_11503 1.201E-03 5.793E-03 0.01128717 0.04687883 ONKEN_UVEAL_MELANOMA_UP autonomic neuropathy DOID_11504 1.201E-03 5.793E-03 0.01128717 0.04687883 ONKEN_UVEAL_MELANOMA_UP diabetic polyneuropathy DOID_12785 1.201E-03 5.793E-03 0.01128717 0.04687883 ONKEN_UVEAL_MELANOMA_UP gallbladder cancer DOID_3121 1.201E-03 5.744E-03 0.07887236 0.21999203 ONKEN_UVEAL_MELANOMA_UP diabetic neuropathy DOID_9743 1.201E-03 5.793E-03 0.01128717 0.04687883 ONKEN_UVEAL_MELANOMA_UP benign glioma DOID_0060101 1.286E-03 6.097E-03 0.19648487 0.35833299 ONKEN_UVEAL_MELANOMA_UP hepatitis B DOID_2043 1.286E-03 6.047E-03 1.286E-03 0.01060332 ONKEN_UVEAL_MELANOMA_UP benign ependymoma DOID_4844 1.286E-03 6.097E-03 0.19648487 0.35833299 ONKEN_UVEAL_MELANOMA_UP leukodystrophy DOID_10579 1.405E-03 6.553E-03 0.01264086 0.05137608 ONKEN_UVEAL_MELANOMA_UP autonomic nervous system disease DOID_11465 1.515E-03 7.011E-03 0.01335099 0.053498 ONKEN_UVEAL_MELANOMA_UP focal epilepsy DOID_2234 1.583E-03 7.263E-03 0.01017676 0.04488819 ONKEN_UVEAL_MELANOMA_UP lung small cell carcinoma DOID_5409 1.754E-03 7.985E-03 0.0937372 0.25398317 ONKEN_UVEAL_MELANOMA_UP spastic quadriplegia DOID_10970 1.879E-03 8.484E-03 1.879E-03 0.01444557 ONKEN_UVEAL_MELANOMA_UP severe combined immunodeficiency DOID_627 1.879E-03 8.417E-03 1.879E-03 0.01425296 ONKEN_UVEAL_MELANOMA_UP X-linked disease DOID_0050735 2.108E-03 9.372E-03 2.108E-03 0.01537954 ONKEN_UVEAL_MELANOMA_UP osteosarcoma DOID_3347 2.108E-03 9.299E-03 2.108E-03 0.01518486 ONKEN_UVEAL_MELANOMA_UP combined T cell and B cell immunodeficiency DOID_628 2.108E-03 9.228E-03 2.108E-03 0.01499505 ONKEN_UVEAL_MELANOMA_UP bile duct adenocarcinoma DOID_4896 2.462E-03 0.01069495 0.10932819 0.27164953 ONKEN_UVEAL_MELANOMA_UP cholangiocarcinoma DOID_4947 2.462E-03 0.01069495 0.10932819 0.27164953 ONKEN_UVEAL_MELANOMA_UP vasculitis DOID_865 2.462E-03 0.01061393 0.01895098 0.07141132 ONKEN_UVEAL_MELANOMA_UP spinal cord disease DOID_319 2.618E-03 0.01119988 2.618E-03 0.01773315 ONKEN_UVEAL_MELANOMA_UP dilated cardiomyopathy DOID_12930 2.825E-03 0.011996 0.07185032 0.20239027 ONKEN_UVEAL_MELANOMA_UP migraine DOID_6364 2.899E-03 0.01221763 2.899E-03 0.01917883 ONKEN_UVEAL_MELANOMA_UP bile duct cancer DOID_4606 3.154E-03 0.01319591 0.12225302 0.27936534 ONKEN_UVEAL_MELANOMA_UP bile duct carcinoma DOID_4897 3.154E-03 0.01319591 0.12225302 0.27936534 ONKEN_UVEAL_MELANOMA_UP renal hypertension DOID_1073 3.197E-03 0.01327975 0.0353776 0.11372798 ONKEN_UVEAL_MELANOMA_UP secondary hypertension DOID_11130 3.197E-03 0.01327975 0.0353776 0.11372798 ONKEN_UVEAL_MELANOMA_UP autoimmune disease of the nervous system DOID_438 3.197E-03 0.01318352 3.197E-03 0.02067415 ONKEN_UVEAL_MELANOMA_UP leukocyte disease DOID_9500 3.346E-03 0.01369545 0.02363122 0.08403851 ONKEN_UVEAL_MELANOMA_UP autoimmune disease of endocrine system DOID_0060005 3.514E-03 0.01428302 0.03757507 0.11812273 ONKEN_UVEAL_MELANOMA_UP supratentorial cancer DOID_1659 3.514E-03 0.01418172 0.26529667 0.43006781 ONKEN_UVEAL_MELANOMA_UP cerebrum cancer DOID_368 3.514E-03 0.01418172 0.26529667 0.43006781 ONKEN_UVEAL_MELANOMA_UP endometrial carcinoma DOID_2871 3.85E-03 0.01542578 0.03982343 0.12182543 ONKEN_UVEAL_MELANOMA_UP congenital disorder of glycosylation type II DOID_0050571 4.167E-03 0.01657953 4.167E-03 0.02634302 ONKEN_UVEAL_MELANOMA_UP childhood type dermatomyositis DOID_14203 4.167E-03 0.01646439 4.167E-03 0.02605354 ONKEN_UVEAL_MELANOMA_UP angioedema DOID_1558 4.167E-03 0.01635084 0.09463781 0.25046008 ONKEN_UVEAL_MELANOMA_UP transient cerebral ischemia DOID_224 4.167E-03 0.01623885 0.09463781 0.24815169 ONKEN_UVEAL_MELANOMA_UP acute kidney failure DOID_3021 4.167E-03 0.01612838 0.09463781 0.24701338 ONKEN_UVEAL_MELANOMA_UP spastic cerebral palsy DOID_0050669 4.204E-03 0.01616232 4.204E-03 0.02572067 ONKEN_UVEAL_MELANOMA_UP cerebral degeneration DOID_1443 4.664E-03 0.01780913 0.02999751 0.10220707 ONKEN_UVEAL_MELANOMA_UP temporal lobe epilepsy DOID_3328 4.913E-03 0.01863507 0.03113773 0.10546053 ONKEN_UVEAL_MELANOMA_UP hereditary spastic paraplegia DOID_2476 4.97E-03 0.01872849 4.97E-03 0.02885716 ONKEN_UVEAL_MELANOMA_UP dermatomyositis DOID_10223 5.059E-03 0.01893979 5.059E-03 0.02907927 ONKEN_UVEAL_MELANOMA_UP invasive lobular carcinoma DOID_3457 5.059E-03 0.018816 5.059E-03 0.02878848 ONKEN_UVEAL_MELANOMA_UP speech disorder DOID_92 5.059E-03 0.01869382 5.059E-03 0.02850345 ONKEN_UVEAL_MELANOMA_UP myocarditis DOID_820 5.383E-03 0.01975961 0.04930173 0.1484269 ONKEN_UVEAL_MELANOMA_UP metal metabolism disorder DOID_896 5.383E-03 0.01963295 5.383E-03 0.03002686 ONKEN_UVEAL_MELANOMA_UP tuberculosis DOID_399 5.437E-03 0.01970513 0.0334856 0.10887602 ONKEN_UVEAL_MELANOMA_UP pneumoconiosis DOID_10316 5.815E-03 0.02094206 0.05178667 0.15508746 ONKEN_UVEAL_MELANOMA_UP male infertility DOID_12336 5.815E-03 0.02081035 5.815E-03 0.03181582 ONKEN_UVEAL_MELANOMA_UP hepatitis C DOID_1883 5.815E-03 0.02068029 0.05178667 0.15427548 ONKEN_UVEAL_MELANOMA_UP paraplegia DOID_607 5.815E-03 0.02055184 5.815E-03 0.03092379 ONKEN_UVEAL_MELANOMA_UP otitis media DOID_10754 6.032E-03 0.02118594 6.032E-03 0.03148736 ONKEN_UVEAL_MELANOMA_UP esophageal carcinoma DOID_1107 6.032E-03 0.02105596 6.032E-03 0.03120111 ONKEN_UVEAL_MELANOMA_UP pituitary cancer DOID_1785 6.032E-03 0.02092757 6.032E-03 0.03092002 ONKEN_UVEAL_MELANOMA_UP esophagus squamous cell carcinoma DOID_3748 6.032E-03 0.02105596 6.032E-03 0.03120111 ONKEN_UVEAL_MELANOMA_UP pituitary carcinoma DOID_4916 6.032E-03 0.02092757 6.032E-03 0.03092002 ONKEN_UVEAL_MELANOMA_UP middle ear disease DOID_5100 6.032E-03 0.02118594 6.032E-03 0.03148736 ONKEN_UVEAL_MELANOMA_UP ocular hypertension DOID_9282 6.032E-03 0.02080074 0.11246508 0.27230907 ONKEN_UVEAL_MELANOMA_UP borderline glaucoma DOID_9283 6.032E-03 0.02080074 0.11246508 0.27230907 ONKEN_UVEAL_MELANOMA_UP nephrosis DOID_2527 6.292E-03 0.02156698 0.03717492 0.11751405 ONKEN_UVEAL_MELANOMA_UP male reproductive system disease DOID_48 6.292E-03 0.02143784 6.292E-03 0.03140455 ONKEN_UVEAL_MELANOMA_UP peripheral vascular disease DOID_341 6.596E-03 0.0223386 0.03844906 0.11889954 ONKEN_UVEAL_MELANOMA_UP berylliosis DOID_10322 7.082E-03 0.02384469 0.12124699 0.28987201 ONKEN_UVEAL_MELANOMA_UP hepatic coma DOID_12550 7.082E-03 0.02370443 7.082E-03 0.03415045 ONKEN_UVEAL_MELANOMA_UP carotid stenosis DOID_13001 7.082E-03 0.02356581 0.12124699 0.28508074 ONKEN_UVEAL_MELANOMA_UP hepatic encephalopathy DOID_13413 7.082E-03 0.02370443 7.082E-03 0.03415045 ONKEN_UVEAL_MELANOMA_UP polyneuropathy DOID_1389 7.082E-03 0.0234288 0.12124699 0.28390757 ONKEN_UVEAL_MELANOMA_UP Lynch syndrome DOID_3883 7.082E-03 0.02329337 7.082E-03 0.03386347 ONKEN_UVEAL_MELANOMA_UP bone resorption disease DOID_0080011 7.907E-03 0.02585622 0.04376502 0.13316737 ONKEN_UVEAL_MELANOMA_UP osteoporosis DOID_11476 7.907E-03 0.02585622 0.04376502 0.13316737 ONKEN_UVEAL_MELANOMA_UP tethered spinal cord syndrome DOID_1089 8.209E-03 0.02669037 8.209E-03 0.03892346 ONKEN_UVEAL_MELANOMA_UP parasitic helminthiasis infectious disease DOID_883 8.209E-03 0.02653872 8.209E-03 0.03860178 ONKEN_UVEAL_MELANOMA_UP narcolepsy DOID_8986 8.209E-03 0.02638879 0.12994224 0.28881693 ONKEN_UVEAL_MELANOMA_UP hepatitis DOID_2237 8.286E-03 0.02648619 0.34146798 0.52370695 ONKEN_UVEAL_MELANOMA_UP intracranial arterial disease DOID_13089 8.843E-03 0.02810918 0.34798913 0.52942731 ONKEN_UVEAL_MELANOMA_UP cerebral arterial disease DOID_3527 8.843E-03 0.02810918 0.34798913 0.52942731 ONKEN_UVEAL_MELANOMA_UP adenoid cystic carcinoma DOID_4866 8.843E-03 0.02795302 8.843E-03 0.04124216 ONKEN_UVEAL_MELANOMA_UP lipid metabolism disorder DOID_3146 8.995E-03 0.02827755 8.995E-03 0.04161169 ONKEN_UVEAL_MELANOMA_UP thoracic aortic aneurysm DOID_14004 9.41E-03 0.02941975 0.13855167 0.29862083 ONKEN_UVEAL_MELANOMA_UP communication disorder DOID_2033 9.41E-03 0.02925899 9.41E-03 0.0431806 ONKEN_UVEAL_MELANOMA_UP oral submucous fibrosis DOID_5773 9.41E-03 0.02909997 0.13855167 0.29198482 ONKEN_UVEAL_MELANOMA_UP benign mesothelioma DOID_2645 9.421E-03 0.02897699 0.07034903 0.19914725 ONKEN_UVEAL_MELANOMA_UP pulmonary emphysema DOID_9675 9.421E-03 0.0288212 0.35444588 0.53638219 ONKEN_UVEAL_MELANOMA_UP auditory system disease DOID_2742 9.772E-03 0.02973509 9.772E-03 0.04378317 ONKEN_UVEAL_MELANOMA_UP salivary gland cancer DOID_8850 0.01002149 0.03033101 0.01002149 0.04454868 ONKEN_UVEAL_MELANOMA_UP angiosarcoma DOID_0001816 0.0106847 0.03216715 0.14707613 0.3065433 ONKEN_UVEAL_MELANOMA_UP spastic diplegia DOID_10965 0.0106847 0.03199785 0.0106847 0.04605751 ONKEN_UVEAL_MELANOMA_UP long QT syndrome DOID_2843 0.0106847 0.03183032 0.0106847 0.04571122 ONKEN_UVEAL_MELANOMA_UP pituitary adenoma DOID_3829 0.0106847 0.03166454 0.0106847 0.04537009 ONKEN_UVEAL_MELANOMA_UP cataract DOID_83 0.01195296 0.03523954 0.01195296 0.04928429 ONKEN_UVEAL_MELANOMA_UP lymphatic system cancer DOID_0060073 0.01203079 0.0352862 0.15551647 0.32061185 ONKEN_UVEAL_MELANOMA_UP methylmalonic acidemia DOID_14749 0.01203079 0.03510524 0.15551647 0.31830529 ONKEN_UVEAL_MELANOMA_UP hyperostosis DOID_205 0.01203079 0.03492613 0.01203079 0.04924836 ONKEN_UVEAL_MELANOMA_UP juvenile rheumatoid arthritis DOID_676 0.01203079 0.03474884 0.15551647 0.31379032 ONKEN_UVEAL_MELANOMA_UP urinary system benign neoplasm DOID_731 0.01203079 0.03457334 0.15551647 0.31268152 ONKEN_UVEAL_MELANOMA_UP reticulosarcoma DOID_8538 0.01203079 0.0352862 0.15551647 0.32061185 ONKEN_UVEAL_MELANOMA_UP lymphosarcoma DOID_8675 0.01203079 0.0352862 0.15551647 0.32061185 ONKEN_UVEAL_MELANOMA_UP pre-eclampsia DOID_10591 0.01335099 0.03817445 0.08769795 0.24106345 ONKEN_UVEAL_MELANOMA_UP lens disease DOID_110 0.01335099 0.03798358 0.01335099 0.05387742 ONKEN_UVEAL_MELANOMA_UP heart valve disease DOID_4079 0.01335099 0.03779461 0.01335099 0.05275497 ONKEN_UVEAL_MELANOMA_UP vascular skin disease DOID_9540 0.01335099 0.03760751 0.08769795 0.23990449 ONKEN_UVEAL_MELANOMA_UP keratosis DOID_161 0.01344695 0.03769119 0.01344695 0.05276767 ONKEN_UVEAL_MELANOMA_UP neuroendocrine tumor DOID_169 0.01344695 0.03750643 0.1638735 0.32376396 ONKEN_UVEAL_MELANOMA_UP ureteral obstruction DOID_5199 0.01344695 0.03732347 0.1638735 0.31932884 ONKEN_UVEAL_MELANOMA_UP hemolytic anemia DOID_583 0.01408345 0.0389004 0.09070262 0.24693681 ONKEN_UVEAL_MELANOMA_UP normocytic anemia DOID_720 0.01408345 0.0389004 0.09070262 0.24693681 ONKEN_UVEAL_MELANOMA_UP Down syndrome DOID_14250 0.01493164 0.04104398 0.01493164 0.05779662 ONKEN_UVEAL_MELANOMA_UP psoriasis DOID_8893 0.01493164 0.04084665 0.01493164 0.0574061 ONKEN_UVEAL_MELANOMA_UP Crohn's disease DOID_8778 0.01535155 0.04179441 0.0701196 0.19949027 ONKEN_UVEAL_MELANOMA_UP membranous glomerulonephritis DOID_10976 0.01648339 0.04466214 0.18034092 0.34319059 ONKEN_UVEAL_MELANOMA_UP esophagitis DOID_11963 0.01648339 0.04445047 0.18034092 0.34091025 ONKEN_UVEAL_MELANOMA_UP neutropenia DOID_1227 0.01978222 0.05309474 0.01978222 0.0740532 ONKEN_UVEAL_MELANOMA_UP parasitic protozoa infectious disease DOID_2789 0.01984153 0.0530039 0.43842193 0.6429435 ONKEN_UVEAL_MELANOMA_UP pustulosis of palm and sole DOID_4398 0.01984153 0.05275621 0.01984153 0.07378974 ONKEN_UVEAL_MELANOMA_UP heart conduction disease DOID_10273 0.02152645 0.05696999 0.02152645 0.07953602 ONKEN_UVEAL_MELANOMA_UP agranulocytosis DOID_12987 0.02152645 0.05670624 0.02152645 0.07902289 ONKEN_UVEAL_MELANOMA_UP muscle cancer DOID_4045 0.02152645 0.05644492 0.02152645 0.07851633 ONKEN_UVEAL_MELANOMA_UP myasthenia gravis DOID_437 0.02152645 0.056186 0.02152645 0.07801623 ONKEN_UVEAL_MELANOMA_UP urinary tract obstruction DOID_5200 0.02152645 0.05592944 0.20443753 0.36465503 ONKEN_UVEAL_MELANOMA_UP sleep disorder DOID_535 0.02152645 0.05567522 0.20443753 0.36351548 ONKEN_UVEAL_MELANOMA_UP congenital nervous system abnormality DOID_2490 0.02169086 0.05584659 0.02169086 0.07811454 ONKEN_UVEAL_MELANOMA_UP Lewy body dementia DOID_12217 0.023332 0.05980138 0.21231168 0.37056855 ONKEN_UVEAL_MELANOMA_UP ureteral disease DOID_1426 0.023332 0.05953321 0.21231168 0.36943531 ONKEN_UVEAL_MELANOMA_UP toxic shock syndrome DOID_14115 0.0251975 0.06400616 0.22010811 0.38067329 ONKEN_UVEAL_MELANOMA_UP sphingolipidosis DOID_1927 0.0251975 0.06372169 0.0251975 0.08905204 ONKEN_UVEAL_MELANOMA_UP neuroectodermal tumor DOID_171 0.02566257 0.06461063 0.13217736 0.29038192 ONKEN_UVEAL_MELANOMA_UP collagen disease DOID_854 0.02566257 0.064326 0.13217736 0.28926507 ONKEN_UVEAL_MELANOMA_UP commensal bacterial infectious disease DOID_0050339 0.02712161 0.06768506 0.22782757 0.39164316 ONKEN_UVEAL_MELANOMA_UP organic acidemia DOID_0060159 0.02712161 0.06738949 0.22782757 0.39046351 ONKEN_UVEAL_MELANOMA_UP reading disorder DOID_13365 0.02712161 0.06709649 0.02712161 0.09467604 ONKEN_UVEAL_MELANOMA_UP urticaria DOID_1555 0.02712161 0.06680603 0.22782757 0.3881254 ONKEN_UVEAL_MELANOMA_UP dyslexia DOID_4428 0.02712161 0.06709649 0.02712161 0.09467604 ONKEN_UVEAL_MELANOMA_UP neuromuscular junction disease DOID_439 0.02910297 0.07137755 0.02910297 0.10097311 ONKEN_UVEAL_MELANOMA_UP hyperglycemia DOID_4195 0.03113773 0.07604021 0.03113773 0.1048365 ONKEN_UVEAL_MELANOMA_UP vitiligo DOID_12306 0.03114028 0.07572146 0.24303862 0.40553951 ONKEN_UVEAL_MELANOMA_UP juvenile myoclonic epilepsy DOID_4890 0.03114028 0.07539924 0.03114028 0.10422836 ONKEN_UVEAL_MELANOMA_UP fragments of torsion dystonia DOID_531 0.03114028 0.07507975 0.03114028 0.10361884 ONKEN_UVEAL_MELANOMA_UP dystonia DOID_543 0.03114028 0.07476296 0.03114028 0.10301641 ONKEN_UVEAL_MELANOMA_UP lung adenocarcinoma DOID_3910 0.03323225 0.07945021 0.2505317 0.41319576 ONKEN_UVEAL_MELANOMA_UP perinatal necrotizing enterocolitis DOID_8677 0.03323225 0.07911779 0.2505317 0.41200155 ONKEN_UVEAL_MELANOMA_UP autoimmune disease of cardiovascular system DOID_0060051 0.0353776 0.08387439 0.0353776 0.11437416 ONKEN_UVEAL_MELANOMA_UP Behcet's disease DOID_13241 0.0353776 0.08387439 0.0353776 0.11437416 ONKEN_UVEAL_MELANOMA_UP renal tubular transport disease DOID_447 0.0353776 0.08352636 0.0353776 0.11308906 ONKEN_UVEAL_MELANOMA_UP central nervous system hereditary degenerative disease DOID_481 0.0353776 0.08318121 0.0353776 0.11245728 ONKEN_UVEAL_MELANOMA_UP polycystic ovary syndrome DOID_11612 0.03757507 0.08798442 0.03757507 0.1174737 ONKEN_UVEAL_MELANOMA_UP multiple epiphyseal dysplasia DOID_12721 0.03757507 0.08762383 0.26529667 0.43129658 ONKEN_UVEAL_MELANOMA_UP dystonic disease DOID_544 0.03757507 0.08726618 0.03757507 0.11683177 ONKEN_UVEAL_MELANOMA_UP dysostosis DOID_1934 0.03982343 0.09211191 0.03982343 0.12248395 ZHU_CMV_8_HR_UP influenza DOID_8469 2.731E-10 1.554E-07 4.812E-08 2.738E-05 ZHU_CMV_8_HR_UP metabolic syndrome X DOID_14221 4.769E-09 1.357E-06 4.633E-07 1.318E-04 ZHU_CMV_8_HR_UP pleurisy DOID_10247 7.461E-09 1.415E-06 1.611E-06 3.056E-04 ZHU_CMV_8_HR_UP pleural disease DOID_1532 1.422E-08 2.022E-06 2.591E-06 2.948E-04 ZHU_CMV_8_HR_UP proteinuria DOID_576 5.71E-08 6.498E-06 7.24E-06 4.578E-04 ZHU_CMV_8_HR_UP sarcoidosis DOID_11335 9.863E-08 9.353E-06 1.085E-05 5.615E-04 ZHU_CMV_8_HR_UP hypersensitivity reaction type IV disease DOID_2916 1.398E-07 1.136E-05 1.406E-05 6.665E-04 ZHU_CMV_8_HR_UP hyperglycemia DOID_4195 2.306E-07 1.64E-05 2.038E-05 8.283E-04 ZHU_CMV_8_HR_UP mouth disease DOID_403 8.734E-07 5.522E-05 5.481E-05 1.559E-03 ZHU_CMV_8_HR_UP cystitis DOID_1679 1.163E-06 6.615E-05 1.96E-04 4.13E-03 ZHU_CMV_8_HR_UP bronchiolitis obliterans DOID_2799 2.162E-06 1.118E-04 2.162E-06 3.075E-04 ZHU_CMV_8_HR_UP bladder disease DOID_365 2.591E-06 1.228E-04 3.309E-04 5.38E-03 ZHU_CMV_8_HR_UP pulmonary sarcoidosis DOID_13406 3.901E-06 1.707E-04 3.901E-06 3.699E-04 ZHU_CMV_8_HR_UP respiratory syncytial virus infectious disease DOID_1273 4.528E-06 1.84E-04 4.528E-06 3.68E-04 ZHU_CMV_8_HR_UP peptic ulcer DOID_750 4.528E-06 1.718E-04 4.773E-04 6.79E-03 ZHU_CMV_8_HR_UP adult respiratory distress syndrome DOID_11394 4.865E-06 1.73E-04 4.865E-06 3.46E-04 ZHU_CMV_8_HR_UP pulmonary emphysema DOID_9675 5.218E-06 1.747E-04 5.239E-04 7.271E-03 ZHU_CMV_8_HR_UP neuritis DOID_1803 7.699E-06 2.434E-04 6.765E-04 8.749E-03 ZHU_CMV_8_HR_UP atopic dermatitis DOID_3310 1.028E-05 3.078E-04 1.028E-05 5.848E-04 ZHU_CMV_8_HR_UP respiratory failure DOID_11162 1.703E-05 4.844E-04 1.703E-05 7.452E-04 ZHU_CMV_8_HR_UP uterine disease DOID_345 1.95E-05 5.285E-04 1.247E-03 0.01339157 ZHU_CMV_8_HR_UP hyperparathyroidism DOID_13543 2.533E-05 6.551E-04 7.624E-03 0.06572915 ZHU_CMV_8_HR_UP diabetic retinopathy DOID_8947 2.725E-05 6.741E-04 2.725E-05 1.034E-03 ZHU_CMV_8_HR_UP aneurysm disease DOID_2403 3.06E-05 7.255E-04 1.678E-03 0.01618568 ZHU_CMV_8_HR_UP pancreatitis DOID_4989 3.178E-05 7.233E-04 1.721E-03 0.01631629 ZHU_CMV_8_HR_UP bacterial pneumonia DOID_874 3.178E-05 6.954E-04 3.178E-05 1.13E-03 ZHU_CMV_8_HR_UP female reproductive system disease DOID_229 3.548E-05 7.478E-04 1.85E-03 0.01698005 ZHU_CMV_8_HR_UP retinal vascular disease DOID_2462 4.085E-05 8.301E-04 4.085E-05 1.367E-03 ZHU_CMV_8_HR_UP primary bacterial infectious disease DOID_0050338 4.372E-05 8.578E-04 4.372E-05 1.382E-03 ZHU_CMV_8_HR_UP parathyroid gland disease DOID_11201 4.384E-05 8.315E-04 9.9E-03 0.07041652 ZHU_CMV_8_HR_UP polyneuropathy DOID_1389 4.384E-05 8.047E-04 4.384E-05 1.313E-03 ZHU_CMV_8_HR_UP polycystic kidney disease DOID_898 5.112E-05 9.09E-04 0.01065803 0.07219543 ZHU_CMV_8_HR_UP encephalomyelitis DOID_640 5.312E-05 9.16E-04 2.414E-03 0.02113053 ZHU_CMV_8_HR_UP Fanconi's anemia DOID_13636 6.735E-05 1.127E-03 6.735E-05 1.825E-03 ZHU_CMV_8_HR_UP psoriasis DOID_8893 9.584E-05 1.558E-03 9.584E-05 2.479E-03 ZHU_CMV_8_HR_UP amnestic disorder DOID_10914 1.064E-04 1.682E-03 0.0151921 0.08731621 ZHU_CMV_8_HR_UP esophagitis DOID_11963 1.064E-04 1.637E-03 0.0151921 0.08644305 ZHU_CMV_8_HR_UP autoimmune hepatitis DOID_2048 1.176E-04 1.761E-03 1.176E-04 2.909E-03 ZHU_CMV_8_HR_UP Goodpasture syndrome DOID_9808 1.543E-04 2.251E-03 1.543E-04 3.659E-03 ZHU_CMV_8_HR_UP bronchiolitis DOID_2942 1.815E-04 2.582E-03 1.815E-04 4.132E-03 ZHU_CMV_8_HR_UP osteosarcoma DOID_3347 1.815E-04 2.519E-03 1.815E-04 3.973E-03 ZHU_CMV_8_HR_UP congenital hypoplastic anemia DOID_1342 2.109E-04 2.858E-03 2.109E-04 4.287E-03 ZHU_CMV_8_HR_UP extrinsic allergic alveolitis DOID_841 2.109E-04 2.791E-03 2.109E-04 4.139E-03 ZHU_CMV_8_HR_UP Sciatic Neuropathy DOID_11446 2.265E-04 2.929E-03 2.265E-04 4.295E-03 ZHU_CMV_8_HR_UP lesion of sciatic nerve DOID_12528 2.265E-04 2.929E-03 2.265E-04 4.295E-03 ZHU_CMV_8_HR_UP mononeuritis of lower limb DOID_9473 2.265E-04 2.929E-03 2.265E-04 4.295E-03 ZHU_CMV_8_HR_UP mononeuritis DOID_1802 2.425E-04 3.067E-03 2.425E-04 4.451E-03 ZHU_CMV_8_HR_UP autoimmune disease of endocrine system DOID_0060005 2.591E-04 3.205E-03 2.591E-04 4.608E-03 ZHU_CMV_8_HR_UP mononeuropathy DOID_1188 2.591E-04 3.137E-03 2.591E-04 4.468E-03 ZHU_CMV_8_HR_UP allergic rhinitis DOID_4481 3.122E-04 3.701E-03 0.02569372 0.11511596 ZHU_CMV_8_HR_UP chronic leukemia DOID_1036 3.309E-04 3.843E-03 0.02643969 0.11753266 ZHU_CMV_8_HR_UP chronic lymphocytic leukemia DOID_1040 3.309E-04 3.843E-03 0.02643969 0.11753266 ZHU_CMV_8_HR_UP autonomic nervous system neoplasm DOID_2621 3.309E-04 3.766E-03 3.309E-04 5.538E-03 ZHU_CMV_8_HR_UP neuroblastoma DOID_769 3.309E-04 3.766E-03 3.309E-04 5.538E-03 ZHU_CMV_8_HR_UP papilloma DOID_2615 3.502E-04 3.908E-03 0.0271851 0.11990946 ZHU_CMV_8_HR_UP myocarditis DOID_820 3.502E-04 3.832E-03 0.0271851 0.11898708 ZHU_CMV_8_HR_UP pneumoconiosis DOID_10316 3.701E-04 3.973E-03 3.701E-04 5.849E-03 ZHU_CMV_8_HR_UP nephroblastoma DOID_2154 3.701E-04 3.9E-03 0.02792996 0.1213141 ZHU_CMV_8_HR_UP spindle cell carcinoma DOID_4015 3.701E-04 3.829E-03 0.02792996 0.11948983 ZHU_CMV_8_HR_UP esophageal disease DOID_6050 3.701E-04 3.76E-03 0.02792996 0.11859811 ZHU_CMV_8_HR_UP aplastic anemia DOID_12449 3.905E-04 3.898E-03 3.905E-04 6.005E-03 ZHU_CMV_8_HR_UP peripheral nervous system neoplasm DOID_1192 4.548E-04 4.462E-03 4.548E-04 6.81E-03 ZHU_CMV_8_HR_UP uveitis DOID_13141 4.548E-04 4.386E-03 4.548E-04 6.635E-03 ZHU_CMV_8_HR_UP systemic scleroderma DOID_418 4.773E-04 4.526E-03 0.03164602 0.12592016 ZHU_CMV_8_HR_UP autoimmune disease of urogenital tract DOID_0060049 5.48E-04 5.112E-03 5.48E-04 7.425E-03 ZHU_CMV_8_HR_UP primary biliary cirrhosis DOID_12236 5.48E-04 5.112E-03 5.48E-04 7.425E-03 ZHU_CMV_8_HR_UP endometriosis of uterus DOID_288 5.48E-04 5.03E-03 0.03386906 0.13199655 ZHU_CMV_8_HR_UP rheumatic disease DOID_1575 5.727E-04 5.172E-03 0.03460898 0.13396265 ZHU_CMV_8_HR_UP endometriosis DOID_289 5.727E-04 5.091E-03 0.03460898 0.1312834 ZHU_CMV_8_HR_UP uveal disease DOID_3480 5.727E-04 5.013E-03 5.727E-04 7.578E-03 ZHU_CMV_8_HR_UP scleroderma DOID_419 5.727E-04 5.172E-03 0.03460898 0.13396265 ZHU_CMV_8_HR_UP diabetic autonomic neuropathy DOID_11503 5.978E-04 5.154E-03 0.03534835 0.13320008 ZHU_CMV_8_HR_UP autonomic neuropathy DOID_11504 5.978E-04 5.154E-03 0.03534835 0.13320008 ZHU_CMV_8_HR_UP diabetic polyneuropathy DOID_12785 5.978E-04 5.154E-03 0.03534835 0.13320008 ZHU_CMV_8_HR_UP diabetic neuropathy DOID_9743 5.978E-04 5.154E-03 0.03534835 0.13320008 ZHU_CMV_8_HR_UP autonomic nervous system disease DOID_11465 6.765E-04 5.745E-03 0.03756319 0.13527504 ZHU_CMV_8_HR_UP bone marrow disease DOID_4961 6.765E-04 5.661E-03 6.765E-04 8.554E-03 ZHU_CMV_8_HR_UP autoimmune disease of gastrointestinal tract DOID_0060031 7.316E-04 6.033E-03 7.316E-04 9.05E-03 ZHU_CMV_8_HR_UP pulmonary tuberculosis DOID_2957 7.316E-04 5.947E-03 7.316E-04 8.857E-03 ZHU_CMV_8_HR_UP aortic aneurysm DOID_3627 7.599E-04 6.09E-03 0.03977312 0.13883991 ZHU_CMV_8_HR_UP bile duct adenocarcinoma DOID_4896 8.785E-04 6.943E-03 0.04271207 0.14552795 ZHU_CMV_8_HR_UP cholangiocarcinoma DOID_4947 8.785E-04 6.943E-03 0.04271207 0.14552795 ZHU_CMV_8_HR_UP bone marrow cancer DOID_4960 8.785E-04 6.847E-03 8.785E-04 0.01041379 ZHU_CMV_8_HR_UP integumentary system cancer DOID_0060122 9.094E-04 6.993E-03 0.04344545 0.1471456 ZHU_CMV_8_HR_UP parasitic protozoa infectious disease DOID_2789 9.094E-04 6.9E-03 9.094E-04 0.01056059 ZHU_CMV_8_HR_UP skin cancer DOID_4159 9.094E-04 6.993E-03 0.04344545 0.1471456 ZHU_CMV_8_HR_UP pustulosis of palm and sole DOID_4398 9.094E-04 6.809E-03 9.094E-04 0.01034938 ZHU_CMV_8_HR_UP glioblastoma DOID_3068 1.005E-03 7.429E-03 0.04564234 0.15276758 ZHU_CMV_8_HR_UP bile duct cancer DOID_4606 1.005E-03 7.334E-03 0.04564234 0.1518742 ZHU_CMV_8_HR_UP bile duct carcinoma DOID_4897 1.005E-03 7.334E-03 0.04564234 0.1518742 ZHU_CMV_8_HR_UP melancholia DOID_2848 1.038E-03 7.479E-03 0.04637355 0.15341017 ZHU_CMV_8_HR_UP neurotic disorder DOID_4964 1.072E-03 7.624E-03 0.04710422 0.15492659 ZHU_CMV_8_HR_UP collagen disease DOID_854 1.106E-03 7.769E-03 0.04783435 0.15464628 ZHU_CMV_8_HR_UP cholestasis DOID_13580 1.247E-03 8.656E-03 1.247E-03 0.01391673 ZHU_CMV_8_HR_UP parasitic infectious disease DOID_1398 1.247E-03 8.551E-03 1.247E-03 0.0136491 ZHU_CMV_8_HR_UP tooth disease DOID_1091 1.321E-03 8.949E-03 1.321E-03 0.01392085 ZHU_CMV_8_HR_UP allergic contact dermatitis DOID_3042 1.321E-03 8.844E-03 1.321E-03 0.01366774 ZHU_CMV_8_HR_UP tuberculosis DOID_399 1.359E-03 8.99E-03 1.359E-03 0.01380622 ZHU_CMV_8_HR_UP astrocytoma DOID_3069 1.397E-03 9.136E-03 0.05365598 0.16961251 ZHU_CMV_8_HR_UP bile duct disease DOID_4138 1.475E-03 9.536E-03 1.475E-03 0.01472208 ZHU_CMV_8_HR_UP male reproductive system disease DOID_48 1.475E-03 9.429E-03 0.05510601 0.17228197 ZHU_CMV_8_HR_UP biliary tract disease DOID_9741 1.514E-03 9.575E-03 1.514E-03 0.0148576 ZHU_CMV_8_HR_UP cystic fibrosis DOID_1485 1.637E-03 0.01023318 0.05799963 0.18033766 ZHU_CMV_8_HR_UP endogenous depression DOID_1595 1.637E-03 0.01012195 0.05799963 0.17935756 ZHU_CMV_8_HR_UP contact dermatitis DOID_2773 1.806E-03 0.01105249 1.806E-03 0.01685052 ZHU_CMV_8_HR_UP mental depression DOID_1596 1.939E-03 0.0117381 0.0630429 0.19080538 ZHU_CMV_8_HR_UP biliary tract cancer DOID_4607 1.939E-03 0.01161454 0.0630429 0.18979583 ZHU_CMV_8_HR_UP chronic kidney failure DOID_784 1.939E-03 0.01149356 0.0630429 0.1887969 ZHU_CMV_8_HR_UP transitional cell carcinoma DOID_2671 2.17E-03 0.01273094 0.06662927 0.19849242 ZHU_CMV_8_HR_UP nervous system cancer DOID_3093 2.266E-03 0.01315806 2.266E-03 0.02046809 ZHU_CMV_8_HR_UP lymphoblastic leukemia DOID_1037 2.414E-03 0.01387358 0.07020237 0.20804766 ZHU_CMV_8_HR_UP carbohydrate metabolic disorder DOID_2978 2.414E-03 0.01373484 2.414E-03 0.02146069 ZHU_CMV_8_HR_UP Crohn's disease DOID_8778 2.464E-03 0.01388162 0.07091541 0.20907185 ZHU_CMV_8_HR_UP ulcerative colitis DOID_8577 2.67E-03 0.01489292 0.07376227 0.21523453 ZHU_CMV_8_HR_UP retinal vascular occlusion DOID_1729 7.624E-03 0.0421177 7.624E-03 0.06474811 ZHU_CMV_8_HR_UP chondrosarcoma DOID_3371 7.624E-03 0.04171273 7.624E-03 0.06379593 ZHU_CMV_8_HR_UP Hermansky-Pudlak syndrome DOID_3753 7.624E-03 0.04131546 7.624E-03 0.06287136 ZHU_CMV_8_HR_UP conjunctival disease DOID_4251 7.624E-03 0.04092569 7.624E-03 0.06197319 ZHU_CMV_8_HR_UP Paget's disease of bone DOID_5408 7.624E-03 0.04054321 7.624E-03 0.06110033 ZHU_CMV_8_HR_UP conjunctivitis DOID_6195 7.624E-03 0.04092569 7.624E-03 0.06197319 ZHU_CMV_8_HR_UP visceral leishmaniasis DOID_9146 7.624E-03 0.04016781 7.624E-03 0.06025172 ZHU_CMV_8_HR_UP familial adenomatous polyposis DOID_0050424 8.383E-03 0.04376308 1.000 1.000 ZHU_CMV_8_HR_UP trypanosomiasis DOID_10113 8.383E-03 0.04336523 8.383E-03 0.06534487 ZHU_CMV_8_HR_UP prediabetes syndrome DOID_11716 8.383E-03 0.04297455 8.383E-03 0.06446183 ZHU_CMV_8_HR_UP common cold DOID_10459 9.142E-03 0.04644561 9.142E-03 0.06935877 ZHU_CMV_8_HR_UP porphyria DOID_13268 9.142E-03 0.04603458 9.142E-03 0.06844616 ZHU_CMV_8_HR_UP aortic valve stenosis DOID_1712 9.142E-03 0.04563077 9.142E-03 0.06755725 ZHU_CMV_8_HR_UP stomach disease DOID_76 9.142E-03 0.04523398 1.000 1.000 ZHU_CMV_8_HR_UP encephalitis DOID_9588 9.142E-03 0.04484403 9.142E-03 0.06669113 ZHU_CMV_8_HR_UP berylliosis DOID_10322 9.9E-03 0.04814805 9.9E-03 0.07130787 ZHU_CMV_8_HR_UP larynx cancer DOID_2596 9.9E-03 0.04774001 1.000 1.000 ZHU_CMV_8_HR_UP laryngeal benign neoplasm DOID_2598 9.9E-03 0.04774001 1.000 1.000 ZHU_CMV_8_HR_UP viral pneumonia DOID_10533 0.01065803 0.05096148 0.01065803 0.07486934 ZHU_CMV_8_HR_UP open-angle glaucoma DOID_1067 0.01065803 0.0505368 1.000 1.000 ZHU_CMV_8_HR_UP hypercalcemia DOID_12678 0.01065803 0.05011914 0.01065803 0.0739563 ZHU_CMV_8_HR_UP eyelid disease DOID_530 0.01065803 0.04970833 0.01065803 0.07306526 ZHU_CMV_8_HR_UP idiopathic pulmonary fibrosis DOID_0050156 0.0114151 0.05280645 1.000 1.000 ZHU_CMV_8_HR_UP skeletal system cancer DOID_0060124 0.0114151 0.05238059 1.000 1.000 ZHU_CMV_8_HR_UP thoracic aortic aneurysm DOID_14004 0.0114151 0.05196154 0.0114151 0.07641403 ZHU_CMV_8_HR_UP renovascular hypertension DOID_1591 0.0114151 0.05154915 0.0114151 0.0755255 ZHU_CMV_8_HR_UP bone cancer DOID_184 0.0114151 0.05238059 1.000 1.000 ZHU_CMV_8_HR_UP lung oat cell carcinoma DOID_5411 0.0114151 0.05114325 0.0114151 0.07465739 ZHU_CMV_8_HR_UP oral submucous fibrosis DOID_5773 0.0114151 0.05074369 1.000 1.000 ZHU_CMV_8_HR_UP silicosis DOID_10325 0.01217162 0.05368722 0.01217162 0.07870058 ZHU_CMV_8_HR_UP hemolytic-uremic syndrome DOID_12554 0.01217162 0.05327424 0.01217162 0.0778163 ZHU_CMV_8_HR_UP thyroiditis DOID_7166 0.01217162 0.05286756 0.01217162 0.07695168 ZHU_CMV_8_HR_UP autoimmune thyroiditis DOID_7188 0.01217162 0.05286756 0.01217162 0.07695168 ZHU_CMV_8_HR_UP tongue cancer DOID_8649 0.01217162 0.05246705 1.000 1.000 ZHU_CMV_8_HR_UP Barrett's esophagus DOID_9206 0.01217162 0.05207256 1.000 1.000 ZHU_CMV_8_HR_UP Graves' disease DOID_12361 0.01292758 0.05489396 0.01292758 0.08083287 ZHU_CMV_8_HR_UP hyperostosis DOID_205 0.01292758 0.05448734 0.01292758 0.07995425 ZHU_CMV_8_HR_UP basal cell carcinoma DOID_2513 0.01292758 0.0540867 0.01292758 0.07909453 ZHU_CMV_8_HR_UP bronchitis DOID_6132 0.01292758 0.0536919 0.01292758 0.07825309 ZHU_CMV_8_HR_UP urinary system benign neoplasm DOID_731 0.01292758 0.05330283 1.000 1.000 ZHU_CMV_8_HR_UP glucose intolerance DOID_10603 0.01368298 0.0560116 0.01368298 0.08195382 ZHU_CMV_8_HR_UP skin carcinoma DOID_3451 0.01368298 0.05561152 0.01368298 0.08110014 ZHU_CMV_8_HR_UP prion disease DOID_649 0.01368298 0.05521711 1.000 1.000 ZHU_CMV_8_HR_UP dissociative disorder DOID_10935 0.01443782 0.05785294 0.01443782 0.08469193 ZHU_CMV_8_HR_UP dissociative amnesia DOID_11037 0.01443782 0.05785294 0.01443782 0.08469193 ZHU_CMV_8_HR_UP granulosa cell tumor DOID_2999 0.01443782 0.05744838 1.000 1.000 ZHU_CMV_8_HR_UP leishmaniasis DOID_9065 0.01443782 0.05704943 0.01443782 0.08382773 ZHU_CMV_8_HR_UP sex cord-gonadal stromal tumor DOID_192 0.0151921 0.0596159 1.000 1.000 ZHU_CMV_8_HR_UP coronary restenosis DOID_4247 0.01594583 0.06214503 0.01594583 0.08983342 ZHU_CMV_8_HR_UP mitochondrial myopathy DOID_699 0.01594583 0.06172228 0.01594583 0.0889527 ZHU_CMV_8_HR_UP gastric ulcer DOID_10808 0.01669899 0.06420087 1.000 1.000 ZHU_CMV_8_HR_UP hepatitis B DOID_2043 0.01669899 0.06376999 0.01669899 0.09224979 ZHU_CMV_8_HR_UP placenta disease DOID_780 0.01669899 0.06334485 0.01669899 0.09136277 ZHU_CMV_8_HR_UP muscle cancer DOID_4045 0.01745161 0.06576135 1.000 1.000 ZHU_CMV_8_HR_UP myasthenia gravis DOID_437 0.01745161 0.06532871 0.01745161 0.09457109 ZHU_CMV_8_HR_UP urinary tract obstruction DOID_5200 0.01745161 0.06490173 1.000 1.000 ZHU_CMV_8_HR_UP aortic valve disease DOID_62 0.01820366 0.06725899 0.01820366 0.09771589 ZHU_CMV_8_HR_UP meningitis DOID_9471 0.01820366 0.06682506 0.01820366 0.09680266 ZHU_CMV_8_HR_UP spastic quadriplegia DOID_10970 0.01895516 0.06913774 0.01895516 0.09986563 ZHU_CMV_8_HR_UP portal hypertension DOID_10762 0.01970611 0.07141895 1.000 1.000 ZHU_CMV_8_HR_UP hypogonadism DOID_1924 0.01970611 0.07096694 0.01970611 0.1028695 ZHU_CMV_8_HR_UP neuromuscular junction disease DOID_439 0.0204565 0.07320596 0.0204565 0.10581589 ZHU_CMV_8_HR_UP cleft lip DOID_9296 0.0204565 0.07274842 0.0204565 0.10486259 ZHU_CMV_8_HR_UP intracranial aneurysm DOID_10941 0.02120633 0.07494661 0.02120633 0.10773575 ZHU_CMV_8_HR_UP myopia DOID_11830 0.02120633 0.07448398 0.02120633 0.10678234 ZHU_CMV_8_HR_UP middle cerebral artery infarction DOID_3525 0.02120633 0.07402702 0.02120633 0.10584565 ZHU_CMV_8_HR_UP fragments of torsion dystonia DOID_531 0.02120633 0.07357563 0.02120633 0.10492525 ZHU_CMV_8_HR_UP dystonia DOID_543 0.02120633 0.07312972 0.02120633 0.10402072 ZHU_CMV_8_HR_UP lung adenocarcinoma DOID_3910 0.02195562 0.0752575 0.02195562 0.1067756 ZHU_CMV_8_HR_UP periodontitis DOID_824 0.02195562 0.07480686 0.02195562 0.10587072 ZHU_CMV_8_HR_UP renal hypertension DOID_1073 0.02270434 0.07689745 0.02270434 0.1085611 ZHU_CMV_8_HR_UP secondary hypertension DOID_11130 0.02270434 0.07689745 0.02270434 0.1085611 ZHU_CMV_8_HR_UP hepatic vascular disease DOID_272 0.02270434 0.07644243 1.000 1.000 ZHU_CMV_8_HR_UP coronary stenosis DOID_4248 0.02270434 0.07599277 0.02270434 0.10765642 ZHU_CMV_8_HR_UP autoimmune disease of the nervous system DOID_438 0.02270434 0.07554837 0.02270434 0.1067667 ZHU_CMV_8_HR_UP central nervous system hereditary degenerative disease DOID_481 0.02270434 0.07510913 0.02270434 0.10589156 ZHU_CMV_8_HR_UP dystonic disease DOID_544 0.02345252 0.07713573 0.02345252 0.10849172 ZHU_CMV_8_HR_UP spastic cerebral palsy DOID_0050669 0.02494721 0.08158023 0.02494721 0.11447548 ZHU_CMV_8_HR_UP gonadal disease DOID_2277 0.02494721 0.08111406 0.02494721 0.11355968 ZHU_CMV_8_HR_UP abdominal aortic aneurysm DOID_7693 0.02494721 0.08065318 1.000 1.000 ZHU_CMV_8_HR_UP celiac disease DOID_10608 0.02569372 0.08259733 0.02569372 0.11602958 ZHU_CMV_8_HR_UP periodontal disease DOID_3388 0.02792996 0.08928172 0.02792996 0.12039505 ZHU_CMV_8_HR_UP thyroid carcinoma DOID_3963 0.02792996 0.08878294 1.000 1.000 ZHU_CMV_8_HR_UP hyperthyroidism DOID_7998 0.02792996 0.08828971 0.02792996 0.11771961 ZHU_CMV_8_HR_UP thyroid cancer DOID_1781 0.02941803 0.09247989 1.000 1.000 ZHU_CMV_8_HR_UP refractive error DOID_9835 0.02941803 0.09197176 0.02941803 0.12307985 ZHU_CMV_8_HR_UP medulloblastoma DOID_3858 0.03016124 0.09378004 0.03016124 0.12526822 ZHU_CMV_8_HR_UP cleft palate DOID_674 0.03016124 0.09327036 0.03016124 0.12436048 ZHU_CMV_8_HR_UP multiple myeloma DOID_9538 0.03016124 0.0927662 0.03016124 0.1234658 ZHU_CMV_8_HR_UP blood platelet disease DOID_2218 0.0309039 0.09453936 0.0309039 0.12560229 ZHU_CMV_8_HR_UP hepatitis DOID_2237 0.03164602 0.09629189 0.03164602 0.12770626 ZHU_CMV_8_HR_UP congenital diaphragmatic hernia DOID_3827 0.03164602 0.09577969 0.03164602 0.12680692 ZHU_CMV_8_HR_UP intracranial arterial disease DOID_13089 0.03238758 0.09750546 0.03238758 0.12797592 ZHU_CMV_8_HR_UP cerebral arterial disease DOID_3527 0.03238758 0.09750546 0.03238758 0.12797592 ZHU_CMV_8_HR_UP benign mesothelioma DOID_2645 0.03312859 0.09921142 0.03312859 0.13000117 ZHU_CMV_8_HR_UP cervix uteri carcinoma in situ DOID_8991 0.03312859 0.09869199 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_1_DN toxic encephalopathy DOID_3602 5.26E-08 2.993E-05 3.102E-06 1.765E-03 MULLIGHAN_MLL_SIGNATURE_1_DN thyroid carcinoma DOID_3963 6.413E-06 1.825E-03 2.389E-04 0.01045588 MULLIGHAN_MLL_SIGNATURE_1_DN thyroid cancer DOID_1781 7.947E-06 1.507E-03 2.796E-04 9.945E-03 MULLIGHAN_MLL_SIGNATURE_1_DN retinal vascular disease DOID_2462 9.894E-06 1.407E-03 1.907E-04 0.01085252 MULLIGHAN_MLL_SIGNATURE_1_DN transitional cell carcinoma DOID_2671 1.168E-05 1.329E-03 2.173E-04 0.01124097 MULLIGHAN_MLL_SIGNATURE_1_DN adenoid cystic carcinoma DOID_4866 1.181E-05 1.12E-03 1.181E-05 3.359E-03 MULLIGHAN_MLL_SIGNATURE_1_DN amino acid metabolic disorder DOID_9252 1.232E-05 1.002E-03 1.232E-05 2.338E-03 MULLIGHAN_MLL_SIGNATURE_1_DN pulmonary emphysema DOID_9675 1.295E-05 9.213E-04 9.036E-03 0.08033643 MULLIGHAN_MLL_SIGNATURE_1_DN salivary gland cancer DOID_8850 1.418E-05 8.966E-04 1.418E-05 2.017E-03 MULLIGHAN_MLL_SIGNATURE_1_DN encephalomyelitis DOID_640 1.52E-05 8.647E-04 2.674E-04 0.01086769 MULLIGHAN_MLL_SIGNATURE_1_DN Crohn's disease DOID_8778 1.599E-05 8.272E-04 2.783E-04 0.01055781 MULLIGHAN_MLL_SIGNATURE_1_DN gallbladder cancer DOID_3121 1.689E-05 8.009E-04 4.869E-04 0.01458071 MULLIGHAN_MLL_SIGNATURE_1_DN pre-eclampsia DOID_10591 2.165E-05 9.475E-04 0.0115541 0.0913095 MULLIGHAN_MLL_SIGNATURE_1_DN lung small cell carcinoma DOID_5409 2.532E-05 1.029E-03 6.558E-04 0.0169612 MULLIGHAN_MLL_SIGNATURE_1_DN aortic aneurysm DOID_3627 2.732E-05 1.036E-03 6.935E-04 0.01644177 MULLIGHAN_MLL_SIGNATURE_1_DN giant cell tumor DOID_200 3.401E-05 1.209E-03 0.01434301 0.10463042 MULLIGHAN_MLL_SIGNATURE_1_DN malignant giant cell tumor DOID_2705 3.401E-05 1.209E-03 0.01434301 0.10463042 MULLIGHAN_MLL_SIGNATURE_1_DN giant cell glioblastoma DOID_3074 3.401E-05 1.209E-03 0.01434301 0.10463042 MULLIGHAN_MLL_SIGNATURE_1_DN bile duct adenocarcinoma DOID_4896 3.648E-05 1.221E-03 8.581E-04 0.0187786 MULLIGHAN_MLL_SIGNATURE_1_DN cholangiocarcinoma DOID_4947 3.648E-05 1.221E-03 8.581E-04 0.0187786 MULLIGHAN_MLL_SIGNATURE_1_DN smallpox DOID_8736 3.909E-05 1.236E-03 3.909E-05 4.448E-03 MULLIGHAN_MLL_SIGNATURE_1_DN glioblastoma DOID_3068 4.772E-05 1.429E-03 0.01686592 0.11562299 MULLIGHAN_MLL_SIGNATURE_1_DN bile duct cancer DOID_4606 4.772E-05 1.358E-03 1.046E-03 0.02203349 MULLIGHAN_MLL_SIGNATURE_1_DN bile duct carcinoma DOID_4897 4.772E-05 1.358E-03 1.046E-03 0.02203349 MULLIGHAN_MLL_SIGNATURE_1_DN oral cavity cancer DOID_8618 4.772E-05 1.293E-03 4.772E-05 4.525E-03 MULLIGHAN_MLL_SIGNATURE_1_DN carotid artery disease DOID_3407 5.766E-05 1.491E-03 1.202E-03 0.02442288 MULLIGHAN_MLL_SIGNATURE_1_DN organic acidemia DOID_0060159 8.205E-05 2.03E-03 8.205E-05 6.669E-03 MULLIGHAN_MLL_SIGNATURE_1_DN astrocytoma DOID_3069 9.152E-05 2.17E-03 0.0230201 0.14393885 MULLIGHAN_MLL_SIGNATURE_1_DN blood coagulation disease DOID_1247 9.658E-05 2.198E-03 9.658E-05 6.87E-03 MULLIGHAN_MLL_SIGNATURE_1_DN diabetic retinopathy DOID_8947 1.13E-04 2.473E-03 1.971E-03 0.02549324 MULLIGHAN_MLL_SIGNATURE_1_DN coronary stenosis DOID_4248 1.269E-04 2.674E-03 1.269E-04 8.023E-03 MULLIGHAN_MLL_SIGNATURE_1_DN aneurysm disease DOID_2403 1.313E-04 2.669E-03 2.202E-03 0.02784239 MULLIGHAN_MLL_SIGNATURE_1_DN female reproductive organ benign neoplasm DOID_0060086 1.543E-04 3.028E-03 4.859E-03 0.05317198 MULLIGHAN_MLL_SIGNATURE_1_DN uterine benign neoplasm DOID_0060095 1.543E-04 3.028E-03 4.859E-03 0.05317198 MULLIGHAN_MLL_SIGNATURE_1_DN uterine fibroid DOID_13223 1.543E-04 3.028E-03 4.859E-03 0.05317198 MULLIGHAN_MLL_SIGNATURE_1_DN biliary tract cancer DOID_4607 1.744E-04 3.307E-03 2.712E-03 0.03282918 MULLIGHAN_MLL_SIGNATURE_1_DN leiomyoma DOID_127 2.022E-04 3.711E-03 5.792E-03 0.06103427 MULLIGHAN_MLL_SIGNATURE_1_DN autonomic nervous system neoplasm DOID_2621 2.022E-04 3.595E-03 5.792E-03 0.05992456 MULLIGHAN_MLL_SIGNATURE_1_DN neuroblastoma DOID_769 2.022E-04 3.595E-03 5.792E-03 0.05992456 MULLIGHAN_MLL_SIGNATURE_1_DN nervous system cancer DOID_3093 2.365E-04 4.077E-03 3.392E-03 0.04020435 MULLIGHAN_MLL_SIGNATURE_1_DN Human immunodeficiency virus infectious disease DOID_526 2.365E-04 3.957E-03 2.365E-04 0.01121178 MULLIGHAN_MLL_SIGNATURE_1_DN peripheral nervous system neoplasm DOID_1192 3.247E-04 5.278E-03 7.882E-03 0.07732766 MULLIGHAN_MLL_SIGNATURE_1_DN blood platelet disease DOID_2218 3.247E-04 5.131E-03 3.247E-04 0.01086632 MULLIGHAN_MLL_SIGNATURE_1_DN respiratory syncytial virus infectious disease DOID_1273 3.488E-04 5.364E-03 8.259E-03 0.07964967 MULLIGHAN_MLL_SIGNATURE_1_DN systemic scleroderma DOID_418 3.488E-04 5.223E-03 8.259E-03 0.07703821 MULLIGHAN_MLL_SIGNATURE_1_DN cervix uteri carcinoma in situ DOID_8991 4.005E-04 5.843E-03 9.036E-03 0.08161161 MULLIGHAN_MLL_SIGNATURE_1_DN autoimmune disease of urogenital tract DOID_0060049 4.281E-04 6.09E-03 4.281E-04 0.01353248 MULLIGHAN_MLL_SIGNATURE_1_DN primary biliary cirrhosis DOID_12236 4.281E-04 6.09E-03 4.281E-04 0.01353248 MULLIGHAN_MLL_SIGNATURE_1_DN endometriosis of uterus DOID_288 4.281E-04 5.941E-03 9.436E-03 0.08260527 MULLIGHAN_MLL_SIGNATURE_1_DN rheumatic disease DOID_1575 4.569E-04 6.19E-03 9.845E-03 0.08487253 MULLIGHAN_MLL_SIGNATURE_1_DN endometriosis DOID_289 4.569E-04 6.046E-03 9.845E-03 0.08360578 MULLIGHAN_MLL_SIGNATURE_1_DN scleroderma DOID_419 4.569E-04 6.19E-03 9.845E-03 0.08487253 MULLIGHAN_MLL_SIGNATURE_1_DN chondrosarcoma DOID_3371 4.619E-04 5.973E-03 0.03197854 0.1749595 MULLIGHAN_MLL_SIGNATURE_1_DN cutaneous leishmaniasis DOID_9111 4.619E-04 5.841E-03 0.03197854 0.17165837 MULLIGHAN_MLL_SIGNATURE_1_DN cannabis abuse DOID_9505 4.619E-04 5.714E-03 0.03197854 0.17005409 MULLIGHAN_MLL_SIGNATURE_1_DN diabetic autonomic neuropathy DOID_11503 4.869E-04 5.894E-03 0.01026052 0.08461209 MULLIGHAN_MLL_SIGNATURE_1_DN autonomic neuropathy DOID_11504 4.869E-04 5.894E-03 0.01026052 0.08461209 MULLIGHAN_MLL_SIGNATURE_1_DN diabetic polyneuropathy DOID_12785 4.869E-04 5.894E-03 0.01026052 0.08461209 MULLIGHAN_MLL_SIGNATURE_1_DN diabetic neuropathy DOID_9743 4.869E-04 5.894E-03 0.01026052 0.08461209 MULLIGHAN_MLL_SIGNATURE_1_DN cataract DOID_83 5.181E-04 6.142E-03 5.181E-04 0.01474025 MULLIGHAN_MLL_SIGNATURE_1_DN myeloma DOID_0070004 5.844E-04 6.786E-03 0.0115541 0.09259555 MULLIGHAN_MLL_SIGNATURE_1_DN lens disease DOID_110 5.844E-04 6.65E-03 5.844E-04 0.01583341 MULLIGHAN_MLL_SIGNATURE_1_DN autonomic nervous system disease DOID_11465 5.844E-04 6.52E-03 0.0115541 0.09005869 MULLIGHAN_MLL_SIGNATURE_1_DN thyroid adenoma DOID_2891 5.844E-04 6.394E-03 0.0115541 0.08765712 MULLIGHAN_MLL_SIGNATURE_1_DN glaucoma DOID_1686 6.558E-04 7.04E-03 0.0124542 0.09203169 MULLIGHAN_MLL_SIGNATURE_1_DN lipodystrophy DOID_811 6.746E-04 7.108E-03 6.746E-04 0.01668912 MULLIGHAN_MLL_SIGNATURE_1_DN hemorrhagic disease DOID_2213 7.326E-04 7.579E-03 7.326E-04 0.01667318 MULLIGHAN_MLL_SIGNATURE_1_DN cannabis dependence DOID_1849 7.956E-04 8.084E-03 0.04137278 0.19139117 MULLIGHAN_MLL_SIGNATURE_1_DN hallucinogen dependence DOID_9977 7.956E-04 8.084E-03 0.04137278 0.19139117 MULLIGHAN_MLL_SIGNATURE_1_DN bone marrow cancer DOID_4960 8.581E-04 8.566E-03 0.01483337 0.10550235 MULLIGHAN_MLL_SIGNATURE_1_DN reproductive organ benign neoplasm DOID_0050622 9.027E-04 8.856E-03 0.01533089 0.1076948 MULLIGHAN_MLL_SIGNATURE_1_DN parasitic protozoa infectious disease DOID_2789 9.027E-04 8.706E-03 0.01533089 0.10638145 MULLIGHAN_MLL_SIGNATURE_1_DN bacterial meningitis DOID_9470 9.262E-04 8.783E-03 0.04448406 0.19321702 MULLIGHAN_MLL_SIGNATURE_1_DN thoracic aortic aneurysm DOID_14004 1.066E-03 9.947E-03 0.04758532 0.2035793 MULLIGHAN_MLL_SIGNATURE_1_DN collagen disease DOID_854 1.202E-03 0.01102969 0.01846358 0.12506878 MULLIGHAN_MLL_SIGNATURE_1_DN chronic myeloid leukemia DOID_8552 1.216E-03 0.01098419 1.216E-03 0.02386221 MULLIGHAN_MLL_SIGNATURE_1_DN Barrett's esophagus DOID_9206 1.216E-03 0.01081256 1.216E-03 0.0230668 MULLIGHAN_MLL_SIGNATURE_1_DN pre-malignant neoplasm DOID_0060071 1.314E-03 0.01150058 0.01956282 0.12943309 MULLIGHAN_MLL_SIGNATURE_1_DN in situ carcinoma DOID_8719 1.314E-03 0.01150058 0.01956282 0.12943309 MULLIGHAN_MLL_SIGNATURE_1_DN lymphatic system cancer DOID_0060073 1.375E-03 0.0118577 1.375E-03 0.02524542 MULLIGHAN_MLL_SIGNATURE_1_DN methylmalonic acidemia DOID_14749 1.375E-03 0.01168072 1.375E-03 0.0244565 MULLIGHAN_MLL_SIGNATURE_1_DN reticulosarcoma DOID_8538 1.375E-03 0.0118577 1.375E-03 0.02524542 MULLIGHAN_MLL_SIGNATURE_1_DN lymphosarcoma DOID_8675 1.375E-03 0.0118577 1.375E-03 0.02524542 MULLIGHAN_MLL_SIGNATURE_1_DN cholestasis DOID_13580 1.432E-03 0.01198308 1.432E-03 0.02469241 MULLIGHAN_MLL_SIGNATURE_1_DN parasitic infectious disease DOID_1398 1.432E-03 0.01180941 0.02068891 0.13531025 MULLIGHAN_MLL_SIGNATURE_1_DN uterine disease DOID_345 1.432E-03 0.01164071 0.02068891 0.13377263 MULLIGHAN_MLL_SIGNATURE_1_DN congenital muscular dystrophy DOID_0050557 1.544E-03 0.01237419 1.544E-03 0.02584022 MULLIGHAN_MLL_SIGNATURE_1_DN allergic contact dermatitis DOID_3042 1.557E-03 0.01230347 1.557E-03 0.02531 MULLIGHAN_MLL_SIGNATURE_1_DN endocrine organ benign neoplasm DOID_0060089 1.622E-03 0.0126405 0.02242755 0.14179193 MULLIGHAN_MLL_SIGNATURE_1_DN brain infarction DOID_3454 1.622E-03 0.01246968 1.622E-03 0.02563213 MULLIGHAN_MLL_SIGNATURE_1_DN dissociative disorder DOID_10935 1.722E-03 0.01306463 1.722E-03 0.02648236 MULLIGHAN_MLL_SIGNATURE_1_DN dissociative amnesia DOID_11037 1.722E-03 0.01306463 1.722E-03 0.02648236 MULLIGHAN_MLL_SIGNATURE_1_DN infertility DOID_5223 1.722E-03 0.01289273 1.722E-03 0.02578546 MULLIGHAN_MLL_SIGNATURE_1_DN leishmaniasis DOID_9065 1.722E-03 0.01272529 0.05989084 0.230256 MULLIGHAN_MLL_SIGNATURE_1_DN pancreatic ductal carcinoma DOID_3587 1.756E-03 0.01281316 0.02361907 0.14607884 MULLIGHAN_MLL_SIGNATURE_1_DN bile duct disease DOID_4138 1.826E-03 0.01315452 1.826E-03 0.02664633 MULLIGHAN_MLL_SIGNATURE_1_DN biliary tract disease DOID_9741 1.898E-03 0.01349953 1.898E-03 0.02699907 MULLIGHAN_MLL_SIGNATURE_1_DN amnestic disorder DOID_10914 1.909E-03 0.0134125 1.909E-03 0.02649786 MULLIGHAN_MLL_SIGNATURE_1_DN brain edema DOID_4724 1.909E-03 0.01324893 1.909E-03 0.02586696 MULLIGHAN_MLL_SIGNATURE_1_DN amyloidosis DOID_9120 1.909E-03 0.0130893 1.909E-03 0.0252654 MULLIGHAN_MLL_SIGNATURE_1_DN pancreatic carcinoma DOID_4905 1.971E-03 0.0133536 0.02545408 0.15573515 MULLIGHAN_MLL_SIGNATURE_1_DN mixed glioma DOID_5076 2.282E-03 0.01527841 0.02798785 0.16588631 MULLIGHAN_MLL_SIGNATURE_1_DN bacterial pneumonia DOID_874 2.282E-03 0.01510075 0.02798785 0.16417614 MULLIGHAN_MLL_SIGNATURE_1_DN contact dermatitis DOID_2773 2.449E-03 0.01601448 2.449E-03 0.03028826 MULLIGHAN_MLL_SIGNATURE_1_DN pulmonary embolism DOID_9477 2.526E-03 0.01633491 0.07203864 0.2594303 MULLIGHAN_MLL_SIGNATURE_1_DN female reproductive system disease DOID_229 2.534E-03 0.01620353 0.0299519 0.17214777 MULLIGHAN_MLL_SIGNATURE_1_DN meningitis DOID_9471 2.75E-03 0.01738702 0.07505119 0.2685794 MULLIGHAN_MLL_SIGNATURE_1_DN lymphoma DOID_0060058 3.603E-03 0.02253001 0.03760002 0.1876703 MULLIGHAN_MLL_SIGNATURE_1_DN dilated cardiomyopathy DOID_12930 3.936E-03 0.02434033 0.0398025 0.19031613 MULLIGHAN_MLL_SIGNATURE_1_DN Sciatic Neuropathy DOID_11446 4.003E-03 0.02449084 4.003E-03 0.04648261 MULLIGHAN_MLL_SIGNATURE_1_DN lesion of sciatic nerve DOID_12528 4.003E-03 0.02449084 4.003E-03 0.04648261 MULLIGHAN_MLL_SIGNATURE_1_DN mononeuritis of lower limb DOID_9473 4.003E-03 0.02449084 4.003E-03 0.04648261 MULLIGHAN_MLL_SIGNATURE_1_DN mononeuritis DOID_1802 4.28E-03 0.02590616 4.28E-03 0.04870358 MULLIGHAN_MLL_SIGNATURE_1_DN mononeuropathy DOID_1188 4.565E-03 0.02734339 4.565E-03 0.05093376 MULLIGHAN_MLL_SIGNATURE_1_DN focal glomerulosclerosis DOID_3945 4.565E-03 0.02705856 0.0958691 0.29646477 MULLIGHAN_MLL_SIGNATURE_1_DN abdominal aortic aneurysm DOID_7693 5.162E-03 0.03027948 0.10173124 0.30789935 MULLIGHAN_MLL_SIGNATURE_1_DN celiac disease DOID_10608 5.473E-03 0.03177643 5.473E-03 0.05875642 MULLIGHAN_MLL_SIGNATURE_1_DN myocarditis DOID_820 6.12E-03 0.03517535 0.11045384 0.32563854 MULLIGHAN_MLL_SIGNATURE_1_DN pneumoconiosis DOID_10316 6.456E-03 0.03673584 6.456E-03 0.06559972 MULLIGHAN_MLL_SIGNATURE_1_DN spindle cell carcinoma DOID_4015 6.456E-03 0.03637212 0.11334267 0.33243288 MULLIGHAN_MLL_SIGNATURE_1_DN esophageal disease DOID_6050 6.456E-03 0.03601553 6.456E-03 0.06444885 MULLIGHAN_MLL_SIGNATURE_1_DN leukopenia DOID_615 6.456E-03 0.03566587 0.11334267 0.33072809 MULLIGHAN_MLL_SIGNATURE_1_DN embryonal cancer DOID_688 7.514E-03 0.04110802 0.12195342 0.34183004 MULLIGHAN_MLL_SIGNATURE_1_DN multiple myeloma DOID_9538 7.514E-03 0.04071652 0.12195342 0.3401544 MULLIGHAN_MLL_SIGNATURE_1_DN hepatitis DOID_2237 8.259E-03 0.04433331 8.259E-03 0.07832218 MULLIGHAN_MLL_SIGNATURE_1_DN intracranial arterial disease DOID_13089 8.644E-03 0.04596433 0.13048123 0.35694144 MULLIGHAN_MLL_SIGNATURE_1_DN cerebral arterial disease DOID_3527 8.644E-03 0.04596433 0.13048123 0.35694144 MULLIGHAN_MLL_SIGNATURE_1_DN lymphatic system disease DOID_75 8.644E-03 0.04553874 8.644E-03 0.07932554 MULLIGHAN_MLL_SIGNATURE_1_DN uveal disease DOID_3480 9.845E-03 0.05139071 9.845E-03 0.08237628 MULLIGHAN_MLL_SIGNATURE_1_DN learning disability DOID_8927 0.0106841 0.05526593 0.0106841 0.08684647 MULLIGHAN_MLL_SIGNATURE_1_DN neuritis DOID_1803 0.0115541 0.05922778 0.0115541 0.08884168 MULLIGHAN_MLL_SIGNATURE_1_DN autoimmune disease of gastrointestinal tract DOID_0060031 0.0124542 0.06327179 0.0124542 0.09324263 MULLIGHAN_MLL_SIGNATURE_1_DN atrophic muscular disease DOID_913 0.01434301 0.07222277 0.01434301 0.10330598 MULLIGHAN_MLL_SIGNATURE_1_DN muscular dystrophy DOID_9884 0.01434301 0.07222277 0.01434301 0.10330598 MULLIGHAN_MLL_SIGNATURE_1_DN vasculitis DOID_865 0.01483337 0.07403674 0.16920396 0.43368042 MULLIGHAN_MLL_SIGNATURE_1_DN leukocyte disease DOID_9500 0.01739158 0.08605052 0.18261487 0.45573623 MULLIGHAN_MLL_SIGNATURE_1_DN hypothyroidism DOID_1459 0.01900982 0.09324645 0.01900982 0.12725397 ZHAN_EARLY_DIFFERENTIATION_GENES_DN funisitis DOID_0050698 4.371E-07 2.487E-04 0.01498394 0.77507811 ZHAN_EARLY_DIFFERENTIATION_GENES_DN sarcoma DOID_1115 1.148E-06 3.267E-04 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN gallbladder cancer DOID_3121 4.551E-06 8.631E-04 0.0317491 0.90326192 ZHAN_EARLY_DIFFERENTIATION_GENES_DN bile duct adenocarcinoma DOID_4896 8.175E-06 1.163E-03 0.03837805 0.8734844 ZHAN_EARLY_DIFFERENTIATION_GENES_DN cholangiocarcinoma DOID_4947 8.175E-06 1.163E-03 0.03837805 0.8734844 ZHAN_EARLY_DIFFERENTIATION_GENES_DN bile duct cancer DOID_4606 1.004E-05 1.142E-03 0.04101739 0.86440354 ZHAN_EARLY_DIFFERENTIATION_GENES_DN bile duct carcinoma DOID_4897 1.004E-05 1.142E-03 0.04101739 0.86440354 ZHAN_EARLY_DIFFERENTIATION_GENES_DN tuberculosis DOID_399 1.587E-05 1.505E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN biliary tract cancer DOID_4607 2.724E-05 2.215E-03 0.05670777 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN primary bacterial infectious disease DOID_0050338 3.127E-05 2.224E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN lymphoma DOID_0060058 3.682E-05 2.328E-03 0.06252778 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN angiosarcoma DOID_0001816 5.395E-05 3.07E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN esophagitis DOID_11963 8.528E-05 4.411E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Kawasaki disease DOID_13378 9.422E-05 4.467E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN lymphadenitis DOID_1602 9.422E-05 4.467E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN lymph node disease DOID_9942 9.422E-05 4.467E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN polyarteritis nodosa DOID_9810 1.134E-04 4.964E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN bronchiolitis DOID_2942 1.455E-04 5.914E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN celiac disease DOID_10608 2.503E-04 9.495E-03 0.02306575 0.93745816 ZHAN_EARLY_DIFFERENTIATION_GENES_DN autonomic nervous system neoplasm DOID_2621 2.654E-04 9.437E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN neuroblastoma DOID_769 2.654E-04 9.437E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN myocarditis DOID_820 2.809E-04 9.401E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN esophageal disease DOID_6050 2.968E-04 9.382E-03 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN peripheral nervous system neoplasm DOID_1192 3.648E-04 0.01092499 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN respiratory syncytial virus infectious disease DOID_1273 3.829E-04 0.01089309 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN lymphatic system disease DOID_75 4.014E-04 0.01087585 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN autoimmune disease of urogenital tract DOID_0060049 4.397E-04 0.01137211 4.397E-04 0.25018641 ZHAN_EARLY_DIFFERENTIATION_GENES_DN primary biliary cirrhosis DOID_12236 4.397E-04 0.01137211 4.397E-04 0.25018641 ZHAN_EARLY_DIFFERENTIATION_GENES_DN pre-eclampsia DOID_10591 5.429E-04 0.01343141 0.03374238 0.87270077 ZHAN_EARLY_DIFFERENTIATION_GENES_DN vascular skin disease DOID_9540 5.429E-04 0.01287176 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN autoimmune disease of gastrointestinal tract DOID_0060031 5.872E-04 0.01336444 0.03506905 0.86757776 ZHAN_EARLY_DIFFERENTIATION_GENES_DN giant cell tumor DOID_200 6.808E-04 0.01489918 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN malignant giant cell tumor DOID_2705 6.808E-04 0.01489918 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN giant cell glioblastoma DOID_3074 6.808E-04 0.01489918 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN pustulosis of palm and sole DOID_4398 7.301E-04 0.01538715 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hypertrophic cardiomyopathy DOID_11984 8.073E-04 0.01640564 0.04101739 0.89764983 ZHAN_EARLY_DIFFERENTIATION_GENES_DN glioblastoma DOID_3068 8.073E-04 0.01583993 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN pre-malignant neoplasm DOID_0060071 9.443E-04 0.01790982 0.04430677 0.90037695 ZHAN_EARLY_DIFFERENTIATION_GENES_DN in situ carcinoma DOID_8719 9.443E-04 0.01790982 0.04430677 0.90037695 ZHAN_EARLY_DIFFERENTIATION_GENES_DN astrocytoma DOID_3069 1.122E-03 0.02060093 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN peripheral vascular disease DOID_341 1.217E-03 0.02163973 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN bone resorption disease DOID_0080011 1.349E-03 0.02325868 0.05280848 0.96929107 ZHAN_EARLY_DIFFERENTIATION_GENES_DN osteoporosis DOID_11476 1.349E-03 0.02325868 0.05280848 0.96929107 ZHAN_EARLY_DIFFERENTIATION_GENES_DN transitional cell carcinoma DOID_2671 1.745E-03 0.02920921 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN primary immunodeficiency disease DOID_612 1.784E-03 0.02900008 0.06059162 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN nervous system cancer DOID_3093 1.823E-03 0.02880894 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN lymphoblastic leukemia DOID_1037 1.942E-03 0.02986084 0.06317231 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Crohn's disease DOID_8778 1.982E-03 0.02968115 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hypersensitivity reaction type I disease DOID_1205 2.023E-03 0.02951651 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN ulcerative colitis DOID_8577 2.148E-03 0.03055721 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN childhood type dermatomyositis DOID_14203 6.838E-03 0.09489602 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN bilirubin metabolic disorder DOID_2741 6.838E-03 0.09263659 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN acute kidney failure DOID_3021 6.838E-03 0.09048225 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Noonan syndrome DOID_3490 6.838E-03 0.08842583 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN conjunctival disease DOID_4251 6.838E-03 0.08646082 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN acute T cell leukemia DOID_5603 6.838E-03 0.08458123 6.838E-03 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN conjunctivitis DOID_6195 6.838E-03 0.08646082 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 6.838E-03 0.08278163 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 6.838E-03 0.08278163 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Hodgkin's granuloma DOID_8651 6.838E-03 0.08278163 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 6.838E-03 0.08278163 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN cutaneous leishmaniasis DOID_9111 6.838E-03 0.08105702 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN visceral leishmaniasis DOID_9146 6.838E-03 0.07940279 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN maturity-onset diabetes of the young DOID_0050524 7.519E-03 0.08556801 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN dermatomyositis DOID_10223 7.519E-03 0.0838902 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN sickle cell anemia DOID_10923 7.519E-03 0.08227693 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN migraine without aura DOID_12783 7.519E-03 0.08072454 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hemochromatosis DOID_2352 7.519E-03 0.07922964 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN chronic monocytic leukemia DOID_8593 7.519E-03 0.0777891 7.519E-03 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN bronchiectasis DOID_9563 7.519E-03 0.07640001 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN otitis media DOID_10754 8.2E-03 0.08185629 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN middle ear disease DOID_5100 8.2E-03 0.08185629 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN peritonitis DOID_8283 8.2E-03 0.08044497 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Hodgkin's lymphoma DOID_8567 8.2E-03 0.0790815 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN encephalitis DOID_9588 8.2E-03 0.07776347 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN berylliosis DOID_10322 8.88E-03 0.08283542 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN vulva cancer DOID_1245 8.88E-03 0.08149937 8.88E-03 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hepatic coma DOID_12550 8.88E-03 0.08020573 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hepatic encephalopathy DOID_13413 8.88E-03 0.08020573 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Lynch syndrome DOID_3883 8.88E-03 0.07895251 8.88E-03 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN monocytic leukemia DOID_8527 8.88E-03 0.07773786 8.88E-03 0.84216013 ZHAN_EARLY_DIFFERENTIATION_GENES_DN psoriatic arthritis DOID_9008 8.88E-03 0.07656001 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hypercalcemia DOID_12678 9.56E-03 0.08119191 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN eyelid disease DOID_530 9.56E-03 0.07999791 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN T-cell leukemia DOID_715 9.56E-03 0.07883852 9.56E-03 0.77712254 ZHAN_EARLY_DIFFERENTIATION_GENES_DN Zellweger syndrome DOID_905 9.56E-03 0.07771225 9.56E-03 0.67998222 ZHAN_EARLY_DIFFERENTIATION_GENES_DN mesenchymal cell neoplasm DOID_3350 0.01023989 0.08206337 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN adrenal cortex disease DOID_3952 0.01023989 0.08092361 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN spindle cell sarcoma DOID_4235 0.01023989 0.08206337 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN lung oat cell carcinoma DOID_5411 0.01023989 0.07981506 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN oral submucous fibrosis DOID_5773 0.01023989 0.07873648 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN epithelioid sarcoma DOID_6193 0.01023989 0.08206337 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hyperhomocysteinemia DOID_9279 0.01023989 0.07768666 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN silicosis DOID_10325 0.01091896 0.0817485 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hemolytic-uremic syndrome DOID_12554 0.01091896 0.08068683 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN thyroiditis DOID_7166 0.01091896 0.07965239 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN autoimmune thyroiditis DOID_7188 0.01091896 0.07965239 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN tongue cancer DOID_8649 0.01091896 0.07864413 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN familial hypertrophic cardiomyopathy DOID_11986 0.01159757 0.08248773 0.01159757 0.73322423 ZHAN_EARLY_DIFFERENTIATION_GENES_DN juvenile rheumatoid arthritis DOID_676 0.01159757 0.08146936 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN peroxisomal disease DOID_906 0.01159757 0.08047583 0.01159757 0.65990181 ZHAN_EARLY_DIFFERENTIATION_GENES_DN adrenal gland disease DOID_9553 0.01159757 0.07950624 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN male reproductive organ benign neoplasm DOID_0060087 0.01227574 0.08315351 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN MHC class II deficiency DOID_5812 0.01295346 0.08671197 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN leishmaniasis DOID_9065 0.01295346 0.08570369 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN pulmonary edema DOID_11396 0.01363073 0.08914811 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN coronary restenosis DOID_4247 0.01430756 0.09251136 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN mitochondrial myopathy DOID_699 0.01430756 0.0914719 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN gastric ulcer DOID_10808 0.01498394 0.09473177 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN neutropenia DOID_1227 0.01498394 0.09369076 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN acquired immunodeficiency syndrome DOID_635 0.01498394 0.09267238 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN placenta disease DOID_780 0.01498394 0.09167591 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN agranulocytosis DOID_12987 0.01565987 0.09479218 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN myasthenia gravis DOID_437 0.01565987 0.09379437 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN hypoglycemia DOID_9993 0.01565987 0.09281734 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN diabetic angiopathy DOID_11713 0.01633535 0.09582286 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN spastic quadriplegia DOID_10970 0.0170104 0.09876444 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN severe combined immunodeficiency DOID_627 0.0170104 0.09776682 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN combined T cell and B cell immunodeficiency DOID_628 0.01768499 0.09963129 1.000 1.000 ZHAN_EARLY_DIFFERENTIATION_GENES_DN ankylosing spondylitis DOID_7147 0.01835914 0.09948907 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN myocarditis DOID_820 5.209E-09 2.964E-06 8.517E-03 0.13461606 VERHAAK_AML_WITH_NPM1_MUTATED_DN ulcerative colitis DOID_8577 5.503E-09 1.566E-06 6.889E-03 0.11529238 VERHAAK_AML_WITH_NPM1_MUTATED_DN myeloma DOID_0070004 4.066E-08 7.711E-06 0.17556173 0.67043373 VERHAAK_AML_WITH_NPM1_MUTATED_DN bone marrow cancer DOID_4960 9.081E-08 1.292E-05 0.19756211 0.68964931 VERHAAK_AML_WITH_NPM1_MUTATED_DN glioblastoma DOID_3068 1.372E-07 1.561E-05 0.02324078 0.27550004 VERHAAK_AML_WITH_NPM1_MUTATED_DN astrocytoma DOID_3069 3.729E-07 3.536E-05 0.03158514 0.35239111 VERHAAK_AML_WITH_NPM1_MUTATED_DN multiple myeloma DOID_9538 4.668E-07 3.794E-05 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN peripheral vascular disease DOID_341 4.76E-07 3.386E-05 0.03403712 0.3521295 VERHAAK_AML_WITH_NPM1_MUTATED_DN aneurysm disease DOID_2403 6.488E-07 4.102E-05 3.572E-03 0.10698661 VERHAAK_AML_WITH_NPM1_MUTATED_DN bone development disease DOID_0080006 1.073E-06 6.108E-05 4.534E-03 0.10748827 VERHAAK_AML_WITH_NPM1_MUTATED_DN vascular skin disease DOID_9540 1.457E-06 7.537E-05 0.01599022 0.21662936 VERHAAK_AML_WITH_NPM1_MUTATED_DN Crohn's disease DOID_8778 2.051E-06 9.724E-05 6.156E-03 0.12077679 VERHAAK_AML_WITH_NPM1_MUTATED_DN giant cell tumor DOID_200 2.579E-06 1.129E-04 0.19445526 0.6872363 VERHAAK_AML_WITH_NPM1_MUTATED_DN malignant giant cell tumor DOID_2705 2.579E-06 1.129E-04 0.19445526 0.6872363 VERHAAK_AML_WITH_NPM1_MUTATED_DN giant cell glioblastoma DOID_3074 2.579E-06 1.129E-04 0.19445526 0.6872363 VERHAAK_AML_WITH_NPM1_MUTATED_DN urticaria DOID_1555 2.954E-06 1.201E-04 4.506E-03 0.11652983 VERHAAK_AML_WITH_NPM1_MUTATED_DN bile duct cancer DOID_4606 3.954E-06 1.5E-04 0.20987092 0.69834242 VERHAAK_AML_WITH_NPM1_MUTATED_DN bile duct carcinoma DOID_4897 3.954E-06 1.5E-04 0.20987092 0.69834242 VERHAAK_AML_WITH_NPM1_MUTATED_DN seminoma DOID_4440 4.022E-06 1.43E-04 0.10244263 0.5499043 VERHAAK_AML_WITH_NPM1_MUTATED_DN hypothyroidism DOID_1459 5.423E-06 1.815E-04 1.191E-04 0.01693692 VERHAAK_AML_WITH_NPM1_MUTATED_DN corneal disease DOID_10124 6.979E-06 2.206E-04 6.773E-03 0.12043524 VERHAAK_AML_WITH_NPM1_MUTATED_DN endocrine organ benign neoplasm DOID_0060089 8.391E-06 2.513E-04 0.23982869 0.74164415 VERHAAK_AML_WITH_NPM1_MUTATED_DN celiac disease DOID_10608 8.947E-06 2.545E-04 0.12299999 0.59817942 VERHAAK_AML_WITH_NPM1_MUTATED_DN germinoma DOID_3304 8.947E-06 2.424E-04 0.12299999 0.59311011 VERHAAK_AML_WITH_NPM1_MUTATED_DN diabetic retinopathy DOID_8947 1.172E-05 3.032E-04 0.25438176 0.76583716 VERHAAK_AML_WITH_NPM1_MUTATED_DN nephroblastoma DOID_2154 1.263E-05 3.124E-04 0.13310262 0.61076927 VERHAAK_AML_WITH_NPM1_MUTATED_DN bacterial pneumonia DOID_874 1.507E-05 3.572E-04 0.0382822 0.35709131 VERHAAK_AML_WITH_NPM1_MUTATED_DN contact dermatitis DOID_2773 1.7E-05 3.869E-04 2.924E-04 0.02772924 VERHAAK_AML_WITH_NPM1_MUTATED_DN embryonal cancer DOID_688 1.732E-05 3.79E-04 0.14308966 0.60759713 VERHAAK_AML_WITH_NPM1_MUTATED_DN biliary tract cancer DOID_4607 2.024E-05 4.266E-04 0.27988342 0.80431146 VERHAAK_AML_WITH_NPM1_MUTATED_DN retinal vascular disease DOID_2462 2.266E-05 4.606E-04 0.28543175 0.816134 VERHAAK_AML_WITH_NPM1_MUTATED_DN endometriosis of uterus DOID_288 2.781E-05 5.457E-04 0.15948142 0.64817806 VERHAAK_AML_WITH_NPM1_MUTATED_DN primary immunodeficiency disease DOID_612 2.818E-05 5.344E-04 4.35E-04 0.03535932 VERHAAK_AML_WITH_NPM1_MUTATED_DN nervous system cancer DOID_3093 2.97E-05 5.452E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN endometriosis DOID_289 3.037E-05 5.401E-04 0.16272221 0.64747508 VERHAAK_AML_WITH_NPM1_MUTATED_DN uveal disease DOID_3480 3.037E-05 5.237E-04 0.16272221 0.64297873 VERHAAK_AML_WITH_NPM1_MUTATED_DN lymphoma DOID_0060058 3.295E-05 5.514E-04 0.05115312 0.39871408 VERHAAK_AML_WITH_NPM1_MUTATED_DN learning disability DOID_8927 3.6E-05 5.853E-04 8.523E-04 0.05388581 VERHAAK_AML_WITH_NPM1_MUTATED_DN thyroid adenoma DOID_2891 4.235E-05 6.694E-04 0.17556173 0.66155382 VERHAAK_AML_WITH_NPM1_MUTATED_DN keratosis DOID_161 4.376E-05 6.73E-04 2.164E-03 0.11195236 VERHAAK_AML_WITH_NPM1_MUTATED_DN dental caries DOID_216 4.376E-05 6.552E-04 4.376E-05 0.02489943 VERHAAK_AML_WITH_NPM1_MUTATED_DN autoimmune disease of gastrointestinal tract DOID_0060031 4.949E-05 7.221E-04 0.18190797 0.67650743 VERHAAK_AML_WITH_NPM1_MUTATED_DN glaucoma DOID_1686 4.949E-05 7.04E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN lung small cell carcinoma DOID_5409 4.949E-05 6.869E-04 0.01722232 0.22789537 VERHAAK_AML_WITH_NPM1_MUTATED_DN dissociative disorder DOID_10935 5.182E-05 7.02E-04 5.182E-05 0.01474232 VERHAAK_AML_WITH_NPM1_MUTATED_DN dissociative amnesia DOID_11037 5.182E-05 7.02E-04 5.182E-05 0.01474232 VERHAAK_AML_WITH_NPM1_MUTATED_DN granulosa cell tumor DOID_2999 5.182E-05 6.857E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN MHC class II deficiency DOID_5812 5.182E-05 6.701E-04 2.413E-03 0.09806333 VERHAAK_AML_WITH_NPM1_MUTATED_DN aortic aneurysm DOID_3627 5.337E-05 6.749E-04 0.01785307 0.23087262 VERHAAK_AML_WITH_NPM1_MUTATED_DN amnestic disorder DOID_10914 6.079E-05 7.52E-04 6.079E-05 0.01152998 VERHAAK_AML_WITH_NPM1_MUTATED_DN sex cord-gonadal stromal tumor DOID_192 6.079E-05 7.36E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN brain edema DOID_4724 6.079E-05 7.206E-04 0.07428658 0.49728312 VERHAAK_AML_WITH_NPM1_MUTATED_DN bile duct adenocarcinoma DOID_4896 7.114E-05 8.261E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN cholangiocarcinoma DOID_4947 7.114E-05 8.261E-04 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN osteochondrodysplasia DOID_2256 7.619E-05 8.67E-04 0.02115041 0.26162144 VERHAAK_AML_WITH_NPM1_MUTATED_DN funisitis DOID_0050698 8.166E-05 9.11E-04 0.08140677 0.53860992 VERHAAK_AML_WITH_NPM1_MUTATED_DN muscle cancer DOID_4045 9.364E-05 1.025E-03 0.08494644 0.52537528 VERHAAK_AML_WITH_NPM1_MUTATED_DN leukocyte disease DOID_9500 9.898E-05 1.063E-03 0.21291871 0.70029333 VERHAAK_AML_WITH_NPM1_MUTATED_DN synostosis DOID_11971 1.067E-04 1.124E-03 3.846E-03 0.10940648 VERHAAK_AML_WITH_NPM1_MUTATED_DN severe combined immunodeficiency DOID_627 1.209E-04 1.251E-03 4.169E-03 0.11297231 VERHAAK_AML_WITH_NPM1_MUTATED_DN combined T cell and B cell immunodeficiency DOID_628 1.363E-04 1.385E-03 4.506E-03 0.11146332 VERHAAK_AML_WITH_NPM1_MUTATED_DN uterine disease DOID_345 1.419E-04 1.417E-03 0.2309618 0.71812713 VERHAAK_AML_WITH_NPM1_MUTATED_DN hyperglycemia DOID_4195 1.502E-04 1.474E-03 0.02920689 0.33237436 VERHAAK_AML_WITH_NPM1_MUTATED_DN ankylosing spondylitis DOID_7147 1.529E-04 1.475E-03 0.09897018 0.55756466 VERHAAK_AML_WITH_NPM1_MUTATED_DN allergic contact dermatitis DOID_3042 1.589E-04 1.507E-03 2.536E-03 0.09018714 VERHAAK_AML_WITH_NPM1_MUTATED_DN tuberculosis DOID_399 1.678E-04 1.566E-03 0.23982869 0.73366949 VERHAAK_AML_WITH_NPM1_MUTATED_DN teeth hard tissue disease DOID_214 1.708E-04 1.567E-03 1.708E-04 0.01943611 VERHAAK_AML_WITH_NPM1_MUTATED_DN invasive ductal carcinoma DOID_3008 2.105E-04 1.901E-03 0.10934771 0.56562587 VERHAAK_AML_WITH_NPM1_MUTATED_DN syndrome DOID_225 2.413E-04 2.145E-03 0.26012521 0.77492798 VERHAAK_AML_WITH_NPM1_MUTATED_DN dysostosis DOID_1934 2.557E-04 2.238E-03 6.773E-03 0.11678568 VERHAAK_AML_WITH_NPM1_MUTATED_DN female reproductive system disease DOID_229 3.063E-04 2.641E-03 0.27429232 0.79628738 VERHAAK_AML_WITH_NPM1_MUTATED_DN allergic rhinitis DOID_4481 3.067E-04 2.605E-03 7.622E-03 0.12391803 VERHAAK_AML_WITH_NPM1_MUTATED_DN alcohol abuse DOID_1574 3.355E-04 2.807E-03 0.04271757 0.37394301 VERHAAK_AML_WITH_NPM1_MUTATED_DN primary bacterial infectious disease DOID_0050338 3.998E-04 3.297E-03 0.29093762 0.82771753 VERHAAK_AML_WITH_NPM1_MUTATED_DN amino acid metabolic disorder DOID_9252 4.35E-04 3.536E-03 4.35E-04 0.03093941 VERHAAK_AML_WITH_NPM1_MUTATED_DN mouth disease DOID_403 5.327E-04 4.269E-03 6.156E-03 0.12509024 VERHAAK_AML_WITH_NPM1_MUTATED_DN uveitis DOID_13141 5.358E-04 4.234E-03 0.14639321 0.61702028 VERHAAK_AML_WITH_NPM1_MUTATED_DN hypersensitivity reaction type I disease DOID_1205 5.54E-04 4.318E-03 6.334E-03 0.12014166 VERHAAK_AML_WITH_NPM1_MUTATED_DN systemic scleroderma DOID_418 5.753E-04 4.424E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN angioedema DOID_1558 6.496E-04 4.928E-03 0.03785507 0.36507688 VERHAAK_AML_WITH_NPM1_MUTATED_DN retinal vascular occlusion DOID_1729 6.496E-04 4.863E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN keratitis DOID_4677 6.496E-04 4.8E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN rheumatic disease DOID_1575 7.523E-04 5.488E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN scleroderma DOID_419 7.523E-04 5.488E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN nervous system benign neoplasm DOID_0060115 7.919E-04 5.704E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN temporal arteritis DOID_13375 7.919E-04 5.632E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN central nervous system vasculitis DOID_525 7.919E-04 5.632E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN chronic monocytic leukemia DOID_8593 7.919E-04 5.563E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN diabetic autonomic neuropathy DOID_11503 8.013E-04 5.56E-03 0.16595059 0.651213 VERHAAK_AML_WITH_NPM1_MUTATED_DN autonomic neuropathy DOID_11504 8.013E-04 5.56E-03 0.16595059 0.651213 VERHAAK_AML_WITH_NPM1_MUTATED_DN diabetic polyneuropathy DOID_12785 8.013E-04 5.56E-03 0.16595059 0.651213 VERHAAK_AML_WITH_NPM1_MUTATED_DN gallbladder cancer DOID_3121 8.013E-04 5.493E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN diabetic neuropathy DOID_9743 8.013E-04 5.56E-03 0.16595059 0.651213 VERHAAK_AML_WITH_NPM1_MUTATED_DN lipodystrophy DOID_811 9.479E-04 6.421E-03 0.04525353 0.36784653 VERHAAK_AML_WITH_NPM1_MUTATED_DN pre-eclampsia DOID_10591 9.604E-04 6.429E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN autonomic nervous system disease DOID_11465 9.604E-04 6.355E-03 0.17556173 0.66596418 VERHAAK_AML_WITH_NPM1_MUTATED_DN brain cancer DOID_1319 9.604E-04 6.282E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN central nervous system cancer DOID_3620 1.018E-03 6.58E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN integumentary system benign neoplasm DOID_0060121 1.077E-03 6.885E-03 0.18190797 0.67211452 VERHAAK_AML_WITH_NPM1_MUTATED_DN pulmonary tuberculosis DOID_2957 1.077E-03 6.808E-03 0.18190797 0.6677783 VERHAAK_AML_WITH_NPM1_MUTATED_DN skin benign neoplasm DOID_3165 1.077E-03 6.885E-03 0.18190797 0.67211452 VERHAAK_AML_WITH_NPM1_MUTATED_DN osteogenesis imperfecta DOID_12347 1.117E-03 6.987E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN monocytic leukemia DOID_8527 1.117E-03 6.911E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN B-cell lymphocytic neoplasm DOID_707 1.202E-03 7.353E-03 0.18820569 0.67351597 VERHAAK_AML_WITH_NPM1_MUTATED_DN open-angle glaucoma DOID_1067 1.3E-03 7.871E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN rhabdomyosarcoma DOID_3247 1.3E-03 7.788E-03 0.05259548 0.39902437 VERHAAK_AML_WITH_NPM1_MUTATED_DN parasitic helminthiasis infectious disease DOID_883 1.3E-03 7.707E-03 0.05259548 0.39377405 VERHAAK_AML_WITH_NPM1_MUTATED_DN narcolepsy DOID_8986 1.3E-03 7.628E-03 0.05259548 0.38866011 VERHAAK_AML_WITH_NPM1_MUTATED_DN bacterial meningitis DOID_9470 1.3E-03 7.55E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN sarcoidosis DOID_11335 1.336E-03 7.677E-03 0.19445526 0.69153153 VERHAAK_AML_WITH_NPM1_MUTATED_DN vasculitis DOID_865 1.406E-03 8E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN integumentary system cancer DOID_0060122 1.478E-03 8.329E-03 0.20065705 0.69196279 VERHAAK_AML_WITH_NPM1_MUTATED_DN skin cancer DOID_4159 1.478E-03 8.329E-03 0.20065705 0.69196279 VERHAAK_AML_WITH_NPM1_MUTATED_DN skeletal system cancer DOID_0060124 1.497E-03 8.349E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN thoracic aortic aneurysm DOID_14004 1.497E-03 8.268E-03 0.0562454 0.40510928 VERHAAK_AML_WITH_NPM1_MUTATED_DN bone cancer DOID_184 1.497E-03 8.349E-03 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN corneal dystrophy DOID_2566 1.497E-03 8.188E-03 1.497E-03 0.08515566 VERHAAK_AML_WITH_NPM1_MUTATED_DN skeletal muscle cancer DOID_4043 1.497E-03 8.11E-03 0.0562454 0.39510658 VERHAAK_AML_WITH_NPM1_MUTATED_DN hypertrophic cardiomyopathy DOID_11984 1.71E-03 9.179E-03 0.20987092 0.70660683 VERHAAK_AML_WITH_NPM1_MUTATED_DN hypersensitivity reaction type IV disease DOID_2916 1.71E-03 9.093E-03 0.20987092 0.70245032 VERHAAK_AML_WITH_NPM1_MUTATED_DN bronchitis DOID_6132 1.929E-03 0.01016122 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN juvenile rheumatoid arthritis DOID_676 1.929E-03 0.010068 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN carotid artery disease DOID_3407 1.963E-03 0.01015383 0.21897931 0.70795014 VERHAAK_AML_WITH_NPM1_MUTATED_DN collagen disease DOID_854 1.963E-03 0.01006235 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN pre-malignant neoplasm DOID_0060071 2.144E-03 0.01089168 0.22499355 0.72328436 VERHAAK_AML_WITH_NPM1_MUTATED_DN congenital heart defect DOID_1682 2.144E-03 0.01079529 0.22499355 0.71922096 VERHAAK_AML_WITH_NPM1_MUTATED_DN in situ carcinoma DOID_8719 2.144E-03 0.01089168 0.22499355 0.72328436 VERHAAK_AML_WITH_NPM1_MUTATED_DN parasitic infectious disease DOID_1398 2.335E-03 0.01165372 0.02843086 0.33014615 VERHAAK_AML_WITH_NPM1_MUTATED_DN agammaglobulinemia DOID_2583 2.413E-03 0.01193814 2.413E-03 0.11440722 VERHAAK_AML_WITH_NPM1_MUTATED_DN testicular cancer DOID_2998 2.413E-03 0.01183523 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN infertility DOID_5223 2.413E-03 0.01173407 2.413E-03 0.10560667 VERHAAK_AML_WITH_NPM1_MUTATED_DN tooth disease DOID_1091 2.536E-03 0.01222876 2.536E-03 0.09619962 VERHAAK_AML_WITH_NPM1_MUTATED_DN brain infarction DOID_3454 2.64E-03 0.01262557 0.23982869 0.73763527 VERHAAK_AML_WITH_NPM1_MUTATED_DN membranous glomerulonephritis DOID_10976 2.674E-03 0.01267989 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN blood protein disease DOID_620 2.674E-03 0.01257509 2.674E-03 0.08950508 VERHAAK_AML_WITH_NPM1_MUTATED_DN amyloidosis DOID_9120 2.674E-03 0.01247202 2.674E-03 0.08453257 VERHAAK_AML_WITH_NPM1_MUTATED_DN blood coagulation disease DOID_1247 2.857E-03 0.01321811 0.03239438 0.35446924 VERHAAK_AML_WITH_NPM1_MUTATED_DN pancreatic ductal carcinoma DOID_3587 2.857E-03 0.01311151 0.24568347 0.74756092 VERHAAK_AML_WITH_NPM1_MUTATED_DN nephrosis DOID_2527 2.97E-03 0.0135183 0.03321173 0.3565561 VERHAAK_AML_WITH_NPM1_MUTATED_DN pancreatic carcinoma DOID_4905 3.203E-03 0.01446274 0.25438176 0.76991076 VERHAAK_AML_WITH_NPM1_MUTATED_DN gastric ulcer DOID_10808 3.235E-03 0.01449309 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN neutropenia DOID_1227 3.235E-03 0.01437987 0.08140677 0.532419 VERHAAK_AML_WITH_NPM1_MUTATED_DN hepatitis B DOID_2043 3.235E-03 0.01426839 0.08140677 0.52636878 VERHAAK_AML_WITH_NPM1_MUTATED_DN agranulocytosis DOID_12987 3.534E-03 0.01546804 0.08494644 0.53705029 VERHAAK_AML_WITH_NPM1_MUTATED_DN opiate dependence DOID_2559 3.534E-03 0.01534997 0.08494644 0.53114864 VERHAAK_AML_WITH_NPM1_MUTATED_DN myasthenia gravis DOID_437 3.534E-03 0.01523368 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN sleep disorder DOID_535 3.534E-03 0.01511914 0.08494644 0.51972608 VERHAAK_AML_WITH_NPM1_MUTATED_DN bone resorption disease DOID_0080011 3.572E-03 0.01516974 0.03741767 0.36708029 VERHAAK_AML_WITH_NPM1_MUTATED_DN osteoporosis DOID_11476 3.572E-03 0.01516974 0.03741767 0.36708029 VERHAAK_AML_WITH_NPM1_MUTATED_DN electroclinical syndrome DOID_0050701 3.701E-03 0.01560035 0.26582471 0.78778262 VERHAAK_AML_WITH_NPM1_MUTATED_DN mixed glioma DOID_5076 3.701E-03 0.01548564 0.26582471 0.78370084 VERHAAK_AML_WITH_NPM1_MUTATED_DN meningitis DOID_9471 3.846E-03 0.01597175 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN metabolic syndrome X DOID_14221 3.967E-03 0.01635831 0.27148061 0.79624984 VERHAAK_AML_WITH_NPM1_MUTATED_DN sphingolipidosis DOID_1927 4.169E-03 0.01706776 0.0919852 0.55680401 VERHAAK_AML_WITH_NPM1_MUTATED_DN papillary adenoma DOID_3172 4.854E-03 0.01972705 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN neuromuscular junction disease DOID_439 4.854E-03 0.01958715 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN microcystic adenoma DOID_5403 4.854E-03 0.01972705 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN follicular adenoma DOID_6204 4.854E-03 0.01972705 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN intracranial aneurysm DOID_10941 5.214E-03 0.02089266 0.10244263 0.56592093 VERHAAK_AML_WITH_NPM1_MUTATED_DN myopia DOID_11830 5.214E-03 0.02074656 0.10244263 0.56047938 VERHAAK_AML_WITH_NPM1_MUTATED_DN B cell deficiency DOID_2115 5.214E-03 0.02060248 5.214E-03 0.1186703 VERHAAK_AML_WITH_NPM1_MUTATED_DN spinal cord disease DOID_319 5.214E-03 0.0204604 5.214E-03 0.11410606 VERHAAK_AML_WITH_NPM1_MUTATED_DN extrinsic allergic alveolitis DOID_841 5.214E-03 0.02032026 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN perinatal necrotizing enterocolitis DOID_8677 5.586E-03 0.02162252 5.586E-03 0.11772262 VERHAAK_AML_WITH_NPM1_MUTATED_DN sarcoma DOID_1115 5.97E-03 0.02295266 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN autoimmune disease of the nervous system DOID_438 5.97E-03 0.02279861 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN encephalomyelitis DOID_640 5.98E-03 0.02268363 0.30720369 0.8653411 VERHAAK_AML_WITH_NPM1_MUTATED_DN multiple epiphyseal dysplasia DOID_12721 6.366E-03 0.02398775 6.366E-03 0.11684354 VERHAAK_AML_WITH_NPM1_MUTATED_DN supratentorial cancer DOID_1659 6.366E-03 0.02382993 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN toxic encephalopathy DOID_3602 6.366E-03 0.02367418 0.11278044 0.57812675 VERHAAK_AML_WITH_NPM1_MUTATED_DN cerebrum cancer DOID_368 6.366E-03 0.02382993 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN focal glomerulosclerosis DOID_3945 6.366E-03 0.02352045 0.11278044 0.57296491 VERHAAK_AML_WITH_NPM1_MUTATED_DN female reproductive organ benign neoplasm DOID_0060086 6.773E-03 0.02486405 0.11620003 0.58511342 VERHAAK_AML_WITH_NPM1_MUTATED_DN uterine benign neoplasm DOID_0060095 6.773E-03 0.02486405 0.11620003 0.58511342 VERHAAK_AML_WITH_NPM1_MUTATED_DN uterine fibroid DOID_13223 6.773E-03 0.02486405 0.11620003 0.58511342 VERHAAK_AML_WITH_NPM1_MUTATED_DN bronchiolitis obliterans DOID_2799 7.192E-03 0.02623252 0.11960653 0.58669064 VERHAAK_AML_WITH_NPM1_MUTATED_DN abdominal aortic aneurysm DOID_7693 7.192E-03 0.02606543 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN leiomyoma DOID_127 8.064E-03 0.02904083 0.12638046 0.60428974 VERHAAK_AML_WITH_NPM1_MUTATED_DN autonomic nervous system neoplasm DOID_2621 8.064E-03 0.02885818 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN neuroblastoma DOID_769 8.064E-03 0.02885818 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN papilloma DOID_2615 8.517E-03 0.03028861 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN pneumoconiosis DOID_10316 8.981E-03 0.03174076 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN thyroid carcinoma DOID_3963 8.981E-03 0.03154483 0.13310262 0.60588311 VERHAAK_AML_WITH_NPM1_MUTATED_DN esophageal disease DOID_6050 8.981E-03 0.0313513 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN leukopenia DOID_615 8.981E-03 0.03116013 0.13310262 0.60107452 VERHAAK_AML_WITH_NPM1_MUTATED_DN aplastic anemia DOID_12449 9.456E-03 0.03260999 9.456E-03 0.14542294 VERHAAK_AML_WITH_NPM1_MUTATED_DN medullomyoblastoma DOID_3861 9.456E-03 0.03241355 0.13644441 0.60653804 VERHAAK_AML_WITH_NPM1_MUTATED_DN adult medulloblastoma DOID_3864 9.456E-03 0.03241355 0.13644441 0.60653804 VERHAAK_AML_WITH_NPM1_MUTATED_DN childhood medulloblastoma DOID_3869 9.456E-03 0.03241355 0.13644441 0.60653804 VERHAAK_AML_WITH_NPM1_MUTATED_DN thyroid cancer DOID_1781 9.943E-03 0.03387598 0.13977341 0.61651991 VERHAAK_AML_WITH_NPM1_MUTATED_DN adenoma DOID_657 9.943E-03 0.03367433 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN refractive error DOID_9835 9.943E-03 0.03347508 0.13977341 0.61177745 VERHAAK_AML_WITH_NPM1_MUTATED_DN calcinosis DOID_182 0.01043959 0.03494193 0.14308966 0.62151157 VERHAAK_AML_WITH_NPM1_MUTATED_DN medulloblastoma DOID_3858 0.01043959 0.03473759 0.14308966 0.61680315 VERHAAK_AML_WITH_NPM1_MUTATED_DN peripheral nervous system neoplasm DOID_1192 0.01094748 0.03621579 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN respiratory syncytial virus infectious disease DOID_1273 0.01146609 0.03771216 0.14968412 0.62168075 VERHAAK_AML_WITH_NPM1_MUTATED_DN peptic ulcer DOID_750 0.01146609 0.03749542 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN intracranial arterial disease DOID_13089 0.01199532 0.03900193 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN cerebral arterial disease DOID_3527 0.01199532 0.03900193 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN benign mesothelioma DOID_2645 0.0125351 0.0405254 0.0125351 0.1876966 VERHAAK_AML_WITH_NPM1_MUTATED_DN cervix uteri carcinoma in situ DOID_8991 0.0125351 0.04029645 0.15622817 0.63952396 VERHAAK_AML_WITH_NPM1_MUTATED_DN pulmonary emphysema DOID_9675 0.0125351 0.04007006 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN autoimmune disease of urogenital tract DOID_0060049 0.01308533 0.04159526 0.01308533 0.19091156 VERHAAK_AML_WITH_NPM1_MUTATED_DN primary biliary cirrhosis DOID_12236 0.01308533 0.04159526 0.01308533 0.19091156 VERHAAK_AML_WITH_NPM1_MUTATED_DN nephrotic syndrome DOID_1184 0.01364592 0.04313627 0.01364592 0.19411321 VERHAAK_AML_WITH_NPM1_MUTATED_DN primitive neuroectodermal tumor DOID_168 0.01364592 0.04289795 0.16272221 0.65665913 VERHAAK_AML_WITH_NPM1_MUTATED_DN uterine cancer DOID_363 0.01421679 0.044447 0.16595059 0.64675263 VERHAAK_AML_WITH_NPM1_MUTATED_DN influenza DOID_8469 0.01421679 0.04420412 0.16595059 0.64235296 VERHAAK_AML_WITH_NPM1_MUTATED_DN leukodystrophy DOID_10579 0.01538903 0.04758889 0.1723703 0.66269394 VERHAAK_AML_WITH_NPM1_MUTATED_DN proteinuria DOID_576 0.01538903 0.04733165 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN bone marrow disease DOID_4961 0.01599022 0.04891631 0.01599022 0.221913 VERHAAK_AML_WITH_NPM1_MUTATED_DN calcium metabolism disease DOID_10575 0.01785307 0.05432297 0.18506288 0.67500497 VERHAAK_AML_WITH_NPM1_MUTATED_DN withdrawal disorder DOID_0060001 0.0184935 0.05597234 0.18820569 0.68209579 VERHAAK_AML_WITH_NPM1_MUTATED_DN hemorrhagic disease DOID_2213 0.0184935 0.05567619 0.18820569 0.67777873 VERHAAK_AML_WITH_NPM1_MUTATED_DN orofacial cleft DOID_0050567 0.01914353 0.05732984 0.01914353 0.24205931 VERHAAK_AML_WITH_NPM1_MUTATED_DN reproductive organ benign neoplasm DOID_0050622 0.02115041 0.0630083 0.20065705 0.69618208 VERHAAK_AML_WITH_NPM1_MUTATED_DN pustulosis of palm and sole DOID_4398 0.02115041 0.06268014 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN smallpox DOID_8736 0.02115041 0.06235537 0.02115041 0.25605502 VERHAAK_AML_WITH_NPM1_MUTATED_DN familial hyperlipidemia DOID_1168 0.02183803 0.06405073 0.20374013 0.69418046 VERHAAK_AML_WITH_NPM1_MUTATED_DN oral cavity cancer DOID_8618 0.02324078 0.0678154 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN melancholia DOID_2848 0.02395574 0.06954498 0.21291871 0.70436481 VERHAAK_AML_WITH_NPM1_MUTATED_DN neurotic disorder DOID_4964 0.02467966 0.07128288 0.21595482 0.7061971 VERHAAK_AML_WITH_NPM1_MUTATED_DN neuroectodermal tumor DOID_171 0.02541246 0.07302873 0.21897931 0.71199557 VERHAAK_AML_WITH_NPM1_MUTATED_DN respiratory failure DOID_11162 0.02615405 0.07478219 1.000 1.000 VERHAAK_AML_WITH_NPM1_MUTATED_DN mineral metabolism disease DOID_0050032 0.02766333 0.07870218 0.2279834 0.72470702 VERHAAK_AML_WITH_NPM1_MUTATED_DN cerebral degeneration DOID_1443 0.02843086 0.08048339 0.2309618 0.72207288 VERHAAK_AML_WITH_NPM1_MUTATED_DN bile duct disease DOID_4138 0.03321173 0.09355185 0.03321173 0.34995321 VERHAAK_AML_WITH_NPM1_MUTATED_DN biliary tract disease DOID_9741 0.03403712 0.09540454 0.03403712 0.34584147 VERHAAK_AML_WITH_NPM1_MUTATED_DN arrhythmogenic right ventricular dysplasia DOID_0050431 0.03413452 0.09520854 0.03413452 0.34074635 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 bone marrow cancer DOID_4960 1.028E-09 5.851E-07 4.395E-05 2.084E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 multiple myeloma DOID_9538 4.819E-09 1.371E-06 1.063E-05 1.513E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 myeloma DOID_0070004 1.94E-08 3.68E-06 2.61E-05 1.65E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 alcohol-related neurodevelopmental disorder DOID_0050667 4.154E-08 5.909E-06 2.013E-05 1.432E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 esophageal carcinoma DOID_1107 6.2E-08 7.056E-06 6.2E-08 3.528E-05 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 esophagus squamous cell carcinoma DOID_3748 6.2E-08 7.056E-06 6.2E-08 3.528E-05 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 B cell deficiency DOID_2115 2.459E-06 2.332E-04 2.459E-06 6.995E-04 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 endogenous depression DOID_1595 7.3E-06 5.934E-04 7.3E-06 1.385E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 mental depression DOID_1596 1.113E-05 7.915E-04 1.113E-05 1.266E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 focal epilepsy DOID_2234 1.113E-05 7.036E-04 1.113E-05 1.055E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 primary immunodeficiency disease DOID_612 1.552E-05 8.832E-04 1.552E-05 1.262E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 dilated cardiomyopathy DOID_12930 2.116E-05 1.095E-03 3.471E-04 0.01161672 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 B-cell lymphocytic neoplasm DOID_707 3.546E-05 1.682E-03 0.01464753 0.15725364 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 agammaglobulinemia DOID_2583 3.584E-05 1.569E-03 3.584E-05 2.039E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 blood protein disease DOID_620 4.206E-05 1.709E-03 4.206E-05 2.176E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 melancholia DOID_2848 6.125E-05 2.324E-03 6.125E-05 2.681E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 neurotic disorder DOID_4964 6.523E-05 2.32E-03 6.523E-05 2.651E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 cerebral degeneration DOID_1443 8.802E-05 2.946E-03 1.641E-03 0.03735638 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 temporal lobe epilepsy DOID_3328 9.32E-05 2.946E-03 9.32E-05 3.535E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 myositis DOID_633 1.06E-04 3.176E-03 3.814E-03 0.06382946 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 diffuse large B-cell lymphoma DOID_0050745 1.318E-04 3.75E-03 0.09415162 0.36443722 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 multiple epiphyseal dysplasia DOID_12721 1.614E-04 4.372E-03 5.008E-03 0.07306747 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 chronic kidney failure DOID_784 2.093E-04 5.413E-03 2.093E-04 7.443E-03 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 bone development disease DOID_0080006 2.189E-04 5.416E-03 3.206E-03 0.05700679 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 transitional cell carcinoma DOID_2671 2.607E-04 6.181E-03 3.644E-03 0.0628348 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 lymphoma DOID_0060058 3.079E-04 7.007E-03 0.04098279 0.26803687 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 learning disability DOID_8927 5.952E-04 0.01302582 0.01169999 0.13869363 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 neuronal ceroid lipofuscinosis DOID_14503 6.193E-04 0.01305153 0.03680419 0.26508331 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 brain cancer DOID_1319 6.712E-04 0.01363883 0.15678715 0.45285221 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 central nervous system cancer DOID_3620 7.113E-04 0.01395693 0.15966014 0.4542331 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 movement disease DOID_480 7.962E-04 0.01510175 7.962E-04 0.02516958 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 obstructive hydrocephalus DOID_14159 8.744E-04 0.01604938 8.744E-04 0.02618583 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 communicating hydrocephalus DOID_1573 8.744E-04 0.01604938 8.744E-04 0.02618583 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 cannabis dependence DOID_1849 8.744E-04 0.01554784 8.744E-04 0.02487654 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 hallucinogen dependence DOID_9977 8.744E-04 0.01554784 8.744E-04 0.02487654 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 sarcoidosis DOID_11335 9.352E-04 0.0161251 0.01569388 0.16536696 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 hydrocephalus DOID_10908 1.018E-03 0.01703411 1.018E-03 0.02757904 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 osteochondrodysplasia DOID_2256 1.036E-03 0.01684007 0.01677136 0.17350733 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 smallpox DOID_8736 1.036E-03 0.01637229 1.036E-03 0.02679102 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 congenital ichthyosiform erythroderma DOID_1699 1.172E-03 0.01802091 1.172E-03 0.02899016 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 intracranial hypertension DOID_9428 1.172E-03 0.01754667 1.172E-03 0.02778223 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 hypersensitivity reaction type IV disease DOID_2916 1.199E-03 0.01749704 0.01844494 0.18095123 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 congenital heart defect DOID_1682 1.506E-03 0.02142406 0.0213834 0.20622292 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 lymphatic system cancer DOID_0060073 1.511E-03 0.02097051 0.05630938 0.2939453 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 reticulosarcoma DOID_8538 1.511E-03 0.02097051 0.05630938 0.2939453 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 lymphosarcoma DOID_8675 1.511E-03 0.02097051 0.05630938 0.2939453 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 astrocytoma DOID_3069 1.934E-03 0.02620136 0.02514703 0.23078484 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 subependymal glioma DOID_4843 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 pilocytic astrocytoma DOID_4851 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 subependymal giant cell astrocytoma DOID_5077 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 fibrillary astrocytoma DOID_6726 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 juvenile pilocytic astrocytoma DOID_6811 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 childhood pilocytic astrocytoma DOID_6812 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 gemistocytic astrocytoma DOID_7005 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 childhood cerebral astrocytoma DOID_7007 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 protoplasmic astrocytoma DOID_7008 2.097E-03 0.02774841 0.06591449 0.3178419 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 aneurysm disease DOID_2403 2.52E-03 0.032594 0.02985053 0.25350674 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 benign glioma DOID_0060101 2.538E-03 0.03209369 0.07226394 0.34265151 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 familial hypercholesterolemia DOID_13810 2.538E-03 0.031396 2.538E-03 0.05554677 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 benign ependymoma DOID_4844 2.538E-03 0.03209369 0.07226394 0.34265151 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 electroclinical syndrome DOID_0050701 2.612E-03 0.03162424 2.612E-03 0.05504961 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 pancreatitis DOID_4989 2.612E-03 0.0309654 2.612E-03 0.05308355 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 metabolic syndrome X DOID_14221 2.802E-03 0.03253541 2.802E-03 0.05497362 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 lipid metabolism disorder DOID_3146 2.802E-03 0.0318847 2.802E-03 0.05314117 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 Lewy body dementia DOID_12217 3.019E-03 0.03368429 0.07857056 0.3438973 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 alcohol abuse DOID_1574 3.102E-03 0.03394091 3.102E-03 0.05693314 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 nervous system cancer DOID_3093 3.876E-03 0.04161553 0.26945205 0.65801809 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 intracranial aneurysm DOID_10941 4.098E-03 0.04318434 4.098E-03 0.06662727 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 juvenile myoclonic epilepsy DOID_4890 4.098E-03 0.04239917 4.098E-03 0.06477651 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 extrinsic allergic alveolitis DOID_841 4.098E-03 0.04164204 0.09105646 0.35487074 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 lymphoblastic leukemia DOID_1037 4.241E-03 0.04233613 4.241E-03 0.06522053 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 lung adenocarcinoma DOID_3910 4.392E-03 0.04308855 0.09415162 0.3619748 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 migraine DOID_6364 4.392E-03 0.04235823 4.392E-03 0.06576673 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 supratentorial cancer DOID_1659 5.008E-03 0.04749386 0.10031059 0.36587643 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 cerebrum cancer DOID_368 5.008E-03 0.04749386 0.10031059 0.36587643 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 dysostosis DOID_1934 5.33E-03 0.04971918 5.33E-03 0.07582175 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 abdominal aortic aneurysm DOID_7693 5.661E-03 0.05195782 0.106428 0.37381193 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 childhood absence epilepsy DOID_1825 6.352E-03 0.0573666 6.352E-03 0.08814867 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 papilloma DOID_2615 6.71E-03 0.05965964 1.000 1.000 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 spindle cell carcinoma DOID_4015 7.078E-03 0.06196102 1.000 1.000 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 esophageal disease DOID_6050 7.078E-03 0.06102221 0.11853928 0.39214449 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 hyperthyroidism DOID_7998 7.078E-03 0.06011144 0.11853928 0.38987776 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 childhood electroclinical syndrome DOID_0050704 7.455E-03 0.06237951 7.455E-03 0.1009954 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 aplastic anemia DOID_12449 7.455E-03 0.06147546 0.12154157 0.39518372 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 adolescence-adult electroclinical syndrome DOID_0050705 8.235E-03 0.06693737 8.235E-03 0.10896782 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 hepatitis DOID_2237 9.05E-03 0.07252613 0.13344956 0.4172132 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 peptic ulcer DOID_750 9.05E-03 0.07151882 9.05E-03 0.1170308 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 cervix uteri carcinoma in situ DOID_8991 9.899E-03 0.07716078 0.13934336 0.42399129 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 nephrotic syndrome DOID_1184 0.01078291 0.08291185 0.01078291 0.13634393 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 Huntington's disease DOID_12858 0.01078291 0.08180636 0.01078291 0.13337993 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 cataract DOID_83 0.01169999 0.08759598 0.01169999 0.14164456 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 leukodystrophy DOID_10579 0.01217095 0.08993857 0.15390441 0.45140003 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 lens disease DOID_110 0.01265011 0.09228091 0.01265011 0.14689614 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 autonomic nervous system disease DOID_11465 0.01265011 0.09111279 0.01265011 0.14395822 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 thyroid adenoma DOID_2891 0.01265011 0.08997388 1.000 1.000 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 bone marrow disease DOID_4961 0.01265011 0.0888631 0.15678715 0.44830094 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 hemolytic anemia DOID_583 0.0131374 0.09116076 0.0131374 0.14657221 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 normocytic anemia DOID_720 0.0131374 0.09116076 0.0131374 0.14657221 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 integumentary system benign neoplasm DOID_0060121 0.01363278 0.09345845 0.16252342 0.45780113 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 skin benign neoplasm DOID_3165 0.01363278 0.09345845 0.16252342 0.45780113 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 aortic aneurysm DOID_3627 0.01413617 0.09575574 0.16537702 0.45679382 SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 withdrawal disorder DOID_0060001 0.01464753 0.09805227 0.01464753 0.16027775 AMIT_EGF_RESPONSE_480_HELA transitional cell carcinoma DOID_2671 1.201E-09 6.836E-07 0.01674469 0.2381932 AMIT_EGF_RESPONSE_480_HELA chronic kidney failure DOID_784 3.49E-08 9.929E-06 3.778E-05 0.02149715 AMIT_EGF_RESPONSE_480_HELA papilloma DOID_2615 1.192E-06 2.262E-04 0.07590377 0.37232106 AMIT_EGF_RESPONSE_480_HELA spindle cell carcinoma DOID_4015 1.335E-06 1.899E-04 3.001E-03 0.07423737 AMIT_EGF_RESPONSE_480_HELA invasive lobular carcinoma DOID_3457 1.649E-06 1.876E-04 0.02382393 0.27664926 AMIT_EGF_RESPONSE_480_HELA alcohol-related neurodevelopmental disorder DOID_0050667 2.327E-06 2.207E-04 1.248E-03 0.05464259 AMIT_EGF_RESPONSE_480_HELA uterine cancer DOID_363 3.545E-06 2.882E-04 0.09794007 0.41587983 AMIT_EGF_RESPONSE_480_HELA brain cancer DOID_1319 4.555E-06 3.24E-04 1.841E-04 0.03492152 AMIT_EGF_RESPONSE_480_HELA central nervous system cancer DOID_3620 4.934E-06 3.12E-04 1.953E-04 0.02778422 AMIT_EGF_RESPONSE_480_HELA lung small cell carcinoma DOID_5409 5.337E-06 3.036E-04 2.07E-04 0.02355105 AMIT_EGF_RESPONSE_480_HELA giant cell tumor DOID_200 7.192E-06 3.72E-04 6.755E-03 0.12811383 AMIT_EGF_RESPONSE_480_HELA malignant giant cell tumor DOID_2705 7.192E-06 3.72E-04 6.755E-03 0.12811383 AMIT_EGF_RESPONSE_480_HELA giant cell glioblastoma DOID_3074 7.192E-06 3.72E-04 6.755E-03 0.12811383 AMIT_EGF_RESPONSE_480_HELA prion disease DOID_649 8.063E-06 3.823E-04 0.03869174 0.30158353 AMIT_EGF_RESPONSE_480_HELA glioblastoma DOID_3068 1.013E-05 4.436E-04 7.97E-03 0.14171966 AMIT_EGF_RESPONSE_480_HELA pre-malignant neoplasm DOID_0060071 1.388E-05 5.641E-04 9.276E-03 0.15994744 AMIT_EGF_RESPONSE_480_HELA in situ carcinoma DOID_8719 1.388E-05 5.641E-04 9.276E-03 0.15994744 AMIT_EGF_RESPONSE_480_HELA astrocytoma DOID_3069 1.962E-05 7.441E-04 0.01096069 0.17818946 AMIT_EGF_RESPONSE_480_HELA papillary adenoma DOID_3172 2.849E-05 1.013E-03 0.05747917 0.33717162 AMIT_EGF_RESPONSE_480_HELA microcystic adenoma DOID_5403 2.849E-05 1.013E-03 0.05747917 0.33717162 AMIT_EGF_RESPONSE_480_HELA follicular adenoma DOID_6204 2.849E-05 1.013E-03 0.05747917 0.33717162 AMIT_EGF_RESPONSE_480_HELA lung adenocarcinoma DOID_3910 3.548E-05 1.188E-03 1.85E-03 0.06192725 AMIT_EGF_RESPONSE_480_HELA nervous system cancer DOID_3093 5.153E-05 1.629E-03 1.104E-03 0.05235673 AMIT_EGF_RESPONSE_480_HELA nephroblastoma DOID_2154 7.45E-05 2.231E-03 0.07792885 0.3789873 AMIT_EGF_RESPONSE_480_HELA adenoma DOID_657 8.735E-05 2.485E-03 0.08196587 0.39192083 AMIT_EGF_RESPONSE_480_HELA multiple myeloma DOID_9538 9.429E-05 2.555E-03 0.08397783 0.39490399 AMIT_EGF_RESPONSE_480_HELA nephrotic syndrome DOID_1184 1.435E-04 3.711E-03 1.435E-04 0.04082643 AMIT_EGF_RESPONSE_480_HELA cerebral infarction DOID_3526 1.63E-04 4.032E-03 5.004E-03 0.10950795 AMIT_EGF_RESPONSE_480_HELA myeloma DOID_0070004 1.841E-04 4.365E-03 0.10385932 0.43452909 AMIT_EGF_RESPONSE_480_HELA neuritis DOID_1803 1.841E-04 4.191E-03 0.10385932 0.42823156 AMIT_EGF_RESPONSE_480_HELA thyroid adenoma DOID_2891 1.841E-04 4.029E-03 0.10385932 0.42515076 AMIT_EGF_RESPONSE_480_HELA rectal neoplasm DOID_1984 2.107E-04 4.44E-03 0.02168149 0.26819061 AMIT_EGF_RESPONSE_480_HELA rectum cancer DOID_1993 2.107E-04 4.44E-03 0.02168149 0.26819061 AMIT_EGF_RESPONSE_480_HELA breast benign neoplasm DOID_0060082 2.571E-04 5.225E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA thoracic benign neoplasm DOID_0060097 2.571E-04 5.225E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA benign breast phyllodes tumor DOID_1631 2.571E-04 5.225E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA bone marrow cancer DOID_4960 2.718E-04 5.334E-03 0.11752211 0.45801425 AMIT_EGF_RESPONSE_480_HELA epidermolysis bullosa DOID_2730 3.081E-04 5.844E-03 3.081E-04 0.02922076 AMIT_EGF_RESPONSE_480_HELA peritonitis DOID_8283 3.081E-04 5.656E-03 0.02596173 0.28965141 AMIT_EGF_RESPONSE_480_HELA vesiculobullous skin disease DOID_2731 3.636E-04 6.466E-03 3.636E-04 0.02955815 AMIT_EGF_RESPONSE_480_HELA cholestasis DOID_13580 4.576E-04 7.89E-03 4.576E-04 0.03254775 AMIT_EGF_RESPONSE_480_HELA renovascular hypertension DOID_1591 4.881E-04 8.169E-03 0.03234741 0.30676129 AMIT_EGF_RESPONSE_480_HELA intermediate coronary syndrome DOID_8805 4.881E-04 7.935E-03 0.03234741 0.28758871 AMIT_EGF_RESPONSE_480_HELA endocrine organ benign neoplasm DOID_0060089 5.194E-04 8.21E-03 0.14423324 0.50659701 AMIT_EGF_RESPONSE_480_HELA brain infarction DOID_3454 5.194E-04 7.988E-03 0.01067126 0.1785866 AMIT_EGF_RESPONSE_480_HELA angiosarcoma DOID_0001816 5.571E-04 8.341E-03 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA nephrosis DOID_2527 5.863E-04 8.555E-03 5.863E-04 0.03707014 AMIT_EGF_RESPONSE_480_HELA bile duct disease DOID_4138 5.863E-04 8.341E-03 5.863E-04 0.03336313 AMIT_EGF_RESPONSE_480_HELA biliary tract disease DOID_9741 6.098E-04 8.463E-03 6.098E-04 0.03154417 AMIT_EGF_RESPONSE_480_HELA colon carcinoma DOID_1520 8.77E-04 0.01188122 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA brain edema DOID_4724 8.77E-04 0.01160492 0.04289844 0.30897735 AMIT_EGF_RESPONSE_480_HELA hepatitis B DOID_2043 1.063E-03 0.01374933 0.04708695 0.32280089 AMIT_EGF_RESPONSE_480_HELA muscular atrophy DOID_767 1.063E-03 0.01344379 0.04708695 0.31895803 AMIT_EGF_RESPONSE_480_HELA sinusitis DOID_0050127 1.163E-03 0.01438361 0.04917441 0.32917928 AMIT_EGF_RESPONSE_480_HELA paranasal sinus disease DOID_1352 1.163E-03 0.01438361 0.04917441 0.32917928 AMIT_EGF_RESPONSE_480_HELA lymphoma DOID_0060058 1.175E-03 0.01422386 0.01817251 0.24619422 AMIT_EGF_RESPONSE_480_HELA encephalomyelitis DOID_640 1.211E-03 0.01435911 0.01853727 0.24529544 AMIT_EGF_RESPONSE_480_HELA meningitis DOID_9471 1.267E-03 0.01470961 0.05125735 0.3277015 AMIT_EGF_RESPONSE_480_HELA toxic shock syndrome DOID_14115 1.375E-03 0.01564669 1.375E-03 0.05588105 AMIT_EGF_RESPONSE_480_HELA commensal bacterial infectious disease DOID_0050339 1.487E-03 0.01659463 1.487E-03 0.05642176 AMIT_EGF_RESPONSE_480_HELA cleft lip DOID_9296 1.604E-03 0.0175526 1.604E-03 0.05704597 AMIT_EGF_RESPONSE_480_HELA middle cerebral artery infarction DOID_3525 1.725E-03 0.01851984 0.05954414 0.34222842 AMIT_EGF_RESPONSE_480_HELA perinatal necrotizing enterocolitis DOID_8677 1.85E-03 0.01949562 1.85E-03 0.05848685 AMIT_EGF_RESPONSE_480_HELA autoimmune disease of cardiovascular system DOID_0060051 1.98E-03 0.02047929 1.98E-03 0.05928215 AMIT_EGF_RESPONSE_480_HELA renal hypertension DOID_1073 1.98E-03 0.02011359 0.06366067 0.35512669 AMIT_EGF_RESPONSE_480_HELA secondary hypertension DOID_11130 1.98E-03 0.02011359 0.06366067 0.35512669 AMIT_EGF_RESPONSE_480_HELA sarcoma DOID_1115 1.98E-03 0.01976072 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA Behcet's disease DOID_13241 1.98E-03 0.02047929 1.98E-03 0.05928215 AMIT_EGF_RESPONSE_480_HELA invasive ductal carcinoma DOID_3008 1.98E-03 0.01942001 1.98E-03 0.05631804 AMIT_EGF_RESPONSE_480_HELA focal glomerulosclerosis DOID_3945 2.113E-03 0.02037853 2.113E-03 0.05725397 AMIT_EGF_RESPONSE_480_HELA endometrial carcinoma DOID_2871 2.251E-03 0.02134451 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA celiac disease DOID_10608 2.538E-03 0.02367863 2.538E-03 0.06565439 AMIT_EGF_RESPONSE_480_HELA endometrial cancer DOID_1380 2.538E-03 0.02329672 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA leiomyoma DOID_127 2.689E-03 0.02428198 0.07387429 0.36872343 AMIT_EGF_RESPONSE_480_HELA adolescence-adult electroclinical syndrome DOID_0050705 3.5E-03 0.03111317 3.5E-03 0.08296845 AMIT_EGF_RESPONSE_480_HELA cleft palate DOID_674 3.5E-03 0.03063451 3.5E-03 0.07964971 AMIT_EGF_RESPONSE_480_HELA adult respiratory distress syndrome DOID_11394 4.034E-03 0.03477986 0.0899876 0.40962353 AMIT_EGF_RESPONSE_480_HELA intracranial arterial disease DOID_13089 4.034E-03 0.03426075 0.0899876 0.40637255 AMIT_EGF_RESPONSE_480_HELA cerebral arterial disease DOID_3527 4.034E-03 0.03426075 0.0899876 0.40637255 AMIT_EGF_RESPONSE_480_HELA adenoid cystic carcinoma DOID_4866 4.034E-03 0.03375692 0.0899876 0.40317277 AMIT_EGF_RESPONSE_480_HELA cervix uteri carcinoma in situ DOID_8991 4.22E-03 0.03480255 0.09198218 0.40888954 AMIT_EGF_RESPONSE_480_HELA salivary gland cancer DOID_8850 4.41E-03 0.03585017 0.09397245 0.41449864 AMIT_EGF_RESPONSE_480_HELA pre-eclampsia DOID_10591 5.419E-03 0.04342689 5.419E-03 0.11419663 AMIT_EGF_RESPONSE_480_HELA heart valve disease DOID_4079 5.419E-03 0.04282374 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA autoimmune disease of gastrointestinal tract DOID_0060031 5.849E-03 0.04559037 5.849E-03 0.1188606 AMIT_EGF_RESPONSE_480_HELA glaucoma DOID_1686 5.849E-03 0.04497428 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA orofacial cleft DOID_0050567 6.523E-03 0.04948523 6.523E-03 0.12797903 AMIT_EGF_RESPONSE_480_HELA vasculitis DOID_865 6.99E-03 0.05233619 6.99E-03 0.12830809 AMIT_EGF_RESPONSE_480_HELA reproductive organ benign neoplasm DOID_0050622 7.23E-03 0.05342584 1.000 1.000 AMIT_EGF_RESPONSE_480_HELA oral cavity cancer DOID_8618 7.97E-03 0.0581414 0.1252368 0.46574994 AMIT_EGF_RESPONSE_480_HELA carotid artery disease DOID_3407 8.743E-03 0.06297281 0.13097906 0.47469482 AMIT_EGF_RESPONSE_480_HELA respiratory failure DOID_11162 9.008E-03 0.06406932 0.13288486 0.4785537 AMIT_EGF_RESPONSE_480_HELA diabetic retinopathy DOID_8947 0.01215273 0.0853692 0.15357804 0.52961155 AMIT_EGF_RESPONSE_480_HELA aneurysm disease DOID_2403 0.01308236 0.0907788 0.15913646 0.53898003 AMIT_EGF_RESPONSE_480_HELA electroclinical syndrome DOID_0050701 0.01339893 0.09185529 0.01339893 0.21177748 AMIT_EGF_RESPONSE_480_HELA pancreatitis DOID_4989 0.01339893 0.09076178 0.01339893 0.20605377 AMIT_EGF_RESPONSE_480_HELA mixed glioma DOID_5076 0.01339893 0.08969399 0.16098124 0.54200191 AMIT_EGF_RESPONSE_480_HELA biliary tract cancer DOID_4607 0.01503127 0.09945108 0.17014532 0.55321536 MOOTHA_PGC bone resorption disease DOID_0080011 1.11E-14 6.313E-12 3.953E-13 2.249E-10 MOOTHA_PGC osteoporosis DOID_11476 1.11E-14 6.313E-12 3.953E-13 2.249E-10 MOOTHA_PGC carbohydrate metabolic disorder DOID_2978 3.176E-12 9.037E-10 3.176E-12 9.037E-10 MOOTHA_PGC mitochondrial metabolism disease DOID_700 2.415E-11 4.581E-09 2.584E-08 4.9E-06 MOOTHA_PGC glycogen metabolism disorder DOID_0050728 1.152E-07 1.638E-05 1.152E-07 1.638E-05 MOOTHA_PGC glycogen storage disease DOID_2747 1.152E-07 1.638E-05 1.152E-07 1.638E-05 MOOTHA_PGC thyroid adenoma DOID_2891 2.469E-07 2.809E-05 1.377E-04 6.531E-03 MOOTHA_PGC hemolytic anemia DOID_583 2.786E-07 2.642E-05 2.786E-07 3.17E-05 MOOTHA_PGC normocytic anemia DOID_720 2.786E-07 2.642E-05 2.786E-07 3.17E-05 MOOTHA_PGC amino acid metabolic disorder DOID_9252 5.324E-07 4.328E-05 8.671E-06 7.048E-04 MOOTHA_PGC endocrine organ benign neoplasm DOID_0060089 2.031E-06 1.445E-04 5.335E-04 0.01597785 MOOTHA_PGC Leigh disease DOID_3652 4.029E-06 2.547E-04 4.029E-06 3.821E-04 MOOTHA_PGC mitochondrial myopathy DOID_699 4.029E-06 2.293E-04 5.339E-03 0.08438335 MOOTHA_PGC brain cancer DOID_1319 6.467E-06 3.345E-04 1.000 1.000 MOOTHA_PGC bone marrow disease DOID_4961 6.467E-06 3.066E-04 1.377E-04 6.029E-03 MOOTHA_PGC central nervous system cancer DOID_3620 7.139E-06 3.125E-04 1.000 1.000 MOOTHA_PGC organic acidemia DOID_0060159 9.861E-06 4.008E-04 3.339E-04 0.01266516 MOOTHA_PGC perinatal necrotizing enterocolitis DOID_8677 1.548E-05 5.87E-04 4.639E-04 0.01552534 MOOTHA_PGC osteopetrosis DOID_13533 2.982E-05 1.06E-03 2.982E-05 2.121E-03 MOOTHA_PGC papilloma DOID_2615 3.73E-05 1.248E-03 8.823E-04 0.0251027 MOOTHA_PGC spindle cell carcinoma DOID_4015 4.165E-05 1.317E-03 0.01603153 0.14954001 MOOTHA_PGC aneurysm disease DOID_2403 6.085E-05 1.822E-03 8.294E-03 0.10975177 MOOTHA_PGC thalassemia DOID_10241 6.096E-05 1.734E-03 2.725E-03 0.05346511 MOOTHA_PGC contact dermatitis DOID_2773 7.275E-05 1.971E-03 7.275E-05 4.599E-03 MOOTHA_PGC familial hypertrophic cardiomyopathy DOID_11986 9.04E-05 2.338E-03 9.04E-05 5.144E-03 MOOTHA_PGC methylmalonic acidemia DOID_14749 9.04E-05 2.236E-03 3.505E-03 0.06043965 MOOTHA_PGC retinal vascular disease DOID_2462 9.646E-05 2.287E-03 1.145E-03 0.02962608 MOOTHA_PGC osteosclerosis DOID_4254 1.081E-04 2.46E-03 1.081E-04 5.59E-03 MOOTHA_PGC cerebral infarction DOID_3526 1.173E-04 2.568E-03 2.041E-03 0.04302065 MOOTHA_PGC nervous system cancer DOID_3093 1.257E-04 2.649E-03 1.000 1.000 MOOTHA_PGC lymphoma DOID_0060058 1.391E-04 2.827E-03 1.525E-03 0.03616644 MOOTHA_PGC encephalomyelitis DOID_640 1.462E-04 2.869E-03 0.39230468 1.000 MOOTHA_PGC alcohol-related neurodevelopmental disorder DOID_0050667 1.536E-04 2.914E-03 0.01405185 0.1378535 MOOTHA_PGC B-cell lymphocytic neoplasm DOID_707 1.861E-04 3.416E-03 2.861E-03 0.05426744 MOOTHA_PGC congenital hemolytic anemia DOID_589 2.619E-04 4.657E-03 2.619E-04 0.01064514 MOOTHA_PGC Goodpasture syndrome DOID_9808 2.619E-04 4.516E-03 0.11813202 0.50539187 MOOTHA_PGC hypertrophic cardiomyopathy DOID_11984 2.984E-04 4.994E-03 4.042E-03 0.06764652 MOOTHA_PGC portal hypertension DOID_10762 3.339E-04 5.428E-03 8.122E-03 0.11003782 MOOTHA_PGC papillary adenoma DOID_3172 3.742E-04 5.914E-03 3.742E-04 0.01330654 MOOTHA_PGC microcystic adenoma DOID_5403 3.742E-04 5.914E-03 3.742E-04 0.01330654 MOOTHA_PGC follicular adenoma DOID_6204 3.742E-04 5.914E-03 3.742E-04 0.01330654 MOOTHA_PGC congenital heart defect DOID_1682 4.039E-04 6.211E-03 0.04681012 0.37514023 MOOTHA_PGC middle cerebral artery infarction DOID_3525 4.175E-04 6.251E-03 9.383E-03 0.11863663 MOOTHA_PGC mineral metabolism disease DOID_0050032 4.278E-04 6.241E-03 0.29612068 0.83412211 MOOTHA_PGC diffuse large B-cell lymphoma DOID_0050745 4.639E-04 6.598E-03 0.01004315 0.12158624 MOOTHA_PGC lung adenocarcinoma DOID_3910 4.639E-04 6.437E-03 0.01004315 0.11662354 MOOTHA_PGC hyperglycemia DOID_4195 4.786E-04 6.484E-03 5.708E-03 0.08777984 MOOTHA_PGC allergic contact dermatitis DOID_3042 5.055E-04 6.689E-03 5.055E-04 0.0159801 MOOTHA_PGC hepatic vascular disease DOID_272 5.134E-04 6.639E-03 0.01072385 0.11734364 MOOTHA_PGC brain infarction DOID_3454 5.335E-04 6.746E-03 6.18E-03 0.09253008 MOOTHA_PGC astrocytoma DOID_3069 5.626E-04 6.959E-03 0.31434346 0.86825936 MOOTHA_PGC endometrial carcinoma DOID_2871 6.224E-04 7.535E-03 0.0121445 0.12564039 MOOTHA_PGC bile duct disease DOID_4138 6.242E-04 7.399E-03 6.929E-03 0.10109571 MOOTHA_PGC biliary tract disease DOID_9741 6.567E-04 7.625E-03 7.191E-03 0.10228612 MOOTHA_PGC endometrial cancer DOID_1380 7.452E-04 8.48E-03 0.01364269 0.13618757 MOOTHA_PGC syndrome DOID_225 7.613E-04 8.494E-03 0.06295125 0.39361827 MOOTHA_PGC leiomyoma DOID_127 8.119E-04 8.884E-03 0.01442031 0.13675264 MOOTHA_PGC mixed glioma DOID_5076 8.373E-04 8.989E-03 0.06580134 0.40259098 MOOTHA_PGC DiGeorge syndrome DOID_11198 9.537E-04 0.01004962 0.04603948 0.37423518 MOOTHA_PGC velocardiofacial syndrome DOID_12583 9.537E-04 0.01004962 0.04603948 0.37423518 MOOTHA_PGC thyroid carcinoma DOID_3963 9.565E-04 9.896E-03 0.17621092 0.61511664 MOOTHA_PGC aplastic anemia DOID_12449 1.035E-03 0.01051164 0.0168647 0.15477439 MOOTHA_PGC biliary tract cancer DOID_4607 1.05E-03 0.01048611 0.01012639 0.11523829 MOOTHA_PGC thyroid cancer DOID_1781 1.116E-03 0.01095287 0.18480183 0.62965413 MOOTHA_PGC adenoma DOID_657 1.116E-03 0.01076723 1.116E-03 0.03025079 MOOTHA_PGC T cell deficiency DOID_11200 1.188E-03 0.01126697 0.05102297 0.39769956 MOOTHA_PGC transient cerebral ischemia DOID_224 1.188E-03 0.01108226 0.05102297 0.38709424 MOOTHA_PGC teratoma DOID_3307 1.188E-03 0.01090352 0.05102297 0.37703984 MOOTHA_PGC malignant teratoma DOID_5563 1.188E-03 0.01090352 0.05102297 0.37703984 MOOTHA_PGC mature teratoma DOID_5566 1.188E-03 0.01090352 0.05102297 0.37703984 MOOTHA_PGC polycythemia DOID_8432 1.188E-03 0.01073044 1.188E-03 0.02939209 MOOTHA_PGC uveitis DOID_13141 1.292E-03 0.01148965 0.19330359 0.64699849 MOOTHA_PGC hepatitis DOID_2237 1.386E-03 0.01213653 0.19752133 0.65342813 MOOTHA_PGC systemic scleroderma DOID_418 1.386E-03 0.01195265 1.000 1.000 MOOTHA_PGC neuronal ceroid lipofuscinosis DOID_14503 1.447E-03 0.01228964 0.05598055 0.38845042 MOOTHA_PGC intracranial arterial disease DOID_13089 1.485E-03 0.01242352 0.0212977 0.18934991 MOOTHA_PGC cerebral arterial disease DOID_3527 1.485E-03 0.01242352 0.0212977 0.18934991 MOOTHA_PGC lymphatic system disease DOID_75 1.485E-03 0.01224347 0.20171713 0.65214233 MOOTHA_PGC benign mesothelioma DOID_2645 1.587E-03 0.01290214 0.20589111 0.66187593 MOOTHA_PGC hypersensitivity reaction type I disease DOID_1205 1.712E-03 0.01372285 0.39865174 1.000 MOOTHA_PGC dilated cardiomyopathy DOID_12930 1.712E-03 0.01353226 0.09162314 0.42385015 MOOTHA_PGC beta thalassemia DOID_12241 1.731E-03 0.01348896 0.06091237 0.40775456 MOOTHA_PGC porphyria DOID_13268 1.731E-03 0.01330667 1.731E-03 0.03938775 MOOTHA_PGC mitochondrial encephalomyopathy DOID_890 1.731E-03 0.01312925 0.06091237 0.38510153 MOOTHA_PGC rheumatic disease DOID_1575 1.805E-03 0.01351684 1.000 1.000 MOOTHA_PGC idiopathic generalized epilepsy DOID_1827 1.805E-03 0.0133413 1.805E-03 0.03951077 MOOTHA_PGC uveal disease DOID_3480 1.805E-03 0.01317026 0.21417402 0.67328739 MOOTHA_PGC scleroderma DOID_419 1.805E-03 0.01351684 1.000 1.000 MOOTHA_PGC gallbladder cancer DOID_3121 1.921E-03 0.01383712 0.02515242 0.22018039 MOOTHA_PGC uterine cancer DOID_363 1.921E-03 0.01366416 0.02515242 0.21684433 MOOTHA_PGC leukodystrophy DOID_10579 2.166E-03 0.01521716 0.22643749 0.70023332 MOOTHA_PGC heart valve disease DOID_4079 2.296E-03 0.01593004 0.23048285 0.69388752 MOOTHA_PGC aortic aneurysm DOID_3627 2.713E-03 0.0185959 0.03141854 0.26682312 MOOTHA_PGC peripheral neuropathy DOID_0060053 2.725E-03 0.01845819 2.725E-03 0.05537458 MOOTHA_PGC nutritional deficiency disease DOID_5113 2.725E-03 0.01824104 0.07555453 0.39440853 MOOTHA_PGC orofacial cleft DOID_0050567 3.015E-03 0.01994636 3.015E-03 0.05533506 MOOTHA_PGC restrictive cardiomyopathy DOID_397 3.104E-03 0.02029784 0.0803846 0.40121787 MOOTHA_PGC tongue cancer DOID_8649 3.104E-03 0.02006718 0.0803846 0.39772902 MOOTHA_PGC giant cell tumor DOID_200 3.173E-03 0.02028742 0.25431677 0.73829715 MOOTHA_PGC malignant giant cell tumor DOID_2705 3.173E-03 0.02028742 0.25431677 0.73829715 MOOTHA_PGC giant cell glioblastoma DOID_3074 3.173E-03 0.02028742 0.25431677 0.73829715 MOOTHA_PGC bile duct adenocarcinoma DOID_4896 3.337E-03 0.02109591 3.337E-03 0.05933225 MOOTHA_PGC cholangiocarcinoma DOID_4947 3.337E-03 0.02109591 3.337E-03 0.05933225 MOOTHA_PGC lymphatic system cancer DOID_0060073 3.505E-03 0.02191767 0.08518956 0.41429793 MOOTHA_PGC reticulosarcoma DOID_8538 3.505E-03 0.02191767 0.08518956 0.41429793 MOOTHA_PGC lymphosarcoma DOID_8675 3.505E-03 0.02191767 0.08518956 0.41429793 MOOTHA_PGC reproductive organ benign neoplasm DOID_0050622 3.505E-03 0.02168012 0.0370578 0.31008659 MOOTHA_PGC prion disease DOID_649 3.93E-03 0.02404447 1.000 1.000 MOOTHA_PGC glioblastoma DOID_3068 4.042E-03 0.02446789 0.27361626 0.78235001 MOOTHA_PGC bile duct cancer DOID_4606 4.042E-03 0.02421033 4.042E-03 0.06571376 MOOTHA_PGC bile duct carcinoma DOID_4897 4.042E-03 0.02421033 4.042E-03 0.06571376 MOOTHA_PGC oral cavity cancer DOID_8618 4.042E-03 0.02395814 0.04061324 0.33491207 MOOTHA_PGC carotid artery disease DOID_3407 4.626E-03 0.0271374 0.28495655 0.81070139 MOOTHA_PGC collagen disease DOID_854 4.626E-03 0.02686049 1.000 1.000 MOOTHA_PGC subependymal glioma DOID_4843 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC pilocytic astrocytoma DOID_4851 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC subependymal giant cell astrocytoma DOID_5077 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC fibrillary astrocytoma DOID_6726 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC juvenile pilocytic astrocytoma DOID_6811 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC childhood pilocytic astrocytoma DOID_6812 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC gemistocytic astrocytoma DOID_7005 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC childhood cerebral astrocytoma DOID_7007 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC protoplasmic astrocytoma DOID_7008 4.847E-03 0.02785779 1.000 1.000 MOOTHA_PGC Kawasaki disease DOID_13378 5.339E-03 0.03037801 1.000 1.000 MOOTHA_PGC lymphadenitis DOID_1602 5.339E-03 0.03037801 1.000 1.000 MOOTHA_PGC lymph node disease DOID_9942 5.339E-03 0.03037801 1.000 1.000 MOOTHA_PGC cholestasis DOID_13580 5.481E-03 0.03087606 0.04937977 0.39023734 MOOTHA_PGC cerebral degeneration DOID_1443 5.481E-03 0.03057336 0.29980338 0.84033558 MOOTHA_PGC funisitis DOID_0050698 5.853E-03 0.03233159 0.10884222 0.4838377 MOOTHA_PGC benign glioma DOID_0060101 5.853E-03 0.03202071 1.000 1.000 MOOTHA_PGC benign ependymoma DOID_4844 5.853E-03 0.03202071 1.000 1.000 MOOTHA_PGC polyarteritis nodosa DOID_9810 6.388E-03 0.03461756 1.000 1.000 MOOTHA_PGC pancreatic ductal carcinoma DOID_3587 6.674E-03 0.03582349 0.31793129 0.86972551 MOOTHA_PGC male reproductive system disease DOID_48 6.929E-03 0.03684797 0.32150045 0.87111311 MOOTHA_PGC pancreatic carcinoma DOID_4905 7.458E-03 0.03929115 0.3285831 0.88608428 MOOTHA_PGC sphingolipidosis DOID_1927 7.523E-03 0.03927243 7.523E-03 0.1044072 MOOTHA_PGC morbid obesity DOID_11981 8.742E-03 0.04522076 0.13188635 0.56002488 MOOTHA_PGC cleft lip DOID_9296 8.742E-03 0.04481336 8.742E-03 0.11305189 MOOTHA_PGC seminoma DOID_4440 9.383E-03 0.0476665 1.000 1.000 MOOTHA_PGC dystonia DOID_543 9.383E-03 0.04724467 9.383E-03 0.11605757 MOOTHA_PGC extrinsic allergic alveolitis DOID_841 9.383E-03 0.04683025 1.000 1.000 MOOTHA_PGC chromosomal disease DOID_0080014 9.492E-03 0.04696348 0.07015561 0.39135827 MOOTHA_PGC gestational diabetes DOID_11714 0.01004315 0.04926339 0.01004315 0.11905319 MOOTHA_PGC migraine DOID_6364 0.01004315 0.04884234 0.14093712 0.56079174 MOOTHA_PGC focal epilepsy DOID_2234 0.01012639 0.04882978 0.07310951 0.39999337 MOOTHA_PGC chronic kidney failure DOID_784 0.01012639 0.04841945 0.01012639 0.11297871 MOOTHA_PGC sarcoma DOID_1115 0.01072385 0.05084891 0.14542723 0.57067651 MOOTHA_PGC central nervous system hereditary degenerative disease DOID_481 0.01072385 0.05042867 0.01072385 0.1151296 MOOTHA_PGC supratentorial cancer DOID_1659 0.01142437 0.05328252 1.000 1.000 MOOTHA_PGC toxic encephalopathy DOID_3602 0.01142437 0.05284933 0.01142437 0.12037903 MOOTHA_PGC cerebrum cancer DOID_368 0.01142437 0.05328252 1.000 1.000 MOOTHA_PGC transitional cell carcinoma DOID_2671 0.01181883 0.05423317 0.3761439 0.9817701 MOOTHA_PGC female reproductive organ benign neoplasm DOID_0060086 0.0121445 0.05528177 0.15433752 0.58938289 MOOTHA_PGC uterine benign neoplasm DOID_0060095 0.0121445 0.05528177 0.15433752 0.58938289 MOOTHA_PGC uterine fibroid DOID_13223 0.0121445 0.05528177 0.15433752 0.58938289 MOOTHA_PGC primary immunodeficiency disease DOID_612 0.01217561 0.0549835 0.08220362 0.40322291 MOOTHA_PGC spastic cerebral palsy DOID_0050669 0.01288401 0.05772444 0.01288401 0.13091079 MOOTHA_PGC age related macular degeneration DOID_10871 0.01288401 0.05727347 0.15875795 0.59429784 MOOTHA_PGC degeneration of macula and posterior pole DOID_2007 0.01288401 0.05727347 0.15875795 0.59429784 MOOTHA_PGC abdominal aortic aneurysm DOID_7693 0.01288401 0.05682949 0.15875795 0.59041354 MOOTHA_PGC germinoma DOID_3304 0.01364269 0.05971301 1.000 1.000 MOOTHA_PGC mouth disease DOID_403 0.01405185 0.06103438 0.01405185 0.135517 MOOTHA_PGC Crohn's disease DOID_8778 0.01405185 0.06057199 0.09003186 0.41990267 MOOTHA_PGC myocarditis DOID_820 0.01521667 0.06509987 0.17188175 0.61509883 MOOTHA_PGC male infertility DOID_12336 0.01603153 0.06807418 0.17621092 0.62275784 MOOTHA_PGC hepatitis C DOID_1883 0.01603153 0.06756993 0.17621092 0.61891366 MOOTHA_PGC macular degeneration DOID_4448 0.01603153 0.06707309 0.17621092 0.61136593 MOOTHA_PGC esophageal disease DOID_6050 0.01603153 0.06658351 0.17621092 0.60766068 MOOTHA_PGC calcinosis DOID_182 0.01858509 0.07662982 0.18906379 0.63655206 MOOTHA_PGC cleft palate DOID_674 0.01858509 0.07607853 0.01858509 0.1678558 MOOTHA_PGC multiple myeloma DOID_9538 0.01858509 0.07553511 1.000 1.000 MOOTHA_PGC peptic ulcer DOID_750 0.02037617 0.08222724 0.19752133 0.64591746 MOOTHA_PGC pulmonary emphysema DOID_9675 0.0222363 0.08910178 0.20589111 0.65815753 HUPER_BREAST_BASAL_VS_LUMINAL_UP integumentary system benign neoplasm DOID_0060121 1.254E-09 7.134E-07 1.544E-05 8.787E-03 HUPER_BREAST_BASAL_VS_LUMINAL_UP skin benign neoplasm DOID_3165 1.254E-09 7.134E-07 1.544E-05 8.787E-03 HUPER_BREAST_BASAL_VS_LUMINAL_UP integumentary system cancer DOID_0060122 2.202E-09 6.264E-07 2.148E-05 6.111E-03 HUPER_BREAST_BASAL_VS_LUMINAL_UP skin cancer DOID_4159 2.202E-09 6.264E-07 2.148E-05 6.111E-03 HUPER_BREAST_BASAL_VS_LUMINAL_UP uterine disease DOID_345 4.976E-09 9.437E-07 1.815E-03 0.1147733 HUPER_BREAST_BASAL_VS_LUMINAL_UP female reproductive system disease DOID_229 1.372E-08 1.952E-06 2.689E-03 0.15297648 HUPER_BREAST_BASAL_VS_LUMINAL_UP giant cell tumor DOID_200 2.16E-07 2.458E-05 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP malignant giant cell tumor DOID_2705 2.16E-07 2.458E-05 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP giant cell glioblastoma DOID_3074 2.16E-07 2.458E-05 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP glioblastoma DOID_3068 3.059E-07 2.901E-05 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP pre-malignant neoplasm DOID_0060071 4.211E-07 3.423E-05 1.711E-03 0.1217221 HUPER_BREAST_BASAL_VS_LUMINAL_UP in situ carcinoma DOID_8719 4.211E-07 3.423E-05 1.711E-03 0.1217221 HUPER_BREAST_BASAL_VS_LUMINAL_UP astrocytoma DOID_3069 5.987E-07 4.258E-05 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP papilloma DOID_2615 5.04E-06 3.186E-04 0.03271921 0.66490109 HUPER_BREAST_BASAL_VS_LUMINAL_UP myocarditis DOID_820 5.04E-06 2.868E-04 5.115E-04 0.05820315 HUPER_BREAST_BASAL_VS_LUMINAL_UP endometriosis of uterus DOID_288 9.959E-06 5.152E-04 7.995E-04 0.07582204 HUPER_BREAST_BASAL_VS_LUMINAL_UP endometriosis DOID_289 1.065E-05 5.049E-04 8.354E-04 0.06790509 HUPER_BREAST_BASAL_VS_LUMINAL_UP leber hereditary optic neuropathy DOID_705 2.969E-05 1.299E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP hyperglycemia DOID_4195 3.622E-05 1.472E-03 0.06179659 0.74813324 HUPER_BREAST_BASAL_VS_LUMINAL_UP childhood type dermatomyositis DOID_14203 3.709E-05 1.407E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP dermatomyositis DOID_10223 4.53E-05 1.611E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP mitochondrial encephalomyopathy DOID_890 5.433E-05 1.819E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP bacterial pneumonia DOID_874 5.64E-05 1.783E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP transitional cell carcinoma DOID_2671 8.014E-05 2.4E-03 3.151E-03 0.16301055 HUPER_BREAST_BASAL_VS_LUMINAL_UP varicose veins DOID_799 8.629E-05 2.455E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP vein disease DOID_866 9.856E-05 2.67E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP keratosis DOID_161 1.255E-04 3.246E-03 1.255E-04 0.02380555 HUPER_BREAST_BASAL_VS_LUMINAL_UP esophagitis DOID_11963 1.557E-04 3.852E-03 0.0183078 0.49605413 HUPER_BREAST_BASAL_VS_LUMINAL_UP mitochondrial myopathy DOID_699 1.72E-04 4.077E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP placenta disease DOID_780 1.891E-04 4.303E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP optic nerve disease DOID_1891 2.069E-04 4.529E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP IgA glomerulonephritis DOID_2986 2.069E-04 4.361E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP myositis DOID_633 2.864E-04 5.821E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP extrinsic allergic alveolitis DOID_841 3.083E-04 6.049E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP lung adenocarcinoma DOID_3910 3.309E-04 6.277E-03 3.309E-04 0.04707648 HUPER_BREAST_BASAL_VS_LUMINAL_UP periodontitis DOID_824 3.309E-04 6.074E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP cranial nerve disease DOID_5656 3.786E-04 6.732E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP pneumoconiosis DOID_10316 5.404E-04 9.317E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP periodontal disease DOID_3388 5.404E-04 9.043E-03 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP esophageal disease DOID_6050 5.404E-04 8.785E-03 0.03361307 0.61696242 HUPER_BREAST_BASAL_VS_LUMINAL_UP peptic ulcer DOID_750 6.966E-04 0.01100948 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP adult respiratory distress syndrome DOID_11394 7.301E-04 0.01122795 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP influenza DOID_8469 8.72E-04 0.01305722 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP pulmonary tuberculosis DOID_2957 1.067E-03 0.01556073 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP calcium metabolism disease DOID_10575 1.108E-03 0.01575756 0.04780612 0.7351806 HUPER_BREAST_BASAL_VS_LUMINAL_UP atopic dermatitis DOID_3310 1.192E-03 0.01654777 0.04956595 0.7231545 HUPER_BREAST_BASAL_VS_LUMINAL_UP mitochondrial metabolism disease DOID_700 1.371E-03 0.01856915 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP oral cavity cancer DOID_8618 1.464E-03 0.01937632 0.0548265 0.72549489 HUPER_BREAST_BASAL_VS_LUMINAL_UP respiratory failure DOID_11162 1.66E-03 0.02147307 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP congenital heart defect DOID_1682 1.711E-03 0.02163948 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP mineral metabolism disease DOID_0050032 1.763E-03 0.0218078 0.06005877 0.74290084 HUPER_BREAST_BASAL_VS_LUMINAL_UP temporal lobe epilepsy DOID_3328 1.869E-03 0.02262083 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP tooth disease DOID_1091 1.922E-03 0.02278784 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP tuberculosis DOID_399 1.977E-03 0.02295653 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP pancreatic ductal carcinoma DOID_3587 2.088E-03 0.02376452 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP male reproductive system disease DOID_48 2.145E-03 0.02393189 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP pancreatic carcinoma DOID_4905 2.261E-03 0.02473784 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP diabetic retinopathy DOID_8947 2.261E-03 0.02427109 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP cystic fibrosis DOID_1485 2.379E-03 0.02507146 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP bone resorption disease DOID_0080011 2.44E-03 0.02524038 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP osteoporosis DOID_11476 2.44E-03 0.02524038 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP lipid metabolism disorder DOID_3146 2.625E-03 0.0266744 0.07301663 0.8655513 HUPER_BREAST_BASAL_VS_LUMINAL_UP focal epilepsy DOID_2234 2.817E-03 0.02812251 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP chronic kidney failure DOID_784 2.817E-03 0.02763764 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP retinal vascular disease DOID_2462 2.949E-03 0.0284377 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP primary bacterial infectious disease DOID_0050338 3.083E-03 0.02923804 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP mouth disease DOID_403 3.576E-03 0.03335305 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP hypersensitivity reaction type I disease DOID_1205 3.649E-03 0.03348659 0.08580089 0.97641416 HUPER_BREAST_BASAL_VS_LUMINAL_UP brachydactyly DOID_0050581 9.195E-03 0.08304668 9.195E-03 0.43599509 HUPER_BREAST_BASAL_VS_LUMINAL_UP hypolipoproteinemia DOID_1387 9.195E-03 0.08174908 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP retinal vascular occlusion DOID_1729 9.195E-03 0.0804914 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP chondrosarcoma DOID_3371 9.195E-03 0.07927183 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP cutaneous leishmaniasis DOID_9111 9.195E-03 0.07808867 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.01010994 0.08459643 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP temporal arteritis DOID_13375 0.01010994 0.0833704 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP central nervous system vasculitis DOID_525 0.01010994 0.0833704 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP bronchiectasis DOID_9563 0.01010994 0.08217939 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP common cold DOID_10459 0.01102409 0.08834798 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP otitis media DOID_10754 0.01102409 0.08712093 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP intracranial arteriosclerosis DOID_13097 0.01102409 0.08592749 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP epidermolysis bullosa DOID_2730 0.01102409 0.08476631 0.01102409 0.48251591 HUPER_BREAST_BASAL_VS_LUMINAL_UP middle ear disease DOID_5100 0.01102409 0.08712093 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP stomach disease DOID_76 0.01102409 0.08363609 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP vascular dementia DOID_8725 0.01102409 0.08592749 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP encephalitis DOID_9588 0.01102409 0.08253562 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP vulva cancer DOID_1245 0.01193742 0.08821285 0.01193742 0.48517068 HUPER_BREAST_BASAL_VS_LUMINAL_UP vesiculobullous skin disease DOID_2731 0.01193742 0.08708192 0.01193742 0.45282597 HUPER_BREAST_BASAL_VS_LUMINAL_UP hypercalcemia DOID_12678 0.01284992 0.09255198 0.01284992 0.45697538 HUPER_BREAST_BASAL_VS_LUMINAL_UP hemangioma DOID_255 0.01376161 0.09787946 1.000 1.000 HUPER_BREAST_BASAL_VS_LUMINAL_UP panic disorder DOID_594 0.01376161 0.09667107 0.01376161 0.46060922 BILD_HRAS_ONCOGENIC_SIGNATURE astrocytoma DOID_3069 3.283E-10 1.868E-07 0.23841427 0.88665178 BILD_HRAS_ONCOGENIC_SIGNATURE influenza DOID_8469 5.194E-10 1.478E-07 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cystic fibrosis DOID_1485 6.31E-10 1.197E-07 0.25552203 0.93200022 BILD_HRAS_ONCOGENIC_SIGNATURE pancreatitis DOID_4989 7.752E-10 1.103E-07 3.492E-03 0.11688053 BILD_HRAS_ONCOGENIC_SIGNATURE giant cell tumor DOID_200 1.862E-09 2.119E-07 0.19086128 0.79270124 BILD_HRAS_ONCOGENIC_SIGNATURE malignant giant cell tumor DOID_2705 1.862E-09 2.119E-07 0.19086128 0.79270124 BILD_HRAS_ONCOGENIC_SIGNATURE giant cell glioblastoma DOID_3074 1.862E-09 2.119E-07 0.19086128 0.79270124 BILD_HRAS_ONCOGENIC_SIGNATURE transitional cell carcinoma DOID_2671 2.008E-09 1.905E-07 4.859E-03 0.13822454 BILD_HRAS_ONCOGENIC_SIGNATURE glioblastoma DOID_3068 3.448E-09 2.803E-07 0.20602995 0.80295234 BILD_HRAS_ONCOGENIC_SIGNATURE uterine disease DOID_345 7.495E-09 5.331E-07 0.22679281 0.85460335 BILD_HRAS_ONCOGENIC_SIGNATURE allergic contact dermatitis DOID_3042 9.21E-09 5.823E-07 9.21E-09 5.24E-06 BILD_HRAS_ONCOGENIC_SIGNATURE contact dermatitis DOID_2773 2.813E-08 1.6E-06 2.813E-08 8.002E-06 BILD_HRAS_ONCOGENIC_SIGNATURE female reproductive system disease DOID_229 3.062E-08 1.584E-06 0.26948658 0.95240908 BILD_HRAS_ONCOGENIC_SIGNATURE chronic kidney failure DOID_784 3.618E-08 1.715E-06 0.0411498 0.45027382 BILD_HRAS_ONCOGENIC_SIGNATURE hypersensitivity reaction type I disease DOID_1205 9.068E-08 3.969E-06 5.982E-03 0.14799113 BILD_HRAS_ONCOGENIC_SIGNATURE respiratory failure DOID_11162 1.782E-07 7.244E-06 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cholestasis DOID_13580 2.34E-07 8.877E-06 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE hyperglycemia DOID_4195 2.555E-07 9.086E-06 2.295E-03 0.08161762 BILD_HRAS_ONCOGENIC_SIGNATURE tongue cancer DOID_8649 3.41E-07 1.141E-05 0.0586855 0.49838879 BILD_HRAS_ONCOGENIC_SIGNATURE Barrett's esophagus DOID_9206 3.41E-07 1.078E-05 0.0586855 0.49105954 BILD_HRAS_ONCOGENIC_SIGNATURE bile duct disease DOID_4138 3.888E-07 1.164E-05 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE biliary tract disease DOID_9741 4.213E-07 1.199E-05 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE prion disease DOID_649 5.7E-07 1.544E-05 2.078E-03 0.07881412 BILD_HRAS_ONCOGENIC_SIGNATURE intracranial arterial disease DOID_13089 6.104E-07 1.579E-05 0.01153043 0.23431486 BILD_HRAS_ONCOGENIC_SIGNATURE cerebral arterial disease DOID_3527 6.104E-07 1.579E-05 0.01153043 0.23431486 BILD_HRAS_ONCOGENIC_SIGNATURE lipid metabolism disorder DOID_3146 7.169E-07 1.774E-05 3.744E-03 0.11833636 BILD_HRAS_ONCOGENIC_SIGNATURE endometriosis of uterus DOID_288 7.701E-07 1.826E-05 0.15646977 0.71799435 BILD_HRAS_ONCOGENIC_SIGNATURE endometriosis DOID_289 8.614E-07 1.961E-05 0.15965534 0.71530622 BILD_HRAS_ONCOGENIC_SIGNATURE pulmonary edema DOID_11396 8.972E-07 1.963E-05 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cerebral infarction DOID_3526 1.07E-06 2.254E-05 0.01422801 0.26985798 BILD_HRAS_ONCOGENIC_SIGNATURE heart valve disease DOID_4079 1.315E-06 2.673E-05 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE nervous system cancer DOID_3093 1.415E-06 2.777E-05 0.04744006 0.47356834 BILD_HRAS_ONCOGENIC_SIGNATURE integumentary system benign neoplasm DOID_0060121 1.604E-06 3.042E-05 0.01656252 0.29450224 BILD_HRAS_ONCOGENIC_SIGNATURE skin benign neoplasm DOID_3165 1.604E-06 3.042E-05 0.01656252 0.29450224 BILD_HRAS_ONCOGENIC_SIGNATURE lymphoma DOID_0060058 1.606E-06 2.948E-05 4.549E-04 0.0431389 BILD_HRAS_ONCOGENIC_SIGNATURE mouth disease DOID_403 1.818E-06 3.232E-05 0.30458891 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE B-cell lymphocytic neoplasm DOID_707 1.94E-06 3.345E-05 5.301E-05 0.01005468 BILD_HRAS_ONCOGENIC_SIGNATURE aortic valve disease DOID_62 1.945E-06 3.255E-05 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE bone marrow cancer DOID_4960 2.545E-06 4.137E-05 0.19391786 0.79380766 BILD_HRAS_ONCOGENIC_SIGNATURE portal hypertension DOID_10762 2.72E-06 4.299E-05 0.09361372 0.59849668 BILD_HRAS_ONCOGENIC_SIGNATURE integumentary system cancer DOID_0060122 2.777E-06 4.27E-05 0.02034637 0.33077376 BILD_HRAS_ONCOGENIC_SIGNATURE skin cancer DOID_4159 2.777E-06 4.27E-05 0.02034637 0.33077376 BILD_HRAS_ONCOGENIC_SIGNATURE familial hyperlipidemia DOID_1168 3.025E-06 4.529E-05 1.464E-03 0.06406281 BILD_HRAS_ONCOGENIC_SIGNATURE oral cavity cancer DOID_8618 3.572E-06 5.212E-05 0.02236068 0.33482179 BILD_HRAS_ONCOGENIC_SIGNATURE middle cerebral artery infarction DOID_3525 3.704E-06 5.268E-05 5.008E-03 0.13569346 BILD_HRAS_ONCOGENIC_SIGNATURE leber hereditary optic neuropathy DOID_705 4.341E-06 6.025E-05 0.03344368 0.44254549 BILD_HRAS_ONCOGENIC_SIGNATURE pleurisy DOID_10247 4.928E-06 6.676E-05 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE hepatic vascular disease DOID_272 4.928E-06 6.521E-05 0.10722188 0.61009249 BILD_HRAS_ONCOGENIC_SIGNATURE pre-malignant neoplasm DOID_0060071 5.286E-06 6.836E-05 0.02589213 0.37775948 BILD_HRAS_ONCOGENIC_SIGNATURE in situ carcinoma DOID_8719 5.286E-06 6.836E-05 0.02589213 0.37775948 BILD_HRAS_ONCOGENIC_SIGNATURE mineral metabolism disease DOID_0050032 5.695E-06 7.201E-05 0.02662389 0.37872476 BILD_HRAS_ONCOGENIC_SIGNATURE retinal vascular occlusion DOID_1729 6.185E-06 7.65E-05 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE temporal lobe epilepsy DOID_3328 6.587E-06 7.975E-05 0.02811229 0.39014372 BILD_HRAS_ONCOGENIC_SIGNATURE brain infarction DOID_3454 7.585E-06 8.992E-05 0.0296334 0.40146196 BILD_HRAS_ONCOGENIC_SIGNATURE pleural disease DOID_1532 9.279E-06 1.077E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE peripheral vascular disease DOID_341 9.934E-06 1.131E-04 0.2470164 0.90678922 BILD_HRAS_ONCOGENIC_SIGNATURE papilloma DOID_2615 1.041E-05 1.161E-04 0.12725462 0.65825346 BILD_HRAS_ONCOGENIC_SIGNATURE diabetic retinopathy DOID_8947 1.06E-05 1.16E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE common cold DOID_10459 1.128E-05 1.211E-04 0.04434287 0.46724249 BILD_HRAS_ONCOGENIC_SIGNATURE aortic valve insufficiency DOID_57 1.128E-05 1.188E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE esophageal disease DOID_6050 1.164E-05 1.204E-04 0.13054974 0.66323931 BILD_HRAS_ONCOGENIC_SIGNATURE bacterial pneumonia DOID_874 1.363E-05 1.385E-04 0.26113938 0.93451764 BILD_HRAS_ONCOGENIC_SIGNATURE adenoma DOID_657 1.441E-05 1.438E-04 0.13710296 0.67251366 BILD_HRAS_ONCOGENIC_SIGNATURE focal epilepsy DOID_2234 1.832E-05 1.797E-04 0.0411498 0.45910272 BILD_HRAS_ONCOGENIC_SIGNATURE biliary tract cancer DOID_4607 1.832E-05 1.767E-04 0.27499928 0.95996682 BILD_HRAS_ONCOGENIC_SIGNATURE systemic scleroderma DOID_418 1.943E-05 1.843E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE peptic ulcer DOID_750 1.943E-05 1.813E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE retinal vascular disease DOID_2462 2.051E-05 1.882E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE primary bacterial infectious disease DOID_0050338 2.29E-05 2.068E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE varicose veins DOID_799 2.313E-05 2.056E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE pulmonary emphysema DOID_9675 2.343E-05 2.051E-04 0.15327221 0.70903973 BILD_HRAS_ONCOGENIC_SIGNATURE Human immunodeficiency virus infectious disease DOID_526 2.689E-05 2.318E-04 5.165E-03 0.13359053 BILD_HRAS_ONCOGENIC_SIGNATURE rheumatic disease DOID_1575 2.8E-05 2.378E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE scleroderma DOID_419 2.8E-05 2.378E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE vein disease DOID_866 2.839E-05 2.375E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE encephalomyelitis DOID_640 3.139E-05 2.589E-04 0.30194925 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE Crohn's disease DOID_8778 3.302E-05 2.684E-04 0.30458891 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE dilated cardiomyopathy DOID_12930 3.471E-05 2.782E-04 0.05213344 0.46349889 BILD_HRAS_ONCOGENIC_SIGNATURE proteinuria DOID_576 3.604E-05 2.848E-04 0.01479718 0.27159981 BILD_HRAS_ONCOGENIC_SIGNATURE myeloma DOID_0070004 3.906E-05 3.044E-04 0.17227861 0.75989555 BILD_HRAS_ONCOGENIC_SIGNATURE brain cancer DOID_1319 3.906E-05 3.003E-04 0.17227861 0.7540502 BILD_HRAS_ONCOGENIC_SIGNATURE thyroid adenoma DOID_2891 3.906E-05 2.963E-04 0.17227861 0.74829409 BILD_HRAS_ONCOGENIC_SIGNATURE ulcerative colitis DOID_8577 4.018E-05 3.008E-04 0.31504878 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE central nervous system cancer DOID_3620 4.226E-05 3.123E-04 0.17540489 0.74481627 BILD_HRAS_ONCOGENIC_SIGNATURE pulmonary tuberculosis DOID_2957 4.565E-05 3.33E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE calcium metabolism disease DOID_10575 4.923E-05 3.546E-04 0.01716998 0.29605204 BILD_HRAS_ONCOGENIC_SIGNATURE reproductive organ benign neoplasm DOID_0050622 7.029E-05 5E-04 0.19696298 0.80051382 BILD_HRAS_ONCOGENIC_SIGNATURE familial hypercholesterolemia DOID_13810 7.678E-05 5.394E-04 0.0797996 0.56757469 BILD_HRAS_ONCOGENIC_SIGNATURE sinusitis DOID_0050127 8.805E-05 6.11E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE paranasal sinus disease DOID_1352 8.805E-05 6.11E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE optic nerve disease DOID_1891 8.805E-05 6.036E-04 0.08327261 0.58496438 BILD_HRAS_ONCOGENIC_SIGNATURE IgA glomerulonephritis DOID_2986 8.805E-05 5.965E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE urinary tract obstruction DOID_5200 8.805E-05 5.894E-04 0.08327261 0.56407279 BILD_HRAS_ONCOGENIC_SIGNATURE collagen disease DOID_854 1.034E-04 6.844E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE bronchiolitis DOID_2942 1.282E-04 8.385E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cystitis DOID_1679 1.438E-04 9.3E-04 0.09703495 0.59368692 BILD_HRAS_ONCOGENIC_SIGNATURE endocrine organ benign neoplasm DOID_0060089 1.55E-04 9.909E-04 0.23552527 0.88167026 BILD_HRAS_ONCOGENIC_SIGNATURE tuberculosis DOID_399 1.55E-04 9.798E-04 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE extrinsic allergic alveolitis DOID_841 1.606E-04 1.004E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE pancreatic ductal carcinoma DOID_3587 1.726E-04 1.068E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE diffuse large B-cell lymphoma DOID_0050745 1.787E-04 1.093E-03 1.787E-04 0.02541839 BILD_HRAS_ONCOGENIC_SIGNATURE periodontitis DOID_824 1.787E-04 1.082E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE male reproductive system disease DOID_48 1.819E-04 1.09E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE sarcoma DOID_1115 1.98E-04 1.174E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE invasive ductal carcinoma DOID_3008 1.98E-04 1.161E-03 1.98E-04 0.02253181 BILD_HRAS_ONCOGENIC_SIGNATURE pancreatic carcinoma DOID_4905 2.017E-04 1.171E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cranial nerve disease DOID_5656 2.186E-04 1.256E-03 0.1105921 0.61094081 BILD_HRAS_ONCOGENIC_SIGNATURE aneurysm disease DOID_2403 2.341E-04 1.332E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE dysostosis DOID_1934 2.406E-04 1.355E-03 6.507E-03 0.15426904 BILD_HRAS_ONCOGENIC_SIGNATURE metabolic syndrome X DOID_14221 2.702E-04 1.507E-03 0.26671463 0.94850391 BILD_HRAS_ONCOGENIC_SIGNATURE germinoma DOID_3304 2.886E-04 1.594E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE allergic rhinitis DOID_4481 2.886E-04 1.579E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE bladder disease DOID_365 3.148E-04 1.706E-03 0.1239471 0.64702663 BILD_HRAS_ONCOGENIC_SIGNATURE bone development disease DOID_0080006 3.242E-04 1.74E-03 0.04202768 0.45120286 BILD_HRAS_ONCOGENIC_SIGNATURE pneumoconiosis DOID_10316 3.717E-04 1.976E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE periodontal disease DOID_3388 3.717E-04 1.958E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE spindle cell carcinoma DOID_4015 3.717E-04 1.94E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE multiple myeloma DOID_9538 4.687E-04 2.424E-03 0.14036115 0.67113862 BILD_HRAS_ONCOGENIC_SIGNATURE alcohol-related neurodevelopmental disorder DOID_0050667 4.927E-04 2.525E-03 0.30458891 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE blood platelet disease DOID_2218 5.043E-04 2.562E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE adult respiratory distress syndrome DOID_11394 5.806E-04 2.924E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cervix uteri carcinoma in situ DOID_8991 6.214E-04 3.102E-03 0.15327221 0.71485154 BILD_HRAS_ONCOGENIC_SIGNATURE brachydactyly DOID_0050581 6.233E-04 3.084E-03 6.233E-04 0.05066582 BILD_HRAS_ONCOGENIC_SIGNATURE hypolipoproteinemia DOID_1387 6.233E-04 3.057E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE childhood type dermatomyositis DOID_14203 6.233E-04 3.031E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cutaneous leishmaniasis DOID_9111 6.233E-04 3.006E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE gallbladder cancer DOID_3121 7.545E-04 3.608E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE familial adenomatous polyposis DOID_0050424 7.599E-04 3.603E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE dermatomyositis DOID_10223 7.599E-04 3.574E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cataract DOID_83 8.026E-04 3.743E-03 8.026E-04 0.05708751 BILD_HRAS_ONCOGENIC_SIGNATURE learning disability DOID_8927 8.026E-04 3.713E-03 0.16599069 0.73788048 BILD_HRAS_ONCOGENIC_SIGNATURE pre-eclampsia DOID_10591 9.046E-04 4.151E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE lens disease DOID_110 9.046E-04 4.118E-03 9.046E-04 0.05718842 BILD_HRAS_ONCOGENIC_SIGNATURE neuritis DOID_1803 9.046E-04 4.085E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE vascular skin disease DOID_9540 9.046E-04 4.053E-03 0.17227861 0.73704155 BILD_HRAS_ONCOGENIC_SIGNATURE stomach disease DOID_76 9.097E-04 4.044E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE mitochondrial encephalomyopathy DOID_890 9.097E-04 4.012E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE encephalitis DOID_9588 9.097E-04 3.982E-03 0.04434287 0.45055526 BILD_HRAS_ONCOGENIC_SIGNATURE glaucoma DOID_1686 1.014E-03 4.406E-03 0.17851944 0.74689385 BILD_HRAS_ONCOGENIC_SIGNATURE aortic aneurysm DOID_3627 1.072E-03 4.622E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cannabis dependence DOID_1849 1.072E-03 4.588E-03 1.072E-03 0.06101956 BILD_HRAS_ONCOGENIC_SIGNATURE vesiculobullous skin disease DOID_2731 1.072E-03 4.554E-03 1.072E-03 0.05547233 BILD_HRAS_ONCOGENIC_SIGNATURE hallucinogen dependence DOID_9977 1.072E-03 4.588E-03 1.072E-03 0.06101956 BILD_HRAS_ONCOGENIC_SIGNATURE hemorrhagic disease DOID_2213 1.132E-03 4.772E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE Legionnaires' disease DOID_10457 1.248E-03 5.222E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE legionellosis DOID_10458 1.248E-03 5.222E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE viral pneumonia DOID_10533 1.248E-03 5.183E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE hypercalcemia DOID_12678 1.248E-03 5.146E-03 1.248E-03 0.05917794 BILD_HRAS_ONCOGENIC_SIGNATURE sarcoidosis DOID_11335 1.258E-03 5.151E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE bile duct adenocarcinoma DOID_4896 1.325E-03 5.384E-03 0.19391786 0.79955989 BILD_HRAS_ONCOGENIC_SIGNATURE cholangiocarcinoma DOID_4947 1.325E-03 5.384E-03 0.19391786 0.79955989 BILD_HRAS_ONCOGENIC_SIGNATURE vasculitis DOID_865 1.325E-03 5.345E-03 0.0196928 0.32956484 BILD_HRAS_ONCOGENIC_SIGNATURE parasitic protozoa infectious disease DOID_2789 1.393E-03 5.582E-03 0.19696298 0.78923897 BILD_HRAS_ONCOGENIC_SIGNATURE idiopathic pulmonary fibrosis DOID_0050156 1.436E-03 5.716E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE thoracic aortic aneurysm DOID_14004 1.436E-03 5.676E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE oral submucous fibrosis DOID_5773 1.436E-03 5.637E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE intermediate coronary syndrome DOID_8805 1.436E-03 5.598E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE hyperhomocysteinemia DOID_9279 1.436E-03 5.56E-03 0.05512001 0.48251207 BILD_HRAS_ONCOGENIC_SIGNATURE hypersensitivity reaction type IV disease DOID_2916 1.611E-03 6.196E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE bile duct cancer DOID_4606 1.611E-03 6.154E-03 0.20602995 0.79749008 BILD_HRAS_ONCOGENIC_SIGNATURE bile duct carcinoma DOID_4897 1.611E-03 6.154E-03 0.20602995 0.79749008 BILD_HRAS_ONCOGENIC_SIGNATURE angiosarcoma DOID_0001816 1.638E-03 6.212E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE leukocyte disease DOID_9500 1.689E-03 6.364E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE neuroectodermal tumor DOID_171 1.85E-03 6.926E-03 1.85E-03 0.0751994 BILD_HRAS_ONCOGENIC_SIGNATURE bronchitis DOID_6132 1.851E-03 6.885E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE male reproductive organ benign neoplasm DOID_0060087 2.078E-03 7.677E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE ureteral obstruction DOID_5199 2.078E-03 7.627E-03 0.06577645 0.51269588 BILD_HRAS_ONCOGENIC_SIGNATURE parasitic infectious disease DOID_1398 2.201E-03 8.029E-03 0.22679281 0.86030071 BILD_HRAS_ONCOGENIC_SIGNATURE granulosa cell tumor DOID_2999 2.316E-03 8.395E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE leishmaniasis DOID_9065 2.316E-03 8.342E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE tooth disease DOID_1091 2.391E-03 8.557E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE amnestic disorder DOID_10914 2.567E-03 9.13E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE esophagitis DOID_11963 2.567E-03 9.074E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE sex cord-gonadal stromal tumor DOID_192 2.567E-03 9.018E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE brain edema DOID_4724 2.567E-03 8.962E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE subependymal glioma DOID_4843 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE pilocytic astrocytoma DOID_4851 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE subependymal giant cell astrocytoma DOID_5077 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE fibrillary astrocytoma DOID_6726 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE juvenile pilocytic astrocytoma DOID_6811 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE childhood pilocytic astrocytoma DOID_6812 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE gemistocytic astrocytoma DOID_7005 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE childhood cerebral astrocytoma DOID_7007 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE protoplasmic astrocytoma DOID_7008 2.567E-03 8.908E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE blood coagulation disease DOID_1247 2.695E-03 9.293E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE Kawasaki disease DOID_13378 2.831E-03 9.703E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE lymphadenitis DOID_1602 2.831E-03 9.703E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE mitochondrial myopathy DOID_699 2.831E-03 9.645E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE lymph node disease DOID_9942 2.831E-03 9.703E-03 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE benign glioma DOID_0060101 3.106E-03 0.01052 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE gastric ulcer DOID_10808 3.106E-03 0.01045775 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE neutropenia DOID_1227 3.106E-03 0.01039624 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE benign ependymoma DOID_4844 3.106E-03 0.01052 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE placenta disease DOID_780 3.106E-03 0.01033544 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE bone resorption disease DOID_0080011 3.37E-03 0.01114943 0.25833598 0.93626226 BILD_HRAS_ONCOGENIC_SIGNATURE osteoporosis DOID_11476 3.37E-03 0.01114943 0.25833598 0.93626226 BILD_HRAS_ONCOGENIC_SIGNATURE agranulocytosis DOID_12987 3.394E-03 0.01116132 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE muscle cancer DOID_4045 3.394E-03 0.01109717 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE polyarteritis nodosa DOID_9810 3.394E-03 0.01103376 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE diabetic angiopathy DOID_11713 3.693E-03 0.01193895 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE synostosis DOID_11971 3.693E-03 0.01187149 0.0867326 0.58059821 BILD_HRAS_ONCOGENIC_SIGNATURE ureteral disease DOID_1426 3.693E-03 0.0118048 0.0867326 0.57384706 BILD_HRAS_ONCOGENIC_SIGNATURE meningitis DOID_9471 3.693E-03 0.01173885 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE Goodpasture syndrome DOID_9808 3.693E-03 0.01167364 0.0867326 0.56725112 BILD_HRAS_ONCOGENIC_SIGNATURE acute pancreatitis DOID_2913 4.004E-03 0.01258754 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE auditory system disease DOID_2742 4.006E-03 0.01252348 0.04027901 0.4876331 BILD_HRAS_ONCOGENIC_SIGNATURE commensal bacterial infectious disease DOID_0050339 4.327E-03 0.01345425 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE osteosarcoma DOID_3347 4.327E-03 0.01338113 0.09361372 0.58534291 BILD_HRAS_ONCOGENIC_SIGNATURE autosomal dominant nonsyndromic deafness DOID_0050564 4.662E-03 0.01433812 4.662E-03 0.13960798 BILD_HRAS_ONCOGENIC_SIGNATURE papillary adenoma DOID_3172 4.662E-03 0.01426103 0.09703495 0.58118825 BILD_HRAS_ONCOGENIC_SIGNATURE microcystic adenoma DOID_5403 4.662E-03 0.01426103 0.09703495 0.58118825 BILD_HRAS_ONCOGENIC_SIGNATURE follicular adenoma DOID_6204 4.662E-03 0.01426103 0.09703495 0.58118825 BILD_HRAS_ONCOGENIC_SIGNATURE myositis DOID_633 4.662E-03 0.01418477 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE intracranial aneurysm DOID_10941 5.008E-03 0.01515725 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE seminoma DOID_4440 5.008E-03 0.01507705 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE lung adenocarcinoma DOID_3910 5.366E-03 0.016069 0.10383898 0.60911731 BILD_HRAS_ONCOGENIC_SIGNATURE perinatal necrotizing enterocolitis DOID_8677 5.366E-03 0.01598487 0.10383898 0.59681191 BILD_HRAS_ONCOGENIC_SIGNATURE multiple epiphyseal dysplasia DOID_12721 6.115E-03 0.01812296 0.1105921 0.62303865 BILD_HRAS_ONCOGENIC_SIGNATURE supratentorial cancer DOID_1659 6.115E-03 0.01802906 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE toxic encephalopathy DOID_3602 6.115E-03 0.01793612 0.1105921 0.61693043 BILD_HRAS_ONCOGENIC_SIGNATURE cerebrum cancer DOID_368 6.115E-03 0.01802906 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE female reproductive organ benign neoplasm DOID_0060086 6.507E-03 0.01898696 0.11394968 0.62343625 BILD_HRAS_ONCOGENIC_SIGNATURE uterine benign neoplasm DOID_0060095 6.507E-03 0.01898696 0.11394968 0.62343625 BILD_HRAS_ONCOGENIC_SIGNATURE uterine fibroid DOID_13223 6.507E-03 0.01898696 0.11394968 0.62343625 BILD_HRAS_ONCOGENIC_SIGNATURE age related macular degeneration DOID_10871 6.91E-03 0.02005938 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE degeneration of macula and posterior pole DOID_2007 6.91E-03 0.02005938 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE abdominal aortic aneurysm DOID_7693 6.91E-03 0.01995755 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE Charcot-Marie-Tooth disease DOID_10595 7.324E-03 0.02104597 0.12062714 0.64146582 BILD_HRAS_ONCOGENIC_SIGNATURE autonomic nervous system neoplasm DOID_2621 7.748E-03 0.02215476 0.1239471 0.65301762 BILD_HRAS_ONCOGENIC_SIGNATURE neuroblastoma DOID_769 7.748E-03 0.02215476 0.1239471 0.65301762 BILD_HRAS_ONCOGENIC_SIGNATURE myocarditis DOID_820 8.184E-03 0.02328338 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE metal metabolism disorder DOID_896 8.184E-03 0.02316754 8.184E-03 0.18626701 BILD_HRAS_ONCOGENIC_SIGNATURE thyroid carcinoma DOID_3963 8.63E-03 0.02431033 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE macular degeneration DOID_4448 8.63E-03 0.02419057 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE leukopenia DOID_615 8.63E-03 0.02407199 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE medullomyoblastoma DOID_3861 9.087E-03 0.02522332 9.087E-03 0.19887621 BILD_HRAS_ONCOGENIC_SIGNATURE adult medulloblastoma DOID_3864 9.087E-03 0.02522332 9.087E-03 0.19887621 BILD_HRAS_ONCOGENIC_SIGNATURE childhood medulloblastoma DOID_3869 9.087E-03 0.02522332 9.087E-03 0.19887621 BILD_HRAS_ONCOGENIC_SIGNATURE thyroid cancer DOID_1781 9.555E-03 0.02639278 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE pulmonary sarcoidosis DOID_13406 0.01003344 0.02757985 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE calcinosis DOID_182 0.01003344 0.02744725 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE medulloblastoma DOID_3858 0.01003344 0.02731593 0.01003344 0.2114455 BILD_HRAS_ONCOGENIC_SIGNATURE peripheral nervous system neoplasm DOID_1192 0.01052211 0.02850992 0.14360713 0.68093714 BILD_HRAS_ONCOGENIC_SIGNATURE hepatitis DOID_2237 0.01102114 0.02972051 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE lymphatic system disease DOID_75 0.01153043 0.03094725 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE benign mesothelioma DOID_2645 0.01204991 0.03218967 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE primitive neuroectodermal tumor DOID_168 0.01311909 0.03488206 0.01311909 0.25740553 BILD_HRAS_ONCOGENIC_SIGNATURE diabetic autonomic neuropathy DOID_11503 0.01366862 0.03617417 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE autonomic neuropathy DOID_11504 0.01366862 0.03617417 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE diabetic polyneuropathy DOID_12785 0.01366862 0.03617417 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE diabetic neuropathy DOID_9743 0.01366862 0.03617417 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE autonomic nervous system disease DOID_11465 0.01537604 0.04050447 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE withdrawal disorder DOID_0060001 0.01778682 0.04663916 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE osteochondrodysplasia DOID_2256 0.02034637 0.05310588 0.19696298 0.79483641 BILD_HRAS_ONCOGENIC_SIGNATURE smallpox DOID_8736 0.02034637 0.05286339 0.19696298 0.78371982 BILD_HRAS_ONCOGENIC_SIGNATURE mitochondrial metabolism disease DOID_700 0.02100892 0.0543367 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE nonsyndromic deafness DOID_0050563 0.02236068 0.05757117 0.02236068 0.353423 BILD_HRAS_ONCOGENIC_SIGNATURE retinitis pigmentosa DOID_10584 0.02236068 0.05731184 0.02236068 0.34387103 BILD_HRAS_ONCOGENIC_SIGNATURE melancholia DOID_2848 0.02304974 0.05881303 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE neurotic disorder DOID_4964 0.02374749 0.06032288 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE carotid artery disease DOID_3407 0.02445386 0.06184109 0.21499526 0.8265696 BILD_HRAS_ONCOGENIC_SIGNATURE congenital heart defect DOID_1682 0.02589213 0.06518858 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE nephrosis DOID_2527 0.03197513 0.08014911 0.2441598 0.90212289 BILD_HRAS_ONCOGENIC_SIGNATURE endogenous depression DOID_1595 0.03520664 0.08786219 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE syndrome DOID_225 0.03520664 0.08747851 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE congenital disorder of glycosylation type II DOID_0050571 0.03709039 0.09175841 0.03709039 0.47964621 BILD_HRAS_ONCOGENIC_SIGNATURE hyperparathyroidism DOID_13543 0.03709039 0.09136118 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE chondrosarcoma DOID_3371 0.03709039 0.09096738 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE Noonan syndrome DOID_3490 0.03709039 0.09057697 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE insulinoma DOID_3892 0.03709039 0.09018989 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE hypokalemia DOID_4500 0.03709039 0.0898061 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE holoprosencephaly DOID_4621 0.03709039 0.08942556 0.03709039 0.46898741 BILD_HRAS_ONCOGENIC_SIGNATURE keratitis DOID_4677 0.03709039 0.08904824 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE cannabis abuse DOID_9505 0.03709039 0.08867409 0.03709039 0.45879203 BILD_HRAS_ONCOGENIC_SIGNATURE Charcot-Marie-Tooth disease type 4 DOID_0050541 0.04072344 0.09695245 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE migraine without aura DOID_12783 0.04072344 0.09654849 0.04072344 0.48274243 BILD_HRAS_ONCOGENIC_SIGNATURE temporal arteritis DOID_13375 0.04072344 0.09614787 0.04072344 0.47289054 BILD_HRAS_ONCOGENIC_SIGNATURE craniosynostosis DOID_2340 0.04072344 0.09575056 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE hemochromatosis DOID_2352 0.04072344 0.09535653 0.04072344 0.46343273 BILD_HRAS_ONCOGENIC_SIGNATURE prostatic adenoma DOID_2883 0.04072344 0.09496572 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE central nervous system vasculitis DOID_525 0.04072344 0.09614787 0.04072344 0.47289054 BILD_HRAS_ONCOGENIC_SIGNATURE eosinophilic pneumonia DOID_5870 0.04072344 0.09457811 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE pulmonary eosinophilia DOID_9498 0.04072344 0.09457811 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE Loeffler syndrome DOID_9503 0.04072344 0.09457811 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE bronchiectasis DOID_9563 0.04072344 0.09419364 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE mental depression DOID_1596 0.0411498 0.09479449 1.000 1.000 BILD_HRAS_ONCOGENIC_SIGNATURE peritonitis DOID_8283 0.04434287 0.09972765 1.000 1.000 VALK_AML_CLUSTER_2 respiratory syncytial virus infectious disease DOID_1273 1.612E-04 0.09174521 1.000 1.000 VALK_AML_CLUSTER_2 adenoid cystic carcinoma DOID_4866 1.691E-04 0.04809761 1.691E-04 0.09619521 VALK_AML_CLUSTER_2 salivary gland cancer DOID_8850 1.853E-04 0.03513586 1.853E-04 0.05270379 VALK_AML_CLUSTER_2 oral cavity cancer DOID_8618 3.41E-04 0.04850604 3.41E-04 0.06467471 VALK_AML_CLUSTER_2 leukocyte disease DOID_9500 3.523E-04 0.04008775 1.000 1.000 VALK_AML_CLUSTER_2 allergic contact dermatitis DOID_3042 4.489E-04 0.04257359 0.03093633 0.39117267 VALK_AML_CLUSTER_2 contact dermatitis DOID_2773 6.154E-04 0.05002322 0.03614839 0.38089697 VALK_AML_CLUSTER_2 encephalomyelitis DOID_640 8.246E-04 0.05864682 0.04176502 0.40972927 BROWNE_HCMV_INFECTION_48HR_UP pre-malignant neoplasm DOID_0060071 4.534E-07 2.58E-04 4.534E-07 2.58E-04 BROWNE_HCMV_INFECTION_48HR_UP in situ carcinoma DOID_8719 4.534E-07 2.58E-04 4.534E-07 2.58E-04 BROWNE_HCMV_INFECTION_48HR_UP endometriosis DOID_289 3.922E-06 1.116E-03 1.65E-04 0.03129217 BROWNE_HCMV_INFECTION_48HR_UP allergic contact dermatitis DOID_3042 2.113E-05 4.007E-03 5.718E-04 0.04066769 BROWNE_HCMV_INFECTION_48HR_UP sphingolipidosis DOID_1927 2.588E-05 3.682E-03 1.509E-03 0.04519223 BROWNE_HCMV_INFECTION_48HR_UP contact dermatitis DOID_2773 3.947E-05 4.492E-03 9.069E-04 0.04691039 BROWNE_HCMV_INFECTION_48HR_UP female reproductive system disease DOID_229 4.14E-05 3.926E-03 9.393E-04 0.04454013 BROWNE_HCMV_INFECTION_48HR_UP cervix uteri carcinoma in situ DOID_8991 1.444E-04 0.01173939 1.444E-04 0.04108786 BROWNE_HCMV_INFECTION_48HR_UP endometriosis of uterus DOID_288 1.545E-04 0.01098746 4.834E-03 0.09823156 BROWNE_HCMV_INFECTION_48HR_UP neuronal ceroid lipofuscinosis DOID_14503 2.825E-04 0.01786027 2.825E-04 0.04018561 BROWNE_HCMV_INFECTION_48HR_UP Hirschsprung's disease DOID_10487 3.994E-04 0.02272821 3.994E-04 0.04545641 BROWNE_HCMV_INFECTION_48HR_UP megacolon DOID_11372 4.653E-04 0.02406971 4.653E-04 0.04412779 BROWNE_HCMV_INFECTION_48HR_UP T-cell leukemia DOID_715 4.653E-04 0.0220639 4.653E-04 0.03782382 BROWNE_HCMV_INFECTION_48HR_UP uterine disease DOID_345 5.252E-04 0.02298814 0.01075003 0.16531799 BROWNE_HCMV_INFECTION_48HR_UP hyperostosis DOID_205 6.923E-04 0.02813767 6.923E-04 0.04376971 BROWNE_HCMV_INFECTION_48HR_UP conduct disorder DOID_12995 8.679E-04 0.032922 8.679E-04 0.049383 BROWNE_HCMV_INFECTION_48HR_UP colonic disease DOID_5353 9.629E-04 0.03424263 9.629E-04 0.04214478 BROWNE_HCMV_INFECTION_48HR_UP bone development disease DOID_0080006 1.041E-03 0.03484597 1.041E-03 0.04231296 BROWNE_HCMV_INFECTION_48HR_UP amino acid metabolic disorder DOID_9252 1.226E-03 0.03874563 1.226E-03 0.04649475 BROWNE_HCMV_INFECTION_48HR_UP urinary tract obstruction DOID_5200 1.276E-03 0.03822589 1.276E-03 0.04539325 BROWNE_HCMV_INFECTION_48HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.43E-03 0.04067543 1.43E-03 0.04785345 BROWNE_HCMV_INFECTION_48HR_UP dilated cardiomyopathy DOID_12930 1.473E-03 0.03990898 1.473E-03 0.04656047 BROWNE_HCMV_INFECTION_48HR_UP morbid obesity DOID_11981 1.76E-03 0.04552881 1.76E-03 0.05008169 BROWNE_HCMV_INFECTION_48HR_UP ankylosing spondylitis DOID_7147 1.76E-03 0.0435493 0.06016732 0.43891288 BROWNE_HCMV_INFECTION_48HR_UP perinatal necrotizing enterocolitis DOID_8677 2.03E-03 0.04813078 2.03E-03 0.05500661 BROWNE_HCMV_INFECTION_48HR_UP multiple epiphyseal dysplasia DOID_12721 2.318E-03 0.05276279 2.318E-03 0.05995771 BROWNE_HCMV_INFECTION_48HR_UP lymphoid leukemia DOID_10747 3.468E-03 0.07590556 3.468E-03 0.08580629 BROWNE_HCMV_INFECTION_48HR_UP medullomyoblastoma DOID_3861 3.468E-03 0.07309425 3.468E-03 0.08223103 BROWNE_HCMV_INFECTION_48HR_UP adult medulloblastoma DOID_3864 3.468E-03 0.07309425 3.468E-03 0.08223103 BROWNE_HCMV_INFECTION_48HR_UP childhood medulloblastoma DOID_3869 3.468E-03 0.07309425 3.468E-03 0.08223103 BROWNE_HCMV_INFECTION_48HR_UP medulloblastoma DOID_3858 3.837E-03 0.07797167 3.837E-03 0.08732827 BROWNE_HCMV_INFECTION_48HR_UP embryonal cancer DOID_688 3.837E-03 0.075283 3.837E-03 0.08396949 BROWNE_HCMV_INFECTION_48HR_UP intracranial arterial disease DOID_13089 4.422E-03 0.08387463 0.09411844 0.51493647 BROWNE_HCMV_INFECTION_48HR_UP cerebral arterial disease DOID_3527 4.422E-03 0.08387463 0.09411844 0.51493647 BROWNE_HCMV_INFECTION_48HR_UP spinocerebellar ataxia DOID_1441 4.834E-03 0.08872528 4.834E-03 0.10186976 BROWNE_HCMV_INFECTION_48HR_UP primitive neuroectodermal tumor DOID_168 5.046E-03 0.0897262 5.046E-03 0.09900822 BROWNE_HCMV_INFECTION_48HR_UP gallbladder cancer DOID_3121 5.263E-03 0.09073939 0.10241501 0.52976491 BROWNE_HCMV_INFECTION_48HR_UP cataract DOID_83 5.483E-03 0.09176341 5.483E-03 0.10399853 BROWNE_HCMV_INFECTION_48HR_UP spinocerebellar degeneration DOID_2478 5.708E-03 0.09279702 5.708E-03 0.10477082 BROWNE_HCMV_INFECTION_48HR_UP lens disease DOID_110 5.937E-03 0.0938391 5.937E-03 0.10556898 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN common cold DOID_10459 5.043E-06 2.87E-03 3.477E-03 0.21981049 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN urticaria DOID_1555 2.478E-05 7.05E-03 7.519E-03 0.23768891 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN papillary adenoma DOID_3172 2.676E-05 5.075E-03 7.807E-03 0.23380888 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN microcystic adenoma DOID_5403 2.676E-05 5.075E-03 7.807E-03 0.23380888 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN follicular adenoma DOID_6204 2.676E-05 5.075E-03 7.807E-03 0.23380888 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN papilloma DOID_2615 4.796E-05 6.822E-03 0.01039743 0.20400471 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN adenoma DOID_657 5.638E-05 6.416E-03 0.01125943 0.20666499 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN neuritis DOID_1803 9.305E-05 8.824E-03 9.305E-05 0.05294468 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN thyroid adenoma DOID_2891 9.305E-05 7.564E-03 0.01441426 0.24122687 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN vascular skin disease DOID_9540 9.305E-05 6.618E-03 0.01441426 0.23433468 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN endocrine organ benign neoplasm DOID_0060089 1.881E-04 0.01189396 0.02041172 0.27653021 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN brain infarction DOID_3454 1.881E-04 0.01070457 0.02041172 0.27009928 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN peripheral vascular disease DOID_341 2.1E-04 0.0108602 0.02155033 0.27249189 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN bacterial pneumonia DOID_874 2.389E-04 0.01132739 0.02297189 0.2723126 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN encephalomyelitis DOID_640 3.367E-04 0.0147391 3.367E-04 0.09580415 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN hypersensitivity reaction type I disease DOID_1205 3.51E-04 0.01426725 3.51E-04 0.06658051 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN tic disorder DOID_2769 3.477E-03 0.09891472 3.477E-03 0.19782944 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP glioblastoma DOID_3068 8.717E-12 4.96E-09 8.717E-12 4.96E-09 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP encephalomyelitis DOID_640 3.943E-11 1.122E-08 2.37E-07 1.927E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP astrocytoma DOID_3069 4.865E-11 9.227E-09 4.865E-11 1.384E-08 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP giant cell tumor DOID_200 3.456E-09 4.915E-07 3.456E-09 6.554E-07 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP malignant giant cell tumor DOID_2705 3.456E-09 4.915E-07 3.456E-09 6.554E-07 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP giant cell glioblastoma DOID_3074 3.456E-09 4.915E-07 3.456E-09 6.554E-07 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP nephroblastoma DOID_2154 4.336E-09 4.934E-07 4.336E-09 6.168E-07 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bone development disease DOID_0080006 6.035E-09 5.723E-07 6.035E-09 6.868E-07 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP aneurysm disease DOID_2403 5.57E-08 4.528E-06 1.883E-03 0.01164561 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP female reproductive system disease DOID_229 8.232E-08 5.855E-06 1.351E-06 5.492E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pneumoconiosis DOID_10316 1.517E-07 9.59E-06 1.027E-04 1.329E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP oral cavity cancer DOID_8618 1.606E-07 9.138E-06 1.606E-07 1.523E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP membranous glomerulonephritis DOID_10976 1.713E-07 8.862E-06 0.12397259 0.24324278 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP lymphoma DOID_0060058 2.183E-07 1.035E-05 3.132E-06 9.381E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cholestasis DOID_13580 3.431E-07 1.502E-05 8.9E-05 1.235E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP uterine disease DOID_345 3.431E-07 1.395E-05 6.021E-06 1.557E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP synostosis DOID_11971 4.597E-07 1.744E-05 4.597E-07 3.269E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP endometriosis of uterus DOID_288 5.085E-07 1.808E-05 1.18E-05 2.798E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pancreatic ductal carcinoma DOID_3587 5.608E-07 1.877E-05 5.608E-07 3.545E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP endometriosis DOID_289 5.816E-07 1.838E-05 1.317E-05 2.775E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bile duct disease DOID_4138 6.159E-07 1.844E-05 1.332E-04 1.579E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP gallbladder cancer DOID_3121 6.63E-07 1.886E-05 1.466E-05 2.979E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP uterine cancer DOID_363 6.63E-07 1.797E-05 1.466E-05 2.876E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP biliary tract disease DOID_9741 6.755E-07 1.747E-05 1.419E-04 1.584E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pancreatic carcinoma DOID_4905 7.399E-07 1.83E-05 7.399E-07 4.21E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP learning disability DOID_8927 7.536E-07 1.787E-05 7.536E-07 3.898E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP ankylosing spondylitis DOID_7147 8.59E-07 1.955E-05 7.372E-04 5.448E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cleft lip DOID_9296 8.59E-07 1.88E-05 8.59E-07 4.073E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pancreatitis DOID_4989 1.051E-06 2.216E-05 1.051E-06 4.602E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hemolytic anemia DOID_583 1.088E-06 2.211E-05 2.197E-05 3.907E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP normocytic anemia DOID_720 1.088E-06 2.211E-05 2.197E-05 3.907E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autoimmune disease of the nervous system DOID_438 1.492E-06 2.928E-05 4.421E-05 6.289E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP biliary tract cancer DOID_4607 1.588E-06 3.013E-05 2.191E-05 4.022E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autoimmune disease of endocrine system DOID_0060005 1.77E-06 3.248E-05 1.111E-03 7.805E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP toxic encephalopathy DOID_3602 1.77E-06 3.146E-05 1.77E-06 6.712E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP sarcoidosis DOID_11335 1.908E-06 3.29E-05 5.18E-04 4.211E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP dysostosis DOID_1934 2.086E-06 3.491E-05 2.086E-06 7.418E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP primary bacterial infectious disease DOID_0050338 2.168E-06 3.525E-05 2.907E-03 0.01490244 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP transitional cell carcinoma DOID_2671 2.338E-06 3.695E-05 2.338E-06 7.826E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP communication disorder DOID_2033 2.38E-06 3.66E-05 2.38E-06 7.524E-05 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP Human immunodeficiency virus infectious disease DOID_526 2.711E-06 4.059E-05 3.693E-04 3.184E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP silicosis DOID_10325 3.157E-06 4.606E-05 1.489E-04 1.629E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hypersensitivity reaction type IV disease DOID_2916 3.174E-06 4.515E-05 7.173E-04 5.591E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP mouth disease DOID_403 3.607E-06 5.006E-05 3.607E-06 1.026E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hypersensitivity reaction type I disease DOID_1205 3.866E-06 5.237E-05 3.96E-03 0.01893588 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP neuroectodermal tumor DOID_171 4.216E-06 5.579E-05 4.216E-06 1.142E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP embryonal cancer DOID_688 6.529E-06 8.443E-05 1.4E-04 1.593E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP brain infarction DOID_3454 7.749E-06 9.799E-05 1.269E-03 8.493E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP adenoid cystic carcinoma DOID_4866 9.398E-06 1.163E-04 9.398E-06 2.325E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cervix uteri carcinoma in situ DOID_8991 1.055E-05 1.277E-04 2.037E-04 1.998E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP salivary gland cancer DOID_8850 1.18E-05 1.399E-04 1.18E-05 2.686E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP primitive neuroectodermal tumor DOID_168 1.317E-05 1.529E-04 1.317E-05 2.882E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP syndrome DOID_225 1.337E-05 1.522E-04 1.709E-04 1.8E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP myasthenia gravis DOID_437 1.481E-05 1.653E-04 4.551E-04 3.808E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP mixed glioma DOID_5076 1.547E-05 1.693E-04 1.925E-04 1.922E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP congenital hemolytic anemia DOID_589 1.768E-05 1.898E-04 1.768E-05 3.354E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP thyroid adenoma DOID_2891 1.992E-05 2.099E-04 3.35E-04 2.979E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP heart valve disease DOID_4079 1.992E-05 2.061E-04 3.35E-04 2.933E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP focal epilepsy DOID_2234 2.191E-05 2.226E-04 2.461E-03 0.01359348 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.418E-05 2.414E-04 4.935E-03 0.02193608 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP aortic aneurysm DOID_3627 2.655E-05 2.605E-04 0.0479027 0.14122611 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP movement disease DOID_480 2.655E-05 2.561E-04 2.655E-05 4.578E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP neuromuscular junction disease DOID_439 2.875E-05 2.727E-04 7.372E-04 5.519E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP B-cell lymphocytic neoplasm DOID_707 2.911E-05 2.715E-04 4.507E-04 3.827E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP orofacial cleft DOID_0050567 3.185E-05 2.923E-04 3.185E-05 5.329E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP Sjogren's syndrome DOID_12894 3.286E-05 2.968E-04 0.06402844 0.18035735 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP angioedema DOID_1558 3.286E-05 2.921E-04 1.882E-03 0.01203365 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP atrophic muscular disease DOID_913 3.478E-05 3.045E-04 3.478E-05 5.654E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP muscular dystrophy DOID_9884 3.478E-05 3.045E-04 3.478E-05 5.654E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP diffuse large B-cell lymphoma DOID_0050745 3.851E-05 3.32E-04 3.851E-05 6.087E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP osteochondrodysplasia DOID_2256 4.128E-05 3.505E-04 4.128E-05 6.348E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP Crohn's disease DOID_8778 4.373E-05 3.659E-04 4.373E-05 6.547E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP invasive ductal carcinoma DOID_3008 4.421E-05 3.646E-04 4.421E-05 6.45E-04 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bile duct cancer DOID_4606 5.274E-05 4.287E-04 7.173E-04 5.516E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bile duct carcinoma DOID_4897 5.274E-05 4.287E-04 7.173E-04 5.516E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP endometrial carcinoma DOID_2871 5.741E-05 4.601E-04 1.22E-03 8.364E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP celiac disease DOID_10608 7.328E-05 5.791E-04 0.02115156 0.0720673 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP endometrial cancer DOID_1380 7.328E-05 5.712E-04 1.458E-03 9.645E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pre-malignant neoplasm DOID_0060071 7.713E-05 5.93E-04 9.655E-04 6.867E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP in situ carcinoma DOID_8719 7.713E-05 5.93E-04 9.655E-04 6.867E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP systemic mycosis DOID_0050136 9.212E-05 6.988E-04 0.02354995 0.07790651 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP fungal infectious disease DOID_1564 9.212E-05 6.988E-04 0.02354995 0.07790651 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP papilloma DOID_2615 9.212E-05 6.897E-04 9.212E-05 1.248E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP temporal lobe epilepsy DOID_3328 9.545E-05 7.053E-04 0.01078038 0.04259746 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP narcolepsy DOID_8986 9.774E-05 7.13E-04 0.0884813 0.19743475 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP tooth disease DOID_1091 1.022E-04 7.364E-04 1.022E-04 1.353E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP spindle cell carcinoma DOID_4015 1.027E-04 7.308E-04 1.027E-04 1.299E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hyperthyroidism DOID_7998 1.027E-04 7.218E-04 1.027E-04 1.271E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP endocrine organ benign neoplasm DOID_0060089 1.094E-04 7.591E-04 1.269E-03 8.594E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP tuberculosis DOID_399 1.094E-04 7.5E-04 0.08005252 0.19549305 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP thalassemia DOID_10241 1.216E-04 8.235E-04 1.216E-04 1.472E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pulmonary sarcoidosis DOID_13406 1.4E-04 9.371E-04 2.338E-03 0.01330215 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP medulloblastoma DOID_3858 1.4E-04 9.262E-04 1.4E-04 1.626E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP thyroiditis DOID_7166 1.489E-04 9.739E-04 0.10046806 0.21172713 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autoimmune thyroiditis DOID_7188 1.489E-04 9.739E-04 0.10046806 0.21172713 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hepatitis DOID_2237 1.697E-04 1.097E-03 2.69E-03 0.01444096 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP endogenous depression DOID_1595 1.709E-04 1.092E-03 1.709E-04 1.834E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bronchitis DOID_6132 1.799E-04 1.138E-03 1.799E-04 1.861E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP electroclinical syndrome DOID_0050701 1.925E-04 1.204E-03 1.925E-04 1.956E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP benign mesothelioma DOID_2645 2.037E-04 1.26E-03 3.074E-03 0.01561561 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP prion disease DOID_649 2.149E-04 1.315E-03 6.181E-03 0.02644366 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP uveal disease DOID_3480 2.423E-04 1.467E-03 0.03706816 0.11462927 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP testicular cancer DOID_2998 2.539E-04 1.521E-03 2.539E-04 2.449E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP mental depression DOID_1596 2.557E-04 1.516E-03 2.557E-04 2.425E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP influenza DOID_8469 2.635E-04 1.546E-03 0.03855079 0.11856973 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cataract DOID_83 2.86E-04 1.661E-03 2.86E-04 2.668E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP colon carcinoma DOID_1520 2.973E-04 1.709E-03 2.973E-04 2.728E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP proteinuria DOID_576 3.098E-04 1.763E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP lens disease DOID_110 3.35E-04 1.887E-03 3.35E-04 3.026E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP nervous system cancer DOID_3093 3.693E-04 2.06E-03 3.276E-03 0.01593328 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.494E-04 2.482E-03 0.02584308 0.08402692 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP sleep disorder DOID_535 4.551E-04 2.49E-03 0.14119864 0.26170042 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP dilated cardiomyopathy DOID_12930 4.713E-04 2.554E-03 3.96E-03 0.01877808 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP aortic valve disease DOID_62 5.176E-04 2.778E-03 5.176E-04 4.268E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP Goodpasture syndrome DOID_9808 5.176E-04 2.753E-03 0.14686536 0.26956899 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bile duct adenocarcinoma DOID_4896 5.543E-04 2.92E-03 5.543E-04 4.442E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cholangiocarcinoma DOID_4947 5.543E-04 2.92E-03 5.543E-04 4.442E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bone marrow cancer DOID_4960 5.543E-04 2.893E-03 6.378E-03 0.02708199 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP sphingolipidosis DOID_1927 5.853E-04 3.028E-03 0.01175812 0.04614048 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pustulosis of palm and sole DOID_4398 5.923E-04 3.036E-03 0.05625554 0.16248427 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP urticaria DOID_1555 6.585E-04 3.345E-03 0.01268309 0.0494293 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP osteosarcoma DOID_3347 6.585E-04 3.316E-03 6.585E-04 5.204E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP congenital nervous system abnormality DOID_2490 6.737E-04 3.363E-03 7.352E-03 0.03075963 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP papillary adenoma DOID_3172 7.372E-04 3.647E-03 7.372E-04 5.593E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP microcystic adenoma DOID_5403 7.372E-04 3.647E-03 7.372E-04 5.593E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP follicular adenoma DOID_6204 7.372E-04 3.647E-03 7.372E-04 5.593E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP myositis DOID_633 7.372E-04 3.616E-03 0.16364301 0.29559641 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP melancholia DOID_2848 7.629E-04 3.71E-03 7.629E-04 5.565E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP neurotic disorder DOID_4964 8.104E-04 3.908E-03 8.104E-04 5.837E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hypothyroidism DOID_1459 9.117E-04 4.359E-03 9.162E-03 0.03805084 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP mineral metabolism disease DOID_0050032 1.022E-03 4.844E-03 9.952E-03 0.04016 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP parasitic infectious disease DOID_1398 1.08E-03 5.078E-03 0.0743171 0.19047943 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP multiple epiphyseal dysplasia DOID_12721 1.111E-03 5.182E-03 1.111E-03 7.71E-03 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP age related macular degeneration DOID_10871 1.336E-03 6.178E-03 0.19621876 0.33228712 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP degeneration of macula and posterior pole DOID_2007 1.336E-03 6.178E-03 0.19621876 0.33228712 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP opportunistic mycosis DOID_2473 1.336E-03 6.129E-03 0.0199931 0.06936631 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP abdominal aortic aneurysm DOID_7693 1.336E-03 6.08E-03 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP nephrosis DOID_2527 1.479E-03 6.681E-03 0.01302214 0.05006483 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP peripheral vascular disease DOID_341 1.555E-03 6.966E-03 0.01349994 0.05155347 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP chronic leukemia DOID_1036 1.587E-03 7.053E-03 0.02233731 0.0752067 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP chronic lymphocytic leukemia DOID_1040 1.587E-03 7.053E-03 0.02233731 0.0752067 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autonomic nervous system neoplasm DOID_2621 1.587E-03 6.999E-03 1.587E-03 0.01037719 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP neuroblastoma DOID_769 1.587E-03 6.999E-03 1.587E-03 0.01037719 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP macular degeneration DOID_4448 1.865E-03 8.165E-03 0.21723069 0.35931471 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP Gilles de la Tourette syndrome DOID_11119 1.882E-03 8.176E-03 1.882E-03 0.0121704 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP polycythemia DOID_8432 1.882E-03 8.114E-03 1.882E-03 0.01189994 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cannabis abuse DOID_9505 1.882E-03 8.053E-03 1.882E-03 0.01176917 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bacterial pneumonia DOID_874 1.972E-03 8.373E-03 0.01603774 0.05775616 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP medullomyoblastoma DOID_3861 2.016E-03 8.495E-03 2.016E-03 0.0123318 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP adult medulloblastoma DOID_3864 2.016E-03 8.495E-03 2.016E-03 0.0123318 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP childhood medulloblastoma DOID_3869 2.016E-03 8.495E-03 2.016E-03 0.0123318 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP contact dermatitis DOID_2773 2.159E-03 9.031E-03 2.159E-03 0.01306582 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP adenoma DOID_657 2.173E-03 9.025E-03 2.173E-03 0.01301498 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP chromosomal disease DOID_0080014 2.256E-03 9.303E-03 2.256E-03 0.01337274 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP breast benign neoplasm DOID_0060082 2.291E-03 9.376E-03 2.291E-03 0.01343617 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP thoracic benign neoplasm DOID_0060097 2.291E-03 9.376E-03 2.291E-03 0.01343617 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP temporal arteritis DOID_13375 2.291E-03 9.309E-03 0.07020224 0.18323428 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP benign breast phyllodes tumor DOID_1631 2.291E-03 9.376E-03 2.291E-03 0.01343617 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP craniosynostosis DOID_2340 2.291E-03 9.243E-03 2.291E-03 0.01329907 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP central nervous system vasculitis DOID_525 2.291E-03 9.309E-03 0.07020224 0.18323428 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP speech disorder DOID_92 2.291E-03 9.178E-03 2.291E-03 0.01316474 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cleft palate DOID_674 2.338E-03 9.302E-03 2.338E-03 0.01317045 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP multiple myeloma DOID_9538 2.338E-03 9.238E-03 0.02866131 0.09213721 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP alcohol abuse DOID_1574 2.461E-03 9.656E-03 2.461E-03 0.01372675 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP chronic kidney failure DOID_784 2.461E-03 9.59E-03 0.01882526 0.06653151 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP peripheral nervous system neoplasm DOID_1192 2.51E-03 9.716E-03 2.51E-03 0.01373365 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP uveitis DOID_13141 2.51E-03 9.651E-03 0.23769547 0.38314086 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP retinal vascular disease DOID_2462 2.678E-03 0.01022498 2.678E-03 0.01450973 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP beta thalassemia DOID_12241 2.737E-03 0.01038121 2.737E-03 0.0145531 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP relapsing-remitting multiple sclerosis DOID_2378 2.737E-03 0.01031247 0.07633547 0.18884731 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP epidermolysis bullosa DOID_2730 2.737E-03 0.01024462 2.737E-03 0.01441835 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP tic disorder DOID_2769 2.737E-03 0.01017766 2.737E-03 0.01428608 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP aortic valve insufficiency DOID_57 2.737E-03 0.01011157 2.737E-03 0.0141562 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP adult respiratory distress syndrome DOID_11394 2.878E-03 0.01056519 0.03275776 0.1047144 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP lymphatic system disease DOID_75 2.878E-03 0.01049747 0.03275776 0.1041294 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP primary immunodeficiency disease DOID_612 3.15E-03 0.01141579 0.02250206 0.07487529 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP amino acid metabolic disorder DOID_9252 3.15E-03 0.01134353 3.15E-03 0.01586087 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP infancy electroclinical syndrome DOID_0050703 3.22E-03 0.01152404 3.22E-03 0.01607301 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP berylliosis DOID_10322 3.22E-03 0.01145202 0.0824284 0.19873627 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP carotid stenosis DOID_13001 3.22E-03 0.01138089 0.0824284 0.195424 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP polyneuropathy DOID_1389 3.22E-03 0.01131063 0.0824284 0.19461312 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cannabis dependence DOID_1849 3.22E-03 0.01124124 3.22E-03 0.01593324 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP larynx cancer DOID_2596 3.22E-03 0.0111727 0.0824284 0.19222033 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP laryngeal benign neoplasm DOID_2598 3.22E-03 0.0111727 0.0824284 0.19222033 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP vesiculobullous skin disease DOID_2731 3.22E-03 0.01110499 3.22E-03 0.01579588 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hallucinogen dependence DOID_9977 3.22E-03 0.01124124 3.22E-03 0.01593324 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP idiopathic generalized epilepsy DOID_1827 3.489E-03 0.01195975 0.03706816 0.11588893 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP diabetic autonomic neuropathy DOID_11503 3.709E-03 0.01263748 3.709E-03 0.01788524 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autonomic neuropathy DOID_11504 3.709E-03 0.01263748 3.709E-03 0.01788524 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP diabetic polyneuropathy DOID_12785 3.709E-03 0.01263748 3.709E-03 0.01788524 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP diabetic neuropathy DOID_9743 3.709E-03 0.01263748 3.709E-03 0.01788524 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cerebral infarction DOID_3526 3.937E-03 0.01333516 0.04005573 0.12253606 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP idiopathic pulmonary fibrosis DOID_0050156 4.297E-03 0.01446894 0.09449444 0.21002865 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP peripheral neuropathy DOID_0060053 4.297E-03 0.01438383 4.297E-03 0.02020868 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP nutritional deficiency disease DOID_5113 4.297E-03 0.01429971 4.297E-03 0.02004304 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP ulcerative colitis DOID_8577 4.414E-03 0.01460138 4.414E-03 0.02041819 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP myeloma DOID_0070004 4.419E-03 0.01453376 0.0431311 0.13123849 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pre-eclampsia DOID_10591 4.419E-03 0.01445023 4.419E-03 0.02027694 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autonomic nervous system disease DOID_11465 4.419E-03 0.01436766 4.419E-03 0.02011472 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bone marrow disease DOID_4961 4.419E-03 0.01428602 4.419E-03 0.01995508 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP vascular skin disease DOID_9540 4.419E-03 0.01420531 0.0431311 0.13054041 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hemolytic-uremic syndrome DOID_12554 4.89E-03 0.01563184 0.10046806 0.21330719 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP tongue cancer DOID_8649 4.89E-03 0.01554452 4.89E-03 0.0219092 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP glaucoma DOID_1686 4.935E-03 0.01559899 0.04629149 0.13863084 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pulmonary tuberculosis DOID_2957 4.935E-03 0.01551281 0.04629149 0.13790502 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP lymphatic system cancer DOID_0060073 5.518E-03 0.01725172 0.10640243 0.2201563 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP schizophreniform disorder DOID_11328 5.518E-03 0.01715745 5.518E-03 0.02433964 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP Graves' disease DOID_12361 5.518E-03 0.0170642 5.518E-03 0.02415241 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP schizoaffective disorder DOID_5418 5.518E-03 0.01715745 5.518E-03 0.02433964 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP juvenile rheumatoid arthritis DOID_676 5.518E-03 0.01697196 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP reticulosarcoma DOID_8538 5.518E-03 0.01725172 0.10640243 0.2201563 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP lymphosarcoma DOID_8675 5.518E-03 0.01725172 0.10640243 0.2201563 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP adrenal gland disease DOID_9553 5.518E-03 0.01688072 0.10640243 0.21699994 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP congenital muscular dystrophy DOID_0050557 6.181E-03 0.01880752 6.181E-03 0.02684738 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP glucose intolerance DOID_10603 6.181E-03 0.01870748 0.11229781 0.22739307 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP dental caries DOID_216 6.181E-03 0.0186085 6.181E-03 0.02664399 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP eosinophilia DOID_999 6.181E-03 0.01851056 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP vasculitis DOID_865 6.378E-03 0.01899993 0.0545465 0.15916389 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP reproductive organ benign neoplasm DOID_0050622 6.693E-03 0.0198362 6.693E-03 0.02821148 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP parasitic protozoa infectious disease DOID_2789 6.693E-03 0.01973342 0.31888978 0.49576035 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP amyloidosis DOID_9120 7.61E-03 0.02231879 0.12397259 0.23912002 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP leukocyte disease DOID_9500 8.048E-03 0.02348279 0.33670657 0.52061423 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autoimmune hepatitis DOID_2048 8.374E-03 0.02431095 0.12975251 0.2485831 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP carotid artery disease DOID_3407 8.781E-03 0.02536198 0.06688917 0.18210496 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP respiratory failure DOID_11162 9.162E-03 0.02632811 0.06872179 0.18620332 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hepatitis B DOID_2043 9.172E-03 0.02622519 9.172E-03 0.03781748 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP muscular atrophy DOID_767 9.172E-03 0.02609406 9.172E-03 0.03754541 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP congenital heart defect DOID_1682 9.552E-03 0.02704 9.552E-03 0.03882172 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP uremia DOID_4676 0.01000207 0.02817415 0.14119864 0.26341649 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP lingual-facial-buccal dyskinesia DOID_9854 0.01000207 0.02803537 0.01000207 0.04007873 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cerebral degeneration DOID_1443 0.01036125 0.02889976 0.01036125 0.04122763 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hyperglycemia DOID_4195 0.01078038 0.02992212 0.07621372 0.19446461 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP spastic quadriplegia DOID_10970 0.01175812 0.03247752 0.15249482 0.27900178 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hypogonadism DOID_1924 0.01268309 0.03486318 0.01268309 0.04909305 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cystitis DOID_1679 0.01363876 0.03730988 0.01363876 0.05173637 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP diabetic retinopathy DOID_8947 0.01398764 0.03808117 0.01398764 0.05270837 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP intracranial aneurysm DOID_10941 0.01462469 0.03962596 0.01462469 0.05474639 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP teeth hard tissue disease DOID_214 0.01462469 0.03943816 0.01462469 0.05438857 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP middle cerebral artery infarction DOID_3525 0.01462469 0.03925213 0.1691622 0.30268331 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP seminoma DOID_4440 0.01462469 0.03906785 0.01462469 0.0540354 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP juvenile myoclonic epilepsy DOID_4890 0.01462469 0.03888529 0.01462469 0.05368678 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP fragments of torsion dystonia DOID_531 0.01462469 0.03870442 0.01462469 0.05334264 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP perinatal necrotizing enterocolitis DOID_8677 0.01564045 0.041201 0.01564045 0.05668418 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pleurisy DOID_10247 0.01668559 0.04375163 0.180092 0.31627268 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP malaria DOID_12365 0.01668559 0.04355093 0.180092 0.3133711 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP mononeuritis DOID_1802 0.01668559 0.04335207 0.180092 0.3124157 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP central nervous system hereditary degenerative disease DOID_481 0.01668559 0.04315501 0.01668559 0.05971134 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP metabolic syndrome X DOID_14221 0.01712267 0.04408506 0.10216047 0.21215075 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP mononeuropathy DOID_1188 0.0177597 0.04551923 0.18550308 0.31888596 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP focal glomerulosclerosis DOID_3945 0.0177597 0.04531511 0.18550308 0.31697073 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP dystonic disease DOID_544 0.0177597 0.04511281 0.0177597 0.06315793 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP corneal disease DOID_10124 0.01886234 0.04770077 0.01886234 0.06625107 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP spastic cerebral palsy DOID_0050669 0.0199931 0.05033661 0.19621876 0.33327903 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP gonadal disease DOID_2277 0.0199931 0.05011487 0.0199931 0.06979187 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bronchiolitis obliterans DOID_2799 0.0199931 0.04989507 0.0199931 0.06894591 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP Charcot-Marie-Tooth disease DOID_10595 0.02115156 0.05255563 0.02115156 0.07250144 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP germinoma DOID_3304 0.02115156 0.05232713 0.02115156 0.07163833 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pleural disease DOID_1532 0.02233731 0.05502135 0.20679402 0.34709674 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP bladder disease DOID_365 0.02233731 0.05478419 0.02233731 0.0747643 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP male infertility DOID_12336 0.02478906 0.06053638 0.02478906 0.08153165 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hepatitis C DOID_1883 0.02478906 0.06027767 1.000 1.000 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP periodontal disease DOID_3388 0.02478906 0.06002117 0.02478906 0.08106308 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP thyroid carcinoma DOID_3963 0.02478906 0.05976685 0.21723069 0.36036228 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP esophageal disease DOID_6050 0.02478906 0.05951467 0.21723069 0.35827322 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP lymphoblastic leukemia DOID_1037 0.02515474 0.06013886 0.13011474 0.24844056 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP thyroid cancer DOID_1781 0.02734514 0.06510202 0.22753058 0.36989971 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP adolescence-adult electroclinical syndrome DOID_0050705 0.02866131 0.06795119 0.02866131 0.09266071 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP calcinosis DOID_182 0.02866131 0.06766923 0.23262979 0.37711211 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP microcephaly DOID_10907 0.03000239 0.07054282 0.23769547 0.38422933 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP peptic ulcer DOID_750 0.031368 0.07345018 0.24272785 0.38795547 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP intracranial arterial disease DOID_13089 0.03275776 0.07639001 0.24772714 0.39483681 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP cerebral arterial disease DOID_3527 0.03275776 0.07639001 0.24772714 0.39483681 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP pulmonary emphysema DOID_9675 0.03417128 0.07936106 0.03417128 0.10801922 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP autoimmune disease of urogenital tract DOID_0060049 0.03560821 0.08236207 0.03560821 0.11193961 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP primary biliary cirrhosis DOID_12236 0.03560821 0.08236207 0.03560821 0.11193961 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP nephrotic syndrome DOID_1184 0.03706816 0.08539184 0.26252863 0.41725919 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP hyperinsulinism DOID_2018 0.03706816 0.08504752 0.03706816 0.11525566 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP brain cancer DOID_1319 0.0431311 0.09856063 0.28181368 0.44296128 HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP neuritis DOID_1803 0.0431311 0.09816639 0.28181368 0.441741 DAIRKEE_CANCER_PRONE_RESPONSE_BPA cervix uteri carcinoma in situ DOID_8991 5.218E-06 2.969E-03 5.239E-04 0.09937182 DAIRKEE_CANCER_PRONE_RESPONSE_BPA lung small cell carcinoma DOID_5409 8.672E-06 2.467E-03 7.316E-04 0.08325681 DAIRKEE_CANCER_PRONE_RESPONSE_BPA pre-malignant neoplasm DOID_0060071 1.783E-05 3.381E-03 1.176E-03 0.09556401 DAIRKEE_CANCER_PRONE_RESPONSE_BPA in situ carcinoma DOID_8719 1.783E-05 3.381E-03 1.176E-03 0.09556401 DAIRKEE_CANCER_PRONE_RESPONSE_BPA breast benign neoplasm DOID_0060082 3.094E-05 4.401E-03 3.094E-05 0.01760581 DAIRKEE_CANCER_PRONE_RESPONSE_BPA thoracic benign neoplasm DOID_0060097 3.094E-05 4.401E-03 3.094E-05 0.01760581 DAIRKEE_CANCER_PRONE_RESPONSE_BPA benign breast phyllodes tumor DOID_1631 3.094E-05 4.401E-03 3.094E-05 0.01760581 DAIRKEE_CANCER_PRONE_RESPONSE_BPA nervous system cancer DOID_3093 4.827E-05 5.493E-03 0.0680601 0.56950286 DAIRKEE_CANCER_PRONE_RESPONSE_BPA portal hypertension DOID_10762 1.815E-04 0.01721604 0.01970611 0.56063879 DAIRKEE_CANCER_PRONE_RESPONSE_BPA hepatic vascular disease DOID_272 2.425E-04 0.01971371 0.02270434 0.47847299 DAIRKEE_CANCER_PRONE_RESPONSE_BPA endometrial carcinoma DOID_2871 2.763E-04 0.01964973 0.02420014 0.47482338 DAIRKEE_CANCER_PRONE_RESPONSE_BPA endometrial cancer DOID_1380 3.122E-04 0.01973664 0.02569372 0.47160411 DAIRKEE_CANCER_PRONE_RESPONSE_BPA refractive error DOID_9835 4.114E-04 0.02340676 0.02941803 0.44049631 DAIRKEE_CANCER_PRONE_RESPONSE_BPA adenoid cystic carcinoma DOID_4866 5.004E-04 0.02588179 5.004E-04 0.14234986 DAIRKEE_CANCER_PRONE_RESPONSE_BPA salivary gland cancer DOID_8850 5.48E-04 0.02598612 5.48E-04 0.07795835 DAIRKEE_CANCER_PRONE_RESPONSE_BPA uterine cancer DOID_363 5.978E-04 0.02616724 0.03534835 0.46774914 DAIRKEE_CANCER_PRONE_RESPONSE_BPA B-cell lymphocytic neoplasm DOID_707 7.888E-04 0.03205872 0.04050867 0.50107467 DAIRKEE_CANCER_PRONE_RESPONSE_BPA giant cell tumor DOID_200 8.481E-04 0.0321701 1.000 1.000 DAIRKEE_CANCER_PRONE_RESPONSE_BPA malignant giant cell tumor DOID_2705 8.481E-04 0.0321701 1.000 1.000 DAIRKEE_CANCER_PRONE_RESPONSE_BPA giant cell glioblastoma DOID_3074 8.481E-04 0.0321701 1.000 1.000 DAIRKEE_CANCER_PRONE_RESPONSE_BPA reproductive organ benign neoplasm DOID_0050622 9.094E-04 0.0323418 0.04344545 0.52596726 DAIRKEE_CANCER_PRONE_RESPONSE_BPA hypertrophic cardiomyopathy DOID_11984 1.005E-03 0.03365085 0.04564234 0.51940978 DAIRKEE_CANCER_PRONE_RESPONSE_BPA glioblastoma DOID_3068 1.005E-03 0.03178136 1.000 1.000 DAIRKEE_CANCER_PRONE_RESPONSE_BPA oral cavity cancer DOID_8618 1.005E-03 0.03010866 1.005E-03 0.09534408 DAIRKEE_CANCER_PRONE_RESPONSE_BPA astrocytoma DOID_3069 1.397E-03 0.0397431 1.000 1.000 DAIRKEE_CANCER_PRONE_RESPONSE_BPA mixed glioma DOID_5076 1.721E-03 0.04661797 0.05944324 0.5544787 DAIRKEE_CANCER_PRONE_RESPONSE_BPA metabolic syndrome X DOID_14221 1.806E-03 0.04672191 1.806E-03 0.12848524 DAIRKEE_CANCER_PRONE_RESPONSE_BPA lymphoma DOID_0060058 2.364E-03 0.05848718 0.06948881 0.57303091 DAIRKEE_CANCER_PRONE_RESPONSE_BPA dilated cardiomyopathy DOID_12930 2.515E-03 0.05962014 2.515E-03 0.15898703 OLSSON_E2F3_TARGETS_UP endometriosis of uterus DOID_288 1.066E-04 0.06063739 1.066E-04 0.06063739 OLSSON_E2F3_TARGETS_UP endometriosis DOID_289 1.114E-04 0.03169069 1.114E-04 0.03169069 OLSSON_E2F3_TARGETS_UP uterine disease DOID_345 2.441E-04 0.04630264 2.441E-04 0.04630264 OLSSON_E2F3_TARGETS_UP brain infarction DOID_3454 2.662E-04 0.03786062 0.02407856 0.52694994 OLSSON_E2F3_TARGETS_UP female reproductive system disease DOID_229 3.636E-04 0.04138142 3.636E-04 0.05172677 OLSSON_E2F3_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 4.962E-04 0.0470543 4.962E-04 0.05646516 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP giant cell tumor DOID_200 1.865E-09 1.061E-06 5.613E-06 6.388E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP malignant giant cell tumor DOID_2705 1.865E-09 1.061E-06 5.613E-06 6.388E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP giant cell glioblastoma DOID_3074 1.865E-09 1.061E-06 5.613E-06 6.388E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP glioblastoma DOID_3068 3.164E-09 9E-07 7.914E-06 7.505E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP collagen disease DOID_854 4.251E-09 8.062E-07 9.59E-06 7.795E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP astrocytoma DOID_3069 8.744E-09 1.244E-06 1.534E-05 9.696E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP peripheral vascular disease DOID_341 1.121E-08 1.276E-06 4.991E-07 1.42E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP bacterial pneumonia DOID_874 1.66E-08 1.574E-06 6.897E-07 1.308E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP hypersensitivity reaction type I disease DOID_1205 5.31E-08 4.316E-06 5.31E-08 3.021E-05 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP angioedema DOID_1558 9.95E-07 7.077E-05 9.95E-07 1.415E-04 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP mouth disease DOID_403 1.709E-06 1.081E-04 1.043E-03 0.02119852 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP pre-eclampsia DOID_10591 3.553E-06 2.022E-04 1.532E-04 7.922E-03 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP tooth disease DOID_1091 1.371E-05 7.092E-04 4.153E-04 0.01476857 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP urinary tract obstruction DOID_5200 1.44E-05 6.83E-04 1.44E-05 1.024E-03 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP brain infarction DOID_3454 1.451E-05 6.349E-04 4.33E-04 0.01368654 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP tuberculosis DOID_399 1.451E-05 5.896E-04 4.33E-04 0.0129662 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP pancreatic ductal carcinoma DOID_3587 1.62E-05 6.145E-04 4.698E-04 0.01336478 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP diabetic angiopathy DOID_11713 1.644E-05 5.845E-04 1.12E-03 0.02197511 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP pancreatic carcinoma DOID_4905 1.901E-05 6.361E-04 5.286E-04 0.01432325 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP urticaria DOID_1555 2.105E-05 6.655E-04 2.105E-05 1.198E-03 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP periodontitis DOID_824 2.945E-05 8.821E-04 1.637E-03 0.02821878 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP thrombocytopenia DOID_1588 3.268E-05 9.297E-04 1.751E-03 0.02846878 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP primary bacterial infectious disease DOID_0050338 3.545E-05 9.604E-04 8.377E-04 0.01906668 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP focal glomerulosclerosis DOID_3945 3.613E-05 9.344E-04 1.869E-03 0.02874885 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP abdominal aortic aneurysm DOID_7693 4.372E-05 1.082E-03 2.117E-03 0.03170027 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP periodontal disease DOID_3388 6.19E-05 1.467E-03 2.656E-03 0.03875343 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP blood platelet disease DOID_2218 8.442E-05 1.921E-03 3.253E-03 0.04304623 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP systemic scleroderma DOID_418 9.077E-05 1.987E-03 3.411E-03 0.04411261 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP adult respiratory distress syndrome DOID_11394 9.744E-05 2.053E-03 3.573E-03 0.04517625 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP rheumatic disease DOID_1575 1.193E-04 2.425E-03 4.079E-03 0.05045286 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP scleroderma DOID_419 1.193E-04 2.425E-03 4.079E-03 0.05045286 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP autonomic nervous system disease DOID_11465 1.532E-04 3.005E-03 4.802E-03 0.05576166 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP vascular skin disease DOID_9540 1.532E-04 2.905E-03 1.532E-04 7.262E-03 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP integumentary system benign neoplasm DOID_0060121 1.722E-04 3.16E-03 5.184E-03 0.05783833 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP skin benign neoplasm DOID_3165 1.722E-04 3.16E-03 5.184E-03 0.05783833 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP aortic aneurysm DOID_3627 1.822E-04 3.241E-03 5.38E-03 0.0588724 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP facioscapulohumeral muscular dystrophy DOID_11727 1.861E-04 3.208E-03 1.861E-04 8.143E-03 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP hemorrhagic disease DOID_2213 1.927E-04 3.225E-03 5.58E-03 0.05990364 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP atrophic muscular disease DOID_913 2.147E-04 3.49E-03 2.147E-04 8.726E-03 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP muscular dystrophy DOID_9884 2.147E-04 3.49E-03 2.147E-04 8.726E-03 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP integumentary system cancer DOID_0060122 2.383E-04 3.766E-03 6.411E-03 0.06514326 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP skin cancer DOID_4159 2.383E-04 3.766E-03 6.411E-03 0.06514326 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP aortic valve insufficiency DOID_57 2.721E-04 4.185E-03 2.721E-04 0.01032349 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP carotid artery disease DOID_3407 3.189E-04 4.775E-03 7.757E-03 0.07356468 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP psoriatic arthritis DOID_9008 3.212E-04 4.686E-03 0.02642328 0.17898627 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP respiratory failure DOID_11162 3.338E-04 4.749E-03 7.993E-03 0.07455695 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP allergic contact dermatitis DOID_3042 4.153E-04 5.763E-03 9.219E-03 0.08326361 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP Ehlers-Danlos syndrome DOID_13359 4.312E-04 5.842E-03 4.312E-04 0.0144336 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP varicose veins DOID_799 4.312E-04 5.706E-03 0.03042676 0.18818287 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP blood coagulation disease DOID_1247 4.698E-04 6.075E-03 9.992E-03 0.08883816 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP vein disease DOID_866 4.922E-04 6.223E-03 0.03242239 0.18824839 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP aneurysm disease DOID_2403 5.92E-04 7.323E-03 0.01162216 0.10173862 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP ureteral obstruction DOID_5199 6.259E-04 7.577E-03 6.259E-04 0.01618692 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP contact dermatitis DOID_2773 6.601E-04 7.824E-03 0.01247791 0.10757474 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP psoriasis DOID_8893 6.986E-04 8.112E-03 6.986E-04 0.01728161 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP membranous glomerulonephritis DOID_10976 7.751E-04 8.821E-03 7.751E-04 0.01837719 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP transitional cell carcinoma DOID_2671 8.653E-04 9.654E-03 8.653E-04 0.01893758 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP nervous system cancer DOID_3093 9.223E-04 0.01009184 0.17279972 0.47044516 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP Human immunodeficiency virus infectious disease DOID_526 9.223E-04 9.901E-03 9.223E-04 0.01943613 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP sinusitis DOID_0050127 1.028E-03 0.01083243 0.04627878 0.23723085 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP paranasal sinus disease DOID_1352 1.028E-03 0.01083243 0.04627878 0.23723085 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP pulmonary embolism DOID_9477 1.028E-03 0.01063547 0.04627878 0.23303207 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP ureteral disease DOID_1426 1.12E-03 0.01137997 1.12E-03 0.02124261 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP aortic valve disease DOID_62 1.12E-03 0.01118032 1.12E-03 0.02055736 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP osteosarcoma DOID_3347 1.315E-03 0.0129038 1.315E-03 0.02338813 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP intracranial aneurysm DOID_10941 1.526E-03 0.01471447 0.05605608 0.26144188 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP middle cerebral artery infarction DOID_3525 1.526E-03 0.01446923 0.05605608 0.25516727 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP renal hypertension DOID_1073 1.751E-03 0.01633455 0.05993924 0.2545181 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP secondary hypertension DOID_11130 1.751E-03 0.01633455 0.05993924 0.2545181 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP sarcoma DOID_1115 1.751E-03 0.01607109 0.05993924 0.25263278 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP malaria DOID_12365 1.751E-03 0.01581599 1.751E-03 0.0293061 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP autoimmune disease of endocrine system DOID_0060005 1.869E-03 0.01662043 1.869E-03 0.02954743 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP allergic rhinitis DOID_4481 2.246E-03 0.01966455 0.0676583 0.25837297 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP myocarditis DOID_820 2.516E-03 0.02169077 0.07149433 0.26415763 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP hyperthyroidism DOID_7998 2.656E-03 0.02255797 2.656E-03 0.03778459 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP pulmonary sarcoidosis DOID_13406 3.098E-03 0.02592704 3.098E-03 0.04300095 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP calcinosis DOID_182 3.098E-03 0.02555129 0.07911972 0.28313912 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP multiple myeloma DOID_9538 3.098E-03 0.02518627 3.098E-03 0.04197712 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP intracranial arterial disease DOID_13089 3.573E-03 0.02863283 0.08479816 0.29969038 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP cerebral arterial disease DOID_3527 3.573E-03 0.02863283 0.08479816 0.29969038 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP pulmonary emphysema DOID_9675 3.738E-03 0.02954039 0.08668328 0.29892597 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP endometriosis of uterus DOID_288 3.907E-03 0.03045038 0.08856457 0.30357372 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP endometriosis DOID_289 4.079E-03 0.03136259 0.09044203 0.30271479 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP diabetic autonomic neuropathy DOID_11503 4.254E-03 0.03227682 0.09231567 0.30717905 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP autonomic neuropathy DOID_11504 4.254E-03 0.03227682 0.09231567 0.30717905 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP diabetic polyneuropathy DOID_12785 4.254E-03 0.03227682 0.09231567 0.30717905 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP uterine cancer DOID_363 4.254E-03 0.03185212 4.254E-03 0.05150556 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP influenza DOID_8469 4.254E-03 0.03143846 0.09231567 0.30539312 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP diabetic neuropathy DOID_9743 4.254E-03 0.03227682 0.09231567 0.30717905 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP cerebral infarction DOID_3526 4.433E-03 0.03234177 0.0941855 0.30977776 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP myeloma DOID_0070004 4.802E-03 0.03458635 4.802E-03 0.05692336 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP brain cancer DOID_1319 4.802E-03 0.03415402 0.09791377 0.32018929 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP heart valve disease DOID_4079 4.802E-03 0.03373236 4.802E-03 0.05464643 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP central nervous system cancer DOID_3620 4.991E-03 0.03463501 0.09977222 0.32255905 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP pulmonary tuberculosis DOID_2957 5.184E-03 0.03553922 0.10162689 0.32486348 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP calcium metabolism disease DOID_10575 5.38E-03 0.03644482 0.10347779 0.32893218 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP sarcoidosis DOID_11335 5.989E-03 0.04009024 5.989E-03 0.06310501 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP bone marrow cancer DOID_4960 6.198E-03 0.04101051 6.198E-03 0.06412553 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP vasculitis DOID_865 6.198E-03 0.04053913 0.1108438 0.34845372 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP osteochondrodysplasia DOID_2256 6.411E-03 0.0414548 6.411E-03 0.0640004 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP parasitic protozoa infectious disease DOID_2789 6.411E-03 0.04098902 6.411E-03 0.06289694 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP hypersensitivity reaction type IV disease DOID_2916 7.07E-03 0.04469568 7.07E-03 0.06817985 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP mineral metabolism disease DOID_0050032 8.474E-03 0.0529848 0.12899848 0.3842939 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP parasitic infectious disease DOID_1398 8.719E-03 0.05392556 8.719E-03 0.08001858 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP uterine disease DOID_345 8.719E-03 0.05334572 0.1307937 0.38560421 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP male reproductive system disease DOID_48 0.01025633 0.0620835 0.14148853 0.41074988 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP cystic fibrosis DOID_1485 0.01134292 0.06793811 0.14854615 0.42688262 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP syndrome DOID_225 0.01134292 0.06723042 0.14854615 0.4226138 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP bone resorption disease DOID_0080011 0.01162216 0.06817536 0.15030159 0.42548061 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP osteoporosis DOID_11476 0.01162216 0.06817536 0.15030159 0.42548061 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP female reproductive system disease DOID_229 0.01276913 0.07413911 0.15728767 0.43656919 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP bone development disease DOID_0080006 0.01366047 0.07851318 0.01366047 0.11601202 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP primary immunodeficiency disease DOID_612 0.01520426 0.08651225 0.17109017 0.46803033 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP lymphoblastic leukemia DOID_1037 0.01649078 0.09290349 0.01649078 0.13798901 WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP Crohn's disease DOID_8778 0.01681945 0.09382615 0.01681945 0.13869953 ZUCCHI_METASTASIS_DN Legionnaires' disease DOID_10457 1.306E-07 7.432E-05 1.306E-07 7.432E-05 ZUCCHI_METASTASIS_DN legionellosis DOID_10458 1.306E-07 7.432E-05 1.306E-07 7.432E-05 ZUCCHI_METASTASIS_DN cystic fibrosis DOID_1485 3.269E-07 9.3E-05 2.645E-05 2.15E-03 ZUCCHI_METASTASIS_DN bacterial pneumonia DOID_874 3.621E-07 6.868E-05 3.621E-07 1.03E-04 ZUCCHI_METASTASIS_DN pleurisy DOID_10247 1.445E-06 2.056E-04 1.445E-06 2.741E-04 ZUCCHI_METASTASIS_DN pleural disease DOID_1532 2.324E-06 2.645E-04 2.324E-06 3.306E-04 ZUCCHI_METASTASIS_DN pulmonary emphysema DOID_9675 4.682E-06 4.44E-04 4.682E-06 5.328E-04 ZUCCHI_METASTASIS_DN neuritis DOID_1803 6.909E-06 5.616E-04 6.909E-06 6.552E-04 ZUCCHI_METASTASIS_DN cholestasis DOID_13580 1.751E-05 1.245E-03 1.163E-03 0.04410467 ZUCCHI_METASTASIS_DN bile duct disease DOID_4138 2.258E-05 1.428E-03 1.375E-03 0.04345958 ZUCCHI_METASTASIS_DN biliary tract disease DOID_9741 2.351E-05 1.338E-03 1.412E-03 0.04016691 ZUCCHI_METASTASIS_DN primary bacterial infectious disease DOID_0050338 3.927E-05 2.031E-03 3.927E-05 2.793E-03 ZUCCHI_METASTASIS_DN viral pneumonia DOID_10533 4.761E-05 2.257E-03 4.761E-05 3.01E-03 ZUCCHI_METASTASIS_DN esophagitis DOID_11963 9.912E-05 4.339E-03 0.0146719 0.19414683 ZUCCHI_METASTASIS_DN acute pancreatitis DOID_2913 1.562E-04 6.347E-03 1.562E-04 8.885E-03 ZUCCHI_METASTASIS_DN esophageal disease DOID_6050 3.448E-04 0.01307828 0.02697962 0.24367307 ZUCCHI_METASTASIS_DN hepatitis DOID_2237 4.447E-04 0.01581464 4.447E-04 0.02300311 ZUCCHI_METASTASIS_DN peptic ulcer DOID_750 4.447E-04 0.01488436 0.03057123 0.2521019 ZUCCHI_METASTASIS_DN influenza DOID_8469 5.571E-04 0.01760912 5.571E-04 0.02641368 ZUCCHI_METASTASIS_DN pulmonary tuberculosis DOID_2957 6.817E-04 0.02041658 6.817E-04 0.02983962 ZUCCHI_METASTASIS_DN pustulosis of palm and sole DOID_4398 8.475E-04 0.02411275 8.475E-04 0.03444678 ZUCCHI_METASTASIS_DN tuberculosis DOID_399 1.267E-03 0.03431902 1.267E-03 0.04504371 ZUCCHI_METASTASIS_DN pancreatic ductal carcinoma DOID_3587 1.338E-03 0.0346126 1.338E-03 0.04479278 ZUCCHI_METASTASIS_DN male reproductive system disease DOID_48 1.375E-03 0.03401185 1.375E-03 0.04117224 ZUCCHI_METASTASIS_DN pancreatic carcinoma DOID_4905 1.449E-03 0.03436141 1.449E-03 0.03927018 ZUCCHI_METASTASIS_DN pancreatitis DOID_4989 1.604E-03 0.03650835 1.604E-03 0.04148676 ZUCCHI_METASTASIS_DN transitional cell carcinoma DOID_2671 2.024E-03 0.04428884 2.024E-03 0.05006564 ZUCCHI_METASTASIS_DN nervous system cancer DOID_3093 2.113E-03 0.04453533 2.113E-03 0.05010225 ZUCCHI_METASTASIS_DN encephalomyelitis DOID_640 2.251E-03 0.04574449 2.251E-03 0.05123383 ZUCCHI_METASTASIS_DN mouth disease DOID_403 2.298E-03 0.04508627 2.298E-03 0.05028853 ZUCCHI_METASTASIS_DN hypersensitivity reaction type I disease DOID_1205 2.345E-03 0.04448067 2.345E-03 0.04942296 ZUCCHI_METASTASIS_DN ulcerative colitis DOID_8577 2.49E-03 0.04570139 0.0713108 0.41830771 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN epidermolysis bullosa DOID_2730 4.885E-08 2.78E-05 4.885E-08 2.78E-05 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN vesiculobullous skin disease DOID_2731 6.348E-08 1.806E-05 6.348E-08 1.806E-05 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN giant cell tumor DOID_200 6.044E-06 1.146E-03 0.0348661 0.4838735 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN malignant giant cell tumor DOID_2705 6.044E-06 1.146E-03 0.0348661 0.4838735 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN giant cell glioblastoma DOID_3074 6.044E-06 1.146E-03 0.0348661 0.4838735 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN glioblastoma DOID_3068 7.831E-06 1.114E-03 0.03792185 0.44953198 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN astrocytoma DOID_3069 1.292E-05 1.47E-03 0.0446119 0.48815715 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN diabetic retinopathy DOID_8947 1.52E-05 1.442E-03 1.064E-03 0.12105535 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN retinal vascular disease DOID_2462 2.282E-05 1.855E-03 1.39E-03 0.13185639 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN aortic valve insufficiency DOID_57 2.525E-05 1.796E-03 7.571E-03 0.39164992 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN ulcerative colitis DOID_8577 3.462E-05 2.189E-03 1.831E-03 0.14879656 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN angiosarcoma DOID_0001816 4.584E-05 2.608E-03 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN aortic valve disease DOID_62 1.051E-04 5.437E-03 0.01508792 0.39022857 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN sarcoma DOID_1115 1.653E-04 7.837E-03 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN multiple myeloma DOID_9538 2.952E-04 0.01292114 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN myeloma DOID_0070004 4.618E-04 0.01877064 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN heart valve disease DOID_4079 4.618E-04 0.01751926 0.03118693 0.46698319 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN hemorrhagic disease DOID_2213 5.387E-04 0.01915664 0.0336412 0.4785461 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN bile duct adenocarcinoma DOID_4896 6.001E-04 0.02008539 0.035478 0.46946467 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN cholangiocarcinoma DOID_4947 6.001E-04 0.02008539 0.035478 0.46946467 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN bone marrow cancer DOID_4960 6.001E-04 0.01896954 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN vasculitis DOID_865 6.001E-04 0.01797114 0.035478 0.45879502 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN hypertrophic cardiomyopathy DOID_11984 6.87E-04 0.01954548 0.03792185 0.45909649 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN bile duct cancer DOID_4606 6.87E-04 0.01861474 0.03792185 0.44035786 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN bile duct carcinoma DOID_4897 6.87E-04 0.01861474 0.03792185 0.44035786 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN blood coagulation disease DOID_1247 9.82E-04 0.0253989 0.04521787 0.48545224 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN pancreatic ductal carcinoma DOID_3587 9.82E-04 0.0242946 9.82E-04 0.18625862 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN pancreatic carcinoma DOID_4905 1.064E-03 0.02521987 1.064E-03 0.15131919 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN mixed glioma DOID_5076 1.178E-03 0.02680313 0.04944936 0.49362609 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN biliary tract cancer DOID_4607 1.328E-03 0.02905995 0.05246085 0.50593596 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN transitional cell carcinoma DOID_2671 1.487E-03 0.0313329 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN nervous system cancer DOID_3093 1.553E-03 0.03155497 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN lymphoblastic leukemia DOID_1037 1.654E-03 0.0324599 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.689E-03 0.03203315 0.05905396 0.5508476 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN Crohn's disease DOID_8778 1.689E-03 0.03099983 0.05905396 0.54196296 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN rectal neoplasm DOID_1984 6.313E-03 0.09978616 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN rectum cancer DOID_1993 6.313E-03 0.09978616 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN adrenal gland hyperfunction DOID_3947 6.313E-03 0.09708923 6.313E-03 0.39914463 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN invasive lobular carcinoma DOID_3457 6.943E-03 0.09875835 1.000 1.000 SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN chronic monocytic leukemia DOID_8593 6.943E-03 0.09634961 6.943E-03 0.3950334 MIZUKAMI_HYPOXIA_UP diabetic retinopathy DOID_8947 4.855E-14 2.762E-11 1.681E-06 9.566E-04 MIZUKAMI_HYPOXIA_UP retinal vascular disease DOID_2462 1.12E-13 3.185E-11 2.53E-06 7.197E-04 MIZUKAMI_HYPOXIA_UP insulinoma DOID_3892 2.904E-09 5.507E-07 4.127E-06 7.828E-04 MIZUKAMI_HYPOXIA_UP islet cell tumor DOID_1799 5.322E-09 7.57E-07 6.051E-06 8.608E-04 MIZUKAMI_HYPOXIA_UP pulmonary edema DOID_11396 2.754E-08 3.134E-06 6.313E-03 0.25658622 MIZUKAMI_HYPOXIA_UP gastric ulcer DOID_10808 3.718E-08 3.526E-06 1.000 1.000 MIZUKAMI_HYPOXIA_UP renal hypertension DOID_1073 9.789E-08 7.957E-06 9.456E-03 0.2690252 MIZUKAMI_HYPOXIA_UP secondary hypertension DOID_11130 9.789E-08 7.957E-06 9.456E-03 0.2690252 MIZUKAMI_HYPOXIA_UP adenoma DOID_657 2.2E-07 1.565E-05 6.762E-05 7.695E-03 MIZUKAMI_HYPOXIA_UP peptic ulcer DOID_750 2.762E-07 1.746E-05 1.000 1.000 MIZUKAMI_HYPOXIA_UP diabetic autonomic neuropathy DOID_11503 3.898E-07 2.218E-05 0.01477806 0.28995565 MIZUKAMI_HYPOXIA_UP autonomic neuropathy DOID_11504 3.898E-07 2.218E-05 0.01477806 0.28995565 MIZUKAMI_HYPOXIA_UP diabetic polyneuropathy DOID_12785 3.898E-07 2.218E-05 0.01477806 0.28995565 MIZUKAMI_HYPOXIA_UP gallbladder cancer DOID_3121 3.898E-07 2.016E-05 0.01477806 0.28029047 MIZUKAMI_HYPOXIA_UP diabetic neuropathy DOID_9743 3.898E-07 2.218E-05 0.01477806 0.28995565 MIZUKAMI_HYPOXIA_UP autonomic nervous system disease DOID_11465 4.709E-07 2.233E-05 0.0157145 0.27095616 MIZUKAMI_HYPOXIA_UP respiratory failure DOID_11162 1.047E-06 4.581E-05 0.02038452 0.31348087 MIZUKAMI_HYPOXIA_UP uterine disease DOID_345 1.2E-06 4.878E-05 2.068E-04 0.01961231 MIZUKAMI_HYPOXIA_UP brain infarction DOID_3454 1.368E-06 5.19E-05 0.02224683 0.32457559 MIZUKAMI_HYPOXIA_UP pancreatic ductal carcinoma DOID_3587 1.488E-06 5.292E-05 1.000 1.000 MIZUKAMI_HYPOXIA_UP peripheral vascular disease DOID_341 1.615E-06 5.406E-05 0.02348657 0.33409647 MIZUKAMI_HYPOXIA_UP pancreatic carcinoma DOID_4905 1.681E-06 5.314E-05 1.000 1.000 MIZUKAMI_HYPOXIA_UP female reproductive system disease DOID_229 2.195E-06 6.572E-05 3.081E-04 0.02504637 MIZUKAMI_HYPOXIA_UP biliary tract cancer DOID_4607 2.358E-06 6.709E-05 0.02657962 0.3517163 MIZUKAMI_HYPOXIA_UP keratitis DOID_4677 4.127E-06 1.118E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP renovascular hypertension DOID_1591 9.622E-06 2.489E-04 4.738E-03 0.2246758 MIZUKAMI_HYPOXIA_UP bronchitis DOID_6132 1.246E-05 3.082E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP brain edema DOID_4724 1.74E-05 4.124E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP diabetic angiopathy DOID_11713 2.525E-05 5.747E-04 7.571E-03 0.23934162 MIZUKAMI_HYPOXIA_UP toxic shock syndrome DOID_14115 2.744E-05 6.006E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP commensal bacterial infectious disease DOID_0050339 2.972E-05 6.264E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP portal hypertension DOID_10762 2.972E-05 6.04E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP extrinsic allergic alveolitis DOID_841 3.456E-05 6.781E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP periodontitis DOID_824 3.711E-05 7.039E-04 9.142E-03 0.27378463 MIZUKAMI_HYPOXIA_UP hepatic vascular disease DOID_272 3.976E-05 7.297E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP female reproductive organ benign neoplasm DOID_0060086 4.532E-05 8.058E-04 0.01008355 0.27321622 MIZUKAMI_HYPOXIA_UP uterine benign neoplasm DOID_0060095 4.532E-05 8.058E-04 0.01008355 0.27321622 MIZUKAMI_HYPOXIA_UP corneal disease DOID_10124 4.532E-05 7.813E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP uterine fibroid DOID_13223 4.532E-05 8.058E-04 0.01008355 0.27321622 MIZUKAMI_HYPOXIA_UP abdominal aortic aneurysm DOID_7693 4.823E-05 8.072E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP leiomyoma DOID_127 5.433E-05 8.833E-04 0.01102409 0.28512304 MIZUKAMI_HYPOXIA_UP bladder disease DOID_365 5.433E-05 8.587E-04 1.000 1.000 MIZUKAMI_HYPOXIA_UP periodontal disease DOID_3388 6.079E-05 9.349E-04 0.01165066 0.28822719 MIZUKAMI_HYPOXIA_UP cleft palate DOID_674 7.116E-05 1.066E-03 0.01258983 0.28654459 MIZUKAMI_HYPOXIA_UP benign mesothelioma DOID_2645 8.625E-05 1.258E-03 0.01384079 0.30290039 MIZUKAMI_HYPOXIA_UP endometriosis of uterus DOID_288 9.024E-05 1.284E-03 0.0141533 0.29826777 MIZUKAMI_HYPOXIA_UP endometriosis DOID_289 9.433E-05 1.309E-03 0.01446573 0.2939642 MIZUKAMI_HYPOXIA_UP cerebral infarction DOID_3526 1.028E-04 1.392E-03 0.0150903 0.27697996 MIZUKAMI_HYPOXIA_UP myeloma DOID_0070004 1.116E-04 1.476E-03 0.0157145 0.27942354 MIZUKAMI_HYPOXIA_UP aortic aneurysm DOID_3627 1.254E-04 1.622E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP orofacial cleft DOID_0050567 1.351E-04 1.709E-03 0.01727344 0.28907609 MIZUKAMI_HYPOXIA_UP bile duct adenocarcinoma DOID_4896 1.452E-04 1.796E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP cholangiocarcinoma DOID_4947 1.452E-04 1.796E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP bone marrow cancer DOID_4960 1.452E-04 1.758E-03 0.01789638 0.29094399 MIZUKAMI_HYPOXIA_UP reproductive organ benign neoplasm DOID_0050622 1.503E-04 1.782E-03 0.01820771 0.28778302 MIZUKAMI_HYPOXIA_UP pustulosis of palm and sole DOID_4398 1.503E-04 1.746E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP bile duct cancer DOID_4606 1.663E-04 1.893E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP bile duct carcinoma DOID_4897 1.663E-04 1.893E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP tooth disease DOID_1091 2.192E-04 2.445E-03 0.02193667 0.32847282 MIZUKAMI_HYPOXIA_UP biliary tract disease DOID_9741 2.516E-04 2.753E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP cystic fibrosis DOID_1485 2.721E-04 2.922E-03 0.02441543 0.33883851 MIZUKAMI_HYPOXIA_UP syndrome DOID_225 2.721E-04 2.868E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP aneurysm disease DOID_2403 2.792E-04 2.888E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP pancreatitis DOID_4989 2.863E-04 2.909E-03 0.02503422 0.33915404 MIZUKAMI_HYPOXIA_UP primary bacterial infectious disease DOID_0050338 3.542E-04 3.536E-03 0.02781432 0.35968968 MIZUKAMI_HYPOXIA_UP encephalomyelitis DOID_640 4.034E-04 3.958E-03 1.000 1.000 MIZUKAMI_HYPOXIA_UP mouth disease DOID_403 4.119E-04 3.973E-03 0.02997159 0.36284753 MIZUKAMI_HYPOXIA_UP ulcerative colitis DOID_8577 4.469E-04 4.238E-03 0.03120235 0.3698778 MIZUKAMI_HYPOXIA_UP arrhythmogenic right ventricular dysplasia DOID_0050431 2.845E-03 0.0265422 2.845E-03 0.20238427 MIZUKAMI_HYPOXIA_UP retinal vascular occlusion DOID_1729 3.161E-03 0.02901146 1.000 1.000 MIZUKAMI_HYPOXIA_UP trypanosomiasis DOID_10113 3.477E-03 0.0314015 1.000 1.000 MIZUKAMI_HYPOXIA_UP pneumocystosis DOID_11339 3.477E-03 0.03091085 1.000 1.000 MIZUKAMI_HYPOXIA_UP eosinophilic pneumonia DOID_5870 3.477E-03 0.0304353 1.000 1.000 MIZUKAMI_HYPOXIA_UP pulmonary eosinophilia DOID_9498 3.477E-03 0.0304353 1.000 1.000 MIZUKAMI_HYPOXIA_UP Loeffler syndrome DOID_9503 3.477E-03 0.0304353 1.000 1.000 MIZUKAMI_HYPOXIA_UP common cold DOID_10459 3.792E-03 0.03269434 3.792E-03 0.23975848 MIZUKAMI_HYPOXIA_UP otitis media DOID_10754 3.792E-03 0.03220636 1.000 1.000 MIZUKAMI_HYPOXIA_UP middle ear disease DOID_5100 3.792E-03 0.03220636 1.000 1.000 MIZUKAMI_HYPOXIA_UP essential hypertension DOID_10825 4.108E-03 0.03437215 1.000 1.000 MIZUKAMI_HYPOXIA_UP hepatic coma DOID_12550 4.108E-03 0.033874 1.000 1.000 MIZUKAMI_HYPOXIA_UP hepatic encephalopathy DOID_13413 4.108E-03 0.033874 1.000 1.000 MIZUKAMI_HYPOXIA_UP Leydig cell tumor DOID_2696 4.108E-03 0.03339009 4.108E-03 0.23373062 MIZUKAMI_HYPOXIA_UP sex cord-stromal neoplasm DOID_4757 4.108E-03 0.03339009 4.108E-03 0.23373062 MIZUKAMI_HYPOXIA_UP epilepsy with generalized tonic-clonic seizures DOID_7725 4.108E-03 0.03291981 1.000 1.000 MIZUKAMI_HYPOXIA_UP psoriatic arthritis DOID_9008 4.108E-03 0.03246259 1.000 1.000 MIZUKAMI_HYPOXIA_UP Legionnaires' disease DOID_10457 4.423E-03 0.03447581 4.423E-03 0.22879399 MIZUKAMI_HYPOXIA_UP legionellosis DOID_10458 4.423E-03 0.03447581 4.423E-03 0.22879399 MIZUKAMI_HYPOXIA_UP rhabdomyosarcoma DOID_3247 4.423E-03 0.03400992 1.000 1.000 MIZUKAMI_HYPOXIA_UP parasitic helminthiasis infectious disease DOID_883 4.423E-03 0.03355645 1.000 1.000 MIZUKAMI_HYPOXIA_UP skeletal muscle cancer DOID_4043 4.738E-03 0.03547513 1.000 1.000 MIZUKAMI_HYPOXIA_UP oral submucous fibrosis DOID_5773 4.738E-03 0.03501441 1.000 1.000 MIZUKAMI_HYPOXIA_UP angiosarcoma DOID_0001816 5.053E-03 0.03686453 1.000 1.000 MIZUKAMI_HYPOXIA_UP silicosis DOID_10325 5.053E-03 0.03639789 1.000 1.000 MIZUKAMI_HYPOXIA_UP urinary system benign neoplasm DOID_731 5.369E-03 0.03818381 5.369E-03 0.23497728 MIZUKAMI_HYPOXIA_UP eosinophilia DOID_999 5.684E-03 0.03992499 1.000 1.000 MIZUKAMI_HYPOXIA_UP granulosa cell tumor DOID_2999 5.998E-03 0.04162307 1.000 1.000 MIZUKAMI_HYPOXIA_UP psoriasis DOID_8893 5.998E-03 0.04112159 1.000 1.000 MIZUKAMI_HYPOXIA_UP esophagitis DOID_11963 6.313E-03 0.04276437 6.313E-03 0.23948047 MIZUKAMI_HYPOXIA_UP sex cord-gonadal stromal tumor DOID_192 6.313E-03 0.04226126 1.000 1.000 MIZUKAMI_HYPOXIA_UP Kawasaki disease DOID_13378 6.628E-03 0.04385198 1.000 1.000 MIZUKAMI_HYPOXIA_UP lymphadenitis DOID_1602 6.628E-03 0.04385198 1.000 1.000 MIZUKAMI_HYPOXIA_UP lymph node disease DOID_9942 6.628E-03 0.04385198 1.000 1.000 MIZUKAMI_HYPOXIA_UP acquired immunodeficiency syndrome DOID_635 6.942E-03 0.04540554 6.942E-03 0.24689263 MIZUKAMI_HYPOXIA_UP placenta disease DOID_780 6.942E-03 0.04488957 6.942E-03 0.23236953 MIZUKAMI_HYPOXIA_UP muscle cancer DOID_4045 7.257E-03 0.04639597 1.000 1.000 MIZUKAMI_HYPOXIA_UP uremia DOID_4676 7.257E-03 0.04588046 1.000 1.000 MIZUKAMI_HYPOXIA_UP polyarteritis nodosa DOID_9810 7.257E-03 0.04537628 1.000 1.000 MIZUKAMI_HYPOXIA_UP Lewy body dementia DOID_12217 7.571E-03 0.04682771 1.000 1.000 MIZUKAMI_HYPOXIA_UP acute pancreatitis DOID_2913 7.886E-03 0.04824736 1.000 1.000 MIZUKAMI_HYPOXIA_UP bronchiolitis DOID_2942 8.2E-03 0.04963626 1.000 1.000 MIZUKAMI_HYPOXIA_UP cystitis DOID_1679 8.514E-03 0.05099537 1.000 1.000 MIZUKAMI_HYPOXIA_UP cleft lip DOID_9296 8.514E-03 0.05046417 1.000 1.000 MIZUKAMI_HYPOXIA_UP middle cerebral artery infarction DOID_3525 8.828E-03 0.05178619 1.000 1.000 MIZUKAMI_HYPOXIA_UP seminoma DOID_4440 8.828E-03 0.05125775 1.000 1.000 MIZUKAMI_HYPOXIA_UP gestational diabetes DOID_11714 9.142E-03 0.05254452 1.000 1.000 MIZUKAMI_HYPOXIA_UP perinatal necrotizing enterocolitis DOID_8677 9.142E-03 0.05201908 1.000 1.000 MIZUKAMI_HYPOXIA_UP pleurisy DOID_10247 9.456E-03 0.05327232 1.000 1.000 MIZUKAMI_HYPOXIA_UP sarcoma DOID_1115 9.456E-03 0.05275004 1.000 1.000 MIZUKAMI_HYPOXIA_UP malaria DOID_12365 9.456E-03 0.0522379 1.000 1.000 MIZUKAMI_HYPOXIA_UP focal glomerulosclerosis DOID_3945 9.77E-03 0.05345239 1.000 1.000 MIZUKAMI_HYPOXIA_UP age related macular degeneration DOID_10871 0.01039715 0.05634268 1.000 1.000 MIZUKAMI_HYPOXIA_UP degeneration of macula and posterior pole DOID_2007 0.01039715 0.05634268 1.000 1.000 MIZUKAMI_HYPOXIA_UP opportunistic mycosis DOID_2473 0.01039715 0.05581114 1.000 1.000 MIZUKAMI_HYPOXIA_UP bronchiolitis obliterans DOID_2799 0.01039715 0.05528954 1.000 1.000 MIZUKAMI_HYPOXIA_UP germinoma DOID_3304 0.01071067 0.05642935 1.000 1.000 MIZUKAMI_HYPOXIA_UP allergic rhinitis DOID_4481 0.01071067 0.05591165 1.000 1.000 MIZUKAMI_HYPOXIA_UP pleural disease DOID_1532 0.01102409 0.05702461 1.000 1.000 MIZUKAMI_HYPOXIA_UP systemic mycosis DOID_0050136 0.01133742 0.05811704 1.000 1.000 MIZUKAMI_HYPOXIA_UP fungal infectious disease DOID_1564 0.01133742 0.05811704 1.000 1.000 MIZUKAMI_HYPOXIA_UP pneumoconiosis DOID_10316 0.01165066 0.05918951 1.000 1.000 MIZUKAMI_HYPOXIA_UP macular degeneration DOID_4448 0.01165066 0.05866571 1.000 1.000 MIZUKAMI_HYPOXIA_UP esophageal disease DOID_6050 0.01165066 0.0581511 0.01165066 0.27621772 MIZUKAMI_HYPOXIA_UP paraplegia DOID_607 0.01165066 0.05764544 1.000 1.000 MIZUKAMI_HYPOXIA_UP adolescence-adult electroclinical syndrome DOID_0050705 0.01258983 0.0617553 1.000 1.000 MIZUKAMI_HYPOXIA_UP pulmonary sarcoidosis DOID_13406 0.01258983 0.06122748 1.000 1.000 MIZUKAMI_HYPOXIA_UP uveitis DOID_13141 0.01290271 0.0622173 1.000 1.000 MIZUKAMI_HYPOXIA_UP hepatitis DOID_2237 0.01321549 0.06319005 1.000 1.000 MIZUKAMI_HYPOXIA_UP congenital diaphragmatic hernia DOID_3827 0.01321549 0.06266347 1.000 1.000 MIZUKAMI_HYPOXIA_UP systemic scleroderma DOID_418 0.01321549 0.06214559 1.000 1.000 MIZUKAMI_HYPOXIA_UP intracranial arterial disease DOID_13089 0.01352819 0.06309458 1.000 1.000 MIZUKAMI_HYPOXIA_UP cerebral arterial disease DOID_3527 0.01352819 0.06309458 1.000 1.000 MIZUKAMI_HYPOXIA_UP lymphatic system disease DOID_75 0.01352819 0.06258162 1.000 1.000 MIZUKAMI_HYPOXIA_UP cervix uteri carcinoma in situ DOID_8991 0.01384079 0.06351137 1.000 1.000 MIZUKAMI_HYPOXIA_UP pulmonary emphysema DOID_9675 0.01384079 0.06300328 1.000 1.000 MIZUKAMI_HYPOXIA_UP autoimmune disease of urogenital tract DOID_0060049 0.0141533 0.06391452 1.000 1.000 MIZUKAMI_HYPOXIA_UP primary biliary cirrhosis DOID_12236 0.0141533 0.06391452 1.000 1.000 MIZUKAMI_HYPOXIA_UP nephrotic syndrome DOID_1184 0.01446573 0.06481101 1.000 1.000 MIZUKAMI_HYPOXIA_UP rheumatic disease DOID_1575 0.01446573 0.06430467 1.000 1.000 MIZUKAMI_HYPOXIA_UP hyperinsulinism DOID_2018 0.01446573 0.06380618 1.000 1.000 MIZUKAMI_HYPOXIA_UP uveal disease DOID_3480 0.01446573 0.06331537 1.000 1.000 MIZUKAMI_HYPOXIA_UP scleroderma DOID_419 0.01446573 0.06430467 1.000 1.000 MIZUKAMI_HYPOXIA_UP influenza DOID_8469 0.01477806 0.06418866 1.000 1.000 MIZUKAMI_HYPOXIA_UP learning disability DOID_8927 0.0150903 0.06504832 1.000 1.000 MIZUKAMI_HYPOXIA_UP leukodystrophy DOID_10579 0.01540245 0.06589467 1.000 1.000 MIZUKAMI_HYPOXIA_UP proteinuria DOID_576 0.01540245 0.06540292 1.000 1.000 MIZUKAMI_HYPOXIA_UP pre-eclampsia DOID_10591 0.0157145 0.06623373 1.000 1.000 MIZUKAMI_HYPOXIA_UP brain cancer DOID_1319 0.0157145 0.06574671 1.000 1.000 MIZUKAMI_HYPOXIA_UP neuritis DOID_1803 0.0157145 0.06526681 1.000 1.000 MIZUKAMI_HYPOXIA_UP vascular skin disease DOID_9540 0.0157145 0.06479386 1.000 1.000 MIZUKAMI_HYPOXIA_UP central nervous system cancer DOID_3620 0.01602647 0.06560477 1.000 1.000 MIZUKAMI_HYPOXIA_UP pulmonary tuberculosis DOID_2957 0.01633835 0.06640372 1.000 1.000 MIZUKAMI_HYPOXIA_UP withdrawal disorder DOID_0060001 0.01696183 0.06844882 1.000 1.000 MIZUKAMI_HYPOXIA_UP sarcoidosis DOID_11335 0.01758495 0.07046366 1.000 1.000 MIZUKAMI_HYPOXIA_UP giant cell tumor DOID_200 0.01758495 0.0699709 1.000 1.000 MIZUKAMI_HYPOXIA_UP malignant giant cell tumor DOID_2705 0.01758495 0.0699709 1.000 1.000 MIZUKAMI_HYPOXIA_UP giant cell glioblastoma DOID_3074 0.01758495 0.0699709 1.000 1.000 MIZUKAMI_HYPOXIA_UP parasitic protozoa infectious disease DOID_2789 0.01820771 0.07194576 1.000 1.000 MIZUKAMI_HYPOXIA_UP mitochondrial metabolism disease DOID_700 0.01851896 0.07267094 1.000 1.000 MIZUKAMI_HYPOXIA_UP hypertrophic cardiomyopathy DOID_11984 0.01914117 0.07459813 1.000 1.000 MIZUKAMI_HYPOXIA_UP hypersensitivity reaction type IV disease DOID_2916 0.01914117 0.07409066 1.000 1.000 MIZUKAMI_HYPOXIA_UP glioblastoma DOID_3068 0.01914117 0.07359005 1.000 1.000 MIZUKAMI_HYPOXIA_UP melancholia DOID_2848 0.01945215 0.0742837 1.000 1.000 MIZUKAMI_HYPOXIA_UP leukocyte disease DOID_9500 0.01945215 0.07378847 1.000 1.000 MIZUKAMI_HYPOXIA_UP neurotic disorder DOID_4964 0.01976303 0.07447128 1.000 1.000 MIZUKAMI_HYPOXIA_UP collagen disease DOID_854 0.02007382 0.07514476 1.000 1.000 MIZUKAMI_HYPOXIA_UP hypothyroidism DOID_1459 0.02038452 0.0758091 1.000 1.000 MIZUKAMI_HYPOXIA_UP pre-malignant neoplasm DOID_0060071 0.02069513 0.07646448 1.000 1.000 MIZUKAMI_HYPOXIA_UP congenital heart defect DOID_1682 0.02069513 0.07597116 1.000 1.000 MIZUKAMI_HYPOXIA_UP in situ carcinoma DOID_8719 0.02069513 0.07646448 1.000 1.000 MIZUKAMI_HYPOXIA_UP endocrine pancreas disease DOID_1428 0.02100565 0.07661677 1.000 1.000 MIZUKAMI_HYPOXIA_UP cholestasis DOID_13580 0.02131608 0.07725383 1.000 1.000 MIZUKAMI_HYPOXIA_UP parasitic infectious disease DOID_1398 0.02131608 0.07676488 1.000 1.000 MIZUKAMI_HYPOXIA_UP cerebral degeneration DOID_1443 0.02131608 0.07628208 1.000 1.000 MIZUKAMI_HYPOXIA_UP temporal lobe epilepsy DOID_3328 0.02162642 0.07690897 1.000 1.000 MIZUKAMI_HYPOXIA_UP tuberculosis DOID_399 0.02224683 0.0786239 1.000 1.000 MIZUKAMI_HYPOXIA_UP astrocytoma DOID_3069 0.0225569 0.07922764 1.000 1.000 MIZUKAMI_HYPOXIA_UP nephrosis DOID_2527 0.02317677 0.08090542 1.000 1.000 MIZUKAMI_HYPOXIA_UP bile duct disease DOID_4138 0.02317677 0.08041209 1.000 1.000 MIZUKAMI_HYPOXIA_UP endogenous depression DOID_1595 0.02441543 0.08419624 1.000 1.000 MIZUKAMI_HYPOXIA_UP electroclinical syndrome DOID_0050701 0.02503422 0.08581006 1.000 1.000 MIZUKAMI_HYPOXIA_UP mixed glioma DOID_5076 0.02503422 0.08529623 1.000 1.000 MIZUKAMI_HYPOXIA_UP bacterial pneumonia DOID_874 0.02503422 0.08478851 1.000 1.000 MIZUKAMI_HYPOXIA_UP auditory system disease DOID_2742 0.02627072 0.08844992 1.000 1.000 MIZUKAMI_HYPOXIA_UP mental depression DOID_1596 0.02657962 0.08896354 1.000 1.000 MIZUKAMI_HYPOXIA_UP focal epilepsy DOID_2234 0.02657962 0.08844328 1.000 1.000 MIZUKAMI_HYPOXIA_UP transitional cell carcinoma DOID_2671 0.02812277 0.09303404 1.000 1.000 MIZUKAMI_HYPOXIA_UP nervous system cancer DOID_3093 0.0287394 0.09452438 1.000 1.000 MIZUKAMI_HYPOXIA_UP Human immunodeficiency virus infectious disease DOID_526 0.0287394 0.09398114 0.0287394 0.36339374 MIZUKAMI_HYPOXIA_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.02997159 0.09745048 0.02997159 0.37073552 MIZUKAMI_HYPOXIA_UP Crohn's disease DOID_8778 0.02997159 0.09689678 1.000 1.000 ROSS_AML_WITH_PML_RARA_FUSION urticaria DOID_1555 1.262E-08 7.182E-06 1.262E-08 7.182E-06 ROSS_AML_WITH_PML_RARA_FUSION vascular skin disease DOID_9540 1.911E-07 5.438E-05 1.911E-07 5.438E-05 ROSS_AML_WITH_PML_RARA_FUSION peripheral vascular disease DOID_341 9.908E-07 1.879E-04 9.908E-07 1.879E-04 ROSS_AML_WITH_PML_RARA_FUSION bile duct adenocarcinoma DOID_4896 2.619E-05 3.725E-03 1.508E-03 0.07150355 ROSS_AML_WITH_PML_RARA_FUSION cholangiocarcinoma DOID_4947 2.619E-05 3.725E-03 1.508E-03 0.07150355 ROSS_AML_WITH_PML_RARA_FUSION bile duct cancer DOID_4606 3.212E-05 3.655E-03 1.725E-03 0.07009751 ROSS_AML_WITH_PML_RARA_FUSION bile duct carcinoma DOID_4897 3.212E-05 3.655E-03 1.725E-03 0.07009751 ROSS_AML_WITH_PML_RARA_FUSION oral cavity cancer DOID_8618 3.212E-05 3.046E-03 3.212E-05 4.569E-03 ROSS_AML_WITH_PML_RARA_FUSION carotid artery disease DOID_3407 3.711E-05 3.016E-03 1.896E-03 0.07193771 ROSS_AML_WITH_PML_RARA_FUSION hypothyroidism DOID_1459 3.888E-05 2.765E-03 3.888E-05 4.424E-03 ROSS_AML_WITH_PML_RARA_FUSION pancreatic ductal carcinoma DOID_3587 5.505E-05 3.48E-03 2.458E-03 0.08741726 ROSS_AML_WITH_PML_RARA_FUSION pancreatic carcinoma DOID_4905 6.209E-05 3.533E-03 2.661E-03 0.08905662 ROSS_AML_WITH_PML_RARA_FUSION biliary tract cancer DOID_4607 8.67E-05 4.485E-03 3.314E-03 0.08979569 ROSS_AML_WITH_PML_RARA_FUSION myopia DOID_11830 3.638E-04 0.01724819 3.638E-04 0.03449638 ROSS_AML_WITH_PML_RARA_FUSION pleurisy DOID_10247 4.181E-04 0.0182991 4.181E-04 0.03398404 ROSS_AML_WITH_PML_RARA_FUSION renal hypertension DOID_1073 4.181E-04 0.01699202 0.02964862 0.31830313 ROSS_AML_WITH_PML_RARA_FUSION secondary hypertension DOID_11130 4.181E-04 0.01699202 0.02964862 0.31830313 ROSS_AML_WITH_PML_RARA_FUSION pleural disease DOID_1532 5.701E-04 0.02162403 5.701E-04 0.04054506 ROSS_AML_WITH_PML_RARA_FUSION refractive error DOID_9835 7.081E-04 0.02518323 7.081E-04 0.04477018 ROSS_AML_WITH_PML_RARA_FUSION intracranial arterial disease DOID_13089 8.608E-04 0.02881073 0.04222891 0.36966541 ROSS_AML_WITH_PML_RARA_FUSION cerebral arterial disease DOID_3527 8.608E-04 0.02881073 0.04222891 0.36966541 ROSS_AML_WITH_PML_RARA_FUSION adenoid cystic carcinoma DOID_4866 8.608E-04 0.02721014 8.608E-04 0.04897825 ROSS_AML_WITH_PML_RARA_FUSION salivary gland cancer DOID_8850 9.425E-04 0.02822594 9.425E-04 0.04875389 ROSS_AML_WITH_PML_RARA_FUSION diabetic autonomic neuropathy DOID_11503 1.028E-03 0.02924246 0.04606772 0.36919061 ROSS_AML_WITH_PML_RARA_FUSION autonomic neuropathy DOID_11504 1.028E-03 0.02924246 0.04606772 0.36919061 ROSS_AML_WITH_PML_RARA_FUSION diabetic polyneuropathy DOID_12785 1.028E-03 0.02924246 0.04606772 0.36919061 ROSS_AML_WITH_PML_RARA_FUSION gallbladder cancer DOID_3121 1.028E-03 0.02784996 0.04606772 0.36406296 ROSS_AML_WITH_PML_RARA_FUSION diabetic neuropathy DOID_9743 1.028E-03 0.02924246 0.04606772 0.36919061 ROSS_AML_WITH_PML_RARA_FUSION autonomic nervous system disease DOID_11465 1.163E-03 0.03006829 0.04893699 0.35698908 ROSS_AML_WITH_PML_RARA_FUSION aortic aneurysm DOID_3627 1.305E-03 0.03229193 0.05179786 0.35509616 ROSS_AML_WITH_PML_RARA_FUSION giant cell tumor DOID_200 1.456E-03 0.03451911 0.05465034 0.36583583 ROSS_AML_WITH_PML_RARA_FUSION malignant giant cell tumor DOID_2705 1.456E-03 0.03451911 0.05465034 0.36583583 ROSS_AML_WITH_PML_RARA_FUSION giant cell glioblastoma DOID_3074 1.456E-03 0.03451911 0.05465034 0.36583583 ROSS_AML_WITH_PML_RARA_FUSION vasculitis DOID_865 1.508E-03 0.0343217 1.508E-03 0.06600327 ROSS_AML_WITH_PML_RARA_FUSION glioblastoma DOID_3068 1.725E-03 0.03774481 0.05938593 0.3796696 ROSS_AML_WITH_PML_RARA_FUSION pre-malignant neoplasm DOID_0060071 2.015E-03 0.04246908 0.06409842 0.38799999 ROSS_AML_WITH_PML_RARA_FUSION in situ carcinoma DOID_8719 2.015E-03 0.04246908 0.06409842 0.38799999 ROSS_AML_WITH_PML_RARA_FUSION parasitic infectious disease DOID_1398 2.137E-03 0.04343673 0.06597697 0.38701953 ROSS_AML_WITH_PML_RARA_FUSION astrocytoma DOID_3069 2.392E-03 0.04693843 0.06972306 0.39279625 ROSS_AML_WITH_PML_RARA_FUSION diabetic retinopathy DOID_8947 2.661E-03 0.05046542 0.07345452 0.39805356 ROSS_AML_WITH_PML_RARA_FUSION aneurysm disease DOID_2403 2.871E-03 0.05269615 0.07624355 0.39800534 ROSS_AML_WITH_PML_RARA_FUSION bacterial pneumonia DOID_874 2.943E-03 0.05232536 2.943E-03 0.09302286 ROSS_AML_WITH_PML_RARA_FUSION metabolic syndrome X DOID_14221 3.089E-03 0.05325772 3.089E-03 0.09250025 ROSS_AML_WITH_PML_RARA_FUSION chromosomal disease DOID_0080014 3.163E-03 0.05293427 3.163E-03 0.08998827 ROSS_AML_WITH_PML_RARA_FUSION retinal vascular disease DOID_2462 3.468E-03 0.05638699 0.08364106 0.40676721 ROSS_AML_WITH_PML_RARA_FUSION encephalomyelitis DOID_640 4.119E-03 0.06510129 0.09098087 0.42432883 ROSS_AML_WITH_PML_RARA_FUSION dilated cardiomyopathy DOID_12930 4.29E-03 0.06596825 0.09280687 0.42245685 ROSS_AML_WITH_PML_RARA_FUSION ulcerative colitis DOID_8577 4.552E-03 0.06815927 4.552E-03 0.11772965 MOOTHA_GLUCONEOGENESIS carbohydrate metabolic disorder DOID_2978 4.878E-20 2.776E-17 4.878E-20 2.776E-17 MOOTHA_GLUCONEOGENESIS glycogen metabolism disorder DOID_0050728 4.128E-12 1.174E-09 4.128E-12 1.174E-09 MOOTHA_GLUCONEOGENESIS glycogen storage disease DOID_2747 4.128E-12 1.174E-09 4.128E-12 1.174E-09 MOOTHA_GLUCONEOGENESIS hemolytic anemia DOID_583 6.557E-06 1.244E-03 6.557E-06 1.244E-03 MOOTHA_GLUCONEOGENESIS normocytic anemia DOID_720 6.557E-06 1.244E-03 6.557E-06 1.244E-03 MOOTHA_GLUCONEOGENESIS bone resorption disease DOID_0080011 2.457E-05 3.495E-03 2.457E-05 3.495E-03 MOOTHA_GLUCONEOGENESIS osteoporosis DOID_11476 2.457E-05 3.495E-03 2.457E-05 3.495E-03 MOOTHA_GLUCONEOGENESIS nutritional deficiency disease DOID_5113 5.099E-05 5.803E-03 5.099E-05 5.803E-03 MOOTHA_GLUCONEOGENESIS congenital hemolytic anemia DOID_589 1.335E-04 0.01266159 1.335E-04 0.01266159 MOOTHA_GLUCONEOGENESIS lung adenocarcinoma DOID_3910 1.96E-04 0.01592958 1.96E-04 0.01592958 MOOTHA_GLUCONEOGENESIS hyperglycemia DOID_4195 1.113E-03 0.07913848 1.113E-03 0.07913848 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN primary bacterial infectious disease DOID_0050338 2.039E-14 1.16E-11 7.611E-05 4.812E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN aneurysm disease DOID_2403 1.766E-13 5.025E-11 2.495E-06 4.733E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hypersensitivity reaction type I disease DOID_1205 1.803E-12 3.419E-10 8.253E-06 7.827E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN tuberculosis DOID_399 2.026E-12 2.882E-10 4.049E-04 0.01151805 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pulmonary tuberculosis DOID_2957 3.772E-12 4.293E-10 2.087E-03 0.02827474 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN carotid artery disease DOID_3407 2.686E-11 2.547E-09 2.783E-08 1.583E-05 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN respiratory failure DOID_11162 3.105E-11 2.524E-09 2.886E-04 0.01172791 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN influenza DOID_8469 7.068E-11 5.027E-09 8.137E-05 4.63E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN peripheral vascular disease DOID_341 1.17E-10 7.398E-09 3.343E-05 2.717E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN bacterial pneumonia DOID_874 2.116E-10 1.204E-08 7.027E-03 0.06151678 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN sarcoidosis DOID_11335 3.076E-10 1.591E-08 2.581E-03 0.02997032 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hypersensitivity reaction type IV disease DOID_2916 6.247E-10 2.962E-08 3.292E-03 0.03534324 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN uveitis DOID_13141 1.106E-09 4.842E-08 0.18092728 0.43255305 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN uveal disease DOID_3480 2.581E-09 1.049E-07 0.20063415 0.45847723 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pancreatitis DOID_4989 5.685E-09 2.157E-07 2.687E-06 3.822E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN aortic aneurysm DOID_3627 7.222E-09 2.568E-07 2.204E-03 0.02917054 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pleural disease DOID_1532 1.739E-08 5.821E-07 0.15664029 0.40512874 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN systemic mycosis DOID_0050136 2.079E-08 6.571E-07 0.01324509 0.09539816 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN fungal infectious disease DOID_1564 2.079E-08 6.571E-07 0.01324509 0.09539816 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN encephalomyelitis DOID_640 2.241E-08 6.711E-07 1.212E-03 0.02377902 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pulmonary sarcoidosis DOID_13406 4.031E-08 1.147E-06 0.01619259 0.11100706 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN brain infarction DOID_3454 5.789E-08 1.569E-06 5.046E-03 0.05037549 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN adult respiratory distress syndrome DOID_11394 6.325E-08 1.636E-06 1.203E-03 0.024453 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pulmonary emphysema DOID_9675 7.294E-08 1.805E-06 0.0193923 0.12683008 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN sphingolipidosis DOID_1927 1.252E-07 2.969E-06 1.252E-07 3.563E-05 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN urticaria DOID_1555 1.544E-07 3.515E-06 7.053E-03 0.06080443 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN contact dermatitis DOID_2773 1.582E-07 3.463E-06 5.142E-05 3.657E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN vascular skin disease DOID_9540 1.603E-07 3.378E-06 1.864E-03 0.02587086 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN chronic kidney failure DOID_784 2.029E-07 4.124E-06 8.003E-04 0.01821572 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN common cold DOID_10459 2.579E-07 5.06E-06 1.498E-03 0.02840444 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pleurisy DOID_10247 3.293E-07 6.247E-06 0.13585496 0.36986352 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN bone marrow cancer DOID_4960 3.559E-07 6.532E-06 1.735E-04 8.976E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN opportunistic mycosis DOID_2473 5.421E-07 9.639E-06 0.01120658 0.08856314 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN collagen disease DOID_854 7.149E-07 1.233E-05 0.03880988 0.20638151 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pneumoconiosis DOID_10316 9.8E-07 1.64E-05 0.01395772 0.0992743 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN allergic contact dermatitis DOID_3042 1.22E-06 1.984E-05 3.835E-04 0.01148443 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN multiple myeloma DOID_9538 1.462E-06 2.311E-05 9.737E-04 0.02130875 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN systemic scleroderma DOID_418 1.875E-06 2.884E-05 0.0177616 0.12031368 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN leishmaniasis DOID_9065 1.966E-06 2.944E-05 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cystic fibrosis DOID_1485 2.315E-06 3.378E-05 6.553E-03 0.05918563 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pulmonary edema DOID_11396 2.449E-06 3.483E-05 0.09274365 0.30503546 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN rheumatic disease DOID_1575 2.975E-06 4.128E-05 0.02108336 0.13039602 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN scleroderma DOID_419 2.975E-06 4.128E-05 0.02108336 0.13039602 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN funisitis DOID_0050698 3.669E-06 4.97E-05 3.669E-06 4.175E-04 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN proteinuria DOID_576 4.09E-06 5.412E-05 0.0237303 0.14065144 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN myeloma DOID_0070004 4.526E-06 5.854E-05 1.864E-03 0.02866771 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN neuritis DOID_1803 4.526E-06 5.723E-05 1.864E-03 0.02651763 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN heart valve disease DOID_4079 4.526E-06 5.599E-05 0.02464139 0.1430709 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autoimmune disease of gastrointestinal tract DOID_0060031 5.509E-06 6.669E-05 0.02650578 0.1523413 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Human immunodeficiency virus infectious disease DOID_526 6.076E-06 7.203E-05 0.01029698 0.08369973 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN bronchiolitis DOID_2942 7.385E-06 8.576E-05 7.053E-03 0.0598969 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN mouth disease DOID_403 7.774E-06 8.846E-05 0.01155201 0.08764128 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN giant cell tumor DOID_200 7.971E-06 8.893E-05 0.03039908 0.17125821 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN malignant giant cell tumor DOID_2705 7.971E-06 8.893E-05 0.03039908 0.17125821 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN giant cell glioblastoma DOID_3074 7.971E-06 8.893E-05 0.03039908 0.17125821 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN spinal muscular atrophy DOID_12377 8.637E-06 9.45E-05 3.019E-04 0.01145324 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cystitis DOID_1679 8.637E-06 9.272E-05 0.12314004 0.34859046 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN myositis DOID_633 8.637E-06 9.1E-05 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN intracranial aneurysm DOID_10941 1.004E-05 1.038E-04 3.37E-04 0.01198306 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN periodontitis DOID_824 1.16E-05 1.179E-04 0.13163716 0.36184322 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN glioblastoma DOID_3068 1.217E-05 1.215E-04 0.03556163 0.19456317 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN transient cerebral ischemia DOID_224 1.316E-05 1.291E-04 0.04749382 0.23915028 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cutaneous leishmaniasis DOID_9111 1.316E-05 1.269E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN dermatomyositis DOID_10223 1.803E-05 1.71E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN mineral metabolism disease DOID_0050032 1.93E-05 1.8E-04 0.04216642 0.22011643 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN abdominal aortic aneurysm DOID_7693 1.968E-05 1.807E-04 0.01120658 0.08734995 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN parasitic infectious disease DOID_1398 2.075E-05 1.874E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cerebral degeneration DOID_1443 2.075E-05 1.845E-04 4.472E-03 0.04543941 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN allergic rhinitis DOID_4481 2.222E-05 1.945E-04 0.01186934 0.08770981 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN encephalitis DOID_9588 2.396E-05 2.066E-04 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN bladder disease DOID_365 2.5E-05 2.123E-04 0.15664029 0.40147893 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN astrocytoma DOID_3069 2.742E-05 2.294E-04 0.04799105 0.22755755 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN periodontal disease DOID_3388 3.129E-05 2.581E-04 0.1648145 0.41495333 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN esophageal disease DOID_6050 3.129E-05 2.544E-04 0.1648145 0.40773675 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN viral pneumonia DOID_10533 3.936E-05 3.154E-04 0.06585701 0.25843198 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN calcinosis DOID_182 4.281E-05 3.383E-04 0.17692831 0.43022311 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN metabolic syndrome X DOID_14221 5.142E-05 4.008E-04 0.06044399 0.26055023 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN respiratory syncytial virus infectious disease DOID_1273 5.204E-05 4.001E-04 0.18490694 0.43838353 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN intracranial arterial disease DOID_13089 5.716E-05 4.336E-04 0.18886735 0.44224496 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cerebral arterial disease DOID_3527 5.716E-05 4.336E-04 0.18886735 0.44224496 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN silicosis DOID_10325 6.012E-05 4.501E-04 2.688E-03 0.03059359 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN primary immunodeficiency disease DOID_612 8.46E-05 6.252E-04 9.996E-03 0.08243315 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN amino acid metabolic disorder DOID_9252 8.46E-05 6.172E-04 1.033E-03 0.02176658 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN prion disease DOID_649 8.698E-05 6.265E-04 3.406E-03 0.03523538 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN leukodystrophy DOID_10579 9.593E-05 6.823E-04 0.0237303 0.14213198 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN membranous glomerulonephritis DOID_10976 1.207E-04 8.476E-04 0.09274365 0.30680893 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN calcium metabolism disease DOID_10575 1.306E-04 9.062E-04 0.22743394 0.50748984 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autoimmune hepatitis DOID_2048 1.403E-04 9.616E-04 0.09714932 0.30881542 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN mitochondrial myopathy DOID_699 1.403E-04 9.501E-04 0.09714932 0.30709978 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN atopic dermatitis DOID_3310 1.51E-04 1.011E-03 0.23492554 0.51611055 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN vasculitis DOID_865 1.735E-04 1.148E-03 0.24234489 0.52833043 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN IgA glomerulonephritis DOID_2986 1.854E-04 1.213E-03 0.10589692 0.32050716 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lingual-facial-buccal dyskinesia DOID_9854 1.854E-04 1.199E-03 1.854E-04 8.793E-03 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hypoglycemia DOID_9993 1.854E-04 1.186E-03 0.10589692 0.3171334 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN parasitic protozoa infectious disease DOID_2789 1.857E-04 1.174E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN diabetic angiopathy DOID_11713 2.112E-04 1.32E-03 6.028E-03 0.05813173 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Lewy body dementia DOID_12217 2.112E-04 1.306E-03 0.11023906 0.3284085 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN acute pancreatitis DOID_2913 2.391E-04 1.463E-03 6.531E-03 0.05993842 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN commensal bacterial infectious disease DOID_0050339 2.693E-04 1.63E-03 2.693E-04 0.01178891 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN portal hypertension DOID_10762 2.693E-04 1.613E-03 0.11886052 0.34330779 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN endocrine pancreas disease DOID_1428 3.242E-04 1.922E-03 0.04216642 0.21811537 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN spinal cord disease DOID_319 3.37E-04 1.977E-03 0.12739889 0.35534297 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN fragments of torsion dystonia DOID_531 3.37E-04 1.956E-03 3.37E-04 0.01127818 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN extrinsic allergic alveolitis DOID_841 3.37E-04 1.937E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cholestasis DOID_13580 3.432E-04 1.953E-03 3.432E-04 0.01084866 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hyperglycemia DOID_4195 3.629E-04 2.045E-03 0.04446239 0.22588484 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lung adenocarcinoma DOID_3910 3.745E-04 2.089E-03 8.727E-03 0.07302582 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN perinatal necrotizing enterocolitis DOID_8677 3.745E-04 2.069E-03 0.13163716 0.36010359 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN tooth disease DOID_1091 3.835E-04 2.098E-03 0.28885668 0.6087387 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hepatic vascular disease DOID_272 4.146E-04 2.247E-03 0.13585496 0.36291772 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autoimmune disease of the nervous system DOID_438 4.146E-04 2.226E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN central nervous system hereditary degenerative disease DOID_481 4.146E-04 2.205E-03 4.146E-04 0.01123446 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN dystonic disease DOID_544 4.574E-04 2.41E-03 4.574E-04 0.01183052 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN bile duct disease DOID_4138 4.74E-04 2.475E-03 4.74E-04 0.01172739 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN biliary tract disease DOID_9741 4.989E-04 2.58E-03 4.989E-04 0.01182727 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN diabetic retinopathy DOID_8947 5.246E-04 2.689E-03 0.30935483 0.63776413 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN bone resorption disease DOID_0080011 6.075E-04 3.086E-03 0.05660106 0.25764804 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN osteoporosis DOID_11476 6.075E-04 3.086E-03 0.05660106 0.25764804 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hyperthyroidism DOID_7998 7.74E-04 3.897E-03 0.01395772 0.09804869 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN focal epilepsy DOID_2234 8.003E-04 3.995E-03 0.06437376 0.25794838 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN retinal vascular disease DOID_2462 8.732E-04 4.321E-03 0.34542044 0.69944566 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN thyroid cancer DOID_1781 9.039E-04 4.434E-03 0.01543165 0.10708058 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN childhood type dermatomyositis DOID_14203 1.028E-03 4.998E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN progressive muscular atrophy DOID_318 1.028E-03 4.955E-03 0.04749382 0.23296536 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN nervous system cancer DOID_3093 1.076E-03 5.144E-03 0.07386261 0.27114726 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hepatitis DOID_2237 1.123E-03 5.327E-03 0.18490694 0.43656451 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lymphoma DOID_0060058 1.165E-03 5.48E-03 0.07665161 0.27780104 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lymphatic system disease DOID_75 1.203E-03 5.612E-03 0.01856932 0.12285979 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN carbohydrate metabolic disorder DOID_2978 1.212E-03 5.606E-03 0.01123038 0.08635255 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pneumocystosis DOID_11339 1.252E-03 5.745E-03 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN neuronal ceroid lipofuscinosis DOID_14503 1.252E-03 5.699E-03 0.052118 0.24109871 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Crohn's disease DOID_8778 1.26E-03 5.689E-03 0.01155201 0.0864881 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN dilated cardiomyopathy DOID_12930 1.309E-03 5.865E-03 0.01187891 0.08665515 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autoimmune disease of urogenital tract DOID_0060049 1.374E-03 6.107E-03 0.02023037 0.13080771 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN primary biliary cirrhosis DOID_12236 1.374E-03 6.107E-03 0.02023037 0.13080771 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN otitis media DOID_10754 1.498E-03 6.606E-03 0.05671985 0.25613965 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN osteopetrosis DOID_13533 1.498E-03 6.555E-03 1.498E-03 0.02748817 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN middle ear disease DOID_5100 1.498E-03 6.606E-03 0.05671985 0.25613965 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN mitochondrial encephalomyopathy DOID_890 1.498E-03 6.505E-03 0.05671985 0.24636333 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN progressive myoclonus epilepsy DOID_891 1.498E-03 6.456E-03 1.498E-03 0.02662917 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN diabetic autonomic neuropathy DOID_11503 1.559E-03 6.669E-03 1.559E-03 0.02687625 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autonomic neuropathy DOID_11504 1.559E-03 6.669E-03 1.559E-03 0.02687625 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN diabetic polyneuropathy DOID_12785 1.559E-03 6.669E-03 1.559E-03 0.02687625 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN diabetic neuropathy DOID_9743 1.559E-03 6.669E-03 1.559E-03 0.02687625 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cerebral infarction DOID_3526 1.657E-03 7.035E-03 0.2083842 0.47428244 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN cataract DOID_83 1.657E-03 6.983E-03 1.657E-03 0.02772616 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN learning disability DOID_8927 1.657E-03 6.932E-03 0.02283349 0.13821549 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN variable age at onset electroclinical syndrome DOID_0050706 1.764E-03 7.327E-03 1.764E-03 0.02868159 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN carotid stenosis DOID_13001 1.764E-03 7.274E-03 1.764E-03 0.02788488 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lens disease DOID_110 1.864E-03 7.631E-03 1.864E-03 0.02791329 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autonomic nervous system disease DOID_11465 1.864E-03 7.576E-03 1.864E-03 0.02719757 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Legionnaires' disease DOID_10457 2.052E-03 8.28E-03 0.06585701 0.26022665 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN legionellosis DOID_10458 2.052E-03 8.28E-03 0.06585701 0.26022665 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN aspergillosis DOID_13564 2.052E-03 8.221E-03 0.06585701 0.2549159 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN integumentary system benign neoplasm DOID_0060121 2.087E-03 8.304E-03 0.02650578 0.15081789 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN skin benign neoplasm DOID_3165 2.087E-03 8.304E-03 0.02650578 0.15081789 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN movement disease DOID_480 2.204E-03 8.711E-03 2.204E-03 0.02850757 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hemorrhagic disease DOID_2213 2.326E-03 9.127E-03 0.23118881 0.51385326 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN B-cell lymphocytic neoplasm DOID_707 2.326E-03 9.064E-03 0.23118881 0.51185383 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN peripheral neuropathy DOID_0060053 2.36E-03 9.134E-03 2.36E-03 0.02983879 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN membranoproliferative glomerulonephritis DOID_2920 2.36E-03 9.073E-03 2.36E-03 0.02919013 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN mesenchymal cell neoplasm DOID_3350 2.36E-03 9.012E-03 0.07039252 0.26178656 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN arthropathy DOID_381 2.36E-03 8.952E-03 2.36E-03 0.02856906 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN spindle cell sarcoma DOID_4235 2.36E-03 9.012E-03 0.07039252 0.26178656 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN epithelioid sarcoma DOID_6193 2.36E-03 9.012E-03 0.07039252 0.26178656 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hyperhomocysteinemia DOID_9279 2.36E-03 8.892E-03 2.36E-03 0.02797387 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN spastic diplegia DOID_10965 2.688E-03 0.01006368 2.688E-03 0.02999372 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN mitochondrial metabolism disease DOID_700 2.995E-03 0.01113753 0.24969268 0.53816338 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN juvenile rheumatoid arthritis DOID_676 3.037E-03 0.01122154 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hypertrophic cardiomyopathy DOID_11984 3.292E-03 0.01208511 3.292E-03 0.03602292 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN oral cavity cancer DOID_8618 3.292E-03 0.01200764 0.03556163 0.19271019 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN osteosclerosis DOID_4254 3.406E-03 0.0123436 3.406E-03 0.03588789 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN leukocyte disease DOID_9500 3.447E-03 0.01241444 0.26058168 0.555322 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN esophagitis DOID_11963 4.203E-03 0.01503972 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Kawasaki disease DOID_13378 4.63E-03 0.01646645 0.09714932 0.31055034 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lymphadenitis DOID_1602 4.63E-03 0.01646645 0.09714932 0.31055034 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lymph node disease DOID_9942 4.63E-03 0.01646645 0.09714932 0.31055034 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN temporal lobe epilepsy DOID_3328 4.659E-03 0.01646512 0.28538197 0.60365183 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN endocrine organ benign neoplasm DOID_0060089 5.046E-03 0.01772471 0.29231458 0.61375275 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN neutropenia DOID_1227 5.077E-03 0.01772324 0.1015337 0.31569769 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN acquired immunodeficiency syndrome DOID_635 5.077E-03 0.01761517 0.1015337 0.31398195 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN blood coagulation disease DOID_1247 5.453E-03 0.01880402 0.29918029 0.62585876 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN sinusitis DOID_0050127 5.543E-03 0.01899982 0.10589692 0.32570458 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN agranulocytosis DOID_12987 5.543E-03 0.01888605 0.10589692 0.32395348 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN paranasal sinus disease DOID_1352 5.543E-03 0.01899982 0.10589692 0.32570458 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN myasthenia gravis DOID_437 5.543E-03 0.01877364 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN uremia DOID_4676 5.543E-03 0.01866255 5.543E-03 0.05437881 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN sleep disorder DOID_535 5.543E-03 0.01855277 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN polyarteritis nodosa DOID_9810 5.543E-03 0.01844427 0.10589692 0.31881136 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN nephrosis DOID_2527 5.663E-03 0.01873468 0.05039837 0.23699727 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN male reproductive system disease DOID_48 5.663E-03 0.01862638 0.30258826 0.62836759 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Goodpasture syndrome DOID_9808 6.028E-03 0.01971133 0.11023906 0.32167192 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN spastic quadriplegia DOID_10970 6.531E-03 0.02123532 6.531E-03 0.06193636 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN toxic shock syndrome DOID_14115 6.531E-03 0.02111467 6.531E-03 0.06092101 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN syndrome DOID_225 6.553E-03 0.02106607 0.31605611 0.64922717 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN electroclinical syndrome DOID_0050701 7.027E-03 0.02246399 7.027E-03 0.06247798 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lipid metabolism disorder DOID_3146 7.522E-03 0.02390947 0.06044399 0.2585912 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN neuromuscular junction disease DOID_439 7.593E-03 0.0240022 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN middle cerebral artery infarction DOID_3525 8.151E-03 0.02562423 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN biliary tract cancer DOID_4607 8.301E-03 0.02595076 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN gestational diabetes DOID_11714 8.727E-03 0.02713528 0.13163716 0.36537339 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autoimmune disease of cardiovascular system DOID_0060051 9.321E-03 0.02882392 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN renal hypertension DOID_1073 9.321E-03 0.02866811 0.13585496 0.36810226 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN secondary hypertension DOID_11130 9.321E-03 0.02866811 0.13585496 0.36810226 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN sarcoma DOID_1115 9.321E-03 0.02851398 0.13585496 0.3663577 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Behcet's disease DOID_13241 9.321E-03 0.02882392 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN thrombocytopenia DOID_1588 9.321E-03 0.0283615 0.13585496 0.3646296 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN coronary stenosis DOID_4248 9.321E-03 0.02821064 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autoimmune disease of endocrine system DOID_0060005 9.932E-03 0.02990168 0.14005239 0.37238229 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN polycystic ovary syndrome DOID_11612 9.932E-03 0.0297443 0.14005239 0.37065028 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN spastic cerebral palsy DOID_0050669 0.01120658 0.03338506 0.01120658 0.08981051 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN lymphoblastic leukemia DOID_1037 0.01123038 0.03328171 0.07805851 0.28110946 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.01155201 0.03405749 0.07947355 0.27573443 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN celiac disease DOID_10608 0.01186934 0.03481266 0.15252339 0.39810004 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN chronic leukemia DOID_1036 0.0125489 0.03661705 0.15664029 0.40697864 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN chronic lymphocytic leukemia DOID_1040 0.0125489 0.03661705 0.15664029 0.40697864 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN autonomic nervous system neoplasm DOID_2621 0.0125489 0.03643023 0.15664029 0.40329558 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN neuroblastoma DOID_769 0.0125489 0.03643023 0.15664029 0.40329558 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN ulcerative colitis DOID_8577 0.01289137 0.03723447 0.08521271 0.29033551 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN papilloma DOID_2615 0.01324509 0.0380629 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN myocarditis DOID_820 0.01324509 0.03787163 0.16073729 0.41013237 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN thyroid carcinoma DOID_3963 0.01395772 0.03970972 0.1648145 0.41312534 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN spindle cell carcinoma DOID_4015 0.01395772 0.03951216 0.1648145 0.41131338 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN macular degeneration DOID_4448 0.01395772 0.03931656 0.1648145 0.40951726 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN leukopenia DOID_615 0.01395772 0.03912288 0.1648145 0.40597165 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN peripheral nervous system neoplasm DOID_1192 0.0169693 0.04733104 0.18092728 0.43437816 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN blood platelet disease DOID_2218 0.0169693 0.04710015 0.18092728 0.4307432 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN peptic ulcer DOID_750 0.0177616 0.04905995 0.18490694 0.43476052 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN adenoid cystic carcinoma DOID_4866 0.01856932 0.0510432 0.01856932 0.1243052 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN benign mesothelioma DOID_2645 0.0193923 0.05304912 0.19280864 0.44962342 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN endometriosis of uterus DOID_288 0.02023037 0.05507693 0.02023037 0.12933796 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN salivary gland cancer DOID_8850 0.02023037 0.05481466 0.02023037 0.12790087 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN nephrotic syndrome DOID_1184 0.02108336 0.05685514 0.20063415 0.46406841 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN Huntington's disease DOID_12858 0.02108336 0.05658695 0.02108336 0.13182895 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN endometriosis DOID_289 0.02108336 0.05632129 0.02108336 0.12899391 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN gallbladder cancer DOID_3121 0.02195113 0.05836538 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pre-eclampsia DOID_10591 0.02464139 0.06521371 0.02464139 0.14454586 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN brain cancer DOID_1319 0.02464139 0.0649118 0.21605952 0.48784868 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN thyroid adenoma DOID_2891 0.02464139 0.06461266 1.000 1.000 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN central nervous system cancer DOID_3620 0.0255666 0.06673117 0.21986938 0.49448884 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN hemolytic anemia DOID_583 0.0255666 0.06642646 0.21986938 0.49254203 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN normocytic anemia DOID_720 0.0255666 0.06642646 0.21986938 0.49254203 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN atrophic muscular disease DOID_913 0.03039908 0.07862309 0.2386442 0.52226366 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN muscular dystrophy DOID_9884 0.03039908 0.07862309 0.2386442 0.52226366 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN osteochondrodysplasia DOID_2256 0.03242555 0.08348478 0.03242555 0.18088369 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN pustulosis of palm and sole DOID_4398 0.03242555 0.08310872 0.24602768 0.53228043 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN smallpox DOID_8736 0.03242555 0.08273604 0.03242555 0.17912753 RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN neuroectodermal tumor DOID_171 0.03880988 0.09858403 0.03880988 0.20832851 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN myocarditis DOID_820 8.365E-07 4.76E-04 5.271E-05 4.998E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN pulmonary emphysema DOID_9675 1.905E-06 5.418E-04 9.664E-05 6.11E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN vasculitis DOID_865 5.434E-06 1.031E-03 5.434E-06 3.092E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN blood protein disease DOID_620 8.612E-06 1.225E-03 8.612E-06 2.45E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN pancreatic ductal carcinoma DOID_3587 1.461E-05 1.663E-03 1.461E-05 2.772E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN pancreatic carcinoma DOID_4905 1.715E-05 1.626E-03 1.715E-05 2.439E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN female reproductive system disease DOID_229 2.43E-05 1.975E-03 2.43E-05 2.765E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN pneumoconiosis DOID_10316 5.727E-05 4.074E-03 2.524E-03 0.05744559 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN uveitis DOID_13141 7.812E-05 4.939E-03 7.812E-05 6.35E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN adult respiratory distress syndrome DOID_11394 9.018E-05 5.131E-03 9.018E-05 6.414E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN endometriosis DOID_289 1.105E-04 5.713E-03 1.105E-04 6.285E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN uveal disease DOID_3480 1.105E-04 5.237E-03 1.105E-04 5.713E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN cerebral infarction DOID_3526 1.255E-04 5.492E-03 0.09188274 0.38442117 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN respiratory failure DOID_11162 3.092E-04 0.01256855 3.092E-04 0.01466331 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN cholestasis DOID_13580 3.533E-04 0.01340114 0.1276608 0.44838886 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN uterine disease DOID_345 3.533E-04 0.01256357 3.533E-04 0.01546285 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN brain infarction DOID_3454 4.012E-04 0.01342729 0.13290614 0.46111947 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN bile duct disease DOID_4138 4.53E-04 0.014321 0.13812035 0.47060168 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN silicosis DOID_10325 4.673E-04 0.01399541 0.03160351 0.23054354 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN hemolytic-uremic syndrome DOID_12554 4.673E-04 0.01329564 0.03160351 0.22762527 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN biliary tract disease DOID_9741 4.712E-04 0.01276824 0.13985154 0.47366384 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN Graves' disease DOID_12361 5.29E-04 0.01368074 5.29E-04 0.02149831 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN auditory system disease DOID_2742 6.564E-04 0.01623908 6.564E-04 0.02489993 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN agammaglobulinemia DOID_2583 6.634E-04 0.01572714 6.634E-04 0.02359071 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN amino acid metabolic disorder DOID_9252 8.285E-04 0.01885761 8.285E-04 0.02773177 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN funisitis DOID_0050698 8.926E-04 0.01953491 8.926E-04 0.02821709 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN mouth disease DOID_403 9.675E-04 0.02038895 0.01601467 0.16874717 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN sinusitis DOID_0050127 9.764E-04 0.01984135 0.04511816 0.27604554 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN paranasal sinus disease DOID_1352 9.764E-04 0.01984135 0.04511816 0.27604554 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN ulcerative colitis DOID_8577 1.089E-03 0.02136027 0.01729528 0.17264941 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN B cell deficiency DOID_2115 1.449E-03 0.02748913 1.449E-03 0.04340388 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN middle cerebral artery infarction DOID_3525 1.449E-03 0.02660238 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN Sciatic Neuropathy DOID_11446 1.555E-03 0.02764414 1.555E-03 0.04423062 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN lesion of sciatic nerve DOID_12528 1.555E-03 0.02764414 1.555E-03 0.04423062 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN lung adenocarcinoma DOID_3910 1.555E-03 0.02680644 1.555E-03 0.0421244 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN mononeuritis of lower limb DOID_9473 1.555E-03 0.02764414 1.555E-03 0.04423062 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN mononeuritis DOID_1802 1.664E-03 0.0278403 1.664E-03 0.04302592 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN autoimmune disease of endocrine system DOID_0060005 1.776E-03 0.02887256 1.776E-03 0.0439365 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN mononeuropathy DOID_1188 1.776E-03 0.02807054 1.776E-03 0.04210581 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN toxic encephalopathy DOID_3602 1.776E-03 0.02731188 0.06033568 0.30114916 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN bronchiolitis obliterans DOID_2799 2.011E-03 0.03011788 0.06410251 0.3091045 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN hyperthyroidism DOID_7998 2.524E-03 0.0368241 2.524E-03 0.05523615 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN autosomal recessive nonsyndromic deafness DOID_0050565 2.801E-03 0.03984331 2.801E-03 0.05902713 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN pulmonary sarcoidosis DOID_13406 2.945E-03 0.04086443 2.945E-03 0.0598372 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN hepatitis DOID_2237 3.242E-03 0.04392014 3.242E-03 0.06360848 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN intracranial arterial disease DOID_13089 3.396E-03 0.04493315 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN cerebral arterial disease DOID_3527 3.396E-03 0.04493315 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN endometriosis of uterus DOID_288 3.713E-03 0.04801819 3.713E-03 0.07042668 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN leukodystrophy DOID_10579 4.388E-03 0.05548435 4.388E-03 0.08054179 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN neuritis DOID_1803 4.565E-03 0.05646668 4.565E-03 0.08117085 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN hemolytic anemia DOID_583 4.745E-03 0.05744665 0.09734033 0.39004683 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN normocytic anemia DOID_720 4.745E-03 0.05744665 0.09734033 0.39004683 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN glaucoma DOID_1686 4.929E-03 0.05842424 4.929E-03 0.08498072 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN sarcoidosis DOID_11335 5.694E-03 0.06612568 5.694E-03 0.09529877 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN giant cell tumor DOID_200 5.694E-03 0.06480316 5.694E-03 0.09257595 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN malignant giant cell tumor DOID_2705 5.694E-03 0.06480316 5.694E-03 0.09257595 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN giant cell glioblastoma DOID_3074 5.694E-03 0.06480316 5.694E-03 0.09257595 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN nonsyndromic deafness DOID_0050563 6.723E-03 0.07501042 6.723E-03 0.10626477 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN hypersensitivity reaction type IV disease DOID_2916 6.723E-03 0.07356792 6.723E-03 0.10339275 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN glioblastoma DOID_3068 6.723E-03 0.07217984 6.723E-03 0.10067189 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN bile duct cancer DOID_4606 6.723E-03 0.07084318 6.723E-03 0.09809056 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN bile duct carcinoma DOID_4897 6.723E-03 0.07084318 6.723E-03 0.09809056 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN cerebral degeneration DOID_1443 8.294E-03 0.08580419 8.294E-03 0.11798077 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN temporal lobe epilepsy DOID_3328 8.53E-03 0.0866757 8.53E-03 0.11838632 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN hyperglycemia DOID_4195 8.53E-03 0.08515507 8.53E-03 0.11556759 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN tooth disease DOID_1091 8.77E-03 0.08603724 0.13116116 0.45785706 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN endocrine organ benign neoplasm DOID_0060089 9.013E-03 0.0869184 9.013E-03 0.11926013 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN astrocytoma DOID_3069 9.258E-03 0.08779849 9.258E-03 0.11972522 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN nephrosis DOID_2527 9.758E-03 0.09102333 9.758E-03 0.12338718 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN male reproductive system disease DOID_48 9.758E-03 0.08955521 9.758E-03 0.12070485 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN cystic fibrosis DOID_1485 0.01079352 0.09748431 0.01079352 0.13067046 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN giant cell tumor DOID_200 1.915E-07 1.09E-04 1.768E-05 2.515E-03 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN malignant giant cell tumor DOID_2705 1.915E-07 1.09E-04 1.768E-05 2.515E-03 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN giant cell glioblastoma DOID_3074 1.915E-07 1.09E-04 1.768E-05 2.515E-03 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN glioblastoma DOID_3068 2.713E-07 7.717E-05 2.289E-05 2.171E-03 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN astrocytoma DOID_3069 5.311E-07 1.007E-04 3.767E-05 3.062E-03 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN granulosa cell tumor DOID_2999 6.323E-07 8.995E-05 0.01690705 0.30062847 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN sex cord-gonadal stromal tumor DOID_192 7.435E-07 8.461E-05 0.01778917 0.29770692 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN bone development disease DOID_0080006 1.086E-06 1.03E-04 1.086E-06 6.182E-04 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN lymphoblastic leukemia DOID_1037 1.62E-06 1.316E-04 1.62E-06 4.608E-04 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN uterine cancer DOID_363 1.04E-05 7.398E-04 0.04131803 0.32205422 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN orofacial cleft DOID_0050567 1.675E-05 1.059E-03 1.675E-05 3.176E-03 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN osteochondrodysplasia DOID_2256 1.966E-05 1.119E-03 1.966E-05 2.237E-03 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN endocrine organ benign neoplasm DOID_0060089 3.613E-05 1.869E-03 0.0617726 0.37794206 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN nervous system cancer DOID_3093 7.836E-05 3.716E-03 3.107E-03 0.10398823 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN angiosarcoma DOID_0001816 9.295E-05 4.068E-03 0.01425608 0.28970398 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN muscle cancer DOID_4045 1.952E-04 7.933E-03 1.000 1.000 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN synostosis DOID_11971 2.128E-04 8.073E-03 2.128E-04 0.01513665 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN seminoma DOID_4440 2.908E-04 0.01034203 1.000 1.000 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN extrinsic allergic alveolitis DOID_841 2.908E-04 9.734E-03 0.0248185 0.306994 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN sarcoma DOID_1115 3.343E-04 0.01056726 0.02656818 0.31494368 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN toxic encephalopathy DOID_3602 3.571E-04 0.0106955 0.02744189 0.31228866 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN dysostosis DOID_1934 3.807E-04 0.01083201 3.807E-04 0.02407114 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN endometrial cancer DOID_1380 4.301E-04 0.01165501 0.03005843 0.31672674 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN germinoma DOID_3304 4.301E-04 0.01112524 1.000 1.000 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN chronic leukemia DOID_1036 4.56E-04 0.01128014 4.56E-04 0.02594431 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN chronic lymphocytic leukemia DOID_1040 4.56E-04 0.01128014 4.56E-04 0.02594431 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN autonomic nervous system neoplasm DOID_2621 4.56E-04 0.01081013 4.56E-04 0.02358574 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN neuroblastoma DOID_769 4.56E-04 0.01081013 4.56E-04 0.02358574 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN multiple myeloma DOID_9538 5.961E-04 0.01356624 0.03527102 0.30875711 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN peripheral nervous system neoplasm DOID_1192 6.263E-04 0.01370571 6.263E-04 0.0296957 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN myeloma DOID_0070004 9.309E-04 0.01961724 0.04389832 0.33304196 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN pre-eclampsia DOID_10591 9.309E-04 0.01891663 0.04389832 0.32865983 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN vascular skin disease DOID_9540 9.309E-04 0.01826433 0.04389832 0.31617907 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN bone marrow cancer DOID_4960 1.208E-03 0.02291239 0.04989283 0.33796454 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN neuroectodermal tumor DOID_171 1.52E-03 0.02789854 1.52E-03 0.06652728 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN collagen disease DOID_854 1.52E-03 0.02702671 0.05585085 0.35706893 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN respiratory failure DOID_11162 1.567E-03 0.02702454 0.05669903 0.35846388 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN temporal lobe epilepsy DOID_3328 1.764E-03 0.02951775 0.06008436 0.37160873 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN tuberculosis DOID_399 1.866E-03 0.03033928 1.866E-03 0.07584821 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN pancreatic ductal carcinoma DOID_3587 1.971E-03 0.03115894 0.0634579 0.38412283 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN peripheral vascular disease DOID_341 2.079E-03 0.03197672 0.06514026 0.38211142 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN pancreatic carcinoma DOID_4905 2.134E-03 0.03195879 0.06598034 0.37922033 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN diabetic retinopathy DOID_8947 2.134E-03 0.03113933 0.06598034 0.37542813 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN bone resorption disease DOID_0080011 2.303E-03 0.03276651 2.303E-03 0.08737736 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN osteoporosis DOID_11476 2.303E-03 0.03276651 2.303E-03 0.08737736 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN focal epilepsy DOID_2234 2.66E-03 0.03691663 0.07350815 0.40217441 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN retinal vascular disease DOID_2462 2.784E-03 0.03772152 0.07517298 0.40352291 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN primary bacterial infectious disease DOID_0050338 2.911E-03 0.03852461 2.911E-03 0.10353488 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN transitional cell carcinoma DOID_2671 2.976E-03 0.03848314 0.07766479 0.41300249 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN encephalomyelitis DOID_640 3.308E-03 0.04183241 0.08180333 0.41933417 BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.377E-03 0.0417703 0.08262887 0.41978417 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP metabolic syndrome X DOID_14221 6.497E-14 3.697E-11 0.0112857 0.11675566 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP aneurysm disease DOID_2403 3.331E-12 9.476E-10 4.974E-07 2.83E-04 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP primary immunodeficiency disease DOID_612 1.065E-11 2.02E-09 1.008E-06 2.867E-04 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP tuberculosis DOID_399 9.711E-11 1.381E-08 0.12964276 0.40755101 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP primary bacterial infectious disease DOID_0050338 4.893E-10 5.569E-08 0.15978273 0.46864111 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hypersensitivity reaction type I disease DOID_1205 9.011E-10 8.545E-08 1.384E-06 2.625E-04 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP opportunistic mycosis DOID_2473 5.616E-09 4.565E-07 3.734E-05 4.25E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP endocrine organ benign neoplasm DOID_0060089 5.824E-09 4.143E-07 8.562E-03 0.09942412 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP systemic mycosis DOID_0050136 8.88E-09 5.614E-07 4.866E-05 4.615E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP fungal infectious disease DOID_1564 8.88E-09 5.614E-07 4.866E-05 4.615E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP respiratory syncytial virus infectious disease DOID_1273 1.986E-08 1.13E-06 7.759E-05 5.518E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP encephalomyelitis DOID_640 3.406E-08 1.762E-06 8.686E-04 0.01976992 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP influenza DOID_8469 3.554E-08 1.685E-06 3.839E-03 0.05327268 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Crohn's disease DOID_8778 3.628E-08 1.588E-06 0.01522702 0.14685041 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pulmonary tuberculosis DOID_2957 5.975E-08 2.429E-06 0.09667108 0.34378654 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP sarcoidosis DOID_11335 8.729E-08 3.311E-06 0.10371334 0.35983471 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hypersensitivity reaction type IV disease DOID_2916 1.349E-07 4.798E-06 0.11244005 0.36769189 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP carotid artery disease DOID_3407 1.721E-07 5.761E-06 7.007E-03 0.08667836 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP cholestasis DOID_13580 2.339E-07 7.394E-06 7.878E-03 0.09339188 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP brain infarction DOID_3454 2.908E-07 8.71E-06 8.562E-03 0.09743564 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP gestational diabetes DOID_11714 3.06E-07 8.707E-06 0.05510601 0.26799417 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pancreatic ductal carcinoma DOID_3587 3.345E-07 9.064E-06 0.13304363 0.41594408 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bile duct disease DOID_4138 3.582E-07 9.265E-06 9.271E-03 0.1034383 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP biliary tract disease DOID_9741 3.832E-07 9.48E-06 9.513E-03 0.10409789 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pancreatic carcinoma DOID_4905 4.096E-07 9.71E-06 0.13812035 0.42481341 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP cystic fibrosis DOID_1485 4.666E-07 1.062E-05 4.889E-04 0.01464098 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pancreatitis DOID_4989 5.297E-07 1.159E-05 5.265E-04 0.01497933 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bacterial pneumonia DOID_874 5.297E-07 1.116E-05 0.01076552 0.11343666 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP conjunctival disease DOID_4251 8.483E-07 1.724E-05 0.01935111 0.17759329 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP conjunctivitis DOID_6195 8.483E-07 1.724E-05 0.01935111 0.17759329 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pneumocystosis DOID_11339 1.165E-06 2.285E-05 0.02126579 0.19206719 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.315E-06 2.493E-05 0.01522702 0.14938231 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP adult respiratory distress syndrome DOID_11394 1.558E-06 2.859E-05 8.329E-05 5.266E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pulmonary emphysema DOID_9675 1.711E-06 3.042E-05 0.08242241 0.31688074 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Huntington's disease DOID_12858 2.051E-06 3.536E-05 3.68E-03 0.053689 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP eyelid disease DOID_530 2.559E-06 4.282E-05 0.02698771 0.20205269 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP membranoproliferative glomerulonephritis DOID_2920 3.194E-06 5.192E-05 3.882E-04 0.01380606 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP glaucoma DOID_1686 3.372E-06 5.33E-05 4.679E-03 0.06191625 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP aortic aneurysm DOID_3627 3.642E-06 5.601E-05 4.856E-03 0.0628029 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hemolytic-uremic syndrome DOID_12554 3.925E-06 5.878E-05 0.03078397 0.20852477 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP giant cell tumor DOID_200 4.548E-06 6.635E-05 1.837E-04 9.503E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP malignant giant cell tumor DOID_2705 4.548E-06 6.635E-05 1.837E-04 9.503E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP giant cell glioblastoma DOID_3074 4.548E-06 6.635E-05 1.837E-04 9.503E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP prion disease DOID_649 5.704E-06 8.114E-05 5.635E-04 0.01457544 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP glioblastoma DOID_3068 6.414E-06 8.902E-05 2.368E-04 0.01123064 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP membranous glomerulonephritis DOID_10976 7.946E-06 1.077E-04 6.981E-04 0.01654998 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP respiratory failure DOID_11162 8.273E-06 1.095E-04 2.859E-04 0.01251157 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP coronary restenosis DOID_4247 9.258E-06 1.197E-04 0.04021083 0.22213557 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP astrocytoma DOID_3069 1.244E-05 1.573E-04 3.865E-04 0.01466108 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP nephrosis DOID_2527 1.387E-05 1.716E-04 4.189E-04 0.01402141 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP ureteral disease DOID_1426 1.403E-05 1.698E-04 1.009E-03 0.02126206 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bronchiolitis DOID_2942 1.797E-05 2.13E-04 0.04954723 0.24949005 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP ankylosing spondylitis DOID_7147 2.019E-05 2.344E-04 0.05140373 0.25433673 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP intracranial aneurysm DOID_10941 2.258E-05 2.57E-04 2.258E-05 3.212E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP renal hypertension DOID_1073 2.791E-05 3.113E-04 1.578E-03 0.02896659 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP secondary hypertension DOID_11130 2.791E-05 3.113E-04 1.578E-03 0.02896659 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP coronary stenosis DOID_4248 2.791E-05 3.053E-04 0.0569518 0.26561944 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP autoimmune disease of endocrine system DOID_0060005 3.085E-05 3.312E-04 1.685E-03 0.02905098 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP focal glomerulosclerosis DOID_3945 3.085E-05 3.251E-04 0.05879403 0.26550636 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP corneal disease DOID_10124 3.4E-05 3.517E-04 0.06063271 0.27165363 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP age related macular degeneration DOID_10871 3.734E-05 3.794E-04 0.06246785 0.2776891 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP degeneration of macula and posterior pole DOID_2007 3.734E-05 3.794E-04 0.06246785 0.2776891 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP abdominal aortic aneurysm DOID_7693 3.734E-05 3.728E-04 1.908E-03 0.03102356 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pleural disease DOID_1532 4.467E-05 4.382E-04 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pneumoconiosis DOID_10316 5.288E-05 5.1E-04 0.0697731 0.29850295 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP nephroblastoma DOID_2154 5.288E-05 5.015E-04 5.288E-05 4.299E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP thyroid carcinoma DOID_3963 5.288E-05 4.933E-04 0.0697731 0.29408068 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP macular degeneration DOID_4448 5.288E-05 4.853E-04 0.0697731 0.29191832 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP thyroid cancer DOID_1781 6.203E-05 5.602E-04 0.07340464 0.30266114 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pulmonary sarcoidosis DOID_13406 6.696E-05 5.953E-04 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP uveitis DOID_13141 7.215E-05 6.316E-04 2.934E-03 0.04511876 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP congenital diaphragmatic hernia DOID_3827 7.759E-05 6.689E-04 0.07882574 0.30720441 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP intracranial arterial disease DOID_13089 8.329E-05 7.073E-04 0.08062581 0.3120822 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP cerebral arterial disease DOID_3527 8.329E-05 7.073E-04 0.08062581 0.3120822 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hyperinsulinism DOID_2018 1.02E-04 8.537E-04 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP uveal disease DOID_3480 1.02E-04 8.413E-04 3.68E-03 0.05234677 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP diabetic autonomic neuropathy DOID_11503 1.088E-04 8.846E-04 0.08779146 0.33302226 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP autonomic neuropathy DOID_11504 1.088E-04 8.846E-04 0.08779146 0.33302226 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP diabetic polyneuropathy DOID_12785 1.088E-04 8.846E-04 0.08779146 0.33302226 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP diabetic neuropathy DOID_9743 1.088E-04 8.846E-04 0.08779146 0.33302226 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP cerebral infarction DOID_3526 1.159E-04 9.29E-04 0.08957424 0.33531411 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pre-eclampsia DOID_10591 1.31E-04 1.035E-03 0.09312951 0.3440954 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP autonomic nervous system disease DOID_11465 1.31E-04 1.021E-03 0.09312951 0.34187543 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP neuritis DOID_1803 1.31E-04 1.007E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP thyroid adenoma DOID_2891 1.31E-04 9.938E-04 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP heart valve disease DOID_4079 1.31E-04 9.807E-04 4.334E-03 0.05870964 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hemolytic anemia DOID_583 1.39E-04 1.027E-03 0.09490201 0.34176735 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP normocytic anemia DOID_720 1.39E-04 1.027E-03 0.09490201 0.34176735 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.473E-04 1.074E-03 0.09667108 0.34594872 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP phagocyte bactericidal dysfunction DOID_3262 1.674E-04 1.206E-03 1.674E-04 9.527E-03 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP adrenal gland hyperfunction DOID_3947 1.674E-04 1.191E-03 0.01935111 0.18050465 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP parasitic protozoa infectious disease DOID_2789 2.039E-04 1.432E-03 0.10721414 0.35675347 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pustulosis of palm and sole DOID_4398 2.039E-04 1.415E-03 5.789E-03 0.07320028 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP invasive lobular carcinoma DOID_3457 2.044E-04 1.401E-03 0.02126579 0.18333686 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP heroin dependence DOID_9976 2.044E-04 1.384E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hypertrophic cardiomyopathy DOID_11984 2.368E-04 1.586E-03 0.11244005 0.36981727 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pituitary cancer DOID_1785 2.45E-04 1.621E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pituitary carcinoma DOID_4916 2.45E-04 1.621E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP leukocyte disease DOID_9500 2.485E-04 1.626E-03 0.11417531 0.36912357 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hypothyroidism DOID_1459 2.859E-04 1.848E-03 2.859E-04 0.01161789 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP impotence DOID_1875 2.891E-04 1.848E-03 0.02508408 0.19551835 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Lynch syndrome DOID_3883 2.891E-04 1.828E-03 0.02508408 0.19287621 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP congenital heart defect DOID_1682 2.99E-04 1.87E-03 7.437E-03 0.09003608 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP endocrine pancreas disease DOID_1428 3.126E-04 1.934E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP parasitic infectious disease DOID_1398 3.266E-04 1.998E-03 0.12451678 0.39581032 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP uterine disease DOID_345 3.266E-04 1.977E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP allergic contact dermatitis DOID_3042 3.557E-04 2.131E-03 0.1279374 0.40442434 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP skeletal system cancer DOID_0060124 3.882E-04 2.301E-03 0.02888767 0.21073185 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bone cancer DOID_184 3.882E-04 2.301E-03 0.02888767 0.21073185 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP adrenal cortex disease DOID_3952 3.882E-04 2.277E-03 0.02888767 0.20292696 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP male reproductive system disease DOID_48 4.189E-04 2.432E-03 0.13473914 0.418943 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP peripheral vascular disease DOID_341 4.358E-04 2.505E-03 0.13643138 0.4218992 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP silicosis DOID_10325 4.431E-04 2.521E-03 0.03078397 0.21103711 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP spastic diplegia DOID_10965 4.431E-04 2.496E-03 4.431E-04 0.01400748 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pituitary adenoma DOID_3829 4.431E-04 2.472E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP diabetic retinopathy DOID_8947 4.53E-04 2.503E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Graves' disease DOID_12361 5.016E-04 2.744E-03 0.03267662 0.21371263 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP penile disease DOID_1529 5.016E-04 2.718E-03 0.03267662 0.21128407 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP adrenal gland disease DOID_9553 5.016E-04 2.692E-03 0.03267662 0.2089101 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP mixed glioma DOID_5076 5.265E-04 2.8E-03 0.01076552 0.11557697 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP glucose intolerance DOID_10603 5.635E-04 2.969E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP sexual dysfunction DOID_1876 5.635E-04 2.942E-03 0.03456563 0.21613013 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP ureteral obstruction DOID_5199 5.635E-04 2.915E-03 5.635E-04 0.01526951 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP contact dermatitis DOID_2773 5.659E-04 2.901E-03 0.14818599 0.44849908 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP female reproductive system disease DOID_229 5.863E-04 2.979E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP chronic kidney failure DOID_784 6.286E-04 3.165E-03 0.15317523 0.45394118 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP testicular cancer DOID_2998 6.291E-04 3.14E-03 6.291E-04 0.01556225 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP retinal vascular disease DOID_2462 6.726E-04 3.328E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP autoimmune hepatitis DOID_2048 7.706E-04 3.78E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP nervous system cancer DOID_3093 7.914E-04 3.849E-03 0.01404824 0.14023591 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP acquired immunodeficiency syndrome DOID_635 8.466E-04 4.082E-03 0.04208532 0.23025527 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP dilated cardiomyopathy DOID_12930 9.227E-04 4.412E-03 0.17284553 0.49671266 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP sexual disorder DOID_0060043 9.26E-04 4.391E-03 0.0439562 0.23595357 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP opiate dependence DOID_2559 9.26E-04 4.355E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP IgA glomerulonephritis DOID_2986 9.26E-04 4.319E-03 0.0439562 0.23374839 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP urinary tract obstruction DOID_5200 9.26E-04 4.284E-03 9.26E-04 0.02026543 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP diabetic angiopathy DOID_11713 1.009E-03 4.63E-03 0.04582347 0.23920694 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Goodpasture syndrome DOID_9808 1.009E-03 4.593E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP acute pancreatitis DOID_2913 1.095E-03 4.946E-03 0.04768715 0.24226775 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP portal hypertension DOID_10762 1.185E-03 5.309E-03 1.185E-03 0.02408177 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP myositis DOID_633 1.278E-03 5.682E-03 0.05140373 0.25656775 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP B cell deficiency DOID_2115 1.375E-03 6.064E-03 1.375E-03 0.02697491 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP seminoma DOID_4440 1.375E-03 6.017E-03 1.375E-03 0.02607575 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP extrinsic allergic alveolitis DOID_841 1.375E-03 5.972E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Sciatic Neuropathy DOID_11446 1.475E-03 6.357E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP lesion of sciatic nerve DOID_12528 1.475E-03 6.357E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP migraine DOID_6364 1.475E-03 6.309E-03 0.05510601 0.26349007 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP perinatal necrotizing enterocolitis DOID_8677 1.475E-03 6.262E-03 0.05510601 0.26129432 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP mononeuritis of lower limb DOID_9473 1.475E-03 6.357E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pleurisy DOID_10247 1.578E-03 6.652E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP malaria DOID_12365 1.578E-03 6.603E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP mononeuritis DOID_1802 1.578E-03 6.554E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hepatic vascular disease DOID_272 1.578E-03 6.507E-03 1.578E-03 0.02806139 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP mononeuropathy DOID_1188 1.685E-03 6.897E-03 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP toxic encephalopathy DOID_3602 1.685E-03 6.848E-03 0.05879403 0.26763041 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP spastic cerebral palsy DOID_0050669 1.908E-03 7.701E-03 1.908E-03 0.03193602 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP germinoma DOID_3304 2.025E-03 8.114E-03 2.025E-03 0.03200651 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hepatitis C DOID_1883 2.395E-03 9.53E-03 0.0697731 0.29627531 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hyperthyroidism DOID_7998 2.395E-03 9.463E-03 0.0697731 0.28978753 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP calcinosis DOID_182 2.794E-03 0.01096526 0.07521516 0.30569589 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP multiple myeloma DOID_9538 2.794E-03 0.01089016 0.07521516 0.29928269 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hepatitis DOID_2237 3.077E-03 0.01190923 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP benign mesothelioma DOID_2645 3.372E-03 0.01296382 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP autoimmune disease of urogenital tract DOID_0060049 3.524E-03 0.01345877 3.524E-03 0.05277255 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP primary biliary cirrhosis DOID_12236 3.524E-03 0.01345877 3.524E-03 0.05277255 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP endometriosis of uterus DOID_288 3.524E-03 0.01336905 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP endometriosis DOID_289 3.68E-03 0.01386669 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP uterine cancer DOID_363 3.839E-03 0.0143696 0.08779146 0.33081681 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP proteinuria DOID_576 4.165E-03 0.0154912 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP myeloma DOID_0070004 4.334E-03 0.01601172 0.09312951 0.34634439 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP brain cancer DOID_1319 4.334E-03 0.01590842 0.09312951 0.33968392 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP vascular skin disease DOID_9540 4.334E-03 0.01580644 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP central nervous system cancer DOID_3620 4.505E-03 0.01632625 0.09490201 0.34394421 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP calcium metabolism disease DOID_10575 4.856E-03 0.01748942 0.09843675 0.34574389 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bile duct adenocarcinoma DOID_4896 5.597E-03 0.02002784 0.10546543 0.361505 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP cholangiocarcinoma DOID_4947 5.597E-03 0.02002784 0.10546543 0.361505 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bone marrow cancer DOID_4960 5.597E-03 0.01990267 0.10546543 0.3593403 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP vasculitis DOID_865 5.597E-03 0.01977905 0.10546543 0.35720137 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bile duct cancer DOID_4606 6.385E-03 0.02242595 0.11244005 0.36559079 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bile duct carcinoma DOID_4897 6.385E-03 0.02242595 0.11244005 0.36559079 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP mineral metabolism disease DOID_0050032 7.656E-03 0.02672656 0.12280151 0.39255089 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP hyperglycemia DOID_4195 8.103E-03 0.02811484 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP blood coagulation disease DOID_1247 9.032E-03 0.03114678 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bone resorption disease DOID_0080011 0.01050954 0.03602367 0.14316775 0.43562808 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP osteoporosis DOID_11476 0.01050954 0.03602367 0.14316775 0.43562808 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP alcohol abuse DOID_1574 0.01208637 0.0411805 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP biliary tract cancer DOID_4607 0.01208637 0.04093538 0.15317523 0.45631783 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP transitional cell carcinoma DOID_2671 0.01347448 0.04536673 0.01347448 0.1369103 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Human immunodeficiency virus infectious disease DOID_526 0.01404824 0.04702028 0.16470496 0.47814858 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP lymphoma DOID_0060058 0.01463245 0.04868926 0.16797063 0.48515374 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP ulcerative colitis DOID_8577 0.0164469 0.05440863 0.17769225 0.50807484 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP gallbladder disease DOID_0000000 0.01935111 0.06364615 0.01935111 0.18351306 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP familial combined hyperlipidemia DOID_13809 0.01935111 0.06328037 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP childhood type dermatomyositis DOID_14203 0.01935111 0.06291876 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP angioedema DOID_1558 0.01935111 0.06256127 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP keratitis DOID_4677 0.01935111 0.06220782 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP dermatomyositis DOID_10223 0.02126579 0.06797884 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP sickle cell anemia DOID_10923 0.02126579 0.06759907 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP migraine without aura DOID_12783 0.02126579 0.06722351 0.02126579 0.18906614 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP prostatic adenoma DOID_2883 0.02126579 0.06685211 0.02126579 0.18615743 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP eosinophilic pneumonia DOID_5870 0.02126579 0.06648479 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pulmonary eosinophilia DOID_9498 0.02126579 0.06648479 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Loeffler syndrome DOID_9503 0.02126579 0.06648479 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bronchiectasis DOID_9563 0.02126579 0.06612149 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP otitis media DOID_10754 0.02317677 0.07167165 0.02317677 0.1968296 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP esophageal carcinoma DOID_1107 0.02317677 0.07128423 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP intracranial arteriosclerosis DOID_13097 0.02317677 0.07090098 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP diarrhea DOID_13250 0.02317677 0.07052184 0.02317677 0.19393505 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP relapsing-remitting multiple sclerosis DOID_2378 0.02317677 0.07014672 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP esophagus squamous cell carcinoma DOID_3748 0.02317677 0.07128423 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP middle ear disease DOID_5100 0.02317677 0.07167165 0.02317677 0.1968296 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP pituitary gland disease DOID_53 0.02317677 0.06977557 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP aortic valve insufficiency DOID_57 0.02317677 0.06940833 0.02317677 0.19112439 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP lipodystrophy DOID_811 0.02317677 0.06904494 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP peritonitis DOID_8283 0.02317677 0.06868533 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP vascular dementia DOID_8725 0.02317677 0.07090098 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP ocular hypertension DOID_9282 0.02317677 0.06832945 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP borderline glaucoma DOID_9283 0.02317677 0.06832945 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP leprosy DOID_1024 0.02508408 0.07357134 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Hirschsprung's disease DOID_10487 0.02508408 0.07319405 0.02508408 0.2038977 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP essential hypertension DOID_10825 0.02508408 0.07282061 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP newborn respiratory distress syndrome DOID_12716 0.02508408 0.07245096 0.02508408 0.2010259 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP carotid stenosis DOID_13001 0.02508408 0.07208505 0.02508408 0.19823388 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP larynx cancer DOID_2596 0.02508408 0.07172281 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP laryngeal benign neoplasm DOID_2598 0.02508408 0.07172281 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP intracranial thrombosis DOID_4193 0.02508408 0.0713642 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP viral pneumonia DOID_10533 0.02698771 0.07639803 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP open-angle glaucoma DOID_1067 0.02698771 0.07601983 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP megacolon DOID_11372 0.02698771 0.07564534 0.02698771 0.20474673 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP aspergillosis DOID_13564 0.02698771 0.07527453 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP narcolepsy DOID_8986 0.02698771 0.07490734 0.02698771 0.19942863 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP thoracic aortic aneurysm DOID_14004 0.02888767 0.07979167 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP renovascular hypertension DOID_1591 0.02888767 0.0794062 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP communication disorder DOID_2033 0.02888767 0.07902444 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP mesenchymal cell neoplasm DOID_3350 0.02888767 0.07864633 0.02888767 0.20806435 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP arthropathy DOID_381 0.02888767 0.07827183 0.02888767 0.20546355 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP spindle cell sarcoma DOID_4235 0.02888767 0.07864633 0.02888767 0.20806435 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP lung oat cell carcinoma DOID_5411 0.02888767 0.07790087 0.02888767 0.20045224 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP epithelioid sarcoma DOID_6193 0.02888767 0.07864633 0.02888767 0.20806435 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP varicose veins DOID_799 0.02888767 0.07753341 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP thyroiditis DOID_7166 0.03078397 0.08223512 0.03078397 0.20607154 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP autoimmune thyroiditis DOID_7188 0.03078397 0.08223512 0.03078397 0.20607154 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP vein disease DOID_866 0.03078397 0.08185084 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Barrett's esophagus DOID_9206 0.03078397 0.08147014 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP familial hypertrophic cardiomyopathy DOID_11986 0.03267662 0.0860787 0.03267662 0.21619766 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP bronchitis DOID_6132 0.03267662 0.08568202 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP male reproductive organ benign neoplasm DOID_0060087 0.03456563 0.09021946 0.03456563 0.21853158 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP eosinophilia DOID_999 0.03456563 0.0898075 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP dissociative disorder DOID_10935 0.03645099 0.09427552 0.03645099 0.22544147 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP dissociative amnesia DOID_11037 0.03645099 0.09427552 0.03645099 0.22544147 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Down syndrome DOID_14250 0.03645099 0.09384894 0.03645099 0.22301736 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP heart septal defect DOID_1681 0.03645099 0.09342619 0.03645099 0.22064484 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP agammaglobulinemia DOID_2583 0.03645099 0.09300724 0.03645099 0.21832226 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP granulosa cell tumor DOID_2999 0.03645099 0.09259203 0.03645099 0.21604807 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP leishmaniasis DOID_9065 0.03645099 0.09218051 0.03645099 0.21382077 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP amnestic disorder DOID_10914 0.03833273 0.09651027 0.03833273 0.2225645 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP colon carcinoma DOID_1520 0.03833273 0.09608511 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP sex cord-gonadal stromal tumor DOID_192 0.03833273 0.09566369 0.03833273 0.22031637 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP brain edema DOID_4724 0.03833273 0.09524594 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP colonic disease DOID_5353 0.03833273 0.09483183 0.03833273 0.21811321 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP blood protein disease DOID_620 0.03833273 0.0944213 0.03833273 0.21595367 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP amyloidosis DOID_9120 0.03833273 0.09401431 0.03833273 0.21383648 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP juvenile absence epilepsy DOID_0060172 0.04021083 0.09819727 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP Kawasaki disease DOID_13378 0.04021083 0.09777762 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP lymphadenitis DOID_1602 0.04021083 0.09777762 1.000 1.000 LIU_VAV3_PROSTATE_CARCINOGENESIS_UP lymph node disease DOID_9942 0.04021083 0.09777762 1.000 1.000 ZHU_CMV_24_HR_DN aneurysm disease DOID_2403 2.654E-12 1.51E-09 9.972E-03 0.43646895 ZHU_CMV_24_HR_DN uterine disease DOID_345 5.838E-11 1.661E-08 7.473E-03 0.42519321 ZHU_CMV_24_HR_DN Ehlers-Danlos syndrome DOID_13359 6.346E-11 1.204E-08 0.02811727 0.69559685 ZHU_CMV_24_HR_DN female reproductive system disease DOID_229 2.445E-10 3.478E-08 0.01096069 0.44547364 ZHU_CMV_24_HR_DN aortic aneurysm DOID_3627 5.734E-08 6.525E-06 0.09590581 1.000 ZHU_CMV_24_HR_DN osteochondrodysplasia DOID_2256 9.088E-08 8.619E-06 5.489E-03 0.52054676 ZHU_CMV_24_HR_DN collagen disease DOID_854 1.499E-07 1.218E-05 0.11464333 1.000 ZHU_CMV_24_HR_DN mineral metabolism disease DOID_0050032 1.89E-07 1.345E-05 0.11968676 1.000 ZHU_CMV_24_HR_DN diabetic retinopathy DOID_8947 3.569E-07 2.256E-05 0.13464766 1.000 ZHU_CMV_24_HR_DN bone resorption disease DOID_0080011 4.334E-07 2.466E-05 9.972E-03 0.47284136 ZHU_CMV_24_HR_DN osteoporosis DOID_11476 4.334E-07 2.466E-05 9.972E-03 0.47284136 ZHU_CMV_24_HR_DN bone development disease DOID_0080006 6.629E-07 3.429E-05 0.01172941 0.39259038 ZHU_CMV_24_HR_DN retinal vascular disease DOID_2462 7.023E-07 3.33E-05 0.15259305 1.000 ZHU_CMV_24_HR_DN transitional cell carcinoma DOID_2671 8.316E-07 3.64E-05 1.000 1.000 ZHU_CMV_24_HR_DN adenoma DOID_657 9.351E-07 3.801E-05 1.000 1.000 ZHU_CMV_24_HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.146E-06 4.349E-05 1.000 1.000 ZHU_CMV_24_HR_DN adult respiratory distress syndrome DOID_11394 1.395E-06 4.961E-05 1.000 1.000 ZHU_CMV_24_HR_DN aortic valve insufficiency DOID_57 1.427E-06 4.777E-05 1.000 1.000 ZHU_CMV_24_HR_DN endometriosis of uterus DOID_288 1.679E-06 5.309E-05 3.34E-03 0.47513993 ZHU_CMV_24_HR_DN endometriosis DOID_289 1.837E-06 5.501E-05 3.488E-03 0.39690342 ZHU_CMV_24_HR_DN osteogenesis imperfecta DOID_12347 1.853E-06 5.272E-05 0.02441384 0.66149869 ZHU_CMV_24_HR_DN heart valve disease DOID_4079 2.577E-06 6.983E-05 1.000 1.000 ZHU_CMV_24_HR_DN oral submucous fibrosis DOID_5773 2.94E-06 7.603E-05 1.000 1.000 ZHU_CMV_24_HR_DN atrophic muscular disease DOID_913 4.075E-06 1.008E-04 1.694E-04 0.09637113 ZHU_CMV_24_HR_DN muscular dystrophy DOID_9884 4.075E-06 1.008E-04 1.694E-04 0.09637113 ZHU_CMV_24_HR_DN respiratory failure DOID_11162 7.416E-06 1.758E-04 1.000 1.000 ZHU_CMV_24_HR_DN pre-malignant neoplasm DOID_0060071 7.883E-06 1.794E-04 1.000 1.000 ZHU_CMV_24_HR_DN in situ carcinoma DOID_8719 7.883E-06 1.794E-04 1.000 1.000 ZHU_CMV_24_HR_DN endocrine pancreas disease DOID_1428 8.371E-06 1.832E-04 1.000 1.000 ZHU_CMV_24_HR_DN placenta disease DOID_780 9.856E-06 2.077E-04 1.000 1.000 ZHU_CMV_24_HR_DN aortic valve disease DOID_62 1.292E-05 2.625E-04 1.000 1.000 ZHU_CMV_24_HR_DN toxic shock syndrome DOID_14115 1.466E-05 2.876E-04 1.000 1.000 ZHU_CMV_24_HR_DN commensal bacterial infectious disease DOID_0050339 1.655E-05 3.139E-04 1.000 1.000 ZHU_CMV_24_HR_DN encephalomyelitis DOID_640 3.34E-05 6.131E-04 0.16541325 1.000 ZHU_CMV_24_HR_DN abdominal aortic aneurysm DOID_7693 3.44E-05 6.116E-04 1.000 1.000 ZHU_CMV_24_HR_DN mouth disease DOID_403 3.481E-05 6.001E-04 1.000 1.000 ZHU_CMV_24_HR_DN hypersensitivity reaction type I disease DOID_1205 3.625E-05 6.067E-04 0.1685883 1.000 ZHU_CMV_24_HR_DN papilloma DOID_2615 4.483E-05 7.288E-04 1.000 1.000 ZHU_CMV_24_HR_DN hyperthyroidism DOID_7998 4.872E-05 7.7E-04 1.000 1.000 ZHU_CMV_24_HR_DN calcinosis DOID_182 6.17E-05 9.488E-04 1.000 1.000 ZHU_CMV_24_HR_DN multiple myeloma DOID_9538 6.17E-05 9.238E-04 1.000 1.000 ZHU_CMV_24_HR_DN cervix uteri carcinoma in situ DOID_8991 8.225E-05 1.2E-03 1.000 1.000 ZHU_CMV_24_HR_DN autoimmune disease of urogenital tract DOID_0060049 8.801E-05 1.252E-03 1.000 1.000 ZHU_CMV_24_HR_DN primary biliary cirrhosis DOID_12236 8.801E-05 1.252E-03 1.000 1.000 ZHU_CMV_24_HR_DN nephrotic syndrome DOID_1184 9.402E-05 1.305E-03 0.08377889 0.99312896 ZHU_CMV_24_HR_DN myeloma DOID_0070004 1.207E-04 1.636E-03 1.000 1.000 ZHU_CMV_24_HR_DN neuritis DOID_1803 1.207E-04 1.598E-03 1.000 1.000 ZHU_CMV_24_HR_DN thyroid adenoma DOID_2891 1.207E-04 1.561E-03 1.000 1.000 ZHU_CMV_24_HR_DN glaucoma DOID_1686 1.358E-04 1.717E-03 1.000 1.000 ZHU_CMV_24_HR_DN calcium metabolism disease DOID_10575 1.437E-04 1.778E-03 1.000 1.000 ZHU_CMV_24_HR_DN hemorrhagic disease DOID_2213 1.52E-04 1.84E-03 1.000 1.000 ZHU_CMV_24_HR_DN chondrosarcoma DOID_3371 1.585E-04 1.879E-03 1.000 1.000 ZHU_CMV_24_HR_DN insulinoma DOID_3892 1.585E-04 1.84E-03 1.000 1.000 ZHU_CMV_24_HR_DN bone marrow cancer DOID_4960 1.785E-04 2.032E-03 1.000 1.000 ZHU_CMV_24_HR_DN reproductive organ benign neoplasm DOID_0050622 1.88E-04 2.098E-03 1.000 1.000 ZHU_CMV_24_HR_DN congenital nervous system abnormality DOID_2490 2.079E-04 2.275E-03 2.079E-04 0.05916158 ZHU_CMV_24_HR_DN hypertrophic cardiomyopathy DOID_11984 2.184E-04 2.345E-03 0.10957142 1.000 ZHU_CMV_24_HR_DN melancholia DOID_2848 2.292E-04 2.415E-03 6.249E-03 0.44444353 ZHU_CMV_24_HR_DN islet cell tumor DOID_1799 2.319E-04 2.399E-03 1.000 1.000 ZHU_CMV_24_HR_DN neurotic disorder DOID_4964 2.403E-04 2.442E-03 6.446E-03 0.40751555 ZHU_CMV_24_HR_DN congenital heart defect DOID_1682 2.758E-04 2.753E-03 0.11800877 1.000 ZHU_CMV_24_HR_DN aspergillosis DOID_13564 3.189E-04 3.129E-03 1.000 1.000 ZHU_CMV_24_HR_DN endocrine organ benign neoplasm DOID_0060089 3.422E-04 3.3E-03 1.000 1.000 ZHU_CMV_24_HR_DN blood coagulation disease DOID_1247 3.713E-04 3.521E-03 1.000 1.000 ZHU_CMV_24_HR_DN nephrosis DOID_2527 3.865E-04 3.605E-03 0.13134484 1.000 ZHU_CMV_24_HR_DN peripheral vascular disease DOID_341 4.021E-04 3.69E-03 0.1329978 1.000 ZHU_CMV_24_HR_DN silicosis DOID_10325 4.195E-04 3.789E-03 1.000 1.000 ZHU_CMV_24_HR_DN spastic diplegia DOID_10965 4.195E-04 3.73E-03 1.000 1.000 ZHU_CMV_24_HR_DN restrictive cardiomyopathy DOID_397 4.195E-04 3.673E-03 0.02996379 0.63145907 ZHU_CMV_24_HR_DN endogenous depression DOID_1595 4.511E-04 3.889E-03 9.731E-03 0.50338128 ZHU_CMV_24_HR_DN familial hypertrophic cardiomyopathy DOID_11986 4.749E-04 4.033E-03 4.749E-04 0.090071 ZHU_CMV_24_HR_DN urinary system benign neoplasm DOID_731 4.749E-04 3.974E-03 1.000 1.000 ZHU_CMV_24_HR_DN bacterial pneumonia DOID_874 4.859E-04 4.007E-03 1.000 1.000 ZHU_CMV_24_HR_DN ureteral obstruction DOID_5199 5.336E-04 4.337E-03 1.000 1.000 ZHU_CMV_24_HR_DN mental depression DOID_1596 5.802E-04 4.649E-03 0.0114706 0.40792312 ZHU_CMV_24_HR_DN chronic kidney failure DOID_784 5.802E-04 4.585E-03 1.000 1.000 ZHU_CMV_24_HR_DN primary immunodeficiency disease DOID_612 7.078E-04 5.517E-03 0.15902724 1.000 ZHU_CMV_24_HR_DN coronary restenosis DOID_4247 7.297E-04 5.611E-03 1.000 1.000 ZHU_CMV_24_HR_DN Human immunodeficiency virus infectious disease DOID_526 7.307E-04 5.543E-03 1.000 1.000 ZHU_CMV_24_HR_DN acquired immunodeficiency syndrome DOID_635 8.017E-04 6.002E-03 1.000 1.000 ZHU_CMV_24_HR_DN muscular atrophy DOID_767 8.017E-04 5.924E-03 1.000 1.000 ZHU_CMV_24_HR_DN dilated cardiomyopathy DOID_12930 8.52E-04 6.216E-03 0.01474311 0.46604594 ZHU_CMV_24_HR_DN urinary tract obstruction DOID_5200 8.769E-04 6.316E-03 1.000 1.000 ZHU_CMV_24_HR_DN hypoglycemia DOID_9993 8.769E-04 6.237E-03 1.000 1.000 ZHU_CMV_24_HR_DN ulcerative colitis DOID_8577 9.306E-04 6.538E-03 1.000 1.000 ZHU_CMV_24_HR_DN diabetic angiopathy DOID_11713 9.555E-04 6.63E-03 1.000 1.000 ZHU_CMV_24_HR_DN Lewy body dementia DOID_12217 9.555E-04 6.55E-03 1.000 1.000 ZHU_CMV_24_HR_DN ureteral disease DOID_1426 9.555E-04 6.472E-03 1.000 1.000 ZHU_CMV_24_HR_DN spastic quadriplegia DOID_10970 1.037E-03 6.944E-03 1.000 1.000 ZHU_CMV_24_HR_DN papillary adenoma DOID_3172 1.211E-03 8.01E-03 1.000 1.000 ZHU_CMV_24_HR_DN microcystic adenoma DOID_5403 1.211E-03 8.01E-03 1.000 1.000 ZHU_CMV_24_HR_DN follicular adenoma DOID_6204 1.211E-03 8.01E-03 1.000 1.000 ZHU_CMV_24_HR_DN intracranial aneurysm DOID_10941 1.302E-03 8.517E-03 0.05185394 0.86779099 ZHU_CMV_24_HR_DN Sciatic Neuropathy DOID_11446 1.397E-03 9.033E-03 1.000 1.000 ZHU_CMV_24_HR_DN lesion of sciatic nerve DOID_12528 1.397E-03 9.033E-03 1.000 1.000 ZHU_CMV_24_HR_DN lung adenocarcinoma DOID_3910 1.397E-03 8.931E-03 0.05365598 0.87229291 ZHU_CMV_24_HR_DN periodontitis DOID_824 1.397E-03 8.832E-03 1.000 1.000 ZHU_CMV_24_HR_DN mononeuritis of lower limb DOID_9473 1.397E-03 9.033E-03 1.000 1.000 ZHU_CMV_24_HR_DN autoimmune disease of cardiovascular system DOID_0060051 1.495E-03 9.347E-03 1.000 1.000 ZHU_CMV_24_HR_DN sarcoma DOID_1115 1.495E-03 9.246E-03 1.000 1.000 ZHU_CMV_24_HR_DN Behcet's disease DOID_13241 1.495E-03 9.347E-03 1.000 1.000 ZHU_CMV_24_HR_DN mononeuritis DOID_1802 1.495E-03 9.146E-03 1.000 1.000 ZHU_CMV_24_HR_DN hepatic vascular disease DOID_272 1.495E-03 9.049E-03 1.000 1.000 ZHU_CMV_24_HR_DN coronary stenosis DOID_4248 1.495E-03 8.954E-03 1.000 1.000 ZHU_CMV_24_HR_DN mononeuropathy DOID_1188 1.596E-03 9.46E-03 1.000 1.000 ZHU_CMV_24_HR_DN multiple epiphyseal dysplasia DOID_12721 1.596E-03 9.362E-03 0.05724992 0.88041099 ZHU_CMV_24_HR_DN toxic encephalopathy DOID_3602 1.596E-03 9.267E-03 0.05724992 0.85724228 ZHU_CMV_24_HR_DN focal glomerulosclerosis DOID_3945 1.596E-03 9.173E-03 0.05724992 0.83526171 ZHU_CMV_24_HR_DN endometrial carcinoma DOID_2871 1.7E-03 9.675E-03 1.000 1.000 ZHU_CMV_24_HR_DN spastic cerebral palsy DOID_0050669 1.808E-03 0.01018466 1.000 1.000 ZHU_CMV_24_HR_DN opportunistic mycosis DOID_2473 1.808E-03 0.01008481 1.000 1.000 ZHU_CMV_24_HR_DN endometrial cancer DOID_1380 1.918E-03 0.01059808 1.000 1.000 ZHU_CMV_24_HR_DN systemic mycosis DOID_0050136 2.149E-03 0.01175827 1.000 1.000 ZHU_CMV_24_HR_DN fungal infectious disease DOID_1564 2.149E-03 0.01175827 1.000 1.000 ZHU_CMV_24_HR_DN pneumoconiosis DOID_10316 2.269E-03 0.0122967 1.000 1.000 ZHU_CMV_24_HR_DN hepatitis C DOID_1883 2.269E-03 0.01218069 1.000 1.000 ZHU_CMV_24_HR_DN periodontal disease DOID_3388 2.269E-03 0.01206686 1.000 1.000 ZHU_CMV_24_HR_DN spindle cell carcinoma DOID_4015 2.269E-03 0.01195513 0.0679512 0.94303005 ZHU_CMV_24_HR_DN refractive error DOID_9835 2.519E-03 0.01314712 0.0714916 0.92451639 ZHU_CMV_24_HR_DN uveitis DOID_13141 2.78E-03 0.01438121 1.000 1.000 ZHU_CMV_24_HR_DN blood platelet disease DOID_2218 2.78E-03 0.01425165 1.000 1.000 ZHU_CMV_24_HR_DN adenoid cystic carcinoma DOID_4866 3.054E-03 0.01551601 0.07853267 0.97141498 ZHU_CMV_24_HR_DN salivary gland cancer DOID_8850 3.34E-03 0.01681911 0.08203343 0.99312816 ZHU_CMV_24_HR_DN hyperinsulinism DOID_2018 3.488E-03 0.01740804 1.000 1.000 ZHU_CMV_24_HR_DN uveal disease DOID_3480 3.488E-03 0.01725667 1.000 1.000 ZHU_CMV_24_HR_DN diabetic autonomic neuropathy DOID_11503 3.638E-03 0.01784639 1.000 1.000 ZHU_CMV_24_HR_DN autonomic neuropathy DOID_11504 3.638E-03 0.01784639 1.000 1.000 ZHU_CMV_24_HR_DN diabetic polyneuropathy DOID_12785 3.638E-03 0.01784639 1.000 1.000 ZHU_CMV_24_HR_DN gallbladder cancer DOID_3121 3.638E-03 0.01769386 0.08552108 0.99309173 ZHU_CMV_24_HR_DN uterine cancer DOID_363 3.638E-03 0.01754391 1.000 1.000 ZHU_CMV_24_HR_DN diabetic neuropathy DOID_9743 3.638E-03 0.01784639 1.000 1.000 ZHU_CMV_24_HR_DN cataract DOID_83 3.792E-03 0.01813064 0.08726 0.99301881 ZHU_CMV_24_HR_DN leukodystrophy DOID_10579 3.948E-03 0.01872171 1.000 1.000 ZHU_CMV_24_HR_DN lens disease DOID_110 4.108E-03 0.01931695 0.09072807 1.000 ZHU_CMV_24_HR_DN autonomic nervous system disease DOID_11465 4.108E-03 0.01915862 1.000 1.000 ZHU_CMV_24_HR_DN brain cancer DOID_1319 4.108E-03 0.01900285 1.000 1.000 ZHU_CMV_24_HR_DN central nervous system cancer DOID_3620 4.27E-03 0.01959498 1.000 1.000 ZHU_CMV_24_HR_DN hemolytic anemia DOID_583 4.27E-03 0.01943822 1.000 1.000 ZHU_CMV_24_HR_DN normocytic anemia DOID_720 4.27E-03 0.01943822 1.000 1.000 ZHU_CMV_24_HR_DN vasculitis DOID_865 5.306E-03 0.02396246 1.000 1.000 ZHU_CMV_24_HR_DN smallpox DOID_8736 5.489E-03 0.02459276 1.000 1.000 ZHU_CMV_24_HR_DN familial hyperlipidemia DOID_1168 5.675E-03 0.02522594 1.000 1.000 ZHU_CMV_24_HR_DN nonsyndromic deafness DOID_0050563 6.055E-03 0.02670589 6.055E-03 0.49215144 ZHU_CMV_24_HR_DN oral cavity cancer DOID_8618 6.055E-03 0.02650046 0.10957142 1.000 ZHU_CMV_24_HR_DN hypothyroidism DOID_1459 6.848E-03 0.02974511 1.000 1.000 ZHU_CMV_24_HR_DN parasitic infectious disease DOID_1398 7.473E-03 0.03221161 1.000 1.000 ZHU_CMV_24_HR_DN cerebral degeneration DOID_1443 7.473E-03 0.03196941 1.000 1.000 ZHU_CMV_24_HR_DN temporal lobe epilepsy DOID_3328 7.686E-03 0.03263816 0.12303329 1.000 ZHU_CMV_24_HR_DN hyperglycemia DOID_4195 7.686E-03 0.0323964 1.000 1.000 ZHU_CMV_24_HR_DN tooth disease DOID_1091 7.903E-03 0.03306363 1.000 1.000 ZHU_CMV_24_HR_DN pancreatic ductal carcinoma DOID_3587 8.568E-03 0.03558667 0.12968877 1.000 ZHU_CMV_24_HR_DN pancreatic carcinoma DOID_4905 9.258E-03 0.03817326 0.13464766 1.000 ZHU_CMV_24_HR_DN cystic fibrosis DOID_1485 9.731E-03 0.03983593 1.000 1.000 ZHU_CMV_24_HR_DN mixed glioma DOID_5076 0.01021528 0.04151784 1.000 1.000 ZHU_CMV_24_HR_DN metabolic syndrome X DOID_14221 0.01070961 0.04321823 1.000 1.000 ZHU_CMV_24_HR_DN lipid metabolism disorder DOID_3146 0.01070961 0.04291388 1.000 1.000 ZHU_CMV_24_HR_DN auditory system disease DOID_2742 0.01121435 0.04462214 0.01121435 0.42539774 ZHU_CMV_24_HR_DN focal epilepsy DOID_2234 0.0114706 0.04532479 0.14935778 1.000 ZHU_CMV_24_HR_DN biliary tract cancer DOID_4607 0.0114706 0.04501221 0.14935778 1.000 ZHU_CMV_24_HR_DN primary bacterial infectious disease DOID_0050338 0.01252118 0.04879831 1.000 1.000 ZHU_CMV_24_HR_DN nervous system cancer DOID_3093 0.01333572 0.0516192 1.000 1.000 ZHU_CMV_24_HR_DN facioscapulohumeral muscular dystrophy DOID_11727 0.01883257 0.07240361 1.000 1.000 ZHU_CMV_24_HR_DN hyperparathyroidism DOID_13543 0.01883257 0.07191768 1.000 1.000 ZHU_CMV_24_HR_DN ventricular septal defect DOID_1657 0.01883257 0.07143823 1.000 1.000 ZHU_CMV_24_HR_DN bilirubin metabolic disorder DOID_2741 0.01883257 0.07096513 1.000 1.000 ZHU_CMV_24_HR_DN hypokalemia DOID_4500 0.01883257 0.07049826 1.000 1.000 ZHU_CMV_24_HR_DN holoprosencephaly DOID_4621 0.01883257 0.07003748 0.01883257 0.56398604 ZHU_CMV_24_HR_DN nervous system benign neoplasm DOID_0060115 0.02069648 0.07646948 1.000 1.000 ZHU_CMV_24_HR_DN common variable immunodeficiency DOID_12177 0.02069648 0.07597613 1.000 1.000 ZHU_CMV_24_HR_DN migraine without aura DOID_12783 0.02069648 0.0754891 1.000 1.000 ZHU_CMV_24_HR_DN invasive lobular carcinoma DOID_3457 0.02069648 0.07500828 1.000 1.000 ZHU_CMV_24_HR_DN chronic monocytic leukemia DOID_8593 0.02069648 0.07453354 1.000 1.000 ZHU_CMV_24_HR_DN bronchiectasis DOID_9563 0.02069648 0.07406478 1.000 1.000 ZHU_CMV_24_HR_DN beta thalassemia DOID_12241 0.0225569 0.08021799 1.000 1.000 ZHU_CMV_24_HR_DN porphyria DOID_13268 0.0225569 0.07971974 1.000 1.000 ZHU_CMV_24_HR_DN stomach disease DOID_76 0.0225569 0.07922764 1.000 1.000 ZHU_CMV_24_HR_DN ocular hypertension DOID_9282 0.0225569 0.07874158 1.000 1.000 ZHU_CMV_24_HR_DN borderline glaucoma DOID_9283 0.0225569 0.07874158 1.000 1.000 ZHU_CMV_24_HR_DN essential hypertension DOID_10825 0.02441384 0.0847041 0.02441384 0.69457363 ZHU_CMV_24_HR_DN parathyroid gland disease DOID_11201 0.02441384 0.08419074 1.000 1.000 ZHU_CMV_24_HR_DN newborn respiratory distress syndrome DOID_12716 0.02441384 0.08368357 1.000 1.000 ZHU_CMV_24_HR_DN polyneuropathy DOID_1389 0.02441384 0.08318247 1.000 1.000 ZHU_CMV_24_HR_DN Leydig cell tumor DOID_2696 0.02441384 0.08268734 1.000 1.000 ZHU_CMV_24_HR_DN sex cord-stromal neoplasm DOID_4757 0.02441384 0.08268734 1.000 1.000 ZHU_CMV_24_HR_DN monocytic leukemia DOID_8527 0.02441384 0.08219806 1.000 1.000 ZHU_CMV_24_HR_DN Legionnaires' disease DOID_10457 0.02626729 0.08791816 1.000 1.000 ZHU_CMV_24_HR_DN legionellosis DOID_10458 0.02626729 0.08791816 1.000 1.000 ZHU_CMV_24_HR_DN tethered spinal cord syndrome DOID_1089 0.02626729 0.08740402 1.000 1.000 ZHU_CMV_24_HR_DN rhabdomyosarcoma DOID_3247 0.02626729 0.08689586 1.000 1.000 ZHU_CMV_24_HR_DN congenital structural myopathy DOID_422 0.02626729 0.08639357 0.02626729 0.67936763 ZHU_CMV_24_HR_DN parasitic helminthiasis infectious disease DOID_883 0.02626729 0.08589706 1.000 1.000 ZHU_CMV_24_HR_DN skeletal system cancer DOID_0060124 0.02811727 0.0914213 1.000 1.000 ZHU_CMV_24_HR_DN thalassemia DOID_10241 0.02811727 0.09090186 1.000 1.000 ZHU_CMV_24_HR_DN thoracic aortic aneurysm DOID_14004 0.02811727 0.09038829 0.02811727 0.66661365 ZHU_CMV_24_HR_DN renovascular hypertension DOID_1591 0.02811727 0.08988049 1.000 1.000 ZHU_CMV_24_HR_DN bone cancer DOID_184 0.02811727 0.0914213 1.000 1.000 ZHU_CMV_24_HR_DN hemangioma DOID_255 0.02811727 0.08937837 1.000 1.000 ZHU_CMV_24_HR_DN arthropathy DOID_381 0.02811727 0.08888182 0.02811727 0.6399491 ZHU_CMV_24_HR_DN skeletal muscle cancer DOID_4043 0.02811727 0.08839076 1.000 1.000 ZHU_CMV_24_HR_DN panic disorder DOID_594 0.02811727 0.0879051 0.02811727 0.61533567 ZHU_CMV_24_HR_DN intermediate coronary syndrome DOID_8805 0.02811727 0.08742474 1.000 1.000 ZHU_CMV_24_HR_DN angiosarcoma DOID_0001816 0.02996379 0.09265975 1.000 1.000 ZHU_CMV_24_HR_DN hemolytic-uremic syndrome DOID_12554 0.02996379 0.09215889 1.000 1.000 ZHU_CMV_24_HR_DN chronic myeloid leukemia DOID_8552 0.02996379 0.09166341 0.02996379 0.60890696 ZHU_CMV_24_HR_DN lymphatic system cancer DOID_0060073 0.03180684 0.09678125 1.000 1.000 ZHU_CMV_24_HR_DN schizophreniform disorder DOID_11328 0.03180684 0.09626646 1.000 1.000 ZHU_CMV_24_HR_DN Graves' disease DOID_12361 0.03180684 0.09575711 1.000 1.000 ZHU_CMV_24_HR_DN schizoaffective disorder DOID_5418 0.03180684 0.09626646 1.000 1.000 ZHU_CMV_24_HR_DN reticulosarcoma DOID_8538 0.03180684 0.09678125 1.000 1.000 ZHU_CMV_24_HR_DN lymphosarcoma DOID_8675 0.03180684 0.09678125 1.000 1.000 ZHU_CMV_24_HR_DN inherited blood coagulation disease DOID_2214 0.03364645 0.09971264 1.000 1.000 ZHU_CMV_24_HR_DN eosinophilia DOID_999 0.03364645 0.099196 1.000 1.000 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION autoimmune disease of urogenital tract DOID_0060049 3.316E-05 0.01886692 1.759E-03 0.14299056 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION primary biliary cirrhosis DOID_12236 3.316E-05 0.01886692 1.759E-03 0.14299056 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION hyperparathyroidism DOID_13543 8.245E-05 0.02345816 0.01363359 0.45632431 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION parathyroid gland disease DOID_11201 1.425E-04 0.02703582 0.017688 0.4792606 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION focal epilepsy DOID_2234 2.22E-04 0.03158495 2.22E-04 0.12633981 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION lymphoma DOID_0060058 2.987E-04 0.03399507 2.987E-04 0.08498768 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION dilated cardiomyopathy DOID_12930 3.276E-04 0.03107021 3.276E-04 0.06214041 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION ulcerative colitis DOID_8577 3.583E-04 0.02912284 3.583E-04 0.05096497 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION hepatitis B DOID_2043 4.188E-04 0.0297889 0.02975341 0.49793209 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION uremia DOID_4676 4.583E-04 0.02897538 4.583E-04 0.05215568 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION leukopenia DOID_615 1.192E-03 0.06780943 1.192E-03 0.11301572 KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION cervix uteri carcinoma in situ DOID_8991 1.682E-03 0.08702604 0.05863808 0.50553136 WANG_CISPLATIN_RESPONSE_AND_XPC_UP pancreatic ductal carcinoma DOID_3587 5.738E-09 3.265E-06 5.068E-06 5.768E-04 WANG_CISPLATIN_RESPONSE_AND_XPC_UP nephrosis DOID_2527 6.32E-09 1.798E-06 5.421E-06 5.141E-04 WANG_CISPLATIN_RESPONSE_AND_XPC_UP pancreatic carcinoma DOID_4905 7.635E-09 1.448E-06 6.184E-06 5.027E-04 WANG_CISPLATIN_RESPONSE_AND_XPC_UP uterine cancer DOID_363 1.262E-08 1.795E-06 1.262E-08 7.179E-06 WANG_CISPLATIN_RESPONSE_AND_XPC_UP endometrial carcinoma DOID_2871 7.591E-08 8.638E-06 7.591E-08 2.16E-05 WANG_CISPLATIN_RESPONSE_AND_XPC_UP endometrial cancer DOID_1380 1.043E-07 9.893E-06 1.043E-07 1.979E-05 WANG_CISPLATIN_RESPONSE_AND_XPC_UP embryonal cancer DOID_688 2.427E-07 1.973E-05 2.427E-07 3.453E-05 WANG_CISPLATIN_RESPONSE_AND_XPC_UP nephrotic syndrome DOID_1184 4.975E-07 3.539E-05 5.132E-04 0.01390554 WANG_CISPLATIN_RESPONSE_AND_XPC_UP biliary tract cancer DOID_4607 1.072E-05 6.775E-04 3.035E-03 0.03673728 WANG_CISPLATIN_RESPONSE_AND_XPC_UP systemic scleroderma DOID_418 1.256E-05 7.148E-04 8.916E-03 0.07571728 WANG_CISPLATIN_RESPONSE_AND_XPC_UP transitional cell carcinoma DOID_2671 1.417E-05 7.328E-04 1.417E-05 1.008E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP rheumatic disease DOID_1575 1.812E-05 8.594E-04 0.01062387 0.082808 WANG_CISPLATIN_RESPONSE_AND_XPC_UP primitive neuroectodermal tumor DOID_168 1.812E-05 7.933E-04 1.812E-05 1.146E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP scleroderma DOID_419 1.812E-05 8.594E-04 0.01062387 0.082808 WANG_CISPLATIN_RESPONSE_AND_XPC_UP bile duct adenocarcinoma DOID_4896 4.263E-05 1.733E-03 0.01599241 0.10581027 WANG_CISPLATIN_RESPONSE_AND_XPC_UP cholangiocarcinoma DOID_4947 4.263E-05 1.733E-03 0.01599241 0.10581027 WANG_CISPLATIN_RESPONSE_AND_XPC_UP familial hyperlipidemia DOID_1168 4.886E-05 1.854E-03 1.065E-03 0.02243345 WANG_CISPLATIN_RESPONSE_AND_XPC_UP bile duct cancer DOID_4606 5.574E-05 1.982E-03 0.01817757 0.11365973 WANG_CISPLATIN_RESPONSE_AND_XPC_UP bile duct carcinoma DOID_4897 5.574E-05 1.982E-03 0.01817757 0.11365973 WANG_CISPLATIN_RESPONSE_AND_XPC_UP neuroectodermal tumor DOID_171 6.733E-05 2.254E-03 6.733E-05 3.831E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP collagen disease DOID_854 6.733E-05 2.128E-03 0.01989438 0.12304244 WANG_CISPLATIN_RESPONSE_AND_XPC_UP pre-malignant neoplasm DOID_0060071 7.598E-05 2.275E-03 7.598E-05 3.93E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP in situ carcinoma DOID_8719 7.598E-05 2.275E-03 7.598E-05 3.93E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP lung adenocarcinoma DOID_3910 1.288E-04 3.665E-03 4.326E-03 0.04826573 WANG_CISPLATIN_RESPONSE_AND_XPC_UP sarcoma DOID_1115 1.428E-04 3.869E-03 1.428E-04 6.77E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP invasive ductal carcinoma DOID_3008 1.428E-04 3.693E-03 1.428E-04 6.249E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP pancreatitis DOID_4989 1.608E-04 3.977E-03 2.555E-03 0.03546257 WANG_CISPLATIN_RESPONSE_AND_XPC_UP mixed glioma DOID_5076 1.608E-04 3.811E-03 1.608E-04 6.534E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP lipid metabolism disorder DOID_3146 1.769E-04 4.025E-03 2.741E-03 0.03465714 WANG_CISPLATIN_RESPONSE_AND_XPC_UP retinal vascular disease DOID_2462 2.222E-04 4.862E-03 2.222E-04 8.428E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP macular degeneration DOID_4448 2.686E-04 5.66E-03 2.686E-04 9.551E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP nervous system cancer DOID_3093 2.753E-04 5.594E-03 2.753E-04 9.214E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP lymphoma DOID_0060058 2.989E-04 5.865E-03 2.989E-04 9.448E-03 WANG_CISPLATIN_RESPONSE_AND_XPC_UP calcinosis DOID_182 3.39E-04 6.43E-03 8.113E-03 0.0744521 WANG_CISPLATIN_RESPONSE_AND_XPC_UP multiple myeloma DOID_9538 3.39E-04 6.222E-03 8.113E-03 0.07212548 WANG_CISPLATIN_RESPONSE_AND_XPC_UP ulcerative colitis DOID_8577 3.784E-04 6.728E-03 4.789E-03 0.05141589 WANG_CISPLATIN_RESPONSE_AND_XPC_UP hepatitis DOID_2237 3.92E-04 6.758E-03 8.916E-03 0.07686451 WANG_CISPLATIN_RESPONSE_AND_XPC_UP peptic ulcer DOID_750 3.92E-04 6.56E-03 3.92E-04 0.01173815 WANG_CISPLATIN_RESPONSE_AND_XPC_UP benign mesothelioma DOID_2645 4.5E-04 7.315E-03 9.753E-03 0.07927812 WANG_CISPLATIN_RESPONSE_AND_XPC_UP cervix uteri carcinoma in situ DOID_8991 4.5E-04 7.112E-03 4.5E-04 0.01280154 WANG_CISPLATIN_RESPONSE_AND_XPC_UP gallbladder cancer DOID_3121 5.469E-04 8.41E-03 0.01107174 0.08399761 WANG_CISPLATIN_RESPONSE_AND_XPC_UP proteinuria DOID_576 6.183E-04 9.258E-03 0.01199206 0.08978264 WANG_CISPLATIN_RESPONSE_AND_XPC_UP myeloma DOID_0070004 6.562E-04 9.573E-03 0.01246439 0.09210696 WANG_CISPLATIN_RESPONSE_AND_XPC_UP hemolytic anemia DOID_583 6.955E-04 9.893E-03 0.01294475 0.09093288 WANG_CISPLATIN_RESPONSE_AND_XPC_UP normocytic anemia DOID_720 6.955E-04 9.893E-03 0.01294475 0.09093288 WANG_CISPLATIN_RESPONSE_AND_XPC_UP esophageal carcinoma DOID_1107 7.302E-04 0.01013315 7.302E-04 0.0188845 WANG_CISPLATIN_RESPONSE_AND_XPC_UP esophagus squamous cell carcinoma DOID_3748 7.302E-04 0.01013315 7.302E-04 0.0188845 WANG_CISPLATIN_RESPONSE_AND_XPC_UP calcium metabolism disease DOID_10575 7.785E-04 0.01054648 0.01392935 0.09549158 WANG_CISPLATIN_RESPONSE_AND_XPC_UP vulva cancer DOID_1245 8.61E-04 0.0113933 8.61E-04 0.02130051 WANG_CISPLATIN_RESPONSE_AND_XPC_UP Lynch syndrome DOID_3883 8.61E-04 0.01113436 8.61E-04 0.02041299 WANG_CISPLATIN_RESPONSE_AND_XPC_UP giant cell tumor DOID_200 9.144E-04 0.01156212 9.144E-04 0.02081181 WANG_CISPLATIN_RESPONSE_AND_XPC_UP malignant giant cell tumor DOID_2705 9.144E-04 0.01156212 9.144E-04 0.02081181 WANG_CISPLATIN_RESPONSE_AND_XPC_UP giant cell glioblastoma DOID_3074 9.144E-04 0.01156212 9.144E-04 0.02081181 WANG_CISPLATIN_RESPONSE_AND_XPC_UP bone marrow cancer DOID_4960 9.628E-04 0.01190985 0.01599241 0.10459406 WANG_CISPLATIN_RESPONSE_AND_XPC_UP vasculitis DOID_865 9.628E-04 0.01165644 9.628E-04 0.02107126 WANG_CISPLATIN_RESPONSE_AND_XPC_UP pustulosis of palm and sole DOID_4398 1.013E-03 0.01200663 0.0165274 0.10686465 WANG_CISPLATIN_RESPONSE_AND_XPC_UP glioblastoma DOID_3068 1.173E-03 0.01361787 1.173E-03 0.02383126 WANG_CISPLATIN_RESPONSE_AND_XPC_UP oral cavity cancer DOID_8618 1.173E-03 0.01334551 1.173E-03 0.0230095 WANG_CISPLATIN_RESPONSE_AND_XPC_UP angiosarcoma DOID_0001816 1.316E-03 0.01468092 1.316E-03 0.02495756 WANG_CISPLATIN_RESPONSE_AND_XPC_UP hemolytic-uremic syndrome DOID_12554 1.316E-03 0.01439859 0.05268479 0.21566651 WANG_CISPLATIN_RESPONSE_AND_XPC_UP vein disease DOID_866 1.316E-03 0.01412692 1.316E-03 0.02415248 WANG_CISPLATIN_RESPONSE_AND_XPC_UP urinary system benign neoplasm DOID_731 1.488E-03 0.01567933 1.488E-03 0.02645886 WANG_CISPLATIN_RESPONSE_AND_XPC_UP adrenal gland disease DOID_9553 1.488E-03 0.01539425 1.488E-03 0.02565708 WANG_CISPLATIN_RESPONSE_AND_XPC_UP mineral metabolism disease DOID_0050032 1.538E-03 0.01562865 0.02167636 0.13121116 WANG_CISPLATIN_RESPONSE_AND_XPC_UP allergic contact dermatitis DOID_3042 1.745E-03 0.0174166 1.745E-03 0.02919842 WANG_CISPLATIN_RESPONSE_AND_XPC_UP endocrine organ benign neoplasm DOID_0060089 1.817E-03 0.01782769 1.817E-03 0.02954302 WANG_CISPLATIN_RESPONSE_AND_XPC_UP astrocytoma DOID_3069 1.892E-03 0.01824273 1.892E-03 0.02989781 WANG_CISPLATIN_RESPONSE_AND_XPC_UP blood coagulation disease DOID_1247 1.968E-03 0.01866169 0.02542994 0.14764932 WANG_CISPLATIN_RESPONSE_AND_XPC_UP diabetic retinopathy DOID_8947 2.208E-03 0.02059553 2.208E-03 0.0339548 WANG_CISPLATIN_RESPONSE_AND_XPC_UP gastric ulcer DOID_10808 2.5E-03 0.02294071 2.5E-03 0.03742957 WANG_CISPLATIN_RESPONSE_AND_XPC_UP familial hypercholesterolemia DOID_13810 2.5E-03 0.02257657 2.5E-03 0.03646984 WANG_CISPLATIN_RESPONSE_AND_XPC_UP thrombophilia DOID_2452 2.5E-03 0.02222381 2.5E-03 0.0355581 WANG_CISPLATIN_RESPONSE_AND_XPC_UP pulmonary embolism DOID_9477 2.732E-03 0.02391307 2.732E-03 0.03700832 WANG_CISPLATIN_RESPONSE_AND_XPC_UP metabolic syndrome X DOID_14221 2.741E-03 0.02362987 2.741E-03 0.0362691 WANG_CISPLATIN_RESPONSE_AND_XPC_UP contact dermatitis DOID_2773 2.741E-03 0.02327718 2.741E-03 0.0354448 WANG_CISPLATIN_RESPONSE_AND_XPC_UP female reproductive system disease DOID_229 2.837E-03 0.02373677 2.837E-03 0.03508914 WANG_CISPLATIN_RESPONSE_AND_XPC_UP bronchiolitis DOID_2942 3.486E-03 0.02874675 0.08420445 0.28350491 WANG_CISPLATIN_RESPONSE_AND_XPC_UP amino acid metabolic disorder DOID_9252 3.678E-03 0.02989739 3.678E-03 0.04360036 WANG_CISPLATIN_RESPONSE_AND_XPC_UP cleft lip DOID_9296 3.757E-03 0.0301055 3.757E-03 0.04362225 WANG_CISPLATIN_RESPONSE_AND_XPC_UP Human immunodeficiency virus infectious disease DOID_526 3.793E-03 0.02997336 0.0388688 0.19571989 WANG_CISPLATIN_RESPONSE_AND_XPC_UP carbohydrate metabolic disorder DOID_2978 4.15E-03 0.03234632 4.15E-03 0.04722563 WANG_CISPLATIN_RESPONSE_AND_XPC_UP mouth disease DOID_403 4.273E-03 0.0328582 0.04197653 0.19577578 WANG_CISPLATIN_RESPONSE_AND_XPC_UP periodontitis DOID_824 4.326E-03 0.0328207 0.09345581 0.29217777 WANG_CISPLATIN_RESPONSE_AND_XPC_UP renal tubular transport disease DOID_447 4.625E-03 0.03462598 4.625E-03 0.0506072 WANG_CISPLATIN_RESPONSE_AND_XPC_UP supratentorial cancer DOID_1659 4.933E-03 0.03645292 4.933E-03 0.05197916 WANG_CISPLATIN_RESPONSE_AND_XPC_UP cerebrum cancer DOID_368 4.933E-03 0.03645292 4.933E-03 0.05197916 WANG_CISPLATIN_RESPONSE_AND_XPC_UP age related macular degeneration DOID_10871 5.577E-03 0.04068154 5.577E-03 0.05769382 WANG_CISPLATIN_RESPONSE_AND_XPC_UP degeneration of macula and posterior pole DOID_2007 5.577E-03 0.04068154 5.577E-03 0.05769382 WANG_CISPLATIN_RESPONSE_AND_XPC_UP opportunistic mycosis DOID_2473 5.577E-03 0.04016658 0.10564687 0.32146025 WANG_CISPLATIN_RESPONSE_AND_XPC_UP germinoma DOID_3304 5.912E-03 0.0420509 5.912E-03 0.06007272 WANG_CISPLATIN_RESPONSE_AND_XPC_UP autonomic nervous system neoplasm DOID_2621 6.257E-03 0.04395204 6.257E-03 0.06245816 WANG_CISPLATIN_RESPONSE_AND_XPC_UP neuroblastoma DOID_769 6.257E-03 0.04395204 6.257E-03 0.06245816 WANG_CISPLATIN_RESPONSE_AND_XPC_UP systemic mycosis DOID_0050136 6.61E-03 0.04586894 0.11468328 0.33986868 WANG_CISPLATIN_RESPONSE_AND_XPC_UP fungal infectious disease DOID_1564 6.61E-03 0.04586894 0.11468328 0.33986868 WANG_CISPLATIN_RESPONSE_AND_XPC_UP hepatitis C DOID_1883 6.973E-03 0.04780059 6.973E-03 0.06840429 WANG_CISPLATIN_RESPONSE_AND_XPC_UP periodontal disease DOID_3388 6.973E-03 0.04723153 0.11767524 0.33988433 WANG_CISPLATIN_RESPONSE_AND_XPC_UP medullomyoblastoma DOID_3861 7.344E-03 0.0491608 7.344E-03 0.07082488 WANG_CISPLATIN_RESPONSE_AND_XPC_UP adult medulloblastoma DOID_3864 7.344E-03 0.0491608 7.344E-03 0.07082488 WANG_CISPLATIN_RESPONSE_AND_XPC_UP childhood medulloblastoma DOID_3869 7.344E-03 0.0491608 7.344E-03 0.07082488 WANG_CISPLATIN_RESPONSE_AND_XPC_UP adenoma DOID_657 7.724E-03 0.05110318 7.724E-03 0.07324789 WANG_CISPLATIN_RESPONSE_AND_XPC_UP refractive error DOID_9835 7.724E-03 0.05051579 7.724E-03 0.0720471 WANG_CISPLATIN_RESPONSE_AND_XPC_UP medulloblastoma DOID_3858 8.113E-03 0.05245489 8.113E-03 0.07327032 WANG_CISPLATIN_RESPONSE_AND_XPC_UP peripheral nervous system neoplasm DOID_1192 8.51E-03 0.05440566 8.51E-03 0.0744939 WANG_CISPLATIN_RESPONSE_AND_XPC_UP uveitis DOID_13141 8.51E-03 0.05380115 0.12954309 0.35608706 WANG_CISPLATIN_RESPONSE_AND_XPC_UP adult respiratory distress syndrome DOID_11394 9.33E-03 0.05833909 1.000 1.000 WANG_CISPLATIN_RESPONSE_AND_XPC_UP adenoid cystic carcinoma DOID_4866 9.33E-03 0.05770497 9.33E-03 0.07807143 WANG_CISPLATIN_RESPONSE_AND_XPC_UP lymphatic system disease DOID_75 9.33E-03 0.05708449 9.33E-03 0.07693996 WANG_CISPLATIN_RESPONSE_AND_XPC_UP autoimmune disease of urogenital tract DOID_0060049 0.01018428 0.0616474 0.01018428 0.08161768 WANG_CISPLATIN_RESPONSE_AND_XPC_UP primary biliary cirrhosis DOID_12236 0.01018428 0.0616474 0.01018428 0.08161768 WANG_CISPLATIN_RESPONSE_AND_XPC_UP salivary gland cancer DOID_8850 0.01018428 0.06099848 0.01018428 0.0804841 WANG_CISPLATIN_RESPONSE_AND_XPC_UP endometriosis DOID_289 0.01062387 0.06296859 0.01062387 0.08168898 WANG_CISPLATIN_RESPONSE_AND_XPC_UP uveal disease DOID_3480 0.01062387 0.06231943 0.14415541 0.38690767 WANG_CISPLATIN_RESPONSE_AND_XPC_UP brain cancer DOID_1319 0.01246439 0.07236975 0.01246439 0.0909261 WANG_CISPLATIN_RESPONSE_AND_XPC_UP thyroid adenoma DOID_2891 0.01246439 0.07163875 0.01246439 0.08977514 WANG_CISPLATIN_RESPONSE_AND_XPC_UP heart valve disease DOID_4079 0.01246439 0.07092236 0.1556698 0.40079692 WANG_CISPLATIN_RESPONSE_AND_XPC_UP central nervous system cancer DOID_3620 0.01294475 0.07292637 0.01294475 0.09206954 WANG_CISPLATIN_RESPONSE_AND_XPC_UP lung small cell carcinoma DOID_5409 0.01343309 0.07493559 0.01343309 0.09321256 WANG_CISPLATIN_RESPONSE_AND_XPC_UP hemorrhagic disease DOID_2213 0.01443347 0.07973442 0.16703048 0.42428726 WANG_CISPLATIN_RESPONSE_AND_XPC_UP B-cell lymphocytic neoplasm DOID_707 0.01443347 0.07896774 0.01443347 0.09776959 WANG_CISPLATIN_RESPONSE_AND_XPC_UP orofacial cleft DOID_0050567 0.01494539 0.0809898 0.01494539 0.10004622 WANG_CISPLATIN_RESPONSE_AND_XPC_UP osteochondrodysplasia DOID_2256 0.0165274 0.08871782 0.17823948 0.4467765 WANG_CISPLATIN_RESPONSE_AND_XPC_UP congenital nervous system abnormality DOID_2490 0.01762003 0.09369904 0.01762003 0.11264941 WANG_CISPLATIN_RESPONSE_AND_XPC_UP hypertrophic cardiomyopathy DOID_11984 0.01817757 0.09576884 0.01817757 0.11492261 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN adenoma DOID_657 6.762E-05 0.03847329 0.01227687 0.36765983 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN hypertrophic cardiomyopathy DOID_11984 1.663E-04 0.04732407 0.01914117 0.41889721 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN carotid artery disease DOID_3407 1.832E-04 0.0347377 0.02007382 0.42303715 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN pancreatic ductal carcinoma DOID_3587 2.384E-04 0.0339086 0.02286688 0.43370853 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN pancreatic carcinoma DOID_4905 2.584E-04 0.02940291 0.02379628 0.42312761 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN diabetic retinopathy DOID_8947 2.584E-04 0.02450242 0.02379628 0.41030556 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN aneurysm disease DOID_2403 2.792E-04 0.02269237 2.792E-04 0.15884662 SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN retinal vascular disease DOID_2462 3.385E-04 0.02407538 0.02719715 0.40724146 RADAEVA_RESPONSE_TO_IFNA1_UP cervix uteri carcinoma in situ DOID_8991 5.54E-08 3.152E-05 5.54E-08 3.152E-05 RADAEVA_RESPONSE_TO_IFNA1_UP pre-malignant neoplasm DOID_0060071 2.903E-07 8.26E-05 2.903E-07 8.26E-05 RADAEVA_RESPONSE_TO_IFNA1_UP in situ carcinoma DOID_8719 2.903E-07 8.26E-05 2.903E-07 8.26E-05 RADAEVA_RESPONSE_TO_IFNA1_UP psoriasis DOID_8893 5.245E-07 9.947E-05 5.245E-07 9.947E-05 RADAEVA_RESPONSE_TO_IFNA1_UP transitional cell carcinoma DOID_2671 1.015E-06 1.444E-04 1.015E-06 1.444E-04 RADAEVA_RESPONSE_TO_IFNA1_UP encephalomyelitis DOID_640 1.261E-06 1.435E-04 1.261E-06 1.435E-04 RADAEVA_RESPONSE_TO_IFNA1_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.315E-06 1.247E-04 1.315E-06 1.247E-04 RADAEVA_RESPONSE_TO_IFNA1_UP pulmonary sarcoidosis DOID_13406 5.283E-06 4.295E-04 5.277E-04 0.02144717 RADAEVA_RESPONSE_TO_IFNA1_UP diabetic autonomic neuropathy DOID_11503 8.636E-06 6.143E-04 8.636E-06 7.02E-04 RADAEVA_RESPONSE_TO_IFNA1_UP autonomic neuropathy DOID_11504 8.636E-06 6.143E-04 8.636E-06 7.02E-04 RADAEVA_RESPONSE_TO_IFNA1_UP diabetic polyneuropathy DOID_12785 8.636E-06 6.143E-04 8.636E-06 7.02E-04 RADAEVA_RESPONSE_TO_IFNA1_UP diabetic neuropathy DOID_9743 8.636E-06 6.143E-04 8.636E-06 7.02E-04 RADAEVA_RESPONSE_TO_IFNA1_UP autonomic nervous system disease DOID_11465 1.042E-05 6.589E-04 1.042E-05 7.412E-04 RADAEVA_RESPONSE_TO_IFNA1_UP sarcoidosis DOID_11335 1.469E-05 8.357E-04 1.033E-03 0.02939239 RADAEVA_RESPONSE_TO_IFNA1_UP hypersensitivity reaction type IV disease DOID_2916 1.902E-05 9.836E-04 1.224E-03 0.03166865 RADAEVA_RESPONSE_TO_IFNA1_UP diabetic retinopathy DOID_8947 3.683E-05 1.746E-03 1.892E-03 0.04140431 RADAEVA_RESPONSE_TO_IFNA1_UP retinal detachment DOID_5327 4.532E-05 1.983E-03 4.532E-05 2.865E-03 RADAEVA_RESPONSE_TO_IFNA1_UP retinal vascular disease DOID_2462 5.517E-05 2.242E-03 2.469E-03 0.04390359 RADAEVA_RESPONSE_TO_IFNA1_UP Human immunodeficiency virus infectious disease DOID_526 6.518E-05 2.473E-03 6.518E-05 3.709E-03 RADAEVA_RESPONSE_TO_IFNA1_UP cystitis DOID_1679 2.391E-04 8.503E-03 0.02254954 0.18329554 RADAEVA_RESPONSE_TO_IFNA1_UP bronchiolitis obliterans DOID_2799 3.585E-04 0.01200024 0.02749324 0.18847772 RADAEVA_RESPONSE_TO_IFNA1_UP autonomic nervous system neoplasm DOID_2621 4.036E-04 0.01275827 4.036E-04 0.02087717 RADAEVA_RESPONSE_TO_IFNA1_UP bladder disease DOID_365 4.036E-04 0.01208678 0.02913574 0.19055447 RADAEVA_RESPONSE_TO_IFNA1_UP neuroblastoma DOID_769 4.036E-04 0.01275827 4.036E-04 0.02087717 RADAEVA_RESPONSE_TO_IFNA1_UP nephroblastoma DOID_2154 4.513E-04 0.01283908 4.513E-04 0.02139847 RADAEVA_RESPONSE_TO_IFNA1_UP adenoma DOID_657 5.016E-04 0.01359036 5.016E-04 0.02195366 RADAEVA_RESPONSE_TO_IFNA1_UP peripheral nervous system neoplasm DOID_1192 5.545E-04 0.01434055 5.545E-04 0.0210328 RADAEVA_RESPONSE_TO_IFNA1_UP respiratory syncytial virus infectious disease DOID_1273 5.819E-04 0.01439531 0.03486339 0.20450793 RADAEVA_RESPONSE_TO_IFNA1_UP autoimmune disease of urogenital tract DOID_0060049 6.68E-04 0.01583739 0.03730806 0.21228287 RADAEVA_RESPONSE_TO_IFNA1_UP primary biliary cirrhosis DOID_12236 6.68E-04 0.01583739 0.03730806 0.21228287 RADAEVA_RESPONSE_TO_IFNA1_UP endometriosis of uterus DOID_288 6.68E-04 0.01520389 6.68E-04 0.02375608 RADAEVA_RESPONSE_TO_IFNA1_UP endometriosis DOID_289 6.98E-04 0.01527558 6.98E-04 0.02336266 RADAEVA_RESPONSE_TO_IFNA1_UP influenza DOID_8469 7.286E-04 0.0153555 7.286E-04 0.02303325 RADAEVA_RESPONSE_TO_IFNA1_UP glaucoma DOID_1686 8.914E-04 0.01811524 8.914E-04 0.02669615 RADAEVA_RESPONSE_TO_IFNA1_UP atopic dermatitis DOID_3310 9.968E-04 0.01955695 0.04541372 0.22276213 RADAEVA_RESPONSE_TO_IFNA1_UP reproductive organ benign neoplasm DOID_0050622 1.108E-03 0.0210106 1.108E-03 0.03001515 RADAEVA_RESPONSE_TO_IFNA1_UP uterine disease DOID_345 1.519E-03 0.02787363 1.519E-03 0.03756881 RADAEVA_RESPONSE_TO_IFNA1_UP allergic contact dermatitis DOID_3042 1.608E-03 0.02859643 1.608E-03 0.03812857 RADAEVA_RESPONSE_TO_IFNA1_UP endocrine organ benign neoplasm DOID_0060089 1.654E-03 0.02851863 1.654E-03 0.03764459 RADAEVA_RESPONSE_TO_IFNA1_UP syndrome DOID_225 1.991E-03 0.0333268 1.991E-03 0.04196708 RADAEVA_RESPONSE_TO_IFNA1_UP pancreatitis DOID_4989 2.093E-03 0.03403138 2.093E-03 0.04253922 RADAEVA_RESPONSE_TO_IFNA1_UP mixed glioma DOID_5076 2.093E-03 0.03308606 2.093E-03 0.04107235 RADAEVA_RESPONSE_TO_IFNA1_UP bacterial pneumonia DOID_874 2.093E-03 0.03219184 0.06538968 0.26576234 RADAEVA_RESPONSE_TO_IFNA1_UP contact dermatitis DOID_2773 2.198E-03 0.03290706 2.198E-03 0.04168228 RADAEVA_RESPONSE_TO_IFNA1_UP female reproductive system disease DOID_229 2.251E-03 0.03283771 2.251E-03 0.04131195 RADAEVA_RESPONSE_TO_IFNA1_UP primary bacterial infectious disease DOID_0050338 2.582E-03 0.03672725 0.07248141 0.2824789 RADAEVA_RESPONSE_TO_IFNA1_UP nervous system cancer DOID_3093 2.756E-03 0.03824163 2.756E-03 0.04751233 RADAEVA_RESPONSE_TO_IFNA1_UP lymphoma DOID_0060058 2.874E-03 0.03894001 2.874E-03 0.04810237 RADAEVA_RESPONSE_TO_IFNA1_UP mouth disease DOID_403 2.995E-03 0.03963735 2.995E-03 0.04869731 RADAEVA_RESPONSE_TO_IFNA1_UP conjunctival disease DOID_4251 8.41E-03 0.09969149 8.41E-03 0.11962979 RADAEVA_RESPONSE_TO_IFNA1_UP acute T cell leukemia DOID_5603 8.41E-03 0.09765697 8.41E-03 0.11671199 RADAEVA_RESPONSE_TO_IFNA1_UP conjunctivitis DOID_6195 8.41E-03 0.09969149 8.41E-03 0.11962979 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP contact dermatitis DOID_2773 4.252E-08 2.419E-05 4.252E-08 2.419E-05 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP prion disease DOID_649 1.176E-06 3.345E-04 1.99E-04 0.01132594 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP allergic contact dermatitis DOID_3042 1.368E-06 2.595E-04 1.368E-06 3.892E-04 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP tuberculosis DOID_399 1.448E-06 2.06E-04 7.889E-05 0.01122217 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP funisitis DOID_0050698 2.212E-06 2.517E-04 2.996E-04 0.01311504 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP myasthenia gravis DOID_437 2.541E-06 2.41E-04 3.279E-04 0.0124397 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP primary bacterial infectious disease DOID_0050338 3.585E-06 2.914E-04 1.545E-04 0.01465024 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP Human immunodeficiency virus infectious disease DOID_526 4.092E-06 2.911E-04 1.704E-04 0.01385235 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP neuromuscular junction disease DOID_439 4.184E-06 2.645E-04 4.536E-04 0.01433949 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP encephalomyelitis DOID_640 4.651E-06 2.646E-04 1.874E-04 0.01184643 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP hypersensitivity reaction type I disease DOID_1205 5.053E-06 2.614E-04 1.993E-04 9.449E-03 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP autoimmune disease of the nervous system DOID_438 5.793E-06 2.747E-04 5.609E-04 0.0159587 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP celiac disease DOID_10608 8.511E-06 3.725E-04 7.213E-04 0.01954344 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP esophageal disease DOID_6050 1.102E-05 4.481E-04 8.544E-04 0.021137 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP uveitis DOID_13141 1.508E-05 5.719E-04 1.049E-03 0.02486678 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP uveal disease DOID_3480 2.138E-05 7.604E-04 1.319E-03 0.02886584 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.098E-05 1.037E-03 1.682E-03 0.03190955 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP pulmonary tuberculosis DOID_2957 3.098E-05 9.792E-04 1.682E-03 0.0299152 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP B-cell lymphocytic neoplasm DOID_707 3.471E-05 1.04E-03 1.813E-03 0.03034029 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP Sjogren's syndrome DOID_12894 5.889E-05 1.675E-03 0.01154706 0.14600622 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP brain infarction DOID_3454 7.889E-05 2.138E-03 7.889E-05 0.0149629 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP aneurysm disease DOID_2403 1.084E-04 2.805E-03 1.084E-04 0.01234131 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP narcolepsy DOID_8986 1.187E-04 2.938E-03 0.01612932 0.15823414 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP thyroiditis DOID_7166 1.563E-04 3.707E-03 0.01841265 0.1689806 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP autoimmune thyroiditis DOID_7188 1.563E-04 3.707E-03 0.01841265 0.1689806 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP juvenile rheumatoid arthritis DOID_676 1.771E-04 4.03E-03 0.01955237 0.17383282 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP lymphoma DOID_0060058 1.816E-04 3.974E-03 5.377E-03 0.06953745 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP lymphoblastic leukemia DOID_1037 1.874E-04 3.949E-03 1.874E-04 0.01332724 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP eosinophilia DOID_999 1.99E-04 4.045E-03 1.99E-04 0.01029631 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP acquired immunodeficiency syndrome DOID_635 2.996E-04 5.879E-03 2.996E-04 0.01217825 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP sleep disorder DOID_535 3.279E-04 6.22E-03 0.02636361 0.21429847 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP urticaria DOID_1555 4.203E-04 7.715E-03 0.02975186 0.22571747 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP bronchiolitis DOID_2942 4.203E-04 7.474E-03 4.203E-04 0.01494799 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP osteosarcoma DOID_3347 4.203E-04 7.248E-03 4.203E-04 0.0140687 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP myositis DOID_633 4.536E-04 7.591E-03 0.03087872 0.22525629 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ankylosing spondylitis DOID_7147 4.536E-04 7.375E-03 0.03087872 0.22240495 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP vitiligo DOID_12306 4.882E-04 7.716E-03 0.03200429 0.22482029 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP invasive ductal carcinoma DOID_3008 5.609E-04 8.626E-03 5.609E-04 0.01679863 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP autoimmune disease of endocrine system DOID_0060005 5.992E-04 8.972E-03 0.03537336 0.22363827 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP opportunistic mycosis DOID_2473 6.794E-04 9.912E-03 0.03761304 0.23518484 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP systemic mycosis DOID_0050136 8.088E-04 0.01150529 0.04096303 0.23543399 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP fungal infectious disease DOID_1564 8.088E-04 0.01150529 0.04096303 0.23543399 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP nephroblastoma DOID_2154 8.544E-04 0.01185734 8.544E-04 0.02209778 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP respiratory syncytial virus infectious disease DOID_1273 1.1E-03 0.01490908 1.1E-03 0.02504725 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP systemic scleroderma DOID_418 1.1E-03 0.01456235 0.04762886 0.25566811 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP rheumatic disease DOID_1575 1.319E-03 0.01705709 0.05204757 0.27169784 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP scleroderma DOID_419 1.319E-03 0.01705709 0.05204757 0.27169784 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP diabetic autonomic neuropathy DOID_11503 1.377E-03 0.01740646 1.377E-03 0.02901077 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP autonomic neuropathy DOID_11504 1.377E-03 0.01740646 1.377E-03 0.02901077 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP diabetic polyneuropathy DOID_12785 1.377E-03 0.01740646 1.377E-03 0.02901077 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP diabetic neuropathy DOID_9743 1.377E-03 0.01740646 1.377E-03 0.02901077 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP autonomic nervous system disease DOID_11465 1.557E-03 0.01925379 1.557E-03 0.03163122 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP neuritis DOID_1803 1.557E-03 0.01884413 1.557E-03 0.03054049 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP vascular skin disease DOID_9540 1.557E-03 0.01845155 0.05644623 0.27218566 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP glaucoma DOID_1686 1.682E-03 0.01953646 1.682E-03 0.03088021 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP aortic aneurysm DOID_3627 1.747E-03 0.0198819 1.747E-03 0.03012409 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP bile duct adenocarcinoma DOID_4896 2.018E-03 0.02250934 2.018E-03 0.03279932 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP cholangiocarcinoma DOID_4947 2.018E-03 0.02250934 2.018E-03 0.03279932 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP pustulosis of palm and sole DOID_4398 2.088E-03 0.02284809 0.06518382 0.30154139 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP bile duct cancer DOID_4606 2.307E-03 0.02476264 2.307E-03 0.03645611 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP bile duct carcinoma DOID_4897 2.307E-03 0.02476264 2.307E-03 0.03645611 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP leukocyte disease DOID_9500 2.382E-03 0.02509574 2.382E-03 0.03662622 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP collagen disease DOID_854 2.535E-03 0.02622957 0.07168506 0.3186625 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP nephrosis DOID_2527 3.372E-03 0.03426152 3.372E-03 0.05049066 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP peripheral vascular disease DOID_341 3.462E-03 0.03455724 0.08348944 0.34176614 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP endogenous depression DOID_1595 3.738E-03 0.03667083 3.738E-03 0.05453611 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP alcohol abuse DOID_1574 4.421E-03 0.042636 4.421E-03 0.06288809 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP mental depression DOID_1596 4.421E-03 0.0419254 4.421E-03 0.06135424 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP biliary tract cancer DOID_4607 4.421E-03 0.04123809 4.421E-03 0.05989342 ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP chronic kidney failure DOID_784 4.421E-03 0.04057296 4.421E-03 0.05850055 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP oral cavity cancer DOID_8618 6.48E-07 3.687E-04 6.48E-07 3.687E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP Graves' disease DOID_12361 1.038E-05 2.954E-03 4.922E-03 0.40010524 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP autoimmune disease of endocrine system DOID_0060005 3.543E-05 6.719E-03 8.959E-03 0.42481742 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP hyperthyroidism DOID_7998 5.069E-05 7.211E-03 0.01068484 0.33775958 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP adenoid cystic carcinoma DOID_4866 6.867E-05 7.814E-03 6.867E-05 0.01953553 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP salivary gland cancer DOID_8850 7.526E-05 7.137E-03 7.526E-05 0.01427394 BROWNE_HCMV_INFECTION_2HR_UP cerebral infarction DOID_3526 2.524E-10 1.436E-07 6.103E-06 3.472E-03 BROWNE_HCMV_INFECTION_2HR_UP cholestasis DOID_13580 1.521E-09 4.327E-07 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP brain infarction DOID_3454 1.897E-09 3.598E-07 1.994E-05 5.672E-03 BROWNE_HCMV_INFECTION_2HR_UP bile duct disease DOID_4138 2.343E-09 3.333E-07 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP biliary tract disease DOID_9741 2.509E-09 2.856E-07 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP middle cerebral artery infarction DOID_3525 4.813E-09 4.564E-07 1.965E-04 0.02236017 BROWNE_HCMV_INFECTION_2HR_UP intracranial arterial disease DOID_13089 2.879E-08 2.34E-06 4.662E-04 0.04420936 BROWNE_HCMV_INFECTION_2HR_UP cerebral arterial disease DOID_3527 2.879E-08 2.34E-06 4.662E-04 0.04420936 BROWNE_HCMV_INFECTION_2HR_UP alcohol abuse DOID_1574 4.624E-07 3.289E-05 3.422E-05 6.49E-03 BROWNE_HCMV_INFECTION_2HR_UP cystic fibrosis DOID_1485 2.645E-05 1.672E-03 0.05605608 0.67863637 BROWNE_HCMV_INFECTION_2HR_UP pancreatitis DOID_4989 2.853E-05 1.624E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP bacterial pneumonia DOID_874 2.853E-05 1.476E-03 0.0574528 0.66715595 BROWNE_HCMV_INFECTION_2HR_UP alcohol dependence DOID_0050741 4.761E-05 2.257E-03 4.761E-05 6.772E-03 BROWNE_HCMV_INFECTION_2HR_UP bronchitis DOID_6132 7.105E-05 3.11E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP brain edema DOID_4724 9.912E-05 4.029E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP acute pancreatitis DOID_2913 1.562E-04 5.924E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP urticaria DOID_1555 1.691E-04 6.013E-03 0.01903285 0.49225865 BROWNE_HCMV_INFECTION_2HR_UP pleurisy DOID_10247 2.259E-04 7.561E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP spastic cerebral palsy DOID_0050669 2.738E-04 8.656E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP allergic rhinitis DOID_4481 2.908E-04 8.709E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP pleural disease DOID_1532 3.083E-04 8.771E-03 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP respiratory syncytial virus infectious disease DOID_1273 4.447E-04 0.01204925 0.03057123 0.49700089 BROWNE_HCMV_INFECTION_2HR_UP adult respiratory distress syndrome DOID_11394 4.662E-04 0.0120571 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP influenza DOID_8469 5.571E-04 0.01378105 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP vascular skin disease DOID_9540 6.304E-04 0.01494564 0.03629124 0.55810038 BROWNE_HCMV_INFECTION_2HR_UP pulmonary tuberculosis DOID_2957 6.817E-04 0.0155166 0.03771615 0.56474965 BROWNE_HCMV_INFECTION_2HR_UP withdrawal disorder DOID_0060001 7.351E-04 0.01608655 7.351E-04 0.05975005 BROWNE_HCMV_INFECTION_2HR_UP bone marrow cancer DOID_4960 8.187E-04 0.01725326 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP parasitic protozoa infectious disease DOID_2789 8.475E-04 0.01722339 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP pustulosis of palm and sole DOID_4398 8.475E-04 0.01662948 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP leukocyte disease DOID_9500 9.678E-04 0.01835614 0.04481027 0.60707242 BROWNE_HCMV_INFECTION_2HR_UP carotid artery disease DOID_3407 1.031E-03 0.01892098 0.04622303 0.61164888 BROWNE_HCMV_INFECTION_2HR_UP respiratory failure DOID_11162 1.063E-03 0.01890296 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP parasitic infectious disease DOID_1398 1.163E-03 0.02004758 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP tuberculosis DOID_399 1.267E-03 0.02119704 0.05115184 0.64678654 BROWNE_HCMV_INFECTION_2HR_UP peripheral vascular disease DOID_341 1.412E-03 0.02295252 0.05395726 0.66742786 BROWNE_HCMV_INFECTION_2HR_UP contact dermatitis DOID_2773 1.684E-03 0.02662045 0.05884752 0.66968479 BROWNE_HCMV_INFECTION_2HR_UP focal epilepsy DOID_2234 1.808E-03 0.02780491 0.06093588 0.67985321 BROWNE_HCMV_INFECTION_2HR_UP chronic kidney failure DOID_784 1.808E-03 0.0270732 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP primary bacterial infectious disease DOID_0050338 1.98E-03 0.02888292 0.0637134 0.69717163 BROWNE_HCMV_INFECTION_2HR_UP primary immunodeficiency disease DOID_612 2.068E-03 0.02942125 0.06509919 0.69889507 BROWNE_HCMV_INFECTION_2HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.298E-03 0.03189029 0.06855502 0.72236674 BROWNE_HCMV_INFECTION_2HR_UP ulcerative colitis DOID_8577 2.49E-03 0.03373198 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP gallbladder disease DOID_0000000 7.362E-03 0.0974193 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP T cell deficiency DOID_11200 7.362E-03 0.09520523 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP familial combined hyperlipidemia DOID_13809 7.362E-03 0.09308956 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP chondrosarcoma DOID_3371 7.362E-03 0.09106587 7.362E-03 0.52362876 BROWNE_HCMV_INFECTION_2HR_UP conjunctival disease DOID_4251 7.362E-03 0.0891283 7.362E-03 0.46544778 BROWNE_HCMV_INFECTION_2HR_UP conjunctivitis DOID_6195 7.362E-03 0.0891283 7.362E-03 0.46544778 BROWNE_HCMV_INFECTION_2HR_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.362E-03 0.08727146 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.362E-03 0.08727146 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP Hodgkin's granuloma DOID_8651 7.362E-03 0.08727146 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 7.362E-03 0.08727146 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP cutaneous leishmaniasis DOID_9111 7.362E-03 0.08549041 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP bronchiectasis DOID_9563 8.095E-03 0.09212587 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP neonatoal period electroclinical syndrome DOID_0050702 8.828E-03 0.09849529 8.828E-03 0.502326 BROWNE_HCMV_INFECTION_2HR_UP aortic valve stenosis DOID_1712 8.828E-03 0.09660115 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP relapsing-remitting multiple sclerosis DOID_2378 8.828E-03 0.09477849 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP Hodgkin's lymphoma DOID_8567 8.828E-03 0.09302333 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP encephalitis DOID_9588 8.828E-03 0.091332 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP newborn respiratory distress syndrome DOID_12716 9.561E-03 0.09714159 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP carotid stenosis DOID_13001 9.561E-03 0.09543736 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP larynx cancer DOID_2596 9.561E-03 0.09379188 9.561E-03 0.49453902 BROWNE_HCMV_INFECTION_2HR_UP laryngeal benign neoplasm DOID_2598 9.561E-03 0.09379188 9.561E-03 0.49453902 BROWNE_HCMV_INFECTION_2HR_UP epilepsy with generalized tonic-clonic seizures DOID_7725 9.561E-03 0.09220219 9.561E-03 0.45332744 BROWNE_HCMV_INFECTION_2HR_UP Legionnaires' disease DOID_10457 0.01029227 0.09760503 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP legionellosis DOID_10458 0.01029227 0.09760503 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP viral pneumonia DOID_10533 0.01029227 0.09600495 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP eyelid disease DOID_530 0.01029227 0.09445648 0.01029227 0.45048474 BROWNE_HCMV_INFECTION_2HR_UP intermediate coronary syndrome DOID_8805 0.01102351 0.09956155 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP hyperhomocysteinemia DOID_9279 0.01102351 0.0980059 1.000 1.000 BROWNE_HCMV_INFECTION_2HR_UP tongue cancer DOID_8649 0.01175423 0.09982324 0.01175423 0.47772548 BROWNE_HCMV_INFECTION_2HR_UP Barrett's esophagus DOID_9206 0.01175423 0.09835525 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 portal hypertension DOID_10762 1.296E-07 7.373E-05 4.723E-05 8.958E-03 SESTO_RESPONSE_TO_UV_C3 hepatic vascular disease DOID_272 2.021E-07 5.751E-05 6.316E-05 7.187E-03 SESTO_RESPONSE_TO_UV_C3 peptic ulcer DOID_750 5.699E-07 1.081E-04 1.247E-04 0.01013319 SESTO_RESPONSE_TO_UV_C3 giant cell tumor DOID_200 1.372E-06 1.951E-04 2.223E-04 0.01405173 SESTO_RESPONSE_TO_UV_C3 malignant giant cell tumor DOID_2705 1.372E-06 1.951E-04 2.223E-04 0.01405173 SESTO_RESPONSE_TO_UV_C3 giant cell glioblastoma DOID_3074 1.372E-06 1.951E-04 2.223E-04 0.01405173 SESTO_RESPONSE_TO_UV_C3 glioblastoma DOID_3068 1.779E-06 2.024E-04 2.638E-04 0.01364627 SESTO_RESPONSE_TO_UV_C3 hyperglycemia DOID_4195 2.584E-06 2.451E-04 3.376E-04 0.01477563 SESTO_RESPONSE_TO_UV_C3 astrocytoma DOID_3069 2.94E-06 2.39E-04 3.675E-04 0.01493814 SESTO_RESPONSE_TO_UV_C3 cystic fibrosis DOID_1485 3.745E-06 2.663E-04 4.312E-04 0.01635808 SESTO_RESPONSE_TO_UV_C3 biliary tract cancer DOID_4607 4.854E-06 3.069E-04 5.118E-04 0.01713141 SESTO_RESPONSE_TO_UV_C3 chronic kidney failure DOID_784 4.854E-06 2.762E-04 5.118E-04 0.01617966 SESTO_RESPONSE_TO_UV_C3 cutaneous leishmaniasis DOID_9111 6.563E-06 3.395E-04 6.563E-06 3.734E-03 SESTO_RESPONSE_TO_UV_C3 ulcerative colitis DOID_8577 7.918E-06 3.754E-04 7.073E-04 0.02118054 SESTO_RESPONSE_TO_UV_C3 stomach disease DOID_76 9.622E-06 4.211E-04 4.738E-03 0.09628963 SESTO_RESPONSE_TO_UV_C3 Barrett's esophagus DOID_9206 1.748E-05 7.104E-04 6.313E-03 0.09978222 SESTO_RESPONSE_TO_UV_C3 leishmaniasis DOID_9065 2.489E-05 9.441E-04 2.489E-05 7.081E-03 SESTO_RESPONSE_TO_UV_C3 esophagitis DOID_11963 2.765E-05 9.832E-04 7.886E-03 0.10943626 SESTO_RESPONSE_TO_UV_C3 osteosarcoma DOID_3347 4.723E-05 1.581E-03 4.723E-05 6.718E-03 SESTO_RESPONSE_TO_UV_C3 cystitis DOID_1679 5.099E-05 1.612E-03 0.01063177 0.10802642 SESTO_RESPONSE_TO_UV_C3 pleurisy DOID_10247 6.316E-05 1.891E-03 0.01180655 0.10663374 SESTO_RESPONSE_TO_UV_C3 pleural disease DOID_1532 8.629E-05 2.455E-03 0.01376161 0.116871 SESTO_RESPONSE_TO_UV_C3 bladder disease DOID_365 8.629E-05 2.338E-03 0.01376161 0.1151523 SESTO_RESPONSE_TO_UV_C3 esophageal disease DOID_6050 9.654E-05 2.497E-03 0.01454262 0.11654583 SESTO_RESPONSE_TO_UV_C3 adolescence-adult electroclinical syndrome DOID_0050705 1.13E-04 2.795E-03 1.13E-04 0.01071478 SESTO_RESPONSE_TO_UV_C3 systemic scleroderma DOID_418 1.247E-04 2.956E-03 0.01649264 0.12512412 SESTO_RESPONSE_TO_UV_C3 intracranial arterial disease DOID_13089 1.307E-04 2.975E-03 1.307E-04 9.297E-03 SESTO_RESPONSE_TO_UV_C3 cerebral arterial disease DOID_3527 1.307E-04 2.975E-03 1.307E-04 9.297E-03 SESTO_RESPONSE_TO_UV_C3 rheumatic disease DOID_1575 1.497E-04 3.277E-03 0.01805005 0.1316728 SESTO_RESPONSE_TO_UV_C3 scleroderma DOID_419 1.497E-04 3.277E-03 0.01805005 0.1316728 SESTO_RESPONSE_TO_UV_C3 gallbladder cancer DOID_3121 1.563E-04 3.295E-03 0.01843904 0.13114769 SESTO_RESPONSE_TO_UV_C3 influenza DOID_8469 1.563E-04 3.177E-03 0.01843904 0.12952859 SESTO_RESPONSE_TO_UV_C3 B-cell lymphocytic neoplasm DOID_707 2.066E-04 4.054E-03 0.02115798 0.1352684 SESTO_RESPONSE_TO_UV_C3 bile duct adenocarcinoma DOID_4896 2.303E-04 4.368E-03 0.02232108 0.13956806 SESTO_RESPONSE_TO_UV_C3 cholangiocarcinoma DOID_4947 2.303E-04 4.368E-03 0.02232108 0.13956806 SESTO_RESPONSE_TO_UV_C3 parasitic protozoa infectious disease DOID_2789 2.385E-04 4.377E-03 2.385E-04 0.01356832 SESTO_RESPONSE_TO_UV_C3 bile duct cancer DOID_4606 2.638E-04 4.691E-03 0.02386988 0.14448893 SESTO_RESPONSE_TO_UV_C3 bile duct carcinoma DOID_4897 2.638E-04 4.691E-03 0.02386988 0.14448893 SESTO_RESPONSE_TO_UV_C3 melancholia DOID_2848 2.725E-04 4.699E-03 0.02425672 0.14528497 SESTO_RESPONSE_TO_UV_C3 neurotic disorder DOID_4964 2.814E-04 4.71E-03 0.02464342 0.14455777 SESTO_RESPONSE_TO_UV_C3 collagen disease DOID_854 2.904E-04 4.722E-03 0.02502997 0.14532708 SESTO_RESPONSE_TO_UV_C3 parasitic infectious disease DOID_1398 3.279E-04 5.182E-03 3.279E-04 0.01554652 SESTO_RESPONSE_TO_UV_C3 male reproductive system disease DOID_48 3.882E-04 5.97E-03 0.02888767 0.15079894 SESTO_RESPONSE_TO_UV_C3 endogenous depression DOID_1595 4.312E-04 6.457E-03 0.03042676 0.15321083 SESTO_RESPONSE_TO_UV_C3 electroclinical syndrome DOID_0050701 4.536E-04 6.617E-03 4.536E-04 0.0161301 SESTO_RESPONSE_TO_UV_C3 pancreatitis DOID_4989 4.536E-04 6.452E-03 0.03119544 0.15434964 SESTO_RESPONSE_TO_UV_C3 mental depression DOID_1596 5.118E-04 7.103E-03 0.03311468 0.15701877 SESTO_RESPONSE_TO_UV_C3 lymphoma DOID_0060058 6.254E-04 8.473E-03 0.03656036 0.16510196 SESTO_RESPONSE_TO_UV_C3 mouth disease DOID_403 6.521E-04 8.629E-03 0.03732451 0.16591912 SESTO_RESPONSE_TO_UV_C3 leber hereditary optic neuropathy DOID_705 3.556E-03 0.04598187 3.556E-03 0.10116011 SESTO_RESPONSE_TO_UV_C3 hyperparathyroidism DOID_13543 3.95E-03 0.04994639 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 hypolipoproteinemia DOID_1387 3.95E-03 0.0488606 3.95E-03 0.10702798 SESTO_RESPONSE_TO_UV_C3 childhood type dermatomyositis DOID_14203 3.95E-03 0.04782101 3.95E-03 0.10216307 SESTO_RESPONSE_TO_UV_C3 retinal vascular occlusion DOID_1729 3.95E-03 0.04682474 3.95E-03 0.0977212 SESTO_RESPONSE_TO_UV_C3 transient cerebral ischemia DOID_224 3.95E-03 0.04586913 3.95E-03 0.09364948 SESTO_RESPONSE_TO_UV_C3 familial adenomatous polyposis DOID_0050424 4.344E-03 0.0494378 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 dermatomyositis DOID_10223 4.344E-03 0.04846843 4.344E-03 0.0988756 SESTO_RESPONSE_TO_UV_C3 bronchiectasis DOID_9563 4.344E-03 0.04753635 4.344E-03 0.09507269 SESTO_RESPONSE_TO_UV_C3 intracranial arteriosclerosis DOID_13097 4.738E-03 0.05086999 4.738E-03 0.09985591 SESTO_RESPONSE_TO_UV_C3 vascular dementia DOID_8725 4.738E-03 0.05086999 4.738E-03 0.09985591 SESTO_RESPONSE_TO_UV_C3 mitochondrial encephalomyopathy DOID_890 4.738E-03 0.04992795 4.738E-03 0.0929693 SESTO_RESPONSE_TO_UV_C3 encephalitis DOID_9588 4.738E-03 0.04902017 4.738E-03 0.08987032 SESTO_RESPONSE_TO_UV_C3 parathyroid gland disease DOID_11201 5.132E-03 0.05214726 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 larynx cancer DOID_2596 5.132E-03 0.05123239 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 laryngeal benign neoplasm DOID_2598 5.132E-03 0.05123239 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 epilepsy with generalized tonic-clonic seizures DOID_7725 5.132E-03 0.05034907 5.132E-03 0.09420149 SESTO_RESPONSE_TO_UV_C3 open-angle glaucoma DOID_1067 5.526E-03 0.05329322 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 polycystic kidney disease DOID_898 5.526E-03 0.052405 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 idiopathic pulmonary fibrosis DOID_0050156 5.92E-03 0.05521756 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 skeletal system cancer DOID_0060124 5.92E-03 0.05432696 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 bone cancer DOID_184 5.92E-03 0.05432696 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 oral submucous fibrosis DOID_5773 5.92E-03 0.05346463 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 varicose veins DOID_799 5.92E-03 0.05262924 5.92E-03 0.10525848 SESTO_RESPONSE_TO_UV_C3 intermediate coronary syndrome DOID_8805 5.92E-03 0.05181956 5.92E-03 0.10206883 SESTO_RESPONSE_TO_UV_C3 spastic diplegia DOID_10965 6.313E-03 0.05442666 6.313E-03 0.10565176 SESTO_RESPONSE_TO_UV_C3 tongue cancer DOID_8649 6.313E-03 0.05361433 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 vein disease DOID_866 6.313E-03 0.05282588 6.313E-03 0.10263314 SESTO_RESPONSE_TO_UV_C3 methylmalonic acidemia DOID_14749 6.706E-03 0.05530385 6.706E-03 0.1031342 SESTO_RESPONSE_TO_UV_C3 urinary system benign neoplasm DOID_731 6.706E-03 0.05451379 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 glucose intolerance DOID_10603 7.1E-03 0.05689702 7.1E-03 0.10630759 SESTO_RESPONSE_TO_UV_C3 prion disease DOID_649 7.1E-03 0.05610679 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 Down syndrome DOID_14250 7.493E-03 0.05840177 7.493E-03 0.10931613 SESTO_RESPONSE_TO_UV_C3 granulosa cell tumor DOID_2999 7.493E-03 0.05761255 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 amnestic disorder DOID_10914 7.886E-03 0.05982516 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 pulmonary edema DOID_11396 7.886E-03 0.05903798 7.886E-03 0.11217217 SESTO_RESPONSE_TO_UV_C3 sex cord-gonadal stromal tumor DOID_192 7.886E-03 0.05827126 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 Kawasaki disease DOID_13378 8.278E-03 0.06038925 8.278E-03 0.11215147 SESTO_RESPONSE_TO_UV_C3 lymphadenitis DOID_1602 8.278E-03 0.06038925 8.278E-03 0.11215147 SESTO_RESPONSE_TO_UV_C3 mitochondrial myopathy DOID_699 8.278E-03 0.05962483 8.278E-03 0.1095433 SESTO_RESPONSE_TO_UV_C3 lymph node disease DOID_9942 8.278E-03 0.06038925 8.278E-03 0.11215147 SESTO_RESPONSE_TO_UV_C3 gastric ulcer DOID_10808 8.671E-03 0.06167193 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 neutropenia DOID_1227 8.671E-03 0.06091055 8.671E-03 0.11213078 SESTO_RESPONSE_TO_UV_C3 sinusitis DOID_0050127 9.063E-03 0.06289103 9.063E-03 0.11460143 SESTO_RESPONSE_TO_UV_C3 agranulocytosis DOID_12987 9.063E-03 0.06213331 9.063E-03 0.1121101 SESTO_RESPONSE_TO_UV_C3 paranasal sinus disease DOID_1352 9.063E-03 0.06289103 9.063E-03 0.11460143 SESTO_RESPONSE_TO_UV_C3 optic nerve disease DOID_1891 9.063E-03 0.06139362 9.063E-03 0.10972478 SESTO_RESPONSE_TO_UV_C3 IgA glomerulonephritis DOID_2986 9.063E-03 0.06067135 9.063E-03 0.10743884 SESTO_RESPONSE_TO_UV_C3 muscle cancer DOID_4045 9.063E-03 0.05996587 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 urinary tract obstruction DOID_5200 9.063E-03 0.0592766 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 sleep disorder DOID_535 9.063E-03 0.05860301 9.063E-03 0.10524621 SESTO_RESPONSE_TO_UV_C3 polyarteritis nodosa DOID_9810 9.063E-03 0.05794454 9.063E-03 0.10314129 SESTO_RESPONSE_TO_UV_C3 hypoglycemia DOID_9993 9.063E-03 0.05730072 9.063E-03 0.10111891 SESTO_RESPONSE_TO_UV_C3 Goodpasture syndrome DOID_9808 9.456E-03 0.05912409 9.456E-03 0.10346715 SESTO_RESPONSE_TO_UV_C3 organic acidemia DOID_0060159 0.01023989 0.06333152 0.01023989 0.10993395 SESTO_RESPONSE_TO_UV_C3 urticaria DOID_1555 0.01023989 0.06265053 0.01023989 0.10789814 SESTO_RESPONSE_TO_UV_C3 bronchiolitis DOID_2942 0.01023989 0.06198404 0.01023989 0.10593636 SESTO_RESPONSE_TO_UV_C3 myositis DOID_633 0.01063177 0.06367873 0.01063177 0.10613122 SESTO_RESPONSE_TO_UV_C3 middle cerebral artery infarction DOID_3525 0.01102351 0.06533726 0.01102351 0.10814444 SESTO_RESPONSE_TO_UV_C3 juvenile myoclonic epilepsy DOID_4890 0.01102351 0.06466368 0.01102351 0.10631148 SESTO_RESPONSE_TO_UV_C3 extrinsic allergic alveolitis DOID_841 0.01102351 0.06400385 0.01102351 0.10453962 SESTO_RESPONSE_TO_UV_C3 periodontitis DOID_824 0.0114151 0.06560801 0.0114151 0.10647857 SESTO_RESPONSE_TO_UV_C3 perinatal necrotizing enterocolitis DOID_8677 0.0114151 0.06495193 0.0114151 0.10476117 SESTO_RESPONSE_TO_UV_C3 thrombocytopenia DOID_1588 0.01180655 0.06651412 0.01180655 0.10496759 SESTO_RESPONSE_TO_UV_C3 cranial nerve disease DOID_5656 0.01219785 0.06804487 0.01219785 0.1067781 SESTO_RESPONSE_TO_UV_C3 spastic cerebral palsy DOID_0050669 0.01298002 0.07170516 0.01298002 0.1119035 SESTO_RESPONSE_TO_UV_C3 abdominal aortic aneurysm DOID_7693 0.01298002 0.07101568 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 allergic rhinitis DOID_4481 0.01337089 0.07245748 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 chronic leukemia DOID_1036 0.01376161 0.07387129 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 chronic lymphocytic leukemia DOID_1040 0.01376161 0.07387129 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 papilloma DOID_2615 0.01415219 0.07525791 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 myocarditis DOID_820 0.01415219 0.07456108 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 pneumoconiosis DOID_10316 0.01454262 0.07591517 0.01454262 0.11992397 SESTO_RESPONSE_TO_UV_C3 nephroblastoma DOID_2154 0.01454262 0.07522503 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 periodontal disease DOID_3388 0.01454262 0.07454733 0.01454262 0.11821077 SESTO_RESPONSE_TO_UV_C3 thyroid carcinoma DOID_3963 0.01454262 0.07388173 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 spindle cell carcinoma DOID_4015 0.01454262 0.07322791 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 leukopenia DOID_615 0.01454262 0.07258556 0.01454262 0.11492713 SESTO_RESPONSE_TO_UV_C3 thyroid cancer DOID_1781 0.01532306 0.07581584 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 calcinosis DOID_182 0.01571306 0.07707529 0.01571306 0.1224758 SESTO_RESPONSE_TO_UV_C3 blood platelet disease DOID_2218 0.01610292 0.0783125 0.01610292 0.12381841 SESTO_RESPONSE_TO_UV_C3 adult respiratory distress syndrome DOID_11394 0.0168822 0.08140656 0.0168822 0.1263944 SESTO_RESPONSE_TO_UV_C3 lymphatic system disease DOID_75 0.0168822 0.08072247 0.0168822 0.12475291 SESTO_RESPONSE_TO_UV_C3 cervix uteri carcinoma in situ DOID_8991 0.01727163 0.08189631 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 pulmonary emphysema DOID_9675 0.01727163 0.08121948 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 endometriosis of uterus DOID_288 0.01766091 0.08236933 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 nephrotic syndrome DOID_1184 0.01805005 0.08349982 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 Huntington's disease DOID_12858 0.01805005 0.08282644 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 idiopathic generalized epilepsy DOID_1827 0.01805005 0.08216382 0.01805005 0.13000605 SESTO_RESPONSE_TO_UV_C3 endometriosis DOID_289 0.01805005 0.08151173 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 diabetic autonomic neuropathy DOID_11503 0.01843904 0.08261272 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 autonomic neuropathy DOID_11504 0.01843904 0.08261272 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 diabetic polyneuropathy DOID_12785 0.01843904 0.08261272 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 diabetic neuropathy DOID_9743 0.01843904 0.08261272 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 cerebral infarction DOID_3526 0.01882789 0.08369587 0.01882789 0.13064721 SESTO_RESPONSE_TO_UV_C3 learning disability DOID_8927 0.01882789 0.08304706 0.01882789 0.12907315 SESTO_RESPONSE_TO_UV_C3 proteinuria DOID_576 0.0192166 0.08410958 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 autonomic nervous system disease DOID_11465 0.01960516 0.08515524 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 neuritis DOID_1803 0.01960516 0.08451013 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 thyroid adenoma DOID_2891 0.01960516 0.08387471 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 heart valve disease DOID_4079 0.01960516 0.08324878 0.01960516 0.13280163 SESTO_RESPONSE_TO_UV_C3 vascular skin disease DOID_9540 0.01960516 0.08263213 0.01960516 0.13123926 SESTO_RESPONSE_TO_UV_C3 integumentary system benign neoplasm DOID_0060121 0.02038186 0.08527409 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 glaucoma DOID_1686 0.02038186 0.08465165 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 pulmonary tuberculosis DOID_2957 0.02038186 0.08403823 0.02038186 0.13485204 SESTO_RESPONSE_TO_UV_C3 skin benign neoplasm DOID_3165 0.02038186 0.08527409 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 calcium metabolism disease DOID_10575 0.02076999 0.08502247 0.02076999 0.13584049 SESTO_RESPONSE_TO_UV_C3 aortic aneurysm DOID_3627 0.02076999 0.08441516 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 withdrawal disorder DOID_0060001 0.02115798 0.08538218 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 hemorrhagic disease DOID_2213 0.02115798 0.0847809 0.02115798 0.13680554 SESTO_RESPONSE_TO_UV_C3 atopic dermatitis DOID_3310 0.02154582 0.08573127 0.02154582 0.13621746 SESTO_RESPONSE_TO_UV_C3 sarcoidosis DOID_11335 0.02193352 0.08666787 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 integumentary system cancer DOID_0060122 0.02270849 0.08911126 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 osteochondrodysplasia DOID_2256 0.02270849 0.08850091 0.02270849 0.14044709 SESTO_RESPONSE_TO_UV_C3 skin cancer DOID_4159 0.02270849 0.08911126 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 mitochondrial metabolism disease DOID_700 0.02309576 0.08939789 0.02309576 0.14130634 SESTO_RESPONSE_TO_UV_C3 hypersensitivity reaction type IV disease DOID_2916 0.02386988 0.09177 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 oral cavity cancer DOID_8618 0.02386988 0.09115409 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 leukocyte disease DOID_9500 0.02425672 0.09201382 0.02425672 0.14377159 SESTO_RESPONSE_TO_UV_C3 respiratory failure DOID_11162 0.02541638 0.09577432 0.02541638 0.14608003 SESTO_RESPONSE_TO_UV_C3 pre-malignant neoplasm DOID_0060071 0.02580265 0.0965902 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 in situ carcinoma DOID_8719 0.02580265 0.0965902 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 mineral metabolism disease DOID_0050032 0.02618878 0.09739488 0.02618878 0.14901416 SESTO_RESPONSE_TO_UV_C3 endocrine pancreas disease DOID_1428 0.02618878 0.09676244 0.02618878 0.14753877 SESTO_RESPONSE_TO_UV_C3 cholestasis DOID_13580 0.02657476 0.0975551 0.02657476 0.1482455 SESTO_RESPONSE_TO_UV_C3 uterine disease DOID_345 0.02657476 0.09692975 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 temporal lobe epilepsy DOID_3328 0.0269606 0.09771073 0.0269606 0.14893771 SESTO_RESPONSE_TO_UV_C3 tooth disease DOID_1091 0.0273463 0.09848131 0.0273463 0.14961583 SESTO_RESPONSE_TO_UV_C3 endocrine organ benign neoplasm DOID_0060089 0.02773186 0.09924168 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 brain infarction DOID_3454 0.02773186 0.09862142 0.02773186 0.15028026 SESTO_RESPONSE_TO_UV_C3 tuberculosis DOID_399 0.02773186 0.09800887 0.02773186 0.14886252 SESTO_RESPONSE_TO_UV_C3 pancreatic ductal carcinoma DOID_3587 0.02850254 0.0994966 1.000 1.000 SESTO_RESPONSE_TO_UV_C3 bile duct disease DOID_4138 0.02888767 0.09961869 0.02888767 0.15219522 SESTO_RESPONSE_TO_UV_C3 biliary tract disease DOID_9741 0.02927265 0.09973737 0.02927265 0.15005532 SESTO_RESPONSE_TO_UV_C3 diabetic retinopathy DOID_8947 0.0296575 0.09985276 0.0296575 0.15067068 TSUNODA_CISPLATIN_RESISTANCE_DN diabetic autonomic neuropathy DOID_11503 8.636E-06 4.914E-03 7.286E-04 0.20729929 TSUNODA_CISPLATIN_RESISTANCE_DN autonomic neuropathy DOID_11504 8.636E-06 4.914E-03 7.286E-04 0.20729929 TSUNODA_CISPLATIN_RESISTANCE_DN diabetic polyneuropathy DOID_12785 8.636E-06 4.914E-03 7.286E-04 0.20729929 TSUNODA_CISPLATIN_RESISTANCE_DN diabetic neuropathy DOID_9743 8.636E-06 4.914E-03 7.286E-04 0.20729929 TSUNODA_CISPLATIN_RESISTANCE_DN autonomic nervous system disease DOID_11465 1.042E-05 2.965E-03 8.244E-04 0.1172714 TSUNODA_CISPLATIN_RESISTANCE_DN giant cell tumor DOID_200 1.469E-05 2.786E-03 0.04622064 0.33717365 TSUNODA_CISPLATIN_RESISTANCE_DN malignant giant cell tumor DOID_2705 1.469E-05 2.786E-03 0.04622064 0.33717365 TSUNODA_CISPLATIN_RESISTANCE_DN giant cell glioblastoma DOID_3074 1.469E-05 2.786E-03 0.04622064 0.33717365 TSUNODA_CISPLATIN_RESISTANCE_DN glioblastoma DOID_3068 1.902E-05 2.705E-03 0.05024534 0.34865363 TSUNODA_CISPLATIN_RESISTANCE_DN transient cerebral ischemia DOID_224 3.093E-05 3.52E-03 3.093E-05 0.01759885 TSUNODA_CISPLATIN_RESISTANCE_DN astrocytoma DOID_3069 3.131E-05 2.969E-03 0.05904185 0.37327567 TSUNODA_CISPLATIN_RESISTANCE_DN male reproductive system disease DOID_48 3.4E-05 2.763E-03 1.795E-03 0.1459007 TSUNODA_CISPLATIN_RESISTANCE_DN aneurysm disease DOID_2403 4.135E-05 2.941E-03 0.06459847 0.39523153 TSUNODA_CISPLATIN_RESISTANCE_DN transitional cell carcinoma DOID_2671 6.105E-05 3.86E-03 0.07326615 0.42539224 TSUNODA_CISPLATIN_RESISTANCE_DN parasitic helminthiasis infectious disease DOID_883 6.241E-05 3.551E-03 0.01175454 0.33441662 TSUNODA_CISPLATIN_RESISTANCE_DN polycystic kidney disease DOID_898 6.241E-05 3.229E-03 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN Crohn's disease DOID_8778 7.399E-05 3.508E-03 2.995E-03 0.13110815 TSUNODA_CISPLATIN_RESISTANCE_DN hemolytic-uremic syndrome DOID_12554 8.222E-05 3.599E-03 0.01342279 0.33206822 TSUNODA_CISPLATIN_RESISTANCE_DN Barrett's esophagus DOID_9206 8.222E-05 3.342E-03 0.01342279 0.29375266 TSUNODA_CISPLATIN_RESISTANCE_DN granulosa cell tumor DOID_2999 1.17E-04 4.437E-03 0.01592006 0.32351837 TSUNODA_CISPLATIN_RESISTANCE_DN esophagitis DOID_11963 1.299E-04 4.62E-03 0.01675112 0.32866855 TSUNODA_CISPLATIN_RESISTANCE_DN sex cord-gonadal stromal tumor DOID_192 1.299E-04 4.348E-03 0.01675112 0.31771293 TSUNODA_CISPLATIN_RESISTANCE_DN urinary tract obstruction DOID_5200 1.727E-04 5.459E-03 0.01924023 0.31279111 TSUNODA_CISPLATIN_RESISTANCE_DN pleurisy DOID_10247 2.958E-04 8.86E-03 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN autoimmune disease of the nervous system DOID_438 2.958E-04 8.417E-03 0.02502442 0.29058973 TSUNODA_CISPLATIN_RESISTANCE_DN age related macular degeneration DOID_10871 3.585E-04 9.714E-03 0.02749324 0.27935091 TSUNODA_CISPLATIN_RESISTANCE_DN degeneration of macula and posterior pole DOID_2007 3.585E-04 9.714E-03 0.02749324 0.27935091 TSUNODA_CISPLATIN_RESISTANCE_DN pleural disease DOID_1532 4.036E-04 0.01043859 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN papilloma DOID_2615 4.271E-04 0.0105665 0.02995599 0.29903436 TSUNODA_CISPLATIN_RESISTANCE_DN macular degeneration DOID_4448 4.513E-04 0.01069924 0.03077557 0.29680164 TSUNODA_CISPLATIN_RESISTANCE_DN esophageal disease DOID_6050 4.513E-04 0.01027127 0.03077557 0.29185495 TSUNODA_CISPLATIN_RESISTANCE_DN uveitis DOID_13141 5.545E-04 0.01213431 0.03404716 0.31758748 TSUNODA_CISPLATIN_RESISTANCE_DN peptic ulcer DOID_750 5.819E-04 0.01226267 0.03486339 0.31487728 TSUNODA_CISPLATIN_RESISTANCE_DN endometriosis of uterus DOID_288 6.68E-04 0.0135749 0.03730806 0.31684011 TSUNODA_CISPLATIN_RESISTANCE_DN Huntington's disease DOID_12858 6.98E-04 0.01369535 0.03812162 0.31898825 TSUNODA_CISPLATIN_RESISTANCE_DN endometriosis DOID_289 6.98E-04 0.01323884 0.03812162 0.31436523 TSUNODA_CISPLATIN_RESISTANCE_DN uveal disease DOID_3480 6.98E-04 0.01281178 0.03812162 0.3098743 TSUNODA_CISPLATIN_RESISTANCE_DN influenza DOID_8469 7.286E-04 0.01295621 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN proteinuria DOID_576 7.918E-04 0.01365331 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN pre-eclampsia DOID_10591 8.244E-04 0.01379664 8.244E-04 0.15636187 TSUNODA_CISPLATIN_RESISTANCE_DN neuritis DOID_1803 8.244E-04 0.01340245 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN heart valve disease DOID_4079 8.244E-04 0.01303016 8.244E-04 0.09381712 TSUNODA_CISPLATIN_RESISTANCE_DN hemolytic anemia DOID_583 8.576E-04 0.01318851 0.04217942 0.32432556 TSUNODA_CISPLATIN_RESISTANCE_DN normocytic anemia DOID_720 8.576E-04 0.01318851 0.04217942 0.32432556 TSUNODA_CISPLATIN_RESISTANCE_DN glaucoma DOID_1686 8.914E-04 0.01334807 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN aortic aneurysm DOID_3627 9.259E-04 0.01350873 0.0437979 0.32790793 TSUNODA_CISPLATIN_RESISTANCE_DN sarcoidosis DOID_11335 1.033E-03 0.01469619 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN bile duct adenocarcinoma DOID_4896 1.07E-03 0.0148513 0.0470269 0.33871273 TSUNODA_CISPLATIN_RESISTANCE_DN cholangiocarcinoma DOID_4947 1.07E-03 0.0148513 0.0470269 0.33871273 TSUNODA_CISPLATIN_RESISTANCE_DN vasculitis DOID_865 1.07E-03 0.0144977 1.07E-03 0.1014839 TSUNODA_CISPLATIN_RESISTANCE_DN hypersensitivity reaction type IV disease DOID_2916 1.224E-03 0.01620257 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN bile duct cancer DOID_4606 1.224E-03 0.01583433 0.05024534 0.34445298 TSUNODA_CISPLATIN_RESISTANCE_DN bile duct carcinoma DOID_4897 1.224E-03 0.01583433 0.05024534 0.34445298 TSUNODA_CISPLATIN_RESISTANCE_DN pre-malignant neoplasm DOID_0060071 1.431E-03 0.01809978 0.05425358 0.36750343 TSUNODA_CISPLATIN_RESISTANCE_DN in situ carcinoma DOID_8719 1.431E-03 0.01809978 0.05425358 0.36750343 TSUNODA_CISPLATIN_RESISTANCE_DN parasitic infectious disease DOID_1398 1.519E-03 0.0187844 0.05585229 0.36953432 TSUNODA_CISPLATIN_RESISTANCE_DN uterine disease DOID_345 1.519E-03 0.01838474 0.05585229 0.3652868 TSUNODA_CISPLATIN_RESISTANCE_DN endocrine organ benign neoplasm DOID_0060089 1.654E-03 0.01960655 0.05824544 0.37237813 TSUNODA_CISPLATIN_RESISTANCE_DN pancreatic ductal carcinoma DOID_3587 1.747E-03 0.0202903 0.0598376 0.37414941 TSUNODA_CISPLATIN_RESISTANCE_DN peripheral vascular disease DOID_341 1.843E-03 0.02097468 1.843E-03 0.13109176 TSUNODA_CISPLATIN_RESISTANCE_DN pancreatic carcinoma DOID_4905 1.892E-03 0.02110808 0.06222097 0.38482315 TSUNODA_CISPLATIN_RESISTANCE_DN diabetic retinopathy DOID_8947 1.892E-03 0.02070215 1.892E-03 0.11961244 TSUNODA_CISPLATIN_RESISTANCE_DN pancreatitis DOID_4989 2.093E-03 0.02247355 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN mixed glioma DOID_5076 2.093E-03 0.02205737 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN metabolic syndrome X DOID_14221 2.198E-03 0.02273579 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN contact dermatitis DOID_2773 2.198E-03 0.02232979 2.198E-03 0.12504683 TSUNODA_CISPLATIN_RESISTANCE_DN female reproductive system disease DOID_229 2.251E-03 0.0224679 0.0677594 0.41016065 TSUNODA_CISPLATIN_RESISTANCE_DN biliary tract cancer DOID_4607 2.359E-03 0.02313977 0.06933599 0.41096017 TSUNODA_CISPLATIN_RESISTANCE_DN retinal vascular disease DOID_2462 2.469E-03 0.02381211 2.469E-03 0.12771952 TSUNODA_CISPLATIN_RESISTANCE_DN amino acid metabolic disorder DOID_9252 2.697E-03 0.02557713 2.697E-03 0.12788567 TSUNODA_CISPLATIN_RESISTANCE_DN encephalomyelitis DOID_640 2.935E-03 0.02737335 0.07718023 0.43915553 TSUNODA_CISPLATIN_RESISTANCE_DN congenital disorder of glycosylation type II DOID_0050571 8.41E-03 0.07718051 8.41E-03 0.3417994 TSUNODA_CISPLATIN_RESISTANCE_DN hyperparathyroidism DOID_13543 8.41E-03 0.07595542 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN angioedema DOID_1558 8.41E-03 0.07476862 8.41E-03 0.31901278 TSUNODA_CISPLATIN_RESISTANCE_DN polycythemia DOID_8432 8.41E-03 0.07361833 8.41E-03 0.29907448 TSUNODA_CISPLATIN_RESISTANCE_DN familial adenomatous polyposis DOID_0050424 9.247E-03 0.07972062 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN pneumocystosis DOID_11339 9.247E-03 0.07853076 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN craniosynostosis DOID_2340 9.247E-03 0.0773759 9.247E-03 0.30950359 TSUNODA_CISPLATIN_RESISTANCE_DN otitis media DOID_10754 0.01008355 0.08315276 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN middle ear disease DOID_5100 0.01008355 0.08315276 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN retinal detachment DOID_5327 0.01008355 0.08196487 0.01008355 0.31875226 TSUNODA_CISPLATIN_RESISTANCE_DN aortic valve insufficiency DOID_57 0.01008355 0.08081043 0.01008355 0.30197582 TSUNODA_CISPLATIN_RESISTANCE_DN stomach disease DOID_76 0.01008355 0.07968806 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN ocular hypertension DOID_9282 0.01008355 0.07859645 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN borderline glaucoma DOID_9283 0.01008355 0.07859645 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN parathyroid gland disease DOID_11201 0.01091939 0.08396123 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN polyneuropathy DOID_1389 0.01091939 0.08284175 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN larynx cancer DOID_2596 0.01091939 0.08175172 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN laryngeal benign neoplasm DOID_2598 0.01091939 0.08175172 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN open-angle glaucoma DOID_1067 0.01175454 0.08686146 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN idiopathic pulmonary fibrosis DOID_0050156 0.01258901 0.09183519 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN skeletal system cancer DOID_0060124 0.01258901 0.09067272 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN thoracic aortic aneurysm DOID_14004 0.01258901 0.08953931 0.01258901 0.34110214 TSUNODA_CISPLATIN_RESISTANCE_DN bone cancer DOID_184 0.01258901 0.09067272 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN oral submucous fibrosis DOID_5773 0.01258901 0.08843389 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN varicose veins DOID_799 0.01258901 0.08735543 0.01258901 0.3255975 TSUNODA_CISPLATIN_RESISTANCE_DN silicosis DOID_10325 0.01342279 0.09201891 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN thyroiditis DOID_7166 0.01342279 0.09092344 0.01342279 0.31823205 TSUNODA_CISPLATIN_RESISTANCE_DN autoimmune thyroiditis DOID_7188 0.01342279 0.09092344 0.01342279 0.31823205 TSUNODA_CISPLATIN_RESISTANCE_DN tongue cancer DOID_8649 0.01342279 0.08985375 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN vein disease DOID_866 0.01342279 0.08880894 0.01342279 0.30550276 TSUNODA_CISPLATIN_RESISTANCE_DN urinary system benign neoplasm DOID_731 0.0142559 0.09323684 1.000 1.000 TSUNODA_CISPLATIN_RESISTANCE_DN male reproductive organ benign neoplasm DOID_0060087 0.01508832 0.0975597 0.01508832 0.31797235 TSUNODA_CISPLATIN_RESISTANCE_DN prion disease DOID_649 0.01508832 0.09646352 1.000 1.000 LIU_PROSTATE_CANCER_DN aneurysm disease DOID_2403 5.302E-18 3.017E-15 1.937E-16 1.102E-13 LIU_PROSTATE_CANCER_DN bone development disease DOID_0080006 2.056E-17 5.849E-15 6.781E-16 1.929E-13 LIU_PROSTATE_CANCER_DN osteochondrodysplasia DOID_2256 5.553E-12 1.053E-09 1.761E-10 2.504E-08 LIU_PROSTATE_CANCER_DN oral cavity cancer DOID_8618 9.431E-12 1.342E-09 9.431E-12 1.789E-09 LIU_PROSTATE_CANCER_DN intracranial aneurysm DOID_10941 5.544E-10 6.31E-08 2.709E-08 2.569E-06 LIU_PROSTATE_CANCER_DN toxic encephalopathy DOID_3602 1.211E-09 1.148E-07 1.84E-06 5.51E-05 LIU_PROSTATE_CANCER_DN aortic aneurysm DOID_3627 2.335E-09 1.898E-07 2.335E-09 2.657E-07 LIU_PROSTATE_CANCER_DN auditory system disease DOID_2742 5.238E-09 3.725E-07 9.617E-08 6.84E-06 LIU_PROSTATE_CANCER_DN transitional cell carcinoma DOID_2671 9.707E-09 6.137E-07 3.173E-05 6.448E-04 LIU_PROSTATE_CANCER_DN thoracic aortic aneurysm DOID_14004 3.547E-08 2.018E-06 3.547E-08 2.883E-06 LIU_PROSTATE_CANCER_DN multiple epiphyseal dysplasia DOID_12721 5.206E-08 2.693E-06 1.84E-06 5.816E-05 LIU_PROSTATE_CANCER_DN testicular cancer DOID_2998 1.344E-07 6.373E-06 2.599E-04 2.958E-03 LIU_PROSTATE_CANCER_DN dilated cardiomyopathy DOID_12930 2.96E-07 1.296E-05 2.96E-07 1.871E-05 LIU_PROSTATE_CANCER_DN adenoid cystic carcinoma DOID_4866 4.032E-07 1.639E-05 4.032E-07 2.294E-05 LIU_PROSTATE_CANCER_DN pulmonary emphysema DOID_9675 4.643E-07 1.761E-05 2.1E-04 2.715E-03 LIU_PROSTATE_CANCER_DN synostosis DOID_11971 4.781E-07 1.7E-05 4.781E-07 2.473E-05 LIU_PROSTATE_CANCER_DN endometriosis of uterus DOID_288 5.328E-07 1.783E-05 2.293E-04 2.836E-03 LIU_PROSTATE_CANCER_DN salivary gland cancer DOID_8850 5.328E-07 1.684E-05 5.328E-07 2.526E-05 LIU_PROSTATE_CANCER_DN pancreatic ductal carcinoma DOID_3587 5.915E-07 1.772E-05 1.448E-03 0.01084325 LIU_PROSTATE_CANCER_DN endometriosis DOID_289 6.093E-07 1.733E-05 2.498E-04 2.961E-03 LIU_PROSTATE_CANCER_DN diabetic autonomic neuropathy DOID_11503 6.946E-07 1.882E-05 6.946E-07 3.04E-05 LIU_PROSTATE_CANCER_DN autonomic neuropathy DOID_11504 6.946E-07 1.882E-05 6.946E-07 3.04E-05 LIU_PROSTATE_CANCER_DN diabetic polyneuropathy DOID_12785 6.946E-07 1.882E-05 6.946E-07 3.04E-05 LIU_PROSTATE_CANCER_DN diabetic neuropathy DOID_9743 6.946E-07 1.882E-05 6.946E-07 3.04E-05 LIU_PROSTATE_CANCER_DN pancreatic carcinoma DOID_4905 7.804E-07 2.018E-05 1.681E-03 0.01226191 LIU_PROSTATE_CANCER_DN epidermolysis bullosa DOID_2730 9.049E-07 2.239E-05 9.049E-07 3.678E-05 LIU_PROSTATE_CANCER_DN autonomic nervous system disease DOID_11465 1.011E-06 2.397E-05 1.011E-06 3.835E-05 LIU_PROSTATE_CANCER_DN mixed glioma DOID_5076 1.109E-06 2.523E-05 2.03E-03 0.0140843 LIU_PROSTATE_CANCER_DN glaucoma DOID_1686 1.281E-06 2.803E-05 1.281E-06 4.555E-05 LIU_PROSTATE_CANCER_DN vesiculobullous skin disease DOID_2731 1.3E-06 2.74E-05 1.3E-06 4.352E-05 LIU_PROSTATE_CANCER_DN biliary tract cancer DOID_4607 1.675E-06 3.403E-05 2.532E-03 0.01600975 LIU_PROSTATE_CANCER_DN dysostosis DOID_1934 2.169E-06 4.255E-05 2.169E-06 6.17E-05 LIU_PROSTATE_CANCER_DN bile duct adenocarcinoma DOID_4896 2.221E-06 4.212E-05 5.711E-04 5.507E-03 LIU_PROSTATE_CANCER_DN cholangiocarcinoma DOID_4947 2.221E-06 4.212E-05 5.711E-04 5.507E-03 LIU_PROSTATE_CANCER_DN reproductive organ benign neoplasm DOID_0050622 2.463E-06 4.521E-05 4.287E-05 8.411E-04 LIU_PROSTATE_CANCER_DN nervous system cancer DOID_3093 2.857E-06 5.081E-05 0.02363116 0.08564415 LIU_PROSTATE_CANCER_DN tongue cancer DOID_8649 3.258E-06 5.618E-05 3.258E-06 8.828E-05 LIU_PROSTATE_CANCER_DN bile duct cancer DOID_4606 3.323E-06 5.561E-05 7.389E-04 6.782E-03 LIU_PROSTATE_CANCER_DN bile duct carcinoma DOID_4897 3.323E-06 5.561E-05 7.389E-04 6.782E-03 LIU_PROSTATE_CANCER_DN leiomyoma DOID_127 3.44E-06 5.592E-05 8.488E-05 1.342E-03 LIU_PROSTATE_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.801E-06 6.007E-05 4.659E-04 4.734E-03 LIU_PROSTATE_CANCER_DN carotid artery disease DOID_3407 4.413E-06 6.786E-05 8.858E-04 7.637E-03 LIU_PROSTATE_CANCER_DN uterine disease DOID_345 6.301E-06 9.435E-05 1.112E-03 9.039E-03 LIU_PROSTATE_CANCER_DN multiple myeloma DOID_9538 6.786E-06 9.901E-05 2.391E-03 0.01546077 LIU_PROSTATE_CANCER_DN granulosa cell tumor DOID_2999 6.831E-06 9.717E-05 2.599E-04 2.9E-03 LIU_PROSTATE_CANCER_DN sex cord-gonadal stromal tumor DOID_192 8.494E-06 1.179E-04 3.043E-04 3.148E-03 LIU_PROSTATE_CANCER_DN brain edema DOID_4724 8.494E-06 1.151E-04 7.727E-03 0.03633693 LIU_PROSTATE_CANCER_DN nephrosis DOID_2527 1.032E-05 1.365E-04 1.032E-05 2.668E-04 LIU_PROSTATE_CANCER_DN diabetic retinopathy DOID_8947 1.204E-05 1.557E-04 1.568E-04 2.231E-03 LIU_PROSTATE_CANCER_DN gallbladder cancer DOID_3121 1.523E-05 1.926E-04 0.03911061 0.12572846 LIU_PROSTATE_CANCER_DN heart conduction disease DOID_10273 1.528E-05 1.89E-04 1.528E-05 3.781E-04 LIU_PROSTATE_CANCER_DN cataract DOID_83 1.691E-05 2.047E-04 1.691E-05 4.009E-04 LIU_PROSTATE_CANCER_DN female reproductive system disease DOID_229 2E-05 2.37E-04 2.322E-03 0.01591872 LIU_PROSTATE_CANCER_DN myeloma DOID_0070004 2.07E-05 2.404E-04 4.518E-03 0.02402504 LIU_PROSTATE_CANCER_DN lens disease DOID_110 2.07E-05 2.356E-04 2.07E-05 4.711E-04 LIU_PROSTATE_CANCER_DN brain cancer DOID_1319 2.07E-05 2.309E-04 0.04375304 0.13830822 LIU_PROSTATE_CANCER_DN central nervous system cancer DOID_3620 2.282E-05 2.498E-04 0.0453439 0.14098732 LIU_PROSTATE_CANCER_DN lung small cell carcinoma DOID_5409 2.512E-05 2.696E-04 2.512E-05 5.497E-04 LIU_PROSTATE_CANCER_DN retinal vascular disease DOID_2462 2.617E-05 2.757E-04 2.956E-04 3.115E-03 LIU_PROSTATE_CANCER_DN autosomal dominant nonsyndromic deafness DOID_0050564 2.966E-05 3.069E-04 2.966E-05 6.251E-04 LIU_PROSTATE_CANCER_DN retinal vascular occlusion DOID_1729 3.365E-05 3.419E-04 1.912E-03 0.01343121 LIU_PROSTATE_CANCER_DN bone marrow cancer DOID_4960 3.939E-05 3.932E-04 6.519E-03 0.03170345 LIU_PROSTATE_CANCER_DN lung adenocarcinoma DOID_3910 3.973E-05 3.897E-04 9.332E-04 7.809E-03 LIU_PROSTATE_CANCER_DN integumentary system cancer DOID_0060122 4.287E-05 4.134E-04 4.287E-05 8.131E-04 LIU_PROSTATE_CANCER_DN skin cancer DOID_4159 4.287E-05 4.134E-04 4.287E-05 8.131E-04 LIU_PROSTATE_CANCER_DN hypersensitivity reaction type I disease DOID_1205 4.845E-05 4.595E-04 4.073E-03 0.02250308 LIU_PROSTATE_CANCER_DN supratentorial cancer DOID_1659 5.208E-05 4.858E-04 0.01802737 0.06793096 LIU_PROSTATE_CANCER_DN cerebrum cancer DOID_368 5.208E-05 4.858E-04 0.01802737 0.06793096 LIU_PROSTATE_CANCER_DN nonsyndromic deafness DOID_0050563 5.476E-05 5.026E-04 5.476E-05 1.005E-03 LIU_PROSTATE_CANCER_DN female reproductive organ benign neoplasm DOID_0060086 5.921E-05 5.348E-04 1.248E-03 0.01000374 LIU_PROSTATE_CANCER_DN uterine benign neoplasm DOID_0060095 5.921E-05 5.348E-04 1.248E-03 0.01000374 LIU_PROSTATE_CANCER_DN corneal disease DOID_10124 5.921E-05 5.264E-04 1.248E-03 9.865E-03 LIU_PROSTATE_CANCER_DN uterine fibroid DOID_13223 5.921E-05 5.348E-04 1.248E-03 0.01000374 LIU_PROSTATE_CANCER_DN otitis media DOID_10754 6.108E-05 5.347E-04 6.108E-05 1.086E-03 LIU_PROSTATE_CANCER_DN middle ear disease DOID_5100 6.108E-05 5.347E-04 6.108E-05 1.086E-03 LIU_PROSTATE_CANCER_DN collagen disease DOID_854 6.906E-05 5.954E-04 8.858E-04 7.523E-03 LIU_PROSTATE_CANCER_DN Charcot-Marie-Tooth disease DOID_10595 7.557E-05 6.418E-04 7.557E-05 1.303E-03 LIU_PROSTATE_CANCER_DN endometrial cancer DOID_1380 7.557E-05 6.323E-04 7.557E-05 1.265E-03 LIU_PROSTATE_CANCER_DN germinoma DOID_3304 7.557E-05 6.232E-04 1.491E-03 0.01102022 LIU_PROSTATE_CANCER_DN osteogenesis imperfecta DOID_12347 7.901E-05 6.423E-04 7.901E-05 1.285E-03 LIU_PROSTATE_CANCER_DN larynx cancer DOID_2596 7.901E-05 6.332E-04 0.08306176 0.21005397 LIU_PROSTATE_CANCER_DN laryngeal benign neoplasm DOID_2598 7.901E-05 6.332E-04 0.08306176 0.21005397 LIU_PROSTATE_CANCER_DN open-angle glaucoma DOID_1067 1.001E-04 7.908E-04 1.001E-04 1.539E-03 LIU_PROSTATE_CANCER_DN nephroblastoma DOID_2154 1.059E-04 8.258E-04 1.059E-04 1.586E-03 LIU_PROSTATE_CANCER_DN endocrine organ benign neoplasm DOID_0060089 1.136E-04 8.731E-04 1.306E-03 0.01004473 LIU_PROSTATE_CANCER_DN astrocytoma DOID_3069 1.214E-04 9.208E-04 0.0831161 0.20833947 LIU_PROSTATE_CANCER_DN skeletal system cancer DOID_0060124 1.245E-04 9.319E-04 4.365E-03 0.02387959 LIU_PROSTATE_CANCER_DN bone cancer DOID_184 1.245E-04 9.319E-04 4.365E-03 0.02387959 LIU_PROSTATE_CANCER_DN cleft palate DOID_674 1.443E-04 1.067E-03 1.443E-04 2.106E-03 LIU_PROSTATE_CANCER_DN peripheral vascular disease DOID_341 1.473E-04 1.075E-03 0.01378927 0.05899318 LIU_PROSTATE_CANCER_DN syndrome DOID_225 1.773E-04 1.277E-03 1.85E-03 0.01315541 LIU_PROSTATE_CANCER_DN familial hypertrophic cardiomyopathy DOID_11986 1.842E-04 1.31E-03 1.842E-04 2.556E-03 LIU_PROSTATE_CANCER_DN bone resorption disease DOID_0080011 1.883E-04 1.322E-03 1.883E-04 2.55E-03 LIU_PROSTATE_CANCER_DN osteoporosis DOID_11476 1.883E-04 1.322E-03 1.883E-04 2.55E-03 LIU_PROSTATE_CANCER_DN electroclinical syndrome DOID_0050701 1.997E-04 1.386E-03 1.997E-04 2.643E-03 LIU_PROSTATE_CANCER_DN skin carcinoma DOID_3451 2.2E-04 1.508E-03 2.2E-04 2.781E-03 LIU_PROSTATE_CANCER_DN nephrotic syndrome DOID_1184 2.498E-04 1.692E-03 2.498E-04 3.024E-03 LIU_PROSTATE_CANCER_DN uveal disease DOID_3480 2.498E-04 1.672E-03 2.498E-04 2.901E-03 LIU_PROSTATE_CANCER_DN infertility DOID_5223 2.599E-04 1.72E-03 2.599E-04 2.844E-03 LIU_PROSTATE_CANCER_DN focal epilepsy DOID_2234 2.653E-04 1.735E-03 2.532E-03 0.01618963 LIU_PROSTATE_CANCER_DN uterine cancer DOID_363 2.716E-04 1.756E-03 2.716E-04 2.916E-03 LIU_PROSTATE_CANCER_DN pre-eclampsia DOID_10591 3.453E-04 2.207E-03 4.518E-03 0.02380258 LIU_PROSTATE_CANCER_DN neuritis DOID_1803 3.453E-04 2.183E-03 4.518E-03 0.02358421 LIU_PROSTATE_CANCER_DN heart valve disease DOID_4079 3.453E-04 2.159E-03 4.518E-03 0.02336981 LIU_PROSTATE_CANCER_DN vascular skin disease DOID_9540 3.453E-04 2.135E-03 0.04375304 0.13678835 LIU_PROSTATE_CANCER_DN IgA glomerulonephritis DOID_2986 4.658E-04 2.85E-03 0.01015562 0.04622836 LIU_PROSTATE_CANCER_DN orofacial cleft DOID_0050567 4.982E-04 3.016E-03 4.982E-04 4.973E-03 LIU_PROSTATE_CANCER_DN atopic dermatitis DOID_3310 4.982E-04 2.984E-03 0.0519149 0.16054118 LIU_PROSTATE_CANCER_DN atrophic muscular disease DOID_913 5.337E-04 3.164E-03 5.337E-04 5.236E-03 LIU_PROSTATE_CANCER_DN muscular dystrophy DOID_9884 5.337E-04 3.164E-03 5.337E-04 5.236E-03 LIU_PROSTATE_CANCER_DN spastic quadriplegia DOID_10970 5.99E-04 3.514E-03 5.99E-04 5.681E-03 LIU_PROSTATE_CANCER_DN portal hypertension DOID_10762 6.739E-04 3.912E-03 0.01287646 0.05635927 LIU_PROSTATE_CANCER_DN urticaria DOID_1555 6.739E-04 3.873E-03 0.01287646 0.05592904 LIU_PROSTATE_CANCER_DN hypertrophic cardiomyopathy DOID_11984 7.389E-04 4.205E-03 7.389E-04 6.893E-03 LIU_PROSTATE_CANCER_DN papillary adenoma DOID_3172 7.544E-04 4.25E-03 0.01384622 0.05835927 LIU_PROSTATE_CANCER_DN microcystic adenoma DOID_5403 7.544E-04 4.25E-03 0.01384622 0.05835927 LIU_PROSTATE_CANCER_DN follicular adenoma DOID_6204 7.544E-04 4.25E-03 0.01384622 0.05835927 LIU_PROSTATE_CANCER_DN cleft lip DOID_9296 7.544E-04 4.208E-03 7.544E-04 6.813E-03 LIU_PROSTATE_CANCER_DN leukocyte disease DOID_9500 7.858E-04 4.341E-03 7.858E-04 6.986E-03 LIU_PROSTATE_CANCER_DN seminoma DOID_4440 8.408E-04 4.6E-03 0.01484664 0.06211574 LIU_PROSTATE_CANCER_DN dystonia DOID_543 8.408E-04 4.556E-03 8.408E-04 7.36E-03 LIU_PROSTATE_CANCER_DN neuroectodermal tumor DOID_171 8.858E-04 4.755E-03 0.06782219 0.1901026 LIU_PROSTATE_CANCER_DN Sciatic Neuropathy DOID_11446 9.332E-04 4.963E-03 0.01587727 0.064994 LIU_PROSTATE_CANCER_DN lesion of sciatic nerve DOID_12528 9.332E-04 4.963E-03 0.01587727 0.064994 LIU_PROSTATE_CANCER_DN mononeuritis of lower limb DOID_9473 9.332E-04 4.963E-03 0.01587727 0.064994 LIU_PROSTATE_CANCER_DN hypothyroidism DOID_1459 9.39E-04 4.947E-03 9.39E-04 7.743E-03 LIU_PROSTATE_CANCER_DN pre-malignant neoplasm DOID_0060071 9.944E-04 5.191E-03 0.07155053 0.19203892 LIU_PROSTATE_CANCER_DN congenital heart defect DOID_1682 9.944E-04 5.144E-03 9.76E-03 0.04478563 LIU_PROSTATE_CANCER_DN in situ carcinoma DOID_8719 9.944E-04 5.191E-03 0.07155053 0.19203892 LIU_PROSTATE_CANCER_DN sarcoma DOID_1115 1.032E-03 5.289E-03 1.000 1.000 LIU_PROSTATE_CANCER_DN mononeuritis DOID_1802 1.032E-03 5.242E-03 0.01693766 0.0673953 LIU_PROSTATE_CANCER_DN hepatic vascular disease DOID_272 1.032E-03 5.196E-03 0.01693766 0.06692727 LIU_PROSTATE_CANCER_DN mononeuropathy DOID_1188 1.137E-03 5.674E-03 0.01802737 0.06838383 LIU_PROSTATE_CANCER_DN endometrial carcinoma DOID_2871 1.248E-03 6.176E-03 1.248E-03 9.73E-03 LIU_PROSTATE_CANCER_DN spastic cerebral palsy DOID_0050669 1.366E-03 6.702E-03 1.366E-03 0.01036637 LIU_PROSTATE_CANCER_DN allergic rhinitis DOID_4481 1.491E-03 7.253E-03 0.02146816 0.07932066 LIU_PROSTATE_CANCER_DN papilloma DOID_2615 1.762E-03 8.497E-03 0.02390081 0.08607319 LIU_PROSTATE_CANCER_DN myocarditis DOID_820 1.762E-03 8.425E-03 1.762E-03 0.01269151 LIU_PROSTATE_CANCER_DN spindle cell carcinoma DOID_4015 1.908E-03 9.048E-03 0.21876801 0.40415259 LIU_PROSTATE_CANCER_DN keratitis DOID_4677 1.912E-03 8.991E-03 0.06452544 0.18542916 LIU_PROSTATE_CANCER_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.912E-03 8.917E-03 0.06452544 0.18266156 LIU_PROSTATE_CANCER_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.912E-03 8.917E-03 0.06452544 0.18266156 LIU_PROSTATE_CANCER_DN Hodgkin's granuloma DOID_8651 1.912E-03 8.917E-03 0.06452544 0.18266156 LIU_PROSTATE_CANCER_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 1.912E-03 8.917E-03 0.06452544 0.18266156 LIU_PROSTATE_CANCER_DN medullomyoblastoma DOID_3861 2.062E-03 9.537E-03 0.02644064 0.09173611 LIU_PROSTATE_CANCER_DN adult medulloblastoma DOID_3864 2.062E-03 9.537E-03 0.02644064 0.09173611 LIU_PROSTATE_CANCER_DN childhood medulloblastoma DOID_3869 2.062E-03 9.537E-03 0.02644064 0.09173611 LIU_PROSTATE_CANCER_DN contact dermatitis DOID_2773 2.222E-03 0.01019426 0.01748501 0.06722279 LIU_PROSTATE_CANCER_DN adenoma DOID_657 2.223E-03 0.01011733 0.02774972 0.09569448 LIU_PROSTATE_CANCER_DN nervous system benign neoplasm DOID_0060115 2.327E-03 0.01050689 2.327E-03 0.01576034 LIU_PROSTATE_CANCER_DN craniosynostosis DOID_2340 2.327E-03 0.01042416 2.327E-03 0.01557492 LIU_PROSTATE_CANCER_DN prostatic adenoma DOID_2883 2.327E-03 0.01034272 2.327E-03 0.01539382 LIU_PROSTATE_CANCER_DN medulloblastoma DOID_3858 2.391E-03 0.01054688 0.02908438 0.09850603 LIU_PROSTATE_CANCER_DN embryonal cancer DOID_688 2.391E-03 0.01046575 2.391E-03 0.01563848 LIU_PROSTATE_CANCER_DN chronic kidney failure DOID_784 2.532E-03 0.01099906 0.01922147 0.07148377 LIU_PROSTATE_CANCER_DN uveitis DOID_13141 2.567E-03 0.01106676 2.567E-03 0.01605288 LIU_PROSTATE_CANCER_DN systemic scleroderma DOID_418 2.751E-03 0.01177087 0.03182887 0.10653311 LIU_PROSTATE_CANCER_DN familial atrial fibrillation DOID_0050650 2.78E-03 0.01180366 2.78E-03 0.01719229 LIU_PROSTATE_CANCER_DN neonatoal period electroclinical syndrome DOID_0050702 2.78E-03 0.01171623 2.78E-03 0.01700743 LIU_PROSTATE_CANCER_DN lipodystrophy DOID_811 2.78E-03 0.01163008 2.78E-03 0.0168265 LIU_PROSTATE_CANCER_DN peritonitis DOID_8283 2.78E-03 0.01154519 1.000 1.000 LIU_PROSTATE_CANCER_DN Hodgkin's lymphoma DOID_8567 2.78E-03 0.01146153 0.076924 0.2007787 LIU_PROSTATE_CANCER_DN progressive myoclonus epilepsy DOID_891 2.78E-03 0.01137907 2.78E-03 0.01664938 LIU_PROSTATE_CANCER_DN intracranial arterial disease DOID_13089 2.943E-03 0.01196251 0.03323793 0.11059871 LIU_PROSTATE_CANCER_DN cerebral arterial disease DOID_3527 2.943E-03 0.01196251 0.03323793 0.11059871 LIU_PROSTATE_CANCER_DN benign mesothelioma DOID_2645 3.143E-03 0.01268477 0.034671 0.11469651 LIU_PROSTATE_CANCER_DN cervix uteri carcinoma in situ DOID_8991 3.143E-03 0.01259544 0.25443874 0.45384214 LIU_PROSTATE_CANCER_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 3.271E-03 0.01301466 3.271E-03 0.01938643 LIU_PROSTATE_CANCER_DN variable age at onset electroclinical syndrome DOID_0050706 3.271E-03 0.01292428 3.271E-03 0.01918657 LIU_PROSTATE_CANCER_DN polyneuropathy DOID_1389 3.271E-03 0.01283515 3.271E-03 0.01899079 LIU_PROSTATE_CANCER_DN rheumatic disease DOID_1575 3.568E-03 0.01390491 0.03760772 0.12227881 LIU_PROSTATE_CANCER_DN primitive neuroectodermal tumor DOID_168 3.568E-03 0.01381032 0.03760772 0.12158404 LIU_PROSTATE_CANCER_DN scleroderma DOID_419 3.568E-03 0.01390491 0.03760772 0.12227881 LIU_PROSTATE_CANCER_DN lymphoma DOID_0060058 3.641E-03 0.0139981 0.12956378 0.27508132 LIU_PROSTATE_CANCER_DN lymphoblastic leukemia DOID_1037 3.782E-03 0.01444079 3.782E-03 0.02173412 LIU_PROSTATE_CANCER_DN encephalomyelitis DOID_640 3.782E-03 0.01434452 0.02567456 0.09130516 LIU_PROSTATE_CANCER_DN congenital structural myopathy DOID_422 3.799E-03 0.01431649 3.799E-03 0.0216179 LIU_PROSTATE_CANCER_DN eating disorder DOID_8670 3.799E-03 0.0142223 3.799E-03 0.02140386 LIU_PROSTATE_CANCER_DN polycystic kidney disease DOID_898 3.799E-03 0.01412935 3.799E-03 0.02119402 LIU_PROSTATE_CANCER_DN Crohn's disease DOID_8778 3.926E-03 0.01450456 0.02637614 0.09321753 LIU_PROSTATE_CANCER_DN proteinuria DOID_576 4.268E-03 0.01566597 0.04218363 0.13409211 LIU_PROSTATE_CANCER_DN Ehlers-Danlos syndrome DOID_13359 4.365E-03 0.01591972 4.365E-03 0.02365216 LIU_PROSTATE_CANCER_DN membranoproliferative glomerulonephritis DOID_2920 4.365E-03 0.01581832 4.365E-03 0.02342903 LIU_PROSTATE_CANCER_DN mesenchymal cell neoplasm DOID_3350 4.365E-03 0.01571821 1.000 1.000 LIU_PROSTATE_CANCER_DN spindle cell sarcoma DOID_4235 4.365E-03 0.01571821 1.000 1.000 LIU_PROSTATE_CANCER_DN epithelioid sarcoma DOID_6193 4.365E-03 0.01571821 1.000 1.000 LIU_PROSTATE_CANCER_DN intermediate coronary syndrome DOID_8805 4.365E-03 0.01561935 0.09521561 0.22203968 LIU_PROSTATE_CANCER_DN thyroid adenoma DOID_2891 4.518E-03 0.01606674 0.04375304 0.13754408 LIU_PROSTATE_CANCER_DN ulcerative colitis DOID_8577 4.539E-03 0.01604317 0.14309719 0.29183621 LIU_PROSTATE_CANCER_DN spastic diplegia DOID_10965 4.966E-03 0.01744363 4.966E-03 0.02545827 LIU_PROSTATE_CANCER_DN chronic myeloid leukemia DOID_8552 4.966E-03 0.01733661 0.10123223 0.23320298 LIU_PROSTATE_CANCER_DN integumentary system benign neoplasm DOID_0060121 5.045E-03 0.01750312 5.045E-03 0.02562958 LIU_PROSTATE_CANCER_DN skin benign neoplasm DOID_3165 5.045E-03 0.01750312 5.045E-03 0.02562958 LIU_PROSTATE_CANCER_DN methylmalonic acidemia DOID_14749 5.604E-03 0.01932531 5.604E-03 0.02821837 LIU_PROSTATE_CANCER_DN basal cell carcinoma DOID_2513 5.604E-03 0.01920889 5.604E-03 0.02797084 LIU_PROSTATE_CANCER_DN bronchitis DOID_6132 5.604E-03 0.01909387 1.000 1.000 LIU_PROSTATE_CANCER_DN urinary system benign neoplasm DOID_731 5.604E-03 0.01898021 5.604E-03 0.02772761 LIU_PROSTATE_CANCER_DN giant cell tumor DOID_200 6.206E-03 0.02089455 0.05360782 0.16488027 LIU_PROSTATE_CANCER_DN malignant giant cell tumor DOID_2705 6.206E-03 0.02089455 0.05360782 0.16488027 LIU_PROSTATE_CANCER_DN giant cell glioblastoma DOID_3074 6.206E-03 0.02089455 0.05360782 0.16488027 LIU_PROSTATE_CANCER_DN male reproductive organ benign neoplasm DOID_0060087 6.277E-03 0.0210095 6.277E-03 0.03078979 LIU_PROSTATE_CANCER_DN prion disease DOID_649 6.277E-03 0.02088664 0.11314617 0.24857208 LIU_PROSTATE_CANCER_DN smallpox DOID_8736 6.841E-03 0.02263193 6.841E-03 0.03298891 LIU_PROSTATE_CANCER_DN congenital nervous system abnormality DOID_2490 7.514E-03 0.02471331 7.514E-03 0.03592776 LIU_PROSTATE_CANCER_DN membranous glomerulonephritis DOID_10976 7.727E-03 0.02526879 7.727E-03 0.03663974 LIU_PROSTATE_CANCER_DN subependymal glioma DOID_4843 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN pilocytic astrocytoma DOID_4851 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN subependymal giant cell astrocytoma DOID_5077 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN fibrillary astrocytoma DOID_6726 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN juvenile pilocytic astrocytoma DOID_6811 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN childhood pilocytic astrocytoma DOID_6812 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN gemistocytic astrocytoma DOID_7005 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN childhood cerebral astrocytoma DOID_7007 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN protoplasmic astrocytoma DOID_7008 7.727E-03 0.02512439 1.000 1.000 LIU_PROSTATE_CANCER_DN amyloidosis DOID_9120 7.727E-03 0.02498164 7.727E-03 0.03603909 LIU_PROSTATE_CANCER_DN glioblastoma DOID_3068 7.864E-03 0.02528134 0.06235684 0.18674233 LIU_PROSTATE_CANCER_DN juvenile absence epilepsy DOID_0060172 8.503E-03 0.02718218 8.503E-03 0.03933681 LIU_PROSTATE_CANCER_DN benign glioma DOID_0060101 9.313E-03 0.02960397 1.000 1.000 LIU_PROSTATE_CANCER_DN gastric ulcer DOID_10808 9.313E-03 0.0294395 0.13650418 0.2855547 LIU_PROSTATE_CANCER_DN benign ependymoma DOID_4844 9.313E-03 0.02960397 1.000 1.000 LIU_PROSTATE_CANCER_DN respiratory failure DOID_11162 9.362E-03 0.02942933 0.35200644 0.60878926 LIU_PROSTATE_CANCER_DN sinusitis DOID_0050127 0.01015562 0.03175025 1.000 1.000 LIU_PROSTATE_CANCER_DN paranasal sinus disease DOID_1352 0.01015562 0.03175025 1.000 1.000 LIU_PROSTATE_CANCER_DN muscle cancer DOID_4045 0.01015562 0.03157675 0.1422473 0.29432259 LIU_PROSTATE_CANCER_DN uremia DOID_4676 0.01015562 0.03140514 0.01015562 0.04586147 LIU_PROSTATE_CANCER_DN pulmonary embolism DOID_9477 0.01015562 0.03123538 0.1422473 0.29114645 LIU_PROSTATE_CANCER_DN lingual-facial-buccal dyskinesia DOID_9854 0.01015562 0.03106745 1.000 1.000 LIU_PROSTATE_CANCER_DN parasitic infectious disease DOID_1398 0.01058612 0.03221123 0.01058612 0.04742914 LIU_PROSTATE_CANCER_DN temporal lobe epilepsy DOID_3328 0.01101392 0.03333469 0.07726415 0.20074568 LIU_PROSTATE_CANCER_DN hyperglycemia DOID_4195 0.01101392 0.03315832 0.01101392 0.04896033 LIU_PROSTATE_CANCER_DN meningitis DOID_9471 0.01103069 0.03303403 1.000 1.000 LIU_PROSTATE_CANCER_DN allergic contact dermatitis DOID_3042 0.0114516 0.03411497 0.07919982 0.20483952 LIU_PROSTATE_CANCER_DN brain infarction DOID_3454 0.01189918 0.03526373 0.08115056 0.20893515 LIU_PROSTATE_CANCER_DN organic acidemia DOID_0060159 0.01287646 0.0379622 0.01287646 0.05679616 LIU_PROSTATE_CANCER_DN bronchiolitis DOID_2942 0.01287646 0.03776652 0.01287646 0.05550534 LIU_PROSTATE_CANCER_DN osteosarcoma DOID_3347 0.01287646 0.03757284 0.15924937 0.31245824 LIU_PROSTATE_CANCER_DN morbid obesity DOID_11981 0.01384622 0.04019644 0.01384622 0.05879479 LIU_PROSTATE_CANCER_DN hypotrichosis DOID_4535 0.01484664 0.04288193 0.01484664 0.06166234 LIU_PROSTATE_CANCER_DN juvenile myoclonic epilepsy DOID_4890 0.01484664 0.04266535 0.01484664 0.06121551 LIU_PROSTATE_CANCER_DN fragments of torsion dystonia DOID_531 0.01484664 0.04245096 1.000 1.000 LIU_PROSTATE_CANCER_DN migraine DOID_6364 0.01587727 0.04517083 0.01587727 0.06452976 LIU_PROSTATE_CANCER_DN autoimmune disease of cardiovascular system DOID_0060051 0.01693766 0.0479479 0.01693766 0.06835126 LIU_PROSTATE_CANCER_DN malaria DOID_12365 0.01693766 0.04771053 0.01693766 0.06786991 LIU_PROSTATE_CANCER_DN Behcet's disease DOID_13241 0.01693766 0.0479479 0.01693766 0.06835126 LIU_PROSTATE_CANCER_DN invasive ductal carcinoma DOID_3008 0.01693766 0.0474755 0.01693766 0.06646571 LIU_PROSTATE_CANCER_DN autoimmune disease of the nervous system DOID_438 0.01693766 0.04724278 0.01693766 0.06601046 LIU_PROSTATE_CANCER_DN renal tubular transport disease DOID_447 0.01693766 0.04701233 0.01693766 0.06556141 LIU_PROSTATE_CANCER_DN central nervous system hereditary degenerative disease DOID_481 0.01693766 0.04678411 1.000 1.000 LIU_PROSTATE_CANCER_DN polycystic ovary syndrome DOID_11612 0.01802737 0.0495535 0.01802737 0.06884279 LIU_PROSTATE_CANCER_DN focal glomerulosclerosis DOID_3945 0.01802737 0.04931526 0.01802737 0.06748405 LIU_PROSTATE_CANCER_DN dystonic disease DOID_544 0.01802737 0.04907931 1.000 1.000 LIU_PROSTATE_CANCER_DN cranial nerve disease DOID_5656 0.01802737 0.0488456 0.18684342 0.35437969 LIU_PROSTATE_CANCER_DN age related macular degeneration DOID_10871 0.02029305 0.05472391 0.19762677 0.37358681 LIU_PROSTATE_CANCER_DN degeneration of macula and posterior pole DOID_2007 0.02029305 0.05472391 0.19762677 0.37358681 LIU_PROSTATE_CANCER_DN primary bacterial infectious disease DOID_0050338 0.02167987 0.05818796 0.11853321 0.25841147 LIU_PROSTATE_CANCER_DN childhood absence epilepsy DOID_1825 0.02267089 0.06056213 0.02267089 0.08322409 LIU_PROSTATE_CANCER_DN amino acid metabolic disorder DOID_9252 0.02297049 0.06107575 0.02297049 0.08378341 LIU_PROSTATE_CANCER_DN hair disease DOID_421 0.02390081 0.06325378 0.02390081 0.08553184 LIU_PROSTATE_CANCER_DN macular degeneration DOID_4448 0.02515753 0.06627147 0.21876801 0.40284466 LIU_PROSTATE_CANCER_DN mouth disease DOID_403 0.02637614 0.0691614 0.13404098 0.28247895 LIU_PROSTATE_CANCER_DN childhood electroclinical syndrome DOID_0050704 0.02644064 0.06901249 0.02644064 0.09286866 LIU_PROSTATE_CANCER_DN lymphoid leukemia DOID_10747 0.02644064 0.06869736 0.02644064 0.09229891 LIU_PROSTATE_CANCER_DN refractive error DOID_9835 0.02774972 0.07177086 0.02774972 0.09511801 LIU_PROSTATE_CANCER_DN adolescence-adult electroclinical syndrome DOID_0050705 0.02908438 0.07488241 0.02908438 0.09909589 LIU_PROSTATE_CANCER_DN congenital diaphragmatic hernia DOID_3827 0.03182887 0.08157941 0.03182887 0.10716349 LIU_PROSTATE_CANCER_DN peptic ulcer DOID_750 0.03182887 0.08121358 0.24441597 0.44010344 LIU_PROSTATE_CANCER_DN adult respiratory distress syndrome DOID_11394 0.03323793 0.08443027 0.24944402 0.44774021 LIU_PROSTATE_CANCER_DN lymphatic system disease DOID_75 0.03323793 0.08405502 0.24944402 0.44633222 LIU_PROSTATE_CANCER_DN spinocerebellar ataxia DOID_1441 0.03612772 0.09095874 0.03612772 0.11882471 LIU_PROSTATE_CANCER_DN Huntington's disease DOID_12858 0.03760772 0.0942678 0.03760772 0.12298156 GEISS_RESPONSE_TO_DSRNA_UP brain infarction DOID_3454 1.386E-07 7.889E-05 1.009E-03 0.09567738 GEISS_RESPONSE_TO_DSRNA_UP leiomyoma DOID_127 1.635E-06 4.651E-04 0.02283362 0.51969328 GEISS_RESPONSE_TO_DSRNA_UP cerebral infarction DOID_3526 4.296E-06 8.148E-04 4.622E-04 0.08767098 GEISS_RESPONSE_TO_DSRNA_UP myeloma DOID_0070004 4.864E-06 6.919E-04 0.03246548 0.55978362 GEISS_RESPONSE_TO_DSRNA_UP pulmonary tuberculosis DOID_2957 5.48E-06 6.236E-04 0.03374282 0.5485619 GEISS_RESPONSE_TO_DSRNA_UP bone marrow cancer DOID_4960 7.239E-06 6.865E-04 0.0369291 0.56790961 GEISS_RESPONSE_TO_DSRNA_UP tuberculosis DOID_399 1.405E-05 1.142E-03 0.04579709 0.62044152 GEISS_RESPONSE_TO_DSRNA_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.873E-05 1.332E-03 6.576E-03 0.41572632 GEISS_RESPONSE_TO_DSRNA_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.873E-05 1.332E-03 6.576E-03 0.41572632 GEISS_RESPONSE_TO_DSRNA_UP Hodgkin's granuloma DOID_8651 1.873E-05 1.332E-03 6.576E-03 0.41572632 GEISS_RESPONSE_TO_DSRNA_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 1.873E-05 1.332E-03 6.576E-03 0.41572632 GEISS_RESPONSE_TO_DSRNA_UP electroclinical syndrome DOID_0050701 2.012E-05 1.272E-03 0.05145649 0.66542598 GEISS_RESPONSE_TO_DSRNA_UP Hodgkin's lymphoma DOID_8567 2.744E-05 1.561E-03 7.886E-03 0.40790952 GEISS_RESPONSE_TO_DSRNA_UP primary bacterial infectious disease DOID_0050338 2.771E-05 1.433E-03 0.05708366 0.70610006 GEISS_RESPONSE_TO_DSRNA_UP transitional cell carcinoma DOID_2671 2.865E-05 1.359E-03 0.05770692 0.69862207 GEISS_RESPONSE_TO_DSRNA_UP Human immunodeficiency virus infectious disease DOID_526 3.06E-05 1.339E-03 0.05895225 0.69882982 GEISS_RESPONSE_TO_DSRNA_UP hepatitis B DOID_2043 9.566E-05 3.888E-03 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP sinusitis DOID_0050127 1.047E-04 3.973E-03 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP paranasal sinus disease DOID_1352 1.047E-04 3.973E-03 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP middle cerebral artery infarction DOID_3525 1.562E-04 5.553E-03 1.562E-04 0.08885255 GEISS_RESPONSE_TO_DSRNA_UP female reproductive organ benign neoplasm DOID_0060086 2.046E-04 6.847E-03 0.02089624 0.49541496 GEISS_RESPONSE_TO_DSRNA_UP uterine benign neoplasm DOID_0060095 2.046E-04 6.847E-03 0.02089624 0.49541496 GEISS_RESPONSE_TO_DSRNA_UP uterine fibroid DOID_13223 2.046E-04 6.847E-03 0.02089624 0.49541496 GEISS_RESPONSE_TO_DSRNA_UP adolescence-adult electroclinical syndrome DOID_0050705 3.207E-04 0.01013664 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP multiple myeloma DOID_9538 3.207E-04 9.603E-03 0.02605443 0.47822478 GEISS_RESPONSE_TO_DSRNA_UP systemic scleroderma DOID_418 3.537E-04 0.01006222 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP intracranial arterial disease DOID_13089 3.708E-04 0.01004648 3.708E-04 0.10548801 GEISS_RESPONSE_TO_DSRNA_UP cerebral arterial disease DOID_3527 3.708E-04 0.01004648 3.708E-04 0.10548801 GEISS_RESPONSE_TO_DSRNA_UP rheumatic disease DOID_1575 4.245E-04 0.01097834 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP scleroderma DOID_419 4.245E-04 0.01097834 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP reproductive organ benign neoplasm DOID_0050622 6.746E-04 0.01669009 0.03756514 0.56248853 GEISS_RESPONSE_TO_DSRNA_UP pustulosis of palm and sole DOID_4398 6.746E-04 0.01599467 0.03756514 0.54806574 GEISS_RESPONSE_TO_DSRNA_UP collagen disease DOID_854 8.208E-04 0.01868151 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP congenital heart defect DOID_1682 8.726E-04 0.01909698 8.726E-04 0.12413039 GEISS_RESPONSE_TO_DSRNA_UP allergic contact dermatitis DOID_3042 9.809E-04 0.02067106 9.809E-04 0.11162374 GEISS_RESPONSE_TO_DSRNA_UP biliary tract disease DOID_9741 1.125E-03 0.02285798 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP cystic fibrosis DOID_1485 1.216E-03 0.02385417 0.05020164 0.66429609 GEISS_RESPONSE_TO_DSRNA_UP bacterial pneumonia DOID_874 1.278E-03 0.024245 0.05145649 0.65063873 GEISS_RESPONSE_TO_DSRNA_UP contact dermatitis DOID_2773 1.342E-03 0.02463843 1.342E-03 0.10911306 GEISS_RESPONSE_TO_DSRNA_UP primary immunodeficiency disease DOID_612 1.649E-03 0.02932464 1.000 1.000 GEISS_RESPONSE_TO_DSRNA_UP lymphoma DOID_0060058 1.758E-03 0.03031587 0.060196 0.69901074 YAGI_AML_WITH_T_8_21_TRANSLOCATION primary immunodeficiency disease DOID_612 8.684E-11 4.941E-08 1.147E-05 1.306E-03 YAGI_AML_WITH_T_8_21_TRANSLOCATION female reproductive organ benign neoplasm DOID_0060086 4.052E-10 1.153E-07 0.01333558 0.11673761 YAGI_AML_WITH_T_8_21_TRANSLOCATION uterine benign neoplasm DOID_0060095 4.052E-10 1.153E-07 0.01333558 0.11673761 YAGI_AML_WITH_T_8_21_TRANSLOCATION uterine fibroid DOID_13223 4.052E-10 1.153E-07 0.01333558 0.11673761 YAGI_AML_WITH_T_8_21_TRANSLOCATION leiomyoma DOID_127 7.983E-10 1.514E-07 0.01582644 0.13243008 YAGI_AML_WITH_T_8_21_TRANSLOCATION reproductive organ benign neoplasm DOID_0050622 1.087E-09 1.546E-07 0.04051301 0.29937539 YAGI_AML_WITH_T_8_21_TRANSLOCATION funisitis DOID_0050698 1.759E-09 2.002E-07 6.438E-03 0.08934341 YAGI_AML_WITH_T_8_21_TRANSLOCATION transitional cell carcinoma DOID_2671 1.821E-09 1.727E-07 1.556E-03 0.05208647 YAGI_AML_WITH_T_8_21_TRANSLOCATION Human immunodeficiency virus infectious disease DOID_526 4.499E-08 3.657E-06 0.09104873 0.41445383 YAGI_AML_WITH_T_8_21_TRANSLOCATION MHC class II deficiency DOID_5812 5.175E-08 3.681E-06 1.478E-04 0.01051474 YAGI_AML_WITH_T_8_21_TRANSLOCATION neuroectodermal tumor DOID_171 6.446E-08 4.075E-06 2.777E-05 2.257E-03 YAGI_AML_WITH_T_8_21_TRANSLOCATION severe combined immunodeficiency DOID_627 2.302E-07 1.31E-05 3.425E-04 0.01623943 YAGI_AML_WITH_T_8_21_TRANSLOCATION combined T cell and B cell immunodeficiency DOID_628 2.837E-07 1.468E-05 3.856E-04 0.01687715 YAGI_AML_WITH_T_8_21_TRANSLOCATION autoimmune disease of cardiovascular system DOID_0060051 6.038E-07 2.863E-05 5.925E-04 0.02247438 YAGI_AML_WITH_T_8_21_TRANSLOCATION Behcet's disease DOID_13241 6.038E-07 2.863E-05 5.925E-04 0.02247438 YAGI_AML_WITH_T_8_21_TRANSLOCATION invasive ductal carcinoma DOID_3008 6.038E-07 2.643E-05 2.157E-05 2.046E-03 YAGI_AML_WITH_T_8_21_TRANSLOCATION vasculitis DOID_865 7.293E-07 2.964E-05 2.769E-04 0.01575758 YAGI_AML_WITH_T_8_21_TRANSLOCATION pustulosis of palm and sole DOID_4398 8.098E-07 3.072E-05 0.04051301 0.29553725 YAGI_AML_WITH_T_8_21_TRANSLOCATION hypersensitivity reaction type I disease DOID_1205 1.144E-06 4.068E-05 0.09952549 0.43229009 YAGI_AML_WITH_T_8_21_TRANSLOCATION pre-malignant neoplasm DOID_0060071 1.753E-06 5.866E-05 4.862E-04 0.0197612 YAGI_AML_WITH_T_8_21_TRANSLOCATION in situ carcinoma DOID_8719 1.753E-06 5.866E-05 4.862E-04 0.0197612 YAGI_AML_WITH_T_8_21_TRANSLOCATION juvenile rheumatoid arthritis DOID_676 1.981E-06 6.262E-05 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION medullomyoblastoma DOID_3861 2.052E-06 6.146E-05 2.052E-06 1.168E-03 YAGI_AML_WITH_T_8_21_TRANSLOCATION adult medulloblastoma DOID_3864 2.052E-06 6.146E-05 2.052E-06 1.168E-03 YAGI_AML_WITH_T_8_21_TRANSLOCATION childhood medulloblastoma DOID_3869 2.052E-06 6.146E-05 2.052E-06 1.168E-03 YAGI_AML_WITH_T_8_21_TRANSLOCATION medulloblastoma DOID_3858 2.666E-06 7.586E-05 2.666E-06 7.586E-04 YAGI_AML_WITH_T_8_21_TRANSLOCATION infertility DOID_5223 3.199E-06 8.667E-05 3.199E-06 6.067E-04 YAGI_AML_WITH_T_8_21_TRANSLOCATION primitive neuroectodermal tumor DOID_168 5.408E-06 1.399E-04 5.408E-06 7.693E-04 YAGI_AML_WITH_T_8_21_TRANSLOCATION mixed glioma DOID_5076 5.438E-06 1.345E-04 9.811E-03 0.10150185 YAGI_AML_WITH_T_8_21_TRANSLOCATION myeloma DOID_0070004 8.212E-06 1.947E-04 2.639E-03 0.05561277 YAGI_AML_WITH_T_8_21_TRANSLOCATION autoimmune disease of gastrointestinal tract DOID_0060031 9.984E-06 2.272E-04 0.24894654 0.68762418 YAGI_AML_WITH_T_8_21_TRANSLOCATION glaucoma DOID_1686 9.984E-06 2.185E-04 0.0331972 0.24854217 YAGI_AML_WITH_T_8_21_TRANSLOCATION primary bacterial infectious disease DOID_0050338 1.009E-05 2.127E-04 0.38750638 0.95039281 YAGI_AML_WITH_T_8_21_TRANSLOCATION urticaria DOID_1555 1.197E-05 2.433E-04 8.928E-03 0.09960988 YAGI_AML_WITH_T_8_21_TRANSLOCATION lymphoblastic leukemia DOID_1037 1.469E-05 2.883E-04 0.01557239 0.13224908 YAGI_AML_WITH_T_8_21_TRANSLOCATION bone marrow cancer DOID_4960 1.573E-05 2.984E-04 3.83E-03 0.07515581 YAGI_AML_WITH_T_8_21_TRANSLOCATION bile duct cancer DOID_4606 2.196E-05 4.03E-04 0.2852816 0.74461115 YAGI_AML_WITH_T_8_21_TRANSLOCATION bile duct carcinoma DOID_4897 2.196E-05 4.03E-04 0.2852816 0.74461115 YAGI_AML_WITH_T_8_21_TRANSLOCATION leukocyte disease DOID_9500 2.378E-05 4.228E-04 0.04569515 0.32500677 YAGI_AML_WITH_T_8_21_TRANSLOCATION autoimmune disease of endocrine system DOID_0060005 2.466E-05 4.252E-04 0.15685688 0.53766003 YAGI_AML_WITH_T_8_21_TRANSLOCATION celiac disease DOID_10608 3.588E-05 6.005E-04 0.17067027 0.56133749 YAGI_AML_WITH_T_8_21_TRANSLOCATION brain infarction DOID_3454 4.597E-05 7.473E-04 7.075E-03 0.09148815 YAGI_AML_WITH_T_8_21_TRANSLOCATION tuberculosis DOID_399 4.597E-05 7.265E-04 0.32360533 0.8257015 YAGI_AML_WITH_T_8_21_TRANSLOCATION esophageal disease DOID_6050 5.045E-05 7.758E-04 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION blood coagulation disease DOID_1247 5.256E-05 7.87E-04 7.637E-03 0.09657086 YAGI_AML_WITH_T_8_21_TRANSLOCATION open-angle glaucoma DOID_1067 5.667E-05 8.268E-04 0.07414368 0.38006983 YAGI_AML_WITH_T_8_21_TRANSLOCATION narcolepsy DOID_8986 5.667E-05 8.061E-04 0.07414368 0.37334293 YAGI_AML_WITH_T_8_21_TRANSLOCATION multiple myeloma DOID_9538 6.891E-05 9.564E-04 0.02037989 0.16565941 YAGI_AML_WITH_T_8_21_TRANSLOCATION syndrome DOID_225 7.225E-05 9.788E-04 9.157E-03 0.09831244 YAGI_AML_WITH_T_8_21_TRANSLOCATION thyroiditis DOID_7166 8.648E-05 1.144E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION autoimmune thyroiditis DOID_7188 8.648E-05 1.144E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION adenoid cystic carcinoma DOID_4866 9.187E-05 1.188E-03 1.709E-03 0.05402303 YAGI_AML_WITH_T_8_21_TRANSLOCATION cervix uteri carcinoma in situ DOID_8991 1.006E-04 1.272E-03 1.827E-03 0.05470408 YAGI_AML_WITH_T_8_21_TRANSLOCATION biliary tract cancer DOID_4607 1.088E-04 1.346E-03 0.3738465 0.92486373 YAGI_AML_WITH_T_8_21_TRANSLOCATION endometriosis of uterus DOID_288 1.1E-04 1.331E-03 1.949E-03 0.05281664 YAGI_AML_WITH_T_8_21_TRANSLOCATION salivary gland cancer DOID_8850 1.1E-04 1.304E-03 1.949E-03 0.05041588 YAGI_AML_WITH_T_8_21_TRANSLOCATION nephrotic syndrome DOID_1184 1.199E-04 1.393E-03 2.077E-03 0.05138136 YAGI_AML_WITH_T_8_21_TRANSLOCATION endometriosis DOID_289 1.199E-04 1.365E-03 2.077E-03 0.04924047 YAGI_AML_WITH_T_8_21_TRANSLOCATION uterine cancer DOID_363 1.305E-04 1.456E-03 0.02754863 0.21472839 YAGI_AML_WITH_T_8_21_TRANSLOCATION dissociative disorder DOID_10935 1.478E-04 1.618E-03 4.817E-03 0.08062 YAGI_AML_WITH_T_8_21_TRANSLOCATION dissociative amnesia DOID_11037 1.478E-04 1.618E-03 4.817E-03 0.08062 YAGI_AML_WITH_T_8_21_TRANSLOCATION spinocerebellar degeneration DOID_2478 1.537E-04 1.65E-03 1.537E-04 9.718E-03 YAGI_AML_WITH_T_8_21_TRANSLOCATION vascular skin disease DOID_9540 1.664E-04 1.753E-03 0.03088719 0.23433083 YAGI_AML_WITH_T_8_21_TRANSLOCATION amnestic disorder DOID_10914 1.732E-04 1.792E-03 5.333E-03 0.08201873 YAGI_AML_WITH_T_8_21_TRANSLOCATION lymphoma DOID_0060058 1.75E-04 1.778E-03 0.4041649 0.98699497 YAGI_AML_WITH_T_8_21_TRANSLOCATION pulmonary tuberculosis DOID_2957 1.939E-04 1.936E-03 0.24894654 0.68430232 YAGI_AML_WITH_T_8_21_TRANSLOCATION lung small cell carcinoma DOID_5409 1.939E-04 1.902E-03 2.952E-03 0.05998319 YAGI_AML_WITH_T_8_21_TRANSLOCATION B-cell lymphocytic neoplasm DOID_707 2.246E-04 2.166E-03 0.25717666 0.69352378 YAGI_AML_WITH_T_8_21_TRANSLOCATION hepatitis B DOID_2043 2.321E-04 2.201E-03 0.11402781 0.46344161 YAGI_AML_WITH_T_8_21_TRANSLOCATION myasthenia gravis DOID_437 2.659E-04 2.48E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION sleep disorder DOID_535 2.659E-04 2.44E-03 0.11889155 0.47307198 YAGI_AML_WITH_T_8_21_TRANSLOCATION bile duct adenocarcinoma DOID_4896 2.769E-04 2.501E-03 0.26935385 0.71954149 YAGI_AML_WITH_T_8_21_TRANSLOCATION cholangiocarcinoma DOID_4947 2.769E-04 2.501E-03 0.26935385 0.71954149 YAGI_AML_WITH_T_8_21_TRANSLOCATION sphingolipidosis DOID_1927 3.425E-04 3.045E-03 3.425E-04 0.01771575 YAGI_AML_WITH_T_8_21_TRANSLOCATION oral cavity cancer DOID_8618 3.597E-04 3.148E-03 4.637E-03 0.07994574 YAGI_AML_WITH_T_8_21_TRANSLOCATION neuromuscular junction disease DOID_439 4.32E-04 3.725E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION myositis DOID_633 4.32E-04 3.669E-03 0.13808222 0.51352146 YAGI_AML_WITH_T_8_21_TRANSLOCATION hypothyroidism DOID_1459 4.587E-04 3.838E-03 5.538E-03 0.08292302 YAGI_AML_WITH_T_8_21_TRANSLOCATION parasitic infectious disease DOID_1398 5.447E-04 4.492E-03 6.278E-03 0.0915966 YAGI_AML_WITH_T_8_21_TRANSLOCATION uterine disease DOID_345 5.447E-04 4.428E-03 6.278E-03 0.08930668 YAGI_AML_WITH_T_8_21_TRANSLOCATION sarcoma DOID_1115 5.925E-04 4.748E-03 0.01177965 0.11171032 YAGI_AML_WITH_T_8_21_TRANSLOCATION autoimmune disease of the nervous system DOID_438 5.925E-04 4.682E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION endocrine organ benign neoplasm DOID_0060089 6.416E-04 5.001E-03 0.32360533 0.82942088 YAGI_AML_WITH_T_8_21_TRANSLOCATION polycystic ovary syndrome DOID_11612 6.533E-04 5.023E-03 0.01254698 0.11332114 YAGI_AML_WITH_T_8_21_TRANSLOCATION pancreatic ductal carcinoma DOID_3587 7.127E-04 5.407E-03 7.637E-03 0.09447149 YAGI_AML_WITH_T_8_21_TRANSLOCATION nephrosis DOID_2527 7.502E-04 5.617E-03 7.928E-03 0.09598454 YAGI_AML_WITH_T_8_21_TRANSLOCATION peripheral vascular disease DOID_341 7.891E-04 5.831E-03 0.06405546 0.35732901 YAGI_AML_WITH_T_8_21_TRANSLOCATION pancreatic carcinoma DOID_4905 8.294E-04 6.05E-03 8.53E-03 0.10111443 YAGI_AML_WITH_T_8_21_TRANSLOCATION chronic leukemia DOID_1036 9.36E-04 6.742E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION chronic lymphocytic leukemia DOID_1040 9.36E-04 6.742E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION bacterial pneumonia DOID_874 1.005E-03 7.149E-03 9.811E-03 0.09968932 YAGI_AML_WITH_T_8_21_TRANSLOCATION papilloma DOID_2615 1.017E-03 7.144E-03 0.17975385 0.5713963 YAGI_AML_WITH_T_8_21_TRANSLOCATION myocarditis DOID_820 1.017E-03 7.057E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION DiGeorge syndrome DOID_11198 1.051E-03 7.208E-03 0.04831388 0.33525119 YAGI_AML_WITH_T_8_21_TRANSLOCATION velocardiofacial syndrome DOID_12583 1.051E-03 7.208E-03 0.04831388 0.33525119 YAGI_AML_WITH_T_8_21_TRANSLOCATION lipid metabolism disorder DOID_3146 1.102E-03 7.466E-03 0.01049163 0.10473225 YAGI_AML_WITH_T_8_21_TRANSLOCATION leukopenia DOID_615 1.102E-03 7.379E-03 0.01758874 0.14504341 YAGI_AML_WITH_T_8_21_TRANSLOCATION female reproductive system disease DOID_229 1.153E-03 7.629E-03 0.01084183 0.10636209 YAGI_AML_WITH_T_8_21_TRANSLOCATION mental depression DOID_1596 1.26E-03 8.239E-03 1.26E-03 0.04479703 YAGI_AML_WITH_T_8_21_TRANSLOCATION T cell deficiency DOID_11200 1.31E-03 8.468E-03 0.05353658 0.35421294 YAGI_AML_WITH_T_8_21_TRANSLOCATION Sjogren's syndrome DOID_12894 1.31E-03 8.373E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION angioedema DOID_1558 1.31E-03 8.28E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION chondrosarcoma DOID_3371 1.31E-03 8.189E-03 0.05353658 0.34227318 YAGI_AML_WITH_T_8_21_TRANSLOCATION uveitis DOID_13141 1.488E-03 9.204E-03 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION systemic scleroderma DOID_418 1.596E-03 9.766E-03 0.20641473 0.61171866 YAGI_AML_WITH_T_8_21_TRANSLOCATION nervous system cancer DOID_3093 1.687E-03 0.01021362 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION encephalomyelitis DOID_640 1.898E-03 0.01136859 0.4074421 0.99074595 YAGI_AML_WITH_T_8_21_TRANSLOCATION aortic valve stenosis DOID_1712 1.907E-03 0.01130235 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION lipodystrophy DOID_811 1.907E-03 0.01118583 0.06389656 0.36724385 YAGI_AML_WITH_T_8_21_TRANSLOCATION ocular hypertension DOID_9282 1.907E-03 0.01107169 0.06389656 0.35997169 YAGI_AML_WITH_T_8_21_TRANSLOCATION borderline glaucoma DOID_9283 1.907E-03 0.01107169 0.06389656 0.35997169 YAGI_AML_WITH_T_8_21_TRANSLOCATION autoimmune disease of urogenital tract DOID_0060049 1.949E-03 0.01120353 0.02540979 0.20363623 YAGI_AML_WITH_T_8_21_TRANSLOCATION primary biliary cirrhosis DOID_12236 1.949E-03 0.01120353 0.02540979 0.20363623 YAGI_AML_WITH_T_8_21_TRANSLOCATION spinocerebellar ataxia DOID_1441 1.949E-03 0.01109149 1.949E-03 0.05545747 YAGI_AML_WITH_T_8_21_TRANSLOCATION rheumatic disease DOID_1575 2.077E-03 0.01170071 0.22370774 0.64614062 YAGI_AML_WITH_T_8_21_TRANSLOCATION uveal disease DOID_3480 2.077E-03 0.01158599 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION scleroderma DOID_419 2.077E-03 0.01170071 0.22370774 0.64614062 YAGI_AML_WITH_T_8_21_TRANSLOCATION gallbladder cancer DOID_3121 2.21E-03 0.01220663 0.22797206 0.64858052 YAGI_AML_WITH_T_8_21_TRANSLOCATION learning disability DOID_8927 2.347E-03 0.0128435 2.347E-03 0.05342896 YAGI_AML_WITH_T_8_21_TRANSLOCATION parasitic helminthiasis infectious disease DOID_883 2.61E-03 0.01414524 2.61E-03 0.057125 YAGI_AML_WITH_T_8_21_TRANSLOCATION brain cancer DOID_1319 2.639E-03 0.01416552 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION neuritis DOID_1803 2.639E-03 0.01403313 0.24062568 0.67115692 YAGI_AML_WITH_T_8_21_TRANSLOCATION central nervous system cancer DOID_3620 2.793E-03 0.01471295 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION adrenal cortex disease DOID_3952 3.001E-03 0.01566582 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION panic disorder DOID_594 3.001E-03 0.0155234 0.07922529 0.38861373 YAGI_AML_WITH_T_8_21_TRANSLOCATION aortic aneurysm DOID_3627 3.116E-03 0.01597452 0.25307288 0.69230033 YAGI_AML_WITH_T_8_21_TRANSLOCATION hemorrhagic disease DOID_2213 3.286E-03 0.01669606 0.25717666 0.69682628 YAGI_AML_WITH_T_8_21_TRANSLOCATION angiosarcoma DOID_0001816 3.417E-03 0.01720782 0.08427916 0.40987042 YAGI_AML_WITH_T_8_21_TRANSLOCATION Barrett's esophagus DOID_9206 3.417E-03 0.01705688 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION hyperostosis DOID_205 3.859E-03 0.01909403 3.859E-03 0.07319379 YAGI_AML_WITH_T_8_21_TRANSLOCATION urinary system benign neoplasm DOID_731 3.859E-03 0.01892943 0.08930541 0.4097966 YAGI_AML_WITH_T_8_21_TRANSLOCATION adrenal gland disease DOID_9553 3.859E-03 0.01876764 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION smallpox DOID_8736 4.023E-03 0.01940008 4.023E-03 0.07384545 YAGI_AML_WITH_T_8_21_TRANSLOCATION familial hyperlipidemia DOID_1168 4.222E-03 0.02018657 0.04178639 0.3009678 YAGI_AML_WITH_T_8_21_TRANSLOCATION keratosis DOID_161 4.326E-03 0.02051167 4.326E-03 0.07691875 YAGI_AML_WITH_T_8_21_TRANSLOCATION neuroendocrine tumor DOID_169 4.326E-03 0.02034215 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION agammaglobulinemia DOID_2583 4.817E-03 0.02246787 0.0992757 0.4378905 YAGI_AML_WITH_T_8_21_TRANSLOCATION testicular cancer DOID_2998 4.817E-03 0.0222852 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION melancholia DOID_2848 4.853E-03 0.02226838 4.853E-03 0.0788937 YAGI_AML_WITH_T_8_21_TRANSLOCATION neurotic disorder DOID_4964 5.075E-03 0.02310211 5.075E-03 0.08021565 YAGI_AML_WITH_T_8_21_TRANSLOCATION collagen disease DOID_854 5.303E-03 0.0239499 0.29700021 0.77165809 YAGI_AML_WITH_T_8_21_TRANSLOCATION colon carcinoma DOID_1520 5.333E-03 0.02389522 0.10422003 0.44587368 YAGI_AML_WITH_T_8_21_TRANSLOCATION blood protein disease DOID_620 5.333E-03 0.02370854 0.10422003 0.43926814 YAGI_AML_WITH_T_8_21_TRANSLOCATION autoimmune hepatitis DOID_2048 5.874E-03 0.02590759 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION endocrine pancreas disease DOID_1428 6.025E-03 0.02637186 0.05249339 0.35139695 YAGI_AML_WITH_T_8_21_TRANSLOCATION gastric ulcer DOID_10808 6.438E-03 0.02796244 0.11402781 0.46677572 YAGI_AML_WITH_T_8_21_TRANSLOCATION neutropenia DOID_1227 6.438E-03 0.02775061 6.438E-03 0.08721619 YAGI_AML_WITH_T_8_21_TRANSLOCATION hyperglycemia DOID_4195 6.537E-03 0.02796805 0.05530748 0.33126271 YAGI_AML_WITH_T_8_21_TRANSLOCATION agranulocytosis DOID_12987 7.026E-03 0.02983237 7.026E-03 0.092966 YAGI_AML_WITH_T_8_21_TRANSLOCATION uremia DOID_4676 7.026E-03 0.02961139 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION aortic valve disease DOID_62 7.637E-03 0.03195072 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION toxic shock syndrome DOID_14115 8.271E-03 0.03435185 0.12853946 0.50095172 YAGI_AML_WITH_T_8_21_TRANSLOCATION commensal bacterial infectious disease DOID_0050339 8.928E-03 0.03681235 0.13332391 0.5160633 YAGI_AML_WITH_T_8_21_TRANSLOCATION X-linked disease DOID_0050735 8.928E-03 0.03654751 8.928E-03 0.10367559 YAGI_AML_WITH_T_8_21_TRANSLOCATION portal hypertension DOID_10762 8.928E-03 0.03628646 8.928E-03 0.10160208 YAGI_AML_WITH_T_8_21_TRANSLOCATION bronchiolitis DOID_2942 8.928E-03 0.03602911 0.13332391 0.50574203 YAGI_AML_WITH_T_8_21_TRANSLOCATION endogenous depression DOID_1595 9.157E-03 0.03669408 9.157E-03 0.10020306 YAGI_AML_WITH_T_8_21_TRANSLOCATION aneurysm disease DOID_2403 9.481E-03 0.03772518 0.35278619 0.88820947 YAGI_AML_WITH_T_8_21_TRANSLOCATION spinal muscular atrophy DOID_12377 9.608E-03 0.03796421 9.608E-03 0.10123788 YAGI_AML_WITH_T_8_21_TRANSLOCATION papillary adenoma DOID_3172 9.608E-03 0.03770238 0.13808222 0.51689989 YAGI_AML_WITH_T_8_21_TRANSLOCATION microcystic adenoma DOID_5403 9.608E-03 0.03770238 0.13808222 0.51689989 YAGI_AML_WITH_T_8_21_TRANSLOCATION follicular adenoma DOID_6204 9.608E-03 0.03770238 0.13808222 0.51689989 YAGI_AML_WITH_T_8_21_TRANSLOCATION ankylosing spondylitis DOID_7147 9.608E-03 0.03744415 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION pancreatitis DOID_4989 9.811E-03 0.03797688 0.35634456 0.89321611 YAGI_AML_WITH_T_8_21_TRANSLOCATION vitiligo DOID_12306 0.0103098 0.03963702 0.14281453 0.52767188 YAGI_AML_WITH_T_8_21_TRANSLOCATION B cell deficiency DOID_2115 0.0103098 0.03937099 0.14281453 0.52426754 YAGI_AML_WITH_T_8_21_TRANSLOCATION seminoma DOID_4440 0.0103098 0.03910852 0.14281453 0.51758897 YAGI_AML_WITH_T_8_21_TRANSLOCATION metabolic syndrome X DOID_14221 0.01049163 0.03953469 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION contact dermatitis DOID_2773 0.01049163 0.03927459 0.07480064 0.37334707 YAGI_AML_WITH_T_8_21_TRANSLOCATION Sciatic Neuropathy DOID_11446 0.01103383 0.04103433 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION lesion of sciatic nerve DOID_12528 0.01103383 0.04103433 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION lung adenocarcinoma DOID_3910 0.01103383 0.04076787 0.01103383 0.10641105 YAGI_AML_WITH_T_8_21_TRANSLOCATION mononeuritis of lower limb DOID_9473 0.01103383 0.04103433 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION mononeuritis DOID_1802 0.01177965 0.0432427 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION hepatic vascular disease DOID_272 0.01177965 0.04296551 0.01177965 0.109879 YAGI_AML_WITH_T_8_21_TRANSLOCATION coronary stenosis DOID_4248 0.01177965 0.04269184 0.01177965 0.10810676 YAGI_AML_WITH_T_8_21_TRANSLOCATION mononeuropathy DOID_1188 0.01254698 0.04518501 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION toxic encephalopathy DOID_3602 0.01254698 0.04490083 0.15685688 0.53444051 YAGI_AML_WITH_T_8_21_TRANSLOCATION focal glomerulosclerosis DOID_3945 0.01254698 0.0446202 0.01254698 0.1115505 YAGI_AML_WITH_T_8_21_TRANSLOCATION amino acid metabolic disorder DOID_9252 0.01388636 0.04907665 0.01388636 0.11971729 YAGI_AML_WITH_T_8_21_TRANSLOCATION opportunistic mycosis DOID_2473 0.01414519 0.0496828 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION abdominal aortic aneurysm DOID_7693 0.01414519 0.049378 0.16609102 0.54945226 YAGI_AML_WITH_T_8_21_TRANSLOCATION endometrial cancer DOID_1380 0.01497556 0.05195789 0.17067027 0.55811141 YAGI_AML_WITH_T_8_21_TRANSLOCATION germinoma DOID_3304 0.01497556 0.051643 0.17067027 0.55492221 YAGI_AML_WITH_T_8_21_TRANSLOCATION alcohol-related neurodevelopmental disorder DOID_0050667 0.0160111 0.05488143 0.41070135 0.99442157 YAGI_AML_WITH_T_8_21_TRANSLOCATION Crohn's disease DOID_8778 0.0160111 0.0545528 0.41070135 0.99020792 YAGI_AML_WITH_T_8_21_TRANSLOCATION systemic mycosis DOID_0050136 0.01669759 0.05655313 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION fungal infectious disease DOID_1564 0.01669759 0.05655313 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION metal metabolism disorder DOID_896 0.01669759 0.0562185 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION pneumoconiosis DOID_10316 0.01758874 0.05887056 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION male infertility DOID_12336 0.01758874 0.05852629 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION nephroblastoma DOID_2154 0.01758874 0.05818602 0.18425843 0.58246137 YAGI_AML_WITH_T_8_21_TRANSLOCATION spindle cell carcinoma DOID_4015 0.01758874 0.05784968 0.18425843 0.57924336 YAGI_AML_WITH_T_8_21_TRANSLOCATION adenoma DOID_657 0.01943014 0.06353879 0.19319388 0.58784661 YAGI_AML_WITH_T_8_21_TRANSLOCATION embryonal cancer DOID_688 0.02037989 0.06626377 0.19762501 0.598131 YAGI_AML_WITH_T_8_21_TRANSLOCATION peptic ulcer DOID_750 0.02233633 0.07221233 0.20641473 0.60854913 YAGI_AML_WITH_T_8_21_TRANSLOCATION hyperinsulinism DOID_2018 0.02647038 0.08509404 0.02647038 0.20918952 YAGI_AML_WITH_T_8_21_TRANSLOCATION influenza DOID_8469 0.02754863 0.08806277 1.000 1.000 YAGI_AML_WITH_T_8_21_TRANSLOCATION proteinuria DOID_576 0.02975726 0.09459152 0.23643091 0.66598607 YAGI_AML_WITH_T_8_21_TRANSLOCATION autonomic nervous system disease DOID_11465 0.03088719 0.09763785 0.03088719 0.23749747 YAGI_AML_WITH_T_8_21_TRANSLOCATION thyroid adenoma DOID_2891 0.03088719 0.09709841 0.24062568 0.66788298 YAGI_AML_WITH_T_8_21_TRANSLOCATION heart valve disease DOID_4079 0.03088719 0.0965649 1.000 1.000 DANG_MYC_TARGETS_UP lymphoma DOID_0060058 3.936E-11 2.24E-08 5.875E-05 2.571E-03 DANG_MYC_TARGETS_UP aplastic anemia DOID_12449 2.573E-10 7.32E-08 2.243E-08 4.254E-06 DANG_MYC_TARGETS_UP transitional cell carcinoma DOID_2671 1.308E-09 2.481E-07 0.01712693 0.406051 DANG_MYC_TARGETS_UP bone marrow disease DOID_4961 1.45E-09 2.063E-07 9.272E-08 1.319E-05 DANG_MYC_TARGETS_UP muscle cancer DOID_4045 1.543E-09 1.756E-07 1.923E-07 2.188E-05 DANG_MYC_TARGETS_UP congenital hypoplastic anemia DOID_1342 4.468E-09 4.237E-07 4.468E-09 2.542E-06 DANG_MYC_TARGETS_UP Diamond-Blackfan anemia DOID_1339 4.661E-09 3.789E-07 4.661E-09 1.326E-06 DANG_MYC_TARGETS_UP teratoma DOID_3307 4.661E-09 3.315E-07 1.000 1.000 DANG_MYC_TARGETS_UP malignant teratoma DOID_5563 4.661E-09 3.315E-07 1.000 1.000 DANG_MYC_TARGETS_UP mature teratoma DOID_5566 4.661E-09 3.315E-07 1.000 1.000 DANG_MYC_TARGETS_UP pre-malignant neoplasm DOID_0060071 8.06E-09 5.096E-07 3.804E-07 3.607E-05 DANG_MYC_TARGETS_UP in situ carcinoma DOID_8719 8.06E-09 5.096E-07 3.804E-07 3.607E-05 DANG_MYC_TARGETS_UP vulva cancer DOID_1245 1.579E-08 8.984E-07 2.953E-06 1.867E-04 DANG_MYC_TARGETS_UP embryonal cancer DOID_688 2.93E-08 1.516E-06 3.583E-03 0.10728704 DANG_MYC_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 4.802E-08 2.277E-06 2.845E-06 2.023E-04 DANG_MYC_TARGETS_UP spinal cord disease DOID_319 4.408E-07 1.93E-05 4.408E-07 3.583E-05 DANG_MYC_TARGETS_UP nephroblastoma DOID_2154 1.401E-06 5.692E-05 0.07883074 0.69007214 DANG_MYC_TARGETS_UP breast benign neoplasm DOID_0060082 1.709E-06 6.484E-05 1.000 1.000 DANG_MYC_TARGETS_UP thoracic benign neoplasm DOID_0060097 1.709E-06 6.484E-05 1.000 1.000 DANG_MYC_TARGETS_UP benign breast phyllodes tumor DOID_1631 1.709E-06 6.484E-05 1.000 1.000 DANG_MYC_TARGETS_UP nervous system cancer DOID_3093 2.001E-06 7.115E-05 0.18479658 1.000 DANG_MYC_TARGETS_UP tethered spinal cord syndrome DOID_1089 3.753E-06 1.256E-04 3.753E-06 2.135E-04 DANG_MYC_TARGETS_UP rhabdomyosarcoma DOID_3247 3.753E-06 1.186E-04 3.753E-06 1.941E-04 DANG_MYC_TARGETS_UP skeletal muscle cancer DOID_4043 4.683E-06 1.403E-04 4.683E-06 2.221E-04 DANG_MYC_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 6.517E-06 1.854E-04 2.399E-04 9.749E-03 DANG_MYC_TARGETS_UP lymphatic system cancer DOID_0060073 6.977E-06 1.89E-04 0.0370145 0.51368908 DANG_MYC_TARGETS_UP reticulosarcoma DOID_8538 6.977E-06 1.89E-04 0.0370145 0.51368908 DANG_MYC_TARGETS_UP lymphosarcoma DOID_8675 6.977E-06 1.89E-04 0.0370145 0.51368908 DANG_MYC_TARGETS_UP integumentary system cancer DOID_0060122 8.684E-06 2.246E-04 0.12080716 0.82818402 DANG_MYC_TARGETS_UP skin cancer DOID_4159 8.684E-06 2.246E-04 0.12080716 0.82818402 DANG_MYC_TARGETS_UP testicular cancer DOID_2998 9.911E-06 2.452E-04 1.000 1.000 DANG_MYC_TARGETS_UP colon carcinoma DOID_1520 1.164E-05 2.76E-04 0.04340446 0.52547107 DANG_MYC_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.378E-05 1.452E-03 0.19201539 1.000 DANG_MYC_TARGETS_UP thyroid carcinoma DOID_3963 7.721E-05 1.69E-03 1.000 1.000 DANG_MYC_TARGETS_UP thyroid cancer DOID_1781 9.053E-05 1.908E-03 1.000 1.000 DANG_MYC_TARGETS_UP peripheral nervous system neoplasm DOID_1192 1.053E-04 2.139E-03 1.000 1.000 DANG_MYC_TARGETS_UP intracranial arterial disease DOID_13089 1.215E-04 2.383E-03 1.000 1.000 DANG_MYC_TARGETS_UP cerebral arterial disease DOID_3527 1.215E-04 2.383E-03 1.000 1.000 DANG_MYC_TARGETS_UP brain cancer DOID_1319 1.908E-04 3.618E-03 0.10504382 0.79693244 DANG_MYC_TARGETS_UP thyroid adenoma DOID_2891 1.908E-04 3.501E-03 0.10504382 0.78644648 DANG_MYC_TARGETS_UP central nervous system cancer DOID_3620 2.024E-04 3.598E-03 0.10702941 0.79090561 DANG_MYC_TARGETS_UP integumentary system benign neoplasm DOID_0060121 2.144E-04 3.697E-03 0.10901064 0.78515259 DANG_MYC_TARGETS_UP skin benign neoplasm DOID_3165 2.144E-04 3.697E-03 0.10901064 0.78515259 DANG_MYC_TARGETS_UP rectal neoplasm DOID_1984 2.158E-04 3.611E-03 1.000 1.000 DANG_MYC_TARGETS_UP rectum cancer DOID_1993 2.158E-04 3.611E-03 1.000 1.000 DANG_MYC_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 2.965E-04 4.82E-03 0.12080716 0.83828383 DANG_MYC_TARGETS_UP beta thalassemia DOID_12241 3.156E-04 4.988E-03 0.02627072 0.4982679 DANG_MYC_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 3.442E-04 5.293E-03 1.000 1.000 DANG_MYC_TARGETS_UP thalassemia DOID_10241 4.999E-04 7.485E-03 0.03273112 0.51733349 DANG_MYC_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 5.379E-04 7.848E-03 0.14583945 0.93238926 DANG_MYC_TARGETS_UP tongue cancer DOID_8649 5.705E-04 8.115E-03 1.000 1.000 DANG_MYC_TARGETS_UP basal cell carcinoma DOID_2513 6.456E-04 8.96E-03 1.000 1.000 DANG_MYC_TARGETS_UP pancreatic carcinoma DOID_4905 6.564E-04 8.893E-03 0.15527858 0.97091774 DANG_MYC_TARGETS_UP keratosis DOID_161 7.253E-04 9.597E-03 0.03914916 0.51804357 DANG_MYC_TARGETS_UP skin carcinoma DOID_3451 7.253E-04 9.379E-03 1.000 1.000 DANG_MYC_TARGETS_UP bone resorption disease DOID_0080011 7.349E-04 9.292E-03 7.349E-04 0.02787583 DANG_MYC_TARGETS_UP osteoporosis DOID_11476 7.349E-04 9.292E-03 7.349E-04 0.02787583 DANG_MYC_TARGETS_UP mixed glioma DOID_5076 7.623E-04 9.429E-03 1.000 1.000 DANG_MYC_TARGETS_UP lymphoblastic leukemia DOID_1037 1.254E-03 0.0151803 1.000 1.000 DANG_MYC_TARGETS_UP osteosarcoma DOID_3347 1.523E-03 0.01805424 0.05605896 0.60184052 DANG_MYC_TARGETS_UP spinal muscular atrophy DOID_12377 1.643E-03 0.01907321 1.643E-03 0.05841171 DANG_MYC_TARGETS_UP papillary adenoma DOID_3172 1.643E-03 0.01869175 0.0581519 0.61274872 DANG_MYC_TARGETS_UP microcystic adenoma DOID_5403 1.643E-03 0.01869175 0.0581519 0.61274872 DANG_MYC_TARGETS_UP follicular adenoma DOID_6204 1.643E-03 0.01869175 0.0581519 0.61274872 DANG_MYC_TARGETS_UP middle cerebral artery infarction DOID_3525 1.766E-03 0.01970653 1.000 1.000 DANG_MYC_TARGETS_UP seminoma DOID_4440 1.766E-03 0.01932756 1.000 1.000 DANG_MYC_TARGETS_UP lung adenocarcinoma DOID_3910 1.894E-03 0.0203383 0.06232403 0.60105721 DANG_MYC_TARGETS_UP perinatal necrotizing enterocolitis DOID_8677 1.894E-03 0.01996167 1.894E-03 0.06340765 DANG_MYC_TARGETS_UP germinoma DOID_3304 2.599E-03 0.02688721 1.000 1.000 DANG_MYC_TARGETS_UP chronic leukemia DOID_1036 2.752E-03 0.02796733 1.000 1.000 DANG_MYC_TARGETS_UP chronic lymphocytic leukemia DOID_1040 2.752E-03 0.02796733 1.000 1.000 DANG_MYC_TARGETS_UP autonomic nervous system neoplasm DOID_2621 2.752E-03 0.02747668 1.000 1.000 DANG_MYC_TARGETS_UP neuroblastoma DOID_769 2.752E-03 0.02747668 1.000 1.000 DANG_MYC_TARGETS_UP papilloma DOID_2615 2.91E-03 0.02855034 0.07678321 0.68265069 DANG_MYC_TARGETS_UP myocarditis DOID_820 2.91E-03 0.02806644 2.91E-03 0.09199554 DANG_MYC_TARGETS_UP adenoma DOID_657 3.408E-03 0.03232185 0.08291235 0.69378124 DANG_MYC_TARGETS_UP congenital diaphragmatic hernia DOID_3827 3.943E-03 0.03678188 3.943E-03 0.11218474 DANG_MYC_TARGETS_UP benign mesothelioma DOID_2645 4.32E-03 0.03964741 1.000 1.000 DANG_MYC_TARGETS_UP Huntington's disease DOID_12858 4.713E-03 0.04256674 4.713E-03 0.12770022 DANG_MYC_TARGETS_UP uterine cancer DOID_363 4.915E-03 0.04370127 0.09906084 0.76169757 DANG_MYC_TARGETS_UP cerebral infarction DOID_3526 5.122E-03 0.04483549 1.000 1.000 DANG_MYC_TARGETS_UP spinocerebellar degeneration DOID_2478 5.332E-03 0.04596926 5.332E-03 0.13790779 DANG_MYC_TARGETS_UP glaucoma DOID_1686 5.986E-03 0.05084021 0.10901064 0.77533818 DANG_MYC_TARGETS_UP bone marrow cancer DOID_4960 7.154E-03 0.05986259 1.000 1.000 DANG_MYC_TARGETS_UP pustulosis of palm and sole DOID_4398 7.399E-03 0.06101465 1.000 1.000 DANG_MYC_TARGETS_UP oral cavity cancer DOID_8618 8.156E-03 0.06629804 1.000 1.000 DANG_MYC_TARGETS_UP carotid artery disease DOID_3407 8.947E-03 0.07169981 1.000 1.000 DANG_MYC_TARGETS_UP cerebral degeneration DOID_1443 0.01005186 0.0794376 0.14012602 0.93802003 DANG_MYC_TARGETS_UP hyperglycemia DOID_4195 0.01033715 0.0805731 0.14203468 0.92893943 DANG_MYC_TARGETS_UP tooth disease DOID_1091 0.010626 0.08170534 0.010626 0.26287805 DANG_MYC_TARGETS_UP brain infarction DOID_3454 0.01091841 0.08283433 1.000 1.000 DANG_MYC_TARGETS_UP pancreatic ductal carcinoma DOID_3587 0.01151381 0.08620209 0.14962754 0.94597857 BROWNE_HCMV_INFECTION_30MIN_DN gallbladder cancer DOID_3121 2.119E-06 1.206E-03 1.045E-04 0.029731 BROWNE_HCMV_INFECTION_30MIN_DN Legionnaires' disease DOID_10457 2.455E-06 6.986E-04 0.02662756 0.27547421 BROWNE_HCMV_INFECTION_30MIN_DN legionellosis DOID_10458 2.455E-06 6.986E-04 0.02662756 0.27547421 BROWNE_HCMV_INFECTION_30MIN_DN coronary restenosis DOID_4247 8.885E-06 1.685E-03 7.5E-04 0.04741641 BROWNE_HCMV_INFECTION_30MIN_DN biliary tract cancer DOID_4607 2.276E-05 3.238E-03 6.04E-04 0.04296253 BROWNE_HCMV_INFECTION_30MIN_DN sarcoma DOID_1115 2.679E-05 3.048E-03 0.0562035 0.35932352 BROWNE_HCMV_INFECTION_30MIN_DN coronary stenosis DOID_4248 2.679E-05 2.54E-03 1.536E-03 0.05463276 BROWNE_HCMV_INFECTION_30MIN_DN dilated cardiomyopathy DOID_12930 3.828E-05 3.111E-03 3.828E-05 0.02178033 BROWNE_HCMV_INFECTION_30MIN_DN hepatitis DOID_2237 7.45E-05 5.299E-03 0.0778021 0.39882338 BROWNE_HCMV_INFECTION_30MIN_DN calcium metabolism disease DOID_10575 1.497E-04 9.466E-03 1.497E-04 0.02839882 BROWNE_HCMV_INFECTION_30MIN_DN phagocyte bactericidal dysfunction DOID_3262 1.629E-04 9.271E-03 0.01909187 0.24140615 BROWNE_HCMV_INFECTION_30MIN_DN bile duct cancer DOID_4606 2.275E-04 0.01176837 6.219E-03 0.13105398 BROWNE_HCMV_INFECTION_30MIN_DN bile duct carcinoma DOID_4897 2.275E-04 0.01176837 6.219E-03 0.13105398 BROWNE_HCMV_INFECTION_30MIN_DN neuroectodermal tumor DOID_171 2.623E-04 0.0124368 6.825E-03 0.13391867 BROWNE_HCMV_INFECTION_30MIN_DN mineral metabolism disease DOID_0050032 3.003E-04 0.01314526 3.003E-04 0.04272208 BROWNE_HCMV_INFECTION_30MIN_DN hypercalcemia DOID_12678 3.278E-04 0.01332464 3.278E-04 0.03730901 BROWNE_HCMV_INFECTION_30MIN_DN allergic contact dermatitis DOID_3042 3.418E-04 0.01296427 0.1263211 0.50617399 BROWNE_HCMV_INFECTION_30MIN_DN endocrine organ benign neoplasm DOID_0060089 3.564E-04 0.01267272 3.564E-04 0.03379391 BROWNE_HCMV_INFECTION_30MIN_DN tuberculosis DOID_399 3.564E-04 0.01192726 0.12800654 0.5093407 BROWNE_HCMV_INFECTION_30MIN_DN mesenchymal cell neoplasm DOID_3350 3.778E-04 0.01194311 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN spindle cell sarcoma DOID_4235 3.778E-04 0.01194311 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN epithelioid sarcoma DOID_6193 3.778E-04 0.01194311 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN male reproductive system disease DOID_48 4.025E-04 0.01205372 4.025E-04 0.03271724 BROWNE_HCMV_INFECTION_30MIN_DN bone resorption disease DOID_0080011 4.876E-04 0.0138732 0.01023922 0.1713563 BROWNE_HCMV_INFECTION_30MIN_DN osteoporosis DOID_11476 4.876E-04 0.0138732 0.01023922 0.1713563 BROWNE_HCMV_INFECTION_30MIN_DN pancreatitis DOID_4989 5.059E-04 0.01370844 0.01048879 0.17051772 BROWNE_HCMV_INFECTION_30MIN_DN mixed glioma DOID_5076 5.059E-04 0.01308533 0.14303186 0.53542848 BROWNE_HCMV_INFECTION_30MIN_DN contact dermatitis DOID_2773 5.438E-04 0.01345426 0.14633598 0.54068296 BROWNE_HCMV_INFECTION_30MIN_DN primary bacterial infectious disease DOID_0050338 6.907E-04 0.01637538 0.15780177 0.56118255 BROWNE_HCMV_INFECTION_30MIN_DN primary immunodeficiency disease DOID_612 7.368E-04 0.01677059 0.01340887 0.20078021 BROWNE_HCMV_INFECTION_30MIN_DN alcohol-related neurodevelopmental disorder DOID_0050667 8.607E-04 0.01883537 8.607E-04 0.04897197 BROWNE_HCMV_INFECTION_30MIN_DN mouth disease DOID_403 8.607E-04 0.01813777 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN Crohn's disease DOID_8778 8.607E-04 0.01748999 0.16911564 0.57967951 BROWNE_HCMV_INFECTION_30MIN_DN hypersensitivity reaction type I disease DOID_1205 8.869E-04 0.01740186 0.17071962 0.58167344 BROWNE_HCMV_INFECTION_30MIN_DN sexual disorder DOID_0060043 9.013E-04 0.01709499 9.013E-04 0.0466227 BROWNE_HCMV_INFECTION_30MIN_DN congenital hemolytic anemia DOID_589 9.82E-04 0.01802503 9.82E-04 0.04656465 BROWNE_HCMV_INFECTION_30MIN_DN osteosarcoma DOID_3347 1.154E-03 0.02051068 1.154E-03 0.05048783 BROWNE_HCMV_INFECTION_30MIN_DN diffuse large B-cell lymphoma DOID_0050745 1.436E-03 0.0247535 1.436E-03 0.05834753 BROWNE_HCMV_INFECTION_30MIN_DN periodontitis DOID_824 1.436E-03 0.02402545 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN invasive ductal carcinoma DOID_3008 1.536E-03 0.02497498 1.536E-03 0.05827495 BROWNE_HCMV_INFECTION_30MIN_DN myocarditis DOID_820 2.208E-03 0.03490438 2.208E-03 0.07391516 BROWNE_HCMV_INFECTION_30MIN_DN male infertility DOID_12336 2.332E-03 0.03585703 2.332E-03 0.07370613 BROWNE_HCMV_INFECTION_30MIN_DN periodontal disease DOID_3388 2.332E-03 0.03491343 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN esophageal disease DOID_6050 2.332E-03 0.03401821 2.332E-03 0.06982686 BROWNE_HCMV_INFECTION_30MIN_DN aplastic anemia DOID_12449 2.458E-03 0.03496691 0.0706573 0.39033011 BROWNE_HCMV_INFECTION_30MIN_DN medulloblastoma DOID_3858 2.721E-03 0.0377566 2.721E-03 0.07740103 BROWNE_HCMV_INFECTION_30MIN_DN endometriosis of uterus DOID_288 3.432E-03 0.04649111 0.08312512 0.41128866 BROWNE_HCMV_INFECTION_30MIN_DN primitive neuroectodermal tumor DOID_168 3.583E-03 0.04741509 3.583E-03 0.09708804 BROWNE_HCMV_INFECTION_30MIN_DN endometriosis DOID_289 3.583E-03 0.04633747 0.08489272 0.41285435 BROWNE_HCMV_INFECTION_30MIN_DN diabetic autonomic neuropathy DOID_11503 3.738E-03 0.0472627 0.08665696 0.41435134 BROWNE_HCMV_INFECTION_30MIN_DN autonomic neuropathy DOID_11504 3.738E-03 0.0472627 0.08665696 0.41435134 BROWNE_HCMV_INFECTION_30MIN_DN diabetic polyneuropathy DOID_12785 3.738E-03 0.0472627 0.08665696 0.41435134 BROWNE_HCMV_INFECTION_30MIN_DN uterine cancer DOID_363 3.738E-03 0.04623525 3.738E-03 0.0966737 BROWNE_HCMV_INFECTION_30MIN_DN diabetic neuropathy DOID_9743 3.738E-03 0.0472627 0.08665696 0.41435134 BROWNE_HCMV_INFECTION_30MIN_DN myeloma DOID_0070004 4.22E-03 0.05108885 0.09192957 0.43229689 BROWNE_HCMV_INFECTION_30MIN_DN autonomic nervous system disease DOID_11465 4.22E-03 0.05002449 0.09192957 0.42526767 BROWNE_HCMV_INFECTION_30MIN_DN thyroid adenoma DOID_2891 4.22E-03 0.04900359 4.22E-03 0.10439895 BROWNE_HCMV_INFECTION_30MIN_DN heart valve disease DOID_4079 4.22E-03 0.04802351 4.22E-03 0.10004899 BROWNE_HCMV_INFECTION_30MIN_DN bone marrow disease DOID_4961 4.22E-03 0.04708188 0.09192957 0.42183809 BROWNE_HCMV_INFECTION_30MIN_DN hemolytic anemia DOID_583 4.387E-03 0.0480016 4.387E-03 0.09984332 BROWNE_HCMV_INFECTION_30MIN_DN normocytic anemia DOID_720 4.387E-03 0.0480016 4.387E-03 0.09984332 BROWNE_HCMV_INFECTION_30MIN_DN B-cell lymphocytic neoplasm DOID_707 4.905E-03 0.05266184 4.905E-03 0.10734914 BROWNE_HCMV_INFECTION_30MIN_DN bile duct adenocarcinoma DOID_4896 5.451E-03 0.05743221 0.10411585 0.45570707 BROWNE_HCMV_INFECTION_30MIN_DN cholangiocarcinoma DOID_4947 5.451E-03 0.05743221 0.10411585 0.45570707 BROWNE_HCMV_INFECTION_30MIN_DN bone marrow cancer DOID_4960 5.451E-03 0.05638798 0.10411585 0.45222839 BROWNE_HCMV_INFECTION_30MIN_DN parasitic protozoa infectious disease DOID_2789 5.638E-03 0.05728787 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN leukocyte disease DOID_9500 6.418E-03 0.06406803 6.418E-03 0.13042421 BROWNE_HCMV_INFECTION_30MIN_DN cholestasis DOID_13580 7.674E-03 0.07528751 7.674E-03 0.14555586 BROWNE_HCMV_INFECTION_30MIN_DN parasitic infectious disease DOID_1398 7.674E-03 0.07401145 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN uterine disease DOID_345 7.674E-03 0.07277793 0.12294059 0.49612194 BROWNE_HCMV_INFECTION_30MIN_DN temporal lobe epilepsy DOID_3328 7.894E-03 0.0736305 7.894E-03 0.14488582 BROWNE_HCMV_INFECTION_30MIN_DN tooth disease DOID_1091 8.116E-03 0.07448134 1.000 1.000 BROWNE_HCMV_INFECTION_30MIN_DN astrocytoma DOID_3069 8.568E-03 0.07738689 0.12968877 0.51245075 BROWNE_HCMV_INFECTION_30MIN_DN pancreatic ductal carcinoma DOID_3587 8.799E-03 0.07822672 0.13136779 0.51197448 BROWNE_HCMV_INFECTION_30MIN_DN bile duct disease DOID_4138 9.032E-03 0.0790649 9.032E-03 0.16060057 BROWNE_HCMV_INFECTION_30MIN_DN biliary tract disease DOID_9741 9.268E-03 0.07990139 9.268E-03 0.15980278 BROWNE_HCMV_INFECTION_30MIN_DN pancreatic carcinoma DOID_4905 9.507E-03 0.08073619 0.13638573 0.52434784 BROWNE_HCMV_INFECTION_30MIN_DN aneurysm disease DOID_2403 0.01023922 0.08567815 0.14137507 0.53273124 BROWNE_HCMV_INFECTION_30MIN_DN bacterial pneumonia DOID_874 0.01048879 0.0864945 0.14303186 0.53192895 BROWNE_HCMV_INFECTION_30MIN_DN female reproductive system disease DOID_229 0.01125357 0.09147542 0.14798333 0.53975971 BROWNE_HCMV_INFECTION_30MIN_DN alcohol abuse DOID_1574 0.0117767 0.09437945 0.0117767 0.18613725 BROWNE_HCMV_INFECTION_30MIN_DN focal epilepsy DOID_2234 0.0117767 0.09306862 0.0117767 0.18110651 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP transitional cell carcinoma DOID_2671 8.331E-33 4.74E-30 2.129E-10 1.211E-07 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pre-malignant neoplasm DOID_0060071 6.586E-19 1.874E-16 8.478E-10 2.412E-07 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP in situ carcinoma DOID_8719 6.586E-19 1.874E-16 8.478E-10 2.412E-07 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP endometrial carcinoma DOID_2871 1.405E-18 2.665E-16 3.236E-08 6.138E-06 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP endometrial cancer DOID_1380 2.843E-18 4.044E-16 4.452E-08 6.333E-06 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP uterine cancer DOID_363 1.089E-16 1.239E-14 2.383E-07 2.712E-05 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP biliary tract cancer DOID_4607 1.064E-15 1.009E-13 0.02462052 0.21889178 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP reproductive organ benign neoplasm DOID_0050622 8.334E-14 6.774E-12 6.19E-04 0.02515724 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymphoma DOID_0060058 1.702E-13 1.211E-11 3.086E-07 2.926E-05 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cervix uteri carcinoma in situ DOID_8991 5.422E-13 3.428E-11 7.743E-06 5.508E-04 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP astrocytoma DOID_3069 6.445E-13 3.667E-11 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mixed glioma DOID_5076 1.723E-12 8.914E-11 0.02199363 0.20515372 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bile duct adenocarcinoma DOID_4896 4.903E-12 2.325E-10 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cholangiocarcinoma DOID_4947 4.903E-12 2.325E-10 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP nervous system cancer DOID_3093 6.276E-12 2.747E-10 0.02850115 0.22841064 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bile duct cancer DOID_4606 8.656E-12 3.518E-10 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bile duct carcinoma DOID_4897 8.656E-12 3.518E-10 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP intracranial arterial disease DOID_13089 3.701E-11 1.404E-09 0.1155067 0.44407645 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cerebral arterial disease DOID_3527 3.701E-11 1.404E-09 0.1155067 0.44407645 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP gallbladder cancer DOID_3121 7.157E-11 2.545E-09 7.995E-03 0.10831414 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP brain cancer DOID_1319 1.129E-10 3.778E-09 9.01E-03 0.10907876 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP central nervous system cancer DOID_3620 1.305E-10 4.126E-09 9.36E-03 0.10869615 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.59E-10 1.075E-08 2.65E-03 0.0628343 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mouth disease DOID_403 3.59E-10 1.021E-08 2.65E-03 0.06032093 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hypersensitivity reaction type I disease DOID_1205 3.904E-10 1.058E-08 2.729E-03 0.05751686 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP varicose veins DOID_799 5.016E-10 1.297E-08 0.04189754 0.26197475 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP vein disease DOID_866 7.279E-10 1.801E-08 0.04462804 0.25393357 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP tuberculosis DOID_399 1.431E-09 3.393E-08 0.01758382 0.17552975 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP male reproductive system disease DOID_48 1.923E-09 4.376E-08 6.146E-05 3.886E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP testicular cancer DOID_2998 1.925E-09 4.212E-08 0.05277337 0.29153447 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP diabetic retinopathy DOID_8947 2.325E-09 4.9E-08 0.19509508 0.62717005 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP aneurysm disease DOID_2403 3.061E-09 6.221E-08 0.2019684 0.6420113 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP placenta disease DOID_780 4.329E-09 8.494E-08 1.789E-03 0.0484864 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP retinal vascular disease DOID_2462 6.057E-09 1.149E-07 0.22001429 0.67669259 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP primary bacterial infectious disease DOID_0050338 7.109E-09 1.305E-07 0.02680959 0.23468699 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP glaucoma DOID_1686 8.5E-09 1.511E-07 0.13795504 0.49681275 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pulmonary tuberculosis DOID_2957 8.5E-09 1.466E-07 0.13795504 0.49368814 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Human immunodeficiency virus infectious disease DOID_526 8.976E-09 1.502E-07 1.435E-04 8.165E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP calcium metabolism disease DOID_10575 9.562E-09 1.555E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP giant cell tumor DOID_200 1.343E-08 2.123E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP malignant giant cell tumor DOID_2705 1.343E-08 2.123E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP giant cell glioblastoma DOID_3074 1.343E-08 2.123E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP intracranial aneurysm DOID_10941 1.594E-08 2.451E-07 0.07679882 0.36114484 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP periodontitis DOID_824 1.922E-08 2.877E-07 0.07943075 0.36156879 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP glioblastoma DOID_3068 2.271E-08 3.313E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP peritonitis DOID_8283 3.029E-08 4.309E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP carotid artery disease DOID_3407 3.045E-08 4.225E-07 0.16701033 0.5589934 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mineral metabolism disease DOID_0050032 4.025E-08 5.453E-07 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP uterine disease DOID_345 4.404E-08 5.828E-07 0.01620825 0.16768175 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP allergic rhinitis DOID_4481 4.452E-08 5.757E-07 4.25E-03 0.07328339 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP periodontal disease DOID_3388 6.927E-08 8.758E-07 0.10022038 0.42241033 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP calcinosis DOID_182 1.039E-07 1.285E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP female reproductive system disease DOID_229 1.467E-07 1.776E-06 0.02355498 0.21274259 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP leishmaniasis DOID_9065 2.336E-07 2.769E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP diabetic autonomic neuropathy DOID_11503 2.383E-07 2.767E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP autonomic neuropathy DOID_11504 2.383E-07 2.767E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP diabetic polyneuropathy DOID_12785 2.383E-07 2.767E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP influenza DOID_8469 2.383E-07 2.712E-06 7.995E-03 0.10579521 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP diabetic neuropathy DOID_9743 2.383E-07 2.767E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pre-eclampsia DOID_10591 3.269E-07 3.647E-06 0.13301581 0.48829675 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP autonomic nervous system disease DOID_11465 3.269E-07 3.577E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP neuritis DOID_1803 3.269E-07 3.51E-06 0.13301581 0.48516665 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP heart valve disease DOID_4079 3.269E-07 3.445E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP encephalomyelitis DOID_640 3.286E-07 3.4E-06 0.03023445 0.23566302 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mitochondrial myopathy DOID_699 3.591E-07 3.648E-06 0.05816533 0.31823148 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lung small cell carcinoma DOID_5409 3.992E-07 3.985E-06 0.13795504 0.49060259 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP meningitis DOID_9471 6.333E-07 6.213E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP integumentary system cancer DOID_0060122 6.943E-07 6.696E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP parasitic protozoa infectious disease DOID_2789 6.943E-07 6.585E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP skin cancer DOID_4159 6.943E-07 6.696E-06 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP portal hypertension DOID_10762 8.871E-07 8.275E-06 2.499E-03 0.0618239 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hypertrophic cardiomyopathy DOID_11984 8.954E-07 8.217E-06 0.01318954 0.14160087 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP oral cavity cancer DOID_8618 8.954E-07 8.087E-06 7.175E-04 0.02721766 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP neuroectodermal tumor DOID_171 1.14E-06 1.013E-05 0.16701033 0.56230105 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Sciatic Neuropathy DOID_11446 1.4E-06 1.226E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lesion of sciatic nerve DOID_12528 1.4E-06 1.226E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mononeuritis of lower limb DOID_9473 1.4E-06 1.226E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP parasitic infectious disease DOID_1398 1.544E-06 1.331E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mononeuritis DOID_1802 1.612E-06 1.369E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hepatic vascular disease DOID_272 1.612E-06 1.349E-05 3.32E-03 0.06094035 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP tooth disease DOID_1091 1.785E-06 1.472E-05 0.18117199 0.58906778 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mononeuropathy DOID_1188 1.847E-06 1.501E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP supratentorial cancer DOID_1659 1.847E-06 1.48E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP toxic encephalopathy DOID_3602 1.847E-06 1.459E-05 0.08467235 0.37060436 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cerebrum cancer DOID_368 1.847E-06 1.48E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP endocrine organ benign neoplasm DOID_0060089 1.916E-06 1.493E-05 0.01758382 0.17866421 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP peripheral vascular disease DOID_341 2.517E-06 1.935E-05 0.19279096 0.62328441 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP facioscapulohumeral muscular dystrophy DOID_11727 2.659E-06 2.017E-05 3.565E-04 0.01843923 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.659E-06 1.991E-05 0.02812863 0.2319593 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.659E-06 1.991E-05 0.02812863 0.2319593 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Hodgkin's granuloma DOID_8651 2.659E-06 1.991E-05 0.02812863 0.2319593 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 2.659E-06 1.991E-05 0.02812863 0.2319593 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cutaneous leishmaniasis DOID_9111 2.659E-06 1.965E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bone resorption disease DOID_0080011 3.257E-06 2.376E-05 0.02148317 0.20718512 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP osteoporosis DOID_11476 3.257E-06 2.376E-05 0.02148317 0.20718512 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP breast benign neoplasm DOID_0060082 3.648E-06 2.628E-05 0.03089801 0.23758063 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thoracic benign neoplasm DOID_0060097 3.648E-06 2.628E-05 0.03089801 0.23758063 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP benign breast phyllodes tumor DOID_1631 3.648E-06 2.628E-05 0.03089801 0.23758063 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pneumoconiosis DOID_10316 3.826E-06 2.721E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP male infertility DOID_12336 3.826E-06 2.687E-05 3.826E-06 3.11E-04 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP spindle cell carcinoma DOID_4015 3.826E-06 2.655E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP metabolic syndrome X DOID_14221 3.916E-06 2.685E-05 0.02302957 0.21135203 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP medullomyoblastoma DOID_3861 4.266E-06 2.89E-05 0.10278615 0.41775229 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP adult medulloblastoma DOID_3864 4.266E-06 2.89E-05 0.10278615 0.41775229 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP childhood medulloblastoma DOID_3869 4.266E-06 2.89E-05 0.10278615 0.41775229 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP chronic kidney failure DOID_784 4.676E-06 3.13E-05 0.21554108 0.67017965 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP intracranial arteriosclerosis DOID_13097 4.855E-06 3.212E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP retinal detachment DOID_5327 4.855E-06 3.175E-05 0.03365956 0.23940365 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Hodgkin's lymphoma DOID_8567 4.855E-06 3.139E-05 0.03365956 0.23644805 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP vascular dementia DOID_8725 4.855E-06 3.212E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP medulloblastoma DOID_3858 5.259E-06 3.362E-05 0.10789598 0.43234374 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP larynx cancer DOID_2596 6.298E-06 3.982E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP laryngeal benign neoplasm DOID_2598 6.298E-06 3.982E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Leydig cell tumor DOID_2696 6.298E-06 3.938E-05 0.03641333 0.24375508 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP sex cord-stromal neoplasm DOID_4757 6.298E-06 3.938E-05 0.03641333 0.24375508 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP benign mesothelioma DOID_2645 7.743E-06 4.789E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymphoblastic leukemia DOID_1037 8.076E-06 4.941E-05 0.03023445 0.23893612 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP primitive neuroectodermal tumor DOID_168 9.268E-06 5.61E-05 0.1230531 0.46678141 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP skeletal system cancer DOID_0060124 9.978E-06 5.976E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bone cancer DOID_184 9.978E-06 5.976E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lung oat cell carcinoma DOID_5411 9.978E-06 5.914E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP intermediate coronary syndrome DOID_8805 9.978E-06 5.853E-05 0.04189754 0.2591272 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP ulcerative colitis DOID_8577 1.038E-05 6.024E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cerebral infarction DOID_3526 1.1E-05 6.324E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP male reproductive organ benign neoplasm DOID_0060087 1.778E-05 1.012E-04 1.194E-03 0.03774638 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP orofacial cleft DOID_0050567 1.899E-05 1.07E-04 0.01082202 0.11841788 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP atopic dermatitis DOID_3310 1.899E-05 1.059E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP atrophic muscular disease DOID_913 2.041E-05 1.127E-04 5.584E-04 0.02443971 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP muscular dystrophy DOID_9884 2.041E-05 1.127E-04 5.584E-04 0.02443971 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pustulosis of palm and sole DOID_4398 2.347E-05 1.284E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP subependymal glioma DOID_4843 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pilocytic astrocytoma DOID_4851 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP subependymal giant cell astrocytoma DOID_5077 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP fibrillary astrocytoma DOID_6726 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP juvenile pilocytic astrocytoma DOID_6811 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP childhood pilocytic astrocytoma DOID_6812 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP gemistocytic astrocytoma DOID_7005 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP childhood cerebral astrocytoma DOID_7007 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP protoplasmic astrocytoma DOID_7008 2.474E-05 1.341E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mitochondrial metabolism disease DOID_700 2.512E-05 1.349E-04 0.15502379 0.53459718 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP leukocyte disease DOID_9500 3.059E-05 1.627E-04 0.16223606 0.55276838 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP benign glioma DOID_0060101 3.328E-05 1.754E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP neutropenia DOID_1227 3.328E-05 1.737E-04 0.0608499 0.32974849 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hepatitis B DOID_2043 3.328E-05 1.722E-04 0.0608499 0.32663765 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP benign ependymoma DOID_4844 3.328E-05 1.754E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP collagen disease DOID_854 3.469E-05 1.778E-04 8.255E-04 0.02763007 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP sinusitis DOID_0050127 3.82E-05 1.941E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP agranulocytosis DOID_12987 3.82E-05 1.923E-04 0.06352688 0.33469254 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP paranasal sinus disease DOID_1352 3.82E-05 1.941E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP optic nerve disease DOID_1891 3.82E-05 1.906E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP IgA glomerulonephritis DOID_2986 3.82E-05 1.89E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pulmonary embolism DOID_9477 3.82E-05 1.874E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP endocrine pancreas disease DOID_1428 4.157E-05 2.022E-04 0.17412123 0.57268775 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP diabetic angiopathy DOID_11713 4.356E-05 2.101E-04 0.0661963 0.33630086 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cholestasis DOID_13580 4.408E-05 2.108E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hyperglycemia DOID_4195 4.669E-05 2.214E-04 0.17882839 0.58478939 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP brain infarction DOID_3454 5.224E-05 2.457E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP urticaria DOID_1555 5.573E-05 2.599E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bronchiolitis DOID_2942 5.573E-05 2.578E-04 0.07151255 0.34778327 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP osteosarcoma DOID_3347 5.573E-05 2.557E-04 0.07151255 0.34483595 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bile duct disease DOID_4138 6.146E-05 2.798E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cleft lip DOID_9296 6.257E-05 2.825E-04 2.694E-03 0.05895607 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP biliary tract disease DOID_9741 6.478E-05 2.902E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pancreatic carcinoma DOID_4905 6.823E-05 3.033E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP spinal cord disease DOID_319 6.993E-05 3.084E-04 2.896E-03 0.05681756 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP middle cerebral artery infarction DOID_3525 6.993E-05 3.061E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP seminoma DOID_4440 6.993E-05 3.037E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cystic fibrosis DOID_1485 7.553E-05 3.256E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lung adenocarcinoma DOID_3910 7.783E-05 3.33E-04 3.105E-03 0.0588827 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP sarcoma DOID_1115 8.63E-05 3.665E-04 0.08205526 0.3676334 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cranial nerve disease DOID_5656 9.535E-05 4.019E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP female reproductive organ benign neoplasm DOID_0060086 1.05E-04 4.393E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP uterine benign neoplasm DOID_0060095 1.05E-04 4.393E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP uterine fibroid DOID_13223 1.05E-04 4.393E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP germinoma DOID_3304 1.262E-04 5.239E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP chronic leukemia DOID_1036 1.377E-04 5.677E-04 0.095067 0.40368001 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP chronic lymphocytic leukemia DOID_1040 1.377E-04 5.677E-04 0.095067 0.40368001 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP leiomyoma DOID_127 1.377E-04 5.637E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pleural disease DOID_1532 1.377E-04 5.596E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP autonomic nervous system neoplasm DOID_2621 1.377E-04 5.557E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP neuroblastoma DOID_769 1.377E-04 5.557E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP papilloma DOID_2615 1.499E-04 6.007E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP myocarditis DOID_820 1.499E-04 5.965E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thyroid carcinoma DOID_3963 1.628E-04 6.432E-04 0.10022038 0.41930437 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP leukopenia DOID_615 1.628E-04 6.388E-04 0.10022038 0.41624375 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP dilated cardiomyopathy DOID_12930 1.76E-04 6.86E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thyroid cancer DOID_1781 1.907E-04 7.381E-04 0.10534468 0.42511434 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP adenoma DOID_657 1.907E-04 7.331E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP refractive error DOID_9835 1.907E-04 7.282E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cleft palate DOID_674 2.057E-04 7.803E-04 5.844E-03 0.0923683 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP multiple myeloma DOID_9538 2.057E-04 7.752E-04 0.10789598 0.42633897 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP peripheral nervous system neoplasm DOID_1192 2.215E-04 8.292E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP respiratory syncytial virus infectious disease DOID_1273 2.38E-04 8.853E-04 0.11297697 0.44030065 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP adult respiratory distress syndrome DOID_11394 2.554E-04 9.435E-04 0.1155067 0.44709737 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP adenoid cystic carcinoma DOID_4866 2.554E-04 9.374E-04 6.728E-03 0.10074522 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pulmonary emphysema DOID_9675 2.735E-04 9.975E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP leber hereditary optic neuropathy DOID_705 2.857E-04 1.035E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP salivary gland cancer DOID_8850 2.924E-04 1.053E-03 7.349E-03 0.10722221 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cataract DOID_83 3.542E-04 1.268E-03 8.327E-03 0.10768687 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP brachydactyly DOID_0050581 3.565E-04 1.268E-03 0.02812863 0.2425029 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP childhood type dermatomyositis DOID_14203 3.565E-04 1.26E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP retinal vascular occlusion DOID_1729 3.565E-04 1.252E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP chondrosarcoma DOID_3371 3.565E-04 1.244E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP myeloma DOID_0070004 3.997E-04 1.387E-03 0.13301581 0.49146751 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lens disease DOID_110 3.997E-04 1.378E-03 9.01E-03 0.11145004 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thyroid adenoma DOID_2891 3.997E-04 1.37E-03 0.13301581 0.48207641 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP vascular skin disease DOID_9540 3.997E-04 1.362E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hemolytic anemia DOID_583 4.238E-04 1.436E-03 9.36E-03 0.10652223 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP normocytic anemia DOID_720 4.238E-04 1.436E-03 9.36E-03 0.10652223 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP dermatomyositis DOID_10223 4.349E-04 1.464E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP prostatic adenoma DOID_2883 4.349E-04 1.456E-03 4.349E-04 0.02062032 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP invasive lobular carcinoma DOID_3457 4.349E-04 1.447E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP integumentary system benign neoplasm DOID_0060121 4.489E-04 1.485E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP skin benign neoplasm DOID_3165 4.489E-04 1.485E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP B-cell lymphocytic neoplasm DOID_707 5.017E-04 1.65E-03 0.01044775 0.11656411 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pituitary cancer DOID_1785 5.209E-04 1.703E-03 0.03365956 0.24243408 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pituitary carcinoma DOID_4916 5.209E-04 1.703E-03 0.03365956 0.24243408 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP aortic valve insufficiency DOID_57 5.209E-04 1.694E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP stomach disease DOID_76 5.209E-04 1.684E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mitochondrial encephalomyopathy DOID_890 5.209E-04 1.674E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP ocular hypertension DOID_9282 5.209E-04 1.665E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP borderline glaucoma DOID_9283 5.209E-04 1.665E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP encephalitis DOID_9588 5.209E-04 1.656E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bone marrow cancer DOID_4960 5.882E-04 1.859E-03 0.15018146 0.53076554 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP vulva cancer DOID_1245 6.144E-04 1.932E-03 0.03641333 0.2496287 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Lynch syndrome DOID_3883 6.144E-04 1.921E-03 0.03641333 0.24092072 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP intracranial thrombosis DOID_4193 6.144E-04 1.91E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP tethered spinal cord syndrome DOID_1089 7.155E-04 2.213E-03 0.03915931 0.25611089 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP melancholia DOID_2848 7.524E-04 2.314E-03 0.16223606 0.55609831 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP neurotic disorder DOID_4964 7.884E-04 2.412E-03 0.16462658 0.55757453 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Ehlers-Danlos syndrome DOID_13359 8.241E-04 2.507E-03 8.241E-04 0.02930551 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thoracic aortic aneurysm DOID_14004 8.241E-04 2.494E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP membranoproliferative glomerulonephritis DOID_2920 8.241E-04 2.481E-03 0.04189754 0.26488558 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mesenchymal cell neoplasm DOID_3350 8.241E-04 2.468E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP spindle cell sarcoma DOID_4235 8.241E-04 2.468E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP oral submucous fibrosis DOID_5773 8.241E-04 2.455E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP epithelioid sarcoma DOID_6193 8.241E-04 2.468E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP respiratory failure DOID_11162 8.637E-04 2.559E-03 0.16938734 0.56363391 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP angiosarcoma DOID_0001816 9.4E-04 2.771E-03 0.04462804 0.2701421 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pituitary adenoma DOID_3829 9.4E-04 2.757E-03 0.04462804 0.26451414 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thyroiditis DOID_7166 9.4E-04 2.743E-03 0.04462804 0.26178719 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP autoimmune thyroiditis DOID_7188 9.4E-04 2.743E-03 0.04462804 0.26178719 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP chronic myeloid leukemia DOID_8552 9.4E-04 2.729E-03 0.04462804 0.25911589 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP tongue cancer DOID_8649 9.4E-04 2.715E-03 0.04462804 0.25649856 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Barrett's esophagus DOID_9206 9.4E-04 2.701E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP basal cell carcinoma DOID_2513 1.063E-03 3.041E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP skin carcinoma DOID_3451 1.194E-03 3.397E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP ureteral obstruction DOID_5199 1.194E-03 3.38E-03 0.05006594 0.2792894 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP prion disease DOID_649 1.194E-03 3.364E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP blood coagulation disease DOID_1247 1.21E-03 3.391E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pancreatic ductal carcinoma DOID_3587 1.21E-03 3.374E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP nephrosis DOID_2527 1.258E-03 3.492E-03 0.01900717 0.18646693 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP dissociative disorder DOID_10935 1.332E-03 3.679E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP dissociative amnesia DOID_11037 1.332E-03 3.679E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP granulosa cell tumor DOID_2999 1.332E-03 3.662E-03 1.332E-03 0.03989251 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP endogenous depression DOID_1595 1.464E-03 4.006E-03 0.19968378 0.63831501 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP syndrome DOID_225 1.464E-03 3.987E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP amnestic disorder DOID_10914 1.477E-03 4.003E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP sex cord-gonadal stromal tumor DOID_192 1.477E-03 3.984E-03 1.477E-03 0.04203055 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP brain edema DOID_4724 1.477E-03 3.965E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pancreatitis DOID_4989 1.575E-03 4.207E-03 0.02199363 0.20857295 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bacterial pneumonia DOID_874 1.575E-03 4.188E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP auditory system disease DOID_2742 1.812E-03 4.794E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mental depression DOID_1596 1.874E-03 4.937E-03 0.21554108 0.67386196 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bone development disease DOID_0080006 1.938E-03 5.081E-03 0.21778085 0.67346362 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP urinary tract obstruction DOID_5200 1.956E-03 5.106E-03 0.06352688 0.32860722 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lingual-facial-buccal dyskinesia DOID_9854 1.956E-03 5.083E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hypoglycemia DOID_9993 1.956E-03 5.06E-03 0.06352688 0.3256468 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP synostosis DOID_11971 2.13E-03 5.484E-03 0.0661963 0.33332474 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP ureteral disease DOID_1426 2.13E-03 5.46E-03 0.0661963 0.32752779 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP congenital hemolytic anemia DOID_589 2.13E-03 5.435E-03 2.13E-03 0.05509347 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP aortic valve disease DOID_62 2.13E-03 5.411E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP acute pancreatitis DOID_2913 2.311E-03 5.844E-03 0.06885819 0.33776128 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Crohn's disease DOID_8778 2.65E-03 6.673E-03 0.239833 0.72587753 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP papillary adenoma DOID_3172 2.694E-03 6.753E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP microcystic adenoma DOID_5403 2.694E-03 6.753E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP follicular adenoma DOID_6204 2.694E-03 6.753E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP myositis DOID_633 2.694E-03 6.723E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP congenital hypoplastic anemia DOID_1342 2.896E-03 7.195E-03 2.896E-03 0.05884676 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP fragments of torsion dystonia DOID_531 2.896E-03 7.164E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP extrinsic allergic alveolitis DOID_841 2.896E-03 7.133E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP diffuse large B-cell lymphoma DOID_0050745 3.105E-03 7.614E-03 0.07943075 0.36744796 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP gestational diabetes DOID_11714 3.105E-03 7.581E-03 0.07943075 0.36448467 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP perinatal necrotizing enterocolitis DOID_8677 3.105E-03 7.549E-03 0.07943075 0.3586992 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pleurisy DOID_10247 3.32E-03 8.039E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP renal hypertension DOID_1073 3.32E-03 8.005E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP secondary hypertension DOID_11130 3.32E-03 8.005E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thrombocytopenia DOID_1588 3.32E-03 7.971E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP central nervous system hereditary degenerative disease DOID_481 3.32E-03 7.938E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP autoimmune disease of endocrine system DOID_0060005 3.543E-03 8.434E-03 0.08467235 0.37347726 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP dystonic disease DOID_544 3.543E-03 8.399E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP dysostosis DOID_1934 3.772E-03 8.905E-03 0.08728205 0.37623853 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP spastic cerebral palsy DOID_0050669 4.008E-03 9.423E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP gonadal disease DOID_2277 4.008E-03 9.384E-03 0.08988438 0.38454293 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Charcot-Marie-Tooth disease DOID_10595 4.25E-03 9.911E-03 4.25E-03 0.0755735 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP metal metabolism disorder DOID_896 4.755E-03 0.01104388 4.755E-03 0.07958092 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP nephroblastoma DOID_2154 5.018E-03 0.01160599 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP esophageal disease DOID_6050 5.018E-03 0.011559 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymphoid leukemia DOID_10747 5.287E-03 0.01212949 0.10278615 0.4207577 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP aplastic anemia DOID_12449 5.287E-03 0.01208077 5.287E-03 0.08594607 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP embryonal cancer DOID_688 5.844E-03 0.01330103 0.10789598 0.42932036 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP blood platelet disease DOID_2218 6.132E-03 0.01390168 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hepatitis DOID_2237 6.427E-03 0.01451197 6.427E-03 0.09883825 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP congenital diaphragmatic hernia DOID_3827 6.427E-03 0.01445461 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP peptic ulcer DOID_750 6.427E-03 0.0143977 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymphatic system disease DOID_75 6.728E-03 0.01501301 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP nephrotic syndrome DOID_1184 7.669E-03 0.01704558 7.669E-03 0.10909171 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Huntington's disease DOID_12858 7.669E-03 0.01697925 7.669E-03 0.10643094 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hyperinsulinism DOID_2018 7.669E-03 0.01691344 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP leukodystrophy DOID_10579 8.666E-03 0.01903757 8.666E-03 0.10957182 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bone marrow disease DOID_4961 9.01E-03 0.01971808 9.01E-03 0.10680629 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP aortic aneurysm DOID_3627 0.01007938 0.02197382 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP movement disease DOID_480 0.01007938 0.02188995 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hemorrhagic disease DOID_2213 0.01044775 0.02260369 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP congenital heart defect DOID_1682 0.0153182 0.03301536 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cerebral degeneration DOID_1443 0.01620825 0.03480187 0.01620825 0.17078697 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP temporal lobe epilepsy DOID_3328 0.01666141 0.03564039 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lipid metabolism disorder DOID_3146 0.02302957 0.049078 0.20878358 0.65998809 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP chromosomal disease DOID_0080014 0.02355498 0.05001038 0.21104246 0.66344288 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP focal epilepsy DOID_2234 0.02462052 0.05207834 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP primary immunodeficiency disease DOID_612 0.02793262 0.05886541 0.22888502 0.70019128 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP interstitial nephritis DOID_1063 0.02812863 0.05905975 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP T cell deficiency DOID_11200 0.02812863 0.05884262 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hyperparathyroidism DOID_13543 0.02812863 0.05862708 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hypolipoproteinemia DOID_1387 0.02812863 0.05841311 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP gonadal dysgenesis DOID_14447 0.02812863 0.0582007 0.02812863 0.23888346 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP angioedema DOID_1558 0.02812863 0.05798982 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP rectal neoplasm DOID_1984 0.02812863 0.05778047 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP rectum cancer DOID_1993 0.02812863 0.05778047 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP acute kidney failure DOID_3021 0.02812863 0.05757263 0.02812863 0.23537046 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP teratoma DOID_3307 0.02812863 0.05736628 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP labyrinthine disease DOID_4539 0.02812863 0.0571614 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP malignant teratoma DOID_5563 0.02812863 0.05736628 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP mature teratoma DOID_5566 0.02812863 0.05736628 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP acute T cell leukemia DOID_5603 0.02812863 0.05695798 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP visceral leishmaniasis DOID_9146 0.02812863 0.056756 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cannabis abuse DOID_9505 0.02812863 0.05655545 0.02812863 0.22864559 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP familial adenomatous polyposis DOID_0050424 0.03089801 0.06190481 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP nervous system benign neoplasm DOID_0060115 0.03089801 0.0616876 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP adrenoleukodystrophy DOID_10588 0.03089801 0.06147191 0.03089801 0.23441288 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP sickle cell anemia DOID_10923 0.03089801 0.06125772 0.03089801 0.2313285 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP polydactyly DOID_1148 0.03089801 0.06104502 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP prediabetes syndrome DOID_11716 0.03089801 0.06083379 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hemochromatosis DOID_2352 0.03089801 0.06062402 0.03089801 0.22832424 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP inner ear disease DOID_2952 0.03089801 0.06041569 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bronchiectasis DOID_9563 0.03089801 0.06020879 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP familial atrial fibrillation DOID_0050650 0.03365956 0.06536619 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP common cold DOID_10459 0.03365956 0.06514385 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP otitis media DOID_10754 0.03365956 0.06492302 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP beta thalassemia DOID_12241 0.03365956 0.06470369 0.03365956 0.24554221 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP islet cell tumor DOID_1799 0.03365956 0.06448583 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP middle ear disease DOID_5100 0.03365956 0.06492302 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lipodystrophy DOID_811 0.03365956 0.06426944 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 0.03641333 0.06929492 0.03641333 0.25267295 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP berylliosis DOID_10322 0.03641333 0.06906394 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP parathyroid gland disease DOID_11201 0.03641333 0.06883449 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP carotid stenosis DOID_13001 0.03641333 0.06860656 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP polyneuropathy DOID_1389 0.03641333 0.06838014 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP cannabis dependence DOID_1849 0.03641333 0.0681552 0.03641333 0.24665693 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hallucinogen dependence DOID_9977 0.03641333 0.0681552 0.03641333 0.24665693 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP open-angle glaucoma DOID_1067 0.03915931 0.07305458 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hypercalcemia DOID_12678 0.03915931 0.07281584 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP T-cell leukemia DOID_715 0.03915931 0.07257866 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP parasitic helminthiasis infectious disease DOID_883 0.03915931 0.07234301 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP idiopathic pulmonary fibrosis DOID_0050156 0.04189754 0.07715114 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP thalassemia DOID_10241 0.04189754 0.07690226 0.04189754 0.2709057 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP communication disorder DOID_2033 0.04189754 0.07665499 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hemangioma DOID_255 0.04189754 0.0764093 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP corneal dystrophy DOID_2566 0.04189754 0.07616518 0.04189754 0.26786182 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hyperhomocysteinemia DOID_9279 0.04189754 0.07592262 0.04189754 0.25634088 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP spastic diplegia DOID_10965 0.04462804 0.08061383 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP hemolytic-uremic syndrome DOID_12554 0.04462804 0.08035872 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Fanconi's anemia DOID_13636 0.04462804 0.08010523 0.04462804 0.2672985 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP long QT syndrome DOID_2843 0.04462804 0.07985332 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymphatic system cancer DOID_0060073 0.04735084 0.08445964 0.04735084 0.26675867 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP drug-induced mental disorder DOID_1203 0.04735084 0.0841957 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP drug psychosis DOID_1742 0.04735084 0.0841957 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP bronchitis DOID_6132 0.04735084 0.08393341 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP urinary system benign neoplasm DOID_731 0.04735084 0.08367275 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP reticulosarcoma DOID_8538 0.04735084 0.08445964 0.04735084 0.26675867 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP substance-induced psychosis DOID_8646 0.04735084 0.0841957 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymphosarcoma DOID_8675 0.04735084 0.08445964 0.04735084 0.26675867 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP keratosis DOID_161 0.05006594 0.08819665 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP neuroendocrine tumor DOID_169 0.05006594 0.08792444 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP eosinophilia DOID_999 0.05006594 0.0876539 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Down syndrome DOID_14250 0.05277337 0.09211058 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP heart septal defect DOID_1681 0.05277337 0.0918289 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP infertility DOID_5223 0.05277337 0.09154893 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP pulmonary edema DOID_11396 0.05547317 0.09593991 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP esophagitis DOID_11963 0.05547317 0.09564918 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP colon carcinoma DOID_1520 0.05547317 0.09536021 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP alopecia DOID_987 0.05547317 0.09507298 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP Kawasaki disease DOID_13378 0.05816533 0.09938761 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymphadenitis DOID_1602 0.05816533 0.09938761 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP autoimmune hepatitis DOID_2048 0.05816533 0.09909004 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP coronary restenosis DOID_4247 0.05816533 0.09879425 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP lymph node disease DOID_9942 0.05816533 0.09938761 1.000 1.000 ONDER_CDH1_TARGETS_1_DN cystic fibrosis DOID_1485 5.587E-10 3.179E-07 9.896E-07 5.631E-04 ONDER_CDH1_TARGETS_1_DN glioblastoma DOID_3068 5.733E-09 1.631E-06 1.167E-05 3.32E-03 ONDER_CDH1_TARGETS_1_DN astrocytoma DOID_3069 1.581E-08 3E-06 2.257E-05 4.281E-03 ONDER_CDH1_TARGETS_1_DN aplastic anemia DOID_12449 2.526E-08 3.594E-06 8.977E-05 8.513E-03 ONDER_CDH1_TARGETS_1_DN bacterial pneumonia DOID_874 2.998E-08 3.412E-06 3.422E-05 4.868E-03 ONDER_CDH1_TARGETS_1_DN influenza DOID_8469 7.598E-08 7.205E-06 5.146E-03 0.06808987 ONDER_CDH1_TARGETS_1_DN bone marrow disease DOID_4961 1.044E-07 8.485E-06 2.045E-04 0.0116366 ONDER_CDH1_TARGETS_1_DN giant cell tumor DOID_200 1.862E-07 1.324E-05 2.864E-04 0.01481519 ONDER_CDH1_TARGETS_1_DN malignant giant cell tumor DOID_2705 1.862E-07 1.324E-05 2.864E-04 0.01481519 ONDER_CDH1_TARGETS_1_DN giant cell glioblastoma DOID_3074 1.862E-07 1.324E-05 2.864E-04 0.01481519 ONDER_CDH1_TARGETS_1_DN cystitis DOID_1679 4.162E-07 2.631E-05 1.000 1.000 ONDER_CDH1_TARGETS_1_DN pleurisy DOID_10247 6.465E-07 3.679E-05 2.123E-03 0.04165484 ONDER_CDH1_TARGETS_1_DN pleural disease DOID_1532 1.225E-06 6.334E-05 2.883E-03 0.05125628 ONDER_CDH1_TARGETS_1_DN bladder disease DOID_365 1.225E-06 5.806E-05 1.000 1.000 ONDER_CDH1_TARGETS_1_DN transitional cell carcinoma DOID_2671 2.017E-06 8.826E-05 1.148E-03 0.02722351 ONDER_CDH1_TARGETS_1_DN peptic ulcer DOID_750 2.586E-06 1.051E-04 4.129E-03 0.06349131 ONDER_CDH1_TARGETS_1_DN mouth disease DOID_403 2.775E-06 1.053E-04 0.02020612 0.18249653 ONDER_CDH1_TARGETS_1_DN cervix uteri carcinoma in situ DOID_8991 3.126E-06 1.112E-04 1.396E-04 9.926E-03 ONDER_CDH1_TARGETS_1_DN ulcerative colitis DOID_8577 3.394E-06 1.136E-04 1.555E-03 0.03276872 ONDER_CDH1_TARGETS_1_DN rheumatic disease DOID_1575 3.745E-06 1.184E-04 0.09925251 0.3667187 ONDER_CDH1_TARGETS_1_DN scleroderma DOID_419 3.745E-06 1.184E-04 0.09925251 0.3667187 ONDER_CDH1_TARGETS_1_DN uterine cancer DOID_363 4.086E-06 1.224E-04 1.7E-04 0.01074922 ONDER_CDH1_TARGETS_1_DN integumentary system benign neoplasm DOID_0060121 6.148E-06 1.749E-04 6.266E-03 0.07750434 ONDER_CDH1_TARGETS_1_DN skin benign neoplasm DOID_3165 6.148E-06 1.749E-04 6.266E-03 0.07750434 ONDER_CDH1_TARGETS_1_DN integumentary system cancer DOID_0060122 9.536E-06 2.584E-04 7.743E-03 0.08990809 ONDER_CDH1_TARGETS_1_DN skin cancer DOID_4159 9.536E-06 2.584E-04 7.743E-03 0.08990809 ONDER_CDH1_TARGETS_1_DN leishmaniasis DOID_9065 1.064E-05 2.751E-04 0.04224202 0.24526236 ONDER_CDH1_TARGETS_1_DN collagen disease DOID_854 1.413E-05 3.496E-04 0.13538253 0.43768556 ONDER_CDH1_TARGETS_1_DN pre-malignant neoplasm DOID_0060071 1.598E-05 3.788E-04 4.651E-04 0.01654139 ONDER_CDH1_TARGETS_1_DN in situ carcinoma DOID_8719 1.598E-05 3.788E-04 4.651E-04 0.01654139 ONDER_CDH1_TARGETS_1_DN neutropenia DOID_1227 1.682E-05 3.829E-04 1.000 1.000 ONDER_CDH1_TARGETS_1_DN agranulocytosis DOID_12987 1.931E-05 4.227E-04 1.000 1.000 ONDER_CDH1_TARGETS_1_DN portal hypertension DOID_10762 2.822E-05 5.946E-04 0.05735615 0.28627761 ONDER_CDH1_TARGETS_1_DN pancreatitis DOID_4989 3.422E-05 6.955E-04 8.163E-04 0.02019337 ONDER_CDH1_TARGETS_1_DN congenital hypoplastic anemia DOID_1342 3.544E-05 6.953E-04 3.544E-05 4.033E-03 ONDER_CDH1_TARGETS_1_DN chronic kidney failure DOID_784 4.344E-05 8.238E-04 0.01607474 0.15769872 ONDER_CDH1_TARGETS_1_DN hepatic vascular disease DOID_272 4.377E-05 8.035E-04 0.06588669 0.29519314 ONDER_CDH1_TARGETS_1_DN lymphoma DOID_0060058 6.441E-05 1.145E-03 0.19244254 0.55867246 ONDER_CDH1_TARGETS_1_DN hypersensitivity reaction type I disease DOID_1205 7.281E-05 1.255E-03 1.425E-03 0.03242733 ONDER_CDH1_TARGETS_1_DN myocarditis DOID_820 7.623E-05 1.276E-03 3.048E-03 0.05254946 ONDER_CDH1_TARGETS_1_DN nephroblastoma DOID_2154 8.282E-05 1.346E-03 3.217E-03 0.05383919 ONDER_CDH1_TARGETS_1_DN spindle cell carcinoma DOID_4015 8.282E-05 1.309E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN leukopenia DOID_615 8.282E-05 1.274E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN multiple myeloma DOID_9538 1.048E-04 1.569E-03 0.08688068 0.33859664 ONDER_CDH1_TARGETS_1_DN hepatitis DOID_2237 1.214E-04 1.771E-03 1.214E-04 9.865E-03 ONDER_CDH1_TARGETS_1_DN systemic scleroderma DOID_418 1.214E-04 1.726E-03 0.09102318 0.34528125 ONDER_CDH1_TARGETS_1_DN intracranial arterial disease DOID_13089 1.303E-04 1.808E-03 4.324E-03 0.06474099 ONDER_CDH1_TARGETS_1_DN cerebral arterial disease DOID_3527 1.303E-04 1.808E-03 4.324E-03 0.06474099 ONDER_CDH1_TARGETS_1_DN pulmonary emphysema DOID_9675 1.396E-04 1.891E-03 4.523E-03 0.06433816 ONDER_CDH1_TARGETS_1_DN gallbladder cancer DOID_3121 1.7E-04 2.25E-03 0.10129831 0.37186285 ONDER_CDH1_TARGETS_1_DN myeloma DOID_0070004 2.045E-04 2.645E-03 0.10740821 0.38437276 ONDER_CDH1_TARGETS_1_DN cutaneous leishmaniasis DOID_9111 2.262E-04 2.86E-03 0.02245717 0.18519032 ONDER_CDH1_TARGETS_1_DN calcium metabolism disease DOID_10575 2.432E-04 3.009E-03 6.502E-03 0.07871455 ONDER_CDH1_TARGETS_1_DN B-cell lymphocytic neoplasm DOID_707 2.571E-04 3.113E-03 0.1154909 0.39349895 ONDER_CDH1_TARGETS_1_DN bone marrow cancer DOID_4960 3.018E-04 3.578E-03 0.12150541 0.40909219 ONDER_CDH1_TARGETS_1_DN parasitic protozoa infectious disease DOID_2789 3.178E-04 3.69E-03 0.12350125 0.40855938 ONDER_CDH1_TARGETS_1_DN beta thalassemia DOID_12241 3.308E-04 3.764E-03 3.308E-04 0.01568404 ONDER_CDH1_TARGETS_1_DN stomach disease DOID_76 3.308E-04 3.69E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN oral cavity cancer DOID_8618 3.688E-04 4.036E-03 8.534E-03 0.09521277 ONDER_CDH1_TARGETS_1_DN melancholia DOID_2848 3.869E-04 4.154E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN leukocyte disease DOID_9500 3.869E-04 4.077E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN neurotic disorder DOID_4964 4.056E-04 4.196E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN neuroectodermal tumor DOID_171 4.249E-04 4.317E-03 4.249E-04 0.01859701 ONDER_CDH1_TARGETS_1_DN respiratory failure DOID_11162 4.447E-04 4.439E-03 9.643E-03 0.10551937 ONDER_CDH1_TARGETS_1_DN Legionnaires' disease DOID_10457 4.547E-04 4.461E-03 4.547E-04 0.01848105 ONDER_CDH1_TARGETS_1_DN legionellosis DOID_10458 4.547E-04 4.461E-03 4.547E-04 0.01848105 ONDER_CDH1_TARGETS_1_DN viral pneumonia DOID_10533 4.547E-04 4.385E-03 4.547E-04 0.01724898 ONDER_CDH1_TARGETS_1_DN congenital heart defect DOID_1682 4.651E-04 4.411E-03 4.651E-04 0.01556837 ONDER_CDH1_TARGETS_1_DN mineral metabolism disease DOID_0050032 4.861E-04 4.535E-03 0.01022064 0.10972729 ONDER_CDH1_TARGETS_1_DN cholestasis DOID_13580 5.078E-04 4.66E-03 5.078E-04 0.01605057 ONDER_CDH1_TARGETS_1_DN parasitic infectious disease DOID_1398 5.078E-04 4.586E-03 0.1432148 0.46039107 ONDER_CDH1_TARGETS_1_DN thalassemia DOID_10241 5.239E-04 4.658E-03 5.239E-04 0.01568947 ONDER_CDH1_TARGETS_1_DN hyperglycemia DOID_4195 5.3E-04 4.639E-03 0.14516188 0.46143637 ONDER_CDH1_TARGETS_1_DN Fanconi's anemia DOID_13636 5.979E-04 5.154E-03 5.979E-04 0.01700917 ONDER_CDH1_TARGETS_1_DN Barrett's esophagus DOID_9206 5.979E-04 5.077E-03 0.03569145 0.22818466 ONDER_CDH1_TARGETS_1_DN bile duct disease DOID_4138 6.504E-04 5.442E-03 6.504E-04 0.01762166 ONDER_CDH1_TARGETS_1_DN male reproductive system disease DOID_48 6.504E-04 5.363E-03 0.1548319 0.4762127 ONDER_CDH1_TARGETS_1_DN biliary tract disease DOID_9741 6.764E-04 5.498E-03 6.764E-04 0.01749295 ONDER_CDH1_TARGETS_1_DN lymphatic system cancer DOID_0060073 6.766E-04 5.422E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN urinary system benign neoplasm DOID_731 6.766E-04 5.347E-03 0.03787988 0.23175969 ONDER_CDH1_TARGETS_1_DN reticulosarcoma DOID_8538 6.766E-04 5.422E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN lymphosarcoma DOID_8675 6.766E-04 5.422E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN endogenous depression DOID_1595 7.583E-04 5.91E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN amnestic disorder DOID_10914 9.41E-04 7.236E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN pulmonary edema DOID_11396 9.41E-04 7.139E-03 0.04441576 0.25272566 ONDER_CDH1_TARGETS_1_DN esophagitis DOID_11963 9.41E-04 7.045E-03 0.04441576 0.25022343 ONDER_CDH1_TARGETS_1_DN mental depression DOID_1596 9.733E-04 7.192E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN biliary tract cancer DOID_4607 9.733E-04 7.1E-03 0.17572699 0.52077426 ONDER_CDH1_TARGETS_1_DN primary bacterial infectious disease DOID_0050338 1.112E-03 8.008E-03 0.0175302 0.1690624 ONDER_CDH1_TARGETS_1_DN muscle cancer DOID_4045 1.248E-03 8.873E-03 1.000 1.000 ONDER_CDH1_TARGETS_1_DN encephalomyelitis DOID_640 1.342E-03 9.426E-03 0.01981397 0.1848221 ONDER_CDH1_TARGETS_1_DN dilated cardiomyopathy DOID_12930 1.425E-03 9.886E-03 0.02060152 0.1803425 ONDER_CDH1_TARGETS_1_DN acute pancreatitis DOID_2913 1.475E-03 0.01011147 1.475E-03 0.03227891 ONDER_CDH1_TARGETS_1_DN bronchiolitis DOID_2942 1.596E-03 0.01080776 1.000 1.000 ONDER_CDH1_TARGETS_1_DN middle cerebral artery infarction DOID_3525 1.85E-03 0.01238584 1.85E-03 0.03759987 ONDER_CDH1_TARGETS_1_DN periodontitis DOID_824 1.984E-03 0.01312928 0.06376124 0.29024115 ONDER_CDH1_TARGETS_1_DN sarcoma DOID_1115 2.123E-03 0.01388495 1.000 1.000 ONDER_CDH1_TARGETS_1_DN thrombocytopenia DOID_1588 2.123E-03 0.01372716 1.000 1.000 ONDER_CDH1_TARGETS_1_DN focal glomerulosclerosis DOID_3945 2.266E-03 0.01448766 2.266E-03 0.04298005 ONDER_CDH1_TARGETS_1_DN gonadal disease DOID_2277 2.566E-03 0.01621993 2.566E-03 0.04709011 ONDER_CDH1_TARGETS_1_DN periodontal disease DOID_3388 3.217E-03 0.02011574 0.08063194 0.33246068 ONDER_CDH1_TARGETS_1_DN esophageal disease DOID_6050 3.217E-03 0.01989709 0.08063194 0.32771124 ONDER_CDH1_TARGETS_1_DN calcinosis DOID_182 3.751E-03 0.02295093 0.08688068 0.34093179 ONDER_CDH1_TARGETS_1_DN medulloblastoma DOID_3858 3.751E-03 0.02270677 3.751E-03 0.06098391 ONDER_CDH1_TARGETS_1_DN cleft palate DOID_674 3.751E-03 0.02246776 3.751E-03 0.05928991 ONDER_CDH1_TARGETS_1_DN blood platelet disease DOID_2218 3.938E-03 0.0233396 1.000 1.000 ONDER_CDH1_TARGETS_1_DN adult respiratory distress syndrome DOID_11394 4.324E-03 0.02536245 0.09308745 0.35077324 ONDER_CDH1_TARGETS_1_DN adenoid cystic carcinoma DOID_4866 4.324E-03 0.02510365 4.324E-03 0.06308096 ONDER_CDH1_TARGETS_1_DN salivary gland cancer DOID_8850 4.726E-03 0.02716439 4.726E-03 0.06559207 ONDER_CDH1_TARGETS_1_DN Huntington's disease DOID_12858 4.934E-03 0.02807391 0.09925251 0.36911555 ONDER_CDH1_TARGETS_1_DN primitive neuroectodermal tumor DOID_168 4.934E-03 0.02779595 4.934E-03 0.06684265 ONDER_CDH1_TARGETS_1_DN cerebral infarction DOID_3526 5.361E-03 0.02990866 5.361E-03 0.06933372 ONDER_CDH1_TARGETS_1_DN learning disability DOID_8927 5.361E-03 0.02961829 0.10333952 0.3745235 ONDER_CDH1_TARGETS_1_DN heart valve disease DOID_4079 5.805E-03 0.03176265 0.10740821 0.37959794 ONDER_CDH1_TARGETS_1_DN autoimmune disease of gastrointestinal tract DOID_0060031 6.266E-03 0.03395428 6.266E-03 0.07922666 ONDER_CDH1_TARGETS_1_DN pulmonary tuberculosis DOID_2957 6.266E-03 0.03363396 0.11145864 0.38907954 ONDER_CDH1_TARGETS_1_DN lung small cell carcinoma DOID_5409 6.266E-03 0.03331962 0.11145864 0.3867071 ONDER_CDH1_TARGETS_1_DN withdrawal disorder DOID_0060001 6.742E-03 0.03552082 0.1154909 0.39586942 ONDER_CDH1_TARGETS_1_DN hemorrhagic disease DOID_2213 6.742E-03 0.03519494 1.000 1.000 ONDER_CDH1_TARGETS_1_DN orofacial cleft DOID_0050567 6.986E-03 0.03613803 6.986E-03 0.08281631 ONDER_CDH1_TARGETS_1_DN atopic dermatitis DOID_3310 6.986E-03 0.03581246 0.11750025 0.39796215 ONDER_CDH1_TARGETS_1_DN congenital nervous system abnormality DOID_2490 8.266E-03 0.04199575 8.266E-03 0.09407047 ONDER_CDH1_TARGETS_1_DN hypersensitivity reaction type IV disease DOID_2916 8.534E-03 0.04297213 0.12946192 0.4209362 ONDER_CDH1_TARGETS_1_DN tooth disease DOID_1091 0.01111481 0.05547653 0.14710459 0.46501396 ONDER_CDH1_TARGETS_1_DN allergic contact dermatitis DOID_3042 0.01111481 0.05499413 0.01111481 0.11711712 ONDER_CDH1_TARGETS_1_DN endocrine organ benign neoplasm DOID_0060089 0.01142027 0.0560184 0.14904294 0.4685383 ONDER_CDH1_TARGETS_1_DN brain infarction DOID_3454 0.01142027 0.05553961 0.01142027 0.1181479 ONDER_CDH1_TARGETS_1_DN tuberculosis DOID_399 0.01142027 0.05506894 0.14904294 0.46596392 ONDER_CDH1_TARGETS_1_DN blood coagulation disease DOID_1247 0.01204221 0.05758 1.000 1.000 ONDER_CDH1_TARGETS_1_DN pancreatic ductal carcinoma DOID_3587 0.01204221 0.05710016 0.15290658 0.47543085 ONDER_CDH1_TARGETS_1_DN nephrosis DOID_2527 0.01235865 0.05811632 0.1548319 0.47880081 ONDER_CDH1_TARGETS_1_DN pancreatic carcinoma DOID_4905 0.01300239 0.06064227 0.15866956 0.48539236 ONDER_CDH1_TARGETS_1_DN diabetic retinopathy DOID_8947 0.01300239 0.06014925 0.15866956 0.48279668 ONDER_CDH1_TARGETS_1_DN aneurysm disease DOID_2403 0.01399484 0.06421827 0.16439378 0.49492096 ONDER_CDH1_TARGETS_1_DN contact dermatitis DOID_2773 0.01501912 0.06836702 0.01501912 0.15260496 ONDER_CDH1_TARGETS_1_DN alcohol abuse DOID_1574 0.01607474 0.07259147 0.01607474 0.16046536 ONDER_CDH1_TARGETS_1_DN retinal vascular disease DOID_2462 0.01679567 0.0752499 0.17947086 0.52638619 ONDER_CDH1_TARGETS_1_DN amino acid metabolic disorder DOID_9252 0.01827818 0.08125221 0.01827818 0.17333804 ONDER_CDH1_TARGETS_1_DN lymphoblastic leukemia DOID_1037 0.01981397 0.0873965 0.19427901 0.5611409 ONDER_CDH1_TARGETS_1_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.02020612 0.08844063 0.02020612 0.18544002 ONDER_CDH1_TARGETS_1_DN arrhythmogenic right ventricular dysplasia DOID_0050431 0.02023408 0.08788694 0.02023408 0.17989359 ONDER_CDH1_TARGETS_1_DN leber hereditary optic neuropathy DOID_705 0.02023408 0.08722113 1.000 1.000 ONDER_CDH1_TARGETS_1_DN brachydactyly DOID_0050581 0.02245717 0.09607618 0.02245717 0.19360807 ONDER_CDH1_TARGETS_1_DN hyperparathyroidism DOID_13543 0.02245717 0.0953592 1.000 1.000 ONDER_CDH1_TARGETS_1_DN hypolipoproteinemia DOID_1387 0.02245717 0.09465283 1.000 1.000 ONDER_CDH1_TARGETS_1_DN childhood type dermatomyositis DOID_14203 0.02245717 0.09395686 1.000 1.000 ONDER_CDH1_TARGETS_1_DN retinal vascular occlusion DOID_1729 0.02245717 0.09327104 1.000 1.000 ONDER_CDH1_TARGETS_1_DN bilirubin metabolic disorder DOID_2741 0.02245717 0.09259516 1.000 1.000 ONDER_CDH1_TARGETS_1_DN acute kidney failure DOID_3021 0.02245717 0.09192901 0.02245717 0.19071839 ONDER_CDH1_TARGETS_1_DN insulinoma DOID_3892 0.02245717 0.09127237 0.02245717 0.18791371 ONDER_CDH1_TARGETS_1_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.02245717 0.09062505 1.000 1.000 ONDER_CDH1_TARGETS_1_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.02245717 0.09062505 1.000 1.000 ONDER_CDH1_TARGETS_1_DN Hodgkin's granuloma DOID_8651 0.02245717 0.09062505 1.000 1.000 ONDER_CDH1_TARGETS_1_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 0.02245717 0.09062505 1.000 1.000 ONDER_CDH1_TARGETS_1_DN visceral leishmaniasis DOID_9146 0.02245717 0.08998685 1.000 1.000 ONDER_CDH1_TARGETS_1_DN cannabis abuse DOID_9505 0.02245717 0.08935757 0.02245717 0.18254475 ONDER_CDH1_TARGETS_1_DN familial adenomatous polyposis DOID_0050424 0.02467529 0.09750166 1.000 1.000 ONDER_CDH1_TARGETS_1_DN dermatomyositis DOID_10223 0.02467529 0.09682923 1.000 1.000 ONDER_CDH1_TARGETS_1_DN sickle cell anemia DOID_10923 0.02467529 0.09616602 0.02467529 0.19774984 ONDER_CDH1_TARGETS_1_DN pneumocystosis DOID_11339 0.02467529 0.09551183 1.000 1.000 ONDER_CDH1_TARGETS_1_DN temporal arteritis DOID_13375 0.02467529 0.09486648 0.02467529 0.19500331 ONDER_CDH1_TARGETS_1_DN central nervous system vasculitis DOID_525 0.02467529 0.09486648 0.02467529 0.19500331 ONDER_CDH1_TARGETS_1_DN bronchiectasis DOID_9563 0.02467529 0.09422979 1.000 1.000 ONDER_CDH1_TARGETS_1_DN pituitary cancer DOID_1785 0.02688842 0.09999682 0.02688842 0.20675019 ONDER_CDH1_TARGETS_1_DN islet cell tumor DOID_1799 0.02688842 0.09934749 0.02688842 0.20399352 ONDER_CDH1_TARGETS_1_DN relapsing-remitting multiple sclerosis DOID_2378 0.02688842 0.09870654 0.02688842 0.20130939 ONDER_CDH1_TARGETS_1_DN pituitary carcinoma DOID_4916 0.02688842 0.09999682 0.02688842 0.20675019 ONDER_CDH1_TARGETS_1_DN lipodystrophy DOID_811 0.02688842 0.09807381 0.02688842 0.19869498 ONDER_CDH1_TARGETS_1_DN Hodgkin's lymphoma DOID_8567 0.02688842 0.09744913 1.000 1.000 ONDER_CDH1_TARGETS_1_DN mitochondrial encephalomyopathy DOID_890 0.02688842 0.09683237 1.000 1.000 ONDER_CDH1_TARGETS_1_DN encephalitis DOID_9588 0.02688842 0.09622336 1.000 1.000 GOZGIT_ESR1_TARGETS_DN endometriosis DOID_289 3.661E-13 2.083E-10 6.637E-05 2.36E-03 GOZGIT_ESR1_TARGETS_DN female reproductive system disease DOID_229 8.69E-13 2.472E-10 1.248E-05 1.183E-03 GOZGIT_ESR1_TARGETS_DN endometriosis of uterus DOID_288 9.746E-12 1.848E-09 7.977E-04 0.0126084 GOZGIT_ESR1_TARGETS_DN bone development disease DOID_0080006 4.828E-10 6.868E-08 1.577E-05 1.282E-03 GOZGIT_ESR1_TARGETS_DN uterine disease DOID_345 7.356E-10 8.372E-08 3.692E-03 0.03388099 GOZGIT_ESR1_TARGETS_DN transitional cell carcinoma DOID_2671 7.945E-10 7.534E-08 9.89E-03 0.06184081 GOZGIT_ESR1_TARGETS_DN pre-eclampsia DOID_10591 1.908E-08 1.551E-06 0.01118522 0.06494278 GOZGIT_ESR1_TARGETS_DN heart valve disease DOID_4079 1.908E-08 1.357E-06 0.01118522 0.06364392 GOZGIT_ESR1_TARGETS_DN mineral metabolism disease DOID_0050032 2.022E-07 1.278E-05 3.744E-05 1.775E-03 GOZGIT_ESR1_TARGETS_DN diabetic autonomic neuropathy DOID_11503 2.513E-07 1.43E-05 7.371E-05 2.467E-03 GOZGIT_ESR1_TARGETS_DN autonomic neuropathy DOID_11504 2.513E-07 1.43E-05 7.371E-05 2.467E-03 GOZGIT_ESR1_TARGETS_DN diabetic polyneuropathy DOID_12785 2.513E-07 1.43E-05 7.371E-05 2.467E-03 GOZGIT_ESR1_TARGETS_DN diabetic neuropathy DOID_9743 2.513E-07 1.43E-05 7.371E-05 2.467E-03 GOZGIT_ESR1_TARGETS_DN encephalomyelitis DOID_640 2.634E-07 1.363E-05 1.94E-03 0.02299139 GOZGIT_ESR1_TARGETS_DN autonomic nervous system disease DOID_11465 3.898E-07 1.848E-05 9.952E-05 2.98E-03 GOZGIT_ESR1_TARGETS_DN glaucoma DOID_1686 5.139E-07 2.249E-05 8.581E-06 1.628E-03 GOZGIT_ESR1_TARGETS_DN lung small cell carcinoma DOID_5409 5.139E-07 2.088E-05 5.139E-07 2.924E-04 GOZGIT_ESR1_TARGETS_DN calcium metabolism disease DOID_10575 5.874E-07 2.228E-05 9.602E-06 1.093E-03 GOZGIT_ESR1_TARGETS_DN leiomyoma DOID_127 7.811E-07 2.778E-05 0.04161222 0.15577205 GOZGIT_ESR1_TARGETS_DN osteochondrodysplasia DOID_2256 1.101E-06 3.686E-05 2.026E-04 4.611E-03 GOZGIT_ESR1_TARGETS_DN focal epilepsy DOID_2234 1.291E-06 4.081E-05 1.427E-04 3.691E-03 GOZGIT_ESR1_TARGETS_DN chronic kidney failure DOID_784 1.291E-06 3.866E-05 8.123E-03 0.0537435 GOZGIT_ESR1_TARGETS_DN uremia DOID_4676 1.94E-06 5.519E-05 1.215E-03 0.01570588 GOZGIT_ESR1_TARGETS_DN aortic valve disease DOID_62 2.432E-06 6.589E-05 1.000 1.000 GOZGIT_ESR1_TARGETS_DN benign mesothelioma DOID_2645 3.167E-06 8.19E-05 0.06269306 0.20268382 GOZGIT_ESR1_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.256E-06 8.056E-05 3.232E-05 1.839E-03 GOZGIT_ESR1_TARGETS_DN mouth disease DOID_403 3.256E-06 7.721E-05 3.232E-05 1.672E-03 GOZGIT_ESR1_TARGETS_DN temporal lobe epilepsy DOID_3328 3.622E-06 8.243E-05 4.573E-04 8.674E-03 GOZGIT_ESR1_TARGETS_DN teeth hard tissue disease DOID_214 5.455E-06 1.194E-04 5.455E-06 1.552E-03 GOZGIT_ESR1_TARGETS_DN male reproductive system disease DOID_48 5.806E-06 1.224E-04 4.995E-03 0.04242401 GOZGIT_ESR1_TARGETS_DN syndrome DOID_225 8.258E-06 1.678E-04 8.028E-04 0.01202142 GOZGIT_ESR1_TARGETS_DN corneal dystrophy DOID_2566 9.096E-06 1.785E-04 9.096E-06 1.294E-03 GOZGIT_ESR1_TARGETS_DN polycystic ovary syndrome DOID_11612 9.218E-06 1.748E-04 1.865E-04 4.422E-03 GOZGIT_ESR1_TARGETS_DN multiple epiphyseal dysplasia DOID_12721 9.218E-06 1.692E-04 2.919E-03 0.02913412 GOZGIT_ESR1_TARGETS_DN pancreatitis DOID_4989 9.774E-06 1.738E-04 0.03833669 0.14639984 GOZGIT_ESR1_TARGETS_DN mixed glioma DOID_5076 9.774E-06 1.685E-04 1.019E-04 2.9E-03 GOZGIT_ESR1_TARGETS_DN contact dermatitis DOID_2773 1.151E-05 1.927E-04 7.169E-03 0.05099224 GOZGIT_ESR1_TARGETS_DN angiosarcoma DOID_0001816 1.204E-05 1.957E-04 4.029E-04 7.906E-03 GOZGIT_ESR1_TARGETS_DN gonadal disease DOID_2277 1.268E-05 2.004E-04 3.495E-03 0.03313956 GOZGIT_ESR1_TARGETS_DN bronchitis DOID_6132 1.563E-05 2.404E-04 1.000 1.000 GOZGIT_ESR1_TARGETS_DN dental caries DOID_216 1.995E-05 2.987E-04 1.995E-05 1.419E-03 GOZGIT_ESR1_TARGETS_DN prion disease DOID_649 1.995E-05 2.91E-04 5.791E-04 9.985E-03 GOZGIT_ESR1_TARGETS_DN pneumoconiosis DOID_10316 2.259E-05 3.214E-04 0.29130175 0.50843771 GOZGIT_ESR1_TARGETS_DN hyperthyroidism DOID_7998 2.259E-05 3.136E-04 4.843E-03 0.04175134 GOZGIT_ESR1_TARGETS_DN leukocyte disease DOID_9500 2.397E-05 3.248E-04 2.641E-03 0.02835033 GOZGIT_ESR1_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 2.452E-05 3.244E-04 0.0106615 0.06254012 GOZGIT_ESR1_TARGETS_DN infertility DOID_5223 2.508E-05 3.244E-04 2.508E-05 1.586E-03 GOZGIT_ESR1_TARGETS_DN respiratory failure DOID_11162 3.147E-05 3.979E-04 0.02253144 0.09861838 GOZGIT_ESR1_TARGETS_DN calcinosis DOID_182 3.334E-05 4.124E-04 5.074E-04 9.313E-03 GOZGIT_ESR1_TARGETS_DN congenital heart defect DOID_1682 3.435E-05 4.159E-04 3.315E-03 0.03196656 GOZGIT_ESR1_TARGETS_DN ulcerative colitis DOID_8577 4.206E-05 4.985E-04 0.01413118 0.07657756 GOZGIT_ESR1_TARGETS_DN adenoid cystic carcinoma DOID_4866 4.768E-05 5.536E-04 4.768E-05 2.087E-03 GOZGIT_ESR1_TARGETS_DN tooth disease DOID_1091 4.805E-05 5.469E-04 4.805E-05 1.953E-03 GOZGIT_ESR1_TARGETS_DN tuberculosis DOID_399 5.209E-05 5.811E-04 0.14046469 0.31969764 GOZGIT_ESR1_TARGETS_DN salivary gland cancer DOID_8850 5.96E-05 6.522E-04 5.96E-05 2.261E-03 GOZGIT_ESR1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 6.096E-05 6.544E-04 5.931E-04 9.926E-03 GOZGIT_ESR1_TARGETS_DN bile duct disease DOID_4138 6.582E-05 6.936E-04 0.15003291 0.33609736 GOZGIT_ESR1_TARGETS_DN biliary tract disease DOID_9741 7.099E-05 7.345E-04 0.15325091 0.34195987 GOZGIT_ESR1_TARGETS_DN gallbladder cancer DOID_3121 7.371E-05 7.489E-04 9.412E-04 0.01338859 GOZGIT_ESR1_TARGETS_DN pancreatic carcinoma DOID_4905 7.648E-05 7.635E-04 7.132E-04 0.01159509 GOZGIT_ESR1_TARGETS_DN cystic fibrosis DOID_1485 8.848E-05 8.68E-04 6.017E-03 0.04755311 GOZGIT_ESR1_TARGETS_DN reading disorder DOID_13365 9.192E-05 8.865E-04 9.192E-05 2.906E-03 GOZGIT_ESR1_TARGETS_DN hypogonadism DOID_1924 9.192E-05 8.717E-04 1.747E-03 0.02160706 GOZGIT_ESR1_TARGETS_DN dyslexia DOID_4428 9.192E-05 8.865E-04 9.192E-05 2.906E-03 GOZGIT_ESR1_TARGETS_DN bone resorption disease DOID_0080011 9.501E-05 8.862E-04 6.293E-03 0.04650147 GOZGIT_ESR1_TARGETS_DN osteoporosis DOID_11476 9.501E-05 8.862E-04 6.293E-03 0.04650147 GOZGIT_ESR1_TARGETS_DN myositis DOID_633 1.071E-04 9.831E-04 0.22215748 0.4241866 GOZGIT_ESR1_TARGETS_DN pulmonary tuberculosis DOID_2957 1.202E-04 1.086E-03 0.38369488 0.63098956 GOZGIT_ESR1_TARGETS_DN craniosynostosis DOID_2340 1.229E-04 1.092E-03 0.09726997 0.26230623 GOZGIT_ESR1_TARGETS_DN vitiligo DOID_12306 1.241E-04 1.086E-03 0.02757366 0.11621787 GOZGIT_ESR1_TARGETS_DN mental depression DOID_1596 1.427E-04 1.23E-03 1.427E-04 3.867E-03 GOZGIT_ESR1_TARGETS_DN biliary tract cancer DOID_4607 1.427E-04 1.212E-03 1.184E-03 0.01603369 GOZGIT_ESR1_TARGETS_DN Sciatic Neuropathy DOID_11446 1.429E-04 1.195E-03 2.405E-03 0.02683333 GOZGIT_ESR1_TARGETS_DN gestational diabetes DOID_11714 1.429E-04 1.178E-03 2.405E-03 0.0263173 GOZGIT_ESR1_TARGETS_DN lesion of sciatic nerve DOID_12528 1.429E-04 1.195E-03 2.405E-03 0.02683333 GOZGIT_ESR1_TARGETS_DN mononeuritis of lower limb DOID_9473 1.429E-04 1.195E-03 2.405E-03 0.02683333 GOZGIT_ESR1_TARGETS_DN pituitary gland disease DOID_53 1.627E-04 1.323E-03 1.627E-04 4.025E-03 GOZGIT_ESR1_TARGETS_DN aortic valve insufficiency DOID_57 1.627E-04 1.304E-03 1.000 1.000 GOZGIT_ESR1_TARGETS_DN sarcoma DOID_1115 1.637E-04 1.293E-03 2.654E-03 0.02796683 GOZGIT_ESR1_TARGETS_DN mononeuritis DOID_1802 1.637E-04 1.276E-03 2.654E-03 0.02745834 GOZGIT_ESR1_TARGETS_DN atrophic muscular disease DOID_913 1.715E-04 1.318E-03 1.816E-03 0.02198217 GOZGIT_ESR1_TARGETS_DN muscular dystrophy DOID_9884 1.715E-04 1.318E-03 1.816E-03 0.02198217 GOZGIT_ESR1_TARGETS_DN primary bacterial infectious disease DOID_0050338 1.838E-04 1.395E-03 0.19948388 0.40537975 GOZGIT_ESR1_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 1.865E-04 1.397E-03 0.033312 0.13254915 GOZGIT_ESR1_TARGETS_DN mononeuropathy DOID_1188 1.865E-04 1.378E-03 2.919E-03 0.02965437 GOZGIT_ESR1_TARGETS_DN vasculitis DOID_865 1.865E-04 1.361E-03 0.01592736 0.07949711 GOZGIT_ESR1_TARGETS_DN pustulosis of palm and sole DOID_4398 2.026E-04 1.459E-03 0.10082815 0.26934844 GOZGIT_ESR1_TARGETS_DN polyneuropathy DOID_1389 2.101E-04 1.494E-03 0.11391352 0.28428417 GOZGIT_ESR1_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 2.116E-04 1.487E-03 0.2575318 0.46667386 GOZGIT_ESR1_TARGETS_DN uterine benign neoplasm DOID_0060095 2.116E-04 1.487E-03 0.2575318 0.46667386 GOZGIT_ESR1_TARGETS_DN corneal disease DOID_10124 2.116E-04 1.469E-03 2.116E-04 4.631E-03 GOZGIT_ESR1_TARGETS_DN uterine fibroid DOID_13223 2.116E-04 1.487E-03 0.2575318 0.46667386 GOZGIT_ESR1_TARGETS_DN dysostosis DOID_1934 2.116E-04 1.451E-03 0.03531956 0.13859884 GOZGIT_ESR1_TARGETS_DN endometrial carcinoma DOID_2871 2.116E-04 1.434E-03 0.2575318 0.46519235 GOZGIT_ESR1_TARGETS_DN nervous system cancer DOID_3093 2.204E-04 1.475E-03 1.684E-03 0.02128806 GOZGIT_ESR1_TARGETS_DN lymphoma DOID_0060058 2.478E-04 1.64E-03 0.05699773 0.18855646 GOZGIT_ESR1_TARGETS_DN oral cavity cancer DOID_8618 2.572E-04 1.682E-03 2.572E-04 5.419E-03 GOZGIT_ESR1_TARGETS_DN endometrial cancer DOID_1380 2.69E-04 1.739E-03 0.27122816 0.48378942 GOZGIT_ESR1_TARGETS_DN Crohn's disease DOID_8778 2.778E-04 1.776E-03 0.05995738 0.19494712 GOZGIT_ESR1_TARGETS_DN dilated cardiomyopathy DOID_12930 2.939E-04 1.858E-03 2.939E-04 5.972E-03 GOZGIT_ESR1_TARGETS_DN carotid artery disease DOID_3407 3.222E-04 2.015E-03 2.965E-03 0.02908384 GOZGIT_ESR1_TARGETS_DN collagen disease DOID_854 3.222E-04 1.993E-03 0.11871118 0.29114941 GOZGIT_ESR1_TARGETS_DN arthropathy DOID_381 3.296E-04 2.017E-03 0.13025106 0.30880356 GOZGIT_ESR1_TARGETS_DN adrenal cortex disease DOID_3952 3.296E-04 1.995E-03 0.13025106 0.30752222 GOZGIT_ESR1_TARGETS_DN metal metabolism disorder DOID_896 3.367E-04 2.017E-03 0.04379643 0.15974467 GOZGIT_ESR1_TARGETS_DN esophageal disease DOID_6050 3.748E-04 2.221E-03 0.04602235 0.1616464 GOZGIT_ESR1_TARGETS_DN cholestasis DOID_13580 4.274E-04 2.507E-03 0.4690432 0.75819766 GOZGIT_ESR1_TARGETS_DN Graves' disease DOID_12361 4.859E-04 2.821E-03 0.0106048 0.06488315 GOZGIT_ESR1_TARGETS_DN juvenile rheumatoid arthritis DOID_676 4.859E-04 2.793E-03 1.000 1.000 GOZGIT_ESR1_TARGETS_DN adrenal gland disease DOID_9553 4.859E-04 2.765E-03 0.14628822 0.33030951 GOZGIT_ESR1_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 5.219E-04 2.94E-03 0.02832042 0.11762275 GOZGIT_ESR1_TARGETS_DN sexual dysfunction DOID_1876 5.791E-04 3.231E-03 5.791E-04 0.01029733 GOZGIT_ESR1_TARGETS_DN ureteral obstruction DOID_5199 5.791E-04 3.199E-03 0.15419588 0.34272443 GOZGIT_ESR1_TARGETS_DN hepatitis DOID_2237 6.125E-04 3.351E-03 0.05774458 0.18992294 GOZGIT_ESR1_TARGETS_DN congenital diaphragmatic hernia DOID_3827 6.125E-04 3.319E-03 6.916E-03 0.04981406 GOZGIT_ESR1_TARGETS_DN peptic ulcer DOID_750 6.125E-04 3.288E-03 0.05774458 0.18883143 GOZGIT_ESR1_TARGETS_DN adult respiratory distress syndrome DOID_11394 6.704E-04 3.565E-03 0.32980988 0.55851732 GOZGIT_ESR1_TARGETS_DN peripheral vascular disease DOID_341 6.713E-04 3.537E-03 0.03257609 0.13053378 GOZGIT_ESR1_TARGETS_DN diabetic retinopathy DOID_8947 7.132E-04 3.723E-03 0.15648231 0.34645305 GOZGIT_ESR1_TARGETS_DN endogenous depression DOID_1595 8.028E-04 4.153E-03 8.028E-04 0.01234633 GOZGIT_ESR1_TARGETS_DN aneurysm disease DOID_2403 8.507E-04 4.361E-03 0.03714569 0.14476641 GOZGIT_ESR1_TARGETS_DN rheumatic disease DOID_1575 8.674E-04 4.407E-03 0.06777935 0.21545504 GOZGIT_ESR1_TARGETS_DN uveal disease DOID_3480 8.674E-04 4.368E-03 0.06777935 0.21074564 GOZGIT_ESR1_TARGETS_DN scleroderma DOID_419 8.674E-04 4.407E-03 0.06777935 0.21545504 GOZGIT_ESR1_TARGETS_DN electroclinical syndrome DOID_0050701 9.006E-04 4.495E-03 9.006E-04 0.01313922 GOZGIT_ESR1_TARGETS_DN uterine cancer DOID_363 9.412E-04 4.657E-03 0.35431556 0.59295751 GOZGIT_ESR1_TARGETS_DN influenza DOID_8469 9.412E-04 4.617E-03 0.07037207 0.21761798 GOZGIT_ESR1_TARGETS_DN learning disability DOID_8927 1.019E-03 4.957E-03 1.019E-03 0.01414647 GOZGIT_ESR1_TARGETS_DN hepatitis B DOID_2043 1.063E-03 5.128E-03 0.01747353 0.08425793 GOZGIT_ESR1_TARGETS_DN neuritis DOID_1803 1.189E-03 5.686E-03 0.01118522 0.06428679 GOZGIT_ESR1_TARGETS_DN sexual disorder DOID_0060043 1.215E-03 5.759E-03 1.215E-03 0.01607114 GOZGIT_ESR1_TARGETS_DN urinary tract obstruction DOID_5200 1.215E-03 5.711E-03 0.19265195 0.39573631 GOZGIT_ESR1_TARGETS_DN retinal vascular disease DOID_2462 1.313E-03 6.125E-03 0.19276891 0.39313802 GOZGIT_ESR1_TARGETS_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.378E-03 6.373E-03 0.08379883 0.24705458 GOZGIT_ESR1_TARGETS_DN synostosis DOID_11971 1.379E-03 6.326E-03 0.20013134 0.4038111 GOZGIT_ESR1_TARGETS_DN Lewy body dementia DOID_12217 1.379E-03 6.275E-03 0.02062595 0.09241077 GOZGIT_ESR1_TARGETS_DN ureteral disease DOID_1426 1.379E-03 6.225E-03 0.20013134 0.40238421 GOZGIT_ESR1_TARGETS_DN giant cell tumor DOID_200 1.816E-03 8.135E-03 0.01519112 0.07717631 GOZGIT_ESR1_TARGETS_DN malignant giant cell tumor DOID_2705 1.816E-03 8.135E-03 0.01519112 0.07717631 GOZGIT_ESR1_TARGETS_DN giant cell glioblastoma DOID_3074 1.816E-03 8.135E-03 0.01519112 0.07717631 GOZGIT_ESR1_TARGETS_DN autosomal dominant nonsyndromic deafness DOID_0050564 1.952E-03 8.676E-03 1.952E-03 0.02266421 GOZGIT_ESR1_TARGETS_DN spinal muscular atrophy DOID_12377 1.952E-03 8.609E-03 0.22215748 0.42995785 GOZGIT_ESR1_TARGETS_DN ankylosing spondylitis DOID_7147 1.952E-03 8.543E-03 1.000 1.000 GOZGIT_ESR1_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 2.067E-03 8.979E-03 0.41719566 0.67824094 GOZGIT_ESR1_TARGETS_DN intracranial aneurysm DOID_10941 2.171E-03 9.359E-03 0.02757366 0.11708517 GOZGIT_ESR1_TARGETS_DN myopia DOID_11830 2.171E-03 9.288E-03 2.171E-03 0.02470681 GOZGIT_ESR1_TARGETS_DN hypotrichosis DOID_4535 2.171E-03 9.219E-03 0.22936429 0.43214663 GOZGIT_ESR1_TARGETS_DN lung adenocarcinoma DOID_3910 2.405E-03 0.01013703 0.029438 0.12050519 GOZGIT_ESR1_TARGETS_DN migraine DOID_6364 2.405E-03 0.0100625 0.029438 0.11964444 GOZGIT_ESR1_TARGETS_DN glioblastoma DOID_3068 2.488E-03 0.01033444 0.01907033 0.08750819 GOZGIT_ESR1_TARGETS_DN toxic encephalopathy DOID_3602 2.919E-03 0.01203366 0.033312 0.13162867 GOZGIT_ESR1_TARGETS_DN cranial nerve disease DOID_5656 2.919E-03 0.01194709 0.25058766 0.45554115 GOZGIT_ESR1_TARGETS_DN hypothyroidism DOID_1459 3.136E-03 0.01274679 0.02253144 0.09786556 GOZGIT_ESR1_TARGETS_DN pre-malignant neoplasm DOID_0060071 3.315E-03 0.01337608 0.02344652 0.10106873 GOZGIT_ESR1_TARGETS_DN in situ carcinoma DOID_8719 3.315E-03 0.01337608 0.02344652 0.10106873 GOZGIT_ESR1_TARGETS_DN age related macular degeneration DOID_10871 3.495E-03 0.01400263 0.03737279 0.14368324 GOZGIT_ESR1_TARGETS_DN degeneration of macula and posterior pole DOID_2007 3.495E-03 0.01400263 0.03737279 0.14368324 GOZGIT_ESR1_TARGETS_DN Sjogren's syndrome DOID_12894 3.662E-03 0.01457176 1.000 1.000 GOZGIT_ESR1_TARGETS_DN acute kidney failure DOID_3021 3.662E-03 0.01447056 0.08883167 0.25272611 GOZGIT_ESR1_TARGETS_DN insulinoma DOID_3892 3.662E-03 0.01437077 3.662E-03 0.03416002 GOZGIT_ESR1_TARGETS_DN adrenal gland hyperfunction DOID_3947 3.662E-03 0.01427234 0.08883167 0.24899124 GOZGIT_ESR1_TARGETS_DN cerebral degeneration DOID_1443 3.692E-03 0.01428994 0.13103671 0.30809872 GOZGIT_ESR1_TARGETS_DN celiac disease DOID_10608 3.807E-03 0.01463504 0.03947068 0.14972543 GOZGIT_ESR1_TARGETS_DN allergic contact dermatitis DOID_3042 4.097E-03 0.01564559 0.1373057 0.32019239 GOZGIT_ESR1_TARGETS_DN pleural disease DOID_1532 4.135E-03 0.01568643 0.27798157 0.49274615 GOZGIT_ESR1_TARGETS_DN autonomic nervous system neoplasm DOID_2621 4.135E-03 0.01558254 4.135E-03 0.03734864 GOZGIT_ESR1_TARGETS_DN neuroblastoma DOID_769 4.135E-03 0.01558254 4.135E-03 0.03734864 GOZGIT_ESR1_TARGETS_DN nervous system benign neoplasm DOID_0060115 4.449E-03 0.01665318 0.09726997 0.26737495 GOZGIT_ESR1_TARGETS_DN eosinophilic pneumonia DOID_5870 4.449E-03 0.01654433 1.000 1.000 GOZGIT_ESR1_TARGETS_DN speech disorder DOID_92 4.449E-03 0.0164369 4.449E-03 0.03955129 GOZGIT_ESR1_TARGETS_DN pulmonary eosinophilia DOID_9498 4.449E-03 0.01654433 1.000 1.000 GOZGIT_ESR1_TARGETS_DN Loeffler syndrome DOID_9503 4.449E-03 0.01654433 1.000 1.000 GOZGIT_ESR1_TARGETS_DN bronchiectasis DOID_9563 4.449E-03 0.01633086 0.09726997 0.26106894 GOZGIT_ESR1_TARGETS_DN hair disease DOID_421 4.481E-03 0.01634265 0.28467257 0.49839599 GOZGIT_ESR1_TARGETS_DN myocarditis DOID_820 4.481E-03 0.01623855 0.04379643 0.16077528 GOZGIT_ESR1_TARGETS_DN astrocytoma DOID_3069 4.531E-03 0.01631823 0.02935473 0.12103507 GOZGIT_ESR1_TARGETS_DN male infertility DOID_12336 4.843E-03 0.01733074 0.04602235 0.16573871 GOZGIT_ESR1_TARGETS_DN nephroblastoma DOID_2154 4.843E-03 0.01722243 0.04602235 0.16469633 GOZGIT_ESR1_TARGETS_DN thyroid carcinoma DOID_3963 4.843E-03 0.01711546 0.04602235 0.16366698 GOZGIT_ESR1_TARGETS_DN spindle cell carcinoma DOID_4015 4.843E-03 0.01700981 0.29130175 0.5038015 GOZGIT_ESR1_TARGETS_DN macular degeneration DOID_4448 4.843E-03 0.01690545 0.04602235 0.16265041 GOZGIT_ESR1_TARGETS_DN leukopenia DOID_615 4.843E-03 0.01680237 4.843E-03 0.04239367 GOZGIT_ESR1_TARGETS_DN nephrosis DOID_2527 4.995E-03 0.01722672 0.15003291 0.3374258 GOZGIT_ESR1_TARGETS_DN medullomyoblastoma DOID_3861 5.222E-03 0.01790061 0.04828902 0.16652394 GOZGIT_ESR1_TARGETS_DN adult medulloblastoma DOID_3864 5.222E-03 0.01790061 0.04828902 0.16652394 GOZGIT_ESR1_TARGETS_DN childhood medulloblastoma DOID_3869 5.222E-03 0.01790061 0.04828902 0.16652394 GOZGIT_ESR1_TARGETS_DN ovarian disease DOID_1100 5.306E-03 0.01807798 5.306E-03 0.0443974 GOZGIT_ESR1_TARGETS_DN aortic valve stenosis DOID_1712 5.306E-03 0.01797038 1.000 1.000 GOZGIT_ESR1_TARGETS_DN islet cell tumor DOID_1799 5.306E-03 0.01786404 5.306E-03 0.04375396 GOZGIT_ESR1_TARGETS_DN thyroid cancer DOID_1781 5.619E-03 0.01880773 0.05059549 0.17342672 GOZGIT_ESR1_TARGETS_DN adenoma DOID_657 5.619E-03 0.01869774 5.619E-03 0.04567592 GOZGIT_ESR1_TARGETS_DN refractive error DOID_9835 5.619E-03 0.01858904 5.619E-03 0.04503259 GOZGIT_ESR1_TARGETS_DN medulloblastoma DOID_3858 6.034E-03 0.01984478 0.05294085 0.17824465 GOZGIT_ESR1_TARGETS_DN variable age at onset electroclinical syndrome DOID_0050706 6.232E-03 0.02038048 6.232E-03 0.04857814 GOZGIT_ESR1_TARGETS_DN Hirschsprung's disease DOID_10487 6.232E-03 0.02026402 6.232E-03 0.04792168 GOZGIT_ESR1_TARGETS_DN major depressive disorder DOID_1470 6.232E-03 0.02014889 6.232E-03 0.04728272 GOZGIT_ESR1_TARGETS_DN impotence DOID_1875 6.232E-03 0.02003505 6.232E-03 0.04666058 GOZGIT_ESR1_TARGETS_DN peripheral nervous system neoplasm DOID_1192 6.466E-03 0.02066916 6.466E-03 0.04716807 GOZGIT_ESR1_TARGETS_DN uveitis DOID_13141 6.466E-03 0.02055369 0.31721145 0.54039914 GOZGIT_ESR1_TARGETS_DN bacterial pneumonia DOID_874 6.577E-03 0.02078943 0.16953161 0.365392 GOZGIT_ESR1_TARGETS_DN systemic scleroderma DOID_418 6.916E-03 0.02174205 0.32353991 0.54953495 GOZGIT_ESR1_TARGETS_DN metabolic syndrome X DOID_14221 7.169E-03 0.02241417 0.17612351 0.37393386 GOZGIT_ESR1_TARGETS_DN lipid metabolism disorder DOID_3146 7.169E-03 0.02229169 0.04077652 0.15365458 GOZGIT_ESR1_TARGETS_DN alcohol dependence DOID_0050741 7.227E-03 0.02234814 0.12212019 0.29822483 GOZGIT_ESR1_TARGETS_DN open-angle glaucoma DOID_1067 7.227E-03 0.02222734 7.227E-03 0.05076614 GOZGIT_ESR1_TARGETS_DN megacolon DOID_11372 7.227E-03 0.02210784 7.227E-03 0.05014704 GOZGIT_ESR1_TARGETS_DN hypercalcemia DOID_12678 7.227E-03 0.02198961 7.227E-03 0.04954286 GOZGIT_ESR1_TARGETS_DN lymphatic system disease DOID_75 7.385E-03 0.02235026 7.385E-03 0.05002201 GOZGIT_ESR1_TARGETS_DN chromosomal disease DOID_0080014 7.479E-03 0.02251477 7.479E-03 0.05006226 GOZGIT_ESR1_TARGETS_DN auditory system disease DOID_2742 7.796E-03 0.02334804 0.04329293 0.15995895 GOZGIT_ESR1_TARGETS_DN pulmonary emphysema DOID_9675 7.871E-03 0.02344932 1.000 1.000 GOZGIT_ESR1_TARGETS_DN skeletal system cancer DOID_0060124 8.288E-03 0.02456159 0.13025106 0.31271246 GOZGIT_ESR1_TARGETS_DN bone cancer DOID_184 8.288E-03 0.02456159 0.13025106 0.31271246 GOZGIT_ESR1_TARGETS_DN communication disorder DOID_2033 8.288E-03 0.02443433 8.288E-03 0.05420489 GOZGIT_ESR1_TARGETS_DN lung oat cell carcinoma DOID_5411 8.288E-03 0.02430838 8.288E-03 0.05358893 GOZGIT_ESR1_TARGETS_DN panic disorder DOID_594 8.288E-03 0.02418372 8.288E-03 0.05298681 GOZGIT_ESR1_TARGETS_DN primitive neuroectodermal tumor DOID_168 8.901E-03 0.02583886 0.06777935 0.21425807 GOZGIT_ESR1_TARGETS_DN silicosis DOID_10325 9.414E-03 0.02719169 0.13830684 0.32121059 GOZGIT_ESR1_TARGETS_DN hemolytic-uremic syndrome DOID_12554 9.414E-03 0.02705436 0.13830684 0.31990485 GOZGIT_ESR1_TARGETS_DN Barrett's esophagus DOID_9206 9.414E-03 0.02691841 9.414E-03 0.05951959 GOZGIT_ESR1_TARGETS_DN primary immunodeficiency disease DOID_612 0.01027115 0.02922143 0.052693 0.17953483 GOZGIT_ESR1_TARGETS_DN leukodystrophy DOID_10579 0.01058546 0.02996579 0.07565253 0.23268265 GOZGIT_ESR1_TARGETS_DN schizophreniform disorder DOID_11328 0.0106048 0.02987195 0.0106048 0.06558841 GOZGIT_ESR1_TARGETS_DN penile disease DOID_1529 0.0106048 0.02972479 0.0106048 0.06419291 GOZGIT_ESR1_TARGETS_DN hyperostosis DOID_205 0.0106048 0.02957908 0.0106048 0.06351719 GOZGIT_ESR1_TARGETS_DN schizoaffective disorder DOID_5418 0.0106048 0.02987195 0.0106048 0.06558841 GOZGIT_ESR1_TARGETS_DN urinary system benign neoplasm DOID_731 0.0106048 0.0294348 0.0106048 0.06285555 GOZGIT_ESR1_TARGETS_DN brain cancer DOID_1319 0.01118522 0.03089511 0.07833867 0.23964894 GOZGIT_ESR1_TARGETS_DN thyroid adenoma DOID_2891 0.01118522 0.03074586 0.07833867 0.2383674 GOZGIT_ESR1_TARGETS_DN vascular skin disease DOID_9540 0.01118522 0.03059804 0.07833867 0.23584499 GOZGIT_ESR1_TARGETS_DN central nervous system cancer DOID_3620 0.01180424 0.0321369 0.08105436 0.24146561 GOZGIT_ESR1_TARGETS_DN hemolytic anemia DOID_583 0.01180424 0.03198387 0.08105436 0.24020797 GOZGIT_ESR1_TARGETS_DN normocytic anemia DOID_720 0.01180424 0.03198387 0.08105436 0.24020797 GOZGIT_ESR1_TARGETS_DN congenital muscular dystrophy DOID_0050557 0.01185802 0.0319773 0.01185802 0.06680407 GOZGIT_ESR1_TARGETS_DN eosinophilia DOID_999 0.01185802 0.03182647 1.000 1.000 GOZGIT_ESR1_TARGETS_DN lymphoblastic leukemia DOID_1037 0.01188958 0.03176137 0.58718656 0.93850886 GOZGIT_ESR1_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 0.01275663 0.03391834 0.59481439 0.94538935 GOZGIT_ESR1_TARGETS_DN movement disease DOID_480 0.01310039 0.03467034 0.01310039 0.07307963 GOZGIT_ESR1_TARGETS_DN conduct disorder DOID_12995 0.01317272 0.03470037 0.1620305 0.35596662 GOZGIT_ESR1_TARGETS_DN agammaglobulinemia DOID_2583 0.01317272 0.03454046 0.1620305 0.35189066 GOZGIT_ESR1_TARGETS_DN testicular cancer DOID_2998 0.01317272 0.03438202 0.01317272 0.07276971 GOZGIT_ESR1_TARGETS_DN granulosa cell tumor DOID_2999 0.01317272 0.03422502 0.01317272 0.07207 GOZGIT_ESR1_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 0.01377769 0.03563413 0.08937107 0.24685505 GOZGIT_ESR1_TARGETS_DN atopic dermatitis DOID_3310 0.01447458 0.03726714 0.40067864 0.65325543 GOZGIT_ESR1_TARGETS_DN pulmonary edema DOID_11396 0.01454769 0.03728665 0.01454769 0.0780909 GOZGIT_ESR1_TARGETS_DN limb-girdle muscular dystrophy DOID_11724 0.01454769 0.03711944 0.01454769 0.07736108 GOZGIT_ESR1_TARGETS_DN colon carcinoma DOID_1520 0.01454769 0.03695373 0.01454769 0.07664477 GOZGIT_ESR1_TARGETS_DN sex cord-gonadal stromal tumor DOID_192 0.01454769 0.03678949 0.01454769 0.07594161 GOZGIT_ESR1_TARGETS_DN colonic disease DOID_5353 0.01454769 0.03662671 0.01454769 0.07525123 GOZGIT_ESR1_TARGETS_DN blood protein disease DOID_620 0.01454769 0.03646536 0.16979275 0.36184298 GOZGIT_ESR1_TARGETS_DN amyloidosis DOID_9120 0.01454769 0.03630542 0.01454769 0.07457329 GOZGIT_ESR1_TARGETS_DN alopecia DOID_987 0.01454769 0.03614688 1.000 1.000 GOZGIT_ESR1_TARGETS_DN sarcoidosis DOID_11335 0.01519112 0.03758151 1.000 1.000 GOZGIT_ESR1_TARGETS_DN bile duct adenocarcinoma DOID_4896 0.01592736 0.03923234 0.01592736 0.08020062 GOZGIT_ESR1_TARGETS_DN cholangiocarcinoma DOID_4947 0.01592736 0.03923234 0.01592736 0.08020062 GOZGIT_ESR1_TARGETS_DN bone marrow cancer DOID_4960 0.01592736 0.03906323 1.000 1.000 GOZGIT_ESR1_TARGETS_DN autoimmune hepatitis DOID_2048 0.01598169 0.03902825 1.000 1.000 GOZGIT_ESR1_TARGETS_DN smallpox DOID_8736 0.01668337 0.04056768 0.01668337 0.0825464 GOZGIT_ESR1_TARGETS_DN familial hyperlipidemia DOID_1168 0.01745917 0.04227348 0.10375338 0.27586762 GOZGIT_ESR1_TARGETS_DN gastric ulcer DOID_10808 0.01747353 0.04212897 0.01747353 0.08571065 GOZGIT_ESR1_TARGETS_DN neutropenia DOID_1227 0.01747353 0.04195121 0.01747353 0.08497808 GOZGIT_ESR1_TARGETS_DN thrombophilia DOID_2452 0.01747353 0.04177494 0.18510282 0.38721876 GOZGIT_ESR1_TARGETS_DN congenital nervous system abnormality DOID_2490 0.01825481 0.04346021 0.01825481 0.08728563 GOZGIT_ESR1_TARGETS_DN agranulocytosis DOID_12987 0.019022 0.045098 0.019022 0.090196 GOZGIT_ESR1_TARGETS_DN optic nerve disease DOID_1891 0.019022 0.04491087 1.000 1.000 GOZGIT_ESR1_TARGETS_DN opiate dependence DOID_2559 0.019022 0.04472529 0.019022 0.08945057 GOZGIT_ESR1_TARGETS_DN myasthenia gravis DOID_437 0.019022 0.04454123 0.19265195 0.39717014 GOZGIT_ESR1_TARGETS_DN pulmonary embolism DOID_9477 0.019022 0.04435869 1.000 1.000 GOZGIT_ESR1_TARGETS_DN polyarteritis nodosa DOID_9810 0.019022 0.04417763 0.019022 0.08871737 GOZGIT_ESR1_TARGETS_DN nonsyndromic deafness DOID_0050563 0.01907033 0.04410982 0.01907033 0.08821964 GOZGIT_ESR1_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 0.01907033 0.04393124 0.10967216 0.27858686 GOZGIT_ESR1_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 0.01907033 0.0437541 1.000 1.000 GOZGIT_ESR1_TARGETS_DN bile duct cancer DOID_4606 0.01907033 0.04357838 0.01907033 0.08680813 GOZGIT_ESR1_TARGETS_DN bile duct carcinoma DOID_4897 0.01907033 0.04357838 0.01907033 0.08680813 GOZGIT_ESR1_TARGETS_DN melancholia DOID_2848 0.01990573 0.04530544 0.01990573 0.08989175 GOZGIT_ESR1_TARGETS_DN Goodpasture syndrome DOID_9808 0.02062595 0.04675764 0.20013134 0.39956046 GOZGIT_ESR1_TARGETS_DN neurotic disorder DOID_4964 0.02076104 0.04687712 0.02076104 0.09228933 GOZGIT_ESR1_TARGETS_DN neuroectodermal tumor DOID_171 0.02163628 0.04866025 0.11871118 0.2924098 GOZGIT_ESR1_TARGETS_DN spastic quadriplegia DOID_10970 0.02228422 0.04992017 0.02228422 0.09829243 GOZGIT_ESR1_TARGETS_DN portal hypertension DOID_10762 0.02399568 0.05354329 0.21488347 0.41872841 GOZGIT_ESR1_TARGETS_DN bronchiolitis DOID_2942 0.02399568 0.05333414 1.000 1.000 GOZGIT_ESR1_TARGETS_DN osteosarcoma DOID_3347 0.02399568 0.05312661 0.21488347 0.4172993 GOZGIT_ESR1_TARGETS_DN endocrine pancreas disease DOID_1428 0.02438153 0.05377167 0.12792788 0.30974879 GOZGIT_ESR1_TARGETS_DN morbid obesity DOID_11981 0.02575919 0.05659065 0.02575919 0.11020285 GOZGIT_ESR1_TARGETS_DN neuromuscular junction disease DOID_439 0.02575919 0.056373 0.22215748 0.42561484 GOZGIT_ESR1_TARGETS_DN hyperglycemia DOID_4195 0.02631124 0.05736052 0.13416285 0.31415086 GOZGIT_ESR1_TARGETS_DN B cell deficiency DOID_2115 0.02757366 0.05988326 0.22936429 0.43502761 GOZGIT_ESR1_TARGETS_DN spinal cord disease DOID_319 0.02757366 0.05965556 1.000 1.000 GOZGIT_ESR1_TARGETS_DN juvenile myoclonic epilepsy DOID_4890 0.02757366 0.05942959 0.02757366 0.11536333 GOZGIT_ESR1_TARGETS_DN pleurisy DOID_10247 0.03135113 0.0673162 1.000 1.000 GOZGIT_ESR1_TARGETS_DN hepatic vascular disease DOID_272 0.03135113 0.06706313 0.24357877 0.45292915 GOZGIT_ESR1_TARGETS_DN invasive ductal carcinoma DOID_3008 0.03135113 0.06681196 1.000 1.000 GOZGIT_ESR1_TARGETS_DN coronary stenosis DOID_4248 0.03135113 0.06656266 0.03135113 0.12651627 GOZGIT_ESR1_TARGETS_DN autoimmune disease of the nervous system DOID_438 0.03135113 0.06631522 0.24357877 0.45145381 GOZGIT_ESR1_TARGETS_DN supratentorial cancer DOID_1659 0.033312 0.07020196 0.25058766 0.45994961 GOZGIT_ESR1_TARGETS_DN cerebrum cancer DOID_368 0.033312 0.07020196 0.25058766 0.45994961 GOZGIT_ESR1_TARGETS_DN focal glomerulosclerosis DOID_3945 0.033312 0.06994291 0.25058766 0.45847068 GOZGIT_ESR1_TARGETS_DN spastic cerebral palsy DOID_0050669 0.03737279 0.07818058 0.03737279 0.14466067 GOZGIT_ESR1_TARGETS_DN opportunistic mycosis DOID_2473 0.03737279 0.07789421 0.26441176 0.47610852 GOZGIT_ESR1_TARGETS_DN bronchiolitis obliterans DOID_2799 0.03737279 0.07760992 1.000 1.000 GOZGIT_ESR1_TARGETS_DN germinoma DOID_3304 0.03947068 0.08166842 0.27122816 0.48227757 GOZGIT_ESR1_TARGETS_DN allergic rhinitis DOID_4481 0.03947068 0.08137252 1.000 1.000 GOZGIT_ESR1_TARGETS_DN chronic leukemia DOID_1036 0.04161222 0.0854778 1.000 1.000 GOZGIT_ESR1_TARGETS_DN chronic lymphocytic leukemia DOID_1040 0.04161222 0.0854778 1.000 1.000 GOZGIT_ESR1_TARGETS_DN childhood absence epilepsy DOID_1825 0.04161222 0.08517033 0.04161222 0.15475393 GOZGIT_ESR1_TARGETS_DN systemic mycosis DOID_0050136 0.04379643 0.0893196 0.28467257 0.50148203 GOZGIT_ESR1_TARGETS_DN fungal infectious disease DOID_1564 0.04379643 0.0893196 0.28467257 0.50148203 GOZGIT_ESR1_TARGETS_DN alcohol abuse DOID_1574 0.04457964 0.0905922 0.04457964 0.16156571 GOZGIT_ESR1_TARGETS_DN childhood electroclinical syndrome DOID_0050704 0.04828902 0.09778096 0.04828902 0.16856718 GOZGIT_ESR1_TARGETS_DN lymphoid leukemia DOID_10747 0.04828902 0.09743422 0.29786966 0.51204784 GOZGIT_ESR1_TARGETS_DN aplastic anemia DOID_12449 0.04828902 0.09708993 0.04828902 0.16753933 DING_LUNG_CANCER_MUTATED_FREQUENTLY nervous system cancer DOID_3093 6.743E-09 3.837E-06 1.639E-06 9.327E-04 DING_LUNG_CANCER_MUTATED_FREQUENTLY benign mesothelioma DOID_2645 1.74E-07 4.951E-05 5.889E-05 8.377E-03 DING_LUNG_CANCER_MUTATED_FREQUENTLY astrocytoma DOID_3069 7.807E-07 1.481E-04 1.585E-04 0.01803636 DING_LUNG_CANCER_MUTATED_FREQUENTLY breast benign neoplasm DOID_0060082 3.44E-06 4.893E-04 2.898E-03 0.18322372 DING_LUNG_CANCER_MUTATED_FREQUENTLY thoracic benign neoplasm DOID_0060097 3.44E-06 4.893E-04 2.898E-03 0.18322372 DING_LUNG_CANCER_MUTATED_FREQUENTLY benign breast phyllodes tumor DOID_1631 3.44E-06 4.893E-04 2.898E-03 0.18322372 DING_LUNG_CANCER_MUTATED_FREQUENTLY mesenchymal cell neoplasm DOID_3350 6.563E-06 7.469E-04 3.95E-03 0.20432614 DING_LUNG_CANCER_MUTATED_FREQUENTLY spindle cell sarcoma DOID_4235 6.563E-06 7.469E-04 3.95E-03 0.20432614 DING_LUNG_CANCER_MUTATED_FREQUENTLY epithelioid sarcoma DOID_6193 6.563E-06 7.469E-04 3.95E-03 0.20432614 DING_LUNG_CANCER_MUTATED_FREQUENTLY colon carcinoma DOID_1520 1.187E-05 1.125E-03 5.264E-03 0.23038507 DING_LUNG_CANCER_MUTATED_FREQUENTLY subependymal glioma DOID_4843 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY pilocytic astrocytoma DOID_4851 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY subependymal giant cell astrocytoma DOID_5077 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY fibrillary astrocytoma DOID_6726 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY juvenile pilocytic astrocytoma DOID_6811 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY childhood pilocytic astrocytoma DOID_6812 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY gemistocytic astrocytoma DOID_7005 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY childhood cerebral astrocytoma DOID_7007 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY protoplasmic astrocytoma DOID_7008 1.187E-05 9.647E-04 5.264E-03 0.21392899 DING_LUNG_CANCER_MUTATED_FREQUENTLY benign glioma DOID_0060101 1.442E-05 1.026E-03 5.789E-03 0.20585779 DING_LUNG_CANCER_MUTATED_FREQUENTLY benign ependymoma DOID_4844 1.442E-05 1.026E-03 5.789E-03 0.20585779 DING_LUNG_CANCER_MUTATED_FREQUENTLY osteosarcoma DOID_3347 2.028E-05 1.282E-03 6.838E-03 0.22886687 DING_LUNG_CANCER_MUTATED_FREQUENTLY papillary adenoma DOID_3172 2.19E-05 1.246E-03 7.1E-03 0.22443895 DING_LUNG_CANCER_MUTATED_FREQUENTLY microcystic adenoma DOID_5403 2.19E-05 1.246E-03 7.1E-03 0.22443895 DING_LUNG_CANCER_MUTATED_FREQUENTLY follicular adenoma DOID_6204 2.19E-05 1.246E-03 7.1E-03 0.22443895 DING_LUNG_CANCER_MUTATED_FREQUENTLY seminoma DOID_4440 2.358E-05 1.22E-03 2.358E-05 6.71E-03 DING_LUNG_CANCER_MUTATED_FREQUENTLY sarcoma DOID_1115 2.713E-05 1.287E-03 7.886E-03 0.22435908 DING_LUNG_CANCER_MUTATED_FREQUENTLY supratentorial cancer DOID_1659 2.9E-05 1.269E-03 8.148E-03 0.22077164 DING_LUNG_CANCER_MUTATED_FREQUENTLY cerebrum cancer DOID_368 2.9E-05 1.269E-03 8.148E-03 0.22077164 DING_LUNG_CANCER_MUTATED_FREQUENTLY germinoma DOID_3304 3.497E-05 1.421E-03 3.497E-05 6.633E-03 DING_LUNG_CANCER_MUTATED_FREQUENTLY papilloma DOID_2615 3.926E-05 1.489E-03 9.457E-03 0.23394725 DING_LUNG_CANCER_MUTATED_FREQUENTLY adenoma DOID_657 4.616E-05 1.642E-03 0.01024097 0.21581896 DING_LUNG_CANCER_MUTATED_FREQUENTLY peripheral nervous system neoplasm DOID_1192 5.107E-05 1.709E-03 0.01076359 0.2041495 DING_LUNG_CANCER_MUTATED_FREQUENTLY brain cancer DOID_1319 7.619E-05 2.409E-03 0.01311233 0.19633991 DING_LUNG_CANCER_MUTATED_FREQUENTLY thyroid adenoma DOID_2891 7.619E-05 2.282E-03 0.01311233 0.19130555 DING_LUNG_CANCER_MUTATED_FREQUENTLY central nervous system cancer DOID_3620 7.929E-05 2.256E-03 0.01337299 0.19023081 DING_LUNG_CANCER_MUTATED_FREQUENTLY lung small cell carcinoma DOID_5409 8.245E-05 2.234E-03 0.01363359 0.18920764 DING_LUNG_CANCER_MUTATED_FREQUENTLY bile duct adenocarcinoma DOID_4896 9.917E-05 2.565E-03 0.01493566 0.19763693 DING_LUNG_CANCER_MUTATED_FREQUENTLY cholangiocarcinoma DOID_4947 9.917E-05 2.565E-03 0.01493566 0.19763693 DING_LUNG_CANCER_MUTATED_FREQUENTLY bile duct cancer DOID_4606 1.136E-04 2.812E-03 0.01597619 0.19341392 DING_LUNG_CANCER_MUTATED_FREQUENTLY bile duct carcinoma DOID_4897 1.136E-04 2.812E-03 0.01597619 0.19341392 DING_LUNG_CANCER_MUTATED_FREQUENTLY endocrine organ benign neoplasm DOID_0060089 1.541E-04 3.654E-03 0.01857321 0.1993992 DING_LUNG_CANCER_MUTATED_FREQUENTLY pancreatic carcinoma DOID_4905 1.766E-04 4.02E-03 0.01986941 0.20555804 DING_LUNG_CANCER_MUTATED_FREQUENTLY biliary tract cancer DOID_4607 2.21E-04 4.836E-03 0.02219867 0.21777665 DING_LUNG_CANCER_MUTATED_FREQUENTLY rectal neoplasm DOID_1984 2.635E-03 0.05552893 2.635E-03 0.24988019 DING_LUNG_CANCER_MUTATED_FREQUENTLY rectum cancer DOID_1993 2.635E-03 0.05552893 2.635E-03 0.24988019 DING_LUNG_CANCER_MUTATED_FREQUENTLY alopecia areata DOID_986 2.635E-03 0.05354575 2.635E-03 0.21418302 DING_LUNG_CANCER_MUTATED_FREQUENTLY familial adenomatous polyposis DOID_0050424 2.898E-03 0.05686253 2.898E-03 0.20612669 DING_LUNG_CANCER_MUTATED_FREQUENTLY intracranial arteriosclerosis DOID_13097 3.161E-03 0.05995701 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY vascular dementia DOID_8725 3.161E-03 0.05995701 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY vulva cancer DOID_1245 3.424E-03 0.0628507 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY Lynch syndrome DOID_3883 3.424E-03 0.06088661 3.424E-03 0.19483716 DING_LUNG_CANCER_MUTATED_FREQUENTLY lung oat cell carcinoma DOID_5411 3.95E-03 0.06810871 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY angiosarcoma DOID_0001816 4.213E-03 0.07050418 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY tongue cancer DOID_8649 4.213E-03 0.06848978 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY basal cell carcinoma DOID_2513 4.476E-03 0.07074059 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY male reproductive organ benign neoplasm DOID_0060087 4.738E-03 0.07286879 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY keratosis DOID_161 4.738E-03 0.07095119 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY skin carcinoma DOID_3451 4.738E-03 0.06913192 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY testicular cancer DOID_2998 5.001E-03 0.07113983 5.001E-03 0.23713277 DING_LUNG_CANCER_MUTATED_FREQUENTLY infertility DOID_5223 5.001E-03 0.06940471 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY alopecia DOID_987 5.264E-03 0.07130966 5.264E-03 0.19966706 DING_LUNG_CANCER_MUTATED_FREQUENTLY coronary restenosis DOID_4247 5.526E-03 0.07312519 1.000 1.000 DING_LUNG_CANCER_MUTATED_FREQUENTLY hypotrichosis DOID_4535 7.362E-03 0.09520523 7.362E-03 0.22047527 DING_LUNG_CANCER_MUTATED_FREQUENTLY coronary stenosis DOID_4248 7.886E-03 0.09971515 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN aneurysm disease DOID_2403 1.852E-18 1.054E-15 6.851E-11 1.949E-08 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN transitional cell carcinoma DOID_2671 4.34E-13 1.235E-10 1.552E-06 8.83E-05 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN leiomyoma DOID_127 7.111E-13 1.349E-10 3.941E-11 2.242E-08 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN glaucoma DOID_1686 8.705E-13 1.238E-10 8.536E-07 5.397E-05 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN aortic aneurysm DOID_3627 1.067E-12 1.214E-10 3.889E-08 3.161E-06 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN dilated cardiomyopathy DOID_12930 1.087E-12 1.031E-10 1.032E-08 9.783E-07 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bile duct adenocarcinoma DOID_4896 2.313E-12 1.88E-10 0.04887153 0.18538599 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cholangiocarcinoma DOID_4947 2.313E-12 1.88E-10 0.04887153 0.18538599 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bile duct cancer DOID_4606 4.726E-12 3.362E-10 0.05515008 0.20644998 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bile duct carcinoma DOID_4897 4.726E-12 3.362E-10 0.05515008 0.20644998 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN biliary tract cancer DOID_4607 5.853E-12 3.7E-10 0.01600041 0.07462485 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN female reproductive organ benign neoplasm DOID_0060086 1.79E-11 1.018E-09 9.485E-10 1.799E-07 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN uterine benign neoplasm DOID_0060095 1.79E-11 1.018E-09 9.485E-10 1.799E-07 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN uterine fibroid DOID_13223 1.79E-11 1.018E-09 9.485E-10 1.799E-07 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pancreatic ductal carcinoma DOID_3587 3.052E-11 1.579E-09 1.121E-03 0.01301195 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pancreatic carcinoma DOID_4905 4.613E-11 2.188E-09 1.302E-03 0.01452458 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN atrophic muscular disease DOID_913 6.815E-11 2.983E-09 5.76E-08 4.096E-06 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN muscular dystrophy DOID_9884 6.815E-11 2.983E-09 5.76E-08 4.096E-06 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN reproductive organ benign neoplasm DOID_0050622 9.477E-11 3.852E-09 2.839E-09 4.039E-07 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bone development disease DOID_0080006 1.621E-10 6.15E-09 3.521E-09 4.007E-07 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN intracranial arterial disease DOID_13089 2.327E-10 8.275E-09 1.469E-04 3.343E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cerebral arterial disease DOID_3527 2.327E-10 8.275E-09 1.469E-04 3.343E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mouth disease DOID_403 4.893E-10 1.638E-08 3.062E-03 0.02386408 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN diabetic autonomic neuropathy DOID_11503 4.939E-10 1.561E-08 3.118E-03 0.02397807 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autonomic neuropathy DOID_11504 4.939E-10 1.561E-08 3.118E-03 0.02397807 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN diabetic polyneuropathy DOID_12785 4.939E-10 1.561E-08 3.118E-03 0.02397807 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN diabetic neuropathy DOID_9743 4.939E-10 1.561E-08 3.118E-03 0.02397807 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autonomic nervous system disease DOID_11465 8.299E-10 2.485E-08 3.718E-03 0.02678202 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN meningitis DOID_9471 6.524E-09 1.856E-07 0.1386703 0.32470535 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN aortic valve insufficiency DOID_57 6.704E-09 1.817E-07 4.964E-05 1.662E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN encephalomyelitis DOID_640 8.573E-09 2.217E-07 2.948E-03 0.02329897 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN uterine disease DOID_345 1.038E-08 2.568E-07 8.589E-04 0.0108601 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN gallbladder cancer DOID_3121 1.638E-08 3.883E-07 0.0344535 0.13613917 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN thoracic aortic aneurysm DOID_14004 2.504E-08 5.698E-07 1.013E-04 2.619E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN neuritis DOID_1803 2.56E-08 5.603E-07 3.718E-03 0.02644725 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN heart valve disease DOID_4079 2.56E-08 5.395E-07 2.65E-04 4.712E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN female reproductive system disease DOID_229 5.115E-08 1.039E-06 1.803E-03 0.01738665 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN osteochondrodysplasia DOID_2256 7.389E-08 1.45E-06 1.645E-06 8.511E-05 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pleural disease DOID_1532 7.432E-08 1.41E-06 0.01990249 0.08711168 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN periodontal disease DOID_3388 1.053E-07 1.934E-06 0.02209828 0.09525697 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN brain infarction DOID_3454 3.052E-07 5.427E-06 9.861E-03 0.05610739 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN aortic valve disease DOID_62 3.386E-07 5.838E-06 4.323E-04 6.648E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN nephrosis DOID_2527 4.066E-07 6.804E-06 1.179E-03 0.01341552 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cataract DOID_83 5.253E-07 8.54E-06 2.261E-04 4.435E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN myeloma DOID_0070004 6.732E-07 1.064E-05 3.718E-03 0.02712538 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lens disease DOID_110 6.732E-07 1.035E-05 2.65E-04 4.864E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mixed glioma DOID_5076 6.954E-07 1.041E-05 0.01361192 0.06977641 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN intracranial aneurysm DOID_10941 7.672E-07 1.119E-05 0.01300717 0.06916898 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN middle cerebral artery infarction DOID_3525 7.672E-07 1.091E-05 0.01300717 0.06789982 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN metabolic syndrome X DOID_14221 8.235E-07 1.143E-05 0.09209532 0.26600121 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Sciatic Neuropathy DOID_11446 9.224E-07 1.25E-05 0.01391417 0.07068893 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lesion of sciatic nerve DOID_12528 9.224E-07 1.25E-05 0.01391417 0.07068893 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mononeuritis of lower limb DOID_9473 9.224E-07 1.25E-05 0.01391417 0.07068893 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN larynx cancer DOID_2596 9.848E-07 1.303E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN laryngeal benign neoplasm DOID_2598 9.848E-07 1.303E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pleurisy DOID_10247 1.101E-06 1.424E-05 0.01484777 0.07283089 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mononeuritis DOID_1802 1.101E-06 1.393E-05 0.01484777 0.07220841 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mononeuropathy DOID_1188 1.306E-06 1.616E-05 0.01580764 0.07495454 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN focal glomerulosclerosis DOID_3945 1.306E-06 1.582E-05 9.298E-04 0.01125633 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bone marrow cancer DOID_4960 1.483E-06 1.758E-05 5.378E-03 0.03399904 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN vasculitis DOID_865 1.483E-06 1.722E-05 2.824E-05 1.236E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pustulosis of palm and sole DOID_4398 1.645E-06 1.872E-05 4.696E-04 7.032E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN skeletal system cancer DOID_0060124 1.862E-06 2.077E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bone cancer DOID_184 1.862E-06 2.077E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN oral submucous fibrosis DOID_5773 1.862E-06 2.037E-05 0.08906851 0.26123702 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lymphoma DOID_0060058 2.082E-06 2.235E-05 3.074E-04 5.3E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hypersensitivity reaction type IV disease DOID_2916 2.222E-06 2.342E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lymphoblastic leukemia DOID_1037 2.236E-06 2.313E-05 3.228E-04 5.403E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hypothyroidism DOID_1459 3.238E-06 3.29E-05 7.245E-04 9.815E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN spindle cell carcinoma DOID_4015 3.252E-06 3.246E-05 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pre-malignant neoplasm DOID_0060071 3.544E-06 3.477E-05 7.675E-04 9.925E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN in situ carcinoma DOID_8719 3.544E-06 3.477E-05 7.675E-04 9.925E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mineral metabolism disease DOID_0050032 3.872E-06 3.735E-05 8.415E-03 0.04936406 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cholestasis DOID_13580 4.225E-06 4.007E-05 6.651E-05 1.992E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN tooth disease DOID_1091 5.01E-06 4.673E-05 0.07022291 0.23783832 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN allergic contact dermatitis DOID_3042 5.01E-06 4.597E-05 7.645E-05 2.175E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN astrocytoma DOID_3069 5.908E-06 5.336E-05 0.36117105 0.67379123 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN amnestic disorder DOID_10914 6.449E-06 5.734E-05 0.11696609 0.301148 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN brain edema DOID_4724 6.449E-06 5.646E-05 6.754E-03 0.04132245 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bile duct disease DOID_4138 6.933E-06 5.977E-05 9.973E-05 2.702E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN male reproductive system disease DOID_48 6.933E-06 5.888E-05 0.07730488 0.25573532 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN adult respiratory distress syndrome DOID_11394 6.966E-06 5.829E-05 2.417E-03 0.02115732 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN biliary tract disease DOID_9741 7.497E-06 6.183E-05 1.063E-04 2.521E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pulmonary emphysema DOID_9675 7.82E-06 6.357E-05 0.2394768 0.47811333 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN endometriosis of uterus DOID_288 8.753E-06 7.015E-05 2.754E-03 0.02304351 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN nephrotic syndrome DOID_1184 9.771E-06 7.722E-05 2.933E-03 0.02418379 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN endometriosis DOID_289 9.771E-06 7.616E-05 2.933E-03 0.02350256 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bone resorption disease DOID_0080011 1.014E-05 7.795E-05 1.503E-03 0.01583428 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN osteoporosis DOID_11476 1.014E-05 7.795E-05 1.503E-03 0.01583428 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN influenza DOID_8469 1.088E-05 8.254E-05 0.0344535 0.13520028 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pancreatitis DOID_4989 1.09E-05 8.164E-05 0.01361192 0.07041074 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN uremia DOID_4676 1.162E-05 8.584E-05 3.8E-04 6.177E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pulmonary embolism DOID_9477 1.162E-05 8.474E-05 0.13329457 0.3160192 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cerebral infarction DOID_3526 1.208E-05 8.703E-05 0.03580751 0.13955119 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN contact dermatitis DOID_2773 1.258E-05 8.944E-05 1.623E-04 3.551E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN auditory system disease DOID_2742 1.445E-05 1.015E-04 1.818E-04 3.694E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pre-eclampsia DOID_10591 1.48E-05 1.027E-04 2.65E-04 5.026E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN spastic quadriplegia DOID_10970 1.643E-05 1.127E-04 0.01044955 0.05886925 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.797E-05 1.218E-04 4.155E-03 0.02918647 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lung small cell carcinoma DOID_5409 1.797E-05 1.203E-04 4.155E-03 0.02883054 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN primary bacterial infectious disease DOID_0050338 2.013E-05 1.332E-04 0.0180699 0.08160135 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autosomal dominant nonsyndromic deafness DOID_0050564 2.258E-05 1.477E-04 2.258E-05 1.071E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN sarcoidosis DOID_11335 2.589E-05 1.674E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN giant cell tumor DOID_200 2.589E-05 1.655E-04 0.29422781 0.56368896 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN malignant giant cell tumor DOID_2705 2.589E-05 1.655E-04 0.29422781 0.56368896 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN giant cell glioblastoma DOID_3074 2.589E-05 1.655E-04 0.29422781 0.56368896 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lung adenocarcinoma DOID_3910 3.026E-05 1.913E-04 0.01391417 0.06944877 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN periodontitis DOID_824 3.026E-05 1.892E-04 0.165055 0.36686053 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN parasitic protozoa infectious disease DOID_2789 3.075E-05 1.902E-04 0.30296345 0.57654248 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hypersensitivity reaction type I disease DOID_1205 3.285E-05 2.01E-04 0.02263491 0.09611389 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN congenital nervous system abnormality DOID_2490 3.628E-05 2.196E-04 3.628E-05 1.475E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN nonsyndromic deafness DOID_0050563 3.932E-05 2.355E-04 3.932E-05 1.492E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN glioblastoma DOID_3068 3.932E-05 2.331E-04 0.31586544 0.59909145 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN toxic encephalopathy DOID_3602 3.97E-05 2.329E-04 0.17538212 0.37943889 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN corneal disease DOID_10124 4.515E-05 2.622E-04 4.515E-05 1.606E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN neuroectodermal tumor DOID_171 4.964E-05 2.853E-04 6.832E-04 9.718E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN carotid artery disease DOID_3407 4.964E-05 2.824E-04 0.32852962 0.62104104 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN peritonitis DOID_8283 4.964E-05 2.797E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN ocular hypertension DOID_9282 4.964E-05 2.769E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN borderline glaucoma DOID_9283 4.964E-05 2.769E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN spastic cerebral palsy DOID_0050669 5.113E-05 2.825E-04 0.01780469 0.08170054 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN abdominal aortic aneurysm DOID_7693 5.113E-05 2.797E-04 0.01780469 0.08104693 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN respiratory failure DOID_11162 5.351E-05 2.9E-04 7.743E-03 0.0468682 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN allergic rhinitis DOID_4481 5.767E-05 3.096E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN osteogenesis imperfecta DOID_12347 6.424E-05 3.416E-04 6.424E-05 2.031E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN intracranial thrombosis DOID_4193 6.424E-05 3.384E-04 0.0776653 0.24688019 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN parasitic infectious disease DOID_1398 6.651E-05 3.472E-04 0.34505278 0.65011601 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hyperglycemia DOID_4195 7.135E-05 3.691E-04 9.121E-03 0.05295879 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN myocarditis DOID_820 7.254E-05 3.718E-04 0.02098831 0.09116296 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN nephroblastoma DOID_2154 8.094E-05 4.112E-04 1.564E-03 0.01617863 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN open-angle glaucoma DOID_1067 8.138E-05 4.098E-04 3.315E-03 0.0248179 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bacterial meningitis DOID_9470 8.138E-05 4.062E-04 0.08338456 0.25785769 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN corneal dystrophy DOID_2566 1.013E-04 5.01E-04 1.013E-04 2.505E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN intermediate coronary syndrome DOID_8805 1.013E-04 4.967E-04 0.08906851 0.25857134 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN peripheral vascular disease DOID_341 1.063E-04 5.171E-04 0.07910935 0.25007344 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pulmonary sarcoidosis DOID_13406 1.104E-04 5.322E-04 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN diabetic retinopathy DOID_8947 1.132E-04 5.415E-04 0.08092694 0.25440568 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN thyroiditis DOID_7166 1.241E-04 5.883E-04 4.336E-03 0.02936939 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autoimmune thyroiditis DOID_7188 1.241E-04 5.883E-04 4.336E-03 0.02936939 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN vein disease DOID_866 1.241E-04 5.834E-04 4.336E-03 0.02902387 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN endogenous depression DOID_1595 1.281E-04 5.975E-04 0.38461079 0.71284541 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN congenital muscular dystrophy DOID_0050557 1.791E-04 8.286E-04 1.791E-04 3.775E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN prion disease DOID_649 1.791E-04 8.22E-04 0.10591064 0.28560736 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Huntington's disease DOID_12858 1.914E-04 8.714E-04 0.03312009 0.13178554 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mental depression DOID_1596 1.922E-04 8.678E-04 0.41087682 0.75173283 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN uterine cancer DOID_363 2.082E-04 9.329E-04 3.118E-03 0.02365836 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN dissociative disorder DOID_10935 2.117E-04 9.413E-04 0.11145549 0.2963466 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN dissociative amnesia DOID_11037 2.117E-04 9.413E-04 0.11145549 0.2963466 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN retinal vascular disease DOID_2462 2.143E-04 9.453E-04 0.10172229 0.28234137 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autoimmune hepatitis DOID_2048 2.88E-04 1.26E-03 0.12244267 0.30423528 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN thrombophilia DOID_2452 3.319E-04 1.442E-03 8.145E-03 0.04827505 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN placenta disease DOID_780 3.319E-04 1.431E-03 0.12788543 0.31230389 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN calcium metabolism disease DOID_10575 3.321E-04 1.421E-03 0.04287607 0.16484112 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN withdrawal disorder DOID_0060001 3.569E-04 1.515E-03 0.04434742 0.16935356 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN B-cell lymphocytic neoplasm DOID_707 3.569E-04 1.504E-03 4.621E-03 0.03057455 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN sinusitis DOID_0050127 3.8E-04 1.59E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN paranasal sinus disease DOID_1352 3.8E-04 1.59E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN urinary tract obstruction DOID_5200 3.8E-04 1.578E-03 0.13329457 0.31734146 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN diabetic angiopathy DOID_11713 4.323E-04 1.782E-03 0.1386703 0.3274 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN synostosis DOID_11971 4.323E-04 1.769E-03 4.323E-04 6.832E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN integumentary system cancer DOID_0060122 4.696E-04 1.909E-03 0.30296345 0.57847719 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN skin cancer DOID_4159 4.696E-04 1.909E-03 0.30296345 0.57847719 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN urticaria DOID_1555 5.502E-04 2.22E-03 0.14932236 0.33850369 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hypertrophic cardiomyopathy DOID_11984 5.693E-04 2.281E-03 6.496E-03 0.04061765 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN oral cavity cancer DOID_8618 5.693E-04 2.265E-03 6.496E-03 0.04017615 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN melancholia DOID_2848 6.056E-04 2.393E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cystitis DOID_1679 6.162E-04 2.418E-03 0.1545991 0.34632634 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN ankylosing spondylitis DOID_7147 6.162E-04 2.401E-03 6.162E-04 8.99E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN neurotic disorder DOID_4964 6.436E-04 2.491E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN vitiligo DOID_12306 6.87E-04 2.641E-03 6.87E-04 9.534E-03 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN diffuse large B-cell lymphoma DOID_0050745 7.628E-04 2.913E-03 7.628E-04 0.01009323 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN gestational diabetes DOID_11714 7.628E-04 2.893E-03 0.01391417 0.07006336 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autoimmune disease of cardiovascular system DOID_0060051 8.436E-04 3.179E-03 0.01484777 0.0734642 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Behcet's disease DOID_13241 8.436E-04 3.179E-03 0.01484777 0.0734642 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autoimmune disease of the nervous system DOID_438 8.436E-04 3.158E-03 0.17023456 0.36970788 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN temporal lobe epilepsy DOID_3328 9.073E-04 3.374E-03 0.06848759 0.23334994 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autoimmune disease of endocrine system DOID_0060005 9.298E-04 3.435E-03 0.01580764 0.07558441 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN polycystic ovary syndrome DOID_11612 9.298E-04 3.413E-03 9.298E-04 0.01150103 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN multiple epiphyseal dysplasia DOID_12721 9.298E-04 3.391E-03 0.01580764 0.07433508 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN endocrine organ benign neoplasm DOID_0060089 1.01E-03 3.66E-03 9.861E-03 0.05667413 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN dysostosis DOID_1934 1.021E-03 3.678E-03 1.021E-03 0.01210664 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN endometrial carcinoma DOID_2871 1.021E-03 3.655E-03 0.01679339 0.0776865 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN blood coagulation disease DOID_1247 1.121E-03 3.985E-03 0.01063412 0.05874579 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN celiac disease DOID_10608 1.221E-03 4.315E-03 0.01884117 0.08375489 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN endometrial cancer DOID_1380 1.221E-03 4.288E-03 0.01884117 0.08310562 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN chronic leukemia DOID_1036 1.329E-03 4.64E-03 0.19565635 0.4201074 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN chronic lymphocytic leukemia DOID_1040 1.329E-03 4.64E-03 0.19565635 0.4201074 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bladder disease DOID_365 1.329E-03 4.612E-03 0.19565635 0.41852805 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cystic fibrosis DOID_1485 1.434E-03 4.944E-03 0.38461079 0.71517497 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN syndrome DOID_225 1.434E-03 4.914E-03 1.434E-03 0.01568611 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN papilloma DOID_2615 1.444E-03 4.919E-03 0.20064686 0.42759574 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN metal metabolism disorder DOID_896 1.444E-03 4.889E-03 1.444E-03 0.01549832 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bacterial pneumonia DOID_874 1.574E-03 5.3E-03 0.08832396 0.27165585 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hyperparathyroidism DOID_13543 1.666E-03 5.577E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN angioedema DOID_1558 1.666E-03 5.544E-03 0.06029343 0.21991641 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN rectal neoplasm DOID_1984 1.666E-03 5.512E-03 0.06029343 0.21851567 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN rectum cancer DOID_1993 1.666E-03 5.512E-03 0.06029343 0.21851567 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN chondrosarcoma DOID_3371 1.666E-03 5.48E-03 1.666E-03 0.01693015 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hypokalemia DOID_4500 1.666E-03 5.449E-03 0.06029343 0.2144185 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN holoprosencephaly DOID_4621 1.666E-03 5.418E-03 1.666E-03 0.01663313 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN medullomyoblastoma DOID_3861 1.69E-03 5.464E-03 1.69E-03 0.01658112 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN adult medulloblastoma DOID_3864 1.69E-03 5.464E-03 1.69E-03 0.01658112 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN childhood medulloblastoma DOID_3869 1.69E-03 5.464E-03 1.69E-03 0.01658112 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN calcinosis DOID_182 1.962E-03 6.306E-03 0.02556974 0.10619839 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN medulloblastoma DOID_3858 1.962E-03 6.27E-03 1.962E-03 0.01860187 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cleft palate DOID_674 1.962E-03 6.235E-03 1.962E-03 0.01829692 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN multiple myeloma DOID_9538 1.962E-03 6.201E-03 0.22030249 0.45253471 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN focal epilepsy DOID_2234 1.967E-03 6.185E-03 0.09783852 0.27696577 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN chronic kidney failure DOID_784 1.967E-03 6.151E-03 0.41087682 0.74932343 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 2.028E-03 6.306E-03 2.028E-03 0.01861363 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN trypanosomiasis DOID_10113 2.028E-03 6.272E-03 0.06611995 0.23081136 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN prediabetes syndrome DOID_11716 2.028E-03 6.238E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN temporal arteritis DOID_13375 2.028E-03 6.205E-03 2.028E-03 0.01831818 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN craniosynostosis DOID_2340 2.028E-03 6.171E-03 2.028E-03 0.01803196 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN central nervous system vasculitis DOID_525 2.028E-03 6.205E-03 2.028E-03 0.01831818 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN peripheral nervous system neoplasm DOID_1192 2.107E-03 6.376E-03 0.22514073 0.46080962 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN respiratory syncytial virus infectious disease DOID_1273 2.259E-03 6.8E-03 0.22994907 0.46728936 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN congenital diaphragmatic hernia DOID_3827 2.259E-03 6.764E-03 0.22994907 0.46397525 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pituitary cancer DOID_1785 2.424E-03 7.221E-03 2.424E-03 0.02089705 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pituitary carcinoma DOID_4916 2.424E-03 7.221E-03 2.424E-03 0.02089705 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN stomach disease DOID_76 2.424E-03 7.183E-03 0.0719105 0.23928114 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lipodystrophy DOID_811 2.424E-03 7.146E-03 2.424E-03 0.02058515 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN benign mesothelioma DOID_2645 2.582E-03 7.573E-03 0.03051632 0.12402704 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cervix uteri carcinoma in situ DOID_8991 2.582E-03 7.534E-03 0.2394768 0.47979683 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN nervous system cancer DOID_3093 2.625E-03 7.621E-03 0.43602633 0.79012414 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Human immunodeficiency virus infectious disease DOID_526 2.625E-03 7.582E-03 0.11161205 0.28866934 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autoimmune disease of urogenital tract DOID_0060049 2.754E-03 7.914E-03 0.03180759 0.12835831 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN primary biliary cirrhosis DOID_12236 2.754E-03 7.914E-03 0.03180759 0.12835831 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN berylliosis DOID_10322 2.853E-03 8.157E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN parathyroid gland disease DOID_11201 2.853E-03 8.117E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN polyneuropathy DOID_1389 2.853E-03 8.076E-03 0.0776653 0.25252316 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Lynch syndrome DOID_3883 2.853E-03 8.036E-03 0.0776653 0.24826716 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN epilepsy with generalized tonic-clonic seizures DOID_7725 2.853E-03 7.997E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN primitive neuroectodermal tumor DOID_168 2.933E-03 8.18E-03 2.933E-03 0.02383831 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Crohn's disease DOID_8778 3.062E-03 8.498E-03 0.11969626 0.29871567 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN viral pneumonia DOID_10533 3.315E-03 9.156E-03 0.08338456 0.25926675 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN congenital structural myopathy DOID_422 3.315E-03 9.112E-03 3.315E-03 0.02449559 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN proteinuria DOID_576 3.511E-03 9.605E-03 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN ulcerative colitis DOID_8577 3.545E-03 9.652E-03 0.1279205 0.31105455 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN vascular skin disease DOID_9540 3.718E-03 0.01007514 0.2673614 0.51921037 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN idiopathic pulmonary fibrosis DOID_0050156 3.809E-03 0.01027239 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN communication disorder DOID_2033 3.809E-03 0.01022393 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN membranoproliferative glomerulonephritis DOID_2920 3.809E-03 0.01017594 0.08906851 0.26534022 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN mesenchymal cell neoplasm DOID_3350 3.809E-03 0.01012838 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN spindle cell sarcoma DOID_4235 3.809E-03 0.01012838 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lung oat cell carcinoma DOID_5411 3.809E-03 0.01008128 0.08906851 0.26259058 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN epithelioid sarcoma DOID_6193 3.809E-03 0.01012838 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN varicose veins DOID_799 3.809E-03 0.0100346 0.08906851 0.25989734 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN integumentary system benign neoplasm DOID_0060121 4.155E-03 0.01089449 0.27642815 0.53499189 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pulmonary tuberculosis DOID_2957 4.155E-03 0.01084452 0.27642815 0.53317836 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN skin benign neoplasm DOID_3165 4.155E-03 0.01089449 0.27642815 0.53499189 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN spastic diplegia DOID_10965 4.336E-03 0.01126497 0.09471736 0.27219282 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pituitary adenoma DOID_3829 4.336E-03 0.01121377 4.336E-03 0.02972324 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN chronic myeloid leukemia DOID_8552 4.336E-03 0.01116303 0.09471736 0.27082502 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN tongue cancer DOID_8649 4.336E-03 0.01111274 0.09471736 0.26947089 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN orofacial cleft DOID_0050567 4.866E-03 0.01241495 4.866E-03 0.03182224 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lymphatic system cancer DOID_0060073 4.894E-03 0.0124312 4.894E-03 0.03164306 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN schizophreniform disorder DOID_11328 4.894E-03 0.01237595 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN familial hypertrophic cardiomyopathy DOID_11986 4.894E-03 0.01232119 4.894E-03 0.03128752 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN penile disease DOID_1529 4.894E-03 0.01226691 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN schizoaffective disorder DOID_5418 4.894E-03 0.01237595 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN urinary system benign neoplasm DOID_731 4.894E-03 0.01221311 0.10033133 0.27984573 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN reticulosarcoma DOID_8538 4.894E-03 0.0124312 4.894E-03 0.03164306 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lymphosarcoma DOID_8675 4.894E-03 0.0124312 4.894E-03 0.03164306 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN neuroendocrine tumor DOID_169 5.483E-03 0.01362412 0.10591064 0.28972669 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN osteosclerosis DOID_4254 5.483E-03 0.01356488 0.10591064 0.28834044 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN ureteral obstruction DOID_5199 5.483E-03 0.01350616 0.10591064 0.28696739 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN granulosa cell tumor DOID_2999 6.103E-03 0.01496896 0.11145549 0.29224964 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN leishmaniasis DOID_9065 6.103E-03 0.01490471 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN sex cord-gonadal stromal tumor DOID_192 6.754E-03 0.01642302 0.11696609 0.29711477 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN collagen disease DOID_854 7.419E-03 0.01796298 0.06003429 0.22181502 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN congenital heart defect DOID_1682 8.075E-03 0.01946867 8.075E-03 0.04836428 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hepatitis B DOID_2043 8.145E-03 0.01955445 0.12788543 0.31500782 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN muscular atrophy DOID_767 8.145E-03 0.01947229 0.12788543 0.31365003 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN opiate dependence DOID_2559 8.884E-03 0.02115141 0.13329457 0.31867482 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN IgA glomerulonephritis DOID_2986 8.884E-03 0.02106328 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN myasthenia gravis DOID_437 8.884E-03 0.02097588 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN ureteral disease DOID_1426 9.653E-03 0.02269582 0.1386703 0.32604711 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Goodpasture syndrome DOID_9808 9.653E-03 0.02260242 0.1386703 0.32337459 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN tuberculosis DOID_399 9.861E-03 0.02299483 0.3571789 0.6685355 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN severe combined immunodeficiency DOID_627 0.01044955 0.02426855 0.01044955 0.0582921 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN X-linked disease DOID_0050735 0.01127449 0.026078 0.14932236 0.34259849 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN portal hypertension DOID_10762 0.01127449 0.02597242 0.14932236 0.3398577 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN reading disorder DOID_13365 0.01127449 0.02586769 0.01127449 0.06168449 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN bronchiolitis DOID_2942 0.01127449 0.0257638 0.14932236 0.33716042 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN dyslexia DOID_4428 0.01127449 0.02586769 0.01127449 0.06168449 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN combined T cell and B cell immunodeficiency DOID_628 0.01127449 0.02566075 0.01127449 0.06109702 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN neuromuscular junction disease DOID_439 0.01212716 0.02749145 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN cleft lip DOID_9296 0.01212716 0.02738235 0.01212716 0.06509767 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN myopia DOID_11830 0.01300717 0.02925328 0.01300717 0.06852853 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN fragments of torsion dystonia DOID_531 0.01300717 0.02913811 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN electroclinical syndrome DOID_0050701 0.01361192 0.03037326 0.39223214 0.72461067 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN renal hypertension DOID_1073 0.01484777 0.0330015 0.17023456 0.37543979 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN secondary hypertension DOID_11130 0.01484777 0.0330015 0.17023456 0.37543979 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN sarcoma DOID_1115 0.01484777 0.03287309 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hepatic vascular disease DOID_272 0.01484777 0.03274567 0.17023456 0.37255179 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN invasive ductal carcinoma DOID_3008 0.01484777 0.03261924 0.01484777 0.07159647 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN coronary stenosis DOID_4248 0.01484777 0.03249378 0.17023456 0.37112439 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN central nervous system hereditary degenerative disease DOID_481 0.01484777 0.03236929 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN dystonic disease DOID_544 0.01580764 0.03433032 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN Charcot-Marie-Tooth disease DOID_10595 0.01884117 0.04076283 0.01884117 0.08441437 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN autonomic nervous system neoplasm DOID_2621 0.01990249 0.0428959 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN neuroblastoma DOID_769 0.01990249 0.0428959 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN carbohydrate metabolic disorder DOID_2978 0.02144029 0.04603594 0.11766161 0.29493154 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN alcohol-related neurodevelopmental disorder DOID_0050667 0.02203315 0.04713106 0.44991446 0.81270262 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN pneumoconiosis DOID_10316 0.02209828 0.04709334 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN thyroid carcinoma DOID_3963 0.02209828 0.04691761 0.20560654 0.43329675 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hyperthyroidism DOID_7998 0.02209828 0.0467432 0.02209828 0.09454076 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN lymphoid leukemia DOID_10747 0.02323206 0.04895942 0.02323206 0.09791884 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN thyroid cancer DOID_1781 0.02438933 0.05120858 0.21543417 0.44737972 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN adenoma DOID_657 0.02438933 0.05102032 0.21543417 0.44575288 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN refractive error DOID_9835 0.02438933 0.05083343 0.02438933 0.10204063 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN adolescence-adult electroclinical syndrome DOID_0050705 0.02556974 0.0530992 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN microcephaly DOID_10907 0.02677296 0.0553957 0.02677296 0.11038998 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN hepatitis DOID_2237 0.02799869 0.05772193 0.22994907 0.46562641 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN systemic scleroderma DOID_418 0.02799869 0.05751354 0.22994907 0.46233576 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN peptic ulcer DOID_750 0.02799869 0.05730666 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN adenoid cystic carcinoma DOID_4866 0.02924658 0.05964624 0.02924658 0.1197216 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN salivary gland cancer DOID_8850 0.03180759 0.06463758 0.03180759 0.12745437 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN rheumatic disease DOID_1575 0.03312009 0.06706524 0.24888714 0.49343828 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN uveal disease DOID_3480 0.03312009 0.06682742 0.24888714 0.49172495 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN scleroderma DOID_419 0.03312009 0.06706524 0.24888714 0.49343828 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN learning disability DOID_8927 0.03580751 0.07199461 0.03580751 0.13860186 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN thyroid adenoma DOID_2891 0.03857613 0.07728809 0.2673614 0.52277883 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN movement disease DOID_480 0.04287607 0.0856017 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN atopic dermatitis DOID_3310 0.0458373 0.09119378 1.000 1.000 CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN smallpox DOID_8736 0.05041532 0.09995232 0.05041532 0.18997559 ROSS_AML_WITH_AML1_ETO_FUSION medullomyoblastoma DOID_3861 7.051E-06 4.012E-03 7.051E-06 4.012E-03 ROSS_AML_WITH_AML1_ETO_FUSION adult medulloblastoma DOID_3864 7.051E-06 4.012E-03 7.051E-06 4.012E-03 ROSS_AML_WITH_AML1_ETO_FUSION childhood medulloblastoma DOID_3869 7.051E-06 4.012E-03 7.051E-06 4.012E-03 ROSS_AML_WITH_AML1_ETO_FUSION medulloblastoma DOID_3858 8.246E-06 2.346E-03 8.246E-06 2.346E-03 ROSS_AML_WITH_AML1_ETO_FUSION primitive neuroectodermal tumor DOID_168 1.262E-05 2.393E-03 1.262E-05 2.393E-03 ROSS_AML_WITH_AML1_ETO_FUSION neuroectodermal tumor DOID_171 3.422E-05 4.868E-03 3.422E-05 4.868E-03 ROSS_AML_WITH_AML1_ETO_FUSION sarcoma DOID_1115 3.963E-04 0.04509574 0.0288794 0.35722558 ROSS_AML_WITH_AML1_ETO_FUSION myocarditis DOID_820 5.718E-04 0.05422555 5.718E-04 0.06507066 ROSS_AML_WITH_AML1_ETO_FUSION multiple myeloma DOID_9538 7.062E-04 0.05740422 0.03832428 0.41144372 ROSS_AML_WITH_AML1_ETO_FUSION adenoid cystic carcinoma DOID_4866 8.161E-04 0.0580423 0.04114028 0.41068103 ROSS_AML_WITH_AML1_ETO_FUSION cervix uteri carcinoma in situ DOID_8991 8.544E-04 0.05401679 0.04207716 0.40579498 ROSS_AML_WITH_AML1_ETO_FUSION salivary gland cancer DOID_8850 8.936E-04 0.05084504 0.04301315 0.40122102 ROSS_AML_WITH_AML1_ETO_FUSION learning disability DOID_8927 1.016E-03 0.05256899 1.016E-03 0.09637648 ROSS_AML_WITH_AML1_ETO_FUSION myeloma DOID_0070004 1.102E-03 0.05226786 0.04767977 0.42390295 ROSS_AML_WITH_AML1_ETO_FUSION glaucoma DOID_1686 1.192E-03 0.0521611 1.192E-03 0.09687061 ROSS_AML_WITH_AML1_ETO_FUSION bone marrow cancer DOID_4960 1.43E-03 0.05811904 0.05417586 0.45332447 ROSS_AML_WITH_AML1_ETO_FUSION reproductive organ benign neoplasm DOID_0050622 1.48E-03 0.05614727 0.05510034 0.45437821 ROSS_AML_WITH_AML1_ETO_FUSION oral cavity cancer DOID_8618 1.636E-03 0.05816726 0.05786853 0.44496208 ROSS_AML_WITH_AML1_ETO_FUSION pre-malignant neoplasm DOID_0060071 1.911E-03 0.06397254 0.06246465 0.46766296 ROSS_AML_WITH_AML1_ETO_FUSION in situ carcinoma DOID_8719 1.911E-03 0.06397254 0.06246465 0.46766296 ROSS_AML_WITH_AML1_ETO_FUSION mixed glioma DOID_5076 2.792E-03 0.08824732 2.792E-03 0.19855648 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER biliary tract cancer DOID_4607 1.419E-16 8.073E-14 0.04819503 0.72165718 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER bile duct adenocarcinoma DOID_4896 1.985E-15 5.649E-13 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER cholangiocarcinoma DOID_4947 1.985E-15 5.649E-13 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER bile duct cancer DOID_4606 3.272E-15 6.205E-13 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER bile duct carcinoma DOID_4897 3.272E-15 6.205E-13 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER endometrial carcinoma DOID_2871 8.047E-12 1.145E-09 0.0184112 0.80584422 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER transitional cell carcinoma DOID_2671 1.093E-11 1.244E-09 0.05095986 0.72490399 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER endometrial cancer DOID_1380 1.111E-11 1.054E-09 0.01955109 0.79461235 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER breast benign neoplasm DOID_0060082 2.798E-11 2.274E-09 6.366E-03 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER thoracic benign neoplasm DOID_0060097 2.798E-11 2.274E-09 6.366E-03 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER benign breast phyllodes tumor DOID_1631 2.798E-11 2.274E-09 6.366E-03 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER uterine cancer DOID_363 6.095E-11 4.335E-09 0.02692965 0.63845702 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER nephroblastoma DOID_2154 5.544E-09 3.505E-07 0.02125856 0.75600763 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER spindle cell carcinoma DOID_4015 5.544E-09 3.155E-07 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER gallbladder cancer DOID_3121 1.492E-08 7.716E-07 0.02692965 0.66621602 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER integumentary system benign neoplasm DOID_0060121 2.26E-08 1.071E-06 0.02975341 0.67718764 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER skin benign neoplasm DOID_3165 2.26E-08 1.071E-06 0.02975341 0.67718764 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER Lynch syndrome DOID_3883 4.832E-08 2.115E-06 7.519E-03 0.85565758 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER metabolic syndrome X DOID_14221 1.443E-07 5.866E-06 0.04653245 0.75648463 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER adenoma DOID_657 1.529E-06 5.8E-05 0.0223953 0.67068021 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER integumentary system cancer DOID_0060122 5.126E-06 1.823E-04 0.03313161 0.67328157 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER skin cancer DOID_4159 5.126E-06 1.823E-04 0.03313161 0.67328157 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER neuroectodermal tumor DOID_171 6.906E-06 2.311E-04 0.03649857 0.66992539 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER pancreatic ductal carcinoma DOID_3587 1.027E-05 3.248E-04 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER pancreatic carcinoma DOID_4905 1.16E-05 3.474E-04 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER insulinoma DOID_3892 1.442E-05 4.104E-04 5.789E-03 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER female reproductive system disease DOID_229 1.512E-05 4.097E-04 0.04708695 0.72412092 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER invasive lobular carcinoma DOID_3457 1.762E-05 4.558E-04 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER islet cell tumor DOID_1799 2.114E-05 5.23E-04 6.942E-03 0.98757051 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER aortic valve insufficiency DOID_57 2.114E-05 5.012E-04 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER thoracic aortic aneurysm DOID_14004 3.36E-05 7.647E-04 8.671E-03 0.82229241 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER penile disease DOID_1529 4.349E-05 9.517E-04 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER colon carcinoma DOID_1520 6.069E-05 1.279E-03 0.01154525 0.72991612 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER placenta disease DOID_780 7.374E-05 1.498E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER uremia DOID_4676 8.073E-05 1.584E-03 0.01326602 0.75483657 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER aortic valve disease DOID_62 8.804E-05 1.67E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER sarcoma DOID_1115 1.385E-04 2.541E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER multiple epiphyseal dysplasia DOID_12721 1.48E-04 2.631E-03 0.01784078 0.92285509 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER autonomic nervous system neoplasm DOID_2621 1.891E-04 3.26E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER neuroblastoma DOID_769 1.891E-04 3.26E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER papilloma DOID_2615 2.001E-04 3.349E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER medullomyoblastoma DOID_3861 2.231E-04 3.628E-03 0.02182709 0.68997849 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER adult medulloblastoma DOID_3864 2.231E-04 3.628E-03 0.02182709 0.68997849 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER childhood medulloblastoma DOID_3869 2.231E-04 3.628E-03 0.02182709 0.68997849 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER medulloblastoma DOID_3858 2.474E-04 3.91E-03 0.02296319 0.6533028 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER peripheral nervous system neoplasm DOID_1192 2.6E-04 3.998E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER congenital diaphragmatic hernia DOID_3827 2.729E-04 4.086E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER primitive neuroectodermal tumor DOID_168 3.276E-04 4.78E-03 0.02636395 0.71433755 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER diabetic autonomic neuropathy DOID_11503 3.42E-04 4.866E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER autonomic neuropathy DOID_11504 3.42E-04 4.866E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER diabetic polyneuropathy DOID_12785 3.42E-04 4.866E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER diabetic neuropathy DOID_9743 3.42E-04 4.866E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER myeloma DOID_0070004 3.872E-04 5.374E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER autonomic nervous system disease DOID_11465 3.872E-04 5.246E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER heart valve disease DOID_4079 3.872E-04 5.124E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER aortic aneurysm DOID_3627 4.351E-04 5.627E-03 0.03031723 0.66348081 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER bone marrow cancer DOID_4960 5.032E-04 6.363E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER osteochondrodysplasia DOID_2256 5.21E-04 6.445E-03 0.03313161 0.65006496 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER familial hyperlipidemia DOID_1168 5.391E-04 6.527E-03 0.03369355 0.63905425 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER carotid artery disease DOID_3407 6.341E-04 7.517E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER endocrine pancreas disease DOID_1428 6.947E-04 8.067E-03 0.03817785 0.65827876 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER uterine disease DOID_345 7.155E-04 8.142E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER male reproductive system disease DOID_48 8.466E-04 9.445E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER diabetic retinopathy DOID_8947 8.926E-04 9.767E-03 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER aneurysm disease DOID_2403 9.64E-04 0.01034899 0.04486709 0.75086394 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER mixed glioma DOID_5076 9.883E-04 0.01041413 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER lipid metabolism disorder DOID_3146 1.038E-03 0.01073819 0.04653245 0.73547117 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER bone development disease DOID_0080006 1.141E-03 0.01159082 0.04874861 0.71122974 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER retinal vascular disease DOID_2462 1.167E-03 0.01165133 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER nervous system cancer DOID_3093 1.304E-03 0.01279003 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER alcohol-related neurodevelopmental disorder DOID_0050667 1.418E-03 0.01367739 1.418E-03 0.8069662 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER mouth disease DOID_403 1.418E-03 0.01344944 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER dilated cardiomyopathy DOID_12930 1.448E-03 0.01350272 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER brachydactyly DOID_0050581 5.789E-03 0.05312459 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER rectal neoplasm DOID_1984 5.789E-03 0.05228134 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER rectum cancer DOID_1993 5.789E-03 0.05228134 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER teratoma DOID_3307 5.789E-03 0.05146445 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER malignant teratoma DOID_5563 5.789E-03 0.05146445 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER mature teratoma DOID_5566 5.789E-03 0.05146445 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER familial adenomatous polyposis DOID_0050424 6.366E-03 0.05572453 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER esophageal carcinoma DOID_1107 6.942E-03 0.05985276 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER aortic valve stenosis DOID_1712 6.942E-03 0.05895943 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER esophagus squamous cell carcinoma DOID_3748 6.942E-03 0.05985276 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER berylliosis DOID_10322 7.519E-03 0.062916 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER polyneuropathy DOID_1389 7.519E-03 0.06200417 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER impotence DOID_1875 7.519E-03 0.0611184 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER larynx cancer DOID_2596 7.519E-03 0.06025758 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER laryngeal benign neoplasm DOID_2598 7.519E-03 0.06025758 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER rhabdomyosarcoma DOID_3247 8.095E-03 0.06397378 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER parasitic helminthiasis infectious disease DOID_883 8.095E-03 0.06309742 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER skeletal system cancer DOID_0060124 8.671E-03 0.06667236 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER bone cancer DOID_184 8.671E-03 0.06667236 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER membranoproliferative glomerulonephritis DOID_2920 8.671E-03 0.06578339 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER mesenchymal cell neoplasm DOID_3350 8.671E-03 0.06491782 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER skeletal muscle cancer DOID_4043 8.671E-03 0.06407473 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER spindle cell sarcoma DOID_4235 8.671E-03 0.06491782 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER oral submucous fibrosis DOID_5773 8.671E-03 0.06325326 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER epithelioid sarcoma DOID_6193 8.671E-03 0.06491782 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER angiosarcoma DOID_0001816 9.246E-03 0.06659766 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER spastic diplegia DOID_10965 9.246E-03 0.06576519 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER Barrett's esophagus DOID_9206 9.246E-03 0.06495328 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER urinary system benign neoplasm DOID_731 9.822E-03 0.06815237 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER neuroendocrine tumor DOID_169 0.01039647 0.0712722 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER sexual dysfunction DOID_1876 0.01039647 0.07042372 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER skin carcinoma DOID_3451 0.01039647 0.06959521 0.01039647 0.84508468 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER osteosclerosis DOID_4254 0.01039647 0.06878596 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER ureteral obstruction DOID_5199 0.01039647 0.06799532 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER granulosa cell tumor DOID_2999 0.01097102 0.07093761 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER pulmonary edema DOID_11396 0.01154525 0.07381174 0.01154525 0.82115564 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER sex cord-gonadal stromal tumor DOID_192 0.01154525 0.07299161 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER autoimmune hepatitis DOID_2048 0.01211916 0.07577802 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER benign glioma DOID_0060101 0.01269275 0.07850188 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER benign ependymoma DOID_4844 0.01269275 0.07850188 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER acquired immunodeficiency syndrome DOID_635 0.01269275 0.07765778 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER muscular atrophy DOID_767 0.01269275 0.07683163 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER sinusitis DOID_0050127 0.01326602 0.07945648 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER sexual disorder DOID_0060043 0.01326602 0.07862881 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER paranasal sinus disease DOID_1352 0.01326602 0.07945648 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER IgA glomerulonephritis DOID_2986 0.01326602 0.0778182 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER muscle cancer DOID_4045 0.01326602 0.07702414 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER urinary tract obstruction DOID_5200 0.01326602 0.07624612 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER hypoglycemia DOID_9993 0.01326602 0.07548366 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER Lewy body dementia DOID_12217 0.01383898 0.07796413 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER ureteral disease DOID_1426 0.01383898 0.07719978 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER meningitis DOID_9471 0.01383898 0.07645027 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER spastic quadriplegia DOID_10970 0.01441161 0.07884816 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER urticaria DOID_1555 0.01498394 0.08119866 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER papillary adenoma DOID_3172 0.01555594 0.08350311 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER microcystic adenoma DOID_5403 0.01555594 0.08350311 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER follicular adenoma DOID_6204 0.01555594 0.08350311 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER myopia DOID_11830 0.01612763 0.08576279 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER seminoma DOID_4440 0.01612763 0.08496869 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER lung adenocarcinoma DOID_3910 0.01669899 0.08717182 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER migraine DOID_6364 0.01669899 0.08637935 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER periodontitis DOID_824 0.01669899 0.08560115 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER autoimmune disease of cardiovascular system DOID_0060051 0.01727005 0.08773801 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER Behcet's disease DOID_13241 0.01727005 0.08773801 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER thrombocytopenia DOID_1588 0.01727005 0.08696157 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER focal glomerulosclerosis DOID_3945 0.01784078 0.08904742 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER female reproductive organ benign neoplasm DOID_0060086 0.0184112 0.09109543 0.0184112 0.87299791 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER uterine benign neoplasm DOID_0060095 0.0184112 0.09109543 0.0184112 0.87299791 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER uterine fibroid DOID_13223 0.0184112 0.09109543 0.0184112 0.87299791 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER spastic cerebral palsy DOID_0050669 0.01898131 0.09310658 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER germinoma DOID_3304 0.01955109 0.09508182 1.000 1.000 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER leiomyoma DOID_127 0.02012057 0.09702205 0.02012057 0.76324015 BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER esophageal disease DOID_6050 0.02125856 0.09996795 1.000 1.000 SESTO_RESPONSE_TO_UV_C5 pancreatic ductal carcinoma DOID_3587 3.337E-07 1.899E-04 1.536E-03 0.09712491 SESTO_RESPONSE_TO_UV_C5 pancreatic carcinoma DOID_4905 3.927E-07 1.117E-04 1.664E-03 0.09465703 SESTO_RESPONSE_TO_UV_C5 giant cell tumor DOID_200 1.205E-05 2.285E-03 0.04339437 0.46587538 SESTO_RESPONSE_TO_UV_C5 malignant giant cell tumor DOID_2705 1.205E-05 2.285E-03 0.04339437 0.46587538 SESTO_RESPONSE_TO_UV_C5 giant cell glioblastoma DOID_3074 1.205E-05 2.285E-03 0.04339437 0.46587538 SESTO_RESPONSE_TO_UV_C5 glioblastoma DOID_3068 1.56E-05 2.219E-03 0.0471791 0.44741516 SESTO_RESPONSE_TO_UV_C5 astrocytoma DOID_3069 2.57E-05 2.925E-03 0.05545464 0.49302638 SESTO_RESPONSE_TO_UV_C5 lymphoma DOID_0060058 5.709E-05 5.414E-03 2.529E-03 0.13081554 SESTO_RESPONSE_TO_UV_C5 encephalomyelitis DOID_640 5.892E-05 4.789E-03 5.892E-05 0.03352559 SESTO_RESPONSE_TO_UV_C5 skeletal system cancer DOID_0060124 6.316E-05 4.492E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C5 bone cancer DOID_184 6.316E-05 4.492E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C5 migraine DOID_6364 2.425E-04 0.01533288 0.02270434 0.41673454 SESTO_RESPONSE_TO_UV_C5 sarcoma DOID_1115 2.597E-04 0.01477801 0.02347829 0.40482272 SESTO_RESPONSE_TO_UV_C5 multiple myeloma DOID_9538 4.634E-04 0.02397135 0.0311853 0.39432085 SESTO_RESPONSE_TO_UV_C5 adenoid cystic carcinoma DOID_4866 5.357E-04 0.02540132 5.357E-04 0.15240795 SESTO_RESPONSE_TO_UV_C5 salivary gland cancer DOID_8850 5.867E-04 0.02568116 5.867E-04 0.11128503 SESTO_RESPONSE_TO_UV_C5 primitive neuroectodermal tumor DOID_168 6.131E-04 0.02491848 1.000 1.000 SESTO_RESPONSE_TO_UV_C5 diabetic autonomic neuropathy DOID_11503 6.4E-04 0.02427897 6.4E-04 0.09104613 SESTO_RESPONSE_TO_UV_C5 autonomic neuropathy DOID_11504 6.4E-04 0.02427897 6.4E-04 0.09104613 SESTO_RESPONSE_TO_UV_C5 diabetic polyneuropathy DOID_12785 6.4E-04 0.02427897 6.4E-04 0.09104613 SESTO_RESPONSE_TO_UV_C5 diabetic neuropathy DOID_9743 6.4E-04 0.02427897 6.4E-04 0.09104613 SESTO_RESPONSE_TO_UV_C5 myeloma DOID_0070004 7.242E-04 0.02575558 0.0388335 0.46033879 SESTO_RESPONSE_TO_UV_C5 autonomic nervous system disease DOID_11465 7.242E-04 0.02424055 7.242E-04 0.08241787 SESTO_RESPONSE_TO_UV_C5 B-cell lymphocytic neoplasm DOID_707 8.444E-04 0.02669123 0.04187641 0.46720933 SESTO_RESPONSE_TO_UV_C5 bone marrow cancer DOID_4960 9.403E-04 0.02816051 0.04415248 0.46523627 SESTO_RESPONSE_TO_UV_C5 integumentary system cancer DOID_0060122 9.734E-04 0.02769432 9.734E-04 0.09231439 SESTO_RESPONSE_TO_UV_C5 skin cancer DOID_4159 9.734E-04 0.02769432 9.734E-04 0.09231439 SESTO_RESPONSE_TO_UV_C5 oral cavity cancer DOID_8618 1.076E-03 0.02915677 1.076E-03 0.08747031 SESTO_RESPONSE_TO_UV_C5 neuroectodermal tumor DOID_171 1.184E-03 0.03061508 1.000 1.000 SESTO_RESPONSE_TO_UV_C5 congenital heart defect DOID_1682 1.258E-03 0.03112722 1.258E-03 0.08949076 SESTO_RESPONSE_TO_UV_C5 nervous system cancer DOID_3093 2.424E-03 0.05747584 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 transitional cell carcinoma DOID_2671 1.308E-09 7.443E-07 4.956E-05 0.01409907 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 bone marrow cancer DOID_4960 3.271E-09 9.305E-07 7.154E-03 0.22614755 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 invasive lobular carcinoma DOID_3457 7.312E-09 1.387E-06 0.02410779 0.31900771 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 pre-malignant neoplasm DOID_0060071 8.06E-09 1.147E-06 4.341E-04 0.06175673 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 in situ carcinoma DOID_8719 8.06E-09 1.147E-06 4.341E-04 0.06175673 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 alcohol-related neurodevelopmental disorder DOID_0050667 7.8E-08 8.876E-06 1.292E-03 0.14706377 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 myeloma DOID_0070004 9.272E-08 8.793E-06 0.10504382 0.62915719 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 reproductive organ benign neoplasm DOID_0050622 1.978E-07 1.607E-05 0.12080716 0.66737159 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 seminoma DOID_4440 4.408E-07 3.136E-05 1.766E-03 0.14357617 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 focal glomerulosclerosis DOID_3945 6.74E-07 4.261E-05 0.06647791 0.49770959 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 germinoma DOID_3304 9.885E-07 5.624E-05 2.599E-03 0.16431074 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 nephroblastoma DOID_2154 1.401E-06 7.245E-05 0.07883074 0.56778087 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 medullomyoblastoma DOID_3861 1.563E-06 7.41E-05 0.08087378 0.56118513 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 adult medulloblastoma DOID_3864 1.563E-06 7.41E-05 0.08087378 0.56118513 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 childhood medulloblastoma DOID_3869 1.563E-06 7.41E-05 0.08087378 0.56118513 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 medulloblastoma DOID_3858 1.928E-06 8.44E-05 0.08494644 0.57541103 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 embryonal cancer DOID_688 1.928E-06 7.837E-05 3.583E-03 0.16987114 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 nervous system cancer DOID_3093 2.001E-06 7.59E-05 0.01785011 0.31739733 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 cervix uteri carcinoma in situ DOID_8991 2.845E-06 1.012E-04 1.301E-04 0.02468376 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 Leydig cell tumor DOID_2696 2.953E-06 9.885E-05 0.02842891 0.34417122 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 Lynch syndrome DOID_3883 2.953E-06 9.336E-05 2.953E-06 1.68E-03 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 sex cord-stromal neoplasm DOID_4757 2.953E-06 9.885E-05 0.02842891 0.34417122 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 primitive neuroectodermal tumor DOID_168 3.408E-06 1.021E-04 0.09705775 0.62051528 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 brain cancer DOID_1319 4.778E-06 1.359E-04 5.546E-03 0.22541887 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 central nervous system cancer DOID_3620 5.176E-06 1.402E-04 5.764E-03 0.21866502 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 angiosarcoma DOID_0001816 5.755E-06 1.488E-04 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 vasculitis DOID_865 8.099E-06 2.004E-04 7.154E-03 0.21424505 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 colon carcinoma DOID_1520 1.164E-05 2.76E-04 0.04340446 0.40487115 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 neuroectodermal tumor DOID_171 1.287E-05 2.93E-04 0.13244933 0.67895198 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 placenta disease DOID_780 1.567E-05 3.43E-04 0.04764114 0.42355955 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 female reproductive system disease DOID_229 3.606E-05 7.6E-04 0.01469825 0.29868952 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 sarcoma DOID_1115 4.08E-05 8.291E-04 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 thrombocytopenia DOID_1588 4.08E-05 8.005E-04 2.027E-03 0.14415835 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 endometrial carcinoma DOID_2871 4.968E-05 9.423E-04 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 endometrial cancer DOID_1380 5.975E-05 1.097E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 hyperthyroidism DOID_7998 7.721E-05 1.373E-03 3.072E-03 0.15891212 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 multiple myeloma DOID_9538 9.771E-05 1.685E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 blood platelet disease DOID_2218 1.053E-04 1.761E-03 3.761E-03 0.16460912 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 uterine cancer DOID_363 1.586E-04 2.578E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 pre-eclampsia DOID_10591 1.908E-04 3.015E-03 0.10504382 0.62260347 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 hemorrhagic disease DOID_2213 2.399E-04 3.689E-03 6.442E-03 0.21561859 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 breast benign neoplasm DOID_0060082 2.634E-04 3.944E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 thoracic benign neoplasm DOID_0060097 2.634E-04 3.944E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 benign breast phyllodes tumor DOID_1631 2.634E-04 3.944E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 newborn respiratory distress syndrome DOID_12716 3.724E-04 5.434E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 respiratory failure DOID_11162 4.151E-04 5.904E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 tethered spinal cord syndrome DOID_1089 4.339E-04 6.021E-03 0.03058237 0.36252851 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 uterine disease DOID_345 4.74E-04 6.421E-03 0.14012602 0.70559029 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 blood coagulation disease DOID_1247 5.835E-04 7.722E-03 0.01151381 0.28484168 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 nephrosis DOID_2527 6.072E-04 7.852E-03 0.15151536 0.72447261 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 urinary system benign neoplasm DOID_731 6.456E-04 8.164E-03 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 endogenous depression DOID_1595 7.081E-04 8.759E-03 0.15902531 0.73565369 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 ureteral obstruction DOID_5199 7.253E-04 8.781E-03 0.03914916 0.41251618 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 prion disease DOID_649 7.253E-04 8.598E-03 0.03914916 0.40501588 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 aneurysm disease DOID_2403 7.349E-04 8.533E-03 0.01338352 0.31730087 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 pancreatitis DOID_4989 7.623E-04 8.675E-03 0.16275562 0.7408636 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 Down syndrome DOID_14250 8.095E-04 9.031E-03 0.04127915 0.41206727 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 testicular cancer DOID_2998 8.095E-04 8.857E-03 0.04127915 0.40496266 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 chromosomal disease DOID_0080014 8.484E-04 9.108E-03 0.01469825 0.3097521 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 mental depression DOID_1596 9.091E-04 9.579E-03 0.17201002 0.75871085 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 chronic kidney failure DOID_784 9.091E-04 9.405E-03 0.01537571 0.3016821 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 muscular atrophy DOID_767 1.089E-03 0.01106265 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 urinary tract obstruction DOID_5200 1.191E-03 0.01188656 0.04975253 0.42892708 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 lymphoma DOID_0060058 1.216E-03 0.01193179 0.18841392 0.79412976 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 lymphoblastic leukemia DOID_1037 1.254E-03 0.01209278 0.01895881 0.32689586 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 ureteral disease DOID_1426 1.297E-03 0.0123011 0.05185928 0.44041689 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 dilated cardiomyopathy DOID_12930 1.331E-03 0.01241935 0.01971371 0.3204886 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 toxic shock syndrome DOID_14115 1.408E-03 0.01292085 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 ulcerative colitis DOID_8577 1.453E-03 0.01312535 1.453E-03 0.13781615 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 commensal bacterial infectious disease DOID_0050339 1.523E-03 0.01354068 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 spinal cord disease DOID_319 1.766E-03 0.01546205 0.06024025 0.48277049 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 autoimmune disease of cardiovascular system DOID_0060051 2.027E-03 0.01747374 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 Behcet's disease DOID_13241 2.027E-03 0.01747374 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 female reproductive organ benign neoplasm DOID_0060086 2.304E-03 0.0195704 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 uterine benign neoplasm DOID_0060095 2.304E-03 0.0195704 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 uterine fibroid DOID_13223 2.304E-03 0.0195704 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 leiomyoma DOID_127 2.752E-03 0.02303192 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 papilloma DOID_2615 2.91E-03 0.02399884 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 metal metabolism disorder DOID_896 2.91E-03 0.023656 2.91E-03 0.16559198 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 calcinosis DOID_182 3.583E-03 0.02871062 0.08494644 0.58234369 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 cleft palate DOID_674 3.583E-03 0.02831186 0.08494644 0.56864149 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 adult respiratory distress syndrome DOID_11394 4.13E-03 0.03218866 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 nephrotic syndrome DOID_1184 4.713E-03 0.03623925 0.09705775 0.63478 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 diabetic autonomic neuropathy DOID_11503 4.915E-03 0.03729175 0.09906084 0.61940242 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 autonomic neuropathy DOID_11504 4.915E-03 0.03729175 0.09906084 0.61940242 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 diabetic polyneuropathy DOID_12785 4.915E-03 0.03729175 0.09906084 0.61940242 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 diabetic neuropathy DOID_9743 4.915E-03 0.03729175 0.09906084 0.61940242 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 cataract DOID_83 5.122E-03 0.03834615 0.10105955 0.62503133 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 learning disability DOID_8927 5.122E-03 0.03784814 0.10105955 0.61831056 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 lens disease DOID_110 5.546E-03 0.0404598 0.10504382 0.61618487 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 autonomic nervous system disease DOID_11465 5.546E-03 0.03994765 0.10504382 0.60989727 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 pulmonary tuberculosis DOID_2957 5.986E-03 0.04257868 0.10901064 0.6265359 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 calcium metabolism disease DOID_10575 6.212E-03 0.04363965 0.11098753 0.63151905 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 withdrawal disorder DOID_0060001 6.442E-03 0.04470141 6.442E-03 0.22909475 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 B-cell lymphocytic neoplasm DOID_707 6.442E-03 0.04416284 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 orofacial cleft DOID_0050567 6.676E-03 0.04521903 0.11492832 0.64746746 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 bile duct adenocarcinoma DOID_4896 7.154E-03 0.04789007 0.11885185 0.66300687 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 cholangiocarcinoma DOID_4947 7.154E-03 0.04789007 0.11885185 0.66300687 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 osteochondrodysplasia DOID_2256 7.399E-03 0.04895362 7.399E-03 0.21050056 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 hypertrophic cardiomyopathy DOID_11984 8.156E-03 0.05334325 0.12664741 0.67348017 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 bile duct cancer DOID_4606 8.156E-03 0.05273708 0.12664741 0.66724424 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 bile duct carcinoma DOID_4897 8.156E-03 0.05273708 0.12664741 0.66724424 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 oral cavity cancer DOID_8618 8.156E-03 0.05214453 0.12664741 0.66112274 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 melancholia DOID_2848 8.416E-03 0.05320788 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 leukocyte disease DOID_9500 8.416E-03 0.05262318 0.12858563 0.66513841 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 neurotic disorder DOID_4964 8.68E-03 0.05368102 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 carotid artery disease DOID_3407 8.947E-03 0.05473857 8.947E-03 0.24241366 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 hypothyroidism DOID_1459 9.218E-03 0.05579573 9.218E-03 0.23839992 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 mineral metabolism disease DOID_0050032 9.77E-03 0.05851809 0.13821316 0.70217222 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 tuberculosis DOID_399 0.01091841 0.06471432 0.14583945 0.70925337 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 diabetic retinopathy DOID_8947 0.01243313 0.07293249 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 cystic fibrosis DOID_1485 0.0130633 0.0758471 0.15902531 0.74168364 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 bacterial pneumonia DOID_874 0.01370714 0.07878143 0.16275562 0.73498373 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 metabolic syndrome X DOID_14221 0.01436452 0.08173414 0.01436452 0.32693654 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 lipid metabolism disorder DOID_3146 0.01436452 0.08092489 0.01436452 0.31436206 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 biliary tract cancer DOID_4607 0.01537571 0.08577236 0.17201002 0.74712747 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 bone development disease DOID_0080006 0.01571941 0.08683829 0.01571941 0.2981448 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 retinal vascular disease DOID_2462 0.0160664 0.08790172 1.000 1.000 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 primary bacterial infectious disease DOID_0050338 0.01677017 0.09087836 0.17934069 0.77306709 HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 amino acid metabolic disorder DOID_9252 0.01748692 0.09386845 0.01748692 0.32096954 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN gallbladder cancer DOID_3121 1.501E-05 8.539E-03 6.184E-03 0.23456848 GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN biliary tract cancer DOID_4607 4.946E-05 0.01407209 0.0111609 0.21898447 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN pre-malignant neoplasm DOID_0060071 1.127E-08 6.412E-06 3.089E-04 0.08787321 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN in situ carcinoma DOID_8719 1.127E-08 6.412E-06 3.089E-04 0.08787321 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN nervous system cancer DOID_3093 4.342E-08 1.235E-05 0.03579565 0.8855532 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN cervix uteri carcinoma in situ DOID_8991 6.572E-07 1.246E-04 0.01727163 0.81896313 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN brain cancer DOID_1319 9.712E-07 1.382E-04 0.01960516 0.79680979 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN central nervous system cancer DOID_3620 1.032E-06 1.174E-04 0.01999358 0.75842315 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN lymphoma DOID_0060058 6.573E-06 6.233E-04 0.03656036 0.86678528 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN dilated cardiomyopathy DOID_12930 7.225E-06 5.873E-04 7.225E-06 4.111E-03 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN acute pancreatitis DOID_2913 4.361E-05 3.101E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN spindle cell carcinoma DOID_4015 9.654E-05 6.103E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN congenital diaphragmatic hernia DOID_3827 1.247E-04 7.093E-03 0.01649264 0.85311903 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN diabetic autonomic neuropathy DOID_11503 1.563E-04 8.087E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN autonomic neuropathy DOID_11504 1.563E-04 8.087E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN diabetic polyneuropathy DOID_12785 1.563E-04 8.087E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN gallbladder cancer DOID_3121 1.563E-04 7.413E-03 0.01843904 0.80706274 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN diabetic neuropathy DOID_9743 1.563E-04 8.087E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN myeloma DOID_0070004 1.77E-04 7.749E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN autonomic nervous system disease DOID_11465 1.77E-04 7.195E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN heart valve disease DOID_4079 1.77E-04 6.716E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN B-cell lymphocytic neoplasm DOID_707 2.066E-04 7.348E-03 0.02115798 0.70816987 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN giant cell tumor DOID_200 2.223E-04 7.439E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN malignant giant cell tumor DOID_2705 2.223E-04 7.439E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN giant cell glioblastoma DOID_3074 2.223E-04 7.439E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN bone marrow cancer DOID_4960 2.303E-04 7.28E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN reproductive organ benign neoplasm DOID_0050622 2.385E-04 7.141E-03 0.02270849 0.71784069 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN integumentary system cancer DOID_0060122 2.385E-04 6.784E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN skin cancer DOID_4159 2.385E-04 6.784E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN hypertrophic cardiomyopathy DOID_11984 2.638E-04 7.148E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN glioblastoma DOID_3068 2.638E-04 6.823E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN astrocytoma DOID_3069 3.675E-04 9.093E-03 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN pancreatitis DOID_4989 4.536E-04 0.0107534 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN biliary tract cancer DOID_4607 5.118E-04 0.01164936 0.03311468 0.89725014 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN chronic kidney failure DOID_784 5.118E-04 0.0112013 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN transitional cell carcinoma DOID_2671 5.735E-04 0.01208694 0.03503037 0.90601264 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN encephalomyelitis DOID_640 6.387E-04 0.01297911 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN hypersensitivity reaction type I disease DOID_1205 6.657E-04 0.01306165 0.03770638 0.8581971 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN insulinoma DOID_3892 3.95E-03 0.07491959 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN nervous system benign neoplasm DOID_0060115 4.344E-03 0.07973839 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN polydactyly DOID_1148 4.344E-03 0.07724656 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN pituitary cancer DOID_1785 4.738E-03 0.08170029 4.738E-03 0.89870319 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN islet cell tumor DOID_1799 4.738E-03 0.07929734 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN pituitary carcinoma DOID_4916 4.738E-03 0.08170029 4.738E-03 0.89870319 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN retinal detachment DOID_5327 4.738E-03 0.0770317 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN aortic valve insufficiency DOID_57 4.738E-03 0.07489193 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN stomach disease DOID_76 4.738E-03 0.07286783 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN encephalitis DOID_9588 4.738E-03 0.07095025 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN berylliosis DOID_10322 5.132E-03 0.07487811 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN Leydig cell tumor DOID_2696 5.132E-03 0.07300616 5.132E-03 0.73006158 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN sex cord-stromal neoplasm DOID_4757 5.132E-03 0.07300616 5.132E-03 0.73006158 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN skeletal system cancer DOID_0060124 5.92E-03 0.08215296 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN renovascular hypertension DOID_1591 5.92E-03 0.08019694 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN bone cancer DOID_184 5.92E-03 0.08215296 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN hemangioma DOID_255 5.92E-03 0.07833189 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN oral submucous fibrosis DOID_5773 5.92E-03 0.07655162 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN intermediate coronary syndrome DOID_8805 5.92E-03 0.07485048 5.92E-03 0.67365428 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN angiosarcoma DOID_0001816 6.313E-03 0.07809043 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN spastic diplegia DOID_10965 6.313E-03 0.07642893 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN long QT syndrome DOID_2843 6.313E-03 0.07483666 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN pituitary adenoma DOID_3829 6.313E-03 0.07330938 6.313E-03 0.59869331 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN Barrett's esophagus DOID_9206 6.313E-03 0.0718432 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN penile disease DOID_1529 6.706E-03 0.07482285 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN osteosclerosis DOID_4254 7.1E-03 0.07768632 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN ureteral obstruction DOID_5199 7.1E-03 0.07622054 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN autoimmune hepatitis DOID_2048 8.278E-03 0.08722892 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN placenta disease DOID_780 8.671E-03 0.08970463 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN IgA glomerulonephritis DOID_2986 9.063E-03 0.09209044 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN uremia DOID_4676 9.063E-03 0.09047482 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN urinary tract obstruction DOID_5200 9.063E-03 0.0889149 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN ureteral disease DOID_1426 9.456E-03 0.09119139 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN aortic valve disease DOID_62 9.456E-03 0.08967153 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN spastic quadriplegia DOID_10970 9.848E-03 0.09185962 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN portal hypertension DOID_10762 0.01023989 0.0939758 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN urticaria DOID_1555 0.01023989 0.09248412 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN focal glomerulosclerosis DOID_3945 0.01219785 0.09915109 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN endometrial carcinoma DOID_2871 0.01258901 0.09948812 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN gonadal disease DOID_2277 0.01298002 0.09980583 0.01298002 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN esophageal disease DOID_6050 0.01454262 0.09969583 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN medulloblastoma DOID_3858 0.01571306 0.09934148 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN embryonal cancer DOID_688 0.01571306 0.09824982 0.01571306 0.89407332 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN multiple myeloma DOID_9538 0.01571306 0.09718188 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN peripheral nervous system neoplasm DOID_1192 0.01610292 0.09852217 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN uveitis DOID_13141 0.01610292 0.09747407 1.000 1.000 ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN peptic ulcer DOID_750 0.01649264 0.0987822 1.000 1.000 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP primary bacterial infectious disease DOID_0050338 2.021E-06 1.15E-03 5.443E-05 7.742E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP aortic valve insufficiency DOID_57 2.53E-06 7.197E-04 3.385E-04 0.02407538 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP hypersensitivity reaction type I disease DOID_1205 3.092E-06 5.865E-04 7.617E-05 8.668E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP Ehlers-Danlos syndrome DOID_13359 5.206E-06 7.406E-04 5.206E-06 2.962E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP heart valve disease DOID_4079 5.496E-06 6.254E-04 5.937E-03 0.12993105 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP atrophic muscular disease DOID_913 8.673E-06 8.225E-04 8.673E-06 2.468E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP muscular dystrophy DOID_9884 8.673E-06 8.225E-04 8.673E-06 2.468E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP collagen disease DOID_854 1.48E-05 1.203E-03 1.48E-05 2.806E-03 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP tuberculosis DOID_399 2.235E-05 1.59E-03 5.96E-04 0.03768153 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP aortic valve disease DOID_62 2.282E-05 1.442E-03 1.39E-03 0.05274256 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP diabetic retinopathy DOID_8947 2.926E-05 1.665E-03 0.01329122 0.18445615 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP retinal vascular disease DOID_2462 4.979E-05 2.576E-03 0.01716553 0.20781253 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP diabetic autonomic neuropathy DOID_11503 1.759E-04 8.343E-03 1.759E-04 0.01668519 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP autonomic neuropathy DOID_11504 1.759E-04 8.343E-03 1.759E-04 0.01668519 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP diabetic polyneuropathy DOID_12785 1.759E-04 8.343E-03 1.759E-04 0.01668519 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP diabetic neuropathy DOID_9743 1.759E-04 8.343E-03 1.759E-04 0.01668519 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP autonomic nervous system disease DOID_11465 2.116E-04 9.262E-03 2.116E-04 0.01720146 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP pulmonary tuberculosis DOID_2957 2.378E-04 9.666E-03 6.408E-03 0.13503343 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP giant cell tumor DOID_200 2.963E-04 0.01124074 7.398E-03 0.14514706 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP malignant giant cell tumor DOID_2705 2.963E-04 0.01124074 7.398E-03 0.14514706 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP giant cell glioblastoma DOID_3074 2.963E-04 0.01124074 7.398E-03 0.14514706 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP glioblastoma DOID_3068 3.816E-04 0.01356941 8.726E-03 0.15515618 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP Legionnaires' disease DOID_10457 4.653E-04 0.01557452 0.03165836 0.24676175 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP legionellosis DOID_10458 4.653E-04 0.01557452 0.03165836 0.24676175 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP astrocytoma DOID_3069 6.209E-04 0.01962746 0.01199079 0.18439891 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP peripheral vascular disease DOID_341 6.995E-04 0.02094869 0.01296058 0.18436426 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP congenital muscular dystrophy DOID_0050557 7.777E-04 0.02212538 7.777E-04 0.04425076 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP electroclinical syndrome DOID_0050701 8.441E-04 0.02287176 8.441E-04 0.04366428 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP pancreatitis DOID_4989 8.441E-04 0.02183214 0.01465014 0.19385877 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP amyloidosis DOID_9120 9.629E-04 0.02382096 9.629E-04 0.04565684 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP focal epilepsy DOID_2234 1.006E-03 0.0238609 1.006E-03 0.04405089 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP placenta disease DOID_780 1.167E-03 0.02656502 1.167E-03 0.04743754 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP transitional cell carcinoma DOID_2671 1.187E-03 0.02598243 0.01829581 0.21688162 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP encephalomyelitis DOID_640 1.387E-03 0.02923656 0.02024754 0.23041697 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP Goodpasture syndrome DOID_9808 1.39E-03 0.02825494 0.05366288 0.26322567 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP urticaria DOID_1555 1.632E-03 0.03202833 0.0580041 0.27734732 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP cystitis DOID_1679 1.76E-03 0.0333878 0.06016732 0.278335 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP myositis DOID_633 1.76E-03 0.03231077 0.06016732 0.27170797 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP coronary stenosis DOID_4248 2.172E-03 0.03861897 2.172E-03 0.07723794 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP toxic encephalopathy DOID_3602 2.318E-03 0.03997181 2.318E-03 0.07759234 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP endometrial carcinoma DOID_2871 2.469E-03 0.04132102 0.07090999 0.27826056 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP opportunistic mycosis DOID_2473 2.624E-03 0.04266658 2.624E-03 0.08296279 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP endometrial cancer DOID_1380 2.784E-03 0.04400844 0.07517298 0.2909757 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP allergic rhinitis DOID_4481 2.784E-03 0.04281902 0.07517298 0.28900965 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP bladder disease DOID_365 2.949E-03 0.04415327 0.07729723 0.29127233 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP systemic mycosis DOID_0050136 3.118E-03 0.04548407 3.118E-03 0.09336205 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP fungal infectious disease DOID_1564 3.118E-03 0.04548407 3.118E-03 0.09336205 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP myocarditis DOID_820 3.118E-03 0.04434697 3.118E-03 0.08869394 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP pneumoconiosis DOID_10316 3.291E-03 0.04566967 3.291E-03 0.08916459 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP male infertility DOID_12336 3.291E-03 0.04458229 3.291E-03 0.08511165 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP spindle cell carcinoma DOID_4015 3.291E-03 0.0435455 0.08153125 0.29548588 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP lymphoid leukemia DOID_10747 3.468E-03 0.04485329 3.468E-03 0.08580629 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP respiratory syncytial virus infectious disease DOID_1273 4.223E-03 0.05339493 0.09203248 0.30986084 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP pulmonary emphysema DOID_9675 4.626E-03 0.05722058 0.09619966 0.31100914 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP uterine cancer DOID_363 5.263E-03 0.06371063 0.10241501 0.31499535 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP myeloma DOID_0070004 5.937E-03 0.07037932 5.937E-03 0.14075864 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP neuritis DOID_1803 5.937E-03 0.06894301 5.937E-03 0.1351283 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP vascular skin disease DOID_9540 5.937E-03 0.06756415 0.1085881 0.32865229 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP calcium metabolism disease DOID_10575 6.649E-03 0.07418164 0.11471922 0.34355389 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP orofacial cleft DOID_0050567 7.144E-03 0.07817222 7.144E-03 0.14517699 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP bile duct adenocarcinoma DOID_4896 7.655E-03 0.08218618 0.12282925 0.36212355 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP cholangiocarcinoma DOID_4947 7.655E-03 0.08218618 0.12282925 0.36212355 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP bone marrow cancer DOID_4960 7.655E-03 0.08066421 7.655E-03 0.14519559 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP vasculitis DOID_865 7.655E-03 0.07919759 0.12282925 0.36025693 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP parasitic protozoa infectious disease DOID_2789 7.917E-03 0.08044202 0.12484526 0.36059366 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP pustulosis of palm and sole DOID_4398 7.917E-03 0.07903076 7.917E-03 0.14531462 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP bile duct cancer DOID_4606 8.726E-03 0.08560341 0.13086583 0.37231329 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP bile duct carcinoma DOID_4897 8.726E-03 0.08560341 0.13086583 0.37231329 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP neuroectodermal tumor DOID_171 9.57E-03 0.09229482 9.57E-03 0.16501195 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP carotid artery disease DOID_3407 9.57E-03 0.09075657 9.57E-03 0.16015865 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP mineral metabolism disease DOID_0050032 0.0104493 0.09746968 0.14278442 0.4002184 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP parasitic infectious disease DOID_1398 0.01075003 0.09865751 0.14475508 0.40375315 GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP uterine disease DOID_345 0.01075003 0.09709152 0.01075003 0.17476473 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP bone resorption disease DOID_0080011 5.264E-07 2.995E-04 5.264E-07 2.995E-04 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP osteoporosis DOID_11476 5.264E-07 2.995E-04 5.264E-07 2.995E-04 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP funisitis DOID_0050698 1.48E-04 0.04209487 1.48E-04 0.04209487 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP muscular atrophy DOID_767 1.48E-04 0.02806325 0.01784078 0.375978 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP glycogen metabolism disorder DOID_0050728 1.62E-04 0.02304021 1.62E-04 0.03072027 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP glycogen storage disease DOID_2747 1.62E-04 0.02304021 1.62E-04 0.03072027 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP lung adenocarcinoma DOID_3910 2.591E-04 0.02948859 2.591E-04 0.03686073 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP allergic contact dermatitis DOID_3042 1.51E-03 0.09543511 1.51E-03 0.1073645 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP pancreatic ductal carcinoma DOID_3587 1.64E-03 0.09332464 1.64E-03 0.10369404 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP pancreatic carcinoma DOID_4905 1.776E-03 0.09186723 1.776E-03 0.10105396 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP pancreatitis DOID_4989 1.965E-03 0.0931818 1.965E-03 0.10165287 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP mixed glioma DOID_5076 1.965E-03 0.08601397 0.06341167 0.52291651 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP contact dermatitis DOID_2773 2.063E-03 0.08385415 2.063E-03 0.09782984 SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP carbohydrate metabolic disorder DOID_2978 2.756E-03 0.09799776 2.756E-03 0.12061263 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN Ehlers-Danlos syndrome DOID_13359 9.229E-18 5.251E-15 7.347E-15 4.181E-12 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN heart valve disease DOID_4079 1.391E-13 3.959E-11 3.011E-09 5.71E-07 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN collagen disease DOID_854 8.554E-13 1.622E-10 1.056E-10 3.005E-08 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN aneurysm disease DOID_2403 3.868E-10 5.502E-08 2.026E-06 1.647E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN bone development disease DOID_0080006 6.503E-10 7.401E-08 4.802E-08 6.831E-06 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN aortic valve insufficiency DOID_57 7.052E-10 6.688E-08 2.969E-07 3.378E-05 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN oral submucous fibrosis DOID_5773 1.94E-09 1.577E-07 1.307E-04 6.761E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN osteochondrodysplasia DOID_2256 6.468E-09 4.6E-07 5.82E-07 5.519E-05 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN aortic valve disease DOID_62 1.499E-08 9.477E-07 2.705E-06 1.924E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN focal glomerulosclerosis DOID_3945 4.413E-08 2.511E-06 5.722E-04 0.02325737 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN intracranial aneurysm DOID_10941 4.365E-06 2.258E-04 4.662E-04 0.02040432 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN mouth disease DOID_403 4.417E-06 2.094E-04 5.356E-03 0.1385176 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN multiple epiphyseal dysplasia DOID_12721 5.975E-06 2.615E-04 5.975E-06 3.778E-04 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN calcinosis DOID_182 1.304E-05 5.3E-04 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN nephrotic syndrome DOID_1184 1.994E-05 7.564E-04 1.26E-03 0.04217357 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN calcium metabolism disease DOID_10575 3.06E-05 1.088E-03 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN aortic aneurysm DOID_3627 3.06E-05 1.024E-03 1.669E-03 0.0527643 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN atrophic muscular disease DOID_913 3.613E-05 1.142E-03 3.613E-05 2.056E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN muscular dystrophy DOID_9884 3.613E-05 1.142E-03 3.613E-05 2.056E-03 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN mineral metabolism disease DOID_0050032 6.189E-05 1.854E-03 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN nephrosis DOID_2527 8.329E-05 2.37E-03 3.223E-03 0.09168713 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN osteogenesis imperfecta DOID_12347 9.724E-05 2.635E-03 0.01464743 0.29765677 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN larynx cancer DOID_2596 9.724E-05 2.515E-03 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN laryngeal benign neoplasm DOID_2598 9.724E-05 2.515E-03 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN thoracic aortic aneurysm DOID_14004 1.307E-04 3.234E-03 0.0168822 0.32019915 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN ureteral obstruction DOID_5199 1.901E-04 4.506E-03 0.02022508 0.30284399 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN coronary restenosis DOID_4247 2.603E-04 5.924E-03 0.02355686 0.31913932 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN urinary tract obstruction DOID_5200 3.131E-04 6.853E-03 0.02577189 0.31878706 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN ureteral disease DOID_1426 3.414E-04 7.194E-03 0.02687756 0.31210885 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN spastic quadriplegia DOID_10970 3.708E-04 7.535E-03 3.708E-04 0.01758133 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN periodontitis DOID_824 5.004E-04 9.817E-03 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN coronary stenosis DOID_4248 5.357E-04 0.01016053 0.03348592 0.33427172 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN spastic cerebral palsy DOID_0050669 6.488E-04 0.0119092 6.488E-04 0.02461236 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN abdominal aortic aneurysm DOID_7693 6.488E-04 0.01153704 0.03677364 0.34873668 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN hepatitis C DOID_1883 8.161E-04 0.01407086 0.04114028 0.36576279 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN periodontal disease DOID_3388 8.161E-04 0.01365701 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN lymphoid leukemia DOID_10747 8.608E-04 0.01399379 8.608E-04 0.03061141 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN hepatitis DOID_2237 1.051E-03 0.01661495 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN glaucoma DOID_1686 1.607E-03 0.02471823 0.05734364 0.44092607 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN giant cell tumor DOID_200 1.861E-03 0.02787176 0.06161917 0.45534163 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN malignant giant cell tumor DOID_2705 1.861E-03 0.02787176 0.06161917 0.45534163 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN giant cell glioblastoma DOID_3074 1.861E-03 0.02787176 0.06161917 0.45534163 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN parasitic protozoa infectious disease DOID_2789 1.995E-03 0.02910793 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN glioblastoma DOID_3068 2.204E-03 0.0313515 0.06693695 0.47608905 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN oral cavity cancer DOID_8618 2.204E-03 0.03058683 2.204E-03 0.06600315 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN parasitic infectious disease DOID_1398 2.73E-03 0.03698184 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN tooth disease DOID_1091 2.89E-03 0.03823924 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN astrocytoma DOID_3069 3.054E-03 0.03949529 0.07853267 0.53196535 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN bone resorption disease DOID_0080011 3.663E-03 0.04631642 0.08583835 0.56793049 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN osteoporosis DOID_11476 3.663E-03 0.04631642 0.08583835 0.56793049 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN lymphoblastic leukemia DOID_1037 5.248E-03 0.06491388 5.248E-03 0.14219232 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN encephalomyelitis DOID_640 5.248E-03 0.06353274 1.000 1.000 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN Crohn's disease DOID_8778 5.356E-03 0.06348723 5.356E-03 0.1324951 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN hypersensitivity reaction type I disease DOID_1205 5.465E-03 0.06345539 0.10436559 0.65257167 TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN ulcerative colitis DOID_8577 5.797E-03 0.06597107 0.1074176 0.66435449 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN parasitic infectious disease DOID_1398 5.285E-09 3.007E-06 4.797E-06 2.729E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autoimmune disease of urogenital tract DOID_0060049 1.385E-08 3.939E-06 6.007E-07 1.139E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN primary biliary cirrhosis DOID_12236 1.385E-08 3.939E-06 6.007E-07 1.139E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN syndrome DOID_225 1.398E-08 2.652E-06 1.398E-08 7.955E-06 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN encephalomyelitis DOID_640 5.559E-08 7.908E-06 1.276E-06 1.815E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN Crohn's disease DOID_8778 5.979E-08 6.804E-06 1.357E-06 1.544E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hypersensitivity reaction type I disease DOID_1205 6.424E-08 6.093E-06 1.442E-06 1.367E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN parasitic protozoa infectious disease DOID_2789 6.623E-08 5.383E-06 5.784E-05 1.936E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hypersensitivity reaction type IV disease DOID_2916 9.005E-08 6.405E-06 2.793E-06 2.271E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN pneumoconiosis DOID_10316 2.193E-07 1.386E-05 2.193E-07 6.239E-05 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN endometriosis of uterus DOID_288 6.007E-07 3.418E-05 5.738E-04 9.603E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN endometriosis DOID_289 6.72E-07 3.476E-05 6.123E-04 9.954E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN primary immunodeficiency disease DOID_612 9.899E-07 4.694E-05 2.003E-05 1.036E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.252E-06 5.481E-05 8.775E-04 0.01248249 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN sarcoidosis DOID_11335 1.819E-06 7.395E-05 5.035E-05 1.791E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN malaria DOID_12365 4.038E-06 1.532E-04 4.038E-06 2.872E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN toxic encephalopathy DOID_3602 4.624E-06 1.644E-04 4.624E-06 2.923E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN uterine disease DOID_345 4.797E-06 1.606E-04 1.908E-03 0.01974412 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN allergic contact dermatitis DOID_3042 5.538E-06 1.751E-04 0.02631771 0.14261692 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN contact dermatitis DOID_2773 1.206E-05 3.612E-04 0.03520132 0.17725264 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN female reproductive system disease DOID_229 1.28E-05 3.641E-04 3.365E-03 0.02945567 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hepatitis DOID_2237 1.595E-05 4.322E-04 0.01001368 0.06474754 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN parasitic helminthiasis infectious disease DOID_883 1.597E-05 4.13E-04 1.13E-03 0.01397889 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN primary bacterial infectious disease DOID_0050338 1.798E-05 4.449E-04 4.095E-03 0.03426204 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN spinocerebellar ataxia DOID_1441 2.106E-05 4.993E-04 2.106E-05 9.985E-04 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN Human immunodeficiency virus infectious disease DOID_526 2.112E-05 4.808E-04 3.467E-04 7.306E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN lymphoma DOID_0060058 2.344E-05 5.13E-04 3.763E-04 7.646E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN silicosis DOID_10325 2.444E-05 5.15E-04 2.444E-05 1.07E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN spinocerebellar degeneration DOID_2478 2.962E-05 6.018E-04 2.962E-05 1.204E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN neuritis DOID_1803 3.21E-05 6.298E-04 7.823E-04 0.01171421 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN MHC class II deficiency DOID_5812 4.195E-05 7.957E-04 4.195E-05 1.591E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hepatitis B DOID_2043 6.615E-05 1.214E-03 2.815E-03 0.02715108 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN myasthenia gravis DOID_437 7.587E-05 1.349E-03 7.587E-05 2.398E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN severe combined immunodeficiency DOID_627 9.802E-05 1.69E-03 9.802E-05 2.935E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN bronchiolitis DOID_2942 1.105E-04 1.849E-03 3.924E-03 0.03332435 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN combined T cell and B cell immunodeficiency DOID_628 1.105E-04 1.797E-03 1.105E-04 3.144E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN neuromuscular junction disease DOID_439 1.24E-04 1.96E-03 1.24E-04 3.36E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN tuberculosis DOID_399 1.278E-04 1.965E-03 0.02701795 0.14503029 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN B cell deficiency DOID_2115 1.385E-04 2.074E-03 4.543E-03 0.03692424 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN nephrosis DOID_2527 1.501E-04 2.189E-03 1.501E-04 3.881E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN male reproductive system disease DOID_48 1.501E-04 2.135E-03 2.43E-03 0.02469334 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN diffuse large B-cell lymphoma DOID_0050745 1.541E-04 2.139E-03 4.868E-03 0.03794056 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autoimmune disease of the nervous system DOID_438 1.708E-04 2.314E-03 1.708E-04 4.225E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN polycystic ovary syndrome DOID_11612 1.886E-04 2.495E-03 1.886E-04 4.471E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN bacterial pneumonia DOID_874 2.029E-04 2.623E-03 3.032E-03 0.02828638 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN bronchiolitis obliterans DOID_2799 2.277E-04 2.879E-03 0.11187746 0.31829137 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN celiac disease DOID_10608 2.491E-04 3.081E-03 2.491E-04 5.669E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN biliary tract cancer DOID_4607 2.561E-04 3.101E-03 3.598E-03 0.03102263 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN spindle cell carcinoma DOID_4015 3.209E-04 3.804E-03 7.837E-03 0.05372411 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN leukopenia DOID_615 3.209E-04 3.726E-03 3.209E-04 7.022E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN lymphoblastic leukemia DOID_1037 3.917E-04 4.458E-03 3.917E-04 7.686E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN pulmonary sarcoidosis DOID_13406 4.048E-04 4.516E-03 9.114E-03 0.06030123 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN dilated cardiomyopathy DOID_12930 4.24E-04 4.639E-03 4.24E-04 8.042E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN ulcerative colitis DOID_8577 4.759E-04 5.109E-03 4.759E-04 8.735E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN lymphatic system disease DOID_75 5.017E-04 5.286E-03 5.017E-04 8.921E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN visceral leishmaniasis DOID_9146 5.641E-04 5.836E-03 0.03530401 0.16880659 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN cannabis abuse DOID_9505 5.641E-04 5.732E-03 5.641E-04 9.727E-03 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN uveal disease DOID_3480 6.123E-04 6.112E-03 0.01192559 0.07375717 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN diabetic autonomic neuropathy DOID_11503 6.523E-04 6.399E-03 0.15550065 0.40401766 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autonomic neuropathy DOID_11504 6.523E-04 6.399E-03 0.15550065 0.40401766 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN diabetic polyneuropathy DOID_12785 6.523E-04 6.399E-03 0.15550065 0.40401766 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN influenza DOID_8469 6.523E-04 6.291E-03 0.01242662 0.07602955 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN diabetic neuropathy DOID_9743 6.523E-04 6.399E-03 0.15550065 0.40401766 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN trypanosomiasis DOID_10113 6.879E-04 6.523E-03 0.03876563 0.17646114 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN cataract DOID_83 6.94E-04 6.473E-03 6.94E-04 0.01096872 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN pre-eclampsia DOID_10591 7.823E-04 7.18E-03 0.01398393 0.08464739 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN lens disease DOID_110 7.823E-04 7.066E-03 7.823E-04 0.01203081 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autonomic nervous system disease DOID_11465 7.823E-04 6.955E-03 0.16456806 0.41990685 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN retinal detachment DOID_5327 8.235E-04 7.209E-03 8.235E-04 0.01201467 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN movement disease DOID_480 9.277E-04 7.998E-03 9.277E-04 0.01287502 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN berylliosis DOID_10322 9.709E-04 8.246E-03 9.709E-04 0.01315394 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN cannabis dependence DOID_1849 9.709E-04 8.124E-03 9.709E-04 0.01284803 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN impotence DOID_1875 9.709E-04 8.007E-03 9.709E-04 0.01255603 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hallucinogen dependence DOID_9977 9.709E-04 8.124E-03 9.709E-04 0.01284803 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN B-cell lymphocytic neoplasm DOID_707 9.797E-04 7.964E-03 0.01618419 0.09592503 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN atrophic muscular disease DOID_913 1.089E-03 8.729E-03 1.089E-03 0.01377238 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN muscular dystrophy DOID_9884 1.089E-03 8.729E-03 1.089E-03 0.01377238 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN Legionnaires' disease DOID_10457 1.13E-03 8.931E-03 0.04907666 0.19665227 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN legionellosis DOID_10458 1.13E-03 8.931E-03 0.04907666 0.19665227 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN eyelid disease DOID_530 1.13E-03 8.809E-03 1.000 1.000 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN bile duct adenocarcinoma DOID_4896 1.147E-03 8.817E-03 1.147E-03 0.01388258 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN cholangiocarcinoma DOID_4947 1.147E-03 8.817E-03 1.147E-03 0.01388258 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN membranoproliferative glomerulonephritis DOID_2920 1.301E-03 9.87E-03 1.301E-03 0.01542112 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN oral submucous fibrosis DOID_5773 1.301E-03 9.74E-03 0.05248922 0.19648925 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN bile duct cancer DOID_4606 1.396E-03 0.01031449 1.396E-03 0.01620849 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN bile duct carcinoma DOID_4897 1.396E-03 0.01031449 1.396E-03 0.01620849 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN leukocyte disease DOID_9500 1.463E-03 0.0106721 1.463E-03 0.01664847 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hypothyroidism DOID_1459 1.676E-03 0.01207475 1.676E-03 0.01870403 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN lymphatic system cancer DOID_0060073 1.677E-03 0.01192821 0.0592779 0.21483519 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN Graves' disease DOID_12361 1.677E-03 0.01178094 1.677E-03 0.01835109 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN penile disease DOID_1529 1.677E-03 0.01163727 1.677E-03 0.01800484 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN bronchitis DOID_6132 1.677E-03 0.01149707 0.0592779 0.21080703 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN reticulosarcoma DOID_8538 1.677E-03 0.01192821 0.0592779 0.21483519 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN lymphosarcoma DOID_8675 1.677E-03 0.01192821 0.0592779 0.21483519 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN pre-malignant neoplasm DOID_0060071 1.752E-03 0.01186578 0.0235929 0.13033359 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN in situ carcinoma DOID_8719 1.752E-03 0.01186578 0.0235929 0.13033359 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN sexual dysfunction DOID_1876 1.882E-03 0.01260023 1.882E-03 0.01983369 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN leishmaniasis DOID_9065 2.099E-03 0.0138862 0.0660183 0.22629163 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN peripheral vascular disease DOID_341 2.525E-03 0.01651376 2.525E-03 0.02520522 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autoimmune hepatitis DOID_2048 2.565E-03 0.01658758 1.000 1.000 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN neutropenia DOID_1227 2.815E-03 0.01799903 2.815E-03 0.0276192 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN acquired immunodeficiency syndrome DOID_635 2.815E-03 0.01779904 0.07603911 0.2444421 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN electroclinical syndrome DOID_0050701 3.032E-03 0.0189612 3.032E-03 0.02875782 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN sexual disorder DOID_0060043 3.076E-03 0.01902571 3.076E-03 0.0282317 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN agranulocytosis DOID_12987 3.076E-03 0.01882113 3.076E-03 0.02778358 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN metabolic syndrome X DOID_14221 3.252E-03 0.01968322 0.03520132 0.17883526 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN diabetic angiopathy DOID_11713 3.348E-03 0.0200528 3.348E-03 0.02976588 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN Goodpasture syndrome DOID_9808 3.348E-03 0.01984392 0.08266028 0.25842691 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN chronic kidney failure DOID_784 3.598E-03 0.02110818 0.03757982 0.17244286 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN ankylosing spondylitis DOID_7147 4.228E-03 0.02454801 4.228E-03 0.03486529 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hypotrichosis DOID_4535 4.543E-03 0.02610805 4.543E-03 0.03640418 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN fragments of torsion dystonia DOID_531 4.543E-03 0.02584697 4.543E-03 0.03589857 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN extrinsic allergic alveolitis DOID_841 4.543E-03 0.02559106 0.09576165 0.28678095 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN Sciatic Neuropathy DOID_11446 4.868E-03 0.02715354 0.09900787 0.29495014 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN lesion of sciatic nerve DOID_12528 4.868E-03 0.02715354 0.09900787 0.29495014 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN mononeuritis of lower limb DOID_9473 4.868E-03 0.02715354 0.09900787 0.29495014 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN mouth disease DOID_403 5.059E-03 0.02794601 0.04680163 0.18886613 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autoimmune disease of cardiovascular system DOID_0060051 5.203E-03 0.02846686 5.203E-03 0.04000748 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN Behcet's disease DOID_13241 5.203E-03 0.02846686 5.203E-03 0.04000748 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN mononeuritis DOID_1802 5.203E-03 0.02819575 0.10224252 0.30143001 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN central nervous system hereditary degenerative disease DOID_481 5.203E-03 0.02792975 5.203E-03 0.03947404 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autoimmune disease of endocrine system DOID_0060005 5.549E-03 0.02950775 5.549E-03 0.04154381 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN mononeuropathy DOID_1188 5.549E-03 0.02923453 0.10546564 0.30308054 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN dystonic disease DOID_544 5.549E-03 0.02896633 5.549E-03 0.04100428 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN chronic leukemia DOID_1036 7.034E-03 0.03638543 7.034E-03 0.05131279 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN chronic lymphocytic leukemia DOID_1040 7.034E-03 0.03638543 7.034E-03 0.05131279 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN autonomic nervous system neoplasm DOID_2621 7.034E-03 0.03605763 7.034E-03 0.05066326 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN neuroblastoma DOID_769 7.034E-03 0.03605763 7.034E-03 0.05066326 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hair disease DOID_421 7.43E-03 0.03774944 7.43E-03 0.05284922 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hepatitis C DOID_1883 7.837E-03 0.03946107 0.12456455 0.34574259 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN nephroblastoma DOID_2154 7.837E-03 0.03911492 7.837E-03 0.05505063 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN thyroid carcinoma DOID_3963 7.837E-03 0.03877479 7.837E-03 0.05437928 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hyperthyroidism DOID_7998 7.837E-03 0.03844053 7.837E-03 0.05308454 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN thyroid cancer DOID_1781 8.679E-03 0.04220622 8.679E-03 0.05809562 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN peripheral nervous system neoplasm DOID_1192 9.559E-03 0.04609439 9.559E-03 0.06251883 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN uveitis DOID_13141 9.559E-03 0.04570705 0.13707172 0.36616812 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN respiratory syncytial virus infectious disease DOID_1273 0.01001368 0.04748153 0.1401707 0.37269686 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN systemic scleroderma DOID_418 0.01001368 0.04708912 0.01001368 0.06402004 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN cervix uteri carcinoma in situ DOID_8991 0.01095104 0.05107495 0.14633555 0.38548577 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN nephrotic syndrome DOID_1184 0.01192559 0.05516797 0.01192559 0.07539622 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN rheumatic disease DOID_1575 0.01192559 0.05472306 0.01192559 0.07456769 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN scleroderma DOID_419 0.01192559 0.05472306 0.01192559 0.07456769 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN leukodystrophy DOID_10579 0.01345586 0.06125109 0.16155638 0.41595286 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN proteinuria DOID_576 0.01345586 0.06076497 0.16155638 0.41407919 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN thyroid adenoma DOID_2891 0.01398393 0.0626524 0.16456806 0.41803227 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN glaucoma DOID_1686 0.0150666 0.06697572 0.0150666 0.09024098 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN pulmonary tuberculosis DOID_2957 0.0150666 0.06645653 0.17055925 0.42752517 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN atopic dermatitis DOID_3310 0.01675591 0.07333933 1.000 1.000 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN giant cell tumor DOID_200 0.01733616 0.07529981 0.01733616 0.10169355 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN malignant giant cell tumor DOID_2705 0.01733616 0.07529981 0.01733616 0.10169355 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN giant cell glioblastoma DOID_3074 0.01733616 0.07529981 0.01733616 0.10169355 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN vasculitis DOID_865 0.01792487 0.07726704 0.01792487 0.10407397 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN reproductive organ benign neoplasm DOID_0050622 0.01852196 0.07924059 0.18827811 0.46376729 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN hypertrophic cardiomyopathy DOID_11984 0.02036294 0.08646652 0.02036294 0.1170355 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN glioblastoma DOID_3068 0.02036294 0.08582603 0.02036294 0.11586514 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN collagen disease DOID_854 0.02227706 0.09320328 0.02227706 0.12550145 DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN respiratory failure DOID_11162 0.02293105 0.09523916 0.02293105 0.12791926 MOOTHA_MITOCHONDRIA mitochondrial metabolism disease DOID_700 1.756E-40 9.99E-38 2.327E-38 1.324E-35 MOOTHA_MITOCHONDRIA amino acid metabolic disorder DOID_9252 3.55E-31 1.01E-28 2.173E-29 6.183E-27 MOOTHA_MITOCHONDRIA organic acidemia DOID_0060159 1.42E-20 2.694E-18 1.984E-18 2.822E-16 MOOTHA_MITOCHONDRIA Leigh disease DOID_3652 9.296E-20 1.322E-17 9.296E-20 1.763E-17 MOOTHA_MITOCHONDRIA mitochondrial myopathy DOID_699 2.329E-15 2.651E-13 2.778E-13 3.161E-11 MOOTHA_MITOCHONDRIA carbohydrate metabolic disorder DOID_2978 3.147E-10 2.984E-08 3.147E-10 2.984E-08 MOOTHA_MITOCHONDRIA endocrine organ benign neoplasm DOID_0060089 4.554E-10 3.702E-08 4.464E-06 1.693E-04 MOOTHA_MITOCHONDRIA congenital hemolytic anemia DOID_589 5.305E-09 3.773E-07 5.305E-09 4.312E-07 MOOTHA_MITOCHONDRIA alcohol-related neurodevelopmental disorder DOID_0050667 6.965E-09 4.404E-07 2.891E-04 4.839E-03 MOOTHA_MITOCHONDRIA diffuse large B-cell lymphoma DOID_0050745 1.826E-08 1.039E-06 6.9E-04 0.01033176 MOOTHA_MITOCHONDRIA perinatal necrotizing enterocolitis DOID_8677 1.826E-08 9.446E-07 7.778E-07 4.024E-05 MOOTHA_MITOCHONDRIA hypertrophic cardiomyopathy DOID_11984 8.337E-08 3.953E-06 1.819E-06 8.626E-05 MOOTHA_MITOCHONDRIA lymphoma DOID_0060058 1.044E-07 4.571E-06 2.506E-03 0.02376134 MOOTHA_MITOCHONDRIA cholestasis DOID_13580 1.788E-07 7.267E-06 3.463E-06 1.408E-04 MOOTHA_MITOCHONDRIA bile duct disease DOID_4138 3.22E-07 1.221E-05 5.689E-06 2.023E-04 MOOTHA_MITOCHONDRIA biliary tract disease DOID_9741 3.533E-07 1.256E-05 6.153E-06 2.059E-04 MOOTHA_MITOCHONDRIA leukodystrophy DOID_10579 4.864E-07 1.628E-05 1.133E-05 3.393E-04 MOOTHA_MITOCHONDRIA porphyria DOID_13268 5.968E-07 1.886E-05 5.968E-07 4.244E-05 MOOTHA_MITOCHONDRIA mitochondrial encephalomyopathy DOID_890 5.968E-07 1.787E-05 5.968E-07 3.773E-05 MOOTHA_MITOCHONDRIA hemolytic anemia DOID_583 6.203E-07 1.765E-05 6.203E-07 3.529E-05 MOOTHA_MITOCHONDRIA normocytic anemia DOID_720 6.203E-07 1.765E-05 6.203E-07 3.529E-05 MOOTHA_MITOCHONDRIA chronic kidney failure DOID_784 8.352E-07 2.263E-05 1.271E-05 3.289E-04 MOOTHA_MITOCHONDRIA B-cell lymphocytic neoplasm DOID_707 8.763E-07 2.266E-05 4.197E-03 0.03411192 MOOTHA_MITOCHONDRIA papilloma DOID_2615 2.386E-06 5.904E-05 0.01967339 0.11194156 MOOTHA_MITOCHONDRIA spindle cell carcinoma DOID_4015 2.746E-06 6.51E-05 0.02071664 0.11444435 MOOTHA_MITOCHONDRIA lymphatic system cancer DOID_0060073 2.802E-06 6.378E-05 1.354E-04 2.657E-03 MOOTHA_MITOCHONDRIA methylmalonic acidemia DOID_14749 2.802E-06 6.133E-05 1.354E-04 2.568E-03 MOOTHA_MITOCHONDRIA reticulosarcoma DOID_8538 2.802E-06 6.378E-05 1.354E-04 2.657E-03 MOOTHA_MITOCHONDRIA lymphosarcoma DOID_8675 2.802E-06 6.378E-05 1.354E-04 2.657E-03 MOOTHA_MITOCHONDRIA adrenal gland disease DOID_9553 2.802E-06 5.906E-05 2.802E-06 1.227E-04 MOOTHA_MITOCHONDRIA endocrine pancreas disease DOID_1428 3.173E-06 6.449E-05 5.258E-05 1.197E-03 MOOTHA_MITOCHONDRIA cerebral degeneration DOID_1443 3.463E-06 6.795E-05 5.647E-05 1.236E-03 MOOTHA_MITOCHONDRIA adenoma DOID_657 3.592E-06 6.812E-05 1.651E-03 0.01957592 MOOTHA_MITOCHONDRIA hepatitis DOID_2237 5.23E-06 9.599E-05 2.047E-03 0.0215718 MOOTHA_MITOCHONDRIA spinocerebellar ataxia DOID_1441 7.402E-06 1.316E-04 7.402E-06 2.34E-04 MOOTHA_MITOCHONDRIA Huntington's disease DOID_12858 8.264E-06 1.425E-04 1.677E-04 3.078E-03 MOOTHA_MITOCHONDRIA hypoglycemia DOID_9993 1.014E-05 1.696E-04 3.434E-04 5.428E-03 MOOTHA_MITOCHONDRIA spinocerebellar degeneration DOID_2478 1.133E-05 1.842E-04 1.133E-05 3.223E-04 MOOTHA_MITOCHONDRIA thyroid adenoma DOID_2891 1.253E-05 1.98E-04 0.03622794 0.17469236 MOOTHA_MITOCHONDRIA alcohol abuse DOID_1574 1.271E-05 1.955E-04 1.271E-05 3.445E-04 MOOTHA_MITOCHONDRIA biliary tract cancer DOID_4607 1.271E-05 1.904E-04 1.735E-03 0.02014304 MOOTHA_MITOCHONDRIA transitional cell carcinoma DOID_2671 1.766E-05 2.576E-04 2.139E-03 0.02212667 MOOTHA_MITOCHONDRIA papillary adenoma DOID_3172 1.972E-05 2.805E-04 0.01135337 0.07783214 MOOTHA_MITOCHONDRIA microcystic adenoma DOID_5403 1.972E-05 2.805E-04 0.01135337 0.07783214 MOOTHA_MITOCHONDRIA follicular adenoma DOID_6204 1.972E-05 2.805E-04 0.01135337 0.07783214 MOOTHA_MITOCHONDRIA transient cerebral ischemia DOID_224 2.465E-05 3.42E-04 1.556E-03 0.01924999 MOOTHA_MITOCHONDRIA phagocyte bactericidal dysfunction DOID_3262 2.465E-05 3.339E-04 2.465E-05 6.097E-04 MOOTHA_MITOCHONDRIA adrenal gland hyperfunction DOID_3947 2.465E-05 3.261E-04 2.465E-05 5.843E-04 MOOTHA_MITOCHONDRIA chronic leukemia DOID_1036 5.665E-05 7.326E-04 1.204E-03 0.01592756 MOOTHA_MITOCHONDRIA chronic lymphocytic leukemia DOID_1040 5.665E-05 7.326E-04 1.204E-03 0.01592756 MOOTHA_MITOCHONDRIA leiomyoma DOID_127 5.665E-05 7.164E-04 1.204E-03 0.01556557 MOOTHA_MITOCHONDRIA hyperglycemia DOID_4195 6.059E-05 7.495E-04 6.059E-05 1.277E-03 MOOTHA_MITOCHONDRIA aplastic anemia DOID_12449 7.875E-05 9.534E-04 1.531E-03 0.01935971 MOOTHA_MITOCHONDRIA adrenal cortex disease DOID_3952 9.14E-05 1.083E-03 9.14E-05 1.857E-03 MOOTHA_MITOCHONDRIA bone resorption disease DOID_0080011 1.158E-04 1.344E-03 0.01199713 0.08031023 MOOTHA_MITOCHONDRIA osteoporosis DOID_11476 1.158E-04 1.344E-03 0.01199713 0.08031023 MOOTHA_MITOCHONDRIA intracranial arterial disease DOID_13089 1.286E-04 1.464E-03 2.191E-03 0.02226347 MOOTHA_MITOCHONDRIA cerebral arterial disease DOID_3527 1.286E-04 1.464E-03 2.191E-03 0.02226347 MOOTHA_MITOCHONDRIA keratosis DOID_161 1.618E-04 1.805E-03 0.10248642 0.30059162 MOOTHA_MITOCHONDRIA hyperinsulinism DOID_2018 1.677E-04 1.835E-03 1.677E-04 2.982E-03 MOOTHA_MITOCHONDRIA uveal disease DOID_3480 1.677E-04 1.8E-03 0.03108727 0.15653678 MOOTHA_MITOCHONDRIA diabetic autonomic neuropathy DOID_11503 1.824E-04 1.922E-03 2.829E-03 0.02596155 MOOTHA_MITOCHONDRIA autonomic neuropathy DOID_11504 1.824E-04 1.922E-03 2.829E-03 0.02596155 MOOTHA_MITOCHONDRIA diabetic polyneuropathy DOID_12785 1.824E-04 1.922E-03 2.829E-03 0.02596155 MOOTHA_MITOCHONDRIA diabetic neuropathy DOID_9743 1.824E-04 1.922E-03 2.829E-03 0.02596155 MOOTHA_MITOCHONDRIA primary immunodeficiency disease DOID_612 2.254E-04 2.331E-03 2.254E-04 3.886E-03 MOOTHA_MITOCHONDRIA autonomic nervous system disease DOID_11465 2.323E-04 2.36E-03 3.375E-03 0.02909406 MOOTHA_MITOCHONDRIA bone marrow disease DOID_4961 2.323E-04 2.319E-03 3.375E-03 0.02865982 MOOTHA_MITOCHONDRIA nervous system cancer DOID_3093 2.372E-04 2.327E-03 0.01800758 0.10673245 MOOTHA_MITOCHONDRIA integumentary system benign neoplasm DOID_0060121 2.705E-04 2.609E-03 0.03891248 0.18451001 MOOTHA_MITOCHONDRIA skin benign neoplasm DOID_3165 2.705E-04 2.609E-03 0.03891248 0.18451001 MOOTHA_MITOCHONDRIA lymphoblastic leukemia DOID_1037 2.754E-04 2.612E-03 2.604E-03 0.02428623 MOOTHA_MITOCHONDRIA hemorrhagic disease DOID_2213 3.131E-04 2.92E-03 3.131E-04 5.089E-03 MOOTHA_MITOCHONDRIA bile duct adenocarcinoma DOID_4896 3.856E-04 3.539E-03 4.886E-03 0.03861207 MOOTHA_MITOCHONDRIA cholangiocarcinoma DOID_4947 3.856E-04 3.539E-03 4.886E-03 0.03861207 MOOTHA_MITOCHONDRIA reproductive organ benign neoplasm DOID_0050622 4.122E-04 3.723E-03 0.04739716 0.21926002 MOOTHA_MITOCHONDRIA integumentary system cancer DOID_0060122 4.122E-04 3.665E-03 0.04739716 0.2174918 MOOTHA_MITOCHONDRIA skin cancer DOID_4159 4.122E-04 3.665E-03 0.04739716 0.2174918 MOOTHA_MITOCHONDRIA bronchiolitis DOID_2942 4.975E-04 4.355E-03 0.01055366 0.07323208 MOOTHA_MITOCHONDRIA hypersensitivity reaction type IV disease DOID_2916 5E-04 4.31E-03 0.05186916 0.23423454 MOOTHA_MITOCHONDRIA bile duct cancer DOID_4606 5E-04 4.246E-03 5.906E-03 0.04540855 MOOTHA_MITOCHONDRIA bile duct carcinoma DOID_4897 5E-04 4.246E-03 5.906E-03 0.04540855 MOOTHA_MITOCHONDRIA oral cavity cancer DOID_8618 5E-04 4.183E-03 0.05186916 0.23057462 MOOTHA_MITOCHONDRIA carotid artery disease DOID_3407 6.002E-04 4.95E-03 0.05648526 0.24165496 MOOTHA_MITOCHONDRIA spinal cord disease DOID_319 6.213E-04 5.051E-03 6.213E-04 9.555E-03 MOOTHA_MITOCHONDRIA extrinsic allergic alveolitis DOID_841 6.213E-04 4.98E-03 0.15483201 0.3701656 MOOTHA_MITOCHONDRIA thrombocytopenia DOID_1588 7.633E-04 6.032E-03 7.633E-04 0.01113617 MOOTHA_MITOCHONDRIA temporal lobe epilepsy DOID_3328 7.979E-04 6.219E-03 8.302E-03 0.06135049 MOOTHA_MITOCHONDRIA cranial nerve disease DOID_5656 8.414E-04 6.469E-03 8.414E-04 0.01196822 MOOTHA_MITOCHONDRIA brain infarction DOID_3454 8.884E-04 6.74E-03 8.884E-04 0.01232981 MOOTHA_MITOCHONDRIA female reproductive organ benign neoplasm DOID_0060086 9.243E-04 6.92E-03 0.01573267 0.09625689 MOOTHA_MITOCHONDRIA uterine benign neoplasm DOID_0060095 9.243E-04 6.92E-03 0.01573267 0.09625689 MOOTHA_MITOCHONDRIA uterine fibroid DOID_13223 9.243E-04 6.92E-03 0.01573267 0.09625689 MOOTHA_MITOCHONDRIA blood coagulation disease DOID_1247 9.86E-04 7.286E-03 9.86E-04 0.013358 MOOTHA_MITOCHONDRIA allergic rhinitis DOID_4481 1.105E-03 8.063E-03 0.18476854 0.40907898 MOOTHA_MITOCHONDRIA autonomic nervous system neoplasm DOID_2621 1.204E-03 8.669E-03 0.01865305 0.10720792 MOOTHA_MITOCHONDRIA neuroblastoma DOID_769 1.204E-03 8.669E-03 0.01865305 0.10720792 MOOTHA_MITOCHONDRIA hyperthyroidism DOID_7998 1.416E-03 0.01007433 0.02071664 0.11120536 MOOTHA_MITOCHONDRIA acute kidney failure DOID_3021 1.556E-03 0.01093209 0.05829594 0.23525099 MOOTHA_MITOCHONDRIA teratoma DOID_3307 1.556E-03 0.01079878 1.556E-03 0.01884042 MOOTHA_MITOCHONDRIA malignant teratoma DOID_5563 1.556E-03 0.01079878 1.556E-03 0.01884042 MOOTHA_MITOCHONDRIA mature teratoma DOID_5566 1.556E-03 0.01079878 1.556E-03 0.01884042 MOOTHA_MITOCHONDRIA female reproductive system disease DOID_229 1.589E-03 0.01089324 0.01369931 0.08661011 MOOTHA_MITOCHONDRIA focal epilepsy DOID_2234 1.735E-03 0.0117501 0.01459923 0.09128531 MOOTHA_MITOCHONDRIA multiple myeloma DOID_9538 1.777E-03 0.01189853 0.2136492 0.4502459 MOOTHA_MITOCHONDRIA adrenoleukodystrophy DOID_10588 1.895E-03 0.01253501 0.06393608 0.24092468 MOOTHA_MITOCHONDRIA sickle cell anemia DOID_10923 1.895E-03 0.01239093 1.895E-03 0.02156023 MOOTHA_MITOCHONDRIA prediabetes syndrome DOID_11716 1.895E-03 0.01225013 1.895E-03 0.02113748 MOOTHA_MITOCHONDRIA neuronal ceroid lipofuscinosis DOID_14503 1.895E-03 0.01211249 0.06393608 0.23933965 MOOTHA_MITOCHONDRIA microcephaly DOID_10907 1.909E-03 0.0120715 1.909E-03 0.02089298 MOOTHA_MITOCHONDRIA peripheral nervous system neoplasm DOID_1192 1.909E-03 0.01193885 0.02511271 0.12990121 MOOTHA_MITOCHONDRIA uveitis DOID_13141 1.909E-03 0.01180908 0.21836261 0.4584809 MOOTHA_MITOCHONDRIA blood platelet disease DOID_2218 1.909E-03 0.0116821 1.909E-03 0.02049878 MOOTHA_MITOCHONDRIA beta thalassemia DOID_12241 2.265E-03 0.01370763 2.265E-03 0.02260556 MOOTHA_MITOCHONDRIA intracranial arteriosclerosis DOID_13097 2.265E-03 0.01356334 0.06954258 0.2536521 MOOTHA_MITOCHONDRIA retinal detachment DOID_5327 2.265E-03 0.01342205 2.265E-03 0.02221581 MOOTHA_MITOCHONDRIA vascular dementia DOID_8725 2.265E-03 0.01356334 0.06954258 0.2536521 MOOTHA_MITOCHONDRIA ocular hypertension DOID_9282 2.265E-03 0.01328368 0.06954258 0.24886621 MOOTHA_MITOCHONDRIA borderline glaucoma DOID_9283 2.265E-03 0.01328368 0.06954258 0.24886621 MOOTHA_MITOCHONDRIA Human immunodeficiency virus infectious disease DOID_526 2.317E-03 0.0134539 2.317E-03 0.02234715 MOOTHA_MITOCHONDRIA benign mesothelioma DOID_2645 2.341E-03 0.01345573 1.000 1.000 MOOTHA_MITOCHONDRIA dilated cardiomyopathy DOID_12930 2.808E-03 0.01597476 0.11503431 0.31929036 MOOTHA_MITOCHONDRIA tethered spinal cord syndrome DOID_1089 3.098E-03 0.01745179 3.098E-03 0.02797826 MOOTHA_MITOCHONDRIA parasitic helminthiasis infectious disease DOID_883 3.098E-03 0.01728069 3.098E-03 0.0275411 MOOTHA_MITOCHONDRIA myeloma DOID_0070004 3.375E-03 0.01864279 0.25953738 0.52182604 MOOTHA_MITOCHONDRIA pre-eclampsia DOID_10591 3.375E-03 0.01846354 3.375E-03 0.02954166 MOOTHA_MITOCHONDRIA brain cancer DOID_1319 3.375E-03 0.01828769 0.25953738 0.51998862 MOOTHA_MITOCHONDRIA peripheral neuropathy DOID_0060053 3.56E-03 0.01911135 3.56E-03 0.02979122 MOOTHA_MITOCHONDRIA thalassemia DOID_10241 3.56E-03 0.01893274 3.56E-03 0.02935947 MOOTHA_MITOCHONDRIA lung oat cell carcinoma DOID_5411 3.56E-03 0.01875744 0.08616229 0.27086377 MOOTHA_MITOCHONDRIA central nervous system cancer DOID_3620 3.57E-03 0.01863577 0.26397691 0.52702758 MOOTHA_MITOCHONDRIA glaucoma DOID_1686 3.772E-03 0.01951128 0.03891248 0.18298513 MOOTHA_MITOCHONDRIA restrictive cardiomyopathy DOID_397 4.053E-03 0.02077567 0.09163625 0.27882901 MOOTHA_MITOCHONDRIA tongue cancer DOID_8649 4.053E-03 0.02059018 1.000 1.000 MOOTHA_MITOCHONDRIA drug-induced mental disorder DOID_1203 4.575E-03 0.02303812 0.09707756 0.2876934 MOOTHA_MITOCHONDRIA drug psychosis DOID_1742 4.575E-03 0.02303812 0.09707756 0.2876934 MOOTHA_MITOCHONDRIA urinary system benign neoplasm DOID_731 4.575E-03 0.02283603 4.575E-03 0.03666631 MOOTHA_MITOCHONDRIA substance-induced psychosis DOID_8646 4.575E-03 0.02303812 0.09707756 0.2876934 MOOTHA_MITOCHONDRIA sarcoidosis DOID_11335 4.649E-03 0.02300258 0.28578017 0.55879354 MOOTHA_MITOCHONDRIA bone marrow cancer DOID_4960 4.886E-03 0.02396611 0.29006304 0.56138051 MOOTHA_MITOCHONDRIA ureteral obstruction DOID_5199 5.127E-03 0.02493347 0.10248642 0.29752436 MOOTHA_MITOCHONDRIA pustulosis of palm and sole DOID_4398 5.13E-03 0.02473658 0.29432034 0.56386623 MOOTHA_MITOCHONDRIA congenital nervous system abnormality DOID_2490 5.64E-03 0.0269661 5.64E-03 0.04395843 MOOTHA_MITOCHONDRIA melancholia DOID_2848 6.179E-03 0.02929751 0.05339217 0.23550501 MOOTHA_MITOCHONDRIA colon carcinoma DOID_1520 6.317E-03 0.02970497 0.11320756 0.31888664 MOOTHA_MITOCHONDRIA neurotic disorder DOID_4964 6.459E-03 0.03012624 0.05493095 0.23859322 MOOTHA_MITOCHONDRIA coronary restenosis DOID_4247 6.954E-03 0.03217126 0.11852022 0.32422117 MOOTHA_MITOCHONDRIA hypothyroidism DOID_1459 7.043E-03 0.03231943 7.043E-03 0.05343479 MOOTHA_MITOCHONDRIA muscular atrophy DOID_767 7.62E-03 0.03468565 0.12380118 0.33385248 MOOTHA_MITOCHONDRIA mineral metabolism disease DOID_0050032 7.657E-03 0.03457993 0.06123893 0.23704047 MOOTHA_MITOCHONDRIA parasitic infectious disease DOID_1398 7.976E-03 0.03573493 7.976E-03 0.05971495 MOOTHA_MITOCHONDRIA uterine disease DOID_345 7.976E-03 0.03545575 0.06285295 0.24164413 MOOTHA_MITOCHONDRIA optic nerve disease DOID_1891 8.313E-03 0.03666683 8.313E-03 0.0606413 MOOTHA_MITOCHONDRIA urinary tract obstruction DOID_5200 8.313E-03 0.03638478 0.12905065 0.34153406 MOOTHA_MITOCHONDRIA Lewy body dementia DOID_12217 9.033E-03 0.03923521 0.13426881 0.35206891 MOOTHA_MITOCHONDRIA ureteral disease DOID_1426 9.033E-03 0.03893797 0.13426881 0.35045391 MOOTHA_MITOCHONDRIA astrocytoma DOID_3069 9.328E-03 0.03990594 0.0694503 0.25494982 MOOTHA_MITOCHONDRIA nephrosis DOID_2527 0.01005065 0.04267777 0.01005065 0.07239014 MOOTHA_MITOCHONDRIA male reproductive system disease DOID_48 0.01005065 0.04236164 0.01005065 0.07148527 MOOTHA_MITOCHONDRIA hypogonadism DOID_1924 0.01055366 0.04415463 0.01055366 0.07413618 MOOTHA_MITOCHONDRIA pancreatic carcinoma DOID_4905 0.01080526 0.04487732 0.07626292 0.25984193 MOOTHA_MITOCHONDRIA endogenous depression DOID_1595 0.01159181 0.04779522 0.07974561 0.26849262 MOOTHA_MITOCHONDRIA syndrome DOID_225 0.01159181 0.04745137 0.01159181 0.07852072 MOOTHA_MITOCHONDRIA middle cerebral artery infarction DOID_3525 0.01217891 0.04949857 0.01217891 0.08057907 MOOTHA_MITOCHONDRIA electroclinical syndrome DOID_0050701 0.01241052 0.05008218 0.01241052 0.08116768 MOOTHA_MITOCHONDRIA mixed glioma DOID_5076 0.01241052 0.04972949 0.08327697 0.26923067 MOOTHA_MITOCHONDRIA bacterial pneumonia DOID_874 0.01241052 0.04938173 0.08327697 0.26770959 MOOTHA_MITOCHONDRIA lung adenocarcinoma DOID_3910 0.01302994 0.05148636 0.15989637 0.37751466 MOOTHA_MITOCHONDRIA metabolic syndrome X DOID_14221 0.01326159 0.05204032 0.01326159 0.08574825 MOOTHA_MITOCHONDRIA contact dermatitis DOID_2773 0.01326159 0.05168387 0.08685536 0.26713892 MOOTHA_MITOCHONDRIA lipid metabolism disorder DOID_3146 0.01326159 0.05133228 0.01326159 0.08478478 MOOTHA_MITOCHONDRIA pleurisy DOID_10247 0.01390613 0.05346343 0.16493051 0.38619532 MOOTHA_MITOCHONDRIA coronary stenosis DOID_4248 0.01390613 0.05310462 0.16493051 0.37994115 MOOTHA_MITOCHONDRIA mental depression DOID_1596 0.01459923 0.05537976 0.09230759 0.27643694 MOOTHA_MITOCHONDRIA polycystic ovary syndrome DOID_11612 0.01480715 0.05579648 0.01480715 0.091579 MOOTHA_MITOCHONDRIA spastic cerebral palsy DOID_0050669 0.01668238 0.06244916 0.01668238 0.10098162 MOOTHA_MITOCHONDRIA gonadal disease DOID_2277 0.01668238 0.06204099 0.01668238 0.09991865 MOOTHA_MITOCHONDRIA pleural disease DOID_1532 0.01865305 0.06891938 0.18965429 0.41826857 MOOTHA_MITOCHONDRIA childhood absence epilepsy DOID_1825 0.01865305 0.06847474 0.01865305 0.1094184 MOOTHA_MITOCHONDRIA hereditary spastic paraplegia DOID_2476 0.01865305 0.0680358 0.01865305 0.10830188 MOOTHA_MITOCHONDRIA encephalomyelitis DOID_640 0.01959217 0.07100603 0.11115257 0.31781814 MOOTHA_MITOCHONDRIA pneumoconiosis DOID_10316 0.02071664 0.07460613 0.1993385 0.43291454 MOOTHA_MITOCHONDRIA male infertility DOID_12336 0.02071664 0.07413691 0.02071664 0.11671058 MOOTHA_MITOCHONDRIA nephroblastoma DOID_2154 0.02071664 0.07367355 0.02071664 0.11556635 MOOTHA_MITOCHONDRIA thyroid carcinoma DOID_3963 0.02071664 0.07321595 1.000 1.000 MOOTHA_MITOCHONDRIA paraplegia DOID_607 0.02071664 0.072764 0.02071664 0.11334392 MOOTHA_MITOCHONDRIA leukopenia DOID_615 0.02071664 0.0723176 0.02071664 0.11226446 MOOTHA_MITOCHONDRIA childhood electroclinical syndrome DOID_0050704 0.0217825 0.07557466 0.0217825 0.11583406 MOOTHA_MITOCHONDRIA medullomyoblastoma DOID_3861 0.0217825 0.07511664 0.0217825 0.11476153 MOOTHA_MITOCHONDRIA adult medulloblastoma DOID_3864 0.0217825 0.07511664 0.0217825 0.11476153 MOOTHA_MITOCHONDRIA childhood medulloblastoma DOID_3869 0.0217825 0.07511664 0.0217825 0.11476153 MOOTHA_MITOCHONDRIA thyroid cancer DOID_1781 0.02287067 0.07839405 1.000 1.000 MOOTHA_MITOCHONDRIA pulmonary sarcoidosis DOID_13406 0.02398084 0.08170718 0.2136492 0.45360595 MOOTHA_MITOCHONDRIA medulloblastoma DOID_3858 0.02398084 0.08122083 0.02398084 0.12518439 MOOTHA_MITOCHONDRIA salivary gland cancer DOID_8850 0.0298513 0.09991405 0.0298513 0.15302152 MANALO_HYPOXIA_UP collagen disease DOID_854 1.163E-14 6.616E-12 1.697E-09 4.827E-07 MANALO_HYPOXIA_UP pre-eclampsia DOID_10591 2.833E-10 8.059E-08 0.0115541 0.10435371 MANALO_HYPOXIA_UP giant cell tumor DOID_200 6.472E-10 1.227E-07 0.01434301 0.11658818 MANALO_HYPOXIA_UP malignant giant cell tumor DOID_2705 6.472E-10 1.227E-07 0.01434301 0.11658818 MANALO_HYPOXIA_UP giant cell glioblastoma DOID_3074 6.472E-10 1.227E-07 0.01434301 0.11658818 MANALO_HYPOXIA_UP Ehlers-Danlos syndrome DOID_13359 9.69E-10 1.378E-07 9.69E-10 5.514E-07 MANALO_HYPOXIA_UP glioblastoma DOID_3068 1.201E-09 1.367E-07 0.01686592 0.12968525 MANALO_HYPOXIA_UP astrocytoma DOID_3069 3.938E-09 3.735E-07 0.0230201 0.16580298 MANALO_HYPOXIA_UP diabetic retinopathy DOID_8947 5.783E-09 4.7E-07 0.2190338 0.56650105 MANALO_HYPOXIA_UP hyperinsulinism DOID_2018 8.686E-09 6.178E-07 4.082E-07 7.741E-05 MANALO_HYPOXIA_UP chronic kidney failure DOID_784 1.274E-08 8.057E-07 0.03129093 0.2023243 MANALO_HYPOXIA_UP retinal vascular disease DOID_2462 1.501E-08 8.539E-07 0.24651558 0.6261936 MANALO_HYPOXIA_UP focal glomerulosclerosis DOID_3945 5.26E-08 2.721E-06 4.565E-03 0.05526854 MANALO_HYPOXIA_UP endocrine pancreas disease DOID_1428 8.755E-08 4.151E-06 2.723E-06 3.099E-04 MANALO_HYPOXIA_UP skeletal system cancer DOID_0060124 1.401E-07 6.131E-06 1.474E-05 1.398E-03 MANALO_HYPOXIA_UP bone cancer DOID_184 1.401E-07 6.131E-06 1.474E-05 1.398E-03 MANALO_HYPOXIA_UP pancreatic ductal carcinoma DOID_3587 1.47E-07 5.974E-06 0.02361907 0.1659167 MANALO_HYPOXIA_UP nephrosis DOID_2527 1.595E-07 6.052E-06 1.018E-04 6.439E-03 MANALO_HYPOXIA_UP pancreatic carcinoma DOID_4905 1.873E-07 6.66E-06 0.02545408 0.17662645 MANALO_HYPOXIA_UP aneurysm disease DOID_2403 2.362E-07 7.907E-06 2.202E-03 0.04041637 MANALO_HYPOXIA_UP systemic scleroderma DOID_418 2.559E-07 8.09E-06 8.259E-03 0.08544238 MANALO_HYPOXIA_UP rheumatic disease DOID_1575 4.082E-07 1.222E-05 9.845E-03 0.09494216 MANALO_HYPOXIA_UP scleroderma DOID_419 4.082E-07 1.222E-05 9.845E-03 0.09494216 MANALO_HYPOXIA_UP nervous system cancer DOID_3093 5.856E-07 1.666E-05 2.365E-04 8.969E-03 MANALO_HYPOXIA_UP dilated cardiomyopathy DOID_12930 8.008E-07 2.17E-05 2.896E-04 9.692E-03 MANALO_HYPOXIA_UP gestational diabetes DOID_11714 2.353E-06 6.086E-05 2.353E-06 3.347E-04 MANALO_HYPOXIA_UP abdominal aortic aneurysm DOID_7693 4.014E-06 9.929E-05 0.10173124 0.34455403 MANALO_HYPOXIA_UP peptic ulcer DOID_750 1.073E-05 2.545E-04 0.12764779 0.39049245 MANALO_HYPOXIA_UP oral submucous fibrosis DOID_5773 1.474E-05 3.354E-04 1.066E-03 0.0233381 MANALO_HYPOXIA_UP nephrotic syndrome DOID_1184 1.549E-05 3.391E-04 4.569E-04 0.01444244 MANALO_HYPOXIA_UP mouth disease DOID_403 1.599E-05 3.37E-04 2.783E-04 9.898E-03 MANALO_HYPOXIA_UP diabetic autonomic neuropathy DOID_11503 1.689E-05 3.433E-04 0.01026052 0.0973039 MANALO_HYPOXIA_UP autonomic neuropathy DOID_11504 1.689E-05 3.433E-04 0.01026052 0.0973039 MANALO_HYPOXIA_UP diabetic polyneuropathy DOID_12785 1.689E-05 3.433E-04 0.01026052 0.0973039 MANALO_HYPOXIA_UP diabetic neuropathy DOID_9743 1.689E-05 3.433E-04 0.01026052 0.0973039 MANALO_HYPOXIA_UP angiosarcoma DOID_0001816 1.81E-05 3.55E-04 1.216E-03 0.02562978 MANALO_HYPOXIA_UP autonomic nervous system disease DOID_11465 2.165E-05 4.106E-04 0.0115541 0.10272319 MANALO_HYPOXIA_UP brain cancer DOID_1319 2.165E-05 3.973E-04 0.0115541 0.10114283 MANALO_HYPOXIA_UP heart valve disease DOID_4079 2.165E-05 3.849E-04 2.165E-05 1.76E-03 MANALO_HYPOXIA_UP central nervous system cancer DOID_3620 2.343E-05 4.04E-04 0.01200042 0.10191398 MANALO_HYPOXIA_UP aortic aneurysm DOID_3627 2.732E-05 4.572E-04 0.15831828 0.44375913 MANALO_HYPOXIA_UP vasculitis DOID_865 3.648E-05 5.931E-04 8.581E-04 0.02122798 MANALO_HYPOXIA_UP familial hyperlipidemia DOID_1168 4.183E-05 6.611E-04 9.489E-04 0.02159618 MANALO_HYPOXIA_UP gastric ulcer DOID_10808 4.906E-05 7.545E-04 0.06901637 0.29750237 MANALO_HYPOXIA_UP spastic quadriplegia DOID_10970 7.275E-05 1.089E-03 7.275E-05 5.174E-03 MANALO_HYPOXIA_UP toxic shock syndrome DOID_14115 7.275E-05 1.061E-03 0.07805403 0.31057862 MANALO_HYPOXIA_UP commensal bacterial infectious disease DOID_0050339 8.205E-05 1.167E-03 0.0810472 0.32024901 MANALO_HYPOXIA_UP portal hypertension DOID_10762 8.205E-05 1.139E-03 1.000 1.000 MANALO_HYPOXIA_UP intracranial aneurysm DOID_10941 1.029E-04 1.394E-03 3.735E-03 0.05183076 MANALO_HYPOXIA_UP autoimmune disease of cardiovascular system DOID_0060051 1.269E-04 1.679E-03 4.28E-03 0.05534497 MANALO_HYPOXIA_UP renal hypertension DOID_1073 1.269E-04 1.641E-03 1.000 1.000 MANALO_HYPOXIA_UP secondary hypertension DOID_11130 1.269E-04 1.641E-03 1.000 1.000 MANALO_HYPOXIA_UP sarcoma DOID_1115 1.269E-04 1.605E-03 4.28E-03 0.05411509 MANALO_HYPOXIA_UP Behcet's disease DOID_13241 1.269E-04 1.679E-03 4.28E-03 0.05534497 MANALO_HYPOXIA_UP hepatic vascular disease DOID_272 1.269E-04 1.57E-03 1.000 1.000 MANALO_HYPOXIA_UP mixed glioma DOID_5076 1.379E-04 1.67E-03 1.379E-04 7.847E-03 MANALO_HYPOXIA_UP bacterial pneumonia DOID_874 1.379E-04 1.635E-03 0.22914033 0.58730113 MANALO_HYPOXIA_UP supratentorial cancer DOID_1659 1.402E-04 1.628E-03 4.565E-03 0.05647003 MANALO_HYPOXIA_UP cerebrum cancer DOID_368 1.402E-04 1.628E-03 4.565E-03 0.05647003 MANALO_HYPOXIA_UP lipid metabolism disorder DOID_3146 1.518E-04 1.727E-03 2.449E-03 0.04097824 MANALO_HYPOXIA_UP endometrial carcinoma DOID_2871 1.543E-04 1.722E-03 1.543E-04 7.982E-03 MANALO_HYPOXIA_UP female reproductive system disease DOID_229 1.59E-04 1.74E-03 0.0299519 0.19589229 MANALO_HYPOXIA_UP spastic cerebral palsy DOID_0050669 1.693E-04 1.818E-03 1.693E-04 8.029E-03 MANALO_HYPOXIA_UP age related macular degeneration DOID_10871 1.693E-04 1.784E-03 5.162E-03 0.06118979 MANALO_HYPOXIA_UP degeneration of macula and posterior pole DOID_2007 1.693E-04 1.784E-03 5.162E-03 0.06118979 MANALO_HYPOXIA_UP endometrial cancer DOID_1380 1.853E-04 1.917E-03 1.853E-04 8.11E-03 MANALO_HYPOXIA_UP metal metabolism disorder DOID_896 2.2E-04 2.236E-03 2.2E-04 8.943E-03 MANALO_HYPOXIA_UP macular degeneration DOID_4448 2.389E-04 2.385E-03 6.456E-03 0.07203106 MANALO_HYPOXIA_UP lymphoma DOID_0060058 2.568E-04 2.519E-03 3.603E-03 0.05257002 MANALO_HYPOXIA_UP encephalomyelitis DOID_640 2.674E-04 2.579E-03 0.26589777 0.66068047 MANALO_HYPOXIA_UP calcinosis DOID_182 3.016E-04 2.86E-03 7.514E-03 0.0806648 MANALO_HYPOXIA_UP ulcerative colitis DOID_8577 3.253E-04 3.034E-03 0.04205278 0.21556785 MANALO_HYPOXIA_UP cervix uteri carcinoma in situ DOID_8991 4.005E-04 3.676E-03 0.13330553 0.40346196 MANALO_HYPOXIA_UP pulmonary emphysema DOID_9675 4.005E-04 3.617E-03 0.13330553 0.40132724 MANALO_HYPOXIA_UP acute kidney failure DOID_3021 4.619E-04 4.107E-03 0.03197854 0.1977803 MANALO_HYPOXIA_UP teratoma DOID_3307 4.619E-04 4.044E-03 4.619E-04 0.0138332 MANALO_HYPOXIA_UP malignant teratoma DOID_5563 4.619E-04 4.044E-03 4.619E-04 0.0138332 MANALO_HYPOXIA_UP mature teratoma DOID_5566 4.619E-04 4.044E-03 4.619E-04 0.0138332 MANALO_HYPOXIA_UP polycythemia DOID_8432 4.619E-04 3.982E-03 4.619E-04 0.01314154 MANALO_HYPOXIA_UP uterine cancer DOID_363 4.869E-04 4.135E-03 4.869E-04 0.01319207 MANALO_HYPOXIA_UP proteinuria DOID_576 5.506E-04 4.607E-03 0.01111531 0.10368218 MANALO_HYPOXIA_UP nervous system benign neoplasm DOID_0060115 5.634E-04 4.646E-03 5.634E-04 0.0145707 MANALO_HYPOXIA_UP glaucoma DOID_1686 6.558E-04 5.331E-03 0.15557483 0.44040836 MANALO_HYPOXIA_UP pituitary gland disease DOID_53 6.746E-04 5.406E-03 0.03825146 0.21549584 MANALO_HYPOXIA_UP calcium metabolism disease DOID_10575 6.935E-04 5.481E-03 0.0129154 0.10807155 MANALO_HYPOXIA_UP pustulosis of palm and sole DOID_4398 9.027E-04 7.036E-03 0.17190349 0.47025521 MANALO_HYPOXIA_UP smallpox DOID_8736 9.027E-04 6.941E-03 9.027E-04 0.02140258 MANALO_HYPOXIA_UP hypertrophic cardiomyopathy DOID_11984 1.046E-03 7.932E-03 1.000 1.000 MANALO_HYPOXIA_UP renovascular hypertension DOID_1591 1.066E-03 7.984E-03 1.000 1.000 MANALO_HYPOXIA_UP hemangioma DOID_255 1.066E-03 7.88E-03 0.04758532 0.23750918 MANALO_HYPOXIA_UP arthropathy DOID_381 1.066E-03 7.779E-03 0.04758532 0.2334142 MANALO_HYPOXIA_UP carotid artery disease DOID_3407 1.202E-03 8.656E-03 1.000 1.000 MANALO_HYPOXIA_UP spastic diplegia DOID_10965 1.216E-03 8.65E-03 1.216E-03 0.02471443 MANALO_HYPOXIA_UP respiratory failure DOID_11162 1.257E-03 8.83E-03 1.000 1.000 MANALO_HYPOXIA_UP hypothyroidism DOID_1459 1.257E-03 8.722E-03 1.257E-03 0.02466352 MANALO_HYPOXIA_UP pre-malignant neoplasm DOID_0060071 1.314E-03 9.006E-03 0.19318881 0.52096888 MANALO_HYPOXIA_UP congenital heart defect DOID_1682 1.314E-03 8.899E-03 0.19318881 0.51851148 MANALO_HYPOXIA_UP in situ carcinoma DOID_8719 1.314E-03 9.006E-03 0.19318881 0.52096888 MANALO_HYPOXIA_UP mineral metabolism disease DOID_0050032 1.372E-03 9.185E-03 0.02012254 0.15065425 MANALO_HYPOXIA_UP bronchitis DOID_6132 1.375E-03 9.1E-03 1.000 1.000 MANALO_HYPOXIA_UP uterine disease DOID_345 1.432E-03 9.366E-03 0.19842479 0.52513352 MANALO_HYPOXIA_UP prion disease DOID_649 1.544E-03 9.984E-03 0.05682932 0.26077327 MANALO_HYPOXIA_UP psoriasis DOID_8893 1.722E-03 0.01100952 1.722E-03 0.03266158 MANALO_HYPOXIA_UP syndrome DOID_225 2.123E-03 0.01342407 0.02670867 0.18309921 MANALO_HYPOXIA_UP hepatitis B DOID_2043 2.312E-03 0.0144534 2.312E-03 0.04110185 MANALO_HYPOXIA_UP metabolic syndrome X DOID_14221 2.449E-03 0.01514413 0.02929124 0.19607898 MANALO_HYPOXIA_UP contact dermatitis DOID_2773 2.449E-03 0.01498129 2.449E-03 0.04222001 MANALO_HYPOXIA_UP glycogen metabolism disorder DOID_0050728 2.526E-03 0.01529225 2.526E-03 0.04107062 MANALO_HYPOXIA_UP glycogen storage disease DOID_2747 2.526E-03 0.01529225 2.526E-03 0.04107062 MANALO_HYPOXIA_UP pulmonary embolism DOID_9477 2.526E-03 0.01513128 1.000 1.000 MANALO_HYPOXIA_UP Lewy body dementia DOID_12217 2.75E-03 0.01630033 0.07505119 0.30286614 MANALO_HYPOXIA_UP aortic valve disease DOID_62 2.75E-03 0.01613228 2.75E-03 0.04346754 MANALO_HYPOXIA_UP X-linked disease DOID_0050735 3.225E-03 0.01872302 3.225E-03 0.0495907 MANALO_HYPOXIA_UP hypogonadism DOID_1924 3.225E-03 0.0185339 0.0810472 0.31586204 MANALO_HYPOXIA_UP Human immunodeficiency virus infectious disease DOID_526 3.392E-03 0.01929809 3.392E-03 0.05078444 MANALO_HYPOXIA_UP ankylosing spondylitis DOID_7147 3.475E-03 0.01957874 0.08403074 0.31664562 MANALO_HYPOXIA_UP carbohydrate metabolic disorder DOID_2978 3.712E-03 0.02070711 3.712E-03 0.05280312 MANALO_HYPOXIA_UP myopia DOID_11830 3.735E-03 0.02063166 3.735E-03 0.0505967 MANALO_HYPOXIA_UP seminoma DOID_4440 3.735E-03 0.02043328 0.08700466 0.32146528 MANALO_HYPOXIA_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.823E-03 0.02071571 0.03906297 0.21579447 MANALO_HYPOXIA_UP Crohn's disease DOID_8778 3.823E-03 0.02052028 1.000 1.000 MANALO_HYPOXIA_UP hypersensitivity reaction type I disease DOID_1205 3.936E-03 0.02092814 0.0398025 0.21776558 MANALO_HYPOXIA_UP diffuse large B-cell lymphoma DOID_0050745 4.003E-03 0.02108933 4.003E-03 0.05296855 MANALO_HYPOXIA_UP female reproductive organ benign neoplasm DOID_0060086 4.859E-03 0.02536645 0.0988049 0.3428048 MANALO_HYPOXIA_UP uterine benign neoplasm DOID_0060095 4.859E-03 0.02536645 0.0988049 0.3428048 MANALO_HYPOXIA_UP corneal disease DOID_10124 4.859E-03 0.02513584 0.0988049 0.3407272 MANALO_HYPOXIA_UP uterine fibroid DOID_13223 4.859E-03 0.02536645 0.0988049 0.3428048 MANALO_HYPOXIA_UP gonadal disease DOID_2277 5.162E-03 0.02646045 0.10173124 0.34661723 MANALO_HYPOXIA_UP germinoma DOID_3304 5.473E-03 0.02780438 0.10464816 0.35026356 MANALO_HYPOXIA_UP allergic rhinitis DOID_4481 5.473E-03 0.02755832 1.000 1.000 MANALO_HYPOXIA_UP leiomyoma DOID_127 5.792E-03 0.02891097 0.10755569 0.35788997 MANALO_HYPOXIA_UP hair disease DOID_421 6.12E-03 0.03028139 6.12E-03 0.07106856 MANALO_HYPOXIA_UP myocarditis DOID_820 6.12E-03 0.03002034 0.11045384 0.36328461 MANALO_HYPOXIA_UP hepatitis C DOID_1883 6.456E-03 0.03139816 6.456E-03 0.07347168 MANALO_HYPOXIA_UP thyroid carcinoma DOID_3963 6.456E-03 0.03113207 0.11334267 0.36852559 MANALO_HYPOXIA_UP thyroid cancer DOID_1781 7.153E-03 0.03420213 0.11909243 0.37856755 MANALO_HYPOXIA_UP refractive error DOID_9835 7.153E-03 0.03391711 7.153E-03 0.07827026 MANALO_HYPOXIA_UP microcephaly DOID_10907 7.882E-03 0.03706615 7.882E-03 0.08305563 MANALO_HYPOXIA_UP adult respiratory distress syndrome DOID_11394 8.644E-03 0.04031298 1.000 1.000 MANALO_HYPOXIA_UP intracranial arterial disease DOID_13089 8.644E-03 0.03998523 1.000 1.000 MANALO_HYPOXIA_UP cerebral arterial disease DOID_3527 8.644E-03 0.03998523 1.000 1.000 MANALO_HYPOXIA_UP adenoid cystic carcinoma DOID_4866 8.644E-03 0.03966277 8.644E-03 0.08782471 MANALO_HYPOXIA_UP lymphatic system disease DOID_75 8.644E-03 0.03934547 1.000 1.000 MANALO_HYPOXIA_UP autoimmune disease of urogenital tract DOID_0060049 9.436E-03 0.04261383 9.436E-03 0.09419899 MANALO_HYPOXIA_UP primary biliary cirrhosis DOID_12236 9.436E-03 0.04261383 9.436E-03 0.09419899 MANALO_HYPOXIA_UP endometriosis of uterus DOID_288 9.436E-03 0.04227829 1.000 1.000 MANALO_HYPOXIA_UP salivary gland cancer DOID_8850 9.436E-03 0.04194799 9.436E-03 0.09257487 MANALO_HYPOXIA_UP endometriosis DOID_289 9.845E-03 0.04342316 1.000 1.000 MANALO_HYPOXIA_UP learning disability DOID_8927 0.0106841 0.04676348 0.14451205 0.42385236 MANALO_HYPOXIA_UP leukodystrophy DOID_10579 0.01111531 0.04827949 0.14729115 0.42978803 MANALO_HYPOXIA_UP myeloma DOID_0070004 0.0115541 0.04980518 0.0115541 0.10603684 MANALO_HYPOXIA_UP neuritis DOID_1803 0.0115541 0.04943071 0.1500613 0.43123676 MANALO_HYPOXIA_UP thyroid adenoma DOID_2891 0.0115541 0.04906182 0.1500613 0.42906974 MANALO_HYPOXIA_UP bone marrow disease DOID_4961 0.0115541 0.0486984 0.0115541 0.09961036 MANALO_HYPOXIA_UP lung small cell carcinoma DOID_5409 0.0124542 0.05210618 0.15557483 0.43822812 MANALO_HYPOXIA_UP B-cell lymphocytic neoplasm DOID_707 0.01338398 0.05558746 0.01338398 0.1103693 MANALO_HYPOXIA_UP bone marrow cancer DOID_4960 0.01483337 0.06116079 0.01483337 0.11887589 MANALO_HYPOXIA_UP reproductive organ benign neoplasm DOID_0050622 0.01533089 0.0627574 0.17190349 0.4748208 MANALO_HYPOXIA_UP osteochondrodysplasia DOID_2256 0.01533089 0.06230913 0.01533089 0.12115665 MANALO_HYPOXIA_UP parasitic protozoa infectious disease DOID_2789 0.01533089 0.06186722 0.17190349 0.47252698 MANALO_HYPOXIA_UP congenital nervous system abnormality DOID_2490 0.01634722 0.065504 0.01634722 0.12741873 MANALO_HYPOXIA_UP oral cavity cancer DOID_8618 0.01686592 0.06710985 0.01686592 0.12795611 MANALO_HYPOXIA_UP leukocyte disease DOID_9500 0.01739158 0.0687209 0.18261487 0.4971668 MANALO_HYPOXIA_UP parasitic infectious disease DOID_1398 0.02068891 0.08118615 0.19842479 0.53006435 MANALO_HYPOXIA_UP cerebral degeneration DOID_1443 0.02068891 0.08063008 0.19842479 0.52758741 MANALO_HYPOXIA_UP temporal lobe epilepsy DOID_3328 0.02126191 0.08229949 1.000 1.000 MANALO_HYPOXIA_UP hyperglycemia DOID_4195 0.02126191 0.08174341 0.02126191 0.15711721 MANALO_HYPOXIA_UP tooth disease DOID_1091 0.02184147 0.08340802 0.20362706 0.53640648 MANALO_HYPOXIA_UP allergic contact dermatitis DOID_3042 0.02184147 0.08285196 0.02184147 0.1593307 MANALO_HYPOXIA_UP endocrine organ benign neoplasm DOID_0060089 0.02242755 0.08451175 0.20621563 0.54072209 MANALO_HYPOXIA_UP brain infarction DOID_3454 0.02242755 0.08395575 0.20621563 0.53824171 MANALO_HYPOXIA_UP blood coagulation disease DOID_1247 0.02361907 0.08783825 0.02361907 0.16799066 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP allergic contact dermatitis DOID_3042 2.28E-08 1.297E-05 8.967E-07 2.551E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pancreatitis DOID_4989 5.123E-08 1.457E-05 1.747E-06 3.313E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP contact dermatitis DOID_2773 5.946E-08 1.128E-05 1.975E-06 2.809E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP oral cavity cancer DOID_8618 4.486E-07 6.381E-05 4.486E-07 2.552E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP middle cerebral artery infarction DOID_3525 6.932E-07 7.889E-05 4.623E-05 2.024E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP intracranial arterial disease DOID_13089 4.061E-06 3.851E-04 1.695E-04 6.029E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP cerebral arterial disease DOID_3527 4.061E-06 3.851E-04 1.695E-04 6.029E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP adenoid cystic carcinoma DOID_4866 4.061E-06 3.301E-04 4.061E-06 4.621E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP salivary gland cancer DOID_8850 4.884E-06 3.474E-04 4.884E-06 4.632E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP cerebral infarction DOID_3526 6.343E-06 4.01E-04 2.355E-04 7.052E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP myeloma DOID_0070004 7.478E-06 4.255E-04 7.478E-06 6.079E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP bone marrow cancer DOID_4960 1.266E-05 6.548E-04 1.266E-05 9.003E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP glioblastoma DOID_3068 1.66E-05 7.869E-04 1.66E-05 1.049E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP brain infarction DOID_3454 3.032E-05 1.327E-03 7.467E-04 0.01931269 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP astrocytoma DOID_3069 3.204E-05 1.302E-03 3.204E-05 1.823E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pancreatic ductal carcinoma DOID_3587 3.384E-05 1.284E-03 3.384E-05 1.75E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pancreatic carcinoma DOID_4905 3.966E-05 1.41E-03 3.966E-05 1.88E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP focal epilepsy DOID_2234 6.153E-05 2.06E-03 1.258E-03 0.02652153 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP biliary tract cancer DOID_4607 6.153E-05 1.945E-03 6.153E-05 2.501E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP mouth disease DOID_403 9.887E-05 2.961E-03 1.785E-03 0.03385751 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pneumoconiosis DOID_10316 1.079E-04 3.07E-03 3.829E-03 0.0605118 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pulmonary sarcoidosis DOID_13406 1.365E-04 3.697E-03 4.462E-03 0.06862235 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP multiple myeloma DOID_9538 1.365E-04 3.529E-03 1.365E-04 5.176E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pulmonary emphysema DOID_9675 1.816E-04 4.493E-03 1.816E-04 6.079E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP gallbladder cancer DOID_3121 2.212E-04 5.243E-03 2.212E-04 6.991E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP proteinuria DOID_576 2.504E-04 5.699E-03 6.631E-03 0.09674656 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pulmonary tuberculosis DOID_2957 2.987E-04 6.538E-03 7.441E-03 0.10584867 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP sarcoidosis DOID_11335 3.72E-04 7.84E-03 8.587E-03 0.1163288 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP giant cell tumor DOID_200 3.72E-04 7.56E-03 3.72E-04 0.01058382 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP malignant giant cell tumor DOID_2705 3.72E-04 7.56E-03 3.72E-04 0.01058382 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP giant cell glioblastoma DOID_3074 3.72E-04 7.56E-03 3.72E-04 0.01058382 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP common cold DOID_10459 3.95E-04 7.75E-03 0.02935567 0.21978129 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP hypersensitivity reaction type IV disease DOID_2916 4.787E-04 9.079E-03 0.0101222 0.13089848 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP cholestasis DOID_13580 6.583E-04 0.01208253 6.583E-04 0.01783612 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP temporal lobe epilepsy DOID_3328 6.87E-04 0.01221511 0.01281125 0.14876734 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP silicosis DOID_10325 7.136E-04 0.01230376 0.03895015 0.22848077 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP hemolytic-uremic syndrome DOID_12554 7.136E-04 0.01194189 0.03895015 0.223865 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP tuberculosis DOID_399 7.467E-04 0.0121394 0.01352698 0.15091871 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP bile duct disease DOID_4138 8.424E-04 0.01331414 8.424E-04 0.02083952 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP male reproductive system disease DOID_48 8.424E-04 0.01295429 0.01463245 0.16011274 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP biliary tract disease DOID_9741 8.759E-04 0.01311546 8.759E-04 0.02076615 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP ureteral obstruction DOID_5199 9.069E-04 0.01323107 0.04371214 0.23464347 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP amyloidosis DOID_9120 1.123E-03 0.01596833 1.123E-03 0.02554933 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP lipid metabolism disorder DOID_3146 1.134E-03 0.01574417 1.134E-03 0.02482735 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP primary bacterial infectious disease DOID_0050338 1.437E-03 0.01946368 0.02071295 0.1997571 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP sinusitis DOID_0050127 1.488E-03 0.0196841 1.488E-03 0.03022916 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP paranasal sinus disease DOID_1352 1.488E-03 0.0196841 1.488E-03 0.03022916 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP urinary tract obstruction DOID_5200 1.488E-03 0.01923674 0.05551523 0.26544676 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP Human immunodeficiency virus infectious disease DOID_526 1.58E-03 0.01998087 1.58E-03 0.0310048 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP ureteral disease DOID_1426 1.62E-03 0.02004077 0.05785849 0.26984821 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP acute pancreatitis DOID_2913 1.758E-03 0.02128561 0.060196 0.27622198 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP hypersensitivity reaction type I disease DOID_1205 1.839E-03 0.02179735 1.839E-03 0.03375074 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP ulcerative colitis DOID_8577 2.006E-03 0.02329263 0.02572776 0.20618444 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP myositis DOID_633 2.05E-03 0.02333455 0.06485383 0.28386021 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP intracranial aneurysm DOID_10941 2.205E-03 0.0245971 2.205E-03 0.03920163 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP gestational diabetes DOID_11714 2.364E-03 0.02586933 0.06948881 0.29072892 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP periodontitis DOID_824 2.364E-03 0.02538123 0.06948881 0.28651545 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP toxic encephalopathy DOID_3602 2.699E-03 0.02843953 0.07410106 0.29078279 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP opportunistic mycosis DOID_2473 3.055E-03 0.03160353 3.055E-03 0.05267255 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP bronchiolitis obliterans DOID_2799 3.055E-03 0.03103918 0.0786907 0.3005034 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP Charcot-Marie-Tooth disease DOID_10595 3.241E-03 0.03234843 3.241E-03 0.05423119 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP systemic mycosis DOID_0050136 3.627E-03 0.03558604 3.627E-03 0.05897116 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP fungal infectious disease DOID_1564 3.627E-03 0.03558604 3.627E-03 0.05897116 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP periodontal disease DOID_3388 3.829E-03 0.03692245 0.08780254 0.31821431 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP respiratory syncytial virus infectious disease DOID_1273 4.91E-03 0.04656163 4.91E-03 0.07351836 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP adult respiratory distress syndrome DOID_11394 5.141E-03 0.04795525 0.10130339 0.34310495 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP influenza DOID_8469 6.115E-03 0.05612049 0.11019394 0.35625199 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP pre-eclampsia DOID_10591 6.896E-03 0.06228612 0.11680469 0.3692326 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP neuritis DOID_1803 6.896E-03 0.06131289 0.11680469 0.3631796 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP hemolytic anemia DOID_583 7.166E-03 0.06273293 0.11899746 0.36015719 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP normocytic anemia DOID_720 7.166E-03 0.06273293 0.11899746 0.36015719 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP lung small cell carcinoma DOID_5409 7.441E-03 0.06415071 7.441E-03 0.103267 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP hypertrophic cardiomyopathy DOID_11984 0.0101222 0.08596318 0.0101222 0.13394263 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP melancholia DOID_2848 0.01044287 0.08738226 0.01044287 0.13204431 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP neurotic disorder DOID_4964 0.01076801 0.08879703 0.01076801 0.13319554 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP collagen disease DOID_854 0.01109758 0.09020747 0.01109758 0.13435155 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP respiratory failure DOID_11162 0.01143157 0.09161358 0.14913654 0.41394484 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP uterine disease DOID_345 0.01245982 0.09846718 0.01245982 0.14770077 BENPORATH_NANOG_TARGETS pre-malignant neoplasm DOID_0060071 1.437E-12 8.179E-10 7.116E-10 2.024E-07 BENPORATH_NANOG_TARGETS in situ carcinoma DOID_8719 1.437E-12 8.179E-10 7.116E-10 2.024E-07 BENPORATH_NANOG_TARGETS embryonal cancer DOID_688 3.56E-12 1.013E-09 1.229E-10 6.991E-08 BENPORATH_NANOG_TARGETS transitional cell carcinoma DOID_2671 6.518E-11 1.236E-08 2.459E-06 1.272E-04 BENPORATH_NANOG_TARGETS invasive ductal carcinoma DOID_3008 3.05E-10 4.339E-08 1.13E-08 2.142E-06 BENPORATH_NANOG_TARGETS leiomyoma DOID_127 1.177E-09 1.339E-07 1.955E-05 4.449E-04 BENPORATH_NANOG_TARGETS nephroblastoma DOID_2154 1.899E-09 1.801E-07 2.584E-05 5.445E-04 BENPORATH_NANOG_TARGETS cervix uteri carcinoma in situ DOID_8991 8.224E-09 6.685E-07 3.72E-06 1.628E-04 BENPORATH_NANOG_TARGETS astrocytoma DOID_3069 2.926E-08 2.081E-06 5.8E-06 2.2E-04 BENPORATH_NANOG_TARGETS adenoid cystic carcinoma DOID_4866 1.608E-07 1.016E-05 1.608E-07 2.287E-05 BENPORATH_NANOG_TARGETS salivary gland cancer DOID_8850 2.227E-07 1.267E-05 2.227E-07 2.534E-05 BENPORATH_NANOG_TARGETS nervous system cancer DOID_3093 2.527E-07 1.307E-05 2.931E-05 5.957E-04 BENPORATH_NANOG_TARGETS carbohydrate metabolic disorder DOID_2978 3.333E-07 1.58E-05 3.333E-07 3.161E-05 BENPORATH_NANOG_TARGETS focal glomerulosclerosis DOID_3945 4.307E-07 1.885E-05 3.158E-03 0.02165261 BENPORATH_NANOG_TARGETS female reproductive organ benign neoplasm DOID_0060086 5.259E-07 2.137E-05 3.461E-03 0.02316727 BENPORATH_NANOG_TARGETS uterine benign neoplasm DOID_0060095 5.259E-07 2.137E-05 3.461E-03 0.02316727 BENPORATH_NANOG_TARGETS uterine fibroid DOID_13223 5.259E-07 2.137E-05 3.461E-03 0.02316727 BENPORATH_NANOG_TARGETS central nervous system cancer DOID_3620 5.41E-07 2.052E-05 1.249E-04 1.973E-03 BENPORATH_NANOG_TARGETS nephrosis DOID_2527 5.456E-07 1.94E-05 6.971E-06 2.333E-04 BENPORATH_NANOG_TARGETS germinoma DOID_3304 7.68E-07 2.571E-05 1.689E-05 4.177E-04 BENPORATH_NANOG_TARGETS aneurysm disease DOID_2403 9.062E-07 2.865E-05 1.108E-04 1.91E-03 BENPORATH_NANOG_TARGETS orofacial cleft DOID_0050567 9.178E-07 2.749E-05 1.399E-05 3.618E-04 BENPORATH_NANOG_TARGETS hyperthyroidism DOID_7998 1.296E-06 3.687E-05 1.296E-06 1.053E-04 BENPORATH_NANOG_TARGETS reproductive organ benign neoplasm DOID_0050622 1.327E-06 3.596E-05 2.288E-03 0.01759507 BENPORATH_NANOG_TARGETS aplastic anemia DOID_12449 1.527E-06 3.949E-05 1.527E-06 1.086E-04 BENPORATH_NANOG_TARGETS medullomyoblastoma DOID_3861 1.527E-06 3.777E-05 4.622E-04 5.367E-03 BENPORATH_NANOG_TARGETS adult medulloblastoma DOID_3864 1.527E-06 3.777E-05 4.622E-04 5.367E-03 BENPORATH_NANOG_TARGETS childhood medulloblastoma DOID_3869 1.527E-06 3.777E-05 4.622E-04 5.367E-03 BENPORATH_NANOG_TARGETS congenital nervous system abnormality DOID_2490 1.677E-06 3.976E-05 1.677E-06 1.06E-04 BENPORATH_NANOG_TARGETS bone development disease DOID_0080006 1.74E-06 3.959E-05 1.888E-05 4.476E-04 BENPORATH_NANOG_TARGETS glioblastoma DOID_3068 1.879E-06 4.112E-05 2.926E-04 3.871E-03 BENPORATH_NANOG_TARGETS oral cavity cancer DOID_8618 1.879E-06 3.96E-05 1.879E-06 1.069E-04 BENPORATH_NANOG_TARGETS medulloblastoma DOID_3858 2.089E-06 4.245E-05 5.637E-04 6.169E-03 BENPORATH_NANOG_TARGETS congenital heart defect DOID_1682 3.22E-06 6.318E-05 3.22E-06 1.527E-04 BENPORATH_NANOG_TARGETS primitive neuroectodermal tumor DOID_168 4.858E-06 9.214E-05 9.625E-04 8.833E-03 BENPORATH_NANOG_TARGETS papillary adenoma DOID_3172 5.175E-06 9.498E-05 5.175E-06 2.103E-04 BENPORATH_NANOG_TARGETS microcystic adenoma DOID_5403 5.175E-06 9.498E-05 5.175E-06 2.103E-04 BENPORATH_NANOG_TARGETS follicular adenoma DOID_6204 5.175E-06 9.498E-05 5.175E-06 2.103E-04 BENPORATH_NANOG_TARGETS cleft lip DOID_9296 5.175E-06 9.201E-05 1.193E-04 1.94E-03 BENPORATH_NANOG_TARGETS endocrine organ benign neoplasm DOID_0060089 5.279E-06 9.103E-05 6.082E-05 1.116E-03 BENPORATH_NANOG_TARGETS brain infarction DOID_3454 5.279E-06 8.835E-05 5.925E-04 6.361E-03 BENPORATH_NANOG_TARGETS uterine cancer DOID_363 5.525E-06 8.982E-05 1.044E-03 9.141E-03 BENPORATH_NANOG_TARGETS congenital hypoplastic anemia DOID_1342 6.25E-06 9.879E-05 6.25E-06 2.223E-04 BENPORATH_NANOG_TARGETS seminoma DOID_4440 6.25E-06 9.612E-05 1.382E-04 2.069E-03 BENPORATH_NANOG_TARGETS brain cancer DOID_1319 7.982E-06 1.195E-04 1.318E-03 0.01087174 BENPORATH_NANOG_TARGETS thyroid adenoma DOID_2891 7.982E-06 1.165E-04 7.982E-06 2.523E-04 BENPORATH_NANOG_TARGETS bone marrow disease DOID_4961 7.982E-06 1.135E-04 7.982E-06 2.39E-04 BENPORATH_NANOG_TARGETS diabetic retinopathy DOID_8947 8.332E-06 1.156E-04 6.055E-03 0.03281293 BENPORATH_NANOG_TARGETS lung small cell carcinoma DOID_5409 1.006E-05 1.363E-04 1.006E-05 2.863E-04 BENPORATH_NANOG_TARGETS oral submucous fibrosis DOID_5773 1.016E-05 1.344E-04 0.13371868 0.29376806 BENPORATH_NANOG_TARGETS mixed glioma DOID_5076 1.172E-05 1.516E-04 1.02E-03 9.072E-03 BENPORATH_NANOG_TARGETS endometrial carcinoma DOID_2871 1.241E-05 1.57E-04 3.461E-03 0.02263469 BENPORATH_NANOG_TARGETS Fanconi's anemia DOID_13636 1.344E-05 1.663E-04 1.344E-05 3.643E-04 BENPORATH_NANOG_TARGETS giant cell tumor DOID_200 1.554E-05 1.882E-04 2.011E-03 0.01567215 BENPORATH_NANOG_TARGETS malignant giant cell tumor DOID_2705 1.554E-05 1.882E-04 2.011E-03 0.01567215 BENPORATH_NANOG_TARGETS giant cell glioblastoma DOID_3074 1.554E-05 1.882E-04 2.011E-03 0.01567215 BENPORATH_NANOG_TARGETS endometrial cancer DOID_1380 1.689E-05 2.002E-04 4.117E-03 0.02465989 BENPORATH_NANOG_TARGETS vasculitis DOID_865 1.723E-05 2.001E-04 0.01715119 0.06684264 BENPORATH_NANOG_TARGETS mental depression DOID_1596 1.748E-05 1.99E-04 1.661E-04 2.424E-03 BENPORATH_NANOG_TARGETS biliary tract cancer DOID_4607 1.748E-05 1.951E-04 0.04775597 0.1460922 BENPORATH_NANOG_TARGETS retinal vascular disease DOID_2462 2.036E-05 2.228E-04 9.686E-03 0.04374243 BENPORATH_NANOG_TARGETS papilloma DOID_2615 2.252E-05 2.418E-04 2.252E-05 4.929E-04 BENPORATH_NANOG_TARGETS melancholia DOID_2848 2.805E-05 2.956E-04 3.158E-04 3.993E-03 BENPORATH_NANOG_TARGETS neurotic disorder DOID_4964 3.076E-05 3.182E-04 3.403E-04 4.21E-03 BENPORATH_NANOG_TARGETS adenoma DOID_657 3.36E-05 3.414E-04 3.36E-05 6.593E-04 BENPORATH_NANOG_TARGETS neuroectodermal tumor DOID_171 3.367E-05 3.361E-04 3.277E-03 0.02220095 BENPORATH_NANOG_TARGETS lymphoblastic leukemia DOID_1037 3.609E-05 3.54E-04 3.049E-04 3.943E-03 BENPORATH_NANOG_TARGETS encephalomyelitis DOID_640 3.609E-05 3.48E-04 0.01306226 0.05465019 BENPORATH_NANOG_TARGETS hypothyroidism DOID_1459 3.68E-05 3.49E-04 3.68E-05 6.98E-04 BENPORATH_NANOG_TARGETS dilated cardiomyopathy DOID_12930 4.128E-05 3.85E-04 2.399E-03 0.01772983 BENPORATH_NANOG_TARGETS benign mesothelioma DOID_2645 6.096E-05 5.594E-04 8.127E-04 7.973E-03 BENPORATH_NANOG_TARGETS uremia DOID_4676 6.205E-05 5.604E-04 1.316E-03 0.01101525 BENPORATH_NANOG_TARGETS urinary tract obstruction DOID_5200 6.205E-05 5.517E-04 6.205E-05 1.103E-03 BENPORATH_NANOG_TARGETS pancreatic ductal carcinoma DOID_3587 7.115E-05 6.228E-04 0.15349676 0.31992548 BENPORATH_NANOG_TARGETS diabetic autonomic neuropathy DOID_11503 8.411E-05 7.251E-04 0.0738751 0.21337529 BENPORATH_NANOG_TARGETS autonomic neuropathy DOID_11504 8.411E-05 7.251E-04 0.0738751 0.21337529 BENPORATH_NANOG_TARGETS diabetic polyneuropathy DOID_12785 8.411E-05 7.251E-04 0.0738751 0.21337529 BENPORATH_NANOG_TARGETS gallbladder cancer DOID_3121 8.411E-05 7.143E-04 0.01018815 0.04528953 BENPORATH_NANOG_TARGETS diabetic neuropathy DOID_9743 8.411E-05 7.251E-04 0.0738751 0.21337529 BENPORATH_NANOG_TARGETS pancreatic carcinoma DOID_4905 8.921E-05 7.465E-04 0.16351213 0.32875761 BENPORATH_NANOG_TARGETS endogenous depression DOID_1595 1.032E-04 8.507E-04 9.1E-04 8.489E-03 BENPORATH_NANOG_TARGETS bone resorption disease DOID_0080011 1.108E-04 9.002E-04 9.641E-04 8.707E-03 BENPORATH_NANOG_TARGETS osteoporosis DOID_11476 1.108E-04 9.002E-04 9.641E-04 8.707E-03 BENPORATH_NANOG_TARGETS pre-eclampsia DOID_10591 1.135E-04 9.096E-04 0.38041624 0.61493421 BENPORATH_NANOG_TARGETS autonomic nervous system disease DOID_11465 1.135E-04 8.969E-04 0.08219788 0.23153758 BENPORATH_NANOG_TARGETS spinal muscular atrophy DOID_12377 1.193E-04 9.302E-04 1.193E-04 1.997E-03 BENPORATH_NANOG_TARGETS bronchiectasis DOID_9563 1.335E-04 1.026E-03 0.09991059 0.24933826 BENPORATH_NANOG_TARGETS lipid metabolism disorder DOID_3146 1.362E-04 1.033E-03 1.14E-03 9.685E-03 BENPORATH_NANOG_TARGETS glaucoma DOID_1686 1.371E-04 1.026E-03 0.01341135 0.05529751 BENPORATH_NANOG_TARGETS spinal cord disease DOID_319 1.382E-04 1.021E-03 1.382E-04 2.125E-03 BENPORATH_NANOG_TARGETS aortic aneurysm DOID_3627 1.502E-04 1.095E-03 0.01411767 0.05737826 BENPORATH_NANOG_TARGETS supratentorial cancer DOID_1659 2.076E-04 1.495E-03 3.158E-03 0.02191667 BENPORATH_NANOG_TARGETS cerebrum cancer DOID_368 2.076E-04 1.495E-03 3.158E-03 0.02191667 BENPORATH_NANOG_TARGETS vulva cancer DOID_1245 2.281E-04 1.623E-03 2.281E-04 3.245E-03 BENPORATH_NANOG_TARGETS Lynch syndrome DOID_3883 2.281E-04 1.603E-03 2.281E-04 3.166E-03 BENPORATH_NANOG_TARGETS osteochondrodysplasia DOID_2256 2.306E-04 1.6E-03 2.288E-03 0.01736047 BENPORATH_NANOG_TARGETS congenital disorder of glycosylation DOID_5212 2.355E-04 1.615E-03 2.355E-04 3.191E-03 BENPORATH_NANOG_TARGETS abdominal aortic aneurysm DOID_7693 2.66E-04 1.802E-03 0.0393246 0.12570616 BENPORATH_NANOG_TARGETS hypertrophic cardiomyopathy DOID_11984 2.926E-04 1.958E-03 0.02052018 0.07532893 BENPORATH_NANOG_TARGETS bile duct cancer DOID_4606 2.926E-04 1.936E-03 0.44239712 0.69537005 BENPORATH_NANOG_TARGETS bile duct carcinoma DOID_4897 2.926E-04 1.936E-03 0.44239712 0.69537005 BENPORATH_NANOG_TARGETS skeletal system cancer DOID_0060124 3.579E-04 2.34E-03 0.13371868 0.2995509 BENPORATH_NANOG_TARGETS bone cancer DOID_184 3.579E-04 2.34E-03 0.13371868 0.2995509 BENPORATH_NANOG_TARGETS varicose veins DOID_799 3.579E-04 2.314E-03 8.748E-03 0.04079837 BENPORATH_NANOG_TARGETS myocarditis DOID_820 3.744E-04 2.394E-03 0.04606051 0.14166718 BENPORATH_NANOG_TARGETS ulcerative colitis DOID_8577 4.019E-04 2.541E-03 0.07060462 0.20602067 BENPORATH_NANOG_TARGETS spindle cell carcinoma DOID_4015 4.166E-04 2.605E-03 4.166E-04 5.044E-03 BENPORATH_NANOG_TARGETS vein disease DOID_866 4.373E-04 2.705E-03 9.935E-03 0.0445111 BENPORATH_NANOG_TARGETS lymphoid leukemia DOID_10747 4.622E-04 2.828E-03 4.622E-04 5.479E-03 BENPORATH_NANOG_TARGETS parasitic infectious disease DOID_1398 4.855E-04 2.939E-03 4.078E-03 0.02495062 BENPORATH_NANOG_TARGETS congenital disorder of glycosylation type I DOID_0050570 5.273E-04 3.158E-03 5.273E-04 6.001E-03 BENPORATH_NANOG_TARGETS peroxisomal disease DOID_906 5.273E-04 3.125E-03 5.273E-04 5.883E-03 BENPORATH_NANOG_TARGETS calcinosis DOID_182 5.637E-04 3.307E-03 0.31812922 0.52928516 BENPORATH_NANOG_TARGETS cleft palate DOID_674 5.637E-04 3.273E-03 6.518E-03 0.03466293 BENPORATH_NANOG_TARGETS microcephaly DOID_10907 6.2E-04 3.564E-03 6.2E-04 6.533E-03 BENPORATH_NANOG_TARGETS ureteral obstruction DOID_5199 6.283E-04 3.575E-03 6.283E-04 6.5E-03 BENPORATH_NANOG_TARGETS congenital diaphragmatic hernia DOID_3827 6.802E-04 3.832E-03 7.469E-03 0.03760889 BENPORATH_NANOG_TARGETS heart septal defect DOID_1681 7.409E-04 4.133E-03 7.409E-04 7.528E-03 BENPORATH_NANOG_TARGETS granulosa cell tumor DOID_2999 7.409E-04 4.093E-03 7.409E-04 7.396E-03 BENPORATH_NANOG_TARGETS intracranial arterial disease DOID_13089 7.444E-04 4.073E-03 0.06323958 0.18548103 BENPORATH_NANOG_TARGETS cerebral arterial disease DOID_3527 7.444E-04 4.073E-03 0.06323958 0.18548103 BENPORATH_NANOG_TARGETS colon carcinoma DOID_1520 8.655E-04 4.69E-03 8.655E-04 8.347E-03 BENPORATH_NANOG_TARGETS sex cord-gonadal stromal tumor DOID_192 8.655E-04 4.646E-03 8.655E-04 8.208E-03 BENPORATH_NANOG_TARGETS subependymal glioma DOID_4843 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS pilocytic astrocytoma DOID_4851 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS subependymal giant cell astrocytoma DOID_5077 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS fibrillary astrocytoma DOID_6726 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS juvenile pilocytic astrocytoma DOID_6811 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS childhood pilocytic astrocytoma DOID_6812 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS gemistocytic astrocytoma DOID_7005 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS childhood cerebral astrocytoma DOID_7007 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS protoplasmic astrocytoma DOID_7008 8.655E-04 4.602E-03 0.01534135 0.06061966 BENPORATH_NANOG_TARGETS nephrotic syndrome DOID_1184 9.625E-04 5.071E-03 9.604E-03 0.04371966 BENPORATH_NANOG_TARGETS electroclinical syndrome DOID_0050701 1.02E-03 5.327E-03 7.247E-03 0.03681768 BENPORATH_NANOG_TARGETS cerebral infarction DOID_3526 1.131E-03 5.848E-03 0.01079199 0.04760187 BENPORATH_NANOG_TARGETS metabolic syndrome X DOID_14221 1.14E-03 5.846E-03 1.14E-03 9.832E-03 BENPORATH_NANOG_TARGETS benign glioma DOID_0060101 1.153E-03 5.857E-03 0.01842048 0.07034399 BENPORATH_NANOG_TARGETS familial hypercholesterolemia DOID_13810 1.153E-03 5.805E-03 0.01842048 0.06987503 BENPORATH_NANOG_TARGETS benign ependymoma DOID_4844 1.153E-03 5.857E-03 0.01842048 0.07034399 BENPORATH_NANOG_TARGETS proteinuria DOID_576 1.222E-03 6.099E-03 0.01141612 0.0492104 BENPORATH_NANOG_TARGETS pulmonary embolism DOID_9477 1.316E-03 6.513E-03 0.19758276 0.36740062 BENPORATH_NANOG_TARGETS focal epilepsy DOID_2234 1.34E-03 6.571E-03 8.942E-03 0.04136577 BENPORATH_NANOG_TARGETS synostosis DOID_11971 1.494E-03 7.265E-03 1.494E-03 0.01214336 BENPORATH_NANOG_TARGETS ureteral disease DOID_1426 1.494E-03 7.204E-03 1.494E-03 0.01197233 BENPORATH_NANOG_TARGETS integumentary system benign neoplasm DOID_0060121 1.527E-03 7.301E-03 0.01341135 0.05570114 BENPORATH_NANOG_TARGETS skin benign neoplasm DOID_3165 1.527E-03 7.301E-03 0.01341135 0.05570114 BENPORATH_NANOG_TARGETS calcium metabolism disease DOID_10575 1.639E-03 7.773E-03 0.39797122 0.63787499 BENPORATH_NANOG_TARGETS movement disease DOID_480 1.639E-03 7.708E-03 1.639E-03 0.01295446 BENPORATH_NANOG_TARGETS myositis DOID_633 2.114E-03 9.859E-03 0.027132 0.09471232 BENPORATH_NANOG_TARGETS bile duct adenocarcinoma DOID_4896 2.146E-03 9.929E-03 1.000 1.000 BENPORATH_NANOG_TARGETS cholangiocarcinoma DOID_4947 2.146E-03 9.929E-03 1.000 1.000 BENPORATH_NANOG_TARGETS integumentary system cancer DOID_0060122 2.288E-03 0.01050028 0.01796189 0.06952596 BENPORATH_NANOG_TARGETS parasitic protozoa infectious disease DOID_2789 2.288E-03 0.01041628 0.01796189 0.06905619 BENPORATH_NANOG_TARGETS skin cancer DOID_4159 2.288E-03 0.01050028 0.01796189 0.06952596 BENPORATH_NANOG_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 2.293E-03 0.01035582 2.293E-03 0.01716886 BENPORATH_NANOG_TARGETS intracranial aneurysm DOID_10941 2.351E-03 0.01053289 0.23509063 0.42064959 BENPORATH_NANOG_TARGETS middle cerebral artery infarction DOID_3525 2.351E-03 0.01045061 0.02903824 0.09893866 BENPORATH_NANOG_TARGETS familial hyperlipidemia DOID_1168 2.437E-03 0.01074714 0.01879361 0.07035239 BENPORATH_NANOG_TARGETS lung adenocarcinoma DOID_3910 2.604E-03 0.01139677 2.604E-03 0.01899461 BENPORATH_NANOG_TARGETS retinitis pigmentosa DOID_10584 2.753E-03 0.01195567 2.753E-03 0.01982522 BENPORATH_NANOG_TARGETS autoimmune disease of cardiovascular system DOID_0060051 2.873E-03 0.01238394 0.03300516 0.11047021 BENPORATH_NANOG_TARGETS renal hypertension DOID_1073 2.873E-03 0.01229083 0.24959952 0.4356507 BENPORATH_NANOG_TARGETS secondary hypertension DOID_11130 2.873E-03 0.01229083 0.24959952 0.4356507 BENPORATH_NANOG_TARGETS sarcoma DOID_1115 2.873E-03 0.01219911 0.03300516 0.10982418 BENPORATH_NANOG_TARGETS Behcet's disease DOID_13241 2.873E-03 0.01238394 0.03300516 0.11047021 BENPORATH_NANOG_TARGETS arrhythmogenic right ventricular dysplasia DOID_0050431 3.114E-03 0.01312692 3.114E-03 0.02215168 BENPORATH_NANOG_TARGETS autoimmune disease of endocrine system DOID_0060005 3.158E-03 0.01321446 3.158E-03 0.02218724 BENPORATH_NANOG_TARGETS multiple epiphyseal dysplasia DOID_12721 3.158E-03 0.01311801 0.03506355 0.11400663 BENPORATH_NANOG_TARGETS carotid artery disease DOID_3407 3.277E-03 0.01351362 0.12427847 0.28629331 BENPORATH_NANOG_TARGETS dysostosis DOID_1934 3.461E-03 0.01416703 3.461E-03 0.02289788 BENPORATH_NANOG_TARGETS respiratory failure DOID_11162 3.467E-03 0.0140891 0.02422626 0.08669648 BENPORATH_NANOG_TARGETS mineral metabolism disease DOID_0050032 3.867E-03 0.015604 0.47355721 0.74025838 BENPORATH_NANOG_TARGETS facioscapulohumeral muscular dystrophy DOID_11727 3.869E-03 0.01550182 3.869E-03 0.0250143 BENPORATH_NANOG_TARGETS ventricular septal defect DOID_1657 3.869E-03 0.01539342 3.869E-03 0.02473324 BENPORATH_NANOG_TARGETS transient cerebral ischemia DOID_224 3.869E-03 0.01528652 3.869E-03 0.02445843 BENPORATH_NANOG_TARGETS progressive muscular atrophy DOID_318 3.869E-03 0.01518109 3.869E-03 0.02418965 BENPORATH_NANOG_TARGETS holoprosencephaly DOID_4621 3.869E-03 0.01507711 3.869E-03 0.02392672 BENPORATH_NANOG_TARGETS uterine disease DOID_345 4.078E-03 0.01578509 0.1370951 0.29887783 BENPORATH_NANOG_TARGETS Charcot-Marie-Tooth disease DOID_10595 4.117E-03 0.01582898 4.117E-03 0.02492223 BENPORATH_NANOG_TARGETS allergic rhinitis DOID_4481 4.117E-03 0.01572275 0.27779911 0.47184387 BENPORATH_NANOG_TARGETS temporal lobe epilepsy DOID_3328 4.297E-03 0.0163001 0.02826926 0.09748613 BENPORATH_NANOG_TARGETS chronic leukemia DOID_1036 4.472E-03 0.01685053 0.04377071 0.13836409 BENPORATH_NANOG_TARGETS chronic lymphocytic leukemia DOID_1040 4.472E-03 0.01685053 0.04377071 0.13836409 BENPORATH_NANOG_TARGETS childhood absence epilepsy DOID_1825 4.472E-03 0.01673967 4.472E-03 0.02650448 BENPORATH_NANOG_TARGETS familial adenomatous polyposis DOID_0050424 4.699E-03 0.01747416 4.699E-03 0.02756234 BENPORATH_NANOG_TARGETS trypanosomiasis DOID_10113 4.699E-03 0.0173607 4.699E-03 0.02728109 BENPORATH_NANOG_TARGETS neuronal ceroid lipofuscinosis DOID_14503 4.699E-03 0.01724869 4.699E-03 0.02700553 BENPORATH_NANOG_TARGETS hemochromatosis DOID_2352 4.699E-03 0.01713812 4.699E-03 0.02673547 BENPORATH_NANOG_TARGETS invasive lobular carcinoma DOID_3457 4.699E-03 0.01702896 0.09991059 0.25266277 BENPORATH_NANOG_TARGETS metal metabolism disorder DOID_896 4.844E-03 0.01744542 4.844E-03 0.02729085 BENPORATH_NANOG_TARGETS thyroid carcinoma DOID_3963 5.235E-03 0.01873375 5.235E-03 0.02920262 BENPORATH_NANOG_TARGETS lipodystrophy DOID_811 5.603E-03 0.0199259 5.603E-03 0.03095285 BENPORATH_NANOG_TARGETS ocular hypertension DOID_9282 5.603E-03 0.01980213 1.000 1.000 BENPORATH_NANOG_TARGETS borderline glaucoma DOID_9283 5.603E-03 0.01980213 1.000 1.000 BENPORATH_NANOG_TARGETS childhood electroclinical syndrome DOID_0050704 5.644E-03 0.0198237 5.644E-03 0.03087923 BENPORATH_NANOG_TARGETS biliary tract disease DOID_9741 5.779E-03 0.02017328 0.16016048 0.32316068 BENPORATH_NANOG_TARGETS thyroid cancer DOID_1781 6.072E-03 0.02106598 6.072E-03 0.03259265 BENPORATH_NANOG_TARGETS osteogenesis imperfecta DOID_12347 6.58E-03 0.02269215 6.58E-03 0.03466856 BENPORATH_NANOG_TARGETS larynx cancer DOID_2596 6.58E-03 0.02255545 1.000 1.000 BENPORATH_NANOG_TARGETS laryngeal benign neoplasm DOID_2598 6.58E-03 0.02255545 1.000 1.000 BENPORATH_NANOG_TARGETS vesiculobullous skin disease DOID_2731 6.58E-03 0.02242038 6.58E-03 0.0343505 BENPORATH_NANOG_TARGETS monocytic leukemia DOID_8527 6.58E-03 0.02228693 6.58E-03 0.03403822 BENPORATH_NANOG_TARGETS syndrome DOID_225 6.633E-03 0.02233365 6.633E-03 0.03400349 BENPORATH_NANOG_TARGETS open-angle glaucoma DOID_1067 7.629E-03 0.02553468 7.629E-03 0.03807804 BENPORATH_NANOG_TARGETS tethered spinal cord syndrome DOID_1089 7.629E-03 0.02538536 7.629E-03 0.03774692 BENPORATH_NANOG_TARGETS rhabdomyosarcoma DOID_3247 7.629E-03 0.02523777 7.629E-03 0.03742152 BENPORATH_NANOG_TARGETS congenital structural myopathy DOID_422 7.629E-03 0.02509189 7.629E-03 0.03710168 BENPORATH_NANOG_TARGETS Zellweger syndrome DOID_905 7.629E-03 0.02494768 7.629E-03 0.03678726 BENPORATH_NANOG_TARGETS contact dermatitis DOID_2773 7.897E-03 0.02567676 0.18386521 0.35706246 BENPORATH_NANOG_TARGETS adult respiratory distress syndrome DOID_11394 7.973E-03 0.02577713 0.06323958 0.18644207 BENPORATH_NANOG_TARGETS female reproductive system disease DOID_229 8.236E-03 0.02647603 0.18729309 0.3624822 BENPORATH_NANOG_TARGETS pulmonary emphysema DOID_9675 8.497E-03 0.02716234 1.000 1.000 BENPORATH_NANOG_TARGETS auditory system disease DOID_2742 8.584E-03 0.02728728 8.584E-03 0.04104557 BENPORATH_NANOG_TARGETS thoracic aortic aneurysm DOID_14004 8.748E-03 0.02765223 1.000 1.000 BENPORATH_NANOG_TARGETS hemangioma DOID_255 8.748E-03 0.02749945 0.13371868 0.29721066 BENPORATH_NANOG_TARGETS membranoproliferative glomerulonephritis DOID_2920 8.748E-03 0.02734836 8.748E-03 0.04147834 BENPORATH_NANOG_TARGETS mesenchymal cell neoplasm DOID_3350 8.748E-03 0.02719891 0.13371868 0.2960542 BENPORATH_NANOG_TARGETS skeletal muscle cancer DOID_4043 8.748E-03 0.02705109 8.748E-03 0.04113554 BENPORATH_NANOG_TARGETS spindle cell sarcoma DOID_4235 8.748E-03 0.02719891 0.13371868 0.2960542 BENPORATH_NANOG_TARGETS epithelioid sarcoma DOID_6193 8.748E-03 0.02719891 0.13371868 0.2960542 BENPORATH_NANOG_TARGETS spinocerebellar ataxia DOID_1441 9.041E-03 0.02780683 9.041E-03 0.04148599 BENPORATH_NANOG_TARGETS endometriosis of uterus DOID_288 9.041E-03 0.02765733 0.35001635 0.57229684 BENPORATH_NANOG_TARGETS endometriosis DOID_289 9.604E-03 0.02922437 0.35621304 0.57910063 BENPORATH_NANOG_TARGETS angiosarcoma DOID_0001816 9.935E-03 0.03006867 0.14197094 0.30832619 BENPORATH_NANOG_TARGETS Graves' disease DOID_12361 0.01118915 0.03368585 0.01118915 0.04897404 BENPORATH_NANOG_TARGETS urinary system benign neoplasm DOID_731 0.01118915 0.03350856 0.1501448 0.31408967 BENPORATH_NANOG_TARGETS primary immunodeficiency disease DOID_612 0.01129323 0.03364318 0.05638578 0.16886058 BENPORATH_NANOG_TARGETS spinocerebellar degeneration DOID_2478 0.01141612 0.03383215 0.01141612 0.04958605 BENPORATH_NANOG_TARGETS neuritis DOID_1803 0.01206066 0.03555707 0.01206066 0.05159785 BENPORATH_NANOG_TARGETS keratosis DOID_161 0.01250925 0.03668951 0.01250925 0.05311765 BENPORATH_NANOG_TARGETS prion disease DOID_649 0.01250925 0.03650136 0.15824101 0.32156833 BENPORATH_NANOG_TARGETS lymphoma DOID_0060058 0.01260451 0.03659165 0.01260451 0.05312566 BENPORATH_NANOG_TARGETS mouth disease DOID_403 0.01353048 0.03908042 0.60135323 0.92229107 BENPORATH_NANOG_TARGETS Crohn's disease DOID_8778 0.01353048 0.03888305 0.2324972 0.41732146 BENPORATH_NANOG_TARGETS infertility DOID_5223 0.01389377 0.0397264 0.01389377 0.05687449 BENPORATH_NANOG_TARGETS B-cell lymphocytic neoplasm DOID_707 0.01484476 0.04223334 0.01484476 0.05990544 BENPORATH_NANOG_TARGETS microphthalmia DOID_10629 0.01534135 0.04342901 0.01534135 0.06147346 BENPORATH_NANOG_TARGETS membranous glomerulonephritis DOID_10976 0.01534135 0.04321401 0.01534135 0.06104357 BENPORATH_NANOG_TARGETS atrophic muscular disease DOID_913 0.01636146 0.04586045 0.01636146 0.06420463 BENPORATH_NANOG_TARGETS muscular dystrophy DOID_9884 0.01636146 0.04586045 0.01636146 0.06420463 BENPORATH_NANOG_TARGETS gastric ulcer DOID_10808 0.01842048 0.0513787 0.18986392 0.3662121 BENPORATH_NANOG_TARGETS muscular atrophy DOID_767 0.01842048 0.05112807 0.01842048 0.06941228 BENPORATH_NANOG_TARGETS sinusitis DOID_0050127 0.02004944 0.05537928 0.19758276 0.37350362 BENPORATH_NANOG_TARGETS paranasal sinus disease DOID_1352 0.02004944 0.05537928 0.19758276 0.37350362 BENPORATH_NANOG_TARGETS muscle cancer DOID_4045 0.02004944 0.05511175 0.02004944 0.07456296 BENPORATH_NANOG_TARGETS hypoglycemia DOID_9993 0.02004944 0.05484679 0.19758276 0.36620388 BENPORATH_NANOG_TARGETS nonsyndromic deafness DOID_0050563 0.02052018 0.05586595 0.02052018 0.07581808 BENPORATH_NANOG_TARGETS aortic valve disease DOID_62 0.02173631 0.05889504 0.02173631 0.07928179 BENPORATH_NANOG_TARGETS spastic quadriplegia DOID_10970 0.02347984 0.06331767 0.02347984 0.08509572 BENPORATH_NANOG_TARGETS sphingolipidosis DOID_1927 0.02347984 0.063019 0.02347984 0.08455714 BENPORATH_NANOG_TARGETS reading disorder DOID_13365 0.0252788 0.06752882 0.0252788 0.08989775 BENPORATH_NANOG_TARGETS osteosarcoma DOID_3347 0.0252788 0.06721327 0.0252788 0.08933938 BENPORATH_NANOG_TARGETS dyslexia DOID_4428 0.0252788 0.06752882 0.0252788 0.08989775 BENPORATH_NANOG_TARGETS combined T cell and B cell immunodeficiency DOID_628 0.0252788 0.06690065 0.0252788 0.0887879 BENPORATH_NANOG_TARGETS cerebral degeneration DOID_1443 0.02722699 0.07172296 0.02722699 0.09446439 BENPORATH_NANOG_TARGETS myopia DOID_11830 0.02903824 0.07614174 0.02903824 0.09953468 BENPORATH_NANOG_TARGETS allergic contact dermatitis DOID_3042 0.02933249 0.0765605 0.14360867 0.30490049 BENPORATH_NANOG_TARGETS tuberculosis DOID_399 0.03041664 0.0790277 0.1468896 0.31070699 BENPORATH_NANOG_TARGETS diffuse large B-cell lymphoma DOID_0050745 0.03099634 0.08016781 0.03099634 0.10498166 BENPORATH_NANOG_TARGETS Sciatic Neuropathy DOID_11446 0.03099634 0.07980506 0.03099634 0.10436046 BENPORATH_NANOG_TARGETS gestational diabetes DOID_11714 0.03099634 0.07944558 0.24237971 0.42830452 BENPORATH_NANOG_TARGETS lesion of sciatic nerve DOID_12528 0.03099634 0.07980506 0.03099634 0.10436046 BENPORATH_NANOG_TARGETS periodontitis DOID_824 0.03099634 0.07908932 1.000 1.000 BENPORATH_NANOG_TARGETS mononeuritis of lower limb DOID_9473 0.03099634 0.07980506 0.03099634 0.10436046 BENPORATH_NANOG_TARGETS mononeuritis DOID_1802 0.03300516 0.083839 0.03300516 0.10918567 BENPORATH_NANOG_TARGETS bile duct disease DOID_4138 0.03379408 0.08546148 0.15682184 0.32566286 BENPORATH_NANOG_TARGETS male reproductive system disease DOID_48 0.03379408 0.08508333 0.15682184 0.32447864 BENPORATH_NANOG_TARGETS polycystic ovary syndrome DOID_11612 0.03506355 0.08789058 0.03506355 0.11532463 BENPORATH_NANOG_TARGETS mononeuropathy DOID_1188 0.03506355 0.08750509 0.03506355 0.11466184 BENPORATH_NANOG_TARGETS cranial nerve disease DOID_5656 0.03506355 0.08712297 0.03506355 0.11335887 BENPORATH_NANOG_TARGETS spastic cerebral palsy DOID_0050669 0.0393246 0.09728563 0.0393246 0.12641636 DER_IFN_GAMMA_RESPONSE_UP multiple myeloma DOID_9538 1.195E-09 6.799E-07 1.497E-05 4.26E-03 DER_IFN_GAMMA_RESPONSE_UP myeloma DOID_0070004 3.814E-09 1.085E-06 2.946E-05 5.587E-03 DER_IFN_GAMMA_RESPONSE_UP bone marrow cancer DOID_4960 7.49E-09 1.421E-06 4.372E-05 6.219E-03 DER_IFN_GAMMA_RESPONSE_UP thyroiditis DOID_7166 8.657E-07 1.231E-04 1.636E-04 0.01329672 DER_IFN_GAMMA_RESPONSE_UP autoimmune thyroiditis DOID_7188 8.657E-07 1.231E-04 1.636E-04 0.01329672 DER_IFN_GAMMA_RESPONSE_UP psoriasis DOID_8893 1.494E-06 1.7E-04 1.494E-06 8.502E-04 DER_IFN_GAMMA_RESPONSE_UP tuberculosis DOID_399 1.588E-06 1.505E-04 3.25E-03 0.07704823 DER_IFN_GAMMA_RESPONSE_UP bacterial pneumonia DOID_874 2.564E-06 2.084E-04 4.105E-03 0.08650283 DER_IFN_GAMMA_RESPONSE_UP contact dermatitis DOID_2773 2.831E-06 2.013E-04 1.296E-04 0.01229103 DER_IFN_GAMMA_RESPONSE_UP primary bacterial infectious disease DOID_0050338 3.928E-06 2.483E-04 5.052E-03 0.10267228 DER_IFN_GAMMA_RESPONSE_UP middle cerebral artery infarction DOID_3525 5.014E-06 2.853E-04 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP encephalomyelitis DOID_640 5.095E-06 2.635E-04 2.004E-04 0.0126696 DER_IFN_GAMMA_RESPONSE_UP autoimmune disease of endocrine system DOID_0060005 6.863E-06 3.254E-04 6.267E-04 0.02377402 DER_IFN_GAMMA_RESPONSE_UP respiratory syncytial virus infectious disease DOID_1273 1.737E-05 7.602E-04 0.04868518 0.4014763 DER_IFN_GAMMA_RESPONSE_UP adult respiratory distress syndrome DOID_11394 1.865E-05 7.582E-04 0.04981563 0.4049299 DER_IFN_GAMMA_RESPONSE_UP intracranial arterial disease DOID_13089 1.865E-05 7.076E-04 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP cerebral arterial disease DOID_3527 1.865E-05 7.076E-04 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP cerebral infarction DOID_3526 2.604E-05 9.259E-04 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.316E-05 1.11E-03 1.759E-03 0.05268073 DER_IFN_GAMMA_RESPONSE_UP pulmonary tuberculosis DOID_2957 3.316E-05 1.048E-03 0.05993079 0.43165339 DER_IFN_GAMMA_RESPONSE_UP parasitic protozoa infectious disease DOID_2789 4.607E-05 1.38E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP pustulosis of palm and sole DOID_4398 4.607E-05 1.311E-03 2.183E-03 0.05646101 DER_IFN_GAMMA_RESPONSE_UP respiratory failure DOID_11162 6.483E-05 1.757E-03 0.07435593 0.47537667 DER_IFN_GAMMA_RESPONSE_UP parasitic infectious disease DOID_1398 7.42E-05 1.919E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP bronchiectasis DOID_9563 7.526E-05 1.862E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP hyperglycemia DOID_4195 7.751E-05 1.838E-03 0.07875073 0.4924084 DER_IFN_GAMMA_RESPONSE_UP allergic contact dermatitis DOID_3042 8.091E-05 1.842E-03 8.091E-05 9.208E-03 DER_IFN_GAMMA_RESPONSE_UP brain infarction DOID_3454 8.441E-05 1.847E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP peripheral vascular disease DOID_341 9.94E-05 2.095E-03 0.0853047 0.521918 DER_IFN_GAMMA_RESPONSE_UP lymphoma DOID_0060058 1.942E-04 3.947E-03 1.942E-04 0.01381464 DER_IFN_GAMMA_RESPONSE_UP Crohn's disease DOID_8778 2.067E-04 4.055E-03 0.10788654 0.5959946 DER_IFN_GAMMA_RESPONSE_UP ureteral obstruction DOID_5199 2.082E-04 3.95E-03 2.082E-04 0.0118494 DER_IFN_GAMMA_RESPONSE_UP autoimmune hepatitis DOID_2048 2.852E-04 5.235E-03 0.02463956 0.3186343 DER_IFN_GAMMA_RESPONSE_UP urinary tract obstruction DOID_5200 3.431E-04 6.1E-03 3.431E-04 0.01774566 DER_IFN_GAMMA_RESPONSE_UP diabetic angiopathy DOID_11713 3.74E-04 6.448E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP ureteral disease DOID_1426 3.74E-04 6.258E-03 3.74E-04 0.01773226 DER_IFN_GAMMA_RESPONSE_UP meningitis DOID_9471 3.74E-04 6.08E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP spastic quadriplegia DOID_10970 4.062E-04 6.42E-03 0.02926504 0.35429372 DER_IFN_GAMMA_RESPONSE_UP urticaria DOID_1555 4.397E-04 6.762E-03 0.03041805 0.35322183 DER_IFN_GAMMA_RESPONSE_UP ankylosing spondylitis DOID_7147 4.745E-04 7.105E-03 0.03156972 0.35926345 DER_IFN_GAMMA_RESPONSE_UP pleurisy DOID_10247 5.867E-04 8.56E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP sarcoma DOID_1115 5.867E-04 8.346E-03 5.867E-04 0.02568116 DER_IFN_GAMMA_RESPONSE_UP malaria DOID_12365 5.867E-04 8.143E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP thrombocytopenia DOID_1588 5.867E-04 7.949E-03 5.867E-04 0.02384679 DER_IFN_GAMMA_RESPONSE_UP spastic cerebral palsy DOID_0050669 7.106E-04 9.403E-03 0.03845173 0.39069708 DER_IFN_GAMMA_RESPONSE_UP celiac disease DOID_10608 7.544E-04 9.756E-03 0.03959408 0.38843154 DER_IFN_GAMMA_RESPONSE_UP chronic leukemia DOID_1036 7.995E-04 0.01010961 0.04073509 0.392852 DER_IFN_GAMMA_RESPONSE_UP chronic lymphocytic leukemia DOID_1040 7.995E-04 0.01010961 0.04073509 0.392852 DER_IFN_GAMMA_RESPONSE_UP pleural disease DOID_1532 7.995E-04 9.89E-03 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP nephroblastoma DOID_2154 8.936E-04 0.01081809 8.936E-04 0.03177815 DER_IFN_GAMMA_RESPONSE_UP blood platelet disease DOID_2218 1.097E-03 0.01300279 1.097E-03 0.03671375 DER_IFN_GAMMA_RESPONSE_UP congenital diaphragmatic hernia DOID_3827 1.151E-03 0.01336421 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP Huntington's disease DOID_12858 1.379E-03 0.01569627 1.379E-03 0.04360076 DER_IFN_GAMMA_RESPONSE_UP influenza DOID_8469 1.44E-03 0.01606032 0.05432433 0.42343207 DER_IFN_GAMMA_RESPONSE_UP cataract DOID_83 1.501E-03 0.01642393 0.05544823 0.42635191 DER_IFN_GAMMA_RESPONSE_UP proteinuria DOID_576 1.564E-03 0.01678709 0.05657082 0.42918398 DER_IFN_GAMMA_RESPONSE_UP lens disease DOID_110 1.628E-03 0.01714979 0.05769211 0.43193174 DER_IFN_GAMMA_RESPONSE_UP vascular skin disease DOID_9540 1.628E-03 0.01683798 0.05769211 0.42632224 DER_IFN_GAMMA_RESPONSE_UP glaucoma DOID_1686 1.759E-03 0.01787382 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP hemorrhagic disease DOID_2213 1.896E-03 0.01892222 1.896E-03 0.05392833 DER_IFN_GAMMA_RESPONSE_UP B-cell lymphocytic neoplasm DOID_707 1.896E-03 0.01859597 1.896E-03 0.05136031 DER_IFN_GAMMA_RESPONSE_UP bile duct adenocarcinoma DOID_4896 2.109E-03 0.0203426 0.06550475 0.4659025 DER_IFN_GAMMA_RESPONSE_UP cholangiocarcinoma DOID_4947 2.109E-03 0.0203426 0.06550475 0.4659025 DER_IFN_GAMMA_RESPONSE_UP integumentary system cancer DOID_0060122 2.183E-03 0.02070237 0.06661565 0.46224764 DER_IFN_GAMMA_RESPONSE_UP skin cancer DOID_4159 2.183E-03 0.02070237 0.06661565 0.46224764 DER_IFN_GAMMA_RESPONSE_UP mitochondrial metabolism disease DOID_700 2.258E-03 0.02106161 0.06772527 0.46428527 DER_IFN_GAMMA_RESPONSE_UP hypertrophic cardiomyopathy DOID_11984 2.411E-03 0.02212975 0.06994063 0.47376452 DER_IFN_GAMMA_RESPONSE_UP hypersensitivity reaction type IV disease DOID_2916 2.411E-03 0.02177848 0.06994063 0.46819082 DER_IFN_GAMMA_RESPONSE_UP bile duct cancer DOID_4606 2.411E-03 0.02143819 0.06994063 0.46274674 DER_IFN_GAMMA_RESPONSE_UP bile duct carcinoma DOID_4897 2.411E-03 0.02143819 0.06994063 0.46274674 DER_IFN_GAMMA_RESPONSE_UP hypothyroidism DOID_1459 2.732E-03 0.02391988 2.732E-03 0.06759965 DER_IFN_GAMMA_RESPONSE_UP endocrine pancreas disease DOID_1428 2.9E-03 0.02500344 0.07655589 0.48400332 DER_IFN_GAMMA_RESPONSE_UP cholestasis DOID_13580 2.986E-03 0.02535753 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP blood coagulation disease DOID_1247 3.432E-03 0.0287151 3.432E-03 0.07810507 DER_IFN_GAMMA_RESPONSE_UP nephrosis DOID_2527 3.524E-03 0.02906314 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP bile duct disease DOID_4138 3.524E-03 0.02864796 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP male reproductive system disease DOID_48 3.524E-03 0.02824446 0.08421555 0.52085484 DER_IFN_GAMMA_RESPONSE_UP biliary tract disease DOID_9741 3.618E-03 0.02859373 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP diabetic retinopathy DOID_8947 3.713E-03 0.02894247 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP cystic fibrosis DOID_1485 3.907E-03 0.03003889 0.08856457 0.53609828 DER_IFN_GAMMA_RESPONSE_UP electroclinical syndrome DOID_0050701 4.105E-03 0.03114102 0.0907315 0.53777314 DER_IFN_GAMMA_RESPONSE_UP pancreatitis DOID_4989 4.105E-03 0.03073127 0.0907315 0.53222909 DER_IFN_GAMMA_RESPONSE_UP mixed glioma DOID_5076 4.105E-03 0.03033216 4.105E-03 0.08982986 DER_IFN_GAMMA_RESPONSE_UP metabolic syndrome X DOID_14221 4.307E-03 0.03142159 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP biliary tract cancer DOID_4607 4.62E-03 0.0332748 0.09612681 0.55812402 DER_IFN_GAMMA_RESPONSE_UP retinal vascular disease DOID_2462 4.834E-03 0.03438105 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP amino acid metabolic disorder DOID_9252 5.275E-03 0.03705823 0.10255987 0.58946028 DER_IFN_GAMMA_RESPONSE_UP lymphoblastic leukemia DOID_1037 5.735E-03 0.03979407 0.10682369 0.60180871 DER_IFN_GAMMA_RESPONSE_UP carbohydrate metabolic disorder DOID_2978 5.735E-03 0.03931462 0.10682369 0.59590862 DER_IFN_GAMMA_RESPONSE_UP hypersensitivity reaction type I disease DOID_1205 5.971E-03 0.04044753 0.10894816 0.59607216 DER_IFN_GAMMA_RESPONSE_UP dilated cardiomyopathy DOID_12930 5.971E-03 0.03997167 0.10894816 0.59039529 DER_IFN_GAMMA_RESPONSE_UP ulcerative colitis DOID_8577 6.334E-03 0.041907 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP hyperparathyroidism DOID_13543 0.0118081 0.07722767 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP angioedema DOID_1558 0.0118081 0.07635009 0.0118081 0.23168302 DER_IFN_GAMMA_RESPONSE_UP retinal vascular occlusion DOID_1729 0.0118081 0.07549222 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP transient cerebral ischemia DOID_224 0.0118081 0.07465342 0.0118081 0.22396025 DER_IFN_GAMMA_RESPONSE_UP conjunctival disease DOID_4251 0.0118081 0.07383305 0.0118081 0.21673573 DER_IFN_GAMMA_RESPONSE_UP Paget's disease of bone DOID_5408 0.0118081 0.07303052 0.0118081 0.20996274 DER_IFN_GAMMA_RESPONSE_UP conjunctivitis DOID_6195 0.0118081 0.07383305 0.0118081 0.21673573 DER_IFN_GAMMA_RESPONSE_UP visceral leishmaniasis DOID_9146 0.0118081 0.07224524 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP prediabetes syndrome DOID_11716 0.01298138 0.07857879 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP retinal detachment DOID_5327 0.0141533 0.08477084 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP ocular hypertension DOID_9282 0.0141533 0.08388781 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP borderline glaucoma DOID_9283 0.0141533 0.08388781 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP berylliosis DOID_10322 0.01532386 0.08988947 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP parathyroid gland disease DOID_11201 0.01532386 0.08897224 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP newborn respiratory distress syndrome DOID_12716 0.01532386 0.08807353 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP polyneuropathy DOID_1389 0.01532386 0.08719279 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP psoriatic arthritis DOID_9008 0.01532386 0.0863295 0.01532386 0.26422058 DER_IFN_GAMMA_RESPONSE_UP open-angle glaucoma DOID_1067 0.01649307 0.09200544 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP hypercalcemia DOID_12678 0.01649307 0.09111219 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP eyelid disease DOID_530 0.01649307 0.09023611 0.01649307 0.27601633 DER_IFN_GAMMA_RESPONSE_UP parasitic helminthiasis infectious disease DOID_883 0.01649307 0.08937672 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP bacterial meningitis DOID_9470 0.01649307 0.08853354 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP skeletal system cancer DOID_0060124 0.01766091 0.09391644 0.01766091 0.28711597 DER_IFN_GAMMA_RESPONSE_UP bone cancer DOID_184 0.01766091 0.09391644 0.01766091 0.28711597 DER_IFN_GAMMA_RESPONSE_UP mesenchymal cell neoplasm DOID_3350 0.01766091 0.09304684 0.01766091 0.27914052 DER_IFN_GAMMA_RESPONSE_UP spindle cell sarcoma DOID_4235 0.01766091 0.09304684 0.01766091 0.27914052 DER_IFN_GAMMA_RESPONSE_UP nutritional deficiency disease DOID_5113 0.01766091 0.0921932 0.01766091 0.27159618 DER_IFN_GAMMA_RESPONSE_UP lung oat cell carcinoma DOID_5411 0.01766091 0.09135508 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP epithelioid sarcoma DOID_6193 0.01766091 0.09304684 0.01766091 0.27914052 DER_IFN_GAMMA_RESPONSE_UP varicose veins DOID_799 0.01766091 0.09053206 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP hyperhomocysteinemia DOID_9279 0.01766091 0.08972374 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP angiosarcoma DOID_0001816 0.0188274 0.09480346 0.0188274 0.28191555 DER_IFN_GAMMA_RESPONSE_UP spastic diplegia DOID_10965 0.0188274 0.09397185 0.0188274 0.27468695 DER_IFN_GAMMA_RESPONSE_UP hemolytic-uremic syndrome DOID_12554 0.0188274 0.0931547 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP vein disease DOID_866 0.0188274 0.09235165 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP familial hypertrophic cardiomyopathy DOID_11986 0.01999253 0.09722865 0.01999253 0.28439381 DER_IFN_GAMMA_RESPONSE_UP methylmalonic acidemia DOID_14749 0.01999253 0.09640468 0.01999253 0.27745737 DER_IFN_GAMMA_RESPONSE_UP hyperostosis DOID_205 0.01999253 0.09559456 0.01999253 0.27085125 DER_IFN_GAMMA_RESPONSE_UP basal cell carcinoma DOID_2513 0.01999253 0.09479794 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP bronchitis DOID_6132 0.01999253 0.09401448 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP skin carcinoma DOID_3451 0.02115632 0.09867167 1.000 1.000 DER_IFN_GAMMA_RESPONSE_UP prion disease DOID_649 0.02115632 0.09786946 0.02115632 0.27995219 AMIT_EGF_RESPONSE_60_HELA brain cancer DOID_1319 5.353E-08 3.046E-05 6.304E-04 0.05978256 AMIT_EGF_RESPONSE_60_HELA central nervous system cancer DOID_3620 5.806E-08 1.652E-05 6.558E-04 0.05330937 AMIT_EGF_RESPONSE_60_HELA giant cell tumor DOID_200 8.512E-08 1.614E-05 9.742E-06 5.543E-03 AMIT_EGF_RESPONSE_60_HELA malignant giant cell tumor DOID_2705 8.512E-08 1.614E-05 9.742E-06 5.543E-03 AMIT_EGF_RESPONSE_60_HELA giant cell glioblastoma DOID_3074 8.512E-08 1.614E-05 9.742E-06 5.543E-03 AMIT_EGF_RESPONSE_60_HELA glioblastoma DOID_3068 1.206E-07 1.716E-05 1.262E-05 3.59E-03 AMIT_EGF_RESPONSE_60_HELA astrocytoma DOID_3069 2.365E-07 2.691E-05 2.079E-05 3.944E-03 AMIT_EGF_RESPONSE_60_HELA nervous system cancer DOID_3093 6.358E-07 6.03E-05 2.113E-03 0.10020449 AMIT_EGF_RESPONSE_60_HELA bone marrow cancer DOID_4960 1.028E-05 8.355E-04 8.187E-04 0.05822975 AMIT_EGF_RESPONSE_60_HELA pre-malignant neoplasm DOID_0060071 1.6E-05 1.138E-03 1.096E-03 0.06927925 AMIT_EGF_RESPONSE_60_HELA congenital heart defect DOID_1682 1.6E-05 1.012E-03 1.096E-03 0.06235133 AMIT_EGF_RESPONSE_60_HELA in situ carcinoma DOID_8719 1.6E-05 1.138E-03 1.096E-03 0.06927925 AMIT_EGF_RESPONSE_60_HELA alcohol-related neurodevelopmental disorder DOID_0050667 4.923E-05 2.801E-03 2.298E-03 0.10057707 AMIT_EGF_RESPONSE_60_HELA angiosarcoma DOID_0001816 6.272E-05 3.244E-03 0.01175423 0.24770951 AMIT_EGF_RESPONSE_60_HELA restrictive cardiomyopathy DOID_397 6.272E-05 2.974E-03 0.01175423 0.23886274 AMIT_EGF_RESPONSE_60_HELA muscular atrophy DOID_767 1.204E-04 5.27E-03 1.204E-04 0.01712758 AMIT_EGF_RESPONSE_60_HELA myositis DOID_633 1.825E-04 7.419E-03 0.01975786 0.23421296 AMIT_EGF_RESPONSE_60_HELA extrinsic allergic alveolitis DOID_841 1.965E-04 7.453E-03 1.000 1.000 AMIT_EGF_RESPONSE_60_HELA sarcoma DOID_1115 2.259E-04 8.034E-03 0.0219298 0.23543499 AMIT_EGF_RESPONSE_60_HELA focal glomerulosclerosis DOID_3945 2.414E-04 8.079E-03 2.414E-04 0.02746888 AMIT_EGF_RESPONSE_60_HELA abdominal aortic aneurysm DOID_7693 2.738E-04 8.656E-03 0.02409709 0.24054817 AMIT_EGF_RESPONSE_60_HELA papilloma DOID_2615 3.263E-04 9.771E-03 0.02625976 0.25325089 AMIT_EGF_RESPONSE_60_HELA multiple myeloma DOID_9538 4.032E-04 0.01147195 0.02913612 0.26739442 AMIT_EGF_RESPONSE_60_HELA cervix uteri carcinoma in situ DOID_8991 4.882E-04 0.01322669 0.03200429 0.28016067 AMIT_EGF_RESPONSE_60_HELA learning disability DOID_8927 5.81E-04 0.01502701 0.03486429 0.27175046 AMIT_EGF_RESPONSE_60_HELA myeloma DOID_0070004 6.304E-04 0.01559545 0.03629124 0.27532952 AMIT_EGF_RESPONSE_60_HELA pre-eclampsia DOID_10591 6.304E-04 0.01494564 0.03629124 0.27170676 AMIT_EGF_RESPONSE_60_HELA aortic aneurysm DOID_3627 7.082E-04 0.01611774 0.03842784 0.27331799 AMIT_EGF_RESPONSE_60_HELA oral cavity cancer DOID_8618 9.37E-04 0.02050628 0.04410313 0.28196271 AMIT_EGF_RESPONSE_60_HELA respiratory failure DOID_11162 1.063E-03 0.02240351 0.04692865 0.29343299 AMIT_EGF_RESPONSE_60_HELA pancreatic ductal carcinoma DOID_3587 1.338E-03 0.02719562 0.05255555 0.31478008 AMIT_EGF_RESPONSE_60_HELA pancreatic carcinoma DOID_4905 1.449E-03 0.02843703 0.05465737 0.31414184 AMIT_EGF_RESPONSE_60_HELA diabetic retinopathy DOID_8947 1.449E-03 0.02748913 0.05465737 0.31100042 AMIT_EGF_RESPONSE_60_HELA syndrome DOID_225 1.526E-03 0.02800495 0.05605608 0.31580108 AMIT_EGF_RESPONSE_60_HELA aneurysm disease DOID_2403 1.565E-03 0.02782178 0.05675469 0.31660213 AMIT_EGF_RESPONSE_60_HELA mixed glioma DOID_5076 1.604E-03 0.02765784 1.604E-03 0.08297352 AMIT_EGF_RESPONSE_60_HELA retinal vascular disease DOID_2462 1.893E-03 0.03167874 0.06232563 0.32535122 AMIT_EGF_RESPONSE_60_HELA Crohn's disease DOID_8778 2.298E-03 0.0373572 0.06855502 0.35142166 AMIT_EGF_RESPONSE_60_HELA Noonan syndrome DOID_3490 7.362E-03 0.09973881 7.362E-03 0.24641353 AMIT_EGF_RESPONSE_60_HELA keratitis DOID_4677 7.362E-03 0.0974193 1.000 1.000 AMIT_EGF_RESPONSE_60_HELA migraine without aura DOID_12783 8.095E-03 0.09800625 8.095E-03 0.24243651 AMIT_EGF_RESPONSE_60_HELA neuronal ceroid lipofuscinosis DOID_14503 8.095E-03 0.09596445 1.000 1.000 AMIT_EGF_RESPONSE_60_HELA invasive lobular carcinoma DOID_3457 8.095E-03 0.09400599 8.095E-03 0.23031468 OZANNE_AP1_TARGETS_UP abdominal aortic aneurysm DOID_7693 2.714E-07 1.545E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP aortic aneurysm DOID_3627 1.16E-06 3.3E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 1.779E-06 3.374E-04 0.02386988 0.43812773 OZANNE_AP1_TARGETS_UP carotid artery disease DOID_3407 2.058E-06 2.927E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP astrocytoma DOID_3069 2.94E-06 3.346E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP aneurysm disease DOID_2403 3.892E-06 3.69E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP mouth disease DOID_403 7.003E-06 5.692E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP aortic valve stenosis DOID_1712 9.622E-06 6.843E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP ocular hypertension DOID_9282 9.622E-06 6.083E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP borderline glaucoma DOID_9283 9.622E-06 6.083E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP carotid stenosis DOID_13001 1.137E-05 6.469E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP larynx cancer DOID_2596 1.137E-05 5.881E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP laryngeal benign neoplasm DOID_2598 1.137E-05 5.881E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP thoracic aortic aneurysm DOID_14004 1.53E-05 7.253E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP oral submucous fibrosis DOID_5773 1.53E-05 6.695E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP varicose veins DOID_799 1.53E-05 6.217E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP vein disease DOID_866 1.748E-05 6.63E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP subependymal glioma DOID_4843 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP pilocytic astrocytoma DOID_4851 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP subependymal giant cell astrocytoma DOID_5077 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP fibrillary astrocytoma DOID_6726 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP juvenile pilocytic astrocytoma DOID_6811 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP childhood pilocytic astrocytoma DOID_6812 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP gemistocytic astrocytoma DOID_7005 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP childhood cerebral astrocytoma DOID_7007 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP protoplasmic astrocytoma DOID_7008 2.765E-05 9.832E-04 1.000 1.000 OZANNE_AP1_TARGETS_UP benign glioma DOID_0060101 3.36E-05 1.125E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP benign ependymoma DOID_4844 3.36E-05 1.125E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP aortic valve disease DOID_62 4.013E-05 1.268E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP lung adenocarcinoma DOID_3910 5.896E-05 1.766E-03 0.0114151 0.49963022 OZANNE_AP1_TARGETS_UP supratentorial cancer DOID_1659 6.75E-05 1.92E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP cerebrum cancer DOID_368 6.75E-05 1.92E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP spindle cell carcinoma DOID_4015 9.654E-05 2.616E-03 0.01454262 0.45970853 OZANNE_AP1_TARGETS_UP pulmonary emphysema DOID_9675 1.369E-04 3.541E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP rheumatic disease DOID_1575 1.497E-04 3.704E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP scleroderma DOID_419 1.497E-04 3.704E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP brain cancer DOID_1319 1.77E-04 4.197E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP heart valve disease DOID_4079 1.77E-04 4.029E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP central nervous system cancer DOID_3620 1.842E-04 4.032E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP glaucoma DOID_1686 1.915E-04 4.037E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP giant cell tumor DOID_200 2.223E-04 4.517E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP malignant giant cell tumor DOID_2705 2.223E-04 4.517E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP giant cell glioblastoma DOID_3074 2.223E-04 4.517E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP bile duct adenocarcinoma DOID_4896 2.303E-04 4.518E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP cholangiocarcinoma DOID_4947 2.303E-04 4.518E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP glioblastoma DOID_3068 2.638E-04 5.004E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP bile duct cancer DOID_4606 2.638E-04 4.842E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP bile duct carcinoma DOID_4897 2.638E-04 4.842E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP collagen disease DOID_854 2.904E-04 5.164E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP allergic contact dermatitis DOID_3042 3.474E-04 5.991E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP diabetic retinopathy DOID_8947 4.094E-04 6.852E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP contact dermatitis DOID_2773 4.765E-04 7.746E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP biliary tract cancer DOID_4607 5.118E-04 8.09E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP retinal vascular disease DOID_2462 5.361E-04 8.244E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP transitional cell carcinoma DOID_2671 5.735E-04 8.588E-03 0.03503037 0.49830695 OZANNE_AP1_TARGETS_UP nervous system cancer DOID_3093 5.992E-04 8.742E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP dilated cardiomyopathy DOID_12930 6.657E-04 9.47E-03 1.000 1.000 OZANNE_AP1_TARGETS_UP rectal neoplasm DOID_1984 3.95E-03 0.05481921 1.000 1.000 OZANNE_AP1_TARGETS_UP rectum cancer DOID_1993 3.95E-03 0.05481921 1.000 1.000 OZANNE_AP1_TARGETS_UP breast benign neoplasm DOID_0060082 4.344E-03 0.05885452 1.000 1.000 OZANNE_AP1_TARGETS_UP thoracic benign neoplasm DOID_0060097 4.344E-03 0.05885452 1.000 1.000 OZANNE_AP1_TARGETS_UP temporal arteritis DOID_13375 4.344E-03 0.05748581 1.000 1.000 OZANNE_AP1_TARGETS_UP benign breast phyllodes tumor DOID_1631 4.344E-03 0.05885452 1.000 1.000 OZANNE_AP1_TARGETS_UP invasive lobular carcinoma DOID_3457 4.344E-03 0.05617932 4.344E-03 1.000 OZANNE_AP1_TARGETS_UP central nervous system vasculitis DOID_525 4.344E-03 0.05748581 1.000 1.000 OZANNE_AP1_TARGETS_UP eosinophilic pneumonia DOID_5870 4.344E-03 0.05493089 4.344E-03 1.000 OZANNE_AP1_TARGETS_UP pulmonary eosinophilia DOID_9498 4.344E-03 0.05493089 4.344E-03 1.000 OZANNE_AP1_TARGETS_UP Loeffler syndrome DOID_9503 4.344E-03 0.05493089 4.344E-03 1.000 OZANNE_AP1_TARGETS_UP bronchiectasis DOID_9563 4.344E-03 0.05373674 1.000 1.000 OZANNE_AP1_TARGETS_UP epidermolysis bullosa DOID_2730 4.738E-03 0.05736403 1.000 1.000 OZANNE_AP1_TARGETS_UP aortic valve insufficiency DOID_57 4.738E-03 0.05616895 1.000 1.000 OZANNE_AP1_TARGETS_UP encephalitis DOID_9588 4.738E-03 0.05502264 1.000 1.000 OZANNE_AP1_TARGETS_UP osteogenesis imperfecta DOID_12347 5.132E-03 0.05840493 5.132E-03 0.97341543 OZANNE_AP1_TARGETS_UP vesiculobullous skin disease DOID_2731 5.132E-03 0.05725973 1.000 1.000 OZANNE_AP1_TARGETS_UP bacterial meningitis DOID_9470 5.526E-03 0.06046731 1.000 1.000 OZANNE_AP1_TARGETS_UP skeletal system cancer DOID_0060124 5.92E-03 0.06355229 1.000 1.000 OZANNE_AP1_TARGETS_UP bone cancer DOID_184 5.92E-03 0.06355229 1.000 1.000 OZANNE_AP1_TARGETS_UP membranoproliferative glomerulonephritis DOID_2920 5.92E-03 0.0623754 5.92E-03 0.84206785 OZANNE_AP1_TARGETS_UP arthropathy DOID_381 5.92E-03 0.0612413 1.000 1.000 OZANNE_AP1_TARGETS_UP intermediate coronary syndrome DOID_8805 5.92E-03 0.0601477 1.000 1.000 OZANNE_AP1_TARGETS_UP spastic diplegia DOID_10965 6.313E-03 0.06302035 6.313E-03 0.71843197 OZANNE_AP1_TARGETS_UP eosinophilia DOID_999 7.1E-03 0.0696498 7.1E-03 0.67328143 OZANNE_AP1_TARGETS_UP membranous glomerulonephritis DOID_10976 7.886E-03 0.07604893 7.886E-03 0.64098382 OZANNE_AP1_TARGETS_UP esophagitis DOID_11963 7.886E-03 0.07478145 7.886E-03 0.56086084 OZANNE_AP1_TARGETS_UP brain edema DOID_4724 7.886E-03 0.07355552 1.000 1.000 OZANNE_AP1_TARGETS_UP coronary restenosis DOID_4247 8.278E-03 0.07597358 1.000 1.000 OZANNE_AP1_TARGETS_UP gastric ulcer DOID_10808 8.671E-03 0.07831356 1.000 1.000 OZANNE_AP1_TARGETS_UP familial hypercholesterolemia DOID_13810 8.671E-03 0.07708991 1.000 1.000 OZANNE_AP1_TARGETS_UP sinusitis DOID_0050127 9.063E-03 0.07933945 1.000 1.000 OZANNE_AP1_TARGETS_UP paranasal sinus disease DOID_1352 9.063E-03 0.07933945 1.000 1.000 OZANNE_AP1_TARGETS_UP opiate dependence DOID_2559 9.063E-03 0.07813734 1.000 1.000 OZANNE_AP1_TARGETS_UP uremia DOID_4676 9.063E-03 0.07697111 9.063E-03 0.57300716 OZANNE_AP1_TARGETS_UP pulmonary embolism DOID_9477 9.063E-03 0.07583918 1.000 1.000 OZANNE_AP1_TARGETS_UP diabetic angiopathy DOID_11713 9.456E-03 0.07797525 9.456E-03 0.5380292 OZANNE_AP1_TARGETS_UP meningitis DOID_9471 9.456E-03 0.07686131 1.000 1.000 OZANNE_AP1_TARGETS_UP spastic quadriplegia DOID_10970 9.848E-03 0.07892165 9.848E-03 0.50940336 OZANNE_AP1_TARGETS_UP intracranial aneurysm DOID_10941 0.01102351 0.08711635 1.000 1.000 OZANNE_AP1_TARGETS_UP vitiligo DOID_12306 0.01102351 0.08592298 0.01102351 0.52269812 OZANNE_AP1_TARGETS_UP middle cerebral artery infarction DOID_3525 0.01102351 0.08476186 1.000 1.000 OZANNE_AP1_TARGETS_UP periodontitis DOID_824 0.0114151 0.08660257 1.000 1.000 OZANNE_AP1_TARGETS_UP renal hypertension DOID_1073 0.01180655 0.08839376 1.000 1.000 OZANNE_AP1_TARGETS_UP secondary hypertension DOID_11130 0.01180655 0.08839376 1.000 1.000 OZANNE_AP1_TARGETS_UP invasive ductal carcinoma DOID_3008 0.01180655 0.08724579 0.01180655 0.47985184 OZANNE_AP1_TARGETS_UP coronary stenosis DOID_4248 0.01180655 0.08612725 1.000 1.000 OZANNE_AP1_TARGETS_UP focal glomerulosclerosis DOID_3945 0.01219785 0.0878554 1.000 1.000 OZANNE_AP1_TARGETS_UP endometrial carcinoma DOID_2871 0.01258901 0.08953931 1.000 1.000 OZANNE_AP1_TARGETS_UP spastic cerebral palsy DOID_0050669 0.01298002 0.09118063 0.01298002 0.4923754 OZANNE_AP1_TARGETS_UP bronchiolitis obliterans DOID_2799 0.01298002 0.09006867 1.000 1.000 OZANNE_AP1_TARGETS_UP endometrial cancer DOID_1380 0.01337089 0.09166307 1.000 1.000 OZANNE_AP1_TARGETS_UP allergic rhinitis DOID_4481 0.01337089 0.09057185 1.000 1.000 OZANNE_AP1_TARGETS_UP leiomyoma DOID_127 0.01376161 0.09212184 0.01376161 0.48939729 OZANNE_AP1_TARGETS_UP myocarditis DOID_820 0.01415219 0.09363484 1.000 1.000 OZANNE_AP1_TARGETS_UP nephroblastoma DOID_2154 0.01454262 0.09511211 0.01454262 0.48675021 OZANNE_AP1_TARGETS_UP periodontal disease DOID_3388 0.01454262 0.09403129 1.000 1.000 OZANNE_AP1_TARGETS_UP esophageal disease DOID_6050 0.01454262 0.09297476 0.01454262 0.43551335 OZANNE_AP1_TARGETS_UP medullomyoblastoma DOID_3861 0.01493292 0.09440921 0.01493292 0.42484144 OZANNE_AP1_TARGETS_UP adult medulloblastoma DOID_3864 0.01493292 0.09440921 0.01493292 0.42484144 OZANNE_AP1_TARGETS_UP childhood medulloblastoma DOID_3869 0.01493292 0.09440921 0.01493292 0.42484144 OZANNE_AP1_TARGETS_UP calcinosis DOID_182 0.01571306 0.09824982 1.000 1.000 OZANNE_AP1_TARGETS_UP medulloblastoma DOID_3858 0.01571306 0.09718188 0.01571306 0.4257492 OZANNE_AP1_TARGETS_UP multiple myeloma DOID_9538 0.01571306 0.09613692 0.01571306 0.40639696 OZANNE_AP1_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 0.01649264 0.09983308 1.000 1.000 OZANNE_AP1_TARGETS_UP hepatitis DOID_2237 0.01649264 0.0987822 0.01649264 0.40801345 OZANNE_AP1_TARGETS_UP systemic scleroderma DOID_418 0.01649264 0.09775322 1.000 1.000 OZANNE_AP1_TARGETS_UP peptic ulcer DOID_750 0.01649264 0.09674546 1.000 1.000 OZANNE_AP1_TARGETS_UP adult respiratory distress syndrome DOID_11394 0.0168822 0.09802015 1.000 1.000 OZANNE_AP1_TARGETS_UP intracranial arterial disease DOID_13089 0.0168822 0.09703004 1.000 1.000 OZANNE_AP1_TARGETS_UP cerebral arterial disease DOID_3527 0.0168822 0.09703004 1.000 1.000 OZANNE_AP1_TARGETS_UP benign mesothelioma DOID_2645 0.01727163 0.09827558 1.000 1.000 OZANNE_AP1_TARGETS_UP endometriosis of uterus DOID_288 0.01766091 0.09949563 1.000 1.000 OZANNE_AP1_TARGETS_UP primitive neuroectodermal tumor DOID_168 0.01805005 0.09971338 0.01805005 0.42793659 OZANNE_AP1_TARGETS_UP hyperinsulinism DOID_2018 0.01805005 0.0987546 0.01805005 0.41081912 OZANNE_AP1_TARGETS_UP endometriosis DOID_289 0.01805005 0.09781408 1.000 1.000 OZANNE_AP1_TARGETS_UP diabetic autonomic neuropathy DOID_11503 0.01843904 0.09897939 1.000 1.000 OZANNE_AP1_TARGETS_UP autonomic neuropathy DOID_11504 0.01843904 0.09897939 1.000 1.000 OZANNE_AP1_TARGETS_UP diabetic polyneuropathy DOID_12785 0.01843904 0.09897939 1.000 1.000 OZANNE_AP1_TARGETS_UP uterine cancer DOID_363 0.01843904 0.09805435 1.000 1.000 OZANNE_AP1_TARGETS_UP influenza DOID_8469 0.01843904 0.09714644 1.000 1.000 OZANNE_AP1_TARGETS_UP diabetic neuropathy DOID_9743 0.01843904 0.09897939 1.000 1.000 OZANNE_AP1_TARGETS_UP cerebral infarction DOID_3526 0.01882789 0.09828506 1.000 1.000 OZANNE_AP1_TARGETS_UP proteinuria DOID_576 0.0192166 0.09940223 0.0192166 0.42054788 OZANNE_AP1_TARGETS_UP pre-eclampsia DOID_10591 0.01960516 0.09960122 1.000 1.000 OZANNE_AP1_TARGETS_UP autonomic nervous system disease DOID_11465 0.01960516 0.0987198 1.000 1.000 OZANNE_AP1_TARGETS_UP lung small cell carcinoma DOID_5409 0.02038186 0.09997652 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER pancreatic ductal carcinoma DOID_3587 5.542E-11 3.153E-08 2.75E-06 1.565E-03 LI_AMPLIFIED_IN_LUNG_CANCER pancreatic carcinoma DOID_4905 7.716E-11 2.195E-08 3.358E-06 9.555E-04 LI_AMPLIFIED_IN_LUNG_CANCER transitional cell carcinoma DOID_2671 3.065E-10 5.812E-08 1.569E-04 0.01275611 LI_AMPLIFIED_IN_LUNG_CANCER benign mesothelioma DOID_2645 3.947E-09 5.614E-07 7.677E-03 0.12480659 LI_AMPLIFIED_IN_LUNG_CANCER bone resorption disease DOID_0080011 4.205E-09 4.785E-07 4.068E-06 7.715E-04 LI_AMPLIFIED_IN_LUNG_CANCER osteoporosis DOID_11476 4.205E-09 4.785E-07 4.068E-06 7.715E-04 LI_AMPLIFIED_IN_LUNG_CANCER biliary tract cancer DOID_4607 7.056E-09 6.691E-07 1.258E-04 0.01192861 LI_AMPLIFIED_IN_LUNG_CANCER heart valve disease DOID_4079 8.756E-09 7.118E-07 0.13873453 0.69858362 LI_AMPLIFIED_IN_LUNG_CANCER bile duct cancer DOID_4606 2.979E-08 2.119E-06 8.182E-04 0.02738553 LI_AMPLIFIED_IN_LUNG_CANCER bile duct carcinoma DOID_4897 2.979E-08 2.119E-06 8.182E-04 0.02738553 LI_AMPLIFIED_IN_LUNG_CANCER collagen disease DOID_854 3.994E-08 2.525E-06 0.17403807 0.79861018 LI_AMPLIFIED_IN_LUNG_CANCER endometrial carcinoma DOID_2871 4.063E-08 2.312E-06 0.09113877 0.55168041 LI_AMPLIFIED_IN_LUNG_CANCER endometrial cancer DOID_1380 5.588E-08 2.89E-06 0.09655335 0.56637996 LI_AMPLIFIED_IN_LUNG_CANCER calcinosis DOID_182 1.303E-07 6.177E-06 0.112606 0.62206616 LI_AMPLIFIED_IN_LUNG_CANCER multiple myeloma DOID_9538 1.303E-07 5.702E-06 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER uterine cancer DOID_363 2.987E-07 1.214E-05 0.13097708 0.68372439 LI_AMPLIFIED_IN_LUNG_CANCER myeloma DOID_0070004 4.096E-07 1.554E-05 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER calcium metabolism disease DOID_10575 5.509E-07 1.959E-05 0.14642335 0.71209302 LI_AMPLIFIED_IN_LUNG_CANCER bile duct adenocarcinoma DOID_4896 7.962E-07 2.665E-05 0.0126306 0.1891266 LI_AMPLIFIED_IN_LUNG_CANCER cholangiocarcinoma DOID_4947 7.962E-07 2.665E-05 0.0126306 0.1891266 LI_AMPLIFIED_IN_LUNG_CANCER bone marrow cancer DOID_4960 7.962E-07 2.517E-05 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER hypertrophic cardiomyopathy DOID_11984 1.121E-06 3.356E-05 0.01437115 0.20442962 LI_AMPLIFIED_IN_LUNG_CANCER oral cavity cancer DOID_8618 1.121E-06 3.188E-05 8.182E-04 0.02586411 LI_AMPLIFIED_IN_LUNG_CANCER intracranial aneurysm DOID_10941 1.45E-06 3.928E-05 0.08021293 0.52461098 LI_AMPLIFIED_IN_LUNG_CANCER middle cerebral artery infarction DOID_3525 1.45E-06 3.749E-05 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER lung adenocarcinoma DOID_3910 1.678E-06 4.151E-05 8.904E-05 0.01266532 LI_AMPLIFIED_IN_LUNG_CANCER mineral metabolism disease DOID_0050032 1.793E-06 4.252E-05 0.18141444 0.81924455 LI_AMPLIFIED_IN_LUNG_CANCER cholestasis DOID_13580 1.931E-06 4.395E-05 0.18385868 0.81730931 LI_AMPLIFIED_IN_LUNG_CANCER brain infarction DOID_3454 2.395E-06 5.241E-05 0.19114811 0.83025402 LI_AMPLIFIED_IN_LUNG_CANCER bile duct disease DOID_4138 2.942E-06 6.2E-05 0.19837301 0.85510789 LI_AMPLIFIED_IN_LUNG_CANCER biliary tract disease DOID_9741 3.145E-06 6.391E-05 0.20076706 0.85892074 LI_AMPLIFIED_IN_LUNG_CANCER aneurysm disease DOID_2403 4.068E-06 7.981E-05 0.21027262 0.88626016 LI_AMPLIFIED_IN_LUNG_CANCER hepatitis DOID_2237 7.674E-06 1.455E-04 7.014E-03 0.12094424 LI_AMPLIFIED_IN_LUNG_CANCER intracranial arterial disease DOID_13089 8.441E-06 1.549E-04 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER cerebral arterial disease DOID_3527 8.441E-06 1.549E-04 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER adenoid cystic carcinoma DOID_4866 8.441E-06 1.501E-04 2.917E-04 0.01844264 LI_AMPLIFIED_IN_LUNG_CANCER endometriosis of uterus DOID_288 1.014E-05 1.749E-04 3.34E-04 0.01900268 LI_AMPLIFIED_IN_LUNG_CANCER salivary gland cancer DOID_8850 1.014E-05 1.698E-04 3.34E-04 0.01727517 LI_AMPLIFIED_IN_LUNG_CANCER endometriosis DOID_289 1.109E-05 1.802E-04 3.565E-04 0.0169037 LI_AMPLIFIED_IN_LUNG_CANCER Ehlers-Danlos syndrome DOID_13359 1.143E-05 1.806E-04 0.04379698 0.40194327 LI_AMPLIFIED_IN_LUNG_CANCER oral submucous fibrosis DOID_5773 1.143E-05 1.758E-04 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER ulcerative colitis DOID_8577 1.293E-05 1.936E-04 0.03606975 0.38006825 LI_AMPLIFIED_IN_LUNG_CANCER cerebral infarction DOID_3526 1.316E-05 1.92E-04 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER pre-eclampsia DOID_10591 1.55E-05 2.205E-04 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER prion disease DOID_649 2.036E-05 2.826E-04 0.05232547 0.41934076 LI_AMPLIFIED_IN_LUNG_CANCER pulmonary embolism DOID_9477 4.372E-05 5.923E-04 2.139E-03 0.04867322 LI_AMPLIFIED_IN_LUNG_CANCER respiratory failure DOID_11162 4.403E-05 5.826E-04 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER pre-malignant neoplasm DOID_0060071 4.676E-05 6.048E-04 0.01668338 0.2315327 LI_AMPLIFIED_IN_LUNG_CANCER in situ carcinoma DOID_8719 4.676E-05 6.048E-04 0.01668338 0.2315327 LI_AMPLIFIED_IN_LUNG_CANCER uterine disease DOID_345 5.26E-05 6.651E-04 1.122E-03 0.03360771 LI_AMPLIFIED_IN_LUNG_CANCER hyperglycemia DOID_4195 5.571E-05 6.891E-04 1.171E-03 0.03330653 LI_AMPLIFIED_IN_LUNG_CANCER perinatal necrotizing enterocolitis DOID_8677 8.904E-05 1.078E-03 8.904E-05 0.01013226 LI_AMPLIFIED_IN_LUNG_CANCER invasive ductal carcinoma DOID_3008 9.871E-05 1.17E-03 0.08569202 0.53581056 LI_AMPLIFIED_IN_LUNG_CANCER pancreatitis DOID_4989 9.938E-05 1.154E-03 1.793E-03 0.04857412 LI_AMPLIFIED_IN_LUNG_CANCER mixed glioma DOID_5076 9.938E-05 1.131E-03 1.793E-03 0.04636621 LI_AMPLIFIED_IN_LUNG_CANCER female reproductive system disease DOID_229 1.147E-04 1.279E-03 1.992E-03 0.04927781 LI_AMPLIFIED_IN_LUNG_CANCER opportunistic mycosis DOID_2473 1.318E-04 1.442E-03 4.377E-03 0.08895052 LI_AMPLIFIED_IN_LUNG_CANCER nervous system cancer DOID_3093 1.708E-04 1.834E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER systemic mycosis DOID_0050136 1.714E-04 1.806E-03 5.192E-03 0.10187975 LI_AMPLIFIED_IN_LUNG_CANCER fungal infectious disease DOID_1564 1.714E-04 1.806E-03 5.192E-03 0.10187975 LI_AMPLIFIED_IN_LUNG_CANCER myocarditis DOID_820 1.714E-04 1.773E-03 5.192E-03 0.09848376 LI_AMPLIFIED_IN_LUNG_CANCER nephroblastoma DOID_2154 1.861E-04 1.891E-03 0.10461533 0.59526123 LI_AMPLIFIED_IN_LUNG_CANCER carbohydrate metabolic disorder DOID_2978 1.933E-04 1.93E-03 1.933E-04 0.01374824 LI_AMPLIFIED_IN_LUNG_CANCER dilated cardiomyopathy DOID_12930 2.094E-04 2.054E-03 3.101E-03 0.06787277 LI_AMPLIFIED_IN_LUNG_CANCER embryonal cancer DOID_688 2.351E-04 2.267E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER systemic scleroderma DOID_418 2.719E-04 2.579E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER peptic ulcer DOID_750 2.719E-04 2.537E-03 7.014E-03 0.11738706 LI_AMPLIFIED_IN_LUNG_CANCER cervix uteri carcinoma in situ DOID_8991 3.124E-04 2.867E-03 0.12315038 0.66735778 LI_AMPLIFIED_IN_LUNG_CANCER arrhythmogenic right ventricular dysplasia DOID_0050431 3.127E-04 2.824E-03 0.02651113 0.33521849 LI_AMPLIFIED_IN_LUNG_CANCER rheumatic disease DOID_1575 3.565E-04 3.169E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER scleroderma DOID_419 3.565E-04 3.169E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER gallbladder cancer DOID_3121 3.8E-04 3.326E-03 8.722E-03 0.13785316 LI_AMPLIFIED_IN_LUNG_CANCER Diamond-Blackfan anemia DOID_1339 3.901E-04 3.363E-03 3.901E-04 0.01707558 LI_AMPLIFIED_IN_LUNG_CANCER teratoma DOID_3307 3.901E-04 3.313E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER malignant teratoma DOID_5563 3.901E-04 3.313E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER mature teratoma DOID_5566 3.901E-04 3.313E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER proteinuria DOID_576 4.299E-04 3.597E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER invasive lobular carcinoma DOID_3457 4.759E-04 3.924E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER diarrhea DOID_13250 5.7E-04 4.633E-03 5.7E-04 0.02316479 LI_AMPLIFIED_IN_LUNG_CANCER epidermolysis bullosa DOID_2730 5.7E-04 4.568E-03 5.7E-04 0.02162047 LI_AMPLIFIED_IN_LUNG_CANCER aortic valve insufficiency DOID_57 5.7E-04 4.504E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER osteogenesis imperfecta DOID_12347 6.723E-04 5.24E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER vesiculobullous skin disease DOID_2731 6.723E-04 5.169E-03 6.723E-04 0.02390784 LI_AMPLIFIED_IN_LUNG_CANCER integumentary system cancer DOID_0060122 7.06E-04 5.357E-03 0.01305648 0.19049063 LI_AMPLIFIED_IN_LUNG_CANCER osteochondrodysplasia DOID_2256 7.06E-04 5.286E-03 0.15908713 0.75433814 LI_AMPLIFIED_IN_LUNG_CANCER skin cancer DOID_4159 7.06E-04 5.357E-03 0.01305648 0.19049063 LI_AMPLIFIED_IN_LUNG_CANCER rhabdomyosarcoma DOID_3247 7.828E-04 5.785E-03 0.04093728 0.39480191 LI_AMPLIFIED_IN_LUNG_CANCER skeletal muscle cancer DOID_4043 9.015E-04 6.576E-03 0.04379698 0.38339204 LI_AMPLIFIED_IN_LUNG_CANCER varicose veins DOID_799 9.015E-04 6.493E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER carotid artery disease DOID_3407 9.411E-04 6.693E-03 0.17403807 0.80510294 LI_AMPLIFIED_IN_LUNG_CANCER vein disease DOID_866 1.028E-03 7.223E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER methylmalonic acidemia DOID_14749 1.163E-03 8.071E-03 0.04949105 0.42030462 LI_AMPLIFIED_IN_LUNG_CANCER urinary system benign neoplasm DOID_731 1.163E-03 7.973E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER endocrine organ benign neoplasm DOID_0060089 1.272E-03 8.613E-03 0.01914274 0.25330743 LI_AMPLIFIED_IN_LUNG_CANCER ureteral obstruction DOID_5199 1.306E-03 8.742E-03 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER pulmonary edema DOID_11396 1.615E-03 0.01068808 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER brain edema DOID_4724 1.615E-03 0.01056522 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER cystic fibrosis DOID_1485 1.667E-03 0.01077961 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER gastric ulcer DOID_10808 1.956E-03 0.01250767 0.06357962 0.46982863 LI_AMPLIFIED_IN_LUNG_CANCER glycogen metabolism disorder DOID_0050728 2.139E-03 0.01352034 2.139E-03 0.05070127 LI_AMPLIFIED_IN_LUNG_CANCER optic nerve disease DOID_1891 2.139E-03 0.01337176 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER glycogen storage disease DOID_2747 2.139E-03 0.01352034 2.139E-03 0.05070127 LI_AMPLIFIED_IN_LUNG_CANCER muscle cancer DOID_4045 2.139E-03 0.01322642 0.0663724 0.47207368 LI_AMPLIFIED_IN_LUNG_CANCER urinary tract obstruction DOID_5200 2.139E-03 0.0130842 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER bone development disease DOID_0080006 2.204E-03 0.01334326 0.22663848 0.92775034 LI_AMPLIFIED_IN_LUNG_CANCER ureteral disease DOID_1426 2.328E-03 0.01394603 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER aortic valve disease DOID_62 2.328E-03 0.01380075 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER Goodpasture syndrome DOID_9808 2.328E-03 0.01365848 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER amino acid metabolic disorder DOID_9252 2.589E-03 0.01503009 0.03035747 0.36751913 LI_AMPLIFIED_IN_LUNG_CANCER organic acidemia DOID_0060159 2.731E-03 0.01569729 0.07470129 0.51210884 LI_AMPLIFIED_IN_LUNG_CANCER lymphoma DOID_0060058 2.838E-03 0.01614753 0.03221806 0.38191826 LI_AMPLIFIED_IN_LUNG_CANCER encephalomyelitis DOID_640 2.924E-03 0.01647348 0.24718723 0.99048969 LI_AMPLIFIED_IN_LUNG_CANCER mouth disease DOID_403 3.012E-03 0.01680195 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER congenital hypoplastic anemia DOID_1342 3.164E-03 0.01748007 3.164E-03 0.06668324 LI_AMPLIFIED_IN_LUNG_CANCER seminoma DOID_4440 3.164E-03 0.017312 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER hypotrichosis DOID_4535 3.164E-03 0.01714712 0.08021293 0.51282197 LI_AMPLIFIED_IN_LUNG_CANCER Sciatic Neuropathy DOID_11446 3.392E-03 0.01820813 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER lesion of sciatic nerve DOID_12528 3.392E-03 0.01820813 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER mononeuritis of lower limb DOID_9473 3.392E-03 0.01820813 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER sarcoma DOID_1115 3.627E-03 0.01928889 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER thrombocytopenia DOID_1588 3.627E-03 0.01911029 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER mononeuritis DOID_1802 3.627E-03 0.01893496 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER coronary stenosis DOID_4248 3.627E-03 0.01876283 0.08569202 0.52998653 LI_AMPLIFIED_IN_LUNG_CANCER mononeuropathy DOID_1188 3.87E-03 0.01983757 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER cranial nerve disease DOID_5656 3.87E-03 0.01966045 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER germinoma DOID_3304 4.642E-03 0.023373 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER autonomic nervous system neoplasm DOID_2621 4.914E-03 0.02452447 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER neuroblastoma DOID_769 4.914E-03 0.02452447 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER hair disease DOID_421 5.192E-03 0.02569142 0.10193596 0.58587435 LI_AMPLIFIED_IN_LUNG_CANCER esophageal disease DOID_6050 5.479E-03 0.02687321 0.10461533 0.58936756 LI_AMPLIFIED_IN_LUNG_CANCER aplastic anemia DOID_12449 5.772E-03 0.02806926 5.772E-03 0.1059388 LI_AMPLIFIED_IN_LUNG_CANCER adenoma DOID_657 6.072E-03 0.02927898 6.072E-03 0.10796625 LI_AMPLIFIED_IN_LUNG_CANCER peripheral nervous system neoplasm DOID_1192 6.693E-03 0.03200398 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER blood platelet disease DOID_2218 6.693E-03 0.03173728 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER adult respiratory distress syndrome DOID_11394 7.342E-03 0.03452689 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER pulmonary emphysema DOID_9675 7.677E-03 0.03580517 0.12315038 0.66106195 LI_AMPLIFIED_IN_LUNG_CANCER nephrotic syndrome DOID_1184 8.367E-03 0.03870516 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER learning disability DOID_8927 9.083E-03 0.04168128 0.13357056 0.69092409 LI_AMPLIFIED_IN_LUNG_CANCER brain cancer DOID_1319 9.826E-03 0.04473016 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER neuritis DOID_1803 9.826E-03 0.04437516 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER thyroid adenoma DOID_2891 9.826E-03 0.04402575 0.13873453 0.70482098 LI_AMPLIFIED_IN_LUNG_CANCER bone marrow disease DOID_4961 9.826E-03 0.0436818 9.826E-03 0.15111542 LI_AMPLIFIED_IN_LUNG_CANCER central nervous system cancer DOID_3620 0.01020782 0.04502519 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER hemolytic anemia DOID_583 0.01020782 0.04467884 0.14130507 0.70528582 LI_AMPLIFIED_IN_LUNG_CANCER normocytic anemia DOID_720 0.01020782 0.04467884 0.14130507 0.70528582 LI_AMPLIFIED_IN_LUNG_CANCER integumentary system benign neoplasm DOID_0060121 0.01059564 0.04602229 0.143868 0.71183383 LI_AMPLIFIED_IN_LUNG_CANCER skin benign neoplasm DOID_3165 0.01059564 0.04602229 0.143868 0.71183383 LI_AMPLIFIED_IN_LUNG_CANCER hemorrhagic disease DOID_2213 0.01139058 0.04910029 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER melancholia DOID_2848 0.01482159 0.06340966 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER neurotic disorder DOID_4964 0.01527807 0.0648748 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER endocrine pancreas disease DOID_1428 0.01716363 0.07234153 0.18141444 0.81279381 LI_AMPLIFIED_IN_LUNG_CANCER parasitic infectious disease DOID_1398 0.01764974 0.07384338 0.18385868 0.81097358 LI_AMPLIFIED_IN_LUNG_CANCER cerebral degeneration DOID_1443 0.01764974 0.07330437 0.18385868 0.80473532 LI_AMPLIFIED_IN_LUNG_CANCER temporal lobe epilepsy DOID_3328 0.01814165 0.07480143 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER allergic contact dermatitis DOID_3042 0.01863933 0.07630056 0.01863933 0.25251851 LI_AMPLIFIED_IN_LUNG_CANCER tuberculosis DOID_399 0.01914274 0.07780157 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER blood coagulation disease DOID_1247 0.02016661 0.08138157 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER nephrosis DOID_2527 0.02068699 0.08289365 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER endogenous depression DOID_1595 0.02282395 0.090817 1.000 1.000 LI_AMPLIFIED_IN_LUNG_CANCER syndrome DOID_225 0.02282395 0.09018632 0.20790679 0.88282808 LI_AMPLIFIED_IN_LUNG_CANCER contact dermatitis DOID_2773 0.02504785 0.09829121 0.02504785 0.32391422 STANELLE_E2F1_TARGETS transitional cell carcinoma DOID_2671 7.966E-12 4.533E-09 1.137E-03 0.08083424 STANELLE_E2F1_TARGETS reproductive organ benign neoplasm DOID_0050622 1.403E-10 3.991E-08 4.741E-04 0.03853849 STANELLE_E2F1_TARGETS urinary system benign neoplasm DOID_731 9.91E-08 1.88E-05 3.955E-05 0.01125058 STANELLE_E2F1_TARGETS male reproductive organ benign neoplasm DOID_0060087 1.189E-07 1.691E-05 9.926E-03 0.47066392 STANELLE_E2F1_TARGETS colon carcinoma DOID_1520 1.66E-07 1.889E-05 5.519E-05 0.01046798 STANELLE_E2F1_TARGETS cervix uteri carcinoma in situ DOID_8991 1.912E-06 1.813E-04 0.02409835 0.44232134 STANELLE_E2F1_TARGETS uterine cancer DOID_363 2.338E-06 1.9E-04 2.338E-06 1.33E-03 STANELLE_E2F1_TARGETS myeloma DOID_0070004 2.823E-06 2.008E-04 1.000 1.000 STANELLE_E2F1_TARGETS bone marrow cancer DOID_4960 4.204E-06 2.658E-04 1.000 1.000 STANELLE_E2F1_TARGETS pre-malignant neoplasm DOID_0060071 6.554E-06 3.729E-04 0.03593912 0.49876488 STANELLE_E2F1_TARGETS in situ carcinoma DOID_8719 6.554E-06 3.729E-04 0.03593912 0.49876488 STANELLE_E2F1_TARGETS Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.312E-05 6.784E-04 1.000 1.000 STANELLE_E2F1_TARGETS Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.312E-05 6.784E-04 1.000 1.000 STANELLE_E2F1_TARGETS Hodgkin's granuloma DOID_8651 1.312E-05 6.784E-04 1.000 1.000 STANELLE_E2F1_TARGETS Hodgkin's lymphoma, mixed cellularity DOID_8654 1.312E-05 6.784E-04 1.000 1.000 STANELLE_E2F1_TARGETS prostatic adenoma DOID_2883 1.602E-05 7.598E-04 6.077E-03 0.31435541 STANELLE_E2F1_TARGETS nervous system cancer DOID_3093 1.782E-05 7.799E-04 0.04975637 0.6154647 STANELLE_E2F1_TARGETS Hodgkin's lymphoma DOID_8567 1.922E-05 7.813E-04 1.000 1.000 STANELLE_E2F1_TARGETS cleft lip DOID_9296 1.017E-04 3.859E-03 0.01485393 0.44483625 STANELLE_E2F1_TARGETS female reproductive organ benign neoplasm DOID_0060086 1.435E-04 5.103E-03 0.0175815 0.43495107 STANELLE_E2F1_TARGETS uterine benign neoplasm DOID_0060095 1.435E-04 5.103E-03 0.0175815 0.43495107 STANELLE_E2F1_TARGETS corneal disease DOID_10124 1.435E-04 4.803E-03 1.000 1.000 STANELLE_E2F1_TARGETS uterine fibroid DOID_13223 1.435E-04 5.103E-03 0.0175815 0.43495107 STANELLE_E2F1_TARGETS endometrial carcinoma DOID_2871 1.435E-04 4.536E-03 1.435E-04 0.02041322 STANELLE_E2F1_TARGETS endometrial cancer DOID_1380 1.622E-04 4.857E-03 1.622E-04 0.01845834 STANELLE_E2F1_TARGETS leiomyoma DOID_127 1.72E-04 4.893E-03 0.01921459 0.42050389 STANELLE_E2F1_TARGETS cleft palate DOID_674 2.251E-04 6.098E-03 0.02193066 0.4302946 STANELLE_E2F1_TARGETS embryonal cancer DOID_688 2.251E-04 5.821E-03 2.251E-04 0.02134386 STANELLE_E2F1_TARGETS multiple myeloma DOID_9538 2.251E-04 5.568E-03 1.000 1.000 STANELLE_E2F1_TARGETS orofacial cleft DOID_0050567 4.264E-04 0.01010811 0.03003594 0.47473478 STANELLE_E2F1_TARGETS melancholia DOID_2848 5.417E-04 0.01232797 1.000 1.000 STANELLE_E2F1_TARGETS neurotic disorder DOID_4964 5.592E-04 0.01223838 1.000 1.000 STANELLE_E2F1_TARGETS endogenous depression DOID_1595 8.556E-04 0.01803071 1.000 1.000 STANELLE_E2F1_TARGETS mixed glioma DOID_5076 8.997E-04 0.01828355 0.04340278 0.57432983 STANELLE_E2F1_TARGETS mental depression DOID_1596 1.015E-03 0.01991028 1.000 1.000 STANELLE_E2F1_TARGETS lymphoma DOID_0060058 1.239E-03 0.02349433 1.000 1.000 STANELLE_E2F1_TARGETS lymphoblastic leukemia DOID_1037 1.265E-03 0.02321766 0.05133848 0.62152329 STANELLE_E2F1_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 1.291E-03 0.022963 0.05186529 0.6148198 STANELLE_E2F1_TARGETS mouth disease DOID_403 1.291E-03 0.02226715 1.000 1.000 STANELLE_E2F1_TARGETS hyperparathyroidism DOID_13543 5.526E-03 0.09248185 1.000 1.000 STANELLE_E2F1_TARGETS transient cerebral ischemia DOID_224 5.526E-03 0.08983951 5.526E-03 0.34937589 STANELLE_E2F1_TARGETS keratitis DOID_4677 5.526E-03 0.08734397 1.000 1.000 STANELLE_E2F1_TARGETS acute T cell leukemia DOID_5603 5.526E-03 0.08498332 1.000 1.000 STANELLE_E2F1_TARGETS polycythemia DOID_8432 5.526E-03 0.08274692 1.000 1.000 STANELLE_E2F1_TARGETS migraine without aura DOID_12783 6.077E-03 0.08866435 6.077E-03 0.34579095 STANELLE_E2F1_TARGETS invasive lobular carcinoma DOID_3457 6.077E-03 0.08644774 1.000 1.000 STANELLE_E2F1_TARGETS diarrhea DOID_13250 6.628E-03 0.09198221 1.000 1.000 STANELLE_E2F1_TARGETS retinal detachment DOID_5327 6.628E-03 0.08979216 1.000 1.000 STANELLE_E2F1_TARGETS parathyroid gland disease DOID_11201 7.178E-03 0.09498759 1.000 1.000 STANELLE_E2F1_TARGETS vulva cancer DOID_1245 7.178E-03 0.09282878 1.000 1.000 STANELLE_E2F1_TARGETS epilepsy with generalized tonic-clonic seizures DOID_7725 7.178E-03 0.09076592 1.000 1.000 STANELLE_E2F1_TARGETS rhabdomyosarcoma DOID_3247 7.728E-03 0.09559775 1.000 1.000 STANELLE_E2F1_TARGETS T-cell leukemia DOID_715 7.728E-03 0.09356376 1.000 1.000 STANELLE_E2F1_TARGETS hemangioma DOID_255 8.278E-03 0.09813254 1.000 1.000 STANELLE_E2F1_TARGETS skeletal muscle cancer DOID_4043 8.278E-03 0.09612983 1.000 1.000 STANELLE_E2F1_TARGETS oral submucous fibrosis DOID_5773 8.278E-03 0.09420724 1.000 1.000 STANELLE_E2F1_TARGETS angiosarcoma DOID_0001816 8.828E-03 0.09849141 1.000 1.000 STANELLE_E2F1_TARGETS chronic myeloid leukemia DOID_8552 8.828E-03 0.09659735 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autoimmune disease of endocrine system DOID_0060005 3.054E-09 1.738E-06 3.532E-06 4.019E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bone resorption disease DOID_0080011 9.615E-09 2.735E-06 2.466E-06 4.678E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP osteoporosis DOID_11476 9.615E-09 2.735E-06 2.466E-06 4.678E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP carbohydrate metabolic disorder DOID_2978 4.937E-08 9.364E-06 4.937E-08 2.809E-05 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP thyroiditis DOID_7166 9.967E-08 1.418E-05 2.258E-04 7.138E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autoimmune thyroiditis DOID_7188 9.967E-08 1.418E-05 2.258E-04 7.138E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP focal glomerulosclerosis DOID_3945 1.145E-07 1.303E-05 1.145E-07 3.258E-05 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP syndrome DOID_225 1.489E-07 1.412E-05 3.28E-04 9.332E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP membranous glomerulonephritis DOID_10976 3.451E-07 2.805E-05 4.494E-04 0.0106551 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP collagen disease DOID_854 5.824E-07 4.142E-05 0.38642637 0.70248117 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP lymphoma DOID_0060058 6.366E-07 4.025E-05 8.485E-05 5.364E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP encephalomyelitis DOID_640 6.906E-07 3.93E-05 0.16287711 0.3877702 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP spastic quadriplegia DOID_10970 1.146E-06 5.93E-05 8.816E-04 0.01672153 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP peripheral vascular disease DOID_341 1.733E-06 8.217E-05 0.0196043 0.12533533 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP aneurysm disease DOID_2403 2.466E-06 1.079E-04 0.02245933 0.13040161 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP mixed glioma DOID_5076 2.685E-06 1.091E-04 2.685E-06 3.82E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP thoracic aortic aneurysm DOID_14004 4.168E-06 1.581E-04 5.657E-03 0.05852368 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP spastic cerebral palsy DOID_0050669 4.872E-06 1.733E-04 2E-03 0.03075237 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP amino acid metabolic disorder DOID_9252 6.372E-06 2.133E-04 6.372E-06 6.043E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Human immunodeficiency virus infectious disease DOID_526 6.853E-06 2.166E-04 5.4E-03 0.05689978 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP lymphoblastic leukemia DOID_1037 8.478E-06 2.539E-04 8.108E-04 0.01590863 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hypersensitivity reaction type I disease DOID_1205 9.729E-06 2.768E-04 6.502E-03 0.06270757 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hypothyroidism DOID_1459 1.035E-05 2.803E-04 1.035E-05 8.41E-04 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pre-malignant neoplasm DOID_0060071 1.131E-05 2.925E-04 0.01396108 0.10591809 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP congenital heart defect DOID_1682 1.131E-05 2.798E-04 1.495E-04 5.672E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP in situ carcinoma DOID_8719 1.131E-05 2.925E-04 0.01396108 0.10591809 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP multiple myeloma DOID_9538 1.293E-05 3.066E-04 3.482E-03 0.04503266 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP systemic scleroderma DOID_418 1.651E-05 3.759E-04 0.27418139 0.5493282 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP blood coagulation disease DOID_1247 2.027E-05 4.435E-04 2.407E-04 7.208E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP cervix uteri carcinoma in situ DOID_8991 2.082E-05 4.388E-04 0.04414156 0.21467135 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP glycogen metabolism disorder DOID_0050728 2.577E-05 5.238E-04 2.577E-05 1.833E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP glycogen storage disease DOID_2747 2.577E-05 5.238E-04 2.577E-05 1.833E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP uremia DOID_4676 2.577E-05 5.057E-04 0.01309705 0.10070572 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Huntington's disease DOID_12858 2.596E-05 4.923E-04 4.14E-04 0.01024308 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP rheumatic disease DOID_1575 2.596E-05 4.765E-04 0.29601152 0.57879915 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP scleroderma DOID_419 2.596E-05 4.765E-04 0.29601152 0.57879915 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP myeloma DOID_0070004 3.914E-05 6.96E-04 6.534E-03 0.06196494 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pre-eclampsia DOID_10591 3.914E-05 6.749E-04 5.706E-04 0.01248715 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP vascular skin disease DOID_9540 3.914E-05 6.55E-04 0.05550359 0.25886509 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP urticaria DOID_1555 4.274E-05 6.948E-04 0.01657512 0.11501516 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autoimmune disease of gastrointestinal tract DOID_0060031 4.742E-05 7.495E-04 7.286E-03 0.06096764 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP alcohol abuse DOID_1574 4.825E-05 7.42E-04 4.881E-04 0.01111024 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP angioedema DOID_1558 5.005E-05 7.494E-04 2.486E-03 0.03536219 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP aortic aneurysm DOID_3627 5.204E-05 7.592E-04 0.06152724 0.27784921 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hemorrhagic disease DOID_2213 5.699E-05 8.107E-04 7.651E-04 0.01554861 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP primary immunodeficiency disease DOID_612 7.08E-05 9.825E-04 5.196E-03 0.05577998 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bone marrow cancer DOID_4960 7.407E-05 1.003E-03 9.383E-03 0.0762686 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP polycystic ovary syndrome DOID_11612 8.731E-05 1.155E-03 1.666E-03 0.02633259 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP congenital nervous system abnormality DOID_2490 9.484E-05 1.226E-03 9.484E-05 5.396E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP congenital disorder of glycosylation DOID_5212 9.918E-05 1.254E-03 9.918E-05 5.13E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hypertrophic cardiomyopathy DOID_11984 1.027E-04 1.27E-03 1.027E-04 4.868E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP oral cavity cancer DOID_8618 1.027E-04 1.243E-03 1.027E-04 4.494E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP osteogenesis imperfecta DOID_12347 1.173E-04 1.39E-03 0.0943935 0.32161619 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP celiac disease DOID_10608 1.264E-04 1.468E-03 0.02749904 0.15340151 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP allergic rhinitis DOID_4481 1.264E-04 1.438E-03 2.181E-03 0.03182029 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP chronic leukemia DOID_1036 1.419E-04 1.583E-03 0.02902188 0.15878317 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP chronic lymphocytic leukemia DOID_1040 1.419E-04 1.583E-03 0.02902188 0.15878317 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hypercalcemia DOID_12678 1.484E-04 1.624E-03 1.484E-04 6.033E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP cholestasis DOID_13580 1.723E-04 1.85E-03 0.09456494 0.31651442 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP nephroblastoma DOID_2154 1.768E-04 1.863E-03 0.03216583 0.16946629 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP thyroid carcinoma DOID_3963 1.768E-04 1.829E-03 1.768E-04 6.288E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP thyroid cancer DOID_1781 2.176E-04 2.211E-03 2.176E-04 7.283E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP spastic diplegia DOID_10965 2.258E-04 2.254E-03 0.11488359 0.3335141 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP embryonal cancer DOID_688 2.403E-04 2.358E-03 3.482E-03 0.04607993 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pancreatic ductal carcinoma DOID_3587 2.407E-04 2.321E-03 0.01825704 0.1207937 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP nephrosis DOID_2527 2.565E-04 2.433E-03 0.01892399 0.12376723 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bile duct disease DOID_4138 2.565E-04 2.393E-03 0.10892675 0.32280897 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP peroxisomal disease DOID_906 2.726E-04 2.502E-03 7.254E-03 0.06160643 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP biliary tract disease DOID_9741 2.732E-04 2.467E-03 0.11137394 0.32835116 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pancreatic carcinoma DOID_4905 2.906E-04 2.584E-03 0.02029798 0.12832832 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP ureteral obstruction DOID_5199 3.253E-04 2.848E-03 0.12828632 0.34759484 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP prion disease DOID_649 3.253E-04 2.805E-03 0.12828632 0.34594747 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP salivary gland cancer DOID_8850 3.803E-04 3.23E-03 3.803E-04 0.01030424 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP MHC class II deficiency DOID_5812 3.842E-04 3.215E-03 3.842E-04 9.936E-03 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP uveal disease DOID_3480 4.14E-04 3.414E-03 0.0478227 0.22866483 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP brain edema DOID_4724 4.494E-04 3.653E-03 9.984E-03 0.08001155 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP cataract DOID_83 4.879E-04 3.91E-03 5.83E-03 0.05820242 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP focal epilepsy DOID_2234 4.881E-04 3.858E-03 4.078E-03 0.04833829 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bone development disease DOID_0080006 5.151E-04 4.015E-03 0.02797076 0.15451805 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP proteinuria DOID_576 5.281E-04 4.06E-03 0.05354481 0.25179335 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP lens disease DOID_110 5.706E-04 4.329E-03 6.534E-03 0.06094913 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP gastric ulcer DOID_10808 6.003E-04 4.495E-03 0.15448806 0.38554256 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hepatitis B DOID_2043 6.003E-04 4.436E-03 0.01201788 0.09367358 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hemolytic anemia DOID_583 6.155E-04 4.49E-03 6.155E-04 0.01297069 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP normocytic anemia DOID_720 6.155E-04 4.49E-03 6.155E-04 0.01297069 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP transitional cell carcinoma DOID_2671 6.342E-04 4.568E-03 4.997E-03 0.05467446 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP myasthenia gravis DOID_437 6.865E-04 4.883E-03 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP urinary tract obstruction DOID_5200 6.865E-04 4.823E-03 0.16091492 0.3863316 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP B-cell lymphocytic neoplasm DOID_707 7.651E-04 5.309E-03 0.06358262 0.28264463 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP ureteral disease DOID_1426 7.802E-04 5.349E-03 0.1672931 0.39497831 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP mouth disease DOID_403 8.501E-04 5.759E-03 0.03697344 0.18454289 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP severe combined immunodeficiency DOID_627 8.816E-04 5.902E-03 8.816E-04 0.01618213 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP vasculitis DOID_865 9.388E-04 6.211E-03 0.35272878 0.66238506 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP organic acidemia DOID_0060159 9.91E-04 6.482E-03 9.91E-04 0.01762206 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP osteosarcoma DOID_3347 9.91E-04 6.408E-03 0.01657512 0.11362943 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP combined T cell and B cell immunodeficiency DOID_628 9.91E-04 6.336E-03 9.91E-04 0.01708806 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP osteochondrodysplasia DOID_2256 1.002E-03 6.337E-03 0.07202913 0.31285936 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pustulosis of palm and sole DOID_4398 1.002E-03 6.268E-03 0.35765333 0.66504819 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP ulcerative colitis DOID_8577 1.022E-03 6.319E-03 0.17634568 0.40955384 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP neuromuscular junction disease DOID_439 1.109E-03 6.783E-03 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP vitiligo DOID_12306 1.235E-03 7.474E-03 0.01908764 0.12341892 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP dystonia DOID_543 1.235E-03 7.396E-03 1.235E-03 0.02066469 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP extrinsic allergic alveolitis DOID_841 1.235E-03 7.319E-03 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autoimmune disease of cardiovascular system DOID_0060051 1.513E-03 8.877E-03 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP sarcoma DOID_1115 1.513E-03 8.786E-03 0.02174914 0.13026593 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Behcet's disease DOID_13241 1.513E-03 8.877E-03 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP thrombocytopenia DOID_1588 1.513E-03 8.697E-03 1.513E-03 0.02460118 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autoimmune disease of the nervous system DOID_438 1.513E-03 8.61E-03 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP respiratory failure DOID_11162 1.535E-03 8.645E-03 0.39109541 0.70870474 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP uterine disease DOID_345 1.813E-03 0.01011559 0.09456494 0.31283402 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP corneal disease DOID_10124 1.828E-03 0.01009904 0.02455459 0.13971562 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP temporal lobe epilepsy DOID_3328 1.914E-03 0.01046944 0.01572258 0.11182686 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP endocrine organ benign neoplasm DOID_0060089 2.125E-03 0.01151771 2.125E-03 0.03182524 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP brain infarction DOID_3454 2.125E-03 0.01140905 0.41837541 0.75334053 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP leiomyoma DOID_127 2.372E-03 0.01261465 0.23434315 0.49385648 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP facioscapulohumeral muscular dystrophy DOID_11727 2.486E-03 0.01309711 0.07343076 0.31653109 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Sjogren's syndrome DOID_12894 2.486E-03 0.01297695 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP lateral sclerosis DOID_230 2.486E-03 0.01285898 0.07343076 0.30497887 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP diabetic retinopathy DOID_8947 2.725E-03 0.01396727 0.44017588 0.78268774 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pneumoconiosis DOID_10316 2.785E-03 0.01414813 0.24594277 0.50887795 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP macular degeneration DOID_4448 2.785E-03 0.01402293 0.24594277 0.50520375 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hyperthyroidism DOID_7998 2.785E-03 0.01389992 0.03216583 0.16638508 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP breast benign neoplasm DOID_0060082 3.023E-03 0.01495796 0.08047153 0.30938039 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP thoracic benign neoplasm DOID_0060097 3.023E-03 0.01495796 0.08047153 0.30938039 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP sickle cell anemia DOID_10923 3.023E-03 0.01482902 0.08047153 0.30730402 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP benign breast phyllodes tumor DOID_1631 3.023E-03 0.01495796 0.08047153 0.30938039 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP invasive lobular carcinoma DOID_3457 3.023E-03 0.01470227 0.08047153 0.30323376 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP chronic monocytic leukemia DOID_8593 3.023E-03 0.01457768 3.023E-03 0.04195526 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP adenoma DOID_657 3.239E-03 0.01548811 3.239E-03 0.04388297 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP contact dermatitis DOID_2773 3.585E-03 0.01700038 3.585E-03 0.04533434 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP esophageal carcinoma DOID_1107 3.61E-03 0.01697417 0.08745897 0.32314386 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP esophagus squamous cell carcinoma DOID_3748 3.61E-03 0.01697417 0.08745897 0.32314386 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP microcephaly DOID_10907 3.736E-03 0.01742603 3.736E-03 0.04621685 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP uveitis DOID_13141 3.736E-03 0.01728435 0.26861926 0.54393011 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP blood platelet disease DOID_2218 3.736E-03 0.01714496 3.736E-03 0.04523351 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP female reproductive system disease DOID_229 3.745E-03 0.01704589 0.13143766 0.35111749 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP respiratory syncytial virus infectious disease DOID_1273 4.001E-03 0.0180697 0.27418139 0.55322415 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hepatitis DOID_2237 4.001E-03 0.01792741 0.04057216 0.20074399 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP peptic ulcer DOID_750 4.001E-03 0.01778736 0.27418139 0.54740073 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP monocytic leukemia DOID_8527 4.245E-03 0.01872227 4.245E-03 0.04928924 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP adenoid cystic carcinoma DOID_4866 4.278E-03 0.01872259 4.278E-03 0.04867874 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP retinal vascular disease DOID_2462 4.43E-03 0.01924285 0.48531287 0.84447408 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP benign mesothelioma DOID_2645 4.565E-03 0.01967816 0.04414156 0.21652196 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP endometriosis of uterus DOID_288 4.864E-03 0.02080901 0.29061611 0.57020885 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP rhabdomyosarcoma DOID_3247 4.927E-03 0.02092258 0.10127552 0.32741915 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Zellweger syndrome DOID_905 4.927E-03 0.0207676 4.927E-03 0.05497305 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bacterial meningitis DOID_9470 4.927E-03 0.0206149 0.10127552 0.32193168 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP endometriosis DOID_289 5.174E-03 0.02149088 0.29601152 0.5748483 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP nervous system cancer DOID_3093 5.4E-03 0.02226513 0.15488982 0.37825024 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP diabetic autonomic neuropathy DOID_11503 5.497E-03 0.0225003 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autonomic neuropathy DOID_11504 5.497E-03 0.0225003 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP diabetic polyneuropathy DOID_12785 5.497E-03 0.0225003 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP diabetic neuropathy DOID_9743 5.497E-03 0.0225003 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP skeletal system cancer DOID_0060124 5.657E-03 0.02299145 0.10810542 0.34173324 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Ehlers-Danlos syndrome DOID_13359 5.657E-03 0.02282839 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bone cancer DOID_184 5.657E-03 0.02299145 0.10810542 0.34173324 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hemangioma DOID_255 5.657E-03 0.02266762 5.657E-03 0.05747862 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP membranoproliferative glomerulonephritis DOID_2920 5.657E-03 0.02250911 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP skeletal muscle cancer DOID_4043 5.657E-03 0.0223528 0.10810542 0.32894109 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP panic disorder DOID_594 5.657E-03 0.02219864 0.10810542 0.32374728 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP leukodystrophy DOID_10579 6.176E-03 0.02407057 6.176E-03 0.06059143 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.271E-03 0.02427267 0.03697344 0.18617601 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP angiosarcoma DOID_0001816 6.433E-03 0.02473161 0.11488359 0.33695239 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autonomic nervous system disease DOID_11465 6.534E-03 0.02495233 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP thyroid adenoma DOID_2891 6.534E-03 0.02478598 6.534E-03 0.05996608 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP congenital disorder of glycosylation type I DOID_0050570 7.254E-03 0.0273353 7.254E-03 0.06551795 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Graves' disease DOID_12361 7.254E-03 0.02715546 7.254E-03 0.06449423 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP methylmalonic acidemia DOID_14749 7.254E-03 0.02697798 7.254E-03 0.06350201 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP urinary system benign neoplasm DOID_731 7.254E-03 0.0268028 7.254E-03 0.06253986 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP lung small cell carcinoma DOID_5409 7.286E-03 0.02674709 0.05949529 0.27082256 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP calcium metabolism disease DOID_10575 7.681E-03 0.02801421 7.681E-03 0.06333647 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP glucose intolerance DOID_10603 8.12E-03 0.02942959 0.12828632 0.3509371 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP keratosis DOID_161 8.12E-03 0.02924332 0.12828632 0.34925797 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP eosinophilia DOID_999 8.12E-03 0.0290594 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP atrophic muscular disease DOID_913 8.938E-03 0.03178704 0.0677618 0.29888733 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP muscular dystrophy DOID_9884 8.938E-03 0.03178704 0.0677618 0.29888733 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP granulosa cell tumor DOID_2999 9.03E-03 0.03191497 0.13491165 0.35052387 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pulmonary edema DOID_11396 9.984E-03 0.03506679 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP sex cord-gonadal stromal tumor DOID_192 9.984E-03 0.03485166 0.14148679 0.36101339 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP amyloidosis DOID_9120 9.984E-03 0.03463915 9.984E-03 0.07890028 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP funisitis DOID_0050698 0.01201788 0.04144346 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP acquired immunodeficiency syndrome DOID_635 0.01201788 0.0411938 0.15448806 0.38219001 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP carotid artery disease DOID_3407 0.01285265 0.04379137 0.08532442 0.31731763 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP muscle cancer DOID_4045 0.01309705 0.04435847 0.16091492 0.3879686 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP diabetic angiopathy DOID_11713 0.01421677 0.04786592 0.1672931 0.39662406 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Lewy body dementia DOID_12217 0.01421677 0.04758436 0.01421677 0.10643869 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP congenital hemolytic anemia DOID_589 0.01421677 0.04730608 0.01421677 0.10505637 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP meningitis DOID_9471 0.01421677 0.04703105 0.1672931 0.39334617 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP mineral metabolism disease DOID_0050032 0.01453504 0.04780598 0.01453504 0.10603122 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP parasitic infectious disease DOID_1398 0.01512219 0.0494513 0.09456494 0.31466346 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP cerebral degeneration DOID_1443 0.01512219 0.04916872 0.01512219 0.10891805 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hyperglycemia DOID_4195 0.01572258 0.05083039 0.09691845 0.31876645 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP allergic contact dermatitis DOID_3042 0.01633624 0.05251593 0.01633624 0.11475704 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bronchiolitis DOID_2942 0.01657512 0.05298451 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP tuberculosis DOID_399 0.01696319 0.05392209 0.41837541 0.75096406 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP autosomal dominant nonsyndromic deafness DOID_0050564 0.01781243 0.05630708 0.01781243 0.12065803 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP spinal muscular atrophy DOID_12377 0.01781243 0.05599599 0.1861392 0.42879841 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP cystitis DOID_1679 0.01781243 0.05568832 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP papillary adenoma DOID_3172 0.01781243 0.05538401 0.01781243 0.11923852 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP microcystic adenoma DOID_5403 0.01781243 0.05538401 0.01781243 0.11923852 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP follicular adenoma DOID_6204 0.01781243 0.05538401 0.01781243 0.11923852 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP myositis DOID_633 0.01781243 0.05508301 0.1861392 0.42535424 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP ankylosing spondylitis DOID_7147 0.01781243 0.05478527 0.1861392 0.42365283 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP male reproductive system disease DOID_48 0.01892399 0.05789113 0.43155516 0.76976453 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP intracranial aneurysm DOID_10941 0.01908764 0.05807949 0.1923263 0.43599069 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP B cell deficiency DOID_2115 0.01908764 0.05777056 0.1923263 0.43254412 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP seminoma DOID_4440 0.01908764 0.05746489 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP diffuse large B-cell lymphoma DOID_0050745 0.02040008 0.06109289 0.19846652 0.44285274 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP lung adenocarcinoma DOID_3910 0.02040008 0.06077303 0.02040008 0.12755657 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP migraine DOID_6364 0.02040008 0.0604565 0.19846652 0.44112285 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP periodontitis DOID_824 0.02040008 0.06014325 0.02040008 0.12617009 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP perinatal necrotizing enterocolitis DOID_8677 0.02040008 0.05983324 0.02040008 0.12481342 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pleurisy DOID_10247 0.02174914 0.06346289 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP renal hypertension DOID_1073 0.02174914 0.0631391 0.02174914 0.13165173 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP secondary hypertension DOID_11130 0.02174914 0.0631391 0.02174914 0.13165173 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP coronary stenosis DOID_4248 0.02174914 0.06281859 0.02174914 0.12890899 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP renal tubular transport disease DOID_447 0.02174914 0.06250133 0.02174914 0.12758003 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP toxic encephalopathy DOID_3602 0.02313419 0.0661475 0.02313419 0.13296315 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bacterial pneumonia DOID_874 0.02320656 0.06602265 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP female reproductive organ benign neoplasm DOID_0060086 0.02455459 0.06951026 0.21660947 0.47042286 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP uterine benign neoplasm DOID_0060095 0.02455459 0.06951026 0.21660947 0.47042286 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP uterine fibroid DOID_13223 0.02455459 0.06951026 0.21660947 0.47042286 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP chromosomal disease DOID_0080014 0.02552853 0.07190957 0.13143766 0.35277371 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP age related macular degeneration DOID_10871 0.02600974 0.07290416 0.22256571 0.47788638 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP degeneration of macula and posterior pole DOID_2007 0.02600974 0.07290416 0.22256571 0.47788638 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP mental depression DOID_1596 0.02714334 0.07570863 0.02714334 0.15291644 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP chronic kidney failure DOID_784 0.02714334 0.07533932 0.13657616 0.35005332 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP germinoma DOID_3304 0.02749904 0.07595609 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP pleural disease DOID_1532 0.02902188 0.07977512 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP bladder disease DOID_365 0.02902188 0.07939159 1.000 1.000 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP primary bacterial infectious disease DOID_0050338 0.03053282 0.08312525 0.49312101 0.85544468 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP papilloma DOID_2615 0.03057767 0.08285093 0.03057767 0.16570187 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP myocarditis DOID_820 0.03057767 0.08245827 0.03057767 0.16413864 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP male infertility DOID_12336 0.03216583 0.08633188 0.24594277 0.50703419 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP hepatitis C DOID_1883 0.03216583 0.08592657 0.03216583 0.17105009 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP periodontal disease DOID_3388 0.03216583 0.08552504 0.03216583 0.16791155 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP esophageal disease DOID_6050 0.03216583 0.08512725 0.24594277 0.50338647 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP lymphoid leukemia DOID_10747 0.03378578 0.08900051 0.03378578 0.17319019 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP refractive error DOID_9835 0.03543695 0.09291993 0.03543695 0.18003237 FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP Crohn's disease DOID_8778 0.03697344 0.09650408 0.51953146 0.89852097 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN bacterial pneumonia DOID_874 3.927E-11 2.234E-08 2.705E-09 1.539E-06 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN primary bacterial infectious disease DOID_0050338 5.175E-09 1.472E-06 1.093E-05 6.217E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN uveal disease DOID_3480 9.178E-09 1.741E-06 2.28E-03 0.02447793 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN ulcerative colitis DOID_8577 1.048E-08 1.491E-06 4.734E-07 6.733E-05 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pulmonary tuberculosis DOID_2957 1.728E-08 1.966E-06 7.12E-05 2.026E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN aortic aneurysm DOID_3627 1.906E-08 1.807E-06 7.539E-05 2.043E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN sarcoidosis DOID_11335 2.528E-08 2.055E-06 8.892E-05 2.3E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pustulosis of palm and sole DOID_4398 3.025E-08 2.152E-06 9.876E-05 2.342E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hypersensitivity reaction type IV disease DOID_2916 3.914E-08 2.475E-06 1.148E-04 2.613E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN myositis DOID_633 8.429E-08 4.796E-06 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN tuberculosis DOID_399 8.467E-08 4.38E-06 1.804E-04 3.421E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN bile duct disease DOID_4138 1.044E-07 4.95E-06 1.044E-07 2.97E-05 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN biliary tract disease DOID_9741 1.117E-07 4.89E-06 1.117E-07 2.119E-05 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pleurisy DOID_10247 1.312E-07 5.331E-06 1.34E-05 6.93E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN cystic fibrosis DOID_1485 1.362E-07 5.166E-06 6.464E-06 5.254E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN aneurysm disease DOID_2403 1.452E-07 5.164E-06 2.474E-04 4.022E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pancreatitis DOID_4989 1.547E-07 5.178E-06 7.151E-06 5.086E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pleural disease DOID_1532 2.492E-07 7.877E-06 2.148E-05 1.018E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN esophageal disease DOID_6050 3.136E-07 9.391E-06 0.05510034 0.21622135 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN lymphoma DOID_0060058 3.475E-07 9.887E-06 9.187E-03 0.07160998 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hypersensitivity reaction type I disease DOID_1205 4.066E-07 1.102E-05 9.758E-03 0.07305397 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN uveitis DOID_13141 4.787E-07 1.238E-05 0.06087534 0.23092047 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hepatitis DOID_2237 5.284E-07 1.307E-05 3.739E-05 1.52E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN influenza DOID_8469 8.373E-07 1.985E-05 5.252E-05 1.66E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN vascular skin disease DOID_9540 1.077E-06 2.452E-05 2.688E-03 0.02683291 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Legionnaires' disease DOID_10457 1.222E-06 2.675E-05 1.222E-06 1.391E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN legionellosis DOID_10458 1.222E-06 2.675E-05 1.222E-06 1.391E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN autoimmune disease of gastrointestinal tract DOID_0060031 1.264E-06 2.663E-05 2.904E-03 0.02848857 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN B-cell lymphocytic neoplasm DOID_707 1.473E-06 2.993E-05 0.07940557 0.27718876 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN giant cell tumor DOID_200 1.707E-06 3.349E-05 8.892E-05 2.2E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN malignant giant cell tumor DOID_2705 1.707E-06 3.349E-05 8.892E-05 2.2E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN giant cell glioblastoma DOID_3074 1.707E-06 3.349E-05 8.892E-05 2.2E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN glioblastoma DOID_3068 2.411E-06 4.573E-05 1.148E-04 2.513E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN leukocyte disease DOID_9500 2.574E-06 4.725E-05 4.101E-03 0.0382527 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN eosinophilia DOID_999 2.728E-06 4.851E-05 3.464E-04 5.188E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN cholestasis DOID_13580 3.733E-06 6.436E-05 3.733E-06 3.54E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN astrocytoma DOID_3069 4.694E-06 7.856E-05 1.88E-04 3.451E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN peripheral vascular disease DOID_341 5.527E-06 8.985E-05 5.942E-03 0.04971988 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN sleep disorder DOID_535 5.888E-06 9.307E-05 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN acute pancreatitis DOID_2913 7.631E-06 1.173E-04 7.631E-06 4.824E-04 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN urticaria DOID_1555 8.617E-06 1.29E-04 0.03903854 0.19149076 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN cystitis DOID_1679 9.683E-06 1.413E-04 7.878E-04 0.01093289 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN ankylosing spondylitis DOID_7147 9.683E-06 1.377E-04 0.04050972 0.1920836 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Human immunodeficiency virus infectious disease DOID_526 1.246E-05 1.729E-04 8.816E-03 0.06966747 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN encephalomyelitis DOID_640 1.415E-05 1.917E-04 9.376E-03 0.07209109 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN abdominal aortic aneurysm DOID_7693 1.794E-05 2.375E-04 0.04929045 0.20930049 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN celiac disease DOID_10608 1.966E-05 2.542E-04 0.05074621 0.21388586 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN bladder disease DOID_365 2.148E-05 2.716E-04 1.325E-03 0.01604049 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pulmonary sarcoidosis DOID_13406 3.225E-05 3.989E-04 3.225E-05 1.411E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN intracranial arterial disease DOID_13089 4.015E-05 4.861E-04 1.995E-03 0.02270419 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN cerebral arterial disease DOID_3527 4.015E-05 4.861E-04 1.995E-03 0.02270419 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pulmonary emphysema DOID_9675 4.304E-05 5.102E-04 4.304E-05 1.633E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN endometriosis of uterus DOID_288 4.607E-05 5.349E-04 4.607E-05 1.638E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN endometriosis DOID_289 4.923E-05 5.602E-04 4.923E-05 1.648E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN neuritis DOID_1803 6.328E-05 7.06E-04 6.328E-05 1.895E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN atopic dermatitis DOID_3310 8.425E-05 9.219E-04 3.243E-03 0.03127178 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Sjogren's syndrome DOID_12894 1.027E-04 1.103E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN cutaneous leishmaniasis DOID_9111 1.027E-04 1.082E-03 0.01519588 0.10808072 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN oral cavity cancer DOID_8618 1.148E-04 1.188E-03 3.973E-03 0.03767259 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN dermatomyositis DOID_10223 1.254E-04 1.274E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN eosinophilic pneumonia DOID_5870 1.254E-04 1.252E-03 1.254E-04 2.643E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pulmonary eosinophilia DOID_9498 1.254E-04 1.252E-03 1.254E-04 2.643E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Loeffler syndrome DOID_9503 1.254E-04 1.252E-03 1.254E-04 2.643E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN common cold DOID_10459 1.503E-04 1.475E-03 1.503E-04 3.055E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN stomach disease DOID_76 1.503E-04 1.45E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN encephalitis DOID_9588 1.503E-04 1.426E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN parasitic infectious disease DOID_1398 1.587E-04 1.48E-03 4.911E-03 0.04507251 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN uterine disease DOID_345 1.587E-04 1.456E-03 1.587E-04 3.113E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN tooth disease DOID_1091 1.729E-04 1.562E-03 5.196E-03 0.0469328 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN brain infarction DOID_3454 1.804E-04 1.604E-03 5.342E-03 0.04676145 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pancreatic ductal carcinoma DOID_3587 1.959E-04 1.715E-03 1.959E-04 3.483E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN male reproductive system disease DOID_48 2.039E-04 1.758E-03 5.789E-03 0.04916436 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN viral pneumonia DOID_10533 2.069E-04 1.757E-03 2.069E-04 3.567E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN narcolepsy DOID_8986 2.069E-04 1.731E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pancreatic carcinoma DOID_4905 2.207E-04 1.82E-03 2.207E-04 3.693E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN syndrome DOID_225 2.383E-04 1.937E-03 6.411E-03 0.05286989 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN thyroiditis DOID_7166 2.723E-04 2.182E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN autoimmune thyroiditis DOID_7188 2.723E-04 2.182E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN contact dermatitis DOID_2773 2.762E-04 2.183E-03 2.762E-04 4.365E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN female reproductive system disease DOID_229 2.862E-04 2.231E-03 2.862E-04 4.402E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN juvenile rheumatoid arthritis DOID_676 3.083E-04 2.37E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN primary immunodeficiency disease DOID_612 3.752E-04 2.846E-03 8.632E-03 0.06918035 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN leishmaniasis DOID_9065 3.868E-04 2.896E-03 0.028678 0.15997827 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pulmonary edema DOID_11396 4.294E-04 3.173E-03 0.03016477 0.16663841 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN esophagitis DOID_11963 4.294E-04 3.132E-03 0.03016477 0.16503611 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN mouth disease DOID_403 4.389E-04 3.161E-03 9.566E-03 0.07257244 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Crohn's disease DOID_8778 4.389E-04 3.121E-03 4.389E-04 6.403E-03 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN dilated cardiomyopathy DOID_12930 4.524E-04 3.178E-03 9.758E-03 0.07210522 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Kawasaki disease DOID_13378 4.741E-04 3.29E-03 0.03164931 0.16989109 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN lymphadenitis DOID_1602 4.741E-04 3.29E-03 0.03164931 0.16989109 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN autoimmune hepatitis DOID_2048 4.741E-04 3.25E-03 0.03164931 0.16830332 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN mitochondrial myopathy DOID_699 4.741E-04 3.212E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN lymph node disease DOID_9942 4.741E-04 3.29E-03 0.03164931 0.16989109 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hepatitis B DOID_2043 5.21E-04 3.488E-03 0.03313161 0.17455448 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN myasthenia gravis DOID_437 5.701E-04 3.772E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN polyarteritis nodosa DOID_9810 5.701E-04 3.728E-03 0.03461168 0.17903676 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hypoglycemia DOID_9993 5.701E-04 3.686E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN commensal bacterial infectious disease DOID_0050339 7.301E-04 4.668E-03 7.301E-04 0.01038632 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN portal hypertension DOID_10762 7.301E-04 4.616E-03 0.03903854 0.1931559 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN bronchiolitis DOID_2942 7.301E-04 4.565E-03 0.03903854 0.18985409 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN neuromuscular junction disease DOID_439 7.878E-04 4.872E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN vitiligo DOID_12306 8.475E-04 5.186E-03 0.04197869 0.19578586 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN B cell deficiency DOID_2115 8.475E-04 5.13E-03 0.04197869 0.19419411 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN middle cerebral artery infarction DOID_3525 8.475E-04 5.076E-03 8.475E-04 0.01148226 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN extrinsic allergic alveolitis DOID_841 8.475E-04 5.023E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN diffuse large B-cell lymphoma DOID_0050745 9.094E-04 5.335E-03 0.04344545 0.19776369 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN gestational diabetes DOID_11714 9.094E-04 5.28E-03 9.094E-04 0.01203416 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN lung adenocarcinoma DOID_3910 9.094E-04 5.227E-03 0.04344545 0.19619414 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN periodontitis DOID_824 9.094E-04 5.175E-03 0.04344545 0.1946493 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN perinatal necrotizing enterocolitis DOID_8677 9.094E-04 5.123E-03 0.04344545 0.1931286 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hepatic vascular disease DOID_272 9.734E-04 5.43E-03 0.04491 0.1980914 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN autoimmune disease of the nervous system DOID_438 9.734E-04 5.378E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN autoimmune disease of endocrine system DOID_0060005 1.04E-03 5.688E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN polycystic ovary syndrome DOID_11612 1.04E-03 5.633E-03 1.04E-03 0.01344327 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN endometrial carcinoma DOID_2871 1.108E-03 5.946E-03 1.108E-03 0.01400707 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN endometrial cancer DOID_1380 1.25E-03 6.65E-03 1.25E-03 0.01546785 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN chronic leukemia DOID_1036 1.325E-03 6.981E-03 0.05219977 0.21680051 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN chronic lymphocytic leukemia DOID_1040 1.325E-03 6.981E-03 0.05219977 0.21680051 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN papilloma DOID_2615 1.402E-03 7.316E-03 0.05365115 0.2180536 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN myocarditis DOID_820 1.402E-03 7.25E-03 0.05365115 0.21650713 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN nephroblastoma DOID_2154 1.48E-03 7.587E-03 1.48E-03 0.01754602 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN periodontal disease DOID_3388 1.48E-03 7.52E-03 0.05510034 0.21772289 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN adenoma DOID_657 1.644E-03 8.276E-03 1.644E-03 0.01908601 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN calcinosis DOID_182 1.728E-03 8.627E-03 0.05943485 0.23005736 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN systemic scleroderma DOID_418 1.904E-03 9.421E-03 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN peptic ulcer DOID_750 1.904E-03 9.34E-03 0.06231367 0.23326629 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN adenoid cystic carcinoma DOID_4866 1.995E-03 9.703E-03 1.995E-03 0.02225901 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN lymphatic system disease DOID_75 1.995E-03 9.62E-03 0.06374982 0.23708267 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN salivary gland cancer DOID_8850 2.183E-03 0.01043817 2.183E-03 0.02388735 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN rheumatic disease DOID_1575 2.28E-03 0.01081108 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN scleroderma DOID_419 2.28E-03 0.01081108 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN uterine cancer DOID_363 2.379E-03 0.01118728 2.379E-03 0.02506779 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN cerebral infarction DOID_3526 2.48E-03 0.01156665 2.48E-03 0.02565693 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pre-eclampsia DOID_10591 2.688E-03 0.01243477 2.688E-03 0.02731207 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN thyroid adenoma DOID_2891 2.688E-03 0.01233448 0.07374257 0.26556658 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN calcium metabolism disease DOID_10575 3.015E-03 0.01372362 0.07799302 0.27393843 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN parasitic protozoa infectious disease DOID_2789 3.599E-03 0.0162519 0.08503454 0.29147382 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN mitochondrial metabolism disease DOID_700 3.721E-03 0.01667334 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN melancholia DOID_2848 4.101E-03 0.0182298 0.09062968 0.30513781 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN neurotic disorder DOID_4964 4.231E-03 0.01866327 0.09202321 0.30800709 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN collagen disease DOID_854 4.363E-03 0.01909841 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN respiratory failure DOID_11162 4.498E-03 0.01953516 0.09480396 0.3154588 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN mineral metabolism disease DOID_0050032 4.771E-03 0.02056788 0.09757635 0.3209303 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN endocrine pancreas disease DOID_1428 4.771E-03 0.02041323 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN temporal lobe epilepsy DOID_3328 5.053E-03 0.02145596 0.10034039 0.3281246 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hyperglycemia DOID_4195 5.053E-03 0.02129703 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN allergic contact dermatitis DOID_3042 5.196E-03 0.02174093 5.196E-03 0.04619947 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN endocrine organ benign neoplasm DOID_0060089 5.342E-03 0.02218609 0.10309611 0.33520962 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN blood coagulation disease DOID_1247 5.638E-03 0.02324725 0.10584353 0.34218732 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN nephrosis DOID_2527 5.789E-03 0.02369793 5.789E-03 0.04990928 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN diabetic retinopathy DOID_8947 6.097E-03 0.02477811 0.10994916 0.35345239 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN endogenous depression DOID_1595 6.411E-03 0.0258725 0.11267595 0.36018324 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN bone resorption disease DOID_0080011 6.571E-03 0.02633183 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN osteoporosis DOID_11476 6.571E-03 0.02633183 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN mental depression DOID_1596 7.57E-03 0.03012061 0.12215522 0.38190287 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN focal epilepsy DOID_2234 7.57E-03 0.02991144 0.12215522 0.37981597 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN biliary tract cancer DOID_4607 7.57E-03 0.02970516 0.12215522 0.37775175 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN retinal vascular disease DOID_2462 7.917E-03 0.03085448 0.12484526 0.38398352 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN transitional cell carcinoma DOID_2671 8.451E-03 0.03271119 8.451E-03 0.0686935 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN amino acid metabolic disorder DOID_9252 8.632E-03 0.03318787 0.13020105 0.3983032 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN nervous system cancer DOID_3093 8.816E-03 0.03366482 0.13153495 0.40023203 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN lymphoblastic leukemia DOID_1037 9.376E-03 0.03556494 0.13552462 0.41017825 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN leber hereditary optic neuropathy DOID_705 0.01368656 0.05157388 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hypolipoproteinemia DOID_1387 0.01519588 0.05688459 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN childhood type dermatomyositis DOID_14203 0.01519588 0.05651279 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN angioedema DOID_1558 0.01519588 0.05614583 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN retinal vascular occlusion DOID_1729 0.01519588 0.0557836 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN transient cerebral ischemia DOID_224 0.01519588 0.05542601 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN acute kidney failure DOID_3021 0.01519588 0.05507298 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN insulinoma DOID_3892 0.01519588 0.05472441 0.01519588 0.11085202 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Paget's disease of bone DOID_5408 0.01519588 0.05438024 0.01519588 0.10944883 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN familial adenomatous polyposis DOID_0050424 0.01670293 0.0593998 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN adrenoleukodystrophy DOID_10588 0.01670293 0.05903086 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN pneumocystosis DOID_11339 0.01670293 0.05866647 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN common variable immunodeficiency DOID_12177 0.01670293 0.05830655 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN neuronal ceroid lipofuscinosis DOID_14503 0.01670293 0.05795102 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN invasive lobular carcinoma DOID_3457 0.01670293 0.05759981 0.01670293 0.11733294 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN bronchiectasis DOID_9563 0.01670293 0.05725282 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN beta thalassemia DOID_12241 0.01820771 0.06203706 0.01820771 0.12634377 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN mucopolysaccharidosis DOID_12798 0.01820771 0.06166779 0.01820771 0.12482155 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN intracranial arteriosclerosis DOID_13097 0.01820771 0.06130289 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN islet cell tumor DOID_1799 0.01820771 0.06094229 0.01820771 0.12333558 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN vascular dementia DOID_8725 0.01820771 0.06130289 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN mitochondrial encephalomyopathy DOID_890 0.01820771 0.0605859 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN progressive myoclonus epilepsy DOID_891 0.01820771 0.06023366 0.01820771 0.12188457 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN variable age at onset electroclinical syndrome DOID_0050706 0.01971023 0.06482729 0.01971023 0.13040839 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN open-angle glaucoma DOID_1067 0.02121049 0.06936074 0.02121049 0.13872148 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN parasitic helminthiasis infectious disease DOID_883 0.02121049 0.0689644 0.02121049 0.1371451 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN bacterial meningitis DOID_9470 0.02121049 0.06857255 0.02121049 0.13560415 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN thalassemia DOID_10241 0.02270849 0.07300075 0.02270849 0.14356814 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN corneal dystrophy DOID_2566 0.02270849 0.07259063 0.02270849 0.14199047 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN adrenal cortex disease DOID_3952 0.02270849 0.0721851 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN lung oat cell carcinoma DOID_5411 0.02270849 0.07178407 0.02270849 0.14044709 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN varicose veins DOID_799 0.02270849 0.07138747 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN intermediate coronary syndrome DOID_8805 0.02270849 0.07099523 0.02270849 0.13893691 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hyperhomocysteinemia DOID_9279 0.02270849 0.07060728 0.02270849 0.13745886 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN spastic diplegia DOID_10965 0.02420424 0.07484899 0.02420424 0.14497067 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN restrictive cardiomyopathy DOID_397 0.02420424 0.0744444 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN chronic myeloid leukemia DOID_8552 0.02420424 0.07404416 0.02420424 0.14346056 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN tongue cancer DOID_8649 0.02420424 0.0736482 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN vein disease DOID_866 0.02420424 0.07325646 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Barrett's esophagus DOID_9206 0.02420424 0.07286886 0.02420424 0.14198158 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN drug-induced mental disorder DOID_1203 0.02569774 0.07695797 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN methylmalonic acidemia DOID_14749 0.02569774 0.07655505 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN drug psychosis DOID_1742 0.02569774 0.07695797 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN hyperostosis DOID_205 0.02569774 0.07615633 0.02569774 0.14920423 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN substance-induced psychosis DOID_8646 0.02569774 0.07695797 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN adrenal gland disease DOID_9553 0.02569774 0.07576173 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN glucose intolerance DOID_10603 0.02718899 0.07974504 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN dental caries DOID_216 0.02718899 0.07933609 0.02718899 0.15626806 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN prion disease DOID_649 0.02718899 0.07893131 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Down syndrome DOID_14250 0.028678 0.08283139 0.028678 0.16317784 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN agammaglobulinemia DOID_2583 0.028678 0.08241305 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN MHC class II deficiency DOID_5812 0.028678 0.08199891 0.028678 0.16156222 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN membranous glomerulonephritis DOID_10976 0.03016477 0.08581878 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN brain edema DOID_4724 0.03016477 0.08539182 0.03016477 0.16346434 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN blood protein disease DOID_620 0.03016477 0.08496909 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN funisitis DOID_0050698 0.03313161 0.09286642 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN neutropenia DOID_1227 0.03313161 0.0924112 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN thrombophilia DOID_2452 0.03313161 0.09196041 0.03313161 0.17295306 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN sinusitis DOID_0050127 0.03461168 0.09560215 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN agranulocytosis DOID_12987 0.03461168 0.09514031 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN paranasal sinus disease DOID_1352 0.03461168 0.09560215 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN optic nerve disease DOID_1891 0.03461168 0.0946829 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN IgA glomerulonephritis DOID_2986 0.03461168 0.09422987 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN Lewy body dementia DOID_12217 0.03608952 0.09778541 1.000 1.000 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN congenital hemolytic anemia DOID_589 0.03608952 0.09732197 0.03608952 0.18499943 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN meningitis DOID_9471 0.03608952 0.09686291 0.03608952 0.18334765 GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN severe combined immunodeficiency DOID_627 0.03756514 0.09988114 0.03756514 0.18749618 URS_ADIPOCYTE_DIFFERENTIATION_UP familial combined hyperlipidemia DOID_13809 4.329E-10 2.463E-07 4.329E-10 2.463E-07 URS_ADIPOCYTE_DIFFERENTIATION_UP metabolic syndrome X DOID_14221 8.501E-10 2.419E-07 5.975E-08 1.7E-05 URS_ADIPOCYTE_DIFFERENTIATION_UP hyperinsulinism DOID_2018 3.256E-07 6.175E-05 2.611E-05 1.857E-03 URS_ADIPOCYTE_DIFFERENTIATION_UP familial hyperlipidemia DOID_1168 8.974E-07 1.277E-04 8.974E-07 1.702E-04 URS_ADIPOCYTE_DIFFERENTIATION_UP endocrine pancreas disease DOID_1428 1.5E-06 1.707E-04 8.091E-05 4.185E-03 URS_ADIPOCYTE_DIFFERENTIATION_UP diabetic retinopathy DOID_8947 2.491E-06 2.362E-04 2.491E-06 3.543E-04 URS_ADIPOCYTE_DIFFERENTIATION_UP familial hypercholesterolemia DOID_13810 2.705E-06 2.199E-04 2.705E-06 3.078E-04 URS_ADIPOCYTE_DIFFERENTIATION_UP lipid metabolism disorder DOID_3146 3.378E-06 2.402E-04 3.378E-06 3.203E-04 URS_ADIPOCYTE_DIFFERENTIATION_UP retinal vascular disease DOID_2462 4.279E-06 2.705E-04 4.279E-06 3.478E-04 URS_ADIPOCYTE_DIFFERENTIATION_UP hepatitis DOID_2237 1.982E-05 1.128E-03 1.255E-03 0.0396687 URS_ADIPOCYTE_DIFFERENTIATION_UP carotid artery disease DOID_3407 7.055E-05 3.65E-03 7.055E-05 4.461E-03 URS_ADIPOCYTE_DIFFERENTIATION_UP hypothyroidism DOID_1459 7.39E-05 3.504E-03 7.39E-05 4.205E-03 URS_ADIPOCYTE_DIFFERENTIATION_UP lipodystrophy DOID_811 9.85E-05 4.311E-03 9.85E-05 4.671E-03 URS_ADIPOCYTE_DIFFERENTIATION_UP nephrosis DOID_2527 1.088E-04 4.423E-03 1.088E-04 4.763E-03 URS_ADIPOCYTE_DIFFERENTIATION_UP alcohol abuse DOID_1574 1.642E-04 6.23E-03 5.03E-03 0.10221515 URS_ADIPOCYTE_DIFFERENTIATION_UP Crohn's disease DOID_8778 2.353E-04 8.369E-03 6.369E-03 0.10982487 URS_ADIPOCYTE_DIFFERENTIATION_UP muscular atrophy DOID_767 3.42E-04 0.01144829 3.42E-04 0.0139015 URS_ADIPOCYTE_DIFFERENTIATION_UP urinary tract obstruction DOID_5200 3.743E-04 0.01183266 3.743E-04 0.01419919 URS_ADIPOCYTE_DIFFERENTIATION_UP ankylosing spondylitis DOID_7147 5.177E-04 0.01550298 0.03295031 0.27172067 URS_ADIPOCYTE_DIFFERENTIATION_UP gestational diabetes DOID_11714 5.978E-04 0.01700871 0.03534835 0.27180017 URS_ADIPOCYTE_DIFFERENTIATION_UP renal hypertension DOID_1073 6.4E-04 0.01734212 6.4E-04 0.02276153 URS_ADIPOCYTE_DIFFERENTIATION_UP secondary hypertension DOID_11130 6.4E-04 0.01734212 6.4E-04 0.02276153 URS_ADIPOCYTE_DIFFERENTIATION_UP focal glomerulosclerosis DOID_3945 6.836E-04 0.01768151 6.836E-04 0.02288196 URS_ADIPOCYTE_DIFFERENTIATION_UP congenital diaphragmatic hernia DOID_3827 1.255E-03 0.03104507 1.255E-03 0.03758088 URS_ADIPOCYTE_DIFFERENTIATION_UP nephrotic syndrome DOID_1184 1.504E-03 0.03565133 1.504E-03 0.04278159 URS_ADIPOCYTE_DIFFERENTIATION_UP Huntington's disease DOID_12858 1.504E-03 0.03422527 0.05549812 0.33594073 URS_ADIPOCYTE_DIFFERENTIATION_UP proteinuria DOID_576 1.705E-03 0.03730378 1.705E-03 0.04618563 URS_ADIPOCYTE_DIFFERENTIATION_UP pre-eclampsia DOID_10591 1.774E-03 0.03738941 1.774E-03 0.045887 URS_ADIPOCYTE_DIFFERENTIATION_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.917E-03 0.03896519 0.06251097 0.32934023 URS_ADIPOCYTE_DIFFERENTIATION_UP pulmonary tuberculosis DOID_2957 1.917E-03 0.03762156 0.06251097 0.32335222 URS_ADIPOCYTE_DIFFERENTIATION_UP vasculitis DOID_865 2.299E-03 0.04360045 2.299E-03 0.05687015 URS_ADIPOCYTE_DIFFERENTIATION_UP oral cavity cancer DOID_8618 2.628E-03 0.04822804 2.628E-03 0.06229456 URS_ADIPOCYTE_DIFFERENTIATION_UP brain infarction DOID_3454 3.54E-03 0.06294568 0.08438382 0.38411515 URS_ADIPOCYTE_DIFFERENTIATION_UP tuberculosis DOID_399 3.54E-03 0.06103823 0.08438382 0.38106661 URS_ADIPOCYTE_DIFFERENTIATION_UP pancreatic ductal carcinoma DOID_3587 3.738E-03 0.06255357 3.738E-03 0.08507286 URS_ADIPOCYTE_DIFFERENTIATION_UP pancreatic carcinoma DOID_4905 4.044E-03 0.06574413 4.044E-03 0.08850171 URS_ADIPOCYTE_DIFFERENTIATION_UP pancreatitis DOID_4989 4.47E-03 0.07064766 4.47E-03 0.09419688 URS_ADIPOCYTE_DIFFERENTIATION_UP chronic kidney failure DOID_784 5.03E-03 0.07735201 5.03E-03 0.09869049 URS_ADIPOCYTE_DIFFERENTIATION_UP primary bacterial infectious disease DOID_0050338 5.5E-03 0.08235656 0.10464433 0.43781339 URS_ADIPOCYTE_DIFFERENTIATION_UP primary immunodeficiency disease DOID_612 5.742E-03 0.08378102 5.742E-03 0.10891532 URS_ADIPOCYTE_DIFFERENTIATION_UP amino acid metabolic disorder DOID_9252 5.742E-03 0.08168649 5.742E-03 0.10540192 URS_ADIPOCYTE_DIFFERENTIATION_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.369E-03 0.08839562 6.369E-03 0.11325689 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 transitional cell carcinoma DOID_2671 4.621E-06 2.629E-03 4.978E-04 0.09442396 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 Human immunodeficiency virus infectious disease DOID_526 4.937E-06 1.405E-03 4.937E-06 2.809E-03 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 breast benign neoplasm DOID_0060082 6.952E-06 1.319E-03 4.055E-03 0.28842519 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 thoracic benign neoplasm DOID_0060097 6.952E-06 1.319E-03 4.055E-03 0.28842519 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 benign breast phyllodes tumor DOID_1631 6.952E-06 1.319E-03 4.055E-03 0.28842519 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 seminoma DOID_4440 4.761E-05 6.772E-03 1.000 1.000 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 invasive ductal carcinoma DOID_3008 5.476E-05 6.232E-03 0.01102366 0.31362299 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 germinoma DOID_3304 7.056E-05 6.692E-03 1.000 1.000 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 cataract DOID_83 1.415E-04 0.011499 0.01758357 0.38480974 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 lens disease DOID_110 1.536E-04 0.01092224 0.01830995 0.38586532 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 reproductive organ benign neoplasm DOID_0050622 2.069E-04 0.01307865 0.02121049 0.40229231 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 pre-malignant neoplasm DOID_0060071 2.68E-04 0.01524849 2.68E-04 0.07624247 SCHAVOLT_TARGETS_OF_TP53_AND_TP63 in situ carcinoma DOID_8719 2.68E-04 0.01524849 2.68E-04 0.07624247 DASU_IL6_SIGNALING_UP carotid artery disease DOID_3407 9.475E-09 5.391E-06 2.313E-03 0.05721121 DASU_IL6_SIGNALING_UP cystic fibrosis DOID_1485 2.594E-08 7.379E-06 3.411E-03 0.06261145 DASU_IL6_SIGNALING_UP mouth disease DOID_403 7.401E-08 1.404E-05 1.681E-04 0.01063018 DASU_IL6_SIGNALING_UP myeloma DOID_0070004 2.887E-07 4.107E-05 1.000 1.000 DASU_IL6_SIGNALING_UP atrophic muscular disease DOID_913 4.582E-07 5.214E-05 1.776E-03 0.05054106 DASU_IL6_SIGNALING_UP muscular dystrophy DOID_9884 4.582E-07 5.214E-05 1.776E-03 0.05054106 DASU_IL6_SIGNALING_UP bone marrow cancer DOID_4960 4.924E-07 4.67E-05 1.000 1.000 DASU_IL6_SIGNALING_UP uterine disease DOID_345 1.006E-06 8.179E-05 2.606E-03 0.05702715 DASU_IL6_SIGNALING_UP leishmaniasis DOID_9065 1.21E-06 8.606E-05 0.02084563 0.21565757 DASU_IL6_SIGNALING_UP esophagitis DOID_11963 1.422E-06 8.993E-05 2.248E-04 0.01279034 DASU_IL6_SIGNALING_UP autoimmune hepatitis DOID_2048 1.658E-06 9.435E-05 1.000 1.000 DASU_IL6_SIGNALING_UP aneurysm disease DOID_2403 1.84E-06 9.519E-05 3.497E-03 0.06218674 DASU_IL6_SIGNALING_UP placenta disease DOID_780 1.919E-06 9.097E-05 0.02409804 0.22478332 DASU_IL6_SIGNALING_UP female reproductive system disease DOID_229 2.243E-06 9.819E-05 3.852E-03 0.0644649 DASU_IL6_SIGNALING_UP chronic kidney failure DOID_784 2.468E-06 1.003E-04 4.035E-03 0.06560436 DASU_IL6_SIGNALING_UP middle cerebral artery infarction DOID_3525 4.063E-06 1.541E-04 0.03057123 0.25580928 DASU_IL6_SIGNALING_UP hypersensitivity reaction type I disease DOID_1205 4.183E-06 1.487E-04 0.10206557 0.46834925 DASU_IL6_SIGNALING_UP periodontitis DOID_824 4.528E-06 1.515E-04 4.773E-04 0.02468969 DASU_IL6_SIGNALING_UP spastic cerebral palsy DOID_0050669 6.74E-06 2.131E-04 0.03593353 0.28008462 DASU_IL6_SIGNALING_UP abdominal aortic aneurysm DOID_7693 6.74E-06 2.018E-04 6.19E-04 0.02935046 DASU_IL6_SIGNALING_UP pleural disease DOID_1532 8.073E-06 2.297E-04 0.03807033 0.28132489 DASU_IL6_SIGNALING_UP papilloma DOID_2615 8.8E-06 2.384E-04 0.03913699 0.28549936 DASU_IL6_SIGNALING_UP periodontal disease DOID_3388 9.569E-06 2.475E-04 7.786E-04 0.03407795 DASU_IL6_SIGNALING_UP esophageal disease DOID_6050 9.569E-06 2.367E-04 7.786E-04 0.03164381 DASU_IL6_SIGNALING_UP multiple myeloma DOID_9538 1.214E-05 2.878E-04 1.000 1.000 DASU_IL6_SIGNALING_UP peptic ulcer DOID_750 1.408E-05 3.205E-04 1.003E-03 0.03804787 DASU_IL6_SIGNALING_UP intracranial arterial disease DOID_13089 1.513E-05 3.311E-04 0.04657139 0.31546576 DASU_IL6_SIGNALING_UP cerebral arterial disease DOID_3527 1.513E-05 3.311E-04 0.04657139 0.31546576 DASU_IL6_SIGNALING_UP pulmonary emphysema DOID_9675 1.622E-05 3.419E-04 0.04762886 0.31883318 DASU_IL6_SIGNALING_UP cerebral infarction DOID_3526 2.112E-05 4.292E-04 0.05184727 0.3172161 DASU_IL6_SIGNALING_UP heart valve disease DOID_4079 2.39E-05 4.689E-04 0.05394963 0.31323817 DASU_IL6_SIGNALING_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.69E-05 5.103E-04 1.000 1.000 DASU_IL6_SIGNALING_UP pulmonary tuberculosis DOID_2957 2.69E-05 4.938E-04 0.05604744 0.31575243 DASU_IL6_SIGNALING_UP aortic aneurysm DOID_3627 2.85E-05 5.067E-04 1.593E-03 0.05035515 DASU_IL6_SIGNALING_UP integumentary system cancer DOID_0060122 3.739E-05 6.447E-04 1.000 1.000 DASU_IL6_SIGNALING_UP parasitic protozoa infectious disease DOID_2789 3.739E-05 6.257E-04 0.06231367 0.34092765 DASU_IL6_SIGNALING_UP skin cancer DOID_4159 3.739E-05 6.447E-04 1.000 1.000 DASU_IL6_SIGNALING_UP oral cavity cancer DOID_8618 4.351E-05 7.073E-04 2.104E-03 0.05440764 DASU_IL6_SIGNALING_UP cutaneous leishmaniasis DOID_9111 5.361E-05 8.474E-04 0.01102481 0.16954375 DASU_IL6_SIGNALING_UP endocrine pancreas disease DOID_1428 5.765E-05 8.865E-04 0.07163693 0.37742049 DASU_IL6_SIGNALING_UP cholestasis DOID_13580 6.026E-05 9.023E-04 2.606E-03 0.05930824 DASU_IL6_SIGNALING_UP parasitic infectious disease DOID_1398 6.026E-05 8.792E-04 0.07266724 0.37933635 DASU_IL6_SIGNALING_UP tooth disease DOID_1091 6.572E-05 9.349E-04 2.759E-03 0.05813615 DASU_IL6_SIGNALING_UP allergic contact dermatitis DOID_3042 6.572E-05 9.121E-04 6.572E-05 0.03739478 DASU_IL6_SIGNALING_UP brain infarction DOID_3454 6.857E-05 9.289E-04 0.0757515 0.38831173 DASU_IL6_SIGNALING_UP tuberculosis DOID_399 6.857E-05 9.073E-04 0.0757515 0.38484466 DASU_IL6_SIGNALING_UP astrocytoma DOID_3069 7.149E-05 9.245E-04 7.149E-05 0.02033971 DASU_IL6_SIGNALING_UP nephrosis DOID_2527 7.759E-05 9.811E-04 3.077E-03 0.06252344 DASU_IL6_SIGNALING_UP bile duct disease DOID_4138 7.759E-05 9.597E-04 3.077E-03 0.06036746 DASU_IL6_SIGNALING_UP epidermolysis bullosa DOID_2730 7.852E-05 9.506E-04 7.852E-05 0.0148934 DASU_IL6_SIGNALING_UP biliary tract disease DOID_9741 8.076E-05 9.573E-04 3.159E-03 0.05991202 DASU_IL6_SIGNALING_UP berylliosis DOID_10322 9.274E-05 1.077E-03 1.000 1.000 DASU_IL6_SIGNALING_UP carotid stenosis DOID_13001 9.274E-05 1.055E-03 9.274E-05 0.01319169 DASU_IL6_SIGNALING_UP vesiculobullous skin disease DOID_2731 9.274E-05 1.035E-03 9.274E-05 0.01055335 DASU_IL6_SIGNALING_UP bone resorption disease DOID_0080011 9.429E-05 1.032E-03 1.000 1.000 DASU_IL6_SIGNALING_UP osteoporosis DOID_11476 9.429E-05 1.032E-03 1.000 1.000 DASU_IL6_SIGNALING_UP bacterial pneumonia DOID_874 9.788E-05 1.051E-03 3.584E-03 0.06180523 DASU_IL6_SIGNALING_UP metabolic syndrome X DOID_14221 1.053E-04 1.11E-03 1.000 1.000 DASU_IL6_SIGNALING_UP contact dermatitis DOID_2773 1.053E-04 1.09E-03 1.053E-04 9.99E-03 DASU_IL6_SIGNALING_UP oral submucous fibrosis DOID_5773 1.247E-04 1.267E-03 0.01649264 0.19966616 DASU_IL6_SIGNALING_UP intermediate coronary syndrome DOID_8805 1.247E-04 1.244E-03 1.247E-04 0.01013319 DASU_IL6_SIGNALING_UP primary bacterial infectious disease DOID_0050338 1.344E-04 1.318E-03 0.09404781 0.44969081 DASU_IL6_SIGNALING_UP spastic diplegia DOID_10965 1.424E-04 1.373E-03 0.01758265 0.20417407 DASU_IL6_SIGNALING_UP Barrett's esophagus DOID_9206 1.424E-04 1.35E-03 1.424E-04 0.01012607 DASU_IL6_SIGNALING_UP mitochondrial myopathy DOID_699 2.483E-04 2.316E-03 1.000 1.000 DASU_IL6_SIGNALING_UP urinary tract obstruction DOID_5200 2.987E-04 2.741E-03 0.02517982 0.23108581 DASU_IL6_SIGNALING_UP aortic valve disease DOID_62 3.256E-04 2.941E-03 0.02626044 0.23717765 DASU_IL6_SIGNALING_UP spastic quadriplegia DOID_10970 3.537E-04 3.144E-03 1.000 1.000 DASU_IL6_SIGNALING_UP pleurisy DOID_10247 5.11E-04 4.474E-03 0.03271963 0.26596389 DASU_IL6_SIGNALING_UP pneumoconiosis DOID_10316 7.786E-04 6.712E-03 1.000 1.000 DASU_IL6_SIGNALING_UP spindle cell carcinoma DOID_4015 7.786E-04 6.612E-03 1.000 1.000 DASU_IL6_SIGNALING_UP hepatitis DOID_2237 1.003E-03 8.393E-03 0.04551279 0.31581433 DASU_IL6_SIGNALING_UP congenital diaphragmatic hernia DOID_3827 1.003E-03 8.271E-03 1.000 1.000 DASU_IL6_SIGNALING_UP adenoid cystic carcinoma DOID_4866 1.051E-03 8.545E-03 1.051E-03 0.03738363 DASU_IL6_SIGNALING_UP salivary gland cancer DOID_8850 1.151E-03 9.223E-03 1.151E-03 0.03852037 DASU_IL6_SIGNALING_UP nephrotic syndrome DOID_1184 1.202E-03 9.502E-03 0.04974035 0.32531332 DASU_IL6_SIGNALING_UP rheumatic disease DOID_1575 1.202E-03 9.372E-03 0.04974035 0.32161658 DASU_IL6_SIGNALING_UP hyperinsulinism DOID_2018 1.202E-03 9.245E-03 0.04974035 0.31800291 DASU_IL6_SIGNALING_UP scleroderma DOID_419 1.202E-03 9.372E-03 0.04974035 0.32161658 DASU_IL6_SIGNALING_UP diabetic autonomic neuropathy DOID_11503 1.255E-03 9.52E-03 0.05079438 0.31760443 DASU_IL6_SIGNALING_UP autonomic neuropathy DOID_11504 1.255E-03 9.52E-03 0.05079438 0.31760443 DASU_IL6_SIGNALING_UP diabetic polyneuropathy DOID_12785 1.255E-03 9.52E-03 0.05079438 0.31760443 DASU_IL6_SIGNALING_UP influenza DOID_8469 1.255E-03 9.395E-03 0.05079438 0.3141522 DASU_IL6_SIGNALING_UP diabetic neuropathy DOID_9743 1.255E-03 9.52E-03 0.05079438 0.31760443 DASU_IL6_SIGNALING_UP proteinuria DOID_576 1.363E-03 0.010074 1.000 1.000 DASU_IL6_SIGNALING_UP autonomic nervous system disease DOID_11465 1.419E-03 0.01035195 0.05394963 0.31976397 DASU_IL6_SIGNALING_UP brain cancer DOID_1319 1.419E-03 0.01022092 0.05394963 0.31646743 DASU_IL6_SIGNALING_UP central nervous system cancer DOID_3620 1.476E-03 0.01049776 0.05499911 0.31610597 DASU_IL6_SIGNALING_UP integumentary system benign neoplasm DOID_0060121 1.534E-03 0.01077532 1.000 1.000 DASU_IL6_SIGNALING_UP skin benign neoplasm DOID_3165 1.534E-03 0.01077532 1.000 1.000 DASU_IL6_SIGNALING_UP lung small cell carcinoma DOID_5409 1.534E-03 0.01064391 0.05604744 0.31265681 DASU_IL6_SIGNALING_UP calcium metabolism disease DOID_10575 1.593E-03 0.01092039 1.000 1.000 DASU_IL6_SIGNALING_UP sarcoidosis DOID_11335 1.776E-03 0.01203359 1.000 1.000 DASU_IL6_SIGNALING_UP giant cell tumor DOID_200 1.776E-03 0.01189201 1.776E-03 0.05320111 DASU_IL6_SIGNALING_UP malignant giant cell tumor DOID_2705 1.776E-03 0.01189201 1.776E-03 0.05320111 DASU_IL6_SIGNALING_UP giant cell glioblastoma DOID_3074 1.776E-03 0.01189201 1.776E-03 0.05320111 DASU_IL6_SIGNALING_UP bile duct adenocarcinoma DOID_4896 1.84E-03 0.01217261 1.000 1.000 DASU_IL6_SIGNALING_UP cholangiocarcinoma DOID_4947 1.84E-03 0.01217261 1.000 1.000 DASU_IL6_SIGNALING_UP vasculitis DOID_865 1.84E-03 0.01203269 1.000 1.000 DASU_IL6_SIGNALING_UP mitochondrial metabolism disease DOID_700 1.97E-03 0.01273525 1.000 1.000 DASU_IL6_SIGNALING_UP hypersensitivity reaction type IV disease DOID_2916 2.104E-03 0.01344908 1.000 1.000 DASU_IL6_SIGNALING_UP glioblastoma DOID_3068 2.104E-03 0.01329964 2.104E-03 0.05699848 DASU_IL6_SIGNALING_UP bile duct cancer DOID_4606 2.104E-03 0.01315349 1.000 1.000 DASU_IL6_SIGNALING_UP bile duct carcinoma DOID_4897 2.104E-03 0.01315349 1.000 1.000 DASU_IL6_SIGNALING_UP collagen disease DOID_854 2.313E-03 0.0143028 0.06853927 0.36791365 DASU_IL6_SIGNALING_UP pre-malignant neoplasm DOID_0060071 2.457E-03 0.01503329 2.457E-03 0.05825402 DASU_IL6_SIGNALING_UP in situ carcinoma DOID_8719 2.457E-03 0.01503329 2.457E-03 0.05825402 DASU_IL6_SIGNALING_UP mineral metabolism disease DOID_0050032 2.531E-03 0.01532027 1.000 1.000 DASU_IL6_SIGNALING_UP hyperglycemia DOID_4195 2.682E-03 0.01606207 0.07369644 0.3812116 DASU_IL6_SIGNALING_UP pancreatic ductal carcinoma DOID_3587 2.996E-03 0.01775557 0.0778021 0.39176456 DASU_IL6_SIGNALING_UP pancreatic carcinoma DOID_4905 3.242E-03 0.01901697 0.08086968 0.40363902 DASU_IL6_SIGNALING_UP diabetic retinopathy DOID_8947 3.242E-03 0.01882292 0.08086968 0.40012911 DASU_IL6_SIGNALING_UP biliary tract cancer DOID_4607 4.035E-03 0.02319346 1.000 1.000 DASU_IL6_SIGNALING_UP retinal vascular disease DOID_2462 4.223E-03 0.02402772 0.09203248 0.44378375 DASU_IL6_SIGNALING_UP nervous system cancer DOID_3093 4.709E-03 0.02652674 0.09706263 0.45269373 DASU_IL6_SIGNALING_UP lymphoma DOID_0060058 4.91E-03 0.02738919 0.09906706 0.45828583 DASU_IL6_SIGNALING_UP carbohydrate metabolic disorder DOID_2978 5.012E-03 0.02768721 1.000 1.000 DASU_IL6_SIGNALING_UP encephalomyelitis DOID_640 5.012E-03 0.02742098 1.000 1.000 DASU_IL6_SIGNALING_UP Crohn's disease DOID_8778 5.115E-03 0.02771832 1.000 1.000 DASU_IL6_SIGNALING_UP dilated cardiomyopathy DOID_12930 5.219E-03 0.02801527 0.10206557 0.46460246 DASU_IL6_SIGNALING_UP ulcerative colitis DOID_8577 5.537E-03 0.0294441 0.10505433 0.47441202 DASU_IL6_SIGNALING_UP interstitial nephritis DOID_1063 0.01102481 0.05808443 1.000 1.000 DASU_IL6_SIGNALING_UP hyperparathyroidism DOID_13543 0.01102481 0.05755155 1.000 1.000 DASU_IL6_SIGNALING_UP retinal vascular occlusion DOID_1729 0.01102481 0.05702835 1.000 1.000 DASU_IL6_SIGNALING_UP transient cerebral ischemia DOID_224 0.01102481 0.05651458 1.000 1.000 DASU_IL6_SIGNALING_UP acute kidney failure DOID_3021 0.01102481 0.05600999 1.000 1.000 DASU_IL6_SIGNALING_UP Noonan syndrome DOID_3490 0.01102481 0.05551432 0.01102481 0.1742533 DASU_IL6_SIGNALING_UP insulinoma DOID_3892 0.01102481 0.05502736 1.000 1.000 DASU_IL6_SIGNALING_UP visceral leishmaniasis DOID_9146 0.01102481 0.05454886 1.000 1.000 DASU_IL6_SIGNALING_UP familial adenomatous polyposis DOID_0050424 0.01212075 0.05945435 1.000 1.000 DASU_IL6_SIGNALING_UP adrenoleukodystrophy DOID_10588 0.01212075 0.05894619 1.000 1.000 DASU_IL6_SIGNALING_UP pneumocystosis DOID_11339 0.01212075 0.05844665 1.000 1.000 DASU_IL6_SIGNALING_UP prediabetes syndrome DOID_11716 0.01212075 0.0579555 1.000 1.000 DASU_IL6_SIGNALING_UP temporal arteritis DOID_13375 0.01212075 0.05747254 1.000 1.000 DASU_IL6_SIGNALING_UP neuronal ceroid lipofuscinosis DOID_14503 0.01212075 0.05699756 1.000 1.000 DASU_IL6_SIGNALING_UP central nervous system vasculitis DOID_525 0.01212075 0.05747254 1.000 1.000 DASU_IL6_SIGNALING_UP speech disorder DOID_92 0.01212075 0.05653037 0.01212075 0.18149222 DASU_IL6_SIGNALING_UP aortic valve stenosis DOID_1712 0.01321549 0.06113509 0.01321549 0.19281066 DASU_IL6_SIGNALING_UP islet cell tumor DOID_1799 0.01321549 0.06064206 1.000 1.000 DASU_IL6_SIGNALING_UP aortic valve insufficiency DOID_57 0.01321549 0.06015693 1.000 1.000 DASU_IL6_SIGNALING_UP lipodystrophy DOID_811 0.01321549 0.05967949 1.000 1.000 DASU_IL6_SIGNALING_UP ocular hypertension DOID_9282 0.01321549 0.05920957 0.01321549 0.1879904 DASU_IL6_SIGNALING_UP borderline glaucoma DOID_9283 0.01321549 0.05920957 0.01321549 0.1879904 DASU_IL6_SIGNALING_UP parathyroid gland disease DOID_11201 0.01430906 0.06360823 1.000 1.000 DASU_IL6_SIGNALING_UP vulva cancer DOID_1245 0.01430906 0.06311514 0.01430906 0.19858179 DASU_IL6_SIGNALING_UP polyneuropathy DOID_1389 0.01430906 0.06262964 1.000 1.000 DASU_IL6_SIGNALING_UP Legionnaires' disease DOID_10457 0.01540144 0.06689632 0.01540144 0.2086528 DASU_IL6_SIGNALING_UP legionellosis DOID_10458 0.01540144 0.06689632 0.01540144 0.2086528 DASU_IL6_SIGNALING_UP viral pneumonia DOID_10533 0.01540144 0.06638953 0.01540144 0.20380041 DASU_IL6_SIGNALING_UP tethered spinal cord syndrome DOID_1089 0.01540144 0.06589036 1.000 1.000 DASU_IL6_SIGNALING_UP hypercalcemia DOID_12678 0.01540144 0.06539864 1.000 1.000 DASU_IL6_SIGNALING_UP thoracic aortic aneurysm DOID_14004 0.01649264 0.0695134 0.01649264 0.21327976 DASU_IL6_SIGNALING_UP communication disorder DOID_2033 0.01649264 0.06900227 0.01649264 0.20854021 DASU_IL6_SIGNALING_UP arthropathy DOID_381 0.01649264 0.06849861 0.01649264 0.20400672 DASU_IL6_SIGNALING_UP lung oat cell carcinoma DOID_5411 0.01649264 0.06800224 1.000 1.000 DASU_IL6_SIGNALING_UP varicose veins DOID_799 0.01649264 0.06751302 0.01649264 0.19550644 DASU_IL6_SIGNALING_UP hemolytic-uremic syndrome DOID_12554 0.01758265 0.07146092 1.000 1.000 DASU_IL6_SIGNALING_UP restrictive cardiomyopathy DOID_397 0.01758265 0.07095411 1.000 1.000 DASU_IL6_SIGNALING_UP thyroiditis DOID_7166 0.01758265 0.07045443 1.000 1.000 DASU_IL6_SIGNALING_UP autoimmune thyroiditis DOID_7188 0.01758265 0.07045443 1.000 1.000 DASU_IL6_SIGNALING_UP tongue cancer DOID_8649 0.01758265 0.06996174 1.000 1.000 DASU_IL6_SIGNALING_UP vein disease DOID_866 0.01758265 0.0694759 0.01758265 0.20009059 DASU_IL6_SIGNALING_UP drug-induced mental disorder DOID_1203 0.01867149 0.07326951 1.000 1.000 DASU_IL6_SIGNALING_UP methylmalonic acidemia DOID_14749 0.01867149 0.07276766 1.000 1.000 DASU_IL6_SIGNALING_UP penile disease DOID_1529 0.01867149 0.07227264 1.000 1.000 DASU_IL6_SIGNALING_UP drug psychosis DOID_1742 0.01867149 0.07326951 1.000 1.000 DASU_IL6_SIGNALING_UP basal cell carcinoma DOID_2513 0.01867149 0.07178431 1.000 1.000 DASU_IL6_SIGNALING_UP substance-induced psychosis DOID_8646 0.01867149 0.07326951 1.000 1.000 DASU_IL6_SIGNALING_UP congenital muscular dystrophy DOID_0050557 0.01975915 0.07545609 0.01975915 0.22045014 DASU_IL6_SIGNALING_UP male reproductive organ benign neoplasm DOID_0060087 0.01975915 0.07495305 0.01975915 0.21621071 DASU_IL6_SIGNALING_UP skin carcinoma DOID_3451 0.01975915 0.07445667 1.000 1.000 DASU_IL6_SIGNALING_UP osteosclerosis DOID_4254 0.01975915 0.07396682 1.000 1.000 DASU_IL6_SIGNALING_UP ureteral obstruction DOID_5199 0.01975915 0.07348338 1.000 1.000 DASU_IL6_SIGNALING_UP dissociative disorder DOID_10935 0.02084563 0.07702056 1.000 1.000 DASU_IL6_SIGNALING_UP dissociative amnesia DOID_11037 0.02084563 0.07702056 1.000 1.000 DASU_IL6_SIGNALING_UP Down syndrome DOID_14250 0.02084563 0.07652365 0.02084563 0.22379559 DASU_IL6_SIGNALING_UP MHC class II deficiency DOID_5812 0.02084563 0.07603312 0.02084563 0.21965122 DASU_IL6_SIGNALING_UP amnestic disorder DOID_10914 0.02193094 0.07948221 1.000 1.000 DASU_IL6_SIGNALING_UP limb-girdle muscular dystrophy DOID_11724 0.02193094 0.07897915 0.02193094 0.22283404 DASU_IL6_SIGNALING_UP brain edema DOID_4724 0.02193094 0.07848243 0.02193094 0.21892467 DASU_IL6_SIGNALING_UP subependymal glioma DOID_4843 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP pilocytic astrocytoma DOID_4851 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP subependymal giant cell astrocytoma DOID_5077 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP fibrillary astrocytoma DOID_6726 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP juvenile pilocytic astrocytoma DOID_6811 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP childhood pilocytic astrocytoma DOID_6812 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP gemistocytic astrocytoma DOID_7005 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP childhood cerebral astrocytoma DOID_7007 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP protoplasmic astrocytoma DOID_7008 0.02193094 0.07799191 0.02193094 0.21515011 DASU_IL6_SIGNALING_UP coronary restenosis DOID_4247 0.02301508 0.081339 0.02301508 0.22195895 DASU_IL6_SIGNALING_UP benign glioma DOID_0060101 0.02409804 0.08464063 0.02409804 0.22852971 DASU_IL6_SIGNALING_UP benign ependymoma DOID_4844 0.02409804 0.08464063 0.02409804 0.22852971 DASU_IL6_SIGNALING_UP acquired immunodeficiency syndrome DOID_635 0.02409804 0.08412137 1.000 1.000 DASU_IL6_SIGNALING_UP IgA glomerulonephritis DOID_2986 0.02517982 0.08736171 1.000 1.000 DASU_IL6_SIGNALING_UP uremia DOID_4676 0.02517982 0.08683224 1.000 1.000 DASU_IL6_SIGNALING_UP hypoglycemia DOID_9993 0.02517982 0.08630916 1.000 1.000 DASU_IL6_SIGNALING_UP Lewy body dementia DOID_12217 0.02626044 0.0894742 1.000 1.000 DASU_IL6_SIGNALING_UP ureteral disease DOID_1426 0.02626044 0.08894162 1.000 1.000 DASU_IL6_SIGNALING_UP meningitis DOID_9471 0.02626044 0.08841534 1.000 1.000 DASU_IL6_SIGNALING_UP Goodpasture syndrome DOID_9808 0.02626044 0.08789525 1.000 1.000 DASU_IL6_SIGNALING_UP acute pancreatitis DOID_2913 0.02733989 0.09097309 0.02733989 0.24306872 DASU_IL6_SIGNALING_UP severe combined immunodeficiency DOID_627 0.02733989 0.09044417 0.02733989 0.2393292 DASU_IL6_SIGNALING_UP commensal bacterial infectious disease DOID_0050339 0.02841817 0.09346786 0.02841817 0.24499908 DASU_IL6_SIGNALING_UP organic acidemia DOID_0060159 0.02841817 0.09293069 1.000 1.000 DASU_IL6_SIGNALING_UP urticaria DOID_1555 0.02841817 0.09239965 1.000 1.000 DASU_IL6_SIGNALING_UP hypogonadism DOID_1924 0.02841817 0.09187466 1.000 1.000 DASU_IL6_SIGNALING_UP bronchiolitis DOID_2942 0.02841817 0.09135559 1.000 1.000 DASU_IL6_SIGNALING_UP combined T cell and B cell immunodeficiency DOID_628 0.02841817 0.09084236 0.02841817 0.24134238 DASU_IL6_SIGNALING_UP myositis DOID_633 0.02949528 0.09375875 1.000 1.000 DASU_IL6_SIGNALING_UP intracranial aneurysm DOID_10941 0.03057123 0.09663906 1.000 1.000 DASU_IL6_SIGNALING_UP spinal cord disease DOID_319 0.03057123 0.09610514 1.000 1.000 DASU_IL6_SIGNALING_UP seminoma DOID_4440 0.03057123 0.09557709 0.03057123 0.2521019 DASU_IL6_SIGNALING_UP extrinsic allergic alveolitis DOID_841 0.03057123 0.09505481 1.000 1.000 DASU_IL6_SIGNALING_UP diffuse large B-cell lymphoma DOID_0050745 0.03164602 0.09786186 1.000 1.000 DASU_IL6_SIGNALING_UP Sciatic Neuropathy DOID_11446 0.03164602 0.09733288 1.000 1.000 DASU_IL6_SIGNALING_UP gestational diabetes DOID_11714 0.03164602 0.09680958 1.000 1.000 DASU_IL6_SIGNALING_UP lesion of sciatic nerve DOID_12528 0.03164602 0.09733288 1.000 1.000 DASU_IL6_SIGNALING_UP lung adenocarcinoma DOID_3910 0.03164602 0.09629189 1.000 1.000 DASU_IL6_SIGNALING_UP perinatal necrotizing enterocolitis DOID_8677 0.03164602 0.09577969 1.000 1.000 DASU_IL6_SIGNALING_UP mononeuritis of lower limb DOID_9473 0.03164602 0.09733288 1.000 1.000 DASU_IL6_SIGNALING_UP autoimmune disease of cardiovascular system DOID_0060051 0.03271963 0.09850514 1.000 1.000 DASU_IL6_SIGNALING_UP Behcet's disease DOID_13241 0.03271963 0.09850514 1.000 1.000 DASU_IL6_SIGNALING_UP mononeuritis DOID_1802 0.03271963 0.0979867 1.000 1.000 DASU_IL6_SIGNALING_UP coronary stenosis DOID_4248 0.03271963 0.09747368 0.03271963 0.26221792 DASU_IL6_SIGNALING_UP mononeuropathy DOID_1188 0.03379209 0.09962539 1.000 1.000 DASU_IL6_SIGNALING_UP multiple epiphyseal dysplasia DOID_12721 0.03379209 0.09911186 1.000 1.000 DASU_IL6_SIGNALING_UP supratentorial cancer DOID_1659 0.03379209 0.09860359 0.03379209 0.2670514 DASU_IL6_SIGNALING_UP cerebrum cancer DOID_368 0.03379209 0.09860359 0.03379209 0.2670514 DASU_IL6_SIGNALING_UP focal glomerulosclerosis DOID_3945 0.03379209 0.09810051 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP bacterial pneumonia DOID_874 8.271E-15 4.706E-12 8.753E-06 4.981E-03 HINATA_NFKB_TARGETS_FIBROBLAST_UP parasitic infectious disease DOID_1398 1.756E-11 4.996E-09 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP peripheral vascular disease DOID_341 3.564E-11 6.76E-09 2.464E-04 0.03505562 HINATA_NFKB_TARGETS_FIBROBLAST_UP biliary tract disease DOID_9741 3.564E-11 5.07E-09 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP diabetic retinopathy DOID_8947 3.921E-11 4.462E-09 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP cystic fibrosis DOID_1485 4.726E-11 4.482E-09 7.07E-03 0.25141321 HINATA_NFKB_TARGETS_FIBROBLAST_UP chronic kidney failure DOID_784 8.753E-11 7.115E-09 8.344E-03 0.26376694 HINATA_NFKB_TARGETS_FIBROBLAST_UP retinal vascular disease DOID_2462 1.034E-10 7.352E-09 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pulmonary tuberculosis DOID_2957 2.59E-10 1.637E-08 3.206E-03 0.14034384 HINATA_NFKB_TARGETS_FIBROBLAST_UP ulcerative colitis DOID_8577 2.786E-10 1.585E-08 0.14891524 0.81473818 HINATA_NFKB_TARGETS_FIBROBLAST_UP parasitic protozoa infectious disease DOID_2789 5.111E-10 2.644E-08 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP cholestasis DOID_13580 1.365E-09 6.472E-08 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP tuberculosis DOID_399 1.779E-09 7.788E-08 5.892E-03 0.22352107 HINATA_NFKB_TARGETS_FIBROBLAST_UP abdominal aortic aneurysm DOID_7693 2.091E-09 8.498E-08 1.302E-03 0.08232139 HINATA_NFKB_TARGETS_FIBROBLAST_UP nephrosis DOID_2527 2.293E-09 8.698E-08 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP bile duct disease DOID_4138 2.293E-09 8.155E-08 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pleural disease DOID_1532 2.853E-09 9.548E-08 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP aneurysm disease DOID_2403 3.419E-09 1.081E-07 7.246E-03 0.24252052 HINATA_NFKB_TARGETS_FIBROBLAST_UP primary bacterial infectious disease DOID_0050338 7.06E-09 2.114E-07 9.115E-03 0.27297782 HINATA_NFKB_TARGETS_FIBROBLAST_UP transitional cell carcinoma DOID_2671 7.555E-09 2.149E-07 1.397E-05 3.975E-03 HINATA_NFKB_TARGETS_FIBROBLAST_UP mouth disease DOID_403 1.117E-08 3.025E-07 0.14340121 0.79995378 HINATA_NFKB_TARGETS_FIBROBLAST_UP rheumatic disease DOID_1575 1.188E-08 3.074E-07 0.07143891 0.59777555 HINATA_NFKB_TARGETS_FIBROBLAST_UP scleroderma DOID_419 1.188E-08 3.074E-07 0.07143891 0.59777555 HINATA_NFKB_TARGETS_FIBROBLAST_UP hypersensitivity reaction type I disease DOID_1205 1.189E-08 2.941E-07 5.247E-04 0.04976204 HINATA_NFKB_TARGETS_FIBROBLAST_UP myeloma DOID_0070004 1.828E-08 4.334E-07 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP heart valve disease DOID_4079 1.828E-08 4.16E-07 0.0774083 0.63833797 HINATA_NFKB_TARGETS_FIBROBLAST_UP leishmaniasis DOID_9065 2.308E-08 5.052E-07 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP aortic aneurysm DOID_3627 2.467E-08 5.198E-07 3.329E-03 0.1352901 HINATA_NFKB_TARGETS_FIBROBLAST_UP giant cell tumor DOID_200 3.271E-08 6.647E-07 0.08629167 0.66351299 HINATA_NFKB_TARGETS_FIBROBLAST_UP malignant giant cell tumor DOID_2705 3.271E-08 6.647E-07 0.08629167 0.66351299 HINATA_NFKB_TARGETS_FIBROBLAST_UP giant cell glioblastoma DOID_3074 3.271E-08 6.647E-07 0.08629167 0.66351299 HINATA_NFKB_TARGETS_FIBROBLAST_UP bone marrow cancer DOID_4960 3.581E-08 7.027E-07 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP vasculitis DOID_865 3.581E-08 6.792E-07 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP glioblastoma DOID_3068 5.063E-08 9.294E-07 0.09363017 0.66594461 HINATA_NFKB_TARGETS_FIBROBLAST_UP diabetic angiopathy DOID_11713 6.291E-08 1.119E-06 6.87E-04 0.0488637 HINATA_NFKB_TARGETS_FIBROBLAST_UP collagen disease DOID_854 6.465E-08 1.115E-06 0.09800541 0.67186844 HINATA_NFKB_TARGETS_FIBROBLAST_UP respiratory failure DOID_11162 6.995E-08 1.171E-06 0.09945921 0.67371772 HINATA_NFKB_TARGETS_FIBROBLAST_UP tooth disease DOID_1091 1.019E-07 1.656E-06 0.10669367 0.68987155 HINATA_NFKB_TARGETS_FIBROBLAST_UP brain infarction DOID_3454 1.095E-07 1.73E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP astrocytoma DOID_3069 1.175E-07 1.807E-06 0.10957142 0.68512238 HINATA_NFKB_TARGETS_FIBROBLAST_UP periodontitis DOID_824 1.398E-07 2.093E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP autoimmune disease of cardiovascular system DOID_0060051 1.611E-07 2.35E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pleurisy DOID_10247 1.611E-07 2.291E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Behcet's disease DOID_13241 1.611E-07 2.35E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP biliary tract cancer DOID_4607 2.71E-07 3.762E-06 0.12805579 0.74350758 HINATA_NFKB_TARGETS_FIBROBLAST_UP periodontal disease DOID_3388 3.849E-07 5.215E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP retinal vascular occlusion DOID_1729 4.718E-07 6.243E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lateral sclerosis DOID_230 4.718E-07 6.101E-06 0.01597619 0.39523714 HINATA_NFKB_TARGETS_FIBROBLAST_UP cutaneous leishmaniasis DOID_9111 4.718E-07 5.966E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Crohn's disease DOID_8778 4.983E-07 6.164E-06 0.14340121 0.79218724 HINATA_NFKB_TARGETS_FIBROBLAST_UP dilated cardiomyopathy DOID_12930 5.247E-07 6.352E-06 0.01074902 0.27800865 HINATA_NFKB_TARGETS_FIBROBLAST_UP multiple myeloma DOID_9538 5.307E-07 6.291E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP systemic scleroderma DOID_418 6.484E-07 7.53E-06 0.06543153 0.57277755 HINATA_NFKB_TARGETS_FIBROBLAST_UP adult respiratory distress syndrome DOID_11394 7.141E-07 8.126E-06 0.06693695 0.57707763 HINATA_NFKB_TARGETS_FIBROBLAST_UP intracranial arterial disease DOID_13089 7.141E-07 7.967E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP cerebral arterial disease DOID_3527 7.141E-07 7.967E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP benign mesothelioma DOID_2645 7.845E-07 8.585E-06 0.06843998 0.58122909 HINATA_NFKB_TARGETS_FIBROBLAST_UP pulmonary emphysema DOID_9675 7.845E-07 8.423E-06 2.307E-03 0.13124201 HINATA_NFKB_TARGETS_FIBROBLAST_UP encephalitis DOID_9588 8.63E-07 9.093E-06 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP vascular skin disease DOID_9540 1.321E-06 1.367E-05 0.0774083 0.62921886 HINATA_NFKB_TARGETS_FIBROBLAST_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.55E-06 1.575E-05 3.206E-03 0.15203916 HINATA_NFKB_TARGETS_FIBROBLAST_UP hyperhomocysteinemia DOID_9279 1.779E-06 1.776E-05 2.638E-04 0.03002178 HINATA_NFKB_TARGETS_FIBROBLAST_UP bile duct adenocarcinoma DOID_4896 2.247E-06 2.205E-05 0.08776403 0.66583646 HINATA_NFKB_TARGETS_FIBROBLAST_UP cholangiocarcinoma DOID_4947 2.247E-06 2.205E-05 0.08776403 0.66583646 HINATA_NFKB_TARGETS_FIBROBLAST_UP pustulosis of palm and sole DOID_4398 2.411E-06 2.325E-05 0.08923406 0.65940493 HINATA_NFKB_TARGETS_FIBROBLAST_UP bile duct cancer DOID_4606 2.955E-06 2.802E-05 0.09363017 0.65772307 HINATA_NFKB_TARGETS_FIBROBLAST_UP bile duct carcinoma DOID_4897 2.955E-06 2.802E-05 0.09363017 0.65772307 HINATA_NFKB_TARGETS_FIBROBLAST_UP melancholia DOID_2848 3.155E-06 2.943E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP neurotic disorder DOID_4964 3.365E-06 3.088E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP carotid artery disease DOID_3407 3.585E-06 3.238E-05 0.09800541 0.68006196 HINATA_NFKB_TARGETS_FIBROBLAST_UP brain edema DOID_4724 4.431E-06 3.939E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP autoimmune hepatitis DOID_2048 5.164E-06 4.52E-05 0.03326011 0.48525652 HINATA_NFKB_TARGETS_FIBROBLAST_UP mitochondrial myopathy DOID_699 5.164E-06 4.452E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP IgA glomerulonephritis DOID_2986 6.86E-06 5.826E-05 6.304E-04 0.05124358 HINATA_NFKB_TARGETS_FIBROBLAST_UP aortic valve disease DOID_62 7.831E-06 6.553E-05 0.03792185 0.50180314 HINATA_NFKB_TARGETS_FIBROBLAST_UP endogenous depression DOID_1595 7.914E-06 6.526E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP acute pancreatitis DOID_2913 8.889E-06 7.225E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP urticaria DOID_1555 1.004E-05 8.043E-05 0.04101739 0.51864212 HINATA_NFKB_TARGETS_FIBROBLAST_UP mental depression DOID_1596 1.114E-05 8.803E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP spinal muscular atrophy DOID_12377 1.128E-05 8.791E-05 0.04256148 0.51526562 HINATA_NFKB_TARGETS_FIBROBLAST_UP middle cerebral artery infarction DOID_3525 1.262E-05 9.701E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP extrinsic allergic alveolitis DOID_841 1.262E-05 9.572E-05 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP gestational diabetes DOID_11714 1.406E-05 1.052E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lung adenocarcinoma DOID_3910 1.406E-05 1.039E-04 0.04564234 0.49000922 HINATA_NFKB_TARGETS_FIBROBLAST_UP amino acid metabolic disorder DOID_9252 1.46E-05 1.065E-04 9.512E-03 0.27062588 HINATA_NFKB_TARGETS_FIBROBLAST_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.804E-05 1.299E-04 0.14340121 0.80787412 HINATA_NFKB_TARGETS_FIBROBLAST_UP corneal disease DOID_10124 1.902E-05 1.352E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP esophageal disease DOID_6050 2.962E-05 2.081E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hyperthyroidism DOID_7998 2.962E-05 2.055E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP respiratory syncytial virus infectious disease DOID_1273 4.351E-05 2.983E-04 0.06543153 0.5817272 HINATA_NFKB_TARGETS_FIBROBLAST_UP congenital diaphragmatic hernia DOID_3827 4.351E-05 2.947E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP peptic ulcer DOID_750 4.351E-05 2.913E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP nephrotic syndrome DOID_1184 5.727E-05 3.789E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP influenza DOID_8469 6.11E-05 3.996E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP cerebral infarction DOID_3526 6.51E-05 4.21E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP proteinuria DOID_576 6.927E-05 4.429E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP brain cancer DOID_1319 7.361E-05 4.654E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP central nervous system cancer DOID_3620 7.812E-05 4.885E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP calcium metabolism disease DOID_10575 8.767E-05 5.422E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP atopic dermatitis DOID_3310 9.796E-05 5.994E-04 0.08481697 0.67028969 HINATA_NFKB_TARGETS_FIBROBLAST_UP transient cerebral ischemia DOID_224 1.136E-04 6.879E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP acute kidney failure DOID_3021 1.136E-04 6.807E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP keratitis DOID_4677 1.136E-04 6.736E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP mitochondrial metabolism disease DOID_700 1.208E-04 7.088E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hypertrophic cardiomyopathy DOID_11984 1.335E-04 7.749E-04 0.09363017 0.68302011 HINATA_NFKB_TARGETS_FIBROBLAST_UP familial adenomatous polyposis DOID_0050424 1.388E-04 7.975E-04 0.01755994 0.38429247 HINATA_NFKB_TARGETS_FIBROBLAST_UP bronchiectasis DOID_9563 1.388E-04 7.896E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP common cold DOID_10459 1.663E-04 9.371E-04 1.663E-04 0.03154938 HINATA_NFKB_TARGETS_FIBROBLAST_UP aortic valve stenosis DOID_1712 1.663E-04 9.279E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP aortic valve insufficiency DOID_57 1.663E-04 9.189E-04 0.01914117 0.4033825 HINATA_NFKB_TARGETS_FIBROBLAST_UP ocular hypertension DOID_9282 1.663E-04 9.101E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP borderline glaucoma DOID_9283 1.663E-04 9.101E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pre-malignant neoplasm DOID_0060071 1.687E-04 9.144E-04 0.10091069 0.66765331 HINATA_NFKB_TARGETS_FIBROBLAST_UP in situ carcinoma DOID_8719 1.687E-04 9.144E-04 0.10091069 0.66765331 HINATA_NFKB_TARGETS_FIBROBLAST_UP mineral metabolism disease DOID_0050032 1.764E-04 9.471E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP endocrine pancreas disease DOID_1428 1.764E-04 9.383E-04 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP temporal lobe epilepsy DOID_3328 1.925E-04 1.014E-03 0.10525136 0.68836811 HINATA_NFKB_TARGETS_FIBROBLAST_UP hyperglycemia DOID_4195 1.925E-04 1.005E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP newborn respiratory distress syndrome DOID_12716 1.964E-04 1.016E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP carotid stenosis DOID_13001 1.964E-04 1.007E-03 0.02071991 0.40653884 HINATA_NFKB_TARGETS_FIBROBLAST_UP pancreatic ductal carcinoma DOID_3587 2.275E-04 1.156E-03 0.11100687 0.68655337 HINATA_NFKB_TARGETS_FIBROBLAST_UP Legionnaires' disease DOID_10457 2.289E-04 1.152E-03 0.02229614 0.42288343 HINATA_NFKB_TARGETS_FIBROBLAST_UP legionellosis DOID_10458 2.289E-04 1.152E-03 0.02229614 0.42288343 HINATA_NFKB_TARGETS_FIBROBLAST_UP pancreatic carcinoma DOID_4905 2.563E-04 1.279E-03 0.11529959 0.6979305 HINATA_NFKB_TARGETS_FIBROBLAST_UP thoracic aortic aneurysm DOID_14004 2.638E-04 1.305E-03 0.02386988 0.41157454 HINATA_NFKB_TARGETS_FIBROBLAST_UP oral submucous fibrosis DOID_5773 2.638E-04 1.294E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP varicose veins DOID_799 2.638E-04 1.283E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP intermediate coronary syndrome DOID_8805 2.638E-04 1.272E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP bone resorption disease DOID_0080011 2.873E-04 1.374E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP osteoporosis DOID_11476 2.873E-04 1.374E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pancreatitis DOID_4989 2.981E-04 1.414E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP mixed glioma DOID_5076 2.981E-04 1.402E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP vein disease DOID_866 3.012E-04 1.405E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Barrett's esophagus DOID_9206 3.012E-04 1.393E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP metabolic syndrome X DOID_14221 3.206E-04 1.471E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP bronchitis DOID_6132 3.41E-04 1.552E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP focal epilepsy DOID_2234 3.564E-04 1.609E-03 0.12805579 0.7511726 HINATA_NFKB_TARGETS_FIBROBLAST_UP Down syndrome DOID_14250 4.279E-04 1.917E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP nervous system cancer DOID_3093 4.495E-04 1.998E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Human immunodeficiency virus infectious disease DOID_526 4.495E-04 1.983E-03 9.714E-03 0.26319581 HINATA_NFKB_TARGETS_FIBROBLAST_UP pulmonary edema DOID_11396 4.749E-04 2.079E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP esophagitis DOID_11963 4.749E-04 2.063E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lymphoma DOID_0060058 4.787E-04 2.063E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP carbohydrate metabolic disorder DOID_2978 4.937E-04 2.112E-03 0.14201722 0.81624036 HINATA_NFKB_TARGETS_FIBROBLAST_UP encephalomyelitis DOID_640 4.937E-04 2.097E-03 0.14201722 0.80807796 HINATA_NFKB_TARGETS_FIBROBLAST_UP Kawasaki disease DOID_13378 5.244E-04 2.21E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lymphadenitis DOID_1602 5.244E-04 2.21E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lymph node disease DOID_9942 5.244E-04 2.21E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP sinusitis DOID_0050127 6.304E-04 2.638E-03 0.0363704 0.51736898 HINATA_NFKB_TARGETS_FIBROBLAST_UP paranasal sinus disease DOID_1352 6.304E-04 2.638E-03 0.0363704 0.51736898 HINATA_NFKB_TARGETS_FIBROBLAST_UP polyarteritis nodosa DOID_9810 6.304E-04 2.618E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hypoglycemia DOID_9993 6.304E-04 2.599E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Goodpasture syndrome DOID_9808 6.87E-04 2.812E-03 0.03792185 0.49039853 HINATA_NFKB_TARGETS_FIBROBLAST_UP commensal bacterial infectious disease DOID_0050339 8.073E-04 3.281E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP portal hypertension DOID_10762 8.073E-04 3.258E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP bronchiolitis DOID_2942 8.073E-04 3.235E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP myositis DOID_633 8.71E-04 3.466E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP intracranial aneurysm DOID_10941 9.37E-04 3.703E-03 0.04410313 0.52280586 HINATA_NFKB_TARGETS_FIBROBLAST_UP diffuse large B-cell lymphoma DOID_0050745 1.005E-03 3.945E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hepatic vascular disease DOID_272 1.076E-03 4.194E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP focal glomerulosclerosis DOID_3945 1.149E-03 4.448E-03 0.04871344 0.50396264 HINATA_NFKB_TARGETS_FIBROBLAST_UP female reproductive organ benign neoplasm DOID_0060086 1.224E-03 4.708E-03 0.05024534 0.50157189 HINATA_NFKB_TARGETS_FIBROBLAST_UP uterine benign neoplasm DOID_0060095 1.224E-03 4.708E-03 0.05024534 0.50157189 HINATA_NFKB_TARGETS_FIBROBLAST_UP uterine fibroid DOID_13223 1.224E-03 4.708E-03 0.05024534 0.50157189 HINATA_NFKB_TARGETS_FIBROBLAST_UP spastic cerebral palsy DOID_0050669 1.302E-03 4.972E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP age related macular degeneration DOID_10871 1.302E-03 4.939E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP degeneration of macula and posterior pole DOID_2007 1.302E-03 4.939E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP celiac disease DOID_10608 1.382E-03 5.208E-03 0.05330187 0.51404683 HINATA_NFKB_TARGETS_FIBROBLAST_UP leiomyoma DOID_127 1.464E-03 5.481E-03 0.0548265 0.51993801 HINATA_NFKB_TARGETS_FIBROBLAST_UP bladder disease DOID_365 1.464E-03 5.446E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pneumoconiosis DOID_10316 1.636E-03 6.043E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP spindle cell carcinoma DOID_4015 1.636E-03 6.004E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP macular degeneration DOID_4448 1.636E-03 5.966E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP calcinosis DOID_182 1.91E-03 6.921E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP uveitis DOID_13141 2.006E-03 7.222E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hepatitis DOID_2237 2.104E-03 7.528E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lymphatic system disease DOID_75 2.204E-03 7.838E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP cervix uteri carcinoma in situ DOID_8991 2.307E-03 8.152E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP autoimmune disease of urogenital tract DOID_0060049 2.411E-03 8.469E-03 2.411E-03 0.12473132 HINATA_NFKB_TARGETS_FIBROBLAST_UP primary biliary cirrhosis DOID_12236 2.411E-03 8.469E-03 2.411E-03 0.12473132 HINATA_NFKB_TARGETS_FIBROBLAST_UP uveal disease DOID_3480 2.518E-03 8.791E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP gallbladder cancer DOID_3121 2.628E-03 9.116E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP cataract DOID_83 2.739E-03 9.445E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP learning disability DOID_8927 2.739E-03 9.388E-03 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pre-eclampsia DOID_10591 2.968E-03 0.01011369 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lens disease DOID_110 2.968E-03 0.01005349 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP glaucoma DOID_1686 3.206E-03 0.01079568 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lung small cell carcinoma DOID_5409 3.206E-03 0.01073218 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP B-cell lymphocytic neoplasm DOID_707 3.453E-03 0.01149053 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP sarcoidosis DOID_11335 3.709E-03 0.01226853 0.08629167 0.67260221 HINATA_NFKB_TARGETS_FIBROBLAST_UP reproductive organ benign neoplasm DOID_0050622 3.973E-03 0.01306564 0.08923406 0.66808131 HINATA_NFKB_TARGETS_FIBROBLAST_UP integumentary system cancer DOID_0060122 3.973E-03 0.01299055 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP skin cancer DOID_4159 3.973E-03 0.01299055 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hypersensitivity reaction type IV disease DOID_2916 4.384E-03 0.01425519 0.09363017 0.67437429 HINATA_NFKB_TARGETS_FIBROBLAST_UP leukocyte disease DOID_9500 4.526E-03 0.01463157 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP uterine disease DOID_345 5.418E-03 0.01741832 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP endocrine organ benign neoplasm DOID_0060089 5.892E-03 0.01883605 0.10813368 0.68364518 HINATA_NFKB_TARGETS_FIBROBLAST_UP male reproductive system disease DOID_48 6.385E-03 0.02029611 0.11244005 0.68793966 HINATA_NFKB_TARGETS_FIBROBLAST_UP contact dermatitis DOID_2773 7.786E-03 0.02461282 0.12382395 0.74164031 HINATA_NFKB_TARGETS_FIBROBLAST_UP chromosomal disease DOID_0080014 7.97E-03 0.02505541 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP female reproductive system disease DOID_229 7.97E-03 0.02491774 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP alcohol abuse DOID_1574 8.344E-03 0.02594429 0.12805579 0.75899732 HINATA_NFKB_TARGETS_FIBROBLAST_UP leber hereditary optic neuropathy DOID_705 0.01438994 0.04449932 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP interstitial nephritis DOID_1063 0.01597619 0.04913759 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP T cell deficiency DOID_11200 0.01597619 0.04887341 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Sjogren's syndrome DOID_12894 0.01597619 0.04861205 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hyperparathyroidism DOID_13543 0.01597619 0.04835348 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hypolipoproteinemia DOID_1387 0.01597619 0.04809764 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP childhood type dermatomyositis DOID_14203 0.01597619 0.0478445 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP rectal neoplasm DOID_1984 0.01597619 0.047594 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP rectum cancer DOID_1993 0.01597619 0.047594 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP chondrosarcoma DOID_3371 0.01597619 0.04734612 0.01597619 0.37876893 HINATA_NFKB_TARGETS_FIBROBLAST_UP conjunctival disease DOID_4251 0.01597619 0.0471008 0.01597619 0.36361817 HINATA_NFKB_TARGETS_FIBROBLAST_UP conjunctivitis DOID_6195 0.01597619 0.0471008 0.01597619 0.36361817 HINATA_NFKB_TARGETS_FIBROBLAST_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01597619 0.04685801 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01597619 0.04685801 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Hodgkin's granuloma DOID_8651 0.01597619 0.04685801 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01597619 0.04685801 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP visceral leishmaniasis DOID_9146 0.01597619 0.04661771 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP breast benign neoplasm DOID_0060082 0.01755994 0.05097757 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP thoracic benign neoplasm DOID_0060097 0.01755994 0.05097757 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP trypanosomiasis DOID_10113 0.01755994 0.0507188 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP dermatomyositis DOID_10223 0.01755994 0.05046265 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP adrenoleukodystrophy DOID_10588 0.01755994 0.05020907 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP pneumocystosis DOID_11339 0.01755994 0.04995802 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP prediabetes syndrome DOID_11716 0.01755994 0.04970947 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP temporal arteritis DOID_13375 0.01755994 0.04946339 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP neuronal ceroid lipofuscinosis DOID_14503 0.01755994 0.04921972 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP benign breast phyllodes tumor DOID_1631 0.01755994 0.05097757 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP central nervous system vasculitis DOID_525 0.01755994 0.04946339 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP intracranial arteriosclerosis DOID_13097 0.01914117 0.05338886 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP epidermolysis bullosa DOID_2730 0.01914117 0.05312843 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP stomach disease DOID_76 0.01914117 0.05287052 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lipodystrophy DOID_811 0.01914117 0.05261511 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Hodgkin's lymphoma DOID_8567 0.01914117 0.05236215 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP vascular dementia DOID_8725 0.01914117 0.05338886 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP mitochondrial encephalomyopathy DOID_890 0.01914117 0.05211161 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP berylliosis DOID_10322 0.02071991 0.05614108 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP essential hypertension DOID_10825 0.02071991 0.05587501 0.02071991 0.42105808 HINATA_NFKB_TARGETS_FIBROBLAST_UP parathyroid gland disease DOID_11201 0.02071991 0.05561144 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP polyneuropathy DOID_1389 0.02071991 0.05535036 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP larynx cancer DOID_2596 0.02071991 0.05509171 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP laryngeal benign neoplasm DOID_2598 0.02071991 0.05509171 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP vesiculobullous skin disease DOID_2731 0.02071991 0.05483547 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.02071991 0.0545816 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP viral pneumonia DOID_10533 0.02229614 0.05846315 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP tethered spinal cord syndrome DOID_1089 0.02229614 0.05819497 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hypercalcemia DOID_12678 0.02229614 0.05792924 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP rhabdomyosarcoma DOID_3247 0.02229614 0.05766592 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP eyelid disease DOID_530 0.02229614 0.05740499 0.02229614 0.40924203 HINATA_NFKB_TARGETS_FIBROBLAST_UP parasitic helminthiasis infectious disease DOID_883 0.02229614 0.05714641 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP idiopathic pulmonary fibrosis DOID_0050156 0.02386988 0.06090565 0.02386988 0.42443624 HINATA_NFKB_TARGETS_FIBROBLAST_UP renovascular hypertension DOID_1591 0.02386988 0.06063375 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP skeletal muscle cancer DOID_4043 0.02386988 0.06036427 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP nutritional deficiency disease DOID_5113 0.02386988 0.06009717 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lung oat cell carcinoma DOID_5411 0.02386988 0.05983242 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP angiosarcoma DOID_0001816 0.02544112 0.06349122 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP spastic diplegia DOID_10965 0.02544112 0.06321397 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hemolytic-uremic syndrome DOID_12554 0.02544112 0.06293912 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP restrictive cardiomyopathy DOID_397 0.02544112 0.06266666 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP thyroiditis DOID_7166 0.02544112 0.06239655 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP autoimmune thyroiditis DOID_7188 0.02544112 0.06239655 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP tongue cancer DOID_8649 0.02544112 0.06212875 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP schizophreniform disorder DOID_11328 0.02700988 0.06567787 0.02700988 0.4520183 HINATA_NFKB_TARGETS_FIBROBLAST_UP drug-induced mental disorder DOID_1203 0.02700988 0.06539839 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP methylmalonic acidemia DOID_14749 0.02700988 0.06512128 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP drug psychosis DOID_1742 0.02700988 0.06539839 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP basal cell carcinoma DOID_2513 0.02700988 0.06484651 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP schizoaffective disorder DOID_5418 0.02700988 0.06567787 0.02700988 0.4520183 HINATA_NFKB_TARGETS_FIBROBLAST_UP substance-induced psychosis DOID_8646 0.02700988 0.06539839 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP dental caries DOID_216 0.02857615 0.06831862 0.02857615 0.46456663 HINATA_NFKB_TARGETS_FIBROBLAST_UP skin carcinoma DOID_3451 0.02857615 0.06803277 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP ureteral obstruction DOID_5199 0.02857615 0.0677493 0.02857615 0.451662 HINATA_NFKB_TARGETS_FIBROBLAST_UP prion disease DOID_649 0.02857615 0.06746818 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP dissociative disorder DOID_10935 0.03013995 0.07086624 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP dissociative amnesia DOID_11037 0.03013995 0.07086624 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP granulosa cell tumor DOID_2999 0.03013995 0.07057461 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP psoriasis DOID_8893 0.03013995 0.07028537 0.03013995 0.46350354 HINATA_NFKB_TARGETS_FIBROBLAST_UP amnestic disorder DOID_10914 0.03170127 0.07362458 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP sex cord-gonadal stromal tumor DOID_192 0.03170127 0.07332529 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP amyloidosis DOID_9120 0.03170127 0.07302843 0.03170127 0.47468476 HINATA_NFKB_TARGETS_FIBROBLAST_UP gastric ulcer DOID_10808 0.03481649 0.07988138 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP neutropenia DOID_1227 0.03481649 0.07956057 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP acquired immunodeficiency syndrome DOID_635 0.03481649 0.07924233 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP muscular atrophy DOID_767 0.03481649 0.07892663 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP placenta disease DOID_780 0.03481649 0.07861342 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP agranulocytosis DOID_12987 0.0363704 0.08179747 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP optic nerve disease DOID_1891 0.0363704 0.08147543 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP muscle cancer DOID_4045 0.0363704 0.08115592 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP uremia DOID_4676 0.0363704 0.0808389 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP urinary tract obstruction DOID_5200 0.0363704 0.08052435 0.0363704 0.50475022 HINATA_NFKB_TARGETS_FIBROBLAST_UP sleep disorder DOID_535 0.0363704 0.08021224 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP Lewy body dementia DOID_12217 0.03792185 0.08331095 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP ureteral disease DOID_1426 0.03792185 0.08299052 0.03792185 0.51375084 HINATA_NFKB_TARGETS_FIBROBLAST_UP meningitis DOID_9471 0.03792185 0.08267255 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP spastic quadriplegia DOID_10970 0.03947085 0.08572104 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP toxic shock syndrome DOID_14115 0.03947085 0.08539511 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP organic acidemia DOID_0060159 0.04101739 0.08840491 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP hypogonadism DOID_1924 0.04101739 0.0880713 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP osteosarcoma DOID_3347 0.04101739 0.08774021 0.04101739 0.50736729 HINATA_NFKB_TARGETS_FIBROBLAST_UP cystitis DOID_1679 0.04256148 0.09070219 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP cleft lip DOID_9296 0.04256148 0.09036375 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP myopia DOID_11830 0.04410313 0.09328878 0.04410313 0.51213635 HINATA_NFKB_TARGETS_FIBROBLAST_UP teeth hard tissue disease DOID_214 0.04410313 0.09294326 0.04410313 0.50189362 HINATA_NFKB_TARGETS_FIBROBLAST_UP spinal cord disease DOID_319 0.04410313 0.0926003 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP seminoma DOID_4440 0.04410313 0.09225986 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP fragments of torsion dystonia DOID_531 0.04410313 0.09192191 0.04410313 0.49205257 HINATA_NFKB_TARGETS_FIBROBLAST_UP dystonia DOID_543 0.04410313 0.09158643 0.04410313 0.48259002 HINATA_NFKB_TARGETS_FIBROBLAST_UP Sciatic Neuropathy DOID_11446 0.04564234 0.09443814 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP lesion of sciatic nerve DOID_12528 0.04564234 0.09443814 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP perinatal necrotizing enterocolitis DOID_8677 0.04564234 0.09409597 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP mononeuritis of lower limb DOID_9473 0.04564234 0.09443814 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP renal hypertension DOID_1073 0.0471791 0.09691303 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP secondary hypertension DOID_11130 0.0471791 0.09691303 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP sarcoma DOID_1115 0.0471791 0.09656442 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP malaria DOID_12365 0.0471791 0.09621831 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP mononeuritis DOID_1802 0.0471791 0.09587468 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP central nervous system hereditary degenerative disease DOID_481 0.0471791 0.09553349 0.0471791 0.49712795 HINATA_NFKB_TARGETS_FIBROBLAST_UP autoimmune disease of endocrine system DOID_0060005 0.04871344 0.09829059 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP mononeuropathy DOID_1188 0.04871344 0.09794327 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP dystonic disease DOID_544 0.04871344 0.0975984 0.04871344 0.4949633 HINATA_NFKB_TARGETS_FIBROBLAST_UP cranial nerve disease DOID_5656 0.04871344 0.09725595 1.000 1.000 HINATA_NFKB_TARGETS_FIBROBLAST_UP endometrial carcinoma DOID_2871 0.05024534 0.09996363 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 funisitis DOID_0050698 1.421E-08 8.088E-06 1.154E-05 6.569E-03 LUI_THYROID_CANCER_CLUSTER_4 hepatitis B DOID_2043 1.421E-08 4.044E-06 1.154E-05 3.284E-03 LUI_THYROID_CANCER_CLUSTER_4 angioedema DOID_1558 2.252E-06 4.272E-04 2.372E-03 0.44983773 LUI_THYROID_CANCER_CLUSTER_4 thyroiditis DOID_7166 6.001E-06 8.537E-04 3.792E-03 0.30826497 LUI_THYROID_CANCER_CLUSTER_4 autoimmune thyroiditis DOID_7188 6.001E-06 8.537E-04 3.792E-03 0.30826497 LUI_THYROID_CANCER_CLUSTER_4 myasthenia gravis DOID_437 1.264E-05 1.439E-03 5.447E-03 0.38745333 LUI_THYROID_CANCER_CLUSTER_4 urticaria DOID_1555 1.623E-05 1.539E-03 6.156E-03 0.29190143 LUI_THYROID_CANCER_CLUSTER_4 neuromuscular junction disease DOID_439 1.753E-05 1.425E-03 6.392E-03 0.25979695 LUI_THYROID_CANCER_CLUSTER_4 autoimmune disease of the nervous system DOID_438 2.172E-05 1.545E-03 7.1E-03 0.25250046 LUI_THYROID_CANCER_CLUSTER_4 autoimmune disease of endocrine system DOID_0060005 2.321E-05 1.468E-03 7.336E-03 0.24554318 LUI_THYROID_CANCER_CLUSTER_4 celiac disease DOID_10608 2.799E-05 1.593E-03 8.043E-03 0.2288372 LUI_THYROID_CANCER_CLUSTER_4 systemic scleroderma DOID_418 4.292E-05 2.22E-03 9.928E-03 0.23536906 LUI_THYROID_CANCER_CLUSTER_4 rheumatic disease DOID_1575 5.157E-05 2.445E-03 0.0108686 0.2378552 LUI_THYROID_CANCER_CLUSTER_4 scleroderma DOID_419 5.157E-05 2.445E-03 0.0108686 0.2378552 LUI_THYROID_CANCER_CLUSTER_4 vascular skin disease DOID_9540 6.101E-05 2.67E-03 0.01180872 0.23997001 LUI_THYROID_CANCER_CLUSTER_4 autoimmune disease of gastrointestinal tract DOID_0060031 6.602E-05 2.683E-03 0.01227848 0.24091219 LUI_THYROID_CANCER_CLUSTER_4 pulmonary tuberculosis DOID_2957 6.602E-05 2.504E-03 0.01227848 0.23288178 LUI_THYROID_CANCER_CLUSTER_4 sarcoidosis DOID_11335 7.664E-05 2.725E-03 0.0132174 0.22790003 LUI_THYROID_CANCER_CLUSTER_4 pustulosis of palm and sole DOID_4398 8.224E-05 2.753E-03 0.01368656 0.22904869 LUI_THYROID_CANCER_CLUSTER_4 hypersensitivity reaction type IV disease DOID_2916 9.101E-05 2.877E-03 0.01438994 0.2339393 LUI_THYROID_CANCER_CLUSTER_4 collagen disease DOID_854 1.002E-04 3.002E-03 0.01509287 0.22599584 LUI_THYROID_CANCER_CLUSTER_4 tuberculosis DOID_399 1.234E-04 3.512E-03 0.0167313 0.23219783 LUI_THYROID_CANCER_CLUSTER_4 peripheral vascular disease DOID_341 1.378E-04 3.733E-03 0.01766646 0.23377248 LUI_THYROID_CANCER_CLUSTER_4 pancreatitis DOID_4989 1.568E-04 4.055E-03 0.0188343 0.23814926 LUI_THYROID_CANCER_CLUSTER_4 primary bacterial infectious disease DOID_0050338 1.941E-04 4.802E-03 0.0209333 0.23822094 LUI_THYROID_CANCER_CLUSTER_4 Human immunodeficiency virus infectious disease DOID_526 2.074E-04 4.917E-03 0.02163208 0.24134612 LUI_THYROID_CANCER_CLUSTER_4 encephalomyelitis DOID_640 2.211E-04 5.033E-03 0.02233041 0.24434625 LUI_THYROID_CANCER_CLUSTER_4 hypersensitivity reaction type I disease DOID_1205 2.305E-04 5.045E-03 0.02279572 0.24019938 LUI_THYROID_CANCER_CLUSTER_4 Sjogren's syndrome DOID_12894 2.372E-03 0.04998197 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 pneumocystosis DOID_11339 2.609E-03 0.053011 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 prediabetes syndrome DOID_11716 2.609E-03 0.05118303 2.609E-03 0.37107697 LUI_THYROID_CANCER_CLUSTER_4 common variable immunodeficiency DOID_12177 2.609E-03 0.04947693 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 stomach disease DOID_76 2.845E-03 0.0522282 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 encephalitis DOID_9588 2.845E-03 0.05059607 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 berylliosis DOID_10322 3.082E-03 0.05314582 3.082E-03 0.35076239 LUI_THYROID_CANCER_CLUSTER_4 parasitic helminthiasis infectious disease DOID_883 3.319E-03 0.05554474 3.319E-03 0.31475355 LUI_THYROID_CANCER_CLUSTER_4 narcolepsy DOID_8986 3.319E-03 0.05395775 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 adrenal cortex disease DOID_3952 3.556E-03 0.05620006 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 juvenile rheumatoid arthritis DOID_676 4.029E-03 0.06195889 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 adrenal gland disease DOID_9553 4.029E-03 0.06032839 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 prion disease DOID_649 4.266E-03 0.06223268 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 agammaglobulinemia DOID_2583 4.502E-03 0.06404104 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 blood protein disease DOID_620 4.738E-03 0.0657605 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 autoimmune hepatitis DOID_2048 4.975E-03 0.0673974 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 sleep disorder DOID_535 5.447E-03 0.07208434 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 synostosis DOID_11971 5.684E-03 0.07350118 5.684E-03 0.3593391 LUI_THYROID_CANCER_CLUSTER_4 toxic shock syndrome DOID_14115 5.92E-03 0.07485442 5.92E-03 0.33684487 LUI_THYROID_CANCER_CLUSTER_4 commensal bacterial infectious disease DOID_0050339 6.156E-03 0.0761482 6.156E-03 0.31843793 LUI_THYROID_CANCER_CLUSTER_4 hypogonadism DOID_1924 6.156E-03 0.07452803 6.156E-03 0.26944748 LUI_THYROID_CANCER_CLUSTER_4 myositis DOID_633 6.392E-03 0.07577411 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 ankylosing spondylitis DOID_7147 6.392E-03 0.0742277 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 cleft lip DOID_9296 6.392E-03 0.07274315 6.392E-03 0.24247715 LUI_THYROID_CANCER_CLUSTER_4 vitiligo DOID_12306 6.628E-03 0.07395037 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 B cell deficiency DOID_2115 6.628E-03 0.07252825 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 dysostosis DOID_1934 7.572E-03 0.08129118 7.572E-03 0.23935735 LUI_THYROID_CANCER_CLUSTER_4 gonadal disease DOID_2277 7.808E-03 0.08227041 7.808E-03 0.23382117 LUI_THYROID_CANCER_CLUSTER_4 opportunistic mycosis DOID_2473 7.808E-03 0.08077459 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 systemic mycosis DOID_0050136 8.515E-03 0.08651683 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 fungal infectious disease DOID_1564 8.515E-03 0.08651683 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 myocarditis DOID_820 8.515E-03 0.08499899 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 pneumoconiosis DOID_10316 8.75E-03 0.08584481 8.75E-03 0.23709518 LUI_THYROID_CANCER_CLUSTER_4 male infertility DOID_12336 8.75E-03 0.08438981 8.75E-03 0.22631813 LUI_THYROID_CANCER_CLUSTER_4 esophageal disease DOID_6050 8.75E-03 0.08298331 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 cleft palate DOID_674 9.457E-03 0.0882131 9.457E-03 0.23395647 LUI_THYROID_CANCER_CLUSTER_4 uveitis DOID_13141 9.692E-03 0.08895068 1.000 1.000 LUI_THYROID_CANCER_CLUSTER_4 endometriosis of uterus DOID_288 0.01063345 0.09603862 0.01063345 0.24201732 LUI_THYROID_CANCER_CLUSTER_4 endometriosis DOID_289 0.0108686 0.09662867 0.0108686 0.22904574 LUI_THYROID_CANCER_CLUSTER_4 uveal disease DOID_3480 0.0108686 0.09514208 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP lymphoma DOID_0060058 1.274E-08 7.249E-06 2.674E-07 1.521E-04 MULLIGHAN_MLL_SIGNATURE_2_UP bone resorption disease DOID_0080011 8.019E-08 2.281E-05 1.746E-06 4.968E-04 MULLIGHAN_MLL_SIGNATURE_2_UP osteoporosis DOID_11476 8.019E-08 2.281E-05 1.746E-06 4.968E-04 MULLIGHAN_MLL_SIGNATURE_2_UP primary bacterial infectious disease DOID_0050338 3.516E-06 6.668E-04 7.56E-04 0.0358481 MULLIGHAN_MLL_SIGNATURE_2_UP pulmonary tuberculosis DOID_2957 4.08E-06 5.803E-04 1.751E-03 0.04529522 MULLIGHAN_MLL_SIGNATURE_2_UP B-cell lymphocytic neoplasm DOID_707 4.928E-06 5.608E-04 1.108E-04 9.01E-03 MULLIGHAN_MLL_SIGNATURE_2_UP bronchiolitis DOID_2942 5.789E-06 5.49E-04 6.261E-03 0.08689718 MULLIGHAN_MLL_SIGNATURE_2_UP ulcerative colitis DOID_8577 6.919E-06 5.624E-04 9.905E-05 0.01127242 MULLIGHAN_MLL_SIGNATURE_2_UP respiratory failure DOID_11162 1.236E-05 8.791E-04 3.315E-03 0.0628698 MULLIGHAN_MLL_SIGNATURE_2_UP neuronal ceroid lipofuscinosis DOID_14503 1.5E-05 9.483E-04 1.5E-05 2.845E-03 MULLIGHAN_MLL_SIGNATURE_2_UP tuberculosis DOID_399 1.906E-05 1.084E-03 4.252E-03 0.07115348 MULLIGHAN_MLL_SIGNATURE_2_UP chronic kidney failure DOID_784 4.56E-05 2.359E-03 7.014E-03 0.09281444 MULLIGHAN_MLL_SIGNATURE_2_UP primary immunodeficiency disease DOID_612 6.324E-05 2.999E-03 8.217E-04 0.03596682 MULLIGHAN_MLL_SIGNATURE_2_UP influenza DOID_8469 6.409E-05 2.805E-03 0.01956547 0.17394927 MULLIGHAN_MLL_SIGNATURE_2_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.161E-05 3.317E-03 1.003E-03 0.03806594 MULLIGHAN_MLL_SIGNATURE_2_UP integumentary system benign neoplasm DOID_0060121 9.557E-05 3.625E-03 9.557E-05 0.01359413 MULLIGHAN_MLL_SIGNATURE_2_UP skin benign neoplasm DOID_3165 9.557E-05 3.625E-03 9.557E-05 0.01359413 MULLIGHAN_MLL_SIGNATURE_2_UP pulmonary edema DOID_11396 1.005E-04 3.576E-03 3.727E-03 0.06425926 MULLIGHAN_MLL_SIGNATURE_2_UP amyloidosis DOID_9120 1.005E-04 3.365E-03 1.005E-04 9.535E-03 MULLIGHAN_MLL_SIGNATURE_2_UP alopecia DOID_987 1.005E-04 3.178E-03 0.08743708 0.36315109 MULLIGHAN_MLL_SIGNATURE_2_UP hypertrophic cardiomyopathy DOID_11984 1.784E-04 5.343E-03 1.784E-04 0.01269031 MULLIGHAN_MLL_SIGNATURE_2_UP cerebral degeneration DOID_1443 2.716E-04 7.727E-03 2.716E-04 0.01717208 MULLIGHAN_MLL_SIGNATURE_2_UP spinal cord disease DOID_319 2.813E-04 7.622E-03 7.239E-03 0.09361651 MULLIGHAN_MLL_SIGNATURE_2_UP hypotrichosis DOID_4535 2.813E-04 7.275E-03 0.12024436 0.41718929 MULLIGHAN_MLL_SIGNATURE_2_UP periodontitis DOID_824 3.127E-04 7.736E-03 0.12426194 0.42338349 MULLIGHAN_MLL_SIGNATURE_2_UP perinatal necrotizing enterocolitis DOID_8677 3.127E-04 7.414E-03 3.127E-04 0.01779285 MULLIGHAN_MLL_SIGNATURE_2_UP nephrosis DOID_2527 3.757E-04 8.551E-03 4.774E-03 0.07546203 MULLIGHAN_MLL_SIGNATURE_2_UP male reproductive system disease DOID_48 3.757E-04 8.222E-03 0.04514628 0.29191174 MULLIGHAN_MLL_SIGNATURE_2_UP syndrome DOID_225 4.592E-04 9.677E-03 0.04960917 0.29403769 MULLIGHAN_MLL_SIGNATURE_2_UP metabolic syndrome X DOID_14221 5.551E-04 0.01128133 5.551E-04 0.02871611 MULLIGHAN_MLL_SIGNATURE_2_UP hair disease DOID_421 5.969E-04 0.01171107 0.15187877 0.47745316 MULLIGHAN_MLL_SIGNATURE_2_UP periodontal disease DOID_3388 6.474E-04 0.01227843 0.1557527 0.4816483 MULLIGHAN_MLL_SIGNATURE_2_UP progressive muscular atrophy DOID_318 9.095E-04 0.01669429 0.04471263 0.31026203 MULLIGHAN_MLL_SIGNATURE_2_UP phagocyte bactericidal dysfunction DOID_3262 9.095E-04 0.01617259 9.095E-04 0.03696592 MULLIGHAN_MLL_SIGNATURE_2_UP alopecia areata DOID_986 9.095E-04 0.01568251 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP mouth disease DOID_403 1.003E-03 0.0167938 0.35572755 0.76670067 MULLIGHAN_MLL_SIGNATURE_2_UP hypersensitivity reaction type I disease DOID_1205 1.043E-03 0.01695571 1.043E-03 0.0370906 MULLIGHAN_MLL_SIGNATURE_2_UP dilated cardiomyopathy DOID_12930 1.043E-03 0.01648471 0.01006307 0.11227231 MULLIGHAN_MLL_SIGNATURE_2_UP nervous system benign neoplasm DOID_0060115 1.108E-03 0.01704409 0.04907306 0.3102508 MULLIGHAN_MLL_SIGNATURE_2_UP nephrotic syndrome DOID_1184 1.227E-03 0.01837667 0.0187885 0.17525664 MULLIGHAN_MLL_SIGNATURE_2_UP common cold DOID_10459 1.326E-03 0.01934588 0.0534137 0.31332369 MULLIGHAN_MLL_SIGNATURE_2_UP osteopetrosis DOID_13533 1.326E-03 0.01886223 1.326E-03 0.04438172 MULLIGHAN_MLL_SIGNATURE_2_UP relapsing-remitting multiple sclerosis DOID_2378 1.326E-03 0.01840218 1.326E-03 0.04191607 MULLIGHAN_MLL_SIGNATURE_2_UP peritonitis DOID_8283 1.326E-03 0.01796403 1.326E-03 0.03970996 MULLIGHAN_MLL_SIGNATURE_2_UP monocytic leukemia DOID_8527 1.562E-03 0.02067436 1.562E-03 0.04444986 MULLIGHAN_MLL_SIGNATURE_2_UP psoriatic arthritis DOID_9008 1.562E-03 0.02020448 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP neuritis DOID_1803 1.564E-03 0.01977078 1.564E-03 0.04236595 MULLIGHAN_MLL_SIGNATURE_2_UP communication disorder DOID_2033 2.091E-03 0.02586022 2.091E-03 0.05172043 MULLIGHAN_MLL_SIGNATURE_2_UP skeletal muscle cancer DOID_4043 2.091E-03 0.02531 2.091E-03 0.04956541 MULLIGHAN_MLL_SIGNATURE_2_UP reproductive organ benign neoplasm DOID_0050622 2.397E-03 0.02841167 2.397E-03 0.0545504 MULLIGHAN_MLL_SIGNATURE_2_UP integumentary system cancer DOID_0060122 2.397E-03 0.02783184 2.397E-03 0.05245231 MULLIGHAN_MLL_SIGNATURE_2_UP skin cancer DOID_4159 2.397E-03 0.02783184 2.397E-03 0.05245231 MULLIGHAN_MLL_SIGNATURE_2_UP mitochondrial metabolism disease DOID_700 2.517E-03 0.02864083 2.517E-03 0.05303858 MULLIGHAN_MLL_SIGNATURE_2_UP osteosclerosis DOID_4254 3.019E-03 0.03368354 3.019E-03 0.06135216 MULLIGHAN_MLL_SIGNATURE_2_UP ureteral obstruction DOID_5199 3.019E-03 0.03303578 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP prion disease DOID_649 3.019E-03 0.03241246 3.019E-03 0.05923657 MULLIGHAN_MLL_SIGNATURE_2_UP collagen disease DOID_854 3.172E-03 0.03342661 0.25395166 0.61228177 MULLIGHAN_MLL_SIGNATURE_2_UP hypothyroidism DOID_1459 3.315E-03 0.03429262 0.03569798 0.26041219 MULLIGHAN_MLL_SIGNATURE_2_UP agammaglobulinemia DOID_2583 3.364E-03 0.03418252 0.08325157 0.36160414 MULLIGHAN_MLL_SIGNATURE_2_UP pre-malignant neoplasm DOID_0060071 3.461E-03 0.03454998 3.461E-03 0.06352738 MULLIGHAN_MLL_SIGNATURE_2_UP in situ carcinoma DOID_8719 3.461E-03 0.03454998 3.461E-03 0.06352738 MULLIGHAN_MLL_SIGNATURE_2_UP mineral metabolism disease DOID_0050032 3.611E-03 0.03542792 3.611E-03 0.06421311 MULLIGHAN_MLL_SIGNATURE_2_UP blood protein disease DOID_620 3.727E-03 0.03594162 0.08743708 0.36582132 MULLIGHAN_MLL_SIGNATURE_2_UP cholestasis DOID_13580 3.765E-03 0.03570874 0.0387527 0.27562859 MULLIGHAN_MLL_SIGNATURE_2_UP tooth disease DOID_1091 4.086E-03 0.03810994 0.27418186 0.64734225 MULLIGHAN_MLL_SIGNATURE_2_UP funisitis DOID_0050698 4.504E-03 0.04133499 0.0957512 0.38916022 MULLIGHAN_MLL_SIGNATURE_2_UP hepatitis B DOID_2043 4.504E-03 0.04067888 4.504E-03 0.07322198 MULLIGHAN_MLL_SIGNATURE_2_UP bile duct disease DOID_4138 4.774E-03 0.04244739 0.04514628 0.29526705 MULLIGHAN_MLL_SIGNATURE_2_UP IgA glomerulonephritis DOID_2986 4.918E-03 0.04305327 0.09987997 0.38142082 MULLIGHAN_MLL_SIGNATURE_2_UP muscle cancer DOID_4045 4.918E-03 0.04240095 4.918E-03 0.07563412 MULLIGHAN_MLL_SIGNATURE_2_UP urinary tract obstruction DOID_5200 4.918E-03 0.0417681 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP biliary tract disease DOID_9741 4.957E-03 0.04147721 0.04624736 0.29567133 MULLIGHAN_MLL_SIGNATURE_2_UP Lewy body dementia DOID_12217 5.349E-03 0.04411242 5.349E-03 0.08009887 MULLIGHAN_MLL_SIGNATURE_2_UP ureteral disease DOID_1426 5.349E-03 0.04348224 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP Goodpasture syndrome DOID_9808 5.349E-03 0.04286982 0.10399 0.38927834 MULLIGHAN_MLL_SIGNATURE_2_UP cystic fibrosis DOID_1485 5.529E-03 0.04369656 0.04960917 0.29713282 MULLIGHAN_MLL_SIGNATURE_2_UP sphingolipidosis DOID_1927 5.797E-03 0.04518577 5.797E-03 0.08457849 MULLIGHAN_MLL_SIGNATURE_2_UP X-linked disease DOID_0050735 6.261E-03 0.04814573 6.261E-03 0.08906961 MULLIGHAN_MLL_SIGNATURE_2_UP spinal muscular atrophy DOID_12377 6.742E-03 0.05115115 0.11620847 0.41326636 MULLIGHAN_MLL_SIGNATURE_2_UP biliary tract cancer DOID_4607 7.014E-03 0.05251343 7.014E-03 0.09502431 MULLIGHAN_MLL_SIGNATURE_2_UP vitiligo DOID_12306 7.239E-03 0.05349515 0.12024436 0.42233977 MULLIGHAN_MLL_SIGNATURE_2_UP B cell deficiency DOID_2115 7.239E-03 0.05280932 0.12024436 0.41974873 MULLIGHAN_MLL_SIGNATURE_2_UP extrinsic allergic alveolitis DOID_841 7.239E-03 0.05214084 0.12024436 0.41466087 MULLIGHAN_MLL_SIGNATURE_2_UP diffuse large B-cell lymphoma DOID_0050745 7.752E-03 0.05513834 0.12426194 0.42593399 MULLIGHAN_MLL_SIGNATURE_2_UP Sciatic Neuropathy DOID_11446 7.752E-03 0.05445762 7.752E-03 0.09802371 MULLIGHAN_MLL_SIGNATURE_2_UP lesion of sciatic nerve DOID_12528 7.752E-03 0.05445762 7.752E-03 0.09802371 MULLIGHAN_MLL_SIGNATURE_2_UP lung adenocarcinoma DOID_3910 7.752E-03 0.0537935 7.752E-03 0.09589276 MULLIGHAN_MLL_SIGNATURE_2_UP mononeuritis of lower limb DOID_9473 7.752E-03 0.05445762 7.752E-03 0.09802371 MULLIGHAN_MLL_SIGNATURE_2_UP autoimmune disease of cardiovascular system DOID_0060051 8.281E-03 0.05677192 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP pleurisy DOID_10247 8.281E-03 0.05609606 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP Behcet's disease DOID_13241 8.281E-03 0.05677192 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP mononeuritis DOID_1802 8.281E-03 0.05543611 8.281E-03 0.10025679 MULLIGHAN_MLL_SIGNATURE_2_UP coronary stenosis DOID_4248 8.281E-03 0.0547915 0.12826127 0.42929801 MULLIGHAN_MLL_SIGNATURE_2_UP polycystic ovary syndrome DOID_11612 8.826E-03 0.05772466 0.13224244 0.44003479 MULLIGHAN_MLL_SIGNATURE_2_UP mononeuropathy DOID_1188 8.826E-03 0.0570687 8.826E-03 0.10462594 MULLIGHAN_MLL_SIGNATURE_2_UP female reproductive organ benign neoplasm DOID_0060086 9.386E-03 0.0600102 9.386E-03 0.10899812 MULLIGHAN_MLL_SIGNATURE_2_UP uterine benign neoplasm DOID_0060095 9.386E-03 0.0600102 9.386E-03 0.10899812 MULLIGHAN_MLL_SIGNATURE_2_UP uterine fibroid DOID_13223 9.386E-03 0.0600102 9.386E-03 0.10899812 MULLIGHAN_MLL_SIGNATURE_2_UP Crohn's disease DOID_8778 9.784E-03 0.06185725 0.07147611 0.32277706 MULLIGHAN_MLL_SIGNATURE_2_UP opportunistic mycosis DOID_2473 9.962E-03 0.06229198 9.962E-03 0.1133714 MULLIGHAN_MLL_SIGNATURE_2_UP leiomyoma DOID_127 0.01115985 0.06902122 0.01115985 0.12211446 MULLIGHAN_MLL_SIGNATURE_2_UP pleural disease DOID_1532 0.01115985 0.06827905 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP systemic mycosis DOID_0050136 0.0117812 0.07131384 0.0117812 0.12648114 MULLIGHAN_MLL_SIGNATURE_2_UP fungal infectious disease DOID_1564 0.0117812 0.07131384 0.0117812 0.12648114 MULLIGHAN_MLL_SIGNATURE_2_UP myocarditis DOID_820 0.0117812 0.07056317 0.0117812 0.1241389 MULLIGHAN_MLL_SIGNATURE_2_UP pneumoconiosis DOID_10316 0.01241741 0.07359905 1.000 1.000 MULLIGHAN_MLL_SIGNATURE_2_UP lymphoid leukemia DOID_10747 0.01306835 0.0766587 0.01306835 0.13519806 MULLIGHAN_MLL_SIGNATURE_2_UP medullomyoblastoma DOID_3861 0.01306835 0.07587646 0.01306835 0.13278381 MULLIGHAN_MLL_SIGNATURE_2_UP adult medulloblastoma DOID_3864 0.01306835 0.07587646 0.01306835 0.13278381 MULLIGHAN_MLL_SIGNATURE_2_UP childhood medulloblastoma DOID_3869 0.01306835 0.07587646 0.01306835 0.13278381 MULLIGHAN_MLL_SIGNATURE_2_UP pulmonary sarcoidosis DOID_13406 0.01441381 0.08284301 0.16726924 0.50092736 MULLIGHAN_MLL_SIGNATURE_2_UP calcinosis DOID_182 0.01441381 0.08201458 0.01441381 0.14388523 MULLIGHAN_MLL_SIGNATURE_2_UP medulloblastoma DOID_3858 0.01441381 0.08120256 0.01441381 0.14140445 MULLIGHAN_MLL_SIGNATURE_2_UP blood platelet disease DOID_2218 0.01510804 0.08427916 0.17107327 0.49918303 MULLIGHAN_MLL_SIGNATURE_2_UP hepatitis DOID_2237 0.01581641 0.08737415 0.17486002 0.50762935 MULLIGHAN_MLL_SIGNATURE_2_UP congenital diaphragmatic hernia DOID_3827 0.01581641 0.08653402 0.01581641 0.15253454 MULLIGHAN_MLL_SIGNATURE_2_UP peptic ulcer DOID_750 0.01581641 0.08570988 0.17486002 0.50505256 MULLIGHAN_MLL_SIGNATURE_2_UP adult respiratory distress syndrome DOID_11394 0.01653878 0.08877894 0.17862958 0.51333449 MULLIGHAN_MLL_SIGNATURE_2_UP benign mesothelioma DOID_2645 0.01727501 0.09186433 0.18238201 0.51629534 MULLIGHAN_MLL_SIGNATURE_2_UP spinocerebellar ataxia DOID_1441 0.01802497 0.09496486 0.01802497 0.17093676 MULLIGHAN_MLL_SIGNATURE_2_UP Huntington's disease DOID_12858 0.0187885 0.0980794 0.18983582 0.52691014 MULLIGHAN_MLL_SIGNATURE_2_UP primitive neuroectodermal tumor DOID_168 0.0187885 0.09718777 0.0187885 0.17242992 HOFMANN_CELL_LYMPHOMA_DN Sciatic Neuropathy DOID_11446 9.151E-07 5.207E-04 1.677E-04 0.04769783 HOFMANN_CELL_LYMPHOMA_DN lesion of sciatic nerve DOID_12528 9.151E-07 5.207E-04 1.677E-04 0.04769783 HOFMANN_CELL_LYMPHOMA_DN mononeuritis of lower limb DOID_9473 9.151E-07 5.207E-04 1.677E-04 0.04769783 HOFMANN_CELL_LYMPHOMA_DN mononeuritis DOID_1802 1.016E-06 2.891E-04 1.796E-04 0.03405611 HOFMANN_CELL_LYMPHOMA_DN mononeuropathy DOID_1188 1.125E-06 2.133E-04 1.919E-04 0.02729257 HOFMANN_CELL_LYMPHOMA_DN neuritis DOID_1803 4.864E-06 6.919E-04 5.016E-04 0.0570799 HOFMANN_CELL_LYMPHOMA_DN integumentary system cancer DOID_0060122 7.631E-06 8.684E-04 7.631E-06 4.342E-03 HOFMANN_CELL_LYMPHOMA_DN skin cancer DOID_4159 7.631E-06 8.684E-04 7.631E-06 4.342E-03 HOFMANN_CELL_LYMPHOMA_DN bacterial pneumonia DOID_874 2.012E-05 1.908E-03 1.278E-03 0.07273501 HOFMANN_CELL_LYMPHOMA_DN autoimmune disease of urogenital tract DOID_0060049 4.062E-04 0.03301654 0.02926504 0.39647155 HOFMANN_CELL_LYMPHOMA_DN primary biliary cirrhosis DOID_12236 4.062E-04 0.03301654 0.02926504 0.39647155 HOFMANN_CELL_LYMPHOMA_DN influenza DOID_8469 4.432E-04 0.03151949 0.03054643 0.40420743 HOFMANN_CELL_LYMPHOMA_DN integumentary system benign neoplasm DOID_0060121 5.425E-04 0.03429788 5.425E-04 0.05144682 HOFMANN_CELL_LYMPHOMA_DN skin benign neoplasm DOID_3165 5.425E-04 0.03429788 5.425E-04 0.05144682 HOFMANN_CELL_LYMPHOMA_DN hypersensitivity reaction type IV disease DOID_2916 7.46E-04 0.04244619 7.46E-04 0.06063741 HOFMANN_CELL_LYMPHOMA_DN male reproductive system disease DOID_48 1.095E-03 0.05665524 1.095E-03 0.07790095 HOFMANN_CELL_LYMPHOMA_DN diabetic retinopathy DOID_8947 1.155E-03 0.05475467 1.155E-03 0.07300623 HOFMANN_CELL_LYMPHOMA_DN metabolic syndrome X DOID_14221 1.342E-03 0.05875318 0.05270975 0.55540461 HOFMANN_CELL_LYMPHOMA_DN retinal vascular disease DOID_2462 1.509E-03 0.06133231 1.509E-03 0.0780593 HOFMANN_CELL_LYMPHOMA_DN primary bacterial infectious disease DOID_0050338 1.578E-03 0.05987294 0.05708366 0.56983514 HOFMANN_CELL_LYMPHOMA_DN lymphoma DOID_0060058 1.758E-03 0.06252648 1.758E-03 0.08336863 HOFMANN_CELL_LYMPHOMA_DN encephalomyelitis DOID_640 1.795E-03 0.06008976 1.795E-03 0.07857892 HONMA_DOCETAXEL_RESISTANCE lung adenocarcinoma DOID_3910 3.867E-07 2.2E-04 9.584E-05 0.02726529 HONMA_DOCETAXEL_RESISTANCE bone resorption disease DOID_0080011 8.238E-06 2.344E-03 8.238E-06 4.687E-03 HONMA_DOCETAXEL_RESISTANCE osteoporosis DOID_11476 8.238E-06 2.344E-03 8.238E-06 4.687E-03 HONMA_DOCETAXEL_RESISTANCE perinatal necrotizing enterocolitis DOID_8677 9.584E-05 0.01817686 9.584E-05 0.01817686 HONMA_DOCETAXEL_RESISTANCE sarcoma DOID_1115 1.027E-04 0.01460204 0.01493213 0.36940798 HONMA_DOCETAXEL_RESISTANCE pancreatic ductal carcinoma DOID_3587 6.122E-04 0.06967237 0.03596691 0.45478163 HONMA_DOCETAXEL_RESISTANCE pancreatic carcinoma DOID_4905 6.634E-04 0.06290856 0.03741846 0.46285011 HONMA_DOCETAXEL_RESISTANCE mixed glioma DOID_5076 7.346E-04 0.05971542 0.03935064 0.47639394 HONMA_DOCETAXEL_RESISTANCE lymphoma DOID_0060058 1.012E-03 0.07197356 0.04608437 0.53514304 KANG_DOXORUBICIN_RESISTANCE_UP urinary system benign neoplasm DOID_731 1.507E-07 8.574E-05 5.193E-05 5.91E-03 KANG_DOXORUBICIN_RESISTANCE_UP oral cavity cancer DOID_8618 7.831E-06 2.228E-03 7.831E-06 4.456E-03 KANG_DOXORUBICIN_RESISTANCE_UP mixed glioma DOID_5076 1.774E-05 3.364E-03 1.774E-05 5.046E-03 KANG_DOXORUBICIN_RESISTANCE_UP biliary tract cancer DOID_4607 2.128E-05 3.027E-03 2.128E-05 4.036E-03 KANG_DOXORUBICIN_RESISTANCE_UP lymphoma DOID_0060058 2.877E-05 3.274E-03 2.877E-05 4.092E-03 KANG_DOXORUBICIN_RESISTANCE_UP lung oat cell carcinoma DOID_5411 4.013E-05 3.805E-03 9.456E-03 0.24455873 KANG_DOXORUBICIN_RESISTANCE_UP colon carcinoma DOID_1520 7.247E-05 5.891E-03 7.247E-05 6.872E-03 KANG_DOXORUBICIN_RESISTANCE_UP diffuse large B-cell lymphoma DOID_0050745 1.543E-04 0.01097571 1.543E-04 0.01254367 KANG_DOXORUBICIN_RESISTANCE_UP microcephaly DOID_10907 3.102E-04 0.01961341 3.102E-04 0.02206508 KANG_DOXORUBICIN_RESISTANCE_UP adenoid cystic carcinoma DOID_4866 3.414E-04 0.01942378 3.414E-04 0.02158197 KANG_DOXORUBICIN_RESISTANCE_UP salivary gland cancer DOID_8850 3.74E-04 0.01934429 3.74E-04 0.02127872 KANG_DOXORUBICIN_RESISTANCE_UP gallbladder cancer DOID_3121 4.08E-04 0.01934724 4.08E-04 0.02110608 KANG_DOXORUBICIN_RESISTANCE_UP uterine cancer DOID_363 4.08E-04 0.01785899 4.08E-04 0.01934724 KANG_DOXORUBICIN_RESISTANCE_UP lung small cell carcinoma DOID_5409 4.995E-04 0.02030256 0.03241481 0.31800046 KANG_DOXORUBICIN_RESISTANCE_UP B-cell lymphocytic neoplasm DOID_707 5.387E-04 0.02043375 5.387E-04 0.02357741 KANG_DOXORUBICIN_RESISTANCE_UP reproductive organ benign neoplasm DOID_0050622 6.213E-04 0.02209436 6.213E-04 0.0252507 KANG_DOXORUBICIN_RESISTANCE_UP congenital nervous system abnormality DOID_2490 6.647E-04 0.02224935 6.647E-04 0.02521593 KANG_DOXORUBICIN_RESISTANCE_UP pre-malignant neoplasm DOID_0060071 8.037E-04 0.02540629 8.037E-04 0.02858207 KANG_DOXORUBICIN_RESISTANCE_UP in situ carcinoma DOID_8719 8.037E-04 0.02540629 8.037E-04 0.02858207 KANG_DOXORUBICIN_RESISTANCE_UP transitional cell carcinoma DOID_2671 1.487E-03 0.0445257 1.487E-03 0.04976402 MENSE_HYPOXIA_UP nervous system cancer DOID_3093 6.747E-08 3.839E-05 4.931E-03 0.21580599 MENSE_HYPOXIA_UP esophagitis DOID_11963 1.529E-06 4.349E-04 2.357E-04 0.06705011 MENSE_HYPOXIA_UP abdominal aortic aneurysm DOID_7693 7.241E-06 1.373E-03 1.000 1.000 MENSE_HYPOXIA_UP esophageal disease DOID_6050 1.028E-05 1.462E-03 8.161E-04 0.15477948 MENSE_HYPOXIA_UP brain cancer DOID_1319 2.567E-05 2.921E-03 1.000 1.000 MENSE_HYPOXIA_UP central nervous system cancer DOID_3620 2.725E-05 2.584E-03 1.000 1.000 MENSE_HYPOXIA_UP aortic aneurysm DOID_3627 3.06E-05 2.488E-03 1.000 1.000 MENSE_HYPOXIA_UP adrenoleukodystrophy DOID_10588 6.867E-05 4.884E-03 0.0124077 0.47066544 MENSE_HYPOXIA_UP diabetic retinopathy DOID_8947 9.018E-05 5.702E-03 0.0827143 0.73538182 MENSE_HYPOXIA_UP aneurysm disease DOID_2403 1.012E-04 5.759E-03 1.000 1.000 MENSE_HYPOXIA_UP retinal vascular disease DOID_2462 1.348E-04 6.973E-03 0.09411844 0.76504847 MENSE_HYPOXIA_UP urinary system benign neoplasm DOID_731 1.691E-04 8.016E-03 1.691E-04 0.09619521 MENSE_HYPOXIA_UP gastric ulcer DOID_10808 2.861E-04 0.0125233 1.000 1.000 MENSE_HYPOXIA_UP toxic shock syndrome DOID_14115 3.708E-04 0.01506972 0.02798201 0.51360533 MENSE_HYPOXIA_UP commensal bacterial infectious disease DOID_0050339 4.014E-04 0.01522619 0.02908524 0.51717188 MENSE_HYPOXIA_UP portal hypertension DOID_10762 4.014E-04 0.01427455 1.000 1.000 MENSE_HYPOXIA_UP extrinsic allergic alveolitis DOID_841 4.662E-04 0.0156033 1.000 1.000 MENSE_HYPOXIA_UP hepatic vascular disease DOID_272 5.357E-04 0.01693422 1.000 1.000 MENSE_HYPOXIA_UP spindle cell carcinoma DOID_4015 8.161E-04 0.02443887 0.04114028 0.57094679 MENSE_HYPOXIA_UP medullomyoblastoma DOID_3861 8.608E-04 0.02448912 8.608E-04 0.12244562 MENSE_HYPOXIA_UP adult medulloblastoma DOID_3864 8.608E-04 0.02448912 8.608E-04 0.12244562 MENSE_HYPOXIA_UP childhood medulloblastoma DOID_3869 8.608E-04 0.02448912 8.608E-04 0.12244562 MENSE_HYPOXIA_UP medulloblastoma DOID_3858 9.537E-04 0.02584035 9.537E-04 0.10852946 MENSE_HYPOXIA_UP multiple myeloma DOID_9538 9.537E-04 0.02466579 0.04440256 0.5875595 MENSE_HYPOXIA_UP peptic ulcer DOID_750 1.051E-03 0.026006 1.000 1.000 MENSE_HYPOXIA_UP endometriosis of uterus DOID_288 1.206E-03 0.02859468 0.04981563 0.61619768 MENSE_HYPOXIA_UP primitive neuroectodermal tumor DOID_168 1.26E-03 0.02867803 1.26E-03 0.11949178 MENSE_HYPOXIA_UP endometriosis DOID_289 1.26E-03 0.02757503 0.05089464 0.61615004 MENSE_HYPOXIA_UP cerebral infarction DOID_3526 1.371E-03 0.02889813 1.371E-03 0.11146422 MENSE_HYPOXIA_UP learning disability DOID_8927 1.371E-03 0.02786605 0.05304908 0.60369854 MENSE_HYPOXIA_UP leukodystrophy DOID_10579 1.429E-03 0.0280299 0.05412451 0.60385971 MENSE_HYPOXIA_UP myeloma DOID_0070004 1.487E-03 0.02820427 0.05519874 0.60400162 MENSE_HYPOXIA_UP bone marrow disease DOID_4961 1.487E-03 0.02729445 0.05519874 0.58163119 MENSE_HYPOXIA_UP hemolytic anemia DOID_583 1.547E-03 0.02750097 1.547E-03 0.11000388 MENSE_HYPOXIA_UP normocytic anemia DOID_720 1.547E-03 0.02750097 1.547E-03 0.11000388 MENSE_HYPOXIA_UP giant cell tumor DOID_200 1.861E-03 0.03209475 1.000 1.000 MENSE_HYPOXIA_UP malignant giant cell tumor DOID_2705 1.861E-03 0.03209475 1.000 1.000 MENSE_HYPOXIA_UP giant cell glioblastoma DOID_3074 1.861E-03 0.03209475 1.000 1.000 MENSE_HYPOXIA_UP bone marrow cancer DOID_4960 1.928E-03 0.03226035 0.06268509 0.63692524 MENSE_HYPOXIA_UP mitochondrial metabolism disease DOID_700 2.064E-03 0.0335485 0.06481338 0.63584158 MENSE_HYPOXIA_UP glioblastoma DOID_3068 2.204E-03 0.034835 1.000 1.000 MENSE_HYPOXIA_UP neuroectodermal tumor DOID_171 2.423E-03 0.03725806 2.423E-03 0.15317203 MENSE_HYPOXIA_UP carotid artery disease DOID_3407 2.423E-03 0.03627759 0.07011348 0.67617913 MENSE_HYPOXIA_UP collagen disease DOID_854 2.423E-03 0.03534739 1.000 1.000 MENSE_HYPOXIA_UP congenital heart defect DOID_1682 2.574E-03 0.03661635 0.07222529 0.67370806 MENSE_HYPOXIA_UP endocrine pancreas disease DOID_1428 2.651E-03 0.03679602 1.000 1.000 MENSE_HYPOXIA_UP cerebral degeneration DOID_1443 2.73E-03 0.03698184 0.07433242 0.68217982 MENSE_HYPOXIA_UP uterine disease DOID_345 2.73E-03 0.0361218 0.07433242 0.67135156 MENSE_HYPOXIA_UP allergic contact dermatitis DOID_3042 2.89E-03 0.03737017 2.89E-03 0.16442873 MENSE_HYPOXIA_UP brain infarction DOID_3454 2.971E-03 0.03757186 2.971E-03 0.15370307 MENSE_HYPOXIA_UP astrocytoma DOID_3069 3.054E-03 0.0377781 1.000 1.000 MENSE_HYPOXIA_UP pancreatic ductal carcinoma DOID_3587 3.138E-03 0.03798857 1.000 1.000 MENSE_HYPOXIA_UP pancreatic carcinoma DOID_4905 3.396E-03 0.04025262 1.000 1.000 MENSE_HYPOXIA_UP contact dermatitis DOID_2773 3.94E-03 0.04575031 3.94E-03 0.18681376 MENSE_HYPOXIA_UP female reproductive system disease DOID_229 4.034E-03 0.04590941 0.0899876 0.75298444 MENSE_HYPOXIA_UP dilated cardiomyopathy DOID_12930 5.465E-03 0.06096695 0.10436559 0.81347975 OSADA_ASCL1_TARGETS_DN invasive ductal carcinoma DOID_3008 6.816E-07 3.878E-04 0.01727005 0.40944405 OSADA_ASCL1_TARGETS_DN invasive lobular carcinoma DOID_3457 1.762E-05 5.014E-03 1.000 1.000 OSADA_ASCL1_TARGETS_DN papillary adenoma DOID_3172 1.118E-04 0.02121303 1.118E-04 0.0636391 OSADA_ASCL1_TARGETS_DN microcystic adenoma DOID_5403 1.118E-04 0.02121303 1.118E-04 0.0636391 OSADA_ASCL1_TARGETS_DN follicular adenoma DOID_6204 1.118E-04 0.02121303 1.118E-04 0.0636391 OSADA_ASCL1_TARGETS_DN cleft lip DOID_9296 1.118E-04 0.01590977 0.01555594 0.42149187 OSADA_ASCL1_TARGETS_DN leiomyoma DOID_127 1.891E-04 0.02151506 0.02012057 0.35776882 OSADA_ASCL1_TARGETS_DN papilloma DOID_2615 2.001E-04 0.0189772 2.001E-04 0.05693161 OSADA_ASCL1_TARGETS_DN adenoma DOID_657 2.351E-04 0.01911196 2.351E-04 0.04459456 OSADA_ASCL1_TARGETS_DN benign mesothelioma DOID_2645 2.996E-04 0.02131194 0.02523162 0.38802144 OSADA_ASCL1_TARGETS_DN thyroid adenoma DOID_2891 3.872E-04 0.02447934 3.872E-04 0.05507851 OSADA_ASCL1_TARGETS_DN orofacial cleft DOID_0050567 4.686E-04 0.02666058 0.03144391 0.42599018 OSADA_ASCL1_TARGETS_DN pre-malignant neoplasm DOID_0060071 6.742E-04 0.03487383 0.0376184 0.4653233 OSADA_ASCL1_TARGETS_DN in situ carcinoma DOID_8719 6.742E-04 0.03487383 0.0376184 0.4653233 OSADA_ASCL1_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 7.797E-04 0.03696983 7.797E-04 0.0887276 OSADA_ASCL1_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 1.304E-03 0.0570632 1.304E-03 0.12363693 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP focal glomerulosclerosis DOID_3945 2.867E-08 1.631E-05 1.916E-06 1.09E-03 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP temporal lobe epilepsy DOID_3328 5.085E-08 1.447E-05 0.01695312 0.31117175 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP aneurysm disease DOID_2403 1.152E-07 2.185E-05 0.02185557 0.35530909 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP focal epilepsy DOID_2234 1.788E-07 2.543E-05 0.02504475 0.35626157 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP prion disease DOID_649 1.918E-07 2.182E-05 0.05051825 0.39923452 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP transitional cell carcinoma DOID_2671 2.515E-07 2.385E-05 2.265E-03 0.08054167 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP endometrial carcinoma DOID_2871 2.185E-06 1.776E-04 0.08805466 0.48176058 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP endometrial cancer DOID_1380 2.805E-06 1.995E-04 0.09329557 0.4961232 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP mixed glioma DOID_5076 3.627E-06 2.293E-04 1.617E-03 0.07668006 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP polyneuropathy DOID_1389 6.475E-06 3.684E-04 6.258E-04 0.03956467 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP encephalomyelitis DOID_640 8.447E-06 4.369E-04 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP uterine cancer DOID_363 1.048E-05 4.971E-04 0.12664155 0.53377066 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP proteinuria DOID_576 1.24E-05 5.426E-04 0.13166269 0.55085346 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP angiosarcoma DOID_0001816 1.26E-05 5.12E-04 0.0450324 0.37681525 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP glaucoma DOID_1686 1.574E-05 5.969E-04 4.611E-04 0.04372998 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP osteochondrodysplasia DOID_2256 2.434E-05 8.655E-04 6.358E-04 0.03617774 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP brain edema DOID_4724 2.543E-05 8.512E-04 0.05597288 0.41361774 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP oral cavity cancer DOID_8618 2.974E-05 9.4E-04 2.974E-05 8.46E-03 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP gastric ulcer DOID_10808 3.421E-05 1.025E-03 1.822E-03 0.07976019 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP collagen disease DOID_854 3.597E-05 1.023E-03 0.01470431 0.29881252 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP cleft lip DOID_9296 6.431E-05 1.742E-03 6.431E-05 0.01219657 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP diabetic retinopathy DOID_8947 7.073E-05 1.829E-03 1.395E-03 0.07217383 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP sarcoma DOID_1115 8.87E-05 2.194E-03 0.08278373 0.49066606 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP corneal disease DOID_10124 1.079E-04 2.558E-03 3.84E-03 0.11500306 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP bone development disease DOID_0080006 1.145E-04 2.606E-03 1.989E-03 0.08085433 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP age related macular degeneration DOID_10871 1.185E-04 2.592E-03 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP degeneration of macula and posterior pole DOID_2007 1.185E-04 2.592E-03 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP retinal vascular disease DOID_2462 1.198E-04 2.524E-03 2.056E-03 0.07799694 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP spindle cell carcinoma DOID_4015 1.673E-04 3.399E-03 5.108E-03 0.14533297 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP macular degeneration DOID_4448 1.673E-04 3.282E-03 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP hypersensitivity reaction type I disease DOID_1205 1.824E-04 3.459E-03 0.03194755 0.3635631 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP uveitis DOID_13141 2.276E-04 4.177E-03 0.11140486 0.51958495 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP systemic scleroderma DOID_418 2.446E-04 4.349E-03 0.11396247 0.5229407 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP peptic ulcer DOID_750 2.446E-04 4.217E-03 6.543E-03 0.1692168 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP adenoid cystic carcinoma DOID_4866 2.624E-04 4.391E-03 2.624E-04 0.03732422 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP endometriosis of uterus DOID_288 3.004E-04 4.884E-03 7.481E-03 0.185071 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP salivary gland cancer DOID_8850 3.004E-04 4.749E-03 3.004E-04 0.03418992 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP rheumatic disease DOID_1575 3.207E-04 4.932E-03 0.1241202 0.53911749 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP endometriosis DOID_289 3.207E-04 4.802E-03 7.806E-03 0.18507588 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP uveal disease DOID_3480 3.207E-04 4.679E-03 0.1241202 0.5270477 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP scleroderma DOID_419 3.207E-04 4.932E-03 0.1241202 0.53911749 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP retinal vascular occlusion DOID_1729 3.631E-04 5.165E-03 0.02838572 0.38455892 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP keratitis DOID_4677 3.631E-04 5.039E-03 0.02838572 0.36707897 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP cataract DOID_83 3.639E-04 4.93E-03 8.476E-03 0.19291667 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP lens disease DOID_110 4.107E-04 5.434E-03 9.171E-03 0.20069847 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP neuritis DOID_1803 4.107E-04 5.311E-03 0.13416252 0.55317737 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP heart valve disease DOID_4079 4.107E-04 5.193E-03 0.13416252 0.54527483 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP aortic aneurysm DOID_3627 4.878E-04 6.034E-03 0.14161933 0.56350627 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP esophageal carcinoma DOID_1107 5.305E-04 6.423E-03 0.03396632 0.37166987 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP esophagus squamous cell carcinoma DOID_3748 5.305E-04 6.423E-03 0.03396632 0.37166987 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP ocular hypertension DOID_9282 5.305E-04 6.289E-03 0.03396632 0.35790432 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP borderline glaucoma DOID_9283 5.305E-04 6.289E-03 0.03396632 0.35790432 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP orofacial cleft DOID_0050567 5.44E-04 6.317E-03 5.44E-04 0.04421835 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP osteogenesis imperfecta DOID_12347 6.258E-04 7.122E-03 6.258E-04 0.04451025 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP pustulosis of palm and sole DOID_4398 6.358E-04 7.094E-03 0.15390618 0.58773569 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP skeletal system cancer DOID_0060124 8.393E-04 9.184E-03 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP bone cancer DOID_184 8.393E-04 9.184E-03 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP carotid artery disease DOID_3407 8.478E-04 9.102E-03 0.16842057 0.61039048 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP respiratory failure DOID_11162 8.87E-04 9.347E-03 0.17081553 0.61515214 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP pre-malignant neoplasm DOID_0060071 9.273E-04 9.594E-03 0.01558719 0.30583139 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP in situ carcinoma DOID_8719 9.273E-04 9.594E-03 0.01558719 0.30583139 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP uterine disease DOID_345 1.011E-03 0.01027634 0.01649231 0.3128041 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP nephrosis DOID_2527 1.292E-03 0.01289691 0.0193383 0.33343917 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP lipid metabolism disorder DOID_3146 1.736E-03 0.01702969 0.02342758 0.36027824 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP female reproductive system disease DOID_229 1.797E-03 0.01733276 0.02396167 0.35879442 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP hepatitis B DOID_2043 1.822E-03 0.01728137 0.06139645 0.44220986 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP chronic kidney failure DOID_784 1.924E-03 0.01794666 0.21730494 0.70655148 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP sinusitis DOID_0050127 1.992E-03 0.01828235 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP paranasal sinus disease DOID_1352 1.992E-03 0.01828235 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP uremia DOID_4676 1.992E-03 0.01799215 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP pulmonary embolism DOID_9477 1.992E-03 0.01771102 0.06409665 0.44476819 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP Goodpasture syndrome DOID_9808 2.169E-03 0.01898824 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP primary bacterial infectious disease DOID_0050338 2.194E-03 0.01891366 0.22628808 0.73157907 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP amino acid metabolic disorder DOID_9252 2.337E-03 0.01984826 2.337E-03 0.0782255 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP spastic quadriplegia DOID_10970 2.353E-03 0.01969188 0.06947397 0.47060345 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP sphingolipidosis DOID_1927 2.353E-03 0.01940649 0.06947397 0.46506694 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP lymphoblastic leukemia DOID_1037 2.641E-03 0.02146608 2.641E-03 0.08347921 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP Crohn's disease DOID_8778 2.72E-03 0.02180114 0.24176343 0.77282804 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP intracranial aneurysm DOID_10941 2.949E-03 0.02330199 0.07748261 0.4898623 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP middle cerebral artery infarction DOID_3525 2.949E-03 0.02298278 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP seminoma DOID_4440 2.949E-03 0.0226722 0.07748261 0.4844792 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP ulcerative colitis DOID_8577 3.053E-03 0.02316383 0.25046837 0.79175836 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP Sciatic Neuropathy DOID_11446 3.161E-03 0.02366643 0.08013695 0.49030029 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP lesion of sciatic nerve DOID_12528 3.161E-03 0.02366643 0.08013695 0.49030029 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP mononeuritis of lower limb DOID_9473 3.161E-03 0.02366643 0.08013695 0.49030029 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP malaria DOID_12365 3.381E-03 0.02498076 0.08278373 0.48560764 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP mononeuritis DOID_1802 3.381E-03 0.02466049 0.08278373 0.47579739 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP mononeuropathy DOID_1188 3.607E-03 0.02597885 0.08542296 0.47189963 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP spastic cerebral palsy DOID_0050669 4.08E-03 0.02902102 0.09067886 0.49139305 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP germinoma DOID_3304 4.327E-03 0.03039723 0.09329557 0.49152946 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP allergic rhinitis DOID_4481 4.327E-03 0.03002653 0.09329557 0.48702002 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP myocarditis DOID_820 4.841E-03 0.03318901 0.09850665 0.50044894 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP metal metabolism disorder DOID_896 4.841E-03 0.0327939 0.09850665 0.49602019 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP hepatitis C DOID_1883 5.108E-03 0.03419599 0.10110104 0.50023038 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP cleft palate DOID_674 5.949E-03 0.03936238 5.949E-03 0.16119833 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP microcephaly DOID_10907 6.243E-03 0.04082899 0.11140486 0.52387904 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP adult respiratory distress syndrome DOID_11394 6.849E-03 0.04428506 0.11651279 0.53036623 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP intracranial arterial disease DOID_13089 6.849E-03 0.04378747 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP cerebral arterial disease DOID_3527 6.849E-03 0.04378747 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP lymphatic system disease DOID_75 6.849E-03 0.04330095 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP benign mesothelioma DOID_2645 7.162E-03 0.04478074 0.11905584 0.53764106 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP cervix uteri carcinoma in situ DOID_8991 7.162E-03 0.04429399 0.11905584 0.53340766 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP autoimmune disease of urogenital tract DOID_0060049 7.481E-03 0.04577025 0.12159163 0.54051281 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP primary biliary cirrhosis DOID_12236 7.481E-03 0.04577025 0.12159163 0.54051281 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP cerebral infarction DOID_3526 8.476E-03 0.05130762 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP pre-eclampsia DOID_10591 9.171E-03 0.054928 0.13416252 0.55721516 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP brain cancer DOID_1319 9.171E-03 0.05435584 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP thyroid adenoma DOID_2891 9.171E-03 0.05379547 0.13416252 0.54919767 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP central nervous system cancer DOID_3620 9.527E-03 0.05531667 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP giant cell tumor DOID_200 0.01140082 0.06552593 0.14901249 0.58074047 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP malignant giant cell tumor DOID_2705 0.01140082 0.06552593 0.14901249 0.58074047 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP giant cell glioblastoma DOID_3074 0.01140082 0.06552593 0.14901249 0.58074047 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP parasitic protozoa infectious disease DOID_2789 0.01219191 0.06937198 0.15390618 0.59170687 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP familial hyperlipidemia DOID_1168 0.01259624 0.07096299 0.15634256 0.5891319 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP congenital nervous system abnormality DOID_2490 0.01300638 0.07255521 0.15877199 0.5943504 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP retinitis pigmentosa DOID_10584 0.01342229 0.0741484 0.01342229 0.28286243 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP glioblastoma DOID_3068 0.01342229 0.07343544 0.16119448 0.59173974 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP bile duct cancer DOID_4606 0.01342229 0.07273605 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP bile duct carcinoma DOID_4897 0.01342229 0.07273605 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP congenital heart defect DOID_1682 0.01558719 0.08367085 0.17320366 0.61982946 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP mineral metabolism disease DOID_0050032 0.01603699 0.08528079 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP cholestasis DOID_13580 0.01649231 0.08689003 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP parasitic infectious disease DOID_1398 0.01649231 0.08609287 0.17795949 0.62893759 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP endocrine organ benign neoplasm DOID_0060089 0.01789107 0.09254562 0.18504246 0.64200708 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP brain infarction DOID_3454 0.01789107 0.09171187 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP tuberculosis DOID_399 0.01789107 0.09089302 0.18504246 0.63811613 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP astrocytoma DOID_3069 0.01836814 0.09249089 0.18738999 0.64231869 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP blood coagulation disease DOID_1247 0.01885056 0.09408745 0.01885056 0.33518653 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP pancreatic ductal carcinoma DOID_3587 0.01885056 0.0932693 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP bile duct disease DOID_4138 0.0193383 0.09485769 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP male reproductive system disease DOID_48 0.0193383 0.09404694 0.19206496 0.65440096 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP biliary tract disease DOID_9741 0.01983132 0.09562731 1.000 1.000 LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP pancreatic carcinoma DOID_4905 0.02032959 0.09720621 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN breast benign neoplasm DOID_0060082 5.295E-08 3.013E-05 2.676E-05 7.613E-03 FRIDMAN_IMMORTALIZATION_DN thoracic benign neoplasm DOID_0060097 5.295E-08 3.013E-05 2.676E-05 7.613E-03 FRIDMAN_IMMORTALIZATION_DN benign breast phyllodes tumor DOID_1631 5.295E-08 3.013E-05 2.676E-05 7.613E-03 FRIDMAN_IMMORTALIZATION_DN pre-malignant neoplasm DOID_0060071 1.426E-07 4.058E-05 1.431E-05 8.14E-03 FRIDMAN_IMMORTALIZATION_DN in situ carcinoma DOID_8719 1.426E-07 4.058E-05 1.431E-05 8.14E-03 FRIDMAN_IMMORTALIZATION_DN transitional cell carcinoma DOID_2671 4.998E-07 9.479E-05 1.882E-03 0.15298702 FRIDMAN_IMMORTALIZATION_DN nervous system cancer DOID_3093 5.46E-07 7.767E-05 0.06351713 0.4883952 FRIDMAN_IMMORTALIZATION_DN papilloma DOID_2615 2.264E-06 2.577E-04 3.032E-04 0.05749898 FRIDMAN_IMMORTALIZATION_DN cervix uteri carcinoma in situ DOID_8991 4.184E-06 3.968E-04 4.536E-04 0.0645277 FRIDMAN_IMMORTALIZATION_DN brain cancer DOID_1319 6.174E-06 5.019E-04 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN central nervous system cancer DOID_3620 6.557E-06 4.664E-04 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN glaucoma DOID_1686 6.955E-06 4.397E-04 6.336E-04 0.07210463 FRIDMAN_IMMORTALIZATION_DN vulva cancer DOID_1245 3.792E-05 2.157E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN membranoproliferative glomerulonephritis DOID_2920 5.099E-05 2.638E-03 0.01063177 0.35585175 FRIDMAN_IMMORTALIZATION_DN tongue cancer DOID_8649 5.825E-05 2.762E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN subependymal glioma DOID_4843 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN pilocytic astrocytoma DOID_4851 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN subependymal giant cell astrocytoma DOID_5077 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN fibrillary astrocytoma DOID_6726 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN juvenile pilocytic astrocytoma DOID_6811 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN childhood pilocytic astrocytoma DOID_6812 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN gemistocytic astrocytoma DOID_7005 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN childhood cerebral astrocytoma DOID_7007 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN protoplasmic astrocytoma DOID_7008 9.207E-05 4.03E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN benign glioma DOID_0060101 1.118E-04 4.546E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN benign ependymoma DOID_4844 1.118E-04 4.546E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN osteosarcoma DOID_3347 1.571E-04 5.959E-03 0.01835914 0.33697909 FRIDMAN_IMMORTALIZATION_DN papillary adenoma DOID_3172 1.696E-04 6.03E-03 0.01905874 0.33888824 FRIDMAN_IMMORTALIZATION_DN microcystic adenoma DOID_5403 1.696E-04 6.03E-03 0.01905874 0.33888824 FRIDMAN_IMMORTALIZATION_DN follicular adenoma DOID_6204 1.696E-04 6.03E-03 0.01905874 0.33888824 FRIDMAN_IMMORTALIZATION_DN supratentorial cancer DOID_1659 2.243E-04 7.506E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN cerebrum cancer DOID_368 2.243E-04 7.506E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN focal glomerulosclerosis DOID_3945 2.243E-04 7.089E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN germinoma DOID_3304 2.702E-04 8.092E-03 0.02394251 0.32436396 FRIDMAN_IMMORTALIZATION_DN autonomic nervous system neoplasm DOID_2621 2.864E-04 8.149E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN neuroblastoma DOID_769 2.864E-04 8.149E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN adenoma DOID_657 3.561E-04 9.649E-03 0.02741657 0.33191546 FRIDMAN_IMMORTALIZATION_DN embryonal cancer DOID_688 3.747E-04 9.691E-03 0.02810995 0.33322002 FRIDMAN_IMMORTALIZATION_DN multiple myeloma DOID_9538 3.747E-04 9.269E-03 0.02810995 0.32641961 FRIDMAN_IMMORTALIZATION_DN peripheral nervous system neoplasm DOID_1192 3.937E-04 9.334E-03 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN benign mesothelioma DOID_2645 4.536E-04 0.01032443 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN myeloma DOID_0070004 5.859E-04 0.01282135 0.03501764 0.34353508 FRIDMAN_IMMORTALIZATION_DN thyroid adenoma DOID_2891 5.859E-04 0.01234648 0.03501764 0.33771245 FRIDMAN_IMMORTALIZATION_DN lung small cell carcinoma DOID_5409 6.336E-04 0.01287583 0.03639349 0.33947369 FRIDMAN_IMMORTALIZATION_DN bone marrow cancer DOID_4960 7.61E-04 0.0149304 0.03982486 0.35968803 FRIDMAN_IMMORTALIZATION_DN reproductive organ benign neoplasm DOID_0050622 7.878E-04 0.01494161 0.04050972 0.36015674 FRIDMAN_IMMORTALIZATION_DN oral cavity cancer DOID_8618 8.71E-04 0.01598687 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN endocrine organ benign neoplasm DOID_0060089 1.178E-03 0.02093848 0.04937022 0.41311258 FRIDMAN_IMMORTALIZATION_DN astrocytoma DOID_3069 1.211E-03 0.02087493 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN male reproductive system disease DOID_48 1.278E-03 0.02139158 1.278E-03 0.12121894 FRIDMAN_IMMORTALIZATION_DN mixed glioma DOID_5076 1.492E-03 0.02424786 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN lymphoma DOID_0060058 2.05E-03 0.0324091 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN lymphoblastic leukemia DOID_1037 2.094E-03 0.03219719 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.137E-03 0.03200289 1.000 1.000 FRIDMAN_IMMORTALIZATION_DN Paget's disease of bone DOID_5408 7.1E-03 0.09853417 7.1E-03 0.40399011 LEE_LIVER_CANCER_ACOX1_UP diabetic autonomic neuropathy DOID_11503 2.975E-07 1.693E-04 2.443E-05 0.01390042 LEE_LIVER_CANCER_ACOX1_UP autonomic neuropathy DOID_11504 2.975E-07 1.693E-04 2.443E-05 0.01390042 LEE_LIVER_CANCER_ACOX1_UP diabetic polyneuropathy DOID_12785 2.975E-07 1.693E-04 2.443E-05 0.01390042 LEE_LIVER_CANCER_ACOX1_UP diabetic neuropathy DOID_9743 2.975E-07 1.693E-04 2.443E-05 0.01390042 LEE_LIVER_CANCER_ACOX1_UP autonomic nervous system disease DOID_11465 3.832E-07 1.09E-04 2.946E-05 8.38E-03 LEE_LIVER_CANCER_ACOX1_UP allergic contact dermatitis DOID_3042 1.499E-06 2.844E-04 8.091E-05 9.208E-03 LEE_LIVER_CANCER_ACOX1_UP brain infarction DOID_3454 1.588E-06 2.258E-04 0.08094047 0.52335373 LEE_LIVER_CANCER_ACOX1_UP metabolic syndrome X DOID_14221 2.831E-06 3.221E-04 1.296E-04 8.194E-03 LEE_LIVER_CANCER_ACOX1_UP contact dermatitis DOID_2773 2.831E-06 2.684E-04 1.296E-04 7.375E-03 LEE_LIVER_CANCER_ACOX1_UP middle cerebral artery infarction DOID_3525 5.014E-06 4.076E-04 0.03272006 0.44327891 LEE_LIVER_CANCER_ACOX1_UP intracranial arterial disease DOID_13089 1.865E-05 1.327E-03 0.04981563 0.49728234 LEE_LIVER_CANCER_ACOX1_UP cerebral arterial disease DOID_3527 1.865E-05 1.327E-03 0.04981563 0.49728234 LEE_LIVER_CANCER_ACOX1_UP cerebral infarction DOID_3526 2.604E-05 1.646E-03 0.05544823 0.50887163 LEE_LIVER_CANCER_ACOX1_UP lung small cell carcinoma DOID_5409 3.316E-05 1.887E-03 3.316E-05 6.289E-03 LEE_LIVER_CANCER_ACOX1_UP carotid artery disease DOID_3407 6.189E-05 3.201E-03 6.189E-05 8.804E-03 LEE_LIVER_CANCER_ACOX1_UP pancreatic ductal carcinoma DOID_3587 9.17E-05 4.348E-03 9.17E-05 8.697E-03 LEE_LIVER_CANCER_ACOX1_UP pancreatic carcinoma DOID_4905 1.034E-04 4.526E-03 1.034E-04 8.405E-03 LEE_LIVER_CANCER_ACOX1_UP carotid stenosis DOID_13001 1.066E-04 4.331E-03 1.066E-04 7.58E-03 LEE_LIVER_CANCER_ACOX1_UP pulmonary embolism DOID_9477 3.431E-04 0.01301348 1.000 1.000 LEE_LIVER_CANCER_ACOX1_UP diabetic angiopathy DOID_11713 3.74E-04 0.0132992 0.02811068 0.39987443 LEE_LIVER_CANCER_ACOX1_UP toxic encephalopathy DOID_3602 6.267E-04 0.02097707 0.03616306 0.45726181 LEE_LIVER_CANCER_ACOX1_UP adenoid cystic carcinoma DOID_4866 1.206E-03 0.03812624 1.206E-03 0.06238839 LEE_LIVER_CANCER_ACOX1_UP salivary gland cancer DOID_8850 1.32E-03 0.03953987 1.32E-03 0.0626048 LEE_LIVER_CANCER_ACOX1_UP proteinuria DOID_576 1.564E-03 0.04448578 0.05657082 0.50294997 LEE_LIVER_CANCER_ACOX1_UP pustulosis of palm and sole DOID_4398 2.183E-03 0.05914963 0.06661565 0.49226372 LEE_LIVER_CANCER_ACOX1_UP hypertrophic cardiomyopathy DOID_11984 2.411E-03 0.06236566 0.06994063 0.49745275 LEE_LIVER_CANCER_ACOX1_UP oral cavity cancer DOID_8618 2.411E-03 0.05965411 2.411E-03 0.10554188 LEE_LIVER_CANCER_ACOX1_UP blood coagulation disease DOID_1247 3.432E-03 0.08135945 1.000 1.000 LEE_LIVER_CANCER_ACOX1_UP nephrosis DOID_2527 3.524E-03 0.08021428 0.08421555 0.53242939 LEE_LIVER_CANCER_ACOX1_UP peripheral vascular disease DOID_341 3.618E-03 0.07918264 0.0853047 0.521918 LEE_LIVER_CANCER_ACOX1_UP bone resorption disease DOID_0080011 4.005E-03 0.08440371 4.005E-03 0.16277859 LEE_LIVER_CANCER_ACOX1_UP osteoporosis DOID_11476 4.005E-03 0.08440371 4.005E-03 0.16277859 LEE_LIVER_CANCER_ACOX1_UP alcohol abuse DOID_1574 4.62E-03 0.09388246 4.62E-03 0.17524726 LEE_LIVER_CANCER_ACOX1_UP chronic kidney failure DOID_784 4.62E-03 0.09064513 0.09612681 0.5524864 ENK_UV_RESPONSE_EPIDERMIS_DN astrocytoma DOID_3069 1.384E-14 7.877E-12 2.44E-03 0.03154847 ENK_UV_RESPONSE_EPIDERMIS_DN glioblastoma DOID_3068 4.886E-14 1.39E-11 1.323E-03 0.02213871 ENK_UV_RESPONSE_EPIDERMIS_DN transitional cell carcinoma DOID_2671 2.832E-13 5.372E-11 5.454E-07 1.552E-04 ENK_UV_RESPONSE_EPIDERMIS_DN giant cell tumor DOID_200 1.814E-11 2.581E-09 0.07064447 0.29775337 ENK_UV_RESPONSE_EPIDERMIS_DN malignant giant cell tumor DOID_2705 1.814E-11 2.581E-09 0.07064447 0.29775337 ENK_UV_RESPONSE_EPIDERMIS_DN giant cell glioblastoma DOID_3074 1.814E-11 2.581E-09 0.07064447 0.29775337 ENK_UV_RESPONSE_EPIDERMIS_DN ulcerative colitis DOID_8577 2.25E-11 2.561E-09 1.224E-06 1.742E-04 ENK_UV_RESPONSE_EPIDERMIS_DN aneurysm disease DOID_2403 6.271E-10 5.947E-08 3.883E-04 0.01004398 ENK_UV_RESPONSE_EPIDERMIS_DN lipid metabolism disorder DOID_3146 9.123E-10 7.416E-08 4.499E-05 2.327E-03 ENK_UV_RESPONSE_EPIDERMIS_DN chronic kidney failure DOID_784 1.307E-09 9.299E-08 5.442E-04 0.01146846 ENK_UV_RESPONSE_EPIDERMIS_DN hypothyroidism DOID_1459 2.021E-09 1.278E-07 4.201E-08 2.391E-05 ENK_UV_RESPONSE_EPIDERMIS_DN cerebral infarction DOID_3526 3.522E-09 2.004E-07 5.339E-04 0.01168313 ENK_UV_RESPONSE_EPIDERMIS_DN brain infarction DOID_3454 4.521E-09 2.338E-07 2.36E-04 7.898E-03 ENK_UV_RESPONSE_EPIDERMIS_DN metabolic syndrome X DOID_14221 1.651E-08 7.827E-07 4.499E-05 2.56E-03 ENK_UV_RESPONSE_EPIDERMIS_DN intracranial arterial disease DOID_13089 4.079E-08 1.785E-06 3.491E-04 9.458E-03 ENK_UV_RESPONSE_EPIDERMIS_DN cerebral arterial disease DOID_3527 4.079E-08 1.785E-06 3.491E-04 9.458E-03 ENK_UV_RESPONSE_EPIDERMIS_DN nervous system cancer DOID_3093 4.572E-08 1.858E-06 0.51303079 0.92671275 ENK_UV_RESPONSE_EPIDERMIS_DN lymphoma DOID_0060058 5.523E-08 2.095E-06 7.624E-07 1.446E-04 ENK_UV_RESPONSE_EPIDERMIS_DN Huntington's disease DOID_12858 6.641E-08 2.362E-06 2.911E-05 2.366E-03 ENK_UV_RESPONSE_EPIDERMIS_DN gallbladder cancer DOID_3121 7.752E-08 2.595E-06 0.05187234 0.24192919 ENK_UV_RESPONSE_EPIDERMIS_DN endocrine organ benign neoplasm DOID_0060089 8.505E-08 2.689E-06 2.318E-03 0.03217025 ENK_UV_RESPONSE_EPIDERMIS_DN proteinuria DOID_576 1.045E-07 3.129E-06 5.778E-04 0.01174117 ENK_UV_RESPONSE_EPIDERMIS_DN brain cancer DOID_1319 1.207E-07 3.433E-06 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN thyroid adenoma DOID_2891 1.207E-07 3.27E-06 6.242E-04 0.01224723 ENK_UV_RESPONSE_EPIDERMIS_DN central nervous system cancer DOID_3620 1.39E-07 3.594E-06 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN aortic aneurysm DOID_3627 1.826E-07 4.516E-06 8.2E-03 0.07069493 ENK_UV_RESPONSE_EPIDERMIS_DN contact dermatitis DOID_2773 2.646E-07 6.274E-06 3.714E-06 4.227E-04 ENK_UV_RESPONSE_EPIDERMIS_DN integumentary system cancer DOID_0060122 3.445E-07 7.84E-06 9.017E-05 3.947E-03 ENK_UV_RESPONSE_EPIDERMIS_DN skin cancer DOID_4159 3.445E-07 7.84E-06 9.017E-05 3.947E-03 ENK_UV_RESPONSE_EPIDERMIS_DN familial hyperlipidemia DOID_1168 3.883E-07 8.497E-06 0.01099842 0.08572738 ENK_UV_RESPONSE_EPIDERMIS_DN lymphoblastic leukemia DOID_1037 8.27E-07 1.743E-05 9.026E-04 0.01656621 ENK_UV_RESPONSE_EPIDERMIS_DN cervix uteri carcinoma in situ DOID_8991 1.162E-06 2.361E-05 4.88E-03 0.04958211 ENK_UV_RESPONSE_EPIDERMIS_DN allergic contact dermatitis DOID_3042 1.268E-06 2.488E-05 1.821E-05 1.727E-03 ENK_UV_RESPONSE_EPIDERMIS_DN endometriosis of uterus DOID_288 1.332E-06 2.526E-05 5.199E-03 0.05189484 ENK_UV_RESPONSE_EPIDERMIS_DN hyperinsulinism DOID_2018 1.521E-06 2.793E-05 2.911E-05 2.07E-03 ENK_UV_RESPONSE_EPIDERMIS_DN endometriosis DOID_289 1.521E-06 2.705E-05 5.53E-03 0.05424805 ENK_UV_RESPONSE_EPIDERMIS_DN portal hypertension DOID_10762 1.587E-06 2.736E-05 0.01734127 0.11746647 ENK_UV_RESPONSE_EPIDERMIS_DN uterine cancer DOID_363 1.733E-06 2.9E-05 4.924E-04 0.01120602 ENK_UV_RESPONSE_EPIDERMIS_DN bile duct disease DOID_4138 1.854E-06 3.014E-05 0.02014801 0.12461107 ENK_UV_RESPONSE_EPIDERMIS_DN biliary tract disease DOID_9741 2.031E-06 3.211E-05 0.02086958 0.12632756 ENK_UV_RESPONSE_EPIDERMIS_DN middle cerebral artery infarction DOID_3525 2.34E-06 3.599E-05 0.01996514 0.12483698 ENK_UV_RESPONSE_EPIDERMIS_DN intracranial thrombosis DOID_4193 2.43E-06 3.639E-05 4.448E-03 0.04775073 ENK_UV_RESPONSE_EPIDERMIS_DN pancreatitis DOID_4989 3.145E-06 4.589E-05 0.12873554 0.37183008 ENK_UV_RESPONSE_EPIDERMIS_DN integumentary system benign neoplasm DOID_0060121 3.18E-06 4.523E-05 7.249E-04 0.01374862 ENK_UV_RESPONSE_EPIDERMIS_DN skin benign neoplasm DOID_3165 3.18E-06 4.523E-05 7.249E-04 0.01374862 ENK_UV_RESPONSE_EPIDERMIS_DN hepatic vascular disease DOID_272 3.351E-06 4.65E-05 0.02274357 0.1334133 ENK_UV_RESPONSE_EPIDERMIS_DN female reproductive system disease DOID_229 4.03E-06 5.459E-05 4.077E-03 0.04548806 ENK_UV_RESPONSE_EPIDERMIS_DN biliary tract cancer DOID_4607 4.728E-06 6.256E-05 0.1419224 0.38454213 ENK_UV_RESPONSE_EPIDERMIS_DN abdominal aortic aneurysm DOID_7693 5.475E-06 7.08E-05 0.22732689 0.48627443 ENK_UV_RESPONSE_EPIDERMIS_DN Charcot-Marie-Tooth disease DOID_10595 6.378E-06 8.064E-05 2.335E-03 0.0316273 ENK_UV_RESPONSE_EPIDERMIS_DN endometrial cancer DOID_1380 6.378E-06 7.889E-05 2.335E-03 0.03089178 ENK_UV_RESPONSE_EPIDERMIS_DN germinoma DOID_3304 6.378E-06 7.721E-05 0.02874268 0.15725561 ENK_UV_RESPONSE_EPIDERMIS_DN primary bacterial infectious disease DOID_0050338 6.427E-06 7.619E-05 0.15266874 0.39129961 ENK_UV_RESPONSE_EPIDERMIS_DN urinary system benign neoplasm DOID_731 7.894E-06 9.166E-05 0.1243852 0.36294963 ENK_UV_RESPONSE_EPIDERMIS_DN bile duct cancer DOID_4606 8.178E-06 9.307E-05 0.37929523 0.70760323 ENK_UV_RESPONSE_EPIDERMIS_DN bile duct carcinoma DOID_4897 8.178E-06 9.307E-05 0.37929523 0.70760323 ENK_UV_RESPONSE_EPIDERMIS_DN oral cavity cancer DOID_8618 8.178E-06 9.125E-05 1.323E-03 0.02150618 ENK_UV_RESPONSE_EPIDERMIS_DN papilloma DOID_2615 8.532E-06 9.336E-05 0.03195297 0.1683448 ENK_UV_RESPONSE_EPIDERMIS_DN thyroid carcinoma DOID_3963 9.802E-06 1.052E-04 2.98E-03 0.03685743 ENK_UV_RESPONSE_EPIDERMIS_DN carotid artery disease DOID_3407 1.083E-05 1.141E-04 0.08887291 0.32005496 ENK_UV_RESPONSE_EPIDERMIS_DN respiratory failure DOID_11162 1.185E-05 1.226E-04 0.09124081 0.30360245 ENK_UV_RESPONSE_EPIDERMIS_DN granulosa cell tumor DOID_2999 1.27E-05 1.29E-04 0.13796541 0.38107922 ENK_UV_RESPONSE_EPIDERMIS_DN thyroid cancer DOID_1781 1.278E-05 1.276E-04 3.465E-03 0.0410726 ENK_UV_RESPONSE_EPIDERMIS_DN adenoma DOID_657 1.278E-05 1.254E-04 3.465E-03 0.04023438 ENK_UV_RESPONSE_EPIDERMIS_DN pre-malignant neoplasm DOID_0060071 1.295E-05 1.249E-04 0.01487979 0.10717218 ENK_UV_RESPONSE_EPIDERMIS_DN in situ carcinoma DOID_8719 1.295E-05 1.249E-04 0.01487979 0.10717218 ENK_UV_RESPONSE_EPIDERMIS_DN endocrine pancreas disease DOID_1428 1.414E-05 1.341E-04 1.795E-04 6.81E-03 ENK_UV_RESPONSE_EPIDERMIS_DN cholestasis DOID_13580 1.54E-05 1.437E-04 0.09845309 0.31471803 ENK_UV_RESPONSE_EPIDERMIS_DN uterine disease DOID_345 1.54E-05 1.414E-04 0.01611304 0.1104617 ENK_UV_RESPONSE_EPIDERMIS_DN sex cord-gonadal stromal tumor DOID_192 1.578E-05 1.425E-04 0.1446766 0.38288829 ENK_UV_RESPONSE_EPIDERMIS_DN subependymal glioma DOID_4843 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN pilocytic astrocytoma DOID_4851 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN subependymal giant cell astrocytoma DOID_5077 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN fibrillary astrocytoma DOID_6726 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN juvenile pilocytic astrocytoma DOID_6811 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN childhood pilocytic astrocytoma DOID_6812 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN gemistocytic astrocytoma DOID_7005 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN childhood cerebral astrocytoma DOID_7007 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN protoplasmic astrocytoma DOID_7008 1.578E-05 1.403E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN pancreatic ductal carcinoma DOID_3587 2.319E-05 2.03E-04 0.43493069 0.79830826 ENK_UV_RESPONSE_EPIDERMIS_DN benign mesothelioma DOID_2645 2.336E-05 2.014E-04 4.88E-03 0.0504836 ENK_UV_RESPONSE_EPIDERMIS_DN benign glioma DOID_0060101 2.353E-05 1.998E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN benign ependymoma DOID_4844 2.353E-05 1.998E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN nephrosis DOID_2527 2.507E-05 2.098E-04 2.865E-04 8.579E-03 ENK_UV_RESPONSE_EPIDERMIS_DN male reproductive system disease DOID_48 2.507E-05 2.068E-04 0.02014801 0.12327116 ENK_UV_RESPONSE_EPIDERMIS_DN muscle cancer DOID_4045 2.831E-05 2.301E-04 0.16449932 0.4160005 ENK_UV_RESPONSE_EPIDERMIS_DN nephrotic syndrome DOID_1184 2.911E-05 2.333E-04 4.532E-04 0.01121197 ENK_UV_RESPONSE_EPIDERMIS_DN idiopathic generalized epilepsy DOID_1827 2.911E-05 2.301E-04 4.532E-04 0.01074481 ENK_UV_RESPONSE_EPIDERMIS_DN pancreatic carcinoma DOID_4905 2.921E-05 2.276E-04 0.44804477 0.81973464 ENK_UV_RESPONSE_EPIDERMIS_DN meningitis DOID_9471 3.376E-05 2.596E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN bone resorption disease DOID_0080011 3.642E-05 2.763E-04 3.642E-05 2.302E-03 ENK_UV_RESPONSE_EPIDERMIS_DN osteoporosis DOID_11476 3.642E-05 2.763E-04 3.642E-05 2.302E-03 ENK_UV_RESPONSE_EPIDERMIS_DN neuritis DOID_1803 4.387E-05 3.284E-04 0.0579049 0.25943218 ENK_UV_RESPONSE_EPIDERMIS_DN infantile epileptic encephalopathy DOID_2481 5.474E-05 4.045E-04 5.474E-05 2.596E-03 ENK_UV_RESPONSE_EPIDERMIS_DN ankylosing spondylitis DOID_7147 5.474E-05 3.993E-04 1.188E-03 0.02048177 ENK_UV_RESPONSE_EPIDERMIS_DN lung adenocarcinoma DOID_3910 7.318E-05 5.271E-04 1.467E-03 0.0231865 ENK_UV_RESPONSE_EPIDERMIS_DN Charcot-Marie-Tooth disease type 4 DOID_0050541 7.348E-05 5.226E-04 0.08235195 0.31031961 ENK_UV_RESPONSE_EPIDERMIS_DN amino acid metabolic disorder DOID_9252 8.078E-05 5.675E-04 5.65E-03 0.05449374 ENK_UV_RESPONSE_EPIDERMIS_DN bile duct adenocarcinoma DOID_4896 8.293E-05 5.754E-04 0.35956265 0.68197049 ENK_UV_RESPONSE_EPIDERMIS_DN cholangiocarcinoma DOID_4947 8.293E-05 5.754E-04 0.35956265 0.68197049 ENK_UV_RESPONSE_EPIDERMIS_DN coronary stenosis DOID_4248 8.393E-05 5.754E-04 0.02274357 0.13205194 ENK_UV_RESPONSE_EPIDERMIS_DN pustulosis of palm and sole DOID_4398 9.017E-05 6.108E-04 0.01049856 0.08296775 ENK_UV_RESPONSE_EPIDERMIS_DN supratentorial cancer DOID_1659 9.577E-05 6.411E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN cerebrum cancer DOID_368 9.577E-05 6.411E-04 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN islet cell tumor DOID_1799 9.741E-05 6.445E-04 0.0894946 0.30676159 ENK_UV_RESPONSE_EPIDERMIS_DN stomach disease DOID_76 9.741E-05 6.371E-04 0.0894946 0.30310967 ENK_UV_RESPONSE_EPIDERMIS_DN Crohn's disease DOID_8778 1.088E-04 7.033E-04 0.52804857 0.94484162 ENK_UV_RESPONSE_EPIDERMIS_DN corneal disease DOID_10124 1.088E-04 6.955E-04 1.957E-03 0.02930858 ENK_UV_RESPONSE_EPIDERMIS_DN endometrial carcinoma DOID_2871 1.088E-04 6.878E-04 1.957E-03 0.02855708 ENK_UV_RESPONSE_EPIDERMIS_DN parathyroid gland disease DOID_11201 1.259E-04 7.872E-04 0.09658183 0.31583368 ENK_UV_RESPONSE_EPIDERMIS_DN chronic leukemia DOID_1036 1.555E-04 9.619E-04 0.23931559 0.50621029 ENK_UV_RESPONSE_EPIDERMIS_DN chronic lymphocytic leukemia DOID_1040 1.555E-04 9.619E-04 0.23931559 0.50621029 ENK_UV_RESPONSE_EPIDERMIS_DN pleural disease DOID_1532 1.555E-04 9.515E-04 0.23931559 0.50247442 ENK_UV_RESPONSE_EPIDERMIS_DN Zellweger syndrome DOID_905 1.593E-04 9.643E-04 1.593E-04 6.475E-03 ENK_UV_RESPONSE_EPIDERMIS_DN spindle cell carcinoma DOID_4015 1.938E-04 1.161E-03 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN esophageal disease DOID_6050 1.938E-04 1.149E-03 0.03360858 0.17384803 ENK_UV_RESPONSE_EPIDERMIS_DN hyperthyroidism DOID_7998 1.938E-04 1.137E-03 1.938E-04 6.891E-03 ENK_UV_RESPONSE_EPIDERMIS_DN idiopathic pulmonary fibrosis DOID_0050156 1.98E-04 1.15E-03 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN hemangioma DOID_255 1.98E-04 1.138E-03 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN hyperglycemia DOID_4195 2.063E-04 1.174E-03 2.088E-03 0.02969644 ENK_UV_RESPONSE_EPIDERMIS_DN tuberculosis DOID_399 2.36E-04 1.329E-03 0.10581944 0.33083112 ENK_UV_RESPONSE_EPIDERMIS_DN silicosis DOID_10325 2.423E-04 1.352E-03 0.11751535 0.35567145 ENK_UV_RESPONSE_EPIDERMIS_DN chronic myeloid leukemia DOID_8552 2.423E-04 1.338E-03 2.423E-04 7.659E-03 ENK_UV_RESPONSE_EPIDERMIS_DN tongue cancer DOID_8649 2.423E-04 1.326E-03 6.738E-03 0.06184025 ENK_UV_RESPONSE_EPIDERMIS_DN cleft palate DOID_674 2.633E-04 1.427E-03 3.724E-03 0.04238376 ENK_UV_RESPONSE_EPIDERMIS_DN peroxisomal disease DOID_906 2.925E-04 1.57E-03 2.925E-04 8.322E-03 ENK_UV_RESPONSE_EPIDERMIS_DN peripheral vascular disease DOID_341 3.05E-04 1.622E-03 2.83E-03 0.03578827 ENK_UV_RESPONSE_EPIDERMIS_DN diabetic retinopathy DOID_8947 3.244E-04 1.709E-03 0.0216052 0.1280558 ENK_UV_RESPONSE_EPIDERMIS_DN prion disease DOID_649 3.49E-04 1.822E-03 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN adult respiratory distress syndrome DOID_11394 3.491E-04 1.806E-03 0.28544479 0.56200029 ENK_UV_RESPONSE_EPIDERMIS_DN lymphatic system disease DOID_75 3.491E-04 1.789E-03 0.04421061 0.21500717 ENK_UV_RESPONSE_EPIDERMIS_DN syndrome DOID_225 3.661E-04 1.86E-03 0.02311858 0.13287347 ENK_UV_RESPONSE_EPIDERMIS_DN amnestic disorder DOID_10914 4.82E-04 2.427E-03 0.1446766 0.39014684 ENK_UV_RESPONSE_EPIDERMIS_DN esophagitis DOID_11963 4.82E-04 2.406E-03 0.1446766 0.38648349 ENK_UV_RESPONSE_EPIDERMIS_DN colon carcinoma DOID_1520 4.82E-04 2.385E-03 0.1446766 0.38467749 ENK_UV_RESPONSE_EPIDERMIS_DN brain edema DOID_4724 4.82E-04 2.364E-03 0.1446766 0.38111566 ENK_UV_RESPONSE_EPIDERMIS_DN coronary restenosis DOID_4247 5.591E-04 2.719E-03 0.15133571 0.38963809 ENK_UV_RESPONSE_EPIDERMIS_DN retinal vascular disease DOID_2462 6.053E-04 2.919E-03 0.030623 0.16284566 ENK_UV_RESPONSE_EPIDERMIS_DN gastric ulcer DOID_10808 6.436E-04 3.078E-03 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN familial hypercholesterolemia DOID_13810 6.436E-04 3.052E-03 0.01257943 0.09543595 ENK_UV_RESPONSE_EPIDERMIS_DN thrombophilia DOID_2452 6.436E-04 3.027E-03 0.01257943 0.09418022 ENK_UV_RESPONSE_EPIDERMIS_DN muscular atrophy DOID_767 6.436E-04 3.002E-03 0.01257943 0.0929571 ENK_UV_RESPONSE_EPIDERMIS_DN lung small cell carcinoma DOID_5409 7.249E-04 3.353E-03 0.06205492 0.2716096 ENK_UV_RESPONSE_EPIDERMIS_DN sinusitis DOID_0050127 7.359E-04 3.377E-03 0.16449932 0.41785765 ENK_UV_RESPONSE_EPIDERMIS_DN paranasal sinus disease DOID_1352 7.359E-04 3.377E-03 0.16449932 0.41785765 ENK_UV_RESPONSE_EPIDERMIS_DN pulmonary embolism DOID_9477 7.359E-04 3.35E-03 0.16449932 0.4123353 ENK_UV_RESPONSE_EPIDERMIS_DN Human immunodeficiency virus infectious disease DOID_526 7.807E-04 3.525E-03 0.16082973 0.41036824 ENK_UV_RESPONSE_EPIDERMIS_DN B-cell lymphocytic neoplasm DOID_707 8.365E-04 3.748E-03 8.633E-03 0.07224013 ENK_UV_RESPONSE_EPIDERMIS_DN orofacial cleft DOID_0050567 8.967E-04 3.986E-03 9.08E-03 0.07487388 ENK_UV_RESPONSE_EPIDERMIS_DN toxic shock syndrome DOID_14115 9.448E-04 4.168E-03 0.17745943 0.4278577 ENK_UV_RESPONSE_EPIDERMIS_DN sphingolipidosis DOID_1927 9.448E-04 4.136E-03 0.01608902 0.11302039 ENK_UV_RESPONSE_EPIDERMIS_DN alcohol-related neurodevelopmental disorder DOID_0050667 9.462E-04 4.11E-03 0.17183033 0.41604875 ENK_UV_RESPONSE_EPIDERMIS_DN atrophic muscular disease DOID_913 9.598E-04 4.137E-03 9.539E-03 0.07644813 ENK_UV_RESPONSE_EPIDERMIS_DN muscular dystrophy DOID_9884 9.598E-04 4.137E-03 9.539E-03 0.07644813 ENK_UV_RESPONSE_EPIDERMIS_DN hypersensitivity reaction type I disease DOID_1205 9.913E-04 4.241E-03 7.065E-03 0.0638127 ENK_UV_RESPONSE_EPIDERMIS_DN dilated cardiomyopathy DOID_12930 9.913E-04 4.209E-03 0.04027968 0.19929685 ENK_UV_RESPONSE_EPIDERMIS_DN commensal bacterial infectious disease DOID_0050339 1.062E-03 4.476E-03 0.18386416 0.44142914 ENK_UV_RESPONSE_EPIDERMIS_DN spinal muscular atrophy DOID_12377 1.188E-03 4.97E-03 1.188E-03 0.02112183 ENK_UV_RESPONSE_EPIDERMIS_DN papillary adenoma DOID_3172 1.188E-03 4.934E-03 0.01863354 0.12328473 ENK_UV_RESPONSE_EPIDERMIS_DN microcystic adenoma DOID_5403 1.188E-03 4.934E-03 0.01863354 0.12328473 ENK_UV_RESPONSE_EPIDERMIS_DN follicular adenoma DOID_6204 1.188E-03 4.934E-03 0.01863354 0.12328473 ENK_UV_RESPONSE_EPIDERMIS_DN cleft lip DOID_9296 1.188E-03 4.898E-03 0.01863354 0.12186766 ENK_UV_RESPONSE_EPIDERMIS_DN congenital nervous system abnormality DOID_2490 1.244E-03 5.091E-03 0.07959383 0.30600603 ENK_UV_RESPONSE_EPIDERMIS_DN intracranial aneurysm DOID_10941 1.323E-03 5.376E-03 0.01996514 0.1276423 ENK_UV_RESPONSE_EPIDERMIS_DN seminoma DOID_4440 1.323E-03 5.338E-03 0.19652489 0.45272333 ENK_UV_RESPONSE_EPIDERMIS_DN hypertrophic cardiomyopathy DOID_11984 1.323E-03 5.301E-03 0.01203884 0.09256891 ENK_UV_RESPONSE_EPIDERMIS_DN Sciatic Neuropathy DOID_11446 1.467E-03 5.837E-03 0.20278166 0.46153105 ENK_UV_RESPONSE_EPIDERMIS_DN lesion of sciatic nerve DOID_12528 1.467E-03 5.837E-03 0.20278166 0.46153105 ENK_UV_RESPONSE_EPIDERMIS_DN mononeuritis of lower limb DOID_9473 1.467E-03 5.837E-03 0.20278166 0.46153105 ENK_UV_RESPONSE_EPIDERMIS_DN neuroectodermal tumor DOID_171 1.582E-03 6.249E-03 0.08887291 0.32209353 ENK_UV_RESPONSE_EPIDERMIS_DN pleurisy DOID_10247 1.621E-03 6.36E-03 0.20898987 0.46817022 ENK_UV_RESPONSE_EPIDERMIS_DN mononeuritis DOID_1802 1.621E-03 6.316E-03 0.20898987 0.46451264 ENK_UV_RESPONSE_EPIDERMIS_DN invasive ductal carcinoma DOID_3008 1.621E-03 6.273E-03 0.20898987 0.46270519 ENK_UV_RESPONSE_EPIDERMIS_DN autoimmune disease of the nervous system DOID_438 1.621E-03 6.231E-03 0.20898987 0.46091176 ENK_UV_RESPONSE_EPIDERMIS_DN autoimmune disease of endocrine system DOID_0060005 1.784E-03 6.813E-03 1.784E-03 0.0274356 ENK_UV_RESPONSE_EPIDERMIS_DN mononeuropathy DOID_1188 1.784E-03 6.767E-03 0.21514989 0.46904326 ENK_UV_RESPONSE_EPIDERMIS_DN mineral metabolism disease DOID_0050032 1.874E-03 7.06E-03 0.01548946 0.1101688 ENK_UV_RESPONSE_EPIDERMIS_DN allergic rhinitis DOID_4481 2.335E-03 8.739E-03 0.23334459 0.49542191 ENK_UV_RESPONSE_EPIDERMIS_DN blood coagulation disease DOID_1247 2.565E-03 9.541E-03 0.01944048 0.1257004 ENK_UV_RESPONSE_EPIDERMIS_DN hyperparathyroidism DOID_13543 2.606E-03 9.628E-03 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN familial combined hyperlipidemia DOID_13809 2.606E-03 9.566E-03 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN retinal vascular occlusion DOID_1729 2.606E-03 9.505E-03 0.07515347 0.30764261 ENK_UV_RESPONSE_EPIDERMIS_DN insulinoma DOID_3892 2.606E-03 9.444E-03 0.07515347 0.30114312 ENK_UV_RESPONSE_EPIDERMIS_DN keratitis DOID_4677 2.606E-03 9.384E-03 0.07515347 0.29696058 ENK_UV_RESPONSE_EPIDERMIS_DN hair disease DOID_421 2.754E-03 9.855E-03 0.03195297 0.16680035 ENK_UV_RESPONSE_EPIDERMIS_DN pneumoconiosis DOID_10316 2.98E-03 0.01059651 0.25111889 0.51770525 ENK_UV_RESPONSE_EPIDERMIS_DN nephroblastoma DOID_2154 2.98E-03 0.01053069 0.25111889 0.51213852 ENK_UV_RESPONSE_EPIDERMIS_DN familial adenomatous polyposis DOID_0050424 3.169E-03 0.01112933 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN breast benign neoplasm DOID_0060082 3.169E-03 0.01106105 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN thoracic benign neoplasm DOID_0060097 3.169E-03 0.01106105 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN benign breast phyllodes tumor DOID_1631 3.169E-03 0.01106105 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN chronic monocytic leukemia DOID_8593 3.169E-03 0.01099361 3.169E-03 0.03836068 ENK_UV_RESPONSE_EPIDERMIS_DN medullomyoblastoma DOID_3861 3.217E-03 0.01109253 0.03529702 0.17932149 ENK_UV_RESPONSE_EPIDERMIS_DN adult medulloblastoma DOID_3864 3.217E-03 0.01109253 0.03529702 0.17932149 ENK_UV_RESPONSE_EPIDERMIS_DN childhood medulloblastoma DOID_3869 3.217E-03 0.01109253 0.03529702 0.17932149 ENK_UV_RESPONSE_EPIDERMIS_DN electroclinical syndrome DOID_0050701 3.573E-03 0.01224803 0.12873554 0.37372717 ENK_UV_RESPONSE_EPIDERMIS_DN medulloblastoma DOID_3858 3.724E-03 0.01268975 0.03876996 0.19350972 ENK_UV_RESPONSE_EPIDERMIS_DN neonatoal period electroclinical syndrome DOID_0050702 3.783E-03 0.01281225 0.0894946 0.32026682 ENK_UV_RESPONSE_EPIDERMIS_DN beta thalassemia DOID_12241 3.783E-03 0.01273643 0.0894946 0.31433595 ENK_UV_RESPONSE_EPIDERMIS_DN peritonitis DOID_8283 3.783E-03 0.01266151 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN microcephaly DOID_10907 3.996E-03 0.01329513 0.2741807 0.54932682 ENK_UV_RESPONSE_EPIDERMIS_DN uveitis DOID_13141 3.996E-03 0.01321783 0.2741807 0.54548538 ENK_UV_RESPONSE_EPIDERMIS_DN peptic ulcer DOID_750 4.278E-03 0.01407172 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN mental depression DOID_1596 4.438E-03 0.01451435 0.02885747 0.15637998 ENK_UV_RESPONSE_EPIDERMIS_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 4.448E-03 0.01446165 4.448E-03 0.04866901 ENK_UV_RESPONSE_EPIDERMIS_DN carotid stenosis DOID_13001 4.448E-03 0.01437948 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN larynx cancer DOID_2596 4.448E-03 0.01429824 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN laryngeal benign neoplasm DOID_2598 4.448E-03 0.01429824 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN monocytic leukemia DOID_8527 4.448E-03 0.01421791 4.448E-03 0.04686645 ENK_UV_RESPONSE_EPIDERMIS_DN adenoid cystic carcinoma DOID_4866 4.573E-03 0.01453682 0.04421061 0.21686068 ENK_UV_RESPONSE_EPIDERMIS_DN bone development disease DOID_0080006 4.627E-03 0.01462642 0.02973327 0.15960593 ENK_UV_RESPONSE_EPIDERMIS_DN pulmonary emphysema DOID_9675 4.88E-03 0.01534032 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN Legionnaires' disease DOID_10457 5.163E-03 0.01613999 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN legionellosis DOID_10458 5.163E-03 0.01613999 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN rhabdomyosarcoma DOID_3247 5.163E-03 0.01605179 0.10361408 0.32753563 ENK_UV_RESPONSE_EPIDERMIS_DN polycystic kidney disease DOID_898 5.163E-03 0.01596456 0.10361408 0.32572604 ENK_UV_RESPONSE_EPIDERMIS_DN bacterial meningitis DOID_9470 5.163E-03 0.01587826 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN salivary gland cancer DOID_8850 5.199E-03 0.01590326 0.04798513 0.22944152 ENK_UV_RESPONSE_EPIDERMIS_DN primitive neuroectodermal tumor DOID_168 5.53E-03 0.0168256 0.04991493 0.23667995 ENK_UV_RESPONSE_EPIDERMIS_DN uveal disease DOID_3480 5.53E-03 0.0167361 0.30201509 0.5905381 ENK_UV_RESPONSE_EPIDERMIS_DN diabetic autonomic neuropathy DOID_11503 5.873E-03 0.01768155 0.05187234 0.24392861 ENK_UV_RESPONSE_EPIDERMIS_DN autonomic neuropathy DOID_11504 5.873E-03 0.01768155 0.05187234 0.24392861 ENK_UV_RESPONSE_EPIDERMIS_DN diabetic polyneuropathy DOID_12785 5.873E-03 0.01768155 0.05187234 0.24392861 ENK_UV_RESPONSE_EPIDERMIS_DN influenza DOID_8469 5.873E-03 0.01758848 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN diabetic neuropathy DOID_9743 5.873E-03 0.01768155 0.05187234 0.24392861 ENK_UV_RESPONSE_EPIDERMIS_DN peripheral neuropathy DOID_0060053 5.926E-03 0.0176548 0.11059178 0.34386188 ENK_UV_RESPONSE_EPIDERMIS_DN skeletal system cancer DOID_0060124 5.926E-03 0.01756284 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN thalassemia DOID_10241 5.926E-03 0.01747184 0.11059178 0.34199306 ENK_UV_RESPONSE_EPIDERMIS_DN bone cancer DOID_184 5.926E-03 0.01756284 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN corneal dystrophy DOID_2566 5.926E-03 0.01738178 5.926E-03 0.0562011 ENK_UV_RESPONSE_EPIDERMIS_DN arthropathy DOID_381 5.926E-03 0.01729265 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN skeletal muscle cancer DOID_4043 5.926E-03 0.01720442 0.11059178 0.33831572 ENK_UV_RESPONSE_EPIDERMIS_DN intermediate coronary syndrome DOID_8805 5.926E-03 0.01711709 0.11059178 0.33650655 ENK_UV_RESPONSE_EPIDERMIS_DN leukodystrophy DOID_10579 6.598E-03 0.01895991 6.598E-03 0.06154199 ENK_UV_RESPONSE_EPIDERMIS_DN angiosarcoma DOID_0001816 6.738E-03 0.01926681 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN pre-eclampsia DOID_10591 6.979E-03 0.01985506 0.3235146 0.62612179 ENK_UV_RESPONSE_EPIDERMIS_DN autonomic nervous system disease DOID_11465 6.979E-03 0.01975628 0.0579049 0.26149116 ENK_UV_RESPONSE_EPIDERMIS_DN heart valve disease DOID_4079 6.979E-03 0.01965848 0.3235146 0.62399935 ENK_UV_RESPONSE_EPIDERMIS_DN vascular skin disease DOID_9540 6.979E-03 0.01956164 0.0579049 0.25740536 ENK_UV_RESPONSE_EPIDERMIS_DN hemolytic anemia DOID_583 7.373E-03 0.020565 0.05996742 0.26450747 ENK_UV_RESPONSE_EPIDERMIS_DN normocytic anemia DOID_720 7.373E-03 0.020565 0.05996742 0.26450747 ENK_UV_RESPONSE_EPIDERMIS_DN lymphatic system cancer DOID_0060073 7.598E-03 0.02108837 0.1243852 0.36671076 ENK_UV_RESPONSE_EPIDERMIS_DN Graves' disease DOID_12361 7.598E-03 0.020986 7.598E-03 0.06754869 ENK_UV_RESPONSE_EPIDERMIS_DN hyperostosis DOID_205 7.598E-03 0.02088462 7.598E-03 0.06650948 ENK_UV_RESPONSE_EPIDERMIS_DN bronchitis DOID_6132 7.598E-03 0.02078421 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN reticulosarcoma DOID_8538 7.598E-03 0.02108837 0.1243852 0.36671076 ENK_UV_RESPONSE_EPIDERMIS_DN lymphosarcoma DOID_8675 7.598E-03 0.02108837 0.1243852 0.36671076 ENK_UV_RESPONSE_EPIDERMIS_DN pulmonary tuberculosis DOID_2957 7.78E-03 0.02118115 0.33401555 0.63776796 ENK_UV_RESPONSE_EPIDERMIS_DN movement disease DOID_480 8.2E-03 0.02221841 0.06416687 0.2765981 ENK_UV_RESPONSE_EPIDERMIS_DN male reproductive organ benign neoplasm DOID_0060087 8.504E-03 0.02293215 0.13120175 0.37703937 ENK_UV_RESPONSE_EPIDERMIS_DN keratosis DOID_161 8.504E-03 0.02282398 8.504E-03 0.07221916 ENK_UV_RESPONSE_EPIDERMIS_DN withdrawal disorder DOID_0060001 8.633E-03 0.02306258 0.06630278 0.28365624 ENK_UV_RESPONSE_EPIDERMIS_DN hemorrhagic disease DOID_2213 8.633E-03 0.02295481 0.06630278 0.2815394 ENK_UV_RESPONSE_EPIDERMIS_DN dissociative disorder DOID_10935 9.456E-03 0.02502492 0.13796541 0.38481529 ENK_UV_RESPONSE_EPIDERMIS_DN dissociative amnesia DOID_11037 9.456E-03 0.02502492 0.13796541 0.38481529 ENK_UV_RESPONSE_EPIDERMIS_DN Down syndrome DOID_14250 9.456E-03 0.02490906 9.456E-03 0.07686225 ENK_UV_RESPONSE_EPIDERMIS_DN testicular cancer DOID_2998 9.456E-03 0.02479427 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN sarcoidosis DOID_11335 9.539E-03 0.02489824 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN bone marrow cancer DOID_4960 0.01001218 0.02601338 0.35956265 0.67970481 ENK_UV_RESPONSE_EPIDERMIS_DN vasculitis DOID_865 0.01001218 0.02589514 0.07284928 0.30478854 ENK_UV_RESPONSE_EPIDERMIS_DN pulmonary edema DOID_11396 0.01045291 0.02691268 0.1446766 0.38830652 ENK_UV_RESPONSE_EPIDERMIS_DN amyloidosis DOID_9120 0.01045291 0.02679145 0.1446766 0.37761919 ENK_UV_RESPONSE_EPIDERMIS_DN reproductive organ benign neoplasm DOID_0050622 0.01049856 0.02678779 0.07507609 0.31181239 ENK_UV_RESPONSE_EPIDERMIS_DN Kawasaki disease DOID_13378 0.01149436 0.02919773 0.15133571 0.39319643 ENK_UV_RESPONSE_EPIDERMIS_DN lymphadenitis DOID_1602 0.01149436 0.02919773 0.15133571 0.39319643 ENK_UV_RESPONSE_EPIDERMIS_DN lymph node disease DOID_9942 0.01149436 0.02919773 0.15133571 0.39319643 ENK_UV_RESPONSE_EPIDERMIS_DN hypersensitivity reaction type IV disease DOID_2916 0.01203884 0.03044489 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN hepatitis B DOID_2043 0.01257943 0.03167122 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN neurotic disorder DOID_4964 0.0131339 0.03292155 0.08652382 0.31559008 ENK_UV_RESPONSE_EPIDERMIS_DN myasthenia gravis DOID_437 0.01370738 0.03420834 0.16449932 0.41415979 ENK_UV_RESPONSE_EPIDERMIS_DN urinary tract obstruction DOID_5200 0.01370738 0.03405895 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN polyarteritis nodosa DOID_9810 0.01370738 0.03391087 0.16449932 0.41052681 ENK_UV_RESPONSE_EPIDERMIS_DN diabetic angiopathy DOID_11713 0.01487748 0.03664627 0.01487748 0.10852934 ENK_UV_RESPONSE_EPIDERMIS_DN synostosis DOID_11971 0.01487748 0.03648831 0.17100462 0.42121917 ENK_UV_RESPONSE_EPIDERMIS_DN acute pancreatitis DOID_2913 0.01608902 0.03929035 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN cerebral degeneration DOID_1443 0.01611304 0.03918086 0.01611304 0.11180879 ENK_UV_RESPONSE_EPIDERMIS_DN temporal lobe epilepsy DOID_3328 0.01675056 0.04055774 0.41696098 0.7702948 ENK_UV_RESPONSE_EPIDERMIS_DN autosomal dominant nonsyndromic deafness DOID_0050564 0.01863354 0.04492579 0.01863354 0.12473514 ENK_UV_RESPONSE_EPIDERMIS_DN cystitis DOID_1679 0.01863354 0.04473623 0.19021918 0.44725089 ENK_UV_RESPONSE_EPIDERMIS_DN neuromuscular junction disease DOID_439 0.01863354 0.04454826 0.19021918 0.44541035 ENK_UV_RESPONSE_EPIDERMIS_DN vitiligo DOID_12306 0.01996514 0.04753207 0.01996514 0.12622405 ENK_UV_RESPONSE_EPIDERMIS_DN fragments of torsion dystonia DOID_531 0.01996514 0.04733402 0.19652489 0.449087 ENK_UV_RESPONSE_EPIDERMIS_DN diffuse large B-cell lymphoma DOID_0050745 0.02133537 0.05037273 0.02133537 0.12778766 ENK_UV_RESPONSE_EPIDERMIS_DN perinatal necrotizing enterocolitis DOID_8677 0.02133537 0.05016458 0.20278166 0.45786811 ENK_UV_RESPONSE_EPIDERMIS_DN renal hypertension DOID_1073 0.02274357 0.05325552 0.20898987 0.46633425 ENK_UV_RESPONSE_EPIDERMIS_DN secondary hypertension DOID_11130 0.02274357 0.05325552 0.20898987 0.46633425 ENK_UV_RESPONSE_EPIDERMIS_DN sarcoma DOID_1115 0.02274357 0.05303726 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN central nervous system hereditary degenerative disease DOID_481 0.02274357 0.05282078 0.20898987 0.45736629 ENK_UV_RESPONSE_EPIDERMIS_DN cystic fibrosis DOID_1485 0.02311858 0.05347347 0.45661853 0.83274341 ENK_UV_RESPONSE_EPIDERMIS_DN endogenous depression DOID_1595 0.02311858 0.05325698 0.12354606 0.36613388 ENK_UV_RESPONSE_EPIDERMIS_DN polycystic ovary syndrome DOID_11612 0.02418905 0.05549827 0.02418905 0.13763571 ENK_UV_RESPONSE_EPIDERMIS_DN multiple epiphyseal dysplasia DOID_12721 0.02418905 0.05527539 0.02418905 0.13627298 ENK_UV_RESPONSE_EPIDERMIS_DN dystonic disease DOID_544 0.02418905 0.05505428 0.21514989 0.46725302 ENK_UV_RESPONSE_EPIDERMIS_DN mixed glioma DOID_5076 0.02468816 0.05596638 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN bacterial pneumonia DOID_874 0.02468816 0.0557443 0.46505956 0.84542776 ENK_UV_RESPONSE_EPIDERMIS_DN dysostosis DOID_1934 0.02567117 0.05773476 0.22126211 0.4768869 ENK_UV_RESPONSE_EPIDERMIS_DN chromosomal disease DOID_0080014 0.02714775 0.06081523 0.02714775 0.15144185 ENK_UV_RESPONSE_EPIDERMIS_DN spastic cerebral palsy DOID_0050669 0.02718926 0.06066936 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN age related macular degeneration DOID_10871 0.02718926 0.06043237 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN degeneration of macula and posterior pole DOID_2007 0.02718926 0.06043237 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN bronchiolitis obliterans DOID_2799 0.02718926 0.06019723 0.22732689 0.48810943 ENK_UV_RESPONSE_EPIDERMIS_DN auditory system disease DOID_2742 0.02799562 0.06174228 0.02799562 0.15465541 ENK_UV_RESPONSE_EPIDERMIS_DN focal epilepsy DOID_2234 0.02885747 0.06339729 0.48559477 0.87994721 ENK_UV_RESPONSE_EPIDERMIS_DN autonomic nervous system neoplasm DOID_2621 0.03033079 0.06637777 0.23931559 0.50062709 ENK_UV_RESPONSE_EPIDERMIS_DN bladder disease DOID_365 0.03033079 0.06612345 0.23931559 0.49879329 ENK_UV_RESPONSE_EPIDERMIS_DN neuroblastoma DOID_769 0.03033079 0.06637777 0.23931559 0.50062709 ENK_UV_RESPONSE_EPIDERMIS_DN myocarditis DOID_820 0.03195297 0.06939404 0.24524023 0.50927625 ENK_UV_RESPONSE_EPIDERMIS_DN metal metabolism disorder DOID_896 0.03195297 0.06913018 0.24524023 0.50742434 ENK_UV_RESPONSE_EPIDERMIS_DN male infertility DOID_12336 0.03360858 0.07243668 0.25111889 0.51583627 ENK_UV_RESPONSE_EPIDERMIS_DN macular degeneration DOID_4448 0.03360858 0.07216333 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN primary immunodeficiency disease DOID_612 0.03432067 0.07341527 0.03432067 0.1759321 ENK_UV_RESPONSE_EPIDERMIS_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.03701768 0.07888787 0.03701768 0.18639878 ENK_UV_RESPONSE_EPIDERMIS_DN encephalomyelitis DOID_640 0.03823876 0.08118602 0.52433796 0.94414019 ENK_UV_RESPONSE_EPIDERMIS_DN pulmonary sarcoidosis DOID_13406 0.03876996 0.08200784 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN multiple myeloma DOID_9538 0.03876996 0.0817041 0.26848247 0.53981104 ENK_UV_RESPONSE_EPIDERMIS_DN mouth disease DOID_403 0.03925243 0.08241562 0.52804857 0.94782219 ENK_UV_RESPONSE_EPIDERMIS_DN peripheral nervous system neoplasm DOID_1192 0.04055326 0.08483385 0.2741807 0.54739936 ENK_UV_RESPONSE_EPIDERMIS_DN respiratory syncytial virus infectious disease DOID_1273 0.04236701 0.0883034 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN hepatitis DOID_2237 0.04236701 0.08798112 0.27983469 0.55286784 ENK_UV_RESPONSE_EPIDERMIS_DN systemic scleroderma DOID_418 0.04236701 0.08766119 1.000 1.000 ENK_UV_RESPONSE_EPIDERMIS_DN spinocerebellar ataxia DOID_1441 0.04798513 0.09892587 0.04798513 0.23138594 LINDSTEDT_DENDRITIC_CELL_MATURATION_B Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.202E-07 6.838E-05 4.616E-05 0.01313297 LINDSTEDT_DENDRITIC_CELL_MATURATION_B Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.202E-07 6.838E-05 4.616E-05 0.01313297 LINDSTEDT_DENDRITIC_CELL_MATURATION_B Hodgkin's granuloma DOID_8651 1.202E-07 6.838E-05 4.616E-05 0.01313297 LINDSTEDT_DENDRITIC_CELL_MATURATION_B Hodgkin's lymphoma, mixed cellularity DOID_8654 1.202E-07 6.838E-05 4.616E-05 0.01313297 LINDSTEDT_DENDRITIC_CELL_MATURATION_B Hodgkin's lymphoma DOID_8567 2.2E-07 6.259E-05 6.762E-05 0.01282443 LINDSTEDT_DENDRITIC_CELL_MATURATION_B pustulosis of palm and sole DOID_4398 3.897E-07 7.39E-05 2.986E-05 0.01699158 LINDSTEDT_DENDRITIC_CELL_MATURATION_B primary immunodeficiency disease DOID_612 2.396E-06 3.408E-04 3.986E-03 0.28347561 LINDSTEDT_DENDRITIC_CELL_MATURATION_B autoimmune disease of urogenital tract DOID_0060049 1.386E-05 1.577E-03 9.927E-04 0.14121383 LINDSTEDT_DENDRITIC_CELL_MATURATION_B primary biliary cirrhosis DOID_12236 1.386E-05 1.577E-03 9.927E-04 0.14121383 LINDSTEDT_DENDRITIC_CELL_MATURATION_B myeloma DOID_0070004 1.908E-05 1.809E-03 0.05019259 0.50104529 LINDSTEDT_DENDRITIC_CELL_MATURATION_B bone marrow cancer DOID_4960 2.834E-05 2.303E-03 0.05702067 0.52330257 LINDSTEDT_DENDRITIC_CELL_MATURATION_B electroclinical syndrome DOID_0050701 7.828E-05 5.568E-03 3.098E-03 0.25178752 LINDSTEDT_DENDRITIC_CELL_MATURATION_B open-angle glaucoma DOID_1067 9.311E-05 5.886E-03 0.01430868 0.45231332 LINDSTEDT_DENDRITIC_CELL_MATURATION_B renovascular hypertension DOID_1591 1.074E-04 6.109E-03 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_B Human immunodeficiency virus infectious disease DOID_526 1.186E-04 6.137E-03 4.072E-03 0.25741117 LINDSTEDT_DENDRITIC_CELL_MATURATION_B lymphoma DOID_0060058 1.264E-04 5.996E-03 4.246E-03 0.24159576 LINDSTEDT_DENDRITIC_CELL_MATURATION_B severe combined immunodeficiency DOID_627 3.048E-04 0.01333897 0.02541108 0.46641631 LINDSTEDT_DENDRITIC_CELL_MATURATION_B combined T cell and B cell immunodeficiency DOID_628 3.299E-04 0.01340965 0.02641433 0.46967976 LINDSTEDT_DENDRITIC_CELL_MATURATION_B vitiligo DOID_12306 3.832E-04 0.01453778 0.0284178 0.47558026 LINDSTEDT_DENDRITIC_CELL_MATURATION_B juvenile myoclonic epilepsy DOID_4890 3.832E-04 0.01362917 0.0284178 0.44915913 LINDSTEDT_DENDRITIC_CELL_MATURATION_B renal hypertension DOID_1073 4.405E-04 0.01474258 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_B secondary hypertension DOID_11130 4.405E-04 0.01474258 1.000 1.000 LINDSTEDT_DENDRITIC_CELL_MATURATION_B abdominal aortic aneurysm DOID_7693 5.336E-04 0.01686739 0.03340893 0.48742767 LINDSTEDT_DENDRITIC_CELL_MATURATION_B leukopenia DOID_615 6.713E-04 0.02010383 0.03738383 0.5064619 LINDSTEDT_DENDRITIC_CELL_MATURATION_B adenoma DOID_657 7.459E-04 0.0212218 0.03936531 0.50906499 LINDSTEDT_DENDRITIC_CELL_MATURATION_B adolescence-adult electroclinical syndrome DOID_0050705 7.847E-04 0.02126117 0.04035455 0.51026091 LINDSTEDT_DENDRITIC_CELL_MATURATION_B multiple myeloma DOID_9538 7.847E-04 0.02029476 0.04035455 0.49916828 LINDSTEDT_DENDRITIC_CELL_MATURATION_B systemic scleroderma DOID_418 8.65E-04 0.02140047 0.04233007 0.51246404 LINDSTEDT_DENDRITIC_CELL_MATURATION_B spinocerebellar ataxia DOID_1441 9.927E-04 0.02353564 9.927E-04 0.11297107 LINDSTEDT_DENDRITIC_CELL_MATURATION_B rheumatic disease DOID_1575 1.037E-03 0.02360589 0.04626922 0.50629207 LINDSTEDT_DENDRITIC_CELL_MATURATION_B scleroderma DOID_419 1.037E-03 0.02360589 0.04626922 0.50629207 LINDSTEDT_DENDRITIC_CELL_MATURATION_B influenza DOID_8469 1.083E-03 0.02369139 0.04725154 0.48010941 LINDSTEDT_DENDRITIC_CELL_MATURATION_B spinocerebellar degeneration DOID_2478 1.176E-03 0.02478666 1.176E-03 0.11153997 LINDSTEDT_DENDRITIC_CELL_MATURATION_B glaucoma DOID_1686 1.324E-03 0.02689765 0.05214837 0.50292239 LINDSTEDT_DENDRITIC_CELL_MATURATION_B aortic aneurysm DOID_3627 1.375E-03 0.02697108 0.05312478 0.50380004 LINDSTEDT_DENDRITIC_CELL_MATURATION_B leukocyte disease DOID_9500 1.875E-03 0.03556985 0.06186856 0.55005016 LINDSTEDT_DENDRITIC_CELL_MATURATION_B collagen disease DOID_854 1.997E-03 0.03665028 0.06380091 0.55850334 LINDSTEDT_DENDRITIC_CELL_MATURATION_B uterine disease DOID_345 2.25E-03 0.04001529 0.06765398 0.56610464 LINDSTEDT_DENDRITIC_CELL_MATURATION_B aneurysm disease DOID_2403 3.022E-03 0.05210798 0.07817043 0.63541395 LINDSTEDT_DENDRITIC_CELL_MATURATION_B pancreatitis DOID_4989 3.098E-03 0.05183861 0.07912072 0.63408016 LINDSTEDT_DENDRITIC_CELL_MATURATION_B bacterial pneumonia DOID_874 3.098E-03 0.0503575 0.07912072 0.62527349 LINDSTEDT_DENDRITIC_CELL_MATURATION_B female reproductive system disease DOID_229 3.329E-03 0.0526212 0.08196587 0.63888465 LINDSTEDT_DENDRITIC_CELL_MATURATION_B encephalomyelitis DOID_640 4.334E-03 0.06665722 1.000 1.000 KAUFFMANN_DNA_REPAIR_GENES Fanconi's anemia DOID_13636 5.441E-27 3.096E-24 5.441E-27 3.096E-24 KAUFFMANN_DNA_REPAIR_GENES bone marrow disease DOID_4961 2.746E-23 7.812E-21 3.165E-21 6.002E-19 KAUFFMANN_DNA_REPAIR_GENES aplastic anemia DOID_12449 5.009E-23 9.5E-21 7.569E-21 1.077E-18 KAUFFMANN_DNA_REPAIR_GENES congenital hypoplastic anemia DOID_1342 8.768E-23 1.247E-20 8.768E-23 2.494E-20 KAUFFMANN_DNA_REPAIR_GENES Lynch syndrome DOID_3883 3.351E-12 3.814E-10 3.351E-12 3.814E-10 KAUFFMANN_DNA_REPAIR_GENES cervix uteri carcinoma in situ DOID_8991 2.363E-10 2.241E-08 1.258E-08 1.193E-06 KAUFFMANN_DNA_REPAIR_GENES vulva cancer DOID_1245 7.2E-10 5.852E-08 1.138E-07 7.193E-06 KAUFFMANN_DNA_REPAIR_GENES lung adenocarcinoma DOID_3910 8.847E-10 6.292E-08 6.342E-08 4.511E-06 KAUFFMANN_DNA_REPAIR_GENES lymphoblastic leukemia DOID_1037 2.207E-09 1.396E-07 5.847E-08 4.752E-06 KAUFFMANN_DNA_REPAIR_GENES pre-malignant neoplasm DOID_0060071 4.495E-09 2.558E-07 1.517E-07 8.629E-06 KAUFFMANN_DNA_REPAIR_GENES in situ carcinoma DOID_8719 4.495E-09 2.558E-07 1.517E-07 8.629E-06 KAUFFMANN_DNA_REPAIR_GENES brain cancer DOID_1319 2.781E-08 1.439E-06 3.303E-05 1.106E-03 KAUFFMANN_DNA_REPAIR_GENES central nervous system cancer DOID_3620 3.143E-08 1.49E-06 3.575E-05 1.13E-03 KAUFFMANN_DNA_REPAIR_GENES nervous system cancer DOID_3093 4.677E-08 2.047E-06 2.188E-05 1.038E-03 KAUFFMANN_DNA_REPAIR_GENES nephroblastoma DOID_2154 2.274E-07 9.244E-06 3.278E-04 6.218E-03 KAUFFMANN_DNA_REPAIR_GENES basal cell carcinoma DOID_2513 3.745E-07 1.421E-05 1.701E-03 0.02200315 KAUFFMANN_DNA_REPAIR_GENES skin carcinoma DOID_3451 4.801E-07 1.707E-05 1.91E-03 0.0226371 KAUFFMANN_DNA_REPAIR_GENES uterine cancer DOID_363 7.775E-07 2.602E-05 2.58E-05 9.175E-04 KAUFFMANN_DNA_REPAIR_GENES transitional cell carcinoma DOID_2671 9.68E-07 3.06E-05 3.278E-04 6.431E-03 KAUFFMANN_DNA_REPAIR_GENES lymphoma DOID_0060058 1.251E-06 3.746E-05 2.428E-05 1.063E-03 KAUFFMANN_DNA_REPAIR_GENES reproductive organ benign neoplasm DOID_0050622 2.25E-06 6.4E-05 1.232E-03 0.01752206 KAUFFMANN_DNA_REPAIR_GENES integumentary system cancer DOID_0060122 2.25E-06 6.096E-05 1.232E-03 0.01709469 KAUFFMANN_DNA_REPAIR_GENES skin cancer DOID_4159 2.25E-06 6.096E-05 1.232E-03 0.01709469 KAUFFMANN_DNA_REPAIR_GENES osteosarcoma DOID_3347 2.294E-06 5.932E-05 1.129E-04 2.921E-03 KAUFFMANN_DNA_REPAIR_GENES invasive ductal carcinoma DOID_3008 4.158E-06 1.029E-04 1.745E-04 4.137E-03 KAUFFMANN_DNA_REPAIR_GENES breast benign neoplasm DOID_0060082 7.458E-06 1.768E-04 0.03904554 0.26448703 KAUFFMANN_DNA_REPAIR_GENES thoracic benign neoplasm DOID_0060097 7.458E-06 1.768E-04 0.03904554 0.26448703 KAUFFMANN_DNA_REPAIR_GENES benign breast phyllodes tumor DOID_1631 7.458E-06 1.768E-04 0.03904554 0.26448703 KAUFFMANN_DNA_REPAIR_GENES chronic leukemia DOID_1036 7.833E-06 1.783E-04 2.776E-04 5.641E-03 KAUFFMANN_DNA_REPAIR_GENES chronic lymphocytic leukemia DOID_1040 7.833E-06 1.783E-04 2.776E-04 5.641E-03 KAUFFMANN_DNA_REPAIR_GENES embryonal cancer DOID_688 1.348E-05 2.95E-04 4.136E-04 7.354E-03 KAUFFMANN_DNA_REPAIR_GENES biliary tract cancer DOID_4607 1.489E-05 3.139E-04 2.634E-04 5.551E-03 KAUFFMANN_DNA_REPAIR_GENES benign mesothelioma DOID_2645 1.98E-05 4.024E-04 5.486E-04 9.18E-03 KAUFFMANN_DNA_REPAIR_GENES primary immunodeficiency disease DOID_612 2.075E-05 4.072E-04 2.075E-05 1.073E-03 KAUFFMANN_DNA_REPAIR_GENES chronic myeloid leukemia DOID_8552 2.498E-05 4.737E-04 2.498E-05 1.015E-03 KAUFFMANN_DNA_REPAIR_GENES gallbladder cancer DOID_3121 2.58E-05 4.736E-04 2.58E-05 9.787E-04 KAUFFMANN_DNA_REPAIR_GENES male reproductive organ benign neoplasm DOID_0060087 3.62E-05 6.437E-04 1.91E-03 0.02362133 KAUFFMANN_DNA_REPAIR_GENES integumentary system benign neoplasm DOID_0060121 3.862E-05 6.658E-04 8.963E-04 0.01342069 KAUFFMANN_DNA_REPAIR_GENES skin benign neoplasm DOID_3165 3.862E-05 6.658E-04 8.963E-04 0.01342069 KAUFFMANN_DNA_REPAIR_GENES testicular cancer DOID_2998 4.288E-05 7.176E-04 0.06648807 0.34707992 KAUFFMANN_DNA_REPAIR_GENES mitochondrial myopathy DOID_699 5.854E-05 9.517E-04 5.854E-05 1.753E-03 KAUFFMANN_DNA_REPAIR_GENES muscle cancer DOID_4045 7.754E-05 1.226E-03 3.121E-03 0.03414699 KAUFFMANN_DNA_REPAIR_GENES neuroectodermal tumor DOID_171 8.764E-05 1.348E-03 8.764E-05 2.493E-03 KAUFFMANN_DNA_REPAIR_GENES severe combined immunodeficiency DOID_627 1.002E-04 1.5E-03 1.002E-04 2.714E-03 KAUFFMANN_DNA_REPAIR_GENES combined T cell and B cell immunodeficiency DOID_628 1.129E-04 1.648E-03 1.129E-04 2.794E-03 KAUFFMANN_DNA_REPAIR_GENES astrocytoma DOID_3069 1.388E-04 1.974E-03 2.295E-03 0.02611507 KAUFFMANN_DNA_REPAIR_GENES seminoma DOID_4440 1.415E-04 1.964E-03 4.608E-03 0.04766901 KAUFFMANN_DNA_REPAIR_GENES supratentorial cancer DOID_1659 1.927E-04 2.61E-03 5.628E-03 0.05718715 KAUFFMANN_DNA_REPAIR_GENES cerebrum cancer DOID_368 1.927E-04 2.61E-03 5.628E-03 0.05718715 KAUFFMANN_DNA_REPAIR_GENES mixed glioma DOID_5076 2.086E-04 2.761E-03 0.03410233 0.25200297 KAUFFMANN_DNA_REPAIR_GENES endometrial carcinoma DOID_2871 2.121E-04 2.742E-03 2.121E-04 4.826E-03 KAUFFMANN_DNA_REPAIR_GENES endometrial cancer DOID_1380 2.545E-04 3.218E-03 2.545E-04 5.569E-03 KAUFFMANN_DNA_REPAIR_GENES germinoma DOID_3304 2.545E-04 3.148E-03 6.742E-03 0.06730553 KAUFFMANN_DNA_REPAIR_GENES lymphoid leukemia DOID_10747 3.55E-04 4.298E-03 3.55E-04 6.516E-03 KAUFFMANN_DNA_REPAIR_GENES mouth disease DOID_403 4.191E-04 4.968E-03 4.191E-04 7.226E-03 KAUFFMANN_DNA_REPAIR_GENES cataract DOID_83 7.089E-04 8.232E-03 7.089E-04 0.01152448 KAUFFMANN_DNA_REPAIR_GENES lens disease DOID_110 7.991E-04 9.094E-03 7.991E-04 0.01263014 KAUFFMANN_DNA_REPAIR_GENES Seckel syndrome DOID_0050569 8.356E-04 9.322E-03 8.356E-04 0.01284946 KAUFFMANN_DNA_REPAIR_GENES rhabdomyosarcoma DOID_3247 1.147E-03 0.01254649 1.147E-03 0.01672866 KAUFFMANN_DNA_REPAIR_GENES bile duct adenocarcinoma DOID_4896 1.171E-03 0.01257323 0.01817307 0.15206583 KAUFFMANN_DNA_REPAIR_GENES cholangiocarcinoma DOID_4947 1.171E-03 0.01257323 0.01817307 0.15206583 KAUFFMANN_DNA_REPAIR_GENES pustulosis of palm and sole DOID_4398 1.232E-03 0.0129793 0.18952443 0.7048327 KAUFFMANN_DNA_REPAIR_GENES mitochondrial metabolism disease DOID_700 1.294E-03 0.01339071 1.294E-03 0.01753545 KAUFFMANN_DNA_REPAIR_GENES skeletal muscle cancer DOID_4043 1.32E-03 0.01341086 1.32E-03 0.01746531 KAUFFMANN_DNA_REPAIR_GENES lung oat cell carcinoma DOID_5411 1.32E-03 0.01317558 0.05286546 0.29490636 KAUFFMANN_DNA_REPAIR_GENES bile duct cancer DOID_4606 1.425E-03 0.013984 0.0206435 0.16090617 KAUFFMANN_DNA_REPAIR_GENES bile duct carcinoma DOID_4897 1.425E-03 0.013984 0.0206435 0.16090617 KAUFFMANN_DNA_REPAIR_GENES oral cavity cancer DOID_8618 1.425E-03 0.01374698 0.0206435 0.15873176 KAUFFMANN_DNA_REPAIR_GENES urinary system benign neoplasm DOID_731 1.701E-03 0.01613564 1.701E-03 0.02151419 KAUFFMANN_DNA_REPAIR_GENES neuroendocrine tumor DOID_169 1.91E-03 0.0178128 1.91E-03 0.02311874 KAUFFMANN_DNA_REPAIR_GENES MHC class II deficiency DOID_5812 2.129E-03 0.01954103 2.129E-03 0.02472538 KAUFFMANN_DNA_REPAIR_GENES endocrine organ benign neoplasm DOID_0060089 2.205E-03 0.01991487 0.22684625 0.80672198 KAUFFMANN_DNA_REPAIR_GENES colon carcinoma DOID_1520 2.36E-03 0.02098405 0.06986322 0.3549301 KAUFFMANN_DNA_REPAIR_GENES subependymal glioma DOID_4843 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES pilocytic astrocytoma DOID_4851 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES subependymal giant cell astrocytoma DOID_5077 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES fibrillary astrocytoma DOID_6726 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES juvenile pilocytic astrocytoma DOID_6811 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES childhood pilocytic astrocytoma DOID_6812 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES gemistocytic astrocytoma DOID_7005 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES childhood cerebral astrocytoma DOID_7007 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES protoplasmic astrocytoma DOID_7008 2.36E-03 0.02066121 0.06986322 0.34870326 KAUFFMANN_DNA_REPAIR_GENES male reproductive system disease DOID_48 2.481E-03 0.02139121 2.481E-03 0.02768274 KAUFFMANN_DNA_REPAIR_GENES pancreatic carcinoma DOID_4905 2.677E-03 0.02273237 0.03104434 0.23242407 KAUFFMANN_DNA_REPAIR_GENES benign glioma DOID_0060101 2.856E-03 0.02389818 0.07657722 0.37889075 KAUFFMANN_DNA_REPAIR_GENES benign ependymoma DOID_4844 2.856E-03 0.02389818 0.07657722 0.37889075 KAUFFMANN_DNA_REPAIR_GENES chromosomal disease DOID_0080014 3.435E-03 0.02832495 0.03646966 0.25306386 KAUFFMANN_DNA_REPAIR_GENES reading disorder DOID_13365 3.98E-03 0.0323551 3.98E-03 0.04273315 KAUFFMANN_DNA_REPAIR_GENES dyslexia DOID_4428 3.98E-03 0.0323551 3.98E-03 0.04273315 KAUFFMANN_DNA_REPAIR_GENES cleft lip DOID_9296 4.289E-03 0.0343701 4.289E-03 0.04519032 KAUFFMANN_DNA_REPAIR_GENES female reproductive organ benign neoplasm DOID_0060086 5.989E-03 0.04733243 0.10943233 0.4864609 KAUFFMANN_DNA_REPAIR_GENES uterine benign neoplasm DOID_0060095 5.989E-03 0.04733243 0.10943233 0.4864609 KAUFFMANN_DNA_REPAIR_GENES uterine fibroid DOID_13223 5.989E-03 0.04733243 0.10943233 0.4864609 KAUFFMANN_DNA_REPAIR_GENES leiomyoma DOID_127 7.134E-03 0.05560756 0.11906064 0.51714124 KAUFFMANN_DNA_REPAIR_GENES autonomic nervous system neoplasm DOID_2621 7.134E-03 0.05485611 0.11906064 0.5132235 KAUFFMANN_DNA_REPAIR_GENES neuroblastoma DOID_769 7.134E-03 0.05485611 0.11906064 0.5132235 KAUFFMANN_DNA_REPAIR_GENES papilloma DOID_2615 7.536E-03 0.0571737 0.12224705 0.52299679 KAUFFMANN_DNA_REPAIR_GENES male infertility DOID_12336 7.948E-03 0.05950524 7.948E-03 0.07797238 KAUFFMANN_DNA_REPAIR_GENES thyroid carcinoma DOID_3963 7.948E-03 0.05873244 1.000 1.000 KAUFFMANN_DNA_REPAIR_GENES thyroid cancer DOID_1781 8.801E-03 0.06420579 1.000 1.000 KAUFFMANN_DNA_REPAIR_GENES cleft palate DOID_674 9.243E-03 0.06657276 9.243E-03 0.08913979 KAUFFMANN_DNA_REPAIR_GENES multiple myeloma DOID_9538 9.243E-03 0.0657406 9.243E-03 0.08765413 KAUFFMANN_DNA_REPAIR_GENES microcephaly DOID_10907 9.694E-03 0.06809835 9.694E-03 0.09042568 KAUFFMANN_DNA_REPAIR_GENES peripheral nervous system neoplasm DOID_1192 9.694E-03 0.06726789 0.13800832 0.57318785 KAUFFMANN_DNA_REPAIR_GENES intracranial arterial disease DOID_13089 0.01062531 0.07284098 0.14423387 0.59042499 KAUFFMANN_DNA_REPAIR_GENES cerebral arterial disease DOID_3527 0.01062531 0.07284098 0.14423387 0.59042499 KAUFFMANN_DNA_REPAIR_GENES adenoid cystic carcinoma DOID_4866 0.01062531 0.07197383 0.01062531 0.09751293 KAUFFMANN_DNA_REPAIR_GENES salivary gland cancer DOID_8850 0.01159441 0.07761434 0.01159441 0.10471775 KAUFFMANN_DNA_REPAIR_GENES primitive neuroectodermal tumor DOID_168 0.012093 0.08001065 0.012093 0.10751431 KAUFFMANN_DNA_REPAIR_GENES learning disability DOID_8927 0.01311789 0.08579402 0.01311789 0.114832 KAUFFMANN_DNA_REPAIR_GENES myeloma DOID_0070004 0.01417926 0.09168179 0.01417926 0.12224239 KAUFFMANN_DNA_REPAIR_GENES thyroid adenoma DOID_2891 0.01417926 0.09065166 1.000 1.000 KAUFFMANN_DNA_REPAIR_GENES lung small cell carcinoma DOID_5409 0.01527653 0.09658159 0.17170104 0.65569053 MOOTHA_GLYCOGEN_METABOLISM glycogen metabolism disorder DOID_0050728 2.872E-33 1.634E-30 2.872E-33 1.634E-30 MOOTHA_GLYCOGEN_METABOLISM glycogen storage disease DOID_2747 2.872E-33 1.634E-30 2.872E-33 1.634E-30 MOOTHA_GLYCOGEN_METABOLISM carbohydrate metabolic disorder DOID_2978 1.641E-25 4.67E-23 1.641E-25 4.67E-23 WOO_LIVER_CANCER_RECURRENCE_UP bone development disease DOID_0080006 4.436E-19 2.524E-16 6.694E-10 3.809E-07 WOO_LIVER_CANCER_RECURRENCE_UP osteochondrodysplasia DOID_2256 5.105E-15 1.452E-12 1.547E-07 4.401E-05 WOO_LIVER_CANCER_RECURRENCE_UP heart valve disease DOID_4079 1.371E-13 2.6E-11 0.10029662 0.49625022 WOO_LIVER_CANCER_RECURRENCE_UP myeloma DOID_0070004 1.322E-11 1.881E-09 5.045E-03 0.10630927 WOO_LIVER_CANCER_RECURRENCE_UP aortic valve insufficiency DOID_57 2.885E-11 3.283E-09 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP bone marrow cancer DOID_4960 3.459E-11 3.28E-09 6.51E-03 0.1194895 WOO_LIVER_CANCER_RECURRENCE_UP multiple epiphyseal dysplasia DOID_12721 5.148E-11 4.184E-09 3.897E-05 5.544E-03 WOO_LIVER_CANCER_RECURRENCE_UP aortic valve disease DOID_62 1.518E-09 1.08E-07 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP multiple myeloma DOID_9538 2.289E-08 1.447E-06 3.256E-03 0.08421573 WOO_LIVER_CANCER_RECURRENCE_UP oral submucous fibrosis DOID_5773 2.465E-08 1.402E-06 0.03119544 0.29098702 WOO_LIVER_CANCER_RECURRENCE_UP ureteral obstruction DOID_5199 5.499E-08 2.844E-06 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP atrophic muscular disease DOID_913 1.294E-07 6.136E-06 2.314E-04 0.01880788 WOO_LIVER_CANCER_RECURRENCE_UP muscular dystrophy DOID_9884 1.294E-07 6.136E-06 2.314E-04 0.01880788 WOO_LIVER_CANCER_RECURRENCE_UP hepatitis B DOID_2043 1.306E-07 5.717E-06 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP urinary tract obstruction DOID_5200 1.579E-07 6.416E-06 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP ureteral disease DOID_1426 1.891E-07 7.174E-06 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP germinoma DOID_3304 8.123E-07 2.889E-05 5.165E-05 5.877E-03 WOO_LIVER_CANCER_RECURRENCE_UP transitional cell carcinoma DOID_2671 1.408E-06 4.712E-05 0.01562039 0.20669771 WOO_LIVER_CANCER_RECURRENCE_UP adenoma DOID_657 1.429E-06 4.518E-05 3.098E-03 0.08392917 WOO_LIVER_CANCER_RECURRENCE_UP pulmonary emphysema DOID_9675 2.34E-06 7.007E-05 3.928E-03 0.08939275 WOO_LIVER_CANCER_RECURRENCE_UP uterine cancer DOID_363 3.06E-06 8.705E-05 1.372E-04 0.01301206 WOO_LIVER_CANCER_RECURRENCE_UP Ehlers-Danlos syndrome DOID_13359 4.042E-06 1.095E-04 0.03119544 0.30603807 WOO_LIVER_CANCER_RECURRENCE_UP spastic diplegia DOID_10965 4.967E-06 1.285E-04 0.03324063 0.29552998 WOO_LIVER_CANCER_RECURRENCE_UP giant cell tumor DOID_200 6.21E-06 1.536E-04 6.29E-03 0.11930241 WOO_LIVER_CANCER_RECURRENCE_UP malignant giant cell tumor DOID_2705 6.21E-06 1.536E-04 6.29E-03 0.11930241 WOO_LIVER_CANCER_RECURRENCE_UP giant cell glioblastoma DOID_3074 6.21E-06 1.536E-04 6.29E-03 0.11930241 WOO_LIVER_CANCER_RECURRENCE_UP glioblastoma DOID_3068 8.753E-06 2.075E-04 7.424E-03 0.12800646 WOO_LIVER_CANCER_RECURRENCE_UP collagen disease DOID_854 1.061E-05 2.414E-04 0.12655352 0.57149964 WOO_LIVER_CANCER_RECURRENCE_UP autoimmune hepatitis DOID_2048 1.171E-05 2.562E-04 0.04340278 0.32494977 WOO_LIVER_CANCER_RECURRENCE_UP pre-malignant neoplasm DOID_0060071 1.199E-05 2.527E-04 3.762E-04 0.02378472 WOO_LIVER_CANCER_RECURRENCE_UP congenital heart defect DOID_1682 1.199E-05 2.437E-04 3.762E-04 0.02140625 WOO_LIVER_CANCER_RECURRENCE_UP in situ carcinoma DOID_8719 1.199E-05 2.527E-04 3.762E-04 0.02378472 WOO_LIVER_CANCER_RECURRENCE_UP uterine disease DOID_345 1.351E-05 2.65E-04 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP allergic contact dermatitis DOID_3042 1.516E-05 2.875E-04 4.473E-04 0.02313834 WOO_LIVER_CANCER_RECURRENCE_UP astrocytoma DOID_3069 1.696E-05 3.112E-04 0.01021528 0.16607135 WOO_LIVER_CANCER_RECURRENCE_UP synostosis DOID_11971 1.774E-05 3.154E-04 1.178E-03 0.04187989 WOO_LIVER_CANCER_RECURRENCE_UP nephrosis DOID_2527 1.89E-05 3.259E-04 0.01076552 0.1655562 WOO_LIVER_CANCER_RECURRENCE_UP cystic fibrosis DOID_1485 2.328E-05 3.897E-04 0.15205345 0.65544251 WOO_LIVER_CANCER_RECURRENCE_UP bone resorption disease DOID_0080011 2.449E-05 3.981E-04 0.01219707 0.17795207 WOO_LIVER_CANCER_RECURRENCE_UP osteoporosis DOID_11476 2.449E-05 3.981E-04 0.01219707 0.17795207 WOO_LIVER_CANCER_RECURRENCE_UP aneurysm disease DOID_2403 2.449E-05 3.87E-04 0.15384648 0.65327348 WOO_LIVER_CANCER_RECURRENCE_UP contact dermatitis DOID_2773 2.837E-05 4.363E-04 7.106E-04 0.03369601 WOO_LIVER_CANCER_RECURRENCE_UP female reproductive system disease DOID_229 2.976E-05 4.456E-04 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP chronic kidney failure DOID_784 3.268E-05 4.768E-04 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP invasive ductal carcinoma DOID_3008 3.525E-05 5.015E-04 3.525E-05 6.687E-03 WOO_LIVER_CANCER_RECURRENCE_UP dysostosis DOID_1934 4.294E-05 5.959E-04 2.093E-03 0.06617212 WOO_LIVER_CANCER_RECURRENCE_UP endometrial carcinoma DOID_2871 4.294E-05 5.817E-04 2.093E-03 0.06268938 WOO_LIVER_CANCER_RECURRENCE_UP spastic cerebral palsy DOID_0050669 4.716E-05 6.241E-04 0.06736356 0.4034723 WOO_LIVER_CANCER_RECURRENCE_UP carbohydrate metabolic disorder DOID_2978 5.057E-05 6.54E-04 1.089E-03 0.04131111 WOO_LIVER_CANCER_RECURRENCE_UP endometrial cancer DOID_1380 5.165E-05 6.53E-04 2.361E-03 0.06717568 WOO_LIVER_CANCER_RECURRENCE_UP mouth disease DOID_403 5.269E-05 6.517E-04 0.18376139 0.71616597 WOO_LIVER_CANCER_RECURRENCE_UP hypersensitivity reaction type I disease DOID_1205 5.487E-05 6.642E-04 0.01798822 0.23262038 WOO_LIVER_CANCER_RECURRENCE_UP papilloma DOID_2615 6.144E-05 7.283E-04 0.07326056 0.42974491 WOO_LIVER_CANCER_RECURRENCE_UP spindle cell carcinoma DOID_4015 6.676E-05 7.752E-04 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP calcinosis DOID_182 8.45E-05 9.616E-04 0.08106597 0.45222094 WOO_LIVER_CANCER_RECURRENCE_UP cervix uteri carcinoma in situ DOID_8991 1.126E-04 1.256E-03 3.928E-03 0.09311745 WOO_LIVER_CANCER_RECURRENCE_UP nephrotic syndrome DOID_1184 1.286E-04 1.408E-03 0.09265252 0.48814152 WOO_LIVER_CANCER_RECURRENCE_UP cerebral infarction DOID_3526 1.461E-04 1.569E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.856E-04 1.956E-03 0.10409478 0.51060286 WOO_LIVER_CANCER_RECURRENCE_UP glaucoma DOID_1686 1.856E-04 1.92E-03 5.446E-03 0.11066261 WOO_LIVER_CANCER_RECURRENCE_UP pulmonary tuberculosis DOID_2957 1.856E-04 1.886E-03 0.10409478 0.50623873 WOO_LIVER_CANCER_RECURRENCE_UP chondrosarcoma DOID_3371 1.957E-04 1.954E-03 0.02090525 0.26433531 WOO_LIVER_CANCER_RECURRENCE_UP cutaneous leishmaniasis DOID_9111 1.957E-04 1.92E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP calcium metabolism disease DOID_10575 1.964E-04 1.894E-03 0.10598792 0.51107736 WOO_LIVER_CANCER_RECURRENCE_UP temporal arteritis DOID_13375 2.389E-04 2.265E-03 0.02297189 0.27810649 WOO_LIVER_CANCER_RECURRENCE_UP central nervous system vasculitis DOID_525 2.389E-04 2.265E-03 0.02297189 0.27810649 WOO_LIVER_CANCER_RECURRENCE_UP vasculitis DOID_865 2.439E-04 2.275E-03 0.11352106 0.53827904 WOO_LIVER_CANCER_RECURRENCE_UP peritonitis DOID_8283 2.863E-04 2.627E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP oral cavity cancer DOID_8618 2.981E-04 2.693E-03 2.981E-04 0.02120512 WOO_LIVER_CANCER_RECURRENCE_UP osteogenesis imperfecta DOID_12347 3.379E-04 3.004E-03 0.02709225 0.2964517 WOO_LIVER_CANCER_RECURRENCE_UP carotid artery disease DOID_3407 3.436E-04 3.008E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP mineral metabolism disease DOID_0050032 3.932E-04 3.39E-03 0.13208077 0.58714031 WOO_LIVER_CANCER_RECURRENCE_UP tethered spinal cord syndrome DOID_1089 3.936E-04 3.343E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP intermediate coronary syndrome DOID_8805 4.536E-04 3.795E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP brain infarction DOID_3454 4.663E-04 3.846E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP tuberculosis DOID_399 4.663E-04 3.791E-03 0.13939675 0.61012883 WOO_LIVER_CANCER_RECURRENCE_UP pancreatic ductal carcinoma DOID_3587 5.059E-04 4.055E-03 0.01048879 0.16578112 WOO_LIVER_CANCER_RECURRENCE_UP pancreatic carcinoma DOID_4905 5.693E-04 4.499E-03 0.0113286 0.16963088 WOO_LIVER_CANCER_RECURRENCE_UP prion disease DOID_649 6.582E-04 5.13E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP pancreatitis DOID_4989 6.613E-04 5.085E-03 0.01249286 0.17771087 WOO_LIVER_CANCER_RECURRENCE_UP leishmaniasis DOID_9065 7.346E-04 5.573E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP primary bacterial infectious disease DOID_0050338 9.017E-04 6.751E-03 0.17157212 0.69731813 WOO_LIVER_CANCER_RECURRENCE_UP placenta disease DOID_780 9.883E-04 7.303E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP Human immunodeficiency virus infectious disease DOID_526 9.926E-04 7.241E-03 0.17681795 0.70356233 WOO_LIVER_CANCER_RECURRENCE_UP sinusitis DOID_0050127 1.081E-03 7.786E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP glycogen metabolism disorder DOID_0050728 1.081E-03 7.688E-03 1.081E-03 0.04731379 WOO_LIVER_CANCER_RECURRENCE_UP paranasal sinus disease DOID_1352 1.081E-03 7.786E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP glycogen storage disease DOID_2747 1.081E-03 7.688E-03 1.081E-03 0.04731379 WOO_LIVER_CANCER_RECURRENCE_UP IgA glomerulonephritis DOID_2986 1.081E-03 7.594E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP muscle cancer DOID_4045 1.081E-03 7.501E-03 1.081E-03 0.04393424 WOO_LIVER_CANCER_RECURRENCE_UP uremia DOID_4676 1.081E-03 7.411E-03 0.04743804 0.34605443 WOO_LIVER_CANCER_RECURRENCE_UP pulmonary embolism DOID_9477 1.081E-03 7.322E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP encephalomyelitis DOID_640 1.089E-03 7.29E-03 0.18203097 0.71927516 WOO_LIVER_CANCER_RECURRENCE_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.122E-03 7.427E-03 0.18376139 0.72110505 WOO_LIVER_CANCER_RECURRENCE_UP Crohn's disease DOID_8778 1.122E-03 7.341E-03 0.18376139 0.71129409 WOO_LIVER_CANCER_RECURRENCE_UP meningitis DOID_9471 1.178E-03 7.615E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP spastic quadriplegia DOID_10970 1.278E-03 8.172E-03 0.05145649 0.36598429 WOO_LIVER_CANCER_RECURRENCE_UP toxic shock syndrome DOID_14115 1.278E-03 8.082E-03 0.05145649 0.36146596 WOO_LIVER_CANCER_RECURRENCE_UP commensal bacterial infectious disease DOID_0050339 1.383E-03 8.647E-03 0.05345943 0.37095631 WOO_LIVER_CANCER_RECURRENCE_UP papillary adenoma DOID_3172 1.492E-03 9.225E-03 0.0554582 0.35858767 WOO_LIVER_CANCER_RECURRENCE_UP microcystic adenoma DOID_5403 1.492E-03 9.225E-03 0.0554582 0.35858767 WOO_LIVER_CANCER_RECURRENCE_UP follicular adenoma DOID_6204 1.492E-03 9.225E-03 0.0554582 0.35858767 WOO_LIVER_CANCER_RECURRENCE_UP cleft lip DOID_9296 1.492E-03 9.126E-03 0.0554582 0.3545586 WOO_LIVER_CANCER_RECURRENCE_UP intracranial aneurysm DOID_10941 1.604E-03 9.71E-03 0.0574528 0.36322935 WOO_LIVER_CANCER_RECURRENCE_UP spinal cord disease DOID_319 1.604E-03 9.607E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP middle cerebral artery infarction DOID_3525 1.604E-03 9.507E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP seminoma DOID_4440 1.604E-03 9.409E-03 1.604E-03 0.05368875 WOO_LIVER_CANCER_RECURRENCE_UP Sciatic Neuropathy DOID_11446 1.721E-03 9.99E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP lesion of sciatic nerve DOID_12528 1.721E-03 9.99E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP mononeuritis of lower limb DOID_9473 1.721E-03 9.99E-03 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP mononeuritis DOID_1802 1.841E-03 0.01058052 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP mononeuropathy DOID_1188 1.965E-03 0.01118182 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP focal glomerulosclerosis DOID_3945 1.965E-03 0.0110711 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP female reproductive organ benign neoplasm DOID_0060086 2.093E-03 0.01167743 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP uterine benign neoplasm DOID_0060095 2.093E-03 0.01167743 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP uterine fibroid DOID_13223 2.093E-03 0.01167743 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP leiomyoma DOID_127 2.501E-03 0.01381547 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP pleural disease DOID_1532 2.501E-03 0.01368263 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP cleft palate DOID_674 3.256E-03 0.0176452 0.08106597 0.44352439 WOO_LIVER_CANCER_RECURRENCE_UP hepatitis DOID_2237 3.584E-03 0.01924125 0.0849443 0.45171312 WOO_LIVER_CANCER_RECURRENCE_UP systemic scleroderma DOID_418 3.584E-03 0.01906143 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP peptic ulcer DOID_750 3.584E-03 0.01888493 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP intracranial arterial disease DOID_13089 3.754E-03 0.01959769 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP cerebral arterial disease DOID_3527 3.754E-03 0.01959769 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP adenoid cystic carcinoma DOID_4866 3.754E-03 0.01941953 3.754E-03 0.092876 WOO_LIVER_CANCER_RECURRENCE_UP autoimmune disease of urogenital tract DOID_0060049 4.105E-03 0.02104123 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP primary biliary cirrhosis DOID_12236 4.105E-03 0.02104123 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP endometriosis of uterus DOID_288 4.105E-03 0.02085336 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP salivary gland cancer DOID_8850 4.105E-03 0.02066882 4.105E-03 0.08982986 WOO_LIVER_CANCER_RECURRENCE_UP rheumatic disease DOID_1575 4.285E-03 0.02138958 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP primitive neuroectodermal tumor DOID_168 4.285E-03 0.02120358 0.09265252 0.48366315 WOO_LIVER_CANCER_RECURRENCE_UP endometriosis DOID_289 4.285E-03 0.02102079 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP scleroderma DOID_419 4.285E-03 0.02138958 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP diabetic autonomic neuropathy DOID_11503 4.47E-03 0.02173774 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP autonomic neuropathy DOID_11504 4.47E-03 0.02173774 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP diabetic polyneuropathy DOID_12785 4.47E-03 0.02173774 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP gallbladder cancer DOID_3121 4.47E-03 0.02155352 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP diabetic neuropathy DOID_9743 4.47E-03 0.02173774 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP autonomic nervous system disease DOID_11465 5.045E-03 0.02412059 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP neuritis DOID_1803 5.045E-03 0.02391959 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP thyroid adenoma DOID_2891 5.045E-03 0.0237219 0.10029662 0.50060329 WOO_LIVER_CANCER_RECURRENCE_UP lung small cell carcinoma DOID_5409 5.446E-03 0.02539798 5.446E-03 0.10684666 WOO_LIVER_CANCER_RECURRENCE_UP aortic aneurysm DOID_3627 5.651E-03 0.02614375 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP orofacial cleft DOID_0050567 6.074E-03 0.02787057 0.10976236 0.52483012 WOO_LIVER_CANCER_RECURRENCE_UP reproductive organ benign neoplasm DOID_0050622 6.733E-03 0.03064999 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP parasitic protozoa infectious disease DOID_2789 6.733E-03 0.03040673 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP congenital nervous system abnormality DOID_2490 7.19E-03 0.03221477 7.19E-03 0.12785239 WOO_LIVER_CANCER_RECURRENCE_UP neuroectodermal tumor DOID_171 8.145E-03 0.03620791 0.12655352 0.57607163 WOO_LIVER_CANCER_RECURRENCE_UP parasitic infectious disease DOID_1398 9.154E-03 0.04037622 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP temporal lobe epilepsy DOID_3328 9.414E-03 0.0412056 9.414E-03 0.15755081 WOO_LIVER_CANCER_RECURRENCE_UP endocrine organ benign neoplasm DOID_0060089 9.945E-03 0.04319632 0.13939675 0.61485851 WOO_LIVER_CANCER_RECURRENCE_UP male reproductive system disease DOID_48 0.01076552 0.0464059 0.14484373 0.6291304 WOO_LIVER_CANCER_RECURRENCE_UP electroclinical syndrome DOID_0050701 0.01249286 0.05344688 0.15563576 0.65597593 WOO_LIVER_CANCER_RECURRENCE_UP bacterial pneumonia DOID_874 0.01249286 0.05304802 0.01249286 0.17337646 WOO_LIVER_CANCER_RECURRENCE_UP metabolic syndrome X DOID_14221 0.0130938 0.05518794 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP chromosomal disease DOID_0080014 0.01339893 0.05605875 0.16098124 0.67351708 WOO_LIVER_CANCER_RECURRENCE_UP focal epilepsy DOID_2234 0.01401842 0.05822248 0.01401842 0.1899162 WOO_LIVER_CANCER_RECURRENCE_UP biliary tract cancer DOID_4607 0.01401842 0.05780058 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP nervous system cancer DOID_3093 0.01628218 0.06665152 0.17681795 0.708517 WOO_LIVER_CANCER_RECURRENCE_UP ulcerative colitis DOID_8577 0.01904665 0.07741103 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP interstitial nephritis DOID_1063 0.02090525 0.08436233 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP insulinoma DOID_3892 0.02090525 0.08376823 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 0.02297189 0.09140563 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP pneumocystosis DOID_11339 0.02297189 0.09077087 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP migraine without aura DOID_12783 0.02297189 0.09014486 0.02297189 0.28415228 WOO_LIVER_CANCER_RECURRENCE_UP neuronal ceroid lipofuscinosis DOID_14503 0.02297189 0.08952743 0.02297189 0.2723126 WOO_LIVER_CANCER_RECURRENCE_UP craniosynostosis DOID_2340 0.02297189 0.0889184 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP invasive lobular carcinoma DOID_3457 0.02297189 0.0883176 0.02297189 0.2667552 WOO_LIVER_CANCER_RECURRENCE_UP neonatoal period electroclinical syndrome DOID_0050702 0.02503422 0.09560047 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP common cold DOID_10459 0.02503422 0.09496313 0.02503422 0.28488939 WOO_LIVER_CANCER_RECURRENCE_UP islet cell tumor DOID_1799 0.02503422 0.09433424 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP lipodystrophy DOID_811 0.02503422 0.09371362 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP polyneuropathy DOID_1389 0.02709225 0.09945476 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP Leydig cell tumor DOID_2696 0.02709225 0.09881723 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP intracranial thrombosis DOID_4193 0.02709225 0.09818783 1.000 1.000 WOO_LIVER_CANCER_RECURRENCE_UP sex cord-stromal neoplasm DOID_4757 0.02709225 0.09881723 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C3 embryonal cancer DOID_688 4.858E-05 0.02764447 0.01050231 0.74697701 VERRECCHIA_RESPONSE_TO_TGFB1_C3 benign mesothelioma DOID_2645 5.889E-05 0.01675446 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C3 neuritis DOID_1803 7.619E-05 0.01445165 7.619E-05 0.04335495 VERRECCHIA_RESPONSE_TO_TGFB1_C3 alcohol-related neurodevelopmental disorder DOID_0050667 2.818E-04 0.04008632 2.818E-04 0.08017265 ZHU_CMV_ALL_UP influenza DOID_8469 2.312E-08 1.316E-05 3.253E-03 0.07403365 ZHU_CMV_ALL_UP combined T cell and B cell immunodeficiency DOID_628 1.373E-07 3.907E-05 1.373E-07 7.814E-05 ZHU_CMV_ALL_UP pleurisy DOID_10247 2.504E-07 4.749E-05 1.000 1.000 ZHU_CMV_ALL_UP metabolic syndrome X DOID_14221 3.919E-07 5.574E-05 9.598E-03 0.14003413 ZHU_CMV_ALL_UP pleural disease DOID_1532 4.752E-07 5.408E-05 1.000 1.000 ZHU_CMV_ALL_UP primary bacterial infectious disease DOID_0050338 5.904E-07 5.599E-05 0.01122708 0.15970521 ZHU_CMV_ALL_UP primary immunodeficiency disease DOID_612 6.596E-07 5.362E-05 6.596E-07 1.877E-04 ZHU_CMV_ALL_UP nervous system cancer DOID_3093 6.965E-07 4.954E-05 6.965E-07 1.321E-04 ZHU_CMV_ALL_UP respiratory syncytial virus infectious disease DOID_1273 1.006E-06 6.362E-05 0.07266724 0.34745935 ZHU_CMV_ALL_UP autoimmune disease of urogenital tract DOID_0060049 1.334E-06 7.591E-05 2.986E-03 0.0738676 ZHU_CMV_ALL_UP primary biliary cirrhosis DOID_12236 1.334E-06 7.591E-05 2.986E-03 0.0738676 ZHU_CMV_ALL_UP proteinuria DOID_576 1.887E-06 9.76E-05 0.0842618 0.36880742 ZHU_CMV_ALL_UP neuritis DOID_1803 2.048E-06 9.712E-05 0.08590646 0.36752464 ZHU_CMV_ALL_UP pulmonary tuberculosis DOID_2957 2.401E-06 1.051E-04 3.967E-03 0.08061616 ZHU_CMV_ALL_UP sarcoidosis DOID_11335 3.24E-06 1.317E-04 0.09571349 0.38624807 ZHU_CMV_ALL_UP bone marrow cancer DOID_4960 3.48E-06 1.32E-04 1.507E-04 0.01428812 ZHU_CMV_ALL_UP hypersensitivity reaction type IV disease DOID_2916 4.573E-06 1.626E-04 0.10380677 0.41304931 ZHU_CMV_ALL_UP hyperglycemia DOID_4195 7.494E-06 2.508E-04 0.1166078 0.43365907 ZHU_CMV_ALL_UP allergic contact dermatitis DOID_3042 7.937E-06 2.509E-04 2.772E-04 0.02253317 ZHU_CMV_ALL_UP tuberculosis DOID_399 8.4E-06 2.516E-04 7.273E-03 0.12172307 ZHU_CMV_ALL_UP severe combined immunodeficiency DOID_627 1.234E-05 3.511E-04 1.234E-05 1.755E-03 ZHU_CMV_ALL_UP bone resorption disease DOID_0080011 1.285E-05 3.482E-04 3.959E-04 0.0250281 ZHU_CMV_ALL_UP osteoporosis DOID_11476 1.285E-05 3.482E-04 3.959E-04 0.0250281 ZHU_CMV_ALL_UP aneurysm disease DOID_2403 1.285E-05 3.323E-04 0.13235598 0.46487996 ZHU_CMV_ALL_UP pancreatitis DOID_4989 1.351E-05 3.342E-04 9.154E-03 0.13706663 ZHU_CMV_ALL_UP bacterial pneumonia DOID_874 1.351E-05 3.202E-04 0.1339155 0.46747191 ZHU_CMV_ALL_UP osteosarcoma DOID_3347 1.393E-05 3.171E-04 1.393E-05 1.585E-03 ZHU_CMV_ALL_UP contact dermatitis DOID_2773 1.49E-05 3.26E-04 4.416E-04 0.02512921 ZHU_CMV_ALL_UP cystitis DOID_1679 1.565E-05 3.299E-04 0.04733251 0.32844144 ZHU_CMV_ALL_UP extrinsic allergic alveolitis DOID_841 1.751E-05 3.558E-04 0.0490425 0.3135414 ZHU_CMV_ALL_UP mononeuritis DOID_1802 2.164E-05 4.246E-04 0.05245342 0.32092471 ZHU_CMV_ALL_UP mononeuropathy DOID_1188 2.393E-05 4.539E-04 0.05415436 0.3209774 ZHU_CMV_ALL_UP lymphoma DOID_0060058 2.556E-05 4.691E-04 6.583E-04 0.03121321 ZHU_CMV_ALL_UP mouth disease DOID_403 2.777E-05 4.937E-04 0.01296877 0.17998129 ZHU_CMV_ALL_UP bronchiolitis obliterans DOID_2799 2.897E-05 4.996E-04 1.000 1.000 ZHU_CMV_ALL_UP bladder disease DOID_365 3.467E-05 5.802E-04 0.06092807 0.32705729 ZHU_CMV_ALL_UP pulmonary sarcoidosis DOID_13406 5.2E-05 8.453E-04 0.06932803 0.34603201 ZHU_CMV_ALL_UP multiple myeloma DOID_9538 5.2E-05 8.218E-04 2.366E-03 0.06731631 ZHU_CMV_ALL_UP systemic scleroderma DOID_418 6.026E-05 9.267E-04 0.07266724 0.34456385 ZHU_CMV_ALL_UP peptic ulcer DOID_750 6.026E-05 9.023E-04 0.07266724 0.34171622 ZHU_CMV_ALL_UP adult respiratory distress syndrome DOID_11394 6.47E-05 9.439E-04 2.73E-03 0.0706017 ZHU_CMV_ALL_UP pulmonary emphysema DOID_9675 6.934E-05 9.864E-04 0.07599465 0.34592767 ZHU_CMV_ALL_UP rheumatic disease DOID_1575 7.928E-05 1.1E-03 0.0793103 0.35533512 ZHU_CMV_ALL_UP scleroderma DOID_419 7.928E-05 1.1E-03 0.0793103 0.35533512 ZHU_CMV_ALL_UP myeloma DOID_0070004 1.018E-04 1.38E-03 3.673E-03 0.08038998 ZHU_CMV_ALL_UP lung small cell carcinoma DOID_5409 1.145E-04 1.516E-03 3.967E-03 0.0778363 ZHU_CMV_ALL_UP aortic aneurysm DOID_3627 1.212E-04 1.568E-03 0.09082301 0.3772138 ZHU_CMV_ALL_UP B-cell lymphocytic neoplasm DOID_707 1.282E-04 1.621E-03 4.271E-03 0.08101263 ZHU_CMV_ALL_UP atopic dermatitis DOID_3310 1.354E-04 1.675E-03 1.000 1.000 ZHU_CMV_ALL_UP hyperparathyroidism DOID_13543 1.413E-04 1.711E-03 1.000 1.000 ZHU_CMV_ALL_UP conjunctival disease DOID_4251 1.413E-04 1.675E-03 0.01779476 0.23011854 ZHU_CMV_ALL_UP conjunctivitis DOID_6195 1.413E-04 1.675E-03 0.01779476 0.23011854 ZHU_CMV_ALL_UP pustulosis of palm and sole DOID_4398 1.587E-04 1.843E-03 4.911E-03 0.08732799 ZHU_CMV_ALL_UP melancholia DOID_2848 1.935E-04 2.202E-03 0.10541684 0.41083685 ZHU_CMV_ALL_UP neurotic disorder DOID_4964 2.029E-04 2.264E-03 0.10702406 0.41426319 ZHU_CMV_ALL_UP encephalitis DOID_9588 2.068E-04 2.263E-03 0.02131608 0.22460835 ZHU_CMV_ALL_UP collagen disease DOID_854 2.126E-04 2.283E-03 0.10862843 0.41206385 ZHU_CMV_ALL_UP respiratory failure DOID_11162 2.226E-04 2.346E-03 6.13E-03 0.1057002 ZHU_CMV_ALL_UP parathyroid gland disease DOID_11201 2.441E-04 2.526E-03 1.000 1.000 ZHU_CMV_ALL_UP polyneuropathy DOID_1389 2.441E-04 2.48E-03 1.000 1.000 ZHU_CMV_ALL_UP uterine disease DOID_345 2.544E-04 2.54E-03 1.000 1.000 ZHU_CMV_ALL_UP open-angle glaucoma DOID_1067 2.845E-04 2.791E-03 0.02482497 0.25223944 ZHU_CMV_ALL_UP eyelid disease DOID_530 2.845E-04 2.744E-03 0.02482497 0.24781419 ZHU_CMV_ALL_UP polycystic kidney disease DOID_898 2.845E-04 2.698E-03 0.02482497 0.24354153 ZHU_CMV_ALL_UP astrocytoma DOID_3069 3.013E-04 2.81E-03 7.473E-03 0.12148377 ZHU_CMV_ALL_UP diabetic retinopathy DOID_8947 3.533E-04 3.242E-03 1.000 1.000 ZHU_CMV_ALL_UP Fanconi's anemia DOID_13636 3.743E-04 3.38E-03 3.743E-04 0.02662029 ZHU_CMV_ALL_UP cystic fibrosis DOID_1485 3.813E-04 3.39E-03 0.1307937 0.46806046 ZHU_CMV_ALL_UP endogenous depression DOID_1595 3.813E-04 3.338E-03 0.1307937 0.46513508 ZHU_CMV_ALL_UP urinary system benign neoplasm DOID_731 4.237E-04 3.653E-03 0.03006507 0.25919738 ZHU_CMV_ALL_UP female reproductive system disease DOID_229 4.576E-04 3.886E-03 1.000 1.000 ZHU_CMV_ALL_UP mental depression DOID_1596 4.907E-04 4.106E-03 0.14167177 0.48560988 ZHU_CMV_ALL_UP chronic kidney failure DOID_784 4.907E-04 4.046E-03 0.14167177 0.48270204 ZHU_CMV_ALL_UP retinal vascular disease DOID_2462 5.252E-04 4.269E-03 1.000 1.000 ZHU_CMV_ALL_UP psoriasis DOID_8893 5.315E-04 4.259E-03 5.315E-04 0.02749253 ZHU_CMV_ALL_UP amnestic disorder DOID_10914 5.899E-04 4.662E-03 1.000 1.000 ZHU_CMV_ALL_UP esophagitis DOID_11963 5.899E-04 4.598E-03 1.000 1.000 ZHU_CMV_ALL_UP autoimmune hepatitis DOID_2048 6.512E-04 5.007E-03 1.000 1.000 ZHU_CMV_ALL_UP carbohydrate metabolic disorder DOID_2978 6.789E-04 5.15E-03 0.15697956 0.52541984 ZHU_CMV_ALL_UP encephalomyelitis DOID_640 6.789E-04 5.083E-03 1.000 1.000 ZHU_CMV_ALL_UP hepatitis B DOID_2043 7.155E-04 5.287E-03 7.155E-04 0.03131629 ZHU_CMV_ALL_UP urinary tract obstruction DOID_5200 7.827E-04 5.71E-03 0.04046219 0.31112142 ZHU_CMV_ALL_UP ulcerative colitis DOID_8577 7.88E-04 5.676E-03 0.16453227 0.54114948 ZHU_CMV_ALL_UP Goodpasture syndrome DOID_9808 8.529E-04 6.066E-03 1.000 1.000 ZHU_CMV_ALL_UP hypogonadism DOID_1924 1.002E-03 7.039E-03 0.04561949 0.32046282 ZHU_CMV_ALL_UP bronchiolitis DOID_2942 1.002E-03 6.953E-03 1.000 1.000 ZHU_CMV_ALL_UP cleft lip DOID_9296 1.081E-03 7.41E-03 1.081E-03 0.04393048 ZHU_CMV_ALL_UP congenital hypoplastic anemia DOID_1342 1.163E-03 7.876E-03 1.163E-03 0.04410467 ZHU_CMV_ALL_UP Sciatic Neuropathy DOID_11446 1.247E-03 8.35E-03 1.000 1.000 ZHU_CMV_ALL_UP lesion of sciatic nerve DOID_12528 1.247E-03 8.35E-03 1.000 1.000 ZHU_CMV_ALL_UP lung adenocarcinoma DOID_3910 1.247E-03 8.253E-03 1.247E-03 0.04435958 ZHU_CMV_ALL_UP mononeuritis of lower limb DOID_9473 1.247E-03 8.35E-03 1.000 1.000 ZHU_CMV_ALL_UP autoimmune disease of endocrine system DOID_0060005 1.425E-03 9.322E-03 0.05415436 0.32435611 ZHU_CMV_ALL_UP gonadal disease DOID_2277 1.615E-03 0.01044053 0.05754721 0.32420162 ZHU_CMV_ALL_UP abdominal aortic aneurysm DOID_7693 1.615E-03 0.01032322 0.05754721 0.32102317 ZHU_CMV_ALL_UP allergic rhinitis DOID_4481 1.714E-03 0.01083401 0.05923914 0.32101971 ZHU_CMV_ALL_UP chronic leukemia DOID_1036 1.815E-03 0.01135121 1.000 1.000 ZHU_CMV_ALL_UP chronic lymphocytic leukemia DOID_1040 1.815E-03 0.01135121 1.000 1.000 ZHU_CMV_ALL_UP autonomic nervous system neoplasm DOID_2621 1.815E-03 0.01122782 1.815E-03 0.06076233 ZHU_CMV_ALL_UP neuroblastoma DOID_769 1.815E-03 0.01122782 1.815E-03 0.06076233 ZHU_CMV_ALL_UP papilloma DOID_2615 1.92E-03 0.01174686 0.06261402 0.33296613 ZHU_CMV_ALL_UP myocarditis DOID_820 1.92E-03 0.01162189 1.000 1.000 ZHU_CMV_ALL_UP pneumoconiosis DOID_10316 2.027E-03 0.01214262 0.06429698 0.33874984 ZHU_CMV_ALL_UP nephroblastoma DOID_2154 2.027E-03 0.01201614 0.06429698 0.33564204 ZHU_CMV_ALL_UP spindle cell carcinoma DOID_4015 2.027E-03 0.01189226 0.06429698 0.33259075 ZHU_CMV_ALL_UP esophageal disease DOID_6050 2.027E-03 0.01177091 1.000 1.000 ZHU_CMV_ALL_UP aplastic anemia DOID_12449 2.137E-03 0.01228513 2.137E-03 0.06756824 ZHU_CMV_ALL_UP cleft palate DOID_674 2.366E-03 0.01346326 2.366E-03 0.07085928 ZHU_CMV_ALL_UP peripheral nervous system neoplasm DOID_1192 2.485E-03 0.01399736 2.485E-03 0.06732066 ZHU_CMV_ALL_UP uveitis DOID_13141 2.485E-03 0.01386013 1.000 1.000 ZHU_CMV_ALL_UP cervix uteri carcinoma in situ DOID_8991 2.856E-03 0.01577983 0.07599465 0.34871741 ZHU_CMV_ALL_UP endometriosis of uterus DOID_288 2.986E-03 0.0163361 1.000 1.000 ZHU_CMV_ALL_UP endometriosis DOID_289 3.118E-03 0.01689647 1.000 1.000 ZHU_CMV_ALL_UP uveal disease DOID_3480 3.118E-03 0.01673707 1.000 1.000 ZHU_CMV_ALL_UP diabetic autonomic neuropathy DOID_11503 3.253E-03 0.01729758 1.000 1.000 ZHU_CMV_ALL_UP autonomic neuropathy DOID_11504 3.253E-03 0.01729758 1.000 1.000 ZHU_CMV_ALL_UP diabetic polyneuropathy DOID_12785 3.253E-03 0.01729758 1.000 1.000 ZHU_CMV_ALL_UP uterine cancer DOID_363 3.253E-03 0.01713742 3.253E-03 0.07711838 ZHU_CMV_ALL_UP diabetic neuropathy DOID_9743 3.253E-03 0.01729758 1.000 1.000 ZHU_CMV_ALL_UP autonomic nervous system disease DOID_11465 3.673E-03 0.01917559 1.000 1.000 ZHU_CMV_ALL_UP bone marrow disease DOID_4961 3.673E-03 0.01900127 3.673E-03 0.07741257 ZHU_CMV_ALL_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.967E-03 0.02033561 1.000 1.000 ZHU_CMV_ALL_UP glaucoma DOID_1686 3.967E-03 0.02015404 0.08918706 0.37314292 ZHU_CMV_ALL_UP withdrawal disorder DOID_0060001 4.271E-03 0.02150778 0.09245606 0.3784712 ZHU_CMV_ALL_UP orofacial cleft DOID_0050567 4.427E-03 0.0220981 4.427E-03 0.08126398 ZHU_CMV_ALL_UP bile duct adenocarcinoma DOID_4896 4.747E-03 0.0234891 1.000 1.000 ZHU_CMV_ALL_UP cholangiocarcinoma DOID_4947 4.747E-03 0.0234891 1.000 1.000 ZHU_CMV_ALL_UP integumentary system cancer DOID_0060122 4.911E-03 0.02409048 1.000 1.000 ZHU_CMV_ALL_UP parasitic protozoa infectious disease DOID_2789 4.911E-03 0.02388458 1.000 1.000 ZHU_CMV_ALL_UP skin cancer DOID_4159 4.911E-03 0.02409048 1.000 1.000 ZHU_CMV_ALL_UP glioblastoma DOID_3068 5.418E-03 0.02612748 0.10380677 0.41018091 ZHU_CMV_ALL_UP bile duct cancer DOID_4606 5.418E-03 0.02590792 1.000 1.000 ZHU_CMV_ALL_UP bile duct carcinoma DOID_4897 5.418E-03 0.02590792 1.000 1.000 ZHU_CMV_ALL_UP oral cavity cancer DOID_8618 5.418E-03 0.02569202 0.10380677 0.40735208 ZHU_CMV_ALL_UP pre-malignant neoplasm DOID_0060071 6.315E-03 0.02969395 0.11182867 0.42139411 ZHU_CMV_ALL_UP in situ carcinoma DOID_8719 6.315E-03 0.02969395 0.11182867 0.42139411 ZHU_CMV_ALL_UP cholestasis DOID_13580 6.691E-03 0.03120466 0.11501758 0.43055922 ZHU_CMV_ALL_UP parasitic infectious disease DOID_1398 6.691E-03 0.03095097 1.000 1.000 ZHU_CMV_ALL_UP tooth disease DOID_1091 7.077E-03 0.03247288 0.11819521 0.43670827 ZHU_CMV_ALL_UP blood coagulation disease DOID_1247 7.674E-03 0.03493341 7.674E-03 0.12129655 ZHU_CMV_ALL_UP pancreatic ductal carcinoma DOID_3587 7.674E-03 0.03465616 0.12294059 0.45131092 ZHU_CMV_ALL_UP bile duct disease DOID_4138 7.878E-03 0.03529772 0.12451678 0.45416697 ZHU_CMV_ALL_UP male reproductive system disease DOID_48 7.878E-03 0.03502196 1.000 1.000 ZHU_CMV_ALL_UP biliary tract disease DOID_9741 8.085E-03 0.03566148 0.12609018 0.45697652 ZHU_CMV_ALL_UP pancreatic carcinoma DOID_4905 8.294E-03 0.03630177 0.1276608 0.45974048 ZHU_CMV_ALL_UP electroclinical syndrome DOID_0050701 9.154E-03 0.03975979 9.154E-03 0.14077114 ZHU_CMV_ALL_UP biliary tract cancer DOID_4607 0.01028225 0.04432272 1.000 1.000 ZHU_CMV_ALL_UP transitional cell carcinoma DOID_2671 0.01146906 0.04906689 0.1493596 0.50287343 ZHU_CMV_ALL_UP lymphoblastic leukemia DOID_1037 0.01271317 0.05398355 1.000 1.000 ZHU_CMV_ALL_UP Crohn's disease DOID_8778 0.01296877 0.05466098 1.000 1.000 ZHU_CMV_ALL_UP hypersensitivity reaction type I disease DOID_1205 0.01322662 0.05533783 0.16000868 0.53242656 ZHU_CMV_ALL_UP T cell deficiency DOID_11200 0.01779476 0.07390668 0.01779476 0.24107656 ZHU_CMV_ALL_UP retinal vascular occlusion DOID_1729 0.01779476 0.07337113 1.000 1.000 ZHU_CMV_ALL_UP chondrosarcoma DOID_3371 0.01779476 0.07284328 0.01779476 0.23547013 ZHU_CMV_ALL_UP Hermansky-Pudlak syndrome DOID_3753 0.01779476 0.07232297 1.000 1.000 ZHU_CMV_ALL_UP Paget's disease of bone DOID_5408 0.01779476 0.07181004 0.01779476 0.22500479 ZHU_CMV_ALL_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01779476 0.07130434 0.01779476 0.22011338 ZHU_CMV_ALL_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01779476 0.07130434 0.01779476 0.22011338 ZHU_CMV_ALL_UP Hodgkin's granuloma DOID_8651 0.01779476 0.07130434 0.01779476 0.22011338 ZHU_CMV_ALL_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01779476 0.07130434 0.01779476 0.22011338 ZHU_CMV_ALL_UP visceral leishmaniasis DOID_9146 0.01779476 0.0708057 1.000 1.000 ZHU_CMV_ALL_UP familial adenomatous polyposis DOID_0050424 0.01955698 0.07727722 1.000 1.000 ZHU_CMV_ALL_UP breast benign neoplasm DOID_0060082 0.01955698 0.07674427 0.01955698 0.23676425 ZHU_CMV_ALL_UP thoracic benign neoplasm DOID_0060097 0.01955698 0.07674427 0.01955698 0.23676425 ZHU_CMV_ALL_UP trypanosomiasis DOID_10113 0.01955698 0.07621863 1.000 1.000 ZHU_CMV_ALL_UP prediabetes syndrome DOID_11716 0.01955698 0.07570013 1.000 1.000 ZHU_CMV_ALL_UP migraine without aura DOID_12783 0.01955698 0.07518865 0.01955698 0.23183166 ZHU_CMV_ALL_UP benign breast phyllodes tumor DOID_1631 0.01955698 0.07674427 0.01955698 0.23676425 ZHU_CMV_ALL_UP bronchiectasis DOID_9563 0.01955698 0.07468402 0.01955698 0.2271004 ZHU_CMV_ALL_UP common cold DOID_10459 0.02131608 0.08085901 1.000 1.000 ZHU_CMV_ALL_UP porphyria DOID_13268 0.02131608 0.08032352 0.02131608 0.24257702 ZHU_CMV_ALL_UP aortic valve stenosis DOID_1712 0.02131608 0.07979507 0.02131608 0.23782061 ZHU_CMV_ALL_UP stomach disease DOID_76 0.02131608 0.07927354 1.000 1.000 ZHU_CMV_ALL_UP Hodgkin's lymphoma DOID_8567 0.02131608 0.07875877 0.02131608 0.23324714 ZHU_CMV_ALL_UP progressive myoclonus epilepsy DOID_891 0.02131608 0.07825065 0.02131608 0.22884625 ZHU_CMV_ALL_UP variable age at onset electroclinical syndrome DOID_0050706 0.02307208 0.08415393 0.02307208 0.23869115 ZHU_CMV_ALL_UP berylliosis DOID_10322 0.02307208 0.08361792 1.000 1.000 ZHU_CMV_ALL_UP larynx cancer DOID_2596 0.02307208 0.08308869 1.000 1.000 ZHU_CMV_ALL_UP laryngeal benign neoplasm DOID_2598 0.02307208 0.08308869 1.000 1.000 ZHU_CMV_ALL_UP viral pneumonia DOID_10533 0.02482497 0.08883905 1.000 1.000 ZHU_CMV_ALL_UP hypercalcemia DOID_12678 0.02482497 0.0882838 1.000 1.000 ZHU_CMV_ALL_UP narcolepsy DOID_8986 0.02482497 0.08773546 0.02482497 0.2394137 ZHU_CMV_ALL_UP idiopathic pulmonary fibrosis DOID_0050156 0.02657476 0.09333976 1.000 1.000 ZHU_CMV_ALL_UP peripheral neuropathy DOID_0060053 0.02657476 0.09276712 0.02657476 0.25201735 ZHU_CMV_ALL_UP skeletal system cancer DOID_0060124 0.02657476 0.09220147 1.000 1.000 ZHU_CMV_ALL_UP thoracic aortic aneurysm DOID_14004 0.02657476 0.09164267 1.000 1.000 ZHU_CMV_ALL_UP renovascular hypertension DOID_1591 0.02657476 0.09109061 1.000 1.000 ZHU_CMV_ALL_UP bone cancer DOID_184 0.02657476 0.09220147 1.000 1.000 ZHU_CMV_ALL_UP lung oat cell carcinoma DOID_5411 0.02657476 0.09054515 1.000 1.000 ZHU_CMV_ALL_UP oral submucous fibrosis DOID_5773 0.02657476 0.09000619 1.000 1.000 ZHU_CMV_ALL_UP silicosis DOID_10325 0.02832146 0.09535451 0.02832146 0.2641789 ZHU_CMV_ALL_UP hemolytic-uremic syndrome DOID_12554 0.02832146 0.0947936 1.000 1.000 ZHU_CMV_ALL_UP thyroiditis DOID_7166 0.02832146 0.09423926 1.000 1.000 ZHU_CMV_ALL_UP autoimmune thyroiditis DOID_7188 0.02832146 0.09423926 1.000 1.000 ZHU_CMV_ALL_UP chronic myeloid leukemia DOID_8552 0.02832146 0.09369135 0.02832146 0.25991795 ZHU_CMV_ALL_UP tongue cancer DOID_8649 0.02832146 0.09314978 1.000 1.000 ZHU_CMV_ALL_UP Barrett's esophagus DOID_9206 0.02832146 0.09261444 1.000 1.000 ZHU_CMV_ALL_UP Graves' disease DOID_12361 0.03006507 0.09775444 0.03006507 0.27154012 ZHU_CMV_ALL_UP hyperostosis DOID_205 0.03006507 0.09719902 0.03006507 0.2672973 ZHU_CMV_ALL_UP basal cell carcinoma DOID_2513 0.03006507 0.09664987 1.000 1.000 ZHU_CMV_ALL_UP bronchitis DOID_6132 0.03006507 0.0961069 0.03006507 0.26318504 ZHU_CMV_ALL_UP skin carcinoma DOID_3451 0.0318056 0.09998557 1.000 1.000 ZHU_CMV_ALL_UP ureteral obstruction DOID_5199 0.0318056 0.0994362 0.0318056 0.26613806 ZHU_CMV_ALL_UP prion disease DOID_649 0.0318056 0.09889283 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN encephalomyelitis DOID_640 8.459E-07 4.813E-04 0.01987383 0.32309164 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN hypersensitivity reaction type I disease DOID_1205 9.008E-07 2.563E-04 0.02028848 0.31200394 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN Sjogren's syndrome DOID_12894 1.752E-06 3.323E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN narcolepsy DOID_8986 3.541E-06 5.037E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN thyroiditis DOID_7166 4.669E-06 5.313E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN autoimmune thyroiditis DOID_7188 4.669E-06 5.313E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN juvenile rheumatoid arthritis DOID_676 5.291E-06 5.017E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN myasthenia gravis DOID_437 9.836E-06 7.995E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN sleep disorder DOID_535 9.836E-06 6.996E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN urticaria DOID_1555 1.263E-05 7.986E-04 5.474E-03 0.34607129 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN neuromuscular junction disease DOID_439 1.364E-05 7.761E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN myositis DOID_633 1.364E-05 7.056E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN ankylosing spondylitis DOID_7147 1.364E-05 6.468E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN vitiligo DOID_12306 1.469E-05 6.429E-04 5.894E-03 0.27946752 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN autoimmune disease of the nervous system DOID_438 1.69E-05 6.868E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN autoimmune disease of endocrine system DOID_0060005 1.806E-05 6.852E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN celiac disease DOID_10608 2.179E-05 7.747E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN esophageal disease DOID_6050 2.585E-05 8.654E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN uveitis DOID_13141 3.182E-05 1.006E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN uveal disease DOID_3480 4.014E-05 1.202E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN vascular skin disease DOID_9540 4.749E-05 1.351E-03 0.01050342 0.27165655 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN autoimmune disease of gastrointestinal tract DOID_0060031 5.139E-05 1.393E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN B-cell lymphocytic neoplasm DOID_707 5.545E-05 1.434E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN pustulosis of palm and sole DOID_4398 6.403E-05 1.584E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN brain infarction DOID_3454 9.612E-05 2.279E-03 0.01488598 0.28233749 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN peripheral vascular disease DOID_341 1.073E-04 2.442E-03 0.01571883 0.27950045 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN Human immunodeficiency virus infectious disease DOID_526 1.616E-04 3.536E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN lymphoma DOID_0060058 1.687E-04 3.555E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN angioedema DOID_1558 2.108E-03 0.04284677 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN lateral sclerosis DOID_230 2.108E-03 0.0413693 2.108E-03 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN dermatomyositis DOID_10223 2.319E-03 0.04398529 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN pneumocystosis DOID_11339 2.319E-03 0.04256641 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN common variable immunodeficiency DOID_12177 2.319E-03 0.04123621 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN stomach disease DOID_76 2.53E-03 0.04361775 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN encephalitis DOID_9588 2.53E-03 0.04233488 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN cone-rod dystrophy DOID_0050572 2.74E-03 0.04454831 2.74E-03 0.77959534 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN parasitic helminthiasis infectious disease DOID_883 2.951E-03 0.04663815 2.951E-03 0.55965781 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN adrenal cortex disease DOID_3952 3.161E-03 0.04861443 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN spastic diplegia DOID_10965 3.372E-03 0.05048612 3.372E-03 0.47961813 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN adrenal gland disease DOID_9553 3.582E-03 0.05226125 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN glucose intolerance DOID_10603 3.792E-03 0.05394708 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN keratosis DOID_161 3.792E-03 0.0526313 3.792E-03 0.43157664 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN dental caries DOID_216 3.792E-03 0.05137817 3.792E-03 0.3596472 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN prion disease DOID_649 3.792E-03 0.05018333 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN eosinophilia DOID_999 3.792E-03 0.0490428 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN agammaglobulinemia DOID_2583 4.003E-03 0.05061234 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN membranous glomerulonephritis DOID_10976 4.213E-03 0.05211316 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN blood protein disease DOID_620 4.213E-03 0.05100437 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN autoimmune hepatitis DOID_2048 4.423E-03 0.05243403 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN funisitis DOID_0050698 4.633E-03 0.05380488 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN hepatitis B DOID_2043 4.633E-03 0.05272878 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN Lewy body dementia DOID_12217 5.054E-03 0.05638401 5.054E-03 0.41079779 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN spastic quadriplegia DOID_10970 5.264E-03 0.05759854 5.264E-03 0.37439052 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN bronchiolitis DOID_2942 5.474E-03 0.05876682 5.474E-03 0.31146416 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN spinal muscular atrophy DOID_12377 5.684E-03 0.05989143 5.684E-03 0.29401245 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN B cell deficiency DOID_2115 5.894E-03 0.06097473 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN teeth hard tissue disease DOID_214 5.894E-03 0.0598859 5.894E-03 0.25797002 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN pleurisy DOID_10247 6.314E-03 0.06302615 6.314E-03 0.25660648 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN spastic cerebral palsy DOID_0050669 6.943E-03 0.06811458 6.943E-03 0.26337639 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN opportunistic mycosis DOID_2473 6.943E-03 0.0669601 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN bronchiolitis obliterans DOID_2799 6.943E-03 0.0658441 6.943E-03 0.24691536 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN abdominal aortic aneurysm DOID_7693 6.943E-03 0.06476468 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN chronic leukemia DOID_1036 7.363E-03 0.06756944 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN chronic lymphocytic leukemia DOID_1040 7.363E-03 0.06756944 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN pleural disease DOID_1532 7.363E-03 0.06649691 7.363E-03 0.24642974 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN systemic mycosis DOID_0050136 7.572E-03 0.06732191 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN fungal infectious disease DOID_1564 7.572E-03 0.06732191 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN myocarditis DOID_820 7.572E-03 0.06628619 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN hepatitis DOID_2237 8.829E-03 0.07612 8.829E-03 0.27910668 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN systemic scleroderma DOID_418 8.829E-03 0.07498388 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN rheumatic disease DOID_1575 9.667E-03 0.08088762 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN scleroderma DOID_419 9.667E-03 0.08088762 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN uterine cancer DOID_363 9.876E-03 0.08144076 9.876E-03 0.29575856 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN leukodystrophy DOID_10579 0.0102943 0.08367794 0.0102943 0.29287278 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN proteinuria DOID_576 0.0102943 0.08249937 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN neuritis DOID_1803 0.01050342 0.08300617 0.01050342 0.28459257 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN pulmonary tuberculosis DOID_2957 0.01092154 0.08512815 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN aortic aneurysm DOID_3627 0.01113054 0.08558483 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN hemorrhagic disease DOID_2213 0.0113395 0.08602904 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN sarcoidosis DOID_11335 0.01175732 0.08802517 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN giant cell tumor DOID_200 0.01175732 0.08688198 0.01175732 0.29086577 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN malignant giant cell tumor DOID_2705 0.01175732 0.08688198 0.01175732 0.29086577 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN giant cell glioblastoma DOID_3074 0.01175732 0.08688198 0.01175732 0.29086577 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN vasculitis DOID_865 0.01196616 0.08729163 0.01196616 0.28369781 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN retinitis pigmentosa DOID_10584 0.01280117 0.09220083 0.01280117 0.29135463 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN hypersensitivity reaction type IV disease DOID_2916 0.01280117 0.09104832 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN glioblastoma DOID_3068 0.01280117 0.08992427 0.01280117 0.28014868 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN leukocyte disease DOID_9500 0.01300982 0.09027549 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN collagen disease DOID_854 0.01342702 0.09204788 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN hypothyroidism DOID_1459 0.01363556 0.09236467 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN parasitic infectious disease DOID_1398 0.01426094 0.09546444 0.01426094 0.3005362 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN cerebral degeneration DOID_1443 0.01426094 0.09435439 0.01426094 0.28980277 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN hyperglycemia DOID_4195 0.01446933 0.09463274 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN tooth disease DOID_1091 0.01467768 0.09490452 0.01467768 0.28798612 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN tuberculosis DOID_399 0.01488598 0.09516994 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN astrocytoma DOID_3069 0.01509425 0.09542922 0.01509425 0.27705258 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN blood coagulation disease DOID_1247 0.01530248 0.09568256 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN syndrome DOID_225 0.01634306 0.09999141 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN bacterial pneumonia DOID_874 0.01675902 0.09933212 0.01675902 0.28046715 KOBAYASHI_EGFR_SIGNALING_6HR_DN angiosarcoma DOID_0001816 2.797E-08 1.592E-05 6.313E-03 0.71843197 KOBAYASHI_EGFR_SIGNALING_6HR_DN sarcoma DOID_1115 2.021E-07 5.751E-05 0.01180655 0.67179258 KOBAYASHI_EGFR_SIGNALING_6HR_DN pulmonary edema DOID_11396 2.765E-05 5.244E-03 7.886E-03 0.74781445 KOBAYASHI_EGFR_SIGNALING_6HR_DN osteosarcoma DOID_3347 4.723E-05 6.718E-03 4.723E-05 0.0268728 KOBAYASHI_EGFR_SIGNALING_6HR_DN cystitis DOID_1679 5.099E-05 5.803E-03 0.01063177 0.67216441 KOBAYASHI_EGFR_SIGNALING_6HR_DN bladder disease DOID_365 8.629E-05 8.183E-03 0.01376161 0.55931119 KOBAYASHI_EGFR_SIGNALING_6HR_DN systemic scleroderma DOID_418 1.247E-04 0.01013319 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN cervix uteri carcinoma in situ DOID_8991 1.369E-04 9.737E-03 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN rheumatic disease DOID_1575 1.497E-04 9.465E-03 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN scleroderma DOID_419 1.497E-04 9.465E-03 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN brain cancer DOID_1319 1.77E-04 0.01007357 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN central nervous system cancer DOID_3620 1.842E-04 9.529E-03 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN giant cell tumor DOID_200 2.223E-04 0.0105388 0.02193352 0.56728061 KOBAYASHI_EGFR_SIGNALING_6HR_DN malignant giant cell tumor DOID_2705 2.223E-04 0.0105388 0.02193352 0.56728061 KOBAYASHI_EGFR_SIGNALING_6HR_DN giant cell glioblastoma DOID_3074 2.223E-04 0.0105388 0.02193352 0.56728061 KOBAYASHI_EGFR_SIGNALING_6HR_DN reproductive organ benign neoplasm DOID_0050622 2.385E-04 0.01043717 0.02270849 0.56178837 KOBAYASHI_EGFR_SIGNALING_6HR_DN glioblastoma DOID_3068 2.638E-04 0.01072207 0.02386988 0.56591499 KOBAYASHI_EGFR_SIGNALING_6HR_DN collagen disease DOID_854 2.904E-04 0.01101684 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN respiratory failure DOID_11162 2.996E-04 0.01065373 0.02541638 0.51649724 KOBAYASHI_EGFR_SIGNALING_6HR_DN pre-malignant neoplasm DOID_0060071 3.089E-04 0.01033802 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN in situ carcinoma DOID_8719 3.089E-04 0.01033802 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN astrocytoma DOID_3069 3.675E-04 0.01161855 0.02811727 0.53329092 KOBAYASHI_EGFR_SIGNALING_6HR_DN nephrosis DOID_2527 3.882E-04 0.01162616 0.02888767 0.51365887 KOBAYASHI_EGFR_SIGNALING_6HR_DN peripheral vascular disease DOID_341 3.988E-04 0.01134486 0.02927265 0.50473153 KOBAYASHI_EGFR_SIGNALING_6HR_DN diabetic retinopathy DOID_8947 4.094E-04 0.01109411 0.0296575 0.49632694 KOBAYASHI_EGFR_SIGNALING_6HR_DN syndrome DOID_225 4.312E-04 0.01115324 0.03042676 0.48091178 KOBAYASHI_EGFR_SIGNALING_6HR_DN retinal vascular disease DOID_2462 5.361E-04 0.0132628 0.03388138 0.47020744 KOBAYASHI_EGFR_SIGNALING_6HR_DN primary bacterial infectious disease DOID_0050338 5.609E-04 0.01329867 0.03464751 0.4693913 KOBAYASHI_EGFR_SIGNALING_6HR_DN nervous system cancer DOID_3093 5.992E-04 0.01363761 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN encephalomyelitis DOID_640 6.387E-04 0.0139775 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 6.521E-04 0.01374306 0.03732451 0.49389879 KOBAYASHI_EGFR_SIGNALING_6HR_DN hyperparathyroidism DOID_13543 3.95E-03 0.08027098 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN retinal vascular occlusion DOID_1729 3.95E-03 0.07750302 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN insulinoma DOID_3892 3.95E-03 0.07491959 3.95E-03 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN keratitis DOID_4677 3.95E-03 0.07250282 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN invasive lobular carcinoma DOID_3457 4.344E-03 0.07724656 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN common cold DOID_10459 4.738E-03 0.08170029 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN islet cell tumor DOID_1799 4.738E-03 0.07929734 4.738E-03 0.89870319 KOBAYASHI_EGFR_SIGNALING_6HR_DN parathyroid gland disease DOID_11201 5.132E-03 0.08343561 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN intracranial thrombosis DOID_4193 5.132E-03 0.08111795 5.132E-03 0.73006158 KOBAYASHI_EGFR_SIGNALING_6HR_DN Legionnaires' disease DOID_10457 5.526E-03 0.08498109 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN legionellosis DOID_10458 5.526E-03 0.08498109 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN rhabdomyosarcoma DOID_3247 5.526E-03 0.08274474 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN hemangioma DOID_255 5.92E-03 0.08636593 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN skeletal muscle cancer DOID_4043 5.92E-03 0.08420679 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN bronchitis DOID_6132 6.706E-03 0.09307233 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN urinary system benign neoplasm DOID_731 6.706E-03 0.09085632 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN male reproductive organ benign neoplasm DOID_0060087 7.1E-03 0.09394625 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN prion disease DOID_649 7.1E-03 0.0918111 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN granulosa cell tumor DOID_2999 7.493E-03 0.09474064 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN colon carcinoma DOID_1520 7.886E-03 0.09754102 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN sex cord-gonadal stromal tumor DOID_192 7.886E-03 0.09546567 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN brain edema DOID_4724 7.886E-03 0.09347681 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN Kawasaki disease DOID_13378 8.278E-03 0.09612983 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN lymphadenitis DOID_1602 8.278E-03 0.09612983 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN lymph node disease DOID_9942 8.278E-03 0.09612983 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN gastric ulcer DOID_10808 8.671E-03 0.09867509 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN thrombophilia DOID_2452 8.671E-03 0.09674028 8.671E-03 0.70482206 KOBAYASHI_EGFR_SIGNALING_6HR_DN muscle cancer DOID_4045 9.063E-03 0.09917432 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN polyarteritis nodosa DOID_9810 9.063E-03 0.0973031 1.000 1.000 KOBAYASHI_EGFR_SIGNALING_6HR_DN diabetic angiopathy DOID_11713 9.456E-03 0.09963504 9.456E-03 0.6725365 KOBAYASHI_EGFR_SIGNALING_6HR_DN Goodpasture syndrome DOID_9808 9.456E-03 0.09782349 1.000 1.000 ROY_WOUND_BLOOD_VESSEL_UP heart valve disease DOID_4079 6.204E-08 3.53E-05 6.765E-04 0.02961084 ROY_WOUND_BLOOD_VESSEL_UP atrophic muscular disease DOID_913 9.863E-08 2.806E-05 9.863E-08 5.612E-05 ROY_WOUND_BLOOD_VESSEL_UP muscular dystrophy DOID_9884 9.863E-08 2.806E-05 9.863E-08 5.612E-05 ROY_WOUND_BLOOD_VESSEL_UP varicose veins DOID_799 1.82E-07 3.451E-05 5.896E-05 6.709E-03 ROY_WOUND_BLOOD_VESSEL_UP vein disease DOID_866 2.238E-07 3.184E-05 6.735E-05 6.387E-03 ROY_WOUND_BLOOD_VESSEL_UP aneurysm disease DOID_2403 3.986E-07 4.536E-05 1.678E-03 0.05968469 ROY_WOUND_BLOOD_VESSEL_UP aortic valve disease DOID_62 8.057E-07 7.641E-05 1.543E-04 8.781E-03 ROY_WOUND_BLOOD_VESSEL_UP intracranial aneurysm DOID_10941 1.301E-06 1.058E-04 2.109E-04 0.0109116 ROY_WOUND_BLOOD_VESSEL_UP carotid artery disease DOID_3407 1.625E-05 1.156E-03 0.04783435 0.40623499 ROY_WOUND_BLOOD_VESSEL_UP collagen disease DOID_854 1.625E-05 1.027E-03 1.106E-03 0.04495097 ROY_WOUND_BLOOD_VESSEL_UP nephrosis DOID_2527 2.515E-05 1.431E-03 1.475E-03 0.05594391 ROY_WOUND_BLOOD_VESSEL_UP facioscapulohumeral muscular dystrophy DOID_11727 2.533E-05 1.31E-03 2.533E-05 7.206E-03 ROY_WOUND_BLOOD_VESSEL_UP aortic valve insufficiency DOID_57 3.711E-05 1.76E-03 3.711E-05 7.039E-03 ROY_WOUND_BLOOD_VESSEL_UP transitional cell carcinoma DOID_2671 4.521E-05 1.979E-03 2.17E-03 0.07264126 ROY_WOUND_BLOOD_VESSEL_UP mouth disease DOID_403 5.481E-05 2.228E-03 2.464E-03 0.07789132 ROY_WOUND_BLOOD_VESSEL_UP Ehlers-Danlos syndrome DOID_13359 5.896E-05 2.236E-03 5.896E-05 8.387E-03 ROY_WOUND_BLOOD_VESSEL_UP oral submucous fibrosis DOID_5773 5.896E-05 2.097E-03 0.0114151 0.24981511 ROY_WOUND_BLOOD_VESSEL_UP intermediate coronary syndrome DOID_8805 5.896E-05 1.973E-03 1.000 1.000 ROY_WOUND_BLOOD_VESSEL_UP ureteral obstruction DOID_5199 8.579E-05 2.712E-03 8.579E-05 6.973E-03 ROY_WOUND_BLOOD_VESSEL_UP urinary tract obstruction DOID_5200 1.415E-04 4.238E-03 1.415E-04 0.01006584 ROY_WOUND_BLOOD_VESSEL_UP ureteral disease DOID_1426 1.543E-04 4.39E-03 1.543E-04 9.756E-03 ROY_WOUND_BLOOD_VESSEL_UP focal glomerulosclerosis DOID_3945 2.591E-04 7.021E-03 2.591E-04 0.01228691 ROY_WOUND_BLOOD_VESSEL_UP nephrotic syndrome DOID_1184 5.727E-04 0.01481151 0.03460898 0.35165196 HARRIS_HYPOXIA peptic ulcer DOID_750 6.207E-17 3.532E-14 0.07472453 0.31495005 HARRIS_HYPOXIA diabetic retinopathy DOID_8947 2.04E-16 5.803E-14 8.77E-03 0.09241037 HARRIS_HYPOXIA retinal vascular disease DOID_2462 8.415E-16 1.596E-13 0.01136288 0.10262662 HARRIS_HYPOXIA portal hypertension DOID_10762 3.437E-14 4.889E-12 0.04693047 0.25925666 HARRIS_HYPOXIA metabolic syndrome X DOID_14221 3.849E-14 4.381E-12 1.672E-05 1.903E-03 HARRIS_HYPOXIA hepatic vascular disease DOID_272 1.057E-13 1.003E-11 0.05395518 0.27411159 HARRIS_HYPOXIA mineral metabolism disease DOID_0050032 5.343E-13 4.343E-11 6.877E-03 0.07985401 HARRIS_HYPOXIA brain infarction DOID_3454 8.666E-13 6.163E-11 9.43E-06 1.789E-03 HARRIS_HYPOXIA nephrosis DOID_2527 1.222E-12 7.727E-11 1.112E-05 1.582E-03 HARRIS_HYPOXIA cystic fibrosis DOID_1485 1.89E-12 1.076E-10 1.000 1.000 HARRIS_HYPOXIA aneurysm disease DOID_2403 2.1E-12 1.086E-10 4.311E-04 0.01752148 HARRIS_HYPOXIA chronic kidney failure DOID_784 3.841E-12 1.821E-10 0.01086918 0.099751 HARRIS_HYPOXIA pre-eclampsia DOID_10591 5.039E-12 2.206E-10 2.301E-06 1.31E-03 HARRIS_HYPOXIA giant cell tumor DOID_200 1.16E-11 4.714E-10 0.09838787 0.37321799 HARRIS_HYPOXIA malignant giant cell tumor DOID_2705 1.16E-11 4.714E-10 0.09838787 0.37321799 HARRIS_HYPOXIA giant cell glioblastoma DOID_3074 1.16E-11 4.714E-10 0.09838787 0.37321799 HARRIS_HYPOXIA sarcoma DOID_1115 1.824E-11 6.92E-10 1.414E-03 0.03497655 HARRIS_HYPOXIA glioblastoma DOID_3068 2.166E-11 7.703E-10 0.10669367 0.37942935 HARRIS_HYPOXIA uterine disease DOID_345 4.765E-11 1.595E-09 0.11819521 0.40031591 HARRIS_HYPOXIA astrocytoma DOID_3069 7.198E-11 2.275E-09 0.12470185 0.41494358 HARRIS_HYPOXIA angiosarcoma DOID_0001816 7.977E-11 2.389E-09 3.966E-04 0.01735838 HARRIS_HYPOXIA female reproductive system disease DOID_229 1.996E-10 5.68E-09 0.14235209 0.45761773 HARRIS_HYPOXIA diabetic autonomic neuropathy DOID_11503 3.219E-10 8.721E-09 3.443E-03 0.05761952 HARRIS_HYPOXIA autonomic neuropathy DOID_11504 3.219E-10 8.721E-09 3.443E-03 0.05761952 HARRIS_HYPOXIA diabetic polyneuropathy DOID_12785 3.219E-10 8.721E-09 3.443E-03 0.05761952 HARRIS_HYPOXIA uterine cancer DOID_363 3.219E-10 8.325E-09 3.443E-03 0.05441844 HARRIS_HYPOXIA diabetic neuropathy DOID_9743 3.219E-10 8.721E-09 3.443E-03 0.05761952 HARRIS_HYPOXIA transitional cell carcinoma DOID_2671 3.556E-10 8.798E-09 6.312E-04 0.02394466 HARRIS_HYPOXIA cerebral infarction DOID_3526 3.673E-10 8.709E-09 9.823E-05 6.21E-03 HARRIS_HYPOXIA myeloma DOID_0070004 4.743E-10 1.079E-08 3.888E-03 0.05821378 HARRIS_HYPOXIA autonomic nervous system disease DOID_11465 4.743E-10 1.038E-08 3.888E-03 0.05672112 HARRIS_HYPOXIA gastric ulcer DOID_10808 4.768E-10 1.005E-08 0.03985434 0.24649045 HARRIS_HYPOXIA placenta disease DOID_780 4.768E-10 9.689E-09 0.03985434 0.23870654 HARRIS_HYPOXIA muscle cancer DOID_4045 6.084E-10 1.194E-08 1.000 1.000 HARRIS_HYPOXIA uremia DOID_4676 6.084E-10 1.154E-08 0.04162821 0.24673389 HARRIS_HYPOXIA aortic aneurysm DOID_3627 6.822E-10 1.252E-08 1.322E-04 6.267E-03 HARRIS_HYPOXIA bone marrow cancer DOID_4960 1.072E-09 1.906E-08 5.023E-03 0.06646981 HARRIS_HYPOXIA middle cerebral artery infarction DOID_3525 1.764E-09 3.042E-08 1.231E-03 0.03503588 HARRIS_HYPOXIA melancholia DOID_2848 1.803E-09 3.018E-08 5.916E-03 0.07318379 HARRIS_HYPOXIA neurotic disorder DOID_4964 1.99E-09 3.235E-08 6.103E-03 0.07388733 HARRIS_HYPOXIA carotid artery disease DOID_3407 2.193E-09 3.466E-08 6.293E-03 0.07459323 HARRIS_HYPOXIA collagen disease DOID_854 2.193E-09 3.372E-08 0.11164089 0.39212141 HARRIS_HYPOXIA endocrine pancreas disease DOID_1428 2.906E-09 4.352E-08 0.11656111 0.39953779 HARRIS_HYPOXIA focal glomerulosclerosis DOID_3945 3.037E-09 4.431E-08 0.05570337 0.27323463 HARRIS_HYPOXIA parasitic infectious disease DOID_1398 3.183E-09 4.528E-08 0.11819521 0.40271301 HARRIS_HYPOXIA endocrine organ benign neoplasm DOID_0060089 4.147E-09 5.755E-08 0.12307964 0.41195479 HARRIS_HYPOXIA tuberculosis DOID_399 4.147E-09 5.618E-08 7.692E-03 0.08417181 HARRIS_HYPOXIA abdominal aortic aneurysm DOID_7693 4.23E-09 5.597E-08 1.71E-03 0.03891852 HARRIS_HYPOXIA peripheral vascular disease DOID_341 5.796E-09 7.496E-08 8.549E-03 0.09178493 HARRIS_HYPOXIA endogenous depression DOID_1595 7.362E-09 9.308E-08 9.219E-03 0.09537468 HARRIS_HYPOXIA nephroblastoma DOID_2154 7.725E-09 9.555E-08 1.000 1.000 HARRIS_HYPOXIA thyroid carcinoma DOID_3963 7.725E-09 9.352E-08 0.06612583 0.30100477 HARRIS_HYPOXIA thyroid cancer DOID_1781 1.017E-08 1.206E-07 0.06957472 0.30688384 HARRIS_HYPOXIA adenoma DOID_657 1.017E-08 1.181E-07 2.383E-03 0.04674965 HARRIS_HYPOXIA mental depression DOID_1596 1.241E-08 1.412E-07 0.01086918 0.10307604 HARRIS_HYPOXIA nutritional deficiency disease DOID_5113 1.432E-08 1.598E-07 2.7E-06 7.68E-04 HARRIS_HYPOXIA hepatitis DOID_2237 1.497E-08 1.638E-07 6.572E-05 4.674E-03 HARRIS_HYPOXIA systemic scleroderma DOID_418 1.497E-08 1.607E-07 1.000 1.000 HARRIS_HYPOXIA primary bacterial infectious disease DOID_0050338 1.639E-08 1.727E-07 0.01186631 0.10549892 HARRIS_HYPOXIA intracranial arterial disease DOID_13089 1.691E-08 1.75E-07 2.89E-03 0.05304153 HARRIS_HYPOXIA cerebral arterial disease DOID_3527 1.691E-08 1.75E-07 2.89E-03 0.05304153 HARRIS_HYPOXIA pulmonary emphysema DOID_9675 1.905E-08 1.936E-07 1.000 1.000 HARRIS_HYPOXIA rheumatic disease DOID_1575 2.398E-08 2.394E-07 1.000 1.000 HARRIS_HYPOXIA scleroderma DOID_419 2.398E-08 2.394E-07 1.000 1.000 HARRIS_HYPOXIA carbohydrate metabolic disorder DOID_2978 2.43E-08 2.384E-07 2.989E-05 2.429E-03 HARRIS_HYPOXIA encephalomyelitis DOID_640 2.43E-08 2.344E-07 1.000 1.000 HARRIS_HYPOXIA Crohn's disease DOID_8778 2.589E-08 2.455E-07 0.16275956 0.51165851 HARRIS_HYPOXIA proteinuria DOID_576 3.322E-08 3.099E-07 1.000 1.000 HARRIS_HYPOXIA thyroid adenoma DOID_2891 3.686E-08 3.382E-07 0.08832039 0.35390352 HARRIS_HYPOXIA hemolytic anemia DOID_583 4.08E-08 3.685E-07 4.042E-03 0.05749196 HARRIS_HYPOXIA normocytic anemia DOID_720 4.08E-08 3.685E-07 4.042E-03 0.05749196 HARRIS_HYPOXIA pulmonary tuberculosis DOID_2957 4.508E-08 4.008E-07 4.198E-03 0.058264 HARRIS_HYPOXIA integumentary system cancer DOID_0060122 7.88E-08 6.898E-07 1.000 1.000 HARRIS_HYPOXIA parasitic protozoa infectious disease DOID_2789 7.88E-08 6.794E-07 0.10171928 0.37101457 HARRIS_HYPOXIA skin cancer DOID_4159 7.88E-08 6.898E-07 1.000 1.000 HARRIS_HYPOXIA toxic shock syndrome DOID_14115 1.309E-07 1.112E-06 0.04516627 0.25699608 HARRIS_HYPOXIA respiratory failure DOID_11162 1.406E-07 1.177E-06 0.11328396 0.39545137 HARRIS_HYPOXIA commensal bacterial infectious disease DOID_0050339 1.545E-07 1.274E-06 0.04693047 0.26439045 HARRIS_HYPOXIA endometrial carcinoma DOID_2871 3.685E-07 2.995E-06 1.608E-03 0.03812857 HARRIS_HYPOXIA mixed glioma DOID_5076 4.006E-07 3.211E-06 0.13757348 0.44731035 HARRIS_HYPOXIA endometrial cancer DOID_1380 4.739E-07 3.745E-06 1.815E-03 0.03971315 HARRIS_HYPOXIA pleural disease DOID_1532 5.343E-07 4.165E-06 1.000 1.000 HARRIS_HYPOXIA biliary tract cancer DOID_4607 5.428E-07 4.173E-06 0.01086918 0.10138627 HARRIS_HYPOXIA spindle cell carcinoma DOID_4015 6.721E-07 5.099E-06 0.06612583 0.29861585 HARRIS_HYPOXIA insulinoma DOID_3892 7.167E-07 5.366E-06 0.01831379 0.14081818 HARRIS_HYPOXIA nervous system cancer DOID_3093 8.056E-07 5.953E-06 0.01263954 0.11064462 HARRIS_HYPOXIA Human immunodeficiency virus infectious disease DOID_526 8.056E-07 5.877E-06 0.01263954 0.10896819 HARRIS_HYPOXIA multiple myeloma DOID_9538 9.261E-07 6.67E-06 0.07129445 0.3073223 HARRIS_HYPOXIA hypersensitivity reaction type I disease DOID_1205 1.048E-06 7.456E-06 1.000 1.000 HARRIS_HYPOXIA congenital diaphragmatic hernia DOID_3827 1.131E-06 7.946E-06 1.000 1.000 HARRIS_HYPOXIA ulcerative colitis DOID_8577 1.219E-06 8.461E-06 1.000 1.000 HARRIS_HYPOXIA lymphatic system disease DOID_75 1.245E-06 8.538E-06 1.000 1.000 HARRIS_HYPOXIA islet cell tumor DOID_1799 1.31E-06 8.877E-06 0.02193667 0.15799958 HARRIS_HYPOXIA cervix uteri carcinoma in situ DOID_8991 1.368E-06 9.158E-06 0.07814211 0.32454644 HARRIS_HYPOXIA nephrotic syndrome DOID_1184 1.64E-06 1.085E-05 3.3E-03 0.05690704 HARRIS_HYPOXIA berylliosis DOID_10322 1.701E-06 1.113E-05 1.000 1.000 HARRIS_HYPOXIA Leydig cell tumor DOID_2696 1.701E-06 1.1E-05 0.02374317 0.16475444 HARRIS_HYPOXIA sex cord-stromal neoplasm DOID_4757 1.701E-06 1.1E-05 0.02374317 0.16475444 HARRIS_HYPOXIA gallbladder cancer DOID_3121 1.79E-06 1.144E-05 3.443E-03 0.05597325 HARRIS_HYPOXIA learning disability DOID_8927 1.95E-06 1.233E-05 3.588E-03 0.05518406 HARRIS_HYPOXIA rhabdomyosarcoma DOID_3247 2.163E-06 1.352E-05 1.000 1.000 HARRIS_HYPOXIA brain cancer DOID_1319 2.301E-06 1.423E-05 0.08832039 0.35641348 HARRIS_HYPOXIA vascular skin disease DOID_9540 2.301E-06 1.408E-05 1.000 1.000 HARRIS_HYPOXIA central nervous system cancer DOID_3620 2.494E-06 1.51E-05 0.09000596 0.35564856 HARRIS_HYPOXIA autoimmune disease of gastrointestinal tract DOID_0060031 2.698E-06 1.616E-05 0.09168847 0.35979819 HARRIS_HYPOXIA integumentary system benign neoplasm DOID_0060121 2.698E-06 1.599E-05 1.000 1.000 HARRIS_HYPOXIA skin benign neoplasm DOID_3165 2.698E-06 1.599E-05 1.000 1.000 HARRIS_HYPOXIA membranoproliferative glomerulonephritis DOID_2920 2.7E-06 1.584E-05 1.000 1.000 HARRIS_HYPOXIA skeletal muscle cancer DOID_4043 2.7E-06 1.567E-05 1.000 1.000 HARRIS_HYPOXIA calcium metabolism disease DOID_10575 2.914E-06 1.675E-05 1.000 1.000 HARRIS_HYPOXIA Barrett's esophagus DOID_9206 3.318E-06 1.888E-05 0.02914295 0.18843567 HARRIS_HYPOXIA bile duct adenocarcinoma DOID_4896 3.909E-06 2.202E-05 0.1000551 0.37454836 HARRIS_HYPOXIA cholangiocarcinoma DOID_4947 3.909E-06 2.202E-05 0.1000551 0.37454836 HARRIS_HYPOXIA prion disease DOID_649 4.822E-06 2.69E-05 0.03272644 0.20922857 HARRIS_HYPOXIA bile duct cancer DOID_4606 5.136E-06 2.837E-05 0.10669367 0.37707265 HARRIS_HYPOXIA bile duct carcinoma DOID_4897 5.136E-06 2.837E-05 0.10669367 0.37707265 HARRIS_HYPOXIA leishmaniasis DOID_9065 5.719E-06 3.129E-05 1.000 1.000 HARRIS_HYPOXIA pulmonary edema DOID_11396 6.719E-06 3.641E-05 0.03629689 0.22947698 HARRIS_HYPOXIA pre-malignant neoplasm DOID_0060071 7.044E-06 3.781E-05 0.11492403 0.39631378 HARRIS_HYPOXIA in situ carcinoma DOID_8719 7.044E-06 3.781E-05 0.11492403 0.39631378 HARRIS_HYPOXIA Kawasaki disease DOID_13378 7.829E-06 4.163E-05 1.000 1.000 HARRIS_HYPOXIA lymphadenitis DOID_1602 7.829E-06 4.163E-05 1.000 1.000 HARRIS_HYPOXIA autoimmune hepatitis DOID_2048 7.829E-06 4.125E-05 1.000 1.000 HARRIS_HYPOXIA lymph node disease DOID_9942 7.829E-06 4.163E-05 1.000 1.000 HARRIS_HYPOXIA cerebral degeneration DOID_1443 7.937E-06 4.143E-05 1.000 1.000 HARRIS_HYPOXIA hyperglycemia DOID_4195 8.414E-06 4.352E-05 7.279E-03 0.0828384 HARRIS_HYPOXIA polyarteritis nodosa DOID_9810 1.04E-05 5.33E-05 1.000 1.000 HARRIS_HYPOXIA hypoglycemia DOID_9993 1.04E-05 5.282E-05 0.04162821 0.24419024 HARRIS_HYPOXIA pancreatic ductal carcinoma DOID_3587 1.053E-05 5.305E-05 1.000 1.000 HARRIS_HYPOXIA male reproductive system disease DOID_48 1.112E-05 5.551E-05 1.000 1.000 HARRIS_HYPOXIA diabetic angiopathy DOID_11713 1.187E-05 5.871E-05 9.035E-04 0.02705696 HARRIS_HYPOXIA meningitis DOID_9471 1.187E-05 5.821E-05 0.04339885 0.24943382 HARRIS_HYPOXIA Goodpasture syndrome DOID_9808 1.187E-05 5.771E-05 1.000 1.000 HARRIS_HYPOXIA pancreatic carcinoma DOID_4905 1.237E-05 5.963E-05 1.000 1.000 HARRIS_HYPOXIA bone resorption disease DOID_0080011 1.442E-05 6.896E-05 9.447E-03 0.09599082 HARRIS_HYPOXIA osteoporosis DOID_11476 1.442E-05 6.896E-05 9.447E-03 0.09599082 HARRIS_HYPOXIA bacterial pneumonia DOID_874 1.516E-05 7.188E-05 1.000 1.000 HARRIS_HYPOXIA lung adenocarcinoma DOID_3910 2.128E-05 1.001E-04 2.128E-05 2.018E-03 HARRIS_HYPOXIA renal hypertension DOID_1073 2.361E-05 1.101E-04 0.05395518 0.27658106 HARRIS_HYPOXIA secondary hypertension DOID_11130 2.361E-05 1.101E-04 0.05395518 0.27658106 HARRIS_HYPOXIA invasive ductal carcinoma DOID_3008 2.361E-05 1.092E-04 0.05395518 0.27168582 HARRIS_HYPOXIA spastic cerebral palsy DOID_0050669 3.161E-05 1.45E-04 1.000 1.000 HARRIS_HYPOXIA chronic leukemia DOID_1036 3.782E-05 1.721E-04 1.000 1.000 HARRIS_HYPOXIA chronic lymphocytic leukemia DOID_1040 3.782E-05 1.721E-04 1.000 1.000 HARRIS_HYPOXIA papilloma DOID_2615 4.12E-05 1.861E-04 0.06439666 0.2979 HARRIS_HYPOXIA myocarditis DOID_820 4.12E-05 1.846E-04 0.06439666 0.29549758 HARRIS_HYPOXIA pneumoconiosis DOID_10316 4.478E-05 1.99E-04 1.000 1.000 HARRIS_HYPOXIA esophageal disease DOID_6050 4.478E-05 1.975E-04 0.06612583 0.29626454 HARRIS_HYPOXIA calcinosis DOID_182 5.671E-05 2.482E-04 1.000 1.000 HARRIS_HYPOXIA hyperinsulinism DOID_2018 8.644E-05 3.755E-04 1.000 1.000 HARRIS_HYPOXIA cataract DOID_83 9.823E-05 4.234E-04 9.823E-05 5.589E-03 HARRIS_HYPOXIA leukodystrophy DOID_10579 1.045E-04 4.471E-04 1.000 1.000 HARRIS_HYPOXIA lens disease DOID_110 1.11E-04 4.714E-04 1.11E-04 5.743E-03 HARRIS_HYPOXIA heart valve disease DOID_4079 1.11E-04 4.679E-04 1.000 1.000 HARRIS_HYPOXIA glaucoma DOID_1686 1.249E-04 5.224E-04 0.09168847 0.35733382 HARRIS_HYPOXIA hyperparathyroidism DOID_13543 1.498E-04 6.221E-04 1.000 1.000 HARRIS_HYPOXIA retinal vascular occlusion DOID_1729 1.498E-04 6.176E-04 1.000 1.000 HARRIS_HYPOXIA acute kidney failure DOID_3021 1.498E-04 6.132E-04 1.000 1.000 HARRIS_HYPOXIA cutaneous leishmaniasis DOID_9111 1.498E-04 6.088E-04 1.000 1.000 HARRIS_HYPOXIA sarcoidosis DOID_11335 1.558E-04 6.286E-04 1.000 1.000 HARRIS_HYPOXIA atrophic muscular disease DOID_913 1.558E-04 6.242E-04 0.09838787 0.37074635 HARRIS_HYPOXIA muscular dystrophy DOID_9884 1.558E-04 6.242E-04 0.09838787 0.37074635 HARRIS_HYPOXIA vasculitis DOID_865 1.642E-04 6.534E-04 0.1000551 0.37210033 HARRIS_HYPOXIA reproductive organ benign neoplasm DOID_0050622 1.729E-04 6.834E-04 0.10171928 0.37583294 HARRIS_HYPOXIA osteochondrodysplasia DOID_2256 1.729E-04 6.787E-04 0.10171928 0.37340821 HARRIS_HYPOXIA pustulosis of palm and sole DOID_4398 1.729E-04 6.74E-04 0.10171928 0.36865142 HARRIS_HYPOXIA breast benign neoplasm DOID_0060082 1.829E-04 7.078E-04 0.02012688 0.15068678 HARRIS_HYPOXIA thoracic benign neoplasm DOID_0060097 1.829E-04 7.078E-04 0.02012688 0.15068678 HARRIS_HYPOXIA benign breast phyllodes tumor DOID_1631 1.829E-04 7.078E-04 0.02012688 0.15068678 HARRIS_HYPOXIA hypersensitivity reaction type IV disease DOID_2916 2.009E-04 7.725E-04 1.000 1.000 HARRIS_HYPOXIA oral cavity cancer DOID_8618 2.009E-04 7.673E-04 5.732E-03 0.07248287 HARRIS_HYPOXIA beta thalassemia DOID_12241 2.192E-04 8.314E-04 1.000 1.000 HARRIS_HYPOXIA congenital heart defect DOID_1682 2.538E-04 9.563E-04 1.000 1.000 HARRIS_HYPOXIA parathyroid gland disease DOID_11201 2.587E-04 9.685E-04 1.000 1.000 HARRIS_HYPOXIA newborn respiratory distress syndrome DOID_12716 2.587E-04 9.621E-04 1.000 1.000 HARRIS_HYPOXIA polyneuropathy DOID_1389 2.587E-04 9.559E-04 1.000 1.000 HARRIS_HYPOXIA larynx cancer DOID_2596 2.587E-04 9.497E-04 1.000 1.000 HARRIS_HYPOXIA laryngeal benign neoplasm DOID_2598 2.587E-04 9.497E-04 1.000 1.000 HARRIS_HYPOXIA cholestasis DOID_13580 2.772E-04 1.011E-03 1.000 1.000 HARRIS_HYPOXIA temporal lobe epilepsy DOID_3328 2.894E-04 1.049E-03 0.11982632 0.40343892 HARRIS_HYPOXIA viral pneumonia DOID_10533 3.015E-04 1.086E-03 1.000 1.000 HARRIS_HYPOXIA tethered spinal cord syndrome DOID_1089 3.015E-04 1.079E-03 0.02554638 0.1730463 HARRIS_HYPOXIA polycystic kidney disease DOID_898 3.015E-04 1.072E-03 1.000 1.000 HARRIS_HYPOXIA blood coagulation disease DOID_1247 3.418E-04 1.208E-03 0.1263211 0.41788783 HARRIS_HYPOXIA thalassemia DOID_10241 3.474E-04 1.22E-03 1.000 1.000 HARRIS_HYPOXIA oral submucous fibrosis DOID_5773 3.474E-04 1.213E-03 1.000 1.000 HARRIS_HYPOXIA intermediate coronary syndrome DOID_8805 3.474E-04 1.205E-03 0.0273463 0.18093077 HARRIS_HYPOXIA bile duct disease DOID_4138 3.557E-04 1.227E-03 1.000 1.000 HARRIS_HYPOXIA biliary tract disease DOID_9741 3.701E-04 1.268E-03 1.000 1.000 HARRIS_HYPOXIA spastic diplegia DOID_10965 3.966E-04 1.351E-03 1.000 1.000 HARRIS_HYPOXIA hemolytic-uremic syndrome DOID_12554 3.966E-04 1.343E-03 1.000 1.000 HARRIS_HYPOXIA tongue cancer DOID_8649 3.966E-04 1.335E-03 0.02914295 0.1906016 HARRIS_HYPOXIA pancreatitis DOID_4989 4.473E-04 1.497E-03 0.13757348 0.4498811 HARRIS_HYPOXIA penile disease DOID_1529 4.489E-04 1.494E-03 1.000 1.000 HARRIS_HYPOXIA bronchitis DOID_6132 4.489E-04 1.485E-03 1.000 1.000 HARRIS_HYPOXIA urinary system benign neoplasm DOID_731 4.489E-04 1.477E-03 1.000 1.000 HARRIS_HYPOXIA focal epilepsy DOID_2234 5.342E-04 1.747E-03 0.14552332 0.46518408 HARRIS_HYPOXIA bone development disease DOID_0080006 5.528E-04 1.797E-03 0.14710459 0.4676118 HARRIS_HYPOXIA granulosa cell tumor DOID_2999 5.631E-04 1.821E-03 1.000 1.000 HARRIS_HYPOXIA amnestic disorder DOID_10914 6.249E-04 2.009E-03 1.000 1.000 HARRIS_HYPOXIA esophagitis DOID_11963 6.249E-04 1.998E-03 1.000 1.000 HARRIS_HYPOXIA sex cord-gonadal stromal tumor DOID_192 6.249E-04 1.987E-03 1.000 1.000 HARRIS_HYPOXIA brain edema DOID_4724 6.249E-04 1.976E-03 0.03629689 0.22695526 HARRIS_HYPOXIA coronary restenosis DOID_4247 6.899E-04 2.169E-03 1.000 1.000 HARRIS_HYPOXIA lymphoblastic leukemia DOID_1037 7.388E-04 2.31E-03 1.000 1.000 HARRIS_HYPOXIA funisitis DOID_0050698 7.58E-04 2.357E-03 7.58E-04 0.02695579 HARRIS_HYPOXIA benign glioma DOID_0060101 7.58E-04 2.344E-03 1.000 1.000 HARRIS_HYPOXIA benign ependymoma DOID_4844 7.58E-04 2.344E-03 1.000 1.000 HARRIS_HYPOXIA acquired immunodeficiency syndrome DOID_635 7.58E-04 2.331E-03 1.000 1.000 HARRIS_HYPOXIA alcohol-related neurodevelopmental disorder DOID_0050667 7.617E-04 2.33E-03 0.16275956 0.51450105 HARRIS_HYPOXIA mouth disease DOID_403 7.617E-04 2.318E-03 1.000 1.000 HARRIS_HYPOXIA dilated cardiomyopathy DOID_12930 7.849E-04 2.376E-03 0.01397586 0.11869048 HARRIS_HYPOXIA sinusitis DOID_0050127 8.292E-04 2.496E-03 8.292E-04 0.02775322 HARRIS_HYPOXIA glycogen metabolism disorder DOID_0050728 8.292E-04 2.483E-03 8.292E-04 0.02621137 HARRIS_HYPOXIA paranasal sinus disease DOID_1352 8.292E-04 2.496E-03 8.292E-04 0.02775322 HARRIS_HYPOXIA glycogen storage disease DOID_2747 8.292E-04 2.483E-03 8.292E-04 0.02621137 HARRIS_HYPOXIA urinary tract obstruction DOID_5200 8.292E-04 2.47E-03 1.000 1.000 HARRIS_HYPOXIA Lewy body dementia DOID_12217 9.035E-04 2.678E-03 1.000 1.000 HARRIS_HYPOXIA spastic quadriplegia DOID_10970 9.809E-04 2.892E-03 1.000 1.000 HARRIS_HYPOXIA hypogonadism DOID_1924 1.061E-03 3.113E-03 1.000 1.000 HARRIS_HYPOXIA cystitis DOID_1679 1.145E-03 3.341E-03 1.000 1.000 HARRIS_HYPOXIA spinal cord disease DOID_319 1.231E-03 3.575E-03 0.05044923 0.26335422 HARRIS_HYPOXIA dystonia DOID_543 1.231E-03 3.557E-03 1.231E-03 0.0333675 HARRIS_HYPOXIA perinatal necrotizing enterocolitis DOID_8677 1.321E-03 3.797E-03 1.321E-03 0.03416935 HARRIS_HYPOXIA autoimmune disease of cardiovascular system DOID_0060051 1.414E-03 4.043E-03 0.05395518 0.27909543 HARRIS_HYPOXIA pleurisy DOID_10247 1.414E-03 4.022E-03 1.000 1.000 HARRIS_HYPOXIA Behcet's disease DOID_13241 1.414E-03 4.043E-03 0.05395518 0.27909543 HARRIS_HYPOXIA coronary stenosis DOID_4248 1.414E-03 4.002E-03 1.000 1.000 HARRIS_HYPOXIA multiple epiphyseal dysplasia DOID_12721 1.51E-03 4.252E-03 1.000 1.000 HARRIS_HYPOXIA age related macular degeneration DOID_10871 1.71E-03 4.793E-03 1.000 1.000 HARRIS_HYPOXIA degeneration of macula and posterior pole DOID_2007 1.71E-03 4.793E-03 1.000 1.000 HARRIS_HYPOXIA gonadal disease DOID_2277 1.71E-03 4.769E-03 1.000 1.000 HARRIS_HYPOXIA bronchiolitis obliterans DOID_2799 1.71E-03 4.746E-03 1.000 1.000 HARRIS_HYPOXIA celiac disease DOID_10608 1.815E-03 5.012E-03 0.06092885 0.28890431 HARRIS_HYPOXIA allergic rhinitis DOID_4481 1.815E-03 4.988E-03 1.000 1.000 HARRIS_HYPOXIA bladder disease DOID_365 1.922E-03 5.259E-03 1.000 1.000 HARRIS_HYPOXIA metal metabolism disorder DOID_896 2.033E-03 5.535E-03 2.033E-03 0.04284368 HARRIS_HYPOXIA macular degeneration DOID_4448 2.147E-03 5.816E-03 1.000 1.000 HARRIS_HYPOXIA hyperthyroidism DOID_7998 2.147E-03 5.789E-03 2.147E-03 0.04362233 HARRIS_HYPOXIA pulmonary sarcoidosis DOID_13406 2.505E-03 6.724E-03 1.000 1.000 HARRIS_HYPOXIA cleft palate DOID_674 2.505E-03 6.692E-03 2.505E-03 0.04751321 HARRIS_HYPOXIA adult respiratory distress syndrome DOID_11394 2.89E-03 7.684E-03 1.000 1.000 HARRIS_HYPOXIA benign mesothelioma DOID_2645 3.024E-03 8.003E-03 1.000 1.000 HARRIS_HYPOXIA autoimmune disease of urogenital tract DOID_0060049 3.161E-03 8.326E-03 3.161E-03 0.05620067 HARRIS_HYPOXIA primary biliary cirrhosis DOID_12236 3.161E-03 8.326E-03 3.161E-03 0.05620067 HARRIS_HYPOXIA endometriosis of uterus DOID_288 3.161E-03 8.288E-03 1.000 1.000 HARRIS_HYPOXIA Huntington's disease DOID_12858 3.3E-03 8.614E-03 1.000 1.000 HARRIS_HYPOXIA endometriosis DOID_289 3.3E-03 8.575E-03 1.000 1.000 HARRIS_HYPOXIA influenza DOID_8469 3.443E-03 8.905E-03 1.000 1.000 HARRIS_HYPOXIA neuritis DOID_1803 3.888E-03 0.01000961 1.000 1.000 HARRIS_HYPOXIA withdrawal disorder DOID_0060001 4.52E-03 0.01158497 0.09504428 0.36540672 HARRIS_HYPOXIA hemorrhagic disease DOID_2213 4.52E-03 0.01153302 0.09504428 0.36295433 HARRIS_HYPOXIA orofacial cleft DOID_0050567 4.685E-03 0.01190064 4.685E-03 0.0634701 HARRIS_HYPOXIA nonsyndromic deafness DOID_0050563 5.732E-03 0.01449657 5.732E-03 0.07413021 HARRIS_HYPOXIA hypertrophic cardiomyopathy DOID_11984 5.732E-03 0.01443243 1.000 1.000 HARRIS_HYPOXIA allergic contact dermatitis DOID_3042 7.485E-03 0.01876074 7.485E-03 0.08350367 HARRIS_HYPOXIA syndrome DOID_225 9.219E-03 0.02300705 0.13437317 0.4419557 HARRIS_HYPOXIA contact dermatitis DOID_2773 0.01014705 0.02521253 0.01014705 0.10129245 HARRIS_HYPOXIA lipid metabolism disorder DOID_3146 0.01014705 0.02510291 0.14076213 0.45507756 HARRIS_HYPOXIA chromosomal disease DOID_0080014 0.01038529 0.02558108 1.000 1.000 HARRIS_HYPOXIA auditory system disease DOID_2742 0.010626 0.02606119 0.010626 0.10424475 HARRIS_HYPOXIA alcohol abuse DOID_1574 0.01086918 0.02654319 0.01086918 0.10482309 HARRIS_HYPOXIA arrhythmogenic right ventricular dysplasia DOID_0050431 0.01649739 0.04011544 0.01649739 0.13804432 HARRIS_HYPOXIA interstitial nephritis DOID_1063 0.01831379 0.04434275 1.000 1.000 HARRIS_HYPOXIA facioscapulohumeral muscular dystrophy DOID_11727 0.01831379 0.04415485 0.01831379 0.1510224 HARRIS_HYPOXIA Sjogren's syndrome DOID_12894 0.01831379 0.04396855 0.01831379 0.14886494 HARRIS_HYPOXIA gout DOID_13189 0.01831379 0.0437838 0.01831379 0.14676825 HARRIS_HYPOXIA ventricular septal defect DOID_1657 0.01831379 0.04360061 1.000 1.000 HARRIS_HYPOXIA rectal neoplasm DOID_1984 0.01831379 0.04341894 1.000 1.000 HARRIS_HYPOXIA rectum cancer DOID_1993 0.01831379 0.04341894 1.000 1.000 HARRIS_HYPOXIA lateral sclerosis DOID_230 0.01831379 0.04323878 0.01831379 0.1447298 HARRIS_HYPOXIA chondrosarcoma DOID_3371 0.01831379 0.04306011 0.01831379 0.1427472 HARRIS_HYPOXIA keratitis DOID_4677 0.01831379 0.0428829 1.000 1.000 HARRIS_HYPOXIA polycythemia DOID_8432 0.01831379 0.04270715 0.01831379 0.13894061 HARRIS_HYPOXIA visceral leishmaniasis DOID_9146 0.01831379 0.04253284 1.000 1.000 HARRIS_HYPOXIA familial adenomatous polyposis DOID_0050424 0.02012688 0.04655364 1.000 1.000 HARRIS_HYPOXIA trypanosomiasis DOID_10113 0.02012688 0.04636516 0.02012688 0.14872981 HARRIS_HYPOXIA adrenoleukodystrophy DOID_10588 0.02012688 0.04617821 1.000 1.000 HARRIS_HYPOXIA sickle cell anemia DOID_10923 0.02012688 0.04599275 1.000 1.000 HARRIS_HYPOXIA pneumocystosis DOID_11339 0.02012688 0.04580878 1.000 1.000 HARRIS_HYPOXIA prediabetes syndrome DOID_11716 0.02012688 0.04562628 1.000 1.000 HARRIS_HYPOXIA temporal arteritis DOID_13375 0.02012688 0.04544522 1.000 1.000 HARRIS_HYPOXIA hemochromatosis DOID_2352 0.02012688 0.04526559 0.02012688 0.14682302 HARRIS_HYPOXIA central nervous system vasculitis DOID_525 0.02012688 0.04544522 1.000 1.000 HARRIS_HYPOXIA porphyria DOID_13268 0.02193667 0.0491416 1.000 1.000 HARRIS_HYPOXIA pituitary cancer DOID_1785 0.02193667 0.04894889 1.000 1.000 HARRIS_HYPOXIA pituitary carcinoma DOID_4916 0.02193667 0.04894889 1.000 1.000 HARRIS_HYPOXIA aortic valve insufficiency DOID_57 0.02193667 0.04875768 1.000 1.000 HARRIS_HYPOXIA stomach disease DOID_76 0.02193667 0.04856797 1.000 1.000 HARRIS_HYPOXIA lipodystrophy DOID_811 0.02193667 0.04837972 1.000 1.000 HARRIS_HYPOXIA peritonitis DOID_8283 0.02193667 0.04819292 0.02193667 0.15602459 HARRIS_HYPOXIA vulva cancer DOID_1245 0.02374317 0.05196101 0.02374317 0.16678844 HARRIS_HYPOXIA obstructive hydrocephalus DOID_14159 0.02374317 0.05176193 1.000 1.000 HARRIS_HYPOXIA communicating hydrocephalus DOID_1573 0.02374317 0.05176193 1.000 1.000 HARRIS_HYPOXIA impotence DOID_1875 0.02374317 0.05156437 1.000 1.000 HARRIS_HYPOXIA intracranial thrombosis DOID_4193 0.02374317 0.0513683 0.02374317 0.16276944 HARRIS_HYPOXIA open-angle glaucoma DOID_1067 0.02554638 0.05506019 1.000 1.000 HARRIS_HYPOXIA hydrocephalus DOID_10908 0.02554638 0.05485241 1.000 1.000 HARRIS_HYPOXIA hypercalcemia DOID_12678 0.02554638 0.0546462 1.000 1.000 HARRIS_HYPOXIA parasitic helminthiasis infectious disease DOID_883 0.02554638 0.05444153 1.000 1.000 HARRIS_HYPOXIA idiopathic pulmonary fibrosis DOID_0050156 0.0273463 0.05805987 1.000 1.000 HARRIS_HYPOXIA skeletal system cancer DOID_0060124 0.0273463 0.05784404 1.000 1.000 HARRIS_HYPOXIA Ehlers-Danlos syndrome DOID_13359 0.0273463 0.0576298 0.0273463 0.18305937 HARRIS_HYPOXIA renovascular hypertension DOID_1591 0.0273463 0.05741715 1.000 1.000 HARRIS_HYPOXIA bone cancer DOID_184 0.0273463 0.05784404 1.000 1.000 HARRIS_HYPOXIA communication disorder DOID_2033 0.0273463 0.05720605 1.000 1.000 HARRIS_HYPOXIA hemangioma DOID_255 0.0273463 0.05699651 1.000 1.000 HARRIS_HYPOXIA arthropathy DOID_381 0.0273463 0.05678849 1.000 1.000 HARRIS_HYPOXIA lung oat cell carcinoma DOID_5411 0.0273463 0.05658199 1.000 1.000 HARRIS_HYPOXIA varicose veins DOID_799 0.0273463 0.05637698 1.000 1.000 HARRIS_HYPOXIA intracranial hypertension DOID_9428 0.0273463 0.05617345 1.000 1.000 HARRIS_HYPOXIA silicosis DOID_10325 0.02914295 0.0596487 1.000 1.000 HARRIS_HYPOXIA pituitary adenoma DOID_3829 0.02914295 0.05943491 1.000 1.000 HARRIS_HYPOXIA thyroiditis DOID_7166 0.02914295 0.05922264 1.000 1.000 HARRIS_HYPOXIA autoimmune thyroiditis DOID_7188 0.02914295 0.05922264 1.000 1.000 HARRIS_HYPOXIA vein disease DOID_866 0.02914295 0.05901188 1.000 1.000 HARRIS_HYPOXIA lymphatic system cancer DOID_0060073 0.03093633 0.06242117 1.000 1.000 HARRIS_HYPOXIA basal cell carcinoma DOID_2513 0.03093633 0.0622006 1.000 1.000 HARRIS_HYPOXIA reticulosarcoma DOID_8538 0.03093633 0.06242117 1.000 1.000 HARRIS_HYPOXIA lymphosarcoma DOID_8675 0.03093633 0.06242117 1.000 1.000 HARRIS_HYPOXIA sexual dysfunction DOID_1876 0.03272644 0.06556811 1.000 1.000 HARRIS_HYPOXIA skin carcinoma DOID_3451 0.03272644 0.06533805 1.000 1.000 HARRIS_HYPOXIA osteosclerosis DOID_4254 0.03272644 0.06510959 1.000 1.000 HARRIS_HYPOXIA ureteral obstruction DOID_5199 0.03272644 0.06488273 1.000 1.000 HARRIS_HYPOXIA dissociative disorder DOID_10935 0.03451329 0.06818771 1.000 1.000 HARRIS_HYPOXIA dissociative amnesia DOID_11037 0.03451329 0.06818771 1.000 1.000 HARRIS_HYPOXIA Down syndrome DOID_14250 0.03451329 0.06795177 1.000 1.000 HARRIS_HYPOXIA heart septal defect DOID_1681 0.03451329 0.06771745 1.000 1.000 HARRIS_HYPOXIA testicular cancer DOID_2998 0.03451329 0.06748475 1.000 1.000 HARRIS_HYPOXIA MHC class II deficiency DOID_5812 0.03451329 0.06725363 1.000 1.000 HARRIS_HYPOXIA subependymal glioma DOID_4843 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA pilocytic astrocytoma DOID_4851 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA subependymal giant cell astrocytoma DOID_5077 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA fibrillary astrocytoma DOID_6726 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA juvenile pilocytic astrocytoma DOID_6811 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA childhood pilocytic astrocytoma DOID_6812 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA gemistocytic astrocytoma DOID_7005 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA childhood cerebral astrocytoma DOID_7007 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA protoplasmic astrocytoma DOID_7008 0.03629689 0.07048781 1.000 1.000 HARRIS_HYPOXIA mitochondrial myopathy DOID_699 0.03807724 0.0736937 1.000 1.000 HARRIS_HYPOXIA hepatitis B DOID_2043 0.03985434 0.0768716 0.03985434 0.24384001 HARRIS_HYPOXIA thrombophilia DOID_2452 0.03985434 0.0766119 0.03985434 0.24124597 HARRIS_HYPOXIA muscular atrophy DOID_767 0.03985434 0.07635394 1.000 1.000 HARRIS_HYPOXIA sexual disorder DOID_0060043 0.04162821 0.07948474 1.000 1.000 HARRIS_HYPOXIA optic nerve disease DOID_1891 0.04162821 0.07921891 1.000 1.000 HARRIS_HYPOXIA IgA glomerulonephritis DOID_2986 0.04162821 0.07895485 1.000 1.000 HARRIS_HYPOXIA pulmonary embolism DOID_9477 0.04162821 0.07869254 1.000 1.000 HARRIS_HYPOXIA ureteral disease DOID_1426 0.04339885 0.08176804 1.000 1.000 HARRIS_HYPOXIA congenital hemolytic anemia DOID_589 0.04339885 0.08149818 0.04339885 0.25197906 HARRIS_HYPOXIA aortic valve disease DOID_62 0.04339885 0.08123009 1.000 1.000 HARRIS_HYPOXIA acute pancreatitis DOID_2913 0.04516627 0.08426101 1.000 1.000 HARRIS_HYPOXIA severe combined immunodeficiency DOID_627 0.04516627 0.08398565 1.000 1.000 HARRIS_HYPOXIA X-linked disease DOID_0050735 0.04693047 0.08698187 0.04693047 0.26179839 HARRIS_HYPOXIA reading disorder DOID_13365 0.04693047 0.08669947 0.04693047 0.2567638 HARRIS_HYPOXIA urticaria DOID_1555 0.04693047 0.08641889 1.000 1.000 HARRIS_HYPOXIA bronchiolitis DOID_2942 0.04693047 0.08614011 1.000 1.000 HARRIS_HYPOXIA osteosarcoma DOID_3347 0.04693047 0.08586314 0.04693047 0.25431843 HARRIS_HYPOXIA dyslexia DOID_4428 0.04693047 0.08669947 0.04693047 0.2567638 HARRIS_HYPOXIA combined T cell and B cell immunodeficiency DOID_628 0.04693047 0.08558793 1.000 1.000 HARRIS_HYPOXIA morbid obesity DOID_11981 0.04869145 0.08851577 1.000 1.000 HARRIS_HYPOXIA spinal muscular atrophy DOID_12377 0.04869145 0.08823387 0.04869145 0.26137203 HARRIS_HYPOXIA ankylosing spondylitis DOID_7147 0.04869145 0.08795376 1.000 1.000 HARRIS_HYPOXIA cleft lip DOID_9296 0.04869145 0.08767543 0.04869145 0.2589293 HARRIS_HYPOXIA intracranial aneurysm DOID_10941 0.05044923 0.09055398 1.000 1.000 HARRIS_HYPOXIA myopia DOID_11830 0.05044923 0.09026921 0.05044923 0.26579269 HARRIS_HYPOXIA seminoma DOID_4440 0.05044923 0.08998624 1.000 1.000 HARRIS_HYPOXIA extrinsic allergic alveolitis DOID_841 0.05044923 0.08970503 1.000 1.000 HARRIS_HYPOXIA Sciatic Neuropathy DOID_11446 0.0522038 0.09253571 1.000 1.000 HARRIS_HYPOXIA gestational diabetes DOID_11714 0.0522038 0.09224833 1.000 1.000 HARRIS_HYPOXIA lesion of sciatic nerve DOID_12528 0.0522038 0.09253571 1.000 1.000 HARRIS_HYPOXIA periodontitis DOID_824 0.0522038 0.09196273 1.000 1.000 HARRIS_HYPOXIA mononeuritis of lower limb DOID_9473 0.0522038 0.09253571 1.000 1.000 HARRIS_HYPOXIA malaria DOID_12365 0.05395518 0.09475462 1.000 1.000 HARRIS_HYPOXIA thrombocytopenia DOID_1588 0.05395518 0.09446307 1.000 1.000 HARRIS_HYPOXIA mononeuritis DOID_1802 0.05395518 0.09417331 1.000 1.000 HARRIS_HYPOXIA autoimmune disease of endocrine system DOID_0060005 0.05570337 0.09692727 1.000 1.000 HARRIS_HYPOXIA polycystic ovary syndrome DOID_11612 0.05570337 0.09663176 0.05570337 0.27802822 HARRIS_HYPOXIA mononeuropathy DOID_1188 0.05570337 0.09633805 1.000 1.000 HARRIS_HYPOXIA supratentorial cancer DOID_1659 0.05570337 0.09604611 1.000 1.000 HARRIS_HYPOXIA toxic encephalopathy DOID_3602 0.05570337 0.09575594 0.05570337 0.27561058 HARRIS_HYPOXIA cerebrum cancer DOID_368 0.05570337 0.09604611 1.000 1.000 HARRIS_HYPOXIA dystonic disease DOID_544 0.05570337 0.09546752 0.05570337 0.27089929 HARRIS_HYPOXIA cranial nerve disease DOID_5656 0.05570337 0.09518083 1.000 1.000 HARRIS_HYPOXIA female reproductive organ benign neoplasm DOID_0060086 0.05744837 0.09786864 0.05744837 0.277018 HARRIS_HYPOXIA uterine benign neoplasm DOID_0060095 0.05744837 0.09786864 0.05744837 0.277018 HARRIS_HYPOXIA corneal disease DOID_10124 0.05744837 0.09757649 1.000 1.000 HARRIS_HYPOXIA uterine fibroid DOID_13223 0.05744837 0.09786864 0.05744837 0.277018 GOLUB_ALL_VS_AML_DN lymphoma DOID_0060058 1.172E-05 6.671E-03 9.069E-04 0.06450145 GOLUB_ALL_VS_AML_DN Barrett's esophagus DOID_9206 2.545E-05 7.24E-03 2.545E-05 0.01448055 GOLUB_ALL_VS_AML_DN amyloidosis DOID_9120 4.025E-05 7.634E-03 4.025E-05 0.01145087 GOLUB_ALL_VS_AML_DN diffuse large B-cell lymphoma DOID_0050745 8.579E-05 0.01220342 0.01368298 0.25952044 GOLUB_ALL_VS_AML_DN esophageal disease DOID_6050 1.404E-04 0.01597874 1.404E-04 0.02663123 GOLUB_ALL_VS_AML_DN multiple myeloma DOID_9538 1.643E-04 0.01558171 1.643E-04 0.02337256 GOLUB_ALL_VS_AML_DN peptic ulcer DOID_750 1.813E-04 0.0147344 0.01975915 0.31230436 GOLUB_ALL_VS_AML_DN myeloma DOID_0070004 2.573E-04 0.01830191 2.573E-04 0.02928306 GOLUB_ALL_VS_AML_DN B-cell lymphocytic neoplasm DOID_707 3.003E-04 0.01898275 0.02533654 0.35162168 GOLUB_ALL_VS_AML_DN bone marrow cancer DOID_4960 3.346E-04 0.01903831 3.346E-04 0.03173052 GOLUB_ALL_VS_AML_DN pustulosis of palm and sole DOID_4398 3.464E-04 0.01792064 0.02718899 0.35160313 GOLUB_ALL_VS_AML_DN cholestasis DOID_13580 4.761E-04 0.02257485 0.0318056 0.39342147 GOLUB_ALL_VS_AML_DN bile duct disease DOID_4138 5.635E-04 0.02466614 0.03456563 0.39335684 GOLUB_ALL_VS_AML_DN biliary tract disease DOID_9741 5.788E-04 0.02352517 0.03502491 0.38325333 GOLUB_ALL_VS_AML_DN primary immunodeficiency disease DOID_612 8.503E-04 0.03225577 8.503E-04 0.06911951 GOLUB_ALL_VS_AML_DN mouth disease DOID_403 9.456E-04 0.03362633 0.04462228 0.42316793 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN metabolic syndrome X DOID_14221 1.703E-08 9.692E-06 2.049E-04 0.01059638 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN lipid metabolism disorder DOID_3146 1.703E-08 4.846E-06 4.683E-07 1.332E-04 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN carbohydrate metabolic disorder DOID_2978 4.767E-08 9.042E-06 4.767E-08 2.713E-05 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN familial hypercholesterolemia DOID_13810 1.008E-06 1.434E-04 6.191E-05 5.032E-03 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN familial hyperlipidemia DOID_1168 2.119E-06 2.411E-04 5.673E-05 5.38E-03 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN endocrine pancreas disease DOID_1428 3.996E-06 3.79E-04 9.349E-05 5.911E-03 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN toxic encephalopathy DOID_3602 4.232E-06 3.44E-04 1.766E-04 0.01004674 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN blood coagulation disease DOID_1247 6.111E-06 4.347E-04 6.111E-06 1.159E-03 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN pneumoconiosis DOID_10316 8.739E-06 5.525E-04 0.12198722 0.50297628 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN chronic kidney failure DOID_784 1.29E-05 7.343E-04 1.29E-05 1.836E-03 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN hyperinsulinism DOID_2018 2.107E-05 1.09E-03 2.107E-05 2.398E-03 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN silicosis DOID_10325 2.286E-05 1.084E-03 1.000 1.000 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN membranous glomerulonephritis DOID_10976 4.606E-05 2.016E-03 2.227E-03 0.06033433 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN thrombophilia DOID_2452 6.191E-05 2.516E-03 6.191E-05 4.403E-03 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN hypoglycemia DOID_9993 7.101E-05 2.694E-03 2.945E-03 0.07285064 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN cholestasis DOID_13580 9.907E-05 3.523E-03 0.02392963 0.30257684 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN temporal lobe epilepsy DOID_3328 1.049E-04 3.51E-03 1.868E-03 0.0559276 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN brain infarction DOID_3454 1.172E-04 3.706E-03 2.027E-03 0.05766451 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN bile duct disease DOID_4138 1.377E-04 4.124E-03 0.02799045 0.33180341 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN biliary tract disease DOID_9741 1.451E-04 4.127E-03 0.02869237 0.33318278 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN focal epilepsy DOID_2234 2.352E-04 6.374E-03 3.38E-03 0.07397056 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN amino acid metabolic disorder DOID_9252 3.055E-04 7.901E-03 0.04084002 0.35209051 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN Crohn's disease DOID_8778 3.746E-04 9.268E-03 4.755E-03 0.09662392 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN pulmonary sarcoidosis DOID_13406 3.792E-04 8.991E-03 0.13120482 0.51133933 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN cervix uteri carcinoma in situ DOID_8991 5.032E-04 0.01145276 0.0104945 0.19262483 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN hyperparathyroidism DOID_13543 5.397E-04 0.01181006 0.03453751 0.37792006 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN hypolipoproteinemia DOID_1387 5.397E-04 0.01137265 5.397E-04 0.02558847 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN labyrinthine disease DOID_4539 5.397E-04 0.01096649 5.397E-04 0.02362013 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN cerebral infarction DOID_3526 6.505E-04 0.01276245 6.505E-04 0.02643651 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN inner ear disease DOID_2952 6.581E-04 0.01248116 6.581E-04 0.02496232 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN brain cancer DOID_1319 7.333E-04 0.01346045 0.16124204 0.56633778 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN heart valve disease DOID_4079 7.333E-04 0.01303981 0.01340509 0.21187482 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN central nervous system cancer DOID_3620 7.772E-04 0.01340065 0.16418847 0.56620145 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN hemolytic anemia DOID_583 7.772E-04 0.01300652 0.01392051 0.21407486 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN normocytic anemia DOID_720 7.772E-04 0.01300652 0.01392051 0.21407486 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN aortic valve stenosis DOID_1712 7.879E-04 0.01280826 0.0413016 0.32639737 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN peritonitis DOID_8283 7.879E-04 0.01245248 7.879E-04 0.02801807 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN parathyroid gland disease DOID_11201 9.29E-04 0.01428592 0.04466599 0.33440719 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN sarcoidosis DOID_11335 1.021E-03 0.0152938 0.17876724 0.59484538 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN parasitic helminthiasis infectious disease DOID_883 1.081E-03 0.01577587 0.04801866 0.32144253 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN smallpox DOID_8736 1.131E-03 0.0160904 1.131E-03 0.03785976 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN varicose veins DOID_799 1.245E-03 0.01727522 0.05135965 0.31423267 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN hypersensitivity reaction type IV disease DOID_2916 1.309E-03 0.01773754 0.1930936 0.62073591 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN spastic diplegia DOID_10965 1.419E-03 0.01878161 0.054689 0.33104298 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN vein disease DOID_866 1.419E-03 0.01835476 0.054689 0.32414625 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN bronchitis DOID_6132 1.605E-03 0.02029311 0.05800676 0.33005844 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN pre-malignant neoplasm DOID_0060071 1.644E-03 0.02033052 0.02263484 0.29951683 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN in situ carcinoma DOID_8719 1.644E-03 0.02033052 0.02263484 0.29951683 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN parasitic infectious disease DOID_1398 1.791E-03 0.02168123 0.21273468 0.647305 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN inherited blood coagulation disease DOID_2214 1.801E-03 0.02135378 1.801E-03 0.05694342 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN hyperglycemia DOID_4195 1.868E-03 0.02168621 0.0245882 0.30414531 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN endogenous depression DOID_1595 2.65E-03 0.03015915 0.03084003 0.35095958 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN placenta disease DOID_780 2.695E-03 0.03006621 0.07442298 0.3957633 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN glycogen metabolism disorder DOID_0050728 2.945E-03 0.0322224 2.945E-03 0.07616203 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN glycogen storage disease DOID_2747 2.945E-03 0.0322224 2.945E-03 0.07616203 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN contact dermatitis DOID_2773 3.054E-03 0.03278555 3.054E-03 0.07240143 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN aortic valve disease DOID_62 3.205E-03 0.03377225 0.08090968 0.40741244 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN meningitis DOID_9471 3.205E-03 0.03315821 0.08090968 0.40383865 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN auditory system disease DOID_2742 3.269E-03 0.03321571 3.269E-03 0.07440318 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN mental depression DOID_1596 3.38E-03 0.03374096 0.03608848 0.35404041 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN osteosarcoma DOID_3347 3.757E-03 0.03685606 0.08735126 0.42121072 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN transitional cell carcinoma DOID_2671 3.97E-03 0.03828248 0.04003243 0.35591331 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN autosomal dominant nonsyndromic deafness DOID_0050564 4.048E-03 0.03838966 4.048E-03 0.08531036 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN primary immunodeficiency disease DOID_612 4.094E-03 0.03819247 0.04084002 0.35750728 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN nervous system cancer DOID_3093 4.222E-03 0.03874455 0.27654198 0.77133523 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN multiple epiphyseal dysplasia DOID_12721 5.314E-03 0.04799467 5.314E-03 0.10426427 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN ulcerative colitis DOID_8577 5.327E-03 0.04735803 0.29664882 0.79996767 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN spastic cerebral palsy DOID_0050669 6.006E-03 0.05257918 0.10954593 0.46865892 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN metal metabolism disorder DOID_896 7.118E-03 0.06136363 7.118E-03 0.13499998 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN uveitis DOID_13141 9.159E-03 0.0777847 1.000 1.000 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN adult respiratory distress syndrome DOID_11394 0.01004035 0.0840141 1.000 1.000 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN benign mesothelioma DOID_2645 0.0104945 0.08654159 0.14334572 0.53309618 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN Huntington's disease DOID_12858 0.01142959 0.09290627 0.01142959 0.20323246 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN primitive neuroectodermal tumor DOID_168 0.01142959 0.09159773 0.14935287 0.54475503 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN uveal disease DOID_3480 0.01142959 0.09032554 1.000 1.000 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN influenza DOID_8469 0.0119104 0.09283589 1.000 1.000 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN cataract DOID_83 0.01239997 0.09534569 0.01239997 0.21380548 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN leukodystrophy DOID_10579 0.01289822 0.09785446 0.1582853 0.56644236 ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN lens disease DOID_110 0.01340509 0.09905836 0.01340509 0.21792838 NAKAMURA_METASTASIS_MODEL_DN Sciatic Neuropathy DOID_11446 6.137E-07 3.492E-04 0.01669899 0.27147794 NAKAMURA_METASTASIS_MODEL_DN lesion of sciatic nerve DOID_12528 6.137E-07 3.492E-04 0.01669899 0.27147794 NAKAMURA_METASTASIS_MODEL_DN mononeuritis of lower limb DOID_9473 6.137E-07 3.492E-04 0.01669899 0.27147794 NAKAMURA_METASTASIS_MODEL_DN mononeuritis DOID_1802 6.816E-07 1.939E-04 0.01727005 0.26558533 NAKAMURA_METASTASIS_MODEL_DN mononeuropathy DOID_1188 7.543E-07 1.431E-04 0.01784078 0.26029246 NAKAMURA_METASTASIS_MODEL_DN neuritis DOID_1803 3.266E-06 4.646E-04 0.02862485 0.31322186 NAKAMURA_METASTASIS_MODEL_DN migraine without aura DOID_12783 1.762E-05 2.006E-03 1.762E-05 0.0100282 NAKAMURA_METASTASIS_MODEL_DN hypercalcemia DOID_12678 2.913E-05 2.762E-03 2.913E-05 8.287E-03 NAKAMURA_METASTASIS_MODEL_DN thrombophilia DOID_2452 7.374E-05 5.994E-03 0.01269275 0.24904045 NAKAMURA_METASTASIS_MODEL_DN migraine DOID_6364 1.293E-04 9.195E-03 1.293E-04 0.02451977 NAKAMURA_METASTASIS_MODEL_DN autoimmune disease of the nervous system DOID_438 1.385E-04 8.754E-03 1.385E-04 0.01969646 NAKAMURA_METASTASIS_MODEL_DN calcium metabolism disease DOID_10575 4.351E-04 0.02475697 4.351E-04 0.04951395 NAKAMURA_METASTASIS_MODEL_DN parasitic protozoa infectious disease DOID_2789 5.21E-04 0.02695042 5.21E-04 0.04940911 NAKAMURA_METASTASIS_MODEL_DN mineral metabolism disease DOID_0050032 6.947E-04 0.03293972 6.947E-04 0.0564681 NAKAMURA_METASTASIS_MODEL_DN parasitic infectious disease DOID_1398 7.155E-04 0.03131629 7.155E-04 0.05088897 NAKAMURA_METASTASIS_MODEL_DN blood coagulation disease DOID_1247 8.24E-04 0.03348842 0.04152804 0.33756366 NAKAMURA_METASTASIS_MODEL_DN metabolic syndrome X DOID_14221 1.038E-03 0.03937336 1.000 1.000 NAKAMURA_METASTASIS_MODEL_DN bone development disease DOID_0080006 1.141E-03 0.04056788 1.141E-03 0.07212068 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP lymphoma DOID_0060058 2.729E-08 1.553E-05 2.729E-08 1.553E-05 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP diabetic retinopathy DOID_8947 1.965E-07 5.59E-05 2.017E-03 0.03478389 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP retinal vascular disease DOID_2462 4.407E-07 8.36E-05 2.963E-03 0.04437273 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP primary bacterial infectious disease DOID_0050338 5.045E-07 7.176E-05 2.147E-04 0.01018172 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP encephalomyelitis DOID_640 7.426E-07 8.45E-05 1.58E-05 2.998E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP bone marrow cancer DOID_4960 1.261E-06 1.196E-04 3.766E-05 4.285E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hypersensitivity reaction type IV disease DOID_2916 1.773E-06 1.441E-04 1.07E-03 0.02647648 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP pleurisy DOID_10247 2.797E-06 1.989E-04 4.348E-03 0.04850759 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP pleural disease DOID_1532 5.277E-06 3.336E-04 5.884E-03 0.05873596 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP pancreatitis DOID_4989 6.819E-06 3.88E-04 1.423E-04 8.096E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP pulmonary sarcoidosis DOID_13406 9.095E-06 4.704E-04 7.632E-03 0.07237399 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP peripheral nervous system neoplasm DOID_1192 1.005E-05 4.767E-04 1.005E-05 2.86E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP uveitis DOID_13141 1.005E-05 4.4E-04 8.006E-03 0.07230837 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP respiratory syncytial virus infectious disease DOID_1273 1.108E-05 4.504E-04 8.388E-03 0.07457871 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP autoimmune disease of urogenital tract DOID_0060049 1.464E-05 5.554E-04 9.584E-03 0.08019523 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP primary biliary cirrhosis DOID_12236 1.464E-05 5.554E-04 9.584E-03 0.08019523 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP uveal disease DOID_3480 1.6E-05 5.688E-04 9.998E-03 0.08127218 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP diabetic autonomic neuropathy DOID_11503 1.744E-05 5.837E-04 0.01042055 0.08351116 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP autonomic neuropathy DOID_11504 1.744E-05 5.837E-04 0.01042055 0.08351116 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP diabetic polyneuropathy DOID_12785 1.744E-05 5.837E-04 0.01042055 0.08351116 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP diabetic neuropathy DOID_9743 1.744E-05 5.837E-04 0.01042055 0.08351116 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP autonomic nervous system disease DOID_11465 2.235E-05 7.064E-04 0.01173371 0.08670751 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.614E-05 7.827E-04 6.714E-04 0.01819187 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP B-cell lymphocytic neoplasm DOID_707 3.038E-05 8.643E-04 3.038E-05 4.321E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP sarcoidosis DOID_11335 3.51E-05 9.511E-04 0.01456447 0.10358977 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP pustulosis of palm and sole DOID_4398 4.034E-05 1.043E-03 4.034E-05 3.826E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hepatitis B DOID_2043 5.026E-05 1.243E-03 5.026E-05 4.085E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP congenital heart defect DOID_1682 6.717E-05 1.592E-03 6.717E-05 4.777E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hyperglycemia DOID_4195 7.996E-05 1.82E-03 1.529E-03 0.03221584 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP tuberculosis DOID_399 8.941E-05 1.957E-03 1.66E-03 0.03372762 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP extrinsic allergic alveolitis DOID_841 1.054E-04 2.221E-03 0.08768117 0.2741241 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP sarcoma DOID_1115 1.3E-04 2.642E-03 1.3E-04 8.218E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP bacterial pneumonia DOID_874 1.423E-04 2.792E-03 0.02840838 0.17015124 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP focal glomerulosclerosis DOID_3945 1.436E-04 2.723E-03 1.436E-04 7.426E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP corneal disease DOID_10124 1.58E-04 2.901E-03 4.936E-03 0.05201473 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP bronchiolitis obliterans DOID_2799 1.734E-04 3.084E-03 0.1025157 0.30380954 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP bladder disease DOID_365 2.071E-04 3.57E-03 0.10838229 0.31625395 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP transitional cell carcinoma DOID_2671 2.242E-04 3.751E-03 3.261E-03 0.04525949 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP nervous system cancer DOID_3093 2.439E-04 3.965E-03 2.439E-04 0.01067459 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP thyroid carcinoma DOID_3963 2.446E-04 3.867E-03 2.446E-04 9.943E-03 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP esophageal disease DOID_6050 2.446E-04 3.762E-03 6.558E-03 0.06324618 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP thyroid cancer DOID_1781 2.864E-04 4.288E-03 2.864E-04 0.01086334 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP peptic ulcer DOID_750 3.572E-04 5.211E-03 8.388E-03 0.07343134 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP pulmonary emphysema DOID_9675 4.101E-04 5.834E-03 9.177E-03 0.0779402 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP Huntington's disease DOID_12858 4.678E-04 6.492E-03 4.678E-04 0.01663648 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP Noonan syndrome DOID_3490 4.694E-04 6.36E-03 4.694E-04 0.01571187 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP influenza DOID_8469 4.985E-04 6.597E-03 0.01042055 0.08235129 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cataract DOID_83 5.305E-04 6.86E-03 5.305E-04 0.01676926 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP myeloma DOID_0070004 5.983E-04 7.565E-03 0.01173371 0.0878484 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP lens disease DOID_110 5.983E-04 7.401E-03 5.983E-04 0.01791738 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP heart valve disease DOID_4079 5.983E-04 7.243E-03 5.983E-04 0.01702152 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP glaucoma DOID_1686 6.714E-04 7.959E-03 6.714E-04 0.01736496 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP pulmonary tuberculosis DOID_2957 6.714E-04 7.797E-03 0.01264736 0.09226088 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP common cold DOID_10459 6.855E-04 7.801E-03 0.03855687 0.19764739 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP encephalitis DOID_9588 6.855E-04 7.649E-03 0.03855687 0.1813129 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP orofacial cleft DOID_0050567 7.914E-04 8.659E-03 0.0140741 0.10136914 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP viral pneumonia DOID_10533 9.412E-04 0.01010433 0.04483807 0.20248302 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP renovascular hypertension DOID_1591 1.084E-03 0.01141846 0.04796338 0.20366541 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP mesenchymal cell neoplasm DOID_3350 1.084E-03 0.01121086 1.084E-03 0.02569154 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP spindle cell sarcoma DOID_4235 1.084E-03 0.01121086 1.084E-03 0.02569154 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP epithelioid sarcoma DOID_6193 1.084E-03 0.01121086 1.084E-03 0.02569154 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP melancholia DOID_2848 1.122E-03 0.01140007 0.0176583 0.12105506 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP neurotic disorder DOID_4964 1.175E-03 0.01173215 0.01819872 0.12327468 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP spastic diplegia DOID_10965 1.236E-03 0.01212371 1.236E-03 0.02812701 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP Barrett's esophagus DOID_9206 1.236E-03 0.01191823 1.236E-03 0.02704521 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP glucose intolerance DOID_10603 1.569E-03 0.01487866 0.0572786 0.22322959 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP allergic contact dermatitis DOID_3042 1.593E-03 0.01486262 0.0221734 0.14337121 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP brain infarction DOID_3454 1.66E-03 0.01523183 0.022768 0.14556173 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP dissociative disorder DOID_10935 1.75E-03 0.01580339 1.75E-03 0.03433149 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP dissociative amnesia DOID_11037 1.75E-03 0.01580339 1.75E-03 0.03433149 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP conduct disorder DOID_12995 1.75E-03 0.01555646 1.75E-03 0.03318711 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP Down syndrome DOID_14250 1.75E-03 0.01531713 1.75E-03 0.03211656 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP male reproductive system disease DOID_48 1.869E-03 0.01611348 0.02459091 0.15208942 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP amnestic disorder DOID_10914 1.94E-03 0.01647573 1.94E-03 0.03449605 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP esophagitis DOID_11963 1.94E-03 0.01623344 0.06343845 0.23288051 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP biliary tract disease DOID_9741 1.942E-03 0.01601705 0.02521142 0.1542505 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP autoimmune hepatitis DOID_2048 2.14E-03 0.01739236 0.06650339 0.23503373 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cystic fibrosis DOID_1485 2.173E-03 0.0174127 2.173E-03 0.03636182 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP endogenous depression DOID_1595 2.173E-03 0.01717086 0.0271109 0.16410747 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP funisitis DOID_0050698 2.349E-03 0.01830619 2.349E-03 0.03818148 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP contact dermatitis DOID_2773 2.505E-03 0.0192648 0.02973035 0.17621425 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP chromosomal disease DOID_0080014 2.593E-03 0.01967406 2.593E-03 0.04098762 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP mental depression DOID_1596 2.774E-03 0.02077223 0.03175841 0.18629418 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP aortic valve disease DOID_62 2.794E-03 0.02064768 2.794E-03 0.0429695 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP Goodpasture syndrome DOID_9808 2.794E-03 0.02038297 0.07563864 0.25168648 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP acute pancreatitis DOID_2913 3.031E-03 0.02182828 3.031E-03 0.04421625 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP severe combined immunodeficiency DOID_627 3.031E-03 0.02155542 3.031E-03 0.04311084 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP portal hypertension DOID_10762 3.276E-03 0.02301422 3.276E-03 0.04438456 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP combined T cell and B cell immunodeficiency DOID_628 3.276E-03 0.02273356 3.276E-03 0.04335236 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP primary immunodeficiency disease DOID_612 3.364E-03 0.02306462 3.364E-03 0.04350825 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cystitis DOID_1679 3.531E-03 0.02391655 0.08468521 0.27223663 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP ankylosing spondylitis DOID_7147 3.531E-03 0.02363518 3.531E-03 0.04464423 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cleft lip DOID_9296 3.531E-03 0.02336035 0.08468521 0.26919488 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP vitiligo DOID_12306 3.794E-03 0.02481512 3.794E-03 0.04693294 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP middle cerebral artery infarction DOID_3525 3.794E-03 0.02453313 3.794E-03 0.04593437 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hypersensitivity reaction type I disease DOID_1205 4.026E-03 0.02573728 4.026E-03 0.0477212 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP dilated cardiomyopathy DOID_12930 4.026E-03 0.02545131 4.026E-03 0.0467473 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP diffuse large B-cell lymphoma DOID_0050745 4.067E-03 0.02542739 4.067E-03 0.04627785 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP renal hypertension DOID_1073 4.348E-03 0.02689008 0.09364394 0.2880184 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP secondary hypertension DOID_11130 4.348E-03 0.02689008 0.09364394 0.2880184 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hepatic vascular disease DOID_272 4.348E-03 0.02660094 4.348E-03 0.04757476 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP ulcerative colitis DOID_8577 4.384E-03 0.02653624 4.384E-03 0.04706427 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP spastic cerebral palsy DOID_0050669 5.244E-03 0.03140675 5.244E-03 0.05424803 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP celiac disease DOID_10608 5.56E-03 0.03295178 5.56E-03 0.05648876 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP autonomic nervous system neoplasm DOID_2621 5.884E-03 0.03451494 5.884E-03 0.05772327 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP neuroblastoma DOID_769 5.884E-03 0.03451494 5.884E-03 0.05772327 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP adolescence-adult electroclinical syndrome DOID_0050705 7.632E-03 0.0443106 0.12288287 0.34274682 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cleft palate DOID_674 7.632E-03 0.04386302 0.12288287 0.33941918 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP multiple myeloma DOID_9538 7.632E-03 0.04342439 7.632E-03 0.07118753 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP microcephaly DOID_10907 8.006E-03 0.04510324 8.006E-03 0.07347464 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hepatitis DOID_2237 8.388E-03 0.04679448 0.12861738 0.35184274 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP congenital diaphragmatic hernia DOID_3827 8.388E-03 0.04634017 0.12861738 0.35015929 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP systemic scleroderma DOID_418 8.388E-03 0.04589459 0.12861738 0.34849186 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP adult respiratory distress syndrome DOID_11394 8.779E-03 0.04757368 0.13147068 0.35453467 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP intracranial arterial disease DOID_13089 8.779E-03 0.04712487 8.779E-03 0.0756854 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cerebral arterial disease DOID_3527 8.779E-03 0.04712487 8.779E-03 0.0756854 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP spinocerebellar ataxia DOID_1441 9.584E-03 0.0509652 9.584E-03 0.07903298 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP rheumatic disease DOID_1575 9.998E-03 0.05267641 0.13997508 0.37392403 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP scleroderma DOID_419 9.998E-03 0.05267641 0.13997508 0.37392403 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cerebral infarction DOID_3526 0.01085055 0.05664187 0.01085055 0.08457485 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP learning disability DOID_8927 0.01085055 0.05612695 0.01085055 0.08343195 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP spinocerebellar degeneration DOID_2478 0.01128829 0.05786519 0.01128829 0.08564049 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP proteinuria DOID_576 0.01128829 0.05734854 0.14839687 0.38911437 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP neuritis DOID_1803 0.01173371 0.05908388 0.15118591 0.39280723 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP aortic aneurysm DOID_3627 0.01311549 0.06546242 0.1594988 0.40697226 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP atopic dermatitis DOID_3310 0.0140741 0.06963619 1.000 1.000 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP reproductive organ benign neoplasm DOID_0050622 0.01556707 0.07635916 0.17317452 0.43408061 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP parasitic protozoa infectious disease DOID_2789 0.01556707 0.07570652 0.17317452 0.43028952 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP congenital nervous system abnormality DOID_2490 0.01659848 0.08003845 0.01659848 0.11659923 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hypertrophic cardiomyopathy DOID_11984 0.01712487 0.08188276 0.01712487 0.11882986 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP collagen disease DOID_854 0.0187461 0.08888774 0.1892943 0.46226805 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP respiratory failure DOID_11162 0.01930036 0.09075957 0.19195045 0.46675132 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP hypothyroidism DOID_1459 0.01930036 0.09001564 0.01930036 0.12919891 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP mineral metabolism disease DOID_0050032 0.02042939 0.09450669 0.02042939 0.13516655 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP cholestasis DOID_13580 0.02100405 0.09638148 0.02100405 0.1373713 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP parasitic infectious disease DOID_1398 0.02100405 0.09561043 0.19986724 0.47985003 DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP uterine disease DOID_345 0.02100405 0.09485161 0.19986724 0.47583455 RHODES_CANCER_META_SIGNATURE hyperglycemia DOID_4195 2.306E-07 1.312E-04 2.038E-05 0.01159606 RHODES_CANCER_META_SIGNATURE hypertrophic cardiomyopathy DOID_11984 1.406E-05 3.999E-03 1.005E-03 0.06356272 RHODES_CANCER_META_SIGNATURE lymphoma DOID_0060058 5.147E-05 9.763E-03 5.147E-05 0.01464419 RHODES_CANCER_META_SIGNATURE oral submucous fibrosis DOID_5773 5.896E-05 8.387E-03 0.0114151 0.27063303 RHODES_CANCER_META_SIGNATURE varicose veins DOID_799 5.896E-05 6.709E-03 0.0114151 0.25980771 RHODES_CANCER_META_SIGNATURE vein disease DOID_866 6.735E-05 6.387E-03 0.01217162 0.23881555 RHODES_CANCER_META_SIGNATURE intracranial aneurysm DOID_10941 2.109E-04 0.01714679 0.02120633 0.31753695 RHODES_CANCER_META_SIGNATURE middle cerebral artery infarction DOID_3525 2.109E-04 0.01500344 0.02120633 0.30939497 RHODES_CANCER_META_SIGNATURE diffuse large B-cell lymphoma DOID_0050745 2.265E-04 0.01431748 2.265E-04 0.04295244 RHODES_CANCER_META_SIGNATURE intracranial arterial disease DOID_13089 5.004E-04 0.02846997 0.03238758 0.34126911 RHODES_CANCER_META_SIGNATURE cerebral arterial disease DOID_3527 5.004E-04 0.02846997 0.03238758 0.34126911 RHODES_CANCER_META_SIGNATURE adenoid cystic carcinoma DOID_4866 5.004E-04 0.02588179 5.004E-04 0.07117493 RHODES_CANCER_META_SIGNATURE cervix uteri carcinoma in situ DOID_8991 5.239E-04 0.02484295 5.239E-04 0.05962309 RHODES_CANCER_META_SIGNATURE endometriosis of uterus DOID_288 5.48E-04 0.02398718 0.03386906 0.35039083 RHODES_CANCER_META_SIGNATURE salivary gland cancer DOID_8850 5.48E-04 0.02227381 5.48E-04 0.05197223 RHODES_CANCER_META_SIGNATURE endometriosis DOID_289 5.727E-04 0.02172354 0.03460898 0.35165196 RHODES_CANCER_META_SIGNATURE cerebral infarction DOID_3526 6.235E-04 0.02217476 0.03608718 0.35402767 RHODES_CANCER_META_SIGNATURE thyroid adenoma DOID_2891 6.765E-04 0.02264358 6.765E-04 0.05499156 RHODES_CANCER_META_SIGNATURE B-cell lymphocytic neoplasm DOID_707 7.888E-04 0.02493456 7.888E-04 0.05610276 RHODES_CANCER_META_SIGNATURE oral cavity cancer DOID_8618 1.005E-03 0.03010866 1.005E-03 0.05720645 RHODES_CANCER_META_SIGNATURE carotid artery disease DOID_3407 1.106E-03 0.03146568 0.04783435 0.41873453 RHODES_CANCER_META_SIGNATURE collagen disease DOID_854 1.106E-03 0.02996732 0.04783435 0.41239007 RHODES_CANCER_META_SIGNATURE pre-malignant neoplasm DOID_0060071 1.176E-03 0.03040673 1.176E-03 0.06081346 RHODES_CANCER_META_SIGNATURE in situ carcinoma DOID_8719 1.176E-03 0.03040673 1.176E-03 0.06081346 RHODES_CANCER_META_SIGNATURE uterine disease DOID_345 1.247E-03 0.03085884 0.05074947 0.42465368 RHODES_CANCER_META_SIGNATURE allergic contact dermatitis DOID_3042 1.321E-03 0.0313219 0.0522038 0.43049222 RHODES_CANCER_META_SIGNATURE endocrine organ benign neoplasm DOID_0060089 1.359E-03 0.03092594 1.359E-03 0.06442904 RHODES_CANCER_META_SIGNATURE brain infarction DOID_3454 1.359E-03 0.02973648 0.05293016 0.43024658 RHODES_CANCER_META_SIGNATURE pancreatic ductal carcinoma DOID_3587 1.436E-03 0.03025427 0.05438126 0.43581603 RHODES_CANCER_META_SIGNATURE pancreatic carcinoma DOID_4905 1.555E-03 0.0315933 0.05655389 0.44081047 RHODES_CANCER_META_SIGNATURE bone resorption disease DOID_0080011 1.678E-03 0.03292948 0.0587217 0.45152227 RHODES_CANCER_META_SIGNATURE osteoporosis DOID_11476 1.678E-03 0.03292948 0.0587217 0.45152227 RHODES_CANCER_META_SIGNATURE aneurysm disease DOID_2403 1.678E-03 0.03183183 0.0587217 0.44550197 RHODES_CANCER_META_SIGNATURE mixed glioma DOID_5076 1.721E-03 0.03157992 1.721E-03 0.07530596 RHODES_CANCER_META_SIGNATURE contact dermatitis DOID_2773 1.806E-03 0.03212131 0.0608847 0.45583414 RHODES_CANCER_META_SIGNATURE female reproductive system disease DOID_229 1.85E-03 0.03190192 0.06160463 0.45523424 RHODES_CANCER_META_SIGNATURE biliary tract cancer DOID_4607 1.939E-03 0.03245241 0.0630429 0.45988989 RHODES_CANCER_META_SIGNATURE nervous system cancer DOID_3093 2.266E-03 0.03684257 0.0680601 0.47227067 RHODES_CANCER_META_SIGNATURE mouth disease DOID_403 2.464E-03 0.03894566 0.07091541 0.47471608 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE Human immunodeficiency virus infectious disease DOID_526 6.161E-06 3.506E-03 6.161E-06 3.506E-03 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE bronchitis DOID_6132 1.98E-05 5.634E-03 1.000 1.000 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE multiple myeloma DOID_9538 1.13E-04 0.02142955 0.01571306 0.38872753 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE myeloma DOID_0070004 1.77E-04 0.02518392 0.01960516 0.39840489 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE bone marrow cancer DOID_4960 2.303E-04 0.02620688 0.02232108 0.4096998 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE hypertrophic cardiomyopathy DOID_11984 2.638E-04 0.02501815 0.02386988 0.42443624 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE glioblastoma DOID_3068 2.638E-04 0.02144413 0.02386988 0.41157454 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE leukocyte disease DOID_9500 2.725E-04 0.01938464 0.02425672 0.39434493 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE parasitic infectious disease DOID_1398 3.279E-04 0.02072869 0.02657476 0.40867678 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE astrocytoma DOID_3069 3.675E-04 0.0209134 0.02811727 0.42101914 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE peripheral vascular disease DOID_341 3.988E-04 0.02062701 1.000 1.000 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE chronic kidney failure DOID_784 5.118E-04 0.02426949 1.000 1.000 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE transitional cell carcinoma DOID_2671 5.735E-04 0.02510365 0.03503037 0.46354135 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE Crohn's disease DOID_8778 6.521E-04 0.02650447 1.000 1.000 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE hypersensitivity reaction type I disease DOID_1205 6.657E-04 0.02525253 0.03770638 0.46641147 DELLA_RESPONSE_TO_TSA_AND_BUTYRATE ulcerative colitis DOID_8577 7.073E-04 0.02515189 1.000 1.000 BORCZUK_MALIGNANT_MESOTHELIOMA_DN agammaglobulinemia DOID_2583 5.04E-11 2.867E-08 5.04E-11 2.867E-08 BORCZUK_MALIGNANT_MESOTHELIOMA_DN primary immunodeficiency disease DOID_612 5.112E-11 1.455E-08 5.112E-11 1.455E-08 BORCZUK_MALIGNANT_MESOTHELIOMA_DN blood protein disease DOID_620 6.712E-11 1.273E-08 6.712E-11 1.273E-08 BORCZUK_MALIGNANT_MESOTHELIOMA_DN B cell deficiency DOID_2115 4.219E-10 6.002E-08 4.219E-10 6.002E-08 BORCZUK_MALIGNANT_MESOTHELIOMA_DN Human immunodeficiency virus infectious disease DOID_526 8.681E-06 9.879E-04 2.967E-04 0.02813786 BORCZUK_MALIGNANT_MESOTHELIOMA_DN atrophic muscular disease DOID_913 6.786E-05 6.436E-03 2.814E-03 0.14554901 BORCZUK_MALIGNANT_MESOTHELIOMA_DN muscular dystrophy DOID_9884 6.786E-05 6.436E-03 2.814E-03 0.14554901 BORCZUK_MALIGNANT_MESOTHELIOMA_DN common variable immunodeficiency DOID_12177 1.046E-04 8.504E-03 1.046E-04 0.01190582 BORCZUK_MALIGNANT_MESOTHELIOMA_DN chronic kidney failure DOID_784 2.35E-04 0.01671298 6.356E-03 0.20093142 BORCZUK_MALIGNANT_MESOTHELIOMA_DN lymphoma DOID_0060058 3.161E-04 0.01998345 7.72E-03 0.2312069 BORCZUK_MALIGNANT_MESOTHELIOMA_DN severe combined immunodeficiency DOID_627 5.635E-04 0.03206565 5.635E-04 0.04580807 BORCZUK_MALIGNANT_MESOTHELIOMA_DN combined T cell and B cell immunodeficiency DOID_628 6.1E-04 0.03155154 6.1E-04 0.04338337 BORCZUK_MALIGNANT_MESOTHELIOMA_DN diffuse large B-cell lymphoma DOID_0050745 7.599E-04 0.03603366 0.03977312 0.411471 BORCZUK_MALIGNANT_MESOTHELIOMA_DN gestational diabetes DOID_11714 7.599E-04 0.03326184 0.03977312 0.40412331 BORCZUK_MALIGNANT_MESOTHELIOMA_DN autonomic nervous system neoplasm DOID_2621 1.108E-03 0.04502159 0.04780612 0.44592922 BORCZUK_MALIGNANT_MESOTHELIOMA_DN neuroblastoma DOID_769 1.108E-03 0.04502159 0.04780612 0.44592922 BORCZUK_MALIGNANT_MESOTHELIOMA_DN calcinosis DOID_182 1.446E-03 0.05483946 0.05444989 0.49970948 BORCZUK_MALIGNANT_MESOTHELIOMA_DN multiple myeloma DOID_9538 1.446E-03 0.05141199 1.000 1.000 BORCZUK_MALIGNANT_MESOTHELIOMA_DN peripheral nervous system neoplasm DOID_1192 1.518E-03 0.05082372 0.05577318 0.50372916 BORCZUK_MALIGNANT_MESOTHELIOMA_DN systemic scleroderma DOID_418 1.593E-03 0.05035515 0.05709464 0.50760708 BORCZUK_MALIGNANT_MESOTHELIOMA_DN rheumatic disease DOID_1575 1.908E-03 0.05714092 0.0623624 0.52182654 BORCZUK_MALIGNANT_MESOTHELIOMA_DN scleroderma DOID_419 1.908E-03 0.05714092 0.0623624 0.52182654 BORCZUK_MALIGNANT_MESOTHELIOMA_DN learning disability DOID_8927 2.076E-03 0.05905592 2.076E-03 0.13123538 BORCZUK_MALIGNANT_MESOTHELIOMA_DN proteinuria DOID_576 2.162E-03 0.05858472 2.162E-03 0.12302791 BORCZUK_MALIGNANT_MESOTHELIOMA_DN myeloma DOID_0070004 2.25E-03 0.05819983 1.000 1.000 BORCZUK_MALIGNANT_MESOTHELIOMA_DN heart valve disease DOID_4079 2.25E-03 0.05566941 0.06760127 0.55746558 BORCZUK_MALIGNANT_MESOTHELIOMA_DN pulmonary tuberculosis DOID_2957 2.431E-03 0.05764541 0.07020993 0.55485349 BORCZUK_MALIGNANT_MESOTHELIOMA_DN calcium metabolism disease DOID_10575 2.525E-03 0.05745844 0.07151157 0.55739844 BORCZUK_MALIGNANT_MESOTHELIOMA_DN B-cell lymphocytic neoplasm DOID_707 2.619E-03 0.05732223 0.07281143 0.55239604 BORCZUK_MALIGNANT_MESOTHELIOMA_DN bone marrow cancer DOID_4960 2.913E-03 0.06139919 1.000 1.000 BORCZUK_MALIGNANT_MESOTHELIOMA_DN familial hyperlipidemia DOID_1168 3.118E-03 0.06335927 3.118E-03 0.14783829 BORCZUK_MALIGNANT_MESOTHELIOMA_DN collagen disease DOID_854 3.657E-03 0.07175844 0.08571217 0.59475882 BORCZUK_MALIGNANT_MESOTHELIOMA_DN mineral metabolism disease DOID_0050032 4E-03 0.07587274 0.08954793 0.59944438 BORCZUK_MALIGNANT_MESOTHELIOMA_DN allergic contact dermatitis DOID_3042 4.358E-03 0.07998561 4.358E-03 0.19073492 BORCZUK_MALIGNANT_MESOTHELIOMA_DN tuberculosis DOID_399 4.48E-03 0.07966098 0.09463773 0.61895251 BORCZUK_MALIGNANT_MESOTHELIOMA_DN cystic fibrosis DOID_1485 5.38E-03 0.09276864 0.10347779 0.63310603 BORCZUK_MALIGNANT_MESOTHELIOMA_DN endogenous depression DOID_1595 5.38E-03 0.09004015 5.38E-03 0.21866893 BORCZUK_MALIGNANT_MESOTHELIOMA_DN mixed glioma DOID_5076 5.651E-03 0.09187662 0.10598792 0.63481188 BORCZUK_MALIGNANT_MESOTHELIOMA_DN contact dermatitis DOID_2773 5.929E-03 0.09370844 5.929E-03 0.22490026 BORCZUK_MALIGNANT_MESOTHELIOMA_DN lipid metabolism disorder DOID_3146 5.929E-03 0.09117578 5.929E-03 0.21084399 BORCZUK_MALIGNANT_MESOTHELIOMA_DN mental depression DOID_1596 6.356E-03 0.09517804 6.356E-03 0.21275092 JAIN_NFKB_SIGNALING myeloma DOID_0070004 1.712E-07 9.74E-05 1.712E-07 9.74E-05 JAIN_NFKB_SIGNALING bone marrow cancer DOID_4960 2.922E-07 8.312E-05 2.922E-07 8.312E-05 JAIN_NFKB_SIGNALING angiosarcoma DOID_0001816 4.75E-07 9.009E-05 1.103E-04 0.01568471 JAIN_NFKB_SIGNALING sarcoma DOID_1115 3.412E-06 4.853E-04 3.963E-04 0.02505319 JAIN_NFKB_SIGNALING multiple myeloma DOID_9538 8.246E-06 9.384E-04 8.246E-06 1.564E-03 JAIN_NFKB_SIGNALING systemic scleroderma DOID_418 9.569E-06 9.074E-04 7.786E-04 0.03691778 JAIN_NFKB_SIGNALING rheumatic disease DOID_1575 1.262E-05 1.026E-03 9.336E-04 0.04086426 JAIN_NFKB_SIGNALING scleroderma DOID_419 1.262E-05 1.026E-03 9.336E-04 0.04086426 JAIN_NFKB_SIGNALING pustulosis of palm and sole DOID_4398 2.544E-05 1.81E-03 1.48E-03 0.05263807 JAIN_NFKB_SIGNALING collagen disease DOID_854 3.422E-05 2.163E-03 1.799E-03 0.06019906 JAIN_NFKB_SIGNALING astrocytoma DOID_3069 4.872E-05 2.772E-03 2.269E-03 0.06795545 JAIN_NFKB_SIGNALING nervous system cancer DOID_3093 1.012E-04 5.236E-03 3.671E-03 0.07459933 JAIN_NFKB_SIGNALING encephalomyelitis DOID_640 1.113E-04 5.279E-03 3.908E-03 0.07413034 JAIN_NFKB_SIGNALING ulcerative colitis DOID_8577 1.296E-04 5.674E-03 4.32E-03 0.07928841 JAIN_NFKB_SIGNALING prion disease DOID_649 1.404E-04 5.707E-03 1.404E-04 0.01597874 JAIN_NFKB_SIGNALING brain edema DOID_4724 1.742E-04 6.606E-03 0.01934428 0.22013792 JAIN_NFKB_SIGNALING Kawasaki disease DOID_13378 1.924E-04 6.841E-03 0.02030188 0.22214938 JAIN_NFKB_SIGNALING lymphadenitis DOID_1602 1.924E-04 6.841E-03 0.02030188 0.22214938 JAIN_NFKB_SIGNALING lymph node disease DOID_9942 1.924E-04 6.841E-03 0.02030188 0.22214938 JAIN_NFKB_SIGNALING muscle cancer DOID_4045 2.315E-04 7.747E-03 0.02221434 0.21793033 JAIN_NFKB_SIGNALING polyarteritis nodosa DOID_9810 2.315E-04 7.317E-03 0.02221434 0.20721245 JAIN_NFKB_SIGNALING severe combined immunodeficiency DOID_627 2.741E-04 8.21E-03 2.741E-04 0.02599688 JAIN_NFKB_SIGNALING combined T cell and B cell immunodeficiency DOID_628 2.968E-04 8.444E-03 2.968E-04 0.02412512 JAIN_NFKB_SIGNALING ankylosing spondylitis DOID_7147 3.203E-04 8.68E-03 3.203E-04 0.02278423 JAIN_NFKB_SIGNALING hepatic vascular disease DOID_272 3.963E-04 0.01024903 0.0288794 0.21909836 JAIN_NFKB_SIGNALING invasive ductal carcinoma DOID_3008 3.963E-04 9.803E-03 3.963E-04 0.02254787 JAIN_NFKB_SIGNALING age related macular degeneration DOID_10871 4.801E-04 0.01138251 0.0317223 0.22562485 JAIN_NFKB_SIGNALING degeneration of macula and posterior pole DOID_2007 4.801E-04 0.01138251 0.0317223 0.22562485 JAIN_NFKB_SIGNALING macular degeneration DOID_4448 6.041E-04 0.01374935 0.03550024 0.23487951 JAIN_NFKB_SIGNALING blood platelet disease DOID_2218 7.42E-04 0.01623757 7.42E-04 0.0383797 JAIN_NFKB_SIGNALING lymphatic system disease DOID_75 8.161E-04 0.01719772 0.04114028 0.25170773 JAIN_NFKB_SIGNALING pre-eclampsia DOID_10591 1.102E-03 0.02240051 0.04767977 0.27403827 JAIN_NFKB_SIGNALING brain cancer DOID_1319 1.102E-03 0.02162808 0.04767977 0.27129789 JAIN_NFKB_SIGNALING heart valve disease DOID_4079 1.102E-03 0.02090714 1.102E-03 0.04480102 JAIN_NFKB_SIGNALING vascular skin disease DOID_9540 1.102E-03 0.02023272 0.04767977 0.26339601 JAIN_NFKB_SIGNALING central nervous system cancer DOID_3620 1.147E-03 0.02038794 0.04861043 0.26595516 JAIN_NFKB_SIGNALING hemorrhagic disease DOID_2213 1.285E-03 0.02214823 1.285E-03 0.04872611 JAIN_NFKB_SIGNALING giant cell tumor DOID_200 1.381E-03 0.02310585 0.05325049 0.27545028 JAIN_NFKB_SIGNALING malignant giant cell tumor DOID_2705 1.381E-03 0.02310585 0.05325049 0.27545028 JAIN_NFKB_SIGNALING giant cell glioblastoma DOID_3074 1.381E-03 0.02310585 0.05325049 0.27545028 JAIN_NFKB_SIGNALING glioblastoma DOID_3068 1.636E-03 0.02659075 0.05786853 0.28142901 JAIN_NFKB_SIGNALING respiratory failure DOID_11162 1.855E-03 0.0293118 0.06154717 0.29183618 JAIN_NFKB_SIGNALING uterine disease DOID_345 2.027E-03 0.03117701 0.06429698 0.29504018 JAIN_NFKB_SIGNALING allergic contact dermatitis DOID_3042 2.147E-03 0.03214277 2.147E-03 0.06785695 JAIN_NFKB_SIGNALING blood coagulation disease DOID_1247 2.332E-03 0.03401821 2.332E-03 0.06633551 JAIN_NFKB_SIGNALING pancreatic ductal carcinoma DOID_3587 2.332E-03 0.03316776 0.06886258 0.30611569 JAIN_NFKB_SIGNALING bile duct disease DOID_4138 2.395E-03 0.03323726 2.395E-03 0.06489178 JAIN_NFKB_SIGNALING peripheral vascular disease DOID_341 2.459E-03 0.03331439 0.07068275 0.30937294 JAIN_NFKB_SIGNALING biliary tract disease DOID_9741 2.459E-03 0.03253964 2.459E-03 0.0636002 JAIN_NFKB_SIGNALING pancreatic carcinoma DOID_4905 2.524E-03 0.03263954 0.07159153 0.31095863 JAIN_NFKB_SIGNALING diabetic retinopathy DOID_8947 2.524E-03 0.03191422 0.07159153 0.30860288 JAIN_NFKB_SIGNALING syndrome DOID_225 2.656E-03 0.03285617 0.0734065 0.31170373 JAIN_NFKB_SIGNALING bone resorption disease DOID_0080011 2.724E-03 0.03297213 2.724E-03 0.06737783 JAIN_NFKB_SIGNALING osteoporosis DOID_11476 2.724E-03 0.03297213 2.724E-03 0.06737783 JAIN_NFKB_SIGNALING contact dermatitis DOID_2773 2.93E-03 0.0347362 2.93E-03 0.06947239 JAIN_NFKB_SIGNALING lipid metabolism disorder DOID_3146 2.93E-03 0.03402729 2.93E-03 0.0666935 JAIN_NFKB_SIGNALING female reproductive system disease DOID_229 3.001E-03 0.03414919 0.07792885 0.32604055 JAIN_NFKB_SIGNALING retinal vascular disease DOID_2462 3.291E-03 0.03671483 0.08153125 0.33375024 JAIN_NFKB_SIGNALING primary immunodeficiency disease DOID_612 3.593E-03 0.03931971 3.593E-03 0.07863942 JAIN_NFKB_SIGNALING amino acid metabolic disorder DOID_9252 3.593E-03 0.03857783 3.593E-03 0.07572685 JAIN_NFKB_SIGNALING lymphoblastic leukemia DOID_1037 3.908E-03 0.04118352 3.908E-03 0.07668656 JAIN_NFKB_SIGNALING Crohn's disease DOID_8778 3.989E-03 0.04126976 0.08958667 0.35155046 JAIN_NFKB_SIGNALING facioscapulohumeral muscular dystrophy DOID_11727 9.718E-03 0.09874281 9.718E-03 0.17279991 JAIN_NFKB_SIGNALING retinal vascular occlusion DOID_1729 9.718E-03 0.09701048 1.000 1.000 JAIN_NFKB_SIGNALING keratitis DOID_4677 9.718E-03 0.09533788 1.000 1.000 JAIN_NFKB_SIGNALING polycythemia DOID_8432 9.718E-03 0.09372199 9.718E-03 0.16756355 BHATTACHARYA_EMBRYONIC_STEM_CELL embryonal cancer DOID_688 1.833E-07 1.043E-04 1.833E-07 1.043E-04 BHATTACHARYA_EMBRYONIC_STEM_CELL dilated cardiomyopathy DOID_12930 6.6E-06 1.878E-03 2.426E-04 0.03451301 BHATTACHARYA_EMBRYONIC_STEM_CELL pre-malignant neoplasm DOID_0060071 7.736E-05 0.01467178 7.736E-05 0.02200768 BHATTACHARYA_EMBRYONIC_STEM_CELL congenital heart defect DOID_1682 7.736E-05 0.01100384 3.068E-03 0.19394756 BHATTACHARYA_EMBRYONIC_STEM_CELL in situ carcinoma DOID_8719 7.736E-05 0.01467178 7.736E-05 0.02200768 BHATTACHARYA_EMBRYONIC_STEM_CELL endocrine organ benign neoplasm DOID_0060089 9.62E-05 0.01094752 3.54E-03 0.20142617 BHATTACHARYA_EMBRYONIC_STEM_CELL tethered spinal cord syndrome DOID_1089 1.356E-04 0.01285923 1.356E-04 0.02571846 BHATTACHARYA_EMBRYONIC_STEM_CELL heart septal defect DOID_1681 2.538E-04 0.02063031 0.02329965 0.45715529 BHATTACHARYA_EMBRYONIC_STEM_CELL spinal cord disease DOID_319 5.571E-04 0.03962052 5.571E-04 0.06339284 BHATTACHARYA_EMBRYONIC_STEM_CELL middle cerebral artery infarction DOID_3525 5.571E-04 0.03521824 5.571E-04 0.05282737 BHATTACHARYA_EMBRYONIC_STEM_CELL intracranial arterial disease DOID_13089 1.315E-03 0.07482769 1.315E-03 0.10689671 BHATTACHARYA_EMBRYONIC_STEM_CELL cerebral arterial disease DOID_3527 1.315E-03 0.07482769 1.315E-03 0.10689671 BHATTACHARYA_EMBRYONIC_STEM_CELL cerebral infarction DOID_3526 1.636E-03 0.08464042 1.636E-03 0.11638058 BHATTACHARYA_EMBRYONIC_STEM_CELL thyroid adenoma DOID_2891 1.774E-03 0.08412618 0.06017904 0.62257948 BHATTACHARYA_EMBRYONIC_STEM_CELL integumentary system benign neoplasm DOID_0060121 1.917E-03 0.08392503 0.06251097 0.62401306 BHATTACHARYA_EMBRYONIC_STEM_CELL skin benign neoplasm DOID_3165 1.917E-03 0.08392503 0.06251097 0.62401306 BHATTACHARYA_EMBRYONIC_STEM_CELL integumentary system cancer DOID_0060122 2.379E-03 0.09669006 0.06947286 0.65883431 BHATTACHARYA_EMBRYONIC_STEM_CELL skin cancer DOID_4159 2.379E-03 0.09669006 0.06947286 0.65883431 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN mixed glioma DOID_5076 1.285E-06 7.309E-04 7.237E-05 0.02058861 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN chromosomal disease DOID_0080014 1.489E-06 4.237E-04 1.489E-06 8.474E-04 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN bone development disease DOID_0080006 8.977E-05 0.01702626 3.391E-03 0.1484147 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN Down syndrome DOID_14250 1.655E-04 0.02354189 1.655E-04 0.03138918 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN polycystic ovary syndrome DOID_11612 4.466E-04 0.05082672 4.466E-04 0.0635334 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN nephroblastoma DOID_2154 6.373E-04 0.06043451 6.373E-04 0.07252141 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN thyroid carcinoma DOID_3963 6.373E-04 0.05180101 6.373E-04 0.06043451 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN thyroid cancer DOID_1781 7.081E-04 0.05036645 7.081E-04 0.05756166 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN Huntington's disease DOID_12858 9.847E-04 0.0622573 9.847E-04 0.07003947 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN reproductive organ benign neoplasm DOID_0050622 1.561E-03 0.08881261 1.561E-03 0.09868068 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN osteochondrodysplasia DOID_2256 1.561E-03 0.08073874 0.05654736 0.37853467 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN carotid artery disease DOID_3407 1.896E-03 0.08992214 1.896E-03 0.10790657 SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN temporal lobe epilepsy DOID_3328 2.2E-03 0.09628799 0.06691487 0.40504849 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP aneurysm disease DOID_2403 6.076E-20 3.457E-17 1.501E-04 0.0142341 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP primary bacterial infectious disease DOID_0050338 4.703E-19 1.338E-16 0.01909369 0.17244937 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP tuberculosis DOID_399 1.981E-17 3.756E-15 0.07463477 0.40833832 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hypersensitivity reaction type I disease DOID_1205 6.603E-17 9.393E-15 3.914E-04 0.02227027 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bacterial pneumonia DOID_874 1.18E-16 1.343E-14 0.39865771 0.91466224 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP carotid artery disease DOID_3407 1.866E-16 1.77E-14 3.335E-06 4.744E-04 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP aortic aneurysm DOID_3627 6.664E-16 5.417E-14 4.648E-03 0.07557123 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pulmonary emphysema DOID_9675 3.317E-15 2.359E-13 0.24390757 0.67699223 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP contact dermatitis DOID_2773 5.733E-15 3.624E-13 2.756E-09 7.841E-07 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP influenza DOID_8469 7.408E-15 4.215E-13 0.2581933 0.69626534 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pulmonary tuberculosis DOID_2957 2.499E-14 1.293E-12 0.28140798 0.72782336 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP sphingolipidosis DOID_1927 2.628E-14 1.246E-12 1.628E-10 9.265E-08 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP respiratory failure DOID_11162 3.445E-13 1.508E-11 0.06400792 0.40467229 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP allergic contact dermatitis DOID_3042 8.1E-13 3.292E-11 3.188E-07 6.046E-05 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP brain infarction DOID_3454 9.532E-13 3.616E-11 0.07463477 0.41230276 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP sarcoidosis DOID_11335 2.363E-12 8.405E-11 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP giant cell tumor DOID_200 2.363E-12 7.91E-11 0.04915755 0.34963309 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP malignant giant cell tumor DOID_2705 2.363E-12 7.91E-11 0.04915755 0.34963309 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP giant cell glioblastoma DOID_3074 2.363E-12 7.91E-11 0.04915755 0.34963309 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hypersensitivity reaction type IV disease DOID_2916 5.822E-12 1.84E-10 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP glioblastoma DOID_3068 5.822E-12 1.744E-10 0.05723715 0.39238483 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP intracranial arterial disease DOID_13089 6.57E-12 1.869E-10 0.03039912 0.2402375 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cerebral arterial disease DOID_3527 6.57E-12 1.869E-10 0.03039912 0.2402375 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP mineral metabolism disease DOID_0050032 1.549E-11 4.197E-10 8.911E-03 0.13000392 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cholestasis DOID_13580 1.806E-11 4.671E-10 9.279E-03 0.12877496 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP abdominal aortic aneurysm DOID_7693 2.78E-11 6.877E-10 0.01852207 0.1699848 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP astrocytoma DOID_3069 3.258E-11 7.724E-10 0.07645745 0.41432658 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bile duct disease DOID_4138 4.317E-11 9.825E-10 0.0116753 0.14762769 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pleural disease DOID_1532 4.661E-11 1.02E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP biliary tract disease DOID_9741 4.954E-11 1.044E-09 0.01210598 0.14350633 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP common cold DOID_10459 5.412E-11 1.1E-09 0.07338764 0.42609764 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bone marrow cancer DOID_4960 9.705E-11 1.904E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pulmonary sarcoidosis DOID_13406 1.482E-10 2.811E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP multiple myeloma DOID_9538 1.482E-10 2.72E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP chronic kidney failure DOID_784 1.769E-10 3.146E-09 0.01691331 0.16039455 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP respiratory syncytial virus infectious disease DOID_1273 2.25E-10 3.88E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP systemic scleroderma DOID_418 2.25E-10 3.765E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP adult respiratory distress syndrome DOID_11394 2.749E-10 4.47E-09 0.23908504 0.66685974 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP collagen disease DOID_854 2.859E-10 4.519E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP rheumatic disease DOID_1575 4.867E-10 7.485E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP scleroderma DOID_419 4.867E-10 7.485E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP parasitic infectious disease DOID_1398 5.005E-10 7.494E-09 0.35094225 0.83550686 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP encephalomyelitis DOID_640 5.407E-10 7.889E-09 0.12177794 0.47787342 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pleurisy DOID_10247 6.713E-10 9.549E-09 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP myeloma DOID_0070004 9.798E-10 1.36E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP peripheral vascular disease DOID_341 1.227E-09 1.663E-08 1.339E-03 0.05860394 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.359E-09 1.798E-08 4.406E-03 0.07596537 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP leishmaniasis DOID_9065 1.531E-09 1.98E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP calcium metabolism disease DOID_10575 1.591E-09 2.012E-08 0.04452828 0.32482809 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cystic fibrosis DOID_1485 1.753E-09 2.168E-08 0.39095495 0.90797294 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pancreatitis DOID_4989 2.205E-09 2.669E-08 0.01439533 0.15168416 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cutaneous leishmaniasis DOID_9111 2.395E-09 2.839E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP vasculitis DOID_865 2.903E-09 3.371E-08 0.30389909 0.76512647 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pneumoconiosis DOID_10316 3.269E-09 3.72E-08 0.02298082 0.19516544 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP retinal vascular disease DOID_2462 4.693E-09 5.236E-08 0.10534825 0.45070042 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP calcinosis DOID_182 5.825E-09 6.374E-08 0.22443289 0.64172017 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP uveitis DOID_13141 6.987E-09 7.501E-08 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP nervous system cancer DOID_3093 7.734E-09 8.149E-08 0.11554432 0.46627458 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP mouth disease DOID_403 1.129E-08 1.168E-07 0.12387393 0.47948481 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP carotid stenosis DOID_13001 1.204E-08 1.224E-07 2.973E-03 0.07689327 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP urticaria DOID_1555 1.252E-08 1.25E-07 5.849E-04 0.03025682 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP uveal disease DOID_3480 1.619E-08 1.589E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP middle cerebral artery infarction DOID_3525 2.027E-08 1.955E-07 0.16296071 0.54224938 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cerebral infarction DOID_3526 2.204E-08 2.09E-07 0.03720292 0.28606032 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP periodontitis DOID_824 2.543E-08 2.372E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP proteinuria DOID_576 2.557E-08 2.347E-07 0.03862755 0.29305431 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP brain cancer DOID_1319 2.958E-08 2.671E-07 0.27221022 0.72377389 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP heart valve disease DOID_4079 2.958E-08 2.629E-07 0.27221022 0.7137678 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP diabetic retinopathy DOID_8947 2.987E-08 2.615E-07 0.38315395 0.89350246 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP central nervous system cancer DOID_3620 3.41E-08 2.94E-07 0.27682366 0.72253514 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP allergic rhinitis DOID_4481 7.01E-08 5.954E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP biliary tract cancer DOID_4607 7.26E-08 6.075E-07 0.41749279 0.94642788 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP parasitic protozoa infectious disease DOID_2789 8.528E-08 7.032E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP systemic mycosis DOID_0050136 1.005E-07 8.166E-07 0.02182838 0.19108225 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP fungal infectious disease DOID_1564 1.005E-07 8.166E-07 0.02182838 0.19108225 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP periodontal disease DOID_3388 1.193E-07 9.559E-07 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hypertrophic cardiomyopathy DOID_11984 1.218E-07 9.622E-07 4.346E-05 4.945E-03 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autoimmune hepatitis DOID_2048 1.827E-07 1.424E-06 7.742E-03 0.11906097 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP mitochondrial myopathy DOID_699 1.827E-07 1.405E-06 7.742E-03 0.11592779 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP uterine disease DOID_345 2.606E-07 1.977E-06 9.286E-04 0.04403136 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hyperglycemia DOID_4195 2.884E-07 2.16E-06 9.656E-03 0.12777659 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP endometriosis of uterus DOID_288 4.006E-07 2.96E-06 1.903E-04 0.01547248 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP endometriosis DOID_289 4.582E-07 3.343E-06 2.074E-04 0.01475452 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP dermatomyositis DOID_10223 4.992E-07 3.596E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP diabetic autonomic neuropathy DOID_11503 5.225E-07 3.716E-06 3.308E-03 0.07843453 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autonomic neuropathy DOID_11504 5.225E-07 3.716E-06 3.308E-03 0.07843453 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP diabetic polyneuropathy DOID_12785 5.225E-07 3.716E-06 3.308E-03 0.07843453 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP gallbladder cancer DOID_3121 5.225E-07 3.671E-06 0.2581933 0.69958089 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP diabetic neuropathy DOID_9743 5.225E-07 3.716E-06 3.308E-03 0.07843453 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP commensal bacterial infectious disease DOID_0050339 5.755E-07 3.993E-06 0.01173581 0.14516688 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cystitis DOID_1679 7.027E-07 4.817E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP myositis DOID_633 7.027E-07 4.76E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bone resorption disease DOID_0080011 7.345E-07 4.917E-06 0.01391925 0.15230877 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP osteoporosis DOID_11476 7.345E-07 4.917E-06 0.01391925 0.15230877 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP mitochondrial encephalomyopathy DOID_890 7.451E-07 4.93E-06 2.526E-03 0.08455196 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP encephalitis DOID_9588 7.451E-07 4.873E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pre-eclampsia DOID_10591 7.611E-07 4.921E-06 0.0400727 0.30001801 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autonomic nervous system disease DOID_11465 7.611E-07 4.866E-06 3.944E-03 0.0773783 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP vascular skin disease DOID_9540 7.611E-07 4.812E-06 3.944E-03 0.07479903 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP mixed glioma DOID_5076 8.006E-07 5.006E-06 0.09152395 0.4233913 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP intracranial aneurysm DOID_10941 8.51E-07 5.263E-06 0.01353706 0.15405169 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP extrinsic allergic alveolitis DOID_841 8.51E-07 5.207E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lipid metabolism disorder DOID_3146 9.479E-07 5.738E-06 1.862E-03 0.07565733 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP integumentary system benign neoplasm DOID_0060121 9.649E-07 5.779E-06 4.406E-03 0.0737311 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP skin benign neoplasm DOID_3165 9.649E-07 5.779E-06 4.406E-03 0.0737311 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP female reproductive system disease DOID_229 1.03E-06 6.103E-06 1.946E-03 0.07382502 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP larynx cancer DOID_2596 1.071E-06 6.282E-06 0.07925553 0.40627383 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP laryngeal benign neoplasm DOID_2598 1.071E-06 6.282E-06 0.07925553 0.40627383 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP focal glomerulosclerosis DOID_3945 1.449E-06 8.411E-06 0.17876922 0.56510938 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP viral pneumonia DOID_10533 1.492E-06 8.574E-06 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP opportunistic mycosis DOID_2473 2.003E-06 1.14E-05 0.01852207 0.17277144 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP thoracic aortic aneurysm DOID_14004 2.024E-06 1.14E-05 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Human immunodeficiency virus infectious disease DOID_526 2.07E-06 1.155E-05 0.11554432 0.46299095 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bladder disease DOID_365 2.711E-06 1.498E-05 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.757E-06 1.508E-05 0.12387393 0.48276895 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP dilated cardiomyopathy DOID_12930 2.955E-06 1.601E-05 0.02389944 0.19426829 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP myocarditis DOID_820 3.132E-06 1.681E-05 0.20445874 0.61881396 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP ulcerative colitis DOID_8577 3.624E-06 1.927E-05 3.82E-03 0.0805134 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP prion disease DOID_649 4.47E-06 2.355E-05 0.1080445 0.45538756 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cerebral degeneration DOID_1443 4.767E-06 2.489E-05 9.279E-03 0.12570889 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP tooth disease DOID_1091 5.651E-06 2.923E-05 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP endocrine organ benign neoplasm DOID_0060089 6.14E-06 3.147E-05 0.36321338 0.85754527 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP membranous glomerulonephritis DOID_10976 7.008E-06 3.56E-05 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pulmonary edema DOID_11396 7.008E-06 3.529E-05 0.11930749 0.474727 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lymphatic system disease DOID_75 7.714E-06 3.85E-05 2.565E-03 0.07681766 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP IgA glomerulonephritis DOID_2986 1.262E-05 6.243E-05 0.13593696 0.50886927 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP metabolic syndrome X DOID_14221 1.417E-05 6.949E-05 0.01537495 0.15906089 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP neuritis DOID_1803 1.638E-05 7.965E-05 0.27221022 0.7204075 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP thyroid adenoma DOID_2891 1.638E-05 7.898E-05 0.27221022 0.71707228 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP focal epilepsy DOID_2234 1.742E-05 8.327E-05 0.10134234 0.45404558 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP toxic shock syndrome DOID_14115 1.785E-05 8.463E-05 0.01087805 0.14067298 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP glaucoma DOID_1686 1.988E-05 9.351E-05 0.04302338 0.31792603 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bronchiolitis DOID_2942 2.099E-05 9.789E-05 0.15225371 0.5380892 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP transitional cell carcinoma DOID_2671 2.415E-05 1.117E-04 0.11143587 0.46622801 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP spinal muscular atrophy DOID_12377 2.452E-05 1.125E-04 0.01262228 0.14657298 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP primary immunodeficiency disease DOID_612 2.572E-05 1.171E-04 0.02023945 0.17994134 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP amino acid metabolic disorder DOID_9252 2.572E-05 1.161E-04 2.721E-03 0.07742643 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP atopic dermatitis DOID_3310 2.621E-05 1.174E-04 0.29498802 0.74932224 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP childhood type dermatomyositis DOID_14203 2.91E-05 1.293E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP transient cerebral ischemia DOID_224 2.91E-05 1.283E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP mitochondrial metabolism disease DOID_700 3.695E-05 1.617E-04 0.05395244 0.37899923 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autoimmune disease of cardiovascular system DOID_0060051 3.772E-05 1.638E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP renal hypertension DOID_1073 3.772E-05 1.626E-04 0.17353304 0.56102442 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP secondary hypertension DOID_11130 3.772E-05 1.626E-04 0.17353304 0.56102442 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Behcet's disease DOID_13241 3.772E-05 1.638E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autoimmune disease of the nervous system DOID_438 3.772E-05 1.614E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP temporal arteritis DOID_13375 3.982E-05 1.691E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP central nervous system vasculitis DOID_525 3.982E-05 1.691E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP otitis media DOID_10754 5.284E-05 2.227E-04 0.07338764 0.42179363 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP middle ear disease DOID_5100 5.284E-05 2.227E-04 0.07338764 0.42179363 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP ocular hypertension DOID_9282 5.284E-05 2.211E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP borderline glaucoma DOID_9283 5.284E-05 2.211E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP papilloma DOID_2615 7.869E-05 3.268E-04 0.20445874 0.62546788 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP temporal lobe epilepsy DOID_3328 7.879E-05 3.249E-04 0.35505857 0.84178468 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hepatitis C DOID_1883 8.779E-05 3.594E-04 0.2094998 0.63071632 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP thyroid carcinoma DOID_3963 8.779E-05 3.568E-04 0.2094998 0.62411196 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pancreatic ductal carcinoma DOID_3587 1.032E-04 4.163E-04 0.07829418 0.42027725 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hemangioma DOID_255 1.078E-04 4.318E-04 0.09088051 0.43454633 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP varicose veins DOID_799 1.078E-04 4.288E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP thyroid cancer DOID_1781 1.083E-04 4.277E-04 0.21948667 0.63718324 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pancreatic carcinoma DOID_4905 1.249E-04 4.903E-04 0.08388616 0.41869496 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP silicosis DOID_10325 1.32E-04 5.145E-04 0.09663808 0.44344409 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP vein disease DOID_866 1.32E-04 5.11E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hepatitis DOID_2237 1.451E-04 5.58E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP auditory system disease DOID_2742 2.004E-04 7.653E-04 0.01639131 0.16362557 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP learning disability DOID_8927 2.449E-04 9.291E-04 3.513E-03 0.07687051 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP subependymal glioma DOID_4843 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pilocytic astrocytoma DOID_4851 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP subependymal giant cell astrocytoma DOID_5077 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP fibrillary astrocytoma DOID_6726 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP juvenile pilocytic astrocytoma DOID_6811 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP childhood pilocytic astrocytoma DOID_6812 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP gemistocytic astrocytoma DOID_7005 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP childhood cerebral astrocytoma DOID_7007 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP protoplasmic astrocytoma DOID_7008 2.638E-04 9.939E-04 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP leukodystrophy DOID_10579 2.654E-04 9.934E-04 0.26756747 0.71814098 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP funisitis DOID_0050698 3.53E-04 1.313E-03 3.53E-04 0.022317 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP benign glioma DOID_0060101 3.53E-04 1.304E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP benign ependymoma DOID_4844 3.53E-04 1.304E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP acquired immunodeficiency syndrome DOID_635 3.53E-04 1.296E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP carbohydrate metabolic disorder DOID_2978 3.555E-04 1.297E-03 3.179E-03 0.07863851 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Crohn's disease DOID_8778 3.731E-04 1.352E-03 0.02326623 0.19186213 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP sinusitis DOID_0050127 4.04E-04 1.455E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP paranasal sinus disease DOID_1352 4.04E-04 1.455E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP myasthenia gravis DOID_437 4.04E-04 1.446E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP uremia DOID_4676 4.04E-04 1.437E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hypoglycemia DOID_9993 4.04E-04 1.428E-03 0.13593696 0.50554333 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP diabetic angiopathy DOID_11713 4.596E-04 1.614E-03 0.14141033 0.52248363 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Lewy body dementia DOID_12217 4.596E-04 1.604E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Goodpasture syndrome DOID_9808 4.596E-04 1.595E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP integumentary system cancer DOID_0060122 5.083E-04 1.753E-03 0.30831247 0.76942893 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP skin cancer DOID_4159 5.083E-04 1.753E-03 0.30831247 0.76942893 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP spastic quadriplegia DOID_10970 5.199E-04 1.782E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP acute pancreatitis DOID_2913 5.199E-04 1.771E-03 0.14684918 0.53562296 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP portal hypertension DOID_10762 5.849E-04 1.981E-03 0.15225371 0.54485762 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bile duct cancer DOID_4606 6.16E-04 2.074E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bile duct carcinoma DOID_4897 6.16E-04 2.074E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP neuromuscular junction disease DOID_439 6.55E-04 2.192E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP leukocyte disease DOID_9500 6.552E-04 2.18E-03 0.3256891 0.78858339 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP spinal cord disease DOID_319 7.302E-04 2.415E-03 0.16296071 0.54543908 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP gestational diabetes DOID_11714 8.106E-04 2.666E-03 0.1682636 0.55663947 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lung adenocarcinoma DOID_3910 8.106E-04 2.651E-03 0.1682636 0.5534219 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP perinatal necrotizing enterocolitis DOID_8677 8.106E-04 2.636E-03 0.1682636 0.54709708 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pre-malignant neoplasm DOID_0060071 8.3E-04 2.683E-03 0.34263096 0.82260344 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP in situ carcinoma DOID_8719 8.3E-04 2.683E-03 0.34263096 0.82260344 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP endocrine pancreas disease DOID_1428 8.783E-04 2.823E-03 0.06748957 0.39589245 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hepatic vascular disease DOID_272 8.965E-04 2.866E-03 0.17353304 0.55472077 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP coronary stenosis DOID_4248 8.965E-04 2.85E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autoimmune disease of endocrine system DOID_0060005 9.879E-04 3.123E-03 0.01644737 0.16135436 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP supratentorial cancer DOID_1659 9.879E-04 3.106E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cerebrum cancer DOID_368 9.879E-04 3.106E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cranial nerve disease DOID_5656 9.879E-04 3.089E-03 0.17876922 0.56198723 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP spastic cerebral palsy DOID_0050669 1.188E-03 3.694E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bronchiolitis obliterans DOID_2799 1.188E-03 3.674E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP nephrosis DOID_2527 1.274E-03 3.918E-03 0.37525345 0.8786799 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP male reproductive system disease DOID_48 1.274E-03 3.897E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP celiac disease DOID_10608 1.297E-03 3.946E-03 0.1942804 0.60079101 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP leber hereditary optic neuropathy DOID_705 1.395E-03 4.223E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP metal metabolism disorder DOID_896 1.533E-03 4.616E-03 0.02182838 0.18818707 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP syndrome DOID_225 1.548E-03 4.637E-03 0.39095495 0.90062093 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP spindle cell carcinoma DOID_4015 1.661E-03 4.947E-03 0.2094998 0.62086138 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP macular degeneration DOID_4448 1.661E-03 4.921E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP esophageal disease DOID_6050 1.661E-03 4.896E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hyperthyroidism DOID_7998 1.661E-03 4.871E-03 0.02298082 0.19229536 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Sjogren's syndrome DOID_12894 1.737E-03 5.068E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hyperparathyroidism DOID_13543 1.737E-03 5.042E-03 0.06153992 0.41685971 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP progressive muscular atrophy DOID_318 1.737E-03 5.017E-03 0.06153992 0.40248523 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP chondrosarcoma DOID_3371 1.737E-03 4.991E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pneumocystosis DOID_11339 2.114E-03 6.044E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP common variable immunodeficiency DOID_12177 2.114E-03 6.014E-03 0.06748252 0.41736471 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP neuronal ceroid lipofuscinosis DOID_14503 2.114E-03 5.984E-03 0.06748252 0.40848461 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bronchiectasis DOID_9563 2.114E-03 5.955E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP intracranial arteriosclerosis DOID_13097 2.526E-03 7.081E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP osteopetrosis DOID_13533 2.526E-03 7.046E-03 2.526E-03 0.08983645 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP vascular dementia DOID_8725 2.526E-03 7.081E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP progressive myoclonus epilepsy DOID_891 2.526E-03 7.012E-03 2.526E-03 0.07985463 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP benign mesothelioma DOID_2645 2.74E-03 7.568E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autoimmune disease of urogenital tract DOID_0060049 2.922E-03 8.032E-03 0.24869966 0.68694227 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP primary biliary cirrhosis DOID_12236 2.922E-03 8.032E-03 0.24869966 0.68694227 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP variable age at onset electroclinical syndrome DOID_0050706 2.973E-03 8.133E-03 2.973E-03 0.08055485 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP berylliosis DOID_10322 2.973E-03 8.094E-03 0.07925553 0.4137284 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP parathyroid gland disease DOID_11201 2.973E-03 8.055E-03 0.07925553 0.40996723 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP nephrotic syndrome DOID_1184 3.112E-03 8.391E-03 0.25346151 0.69336345 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lymphoblastic leukemia DOID_1037 3.179E-03 8.532E-03 0.45341851 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Legionnaires' disease DOID_10457 3.454E-03 9.227E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP legionellosis DOID_10458 3.454E-03 9.227E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP aspergillosis DOID_13564 3.454E-03 9.184E-03 0.08508641 0.4173635 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP parasitic helminthiasis infectious disease DOID_883 3.454E-03 9.141E-03 0.08508641 0.41028954 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bacterial meningitis DOID_9470 3.454E-03 9.099E-03 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cataract DOID_83 3.513E-03 9.21E-03 3.513E-03 0.07994533 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lens disease DOID_110 3.944E-03 0.01029344 3.944E-03 0.08014181 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP peripheral neuropathy DOID_0060053 3.969E-03 0.01031193 3.969E-03 0.07284877 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP skeletal system cancer DOID_0060124 3.969E-03 0.01026505 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bone cancer DOID_184 3.969E-03 0.01026505 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP membranoproliferative glomerulonephritis DOID_2920 3.969E-03 0.01021861 0.09088051 0.43092511 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP arthropathy DOID_381 3.969E-03 0.01017258 3.969E-03 0.07057225 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP nutritional deficiency disease DOID_5113 3.969E-03 0.01012696 0.09088051 0.42736374 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lung oat cell carcinoma DOID_5411 3.969E-03 0.01008175 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP oral submucous fibrosis DOID_5773 3.969E-03 0.01003694 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hyperhomocysteinemia DOID_9279 3.969E-03 9.993E-03 0.09088051 0.42386076 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hemolytic anemia DOID_583 4.171E-03 0.01045462 0.27682366 0.7192359 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP normocytic anemia DOID_720 4.171E-03 0.01045462 0.27682366 0.7192359 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lung small cell carcinoma DOID_5409 4.406E-03 0.01099499 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP spastic diplegia DOID_10965 4.517E-03 0.01122357 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hemolytic-uremic syndrome DOID_12554 4.517E-03 0.01117477 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP thyroiditis DOID_7166 4.517E-03 0.01112639 0.09663808 0.43989654 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autoimmune thyroiditis DOID_7188 4.517E-03 0.01112639 0.09663808 0.43989654 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP hemorrhagic disease DOID_2213 4.899E-03 0.01201572 0.29048998 0.74791311 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP B-cell lymphocytic neoplasm DOID_707 4.899E-03 0.01196415 0.29048998 0.74454413 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP methylmalonic acidemia DOID_14749 5.098E-03 0.01239652 0.10235933 0.44459893 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bronchitis DOID_6132 5.098E-03 0.01234377 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP juvenile rheumatoid arthritis DOID_676 5.098E-03 0.01229146 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP urinary system benign neoplasm DOID_731 5.098E-03 0.0122396 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP bile duct adenocarcinoma DOID_4896 5.7E-03 0.01362656 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cholangiocarcinoma DOID_4947 5.7E-03 0.01362656 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP male reproductive organ benign neoplasm DOID_0060087 5.711E-03 0.01359761 0.1080445 0.45878597 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP osteosclerosis DOID_4254 5.711E-03 0.01354095 5.711E-03 0.09027302 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP eosinophilia DOID_999 5.711E-03 0.01348477 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP reproductive organ benign neoplasm DOID_0050622 5.983E-03 0.01406713 0.30831247 0.77281849 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pustulosis of palm and sole DOID_4398 5.983E-03 0.01400924 0.30831247 0.76273825 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP familial hyperlipidemia DOID_1168 6.274E-03 0.01463147 0.31269799 0.77023877 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP agammaglobulinemia DOID_2583 6.357E-03 0.0147636 0.11369381 0.468781 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP esophagitis DOID_11963 7.034E-03 0.01626953 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP brain edema DOID_4724 7.034E-03 0.01620367 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP blood protein disease DOID_620 7.034E-03 0.01613833 0.11930749 0.47143028 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP amyloidosis DOID_9120 7.034E-03 0.01607352 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP coronary restenosis DOID_4247 7.742E-03 0.01762102 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP neutropenia DOID_1227 8.481E-03 0.01922588 0.13042884 0.49808061 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP familial hypercholesterolemia DOID_13810 8.481E-03 0.01914959 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP muscular atrophy DOID_767 8.481E-03 0.0190739 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP agranulocytosis DOID_12987 9.25E-03 0.02072201 0.13593696 0.5156542 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP optic nerve disease DOID_1891 9.25E-03 0.02064075 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP opiate dependence DOID_2559 9.25E-03 0.02056012 0.13593696 0.51223927 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP sleep disorder DOID_535 9.25E-03 0.02048012 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP pulmonary embolism DOID_9477 9.25E-03 0.02040074 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lingual-facial-buccal dyskinesia DOID_9854 9.25E-03 0.02032197 9.25E-03 0.13158477 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP meningitis DOID_9471 0.0100494 0.02199272 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP blood coagulation disease DOID_1247 0.01125362 0.02453375 0.3712655 0.87293416 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP organic acidemia DOID_0060159 0.01173581 0.02548731 0.15225371 0.54830608 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP reading disorder DOID_13365 0.01173581 0.0253904 0.01173581 0.14207822 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP osteosarcoma DOID_3347 0.01173581 0.02529423 0.15225371 0.53476766 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP dyslexia DOID_4428 0.01173581 0.0253904 0.01173581 0.14207822 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP papillary adenoma DOID_3172 0.01262228 0.02710217 0.15762415 0.54029001 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP microcystic adenoma DOID_5403 0.01262228 0.02710217 0.15762415 0.54029001 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP follicular adenoma DOID_6204 0.01262228 0.02710217 0.15762415 0.54029001 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP endogenous depression DOID_1595 0.0134523 0.02877579 0.39095495 0.90428199 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP B cell deficiency DOID_2115 0.01353706 0.02884863 0.16296071 0.54866653 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP fragments of torsion dystonia DOID_531 0.01353706 0.02874099 0.01353706 0.15103107 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP electroclinical syndrome DOID_0050701 0.01439533 0.03044961 0.01439533 0.15454613 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP sarcoma DOID_1115 0.01544999 0.03255942 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP thrombocytopenia DOID_1588 0.01544999 0.03243927 0.17353304 0.55785479 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP central nervous system hereditary degenerative disease DOID_481 0.01544999 0.03232001 0.01544999 0.1569829 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP polycystic ovary syndrome DOID_11612 0.01644737 0.03428041 0.17876922 0.56826642 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP dystonic disease DOID_544 0.01644737 0.0341553 0.01644737 0.15861954 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP mental depression DOID_1596 0.01691331 0.03499518 0.41749279 0.95021359 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP age related macular degeneration DOID_10871 0.01852207 0.03818499 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP degeneration of macula and posterior pole DOID_2007 0.01852207 0.03818499 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP chronic leukemia DOID_1036 0.02070086 0.04252271 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP chronic lymphocytic leukemia DOID_1040 0.02070086 0.04252271 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP autonomic nervous system neoplasm DOID_2621 0.02070086 0.04236975 0.19938568 0.61324568 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP neuroblastoma DOID_769 0.02070086 0.04236975 0.19938568 0.61324568 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lymphoma DOID_0060058 0.02202767 0.04492382 0.44992756 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP leukopenia DOID_615 0.02298082 0.0467003 0.2094998 0.61764448 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP lymphoid leukemia DOID_10747 0.02415783 0.04891745 0.21450904 0.6291528 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP adenoma DOID_657 0.02535905 0.05116773 0.21948667 0.63394881 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP embryonal cancer DOID_688 0.02658414 0.05345008 0.02658414 0.21304752 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP microcephaly DOID_10907 0.02783274 0.05576348 0.22934789 0.65249476 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP peripheral nervous system neoplasm DOID_1192 0.02783274 0.05556782 0.22934789 0.64924851 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP blood platelet disease DOID_2218 0.02783274 0.05537353 0.22934789 0.64603441 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP peptic ulcer DOID_750 0.02910451 0.05770198 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP cervix uteri carcinoma in situ DOID_8991 0.03171622 0.06266156 1.000 1.000 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP Huntington's disease DOID_12858 0.03441657 0.06776134 0.03441657 0.26826065 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP movement disease DOID_480 0.04452828 0.08736756 0.04452828 0.32071635 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP atrophic muscular disease DOID_913 0.04915755 0.09611906 0.29945766 0.75729516 RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP muscular dystrophy DOID_9884 0.04915755 0.09611906 0.29945766 0.75729516 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN carbohydrate metabolic disorder DOID_2978 1.248E-06 7.101E-04 1.248E-06 7.101E-04 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN cholestasis DOID_13580 9.907E-06 2.819E-03 9.907E-06 2.819E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN bile duct disease DOID_4138 1.387E-05 2.631E-03 1.387E-05 2.631E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN biliary tract disease DOID_9741 1.463E-05 2.082E-03 1.463E-05 2.082E-03 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN chronic kidney failure DOID_784 2.402E-05 2.734E-03 6.286E-04 0.03576452 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN T cell deficiency DOID_11200 1.674E-04 0.01587849 0.01935111 0.30585511 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN migraine without aura DOID_12783 2.044E-04 0.01661357 2.044E-04 0.023259 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN polyneuropathy DOID_1389 2.891E-04 0.02056383 2.891E-04 0.02741843 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN congenital heart defect DOID_1682 2.99E-04 0.01890638 2.99E-04 0.0243082 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN syndrome DOID_225 4.889E-04 0.02781786 4.889E-04 0.03477233 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN lipid metabolism disorder DOID_3146 5.659E-04 0.02927473 5.659E-04 0.03578023 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN primary immunodeficiency disease DOID_612 7.667E-04 0.03635205 0.01376004 0.26098218 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN Human immunodeficiency virus infectious disease DOID_526 7.914E-04 0.03463842 7.914E-04 0.04093632 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN thrombophilia DOID_2452 8.466E-04 0.03440657 8.466E-04 0.040141 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN diffuse large B-cell lymphoma DOID_0050745 1.475E-03 0.05594391 1.000 1.000 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN migraine DOID_6364 1.475E-03 0.05244741 1.475E-03 0.06455066 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN toxic encephalopathy DOID_3602 1.685E-03 0.05639308 0.05879403 0.40797319 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN autonomic nervous system neoplasm DOID_2621 2.145E-03 0.06780701 0.06612752 0.40898432 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN neuroblastoma DOID_769 2.145E-03 0.06780701 0.06612752 0.40898432 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN papilloma DOID_2615 2.268E-03 0.06793121 2.268E-03 0.09219236 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN adenoma DOID_657 2.658E-03 0.07561848 2.658E-03 0.10082464 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN calcinosis DOID_182 2.794E-03 0.07571251 2.794E-03 0.09937267 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN embryonal cancer DOID_688 2.794E-03 0.07227103 0.07521516 0.40759452 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN peripheral nervous system neoplasm DOID_1192 2.934E-03 0.07258235 0.07702219 0.41344929 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN salivary gland cancer DOID_8850 3.524E-03 0.08355654 3.524E-03 0.11796217 COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN thyroid adenoma DOID_2891 4.334E-03 0.09863219 4.334E-03 0.13698915 FARMER_BREAST_CANCER_CLUSTER_5 Ehlers-Danlos syndrome DOID_13359 7.837E-12 4.459E-09 7.837E-12 4.459E-09 FARMER_BREAST_CANCER_CLUSTER_5 bone development disease DOID_0080006 4.175E-11 1.188E-08 1.205E-08 2.285E-06 FARMER_BREAST_CANCER_CLUSTER_5 osteochondrodysplasia DOID_2256 2.418E-09 4.587E-07 7.403E-07 8.424E-05 FARMER_BREAST_CANCER_CLUSTER_5 collagen disease DOID_854 3.618E-09 5.146E-07 3.618E-09 1.029E-06 FARMER_BREAST_CANCER_CLUSTER_5 osteogenesis imperfecta DOID_12347 6.917E-09 7.871E-07 7.15E-06 5.812E-04 FARMER_BREAST_CANCER_CLUSTER_5 heart valve disease DOID_4079 4.709E-07 4.466E-05 4.709E-07 6.699E-05 FARMER_BREAST_CANCER_CLUSTER_5 aneurysm disease DOID_2403 1.89E-06 1.536E-04 1.89E-06 1.792E-04 FARMER_BREAST_CANCER_CLUSTER_5 spastic diplegia DOID_10965 1.099E-05 7.82E-04 5.053E-03 0.16914313 FARMER_BREAST_CANCER_CLUSTER_5 spastic quadriplegia DOID_10970 2.744E-05 1.735E-03 7.886E-03 0.18695853 FARMER_BREAST_CANCER_CLUSTER_5 intracranial aneurysm DOID_10941 3.456E-05 1.966E-03 3.456E-05 2.458E-03 FARMER_BREAST_CANCER_CLUSTER_5 spastic cerebral palsy DOID_0050669 4.823E-05 2.495E-03 0.01039715 0.21911041 CORRE_MULTIPLE_MYELOMA_UP contact dermatitis DOID_2773 1.751E-06 9.961E-04 3.417E-03 0.14958107 CORRE_MULTIPLE_MYELOMA_UP lipid metabolism disorder DOID_3146 1.751E-06 4.98E-04 9.095E-05 0.0517487 CORRE_MULTIPLE_MYELOMA_UP neuritis DOID_1803 2.06E-05 3.908E-03 0.05144656 0.39030788 CORRE_MULTIPLE_MYELOMA_UP respiratory failure DOID_11162 4.542E-05 6.461E-03 0.06637078 0.4391276 CORRE_MULTIPLE_MYELOMA_UP retinal vascular occlusion DOID_1729 4.858E-05 5.529E-03 0.01050231 0.2987908 CORRE_MULTIPLE_MYELOMA_UP allergic contact dermatitis DOID_3042 5.671E-05 5.378E-03 2.505E-03 0.12958147 CORRE_MULTIPLE_MYELOMA_UP blood coagulation disease DOID_1247 6.429E-05 5.226E-03 2.721E-03 0.12900171 CORRE_MULTIPLE_MYELOMA_UP diabetic retinopathy DOID_8947 7.251E-05 5.157E-03 0.07716945 0.47214428 CORRE_MULTIPLE_MYELOMA_UP bacterial pneumonia DOID_874 8.45E-05 5.342E-03 0.08106597 0.48048475 CORRE_MULTIPLE_MYELOMA_UP retinal vascular disease DOID_2462 1.085E-04 6.171E-03 0.08784631 0.51004643 CORRE_MULTIPLE_MYELOMA_UP intermediate coronary syndrome DOID_8805 1.13E-04 5.844E-03 1.13E-04 0.03214433 CORRE_MULTIPLE_MYELOMA_UP pulmonary edema DOID_11396 2.038E-04 9.662E-03 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP colon carcinoma DOID_1520 2.038E-04 8.919E-03 0.02089706 0.33972643 CORRE_MULTIPLE_MYELOMA_UP thrombophilia DOID_2452 2.474E-04 0.01005539 0.02296319 0.34384358 CORRE_MULTIPLE_MYELOMA_UP urticaria DOID_1555 3.472E-04 0.01316883 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP bronchiolitis DOID_2942 3.472E-04 0.01234578 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP autoimmune disease of cardiovascular system DOID_0060051 4.634E-04 0.01551087 4.634E-04 0.08789494 CORRE_MULTIPLE_MYELOMA_UP Behcet's disease DOID_13241 4.634E-04 0.01551087 4.634E-04 0.08789494 CORRE_MULTIPLE_MYELOMA_UP lymphoid leukemia DOID_10747 7.449E-04 0.02354837 7.449E-04 0.10596765 CORRE_MULTIPLE_MYELOMA_UP calcinosis DOID_182 8.254E-04 0.0247195 0.04136812 0.41295545 CORRE_MULTIPLE_MYELOMA_UP embryonal cancer DOID_688 8.254E-04 0.02348353 8.254E-04 0.0939341 CORRE_MULTIPLE_MYELOMA_UP adult respiratory distress syndrome DOID_11394 9.537E-04 0.02584035 0.04440256 0.40750095 CORRE_MULTIPLE_MYELOMA_UP intracranial arterial disease DOID_13089 9.537E-04 0.02466579 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP cerebral arterial disease DOID_3527 9.537E-04 0.02466579 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP diabetic autonomic neuropathy DOID_11503 1.139E-03 0.02816888 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP autonomic neuropathy DOID_11504 1.139E-03 0.02816888 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP diabetic polyneuropathy DOID_12785 1.139E-03 0.02816888 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP diabetic neuropathy DOID_9743 1.139E-03 0.02816888 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP pre-eclampsia DOID_10591 1.288E-03 0.0305301 0.05144656 0.40100125 CORRE_MULTIPLE_MYELOMA_UP autonomic nervous system disease DOID_11465 1.288E-03 0.0293089 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP vascular skin disease DOID_9540 1.288E-03 0.02818163 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP pulmonary tuberculosis DOID_2957 1.392E-03 0.02933623 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP calcium metabolism disease DOID_10575 1.446E-03 0.02937828 0.05444989 0.39217706 CORRE_MULTIPLE_MYELOMA_UP B-cell lymphocytic neoplasm DOID_707 1.5E-03 0.02943659 1.5E-03 0.14227683 CORRE_MULTIPLE_MYELOMA_UP vasculitis DOID_865 1.67E-03 0.03167302 1.67E-03 0.1357415 CORRE_MULTIPLE_MYELOMA_UP familial hyperlipidemia DOID_1168 1.788E-03 0.03281614 1.788E-03 0.12716256 CORRE_MULTIPLE_MYELOMA_UP oral cavity cancer DOID_8618 1.91E-03 0.03395642 1.91E-03 0.12073393 CORRE_MULTIPLE_MYELOMA_UP congenital heart defect DOID_1682 2.231E-03 0.03846699 2.231E-03 0.12694106 CORRE_MULTIPLE_MYELOMA_UP mineral metabolism disease DOID_0050032 2.298E-03 0.03845878 0.0683433 0.44190154 CORRE_MULTIPLE_MYELOMA_UP tuberculosis DOID_399 2.576E-03 0.04187817 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP peripheral vascular disease DOID_341 2.869E-03 0.04534547 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP cystic fibrosis DOID_1485 3.098E-03 0.0476497 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP chronic kidney failure DOID_784 3.666E-03 0.05489962 0.08591406 0.50397012 CORRE_MULTIPLE_MYELOMA_UP primary bacterial infectious disease DOID_0050338 4.011E-03 0.05852047 1.000 1.000 CORRE_MULTIPLE_MYELOMA_UP transitional cell carcinoma DOID_2671 4.1E-03 0.05831544 4.1E-03 0.16661555 CORRE_MULTIPLE_MYELOMA_UP amino acid metabolic disorder DOID_9252 4.189E-03 0.05813296 4.189E-03 0.15889676 CORRE_MULTIPLE_MYELOMA_UP lymphoma DOID_0060058 4.462E-03 0.06045302 4.462E-03 0.15868918 CORRE_MULTIPLE_MYELOMA_UP lymphoblastic leukemia DOID_1037 4.555E-03 0.0602769 4.555E-03 0.1524651 CORRE_MULTIPLE_MYELOMA_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.649E-03 0.06012035 0.09649225 0.54904092 CORRE_MULTIPLE_MYELOMA_UP mouth disease DOID_403 4.649E-03 0.05878434 0.09649225 0.54360487 CORRE_MULTIPLE_MYELOMA_UP Crohn's disease DOID_8778 4.649E-03 0.05750642 0.09649225 0.53827541 CORRE_MULTIPLE_MYELOMA_UP dilated cardiomyopathy DOID_12930 4.744E-03 0.05742961 4.744E-03 0.14995509 NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON congenital muscular dystrophy DOID_0050557 5.952E-06 3.386E-03 5.952E-06 3.386E-03 NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON reading disorder DOID_13365 1.263E-05 3.594E-03 1.263E-05 3.594E-03 NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON dyslexia DOID_4428 1.263E-05 3.594E-03 1.263E-05 3.594E-03 NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON learning disability DOID_8927 4.374E-05 8.296E-03 4.374E-05 8.296E-03 NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON atrophic muscular disease DOID_913 5.966E-05 8.487E-03 5.966E-05 8.487E-03 NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON muscular dystrophy DOID_9884 5.966E-05 8.487E-03 5.966E-05 8.487E-03 LE_SKI_TARGETS_UP polycystic ovary syndrome DOID_11612 6.75E-05 0.03840486 6.75E-05 0.03840486 LE_SKI_TARGETS_UP leiomyoma DOID_127 8.629E-05 0.0245484 0.01376161 0.46060922 LE_SKI_TARGETS_UP syndrome DOID_225 4.312E-04 0.08179042 4.312E-04 0.12268563 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP allergic contact dermatitis DOID_3042 2.928E-11 1.666E-08 1.38E-09 7.85E-07 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP contact dermatitis DOID_2773 1.074E-10 3.057E-08 4.253E-09 1.21E-06 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP aneurysm disease DOID_2403 1.152E-07 2.185E-05 0.02185557 0.24871636 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP aortic aneurysm DOID_3627 4.605E-07 6.55E-05 0.14161933 0.50363373 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP ureteral disease DOID_1426 6.571E-07 7.478E-05 2.169E-03 0.06171176 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP oral cavity cancer DOID_8618 9.373E-07 8.889E-05 9.373E-07 1.778E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP pancreatic ductal carcinoma DOID_3587 2.302E-06 1.872E-04 1.242E-03 0.05048508 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP pancreatic carcinoma DOID_4905 2.813E-06 2.001E-04 1.395E-03 0.05292747 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP biliary tract cancer DOID_4607 4.892E-06 3.093E-04 1.924E-03 0.06081925 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP embryonal cancer DOID_688 5.455E-06 3.104E-04 5.455E-06 7.76E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP multiple myeloma DOID_9538 5.455E-06 2.822E-04 2.114E-04 0.01718233 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP intracranial arterial disease DOID_13089 7.318E-06 3.47E-04 0.11651279 0.46038736 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP cerebral arterial disease DOID_3527 7.318E-06 3.47E-04 0.11651279 0.46038736 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP adenoid cystic carcinoma DOID_4866 7.318E-06 3.203E-04 7.318E-06 8.328E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP salivary gland cancer DOID_8850 8.796E-06 3.575E-04 8.796E-06 8.341E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP myeloma DOID_0070004 1.345E-05 5.101E-04 4.107E-04 0.02920904 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP ureteral obstruction DOID_5199 1.828E-05 6.501E-04 1.216E-03 0.05322616 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bone marrow cancer DOID_4960 2.271E-05 7.601E-04 6.042E-04 0.03437811 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP urinary tract obstruction DOID_5200 3.926E-05 1.241E-03 1.992E-03 0.05965819 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP diabetic angiopathy DOID_11713 4.478E-05 1.341E-03 0.06678915 0.3486516 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP blood coagulation disease DOID_1247 6.04E-05 1.718E-03 0.01885056 0.23835487 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bile duct disease DOID_4138 6.371E-05 1.726E-03 0.0193383 0.23920636 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP biliary tract disease DOID_9741 6.715E-05 1.737E-03 0.01983132 0.24008558 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP middle cerebral artery infarction DOID_3525 7.187E-05 1.778E-03 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP toxic encephalopathy DOID_3602 9.8E-05 2.323E-03 0.08542296 0.38884529 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP spastic cerebral palsy DOID_0050669 1.185E-04 2.696E-03 4.08E-03 0.08598819 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP abdominal aortic aneurysm DOID_7693 1.185E-04 2.592E-03 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP congenital diaphragmatic hernia DOID_3827 2.446E-04 5.154E-03 6.543E-03 0.1128112 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP lymphatic system disease DOID_75 2.624E-04 5.332E-03 0.11651279 0.45721227 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP hyperinsulinism DOID_2018 3.207E-04 6.293E-03 0.1241202 0.4677112 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP gallbladder cancer DOID_3121 3.419E-04 6.484E-03 8.138E-03 0.12862749 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP cerebral infarction DOID_3526 3.639E-04 6.68E-03 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP aortic valve insufficiency DOID_57 5.305E-04 9.433E-03 5.305E-04 0.03354077 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bile duct cancer DOID_4606 7.37E-04 0.01270729 0.16119448 0.53017145 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bile duct carcinoma DOID_4897 7.37E-04 0.01270729 0.16119448 0.53017145 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP thoracic aortic aneurysm DOID_14004 8.393E-04 0.01404539 0.04227771 0.28301198 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP membranoproliferative glomerulonephritis DOID_2920 8.393E-04 0.0136441 0.04227771 0.27972114 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP carotid artery disease DOID_3407 8.478E-04 0.01340072 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP silicosis DOID_10325 9.574E-04 0.0147227 0.0450324 0.28790379 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP spastic diplegia DOID_10965 9.574E-04 0.01433526 9.574E-04 0.0495218 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP endocrine pancreas disease DOID_1428 9.688E-04 0.0141342 0.17558498 0.55504362 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP cholestasis DOID_13580 1.011E-03 0.01438688 0.17795949 0.55944172 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP uterine disease DOID_345 1.011E-03 0.01403598 0.01649231 0.2234315 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP temporal lobe epilepsy DOID_3328 1.055E-03 0.0142948 0.01695312 0.22433312 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP Graves' disease DOID_12361 1.083E-03 0.01433055 1.083E-03 0.05135113 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP urinary system benign neoplasm DOID_731 1.083E-03 0.01400485 0.04777924 0.28617251 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP brain infarction DOID_3454 1.146E-03 0.01449368 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP male reproductive system disease DOID_48 1.292E-03 0.01598095 0.19206496 0.59072952 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP peripheral vascular disease DOID_341 1.343E-03 0.01625877 0.19439244 0.59467364 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP cystic fibrosis DOID_1485 1.504E-03 0.01782446 0.02134175 0.25298866 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP membranous glomerulonephritis DOID_10976 1.504E-03 0.01747047 0.05597288 0.31224084 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP amyloidosis DOID_9120 1.504E-03 0.01712106 0.05597288 0.30623621 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bone resorption disease DOID_0080011 1.56E-03 0.01740193 1.56E-03 0.05546867 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP osteoporosis DOID_11476 1.56E-03 0.01740193 1.56E-03 0.05546867 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP female reproductive system disease DOID_229 1.797E-03 0.01966602 0.02396167 0.26219592 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP thrombophilia DOID_2452 1.822E-03 0.01956382 0.06139645 0.3295715 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP alcohol abuse DOID_1574 1.924E-03 0.02027308 1.924E-03 0.06439685 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP focal epilepsy DOID_2234 1.924E-03 0.01990448 0.02504475 0.26389746 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP aortic valve disease DOID_62 2.169E-03 0.02203992 2.169E-03 0.05877311 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP spastic quadriplegia DOID_10970 2.353E-03 0.02349207 0.06947397 0.35936991 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP sphingolipidosis DOID_1927 2.353E-03 0.02308703 0.06947397 0.35613234 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP osteosarcoma DOID_3347 2.545E-03 0.024541 2.545E-03 0.0658145 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP lymphoma DOID_0060058 2.563E-03 0.02430331 2.563E-03 0.06339993 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP lymphoblastic leukemia DOID_1037 2.641E-03 0.02463321 0.03075022 0.26114736 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.72E-03 0.02496583 0.24176343 0.70908964 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP seminoma DOID_4440 2.949E-03 0.02663084 2.949E-03 0.06990596 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP Sciatic Neuropathy DOID_11446 3.161E-03 0.02810389 0.08013695 0.37998273 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP gestational diabetes DOID_11714 3.161E-03 0.02767152 0.08013695 0.37684237 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP lesion of sciatic nerve DOID_12528 3.161E-03 0.02810389 0.08013695 0.37998273 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP mononeuritis of lower limb DOID_9473 3.161E-03 0.02810389 0.08013695 0.37998273 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP renal hypertension DOID_1073 3.381E-03 0.02914422 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP secondary hypertension DOID_11130 3.381E-03 0.02914422 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP mononeuritis DOID_1802 3.381E-03 0.02870923 0.08278373 0.38295887 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP invasive ductal carcinoma DOID_3008 3.381E-03 0.02828704 3.381E-03 0.07694074 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP autoimmune disease of endocrine system DOID_0060005 3.607E-03 0.02974391 3.607E-03 0.07893575 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP mononeuropathy DOID_1188 3.607E-03 0.02931899 0.08542296 0.39198114 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP focal glomerulosclerosis DOID_3945 3.607E-03 0.02890605 0.08542296 0.38575922 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bronchiolitis obliterans DOID_2799 4.08E-03 0.03224557 0.09067886 0.40309586 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP Charcot-Marie-Tooth disease DOID_10595 4.327E-03 0.03372844 4.327E-03 0.08793485 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP germinoma DOID_3304 4.327E-03 0.03327265 4.327E-03 0.08490262 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP allergic rhinitis DOID_4481 4.327E-03 0.03282901 0.09329557 0.40834755 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP pneumoconiosis DOID_10316 5.108E-03 0.03824552 0.10110104 0.43580677 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP nephroblastoma DOID_2154 5.108E-03 0.03774882 5.108E-03 0.09688864 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP hyperthyroidism DOID_7998 5.108E-03 0.03726486 5.108E-03 0.0937632 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP lymphoid leukemia DOID_10747 5.382E-03 0.0387647 0.10368804 0.43064595 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP aplastic anemia DOID_12449 5.382E-03 0.03828014 5.382E-03 0.09570035 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP peptic ulcer DOID_750 6.543E-03 0.04596012 0.11396247 0.45345907 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP pulmonary emphysema DOID_9675 7.162E-03 0.0496957 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP endometriosis of uterus DOID_288 7.481E-03 0.05128474 7.481E-03 0.12519509 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP endometriosis DOID_289 7.806E-03 0.05287882 7.806E-03 0.12690918 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP learning disability DOID_8927 8.476E-03 0.0567402 0.1291557 0.47720516 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP proteinuria DOID_576 8.82E-03 0.05835792 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP neuritis DOID_1803 9.171E-03 0.05997885 0.13416252 0.48623234 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP heart valve disease DOID_4079 9.171E-03 0.05929728 9.171E-03 0.14103136 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bone marrow disease DOID_4961 9.171E-03 0.05863101 9.171E-03 0.13732001 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP vascular skin disease DOID_9540 9.171E-03 0.05797956 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP hemolytic anemia DOID_583 9.527E-03 0.0595718 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP normocytic anemia DOID_720 9.527E-03 0.0595718 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP glaucoma DOID_1686 9.89E-03 0.06116717 9.89E-03 0.14429179 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP lung small cell carcinoma DOID_5409 9.89E-03 0.06050946 0.13914082 0.49793162 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP sarcoidosis DOID_11335 0.01140082 0.06901135 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP giant cell tumor DOID_200 0.01140082 0.06828492 0.01140082 0.16217668 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP malignant giant cell tumor DOID_2705 0.01140082 0.06828492 0.01140082 0.16217668 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP giant cell glioblastoma DOID_3074 0.01140082 0.06828492 0.01140082 0.16217668 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP bile duct adenocarcinoma DOID_4896 0.01179343 0.06990062 0.15146283 0.52231728 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP cholangiocarcinoma DOID_4947 0.01179343 0.06990062 0.15146283 0.52231728 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP pustulosis of palm and sole DOID_4398 0.01219191 0.0715175 0.15390618 0.52126558 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP congenital nervous system abnormality DOID_2490 0.01300638 0.07551665 0.15877199 0.53141918 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP hypersensitivity reaction type IV disease DOID_2916 0.01342229 0.0771443 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP glioblastoma DOID_3068 0.01342229 0.07637286 0.01342229 0.18627526 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP congenital heart defect DOID_1682 0.01558719 0.08781297 0.17320366 0.55057477 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP cerebral degeneration DOID_1443 0.01649231 0.09200121 0.17795949 0.5533276 MARZEC_IL2_SIGNALING_UP myeloma DOID_0070004 2.003E-17 1.14E-14 2.045E-04 0.01057873 MARZEC_IL2_SIGNALING_UP bone marrow cancer DOID_4960 8.314E-17 2.365E-14 3.018E-04 0.01321074 MARZEC_IL2_SIGNALING_UP parasitic protozoa infectious disease DOID_2789 1.003E-16 1.902E-14 3.178E-04 0.01291509 MARZEC_IL2_SIGNALING_UP parasitic infectious disease DOID_1398 5.486E-16 7.804E-14 5.078E-04 0.01805689 MARZEC_IL2_SIGNALING_UP hypersensitivity reaction type I disease DOID_1205 2.251E-14 2.561E-12 2.92E-06 3.324E-04 MARZEC_IL2_SIGNALING_UP multiple myeloma DOID_9538 3.639E-14 3.451E-12 1.048E-04 5.963E-03 MARZEC_IL2_SIGNALING_UP allergic contact dermatitis DOID_3042 6.006E-14 4.882E-12 5.754E-07 3.274E-04 MARZEC_IL2_SIGNALING_UP contact dermatitis DOID_2773 2.647E-13 1.883E-11 1.27E-06 2.409E-04 MARZEC_IL2_SIGNALING_UP Human immunodeficiency virus infectious disease DOID_526 4.005E-11 2.532E-09 2.248E-06 3.198E-04 MARZEC_IL2_SIGNALING_UP leishmaniasis DOID_9065 6.054E-10 3.445E-08 8.482E-04 0.02540114 MARZEC_IL2_SIGNALING_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.137E-09 1.105E-07 6.266E-03 0.09903332 MARZEC_IL2_SIGNALING_UP encephalomyelitis DOID_640 2.266E-09 1.074E-07 0.19427901 0.68237504 MARZEC_IL2_SIGNALING_UP ulcerative colitis DOID_8577 3.252E-09 1.423E-07 0.02180703 0.24816399 MARZEC_IL2_SIGNALING_UP giant cell tumor DOID_200 3.383E-09 1.375E-07 8.284E-06 7.856E-04 MARZEC_IL2_SIGNALING_UP malignant giant cell tumor DOID_2705 3.383E-09 1.375E-07 8.284E-06 7.856E-04 MARZEC_IL2_SIGNALING_UP giant cell glioblastoma DOID_3074 3.383E-09 1.375E-07 8.284E-06 7.856E-04 MARZEC_IL2_SIGNALING_UP reproductive organ benign neoplasm DOID_0050622 4.202E-09 1.594E-07 0.12350125 0.52053492 MARZEC_IL2_SIGNALING_UP extrinsic allergic alveolitis DOID_841 5.036E-09 1.791E-07 1.000 1.000 MARZEC_IL2_SIGNALING_UP glioblastoma DOID_3068 5.733E-09 1.919E-07 1.167E-05 9.485E-04 MARZEC_IL2_SIGNALING_UP astrocytoma DOID_3069 1.581E-08 4.999E-07 2.257E-05 1.605E-03 MARZEC_IL2_SIGNALING_UP pneumoconiosis DOID_10316 2.198E-08 6.582E-07 0.08063194 0.40601392 MARZEC_IL2_SIGNALING_UP periodontal disease DOID_3388 2.198E-08 6.253E-07 8.282E-05 5.236E-03 MARZEC_IL2_SIGNALING_UP peptic ulcer DOID_750 4.251E-08 1.152E-06 1.000 1.000 MARZEC_IL2_SIGNALING_UP cervix uteri carcinoma in situ DOID_8991 5.408E-08 1.399E-06 0.09514709 0.43660238 MARZEC_IL2_SIGNALING_UP primary bacterial infectious disease DOID_0050338 5.704E-08 1.411E-06 0.0175302 0.2168409 MARZEC_IL2_SIGNALING_UP mouth disease DOID_403 8.985E-08 2.13E-06 1.383E-03 0.03421269 MARZEC_IL2_SIGNALING_UP Crohn's disease DOID_8778 8.985E-08 2.045E-06 0.19611136 0.68041074 MARZEC_IL2_SIGNALING_UP esophagitis DOID_11963 1.163E-07 2.545E-06 0.04441576 0.34152117 MARZEC_IL2_SIGNALING_UP autoimmune hepatitis DOID_2048 1.434E-07 3.022E-06 1.000 1.000 MARZEC_IL2_SIGNALING_UP leukocyte disease DOID_9500 3.121E-07 6.342E-06 0.1314399 0.54195146 MARZEC_IL2_SIGNALING_UP cleft lip DOID_9296 4.162E-07 8.165E-06 1.721E-03 0.03916148 MARZEC_IL2_SIGNALING_UP pre-malignant neoplasm DOID_0060071 4.279E-07 8.117E-06 0.13930747 0.55821091 MARZEC_IL2_SIGNALING_UP in situ carcinoma DOID_8719 4.279E-07 8.117E-06 0.13930747 0.55821091 MARZEC_IL2_SIGNALING_UP uterine disease DOID_345 4.974E-07 9.129E-06 1.000 1.000 MARZEC_IL2_SIGNALING_UP tooth disease DOID_1091 5.754E-07 1.023E-05 5.528E-04 0.0174743 MARZEC_IL2_SIGNALING_UP tuberculosis DOID_399 6.179E-07 1.065E-05 0.14904294 0.58892661 MARZEC_IL2_SIGNALING_UP sarcoma DOID_1115 6.465E-07 1.082E-05 0.06588669 0.38254621 MARZEC_IL2_SIGNALING_UP malaria DOID_12365 6.465E-07 1.051E-05 0.06588669 0.37868211 MARZEC_IL2_SIGNALING_UP invasive ductal carcinoma DOID_3008 6.465E-07 1.022E-05 6.465E-07 1.839E-04 MARZEC_IL2_SIGNALING_UP male reproductive system disease DOID_48 7.605E-07 1.169E-05 0.1548319 0.59526587 MARZEC_IL2_SIGNALING_UP peripheral vascular disease DOID_341 8.133E-07 1.218E-05 0.01267872 0.17595586 MARZEC_IL2_SIGNALING_UP female reproductive organ benign neoplasm DOID_0060086 8.454E-07 1.233E-05 0.07012331 0.38738022 MARZEC_IL2_SIGNALING_UP uterine benign neoplasm DOID_0060095 8.454E-07 1.233E-05 0.07012331 0.38738022 MARZEC_IL2_SIGNALING_UP uterine fibroid DOID_13223 8.454E-07 1.233E-05 0.07012331 0.38738022 MARZEC_IL2_SIGNALING_UP diabetic retinopathy DOID_8947 8.691E-07 1.236E-05 0.15866956 0.60188652 MARZEC_IL2_SIGNALING_UP cystic fibrosis DOID_1485 9.896E-07 1.373E-05 0.16249 0.61229674 MARZEC_IL2_SIGNALING_UP bone resorption disease DOID_0080011 1.055E-06 1.429E-05 0.01399484 0.18959681 MARZEC_IL2_SIGNALING_UP osteoporosis DOID_11476 1.055E-06 1.429E-05 0.01399484 0.18959681 MARZEC_IL2_SIGNALING_UP mixed glioma DOID_5076 1.123E-06 1.486E-05 0.01433276 0.18965903 MARZEC_IL2_SIGNALING_UP leiomyoma DOID_127 1.225E-06 1.584E-05 0.07644265 0.39541697 MARZEC_IL2_SIGNALING_UP visceral leishmaniasis DOID_9146 1.337E-06 1.691E-05 0.02245717 0.23232968 MARZEC_IL2_SIGNALING_UP female reproductive system disease DOID_229 1.349E-06 1.669E-05 1.000 1.000 MARZEC_IL2_SIGNALING_UP papilloma DOID_2615 1.375E-06 1.665E-05 1.000 1.000 MARZEC_IL2_SIGNALING_UP nephroblastoma DOID_2154 1.539E-06 1.825E-05 3.217E-03 0.06537616 MARZEC_IL2_SIGNALING_UP spindle cell carcinoma DOID_4015 1.539E-06 1.787E-05 1.000 1.000 MARZEC_IL2_SIGNALING_UP esophageal disease DOID_6050 1.539E-06 1.752E-05 0.08063194 0.39551356 MARZEC_IL2_SIGNALING_UP retinal vascular disease DOID_2462 1.704E-06 1.902E-05 0.17947086 0.64225736 MARZEC_IL2_SIGNALING_UP medullomyoblastoma DOID_3861 1.717E-06 1.879E-05 3.391E-03 0.06653073 MARZEC_IL2_SIGNALING_UP adult medulloblastoma DOID_3864 1.717E-06 1.879E-05 3.391E-03 0.06653073 MARZEC_IL2_SIGNALING_UP childhood medulloblastoma DOID_3869 1.717E-06 1.879E-05 3.391E-03 0.06653073 MARZEC_IL2_SIGNALING_UP adenoma DOID_657 1.91E-06 2.051E-05 0.08480245 0.40548397 MARZEC_IL2_SIGNALING_UP transitional cell carcinoma DOID_2671 2.017E-06 2.125E-05 0.18505518 0.65810247 MARZEC_IL2_SIGNALING_UP medulloblastoma DOID_3858 2.119E-06 2.192E-05 3.751E-03 0.07114789 MARZEC_IL2_SIGNALING_UP cleft palate DOID_674 2.119E-06 2.153E-05 3.751E-03 0.0688528 MARZEC_IL2_SIGNALING_UP nervous system cancer DOID_3093 2.248E-06 2.245E-05 0.01865717 0.22116521 MARZEC_IL2_SIGNALING_UP lymphoma DOID_0060058 2.501E-06 2.453E-05 0.01942508 0.22556882 MARZEC_IL2_SIGNALING_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.775E-06 2.676E-05 0.19611136 0.68458504 MARZEC_IL2_SIGNALING_UP primitive neuroectodermal tumor DOID_168 3.745E-06 3.551E-05 4.934E-03 0.08257033 MARZEC_IL2_SIGNALING_UP gallbladder cancer DOID_3121 4.086E-06 3.811E-05 1.000 1.000 MARZEC_IL2_SIGNALING_UP influenza DOID_8469 4.086E-06 3.75E-05 1.000 1.000 MARZEC_IL2_SIGNALING_UP angiosarcoma DOID_0001816 6.178E-06 5.58E-05 0.03569145 0.31243746 MARZEC_IL2_SIGNALING_UP silicosis DOID_10325 6.178E-06 5.493E-05 0.03569145 0.30770356 MARZEC_IL2_SIGNALING_UP bronchitis DOID_6132 7.49E-06 6.556E-05 1.000 1.000 MARZEC_IL2_SIGNALING_UP orofacial cleft DOID_0050567 7.705E-06 6.643E-05 6.986E-03 0.10461008 MARZEC_IL2_SIGNALING_UP vasculitis DOID_865 8.894E-06 7.553E-05 0.12150541 0.51594463 MARZEC_IL2_SIGNALING_UP male reproductive organ benign neoplasm DOID_0060087 8.973E-06 7.508E-05 0.0400634 0.33523639 MARZEC_IL2_SIGNALING_UP neuroectodermal tumor DOID_171 1.413E-05 1.165E-04 9.36E-03 0.13314905 MARZEC_IL2_SIGNALING_UP carotid artery disease DOID_3407 1.413E-05 1.149E-04 0.13538253 0.55023327 MARZEC_IL2_SIGNALING_UP acquired immunodeficiency syndrome DOID_635 1.682E-05 1.348E-04 1.141E-03 0.03245431 MARZEC_IL2_SIGNALING_UP uremia DOID_4676 1.931E-05 1.526E-04 0.05090775 0.36208137 MARZEC_IL2_SIGNALING_UP pancreatic ductal carcinoma DOID_3587 2.384E-05 1.858E-04 0.15290658 0.59591675 MARZEC_IL2_SIGNALING_UP biliary tract disease DOID_9741 2.653E-05 2.04E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP pancreatic carcinoma DOID_4905 2.795E-05 2.121E-04 0.15866956 0.60592603 MARZEC_IL2_SIGNALING_UP bacterial pneumonia DOID_874 3.422E-05 2.562E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP periodontitis DOID_824 3.946E-05 2.916E-04 0.06376124 0.37791817 MARZEC_IL2_SIGNALING_UP biliary tract cancer DOID_4607 4.344E-05 3.169E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP autoimmune disease of cardiovascular system DOID_0060051 4.377E-05 3.153E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP Behcet's disease DOID_13241 4.377E-05 3.153E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP allergic rhinitis DOID_4481 6.41E-05 4.559E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP leukopenia DOID_615 8.282E-05 5.818E-04 0.08063194 0.3921331 MARZEC_IL2_SIGNALING_UP respiratory syncytial virus infectious disease DOID_1273 1.214E-04 8.421E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP congenital diaphragmatic hernia DOID_3827 1.214E-04 8.32E-04 0.09102318 0.4280346 MARZEC_IL2_SIGNALING_UP systemic scleroderma DOID_418 1.214E-04 8.221E-04 0.09102318 0.42452612 MARZEC_IL2_SIGNALING_UP lymphatic system disease DOID_75 1.303E-04 8.719E-04 0.09308745 0.43062406 MARZEC_IL2_SIGNALING_UP endometriosis of uterus DOID_288 1.493E-04 9.877E-04 1.000 1.000 MARZEC_IL2_SIGNALING_UP nephrotic syndrome DOID_1184 1.594E-04 1.043E-03 0.09925251 0.45179744 MARZEC_IL2_SIGNALING_UP rheumatic disease DOID_1575 1.594E-04 1.031E-03 0.09925251 0.44821174 MARZEC_IL2_SIGNALING_UP endometriosis DOID_289 1.594E-04 1.019E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP scleroderma DOID_419 1.594E-04 1.031E-03 0.09925251 0.44821174 MARZEC_IL2_SIGNALING_UP uterine cancer DOID_363 1.7E-04 1.075E-03 0.10129831 0.45384835 MARZEC_IL2_SIGNALING_UP proteinuria DOID_576 1.926E-04 1.204E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP brain cancer DOID_1319 2.045E-04 1.265E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP thyroid adenoma DOID_2891 2.045E-04 1.251E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP heart valve disease DOID_4079 2.045E-04 1.238E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP vascular skin disease DOID_9540 2.045E-04 1.225E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP central nervous system cancer DOID_3620 2.169E-04 1.286E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP chondrosarcoma DOID_3371 2.262E-04 1.327E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP insulinoma DOID_3892 2.262E-04 1.313E-03 0.02245717 0.24109684 MARZEC_IL2_SIGNALING_UP keratitis DOID_4677 2.262E-04 1.3E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP cutaneous leishmaniasis DOID_9111 2.262E-04 1.287E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP atopic dermatitis DOID_3310 2.715E-04 1.53E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP sickle cell anemia DOID_10923 2.76E-04 1.54E-03 2.76E-04 0.01308934 MARZEC_IL2_SIGNALING_UP prostatic adenoma DOID_2883 2.76E-04 1.525E-03 0.02467529 0.24631997 MARZEC_IL2_SIGNALING_UP invasive lobular carcinoma DOID_3457 2.76E-04 1.51E-03 0.02467529 0.24207308 MARZEC_IL2_SIGNALING_UP eosinophilic pneumonia DOID_5870 2.76E-04 1.496E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP pulmonary eosinophilia DOID_9498 2.76E-04 1.496E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP Loeffler syndrome DOID_9503 2.76E-04 1.496E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP integumentary system cancer DOID_0060122 3.178E-04 1.706E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP skin cancer DOID_4159 3.178E-04 1.706E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP common cold DOID_10459 3.308E-04 1.759E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP beta thalassemia DOID_12241 3.308E-04 1.743E-03 3.308E-04 0.01254723 MARZEC_IL2_SIGNALING_UP islet cell tumor DOID_1799 3.308E-04 1.727E-03 0.02688842 0.25931379 MARZEC_IL2_SIGNALING_UP Hodgkin's lymphoma DOID_8567 3.308E-04 1.711E-03 0.02688842 0.2549919 MARZEC_IL2_SIGNALING_UP familial hyperlipidemia DOID_1168 3.342E-04 1.713E-03 8.002E-03 0.11675389 MARZEC_IL2_SIGNALING_UP berylliosis DOID_10322 3.903E-04 1.983E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP collagen disease DOID_854 4.249E-04 2.139E-03 0.13538253 0.54633091 MARZEC_IL2_SIGNALING_UP respiratory failure DOID_11162 4.447E-04 2.22E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP rhabdomyosarcoma DOID_3247 4.547E-04 2.25E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP cholestasis DOID_13580 5.078E-04 2.491E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP idiopathic pulmonary fibrosis DOID_0050156 5.239E-04 2.548E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP thalassemia DOID_10241 5.239E-04 2.526E-03 5.239E-04 0.01753529 MARZEC_IL2_SIGNALING_UP skeletal muscle cancer DOID_4043 5.239E-04 2.505E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP oral submucous fibrosis DOID_5773 5.239E-04 2.484E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP varicose veins DOID_799 5.239E-04 2.464E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP hyperglycemia DOID_4195 5.3E-04 2.472E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP endocrine organ benign neoplasm DOID_0060089 5.762E-04 2.666E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP spastic diplegia DOID_10965 5.979E-04 2.743E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP vein disease DOID_866 5.979E-04 2.721E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP nephrosis DOID_2527 6.504E-04 2.937E-03 0.1548319 0.5993153 MARZEC_IL2_SIGNALING_UP bile duct disease DOID_4138 6.504E-04 2.914E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP lymphatic system cancer DOID_0060073 6.766E-04 3.008E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP urinary system benign neoplasm DOID_731 6.766E-04 2.984E-03 0.03787988 0.32169629 MARZEC_IL2_SIGNALING_UP reticulosarcoma DOID_8538 6.766E-04 3.008E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP lymphosarcoma DOID_8675 6.766E-04 3.008E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP endogenous depression DOID_1595 7.583E-04 3.319E-03 0.16249 0.60826847 MARZEC_IL2_SIGNALING_UP syndrome DOID_225 7.583E-04 3.294E-03 0.16249 0.60429286 MARZEC_IL2_SIGNALING_UP prion disease DOID_649 7.6E-04 3.276E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP eosinophilia DOID_999 7.6E-04 3.252E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP pancreatitis DOID_4989 8.163E-04 3.466E-03 0.16629329 0.6144213 MARZEC_IL2_SIGNALING_UP dissociative disorder DOID_10935 8.482E-04 3.575E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP dissociative amnesia DOID_11037 8.482E-04 3.575E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP Down syndrome DOID_14250 8.482E-04 3.549E-03 0.04224202 0.34834364 MARZEC_IL2_SIGNALING_UP granulosa cell tumor DOID_2999 8.482E-04 3.523E-03 0.04224202 0.33853114 MARZEC_IL2_SIGNALING_UP psoriasis DOID_8893 8.482E-04 3.497E-03 0.04224202 0.32925631 MARZEC_IL2_SIGNALING_UP metabolic syndrome X DOID_14221 8.77E-04 3.59E-03 0.01501912 0.19422449 MARZEC_IL2_SIGNALING_UP lipid metabolism disorder DOID_3146 8.77E-04 3.564E-03 0.01501912 0.18990839 MARZEC_IL2_SIGNALING_UP amnestic disorder DOID_10914 9.41E-04 3.798E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP pulmonary edema DOID_11396 9.41E-04 3.771E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP sex cord-gonadal stromal tumor DOID_192 9.41E-04 3.744E-03 0.04441576 0.33696755 MARZEC_IL2_SIGNALING_UP alopecia DOID_987 9.41E-04 3.718E-03 0.04441576 0.33253377 MARZEC_IL2_SIGNALING_UP mental depression DOID_1596 9.733E-04 3.819E-03 0.17572699 0.64095294 MARZEC_IL2_SIGNALING_UP focal epilepsy DOID_2234 9.733E-04 3.793E-03 0.17572699 0.63687043 MARZEC_IL2_SIGNALING_UP bone development disease DOID_0080006 1.007E-03 3.897E-03 0.17760103 0.63958853 MARZEC_IL2_SIGNALING_UP Kawasaki disease DOID_13378 1.039E-03 3.993E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP lymphadenitis DOID_1602 1.039E-03 3.993E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP lymph node disease DOID_9942 1.039E-03 3.993E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP neutropenia DOID_1227 1.141E-03 4.356E-03 0.04874861 0.36023324 MARZEC_IL2_SIGNALING_UP placenta disease DOID_780 1.141E-03 4.327E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP primary immunodeficiency disease DOID_612 1.185E-03 4.467E-03 0.01827818 0.2212826 MARZEC_IL2_SIGNALING_UP agranulocytosis DOID_12987 1.248E-03 4.67E-03 0.05090775 0.37136551 MARZEC_IL2_SIGNALING_UP IgA glomerulonephritis DOID_2986 1.248E-03 4.64E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP muscle cancer DOID_4045 1.248E-03 4.609E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP myasthenia gravis DOID_437 1.248E-03 4.58E-03 0.05090775 0.36666468 MARZEC_IL2_SIGNALING_UP polyarteritis nodosa DOID_9810 1.248E-03 4.55E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP diabetic angiopathy DOID_11713 1.359E-03 4.925E-03 1.359E-03 0.03682141 MARZEC_IL2_SIGNALING_UP congenital hemolytic anemia DOID_589 1.359E-03 4.894E-03 1.359E-03 0.03514771 MARZEC_IL2_SIGNALING_UP Goodpasture syndrome DOID_9808 1.359E-03 4.863E-03 0.05306205 0.3637627 MARZEC_IL2_SIGNALING_UP toxic shock syndrome DOID_14115 1.475E-03 5.245E-03 0.05521151 0.37399223 MARZEC_IL2_SIGNALING_UP commensal bacterial infectious disease DOID_0050339 1.596E-03 5.639E-03 0.05735615 0.37948427 MARZEC_IL2_SIGNALING_UP combined T cell and B cell immunodeficiency DOID_628 1.596E-03 5.604E-03 1.596E-03 0.03782714 MARZEC_IL2_SIGNALING_UP papillary adenoma DOID_3172 1.721E-03 6.006E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP neuromuscular junction disease DOID_439 1.721E-03 5.97E-03 0.05949597 0.38037314 MARZEC_IL2_SIGNALING_UP microcystic adenoma DOID_5403 1.721E-03 6.006E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP follicular adenoma DOID_6204 1.721E-03 6.006E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP ankylosing spondylitis DOID_7147 1.721E-03 5.934E-03 0.05949597 0.37614677 MARZEC_IL2_SIGNALING_UP B cell deficiency DOID_2115 1.85E-03 6.342E-03 0.061631 0.38117434 MARZEC_IL2_SIGNALING_UP seminoma DOID_4440 1.85E-03 6.304E-03 0.061631 0.37707569 MARZEC_IL2_SIGNALING_UP hypotrichosis DOID_4535 1.85E-03 6.267E-03 0.061631 0.37306425 MARZEC_IL2_SIGNALING_UP gestational diabetes DOID_11714 1.984E-03 6.681E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP thrombocytopenia DOID_1588 2.123E-03 7.106E-03 0.06588669 0.37489529 MARZEC_IL2_SIGNALING_UP autoimmune disease of the nervous system DOID_438 2.123E-03 7.064E-03 0.06588669 0.37118345 MARZEC_IL2_SIGNALING_UP multiple epiphyseal dysplasia DOID_12721 2.266E-03 7.497E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP focal glomerulosclerosis DOID_3945 2.266E-03 7.453E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP corneal disease DOID_10124 2.414E-03 7.893E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP endometrial carcinoma DOID_2871 2.414E-03 7.848E-03 0.07012331 0.38000155 MARZEC_IL2_SIGNALING_UP spastic cerebral palsy DOID_0050669 2.566E-03 8.294E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP age related macular degeneration DOID_10871 2.566E-03 8.247E-03 0.07223449 0.38774929 MARZEC_IL2_SIGNALING_UP degeneration of macula and posterior pole DOID_2007 2.566E-03 8.247E-03 0.07223449 0.38774929 MARZEC_IL2_SIGNALING_UP bronchiolitis obliterans DOID_2799 2.566E-03 8.201E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP celiac disease DOID_10608 2.722E-03 8.652E-03 2.722E-03 0.05956734 MARZEC_IL2_SIGNALING_UP endometrial cancer DOID_1380 2.722E-03 8.604E-03 0.07434093 0.39166657 MARZEC_IL2_SIGNALING_UP germinoma DOID_3304 2.722E-03 8.557E-03 0.07434093 0.3880733 MARZEC_IL2_SIGNALING_UP autonomic nervous system neoplasm DOID_2621 2.883E-03 9.012E-03 2.883E-03 0.06074819 MARZEC_IL2_SIGNALING_UP bladder disease DOID_365 2.883E-03 8.963E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP neuroblastoma DOID_769 2.883E-03 9.012E-03 2.883E-03 0.06074819 MARZEC_IL2_SIGNALING_UP hair disease DOID_421 3.048E-03 9.425E-03 0.07853965 0.40260413 MARZEC_IL2_SIGNALING_UP hepatitis C DOID_1883 3.217E-03 9.895E-03 1.000 1.000 MARZEC_IL2_SIGNALING_UP macular degeneration DOID_4448 3.217E-03 9.842E-03 0.08063194 0.39895281 MARZEC_IL2_SIGNALING_UP aplastic anemia DOID_12449 3.391E-03 0.0103176 0.08271954 0.39887641 MARZEC_IL2_SIGNALING_UP pulmonary sarcoidosis DOID_13406 3.751E-03 0.01135339 1.000 1.000 MARZEC_IL2_SIGNALING_UP embryonal cancer DOID_688 3.751E-03 0.01129332 3.751E-03 0.06670115 MARZEC_IL2_SIGNALING_UP peripheral nervous system neoplasm DOID_1192 3.938E-03 0.01179264 3.938E-03 0.06789701 MARZEC_IL2_SIGNALING_UP blood platelet disease DOID_2218 3.938E-03 0.0117309 0.08895426 0.42179144 MARZEC_IL2_SIGNALING_UP hepatitis DOID_2237 4.129E-03 0.01223531 1.000 1.000 MARZEC_IL2_SIGNALING_UP benign mesothelioma DOID_2645 4.523E-03 0.01333433 1.000 1.000 MARZEC_IL2_SIGNALING_UP pulmonary emphysema DOID_9675 4.523E-03 0.0132656 1.000 1.000 MARZEC_IL2_SIGNALING_UP diabetic autonomic neuropathy DOID_11503 5.146E-03 0.01501469 1.000 1.000 MARZEC_IL2_SIGNALING_UP autonomic neuropathy DOID_11504 5.146E-03 0.01501469 1.000 1.000 MARZEC_IL2_SIGNALING_UP diabetic polyneuropathy DOID_12785 5.146E-03 0.01501469 1.000 1.000 MARZEC_IL2_SIGNALING_UP diabetic neuropathy DOID_9743 5.146E-03 0.01501469 1.000 1.000 MARZEC_IL2_SIGNALING_UP pre-eclampsia DOID_10591 5.805E-03 0.01685365 1.000 1.000 MARZEC_IL2_SIGNALING_UP autonomic nervous system disease DOID_11465 5.805E-03 0.0167681 1.000 1.000 MARZEC_IL2_SIGNALING_UP neuritis DOID_1803 5.805E-03 0.01668341 0.10740821 0.47746304 MARZEC_IL2_SIGNALING_UP bone marrow disease DOID_4961 5.805E-03 0.01659958 0.10740821 0.47376177 MARZEC_IL2_SIGNALING_UP hemolytic anemia DOID_583 6.034E-03 0.01716553 6.034E-03 0.09808876 MARZEC_IL2_SIGNALING_UP normocytic anemia DOID_720 6.034E-03 0.01716553 6.034E-03 0.09808876 MARZEC_IL2_SIGNALING_UP integumentary system benign neoplasm DOID_0060121 6.266E-03 0.01773731 1.000 1.000 MARZEC_IL2_SIGNALING_UP glaucoma DOID_1686 6.266E-03 0.0176495 0.11145864 0.48784589 MARZEC_IL2_SIGNALING_UP pulmonary tuberculosis DOID_2957 6.266E-03 0.01756256 1.000 1.000 MARZEC_IL2_SIGNALING_UP skin benign neoplasm DOID_3165 6.266E-03 0.01773731 1.000 1.000 MARZEC_IL2_SIGNALING_UP lung small cell carcinoma DOID_5409 6.266E-03 0.01747647 6.266E-03 0.09635675 MARZEC_IL2_SIGNALING_UP hemorrhagic disease DOID_2213 6.742E-03 0.01871341 0.1154909 0.50163606 MARZEC_IL2_SIGNALING_UP B-cell lymphocytic neoplasm DOID_707 6.742E-03 0.01862257 0.1154909 0.49783579 MARZEC_IL2_SIGNALING_UP sarcoidosis DOID_11335 7.234E-03 0.01988587 1.000 1.000 MARZEC_IL2_SIGNALING_UP atrophic muscular disease DOID_913 7.234E-03 0.01979027 0.11950508 0.51126611 MARZEC_IL2_SIGNALING_UP muscular dystrophy DOID_9884 7.234E-03 0.01979027 0.11950508 0.51126611 MARZEC_IL2_SIGNALING_UP bile duct adenocarcinoma DOID_4896 7.486E-03 0.0203819 1.000 1.000 MARZEC_IL2_SIGNALING_UP cholangiocarcinoma DOID_4947 7.486E-03 0.0203819 1.000 1.000 MARZEC_IL2_SIGNALING_UP osteochondrodysplasia DOID_2256 7.743E-03 0.02097855 1.000 1.000 MARZEC_IL2_SIGNALING_UP pustulosis of palm and sole DOID_4398 7.743E-03 0.02087913 1.000 1.000 MARZEC_IL2_SIGNALING_UP hypertrophic cardiomyopathy DOID_11984 8.534E-03 0.02290496 0.12946192 0.54164585 MARZEC_IL2_SIGNALING_UP hypersensitivity reaction type IV disease DOID_2916 8.534E-03 0.02279742 1.000 1.000 MARZEC_IL2_SIGNALING_UP bile duct cancer DOID_4606 8.534E-03 0.02269089 1.000 1.000 MARZEC_IL2_SIGNALING_UP bile duct carcinoma DOID_4897 8.534E-03 0.02269089 1.000 1.000 MARZEC_IL2_SIGNALING_UP melancholia DOID_2848 8.806E-03 0.02330406 0.1314399 0.54590731 MARZEC_IL2_SIGNALING_UP neurotic disorder DOID_4964 9.081E-03 0.02392167 0.13341343 0.54613123 MARZEC_IL2_SIGNALING_UP congenital heart defect DOID_1682 9.93E-03 0.02603781 0.13930747 0.55430733 MARZEC_IL2_SIGNALING_UP temporal lobe epilepsy DOID_3328 0.01081303 0.02822301 1.000 1.000 MARZEC_IL2_SIGNALING_UP brain infarction DOID_3454 0.01142027 0.02967185 1.000 1.000 MARZEC_IL2_SIGNALING_UP blood coagulation disease DOID_1247 0.01204221 0.03114554 0.15290658 0.60002652 MARZEC_IL2_SIGNALING_UP chromosomal disease DOID_0080014 0.01536753 0.03956618 0.17196624 0.63128251 MARZEC_IL2_SIGNALING_UP chronic kidney failure DOID_784 0.01607474 0.04120057 1.000 1.000 MARZEC_IL2_SIGNALING_UP lymphoblastic leukemia DOID_1037 0.01981397 0.05055672 0.19427901 0.6866134 MARZEC_IL2_SIGNALING_UP leber hereditary optic neuropathy DOID_705 0.02023408 0.05139817 1.000 1.000 MARZEC_IL2_SIGNALING_UP dilated cardiomyopathy DOID_12930 0.02060152 0.05209894 0.19793958 0.68259166 MARZEC_IL2_SIGNALING_UP brachydactyly DOID_0050581 0.02245717 0.05654041 0.02245717 0.25055161 MARZEC_IL2_SIGNALING_UP facioscapulohumeral muscular dystrophy DOID_11727 0.02245717 0.05629133 0.02245717 0.24573331 MARZEC_IL2_SIGNALING_UP Sjogren's syndrome DOID_12894 0.02245717 0.05604444 1.000 1.000 MARZEC_IL2_SIGNALING_UP hyperparathyroidism DOID_13543 0.02245717 0.0557997 1.000 1.000 MARZEC_IL2_SIGNALING_UP childhood type dermatomyositis DOID_14203 0.02245717 0.0555571 1.000 1.000 MARZEC_IL2_SIGNALING_UP retinal vascular occlusion DOID_1729 0.02245717 0.05531659 1.000 1.000 MARZEC_IL2_SIGNALING_UP holoprosencephaly DOID_4621 0.02245717 0.05507816 1.000 1.000 MARZEC_IL2_SIGNALING_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.02245717 0.05484177 0.02245717 0.23663208 MARZEC_IL2_SIGNALING_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.02245717 0.05484177 0.02245717 0.23663208 MARZEC_IL2_SIGNALING_UP Hodgkin's granuloma DOID_8651 0.02245717 0.05484177 0.02245717 0.23663208 MARZEC_IL2_SIGNALING_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.02245717 0.05484177 0.02245717 0.23663208 MARZEC_IL2_SIGNALING_UP alopecia areata DOID_986 0.02245717 0.0546074 1.000 1.000 MARZEC_IL2_SIGNALING_UP dermatomyositis DOID_10223 0.02467529 0.0597457 1.000 1.000 MARZEC_IL2_SIGNALING_UP pneumocystosis DOID_11339 0.02467529 0.05949254 1.000 1.000 MARZEC_IL2_SIGNALING_UP hemochromatosis DOID_2352 0.02467529 0.05924151 0.02467529 0.25071854 MARZEC_IL2_SIGNALING_UP otitis media DOID_10754 0.02688842 0.06428367 1.000 1.000 MARZEC_IL2_SIGNALING_UP middle ear disease DOID_5100 0.02688842 0.06428367 1.000 1.000 MARZEC_IL2_SIGNALING_UP retinal detachment DOID_5327 0.02688842 0.0640147 1.000 1.000 MARZEC_IL2_SIGNALING_UP aortic valve insufficiency DOID_57 0.02688842 0.06374797 1.000 1.000 MARZEC_IL2_SIGNALING_UP mitochondrial encephalomyopathy DOID_890 0.02688842 0.06348346 1.000 1.000 MARZEC_IL2_SIGNALING_UP ocular hypertension DOID_9282 0.02688842 0.06322113 1.000 1.000 MARZEC_IL2_SIGNALING_UP borderline glaucoma DOID_9283 0.02688842 0.06322113 1.000 1.000 MARZEC_IL2_SIGNALING_UP parathyroid gland disease DOID_11201 0.0290966 0.06813154 1.000 1.000 MARZEC_IL2_SIGNALING_UP vulva cancer DOID_1245 0.0290966 0.06785232 0.0290966 0.27140926 MARZEC_IL2_SIGNALING_UP carotid stenosis DOID_13001 0.0290966 0.06757537 1.000 1.000 MARZEC_IL2_SIGNALING_UP obstructive hydrocephalus DOID_14159 0.0290966 0.06730067 1.000 1.000 MARZEC_IL2_SIGNALING_UP communicating hydrocephalus DOID_1573 0.0290966 0.06730067 1.000 1.000 MARZEC_IL2_SIGNALING_UP larynx cancer DOID_2596 0.0290966 0.0670282 1.000 1.000 MARZEC_IL2_SIGNALING_UP laryngeal benign neoplasm DOID_2598 0.0290966 0.0670282 1.000 1.000 MARZEC_IL2_SIGNALING_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.0290966 0.06675792 1.000 1.000 MARZEC_IL2_SIGNALING_UP Legionnaires' disease DOID_10457 0.03129982 0.07152449 1.000 1.000 MARZEC_IL2_SIGNALING_UP legionellosis DOID_10458 0.03129982 0.07152449 1.000 1.000 MARZEC_IL2_SIGNALING_UP hydrocephalus DOID_10908 0.03129982 0.07123839 1.000 1.000 MARZEC_IL2_SIGNALING_UP eyelid disease DOID_530 0.03129982 0.07095457 1.000 1.000 MARZEC_IL2_SIGNALING_UP narcolepsy DOID_8986 0.03129982 0.07067301 0.03129982 0.28725158 MARZEC_IL2_SIGNALING_UP hemangioma DOID_255 0.0334981 0.07533763 1.000 1.000 MARZEC_IL2_SIGNALING_UP mesenchymal cell neoplasm DOID_3350 0.0334981 0.07504102 1.000 1.000 MARZEC_IL2_SIGNALING_UP spindle cell sarcoma DOID_4235 0.0334981 0.07504102 1.000 1.000 MARZEC_IL2_SIGNALING_UP lung oat cell carcinoma DOID_5411 0.0334981 0.07474674 0.0334981 0.30254634 MARZEC_IL2_SIGNALING_UP panic disorder DOID_594 0.0334981 0.07445476 0.0334981 0.29781905 MARZEC_IL2_SIGNALING_UP epithelioid sarcoma DOID_6193 0.0334981 0.07504102 1.000 1.000 MARZEC_IL2_SIGNALING_UP intermediate coronary syndrome DOID_8805 0.0334981 0.07416506 1.000 1.000 MARZEC_IL2_SIGNALING_UP intracranial hypertension DOID_9428 0.0334981 0.07387759 1.000 1.000 MARZEC_IL2_SIGNALING_UP Barrett's esophagus DOID_9206 0.03569145 0.07841095 1.000 1.000 MARZEC_IL2_SIGNALING_UP penile disease DOID_1529 0.03787988 0.08289866 1.000 1.000 MARZEC_IL2_SIGNALING_UP basal cell carcinoma DOID_2513 0.03787988 0.08258104 1.000 1.000 MARZEC_IL2_SIGNALING_UP skin carcinoma DOID_3451 0.0400634 0.08700792 1.000 1.000 MARZEC_IL2_SIGNALING_UP osteosclerosis DOID_4254 0.0400634 0.08667709 1.000 1.000 MARZEC_IL2_SIGNALING_UP ureteral obstruction DOID_5199 0.0400634 0.08634877 1.000 1.000 MARZEC_IL2_SIGNALING_UP testicular cancer DOID_2998 0.04224202 0.0907008 0.04224202 0.3433673 MARZEC_IL2_SIGNALING_UP infertility DOID_5223 0.04224202 0.09035982 0.04224202 0.33382932 MARZEC_IL2_SIGNALING_UP colon carcinoma DOID_1520 0.04441576 0.09465381 1.000 1.000 MARZEC_IL2_SIGNALING_UP brain edema DOID_4724 0.04441576 0.09430062 1.000 1.000 MARZEC_IL2_SIGNALING_UP coronary restenosis DOID_4247 0.04658462 0.09853772 1.000 1.000 MARZEC_IL2_SIGNALING_UP mitochondrial myopathy DOID_699 0.04658462 0.09817277 1.000 1.000 BROWNE_HCMV_INFECTION_12HR_UP hypothyroidism DOID_1459 9.445E-05 0.05374276 9.445E-05 0.05374276 BROWNE_HCMV_INFECTION_12HR_UP migraine without aura DOID_12783 9.683E-05 0.02754848 9.683E-05 0.02754848 BROWNE_HCMV_INFECTION_12HR_UP intermediate coronary syndrome DOID_8805 1.842E-04 0.03494112 0.01999358 0.29937756 BROWNE_HCMV_INFECTION_12HR_UP metabolic syndrome X DOID_14221 1.884E-04 0.02680534 5.501E-03 0.22357716 BROWNE_HCMV_INFECTION_12HR_UP IgA glomerulonephritis DOID_2986 4.408E-04 0.0501682 0.03049603 0.34704484 BROWNE_HCMV_INFECTION_12HR_UP Goodpasture syndrome DOID_9808 4.805E-04 0.04556823 0.03180105 0.33508889 BROWNE_HCMV_INFECTION_12HR_UP extrinsic allergic alveolitis DOID_841 6.558E-04 0.05330937 6.558E-04 0.12438853 BROWNE_HCMV_INFECTION_12HR_UP migraine DOID_6364 7.038E-04 0.05005786 7.038E-04 0.10011573 BROWNE_HCMV_INFECTION_12HR_UP invasive ductal carcinoma DOID_3008 7.534E-04 0.04763317 7.534E-04 0.08573971 BROWNE_HCMV_INFECTION_12HR_UP opportunistic mycosis DOID_2473 9.121E-04 0.05190108 9.121E-04 0.0865018 BROWNE_HCMV_INFECTION_12HR_UP abdominal aortic aneurysm DOID_7693 9.121E-04 0.0471828 0.04346902 0.33882021 BROWNE_HCMV_INFECTION_12HR_UP germinoma DOID_3304 9.683E-04 0.04591459 9.683E-04 0.07871072 BROWNE_HCMV_INFECTION_12HR_UP systemic mycosis DOID_0050136 1.086E-03 0.04751379 1.086E-03 0.0772099 BROWNE_HCMV_INFECTION_12HR_UP fungal infectious disease DOID_1564 1.086E-03 0.04751379 1.086E-03 0.0772099 BROWNE_HCMV_INFECTION_12HR_UP peptic ulcer DOID_750 1.476E-03 0.05998718 0.05499911 0.35561922 BROWNE_HCMV_INFECTION_12HR_UP pulmonary emphysema DOID_9675 1.619E-03 0.06140971 1.619E-03 0.10234952 BROWNE_HCMV_INFECTION_12HR_UP influenza DOID_8469 1.845E-03 0.06561815 1.845E-03 0.10498904 BROWNE_HCMV_INFECTION_12HR_UP pulmonary tuberculosis DOID_2957 2.254E-03 0.0754308 2.254E-03 0.11657487 BROWNE_HCMV_INFECTION_12HR_UP aortic aneurysm DOID_3627 2.34E-03 0.07397042 0.0689065 0.38819602 BROWNE_HCMV_INFECTION_12HR_UP sarcoidosis DOID_11335 2.608E-03 0.07811429 0.07266447 0.39005739 BROWNE_HCMV_INFECTION_12HR_UP parasitic protozoa infectious disease DOID_2789 2.795E-03 0.07951719 0.07516152 0.39235692 BROWNE_HCMV_INFECTION_12HR_UP hypersensitivity reaction type IV disease DOID_2916 3.086E-03 0.08362429 0.07889474 0.40081343 BROWNE_HCMV_INFECTION_12HR_UP carotid artery disease DOID_3407 3.391E-03 0.08771045 0.08261318 0.40875563 BROWNE_HCMV_INFECTION_12HR_UP congenital heart defect DOID_1682 3.602E-03 0.08911243 0.08508396 0.41027773 BROWNE_HCMV_INFECTION_12HR_UP parasitic infectious disease DOID_1398 3.819E-03 0.09053923 0.08754821 0.41861289 BROWNE_HCMV_INFECTION_12HR_UP endocrine organ benign neoplasm DOID_0060089 4.155E-03 0.09457236 0.0912324 0.42901849 BROWNE_HCMV_INFECTION_12HR_UP tuberculosis DOID_399 4.155E-03 0.09093496 4.155E-03 0.19702575 BROWNE_HCMV_INFECTION_12HR_UP diabetic retinopathy DOID_8947 4.745E-03 0.09999972 0.09734033 0.44666653 HATADA_METHYLATED_IN_LUNG_CANCER_UP bone development disease DOID_0080006 4.115E-09 2.341E-06 1.005E-07 5.72E-05 HATADA_METHYLATED_IN_LUNG_CANCER_UP sleep disorder DOID_535 4.502E-08 1.281E-05 2.803E-06 3.988E-04 HATADA_METHYLATED_IN_LUNG_CANCER_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.151E-07 4.079E-05 2.151E-07 6.118E-05 HATADA_METHYLATED_IN_LUNG_CANCER_UP alcohol abuse DOID_1574 1.971E-06 2.804E-04 1.971E-06 3.739E-04 HATADA_METHYLATED_IN_LUNG_CANCER_UP mouth disease DOID_403 4.018E-06 4.572E-04 6.34E-05 4.008E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP dysostosis DOID_1934 1.104E-05 1.047E-03 1.104E-05 1.257E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP tooth disease DOID_1091 1.374E-05 1.117E-03 2.478E-04 0.01007203 HATADA_METHYLATED_IN_LUNG_CANCER_UP essential hypertension DOID_10825 2.202E-05 1.566E-03 0.05480867 0.26654815 HATADA_METHYLATED_IN_LUNG_CANCER_UP alcohol dependence DOID_0050741 2.794E-05 1.766E-03 1.636E-03 0.03579744 HATADA_METHYLATED_IN_LUNG_CANCER_UP narcolepsy DOID_8986 2.794E-05 1.59E-03 2.794E-05 2.649E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP Ehlers-Danlos syndrome DOID_13359 3.481E-05 1.801E-03 1.882E-03 0.03966208 HATADA_METHYLATED_IN_LUNG_CANCER_UP mental depression DOID_1596 3.535E-05 1.676E-03 3.535E-05 2.874E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP uterine cancer DOID_363 5.208E-05 2.28E-03 5.208E-05 3.704E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP heart valve disease DOID_4079 6.657E-05 2.706E-03 1.342E-03 0.0363583 HATADA_METHYLATED_IN_LUNG_CANCER_UP osteochondrodysplasia DOID_2256 1.194E-04 4.529E-03 2.06E-03 0.03906704 HATADA_METHYLATED_IN_LUNG_CANCER_UP heart conduction disease DOID_10273 1.321E-04 4.697E-03 1.321E-04 7.515E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP opiate dependence DOID_2559 1.321E-04 4.421E-03 1.321E-04 6.832E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP synostosis DOID_11971 1.505E-04 4.757E-03 1.505E-04 7.135E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP hypothyroidism DOID_1459 1.861E-04 5.573E-03 1.861E-04 8.145E-03 HATADA_METHYLATED_IN_LUNG_CANCER_UP endocrine pancreas disease DOID_1428 2.093E-04 5.953E-03 0.03423316 0.2465654 HATADA_METHYLATED_IN_LUNG_CANCER_UP hyperglycemia DOID_4195 2.344E-04 6.352E-03 0.03612137 0.25691324 HATADA_METHYLATED_IN_LUNG_CANCER_UP diabetic retinopathy DOID_8947 3.399E-04 8.79E-03 4.434E-03 0.06639516 HATADA_METHYLATED_IN_LUNG_CANCER_UP endogenous depression DOID_1595 3.753E-04 9.285E-03 3.753E-04 0.01423745 HATADA_METHYLATED_IN_LUNG_CANCER_UP aneurysm disease DOID_2403 3.94E-04 9.342E-03 0.04613644 0.27345451 HATADA_METHYLATED_IN_LUNG_CANCER_UP endometrial cancer DOID_1380 4.31E-04 9.809E-03 4.31E-04 0.01532642 HATADA_METHYLATED_IN_LUNG_CANCER_UP lipid metabolism disorder DOID_3146 4.541E-04 9.938E-03 5.482E-03 0.07997402 HATADA_METHYLATED_IN_LUNG_CANCER_UP bladder disease DOID_365 4.699E-04 9.902E-03 0.01007775 0.10819324 HATADA_METHYLATED_IN_LUNG_CANCER_UP periodontal disease DOID_3388 5.543E-04 0.01126423 0.01121686 0.11604351 HATADA_METHYLATED_IN_LUNG_CANCER_UP retinal vascular disease DOID_2462 5.683E-04 0.01115035 6.459E-03 0.08749754 HATADA_METHYLATED_IN_LUNG_CANCER_UP calcinosis DOID_182 6.982E-04 0.01324176 0.01302628 0.12562629 HATADA_METHYLATED_IN_LUNG_CANCER_UP Human immunodeficiency virus infectious disease DOID_526 7.015E-04 0.01287667 7.015E-04 0.02348099 HATADA_METHYLATED_IN_LUNG_CANCER_UP hepatitis DOID_2237 8.061E-04 0.01433346 0.01429827 0.13122119 HATADA_METHYLATED_IN_LUNG_CANCER_UP dilated cardiomyopathy DOID_12930 8.555E-04 0.01475101 8.555E-04 0.02704351 HATADA_METHYLATED_IN_LUNG_CANCER_UP breast benign neoplasm DOID_0060082 9.971E-04 0.01668677 0.04657514 0.27042096 HATADA_METHYLATED_IN_LUNG_CANCER_UP thoracic benign neoplasm DOID_0060097 9.971E-04 0.01668677 0.04657514 0.27042096 HATADA_METHYLATED_IN_LUNG_CANCER_UP benign breast phyllodes tumor DOID_1631 9.971E-04 0.01668677 0.04657514 0.27042096 HATADA_METHYLATED_IN_LUNG_CANCER_UP craniosynostosis DOID_2340 9.971E-04 0.01621 9.971E-04 0.02986053 HATADA_METHYLATED_IN_LUNG_CANCER_UP hyperinsulinism DOID_2018 1.052E-03 0.01663528 0.18089479 0.44947221 HATADA_METHYLATED_IN_LUNG_CANCER_UP learning disability DOID_8927 1.192E-03 0.01832556 1.192E-03 0.03390228 HATADA_METHYLATED_IN_LUNG_CANCER_UP Charcot-Marie-Tooth disease type 2 DOID_0050539 1.406E-03 0.02105374 1.406E-03 0.03636556 HATADA_METHYLATED_IN_LUNG_CANCER_UP osteogenesis imperfecta DOID_12347 1.406E-03 0.0205139 0.05480867 0.26206835 HATADA_METHYLATED_IN_LUNG_CANCER_UP major depressive disorder DOID_1470 1.406E-03 0.02000106 1.406E-03 0.03478445 HATADA_METHYLATED_IN_LUNG_CANCER_UP lung small cell carcinoma DOID_5409 1.503E-03 0.02086555 1.503E-03 0.03564531 HATADA_METHYLATED_IN_LUNG_CANCER_UP calcium metabolism disease DOID_10575 1.589E-03 0.02152276 0.0221876 0.18842906 HATADA_METHYLATED_IN_LUNG_CANCER_UP movement disease DOID_480 1.589E-03 0.02102223 1.589E-03 0.03615824 HATADA_METHYLATED_IN_LUNG_CANCER_UP orofacial cleft DOID_0050567 1.768E-03 0.02286304 0.0237768 0.19607247 HATADA_METHYLATED_IN_LUNG_CANCER_UP renovascular hypertension DOID_1591 1.882E-03 0.02379725 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP corneal dystrophy DOID_2566 1.882E-03 0.02327991 1.882E-03 0.03824557 HATADA_METHYLATED_IN_LUNG_CANCER_UP oral submucous fibrosis DOID_5773 1.882E-03 0.0227846 0.06297153 0.27992813 HATADA_METHYLATED_IN_LUNG_CANCER_UP panic disorder DOID_594 1.882E-03 0.02230992 1.882E-03 0.03692676 HATADA_METHYLATED_IN_LUNG_CANCER_UP smallpox DOID_8736 2.06E-03 0.02391859 2.06E-03 0.03780681 HATADA_METHYLATED_IN_LUNG_CANCER_UP long QT syndrome DOID_2843 2.145E-03 0.02440774 2.145E-03 0.0381371 HATADA_METHYLATED_IN_LUNG_CANCER_UP oral cavity cancer DOID_8618 2.38E-03 0.02655173 2.38E-03 0.0410345 HATADA_METHYLATED_IN_LUNG_CANCER_UP collagen disease DOID_854 2.729E-03 0.02986279 0.0314764 0.23259834 HATADA_METHYLATED_IN_LUNG_CANCER_UP conduct disorder DOID_12995 3.03E-03 0.03253407 3.03E-03 0.05071487 HATADA_METHYLATED_IN_LUNG_CANCER_UP infertility DOID_5223 3.03E-03 0.03193159 3.03E-03 0.04926588 HATADA_METHYLATED_IN_LUNG_CANCER_UP mineral metabolism disease DOID_0050032 3.108E-03 0.03215771 0.03423316 0.2497265 HATADA_METHYLATED_IN_LUNG_CANCER_UP uterine disease DOID_345 3.242E-03 0.03293725 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP pulmonary edema DOID_11396 3.358E-03 0.03351699 0.08307343 0.31938365 HATADA_METHYLATED_IN_LUNG_CANCER_UP temporal lobe epilepsy DOID_3328 3.378E-03 0.03314246 3.378E-03 0.05339618 HATADA_METHYLATED_IN_LUNG_CANCER_UP endocrine organ benign neoplasm DOID_0060089 3.662E-03 0.03531821 0.03804892 0.26402237 HATADA_METHYLATED_IN_LUNG_CANCER_UP funisitis DOID_0050698 4.059E-03 0.03849324 4.059E-03 0.06242148 HATADA_METHYLATED_IN_LUNG_CANCER_UP placenta disease DOID_780 4.059E-03 0.03786221 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP nephrosis DOID_2527 4.115E-03 0.03776076 0.04101223 0.27780903 HATADA_METHYLATED_IN_LUNG_CANCER_UP peripheral vascular disease DOID_341 4.273E-03 0.0385882 0.0420188 0.28127877 HATADA_METHYLATED_IN_LUNG_CANCER_UP pulmonary embolism DOID_9477 4.433E-03 0.03941248 0.09492822 0.33342072 HATADA_METHYLATED_IN_LUNG_CANCER_UP diabetic angiopathy DOID_11713 4.822E-03 0.04221421 0.09884587 0.34086847 HATADA_METHYLATED_IN_LUNG_CANCER_UP ureteral disease DOID_1426 4.822E-03 0.0415746 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP Goodpasture syndrome DOID_9808 4.822E-03 0.04095409 0.09884587 0.33881505 HATADA_METHYLATED_IN_LUNG_CANCER_UP bone resorption disease DOID_0080011 4.941E-03 0.04134484 0.04613644 0.27633298 HATADA_METHYLATED_IN_LUNG_CANCER_UP osteoporosis DOID_11476 4.941E-03 0.04134484 0.04613644 0.27633298 HATADA_METHYLATED_IN_LUNG_CANCER_UP mixed glioma DOID_5076 5.117E-03 0.04220032 0.04718821 0.26068048 HATADA_METHYLATED_IN_LUNG_CANCER_UP portal hypertension DOID_10762 5.646E-03 0.04589752 0.10663067 0.35481198 HATADA_METHYLATED_IN_LUNG_CANCER_UP hypogonadism DOID_1924 5.646E-03 0.04525107 5.646E-03 0.08032066 HATADA_METHYLATED_IN_LUNG_CANCER_UP female reproductive system disease DOID_229 5.669E-03 0.04480282 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP focal epilepsy DOID_2234 6.056E-03 0.04720495 6.056E-03 0.08404784 HATADA_METHYLATED_IN_LUNG_CANCER_UP intracranial aneurysm DOID_10941 6.53E-03 0.05021189 0.11434862 0.3614687 HATADA_METHYLATED_IN_LUNG_CANCER_UP seminoma DOID_4440 6.53E-03 0.0495424 6.53E-03 0.08641116 HATADA_METHYLATED_IN_LUNG_CANCER_UP periodontitis DOID_824 6.994E-03 0.05236376 0.11818271 0.35392612 HATADA_METHYLATED_IN_LUNG_CANCER_UP amino acid metabolic disorder DOID_9252 7.31E-03 0.05401868 7.31E-03 0.09453269 HATADA_METHYLATED_IN_LUNG_CANCER_UP renal hypertension DOID_1073 7.473E-03 0.05451116 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP secondary hypertension DOID_11130 7.473E-03 0.05451116 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP hepatic vascular disease DOID_272 7.473E-03 0.05382115 0.1220003 0.36155298 HATADA_METHYLATED_IN_LUNG_CANCER_UP multiple epiphyseal dysplasia DOID_12721 7.965E-03 0.05665347 7.965E-03 0.10071729 HATADA_METHYLATED_IN_LUNG_CANCER_UP lymphoblastic leukemia DOID_1037 8.225E-03 0.0577786 8.225E-03 0.10174057 HATADA_METHYLATED_IN_LUNG_CANCER_UP encephalomyelitis DOID_640 8.225E-03 0.05707398 8.225E-03 0.09957588 HATADA_METHYLATED_IN_LUNG_CANCER_UP female reproductive organ benign neoplasm DOID_0060086 8.472E-03 0.05808184 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP uterine benign neoplasm DOID_0060095 8.472E-03 0.05808184 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP corneal disease DOID_10124 8.472E-03 0.05739039 8.472E-03 0.10043318 HATADA_METHYLATED_IN_LUNG_CANCER_UP uterine fibroid DOID_13223 8.472E-03 0.05808184 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP gonadal disease DOID_2277 8.994E-03 0.06020401 8.994E-03 0.10443553 HATADA_METHYLATED_IN_LUNG_CANCER_UP abdominal aortic aneurysm DOID_7693 8.994E-03 0.05950397 0.1333548 0.36834408 HATADA_METHYLATED_IN_LUNG_CANCER_UP ulcerative colitis DOID_8577 9.46E-03 0.06186744 0.06993991 0.29478378 HATADA_METHYLATED_IN_LUNG_CANCER_UP Charcot-Marie-Tooth disease DOID_10595 9.529E-03 0.06161191 9.529E-03 0.10843697 HATADA_METHYLATED_IN_LUNG_CANCER_UP germinoma DOID_3304 9.529E-03 0.06091965 9.529E-03 0.10631075 HATADA_METHYLATED_IN_LUNG_CANCER_UP leiomyoma DOID_127 0.01007775 0.06371379 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP childhood absence epilepsy DOID_1825 0.01007775 0.06301364 0.01007775 0.11027388 HATADA_METHYLATED_IN_LUNG_CANCER_UP hepatitis C DOID_1883 0.01121686 0.06937383 0.01121686 0.11819246 HATADA_METHYLATED_IN_LUNG_CANCER_UP spindle cell carcinoma DOID_4015 0.01121686 0.06862788 0.01121686 0.1139713 HATADA_METHYLATED_IN_LUNG_CANCER_UP childhood electroclinical syndrome DOID_0050704 0.01180669 0.07146815 0.01180669 0.11785976 HATADA_METHYLATED_IN_LUNG_CANCER_UP adenoma DOID_657 0.01240987 0.07432859 0.01240987 0.12174511 HATADA_METHYLATED_IN_LUNG_CANCER_UP cleft palate DOID_674 0.01302628 0.07720782 0.15928424 0.40642481 HATADA_METHYLATED_IN_LUNG_CANCER_UP embryonal cancer DOID_688 0.01302628 0.07641187 0.01302628 0.12353252 HATADA_METHYLATED_IN_LUNG_CANCER_UP multiple myeloma DOID_9538 0.01302628 0.07563215 0.01302628 0.12150739 HATADA_METHYLATED_IN_LUNG_CANCER_UP congenital diaphragmatic hernia DOID_3827 0.01429827 0.08217893 1.000 1.000 HATADA_METHYLATED_IN_LUNG_CANCER_UP adenoid cystic carcinoma DOID_4866 0.01495361 0.08508602 0.01495361 0.13505717 HATADA_METHYLATED_IN_LUNG_CANCER_UP pulmonary emphysema DOID_9675 0.01562168 0.08800727 0.17375333 0.43940287 HATADA_METHYLATED_IN_LUNG_CANCER_UP salivary gland cancer DOID_8850 0.01630236 0.09094161 0.01630236 0.14493819 HATADA_METHYLATED_IN_LUNG_CANCER_UP nephrotic syndrome DOID_1184 0.01699554 0.09388797 0.18089479 0.45543866 SMID_BREAST_CANCER_BASAL_UP oral cavity cancer DOID_8618 1.202E-27 6.838E-25 3.449E-19 1.962E-16 SMID_BREAST_CANCER_BASAL_UP adenoid cystic carcinoma DOID_4866 1.891E-18 5.381E-16 1.891E-18 5.381E-16 SMID_BREAST_CANCER_BASAL_UP salivary gland cancer DOID_8850 3.959E-18 7.51E-16 3.959E-18 7.51E-16 SMID_BREAST_CANCER_BASAL_UP uterine cancer DOID_363 3.609E-16 5.133E-14 1.25E-08 1.016E-06 SMID_BREAST_CANCER_BASAL_UP aortic aneurysm DOID_3627 2.052E-15 2.335E-13 6.336E-07 3.004E-05 SMID_BREAST_CANCER_BASAL_UP biliary tract cancer DOID_4607 2.761E-15 2.619E-13 1.102E-07 6.966E-06 SMID_BREAST_CANCER_BASAL_UP aneurysm disease DOID_2403 2.217E-14 1.802E-12 9.674E-06 2.752E-04 SMID_BREAST_CANCER_BASAL_UP astrocytoma DOID_3069 1.474E-13 1.049E-11 0.03021163 0.1386324 SMID_BREAST_CANCER_BASAL_UP nephrosis DOID_2527 2.14E-13 1.353E-11 4.81E-07 2.488E-05 SMID_BREAST_CANCER_BASAL_UP rheumatic disease DOID_1575 4.14E-13 2.356E-11 0.06912695 0.24130818 SMID_BREAST_CANCER_BASAL_UP scleroderma DOID_419 4.14E-13 2.356E-11 0.06912695 0.24130818 SMID_BREAST_CANCER_BASAL_UP bile duct cancer DOID_4606 4.358E-13 2.255E-11 2.325E-05 5.513E-04 SMID_BREAST_CANCER_BASAL_UP bile duct carcinoma DOID_4897 4.358E-13 2.255E-11 2.325E-05 5.513E-04 SMID_BREAST_CANCER_BASAL_UP collagen disease DOID_854 8.013E-13 3.799E-11 0.12093033 0.33896235 SMID_BREAST_CANCER_BASAL_UP pre-malignant neoplasm DOID_0060071 1.181E-12 5.17E-11 2.884E-06 9.654E-05 SMID_BREAST_CANCER_BASAL_UP in situ carcinoma DOID_8719 1.181E-12 5.17E-11 2.884E-06 9.654E-05 SMID_BREAST_CANCER_BASAL_UP transitional cell carcinoma DOID_2671 2.937E-12 1.194E-10 2.172E-06 7.725E-05 SMID_BREAST_CANCER_BASAL_UP endocrine organ benign neoplasm DOID_0060089 2.946E-12 1.117E-10 5.545E-05 1.169E-03 SMID_BREAST_CANCER_BASAL_UP giant cell tumor DOID_200 4.251E-12 1.512E-10 0.01565333 0.08647324 SMID_BREAST_CANCER_BASAL_UP malignant giant cell tumor DOID_2705 4.251E-12 1.512E-10 0.01565333 0.08647324 SMID_BREAST_CANCER_BASAL_UP giant cell glioblastoma DOID_3074 4.251E-12 1.512E-10 0.01565333 0.08647324 SMID_BREAST_CANCER_BASAL_UP systemic scleroderma DOID_418 5.152E-12 1.724E-10 0.05890823 0.21907702 SMID_BREAST_CANCER_BASAL_UP bile duct adenocarcinoma DOID_4896 5.224E-12 1.651E-10 1.966E-04 3.728E-03 SMID_BREAST_CANCER_BASAL_UP cholangiocarcinoma DOID_4947 5.224E-12 1.651E-10 1.966E-04 3.728E-03 SMID_BREAST_CANCER_BASAL_UP pancreatic carcinoma DOID_4905 6.845E-12 2.05E-10 7.504E-04 9.93E-03 SMID_BREAST_CANCER_BASAL_UP diabetic retinopathy DOID_8947 6.845E-12 1.947E-10 5.712E-03 0.0445216 SMID_BREAST_CANCER_BASAL_UP vesiculobullous skin disease DOID_2731 9.731E-12 2.637E-10 1.049E-09 1.493E-07 SMID_BREAST_CANCER_BASAL_UP glioblastoma DOID_3068 1.145E-11 2.961E-10 0.01964316 0.10160869 SMID_BREAST_CANCER_BASAL_UP mixed glioma DOID_5076 1.286E-11 3.18E-10 0.03943246 0.1674408 SMID_BREAST_CANCER_BASAL_UP abdominal aortic aneurysm DOID_7693 1.583E-11 3.753E-10 2.496E-04 4.438E-03 SMID_BREAST_CANCER_BASAL_UP endometrial cancer DOID_1380 2.135E-11 4.86E-10 1.558E-05 4.03E-04 SMID_BREAST_CANCER_BASAL_UP retinal vascular disease DOID_2462 3.569E-11 7.811E-10 9.15E-03 0.06507598 SMID_BREAST_CANCER_BASAL_UP myocarditis DOID_820 3.77E-11 7.944E-10 2.079E-05 5.143E-04 SMID_BREAST_CANCER_BASAL_UP lung small cell carcinoma DOID_5409 5.098E-11 1.036E-09 1.268E-04 2.487E-03 SMID_BREAST_CANCER_BASAL_UP tongue cancer DOID_8649 6.332E-11 1.242E-09 9.621E-03 0.06517088 SMID_BREAST_CANCER_BASAL_UP pancreatic ductal carcinoma DOID_3587 8.817E-11 1.672E-09 6.242E-04 8.879E-03 SMID_BREAST_CANCER_BASAL_UP embryonal cancer DOID_688 1.059E-10 1.945E-09 1.896E-06 7.194E-05 SMID_BREAST_CANCER_BASAL_UP pulmonary emphysema DOID_9675 2.658E-10 4.726E-09 0.06394796 0.23029362 SMID_BREAST_CANCER_BASAL_UP neuroectodermal tumor DOID_171 4.419E-10 7.619E-09 3.067E-05 6.98E-04 SMID_BREAST_CANCER_BASAL_UP endometrial carcinoma DOID_2871 4.725E-10 7.907E-09 1.145E-05 3.102E-04 SMID_BREAST_CANCER_BASAL_UP gallbladder cancer DOID_3121 4.984E-10 8.102E-09 5.02E-06 1.503E-04 SMID_BREAST_CANCER_BASAL_UP epidermolysis bullosa DOID_2730 5.696E-10 9.002E-09 5.253E-08 3.736E-06 SMID_BREAST_CANCER_BASAL_UP thyroid adenoma DOID_2891 8.94E-10 1.375E-08 1.24E-03 0.01500805 SMID_BREAST_CANCER_BASAL_UP lymphoma DOID_0060058 1.436E-09 2.15E-08 0.05856701 0.22069291 SMID_BREAST_CANCER_BASAL_UP hypersensitivity reaction type I disease DOID_1205 2.018E-09 2.944E-08 3.121E-04 5.074E-03 SMID_BREAST_CANCER_BASAL_UP medullomyoblastoma DOID_3861 2.092E-09 2.976E-08 1.386E-06 6.065E-05 SMID_BREAST_CANCER_BASAL_UP adult medulloblastoma DOID_3864 2.092E-09 2.976E-08 1.386E-06 6.065E-05 SMID_BREAST_CANCER_BASAL_UP childhood medulloblastoma DOID_3869 2.092E-09 2.976E-08 1.386E-06 6.065E-05 SMID_BREAST_CANCER_BASAL_UP medulloblastoma DOID_3858 3.236E-09 4.492E-08 1.896E-06 7.708E-05 SMID_BREAST_CANCER_BASAL_UP multiple myeloma DOID_9538 3.236E-09 4.385E-08 0.31375517 0.58342056 SMID_BREAST_CANCER_BASAL_UP osteochondrodysplasia DOID_2256 3.558E-09 4.708E-08 3.558E-09 4.049E-07 SMID_BREAST_CANCER_BASAL_UP peptic ulcer DOID_750 4.887E-09 6.32E-08 0.05890823 0.21765445 SMID_BREAST_CANCER_BASAL_UP bone development disease DOID_0080006 8.609E-09 1.089E-07 8.609E-09 8.164E-07 SMID_BREAST_CANCER_BASAL_UP primitive neuroectodermal tumor DOID_168 1.046E-08 1.293E-07 4.414E-06 1.395E-04 SMID_BREAST_CANCER_BASAL_UP nervous system cancer DOID_3093 1.668E-08 2.019E-07 0.57961977 0.99338449 SMID_BREAST_CANCER_BASAL_UP myeloma DOID_0070004 2.083E-08 2.469E-07 0.37544348 0.68034185 SMID_BREAST_CANCER_BASAL_UP brain cancer DOID_1319 2.083E-08 2.418E-07 0.37544348 0.67818204 SMID_BREAST_CANCER_BASAL_UP heart valve disease DOID_4079 2.083E-08 2.37E-07 0.07987524 0.27214977 SMID_BREAST_CANCER_BASAL_UP central nervous system cancer DOID_3620 2.45E-08 2.733E-07 0.38129958 0.6844147 SMID_BREAST_CANCER_BASAL_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.525E-08 2.762E-07 2.133E-03 0.02476876 SMID_BREAST_CANCER_BASAL_UP mouth disease DOID_403 2.525E-08 2.71E-07 2.133E-03 0.02427338 SMID_BREAST_CANCER_BASAL_UP thyroid carcinoma DOID_3963 4.812E-08 5.071E-07 0.04696541 0.18819239 SMID_BREAST_CANCER_BASAL_UP sarcoidosis DOID_11335 5.248E-08 5.429E-07 0.01565333 0.08732102 SMID_BREAST_CANCER_BASAL_UP bone marrow cancer DOID_4960 6.055E-08 6.152E-07 0.41530397 0.72934555 SMID_BREAST_CANCER_BASAL_UP pustulosis of palm and sole DOID_4398 6.967E-08 6.954E-07 2.154E-03 0.02403011 SMID_BREAST_CANCER_BASAL_UP thyroid cancer DOID_1781 7.075E-08 6.941E-07 0.05162537 0.20399193 SMID_BREAST_CANCER_BASAL_UP hypersensitivity reaction type IV disease DOID_2916 1.045E-07 1.007E-06 0.01964316 0.10254088 SMID_BREAST_CANCER_BASAL_UP adult respiratory distress syndrome DOID_11394 1.435E-07 1.361E-06 6.993E-04 9.474E-03 SMID_BREAST_CANCER_BASAL_UP intracranial arterial disease DOID_13089 1.435E-07 1.339E-06 0.06141025 0.22398996 SMID_BREAST_CANCER_BASAL_UP cerebral arterial disease DOID_3527 1.435E-07 1.339E-06 0.06141025 0.22398996 SMID_BREAST_CANCER_BASAL_UP carotid artery disease DOID_3407 1.532E-07 1.406E-06 0.02228117 0.11319628 SMID_BREAST_CANCER_BASAL_UP respiratory failure DOID_11162 1.733E-07 1.565E-06 3.266E-03 0.03149458 SMID_BREAST_CANCER_BASAL_UP lung oat cell carcinoma DOID_5411 1.946E-07 1.73E-06 3.407E-04 5.386E-03 SMID_BREAST_CANCER_BASAL_UP middle cerebral artery infarction DOID_3525 2.046E-07 1.791E-06 0.02815576 0.13350524 SMID_BREAST_CANCER_BASAL_UP extrinsic allergic alveolitis DOID_841 2.046E-07 1.764E-06 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP uveal disease DOID_3480 2.327E-07 1.976E-06 9.178E-03 0.06368873 SMID_BREAST_CANCER_BASAL_UP lung adenocarcinoma DOID_3910 2.56E-07 2.142E-06 2.483E-03 0.02523324 SMID_BREAST_CANCER_BASAL_UP cerebral infarction DOID_3526 3.15E-07 2.598E-06 0.01031551 0.06905322 SMID_BREAST_CANCER_BASAL_UP sarcoma DOID_1115 3.175E-07 2.58E-06 0.24599265 0.494593 SMID_BREAST_CANCER_BASAL_UP coronary stenosis DOID_4248 3.175E-07 2.544E-06 0.03200864 0.14340877 SMID_BREAST_CANCER_BASAL_UP brain infarction DOID_3454 3.479E-07 2.749E-06 4.486E-03 0.03867552 SMID_BREAST_CANCER_BASAL_UP multiple epiphyseal dysplasia DOID_12721 3.905E-07 3.044E-06 3.905E-07 2.222E-05 SMID_BREAST_CANCER_BASAL_UP ulcerative colitis DOID_8577 4.501E-07 3.461E-06 0.01467276 0.08348798 SMID_BREAST_CANCER_BASAL_UP B-cell lymphocytic neoplasm DOID_707 7.221E-07 5.479E-06 0.0911003 0.29790845 SMID_BREAST_CANCER_BASAL_UP granulosa cell tumor DOID_2999 7.307E-07 5.471E-06 0.16372485 0.41220992 SMID_BREAST_CANCER_BASAL_UP esophagitis DOID_11963 9.668E-07 7.144E-06 0.17155969 0.42076493 SMID_BREAST_CANCER_BASAL_UP sex cord-gonadal stromal tumor DOID_192 9.668E-07 7.053E-06 0.17155969 0.41716865 SMID_BREAST_CANCER_BASAL_UP brain edema DOID_4724 9.668E-07 6.963E-06 0.01486293 0.08373276 SMID_BREAST_CANCER_BASAL_UP papilloma DOID_2615 9.932E-07 7.064E-06 4.624E-03 0.03926928 SMID_BREAST_CANCER_BASAL_UP contact dermatitis DOID_2773 1.066E-06 7.487E-06 1.244E-04 2.527E-03 SMID_BREAST_CANCER_BASAL_UP esophageal disease DOID_6050 1.176E-06 8.161E-06 0.29409026 0.55593807 SMID_BREAST_CANCER_BASAL_UP coronary restenosis DOID_4247 1.259E-06 8.632E-06 0.17932133 0.42337692 SMID_BREAST_CANCER_BASAL_UP pulmonary sarcoidosis DOID_13406 1.896E-06 1.285E-05 6.225E-03 0.04786383 SMID_BREAST_CANCER_BASAL_UP muscle cancer DOID_4045 2.05E-06 1.373E-05 0.19462774 0.44297274 SMID_BREAST_CANCER_BASAL_UP uveitis DOID_13141 2.204E-06 1.458E-05 0.0564428 0.21410637 SMID_BREAST_CANCER_BASAL_UP amino acid metabolic disorder DOID_9252 2.362E-06 1.545E-05 2.207E-04 4.05E-03 SMID_BREAST_CANCER_BASAL_UP hepatitis DOID_2237 2.551E-06 1.65E-05 0.05890823 0.22051832 SMID_BREAST_CANCER_BASAL_UP congenital diaphragmatic hernia DOID_3827 2.551E-06 1.631E-05 6.39E-04 8.867E-03 SMID_BREAST_CANCER_BASAL_UP aortic valve disease DOID_62 2.57E-06 1.625E-05 0.20217385 0.44587954 SMID_BREAST_CANCER_BASAL_UP benign mesothelioma DOID_2645 3.379E-06 2.113E-05 0.33912785 0.6224637 SMID_BREAST_CANCER_BASAL_UP common cold DOID_10459 3.527E-06 2.181E-05 5.424E-03 0.04408792 SMID_BREAST_CANCER_BASAL_UP cerebral degeneration DOID_1443 3.533E-06 2.162E-05 3.843E-03 0.0336424 SMID_BREAST_CANCER_BASAL_UP uterine disease DOID_345 3.533E-06 2.139E-05 0.02608381 0.12905816 SMID_BREAST_CANCER_BASAL_UP dilated cardiomyopathy DOID_12930 3.826E-06 2.292E-05 0.01324869 0.07852608 SMID_BREAST_CANCER_BASAL_UP autoimmune disease of urogenital tract DOID_0060049 3.869E-06 2.293E-05 0.06652049 0.2380513 SMID_BREAST_CANCER_BASAL_UP primary biliary cirrhosis DOID_12236 3.869E-06 2.293E-05 0.06652049 0.2380513 SMID_BREAST_CANCER_BASAL_UP allergic contact dermatitis DOID_3042 4.3E-06 2.522E-05 5.116E-05 1.12E-03 SMID_BREAST_CANCER_BASAL_UP vulva cancer DOID_1245 5.056E-06 2.936E-05 6.37E-03 0.04833074 SMID_BREAST_CANCER_BASAL_UP larynx cancer DOID_2596 5.056E-06 2.906E-05 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP laryngeal benign neoplasm DOID_2598 5.056E-06 2.906E-05 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP diffuse large B-cell lymphoma DOID_0050745 6.91E-06 3.932E-05 0.03005742 0.14018583 SMID_BREAST_CANCER_BASAL_UP gestational diabetes DOID_11714 6.91E-06 3.893E-05 2.483E-03 0.02569203 SMID_BREAST_CANCER_BASAL_UP neuritis DOID_1803 7.256E-06 4.048E-05 0.0115308 0.07131546 SMID_BREAST_CANCER_BASAL_UP invasive ductal carcinoma DOID_3008 8.228E-06 4.546E-05 0.03200864 0.14454694 SMID_BREAST_CANCER_BASAL_UP thoracic aortic aneurysm DOID_14004 9.511E-06 5.204E-05 8.47E-03 0.06100862 SMID_BREAST_CANCER_BASAL_UP mesenchymal cell neoplasm DOID_3350 9.511E-06 5.154E-05 0.13163966 0.35668079 SMID_BREAST_CANCER_BASAL_UP spindle cell sarcoma DOID_4235 9.511E-06 5.154E-05 0.13163966 0.35668079 SMID_BREAST_CANCER_BASAL_UP epithelioid sarcoma DOID_6193 9.511E-06 5.154E-05 0.13163966 0.35668079 SMID_BREAST_CANCER_BASAL_UP hyperhomocysteinemia DOID_9279 9.511E-06 5.105E-05 3.407E-04 5.102E-03 SMID_BREAST_CANCER_BASAL_UP bacterial pneumonia DOID_874 1.052E-05 5.593E-05 0.17252754 0.4142117 SMID_BREAST_CANCER_BASAL_UP female reproductive system disease DOID_229 1.342E-05 7.07E-05 0.04321687 0.17819128 SMID_BREAST_CANCER_BASAL_UP germinoma DOID_3304 1.558E-05 8.133E-05 0.27386348 0.52823158 SMID_BREAST_CANCER_BASAL_UP reproductive organ benign neoplasm DOID_0050622 1.736E-05 8.978E-05 0.01718838 0.09404029 SMID_BREAST_CANCER_BASAL_UP integumentary system cancer DOID_0060122 1.736E-05 8.897E-05 0.01718838 0.09314467 SMID_BREAST_CANCER_BASAL_UP skin cancer DOID_4159 1.736E-05 8.897E-05 0.01718838 0.09314467 SMID_BREAST_CANCER_BASAL_UP pleural disease DOID_1532 1.804E-05 9.164E-05 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP bladder disease DOID_365 1.804E-05 9.083E-05 0.0424706 0.1763925 SMID_BREAST_CANCER_BASAL_UP prion disease DOID_649 2.085E-05 1.041E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP primary bacterial infectious disease DOID_0050338 2.123E-05 1.05E-04 0.56755656 0.97564858 SMID_BREAST_CANCER_BASAL_UP hypertrophic cardiomyopathy DOID_11984 2.325E-05 1.141E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP nephroblastoma DOID_2154 2.385E-05 1.16E-04 0.04696541 0.18952709 SMID_BREAST_CANCER_BASAL_UP spindle cell carcinoma DOID_4015 2.385E-05 1.15E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP hyperthyroidism DOID_7998 2.385E-05 1.14E-04 3.911E-04 5.707E-03 SMID_BREAST_CANCER_BASAL_UP Down syndrome DOID_14250 2.622E-05 1.243E-04 0.0134591 0.07895079 SMID_BREAST_CANCER_BASAL_UP testicular cancer DOID_2998 2.622E-05 1.233E-04 0.0134591 0.07735583 SMID_BREAST_CANCER_BASAL_UP Human immunodeficiency virus infectious disease DOID_526 2.635E-05 1.229E-04 0.01107716 0.0692627 SMID_BREAST_CANCER_BASAL_UP lymphoblastic leukemia DOID_1037 3.245E-05 1.501E-04 0.06007408 0.22053002 SMID_BREAST_CANCER_BASAL_UP encephalomyelitis DOID_640 3.245E-05 1.489E-04 0.2234597 0.47443497 SMID_BREAST_CANCER_BASAL_UP Crohn's disease DOID_8778 3.473E-05 1.581E-04 0.22690354 0.4729235 SMID_BREAST_CANCER_BASAL_UP congenital heart defect DOID_1682 3.659E-05 1.652E-04 3.451E-03 0.03219153 SMID_BREAST_CANCER_BASAL_UP gastric ulcer DOID_10808 4.839E-05 2.168E-04 0.18701046 0.43789691 SMID_BREAST_CANCER_BASAL_UP hepatitis B DOID_2043 4.839E-05 2.151E-04 0.18701046 0.43610225 SMID_BREAST_CANCER_BASAL_UP cervix uteri carcinoma in situ DOID_8991 5.632E-05 2.484E-04 0.06394796 0.23176046 SMID_BREAST_CANCER_BASAL_UP endometriosis of uterus DOID_288 6.288E-05 2.752E-04 0.06652049 0.23509414 SMID_BREAST_CANCER_BASAL_UP Lewy body dementia DOID_12217 6.927E-05 3.009E-04 0.02106713 0.10799275 SMID_BREAST_CANCER_BASAL_UP Goodpasture syndrome DOID_9808 6.927E-05 2.986E-04 0.20217385 0.444158 SMID_BREAST_CANCER_BASAL_UP nephrotic syndrome DOID_1184 7E-05 2.995E-04 9.178E-03 0.06447502 SMID_BREAST_CANCER_BASAL_UP endometriosis DOID_289 7E-05 2.973E-04 0.06912695 0.23983679 SMID_BREAST_CANCER_BASAL_UP chondrosarcoma DOID_3371 9.305E-05 3.922E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP cystic fibrosis DOID_1485 9.413E-05 3.938E-04 0.16588396 0.41217457 SMID_BREAST_CANCER_BASAL_UP leukodystrophy DOID_10579 9.517E-05 3.953E-04 0.01091333 0.06977173 SMID_BREAST_CANCER_BASAL_UP proteinuria DOID_576 9.517E-05 3.924E-04 0.36953212 0.67176925 SMID_BREAST_CANCER_BASAL_UP portal hypertension DOID_10762 9.602E-05 3.931E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP pre-eclampsia DOID_10591 1.049E-04 4.265E-04 0.07987524 0.27378922 SMID_BREAST_CANCER_BASAL_UP cystitis DOID_1679 1.119E-04 4.515E-04 0.22439177 0.47464281 SMID_BREAST_CANCER_BASAL_UP myositis DOID_633 1.119E-04 4.484E-04 0.02630478 0.12792664 SMID_BREAST_CANCER_BASAL_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.268E-04 5.044E-04 0.01282507 0.07681541 SMID_BREAST_CANCER_BASAL_UP glaucoma DOID_1686 1.268E-04 5.009E-04 0.38710092 0.68831382 SMID_BREAST_CANCER_BASAL_UP familial adenomatous polyposis DOID_0050424 1.271E-04 4.986E-04 0.09832706 0.31431516 SMID_BREAST_CANCER_BASAL_UP breast benign neoplasm DOID_0060082 1.271E-04 4.952E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP thoracic benign neoplasm DOID_0060097 1.271E-04 4.952E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP temporal arteritis DOID_13375 1.271E-04 4.918E-04 0.09832706 0.30740713 SMID_BREAST_CANCER_BASAL_UP benign breast phyllodes tumor DOID_1631 1.271E-04 4.952E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP central nervous system vasculitis DOID_525 1.271E-04 4.918E-04 0.09832706 0.30740713 SMID_BREAST_CANCER_BASAL_UP seminoma DOID_4440 1.296E-04 4.982E-04 0.23165977 0.47586429 SMID_BREAST_CANCER_BASAL_UP auditory system disease DOID_2742 1.421E-04 5.428E-04 1.18E-03 0.01491975 SMID_BREAST_CANCER_BASAL_UP chronic kidney failure DOID_784 1.517E-04 5.756E-04 0.55093365 0.94994318 SMID_BREAST_CANCER_BASAL_UP atopic dermatitis DOID_3310 1.658E-04 6.249E-04 0.09397517 0.30381747 SMID_BREAST_CANCER_BASAL_UP aortic valve stenosis DOID_1712 1.682E-04 6.298E-04 0.10677281 0.31975647 SMID_BREAST_CANCER_BASAL_UP aortic valve insufficiency DOID_57 1.682E-04 6.256E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP pleurisy DOID_10247 1.709E-04 6.314E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP hepatic vascular disease DOID_272 1.709E-04 6.274E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP supratentorial cancer DOID_1659 1.948E-04 7.104E-04 0.2530588 0.50170891 SMID_BREAST_CANCER_BASAL_UP cerebrum cancer DOID_368 1.948E-04 7.104E-04 0.2530588 0.50170891 SMID_BREAST_CANCER_BASAL_UP focal glomerulosclerosis DOID_3945 1.948E-04 7.059E-04 0.2530588 0.49823687 SMID_BREAST_CANCER_BASAL_UP vasculitis DOID_865 1.966E-04 7.079E-04 0.09980199 0.30530825 SMID_BREAST_CANCER_BASAL_UP parasitic protozoa infectious disease DOID_2789 2.135E-04 7.64E-04 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP bronchiolitis obliterans DOID_2799 2.496E-04 8.876E-04 0.2669936 0.5184961 SMID_BREAST_CANCER_BASAL_UP congenital nervous system abnormality DOID_2490 2.506E-04 8.857E-04 2.506E-04 4.321E-03 SMID_BREAST_CANCER_BASAL_UP congenital structural myopathy DOID_422 2.745E-04 9.641E-04 2.745E-04 4.594E-03 SMID_BREAST_CANCER_BASAL_UP allergic rhinitis DOID_4481 2.808E-04 9.802E-04 0.27386348 0.52644702 SMID_BREAST_CANCER_BASAL_UP leiomyoma DOID_127 3.147E-04 1.092E-03 0.0424706 0.17768951 SMID_BREAST_CANCER_BASAL_UP autonomic nervous system neoplasm DOID_2621 3.147E-04 1.085E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP neuroblastoma DOID_769 3.147E-04 1.085E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP skeletal system cancer DOID_0060124 3.407E-04 1.168E-03 8.47E-03 0.06259326 SMID_BREAST_CANCER_BASAL_UP bone cancer DOID_184 3.407E-04 1.168E-03 8.47E-03 0.06259326 SMID_BREAST_CANCER_BASAL_UP oral submucous fibrosis DOID_5773 3.407E-04 1.161E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP panic disorder DOID_594 3.407E-04 1.154E-03 3.407E-04 5.24E-03 SMID_BREAST_CANCER_BASAL_UP hair disease DOID_421 3.514E-04 1.183E-03 4.624E-03 0.03869179 SMID_BREAST_CANCER_BASAL_UP hepatitis C DOID_1883 3.911E-04 1.309E-03 0.04696541 0.19088086 SMID_BREAST_CANCER_BASAL_UP angiosarcoma DOID_0001816 4.165E-04 1.386E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP Barrett's esophagus DOID_9206 4.165E-04 1.378E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP mineral metabolism disease DOID_0050032 4.201E-04 1.382E-03 0.02510261 0.12529283 SMID_BREAST_CANCER_BASAL_UP lymphoid leukemia DOID_10747 4.34E-04 1.419E-03 5.389E-03 0.04443657 SMID_BREAST_CANCER_BASAL_UP cholestasis DOID_13580 4.5E-04 1.463E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP parasitic infectious disease DOID_1398 4.5E-04 1.455E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP adenoma DOID_657 4.8E-04 1.543E-03 0.05162537 0.20258509 SMID_BREAST_CANCER_BASAL_UP hyperglycemia DOID_4195 4.815E-04 1.539E-03 0.13662752 0.36327599 SMID_BREAST_CANCER_BASAL_UP basal cell carcinoma DOID_2513 5.022E-04 1.596E-03 0.01083685 0.07007008 SMID_BREAST_CANCER_BASAL_UP bronchitis DOID_6132 5.022E-04 1.588E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP cleft palate DOID_674 5.294E-04 1.664E-03 0.05401488 0.2076653 SMID_BREAST_CANCER_BASAL_UP tuberculosis DOID_399 5.493E-04 1.717E-03 0.48757421 0.85101143 SMID_BREAST_CANCER_BASAL_UP peripheral nervous system neoplasm DOID_1192 5.824E-04 1.811E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP keratosis DOID_161 5.985E-04 1.851E-03 0.01211664 0.07413302 SMID_BREAST_CANCER_BASAL_UP skin carcinoma DOID_3451 5.985E-04 1.841E-03 0.01211664 0.07334437 SMID_BREAST_CANCER_BASAL_UP respiratory syncytial virus infectious disease DOID_1273 6.39E-04 1.955E-03 0.32656066 0.603289 SMID_BREAST_CANCER_BASAL_UP bile duct disease DOID_4138 6.643E-04 2.021E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP peripheral vascular disease DOID_341 7.064E-04 2.138E-03 0.03351957 0.14900497 SMID_BREAST_CANCER_BASAL_UP biliary tract disease DOID_9741 7.064E-04 2.127E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP subependymal glioma DOID_4843 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP pilocytic astrocytoma DOID_4851 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP subependymal giant cell astrocytoma DOID_5077 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP fibrillary astrocytoma DOID_6726 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP juvenile pilocytic astrocytoma DOID_6811 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP childhood pilocytic astrocytoma DOID_6812 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP gemistocytic astrocytoma DOID_7005 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP childhood cerebral astrocytoma DOID_7007 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP protoplasmic astrocytoma DOID_7008 8.246E-04 2.469E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP Huntington's disease DOID_12858 9.046E-04 2.695E-03 0.06912695 0.24279773 SMID_BREAST_CANCER_BASAL_UP pancreatitis DOID_4989 9.472E-04 2.807E-03 0.52925626 0.91813053 SMID_BREAST_CANCER_BASAL_UP autoimmune hepatitis DOID_2048 9.554E-04 2.817E-03 0.17932133 0.42514099 SMID_BREAST_CANCER_BASAL_UP metabolic syndrome X DOID_14221 1.059E-03 3.106E-03 0.53804969 0.93054795 SMID_BREAST_CANCER_BASAL_UP cataract DOID_83 1.063E-03 3.101E-03 1.063E-03 0.01374501 SMID_BREAST_CANCER_BASAL_UP learning disability DOID_8927 1.063E-03 3.086E-03 0.07443827 0.25669925 SMID_BREAST_CANCER_BASAL_UP benign glioma DOID_0060101 1.099E-03 3.173E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP benign ependymoma DOID_4844 1.099E-03 3.173E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP spinocerebellar degeneration DOID_2478 1.149E-03 3.302E-03 0.01091333 0.06899649 SMID_BREAST_CANCER_BASAL_UP lens disease DOID_110 1.24E-03 3.545E-03 1.24E-03 0.01533432 SMID_BREAST_CANCER_BASAL_UP vascular skin disease DOID_9540 1.24E-03 3.527E-03 0.07987524 0.27052983 SMID_BREAST_CANCER_BASAL_UP sinusitis DOID_0050127 1.255E-03 3.552E-03 0.19462774 0.4465451 SMID_BREAST_CANCER_BASAL_UP paranasal sinus disease DOID_1352 1.255E-03 3.552E-03 0.19462774 0.4465451 SMID_BREAST_CANCER_BASAL_UP uremia DOID_4676 1.255E-03 3.534E-03 0.19462774 0.43945708 SMID_BREAST_CANCER_BASAL_UP meningitis DOID_9471 1.424E-03 3.991E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP integumentary system benign neoplasm DOID_0060121 1.436E-03 4.006E-03 0.38710092 0.69047154 SMID_BREAST_CANCER_BASAL_UP pulmonary tuberculosis DOID_2957 1.436E-03 3.986E-03 0.38710092 0.68616954 SMID_BREAST_CANCER_BASAL_UP skin benign neoplasm DOID_3165 1.436E-03 4.006E-03 0.38710092 0.69047154 SMID_BREAST_CANCER_BASAL_UP calcium metabolism disease DOID_10575 1.542E-03 4.259E-03 0.08825211 0.29713283 SMID_BREAST_CANCER_BASAL_UP primary immunodeficiency disease DOID_612 1.685E-03 4.633E-03 0.01067246 0.07061195 SMID_BREAST_CANCER_BASAL_UP orofacial cleft DOID_0050567 1.77E-03 4.841E-03 0.09397517 0.30555357 SMID_BREAST_CANCER_BASAL_UP osteosarcoma DOID_3347 1.804E-03 4.912E-03 0.21705521 0.46430232 SMID_BREAST_CANCER_BASAL_UP autosomal dominant nonsyndromic deafness DOID_0050564 2.016E-03 5.461E-03 2.016E-03 0.02389348 SMID_BREAST_CANCER_BASAL_UP papillary adenoma DOID_3172 2.016E-03 5.435E-03 0.02630478 0.12902946 SMID_BREAST_CANCER_BASAL_UP microcystic adenoma DOID_5403 2.016E-03 5.435E-03 0.02630478 0.12902946 SMID_BREAST_CANCER_BASAL_UP follicular adenoma DOID_6204 2.016E-03 5.435E-03 0.02630478 0.12902946 SMID_BREAST_CANCER_BASAL_UP ankylosing spondylitis DOID_7147 2.016E-03 5.41E-03 0.02630478 0.12684252 SMID_BREAST_CANCER_BASAL_UP smallpox DOID_8736 2.154E-03 5.754E-03 2.154E-03 0.02356799 SMID_BREAST_CANCER_BASAL_UP intracranial aneurysm DOID_10941 2.242E-03 5.961E-03 2.242E-03 0.02406916 SMID_BREAST_CANCER_BASAL_UP B cell deficiency DOID_2115 2.242E-03 5.933E-03 2.242E-03 0.02362344 SMID_BREAST_CANCER_BASAL_UP perinatal necrotizing enterocolitis DOID_8677 2.483E-03 6.542E-03 0.03005742 0.13904611 SMID_BREAST_CANCER_BASAL_UP renal hypertension DOID_1073 2.74E-03 7.186E-03 0.24599265 0.49634688 SMID_BREAST_CANCER_BASAL_UP secondary hypertension DOID_11130 2.74E-03 7.186E-03 0.24599265 0.49634688 SMID_BREAST_CANCER_BASAL_UP mononeuritis DOID_1802 2.74E-03 7.153E-03 0.03200864 0.14570331 SMID_BREAST_CANCER_BASAL_UP leukocyte disease DOID_9500 2.75E-03 7.146E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP mononeuropathy DOID_1188 3.013E-03 7.793E-03 0.03400833 0.15000573 SMID_BREAST_CANCER_BASAL_UP cranial nerve disease DOID_5656 3.013E-03 7.758E-03 3.013E-03 0.03007813 SMID_BREAST_CANCER_BASAL_UP arrhythmogenic right ventricular dysplasia DOID_0050431 3.014E-03 7.725E-03 3.014E-03 0.02956731 SMID_BREAST_CANCER_BASAL_UP hypothyroidism DOID_1459 3.266E-03 8.333E-03 3.266E-03 0.03096967 SMID_BREAST_CANCER_BASAL_UP female reproductive organ benign neoplasm DOID_0060086 3.302E-03 8.388E-03 0.03605542 0.15781181 SMID_BREAST_CANCER_BASAL_UP uterine benign neoplasm DOID_0060095 3.302E-03 8.388E-03 0.03605542 0.15781181 SMID_BREAST_CANCER_BASAL_UP corneal disease DOID_10124 3.302E-03 8.35E-03 0.03605542 0.15660714 SMID_BREAST_CANCER_BASAL_UP uterine fibroid DOID_13223 3.302E-03 8.388E-03 0.03605542 0.15781181 SMID_BREAST_CANCER_BASAL_UP spastic cerebral palsy DOID_0050669 3.607E-03 9.082E-03 0.03814886 0.16444469 SMID_BREAST_CANCER_BASAL_UP interstitial nephritis DOID_1063 3.744E-03 9.385E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP facioscapulohumeral muscular dystrophy DOID_11727 3.744E-03 9.344E-03 3.744E-03 0.03436119 SMID_BREAST_CANCER_BASAL_UP ventricular septal defect DOID_1657 3.744E-03 9.303E-03 3.744E-03 0.03381577 SMID_BREAST_CANCER_BASAL_UP rectal neoplasm DOID_1984 3.744E-03 9.263E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP rectum cancer DOID_1993 3.744E-03 9.263E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP acute kidney failure DOID_3021 3.744E-03 9.222E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP insulinoma DOID_3892 3.744E-03 9.183E-03 0.08980168 0.30057152 SMID_BREAST_CANCER_BASAL_UP conjunctival disease DOID_4251 3.744E-03 9.143E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP keratitis DOID_4677 3.744E-03 9.104E-03 0.08980168 0.2970765 SMID_BREAST_CANCER_BASAL_UP Paget's disease of bone DOID_5408 3.744E-03 9.066E-03 3.744E-03 0.0332874 SMID_BREAST_CANCER_BASAL_UP conjunctivitis DOID_6195 3.744E-03 9.143E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP cutaneous leishmaniasis DOID_9111 3.744E-03 9.027E-03 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 4.548E-03 0.01091877 0.09832706 0.31255921 SMID_BREAST_CANCER_BASAL_UP bronchiectasis DOID_9563 4.548E-03 0.0108729 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP beta thalassemia DOID_12241 5.424E-03 0.01291278 5.424E-03 0.04346697 SMID_BREAST_CANCER_BASAL_UP pituitary cancer DOID_1785 5.424E-03 0.01285898 5.424E-03 0.04286326 SMID_BREAST_CANCER_BASAL_UP islet cell tumor DOID_1799 5.424E-03 0.01280562 0.10677281 0.31808235 SMID_BREAST_CANCER_BASAL_UP relapsing-remitting multiple sclerosis DOID_2378 5.424E-03 0.0127527 0.10677281 0.31642568 SMID_BREAST_CANCER_BASAL_UP pituitary carcinoma DOID_4916 5.424E-03 0.01285898 5.424E-03 0.04286326 SMID_BREAST_CANCER_BASAL_UP refractive error DOID_9835 5.798E-03 0.01357561 0.05162537 0.20119752 SMID_BREAST_CANCER_BASAL_UP adolescence-adult electroclinical syndrome DOID_0050705 6.225E-03 0.01451608 0.05401488 0.20907799 SMID_BREAST_CANCER_BASAL_UP calcinosis DOID_182 6.225E-03 0.01445683 0.31375517 0.58533341 SMID_BREAST_CANCER_BASAL_UP carotid stenosis DOID_13001 6.37E-03 0.01473498 0.11513967 0.32921846 SMID_BREAST_CANCER_BASAL_UP epilepsy with generalized tonic-clonic seizures DOID_7725 6.37E-03 0.01467532 6.37E-03 0.04769481 SMID_BREAST_CANCER_BASAL_UP electroclinical syndrome DOID_0050701 6.84E-03 0.01569253 0.03943246 0.16869975 SMID_BREAST_CANCER_BASAL_UP open-angle glaucoma DOID_1067 7.386E-03 0.01687915 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP tethered spinal cord syndrome DOID_1089 7.386E-03 0.01681163 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP eyelid disease DOID_530 7.386E-03 0.01674465 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP polycystic kidney disease DOID_898 7.386E-03 0.01667821 0.12342838 0.33927897 SMID_BREAST_CANCER_BASAL_UP bacterial meningitis DOID_9470 7.386E-03 0.01661228 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP chromosomal disease DOID_0080014 7.776E-03 0.01741887 0.18257179 0.42927004 SMID_BREAST_CANCER_BASAL_UP idiopathic pulmonary fibrosis DOID_0050156 8.47E-03 0.01890071 0.13163966 0.36011042 SMID_BREAST_CANCER_BASAL_UP thalassemia DOID_10241 8.47E-03 0.01882688 8.47E-03 0.06179079 SMID_BREAST_CANCER_BASAL_UP renovascular hypertension DOID_1591 8.47E-03 0.01875362 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP membranoproliferative glomerulonephritis DOID_2920 8.47E-03 0.01868094 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP arthropathy DOID_381 8.47E-03 0.01860881 0.13163966 0.35499036 SMID_BREAST_CANCER_BASAL_UP intermediate coronary syndrome DOID_8805 8.47E-03 0.01853724 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP spinocerebellar ataxia DOID_1441 8.639E-03 0.01883313 0.06652049 0.23656348 SMID_BREAST_CANCER_BASAL_UP spastic diplegia DOID_10965 9.621E-03 0.02089448 0.13977424 0.36991414 SMID_BREAST_CANCER_BASAL_UP pituitary adenoma DOID_3829 9.621E-03 0.02081503 9.621E-03 0.06595607 SMID_BREAST_CANCER_BASAL_UP restrictive cardiomyopathy DOID_397 9.621E-03 0.02073619 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP chronic myeloid leukemia DOID_8552 9.621E-03 0.02065794 0.13977424 0.3665048 SMID_BREAST_CANCER_BASAL_UP influenza DOID_8469 9.737E-03 0.02082886 0.35754149 0.65205483 SMID_BREAST_CANCER_BASAL_UP lymphatic system cancer DOID_0060073 0.01083685 0.02309426 0.14783282 0.38585723 SMID_BREAST_CANCER_BASAL_UP drug-induced mental disorder DOID_1203 0.01083685 0.02300809 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP drug psychosis DOID_1742 0.01083685 0.02300809 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP hyperostosis DOID_205 0.01083685 0.02292255 0.01083685 0.07087548 SMID_BREAST_CANCER_BASAL_UP urinary system benign neoplasm DOID_731 0.01083685 0.02283766 0.14783282 0.38234944 SMID_BREAST_CANCER_BASAL_UP reticulosarcoma DOID_8538 0.01083685 0.02309426 0.14783282 0.38585723 SMID_BREAST_CANCER_BASAL_UP substance-induced psychosis DOID_8646 0.01083685 0.02300809 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP lymphosarcoma DOID_8675 0.01083685 0.02309426 0.14783282 0.38585723 SMID_BREAST_CANCER_BASAL_UP male reproductive organ benign neoplasm DOID_0060087 0.01211664 0.02544048 0.15581613 0.40117365 SMID_BREAST_CANCER_BASAL_UP neuroendocrine tumor DOID_169 0.01211664 0.02534695 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP eosinophilia DOID_999 0.01211664 0.0252541 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP heart septal defect DOID_1681 0.0134591 0.02794973 0.0134591 0.07814517 SMID_BREAST_CANCER_BASAL_UP infertility DOID_5223 0.0134591 0.0278481 0.16372485 0.41039401 SMID_BREAST_CANCER_BASAL_UP leishmaniasis DOID_9065 0.0134591 0.0277472 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP withdrawal disorder DOID_0060001 0.01419905 0.029167 0.0911003 0.29963047 SMID_BREAST_CANCER_BASAL_UP amnestic disorder DOID_10914 0.01486293 0.03042089 0.17155969 0.42258642 SMID_BREAST_CANCER_BASAL_UP colon carcinoma DOID_1520 0.01486293 0.03031186 0.17155969 0.41895907 SMID_BREAST_CANCER_BASAL_UP atrophic muscular disease DOID_913 0.01565333 0.0318098 0.09687598 0.31142619 SMID_BREAST_CANCER_BASAL_UP muscular dystrophy DOID_9884 0.01565333 0.0318098 0.09687598 0.31142619 SMID_BREAST_CANCER_BASAL_UP Kawasaki disease DOID_13378 0.01632689 0.03306049 0.17932133 0.42691982 SMID_BREAST_CANCER_BASAL_UP lymphadenitis DOID_1602 0.01632689 0.03306049 0.17932133 0.42691982 SMID_BREAST_CANCER_BASAL_UP lymph node disease DOID_9942 0.01632689 0.03306049 0.17932133 0.42691982 SMID_BREAST_CANCER_BASAL_UP funisitis DOID_0050698 0.01784972 0.03601592 0.01784972 0.09581593 SMID_BREAST_CANCER_BASAL_UP placenta disease DOID_780 0.01784972 0.03588865 0.18701046 0.4325567 SMID_BREAST_CANCER_BASAL_UP optic nerve disease DOID_1891 0.0194302 0.03892881 0.0194302 0.10332507 SMID_BREAST_CANCER_BASAL_UP myasthenia gravis DOID_437 0.0194302 0.03879222 0.19462774 0.4412079 SMID_BREAST_CANCER_BASAL_UP urinary tract obstruction DOID_5200 0.0194302 0.03865658 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP pulmonary embolism DOID_9477 0.0194302 0.03852189 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP polyarteritis nodosa DOID_9810 0.0194302 0.03838814 0.19462774 0.43772009 SMID_BREAST_CANCER_BASAL_UP lingual-facial-buccal dyskinesia DOID_9854 0.0194302 0.0382553 0.19462774 0.43599679 SMID_BREAST_CANCER_BASAL_UP nonsyndromic deafness DOID_0050563 0.01964316 0.03854123 0.01964316 0.10349034 SMID_BREAST_CANCER_BASAL_UP melancholia DOID_2848 0.02050211 0.04008833 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP diabetic angiopathy DOID_11713 0.02106713 0.04105204 0.20217385 0.45112519 SMID_BREAST_CANCER_BASAL_UP neurotic disorder DOID_4964 0.02138145 0.04152233 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP spastic quadriplegia DOID_10970 0.02275931 0.04404778 0.02275931 0.11460219 SMID_BREAST_CANCER_BASAL_UP toxic shock syndrome DOID_14115 0.02275931 0.04389847 0.20964946 0.45880978 SMID_BREAST_CANCER_BASAL_UP acute pancreatitis DOID_2913 0.02275931 0.04375016 0.20964946 0.45705189 SMID_BREAST_CANCER_BASAL_UP severe combined immunodeficiency DOID_627 0.02275931 0.04360285 0.20964946 0.45530741 SMID_BREAST_CANCER_BASAL_UP commensal bacterial infectious disease DOID_0050339 0.02450558 0.04679085 0.21705521 0.46959854 SMID_BREAST_CANCER_BASAL_UP reading disorder DOID_13365 0.02450558 0.04663436 0.21705521 0.4660544 SMID_BREAST_CANCER_BASAL_UP dyslexia DOID_4428 0.02450558 0.04663436 0.21705521 0.4660544 SMID_BREAST_CANCER_BASAL_UP combined T cell and B cell immunodeficiency DOID_628 0.02450558 0.04647891 0.21705521 0.46256336 SMID_BREAST_CANCER_BASAL_UP neuromuscular junction disease DOID_439 0.02630478 0.04972564 0.22439177 0.47113991 SMID_BREAST_CANCER_BASAL_UP cleft lip DOID_9296 0.02630478 0.04956098 0.22439177 0.46940778 SMID_BREAST_CANCER_BASAL_UP temporal lobe epilepsy DOID_3328 0.02708535 0.05086324 0.13662752 0.36498151 SMID_BREAST_CANCER_BASAL_UP tooth disease DOID_1091 0.02810718 0.05260851 0.48272143 0.84513383 SMID_BREAST_CANCER_BASAL_UP myopia DOID_11830 0.02815576 0.05252665 0.02815576 0.13462713 SMID_BREAST_CANCER_BASAL_UP vitiligo DOID_12306 0.02815576 0.052355 0.23165977 0.48107449 SMID_BREAST_CANCER_BASAL_UP spinal cord disease DOID_319 0.02815576 0.05218446 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP hypotrichosis DOID_4535 0.02815576 0.05201503 0.02815576 0.13240189 SMID_BREAST_CANCER_BASAL_UP fragments of torsion dystonia DOID_531 0.02815576 0.0518467 0.23165977 0.47415255 SMID_BREAST_CANCER_BASAL_UP Sciatic Neuropathy DOID_11446 0.03005742 0.05516991 0.23885985 0.48713712 SMID_BREAST_CANCER_BASAL_UP lesion of sciatic nerve DOID_12528 0.03005742 0.05516991 0.23885985 0.48713712 SMID_BREAST_CANCER_BASAL_UP migraine DOID_6364 0.03005742 0.05499251 0.23885985 0.48539735 SMID_BREAST_CANCER_BASAL_UP periodontitis DOID_824 0.03005742 0.05481625 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP mononeuritis of lower limb DOID_9473 0.03005742 0.05516991 0.23885985 0.48713712 SMID_BREAST_CANCER_BASAL_UP autoimmune disease of cardiovascular system DOID_0060051 0.03200864 0.05818822 0.24599265 0.49811324 SMID_BREAST_CANCER_BASAL_UP malaria DOID_12365 0.03200864 0.05800291 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP Behcet's disease DOID_13241 0.03200864 0.05818822 0.24599265 0.49811324 SMID_BREAST_CANCER_BASAL_UP autoimmune disease of the nervous system DOID_438 0.03200864 0.05781878 0.24599265 0.49285148 SMID_BREAST_CANCER_BASAL_UP central nervous system hereditary degenerative disease DOID_481 0.03200864 0.0576358 0.24599265 0.49112218 SMID_BREAST_CANCER_BASAL_UP male reproductive system disease DOID_48 0.03239682 0.05815076 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP toxic encephalopathy DOID_3602 0.03400833 0.06085138 0.2530588 0.49996686 SMID_BREAST_CANCER_BASAL_UP dystonic disease DOID_544 0.03400833 0.06066062 0.2530588 0.49651882 SMID_BREAST_CANCER_BASAL_UP endogenous depression DOID_1595 0.03700775 0.0658044 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP opportunistic mycosis DOID_2473 0.03814886 0.06762212 0.2669936 0.52027177 SMID_BREAST_CANCER_BASAL_UP bone resorption disease DOID_0080011 0.03821022 0.06752055 0.16920017 0.4185865 SMID_BREAST_CANCER_BASAL_UP osteoporosis DOID_11476 0.03821022 0.06752055 0.16920017 0.4185865 SMID_BREAST_CANCER_BASAL_UP Charcot-Marie-Tooth disease DOID_10595 0.04028759 0.07097102 0.27386348 0.53002829 SMID_BREAST_CANCER_BASAL_UP celiac disease DOID_10608 0.04028759 0.07075198 0.04028759 0.16980474 SMID_BREAST_CANCER_BASAL_UP chronic leukemia DOID_1036 0.0424706 0.07435622 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP chronic lymphocytic leukemia DOID_1040 0.0424706 0.07435622 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP systemic mycosis DOID_0050136 0.04469687 0.07801387 0.28741121 0.54694642 SMID_BREAST_CANCER_BASAL_UP fungal infectious disease DOID_1564 0.04469687 0.07801387 0.28741121 0.54694642 SMID_BREAST_CANCER_BASAL_UP metal metabolism disorder DOID_896 0.04469687 0.0777753 0.28741121 0.54512327 SMID_BREAST_CANCER_BASAL_UP alcohol abuse DOID_1574 0.04583703 0.07951606 0.04583703 0.18763503 SMID_BREAST_CANCER_BASAL_UP mental depression DOID_1596 0.04583703 0.07927437 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP focal epilepsy DOID_2234 0.04583703 0.07903415 0.18931492 0.43611414 SMID_BREAST_CANCER_BASAL_UP periodontal disease DOID_3388 0.04696541 0.08073511 1.000 1.000 SMID_BREAST_CANCER_BASAL_UP aplastic anemia DOID_12449 0.04927523 0.08445063 0.30070689 0.56283624 SMID_BREAST_CANCER_BASAL_UP autosomal recessive nonsyndromic deafness DOID_0050565 0.05162537 0.08821273 0.05162537 0.20541844 SMID_BREAST_CANCER_BASAL_UP microcephaly DOID_10907 0.0564428 0.09615556 0.0564428 0.21554333 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 primary immunodeficiency disease DOID_612 3.069E-18 1.746E-15 2.206E-10 1.255E-07 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 contact dermatitis DOID_2773 8.522E-11 2.424E-08 2.546E-09 7.243E-07 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 encephalomyelitis DOID_640 3.259E-10 6.181E-08 7.56E-04 0.02263879 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 allergic contact dermatitis DOID_3042 7.042E-10 1.002E-07 2.184E-08 4.142E-06 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 tuberculosis DOID_399 7.908E-10 8.999E-08 0.26238002 0.79836489 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 aneurysm disease DOID_2403 1.884E-09 1.787E-07 1.192E-06 1.13E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 heart valve disease DOID_4079 1.954E-09 1.589E-07 0.01943947 0.21688351 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 primary bacterial infectious disease DOID_0050338 4.919E-09 3.499E-07 0.31721186 0.94007056 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hypersensitivity reaction type I disease DOID_1205 9.779E-09 6.182E-07 8.173E-04 0.02325308 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 collagen disease DOID_854 1.156E-08 6.579E-07 0.03077682 0.3072283 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 funisitis DOID_0050698 3.325E-08 1.72E-06 3.963E-03 0.07516718 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hepatitis B DOID_2043 3.325E-08 1.577E-06 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 bacterial pneumonia DOID_874 5.583E-08 2.444E-06 4.946E-03 0.0804114 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 neuritis DOID_1803 7.545E-08 3.067E-06 0.01943947 0.22122118 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 combined T cell and B cell immunodeficiency DOID_628 8.192E-08 3.107E-06 8.192E-08 1.165E-05 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pulmonary tuberculosis DOID_2957 9.599E-08 3.414E-06 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 intracranial aneurysm DOID_10941 1.216E-07 4.068E-06 6.072E-06 3.839E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 B cell deficiency DOID_2115 1.216E-07 3.842E-06 2.32E-04 8.799E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 sarcoidosis DOID_11335 1.509E-07 4.52E-06 0.21335998 0.70174466 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 atrophic muscular disease DOID_913 1.509E-07 4.294E-06 9.924E-05 5.133E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 muscular dystrophy DOID_9884 1.509E-07 4.294E-06 9.924E-05 5.133E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hypersensitivity reaction type IV disease DOID_2916 2.536E-07 6.872E-06 0.23004948 0.7395376 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 ulcerative colitis DOID_8577 2.619E-07 6.775E-06 4.747E-06 3.376E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 Ehlers-Danlos syndrome DOID_13359 4.227E-07 1.046E-05 0.0622264 0.41655083 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 ureteral obstruction DOID_5199 9.382E-07 2.224E-05 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 agammaglobulinemia DOID_2583 1.184E-06 2.696E-05 2.958E-03 0.06012078 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 MHC class II deficiency DOID_5812 1.184E-06 2.592E-05 1.184E-06 1.348E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 autoimmune disease of urogenital tract DOID_0060049 1.425E-06 3.003E-05 0.01592975 0.18883391 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 primary biliary cirrhosis DOID_12236 1.425E-06 3.003E-05 0.01592975 0.18883391 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 blood protein disease DOID_620 1.476E-06 2.999E-05 3.278E-03 0.06431695 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 urinary tract obstruction DOID_5200 2.67E-06 5.239E-05 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 autoimmune disease of gastrointestinal tract DOID_0060031 2.959E-06 5.612E-05 0.02092592 0.22465756 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 glaucoma DOID_1686 2.959E-06 5.431E-05 7.412E-05 4.218E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 ureteral disease DOID_1426 3.193E-06 5.678E-05 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 spastic quadriplegia DOID_10970 3.789E-06 6.533E-05 0.10155701 0.50689422 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 severe combined immunodeficiency DOID_627 3.789E-06 6.341E-05 3.789E-06 3.08E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 lung adenocarcinoma DOID_3910 7.02E-06 1.141E-04 2.579E-04 9.172E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 phagocyte bactericidal dysfunction DOID_3262 8.991E-06 1.421E-04 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hypothyroidism DOID_1459 8.993E-06 1.383E-04 1.775E-04 7.216E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 toxic encephalopathy DOID_3602 9.238E-06 1.383E-04 7.78E-03 0.11350141 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 spastic cerebral palsy DOID_0050669 1.193E-05 1.741E-04 0.13183756 0.55567089 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 aortic valve insufficiency DOID_57 1.638E-05 2.33E-04 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 nephroblastoma DOID_2154 1.901E-05 2.638E-04 0.01095747 0.13855118 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 bone resorption disease DOID_0080011 2.338E-05 3.168E-04 4.776E-03 0.07991999 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 osteoporosis DOID_11476 2.338E-05 3.168E-04 4.776E-03 0.07991999 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pulmonary sarcoidosis DOID_13406 2.604E-05 3.446E-04 0.15749969 0.60552244 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 female reproductive system disease DOID_229 2.971E-05 3.842E-04 0.04930695 0.43162542 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 adenoid cystic carcinoma DOID_4866 3.482E-05 4.402E-04 8.337E-04 0.02258987 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 bone development disease DOID_0080006 3.527E-05 4.363E-04 5.195E-04 0.01738713 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 spastic diplegia DOID_10965 4.117E-05 4.985E-04 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 endometriosis of uterus DOID_288 4.175E-05 4.95E-04 0.17536685 0.63154263 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 salivary gland cancer DOID_8850 4.175E-05 4.849E-04 9.527E-04 0.02463922 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 endometriosis DOID_289 4.558E-05 5.187E-04 0.17889483 0.62834048 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 prion disease DOID_649 5.962E-05 6.652E-04 0.07420192 0.42647366 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pre-eclampsia DOID_10591 6.348E-05 6.946E-04 0.19285738 0.66912103 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 autoimmune hepatitis DOID_2048 9.626E-05 1.033E-03 0.08602544 0.47522794 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 coronary restenosis DOID_4247 9.626E-05 1.014E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 parasitic protozoa infectious disease DOID_2789 1.139E-04 1.178E-03 0.22007849 0.71150376 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pustulosis of palm and sole DOID_4398 1.139E-04 1.157E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 myasthenia gravis DOID_437 1.274E-04 1.272E-03 0.0938243 0.48978005 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 congenital nervous system abnormality DOID_2490 1.3E-04 1.276E-03 1.3E-04 6.165E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 oral cavity cancer DOID_8618 1.387E-04 1.337E-03 2.299E-03 0.05030281 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 aortic valve disease DOID_62 1.451E-04 1.376E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 sphingolipidosis DOID_1927 1.644E-04 1.533E-03 1.644E-04 7.195E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 neuromuscular junction disease DOID_439 2.078E-04 1.907E-03 0.10922415 0.51790449 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 myositis DOID_633 2.078E-04 1.876E-03 0.10922415 0.51362429 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 parasitic infectious disease DOID_1398 2.115E-04 1.88E-03 0.25282517 0.78610669 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 uterine disease DOID_345 2.115E-04 1.851E-03 0.25282517 0.77760824 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 endocrine organ benign neoplasm DOID_0060089 2.498E-04 2.153E-03 0.26238002 0.80265717 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 brain infarction DOID_3454 2.498E-04 2.121E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pancreatic ductal carcinoma DOID_3587 2.78E-04 2.326E-03 0.03913748 0.3650693 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 malaria DOID_12365 2.857E-04 2.356E-03 0.12060309 0.52787043 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 coronary stenosis DOID_4248 2.857E-04 2.322E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 autoimmune disease of the nervous system DOID_438 2.857E-04 2.289E-03 0.12060309 0.5198724 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 nephrosis DOID_2527 2.929E-04 2.315E-03 3.976E-03 0.07297789 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 focal glomerulosclerosis DOID_3945 3.153E-04 2.458E-03 7.78E-03 0.11066387 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pancreatic carcinoma DOID_4905 3.244E-04 2.494E-03 0.04209509 0.38019219 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 opportunistic mycosis DOID_2473 3.803E-04 2.885E-03 8.784E-03 0.11900752 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 celiac disease DOID_10608 4.158E-04 3.113E-03 0.13555059 0.56711975 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 germinoma DOID_3304 4.158E-04 3.073E-03 0.13555059 0.56298019 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 systemic mycosis DOID_0050136 4.93E-04 3.597E-03 0.01039409 0.13441448 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 fungal infectious disease DOID_1564 4.93E-04 3.597E-03 0.01039409 0.13441448 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 chronic kidney failure DOID_784 4.97E-04 3.579E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 retinal vascular disease DOID_2462 5.427E-04 3.86E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 transitional cell carcinoma DOID_2671 6.169E-04 4.333E-03 6.857E-03 0.10544428 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 adenoma DOID_657 6.252E-04 4.338E-03 0.01212373 0.14996529 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 nervous system cancer DOID_3093 6.701E-04 4.594E-03 0.32594816 0.96095598 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 calcinosis DOID_182 6.738E-04 4.564E-03 0.15749969 0.60145853 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 microcephaly DOID_10907 7.247E-04 4.851E-03 7.247E-04 0.02290782 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 uveitis DOID_13141 7.247E-04 4.795E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 systemic scleroderma DOID_418 7.78E-04 5.088E-03 0.16469226 0.60850581 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 mouth disease DOID_403 7.862E-04 5.084E-03 0.06376429 0.39436827 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 facioscapulohumeral muscular dystrophy DOID_11727 7.985E-04 5.105E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 angioedema DOID_1558 7.985E-04 5.048E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 conjunctival disease DOID_4251 7.985E-04 4.993E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 conjunctivitis DOID_6195 7.985E-04 4.993E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 common variable immunodeficiency DOID_12177 9.732E-04 6.019E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 nephrotic syndrome DOID_1184 1.016E-03 6.216E-03 1.016E-03 0.02513356 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 rheumatic disease DOID_1575 1.016E-03 6.15E-03 0.17889483 0.63619473 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 uveal disease DOID_3480 1.016E-03 6.085E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 scleroderma DOID_419 1.016E-03 6.15E-03 0.17889483 0.63619473 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 common cold DOID_10459 1.165E-03 6.902E-03 0.05009694 0.43189632 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 relapsing-remitting multiple sclerosis DOID_2378 1.165E-03 6.831E-03 1.165E-03 0.02760883 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 stomach disease DOID_76 1.165E-03 6.761E-03 0.05009694 0.41311822 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 peritonitis DOID_8283 1.165E-03 6.693E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 proteinuria DOID_576 1.222E-03 6.951E-03 0.01871371 0.21730819 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 brain cancer DOID_1319 1.295E-03 7.298E-03 0.19285738 0.66506576 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 thyroid adenoma DOID_2891 1.295E-03 7.227E-03 0.19285738 0.66105934 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 vascular skin disease DOID_9540 1.295E-03 7.157E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 central nervous system cancer DOID_3620 1.372E-03 7.507E-03 0.19631099 0.66886798 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 calcium metabolism disease DOID_10575 1.534E-03 8.312E-03 0.20317421 0.68405992 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 aortic aneurysm DOID_3627 1.534E-03 8.234E-03 0.02168639 0.22851035 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 eyelid disease DOID_530 1.597E-03 8.491E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 narcolepsy DOID_8986 1.597E-03 8.412E-03 0.05820045 0.39423873 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 atopic dermatitis DOID_3310 1.707E-03 8.912E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 thoracic aortic aneurysm DOID_14004 1.837E-03 9.503E-03 1.837E-03 0.04181258 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 membranoproliferative glomerulonephritis DOID_2920 1.837E-03 9.417E-03 0.0622264 0.40235023 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 adrenal cortex disease DOID_3952 1.837E-03 9.333E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 oral submucous fibrosis DOID_5773 1.837E-03 9.251E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 varicose veins DOID_799 1.837E-03 9.169E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 osteochondrodysplasia DOID_2256 1.989E-03 9.842E-03 0.0256568 0.26543123 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 restrictive cardiomyopathy DOID_397 2.094E-03 0.01026981 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 vein disease DOID_866 2.094E-03 0.01018204 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 urinary system benign neoplasm DOID_731 2.366E-03 0.0114098 0.07022706 0.42062315 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 adrenal gland disease DOID_9553 2.366E-03 0.01131392 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 leukocyte disease DOID_9500 2.408E-03 0.0114175 0.23334491 0.74591716 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 carotid artery disease DOID_3407 2.636E-03 0.01239657 0.23989377 0.75833087 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 congenital muscular dystrophy DOID_0050557 2.655E-03 0.01238042 2.655E-03 0.05594115 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 congenital heart defect DOID_1682 2.877E-03 0.01331076 0.03256606 0.31948427 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 testicular cancer DOID_2998 2.958E-03 0.01357566 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 mineral metabolism disease DOID_0050032 3.003E-03 0.01366914 0.24961297 0.7803834 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 cerebral degeneration DOID_1443 3.132E-03 0.01414246 0.25282517 0.78183437 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 subependymal glioma DOID_4843 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pilocytic astrocytoma DOID_4851 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 subependymal giant cell astrocytoma DOID_5077 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 fibrillary astrocytoma DOID_6726 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 juvenile pilocytic astrocytoma DOID_6811 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 childhood pilocytic astrocytoma DOID_6812 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 gemistocytic astrocytoma DOID_7005 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 childhood cerebral astrocytoma DOID_7007 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 protoplasmic astrocytoma DOID_7008 3.278E-03 0.01468655 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 benign glioma DOID_0060101 3.963E-03 0.01761731 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 benign ependymoma DOID_4844 3.963E-03 0.01761731 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 bile duct disease DOID_4138 3.976E-03 0.01753732 3.976E-03 0.07069733 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 peripheral vascular disease DOID_341 4.129E-03 0.01807129 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 biliary tract disease DOID_9741 4.129E-03 0.01793334 4.129E-03 0.07118992 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 diabetic retinopathy DOID_8947 4.285E-03 0.01847141 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 sleep disorder DOID_535 4.328E-03 0.01851787 0.0938243 0.48532751 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pulmonary embolism DOID_9477 4.328E-03 0.01837967 0.0938243 0.48095519 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 meningitis DOID_9471 4.709E-03 0.01984642 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pancreatitis DOID_4989 4.946E-03 0.02069411 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 X-linked disease DOID_0050735 5.514E-03 0.02290028 5.514E-03 0.08714829 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 urticaria DOID_1555 5.514E-03 0.02273434 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 morbid obesity DOID_11981 5.938E-03 0.02430841 0.10922415 0.5311841 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 spinal muscular atrophy DOID_12377 5.938E-03 0.02413477 0.10922415 0.52668254 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 papillary adenoma DOID_3172 5.938E-03 0.02396361 0.10922415 0.52225663 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 microcystic adenoma DOID_5403 5.938E-03 0.02396361 0.10922415 0.52225663 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 follicular adenoma DOID_6204 5.938E-03 0.02396361 0.10922415 0.52225663 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 ankylosing spondylitis DOID_7147 5.938E-03 0.02379485 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 vitiligo DOID_12306 6.377E-03 0.02537503 0.11303329 0.52717986 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 seminoma DOID_4440 6.377E-03 0.02519881 0.11303329 0.52289385 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 extrinsic allergic alveolitis DOID_841 6.377E-03 0.02502503 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 Sciatic Neuropathy DOID_11446 6.83E-03 0.02662017 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 lesion of sciatic nerve DOID_12528 6.83E-03 0.02662017 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 perinatal necrotizing enterocolitis DOID_8677 6.83E-03 0.02643908 0.11682625 0.52341839 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 mononeuritis of lower limb DOID_9473 6.83E-03 0.02662017 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 Human immunodeficiency virus infectious disease DOID_526 7.284E-03 0.02800464 0.32594816 0.95600259 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pleurisy DOID_10247 7.298E-03 0.02786943 0.12060309 0.53196245 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 mononeuritis DOID_1802 7.298E-03 0.02768363 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 lymphoma DOID_0060058 7.727E-03 0.02911745 0.33171055 0.96791438 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 mononeuropathy DOID_1188 7.78E-03 0.02912207 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 multiple epiphyseal dysplasia DOID_12721 7.78E-03 0.02893173 7.78E-03 0.11648829 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 supratentorial cancer DOID_1659 7.78E-03 0.02874386 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 cerebrum cancer DOID_368 7.78E-03 0.02874386 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 Crohn's disease DOID_8778 8.186E-03 0.03004937 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 dysostosis DOID_1934 8.275E-03 0.03018271 8.275E-03 0.11484152 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 Charcot-Marie-Tooth disease DOID_10595 9.307E-03 0.033732 9.307E-03 0.12316101 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 allergic rhinitis DOID_4481 9.307E-03 0.0335185 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pleural disease DOID_1532 9.844E-03 0.03522801 0.13924784 0.57001455 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 papilloma DOID_2615 0.01039409 0.03696398 0.14292938 0.58090583 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 metal metabolism disorder DOID_896 0.01039409 0.03673439 0.14292938 0.57678593 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pneumoconiosis DOID_10316 0.01095747 0.03848644 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hepatitis C DOID_1883 0.01095747 0.03825033 0.14659526 0.58741342 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 spindle cell carcinoma DOID_4015 0.01095747 0.03801709 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 esophageal disease DOID_6050 0.01095747 0.03778668 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hyperthyroidism DOID_7998 0.01095747 0.03755905 0.14659526 0.57526004 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 embryonal cancer DOID_688 0.01272636 0.04336108 0.15749969 0.58958764 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 respiratory syncytial virus infectious disease DOID_1273 0.01397003 0.04731515 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hepatitis DOID_2237 0.01397003 0.04703518 0.16469226 0.61248297 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 intracranial arterial disease DOID_13089 0.01461082 0.04890328 0.01461082 0.17688419 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 cerebral arterial disease DOID_3527 0.01461082 0.04890328 0.01461082 0.17688419 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 lymphatic system disease DOID_75 0.01461082 0.04861729 0.16826562 0.61769768 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 cervix uteri carcinoma in situ DOID_8991 0.0152641 0.05049578 0.1718238 0.62671629 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 pulmonary emphysema DOID_9675 0.0152641 0.05020389 0.1718238 0.62272447 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 influenza DOID_8469 0.01729769 0.05656542 0.18240781 0.63674873 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hemolytic anemia DOID_583 0.02017691 0.06560379 0.02017691 0.22078198 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 normocytic anemia DOID_720 0.02017691 0.06560379 0.02017691 0.22078198 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hemorrhagic disease DOID_2213 0.02245821 0.07260639 0.20658395 0.69144862 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 B-cell lymphocytic neoplasm DOID_707 0.02245821 0.07219618 0.20658395 0.68740506 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 vasculitis DOID_865 0.02484067 0.07940642 0.21672639 0.70872022 HOSHIDA_LIVER_CANCER_SUBCLASS_S1 hypertrophic cardiomyopathy DOID_11984 0.0281696 0.08954469 0.0281696 0.28622322 SENESE_HDAC2_TARGETS_UP bone resorption disease DOID_0080011 1.803E-09 1.026E-06 5.493E-06 3.126E-03 SENESE_HDAC2_TARGETS_UP osteoporosis DOID_11476 1.803E-09 1.026E-06 5.493E-06 3.126E-03 SENESE_HDAC2_TARGETS_UP transitional cell carcinoma DOID_2671 2.134E-07 6.072E-05 3.104E-04 0.04415458 SENESE_HDAC2_TARGETS_UP skeletal system cancer DOID_0060124 1.298E-06 2.463E-04 1.000 1.000 SENESE_HDAC2_TARGETS_UP thoracic aortic aneurysm DOID_14004 1.298E-06 1.847E-04 1.000 1.000 SENESE_HDAC2_TARGETS_UP bone cancer DOID_184 1.298E-06 2.463E-04 1.000 1.000 SENESE_HDAC2_TARGETS_UP carotid artery disease DOID_3407 2.361E-06 2.686E-04 3.933E-03 0.12431797 SENESE_HDAC2_TARGETS_UP mineral metabolism disease DOID_0050032 2.839E-06 2.692E-04 4.301E-03 0.12880822 SENESE_HDAC2_TARGETS_UP aneurysm disease DOID_2403 5.493E-06 4.465E-04 1.000 1.000 SENESE_HDAC2_TARGETS_UP biliary tract cancer DOID_4607 7.355E-06 5.231E-04 6.83E-03 0.18506331 SENESE_HDAC2_TARGETS_UP lymphoma DOID_0060058 1.097E-05 6.936E-04 3.527E-04 0.0401392 SENESE_HDAC2_TARGETS_UP mouth disease DOID_403 1.192E-05 6.785E-04 8.636E-03 0.21364474 SENESE_HDAC2_TARGETS_UP spindle cell carcinoma DOID_4015 2.168E-05 1.121E-03 0.05232425 0.41933093 SENESE_HDAC2_TARGETS_UP multiple myeloma DOID_9538 2.748E-05 1.303E-03 1.556E-03 0.09836495 SENESE_HDAC2_TARGETS_UP influenza DOID_8469 4.478E-05 1.96E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP myeloma DOID_0070004 5.396E-05 2.193E-03 2.421E-03 0.11479162 SENESE_HDAC2_TARGETS_UP pre-eclampsia DOID_10591 5.396E-05 2.047E-03 2.421E-03 0.10596149 SENESE_HDAC2_TARGETS_UP glaucoma DOID_1686 6.071E-05 2.159E-03 0.07276245 0.51113372 SENESE_HDAC2_TARGETS_UP calcium metabolism disease DOID_10575 6.429E-05 2.152E-03 2.716E-03 0.10301588 SENESE_HDAC2_TARGETS_UP aortic aneurysm DOID_3627 6.429E-05 2.032E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP giant cell tumor DOID_200 7.584E-05 2.271E-03 0.07813914 0.52307258 SENESE_HDAC2_TARGETS_UP malignant giant cell tumor DOID_2705 7.584E-05 2.271E-03 0.07813914 0.52307258 SENESE_HDAC2_TARGETS_UP giant cell glioblastoma DOID_3074 7.584E-05 2.271E-03 0.07813914 0.52307258 SENESE_HDAC2_TARGETS_UP bile duct adenocarcinoma DOID_4896 7.997E-05 2.275E-03 0.07947852 0.5198078 SENESE_HDAC2_TARGETS_UP cholangiocarcinoma DOID_4947 7.997E-05 2.275E-03 0.07947852 0.5198078 SENESE_HDAC2_TARGETS_UP bone marrow cancer DOID_4960 7.997E-05 2.167E-03 3.134E-03 0.11144165 SENESE_HDAC2_TARGETS_UP glioblastoma DOID_3068 9.796E-05 2.534E-03 0.08481697 0.53623176 SENESE_HDAC2_TARGETS_UP bile duct cancer DOID_4606 9.796E-05 2.424E-03 0.08481697 0.5303391 SENESE_HDAC2_TARGETS_UP bile duct carcinoma DOID_4897 9.796E-05 2.424E-03 0.08481697 0.5303391 SENESE_HDAC2_TARGETS_UP respiratory failure DOID_11162 1.184E-04 2.807E-03 0.09012503 0.55740369 SENESE_HDAC2_TARGETS_UP epidermolysis bullosa DOID_2730 1.351E-04 3.075E-03 1.351E-04 0.03844286 SENESE_HDAC2_TARGETS_UP tooth disease DOID_1091 1.476E-04 3.231E-03 4.685E-03 0.13328722 SENESE_HDAC2_TARGETS_UP vesiculobullous skin disease DOID_2731 1.595E-04 3.362E-03 1.595E-04 0.03026011 SENESE_HDAC2_TARGETS_UP astrocytoma DOID_3069 1.605E-04 3.262E-03 0.09934148 0.57678879 SENESE_HDAC2_TARGETS_UP bile duct disease DOID_4138 1.741E-04 3.416E-03 0.10195787 0.58014029 SENESE_HDAC2_TARGETS_UP biliary tract disease DOID_9741 1.812E-04 3.436E-03 0.10326327 0.5817505 SENESE_HDAC2_TARGETS_UP cystic fibrosis DOID_1485 2.035E-04 3.735E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP mesenchymal cell neoplasm DOID_3350 2.144E-04 3.812E-03 0.02154582 0.38311161 SENESE_HDAC2_TARGETS_UP spindle cell sarcoma DOID_4235 2.144E-04 3.812E-03 0.02154582 0.38311161 SENESE_HDAC2_TARGETS_UP epithelioid sarcoma DOID_6193 2.144E-04 3.812E-03 0.02154582 0.38311161 SENESE_HDAC2_TARGETS_UP varicose veins DOID_799 2.144E-04 3.696E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP intermediate coronary syndrome DOID_8805 2.144E-04 3.588E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP vein disease DOID_866 2.448E-04 3.979E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP Barrett's esophagus DOID_9206 2.448E-04 3.869E-03 0.02296589 0.37335975 SENESE_HDAC2_TARGETS_UP lymphatic system cancer DOID_0060073 2.771E-04 4.262E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP reticulosarcoma DOID_8538 2.771E-04 4.262E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP lymphosarcoma DOID_8675 2.771E-04 4.262E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP dissociative disorder DOID_10935 3.478E-04 5.208E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP dissociative amnesia DOID_11037 3.478E-04 5.208E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP leishmaniasis DOID_9065 3.478E-04 5.075E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP amnestic disorder DOID_10914 3.861E-04 5.492E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP brain edema DOID_4724 3.861E-04 5.358E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP ulcerative colitis DOID_8577 4.229E-04 5.729E-03 0.13529943 0.69356196 SENESE_HDAC2_TARGETS_UP muscular atrophy DOID_767 4.686E-04 6.2E-03 0.03144391 0.38067207 SENESE_HDAC2_TARGETS_UP sinusitis DOID_0050127 5.127E-04 6.63E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP paranasal sinus disease DOID_1352 5.127E-04 6.63E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP IgA glomerulonephritis DOID_2986 5.127E-04 6.483E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP pulmonary embolism DOID_9477 5.127E-04 6.342E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP meningitis DOID_9471 5.588E-04 6.765E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP intracranial aneurysm DOID_10941 7.625E-04 9.038E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP middle cerebral artery infarction DOID_3525 7.625E-04 8.854E-03 1.000 1.000 SENESE_HDAC2_TARGETS_UP sarcoma DOID_1115 8.758E-04 9.967E-03 0.04263568 0.41827071 SENESE_HDAC2_TARGETS_UP bronchiolitis obliterans DOID_2799 1.06E-03 0.01182708 1.000 1.000 SENESE_HDAC2_TARGETS_UP celiac disease DOID_10608 1.125E-03 0.01231316 1.125E-03 0.10671405 SENESE_HDAC2_TARGETS_UP allergic rhinitis DOID_4481 1.125E-03 0.01208084 1.000 1.000 SENESE_HDAC2_TARGETS_UP myocarditis DOID_820 1.261E-03 0.01329075 0.05094608 0.42629883 SENESE_HDAC2_TARGETS_UP periodontal disease DOID_3388 1.332E-03 0.01378194 0.05232425 0.42532137 SENESE_HDAC2_TARGETS_UP esophageal disease DOID_6050 1.332E-03 0.01353584 0.05232425 0.41350689 SENESE_HDAC2_TARGETS_UP medullomyoblastoma DOID_3861 1.405E-03 0.01402413 1.405E-03 0.11419646 SENESE_HDAC2_TARGETS_UP adult medulloblastoma DOID_3864 1.405E-03 0.01402413 1.405E-03 0.11419646 SENESE_HDAC2_TARGETS_UP childhood medulloblastoma DOID_3869 1.405E-03 0.01402413 1.405E-03 0.11419646 SENESE_HDAC2_TARGETS_UP calcinosis DOID_182 1.556E-03 0.01526353 0.05644696 0.43997698 SENESE_HDAC2_TARGETS_UP medulloblastoma DOID_3858 1.556E-03 0.01500482 1.556E-03 0.11066057 SENESE_HDAC2_TARGETS_UP peptic ulcer DOID_750 1.714E-03 0.01625673 1.000 1.000 SENESE_HDAC2_TARGETS_UP adult respiratory distress syndrome DOID_11394 1.796E-03 0.01675467 1.000 1.000 SENESE_HDAC2_TARGETS_UP intracranial arterial disease DOID_13089 1.796E-03 0.01648443 1.000 1.000 SENESE_HDAC2_TARGETS_UP cerebral arterial disease DOID_3527 1.796E-03 0.01648443 1.000 1.000 SENESE_HDAC2_TARGETS_UP primitive neuroectodermal tumor DOID_168 2.053E-03 0.01854248 2.053E-03 0.11681763 SENESE_HDAC2_TARGETS_UP diabetic autonomic neuropathy DOID_11503 2.142E-03 0.0190463 1.000 1.000 SENESE_HDAC2_TARGETS_UP autonomic neuropathy DOID_11504 2.142E-03 0.0190463 1.000 1.000 SENESE_HDAC2_TARGETS_UP diabetic polyneuropathy DOID_12785 2.142E-03 0.0190463 1.000 1.000 SENESE_HDAC2_TARGETS_UP uterine cancer DOID_363 2.142E-03 0.01875328 2.142E-03 0.11081481 SENESE_HDAC2_TARGETS_UP diabetic neuropathy DOID_9743 2.142E-03 0.0190463 1.000 1.000 SENESE_HDAC2_TARGETS_UP cerebral infarction DOID_3526 2.233E-03 0.01925426 1.000 1.000 SENESE_HDAC2_TARGETS_UP autonomic nervous system disease DOID_11465 2.421E-03 0.02055969 1.000 1.000 SENESE_HDAC2_TARGETS_UP brain cancer DOID_1319 2.421E-03 0.02025734 0.07006257 0.50462784 SENESE_HDAC2_TARGETS_UP heart valve disease DOID_4079 2.421E-03 0.01996376 1.000 1.000 SENESE_HDAC2_TARGETS_UP central nervous system cancer DOID_3620 2.517E-03 0.02046277 0.07141347 0.5079283 SENESE_HDAC2_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.616E-03 0.02096208 2.616E-03 0.1063077 SENESE_HDAC2_TARGETS_UP integumentary system benign neoplasm DOID_0060121 2.616E-03 0.02067094 1.000 1.000 SENESE_HDAC2_TARGETS_UP pulmonary tuberculosis DOID_2957 2.616E-03 0.02038778 1.000 1.000 SENESE_HDAC2_TARGETS_UP skin benign neoplasm DOID_3165 2.616E-03 0.02067094 1.000 1.000 SENESE_HDAC2_TARGETS_UP integumentary system cancer DOID_0060122 3.243E-03 0.02493291 1.000 1.000 SENESE_HDAC2_TARGETS_UP parasitic protozoa infectious disease DOID_2789 3.243E-03 0.02460047 1.000 1.000 SENESE_HDAC2_TARGETS_UP skin cancer DOID_4159 3.243E-03 0.02493291 1.000 1.000 SENESE_HDAC2_TARGETS_UP neuroectodermal tumor DOID_171 3.933E-03 0.02944373 3.933E-03 0.13163079 SENESE_HDAC2_TARGETS_UP congenital heart defect DOID_1682 4.177E-03 0.03086366 0.09144731 0.55354807 SENESE_HDAC2_TARGETS_UP cholestasis DOID_13580 4.427E-03 0.03229722 1.000 1.000 SENESE_HDAC2_TARGETS_UP parasitic infectious disease DOID_1398 4.427E-03 0.0318884 1.000 1.000 SENESE_HDAC2_TARGETS_UP uterine disease DOID_345 4.427E-03 0.03148979 1.000 1.000 SENESE_HDAC2_TARGETS_UP hyperglycemia DOID_4195 4.555E-03 0.03199976 1.000 1.000 SENESE_HDAC2_TARGETS_UP allergic contact dermatitis DOID_3042 4.685E-03 0.03250908 0.0967176 0.57325328 SENESE_HDAC2_TARGETS_UP brain infarction DOID_3454 4.816E-03 0.03301774 1.000 1.000 SENESE_HDAC2_TARGETS_UP tuberculosis DOID_399 4.816E-03 0.03262467 1.000 1.000 SENESE_HDAC2_TARGETS_UP blood coagulation disease DOID_1247 5.084E-03 0.03403307 0.10065061 0.57848684 SENESE_HDAC2_TARGETS_UP pancreatic ductal carcinoma DOID_3587 5.084E-03 0.03363733 1.000 1.000 SENESE_HDAC2_TARGETS_UP male reproductive system disease DOID_48 5.22E-03 0.0341427 1.000 1.000 SENESE_HDAC2_TARGETS_UP pancreatic carcinoma DOID_4905 5.498E-03 0.03555089 1.000 1.000 SENESE_HDAC2_TARGETS_UP diabetic retinopathy DOID_8947 5.498E-03 0.03515144 1.000 1.000 SENESE_HDAC2_TARGETS_UP bacterial pneumonia DOID_874 6.074E-03 0.03839945 1.000 1.000 SENESE_HDAC2_TARGETS_UP contact dermatitis DOID_2773 6.371E-03 0.03983861 0.11234903 0.61467883 SENESE_HDAC2_TARGETS_UP chromosomal disease DOID_0080014 6.523E-03 0.04034122 0.1136396 0.61581838 SENESE_HDAC2_TARGETS_UP female reproductive system disease DOID_229 6.523E-03 0.03990744 1.000 1.000 SENESE_HDAC2_TARGETS_UP chronic kidney failure DOID_784 6.83E-03 0.04134393 1.000 1.000 SENESE_HDAC2_TARGETS_UP retinal vascular disease DOID_2462 7.144E-03 0.04278901 1.000 1.000 SENESE_HDAC2_TARGETS_UP primary bacterial infectious disease DOID_0050338 7.464E-03 0.04424217 1.000 1.000 SENESE_HDAC2_TARGETS_UP nervous system cancer DOID_3093 7.957E-03 0.0466754 0.12517209 0.66563477 SENESE_HDAC2_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.636E-03 0.05014111 8.636E-03 0.22335587 SENESE_HDAC2_TARGETS_UP leber hereditary optic neuropathy DOID_705 0.01298274 0.07461799 1.000 1.000 SENESE_HDAC2_TARGETS_UP childhood type dermatomyositis DOID_14203 0.01441502 0.08202144 1.000 1.000 SENESE_HDAC2_TARGETS_UP chondrosarcoma DOID_3371 0.01441502 0.08120935 1.000 1.000 SENESE_HDAC2_TARGETS_UP Paget's disease of bone DOID_5408 0.01441502 0.08041318 0.01441502 0.341756 SENESE_HDAC2_TARGETS_UP cutaneous leishmaniasis DOID_9111 0.01441502 0.07963246 1.000 1.000 SENESE_HDAC2_TARGETS_UP visceral leishmaniasis DOID_9146 0.01441502 0.07886677 1.000 1.000 SENESE_HDAC2_TARGETS_UP breast benign neoplasm DOID_0060082 0.01584525 0.08586614 1.000 1.000 SENESE_HDAC2_TARGETS_UP thoracic benign neoplasm DOID_0060097 0.01584525 0.08586614 1.000 1.000 SENESE_HDAC2_TARGETS_UP dermatomyositis DOID_10223 0.01584525 0.08505609 1.000 1.000 SENESE_HDAC2_TARGETS_UP pneumocystosis DOID_11339 0.01584525 0.08426117 1.000 1.000 SENESE_HDAC2_TARGETS_UP temporal arteritis DOID_13375 0.01584525 0.08348097 1.000 1.000 SENESE_HDAC2_TARGETS_UP benign breast phyllodes tumor DOID_1631 0.01584525 0.08586614 1.000 1.000 SENESE_HDAC2_TARGETS_UP invasive lobular carcinoma DOID_3457 0.01584525 0.08271509 0.01584525 0.36063781 SENESE_HDAC2_TARGETS_UP central nervous system vasculitis DOID_525 0.01584525 0.08348097 1.000 1.000 SENESE_HDAC2_TARGETS_UP bronchiectasis DOID_9563 0.01584525 0.08196314 1.000 1.000 SENESE_HDAC2_TARGETS_UP common cold DOID_10459 0.01727344 0.08854583 1.000 1.000 SENESE_HDAC2_TARGETS_UP otitis media DOID_10754 0.01727344 0.08775524 1.000 1.000 SENESE_HDAC2_TARGETS_UP esophageal carcinoma DOID_1107 0.01727344 0.08697865 1.000 1.000 SENESE_HDAC2_TARGETS_UP beta thalassemia DOID_12241 0.01727344 0.08621567 1.000 1.000 SENESE_HDAC2_TARGETS_UP osteopetrosis DOID_13533 0.01727344 0.08546597 0.01727344 0.37802257 SENESE_HDAC2_TARGETS_UP pituitary cancer DOID_1785 0.01727344 0.0847292 0.01727344 0.36402174 SENESE_HDAC2_TARGETS_UP esophagus squamous cell carcinoma DOID_3748 0.01727344 0.08697865 1.000 1.000 SENESE_HDAC2_TARGETS_UP pituitary carcinoma DOID_4916 0.01727344 0.0847292 0.01727344 0.36402174 SENESE_HDAC2_TARGETS_UP middle ear disease DOID_5100 0.01727344 0.08775524 1.000 1.000 SENESE_HDAC2_TARGETS_UP aortic valve insufficiency DOID_57 0.01727344 0.08400502 1.000 1.000 SENESE_HDAC2_TARGETS_UP peritonitis DOID_8283 0.01727344 0.08329311 1.000 1.000 SENESE_HDAC2_TARGETS_UP mitochondrial encephalomyopathy DOID_890 0.01727344 0.08259317 1.000 1.000 SENESE_HDAC2_TARGETS_UP ocular hypertension DOID_9282 0.01727344 0.08190489 1.000 1.000 SENESE_HDAC2_TARGETS_UP borderline glaucoma DOID_9283 0.01727344 0.08190489 1.000 1.000 SENESE_HDAC2_TARGETS_UP encephalitis DOID_9588 0.01727344 0.08122799 1.000 1.000 SENESE_HDAC2_TARGETS_UP newborn respiratory distress syndrome DOID_12716 0.0186996 0.0872137 0.0186996 0.38000253 SENESE_HDAC2_TARGETS_UP obstructive hydrocephalus DOID_14159 0.0186996 0.08650464 0.0186996 0.36689899 SENESE_HDAC2_TARGETS_UP communicating hydrocephalus DOID_1573 0.0186996 0.08650464 0.0186996 0.36689899 SENESE_HDAC2_TARGETS_UP impotence DOID_1875 0.0186996 0.08580702 1.000 1.000 SENESE_HDAC2_TARGETS_UP larynx cancer DOID_2596 0.0186996 0.08512057 1.000 1.000 SENESE_HDAC2_TARGETS_UP laryngeal benign neoplasm DOID_2598 0.0186996 0.08512057 1.000 1.000 SENESE_HDAC2_TARGETS_UP Lynch syndrome DOID_3883 0.0186996 0.08444501 1.000 1.000 SENESE_HDAC2_TARGETS_UP intracranial thrombosis DOID_4193 0.0186996 0.08378009 1.000 1.000 SENESE_HDAC2_TARGETS_UP hydrocephalus DOID_10908 0.02012372 0.08945624 0.02012372 0.38167995 SENESE_HDAC2_TARGETS_UP hypercalcemia DOID_12678 0.02012372 0.08876278 0.02012372 0.36936769 SENESE_HDAC2_TARGETS_UP eyelid disease DOID_530 0.02012372 0.08807999 1.000 1.000 SENESE_HDAC2_TARGETS_UP bacterial meningitis DOID_9470 0.02012372 0.08740762 1.000 1.000 SENESE_HDAC2_TARGETS_UP idiopathic pulmonary fibrosis DOID_0050156 0.02154582 0.09287554 1.000 1.000 SENESE_HDAC2_TARGETS_UP thalassemia DOID_10241 0.02154582 0.09217723 1.000 1.000 SENESE_HDAC2_TARGETS_UP membranoproliferative glomerulonephritis DOID_2920 0.02154582 0.09148934 1.000 1.000 SENESE_HDAC2_TARGETS_UP nutritional deficiency disease DOID_5113 0.02154582 0.09081164 1.000 1.000 SENESE_HDAC2_TARGETS_UP oral submucous fibrosis DOID_5773 0.02154582 0.09014391 1.000 1.000 SENESE_HDAC2_TARGETS_UP intracranial hypertension DOID_9428 0.02154582 0.08948592 0.02154582 0.37150216 SENESE_HDAC2_TARGETS_UP spastic diplegia DOID_10965 0.02296589 0.09469269 1.000 1.000 SENESE_HDAC2_TARGETS_UP pituitary adenoma DOID_3829 0.02296589 0.09401145 0.02296589 0.38434092 SENESE_HDAC2_TARGETS_UP penile disease DOID_1529 0.02438394 0.09910328 1.000 1.000 SENESE_HDAC2_TARGETS_UP hyperostosis DOID_205 0.02438394 0.09840042 0.02438394 0.38540166 WEST_ADRENOCORTICAL_TUMOR_DN metabolic syndrome X DOID_14221 1.53E-15 8.704E-13 5.704E-10 1.082E-07 WEST_ADRENOCORTICAL_TUMOR_DN peripheral vascular disease DOID_341 9.817E-12 2.793E-09 2.313E-10 1.316E-07 WEST_ADRENOCORTICAL_TUMOR_DN atrophic muscular disease DOID_913 1.124E-11 2.133E-09 3.319E-10 9.442E-08 WEST_ADRENOCORTICAL_TUMOR_DN muscular dystrophy DOID_9884 1.124E-11 2.133E-09 3.319E-10 9.442E-08 WEST_ADRENOCORTICAL_TUMOR_DN retinal vascular disease DOID_2462 5.189E-11 7.381E-09 4.018E-06 1.143E-04 WEST_ADRENOCORTICAL_TUMOR_DN diabetic autonomic neuropathy DOID_11503 6.327E-11 7.2E-09 5.567E-08 7.92E-06 WEST_ADRENOCORTICAL_TUMOR_DN autonomic neuropathy DOID_11504 6.327E-11 7.2E-09 5.567E-08 7.92E-06 WEST_ADRENOCORTICAL_TUMOR_DN diabetic polyneuropathy DOID_12785 6.327E-11 7.2E-09 5.567E-08 7.92E-06 WEST_ADRENOCORTICAL_TUMOR_DN diabetic neuropathy DOID_9743 6.327E-11 7.2E-09 5.567E-08 7.92E-06 WEST_ADRENOCORTICAL_TUMOR_DN autonomic nervous system disease DOID_11465 1.141E-10 1.082E-08 8.676E-08 7.052E-06 WEST_ADRENOCORTICAL_TUMOR_DN brain infarction DOID_3454 1.322E-10 1.075E-08 5.857E-08 6.665E-06 WEST_ADRENOCORTICAL_TUMOR_DN diabetic retinopathy DOID_8947 2.646E-10 1.882E-08 2.225E-05 4.365E-04 WEST_ADRENOCORTICAL_TUMOR_DN chronic kidney failure DOID_784 8.182E-10 5.173E-08 3.437E-06 1.087E-04 WEST_ADRENOCORTICAL_TUMOR_DN gestational diabetes DOID_11714 1.548E-09 8.81E-08 2.216E-06 9.007E-05 WEST_ADRENOCORTICAL_TUMOR_DN cerebral infarction DOID_3526 2.407E-09 1.245E-07 1.485E-06 6.502E-05 WEST_ADRENOCORTICAL_TUMOR_DN vascular skin disease DOID_9540 3.381E-09 1.603E-07 8.676E-08 6.171E-06 WEST_ADRENOCORTICAL_TUMOR_DN carotid artery disease DOID_3407 2.548E-08 1.115E-06 1.151E-04 1.337E-03 WEST_ADRENOCORTICAL_TUMOR_DN intracranial arterial disease DOID_13089 2.926E-08 1.189E-06 2.904E-04 2.665E-03 WEST_ADRENOCORTICAL_TUMOR_DN cerebral arterial disease DOID_3527 2.926E-08 1.189E-06 2.904E-04 2.665E-03 WEST_ADRENOCORTICAL_TUMOR_DN urticaria DOID_1555 3.195E-08 1.212E-06 1.25E-06 5.928E-05 WEST_ADRENOCORTICAL_TUMOR_DN Crohn's disease DOID_8778 4.386E-08 1.56E-06 7.744E-06 1.836E-04 WEST_ADRENOCORTICAL_TUMOR_DN hyperglycemia DOID_4195 4.662E-08 1.561E-06 1.274E-05 2.788E-04 WEST_ADRENOCORTICAL_TUMOR_DN middle cerebral artery infarction DOID_3525 5.164E-08 1.632E-06 5.258E-05 7.873E-04 WEST_ADRENOCORTICAL_TUMOR_DN varicose veins DOID_799 6.101E-08 1.827E-06 6.101E-08 5.786E-06 WEST_ADRENOCORTICAL_TUMOR_DN ulcerative colitis DOID_8577 6.271E-08 1.784E-06 8.511E-07 4.402E-05 WEST_ADRENOCORTICAL_TUMOR_DN vein disease DOID_866 8.821E-08 2.39E-06 8.821E-08 5.577E-06 WEST_ADRENOCORTICAL_TUMOR_DN pleural disease DOID_1532 2.13E-07 5.509E-06 0.02773659 0.07812929 WEST_ADRENOCORTICAL_TUMOR_DN focal epilepsy DOID_2234 2.422E-07 5.993E-06 3.437E-06 1.15E-04 WEST_ADRENOCORTICAL_TUMOR_DN adrenal gland hyperfunction DOID_3947 5.991E-07 1.42E-05 5.991E-07 3.409E-05 WEST_ADRENOCORTICAL_TUMOR_DN alcohol-related neurodevelopmental disorder DOID_0050667 6.222E-07 1.416E-05 7.744E-06 1.916E-04 WEST_ADRENOCORTICAL_TUMOR_DN cholestasis DOID_13580 7.515E-07 1.645E-05 1.537E-04 1.682E-03 WEST_ADRENOCORTICAL_TUMOR_DN uterine disease DOID_345 7.515E-07 1.584E-05 1.537E-04 1.65E-03 WEST_ADRENOCORTICAL_TUMOR_DN temporal lobe epilepsy DOID_3328 8.311E-07 1.689E-05 1.274E-05 2.899E-04 WEST_ADRENOCORTICAL_TUMOR_DN endocrine organ benign neoplasm DOID_0060089 1.012E-06 1.985E-05 1.503E-05 3.055E-04 WEST_ADRENOCORTICAL_TUMOR_DN bile duct disease DOID_4138 1.343E-06 2.548E-05 2.291E-04 2.287E-03 WEST_ADRENOCORTICAL_TUMOR_DN biliary tract disease DOID_9741 1.472E-06 2.702E-05 2.439E-04 2.353E-03 WEST_ADRENOCORTICAL_TUMOR_DN aneurysm disease DOID_2403 2.096E-06 3.728E-05 3.11E-04 2.809E-03 WEST_ADRENOCORTICAL_TUMOR_DN Sciatic Neuropathy DOID_11446 2.216E-06 3.821E-05 6.063E-05 8.625E-04 WEST_ADRENOCORTICAL_TUMOR_DN lesion of sciatic nerve DOID_12528 2.216E-06 3.821E-05 6.063E-05 8.625E-04 WEST_ADRENOCORTICAL_TUMOR_DN mononeuritis of lower limb DOID_9473 2.216E-06 3.821E-05 6.063E-05 8.625E-04 WEST_ADRENOCORTICAL_TUMOR_DN mixed glioma DOID_5076 2.283E-06 3.821E-05 2.283E-06 8.66E-05 WEST_ADRENOCORTICAL_TUMOR_DN pleurisy DOID_10247 2.643E-06 4.297E-05 0.02077357 0.06221138 WEST_ADRENOCORTICAL_TUMOR_DN mononeuritis DOID_1802 2.643E-06 4.178E-05 6.956E-05 9.204E-04 WEST_ADRENOCORTICAL_TUMOR_DN female reproductive system disease DOID_229 2.928E-06 4.503E-05 3.911E-04 3.179E-03 WEST_ADRENOCORTICAL_TUMOR_DN mononeuropathy DOID_1188 3.133E-06 4.691E-05 7.94E-05 1.004E-03 WEST_ADRENOCORTICAL_TUMOR_DN toxic encephalopathy DOID_3602 3.133E-06 4.57E-05 3.133E-06 1.114E-04 WEST_ADRENOCORTICAL_TUMOR_DN adrenal cortex disease DOID_3952 3.782E-06 5.379E-05 3.782E-06 1.132E-04 WEST_ADRENOCORTICAL_TUMOR_DN primary bacterial infectious disease DOID_0050338 4.679E-06 6.493E-05 5.393E-04 4.204E-03 WEST_ADRENOCORTICAL_TUMOR_DN amino acid metabolic disorder DOID_9252 5.427E-06 7.353E-05 6.182E-05 8.58E-04 WEST_ADRENOCORTICAL_TUMOR_DN autonomic nervous system neoplasm DOID_2621 5.842E-06 7.73E-05 5.842E-06 1.583E-04 WEST_ADRENOCORTICAL_TUMOR_DN neuroblastoma DOID_769 5.842E-06 7.73E-05 5.842E-06 1.583E-04 WEST_ADRENOCORTICAL_TUMOR_DN adrenal gland disease DOID_9553 6.517E-06 8.428E-05 6.517E-06 1.686E-04 WEST_ADRENOCORTICAL_TUMOR_DN encephalomyelitis DOID_640 7.225E-06 9.136E-05 7.864E-05 1.017E-03 WEST_ADRENOCORTICAL_TUMOR_DN hypersensitivity reaction type I disease DOID_1205 8.294E-06 1.026E-04 8.832E-05 1.092E-03 WEST_ADRENOCORTICAL_TUMOR_DN respiratory failure DOID_11162 8.998E-06 1.089E-04 0.01254891 0.04225046 WEST_ADRENOCORTICAL_TUMOR_DN mineral metabolism disease DOID_0050032 1.074E-05 1.273E-04 1.569E-03 0.01014805 WEST_ADRENOCORTICAL_TUMOR_DN endocrine pancreas disease DOID_1428 1.074E-05 1.247E-04 1.432E-04 1.598E-03 WEST_ADRENOCORTICAL_TUMOR_DN parasitic infectious disease DOID_1398 1.17E-05 1.332E-04 0.01416702 0.04686648 WEST_ADRENOCORTICAL_TUMOR_DN peripheral nervous system neoplasm DOID_1192 1.3E-05 1.451E-04 1.3E-05 2.741E-04 WEST_ADRENOCORTICAL_TUMOR_DN membranous glomerulonephritis DOID_10976 1.304E-05 1.426E-04 4.183E-04 3.352E-03 WEST_ADRENOCORTICAL_TUMOR_DN adult respiratory distress syndrome DOID_11394 1.65E-05 1.772E-04 3.994E-03 0.02104252 WEST_ADRENOCORTICAL_TUMOR_DN pulmonary emphysema DOID_9675 1.851E-05 1.95E-04 4.263E-03 0.02109267 WEST_ADRENOCORTICAL_TUMOR_DN hyperinsulinism DOID_2018 2.308E-05 2.388E-04 3.774E-04 3.112E-03 WEST_ADRENOCORTICAL_TUMOR_DN diabetic angiopathy DOID_11713 2.793E-05 2.838E-04 7.266E-04 5.369E-03 WEST_ADRENOCORTICAL_TUMOR_DN ureteral disease DOID_1426 2.793E-05 2.788E-04 0.0135693 0.04515164 WEST_ADRENOCORTICAL_TUMOR_DN cataract DOID_83 2.848E-05 2.794E-04 2.848E-05 5.402E-04 WEST_ADRENOCORTICAL_TUMOR_DN pancreatitis DOID_4989 2.983E-05 2.877E-04 3.297E-04 2.886E-03 WEST_ADRENOCORTICAL_TUMOR_DN bacterial pneumonia DOID_874 2.983E-05 2.829E-04 0.02177511 0.06419709 WEST_ADRENOCORTICAL_TUMOR_DN contact dermatitis DOID_2773 3.433E-05 3.203E-04 3.698E-04 3.14E-03 WEST_ADRENOCORTICAL_TUMOR_DN lens disease DOID_110 3.482E-05 3.196E-04 3.482E-05 6.391E-04 WEST_ADRENOCORTICAL_TUMOR_DN neuritis DOID_1803 3.482E-05 3.145E-04 5.203E-04 4.112E-03 WEST_ADRENOCORTICAL_TUMOR_DN alcohol abuse DOID_1574 4.209E-05 3.743E-04 4.209E-05 7.485E-04 WEST_ADRENOCORTICAL_TUMOR_DN glaucoma DOID_1686 4.22E-05 3.694E-04 6.811E-03 0.02914036 WEST_ADRENOCORTICAL_TUMOR_DN pulmonary tuberculosis DOID_2957 4.22E-05 3.638E-04 6.811E-03 0.0289229 WEST_ADRENOCORTICAL_TUMOR_DN lung small cell carcinoma DOID_5409 4.22E-05 3.584E-04 4.22E-05 7.276E-04 WEST_ADRENOCORTICAL_TUMOR_DN calcium metabolism disease DOID_10575 4.631E-05 3.875E-04 7.181E-03 0.02982489 WEST_ADRENOCORTICAL_TUMOR_DN aortic aneurysm DOID_3627 4.631E-05 3.819E-04 7.181E-03 0.02960877 WEST_ADRENOCORTICAL_TUMOR_DN movement disease DOID_480 4.631E-05 3.765E-04 4.631E-05 7.751E-04 WEST_ADRENOCORTICAL_TUMOR_DN facioscapulohumeral muscular dystrophy DOID_11727 4.652E-05 3.728E-04 4.652E-05 7.563E-04 WEST_ADRENOCORTICAL_TUMOR_DN angioedema DOID_1558 4.652E-05 3.676E-04 4.652E-05 7.353E-04 WEST_ADRENOCORTICAL_TUMOR_DN chondrosarcoma DOID_3371 4.652E-05 3.626E-04 4.652E-05 7.154E-04 WEST_ADRENOCORTICAL_TUMOR_DN atopic dermatitis DOID_3310 5.547E-05 4.265E-04 5.547E-05 8.093E-04 WEST_ADRENOCORTICAL_TUMOR_DN transitional cell carcinoma DOID_2671 5.81E-05 4.408E-04 5.676E-04 4.365E-03 WEST_ADRENOCORTICAL_TUMOR_DN primary immunodeficiency disease DOID_612 6.182E-05 4.628E-04 5.97E-04 4.529E-03 WEST_ADRENOCORTICAL_TUMOR_DN nervous system cancer DOID_3093 6.573E-05 4.857E-04 6.573E-05 8.904E-04 WEST_ADRENOCORTICAL_TUMOR_DN bone marrow cancer DOID_4960 6.596E-05 4.812E-04 8.57E-04 6.173E-03 WEST_ADRENOCORTICAL_TUMOR_DN ocular hypertension DOID_9282 8.435E-05 6.076E-04 0.08541918 0.1806822 WEST_ADRENOCORTICAL_TUMOR_DN borderline glaucoma DOID_9283 8.435E-05 6.076E-04 0.08541918 0.1806822 WEST_ADRENOCORTICAL_TUMOR_DN hypertrophic cardiomyopathy DOID_11984 9.149E-05 6.507E-04 0.01056524 0.03853603 WEST_ADRENOCORTICAL_TUMOR_DN hypersensitivity reaction type IV disease DOID_2916 9.149E-05 6.427E-04 0.01056524 0.03829058 WEST_ADRENOCORTICAL_TUMOR_DN oral cavity cancer DOID_8618 9.149E-05 6.348E-04 9.149E-05 1.108E-03 WEST_ADRENOCORTICAL_TUMOR_DN carotid stenosis DOID_13001 1.091E-04 7.476E-04 4.046E-03 0.0207397 WEST_ADRENOCORTICAL_TUMOR_DN allergic rhinitis DOID_4481 1.15E-04 7.79E-04 0.22357906 0.34949585 WEST_ADRENOCORTICAL_TUMOR_DN neuroectodermal tumor DOID_171 1.151E-04 7.708E-04 1.151E-04 1.365E-03 WEST_ADRENOCORTICAL_TUMOR_DN pre-malignant neoplasm DOID_0060071 1.334E-04 8.823E-04 1.484E-03 9.936E-03 WEST_ADRENOCORTICAL_TUMOR_DN in situ carcinoma DOID_8719 1.334E-04 8.823E-04 1.484E-03 9.936E-03 WEST_ADRENOCORTICAL_TUMOR_DN parasitic helminthiasis infectious disease DOID_883 1.38E-04 9.028E-04 1.38E-04 1.571E-03 WEST_ADRENOCORTICAL_TUMOR_DN myocarditis DOID_820 1.444E-04 9.335E-04 2.401E-03 0.01468716 WEST_ADRENOCORTICAL_TUMOR_DN pneumoconiosis DOID_10316 1.609E-04 1.029E-03 0.03074859 0.08493177 WEST_ADRENOCORTICAL_TUMOR_DN tuberculosis DOID_399 1.885E-04 1.192E-03 0.01589804 0.05169133 WEST_ADRENOCORTICAL_TUMOR_DN refractive error DOID_9835 1.981E-04 1.239E-03 1.981E-04 2.087E-03 WEST_ADRENOCORTICAL_TUMOR_DN tongue cancer DOID_8649 2.1E-04 1.299E-03 2.1E-04 2.173E-03 WEST_ADRENOCORTICAL_TUMOR_DN calcinosis DOID_182 2.188E-04 1.339E-03 0.03549587 0.09350532 WEST_ADRENOCORTICAL_TUMOR_DN cleft palate DOID_674 2.188E-04 1.325E-03 2.188E-04 2.224E-03 WEST_ADRENOCORTICAL_TUMOR_DN multiple myeloma DOID_9538 2.188E-04 1.311E-03 3.25E-03 0.01831028 WEST_ADRENOCORTICAL_TUMOR_DN male reproductive system disease DOID_48 2.291E-04 1.358E-03 2.291E-04 2.247E-03 WEST_ADRENOCORTICAL_TUMOR_DN penile disease DOID_1529 2.537E-04 1.488E-03 2.537E-04 2.406E-03 WEST_ADRENOCORTICAL_TUMOR_DN hyperostosis DOID_205 2.537E-04 1.473E-03 2.537E-04 2.366E-03 WEST_ADRENOCORTICAL_TUMOR_DN bronchitis DOID_6132 2.537E-04 1.458E-03 6.918E-03 0.02894348 WEST_ADRENOCORTICAL_TUMOR_DN respiratory syncytial virus infectious disease DOID_1273 2.649E-04 1.507E-03 0.0388074 0.10037004 WEST_ADRENOCORTICAL_TUMOR_DN congenital diaphragmatic hernia DOID_3827 2.649E-04 1.492E-03 0.0388074 0.09991588 WEST_ADRENOCORTICAL_TUMOR_DN glucose intolerance DOID_10603 3.027E-04 1.689E-03 7.745E-03 0.03147729 WEST_ADRENOCORTICAL_TUMOR_DN ureteral obstruction DOID_5199 3.027E-04 1.672E-03 7.745E-03 0.03060293 WEST_ADRENOCORTICAL_TUMOR_DN benign mesothelioma DOID_2645 3.176E-04 1.738E-03 4.263E-03 0.02127769 WEST_ADRENOCORTICAL_TUMOR_DN electroclinical syndrome DOID_0050701 3.297E-04 1.787E-03 3.297E-04 2.931E-03 WEST_ADRENOCORTICAL_TUMOR_DN endometriosis of uterus DOID_288 3.466E-04 1.86E-03 4.543E-03 0.02228304 WEST_ADRENOCORTICAL_TUMOR_DN infertility DOID_5223 3.575E-04 1.901E-03 3.575E-04 3.082E-03 WEST_ADRENOCORTICAL_TUMOR_DN lipid metabolism disorder DOID_3146 3.698E-04 1.948E-03 3.698E-04 3.094E-03 WEST_ADRENOCORTICAL_TUMOR_DN endometriosis DOID_289 3.774E-04 1.97E-03 4.833E-03 0.02291825 WEST_ADRENOCORTICAL_TUMOR_DN gallbladder cancer DOID_3121 4.101E-04 2.121E-03 5.135E-03 0.02394913 WEST_ADRENOCORTICAL_TUMOR_DN brain edema DOID_4724 4.183E-04 2.144E-03 9.525E-03 0.03637237 WEST_ADRENOCORTICAL_TUMOR_DN autoimmune hepatitis DOID_2048 4.854E-04 2.466E-03 0.01047607 0.03896003 WEST_ADRENOCORTICAL_TUMOR_DN myeloma DOID_0070004 5.203E-04 2.62E-03 6.107E-03 0.02735995 WEST_ADRENOCORTICAL_TUMOR_DN pre-eclampsia DOID_10591 5.203E-04 2.597E-03 6.107E-03 0.0271462 WEST_ADRENOCORTICAL_TUMOR_DN heart valve disease DOID_4079 5.203E-04 2.575E-03 6.107E-03 0.02672857 WEST_ADRENOCORTICAL_TUMOR_DN placenta disease DOID_780 5.589E-04 2.742E-03 0.01146779 0.04027883 WEST_ADRENOCORTICAL_TUMOR_DN Human immunodeficiency virus infectious disease DOID_526 6.276E-04 3.052E-03 4.954E-03 0.02329708 WEST_ADRENOCORTICAL_TUMOR_DN urinary tract obstruction DOID_5200 6.393E-04 3.083E-03 0.01249907 0.04258666 WEST_ADRENOCORTICAL_TUMOR_DN pulmonary embolism DOID_9477 6.393E-04 3.057E-03 0.15731581 0.26961656 WEST_ADRENOCORTICAL_TUMOR_DN lingual-facial-buccal dyskinesia DOID_9854 6.393E-04 3.031E-03 6.393E-04 4.786E-03 WEST_ADRENOCORTICAL_TUMOR_DN orofacial cleft DOID_0050567 7.486E-04 3.52E-03 7.486E-04 5.461E-03 WEST_ADRENOCORTICAL_TUMOR_DN dilated cardiomyopathy DOID_12930 7.981E-04 3.722E-03 0.03568403 0.09313859 WEST_ADRENOCORTICAL_TUMOR_DN sarcoidosis DOID_11335 8.015E-04 3.708E-03 0.06492005 0.15718939 WEST_ADRENOCORTICAL_TUMOR_DN giant cell tumor DOID_200 8.015E-04 3.678E-03 8.36E-03 0.03280749 WEST_ADRENOCORTICAL_TUMOR_DN malignant giant cell tumor DOID_2705 8.015E-04 3.678E-03 8.36E-03 0.03280749 WEST_ADRENOCORTICAL_TUMOR_DN giant cell glioblastoma DOID_3074 8.015E-04 3.678E-03 8.36E-03 0.03280749 WEST_ADRENOCORTICAL_TUMOR_DN bile duct adenocarcinoma DOID_4896 8.57E-04 3.901E-03 8.777E-03 0.03420738 WEST_ADRENOCORTICAL_TUMOR_DN cholangiocarcinoma DOID_4947 8.57E-04 3.901E-03 8.777E-03 0.03420738 WEST_ADRENOCORTICAL_TUMOR_DN vasculitis DOID_865 8.57E-04 3.87E-03 0.34582328 0.51109986 WEST_ADRENOCORTICAL_TUMOR_DN reproductive organ benign neoplasm DOID_0050622 9.152E-04 4.1E-03 9.206E-03 0.03563462 WEST_ADRENOCORTICAL_TUMOR_DN parasitic protozoa infectious disease DOID_2789 9.152E-04 4.068E-03 0.3506794 0.51559839 WEST_ADRENOCORTICAL_TUMOR_DN X-linked disease DOID_0050735 9.232E-04 4.072E-03 9.232E-04 6.566E-03 WEST_ADRENOCORTICAL_TUMOR_DN glioblastoma DOID_3068 1.106E-03 4.842E-03 0.01056524 0.03804823 WEST_ADRENOCORTICAL_TUMOR_DN bile duct cancer DOID_4606 1.106E-03 4.805E-03 0.01056524 0.03780894 WEST_ADRENOCORTICAL_TUMOR_DN bile duct carcinoma DOID_4897 1.106E-03 4.805E-03 0.01056524 0.03780894 WEST_ADRENOCORTICAL_TUMOR_DN intracranial aneurysm DOID_10941 1.151E-03 4.96E-03 0.01822709 0.05698468 WEST_ADRENOCORTICAL_TUMOR_DN myopia DOID_11830 1.151E-03 4.922E-03 1.151E-03 8.083E-03 WEST_ADRENOCORTICAL_TUMOR_DN spinal cord disease DOID_319 1.151E-03 4.886E-03 0.01822709 0.05667329 WEST_ADRENOCORTICAL_TUMOR_DN fragments of torsion dystonia DOID_531 1.151E-03 4.85E-03 1.151E-03 7.984E-03 WEST_ADRENOCORTICAL_TUMOR_DN diffuse large B-cell lymphoma DOID_0050745 1.276E-03 5.34E-03 0.0194827 0.05960029 WEST_ADRENOCORTICAL_TUMOR_DN migraine DOID_6364 1.276E-03 5.301E-03 1.276E-03 8.75E-03 WEST_ADRENOCORTICAL_TUMOR_DN collagen disease DOID_854 1.324E-03 5.458E-03 0.01203446 0.04175369 WEST_ADRENOCORTICAL_TUMOR_DN renal hypertension DOID_1073 1.41E-03 5.774E-03 0.2001066 0.32346777 WEST_ADRENOCORTICAL_TUMOR_DN secondary hypertension DOID_11130 1.41E-03 5.774E-03 0.2001066 0.32346777 WEST_ADRENOCORTICAL_TUMOR_DN central nervous system hereditary degenerative disease DOID_481 1.41E-03 5.732E-03 1.41E-03 9.554E-03 WEST_ADRENOCORTICAL_TUMOR_DN congenital heart defect DOID_1682 1.484E-03 5.99E-03 0.01307579 0.04376545 WEST_ADRENOCORTICAL_TUMOR_DN polycystic ovary syndrome DOID_11612 1.553E-03 6.223E-03 1.553E-03 0.01027548 WEST_ADRENOCORTICAL_TUMOR_DN dystonic disease DOID_544 1.553E-03 6.18E-03 1.553E-03 0.01015738 WEST_ADRENOCORTICAL_TUMOR_DN female reproductive organ benign neoplasm DOID_0060086 1.704E-03 6.735E-03 0.02345877 0.06845149 WEST_ADRENOCORTICAL_TUMOR_DN uterine benign neoplasm DOID_0060095 1.704E-03 6.735E-03 0.02345877 0.06845149 WEST_ADRENOCORTICAL_TUMOR_DN uterine fibroid DOID_13223 1.704E-03 6.735E-03 0.02345877 0.06845149 WEST_ADRENOCORTICAL_TUMOR_DN allergic contact dermatitis DOID_3042 1.845E-03 7.241E-03 1.845E-03 0.01179695 WEST_ADRENOCORTICAL_TUMOR_DN age related macular degeneration DOID_10871 1.865E-03 7.267E-03 0.02485194 0.07141796 WEST_ADRENOCORTICAL_TUMOR_DN degeneration of macula and posterior pole DOID_2007 1.865E-03 7.267E-03 0.02485194 0.07141796 WEST_ADRENOCORTICAL_TUMOR_DN abdominal aortic aneurysm DOID_7693 1.865E-03 7.217E-03 0.21777609 0.34136253 WEST_ADRENOCORTICAL_TUMOR_DN germinoma DOID_3304 2.034E-03 7.82E-03 2.034E-03 0.01285903 WEST_ADRENOCORTICAL_TUMOR_DN astrocytoma DOID_3069 2.047E-03 7.816E-03 0.01650027 0.05334462 WEST_ADRENOCORTICAL_TUMOR_DN pancreatic ductal carcinoma DOID_3587 2.153E-03 8.166E-03 0.10222574 0.20337918 WEST_ADRENOCORTICAL_TUMOR_DN leiomyoma DOID_127 2.213E-03 8.337E-03 0.02773659 0.07851799 WEST_ADRENOCORTICAL_TUMOR_DN holoprosencephaly DOID_4621 2.369E-03 8.867E-03 2.369E-03 0.0148107 WEST_ADRENOCORTICAL_TUMOR_DN cutaneous leishmaniasis DOID_9111 2.369E-03 8.809E-03 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN papilloma DOID_2615 2.401E-03 8.87E-03 2.401E-03 0.0148468 WEST_ADRENOCORTICAL_TUMOR_DN pancreatic carcinoma DOID_4905 2.494E-03 9.156E-03 0.10930946 0.21012529 WEST_ADRENOCORTICAL_TUMOR_DN spindle cell carcinoma DOID_4015 2.598E-03 9.477E-03 2.598E-03 0.0157271 WEST_ADRENOCORTICAL_TUMOR_DN macular degeneration DOID_4448 2.598E-03 9.416E-03 0.03074859 0.08371266 WEST_ADRENOCORTICAL_TUMOR_DN esophageal disease DOID_6050 2.598E-03 9.357E-03 2.598E-03 0.01556155 WEST_ADRENOCORTICAL_TUMOR_DN cystic fibrosis DOID_1485 2.741E-03 9.81E-03 0.02038006 0.06201205 WEST_ADRENOCORTICAL_TUMOR_DN childhood electroclinical syndrome DOID_0050704 2.806E-03 9.977E-03 2.806E-03 0.01662855 WEST_ADRENOCORTICAL_TUMOR_DN medullomyoblastoma DOID_3861 2.806E-03 9.915E-03 2.806E-03 0.01645713 WEST_ADRENOCORTICAL_TUMOR_DN adult medulloblastoma DOID_3864 2.806E-03 9.915E-03 2.806E-03 0.01645713 WEST_ADRENOCORTICAL_TUMOR_DN childhood medulloblastoma DOID_3869 2.806E-03 9.915E-03 2.806E-03 0.01645713 WEST_ADRENOCORTICAL_TUMOR_DN maturity-onset diabetes of the young DOID_0050524 2.881E-03 0.01011874 2.881E-03 0.0167269 WEST_ADRENOCORTICAL_TUMOR_DN pneumocystosis DOID_11339 2.881E-03 0.01005666 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN adenoma DOID_657 3.023E-03 0.01048766 3.023E-03 0.0173735 WEST_ADRENOCORTICAL_TUMOR_DN pulmonary sarcoidosis DOID_13406 3.25E-03 0.01120811 0.03549587 0.09394023 WEST_ADRENOCORTICAL_TUMOR_DN medulloblastoma DOID_3858 3.25E-03 0.01114059 3.25E-03 0.01849338 WEST_ADRENOCORTICAL_TUMOR_DN Usher syndrome DOID_0050439 3.44E-03 0.01172146 3.44E-03 0.01919102 WEST_ADRENOCORTICAL_TUMOR_DN familial atrial fibrillation DOID_0050650 3.44E-03 0.01165169 3.44E-03 0.0190047 WEST_ADRENOCORTICAL_TUMOR_DN osteopetrosis DOID_13533 3.44E-03 0.01158274 3.44E-03 0.01882196 WEST_ADRENOCORTICAL_TUMOR_DN islet cell tumor DOID_1799 3.44E-03 0.01151461 3.44E-03 0.0186427 WEST_ADRENOCORTICAL_TUMOR_DN retinal detachment DOID_5327 3.44E-03 0.01144727 3.44E-03 0.01846683 WEST_ADRENOCORTICAL_TUMOR_DN lipodystrophy DOID_811 3.44E-03 0.01138072 0.08541918 0.18203563 WEST_ADRENOCORTICAL_TUMOR_DN peptic ulcer DOID_750 3.736E-03 0.01228652 0.0388074 0.09946581 WEST_ADRENOCORTICAL_TUMOR_DN mental depression DOID_1596 3.737E-03 0.01222176 3.737E-03 0.01987463 WEST_ADRENOCORTICAL_TUMOR_DN biliary tract cancer DOID_4607 3.737E-03 0.01215192 0.0254857 0.07287118 WEST_ADRENOCORTICAL_TUMOR_DN lymphatic system disease DOID_75 3.994E-03 0.01291245 3.994E-03 0.02084947 WEST_ADRENOCORTICAL_TUMOR_DN infancy electroclinical syndrome DOID_0050703 4.046E-03 0.01300626 4.046E-03 0.02092825 WEST_ADRENOCORTICAL_TUMOR_DN essential hypertension DOID_10825 4.046E-03 0.01293319 0.09220029 0.19287486 WEST_ADRENOCORTICAL_TUMOR_DN impotence DOID_1875 4.046E-03 0.01286093 4.046E-03 0.02055453 WEST_ADRENOCORTICAL_TUMOR_DN larynx cancer DOID_2596 4.046E-03 0.01278948 0.09220029 0.19007958 WEST_ADRENOCORTICAL_TUMOR_DN laryngeal benign neoplasm DOID_2598 4.046E-03 0.01278948 0.09220029 0.19007958 WEST_ADRENOCORTICAL_TUMOR_DN Leydig cell tumor DOID_2696 4.046E-03 0.01271882 4.046E-03 0.02037263 WEST_ADRENOCORTICAL_TUMOR_DN sex cord-stromal neoplasm DOID_4757 4.046E-03 0.01271882 4.046E-03 0.02037263 WEST_ADRENOCORTICAL_TUMOR_DN alcohol dependence DOID_0050741 4.697E-03 0.01468517 4.697E-03 0.0228436 WEST_ADRENOCORTICAL_TUMOR_DN tethered spinal cord syndrome DOID_1089 4.697E-03 0.01460492 0.09893129 0.20032707 WEST_ADRENOCORTICAL_TUMOR_DN eyelid disease DOID_530 4.697E-03 0.01452555 4.697E-03 0.02265001 WEST_ADRENOCORTICAL_TUMOR_DN Huntington's disease DOID_12858 4.833E-03 0.01486589 0.045764 0.11521999 WEST_ADRENOCORTICAL_TUMOR_DN primitive neuroectodermal tumor DOID_168 4.833E-03 0.01478597 4.833E-03 0.02311084 WEST_ADRENOCORTICAL_TUMOR_DN influenza DOID_8469 5.135E-03 0.01562456 0.29522673 0.44322958 WEST_ADRENOCORTICAL_TUMOR_DN lymphoma DOID_0060058 5.345E-03 0.0161779 0.0329645 0.08847548 WEST_ADRENOCORTICAL_TUMOR_DN Ehlers-Danlos syndrome DOID_13359 5.393E-03 0.01623737 5.393E-03 0.02495011 WEST_ADRENOCORTICAL_TUMOR_DN renovascular hypertension DOID_1591 5.393E-03 0.01615191 0.10561257 0.20793617 WEST_ADRENOCORTICAL_TUMOR_DN lung oat cell carcinoma DOID_5411 5.393E-03 0.01606735 5.393E-03 0.0247489 WEST_ADRENOCORTICAL_TUMOR_DN learning disability DOID_8927 5.448E-03 0.01614431 5.448E-03 0.02479767 WEST_ADRENOCORTICAL_TUMOR_DN lymphoblastic leukemia DOID_1037 5.548E-03 0.01635737 5.548E-03 0.02505534 WEST_ADRENOCORTICAL_TUMOR_DN carbohydrate metabolic disorder DOID_2978 5.548E-03 0.01627305 0.03385851 0.09044832 WEST_ADRENOCORTICAL_TUMOR_DN thyroid adenoma DOID_2891 6.107E-03 0.01781904 6.107E-03 0.02693577 WEST_ADRENOCORTICAL_TUMOR_DN silicosis DOID_10325 6.134E-03 0.01780714 0.11224448 0.21431916 WEST_ADRENOCORTICAL_TUMOR_DN hemolytic-uremic syndrome DOID_12554 6.134E-03 0.01771674 0.11224448 0.21360237 WEST_ADRENOCORTICAL_TUMOR_DN long QT syndrome DOID_2843 6.134E-03 0.01762727 6.134E-03 0.02664274 WEST_ADRENOCORTICAL_TUMOR_DN Barrett's esophagus DOID_9206 6.134E-03 0.01753869 6.134E-03 0.0264409 WEST_ADRENOCORTICAL_TUMOR_DN autoimmune disease of gastrointestinal tract DOID_0060031 6.811E-03 0.01937834 0.05697387 0.1409484 WEST_ADRENOCORTICAL_TUMOR_DN drug-induced mental disorder DOID_1203 6.918E-03 0.01958365 6.918E-03 0.02915788 WEST_ADRENOCORTICAL_TUMOR_DN drug psychosis DOID_1742 6.918E-03 0.01958365 6.918E-03 0.02915788 WEST_ADRENOCORTICAL_TUMOR_DN substance-induced psychosis DOID_8646 6.918E-03 0.01958365 6.918E-03 0.02915788 WEST_ADRENOCORTICAL_TUMOR_DN B-cell lymphocytic neoplasm DOID_707 7.562E-03 0.02130196 0.06090208 0.14872653 WEST_ADRENOCORTICAL_TUMOR_DN congenital muscular dystrophy DOID_0050557 7.745E-03 0.02170848 7.745E-03 0.03170375 WEST_ADRENOCORTICAL_TUMOR_DN neuroendocrine tumor DOID_169 7.745E-03 0.02160207 7.745E-03 0.03125405 WEST_ADRENOCORTICAL_TUMOR_DN sexual dysfunction DOID_1876 7.745E-03 0.02149669 7.745E-03 0.03103395 WEST_ADRENOCORTICAL_TUMOR_DN osteosclerosis DOID_4254 7.745E-03 0.02139234 7.745E-03 0.03081693 WEST_ADRENOCORTICAL_TUMOR_DN leishmaniasis DOID_9065 8.614E-03 0.02367796 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN smallpox DOID_8736 9.206E-03 0.02518408 9.206E-03 0.03539385 WEST_ADRENOCORTICAL_TUMOR_DN colonic disease DOID_5353 9.525E-03 0.02593054 9.525E-03 0.03612989 WEST_ADRENOCORTICAL_TUMOR_DN familial hyperlipidemia DOID_1168 9.647E-03 0.02613886 9.647E-03 0.03635205 WEST_ADRENOCORTICAL_TUMOR_DN mitochondrial metabolism disease DOID_700 9.647E-03 0.02601497 9.647E-03 0.03611289 WEST_ADRENOCORTICAL_TUMOR_DN coronary restenosis DOID_4247 0.01047607 0.02811738 0.01047607 0.03870704 WEST_ADRENOCORTICAL_TUMOR_DN nonsyndromic deafness DOID_0050563 0.01056524 0.02822357 0.01056524 0.03878465 WEST_ADRENOCORTICAL_TUMOR_DN melancholia DOID_2848 0.01104267 0.02936112 0.01104267 0.03927049 WEST_ADRENOCORTICAL_TUMOR_DN leukocyte disease DOID_9500 0.01104267 0.02922455 0.0774781 0.17424917 WEST_ADRENOCORTICAL_TUMOR_DN gastric ulcer DOID_10808 0.01146779 0.03020912 0.15101943 0.26769488 WEST_ADRENOCORTICAL_TUMOR_DN familial hypercholesterolemia DOID_13810 0.01146779 0.03006991 0.01146779 0.040529 WEST_ADRENOCORTICAL_TUMOR_DN acquired immunodeficiency syndrome DOID_635 0.01146779 0.02993197 0.15101943 0.26440017 WEST_ADRENOCORTICAL_TUMOR_DN neurotic disorder DOID_4964 0.01153239 0.02996315 0.01153239 0.04025724 WEST_ADRENOCORTICAL_TUMOR_DN sexual disorder DOID_0060043 0.01249907 0.03232715 0.01249907 0.04310286 WEST_ADRENOCORTICAL_TUMOR_DN heart conduction disease DOID_10273 0.01249907 0.03218087 0.01249907 0.04284321 WEST_ADRENOCORTICAL_TUMOR_DN uremia DOID_4676 0.01249907 0.03203591 0.15731581 0.27043111 WEST_ADRENOCORTICAL_TUMOR_DN hypoglycemia DOID_9993 0.01249907 0.03189225 0.01249907 0.04233317 WEST_ADRENOCORTICAL_TUMOR_DN Goodpasture syndrome DOID_9808 0.0135693 0.03446844 0.16356566 0.27781749 WEST_ADRENOCORTICAL_TUMOR_DN cerebral degeneration DOID_1443 0.01416702 0.03582682 0.01416702 0.04659558 WEST_ADRENOCORTICAL_TUMOR_DN acute pancreatitis DOID_2913 0.01467783 0.03695436 0.16976932 0.28664315 WEST_ADRENOCORTICAL_TUMOR_DN organic acidemia DOID_0060159 0.01582405 0.03966469 0.01582405 0.05174646 WEST_ADRENOCORTICAL_TUMOR_DN bronchiolitis DOID_2942 0.01582405 0.03949072 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN autosomal dominant nonsyndromic deafness DOID_0050564 0.01700734 0.0422584 0.01700734 0.0546733 WEST_ADRENOCORTICAL_TUMOR_DN cystitis DOID_1679 0.01700734 0.04207467 0.01700734 0.05436615 WEST_ADRENOCORTICAL_TUMOR_DN papillary adenoma DOID_3172 0.01700734 0.04189253 0.01700734 0.05406243 WEST_ADRENOCORTICAL_TUMOR_DN microcystic adenoma DOID_5403 0.01700734 0.04189253 0.01700734 0.05406243 WEST_ADRENOCORTICAL_TUMOR_DN follicular adenoma DOID_6204 0.01700734 0.04189253 0.01700734 0.05406243 WEST_ADRENOCORTICAL_TUMOR_DN ankylosing spondylitis DOID_7147 0.01700734 0.04171196 0.01700734 0.05376208 WEST_ADRENOCORTICAL_TUMOR_DN blood coagulation disease DOID_1247 0.01711516 0.04179625 0.01711516 0.05380401 WEST_ADRENOCORTICAL_TUMOR_DN nephrosis DOID_2527 0.01774273 0.04314364 0.10457249 0.20732316 WEST_ADRENOCORTICAL_TUMOR_DN seminoma DOID_4440 0.01822709 0.04413282 0.01822709 0.05636528 WEST_ADRENOCORTICAL_TUMOR_DN dystonia DOID_543 0.01822709 0.04394581 0.01822709 0.0560606 WEST_ADRENOCORTICAL_TUMOR_DN periodontitis DOID_824 0.0194827 0.04677491 0.19412883 0.31559802 WEST_ADRENOCORTICAL_TUMOR_DN endogenous depression DOID_1595 0.02038006 0.04872376 0.02038006 0.0616822 WEST_ADRENOCORTICAL_TUMOR_DN syndrome DOID_225 0.02038006 0.04851989 0.02038006 0.06135584 WEST_ADRENOCORTICAL_TUMOR_DN autoimmune disease of cardiovascular system DOID_0060051 0.02077357 0.04925067 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN malaria DOID_12365 0.02077357 0.04904631 0.2001066 0.32164027 WEST_ADRENOCORTICAL_TUMOR_DN Behcet's disease DOID_13241 0.02077357 0.04925067 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN invasive ductal carcinoma DOID_3008 0.02077357 0.04884364 0.02077357 0.06188566 WEST_ADRENOCORTICAL_TUMOR_DN coronary stenosis DOID_4248 0.02077357 0.04864264 0.02077357 0.06156334 WEST_ADRENOCORTICAL_TUMOR_DN bone resorption disease DOID_0080011 0.02107121 0.04913738 0.11651852 0.22026259 WEST_ADRENOCORTICAL_TUMOR_DN osteoporosis DOID_11476 0.02107121 0.04913738 0.11651852 0.22026259 WEST_ADRENOCORTICAL_TUMOR_DN autoimmune disease of endocrine system DOID_0060005 0.02209912 0.05132408 0.02209912 0.0648165 WEST_ADRENOCORTICAL_TUMOR_DN focal glomerulosclerosis DOID_3945 0.02209912 0.05111545 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN endometrial carcinoma DOID_2871 0.02345877 0.05404065 0.02345877 0.06810225 WEST_ADRENOCORTICAL_TUMOR_DN auditory system disease DOID_2742 0.02471811 0.05671213 0.02471811 0.07139395 WEST_ADRENOCORTICAL_TUMOR_DN opportunistic mycosis DOID_2473 0.02485194 0.05679018 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN endometrial cancer DOID_1380 0.02627807 0.05980888 0.02627807 0.0747611 WEST_ADRENOCORTICAL_TUMOR_DN childhood absence epilepsy DOID_1825 0.02773659 0.06287696 0.02773659 0.07774442 WEST_ADRENOCORTICAL_TUMOR_DN hereditary spastic paraplegia DOID_2476 0.02773659 0.06262745 0.02773659 0.07736332 WEST_ADRENOCORTICAL_TUMOR_DN bladder disease DOID_365 0.02773659 0.06237991 0.02773659 0.07698594 WEST_ADRENOCORTICAL_TUMOR_DN systemic mycosis DOID_0050136 0.02922694 0.06547295 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN fungal infectious disease DOID_1564 0.02922694 0.06547295 1.000 1.000 WEST_ADRENOCORTICAL_TUMOR_DN hepatitis C DOID_1883 0.03074859 0.06861155 0.03074859 0.08452148 WEST_ADRENOCORTICAL_TUMOR_DN nephroblastoma DOID_2154 0.03074859 0.06834354 0.03074859 0.08411512 WEST_ADRENOCORTICAL_TUMOR_DN periodontal disease DOID_3388 0.03074859 0.06807761 0.24073185 0.37425253 WEST_ADRENOCORTICAL_TUMOR_DN paraplegia DOID_607 0.03074859 0.06781374 0.03074859 0.08331403 WEST_ADRENOCORTICAL_TUMOR_DN lymphoid leukemia DOID_10747 0.03230098 0.07096238 0.03230098 0.08710548 WEST_ADRENOCORTICAL_TUMOR_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.03388358 0.07415292 0.03388358 0.09009233 WEST_ADRENOCORTICAL_TUMOR_DN mouth disease DOID_403 0.03476503 0.07579043 0.51086228 0.74533496 WEST_ADRENOCORTICAL_TUMOR_DN embryonal cancer DOID_688 0.03549587 0.07708835 0.03549587 0.09307442 WEST_ADRENOCORTICAL_TUMOR_DN blood platelet disease DOID_2218 0.03713731 0.0803465 0.03713731 0.09648918 WEST_ADRENOCORTICAL_TUMOR_DN hepatitis DOID_2237 0.0388074 0.0836417 0.26848477 0.40956524 WEST_ADRENOCORTICAL_TUMOR_DN systemic scleroderma DOID_418 0.0388074 0.08332607 0.26848477 0.40847014 WEST_ADRENOCORTICAL_TUMOR_DN adenoid cystic carcinoma DOID_4866 0.04050561 0.08664546 0.04050561 0.10335288 WEST_ADRENOCORTICAL_TUMOR_DN cervix uteri carcinoma in situ DOID_8991 0.04223145 0.08999885 0.27930078 0.42379239 WEST_ADRENOCORTICAL_TUMOR_DN spinocerebellar ataxia DOID_1441 0.04398441 0.09338481 0.04398441 0.11172826 WEST_ADRENOCORTICAL_TUMOR_DN salivary gland cancer DOID_8850 0.04398441 0.09303766 0.04398441 0.11123169 WEST_ADRENOCORTICAL_TUMOR_DN rheumatic disease DOID_1575 0.045764 0.0964434 0.28995744 0.43647032 WEST_ADRENOCORTICAL_TUMOR_DN scleroderma DOID_419 0.045764 0.0964434 0.28995744 0.43647032 WEST_ADRENOCORTICAL_TUMOR_DN uterine cancer DOID_363 0.04756974 0.0998789 0.04756974 0.11923868 VALK_AML_CLUSTER_9 giant cell tumor DOID_200 4.42E-04 0.08383188 0.03057402 0.36242947 VALK_AML_CLUSTER_9 malignant giant cell tumor DOID_2705 4.42E-04 0.08383188 0.03057402 0.36242947 VALK_AML_CLUSTER_9 giant cell glioblastoma DOID_3074 4.42E-04 0.08383188 0.03057402 0.36242947 VALK_AML_CLUSTER_9 bone marrow cancer DOID_4960 4.579E-04 0.06513849 0.0311118 0.35405232 VALK_AML_CLUSTER_9 glioblastoma DOID_3068 5.244E-04 0.05967138 0.03326011 0.35046304 VALK_AML_CLUSTER_9 bile duct cancer DOID_4606 5.244E-04 0.04972615 5.244E-04 0.29835688 VALK_AML_CLUSTER_9 bile duct carcinoma DOID_4897 5.244E-04 0.04972615 5.244E-04 0.29835688 VALK_AML_CLUSTER_9 congenital heart defect DOID_1682 6.136E-04 0.04987576 6.136E-04 0.17456516 VALK_AML_CLUSTER_9 astrocytoma DOID_3069 7.297E-04 0.05189931 0.0391446 0.37751316 VALK_AML_CLUSTER_9 biliary tract cancer DOID_4607 1.015E-03 0.06415535 1.015E-03 0.19246604 BASSO_HAIRY_CELL_LEUKEMIA_DN transitional cell carcinoma DOID_2671 2.208E-09 1.256E-06 2.208E-09 1.256E-06 BASSO_HAIRY_CELL_LEUKEMIA_DN diabetic retinopathy DOID_8947 3.202E-06 9.109E-04 1.418E-04 0.01152564 BASSO_HAIRY_CELL_LEUKEMIA_DN retinal vascular disease DOID_2462 5.496E-06 1.042E-03 2.116E-04 0.01003419 BASSO_HAIRY_CELL_LEUKEMIA_DN cleft lip DOID_9296 6.174E-06 8.783E-04 6.174E-06 1.757E-03 BASSO_HAIRY_CELL_LEUKEMIA_DN encephalomyelitis DOID_640 7.8E-06 8.876E-04 2.743E-04 0.01200597 BASSO_HAIRY_CELL_LEUKEMIA_DN hypersensitivity reaction type I disease DOID_1205 8.472E-06 8.035E-04 2.916E-04 0.0110631 BASSO_HAIRY_CELL_LEUKEMIA_DN cleft palate DOID_674 2.06E-05 1.675E-03 2.06E-05 3.908E-03 BASSO_HAIRY_CELL_LEUKEMIA_DN gallbladder cancer DOID_3121 3.36E-05 2.39E-03 3.36E-05 4.779E-03 BASSO_HAIRY_CELL_LEUKEMIA_DN neuritis DOID_1803 4.05E-05 2.56E-03 4.05E-05 4.609E-03 BASSO_HAIRY_CELL_LEUKEMIA_DN orofacial cleft DOID_0050567 5.396E-05 3.07E-03 5.396E-05 5.117E-03 BASSO_HAIRY_CELL_LEUKEMIA_DN Legionnaires' disease DOID_10457 1.536E-04 7.943E-03 0.01830995 0.15549796 BASSO_HAIRY_CELL_LEUKEMIA_DN legionellosis DOID_10458 1.536E-04 7.943E-03 0.01830995 0.15549796 BASSO_HAIRY_CELL_LEUKEMIA_DN electroclinical syndrome DOID_0050701 1.651E-04 7.828E-03 1.651E-04 0.01174268 BASSO_HAIRY_CELL_LEUKEMIA_DN oral submucous fibrosis DOID_5773 1.77E-04 7.749E-03 1.77E-04 0.01119285 BASSO_HAIRY_CELL_LEUKEMIA_DN biliary tract cancer DOID_4607 1.976E-04 8.029E-03 1.976E-04 0.01124109 BASSO_HAIRY_CELL_LEUKEMIA_DN spastic diplegia DOID_10965 2.022E-04 7.669E-03 2.022E-04 0.01045722 BASSO_HAIRY_CELL_LEUKEMIA_DN mouth disease DOID_403 2.829E-04 0.0100602 2.829E-04 0.01149737 BASSO_HAIRY_CELL_LEUKEMIA_DN spastic quadriplegia DOID_10970 5.016E-04 0.01678821 5.016E-04 0.01783747 BASSO_HAIRY_CELL_LEUKEMIA_DN ankylosing spondylitis DOID_7147 5.859E-04 0.01851973 5.859E-04 0.01960912 BASSO_HAIRY_CELL_LEUKEMIA_DN gestational diabetes DOID_11714 6.765E-04 0.02026005 6.765E-04 0.02138561 BASSO_HAIRY_CELL_LEUKEMIA_DN dysostosis DOID_1934 8.244E-04 0.02345428 8.244E-04 0.02468872 BASSO_HAIRY_CELL_LEUKEMIA_DN spastic cerebral palsy DOID_0050669 8.769E-04 0.02375851 8.769E-04 0.02494644 BASSO_HAIRY_CELL_LEUKEMIA_DN allergic rhinitis DOID_4481 9.309E-04 0.02407571 0.04389832 0.21910655 BASSO_HAIRY_CELL_LEUKEMIA_DN bladder disease DOID_365 9.865E-04 0.02440407 0.04516044 0.21593521 BASSO_HAIRY_CELL_LEUKEMIA_DN childhood electroclinical syndrome DOID_0050704 1.163E-03 0.0275626 1.163E-03 0.03150011 BASSO_HAIRY_CELL_LEUKEMIA_DN calcinosis DOID_182 1.288E-03 0.0293089 0.05144656 0.22692319 BASSO_HAIRY_CELL_LEUKEMIA_DN adenoid cystic carcinoma DOID_4866 1.487E-03 0.03254339 1.487E-03 0.03846036 BASSO_HAIRY_CELL_LEUKEMIA_DN cervix uteri carcinoma in situ DOID_8991 1.557E-03 0.03280275 1.557E-03 0.03850757 BASSO_HAIRY_CELL_LEUKEMIA_DN salivary gland cancer DOID_8850 1.628E-03 0.0330746 1.628E-03 0.03858703 BASSO_HAIRY_CELL_LEUKEMIA_DN diabetic autonomic neuropathy DOID_11503 1.774E-03 0.03481083 1.774E-03 0.04038056 BASSO_HAIRY_CELL_LEUKEMIA_DN autonomic neuropathy DOID_11504 1.774E-03 0.03481083 1.774E-03 0.04038056 BASSO_HAIRY_CELL_LEUKEMIA_DN diabetic polyneuropathy DOID_12785 1.774E-03 0.03481083 1.774E-03 0.04038056 BASSO_HAIRY_CELL_LEUKEMIA_DN influenza DOID_8469 1.774E-03 0.03365047 0.06017904 0.2445848 BASSO_HAIRY_CELL_LEUKEMIA_DN diabetic neuropathy DOID_9743 1.774E-03 0.03481083 1.774E-03 0.04038056 BASSO_HAIRY_CELL_LEUKEMIA_DN cataract DOID_83 1.85E-03 0.03395227 1.85E-03 0.04048155 BASSO_HAIRY_CELL_LEUKEMIA_DN myeloma DOID_0070004 2.005E-03 0.03565964 2.005E-03 0.04226327 BASSO_HAIRY_CELL_LEUKEMIA_DN lens disease DOID_110 2.005E-03 0.03457904 2.005E-03 0.04075387 BASSO_HAIRY_CELL_LEUKEMIA_DN autonomic nervous system disease DOID_11465 2.005E-03 0.03356201 2.005E-03 0.03934857 BASSO_HAIRY_CELL_LEUKEMIA_DN brain cancer DOID_1319 2.005E-03 0.0326031 2.005E-03 0.03803695 BASSO_HAIRY_CELL_LEUKEMIA_DN heart valve disease DOID_4079 2.005E-03 0.03169746 0.06389736 0.25248334 BASSO_HAIRY_CELL_LEUKEMIA_DN central nervous system cancer DOID_3620 2.086E-03 0.03207259 2.086E-03 0.03828019 BASSO_HAIRY_CELL_LEUKEMIA_DN calcium metabolism disease DOID_10575 2.25E-03 0.03369464 0.06760127 0.2598995 BASSO_HAIRY_CELL_LEUKEMIA_DN bile duct adenocarcinoma DOID_4896 2.597E-03 0.03789685 2.597E-03 0.04618679 BASSO_HAIRY_CELL_LEUKEMIA_DN cholangiocarcinoma DOID_4947 2.597E-03 0.03789685 2.597E-03 0.04618679 BASSO_HAIRY_CELL_LEUKEMIA_DN bone marrow cancer DOID_4960 2.597E-03 0.03694943 2.597E-03 0.04478719 BASSO_HAIRY_CELL_LEUKEMIA_DN reproductive organ benign neoplasm DOID_0050622 2.688E-03 0.0373043 2.688E-03 0.04498459 BASSO_HAIRY_CELL_LEUKEMIA_DN parasitic protozoa infectious disease DOID_2789 2.688E-03 0.0364161 0.07374257 0.27787762 BASSO_HAIRY_CELL_LEUKEMIA_DN bile duct cancer DOID_4606 2.968E-03 0.03927875 2.968E-03 0.04825675 BASSO_HAIRY_CELL_LEUKEMIA_DN bile duct carcinoma DOID_4897 2.968E-03 0.03927875 2.968E-03 0.04825675 BASSO_HAIRY_CELL_LEUKEMIA_DN oral cavity cancer DOID_8618 2.968E-03 0.03838605 2.968E-03 0.04691628 BASSO_HAIRY_CELL_LEUKEMIA_DN melancholia DOID_2848 3.065E-03 0.03875156 3.065E-03 0.04713027 BASSO_HAIRY_CELL_LEUKEMIA_DN neurotic disorder DOID_4964 3.163E-03 0.03911918 3.163E-03 0.04735479 BASSO_HAIRY_CELL_LEUKEMIA_DN carotid artery disease DOID_3407 3.262E-03 0.03948873 3.262E-03 0.04758898 BASSO_HAIRY_CELL_LEUKEMIA_DN respiratory failure DOID_11162 3.363E-03 0.03986005 0.08227383 0.30202456 BASSO_HAIRY_CELL_LEUKEMIA_DN hypothyroidism DOID_1459 3.363E-03 0.03904658 3.363E-03 0.04783205 BASSO_HAIRY_CELL_LEUKEMIA_DN pre-malignant neoplasm DOID_0060071 3.465E-03 0.03942832 3.465E-03 0.04808331 BASSO_HAIRY_CELL_LEUKEMIA_DN in situ carcinoma DOID_8719 3.465E-03 0.03942832 3.465E-03 0.04808331 BASSO_HAIRY_CELL_LEUKEMIA_DN mineral metabolism disease DOID_0050032 3.568E-03 0.03981116 0.08469715 0.30892743 BASSO_HAIRY_CELL_LEUKEMIA_DN parasitic infectious disease DOID_1398 3.673E-03 0.04019499 0.08590646 0.30937201 BASSO_HAIRY_CELL_LEUKEMIA_DN tooth disease DOID_1091 3.888E-03 0.04173818 3.888E-03 0.05266961 BASSO_HAIRY_CELL_LEUKEMIA_DN brain infarction DOID_3454 3.997E-03 0.04211728 3.997E-03 0.05289147 BASSO_HAIRY_CELL_LEUKEMIA_DN pancreatic ductal carcinoma DOID_3587 4.22E-03 0.04365774 4.22E-03 0.05457218 BASSO_HAIRY_CELL_LEUKEMIA_DN biliary tract disease DOID_9741 4.449E-03 0.04520064 4.449E-03 0.05624969 BASSO_HAIRY_CELL_LEUKEMIA_DN pancreatic carcinoma DOID_4905 4.565E-03 0.0455696 4.565E-03 0.05646668 BASSO_HAIRY_CELL_LEUKEMIA_DN cystic fibrosis DOID_1485 4.802E-03 0.04710899 0.09791377 0.34179715 BASSO_HAIRY_CELL_LEUKEMIA_DN endogenous depression DOID_1595 4.802E-03 0.04631053 4.802E-03 0.0581345 BASSO_HAIRY_CELL_LEUKEMIA_DN aneurysm disease DOID_2403 4.923E-03 0.04668233 4.923E-03 0.05835292 BASSO_HAIRY_CELL_LEUKEMIA_DN bacterial pneumonia DOID_874 5.045E-03 0.04705492 0.10029662 0.3437878 BASSO_HAIRY_CELL_LEUKEMIA_DN metabolic syndrome X DOID_14221 5.293E-03 0.04857317 0.10267329 0.34982697 BASSO_HAIRY_CELL_LEUKEMIA_DN mental depression DOID_1596 5.675E-03 0.05125715 5.675E-03 0.06590205 BASSO_HAIRY_CELL_LEUKEMIA_DN focal epilepsy DOID_2234 5.675E-03 0.05045626 5.675E-03 0.06458401 BASSO_HAIRY_CELL_LEUKEMIA_DN bone development disease DOID_0080006 5.805E-03 0.05082024 5.805E-03 0.06477089 BASSO_HAIRY_CELL_LEUKEMIA_DN primary bacterial infectious disease DOID_0050338 6.204E-03 0.05348959 0.11094331 0.37575443 BASSO_HAIRY_CELL_LEUKEMIA_DN nervous system cancer DOID_3093 6.616E-03 0.05618277 6.616E-03 0.07238934 BASSO_HAIRY_CELL_LEUKEMIA_DN alcohol-related neurodevelopmental disorder DOID_0050667 7.183E-03 0.06010067 7.183E-03 0.07711029 ONDER_CDH1_SIGNALING_VIA_CTNNB1 aneurysm disease DOID_2403 2.249E-09 1.28E-06 6.342E-06 3.609E-03 ONDER_CDH1_SIGNALING_VIA_CTNNB1 cystic fibrosis DOID_1485 1.246E-07 3.546E-05 2.263E-04 0.06437864 ONDER_CDH1_SIGNALING_VIA_CTNNB1 bacterial pneumonia DOID_874 1.416E-07 2.686E-05 0.11352106 0.6210912 ONDER_CDH1_SIGNALING_VIA_CTNNB1 aortic aneurysm DOID_3627 1.272E-06 1.81E-04 2.913E-03 0.1507071 ONDER_CDH1_SIGNALING_VIA_CTNNB1 respiratory failure DOID_11162 2.903E-06 3.303E-04 0.09324696 0.57051094 ONDER_CDH1_SIGNALING_VIA_CTNNB1 cholestasis DOID_13580 3.48E-06 3.3E-04 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 bile duct disease DOID_4138 4.884E-06 3.97E-04 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 biliary tract disease DOID_9741 5.153E-06 3.665E-04 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 metabolic syndrome X DOID_14221 7.358E-06 4.652E-04 0.1161904 0.62964133 ONDER_CDH1_SIGNALING_VIA_CTNNB1 chromosomal disease DOID_0080014 7.722E-06 4.394E-04 2.718E-04 0.03093626 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pleurisy DOID_10247 1.271E-05 6.575E-04 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 focal glomerulosclerosis DOID_3945 1.406E-05 6.666E-04 0.04559075 0.45510767 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pleural disease DOID_1532 2.038E-05 8.921E-04 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 congenital diaphragmatic hernia DOID_3827 3.548E-05 1.442E-03 0.06127212 0.49103997 ONDER_CDH1_SIGNALING_VIA_CTNNB1 adult respiratory distress syndrome DOID_11394 3.81E-05 1.445E-03 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 intracranial arterial disease DOID_13089 3.81E-05 1.355E-03 0.06268509 0.4953863 ONDER_CDH1_SIGNALING_VIA_CTNNB1 cerebral arterial disease DOID_3527 3.81E-05 1.355E-03 0.06268509 0.4953863 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pre-eclampsia DOID_10591 6.007E-05 2.01E-03 2.597E-03 0.16421969 ONDER_CDH1_SIGNALING_VIA_CTNNB1 parasitic protozoa infectious disease DOID_2789 9.376E-05 2.964E-03 0.08363048 0.54696254 ONDER_CDH1_SIGNALING_VIA_CTNNB1 bronchiectasis DOID_9563 1.211E-04 3.626E-03 0.01641711 0.37365347 ONDER_CDH1_SIGNALING_VIA_CTNNB1 parasitic infectious disease DOID_1398 1.507E-04 4.286E-03 0.09733789 0.57098205 ONDER_CDH1_SIGNALING_VIA_CTNNB1 newborn respiratory distress syndrome DOID_12716 1.714E-04 4.644E-03 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 nephrosis DOID_2527 1.936E-04 5.008E-03 0.10546543 0.6123452 ONDER_CDH1_SIGNALING_VIA_CTNNB1 diabetic retinopathy DOID_8947 2.096E-04 5.184E-03 0.1081586 0.61542243 ONDER_CDH1_SIGNALING_VIA_CTNNB1 Ehlers-Danlos syndrome DOID_13359 2.303E-04 5.46E-03 2.303E-04 0.04367813 ONDER_CDH1_SIGNALING_VIA_CTNNB1 thoracic aortic aneurysm DOID_14004 2.303E-04 5.241E-03 2.303E-04 0.0327586 ONDER_CDH1_SIGNALING_VIA_CTNNB1 hyperhomocysteinemia DOID_9279 2.303E-04 5.04E-03 0.02232108 0.38486951 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pancreatitis DOID_4989 2.439E-04 5.139E-03 0.11352106 0.62712121 ONDER_CDH1_SIGNALING_VIA_CTNNB1 spastic diplegia DOID_10965 2.629E-04 5.343E-03 0.02379162 0.39815978 ONDER_CDH1_SIGNALING_VIA_CTNNB1 familial hypertrophic cardiomyopathy DOID_11986 2.977E-04 5.841E-03 2.977E-04 0.02823217 ONDER_CDH1_SIGNALING_VIA_CTNNB1 bone development disease DOID_0080006 3.018E-04 5.725E-03 3.018E-04 0.02453423 ONDER_CDH1_SIGNALING_VIA_CTNNB1 retinal vascular disease DOID_2462 3.123E-04 5.732E-03 0.12282925 0.64712819 ONDER_CDH1_SIGNALING_VIA_CTNNB1 transitional cell carcinoma DOID_2671 3.45E-04 6.135E-03 8.172E-03 0.25832552 ONDER_CDH1_SIGNALING_VIA_CTNNB1 Down syndrome DOID_14250 3.736E-04 6.442E-03 0.02819022 0.42211152 ONDER_CDH1_SIGNALING_VIA_CTNNB1 brain edema DOID_4724 4.147E-04 6.94E-03 0.02965209 0.41151321 ONDER_CDH1_SIGNALING_VIA_CTNNB1 dilated cardiomyopathy DOID_12930 4.298E-04 6.987E-03 9.437E-03 0.2684763 ONDER_CDH1_SIGNALING_VIA_CTNNB1 muscular atrophy DOID_767 5.032E-04 7.954E-03 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 acute pancreatitis DOID_2913 6.516E-04 0.01002121 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 bronchiolitis DOID_2942 7.053E-04 0.01056042 0.03837805 0.4456553 ONDER_CDH1_SIGNALING_VIA_CTNNB1 intracranial aneurysm DOID_10941 8.187E-04 0.01194456 8.187E-04 0.05822975 ONDER_CDH1_SIGNALING_VIA_CTNNB1 middle cerebral artery infarction DOID_3525 8.187E-04 0.01164595 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 autoimmune disease of cardiovascular system DOID_0060051 9.403E-04 0.01304999 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 malaria DOID_12365 9.403E-04 0.01273928 0.04415248 0.47401431 ONDER_CDH1_SIGNALING_VIA_CTNNB1 Behcet's disease DOID_13241 9.403E-04 0.01304999 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 spastic cerebral palsy DOID_0050669 1.138E-03 0.01505959 0.04846093 0.45957111 ONDER_CDH1_SIGNALING_VIA_CTNNB1 age related macular degeneration DOID_10871 1.138E-03 0.01471733 0.04846093 0.45203716 ONDER_CDH1_SIGNALING_VIA_CTNNB1 degeneration of macula and posterior pole DOID_2007 1.138E-03 0.01471733 0.04846093 0.45203716 ONDER_CDH1_SIGNALING_VIA_CTNNB1 abdominal aortic aneurysm DOID_7693 1.138E-03 0.01439028 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 macular degeneration DOID_4448 1.43E-03 0.0176884 0.05417586 0.47424713 ONDER_CDH1_SIGNALING_VIA_CTNNB1 respiratory syncytial virus infectious disease DOID_1273 1.84E-03 0.02227328 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pulmonary emphysema DOID_9675 2.018E-03 0.02391617 0.06409596 0.47987632 ONDER_CDH1_SIGNALING_VIA_CTNNB1 nephrotic syndrome DOID_1184 2.203E-03 0.02558287 0.06691145 0.48811044 ONDER_CDH1_SIGNALING_VIA_CTNNB1 influenza DOID_8469 2.299E-03 0.02616027 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 cerebral infarction DOID_3526 2.396E-03 0.02673666 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 proteinuria DOID_576 2.496E-03 0.02731202 0.07111909 0.49958964 ONDER_CDH1_SIGNALING_VIA_CTNNB1 heart valve disease DOID_4079 2.597E-03 0.02788636 2.597E-03 0.14779772 ONDER_CDH1_SIGNALING_VIA_CTNNB1 vascular skin disease DOID_9540 2.597E-03 0.02736995 0.07251749 0.49713796 ONDER_CDH1_SIGNALING_VIA_CTNNB1 glaucoma DOID_1686 2.806E-03 0.02903194 0.07530809 0.50412118 ONDER_CDH1_SIGNALING_VIA_CTNNB1 sarcoidosis DOID_11335 3.247E-03 0.03298798 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 giant cell tumor DOID_200 3.247E-03 0.03240925 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 malignant giant cell tumor DOID_2705 3.247E-03 0.03240925 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 giant cell glioblastoma DOID_3074 3.247E-03 0.03240925 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 atrophic muscular disease DOID_913 3.247E-03 0.03185047 3.247E-03 0.15394392 ONDER_CDH1_SIGNALING_VIA_CTNNB1 muscular dystrophy DOID_9884 3.247E-03 0.03185047 3.247E-03 0.15394392 ONDER_CDH1_SIGNALING_VIA_CTNNB1 vasculitis DOID_865 3.361E-03 0.03241798 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 osteochondrodysplasia DOID_2256 3.478E-03 0.03298442 3.478E-03 0.15223578 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pustulosis of palm and sole DOID_4398 3.478E-03 0.03244369 3.478E-03 0.14136179 ONDER_CDH1_SIGNALING_VIA_CTNNB1 smallpox DOID_8736 3.478E-03 0.0319204 3.478E-03 0.13193767 ONDER_CDH1_SIGNALING_VIA_CTNNB1 hypersensitivity reaction type IV disease DOID_2916 3.839E-03 0.03467722 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 glioblastoma DOID_3068 3.839E-03 0.03413539 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 carotid artery disease DOID_3407 4.218E-03 0.03691968 0.09187927 0.5682533 ONDER_CDH1_SIGNALING_VIA_CTNNB1 collagen disease DOID_854 4.218E-03 0.03636029 4.218E-03 0.14998619 ONDER_CDH1_SIGNALING_VIA_CTNNB1 mineral metabolism disease DOID_0050032 4.612E-03 0.03916896 0.09597626 0.56885931 ONDER_CDH1_SIGNALING_VIA_CTNNB1 hyperglycemia DOID_4195 4.884E-03 0.04087072 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 brain infarction DOID_3454 5.164E-03 0.04258295 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 astrocytoma DOID_3069 5.306E-03 0.04313243 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pancreatic ductal carcinoma DOID_3587 5.451E-03 0.04368083 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 peripheral vascular disease DOID_341 5.744E-03 0.04539625 0.10681301 0.61390509 ONDER_CDH1_SIGNALING_VIA_CTNNB1 pancreatic carcinoma DOID_4905 5.894E-03 0.04594036 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 alcohol abuse DOID_1574 7.319E-03 0.05628035 7.319E-03 0.24498505 ONDER_CDH1_SIGNALING_VIA_CTNNB1 chronic kidney failure DOID_784 7.319E-03 0.05552994 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 primary bacterial infectious disease DOID_0050338 7.998E-03 0.05988015 1.000 1.000 ONDER_CDH1_SIGNALING_VIA_CTNNB1 primary immunodeficiency disease DOID_612 8.348E-03 0.06168563 0.12810504 0.66873179 ONDER_CDH1_SIGNALING_VIA_CTNNB1 amino acid metabolic disorder DOID_9252 8.348E-03 0.06089479 0.12810504 0.66265241 ONDER_CDH1_SIGNALING_VIA_CTNNB1 nervous system cancer DOID_3093 8.525E-03 0.06140116 0.1294191 0.66341864 ONDER_CDH1_SIGNALING_VIA_CTNNB1 hypersensitivity reaction type I disease DOID_1205 9.437E-03 0.06711907 9.437E-03 0.28260663 ONDER_CDH1_SIGNALING_VIA_CTNNB1 ulcerative colitis DOID_8577 0.01000386 0.07027402 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP aneurysm disease DOID_2403 7.455E-18 4.242E-15 3.266E-09 9.292E-07 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP heart valve disease DOID_4079 1.746E-12 4.967E-10 7.046E-09 1.002E-06 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP Ehlers-Danlos syndrome DOID_13359 2.408E-12 4.567E-10 2.408E-12 1.37E-09 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP collagen disease DOID_854 7.251E-10 1.031E-07 3.218E-08 3.052E-06 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bone development disease DOID_0080006 5.955E-09 6.777E-07 5.955E-09 1.129E-06 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP spastic quadriplegia DOID_10970 9.088E-09 8.619E-07 7.806E-07 4.935E-05 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP intracranial aneurysm DOID_10941 1.67E-08 1.357E-06 7.187E-05 3.146E-03 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP focal glomerulosclerosis DOID_3945 2.867E-08 2.039E-06 9.8E-05 3.717E-03 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP aortic valve insufficiency DOID_57 3.144E-08 1.988E-06 3.144E-08 3.578E-06 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP spastic cerebral palsy DOID_0050669 3.986E-08 2.268E-06 2.481E-06 1.412E-04 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP tuberculosis DOID_399 6.047E-08 3.128E-06 0.18504246 0.69269185 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP intracranial arterial disease DOID_13089 1.58E-07 7.493E-06 6.849E-03 0.10825237 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP cerebral arterial disease DOID_3527 1.58E-07 7.493E-06 6.849E-03 0.10825237 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP primary bacterial infectious disease DOID_0050338 2.353E-07 1.03E-05 0.22628808 0.78035101 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP cerebral infarction DOID_3526 2.779E-07 1.129E-05 8.476E-03 0.11483135 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP thyroid adenoma DOID_2891 3.423E-07 1.298E-05 9.171E-03 0.11859455 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pulmonary tuberculosis DOID_2957 4.18E-07 1.486E-05 0.13914082 0.5864528 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP aortic aneurysm DOID_3627 4.605E-07 1.541E-05 4.878E-04 0.01632605 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP uremia DOID_4676 5.488E-07 1.735E-05 1.992E-03 0.04928285 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP aortic valve disease DOID_62 6.571E-07 1.968E-05 6.571E-07 5.342E-05 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP osteochondrodysplasia DOID_2256 7.269E-07 2.068E-05 7.269E-07 5.17E-05 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP middle cerebral artery infarction DOID_3525 1.255E-06 3.401E-05 0.07748261 0.44087607 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP endocrine organ benign neoplasm DOID_0060089 2.005E-06 5.186E-05 0.01789107 0.19960819 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP brain infarction DOID_3454 2.005E-06 4.96E-05 0.01789107 0.19576957 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pleural disease DOID_1532 3.16E-06 7.492E-05 0.09590483 0.48723079 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP esophageal disease DOID_6050 3.969E-06 9.032E-05 5.108E-03 0.08548998 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP multiple myeloma DOID_9538 5.455E-06 1.194E-04 0.10883993 0.49943483 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP encephalomyelitis DOID_640 8.447E-06 1.78E-04 0.23957159 0.81140615 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP spastic diplegia DOID_10965 1.26E-05 2.56E-04 1.26E-05 6.517E-04 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP myeloma DOID_0070004 1.345E-05 2.638E-04 0.13416252 0.57832179 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP glaucoma DOID_1686 1.574E-05 2.985E-04 1.574E-05 7.462E-04 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP prion disease DOID_649 1.828E-05 3.355E-04 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bone marrow cancer DOID_4960 2.271E-05 4.038E-04 0.15146283 0.60691797 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP hepatitis B DOID_2043 3.421E-05 5.899E-04 0.06139645 0.38816199 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP carotid artery disease DOID_3407 3.597E-05 6.019E-04 0.01470431 0.1743073 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP Goodpasture syndrome DOID_9808 4.478E-05 7.28E-04 0.06678915 0.40863467 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP portal hypertension DOID_10762 5.728E-05 9.053E-04 0.07215114 0.43214738 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP peripheral vascular disease DOID_341 6.715E-05 1.033E-03 0.01983132 0.20896337 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP diabetic retinopathy DOID_8947 7.073E-05 1.059E-03 0.02032959 0.20656319 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pleurisy DOID_10247 8.87E-05 1.294E-03 0.08278373 0.45292251 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP hepatic vascular disease DOID_272 8.87E-05 1.262E-03 0.08278373 0.44437681 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP multiple epiphyseal dysplasia DOID_12721 9.8E-05 1.36E-03 9.8E-05 3.983E-03 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP endometrial carcinoma DOID_2871 1.079E-04 1.462E-03 3.84E-03 0.07283527 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP abdominal aortic aneurysm DOID_7693 1.185E-04 1.567E-03 4.08E-03 0.07489294 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP retinal vascular disease DOID_2462 1.198E-04 1.549E-03 0.02614751 0.25216838 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP endometrial cancer DOID_1380 1.296E-04 1.639E-03 4.327E-03 0.076943 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP papilloma DOID_2615 1.54E-04 1.905E-03 0.09850665 0.49602019 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP hepatitis C DOID_1883 1.673E-04 2.025E-03 5.108E-03 0.08808059 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP thyroid carcinoma DOID_3963 1.673E-04 1.983E-03 0.10110104 0.49167943 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mouth disease DOID_403 1.752E-04 2.035E-03 2.72E-03 0.05732894 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP thyroid cancer DOID_1781 1.959E-04 2.23E-03 0.10626766 0.50812017 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP benign mesothelioma DOID_2645 2.81E-04 3.135E-03 0.11905584 0.53340766 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pulmonary emphysema DOID_9675 2.81E-04 3.075E-03 7.162E-03 0.10448839 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP uterine cancer DOID_363 3.419E-04 3.67E-03 8.138E-03 0.11294121 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP brain cancer DOID_1319 4.107E-04 4.327E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP neuritis DOID_1803 4.107E-04 4.249E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP central nervous system cancer DOID_3620 4.354E-04 4.424E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pneumocystosis DOID_11339 4.429E-04 4.422E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP craniosynostosis DOID_2340 4.429E-04 4.345E-03 4.429E-04 0.01575182 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP calcium metabolism disease DOID_10575 4.878E-04 4.704E-03 0.14161933 0.58818538 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP B-cell lymphocytic neoplasm DOID_707 5.154E-04 4.888E-03 0.14409076 0.59411335 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP sarcoidosis DOID_11335 5.736E-04 5.35E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bile duct adenocarcinoma DOID_4896 6.042E-04 5.545E-03 0.15146283 0.61122235 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP cholangiocarcinoma DOID_4947 6.042E-04 5.545E-03 0.15146283 0.61122235 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP osteogenesis imperfecta DOID_12347 6.258E-04 5.652E-03 6.258E-04 0.01978233 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP open-angle glaucoma DOID_1067 7.287E-04 6.479E-03 7.287E-04 0.02182364 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP hypersensitivity reaction type IV disease DOID_2916 7.37E-04 6.451E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bile duct cancer DOID_4606 7.37E-04 6.354E-03 0.16119448 0.62394327 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bile duct carcinoma DOID_4897 7.37E-04 6.354E-03 0.16119448 0.62394327 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP oral cavity cancer DOID_8618 7.37E-04 6.259E-03 0.01342229 0.16249544 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP skeletal system cancer DOID_0060124 8.393E-04 7.023E-03 0.04227771 0.33411137 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bone cancer DOID_184 8.393E-04 7.023E-03 0.04227771 0.33411137 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP membranoproliferative glomerulonephritis DOID_2920 8.393E-04 6.921E-03 0.04227771 0.31652656 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP oral submucous fibrosis DOID_5773 8.393E-04 6.822E-03 8.393E-04 0.02387717 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pre-malignant neoplasm DOID_0060071 9.273E-04 7.432E-03 0.01558719 0.18100225 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP congenital heart defect DOID_1682 9.273E-04 7.328E-03 9.273E-04 0.02512617 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP in situ carcinoma DOID_8719 9.273E-04 7.432E-03 0.01558719 0.18100225 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP restrictive cardiomyopathy DOID_397 9.574E-04 7.462E-03 0.0450324 0.3243473 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP thyroiditis DOID_7166 9.574E-04 7.361E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP autoimmune thyroiditis DOID_7188 9.574E-04 7.361E-03 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP Barrett's esophagus DOID_9206 9.574E-04 7.263E-03 9.574E-04 0.0247609 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mineral metabolism disease DOID_0050032 9.688E-04 7.253E-03 0.17558498 0.67052249 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP methylmalonic acidemia DOID_14749 1.083E-03 8.003E-03 0.04777924 0.33563442 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pancreatic ductal carcinoma DOID_3587 1.242E-03 9.061E-03 0.01885056 0.20237677 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP nephrosis DOID_2527 1.292E-03 9.305E-03 0.19206496 0.7096426 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pancreatic carcinoma DOID_4905 1.395E-03 9.924E-03 0.02032959 0.21031888 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bone resorption disease DOID_0080011 1.56E-03 0.01095677 0.20363612 0.74274968 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP osteoporosis DOID_11476 1.56E-03 0.01095677 0.20363612 0.74274968 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pancreatitis DOID_4989 1.617E-03 0.01122147 0.20593057 0.74633435 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mixed glioma DOID_5076 1.617E-03 0.01108627 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bacterial pneumonia DOID_874 1.617E-03 0.01095429 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP autoimmune hepatitis DOID_2048 1.66E-03 0.01111047 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP coronary restenosis DOID_4247 1.66E-03 0.01098128 0.05868853 0.38383649 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mitochondrial myopathy DOID_699 1.66E-03 0.01085506 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP funisitis DOID_0050698 1.822E-03 0.01178276 0.06139645 0.39698385 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP biliary tract cancer DOID_4607 1.924E-03 0.01230052 0.21730494 0.75394213 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP chronic kidney failure DOID_784 1.924E-03 0.01216385 0.02504475 0.24569764 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP diabetic angiopathy DOID_11713 2.169E-03 0.01356303 2.169E-03 0.05142647 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP synostosis DOID_11971 2.169E-03 0.0134156 2.169E-03 0.04936941 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP meningitis DOID_9471 2.169E-03 0.01327135 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP transitional cell carcinoma DOID_2671 2.265E-03 0.01370922 0.22851785 0.78329313 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP amino acid metabolic disorder DOID_9252 2.337E-03 0.01399825 0.02841104 0.25259189 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP nervous system cancer DOID_3093 2.411E-03 0.01428966 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP organic acidemia DOID_0060159 2.545E-03 0.014927 0.07215114 0.43674469 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP reading disorder DOID_13365 2.545E-03 0.01477468 2.545E-03 0.05568919 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP urticaria DOID_1555 2.545E-03 0.01462544 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP dyslexia DOID_4428 2.545E-03 0.01477468 2.545E-03 0.05568919 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP lymphoma DOID_0060058 2.563E-03 0.01458198 0.23737347 0.80877546 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP lymphoblastic leukemia DOID_1037 2.641E-03 0.01487748 0.03075022 0.26918266 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP papillary adenoma DOID_3172 2.743E-03 0.01530221 0.07482068 0.43441805 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP microcystic adenoma DOID_5403 2.743E-03 0.01530221 0.07482068 0.43441805 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP follicular adenoma DOID_6204 2.743E-03 0.01530221 0.07482068 0.43441805 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP myositis DOID_633 2.743E-03 0.01515364 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP hypersensitivity reaction type I disease DOID_1205 2.801E-03 0.01532664 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP diffuse large B-cell lymphoma DOID_0050745 3.161E-03 0.01712999 0.08013695 0.45146463 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP Sciatic Neuropathy DOID_11446 3.161E-03 0.01696838 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP lesion of sciatic nerve DOID_12528 3.161E-03 0.01696838 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP perinatal necrotizing enterocolitis DOID_8677 3.161E-03 0.0168098 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mononeuritis of lower limb DOID_9473 3.161E-03 0.01696838 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mononeuritis DOID_1802 3.381E-03 0.01781036 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP coronary stenosis DOID_4248 3.381E-03 0.01764696 0.08278373 0.44022375 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP autoimmune disease of endocrine system DOID_0060005 3.607E-03 0.01865754 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mononeuropathy DOID_1188 3.607E-03 0.01848945 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP toxic encephalopathy DOID_3602 3.607E-03 0.01832437 3.607E-03 0.07329748 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP dysostosis DOID_1934 3.84E-03 0.0193368 3.84E-03 0.07534683 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP opportunistic mycosis DOID_2473 4.08E-03 0.02036562 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP celiac disease DOID_10608 4.327E-03 0.02141022 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP systemic mycosis DOID_0050136 4.841E-03 0.02374731 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP fungal infectious disease DOID_1564 4.841E-03 0.02374731 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP periodontal disease DOID_3388 5.108E-03 0.02484324 0.10110104 0.49591805 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP lymphoid leukemia DOID_10747 5.382E-03 0.02595264 5.382E-03 0.08749746 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP adenoma DOID_657 5.662E-03 0.02707496 0.10626766 0.50388584 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP calcinosis DOID_182 5.949E-03 0.02820971 0.10883993 0.50762229 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP uveitis DOID_13141 6.243E-03 0.02935638 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP respiratory syncytial virus infectious disease DOID_1273 6.543E-03 0.0305145 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP hepatitis DOID_2237 6.543E-03 0.03026642 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP congenital diaphragmatic hernia DOID_3827 6.543E-03 0.03002233 0.11396247 0.51464005 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP adenoid cystic carcinoma DOID_4866 6.849E-03 0.03117668 6.849E-03 0.10532663 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP cervix uteri carcinoma in situ DOID_8991 7.162E-03 0.03234164 7.162E-03 0.10723808 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP salivary gland cancer DOID_8850 7.481E-03 0.0335168 7.481E-03 0.10641583 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP nephrotic syndrome DOID_1184 7.806E-03 0.03470173 0.1241202 0.5474759 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP uveal disease DOID_3480 7.806E-03 0.03443272 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP influenza DOID_8469 8.138E-03 0.03561992 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP learning disability DOID_8927 8.476E-03 0.03681616 8.476E-03 0.11216085 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP proteinuria DOID_576 8.82E-03 0.03802107 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP vascular skin disease DOID_9540 9.171E-03 0.03923429 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP autoimmune disease of gastrointestinal tract DOID_0060031 9.89E-03 0.04199537 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP lung small cell carcinoma DOID_5409 9.89E-03 0.0416843 0.13914082 0.58214065 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP giant cell tumor DOID_200 0.01140082 0.04769902 0.14901249 0.60562934 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP malignant giant cell tumor DOID_2705 0.01140082 0.04769902 0.14901249 0.60562934 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP giant cell glioblastoma DOID_3074 0.01140082 0.04769902 0.14901249 0.60562934 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP atrophic muscular disease DOID_913 0.01140082 0.04735085 0.01140082 0.14415705 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP muscular dystrophy DOID_9884 0.01140082 0.04735085 0.01140082 0.14415705 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP integumentary system cancer DOID_0060122 0.01219191 0.05026955 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP parasitic protozoa infectious disease DOID_2789 0.01219191 0.0499079 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP skin cancer DOID_4159 0.01219191 0.05026955 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP pustulosis of palm and sole DOID_4398 0.01219191 0.04955141 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP mitochondrial metabolism disease DOID_700 0.01259624 0.05083165 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP congenital nervous system abnormality DOID_2490 0.01300638 0.05211712 0.01300638 0.1608833 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP glioblastoma DOID_3068 0.01342229 0.05340759 0.16119448 0.62821685 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP respiratory failure DOID_11162 0.01514295 0.05983569 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP hypothyroidism DOID_1459 0.01514295 0.05942303 0.17081553 0.65671648 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP endocrine pancreas disease DOID_1428 0.01603699 0.06250031 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP cholestasis DOID_13580 0.01649231 0.06383757 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP parasitic infectious disease DOID_1398 0.01649231 0.06340624 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP tooth disease DOID_1091 0.01741938 0.066521 0.18268822 0.68840792 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP allergic contact dermatitis DOID_3042 0.01741938 0.06607753 0.01741938 0.19823258 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP astrocytoma DOID_3069 0.01836814 0.06921504 0.18738999 0.69689479 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP bile duct disease DOID_4138 0.0193383 0.0723914 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP biliary tract disease DOID_9741 0.01983132 0.07375178 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP cystic fibrosis DOID_1485 0.02134175 0.07885361 0.2013351 0.73909464 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP metabolic syndrome X DOID_14221 0.02342758 0.0860019 0.21049984 0.75806587 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP contact dermatitis DOID_2773 0.02342758 0.08545061 0.02342758 0.23386482 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP angioedema DOID_1558 0.02838572 0.09970046 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP retinal vascular occlusion DOID_1729 0.02838572 0.0990888 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP transient cerebral ischemia DOID_224 0.02838572 0.0984846 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP acute kidney failure DOID_3021 0.02838572 0.09788773 1.000 1.000 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP holoprosencephaly DOID_4621 0.02838572 0.09729804 0.02838572 0.25637262 VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP visceral leishmaniasis DOID_9146 0.02838572 0.09671542 1.000 1.000 WANG_SMARCE1_TARGETS_UP atrophic muscular disease DOID_913 5.703E-11 3.245E-08 9.197E-08 5.233E-05 WANG_SMARCE1_TARGETS_UP muscular dystrophy DOID_9884 5.703E-11 3.245E-08 9.197E-08 5.233E-05 WANG_SMARCE1_TARGETS_UP aortic valve insufficiency DOID_57 6.79E-10 1.932E-07 0.04616339 0.28551052 WANG_SMARCE1_TARGETS_UP focal glomerulosclerosis DOID_3945 2.261E-09 4.289E-07 6.638E-06 1.889E-03 WANG_SMARCE1_TARGETS_UP ureteral obstruction DOID_5199 7.207E-09 1.025E-06 0.06844492 0.33573411 WANG_SMARCE1_TARGETS_UP urinary tract obstruction DOID_5200 2.786E-08 3.17E-06 0.08661735 0.37911749 WANG_SMARCE1_TARGETS_UP aneurysm disease DOID_2403 2.876E-08 2.727E-06 1.563E-05 2.224E-03 WANG_SMARCE1_TARGETS_UP ureteral disease DOID_1426 3.508E-08 2.851E-06 0.09020936 0.38305318 WANG_SMARCE1_TARGETS_UP aortic valve disease DOID_62 3.508E-08 2.495E-06 0.09020936 0.38021575 WANG_SMARCE1_TARGETS_UP facioscapulohumeral muscular dystrophy DOID_11727 4.725E-08 2.987E-06 6.997E-06 1.327E-03 WANG_SMARCE1_TARGETS_UP giant cell tumor DOID_200 9.197E-08 5.233E-06 7.18E-05 5.107E-03 WANG_SMARCE1_TARGETS_UP malignant giant cell tumor DOID_2705 9.197E-08 5.233E-06 7.18E-05 5.107E-03 WANG_SMARCE1_TARGETS_UP giant cell glioblastoma DOID_3074 9.197E-08 5.233E-06 7.18E-05 5.107E-03 WANG_SMARCE1_TARGETS_UP vasculitis DOID_865 1.025E-07 5.3E-06 7.698E-05 4.867E-03 WANG_SMARCE1_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.118E-07 5.303E-06 4.019E-05 3.811E-03 WANG_SMARCE1_TARGETS_UP osteochondrodysplasia DOID_2256 1.139E-07 4.986E-06 1.567E-03 0.02701912 WANG_SMARCE1_TARGETS_UP glioblastoma DOID_3068 1.548E-07 6.29E-06 1.005E-04 5.197E-03 WANG_SMARCE1_TARGETS_UP collagen disease DOID_854 2.069E-07 7.85E-06 2.08E-03 0.03287325 WANG_SMARCE1_TARGETS_UP Ehlers-Danlos syndrome DOID_13359 3.024E-07 1.076E-05 1.558E-03 0.03283064 WANG_SMARCE1_TARGETS_UP thoracic aortic aneurysm DOID_14004 3.024E-07 1.012E-05 1.558E-03 0.03165812 WANG_SMARCE1_TARGETS_UP astrocytoma DOID_3069 4.203E-07 1.328E-05 1.915E-04 9.082E-03 WANG_SMARCE1_TARGETS_UP brain edema DOID_4724 1.057E-06 3.166E-05 6.458E-05 5.249E-03 WANG_SMARCE1_TARGETS_UP bone development disease DOID_0080006 1.209E-06 3.439E-05 4.798E-03 0.05571157 WANG_SMARCE1_TARGETS_UP heart valve disease DOID_4079 1.611E-06 4.364E-05 0.1788321 0.54707239 WANG_SMARCE1_TARGETS_UP glaucoma DOID_1686 1.963E-06 5.077E-05 0.0178932 0.14972399 WANG_SMARCE1_TARGETS_UP aortic aneurysm DOID_3627 2.161E-06 5.346E-05 1.207E-03 0.02861255 WANG_SMARCE1_TARGETS_UP encephalomyelitis DOID_640 2.171E-06 5.146E-05 6.325E-03 0.06790038 WANG_SMARCE1_TARGETS_UP familial hyperlipidemia DOID_1168 3.699E-06 8.419E-05 8.816E-05 5.016E-03 WANG_SMARCE1_TARGETS_UP multiple epiphyseal dysplasia DOID_12721 6.638E-06 1.453E-04 6.621E-03 0.0697653 WANG_SMARCE1_TARGETS_UP temporal arteritis DOID_13375 9.593E-06 2.022E-04 8.245E-04 0.0234568 WANG_SMARCE1_TARGETS_UP central nervous system vasculitis DOID_525 9.593E-06 2.022E-04 8.245E-04 0.0234568 WANG_SMARCE1_TARGETS_UP nephrosis DOID_2527 1.135E-05 2.307E-04 3.145E-03 0.04161349 WANG_SMARCE1_TARGETS_UP intracranial thrombosis DOID_4193 1.653E-05 3.244E-04 1.163E-03 0.02877803 WANG_SMARCE1_TARGETS_UP metabolic syndrome X DOID_14221 1.875E-05 3.556E-04 4.199E-03 0.04977894 WANG_SMARCE1_TARGETS_UP lipid metabolism disorder DOID_3146 1.875E-05 3.441E-04 3.159E-04 0.01198299 WANG_SMARCE1_TARGETS_UP intracranial arterial disease DOID_13089 2.51E-05 4.463E-04 0.01246835 0.12024564 WANG_SMARCE1_TARGETS_UP cerebral arterial disease DOID_3527 2.51E-05 4.463E-04 0.01246835 0.12024564 WANG_SMARCE1_TARGETS_UP oral submucous fibrosis DOID_5773 2.615E-05 4.509E-04 1.000 1.000 WANG_SMARCE1_TARGETS_UP vein disease DOID_866 3.209E-05 5.37E-04 3.209E-05 3.652E-03 WANG_SMARCE1_TARGETS_UP nephrotic syndrome DOID_1184 3.289E-05 5.347E-04 0.01418185 0.13015279 WANG_SMARCE1_TARGETS_UP diabetic autonomic neuropathy DOID_11503 3.584E-05 5.664E-04 1.000 1.000 WANG_SMARCE1_TARGETS_UP autonomic neuropathy DOID_11504 3.584E-05 5.664E-04 1.000 1.000 WANG_SMARCE1_TARGETS_UP diabetic polyneuropathy DOID_12785 3.584E-05 5.664E-04 1.000 1.000 WANG_SMARCE1_TARGETS_UP diabetic neuropathy DOID_9743 3.584E-05 5.664E-04 1.000 1.000 WANG_SMARCE1_TARGETS_UP pre-eclampsia DOID_10591 4.585E-05 7.051E-04 0.0166148 0.14544343 WANG_SMARCE1_TARGETS_UP autonomic nervous system disease DOID_11465 4.585E-05 6.865E-04 1.000 1.000 WANG_SMARCE1_TARGETS_UP integumentary system benign neoplasm DOID_0060121 5.357E-05 7.816E-04 1.142E-03 0.02953145 WANG_SMARCE1_TARGETS_UP skin benign neoplasm DOID_3165 5.357E-05 7.816E-04 1.142E-03 0.02953145 WANG_SMARCE1_TARGETS_UP integumentary system cancer DOID_0060122 8.243E-05 1.173E-03 1.567E-03 0.02786347 WANG_SMARCE1_TARGETS_UP skin cancer DOID_4159 8.243E-05 1.173E-03 1.567E-03 0.02786347 WANG_SMARCE1_TARGETS_UP uremia DOID_4676 9.946E-05 1.38E-03 3.677E-03 0.04548505 WANG_SMARCE1_TARGETS_UP pulmonary embolism DOID_9477 9.946E-05 1.347E-03 0.08661735 0.37337329 WANG_SMARCE1_TARGETS_UP carotid artery disease DOID_3407 1.212E-04 1.604E-03 0.02638622 0.2056679 WANG_SMARCE1_TARGETS_UP pre-malignant neoplasm DOID_0060071 1.367E-04 1.767E-03 2.271E-03 0.03400958 WANG_SMARCE1_TARGETS_UP congenital heart defect DOID_1682 1.367E-04 1.728E-03 2.271E-03 0.03313754 WANG_SMARCE1_TARGETS_UP in situ carcinoma DOID_8719 1.367E-04 1.767E-03 2.271E-03 0.03400958 WANG_SMARCE1_TARGETS_UP urticaria DOID_1555 1.448E-04 1.791E-03 0.09735134 0.39851015 WANG_SMARCE1_TARGETS_UP intracranial aneurysm DOID_10941 1.813E-04 2.195E-03 5.424E-03 0.06172294 WANG_SMARCE1_TARGETS_UP blood coagulation disease DOID_1247 2.02E-04 2.395E-03 3.026E-03 0.04099403 WANG_SMARCE1_TARGETS_UP peripheral vascular disease DOID_341 2.242E-04 2.604E-03 0.03532169 0.25766718 WANG_SMARCE1_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 2.714E-04 3.089E-03 7.044E-03 0.07157474 WANG_SMARCE1_TARGETS_UP uterine benign neoplasm DOID_0060095 2.714E-04 3.089E-03 7.044E-03 0.07157474 WANG_SMARCE1_TARGETS_UP corneal disease DOID_10124 2.714E-04 3.028E-03 2.714E-04 0.01187983 WANG_SMARCE1_TARGETS_UP uterine fibroid DOID_13223 2.714E-04 3.089E-03 7.044E-03 0.07157474 WANG_SMARCE1_TARGETS_UP age related macular degeneration DOID_10871 2.977E-04 3.258E-03 2.977E-04 0.01209952 WANG_SMARCE1_TARGETS_UP degeneration of macula and posterior pole DOID_2007 2.977E-04 3.258E-03 2.977E-04 0.01209952 WANG_SMARCE1_TARGETS_UP leiomyoma DOID_127 3.551E-04 3.812E-03 8.386E-03 0.08370818 WANG_SMARCE1_TARGETS_UP macular degeneration DOID_4448 4.191E-04 4.416E-03 4.191E-04 0.01490477 WANG_SMARCE1_TARGETS_UP calcinosis DOID_182 5.284E-04 5.466E-03 0.14580972 0.49384363 WANG_SMARCE1_TARGETS_UP mouth disease DOID_403 5.75E-04 5.842E-03 0.31512815 0.79339787 WANG_SMARCE1_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 5.979E-04 5.969E-03 6.699E-03 0.06930212 WANG_SMARCE1_TARGETS_UP systemic scleroderma DOID_418 6.104E-04 5.988E-03 0.15251805 0.49875156 WANG_SMARCE1_TARGETS_UP adenoid cystic carcinoma DOID_4866 6.543E-04 6.31E-03 6.543E-04 0.02189959 WANG_SMARCE1_TARGETS_UP Gilles de la Tourette syndrome DOID_11119 6.763E-04 6.414E-03 6.763E-04 0.0213795 WANG_SMARCE1_TARGETS_UP angioedema DOID_1558 6.763E-04 6.309E-03 0.0386192 0.27467909 WANG_SMARCE1_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 7.002E-04 6.426E-03 0.01302874 0.12153041 WANG_SMARCE1_TARGETS_UP pulmonary emphysema DOID_9675 7.002E-04 6.324E-03 1.000 1.000 WANG_SMARCE1_TARGETS_UP salivary gland cancer DOID_8850 7.48E-04 6.65E-03 7.48E-04 0.02240106 WANG_SMARCE1_TARGETS_UP rheumatic disease DOID_1575 7.979E-04 6.985E-03 0.16577813 0.52404308 WANG_SMARCE1_TARGETS_UP scleroderma DOID_419 7.979E-04 6.985E-03 0.16577813 0.52404308 WANG_SMARCE1_TARGETS_UP gallbladder cancer DOID_3121 8.499E-04 7.327E-03 0.16906082 0.52854728 WANG_SMARCE1_TARGETS_UP tic disorder DOID_2769 9.868E-04 8.381E-03 9.868E-04 0.02673866 WANG_SMARCE1_TARGETS_UP vascular skin disease DOID_9540 1.018E-03 8.522E-03 0.1788321 0.54125247 WANG_SMARCE1_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.142E-03 9.416E-03 0.0178932 0.15195867 WANG_SMARCE1_TARGETS_UP calcium metabolism disease DOID_10575 1.207E-03 9.81E-03 0.18848924 0.5615203 WANG_SMARCE1_TARGETS_UP orofacial cleft DOID_0050567 1.344E-03 0.01076966 1.344E-03 0.03058584 WANG_SMARCE1_TARGETS_UP alcohol dependence DOID_0050741 1.354E-03 0.01069751 1.354E-03 0.02962388 WANG_SMARCE1_TARGETS_UP bacterial meningitis DOID_9470 1.354E-03 0.01055097 1.000 1.000 WANG_SMARCE1_TARGETS_UP corneal dystrophy DOID_2566 1.558E-03 0.01197875 1.558E-03 0.03056646 WANG_SMARCE1_TARGETS_UP membranoproliferative glomerulonephritis DOID_2920 1.558E-03 0.01181903 1.558E-03 0.02954758 WANG_SMARCE1_TARGETS_UP varicose veins DOID_799 1.558E-03 0.01166352 1.558E-03 0.02859443 WANG_SMARCE1_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 1.567E-03 0.01157962 0.02196757 0.17604996 WANG_SMARCE1_TARGETS_UP hemolytic-uremic syndrome DOID_12554 1.776E-03 0.0129545 1.776E-03 0.02971916 WANG_SMARCE1_TARGETS_UP oral cavity cancer DOID_8618 1.812E-03 0.01305175 1.812E-03 0.02945965 WANG_SMARCE1_TARGETS_UP penile disease DOID_1529 2.007E-03 0.01427788 0.06476756 0.33809856 WANG_SMARCE1_TARGETS_UP inherited blood coagulation disease DOID_2214 2.253E-03 0.01582349 2.253E-03 0.03464061 WANG_SMARCE1_TARGETS_UP osteosclerosis DOID_4254 2.253E-03 0.01563052 0.06844492 0.33865354 WANG_SMARCE1_TARGETS_UP mineral metabolism disease DOID_0050032 2.371E-03 0.01625396 0.2320852 0.65374494 WANG_SMARCE1_TARGETS_UP conduct disorder DOID_12995 2.511E-03 0.01700959 2.511E-03 0.03572015 WANG_SMARCE1_TARGETS_UP temporal lobe epilepsy DOID_3328 2.578E-03 0.01725978 0.03031835 0.22698869 WANG_SMARCE1_TARGETS_UP tooth disease DOID_1091 2.686E-03 0.01777204 0.24112011 0.66925533 WANG_SMARCE1_TARGETS_UP membranous glomerulonephritis DOID_10976 2.783E-03 0.01820091 2.783E-03 0.03862145 WANG_SMARCE1_TARGETS_UP pancreatic ductal carcinoma DOID_3587 3.026E-03 0.01956533 0.25004943 0.68733393 WANG_SMARCE1_TARGETS_UP autoimmune hepatitis DOID_2048 3.068E-03 0.01961418 0.07939102 0.37333464 WANG_SMARCE1_TARGETS_UP familial hypercholesterolemia DOID_13810 3.366E-03 0.02128103 3.366E-03 0.04352939 WANG_SMARCE1_TARGETS_UP thrombophilia DOID_2452 3.366E-03 0.02104718 0.08301126 0.37786725 WANG_SMARCE1_TARGETS_UP muscular atrophy DOID_767 3.366E-03 0.0208184 3.366E-03 0.04256207 WANG_SMARCE1_TARGETS_UP pancreatic carcinoma DOID_4905 3.391E-03 0.02074715 0.25887438 0.69810199 WANG_SMARCE1_TARGETS_UP bone resorption disease DOID_0080011 3.782E-03 0.02289285 0.26759616 0.71150569 WANG_SMARCE1_TARGETS_UP osteoporosis DOID_11476 3.782E-03 0.02289285 0.26759616 0.71150569 WANG_SMARCE1_TARGETS_UP pancreatitis DOID_4989 3.918E-03 0.02346735 3.918E-03 0.04743401 WANG_SMARCE1_TARGETS_UP mixed glioma DOID_5076 3.918E-03 0.0232229 0.03971697 0.26277858 WANG_SMARCE1_TARGETS_UP diabetic angiopathy DOID_11713 4.001E-03 0.02347072 0.09020936 0.38593328 WANG_SMARCE1_TARGETS_UP meningitis DOID_9471 4.001E-03 0.02323122 1.000 1.000 WANG_SMARCE1_TARGETS_UP spastic quadriplegia DOID_10970 4.338E-03 0.02493208 0.09378734 0.39238967 WANG_SMARCE1_TARGETS_UP focal epilepsy DOID_2234 4.644E-03 0.0264216 0.04430746 0.28326905 WANG_SMARCE1_TARGETS_UP biliary tract cancer DOID_4607 4.644E-03 0.02616 0.28473505 0.73642838 WANG_SMARCE1_TARGETS_UP chronic kidney failure DOID_784 4.644E-03 0.02590353 0.04430746 0.28012162 WANG_SMARCE1_TARGETS_UP morbid obesity DOID_11981 5.049E-03 0.02789396 0.10090141 0.40718372 WANG_SMARCE1_TARGETS_UP vitiligo DOID_12306 5.424E-03 0.02967449 5.424E-03 0.06051269 WANG_SMARCE1_TARGETS_UP nervous system cancer DOID_3093 5.787E-03 0.03136204 0.05104467 0.29637162 WANG_SMARCE1_TARGETS_UP Sciatic Neuropathy DOID_11446 5.811E-03 0.03119103 1.000 1.000 WANG_SMARCE1_TARGETS_UP gestational diabetes DOID_11714 5.811E-03 0.03089953 0.10796001 0.41788604 WANG_SMARCE1_TARGETS_UP lesion of sciatic nerve DOID_12528 5.811E-03 0.03119103 1.000 1.000 WANG_SMARCE1_TARGETS_UP periodontitis DOID_824 5.811E-03 0.03061342 1.000 1.000 WANG_SMARCE1_TARGETS_UP mononeuritis of lower limb DOID_9473 5.811E-03 0.03119103 1.000 1.000 WANG_SMARCE1_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 6.21E-03 0.03241586 0.11146865 0.42855175 WANG_SMARCE1_TARGETS_UP Behcet's disease DOID_13241 6.21E-03 0.03241586 0.11146865 0.42855175 WANG_SMARCE1_TARGETS_UP mononeuritis DOID_1802 6.21E-03 0.03212117 1.000 1.000 WANG_SMARCE1_TARGETS_UP invasive ductal carcinoma DOID_3008 6.21E-03 0.03183179 6.21E-03 0.06794863 WANG_SMARCE1_TARGETS_UP mononeuropathy DOID_1188 6.621E-03 0.03363684 1.000 1.000 WANG_SMARCE1_TARGETS_UP dilated cardiomyopathy DOID_12930 6.699E-03 0.03373112 0.05606675 0.31276453 WANG_SMARCE1_TARGETS_UP spastic cerebral palsy DOID_0050669 7.48E-03 0.03733201 0.1219125 0.45044294 WANG_SMARCE1_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 7.927E-03 0.03921967 1.000 1.000 WANG_SMARCE1_TARGETS_UP allergic rhinitis DOID_4481 7.927E-03 0.03888157 0.12536662 0.45147852 WANG_SMARCE1_TARGETS_UP autonomic nervous system neoplasm DOID_2621 8.386E-03 0.04078091 0.12880724 0.45807074 WANG_SMARCE1_TARGETS_UP neuroblastoma DOID_769 8.386E-03 0.04078091 0.12880724 0.45807074 WANG_SMARCE1_TARGETS_UP periodontal disease DOID_3388 9.338E-03 0.04502906 1.000 1.000 WANG_SMARCE1_TARGETS_UP pulmonary sarcoidosis DOID_13406 0.01085295 0.05189353 1.000 1.000 WANG_SMARCE1_TARGETS_UP peripheral nervous system neoplasm DOID_1192 0.01138036 0.05396189 0.14917045 0.4963625 WANG_SMARCE1_TARGETS_UP blood platelet disease DOID_2218 0.01138036 0.05351593 0.01138036 0.11164529 WANG_SMARCE1_TARGETS_UP hepatitis DOID_2237 0.01191886 0.05558879 0.15251805 0.504551 WANG_SMARCE1_TARGETS_UP congenital diaphragmatic hernia DOID_3827 0.01191886 0.05513685 0.15251805 0.50163452 WANG_SMARCE1_TARGETS_UP peptic ulcer DOID_750 0.01191886 0.0546922 0.15251805 0.49590155 WANG_SMARCE1_TARGETS_UP benign mesothelioma DOID_2645 0.01302874 0.05930684 0.01302874 0.12355592 WANG_SMARCE1_TARGETS_UP hyperinsulinism DOID_2018 0.01418185 0.06404344 0.01418185 0.12808688 WANG_SMARCE1_TARGETS_UP leukodystrophy DOID_10579 0.01599095 0.07164449 0.17558775 0.54595318 WANG_SMARCE1_TARGETS_UP spinocerebellar degeneration DOID_2478 0.01599095 0.07108477 0.01599095 0.14216954 WANG_SMARCE1_TARGETS_UP proteinuria DOID_576 0.01599095 0.07053373 0.17558775 0.54298604 WANG_SMARCE1_TARGETS_UP myeloma DOID_0070004 0.0166148 0.07272172 1.000 1.000 WANG_SMARCE1_TARGETS_UP neuritis DOID_1803 0.0166148 0.07216659 1.000 1.000 WANG_SMARCE1_TARGETS_UP hemolytic anemia DOID_583 0.01724892 0.07435328 0.01724892 0.14870657 WANG_SMARCE1_TARGETS_UP normocytic anemia DOID_720 0.01724892 0.07435328 0.01724892 0.14870657 WANG_SMARCE1_TARGETS_UP lung small cell carcinoma DOID_5409 0.0178932 0.07655061 0.18528279 0.55487321 WANG_SMARCE1_TARGETS_UP movement disease DOID_480 0.01854757 0.07875795 0.01854757 0.15295023 WANG_SMARCE1_TARGETS_UP hemorrhagic disease DOID_2213 0.01921193 0.08097472 0.01921193 0.15616553 WANG_SMARCE1_TARGETS_UP sarcoidosis DOID_11335 0.02057028 0.08606243 1.000 1.000 WANG_SMARCE1_TARGETS_UP bile duct adenocarcinoma DOID_4896 0.0212641 0.08831587 1.000 1.000 WANG_SMARCE1_TARGETS_UP cholangiocarcinoma DOID_4947 0.0212641 0.08831587 1.000 1.000 WANG_SMARCE1_TARGETS_UP bone marrow cancer DOID_4960 0.0212641 0.0876759 1.000 1.000 WANG_SMARCE1_TARGETS_UP smallpox DOID_8736 0.02196757 0.0899248 0.02196757 0.17360482 WANG_SMARCE1_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 0.024135 0.09809155 0.21369361 0.61721658 WANG_SMARCE1_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 0.024135 0.09739587 1.000 1.000 WANG_SMARCE1_TARGETS_UP bile duct cancer DOID_4606 0.024135 0.09670998 1.000 1.000 WANG_SMARCE1_TARGETS_UP bile duct carcinoma DOID_4897 0.024135 0.09670998 1.000 1.000 WANG_SMARCE1_TARGETS_UP melancholia DOID_2848 0.02487621 0.09898296 0.21678898 0.6229946 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN autonomic nervous system neoplasm DOID_2621 9.478E-07 5.393E-04 9.478E-07 5.393E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN neuroblastoma DOID_769 9.478E-07 5.393E-04 9.478E-07 5.393E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN peripheral nervous system neoplasm DOID_1192 1.54E-06 4.382E-04 1.54E-06 4.382E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN diabetic autonomic neuropathy DOID_11503 2.338E-06 4.434E-04 3.112E-04 0.0160971 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN autonomic neuropathy DOID_11504 2.338E-06 4.434E-04 3.112E-04 0.0160971 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN diabetic polyneuropathy DOID_12785 2.338E-06 4.434E-04 3.112E-04 0.0160971 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN diabetic neuropathy DOID_9743 2.338E-06 4.434E-04 3.112E-04 0.0160971 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN autonomic nervous system disease DOID_11465 2.823E-06 4.016E-04 3.523E-04 0.01541957 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN bile duct adenocarcinoma DOID_4896 4.204E-06 4.784E-04 4.204E-06 7.974E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN cholangiocarcinoma DOID_4947 4.204E-06 4.784E-04 4.204E-06 7.974E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN bile duct cancer DOID_4606 5.164E-06 4.897E-04 5.164E-06 7.345E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN bile duct carcinoma DOID_4897 5.164E-06 4.897E-04 5.164E-06 7.345E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN pancreatic ductal carcinoma DOID_3587 8.885E-06 7.223E-04 8.885E-06 1.011E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN pancreatic carcinoma DOID_4905 1.003E-05 7.136E-04 1.003E-05 9.514E-04 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN biliary tract cancer DOID_4607 1.405E-05 8.883E-04 1.405E-05 1.142E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN nervous system cancer DOID_3093 1.782E-05 1.014E-03 1.782E-05 1.267E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN keratosis DOID_161 4.447E-05 2.3E-03 4.447E-05 2.812E-03 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN hepatitis DOID_2237 2.483E-04 0.0117723 2.483E-04 0.01412676 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN gallbladder cancer DOID_3121 3.112E-04 0.01362062 3.112E-04 0.01475567 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN melancholia DOID_2848 5.417E-04 0.02201423 0.03379648 0.246541 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN neurotic disorder DOID_4964 5.592E-04 0.02121319 0.03433257 0.24728139 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN diabetic retinopathy DOID_8947 8.125E-04 0.02889588 8.125E-04 0.03302387 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN endogenous depression DOID_1595 8.556E-04 0.02863701 0.04233992 0.26768241 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN mental depression DOID_1596 1.015E-03 0.03207767 0.04605501 0.27015775 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN retinal vascular disease DOID_2462 1.063E-03 0.03182376 1.063E-03 0.0403101 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.291E-03 0.0367408 0.05186529 0.29219159 MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN mouth disease DOID_403 1.291E-03 0.03499124 1.291E-03 0.045926 SMID_BREAST_CANCER_LUMINAL_B_UP female reproductive system disease DOID_229 5.621E-08 3.199E-05 1.885E-06 1.073E-03 SMID_BREAST_CANCER_LUMINAL_B_UP uterine disease DOID_345 6.965E-07 1.982E-04 2.348E-05 3.34E-03 SMID_BREAST_CANCER_LUMINAL_B_UP endocrine organ benign neoplasm DOID_0060089 8.65E-07 1.641E-04 2.786E-05 3.17E-03 SMID_BREAST_CANCER_LUMINAL_B_UP transitional cell carcinoma DOID_2671 2.816E-06 4.006E-04 7.073E-05 6.708E-03 SMID_BREAST_CANCER_LUMINAL_B_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.872E-06 4.406E-04 9.095E-05 5.75E-03 SMID_BREAST_CANCER_LUMINAL_B_UP endometriosis DOID_289 4.901E-06 4.648E-04 4.901E-06 1.394E-03 SMID_BREAST_CANCER_LUMINAL_B_UP drug-induced mental disorder DOID_1203 9.175E-06 7.458E-04 9.175E-06 1.74E-03 SMID_BREAST_CANCER_LUMINAL_B_UP drug psychosis DOID_1742 9.175E-06 7.458E-04 9.175E-06 1.74E-03 SMID_BREAST_CANCER_LUMINAL_B_UP substance-induced psychosis DOID_8646 9.175E-06 7.458E-04 9.175E-06 1.74E-03 SMID_BREAST_CANCER_LUMINAL_B_UP reproductive organ benign neoplasm DOID_0050622 1.246E-05 8.863E-04 3.874E-04 0.0183694 SMID_BREAST_CANCER_LUMINAL_B_UP pre-malignant neoplasm DOID_0060071 2.086E-05 1.319E-03 5.665E-04 0.01896207 SMID_BREAST_CANCER_LUMINAL_B_UP in situ carcinoma DOID_8719 2.086E-05 1.319E-03 5.665E-04 0.01896207 SMID_BREAST_CANCER_LUMINAL_B_UP amino acid metabolic disorder DOID_9252 7.385E-05 4.202E-03 7.385E-05 6.003E-03 SMID_BREAST_CANCER_LUMINAL_B_UP nervous system cancer DOID_3093 7.706E-05 3.986E-03 1.486E-03 0.03251201 SMID_BREAST_CANCER_LUMINAL_B_UP carbohydrate metabolic disorder DOID_2978 8.732E-05 4.14E-03 8.732E-05 6.21E-03 SMID_BREAST_CANCER_LUMINAL_B_UP endometriosis of uterus DOID_288 1.823E-04 7.978E-03 1.823E-04 0.01037104 SMID_BREAST_CANCER_LUMINAL_B_UP craniosynostosis DOID_2340 3.159E-04 0.0128372 3.159E-04 0.01633825 SMID_BREAST_CANCER_LUMINAL_B_UP invasive lobular carcinoma DOID_3457 3.159E-04 0.01198139 1.000 1.000 SMID_BREAST_CANCER_LUMINAL_B_UP pituitary cancer DOID_1785 3.784E-04 0.01345776 0.0287394 0.24048115 SMID_BREAST_CANCER_LUMINAL_B_UP pituitary carcinoma DOID_4916 3.784E-04 0.01345776 0.0287394 0.24048115 SMID_BREAST_CANCER_LUMINAL_B_UP Hirschsprung's disease DOID_10487 4.465E-04 0.01494541 4.465E-04 0.019544 SMID_BREAST_CANCER_LUMINAL_B_UP parathyroid gland disease DOID_11201 4.465E-04 0.01411511 0.03109714 0.24238729 SMID_BREAST_CANCER_LUMINAL_B_UP larynx cancer DOID_2596 4.465E-04 0.01337221 4.465E-04 0.018148 SMID_BREAST_CANCER_LUMINAL_B_UP laryngeal benign neoplasm DOID_2598 4.465E-04 0.01337221 4.465E-04 0.018148 SMID_BREAST_CANCER_LUMINAL_B_UP Leydig cell tumor DOID_2696 4.465E-04 0.0127036 4.465E-04 0.01693813 SMID_BREAST_CANCER_LUMINAL_B_UP sex cord-stromal neoplasm DOID_4757 4.465E-04 0.0127036 4.465E-04 0.01693813 SMID_BREAST_CANCER_LUMINAL_B_UP megacolon DOID_11372 5.201E-04 0.01409281 5.201E-04 0.01849682 SMID_BREAST_CANCER_LUMINAL_B_UP temporal lobe epilepsy DOID_3328 6.453E-04 0.01668883 6.453E-04 0.02039746 SMID_BREAST_CANCER_LUMINAL_B_UP pituitary adenoma DOID_3829 6.837E-04 0.01691438 0.03813644 0.24110707 SMID_BREAST_CANCER_LUMINAL_B_UP male reproductive organ benign neoplasm DOID_0060087 8.69E-04 0.02060206 0.04280119 0.24850892 SMID_BREAST_CANCER_LUMINAL_B_UP endogenous depression DOID_1595 9.223E-04 0.02099102 9.223E-04 0.02761977 SMID_BREAST_CANCER_LUMINAL_B_UP electroclinical syndrome DOID_0050701 9.926E-04 0.02172169 9.926E-04 0.0282382 SMID_BREAST_CANCER_LUMINAL_B_UP colonic disease DOID_5353 1.076E-03 0.02266985 1.076E-03 0.02914695 SMID_BREAST_CANCER_LUMINAL_B_UP mental depression DOID_1596 1.183E-03 0.02403679 1.183E-03 0.03059228 SMID_BREAST_CANCER_LUMINAL_B_UP focal epilepsy DOID_2234 1.183E-03 0.02320793 1.183E-03 0.02926218 SMID_BREAST_CANCER_LUMINAL_B_UP chronic kidney failure DOID_784 1.183E-03 0.02243434 1.183E-03 0.02804292 SMID_BREAST_CANCER_LUMINAL_B_UP bone development disease DOID_0080006 1.223E-03 0.02245608 1.223E-03 0.02784554 SMID_BREAST_CANCER_LUMINAL_B_UP IgA glomerulonephritis DOID_2986 1.426E-03 0.02534969 0.05436537 0.27619549 SMID_BREAST_CANCER_LUMINAL_B_UP synostosis DOID_11971 1.553E-03 0.02677391 1.553E-03 0.03272367 SMID_BREAST_CANCER_LUMINAL_B_UP Sciatic Neuropathy DOID_11446 2.266E-03 0.03792617 2.266E-03 0.04605321 SMID_BREAST_CANCER_LUMINAL_B_UP lesion of sciatic nerve DOID_12528 2.266E-03 0.03792617 2.266E-03 0.04605321 SMID_BREAST_CANCER_LUMINAL_B_UP mononeuritis of lower limb DOID_9473 2.266E-03 0.03792617 2.266E-03 0.04605321 SMID_BREAST_CANCER_LUMINAL_B_UP mononeuritis DOID_1802 2.424E-03 0.03941201 2.424E-03 0.04756622 SMID_BREAST_CANCER_LUMINAL_B_UP mononeuropathy DOID_1188 2.587E-03 0.04089529 2.587E-03 0.04907435 SMID_BREAST_CANCER_LUMINAL_B_UP dysostosis DOID_1934 2.756E-03 0.04237586 2.756E-03 0.05057764 SMID_BREAST_CANCER_LUMINAL_B_UP endometrial carcinoma DOID_2871 2.756E-03 0.0412607 2.756E-03 0.04899709 SMID_BREAST_CANCER_LUMINAL_B_UP endometrial cancer DOID_1380 3.107E-03 0.0453282 3.107E-03 0.05356969 SMID_BREAST_CANCER_LUMINAL_B_UP childhood absence epilepsy DOID_1825 3.29E-03 0.04679972 3.29E-03 0.0550585 SMID_BREAST_CANCER_LUMINAL_B_UP autonomic nervous system neoplasm DOID_2621 3.29E-03 0.04565826 3.29E-03 0.0534854 SMID_BREAST_CANCER_LUMINAL_B_UP neuroblastoma DOID_769 3.29E-03 0.04565826 3.29E-03 0.0534854 SMID_BREAST_CANCER_LUMINAL_B_UP papilloma DOID_2615 3.478E-03 0.04711874 0.0837895 0.35056046 SMID_BREAST_CANCER_LUMINAL_B_UP thyroid carcinoma DOID_3963 3.671E-03 0.04857631 3.671E-03 0.0580217 SMID_BREAST_CANCER_LUMINAL_B_UP childhood electroclinical syndrome DOID_0050704 3.869E-03 0.05003084 3.869E-03 0.05949614 SMID_BREAST_CANCER_LUMINAL_B_UP thyroid cancer DOID_1781 4.072E-03 0.05148223 4.072E-03 0.0609658 SMID_BREAST_CANCER_LUMINAL_B_UP peripheral nervous system neoplasm DOID_1192 4.491E-03 0.0555573 4.491E-03 0.06552913 SMID_BREAST_CANCER_LUMINAL_B_UP peptic ulcer DOID_750 4.709E-03 0.05700426 4.709E-03 0.06698001 SMID_BREAST_CANCER_LUMINAL_B_UP adenoid cystic carcinoma DOID_4866 4.931E-03 0.05844745 0.09925625 0.37155793 SMID_BREAST_CANCER_LUMINAL_B_UP pulmonary emphysema DOID_9675 5.157E-03 0.05988683 5.157E-03 0.07157206 SMID_BREAST_CANCER_LUMINAL_B_UP salivary gland cancer DOID_8850 5.389E-03 0.06132234 0.10362769 0.38041391 SMID_BREAST_CANCER_LUMINAL_B_UP hyperinsulinism DOID_2018 5.625E-03 0.06275396 0.10580553 0.38346082 SMID_BREAST_CANCER_LUMINAL_B_UP diabetic autonomic neuropathy DOID_11503 5.865E-03 0.06418164 5.865E-03 0.07946299 SMID_BREAST_CANCER_LUMINAL_B_UP autonomic neuropathy DOID_11504 5.865E-03 0.06418164 5.865E-03 0.07946299 SMID_BREAST_CANCER_LUMINAL_B_UP diabetic polyneuropathy DOID_12785 5.865E-03 0.06418164 5.865E-03 0.07946299 SMID_BREAST_CANCER_LUMINAL_B_UP uterine cancer DOID_363 5.865E-03 0.06297067 5.865E-03 0.07761501 SMID_BREAST_CANCER_LUMINAL_B_UP diabetic neuropathy DOID_9743 5.865E-03 0.06418164 5.865E-03 0.07946299 SMID_BREAST_CANCER_LUMINAL_B_UP learning disability DOID_8927 6.111E-03 0.06439045 6.111E-03 0.07902465 SMID_BREAST_CANCER_LUMINAL_B_UP autonomic nervous system disease DOID_11465 6.616E-03 0.06844083 6.616E-03 0.0836499 SMID_BREAST_CANCER_LUMINAL_B_UP brain cancer DOID_1319 6.616E-03 0.06721867 0.1144647 0.40962523 SMID_BREAST_CANCER_LUMINAL_B_UP neuritis DOID_1803 6.616E-03 0.06603939 6.616E-03 0.08183142 SMID_BREAST_CANCER_LUMINAL_B_UP thyroid adenoma DOID_2891 6.616E-03 0.06490078 6.616E-03 0.08009033 SMID_BREAST_CANCER_LUMINAL_B_UP bone marrow disease DOID_4961 6.616E-03 0.06380077 6.616E-03 0.07842178 SMID_BREAST_CANCER_LUMINAL_B_UP central nervous system cancer DOID_3620 6.875E-03 0.06519568 0.11661649 0.41214152 SMID_BREAST_CANCER_LUMINAL_B_UP withdrawal disorder DOID_0060001 7.68E-03 0.07163488 7.68E-03 0.08917812 SMID_BREAST_CANCER_LUMINAL_B_UP vasculitis DOID_865 8.525E-03 0.07823696 8.525E-03 0.09701383 SMID_BREAST_CANCER_LUMINAL_B_UP oral cavity cancer DOID_8618 9.714E-03 0.08773194 0.13785204 0.45870064 SMID_BREAST_CANCER_LUMINAL_B_UP melancholia DOID_2848 0.0100218 0.08910009 0.0100218 0.11181188 SMID_BREAST_CANCER_LUMINAL_B_UP neurotic disorder DOID_4964 0.01033418 0.09046384 0.01033418 0.11307981 SMID_BREAST_CANCER_LUMINAL_B_UP neuroectodermal tumor DOID_171 0.01065085 0.0918232 0.01065085 0.11434587 SMID_BREAST_CANCER_LUMINAL_B_UP respiratory failure DOID_11162 0.01097177 0.09317817 0.01097177 0.11560995 SMID_BREAST_CANCER_LUMINAL_B_UP endocrine pancreas disease DOID_1428 0.01162631 0.0972849 0.15035017 0.49166233 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP neutropenia DOID_1227 4.349E-05 0.02474474 9.822E-03 0.31047193 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP agranulocytosis DOID_12987 4.762E-05 0.01354712 0.01026588 0.30743609 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP allergic rhinitis DOID_4481 1.053E-04 0.01996816 0.01514051 0.29706722 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP leukopenia DOID_615 1.249E-04 0.01776508 0.01646603 0.27556379 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP movement disease DOID_480 2.573E-04 0.02928194 2.573E-04 0.1464097 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP melancholia DOID_2848 3.523E-04 0.03340646 3.523E-04 0.10021938 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP leukocyte disease DOID_9500 3.523E-04 0.02863411 0.02744689 0.37184002 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP neurotic disorder DOID_4964 3.637E-04 0.0258695 3.637E-04 0.06898532 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP allergic contact dermatitis DOID_3042 4.489E-04 0.02838239 4.489E-04 0.06386038 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP endogenous depression DOID_1595 5.571E-04 0.03169669 5.571E-04 0.06339338 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP contact dermatitis DOID_2773 6.154E-04 0.03183296 6.154E-04 0.05836042 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP mental depression DOID_1596 6.61E-04 0.03134328 6.61E-04 0.05373133 CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP Human immunodeficiency virus infectious disease DOID_526 7.736E-04 0.03386197 0.04047162 0.4428529 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN amino acid metabolic disorder DOID_9252 8.913E-19 5.072E-16 8.913E-19 5.072E-16 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN cholestasis DOID_13580 2.67E-11 7.595E-09 1.274E-09 3.625E-07 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN bile duct disease DOID_4138 5.364E-11 1.017E-08 2.331E-09 4.422E-07 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN biliary tract disease DOID_9741 5.991E-11 8.522E-09 2.565E-09 3.649E-07 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN metabolic syndrome X DOID_14221 4.831E-09 5.498E-07 4.831E-09 5.498E-07 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN lipid metabolism disorder DOID_3146 4.831E-09 4.582E-07 4.831E-09 4.582E-07 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN female reproductive system disease DOID_229 1.727E-07 1.404E-05 4.756E-06 2.082E-04 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN carbohydrate metabolic disorder DOID_2978 3.865E-07 2.749E-05 3.865E-07 3.142E-05 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN thrombophilia DOID_2452 4.888E-07 3.09E-05 4.888E-07 3.477E-05 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN familial hyperlipidemia DOID_1168 8.672E-07 4.934E-05 8.672E-07 5.483E-05 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN endocrine pancreas disease DOID_1428 1.642E-06 8.494E-05 1.642E-06 9.343E-05 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN blood coagulation disease DOID_1247 2.518E-06 1.194E-04 2.518E-06 1.303E-04 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN angioedema DOID_1558 2.888E-06 1.264E-04 2.888E-06 1.369E-04 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN hypoglycemia DOID_9993 4.145E-05 1.685E-03 4.145E-05 1.685E-03 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN uterine disease DOID_345 4.906E-05 1.861E-03 1.066E-03 0.02636921 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN urticaria DOID_1555 6.047E-05 2.15E-03 6.047E-05 2.294E-03 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN dystonia DOID_543 7.586E-05 2.539E-03 7.586E-05 2.698E-03 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN chronic kidney failure DOID_784 1.174E-04 3.711E-03 2.026E-03 0.03719317 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN peptic ulcer DOID_750 2.58E-04 7.727E-03 6.777E-03 0.09886903 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN benign mesothelioma DOID_2645 2.964E-04 8.433E-03 0.12110544 0.56949583 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN hyperinsulinism DOID_2018 3.383E-04 9.166E-03 3.383E-04 0.01132331 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN hypolipoproteinemia DOID_1387 3.765E-04 9.737E-03 3.765E-04 0.01190112 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN vascular skin disease DOID_9540 4.331E-04 0.01071478 4.331E-04 0.01297052 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN hemochromatosis DOID_2352 4.593E-04 0.01088848 4.593E-04 0.01306618 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN porphyria DOID_13268 5.501E-04 0.01251954 5.501E-04 0.01490421 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN vasculitis DOID_865 6.37E-04 0.01394098 0.01220883 0.15788242 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN respiratory failure DOID_11162 9.349E-04 0.01970301 0.01567204 0.18973175 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN mineral metabolism disease DOID_0050032 1.021E-03 0.0207488 1.021E-03 0.02640756 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN hyperglycemia DOID_4195 1.112E-03 0.02181778 1.112E-03 0.02636316 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN lymphatic system cancer DOID_0060073 1.123E-03 0.02129348 0.04863551 0.35478981 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN reticulosarcoma DOID_8538 1.123E-03 0.02129348 0.04863551 0.35478981 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN lymphosarcoma DOID_8675 1.123E-03 0.02129348 0.04863551 0.35478981 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN peroxisomal disease DOID_906 1.123E-03 0.02060659 0.04863551 0.34592006 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN peripheral vascular disease DOID_341 1.415E-03 0.02516028 1.415E-03 0.03220516 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN pulmonary edema DOID_11396 1.559E-03 0.02688918 0.05697154 0.3813742 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN electroclinical syndrome DOID_0050701 1.704E-03 0.02850889 1.704E-03 0.03728086 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN bacterial pneumonia DOID_874 1.704E-03 0.02769435 0.02314443 0.25325343 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN contact dermatitis DOID_2773 1.828E-03 0.02889974 1.828E-03 0.03853299 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN gastric ulcer DOID_10808 1.889E-03 0.02904614 0.06248864 0.41344229 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN familial hypercholesterolemia DOID_13810 1.889E-03 0.02828177 1.889E-03 0.0383824 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN placenta disease DOID_780 1.889E-03 0.0275566 1.889E-03 0.03705887 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN alcohol abuse DOID_1574 2.026E-03 0.02882471 2.026E-03 0.03843294 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN glycogen metabolism disorder DOID_0050728 2.065E-03 0.028654 2.065E-03 0.03671294 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN glycogen storage disease DOID_2747 2.065E-03 0.028654 2.065E-03 0.03671294 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN X-linked disease DOID_0050735 2.637E-03 0.03572688 2.637E-03 0.04547057 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN bronchiolitis DOID_2942 2.637E-03 0.03489602 0.07342706 0.44446806 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN hypersensitivity reaction type I disease DOID_1205 2.949E-03 0.03813617 2.949E-03 0.0493527 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN spinal cord disease DOID_319 3.056E-03 0.03863516 0.07884875 0.44864936 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN ulcerative colitis DOID_8577 3.214E-03 0.03975329 3.214E-03 0.05224717 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN autoimmune disease of cardiovascular system DOID_0060051 3.503E-03 0.04240705 0.08423899 0.46992143 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN Behcet's disease DOID_13241 3.503E-03 0.04240705 0.08423899 0.46992143 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN central nervous system hereditary degenerative disease DOID_481 3.503E-03 0.04152357 3.503E-03 0.05536476 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN polycystic ovary syndrome DOID_11612 3.737E-03 0.04339857 0.08692238 0.4622321 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN metal metabolism disorder DOID_896 5.015E-03 0.05707572 5.015E-03 0.07712935 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN pneumoconiosis DOID_10316 5.292E-03 0.05904157 1.000 1.000 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN calcinosis DOID_182 6.162E-03 0.06743188 6.162E-03 0.09227521 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN hepatitis DOID_2237 6.777E-03 0.07275269 0.11593027 0.55901971 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN endometriosis of uterus DOID_288 7.748E-03 0.08163684 0.12368175 0.57215381 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN endometriosis DOID_289 8.084E-03 0.08363674 0.12625058 0.57013161 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN myeloma DOID_0070004 9.496E-03 0.09648686 0.13645149 0.59267863 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN pre-eclampsia DOID_10591 9.496E-03 0.09479411 0.13645149 0.58818864 CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN heart valve disease DOID_4079 9.496E-03 0.09315973 9.496E-03 0.1350816 SENESE_HDAC3_TARGETS_UP bone marrow cancer DOID_4960 5.117E-14 2.912E-11 7.181E-11 4.086E-08 SENESE_HDAC3_TARGETS_UP aneurysm disease DOID_2403 7.393E-14 2.103E-11 3.129E-08 2.967E-06 SENESE_HDAC3_TARGETS_UP carotid artery disease DOID_3407 1.986E-13 3.767E-11 1.356E-07 7.714E-06 SENESE_HDAC3_TARGETS_UP thoracic aortic aneurysm DOID_14004 1.812E-12 2.577E-10 2.348E-08 2.672E-06 SENESE_HDAC3_TARGETS_UP multiple myeloma DOID_9538 2.388E-12 2.718E-10 4.609E-09 8.741E-07 SENESE_HDAC3_TARGETS_UP myeloma DOID_0070004 2.075E-11 1.968E-09 2.344E-08 3.335E-06 SENESE_HDAC3_TARGETS_UP aortic aneurysm DOID_3627 3.613E-11 2.937E-09 8.887E-07 3.89E-05 SENESE_HDAC3_TARGETS_UP contact dermatitis DOID_2773 8.826E-11 6.278E-09 2.049E-09 5.829E-07 SENESE_HDAC3_TARGETS_UP brain infarction DOID_3454 5.519E-10 3.489E-08 5.058E-06 1.308E-04 SENESE_HDAC3_TARGETS_UP spindle cell carcinoma DOID_4015 2.585E-09 1.471E-07 9.766E-08 6.174E-06 SENESE_HDAC3_TARGETS_UP transitional cell carcinoma DOID_2671 4.733E-09 2.448E-07 8.775E-08 6.242E-06 SENESE_HDAC3_TARGETS_UP allergic contact dermatitis DOID_3042 1.187E-08 5.629E-07 2.536E-07 1.312E-05 SENESE_HDAC3_TARGETS_UP middle cerebral artery infarction DOID_3525 1.657E-08 7.253E-07 6.619E-04 5.978E-03 SENESE_HDAC3_TARGETS_UP cerebral infarction DOID_3526 1.746E-08 7.096E-07 2.153E-04 2.663E-03 SENESE_HDAC3_TARGETS_UP pancreatitis DOID_4989 3.458E-08 1.312E-06 3.458E-08 2.811E-06 SENESE_HDAC3_TARGETS_UP collagen disease DOID_854 1.356E-07 4.821E-06 6.512E-04 5.976E-03 SENESE_HDAC3_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.455E-07 4.869E-06 2.204E-06 7.836E-05 SENESE_HDAC3_TARGETS_UP respiratory failure DOID_11162 1.511E-07 4.778E-06 6.906E-04 6.045E-03 SENESE_HDAC3_TARGETS_UP ulcerative colitis DOID_8577 1.999E-07 5.986E-06 2.899E-06 9.163E-05 SENESE_HDAC3_TARGETS_UP cerebral degeneration DOID_1443 2.072E-07 5.895E-06 3.925E-06 1.117E-04 SENESE_HDAC3_TARGETS_UP intracranial arterial disease DOID_13089 2.484E-07 6.729E-06 2.331E-03 0.01457284 SENESE_HDAC3_TARGETS_UP cerebral arterial disease DOID_3527 2.484E-07 6.729E-06 2.331E-03 0.01457284 SENESE_HDAC3_TARGETS_UP rheumatic disease DOID_1575 3.758E-07 9.719E-06 2.828E-03 0.01547489 SENESE_HDAC3_TARGETS_UP scleroderma DOID_419 3.758E-07 9.719E-06 2.828E-03 0.01547489 SENESE_HDAC3_TARGETS_UP acute pancreatitis DOID_2913 3.952E-07 9.777E-06 3.952E-07 1.874E-05 SENESE_HDAC3_TARGETS_UP heart valve disease DOID_4079 6.246E-07 1.481E-05 2.523E-04 2.93E-03 SENESE_HDAC3_TARGETS_UP ocular hypertension DOID_9282 6.509E-07 1.481E-05 4.778E-05 8.239E-04 SENESE_HDAC3_TARGETS_UP borderline glaucoma DOID_9283 6.509E-07 1.481E-05 4.778E-05 8.239E-04 SENESE_HDAC3_TARGETS_UP glaucoma DOID_1686 7.921E-07 1.734E-05 1.69E-05 3.561E-04 SENESE_HDAC3_TARGETS_UP sarcoma DOID_1115 1.034E-06 2.179E-05 1.034E-06 4.202E-05 SENESE_HDAC3_TARGETS_UP primary bacterial infectious disease DOID_0050338 1.321E-06 2.684E-05 2.222E-03 0.01404619 SENESE_HDAC3_TARGETS_UP nervous system cancer DOID_3093 1.654E-06 3.244E-05 2.622E-04 2.984E-03 SENESE_HDAC3_TARGETS_UP abdominal aortic aneurysm DOID_7693 1.696E-06 3.217E-05 1.078E-03 8.287E-03 SENESE_HDAC3_TARGETS_UP mesenchymal cell neoplasm DOID_3350 1.769E-06 3.247E-05 1.769E-06 6.711E-05 SENESE_HDAC3_TARGETS_UP spindle cell sarcoma DOID_4235 1.769E-06 3.247E-05 1.769E-06 6.711E-05 SENESE_HDAC3_TARGETS_UP epithelioid sarcoma DOID_6193 1.769E-06 3.247E-05 1.769E-06 6.711E-05 SENESE_HDAC3_TARGETS_UP intermediate coronary syndrome DOID_8805 1.769E-06 3.146E-05 9.749E-05 1.387E-03 SENESE_HDAC3_TARGETS_UP mouth disease DOID_403 2.204E-06 3.8E-05 2.883E-05 5.468E-04 SENESE_HDAC3_TARGETS_UP leiomyoma DOID_127 2.297E-06 3.845E-05 2.297E-06 7.689E-05 SENESE_HDAC3_TARGETS_UP mineral metabolism disease DOID_0050032 3.597E-06 5.848E-05 7.744E-04 6.576E-03 SENESE_HDAC3_TARGETS_UP cholestasis DOID_13580 3.925E-06 6.204E-05 3.925E-06 1.175E-04 SENESE_HDAC3_TARGETS_UP parasitic infectious disease DOID_1398 3.925E-06 6.036E-05 6.26E-05 9.894E-04 SENESE_HDAC3_TARGETS_UP refractive error DOID_9835 3.994E-06 5.98E-05 3.994E-06 1.082E-04 SENESE_HDAC3_TARGETS_UP systemic scleroderma DOID_418 5.813E-06 8.482E-05 0.0273436 0.09316474 SENESE_HDAC3_TARGETS_UP brain edema DOID_4724 6.13E-06 8.721E-05 6.588E-03 0.02883716 SENESE_HDAC3_TARGETS_UP bile duct disease DOID_4138 6.443E-06 8.942E-05 6.443E-06 1.594E-04 SENESE_HDAC3_TARGETS_UP adult respiratory distress syndrome DOID_11394 6.546E-06 8.868E-05 0.02856375 0.0967427 SENESE_HDAC3_TARGETS_UP biliary tract disease DOID_9741 6.968E-06 9.22E-05 6.968E-06 1.652E-04 SENESE_HDAC3_TARGETS_UP pulmonary emphysema DOID_9675 7.348E-06 9.503E-05 0.02980536 0.09976029 SENESE_HDAC3_TARGETS_UP endometriosis of uterus DOID_288 8.226E-06 1.04E-04 1.672E-04 2.213E-03 SENESE_HDAC3_TARGETS_UP endometriosis DOID_289 9.183E-06 1.136E-04 1.823E-04 2.357E-03 SENESE_HDAC3_TARGETS_UP bone resorption disease DOID_0080011 9.425E-06 1.141E-04 1.434E-03 0.01059445 SENESE_HDAC3_TARGETS_UP osteoporosis DOID_11476 9.425E-06 1.141E-04 1.434E-03 0.01059445 SENESE_HDAC3_TARGETS_UP sinusitis DOID_0050127 1.104E-05 1.309E-04 8.668E-03 0.03708344 SENESE_HDAC3_TARGETS_UP paranasal sinus disease DOID_1352 1.104E-05 1.309E-04 8.668E-03 0.03708344 SENESE_HDAC3_TARGETS_UP uremia DOID_4676 1.104E-05 1.282E-04 1.104E-05 2.514E-04 SENESE_HDAC3_TARGETS_UP learning disability DOID_8927 1.136E-05 1.292E-04 1.136E-05 2.486E-04 SENESE_HDAC3_TARGETS_UP leukodystrophy DOID_10579 1.259E-05 1.404E-04 2.333E-04 2.824E-03 SENESE_HDAC3_TARGETS_UP proteinuria DOID_576 1.259E-05 1.377E-04 2.333E-04 2.765E-03 SENESE_HDAC3_TARGETS_UP reading disorder DOID_13365 1.838E-05 1.973E-04 1.838E-05 3.735E-04 SENESE_HDAC3_TARGETS_UP dyslexia DOID_4428 1.838E-05 1.973E-04 1.838E-05 3.735E-04 SENESE_HDAC3_TARGETS_UP calcium metabolism disease DOID_10575 1.857E-05 1.956E-04 4.23E-03 0.02039788 SENESE_HDAC3_TARGETS_UP B-cell lymphocytic neoplasm DOID_707 2.036E-05 2.106E-04 3.4E-04 3.454E-03 SENESE_HDAC3_TARGETS_UP intracranial aneurysm DOID_10941 2.493E-05 2.533E-04 0.01269374 0.05050867 SENESE_HDAC3_TARGETS_UP myopia DOID_11830 2.493E-05 2.489E-04 2.493E-05 4.891E-04 SENESE_HDAC3_TARGETS_UP lymphoma DOID_0060058 2.558E-05 2.509E-04 2.898E-04 3.233E-03 SENESE_HDAC3_TARGETS_UP diffuse large B-cell lymphoma DOID_0050745 2.878E-05 2.776E-04 7.349E-04 6.336E-03 SENESE_HDAC3_TARGETS_UP Crohn's disease DOID_8778 2.883E-05 2.734E-04 3.195E-04 3.496E-03 SENESE_HDAC3_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 2.892E-05 2.697E-04 2.892E-05 5.308E-04 SENESE_HDAC3_TARGETS_UP parasitic protozoa infectious disease DOID_2789 2.892E-05 2.654E-04 4.475E-04 4.315E-03 SENESE_HDAC3_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 3.057E-05 2.761E-04 3.352E-04 3.532E-03 SENESE_HDAC3_TARGETS_UP dilated cardiomyopathy DOID_12930 3.057E-05 2.718E-04 3.352E-04 3.468E-03 SENESE_HDAC3_TARGETS_UP coronary stenosis DOID_4248 3.305E-05 2.893E-04 8.129E-04 6.802E-03 SENESE_HDAC3_TARGETS_UP autoimmune disease of the nervous system DOID_438 3.305E-05 2.849E-04 8.129E-04 6.704E-03 SENESE_HDAC3_TARGETS_UP focal glomerulosclerosis DOID_3945 3.776E-05 3.207E-04 8.96E-04 7.18E-03 SENESE_HDAC3_TARGETS_UP female reproductive organ benign neoplasm DOID_0060086 4.295E-05 3.594E-04 4.295E-05 7.637E-04 SENESE_HDAC3_TARGETS_UP uterine benign neoplasm DOID_0060095 4.295E-05 3.594E-04 4.295E-05 7.637E-04 SENESE_HDAC3_TARGETS_UP uterine fibroid DOID_13223 4.295E-05 3.594E-04 4.295E-05 7.637E-04 SENESE_HDAC3_TARGETS_UP encephalitis DOID_9588 4.778E-05 3.94E-04 0.07102318 0.18623128 SENESE_HDAC3_TARGETS_UP pre-malignant neoplasm DOID_0060071 5.42E-05 4.406E-04 5.42E-05 9.071E-04 SENESE_HDAC3_TARGETS_UP congenital heart defect DOID_1682 5.42E-05 4.344E-04 5.42E-05 8.812E-04 SENESE_HDAC3_TARGETS_UP in situ carcinoma DOID_8719 5.42E-05 4.406E-04 5.42E-05 9.071E-04 SENESE_HDAC3_TARGETS_UP pleural disease DOID_1532 6.165E-05 4.872E-04 0.19341065 0.34607126 SENESE_HDAC3_TARGETS_UP uterine disease DOID_345 6.26E-05 4.879E-04 8.189E-04 6.656E-03 SENESE_HDAC3_TARGETS_UP metal metabolism disorder DOID_896 6.902E-05 5.307E-04 6.902E-05 1.061E-03 SENESE_HDAC3_TARGETS_UP nephroblastoma DOID_2154 7.702E-05 5.843E-04 7.702E-05 1.153E-03 SENESE_HDAC3_TARGETS_UP periodontal disease DOID_3388 7.702E-05 5.766E-04 7.702E-05 1.124E-03 SENESE_HDAC3_TARGETS_UP tuberculosis DOID_399 7.703E-05 5.692E-04 9.524E-03 0.03955599 SENESE_HDAC3_TARGETS_UP astrocytoma DOID_3069 8.237E-05 6.009E-04 1.015E-03 7.911E-03 SENESE_HDAC3_TARGETS_UP skeletal system cancer DOID_0060124 9.749E-05 7.022E-04 0.08797969 0.20771968 SENESE_HDAC3_TARGETS_UP bone cancer DOID_184 9.749E-05 7.022E-04 0.08797969 0.20771968 SENESE_HDAC3_TARGETS_UP oral submucous fibrosis DOID_5773 9.749E-05 6.934E-04 3.715E-03 0.01854226 SENESE_HDAC3_TARGETS_UP varicose veins DOID_799 9.749E-05 6.848E-04 3.715E-03 0.01838102 SENESE_HDAC3_TARGETS_UP calcinosis DOID_182 1.051E-04 7.289E-04 0.02496894 0.08610503 SENESE_HDAC3_TARGETS_UP embryonal cancer DOID_688 1.051E-04 7.202E-04 1.051E-04 1.458E-03 SENESE_HDAC3_TARGETS_UP vein disease DOID_866 1.194E-04 8.091E-04 4.229E-03 0.02074209 SENESE_HDAC3_TARGETS_UP cystic fibrosis DOID_1485 1.206E-04 8.076E-04 0.01228848 0.04958967 SENESE_HDAC3_TARGETS_UP hepatitis DOID_2237 1.274E-04 8.431E-04 2.178E-03 0.01392314 SENESE_HDAC3_TARGETS_UP bacterial pneumonia DOID_874 1.36E-04 8.896E-04 0.0131539 0.05197619 SENESE_HDAC3_TARGETS_UP hyperostosis DOID_205 1.444E-04 9.336E-04 1.444E-04 1.956E-03 SENESE_HDAC3_TARGETS_UP female reproductive system disease DOID_229 1.619E-04 1.035E-03 1.72E-03 0.01193818 SENESE_HDAC3_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 1.672E-04 1.057E-03 2.656E-03 0.0155793 SENESE_HDAC3_TARGETS_UP primary biliary cirrhosis DOID_12236 1.672E-04 1.057E-03 2.656E-03 0.0155793 SENESE_HDAC3_TARGETS_UP prion disease DOID_649 1.725E-04 1.078E-03 5.348E-03 0.02494397 SENESE_HDAC3_TARGETS_UP biliary tract cancer DOID_4607 1.811E-04 1.12E-03 1.878E-03 0.01271948 SENESE_HDAC3_TARGETS_UP testicular cancer DOID_2998 2.039E-04 1.247E-03 2.039E-04 2.578E-03 SENESE_HDAC3_TARGETS_UP pre-eclampsia DOID_10591 2.523E-04 1.528E-03 3.587E-03 0.01872545 SENESE_HDAC3_TARGETS_UP brain cancer DOID_1319 2.523E-04 1.511E-03 0.03768882 0.12254251 SENESE_HDAC3_TARGETS_UP neuritis DOID_1803 2.523E-04 1.496E-03 3.587E-03 0.01838805 SENESE_HDAC3_TARGETS_UP central nervous system cancer DOID_3620 2.725E-04 1.599E-03 0.03907227 0.12560521 SENESE_HDAC3_TARGETS_UP coronary restenosis DOID_4247 2.773E-04 1.61E-03 7.253E-03 0.03150254 SENESE_HDAC3_TARGETS_UP pulmonary tuberculosis DOID_2957 2.938E-04 1.689E-03 0.04047482 0.12866018 SENESE_HDAC3_TARGETS_UP muscular atrophy DOID_767 3.197E-04 1.819E-03 3.197E-04 3.432E-03 SENESE_HDAC3_TARGETS_UP giant cell tumor DOID_200 3.911E-04 2.203E-03 4.939E-03 0.02361493 SENESE_HDAC3_TARGETS_UP malignant giant cell tumor DOID_2705 3.911E-04 2.203E-03 4.939E-03 0.02361493 SENESE_HDAC3_TARGETS_UP giant cell glioblastoma DOID_3074 3.911E-04 2.203E-03 4.939E-03 0.02361493 SENESE_HDAC3_TARGETS_UP diabetic angiopathy DOID_11713 4.164E-04 2.323E-03 4.164E-04 4.156E-03 SENESE_HDAC3_TARGETS_UP Lewy body dementia DOID_12217 4.164E-04 2.3E-03 9.418E-03 0.03999203 SENESE_HDAC3_TARGETS_UP aortic valve disease DOID_62 4.164E-04 2.278E-03 4.164E-04 4.085E-03 SENESE_HDAC3_TARGETS_UP meningitis DOID_9471 4.164E-04 2.256E-03 0.13702226 0.27452699 SENESE_HDAC3_TARGETS_UP bile duct adenocarcinoma DOID_4896 4.186E-04 2.247E-03 5.19E-03 0.02460888 SENESE_HDAC3_TARGETS_UP cholangiocarcinoma DOID_4947 4.186E-04 2.247E-03 5.19E-03 0.02460888 SENESE_HDAC3_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 5.425E-04 2.885E-03 0.05391122 0.1667146 SENESE_HDAC3_TARGETS_UP glioblastoma DOID_3068 5.425E-04 2.858E-03 6.271E-03 0.02809418 SENESE_HDAC3_TARGETS_UP bile duct cancer DOID_4606 5.425E-04 2.832E-03 6.271E-03 0.02787469 SENESE_HDAC3_TARGETS_UP bile duct carcinoma DOID_4897 5.425E-04 2.832E-03 6.271E-03 0.02787469 SENESE_HDAC3_TARGETS_UP morbid obesity DOID_11981 5.936E-04 3.071E-03 5.936E-04 5.63E-03 SENESE_HDAC3_TARGETS_UP neuroectodermal tumor DOID_171 6.512E-04 3.338E-03 6.512E-04 6.074E-03 SENESE_HDAC3_TARGETS_UP seminoma DOID_4440 6.619E-04 3.363E-03 6.619E-04 5.884E-03 SENESE_HDAC3_TARGETS_UP Sciatic Neuropathy DOID_11446 7.349E-04 3.701E-03 0.01357958 0.05328815 SENESE_HDAC3_TARGETS_UP gestational diabetes DOID_11714 7.349E-04 3.668E-03 0.01357958 0.05292316 SENESE_HDAC3_TARGETS_UP lesion of sciatic nerve DOID_12528 7.349E-04 3.701E-03 0.01357958 0.05328815 SENESE_HDAC3_TARGETS_UP mononeuritis of lower limb DOID_9473 7.349E-04 3.701E-03 0.01357958 0.05328815 SENESE_HDAC3_TARGETS_UP mononeuritis DOID_1802 8.129E-04 4.022E-03 0.01449149 0.05497104 SENESE_HDAC3_TARGETS_UP mononeuropathy DOID_1188 8.96E-04 4.395E-03 0.01542911 0.05738015 SENESE_HDAC3_TARGETS_UP tooth disease DOID_1091 9.132E-04 4.441E-03 9.132E-04 7.217E-03 SENESE_HDAC3_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 9.631E-04 4.644E-03 9.524E-03 0.03984684 SENESE_HDAC3_TARGETS_UP germinoma DOID_3304 1.177E-03 5.627E-03 1.177E-03 8.928E-03 SENESE_HDAC3_TARGETS_UP peripheral vascular disease DOID_341 1.182E-03 5.605E-03 1.182E-03 8.85E-03 SENESE_HDAC3_TARGETS_UP myocarditis DOID_820 1.391E-03 6.543E-03 0.19835121 0.35159452 SENESE_HDAC3_TARGETS_UP mixed glioma DOID_5076 1.502E-03 7.005E-03 1.502E-03 0.01095685 SENESE_HDAC3_TARGETS_UP esophageal disease DOID_6050 1.507E-03 6.974E-03 0.02157575 0.07485733 SENESE_HDAC3_TARGETS_UP acute kidney failure DOID_3021 1.625E-03 7.455E-03 0.05954482 0.17646355 SENESE_HDAC3_TARGETS_UP Paget's disease of bone DOID_5408 1.625E-03 7.395E-03 1.625E-03 0.01170095 SENESE_HDAC3_TARGETS_UP cutaneous leishmaniasis DOID_9111 1.625E-03 7.336E-03 0.05954482 0.17374872 SENESE_HDAC3_TARGETS_UP medullomyoblastoma DOID_3861 1.629E-03 7.3E-03 1.629E-03 0.01158876 SENESE_HDAC3_TARGETS_UP adult medulloblastoma DOID_3864 1.629E-03 7.3E-03 1.629E-03 0.01158876 SENESE_HDAC3_TARGETS_UP childhood medulloblastoma DOID_3869 1.629E-03 7.3E-03 1.629E-03 0.01158876 SENESE_HDAC3_TARGETS_UP chromosomal disease DOID_0080014 1.72E-03 7.648E-03 1.72E-03 0.01208557 SENESE_HDAC3_TARGETS_UP alcohol abuse DOID_1574 1.878E-03 8.282E-03 1.878E-03 0.01287273 SENESE_HDAC3_TARGETS_UP chronic kidney failure DOID_784 1.878E-03 8.219E-03 0.09575339 0.21366148 SENESE_HDAC3_TARGETS_UP medulloblastoma DOID_3858 1.891E-03 8.214E-03 1.891E-03 0.01265974 SENESE_HDAC3_TARGETS_UP breast benign neoplasm DOID_0060082 1.978E-03 8.525E-03 1.978E-03 0.01308419 SENESE_HDAC3_TARGETS_UP thoracic benign neoplasm DOID_0060097 1.978E-03 8.525E-03 1.978E-03 0.01308419 SENESE_HDAC3_TARGETS_UP temporal arteritis DOID_13375 1.978E-03 8.46E-03 1.000 1.000 SENESE_HDAC3_TARGETS_UP neuronal ceroid lipofuscinosis DOID_14503 1.978E-03 8.397E-03 0.06530154 0.18578288 SENESE_HDAC3_TARGETS_UP benign breast phyllodes tumor DOID_1631 1.978E-03 8.525E-03 1.978E-03 0.01308419 SENESE_HDAC3_TARGETS_UP invasive lobular carcinoma DOID_3457 1.978E-03 8.335E-03 1.978E-03 0.0129338 SENESE_HDAC3_TARGETS_UP central nervous system vasculitis DOID_525 1.978E-03 8.46E-03 1.000 1.000 SENESE_HDAC3_TARGETS_UP peripheral nervous system neoplasm DOID_1192 2.031E-03 8.499E-03 2.031E-03 0.0131344 SENESE_HDAC3_TARGETS_UP uveitis DOID_13141 2.031E-03 8.437E-03 0.22260568 0.3849928 SENESE_HDAC3_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 2.178E-03 8.979E-03 0.22736817 0.39085344 SENESE_HDAC3_TARGETS_UP common cold DOID_10459 2.364E-03 9.675E-03 0.07102318 0.19617567 SENESE_HDAC3_TARGETS_UP esophageal carcinoma DOID_1107 2.364E-03 9.606E-03 2.364E-03 0.01461794 SENESE_HDAC3_TARGETS_UP epidermolysis bullosa DOID_2730 2.364E-03 9.538E-03 2.364E-03 0.01446076 SENESE_HDAC3_TARGETS_UP esophagus squamous cell carcinoma DOID_3748 2.364E-03 9.606E-03 2.364E-03 0.01461794 SENESE_HDAC3_TARGETS_UP aortic valve insufficiency DOID_57 2.364E-03 9.471E-03 2.364E-03 0.01430692 SENESE_HDAC3_TARGETS_UP peritonitis DOID_8283 2.364E-03 9.405E-03 0.07102318 0.188842 SENESE_HDAC3_TARGETS_UP primary immunodeficiency disease DOID_612 2.409E-03 9.519E-03 2.409E-03 0.01442853 SENESE_HDAC3_TARGETS_UP amino acid metabolic disorder DOID_9252 2.409E-03 9.453E-03 0.0185247 0.06629281 SENESE_HDAC3_TARGETS_UP benign mesothelioma DOID_2645 2.49E-03 9.704E-03 0.02980536 0.10035059 SENESE_HDAC3_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 2.49E-03 9.638E-03 2.49E-03 0.01475822 SENESE_HDAC3_TARGETS_UP carotid stenosis DOID_13001 2.782E-03 0.01069576 2.782E-03 0.01615278 SENESE_HDAC3_TARGETS_UP polyneuropathy DOID_1389 2.782E-03 0.01062397 2.782E-03 0.01598962 SENESE_HDAC3_TARGETS_UP larynx cancer DOID_2596 2.782E-03 0.01055315 0.07670994 0.19228175 SENESE_HDAC3_TARGETS_UP laryngeal benign neoplasm DOID_2598 2.782E-03 0.01055315 0.07670994 0.19228175 SENESE_HDAC3_TARGETS_UP vesiculobullous skin disease DOID_2731 2.782E-03 0.01048326 2.782E-03 0.01582972 SENESE_HDAC3_TARGETS_UP intracranial thrombosis DOID_4193 2.782E-03 0.01041429 0.07670994 0.19060243 SENESE_HDAC3_TARGETS_UP lymphoblastic leukemia DOID_1037 2.816E-03 0.01047085 2.816E-03 0.01586178 SENESE_HDAC3_TARGETS_UP encephalomyelitis DOID_640 2.816E-03 0.01040285 2.816E-03 0.01570627 SENESE_HDAC3_TARGETS_UP Huntington's disease DOID_12858 2.828E-03 0.01038315 2.828E-03 0.01562514 SENESE_HDAC3_TARGETS_UP primitive neuroectodermal tumor DOID_168 2.828E-03 0.0103166 2.828E-03 0.01532751 SENESE_HDAC3_TARGETS_UP uveal disease DOID_3480 2.828E-03 0.01025089 0.24612938 0.41680838 SENESE_HDAC3_TARGETS_UP diabetic autonomic neuropathy DOID_11503 3.008E-03 0.01083182 0.03365592 0.11069492 SENESE_HDAC3_TARGETS_UP autonomic neuropathy DOID_11504 3.008E-03 0.01083182 0.03365592 0.11069492 SENESE_HDAC3_TARGETS_UP diabetic polyneuropathy DOID_12785 3.008E-03 0.01083182 0.03365592 0.11069492 SENESE_HDAC3_TARGETS_UP uterine cancer DOID_363 3.008E-03 0.0107637 3.008E-03 0.01614555 SENESE_HDAC3_TARGETS_UP diabetic neuropathy DOID_9743 3.008E-03 0.01083182 0.03365592 0.11069492 SENESE_HDAC3_TARGETS_UP cataract DOID_83 3.194E-03 0.01135849 3.194E-03 0.01698465 SENESE_HDAC3_TARGETS_UP viral pneumonia DOID_10533 3.233E-03 0.01142466 0.08236204 0.20113305 SENESE_HDAC3_TARGETS_UP parasitic helminthiasis infectious disease DOID_883 3.233E-03 0.01135414 3.233E-03 0.01703121 SENESE_HDAC3_TARGETS_UP bacterial meningitis DOID_9470 3.233E-03 0.01128449 0.08236204 0.19690757 SENESE_HDAC3_TARGETS_UP lens disease DOID_110 3.587E-03 0.01244557 3.587E-03 0.01855522 SENESE_HDAC3_TARGETS_UP autonomic nervous system disease DOID_11465 3.587E-03 0.01237014 0.03768882 0.12324678 SENESE_HDAC3_TARGETS_UP thyroid adenoma DOID_2891 3.587E-03 0.01229563 0.03768882 0.12184625 SENESE_HDAC3_TARGETS_UP idiopathic pulmonary fibrosis DOID_0050156 3.715E-03 0.01265759 0.08797969 0.20858518 SENESE_HDAC3_TARGETS_UP peripheral neuropathy DOID_0060053 3.715E-03 0.01258225 3.715E-03 0.01887337 SENESE_HDAC3_TARGETS_UP nutritional deficiency disease DOID_5113 3.715E-03 0.01250779 3.715E-03 0.01870635 SENESE_HDAC3_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 4.009E-03 0.01341703 0.04047482 0.12938299 SENESE_HDAC3_TARGETS_UP integumentary system benign neoplasm DOID_0060121 4.009E-03 0.01333856 0.27342402 0.45490722 SENESE_HDAC3_TARGETS_UP skin benign neoplasm DOID_3165 4.009E-03 0.01333856 0.27342402 0.45490722 SENESE_HDAC3_TARGETS_UP Barrett's esophagus DOID_9206 4.229E-03 0.01398885 4.229E-03 0.02056481 SENESE_HDAC3_TARGETS_UP methylmalonic acidemia DOID_14749 4.773E-03 0.01569907 0.09911246 0.21943577 SENESE_HDAC3_TARGETS_UP sarcoidosis DOID_11335 4.939E-03 0.01615044 0.29107151 0.47866962 SENESE_HDAC3_TARGETS_UP atrophic muscular disease DOID_913 4.939E-03 0.01605815 0.04627034 0.14465839 SENESE_HDAC3_TARGETS_UP muscular dystrophy DOID_9884 4.939E-03 0.01605815 0.04627034 0.14465839 SENESE_HDAC3_TARGETS_UP inherited blood coagulation disease DOID_2214 5.348E-03 0.01729071 5.348E-03 0.02515012 SENESE_HDAC3_TARGETS_UP integumentary system cancer DOID_0060122 5.449E-03 0.01751556 0.29973454 0.49149555 SENESE_HDAC3_TARGETS_UP skin cancer DOID_4159 5.449E-03 0.01751556 0.29973454 0.49149555 SENESE_HDAC3_TARGETS_UP smallpox DOID_8736 5.449E-03 0.01741716 5.449E-03 0.02520532 SENESE_HDAC3_TARGETS_UP Down syndrome DOID_14250 5.953E-03 0.01892477 5.953E-03 0.02731883 SENESE_HDAC3_TARGETS_UP granulosa cell tumor DOID_2999 5.953E-03 0.01881964 5.953E-03 0.02710028 SENESE_HDAC3_TARGETS_UP leishmaniasis DOID_9065 5.953E-03 0.01871566 0.11010992 0.23290909 SENESE_HDAC3_TARGETS_UP congenital nervous system abnormality DOID_2490 5.989E-03 0.01872346 5.989E-03 0.027045 SENESE_HDAC3_TARGETS_UP esophagitis DOID_11963 6.588E-03 0.02048541 0.11555842 0.24085253 SENESE_HDAC3_TARGETS_UP sex cord-gonadal stromal tumor DOID_192 6.588E-03 0.02037408 6.588E-03 0.0290607 SENESE_HDAC3_TARGETS_UP subependymal glioma DOID_4843 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP pilocytic astrocytoma DOID_4851 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP subependymal giant cell astrocytoma DOID_5077 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP fibrillary astrocytoma DOID_6726 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP juvenile pilocytic astrocytoma DOID_6811 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP childhood pilocytic astrocytoma DOID_6812 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP gemistocytic astrocytoma DOID_7005 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP childhood cerebral astrocytoma DOID_7007 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP protoplasmic astrocytoma DOID_7008 6.588E-03 0.02026395 0.11555842 0.23910088 SENESE_HDAC3_TARGETS_UP funisitis DOID_0050698 7.946E-03 0.02430821 7.946E-03 0.03425248 SENESE_HDAC3_TARGETS_UP benign glioma DOID_0060101 7.946E-03 0.02417822 0.12635597 0.25955432 SENESE_HDAC3_TARGETS_UP hepatitis B DOID_2043 7.946E-03 0.02404961 0.12635597 0.25862067 SENESE_HDAC3_TARGETS_UP benign ependymoma DOID_4844 7.946E-03 0.02417822 0.12635597 0.25955432 SENESE_HDAC3_TARGETS_UP endocrine pancreas disease DOID_1428 8.126E-03 0.02446438 0.06361829 0.1846878 SENESE_HDAC3_TARGETS_UP opiate dependence DOID_2559 8.668E-03 0.02595841 0.13170542 0.26764423 SENESE_HDAC3_TARGETS_UP IgA glomerulonephritis DOID_2986 8.668E-03 0.0258225 0.13170542 0.26669176 SENESE_HDAC3_TARGETS_UP myasthenia gravis DOID_437 8.668E-03 0.02568801 0.13170542 0.26480701 SENESE_HDAC3_TARGETS_UP pulmonary embolism DOID_9477 8.668E-03 0.02555491 1.000 1.000 SENESE_HDAC3_TARGETS_UP Goodpasture syndrome DOID_9808 9.418E-03 0.02762336 9.418E-03 0.03969579 SENESE_HDAC3_TARGETS_UP sphingolipidosis DOID_1927 0.01019617 0.0297519 0.01019617 0.04204073 SENESE_HDAC3_TARGETS_UP pancreatic ductal carcinoma DOID_3587 0.01027221 0.02982087 0.07386123 0.1919043 SENESE_HDAC3_TARGETS_UP nephrosis DOID_2527 0.01065874 0.03078591 0.01065874 0.04363183 SENESE_HDAC3_TARGETS_UP male reproductive system disease DOID_48 0.01065874 0.03063043 0.01065874 0.04332018 SENESE_HDAC3_TARGETS_UP organic acidemia DOID_0060159 0.01100168 0.03145706 0.14755888 0.29153126 SENESE_HDAC3_TARGETS_UP pancreatic carcinoma DOID_4905 0.01145683 0.03259468 0.07916758 0.19500585 SENESE_HDAC3_TARGETS_UP diabetic retinopathy DOID_8947 0.01145683 0.03243251 0.37310844 0.59467423 SENESE_HDAC3_TARGETS_UP neuromuscular junction disease DOID_439 0.01183432 0.0333353 0.15277906 0.29368677 SENESE_HDAC3_TARGETS_UP myositis DOID_633 0.01183432 0.03317108 0.15277906 0.29269792 SENESE_HDAC3_TARGETS_UP syndrome DOID_225 0.01228848 0.03427522 0.01228848 0.04924045 SENESE_HDAC3_TARGETS_UP spinal cord disease DOID_319 0.01269374 0.03523288 0.1579674 0.29861612 SENESE_HDAC3_TARGETS_UP extrinsic allergic alveolitis DOID_841 0.01269374 0.03506184 1.000 1.000 SENESE_HDAC3_TARGETS_UP migraine DOID_6364 0.01357958 0.03732745 0.01357958 0.05256314 SENESE_HDAC3_TARGETS_UP periodontitis DOID_824 0.01357958 0.03714799 0.01357958 0.05220798 SENESE_HDAC3_TARGETS_UP perinatal necrotizing enterocolitis DOID_8677 0.01357958 0.03697025 0.16312411 0.30532111 SENESE_HDAC3_TARGETS_UP pleurisy DOID_10247 0.01449149 0.03926503 0.16824937 0.31388161 SENESE_HDAC3_TARGETS_UP renal hypertension DOID_1073 0.01449149 0.03907894 1.000 1.000 SENESE_HDAC3_TARGETS_UP secondary hypertension DOID_11130 0.01449149 0.03907894 1.000 1.000 SENESE_HDAC3_TARGETS_UP malaria DOID_12365 0.01449149 0.0388946 0.01449149 0.05533997 SENESE_HDAC3_TARGETS_UP renal tubular transport disease DOID_447 0.01449149 0.038712 0.01449149 0.05460699 SENESE_HDAC3_TARGETS_UP polycystic ovary syndrome DOID_11612 0.01542911 0.04102412 0.01542911 0.05775765 SENESE_HDAC3_TARGETS_UP supratentorial cancer DOID_1659 0.01542911 0.04083331 0.17334338 0.31816898 SENESE_HDAC3_TARGETS_UP toxic encephalopathy DOID_3602 0.01542911 0.04064427 0.01542911 0.05700755 SENESE_HDAC3_TARGETS_UP cerebrum cancer DOID_368 0.01542911 0.04083331 0.17334338 0.31816898 SENESE_HDAC3_TARGETS_UP retinal vascular disease DOID_2462 0.01645137 0.04313746 0.41412516 0.65093153 SENESE_HDAC3_TARGETS_UP age related macular degeneration DOID_10871 0.01738012 0.04536372 0.01738012 0.06380187 SENESE_HDAC3_TARGETS_UP degeneration of macula and posterior pole DOID_2007 0.01738012 0.04536372 0.01738012 0.06380187 SENESE_HDAC3_TARGETS_UP gonadal disease DOID_2277 0.01738012 0.04515658 0.01738012 0.06339289 SENESE_HDAC3_TARGETS_UP bronchiolitis obliterans DOID_2799 0.01738012 0.04495132 1.000 1.000 SENESE_HDAC3_TARGETS_UP Charcot-Marie-Tooth disease DOID_10595 0.01839283 0.04735531 0.01839283 0.06665938 SENESE_HDAC3_TARGETS_UP celiac disease DOID_10608 0.01839283 0.04714199 0.01839283 0.06623749 SENESE_HDAC3_TARGETS_UP allergic rhinitis DOID_4481 0.01839283 0.0469306 0.18843977 0.33824048 SENESE_HDAC3_TARGETS_UP chronic leukemia DOID_1036 0.0194299 0.04935541 0.0194299 0.06909757 SENESE_HDAC3_TARGETS_UP chronic lymphocytic leukemia DOID_1040 0.0194299 0.04935541 0.0194299 0.06909757 SENESE_HDAC3_TARGETS_UP autonomic nervous system neoplasm DOID_2621 0.0194299 0.04913605 0.0194299 0.0686684 SENESE_HDAC3_TARGETS_UP neuroblastoma DOID_769 0.0194299 0.04913605 0.0194299 0.0686684 SENESE_HDAC3_TARGETS_UP papilloma DOID_2615 0.02049098 0.05159012 0.19835121 0.35379887 SENESE_HDAC3_TARGETS_UP carbohydrate metabolic disorder DOID_2978 0.02073641 0.05197806 0.11520936 0.24279305 SENESE_HDAC3_TARGETS_UP hepatitis C DOID_1883 0.02157575 0.05384475 0.02157575 0.0757815 SENESE_HDAC3_TARGETS_UP thyroid carcinoma DOID_3963 0.02157575 0.05360962 0.20326164 0.35917974 SENESE_HDAC3_TARGETS_UP macular degeneration DOID_4448 0.02157575 0.05337653 0.02157575 0.07531658 SENESE_HDAC3_TARGETS_UP thyroid cancer DOID_1781 0.02381506 0.05866133 0.21299284 0.3729013 SENESE_HDAC3_TARGETS_UP pulmonary sarcoidosis DOID_13406 0.02496894 0.06123849 0.21781396 0.37900962 SENESE_HDAC3_TARGETS_UP cleft palate DOID_674 0.02496894 0.06097566 0.02496894 0.08558632 SENESE_HDAC3_TARGETS_UP peptic ulcer DOID_750 0.0273436 0.06648936 0.22736817 0.38850597 SENESE_HDAC3_TARGETS_UP nephrotic syndrome DOID_1184 0.03235175 0.07833253 0.03235175 0.10764997 SENESE_HDAC3_TARGETS_UP hyperinsulinism DOID_2018 0.03235175 0.07800061 0.03235175 0.10702409 SENESE_HDAC3_TARGETS_UP influenza DOID_8469 0.03365592 0.08080262 0.25074836 0.42211781 VECCHI_GASTRIC_CANCER_EARLY_UP uterine cancer DOID_363 3.752E-11 2.135E-08 1.741E-09 9.907E-07 VECCHI_GASTRIC_CANCER_EARLY_UP endocrine organ benign neoplasm DOID_0060089 1.159E-09 3.297E-07 1.752E-05 7.668E-04 VECCHI_GASTRIC_CANCER_EARLY_UP embryonal cancer DOID_688 2.517E-08 4.774E-06 2.517E-08 7.161E-06 VECCHI_GASTRIC_CANCER_EARLY_UP myeloma DOID_0070004 1.004E-07 1.428E-05 1.487E-03 0.01800595 VECCHI_GASTRIC_CANCER_EARLY_UP thyroid adenoma DOID_2891 1.004E-07 1.143E-05 1.487E-03 0.01763083 VECCHI_GASTRIC_CANCER_EARLY_UP diffuse large B-cell lymphoma DOID_0050745 1.86E-07 1.764E-05 8.492E-06 4.393E-04 VECCHI_GASTRIC_CANCER_EARLY_UP bone marrow cancer DOID_4960 2.234E-07 1.816E-05 2.17E-03 0.02166203 VECCHI_GASTRIC_CANCER_EARLY_UP vesiculobullous skin disease DOID_2731 2.704E-07 1.923E-05 2.704E-07 5.128E-05 VECCHI_GASTRIC_CANCER_EARLY_UP mouth disease DOID_403 2.744E-07 1.735E-05 4.941E-06 3.514E-04 VECCHI_GASTRIC_CANCER_EARLY_UP oral cavity cancer DOID_8618 3.368E-07 1.917E-05 8.299E-06 4.722E-04 VECCHI_GASTRIC_CANCER_EARLY_UP pre-malignant neoplasm DOID_0060071 5.411E-07 2.799E-05 5.411E-07 7.697E-05 VECCHI_GASTRIC_CANCER_EARLY_UP in situ carcinoma DOID_8719 5.411E-07 2.799E-05 5.411E-07 7.697E-05 VECCHI_GASTRIC_CANCER_EARLY_UP aplastic anemia DOID_12449 7.61E-07 3.609E-05 2.557E-05 9.095E-04 VECCHI_GASTRIC_CANCER_EARLY_UP medullomyoblastoma DOID_3861 7.61E-07 3.331E-05 7.61E-07 8.66E-05 VECCHI_GASTRIC_CANCER_EARLY_UP adult medulloblastoma DOID_3864 7.61E-07 3.331E-05 7.61E-07 8.66E-05 VECCHI_GASTRIC_CANCER_EARLY_UP childhood medulloblastoma DOID_3869 7.61E-07 3.331E-05 7.61E-07 8.66E-05 VECCHI_GASTRIC_CANCER_EARLY_UP medulloblastoma DOID_3858 9.904E-07 4.025E-05 9.904E-07 9.393E-05 VECCHI_GASTRIC_CANCER_EARLY_UP multiple myeloma DOID_9538 9.904E-07 3.757E-05 0.01394445 0.08719109 VECCHI_GASTRIC_CANCER_EARLY_UP hepatitis DOID_2237 1.271E-06 4.521E-05 8.943E-04 0.01211572 VECCHI_GASTRIC_CANCER_EARLY_UP primitive neuroectodermal tumor DOID_168 2.019E-06 6.757E-05 2.019E-06 1.641E-04 VECCHI_GASTRIC_CANCER_EARLY_UP bone marrow disease DOID_4961 3.076E-06 9.723E-05 7.652E-05 1.742E-03 VECCHI_GASTRIC_CANCER_EARLY_UP lymphoma DOID_0060058 4.371E-06 1.309E-04 6.797E-05 1.611E-03 VECCHI_GASTRIC_CANCER_EARLY_UP B-cell lymphocytic neoplasm DOID_707 4.525E-06 1.287E-04 1.036E-04 2.268E-03 VECCHI_GASTRIC_CANCER_EARLY_UP congenital nervous system abnormality DOID_2490 7.647E-06 2.072E-04 7.647E-06 4.834E-04 VECCHI_GASTRIC_CANCER_EARLY_UP neuroectodermal tumor DOID_171 1.052E-05 2.721E-04 1.052E-05 4.989E-04 VECCHI_GASTRIC_CANCER_EARLY_UP endometrial carcinoma DOID_2871 1.272E-05 3.148E-04 3.993E-04 6.492E-03 VECCHI_GASTRIC_CANCER_EARLY_UP cholestasis DOID_13580 1.418E-05 3.361E-04 2.541E-04 5.164E-03 VECCHI_GASTRIC_CANCER_EARLY_UP endometrial cancer DOID_1380 1.629E-05 3.708E-04 4.786E-04 7.36E-03 VECCHI_GASTRIC_CANCER_EARLY_UP otitis media DOID_10754 1.892E-05 4.14E-04 1.892E-05 7.689E-04 VECCHI_GASTRIC_CANCER_EARLY_UP epidermolysis bullosa DOID_2730 1.892E-05 3.987E-04 1.892E-05 7.176E-04 VECCHI_GASTRIC_CANCER_EARLY_UP middle ear disease DOID_5100 1.892E-05 4.14E-04 1.892E-05 7.689E-04 VECCHI_GASTRIC_CANCER_EARLY_UP bile duct disease DOID_4138 2.144E-05 4.357E-04 3.516E-04 6.252E-03 VECCHI_GASTRIC_CANCER_EARLY_UP biliary tract disease DOID_9741 2.289E-05 4.491E-04 3.701E-04 6.382E-03 VECCHI_GASTRIC_CANCER_EARLY_UP thyroid carcinoma DOID_3963 2.296E-05 4.355E-04 0.15326474 0.42129294 VECCHI_GASTRIC_CANCER_EARLY_UP thyroid cancer DOID_1781 2.84E-05 5.212E-04 0.16084904 0.43582431 VECCHI_GASTRIC_CANCER_EARLY_UP mixed glioma DOID_5076 3.131E-05 5.567E-04 5.652E-03 0.04529883 VECCHI_GASTRIC_CANCER_EARLY_UP microcephaly DOID_10907 3.472E-05 5.987E-04 3.472E-05 1.162E-03 VECCHI_GASTRIC_CANCER_EARLY_UP biliary tract cancer DOID_4607 4.196E-05 7.022E-04 4.196E-05 1.326E-03 VECCHI_GASTRIC_CANCER_EARLY_UP adenoid cystic carcinoma DOID_4866 4.202E-05 6.831E-04 4.202E-05 1.258E-03 VECCHI_GASTRIC_CANCER_EARLY_UP cervix uteri carcinoma in situ DOID_8991 4.606E-05 7.28E-04 4.606E-05 1.31E-03 VECCHI_GASTRIC_CANCER_EARLY_UP Fanconi's anemia DOID_13636 4.752E-05 7.308E-04 4.752E-05 1.288E-03 VECCHI_GASTRIC_CANCER_EARLY_UP salivary gland cancer DOID_8850 5.037E-05 7.543E-04 5.037E-05 1.303E-03 VECCHI_GASTRIC_CANCER_EARLY_UP transitional cell carcinoma DOID_2671 5.521E-05 8.055E-04 5.521E-05 1.366E-03 VECCHI_GASTRIC_CANCER_EARLY_UP nervous system cancer DOID_3093 6.134E-05 8.725E-04 0.06438885 0.26548737 VECCHI_GASTRIC_CANCER_EARLY_UP coronary restenosis DOID_4247 1.11E-04 1.541E-03 0.09008551 0.3106585 VECCHI_GASTRIC_CANCER_EARLY_UP sarcoidosis DOID_11335 1.195E-04 1.619E-03 0.02627854 0.14952486 VECCHI_GASTRIC_CANCER_EARLY_UP muscle cancer DOID_4045 1.469E-04 1.943E-03 1.469E-04 3.095E-03 VECCHI_GASTRIC_CANCER_EARLY_UP hypersensitivity reaction type IV disease DOID_2916 1.669E-04 2.158E-03 0.03077764 0.16366802 VECCHI_GASTRIC_CANCER_EARLY_UP congenital hypoplastic anemia DOID_1342 2.672E-04 3.379E-03 2.672E-04 5.243E-03 VECCHI_GASTRIC_CANCER_EARLY_UP tooth disease DOID_1091 2.841E-04 3.515E-03 3.891E-03 0.03459157 VECCHI_GASTRIC_CANCER_EARLY_UP lung adenocarcinoma DOID_3910 2.971E-04 3.597E-03 7.496E-03 0.05467952 VECCHI_GASTRIC_CANCER_EARLY_UP astrocytoma DOID_3069 3.166E-04 3.753E-03 0.04164232 0.20968565 VECCHI_GASTRIC_CANCER_EARLY_UP invasive ductal carcinoma DOID_3008 3.29E-04 3.821E-03 3.29E-04 6.24E-03 VECCHI_GASTRIC_CANCER_EARLY_UP coronary stenosis DOID_4248 3.29E-04 3.744E-03 0.12617909 0.37787317 VECCHI_GASTRIC_CANCER_EARLY_UP pancreatic ductal carcinoma DOID_3587 3.338E-04 3.724E-03 3.338E-04 6.126E-03 VECCHI_GASTRIC_CANCER_EARLY_UP pancreatic carcinoma DOID_4905 3.894E-04 4.26E-03 3.894E-04 6.516E-03 VECCHI_GASTRIC_CANCER_EARLY_UP cystic fibrosis DOID_1485 4.299E-04 4.615E-03 4.299E-04 6.795E-03 VECCHI_GASTRIC_CANCER_EARLY_UP aneurysm disease DOID_2403 4.512E-04 4.755E-03 0.29911676 0.67807743 VECCHI_GASTRIC_CANCER_EARLY_UP bacterial pneumonia DOID_874 4.733E-04 4.897E-03 5.652E-03 0.04466967 VECCHI_GASTRIC_CANCER_EARLY_UP papilloma DOID_2615 5.673E-04 5.764E-03 0.01139521 0.07718898 VECCHI_GASTRIC_CANCER_EARLY_UP auditory system disease DOID_2742 5.695E-04 5.685E-03 5.695E-04 8.528E-03 VECCHI_GASTRIC_CANCER_EARLY_UP nephroblastoma DOID_2154 6.153E-04 6.036E-03 6.153E-04 8.977E-03 VECCHI_GASTRIC_CANCER_EARLY_UP esophageal disease DOID_6050 6.153E-04 5.934E-03 0.0120112 0.07855603 VECCHI_GASTRIC_CANCER_EARLY_UP hyperthyroidism DOID_7998 6.153E-04 5.835E-03 0.0120112 0.07766335 VECCHI_GASTRIC_CANCER_EARLY_UP amino acid metabolic disorder DOID_9252 7.699E-04 7.182E-03 8.064E-03 0.0573557 VECCHI_GASTRIC_CANCER_EARLY_UP pulmonary sarcoidosis DOID_13406 7.747E-04 7.11E-03 0.01394445 0.08815988 VECCHI_GASTRIC_CANCER_EARLY_UP blood platelet disease DOID_2218 8.332E-04 7.525E-03 8.332E-04 0.01185168 VECCHI_GASTRIC_CANCER_EARLY_UP teratoma DOID_3307 8.785E-04 7.811E-03 8.785E-04 0.01219243 VECCHI_GASTRIC_CANCER_EARLY_UP chondrosarcoma DOID_3371 8.785E-04 7.691E-03 0.04395286 0.21194217 VECCHI_GASTRIC_CANCER_EARLY_UP malignant teratoma DOID_5563 8.785E-04 7.811E-03 8.785E-04 0.01219243 VECCHI_GASTRIC_CANCER_EARLY_UP mature teratoma DOID_5566 8.785E-04 7.811E-03 8.785E-04 0.01219243 VECCHI_GASTRIC_CANCER_EARLY_UP familial adenomatous polyposis DOID_0050424 1.071E-03 9.23E-03 0.04824108 0.2268527 VECCHI_GASTRIC_CANCER_EARLY_UP neuronal ceroid lipofuscinosis DOID_14503 1.071E-03 9.092E-03 0.04824108 0.22499325 VECCHI_GASTRIC_CANCER_EARLY_UP gallbladder cancer DOID_3121 1.243E-03 0.01039772 1.243E-03 0.01644291 VECCHI_GASTRIC_CANCER_EARLY_UP influenza DOID_8469 1.243E-03 0.01024703 1.243E-03 0.0160692 VECCHI_GASTRIC_CANCER_EARLY_UP common cold DOID_10459 1.281E-03 0.01041226 1.281E-03 0.01619685 VECCHI_GASTRIC_CANCER_EARLY_UP relapsing-remitting multiple sclerosis DOID_2378 1.281E-03 0.01026561 1.281E-03 0.01584475 VECCHI_GASTRIC_CANCER_EARLY_UP brain cancer DOID_1319 1.487E-03 0.01175388 1.000 1.000 VECCHI_GASTRIC_CANCER_EARLY_UP vascular skin disease DOID_9540 1.487E-03 0.01159287 1.487E-03 0.01727101 VECCHI_GASTRIC_CANCER_EARLY_UP central nervous system cancer DOID_3620 1.575E-03 0.01211121 1.000 1.000 VECCHI_GASTRIC_CANCER_EARLY_UP rhabdomyosarcoma DOID_3247 1.756E-03 0.01332045 1.756E-03 0.01998067 VECCHI_GASTRIC_CANCER_EARLY_UP hemorrhagic disease DOID_2213 1.858E-03 0.01390829 1.858E-03 0.02072608 VECCHI_GASTRIC_CANCER_EARLY_UP corneal dystrophy DOID_2566 2.02E-03 0.01492649 2.02E-03 0.02210269 VECCHI_GASTRIC_CANCER_EARLY_UP skeletal muscle cancer DOID_4043 2.02E-03 0.01473513 2.02E-03 0.02168566 VECCHI_GASTRIC_CANCER_EARLY_UP lung oat cell carcinoma DOID_5411 2.02E-03 0.01454861 0.06520361 0.25944654 VECCHI_GASTRIC_CANCER_EARLY_UP intermediate coronary syndrome DOID_8805 2.02E-03 0.01436675 2.02E-03 0.02128407 VECCHI_GASTRIC_CANCER_EARLY_UP hyperhomocysteinemia DOID_9279 2.02E-03 0.01418938 2.02E-03 0.02089709 VECCHI_GASTRIC_CANCER_EARLY_UP giant cell tumor DOID_200 2.063E-03 0.01431201 0.02627854 0.14804442 VECCHI_GASTRIC_CANCER_EARLY_UP malignant giant cell tumor DOID_2705 2.063E-03 0.01431201 0.02627854 0.14804442 VECCHI_GASTRIC_CANCER_EARLY_UP giant cell glioblastoma DOID_3074 2.063E-03 0.01431201 0.02627854 0.14804442 VECCHI_GASTRIC_CANCER_EARLY_UP bile duct adenocarcinoma DOID_4896 2.17E-03 0.01487633 2.17E-03 0.02204885 VECCHI_GASTRIC_CANCER_EARLY_UP cholangiocarcinoma DOID_4947 2.17E-03 0.01487633 2.17E-03 0.02204885 VECCHI_GASTRIC_CANCER_EARLY_UP chronic myeloid leukemia DOID_8552 2.302E-03 0.01559129 2.302E-03 0.02258049 VECCHI_GASTRIC_CANCER_EARLY_UP tongue cancer DOID_8649 2.302E-03 0.01540786 0.06939707 0.26680361 VECCHI_GASTRIC_CANCER_EARLY_UP Barrett's esophagus DOID_9206 2.302E-03 0.0152287 2.302E-03 0.02219777 VECCHI_GASTRIC_CANCER_EARLY_UP urinary system benign neoplasm DOID_731 2.601E-03 0.01701066 2.601E-03 0.02466545 VECCHI_GASTRIC_CANCER_EARLY_UP glioblastoma DOID_3068 2.634E-03 0.01703394 0.03077764 0.16215258 VECCHI_GASTRIC_CANCER_EARLY_UP bile duct cancer DOID_4606 2.634E-03 0.01684255 2.634E-03 0.02457356 VECCHI_GASTRIC_CANCER_EARLY_UP bile duct carcinoma DOID_4897 2.634E-03 0.01684255 2.634E-03 0.02457356 VECCHI_GASTRIC_CANCER_EARLY_UP infertility DOID_5223 3.251E-03 0.02055413 3.251E-03 0.02983664 VECCHI_GASTRIC_CANCER_EARLY_UP parasitic infectious disease DOID_1398 3.585E-03 0.022419 0.03754422 0.19598771 VECCHI_GASTRIC_CANCER_EARLY_UP cerebral degeneration DOID_1443 3.585E-03 0.02217531 0.03754422 0.194206 VECCHI_GASTRIC_CANCER_EARLY_UP esophagitis DOID_11963 3.602E-03 0.02203631 0.08598473 0.30388391 VECCHI_GASTRIC_CANCER_EARLY_UP colon carcinoma DOID_1520 3.602E-03 0.02180188 3.602E-03 0.03252979 VECCHI_GASTRIC_CANCER_EARLY_UP muscular atrophy DOID_767 4.353E-03 0.02607374 4.353E-03 0.03810778 VECCHI_GASTRIC_CANCER_EARLY_UP blood coagulation disease DOID_1247 4.378E-03 0.02594689 4.378E-03 0.03774092 VECCHI_GASTRIC_CANCER_EARLY_UP peripheral vascular disease DOID_341 4.722E-03 0.02769837 4.722E-03 0.04010062 VECCHI_GASTRIC_CANCER_EARLY_UP sinusitis DOID_0050127 4.754E-03 0.02760156 4.754E-03 0.03977871 VECCHI_GASTRIC_CANCER_EARLY_UP paranasal sinus disease DOID_1352 4.754E-03 0.02760156 4.754E-03 0.03977871 VECCHI_GASTRIC_CANCER_EARLY_UP Lewy body dementia DOID_12217 5.171E-03 0.02971923 0.10227842 0.34233189 VECCHI_GASTRIC_CANCER_EARLY_UP acute pancreatitis DOID_2913 5.604E-03 0.03188672 5.604E-03 0.04621264 VECCHI_GASTRIC_CANCER_EARLY_UP pancreatitis DOID_4989 5.652E-03 0.03184373 5.652E-03 0.04594595 VECCHI_GASTRIC_CANCER_EARLY_UP osteosarcoma DOID_3347 6.053E-03 0.03376738 6.053E-03 0.04718181 VECCHI_GASTRIC_CANCER_EARLY_UP chromosomal disease DOID_0080014 6.26E-03 0.03458049 6.26E-03 0.04813231 VECCHI_GASTRIC_CANCER_EARLY_UP papillary adenoma DOID_3172 6.518E-03 0.03566267 6.518E-03 0.04945223 VECCHI_GASTRIC_CANCER_EARLY_UP microcystic adenoma DOID_5403 6.518E-03 0.03566267 6.518E-03 0.04945223 VECCHI_GASTRIC_CANCER_EARLY_UP follicular adenoma DOID_6204 6.518E-03 0.03566267 6.518E-03 0.04945223 VECCHI_GASTRIC_CANCER_EARLY_UP teeth hard tissue disease DOID_214 6.999E-03 0.03792878 6.999E-03 0.05240161 VECCHI_GASTRIC_CANCER_EARLY_UP gestational diabetes DOID_11714 7.496E-03 0.04023587 7.496E-03 0.05538964 VECCHI_GASTRIC_CANCER_EARLY_UP periodontitis DOID_824 7.496E-03 0.03985984 0.12224004 0.38007968 VECCHI_GASTRIC_CANCER_EARLY_UP perinatal necrotizing enterocolitis DOID_8677 7.496E-03 0.03949076 0.12224004 0.37801403 VECCHI_GASTRIC_CANCER_EARLY_UP autoimmune disease of the nervous system DOID_438 8.008E-03 0.04180068 8.008E-03 0.05767435 VECCHI_GASTRIC_CANCER_EARLY_UP corneal disease DOID_10124 9.077E-03 0.04695324 9.077E-03 0.06376365 VECCHI_GASTRIC_CANCER_EARLY_UP alcohol-related neurodevelopmental disorder DOID_0050667 9.331E-03 0.04783444 0.35078589 0.77363244 VECCHI_GASTRIC_CANCER_EARLY_UP hypersensitivity reaction type I disease DOID_1205 9.598E-03 0.04876184 0.07060145 0.26961226 VECCHI_GASTRIC_CANCER_EARLY_UP dilated cardiomyopathy DOID_12930 9.598E-03 0.04833032 0.07060145 0.26781484 VECCHI_GASTRIC_CANCER_EARLY_UP spastic cerebral palsy DOID_0050669 9.634E-03 0.04808773 9.634E-03 0.06685368 VECCHI_GASTRIC_CANCER_EARLY_UP abdominal aortic aneurysm DOID_7693 9.634E-03 0.04766958 1.000 1.000 VECCHI_GASTRIC_CANCER_EARLY_UP autonomic nervous system neoplasm DOID_2621 0.01079366 0.05294475 0.01079366 0.07399508 VECCHI_GASTRIC_CANCER_EARLY_UP neuroblastoma DOID_769 0.01079366 0.05294475 0.01079366 0.07399508 VECCHI_GASTRIC_CANCER_EARLY_UP myocarditis DOID_820 0.01139521 0.05541773 0.01139521 0.07628087 VECCHI_GASTRIC_CANCER_EARLY_UP metal metabolism disorder DOID_896 0.01139521 0.05494809 0.01139521 0.07539389 VECCHI_GASTRIC_CANCER_EARLY_UP hepatitis C DOID_1883 0.0120112 0.05743172 0.15326474 0.42540312 VECCHI_GASTRIC_CANCER_EARLY_UP periodontal disease DOID_3388 0.0120112 0.05695312 0.15326474 0.42333806 VECCHI_GASTRIC_CANCER_EARLY_UP adenoma DOID_657 0.01328596 0.06247695 0.01328596 0.08494057 VECCHI_GASTRIC_CANCER_EARLY_UP calcinosis DOID_182 0.01394445 0.06503598 0.16461583 0.44182266 VECCHI_GASTRIC_CANCER_EARLY_UP peripheral nervous system neoplasm DOID_1192 0.01461682 0.06761764 0.01461682 0.09040185 VECCHI_GASTRIC_CANCER_EARLY_UP uveitis DOID_13141 0.01461682 0.06707234 0.1683658 0.44976592 VECCHI_GASTRIC_CANCER_EARLY_UP systemic scleroderma DOID_418 0.01530294 0.069659 0.17209904 0.45546211 VECCHI_GASTRIC_CANCER_EARLY_UP peptic ulcer DOID_750 0.01530294 0.06910615 0.01530294 0.09362769 VECCHI_GASTRIC_CANCER_EARLY_UP benign mesothelioma DOID_2645 0.01671591 0.07489255 1.000 1.000 VECCHI_GASTRIC_CANCER_EARLY_UP pulmonary emphysema DOID_9675 0.01671591 0.07430745 0.17951561 0.46641271 VECCHI_GASTRIC_CANCER_EARLY_UP autoimmune disease of urogenital tract DOID_0060049 0.01744248 0.07693623 0.01744248 0.1055827 VECCHI_GASTRIC_CANCER_EARLY_UP primary biliary cirrhosis DOID_12236 0.01744248 0.07693623 0.01744248 0.1055827 VECCHI_GASTRIC_CANCER_EARLY_UP spinocerebellar ataxia DOID_1441 0.01744248 0.07634441 0.01744248 0.1044713 VECCHI_GASTRIC_CANCER_EARLY_UP rheumatic disease DOID_1575 0.01818227 0.07897492 0.18686613 0.47680193 VECCHI_GASTRIC_CANCER_EARLY_UP idiopathic generalized epilepsy DOID_1827 0.01818227 0.07837662 0.01818227 0.10776785 VECCHI_GASTRIC_CANCER_EARLY_UP uveal disease DOID_3480 0.01818227 0.07778732 0.18686613 0.47256369 VECCHI_GASTRIC_CANCER_EARLY_UP scleroderma DOID_419 0.01818227 0.07897492 0.18686613 0.47680193 VECCHI_GASTRIC_CANCER_EARLY_UP leukodystrophy DOID_10579 0.02047963 0.086962 0.19776935 0.49355595 VECCHI_GASTRIC_CANCER_EARLY_UP spinocerebellar degeneration DOID_2478 0.02047963 0.08631784 0.02047963 0.12013307 VECCHI_GASTRIC_CANCER_EARLY_UP proteinuria DOID_576 0.02047963 0.08568315 0.19776935 0.49140069 VECCHI_GASTRIC_CANCER_EARLY_UP pre-eclampsia DOID_10591 0.02127097 0.08834441 0.20137135 0.49817522 VECCHI_GASTRIC_CANCER_EARLY_UP heart valve disease DOID_4079 0.02127097 0.08770423 0.20137135 0.4938806 VECCHI_GASTRIC_CANCER_EARLY_UP hemolytic anemia DOID_583 0.02207489 0.09036411 0.02207489 0.1281695 VECCHI_GASTRIC_CANCER_EARLY_UP normocytic anemia DOID_720 0.02207489 0.09036411 0.02207489 0.1281695 VECCHI_GASTRIC_CANCER_EARLY_UP autoimmune disease of gastrointestinal tract DOID_0060031 0.02289124 0.09303654 0.02289124 0.13156682 VECCHI_GASTRIC_CANCER_EARLY_UP lung small cell carcinoma DOID_5409 0.02289124 0.09237671 0.2085272 0.50705974 VECCHI_GASTRIC_CANCER_EARLY_UP calcium metabolism disease DOID_10575 0.02371991 0.09504667 0.21208119 0.51350723 VECCHI_GASTRIC_CANCER_EARLY_UP aortic aneurysm DOID_3627 0.02371991 0.09438201 1.000 1.000 VANHARANTA_UTERINE_FIBROID_UP heart valve disease DOID_4079 5.353E-08 3.046E-05 5.353E-08 3.046E-05 VANHARANTA_UTERINE_FIBROID_UP aortic valve insufficiency DOID_57 7.902E-08 2.248E-05 7.902E-08 2.248E-05 VANHARANTA_UTERINE_FIBROID_UP Ehlers-Danlos syndrome DOID_13359 1.632E-07 3.095E-05 1.632E-07 3.095E-05 VANHARANTA_UTERINE_FIBROID_UP aortic valve disease DOID_62 7.227E-07 1.028E-04 7.227E-07 1.028E-04 VANHARANTA_UTERINE_FIBROID_UP nephrotic syndrome DOID_1184 5.361E-06 6.101E-04 5.361E-06 6.101E-04 VANHARANTA_UTERINE_FIBROID_UP osteochondrodysplasia DOID_2256 1.083E-05 1.027E-03 1.083E-05 1.027E-03 VANHARANTA_UTERINE_FIBROID_UP oral cavity cancer DOID_8618 1.262E-05 1.026E-03 9.37E-04 0.02538873 VANHARANTA_UTERINE_FIBROID_UP collagen disease DOID_854 1.458E-05 1.037E-03 1.458E-05 1.186E-03 VANHARANTA_UTERINE_FIBROID_UP nephrosis DOID_2527 2.258E-05 1.428E-03 2.258E-05 1.606E-03 VANHARANTA_UTERINE_FIBROID_UP bone development disease DOID_0080006 3.544E-05 2.016E-03 3.544E-05 2.24E-03 VANHARANTA_UTERINE_FIBROID_UP ureteral obstruction DOID_5199 7.989E-05 4.133E-03 7.989E-05 4.546E-03 VANHARANTA_UTERINE_FIBROID_UP urinary tract obstruction DOID_5200 1.318E-04 6.25E-03 1.318E-04 6.818E-03 VANHARANTA_UTERINE_FIBROID_UP ureteral disease DOID_1426 1.437E-04 6.291E-03 1.437E-04 6.815E-03 VANHARANTA_UTERINE_FIBROID_UP spastic quadriplegia DOID_10970 1.562E-04 6.347E-03 1.562E-04 6.835E-03 VANHARANTA_UTERINE_FIBROID_UP intracranial aneurysm DOID_10941 1.965E-04 7.453E-03 1.965E-04 7.986E-03 VANHARANTA_UTERINE_FIBROID_UP multiple epiphyseal dysplasia DOID_12721 2.414E-04 8.584E-03 2.414E-04 9.156E-03 VANHARANTA_UTERINE_FIBROID_UP focal glomerulosclerosis DOID_3945 2.414E-04 8.079E-03 2.414E-04 8.584E-03 VANHARANTA_UTERINE_FIBROID_UP spastic cerebral palsy DOID_0050669 2.738E-04 8.656E-03 2.738E-04 9.165E-03 VANHARANTA_UTERINE_FIBROID_UP cleft palate DOID_674 4.032E-04 0.01207574 4.032E-04 0.01274661 VANHARANTA_UTERINE_FIBROID_UP adenoid cystic carcinoma DOID_4866 4.662E-04 0.01326281 0.03128802 0.31233128 VANHARANTA_UTERINE_FIBROID_UP salivary gland cancer DOID_8850 5.106E-04 0.01383557 0.03272006 0.31029524 VANHARANTA_UTERINE_FIBROID_UP lung small cell carcinoma DOID_5409 6.817E-04 0.0176325 6.817E-04 0.02041658 VANHARANTA_UTERINE_FIBROID_UP orofacial cleft DOID_0050567 7.625E-04 0.01886241 7.625E-04 0.02169177 VANHARANTA_UTERINE_FIBROID_UP aneurysm disease DOID_2403 1.565E-03 0.0370957 1.565E-03 0.04046804 VANHARANTA_UTERINE_FIBROID_UP lymphoma DOID_0060058 2.205E-03 0.05017809 2.205E-03 0.0545414 VANHARANTA_UTERINE_FIBROID_UP ulcerative colitis DOID_8577 2.49E-03 0.05449011 2.49E-03 0.05903096 CHIBA_RESPONSE_TO_TSA_UP transient cerebral ischemia DOID_224 1.509E-07 8.586E-05 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP atrophic muscular disease DOID_913 4.582E-07 1.304E-04 0.06022945 1.000 CHIBA_RESPONSE_TO_TSA_UP muscular dystrophy DOID_9884 4.582E-07 1.304E-04 0.06022945 1.000 CHIBA_RESPONSE_TO_TSA_UP oral cavity cancer DOID_8618 6.484E-07 1.23E-04 0.06543153 1.000 CHIBA_RESPONSE_TO_TSA_UP tongue cancer DOID_8649 7.009E-07 9.97E-05 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP ureteral obstruction DOID_5199 1.02E-06 1.16E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP diabetic retinopathy DOID_8947 1.575E-06 1.494E-04 0.08086968 1.000 CHIBA_RESPONSE_TO_TSA_UP metabolic syndrome X DOID_14221 2.137E-06 1.737E-04 3.762E-03 1.000 CHIBA_RESPONSE_TO_TSA_UP urinary tract obstruction DOID_5200 2.205E-06 1.568E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP ureteral disease DOID_1426 2.518E-06 1.592E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP retinal vascular disease DOID_2462 2.709E-06 1.541E-04 0.09203248 1.000 CHIBA_RESPONSE_TO_TSA_UP encephalomyelitis DOID_640 3.849E-06 1.991E-04 0.10006765 1.000 CHIBA_RESPONSE_TO_TSA_UP alcohol-related neurodevelopmental disorder DOID_0050667 4.013E-06 1.903E-04 0.10106715 1.000 CHIBA_RESPONSE_TO_TSA_UP blood platelet disease DOID_2218 1.309E-05 5.728E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP intracranial arterial disease DOID_13089 1.513E-05 6.148E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP cerebral arterial disease DOID_3527 1.513E-05 6.148E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP cerebral infarction DOID_3526 2.112E-05 8.012E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP heart valve disease DOID_4079 2.39E-05 8.498E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP glaucoma DOID_1686 2.69E-05 9.005E-04 0.05604744 1.000 CHIBA_RESPONSE_TO_TSA_UP hemorrhagic disease DOID_2213 3.015E-05 9.53E-04 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP vasculitis DOID_865 3.548E-05 1.063E-03 0.06127212 1.000 CHIBA_RESPONSE_TO_TSA_UP osteochondrodysplasia DOID_2256 3.739E-05 1.064E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP keratitis DOID_4677 5.361E-05 1.453E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP uterine disease DOID_345 6.026E-05 1.559E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP brain infarction DOID_3454 6.857E-05 1.696E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP blood coagulation disease DOID_1247 7.45E-05 1.766E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP male reproductive system disease DOID_48 7.759E-05 1.766E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP relapsing-remitting multiple sclerosis DOID_2378 7.852E-05 1.718E-03 0.01321549 1.000 CHIBA_RESPONSE_TO_TSA_UP aortic valve insufficiency DOID_57 7.852E-05 1.655E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP peripheral vascular disease DOID_341 8.076E-05 1.641E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP aneurysm disease DOID_2403 9.429E-05 1.85E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP contact dermatitis DOID_2773 1.053E-04 1.998E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP female reproductive system disease DOID_229 1.092E-04 2.005E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP bone development disease DOID_0080006 1.214E-04 2.158E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP oral submucous fibrosis DOID_5773 1.247E-04 2.149E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP varicose veins DOID_799 1.247E-04 2.086E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP transitional cell carcinoma DOID_2671 1.389E-04 2.258E-03 4.511E-03 0.85564718 CHIBA_RESPONSE_TO_TSA_UP spastic diplegia DOID_10965 1.424E-04 2.25E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP vein disease DOID_866 1.424E-04 2.189E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP mouth disease DOID_403 1.681E-04 2.518E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP placenta disease DOID_780 2.729E-04 3.982E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP aortic valve disease DOID_62 3.256E-04 4.632E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP spastic quadriplegia DOID_10970 3.537E-04 4.908E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP urticaria DOID_1555 3.829E-04 5.187E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP myositis DOID_633 4.132E-04 5.468E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP intracranial aneurysm DOID_10941 4.447E-04 5.751E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP middle cerebral artery infarction DOID_3525 4.447E-04 5.623E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP sarcoma DOID_1115 5.11E-04 6.321E-03 0.03271963 1.000 CHIBA_RESPONSE_TO_TSA_UP thrombocytopenia DOID_1588 5.11E-04 6.187E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP invasive ductal carcinoma DOID_3008 5.11E-04 6.058E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP polycystic ovary syndrome DOID_11612 5.459E-04 6.339E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP toxic encephalopathy DOID_3602 5.459E-04 6.212E-03 0.03379209 1.000 CHIBA_RESPONSE_TO_TSA_UP focal glomerulosclerosis DOID_3945 5.459E-04 6.091E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP corneal disease DOID_10124 5.819E-04 6.367E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP endometrial carcinoma DOID_2871 5.819E-04 6.247E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP spastic cerebral palsy DOID_0050669 6.19E-04 6.522E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP endometrial cancer DOID_1380 6.572E-04 6.799E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP nephroblastoma DOID_2154 7.786E-04 7.911E-03 0.04020251 0.99457504 CHIBA_RESPONSE_TO_TSA_UP embryonal cancer DOID_688 9.099E-04 9.083E-03 0.04339212 0.98760475 CHIBA_RESPONSE_TO_TSA_UP congenital diaphragmatic hernia DOID_3827 1.003E-03 9.84E-03 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP autoimmune disease of urogenital tract DOID_0060049 1.151E-03 0.01109909 0.04868518 1.000 CHIBA_RESPONSE_TO_TSA_UP primary biliary cirrhosis DOID_12236 1.151E-03 0.01109909 0.04868518 1.000 CHIBA_RESPONSE_TO_TSA_UP diabetic autonomic neuropathy DOID_11503 1.255E-03 0.01190061 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP autonomic neuropathy DOID_11504 1.255E-03 0.01190061 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP diabetic polyneuropathy DOID_12785 1.255E-03 0.01190061 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP uterine cancer DOID_363 1.255E-03 0.01170552 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP diabetic neuropathy DOID_9743 1.255E-03 0.01190061 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP myeloma DOID_0070004 1.419E-03 0.01302343 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP autonomic nervous system disease DOID_11465 1.419E-03 0.01281671 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP vascular skin disease DOID_9540 1.419E-03 0.01261644 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP hemolytic anemia DOID_583 1.476E-03 0.01292032 0.05499911 1.000 CHIBA_RESPONSE_TO_TSA_UP normocytic anemia DOID_720 1.476E-03 0.01292032 0.05499911 1.000 CHIBA_RESPONSE_TO_TSA_UP movement disease DOID_480 1.593E-03 0.01373322 1.593E-03 0.90639261 CHIBA_RESPONSE_TO_TSA_UP orofacial cleft DOID_0050567 1.714E-03 0.01455827 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP bile duct adenocarcinoma DOID_4896 1.84E-03 0.01539477 0.06127212 1.000 CHIBA_RESPONSE_TO_TSA_UP cholangiocarcinoma DOID_4947 1.84E-03 0.01539477 0.06127212 1.000 CHIBA_RESPONSE_TO_TSA_UP bone marrow cancer DOID_4960 1.84E-03 0.01517165 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP reproductive organ benign neoplasm DOID_0050622 1.904E-03 0.01547817 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP hypertrophic cardiomyopathy DOID_11984 2.104E-03 0.0168587 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP bile duct cancer DOID_4606 2.104E-03 0.01662456 0.06543153 1.000 CHIBA_RESPONSE_TO_TSA_UP bile duct carcinoma DOID_4897 2.104E-03 0.01662456 0.06543153 1.000 CHIBA_RESPONSE_TO_TSA_UP carotid artery disease DOID_3407 2.313E-03 0.01802545 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP collagen disease DOID_854 2.313E-03 0.01778186 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP allergic contact dermatitis DOID_3042 2.759E-03 0.02092901 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP endocrine organ benign neoplasm DOID_0060089 2.837E-03 0.02123741 0.0757515 1.000 CHIBA_RESPONSE_TO_TSA_UP pancreatic ductal carcinoma DOID_3587 2.996E-03 0.02213681 0.0778021 1.000 CHIBA_RESPONSE_TO_TSA_UP nephrosis DOID_2527 3.077E-03 0.02244431 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP pancreatic carcinoma DOID_4905 3.242E-03 0.02334995 0.08086968 1.000 CHIBA_RESPONSE_TO_TSA_UP syndrome DOID_225 3.411E-03 0.02426194 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP bone resorption disease DOID_0080011 3.497E-03 0.0245676 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP osteoporosis DOID_11476 3.497E-03 0.0245676 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP mixed glioma DOID_5076 3.584E-03 0.02487284 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP biliary tract cancer DOID_4607 4.035E-03 0.02766449 0.09001277 1.000 CHIBA_RESPONSE_TO_TSA_UP chronic kidney failure DOID_784 4.035E-03 0.02733515 0.09001277 1.000 CHIBA_RESPONSE_TO_TSA_UP primary immunodeficiency disease DOID_612 4.609E-03 0.03085636 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP dilated cardiomyopathy DOID_12930 5.219E-03 0.03453045 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP arrhythmogenic right ventricular dysplasia DOID_0050431 9.928E-03 0.0649294 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP facioscapulohumeral muscular dystrophy DOID_11727 0.01102481 0.07128544 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP childhood type dermatomyositis DOID_14203 0.01102481 0.07048448 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP progressive muscular atrophy DOID_318 0.01102481 0.06970132 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP insulinoma DOID_3892 0.01102481 0.06893537 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP acute T cell leukemia DOID_5603 0.01102481 0.06818607 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP nervous system benign neoplasm DOID_0060115 0.01212075 0.07415811 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP dermatomyositis DOID_10223 0.01212075 0.0733692 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP sickle cell anemia DOID_10923 0.01212075 0.07259689 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP common variable immunodeficiency DOID_12177 0.01212075 0.07184067 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP hemochromatosis DOID_2352 0.01212075 0.07110005 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP prostatic adenoma DOID_2883 0.01212075 0.07037454 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP islet cell tumor DOID_1799 0.01321549 0.07595572 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP epidermolysis bullosa DOID_2730 0.01321549 0.07519616 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP retinal detachment DOID_5327 0.01321549 0.07445164 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP berylliosis DOID_10322 0.01430906 0.07982209 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP Hirschsprung's disease DOID_10487 0.01430906 0.07904712 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP osteogenesis imperfecta DOID_12347 0.01430906 0.07828705 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP vulva cancer DOID_1245 0.01430906 0.07754146 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP Leydig cell tumor DOID_2696 0.01430906 0.07680994 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP vesiculobullous skin disease DOID_2731 0.01430906 0.07609209 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP sex cord-stromal neoplasm DOID_4757 0.01430906 0.07680994 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP epilepsy with generalized tonic-clonic seizures DOID_7725 0.01430906 0.07538753 0.01430906 1.000 CHIBA_RESPONSE_TO_TSA_UP psoriatic arthritis DOID_9008 0.01430906 0.0746959 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP open-angle glaucoma DOID_1067 0.01540144 0.07966743 0.01540144 1.000 CHIBA_RESPONSE_TO_TSA_UP megacolon DOID_11372 0.01540144 0.07894971 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP T-cell leukemia DOID_715 0.01540144 0.0782448 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP Ehlers-Danlos syndrome DOID_13359 0.01649264 0.08304699 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP membranoproliferative glomerulonephritis DOID_2920 0.01649264 0.0823185 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP mesenchymal cell neoplasm DOID_3350 0.01649264 0.08160269 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP spindle cell sarcoma DOID_4235 0.01649264 0.08160269 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP epithelioid sarcoma DOID_6193 0.01649264 0.08160269 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP intermediate coronary syndrome DOID_8805 0.01649264 0.08089922 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP angiosarcoma DOID_0001816 0.01758265 0.0855088 0.01758265 1.000 CHIBA_RESPONSE_TO_TSA_UP hemolytic-uremic syndrome DOID_12554 0.01758265 0.08478415 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP pituitary adenoma DOID_3829 0.01758265 0.08407168 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP restrictive cardiomyopathy DOID_397 0.01758265 0.08337108 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP penile disease DOID_1529 0.01867149 0.0878023 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP congenital muscular dystrophy DOID_0050557 0.01975915 0.09215539 0.01975915 1.000 CHIBA_RESPONSE_TO_TSA_UP male reproductive organ benign neoplasm DOID_0060087 0.01975915 0.09140616 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP glucose intolerance DOID_10603 0.01975915 0.09066901 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP keratosis DOID_161 0.01975915 0.08994366 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP neuroendocrine tumor DOID_169 0.01975915 0.08922982 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP osteosclerosis DOID_4254 0.01975915 0.08852722 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP agammaglobulinemia DOID_2583 0.02084563 0.09266536 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP granulosa cell tumor DOID_2999 0.02084563 0.09194702 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP psoriasis DOID_8893 0.02084563 0.09123974 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP microphthalmia DOID_10629 0.02193094 0.0952573 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP esophagitis DOID_11963 0.02193094 0.09453565 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP sex cord-gonadal stromal tumor DOID_192 0.02193094 0.09382486 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP colonic disease DOID_5353 0.02193094 0.09312467 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP blood protein disease DOID_620 0.02193094 0.09243486 1.000 1.000 CHIBA_RESPONSE_TO_TSA_UP autoimmune hepatitis DOID_2048 0.02301508 0.09629102 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN glioblastoma DOID_3068 1.786E-10 1.016E-07 6.927E-05 0.03941478 WILCOX_PRESPONSE_TO_ROGESTERONE_DN astrocytoma DOID_3069 4.971E-10 1.414E-07 1.136E-04 0.03233301 WILCOX_PRESPONSE_TO_ROGESTERONE_DN giant cell tumor DOID_200 1.063E-08 2.016E-06 2.41E-03 0.15239125 WILCOX_PRESPONSE_TO_ROGESTERONE_DN malignant giant cell tumor DOID_2705 1.063E-08 2.016E-06 2.41E-03 0.15239125 WILCOX_PRESPONSE_TO_ROGESTERONE_DN giant cell glioblastoma DOID_3074 1.063E-08 2.016E-06 2.41E-03 0.15239125 WILCOX_PRESPONSE_TO_ROGESTERONE_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.636E-07 2.327E-05 6.907E-03 0.23116531 WILCOX_PRESPONSE_TO_ROGESTERONE_DN cervix uteri carcinoma in situ DOID_8991 3.218E-07 3.662E-05 1.495E-03 0.12155337 WILCOX_PRESPONSE_TO_ROGESTERONE_DN heart valve disease DOID_4079 5.428E-07 5.147E-05 0.06265953 0.45130722 WILCOX_PRESPONSE_TO_ROGESTERONE_DN Ehlers-Danlos syndrome DOID_13359 9.131E-07 7.423E-05 0.0192166 0.47540196 WILCOX_PRESPONSE_TO_ROGESTERONE_DN oral submucous fibrosis DOID_5773 9.131E-07 6.495E-05 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN collagen disease DOID_854 1.478E-06 9.342E-05 0.07950385 0.49711745 WILCOX_PRESPONSE_TO_ROGESTERONE_DN pre-malignant neoplasm DOID_0060071 1.673E-06 9.519E-05 3.33E-03 0.15788995 WILCOX_PRESPONSE_TO_ROGESTERONE_DN in situ carcinoma DOID_8719 1.673E-06 9.519E-05 3.33E-03 0.15788995 WILCOX_PRESPONSE_TO_ROGESTERONE_DN pancreatic ductal carcinoma DOID_3587 2.51E-06 1.298E-04 4.056E-03 0.17753783 WILCOX_PRESPONSE_TO_ROGESTERONE_DN nephrosis DOID_2527 2.651E-06 1.257E-04 1.233E-04 0.02338646 WILCOX_PRESPONSE_TO_ROGESTERONE_DN pancreatic carcinoma DOID_4905 2.95E-06 1.291E-04 4.388E-03 0.17834254 WILCOX_PRESPONSE_TO_ROGESTERONE_DN transitional cell carcinoma DOID_2671 5.798E-06 2.356E-04 0.11000306 0.60184365 WILCOX_PRESPONSE_TO_ROGESTERONE_DN intracranial aneurysm DOID_10941 6.497E-06 2.465E-04 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN periodontitis DOID_824 7.24E-06 2.575E-04 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN mouth disease DOID_403 7.495E-06 2.509E-04 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN polycystic ovary syndrome DOID_11612 8.891E-06 2.81E-04 7.43E-04 0.10568699 WILCOX_PRESPONSE_TO_ROGESTERONE_DN periodontal disease DOID_3388 1.528E-05 4.577E-04 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN calcinosis DOID_182 1.938E-05 5.514E-04 0.05044338 0.42839229 WILCOX_PRESPONSE_TO_ROGESTERONE_DN diabetic autonomic neuropathy DOID_11503 3.161E-05 8.564E-04 0.05901094 0.45374628 WILCOX_PRESPONSE_TO_ROGESTERONE_DN autonomic neuropathy DOID_11504 3.161E-05 8.564E-04 0.05901094 0.45374628 WILCOX_PRESPONSE_TO_ROGESTERONE_DN diabetic polyneuropathy DOID_12785 3.161E-05 8.564E-04 0.05901094 0.45374628 WILCOX_PRESPONSE_TO_ROGESTERONE_DN uterine cancer DOID_363 3.161E-05 8.175E-04 1.705E-03 0.12123728 WILCOX_PRESPONSE_TO_ROGESTERONE_DN diabetic neuropathy DOID_9743 3.161E-05 8.564E-04 0.05901094 0.45374628 WILCOX_PRESPONSE_TO_ROGESTERONE_DN autonomic nervous system disease DOID_11465 3.81E-05 9.426E-04 0.06265953 0.45709321 WILCOX_PRESPONSE_TO_ROGESTERONE_DN calcium metabolism disease DOID_10575 4.542E-05 1.077E-03 0.06629425 0.45447507 WILCOX_PRESPONSE_TO_ROGESTERONE_DN osteochondrodysplasia DOID_2256 5.955E-05 1.355E-03 0.07232148 0.47849906 WILCOX_PRESPONSE_TO_ROGESTERONE_DN hypothyroidism DOID_1459 8.377E-05 1.833E-03 3.232E-03 0.16716151 WILCOX_PRESPONSE_TO_ROGESTERONE_DN mineral metabolism disease DOID_0050032 9.17E-05 1.933E-03 0.08307458 0.50827348 WILCOX_PRESPONSE_TO_ROGESTERONE_DN tooth disease DOID_1091 1.045E-04 2.124E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN aortic valve insufficiency DOID_57 1.071E-04 2.102E-03 0.01540245 0.46126272 WILCOX_PRESPONSE_TO_ROGESTERONE_DN osteogenesis imperfecta DOID_12347 1.265E-04 2.399E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN syndrome DOID_225 1.442E-04 2.646E-03 4.616E-03 0.17510095 WILCOX_PRESPONSE_TO_ROGESTERONE_DN aneurysm disease DOID_2403 1.497E-04 2.663E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN skeletal system cancer DOID_0060124 1.7E-04 2.931E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN bone cancer DOID_184 1.7E-04 2.931E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN communication disorder DOID_2033 1.7E-04 2.845E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN intermediate coronary syndrome DOID_8805 1.7E-04 2.764E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN bone development disease DOID_0080006 1.926E-04 3.043E-03 0.10537615 0.58783362 WILCOX_PRESPONSE_TO_ROGESTERONE_DN nervous system cancer DOID_3093 2.35E-04 3.614E-03 0.11230771 0.60285933 WILCOX_PRESPONSE_TO_ROGESTERONE_DN ureteral obstruction DOID_5199 2.471E-04 3.7E-03 0.02301628 0.39685643 WILCOX_PRESPONSE_TO_ROGESTERONE_DN agammaglobulinemia DOID_2583 2.759E-04 4.026E-03 0.02427963 0.40632675 WILCOX_PRESPONSE_TO_ROGESTERONE_DN brain edema DOID_4724 3.063E-04 4.358E-03 0.02554138 0.39278503 WILCOX_PRESPONSE_TO_ROGESTERONE_DN blood protein disease DOID_620 3.063E-04 4.251E-03 0.02554138 0.38244858 WILCOX_PRESPONSE_TO_ROGESTERONE_DN hepatitis B DOID_2043 3.718E-04 5.038E-03 0.02806009 0.38941933 WILCOX_PRESPONSE_TO_ROGESTERONE_DN urinary tract obstruction DOID_5200 4.069E-04 5.385E-03 0.02931705 0.37912282 WILCOX_PRESPONSE_TO_ROGESTERONE_DN pulmonary embolism DOID_9477 4.069E-04 5.262E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN diabetic angiopathy DOID_11713 4.435E-04 5.608E-03 0.03057242 0.38657133 WILCOX_PRESPONSE_TO_ROGESTERONE_DN ureteral disease DOID_1426 4.435E-04 5.486E-03 0.03057242 0.37012148 WILCOX_PRESPONSE_TO_ROGESTERONE_DN aortic valve disease DOID_62 4.435E-04 5.37E-03 0.03057242 0.36241062 WILCOX_PRESPONSE_TO_ROGESTERONE_DN meningitis DOID_9471 4.435E-04 5.258E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN B cell deficiency DOID_2115 6.055E-04 7.031E-03 0.03557802 0.39693909 WILCOX_PRESPONSE_TO_ROGESTERONE_DN sarcoma DOID_1115 6.956E-04 7.916E-03 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN focal glomerulosclerosis DOID_3945 7.43E-04 8.289E-03 0.03931559 0.37916225 WILCOX_PRESPONSE_TO_ROGESTERONE_DN corneal disease DOID_10124 7.918E-04 8.665E-03 0.04055829 0.38462783 WILCOX_PRESPONSE_TO_ROGESTERONE_DN endometrial carcinoma DOID_2871 7.918E-04 8.501E-03 7.918E-04 0.09011187 WILCOX_PRESPONSE_TO_ROGESTERONE_DN endometrial cancer DOID_1380 8.941E-04 9.422E-03 8.941E-04 0.08479409 WILCOX_PRESPONSE_TO_ROGESTERONE_DN autonomic nervous system neoplasm DOID_2621 9.475E-04 9.803E-03 0.04427696 0.39989825 WILCOX_PRESPONSE_TO_ROGESTERONE_DN neuroblastoma DOID_769 9.475E-04 9.803E-03 0.04427696 0.39989825 WILCOX_PRESPONSE_TO_ROGESTERONE_DN peripheral nervous system neoplasm DOID_1192 1.299E-03 0.01320302 0.05167198 0.43237289 WILCOX_PRESPONSE_TO_ROGESTERONE_DN intracranial arterial disease DOID_13089 1.429E-03 0.01426083 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN cerebral arterial disease DOID_3527 1.429E-03 0.01426083 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN adenoid cystic carcinoma DOID_4866 1.429E-03 0.01401495 0.05412451 0.43995493 WILCOX_PRESPONSE_TO_ROGESTERONE_DN salivary gland cancer DOID_8850 1.564E-03 0.01507993 0.05657082 0.44706664 WILCOX_PRESPONSE_TO_ROGESTERONE_DN nephrotic syndrome DOID_1184 1.633E-03 0.01548985 0.05779165 0.45045824 WILCOX_PRESPONSE_TO_ROGESTERONE_DN gallbladder cancer DOID_3121 1.705E-03 0.01589997 0.05901094 0.44769633 WILCOX_PRESPONSE_TO_ROGESTERONE_DN pre-eclampsia DOID_10591 1.927E-03 0.01768364 0.06265953 0.46302949 WILCOX_PRESPONSE_TO_ROGESTERONE_DN glaucoma DOID_1686 2.082E-03 0.0188068 0.06508422 0.45719652 WILCOX_PRESPONSE_TO_ROGESTERONE_DN atrophic muscular disease DOID_913 2.41E-03 0.02143002 2.41E-03 0.13715212 WILCOX_PRESPONSE_TO_ROGESTERONE_DN muscular dystrophy DOID_9884 2.41E-03 0.02143002 2.41E-03 0.13715212 WILCOX_PRESPONSE_TO_ROGESTERONE_DN bile duct adenocarcinoma DOID_4896 2.496E-03 0.02184962 0.07111909 0.48174716 WILCOX_PRESPONSE_TO_ROGESTERONE_DN cholangiocarcinoma DOID_4947 2.496E-03 0.02184962 0.07111909 0.48174716 WILCOX_PRESPONSE_TO_ROGESTERONE_DN reproductive organ benign neoplasm DOID_0050622 2.583E-03 0.02226875 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN parasitic protozoa infectious disease DOID_2789 2.583E-03 0.02193638 0.07232148 0.47299907 WILCOX_PRESPONSE_TO_ROGESTERONE_DN hypertrophic cardiomyopathy DOID_11984 2.853E-03 0.02386915 0.0759195 0.49088856 WILCOX_PRESPONSE_TO_ROGESTERONE_DN bile duct cancer DOID_4606 2.853E-03 0.02352322 0.0759195 0.48537296 WILCOX_PRESPONSE_TO_ROGESTERONE_DN bile duct carcinoma DOID_4897 2.853E-03 0.02352322 0.0759195 0.48537296 WILCOX_PRESPONSE_TO_ROGESTERONE_DN oral cavity cancer DOID_8618 2.853E-03 0.02318717 0.0759195 0.47997993 WILCOX_PRESPONSE_TO_ROGESTERONE_DN melancholia DOID_2848 2.945E-03 0.02360318 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN neurotic disorder DOID_4964 3.039E-03 0.02401872 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN carotid artery disease DOID_3407 3.135E-03 0.02443377 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN parasitic infectious disease DOID_1398 3.53E-03 0.02714664 0.0842618 0.51005281 WILCOX_PRESPONSE_TO_ROGESTERONE_DN cerebral degeneration DOID_1443 3.53E-03 0.02678469 0.0842618 0.50468383 WILCOX_PRESPONSE_TO_ROGESTERONE_DN uterine disease DOID_345 3.53E-03 0.02643226 0.0842618 0.49942671 WILCOX_PRESPONSE_TO_ROGESTERONE_DN peripheral vascular disease DOID_341 4.276E-03 0.03159856 0.09253032 0.54278092 WILCOX_PRESPONSE_TO_ROGESTERONE_DN diabetic retinopathy DOID_8947 4.388E-03 0.0320102 0.09370555 0.54406587 WILCOX_PRESPONSE_TO_ROGESTERONE_DN endogenous depression DOID_1595 4.616E-03 0.03324702 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN bone resorption disease DOID_0080011 4.732E-03 0.03365653 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN osteoporosis DOID_11476 4.732E-03 0.03365653 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN mixed glioma DOID_5076 4.849E-03 0.03406536 4.849E-03 0.17245587 WILCOX_PRESPONSE_TO_ROGESTERONE_DN female reproductive system disease DOID_229 5.209E-03 0.03614838 0.10189051 0.57975703 WILCOX_PRESPONSE_TO_ROGESTERONE_DN mental depression DOID_1596 5.456E-03 0.03740396 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN biliary tract cancer DOID_4607 5.456E-03 0.03695868 0.10421575 0.58711644 WILCOX_PRESPONSE_TO_ROGESTERONE_DN retinal vascular disease DOID_2462 5.708E-03 0.03821054 0.10653508 0.58852875 WILCOX_PRESPONSE_TO_ROGESTERONE_DN primary immunodeficiency disease DOID_612 6.228E-03 0.04120443 0.11115612 0.60236029 WILCOX_PRESPONSE_TO_ROGESTERONE_DN dilated cardiomyopathy DOID_12930 7.046E-03 0.04608337 0.1180438 0.61621031 WILCOX_PRESPONSE_TO_ROGESTERONE_DN ulcerative colitis DOID_8577 7.473E-03 0.0483175 0.12146801 0.6283209 WILCOX_PRESPONSE_TO_ROGESTERONE_DN hyperparathyroidism DOID_13543 0.01285161 0.08216366 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN transient cerebral ischemia DOID_224 0.01285161 0.08125073 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN progressive muscular atrophy DOID_318 0.01285161 0.08035786 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN keratitis DOID_4677 0.01285161 0.07948441 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN cutaneous leishmaniasis DOID_9111 0.01285161 0.07862973 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN nervous system benign neoplasm DOID_0060115 0.01412784 0.08551849 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN obsessive-compulsive disorder DOID_10933 0.01412784 0.0846183 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN common variable immunodeficiency DOID_12177 0.01412784 0.08373686 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN invasive lobular carcinoma DOID_3457 0.01412784 0.08287359 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN heroin dependence DOID_9976 0.01412784 0.08202794 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN intracranial arteriosclerosis DOID_13097 0.01540245 0.08852517 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN epidermolysis bullosa DOID_2730 0.01540245 0.08763992 0.01540245 0.48688843 WILCOX_PRESPONSE_TO_ROGESTERONE_DN peritonitis DOID_8283 0.01540245 0.0867722 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN vascular dementia DOID_8725 0.01540245 0.08852517 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN ocular hypertension DOID_9282 0.01540245 0.08592149 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN borderline glaucoma DOID_9283 0.01540245 0.08592149 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN nicotine dependence DOID_0050742 0.01667544 0.09211967 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN parathyroid gland disease DOID_11201 0.01667544 0.09123391 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN carotid stenosis DOID_13001 0.01667544 0.09036501 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN obstructive hydrocephalus DOID_14159 0.01667544 0.08951251 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN communicating hydrocephalus DOID_1573 0.01667544 0.08951251 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN larynx cancer DOID_2596 0.01667544 0.08867595 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN laryngeal benign neoplasm DOID_2598 0.01667544 0.08867595 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN vesiculobullous skin disease DOID_2731 0.01667544 0.08785487 0.01667544 0.47441632 WILCOX_PRESPONSE_TO_ROGESTERONE_DN intracranial thrombosis DOID_4193 0.01667544 0.08704887 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN epilepsy with generalized tonic-clonic seizures DOID_7725 0.01667544 0.08625751 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN psoriatic arthritis DOID_9008 0.01667544 0.08548042 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN alcohol dependence DOID_0050741 0.01794683 0.09117628 0.01794683 0.48627352 WILCOX_PRESPONSE_TO_ROGESTERONE_DN open-angle glaucoma DOID_1067 0.01794683 0.09036941 0.01794683 0.46417018 WILCOX_PRESPONSE_TO_ROGESTERONE_DN hydrocephalus DOID_10908 0.01794683 0.0895767 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN eating disorder DOID_8670 0.01794683 0.08879777 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN bacterial meningitis DOID_9470 0.01794683 0.08803227 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN idiopathic pulmonary fibrosis DOID_0050156 0.0192166 0.09345509 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN thoracic aortic aneurysm DOID_14004 0.0192166 0.09266309 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN hemangioma DOID_255 0.0192166 0.09188441 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN corneal dystrophy DOID_2566 0.0192166 0.09111871 0.0192166 0.45559354 WILCOX_PRESPONSE_TO_ROGESTERONE_DN mesenchymal cell neoplasm DOID_3350 0.0192166 0.09036566 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN spindle cell sarcoma DOID_4235 0.0192166 0.09036566 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN lung oat cell carcinoma DOID_5411 0.0192166 0.08962496 0.0192166 0.4373698 WILCOX_PRESPONSE_TO_ROGESTERONE_DN epithelioid sarcoma DOID_6193 0.0192166 0.09036566 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN varicose veins DOID_799 0.0192166 0.0888963 0.0192166 0.42054788 WILCOX_PRESPONSE_TO_ROGESTERONE_DN intracranial hypertension DOID_9428 0.0192166 0.0881794 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN angiosarcoma DOID_0001816 0.02048476 0.09324665 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN spastic diplegia DOID_10965 0.02048476 0.09250659 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN long QT syndrome DOID_2843 0.02048476 0.0917782 0.02048476 0.43169744 WILCOX_PRESPONSE_TO_ROGESTERONE_DN restrictive cardiomyopathy DOID_397 0.02048476 0.09106118 0.02048476 0.41627968 WILCOX_PRESPONSE_TO_ROGESTERONE_DN vein disease DOID_866 0.02048476 0.09035528 0.02048476 0.40192521 WILCOX_PRESPONSE_TO_ROGESTERONE_DN schizophreniform disorder DOID_11328 0.02175132 0.09520387 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN familial hypertrophic cardiomyopathy DOID_11986 0.02175132 0.09447712 0.02175132 0.4125501 WILCOX_PRESPONSE_TO_ROGESTERONE_DN Graves' disease DOID_12361 0.02175132 0.09376139 0.02175132 0.39924203 WILCOX_PRESPONSE_TO_ROGESTERONE_DN schizoaffective disorder DOID_5418 0.02175132 0.09520387 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN urinary system benign neoplasm DOID_731 0.02175132 0.09305641 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN congenital muscular dystrophy DOID_0050557 0.02301628 0.0977333 0.02301628 0.40925819 WILCOX_PRESPONSE_TO_ROGESTERONE_DN male reproductive organ benign neoplasm DOID_0060087 0.02301628 0.09700935 1.000 1.000 WILCOX_PRESPONSE_TO_ROGESTERONE_DN prion disease DOID_649 0.02301628 0.09629604 1.000 1.000 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP allergic rhinitis DOID_4481 1.899E-06 1.081E-03 2.702E-04 0.02562324 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP brain infarction DOID_3454 1.783E-05 5.071E-03 1.178E-03 0.06700312 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP rectal neoplasm DOID_1984 2.19E-05 4.154E-03 2.19E-05 0.01246279 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP rectum cancer DOID_1993 2.19E-05 4.154E-03 2.19E-05 0.01246279 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP phagocyte bactericidal dysfunction DOID_3262 2.19E-05 3.116E-03 2.19E-05 6.231E-03 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP bacterial pneumonia DOID_874 2.552E-05 2.904E-03 1.492E-03 0.07715227 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP primary immunodeficiency disease DOID_612 3.753E-05 3.559E-03 3.753E-05 7.118E-03 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP amino acid metabolic disorder DOID_9252 3.753E-05 3.051E-03 3.753E-05 5.339E-03 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP encephalomyelitis DOID_640 4.268E-05 3.036E-03 2.094E-03 0.07941974 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP bronchiolitis DOID_2942 1.571E-04 9.931E-03 0.01835914 0.24293841 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP toxic encephalopathy DOID_3602 2.243E-04 0.01275991 2.243E-04 0.02551982 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP bronchiolitis obliterans DOID_2799 2.544E-04 0.01315995 0.02324626 0.26994129 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP peripheral nervous system neoplasm DOID_1192 3.937E-04 0.01866894 3.937E-04 0.03200391 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP systemic scleroderma DOID_418 4.132E-04 0.01808657 0.02949528 0.28935891 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP rheumatic disease DOID_1575 4.959E-04 0.02015329 0.03226025 0.31112007 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP scleroderma DOID_419 4.959E-04 0.02015329 0.03226025 0.31112007 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP pulmonary tuberculosis DOID_2957 6.336E-04 0.02403488 0.03639349 0.32869674 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP bone marrow cancer DOID_4960 7.61E-04 0.02706135 0.03982486 0.32371922 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP hypersensitivity reaction type IV disease DOID_2916 8.71E-04 0.02915253 8.71E-04 0.06194913 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP collagen disease DOID_854 9.583E-04 0.03029148 0.04460902 0.34300719 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP allergic contact dermatitis DOID_3042 1.145E-03 0.03428646 1.145E-03 0.07238254 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP tuberculosis DOID_399 1.178E-03 0.03350156 0.04937022 0.36962704 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP contact dermatitis DOID_2773 1.566E-03 0.04243488 1.566E-03 0.07426104 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP chronic kidney failure DOID_784 1.681E-03 0.04348582 1.681E-03 0.07359139 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP primary bacterial infectious disease DOID_0050338 1.841E-03 0.04554654 0.06150862 0.42680984 CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP nervous system cancer DOID_3093 1.965E-03 0.04659693 1.965E-03 0.07988046 GENTILE_UV_RESPONSE_CLUSTER_D8 sarcoma DOID_1115 1.516E-04 0.08624679 0.01804816 0.44649578 GENTILE_UV_RESPONSE_CLUSTER_D8 multiple myeloma DOID_9538 2.708E-04 0.07703986 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D8 hepatitis DOID_2237 2.987E-04 0.05665161 0.02517982 0.46217162 GENTILE_UV_RESPONSE_CLUSTER_D8 adenoid cystic carcinoma DOID_4866 3.131E-04 0.04454489 3.131E-04 0.17817957 GENTILE_UV_RESPONSE_CLUSTER_D8 salivary gland cancer DOID_8850 3.431E-04 0.03904045 3.431E-04 0.09760113 GENTILE_UV_RESPONSE_CLUSTER_D8 diabetic autonomic neuropathy DOID_11503 3.743E-04 0.03549798 0.02813671 0.43269691 GENTILE_UV_RESPONSE_CLUSTER_D8 autonomic neuropathy DOID_11504 3.743E-04 0.03549798 0.02813671 0.43269691 GENTILE_UV_RESPONSE_CLUSTER_D8 diabetic polyneuropathy DOID_12785 3.743E-04 0.03549798 0.02813671 0.43269691 GENTILE_UV_RESPONSE_CLUSTER_D8 diabetic neuropathy DOID_9743 3.743E-04 0.03549798 0.02813671 0.43269691 GENTILE_UV_RESPONSE_CLUSTER_D8 myeloma DOID_0070004 4.237E-04 0.03444186 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D8 autonomic nervous system disease DOID_11465 4.237E-04 0.03013663 0.02990671 0.4478137 GENTILE_UV_RESPONSE_CLUSTER_D8 bone marrow cancer DOID_4960 5.506E-04 0.03481108 1.000 1.000 GENTILE_UV_RESPONSE_CLUSTER_D8 familial hyperlipidemia DOID_1168 5.899E-04 0.03356269 5.899E-04 0.11187564 GENTILE_UV_RESPONSE_CLUSTER_D8 oral cavity cancer DOID_8618 6.304E-04 0.03260955 6.304E-04 0.08967627 GENTILE_UV_RESPONSE_CLUSTER_D8 mixed glioma DOID_5076 1.081E-03 0.05125661 0.04743804 0.45749568 GENTILE_UV_RESPONSE_CLUSTER_D8 metabolic syndrome X DOID_14221 1.135E-03 0.04968776 1.135E-03 0.12918817 GENTILE_UV_RESPONSE_CLUSTER_D8 lipid metabolism disorder DOID_3146 1.135E-03 0.04613863 1.135E-03 0.10765681 GENTILE_UV_RESPONSE_CLUSTER_D8 nervous system cancer DOID_3093 1.426E-03 0.05407933 0.05436537 0.47590607 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP hypertrophic cardiomyopathy DOID_11984 8.16E-07 4.643E-04 2.665E-05 3.791E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP carotid artery disease DOID_3407 1.039E-06 2.956E-04 7.819E-04 0.02118698 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP carotid stenosis DOID_13001 5.954E-06 1.129E-03 0.03575028 0.23931656 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP obstructive hydrocephalus DOID_14159 5.954E-06 8.469E-04 5.954E-06 3.388E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP communicating hydrocephalus DOID_1573 5.954E-06 8.469E-04 5.954E-06 3.388E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP hydrocephalus DOID_10908 7.562E-06 8.605E-04 7.562E-06 2.151E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP gallbladder cancer DOID_3121 9.386E-06 8.901E-04 3.15E-04 0.013787 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP intracranial hypertension DOID_9428 9.433E-06 7.668E-04 9.433E-06 1.789E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP oral cavity cancer DOID_8618 2.665E-05 1.895E-03 2.665E-05 3.033E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP cerebral degeneration DOID_1443 4.097E-05 2.59E-03 4.097E-05 3.885E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP aneurysm disease DOID_2403 7.382E-05 4.2E-03 0.19862263 0.55400136 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP biliary tract cancer DOID_4607 9.821E-05 5.08E-03 1.777E-03 0.0361032 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP chronic kidney failure DOID_784 9.821E-05 4.657E-03 1.777E-03 0.03485826 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP primary immunodeficiency disease DOID_612 1.28E-04 5.602E-03 1.28E-04 0.01040289 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP hyperthyroidism DOID_7998 1.54E-04 6.26E-03 1.54E-04 0.01095587 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP alcohol-related neurodevelopmental disorder DOID_0050667 1.574E-04 5.97E-03 2.514E-03 0.04206554 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP adenoid cystic carcinoma DOID_4866 2.417E-04 8.595E-03 2.417E-04 0.01528026 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP DiGeorge syndrome DOID_11198 2.752E-04 9.213E-03 2.752E-04 0.01566135 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP velocardiofacial syndrome DOID_12583 2.752E-04 9.213E-03 2.752E-04 0.01566135 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP salivary gland cancer DOID_8850 2.768E-04 8.749E-03 2.768E-04 0.0143169 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP diabetic autonomic neuropathy DOID_11503 3.15E-04 9.433E-03 3.15E-04 0.01493592 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP autonomic neuropathy DOID_11504 3.15E-04 9.433E-03 3.15E-04 0.01493592 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP diabetic polyneuropathy DOID_12785 3.15E-04 9.433E-03 3.15E-04 0.01493592 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP diabetic neuropathy DOID_9743 3.15E-04 9.433E-03 3.15E-04 0.01493592 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP T cell deficiency DOID_11200 3.434E-04 9.77E-03 3.434E-04 0.01395781 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP familial combined hyperlipidemia DOID_13809 3.434E-04 9.305E-03 0.02761427 0.23106648 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP myeloma DOID_0070004 3.784E-04 9.788E-03 3.784E-04 0.01435547 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP autonomic nervous system disease DOID_11465 3.784E-04 9.362E-03 3.784E-04 0.01345825 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP lung small cell carcinoma DOID_5409 4.25E-04 0.01007561 4.25E-04 0.0142244 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP aortic aneurysm DOID_3627 4.496E-04 0.01023217 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP bone marrow cancer DOID_4960 5.57E-04 0.01218957 5.57E-04 0.01760715 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP melancholia DOID_2848 7.127E-04 0.01501912 7.127E-04 0.02134297 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP neurotic disorder DOID_4964 7.468E-04 0.01517609 7.468E-04 0.02124652 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP collagen disease DOID_854 7.819E-04 0.0153423 0.16418278 0.47907694 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP thoracic aortic aneurysm DOID_14004 7.94E-04 0.01506032 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP renovascular hypertension DOID_1591 7.94E-04 0.0145745 0.04113678 0.25442205 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP oral submucous fibrosis DOID_5773 7.94E-04 0.01411905 0.04113678 0.24900882 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP varicose veins DOID_799 7.94E-04 0.0136912 0.04113678 0.24638767 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP vein disease DOID_866 9.058E-04 0.01515917 0.04381885 0.24686063 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP Barrett's esophagus DOID_9206 9.058E-04 0.01472606 9.058E-04 0.02342782 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP uterine disease DOID_345 9.33E-04 0.01474632 9.33E-04 0.02308119 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP hyperostosis DOID_205 1.025E-03 0.0157586 1.025E-03 0.02429451 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP brain infarction DOID_3454 1.058E-03 0.01583592 0.01697621 0.19318926 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP endogenous depression DOID_1595 1.388E-03 0.02024912 1.388E-03 0.03158862 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP amyloidosis DOID_9120 1.424E-03 0.02025336 0.05447299 0.26719941 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP lipid metabolism disorder DOID_3146 1.603E-03 0.02224155 0.02224211 0.20412514 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP female reproductive system disease DOID_229 1.659E-03 0.02248071 1.659E-03 0.036315 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP familial hypercholesterolemia DOID_13810 1.725E-03 0.0228225 0.05975588 0.28814488 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP mental depression DOID_1596 1.777E-03 0.02297476 1.777E-03 0.03744035 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP bone development disease DOID_0080006 1.837E-03 0.0232292 1.837E-03 0.0348438 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP retinal vascular disease DOID_2462 1.899E-03 0.0234883 0.02483072 0.22076059 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP synostosis DOID_11971 2.053E-03 0.02485694 2.053E-03 0.03768633 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP amino acid metabolic disorder DOID_9252 2.159E-03 0.02559162 2.159E-03 0.03838742 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP spastic quadriplegia DOID_10970 2.228E-03 0.02586844 0.06762544 0.30783101 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP lymphoma DOID_0060058 2.368E-03 0.02694412 2.368E-03 0.04082442 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP mouth disease DOID_403 2.514E-03 0.02804369 0.02978156 0.22899605 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP middle cerebral artery infarction DOID_3525 2.792E-03 0.03054643 0.07542975 0.31101108 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP gestational diabetes DOID_11714 2.993E-03 0.03213154 2.993E-03 0.04865633 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP renal hypertension DOID_1073 3.201E-03 0.03372767 0.08059664 0.32295415 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP secondary hypertension DOID_11130 3.201E-03 0.03372767 0.08059664 0.32295415 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP dysostosis DOID_1934 3.636E-03 0.03762092 3.636E-03 0.0574764 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP spastic cerebral palsy DOID_0050669 3.864E-03 0.03926145 0.08829339 0.33945229 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP abdominal aortic aneurysm DOID_7693 3.864E-03 0.03857265 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP autonomic nervous system neoplasm DOID_2621 4.339E-03 0.04256277 4.339E-03 0.06672002 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP neuroblastoma DOID_769 4.339E-03 0.04256277 4.339E-03 0.06672002 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP esophageal disease DOID_6050 4.839E-03 0.04666425 4.839E-03 0.07245239 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP aplastic anemia DOID_12449 5.098E-03 0.04834784 5.098E-03 0.07438129 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP multiple myeloma DOID_9538 5.636E-03 0.05257266 5.636E-03 0.0801733 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP peripheral nervous system neoplasm DOID_1192 5.914E-03 0.05427861 5.914E-03 0.08207985 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP uveitis DOID_13141 5.914E-03 0.05341704 0.10850742 0.37193206 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP intracranial arterial disease DOID_13089 6.489E-03 0.05769492 0.11349117 0.38210931 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP cerebral arterial disease DOID_3527 6.489E-03 0.05769492 0.11349117 0.38210931 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP pulmonary emphysema DOID_9675 6.786E-03 0.05940451 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP autoimmune disease of urogenital tract DOID_0060049 7.089E-03 0.06111459 0.11844731 0.39413169 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP primary biliary cirrhosis DOID_12236 7.089E-03 0.06111459 0.11844731 0.39413169 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP endometriosis of uterus DOID_288 7.089E-03 0.06020244 7.089E-03 0.09603722 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP rheumatic disease DOID_1575 7.398E-03 0.06190095 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP idiopathic generalized epilepsy DOID_1827 7.398E-03 0.06100384 0.12091508 0.39540621 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP endometriosis DOID_289 7.398E-03 0.06013235 7.398E-03 0.09788987 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP uveal disease DOID_3480 7.398E-03 0.05928542 0.12091508 0.39314675 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP scleroderma DOID_419 7.398E-03 0.06190095 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP uterine cancer DOID_363 7.712E-03 0.06094968 7.712E-03 0.09973585 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP cerebral infarction DOID_3526 8.033E-03 0.06261481 0.12583011 0.40450471 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP proteinuria DOID_576 8.36E-03 0.06428048 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP heart valve disease DOID_4079 8.692E-03 0.06594642 0.13071792 0.40867305 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP bone marrow disease DOID_4961 8.692E-03 0.06507871 8.692E-03 0.1099107 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP glaucoma DOID_1686 9.375E-03 0.06927803 0.13557865 0.42155329 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP giant cell tumor DOID_200 0.0108095 0.07885395 0.0108095 0.13370887 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP malignant giant cell tumor DOID_2705 0.0108095 0.07885395 0.0108095 0.13370887 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP giant cell glioblastoma DOID_3074 0.0108095 0.07885395 0.0108095 0.13370887 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP osteochondrodysplasia DOID_2256 0.01156076 0.08326672 0.01156076 0.13995895 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP pustulosis of palm and sole DOID_4398 0.01156076 0.08222588 0.1499999 0.44921022 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP familial hyperlipidemia DOID_1168 0.01194477 0.08390833 0.15238016 0.45158494 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP glioblastoma DOID_3068 0.01272941 0.08832969 0.01272941 0.15089655 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP bile duct cancer DOID_4606 0.01272941 0.08726548 0.15712089 0.46083395 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP bile duct carcinoma DOID_4897 0.01272941 0.08726548 0.15712089 0.46083395 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL multiple myeloma DOID_9538 1.19E-11 6.769E-09 1.142E-06 2.167E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL myeloma DOID_0070004 7.986E-11 2.272E-08 3.544E-06 4.033E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL bone marrow cancer DOID_4960 2.391E-10 4.536E-08 6.823E-06 3.882E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL lymphoma DOID_0060058 5.877E-10 8.36E-08 5.164E-06 3.673E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pulmonary emphysema DOID_9675 1.313E-09 1.495E-07 1.858E-06 2.643E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL endocrine organ benign neoplasm DOID_0060089 1.458E-09 1.382E-07 9.915E-07 2.821E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL B-cell lymphocytic neoplasm DOID_707 5.839E-09 4.746E-07 5.211E-06 3.295E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pre-malignant neoplasm DOID_0060071 2.451E-08 1.743E-06 6.411E-07 3.648E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL in situ carcinoma DOID_8719 2.451E-08 1.743E-06 6.411E-07 3.648E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL thyroid adenoma DOID_2891 1.192E-07 7.536E-06 8.56E-05 1.948E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL transitional cell carcinoma DOID_2671 2.143E-07 1.219E-05 4.009E-06 3.802E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL diffuse large B-cell lymphoma DOID_0050745 2.148E-07 1.111E-05 3.234E-04 6.134E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL amino acid metabolic disorder DOID_9252 2.312E-07 1.096E-05 4.276E-06 3.476E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL alcohol-related neurodevelopmental disorder DOID_0050667 3.34E-07 1.462E-05 8.615E-05 1.885E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL oral cavity cancer DOID_8618 3.994E-07 1.623E-05 9.551E-06 4.941E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cervix uteri carcinoma in situ DOID_8991 1.858E-06 7.047E-05 5.155E-05 1.544E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL endometriosis DOID_289 2.327E-06 8.276E-05 6.153E-05 1.667E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL nervous system cancer DOID_3093 4.557E-06 1.525E-04 8.934E-04 0.01105103 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hypersensitivity reaction type I disease DOID_1205 6.196E-06 1.959E-04 1.088E-03 0.01214138 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL gestational diabetes DOID_11714 9.52E-06 2.851E-04 3.234E-04 5.936E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL invasive ductal carcinoma DOID_3008 1.095E-05 3.114E-04 1.095E-05 5.19E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL endometrial carcinoma DOID_2871 1.426E-05 3.864E-04 1.426E-05 6.241E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL endometrial cancer DOID_1380 1.826E-05 4.722E-04 1.826E-05 7.42E-04 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL leiomyoma DOID_127 2.054E-05 5.081E-04 5.676E-04 8.499E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL papilloma DOID_2615 2.302E-05 5.459E-04 0.0120417 0.07137213 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL thyroid carcinoma DOID_3963 2.572E-05 5.854E-04 6.693E-04 9.289E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Hirschsprung's disease DOID_10487 2.673E-05 5.849E-04 2.673E-05 1.014E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL larynx cancer DOID_2596 2.673E-05 5.632E-04 1.598E-03 0.01567896 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL laryngeal benign neoplasm DOID_2598 2.673E-05 5.632E-04 1.598E-03 0.01567896 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL medullomyoblastoma DOID_3861 2.864E-05 5.821E-04 2.864E-05 1.019E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL adult medulloblastoma DOID_3864 2.864E-05 5.821E-04 2.864E-05 1.019E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL childhood medulloblastoma DOID_3869 2.864E-05 5.821E-04 2.864E-05 1.019E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL thyroid cancer DOID_1781 3.18E-05 6.24E-04 7.819E-04 0.01034701 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL adenoma DOID_657 3.18E-05 6.032E-04 7.819E-04 0.01011185 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL megacolon DOID_11372 3.39E-05 6.222E-04 3.39E-05 1.135E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL medulloblastoma DOID_3858 3.521E-05 6.261E-04 3.521E-05 1.113E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL systemic scleroderma DOID_418 4.281E-05 7.382E-04 9.723E-04 0.011526 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL female reproductive system disease DOID_229 4.295E-05 7.188E-04 6.068E-04 8.631E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL tongue cancer DOID_8649 5.18E-05 8.421E-04 2.437E-03 0.02166204 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL endometriosis of uterus DOID_288 5.638E-05 8.911E-04 1.19E-03 0.01301826 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL rheumatic disease DOID_1575 6.153E-05 9.462E-04 1.268E-03 0.01336548 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL primitive neuroectodermal tumor DOID_168 6.153E-05 9.213E-04 6.153E-05 1.751E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL scleroderma DOID_419 6.153E-05 9.462E-04 1.268E-03 0.01336548 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL drug-induced mental disorder DOID_1203 6.269E-05 9.146E-04 0.07565656 0.22421136 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL drug psychosis DOID_1742 6.269E-05 9.146E-04 0.07565656 0.22421136 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL substance-induced psychosis DOID_8646 6.269E-05 9.146E-04 0.07565656 0.22421136 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL uterine cancer DOID_363 6.701E-05 9.532E-04 6.701E-05 1.733E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL prion disease DOID_649 7.497E-05 1.04E-03 7.497E-05 1.855E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL brain cancer DOID_1319 8.56E-05 1.16E-03 0.02245085 0.11012528 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL neuritis DOID_1803 8.56E-05 1.133E-03 8.56E-05 2.029E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL central nervous system cancer DOID_3620 9.255E-05 1.197E-03 0.02329737 0.11234072 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL colonic disease DOID_5353 1.04E-04 1.315E-03 1.04E-04 2.192E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL meningitis DOID_9471 1.822E-04 2.254E-03 5.47E-03 0.04042012 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL neuroectodermal tumor DOID_171 2.246E-04 2.719E-03 2.246E-04 4.564E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL collagen disease DOID_854 2.246E-04 2.662E-03 3.276E-03 0.02701854 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL papillary adenoma DOID_3172 2.606E-04 3.027E-03 6.893E-03 0.04842446 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL microcystic adenoma DOID_5403 2.606E-04 3.027E-03 6.893E-03 0.04842446 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL follicular adenoma DOID_6204 2.606E-04 3.027E-03 6.893E-03 0.04842446 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cholestasis DOID_13580 2.837E-04 3.229E-03 2.837E-04 5.567E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL uterine disease DOID_345 2.837E-04 3.166E-03 3.888E-03 0.031162 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL lung adenocarcinoma DOID_3910 3.234E-04 3.539E-03 0.12560737 0.3080629 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL astrocytoma DOID_3069 3.533E-04 3.793E-03 4.566E-03 0.03558643 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL mononeuritis DOID_1802 3.581E-04 3.774E-03 3.581E-04 6.368E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL nephrosis DOID_2527 3.924E-04 4.059E-03 3.924E-04 6.765E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL bile duct disease DOID_4138 3.924E-04 3.987E-03 3.924E-04 6.566E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL mononeuropathy DOID_1188 3.952E-04 3.945E-03 3.952E-04 6.424E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL toxic encephalopathy DOID_3602 3.952E-04 3.877E-03 9.023E-03 0.05834062 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL biliary tract disease DOID_9741 4.13E-04 3.983E-03 4.13E-04 6.528E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL female reproductive organ benign neoplasm DOID_0060086 4.346E-04 4.121E-03 9.595E-03 0.06134556 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL uterine benign neoplasm DOID_0060095 4.346E-04 4.121E-03 9.595E-03 0.06134556 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL uterine fibroid DOID_13223 4.346E-04 4.121E-03 9.595E-03 0.06134556 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL abdominal aortic aneurysm DOID_7693 4.764E-04 4.444E-03 0.01018367 0.06230655 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cystic fibrosis DOID_1485 4.795E-04 4.401E-03 5.708E-03 0.04163667 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL electroclinical syndrome DOID_0050701 5.279E-04 4.768E-03 5.279E-04 8.118E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL mixed glioma DOID_5076 5.279E-04 4.693E-03 6.123E-03 0.04410048 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL autonomic nervous system neoplasm DOID_2621 5.676E-04 4.969E-03 5.676E-04 8.282E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL neuroblastoma DOID_769 5.676E-04 4.969E-03 5.676E-04 8.282E-03 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL chronic kidney failure DOID_784 6.638E-04 5.723E-03 7.238E-03 0.0496227 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL spindle cell carcinoma DOID_4015 6.693E-04 5.684E-03 0.15740739 0.35825921 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL arrhythmogenic right ventricular dysplasia DOID_0050431 7.467E-04 6.248E-03 7.467E-04 0.01011535 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL embryonal cancer DOID_688 8.425E-04 6.947E-03 8.425E-04 0.0106527 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL peripheral nervous system neoplasm DOID_1192 9.059E-04 7.364E-03 9.059E-04 0.01096745 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL chondrosarcoma DOID_3371 9.305E-04 7.457E-03 0.04521884 0.19345505 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL labyrinthine disease DOID_4539 9.305E-04 7.353E-03 0.04521884 0.18918766 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 9.305E-04 7.253E-03 0.04521884 0.18780673 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Hodgkin's lymphoma, lymphocytic depletion DOID_8628 9.305E-04 7.253E-03 0.04521884 0.18780673 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Hodgkin's granuloma DOID_8651 9.305E-04 7.253E-03 0.04521884 0.18780673 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Hodgkin's lymphoma, mixed cellularity DOID_8654 9.305E-04 7.253E-03 0.04521884 0.18780673 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cutaneous leishmaniasis DOID_9111 9.305E-04 7.155E-03 0.04521884 0.18644581 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hepatitis DOID_2237 9.723E-04 7.377E-03 0.01616281 0.08758702 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL peptic ulcer DOID_750 9.723E-04 7.28E-03 9.723E-04 0.01129077 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL adenoid cystic carcinoma DOID_4866 1.042E-03 7.698E-03 1.042E-03 0.01185468 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL dilated cardiomyopathy DOID_12930 1.088E-03 7.939E-03 0.01038022 0.06283343 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL benign mesothelioma DOID_2645 1.114E-03 8.025E-03 0.01765215 0.0947554 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL familial adenomatous polyposis DOID_0050424 1.134E-03 8.064E-03 0.04962735 0.20169972 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL temporal arteritis DOID_13375 1.134E-03 7.965E-03 0.04962735 0.19341069 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL inner ear disease DOID_2952 1.134E-03 7.868E-03 0.04962735 0.19209497 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL central nervous system vasculitis DOID_525 1.134E-03 7.965E-03 0.04962735 0.19341069 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL salivary gland cancer DOID_8850 1.19E-03 8.156E-03 1.19E-03 0.01277264 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL idiopathic generalized epilepsy DOID_1827 1.268E-03 8.592E-03 1.268E-03 0.01312248 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL common cold DOID_10459 1.356E-03 9.08E-03 1.356E-03 0.01378241 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pituitary cancer DOID_1785 1.356E-03 8.975E-03 1.356E-03 0.01354061 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pituitary carcinoma DOID_4916 1.356E-03 8.975E-03 1.356E-03 0.01354061 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Hodgkin's lymphoma DOID_8567 1.356E-03 8.871E-03 0.05401561 0.19452458 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL bacterial meningitis DOID_9470 1.859E-03 0.01201964 1.859E-03 0.0179276 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL aortic aneurysm DOID_3627 1.912E-03 0.01222229 0.02502924 0.11769949 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL peripheral neuropathy DOID_0060053 2.138E-03 0.01351954 2.138E-03 0.02027931 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL lung oat cell carcinoma DOID_5411 2.138E-03 0.01337097 2.138E-03 0.01994686 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL sarcoidosis DOID_11335 2.239E-03 0.01385022 0.02772206 0.12929385 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL giant cell tumor DOID_200 2.239E-03 0.01370129 2.239E-03 0.02055194 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL malignant giant cell tumor DOID_2705 2.239E-03 0.01370129 2.239E-03 0.02055194 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL giant cell glioblastoma DOID_3074 2.239E-03 0.01370129 2.239E-03 0.02055194 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL vasculitis DOID_865 2.356E-03 0.01426047 0.02864446 0.13250975 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pituitary adenoma DOID_3829 2.437E-03 0.01459337 2.437E-03 0.02200588 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL reproductive organ benign neoplasm DOID_0050622 2.476E-03 0.01467548 0.02957905 0.13572968 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pustulosis of palm and sole DOID_4398 2.476E-03 0.01452419 0.02957905 0.13464384 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL mitochondrial metabolism disease DOID_700 2.6E-03 0.01509519 0.03052569 0.13785014 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL urinary system benign neoplasm DOID_731 2.753E-03 0.01582287 2.753E-03 0.02409945 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hypertrophic cardiomyopathy DOID_11984 2.859E-03 0.01626737 2.859E-03 0.02464754 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hypersensitivity reaction type IV disease DOID_2916 2.859E-03 0.01610631 0.0324546 0.14427082 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL glioblastoma DOID_3068 2.859E-03 0.01594841 2.859E-03 0.02427966 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL dental caries DOID_216 3.088E-03 0.01705767 3.088E-03 0.02583735 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL carotid artery disease DOID_3407 3.276E-03 0.01792577 1.000 1.000 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Down syndrome DOID_14250 3.441E-03 0.01864476 3.441E-03 0.02796713 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL leishmaniasis DOID_9065 3.441E-03 0.01846886 0.08417446 0.23593728 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL endocrine pancreas disease DOID_1428 3.729E-03 0.01983191 0.03851721 0.16989374 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL esophagitis DOID_11963 3.811E-03 0.02008004 0.0884041 0.2465781 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL temporal lobe epilepsy DOID_3328 4.052E-03 0.02114961 4.052E-03 0.03201816 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL gastric ulcer DOID_10808 4.606E-03 0.02382458 4.606E-03 0.03541492 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL muscle cancer DOID_4045 5.029E-03 0.02578042 5.029E-03 0.03815502 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL polyarteritis nodosa DOID_9810 5.029E-03 0.02555023 5.029E-03 0.03765298 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL bone resorption disease DOID_0080011 5.913E-03 0.02977481 0.05179573 0.19389321 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL osteoporosis DOID_11476 5.913E-03 0.02977481 0.05179573 0.19389321 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL aneurysm disease DOID_2403 5.913E-03 0.02951363 0.05179573 0.19262594 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL osteosarcoma DOID_3347 6.402E-03 0.0316767 0.11337714 0.29059276 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL contact dermatitis DOID_2773 6.556E-03 0.03215718 0.05533711 0.19803029 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL infantile epileptic encephalopathy DOID_2481 6.893E-03 0.03352462 6.893E-03 0.04902976 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL auditory system disease DOID_2742 7.006E-03 0.03378516 0.05774412 0.20281732 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL focal epilepsy DOID_2234 7.238E-03 0.03461079 7.238E-03 0.05022785 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL biliary tract cancer DOID_4607 7.238E-03 0.03432237 0.32545175 0.62141627 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL teeth hard tissue disease DOID_214 7.401E-03 0.0348047 7.401E-03 0.05013534 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL spinal cord disease DOID_319 7.401E-03 0.03451941 0.12154938 0.30201571 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL middle cerebral artery infarction DOID_3525 7.401E-03 0.03423877 0.12154938 0.3007026 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hypotrichosis DOID_4535 7.401E-03 0.03396265 7.401E-03 0.04954551 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Sciatic Neuropathy DOID_11446 7.926E-03 0.03607753 7.926E-03 0.05243826 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL lesion of sciatic nerve DOID_12528 7.926E-03 0.03607753 7.926E-03 0.05243826 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL migraine DOID_6364 7.926E-03 0.0357912 7.926E-03 0.05183553 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL mononeuritis of lower limb DOID_9473 7.926E-03 0.03607753 7.926E-03 0.05243826 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL sarcoma DOID_1115 8.466E-03 0.03793115 0.12964672 0.31391057 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Human immunodeficiency virus infectious disease DOID_526 8.99E-03 0.03996415 0.0677222 0.20829152 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL supratentorial cancer DOID_1659 9.023E-03 0.03979825 0.13366752 0.31690341 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cerebrum cancer DOID_368 9.023E-03 0.03979825 0.13366752 0.31690341 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL lymphoblastic leukemia DOID_1037 9.81E-03 0.0429383 9.81E-03 0.06202199 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL carbohydrate metabolic disorder DOID_2978 9.81E-03 0.04261052 0.0716009 0.21442585 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL mouth disease DOID_403 0.01009284 0.04350624 0.01009284 0.06310795 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL gonadal disease DOID_2277 0.01018367 0.04356774 0.01018367 0.06298379 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL Charcot-Marie-Tooth disease DOID_10595 0.01078761 0.04580707 0.01078761 0.06461208 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pleural disease DOID_1532 0.011407 0.04807838 0.14956686 0.34736139 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hair disease DOID_421 0.0120417 0.05038033 0.0120417 0.07063634 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL myocarditis DOID_820 0.0120417 0.05001259 0.0120417 0.06991556 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL metal metabolism disorder DOID_896 0.0120417 0.04965018 0.0120417 0.06920934 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL nephroblastoma DOID_2154 0.01269155 0.05195316 0.01269155 0.0722149 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL esophageal disease DOID_6050 0.01269155 0.05158207 0.15740739 0.35683188 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL childhood electroclinical syndrome DOID_0050704 0.0133564 0.05389922 0.0133564 0.07524544 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL lymphoid leukemia DOID_10747 0.0133564 0.05351965 0.0133564 0.07450774 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL aplastic anemia DOID_12449 0.0133564 0.05314538 0.16130066 0.36276709 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pulmonary sarcoidosis DOID_13406 0.0147305 0.05820593 0.0147305 0.08137528 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL calcinosis DOID_182 0.0147305 0.05780451 0.16903362 0.37570363 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL microcephaly DOID_10907 0.01543945 0.06017156 0.01543945 0.08447161 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL uveitis DOID_13141 0.01543945 0.05976223 0.17287347 0.38125971 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL intracranial arterial disease DOID_13089 0.01690042 0.06497527 0.18050033 0.39501803 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cerebral arterial disease DOID_3527 0.01690042 0.06497527 0.18050033 0.39501803 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL spinocerebellar ataxia DOID_1441 0.01841784 0.07033391 0.01841784 0.09794161 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL nephrotic syndrome DOID_1184 0.01919736 0.07282199 0.01919736 0.10114166 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hyperinsulinism DOID_2018 0.01919736 0.07233973 0.01919736 0.10021375 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL uveal disease DOID_3480 0.01919736 0.07186381 0.19180971 0.41656383 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL diabetic autonomic neuropathy DOID_11503 0.01999056 0.07434399 0.01999056 0.10340573 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL autonomic neuropathy DOID_11504 0.01999056 0.07434399 0.01999056 0.10340573 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL diabetic polyneuropathy DOID_12785 0.01999056 0.07434399 0.01999056 0.10340573 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL gallbladder cancer DOID_3121 0.01999056 0.07386123 1.000 1.000 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL diabetic neuropathy DOID_9743 0.01999056 0.07434399 0.01999056 0.10340573 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cerebral infarction DOID_3526 0.0207973 0.07634623 0.19926294 0.43110499 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL learning disability DOID_8927 0.0207973 0.07585683 0.0207973 0.1066096 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL spinocerebellar degeneration DOID_2478 0.02161745 0.07834603 0.02161745 0.10982434 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL proteinuria DOID_576 0.02161745 0.07785017 0.02161745 0.10885245 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL pre-eclampsia DOID_10591 0.02245085 0.08034297 0.02245085 0.1120573 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL autonomic nervous system disease DOID_11465 0.02245085 0.07984083 0.02245085 0.11108289 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL bone marrow disease DOID_4961 0.02245085 0.07934492 0.20664783 0.4420399 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL vascular skin disease DOID_9540 0.02245085 0.07885514 0.02245085 0.10918404 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL hemolytic anemia DOID_583 0.02329737 0.08132641 0.02329737 0.11139668 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL normocytic anemia DOID_720 0.02329737 0.08132641 0.02329737 0.11139668 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL autoimmune disease of gastrointestinal tract DOID_0060031 0.02415688 0.0838126 0.21396499 0.45597783 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL integumentary system benign neoplasm DOID_0060121 0.02415688 0.08330464 0.21396499 0.45427642 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL skin benign neoplasm DOID_3165 0.02415688 0.08330464 0.21396499 0.45427642 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL lung small cell carcinoma DOID_5409 0.02415688 0.08280281 0.02415688 0.11454388 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL calcium metabolism disease DOID_10575 0.02502924 0.08527927 0.21759837 0.45856842 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL movement disease DOID_480 0.02502924 0.08477165 0.21759837 0.45687628 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL atrophic muscular disease DOID_913 0.02772206 0.09333639 0.22839862 0.47603961 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL muscular dystrophy DOID_9884 0.02772206 0.09333639 0.22839862 0.47603961 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL bile duct adenocarcinoma DOID_4896 0.02864446 0.0958747 0.23196566 0.4817097 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL cholangiocarcinoma DOID_4947 0.02864446 0.0958747 0.23196566 0.4817097 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL integumentary system cancer DOID_0060122 0.02957905 0.09842386 0.2355163 0.48730463 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL parasitic protozoa infectious disease DOID_2789 0.02957905 0.09785163 0.2355163 0.48553904 FARMER_BREAST_CANCER_BASAL_VS_LULMINAL skin cancer DOID_4159 0.02957905 0.09842386 0.2355163 0.48730463 HELLER_HDAC_TARGETS_DN transitional cell carcinoma DOID_2671 1.129E-10 6.423E-08 0.05085669 0.33261447 HELLER_HDAC_TARGETS_DN oral cavity cancer DOID_8618 1.364E-10 3.881E-08 1.741E-07 3.303E-05 HELLER_HDAC_TARGETS_DN adenoid cystic carcinoma DOID_4866 4.137E-10 7.847E-08 2.029E-08 1.154E-05 HELLER_HDAC_TARGETS_DN salivary gland cancer DOID_8850 5.787E-10 8.232E-08 2.693E-08 7.661E-06 HELLER_HDAC_TARGETS_DN papilloma DOID_2615 6.634E-09 7.549E-07 9.201E-03 0.13424211 HELLER_HDAC_TARGETS_DN adenoma DOID_657 1.1E-08 1.043E-06 0.0107378 0.14901969 HELLER_HDAC_TARGETS_DN multiple myeloma DOID_9538 1.29E-08 1.049E-06 0.14852136 0.5000512 HELLER_HDAC_TARGETS_DN myeloma DOID_0070004 5.167E-08 3.675E-06 0.18208975 0.55405919 HELLER_HDAC_TARGETS_DN papillary adenoma DOID_3172 7.291E-08 4.609E-06 5.249E-03 0.10297982 HELLER_HDAC_TARGETS_DN microcystic adenoma DOID_5403 7.291E-08 4.609E-06 5.249E-03 0.10297982 HELLER_HDAC_TARGETS_DN follicular adenoma DOID_6204 7.291E-08 4.609E-06 5.249E-03 0.10297982 HELLER_HDAC_TARGETS_DN lymphoma DOID_0060058 1.108E-07 6.304E-06 6.489E-03 0.10549078 HELLER_HDAC_TARGETS_DN bone marrow cancer DOID_4960 1.153E-07 5.965E-06 0.2048021 0.59455303 HELLER_HDAC_TARGETS_DN encephalomyelitis DOID_640 1.192E-07 5.653E-06 5.957E-04 0.02420969 HELLER_HDAC_TARGETS_DN allergic contact dermatitis DOID_3042 3.991E-07 1.747E-05 1.854E-04 0.02637136 HELLER_HDAC_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 4.346E-07 1.766E-05 0.03313792 0.29461682 HELLER_HDAC_TARGETS_DN male reproductive system disease DOID_48 5.566E-07 2.111E-05 0.03574034 0.29472831 HELLER_HDAC_TARGETS_DN contact dermatitis DOID_2773 1.025E-06 3.644E-05 3.407E-04 0.02769538 HELLER_HDAC_TARGETS_DN thyroid adenoma DOID_2891 1.777E-06 5.946E-05 0.01724971 0.20030786 HELLER_HDAC_TARGETS_DN Human immunodeficiency virus infectious disease DOID_526 2.019E-06 6.382E-05 5.277E-04 0.02502133 HELLER_HDAC_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 2.618E-06 7.839E-05 0.019942 0.21409425 HELLER_HDAC_TARGETS_DN reproductive organ benign neoplasm DOID_0050622 3.744E-06 1.065E-04 0.20799516 0.59772346 HELLER_HDAC_TARGETS_DN neuroectodermal tumor DOID_171 6.111E-06 1.656E-04 2.201E-03 0.05692589 HELLER_HDAC_TARGETS_DN invasive lobular carcinoma DOID_3457 1.018E-05 2.634E-04 1.000 1.000 HELLER_HDAC_TARGETS_DN leiomyoma DOID_127 1.18E-05 2.92E-04 0.13122747 0.48802897 HELLER_HDAC_TARGETS_DN nephroblastoma DOID_2154 1.48E-05 3.508E-04 1.000 1.000 HELLER_HDAC_TARGETS_DN spindle cell carcinoma DOID_4015 1.48E-05 3.368E-04 0.13818651 0.49142577 HELLER_HDAC_TARGETS_DN medullomyoblastoma DOID_3861 1.649E-05 3.608E-04 4.809E-04 0.03040304 HELLER_HDAC_TARGETS_DN adult medulloblastoma DOID_3864 1.649E-05 3.608E-04 4.809E-04 0.03040304 HELLER_HDAC_TARGETS_DN childhood medulloblastoma DOID_3869 1.649E-05 3.608E-04 4.809E-04 0.03040304 HELLER_HDAC_TARGETS_DN medulloblastoma DOID_3858 2.029E-05 4.275E-04 5.599E-04 0.0245069 HELLER_HDAC_TARGETS_DN peripheral nervous system neoplasm DOID_1192 2.241E-05 4.554E-04 0.01182071 0.15286333 HELLER_HDAC_TARGETS_DN bone development disease DOID_0080006 2.6E-05 5.102E-04 4.086E-04 0.02905952 HELLER_HDAC_TARGETS_DN varicose veins DOID_799 2.775E-05 5.264E-04 1.000 1.000 HELLER_HDAC_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 2.976E-05 5.462E-04 0.16210988 0.53011794 HELLER_HDAC_TARGETS_DN vein disease DOID_866 3.406E-05 6.056E-04 1.000 1.000 HELLER_HDAC_TARGETS_DN primary immunodeficiency disease DOID_612 3.417E-05 5.891E-04 5.063E-04 0.02880923 HELLER_HDAC_TARGETS_DN primitive neuroectodermal tumor DOID_168 3.555E-05 5.95E-04 8.453E-04 0.03206394 HELLER_HDAC_TARGETS_DN nervous system cancer DOID_3093 3.602E-05 5.855E-04 0.05288293 0.32011052 HELLER_HDAC_TARGETS_DN lymphatic system cancer DOID_0060073 4.123E-05 6.517E-04 0.06603012 0.37199146 HELLER_HDAC_TARGETS_DN reticulosarcoma DOID_8538 4.123E-05 6.517E-04 0.06603012 0.37199146 HELLER_HDAC_TARGETS_DN lymphosarcoma DOID_8675 4.123E-05 6.517E-04 0.06603012 0.37199146 HELLER_HDAC_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 4.419E-05 6.796E-04 0.32033835 0.80651557 HELLER_HDAC_TARGETS_DN leukodystrophy DOID_10579 4.573E-05 6.847E-04 0.17879295 0.55289776 HELLER_HDAC_TARGETS_DN neuritis DOID_1803 4.955E-05 7.229E-04 1.079E-03 0.03230362 HELLER_HDAC_TARGETS_DN glaucoma DOID_1686 5.789E-05 8.235E-04 1.000 1.000 HELLER_HDAC_TARGETS_DN testicular cancer DOID_2998 5.841E-05 8.106E-04 0.07350785 0.38023606 HELLER_HDAC_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 1.085E-04 1.47E-03 0.02504321 0.23359977 HELLER_HDAC_TARGETS_DN diabetic angiopathy DOID_11713 1.202E-04 1.591E-03 0.09194298 0.43596298 HELLER_HDAC_TARGETS_DN carotid artery disease DOID_3407 1.309E-04 1.693E-03 0.22688779 0.62669491 HELLER_HDAC_TARGETS_DN toxic shock syndrome DOID_14115 1.362E-04 1.722E-03 0.09558604 0.43510767 HELLER_HDAC_TARGETS_DN pre-malignant neoplasm DOID_0060071 1.475E-04 1.825E-03 0.2330853 0.64070308 HELLER_HDAC_TARGETS_DN in situ carcinoma DOID_8719 1.475E-04 1.825E-03 0.2330853 0.64070308 HELLER_HDAC_TARGETS_DN commensal bacterial infectious disease DOID_0050339 1.535E-04 1.859E-03 0.09921459 0.44451259 HELLER_HDAC_TARGETS_DN cerebral degeneration DOID_1443 1.657E-04 1.964E-03 0.23923346 0.64820875 HELLER_HDAC_TARGETS_DN cleft lip DOID_9296 1.722E-04 2E-03 5.249E-03 0.09954716 HELLER_HDAC_TARGETS_DN vitiligo DOID_12306 1.923E-04 2.189E-03 5.637E-03 0.10347489 HELLER_HDAC_TARGETS_DN B cell deficiency DOID_2115 1.923E-04 2.146E-03 5.637E-03 0.1002413 HELLER_HDAC_TARGETS_DN middle cerebral artery infarction DOID_3525 1.923E-04 2.104E-03 5.637E-03 0.09720368 HELLER_HDAC_TARGETS_DN seminoma DOID_4440 1.923E-04 2.065E-03 0.10642834 0.44857574 HELLER_HDAC_TARGETS_DN pancreatic ductal carcinoma DOID_3587 2.18E-04 2.297E-03 2.18E-04 0.0248118 HELLER_HDAC_TARGETS_DN peripheral vascular disease DOID_341 2.42E-04 2.503E-03 0.03662488 0.29770797 HELLER_HDAC_TARGETS_DN pancreatic carcinoma DOID_4905 2.546E-04 2.587E-03 2.546E-04 0.02414632 HELLER_HDAC_TARGETS_DN female reproductive organ benign neoplasm DOID_0060086 2.878E-04 2.873E-03 0.12068412 0.47358113 HELLER_HDAC_TARGETS_DN uterine benign neoplasm DOID_0060095 2.878E-04 2.873E-03 0.12068412 0.47358113 HELLER_HDAC_TARGETS_DN uterine fibroid DOID_13223 2.878E-04 2.873E-03 0.12068412 0.47358113 HELLER_HDAC_TARGETS_DN germinoma DOID_3304 3.451E-04 3.386E-03 0.12772705 0.4813026 HELLER_HDAC_TARGETS_DN autonomic nervous system neoplasm DOID_2621 3.764E-04 3.63E-03 0.13122747 0.4786438 HELLER_HDAC_TARGETS_DN neuroblastoma DOID_769 3.764E-04 3.63E-03 0.13122747 0.4786438 HELLER_HDAC_TARGETS_DN systemic mycosis DOID_0050136 4.094E-04 3.883E-03 9.201E-03 0.13777479 HELLER_HDAC_TARGETS_DN fungal infectious disease DOID_1564 4.094E-04 3.883E-03 9.201E-03 0.13777479 HELLER_HDAC_TARGETS_DN myocarditis DOID_820 4.094E-04 3.819E-03 9.201E-03 0.13088605 HELLER_HDAC_TARGETS_DN amino acid metabolic disorder DOID_9252 5.063E-04 4.647E-03 5.063E-04 0.02619021 HELLER_HDAC_TARGETS_DN cleft palate DOID_674 5.599E-04 5.057E-03 0.01127348 0.15272877 HELLER_HDAC_TARGETS_DN uveitis DOID_13141 6.023E-04 5.355E-03 0.15193888 0.50854835 HELLER_HDAC_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 6.443E-04 5.64E-03 0.05807145 0.33716992 HELLER_HDAC_TARGETS_DN dilated cardiomyopathy DOID_12930 6.443E-04 5.555E-03 7.075E-03 0.11183206 HELLER_HDAC_TARGETS_DN intracranial arterial disease DOID_13089 6.933E-04 5.887E-03 0.01294947 0.16373882 HELLER_HDAC_TARGETS_DN cerebral arterial disease DOID_3527 6.933E-04 5.887E-03 0.01294947 0.16373882 HELLER_HDAC_TARGETS_DN rectal neoplasm DOID_1984 7.036E-04 5.888E-03 1.000 1.000 HELLER_HDAC_TARGETS_DN rectum cancer DOID_1993 7.036E-04 5.888E-03 1.000 1.000 HELLER_HDAC_TARGETS_DN uveal disease DOID_3480 8.453E-04 6.97E-03 0.16882313 0.53665007 HELLER_HDAC_TARGETS_DN prediabetes syndrome DOID_11716 8.577E-04 6.972E-03 0.0432353 0.29639619 HELLER_HDAC_TARGETS_DN neuronal ceroid lipofuscinosis DOID_14503 8.577E-04 6.874E-03 8.577E-04 0.03050318 HELLER_HDAC_TARGETS_DN gallbladder cancer DOID_3121 9.003E-04 7.115E-03 0.17215969 0.5412092 HELLER_HDAC_TARGETS_DN cerebral infarction DOID_3526 9.575E-04 7.463E-03 0.01596671 0.19750124 HELLER_HDAC_TARGETS_DN cataract DOID_83 9.575E-04 7.362E-03 0.01596671 0.19329908 HELLER_HDAC_TARGETS_DN esophageal carcinoma DOID_1107 1.027E-03 7.788E-03 1.027E-03 0.03436003 HELLER_HDAC_TARGETS_DN beta thalassemia DOID_12241 1.027E-03 7.686E-03 1.027E-03 0.03245114 HELLER_HDAC_TARGETS_DN esophagus squamous cell carcinoma DOID_3748 1.027E-03 7.788E-03 1.027E-03 0.03436003 HELLER_HDAC_TARGETS_DN ocular hypertension DOID_9282 1.027E-03 7.586E-03 1.000 1.000 HELLER_HDAC_TARGETS_DN borderline glaucoma DOID_9283 1.027E-03 7.586E-03 1.000 1.000 HELLER_HDAC_TARGETS_DN lens disease DOID_110 1.079E-03 7.869E-03 0.01724971 0.20448094 HELLER_HDAC_TARGETS_DN hemolytic anemia DOID_583 1.143E-03 8.231E-03 0.01790714 0.19978747 HELLER_HDAC_TARGETS_DN normocytic anemia DOID_720 1.143E-03 8.231E-03 0.01790714 0.19978747 HELLER_HDAC_TARGETS_DN berylliosis DOID_10322 1.21E-03 8.606E-03 0.05089432 0.32907805 HELLER_HDAC_TARGETS_DN viral pneumonia DOID_10533 1.408E-03 9.891E-03 1.000 1.000 HELLER_HDAC_TARGETS_DN aspergillosis DOID_13564 1.408E-03 9.77E-03 0.05470096 0.32421716 HELLER_HDAC_TARGETS_DN polycystic kidney disease DOID_898 1.408E-03 9.652E-03 1.408E-03 0.04005744 HELLER_HDAC_TARGETS_DN orofacial cleft DOID_0050567 1.423E-03 9.638E-03 0.02064083 0.21749319 HELLER_HDAC_TARGETS_DN giant cell tumor DOID_200 1.499E-03 0.01003456 0.02134979 0.22087325 HELLER_HDAC_TARGETS_DN malignant giant cell tumor DOID_2705 1.499E-03 0.01003456 0.02134979 0.22087325 HELLER_HDAC_TARGETS_DN giant cell glioblastoma DOID_3074 1.499E-03 0.01003456 0.02134979 0.22087325 HELLER_HDAC_TARGETS_DN thalassemia DOID_10241 1.62E-03 0.01072062 1.62E-03 0.04390348 HELLER_HDAC_TARGETS_DN osteochondrodysplasia DOID_2256 1.659E-03 0.01084938 0.0227977 0.23164089 HELLER_HDAC_TARGETS_DN parasitic protozoa infectious disease DOID_2789 1.659E-03 0.01072609 0.20799516 0.59174623 HELLER_HDAC_TARGETS_DN angiosarcoma DOID_0001816 1.847E-03 0.01180804 1.000 1.000 HELLER_HDAC_TARGETS_DN thyroiditis DOID_7166 1.847E-03 0.01167684 1.000 1.000 HELLER_HDAC_TARGETS_DN autoimmune thyroiditis DOID_7188 1.847E-03 0.01167684 1.000 1.000 HELLER_HDAC_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 1.918E-03 0.01199271 0.21749811 0.61265558 HELLER_HDAC_TARGETS_DN glioblastoma DOID_3068 1.918E-03 0.01186236 0.02504321 0.22983203 HELLER_HDAC_TARGETS_DN leukocyte disease DOID_9500 2.01E-03 0.01229552 0.22064053 0.61541402 HELLER_HDAC_TARGETS_DN agammaglobulinemia DOID_2583 2.611E-03 0.01580627 0.07350785 0.38372446 HELLER_HDAC_TARGETS_DN MHC class II deficiency DOID_5812 2.611E-03 0.01563989 2.611E-03 0.06459954 HELLER_HDAC_TARGETS_DN parasitic infectious disease DOID_1398 2.617E-03 0.0155098 0.23923346 0.65131023 HELLER_HDAC_TARGETS_DN colon carcinoma DOID_1520 2.894E-03 0.0169747 0.07722438 0.38885551 HELLER_HDAC_TARGETS_DN blood protein disease DOID_620 2.894E-03 0.01680148 0.07722438 0.3820928 HELLER_HDAC_TARGETS_DN amyloidosis DOID_9120 2.894E-03 0.01663177 0.07722438 0.3787989 HELLER_HDAC_TARGETS_DN brain infarction DOID_3454 2.958E-03 0.01683273 0.03313792 0.29008425 HELLER_HDAC_TARGETS_DN astrocytoma DOID_3069 3.078E-03 0.01734005 0.03399678 0.28871889 HELLER_HDAC_TARGETS_DN bile duct disease DOID_4138 3.326E-03 0.01855401 0.03574034 0.29906255 HELLER_HDAC_TARGETS_DN biliary tract disease DOID_9741 3.455E-03 0.01908375 0.03662488 0.2935149 HELLER_HDAC_TARGETS_DN bone resorption disease DOID_0080011 3.999E-03 0.02187782 3.999E-03 0.09480391 HELLER_HDAC_TARGETS_DN osteoporosis DOID_11476 3.999E-03 0.02187782 3.999E-03 0.09480391 HELLER_HDAC_TARGETS_DN aneurysm disease DOID_2403 3.999E-03 0.02166946 0.04024624 0.29359117 HELLER_HDAC_TARGETS_DN Lewy body dementia DOID_12217 4.16E-03 0.02232867 0.09194298 0.42881604 HELLER_HDAC_TARGETS_DN metabolic syndrome X DOID_14221 4.439E-03 0.02360682 0.04304738 0.30617449 HELLER_HDAC_TARGETS_DN severe combined immunodeficiency DOID_627 4.51E-03 0.02375844 4.51E-03 0.10263645 HELLER_HDAC_TARGETS_DN combined T cell and B cell immunodeficiency DOID_628 4.873E-03 0.02543539 4.873E-03 0.10663297 HELLER_HDAC_TARGETS_DN alcohol abuse DOID_1574 4.908E-03 0.02538784 4.908E-03 0.10343193 HELLER_HDAC_TARGETS_DN mental depression DOID_1596 4.908E-03 0.02515912 4.908E-03 0.09973793 HELLER_HDAC_TARGETS_DN biliary tract cancer DOID_4607 4.908E-03 0.02493448 0.28955437 0.7421461 HELLER_HDAC_TARGETS_DN myopia DOID_11830 5.637E-03 0.02838692 0.10642834 0.45532124 HELLER_HDAC_TARGETS_DN diffuse large B-cell lymphoma DOID_0050745 6.039E-03 0.03014312 1.000 1.000 HELLER_HDAC_TARGETS_DN periodontitis DOID_824 6.039E-03 0.02988101 0.11001366 0.45360707 HELLER_HDAC_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 6.039E-03 0.02962342 6.039E-03 0.10106812 HELLER_HDAC_TARGETS_DN autoimmune disease of cardiovascular system DOID_0060051 6.454E-03 0.03138579 0.1135847 0.46496182 HELLER_HDAC_TARGETS_DN sarcoma DOID_1115 6.454E-03 0.03111981 1.000 1.000 HELLER_HDAC_TARGETS_DN malaria DOID_12365 6.454E-03 0.0308583 0.1135847 0.46164067 HELLER_HDAC_TARGETS_DN Behcet's disease DOID_13241 6.454E-03 0.03138579 0.1135847 0.46496182 HELLER_HDAC_TARGETS_DN invasive ductal carcinoma DOID_3008 6.454E-03 0.03060114 0.1135847 0.4519559 HELLER_HDAC_TARGETS_DN Crohn's disease DOID_8778 6.877E-03 0.03233701 0.05701998 0.33447804 HELLER_HDAC_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 6.881E-03 0.03209118 1.000 1.000 HELLER_HDAC_TARGETS_DN dysostosis DOID_1934 7.32E-03 0.03386355 7.32E-03 0.11257342 HELLER_HDAC_TARGETS_DN opportunistic mycosis DOID_2473 7.772E-03 0.03566415 0.12421262 0.47754716 HELLER_HDAC_TARGETS_DN bronchiolitis obliterans DOID_2799 7.772E-03 0.03537883 0.12421262 0.47434215 HELLER_HDAC_TARGETS_DN allergic rhinitis DOID_4481 8.236E-03 0.03719426 0.12772705 0.47813613 HELLER_HDAC_TARGETS_DN hereditary spastic paraplegia DOID_2476 8.713E-03 0.03903564 0.13122747 0.48173182 HELLER_HDAC_TARGETS_DN pneumoconiosis DOID_10316 9.702E-03 0.0431263 0.13818651 0.50081607 HELLER_HDAC_TARGETS_DN periodontal disease DOID_3388 9.702E-03 0.04279199 0.13818651 0.4945165 HELLER_HDAC_TARGETS_DN paraplegia DOID_607 9.702E-03 0.04246282 0.13818651 0.48837343 HELLER_HDAC_TARGETS_DN autosomal recessive nonsyndromic deafness DOID_0050565 0.0107378 0.04663975 0.14509016 0.49732712 HELLER_HDAC_TARGETS_DN refractive error DOID_9835 0.0107378 0.04628642 0.14509016 0.49434912 HELLER_HDAC_TARGETS_DN microcephaly DOID_10907 0.01182071 0.05057133 0.01182071 0.15641829 HELLER_HDAC_TARGETS_DN hepatitis DOID_2237 0.01237941 0.0525663 1.000 1.000 HELLER_HDAC_TARGETS_DN lymphatic system disease DOID_75 0.01294947 0.05457961 1.000 1.000 HELLER_HDAC_TARGETS_DN endometriosis of uterus DOID_288 0.01412326 0.05908925 0.16547321 0.53496737 HELLER_HDAC_TARGETS_DN endometriosis DOID_289 0.01472681 0.06116463 0.16882313 0.53966495 HELLER_HDAC_TARGETS_DN diabetic autonomic neuropathy DOID_11503 0.01534132 0.06325517 0.17215969 0.54421592 HELLER_HDAC_TARGETS_DN autonomic neuropathy DOID_11504 0.01534132 0.06325517 0.17215969 0.54421592 HELLER_HDAC_TARGETS_DN diabetic polyneuropathy DOID_12785 0.01534132 0.06325517 0.17215969 0.54421592 HELLER_HDAC_TARGETS_DN uterine cancer DOID_363 0.01534132 0.06280009 1.000 1.000 HELLER_HDAC_TARGETS_DN diabetic neuropathy DOID_9743 0.01534132 0.06325517 0.17215969 0.54421592 HELLER_HDAC_TARGETS_DN learning disability DOID_8927 0.01596671 0.06489326 0.17548295 0.54562731 HELLER_HDAC_TARGETS_DN autonomic nervous system disease DOID_11465 0.01724971 0.06961053 0.18208975 0.55111206 HELLER_HDAC_TARGETS_DN bone marrow disease DOID_4961 0.01724971 0.06912032 0.01724971 0.1963017 HELLER_HDAC_TARGETS_DN vascular skin disease DOID_9540 0.01724971 0.06863696 0.18208975 0.54819613 HELLER_HDAC_TARGETS_DN pulmonary tuberculosis DOID_2957 0.01857506 0.07339727 0.01857506 0.20325398 HELLER_HDAC_TARGETS_DN sarcoidosis DOID_11335 0.02134979 0.08377951 0.20159625 0.59127973 HELLER_HDAC_TARGETS_DN vasculitis DOID_865 0.02206877 0.08600775 0.2048021 0.591535 HELLER_HDAC_TARGETS_DN pustulosis of palm and sole DOID_4398 0.0227977 0.08824415 0.0227977 0.22757702 HELLER_HDAC_TARGETS_DN smallpox DOID_8736 0.0227977 0.08764791 0.0227977 0.22365328 HELLER_HDAC_TARGETS_DN familial hyperlipidemia DOID_1168 0.02353647 0.08988089 0.02353647 0.22698733 HELLER_HDAC_TARGETS_DN congenital nervous system abnormality DOID_2490 0.02428501 0.09212112 0.02428501 0.2303028 HELLER_HDAC_TARGETS_DN nonsyndromic deafness DOID_0050563 0.02504321 0.09436812 0.21749811 0.61570362 SU_LIVER thrombophilia DOID_2452 3.44E-09 1.957E-06 3.44E-09 1.957E-06 SU_LIVER amino acid metabolic disorder DOID_9252 1.604E-08 4.565E-06 1.205E-06 2.285E-04 SU_LIVER blood coagulation disease DOID_1247 4.961E-07 9.41E-05 4.961E-07 1.412E-04 SU_LIVER lipid metabolism disorder DOID_3146 7.929E-07 1.128E-04 2.336E-03 0.07384887 SU_LIVER meningitis DOID_9471 1.201E-06 1.367E-04 2.004E-04 0.01266824 SU_LIVER spastic cerebral palsy DOID_0050669 3.22E-06 3.054E-04 1.000 1.000 SU_LIVER carotid artery disease DOID_3407 2.414E-05 1.963E-03 1.432E-03 0.05092913 SU_LIVER familial combined hyperlipidemia DOID_13809 3.292E-05 2.341E-03 8.672E-03 0.24670718 SU_LIVER hypolipoproteinemia DOID_1387 3.292E-05 2.081E-03 1.000 1.000 SU_LIVER bacterial pneumonia DOID_874 4.716E-05 2.683E-03 0.06736356 0.67245383 SU_LIVER beta thalassemia DOID_12241 4.823E-05 2.495E-03 4.823E-05 6.861E-03 SU_LIVER chronic kidney failure DOID_784 5.653E-05 2.68E-03 0.07142438 0.70069785 SU_LIVER intracranial thrombosis DOID_4193 5.697E-05 2.493E-03 5.697E-05 6.483E-03 SU_LIVER retinal vascular disease DOID_2462 6.059E-05 2.463E-03 1.000 1.000 SU_LIVER primary immunodeficiency disease DOID_612 6.928E-05 2.628E-03 2.867E-03 0.085847 SU_LIVER thalassemia DOID_10241 7.66E-05 2.724E-03 7.66E-05 7.265E-03 SU_LIVER nutritional deficiency disease DOID_5113 7.66E-05 2.564E-03 0.01298002 0.25467693 SU_LIVER spastic diplegia DOID_10965 8.75E-05 2.766E-03 1.000 1.000 SU_LIVER inherited blood coagulation disease DOID_2214 1.114E-04 3.337E-03 1.114E-04 9.059E-03 SU_LIVER leishmaniasis DOID_9065 1.245E-04 3.542E-03 1.000 1.000 SU_LIVER familial hypercholesterolemia DOID_13810 1.679E-04 4.549E-03 0.01898131 0.34839883 SU_LIVER congenital hemolytic anemia DOID_589 2.004E-04 5.182E-03 2.004E-04 0.01425177 SU_LIVER toxic shock syndrome DOID_14115 2.177E-04 5.385E-03 0.02154244 0.37144393 SU_LIVER commensal bacterial infectious disease DOID_0050339 2.357E-04 5.588E-03 0.02239471 0.3747821 SU_LIVER autoimmune disease of cardiovascular system DOID_0060051 3.148E-04 7.164E-03 1.000 1.000 SU_LIVER Behcet's disease DOID_13241 3.148E-04 7.164E-03 1.000 1.000 SU_LIVER hepatitis DOID_2237 6.19E-04 0.01354637 6.19E-04 0.03522056 SU_LIVER adult respiratory distress syndrome DOID_11394 6.488E-04 0.01367353 0.03677364 0.46498224 SU_LIVER nephrotic syndrome DOID_1184 7.425E-04 0.01508794 7.425E-04 0.03840567 SU_LIVER cerebral infarction DOID_3526 8.083E-04 0.01585938 1.000 1.000 SU_LIVER cataract DOID_83 8.083E-04 0.01533073 8.083E-04 0.03832683 SU_LIVER lens disease DOID_110 8.769E-04 0.01609448 8.769E-04 0.03837914 SU_LIVER hemolytic anemia DOID_583 9.121E-04 0.01621909 9.121E-04 0.0370722 SU_LIVER normocytic anemia DOID_720 9.121E-04 0.01621909 9.121E-04 0.0370722 SU_LIVER pulmonary tuberculosis DOID_2957 9.481E-04 0.01634781 1.000 1.000 SU_LIVER hemorrhagic disease DOID_2213 1.022E-03 0.01710481 1.022E-03 0.03877089 SU_LIVER vasculitis DOID_865 1.138E-03 0.01850179 1.000 1.000 SU_LIVER parasitic protozoa infectious disease DOID_2789 1.178E-03 0.01862014 1.000 1.000 SU_LIVER familial hyperlipidemia DOID_1168 1.219E-03 0.01874238 0.05011927 0.57035731 SU_LIVER respiratory failure DOID_11162 1.477E-03 0.02211258 0.05507751 0.61449224 SU_LIVER parasitic infectious disease DOID_1398 1.615E-03 0.02355811 1.000 1.000 SU_LIVER brain infarction DOID_3454 1.759E-03 0.02501552 1.000 1.000 SU_LIVER tuberculosis DOID_399 1.759E-03 0.02440539 1.000 1.000 SU_LIVER nephrosis DOID_2527 1.908E-03 0.02585297 1.908E-03 0.06387204 SU_LIVER diabetic retinopathy DOID_8947 2.011E-03 0.0266158 1.000 1.000 SU_LIVER metabolic syndrome X DOID_14221 2.336E-03 0.0302109 1.000 1.000 SU_LIVER primary bacterial infectious disease DOID_0050338 2.744E-03 0.03469977 1.000 1.000 SU_LIVER Human immunodeficiency virus infectious disease DOID_526 2.929E-03 0.03622684 1.000 1.000 SU_LIVER Crohn's disease DOID_8778 3.183E-03 0.03854011 0.08029793 0.74900854 SU_LIVER hyperparathyroidism DOID_13543 8.672E-03 0.09868287 1.000 1.000 SU_LIVER childhood type dermatomyositis DOID_14203 8.672E-03 0.09674791 8.672E-03 0.23495921 SU_LIVER angioedema DOID_1558 8.672E-03 0.09488738 8.672E-03 0.22427925 SU_LIVER retinal vascular occlusion DOID_1729 8.672E-03 0.09309705 1.000 1.000 SU_LIVER visceral leishmaniasis DOID_9146 8.672E-03 0.09137303 1.000 1.000 SU_LIVER familial adenomatous polyposis DOID_0050424 9.535E-03 0.09864127 9.535E-03 0.23588129 SU_LIVER dermatomyositis DOID_10223 9.535E-03 0.09687982 9.535E-03 0.2260529 SU_LIVER sickle cell anemia DOID_10923 9.535E-03 0.09518017 9.535E-03 0.21701079 SU_LIVER common variable immunodeficiency DOID_12177 9.535E-03 0.09353913 1.000 1.000 SU_LIVER hemochromatosis DOID_2352 9.535E-03 0.09195372 9.535E-03 0.20866422 SU_LIVER bronchiectasis DOID_9563 9.535E-03 0.09042116 1.000 1.000 SU_LIVER intracranial arteriosclerosis DOID_13097 0.01039715 0.0969833 1.000 1.000 SU_LIVER porphyria DOID_13268 0.01039715 0.09541905 0.01039715 0.21911041 SU_LIVER aortic valve stenosis DOID_1712 0.01039715 0.09390446 1.000 1.000 SU_LIVER vascular dementia DOID_8725 0.01039715 0.0969833 1.000 1.000 SU_LIVER carotid stenosis DOID_13001 0.01125884 0.09855813 1.000 1.000 FRASOR_RESPONSE_TO_ESTRADIOL_DN endocrine organ benign neoplasm DOID_0060089 3.085E-06 1.755E-03 3.085E-06 1.755E-03 FRASOR_RESPONSE_TO_ESTRADIOL_DN endometrial carcinoma DOID_2871 1.243E-05 3.537E-03 9.259E-04 0.10536812 FRASOR_RESPONSE_TO_ESTRADIOL_DN Charcot-Marie-Tooth disease DOID_10595 1.497E-05 2.84E-03 1.045E-03 0.09913614 FRASOR_RESPONSE_TO_ESTRADIOL_DN endometrial cancer DOID_1380 1.497E-05 2.13E-03 1.045E-03 0.08497384 FRASOR_RESPONSE_TO_ESTRADIOL_DN uterine cancer DOID_363 4.005E-05 4.558E-03 1.991E-03 0.10299245 FRASOR_RESPONSE_TO_ESTRADIOL_DN bile duct adenocarcinoma DOID_4896 7.156E-05 6.786E-03 2.913E-03 0.10361113 FRASOR_RESPONSE_TO_ESTRADIOL_DN cholangiocarcinoma DOID_4947 7.156E-05 6.786E-03 2.913E-03 0.10361113 FRASOR_RESPONSE_TO_ESTRADIOL_DN bile duct cancer DOID_4606 8.767E-05 7.127E-03 3.329E-03 0.11141538 FRASOR_RESPONSE_TO_ESTRADIOL_DN bile duct carcinoma DOID_4897 8.767E-05 7.127E-03 3.329E-03 0.11141538 FRASOR_RESPONSE_TO_ESTRADIOL_DN pancreatic ductal carcinoma DOID_3587 1.497E-04 0.01064956 4.729E-03 0.14950226 FRASOR_RESPONSE_TO_ESTRADIOL_DN pancreatic carcinoma DOID_4905 1.687E-04 0.01066809 5.115E-03 0.15318808 FRASOR_RESPONSE_TO_ESTRADIOL_DN biliary tract cancer DOID_4607 2.35E-04 0.01337039 6.356E-03 0.15725068 FRASOR_RESPONSE_TO_ESTRADIOL_DN schizophreniform disorder DOID_11328 2.573E-04 0.01330997 2.573E-04 0.07320485 FRASOR_RESPONSE_TO_ESTRADIOL_DN schizoaffective disorder DOID_5418 2.573E-04 0.01330997 2.573E-04 0.07320485 FRASOR_RESPONSE_TO_ESTRADIOL_DN transitional cell carcinoma DOID_2671 2.781E-04 0.01318745 7.099E-03 0.16831023 FRASOR_RESPONSE_TO_ESTRADIOL_DN Goodpasture syndrome DOID_9808 5.189E-04 0.02271294 5.189E-04 0.09842275 FRASOR_RESPONSE_TO_ESTRADIOL_DN myositis DOID_633 6.582E-04 0.02674978 6.582E-04 0.09362423 FRASOR_RESPONSE_TO_ESTRADIOL_DN chronic leukemia DOID_1036 1.108E-03 0.04202015 1.108E-03 0.07878778 FRASOR_RESPONSE_TO_ESTRADIOL_DN chronic lymphocytic leukemia DOID_1040 1.108E-03 0.04202015 1.108E-03 0.07878778 FRASOR_RESPONSE_TO_ESTRADIOL_DN leiomyoma DOID_127 1.108E-03 0.03939389 1.108E-03 0.07003358 FRASOR_RESPONSE_TO_ESTRADIOL_DN diabetic autonomic neuropathy DOID_11503 1.991E-03 0.06664217 1.991E-03 0.1132917 FRASOR_RESPONSE_TO_ESTRADIOL_DN autonomic neuropathy DOID_11504 1.991E-03 0.06664217 1.991E-03 0.1132917 FRASOR_RESPONSE_TO_ESTRADIOL_DN diabetic polyneuropathy DOID_12785 1.991E-03 0.06664217 1.991E-03 0.1132917 FRASOR_RESPONSE_TO_ESTRADIOL_DN diabetic neuropathy DOID_9743 1.991E-03 0.06664217 1.991E-03 0.1132917 FRASOR_RESPONSE_TO_ESTRADIOL_DN pre-eclampsia DOID_10591 2.25E-03 0.07113313 0.06760127 0.41809919 FRASOR_RESPONSE_TO_ESTRADIOL_DN autonomic nervous system disease DOID_11465 2.25E-03 0.06738928 2.25E-03 0.1066997 FRASOR_RESPONSE_TO_ESTRADIOL_DN glaucoma DOID_1686 2.431E-03 0.0691745 2.431E-03 0.1064223 FRASOR_RESPONSE_TO_ESTRADIOL_DN lung small cell carcinoma DOID_5409 2.431E-03 0.06588047 0.07020993 0.41614012 FRASOR_RESPONSE_TO_ESTRADIOL_DN aortic aneurysm DOID_3627 2.525E-03 0.06529368 2.525E-03 0.10260436 FRASOR_RESPONSE_TO_ESTRADIOL_DN orofacial cleft DOID_0050567 2.716E-03 0.06718427 2.716E-03 0.10301588 FRASOR_RESPONSE_TO_ESTRADIOL_DN giant cell tumor DOID_200 2.814E-03 0.06670996 0.07540578 0.43781521 FRASOR_RESPONSE_TO_ESTRADIOL_DN malignant giant cell tumor DOID_2705 2.814E-03 0.06670996 0.07540578 0.43781521 FRASOR_RESPONSE_TO_ESTRADIOL_DN giant cell glioblastoma DOID_3074 2.814E-03 0.06670996 0.07540578 0.43781521 FRASOR_RESPONSE_TO_ESTRADIOL_DN glioblastoma DOID_3068 3.329E-03 0.07576246 0.08186055 0.44360622 FRASOR_RESPONSE_TO_ESTRADIOL_DN neuroectodermal tumor DOID_171 3.657E-03 0.08003826 0.08571217 0.45157614 FRASOR_RESPONSE_TO_ESTRADIOL_DN astrocytoma DOID_3069 4.604E-03 0.09702399 0.09590581 0.47043454 ZHAN_MULTIPLE_MYELOMA_UP primitive neuroectodermal tumor DOID_168 3.774E-06 2.147E-03 4.245E-04 0.24152343 ZHAN_MULTIPLE_MYELOMA_UP gallbladder cancer DOID_3121 4.029E-06 1.146E-03 0.03054643 0.44566461 ZHAN_MULTIPLE_MYELOMA_UP neuroectodermal tumor DOID_171 1.028E-05 1.949E-03 8.208E-04 0.23351891 ZHAN_MULTIPLE_MYELOMA_UP biliary tract cancer DOID_4607 2.414E-05 3.434E-03 0.05458666 0.60901592 ZHAN_MULTIPLE_MYELOMA_UP papilloma DOID_2615 2.594E-04 0.0295219 0.0234786 0.49478978 ZHAN_MULTIPLE_MYELOMA_UP medullomyoblastoma DOID_3861 2.892E-04 0.02743007 0.02476733 0.45460035 ZHAN_MULTIPLE_MYELOMA_UP adult medulloblastoma DOID_3864 2.892E-04 0.02743007 0.02476733 0.45460035 ZHAN_MULTIPLE_MYELOMA_UP childhood medulloblastoma DOID_3869 2.892E-04 0.02743007 0.02476733 0.45460035 ZHAN_MULTIPLE_MYELOMA_UP medulloblastoma DOID_3858 3.207E-04 0.02606564 0.02605443 0.46328026 ZHAN_MULTIPLE_MYELOMA_UP peripheral nervous system neoplasm DOID_1192 3.37E-04 0.02396736 0.02669736 0.46032724 ZHAN_MULTIPLE_MYELOMA_UP bile duct adenocarcinoma DOID_4896 6.516E-04 0.04119833 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_UP cholangiocarcinoma DOID_4947 6.516E-04 0.04119833 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_UP bile duct cancer DOID_4606 7.46E-04 0.04244619 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_UP bile duct carcinoma DOID_4897 7.46E-04 0.04244619 1.000 1.000 ZHAN_MULTIPLE_MYELOMA_UP pre-malignant neoplasm DOID_0060071 8.726E-04 0.04513832 8.726E-04 0.16550718 ZHAN_MULTIPLE_MYELOMA_UP in situ carcinoma DOID_8719 8.726E-04 0.04513832 8.726E-04 0.16550718 ZHAN_MULTIPLE_MYELOMA_UP chromosomal disease DOID_0080014 1.375E-03 0.06519456 1.375E-03 0.19558367 ZHAN_MULTIPLE_MYELOMA_UP transitional cell carcinoma DOID_2671 1.614E-03 0.07062576 1.614E-03 0.18362697 ZHAN_MULTIPLE_MYELOMA_UP nervous system cancer DOID_3093 1.685E-03 0.06848961 0.05895225 0.64507368 ZHAN_MULTIPLE_MYELOMA_UP carbohydrate metabolic disorder DOID_2978 1.795E-03 0.06810173 1.795E-03 0.17025432 SWEET_KRAS_TARGETS_UP osteochondrodysplasia DOID_2256 5.111E-10 2.908E-07 1.148E-04 0.03266703 SWEET_KRAS_TARGETS_UP bone development disease DOID_0080006 5.733E-09 1.631E-06 3.688E-04 0.02998053 SWEET_KRAS_TARGETS_UP nephrotic syndrome DOID_1184 1.188E-08 2.254E-06 5.727E-05 0.03258661 SWEET_KRAS_TARGETS_UP nephrosis DOID_2527 1.349E-07 1.919E-05 2.368E-04 0.03369191 SWEET_KRAS_TARGETS_UP osteogenesis imperfecta DOID_12347 1.121E-06 1.275E-04 0.02071991 0.38031053 SWEET_KRAS_TARGETS_UP multiple epiphyseal dysplasia DOID_12721 1.725E-05 1.636E-03 1.149E-03 0.07264914 SWEET_KRAS_TARGETS_UP multiple myeloma DOID_9538 3.753E-05 3.051E-03 0.06241352 0.51468543 SWEET_KRAS_TARGETS_UP myeloma DOID_0070004 7.361E-05 5.235E-03 0.0774083 0.5575357 SWEET_KRAS_TARGETS_UP autonomic nervous system disease DOID_11465 7.361E-05 4.654E-03 0.0774083 0.5505665 SWEET_KRAS_TARGETS_UP heart valve disease DOID_4079 7.361E-05 4.188E-03 1.000 1.000 SWEET_KRAS_TARGETS_UP aortic aneurysm DOID_3627 8.767E-05 4.535E-03 0.08186055 0.54798416 SWEET_KRAS_TARGETS_UP bone marrow cancer DOID_4960 1.09E-04 5.169E-03 0.08776403 0.58067133 SWEET_KRAS_TARGETS_UP oral cavity cancer DOID_8618 1.335E-04 5.842E-03 1.335E-04 0.0253145 SWEET_KRAS_TARGETS_UP collagen disease DOID_854 1.54E-04 6.258E-03 0.09800541 0.60614218 SWEET_KRAS_TARGETS_UP aortic valve insufficiency DOID_57 1.663E-04 6.31E-03 1.000 1.000 SWEET_KRAS_TARGETS_UP congenital heart defect DOID_1682 1.687E-04 6.001E-03 0.10091069 0.61739984 SWEET_KRAS_TARGETS_UP brain infarction DOID_3454 2.095E-04 7.014E-03 0.10813368 0.64091735 SWEET_KRAS_TARGETS_UP Ehlers-Danlos syndrome DOID_13359 2.638E-04 8.339E-03 0.02386988 0.41157454 SWEET_KRAS_TARGETS_UP bone resorption disease DOID_0080011 2.873E-04 8.603E-03 7.246E-03 0.20614244 SWEET_KRAS_TARGETS_UP osteoporosis DOID_11476 2.873E-04 8.603E-03 7.246E-03 0.20614244 SWEET_KRAS_TARGETS_UP aneurysm disease DOID_2403 2.873E-04 8.173E-03 0.11957192 0.67362794 SWEET_KRAS_TARGETS_UP tongue cancer DOID_8649 3.012E-04 8.161E-03 3.012E-04 0.03427506 SWEET_KRAS_TARGETS_UP familial hypertrophic cardiomyopathy DOID_11986 3.41E-04 8.819E-03 3.41E-04 0.03233736 SWEET_KRAS_TARGETS_UP ureteral obstruction DOID_5199 3.832E-04 9.48E-03 1.000 1.000 SWEET_KRAS_TARGETS_UP brain edema DOID_4724 4.749E-04 0.01125924 4.749E-04 0.03377772 SWEET_KRAS_TARGETS_UP autoimmune hepatitis DOID_2048 5.244E-04 0.01193428 0.03326011 0.47312511 SWEET_KRAS_TARGETS_UP dilated cardiomyopathy DOID_12930 5.247E-04 0.01148355 0.01074902 0.26592132 SWEET_KRAS_TARGETS_UP uremia DOID_4676 6.304E-04 0.01328537 0.0363704 0.50475022 SWEET_KRAS_TARGETS_UP urinary tract obstruction DOID_5200 6.304E-04 0.0128109 1.000 1.000 SWEET_KRAS_TARGETS_UP ureteral disease DOID_1426 6.87E-04 0.01347964 1.000 1.000 SWEET_KRAS_TARGETS_UP aortic valve disease DOID_62 6.87E-04 0.01303032 1.000 1.000 SWEET_KRAS_TARGETS_UP spastic quadriplegia DOID_10970 7.46E-04 0.01369232 0.03947085 0.53473603 SWEET_KRAS_TARGETS_UP middle cerebral artery infarction DOID_3525 9.37E-04 0.01666136 0.04410313 0.51213635 SWEET_KRAS_TARGETS_UP focal glomerulosclerosis DOID_3945 1.149E-03 0.0198134 0.04871344 0.4778956 SWEET_KRAS_TARGETS_UP corneal disease DOID_10124 1.224E-03 0.02049148 1.224E-03 0.06967104 SWEET_KRAS_TARGETS_UP spastic cerebral palsy DOID_0050669 1.302E-03 0.02116836 0.05177482 0.49099783 SWEET_KRAS_TARGETS_UP abdominal aortic aneurysm DOID_7693 1.302E-03 0.02058035 0.05177482 0.48294868 SWEET_KRAS_TARGETS_UP calcinosis DOID_182 1.91E-03 0.02936771 1.000 1.000 SWEET_KRAS_TARGETS_UP systemic scleroderma DOID_418 2.104E-03 0.03149916 1.000 1.000 SWEET_KRAS_TARGETS_UP intracranial arterial disease DOID_13089 2.204E-03 0.03215538 0.06693695 0.52898783 SWEET_KRAS_TARGETS_UP cerebral arterial disease DOID_3527 2.204E-03 0.03215538 0.06693695 0.52898783 SWEET_KRAS_TARGETS_UP cervix uteri carcinoma in situ DOID_8991 2.307E-03 0.0328105 2.307E-03 0.11931092 SWEET_KRAS_TARGETS_UP rheumatic disease DOID_1575 2.518E-03 0.03494949 1.000 1.000 SWEET_KRAS_TARGETS_UP scleroderma DOID_419 2.518E-03 0.03494949 1.000 1.000 SWEET_KRAS_TARGETS_UP diabetic autonomic neuropathy DOID_11503 2.628E-03 0.03559689 0.07293481 0.55333206 SWEET_KRAS_TARGETS_UP autonomic neuropathy DOID_11504 2.628E-03 0.03559689 0.07293481 0.55333206 SWEET_KRAS_TARGETS_UP diabetic polyneuropathy DOID_12785 2.628E-03 0.03559689 0.07293481 0.55333206 SWEET_KRAS_TARGETS_UP diabetic neuropathy DOID_9743 2.628E-03 0.03559689 0.07293481 0.55333206 SWEET_KRAS_TARGETS_UP cerebral infarction DOID_3526 2.739E-03 0.0362433 0.07442833 0.54999639 SWEET_KRAS_TARGETS_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.206E-03 0.04146523 0.08037882 0.55775059 SWEET_KRAS_TARGETS_UP pulmonary tuberculosis DOID_2957 3.206E-03 0.04054378 0.08037882 0.5510307 SWEET_KRAS_TARGETS_UP calcium metabolism disease DOID_10575 3.329E-03 0.04117525 1.000 1.000 SWEET_KRAS_TARGETS_UP vasculitis DOID_865 3.839E-03 0.04648224 1.000 1.000 SWEET_KRAS_TARGETS_UP parasitic protozoa infectious disease DOID_2789 3.973E-03 0.04709074 0.08923406 0.58361126 SWEET_KRAS_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 4.384E-03 0.05091139 4.384E-03 0.20788816 SWEET_KRAS_TARGETS_UP melancholia DOID_2848 4.526E-03 0.05150312 4.526E-03 0.19808893 SWEET_KRAS_TARGETS_UP neurotic disorder DOID_4964 4.669E-03 0.05209503 4.669E-03 0.18977474 SWEET_KRAS_TARGETS_UP carotid artery disease DOID_3407 4.815E-03 0.05268702 0.09800541 0.61280308 SWEET_KRAS_TARGETS_UP pre-malignant neoplasm DOID_0060071 5.113E-03 0.05488737 5.113E-03 0.19393537 SWEET_KRAS_TARGETS_UP in situ carcinoma DOID_8719 5.113E-03 0.05488737 5.113E-03 0.19393537 SWEET_KRAS_TARGETS_UP mineral metabolism disease DOID_0050032 5.264E-03 0.0554713 1.000 1.000 SWEET_KRAS_TARGETS_UP cholestasis DOID_13580 5.418E-03 0.05605532 0.10380677 0.62836225 SWEET_KRAS_TARGETS_UP parasitic infectious disease DOID_1398 5.418E-03 0.05505433 0.10380677 0.62174791 SWEET_KRAS_TARGETS_UP hyperglycemia DOID_4195 5.574E-03 0.05564567 5.574E-03 0.19823771 SWEET_KRAS_TARGETS_UP tuberculosis DOID_399 5.892E-03 0.05780717 0.10813368 0.63430996 SWEET_KRAS_TARGETS_UP pancreatic ductal carcinoma DOID_3587 6.219E-03 0.05997386 6.219E-03 0.20814456 SWEET_KRAS_TARGETS_UP bile duct disease DOID_4138 6.385E-03 0.06055007 0.11244005 0.65284069 SWEET_KRAS_TARGETS_UP peripheral vascular disease DOID_341 6.553E-03 0.06112618 0.11387095 0.65447043 SWEET_KRAS_TARGETS_UP biliary tract disease DOID_9741 6.553E-03 0.06014028 0.11387095 0.64792573 SWEET_KRAS_TARGETS_UP pancreatic carcinoma DOID_4905 6.723E-03 0.06072272 6.723E-03 0.21252954 SWEET_KRAS_TARGETS_UP endogenous depression DOID_1595 7.07E-03 0.0628533 7.07E-03 0.21171639 SWEET_KRAS_TARGETS_UP metabolic syndrome X DOID_14221 7.786E-03 0.06815857 0.12382395 0.69074342 SWEET_KRAS_TARGETS_UP mental depression DOID_1596 8.344E-03 0.07193644 8.344E-03 0.22608595 SWEET_KRAS_TARGETS_UP chronic kidney failure DOID_784 8.344E-03 0.07086276 1.000 1.000 SWEET_KRAS_TARGETS_UP primary bacterial infectious disease DOID_0050338 9.115E-03 0.07627322 0.13366697 0.72434768 SWEET_KRAS_TARGETS_UP amino acid metabolic disorder DOID_9252 9.512E-03 0.07844228 9.512E-03 0.24602352 SWEET_KRAS_TARGETS_UP Human immunodeficiency virus infectious disease DOID_526 9.714E-03 0.07895874 0.13785204 0.72627601 SWEET_KRAS_TARGETS_UP encephalomyelitis DOID_640 0.01032927 0.08277961 0.14201722 0.72799816 SWEET_KRAS_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.01053821 0.0832811 0.14340121 0.72852934 SWEET_KRAS_TARGETS_UP Crohn's disease DOID_8778 0.01053821 0.08214027 0.14340121 0.72208218 LEONARD_HYPOXIA respiratory failure DOID_11162 2.085E-07 1.186E-04 1.221E-03 0.09922463 LEONARD_HYPOXIA adenoma DOID_657 4.008E-06 1.14E-03 4.405E-04 0.08354126 LEONARD_HYPOXIA myeloma DOID_0070004 8.546E-06 1.621E-03 7.242E-04 0.08241787 LEONARD_HYPOXIA bone marrow cancer DOID_4960 1.271E-05 1.808E-03 9.403E-04 0.08917494 LEONARD_HYPOXIA nephrosis DOID_2527 2.791E-05 3.176E-03 2.791E-05 0.01587802 LEONARD_HYPOXIA Leydig cell tumor DOID_2696 4.696E-05 4.454E-03 0.01024016 0.34274427 LEONARD_HYPOXIA sex cord-stromal neoplasm DOID_4757 4.696E-05 4.454E-03 0.01024016 0.34274427 LEONARD_HYPOXIA pulmonary edema DOID_11396 1.14E-04 9.267E-03 0.01571203 0.40637035 LEONARD_HYPOXIA funisitis DOID_0050698 1.385E-04 9.848E-03 1.385E-04 0.03939292 LEONARD_HYPOXIA muscular atrophy DOID_767 1.385E-04 8.754E-03 0.01727005 0.40944405 LEONARD_HYPOXIA sinusitis DOID_0050127 1.516E-04 8.625E-03 0.01804816 0.39497704 LEONARD_HYPOXIA paranasal sinus disease DOID_1352 1.516E-04 8.625E-03 0.01804816 0.39497704 LEONARD_HYPOXIA portal hypertension DOID_10762 1.944E-04 0.01005708 0.02037893 0.36236277 LEONARD_HYPOXIA hepatic vascular disease DOID_272 2.597E-04 0.01231501 0.02347829 0.35155657 LEONARD_HYPOXIA pulmonary sarcoidosis DOID_13406 4.634E-04 0.02028345 1.000 1.000 LEONARD_HYPOXIA multiple myeloma DOID_9538 4.634E-04 0.01883463 0.0311853 0.40328269 LEONARD_HYPOXIA systemic scleroderma DOID_418 5.11E-04 0.01938542 1.000 1.000 LEONARD_HYPOXIA adult respiratory distress syndrome DOID_11394 5.357E-04 0.01905099 0.03348592 0.39694766 LEONARD_HYPOXIA benign mesothelioma DOID_2645 5.609E-04 0.01877494 1.000 1.000 LEONARD_HYPOXIA cervix uteri carcinoma in situ DOID_8991 5.609E-04 0.01773189 1.000 1.000 LEONARD_HYPOXIA nephrotic syndrome DOID_1184 6.131E-04 0.01836099 6.131E-04 0.08721469 LEONARD_HYPOXIA rheumatic disease DOID_1575 6.131E-04 0.01744294 1.000 1.000 LEONARD_HYPOXIA scleroderma DOID_419 6.131E-04 0.01744294 1.000 1.000 LEONARD_HYPOXIA gallbladder cancer DOID_3121 6.4E-04 0.01734212 0.03654519 0.40772968 LEONARD_HYPOXIA cataract DOID_83 6.675E-04 0.01726508 0.03730855 0.40053891 LEONARD_HYPOXIA learning disability DOID_8927 6.675E-04 0.01651443 0.03730855 0.39312153 LEONARD_HYPOXIA pre-eclampsia DOID_10591 7.242E-04 0.01717039 0.0388335 0.40175021 LEONARD_HYPOXIA lens disease DOID_110 7.242E-04 0.01648357 0.0388335 0.3945761 LEONARD_HYPOXIA glaucoma DOID_1686 7.832E-04 0.01713952 1.000 1.000 LEONARD_HYPOXIA sarcoidosis DOID_11335 9.078E-04 0.01913073 1.000 1.000 LEONARD_HYPOXIA reproductive organ benign neoplasm DOID_0050622 9.734E-04 0.01978165 0.04491 0.41891461 LEONARD_HYPOXIA hypersensitivity reaction type IV disease DOID_2916 1.076E-03 0.02111352 1.000 1.000 LEONARD_HYPOXIA collagen disease DOID_854 1.184E-03 0.02245106 1.000 1.000 LEONARD_HYPOXIA pre-malignant neoplasm DOID_0060071 1.258E-03 0.02309439 1.000 1.000 LEONARD_HYPOXIA in situ carcinoma DOID_8719 1.258E-03 0.02309439 1.000 1.000 LEONARD_HYPOXIA uterine disease DOID_345 1.335E-03 0.02373657 0.05245342 0.44546265 LEONARD_HYPOXIA temporal lobe epilepsy DOID_3328 1.374E-03 0.02369272 1.000 1.000 LEONARD_HYPOXIA allergic contact dermatitis DOID_3042 1.414E-03 0.0236606 1.414E-03 0.10055757 LEONARD_HYPOXIA pancreatic ductal carcinoma DOID_3587 1.536E-03 0.02497498 1.000 1.000 LEONARD_HYPOXIA peripheral vascular disease DOID_341 1.621E-03 0.02561426 0.05769952 0.45598645 LEONARD_HYPOXIA pancreatic carcinoma DOID_4905 1.664E-03 0.02558298 1.000 1.000 LEONARD_HYPOXIA diabetic retinopathy DOID_8947 1.664E-03 0.02490975 0.05844666 0.44940744 LEONARD_HYPOXIA pancreatitis DOID_4989 1.841E-03 0.02685824 1.841E-03 0.11638573 LEONARD_HYPOXIA contact dermatitis DOID_2773 1.933E-03 0.02749398 1.933E-03 0.10997593 LEONARD_HYPOXIA female reproductive system disease DOID_229 1.98E-03 0.02747221 0.06366067 0.458518 LEONARD_HYPOXIA focal epilepsy DOID_2234 2.075E-03 0.02810659 1.000 1.000 LEONARD_HYPOXIA biliary tract cancer DOID_4607 2.075E-03 0.02745295 0.06514526 0.46334563 LEONARD_HYPOXIA retinal vascular disease DOID_2462 2.172E-03 0.02808652 0.06662756 0.46233029 LEONARD_HYPOXIA nervous system cancer DOID_3093 2.424E-03 0.03065378 0.0703234 0.48209656 LEONARD_HYPOXIA carbohydrate metabolic disorder DOID_2978 2.582E-03 0.03193903 2.582E-03 0.13356323 LEONARD_HYPOXIA encephalomyelitis DOID_640 2.582E-03 0.03125948 1.000 1.000 LEONARD_HYPOXIA alcohol-related neurodevelopmental disorder DOID_0050667 2.636E-03 0.03124415 2.636E-03 0.12497659 LEONARD_HYPOXIA retinal vascular occlusion DOID_1729 7.886E-03 0.09157514 1.000 1.000 LEONARD_HYPOXIA rectal neoplasm DOID_1984 7.886E-03 0.08974363 1.000 1.000 LEONARD_HYPOXIA rectum cancer DOID_1993 7.886E-03 0.08974363 1.000 1.000 LEONARD_HYPOXIA acute kidney failure DOID_3021 7.886E-03 0.08798395 7.886E-03 0.34516782 LEONARD_HYPOXIA insulinoma DOID_3892 7.886E-03 0.08629196 7.886E-03 0.32051298 LEONARD_HYPOXIA hypokalemia DOID_4500 7.886E-03 0.08466381 1.000 1.000 LEONARD_HYPOXIA keratitis DOID_4677 7.886E-03 0.08309596 1.000 1.000 LEONARD_HYPOXIA pneumocystosis DOID_11339 8.671E-03 0.08970934 1.000 1.000 LEONARD_HYPOXIA otitis media DOID_10754 9.456E-03 0.09608043 1.000 1.000 LEONARD_HYPOXIA pituitary cancer DOID_1785 9.456E-03 0.09439481 1.000 1.000 LEONARD_HYPOXIA islet cell tumor DOID_1799 9.456E-03 0.09276731 9.456E-03 0.35870027 LEONARD_HYPOXIA pituitary carcinoma DOID_4916 9.456E-03 0.09439481 1.000 1.000 LEONARD_HYPOXIA middle ear disease DOID_5100 9.456E-03 0.09608043 1.000 1.000 LEONARD_HYPOXIA ocular hypertension DOID_9282 9.456E-03 0.09119498 1.000 1.000 LEONARD_HYPOXIA borderline glaucoma DOID_9283 9.456E-03 0.09119498 1.000 1.000 LEONARD_HYPOXIA newborn respiratory distress syndrome DOID_12716 0.01024016 0.09711088 0.01024016 0.36416579 LEONARD_HYPOXIA intracranial thrombosis DOID_4193 0.01024016 0.0955189 0.01024016 0.32370292 ALONSO_METASTASIS_EMT_UP aneurysm disease DOID_2403 2.136E-07 1.216E-04 1.247E-03 0.10135037 ALONSO_METASTASIS_EMT_UP intracranial aneurysm DOID_10941 8.208E-07 2.335E-04 0.01830732 0.28935734 ALONSO_METASTASIS_EMT_UP carotid artery disease DOID_3407 1.028E-05 1.949E-03 8.208E-04 0.11675945 ALONSO_METASTASIS_EMT_UP dilated cardiomyopathy DOID_12930 3.585E-05 5.099E-03 1.871E-03 0.13304561 ALONSO_METASTASIS_EMT_UP membranoproliferative glomerulonephritis DOID_2920 4.361E-05 4.962E-03 4.361E-05 0.02481134 ALONSO_METASTASIS_EMT_UP pulmonary embolism DOID_9477 1.047E-04 9.932E-03 0.01506193 0.31741618 ALONSO_METASTASIS_EMT_UP abdominal aortic aneurysm DOID_7693 2.177E-04 0.01769442 0.02154244 0.2918488 ALONSO_METASTASIS_EMT_UP uveitis DOID_13141 3.37E-04 0.02396736 3.37E-04 0.09586943 ALONSO_METASTASIS_EMT_UP respiratory syncytial virus infectious disease DOID_1273 3.537E-04 0.0223605 0.02733989 0.31747751 ALONSO_METASTASIS_EMT_UP uveal disease DOID_3480 4.245E-04 0.02415234 4.245E-04 0.08050781 ALONSO_METASTASIS_EMT_UP diabetic autonomic neuropathy DOID_11503 4.432E-04 0.02292327 0.03054643 0.31037357 ALONSO_METASTASIS_EMT_UP autonomic neuropathy DOID_11504 4.432E-04 0.02292327 0.03054643 0.31037357 ALONSO_METASTASIS_EMT_UP diabetic polyneuropathy DOID_12785 4.432E-04 0.02292327 0.03054643 0.31037357 ALONSO_METASTASIS_EMT_UP diabetic neuropathy DOID_9743 4.432E-04 0.02292327 0.03054643 0.31037357 ALONSO_METASTASIS_EMT_UP autonomic nervous system disease DOID_11465 5.016E-04 0.02378329 0.03246548 0.31849758 ALONSO_METASTASIS_EMT_UP aortic aneurysm DOID_3627 5.635E-04 0.02466588 0.03438089 0.3207004 ALONSO_METASTASIS_EMT_UP giant cell tumor DOID_200 6.29E-04 0.02556568 1.000 1.000 ALONSO_METASTASIS_EMT_UP malignant giant cell tumor DOID_2705 6.29E-04 0.02556568 1.000 1.000 ALONSO_METASTASIS_EMT_UP giant cell glioblastoma DOID_3074 6.29E-04 0.02556568 1.000 1.000 ALONSO_METASTASIS_EMT_UP glioblastoma DOID_3068 7.46E-04 0.02829746 1.000 1.000 ALONSO_METASTASIS_EMT_UP parasitic infectious disease DOID_1398 9.26E-04 0.03293016 1.000 1.000 ALONSO_METASTASIS_EMT_UP endocrine organ benign neoplasm DOID_0060089 1.009E-03 0.03376849 1.009E-03 0.11481285 ALONSO_METASTASIS_EMT_UP astrocytoma DOID_3069 1.037E-03 0.03279043 1.000 1.000 ALONSO_METASTASIS_EMT_UP nephrosis DOID_2527 1.095E-03 0.0328004 1.095E-03 0.10386794 ALONSO_METASTASIS_EMT_UP pancreatitis DOID_4989 1.278E-03 0.03636751 0.05145649 0.39565869 ALONSO_METASTASIS_EMT_UP transitional cell carcinoma DOID_2671 1.614E-03 0.04372071 1.000 1.000 ALONSO_METASTASIS_EMT_UP encephalomyelitis DOID_640 1.795E-03 0.046433 0.06081729 0.44365432 YANG_BREAST_CANCER_ESR1_UP larynx cancer DOID_2596 3.242E-05 0.01844619 8.54E-03 0.37379881 YANG_BREAST_CANCER_ESR1_UP laryngeal benign neoplasm DOID_2598 3.242E-05 0.01844619 8.54E-03 0.37379881 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN contact dermatitis DOID_2773 1.089E-07 6.198E-05 1.089E-07 6.198E-05 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN primary bacterial infectious disease DOID_0050338 1.78E-07 5.064E-05 1.919E-03 0.06423457 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN Human immunodeficiency virus infectious disease DOID_526 2.17E-07 4.115E-05 0.02658429 0.32883614 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN encephalomyelitis DOID_640 2.627E-07 3.737E-05 1.404E-04 7.991E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN lingual-facial-buccal dyskinesia DOID_9854 4.545E-07 5.173E-05 4.545E-07 1.293E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN fragments of torsion dystonia DOID_531 1.04E-06 9.862E-05 1.04E-06 1.972E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN malaria DOID_12365 1.386E-06 1.127E-04 7.715E-05 4.877E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN central nervous system hereditary degenerative disease DOID_481 1.386E-06 9.859E-05 1.386E-06 1.972E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN allergic contact dermatitis DOID_3042 1.481E-06 9.363E-05 1.481E-06 1.685E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN dystonic disease DOID_544 1.588E-06 9.036E-05 1.588E-06 1.506E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN uveitis DOID_13141 5.005E-06 2.589E-04 0.10657068 0.54629473 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN Crohn's disease DOID_8778 7.069E-06 3.352E-04 2.381E-03 0.06452246 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN uveal disease DOID_3480 7.98E-06 3.493E-04 0.11877197 0.56790965 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN learning disability DOID_8927 9.475E-06 3.851E-04 9.475E-06 7.702E-04 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN movement disease DOID_480 1.411E-05 5.352E-04 1.411E-05 1.004E-03 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN hemorrhagic disease DOID_2213 1.521E-05 5.408E-04 9.72E-03 0.17840616 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN prion disease DOID_649 1.588E-05 5.315E-04 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN parasitic protozoa infectious disease DOID_2789 2.023E-05 6.395E-04 5.545E-04 0.02427092 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN oral cavity cancer DOID_8618 2.473E-05 7.405E-04 0.01227651 0.20545106 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN parasitic infectious disease DOID_1398 3.802E-05 1.082E-03 8.829E-04 0.0358848 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN tuberculosis DOID_399 4.508E-05 1.221E-03 0.17734647 0.68646353 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN blood coagulation disease DOID_1247 5.028E-05 1.301E-03 0.01725911 0.25843239 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN nephrosis DOID_2527 5.305E-05 1.312E-03 0.01770718 0.25834317 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN nervous system cancer DOID_3093 1.24E-04 2.941E-03 0.22355666 0.80002352 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.462E-04 3.328E-03 0.23206252 0.8150838 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN hypersensitivity reaction type I disease DOID_1205 1.522E-04 3.331E-03 0.02930997 0.33354748 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN multiple myeloma DOID_9538 1.84E-04 3.878E-03 0.10411042 0.54347548 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN adenoid cystic carcinoma DOID_4866 2.285E-04 4.643E-03 0.11147114 0.55637789 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN salivary gland cancer DOID_8850 2.617E-04 5.135E-03 0.11634498 0.57565475 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN nephrotic syndrome DOID_1184 2.794E-04 5.299E-03 7.131E-03 0.15027434 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN interstitial nephritis DOID_1063 3.306E-04 6.068E-03 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN teratoma DOID_3307 3.306E-04 5.879E-03 0.02709967 0.32124396 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN malignant teratoma DOID_5563 3.306E-04 5.879E-03 0.02709967 0.32124396 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN mature teratoma DOID_5566 3.306E-04 5.879E-03 0.02709967 0.32124396 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN proteinuria DOID_576 3.371E-04 5.812E-03 0.12601337 0.58771811 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN myeloma DOID_0070004 3.579E-04 5.989E-03 0.12841406 0.59404551 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN pre-eclampsia DOID_10591 3.579E-04 5.818E-03 8.38E-03 0.16442084 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN integumentary system benign neoplasm DOID_0060121 4.019E-04 6.353E-03 4.019E-04 0.02079079 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN pulmonary tuberculosis DOID_2957 4.019E-04 6.181E-03 0.13319584 0.59209715 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN skin benign neoplasm DOID_3165 4.019E-04 6.353E-03 4.019E-04 0.02079079 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN bile duct adenocarcinoma DOID_4896 5.269E-04 7.889E-03 0.14503694 0.62519712 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN cholangiocarcinoma DOID_4947 5.269E-04 7.889E-03 0.14503694 0.62519712 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN bone marrow cancer DOID_4960 5.269E-04 7.687E-03 0.14503694 0.62049639 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN integumentary system cancer DOID_0060122 5.545E-04 7.888E-03 5.545E-04 0.02629349 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN skin cancer DOID_4159 5.545E-04 7.888E-03 5.545E-04 0.02629349 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN bile duct cancer DOID_4606 6.429E-04 8.923E-03 0.15439436 0.63201718 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN bile duct carcinoma DOID_4897 6.429E-04 8.923E-03 0.15439436 0.63201718 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN hemangioma DOID_255 7.646E-04 0.0103581 0.04037546 0.38938365 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN peripheral vascular disease DOID_341 1.173E-03 0.01552476 0.01816016 0.2583283 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN diabetic retinopathy DOID_8947 1.219E-03 0.01576413 0.01861803 0.25838194 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN coronary restenosis DOID_4247 1.513E-03 0.0191286 0.05606976 0.41978545 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN alcohol abuse DOID_1574 1.682E-03 0.02081065 1.682E-03 0.06381931 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN biliary tract cancer DOID_4607 1.682E-03 0.02036787 0.2084463 0.75545186 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN retinal vascular disease DOID_2462 1.798E-03 0.02131776 0.02396852 0.30995653 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN opiate dependence DOID_2559 1.816E-03 0.0210886 1.816E-03 0.06458383 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN meningitis DOID_9471 1.978E-03 0.02250536 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN Goodpasture syndrome DOID_9808 1.978E-03 0.02206408 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN amino acid metabolic disorder DOID_9252 2.045E-03 0.02237568 2.045E-03 0.06464087 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN lymphoma DOID_0060058 2.243E-03 0.0240796 0.02766157 0.32121291 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN lymphoblastic leukemia DOID_1037 2.311E-03 0.02435609 0.22994475 0.81774102 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN organic acidemia DOID_0060159 2.32E-03 0.02400576 2.32E-03 0.06949035 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN urticaria DOID_1555 2.32E-03 0.02357708 0.06895396 0.46708098 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN osteosarcoma DOID_3347 2.32E-03 0.02316345 2.32E-03 0.06601583 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN spinal cord disease DOID_319 2.689E-03 0.02638195 2.689E-03 0.06955242 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN diffuse large B-cell lymphoma DOID_0050745 2.883E-03 0.0278062 2.883E-03 0.07132895 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN gestational diabetes DOID_11714 2.883E-03 0.02734276 2.883E-03 0.06835691 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN lung adenocarcinoma DOID_3910 2.883E-03 0.02689452 0.07660071 0.48428673 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN perinatal necrotizing enterocolitis DOID_8677 2.883E-03 0.02646074 0.07660071 0.4789649 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN autoimmune disease of cardiovascular system DOID_0060051 3.084E-03 0.02785101 0.07913578 0.48943761 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN Behcet's disease DOID_13241 3.084E-03 0.02785101 0.07913578 0.48943761 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN thrombocytopenia DOID_1588 3.084E-03 0.02741584 0.07913578 0.48417484 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN coronary stenosis DOID_4248 3.084E-03 0.02699406 0.07913578 0.47398169 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN autoimmune disease of the nervous system DOID_438 3.084E-03 0.02658505 0.07913578 0.46904438 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN focal glomerulosclerosis DOID_3945 3.29E-03 0.02794442 0.08166396 0.4790391 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN bronchiolitis obliterans DOID_2799 3.723E-03 0.03115244 3.723E-03 0.08473464 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN allergic rhinitis DOID_4481 3.949E-03 0.03256163 0.08920732 0.51271681 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN chronic leukemia DOID_1036 4.18E-03 0.03398104 0.09170811 0.52181914 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN chronic lymphocytic leukemia DOID_1040 4.18E-03 0.03398104 0.09170811 0.52181914 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN thyroid carcinoma DOID_3963 4.663E-03 0.03736672 0.09668931 0.52900207 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN thyroid cancer DOID_1781 5.169E-03 0.04085139 0.10164345 0.54051516 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN calcinosis DOID_182 5.432E-03 0.0423369 0.10411042 0.54850766 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN embryonal cancer DOID_688 5.432E-03 0.04176478 5.432E-03 0.118869 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN peripheral nervous system neoplasm DOID_1192 5.7E-03 0.04324405 0.10657068 0.55126105 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN blood platelet disease DOID_2218 5.7E-03 0.04267505 0.10657068 0.5414171 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN hepatitis DOID_2237 5.974E-03 0.04414818 0.10902425 0.5489805 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN systemic scleroderma DOID_418 5.974E-03 0.04358217 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN rheumatic disease DOID_1575 7.131E-03 0.05135958 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN scleroderma DOID_419 7.131E-03 0.05135958 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN diabetic autonomic neuropathy DOID_11503 7.434E-03 0.05287755 7.434E-03 0.15107872 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN autonomic neuropathy DOID_11504 7.434E-03 0.05287755 7.434E-03 0.15107872 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN diabetic polyneuropathy DOID_12785 7.434E-03 0.05287755 7.434E-03 0.15107872 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN diabetic neuropathy DOID_9743 7.434E-03 0.05287755 7.434E-03 0.15107872 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN autonomic nervous system disease DOID_11465 8.38E-03 0.05886672 8.38E-03 0.15894014 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN brain cancer DOID_1319 8.38E-03 0.05814883 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN vascular skin disease DOID_9540 8.38E-03 0.05744824 0.12841406 0.58454078 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN central nervous system cancer DOID_3620 8.707E-03 0.05897632 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN hemolytic anemia DOID_583 8.707E-03 0.05828249 0.13080821 0.59071325 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN normocytic anemia DOID_720 8.707E-03 0.05828249 0.13080821 0.59071325 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN calcium metabolism disease DOID_10575 9.376E-03 0.06203748 0.13557698 0.59801011 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN withdrawal disorder DOID_0060001 9.72E-03 0.06357001 0.13795165 0.60380375 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN B-cell lymphocytic neoplasm DOID_707 9.72E-03 0.06284762 9.72E-03 0.17283097 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN vasculitis DOID_865 0.01078299 0.06893842 0.14503694 0.61586582 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN reproductive organ benign neoplasm DOID_0050622 0.01114829 0.07048197 0.14738586 0.62120413 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN pustulosis of palm and sole DOID_4398 0.01114829 0.06970744 0.14738586 0.61663645 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN familial hyperlipidemia DOID_1168 0.011519 0.07124251 0.1497284 0.62186466 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN hypersensitivity reaction type IV disease DOID_2916 0.01227651 0.07511114 0.01227651 0.21167685 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN carotid artery disease DOID_3407 0.01345255 0.08143084 0.01345255 0.21869996 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN collagen disease DOID_854 0.01345255 0.08057367 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN congenital heart defect DOID_1682 0.01426271 0.08453628 0.01426271 0.22543008 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN mineral metabolism disease DOID_0050032 0.01467554 0.08608644 0.16824062 0.67892844 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN temporal lobe epilepsy DOID_3328 0.01551655 0.09009102 0.01551655 0.23861945 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN endocrine organ benign neoplasm DOID_0060089 0.01637782 0.09413112 1.000 1.000 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN brain infarction DOID_3454 0.01637782 0.09318981 0.17734647 0.69116534 OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN pancreatic ductal carcinoma DOID_3587 0.01725911 0.09723199 0.1818623 0.6991868 SESTO_RESPONSE_TO_UV_C7 bone resorption disease DOID_0080011 3.445E-06 1.96E-03 3.445E-06 1.96E-03 SESTO_RESPONSE_TO_UV_C7 osteoporosis DOID_11476 3.445E-06 1.96E-03 3.445E-06 1.96E-03 SESTO_RESPONSE_TO_UV_C7 amino acid metabolic disorder DOID_9252 6.059E-06 1.724E-03 6.059E-06 1.724E-03 SESTO_RESPONSE_TO_UV_C7 hypothyroidism DOID_1459 8.377E-05 0.01588769 8.377E-05 0.01588769 SESTO_RESPONSE_TO_UV_C7 uterine disease DOID_345 9.585E-05 0.01363429 9.585E-05 0.01363429 SESTO_RESPONSE_TO_UV_C7 epidermolysis bullosa DOID_2730 1.071E-04 0.01219031 0.01540245 0.41733294 SESTO_RESPONSE_TO_UV_C7 vulva cancer DOID_1245 1.265E-04 0.01199569 1.265E-04 0.01439483 SESTO_RESPONSE_TO_UV_C7 vesiculobullous skin disease DOID_2731 1.265E-04 0.01028202 0.01667544 0.39534694 SESTO_RESPONSE_TO_UV_C7 mixed glioma DOID_5076 1.554E-04 0.0110549 1.554E-04 0.01473987 SESTO_RESPONSE_TO_UV_C7 lipid metabolism disorder DOID_3146 1.672E-04 0.01057282 1.672E-04 0.01359363 SESTO_RESPONSE_TO_UV_C7 female reproductive system disease DOID_229 1.733E-04 9.863E-03 1.733E-04 0.01232927 SESTO_RESPONSE_TO_UV_C7 Charcot-Marie-Tooth disease DOID_10595 8.941E-04 0.04625132 8.941E-04 0.05652939 SESTO_RESPONSE_TO_UV_C7 papilloma DOID_2615 1.002E-03 0.0475332 1.000 1.000 SESTO_RESPONSE_TO_UV_C7 embryonal cancer DOID_688 1.237E-03 0.05414481 0.05044338 0.61068688 SESTO_RESPONSE_TO_UV_C7 endometriosis of uterus DOID_288 1.564E-03 0.06355112 1.564E-03 0.08897157 SESTO_RESPONSE_TO_UV_C7 nephrotic syndrome DOID_1184 1.633E-03 0.06195942 0.05779165 0.64477356 SESTO_RESPONSE_TO_UV_C7 endometriosis DOID_289 1.633E-03 0.05808695 1.633E-03 0.08449012 SESTO_RESPONSE_TO_UV_C7 learning disability DOID_8927 1.777E-03 0.05948437 0.06022868 0.62309305 SESTO_RESPONSE_TO_UV_C7 familial hyperlipidemia DOID_1168 2.671E-03 0.08444754 2.671E-03 0.12667131 HAHTOLA_SEZARY_SYNDROM_DN hypersensitivity reaction type I disease DOID_1205 9.341E-08 5.315E-05 9.341E-08 5.315E-05 HAHTOLA_SEZARY_SYNDROM_DN Human immunodeficiency virus infectious disease DOID_526 9.175E-06 2.61E-03 9.175E-06 2.61E-03 HAHTOLA_SEZARY_SYNDROM_DN acquired immunodeficiency syndrome DOID_635 4.349E-05 8.248E-03 4.349E-05 8.248E-03 HAHTOLA_SEZARY_SYNDROM_DN Goodpasture syndrome DOID_9808 5.193E-05 7.387E-03 0.01070996 0.27699863 HAHTOLA_SEZARY_SYNDROM_DN papillary adenoma DOID_3172 6.599E-05 7.51E-03 0.01204109 0.29788619 HAHTOLA_SEZARY_SYNDROM_DN microcystic adenoma DOID_5403 6.599E-05 7.51E-03 0.01204109 0.29788619 HAHTOLA_SEZARY_SYNDROM_DN follicular adenoma DOID_6204 6.599E-05 7.51E-03 0.01204109 0.29788619 HAHTOLA_SEZARY_SYNDROM_DN vitiligo DOID_12306 7.105E-05 6.738E-03 7.105E-05 0.01010684 HAHTOLA_SEZARY_SYNDROM_DN bronchiolitis obliterans DOID_2799 9.911E-05 8.057E-03 0.0146983 0.29869038 HAHTOLA_SEZARY_SYNDROM_DN papilloma DOID_2615 1.182E-04 8.405E-03 0.01602437 0.29412479 HAHTOLA_SEZARY_SYNDROM_DN adenoma DOID_657 1.389E-04 8.78E-03 0.01734877 0.29913487 HAHTOLA_SEZARY_SYNDROM_DN hepatitis DOID_2237 1.612E-04 9.175E-03 0.01867149 0.29511329 HAHTOLA_SEZARY_SYNDROM_DN endometriosis of uterus DOID_288 1.853E-04 9.583E-03 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN endometriosis DOID_289 1.936E-04 9.181E-03 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN gallbladder cancer DOID_3121 2.022E-04 8.849E-03 0.0208723 0.29690848 HAHTOLA_SEZARY_SYNDROM_DN thyroid adenoma DOID_2891 2.289E-04 9.304E-03 0.02219056 0.30796162 HAHTOLA_SEZARY_SYNDROM_DN autoimmune disease of gastrointestinal tract DOID_0060031 2.477E-04 9.395E-03 0.02306846 0.31252277 HAHTOLA_SEZARY_SYNDROM_DN parasitic protozoa infectious disease DOID_2789 3.083E-04 0.01096228 0.02569774 0.31786989 HAHTOLA_SEZARY_SYNDROM_DN hypothyroidism DOID_1459 3.872E-04 0.01295869 3.872E-04 0.04405955 HAHTOLA_SEZARY_SYNDROM_DN parasitic infectious disease DOID_1398 4.237E-04 0.0133932 0.03006507 0.33543191 HAHTOLA_SEZARY_SYNDROM_DN uterine disease DOID_345 4.237E-04 0.0126883 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN hyperglycemia DOID_4195 4.362E-04 0.01241043 0.03050079 0.33374906 HAHTOLA_SEZARY_SYNDROM_DN allergic contact dermatitis DOID_3042 4.489E-04 0.01216388 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN endocrine organ benign neoplasm DOID_0060089 4.618E-04 0.01194438 0.03137168 0.33680159 HAHTOLA_SEZARY_SYNDROM_DN bacterial pneumonia DOID_874 5.859E-04 0.01449402 0.03528155 0.35848578 HAHTOLA_SEZARY_SYNDROM_DN contact dermatitis DOID_2773 6.154E-04 0.0145901 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN female reproductive system disease DOID_229 6.304E-04 0.01434856 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN biliary tract cancer DOID_4607 6.61E-04 0.01446613 0.03744728 0.37381586 HAHTOLA_SEZARY_SYNDROM_DN chondrosarcoma DOID_3371 4.476E-03 0.09432079 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN Hermansky-Pudlak syndrome DOID_3753 4.476E-03 0.09095219 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN insulinoma DOID_3892 4.476E-03 0.08781591 4.476E-03 0.42444357 HAHTOLA_SEZARY_SYNDROM_DN conjunctival disease DOID_4251 4.476E-03 0.08488871 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN holoprosencephaly DOID_4621 4.476E-03 0.08215037 4.476E-03 0.36380877 HAHTOLA_SEZARY_SYNDROM_DN conjunctivitis DOID_6195 4.476E-03 0.08488871 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN visceral leishmaniasis DOID_9146 4.476E-03 0.07958317 4.476E-03 0.31833268 HAHTOLA_SEZARY_SYNDROM_DN trypanosomiasis DOID_10113 4.922E-03 0.08487081 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN polydactyly DOID_1148 4.922E-03 0.08237461 4.922E-03 0.31119296 HAHTOLA_SEZARY_SYNDROM_DN islet cell tumor DOID_1799 5.369E-03 0.08727728 5.369E-03 0.30547047 HAHTOLA_SEZARY_SYNDROM_DN polyneuropathy DOID_1389 5.815E-03 0.0919046 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN psoriatic arthritis DOID_9008 5.815E-03 0.08942069 5.815E-03 0.30077868 HAHTOLA_SEZARY_SYNDROM_DN viral pneumonia DOID_10533 6.261E-03 0.09374524 6.261E-03 0.29685992 HAHTOLA_SEZARY_SYNDROM_DN rhabdomyosarcoma DOID_3247 6.261E-03 0.09134152 6.261E-03 0.27402455 HAHTOLA_SEZARY_SYNDROM_DN eyelid disease DOID_530 6.261E-03 0.08905798 1.000 1.000 HAHTOLA_SEZARY_SYNDROM_DN skeletal muscle cancer DOID_4043 6.706E-03 0.09307233 6.706E-03 0.27256897 SESTO_RESPONSE_TO_UV_C8 seminoma DOID_4440 6.909E-06 3.931E-03 0.03629124 0.50365156 SESTO_RESPONSE_TO_UV_C8 germinoma DOID_3304 1.255E-05 3.57E-03 0.04389832 0.52037806 SESTO_RESPONSE_TO_UV_C8 giant cell tumor DOID_200 5.696E-05 0.01080288 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 malignant giant cell tumor DOID_2705 5.696E-05 0.01080288 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 giant cell glioblastoma DOID_3074 5.696E-05 0.01080288 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 osteochondrodysplasia DOID_2256 6.328E-05 9.002E-03 6.328E-05 0.03600816 SESTO_RESPONSE_TO_UV_C8 hypertrophic cardiomyopathy DOID_11984 7.361E-05 8.377E-03 2.968E-03 0.21112328 SESTO_RESPONSE_TO_UV_C8 glioblastoma DOID_3068 7.361E-05 6.98E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 keratitis DOID_4677 7.619E-05 6.194E-03 0.01311233 0.67826514 SESTO_RESPONSE_TO_UV_C8 invasive lobular carcinoma DOID_3457 9.305E-05 6.618E-03 0.01441426 0.63090106 SESTO_RESPONSE_TO_UV_C8 epidermolysis bullosa DOID_2730 1.116E-04 7.053E-03 1.116E-04 0.03174002 SESTO_RESPONSE_TO_UV_C8 astrocytoma DOID_3069 1.207E-04 6.87E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 vesiculobullous skin disease DOID_2731 1.317E-04 6.814E-03 1.317E-04 0.02498619 SESTO_RESPONSE_TO_UV_C8 angiosarcoma DOID_0001816 2.022E-04 9.586E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 bone development disease DOID_0080006 2.045E-04 8.951E-03 2.045E-04 0.0290915 SESTO_RESPONSE_TO_UV_C8 transitional cell carcinoma DOID_2671 2.339E-04 9.506E-03 6.34E-03 0.40083588 SESTO_RESPONSE_TO_UV_C8 nervous system cancer DOID_3093 2.496E-04 9.467E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 alcohol-related neurodevelopmental disorder DOID_0050667 2.829E-04 0.0100602 0.11913862 0.78825436 SESTO_RESPONSE_TO_UV_C8 testicular cancer DOID_2998 2.874E-04 9.618E-03 0.02476927 0.61277016 SESTO_RESPONSE_TO_UV_C8 granulosa cell tumor DOID_2999 2.874E-04 9.083E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 sex cord-gonadal stromal tumor DOID_192 3.19E-04 9.554E-03 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 sarcoma DOID_1115 7.242E-04 0.02060447 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 multiple epiphyseal dysplasia DOID_12721 7.735E-04 0.02095897 7.735E-04 0.08802767 SESTO_RESPONSE_TO_UV_C8 focal glomerulosclerosis DOID_3945 7.735E-04 0.02000629 0.04010217 0.51859392 SESTO_RESPONSE_TO_UV_C8 corneal disease DOID_10124 8.244E-04 0.02039503 0.04136919 0.52309043 SESTO_RESPONSE_TO_UV_C8 autonomic nervous system neoplasm DOID_2621 9.865E-04 0.02338723 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 neuroblastoma DOID_769 9.865E-04 0.02338723 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 multiple myeloma DOID_9538 1.288E-03 0.0293089 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 peripheral nervous system neoplasm DOID_1192 1.353E-03 0.02960192 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 cervix uteri carcinoma in situ DOID_8991 1.557E-03 0.03280275 0.05644623 0.60599826 SESTO_RESPONSE_TO_UV_C8 learning disability DOID_8927 1.85E-03 0.03759001 0.06142008 0.60255221 SESTO_RESPONSE_TO_UV_C8 myeloma DOID_0070004 2.005E-03 0.03934857 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 pre-eclampsia DOID_10591 2.005E-03 0.03803695 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 integumentary system benign neoplasm DOID_0060121 2.167E-03 0.03977793 2.167E-03 0.20551932 SESTO_RESPONSE_TO_UV_C8 skin benign neoplasm DOID_3165 2.167E-03 0.03977793 2.167E-03 0.20551932 SESTO_RESPONSE_TO_UV_C8 bone marrow cancer DOID_4960 2.597E-03 0.04618679 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 integumentary system cancer DOID_0060122 2.688E-03 0.04634776 2.688E-03 0.21849659 SESTO_RESPONSE_TO_UV_C8 skin cancer DOID_4159 2.688E-03 0.04634776 2.688E-03 0.21849659 SESTO_RESPONSE_TO_UV_C8 pustulosis of palm and sole DOID_4398 2.688E-03 0.04498459 0.07374257 0.64553108 SESTO_RESPONSE_TO_UV_C8 collagen disease DOID_854 3.262E-03 0.05302772 0.08105981 0.64059763 SESTO_RESPONSE_TO_UV_C8 respiratory failure DOID_11162 3.363E-03 0.05314673 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 pre-malignant neoplasm DOID_0060071 3.465E-03 0.05328151 0.08348627 0.65073548 SESTO_RESPONSE_TO_UV_C8 in situ carcinoma DOID_8719 3.465E-03 0.05328151 0.08348627 0.65073548 SESTO_RESPONSE_TO_UV_C8 pancreatic ductal carcinoma DOID_3587 4.22E-03 0.06318884 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 peripheral vascular disease DOID_341 4.449E-03 0.06490348 0.0943279 0.68810996 SESTO_RESPONSE_TO_UV_C8 pancreatic carcinoma DOID_4905 4.565E-03 0.06493668 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 syndrome DOID_225 4.802E-03 0.06664198 1.000 1.000 SESTO_RESPONSE_TO_UV_C8 chronic kidney failure DOID_784 5.675E-03 0.07688572 0.10622678 0.71955996 PETRETTO_CARDIAC_HYPERTROPHY heart valve disease DOID_4079 4.864E-06 2.768E-03 4.864E-06 2.768E-03 PETRETTO_CARDIAC_HYPERTROPHY aortic valve insufficiency DOID_57 2.744E-05 7.807E-03 2.744E-05 7.807E-03 PETRETTO_CARDIAC_HYPERTROPHY transitional cell carcinoma DOID_2671 2.865E-05 5.434E-03 1.614E-03 0.08346681 PETRETTO_CARDIAC_HYPERTROPHY thoracic aortic aneurysm DOID_14004 4.361E-05 6.203E-03 4.361E-05 8.27E-03 PETRETTO_CARDIAC_HYPERTROPHY aortic valve disease DOID_62 1.142E-04 0.01299629 1.142E-04 0.01624537 PETRETTO_CARDIAC_HYPERTROPHY focal glomerulosclerosis DOID_3945 1.919E-04 0.01819505 1.919E-04 0.02183406 PETRETTO_CARDIAC_HYPERTROPHY dysostosis DOID_1934 2.046E-04 0.01662875 2.046E-04 0.01940021 PETRETTO_CARDIAC_HYPERTROPHY hyperthyroidism DOID_7998 2.741E-04 0.01949766 2.741E-04 0.02228304 PETRETTO_CARDIAC_HYPERTROPHY aortic aneurysm DOID_3627 5.635E-04 0.0356285 5.635E-04 0.04008206 PETRETTO_CARDIAC_HYPERTROPHY aneurysm disease DOID_2403 1.247E-03 0.07094526 1.247E-03 0.07882807 PETRETTO_CARDIAC_HYPERTROPHY bone development disease DOID_0080006 1.475E-03 0.07629561 1.475E-03 0.08392518 DELYS_THYROID_CANCER_DN brain infarction DOID_3454 6.164E-10 3.507E-07 5.255E-07 2.99E-04 DELYS_THYROID_CANCER_DN cerebral infarction DOID_3526 4.87E-08 1.386E-05 1.694E-06 3.214E-04 DELYS_THYROID_CANCER_DN osteosarcoma DOID_3347 7.006E-08 1.329E-05 3.942E-06 3.738E-04 DELYS_THYROID_CANCER_DN uterine disease DOID_345 4.058E-07 5.772E-05 2.867E-03 0.02765053 DELYS_THYROID_CANCER_DN metabolic syndrome X DOID_14221 1.238E-06 1.408E-04 3.851E-04 7.557E-03 DELYS_THYROID_CANCER_DN female reproductive system disease DOID_229 1.329E-06 1.261E-04 5.024E-03 0.04266986 DELYS_THYROID_CANCER_DN alcohol abuse DOID_1574 1.53E-06 1.244E-04 1.53E-06 4.353E-04 DELYS_THYROID_CANCER_DN lingual-facial-buccal dyskinesia DOID_9854 2.357E-06 1.677E-04 2.357E-06 3.353E-04 DELYS_THYROID_CANCER_DN atrophic muscular disease DOID_913 3.68E-06 2.327E-04 3.68E-06 4.188E-04 DELYS_THYROID_CANCER_DN muscular dystrophy DOID_9884 3.68E-06 2.327E-04 3.68E-06 4.188E-04 DELYS_THYROID_CANCER_DN fragments of torsion dystonia DOID_531 5.363E-06 3.052E-04 5.363E-06 4.36E-04 DELYS_THYROID_CANCER_DN central nervous system hereditary degenerative disease DOID_481 7.133E-06 3.689E-04 7.133E-06 5.073E-04 DELYS_THYROID_CANCER_DN dystonic disease DOID_544 8.163E-06 3.871E-04 8.163E-06 5.161E-04 DELYS_THYROID_CANCER_DN sickle cell anemia DOID_10923 1.122E-05 4.911E-04 9.146E-04 0.01406447 DELYS_THYROID_CANCER_DN endogenous depression DOID_1595 1.89E-05 7.683E-04 1.89E-05 1.076E-03 DELYS_THYROID_CANCER_DN mixed glioma DOID_5076 2.138E-05 8.111E-04 2.138E-05 1.106E-03 DELYS_THYROID_CANCER_DN contact dermatitis DOID_2773 2.411E-05 8.574E-04 4.857E-03 0.04252066 DELYS_THYROID_CANCER_DN mental depression DOID_1596 2.869E-05 9.604E-04 2.869E-05 1.361E-03 DELYS_THYROID_CANCER_DN thalassemia DOID_10241 3.056E-05 9.662E-04 3.056E-05 1.338E-03 DELYS_THYROID_CANCER_DN arthropathy DOID_381 3.056E-05 9.153E-04 3.056E-05 1.242E-03 DELYS_THYROID_CANCER_DN benign mesothelioma DOID_2645 3.377E-05 9.608E-04 8.147E-04 0.01287625 DELYS_THYROID_CANCER_DN endometriosis of uterus DOID_288 3.695E-05 1.001E-03 0.01501465 0.09088656 DELYS_THYROID_CANCER_DN tongue cancer DOID_8649 3.75E-05 9.7E-04 3.75E-05 1.423E-03 DELYS_THYROID_CANCER_DN amino acid metabolic disorder DOID_9252 3.988E-05 9.866E-04 3.988E-05 1.418E-03 DELYS_THYROID_CANCER_DN endometriosis DOID_289 4.034E-05 9.563E-04 0.01565495 0.0918316 DELYS_THYROID_CANCER_DN movement disease DOID_480 7.077E-05 1.611E-03 7.077E-05 2.369E-03 DELYS_THYROID_CANCER_DN uremia DOID_4676 1.161E-04 2.541E-03 1.161E-04 3.67E-03 DELYS_THYROID_CANCER_DN hypothyroidism DOID_1459 1.574E-04 3.318E-03 1.574E-04 4.715E-03 DELYS_THYROID_CANCER_DN congenital heart defect DOID_1682 1.671E-04 3.395E-03 1.671E-04 4.753E-03 DELYS_THYROID_CANCER_DN temporal lobe epilepsy DOID_3328 1.985E-04 3.894E-03 1.985E-04 5.378E-03 DELYS_THYROID_CANCER_DN tooth disease DOID_1091 2.098E-04 3.98E-03 2.098E-04 5.427E-03 DELYS_THYROID_CANCER_DN allergic contact dermatitis DOID_3042 2.098E-04 3.851E-03 0.03425283 0.16241552 DELYS_THYROID_CANCER_DN intracranial aneurysm DOID_10941 2.115E-04 3.761E-03 2.115E-04 5.233E-03 DELYS_THYROID_CANCER_DN endocrine organ benign neoplasm DOID_0060089 2.216E-04 3.822E-03 3.24E-03 0.03072951 DELYS_THYROID_CANCER_DN perinatal necrotizing enterocolitis DOID_8677 2.352E-04 3.937E-03 2.352E-04 5.577E-03 DELYS_THYROID_CANCER_DN renal tubular transport disease DOID_447 2.606E-04 4.236E-03 2.606E-04 5.931E-03 DELYS_THYROID_CANCER_DN multiple epiphyseal dysplasia DOID_12721 2.876E-04 4.546E-03 7.324E-03 0.05412008 DELYS_THYROID_CANCER_DN bone resorption disease DOID_0080011 3.34E-04 5.137E-03 3.34E-04 7.31E-03 DELYS_THYROID_CANCER_DN osteoporosis DOID_11476 3.34E-04 5.137E-03 3.34E-04 7.31E-03 DELYS_THYROID_CANCER_DN aneurysm disease DOID_2403 3.34E-04 5.002E-03 3.34E-04 7.04E-03 DELYS_THYROID_CANCER_DN age related macular degeneration DOID_10871 3.47E-04 5.063E-03 8.271E-03 0.05810279 DELYS_THYROID_CANCER_DN degeneration of macula and posterior pole DOID_2007 3.47E-04 5.063E-03 8.271E-03 0.05810279 DELYS_THYROID_CANCER_DN germinoma DOID_3304 3.794E-04 5.397E-03 3.794E-04 7.71E-03 DELYS_THYROID_CANCER_DN focal epilepsy DOID_2234 4.416E-04 6.128E-03 4.416E-04 8.376E-03 DELYS_THYROID_CANCER_DN bone development disease DOID_0080006 4.617E-04 6.254E-03 5.546E-03 0.04573534 DELYS_THYROID_CANCER_DN nephroblastoma DOID_2154 4.882E-04 6.46E-03 0.01032092 0.06908947 DELYS_THYROID_CANCER_DN spindle cell carcinoma DOID_4015 4.882E-04 6.313E-03 0.14240091 0.35852265 DELYS_THYROID_CANCER_DN macular degeneration DOID_4448 4.882E-04 6.173E-03 0.01032092 0.06750121 DELYS_THYROID_CANCER_DN adenoma DOID_657 5.707E-04 7.06E-03 0.01142139 0.07301992 DELYS_THYROID_CANCER_DN lymphoblastic leukemia DOID_1037 6.724E-04 8.141E-03 6.724E-04 0.01234236 DELYS_THYROID_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 6.994E-04 8.291E-03 7.514E-03 0.05412122 DELYS_THYROID_CANCER_DN mouth disease DOID_403 6.994E-04 8.122E-03 6.994E-04 0.01243667 DELYS_THYROID_CANCER_DN congenital diaphragmatic hernia DOID_3827 7.104E-04 8.085E-03 0.01316412 0.08141722 DELYS_THYROID_CANCER_DN dilated cardiomyopathy DOID_12930 7.272E-04 8.113E-03 7.731E-03 0.05498532 DELYS_THYROID_CANCER_DN brachydactyly DOID_0050581 7.503E-04 8.21E-03 7.503E-04 0.01293729 DELYS_THYROID_CANCER_DN insulinoma DOID_3892 7.503E-04 8.055E-03 7.503E-04 0.01255678 DELYS_THYROID_CANCER_DN polycythemia DOID_8432 7.503E-04 7.906E-03 7.503E-04 0.01219802 DELYS_THYROID_CANCER_DN uterine cancer DOID_363 9.884E-04 0.01022545 9.884E-04 0.01479999 DELYS_THYROID_CANCER_DN cataract DOID_83 1.051E-03 0.01068 1.051E-03 0.01533539 DELYS_THYROID_CANCER_DN aortic valve stenosis DOID_1712 1.094E-03 0.01092571 0.0485858 0.1933239 DELYS_THYROID_CANCER_DN islet cell tumor DOID_1799 1.094E-03 0.01073733 1.094E-03 0.01556913 DELYS_THYROID_CANCER_DN lens disease DOID_110 1.184E-03 0.01141799 1.184E-03 0.01643077 DELYS_THYROID_CANCER_DN thyroid adenoma DOID_2891 1.184E-03 0.01122769 0.01833058 0.10225589 DELYS_THYROID_CANCER_DN hemolytic anemia DOID_583 1.254E-03 0.01169842 0.01902758 0.10410281 DELYS_THYROID_CANCER_DN normocytic anemia DOID_720 1.254E-03 0.01169842 0.01902758 0.10410281 DELYS_THYROID_CANCER_DN major depressive disorder DOID_1470 1.29E-03 0.01183864 1.29E-03 0.01747609 DELYS_THYROID_CANCER_DN impotence DOID_1875 1.29E-03 0.01165072 1.29E-03 0.01706966 DELYS_THYROID_CANCER_DN larynx cancer DOID_2596 1.29E-03 0.01146868 1.29E-03 0.01668172 DELYS_THYROID_CANCER_DN laryngeal benign neoplasm DOID_2598 1.29E-03 0.01146868 1.29E-03 0.01668172 DELYS_THYROID_CANCER_DN calcium metabolism disease DOID_10575 1.402E-03 0.01227525 1.402E-03 0.01773091 DELYS_THYROID_CANCER_DN withdrawal disorder DOID_0060001 1.48E-03 0.01276175 1.48E-03 0.01831034 DELYS_THYROID_CANCER_DN Ehlers-Danlos syndrome DOID_13359 1.727E-03 0.01466734 1.727E-03 0.02090876 DELYS_THYROID_CANCER_DN varicose veins DOID_799 1.727E-03 0.01445164 1.727E-03 0.02047316 DELYS_THYROID_CANCER_DN osteochondrodysplasia DOID_2256 1.819E-03 0.01500286 0.02420971 0.12523025 DELYS_THYROID_CANCER_DN angiosarcoma DOID_0001816 1.968E-03 0.01600072 1.968E-03 0.02285817 DELYS_THYROID_CANCER_DN vein disease DOID_866 1.968E-03 0.01577536 1.968E-03 0.02240101 DELYS_THYROID_CANCER_DN retinitis pigmentosa DOID_10584 2.103E-03 0.01661877 2.103E-03 0.0234618 DELYS_THYROID_CANCER_DN hypertrophic cardiomyopathy DOID_11984 2.103E-03 0.01639112 0.02658754 0.13387886 DELYS_THYROID_CANCER_DN oral cavity cancer DOID_8618 2.103E-03 0.01616962 2.103E-03 0.02301061 DELYS_THYROID_CANCER_DN melancholia DOID_2848 2.203E-03 0.01671472 2.203E-03 0.0236529 DELYS_THYROID_CANCER_DN penile disease DOID_1529 2.225E-03 0.01665719 2.225E-03 0.02344345 DELYS_THYROID_CANCER_DN neurotic disorder DOID_4964 2.306E-03 0.01704309 2.306E-03 0.02386032 DELYS_THYROID_CANCER_DN sexual dysfunction DOID_1876 2.496E-03 0.01820931 2.496E-03 0.02536297 DELYS_THYROID_CANCER_DN dental caries DOID_216 2.496E-03 0.01797881 2.496E-03 0.024918 DELYS_THYROID_CANCER_DN pre-malignant neoplasm DOID_0060071 2.634E-03 0.01873243 0.03075007 0.14827788 DELYS_THYROID_CANCER_DN in situ carcinoma DOID_8719 2.634E-03 0.01873243 0.03075007 0.14827788 DELYS_THYROID_CANCER_DN mineral metabolism disease DOID_0050032 2.749E-03 0.01931009 2.749E-03 0.02696754 DELYS_THYROID_CANCER_DN endocrine pancreas disease DOID_1428 2.749E-03 0.0190746 0.03161165 0.15115148 DELYS_THYROID_CANCER_DN parasitic infectious disease DOID_1398 2.867E-03 0.0196552 0.24605949 0.5490504 DELYS_THYROID_CANCER_DN male reproductive system disease DOID_48 3.642E-03 0.02467091 3.642E-03 0.03397306 DELYS_THYROID_CANCER_DN acquired immunodeficiency syndrome DOID_635 3.728E-03 0.024956 0.08727682 0.2684352 DELYS_THYROID_CANCER_DN muscular atrophy DOID_767 3.728E-03 0.02466581 3.728E-03 0.03421386 DELYS_THYROID_CANCER_DN placenta disease DOID_780 3.728E-03 0.02438229 0.08727682 0.266992 DELYS_THYROID_CANCER_DN sexual disorder DOID_0060043 4.072E-03 0.02632946 4.072E-03 0.03677766 DELYS_THYROID_CANCER_DN muscle cancer DOID_4045 4.072E-03 0.02603362 0.09105886 0.27707214 DELYS_THYROID_CANCER_DN congenital hemolytic anemia DOID_589 4.43E-03 0.02800872 4.43E-03 0.03938727 DELYS_THYROID_CANCER_DN aortic valve disease DOID_62 4.43E-03 0.02770094 0.09482532 0.28397688 DELYS_THYROID_CANCER_DN lipid metabolism disorder DOID_3146 4.857E-03 0.03004177 4.857E-03 0.04187641 DELYS_THYROID_CANCER_DN auditory system disease DOID_2742 5.195E-03 0.03178353 5.195E-03 0.04346866 DELYS_THYROID_CANCER_DN biliary tract cancer DOID_4607 5.369E-03 0.03249806 0.04865266 0.19224559 DELYS_THYROID_CANCER_DN papillary adenoma DOID_3172 5.588E-03 0.03347191 0.10603191 0.30625461 DELYS_THYROID_CANCER_DN microcystic adenoma DOID_5403 5.588E-03 0.03347191 0.10603191 0.30625461 DELYS_THYROID_CANCER_DN follicular adenoma DOID_6204 5.588E-03 0.03347191 0.10603191 0.30625461 DELYS_THYROID_CANCER_DN myositis DOID_633 5.588E-03 0.03312325 0.10603191 0.30470787 DELYS_THYROID_CANCER_DN teeth hard tissue disease DOID_214 6.002E-03 0.035208 6.002E-03 0.04878822 DELYS_THYROID_CANCER_DN spinal cord disease DOID_319 6.002E-03 0.03484873 6.002E-03 0.04810106 DELYS_THYROID_CANCER_DN primary bacterial infectious disease DOID_0050338 6.099E-03 0.03505489 6.099E-03 0.04820047 DELYS_THYROID_CANCER_DN gestational diabetes DOID_11714 6.429E-03 0.03658237 6.429E-03 0.05011284 DELYS_THYROID_CANCER_DN periodontitis DOID_824 6.429E-03 0.03622017 6.429E-03 0.04943564 DELYS_THYROID_CANCER_DN nervous system cancer DOID_3093 6.684E-03 0.03728665 6.684E-03 0.05070984 DELYS_THYROID_CANCER_DN Human immunodeficiency virus infectious disease DOID_526 6.684E-03 0.03692464 0.05599846 0.21101408 DELYS_THYROID_CANCER_DN sarcoma DOID_1115 6.87E-03 0.03758605 6.87E-03 0.05143355 DELYS_THYROID_CANCER_DN malaria DOID_12365 6.87E-03 0.03722809 0.11710063 0.32502566 DELYS_THYROID_CANCER_DN toxic encephalopathy DOID_3602 7.324E-03 0.03931364 7.324E-03 0.05342623 DELYS_THYROID_CANCER_DN female reproductive organ benign neoplasm DOID_0060086 7.791E-03 0.04143047 0.12440402 0.33547814 DELYS_THYROID_CANCER_DN uterine benign neoplasm DOID_0060095 7.791E-03 0.04143047 0.12440402 0.33547814 DELYS_THYROID_CANCER_DN corneal disease DOID_10124 7.791E-03 0.04104685 0.12440402 0.33389569 DELYS_THYROID_CANCER_DN uterine fibroid DOID_13223 7.791E-03 0.04143047 0.12440402 0.33547814 DELYS_THYROID_CANCER_DN endometrial cancer DOID_1380 8.764E-03 0.04575209 8.764E-03 0.06081681 DELYS_THYROID_CANCER_DN leiomyoma DOID_127 9.271E-03 0.04795411 0.13524669 0.34979712 DELYS_THYROID_CANCER_DN autonomic nervous system neoplasm DOID_2621 9.271E-03 0.04752209 9.271E-03 0.06355364 DELYS_THYROID_CANCER_DN neuroblastoma DOID_769 9.271E-03 0.04752209 9.271E-03 0.06355364 DELYS_THYROID_CANCER_DN papilloma DOID_2615 9.789E-03 0.04973377 0.13883118 0.35583308 DELYS_THYROID_CANCER_DN metal metabolism disorder DOID_896 9.789E-03 0.04929365 9.789E-03 0.06631169 DELYS_THYROID_CANCER_DN periodontal disease DOID_3388 0.01032092 0.05151408 0.01032092 0.06828611 DELYS_THYROID_CANCER_DN lymphoid leukemia DOID_10747 0.01086495 0.05375788 0.01086495 0.07025178 DELYS_THYROID_CANCER_DN calcinosis DOID_182 0.01199014 0.05881372 0.01199014 0.07580435 DELYS_THYROID_CANCER_DN peripheral nervous system neoplasm DOID_1192 0.01257109 0.06113632 0.01257109 0.07860384 DELYS_THYROID_CANCER_DN cervix uteri carcinoma in situ DOID_8991 0.01438601 0.06936983 0.16698068 0.40089454 DELYS_THYROID_CANCER_DN pulmonary emphysema DOID_9675 0.01438601 0.06878689 0.16698068 0.3992101 DELYS_THYROID_CANCER_DN spinocerebellar ataxia DOID_1441 0.01501465 0.07119447 0.01501465 0.09186383 DELYS_THYROID_CANCER_DN Huntington's disease DOID_12858 0.01565495 0.07361707 0.01565495 0.0937649 DELYS_THYROID_CANCER_DN hyperinsulinism DOID_2018 0.01565495 0.07301365 0.01565495 0.09278818 DELYS_THYROID_CANCER_DN diabetic autonomic neuropathy DOID_11503 0.01630679 0.0754355 0.01630679 0.09467925 DELYS_THYROID_CANCER_DN autonomic neuropathy DOID_11504 0.01630679 0.0754355 0.01630679 0.09467925 DELYS_THYROID_CANCER_DN diabetic polyneuropathy DOID_12785 0.01630679 0.0754355 0.01630679 0.09467925 DELYS_THYROID_CANCER_DN gallbladder cancer DOID_3121 0.01630679 0.07482715 0.17729937 0.41687331 DELYS_THYROID_CANCER_DN diabetic neuropathy DOID_9743 0.01630679 0.0754355 0.01630679 0.09467925 DELYS_THYROID_CANCER_DN learning disability DOID_8927 0.01697009 0.07724783 0.01697009 0.09753514 DELYS_THYROID_CANCER_DN spinocerebellar degeneration DOID_2478 0.01764472 0.0796813 0.01764472 0.10039843 DELYS_THYROID_CANCER_DN autonomic nervous system disease DOID_11465 0.01833058 0.08212678 0.01833058 0.10326833 DELYS_THYROID_CANCER_DN heart valve disease DOID_4079 0.01833058 0.08148516 0.18749105 0.43722297 DELYS_THYROID_CANCER_DN bone marrow disease DOID_4961 0.01833058 0.0808535 0.01833058 0.10126312 DELYS_THYROID_CANCER_DN glaucoma DOID_1686 0.01973561 0.08638123 0.01973561 0.10694819 DELYS_THYROID_CANCER_DN lung small cell carcinoma DOID_5409 0.01973561 0.08572183 0.01973561 0.10593925 DELYS_THYROID_CANCER_DN aortic aneurysm DOID_3627 0.02045456 0.08817155 0.02045456 0.10877238 DELYS_THYROID_CANCER_DN giant cell tumor DOID_200 0.02267598 0.09701226 0.02267598 0.1194688 DELYS_THYROID_CANCER_DN malignant giant cell tumor DOID_2705 0.02267598 0.09701226 0.02267598 0.1194688 DELYS_THYROID_CANCER_DN giant cell glioblastoma DOID_3074 0.02267598 0.09701226 0.02267598 0.1194688 DELYS_THYROID_CANCER_DN bile duct adenocarcinoma DOID_4896 0.02343763 0.09952248 0.02343763 0.12234874 DELYS_THYROID_CANCER_DN cholangiocarcinoma DOID_4947 0.02343763 0.09952248 0.02343763 0.12234874 DELYS_THYROID_CANCER_DN bone marrow cancer DOID_4960 0.02343763 0.09878528 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP allergic contact dermatitis DOID_3042 3.284E-10 1.869E-07 3.284E-10 1.869E-07 LENAOUR_DENDRITIC_CELL_MATURATION_UP contact dermatitis DOID_2773 1.018E-09 2.897E-07 1.018E-09 2.897E-07 LENAOUR_DENDRITIC_CELL_MATURATION_UP Goodpasture syndrome DOID_9808 2.611E-09 4.952E-07 2.909E-07 5.517E-05 LENAOUR_DENDRITIC_CELL_MATURATION_UP encephalomyelitis DOID_640 2.888E-09 4.108E-07 7.674E-05 5.458E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP alcohol-related neurodevelopmental disorder DOID_0050667 3.109E-09 3.538E-07 7.993E-05 5.054E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP pancreatitis DOID_4989 3.687E-08 3.497E-06 3.916E-05 4.456E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP pustulosis of palm and sole DOID_4398 2.643E-07 2.149E-05 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP parasitic infectious disease DOID_1398 5.904E-07 4.199E-05 5.613E-04 0.01330699 LENAOUR_DENDRITIC_CELL_MATURATION_UP tuberculosis DOID_399 7.333E-07 4.636E-05 6.369E-04 0.01449519 LENAOUR_DENDRITIC_CELL_MATURATION_UP opportunistic mycosis DOID_2473 1.102E-06 6.271E-05 6.484E-05 5.271E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP bronchiolitis obliterans DOID_2799 1.102E-06 5.701E-05 1.102E-06 1.568E-04 LENAOUR_DENDRITIC_CELL_MATURATION_UP aneurysm disease DOID_2403 1.251E-06 5.931E-05 8.693E-04 0.01766592 LENAOUR_DENDRITIC_CELL_MATURATION_UP bacterial pneumonia DOID_874 1.332E-06 5.829E-05 9.017E-04 0.01769136 LENAOUR_DENDRITIC_CELL_MATURATION_UP familial combined hyperlipidemia DOID_13809 1.483E-06 6.027E-05 0.0232323 0.17625575 LENAOUR_DENDRITIC_CELL_MATURATION_UP lipid metabolism disorder DOID_3146 1.506E-06 5.712E-05 9.686E-04 0.01777896 LENAOUR_DENDRITIC_CELL_MATURATION_UP systemic mycosis DOID_0050136 1.578E-06 5.612E-05 8.442E-05 4.804E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP fungal infectious disease DOID_1564 1.578E-06 5.612E-05 8.442E-05 4.804E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP chronic kidney failure DOID_784 1.8E-06 6.026E-05 0.01714837 0.13551978 LENAOUR_DENDRITIC_CELL_MATURATION_UP primary bacterial infectious disease DOID_0050338 2.261E-06 7.149E-05 1.228E-03 0.01995567 LENAOUR_DENDRITIC_CELL_MATURATION_UP multiple myeloma DOID_9538 2.431E-06 7.28E-05 1.16E-04 6.002E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP uveal disease DOID_3480 4.294E-06 1.222E-04 1.765E-04 7.172E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP myeloma DOID_0070004 6.017E-06 1.63E-04 2.263E-04 8.585E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP sarcoidosis DOID_11335 9.493E-06 2.455E-04 3.168E-04 0.01060437 LENAOUR_DENDRITIC_CELL_MATURATION_UP bone marrow cancer DOID_4960 1.019E-05 2.521E-04 3.339E-04 0.01055374 LENAOUR_DENDRITIC_CELL_MATURATION_UP parasitic protozoa infectious disease DOID_2789 1.093E-05 2.591E-04 8.271E-03 0.07590776 LENAOUR_DENDRITIC_CELL_MATURATION_UP familial hyperlipidemia DOID_1168 1.17E-05 2.663E-04 8.548E-03 0.07720687 LENAOUR_DENDRITIC_CELL_MATURATION_UP hypersensitivity reaction type IV disease DOID_2916 1.337E-05 2.926E-04 4.079E-04 0.01160416 LENAOUR_DENDRITIC_CELL_MATURATION_UP pulmonary edema DOID_11396 1.385E-05 2.919E-04 1.007E-03 0.01791091 LENAOUR_DENDRITIC_CELL_MATURATION_UP hepatitis B DOID_2043 1.865E-05 3.789E-04 1.221E-03 0.02105166 LENAOUR_DENDRITIC_CELL_MATURATION_UP intracranial aneurysm DOID_10941 3.927E-05 7.704E-04 3.927E-05 3.724E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP middle cerebral artery infarction DOID_3525 3.927E-05 7.447E-04 1.98E-03 0.02816085 LENAOUR_DENDRITIC_CELL_MATURATION_UP malaria DOID_12365 4.85E-05 8.901E-04 0.0681076 0.27880017 LENAOUR_DENDRITIC_CELL_MATURATION_UP endometrial carcinoma DOID_2871 5.905E-05 1.05E-03 2.582E-03 0.03497833 LENAOUR_DENDRITIC_CELL_MATURATION_UP abdominal aortic aneurysm DOID_7693 6.484E-05 1.118E-03 2.744E-03 0.03631372 LENAOUR_DENDRITIC_CELL_MATURATION_UP celiac disease DOID_10608 7.099E-05 1.188E-03 2.911E-03 0.03764905 LENAOUR_DENDRITIC_CELL_MATURATION_UP endometrial cancer DOID_1380 7.099E-05 1.154E-03 2.911E-03 0.0368124 LENAOUR_DENDRITIC_CELL_MATURATION_UP lymphoma DOID_0060058 7.364E-05 1.164E-03 0.1984484 0.54814145 LENAOUR_DENDRITIC_CELL_MATURATION_UP mouth disease DOID_403 7.993E-05 1.229E-03 1.526E-03 0.02285327 LENAOUR_DENDRITIC_CELL_MATURATION_UP hepatitis C DOID_1883 9.172E-05 1.373E-03 3.441E-03 0.04165208 LENAOUR_DENDRITIC_CELL_MATURATION_UP uveitis DOID_13141 1.25E-04 1.823E-03 4.21E-03 0.04791385 LENAOUR_DENDRITIC_CELL_MATURATION_UP hepatitis DOID_2237 1.344E-04 1.911E-03 0.09404781 0.33869118 LENAOUR_DENDRITIC_CELL_MATURATION_UP systemic scleroderma DOID_418 1.344E-04 1.865E-03 0.09404781 0.33656105 LENAOUR_DENDRITIC_CELL_MATURATION_UP intracranial arterial disease DOID_13089 1.442E-04 1.954E-03 4.622E-03 0.051572 LENAOUR_DENDRITIC_CELL_MATURATION_UP cerebral arterial disease DOID_3527 1.442E-04 1.954E-03 4.622E-03 0.051572 LENAOUR_DENDRITIC_CELL_MATURATION_UP adenoid cystic carcinoma DOID_4866 1.442E-04 1.908E-03 1.442E-04 6.837E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP lymphatic system disease DOID_75 1.442E-04 1.865E-03 0.09617699 0.34202942 LENAOUR_DENDRITIC_CELL_MATURATION_UP benign mesothelioma DOID_2645 1.545E-04 1.953E-03 0.09830122 0.34741238 LENAOUR_DENDRITIC_CELL_MATURATION_UP salivary gland cancer DOID_8850 1.652E-04 2.044E-03 1.652E-04 7.232E-03 LENAOUR_DENDRITIC_CELL_MATURATION_UP rheumatic disease DOID_1575 1.765E-04 2.136E-03 0.10253487 0.35358996 LENAOUR_DENDRITIC_CELL_MATURATION_UP scleroderma DOID_419 1.765E-04 2.136E-03 0.10253487 0.35358996 LENAOUR_DENDRITIC_CELL_MATURATION_UP uterine cancer DOID_363 1.882E-04 2.231E-03 5.5E-03 0.0590481 LENAOUR_DENDRITIC_CELL_MATURATION_UP influenza DOID_8469 1.882E-04 2.185E-03 5.5E-03 0.05795462 LENAOUR_DENDRITIC_CELL_MATURATION_UP cerebral infarction DOID_3526 2.004E-04 2.28E-03 5.731E-03 0.05928472 LENAOUR_DENDRITIC_CELL_MATURATION_UP proteinuria DOID_576 2.131E-04 2.377E-03 0.10884853 0.36432244 LENAOUR_DENDRITIC_CELL_MATURATION_UP vascular skin disease DOID_9540 2.263E-04 2.476E-03 0.11094331 0.35867468 LENAOUR_DENDRITIC_CELL_MATURATION_UP angioedema DOID_1558 2.422E-04 2.601E-03 0.0232323 0.1739366 LENAOUR_DENDRITIC_CELL_MATURATION_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.543E-04 2.68E-03 6.696E-03 0.06683856 LENAOUR_DENDRITIC_CELL_MATURATION_UP pulmonary tuberculosis DOID_2957 2.543E-04 2.631E-03 6.696E-03 0.06457284 LENAOUR_DENDRITIC_CELL_MATURATION_UP aortic aneurysm DOID_3627 2.691E-04 2.734E-03 6.948E-03 0.06588661 LENAOUR_DENDRITIC_CELL_MATURATION_UP common variable immunodeficiency DOID_12177 2.956E-04 2.951E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP invasive lobular carcinoma DOID_3457 2.956E-04 2.9E-03 2.956E-04 0.01051303 LENAOUR_DENDRITIC_CELL_MATURATION_UP atopic dermatitis DOID_3310 3.004E-04 2.897E-03 7.464E-03 0.06962702 LENAOUR_DENDRITIC_CELL_MATURATION_UP peritonitis DOID_8283 3.542E-04 3.359E-03 3.542E-04 0.01060747 LENAOUR_DENDRITIC_CELL_MATURATION_UP encephalitis DOID_9588 3.542E-04 3.304E-03 0.02781432 0.16836538 LENAOUR_DENDRITIC_CELL_MATURATION_UP oral cavity cancer DOID_8618 4.079E-04 3.743E-03 4.079E-04 0.01105158 LENAOUR_DENDRITIC_CELL_MATURATION_UP collagen disease DOID_854 4.698E-04 4.243E-03 0.13976403 0.42527129 LENAOUR_DENDRITIC_CELL_MATURATION_UP aspergillosis DOID_13564 4.869E-04 4.329E-03 4.869E-04 0.01259252 LENAOUR_DENDRITIC_CELL_MATURATION_UP respiratory failure DOID_11162 4.917E-04 4.304E-03 0.01029791 0.09155486 LENAOUR_DENDRITIC_CELL_MATURATION_UP adrenal cortex disease DOID_3952 5.609E-04 4.836E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP nutritional deficiency disease DOID_5113 5.609E-04 4.764E-03 5.609E-04 0.01387688 LENAOUR_DENDRITIC_CELL_MATURATION_UP cholestasis DOID_13580 5.613E-04 4.697E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP brain infarction DOID_3454 6.369E-04 5.252E-03 0.0121918 0.10201669 LENAOUR_DENDRITIC_CELL_MATURATION_UP nephrosis DOID_2527 7.187E-04 5.842E-03 7.187E-04 0.0157278 LENAOUR_DENDRITIC_CELL_MATURATION_UP bile duct disease DOID_4138 7.187E-04 5.759E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP lymphatic system cancer DOID_0060073 7.243E-04 5.724E-03 7.243E-04 0.01526436 LENAOUR_DENDRITIC_CELL_MATURATION_UP reticulosarcoma DOID_8538 7.243E-04 5.724E-03 7.243E-04 0.01526436 LENAOUR_DENDRITIC_CELL_MATURATION_UP lymphosarcoma DOID_8675 7.243E-04 5.724E-03 7.243E-04 0.01526436 LENAOUR_DENDRITIC_CELL_MATURATION_UP adrenal gland disease DOID_9553 7.243E-04 5.646E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP peripheral vascular disease DOID_341 7.473E-04 5.747E-03 0.16175909 0.47200472 LENAOUR_DENDRITIC_CELL_MATURATION_UP biliary tract disease DOID_9741 7.473E-04 5.67E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP diabetic retinopathy DOID_8947 7.767E-04 5.815E-03 0.16373085 0.47290788 LENAOUR_DENDRITIC_CELL_MATURATION_UP keratosis DOID_161 8.136E-04 6.012E-03 0.04143322 0.21628899 LENAOUR_DENDRITIC_CELL_MATURATION_UP prion disease DOID_649 8.136E-04 5.935E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP bone resorption disease DOID_0080011 8.693E-04 6.261E-03 0.01493416 0.1231527 LENAOUR_DENDRITIC_CELL_MATURATION_UP osteoporosis DOID_11476 8.693E-04 6.261E-03 0.01493416 0.1231527 LENAOUR_DENDRITIC_CELL_MATURATION_UP mixed glioma DOID_5076 9.017E-04 6.413E-03 0.01529397 0.1243181 LENAOUR_DENDRITIC_CELL_MATURATION_UP agammaglobulinemia DOID_2583 9.079E-04 6.378E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP testicular cancer DOID_2998 9.079E-04 6.3E-03 9.079E-04 0.01722074 LENAOUR_DENDRITIC_CELL_MATURATION_UP metabolic syndrome X DOID_14221 9.686E-04 6.64E-03 0.01602471 0.12842339 LENAOUR_DENDRITIC_CELL_MATURATION_UP blood protein disease DOID_620 1.007E-03 6.823E-03 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP retinal vascular disease DOID_2462 1.15E-03 7.695E-03 0.18511981 0.51888263 LENAOUR_DENDRITIC_CELL_MATURATION_UP funisitis DOID_0050698 1.221E-03 8.078E-03 0.05040751 0.24725751 LENAOUR_DENDRITIC_CELL_MATURATION_UP familial hypercholesterolemia DOID_13810 1.221E-03 7.985E-03 0.05040751 0.2451442 LENAOUR_DENDRITIC_CELL_MATURATION_UP muscular atrophy DOID_767 1.221E-03 7.894E-03 1.221E-03 0.02043249 LENAOUR_DENDRITIC_CELL_MATURATION_UP primary immunodeficiency disease DOID_612 1.309E-03 8.367E-03 0.19276275 0.53765689 LENAOUR_DENDRITIC_CELL_MATURATION_UP amino acid metabolic disorder DOID_9252 1.309E-03 8.274E-03 1.309E-03 0.02068459 LENAOUR_DENDRITIC_CELL_MATURATION_UP myasthenia gravis DOID_437 1.335E-03 8.348E-03 0.05263807 0.24752943 LENAOUR_DENDRITIC_CELL_MATURATION_UP pulmonary embolism DOID_9477 1.335E-03 8.258E-03 0.05263807 0.2455005 LENAOUR_DENDRITIC_CELL_MATURATION_UP Human immunodeficiency virus infectious disease DOID_526 1.351E-03 8.263E-03 0.01989616 0.15298533 LENAOUR_DENDRITIC_CELL_MATURATION_UP lymphoblastic leukemia DOID_1037 1.481E-03 8.965E-03 1.481E-03 0.02277587 LENAOUR_DENDRITIC_CELL_MATURATION_UP Crohn's disease DOID_8778 1.526E-03 9.141E-03 0.20221681 0.55317965 LENAOUR_DENDRITIC_CELL_MATURATION_UP hypersensitivity reaction type I disease DOID_1205 1.572E-03 9.319E-03 0.20409445 0.55564469 LENAOUR_DENDRITIC_CELL_MATURATION_UP sphingolipidosis DOID_1927 1.578E-03 9.259E-03 0.05708366 0.26194034 LENAOUR_DENDRITIC_CELL_MATURATION_UP acute pancreatitis DOID_2913 1.578E-03 9.164E-03 1.578E-03 0.02302805 LENAOUR_DENDRITIC_CELL_MATURATION_UP urticaria DOID_1555 1.707E-03 9.813E-03 0.05929871 0.26567692 LENAOUR_DENDRITIC_CELL_MATURATION_UP bronchiolitis DOID_2942 1.707E-03 9.715E-03 0.05929871 0.26360132 LENAOUR_DENDRITIC_CELL_MATURATION_UP ulcerative colitis DOID_8577 1.716E-03 9.665E-03 0.0232457 0.15935909 LENAOUR_DENDRITIC_CELL_MATURATION_UP neuromuscular junction disease DOID_439 1.841E-03 0.0102703 0.06150862 0.26716341 LENAOUR_DENDRITIC_CELL_MATURATION_UP vitiligo DOID_12306 1.98E-03 0.01093625 0.0637134 0.27257838 LENAOUR_DENDRITIC_CELL_MATURATION_UP B cell deficiency DOID_2115 1.98E-03 0.0108311 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP extrinsic allergic alveolitis DOID_841 1.98E-03 0.01072794 0.0637134 0.26854018 LENAOUR_DENDRITIC_CELL_MATURATION_UP periodontitis DOID_824 2.123E-03 0.01139652 2.123E-03 0.02946417 LENAOUR_DENDRITIC_CELL_MATURATION_UP autoimmune disease of the nervous system DOID_438 2.271E-03 0.01207802 0.0681076 0.27291003 LENAOUR_DENDRITIC_CELL_MATURATION_UP allergic rhinitis DOID_4481 2.911E-03 0.0153385 0.07683491 0.29944566 LENAOUR_DENDRITIC_CELL_MATURATION_UP chronic leukemia DOID_1036 3.083E-03 0.01609433 3.083E-03 0.03813657 LENAOUR_DENDRITIC_CELL_MATURATION_UP chronic lymphocytic leukemia DOID_1040 3.083E-03 0.01609433 3.083E-03 0.03813657 LENAOUR_DENDRITIC_CELL_MATURATION_UP myocarditis DOID_820 3.259E-03 0.01686045 0.08116822 0.31418173 LENAOUR_DENDRITIC_CELL_MATURATION_UP metal metabolism disorder DOID_896 3.259E-03 0.01670856 0.08116822 0.31205888 LENAOUR_DENDRITIC_CELL_MATURATION_UP pneumoconiosis DOID_10316 3.441E-03 0.017479 0.08332732 0.3182097 LENAOUR_DENDRITIC_CELL_MATURATION_UP periodontal disease DOID_3388 3.441E-03 0.01732432 3.441E-03 0.04078433 LENAOUR_DENDRITIC_CELL_MATURATION_UP thyroid carcinoma DOID_3963 3.441E-03 0.01717235 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP esophageal disease DOID_6050 3.441E-03 0.01702302 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP thyroid cancer DOID_1781 3.816E-03 0.01871969 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP adenoma DOID_657 3.816E-03 0.0185597 3.816E-03 0.04431601 LENAOUR_DENDRITIC_CELL_MATURATION_UP nephrotic syndrome DOID_1184 5.274E-03 0.02543164 5.274E-03 0.05771026 LENAOUR_DENDRITIC_CELL_MATURATION_UP idiopathic generalized epilepsy DOID_1827 5.274E-03 0.02521793 0.10253487 0.3514599 LENAOUR_DENDRITIC_CELL_MATURATION_UP diabetic autonomic neuropathy DOID_11503 5.5E-03 0.02607958 0.10464433 0.35442037 LENAOUR_DENDRITIC_CELL_MATURATION_UP autonomic neuropathy DOID_11504 5.5E-03 0.02607958 0.10464433 0.35442037 LENAOUR_DENDRITIC_CELL_MATURATION_UP diabetic polyneuropathy DOID_12785 5.5E-03 0.02607958 0.10464433 0.35442037 LENAOUR_DENDRITIC_CELL_MATURATION_UP gallbladder cancer DOID_3121 5.5E-03 0.02586405 0.10464433 0.3523232 LENAOUR_DENDRITIC_CELL_MATURATION_UP diabetic neuropathy DOID_9743 5.5E-03 0.02607958 0.10464433 0.35442037 LENAOUR_DENDRITIC_CELL_MATURATION_UP pre-eclampsia DOID_10591 6.204E-03 0.02893699 0.11094331 0.36916225 LENAOUR_DENDRITIC_CELL_MATURATION_UP autonomic nervous system disease DOID_11465 6.204E-03 0.02870173 0.11094331 0.36701595 LENAOUR_DENDRITIC_CELL_MATURATION_UP brain cancer DOID_1319 6.204E-03 0.02847027 0.11094331 0.36489448 LENAOUR_DENDRITIC_CELL_MATURATION_UP thyroid adenoma DOID_2891 6.204E-03 0.02824251 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP central nervous system cancer DOID_3620 6.448E-03 0.02911772 0.11303322 0.36336668 LENAOUR_DENDRITIC_CELL_MATURATION_UP hemolytic anemia DOID_583 6.448E-03 0.02888845 6.448E-03 0.06551487 LENAOUR_DENDRITIC_CELL_MATURATION_UP normocytic anemia DOID_720 6.448E-03 0.02888845 6.448E-03 0.06551487 LENAOUR_DENDRITIC_CELL_MATURATION_UP glaucoma DOID_1686 6.696E-03 0.02976405 6.696E-03 0.06568617 LENAOUR_DENDRITIC_CELL_MATURATION_UP hemorrhagic disease DOID_2213 7.204E-03 0.03177533 0.11927385 0.37703788 LENAOUR_DENDRITIC_CELL_MATURATION_UP B-cell lymphocytic neoplasm DOID_707 7.204E-03 0.0315309 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP vasculitis DOID_865 7.998E-03 0.03473963 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP leukocyte disease DOID_9500 9.405E-03 0.04054052 0.13570406 0.41513768 LENAOUR_DENDRITIC_CELL_MATURATION_UP carotid artery disease DOID_3407 9.996E-03 0.04276561 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP congenital heart defect DOID_1682 0.01060365 0.04502595 0.01060365 0.09282272 LENAOUR_DENDRITIC_CELL_MATURATION_UP mineral metabolism disease DOID_0050032 0.01091338 0.04599787 0.14581865 0.43899901 LENAOUR_DENDRITIC_CELL_MATURATION_UP hyperglycemia DOID_4195 0.01154473 0.04830111 0.01154473 0.09952957 LENAOUR_DENDRITIC_CELL_MATURATION_UP tooth disease DOID_1091 0.01186631 0.04928417 0.01186631 0.10077508 LENAOUR_DENDRITIC_CELL_MATURATION_UP endocrine organ benign neoplasm DOID_0060089 0.0121918 0.05026909 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP blood coagulation disease DOID_1247 0.01285444 0.05261996 0.15780177 0.46765212 LENAOUR_DENDRITIC_CELL_MATURATION_UP pancreatic ductal carcinoma DOID_3587 0.01285444 0.0522441 0.15780177 0.46522906 LENAOUR_DENDRITIC_CELL_MATURATION_UP pancreatic carcinoma DOID_4905 0.01387723 0.05600101 0.16373085 0.47532067 LENAOUR_DENDRITIC_CELL_MATURATION_UP alcohol abuse DOID_1574 0.01714837 0.06871425 0.18127156 0.51315182 LENAOUR_DENDRITIC_CELL_MATURATION_UP biliary tract cancer DOID_4607 0.01714837 0.06823374 0.18127156 0.51061146 LENAOUR_DENDRITIC_CELL_MATURATION_UP transitional cell carcinoma DOID_2671 0.01909334 0.0754452 0.01909334 0.14882341 LENAOUR_DENDRITIC_CELL_MATURATION_UP nervous system cancer DOID_3093 0.01989616 0.07807527 0.19466238 0.54030681 LENAOUR_DENDRITIC_CELL_MATURATION_UP dilated cardiomyopathy DOID_12930 0.02196402 0.08559949 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP gallbladder disease DOID_0000000 0.0232323 0.08992641 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP Sjogren's syndrome DOID_12894 0.0232323 0.08931879 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP ventricular septal defect DOID_1657 0.0232323 0.08871934 0.0232323 0.17167768 LENAOUR_DENDRITIC_CELL_MATURATION_UP chondrosarcoma DOID_3371 0.0232323 0.08812788 0.0232323 0.16947669 LENAOUR_DENDRITIC_CELL_MATURATION_UP insulinoma DOID_3892 0.0232323 0.08754425 0.0232323 0.16733141 LENAOUR_DENDRITIC_CELL_MATURATION_UP adrenal gland hyperfunction DOID_3947 0.0232323 0.0869683 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP Paget's disease of bone DOID_5408 0.0232323 0.08639988 0.0232323 0.16523977 LENAOUR_DENDRITIC_CELL_MATURATION_UP acute T cell leukemia DOID_5603 0.0232323 0.08583884 0.0232323 0.16319977 LENAOUR_DENDRITIC_CELL_MATURATION_UP cannabis abuse DOID_9505 0.0232323 0.08528504 0.0232323 0.16120953 LENAOUR_DENDRITIC_CELL_MATURATION_UP breast benign neoplasm DOID_0060082 0.02552597 0.09310435 0.02552597 0.17290808 LENAOUR_DENDRITIC_CELL_MATURATION_UP thoracic benign neoplasm DOID_0060097 0.02552597 0.09310435 0.02552597 0.17290808 LENAOUR_DENDRITIC_CELL_MATURATION_UP trypanosomiasis DOID_10113 0.02552597 0.09251133 0.02552597 0.17087387 LENAOUR_DENDRITIC_CELL_MATURATION_UP pneumocystosis DOID_11339 0.02552597 0.09192582 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP temporal arteritis DOID_13375 0.02552597 0.09134767 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP benign breast phyllodes tumor DOID_1631 0.02552597 0.09310435 0.02552597 0.17290808 LENAOUR_DENDRITIC_CELL_MATURATION_UP hemochromatosis DOID_2352 0.02552597 0.09077674 0.02552597 0.16888696 LENAOUR_DENDRITIC_CELL_MATURATION_UP central nervous system vasculitis DOID_525 0.02552597 0.09134767 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP eosinophilic pneumonia DOID_5870 0.02552597 0.09021291 0.02552597 0.16694573 LENAOUR_DENDRITIC_CELL_MATURATION_UP pulmonary eosinophilia DOID_9498 0.02552597 0.09021291 0.02552597 0.16694573 LENAOUR_DENDRITIC_CELL_MATURATION_UP Loeffler syndrome DOID_9503 0.02552597 0.09021291 0.02552597 0.16694573 LENAOUR_DENDRITIC_CELL_MATURATION_UP esophageal carcinoma DOID_1107 0.02781432 0.09769349 0.02781432 0.17984484 LENAOUR_DENDRITIC_CELL_MATURATION_UP beta thalassemia DOID_12241 0.02781432 0.09709415 0.02781432 0.17782411 LENAOUR_DENDRITIC_CELL_MATURATION_UP diarrhea DOID_13250 0.02781432 0.09650211 0.02781432 0.17584829 LENAOUR_DENDRITIC_CELL_MATURATION_UP osteopetrosis DOID_13533 0.02781432 0.09591725 0.02781432 0.17391589 LENAOUR_DENDRITIC_CELL_MATURATION_UP islet cell tumor DOID_1799 0.02781432 0.09533943 0.02781432 0.1720255 LENAOUR_DENDRITIC_CELL_MATURATION_UP relapsing-remitting multiple sclerosis DOID_2378 0.02781432 0.09476854 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP esophagus squamous cell carcinoma DOID_3748 0.02781432 0.09769349 0.02781432 0.17984484 LENAOUR_DENDRITIC_CELL_MATURATION_UP pituitary gland disease DOID_53 0.02781432 0.09420444 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP stomach disease DOID_76 0.02781432 0.09364702 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP lipodystrophy DOID_811 0.02781432 0.09309615 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP ocular hypertension DOID_9282 0.02781432 0.09255173 0.02781432 0.17017576 LENAOUR_DENDRITIC_CELL_MATURATION_UP borderline glaucoma DOID_9283 0.02781432 0.09255173 0.02781432 0.17017576 LENAOUR_DENDRITIC_CELL_MATURATION_UP berylliosis DOID_10322 0.03009735 0.09956622 0.03009735 0.18026726 LENAOUR_DENDRITIC_CELL_MATURATION_UP essential hypertension DOID_10825 0.03009735 0.09899069 0.03009735 0.17838947 LENAOUR_DENDRITIC_CELL_MATURATION_UP carotid stenosis DOID_13001 0.03009735 0.09842178 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP cannabis dependence DOID_1849 0.03009735 0.09785937 0.03009735 0.17655041 LENAOUR_DENDRITIC_CELL_MATURATION_UP larynx cancer DOID_2596 0.03009735 0.09730335 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP laryngeal benign neoplasm DOID_2598 0.03009735 0.09730335 1.000 1.000 LENAOUR_DENDRITIC_CELL_MATURATION_UP hallucinogen dependence DOID_9977 0.03009735 0.09785937 0.03009735 0.17655041 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP bone development disease DOID_0080006 9.938E-10 5.655E-07 9.938E-10 5.655E-07 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP osteochondrodysplasia DOID_2256 9.178E-09 2.611E-06 9.178E-09 2.611E-06 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP multiple epiphyseal dysplasia DOID_12721 5.825E-08 1.105E-05 5.825E-08 1.105E-05 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP endometrial carcinoma DOID_2871 6.652E-08 9.462E-06 6.652E-08 9.462E-06 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP endometrial cancer DOID_1380 8.563E-08 9.745E-06 8.563E-08 9.745E-06 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP uterine cancer DOID_363 3.256E-07 3.088E-05 3.256E-07 3.088E-05 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP cleft palate DOID_674 1.6E-05 1.301E-03 1.6E-05 1.301E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP adenoid cystic carcinoma DOID_4866 1.994E-05 1.418E-03 1.994E-05 1.418E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP salivary gland cancer DOID_8850 2.289E-05 1.447E-03 2.289E-05 1.447E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP orofacial cleft DOID_0050567 4.196E-05 2.388E-03 4.196E-05 2.388E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP reproductive organ benign neoplasm DOID_0050622 4.923E-05 2.546E-03 4.923E-05 2.546E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP oral cavity cancer DOID_8618 5.727E-05 2.716E-03 5.727E-05 2.716E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP pre-malignant neoplasm DOID_0060071 7.251E-05 3.174E-03 7.251E-05 3.174E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP in situ carcinoma DOID_8719 7.251E-05 3.174E-03 7.251E-05 3.174E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP mixed glioma DOID_5076 1.286E-04 5.229E-03 1.286E-04 5.229E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP lung oat cell carcinoma DOID_5411 1.497E-04 5.679E-03 1.497E-04 5.679E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP biliary tract cancer DOID_4607 1.54E-04 5.477E-03 1.54E-04 5.477E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP transitional cell carcinoma DOID_2671 1.824E-04 6.105E-03 1.824E-04 6.105E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP urinary system benign neoplasm DOID_731 1.936E-04 6.121E-03 1.936E-04 6.121E-03 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP cleft lip DOID_9296 4.959E-04 0.01484979 4.959E-04 0.01484979 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP diffuse large B-cell lymphoma DOID_0050745 5.727E-04 0.01629266 5.727E-04 0.01629266 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP female reproductive organ benign neoplasm DOID_0060086 6.98E-04 0.01891263 6.98E-04 0.01891263 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP uterine benign neoplasm DOID_0060095 6.98E-04 0.01891263 6.98E-04 0.01891263 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP uterine fibroid DOID_13223 6.98E-04 0.01891263 6.98E-04 0.01891263 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP leiomyoma DOID_127 8.354E-04 0.02160616 8.354E-04 0.02160616 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP nephroblastoma DOID_2154 9.336E-04 0.02309719 9.336E-04 0.02309719 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP embryonal cancer DOID_688 1.091E-03 0.02586368 1.091E-03 0.02586368 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP microcephaly DOID_10907 1.146E-03 0.02608229 1.146E-03 0.02608229 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP gallbladder cancer DOID_3121 1.504E-03 0.03290892 1.504E-03 0.03290892 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP thyroid adenoma DOID_2891 1.7E-03 0.0358285 1.7E-03 0.0358285 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP lung small cell carcinoma DOID_5409 1.837E-03 0.0373398 1.837E-03 0.0373398 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP B-cell lymphocytic neoplasm DOID_707 1.98E-03 0.03884708 1.98E-03 0.03884708 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP bile duct adenocarcinoma DOID_4896 2.203E-03 0.04178535 2.203E-03 0.04178535 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP cholangiocarcinoma DOID_4947 2.203E-03 0.04178535 2.203E-03 0.04178535 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP congenital nervous system abnormality DOID_2490 2.438E-03 0.04474245 2.438E-03 0.04474245 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP bile duct cancer DOID_4606 2.518E-03 0.04477903 2.518E-03 0.04477903 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP bile duct carcinoma DOID_4897 2.518E-03 0.04477903 2.518E-03 0.04477903 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP endocrine organ benign neoplasm DOID_0060089 3.393E-03 0.05851144 3.393E-03 0.05851144 NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP lymphoma DOID_0060058 5.864E-03 0.09814007 5.864E-03 0.09814007 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN sarcoma DOID_1115 3.744E-08 2.13E-05 7.1E-03 0.57714391 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN multiple myeloma DOID_9538 9.1E-08 2.589E-05 9.457E-03 0.53809989 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN myeloma DOID_0070004 1.803E-07 3.42E-05 0.01180872 0.61083276 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN bone marrow cancer DOID_4960 2.689E-07 3.826E-05 0.01345201 0.63784936 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN mesenchymal cell neoplasm DOID_3350 5.252E-06 5.977E-04 3.556E-03 0.67440075 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN spindle cell sarcoma DOID_4235 5.252E-06 5.977E-04 3.556E-03 0.67440075 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN epithelioid sarcoma DOID_6193 5.252E-06 5.977E-04 3.556E-03 0.67440075 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN tongue cancer DOID_8649 6.001E-06 5.691E-04 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN testicular cancer DOID_2998 8.549E-06 6.949E-04 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN seminoma DOID_4440 1.888E-05 1.343E-03 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN lung adenocarcinoma DOID_3910 2.027E-05 1.282E-03 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN germinoma DOID_3304 2.799E-05 1.593E-03 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN oral cavity cancer DOID_8618 9.101E-05 4.708E-03 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN transitional cell carcinoma DOID_2671 1.985E-04 9.411E-03 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN nervous system cancer DOID_3093 2.074E-04 9.078E-03 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN lymphoma DOID_0060058 2.165E-04 8.8E-03 0.02209768 0.78584887 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.258E-04 8.566E-03 0.02256309 0.75519999 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Noonan syndrome DOID_3490 2.372E-03 0.08434457 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN labyrinthine disease DOID_4539 2.372E-03 0.07938313 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 2.372E-03 0.07497295 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Hodgkin's lymphoma, lymphocytic depletion DOID_8628 2.372E-03 0.07497295 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Hodgkin's granuloma DOID_8651 2.372E-03 0.07497295 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Hodgkin's lymphoma, mixed cellularity DOID_8654 2.372E-03 0.07497295 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN inner ear disease DOID_2952 2.609E-03 0.07812147 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN invasive lobular carcinoma DOID_3457 2.609E-03 0.07421539 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN chronic monocytic leukemia DOID_8593 2.609E-03 0.07068133 2.609E-03 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN peritonitis DOID_8283 2.845E-03 0.07359428 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Hodgkin's lymphoma DOID_8567 2.845E-03 0.07039453 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Charcot-Marie-Tooth disease type 2 DOID_0050539 3.082E-03 0.0730755 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN larynx cancer DOID_2596 3.082E-03 0.07015248 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN laryngeal benign neoplasm DOID_2598 3.082E-03 0.07015248 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN monocytic leukemia DOID_8527 3.082E-03 0.06745431 3.082E-03 0.87690598 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN angiosarcoma DOID_0001816 3.792E-03 0.07992055 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN chronic myeloid leukemia DOID_8552 3.792E-03 0.07706624 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Barrett's esophagus DOID_9206 3.792E-03 0.07440878 3.792E-03 0.53946369 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN drug-induced mental disorder DOID_1203 4.029E-03 0.07641596 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN drug psychosis DOID_1742 4.029E-03 0.07641596 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN substance-induced psychosis DOID_8646 4.029E-03 0.07641596 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN male reproductive organ benign neoplasm DOID_0060087 4.266E-03 0.07829273 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Down syndrome DOID_14250 4.502E-03 0.0800513 4.502E-03 0.51232835 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN granulosa cell tumor DOID_2999 4.502E-03 0.07762551 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN sex cord-gonadal stromal tumor DOID_192 4.738E-03 0.07929943 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN subependymal glioma DOID_4843 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN pilocytic astrocytoma DOID_4851 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN subependymal giant cell astrocytoma DOID_5077 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN fibrillary astrocytoma DOID_6726 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN juvenile pilocytic astrocytoma DOID_6811 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN childhood pilocytic astrocytoma DOID_6812 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN gemistocytic astrocytoma DOID_7005 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN childhood cerebral astrocytoma DOID_7007 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN protoplasmic astrocytoma DOID_7008 4.738E-03 0.07703373 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN benign glioma DOID_0060101 5.211E-03 0.08236592 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN benign ependymoma DOID_4844 5.211E-03 0.08236592 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN lingual-facial-buccal dyskinesia DOID_9854 5.447E-03 0.08377369 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN meningitis DOID_9471 5.684E-03 0.08510663 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN osteosarcoma DOID_3347 6.156E-03 0.08981583 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN hypotrichosis DOID_4535 6.628E-03 0.09428673 6.628E-03 0.62857817 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN fragments of torsion dystonia DOID_531 6.628E-03 0.09198705 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN central nervous system hereditary degenerative disease DOID_481 7.1E-03 0.09619065 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN supratentorial cancer DOID_1659 7.336E-03 0.09707521 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN toxic encephalopathy DOID_3602 7.336E-03 0.09486896 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN cerebrum cancer DOID_368 7.336E-03 0.09707521 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN dystonic disease DOID_544 7.336E-03 0.09276076 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN Charcot-Marie-Tooth disease DOID_10595 8.043E-03 0.09949443 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN allergic rhinitis DOID_4481 8.043E-03 0.09737753 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN autonomic nervous system neoplasm DOID_2621 8.279E-03 0.09814286 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN neuroblastoma DOID_769 8.279E-03 0.09814286 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN papilloma DOID_2615 8.515E-03 0.09887637 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN hair disease DOID_421 8.515E-03 0.09689884 8.515E-03 0.60561778 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN nephroblastoma DOID_2154 8.75E-03 0.09762743 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN thyroid carcinoma DOID_3963 8.75E-03 0.09574998 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN esophageal disease DOID_6050 8.75E-03 0.09394337 8.75E-03 0.5532221 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN thyroid cancer DOID_1781 9.221E-03 0.09716717 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN adenoma DOID_657 9.221E-03 0.09540049 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN embryonal cancer DOID_688 9.457E-03 0.09608927 1.000 1.000 TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN peripheral nervous system neoplasm DOID_1192 9.692E-03 0.09675337 1.000 1.000 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP Goodpasture syndrome DOID_9808 4.756E-10 2.706E-07 2.146E-07 1.221E-04 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP atopic dermatitis DOID_3310 1.512E-08 4.3E-06 2.754E-06 7.835E-04 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP bronchiolitis obliterans DOID_2799 5.767E-07 1.094E-04 1.245E-04 0.02361063 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP allergic contact dermatitis DOID_3042 5.719E-06 8.135E-04 5.631E-04 0.0640828 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP contact dermatitis DOID_2773 9.217E-06 1.049E-03 7.716E-04 0.07317382 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP primary bacterial infectious disease DOID_0050338 1.179E-05 1.118E-03 9.079E-04 0.07380318 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP hypersensitivity reaction type I disease DOID_1205 1.527E-05 1.241E-03 1.077E-03 0.07659779 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP common cold DOID_10459 1.566E-05 1.114E-03 5.998E-03 0.31028106 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP cystitis DOID_1679 8.29E-05 5.241E-03 0.01344848 0.31884103 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP bladder disease DOID_365 1.402E-04 7.977E-03 0.01740019 0.34140377 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP integumentary system cancer DOID_0060122 3.868E-04 0.02000926 3.868E-04 0.05502547 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP skin cancer DOID_4159 3.868E-04 0.02000926 3.868E-04 0.05502547 ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP tuberculosis DOID_399 5.793E-04 0.02746691 0.03499806 0.36877586 ABE_VEGFA_TARGETS_30MIN chronic kidney failure DOID_784 5.477E-08 3.116E-05 0.03744728 0.33821435 ABE_VEGFA_TARGETS_30MIN spindle cell carcinoma DOID_4015 5.764E-07 1.64E-04 0.01646603 0.26769054 ABE_VEGFA_TARGETS_30MIN bile duct cancer DOID_4606 2.652E-06 5.03E-04 1.000 1.000 ABE_VEGFA_TARGETS_30MIN bile duct carcinoma DOID_4897 2.652E-06 5.03E-04 1.000 1.000 ABE_VEGFA_TARGETS_30MIN pancreatitis DOID_4989 6.023E-06 8.567E-04 5.859E-04 0.33336251 ABE_VEGFA_TARGETS_30MIN biliary tract cancer DOID_4607 7.23E-06 8.228E-04 1.000 1.000 ABE_VEGFA_TARGETS_30MIN amnestic disorder DOID_10914 3.579E-05 3.394E-03 8.932E-03 0.25412962 ABE_VEGFA_TARGETS_30MIN age related macular degeneration DOID_10871 9.911E-05 8.057E-03 0.0146983 0.27877768 ABE_VEGFA_TARGETS_30MIN degeneration of macula and posterior pole DOID_2007 9.911E-05 8.057E-03 0.0146983 0.27877768 ABE_VEGFA_TARGETS_30MIN abdominal aortic aneurysm DOID_7693 9.911E-05 7.049E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN allergic rhinitis DOID_4481 1.053E-04 6.656E-03 0.01514051 0.26921717 ABE_VEGFA_TARGETS_30MIN papilloma DOID_2615 1.182E-04 6.724E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN thyroid carcinoma DOID_3963 1.249E-04 6.46E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN macular degeneration DOID_4448 1.249E-04 5.922E-03 0.01646603 0.26025469 ABE_VEGFA_TARGETS_30MIN thyroid cancer DOID_1781 1.389E-04 6.079E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN pulmonary emphysema DOID_9675 1.771E-04 7.196E-03 0.01955237 0.25872791 ABE_VEGFA_TARGETS_30MIN Huntington's disease DOID_12858 1.936E-04 7.345E-03 0.02043251 0.26422951 ABE_VEGFA_TARGETS_30MIN gallbladder cancer DOID_3121 2.022E-04 7.19E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN influenza DOID_8469 2.022E-04 6.767E-03 0.0208723 0.26391865 ABE_VEGFA_TARGETS_30MIN proteinuria DOID_576 2.198E-04 6.949E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN thyroid adenoma DOID_2891 2.289E-04 6.856E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN aortic aneurysm DOID_3627 2.573E-04 7.32E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN sarcoidosis DOID_11335 2.873E-04 7.785E-03 0.02482206 0.2942448 ABE_VEGFA_TARGETS_30MIN bile duct adenocarcinoma DOID_4896 2.977E-04 7.7E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN cholangiocarcinoma DOID_4947 2.977E-04 7.7E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN bone marrow cancer DOID_4960 2.977E-04 7.365E-03 0.02525999 0.29332521 ABE_VEGFA_TARGETS_30MIN hypersensitivity reaction type IV disease DOID_2916 3.41E-04 8.084E-03 0.02700988 0.30134553 ABE_VEGFA_TARGETS_30MIN cholestasis DOID_13580 4.237E-04 9.643E-03 0.03006507 0.31103686 ABE_VEGFA_TARGETS_30MIN endocrine organ benign neoplasm DOID_0060089 4.618E-04 0.01010678 1.000 1.000 ABE_VEGFA_TARGETS_30MIN astrocytoma DOID_3069 4.749E-04 0.01000789 1.000 1.000 ABE_VEGFA_TARGETS_30MIN bile duct disease DOID_4138 5.016E-04 0.01019255 0.03267662 0.33201783 ABE_VEGFA_TARGETS_30MIN male reproductive system disease DOID_48 5.016E-04 9.841E-03 0.03267662 0.32619296 ABE_VEGFA_TARGETS_30MIN biliary tract disease DOID_9741 5.152E-04 9.771E-03 0.03311124 0.32483266 ABE_VEGFA_TARGETS_30MIN pancreatic carcinoma DOID_4905 5.29E-04 9.709E-03 1.000 1.000 ABE_VEGFA_TARGETS_30MIN aneurysm disease DOID_2403 5.714E-04 0.01015982 1.000 1.000 ABE_VEGFA_TARGETS_30MIN transitional cell carcinoma DOID_2671 7.406E-04 0.0127695 1.000 1.000 ABE_VEGFA_TARGETS_30MIN lymphoma DOID_0060058 8.074E-04 0.0135123 1.000 1.000 ABE_VEGFA_TARGETS_30MIN alcohol-related neurodevelopmental disorder DOID_0050667 8.419E-04 0.01368659 0.04219579 0.37514697 ABE_VEGFA_TARGETS_30MIN dilated cardiomyopathy DOID_12930 8.594E-04 0.01358296 1.000 1.000 ABE_VEGFA_TARGETS_30MIN gallbladder disease DOID_0000000 4.476E-03 0.06882869 1.000 1.000 ABE_VEGFA_TARGETS_30MIN Gilles de la Tourette syndrome DOID_11119 4.476E-03 0.06701741 4.476E-03 1.000 ABE_VEGFA_TARGETS_30MIN hyperparathyroidism DOID_13543 4.476E-03 0.06529901 1.000 1.000 ABE_VEGFA_TARGETS_30MIN familial combined hyperlipidemia DOID_13809 4.476E-03 0.06366654 1.000 1.000 ABE_VEGFA_TARGETS_30MIN childhood type dermatomyositis DOID_14203 4.476E-03 0.06211369 4.476E-03 0.84888714 ABE_VEGFA_TARGETS_30MIN Noonan syndrome DOID_3490 4.476E-03 0.0606348 1.000 1.000 ABE_VEGFA_TARGETS_30MIN labyrinthine disease DOID_4539 4.476E-03 0.05922468 4.476E-03 0.63666535 ABE_VEGFA_TARGETS_30MIN familial adenomatous polyposis DOID_0050424 4.922E-03 0.06365311 1.000 1.000 ABE_VEGFA_TARGETS_30MIN Charcot-Marie-Tooth disease type 4 DOID_0050541 4.922E-03 0.06223859 4.922E-03 0.56014734 ABE_VEGFA_TARGETS_30MIN dermatomyositis DOID_10223 4.922E-03 0.06088558 4.922E-03 0.46678945 ABE_VEGFA_TARGETS_30MIN migraine without aura DOID_12783 4.922E-03 0.05959014 4.922E-03 0.40010524 ABE_VEGFA_TARGETS_30MIN inner ear disease DOID_2952 4.922E-03 0.05834868 4.922E-03 0.35009208 ABE_VEGFA_TARGETS_30MIN Usher syndrome DOID_0050439 5.369E-03 0.06234091 5.369E-03 0.33941163 ABE_VEGFA_TARGETS_30MIN porphyria DOID_13268 5.369E-03 0.06109409 5.369E-03 0.30547047 ABE_VEGFA_TARGETS_30MIN aortic valve stenosis DOID_1712 5.369E-03 0.05989617 5.369E-03 0.27770043 ABE_VEGFA_TARGETS_30MIN relapsing-remitting multiple sclerosis DOID_2378 5.369E-03 0.05874432 1.000 1.000 ABE_VEGFA_TARGETS_30MIN tic disorder DOID_2769 5.369E-03 0.05763594 5.369E-03 0.25455872 ABE_VEGFA_TARGETS_30MIN stomach disease DOID_76 5.369E-03 0.05656861 1.000 1.000 ABE_VEGFA_TARGETS_30MIN parathyroid gland disease DOID_11201 5.815E-03 0.06015574 1.000 1.000 ABE_VEGFA_TARGETS_30MIN carotid stenosis DOID_13001 5.815E-03 0.05908153 1.000 1.000 ABE_VEGFA_TARGETS_30MIN larynx cancer DOID_2596 5.815E-03 0.05804501 1.000 1.000 ABE_VEGFA_TARGETS_30MIN laryngeal benign neoplasm DOID_2598 5.815E-03 0.05804501 1.000 1.000 ABE_VEGFA_TARGETS_30MIN epilepsy with generalized tonic-clonic seizures DOID_7725 5.815E-03 0.05704423 5.815E-03 0.25450504 ABE_VEGFA_TARGETS_30MIN open-angle glaucoma DOID_1067 6.261E-03 0.06037829 1.000 1.000 ABE_VEGFA_TARGETS_30MIN polycystic kidney disease DOID_898 6.261E-03 0.05937198 1.000 1.000 ABE_VEGFA_TARGETS_30MIN narcolepsy DOID_8986 6.261E-03 0.05839867 6.261E-03 0.25445136 ABE_VEGFA_TARGETS_30MIN idiopathic pulmonary fibrosis DOID_0050156 6.706E-03 0.06154783 1.000 1.000 ABE_VEGFA_TARGETS_30MIN peripheral neuropathy DOID_0060053 6.706E-03 0.06057088 6.706E-03 0.2543977 ABE_VEGFA_TARGETS_30MIN skeletal system cancer DOID_0060124 6.706E-03 0.05962446 1.000 1.000 ABE_VEGFA_TARGETS_30MIN bone cancer DOID_184 6.706E-03 0.05962446 1.000 1.000 ABE_VEGFA_TARGETS_30MIN oral submucous fibrosis DOID_5773 6.706E-03 0.05870716 1.000 1.000 ABE_VEGFA_TARGETS_30MIN angiosarcoma DOID_0001816 7.152E-03 0.06165917 1.000 1.000 ABE_VEGFA_TARGETS_30MIN silicosis DOID_10325 7.152E-03 0.06073888 7.152E-03 0.25434406 ABE_VEGFA_TARGETS_30MIN tongue cancer DOID_8649 7.152E-03 0.05984566 1.000 1.000 ABE_VEGFA_TARGETS_30MIN Barrett's esophagus DOID_9206 7.152E-03 0.05897833 1.000 1.000 ABE_VEGFA_TARGETS_30MIN bronchitis DOID_6132 7.597E-03 0.06175625 7.597E-03 0.25429043 ABE_VEGFA_TARGETS_30MIN urinary system benign neoplasm DOID_731 7.597E-03 0.06088644 1.000 1.000 ABE_VEGFA_TARGETS_30MIN male reproductive organ benign neoplasm DOID_0060087 8.043E-03 0.0635592 1.000 1.000 ABE_VEGFA_TARGETS_30MIN prion disease DOID_649 8.043E-03 0.06268853 1.000 1.000 ABE_VEGFA_TARGETS_30MIN dissociative disorder DOID_10935 8.488E-03 0.06526326 8.488E-03 0.2683045 ABE_VEGFA_TARGETS_30MIN dissociative amnesia DOID_11037 8.488E-03 0.06526326 8.488E-03 0.2683045 ABE_VEGFA_TARGETS_30MIN Down syndrome DOID_14250 8.488E-03 0.06439308 8.488E-03 0.25418321 ABE_VEGFA_TARGETS_30MIN granulosa cell tumor DOID_2999 8.488E-03 0.0635458 1.000 1.000 ABE_VEGFA_TARGETS_30MIN membranous glomerulonephritis DOID_10976 8.932E-03 0.06600769 1.000 1.000 ABE_VEGFA_TARGETS_30MIN esophagitis DOID_11963 8.932E-03 0.06516144 1.000 1.000 ABE_VEGFA_TARGETS_30MIN sex cord-gonadal stromal tumor DOID_192 8.932E-03 0.06433661 1.000 1.000 ABE_VEGFA_TARGETS_30MIN subependymal glioma DOID_4843 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN pilocytic astrocytoma DOID_4851 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN subependymal giant cell astrocytoma DOID_5077 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN fibrillary astrocytoma DOID_6726 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN juvenile pilocytic astrocytoma DOID_6811 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN childhood pilocytic astrocytoma DOID_6812 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN gemistocytic astrocytoma DOID_7005 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN childhood cerebral astrocytoma DOID_7007 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN protoplasmic astrocytoma DOID_7008 8.932E-03 0.06353241 1.000 1.000 ABE_VEGFA_TARGETS_30MIN amyloidosis DOID_9120 8.932E-03 0.06274805 1.000 1.000 ABE_VEGFA_TARGETS_30MIN benign glioma DOID_0060101 9.822E-03 0.06815237 1.000 1.000 ABE_VEGFA_TARGETS_30MIN gastric ulcer DOID_10808 9.822E-03 0.06733126 1.000 1.000 ABE_VEGFA_TARGETS_30MIN familial hypercholesterolemia DOID_13810 9.822E-03 0.0665297 1.000 1.000 ABE_VEGFA_TARGETS_30MIN benign ependymoma DOID_4844 9.822E-03 0.06815237 1.000 1.000 ABE_VEGFA_TARGETS_30MIN muscle cancer DOID_4045 0.01026588 0.06872101 1.000 1.000 ABE_VEGFA_TARGETS_30MIN urinary tract obstruction DOID_5200 0.01026588 0.06792193 1.000 1.000 ABE_VEGFA_TARGETS_30MIN sleep disorder DOID_535 0.01026588 0.06714121 0.01026588 0.27815646 ABE_VEGFA_TARGETS_30MIN aortic valve disease DOID_62 0.01070996 0.06924966 0.01070996 0.27699863 ABE_VEGFA_TARGETS_30MIN spastic quadriplegia DOID_10970 0.01115386 0.07130952 1.000 1.000 ABE_VEGFA_TARGETS_30MIN sphingolipidosis DOID_1927 0.01115386 0.07051719 1.000 1.000 ABE_VEGFA_TARGETS_30MIN portal hypertension DOID_10762 0.01159757 0.07251668 1.000 1.000 ABE_VEGFA_TARGETS_30MIN osteosarcoma DOID_3347 0.01159757 0.07172846 0.01159757 0.28691383 ABE_VEGFA_TARGETS_30MIN autosomal dominant nonsyndromic deafness DOID_0050564 0.01204109 0.07367078 0.01204109 0.28547426 ABE_VEGFA_TARGETS_30MIN cystitis DOID_1679 0.01204109 0.07288705 1.000 1.000 ABE_VEGFA_TARGETS_30MIN papillary adenoma DOID_3172 0.01204109 0.07211981 1.000 1.000 ABE_VEGFA_TARGETS_30MIN microcystic adenoma DOID_5403 0.01204109 0.07211981 1.000 1.000 ABE_VEGFA_TARGETS_30MIN follicular adenoma DOID_6204 0.01204109 0.07211981 1.000 1.000 ABE_VEGFA_TARGETS_30MIN myositis DOID_633 0.01204109 0.07136857 0.01204109 0.27405529 ABE_VEGFA_TARGETS_30MIN middle cerebral artery infarction DOID_3525 0.01248443 0.0732334 1.000 1.000 ABE_VEGFA_TARGETS_30MIN seminoma DOID_4440 0.01248443 0.07248612 1.000 1.000 ABE_VEGFA_TARGETS_30MIN lung adenocarcinoma DOID_3910 0.01292758 0.07430092 0.01292758 0.28291503 ABE_VEGFA_TARGETS_30MIN migraine DOID_6364 0.01292758 0.07355791 0.01292758 0.2724367 ABE_VEGFA_TARGETS_30MIN perinatal necrotizing enterocolitis DOID_8677 0.01292758 0.07282961 0.01292758 0.26270682 ABE_VEGFA_TARGETS_30MIN pleurisy DOID_10247 0.01337054 0.07458662 1.000 1.000 ABE_VEGFA_TARGETS_30MIN sarcoma DOID_1115 0.01337054 0.07386248 1.000 1.000 ABE_VEGFA_TARGETS_30MIN hepatic vascular disease DOID_272 0.01337054 0.07315226 1.000 1.000 ABE_VEGFA_TARGETS_30MIN supratentorial cancer DOID_1659 0.01381331 0.07485499 1.000 1.000 ABE_VEGFA_TARGETS_30MIN cerebrum cancer DOID_368 0.01381331 0.07485499 1.000 1.000 ABE_VEGFA_TARGETS_30MIN corneal disease DOID_10124 0.0142559 0.07652458 0.0142559 0.27971052 ABE_VEGFA_TARGETS_30MIN endometrial carcinoma DOID_2871 0.0142559 0.07580939 1.000 1.000 ABE_VEGFA_TARGETS_30MIN spastic cerebral palsy DOID_0050669 0.0146983 0.07743825 1.000 1.000 ABE_VEGFA_TARGETS_30MIN Charcot-Marie-Tooth disease DOID_10595 0.01514051 0.07903623 0.01514051 0.2779016 ABE_VEGFA_TARGETS_30MIN endometrial cancer DOID_1380 0.01514051 0.07831772 1.000 1.000 ABE_VEGFA_TARGETS_30MIN germinoma DOID_3304 0.01514051 0.07761216 1.000 1.000 ABE_VEGFA_TARGETS_30MIN chronic leukemia DOID_1036 0.01558253 0.07916484 1.000 1.000 ABE_VEGFA_TARGETS_30MIN chronic lymphocytic leukemia DOID_1040 0.01558253 0.07916484 1.000 1.000 ABE_VEGFA_TARGETS_30MIN pleural disease DOID_1532 0.01558253 0.07846427 1.000 1.000 ABE_VEGFA_TARGETS_30MIN bladder disease DOID_365 0.01558253 0.07777598 1.000 1.000 ABE_VEGFA_TARGETS_30MIN myocarditis DOID_820 0.01602437 0.07928581 1.000 1.000 ABE_VEGFA_TARGETS_30MIN metal metabolism disorder DOID_896 0.01602437 0.07860232 1.000 1.000 ABE_VEGFA_TARGETS_30MIN pneumoconiosis DOID_10316 0.01646603 0.08007837 0.01646603 0.28391421 ABE_VEGFA_TARGETS_30MIN male infertility DOID_12336 0.01646603 0.07939974 0.01646603 0.27556379 ABE_VEGFA_TARGETS_30MIN nephroblastoma DOID_2154 0.01646603 0.07873251 1.000 1.000 ABE_VEGFA_TARGETS_30MIN esophageal disease DOID_6050 0.01646603 0.07807641 1.000 1.000 ABE_VEGFA_TARGETS_30MIN autosomal recessive nonsyndromic deafness DOID_0050565 0.01734877 0.08158224 0.01734877 0.26679597 ABE_VEGFA_TARGETS_30MIN adenoma DOID_657 0.01734877 0.08091353 1.000 1.000 ABE_VEGFA_TARGETS_30MIN adolescence-adult electroclinical syndrome DOID_0050705 0.01778986 0.0822962 0.01778986 0.26637981 ABE_VEGFA_TARGETS_30MIN pulmonary sarcoidosis DOID_13406 0.01778986 0.08163252 0.01778986 0.25954956 ABE_VEGFA_TARGETS_30MIN multiple myeloma DOID_9538 0.01778986 0.08097946 1.000 1.000 ABE_VEGFA_TARGETS_30MIN microcephaly DOID_10907 0.01823077 0.08232785 1.000 1.000 ABE_VEGFA_TARGETS_30MIN respiratory syncytial virus infectious disease DOID_1273 0.01867149 0.08365416 0.01867149 0.26560196 ABE_VEGFA_TARGETS_30MIN systemic scleroderma DOID_418 0.01867149 0.08300061 1.000 1.000 ABE_VEGFA_TARGETS_30MIN peptic ulcer DOID_750 0.01867149 0.0823572 1.000 1.000 ABE_VEGFA_TARGETS_30MIN adult respiratory distress syndrome DOID_11394 0.01911203 0.08365186 0.01911203 0.26523762 ABE_VEGFA_TARGETS_30MIN intracranial arterial disease DOID_13089 0.01911203 0.0830133 1.000 1.000 ABE_VEGFA_TARGETS_30MIN cerebral arterial disease DOID_3527 0.01911203 0.0830133 1.000 1.000 ABE_VEGFA_TARGETS_30MIN lymphatic system disease DOID_75 0.01911203 0.08238441 1.000 1.000 ABE_VEGFA_TARGETS_30MIN benign mesothelioma DOID_2645 0.01955237 0.08364887 0.01955237 0.2648881 ABE_VEGFA_TARGETS_30MIN cervix uteri carcinoma in situ DOID_8991 0.01955237 0.08302463 1.000 1.000 ABE_VEGFA_TARGETS_30MIN endometriosis of uterus DOID_288 0.01999253 0.08426483 1.000 1.000 ABE_VEGFA_TARGETS_30MIN nephrotic syndrome DOID_1184 0.02043251 0.08548602 1.000 1.000 ABE_VEGFA_TARGETS_30MIN rheumatic disease DOID_1575 0.02043251 0.08486203 1.000 1.000 ABE_VEGFA_TARGETS_30MIN idiopathic generalized epilepsy DOID_1827 0.02043251 0.08424709 1.000 1.000 ABE_VEGFA_TARGETS_30MIN endometriosis DOID_289 0.02043251 0.083641 1.000 1.000 ABE_VEGFA_TARGETS_30MIN scleroderma DOID_419 0.02043251 0.08486203 1.000 1.000 ABE_VEGFA_TARGETS_30MIN diabetic autonomic neuropathy DOID_11503 0.0208723 0.08483099 1.000 1.000 ABE_VEGFA_TARGETS_30MIN autonomic neuropathy DOID_11504 0.0208723 0.08483099 1.000 1.000 ABE_VEGFA_TARGETS_30MIN diabetic polyneuropathy DOID_12785 0.0208723 0.08483099 1.000 1.000 ABE_VEGFA_TARGETS_30MIN uterine cancer DOID_363 0.0208723 0.08422936 1.000 1.000 ABE_VEGFA_TARGETS_30MIN diabetic neuropathy DOID_9743 0.0208723 0.08483099 1.000 1.000 ABE_VEGFA_TARGETS_30MIN cerebral infarction DOID_3526 0.0213119 0.0853977 1.000 1.000 ABE_VEGFA_TARGETS_30MIN myeloma DOID_0070004 0.02219056 0.08829669 1.000 1.000 ABE_VEGFA_TARGETS_30MIN autonomic nervous system disease DOID_11465 0.02219056 0.08768352 1.000 1.000 ABE_VEGFA_TARGETS_30MIN brain cancer DOID_1319 0.02219056 0.0870788 1.000 1.000 ABE_VEGFA_TARGETS_30MIN neuritis DOID_1803 0.02219056 0.08648237 1.000 1.000 ABE_VEGFA_TARGETS_30MIN heart valve disease DOID_4079 0.02219056 0.08589406 0.02219056 0.27448753 ABE_VEGFA_TARGETS_30MIN central nervous system cancer DOID_3620 0.0226296 0.08700165 1.000 1.000 ABE_VEGFA_TARGETS_30MIN integumentary system benign neoplasm DOID_0060121 0.02306846 0.08809367 1.000 1.000 ABE_VEGFA_TARGETS_30MIN glaucoma DOID_1686 0.02306846 0.08750638 1.000 1.000 ABE_VEGFA_TARGETS_30MIN skin benign neoplasm DOID_3165 0.02306846 0.08809367 1.000 1.000 ABE_VEGFA_TARGETS_30MIN movement disease DOID_480 0.02350714 0.08857989 0.02350714 0.28458645 ABE_VEGFA_TARGETS_30MIN withdrawal disorder DOID_0060001 0.02394563 0.08963858 1.000 1.000 ABE_VEGFA_TARGETS_30MIN B-cell lymphocytic neoplasm DOID_707 0.02394563 0.08905271 1.000 1.000 ABE_VEGFA_TARGETS_30MIN giant cell tumor DOID_200 0.02482206 0.09171266 1.000 1.000 ABE_VEGFA_TARGETS_30MIN malignant giant cell tumor DOID_2705 0.02482206 0.09171266 1.000 1.000 ABE_VEGFA_TARGETS_30MIN giant cell glioblastoma DOID_3074 0.02482206 0.09171266 1.000 1.000 ABE_VEGFA_TARGETS_30MIN reproductive organ benign neoplasm DOID_0050622 0.02569774 0.09433558 1.000 1.000 ABE_VEGFA_TARGETS_30MIN integumentary system cancer DOID_0060122 0.02569774 0.09373086 1.000 1.000 ABE_VEGFA_TARGETS_30MIN skin cancer DOID_4159 0.02569774 0.09373086 1.000 1.000 ABE_VEGFA_TARGETS_30MIN pustulosis of palm and sole DOID_4398 0.02569774 0.09313385 1.000 1.000 ABE_VEGFA_TARGETS_30MIN familial hyperlipidemia DOID_1168 0.02613531 0.09412018 1.000 1.000 ABE_VEGFA_TARGETS_30MIN congenital nervous system abnormality DOID_2490 0.02657269 0.09509345 1.000 1.000 ABE_VEGFA_TARGETS_30MIN nonsyndromic deafness DOID_0050563 0.02700988 0.09605389 0.02700988 0.30737244 ABE_VEGFA_TARGETS_30MIN glioblastoma DOID_3068 0.02700988 0.09545728 1.000 1.000 ABE_VEGFA_TARGETS_30MIN oral cavity cancer DOID_8618 0.02700988 0.09486804 1.000 1.000 ABE_VEGFA_TARGETS_30MIN melancholia DOID_2848 0.02744689 0.09581154 1.000 1.000 ABE_VEGFA_TARGETS_30MIN neurotic disorder DOID_4964 0.02788372 0.09674289 1.000 1.000 ABE_VEGFA_TARGETS_30MIN carotid artery disease DOID_3407 0.02832036 0.09766232 1.000 1.000 ABE_VEGFA_TARGETS_30MIN collagen disease DOID_854 0.02832036 0.09707399 1.000 1.000 ABE_VEGFA_TARGETS_30MIN respiratory failure DOID_11162 0.02875681 0.0979798 0.02875681 0.31466589 ABE_VEGFA_TARGETS_30MIN hypothyroidism DOID_1459 0.02875681 0.09739659 0.02875681 0.3087288 ABE_VEGFA_TARGETS_30MIN pre-malignant neoplasm DOID_0060071 0.02919308 0.09828914 1.000 1.000 ABE_VEGFA_TARGETS_30MIN congenital heart defect DOID_1682 0.02919308 0.09771097 0.02919308 0.30760861 ABE_VEGFA_TARGETS_30MIN in situ carcinoma DOID_8719 0.02919308 0.09828914 1.000 1.000 MUNSHI_MULTIPLE_MYELOMA_UP sarcoma DOID_1115 9.799E-08 5.575E-05 8.444E-04 0.03202948 MUNSHI_MULTIPLE_MYELOMA_UP multiple myeloma DOID_9538 3.233E-07 9.199E-05 2.6E-05 4.931E-03 MUNSHI_MULTIPLE_MYELOMA_UP myeloma DOID_0070004 8.062E-07 1.529E-04 5.106E-05 7.263E-03 MUNSHI_MULTIPLE_MYELOMA_UP mesenchymal cell neoplasm DOID_3350 1.228E-06 1.747E-04 0.02115798 0.26753084 MUNSHI_MULTIPLE_MYELOMA_UP spindle cell sarcoma DOID_4235 1.228E-06 1.747E-04 0.02115798 0.26753084 MUNSHI_MULTIPLE_MYELOMA_UP epithelioid sarcoma DOID_6193 1.228E-06 1.747E-04 0.02115798 0.26753084 MUNSHI_MULTIPLE_MYELOMA_UP bone marrow cancer DOID_4960 1.373E-06 1.562E-04 7.569E-05 7.178E-03 MUNSHI_MULTIPLE_MYELOMA_UP neutropenia DOID_1227 4.127E-06 3.914E-04 4.517E-04 0.01976933 MUNSHI_MULTIPLE_MYELOMA_UP agranulocytosis DOID_12987 4.741E-06 3.854E-04 4.942E-04 0.0200872 MUNSHI_MULTIPLE_MYELOMA_UP mixed glioma DOID_5076 5.364E-06 3.815E-04 5.364E-06 3.052E-03 MUNSHI_MULTIPLE_MYELOMA_UP lymphoma DOID_0060058 1.019E-05 6.444E-04 3.341E-04 0.01728086 MUNSHI_MULTIPLE_MYELOMA_UP leukopenia DOID_615 2.051E-05 1.167E-03 1.285E-03 0.04299362 MUNSHI_MULTIPLE_MYELOMA_UP cleft palate DOID_674 2.6E-05 1.345E-03 2.6E-05 7.397E-03 MUNSHI_MULTIPLE_MYELOMA_UP bone marrow disease DOID_4961 5.106E-05 2.421E-03 2.335E-03 0.0603875 MUNSHI_MULTIPLE_MYELOMA_UP orofacial cleft DOID_0050567 6.8E-05 2.976E-03 6.8E-05 7.739E-03 MUNSHI_MULTIPLE_MYELOMA_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 8.896E-05 3.616E-03 8.896E-05 7.231E-03 MUNSHI_MULTIPLE_MYELOMA_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 8.896E-05 3.616E-03 8.896E-05 7.231E-03 MUNSHI_MULTIPLE_MYELOMA_UP Hodgkin's granuloma DOID_8651 8.896E-05 3.616E-03 8.896E-05 7.231E-03 MUNSHI_MULTIPLE_MYELOMA_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 8.896E-05 3.616E-03 8.896E-05 7.231E-03 MUNSHI_MULTIPLE_MYELOMA_UP leukocyte disease DOID_9500 9.734E-05 3.693E-03 3.565E-03 0.0845221 MUNSHI_MULTIPLE_MYELOMA_UP Hodgkin's lymphoma DOID_8567 1.302E-04 4.631E-03 1.302E-04 9.263E-03 MUNSHI_MULTIPLE_MYELOMA_UP bone resorption disease DOID_0080011 2.001E-04 6.697E-03 2.001E-04 0.01264969 MUNSHI_MULTIPLE_MYELOMA_UP osteoporosis DOID_11476 2.001E-04 6.697E-03 2.001E-04 0.01264969 MUNSHI_MULTIPLE_MYELOMA_UP transitional cell carcinoma DOID_2671 2.94E-04 9.293E-03 2.94E-04 0.01672711 MUNSHI_MULTIPLE_MYELOMA_UP primary immunodeficiency disease DOID_612 3.037E-04 9.095E-03 7.52E-03 0.13801977 MUNSHI_MULTIPLE_MYELOMA_UP agammaglobulinemia DOID_2583 3.353E-04 9.538E-03 0.02672549 0.28160753 MUNSHI_MULTIPLE_MYELOMA_UP testicular cancer DOID_2998 3.353E-04 9.084E-03 3.353E-04 0.01589748 MUNSHI_MULTIPLE_MYELOMA_UP blood protein disease DOID_620 3.722E-04 9.626E-03 0.02811251 0.27579343 MUNSHI_MULTIPLE_MYELOMA_UP B cell deficiency DOID_2115 7.351E-04 0.0181848 0.03913902 0.34797037 MUNSHI_MULTIPLE_MYELOMA_UP thrombocytopenia DOID_1588 8.444E-04 0.02001842 1.000 1.000 MUNSHI_MULTIPLE_MYELOMA_UP polycystic ovary syndrome DOID_11612 9.018E-04 0.02052431 0.04324223 0.35659172 MUNSHI_MULTIPLE_MYELOMA_UP thyroid carcinoma DOID_3963 1.285E-03 0.02811122 1.285E-03 0.04568073 MUNSHI_MULTIPLE_MYELOMA_UP spindle cell carcinoma DOID_4015 1.285E-03 0.02707006 0.05139712 0.39520216 MUNSHI_MULTIPLE_MYELOMA_UP esophageal disease DOID_6050 1.285E-03 0.02610327 0.05139712 0.3899328 MUNSHI_MULTIPLE_MYELOMA_UP aplastic anemia DOID_12449 1.355E-03 0.02657909 0.05274962 0.39492805 MUNSHI_MULTIPLE_MYELOMA_UP thyroid cancer DOID_1781 1.427E-03 0.02705725 1.427E-03 0.04509542 MUNSHI_MULTIPLE_MYELOMA_UP blood platelet disease DOID_2218 1.576E-03 0.02892325 1.000 1.000 MUNSHI_MULTIPLE_MYELOMA_UP diabetic autonomic neuropathy DOID_11503 2.066E-03 0.03673636 2.066E-03 0.06187176 MUNSHI_MULTIPLE_MYELOMA_UP autonomic neuropathy DOID_11504 2.066E-03 0.03673636 2.066E-03 0.06187176 MUNSHI_MULTIPLE_MYELOMA_UP diabetic polyneuropathy DOID_12785 2.066E-03 0.03673636 2.066E-03 0.06187176 MUNSHI_MULTIPLE_MYELOMA_UP diabetic neuropathy DOID_9743 2.066E-03 0.03673636 2.066E-03 0.06187176 MUNSHI_MULTIPLE_MYELOMA_UP autonomic nervous system disease DOID_11465 2.335E-03 0.04025833 2.335E-03 0.06642625 MUNSHI_MULTIPLE_MYELOMA_UP thyroid adenoma DOID_2891 2.335E-03 0.03907426 2.335E-03 0.06326309 MUNSHI_MULTIPLE_MYELOMA_UP hemorrhagic disease DOID_2213 2.718E-03 0.04417976 1.000 1.000 MUNSHI_MULTIPLE_MYELOMA_UP osteochondrodysplasia DOID_2256 3.128E-03 0.04943573 3.128E-03 0.07737766 MUNSHI_MULTIPLE_MYELOMA_UP pre-malignant neoplasm DOID_0060071 4.029E-03 0.06196345 4.029E-03 0.09170591 MUNSHI_MULTIPLE_MYELOMA_UP in situ carcinoma DOID_8719 4.029E-03 0.06196345 4.029E-03 0.09170591 MUNSHI_MULTIPLE_MYELOMA_UP endocrine organ benign neoplasm DOID_0060089 4.647E-03 0.06957908 4.647E-03 0.10169251 MUNSHI_MULTIPLE_MYELOMA_UP brain infarction DOID_3454 4.647E-03 0.06779501 4.647E-03 0.09792612 MUNSHI_MULTIPLE_MYELOMA_UP blood coagulation disease DOID_1247 4.905E-03 0.06977694 1.000 1.000 MUNSHI_MULTIPLE_MYELOMA_UP pancreatic ductal carcinoma DOID_3587 4.905E-03 0.06807506 4.905E-03 0.09968134 MUNSHI_MULTIPLE_MYELOMA_UP pancreatic carcinoma DOID_4905 5.305E-03 0.07187177 5.305E-03 0.10409015 MUNSHI_MULTIPLE_MYELOMA_UP syndrome DOID_225 5.58E-03 0.07383472 0.10532492 0.57076075 MUNSHI_MULTIPLE_MYELOMA_UP bone development disease DOID_0080006 6.742E-03 0.08718747 6.742E-03 0.12787495 NAKAJIMA_MAST_CELL hypersensitivity reaction type I disease DOID_1205 2.492E-06 1.418E-03 1.184E-04 0.0224635 NAKAJIMA_MAST_CELL endocrine organ benign neoplasm DOID_0060089 4.672E-05 0.01329202 4.672E-05 0.02658405 NAKAJIMA_MAST_CELL lipodystrophy DOID_811 6.079E-05 0.01153047 0.01165066 0.27621772 NAKAJIMA_MAST_CELL mouth disease DOID_403 1.149E-04 0.01633753 1.149E-04 0.03267506 NAKAJIMA_MAST_CELL urticaria DOID_1555 2.968E-04 0.03377517 0.02507622 0.310182 NAKAJIMA_MAST_CELL middle cerebral artery infarction DOID_3525 3.448E-04 0.03269571 1.000 1.000 NAKAJIMA_MAST_CELL gestational diabetes DOID_11714 3.701E-04 0.03008231 1.000 1.000 NAKAJIMA_MAST_CELL endometrial cancer DOID_1380 5.098E-04 0.03625946 5.098E-04 0.07251892 NAKAJIMA_MAST_CELL calcinosis DOID_182 7.062E-04 0.04464773 0.03832428 0.31603648 NAKAJIMA_MAST_CELL intracranial arterial disease DOID_13089 8.161E-04 0.04643384 1.000 1.000 NAKAJIMA_MAST_CELL cerebral arterial disease DOID_3527 8.161E-04 0.04643384 1.000 1.000 NAKAJIMA_MAST_CELL uterine cancer DOID_363 9.745E-04 0.05040956 9.745E-04 0.11090104 NAKAJIMA_MAST_CELL cerebral infarction DOID_3526 1.016E-03 0.04818824 1.000 1.000 NAKAJIMA_MAST_CELL pre-eclampsia DOID_10591 1.102E-03 0.04824725 1.102E-03 0.10453572 NAKAJIMA_MAST_CELL thyroid adenoma DOID_2891 1.102E-03 0.04480102 1.102E-03 0.08960204 NAKAJIMA_MAST_CELL heart valve disease DOID_4079 1.102E-03 0.04181429 0.04767977 0.35233492 NAKAJIMA_MAST_CELL vascular skin disease DOID_9540 1.102E-03 0.03920089 0.04767977 0.34341505 NAKAJIMA_MAST_CELL calcium metabolism disease DOID_10575 1.238E-03 0.04142669 0.05046911 0.34598701 NAKAJIMA_MAST_CELL movement disease DOID_480 1.238E-03 0.03912521 1.238E-03 0.08803172 NAKAJIMA_MAST_CELL atopic dermatitis DOID_3310 1.332E-03 0.0398951 1.332E-03 0.084223 NAKAJIMA_MAST_CELL congenital heart defect DOID_1682 1.911E-03 0.05437666 1.911E-03 0.10875332 NAKAJIMA_MAST_CELL mineral metabolism disease DOID_0050032 1.969E-03 0.05334802 0.06338125 0.40071035 NAKAJIMA_MAST_CELL cholestasis DOID_13580 2.027E-03 0.05243406 2.027E-03 0.10486812 NAKAJIMA_MAST_CELL parasitic infectious disease DOID_1398 2.027E-03 0.05015432 0.06429698 0.40203277 NAKAJIMA_MAST_CELL brain infarction DOID_3454 2.207E-03 0.05233576 1.000 1.000 NAKAJIMA_MAST_CELL bile duct disease DOID_4138 2.395E-03 0.0545091 2.395E-03 0.11356062 NAKAJIMA_MAST_CELL peripheral vascular disease DOID_341 2.459E-03 0.05381555 0.07068275 0.4324568 NAKAJIMA_MAST_CELL biliary tract disease DOID_9741 2.459E-03 0.05182238 2.459E-03 0.1076311 NAKAJIMA_MAST_CELL syndrome DOID_225 2.656E-03 0.05397799 2.656E-03 0.10795598 NAKAJIMA_MAST_CELL metabolic syndrome X DOID_14221 2.93E-03 0.05749439 1.000 1.000 NAKAJIMA_MAST_CELL primary bacterial infectious disease DOID_0050338 3.441E-03 0.06525492 0.08332732 0.48380862 NAKAJIMA_MAST_CELL encephalomyelitis DOID_640 3.908E-03 0.07173904 3.908E-03 0.14826068 FERRANDO_LYL1_NEIGHBORS alcohol-related neurodevelopmental disorder DOID_0050667 2.712E-08 1.543E-05 4.86E-04 0.05531162 FERRANDO_LYL1_NEIGHBORS multiple myeloma DOID_9538 3.089E-07 8.789E-05 0.01363198 0.19391494 FERRANDO_LYL1_NEIGHBORS myeloma DOID_0070004 6.116E-07 1.16E-04 0.01701307 0.18981247 FERRANDO_LYL1_NEIGHBORS bone marrow cancer DOID_4960 9.118E-07 1.297E-04 0.01937346 0.19339472 FERRANDO_LYL1_NEIGHBORS transitional cell carcinoma DOID_2671 3.637E-06 4.139E-04 4.274E-04 0.06079502 FERRANDO_LYL1_NEIGHBORS extrinsic allergic alveolitis DOID_841 4.082E-05 3.871E-03 9.561E-03 0.22666372 FERRANDO_LYL1_NEIGHBORS diffuse large B-cell lymphoma DOID_0050745 4.384E-05 3.564E-03 1.000 1.000 FERRANDO_LYL1_NEIGHBORS abdominal aortic aneurysm DOID_7693 5.697E-05 4.052E-03 0.01125884 0.22090615 FERRANDO_LYL1_NEIGHBORS papilloma DOID_2615 6.793E-05 4.295E-03 1.000 1.000 FERRANDO_LYL1_NEIGHBORS spindle cell carcinoma DOID_4015 7.18E-05 4.086E-03 1.000 1.000 FERRANDO_LYL1_NEIGHBORS hyperthyroidism DOID_7998 7.18E-05 3.714E-03 0.01261556 0.20509303 FERRANDO_LYL1_NEIGHBORS calcinosis DOID_182 8.404E-05 3.985E-03 8.404E-05 0.04782114 FERRANDO_LYL1_NEIGHBORS uveitis DOID_13141 8.834E-05 3.866E-03 0.01397057 0.189268 FERRANDO_LYL1_NEIGHBORS endometriosis of uterus DOID_288 1.066E-04 4.331E-03 0.01532386 0.19376176 FERRANDO_LYL1_NEIGHBORS endometriosis DOID_289 1.114E-04 4.225E-03 0.01566192 0.18565901 FERRANDO_LYL1_NEIGHBORS uveal disease DOID_3480 1.114E-04 3.961E-03 0.01566192 0.18187005 FERRANDO_LYL1_NEIGHBORS thyroid adenoma DOID_2891 1.317E-04 4.409E-03 1.000 1.000 FERRANDO_LYL1_NEIGHBORS calcium metabolism disease DOID_10575 1.481E-04 4.682E-03 1.481E-04 0.04213592 FERRANDO_LYL1_NEIGHBORS aortic aneurysm DOID_3627 1.481E-04 4.435E-03 0.01802531 0.18314999 FERRANDO_LYL1_NEIGHBORS B-cell lymphocytic neoplasm DOID_707 1.538E-04 4.375E-03 1.000 1.000 FERRANDO_LYL1_NEIGHBORS mineral metabolism disease DOID_0050032 2.37E-04 6.421E-03 2.37E-04 0.04494949 FERRANDO_LYL1_NEIGHBORS endocrine pancreas disease DOID_1428 2.37E-04 6.129E-03 0.02273637 0.21561661 FERRANDO_LYL1_NEIGHBORS uterine disease DOID_345 2.441E-04 6.039E-03 0.02307208 0.21521333 FERRANDO_LYL1_NEIGHBORS endocrine organ benign neoplasm DOID_0060089 2.662E-04 6.31E-03 1.000 1.000 FERRANDO_LYL1_NEIGHBORS bone resorption disease DOID_0080011 3.295E-04 7.499E-03 0.02675782 0.23423382 FERRANDO_LYL1_NEIGHBORS osteoporosis DOID_11476 3.295E-04 7.499E-03 0.02675782 0.23423382 FERRANDO_LYL1_NEIGHBORS aneurysm disease DOID_2403 3.295E-04 7.211E-03 0.02675782 0.23068482 FERRANDO_LYL1_NEIGHBORS contact dermatitis DOID_2773 3.549E-04 7.48E-03 0.02776079 0.22565555 FERRANDO_LYL1_NEIGHBORS female reproductive system disease DOID_229 3.636E-04 7.39E-03 0.0280949 0.2251549 FERRANDO_LYL1_NEIGHBORS nervous system cancer DOID_3093 4.465E-04 8.761E-03 0.03109714 0.24238729 FERRANDO_LYL1_NEIGHBORS lymphoma DOID_0060058 4.661E-04 8.84E-03 1.000 1.000 FERRANDO_LYL1_NEIGHBORS Crohn's disease DOID_8778 4.86E-04 8.921E-03 4.86E-04 0.04609302 FERRANDO_LYL1_NEIGHBORS dilated cardiomyopathy DOID_12930 4.962E-04 8.823E-03 0.03276135 0.24527904 FERRANDO_LYL1_NEIGHBORS ulcerative colitis DOID_8577 5.272E-04 9.09E-03 5.272E-04 0.04285414 FERRANDO_LYL1_NEIGHBORS transient cerebral ischemia DOID_224 3.424E-03 0.05730505 1.000 1.000 FERRANDO_LYL1_NEIGHBORS acute kidney failure DOID_3021 3.424E-03 0.05566776 1.000 1.000 FERRANDO_LYL1_NEIGHBORS chondrosarcoma DOID_3371 3.424E-03 0.05412143 1.000 1.000 FERRANDO_LYL1_NEIGHBORS familial adenomatous polyposis DOID_0050424 3.766E-03 0.0579154 1.000 1.000 FERRANDO_LYL1_NEIGHBORS adrenoleukodystrophy DOID_10588 3.766E-03 0.05639131 1.000 1.000 FERRANDO_LYL1_NEIGHBORS polydactyly DOID_1148 3.766E-03 0.05494538 3.766E-03 0.26785871 FERRANDO_LYL1_NEIGHBORS neuronal ceroid lipofuscinosis DOID_14503 3.766E-03 0.05357174 1.000 1.000 FERRANDO_LYL1_NEIGHBORS invasive lobular carcinoma DOID_3457 3.766E-03 0.05226511 3.766E-03 0.23809663 FERRANDO_LYL1_NEIGHBORS Legionnaires' disease DOID_10457 4.791E-03 0.06490463 4.791E-03 0.27259945 FERRANDO_LYL1_NEIGHBORS legionellosis DOID_10458 4.791E-03 0.06490463 4.791E-03 0.27259945 FERRANDO_LYL1_NEIGHBORS tethered spinal cord syndrome DOID_1089 4.791E-03 0.06339522 4.791E-03 0.24781768 FERRANDO_LYL1_NEIGHBORS aspergillosis DOID_13564 4.791E-03 0.06195442 4.791E-03 0.22716621 FERRANDO_LYL1_NEIGHBORS T-cell leukemia DOID_715 4.791E-03 0.06057765 4.791E-03 0.20969188 FERRANDO_LYL1_NEIGHBORS silicosis DOID_10325 5.474E-03 0.06770514 5.474E-03 0.22245976 FERRANDO_LYL1_NEIGHBORS restrictive cardiomyopathy DOID_397 5.474E-03 0.06626461 1.000 1.000 FERRANDO_LYL1_NEIGHBORS tongue cancer DOID_8649 5.474E-03 0.0648841 1.000 1.000 FERRANDO_LYL1_NEIGHBORS lymphatic system cancer DOID_0060073 5.815E-03 0.06752174 1.000 1.000 FERRANDO_LYL1_NEIGHBORS drug-induced mental disorder DOID_1203 5.815E-03 0.06617131 1.000 1.000 FERRANDO_LYL1_NEIGHBORS methylmalonic acidemia DOID_14749 5.815E-03 0.06487383 1.000 1.000 FERRANDO_LYL1_NEIGHBORS drug psychosis DOID_1742 5.815E-03 0.06617131 1.000 1.000 FERRANDO_LYL1_NEIGHBORS reticulosarcoma DOID_8538 5.815E-03 0.06752174 1.000 1.000 FERRANDO_LYL1_NEIGHBORS substance-induced psychosis DOID_8646 5.815E-03 0.06617131 1.000 1.000 FERRANDO_LYL1_NEIGHBORS lymphosarcoma DOID_8675 5.815E-03 0.06752174 1.000 1.000 FERRANDO_LYL1_NEIGHBORS conduct disorder DOID_12995 6.497E-03 0.07108921 6.497E-03 0.24644258 FERRANDO_LYL1_NEIGHBORS testicular cancer DOID_2998 6.497E-03 0.0697479 6.497E-03 0.23103992 FERRANDO_LYL1_NEIGHBORS granulosa cell tumor DOID_2999 6.497E-03 0.06845627 6.497E-03 0.21744934 FERRANDO_LYL1_NEIGHBORS esophagitis DOID_11963 6.838E-03 0.07073788 1.000 1.000 FERRANDO_LYL1_NEIGHBORS sex cord-gonadal stromal tumor DOID_192 6.838E-03 0.0694747 6.838E-03 0.21614351 FERRANDO_LYL1_NEIGHBORS mitochondrial myopathy DOID_699 7.178E-03 0.0716573 1.000 1.000 FERRANDO_LYL1_NEIGHBORS hypoglycemia DOID_9993 7.859E-03 0.07710428 1.000 1.000 FERRANDO_LYL1_NEIGHBORS diabetic angiopathy DOID_11713 8.2E-03 0.07908046 8.2E-03 0.24556563 FERRANDO_LYL1_NEIGHBORS Lewy body dementia DOID_12217 8.2E-03 0.07776245 1.000 1.000 FERRANDO_LYL1_NEIGHBORS toxic shock syndrome DOID_14115 8.54E-03 0.07966204 8.54E-03 0.24296923 FERRANDO_LYL1_NEIGHBORS commensal bacterial infectious disease DOID_0050339 8.88E-03 0.08149937 8.88E-03 0.24061718 FERRANDO_LYL1_NEIGHBORS organic acidemia DOID_0060159 8.88E-03 0.08020573 1.000 1.000 FERRANDO_LYL1_NEIGHBORS papillary adenoma DOID_3172 9.221E-03 0.08197618 1.000 1.000 FERRANDO_LYL1_NEIGHBORS microcystic adenoma DOID_5403 9.221E-03 0.08197618 1.000 1.000 FERRANDO_LYL1_NEIGHBORS follicular adenoma DOID_6204 9.221E-03 0.08197618 1.000 1.000 FERRANDO_LYL1_NEIGHBORS myositis DOID_633 9.221E-03 0.08071501 1.000 1.000 FERRANDO_LYL1_NEIGHBORS spinal cord disease DOID_319 9.561E-03 0.08242317 9.561E-03 0.24726951 FERRANDO_LYL1_NEIGHBORS seminoma DOID_4440 9.561E-03 0.08119297 9.561E-03 0.23651866 FERRANDO_LYL1_NEIGHBORS Sciatic Neuropathy DOID_11446 9.9E-03 0.08284296 9.9E-03 0.22533286 FERRANDO_LYL1_NEIGHBORS lesion of sciatic nerve DOID_12528 9.9E-03 0.08284296 9.9E-03 0.22533286 FERRANDO_LYL1_NEIGHBORS lung adenocarcinoma DOID_3910 9.9E-03 0.08164234 1.000 1.000 FERRANDO_LYL1_NEIGHBORS perinatal necrotizing enterocolitis DOID_8677 9.9E-03 0.08047602 1.000 1.000 FERRANDO_LYL1_NEIGHBORS mononeuritis of lower limb DOID_9473 9.9E-03 0.08284296 9.9E-03 0.22533286 FERRANDO_LYL1_NEIGHBORS mononeuritis DOID_1802 0.01024016 0.08206553 0.01024016 0.22410202 FERRANDO_LYL1_NEIGHBORS mononeuropathy DOID_1188 0.01057983 0.08361003 0.01057983 0.22296009 FERRANDO_LYL1_NEIGHBORS multiple epiphyseal dysplasia DOID_12721 0.01057983 0.08246469 1.000 1.000 FERRANDO_LYL1_NEIGHBORS female reproductive organ benign neoplasm DOID_0060086 0.01091939 0.08396123 1.000 1.000 FERRANDO_LYL1_NEIGHBORS uterine benign neoplasm DOID_0060095 0.01091939 0.08396123 1.000 1.000 FERRANDO_LYL1_NEIGHBORS uterine fibroid DOID_13223 0.01091939 0.08396123 1.000 1.000 FERRANDO_LYL1_NEIGHBORS opportunistic mycosis DOID_2473 0.01125884 0.08541704 0.01125884 0.22879566 FERRANDO_LYL1_NEIGHBORS germinoma DOID_3304 0.01159818 0.08683374 0.01159818 0.21997882 FERRANDO_LYL1_NEIGHBORS leiomyoma DOID_127 0.01193742 0.08821285 1.000 1.000 FERRANDO_LYL1_NEIGHBORS autonomic nervous system neoplasm DOID_2621 0.01193742 0.08708192 0.01193742 0.21910934 FERRANDO_LYL1_NEIGHBORS neuroblastoma DOID_769 0.01193742 0.08708192 0.01193742 0.21910934 FERRANDO_LYL1_NEIGHBORS systemic mycosis DOID_0050136 0.01227654 0.0884222 0.01227654 0.21829229 FERRANDO_LYL1_NEIGHBORS fungal infectious disease DOID_1564 0.01227654 0.0884222 0.01227654 0.21829229 FERRANDO_LYL1_NEIGHBORS pneumoconiosis DOID_10316 0.01261556 0.0897282 0.01261556 0.21752291 FERRANDO_LYL1_NEIGHBORS nephroblastoma DOID_2154 0.01261556 0.08862045 0.01261556 0.21112518 FERRANDO_LYL1_NEIGHBORS thyroid carcinoma DOID_3963 0.01261556 0.08753971 1.000 1.000 FERRANDO_LYL1_NEIGHBORS esophageal disease DOID_6050 0.01261556 0.08648501 1.000 1.000 FERRANDO_LYL1_NEIGHBORS lymphoid leukemia DOID_10747 0.01295448 0.08775116 0.01295448 0.20475271 FERRANDO_LYL1_NEIGHBORS aplastic anemia DOID_12449 0.01295448 0.0867188 1.000 1.000 FERRANDO_LYL1_NEIGHBORS medullomyoblastoma DOID_3861 0.01295448 0.08571044 0.01295448 0.19921886 FERRANDO_LYL1_NEIGHBORS adult medulloblastoma DOID_3864 0.01295448 0.08571044 0.01295448 0.19921886 FERRANDO_LYL1_NEIGHBORS childhood medulloblastoma DOID_3869 0.01295448 0.08571044 0.01295448 0.19921886 FERRANDO_LYL1_NEIGHBORS thyroid cancer DOID_1781 0.01329328 0.08694113 1.000 1.000 FERRANDO_LYL1_NEIGHBORS adenoma DOID_657 0.01329328 0.08595316 1.000 1.000 FERRANDO_LYL1_NEIGHBORS medulloblastoma DOID_3858 0.01363198 0.08715278 0.01363198 0.20412099 FERRANDO_LYL1_NEIGHBORS embryonal cancer DOID_688 0.01363198 0.08618442 0.01363198 0.19888712 FERRANDO_LYL1_NEIGHBORS peripheral nervous system neoplasm DOID_1192 0.01397057 0.08735446 0.01397057 0.19388429 FERRANDO_LYL1_NEIGHBORS hepatitis DOID_2237 0.01430906 0.08849841 1.000 1.000 FERRANDO_LYL1_NEIGHBORS adult respiratory distress syndrome DOID_11394 0.01464743 0.08961709 0.01464743 0.19382301 FERRANDO_LYL1_NEIGHBORS benign mesothelioma DOID_2645 0.0149857 0.09071133 1.000 1.000 FERRANDO_LYL1_NEIGHBORS cervix uteri carcinoma in situ DOID_8991 0.0149857 0.08975647 1.000 1.000 FERRANDO_LYL1_NEIGHBORS autoimmune disease of urogenital tract DOID_0060049 0.01532386 0.09082582 0.01532386 0.19816543 FERRANDO_LYL1_NEIGHBORS primary biliary cirrhosis DOID_12236 0.01532386 0.09082582 0.01532386 0.19816543 FERRANDO_LYL1_NEIGHBORS primitive neuroectodermal tumor DOID_168 0.01566192 0.0918725 0.01566192 0.19373114 FERRANDO_LYL1_NEIGHBORS hyperinsulinism DOID_2018 0.01566192 0.09093502 0.01566192 0.1896092 FERRANDO_LYL1_NEIGHBORS gallbladder cancer DOID_3121 0.01599987 0.09195883 1.000 1.000 FERRANDO_LYL1_NEIGHBORS influenza DOID_8469 0.01599987 0.09103925 0.01599987 0.18207849 FERRANDO_LYL1_NEIGHBORS leukodystrophy DOID_10579 0.01667544 0.09394383 1.000 1.000 FERRANDO_LYL1_NEIGHBORS brain cancer DOID_1319 0.01701307 0.09490624 1.000 1.000 FERRANDO_LYL1_NEIGHBORS neuritis DOID_1803 0.01701307 0.09398482 0.01701307 0.18616223 FERRANDO_LYL1_NEIGHBORS heart valve disease DOID_4079 0.01701307 0.09308112 0.01701307 0.18264974 FERRANDO_LYL1_NEIGHBORS bone marrow disease DOID_4961 0.01701307 0.09219463 1.000 1.000 FERRANDO_LYL1_NEIGHBORS central nervous system cancer DOID_3620 0.01735059 0.09313665 1.000 1.000 FERRANDO_LYL1_NEIGHBORS hemolytic anemia DOID_583 0.01735059 0.09226621 0.01735059 0.18282379 FERRANDO_LYL1_NEIGHBORS normocytic anemia DOID_720 0.01735059 0.09226621 0.01735059 0.18282379 FERRANDO_LYL1_NEIGHBORS integumentary system benign neoplasm DOID_0060121 0.017688 0.09318956 1.000 1.000 FERRANDO_LYL1_NEIGHBORS glaucoma DOID_1686 0.017688 0.09233461 0.017688 0.18299041 FERRANDO_LYL1_NEIGHBORS skin benign neoplasm DOID_3165 0.017688 0.09318956 1.000 1.000 FERRANDO_LYL1_NEIGHBORS sarcoidosis DOID_11335 0.01903658 0.09847105 1.000 1.000 FERRANDO_LYL1_NEIGHBORS osteochondrodysplasia DOID_2256 0.01971023 0.09924887 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN autoimmune disease of gastrointestinal tract DOID_0060031 9.631E-08 5.48E-05 0.04167344 0.45600363 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN pulmonary tuberculosis DOID_2957 9.631E-08 2.74E-05 0.04167344 0.44739978 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN pustulosis of palm and sole DOID_4398 1.504E-07 2.853E-05 1.04E-03 0.073938 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN tuberculosis DOID_399 3.42E-07 4.864E-05 0.05647695 0.47963263 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN funisitis DOID_0050698 7.543E-07 8.584E-05 0.01784078 0.36255021 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN hepatitis B DOID_2043 7.543E-07 7.154E-05 0.01784078 0.35004848 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN primary bacterial infectious disease DOID_0050338 8.505E-07 6.914E-05 0.07029705 0.51946778 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN myasthenia gravis DOID_437 8.67E-07 6.167E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN urticaria DOID_1555 1.271E-06 8.034E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN neuromuscular junction disease DOID_439 1.429E-06 8.13E-05 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN autoimmune disease of the nervous system DOID_438 1.98E-06 1.024E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN celiac disease DOID_10608 2.912E-06 1.381E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN vascular skin disease DOID_9540 9.453E-06 4.137E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN aortic aneurysm DOID_3627 1.128E-05 4.584E-04 0.04245815 0.44738306 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN brain infarction DOID_3454 2.725E-05 1.034E-03 0.05647695 0.48689979 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN Sjogren's syndrome DOID_12894 2.9E-05 1.031E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN angioedema DOID_1558 2.9E-05 9.707E-04 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN peripheral vascular disease DOID_341 3.212E-05 1.015E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN aneurysm disease DOID_2403 3.753E-05 1.124E-03 0.06264359 0.49505834 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN bacterial pneumonia DOID_874 3.897E-05 1.109E-03 1.965E-03 0.0931818 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN common cold DOID_10459 4.249E-05 1.151E-03 9.77E-03 0.32700284 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN narcolepsy DOID_8986 5.853E-05 1.514E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN encephalomyelitis DOID_640 6.511E-05 1.611E-03 0.07486006 0.53244215 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN hypersensitivity reaction type I disease DOID_1205 6.928E-05 1.643E-03 0.07637624 0.5365195 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN thyroiditis DOID_7166 7.71E-05 1.755E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN autoimmune thyroiditis DOID_7188 7.71E-05 1.755E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN juvenile rheumatoid arthritis DOID_676 8.733E-05 1.911E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN dental caries DOID_216 9.82E-05 2.069E-03 9.82E-05 0.05587584 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN autoimmune hepatitis DOID_2048 1.346E-04 2.735E-03 0.01703656 0.35902983 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN sleep disorder DOID_535 1.62E-04 3.178E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN myositis DOID_633 2.243E-04 4.253E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN ankylosing spondylitis DOID_7147 2.243E-04 4.116E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN teeth hard tissue disease DOID_214 2.414E-04 4.292E-03 2.414E-04 0.06867221 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN autoimmune disease of cardiovascular system DOID_0060051 2.775E-04 4.785E-03 2.775E-04 0.05263137 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN Behcet's disease DOID_13241 2.775E-04 4.785E-03 2.775E-04 0.05263137 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN autoimmune disease of endocrine system DOID_0060005 2.965E-04 4.962E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN abdominal aortic aneurysm DOID_7693 3.363E-04 5.467E-03 0.02664528 0.36978443 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN esophageal disease DOID_6050 4.233E-04 6.691E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN uveitis DOID_13141 5.202E-04 7.999E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN pulmonary emphysema DOID_9675 5.992E-04 8.972E-03 5.992E-04 0.08523362 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN endometriosis of uterus DOID_288 6.267E-04 9.144E-03 0.03616306 0.44732133 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN endometriosis DOID_289 6.549E-04 9.316E-03 0.03695213 0.43803672 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN uveal disease DOID_3480 6.549E-04 9.089E-03 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN uterine cancer DOID_363 6.836E-04 9.262E-03 6.836E-04 0.07779866 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN B-cell lymphocytic neoplasm DOID_707 9.018E-04 0.01193274 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN sarcoidosis DOID_11335 9.695E-04 0.01253704 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN giant cell tumor DOID_200 9.695E-04 0.01225844 9.695E-04 0.09193827 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN malignant giant cell tumor DOID_2705 9.695E-04 0.01225844 9.695E-04 0.09193827 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN giant cell glioblastoma DOID_3074 9.695E-04 0.01225844 9.695E-04 0.09193827 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN vasculitis DOID_865 1.004E-03 0.0124217 1.004E-03 0.08162829 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN hypersensitivity reaction type IV disease DOID_2916 1.149E-03 0.01391154 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN glioblastoma DOID_3068 1.149E-03 0.01362171 1.149E-03 0.07264914 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN uterine disease DOID_345 1.425E-03 0.01655133 0.05415436 0.4814661 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN tooth disease DOID_1091 1.51E-03 0.01717832 1.51E-03 0.0858916 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN astrocytoma DOID_3069 1.596E-03 0.01780666 1.596E-03 0.08255816 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN blood coagulation disease DOID_1247 1.64E-03 0.01794705 0.05802228 0.48550998 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN pancreatitis DOID_4989 1.965E-03 0.02109777 0.06341167 0.49426355 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN contact dermatitis DOID_2773 2.063E-03 0.02173996 2.063E-03 0.09030447 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN female reproductive system disease DOID_229 2.113E-03 0.02186061 0.06571226 0.50527399 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN Human immunodeficiency virus infectious disease DOID_526 2.587E-03 0.02628983 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN lymphoma DOID_0060058 2.699E-03 0.02694271 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN mouth disease DOID_403 2.813E-03 0.02759503 2.813E-03 0.11432227 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN Crohn's disease DOID_8778 2.813E-03 0.02712732 2.813E-03 0.10670079 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN lateral sclerosis DOID_230 8.148E-03 0.07727007 8.148E-03 0.28976277 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN dermatomyositis DOID_10223 8.959E-03 0.08357064 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN pneumocystosis DOID_11339 8.959E-03 0.08222273 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN common variable immunodeficiency DOID_12177 8.959E-03 0.0809176 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN mucopolysaccharidosis DOID_12798 9.77E-03 0.08686013 9.77E-03 0.30883601 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN stomach disease DOID_76 9.77E-03 0.08552382 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN encephalitis DOID_9588 9.77E-03 0.084228 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN cone-rod dystrophy DOID_0050572 0.01057983 0.08984959 0.01057983 0.31683802 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN berylliosis DOID_10322 0.01057983 0.08852827 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN Legionnaires' disease DOID_10457 0.01138916 0.0939193 0.01138916 0.32402159 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN legionellosis DOID_10458 0.01138916 0.0939193 0.01138916 0.32402159 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN parasitic helminthiasis infectious disease DOID_883 0.01138916 0.0925776 0.01138916 0.30859199 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN adrenal cortex disease DOID_3952 0.01219785 0.0977546 1.000 1.000 GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN hyperhomocysteinemia DOID_9279 0.01219785 0.0963969 0.01219785 0.31548075 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP neuroectodermal tumor DOID_171 1.016E-08 5.78E-06 1.556E-04 9.838E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP granulosa cell tumor DOID_2999 1.351E-08 3.843E-06 6.677E-05 7.598E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP sex cord-gonadal stromal tumor DOID_192 1.795E-08 3.404E-06 7.831E-05 6.365E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP transitional cell carcinoma DOID_2671 1.115E-07 1.586E-05 0.05508116 0.3644323 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP nervous system cancer DOID_3093 1.299E-07 1.478E-05 0.05726242 0.36202578 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP pancreatic ductal carcinoma DOID_3587 6.681E-07 6.336E-05 0.03783536 0.36488674 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP pancreatic carcinoma DOID_4905 8.492E-07 6.903E-05 0.0407007 0.37352737 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP primitive neuroectodermal tumor DOID_168 1.453E-06 1.034E-04 4.238E-05 6.028E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP neuritis DOID_1803 2.216E-06 1.401E-04 0.18964176 0.60282773 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP heart conduction disease DOID_10273 2.479E-06 1.411E-04 1.205E-04 8.573E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP glaucoma DOID_1686 2.7E-06 1.397E-04 0.19643388 0.60745041 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP giant cell tumor DOID_200 3.915E-06 1.857E-04 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP malignant giant cell tumor DOID_2705 3.915E-06 1.857E-04 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP giant cell glioblastoma DOID_3074 3.915E-06 1.857E-04 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP glioblastoma DOID_3068 5.996E-06 2.624E-04 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP sarcoma DOID_1115 7.498E-06 3.048E-04 2.704E-04 0.01183664 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP allergic contact dermatitis DOID_3042 1.183E-05 4.489E-04 2.202E-04 0.01044188 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP astrocytoma DOID_3069 1.359E-05 4.832E-04 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP autonomic nervous system neoplasm DOID_2621 1.409E-05 4.718E-04 9.498E-03 0.14222138 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP neuroblastoma DOID_769 1.409E-05 4.718E-04 9.498E-03 0.14222138 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP nephroblastoma DOID_2154 1.766E-05 5.583E-04 0.01057349 0.15040797 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP medullomyoblastoma DOID_3861 1.968E-05 5.893E-04 1.968E-05 0.01119579 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP adult medulloblastoma DOID_3864 1.968E-05 5.893E-04 1.968E-05 0.01119579 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP childhood medulloblastoma DOID_3869 1.968E-05 5.893E-04 1.968E-05 0.01119579 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP medulloblastoma DOID_3858 2.42E-05 6.886E-04 2.42E-05 6.886E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP metabolic syndrome X DOID_14221 2.562E-05 6.941E-04 5.031E-03 0.10602472 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP contact dermatitis DOID_2773 2.562E-05 6.626E-04 4.04E-04 0.0164205 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP peripheral nervous system neoplasm DOID_1192 2.673E-05 6.613E-04 0.01287696 0.17445208 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP chronic kidney failure DOID_784 3.049E-05 7.228E-04 0.04976237 0.3630101 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP skeletal system cancer DOID_0060124 3.174E-05 7.224E-04 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP bone cancer DOID_184 3.174E-05 7.224E-04 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP primary bacterial infectious disease DOID_0050338 3.806E-05 8.33E-04 6.316E-03 0.11592123 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP angiosarcoma DOID_0001816 3.894E-05 8.207E-04 3.894E-05 7.387E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP amino acid metabolic disorder DOID_9252 4.236E-05 8.608E-04 5.996E-04 0.02274482 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP diabetic autonomic neuropathy DOID_11503 4.617E-05 9.059E-04 0.01670012 0.19796601 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP autonomic neuropathy DOID_11504 4.617E-05 9.059E-04 0.01670012 0.19796601 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP diabetic polyneuropathy DOID_12785 4.617E-05 9.059E-04 0.01670012 0.19796601 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP diabetic neuropathy DOID_9743 4.617E-05 9.059E-04 0.01670012 0.19796601 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP pre-eclampsia DOID_10591 5.903E-05 1.12E-03 0.0187708 0.2179711 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP autonomic nervous system disease DOID_11465 5.903E-05 1.084E-03 0.0187708 0.21361168 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP membranous glomerulonephritis DOID_10976 7.831E-05 1.392E-03 7.831E-05 7.426E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP brain edema DOID_4724 7.831E-05 1.35E-03 0.08064062 0.40968314 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP muscular atrophy DOID_767 1.051E-04 1.759E-03 3.821E-03 0.09453477 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP sinusitis DOID_0050127 1.205E-04 1.96E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP paranasal sinus disease DOID_1352 1.205E-04 1.96E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP neurotic disorder DOID_4964 1.464E-04 2.313E-03 2.391E-03 0.06801189 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP hypothyroidism DOID_1459 1.653E-04 2.542E-03 2.613E-03 0.07081306 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP pre-malignant neoplasm DOID_0060071 1.754E-04 2.626E-03 1.754E-04 9.978E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP congenital heart defect DOID_1682 1.754E-04 2.559E-03 1.754E-04 9.071E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP in situ carcinoma DOID_8719 1.754E-04 2.626E-03 1.754E-04 9.978E-03 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP Sciatic Neuropathy DOID_11446 2.441E-04 3.473E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP gestational diabetes DOID_11714 2.441E-04 3.388E-03 6.588E-03 0.1171499 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP lesion of sciatic nerve DOID_12528 2.441E-04 3.473E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP mononeuritis of lower limb DOID_9473 2.441E-04 3.473E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP mononeuritis DOID_1802 2.704E-04 3.664E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP invasive ductal carcinoma DOID_3008 2.704E-04 3.579E-03 7.04E-03 0.12138111 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP mononeuropathy DOID_1188 2.985E-04 3.86E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP supratentorial cancer DOID_1659 2.985E-04 3.774E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP cerebrum cancer DOID_368 2.985E-04 3.774E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP electroclinical syndrome DOID_0050701 3.677E-04 4.548E-03 4.696E-03 0.10276978 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP lipid metabolism disorder DOID_3146 4.04E-04 4.891E-03 5.031E-03 0.10223812 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP leiomyoma DOID_127 4.293E-04 5.089E-03 0.13684931 0.50893634 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP focal epilepsy DOID_2234 4.632E-04 5.379E-03 0.04976237 0.36772451 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP uveitis DOID_13141 6.865E-04 7.812E-03 0.01287696 0.17039506 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP encephalomyelitis DOID_640 7.05E-04 7.866E-03 0.06058988 0.37473521 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP dilated cardiomyopathy DOID_12930 7.623E-04 8.342E-03 8.003E-03 0.12306741 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP holoprosencephaly DOID_4621 7.694E-04 8.26E-03 7.694E-04 0.02736182 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP intracranial arterial disease DOID_13089 7.898E-04 8.323E-03 0.16541699 0.5472225 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP cerebral arterial disease DOID_3527 7.898E-04 8.323E-03 0.16541699 0.5472225 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP lymphatic system disease DOID_75 7.898E-04 8.171E-03 0.01410318 0.18237973 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP cervix uteri carcinoma in situ DOID_8991 8.45E-04 8.586E-03 8.45E-04 0.02828393 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP nervous system benign neoplasm DOID_0060115 9.378E-04 9.361E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP craniosynostosis DOID_2340 9.378E-04 9.2E-03 9.378E-04 0.02964457 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP invasive lobular carcinoma DOID_3457 9.378E-04 9.044E-03 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP uveal disease DOID_3480 9.626E-04 9.129E-03 0.0160331 0.19410284 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP gallbladder cancer DOID_3121 1.025E-03 9.562E-03 0.17934648 0.57981903 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP familial atrial fibrillation DOID_0050650 1.122E-03 0.01029935 0.04919052 0.40564354 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP peritonitis DOID_8283 1.122E-03 0.01013587 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP brain cancer DOID_1319 1.228E-03 0.01091583 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP heart valve disease DOID_4079 1.228E-03 0.0107479 0.18964176 0.59947868 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP central nervous system cancer DOID_3620 1.301E-03 0.01121221 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP intracranial thrombosis DOID_4193 1.323E-03 0.01123261 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP open-angle glaucoma DOID_1067 1.539E-03 0.01287647 0.05715187 0.37378634 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP intermediate coronary syndrome DOID_8805 1.771E-03 0.01460188 0.06110766 0.36219021 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP bile duct adenocarcinoma DOID_4896 1.794E-03 0.01458306 0.21316767 0.64175876 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP cholangiocarcinoma DOID_4947 1.794E-03 0.01458306 0.21316767 0.64175876 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP familial hyperlipidemia DOID_1168 1.981E-03 0.01587671 0.02558449 0.2695847 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP pituitary adenoma DOID_3829 2.018E-03 0.01594856 0.06504697 0.37767066 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP congenital nervous system abnormality DOID_2490 2.079E-03 0.01620482 2.079E-03 0.06226062 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP bile duct cancer DOID_4606 2.18E-03 0.01676136 0.22630501 0.66718938 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP bile duct carcinoma DOID_4897 2.18E-03 0.01676136 0.22630501 0.66718938 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP melancholia DOID_2848 2.284E-03 0.01732574 0.02804695 0.28497702 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP collagen disease DOID_854 2.5E-03 0.01872079 0.02973935 0.2968718 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP neuroendocrine tumor DOID_169 2.559E-03 0.01890965 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP prion disease DOID_649 2.559E-03 0.01866722 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP mineral metabolism disease DOID_0050032 2.849E-03 0.02051874 0.24560341 0.71300174 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP testicular cancer DOID_2998 2.852E-03 0.02028591 0.0767666 0.40073576 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP temporal lobe epilepsy DOID_3328 3.097E-03 0.02175412 0.25192931 0.72765369 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP tuberculosis DOID_399 3.358E-03 0.02329885 0.03597034 0.35288145 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP nephrosis DOID_2527 3.773E-03 0.02586888 3.773E-03 0.09759622 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP hepatitis B DOID_2043 3.821E-03 0.02588452 0.08834025 0.41888002 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP peripheral vascular disease DOID_341 3.919E-03 0.0262326 0.03973666 0.37065838 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP myasthenia gravis DOID_437 4.174E-03 0.02761447 0.092166 0.42292302 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP pulmonary embolism DOID_9477 4.174E-03 0.02729706 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP endogenous depression DOID_1595 4.375E-03 0.02828717 0.04265508 0.36224984 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP syndrome DOID_225 4.375E-03 0.02796933 4.375E-03 0.10371961 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP aneurysm disease DOID_2403 4.534E-03 0.02866289 0.28277677 0.79261074 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP diabetic angiopathy DOID_11713 4.541E-03 0.0283916 0.0959758 0.42664242 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP synostosis DOID_11971 4.541E-03 0.02808299 4.541E-03 0.10334541 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP meningitis DOID_9471 4.541E-03 0.02778102 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP mixed glioma DOID_5076 4.696E-03 0.02842568 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP auditory system disease DOID_2742 5.38E-03 0.03222446 5.38E-03 0.10556289 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP mental depression DOID_1596 5.56E-03 0.03295501 0.04976237 0.37256299 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP biliary tract cancer DOID_4607 5.56E-03 0.03261527 0.30067501 0.82649314 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP autosomal dominant nonsyndromic deafness DOID_0050564 5.727E-03 0.0332528 5.727E-03 0.10862581 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP neuromuscular junction disease DOID_439 5.727E-03 0.03291691 0.10731013 0.4456895 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP intracranial aneurysm DOID_10941 6.151E-03 0.03499839 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP middle cerebral artery infarction DOID_3525 6.151E-03 0.03465187 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP periodontitis DOID_824 6.588E-03 0.03675291 0.11478778 0.4632216 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP Human immunodeficiency virus infectious disease DOID_526 6.92E-03 0.03823026 0.05726242 0.35804747 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP renal hypertension DOID_1073 7.04E-03 0.03851516 0.11850323 0.47484745 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP secondary hypertension DOID_11130 7.04E-03 0.03851516 0.11850323 0.47484745 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP autoimmune disease of the nervous system DOID_438 7.04E-03 0.03814835 0.11850323 0.46502302 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP lymphoma DOID_0060058 7.342E-03 0.03941186 7.342E-03 0.12287226 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP polycystic ovary syndrome DOID_11612 7.505E-03 0.03990757 7.505E-03 0.12200315 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP toxic encephalopathy DOID_3602 7.505E-03 0.03953806 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP alcohol-related neurodevelopmental disorder DOID_0050667 7.779E-03 0.04060624 0.33234342 0.89622466 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP mouth disease DOID_403 7.779E-03 0.04023709 0.33234342 0.89199719 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP female reproductive organ benign neoplasm DOID_0060086 7.983E-03 0.04092188 0.12588771 0.48073896 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP uterine benign neoplasm DOID_0060095 7.983E-03 0.04092188 0.12588771 0.48073896 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP uterine fibroid DOID_13223 7.983E-03 0.04092188 0.12588771 0.48073896 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP dysostosis DOID_1934 7.983E-03 0.04055651 7.983E-03 0.1261758 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP endometrial carcinoma DOID_2871 7.983E-03 0.0401976 0.12588771 0.47753404 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP ulcerative colitis DOID_8577 8.697E-03 0.04340913 0.06627844 0.37712432 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP endometrial cancer DOID_1380 8.98E-03 0.04443085 0.13321071 0.49866377 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP allergic rhinitis DOID_4481 8.98E-03 0.04404782 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP metal metabolism disorder DOID_896 0.01002933 0.04877514 0.01002933 0.14632543 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP periodontal disease DOID_3388 0.01057349 0.05098575 0.14408106 0.52217911 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP spindle cell carcinoma DOID_4015 0.01057349 0.0505573 0.14408106 0.51561082 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP hyperthyroidism DOID_7998 0.01057349 0.05013599 0.01057349 0.14673948 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP adolescence-adult electroclinical syndrome DOID_0050705 0.0122823 0.05775725 0.15481592 0.53713574 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP calcinosis DOID_182 0.0122823 0.05728383 0.15481592 0.53388037 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP embryonal cancer DOID_688 0.0122823 0.0568181 0.15481592 0.53066422 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP multiple myeloma DOID_9538 0.0122823 0.05635989 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP hepatitis DOID_2237 0.01348395 0.06137895 0.16189807 0.54833334 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP congenital diaphragmatic hernia DOID_3827 0.01348395 0.06089182 0.16189807 0.54508876 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP systemic scleroderma DOID_418 0.01348395 0.06041236 0.16189807 0.54188236 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP benign mesothelioma DOID_2645 0.01473452 0.06549954 0.01473452 0.1863098 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP autoimmune disease of urogenital tract DOID_0060049 0.01537786 0.06782948 0.17241086 0.56706231 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP primary biliary cirrhosis DOID_12236 0.01537786 0.06782948 0.17241086 0.56706231 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP nephrotic syndrome DOID_1184 0.0160331 0.07017564 0.0160331 0.19832247 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP Huntington's disease DOID_12858 0.0160331 0.06963995 0.17588592 0.57516718 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP rheumatic disease DOID_1575 0.0160331 0.06911237 0.17588592 0.57188051 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP scleroderma DOID_419 0.0160331 0.06911237 0.17588592 0.57188051 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP uterine cancer DOID_363 0.01670012 0.07144638 0.17934648 0.57654321 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP cerebral infarction DOID_3526 0.01737882 0.07379512 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP myeloma DOID_0070004 0.0187708 0.07911544 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP vascular skin disease DOID_9540 0.0187708 0.0785337 0.18964176 0.59616665 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP pulmonary tuberculosis DOID_2957 0.02020819 0.08393035 0.02020819 0.22545996 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP calcium metabolism disease DOID_10575 0.02094364 0.08635459 0.19980869 0.61454672 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP B-cell lymphocytic neoplasm DOID_707 0.02169013 0.08878911 0.02169013 0.23734013 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP atrophic muscular disease DOID_913 0.02321581 0.09435567 0.20984885 0.63512763 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP muscular dystrophy DOID_9884 0.02321581 0.09435567 0.20984885 0.63512763 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP bone marrow cancer DOID_4960 0.02399478 0.09682999 1.000 1.000 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP reproductive organ benign neoplasm DOID_0050622 0.02478437 0.09931203 0.21647264 0.6482786 DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP smallpox DOID_8736 0.02478437 0.09861754 0.02478437 0.26608129 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN funisitis DOID_0050698 3.406E-07 1.938E-04 3.406E-07 1.938E-04 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN lymphatic system disease DOID_75 2.705E-06 7.697E-04 2.705E-06 7.697E-04 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN tuberculosis DOID_399 1.238E-05 2.349E-03 9.293E-04 0.08812981 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN primary bacterial infectious disease DOID_0050338 2.442E-05 3.474E-03 1.454E-03 0.11821541 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN lymphoblastic leukemia DOID_1037 2.97E-05 3.379E-03 2.97E-05 5.632E-03 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN chronic leukemia DOID_1036 2.256E-04 0.02139709 2.256E-04 0.03209563 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN chronic lymphocytic leukemia DOID_1040 2.256E-04 0.02139709 2.256E-04 0.03209563 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN autoimmune disease of urogenital tract DOID_0060049 3.74E-04 0.03039816 3.74E-04 0.04255743 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN primary biliary cirrhosis DOID_12236 3.74E-04 0.03039816 3.74E-04 0.04255743 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN aortic aneurysm DOID_3627 5.189E-04 0.03690853 0.03302819 0.3915217 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN bile duct adenocarcinoma DOID_4896 6.001E-04 0.03793907 1.000 1.000 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN cholangiocarcinoma DOID_4947 6.001E-04 0.03793907 1.000 1.000 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN bile duct cancer DOID_4606 6.87E-04 0.03909096 1.000 1.000 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN bile duct carcinoma DOID_4897 6.87E-04 0.03909096 1.000 1.000 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN pancreatic ductal carcinoma DOID_3587 9.82E-04 0.0507978 1.000 1.000 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN male reproductive system disease DOID_48 1.009E-03 0.04783964 0.04582347 0.46559922 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN pancreatic carcinoma DOID_4905 1.064E-03 0.04655975 1.000 1.000 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN aneurysm disease DOID_2403 1.149E-03 0.04668418 0.04884597 0.47919577 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN biliary tract cancer DOID_4607 1.328E-03 0.05037058 1.000 1.000 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN primary immunodeficiency disease DOID_612 1.52E-03 0.05404159 1.52E-03 0.10808318 TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN hypersensitivity reaction type I disease DOID_1205 1.724E-03 0.05769691 0.05965115 0.52217699 NGUYEN_NOTCH1_TARGETS_DN lymphoma DOID_0060058 1.266E-05 7.202E-03 8.885E-03 0.25276825 NGUYEN_NOTCH1_TARGETS_DN lymphoblastic leukemia DOID_1037 1.32E-05 3.755E-03 9.067E-03 0.24567309 NGUYEN_NOTCH1_TARGETS_DN papilloma DOID_2615 2.221E-05 4.213E-03 0.05275029 0.38480664 NGUYEN_NOTCH1_TARGETS_DN thyroid carcinoma DOID_3963 2.414E-05 3.435E-03 0.05417586 0.3853258 NGUYEN_NOTCH1_TARGETS_DN thyroid cancer DOID_1781 2.834E-05 3.225E-03 0.05702067 0.38624713 NGUYEN_NOTCH1_TARGETS_DN intracranial arterial disease DOID_13089 3.81E-05 3.613E-03 1.928E-03 0.21937041 NGUYEN_NOTCH1_TARGETS_DN cerebral arterial disease DOID_3527 3.81E-05 3.613E-03 1.928E-03 0.21937041 NGUYEN_NOTCH1_TARGETS_DN cervix uteri carcinoma in situ DOID_8991 4.085E-05 3.32E-03 2.018E-03 0.19132939 NGUYEN_NOTCH1_TARGETS_DN Huntington's disease DOID_12858 4.672E-05 3.323E-03 2.203E-03 0.17908006 NGUYEN_NOTCH1_TARGETS_DN thyroid adenoma DOID_2891 6.007E-05 3.797E-03 0.07251749 0.39297572 NGUYEN_NOTCH1_TARGETS_DN integumentary system benign neoplasm DOID_0060121 6.758E-05 3.845E-03 0.07530809 0.40424812 NGUYEN_NOTCH1_TARGETS_DN skin benign neoplasm DOID_3165 6.758E-05 3.845E-03 0.07530809 0.40424812 NGUYEN_NOTCH1_TARGETS_DN integumentary system cancer DOID_0060122 9.376E-05 4.85E-03 0.08363048 0.42111275 NGUYEN_NOTCH1_TARGETS_DN skin cancer DOID_4159 9.376E-05 4.85E-03 0.08363048 0.42111275 NGUYEN_NOTCH1_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 1.09E-04 5.169E-03 3.839E-03 0.18205542 NGUYEN_NOTCH1_TARGETS_DN oral cavity cancer DOID_8618 1.09E-04 4.771E-03 0.08776403 0.42681824 NGUYEN_NOTCH1_TARGETS_DN familial adenomatous polyposis DOID_0050424 1.211E-04 4.922E-03 0.01641711 0.34597543 NGUYEN_NOTCH1_TARGETS_DN pre-malignant neoplasm DOID_0060071 1.379E-04 5.23E-03 4.479E-03 0.18203078 NGUYEN_NOTCH1_TARGETS_DN in situ carcinoma DOID_8719 1.379E-04 5.23E-03 4.479E-03 0.18203078 NGUYEN_NOTCH1_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 1.713E-04 6.091E-03 0.10141069 0.45435182 NGUYEN_NOTCH1_TARGETS_DN astrocytoma DOID_3069 1.785E-04 5.976E-03 0.10276427 0.45681929 NGUYEN_NOTCH1_TARGETS_DN pancreatic carcinoma DOID_4905 2.096E-04 6.624E-03 0.1081586 0.46622912 NGUYEN_NOTCH1_TARGETS_DN mixed glioma DOID_5076 2.439E-04 7.303E-03 0.11352106 0.47847026 NGUYEN_NOTCH1_TARGETS_DN angiosarcoma DOID_0001816 2.629E-04 7.48E-03 0.02379162 0.34711366 NGUYEN_NOTCH1_TARGETS_DN tongue cancer DOID_8649 2.629E-04 7.124E-03 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN urinary system benign neoplasm DOID_731 2.977E-04 7.7E-03 0.02525999 0.31245511 NGUYEN_NOTCH1_TARGETS_DN transitional cell carcinoma DOID_2671 3.45E-04 8.535E-03 0.12678902 0.50449617 NGUYEN_NOTCH1_TARGETS_DN infertility DOID_5223 3.736E-04 8.857E-03 0.02819022 0.32735179 NGUYEN_NOTCH1_TARGETS_DN alcohol-related neurodevelopmental disorder DOID_0050667 4.169E-04 9.489E-03 9.251E-03 0.23926619 NGUYEN_NOTCH1_TARGETS_DN coronary restenosis DOID_4247 4.579E-04 0.01002131 0.0311118 0.35405232 NGUYEN_NOTCH1_TARGETS_DN papillary adenoma DOID_3172 7.61E-04 0.01603635 0.03982486 0.38407365 NGUYEN_NOTCH1_TARGETS_DN microcystic adenoma DOID_5403 7.61E-04 0.01603635 0.03982486 0.38407365 NGUYEN_NOTCH1_TARGETS_DN follicular adenoma DOID_6204 7.61E-04 0.01603635 0.03982486 0.38407365 NGUYEN_NOTCH1_TARGETS_DN middle cerebral artery infarction DOID_3525 8.187E-04 0.01663707 8.187E-04 0.46583799 NGUYEN_NOTCH1_TARGETS_DN sarcoma DOID_1115 9.403E-04 0.01844999 0.04415248 0.35889655 NGUYEN_NOTCH1_TARGETS_DN coronary stenosis DOID_4248 9.403E-04 0.01783499 0.04415248 0.35384167 NGUYEN_NOTCH1_TARGETS_DN autoimmune disease of endocrine system DOID_0060005 1.004E-03 0.01843219 1.004E-03 0.285699 NGUYEN_NOTCH1_TARGETS_DN toxic encephalopathy DOID_3602 1.004E-03 0.01785619 1.004E-03 0.190466 NGUYEN_NOTCH1_TARGETS_DN Charcot-Marie-Tooth disease DOID_10595 1.208E-03 0.02082945 1.208E-03 0.17184294 NGUYEN_NOTCH1_TARGETS_DN allergic rhinitis DOID_4481 1.208E-03 0.02021682 0.04989283 0.37353975 NGUYEN_NOTCH1_TARGETS_DN chronic leukemia DOID_1036 1.28E-03 0.02080937 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN chronic lymphocytic leukemia DOID_1040 1.28E-03 0.02080937 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN autonomic nervous system neoplasm DOID_2621 1.28E-03 0.02023133 0.05132262 0.37925417 NGUYEN_NOTCH1_TARGETS_DN neuroblastoma DOID_769 1.28E-03 0.02023133 0.05132262 0.37925417 NGUYEN_NOTCH1_TARGETS_DN spindle cell carcinoma DOID_4015 1.43E-03 0.02199099 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN adenoma DOID_657 1.588E-03 0.02377767 0.05702067 0.38170305 NGUYEN_NOTCH1_TARGETS_DN peripheral nervous system neoplasm DOID_1192 1.754E-03 0.02558861 0.05985707 0.37427111 NGUYEN_NOTCH1_TARGETS_DN nephrotic syndrome DOID_1184 2.203E-03 0.03133901 0.06691145 0.39250118 NGUYEN_NOTCH1_TARGETS_DN cerebral infarction DOID_3526 2.396E-03 0.03325779 2.396E-03 0.1704462 NGUYEN_NOTCH1_TARGETS_DN hemorrhagic disease DOID_2213 3.023E-03 0.04094958 3.023E-03 0.19109803 NGUYEN_NOTCH1_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 3.023E-03 0.03999726 0.07809043 0.41142089 NGUYEN_NOTCH1_TARGETS_DN giant cell tumor DOID_200 3.247E-03 0.04198471 0.08086456 0.41829029 NGUYEN_NOTCH1_TARGETS_DN malignant giant cell tumor DOID_2705 3.247E-03 0.04198471 0.08086456 0.41829029 NGUYEN_NOTCH1_TARGETS_DN giant cell glioblastoma DOID_3074 3.247E-03 0.04198471 0.08086456 0.41829029 NGUYEN_NOTCH1_TARGETS_DN bile duct adenocarcinoma DOID_4896 3.361E-03 0.04250358 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN cholangiocarcinoma DOID_4947 3.361E-03 0.04250358 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN osteochondrodysplasia DOID_2256 3.478E-03 0.04302315 3.478E-03 0.19790651 NGUYEN_NOTCH1_TARGETS_DN pustulosis of palm and sole DOID_4398 3.478E-03 0.04210777 0.08363048 0.41741878 NGUYEN_NOTCH1_TARGETS_DN retinitis pigmentosa DOID_10584 3.839E-03 0.04551386 3.839E-03 0.19860592 NGUYEN_NOTCH1_TARGETS_DN glioblastoma DOID_3068 3.839E-03 0.044585 0.08776403 0.43049771 NGUYEN_NOTCH1_TARGETS_DN bile duct cancer DOID_4606 3.839E-03 0.0436933 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN bile duct carcinoma DOID_4897 3.839E-03 0.0436933 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN melancholia DOID_2848 3.964E-03 0.0442219 0.08913781 0.42982554 NGUYEN_NOTCH1_TARGETS_DN neurotic disorder DOID_4964 4.09E-03 0.04475043 0.09050955 0.43277257 NGUYEN_NOTCH1_TARGETS_DN neuroectodermal tumor DOID_171 4.218E-03 0.04527885 4.218E-03 0.18459838 NGUYEN_NOTCH1_TARGETS_DN carotid artery disease DOID_3407 4.218E-03 0.04444035 0.09187927 0.43566086 NGUYEN_NOTCH1_TARGETS_DN brain infarction DOID_3454 5.164E-03 0.05342225 5.164E-03 0.19588157 NGUYEN_NOTCH1_TARGETS_DN blood coagulation disease DOID_1247 5.451E-03 0.05538106 5.451E-03 0.19383369 NGUYEN_NOTCH1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 5.451E-03 0.05440946 0.10411585 0.45923968 NGUYEN_NOTCH1_TARGETS_DN nephrosis DOID_2527 5.597E-03 0.05490391 0.10546543 0.46161407 NGUYEN_NOTCH1_TARGETS_DN diabetic retinopathy DOID_8947 5.894E-03 0.05684146 5.894E-03 0.19727331 NGUYEN_NOTCH1_TARGETS_DN endogenous depression DOID_1595 6.198E-03 0.05878173 0.1108438 0.47421146 NGUYEN_NOTCH1_TARGETS_DN metabolic syndrome X DOID_14221 6.829E-03 0.06369563 0.1161904 0.48612014 NGUYEN_NOTCH1_TARGETS_DN mental depression DOID_1596 7.319E-03 0.06717332 0.12017961 0.48498014 NGUYEN_NOTCH1_TARGETS_DN biliary tract cancer DOID_4607 7.319E-03 0.06610708 1.000 1.000 NGUYEN_NOTCH1_TARGETS_DN bone development disease DOID_0080006 7.486E-03 0.06655965 7.486E-03 0.23665652 NGUYEN_NOTCH1_TARGETS_DN retinal vascular disease DOID_2462 7.655E-03 0.06701335 7.655E-03 0.22925619 NGUYEN_NOTCH1_TARGETS_DN nervous system cancer DOID_3093 8.525E-03 0.07349532 0.1294191 0.50785841 NGUYEN_NOTCH1_TARGETS_DN ulcerative colitis DOID_8577 0.01000386 0.08495815 0.13986183 0.53410322 GAL_LEUKEMIC_STEM_CELL_DN pulmonary tuberculosis DOID_2957 3.254E-15 1.851E-12 8.59E-04 0.02572404 GAL_LEUKEMIC_STEM_CELL_DN bacterial pneumonia DOID_874 6.553E-15 1.864E-12 2.97E-03 0.06035548 GAL_LEUKEMIC_STEM_CELL_DN bronchiolitis DOID_2942 3.101E-14 5.882E-12 1.081E-04 6.152E-03 GAL_LEUKEMIC_STEM_CELL_DN hypersensitivity reaction type I disease DOID_1205 5.911E-14 8.408E-12 1.381E-06 1.123E-04 GAL_LEUKEMIC_STEM_CELL_DN influenza DOID_8469 8.534E-14 9.712E-12 6.385E-04 0.02137008 GAL_LEUKEMIC_STEM_CELL_DN tuberculosis DOID_399 8.969E-14 8.506E-12 2.115E-03 0.05013744 GAL_LEUKEMIC_STEM_CELL_DN primary bacterial infectious disease DOID_0050338 9.358E-13 7.607E-11 4.011E-03 0.07607532 GAL_LEUKEMIC_STEM_CELL_DN allergic contact dermatitis DOID_3042 3.802E-12 2.704E-10 1.983E-07 2.82E-05 GAL_LEUKEMIC_STEM_CELL_DN cystic fibrosis DOID_1485 1.041E-11 6.58E-10 1.788E-04 9.251E-03 GAL_LEUKEMIC_STEM_CELL_DN contact dermatitis DOID_2773 1.653E-11 9.404E-10 5.113E-07 4.848E-05 GAL_LEUKEMIC_STEM_CELL_DN systemic scleroderma DOID_418 1.509E-10 7.804E-09 0.13921366 0.44006985 GAL_LEUKEMIC_STEM_CELL_DN bronchiectasis DOID_9563 2.413E-10 1.144E-08 6.779E-04 0.02142788 GAL_LEUKEMIC_STEM_CELL_DN nephrosis DOID_2527 2.593E-10 1.135E-08 2.769E-07 3.151E-05 GAL_LEUKEMIC_STEM_CELL_DN rheumatic disease DOID_1575 2.958E-10 1.202E-08 0.1514232 0.46074761 GAL_LEUKEMIC_STEM_CELL_DN scleroderma DOID_419 2.958E-10 1.202E-08 0.1514232 0.46074761 GAL_LEUKEMIC_STEM_CELL_DN Human immunodeficiency virus infectious disease DOID_526 1.518E-09 5.757E-08 2.039E-05 1.289E-03 GAL_LEUKEMIC_STEM_CELL_DN bronchiolitis obliterans DOID_2799 1.865E-09 6.634E-08 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN oral cavity cancer DOID_8618 2.307E-09 7.72E-08 2.307E-09 1.312E-06 GAL_LEUKEMIC_STEM_CELL_DN ulcerative colitis DOID_8577 2.963E-09 9.366E-08 4.628E-04 0.01880966 GAL_LEUKEMIC_STEM_CELL_DN collagen disease DOID_854 3.255E-09 9.749E-08 0.20427306 0.54826117 GAL_LEUKEMIC_STEM_CELL_DN leishmaniasis DOID_9065 5.937E-09 1.689E-07 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN adenoid cystic carcinoma DOID_4866 9.973E-09 2.702E-07 9.973E-09 2.837E-06 GAL_LEUKEMIC_STEM_CELL_DN salivary gland cancer DOID_8850 1.325E-08 3.426E-07 1.325E-08 2.512E-06 GAL_LEUKEMIC_STEM_CELL_DN atopic dermatitis DOID_3310 4.579E-08 1.133E-06 0.0165247 0.19188886 GAL_LEUKEMIC_STEM_CELL_DN sarcoidosis DOID_11335 5.114E-08 1.212E-06 0.01709723 0.19456652 GAL_LEUKEMIC_STEM_CELL_DN parasitic protozoa infectious disease DOID_2789 6.338E-08 1.442E-06 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN hypersensitivity reaction type IV disease DOID_2916 8.619E-08 1.886E-06 0.02008401 0.21561894 GAL_LEUKEMIC_STEM_CELL_DN opportunistic mycosis DOID_2473 1.164E-07 2.453E-06 0.11110094 0.4158976 GAL_LEUKEMIC_STEM_CELL_DN parasitic infectious disease DOID_1398 1.665E-07 3.383E-06 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN systemic mycosis DOID_0050136 1.833E-07 3.597E-06 0.12057166 0.42611973 GAL_LEUKEMIC_STEM_CELL_DN fungal infectious disease DOID_1564 1.833E-07 3.597E-06 0.12057166 0.42611973 GAL_LEUKEMIC_STEM_CELL_DN myocarditis DOID_820 1.833E-07 3.477E-06 2.893E-04 0.01371745 GAL_LEUKEMIC_STEM_CELL_DN respiratory syncytial virus infectious disease DOID_1273 4.067E-07 7.464E-06 9.873E-03 0.14044769 GAL_LEUKEMIC_STEM_CELL_DN intracranial arterial disease DOID_13089 4.589E-07 8.159E-06 0.1422823 0.44482762 GAL_LEUKEMIC_STEM_CELL_DN cerebral arterial disease DOID_3527 4.589E-07 8.159E-06 0.1422823 0.44482762 GAL_LEUKEMIC_STEM_CELL_DN pulmonary emphysema DOID_9675 5.162E-07 8.901E-06 0.0107979 0.14985374 GAL_LEUKEMIC_STEM_CELL_DN biliary tract cancer DOID_4607 6.33E-07 1.059E-05 3.525E-03 0.06915665 GAL_LEUKEMIC_STEM_CELL_DN nephrotic syndrome DOID_1184 6.479E-07 1.053E-05 5.993E-04 0.02273247 GAL_LEUKEMIC_STEM_CELL_DN pre-eclampsia DOID_10591 9.9E-07 1.565E-05 0.16346083 0.47942892 GAL_LEUKEMIC_STEM_CELL_DN encephalomyelitis DOID_640 1.222E-06 1.879E-05 0.04532877 0.31453743 GAL_LEUKEMIC_STEM_CELL_DN Goodpasture syndrome DOID_9808 1.546E-06 2.315E-05 0.0820771 0.37064976 GAL_LEUKEMIC_STEM_CELL_DN middle cerebral artery infarction DOID_3525 2.946E-06 4.299E-05 0.09509092 0.38925709 GAL_LEUKEMIC_STEM_CELL_DN extrinsic allergic alveolitis DOID_841 2.946E-06 4.191E-05 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN pleurisy DOID_10247 3.922E-06 5.443E-05 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN cutaneous leishmaniasis DOID_9111 5.203E-06 7.049E-05 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN visceral leishmaniasis DOID_9146 5.203E-06 6.885E-05 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN brain infarction DOID_3454 5.73E-06 7.41E-05 0.02665238 0.26146905 GAL_LEUKEMIC_STEM_CELL_DN male reproductive system disease DOID_48 7.029E-06 8.888E-05 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN pleural disease DOID_1532 7.39E-06 9.141E-05 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN leukopenia DOID_615 9.27E-06 1.122E-04 7.726E-03 0.11881651 GAL_LEUKEMIC_STEM_CELL_DN common cold DOID_10459 9.489E-06 1.125E-04 0.04191056 0.33120987 GAL_LEUKEMIC_STEM_CELL_DN encephalitis DOID_9588 9.489E-06 1.102E-04 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN pancreatitis DOID_4989 1.031E-05 1.174E-04 0.03319943 0.30468509 GAL_LEUKEMIC_STEM_CELL_DN pulmonary sarcoidosis DOID_13406 1.272E-05 1.419E-04 0.13304366 0.43758291 GAL_LEUKEMIC_STEM_CELL_DN embryonal cancer DOID_688 1.272E-05 1.392E-04 1.272E-05 9.049E-04 GAL_LEUKEMIC_STEM_CELL_DN peptic ulcer DOID_750 1.55E-05 1.664E-04 0.13921366 0.43763853 GAL_LEUKEMIC_STEM_CELL_DN aspergillosis DOID_13564 1.562E-05 1.646E-04 0.04872412 0.33004788 GAL_LEUKEMIC_STEM_CELL_DN gallbladder cancer DOID_3121 2.435E-05 2.52E-04 6.385E-04 0.02270571 GAL_LEUKEMIC_STEM_CELL_DN mouth disease DOID_403 2.505E-05 2.545E-04 0.29028655 0.70889719 GAL_LEUKEMIC_STEM_CELL_DN cerebral infarction DOID_3526 2.65E-05 2.645E-04 0.15746335 0.4690924 GAL_LEUKEMIC_STEM_CELL_DN neuritis DOID_1803 3.119E-05 3.06E-04 0.01378979 0.18247414 GAL_LEUKEMIC_STEM_CELL_DN funisitis DOID_0050698 6.471E-05 6.241E-04 2.775E-03 0.0607273 GAL_LEUKEMIC_STEM_CELL_DN neutropenia DOID_1227 6.471E-05 6.137E-04 0.07550069 0.37034393 GAL_LEUKEMIC_STEM_CELL_DN leukocyte disease DOID_9500 7.309E-05 6.817E-04 0.02070574 0.21817711 GAL_LEUKEMIC_STEM_CELL_DN sinusitis DOID_0050127 7.423E-05 6.812E-04 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN agranulocytosis DOID_12987 7.423E-05 6.704E-04 0.07879472 0.37995082 GAL_LEUKEMIC_STEM_CELL_DN paranasal sinus disease DOID_1352 7.423E-05 6.812E-04 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN IgA glomerulonephritis DOID_2986 7.423E-05 6.599E-04 0.07879472 0.37675796 GAL_LEUKEMIC_STEM_CELL_DN carotid artery disease DOID_3407 8.279E-05 7.247E-04 1.57E-03 0.04466011 GAL_LEUKEMIC_STEM_CELL_DN respiratory failure DOID_11162 8.797E-05 7.584E-04 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN pre-malignant neoplasm DOID_0060071 9.339E-05 7.931E-04 1.715E-03 0.04647359 GAL_LEUKEMIC_STEM_CELL_DN in situ carcinoma DOID_8719 9.339E-05 7.931E-04 1.715E-03 0.04647359 GAL_LEUKEMIC_STEM_CELL_DN mineral metabolism disease DOID_0050032 9.905E-05 8.288E-04 0.02393265 0.24759416 GAL_LEUKEMIC_STEM_CELL_DN cerebral degeneration DOID_1443 1.05E-04 8.655E-04 1.869E-03 0.04623165 GAL_LEUKEMIC_STEM_CELL_DN urticaria DOID_1555 1.081E-04 8.789E-04 0.08860707 0.39083272 GAL_LEUKEMIC_STEM_CELL_DN hyperglycemia DOID_4195 1.111E-04 8.904E-04 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN cystitis DOID_1679 1.213E-04 9.588E-04 0.09185474 0.3959496 GAL_LEUKEMIC_STEM_CELL_DN myositis DOID_633 1.213E-04 9.457E-04 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN endocrine organ benign neoplasm DOID_0060089 1.242E-04 9.549E-04 0.02665238 0.26605623 GAL_LEUKEMIC_STEM_CELL_DN periodontitis DOID_824 1.508E-04 1.144E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN diabetic retinopathy DOID_8947 1.617E-04 1.211E-03 0.23767772 0.60918299 GAL_LEUKEMIC_STEM_CELL_DN bone resorption disease DOID_0080011 1.879E-04 1.388E-03 0.03244369 0.30263053 GAL_LEUKEMIC_STEM_CELL_DN osteoporosis DOID_11476 1.879E-04 1.388E-03 0.03244369 0.30263053 GAL_LEUKEMIC_STEM_CELL_DN aneurysm disease DOID_2403 1.879E-04 1.37E-03 0.24580904 0.62719884 GAL_LEUKEMIC_STEM_CELL_DN mixed glioma DOID_5076 1.972E-04 1.42E-03 2.97E-03 0.06259086 GAL_LEUKEMIC_STEM_CELL_DN chronic kidney failure DOID_784 2.49E-04 1.771E-03 0.26181428 0.64770576 GAL_LEUKEMIC_STEM_CELL_DN bladder disease DOID_365 2.659E-04 1.868E-03 0.11742594 0.41759599 GAL_LEUKEMIC_STEM_CELL_DN retinal vascular disease DOID_2462 2.723E-04 1.889E-03 0.26707408 0.65785779 GAL_LEUKEMIC_STEM_CELL_DN transitional cell carcinoma DOID_2671 3.1E-04 2.125E-03 3.1E-04 0.01356702 GAL_LEUKEMIC_STEM_CELL_DN pneumoconiosis DOID_10316 3.14E-04 2.127E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN periodontal disease DOID_3388 3.14E-04 2.102E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN lymphoma DOID_0060058 3.659E-04 2.421E-03 4.674E-03 0.08058585 GAL_LEUKEMIC_STEM_CELL_DN calcinosis DOID_182 3.962E-04 2.591E-03 0.13304366 0.43506806 GAL_LEUKEMIC_STEM_CELL_DN uveitis DOID_13141 4.263E-04 2.757E-03 0.13613413 0.43762892 GAL_LEUKEMIC_STEM_CELL_DN adult respiratory distress syndrome DOID_11394 4.91E-04 3.139E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN endometriosis of uterus DOID_288 5.616E-04 3.551E-03 0.14838703 0.45639038 GAL_LEUKEMIC_STEM_CELL_DN endometriosis DOID_289 5.993E-04 3.747E-03 0.1514232 0.45829682 GAL_LEUKEMIC_STEM_CELL_DN uveal disease DOID_3480 5.993E-04 3.706E-03 0.1514232 0.45587197 GAL_LEUKEMIC_STEM_CELL_DN pneumocystosis DOID_11339 6.779E-04 4.147E-03 0.03848564 0.31283331 GAL_LEUKEMIC_STEM_CELL_DN leukodystrophy DOID_10579 7.217E-04 4.369E-03 0.01326883 0.17976099 GAL_LEUKEMIC_STEM_CELL_DN proteinuria DOID_576 7.217E-04 4.323E-03 0.16046741 0.47308785 GAL_LEUKEMIC_STEM_CELL_DN thyroid adenoma DOID_2891 7.658E-04 4.539E-03 0.01378979 0.178327 GAL_LEUKEMIC_STEM_CELL_DN heart valve disease DOID_4079 7.658E-04 4.492E-03 0.01378979 0.17436418 GAL_LEUKEMIC_STEM_CELL_DN vascular skin disease DOID_9540 7.658E-04 4.446E-03 0.16346083 0.47212797 GAL_LEUKEMIC_STEM_CELL_DN diarrhea DOID_13250 8.115E-04 4.664E-03 0.04191056 0.32667275 GAL_LEUKEMIC_STEM_CELL_DN mitochondrial encephalomyopathy DOID_890 8.115E-04 4.618E-03 0.04191056 0.31796148 GAL_LEUKEMIC_STEM_CELL_DN autoimmune disease of gastrointestinal tract DOID_0060031 8.59E-04 4.839E-03 0.01485793 0.18378616 GAL_LEUKEMIC_STEM_CELL_DN calcium metabolism disease DOID_10575 9.082E-04 5.066E-03 0.17237767 0.48555889 GAL_LEUKEMIC_STEM_CELL_DN aortic aneurysm DOID_3627 9.082E-04 5.017E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN leprosy DOID_1024 9.568E-04 5.235E-03 0.04532337 0.33492207 GAL_LEUKEMIC_STEM_CELL_DN giant cell tumor DOID_200 1.066E-03 5.778E-03 0.18120017 0.50294095 GAL_LEUKEMIC_STEM_CELL_DN malignant giant cell tumor DOID_2705 1.066E-03 5.778E-03 0.18120017 0.50294095 GAL_LEUKEMIC_STEM_CELL_DN giant cell glioblastoma DOID_3074 1.066E-03 5.778E-03 0.18120017 0.50294095 GAL_LEUKEMIC_STEM_CELL_DN viral pneumonia DOID_10533 1.114E-03 5.978E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN eyelid disease DOID_530 1.114E-03 5.922E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN bacterial meningitis DOID_9470 1.114E-03 5.868E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN vasculitis DOID_865 1.123E-03 5.86E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN thoracic aortic aneurysm DOID_14004 1.282E-03 6.632E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN varicose veins DOID_799 1.282E-03 6.572E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN glioblastoma DOID_3068 1.367E-03 6.943E-03 0.19569734 0.53024661 GAL_LEUKEMIC_STEM_CELL_DN chronic myeloid leukemia DOID_8552 1.462E-03 7.361E-03 0.05548957 0.3288913 GAL_LEUKEMIC_STEM_CELL_DN vein disease DOID_866 1.462E-03 7.296E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN lymphatic system cancer DOID_0060073 1.653E-03 8.178E-03 0.05885436 0.34171565 GAL_LEUKEMIC_STEM_CELL_DN reticulosarcoma DOID_8538 1.653E-03 8.178E-03 0.05885436 0.34171565 GAL_LEUKEMIC_STEM_CELL_DN lymphosarcoma DOID_8675 1.653E-03 8.178E-03 0.05885436 0.34171565 GAL_LEUKEMIC_STEM_CELL_DN male reproductive organ benign neoplasm DOID_0060087 1.855E-03 9.1E-03 1.855E-03 0.04798024 GAL_LEUKEMIC_STEM_CELL_DN prion disease DOID_649 1.855E-03 9.022E-03 0.06220726 0.34364982 GAL_LEUKEMIC_STEM_CELL_DN cholestasis DOID_13580 1.869E-03 9.011E-03 0.02460125 0.24996632 GAL_LEUKEMIC_STEM_CELL_DN uterine disease DOID_345 1.869E-03 8.936E-03 0.21556631 0.57049875 GAL_LEUKEMIC_STEM_CELL_DN temporal lobe epilepsy DOID_3328 1.949E-03 9.24E-03 0.21836468 0.57522917 GAL_LEUKEMIC_STEM_CELL_DN tooth disease DOID_1091 2.031E-03 9.549E-03 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN astrocytoma DOID_3069 2.201E-03 0.01026534 0.22670046 0.59443576 GAL_LEUKEMIC_STEM_CELL_DN pancreatic ductal carcinoma DOID_3587 2.289E-03 0.01059082 0.22945939 0.59617532 GAL_LEUKEMIC_STEM_CELL_DN pulmonary edema DOID_11396 2.293E-03 0.01052206 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN colon carcinoma DOID_1520 2.293E-03 0.01043789 2.293E-03 0.05218943 GAL_LEUKEMIC_STEM_CELL_DN amyloidosis DOID_9120 2.293E-03 0.01035505 0.06887753 0.35628465 GAL_LEUKEMIC_STEM_CELL_DN alopecia DOID_987 2.293E-03 0.01027351 0.06887753 0.35307488 GAL_LEUKEMIC_STEM_CELL_DN bile duct disease DOID_4138 2.38E-03 0.01057974 0.0287702 0.27746177 GAL_LEUKEMIC_STEM_CELL_DN peripheral vascular disease DOID_341 2.473E-03 0.0109069 0.23494799 0.60766094 GAL_LEUKEMIC_STEM_CELL_DN biliary tract disease DOID_9741 2.473E-03 0.010823 0.02949068 0.27966995 GAL_LEUKEMIC_STEM_CELL_DN autoimmune hepatitis DOID_2048 2.529E-03 0.0109826 0.07219498 0.36353046 GAL_LEUKEMIC_STEM_CELL_DN mitochondrial myopathy DOID_699 2.529E-03 0.01089939 0.07219498 0.36034159 GAL_LEUKEMIC_STEM_CELL_DN pancreatic carcinoma DOID_4905 2.568E-03 0.01098518 0.23767772 0.61193947 GAL_LEUKEMIC_STEM_CELL_DN gastric ulcer DOID_10808 2.775E-03 0.01178291 0.07550069 0.37356431 GAL_LEUKEMIC_STEM_CELL_DN acquired immunodeficiency syndrome DOID_635 2.775E-03 0.01169563 0.07550069 0.36717859 GAL_LEUKEMIC_STEM_CELL_DN myasthenia gravis DOID_437 3.032E-03 0.01268573 0.07879472 0.37053055 GAL_LEUKEMIC_STEM_CELL_DN hypoglycemia DOID_9993 3.032E-03 0.01259314 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN female reproductive system disease DOID_229 3.296E-03 0.01358926 0.25651702 0.64583267 GAL_LEUKEMIC_STEM_CELL_DN Lewy body dementia DOID_12217 3.3E-03 0.01350881 0.0820771 0.37969 GAL_LEUKEMIC_STEM_CELL_DN meningitis DOID_9471 3.3E-03 0.01341232 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN focal epilepsy DOID_2234 3.525E-03 0.01422371 0.26181428 0.65053417 GAL_LEUKEMIC_STEM_CELL_DN acute pancreatitis DOID_2913 3.579E-03 0.01433986 0.08534787 0.37939794 GAL_LEUKEMIC_STEM_CELL_DN portal hypertension DOID_10762 3.868E-03 0.01539036 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN papillary adenoma DOID_3172 4.168E-03 0.01646781 0.09185474 0.39297253 GAL_LEUKEMIC_STEM_CELL_DN neuromuscular junction disease DOID_439 4.168E-03 0.01635424 0.09185474 0.3900399 GAL_LEUKEMIC_STEM_CELL_DN microcystic adenoma DOID_5403 4.168E-03 0.01646781 0.09185474 0.39297253 GAL_LEUKEMIC_STEM_CELL_DN follicular adenoma DOID_6204 4.168E-03 0.01646781 0.09185474 0.39297253 GAL_LEUKEMIC_STEM_CELL_DN cleft lip DOID_9296 4.168E-03 0.01624223 4.168E-03 0.07649564 GAL_LEUKEMIC_STEM_CELL_DN primary immunodeficiency disease DOID_612 4.269E-03 0.01652302 4.269E-03 0.07590264 GAL_LEUKEMIC_STEM_CELL_DN intracranial aneurysm DOID_10941 4.478E-03 0.01721517 0.09509092 0.39784364 GAL_LEUKEMIC_STEM_CELL_DN hypotrichosis DOID_4535 4.478E-03 0.01709963 0.09509092 0.38373571 GAL_LEUKEMIC_STEM_CELL_DN perinatal necrotizing enterocolitis DOID_8677 4.798E-03 0.01820147 4.798E-03 0.08030059 GAL_LEUKEMIC_STEM_CELL_DN lymphoblastic leukemia DOID_1037 4.814E-03 0.01813896 0.04532877 0.32240087 GAL_LEUKEMIC_STEM_CELL_DN carbohydrate metabolic disorder DOID_2978 4.814E-03 0.01801962 0.04532877 0.31842061 GAL_LEUKEMIC_STEM_CELL_DN renal hypertension DOID_1073 5.129E-03 0.0190748 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN secondary hypertension DOID_11130 5.129E-03 0.0190748 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN sarcoma DOID_1115 5.129E-03 0.01895094 0.10152899 0.39568491 GAL_LEUKEMIC_STEM_CELL_DN thrombocytopenia DOID_1588 5.129E-03 0.01882868 0.10152899 0.39299317 GAL_LEUKEMIC_STEM_CELL_DN hepatic vascular disease DOID_272 5.129E-03 0.01870798 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN autoimmune disease of the nervous system DOID_438 5.129E-03 0.01858882 0.10152899 0.39033781 GAL_LEUKEMIC_STEM_CELL_DN renal tubular transport disease DOID_447 5.129E-03 0.01847117 5.129E-03 0.08338413 GAL_LEUKEMIC_STEM_CELL_DN allergic rhinitis DOID_4481 6.554E-03 0.02345272 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN papilloma DOID_2615 7.326E-03 0.02605147 0.12057166 0.42348936 GAL_LEUKEMIC_STEM_CELL_DN hair disease DOID_421 7.326E-03 0.02588966 0.12057166 0.42089127 GAL_LEUKEMIC_STEM_CELL_DN thyroid carcinoma DOID_3963 7.726E-03 0.0271371 7.726E-03 0.12211697 GAL_LEUKEMIC_STEM_CELL_DN spindle cell carcinoma DOID_4015 7.726E-03 0.02697062 0.12370626 0.42402929 GAL_LEUKEMIC_STEM_CELL_DN lymphoid leukemia DOID_10747 8.137E-03 0.02822985 0.12682977 0.42701856 GAL_LEUKEMIC_STEM_CELL_DN aplastic anemia DOID_12449 8.137E-03 0.02805876 0.12682977 0.42450668 GAL_LEUKEMIC_STEM_CELL_DN thyroid cancer DOID_1781 8.557E-03 0.02932921 8.557E-03 0.12812235 GAL_LEUKEMIC_STEM_CELL_DN adenoma DOID_657 8.557E-03 0.02915359 0.12994222 0.43238084 GAL_LEUKEMIC_STEM_CELL_DN multiple myeloma DOID_9538 8.986E-03 0.0304347 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN microcephaly DOID_10907 9.425E-03 0.03173252 9.425E-03 0.1375076 GAL_LEUKEMIC_STEM_CELL_DN blood platelet disease DOID_2218 9.425E-03 0.03154586 0.13613413 0.43517033 GAL_LEUKEMIC_STEM_CELL_DN hepatitis DOID_2237 9.873E-03 0.03285326 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN lymphatic system disease DOID_75 0.01033097 0.0341763 0.1422823 0.44239687 GAL_LEUKEMIC_STEM_CELL_DN diabetic autonomic neuropathy DOID_11503 0.01225347 0.04030188 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN autonomic neuropathy DOID_11504 0.01225347 0.04030188 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN diabetic polyneuropathy DOID_12785 0.01225347 0.04030188 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN diabetic neuropathy DOID_9743 0.01225347 0.04030188 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN myeloma DOID_0070004 0.01378979 0.04509418 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN autonomic nervous system disease DOID_11465 0.01378979 0.0448365 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN bone marrow disease DOID_4961 0.01378979 0.04458175 0.16346083 0.47453679 GAL_LEUKEMIC_STEM_CELL_DN hemolytic anemia DOID_583 0.01431951 0.04603278 0.16644365 0.47831535 GAL_LEUKEMIC_STEM_CELL_DN normocytic anemia DOID_720 0.01431951 0.04603278 0.16644365 0.47831535 GAL_LEUKEMIC_STEM_CELL_DN integumentary system benign neoplasm DOID_0060121 0.01485793 0.0474953 0.16941592 0.48441035 GAL_LEUKEMIC_STEM_CELL_DN glaucoma DOID_1686 0.01485793 0.04722996 0.16941592 0.4819883 GAL_LEUKEMIC_STEM_CELL_DN skin benign neoplasm DOID_3165 0.01485793 0.0474953 0.16941592 0.48441035 GAL_LEUKEMIC_STEM_CELL_DN hemorrhagic disease DOID_2213 0.01596059 0.05045321 0.17532894 0.48903022 GAL_LEUKEMIC_STEM_CELL_DN B-cell lymphocytic neoplasm DOID_707 0.01596059 0.05017446 0.01596059 0.19322506 GAL_LEUKEMIC_STEM_CELL_DN orofacial cleft DOID_0050567 0.0165247 0.05166239 0.0165247 0.19588654 GAL_LEUKEMIC_STEM_CELL_DN bile duct adenocarcinoma DOID_4896 0.01767813 0.05496642 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN cholangiocarcinoma DOID_4947 0.01767813 0.05496642 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN bone marrow cancer DOID_4960 0.01767813 0.05466769 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN reproductive organ benign neoplasm DOID_0050622 0.01826732 0.05618435 0.01826732 0.20380598 GAL_LEUKEMIC_STEM_CELL_DN integumentary system cancer DOID_0060122 0.01826732 0.05588228 0.1870299 0.51410635 GAL_LEUKEMIC_STEM_CELL_DN skin cancer DOID_4159 0.01826732 0.05588228 0.1870299 0.51410635 GAL_LEUKEMIC_STEM_CELL_DN mitochondrial metabolism disease DOID_700 0.01886474 0.05740127 0.1899293 0.51956622 GAL_LEUKEMIC_STEM_CELL_DN congenital nervous system abnormality DOID_2490 0.01947033 0.05892881 0.01947033 0.21305031 GAL_LEUKEMIC_STEM_CELL_DN bile duct cancer DOID_4606 0.02008401 0.06046457 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN bile duct carcinoma DOID_4897 0.02008401 0.06046457 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN endocrine pancreas disease DOID_1428 0.02393265 0.07167199 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN blood coagulation disease DOID_1247 0.02805695 0.08358328 0.22945939 0.59891007 GAL_LEUKEMIC_STEM_CELL_DN leber hereditary optic neuropathy DOID_705 0.03159931 0.09364586 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN phagocyte bactericidal dysfunction DOID_3262 0.03504857 0.09971319 0.03504857 0.30680982 GAL_LEUKEMIC_STEM_CELL_DN teratoma DOID_3307 0.03504857 0.0992171 0.03504857 0.30216118 GAL_LEUKEMIC_STEM_CELL_DN Hermansky-Pudlak syndrome DOID_3753 0.03504857 0.09872593 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN adrenal gland hyperfunction DOID_3947 0.03504857 0.0982396 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN conjunctival disease DOID_4251 0.03504857 0.09775803 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN hypokalemia DOID_4500 0.03504857 0.09728116 0.03504857 0.29765131 GAL_LEUKEMIC_STEM_CELL_DN malignant teratoma DOID_5563 0.03504857 0.0992171 0.03504857 0.30216118 GAL_LEUKEMIC_STEM_CELL_DN mature teratoma DOID_5566 0.03504857 0.0992171 0.03504857 0.30216118 GAL_LEUKEMIC_STEM_CELL_DN acute T cell leukemia DOID_5603 0.03504857 0.09680892 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN conjunctivitis DOID_6195 0.03504857 0.09775803 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN alopecia areata DOID_986 0.03504857 0.09634125 1.000 1.000 GAL_LEUKEMIC_STEM_CELL_DN chromosomal disease DOID_0080014 0.03550766 0.09713393 0.03550766 0.29711555 MISSIAGLIA_REGULATED_BY_METHYLATION_UP transitional cell carcinoma DOID_2671 9.73E-12 5.536E-09 2.459E-08 1.399E-05 MISSIAGLIA_REGULATED_BY_METHYLATION_UP giant cell tumor DOID_200 1.351E-09 3.844E-07 5.407E-03 0.13984357 MISSIAGLIA_REGULATED_BY_METHYLATION_UP malignant giant cell tumor DOID_2705 1.351E-09 3.844E-07 5.407E-03 0.13984357 MISSIAGLIA_REGULATED_BY_METHYLATION_UP giant cell glioblastoma DOID_3074 1.351E-09 3.844E-07 5.407E-03 0.13984357 MISSIAGLIA_REGULATED_BY_METHYLATION_UP glioblastoma DOID_3068 2.293E-09 4.349E-07 6.385E-03 0.15137518 MISSIAGLIA_REGULATED_BY_METHYLATION_UP brain infarction DOID_3454 5.824E-09 8.285E-07 8.562E-03 0.18043637 MISSIAGLIA_REGULATED_BY_METHYLATION_UP astrocytoma DOID_3069 6.344E-09 7.22E-07 8.796E-03 0.17873901 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Human immunodeficiency virus infectious disease DOID_526 2.808E-08 2.663E-06 3.281E-05 9.334E-03 MISSIAGLIA_REGULATED_BY_METHYLATION_UP tuberculosis DOID_399 2.908E-07 2.364E-05 3.709E-04 0.0422096 MISSIAGLIA_REGULATED_BY_METHYLATION_UP aneurysm disease DOID_2403 4.974E-07 3.538E-05 0.14316775 0.61249963 MISSIAGLIA_REGULATED_BY_METHYLATION_UP primary bacterial infectious disease DOID_0050338 9.023E-07 5.704E-05 7.187E-04 0.04543586 MISSIAGLIA_REGULATED_BY_METHYLATION_UP calcinosis DOID_182 1.159E-06 6.593E-05 2.794E-03 0.12230483 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mouth disease DOID_403 1.315E-06 6.8E-05 0.01522702 0.27948948 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hepatitis DOID_2237 1.415E-06 6.709E-05 3.077E-03 0.12504689 MISSIAGLIA_REGULATED_BY_METHYLATION_UP systemic scleroderma DOID_418 1.415E-06 6.193E-05 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP peritonitis DOID_8283 1.551E-06 6.303E-05 0.02317677 0.31399007 MISSIAGLIA_REGULATED_BY_METHYLATION_UP intracranial arterial disease DOID_13089 1.558E-06 5.909E-05 3.223E-03 0.1222495 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cerebral arterial disease DOID_3527 1.558E-06 5.909E-05 3.223E-03 0.1222495 MISSIAGLIA_REGULATED_BY_METHYLATION_UP ulcerative colitis DOID_8577 1.609E-06 5.724E-05 0.17769225 0.69728892 MISSIAGLIA_REGULATED_BY_METHYLATION_UP rheumatic disease DOID_1575 2.051E-06 6.864E-05 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP scleroderma DOID_419 2.051E-06 6.864E-05 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP polycystic kidney disease DOID_898 2.559E-06 8.088E-05 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP leukodystrophy DOID_10579 2.651E-06 7.938E-05 0.09135359 0.50466208 MISSIAGLIA_REGULATED_BY_METHYLATION_UP proteinuria DOID_576 2.651E-06 7.541E-05 4.165E-03 0.13167521 MISSIAGLIA_REGULATED_BY_METHYLATION_UP heart valve disease DOID_4079 2.877E-06 7.795E-05 4.334E-03 0.12329023 MISSIAGLIA_REGULATED_BY_METHYLATION_UP oral submucous fibrosis DOID_5773 3.194E-06 8.26E-05 0.02888767 0.34972519 MISSIAGLIA_REGULATED_BY_METHYLATION_UP glaucoma DOID_1686 3.372E-06 8.342E-05 0.09667108 0.51407333 MISSIAGLIA_REGULATED_BY_METHYLATION_UP calcium metabolism disease DOID_10575 3.642E-06 8.634E-05 4.856E-03 0.13158703 MISSIAGLIA_REGULATED_BY_METHYLATION_UP prion disease DOID_649 5.704E-06 1.298E-04 5.635E-04 0.04580854 MISSIAGLIA_REGULATED_BY_METHYLATION_UP collagen disease DOID_854 7.775E-06 1.702E-04 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mineral metabolism disease DOID_0050032 9.338E-06 1.968E-04 7.656E-03 0.17425715 MISSIAGLIA_REGULATED_BY_METHYLATION_UP endocrine pancreas disease DOID_1428 9.338E-06 1.898E-04 0.12280151 0.57747156 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cerebral degeneration DOID_1443 9.907E-06 1.944E-04 0.12451678 0.57601665 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hepatitis B DOID_2043 1.07E-05 2.03E-04 8.466E-04 0.0481692 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hypoglycemia DOID_9993 1.229E-05 2.256E-04 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Lewy body dementia DOID_12217 1.403E-05 2.495E-04 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP portal hypertension DOID_10762 1.797E-05 3.099E-04 0.04954723 0.40274822 MISSIAGLIA_REGULATED_BY_METHYLATION_UP bone resorption disease DOID_0080011 1.798E-05 3.01E-04 0.14316775 0.61713978 MISSIAGLIA_REGULATED_BY_METHYLATION_UP osteoporosis DOID_11476 1.798E-05 3.01E-04 0.14316775 0.61713978 MISSIAGLIA_REGULATED_BY_METHYLATION_UP pancreatitis DOID_4989 1.89E-05 3.073E-04 0.14484373 0.61504539 MISSIAGLIA_REGULATED_BY_METHYLATION_UP extrinsic allergic alveolitis DOID_841 2.258E-05 3.569E-04 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP chronic kidney failure DOID_784 2.402E-05 3.694E-04 0.15317523 0.63157033 MISSIAGLIA_REGULATED_BY_METHYLATION_UP periodontitis DOID_824 2.515E-05 3.766E-04 0.05510601 0.41256998 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hepatic vascular disease DOID_272 2.791E-05 4.071E-04 0.0569518 0.40506965 MISSIAGLIA_REGULATED_BY_METHYLATION_UP abdominal aortic aneurysm DOID_7693 3.734E-05 5.312E-04 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP papilloma DOID_2615 4.866E-05 6.754E-04 0.06795207 0.44442213 MISSIAGLIA_REGULATED_BY_METHYLATION_UP nephroblastoma DOID_2154 5.288E-05 7.164E-04 0.0697731 0.44112102 MISSIAGLIA_REGULATED_BY_METHYLATION_UP periodontal disease DOID_3388 5.288E-05 6.998E-04 0.0697731 0.43627354 MISSIAGLIA_REGULATED_BY_METHYLATION_UP spindle cell carcinoma DOID_4015 5.288E-05 6.839E-04 0.0697731 0.43153143 MISSIAGLIA_REGULATED_BY_METHYLATION_UP nephrotic syndrome DOID_1184 1.02E-04 1.29E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cerebral infarction DOID_3526 1.159E-04 1.434E-03 4E-03 0.13389862 MISSIAGLIA_REGULATED_BY_METHYLATION_UP pre-eclampsia DOID_10591 1.31E-04 1.586E-03 4.334E-03 0.12977919 MISSIAGLIA_REGULATED_BY_METHYLATION_UP pulmonary tuberculosis DOID_2957 1.473E-04 1.746E-03 0.09667108 0.50931339 MISSIAGLIA_REGULATED_BY_METHYLATION_UP aortic aneurysm DOID_3627 1.559E-04 1.81E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP B-cell lymphocytic neoplasm DOID_707 1.648E-04 1.876E-03 0.10019901 0.51363276 MISSIAGLIA_REGULATED_BY_METHYLATION_UP retinal vascular occlusion DOID_1729 1.674E-04 1.868E-03 0.01935111 0.33366012 MISSIAGLIA_REGULATED_BY_METHYLATION_UP vasculitis DOID_865 1.936E-04 2.119E-03 5.597E-03 0.13845334 MISSIAGLIA_REGULATED_BY_METHYLATION_UP pustulosis of palm and sole DOID_4398 2.039E-04 2.189E-03 2.039E-04 0.0386764 MISSIAGLIA_REGULATED_BY_METHYLATION_UP familial adenomatous polyposis DOID_0050424 2.044E-04 2.154E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP bronchiectasis DOID_9563 2.044E-04 2.114E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP oral cavity cancer DOID_8618 2.368E-04 2.407E-03 0.11244005 0.55633381 MISSIAGLIA_REGULATED_BY_METHYLATION_UP beta thalassemia DOID_12241 2.45E-04 2.445E-03 2.45E-04 0.03484438 MISSIAGLIA_REGULATED_BY_METHYLATION_UP intracranial arteriosclerosis DOID_13097 2.45E-04 2.403E-03 0.02317677 0.33814316 MISSIAGLIA_REGULATED_BY_METHYLATION_UP aortic valve insufficiency DOID_57 2.45E-04 2.362E-03 0.02317677 0.32164837 MISSIAGLIA_REGULATED_BY_METHYLATION_UP stomach disease DOID_76 2.45E-04 2.323E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP vascular dementia DOID_8725 2.45E-04 2.403E-03 0.02317677 0.33814316 MISSIAGLIA_REGULATED_BY_METHYLATION_UP encephalitis DOID_9588 2.45E-04 2.285E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP melancholia DOID_2848 2.485E-04 2.281E-03 0.11417531 0.56004956 MISSIAGLIA_REGULATED_BY_METHYLATION_UP neurotic disorder DOID_4964 2.606E-04 2.354E-03 0.11590721 0.56368551 MISSIAGLIA_REGULATED_BY_METHYLATION_UP parasitic infectious disease DOID_1398 3.266E-04 2.904E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP open-angle glaucoma DOID_1067 3.369E-04 2.949E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP parasitic helminthiasis infectious disease DOID_883 3.369E-04 2.904E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hyperglycemia DOID_4195 3.41E-04 2.896E-03 0.12622874 0.57922705 MISSIAGLIA_REGULATED_BY_METHYLATION_UP tooth disease DOID_1091 3.557E-04 2.977E-03 0.1279374 0.58237105 MISSIAGLIA_REGULATED_BY_METHYLATION_UP allergic contact dermatitis DOID_3042 3.557E-04 2.934E-03 8.331E-03 0.18232668 MISSIAGLIA_REGULATED_BY_METHYLATION_UP thalassemia DOID_10241 3.882E-04 3.156E-03 3.882E-04 0.03681617 MISSIAGLIA_REGULATED_BY_METHYLATION_UP communication disorder DOID_2033 3.882E-04 3.111E-03 0.02888767 0.37357009 MISSIAGLIA_REGULATED_BY_METHYLATION_UP varicose veins DOID_799 3.882E-04 3.068E-03 0.02888767 0.34243925 MISSIAGLIA_REGULATED_BY_METHYLATION_UP nephrosis DOID_2527 4.189E-04 3.265E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP peripheral vascular disease DOID_341 4.358E-04 3.351E-03 0.13643138 0.60648011 MISSIAGLIA_REGULATED_BY_METHYLATION_UP tongue cancer DOID_8649 4.431E-04 3.362E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP vein disease DOID_866 4.431E-04 3.318E-03 0.03078397 0.35032161 MISSIAGLIA_REGULATED_BY_METHYLATION_UP endogenous depression DOID_1595 4.889E-04 3.613E-03 0.14148853 0.61455707 MISSIAGLIA_REGULATED_BY_METHYLATION_UP metabolic syndrome X DOID_14221 5.659E-04 4.128E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP contact dermatitis DOID_2773 5.659E-04 4.076E-03 0.0112857 0.22143315 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mental depression DOID_1596 6.286E-04 4.471E-03 0.15317523 0.63618034 MISSIAGLIA_REGULATED_BY_METHYLATION_UP psoriasis DOID_8893 6.291E-04 4.419E-03 6.291E-04 0.04474146 MISSIAGLIA_REGULATED_BY_METHYLATION_UP esophagitis DOID_11963 6.981E-04 4.844E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mitochondrial myopathy DOID_699 7.706E-04 5.283E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP nervous system cancer DOID_3093 7.914E-04 5.361E-03 0.01404824 0.26644823 MISSIAGLIA_REGULATED_BY_METHYLATION_UP lymphoma DOID_0060058 8.424E-04 5.639E-03 0.16797063 0.68268063 MISSIAGLIA_REGULATED_BY_METHYLATION_UP benign glioma DOID_0060101 8.466E-04 5.601E-03 0.04208532 0.40587371 MISSIAGLIA_REGULATED_BY_METHYLATION_UP benign ependymoma DOID_4844 8.466E-04 5.601E-03 0.04208532 0.40587371 MISSIAGLIA_REGULATED_BY_METHYLATION_UP alcohol-related neurodevelopmental disorder DOID_0050667 8.954E-04 5.856E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP sinusitis DOID_0050127 9.26E-04 5.988E-03 0.0439562 0.41001767 MISSIAGLIA_REGULATED_BY_METHYLATION_UP paranasal sinus disease DOID_1352 9.26E-04 5.988E-03 0.0439562 0.41001767 MISSIAGLIA_REGULATED_BY_METHYLATION_UP optic nerve disease DOID_1891 9.26E-04 5.92E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP muscle cancer DOID_4045 9.26E-04 5.854E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP urinary tract obstruction DOID_5200 9.26E-04 5.79E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP diabetic angiopathy DOID_11713 1.009E-03 6.24E-03 0.04582347 0.42054123 MISSIAGLIA_REGULATED_BY_METHYLATION_UP aortic valve disease DOID_62 1.009E-03 6.173E-03 0.04582347 0.40739932 MISSIAGLIA_REGULATED_BY_METHYLATION_UP meningitis DOID_9471 1.009E-03 6.107E-03 0.04582347 0.40113164 MISSIAGLIA_REGULATED_BY_METHYLATION_UP toxic shock syndrome DOID_14115 1.095E-03 6.56E-03 0.04768715 0.40498489 MISSIAGLIA_REGULATED_BY_METHYLATION_UP acute pancreatitis DOID_2913 1.095E-03 6.492E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP commensal bacterial infectious disease DOID_0050339 1.185E-03 6.951E-03 0.04954723 0.40858515 MISSIAGLIA_REGULATED_BY_METHYLATION_UP urticaria DOID_1555 1.185E-03 6.881E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cystitis DOID_1679 1.278E-03 7.347E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP myositis DOID_633 1.278E-03 7.273E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP intracranial aneurysm DOID_10941 1.375E-03 7.745E-03 0.05325666 0.42087551 MISSIAGLIA_REGULATED_BY_METHYLATION_UP middle cerebral artery infarction DOID_3525 1.375E-03 7.669E-03 0.05325666 0.4151101 MISSIAGLIA_REGULATED_BY_METHYLATION_UP diffuse large B-cell lymphoma DOID_0050745 1.475E-03 8.147E-03 0.05510601 0.41807091 MISSIAGLIA_REGULATED_BY_METHYLATION_UP perinatal necrotizing enterocolitis DOID_8677 1.475E-03 8.069E-03 0.05510601 0.40721193 MISSIAGLIA_REGULATED_BY_METHYLATION_UP autoimmune disease of cardiovascular system DOID_0060051 1.578E-03 8.552E-03 0.0569518 0.41545605 MISSIAGLIA_REGULATED_BY_METHYLATION_UP pleurisy DOID_10247 1.578E-03 8.471E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Behcet's disease DOID_13241 1.578E-03 8.552E-03 0.0569518 0.41545605 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cranial nerve disease DOID_5656 1.685E-03 8.96E-03 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP endometrial carcinoma DOID_2871 1.795E-03 9.457E-03 1.795E-03 0.0928459 MISSIAGLIA_REGULATED_BY_METHYLATION_UP endometrial cancer DOID_1380 2.025E-03 0.01057096 2.025E-03 0.09601952 MISSIAGLIA_REGULATED_BY_METHYLATION_UP allergic rhinitis DOID_4481 2.025E-03 0.01047486 0.06429945 0.43555221 MISSIAGLIA_REGULATED_BY_METHYLATION_UP pleural disease DOID_1532 2.145E-03 0.01099573 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP bladder disease DOID_365 2.145E-03 0.01089756 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP myocarditis DOID_820 2.268E-03 0.01142206 0.06795207 0.43443512 MISSIAGLIA_REGULATED_BY_METHYLATION_UP thyroid carcinoma DOID_3963 2.395E-03 0.01195375 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP esophageal disease DOID_6050 2.395E-03 0.0118498 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP thyroid cancer DOID_1781 2.658E-03 0.01303767 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP peptic ulcer DOID_750 3.077E-03 0.01496288 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP adult respiratory distress syndrome DOID_11394 3.223E-03 0.01554019 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP benign mesothelioma DOID_2645 3.372E-03 0.01612307 0.08242241 0.48348815 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cervix uteri carcinoma in situ DOID_8991 3.372E-03 0.01598871 0.08242241 0.47855459 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Huntington's disease DOID_12858 3.68E-03 0.01730472 0.08600523 0.48452449 MISSIAGLIA_REGULATED_BY_METHYLATION_UP diabetic autonomic neuropathy DOID_11503 3.839E-03 0.01790311 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP autonomic neuropathy DOID_11504 3.839E-03 0.01790311 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP diabetic polyneuropathy DOID_12785 3.839E-03 0.01790311 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP gallbladder cancer DOID_3121 3.839E-03 0.01775756 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP uterine cancer DOID_363 3.839E-03 0.01761435 3.839E-03 0.13651124 MISSIAGLIA_REGULATED_BY_METHYLATION_UP influenza DOID_8469 3.839E-03 0.01747344 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP diabetic neuropathy DOID_9743 3.839E-03 0.01790311 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP autonomic nervous system disease DOID_11465 4.334E-03 0.01956988 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP brain cancer DOID_1319 4.334E-03 0.01941579 0.09312951 0.50952588 MISSIAGLIA_REGULATED_BY_METHYLATION_UP neuritis DOID_1803 4.334E-03 0.0192641 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP thyroid adenoma DOID_2891 4.334E-03 0.01911477 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP vascular skin disease DOID_9540 4.334E-03 0.01896773 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP central nervous system cancer DOID_3620 4.505E-03 0.01956658 0.09490201 0.51427849 MISSIAGLIA_REGULATED_BY_METHYLATION_UP integumentary system benign neoplasm DOID_0060121 4.679E-03 0.02016969 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP skin benign neoplasm DOID_3165 4.679E-03 0.02016969 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP withdrawal disorder DOID_0060001 5.037E-03 0.02154889 0.10019901 0.52305722 MISSIAGLIA_REGULATED_BY_METHYLATION_UP sarcoidosis DOID_11335 5.407E-03 0.02295939 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP integumentary system cancer DOID_0060122 5.789E-03 0.02440009 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP skin cancer DOID_4159 5.789E-03 0.02440009 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mitochondrial metabolism disease DOID_700 5.985E-03 0.02503903 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hypersensitivity reaction type IV disease DOID_2916 6.385E-03 0.02651828 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP respiratory failure DOID_11162 7.221E-03 0.0297726 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP pre-malignant neoplasm DOID_0060071 7.437E-03 0.03044386 0.12108292 0.57895953 MISSIAGLIA_REGULATED_BY_METHYLATION_UP in situ carcinoma DOID_8719 7.437E-03 0.03044386 0.12108292 0.57895953 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cholestasis DOID_13580 7.878E-03 0.03202007 0.12451678 0.5807381 MISSIAGLIA_REGULATED_BY_METHYLATION_UP uterine disease DOID_345 7.878E-03 0.03179298 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP endocrine organ benign neoplasm DOID_0060089 8.562E-03 0.03430832 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP blood coagulation disease DOID_1247 9.032E-03 0.03593859 0.13304363 0.60080812 MISSIAGLIA_REGULATED_BY_METHYLATION_UP bile duct disease DOID_4138 9.271E-03 0.0366344 0.13473914 0.60367377 MISSIAGLIA_REGULATED_BY_METHYLATION_UP male reproductive system disease DOID_48 9.271E-03 0.03638175 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP biliary tract disease DOID_9741 9.513E-03 0.03707596 0.13643138 0.60177871 MISSIAGLIA_REGULATED_BY_METHYLATION_UP diabetic retinopathy DOID_8947 9.758E-03 0.03777159 0.13812035 0.60454216 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cystic fibrosis DOID_1485 0.01025633 0.03943141 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mixed glioma DOID_5076 0.01076552 0.04111127 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP bacterial pneumonia DOID_874 0.01076552 0.0408372 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP lipid metabolism disorder DOID_3146 0.0112857 0.0425269 0.14818599 0.6245765 MISSIAGLIA_REGULATED_BY_METHYLATION_UP chromosomal disease DOID_0080014 0.01154988 0.04323606 0.14985228 0.62695551 MISSIAGLIA_REGULATED_BY_METHYLATION_UP female reproductive system disease DOID_229 0.01154988 0.04295347 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP biliary tract cancer DOID_4607 0.01208637 0.04465678 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP retinal vascular disease DOID_2462 0.01263362 0.04637761 0.15648536 0.64057678 MISSIAGLIA_REGULATED_BY_METHYLATION_UP encephalomyelitis DOID_640 0.01492844 0.05445054 0.16959874 0.68440909 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Crohn's disease DOID_8778 0.01522702 0.05518582 0.1712237 0.68610061 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hypersensitivity reaction type I disease DOID_1205 0.01552816 0.05592104 0.17284553 0.68775599 MISSIAGLIA_REGULATED_BY_METHYLATION_UP dilated cardiomyopathy DOID_12930 0.01552816 0.05556934 0.17284553 0.68297991 MISSIAGLIA_REGULATED_BY_METHYLATION_UP leber hereditary optic neuropathy DOID_705 0.01743275 0.0619952 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP facioscapulohumeral muscular dystrophy DOID_11727 0.01935111 0.06838996 0.01935111 0.34408699 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hyperparathyroidism DOID_13543 0.01935111 0.0679678 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hypolipoproteinemia DOID_1387 0.01935111 0.06755082 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP childhood type dermatomyositis DOID_14203 0.01935111 0.06713893 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP angioedema DOID_1558 0.01935111 0.06673202 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP transient cerebral ischemia DOID_224 0.01935111 0.06633002 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP acute kidney failure DOID_3021 0.01935111 0.06593284 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Paget's disease of bone DOID_5408 0.01935111 0.06554038 0.01935111 0.32384658 MISSIAGLIA_REGULATED_BY_METHYLATION_UP cutaneous leishmaniasis DOID_9111 0.01935111 0.06515257 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP alopecia areata DOID_986 0.01935111 0.06476932 0.01935111 0.31459382 MISSIAGLIA_REGULATED_BY_METHYLATION_UP breast benign neoplasm DOID_0060082 0.02126579 0.07076159 0.02126579 0.33611757 MISSIAGLIA_REGULATED_BY_METHYLATION_UP thoracic benign neoplasm DOID_0060097 0.02126579 0.07076159 0.02126579 0.33611757 MISSIAGLIA_REGULATED_BY_METHYLATION_UP dermatomyositis DOID_10223 0.02126579 0.07035019 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP adrenoleukodystrophy DOID_10588 0.02126579 0.06994354 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP temporal arteritis DOID_13375 0.02126579 0.06954157 0.02126579 0.32703332 MISSIAGLIA_REGULATED_BY_METHYLATION_UP neuronal ceroid lipofuscinosis DOID_14503 0.02126579 0.06914419 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP benign breast phyllodes tumor DOID_1631 0.02126579 0.07076159 0.02126579 0.33611757 MISSIAGLIA_REGULATED_BY_METHYLATION_UP central nervous system vasculitis DOID_525 0.02126579 0.06954157 0.02126579 0.32703332 MISSIAGLIA_REGULATED_BY_METHYLATION_UP otitis media DOID_10754 0.02317677 0.07492945 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mucopolysaccharidosis DOID_12798 0.02317677 0.07450612 0.02317677 0.34704166 MISSIAGLIA_REGULATED_BY_METHYLATION_UP relapsing-remitting multiple sclerosis DOID_2378 0.02317677 0.07408755 0.02317677 0.32968958 MISSIAGLIA_REGULATED_BY_METHYLATION_UP middle ear disease DOID_5100 0.02317677 0.07492945 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP mitochondrial encephalomyopathy DOID_890 0.02317677 0.07367365 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP essential hypertension DOID_10825 0.02508408 0.07929355 0.02508408 0.33192649 MISSIAGLIA_REGULATED_BY_METHYLATION_UP parathyroid gland disease DOID_11201 0.02508408 0.07885547 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP osteogenesis imperfecta DOID_12347 0.02508408 0.07842219 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP newborn respiratory distress syndrome DOID_12716 0.02508408 0.07799366 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP polyneuropathy DOID_1389 0.02508408 0.07756978 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP larynx cancer DOID_2596 0.02508408 0.07715048 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP laryngeal benign neoplasm DOID_2598 0.02508408 0.07715048 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP intracranial thrombosis DOID_4193 0.02508408 0.07673569 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP rhabdomyosarcoma DOID_3247 0.02698771 0.08211767 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP idiopathic pulmonary fibrosis DOID_0050156 0.02888767 0.0874313 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP skeletal system cancer DOID_0060124 0.02888767 0.0869687 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Ehlers-Danlos syndrome DOID_13359 0.02888767 0.08651097 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP bone cancer DOID_184 0.02888767 0.0869687 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP corneal dystrophy DOID_2566 0.02888767 0.08605803 0.02888767 0.36526853 MISSIAGLIA_REGULATED_BY_METHYLATION_UP skeletal muscle cancer DOID_4043 0.02888767 0.08560981 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP nutritional deficiency disease DOID_5113 0.02888767 0.08516624 0.02888767 0.35732791 MISSIAGLIA_REGULATED_BY_METHYLATION_UP intermediate coronary syndrome DOID_8805 0.02888767 0.08472724 0.02888767 0.33545069 MISSIAGLIA_REGULATED_BY_METHYLATION_UP restrictive cardiomyopathy DOID_397 0.03078397 0.08982605 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP Barrett's esophagus DOID_9206 0.03078397 0.08936776 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP drug-induced mental disorder DOID_1203 0.03267662 0.0943807 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP methylmalonic acidemia DOID_14749 0.03267662 0.09390403 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP drug psychosis DOID_1742 0.03267662 0.0943807 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP hyperostosis DOID_205 0.03267662 0.09343215 0.03267662 0.3645686 MISSIAGLIA_REGULATED_BY_METHYLATION_UP urinary system benign neoplasm DOID_731 0.03267662 0.09296499 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP substance-induced psychosis DOID_8646 0.03267662 0.0943807 1.000 1.000 MISSIAGLIA_REGULATED_BY_METHYLATION_UP glucose intolerance DOID_10603 0.03456563 0.09784996 0.03456563 0.37822773 MISSIAGLIA_REGULATED_BY_METHYLATION_UP inherited blood coagulation disease DOID_2214 0.03456563 0.09736555 0.03456563 0.37109136 MISSIAGLIA_REGULATED_BY_METHYLATION_UP ureteral obstruction DOID_5199 0.03456563 0.09688592 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pleural disease DOID_1532 1.846E-14 1.051E-11 1.137E-05 3.234E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pleurisy DOID_10247 3.274E-10 9.315E-08 7.082E-06 4.029E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cutaneous leishmaniasis DOID_9111 4.329E-10 8.211E-08 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cystic fibrosis DOID_1485 6.259E-10 8.903E-08 4.254E-03 0.08347452 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP primary bacterial infectious disease DOID_0050338 1.402E-09 1.595E-07 1.882E-04 8.236E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP intracranial arterial disease DOID_13089 2.185E-09 2.072E-07 1.315E-03 0.03741385 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cerebral arterial disease DOID_3527 2.185E-09 2.072E-07 1.315E-03 0.03741385 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hypersensitivity reaction type I disease DOID_1205 2.366E-09 1.923E-07 2.426E-04 9.861E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP rheumatic disease DOID_1575 3.103E-09 2.207E-07 0.05549812 0.32894196 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP scleroderma DOID_419 3.103E-09 2.207E-07 0.05549812 0.32894196 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cerebral infarction DOID_3526 3.869E-09 2.446E-07 1.636E-03 0.0404802 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pulmonary tuberculosis DOID_2957 5.851E-09 3.329E-07 1.917E-03 0.04545939 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP leishmaniasis DOID_9065 7.925E-09 4.099E-07 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP collagen disease DOID_854 1.698E-08 8.049E-07 0.07638414 0.39155474 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cholestasis DOID_13580 2.312E-08 1.012E-06 8.457E-05 9.624E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP brain infarction DOID_3454 2.88E-08 1.171E-06 3.54E-03 0.0774716 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP tuberculosis DOID_399 2.88E-08 1.093E-06 3.54E-03 0.07460228 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bile duct disease DOID_4138 3.554E-08 1.264E-06 1.088E-04 8.846E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP biliary tract disease DOID_9741 3.804E-08 1.273E-06 1.133E-04 7.161E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP middle cerebral artery infarction DOID_3525 4.152E-08 1.313E-06 5.571E-04 0.01864495 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP systemic scleroderma DOID_418 2.241E-07 6.712E-06 0.05079438 0.31077422 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP peptic ulcer DOID_750 2.241E-07 6.376E-06 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP lymphatic system disease DOID_75 2.469E-07 6.69E-06 0.05197246 0.31459925 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP influenza DOID_8469 3.555E-07 9.196E-06 1.569E-03 0.04058887 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP heart valve disease DOID_4079 4.578E-07 1.133E-05 0.06017904 0.33902843 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP giant cell tumor DOID_200 7.262E-07 1.722E-05 0.06715787 0.36743106 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP malignant giant cell tumor DOID_2705 7.262E-07 1.722E-05 0.06715787 0.36743106 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP giant cell glioblastoma DOID_3074 7.262E-07 1.722E-05 0.06715787 0.36743106 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP parasitic protozoa infectious disease DOID_2789 8.373E-07 1.906E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP glioblastoma DOID_3068 1.027E-06 2.248E-05 0.07293481 0.38425837 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP respiratory failure DOID_11162 1.328E-06 2.798E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP parasitic infectious disease DOID_1398 1.593E-06 3.237E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP allergic contact dermatitis DOID_3042 1.79E-06 3.512E-05 9.221E-05 8.745E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP astrocytoma DOID_3069 2.005E-06 3.802E-05 0.08552108 0.42314343 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pulmonary edema DOID_11396 2.006E-06 3.682E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP brain edema DOID_4724 2.006E-06 3.567E-05 0.02451112 0.22494884 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP male reproductive system disease DOID_48 2.238E-06 3.859E-05 1.088E-04 7.74E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Kawasaki disease DOID_13378 2.338E-06 3.913E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP lymphadenitis DOID_1602 2.338E-06 3.913E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP lymph node disease DOID_9942 2.338E-06 3.913E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP diabetic retinopathy DOID_8947 2.491E-06 4.05E-05 4.044E-03 0.08218016 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bone resorption disease DOID_0080011 2.909E-06 4.598E-05 4.361E-03 0.08272282 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP osteoporosis DOID_11476 2.909E-06 4.598E-05 4.361E-03 0.08272282 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bacterial pneumonia DOID_874 3.06E-06 4.705E-05 4.47E-03 0.07707017 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP polyarteritis nodosa DOID_9810 3.108E-06 4.654E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP contact dermatitis DOID_2773 3.378E-06 4.928E-05 1.476E-04 7.001E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP chronic kidney failure DOID_784 3.899E-06 5.547E-05 0.10018026 0.4710956 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP retinal vascular disease DOID_2462 4.279E-06 5.938E-05 5.263E-03 0.08807058 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bronchiolitis DOID_2942 4.551E-06 6.165E-05 0.0317491 0.24746902 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP extrinsic allergic alveolitis DOID_841 5.724E-06 7.574E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP ulcerative colitis DOID_8577 7.45E-06 9.634E-05 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pneumoconiosis DOID_10316 1.347E-05 1.703E-04 0.04488246 0.29020592 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hepatitis DOID_2237 1.982E-05 2.451E-04 1.255E-03 0.03758088 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP adult respiratory distress syndrome DOID_11394 2.128E-05 2.577E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pulmonary emphysema DOID_9675 2.282E-05 2.705E-04 1.377E-03 0.03729956 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP vascular skin disease DOID_9540 3.36E-05 3.901E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP integumentary system benign neoplasm DOID_0060121 3.782E-05 4.304E-04 3.782E-05 7.173E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP skin benign neoplasm DOID_3165 3.782E-05 4.304E-04 3.782E-05 7.173E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP calcium metabolism disease DOID_10575 4.005E-05 4.468E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP integumentary system cancer DOID_0060122 5.252E-05 5.747E-04 5.252E-05 7.472E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP skin cancer DOID_4159 5.252E-05 5.747E-04 5.252E-05 7.472E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP leukocyte disease DOID_9500 6.416E-05 6.888E-04 0.07408598 0.38674242 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP childhood type dermatomyositis DOID_14203 6.727E-05 7.088E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP retinal vascular occlusion DOID_1729 6.727E-05 6.959E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP carotid artery disease DOID_3407 7.055E-05 7.169E-04 0.07638414 0.39511433 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mineral metabolism disease DOID_0050032 8.091E-05 8.077E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP dermatomyositis DOID_10223 8.215E-05 8.059E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bronchiectasis DOID_9563 8.215E-05 7.923E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP temporal lobe epilepsy DOID_3328 8.834E-05 8.378E-04 0.08210514 0.41343209 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP peritonitis DOID_8283 9.85E-05 9.188E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP encephalitis DOID_9588 9.85E-05 9.04E-04 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP peripheral vascular disease DOID_341 1.133E-04 1.023E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP aneurysm disease DOID_2403 1.322E-04 1.175E-03 4.361E-03 0.08005434 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Legionnaires' disease DOID_10457 1.356E-04 1.187E-03 1.356E-04 7.716E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP legionellosis DOID_10458 1.356E-04 1.187E-03 1.356E-04 7.716E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP viral pneumonia DOID_10533 1.356E-04 1.169E-03 1.356E-04 7.014E-03 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP varicose veins DOID_799 1.563E-04 1.328E-03 0.01843904 0.19795878 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP intermediate coronary syndrome DOID_8805 1.563E-04 1.308E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP focal epilepsy DOID_2234 1.642E-04 1.354E-03 0.10018026 0.4750214 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP silicosis DOID_10325 1.785E-04 1.451E-03 0.01965641 0.20712033 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP vein disease DOID_866 1.785E-04 1.431E-03 0.01965641 0.2033545 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP transitional cell carcinoma DOID_2671 1.945E-04 1.537E-03 5.621E-03 0.09137601 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Human immunodeficiency virus infectious disease DOID_526 2.075E-04 1.618E-03 5.865E-03 0.09270682 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP encephalomyelitis DOID_640 2.282E-04 1.754E-03 6.242E-03 0.09598664 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mouth disease DOID_403 2.353E-04 1.785E-03 0.11240434 0.49967243 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Crohn's disease DOID_8778 2.353E-04 1.762E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP esophagitis DOID_11963 2.818E-04 2.082E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mitochondrial myopathy DOID_699 3.112E-04 2.27E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP gastric ulcer DOID_10808 3.42E-04 2.464E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP neutropenia DOID_1227 3.42E-04 2.433E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP acquired immunodeficiency syndrome DOID_635 3.42E-04 2.403E-03 0.02692965 0.23216619 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP sinusitis DOID_0050127 3.743E-04 2.597E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP agranulocytosis DOID_12987 3.743E-04 2.566E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP paranasal sinus disease DOID_1352 3.743E-04 2.597E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP IgA glomerulonephritis DOID_2986 3.743E-04 2.536E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP muscle cancer DOID_4045 3.743E-04 2.506E-03 0.02813671 0.23895202 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP uremia DOID_4676 3.743E-04 2.477E-03 3.743E-04 0.01419919 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hypoglycemia DOID_9993 3.743E-04 2.448E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP meningitis DOID_9471 4.08E-04 2.638E-03 0.0293423 0.23515168 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP acute pancreatitis DOID_2913 4.432E-04 2.833E-03 4.432E-04 0.01575974 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP portal hypertension DOID_10762 4.797E-04 3.033E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP urticaria DOID_1555 4.797E-04 2.999E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cystitis DOID_1679 5.177E-04 3.202E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP myositis DOID_633 5.177E-04 3.167E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP periodontitis DOID_824 5.978E-04 3.619E-03 0.03534835 0.26464754 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP sarcoma DOID_1115 6.4E-04 3.834E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hepatic vascular disease DOID_272 6.4E-04 3.794E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP spastic cerebral palsy DOID_0050669 7.75E-04 4.546E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP leiomyoma DOID_127 8.72E-04 5.063E-03 8.72E-04 0.02756523 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bladder disease DOID_365 8.72E-04 5.012E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP metal metabolism disorder DOID_896 9.226E-04 5.249E-03 0.04369576 0.28578032 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP periodontal disease DOID_3388 9.745E-04 5.49E-03 0.04488246 0.28063869 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP esophageal disease DOID_6050 9.745E-04 5.436E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP leukopenia DOID_615 9.745E-04 5.384E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP calcinosis DOID_182 1.139E-03 6.23E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP respiratory syncytial virus infectious disease DOID_1273 1.255E-03 6.8E-03 0.05079438 0.3141522 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP learning disability DOID_8927 1.636E-03 8.783E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pre-eclampsia DOID_10591 1.774E-03 9.435E-03 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP brain cancer DOID_1319 1.774E-03 9.347E-03 0.06017904 0.34241872 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP central nervous system cancer DOID_3620 1.845E-03 9.632E-03 0.06134571 0.34221286 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.917E-03 9.918E-03 0.06251097 0.34532762 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP aortic aneurysm DOID_3627 1.991E-03 0.01020646 1.991E-03 0.04531668 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pustulosis of palm and sole DOID_4398 2.379E-03 0.01208626 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mitochondrial metabolism disease DOID_700 2.461E-03 0.01238986 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP congenital heart defect DOID_1682 3.068E-03 0.01531165 0.07867672 0.39970583 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP endocrine pancreas disease DOID_1428 3.16E-03 0.01563322 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP uterine disease DOID_345 3.253E-03 0.01595553 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP tooth disease DOID_1091 3.443E-03 0.01674414 0.08324517 0.41549565 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pancreatic ductal carcinoma DOID_3587 3.738E-03 0.01802391 0.08665696 0.42506732 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pancreatic carcinoma DOID_4905 4.044E-03 0.01933651 0.09005632 0.43796619 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP syndrome DOID_225 4.254E-03 0.02017301 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pancreatitis DOID_4989 4.47E-03 0.02101914 4.47E-03 0.07947862 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP metabolic syndrome X DOID_14221 4.69E-03 0.02187454 0.09681792 0.4668593 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP female reproductive system disease DOID_229 4.802E-03 0.02221494 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP auditory system disease DOID_2742 4.915E-03 0.02255549 0.09906084 0.47366068 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP amino acid metabolic disorder DOID_9252 5.742E-03 0.02613968 0.10686822 0.49437414 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP nervous system cancer DOID_3093 5.865E-03 0.02648766 0.10797814 0.49548036 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP carbohydrate metabolic disorder DOID_2978 6.242E-03 0.02796461 0.11129981 0.49865821 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP leber hereditary optic neuropathy DOID_705 0.01110371 0.04935944 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP interstitial nephritis DOID_1063 0.01232998 0.05438571 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hypolipoproteinemia DOID_1387 0.01232998 0.05396736 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP transient cerebral ischemia DOID_224 0.01232998 0.0535554 0.01232998 0.18462519 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bilirubin metabolic disorder DOID_2741 0.01232998 0.05314967 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP acute kidney failure DOID_3021 0.01232998 0.05275005 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP labyrinthine disease DOID_4539 0.01232998 0.0523564 0.01232998 0.17989121 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP keratitis DOID_4677 0.01232998 0.05196857 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.01232998 0.05158645 0.01232998 0.17539393 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.01232998 0.05158645 0.01232998 0.17539393 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Hodgkin's granuloma DOID_8651 0.01232998 0.05158645 0.01232998 0.17539393 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.01232998 0.05158645 0.01232998 0.17539393 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP visceral leishmaniasis DOID_9146 0.01232998 0.05120991 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP sickle cell anemia DOID_10923 0.01355476 0.05588883 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pneumocystosis DOID_11339 0.01355476 0.05548675 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP migraine without aura DOID_12783 0.01355476 0.05509042 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP temporal arteritis DOID_13375 0.01355476 0.05469971 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP neuronal ceroid lipofuscinosis DOID_14503 0.01355476 0.0543145 0.01355476 0.18811362 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hemochromatosis DOID_2352 0.01355476 0.05393467 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP inner ear disease DOID_2952 0.01355476 0.05356013 0.01355476 0.18363472 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP invasive lobular carcinoma DOID_3457 0.01355476 0.05319075 0.01355476 0.17936415 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP central nervous system vasculitis DOID_525 0.01355476 0.05469971 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP eosinophilic pneumonia DOID_5870 0.01355476 0.05282643 0.01355476 0.17528769 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pulmonary eosinophilia DOID_9498 0.01355476 0.05282643 0.01355476 0.17528769 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Loeffler syndrome DOID_9503 0.01355476 0.05282643 0.01355476 0.17528769 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP otitis media DOID_10754 0.01477806 0.05720214 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP intracranial arteriosclerosis DOID_13097 0.01477806 0.05681563 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP osteopetrosis DOID_13533 0.01477806 0.05643432 0.01477806 0.18686031 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP aortic valve stenosis DOID_1712 0.01477806 0.05605809 0.01477806 0.18279813 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP epidermolysis bullosa DOID_2730 0.01477806 0.05568685 0.01477806 0.17890881 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP middle ear disease DOID_5100 0.01477806 0.05720214 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP retinal detachment DOID_5327 0.01477806 0.05532049 0.01477806 0.17518154 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP stomach disease DOID_76 0.01477806 0.05495891 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP lipodystrophy DOID_811 0.01477806 0.05460204 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Hodgkin's lymphoma DOID_8567 0.01477806 0.05424977 0.01477806 0.17160641 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP vascular dementia DOID_8725 0.01477806 0.05681563 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mitochondrial encephalomyopathy DOID_890 0.01477806 0.05390201 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP berylliosis DOID_10322 0.01599987 0.05798678 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hepatic coma DOID_12550 0.01599987 0.05761978 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hepatic encephalopathy DOID_13413 0.01599987 0.05761978 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP vesiculobullous skin disease DOID_2731 0.01599987 0.05725739 0.01599987 0.18207849 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP intracranial thrombosis DOID_4193 0.01599987 0.05689953 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP psoriatic arthritis DOID_9008 0.01599987 0.05654612 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP tethered spinal cord syndrome DOID_1089 0.0172202 0.06048328 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hypercalcemia DOID_12678 0.0172202 0.06011222 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP rhabdomyosarcoma DOID_3247 0.0172202 0.05974568 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bacterial meningitis DOID_9470 0.0172202 0.05938359 0.0172202 0.19212336 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP idiopathic pulmonary fibrosis DOID_0050156 0.01843904 0.06320371 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP skeletal system cancer DOID_0060124 0.01843904 0.06282524 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP thoracic aortic aneurysm DOID_14004 0.01843904 0.06245128 0.01843904 0.20176568 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bone cancer DOID_184 0.01843904 0.06282524 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mesenchymal cell neoplasm DOID_3350 0.01843904 0.06208175 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP skeletal muscle cancer DOID_4043 0.01843904 0.06171656 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP spindle cell sarcoma DOID_4235 0.01843904 0.06208175 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP lung oat cell carcinoma DOID_5411 0.01843904 0.06135565 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP oral submucous fibrosis DOID_5773 0.01843904 0.06099893 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP epithelioid sarcoma DOID_6193 0.01843904 0.06208175 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hyperhomocysteinemia DOID_9279 0.01843904 0.06064633 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP angiosarcoma DOID_0001816 0.01965641 0.06427872 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP spastic diplegia DOID_10965 0.01965641 0.06391142 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hemolytic-uremic syndrome DOID_12554 0.01965641 0.06354828 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP thyroiditis DOID_7166 0.01965641 0.06318925 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP autoimmune thyroiditis DOID_7188 0.01965641 0.06318925 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Barrett's esophagus DOID_9206 0.01965641 0.06283426 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP bronchitis DOID_6132 0.0208723 0.06634826 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP urinary system benign neoplasm DOID_731 0.0208723 0.06597966 0.0208723 0.21207748 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP keratosis DOID_161 0.02208671 0.06943282 0.02208671 0.22047966 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP skin carcinoma DOID_3451 0.02208671 0.06905132 0.02208671 0.21667829 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP osteosclerosis DOID_4254 0.02208671 0.06867399 0.02208671 0.21300577 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP ureteral obstruction DOID_5199 0.02208671 0.06830076 0.02208671 0.20945568 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP prion disease DOID_649 0.02208671 0.06793157 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP eosinophilia DOID_999 0.02208671 0.06756635 0.02208671 0.20602198 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Down syndrome DOID_14250 0.02329965 0.07089574 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP granulosa cell tumor DOID_2999 0.02329965 0.07051863 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP sex cord-gonadal stromal tumor DOID_192 0.02451112 0.07379274 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP subependymal glioma DOID_4843 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pilocytic astrocytoma DOID_4851 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP subependymal giant cell astrocytoma DOID_5077 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP fibrillary astrocytoma DOID_6726 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP juvenile pilocytic astrocytoma DOID_6811 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP childhood pilocytic astrocytoma DOID_6812 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP gemistocytic astrocytoma DOID_7005 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP childhood cerebral astrocytoma DOID_7007 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP protoplasmic astrocytoma DOID_7008 0.02451112 0.07340436 0.02451112 0.22137823 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP alopecia DOID_987 0.02451112 0.07302004 0.02451112 0.21791919 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP autoimmune hepatitis DOID_2048 0.02572112 0.07622561 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP coronary restenosis DOID_4247 0.02572112 0.07583065 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP benign glioma DOID_0060101 0.02692965 0.07898437 0.02692965 0.23573797 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hepatitis B DOID_2043 0.02692965 0.07857932 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP benign ependymoma DOID_4844 0.02692965 0.07898437 0.02692965 0.23573797 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP placenta disease DOID_780 0.02692965 0.07817841 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP optic nerve disease DOID_1891 0.02813671 0.08126795 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP urinary tract obstruction DOID_5200 0.02813671 0.0808575 0.02813671 0.23543802 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP sleep disorder DOID_535 0.02813671 0.08045118 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP pulmonary embolism DOID_9477 0.02813671 0.08004893 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP diabetic angiopathy DOID_11713 0.0293423 0.08306353 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP ureteral disease DOID_1426 0.0293423 0.08265232 0.0293423 0.24196767 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP aortic valve disease DOID_62 0.0293423 0.08224517 0.0293423 0.23851099 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP spastic quadriplegia DOID_10970 0.03054643 0.08520059 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP commensal bacterial infectious disease DOID_0050339 0.0317491 0.08812311 0.0317491 0.25090609 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP intracranial aneurysm DOID_10941 0.03415006 0.09432711 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP vitiligo DOID_12306 0.03415006 0.09387142 0.03415006 0.26258627 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP spinal cord disease DOID_319 0.03415006 0.09342011 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP seminoma DOID_4440 0.03415006 0.09297313 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP hypotrichosis DOID_4535 0.03415006 0.0925304 0.03415006 0.25908512 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP Sciatic Neuropathy DOID_11446 0.03534835 0.09532328 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP gestational diabetes DOID_11714 0.03534835 0.09487365 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP lesion of sciatic nerve DOID_12528 0.03534835 0.09532328 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP migraine DOID_6364 0.03534835 0.09442823 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP perinatal necrotizing enterocolitis DOID_8677 0.03534835 0.09398698 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mononeuritis of lower limb DOID_9473 0.03534835 0.09532328 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP malaria DOID_12365 0.03654519 0.09671727 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mononeuritis DOID_1802 0.03654519 0.09626951 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP invasive ductal carcinoma DOID_3008 0.03654519 0.09582587 0.03654519 0.27005472 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP coronary stenosis DOID_4248 0.03654519 0.0953863 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP autoimmune disease of endocrine system DOID_0060005 0.03774058 0.09805657 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP mononeuropathy DOID_1188 0.03774058 0.09761085 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP multiple epiphyseal dysplasia DOID_12721 0.03774058 0.09716918 0.03774058 0.27531266 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP supratentorial cancer DOID_1659 0.03774058 0.09673148 0.03774058 0.27182769 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP toxic encephalopathy DOID_3602 0.03774058 0.0962977 0.03774058 0.26842985 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cerebrum cancer DOID_368 0.03774058 0.09673148 0.03774058 0.27182769 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP cranial nerve disease DOID_5656 0.03774058 0.0958678 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP female reproductive organ benign neoplasm DOID_0060086 0.03893451 0.09846105 0.03893451 0.27350291 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP uterine benign neoplasm DOID_0060095 0.03893451 0.09846105 0.03893451 0.27350291 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP corneal disease DOID_10124 0.03893451 0.09802538 1.000 1.000 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP uterine fibroid DOID_13223 0.03893451 0.09846105 0.03893451 0.27350291 THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP abdominal aortic aneurysm DOID_7693 0.04012699 0.09970419 0.04012699 0.27844218 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP collagen disease DOID_854 8.481E-18 4.826E-15 3.679E-06 2.99E-04 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP aneurysm disease DOID_2403 6.684E-15 1.902E-12 1.609E-08 2.289E-06 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP congenital nervous system abnormality DOID_2490 1.018E-12 1.931E-10 1.018E-12 5.793E-10 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Ehlers-Danlos syndrome DOID_13359 9.717E-12 1.382E-09 1.67E-09 3.168E-07 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hypersensitivity reaction type IV disease DOID_2916 5.928E-11 6.746E-09 0.0206435 0.17023406 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP microcephaly DOID_10907 1.399E-10 1.327E-08 1.399E-10 3.98E-08 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP systemic scleroderma DOID_418 1.674E-10 1.36E-08 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP nephrosis DOID_2527 2.917E-10 2.074E-08 2.481E-03 0.05042214 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP rheumatic disease DOID_1575 3.281E-10 2.074E-08 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP scleroderma DOID_419 3.281E-10 2.074E-08 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP mixed glioma DOID_5076 5.509E-10 3.135E-08 0.03410233 0.24255286 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP heart valve disease DOID_4079 6.049E-10 3.129E-08 3.303E-05 1.88E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP aortic aneurysm DOID_3627 9.251E-10 4.387E-08 4.165E-05 2.155E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP primary bacterial infectious disease DOID_0050338 1.306E-09 5.717E-08 4.179E-03 0.06794222 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP sarcoidosis DOID_11335 1.379E-09 5.606E-08 0.01757651 0.15626617 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP oral submucous fibrosis DOID_5773 1.67E-09 6.336E-08 0.05286546 0.27852267 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pleural disease DOID_1532 2.97E-09 1.056E-07 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP allergic contact dermatitis DOID_3042 6.837E-09 2.288E-07 2.163E-07 2.461E-05 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP contact dermatitis DOID_2773 2.092E-08 6.611E-07 5.574E-07 5.286E-05 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP myeloma DOID_0070004 2.781E-08 8.328E-07 0.16567386 0.54177258 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP transitional cell carcinoma DOID_2671 4.013E-08 1.142E-06 0.27834511 0.7725774 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP lymphoma DOID_0060058 5.432E-08 1.472E-06 3.869E-04 0.01222892 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bone marrow cancer DOID_4960 6.221E-08 1.609E-06 0.18658053 0.58013291 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP mouth disease DOID_403 6.288E-08 1.555E-06 0.0474185 0.26981126 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Crohn's disease DOID_8778 6.288E-08 1.491E-06 5.163E-03 0.06994152 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hypersensitivity reaction type I disease DOID_1205 6.756E-08 1.538E-06 4.359E-04 0.01305366 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP focal glomerulosclerosis DOID_3945 9.021E-08 1.974E-06 1.927E-04 7.831E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP oral cavity cancer DOID_8618 9.406E-08 1.982E-06 7.259E-05 3.442E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP osteogenesis imperfecta DOID_12347 1.138E-07 2.312E-06 9.851E-04 0.02437138 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bronchiolitis obliterans DOID_2799 1.253E-07 2.458E-06 6.361E-03 0.0786796 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bladder disease DOID_365 1.704E-07 3.231E-06 0.11906064 0.43706776 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP thoracic aortic aneurysm DOID_14004 2.16E-07 3.964E-06 1.32E-03 0.03129201 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP nephroblastoma DOID_2154 2.274E-07 4.044E-06 3.278E-04 0.01097284 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP brain infarction DOID_3454 2.355E-07 4.061E-06 0.02738554 0.207765 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP tuberculosis DOID_399 2.355E-07 3.942E-06 0.02738554 0.20503125 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP peripheral vascular disease DOID_341 3.273E-07 5.32E-06 2.578E-03 0.05057901 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pulmonary sarcoidosis DOID_13406 3.404E-07 5.38E-06 0.13487871 0.46232521 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP prion disease DOID_649 4.801E-07 7.383E-06 1.91E-03 0.04179158 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bacterial pneumonia DOID_874 4.812E-07 7.206E-06 0.25167994 0.71602943 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pulmonary emphysema DOID_9675 5.553E-07 8.101E-06 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP nephrotic syndrome DOID_1184 6.968E-07 9.912E-06 0.012093 0.12742436 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bone development disease DOID_0080006 7.397E-07 1.027E-05 2.755E-04 9.796E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP primary immunodeficiency disease DOID_612 1.033E-06 1.4E-05 4.447E-03 0.07029325 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Human immunodeficiency virus infectious disease DOID_526 1.102E-06 1.458E-05 0.04393428 0.26880218 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP myasthenia gravis DOID_437 1.37E-06 1.772E-05 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP urinary tract obstruction DOID_5200 1.37E-06 1.732E-05 0.07991615 0.36969342 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP spastic quadriplegia DOID_10970 1.946E-06 2.407E-05 1.002E-04 4.384E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP vasculitis DOID_865 2.062E-06 2.496E-05 0.01817307 0.15667389 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pustulosis of palm and sole DOID_4398 2.25E-06 2.667E-05 0.01877812 0.15712864 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cystitis DOID_1679 2.685E-06 3.118E-05 0.09315247 0.3955504 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP neuromuscular junction disease DOID_439 2.685E-06 3.055E-05 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP B cell deficiency DOID_2115 3.124E-06 3.485E-05 4.608E-03 0.06554488 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pleurisy DOID_10247 4.158E-06 4.549E-05 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP autoimmune disease of the nervous system DOID_438 4.158E-06 4.463E-05 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP spastic cerebral palsy DOID_0050669 6.156E-06 6.486E-05 2.326E-04 8.825E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP temporal arteritis DOID_13375 7.458E-06 7.715E-05 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP central nervous system vasculitis DOID_525 7.458E-06 7.715E-05 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cystic fibrosis DOID_1485 9.782E-06 9.939E-05 0.03255907 0.23450776 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP periodontal disease DOID_3388 9.825E-06 9.808E-05 0.12542203 0.4432617 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP thyroid carcinoma DOID_3963 9.825E-06 9.638E-05 7.948E-03 0.09421663 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP aortic valve insufficiency DOID_57 9.917E-06 9.564E-05 8.356E-04 0.02161046 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP encephalitis DOID_9588 9.917E-06 9.405E-05 0.04251917 0.26586164 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP thyroid cancer DOID_1781 1.217E-05 1.135E-04 8.801E-03 0.10016103 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cleft palate DOID_674 1.348E-05 1.237E-04 9.243E-03 0.10312251 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP multiple myeloma DOID_9538 1.348E-05 1.218E-04 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP viral pneumonia DOID_10533 1.632E-05 1.451E-04 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP congenital diaphragmatic hernia DOID_3827 1.642E-05 1.437E-04 4.78E-04 0.01359964 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP intracranial arterial disease DOID_13089 1.805E-05 1.556E-04 0.01062531 0.11407173 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cerebral arterial disease DOID_3527 1.805E-05 1.556E-04 0.01062531 0.11407173 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP adenoid cystic carcinoma DOID_4866 1.805E-05 1.533E-04 1.805E-05 1.284E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP salivary gland cancer DOID_8850 2.167E-05 1.814E-04 2.167E-05 1.37E-03 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP gallbladder cancer DOID_3121 2.58E-05 2.128E-04 0.01260085 0.13036151 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cerebral infarction DOID_3526 2.807E-05 2.281E-04 0.01311789 0.13328714 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP ulcerative colitis DOID_8577 3.273E-05 2.623E-04 0.05100018 0.27637242 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP thyroid adenoma DOID_2891 3.303E-05 2.611E-04 0.01417926 0.13910341 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP ureteral obstruction DOID_5199 3.62E-05 2.822E-04 0.06310076 0.3122116 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pulmonary tuberculosis DOID_2957 3.862E-05 2.969E-04 0.01527653 0.14249743 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP B-cell lymphocytic neoplasm DOID_707 4.486E-05 3.403E-04 0.01640913 0.15059347 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP orofacial cleft DOID_0050567 4.824E-05 3.612E-04 0.01698851 0.15343589 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP osteochondrodysplasia DOID_2256 5.951E-05 4.398E-04 0.01877812 0.15947385 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP parasitic protozoa infectious disease DOID_2789 5.951E-05 4.341E-04 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP muscle cancer DOID_4045 7.754E-05 5.585E-04 0.07991615 0.37272369 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP carotid artery disease DOID_3407 8.764E-05 6.233E-04 0.02258283 0.18356618 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP diabetic angiopathy DOID_11713 8.838E-05 6.209E-04 0.0832431 0.37591528 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP ureteral disease DOID_1426 8.838E-05 6.133E-04 0.0832431 0.37295531 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP aortic valve disease DOID_62 8.838E-05 6.059E-04 3.396E-03 0.05856041 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP parasitic infectious disease DOID_1398 1.111E-04 7.525E-04 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP tooth disease DOID_1091 1.244E-04 8.325E-04 0.22403695 0.66394283 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cleft lip DOID_9296 1.267E-04 8.384E-04 0.09315247 0.38408517 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP endocrine organ benign neoplasm DOID_0060089 1.314E-04 8.596E-04 0.02738554 0.21057263 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP intracranial aneurysm DOID_10941 1.415E-04 9.152E-04 4.608E-03 0.07085933 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP middle cerebral artery infarction DOID_3525 1.415E-04 9.05E-04 0.0964319 0.3919268 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pancreatic ductal carcinoma DOID_3587 1.464E-04 9.256E-04 0.0288268 0.21301885 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP male reproductive system disease DOID_48 1.543E-04 9.65E-04 0.23521373 0.68283986 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP diffuse large B-cell lymphoma DOID_0050745 1.575E-04 9.739E-04 4.937E-03 0.06852111 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP gestational diabetes DOID_11714 1.575E-04 9.634E-04 0.09969956 0.4023337 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP periodontitis DOID_824 1.575E-04 9.532E-04 0.09969956 0.39950036 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pancreatic carcinoma DOID_4905 1.711E-04 1.025E-03 0.03104434 0.22646448 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP invasive ductal carcinoma DOID_3008 1.745E-04 1.034E-03 5.278E-03 0.06983587 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bone resorption disease DOID_0080011 1.987E-04 1.166E-03 2.987E-03 0.05483351 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP osteoporosis DOID_11476 1.987E-04 1.166E-03 2.987E-03 0.05483351 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP metabolic syndrome X DOID_14221 2.294E-04 1.332E-03 0.03567364 0.23602676 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP opportunistic mycosis DOID_2473 2.326E-04 1.337E-03 0.11265332 0.42170879 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP abdominal aortic aneurysm DOID_7693 2.326E-04 1.324E-03 6.361E-03 0.07700557 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP biliary tract cancer DOID_4607 2.634E-04 1.484E-03 0.03808214 0.24906593 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP systemic mycosis DOID_0050136 3.021E-04 1.685E-03 0.12224705 0.44588829 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP fungal infectious disease DOID_1564 3.021E-04 1.685E-03 0.12224705 0.44588829 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP myocarditis DOID_820 3.021E-04 1.669E-03 0.12224705 0.44024413 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP aplastic anemia DOID_12449 3.55E-04 1.942E-03 8.37E-03 0.09719226 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP encephalomyelitis DOID_640 4.027E-04 2.182E-03 0.04653817 0.26747695 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP embryonal cancer DOID_688 4.136E-04 2.22E-03 9.243E-03 0.10113938 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hepatitis DOID_2237 4.78E-04 2.542E-03 0.1411267 0.47798268 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP adult respiratory distress syndrome DOID_11394 5.125E-04 2.7E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP lymphatic system disease DOID_75 5.125E-04 2.675E-03 0.14423387 0.48561582 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP keratitis DOID_4677 5.724E-04 2.961E-03 0.03555939 0.23803876 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cutaneous leishmaniasis DOID_9111 5.724E-04 2.934E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP autoimmune disease of urogenital tract DOID_0060049 5.862E-04 2.978E-03 0.15041479 0.500503 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP primary biliary cirrhosis DOID_12236 5.862E-04 2.978E-03 0.15041479 0.500503 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP diabetic autonomic neuropathy DOID_11503 6.663E-04 3.355E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP autonomic neuropathy DOID_11504 6.663E-04 3.355E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP diabetic polyneuropathy DOID_12785 6.663E-04 3.355E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP influenza DOID_8469 6.663E-04 3.326E-03 0.15655138 0.51490021 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP diabetic neuropathy DOID_9743 6.663E-04 3.355E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP breast benign neoplasm DOID_0060082 6.979E-04 3.453E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP thoracic benign neoplasm DOID_0060097 6.979E-04 3.453E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP benign breast phyllodes tumor DOID_1631 6.979E-04 3.453E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP proteinuria DOID_576 7.531E-04 3.694E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP autonomic nervous system disease DOID_11465 7.991E-04 3.886E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bone marrow disease DOID_4961 7.991E-04 3.853E-03 0.01417926 0.13674572 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP vascular skin disease DOID_9540 7.991E-04 3.821E-03 0.01417926 0.13446663 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Seckel syndrome DOID_0050569 8.356E-04 3.962E-03 8.356E-04 0.02263953 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP peritonitis DOID_8283 8.356E-04 3.929E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP autoimmune disease of gastrointestinal tract DOID_0060031 8.963E-04 4.18E-03 0.17170104 0.54886455 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP atopic dermatitis DOID_3310 1.056E-03 4.883E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP giant cell tumor DOID_200 1.112E-03 5.105E-03 0.18362601 0.57408353 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP malignant giant cell tumor DOID_2705 1.112E-03 5.105E-03 0.18362601 0.57408353 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP giant cell glioblastoma DOID_3074 1.112E-03 5.105E-03 0.18362601 0.57408353 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP atrophic muscular disease DOID_913 1.112E-03 5.064E-03 0.01757651 0.15386207 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP muscular dystrophy DOID_9884 1.112E-03 5.064E-03 0.01757651 0.15386207 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP tethered spinal cord syndrome DOID_1089 1.147E-03 5.178E-03 0.04942909 0.27573679 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP rhabdomyosarcoma DOID_3247 1.147E-03 5.137E-03 0.04942909 0.27305974 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP parasitic helminthiasis infectious disease DOID_883 1.147E-03 5.097E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP polycystic kidney disease DOID_898 1.147E-03 5.058E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP reproductive organ benign neoplasm DOID_0050622 1.232E-03 5.391E-03 0.18952443 0.58608371 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP idiopathic pulmonary fibrosis DOID_0050156 1.32E-03 5.733E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP skeletal system cancer DOID_0060124 1.32E-03 5.689E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bone cancer DOID_184 1.32E-03 5.689E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP membranoproliferative glomerulonephritis DOID_2920 1.32E-03 5.647E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP skeletal muscle cancer DOID_4043 1.32E-03 5.605E-03 0.05286546 0.28112569 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP glioblastoma DOID_3068 1.425E-03 6.008E-03 0.19829283 0.6033616 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP spastic diplegia DOID_10965 1.505E-03 6.296E-03 0.0562895 0.29117025 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Fanconi's anemia DOID_13636 1.505E-03 6.25E-03 1.505E-03 0.03425059 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP tongue cancer DOID_8649 1.505E-03 6.205E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP lymphatic system cancer DOID_0060073 1.701E-03 6.965E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bronchitis DOID_6132 1.701E-03 6.915E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP reticulosarcoma DOID_8538 1.701E-03 6.965E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP lymphosarcoma DOID_8675 1.701E-03 6.965E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP respiratory failure DOID_11162 1.712E-03 6.908E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP mineral metabolism disease DOID_0050032 1.868E-03 7.484E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hyperglycemia DOID_4195 2.032E-03 8.085E-03 0.02597455 0.20245918 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP heart septal defect DOID_1681 2.129E-03 8.413E-03 2.129E-03 0.04487199 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP testicular cancer DOID_2998 2.129E-03 8.355E-03 0.06648807 0.32334796 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP leishmaniasis DOID_9065 2.129E-03 8.298E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP astrocytoma DOID_3069 2.295E-03 8.883E-03 0.22964546 0.67703765 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Kawasaki disease DOID_13378 2.603E-03 0.01000567 0.07322625 0.34434494 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP lymphadenitis DOID_1602 2.603E-03 0.01000567 0.07322625 0.34434494 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP autoimmune hepatitis DOID_2048 2.603E-03 9.939E-03 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP lymph node disease DOID_9942 2.603E-03 0.01000567 0.07322625 0.34434494 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP diabetic retinopathy DOID_8947 2.677E-03 0.01015379 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP gastric ulcer DOID_10808 2.856E-03 0.01076209 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hepatitis B DOID_2043 2.856E-03 0.01069129 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP acquired immunodeficiency syndrome DOID_635 2.856E-03 0.01062141 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP endogenous depression DOID_1595 2.882E-03 0.01064664 0.24623069 0.70760233 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP syndrome DOID_225 2.882E-03 0.01057795 2.882E-03 0.05465274 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pancreatitis DOID_4989 3.096E-03 0.01129129 0.25167994 0.71962757 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP uremia DOID_4676 3.121E-03 0.01130983 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP polyarteritis nodosa DOID_9810 3.121E-03 0.01123825 0.07991615 0.36377832 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP synostosis DOID_11971 3.396E-03 0.01215405 3.396E-03 0.06039042 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP meningitis DOID_9471 3.396E-03 0.01207808 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP mental depression DOID_1596 3.673E-03 0.01298123 0.26513258 0.74315486 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP chronic kidney failure DOID_784 3.673E-03 0.0129011 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP retinal vascular disease DOID_2462 3.921E-03 0.01368798 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP portal hypertension DOID_10762 3.98E-03 0.0138101 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP reading disorder DOID_13365 3.98E-03 0.01372641 3.98E-03 0.06661344 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP dyslexia DOID_4428 3.98E-03 0.01372641 3.98E-03 0.06661344 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP vitiligo DOID_12306 4.608E-03 0.01579395 4.608E-03 0.06899461 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP congenital hypoplastic anemia DOID_1342 4.608E-03 0.01569937 4.608E-03 0.06722552 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP spinal cord disease DOID_319 4.608E-03 0.01560592 0.0964319 0.39474642 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP seminoma DOID_4440 4.608E-03 0.01551358 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP extrinsic allergic alveolitis DOID_841 4.608E-03 0.01542233 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP sarcoma DOID_1115 5.278E-03 0.01756107 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP malaria DOID_12365 5.278E-03 0.01745897 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP thrombocytopenia DOID_1588 5.278E-03 0.01735805 0.10295549 0.4068172 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hepatic vascular disease DOID_272 5.278E-03 0.01725829 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP coronary stenosis DOID_4248 5.278E-03 0.01715967 0.10295549 0.40401156 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP dilated cardiomyopathy DOID_12930 5.313E-03 0.01717829 0.04830492 0.27213366 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cranial nerve disease DOID_5656 5.628E-03 0.01809311 5.628E-03 0.07278365 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP female reproductive organ benign neoplasm DOID_0060086 5.989E-03 0.0191457 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP uterine benign neoplasm DOID_0060095 5.989E-03 0.0191457 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP corneal disease DOID_10124 5.989E-03 0.01903874 0.10943233 0.42072294 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP uterine fibroid DOID_13223 5.989E-03 0.0191457 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP dysostosis DOID_1934 5.989E-03 0.01893297 5.989E-03 0.07573189 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP germinoma DOID_3304 6.742E-03 0.02119566 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP chronic leukemia DOID_1036 7.134E-03 0.02230413 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP chronic lymphocytic leukemia DOID_1040 7.134E-03 0.02230413 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP leiomyoma DOID_127 7.134E-03 0.02218225 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP papilloma DOID_2615 7.536E-03 0.0233045 0.12224705 0.44304824 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP calcinosis DOID_182 9.243E-03 0.02842837 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP blood platelet disease DOID_2218 9.694E-03 0.02965573 0.13800832 0.47021997 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP respiratory syncytial virus infectious disease DOID_1273 0.01015495 0.03089928 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP peptic ulcer DOID_750 0.01015495 0.03073492 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP benign mesothelioma DOID_2645 0.01110516 0.03343298 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cervix uteri carcinoma in situ DOID_8991 0.01110516 0.03325702 0.14732989 0.4931218 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP learning disability DOID_8927 0.01311789 0.03907895 0.01311789 0.13094877 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pre-eclampsia DOID_10591 0.01417926 0.04202082 0.16567386 0.53867674 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP brain cancer DOID_1319 0.01417926 0.0418031 0.16567386 0.53561607 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP neuritis DOID_1803 0.01417926 0.04158762 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP central nervous system cancer DOID_3620 0.01472344 0.04296224 0.16869287 0.54229517 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP integumentary system benign neoplasm DOID_0060121 0.01527653 0.04434869 0.17170104 0.54579827 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP glaucoma DOID_1686 0.01527653 0.04412357 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP skin benign neoplasm DOID_3165 0.01527653 0.04434869 0.17170104 0.54579827 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP lung small cell carcinoma DOID_5409 0.01527653 0.04390072 0.17170104 0.54276605 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP calcium metabolism disease DOID_10575 0.01583845 0.04528681 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hemorrhagic disease DOID_2213 0.01640913 0.04668397 0.17768498 0.55857876 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bile duct adenocarcinoma DOID_4896 0.01817307 0.05144516 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP cholangiocarcinoma DOID_4947 0.01817307 0.05144516 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP integumentary system cancer DOID_0060122 0.01877812 0.05289479 0.18952443 0.58291569 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP skin cancer DOID_4159 0.01877812 0.05289479 0.18952443 0.58291569 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bile duct cancer DOID_4606 0.0206435 0.05786281 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP bile duct carcinoma DOID_4897 0.0206435 0.05786281 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP melancholia DOID_2848 0.02128182 0.05935957 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP neurotic disorder DOID_4964 0.02192828 0.06086435 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hypothyroidism DOID_1459 0.0232454 0.06420696 0.0232454 0.18629062 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pre-malignant neoplasm DOID_0060071 0.02391592 0.06573991 0.21269803 0.64034486 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP congenital heart defect DOID_1682 0.02391592 0.06542385 0.02391592 0.18900223 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP in situ carcinoma DOID_8719 0.02391592 0.06573991 0.21269803 0.64034486 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP blood coagulation disease DOID_1247 0.0288268 0.07848063 0.23243461 0.68172831 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP biliary tract disease DOID_9741 0.03029782 0.08209268 0.23798287 0.68737183 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP interstitial nephritis DOID_1063 0.03555939 0.09589239 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP T cell deficiency DOID_11200 0.03555939 0.09544007 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP facioscapulohumeral muscular dystrophy DOID_11727 0.03555939 0.09499199 0.03555939 0.24979376 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP hyperparathyroidism DOID_13543 0.03555939 0.09454811 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP childhood type dermatomyositis DOID_14203 0.03555939 0.09410835 0.03555939 0.24674749 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP ventricular septal defect DOID_1657 0.03555939 0.09367266 0.03555939 0.24377463 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP rectal neoplasm DOID_1984 0.03555939 0.09324099 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP rectum cancer DOID_1993 0.03555939 0.09324099 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP phagocyte bactericidal dysfunction DOID_3262 0.03555939 0.09281328 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP chondrosarcoma DOID_3371 0.03555939 0.09238947 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP holoprosencephaly DOID_4621 0.03555939 0.09196952 0.03555939 0.24087255 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 0.03555939 0.09155337 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 0.03555939 0.09155337 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Hodgkin's granuloma DOID_8651 0.03555939 0.09155337 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 0.03555939 0.09155337 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP visceral leishmaniasis DOID_9146 0.03555939 0.09114097 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP alcohol abuse DOID_1574 0.03808214 0.09716922 0.26513258 0.74683385 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP familial adenomatous polyposis DOID_0050424 0.03904554 0.09918264 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP dermatomyositis DOID_10223 0.03904554 0.09874183 0.03904554 0.2524649 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP adrenoleukodystrophy DOID_10588 0.03904554 0.09830491 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP pneumocystosis DOID_11339 0.03904554 0.09787185 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP prediabetes syndrome DOID_11716 0.03904554 0.09744259 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP common variable immunodeficiency DOID_12177 0.03904554 0.09701708 1.000 1.000 SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP craniosynostosis DOID_2340 0.03904554 0.09659526 0.03904554 0.24962821 BROWNE_HCMV_INFECTION_10HR_UP tooth disease DOID_1091 2.68E-08 1.525E-05 1.79E-06 1.018E-03 BROWNE_HCMV_INFECTION_10HR_UP mouth disease DOID_403 1.321E-07 3.759E-05 6.334E-06 1.802E-03 BROWNE_HCMV_INFECTION_10HR_UP Sciatic Neuropathy DOID_11446 6.379E-06 1.21E-03 5.978E-04 0.03092492 BROWNE_HCMV_INFECTION_10HR_UP lesion of sciatic nerve DOID_12528 6.379E-06 1.21E-03 5.978E-04 0.03092492 BROWNE_HCMV_INFECTION_10HR_UP mononeuritis of lower limb DOID_9473 6.379E-06 1.21E-03 5.978E-04 0.03092492 BROWNE_HCMV_INFECTION_10HR_UP mononeuritis DOID_1802 7.082E-06 1.007E-03 6.4E-04 0.03034871 BROWNE_HCMV_INFECTION_10HR_UP mononeuropathy DOID_1188 7.833E-06 8.914E-04 6.836E-04 0.02992256 BROWNE_HCMV_INFECTION_10HR_UP bronchiolitis obliterans DOID_2799 9.492E-06 9.001E-04 7.75E-04 0.03149989 BROWNE_HCMV_INFECTION_10HR_UP periodontal disease DOID_3388 1.347E-05 1.095E-03 9.745E-04 0.03465657 BROWNE_HCMV_INFECTION_10HR_UP cleft palate DOID_674 1.708E-05 1.215E-03 1.708E-05 3.24E-03 BROWNE_HCMV_INFECTION_10HR_UP intracranial arterial disease DOID_13089 2.128E-05 1.346E-03 1.315E-03 0.03741385 BROWNE_HCMV_INFECTION_10HR_UP cerebral arterial disease DOID_3527 2.128E-05 1.346E-03 1.315E-03 0.03741385 BROWNE_HCMV_INFECTION_10HR_UP cerebral infarction DOID_3526 2.97E-05 1.69E-03 1.636E-03 0.04232021 BROWNE_HCMV_INFECTION_10HR_UP neuritis DOID_1803 3.36E-05 1.738E-03 1.774E-03 0.04389192 BROWNE_HCMV_INFECTION_10HR_UP orofacial cleft DOID_0050567 4.478E-05 2.123E-03 4.478E-05 6.369E-03 BROWNE_HCMV_INFECTION_10HR_UP Noonan syndrome DOID_3490 6.727E-05 2.944E-03 6.727E-05 7.655E-03 BROWNE_HCMV_INFECTION_10HR_UP allergic contact dermatitis DOID_3042 9.221E-05 3.748E-03 9.221E-05 8.745E-03 BROWNE_HCMV_INFECTION_10HR_UP brain infarction DOID_3454 9.62E-05 3.649E-03 3.54E-03 0.07460228 BROWNE_HCMV_INFECTION_10HR_UP polyneuropathy DOID_1389 1.163E-04 4.137E-03 0.01599987 0.21676011 BROWNE_HCMV_INFECTION_10HR_UP contact dermatitis DOID_2773 1.476E-04 4.942E-03 1.476E-04 0.01200113 BROWNE_HCMV_INFECTION_10HR_UP neuroendocrine tumor DOID_169 2.273E-04 7.184E-03 2.273E-04 0.01616414 BROWNE_HCMV_INFECTION_10HR_UP encephalomyelitis DOID_640 2.282E-04 6.833E-03 6.242E-03 0.10762138 BROWNE_HCMV_INFECTION_10HR_UP colon carcinoma DOID_1520 2.818E-04 8.017E-03 2.818E-04 0.01781457 BROWNE_HCMV_INFECTION_10HR_UP autoimmune hepatitis DOID_2048 3.112E-04 8.432E-03 0.02572112 0.27102437 BROWNE_HCMV_INFECTION_10HR_UP Goodpasture syndrome DOID_9808 4.08E-04 0.01055304 0.0293423 0.28297914 BROWNE_HCMV_INFECTION_10HR_UP bronchiolitis DOID_2942 4.797E-04 0.01186753 0.0317491 0.28674981 BROWNE_HCMV_INFECTION_10HR_UP cleft lip DOID_9296 5.177E-04 0.01227319 5.177E-04 0.02945565 BROWNE_HCMV_INFECTION_10HR_UP middle cerebral artery infarction DOID_3525 5.571E-04 0.01267857 0.03415006 0.28161426 BROWNE_HCMV_INFECTION_10HR_UP periodontitis DOID_824 5.978E-04 0.01308362 0.03534835 0.27552346 BROWNE_HCMV_INFECTION_10HR_UP pleurisy DOID_10247 6.4E-04 0.01348832 0.03654519 0.28100289 BROWNE_HCMV_INFECTION_10HR_UP germinoma DOID_3304 8.228E-04 0.01672111 8.228E-04 0.03121273 BROWNE_HCMV_INFECTION_10HR_UP pleural disease DOID_1532 8.72E-04 0.01710945 0.04250762 0.31008761 BROWNE_HCMV_INFECTION_10HR_UP esophageal disease DOID_6050 9.745E-04 0.01848351 9.745E-04 0.03261795 BROWNE_HCMV_INFECTION_10HR_UP pulmonary sarcoidosis DOID_13406 1.139E-03 0.02089949 1.139E-03 0.03599357 BROWNE_HCMV_INFECTION_10HR_UP multiple myeloma DOID_9538 1.139E-03 0.02024639 0.04843392 0.32808217 BROWNE_HCMV_INFECTION_10HR_UP respiratory syncytial virus infectious disease DOID_1273 1.255E-03 0.02163747 0.05079438 0.33220693 BROWNE_HCMV_INFECTION_10HR_UP peptic ulcer DOID_750 1.255E-03 0.02100108 1.255E-03 0.03758088 BROWNE_HCMV_INFECTION_10HR_UP Huntington's disease DOID_12858 1.504E-03 0.02444662 1.504E-03 0.04074437 BROWNE_HCMV_INFECTION_10HR_UP influenza DOID_8469 1.569E-03 0.02480431 0.05667048 0.32903575 BROWNE_HCMV_INFECTION_10HR_UP myeloma DOID_0070004 1.774E-03 0.02728416 0.06017904 0.33902843 BROWNE_HCMV_INFECTION_10HR_UP autoimmune disease of gastrointestinal tract DOID_0060031 1.917E-03 0.02871119 0.06251097 0.33874995 BROWNE_HCMV_INFECTION_10HR_UP pulmonary tuberculosis DOID_2957 1.917E-03 0.02797501 0.06251097 0.33555419 BROWNE_HCMV_INFECTION_10HR_UP lung small cell carcinoma DOID_5409 1.917E-03 0.02727563 0.06251097 0.33241817 BROWNE_HCMV_INFECTION_10HR_UP atopic dermatitis DOID_3310 2.142E-03 0.0297308 0.06599827 0.34452306 BROWNE_HCMV_INFECTION_10HR_UP sarcoidosis DOID_11335 2.22E-03 0.03007413 2.22E-03 0.05262973 BROWNE_HCMV_INFECTION_10HR_UP bone marrow cancer DOID_4960 2.299E-03 0.03041892 0.06831607 0.3501968 BROWNE_HCMV_INFECTION_10HR_UP parasitic protozoa infectious disease DOID_2789 2.379E-03 0.03076502 0.06947286 0.34982353 BROWNE_HCMV_INFECTION_10HR_UP hypersensitivity reaction type IV disease DOID_2916 2.628E-03 0.03322376 2.628E-03 0.05980278 BROWNE_HCMV_INFECTION_10HR_UP neuroectodermal tumor DOID_171 2.888E-03 0.03572041 2.888E-03 0.06319765 BROWNE_HCMV_INFECTION_10HR_UP mineral metabolism disease DOID_0050032 3.16E-03 0.03825149 0.07982092 0.37848418 BROWNE_HCMV_INFECTION_10HR_UP endocrine pancreas disease DOID_1428 3.16E-03 0.03745458 0.07982092 0.37535621 BROWNE_HCMV_INFECTION_10HR_UP parasitic infectious disease DOID_1398 3.253E-03 0.03777227 0.08096372 0.3776095 BROWNE_HCMV_INFECTION_10HR_UP uterine disease DOID_345 3.253E-03 0.03701682 0.08096372 0.37151902 BROWNE_HCMV_INFECTION_10HR_UP hyperglycemia DOID_4195 3.347E-03 0.0373449 0.08210514 0.3707764 BROWNE_HCMV_INFECTION_10HR_UP tuberculosis DOID_399 3.54E-03 0.0387358 0.08438382 0.37511245 BROWNE_HCMV_INFECTION_10HR_UP bile duct disease DOID_4138 3.839E-03 0.04121094 0.08779146 0.38723518 BROWNE_HCMV_INFECTION_10HR_UP male reproductive system disease DOID_48 3.839E-03 0.04044777 3.839E-03 0.07800642 BROWNE_HCMV_INFECTION_10HR_UP biliary tract disease DOID_9741 3.941E-03 0.04076827 0.08892458 0.38921602 BROWNE_HCMV_INFECTION_10HR_UP diabetic retinopathy DOID_8947 4.044E-03 0.04109008 0.09005632 0.39116064 BROWNE_HCMV_INFECTION_10HR_UP endogenous depression DOID_1595 4.254E-03 0.04246949 0.09231567 0.39793649 BROWNE_HCMV_INFECTION_10HR_UP pancreatitis DOID_4989 4.47E-03 0.04385027 4.47E-03 0.08770054 BROWNE_HCMV_INFECTION_10HR_UP bacterial pneumonia DOID_874 4.47E-03 0.04310705 0.09456954 0.40156766 BROWNE_HCMV_INFECTION_10HR_UP metabolic syndrome X DOID_14221 4.69E-03 0.04447823 0.09681792 0.40806961 BROWNE_HCMV_INFECTION_10HR_UP female reproductive system disease DOID_229 4.802E-03 0.04479405 0.09794007 0.40677297 BROWNE_HCMV_INFECTION_10HR_UP mental depression DOID_1596 5.03E-03 0.04616168 0.10018026 0.41306209 BROWNE_HCMV_INFECTION_10HR_UP focal epilepsy DOID_2234 5.03E-03 0.04542896 5.03E-03 0.09540081 BROWNE_HCMV_INFECTION_10HR_UP retinal vascular disease DOID_2462 5.263E-03 0.0467875 0.10241501 0.41329178 BROWNE_HCMV_INFECTION_10HR_UP primary bacterial infectious disease DOID_0050338 5.5E-03 0.04814691 0.10464433 0.41931424 BROWNE_HCMV_INFECTION_10HR_UP transitional cell carcinoma DOID_2671 5.621E-03 0.04845698 5.621E-03 0.10316646 BROWNE_HCMV_INFECTION_10HR_UP primary immunodeficiency disease DOID_612 5.742E-03 0.04876805 5.742E-03 0.10210811 BROWNE_HCMV_INFECTION_10HR_UP carbohydrate metabolic disorder DOID_2978 6.242E-03 0.05222802 0.11129981 0.43978884 BROWNE_HCMV_INFECTION_10HR_UP hypersensitivity reaction type I disease DOID_1205 6.498E-03 0.0535886 0.11350753 0.44236838 BROWNE_HCMV_INFECTION_10HR_UP ventricular septal defect DOID_1657 0.01232998 0.09881348 0.01232998 0.2063458 BROWNE_HCMV_INFECTION_10HR_UP retinal vascular occlusion DOID_1729 0.01232998 0.09744107 1.000 1.000 BROWNE_HCMV_INFECTION_10HR_UP phagocyte bactericidal dysfunction DOID_3262 0.01232998 0.09610626 0.01232998 0.2004502 BROWNE_HCMV_INFECTION_10HR_UP Hermansky-Pudlak syndrome DOID_3753 0.01232998 0.09480753 0.01232998 0.19488214 BROWNE_HCMV_INFECTION_10HR_UP conjunctival disease DOID_4251 0.01232998 0.09354343 0.01232998 0.18961505 BROWNE_HCMV_INFECTION_10HR_UP hypokalemia DOID_4500 0.01232998 0.09231259 0.01232998 0.18462519 BROWNE_HCMV_INFECTION_10HR_UP conjunctivitis DOID_6195 0.01232998 0.09354343 0.01232998 0.18961505 BROWNE_HCMV_INFECTION_10HR_UP visceral leishmaniasis DOID_9146 0.01232998 0.09111373 1.000 1.000 BROWNE_HCMV_INFECTION_10HR_UP maturity-onset diabetes of the young DOID_0050524 0.01355476 0.09888024 0.01355476 0.19776047 BROWNE_HCMV_INFECTION_10HR_UP trypanosomiasis DOID_10113 0.01355476 0.09762859 0.01355476 0.19281646 BROWNE_HCMV_INFECTION_10HR_UP prediabetes syndrome DOID_11716 0.01355476 0.09640823 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN oral cavity cancer DOID_8618 2.448E-09 1.393E-06 1.382E-03 0.15727686 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN tongue cancer DOID_8649 3.661E-07 1.042E-04 0.01425608 0.90130128 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN intracranial arterial disease DOID_13089 7.936E-06 1.505E-03 6.889E-04 0.0979943 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN cerebral arterial disease DOID_3527 7.936E-06 1.505E-03 6.889E-04 0.0979943 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN cerebral infarction DOID_3526 1.109E-05 1.577E-03 0.04217888 0.74999316 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN neuritis DOID_1803 1.255E-05 1.428E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN glaucoma DOID_1686 1.413E-05 1.34E-03 0.04561478 0.68302126 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN aortic aneurysm DOID_3627 1.497E-05 1.217E-03 1.497E-05 8.519E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN pre-malignant neoplasm DOID_0060071 2.901E-05 2.064E-03 0.05754647 0.74418053 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN congenital heart defect DOID_1682 2.901E-05 1.834E-03 1.615E-03 0.15319382 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN in situ carcinoma DOID_8719 2.901E-05 2.064E-03 0.05754647 0.74418053 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN brain infarction DOID_3454 3.613E-05 2.056E-03 0.0617726 0.76410025 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN aneurysm disease DOID_2403 4.974E-05 2.573E-03 4.974E-05 0.0141511 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN epidermolysis bullosa DOID_2730 5.124E-05 2.429E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN vesiculobullous skin disease DOID_2731 6.052E-05 2.649E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN thoracic aortic aneurysm DOID_14004 8.137E-05 3.307E-03 8.137E-05 0.01543395 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN basal cell carcinoma DOID_2513 1.053E-04 3.994E-03 0.01514051 0.86149495 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN skin carcinoma DOID_3451 1.184E-04 4.21E-03 0.01602416 0.82888629 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN middle cerebral artery infarction DOID_3525 2.908E-04 9.734E-03 0.0248185 0.78454022 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN migraine DOID_6364 3.122E-04 9.868E-03 0.02569372 0.73098637 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN female reproductive organ benign neoplasm DOID_0060086 3.807E-04 0.01140212 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN uterine benign neoplasm DOID_0060095 3.807E-04 0.01140212 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN uterine fibroid DOID_13223 3.807E-04 0.01140212 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN leiomyoma DOID_127 4.56E-04 0.01297216 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN myocarditis DOID_820 4.825E-04 0.01307382 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN adenoid cystic carcinoma DOID_4866 6.889E-04 0.01781715 0.03786712 0.7695139 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN cervix uteri carcinoma in situ DOID_8991 7.213E-04 0.01784401 0.03873097 0.7599284 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN salivary gland cancer DOID_8850 7.544E-04 0.01788583 0.03959408 0.75096765 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN leukodystrophy DOID_10579 8.941E-04 0.02035058 0.04303898 0.72026992 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN reproductive organ benign neoplasm DOID_0050622 1.25E-03 0.0273662 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN integumentary system cancer DOID_0060122 1.25E-03 0.02635264 0.05074621 0.72186478 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN skin cancer DOID_4159 1.25E-03 0.02635264 0.05074621 0.72186478 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN melancholia DOID_2848 1.427E-03 0.02900504 0.05415227 0.75152786 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN neurotic disorder DOID_4964 1.473E-03 0.02890683 0.05500193 0.74514523 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN cerebral degeneration DOID_1443 1.714E-03 0.03250202 0.05923914 0.74904599 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN endogenous depression DOID_1595 2.246E-03 0.04123212 0.0676583 0.80203276 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN mixed glioma DOID_5076 2.361E-03 0.0419848 0.06933333 0.80511565 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN alcohol abuse DOID_1574 2.66E-03 0.04586611 0.07350815 0.82012036 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN mental depression DOID_1596 2.66E-03 0.04451711 0.07350815 0.80434882 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN focal epilepsy DOID_2234 2.66E-03 0.04324519 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN transitional cell carcinoma DOID_2671 2.976E-03 0.04703494 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN encephalomyelitis DOID_640 3.308E-03 0.05087725 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN hypersensitivity reaction type I disease DOID_1205 3.446E-03 0.05159964 0.08345369 0.86336636 BASSO_CD40_SIGNALING_UP lymphoma DOID_0060058 1.569E-13 8.929E-11 3.032E-05 0.01725239 BASSO_CD40_SIGNALING_UP rheumatic disease DOID_1575 3.011E-12 8.565E-10 3.393E-03 0.14852905 BASSO_CD40_SIGNALING_UP scleroderma DOID_419 3.011E-12 8.565E-10 3.393E-03 0.14852905 BASSO_CD40_SIGNALING_UP B-cell lymphocytic neoplasm DOID_707 9.844E-12 1.867E-09 4.647E-03 0.15552972 BASSO_CD40_SIGNALING_UP collagen disease DOID_854 3.402E-11 4.84E-09 6.468E-03 0.17525105 BASSO_CD40_SIGNALING_UP tuberculosis DOID_399 7.209E-11 8.203E-09 7.906E-03 0.18743276 BASSO_CD40_SIGNALING_UP systemic scleroderma DOID_418 1.729E-10 1.639E-08 2.837E-03 0.16140431 BASSO_CD40_SIGNALING_UP primary bacterial infectious disease DOID_0050338 3.637E-10 2.956E-08 0.0121918 0.24775482 BASSO_CD40_SIGNALING_UP vascular skin disease DOID_9540 5.176E-10 3.681E-08 0.08952501 0.61373167 BASSO_CD40_SIGNALING_UP pulmonary tuberculosis DOID_2957 6.611E-10 4.18E-08 0.09293664 0.61489476 BASSO_CD40_SIGNALING_UP urticaria DOID_1555 1.273E-09 7.245E-08 0.04758531 0.51086867 BASSO_CD40_SIGNALING_UP pustulosis of palm and sole DOID_4398 1.303E-09 6.739E-08 0.10309611 0.637627 BASSO_CD40_SIGNALING_UP leukocyte disease DOID_9500 1.967E-09 9.328E-08 0.10980667 0.65083328 BASSO_CD40_SIGNALING_UP bronchiectasis DOID_9563 3.689E-09 1.615E-07 1.000 1.000 BASSO_CD40_SIGNALING_UP celiac disease DOID_10608 5.324E-09 2.164E-07 3.613E-05 0.01027808 BASSO_CD40_SIGNALING_UP encephalitis DOID_9588 5.526E-09 2.096E-07 1.000 1.000 BASSO_CD40_SIGNALING_UP peripheral vascular disease DOID_341 6.321E-09 2.248E-07 0.13127596 0.7252041 BASSO_CD40_SIGNALING_UP syndrome DOID_225 8.028E-09 2.687E-07 9.474E-03 0.21562054 BASSO_CD40_SIGNALING_UP bacterial pneumonia DOID_874 9.365E-09 2.96E-07 0.13939675 0.7553976 BASSO_CD40_SIGNALING_UP contact dermatitis DOID_2773 1.088E-08 3.258E-07 5.013E-04 0.04754215 BASSO_CD40_SIGNALING_UP hypersensitivity reaction type I disease DOID_1205 3.004E-08 8.545E-07 0.16645156 0.83814991 BASSO_CD40_SIGNALING_UP ulcerative colitis DOID_8577 3.607E-08 9.774E-07 0.01520904 0.27043572 BASSO_CD40_SIGNALING_UP autoimmune disease of gastrointestinal tract DOID_0060031 4.845E-08 1.253E-06 1.302E-04 0.02470165 BASSO_CD40_SIGNALING_UP sarcoidosis DOID_11335 7.079E-08 1.751E-06 4.989E-03 0.15769708 BASSO_CD40_SIGNALING_UP hypersensitivity reaction type IV disease DOID_2916 1.095E-07 2.595E-06 5.892E-03 0.1676408 BASSO_CD40_SIGNALING_UP myositis DOID_633 1.918E-07 4.366E-06 1.000 1.000 BASSO_CD40_SIGNALING_UP brain infarction DOID_3454 2.361E-07 5.167E-06 0.12472498 0.70968514 BASSO_CD40_SIGNALING_UP diffuse large B-cell lymphoma DOID_0050745 2.588E-07 5.455E-06 0.05293016 0.51926311 BASSO_CD40_SIGNALING_UP autoimmune disease of endocrine system DOID_0060005 3.42E-07 6.949E-06 0.05647695 0.49439056 BASSO_CD40_SIGNALING_UP primary immunodeficiency disease DOID_612 8.192E-07 1.607E-05 0.15699994 0.82715711 BASSO_CD40_SIGNALING_UP Human immunodeficiency virus infectious disease DOID_526 8.65E-07 1.641E-05 0.15858252 0.82030412 BASSO_CD40_SIGNALING_UP encephalomyelitis DOID_640 1.015E-06 1.863E-05 0.01380133 0.26176519 BASSO_CD40_SIGNALING_UP dermatomyositis DOID_10223 1.027E-06 1.827E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP adult respiratory distress syndrome DOID_11394 1.319E-06 2.274E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP lymphatic system disease DOID_75 1.319E-06 2.207E-05 0.07748436 0.56523845 BASSO_CD40_SIGNALING_UP stomach disease DOID_76 1.368E-06 2.224E-05 0.02224683 0.3164612 BASSO_CD40_SIGNALING_UP psoriatic arthritis DOID_9008 1.776E-06 2.807E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP cerebral infarction DOID_3526 2.064E-06 3.175E-05 0.08610072 0.61239137 BASSO_CD40_SIGNALING_UP myeloma DOID_0070004 2.437E-06 3.648E-05 3.997E-03 0.1516222 BASSO_CD40_SIGNALING_UP thyroiditis DOID_7166 3.464E-06 5.053E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP autoimmune thyroiditis DOID_7188 3.464E-06 5.053E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP bone marrow cancer DOID_4960 4.138E-06 5.886E-05 5.164E-03 0.15464334 BASSO_CD40_SIGNALING_UP parasitic protozoa infectious disease DOID_2789 4.438E-06 6.159E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP eosinophilia DOID_999 5.033E-06 6.819E-05 0.03318655 0.40176903 BASSO_CD40_SIGNALING_UP leishmaniasis DOID_9065 5.969E-06 7.899E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP respiratory failure DOID_11162 7.013E-06 9.069E-05 1.000 1.000 BASSO_CD40_SIGNALING_UP Kawasaki disease DOID_13378 8.171E-06 1.033E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP lymphadenitis DOID_1602 8.171E-06 1.033E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP lymph node disease DOID_9942 8.171E-06 1.033E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP cholestasis DOID_13580 8.4E-06 1.039E-04 0.1197798 0.69545621 BASSO_CD40_SIGNALING_UP parasitic infectious disease DOID_1398 8.4E-06 1.017E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP uterine disease DOID_345 8.4E-06 9.957E-05 7.273E-03 0.18811747 BASSO_CD40_SIGNALING_UP allergic contact dermatitis DOID_3042 9.43E-06 1.095E-04 7.692E-03 0.19030147 BASSO_CD40_SIGNALING_UP hepatitis B DOID_2043 9.449E-06 1.075E-04 0.04041255 0.45989485 BASSO_CD40_SIGNALING_UP sinusitis DOID_0050127 1.085E-05 1.211E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP paranasal sinus disease DOID_1352 1.085E-05 1.211E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP myasthenia gravis DOID_437 1.085E-05 1.187E-04 0.04221072 0.46188267 BASSO_CD40_SIGNALING_UP sleep disorder DOID_535 1.085E-05 1.165E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP polyarteritis nodosa DOID_9810 1.085E-05 1.143E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP pancreatic ductal carcinoma DOID_3587 1.115E-05 1.153E-04 3.564E-04 0.05069087 BASSO_CD40_SIGNALING_UP bile duct disease DOID_4138 1.177E-05 1.196E-04 0.12964276 0.72320326 BASSO_CD40_SIGNALING_UP Goodpasture syndrome DOID_9808 1.238E-05 1.236E-04 9.293E-04 0.07553984 BASSO_CD40_SIGNALING_UP biliary tract disease DOID_9741 1.241E-05 1.218E-04 0.13127596 0.71823099 BASSO_CD40_SIGNALING_UP pancreatic carcinoma DOID_4905 1.308E-05 1.262E-04 4.012E-04 0.04565278 BASSO_CD40_SIGNALING_UP cystic fibrosis DOID_1485 1.451E-05 1.376E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP bone resorption disease DOID_0080011 1.526E-05 1.423E-04 9.708E-03 0.21245708 BASSO_CD40_SIGNALING_UP osteoporosis DOID_11476 1.526E-05 1.423E-04 9.708E-03 0.21245708 BASSO_CD40_SIGNALING_UP bronchiolitis DOID_2942 1.587E-05 1.456E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP cystitis DOID_1679 1.783E-05 1.61E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP neuromuscular junction disease DOID_439 1.783E-05 1.585E-04 0.04937022 0.51075737 BASSO_CD40_SIGNALING_UP ankylosing spondylitis DOID_7147 1.783E-05 1.56E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP female reproductive system disease DOID_229 1.856E-05 1.6E-04 0.01067126 0.22488683 BASSO_CD40_SIGNALING_UP vitiligo DOID_12306 1.994E-05 1.693E-04 0.05115184 0.51973919 BASSO_CD40_SIGNALING_UP extrinsic allergic alveolitis DOID_841 1.994E-05 1.668E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP pleurisy DOID_10247 2.464E-05 2.032E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP malaria DOID_12365 2.464E-05 2.003E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP autoimmune disease of the nervous system DOID_438 2.464E-05 1.975E-04 0.0547052 0.48636338 BASSO_CD40_SIGNALING_UP lymphoblastic leukemia DOID_1037 3.161E-05 2.498E-04 0.01380133 0.27079157 BASSO_CD40_SIGNALING_UP opportunistic mycosis DOID_2473 3.298E-05 2.571E-04 1.759E-03 0.12507761 BASSO_CD40_SIGNALING_UP chronic leukemia DOID_1036 3.946E-05 3.034E-04 0.0635313 0.52390304 BASSO_CD40_SIGNALING_UP chronic lymphocytic leukemia DOID_1040 3.946E-05 3.034E-04 0.0635313 0.52390304 BASSO_CD40_SIGNALING_UP pleural disease DOID_1532 3.946E-05 2.994E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP bladder disease DOID_365 3.946E-05 2.954E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP systemic mycosis DOID_0050136 4.299E-05 3.177E-04 2.091E-03 0.13217779 BASSO_CD40_SIGNALING_UP fungal infectious disease DOID_1564 4.299E-05 3.177E-04 2.091E-03 0.13217779 BASSO_CD40_SIGNALING_UP pneumoconiosis DOID_10316 4.672E-05 3.408E-04 0.06703895 0.54493088 BASSO_CD40_SIGNALING_UP esophageal disease DOID_6050 4.672E-05 3.365E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP pulmonary sarcoidosis DOID_13406 5.917E-05 4.208E-04 0.07227615 0.55574496 BASSO_CD40_SIGNALING_UP multiple myeloma DOID_9538 5.917E-05 4.156E-04 0.07227615 0.54833503 BASSO_CD40_SIGNALING_UP congenital diaphragmatic hernia DOID_3827 6.857E-05 4.758E-04 0.0757515 0.5671395 BASSO_CD40_SIGNALING_UP intracranial arterial disease DOID_13089 7.361E-05 5.046E-04 0.07748436 0.57257921 BASSO_CD40_SIGNALING_UP cerebral arterial disease DOID_3527 7.361E-05 5.046E-04 0.07748436 0.57257921 BASSO_CD40_SIGNALING_UP endometriosis of uterus DOID_288 8.441E-05 5.718E-04 3.25E-03 0.15409645 BASSO_CD40_SIGNALING_UP endometriosis DOID_289 9.018E-05 6.037E-04 3.393E-03 0.13791983 BASSO_CD40_SIGNALING_UP influenza DOID_8469 9.62E-05 6.365E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP neuritis DOID_1803 1.158E-04 7.575E-04 3.997E-03 0.14214582 BASSO_CD40_SIGNALING_UP atopic dermatitis DOID_3310 1.54E-04 9.956E-04 0.09803048 0.63385615 BASSO_CD40_SIGNALING_UP Sjogren's syndrome DOID_12894 1.541E-04 9.853E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP childhood type dermatomyositis DOID_14203 1.541E-04 9.743E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP angioedema DOID_1558 1.541E-04 9.636E-04 0.01857321 0.3202472 BASSO_CD40_SIGNALING_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 1.541E-04 9.531E-04 0.01857321 0.29355994 BASSO_CD40_SIGNALING_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 1.541E-04 9.531E-04 0.01857321 0.29355994 BASSO_CD40_SIGNALING_UP Hodgkin's granuloma DOID_8651 1.541E-04 9.531E-04 0.01857321 0.29355994 BASSO_CD40_SIGNALING_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 1.541E-04 9.531E-04 0.01857321 0.29355994 BASSO_CD40_SIGNALING_UP cutaneous leishmaniasis DOID_9111 1.541E-04 9.429E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP visceral leishmaniasis DOID_9146 1.541E-04 9.329E-04 1.000 1.000 BASSO_CD40_SIGNALING_UP migraine without aura DOID_12783 1.881E-04 1.127E-03 0.02041172 0.31389916 BASSO_CD40_SIGNALING_UP invasive lobular carcinoma DOID_3457 1.881E-04 1.115E-03 0.02041172 0.30563866 BASSO_CD40_SIGNALING_UP eosinophilic pneumonia DOID_5870 1.881E-04 1.104E-03 0.02041172 0.29780177 BASSO_CD40_SIGNALING_UP pulmonary eosinophilia DOID_9498 1.881E-04 1.104E-03 0.02041172 0.29780177 BASSO_CD40_SIGNALING_UP Loeffler syndrome DOID_9503 1.881E-04 1.104E-03 0.02041172 0.29780177 BASSO_CD40_SIGNALING_UP Hodgkin's lymphoma DOID_8567 2.255E-04 1.309E-03 0.02224683 0.30874263 BASSO_CD40_SIGNALING_UP berylliosis DOID_10322 2.662E-04 1.53E-03 0.02407856 0.32620711 BASSO_CD40_SIGNALING_UP hepatic coma DOID_12550 2.662E-04 1.514E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP hepatic encephalopathy DOID_13413 2.662E-04 1.514E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP endocrine pancreas disease DOID_1428 2.767E-04 1.559E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP hyperglycemia DOID_4195 3.018E-04 1.684E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP narcolepsy DOID_8986 3.101E-04 1.713E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP hyperhomocysteinemia DOID_9279 3.574E-04 1.955E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP juvenile rheumatoid arthritis DOID_676 4.618E-04 2.503E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP prion disease DOID_649 5.189E-04 2.786E-03 0.03318655 0.41050314 BASSO_CD40_SIGNALING_UP biliary tract cancer DOID_4607 5.569E-04 2.961E-03 0.14744268 0.78406432 BASSO_CD40_SIGNALING_UP pulmonary edema DOID_11396 6.429E-04 3.387E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP mitochondrial myopathy DOID_699 7.097E-04 3.705E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP funisitis DOID_0050698 7.797E-04 4.033E-03 0.04041255 0.46928045 BASSO_CD40_SIGNALING_UP neutropenia DOID_1227 7.797E-04 3.997E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP acquired immunodeficiency syndrome DOID_635 7.797E-04 3.961E-03 0.04041255 0.4508773 BASSO_CD40_SIGNALING_UP mouth disease DOID_403 7.938E-04 3.997E-03 0.16488358 0.83766748 BASSO_CD40_SIGNALING_UP Crohn's disease DOID_8778 7.938E-04 3.962E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP agranulocytosis DOID_12987 8.529E-04 4.22E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP hypoglycemia DOID_9993 8.529E-04 4.184E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP diabetic angiopathy DOID_11713 9.293E-04 4.519E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP spastic quadriplegia DOID_10970 1.009E-03 4.865E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP B cell deficiency DOID_2115 1.267E-03 6.056E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP middle cerebral artery infarction DOID_3525 1.267E-03 6.006E-03 0.05115184 0.51062096 BASSO_CD40_SIGNALING_UP migraine DOID_6364 1.359E-03 6.39E-03 0.05293016 0.49372558 BASSO_CD40_SIGNALING_UP perinatal necrotizing enterocolitis DOID_8677 1.359E-03 6.337E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP autoimmune disease of cardiovascular system DOID_0060051 1.454E-03 6.727E-03 0.0547052 0.50205253 BASSO_CD40_SIGNALING_UP Behcet's disease DOID_13241 1.454E-03 6.727E-03 0.0547052 0.50205253 BASSO_CD40_SIGNALING_UP spastic cerebral palsy DOID_0050669 1.759E-03 8.07E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP allergic rhinitis DOID_4481 1.866E-03 8.495E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP leiomyoma DOID_127 1.977E-03 8.928E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP myocarditis DOID_820 2.091E-03 9.367E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP nephroblastoma DOID_2154 2.207E-03 9.813E-03 0.06703895 0.5372558 BASSO_CD40_SIGNALING_UP leukopenia DOID_615 2.207E-03 9.737E-03 1.000 1.000 BASSO_CD40_SIGNALING_UP adenoma DOID_657 2.45E-03 0.0107241 1.000 1.000 BASSO_CD40_SIGNALING_UP uveitis DOID_13141 2.705E-03 0.01174841 1.000 1.000 BASSO_CD40_SIGNALING_UP respiratory syncytial virus infectious disease DOID_1273 2.837E-03 0.0122276 1.000 1.000 BASSO_CD40_SIGNALING_UP hepatitis DOID_2237 2.837E-03 0.01213566 1.000 1.000 BASSO_CD40_SIGNALING_UP peptic ulcer DOID_750 2.837E-03 0.0120451 1.000 1.000 BASSO_CD40_SIGNALING_UP autoimmune disease of urogenital tract DOID_0060049 3.25E-03 0.01369746 3.25E-03 0.16810522 BASSO_CD40_SIGNALING_UP primary biliary cirrhosis DOID_12236 3.25E-03 0.01369746 3.25E-03 0.16810522 BASSO_CD40_SIGNALING_UP uveal disease DOID_3480 3.393E-03 0.01419763 1.000 1.000 BASSO_CD40_SIGNALING_UP gallbladder cancer DOID_3121 3.54E-03 0.01470264 1.000 1.000 BASSO_CD40_SIGNALING_UP calcium metabolism disease DOID_10575 4.48E-03 0.01847211 1.000 1.000 BASSO_CD40_SIGNALING_UP vasculitis DOID_865 5.164E-03 0.0211383 0.10141069 0.6411409 BASSO_CD40_SIGNALING_UP mitochondrial metabolism disease DOID_700 5.523E-03 0.02244539 1.000 1.000 BASSO_CD40_SIGNALING_UP mineral metabolism disease DOID_0050032 7.068E-03 0.02852269 1.000 1.000 BASSO_CD40_SIGNALING_UP endocrine organ benign neoplasm DOID_0060089 7.906E-03 0.03167878 0.12472498 0.71685368 BASSO_CD40_SIGNALING_UP nephrosis DOID_2527 8.562E-03 0.0340684 0.12964276 0.73036369 BASSO_CD40_SIGNALING_UP diabetic retinopathy DOID_8947 9.013E-03 0.0356124 1.000 1.000 BASSO_CD40_SIGNALING_UP pancreatitis DOID_4989 9.945E-03 0.03902564 1.000 1.000 BASSO_CD40_SIGNALING_UP alcohol abuse DOID_1574 0.01116809 0.04352493 0.14744268 0.79146116 BASSO_CD40_SIGNALING_UP chronic kidney failure DOID_784 0.01116809 0.04322885 1.000 1.000 BASSO_CD40_SIGNALING_UP retinal vascular disease DOID_2462 0.01167496 0.04488549 1.000 1.000 BASSO_CD40_SIGNALING_UP transitional cell carcinoma DOID_2671 0.01245393 0.04755898 1.000 1.000 BASSO_CD40_SIGNALING_UP amino acid metabolic disorder DOID_9252 0.01271853 0.04824562 1.000 1.000 BASSO_CD40_SIGNALING_UP alcohol-related neurodevelopmental disorder DOID_0050667 0.01407808 0.0530492 0.16488358 0.84521403 BASSO_CD40_SIGNALING_UP dilated cardiomyopathy DOID_12930 0.01435724 0.0537452 0.01435724 0.26352487 BASSO_CD40_SIGNALING_UP leber hereditary optic neuropathy DOID_705 0.0167313 0.06222295 1.000 1.000 BASSO_CD40_SIGNALING_UP T cell deficiency DOID_11200 0.01857321 0.0686244 1.000 1.000 BASSO_CD40_SIGNALING_UP hypolipoproteinemia DOID_1387 0.01857321 0.06818166 1.000 1.000 BASSO_CD40_SIGNALING_UP retinal vascular occlusion DOID_1729 0.01857321 0.0677446 1.000 1.000 BASSO_CD40_SIGNALING_UP bilirubin metabolic disorder DOID_2741 0.01857321 0.06731311 1.000 1.000 BASSO_CD40_SIGNALING_UP acute kidney failure DOID_3021 0.01857321 0.06688707 1.000 1.000 BASSO_CD40_SIGNALING_UP phagocyte bactericidal dysfunction DOID_3262 0.01857321 0.0664664 0.01857321 0.31082817 BASSO_CD40_SIGNALING_UP chondrosarcoma DOID_3371 0.01857321 0.06605099 1.000 1.000 BASSO_CD40_SIGNALING_UP insulinoma DOID_3892 0.01857321 0.06564073 1.000 1.000 BASSO_CD40_SIGNALING_UP polycythemia DOID_8432 0.01857321 0.06523554 0.01857321 0.30194736 BASSO_CD40_SIGNALING_UP sickle cell anemia DOID_10923 0.02041172 0.07125318 1.000 1.000 BASSO_CD40_SIGNALING_UP pneumocystosis DOID_11339 0.02041172 0.07081871 1.000 1.000 BASSO_CD40_SIGNALING_UP common variable immunodeficiency DOID_12177 0.02041172 0.07038951 1.000 1.000 BASSO_CD40_SIGNALING_UP hemochromatosis DOID_2352 0.02041172 0.06996548 1.000 1.000 BASSO_CD40_SIGNALING_UP otitis media DOID_10754 0.02224683 0.07579909 1.000 1.000 BASSO_CD40_SIGNALING_UP intracranial arteriosclerosis DOID_13097 0.02224683 0.0753479 1.000 1.000 BASSO_CD40_SIGNALING_UP islet cell tumor DOID_1799 0.02224683 0.07490206 1.000 1.000 BASSO_CD40_SIGNALING_UP middle ear disease DOID_5100 0.02224683 0.07579909 1.000 1.000 BASSO_CD40_SIGNALING_UP peritonitis DOID_8283 0.02224683 0.07446146 1.000 1.000 BASSO_CD40_SIGNALING_UP vascular dementia DOID_8725 0.02224683 0.0753479 1.000 1.000 BASSO_CD40_SIGNALING_UP mitochondrial encephalomyopathy DOID_890 0.02224683 0.07402601 1.000 1.000 BASSO_CD40_SIGNALING_UP leprosy DOID_1024 0.02407856 0.07965522 1.000 1.000 BASSO_CD40_SIGNALING_UP newborn respiratory distress syndrome DOID_12716 0.02407856 0.07919479 1.000 1.000 BASSO_CD40_SIGNALING_UP viral pneumonia DOID_10533 0.0259069 0.08471853 1.000 1.000 BASSO_CD40_SIGNALING_UP open-angle glaucoma DOID_1067 0.0259069 0.08423442 1.000 1.000 BASSO_CD40_SIGNALING_UP hypercalcemia DOID_12678 0.0259069 0.08375582 1.000 1.000 BASSO_CD40_SIGNALING_UP aspergillosis DOID_13564 0.0259069 0.08328262 0.0259069 0.34281451 BASSO_CD40_SIGNALING_UP mesenchymal cell neoplasm DOID_3350 0.02773186 0.08864847 1.000 1.000 BASSO_CD40_SIGNALING_UP adrenal cortex disease DOID_3952 0.02773186 0.08815323 1.000 1.000 BASSO_CD40_SIGNALING_UP spindle cell sarcoma DOID_4235 0.02773186 0.08864847 1.000 1.000 BASSO_CD40_SIGNALING_UP lung oat cell carcinoma DOID_5411 0.02773186 0.08766349 1.000 1.000 BASSO_CD40_SIGNALING_UP oral submucous fibrosis DOID_5773 0.02773186 0.08717916 1.000 1.000 BASSO_CD40_SIGNALING_UP epithelioid sarcoma DOID_6193 0.02773186 0.08864847 1.000 1.000 BASSO_CD40_SIGNALING_UP varicose veins DOID_799 0.02773186 0.08670015 1.000 1.000 BASSO_CD40_SIGNALING_UP silicosis DOID_10325 0.02955345 0.09189024 1.000 1.000 BASSO_CD40_SIGNALING_UP hemolytic-uremic syndrome DOID_12554 0.02955345 0.09139083 1.000 1.000 BASSO_CD40_SIGNALING_UP tongue cancer DOID_8649 0.02955345 0.09089683 0.02955345 0.38217985 BASSO_CD40_SIGNALING_UP vein disease DOID_866 0.02955345 0.09040814 1.000 1.000 BASSO_CD40_SIGNALING_UP lymphatic system cancer DOID_0060073 0.03137168 0.09545714 1.000 1.000 BASSO_CD40_SIGNALING_UP Graves' disease DOID_12361 0.03137168 0.09494938 0.03137168 0.39667743 BASSO_CD40_SIGNALING_UP bronchitis DOID_6132 0.03137168 0.09444701 1.000 1.000 BASSO_CD40_SIGNALING_UP reticulosarcoma DOID_8538 0.03137168 0.09545714 1.000 1.000 BASSO_CD40_SIGNALING_UP lymphosarcoma DOID_8675 0.03137168 0.09545714 1.000 1.000 BASSO_CD40_SIGNALING_UP adrenal gland disease DOID_9553 0.03137168 0.09394992 1.000 1.000 BASSO_CD40_SIGNALING_UP glucose intolerance DOID_10603 0.03318655 0.09886463 1.000 1.000 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN mouth disease DOID_403 8.358E-08 4.756E-05 4.417E-06 2.513E-03 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN periodontal disease DOID_3388 1.028E-05 2.925E-03 1.028E-05 2.925E-03 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN influenza DOID_8469 2.128E-05 4.037E-03 1.315E-03 0.07482769 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN pre-malignant neoplasm DOID_0060071 5.917E-05 8.417E-03 5.917E-05 0.01122218 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN in situ carcinoma DOID_8719 5.917E-05 8.417E-03 5.917E-05 0.01122218 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN tooth disease DOID_1091 7.056E-05 8.029E-03 7.056E-05 0.01003656 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN biliary tract cancer DOID_4607 1.258E-04 0.01193078 4.226E-03 0.1603112 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN chronic kidney failure DOID_784 1.258E-04 0.01022638 1.258E-04 0.01431693 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN alcohol-related neurodevelopmental disorder DOID_0050667 1.804E-04 0.01283231 1.804E-04 0.01710975 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN hypersensitivity reaction type I disease DOID_1205 1.86E-04 0.01176125 1.86E-04 0.0151216 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN familial hypercholesterolemia DOID_13810 2.861E-04 0.01628029 0.02466499 0.33415184 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN opiate dependence DOID_2559 3.131E-04 0.01619814 0.02577189 0.33327738 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN pulmonary embolism DOID_9477 3.131E-04 0.0148483 0.02577189 0.32587121 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN periodontitis DOID_824 5.004E-04 0.02189998 5.004E-04 0.03558746 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN peptic ulcer DOID_750 1.051E-03 0.04272414 0.04657139 0.32316004 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN cervix uteri carcinoma in situ DOID_8991 1.153E-03 0.04374953 1.153E-03 0.07291589 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN pulmonary emphysema DOID_9675 1.153E-03 0.04101519 0.04873542 0.33012444 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN diabetic autonomic neuropathy DOID_11503 1.315E-03 0.04401629 0.05197246 0.33227337 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN autonomic neuropathy DOID_11504 1.315E-03 0.04401629 0.05197246 0.33227337 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN diabetic polyneuropathy DOID_12785 1.315E-03 0.04401629 0.05197246 0.33227337 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN diabetic neuropathy DOID_9743 1.315E-03 0.04401629 0.05197246 0.33227337 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN autonomic nervous system disease DOID_11465 1.487E-03 0.04700711 0.05519874 0.34514378 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN brain cancer DOID_1319 1.487E-03 0.04453305 0.05519874 0.34139222 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN central nervous system cancer DOID_3620 1.547E-03 0.04400155 0.05627178 0.33703837 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN withdrawal disorder DOID_0060001 1.732E-03 0.04693229 0.05948377 0.33846267 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN bile duct adenocarcinoma DOID_4896 1.928E-03 0.04985691 0.06268509 0.34295974 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN cholangiocarcinoma DOID_4947 1.928E-03 0.04985691 0.06268509 0.34295974 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN familial hyperlipidemia DOID_1168 2.064E-03 0.05105206 0.06481338 0.34466179 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN hypertrophic cardiomyopathy DOID_11984 2.204E-03 0.0522525 0.06693695 0.35265855 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN bile duct cancer DOID_4606 2.204E-03 0.0501624 0.06693695 0.34942315 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN bile duct carcinoma DOID_4897 2.204E-03 0.0501624 0.06693695 0.34942315 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN hyperglycemia DOID_4195 2.809E-03 0.06147903 0.07538423 0.37298808 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN allergic contact dermatitis DOID_3042 2.89E-03 0.06089953 0.07643488 0.37492626 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN endocrine organ benign neoplasm DOID_0060089 2.971E-03 0.06038335 2.971E-03 0.15370307 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN diabetic retinopathy DOID_8947 3.396E-03 0.06662502 0.0827143 0.39549947 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN bone resorption disease DOID_0080011 3.663E-03 0.06947463 0.08583835 0.40365308 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN osteoporosis DOID_11476 3.663E-03 0.06947463 0.08583835 0.40365308 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN mixed glioma DOID_5076 3.754E-03 0.068908 3.754E-03 0.17801233 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN bacterial pneumonia DOID_874 3.754E-03 0.06675462 0.08687739 0.40519046 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN metabolic syndrome X DOID_14221 3.94E-03 0.06793228 3.94E-03 0.17244347 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN contact dermatitis DOID_2773 3.94E-03 0.06593427 0.08895201 0.41149346 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN lipid metabolism disorder DOID_3146 3.94E-03 0.06405043 0.08895201 0.40817496 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN alcohol abuse DOID_1574 4.226E-03 0.06679633 4.226E-03 0.171762 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN retinal vascular disease DOID_2462 4.422E-03 0.06800645 0.09411844 0.42502693 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN nervous system cancer DOID_3093 4.931E-03 0.07382836 0.09925625 0.44122505 XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN lymphoblastic leukemia DOID_1037 5.248E-03 0.07656509 5.248E-03 0.18662742 FARMER_BREAST_CANCER_CLUSTER_7 invasive ductal carcinoma DOID_3008 2.713E-05 0.01543882 1.000 1.000 FARMER_BREAST_CANCER_CLUSTER_7 spindle cell carcinoma DOID_4015 4.15E-05 0.01180705 9.718E-03 0.55295972 FARMER_BREAST_CANCER_CLUSTER_7 chronic kidney failure DOID_784 2.21E-04 0.04190932 2.21E-04 0.12572796 HENDRICKS_SMARCA4_TARGETS_DN cerebral degeneration DOID_1443 2.897E-05 0.01648552 1.615E-03 0.22969157 HENDRICKS_SMARCA4_TARGETS_DN hypersensitivity reaction type I disease DOID_1205 8.378E-05 0.02383665 0.08110052 0.62359727 HENDRICKS_SMARCA4_TARGETS_DN funisitis DOID_0050698 1.679E-04 0.03184297 0.01898131 0.5684402 HENDRICKS_SMARCA4_TARGETS_DN toxic shock syndrome DOID_14115 2.177E-04 0.03096523 1.000 1.000 HENDRICKS_SMARCA4_TARGETS_DN commensal bacterial infectious disease DOID_0050339 2.357E-04 0.02682192 1.000 1.000 HENDRICKS_SMARCA4_TARGETS_DN opportunistic mycosis DOID_2473 3.815E-04 0.03617458 1.000 1.000 HENDRICKS_SMARCA4_TARGETS_DN systemic mycosis DOID_0050136 4.544E-04 0.03693635 1.000 1.000 HENDRICKS_SMARCA4_TARGETS_DN fungal infectious disease DOID_1564 4.544E-04 0.03693635 1.000 1.000 HENDRICKS_SMARCA4_TARGETS_DN male infertility DOID_12336 4.801E-04 0.03414753 0.0317223 0.44024361 HENDRICKS_SMARCA4_TARGETS_DN adenoma DOID_657 5.336E-04 0.03373478 5.336E-04 0.30361305 HENDRICKS_SMARCA4_TARGETS_DN systemic scleroderma DOID_418 6.19E-04 0.03522056 0.03593353 0.43502504 HENDRICKS_SMARCA4_TARGETS_DN rheumatic disease DOID_1575 7.425E-04 0.03840567 0.03928972 0.45624182 HENDRICKS_SMARCA4_TARGETS_DN scleroderma DOID_419 7.425E-04 0.03840567 0.03928972 0.45624182 HENDRICKS_SMARCA4_TARGETS_DN neuritis DOID_1803 8.769E-04 0.0415774 0.04263458 0.45771837 HENDRICKS_SMARCA4_TARGETS_DN thyroid adenoma DOID_2891 8.769E-04 0.03837914 8.769E-04 0.24946439 HENDRICKS_SMARCA4_TARGETS_DN withdrawal disorder DOID_0060001 1.022E-03 0.04154024 1.022E-03 0.19385447 HENDRICKS_SMARCA4_TARGETS_DN hypertrophic cardiomyopathy DOID_11984 1.302E-03 0.04939283 0.05177482 0.49931983 HENDRICKS_SMARCA4_TARGETS_DN collagen disease DOID_854 1.432E-03 0.05092913 0.05425288 0.5060638 HENDRICKS_SMARCA4_TARGETS_DN endocrine organ benign neoplasm DOID_0060089 1.759E-03 0.05886005 1.759E-03 0.20012418 HENDRICKS_SMARCA4_TARGETS_DN male reproductive system disease DOID_48 1.908E-03 0.06032359 0.06246785 0.52270889 HENDRICKS_SMARCA4_TARGETS_DN encephalomyelitis DOID_640 3.119E-03 0.09340058 1.000 1.000 HASINA_NOL7_TARGETS_UP diabetic retinopathy DOID_8947 9.197E-07 5.233E-04 1.766E-04 0.02009965 HASINA_NOL7_TARGETS_UP aneurysm disease DOID_2403 1.034E-06 2.942E-04 1.909E-04 0.01809968 HASINA_NOL7_TARGETS_UP retinal vascular disease DOID_2462 1.385E-06 2.626E-04 2.315E-04 0.01881616 HASINA_NOL7_TARGETS_UP thrombophilia DOID_2452 1.442E-05 2.052E-03 1.442E-05 8.208E-03 HASINA_NOL7_TARGETS_UP toxic shock syndrome DOID_14115 1.873E-05 2.131E-03 1.000 1.000 HASINA_NOL7_TARGETS_UP commensal bacterial infectious disease DOID_0050339 2.028E-05 1.924E-03 1.000 1.000 HASINA_NOL7_TARGETS_UP portal hypertension DOID_10762 2.028E-05 1.649E-03 6.838E-03 0.21615204 HASINA_NOL7_TARGETS_UP intracranial aneurysm DOID_10941 2.358E-05 1.677E-03 2.358E-05 6.71E-03 HASINA_NOL7_TARGETS_UP hepatic vascular disease DOID_272 2.713E-05 1.715E-03 7.886E-03 0.23616746 HASINA_NOL7_TARGETS_UP spindle cell carcinoma DOID_4015 4.15E-05 2.361E-03 1.000 1.000 HASINA_NOL7_TARGETS_UP pre-eclampsia DOID_10591 7.619E-05 3.941E-03 0.01311233 0.28695833 HASINA_NOL7_TARGETS_UP hypertrophic cardiomyopathy DOID_11984 1.136E-04 5.389E-03 0.01597619 0.2840767 HASINA_NOL7_TARGETS_UP blood coagulation disease DOID_1247 1.629E-04 7.131E-03 1.629E-04 0.03090303 HASINA_NOL7_TARGETS_UP nephrosis DOID_2527 1.674E-04 6.805E-03 1.674E-04 0.02381774 HASINA_NOL7_TARGETS_UP transitional cell carcinoma DOID_2671 2.477E-04 9.397E-03 2.477E-04 0.01761857 HASINA_NOL7_TARGETS_UP chondrosarcoma DOID_3371 2.635E-03 0.09370507 2.635E-03 0.16658679 HASINA_NOL7_TARGETS_UP insulinoma DOID_3892 2.635E-03 0.08819301 1.000 1.000 HASINA_NOL7_TARGETS_UP islet cell tumor DOID_1799 3.161E-03 0.09992835 1.000 1.000 HASINA_NOL7_TARGETS_UP aortic valve insufficiency DOID_57 3.161E-03 0.09466897 3.161E-03 0.17987103 HASINA_NOL7_TARGETS_UP peritonitis DOID_8283 3.161E-03 0.08993552 1.000 1.000 HASINA_NOL7_TARGETS_UP intracranial thrombosis DOID_4193 3.424E-03 0.0927796 3.424E-03 0.17712469 HASINA_NOL7_TARGETS_UP hemangioma DOID_255 3.95E-03 0.0977212 1.000 1.000 HASINA_NOL7_TARGETS_UP oral submucous fibrosis DOID_5773 3.95E-03 0.09364948 3.95E-03 0.18729896 HASINA_NOL7_TARGETS_UP varicose veins DOID_799 3.95E-03 0.0899035 3.95E-03 0.17289135 HASINA_NOL7_TARGETS_UP vein disease DOID_866 4.213E-03 0.09219778 4.213E-03 0.17122445 HASINA_NOL7_TARGETS_UP urinary system benign neoplasm DOID_731 4.476E-03 0.09432079 1.000 1.000 HASINA_NOL7_TARGETS_UP prion disease DOID_649 4.738E-03 0.09629089 1.000 1.000 HASINA_NOL7_TARGETS_UP meningitis DOID_9471 6.313E-03 0.09978616 1.000 1.000 JAZAG_TGFB1_SIGNALING_UP autoimmune disease of the nervous system DOID_438 7.151E-08 4.069E-05 7.151E-08 4.069E-05 JAZAG_TGFB1_SIGNALING_UP polyneuropathy DOID_1389 6.116E-07 1.74E-04 1.317E-04 0.01499172 JAZAG_TGFB1_SIGNALING_UP Sciatic Neuropathy DOID_11446 7.699E-06 1.46E-03 6.765E-04 0.03207841 JAZAG_TGFB1_SIGNALING_UP lesion of sciatic nerve DOID_12528 7.699E-06 1.46E-03 6.765E-04 0.03207841 JAZAG_TGFB1_SIGNALING_UP mononeuritis of lower limb DOID_9473 7.699E-06 1.46E-03 6.765E-04 0.03207841 JAZAG_TGFB1_SIGNALING_UP encephalomyelitis DOID_640 7.8E-06 1.109E-03 2.743E-04 0.01950971 JAZAG_TGFB1_SIGNALING_UP mononeuritis DOID_1802 8.546E-06 9.725E-04 7.242E-04 0.03169918 JAZAG_TGFB1_SIGNALING_UP mononeuropathy DOID_1188 9.453E-06 8.965E-04 7.735E-04 0.03143845 JAZAG_TGFB1_SIGNALING_UP uterine cancer DOID_363 3.36E-05 2.731E-03 3.36E-05 9.558E-03 JAZAG_TGFB1_SIGNALING_UP neuritis DOID_1803 4.05E-05 2.88E-03 2.005E-03 0.05186856 JAZAG_TGFB1_SIGNALING_UP cerebral degeneration DOID_1443 1.018E-04 6.438E-03 1.018E-04 0.01931462 JAZAG_TGFB1_SIGNALING_UP Hirschsprung's disease DOID_10487 1.317E-04 7.496E-03 1.317E-04 0.01873965 JAZAG_TGFB1_SIGNALING_UP megacolon DOID_11372 1.536E-04 7.943E-03 1.536E-04 0.01456299 JAZAG_TGFB1_SIGNALING_UP mixed glioma DOID_5076 1.651E-04 7.828E-03 1.651E-04 0.01342021 JAZAG_TGFB1_SIGNALING_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.829E-04 0.01238178 2.829E-04 0.0178848 JAZAG_TGFB1_SIGNALING_UP colonic disease DOID_5353 3.19E-04 0.01296547 3.19E-04 0.01815165 JAZAG_TGFB1_SIGNALING_UP autoimmune hepatitis DOID_2048 3.523E-04 0.01336363 0.02734132 0.24693982 JAZAG_TGFB1_SIGNALING_UP bronchiolitis DOID_2942 5.429E-04 0.01930765 0.03374238 0.25262391 JAZAG_TGFB1_SIGNALING_UP spinal muscular atrophy DOID_12377 5.859E-04 0.01960912 5.859E-04 0.03030501 JAZAG_TGFB1_SIGNALING_UP endometrial carcinoma DOID_2871 8.244E-04 0.02606031 8.244E-04 0.03127237 JAZAG_TGFB1_SIGNALING_UP endometrial cancer DOID_1380 9.309E-04 0.02787713 9.309E-04 0.0331041 JAZAG_TGFB1_SIGNALING_UP hereditary spastic paraplegia DOID_2476 9.865E-04 0.02806468 9.865E-04 0.03301727 JAZAG_TGFB1_SIGNALING_UP paraplegia DOID_607 1.102E-03 0.02986735 1.102E-03 0.03484524 JAZAG_TGFB1_SIGNALING_UP hyperthyroidism DOID_7998 1.102E-03 0.02850974 1.102E-03 0.03301128 JAZAG_TGFB1_SIGNALING_UP respiratory syncytial virus infectious disease DOID_1273 1.419E-03 0.03510663 0.05394963 0.29516674 JAZAG_TGFB1_SIGNALING_UP peptic ulcer DOID_750 1.419E-03 0.03364385 0.05394963 0.28959756 JAZAG_TGFB1_SIGNALING_UP autoimmune disease of urogenital tract DOID_0060049 1.628E-03 0.03704355 0.05769211 0.30116342 JAZAG_TGFB1_SIGNALING_UP primary biliary cirrhosis DOID_12236 1.628E-03 0.03704355 0.05769211 0.30116342 JAZAG_TGFB1_SIGNALING_UP endometriosis of uterus DOID_288 1.628E-03 0.0356188 0.05769211 0.29842557 JAZAG_TGFB1_SIGNALING_UP Huntington's disease DOID_12858 1.7E-03 0.0358285 1.7E-03 0.04836848 JAZAG_TGFB1_SIGNALING_UP endometriosis DOID_289 1.7E-03 0.03454891 0.05893638 0.29676814 JAZAG_TGFB1_SIGNALING_UP diabetic autonomic neuropathy DOID_11503 1.774E-03 0.03481083 0.06017904 0.3003673 JAZAG_TGFB1_SIGNALING_UP autonomic neuropathy DOID_11504 1.774E-03 0.03481083 0.06017904 0.3003673 JAZAG_TGFB1_SIGNALING_UP diabetic polyneuropathy DOID_12785 1.774E-03 0.03481083 0.06017904 0.3003673 JAZAG_TGFB1_SIGNALING_UP diabetic neuropathy DOID_9743 1.774E-03 0.03481083 0.06017904 0.3003673 JAZAG_TGFB1_SIGNALING_UP leukodystrophy DOID_10579 1.927E-03 0.03654619 1.927E-03 0.05220885 JAZAG_TGFB1_SIGNALING_UP pre-eclampsia DOID_10591 2.005E-03 0.03680995 0.06389736 0.31074872 JAZAG_TGFB1_SIGNALING_UP autonomic nervous system disease DOID_11465 2.005E-03 0.03565964 0.06389736 0.30552605 JAZAG_TGFB1_SIGNALING_UP autoimmune disease of gastrointestinal tract DOID_0060031 2.167E-03 0.03736715 0.06636824 0.30454457 JAZAG_TGFB1_SIGNALING_UP pulmonary tuberculosis DOID_2957 2.167E-03 0.03626812 0.06636824 0.30210821 JAZAG_TGFB1_SIGNALING_UP giant cell tumor DOID_200 2.508E-03 0.0407805 2.508E-03 0.06205729 JAZAG_TGFB1_SIGNALING_UP malignant giant cell tumor DOID_2705 2.508E-03 0.0407805 2.508E-03 0.06205729 JAZAG_TGFB1_SIGNALING_UP giant cell glioblastoma DOID_3074 2.508E-03 0.0407805 2.508E-03 0.06205729 JAZAG_TGFB1_SIGNALING_UP vasculitis DOID_865 2.597E-03 0.04105492 2.597E-03 0.06158238 JAZAG_TGFB1_SIGNALING_UP smallpox DOID_8736 2.688E-03 0.04133719 2.688E-03 0.06117905 JAZAG_TGFB1_SIGNALING_UP retinitis pigmentosa DOID_10584 2.968E-03 0.04444701 2.968E-03 0.06496101 JAZAG_TGFB1_SIGNALING_UP glioblastoma DOID_3068 2.968E-03 0.04330734 2.968E-03 0.06255505 JAZAG_TGFB1_SIGNALING_UP uterine disease DOID_345 3.673E-03 0.05225349 0.08590646 0.34182362 JAZAG_TGFB1_SIGNALING_UP tuberculosis DOID_399 3.997E-03 0.05547154 0.08952501 0.35374812 JAZAG_TGFB1_SIGNALING_UP astrocytoma DOID_3069 4.108E-03 0.05565122 4.108E-03 0.08347683 JAZAG_TGFB1_SIGNALING_UP peripheral vascular disease DOID_341 4.449E-03 0.05886595 4.449E-03 0.087284 JAZAG_TGFB1_SIGNALING_UP diabetic retinopathy DOID_8947 4.565E-03 0.05903334 0.09552474 0.36725391 JAZAG_TGFB1_SIGNALING_UP pancreatitis DOID_4989 5.045E-03 0.06378556 0.10029662 0.37299853 JAZAG_TGFB1_SIGNALING_UP female reproductive system disease DOID_229 5.419E-03 0.06702846 0.10385932 0.37882023 JAZAG_TGFB1_SIGNALING_UP retinal vascular disease DOID_2462 5.937E-03 0.07187675 0.1085881 0.38859516 JAZAG_TGFB1_SIGNALING_UP primary bacterial infectious disease DOID_0050338 6.204E-03 0.07354819 0.11094331 0.39454215 JAZAG_TGFB1_SIGNALING_UP amino acid metabolic disorder DOID_9252 6.477E-03 0.07521431 6.477E-03 0.12285003 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 amino acid metabolic disorder DOID_9252 7.192E-29 4.092E-26 4.478E-27 2.548E-24 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 bile duct disease DOID_4138 1.976E-13 5.623E-11 6.788E-12 1.287E-09 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 biliary tract disease DOID_9741 2.306E-13 4.373E-11 7.797E-12 1.109E-09 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 lipid metabolism disorder DOID_3146 6.384E-13 9.082E-11 6.384E-13 1.816E-10 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 cholestasis DOID_13580 2.823E-12 3.213E-10 9.514E-11 9.023E-09 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 carbohydrate metabolic disorder DOID_2978 8.679E-11 8.231E-09 8.679E-11 9.877E-09 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 familial hyperlipidemia DOID_1168 8.824E-10 7.172E-08 8.824E-10 7.172E-08 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 thrombophilia DOID_2452 1.349E-09 9.597E-08 1.349E-09 9.597E-08 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 organic acidemia DOID_0060159 4.091E-09 2.587E-07 2.279E-07 1.179E-05 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 diabetic autonomic neuropathy DOID_11503 5.2E-09 2.959E-07 1.741E-07 9.906E-06 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 autonomic neuropathy DOID_11504 5.2E-09 2.959E-07 1.741E-07 9.906E-06 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 diabetic polyneuropathy DOID_12785 5.2E-09 2.959E-07 1.741E-07 9.906E-06 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 diabetic neuropathy DOID_9743 5.2E-09 2.959E-07 1.741E-07 9.906E-06 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 autonomic nervous system disease DOID_11465 8.15E-09 4.216E-07 2.543E-07 1.206E-05 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 chronic kidney failure DOID_784 1.704E-08 8.082E-07 3.449E-07 1.51E-05 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hepatitis DOID_2237 8.693E-08 3.805E-06 7.052E-05 1.338E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pulmonary embolism DOID_9477 1.181E-07 4.799E-06 6.032E-06 1.907E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 blood coagulation disease DOID_1247 1.201E-07 4.554E-06 1.201E-07 7.591E-06 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 bone resorption disease DOID_0080011 2.08E-07 7.397E-06 6.232E-05 1.313E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 osteoporosis DOID_11476 2.08E-07 7.397E-06 6.232E-05 1.313E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 lung adenocarcinoma DOID_3910 4.062E-07 1.36E-05 4.707E-04 5.357E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 intracranial thrombosis DOID_4193 5.075E-07 1.604E-05 5.075E-07 2.063E-05 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 vasculitis DOID_865 5.633E-07 1.687E-05 2.341E-04 3.027E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 alcohol-related neurodevelopmental disorder DOID_0050667 7.933E-07 2.257E-05 1.679E-03 0.01540859 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 carotid artery disease DOID_3407 1.129E-06 3.059E-05 2.247E-05 5.559E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hyperthyroidism DOID_7998 1.441E-06 3.727E-05 9.705E-04 9.521E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hyperglycemia DOID_4195 1.766E-06 4.369E-05 1.766E-06 6.699E-05 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 uveitis DOID_13141 2.435E-06 5.774E-05 6.407E-05 1.302E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 nephrosis DOID_2527 2.67E-06 6.078E-05 4.55E-05 1.036E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 membranous glomerulonephritis DOID_10976 3.341E-06 7.312E-05 3.341E-06 1.188E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 amyloidosis DOID_9120 3.341E-06 7.042E-05 3.341E-06 1.118E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 uveal disease DOID_3480 4.361E-06 8.862E-05 1.011E-04 1.644E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pre-eclampsia DOID_10591 6.627E-06 1.3E-04 6.627E-06 1.985E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 thyroid adenoma DOID_2891 6.627E-06 1.257E-04 1.404E-04 2.159E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 retinal vascular disease DOID_2462 6.879E-06 1.263E-04 0.01093236 0.05706894 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 autoimmune disease of gastrointestinal tract DOID_0060031 8.06E-06 1.433E-04 8.06E-06 2.293E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hypolipoproteinemia DOID_1387 1.664E-05 2.869E-04 1.664E-05 4.508E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 angioedema DOID_1558 1.664E-05 2.784E-04 1.664E-05 4.303E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 autoimmune disease of cardiovascular system DOID_0060051 1.814E-05 2.949E-04 0.01082743 0.05867436 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 Behcet's disease DOID_13241 1.814E-05 2.949E-04 0.01082743 0.05867436 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 respiratory failure DOID_11162 2.424E-05 3.831E-04 3.883E-04 4.7E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 spastic cerebral palsy DOID_0050669 2.675E-05 4.114E-04 2.675E-05 6.342E-04 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 endocrine pancreas disease DOID_1428 2.81E-05 4.208E-04 4.36E-04 5.168E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 endocrine organ benign neoplasm DOID_0060089 3.725E-05 5.434E-04 5.437E-04 5.949E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 papilloma DOID_2615 3.804E-05 5.411E-04 8.953E-04 9.097E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 peripheral vascular disease DOID_341 4.854E-05 6.737E-04 6.691E-04 7.051E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 diabetic retinopathy DOID_8947 5.174E-05 7.01E-04 0.06067862 0.21578835 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 adenoma DOID_657 5.246E-05 6.942E-04 5.246E-05 1.148E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pancreatitis DOID_4989 6.619E-05 8.56E-04 6.619E-05 1.299E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 mixed glioma DOID_5076 6.619E-05 8.37E-04 8.703E-03 0.05053029 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 bacterial pneumonia DOID_874 6.619E-05 8.188E-04 8.531E-04 8.826E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 peptic ulcer DOID_750 7.052E-05 8.538E-04 1.407E-03 0.01312025 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 adult respiratory distress syndrome DOID_11394 7.744E-05 9.18E-04 7.744E-05 1.421E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 female reproductive system disease DOID_229 7.893E-05 9.166E-04 7.893E-05 1.404E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 benign mesothelioma DOID_2645 8.483E-05 9.654E-04 0.2068176 0.43264417 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 alcohol abuse DOID_1574 8.842E-05 9.865E-04 8.842E-05 1.525E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 lymphatic system cancer DOID_0060073 9.176E-05 1.004E-03 9.176E-05 1.536E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 reticulosarcoma DOID_8538 9.176E-05 1.004E-03 9.176E-05 1.536E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 lymphosarcoma DOID_8675 9.176E-05 1.004E-03 9.176E-05 1.536E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 primary immunodeficiency disease DOID_612 1.222E-04 1.312E-03 1.222E-04 1.932E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 myeloma DOID_0070004 1.404E-04 1.48E-03 2.329E-03 0.01892906 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 vascular skin disease DOID_9540 1.404E-04 1.453E-03 1.404E-04 2.103E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 brain edema DOID_4724 1.521E-04 1.545E-03 1.521E-04 2.218E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 Crohn's disease DOID_8778 1.573E-04 1.57E-03 1.573E-04 2.237E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 dilated cardiomyopathy DOID_12930 1.651E-04 1.62E-03 0.0924047 0.25278016 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 autoimmune hepatitis DOID_2048 1.767E-04 1.704E-03 1.767E-04 2.452E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 gastric ulcer DOID_10808 2.038E-04 1.933E-03 5.91E-03 0.04003316 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 familial hypercholesterolemia DOID_13810 2.038E-04 1.901E-03 2.038E-04 2.761E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 glycogen metabolism disorder DOID_0050728 2.335E-04 2.143E-03 2.335E-04 3.09E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 glycogen storage disease DOID_2747 2.335E-04 2.143E-03 2.335E-04 3.09E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hypoglycemia DOID_9993 2.335E-04 2.109E-03 6.451E-03 0.04124042 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 bone marrow cancer DOID_4960 2.341E-04 2.081E-03 3.384E-03 0.02468788 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 urticaria DOID_1555 3.388E-04 2.966E-03 3.388E-04 4.284E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 papillary adenoma DOID_3172 3.797E-04 3.274E-03 3.797E-04 4.697E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 microcystic adenoma DOID_5403 3.797E-04 3.274E-03 3.797E-04 4.697E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 follicular adenoma DOID_6204 3.797E-04 3.274E-03 3.797E-04 4.697E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 uterine disease DOID_345 4.613E-04 3.918E-03 4.613E-04 5.357E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 diffuse large B-cell lymphoma DOID_0050745 4.707E-04 3.939E-03 0.14159771 0.33852561 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 perinatal necrotizing enterocolitis DOID_8677 4.707E-04 3.882E-03 0.01014033 0.05547933 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hepatic vascular disease DOID_272 5.21E-04 4.235E-03 5.21E-04 5.813E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 brain infarction DOID_3454 5.437E-04 4.357E-03 5.437E-04 5.837E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 age related macular degeneration DOID_10871 6.921E-04 5.469E-03 0.01300779 0.06492485 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 degeneration of macula and posterior pole DOID_2007 6.921E-04 5.469E-03 0.01300779 0.06492485 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 contact dermatitis DOID_2773 9.358E-04 7.294E-03 9.358E-04 9.342E-03 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pneumoconiosis DOID_10316 9.705E-04 7.462E-03 0.01618443 0.07938744 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 macular degeneration DOID_4448 9.705E-04 7.363E-03 0.01618443 0.07870891 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 thyroid cancer DOID_1781 1.133E-03 8.481E-03 0.01788431 0.08623875 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 gallbladder disease DOID_0000000 1.2E-03 8.867E-03 1.2E-03 0.01157263 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 transient cerebral ischemia DOID_224 1.2E-03 8.754E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 acute kidney failure DOID_3021 1.2E-03 8.643E-03 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 conjunctival disease DOID_4251 1.2E-03 8.535E-03 1.2E-03 0.01137975 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 conjunctivitis DOID_6195 1.2E-03 8.535E-03 1.2E-03 0.01137975 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 multiple myeloma DOID_9538 1.22E-03 8.569E-03 0.01876138 0.0897078 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 lymphoma DOID_0060058 1.554E-03 0.01078216 0.08761983 0.24559449 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hypersensitivity reaction type I disease DOID_1205 1.744E-03 0.0119564 1.744E-03 0.01575209 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 osteopetrosis DOID_13533 1.748E-03 0.01183947 1.748E-03 0.01553931 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 nephrotic syndrome DOID_1184 1.831E-03 0.01226027 1.831E-03 0.01603266 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hyperinsulinism DOID_2018 1.831E-03 0.01211771 1.831E-03 0.01578974 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 influenza DOID_8469 1.949E-03 0.01274604 0.02538799 0.11374618 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 ulcerative colitis DOID_8577 1.95E-03 0.01260787 1.95E-03 0.01655959 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 Hirschsprung's disease DOID_10487 2.058E-03 0.01316047 2.058E-03 0.01722474 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 carotid stenosis DOID_13001 2.058E-03 0.01301424 2.058E-03 0.0169751 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 cataract DOID_83 2.071E-03 0.01294829 0.02640178 0.11645435 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 leukodystrophy DOID_10579 2.197E-03 0.0135905 0.02743175 0.12006666 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 proteinuria DOID_576 2.197E-03 0.01344437 0.02743175 0.11915012 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 lens disease DOID_110 2.329E-03 0.01409611 0.02847771 0.12275619 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 bone marrow disease DOID_4961 2.329E-03 0.01394773 0.02847771 0.12183321 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 megacolon DOID_11372 2.393E-03 0.01418524 2.393E-03 0.01918005 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hemolytic anemia DOID_583 2.465E-03 0.01445827 2.465E-03 0.0194785 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 normocytic anemia DOID_720 2.465E-03 0.01445827 2.465E-03 0.0194785 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 movement disease DOID_480 2.751E-03 0.01597498 2.751E-03 0.02144587 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hemangioma DOID_255 2.752E-03 0.01581689 2.752E-03 0.02116043 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 nutritional deficiency disease DOID_5113 2.752E-03 0.01565872 0.07592222 0.22978588 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hemorrhagic disease DOID_2213 2.902E-03 0.01634941 2.902E-03 0.0220172 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 B-cell lymphocytic neoplasm DOID_707 2.902E-03 0.01618912 0.24753386 0.49593931 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 spastic diplegia DOID_10965 3.134E-03 0.01731458 3.134E-03 0.02346581 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 hemolytic-uremic syndrome DOID_12554 3.134E-03 0.01714809 3.134E-03 0.02316106 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 schizophreniform disorder DOID_11328 3.54E-03 0.01918312 3.54E-03 0.02549655 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 methylmalonic acidemia DOID_14749 3.54E-03 0.01900214 0.08560193 0.24353749 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 schizoaffective disorder DOID_5418 3.54E-03 0.01918312 3.54E-03 0.02549655 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 peroxisomal disease DOID_906 3.54E-03 0.01882455 0.08560193 0.24112623 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pustulosis of palm and sole DOID_4398 3.555E-03 0.01873074 0.03739793 0.15646633 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 inherited blood coagulation disease DOID_2214 3.969E-03 0.02071747 3.969E-03 0.02822755 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 osteosclerosis DOID_4254 3.969E-03 0.02052913 3.969E-03 0.02787906 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 ureteral obstruction DOID_5199 3.969E-03 0.02034418 0.09040388 0.24850149 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 colonic disease DOID_5353 4.895E-03 0.02486645 4.895E-03 0.03396393 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 blood protein disease DOID_620 4.895E-03 0.02464639 4.895E-03 0.03355473 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 mitochondrial myopathy DOID_699 5.391E-03 0.02690895 0.10465972 0.27958393 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 parasitic infectious disease DOID_1398 5.557E-03 0.02749736 0.04982467 0.20250168 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 cerebral degeneration DOID_1443 5.557E-03 0.02726031 0.04982467 0.20106549 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 muscular atrophy DOID_767 5.91E-03 0.02874175 5.91E-03 0.03956218 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 placenta disease DOID_780 5.91E-03 0.02849818 5.91E-03 0.03910215 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 allergic contact dermatitis DOID_3042 6.024E-03 0.02880382 6.024E-03 0.03939833 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 uremia DOID_4676 6.451E-03 0.03058664 6.451E-03 0.04170906 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 urinary tract obstruction DOID_5200 6.451E-03 0.03033386 0.11403988 0.2922914 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 Lewy body dementia DOID_12217 7.013E-03 0.03270754 0.11869323 0.30150199 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 ureteral disease DOID_1426 7.013E-03 0.03244162 0.11869323 0.30016198 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 meningitis DOID_9471 7.013E-03 0.03218 7.013E-03 0.04433689 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 male reproductive system disease DOID_48 7.026E-03 0.03198033 7.026E-03 0.04392903 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 spastic quadriplegia DOID_10970 7.597E-03 0.03430489 7.597E-03 0.04698278 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 toxic shock syndrome DOID_14115 7.597E-03 0.03403477 7.597E-03 0.04647759 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 acute pancreatitis DOID_2913 7.597E-03 0.03376888 7.597E-03 0.04598315 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 cystic fibrosis DOID_1485 8.12E-03 0.03581681 8.12E-03 0.04863546 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 endogenous depression DOID_1595 8.12E-03 0.03554129 0.06350791 0.21009304 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 commensal bacterial infectious disease DOID_0050339 8.201E-03 0.03562253 8.201E-03 0.04860991 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 portal hypertension DOID_10762 8.201E-03 0.03535266 8.201E-03 0.04810877 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 aneurysm disease DOID_2403 8.409E-03 0.03597348 0.06493907 0.21235821 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 morbid obesity DOID_11981 8.827E-03 0.03748202 8.827E-03 0.05073323 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 infantile epileptic encephalopathy DOID_2481 8.827E-03 0.03720437 8.827E-03 0.0502259 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 metabolic syndrome X DOID_14221 9.31E-03 0.0389499 9.31E-03 0.05244739 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 fragments of torsion dystonia DOID_531 9.473E-03 0.03934599 9.473E-03 0.05284706 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 dystonia DOID_543 9.473E-03 0.03906087 9.473E-03 0.05233399 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 extrinsic allergic alveolitis DOID_841 9.473E-03 0.03877986 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 mental depression DOID_1596 0.010265 0.0417199 0.07374752 0.2280562 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pleurisy DOID_10247 0.01082743 0.04369367 0.14610703 0.34353264 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 renal hypertension DOID_1073 0.01082743 0.04338597 0.01082743 0.05812082 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 secondary hypertension DOID_11130 0.01082743 0.04338597 0.01082743 0.05812082 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 renal tubular transport disease DOID_447 0.01082743 0.04308257 0.01082743 0.05757764 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 central nervous system hereditary degenerative disease DOID_481 0.01082743 0.04278338 0.01082743 0.05704451 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 autoimmune disease of endocrine system DOID_0060005 0.01153452 0.04526305 0.01153452 0.05966493 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 dystonic disease DOID_544 0.01153452 0.04495303 0.01153452 0.05912741 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 primary bacterial infectious disease DOID_0050338 0.01162427 0.04499462 0.01162427 0.05905544 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 corneal disease DOID_10124 0.01226138 0.04714005 0.15505508 0.35290536 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 congenital disorder of glycosylation DOID_5212 0.01226138 0.04682367 0.01226138 0.06174095 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 celiac disease DOID_10608 0.01377352 0.05224755 0.01377352 0.06814898 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pleural disease DOID_1532 0.01455835 0.05485895 0.16830252 0.37554563 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 thyroid carcinoma DOID_3963 0.01618443 0.06058515 0.17701913 0.38739956 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 spindle cell carcinoma DOID_4015 0.01618443 0.06018917 1.000 1.000 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 aplastic anemia DOID_12449 0.01702526 0.062905 0.18134329 0.39233587 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 congenital diaphragmatic hernia DOID_3827 0.02056875 0.07550724 0.02056875 0.09753018 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 intracranial arterial disease DOID_13089 0.02149863 0.07841489 0.02149863 0.10109688 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 cerebral arterial disease DOID_3527 0.02149863 0.07841489 0.02149863 0.10109688 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 pulmonary emphysema DOID_9675 0.0224457 0.08134779 0.0224457 0.10468527 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 autoimmune disease of urogenital tract DOID_0060049 0.02340975 0.08430472 0.02340975 0.10829387 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 primary biliary cirrhosis DOID_12236 0.02340975 0.08430472 0.02340975 0.10829387 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 endometriosis of uterus DOID_288 0.02340975 0.08377451 0.02340975 0.10742054 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 Huntington's disease DOID_12858 0.02439058 0.08673899 0.21513252 0.44675331 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 idiopathic generalized epilepsy DOID_1827 0.02439058 0.08620024 0.02439058 0.11102591 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 endometriosis DOID_289 0.02439058 0.08566814 0.02439058 0.11014475 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 cerebral infarction DOID_3526 0.02640178 0.09216326 0.02640178 0.11736415 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 brain cancer DOID_1319 0.02847771 0.09880376 0.23150308 0.4772654 HOSHIDA_LIVER_CANCER_SUBCLASS_S3 heart valve disease DOID_4079 0.02847771 0.09820495 0.23150308 0.47383184 DAZARD_UV_RESPONSE_CLUSTER_G2 middle cerebral artery infarction DOID_3525 4.078E-07 2.321E-04 4.078E-07 2.321E-04 DAZARD_UV_RESPONSE_CLUSTER_G2 intracranial arterial disease DOID_13089 1.529E-06 4.349E-04 1.529E-06 4.349E-04 DAZARD_UV_RESPONSE_CLUSTER_G2 cerebral arterial disease DOID_3527 1.529E-06 4.349E-04 1.529E-06 4.349E-04 DAZARD_UV_RESPONSE_CLUSTER_G2 cerebral infarction DOID_3526 2.139E-06 4.057E-04 2.139E-06 4.057E-04 DAZARD_UV_RESPONSE_CLUSTER_G2 cholestasis DOID_13580 6.156E-06 8.756E-04 5.899E-04 0.02397362 DAZARD_UV_RESPONSE_CLUSTER_G2 brain infarction DOID_3454 7.013E-06 7.981E-04 7.013E-06 9.976E-04 DAZARD_UV_RESPONSE_CLUSTER_G2 bile duct disease DOID_4138 7.946E-06 7.536E-04 6.981E-04 0.02647997 DAZARD_UV_RESPONSE_CLUSTER_G2 biliary tract disease DOID_9741 8.274E-06 6.726E-04 7.17E-04 0.02549704 DAZARD_UV_RESPONSE_CLUSTER_G2 cystic fibrosis DOID_1485 9.313E-06 6.624E-04 7.751E-04 0.02594426 DAZARD_UV_RESPONSE_CLUSTER_G2 Legionnaires' disease DOID_10457 2.397E-05 1.515E-03 2.397E-05 2.728E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 legionellosis DOID_10458 2.397E-05 1.515E-03 2.397E-05 2.728E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 viral pneumonia DOID_10533 2.397E-05 1.364E-03 2.397E-05 2.273E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 esophagitis DOID_11963 4.995E-05 2.584E-03 0.01050093 0.18671973 DAZARD_UV_RESPONSE_CLUSTER_G2 acute pancreatitis DOID_2913 7.875E-05 3.734E-03 7.875E-05 6.401E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 osteosarcoma DOID_3347 8.528E-05 3.733E-03 8.528E-05 6.066E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 pleurisy DOID_10247 1.14E-04 4.633E-03 1.14E-04 7.207E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 invasive ductal carcinoma DOID_3008 1.14E-04 4.324E-03 1.14E-04 6.487E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 pleural disease DOID_1532 1.557E-04 5.537E-03 1.557E-04 8.053E-03 DAZARD_UV_RESPONSE_CLUSTER_G2 esophageal disease DOID_6050 1.742E-04 5.829E-03 0.01934428 0.22463053 DAZARD_UV_RESPONSE_CLUSTER_G2 hepatitis DOID_2237 2.248E-04 7.106E-03 2.248E-04 0.01065862 DAZARD_UV_RESPONSE_CLUSTER_G2 peptic ulcer DOID_750 2.248E-04 6.732E-03 0.02193094 0.24468052 DAZARD_UV_RESPONSE_CLUSTER_G2 influenza DOID_8469 2.818E-04 8.017E-03 2.818E-04 0.01233316 DAZARD_UV_RESPONSE_CLUSTER_G2 pancreatitis DOID_4989 8.151E-04 0.02208656 8.151E-04 0.02576766 DAZARD_UV_RESPONSE_CLUSTER_G2 bacterial pneumonia DOID_874 8.151E-04 0.02108263 8.151E-04 0.02441146 DAZARD_UV_RESPONSE_CLUSTER_G2 primary bacterial infectious disease DOID_0050338 1.007E-03 0.02491952 1.007E-03 0.02865745 DAZARD_UV_RESPONSE_CLUSTER_G2 ulcerative colitis DOID_8577 1.269E-03 0.03008217 0.05146643 0.40115614 MOREIRA_RESPONSE_TO_TSA_DN respiratory syncytial virus infectious disease DOID_1273 5.699E-07 3.243E-04 1.247E-04 0.01418647 MOREIRA_RESPONSE_TO_TSA_DN contact dermatitis DOID_2773 4.355E-06 1.239E-03 4.765E-04 0.02259223 MOREIRA_RESPONSE_TO_TSA_DN alcohol-related neurodevelopmental disorder DOID_0050667 7.003E-06 1.328E-03 6.521E-04 0.02319141 MOREIRA_RESPONSE_TO_TSA_DN MHC class II deficiency DOID_5812 2.489E-05 3.54E-03 2.489E-05 0.01416187 MOREIRA_RESPONSE_TO_TSA_DN subependymal glioma DOID_4843 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN pilocytic astrocytoma DOID_4851 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN subependymal giant cell astrocytoma DOID_5077 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN fibrillary astrocytoma DOID_6726 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN juvenile pilocytic astrocytoma DOID_6811 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN childhood pilocytic astrocytoma DOID_6812 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN gemistocytic astrocytoma DOID_7005 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN childhood cerebral astrocytoma DOID_7007 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN protoplasmic astrocytoma DOID_7008 2.765E-05 3.146E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN benign glioma DOID_0060101 3.36E-05 3.186E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN benign ependymoma DOID_4844 3.36E-05 3.186E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN uremia DOID_4676 3.679E-05 2.991E-03 9.063E-03 0.19834863 MOREIRA_RESPONSE_TO_TSA_DN severe combined immunodeficiency DOID_627 4.361E-05 3.101E-03 4.361E-05 0.01240567 MOREIRA_RESPONSE_TO_TSA_DN combined T cell and B cell immunodeficiency DOID_628 4.723E-05 2.986E-03 4.723E-05 8.958E-03 MOREIRA_RESPONSE_TO_TSA_DN supratentorial cancer DOID_1659 6.75E-05 3.84E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN toxic encephalopathy DOID_3602 6.75E-05 3.491E-03 6.75E-05 9.601E-03 MOREIRA_RESPONSE_TO_TSA_DN cerebrum cancer DOID_368 6.75E-05 3.84E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN congenital diaphragmatic hernia DOID_3827 1.247E-04 5.911E-03 0.01649264 0.19966616 MOREIRA_RESPONSE_TO_TSA_DN systemic scleroderma DOID_418 1.247E-04 5.456E-03 1.247E-04 0.01182206 MOREIRA_RESPONSE_TO_TSA_DN autoimmune disease of urogenital tract DOID_0060049 1.432E-04 5.822E-03 1.432E-04 0.01164342 MOREIRA_RESPONSE_TO_TSA_DN primary biliary cirrhosis DOID_12236 1.432E-04 5.822E-03 1.432E-04 0.01164342 MOREIRA_RESPONSE_TO_TSA_DN rheumatic disease DOID_1575 1.497E-04 5.679E-03 1.497E-04 0.01064865 MOREIRA_RESPONSE_TO_TSA_DN scleroderma DOID_419 1.497E-04 5.679E-03 1.497E-04 0.01064865 MOREIRA_RESPONSE_TO_TSA_DN brain cancer DOID_1319 1.77E-04 6.296E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN neuritis DOID_1803 1.77E-04 5.926E-03 1.77E-04 0.01119285 MOREIRA_RESPONSE_TO_TSA_DN central nervous system cancer DOID_3620 1.842E-04 5.824E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN giant cell tumor DOID_200 2.223E-04 6.656E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN malignant giant cell tumor DOID_2705 2.223E-04 6.656E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN giant cell glioblastoma DOID_3074 2.223E-04 6.656E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN glioblastoma DOID_3068 2.638E-04 7.505E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN leukocyte disease DOID_9500 2.725E-04 7.385E-03 0.02425672 0.26542447 MOREIRA_RESPONSE_TO_TSA_DN collagen disease DOID_854 2.904E-04 7.511E-03 2.904E-04 0.01652526 MOREIRA_RESPONSE_TO_TSA_DN allergic contact dermatitis DOID_3042 3.474E-04 8.595E-03 3.474E-04 0.0179716 MOREIRA_RESPONSE_TO_TSA_DN astrocytoma DOID_3069 3.675E-04 8.714E-03 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN nephrosis DOID_2527 3.882E-04 8.836E-03 0.02888767 0.30439044 MOREIRA_RESPONSE_TO_TSA_DN metabolic syndrome X DOID_14221 4.765E-04 0.01042718 0.03196357 0.33067761 MOREIRA_RESPONSE_TO_TSA_DN primary immunodeficiency disease DOID_612 5.863E-04 0.01235573 5.863E-04 0.02566191 MOREIRA_RESPONSE_TO_TSA_DN nervous system cancer DOID_3093 5.992E-04 0.01217644 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN Human immunodeficiency virus infectious disease DOID_526 5.992E-04 0.01175656 5.992E-04 0.02435288 MOREIRA_RESPONSE_TO_TSA_DN encephalomyelitis DOID_640 6.387E-04 0.01211384 6.387E-04 0.02422767 MOREIRA_RESPONSE_TO_TSA_DN Crohn's disease DOID_8778 6.521E-04 0.01196976 0.03732451 0.37259031 MOREIRA_RESPONSE_TO_TSA_DN familial combined hyperlipidemia DOID_13809 3.95E-03 0.07023711 3.95E-03 0.13221103 MOREIRA_RESPONSE_TO_TSA_DN acute T cell leukemia DOID_5603 3.95E-03 0.06810871 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN alopecia areata DOID_986 3.95E-03 0.06610552 3.95E-03 0.12486598 MOREIRA_RESPONSE_TO_TSA_DN bronchiectasis DOID_9563 4.344E-03 0.07062543 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN berylliosis DOID_10322 5.132E-03 0.08111795 5.132E-03 0.15369717 MOREIRA_RESPONSE_TO_TSA_DN newborn respiratory distress syndrome DOID_12716 5.132E-03 0.07892558 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN T-cell leukemia DOID_715 5.526E-03 0.08274474 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN idiopathic pulmonary fibrosis DOID_0050156 5.92E-03 0.08636593 5.92E-03 0.16841357 MOREIRA_RESPONSE_TO_TSA_DN hyperhomocysteinemia DOID_9279 5.92E-03 0.08420679 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN silicosis DOID_10325 6.313E-03 0.08761365 6.313E-03 0.17105523 MOREIRA_RESPONSE_TO_TSA_DN bronchitis DOID_6132 6.706E-03 0.09085632 1.000 1.000 MOREIRA_RESPONSE_TO_TSA_DN prion disease DOID_649 7.1E-03 0.09394625 7.1E-03 0.18362221 MOREIRA_RESPONSE_TO_TSA_DN alopecia DOID_987 7.886E-03 0.09970859 7.886E-03 0.19508203 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN lymphoma DOID_0060058 4.13E-09 2.35E-06 9.455E-06 5.38E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN endometrial carcinoma DOID_2871 1.189E-07 3.382E-05 9.259E-04 0.07526295 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN biliary tract cancer DOID_4607 1.326E-07 2.515E-05 2.35E-04 0.02674078 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN endometrial cancer DOID_1380 1.53E-07 2.176E-05 1.045E-03 0.07435211 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN autonomic nervous system neoplasm DOID_2621 1.725E-07 1.964E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN neuroblastoma DOID_769 1.725E-07 1.964E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN transitional cell carcinoma DOID_2671 1.767E-07 1.676E-05 2.781E-04 0.02637489 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN peripheral nervous system neoplasm DOID_1192 3.317E-07 2.696E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN gallbladder cancer DOID_3121 5.805E-07 4.129E-05 1.991E-03 0.1132917 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN uterine cancer DOID_363 5.805E-07 3.67E-05 1.991E-03 0.10299245 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN myeloma DOID_0070004 7.472E-07 4.252E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN giant cell tumor DOID_200 1.184E-06 6.126E-05 0.07540578 0.80954511 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN malignant giant cell tumor DOID_2705 1.184E-06 6.126E-05 0.07540578 0.80954511 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN giant cell glioblastoma DOID_3074 1.184E-06 6.126E-05 0.07540578 0.80954511 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN bone marrow cancer DOID_4960 1.272E-06 6.033E-05 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN glioblastoma DOID_3068 1.674E-06 7.327E-05 0.08186055 0.83176167 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN pre-malignant neoplasm DOID_0060071 2.3E-06 9.348E-05 1.109E-04 0.0157792 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN in situ carcinoma DOID_8719 2.3E-06 9.348E-05 1.109E-04 0.0157792 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN astrocytoma DOID_3069 3.263E-06 1.238E-04 0.09590581 0.83954472 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN sinusitis DOID_0050127 4.479E-06 1.593E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN paranasal sinus disease DOID_1352 4.479E-06 1.593E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN nervous system cancer DOID_3093 8.681E-06 2.906E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN spindle cell carcinoma DOID_4015 1.938E-05 6.127E-04 0.05046911 0.77613301 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN multiple myeloma DOID_9538 2.457E-05 7.359E-04 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN intracranial arterial disease DOID_13089 3.06E-05 8.706E-04 0.0584143 0.79137467 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN cerebral arterial disease DOID_3527 3.06E-05 8.706E-04 0.0584143 0.79137467 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN cervix uteri carcinoma in situ DOID_8991 3.281E-05 8.89E-04 1.747E-03 0.110455 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN cataract DOID_83 4.268E-05 1.104E-03 4.268E-05 0.01214207 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN lens disease DOID_110 4.827E-05 1.194E-03 4.827E-05 9.155E-03 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN B-cell lymphocytic neoplasm DOID_707 6.084E-05 1.442E-03 0.07281143 0.79672506 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN neuroectodermal tumor DOID_171 1.012E-04 2.303E-03 0.08571217 0.84086592 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN encephalitis DOID_9588 1.254E-04 2.745E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN mixed glioma DOID_5076 1.964E-04 4.14E-03 0.10598792 0.83759901 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN lung oat cell carcinoma DOID_5411 1.99E-04 4.044E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN chronic myeloid leukemia DOID_8552 2.272E-04 4.459E-03 0.0221395 0.54771206 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN IgA glomerulonephritis DOID_2986 4.761E-04 9.03E-03 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN hypoglycemia DOID_9993 4.761E-04 8.739E-03 0.03167364 0.69316542 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN portal hypertension DOID_10762 6.1E-04 0.01084584 0.03573172 0.70108105 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN middle cerebral artery infarction DOID_3525 7.082E-04 0.01221041 0.03842784 0.70533676 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN diffuse large B-cell lymphoma DOID_0050745 7.599E-04 0.01271776 0.03977312 0.70721578 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN periodontitis DOID_824 7.599E-04 0.0123544 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN sarcoma DOID_1115 8.135E-04 0.01285765 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN hepatic vascular disease DOID_272 8.135E-04 0.01251015 0.04111656 0.70894909 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN pleural disease DOID_1532 1.108E-03 0.0165869 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN periodontal disease DOID_3388 1.238E-03 0.01805779 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN medullomyoblastoma DOID_3861 1.305E-03 0.01856786 0.05179786 0.75571746 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN adult medulloblastoma DOID_3864 1.305E-03 0.01856786 0.05179786 0.75571746 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN childhood medulloblastoma DOID_3869 1.305E-03 0.01856786 0.05179786 0.75571746 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN medulloblastoma DOID_3858 1.446E-03 0.02006322 0.05444989 0.75565823 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN adult respiratory distress syndrome DOID_11394 1.669E-03 0.02261327 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN benign mesothelioma DOID_2645 1.747E-03 0.02311849 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN primitive neuroectodermal tumor DOID_168 1.908E-03 0.02467449 0.0623624 0.8064592 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN cerebral infarction DOID_3526 2.076E-03 0.02624708 0.06498544 0.80384159 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN heart valve disease DOID_4079 2.25E-03 0.0278347 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN lung small cell carcinoma DOID_5409 2.431E-03 0.02943596 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN bile duct adenocarcinoma DOID_4896 2.913E-03 0.03453704 0.07670029 0.80819379 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN cholangiocarcinoma DOID_4947 2.913E-03 0.03453704 0.07670029 0.80819379 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN hypertrophic cardiomyopathy DOID_11984 3.329E-03 0.03865431 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN bile duct cancer DOID_4606 3.329E-03 0.03788123 0.08186055 0.81716936 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN bile duct carcinoma DOID_4897 3.329E-03 0.03788123 0.08186055 0.81716936 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN respiratory failure DOID_11162 3.77E-03 0.04206164 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN endocrine pancreas disease DOID_1428 4E-03 0.04377273 0.08954793 0.86360632 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN temporal lobe epilepsy DOID_3328 4.237E-03 0.04548789 0.09209633 0.85906249 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN tooth disease DOID_1091 4.358E-03 0.04591767 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN brain infarction DOID_3454 4.48E-03 0.04634821 0.09463773 0.84138857 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN pancreatic ductal carcinoma DOID_3587 4.729E-03 0.0480543 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN peripheral vascular disease DOID_341 4.985E-03 0.04976327 0.09969961 0.83425114 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN pancreatic carcinoma DOID_4905 5.115E-03 0.0501823 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN diabetic retinopathy DOID_8947 5.115E-03 0.04933176 0.10096073 0.82066654 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN bone resorption disease DOID_0080011 5.515E-03 0.0523014 0.10473372 0.83934487 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN osteoporosis DOID_11476 5.515E-03 0.0523014 0.10473372 0.83934487 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN pancreatitis DOID_4989 5.651E-03 0.0527161 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN focal epilepsy DOID_2234 6.356E-03 0.05833493 0.11223314 0.85147542 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN chronic kidney failure DOID_784 6.356E-03 0.05740898 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN retinal vascular disease DOID_2462 6.649E-03 0.05911349 0.11471922 0.85888472 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN primary immunodeficiency disease DOID_612 7.252E-03 0.06348532 0.11967092 0.88432145 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN Human immunodeficiency virus infectious disease DOID_526 7.407E-03 0.06385599 7.407E-03 0.35120793 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN lymphoblastic leukemia DOID_1037 7.879E-03 0.06691661 0.12459543 0.89740255 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN alcohol-related neurodevelopmental disorder DOID_0050667 8.04E-03 0.06727549 8.04E-03 0.35190259 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN mouth disease DOID_403 8.04E-03 0.06630049 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN ulcerative colitis DOID_8577 8.697E-03 0.07069088 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN cutaneous leishmaniasis DOID_9111 0.01389413 0.09882198 1.000 1.000 KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN cannabis abuse DOID_9505 0.01389413 0.09760196 0.01389413 0.49410992 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN aortic valve stenosis DOID_1712 3.711E-05 0.02111694 9.142E-03 0.40014676 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN dissociative disorder DOID_10935 9.584E-05 0.02726529 0.01443782 0.45639543 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN dissociative amnesia DOID_11037 9.584E-05 0.02726529 0.01443782 0.45639543 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN amnestic disorder DOID_10914 1.064E-04 0.02018692 0.0151921 0.43221524 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN aortic valve disease DOID_62 1.543E-04 0.02195141 0.01820366 0.4503428 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN Charcot-Marie-Tooth disease DOID_10595 3.122E-04 0.03552596 3.122E-04 0.1776298 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN proteinuria DOID_576 6.498E-04 0.06161975 0.03682546 0.55141278 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN heart valve disease DOID_4079 6.765E-04 0.05499156 0.03756319 0.50889181 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN bile duct adenocarcinoma DOID_4896 8.785E-04 0.06248273 8.785E-04 0.24993092 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN cholangiocarcinoma DOID_4947 8.785E-04 0.06248273 8.785E-04 0.24993092 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN hypertrophic cardiomyopathy DOID_11984 1.005E-03 0.06356272 0.04564234 0.55256359 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN bile duct cancer DOID_4606 1.005E-03 0.05720645 1.005E-03 0.19068817 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN bile duct carcinoma DOID_4897 1.005E-03 0.05720645 1.005E-03 0.19068817 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN cholestasis DOID_13580 1.247E-03 0.06452302 0.05074947 0.53474907 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN pancreatic ductal carcinoma DOID_3587 1.436E-03 0.06807212 1.436E-03 0.20421635 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN bile duct disease DOID_4138 1.475E-03 0.06455066 0.05510601 0.54060894 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN biliary tract disease DOID_9741 1.514E-03 0.06155293 0.05583022 0.5384304 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN pancreatic carcinoma DOID_4905 1.555E-03 0.05897416 1.555E-03 0.17692247 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN pancreatitis DOID_4989 1.721E-03 0.06118609 1.721E-03 0.1631629 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN mixed glioma DOID_5076 1.721E-03 0.05758691 1.721E-03 0.13985392 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN biliary tract cancer DOID_4607 1.939E-03 0.06129899 1.939E-03 0.13792272 HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN carbohydrate metabolic disorder DOID_2978 2.414E-03 0.07228864 2.414E-03 0.15260936 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP heart valve disease DOID_4079 1.692E-10 9.625E-08 5.016E-04 0.04077136 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP Ehlers-Danlos syndrome DOID_13359 1.997E-10 5.681E-08 9.848E-03 0.32961394 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP bone development disease DOID_0080006 2.737E-09 5.191E-07 2.5E-05 3.557E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP aortic valve insufficiency DOID_57 5.551E-08 7.896E-06 7.886E-03 0.34515421 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP osteochondrodysplasia DOID_2256 6.089E-08 6.929E-06 6.746E-04 0.04265246 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP collagen disease DOID_854 9.095E-08 8.625E-06 0.04137294 0.46159218 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP ureteral obstruction DOID_5199 2.053E-07 1.669E-05 0.01180624 0.30535225 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP urinary tract obstruction DOID_5200 4.447E-07 3.163E-05 0.01506193 0.34280947 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP ureteral disease DOID_1426 5.08E-07 3.212E-05 0.01571183 0.3192868 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP aortic valve disease DOID_62 5.08E-07 2.89E-05 0.01571183 0.30827691 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP adenoid cystic carcinoma DOID_4866 3.072E-06 1.589E-04 3.072E-06 1.748E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP salivary gland cancer DOID_8850 3.529E-06 1.673E-04 3.529E-06 1.004E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP atrophic muscular disease DOID_913 6.861E-06 3.003E-04 6.29E-04 0.04473993 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP muscular dystrophy DOID_9884 6.861E-06 3.003E-04 6.29E-04 0.04473993 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP oral cavity cancer DOID_8618 8.889E-06 3.613E-04 8.889E-06 1.686E-03 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP facioscapulohumeral muscular dystrophy DOID_11727 1.873E-05 7.103E-04 6.576E-03 0.34013972 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP bone resorption disease DOID_0080011 1.938E-05 6.891E-04 0.05082926 0.4986526 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP osteoporosis DOID_11476 1.938E-05 6.891E-04 0.05082926 0.4986526 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP aneurysm disease DOID_2403 1.938E-05 6.486E-04 1.247E-03 0.07094526 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP osteogenesis imperfecta DOID_12347 3.242E-05 1.025E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP oral submucous fibrosis DOID_5773 4.361E-05 1.306E-03 1.000 1.000 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP spastic quadriplegia DOID_10970 1.241E-04 3.53E-03 0.01636132 0.31031967 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP intracranial aneurysm DOID_10941 1.562E-04 4.231E-03 0.01830732 0.32552701 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP multiple epiphyseal dysplasia DOID_12721 1.919E-04 4.962E-03 1.919E-04 0.02183406 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP focal glomerulosclerosis DOID_3945 1.919E-04 4.747E-03 1.919E-04 0.01819505 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP spastic cerebral palsy DOID_0050669 2.177E-04 5.161E-03 0.02154244 0.36051911 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP nephroblastoma DOID_2154 2.741E-04 6.239E-03 0.02412317 0.39217382 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP nephrotic syndrome DOID_1184 4.245E-04 9.289E-03 0.02990594 0.40515423 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP nephrosis DOID_2527 1.095E-03 0.02308176 0.04768715 0.48453549 TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP mouth disease DOID_403 1.833E-03 0.03724428 1.000 1.000 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP oral cavity cancer DOID_8618 1.398E-07 7.952E-05 1.398E-07 7.952E-05 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP allergic contact dermatitis DOID_3042 2.444E-07 6.953E-05 2.444E-07 6.953E-05 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP contact dermatitis DOID_2773 4.633E-07 8.787E-05 4.633E-07 8.787E-05 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP adenoid cystic carcinoma DOID_4866 4.865E-06 6.92E-04 4.865E-06 6.92E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP salivary gland cancer DOID_8850 5.588E-06 6.359E-04 5.588E-06 6.359E-04 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP temporal lobe epilepsy DOID_3328 2.038E-05 1.933E-03 1.284E-03 0.04566211 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP focal epilepsy DOID_2234 3.81E-05 3.097E-03 1.939E-03 0.06129899 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP biliary tract cancer DOID_4607 3.81E-05 2.71E-03 3.81E-05 3.614E-03 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP hemolytic-uremic syndrome DOID_12554 6.735E-05 4.258E-03 0.01217162 0.22340809 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP ureteral obstruction DOID_5199 8.579E-05 4.881E-03 0.01368298 0.21626703 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP urinary tract obstruction DOID_5200 1.415E-04 7.321E-03 0.01745161 0.25461447 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP ureteral disease DOID_1426 1.543E-04 7.317E-03 0.01820366 0.2466163 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP middle cerebral artery infarction DOID_3525 2.109E-04 9.233E-03 2.109E-04 0.01714679 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP gestational diabetes DOID_11714 2.265E-04 9.204E-03 2.265E-04 0.01610717 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP toxic encephalopathy DOID_3602 2.591E-04 9.83E-03 2.591E-04 0.01638255 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP multiple myeloma DOID_9538 4.328E-04 0.01539188 4.328E-04 0.02462701 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP intracranial arterial disease DOID_13089 5.004E-04 0.01674704 5.004E-04 0.02588179 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP cerebral arterial disease DOID_3527 5.004E-04 0.01674704 5.004E-04 0.02588179 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP gallbladder cancer DOID_3121 5.978E-04 0.01889856 5.978E-04 0.02834785 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP cerebral infarction DOID_3526 6.235E-04 0.01867348 6.235E-04 0.02729201 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP myeloma DOID_0070004 6.765E-04 0.01924705 6.765E-04 0.02749578 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP hemolytic anemia DOID_583 7.038E-04 0.01906966 0.03830038 0.33527563 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP normocytic anemia DOID_720 7.038E-04 0.01906966 0.03830038 0.33527563 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP bone marrow cancer DOID_4960 8.785E-04 0.02272099 8.785E-04 0.03332412 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP brain infarction DOID_3454 1.359E-03 0.03361515 1.359E-03 0.04547932 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP cystic fibrosis DOID_1485 1.637E-03 0.03880082 0.05799963 0.38374176 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP mouth disease DOID_403 2.464E-03 0.05608175 0.07091541 0.39951353 TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP ulcerative colitis DOID_8577 2.67E-03 0.05842607 0.07376227 0.40748284 BOWIE_RESPONSE_TO_TAMOXIFEN tuberculosis DOID_399 2.191E-07 1.247E-04 0.01303725 0.43636447 BOWIE_RESPONSE_TO_TAMOXIFEN primary bacterial infectious disease DOID_0050338 4.348E-07 1.237E-04 0.01631922 0.51586878 BOWIE_RESPONSE_TO_TAMOXIFEN conjunctival disease DOID_4251 1.314E-06 2.492E-04 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN conjunctivitis DOID_6195 1.314E-06 2.492E-04 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN eyelid disease DOID_530 2.657E-06 3.779E-04 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN respiratory syncytial virus infectious disease DOID_1273 2.507E-05 2.853E-03 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN influenza DOID_8469 3.147E-05 2.984E-03 8.647E-03 0.37845906 BOWIE_RESPONSE_TO_TAMOXIFEN autoimmune disease of gastrointestinal tract DOID_0060031 3.858E-05 3.136E-03 9.563E-03 0.36274774 BOWIE_RESPONSE_TO_TAMOXIFEN pulmonary tuberculosis DOID_2957 3.858E-05 2.744E-03 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN bacterial pneumonia DOID_874 9.171E-05 5.798E-03 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN encephalomyelitis DOID_640 1.294E-04 7.364E-03 0.01741113 0.52141761 BOWIE_RESPONSE_TO_TAMOXIFEN Hermansky-Pudlak syndrome DOID_3753 1.845E-03 0.09544278 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN trypanosomiasis DOID_10113 2.029E-03 0.09623052 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN periodontal disease DOID_3388 6.812E-03 0.09939055 6.812E-03 0.35238467 BOWIE_RESPONSE_TO_TAMOXIFEN esophageal disease DOID_6050 6.812E-03 0.09690578 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN aplastic anemia DOID_12449 6.996E-03 0.09708974 6.996E-03 0.33172329 BOWIE_RESPONSE_TO_TAMOXIFEN pulmonary sarcoidosis DOID_13406 7.363E-03 0.09975062 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN uveitis DOID_13141 7.546E-03 0.09985871 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN hepatitis DOID_2237 7.73E-03 0.09996151 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN peptic ulcer DOID_750 7.73E-03 0.09774014 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN uveal disease DOID_3480 8.463E-03 0.09827895 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN diabetic autonomic neuropathy DOID_11503 8.647E-03 0.09839936 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN autonomic neuropathy DOID_11504 8.647E-03 0.09839936 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN diabetic polyneuropathy DOID_12785 8.647E-03 0.09839936 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN diabetic neuropathy DOID_9743 8.647E-03 0.09839936 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN neuritis DOID_1803 9.196E-03 0.09873144 1.000 1.000 BOWIE_RESPONSE_TO_TAMOXIFEN bone marrow disease DOID_4961 9.196E-03 0.09690308 9.196E-03 0.37376902 SU_TESTIS B-cell lymphocytic neoplasm DOID_707 7.799E-06 4.437E-03 7.799E-06 4.437E-03 SU_TESTIS nervous system benign neoplasm DOID_0060115 2.676E-05 7.613E-03 2.676E-05 7.613E-03 SU_TESTIS lymphoma DOID_0060058 4.135E-05 7.843E-03 4.135E-05 7.843E-03 SU_TESTIS skeletal system cancer DOID_0060124 5.099E-05 7.254E-03 5.099E-05 7.254E-03 SU_TESTIS bone cancer DOID_184 5.099E-05 7.254E-03 5.099E-05 7.254E-03 SU_TESTIS colon carcinoma DOID_1520 9.207E-05 0.01047797 9.207E-05 0.01047797 SU_TESTIS diffuse large B-cell lymphoma DOID_0050745 1.96E-04 0.01858451 1.96E-04 0.01858451 SU_TESTIS supratentorial cancer DOID_1659 2.243E-04 0.01822844 2.243E-04 0.01822844 SU_TESTIS cerebrum cancer DOID_368 2.243E-04 0.01822844 2.243E-04 0.01822844 SU_TESTIS thyroid carcinoma DOID_3963 3.203E-04 0.02278423 3.203E-04 0.02278423 SU_TESTIS thyroid cancer DOID_1781 3.561E-04 0.02251357 3.561E-04 0.02251357 SU_TESTIS benign mesothelioma DOID_2645 4.536E-04 0.02581108 4.536E-04 0.02581108 SU_TESTIS gallbladder cancer DOID_3121 5.177E-04 0.02677787 5.177E-04 0.02677787 SU_TESTIS myeloma DOID_0070004 5.859E-04 0.02777959 0.03501764 0.43315293 SU_TESTIS brain cancer DOID_1319 5.859E-04 0.0256427 5.859E-04 0.02777959 SU_TESTIS thyroid adenoma DOID_2891 5.859E-04 0.02381108 5.859E-04 0.0256427 SU_TESTIS central nervous system cancer DOID_3620 6.095E-04 0.02312061 6.095E-04 0.02477208 SU_TESTIS bone marrow cancer DOID_4960 7.61E-04 0.02706135 0.03982486 0.47209053 SU_TESTIS neuroectodermal tumor DOID_171 9.583E-04 0.03207333 0.04460902 0.50765065 SU_TESTIS endocrine organ benign neoplasm DOID_0060089 1.178E-03 0.03722396 1.178E-03 0.04466875 SU_TESTIS biliary tract cancer DOID_4607 1.681E-03 0.050352 1.681E-03 0.059793 SU_TESTIS nervous system cancer DOID_3093 1.965E-03 0.05591632 1.965E-03 0.06578391 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF funisitis DOID_0050698 3.469E-06 1.974E-03 0.02918928 0.87414227 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF multiple myeloma DOID_9538 2.188E-05 6.224E-03 0.0524487 0.82898084 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF myeloma DOID_0070004 4.299E-05 8.154E-03 0.0651336 0.74122038 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF bone marrow cancer DOID_4960 6.375E-05 9.069E-03 0.07391382 0.72512005 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF Williams-Beuren syndrome DOID_1928 1.842E-04 0.02096467 1.842E-04 0.10482337 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF infertility DOID_5223 2.99E-04 0.02835424 2.99E-04 0.08506272 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF hepatitis B DOID_2043 4.029E-04 0.03274656 0.02918928 0.83043515 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF invasive ductal carcinoma DOID_3008 7.534E-04 0.05358732 0.0395951 0.7768832 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF supratentorial cancer DOID_1659 8.047E-04 0.05087445 1.000 1.000 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF cerebrum cancer DOID_368 8.047E-04 0.05087445 1.000 1.000 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF myocarditis DOID_820 1.086E-03 0.06176792 1.000 1.000 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF spindle cell carcinoma DOID_4015 1.147E-03 0.05931038 0.04861043 0.89223666 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF medullomyoblastoma DOID_3861 1.209E-03 0.05733899 0.04989155 0.86025121 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF adult medulloblastoma DOID_3864 1.209E-03 0.05733899 0.04989155 0.86025121 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF childhood medulloblastoma DOID_3869 1.209E-03 0.05733899 0.04989155 0.86025121 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF medulloblastoma DOID_3858 1.339E-03 0.05862472 0.0524487 0.87774442 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF endometriosis of uterus DOID_288 1.693E-03 0.06879729 0.0588121 0.79676394 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF primitive neuroectodermal tumor DOID_168 1.768E-03 0.06707185 0.06007974 0.75967499 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF endometriosis DOID_289 1.768E-03 0.06287986 0.06007974 0.74316032 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF learning disability DOID_8927 1.924E-03 0.06438809 1.924E-03 0.36486586 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF brain cancer DOID_1319 2.086E-03 0.06592699 1.000 1.000 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF central nervous system cancer DOID_3620 2.169E-03 0.06495064 1.000 1.000 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF giant cell tumor DOID_200 2.608E-03 0.07420857 0.07266447 0.73832292 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF malignant giant cell tumor DOID_2705 2.608E-03 0.07420857 0.07266447 0.73832292 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF giant cell glioblastoma DOID_3074 2.608E-03 0.07420857 0.07266447 0.73832292 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF glioblastoma DOID_3068 3.086E-03 0.08362429 0.07889474 0.72405007 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF oral cavity cancer DOID_8618 3.086E-03 0.07982319 3.086E-03 0.43902755 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF neuroectodermal tumor DOID_171 3.391E-03 0.08389695 0.08261318 0.73448277 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF congenital heart defect DOID_1682 3.602E-03 0.08539941 3.602E-03 0.40991718 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF parasitic infectious disease DOID_1398 3.819E-03 0.08691766 3.819E-03 0.36215693 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF uterine disease DOID_345 3.819E-03 0.08357468 0.08754821 0.73257256 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF tuberculosis DOID_399 4.155E-03 0.087567 1.000 1.000 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF astrocytoma DOID_3069 4.27E-03 0.08677778 0.09245722 0.75154513 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF peripheral vascular disease DOID_341 4.624E-03 0.09073078 1.000 1.000 ROSS_ACUTE_MYELOID_LEUKEMIA_CBF mixed glioma DOID_5076 5.243E-03 0.09944798 0.10219768 0.76513792 KENNY_CTNNB1_TARGETS_UP tuberculosis DOID_399 1.918E-07 1.091E-04 1.783E-05 3.381E-03 KENNY_CTNNB1_TARGETS_UP primary bacterial infectious disease DOID_0050338 4.778E-07 1.359E-04 3.512E-05 3.996E-03 KENNY_CTNNB1_TARGETS_UP encephalomyelitis DOID_640 6.212E-07 1.178E-04 2.094E-03 0.05672839 KENNY_CTNNB1_TARGETS_UP hepatitis C DOID_1883 2.463E-06 3.503E-04 3.203E-04 0.02278423 KENNY_CTNNB1_TARGETS_UP pulmonary tuberculosis DOID_2957 6.955E-06 7.915E-04 6.955E-06 3.957E-03 KENNY_CTNNB1_TARGETS_UP carotid artery disease DOID_3407 1.304E-05 1.236E-03 9.583E-04 0.03407791 KENNY_CTNNB1_TARGETS_UP allergic contact dermatitis DOID_3042 1.708E-05 1.388E-03 1.708E-05 4.859E-03 KENNY_CTNNB1_TARGETS_UP contact dermatitis DOID_2773 2.748E-05 1.954E-03 2.748E-05 3.909E-03 KENNY_CTNNB1_TARGETS_UP biliary tract cancer DOID_4607 3.06E-05 1.935E-03 1.681E-03 0.0478344 KENNY_CTNNB1_TARGETS_UP larynx cancer DOID_2596 3.792E-05 2.157E-03 1.000 1.000 KENNY_CTNNB1_TARGETS_UP laryngeal benign neoplasm DOID_2598 3.792E-05 2.157E-03 1.000 1.000 KENNY_CTNNB1_TARGETS_UP juvenile rheumatoid arthritis DOID_676 6.599E-05 3.414E-03 6.599E-05 6.258E-03 KENNY_CTNNB1_TARGETS_UP periodontitis DOID_824 1.96E-04 9.292E-03 0.0204565 0.25866106 KENNY_CTNNB1_TARGETS_UP autoimmune disease of cardiovascular system DOID_0060051 2.099E-04 9.186E-03 2.099E-04 0.01705991 KENNY_CTNNB1_TARGETS_UP Behcet's disease DOID_13241 2.099E-04 9.186E-03 2.099E-04 0.01705991 KENNY_CTNNB1_TARGETS_UP focal glomerulosclerosis DOID_3945 2.243E-04 9.114E-03 1.000 1.000 KENNY_CTNNB1_TARGETS_UP allergic rhinitis DOID_4481 2.702E-04 0.01024929 0.02394251 0.27246573 KENNY_CTNNB1_TARGETS_UP myocarditis DOID_820 3.032E-04 0.01078106 0.02533356 0.2719773 KENNY_CTNNB1_TARGETS_UP periodontal disease DOID_3388 3.203E-04 0.01072199 0.02602837 0.26446687 KENNY_CTNNB1_TARGETS_UP calcinosis DOID_182 3.747E-04 0.01184404 1.000 1.000 KENNY_CTNNB1_TARGETS_UP respiratory syncytial virus infectious disease DOID_1273 4.132E-04 0.01237502 0.02949528 0.27971361 KENNY_CTNNB1_TARGETS_UP intracranial arterial disease DOID_13089 4.332E-04 0.01232433 0.03018724 0.27704095 KENNY_CTNNB1_TARGETS_UP cerebral arterial disease DOID_3527 4.332E-04 0.01232433 0.03018724 0.27704095 KENNY_CTNNB1_TARGETS_UP pulmonary emphysema DOID_9675 4.536E-04 0.01229099 0.03087872 0.27888874 KENNY_CTNNB1_TARGETS_UP autoimmune disease of urogenital tract DOID_0060049 4.745E-04 0.01227261 4.745E-04 0.02999971 KENNY_CTNNB1_TARGETS_UP primary biliary cirrhosis DOID_12236 4.745E-04 0.01227261 4.745E-04 0.02999971 KENNY_CTNNB1_TARGETS_UP endometriosis of uterus DOID_288 4.745E-04 0.01173902 0.03156972 0.2763565 KENNY_CTNNB1_TARGETS_UP endometriosis DOID_289 4.959E-04 0.01175609 0.03226025 0.26994241 KENNY_CTNNB1_TARGETS_UP gallbladder cancer DOID_3121 5.177E-04 0.01178226 0.03295031 0.26783894 KENNY_CTNNB1_TARGETS_UP influenza DOID_8469 5.177E-04 0.0113291 5.177E-04 0.02945565 KENNY_CTNNB1_TARGETS_UP glaucoma DOID_1686 6.336E-04 0.01335271 0.03639349 0.27983642 KENNY_CTNNB1_TARGETS_UP calcium metabolism disease DOID_10575 6.582E-04 0.01337489 1.000 1.000 KENNY_CTNNB1_TARGETS_UP atopic dermatitis DOID_3310 7.087E-04 0.01390421 7.087E-04 0.03665654 KENNY_CTNNB1_TARGETS_UP sarcoidosis DOID_11335 7.346E-04 0.01393242 7.346E-04 0.03483105 KENNY_CTNNB1_TARGETS_UP giant cell tumor DOID_200 7.346E-04 0.01348299 0.03913953 0.29303147 KENNY_CTNNB1_TARGETS_UP malignant giant cell tumor DOID_2705 7.346E-04 0.01348299 0.03913953 0.29303147 KENNY_CTNNB1_TARGETS_UP giant cell glioblastoma DOID_3074 7.346E-04 0.01348299 0.03913953 0.29303147 KENNY_CTNNB1_TARGETS_UP atrophic muscular disease DOID_913 7.346E-04 0.01306165 7.346E-04 0.03215174 KENNY_CTNNB1_TARGETS_UP muscular dystrophy DOID_9884 7.346E-04 0.01306165 7.346E-04 0.03215174 KENNY_CTNNB1_TARGETS_UP bile duct adenocarcinoma DOID_4896 7.61E-04 0.01312065 0.03982486 0.2942902 KENNY_CTNNB1_TARGETS_UP cholangiocarcinoma DOID_4947 7.61E-04 0.01312065 0.03982486 0.2942902 KENNY_CTNNB1_TARGETS_UP vasculitis DOID_865 7.61E-04 0.01273475 7.61E-04 0.03092726 KENNY_CTNNB1_TARGETS_UP reproductive organ benign neoplasm DOID_0050622 7.878E-04 0.0128071 0.04050972 0.29551323 KENNY_CTNNB1_TARGETS_UP parasitic protozoa infectious disease DOID_2789 7.878E-04 0.01245135 1.000 1.000 KENNY_CTNNB1_TARGETS_UP hypersensitivity reaction type IV disease DOID_2916 8.71E-04 0.01339441 8.71E-04 0.03303954 KENNY_CTNNB1_TARGETS_UP glioblastoma DOID_3068 8.71E-04 0.01304192 0.04256148 0.30271855 KENNY_CTNNB1_TARGETS_UP bile duct cancer DOID_4606 8.71E-04 0.01270751 0.04256148 0.29898128 KENNY_CTNNB1_TARGETS_UP bile duct carcinoma DOID_4897 8.71E-04 0.01270751 0.04256148 0.29898128 KENNY_CTNNB1_TARGETS_UP hypothyroidism DOID_1459 9.882E-04 0.01405773 9.882E-04 0.03307701 KENNY_CTNNB1_TARGETS_UP pre-malignant neoplasm DOID_0060071 1.019E-03 0.01413724 0.0459717 0.3151554 KENNY_CTNNB1_TARGETS_UP in situ carcinoma DOID_8719 1.019E-03 0.01413724 0.0459717 0.3151554 KENNY_CTNNB1_TARGETS_UP mineral metabolism disease DOID_0050032 1.05E-03 0.01421904 1.000 1.000 KENNY_CTNNB1_TARGETS_UP parasitic infectious disease DOID_1398 1.081E-03 0.01430295 1.000 1.000 KENNY_CTNNB1_TARGETS_UP uterine disease DOID_345 1.081E-03 0.01397788 0.04733251 0.31684939 KENNY_CTNNB1_TARGETS_UP tooth disease DOID_1091 1.145E-03 0.01447651 0.04869145 0.32215622 KENNY_CTNNB1_TARGETS_UP endocrine organ benign neoplasm DOID_0060089 1.178E-03 0.0145659 0.04937022 0.32289259 KENNY_CTNNB1_TARGETS_UP astrocytoma DOID_3069 1.211E-03 0.01465687 0.05004852 0.31997315 KENNY_CTNNB1_TARGETS_UP pancreatic ductal carcinoma DOID_3587 1.244E-03 0.01474931 0.05072636 0.31717912 KENNY_CTNNB1_TARGETS_UP pancreatic carcinoma DOID_4905 1.348E-03 0.01564822 0.05275708 0.32629107 KENNY_CTNNB1_TARGETS_UP syndrome DOID_225 1.419E-03 0.01614435 1.419E-03 0.04484541 KENNY_CTNNB1_TARGETS_UP aneurysm disease DOID_2403 1.455E-03 0.01623178 1.000 1.000 KENNY_CTNNB1_TARGETS_UP mixed glioma DOID_5076 1.492E-03 0.01632067 0.0554582 0.32870537 KENNY_CTNNB1_TARGETS_UP bacterial pneumonia DOID_874 1.492E-03 0.01601273 1.492E-03 0.0446671 KENNY_CTNNB1_TARGETS_UP female reproductive system disease DOID_229 1.604E-03 0.01690251 0.05747917 0.33717162 KENNY_CTNNB1_TARGETS_UP transitional cell carcinoma DOID_2671 1.882E-03 0.01947108 0.06217859 0.35379615 KENNY_CTNNB1_TARGETS_UP alcohol-related neurodevelopmental disorder DOID_0050667 2.137E-03 0.02171625 0.06618869 0.36922907 KENNY_CTNNB1_TARGETS_UP mouth disease DOID_403 2.137E-03 0.02133526 0.06618869 0.36564432 KENNY_CTNNB1_TARGETS_UP hypersensitivity reaction type I disease DOID_1205 2.181E-03 0.02139945 0.06685543 0.36229278 KENNY_CTNNB1_TARGETS_UP transient cerebral ischemia DOID_224 7.1E-03 0.0684729 7.1E-03 0.18363187 KENNY_CTNNB1_TARGETS_UP cutaneous leishmaniasis DOID_9111 7.1E-03 0.06733169 1.000 1.000 KENNY_CTNNB1_TARGETS_UP alopecia areata DOID_986 7.1E-03 0.06622789 7.1E-03 0.17564787 KENNY_CTNNB1_TARGETS_UP prostatic adenoma DOID_2883 7.807E-03 0.07165111 7.807E-03 0.18509869 KENNY_CTNNB1_TARGETS_UP intracranial arteriosclerosis DOID_13097 8.514E-03 0.07689778 1.000 1.000 KENNY_CTNNB1_TARGETS_UP diarrhea DOID_13250 8.514E-03 0.07569625 8.514E-03 0.1937824 KENNY_CTNNB1_TARGETS_UP vascular dementia DOID_8725 8.514E-03 0.07689778 1.000 1.000 KENNY_CTNNB1_TARGETS_UP ocular hypertension DOID_9282 8.514E-03 0.07453169 1.000 1.000 KENNY_CTNNB1_TARGETS_UP borderline glaucoma DOID_9283 8.514E-03 0.07453169 1.000 1.000 KENNY_CTNNB1_TARGETS_UP berylliosis DOID_10322 9.221E-03 0.07949206 9.221E-03 0.20178753 KENNY_CTNNB1_TARGETS_UP carotid stenosis DOID_13001 9.221E-03 0.07830561 1.000 1.000 KENNY_CTNNB1_TARGETS_UP major depressive disorder DOID_1470 9.221E-03 0.07715405 9.221E-03 0.19431391 KENNY_CTNNB1_TARGETS_UP intracranial thrombosis DOID_4193 9.221E-03 0.07603588 9.221E-03 0.18737413 KENNY_CTNNB1_TARGETS_UP psoriatic arthritis DOID_9008 9.221E-03 0.07494965 9.221E-03 0.18091295 KENNY_CTNNB1_TARGETS_UP skeletal system cancer DOID_0060124 0.01063177 0.08520394 1.000 1.000 KENNY_CTNNB1_TARGETS_UP thoracic aortic aneurysm DOID_14004 0.01063177 0.08402055 1.000 1.000 KENNY_CTNNB1_TARGETS_UP bone cancer DOID_184 0.01063177 0.08520394 1.000 1.000 KENNY_CTNNB1_TARGETS_UP adrenal cortex disease DOID_3952 0.01063177 0.08286958 0.01063177 0.20164932 KENNY_CTNNB1_TARGETS_UP oral submucous fibrosis DOID_5773 0.01063177 0.08174973 1.000 1.000 KENNY_CTNNB1_TARGETS_UP thyroiditis DOID_7166 0.01133668 0.08600758 0.01133668 0.20808286 KENNY_CTNNB1_TARGETS_UP autoimmune thyroiditis DOID_7188 0.01133668 0.08600758 0.01133668 0.20808286 KENNY_CTNNB1_TARGETS_UP Graves' disease DOID_12361 0.01204109 0.09014977 0.01204109 0.2141057 KENNY_CTNNB1_TARGETS_UP adrenal gland disease DOID_9553 0.01204109 0.08897899 0.01204109 0.20761764 KENNY_CTNNB1_TARGETS_UP male reproductive organ benign neoplasm DOID_0060087 0.01274503 0.09297335 0.01274503 0.21329179 KENNY_CTNNB1_TARGETS_UP keratosis DOID_161 0.01274503 0.09179647 0.01274503 0.20719774 KENNY_CTNNB1_TARGETS_UP prion disease DOID_649 0.01274503 0.09064901 1.000 1.000 KENNY_CTNNB1_TARGETS_UP leishmaniasis DOID_9065 0.01344848 0.09447142 1.000 1.000 KENNY_CTNNB1_TARGETS_UP limb-girdle muscular dystrophy DOID_11724 0.01415145 0.09819724 0.01415145 0.2236715 KENNY_CTNNB1_TARGETS_UP alopecia DOID_987 0.01415145 0.09701414 0.01415145 0.21762632 MOHANKUMAR_TLX1_TARGETS_DN bone resorption disease DOID_0080011 2.341E-06 1.332E-03 2.341E-06 1.332E-03 MOHANKUMAR_TLX1_TARGETS_DN osteoporosis DOID_11476 2.341E-06 1.332E-03 2.341E-06 1.332E-03 MOHANKUMAR_TLX1_TARGETS_DN pulmonary sarcoidosis DOID_13406 4.028E-06 1.146E-03 0.10126097 0.46465721 MOHANKUMAR_TLX1_TARGETS_DN sarcoidosis DOID_11335 1.567E-05 2.972E-03 0.1388609 0.51641733 MOHANKUMAR_TLX1_TARGETS_DN hypersensitivity reaction type IV disease DOID_2916 2.203E-05 3.134E-03 0.15028828 0.54122806 MOHANKUMAR_TLX1_TARGETS_DN cystic fibrosis DOID_1485 5.818E-05 6.62E-03 0.01850445 0.26997513 MOHANKUMAR_TLX1_TARGETS_DN opportunistic mycosis DOID_2473 9.448E-05 8.96E-03 0.08430412 0.42829505 MOHANKUMAR_TLX1_TARGETS_DN systemic mycosis DOID_0050136 1.229E-04 9.992E-03 0.09160979 0.45724534 MOHANKUMAR_TLX1_TARGETS_DN fungal infectious disease DOID_1564 1.229E-04 9.992E-03 0.09160979 0.45724534 MOHANKUMAR_TLX1_TARGETS_DN medulloblastoma DOID_3858 1.688E-04 0.01200465 1.688E-04 0.0480186 MOHANKUMAR_TLX1_TARGETS_DN primitive neuroectodermal tumor DOID_168 2.563E-04 0.01620603 2.563E-04 0.04861808 MOHANKUMAR_TLX1_TARGETS_DN gallbladder cancer DOID_3121 2.733E-04 0.01554982 0.11790687 0.48265474 MOHANKUMAR_TLX1_TARGETS_DN conjunctival disease DOID_4251 3.119E-04 0.01613186 0.0263273 0.31208818 MOHANKUMAR_TLX1_TARGETS_DN conjunctivitis DOID_6195 3.119E-04 0.01613186 0.0263273 0.31208818 MOHANKUMAR_TLX1_TARGETS_DN otitis media DOID_10754 4.558E-04 0.02161307 0.03150981 0.32016218 MOHANKUMAR_TLX1_TARGETS_DN epidermolysis bullosa DOID_2730 4.558E-04 0.01995052 4.558E-04 0.0648392 MOHANKUMAR_TLX1_TARGETS_DN middle ear disease DOID_5100 4.558E-04 0.02161307 0.03150981 0.32016218 MOHANKUMAR_TLX1_TARGETS_DN bile duct adenocarcinoma DOID_4896 4.837E-04 0.01965943 0.14115848 0.5215531 MOHANKUMAR_TLX1_TARGETS_DN cholangiocarcinoma DOID_4947 4.837E-04 0.01965943 0.14115848 0.5215531 MOHANKUMAR_TLX1_TARGETS_DN vasculitis DOID_865 4.837E-04 0.0183488 0.01019619 0.20005619 MOHANKUMAR_TLX1_TARGETS_DN impotence DOID_1875 5.378E-04 0.01912375 5.378E-04 0.061196 MOHANKUMAR_TLX1_TARGETS_DN vesiculobullous skin disease DOID_2731 5.378E-04 0.01799882 5.378E-04 0.05099666 MOHANKUMAR_TLX1_TARGETS_DN bile duct cancer DOID_4606 5.904E-04 0.01866307 0.15028828 0.53782411 MOHANKUMAR_TLX1_TARGETS_DN bile duct carcinoma DOID_4897 5.904E-04 0.01866307 0.15028828 0.53782411 MOHANKUMAR_TLX1_TARGETS_DN megacolon DOID_11372 6.263E-04 0.01875561 0.03666501 0.31137897 MOHANKUMAR_TLX1_TARGETS_DN eyelid disease DOID_530 6.263E-04 0.01781783 0.03666501 0.30235349 MOHANKUMAR_TLX1_TARGETS_DN neuroectodermal tumor DOID_171 6.795E-04 0.0184121 6.795E-04 0.05523631 MOHANKUMAR_TLX1_TARGETS_DN respiratory failure DOID_11162 7.11E-04 0.01839012 0.15932198 0.55959387 MOHANKUMAR_TLX1_TARGETS_DN hypothyroidism DOID_1459 7.11E-04 0.01759055 7.11E-04 0.05057282 MOHANKUMAR_TLX1_TARGETS_DN arthropathy DOID_381 7.214E-04 0.01710277 0.03923241 0.30579784 MOHANKUMAR_TLX1_TARGETS_DN mineral metabolism disease DOID_0050032 7.768E-04 0.01768037 0.01388406 0.23235382 MOHANKUMAR_TLX1_TARGETS_DN vein disease DOID_866 8.23E-04 0.01801115 8.23E-04 0.05203221 MOHANKUMAR_TLX1_TARGETS_DN tuberculosis DOID_399 9.197E-04 0.01938179 0.17269452 0.57801872 MOHANKUMAR_TLX1_TARGETS_DN penile disease DOID_1529 9.311E-04 0.01892168 9.311E-04 0.05298071 MOHANKUMAR_TLX1_TARGETS_DN astrocytoma DOID_3069 9.578E-04 0.01879345 0.01591314 0.25870215 MOHANKUMAR_TLX1_TARGETS_DN pancreatic ductal carcinoma DOID_3587 9.97E-04 0.01890913 0.17710506 0.58588826 MOHANKUMAR_TLX1_TARGETS_DN sexual dysfunction DOID_1876 1.046E-03 0.0191935 1.046E-03 0.05409076 MOHANKUMAR_TLX1_TARGETS_DN pancreatic carcinoma DOID_4905 1.12E-03 0.01992173 0.18367726 0.59721349 MOHANKUMAR_TLX1_TARGETS_DN infertility DOID_5223 1.167E-03 0.02011649 1.167E-03 0.05532034 MOHANKUMAR_TLX1_TARGETS_DN colonic disease DOID_5353 1.294E-03 0.02165661 0.05196815 0.36060828 MOHANKUMAR_TLX1_TARGETS_DN female reproductive system disease DOID_229 1.445E-03 0.02348709 0.02079019 0.2816576 MOHANKUMAR_TLX1_TARGETS_DN alcohol abuse DOID_1574 1.547E-03 0.02445251 0.02173583 0.2876206 MOHANKUMAR_TLX1_TARGETS_DN biliary tract cancer DOID_4607 1.547E-03 0.02379163 0.20308363 0.63491529 MOHANKUMAR_TLX1_TARGETS_DN sexual disorder DOID_0060043 1.714E-03 0.02566794 1.714E-03 0.07502936 MOHANKUMAR_TLX1_TARGETS_DN IgA glomerulonephritis DOID_2986 1.714E-03 0.02500979 0.05952921 0.38933475 MOHANKUMAR_TLX1_TARGETS_DN pulmonary embolism DOID_9477 1.714E-03 0.02438454 1.714E-03 0.06967012 MOHANKUMAR_TLX1_TARGETS_DN primary bacterial infectious disease DOID_0050338 1.765E-03 0.02449726 0.21156138 0.65423059 MOHANKUMAR_TLX1_TARGETS_DN transitional cell carcinoma DOID_2671 1.823E-03 0.02469111 1.823E-03 0.0691351 MOHANKUMAR_TLX1_TARGETS_DN nervous system cancer DOID_3093 1.941E-03 0.0256808 0.21786105 0.66646739 MOHANKUMAR_TLX1_TARGETS_DN lymphoma DOID_0060058 2.064E-03 0.02668593 2.064E-03 0.07338631 MOHANKUMAR_TLX1_TARGETS_DN encephalomyelitis DOID_640 2.127E-03 0.02689206 0.22411087 0.67470415 MOHANKUMAR_TLX1_TARGETS_DN bronchiolitis DOID_2942 2.191E-03 0.02709688 1.000 1.000 MOHANKUMAR_TLX1_TARGETS_DN mouth disease DOID_403 2.191E-03 0.02652728 0.22618313 0.67381258 MOHANKUMAR_TLX1_TARGETS_DN gestational diabetes DOID_11714 2.722E-03 0.03227153 2.722E-03 0.09111961 MOHANKUMAR_TLX1_TARGETS_DN lung adenocarcinoma DOID_3910 2.722E-03 0.03161292 2.722E-03 0.08605741 MOHANKUMAR_TLX1_TARGETS_DN migraine DOID_6364 2.722E-03 0.03098067 0.07447267 0.41955396 MOHANKUMAR_TLX1_TARGETS_DN periodontitis DOID_824 2.722E-03 0.0303732 1.000 1.000 MOHANKUMAR_TLX1_TARGETS_DN perinatal necrotizing enterocolitis DOID_8677 2.722E-03 0.0297891 0.07447267 0.41544068 MOHANKUMAR_TLX1_TARGETS_DN toxic encephalopathy DOID_3602 3.107E-03 0.0333585 0.07940139 0.41448983 MOHANKUMAR_TLX1_TARGETS_DN endometrial carcinoma DOID_2871 3.309E-03 0.03486302 3.309E-03 0.09908438 MOHANKUMAR_TLX1_TARGETS_DN endometrial cancer DOID_1380 3.729E-03 0.03858095 3.729E-03 0.10609762 MOHANKUMAR_TLX1_TARGETS_DN pleural disease DOID_1532 3.948E-03 0.04011897 3.948E-03 0.10698393 MOHANKUMAR_TLX1_TARGETS_DN autonomic nervous system neoplasm DOID_2621 3.948E-03 0.03941513 0.089181 0.44906185 MOHANKUMAR_TLX1_TARGETS_DN neuroblastoma DOID_769 3.948E-03 0.03941513 0.089181 0.44906185 MOHANKUMAR_TLX1_TARGETS_DN periodontal disease DOID_3388 4.404E-03 0.04320795 1.000 1.000 MOHANKUMAR_TLX1_TARGETS_DN medullomyoblastoma DOID_3861 4.641E-03 0.04475786 4.641E-03 0.12003244 MOHANKUMAR_TLX1_TARGETS_DN adult medulloblastoma DOID_3864 4.641E-03 0.04475786 4.641E-03 0.12003244 MOHANKUMAR_TLX1_TARGETS_DN childhood medulloblastoma DOID_3869 4.641E-03 0.04475786 4.641E-03 0.12003244 MOHANKUMAR_TLX1_TARGETS_DN peripheral nervous system neoplasm DOID_1192 5.385E-03 0.05107109 0.10365786 0.4718506 MOHANKUMAR_TLX1_TARGETS_DN respiratory syncytial virus infectious disease DOID_1273 5.645E-03 0.05265443 1.000 1.000 MOHANKUMAR_TLX1_TARGETS_DN adult respiratory distress syndrome DOID_11394 5.91E-03 0.05423841 0.10843267 0.48201712 MOHANKUMAR_TLX1_TARGETS_DN adenoid cystic carcinoma DOID_4866 5.91E-03 0.05337749 5.91E-03 0.1462079 MOHANKUMAR_TLX1_TARGETS_DN benign mesothelioma DOID_2645 6.181E-03 0.05495048 0.11081063 0.48130722 MOHANKUMAR_TLX1_TARGETS_DN endometriosis of uterus DOID_288 6.457E-03 0.05652386 0.1131823 0.484216 MOHANKUMAR_TLX1_TARGETS_DN salivary gland cancer DOID_8850 6.457E-03 0.05566744 6.457E-03 0.15308545 MOHANKUMAR_TLX1_TARGETS_DN endometriosis DOID_289 6.739E-03 0.0572302 0.11554771 0.48343122 MOHANKUMAR_TLX1_TARGETS_DN diabetic autonomic neuropathy DOID_11503 7.026E-03 0.0587931 0.11790687 0.48615224 MOHANKUMAR_TLX1_TARGETS_DN autonomic neuropathy DOID_11504 7.026E-03 0.0587931 0.11790687 0.48615224 MOHANKUMAR_TLX1_TARGETS_DN diabetic polyneuropathy DOID_12785 7.026E-03 0.0587931 0.11790687 0.48615224 MOHANKUMAR_TLX1_TARGETS_DN uterine cancer DOID_363 7.026E-03 0.05794103 7.026E-03 0.15991724 MOHANKUMAR_TLX1_TARGETS_DN diabetic neuropathy DOID_9743 7.026E-03 0.0587931 0.11790687 0.48615224 MOHANKUMAR_TLX1_TARGETS_DN autonomic nervous system disease DOID_11465 7.921E-03 0.06438702 0.12494704 0.49716689 MOHANKUMAR_TLX1_TARGETS_DN heart valve disease DOID_4079 7.921E-03 0.06348016 0.12494704 0.48695113 MOHANKUMAR_TLX1_TARGETS_DN vascular skin disease DOID_9540 7.921E-03 0.06259849 0.12494704 0.48037071 MOHANKUMAR_TLX1_TARGETS_DN glaucoma DOID_1686 8.545E-03 0.06660121 0.12960955 0.49165222 MOHANKUMAR_TLX1_TARGETS_DN lung small cell carcinoma DOID_5409 8.545E-03 0.06570119 8.545E-03 0.1869957 MOHANKUMAR_TLX1_TARGETS_DN calcium metabolism disease DOID_10575 8.864E-03 0.06725123 0.13193157 0.49714611 MOHANKUMAR_TLX1_TARGETS_DN B-cell lymphocytic neoplasm DOID_707 9.189E-03 0.06880013 9.189E-03 0.19365964 MOHANKUMAR_TLX1_TARGETS_DN giant cell tumor DOID_200 9.855E-03 0.07282754 9.855E-03 0.20027574 MOHANKUMAR_TLX1_TARGETS_DN malignant giant cell tumor DOID_2705 9.855E-03 0.07282754 9.855E-03 0.20027574 MOHANKUMAR_TLX1_TARGETS_DN giant cell glioblastoma DOID_3074 9.855E-03 0.07282754 9.855E-03 0.20027574 MOHANKUMAR_TLX1_TARGETS_DN integumentary system cancer DOID_0060122 0.01054215 0.07690365 0.01054215 0.19994949 MOHANKUMAR_TLX1_TARGETS_DN skin cancer DOID_4159 0.01054215 0.07690365 0.01054215 0.19994949 MOHANKUMAR_TLX1_TARGETS_DN smallpox DOID_8736 0.01054215 0.07593018 0.01054215 0.1934995 MOHANKUMAR_TLX1_TARGETS_DN glioblastoma DOID_3068 0.01161083 0.08258202 0.01161083 0.20645505 MOHANKUMAR_TLX1_TARGETS_DN oral cavity cancer DOID_8618 0.01161083 0.08156249 0.01161083 0.20019884 MOHANKUMAR_TLX1_TARGETS_DN melancholia DOID_2848 0.01197722 0.08311019 0.15255568 0.54252613 MOHANKUMAR_TLX1_TARGETS_DN neurotic disorder DOID_4964 0.01234864 0.0846551 0.15481708 0.54714857 MOHANKUMAR_TLX1_TARGETS_DN uterine disease DOID_345 0.01428021 0.09673142 0.16603479 0.56571135 VERRECCHIA_RESPONSE_TO_TGFB1_C1 transitional cell carcinoma DOID_2671 3.973E-08 2.261E-05 5.766E-06 3.281E-03 VERRECCHIA_RESPONSE_TO_TGFB1_C1 diabetic angiopathy DOID_11713 4.013E-05 0.01141582 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 gestational diabetes DOID_11714 5.896E-05 0.01118244 0.0114151 0.64951928 VERRECCHIA_RESPONSE_TO_TGFB1_C1 nephroblastoma DOID_2154 9.654E-05 0.01373257 0.01454262 0.55165024 VERRECCHIA_RESPONSE_TO_TGFB1_C1 multiple myeloma DOID_9538 1.13E-04 0.01285773 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 cervix uteri carcinoma in situ DOID_8991 1.369E-04 0.01298323 1.369E-04 0.03894968 VERRECCHIA_RESPONSE_TO_TGFB1_C1 myeloma DOID_0070004 1.77E-04 0.01439081 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 bone marrow cancer DOID_4960 2.303E-04 0.0163793 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 osteochondrodysplasia DOID_2256 2.385E-04 0.01507591 0.02270849 0.61529202 VERRECCHIA_RESPONSE_TO_TGFB1_C1 pre-malignant neoplasm DOID_0060071 3.089E-04 0.01757464 3.089E-04 0.05858214 VERRECCHIA_RESPONSE_TO_TGFB1_C1 in situ carcinoma DOID_8719 3.089E-04 0.01757464 3.089E-04 0.05858214 VERRECCHIA_RESPONSE_TO_TGFB1_C1 cholestasis DOID_13580 3.279E-04 0.01695984 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 pancreatic ductal carcinoma DOID_3587 3.778E-04 0.01791466 3.778E-04 0.05374399 VERRECCHIA_RESPONSE_TO_TGFB1_C1 bile duct disease DOID_4138 3.882E-04 0.01699208 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 peripheral vascular disease DOID_341 3.988E-04 0.01620694 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 biliary tract disease DOID_9741 3.988E-04 0.01512648 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 pancreatic carcinoma DOID_4905 4.094E-04 0.01456102 4.094E-04 0.04659525 VERRECCHIA_RESPONSE_TO_TGFB1_C1 aneurysm disease DOID_2403 4.423E-04 0.01480512 0.03081117 0.67429064 VERRECCHIA_RESPONSE_TO_TGFB1_C1 bone development disease DOID_0080006 5.239E-04 0.01656111 0.0334981 0.70594146 VERRECCHIA_RESPONSE_TO_TGFB1_C1 nervous system cancer DOID_3093 5.992E-04 0.01794423 0.03579565 0.7274187 VERRECCHIA_RESPONSE_TO_TGFB1_C1 alcohol-related neurodevelopmental disorder DOID_0050667 6.521E-04 0.01855313 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 arrhythmogenic right ventricular dysplasia DOID_0050431 3.556E-03 0.09634296 3.556E-03 0.33720038 VERRECCHIA_RESPONSE_TO_TGFB1_C1 teratoma DOID_3307 3.95E-03 0.0977212 3.95E-03 0.32108394 VERRECCHIA_RESPONSE_TO_TGFB1_C1 malignant teratoma DOID_5563 3.95E-03 0.0977212 3.95E-03 0.32108394 VERRECCHIA_RESPONSE_TO_TGFB1_C1 mature teratoma DOID_5566 3.95E-03 0.0977212 3.95E-03 0.32108394 VERRECCHIA_RESPONSE_TO_TGFB1_C1 eosinophilic pneumonia DOID_5870 4.344E-03 0.0988756 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 pulmonary eosinophilia DOID_9498 4.344E-03 0.0988756 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 Loeffler syndrome DOID_9503 4.344E-03 0.0988756 1.000 1.000 VERRECCHIA_RESPONSE_TO_TGFB1_C1 intracranial thrombosis DOID_4193 5.132E-03 0.09734154 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_UP transitional cell carcinoma DOID_2671 7.649E-09 4.352E-06 4.521E-05 0.02572201 MURAKAMI_UV_RESPONSE_6HR_UP diabetic autonomic neuropathy DOID_11503 6.379E-06 1.815E-03 0.03534835 0.55870036 MURAKAMI_UV_RESPONSE_6HR_UP autonomic neuropathy DOID_11504 6.379E-06 1.815E-03 0.03534835 0.55870036 MURAKAMI_UV_RESPONSE_6HR_UP diabetic polyneuropathy DOID_12785 6.379E-06 1.815E-03 0.03534835 0.55870036 MURAKAMI_UV_RESPONSE_6HR_UP diabetic neuropathy DOID_9743 6.379E-06 1.815E-03 0.03534835 0.55870036 MURAKAMI_UV_RESPONSE_6HR_UP autonomic nervous system disease DOID_11465 7.699E-06 1.46E-03 0.03756319 0.54803733 MURAKAMI_UV_RESPONSE_6HR_UP integumentary system benign neoplasm DOID_0060121 8.672E-06 1.234E-03 7.316E-04 0.10407102 MURAKAMI_UV_RESPONSE_6HR_UP skin benign neoplasm DOID_3165 8.672E-06 1.234E-03 7.316E-04 0.10407102 MURAKAMI_UV_RESPONSE_6HR_UP integumentary system cancer DOID_0060122 1.207E-05 1.374E-03 9.094E-04 0.08624479 MURAKAMI_UV_RESPONSE_6HR_UP skin cancer DOID_4159 1.207E-05 1.374E-03 9.094E-04 0.08624479 MURAKAMI_UV_RESPONSE_6HR_UP teratoma DOID_3307 2.533E-05 2.402E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_UP malignant teratoma DOID_5563 2.533E-05 2.402E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_UP mature teratoma DOID_5566 2.533E-05 2.402E-03 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_UP alcohol-related neurodevelopmental disorder DOID_0050667 5.481E-05 4.455E-03 2.464E-03 0.15578264 MURAKAMI_UV_RESPONSE_6HR_UP dilated cardiomyopathy DOID_12930 5.653E-05 4.021E-03 2.515E-03 0.14308833 MURAKAMI_UV_RESPONSE_6HR_UP keratosis DOID_161 8.579E-05 5.424E-03 8.579E-05 0.02440684 MURAKAMI_UV_RESPONSE_6HR_UP esophageal disease DOID_6050 3.701E-04 0.02105762 3.701E-04 0.07019206 MURAKAMI_UV_RESPONSE_6HR_UP embryonal cancer DOID_688 4.328E-04 0.02238819 0.03016124 0.57205822 MURAKAMI_UV_RESPONSE_6HR_UP benign mesothelioma DOID_2645 5.239E-04 0.02484295 0.03312859 0.57121727 MURAKAMI_UV_RESPONSE_6HR_UP pre-eclampsia DOID_10591 6.765E-04 0.02961084 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_UP reproductive organ benign neoplasm DOID_0050622 9.094E-04 0.03696205 9.094E-04 0.10349375 MURAKAMI_UV_RESPONSE_6HR_UP hypertrophic cardiomyopathy DOID_11984 1.005E-03 0.03813763 0.04564234 0.59023838 MURAKAMI_UV_RESPONSE_6HR_UP cholestasis DOID_13580 1.247E-03 0.04435958 0.05074947 0.60159271 MURAKAMI_UV_RESPONSE_6HR_UP blood coagulation disease DOID_1247 1.436E-03 0.04805091 1.000 1.000 MURAKAMI_UV_RESPONSE_6HR_UP bile duct disease DOID_4138 1.475E-03 0.04661992 0.05510601 0.63990446 MURAKAMI_UV_RESPONSE_6HR_UP biliary tract disease DOID_9741 1.514E-03 0.04535479 0.05583022 0.63534788 MURAKAMI_UV_RESPONSE_6HR_UP amino acid metabolic disorder DOID_9252 2.218E-03 0.06310273 2.218E-03 0.18029352 MURAKAMI_UV_RESPONSE_6HR_UP nervous system cancer DOID_3093 2.266E-03 0.06140428 0.0680601 0.74473451 MURAKAMI_UV_RESPONSE_6HR_UP Human immunodeficiency virus infectious disease DOID_526 2.266E-03 0.05861318 0.0680601 0.73068292 MURAKAMI_UV_RESPONSE_6HR_UP lymphoma DOID_0060058 2.364E-03 0.05848718 2.364E-03 0.16815064 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN cerebral infarction DOID_3526 5.854E-07 3.331E-04 1.999E-03 0.14218303 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN cholestasis DOID_13580 2.401E-06 6.831E-04 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN brain infarction DOID_3454 2.856E-06 5.417E-04 4.316E-03 0.17542265 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN bile duct disease DOID_4138 3.372E-06 4.797E-04 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN biliary tract disease DOID_9741 3.558E-06 4.049E-04 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN middle cerebral artery infarction DOID_3525 7.782E-06 7.38E-04 0.03771615 0.4566061 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN intracranial arterial disease DOID_13089 2.889E-05 2.349E-03 0.05734364 0.55302591 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN cerebral arterial disease DOID_3527 2.889E-05 2.349E-03 0.05734364 0.55302591 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN pulmonary emphysema DOID_9675 3.098E-05 2.203E-03 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN hemolytic anemia DOID_583 4.838E-05 3.059E-03 2.254E-03 0.12823236 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN normocytic anemia DOID_720 4.838E-05 3.059E-03 2.254E-03 0.12823236 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN bone marrow cancer DOID_4960 6.758E-05 3.845E-03 0.07530809 0.54240887 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN parasitic protozoa infectious disease DOID_2789 7.12E-05 3.683E-03 0.07657833 0.53793916 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN parasitic infectious disease DOID_1398 1.145E-04 5.431E-03 0.08918706 0.57019592 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN porphyria DOID_13268 1.207E-04 5.284E-03 1.207E-04 0.06868973 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN allergic contact dermatitis DOID_3042 1.249E-04 5.074E-03 1.249E-04 0.03552121 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN cystic fibrosis DOID_1485 1.722E-04 6.531E-03 0.10162689 0.59614124 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN mixed glioma DOID_5076 1.856E-04 6.6E-03 1.856E-04 0.03520085 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN lung oat cell carcinoma DOID_5411 1.915E-04 6.411E-03 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN contact dermatitis DOID_2773 1.997E-04 6.312E-03 1.997E-04 0.0284022 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN Barrett's esophagus DOID_9206 2.187E-04 6.55E-03 0.02172606 0.36359208 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN urinary system benign neoplasm DOID_731 2.477E-04 7.046E-03 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN transitional cell carcinoma DOID_2671 2.628E-04 7.121E-03 6.842E-03 0.20489397 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN congenital hemolytic anemia DOID_589 4.995E-04 0.01291981 4.995E-04 0.05684717 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN osteosarcoma DOID_3347 5.872E-04 0.01452656 0.03506905 0.44342863 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN sarcoma DOID_1115 7.832E-04 0.01856781 7.832E-04 0.07427124 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN malaria DOID_12365 7.832E-04 0.0178251 0.04035612 0.46862515 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN thrombocytopenia DOID_1588 7.832E-04 0.01713952 0.04035612 0.45925265 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN esophageal disease DOID_6050 1.192E-03 0.0251146 0.04954021 0.53185624 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN lymphoid leukemia DOID_10747 1.257E-03 0.02554067 0.05084517 0.53575742 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN multiple myeloma DOID_9538 1.392E-03 0.02731304 0.05344981 0.54308826 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN blood platelet disease DOID_2218 1.462E-03 0.02773227 0.0547495 0.5465345 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN peptic ulcer DOID_750 1.534E-03 0.02815487 0.05604744 0.54984474 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN benign mesothelioma DOID_2645 1.682E-03 0.0299152 0.05863808 0.55608449 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN diabetic autonomic neuropathy DOID_11503 1.917E-03 0.03306137 1.917E-03 0.15586076 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN autonomic neuropathy DOID_11504 1.917E-03 0.03306137 1.917E-03 0.15586076 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN diabetic polyneuropathy DOID_12785 1.917E-03 0.03306137 1.917E-03 0.15586076 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN influenza DOID_8469 1.917E-03 0.03208898 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN diabetic neuropathy DOID_9743 1.917E-03 0.03306137 1.917E-03 0.15586076 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN myeloma DOID_0070004 2.167E-03 0.03523188 0.06636824 0.55534598 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN autonomic nervous system disease DOID_11465 2.167E-03 0.03425322 2.167E-03 0.13701288 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN lung small cell carcinoma DOID_5409 2.342E-03 0.03601214 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN hemorrhagic disease DOID_2213 2.523E-03 0.03777483 0.07148705 0.54234841 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN giant cell tumor DOID_200 2.71E-03 0.0395405 0.07403612 0.54709811 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN malignant giant cell tumor DOID_2705 2.71E-03 0.0395405 0.07403612 0.54709811 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN giant cell glioblastoma DOID_3074 2.71E-03 0.0395405 0.07403612 0.54709811 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN glioblastoma DOID_3068 3.206E-03 0.04561175 0.08037882 0.54447081 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN melancholia DOID_2848 3.31E-03 0.04594236 3.31E-03 0.17123971 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN neurotic disorder DOID_4964 3.416E-03 0.04627843 3.416E-03 0.16197451 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN carotid artery disease DOID_3407 3.523E-03 0.04661952 3.523E-03 0.15420304 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN astrocytoma DOID_3069 4.436E-03 0.05736089 0.09418313 0.57623875 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN blood coagulation disease DOID_1247 4.557E-03 0.05761571 0.09542795 0.57764364 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN pancreatic ductal carcinoma DOID_3587 4.557E-03 0.0563632 4.557E-03 0.17284713 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN pancreatic carcinoma DOID_4905 4.929E-03 0.05966731 4.929E-03 0.17527273 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN endogenous depression DOID_1595 5.184E-03 0.06145323 5.184E-03 0.17351499 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN pancreatitis DOID_4989 5.446E-03 0.06323578 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN bacterial pneumonia DOID_874 5.446E-03 0.06197106 1.000 1.000 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN chromosomal disease DOID_0080014 5.849E-03 0.0652568 0.10778416 0.61329188 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN mental depression DOID_1596 6.125E-03 0.06702556 6.125E-03 0.19362941 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN primary bacterial infectious disease DOID_0050338 6.696E-03 0.07188298 0.11511827 0.63594463 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN lymphoma DOID_0060058 7.441E-03 0.07840642 7.441E-03 0.21169734 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN lymphoblastic leukemia DOID_1037 7.594E-03 0.07856779 0.12239324 0.66325482 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN dilated cardiomyopathy DOID_12930 7.905E-03 0.08032545 0.12480517 0.65753837 ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN ulcerative colitis DOID_8577 8.383E-03 0.08368017 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN alcohol-related neurodevelopmental disorder DOID_0050667 2.988E-08 1.7E-05 2.783E-04 0.01759635 GRUETZMANN_PANCREATIC_CANCER_DN multiple myeloma DOID_9538 1.99E-07 5.662E-05 7.514E-03 0.15834201 GRUETZMANN_PANCREATIC_CANCER_DN nervous system cancer DOID_3093 5.856E-07 1.111E-04 3.392E-03 0.10156887 GRUETZMANN_PANCREATIC_CANCER_DN myeloma DOID_0070004 6.244E-07 8.882E-05 0.0115541 0.1933613 GRUETZMANN_PANCREATIC_CANCER_DN bone marrow cancer DOID_4960 1.212E-06 1.379E-04 0.01483337 0.22211022 GRUETZMANN_PANCREATIC_CANCER_DN seminoma DOID_4440 2.034E-06 1.929E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN Diamond-Blackfan anemia DOID_1339 3.933E-06 3.197E-04 3.933E-06 2.238E-03 GRUETZMANN_PANCREATIC_CANCER_DN germinoma DOID_3304 4.537E-06 3.227E-04 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN chronic kidney failure DOID_784 8.829E-06 5.582E-04 2.712E-03 0.0964357 GRUETZMANN_PANCREATIC_CANCER_DN peripheral nervous system neoplasm DOID_1192 9.736E-06 5.54E-04 7.882E-03 0.16017871 GRUETZMANN_PANCREATIC_CANCER_DN Zellweger syndrome DOID_905 1.182E-05 6.113E-04 1.182E-05 3.362E-03 GRUETZMANN_PANCREATIC_CANCER_DN angiosarcoma DOID_0001816 1.81E-05 8.58E-04 0.0506766 0.32767026 GRUETZMANN_PANCREATIC_CANCER_DN leukodystrophy DOID_10579 1.996E-05 8.739E-04 0.01111531 0.19165493 GRUETZMANN_PANCREATIC_CANCER_DN peroxisomal disease DOID_906 2.192E-05 8.909E-04 2.192E-05 4.158E-03 GRUETZMANN_PANCREATIC_CANCER_DN glaucoma DOID_1686 2.532E-05 9.604E-04 0.0124542 0.19684556 GRUETZMANN_PANCREATIC_CANCER_DN calcium metabolism disease DOID_10575 2.732E-05 9.715E-04 2.732E-05 3.886E-03 GRUETZMANN_PANCREATIC_CANCER_DN granulosa cell tumor DOID_2999 3.109E-05 1.041E-03 1.722E-03 0.08165394 GRUETZMANN_PANCREATIC_CANCER_DN sex cord-gonadal stromal tumor DOID_192 3.649E-05 1.153E-03 1.909E-03 0.08357018 GRUETZMANN_PANCREATIC_CANCER_DN melancholia DOID_2848 5.088E-05 1.524E-03 0.01739158 0.2537387 GRUETZMANN_PANCREATIC_CANCER_DN neurotic disorder DOID_4964 5.42E-05 1.542E-03 0.01792415 0.25497104 GRUETZMANN_PANCREATIC_CANCER_DN mineral metabolism disease DOID_0050032 6.904E-05 1.871E-03 6.904E-05 7.857E-03 GRUETZMANN_PANCREATIC_CANCER_DN cerebral degeneration DOID_1443 7.318E-05 1.893E-03 0.02068891 0.27376725 GRUETZMANN_PANCREATIC_CANCER_DN endocrine organ benign neoplasm DOID_0060089 8.665E-05 2.144E-03 0.02242755 0.28358387 GRUETZMANN_PANCREATIC_CANCER_DN bile duct disease DOID_4138 1.018E-04 2.415E-03 0.02422443 0.29327018 GRUETZMANN_PANCREATIC_CANCER_DN congenital hypoplastic anemia DOID_1342 1.029E-04 2.342E-03 1.029E-04 9.757E-03 GRUETZMANN_PANCREATIC_CANCER_DN biliary tract disease DOID_9741 1.073E-04 2.349E-03 0.02483611 0.28840298 GRUETZMANN_PANCREATIC_CANCER_DN endogenous depression DOID_1595 1.25E-04 2.634E-03 0.02670867 0.29798499 GRUETZMANN_PANCREATIC_CANCER_DN sarcoma DOID_1115 1.269E-04 2.579E-03 0.09292381 0.44061375 GRUETZMANN_PANCREATIC_CANCER_DN alcohol abuse DOID_1574 1.744E-04 3.421E-03 2.712E-03 0.10286475 GRUETZMANN_PANCREATIC_CANCER_DN mental depression DOID_1596 1.744E-04 3.307E-03 0.03129093 0.32371887 GRUETZMANN_PANCREATIC_CANCER_DN autonomic nervous system neoplasm DOID_2621 2.022E-04 3.711E-03 0.10755569 0.45671034 GRUETZMANN_PANCREATIC_CANCER_DN neuroblastoma DOID_769 2.022E-04 3.711E-03 0.10755569 0.45671034 GRUETZMANN_PANCREATIC_CANCER_DN amino acid metabolic disorder DOID_9252 2.267E-04 4.032E-03 2.267E-04 0.01843048 GRUETZMANN_PANCREATIC_CANCER_DN nephroblastoma DOID_2154 2.389E-04 4.119E-03 6.456E-03 0.15306601 GRUETZMANN_PANCREATIC_CANCER_DN aplastic anemia DOID_12449 2.587E-04 4.33E-03 2.587E-04 0.01840357 GRUETZMANN_PANCREATIC_CANCER_DN adenoma DOID_657 2.796E-04 4.546E-03 7.153E-03 0.16280214 GRUETZMANN_PANCREATIC_CANCER_DN dilated cardiomyopathy DOID_12930 2.896E-04 4.577E-03 0.0398025 0.27960025 GRUETZMANN_PANCREATIC_CANCER_DN calcinosis DOID_182 3.016E-04 4.638E-03 3.016E-04 0.01716161 GRUETZMANN_PANCREATIC_CANCER_DN ulcerative colitis DOID_8577 3.253E-04 4.871E-03 4.286E-03 0.10602936 GRUETZMANN_PANCREATIC_CANCER_DN Noonan syndrome DOID_3490 4.619E-04 6.739E-03 0.03197854 0.28882203 GRUETZMANN_PANCREATIC_CANCER_DN uterine cancer DOID_363 4.869E-04 6.926E-03 0.01026052 0.18244481 GRUETZMANN_PANCREATIC_CANCER_DN cerebral infarction DOID_3526 5.181E-04 7.19E-03 0.14451205 0.54096947 GRUETZMANN_PANCREATIC_CANCER_DN bone marrow disease DOID_4961 5.844E-04 7.917E-03 5.844E-04 0.03022743 GRUETZMANN_PANCREATIC_CANCER_DN pituitary cancer DOID_1785 6.746E-04 8.927E-03 0.03825146 0.28266338 GRUETZMANN_PANCREATIC_CANCER_DN pituitary carcinoma DOID_4916 6.746E-04 8.927E-03 0.03825146 0.28266338 GRUETZMANN_PANCREATIC_CANCER_DN bacterial meningitis DOID_9470 9.262E-04 0.01197735 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN pituitary adenoma DOID_3829 1.216E-03 0.01537787 0.0506766 0.32398857 GRUETZMANN_PANCREATIC_CANCER_DN cholestasis DOID_13580 1.432E-03 0.01771412 0.19842479 0.62724281 GRUETZMANN_PANCREATIC_CANCER_DN temporal lobe epilepsy DOID_3328 1.494E-03 0.01808264 0.02126191 0.27495511 GRUETZMANN_PANCREATIC_CANCER_DN glucose intolerance DOID_10603 1.544E-03 0.01830349 0.05682932 0.35147701 GRUETZMANN_PANCREATIC_CANCER_DN brain infarction DOID_3454 1.622E-03 0.01883177 0.20621563 0.6342524 GRUETZMANN_PANCREATIC_CANCER_DN lingual-facial-buccal dyskinesia DOID_9854 2.526E-03 0.02874944 0.07203864 0.39796105 GRUETZMANN_PANCREATIC_CANCER_DN chromosomal disease DOID_0080014 2.534E-03 0.02827674 2.534E-03 0.10300814 GRUETZMANN_PANCREATIC_CANCER_DN focal epilepsy DOID_2234 2.712E-03 0.02967252 0.03129093 0.31793818 GRUETZMANN_PANCREATIC_CANCER_DN Lewy body dementia DOID_12217 2.75E-03 0.02952512 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN meningitis DOID_9471 2.75E-03 0.02897836 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN sphingolipidosis DOID_1927 2.983E-03 0.03086008 2.983E-03 0.09984143 GRUETZMANN_PANCREATIC_CANCER_DN acute pancreatitis DOID_2913 2.983E-03 0.030309 0.07805403 0.41507236 GRUETZMANN_PANCREATIC_CANCER_DN primary bacterial infectious disease DOID_0050338 3.089E-03 0.03083318 0.03403858 0.28482283 GRUETZMANN_PANCREATIC_CANCER_DN transitional cell carcinoma DOID_2671 3.188E-03 0.03127294 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN osteosarcoma DOID_3347 3.225E-03 0.03109925 3.225E-03 0.10193644 GRUETZMANN_PANCREATIC_CANCER_DN papillary adenoma DOID_3172 3.475E-03 0.03295755 0.08403074 0.42690615 GRUETZMANN_PANCREATIC_CANCER_DN microcystic adenoma DOID_5403 3.475E-03 0.03295755 0.08403074 0.42690615 GRUETZMANN_PANCREATIC_CANCER_DN follicular adenoma DOID_6204 3.475E-03 0.03295755 0.08403074 0.42690615 GRUETZMANN_PANCREATIC_CANCER_DN lymphoma DOID_0060058 3.603E-03 0.03361034 0.2635023 0.76108025 GRUETZMANN_PANCREATIC_CANCER_DN myopia DOID_11830 3.735E-03 0.03427518 3.735E-03 0.10625306 GRUETZMANN_PANCREATIC_CANCER_DN middle cerebral artery infarction DOID_3525 3.735E-03 0.03373113 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN fragments of torsion dystonia DOID_531 3.735E-03 0.03320408 0.08700466 0.42677287 GRUETZMANN_PANCREATIC_CANCER_DN migraine DOID_6364 4.003E-03 0.03504073 0.08996901 0.43383362 GRUETZMANN_PANCREATIC_CANCER_DN periodontitis DOID_824 4.003E-03 0.03450981 0.08996901 0.43018796 GRUETZMANN_PANCREATIC_CANCER_DN perinatal necrotizing enterocolitis DOID_8677 4.003E-03 0.03399474 4.003E-03 0.10845941 GRUETZMANN_PANCREATIC_CANCER_DN renal tubular transport disease DOID_447 4.28E-03 0.03581145 4.28E-03 0.11068995 GRUETZMANN_PANCREATIC_CANCER_DN central nervous system hereditary degenerative disease DOID_481 4.28E-03 0.03529245 0.09292381 0.42986707 GRUETZMANN_PANCREATIC_CANCER_DN supratentorial cancer DOID_1659 4.565E-03 0.03710888 0.0958691 0.43639614 GRUETZMANN_PANCREATIC_CANCER_DN cerebrum cancer DOID_368 4.565E-03 0.03710888 0.0958691 0.43639614 GRUETZMANN_PANCREATIC_CANCER_DN dystonic disease DOID_544 4.565E-03 0.03658622 0.0958691 0.43293268 GRUETZMANN_PANCREATIC_CANCER_DN Charcot-Marie-Tooth disease DOID_10595 5.473E-03 0.04325125 0.10464816 0.45454049 GRUETZMANN_PANCREATIC_CANCER_DN endometrial cancer DOID_1380 5.473E-03 0.04265877 0.10464816 0.451097 GRUETZMANN_PANCREATIC_CANCER_DN papilloma DOID_2615 6.12E-03 0.04705891 0.11045384 0.4655425 GRUETZMANN_PANCREATIC_CANCER_DN periodontal disease DOID_3388 6.456E-03 0.04898112 0.11334267 0.47074437 GRUETZMANN_PANCREATIC_CANCER_DN refractive error DOID_9835 7.153E-03 0.05355334 7.153E-03 0.15654052 GRUETZMANN_PANCREATIC_CANCER_DN embryonal cancer DOID_688 7.514E-03 0.05552252 0.12195342 0.48525523 GRUETZMANN_PANCREATIC_CANCER_DN hepatitis DOID_2237 8.259E-03 0.06024783 0.12764779 0.50438608 GRUETZMANN_PANCREATIC_CANCER_DN intracranial arterial disease DOID_13089 8.644E-03 0.06225549 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN cerebral arterial disease DOID_3527 8.644E-03 0.06225549 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN benign mesothelioma DOID_2645 9.036E-03 0.06426914 9.036E-03 0.17729418 GRUETZMANN_PANCREATIC_CANCER_DN Huntington's disease DOID_12858 9.845E-03 0.0691554 0.13892688 0.53053284 GRUETZMANN_PANCREATIC_CANCER_DN idiopathic generalized epilepsy DOID_1827 9.845E-03 0.06831204 9.845E-03 0.18671957 GRUETZMANN_PANCREATIC_CANCER_DN uveal disease DOID_3480 9.845E-03 0.067489 9.845E-03 0.18069636 GRUETZMANN_PANCREATIC_CANCER_DN diabetic autonomic neuropathy DOID_11503 0.01026052 0.06950279 0.14172397 0.53404596 GRUETZMANN_PANCREATIC_CANCER_DN autonomic neuropathy DOID_11504 0.01026052 0.06950279 0.14172397 0.53404596 GRUETZMANN_PANCREATIC_CANCER_DN diabetic polyneuropathy DOID_12785 0.01026052 0.06950279 0.14172397 0.53404596 GRUETZMANN_PANCREATIC_CANCER_DN diabetic neuropathy DOID_9743 0.01026052 0.06950279 0.14172397 0.53404596 GRUETZMANN_PANCREATIC_CANCER_DN proteinuria DOID_576 0.01111531 0.07440721 0.14729115 0.54421212 GRUETZMANN_PANCREATIC_CANCER_DN autonomic nervous system disease DOID_11465 0.0115541 0.07644516 0.1500613 0.54385273 GRUETZMANN_PANCREATIC_CANCER_DN brain cancer DOID_1319 0.0115541 0.07556648 0.1500613 0.54041062 GRUETZMANN_PANCREATIC_CANCER_DN thyroid adenoma DOID_2891 0.0115541 0.07470777 0.1500613 0.53701181 GRUETZMANN_PANCREATIC_CANCER_DN heart valve disease DOID_4079 0.0115541 0.07386836 0.0115541 0.18783669 GRUETZMANN_PANCREATIC_CANCER_DN central nervous system cancer DOID_3620 0.01200042 0.07586929 0.15282251 0.54009945 GRUETZMANN_PANCREATIC_CANCER_DN pulmonary tuberculosis DOID_2957 0.0124542 0.07787297 0.0124542 0.19152541 GRUETZMANN_PANCREATIC_CANCER_DN movement disease DOID_480 0.0129154 0.07987897 0.15831828 0.55265708 GRUETZMANN_PANCREATIC_CANCER_DN withdrawal disorder DOID_0060001 0.01338398 0.0818869 0.16105289 0.55877498 GRUETZMANN_PANCREATIC_CANCER_DN B-cell lymphocytic neoplasm DOID_707 0.01338398 0.08101576 0.16105289 0.55538847 GRUETZMANN_PANCREATIC_CANCER_DN bile duct adenocarcinoma DOID_4896 0.01483337 0.08884409 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN cholangiocarcinoma DOID_4947 0.01483337 0.08884409 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN hypertrophic cardiomyopathy DOID_11984 0.01686592 0.09996571 0.17994998 0.58845711 GRUETZMANN_PANCREATIC_CANCER_DN bile duct cancer DOID_4606 0.01686592 0.09893514 1.000 1.000 GRUETZMANN_PANCREATIC_CANCER_DN bile duct carcinoma DOID_4897 0.01686592 0.09893514 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP primary bacterial infectious disease DOID_0050338 4.411E-18 2.51E-15 5.514E-11 3.137E-08 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bacterial pneumonia DOID_874 8.287E-16 2.358E-13 7.446E-09 6.053E-07 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP chronic kidney failure DOID_784 2.021E-15 3.834E-13 6.879E-10 6.523E-08 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP tuberculosis DOID_399 4.848E-15 6.896E-13 5.102E-08 2.233E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP ulcerative colitis DOID_8577 2.133E-14 2.428E-12 1.993E-10 2.268E-08 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bile duct disease DOID_4138 2.564E-13 2.431E-11 1.694E-10 3.213E-08 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP biliary tract disease DOID_9741 3.032E-13 2.465E-11 1.942E-10 2.763E-08 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP influenza DOID_8469 1.451E-12 1.032E-10 2.356E-05 3.192E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP neuritis DOID_1803 2.824E-12 1.785E-10 7.679E-08 2.913E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pulmonary tuberculosis DOID_2957 4.294E-12 2.443E-10 3.875E-05 4.323E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP respiratory failure DOID_11162 4.471E-11 2.313E-09 8.125E-06 1.541E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP cholestasis DOID_13580 7.124E-11 3.378E-09 3.612E-08 1.868E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pleural disease DOID_1532 1.415E-10 6.195E-09 2.103E-03 0.01013931 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP blood coagulation disease DOID_1247 1.475E-10 5.993E-09 1.475E-10 4.195E-08 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP giant cell tumor DOID_200 2.833E-10 1.075E-08 7.485E-09 5.324E-07 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP malignant giant cell tumor DOID_2705 2.833E-10 1.075E-08 7.485E-09 5.324E-07 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP giant cell glioblastoma DOID_3074 2.833E-10 1.075E-08 7.485E-09 5.324E-07 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP cystic fibrosis DOID_1485 2.893E-10 1.029E-08 2.335E-05 3.24E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP glioblastoma DOID_3068 6.282E-10 2.103E-08 1.504E-08 9.507E-07 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP adult respiratory distress syndrome DOID_11394 8.292E-10 2.621E-08 2.713E-04 2.086E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP periodontitis DOID_824 1.367E-09 4.094E-08 1.212E-03 6.387E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mononeuritis DOID_1802 1.772E-09 5.042E-08 6.489E-05 6.258E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP encephalomyelitis DOID_640 2.084E-09 5.646E-08 3.431E-08 1.952E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mononeuropathy DOID_1188 2.275E-09 5.884E-08 7.408E-05 6.69E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP astrocytoma DOID_3069 2.875E-09 7.113E-08 5.703E-08 2.318E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pancreatitis DOID_4989 7.446E-09 1.765E-07 1.314E-07 4.672E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP periodontal disease DOID_3388 8.581E-09 1.953E-07 2.47E-03 0.0110649 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP parasitic protozoa infectious disease DOID_2789 9.974E-09 2.183E-07 4.155E-06 9.456E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mitochondrial metabolism disease DOID_700 1.147E-08 2.416E-07 7.161E-05 6.572E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP IgA glomerulonephritis DOID_2986 1.283E-08 2.607E-07 0.01207956 0.03861389 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Goodpasture syndrome DOID_9808 1.7E-08 3.336E-07 2.604E-05 3.367E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP leukocyte disease DOID_9500 1.716E-08 3.254E-07 3.51E-07 1.051E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP intracranial thrombosis DOID_4193 2.42E-08 4.442E-07 1.866E-06 4.617E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP intracranial arterial disease DOID_13089 2.587E-08 4.601E-07 2.713E-04 2.058E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP cerebral arterial disease DOID_3527 2.587E-08 4.601E-07 2.713E-04 2.058E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP parasitic infectious disease DOID_1398 3.612E-08 6.228E-07 1.057E-05 1.823E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hypersensitivity reaction type I disease DOID_1205 4.12E-08 6.895E-07 7.381E-06 1.5E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP allergic contact dermatitis DOID_3042 4.555E-08 7.406E-07 4.555E-08 2.16E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP middle cerebral artery infarction DOID_3525 4.644E-08 7.34E-07 4.904E-05 5.366E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP brain infarction DOID_3454 5.102E-08 7.846E-07 1.358E-05 2.147E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP cerebral infarction DOID_3526 5.731E-08 8.582E-07 2.614E-05 3.306E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Sciatic Neuropathy DOID_11446 5.819E-08 8.49E-07 1.212E-03 6.447E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lesion of sciatic nerve DOID_12528 5.819E-08 8.49E-07 1.212E-03 6.447E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mononeuritis of lower limb DOID_9473 5.819E-08 8.49E-07 1.212E-03 6.447E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pleurisy DOID_10247 7.23E-08 1.028E-06 0.0200884 0.05922434 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP heart valve disease DOID_4079 7.679E-08 1.066E-06 3.197E-05 3.712E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hemolytic-uremic syndrome DOID_12554 8.068E-08 1.093E-06 5.924E-03 0.02160906 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hemolytic anemia DOID_583 8.846E-08 1.17E-06 5.248E-04 3.472E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP normocytic anemia DOID_720 8.846E-08 1.17E-06 5.248E-04 3.472E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bone resorption disease DOID_0080011 1.19E-07 1.539E-06 2.864E-04 2.116E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP osteoporosis DOID_11476 1.19E-07 1.539E-06 2.864E-04 2.116E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hemorrhagic disease DOID_2213 1.328E-07 1.679E-06 1.328E-07 4.445E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP atopic dermatitis DOID_3310 1.512E-07 1.871E-06 5.095E-05 5.47E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP contact dermatitis DOID_2773 1.595E-07 1.931E-06 1.595E-07 5.042E-06 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pneumoconiosis DOID_10316 2.712E-07 3.215E-06 0.23698833 0.36843268 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP primary immunodeficiency disease DOID_612 3.594E-07 4.174E-06 4.826E-06 1.056E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP multiple myeloma DOID_9538 4.397E-07 5.004E-06 1.054E-05 1.873E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mouth disease DOID_403 5.435E-07 6.064E-06 5.407E-03 0.02023981 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP sinusitis DOID_0050127 5.961E-07 6.523E-06 6.068E-04 3.753E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP paranasal sinus disease DOID_1352 5.961E-07 6.523E-06 6.068E-04 3.753E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP uterine disease DOID_345 6.665E-07 7.156E-06 1.414E-04 1.149E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP meningitis DOID_9471 7.485E-07 7.887E-06 6.898E-04 3.965E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP benign mesothelioma DOID_2645 7.891E-07 8.164E-06 7.891E-07 2.245E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP tooth disease DOID_1091 8.141E-07 8.272E-06 0.01459747 0.0451411 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP acute pancreatitis DOID_2913 9.301E-07 9.285E-06 3.082E-05 3.731E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP rheumatic disease DOID_1575 1.034E-06 1.015E-05 2.118E-05 3.013E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP scleroderma DOID_419 1.034E-06 1.015E-05 2.118E-05 3.013E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pancreatic ductal carcinoma DOID_3587 1.086E-06 1.047E-05 1.086E-06 2.943E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bronchiolitis DOID_2942 1.145E-06 1.086E-05 0.17307453 0.2913592 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP common cold DOID_10459 1.3E-06 1.212E-05 3.322E-03 0.01389691 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP peritonitis DOID_8283 1.3E-06 1.193E-05 7.999E-05 7.002E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP peripheral vascular disease DOID_341 1.307E-06 1.18E-05 1.864E-05 2.719E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP learning disability DOID_8927 1.339E-06 1.19E-05 2.614E-05 3.234E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pancreatic carcinoma DOID_4905 1.43E-06 1.252E-05 1.43E-06 3.7E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP myeloma DOID_0070004 1.713E-06 1.476E-05 3.197E-05 3.789E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP aneurysm disease DOID_2403 1.862E-06 1.581E-05 2.864E-04 2.089E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP female reproductive system disease DOID_229 2.601E-06 2.177E-05 3.603E-04 2.47E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP focal glomerulosclerosis DOID_3945 2.87E-06 2.367E-05 2.87E-06 6.804E-05 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP biliary tract cancer DOID_4607 3.054E-06 2.483E-05 4.023E-04 2.693E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP varicose veins DOID_799 3.522E-06 2.823E-05 5.209E-03 0.01989134 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bone marrow cancer DOID_4960 3.748E-06 2.962E-05 6.06E-05 6.05E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bronchiolitis obliterans DOID_2799 3.962E-06 3.088E-05 1.772E-03 8.843E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP integumentary system cancer DOID_0060122 4.155E-06 3.195E-05 8.562E-04 4.824E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP skin cancer DOID_4159 4.155E-06 3.195E-05 8.562E-04 4.824E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP vein disease DOID_866 4.669E-06 3.543E-05 5.924E-03 0.02120135 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP chronic leukemia DOID_1036 5.355E-06 4.009E-05 1.205E-04 1.023E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP chronic lymphocytic leukemia DOID_1040 5.355E-06 4.009E-05 1.205E-04 1.023E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lymphoblastic leukemia DOID_1037 6.428E-06 4.75E-05 7.125E-05 6.646E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP alcohol-related neurodevelopmental disorder DOID_0050667 6.891E-06 5.027E-05 6.891E-06 1.452E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Crohn's disease DOID_8778 6.891E-06 4.963E-05 7.554E-05 6.716E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP collagen disease DOID_854 7.42E-06 5.277E-05 1.059E-04 9.128E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP prion disease DOID_649 7.761E-06 5.452E-05 2.872E-04 2.043E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP eosinophilia DOID_999 7.761E-06 5.386E-05 7.761E-06 1.523E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP congenital heart defect DOID_1682 8.883E-06 6.09E-05 8.883E-06 1.63E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP temporal lobe epilepsy DOID_3328 1.151E-05 7.796E-05 0.0902168 0.19974069 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP blood platelet disease DOID_2218 1.193E-05 7.984E-05 1.193E-05 1.996E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hepatitis DOID_2237 1.346E-05 8.905E-05 1.346E-05 2.188E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP systemic scleroderma DOID_418 1.346E-05 8.803E-05 2.475E-04 1.929E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mitochondrial myopathy DOID_699 1.492E-05 9.648E-05 0.14228573 0.25459302 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lymphatic system disease DOID_75 1.514E-05 9.679E-05 2.713E-04 2.031E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pulmonary emphysema DOID_9675 1.698E-05 1.073E-04 1.698E-05 2.611E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP nephrosis DOID_2527 1.725E-05 1.079E-04 2.108E-04 1.666E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP male reproductive system disease DOID_48 1.725E-05 1.067E-04 0.01692509 0.05149935 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP neutropenia DOID_1227 1.813E-05 1.109E-04 5.305E-04 3.47E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP thrombophilia DOID_2452 1.813E-05 1.098E-04 1.813E-05 2.715E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP diabetic retinopathy DOID_8947 2.011E-05 1.205E-04 0.01816214 0.05439083 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP agranulocytosis DOID_12987 2.182E-05 1.294E-04 6.068E-04 3.713E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pulmonary embolism DOID_9477 2.182E-05 1.28E-04 6.068E-04 3.673E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP gallbladder cancer DOID_3121 2.356E-05 1.368E-04 3.832E-04 2.596E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP diabetic angiopathy DOID_11713 2.604E-05 1.497E-04 2.604E-05 3.446E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP proteinuria DOID_576 2.894E-05 1.647E-04 5.492E-03 0.02042627 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP metabolic syndrome X DOID_14221 3.106E-05 1.75E-04 3.081E-03 0.01308183 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP osteosarcoma DOID_3347 3.622E-05 2.02E-04 3.622E-05 4.122E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP focal epilepsy DOID_2234 3.81E-05 2.105E-04 0.12752281 0.23558597 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP autoimmune disease of gastrointestinal tract DOID_0060031 3.875E-05 2.12E-04 5.653E-04 3.614E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP integumentary system benign neoplasm DOID_0060121 3.875E-05 2.1E-04 5.653E-04 3.574E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP skin benign neoplasm DOID_3165 3.875E-05 2.1E-04 5.653E-04 3.574E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lung small cell carcinoma DOID_5409 3.875E-05 2.08E-04 5.653E-04 3.535E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP myositis DOID_633 4.227E-05 2.248E-04 0.17909885 0.29797441 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP retinal vascular disease DOID_2462 4.346E-05 2.29E-04 0.02584349 0.07208307 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP childhood type dermatomyositis DOID_14203 4.41E-05 2.302E-04 0.07047084 0.17821291 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP intracranial aneurysm DOID_10941 4.904E-05 2.537E-04 0.01762289 0.05333737 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP sarcoidosis DOID_11335 5.562E-05 2.851E-04 7.962E-03 0.02762272 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP perinatal necrotizing enterocolitis DOID_8677 5.656E-05 2.873E-04 5.656E-05 5.96E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP nervous system cancer DOID_3093 5.953E-05 2.998E-04 5.953E-05 6.159E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Human immunodeficiency virus infectious disease DOID_526 5.953E-05 2.971E-04 5.953E-05 6.049E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP dermatomyositis DOID_10223 6.031E-05 2.984E-04 0.07723979 0.18466151 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP malaria DOID_12365 6.489E-05 3.183E-04 6.489E-05 6.366E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lymphoma DOID_0060058 6.716E-05 3.266E-04 6.716E-05 6.369E-04 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mitochondrial encephalomyopathy DOID_890 7.999E-05 3.857E-04 0.08395962 0.18882619 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hypersensitivity reaction type IV disease DOID_2916 8.409E-05 4.021E-04 0.01006597 0.03291688 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP opportunistic mycosis DOID_2473 9.524E-05 4.516E-04 1.772E-03 8.921E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP carotid artery disease DOID_3407 1.059E-04 4.979E-04 1.239E-03 6.469E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP celiac disease DOID_10608 1.073E-04 5.005E-04 1.933E-03 9.4E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP viral pneumonia DOID_10533 1.309E-04 6.056E-04 1.309E-04 1.095E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP aspergillosis DOID_13564 1.309E-04 6.008E-04 1.309E-04 1.08E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP systemic mycosis DOID_0050136 1.348E-04 6.135E-04 2.282E-03 0.01081863 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP fungal infectious disease DOID_1564 1.348E-04 6.135E-04 2.282E-03 0.01081863 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP leukopenia DOID_615 1.502E-04 6.785E-04 2.47E-03 0.01097846 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP idiopathic pulmonary fibrosis DOID_0050156 1.628E-04 7.293E-04 5.209E-03 0.02044006 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP communication disorder DOID_2033 1.628E-04 7.236E-04 1.628E-04 1.304E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP intermediate coronary syndrome DOID_8805 1.628E-04 7.179E-04 5.209E-03 0.01975873 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pulmonary sarcoidosis DOID_13406 2.044E-04 8.945E-04 0.03435423 0.09308361 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP inherited blood coagulation disease DOID_2214 2.872E-04 1.248E-03 2.872E-04 2.069E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP endometriosis of uterus DOID_288 3.238E-04 1.396E-03 3.238E-04 2.275E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP leishmaniasis DOID_9065 3.392E-04 1.451E-03 0.12965277 0.23645008 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP nephrotic syndrome DOID_1184 3.526E-04 1.497E-03 4.598E-03 0.01829698 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP endometriosis DOID_289 3.526E-04 1.486E-03 3.526E-04 2.447E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pulmonary edema DOID_11396 3.97E-04 1.661E-03 9.203E-03 0.03062124 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP brain edema DOID_4724 3.97E-04 1.649E-03 9.203E-03 0.03044321 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Kawasaki disease DOID_13378 4.606E-04 1.899E-03 0.01012271 0.03272628 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lymphadenitis DOID_1602 4.606E-04 1.899E-03 0.01012271 0.03272628 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lymph node disease DOID_9942 4.606E-04 1.899E-03 0.01012271 0.03272628 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP vascular skin disease DOID_9540 4.864E-04 1.991E-03 5.812E-03 0.02133571 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP placenta disease DOID_780 5.305E-04 2.156E-03 0.14853353 0.26165814 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP amino acid metabolic disorder DOID_9252 5.506E-04 2.222E-03 5.506E-04 3.56E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP optic nerve disease DOID_1891 6.068E-04 2.432E-03 0.15473598 0.270076 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP polyarteritis nodosa DOID_9810 6.068E-04 2.415E-03 0.01207956 0.03818484 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lingual-facial-buccal dyskinesia DOID_9854 6.068E-04 2.398E-03 6.068E-04 3.635E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP calcium metabolism disease DOID_10575 6.08E-04 2.386E-03 0.05709326 0.14567741 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP aortic aneurysm DOID_3627 6.08E-04 2.37E-03 6.08E-04 3.604E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP movement disease DOID_480 6.08E-04 2.354E-03 6.08E-04 3.567E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP aortic valve disease DOID_62 6.898E-04 2.652E-03 6.898E-04 4.005E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP dilated cardiomyopathy DOID_12930 7.365E-04 2.812E-03 7.365E-04 4.19E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP sphingolipidosis DOID_1927 7.797E-04 2.957E-03 0.01418764 0.04435585 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bile duct adenocarcinoma DOID_4896 8.017E-04 3.021E-03 8.359E-03 0.02848177 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP cholangiocarcinoma DOID_4947 8.017E-04 3.021E-03 8.359E-03 0.02848177 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pustulosis of palm and sole DOID_4398 8.562E-04 3.205E-03 8.769E-03 0.02952263 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP reading disorder DOID_13365 8.766E-04 3.26E-03 8.766E-04 4.89E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP dyslexia DOID_4428 8.766E-04 3.26E-03 8.766E-04 4.89E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP combined T cell and B cell immunodeficiency DOID_628 8.766E-04 3.239E-03 8.766E-04 4.843E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hypertrophic cardiomyopathy DOID_11984 1.035E-03 3.801E-03 1.035E-03 5.665E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bile duct cancer DOID_4606 1.035E-03 3.776E-03 0.01006597 0.03272879 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bile duct carcinoma DOID_4897 1.035E-03 3.776E-03 0.01006597 0.03272879 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP oral cavity cancer DOID_8618 1.035E-03 3.752E-03 1.035E-03 5.611E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP fragments of torsion dystonia DOID_531 1.093E-03 3.935E-03 1.093E-03 5.866E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP extrinsic allergic alveolitis DOID_841 1.093E-03 3.91E-03 0.18507944 0.30348762 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP thrombocytopenia DOID_1588 1.34E-03 4.765E-03 1.34E-03 6.93E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP central nervous system hereditary degenerative disease DOID_481 1.34E-03 4.735E-03 1.34E-03 6.868E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mineral metabolism disease DOID_0050032 1.47E-03 5.162E-03 0.0858177 0.19074324 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP dystonic disease DOID_544 1.475E-03 5.15E-03 1.475E-03 7.496E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP cranial nerve disease DOID_5656 1.475E-03 5.119E-03 0.20276199 0.32407744 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hyperglycemia DOID_4195 1.639E-03 5.652E-03 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP abdominal aortic aneurysm DOID_7693 1.772E-03 6.073E-03 1.772E-03 8.766E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP endocrine organ benign neoplasm DOID_0060089 1.821E-03 6.206E-03 1.821E-03 8.934E-03 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP leber hereditary optic neuropathy DOID_705 1.838E-03 6.225E-03 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP allergic rhinitis DOID_4481 1.933E-03 6.507E-03 0.02542 0.07125112 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP autonomic nervous system neoplasm DOID_2621 2.103E-03 7.038E-03 2.103E-03 0.01005411 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP neuroblastoma DOID_769 2.103E-03 7.038E-03 2.103E-03 0.01005411 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP myocarditis DOID_820 2.282E-03 7.592E-03 2.282E-03 0.01072922 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP familial combined hyperlipidemia DOID_13809 2.287E-03 7.564E-03 2.287E-03 0.0106645 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP retinal vascular occlusion DOID_1729 2.287E-03 7.521E-03 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP acute kidney failure DOID_3021 2.287E-03 7.477E-03 2.287E-03 0.01057779 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP phagocyte bactericidal dysfunction DOID_3262 2.287E-03 7.435E-03 2.287E-03 0.01049249 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP chondrosarcoma DOID_3371 2.287E-03 7.392E-03 0.07047084 0.17433872 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP insulinoma DOID_3892 2.287E-03 7.351E-03 2.287E-03 0.01040855 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Paget's disease of bone DOID_5408 2.287E-03 7.309E-03 2.287E-03 0.01032594 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP cutaneous leishmaniasis DOID_9111 2.287E-03 7.269E-03 0.07047084 0.17062939 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP endogenous depression DOID_1595 2.57E-03 8.124E-03 0.11077727 0.21810473 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Charcot-Marie-Tooth disease type 4 DOID_0050541 2.781E-03 8.743E-03 2.781E-03 0.01226797 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP eosinophilic pneumonia DOID_5870 2.781E-03 8.695E-03 2.781E-03 0.01217361 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP chronic monocytic leukemia DOID_8593 2.781E-03 8.648E-03 2.781E-03 0.01208068 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP speech disorder DOID_92 2.781E-03 8.601E-03 2.781E-03 0.01198916 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pulmonary eosinophilia DOID_9498 2.781E-03 8.695E-03 2.781E-03 0.01217361 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Loeffler syndrome DOID_9503 2.781E-03 8.695E-03 2.781E-03 0.01217361 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP adenoma DOID_657 2.874E-03 8.839E-03 2.874E-03 0.01229504 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lipid metabolism disorder DOID_3146 3.081E-03 9.425E-03 0.02216767 0.06370405 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP calcinosis DOID_182 3.09E-03 9.403E-03 0.03435423 0.09264246 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP peripheral nervous system neoplasm DOID_1192 3.317E-03 0.01003779 3.317E-03 0.01397855 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP osteopetrosis DOID_13533 3.322E-03 1E-02 3.322E-03 0.01379547 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP islet cell tumor DOID_1799 3.322E-03 9.947E-03 3.322E-03 0.01369551 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP ocular hypertension DOID_9282 3.322E-03 9.895E-03 0.08395962 0.18808278 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP borderline glaucoma DOID_9283 3.322E-03 9.895E-03 0.08395962 0.18808278 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP encephalitis DOID_9588 3.322E-03 9.844E-03 0.08395962 0.1873452 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP alcohol abuse DOID_1574 3.506E-03 0.01033778 3.506E-03 0.0143539 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mental depression DOID_1596 3.506E-03 0.01028449 0.12752281 0.23635335 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP respiratory syncytial virus infectious disease DOID_1273 3.553E-03 0.01036634 0.03756558 0.10082459 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP peptic ulcer DOID_750 3.553E-03 0.01031345 0.03756558 0.10035123 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP polyneuropathy DOID_1389 3.907E-03 0.01128382 0.0906307 0.19682774 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP monocytic leukemia DOID_8527 3.907E-03 0.01122683 3.907E-03 0.01587795 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Legionnaires' disease DOID_10457 4.536E-03 0.01296977 4.536E-03 0.01830485 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP legionellosis DOID_10458 4.536E-03 0.01296977 4.536E-03 0.01830485 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP bacterial meningitis DOID_9470 4.536E-03 0.01290492 4.536E-03 0.01817594 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Huntington's disease DOID_12858 4.598E-03 0.01301725 4.598E-03 0.01816991 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP peripheral neuropathy DOID_0060053 5.209E-03 0.01467232 5.209E-03 0.02030006 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP thoracic aortic aneurysm DOID_14004 5.209E-03 0.01460005 5.209E-03 0.02016197 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP arthropathy DOID_381 5.209E-03 0.01452848 5.209E-03 0.02002574 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lung oat cell carcinoma DOID_5411 5.209E-03 0.01445761 0.10382798 0.21024243 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hyperhomocysteinemia DOID_9279 5.209E-03 0.01438742 5.209E-03 0.01962788 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP pre-eclampsia DOID_10591 5.812E-03 0.01597601 0.05147298 0.13373573 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP brain cancer DOID_1319 5.812E-03 0.01589921 5.812E-03 0.02147425 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP silicosis DOID_10325 5.924E-03 0.01612925 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP restrictive cardiomyopathy DOID_397 5.924E-03 0.01605245 5.924E-03 0.02147143 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP tongue cancer DOID_8649 5.924E-03 0.01597637 5.924E-03 0.02133553 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP central nervous system cancer DOID_3620 6.142E-03 0.01648613 6.142E-03 0.02184413 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP glaucoma DOID_1686 6.484E-03 0.01732088 0.05519677 0.14147281 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hyperostosis DOID_205 6.682E-03 0.01776741 6.682E-03 0.02361631 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP B-cell lymphocytic neoplasm DOID_707 7.2E-03 0.01905543 7.2E-03 0.02528962 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP skin carcinoma DOID_3451 7.482E-03 0.01970868 0.12326694 0.22996356 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP osteosclerosis DOID_4254 7.482E-03 0.01961785 7.482E-03 0.02611702 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP ureteral obstruction DOID_5199 7.482E-03 0.01952786 0.12326694 0.22921205 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP dissociative disorder DOID_10935 8.322E-03 0.0216219 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP dissociative amnesia DOID_11037 8.322E-03 0.0216219 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Down syndrome DOID_14250 8.322E-03 0.02152362 8.322E-03 0.02869816 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP MHC class II deficiency DOID_5812 8.322E-03 0.02142623 8.322E-03 0.02852528 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP vasculitis DOID_865 8.359E-03 0.02142548 8.359E-03 0.02831224 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP smallpox DOID_8736 8.769E-03 0.02237365 8.769E-03 0.02934897 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP amnestic disorder DOID_10914 9.203E-03 0.02337604 1.000 1.000 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP amyloidosis DOID_9120 9.203E-03 0.02327214 9.203E-03 0.03026724 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP autoimmune hepatitis DOID_2048 0.01012271 0.02548595 0.14228573 0.25620437 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Leigh disease DOID_3652 0.01012271 0.02537368 0.01012271 0.03254138 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP melancholia DOID_2848 0.01052184 0.02625846 0.36452988 0.52644036 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP neurotic disorder DOID_4964 0.01098951 0.02730582 0.36916382 0.53178281 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hepatitis B DOID_2043 0.01108193 0.02741574 0.14853353 0.26328841 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP uremia DOID_4676 0.01207956 0.02975442 0.01207956 0.03839817 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP urinary tract obstruction DOID_5200 0.01207956 0.02962617 0.15473598 0.26842919 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP sleep disorder DOID_535 0.01207956 0.02949902 0.15473598 0.2676133 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hypoglycemia DOID_9993 0.01207956 0.02937296 0.15473598 0.26680235 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP endocrine pancreas disease DOID_1428 0.01297915 0.03142611 0.38736528 0.55519105 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP ureteral disease DOID_1426 0.013115 0.03162048 0.16089342 0.27574806 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP congenital hemolytic anemia DOID_589 0.013115 0.03148706 0.013115 0.04122891 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP severe combined immunodeficiency DOID_627 0.01418764 0.03391918 0.01418764 0.04411347 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP commensal bacterial infectious disease DOID_0050339 0.01529689 0.03641811 0.01529689 0.04704826 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP portal hypertension DOID_10762 0.01529689 0.03626637 0.17307453 0.29396838 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP urticaria DOID_1555 0.01529689 0.03611589 0.17307453 0.29309348 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hypogonadism DOID_1924 0.01529689 0.03596665 0.17307453 0.29222376 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP ankylosing spondylitis DOID_7147 0.01644217 0.03850038 0.01644217 0.05029888 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP B cell deficiency DOID_2115 0.01762289 0.041096 0.01762289 0.05305516 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP diffuse large B-cell lymphoma DOID_0050745 0.01883849 0.04375143 0.01883849 0.05612095 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP gestational diabetes DOID_11714 0.01883849 0.04357358 0.01883849 0.05582865 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP renal hypertension DOID_1073 0.0200884 0.04627651 0.0200884 0.05891906 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP secondary hypertension DOID_11130 0.0200884 0.04627651 0.0200884 0.05891906 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP sarcoma DOID_1115 0.0200884 0.04608991 0.0200884 0.05861691 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hepatic vascular disease DOID_272 0.0200884 0.04590481 0.1969107 0.32196031 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP mixed glioma DOID_5076 0.02078336 0.04730292 0.02078336 0.06033536 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP toxic encephalopathy DOID_3602 0.02137205 0.04844899 0.02137205 0.06172943 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP endometrial carcinoma DOID_2871 0.0226889 0.0512301 0.0226889 0.06487429 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP chromosomal disease DOID_0080014 0.02287826 0.05145348 0.02287826 0.06508865 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP spastic cerebral palsy DOID_0050669 0.0240384 0.05384979 0.21433743 0.33877222 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP gonadal disease DOID_2277 0.0240384 0.05363862 0.21433743 0.33783379 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP Charcot-Marie-Tooth disease DOID_10595 0.02542 0.05649991 0.02542 0.07196009 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP endometrial cancer DOID_1380 0.02542 0.05628007 0.02542 0.07160385 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP hepatitis C DOID_1883 0.0297521 0.06561607 0.0297521 0.08258022 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP thyroid carcinoma DOID_3963 0.0297521 0.06536272 0.0297521 0.08217934 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP spindle cell carcinoma DOID_4015 0.0297521 0.06511133 0.0297521 0.08178234 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP lymphoid leukemia DOID_10747 0.03125683 0.06814227 0.03125683 0.08550545 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP carbohydrate metabolic disorder DOID_2978 0.03236153 0.07028134 0.1523664 0.26758174 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP thyroid cancer DOID_1781 0.03279104 0.07094335 0.03279104 0.08927321 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP uveitis DOID_13141 0.03594591 0.07747433 0.2589885 0.39088715 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP congenital diaphragmatic hernia DOID_3827 0.03756558 0.08065967 0.26438906 0.39798247 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP adenoid cystic carcinoma DOID_4866 0.03921274 0.08387988 0.03921274 0.10426191 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP autoimmune disease of urogenital tract DOID_0060049 0.04258764 0.09075793 0.04258764 0.11270868 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP primary biliary cirrhosis DOID_12236 0.04258764 0.09075793 0.04258764 0.11270868 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP salivary gland cancer DOID_8850 0.04258764 0.09041928 0.04258764 0.11218688 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP uveal disease DOID_3480 0.04431442 0.09373571 0.28560194 0.42541231 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP diabetic autonomic neuropathy DOID_11503 0.04606681 0.09708153 0.04606681 0.12079269 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP autonomic neuropathy DOID_11504 0.04606681 0.09708153 0.04606681 0.12079269 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP diabetic polyneuropathy DOID_12785 0.04606681 0.09708153 0.04606681 0.12079269 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP uterine cancer DOID_363 0.04606681 0.0967233 0.04606681 0.1202386 FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP diabetic neuropathy DOID_9743 0.04606681 0.09708153 0.04606681 0.12079269 KORKOLA_TERATOMA_UP aspergillosis DOID_13564 4.552E-06 2.59E-03 3.319E-03 0.37770427 KORKOLA_TERATOMA_UP opportunistic mycosis DOID_2473 2.635E-05 7.497E-03 7.808E-03 0.29617349 KORKOLA_TERATOMA_UP germinoma DOID_3304 2.799E-05 5.31E-03 2.799E-05 0.0159286 KORKOLA_TERATOMA_UP systemic mycosis DOID_0050136 3.143E-05 4.471E-03 8.515E-03 0.30280889 KORKOLA_TERATOMA_UP fungal infectious disease DOID_1564 3.143E-05 4.471E-03 8.515E-03 0.30280889 KORKOLA_TERATOMA_UP embryonal cancer DOID_688 3.889E-05 4.426E-03 3.889E-05 0.01106518 HELLER_SILENCED_BY_METHYLATION_UP brain infarction DOID_3454 1.025E-14 5.834E-12 2.326E-04 7.785E-03 HELLER_SILENCED_BY_METHYLATION_UP systemic mycosis DOID_0050136 2.728E-14 7.763E-12 1.58E-05 1.499E-03 HELLER_SILENCED_BY_METHYLATION_UP fungal infectious disease DOID_1564 2.728E-14 7.763E-12 1.58E-05 1.499E-03 HELLER_SILENCED_BY_METHYLATION_UP sarcoidosis DOID_11335 3.814E-14 7.234E-12 0.02321581 0.16721258 HELLER_SILENCED_BY_METHYLATION_UP hypersensitivity reaction type IV disease DOID_2916 9.489E-14 1.35E-11 0.02721588 0.18218627 HELLER_SILENCED_BY_METHYLATION_UP primary bacterial infectious disease DOID_0050338 1.371E-13 1.56E-11 0.05400188 0.25186121 HELLER_SILENCED_BY_METHYLATION_UP collagen disease DOID_854 1.577E-13 1.495E-11 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP Human immunodeficiency virus infectious disease DOID_526 1.996E-13 1.623E-11 6.248E-04 0.01481356 HELLER_SILENCED_BY_METHYLATION_UP encephalomyelitis DOID_640 2.869E-13 2.04E-11 7.559E-03 0.07168006 HELLER_SILENCED_BY_METHYLATION_UP opportunistic mycosis DOID_2473 1.018E-12 6.435E-11 1.109E-05 1.262E-03 HELLER_SILENCED_BY_METHYLATION_UP aneurysm disease DOID_2403 1.421E-12 8.087E-11 2.138E-05 1.52E-03 HELLER_SILENCED_BY_METHYLATION_UP contact dermatitis DOID_2773 2.088E-12 1.08E-10 2.196E-09 1.25E-06 HELLER_SILENCED_BY_METHYLATION_UP funisitis DOID_0050698 3.232E-12 1.532E-10 2.055E-06 3.897E-04 HELLER_SILENCED_BY_METHYLATION_UP myasthenia gravis DOID_437 4.629E-12 2.026E-10 4.174E-03 0.05397373 HELLER_SILENCED_BY_METHYLATION_UP systemic scleroderma DOID_418 8.381E-12 3.406E-10 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP hypersensitivity reaction type I disease DOID_1205 1.163E-11 4.413E-10 7.623E-04 0.01735103 HELLER_SILENCED_BY_METHYLATION_UP neuromuscular junction disease DOID_439 1.654E-11 5.88E-10 5.727E-03 0.06389754 HELLER_SILENCED_BY_METHYLATION_UP rheumatic disease DOID_1575 1.827E-11 6.114E-10 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP scleroderma DOID_419 1.827E-11 6.114E-10 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP tuberculosis DOID_399 1.905E-11 6.022E-10 0.03597034 0.22741249 HELLER_SILENCED_BY_METHYLATION_UP peripheral vascular disease DOID_341 3.167E-11 9.486E-10 0.03973666 0.24576262 HELLER_SILENCED_BY_METHYLATION_UP autoimmune disease of the nervous system DOID_438 3.751E-11 1.067E-09 7.04E-03 0.07027328 HELLER_SILENCED_BY_METHYLATION_UP autoimmune disease of endocrine system DOID_0060005 4.828E-11 1.308E-09 7.505E-03 0.07362259 HELLER_SILENCED_BY_METHYLATION_UP bacterial pneumonia DOID_874 5.745E-11 1.486E-09 0.28579111 0.66645549 HELLER_SILENCED_BY_METHYLATION_UP aortic aneurysm DOID_3627 6.053E-11 1.497E-09 1.454E-03 0.02585461 HELLER_SILENCED_BY_METHYLATION_UP myocarditis DOID_820 1.506E-10 3.57E-09 4.669E-04 0.01207566 HELLER_SILENCED_BY_METHYLATION_UP pulmonary sarcoidosis DOID_13406 3.317E-10 7.548E-09 0.0122823 0.11093058 HELLER_SILENCED_BY_METHYLATION_UP ulcerative colitis DOID_8577 4.388E-10 9.604E-09 6.653E-05 2.524E-03 HELLER_SILENCED_BY_METHYLATION_UP urticaria DOID_1555 1.063E-09 2.24E-08 0.1035478 0.37055783 HELLER_SILENCED_BY_METHYLATION_UP cerebral infarction DOID_3526 1.274E-09 2.588E-08 0.01737882 0.13734092 HELLER_SILENCED_BY_METHYLATION_UP ankylosing spondylitis DOID_7147 1.362E-09 2.673E-08 5.727E-03 0.06266874 HELLER_SILENCED_BY_METHYLATION_UP vascular skin disease DOID_9540 1.716E-09 3.254E-08 0.0187708 0.14240778 HELLER_SILENCED_BY_METHYLATION_UP middle cerebral artery infarction DOID_3525 1.728E-09 3.171E-08 0.11105677 0.37171353 HELLER_SILENCED_BY_METHYLATION_UP bronchiolitis obliterans DOID_2799 4.992E-09 8.876E-08 0.12955686 0.39847488 HELLER_SILENCED_BY_METHYLATION_UP thyroiditis DOID_7166 5.126E-09 8.839E-08 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP autoimmune thyroiditis DOID_7188 5.126E-09 8.839E-08 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP celiac disease DOID_10608 6.041E-09 1.011E-07 8.98E-03 0.08376307 HELLER_SILENCED_BY_METHYLATION_UP lymphoma DOID_0060058 6.574E-09 1.069E-07 4.949E-05 2.166E-03 HELLER_SILENCED_BY_METHYLATION_UP multiple myeloma DOID_9538 1.689E-08 2.669E-07 0.15481592 0.4360904 HELLER_SILENCED_BY_METHYLATION_UP allergic contact dermatitis DOID_3042 1.919E-08 2.952E-07 5.2E-07 1.479E-04 HELLER_SILENCED_BY_METHYLATION_UP uveitis DOID_13141 1.971E-08 2.952E-07 0.1583644 0.44171247 HELLER_SILENCED_BY_METHYLATION_UP pancreatic ductal carcinoma DOID_3587 2.582E-08 3.766E-07 2.589E-04 8.183E-03 HELLER_SILENCED_BY_METHYLATION_UP adult respiratory distress syndrome DOID_11394 2.654E-08 3.776E-07 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP intracranial arterial disease DOID_13089 2.654E-08 3.684E-07 0.16541699 0.45913302 HELLER_SILENCED_BY_METHYLATION_UP cerebral arterial disease DOID_3527 2.654E-08 3.684E-07 0.16541699 0.45913302 HELLER_SILENCED_BY_METHYLATION_UP pancreatic carcinoma DOID_4905 3.428E-08 4.643E-07 3.022E-04 8.597E-03 HELLER_SILENCED_BY_METHYLATION_UP endometriosis of uterus DOID_288 3.522E-08 4.66E-07 0.01537786 0.12867652 HELLER_SILENCED_BY_METHYLATION_UP endometriosis DOID_289 4.036E-08 5.219E-07 0.0160331 0.13032619 HELLER_SILENCED_BY_METHYLATION_UP uveal disease DOID_3480 4.036E-08 5.103E-07 0.17588592 0.48114947 HELLER_SILENCED_BY_METHYLATION_UP influenza DOID_8469 4.611E-08 5.703E-07 0.17934648 0.48364051 HELLER_SILENCED_BY_METHYLATION_UP myeloma DOID_0070004 6.753E-08 8.175E-07 0.18964176 0.5066017 HELLER_SILENCED_BY_METHYLATION_UP autoimmune disease of gastrointestinal tract DOID_0060031 8.592E-08 1.019E-06 0.02020819 0.1512955 HELLER_SILENCED_BY_METHYLATION_UP pulmonary tuberculosis DOID_2957 8.592E-08 9.977E-07 0.19643388 0.50347241 HELLER_SILENCED_BY_METHYLATION_UP primary immunodeficiency disease DOID_612 1.204E-07 1.37E-06 4.236E-05 2.191E-03 HELLER_SILENCED_BY_METHYLATION_UP encephalitis DOID_9588 1.437E-07 1.603E-06 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP bone marrow cancer DOID_4960 1.505E-07 1.647E-06 0.21316767 0.53198423 HELLER_SILENCED_BY_METHYLATION_UP vasculitis DOID_865 1.505E-07 1.616E-06 0.02399478 0.17066286 HELLER_SILENCED_BY_METHYLATION_UP Crohn's disease DOID_8778 1.742E-07 1.836E-06 5.475E-05 2.225E-03 HELLER_SILENCED_BY_METHYLATION_UP bile duct cancer DOID_4606 2.272E-07 2.35E-06 2.18E-03 0.03352272 HELLER_SILENCED_BY_METHYLATION_UP bile duct carcinoma DOID_4897 2.272E-07 2.35E-06 2.18E-03 0.03352272 HELLER_SILENCED_BY_METHYLATION_UP abdominal aortic aneurysm DOID_7693 2.629E-07 2.672E-06 0.12955686 0.39633255 HELLER_SILENCED_BY_METHYLATION_UP respiratory failure DOID_11162 3.333E-07 3.327E-06 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP parasitic infectious disease DOID_1398 4.371E-07 4.288E-06 2.971E-03 0.04025298 HELLER_SILENCED_BY_METHYLATION_UP uterine disease DOID_345 4.371E-07 4.215E-06 0.03324249 0.2149429 HELLER_SILENCED_BY_METHYLATION_UP juvenile rheumatoid arthritis DOID_676 6.795E-07 6.444E-06 0.06896985 0.28437567 HELLER_SILENCED_BY_METHYLATION_UP prion disease DOID_649 8.708E-07 8.122E-06 2.559E-03 0.03733444 HELLER_SILENCED_BY_METHYLATION_UP respiratory syncytial virus infectious disease DOID_1273 9.142E-07 8.39E-06 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP bone resorption disease DOID_0080011 1.069E-06 9.651E-06 3.505E-04 9.496E-03 HELLER_SILENCED_BY_METHYLATION_UP osteoporosis DOID_11476 1.069E-06 9.651E-06 3.505E-04 9.496E-03 HELLER_SILENCED_BY_METHYLATION_UP pancreatitis DOID_4989 1.151E-06 1.024E-05 0.04464394 0.25150895 HELLER_SILENCED_BY_METHYLATION_UP membranous glomerulonephritis DOID_10976 1.37E-06 1.199E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP female reproductive system disease DOID_229 1.431E-06 1.234E-05 0.04769036 0.24668922 HELLER_SILENCED_BY_METHYLATION_UP biliary tract cancer DOID_4607 1.647E-06 1.399E-05 5.56E-03 0.06456493 HELLER_SILENCED_BY_METHYLATION_UP familial hypercholesterolemia DOID_13810 2.055E-06 1.719E-05 3.821E-03 0.05056511 HELLER_SILENCED_BY_METHYLATION_UP neuritis DOID_1803 2.216E-06 1.828E-05 0.0187708 0.14630937 HELLER_SILENCED_BY_METHYLATION_UP giant cell tumor DOID_200 3.915E-06 3.183E-05 0.20984885 0.52833626 HELLER_SILENCED_BY_METHYLATION_UP malignant giant cell tumor DOID_2705 3.915E-06 3.183E-05 0.20984885 0.52833626 HELLER_SILENCED_BY_METHYLATION_UP giant cell glioblastoma DOID_3074 3.915E-06 3.183E-05 0.20984885 0.52833626 HELLER_SILENCED_BY_METHYLATION_UP bronchiolitis DOID_2942 4.144E-06 3.321E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP bile duct adenocarcinoma DOID_4896 4.277E-06 3.38E-05 1.794E-03 0.02835595 HELLER_SILENCED_BY_METHYLATION_UP cholangiocarcinoma DOID_4947 4.277E-06 3.38E-05 1.794E-03 0.02835595 HELLER_SILENCED_BY_METHYLATION_UP parasitic protozoa infectious disease DOID_2789 4.665E-06 3.636E-05 0.02478437 0.17197937 HELLER_SILENCED_BY_METHYLATION_UP pustulosis of palm and sole DOID_4398 4.665E-06 3.587E-05 0.02478437 0.16990733 HELLER_SILENCED_BY_METHYLATION_UP myositis DOID_633 4.849E-06 3.679E-05 0.10731013 0.37231379 HELLER_SILENCED_BY_METHYLATION_UP familial hyperlipidemia DOID_1168 5.08E-06 3.803E-05 0.02558449 0.17330445 HELLER_SILENCED_BY_METHYLATION_UP intracranial aneurysm DOID_10941 5.639E-06 4.167E-05 2.196E-04 7.808E-03 HELLER_SILENCED_BY_METHYLATION_UP extrinsic allergic alveolitis DOID_841 5.639E-06 4.114E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP glioblastoma DOID_3068 5.996E-06 4.318E-05 0.22630501 0.55265043 HELLER_SILENCED_BY_METHYLATION_UP invasive ductal carcinoma DOID_3008 7.498E-06 5.333E-05 2.704E-04 8.099E-03 HELLER_SILENCED_BY_METHYLATION_UP neuroectodermal tumor DOID_171 7.607E-06 5.344E-05 7.607E-06 1.082E-03 HELLER_SILENCED_BY_METHYLATION_UP Sjogren's syndrome DOID_12894 8.501E-06 5.899E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP angioedema DOID_1558 8.501E-06 5.828E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP pre-malignant neoplasm DOID_0060071 8.856E-06 5.999E-05 2.73E-03 0.03882839 HELLER_SILENCED_BY_METHYLATION_UP in situ carcinoma DOID_8719 8.856E-06 5.999E-05 2.73E-03 0.03882839 HELLER_SILENCED_BY_METHYLATION_UP temporal arteritis DOID_13375 1.165E-05 7.801E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP central nervous system vasculitis DOID_525 1.165E-05 7.801E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP allergic rhinitis DOID_4481 1.252E-05 8.287E-05 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP astrocytoma DOID_3069 1.359E-05 8.886E-05 0.26131946 0.61954488 HELLER_SILENCED_BY_METHYLATION_UP pneumoconiosis DOID_10316 1.766E-05 1.142E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP esophageal disease DOID_6050 1.766E-05 1.129E-04 0.14408106 0.42258825 HELLER_SILENCED_BY_METHYLATION_UP diabetic retinopathy DOID_8947 1.77E-05 1.119E-04 0.27365769 0.64078693 HELLER_SILENCED_BY_METHYLATION_UP medullomyoblastoma DOID_3861 1.968E-05 1.23E-04 1.968E-05 1.599E-03 HELLER_SILENCED_BY_METHYLATION_UP adult medulloblastoma DOID_3864 1.968E-05 1.23E-04 1.968E-05 1.599E-03 HELLER_SILENCED_BY_METHYLATION_UP childhood medulloblastoma DOID_3869 1.968E-05 1.23E-04 1.968E-05 1.599E-03 HELLER_SILENCED_BY_METHYLATION_UP medulloblastoma DOID_3858 2.42E-05 1.497E-04 2.42E-05 1.53E-03 HELLER_SILENCED_BY_METHYLATION_UP aspergillosis DOID_13564 2.547E-05 1.558E-04 1.539E-03 0.02575295 HELLER_SILENCED_BY_METHYLATION_UP narcolepsy DOID_8986 2.547E-05 1.542E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP bacterial meningitis DOID_9470 2.547E-05 1.526E-04 0.05715187 0.25809057 HELLER_SILENCED_BY_METHYLATION_UP metabolic syndrome X DOID_14221 2.562E-05 1.518E-04 5.031E-03 0.06090782 HELLER_SILENCED_BY_METHYLATION_UP lipid metabolism disorder DOID_3146 2.562E-05 1.503E-04 0.04666659 0.24360815 HELLER_SILENCED_BY_METHYLATION_UP chromosomal disease DOID_0080014 2.717E-05 1.577E-04 2.717E-05 1.546E-03 HELLER_SILENCED_BY_METHYLATION_UP chronic kidney failure DOID_784 3.049E-05 1.752E-04 5.56E-03 0.06327363 HELLER_SILENCED_BY_METHYLATION_UP thoracic aortic aneurysm DOID_14004 3.174E-05 1.806E-04 0.06110766 0.27164266 HELLER_SILENCED_BY_METHYLATION_UP adrenal cortex disease DOID_3952 3.174E-05 1.788E-04 0.06110766 0.26143053 HELLER_SILENCED_BY_METHYLATION_UP retinal vascular disease DOID_2462 3.411E-05 1.903E-04 0.30654189 0.70616331 HELLER_SILENCED_BY_METHYLATION_UP cervix uteri carcinoma in situ DOID_8991 3.548E-05 1.96E-04 0.01473452 0.12513344 HELLER_SILENCED_BY_METHYLATION_UP pulmonary emphysema DOID_9675 3.548E-05 1.941E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP autoimmune disease of urogenital tract DOID_0060049 3.882E-05 2.104E-04 9.026E-04 0.01771013 HELLER_SILENCED_BY_METHYLATION_UP primary biliary cirrhosis DOID_12236 3.882E-05 2.104E-04 9.026E-04 0.01771013 HELLER_SILENCED_BY_METHYLATION_UP primitive neuroectodermal tumor DOID_168 4.238E-05 2.275E-04 4.238E-05 2.009E-03 HELLER_SILENCED_BY_METHYLATION_UP uterine cancer DOID_363 4.617E-05 2.455E-04 0.01670012 0.13383617 HELLER_SILENCED_BY_METHYLATION_UP adrenal gland disease DOID_9553 4.714E-05 2.484E-04 0.06896985 0.28031316 HELLER_SILENCED_BY_METHYLATION_UP lymphoblastic leukemia DOID_1037 5.207E-05 2.718E-04 0.06058988 0.27146173 HELLER_SILENCED_BY_METHYLATION_UP proteinuria DOID_576 5.449E-05 2.818E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP pre-eclampsia DOID_10591 5.903E-05 3.026E-04 0.18964176 0.50423441 HELLER_SILENCED_BY_METHYLATION_UP B-cell lymphocytic neoplasm DOID_707 8.002E-05 4.065E-04 0.02169013 0.16028165 HELLER_SILENCED_BY_METHYLATION_UP hepatitis B DOID_2043 1.051E-04 5.294E-04 0.08834025 0.33510401 HELLER_SILENCED_BY_METHYLATION_UP uremia DOID_4676 1.205E-04 6.016E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP sleep disorder DOID_535 1.205E-04 5.964E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP diabetic angiopathy DOID_11713 1.373E-04 6.736E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP meningitis DOID_9471 1.373E-04 6.679E-04 0.0959758 0.35461188 HELLER_SILENCED_BY_METHYLATION_UP toxic shock syndrome DOID_14115 1.556E-04 7.502E-04 0.09976971 0.36625138 HELLER_SILENCED_BY_METHYLATION_UP carotid artery disease DOID_3407 1.556E-04 7.44E-04 0.23601476 0.56903559 HELLER_SILENCED_BY_METHYLATION_UP commensal bacterial infectious disease DOID_0050339 1.753E-04 8.313E-04 0.1035478 0.37290314 HELLER_SILENCED_BY_METHYLATION_UP cystitis DOID_1679 1.966E-04 9.247E-04 0.10731013 0.37925131 HELLER_SILENCED_BY_METHYLATION_UP cholestasis DOID_13580 1.969E-04 9.182E-04 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP vitiligo DOID_12306 2.196E-04 1.016E-03 0.11105677 0.37839102 HELLER_SILENCED_BY_METHYLATION_UP B cell deficiency DOID_2115 2.196E-04 1.007E-03 0.11105677 0.37391301 HELLER_SILENCED_BY_METHYLATION_UP autoimmune disease of cardiovascular system DOID_0060051 2.704E-04 1.231E-03 7.04E-03 0.07152816 HELLER_SILENCED_BY_METHYLATION_UP pleurisy DOID_10247 2.704E-04 1.221E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP renal hypertension DOID_1073 2.704E-04 1.212E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP secondary hypertension DOID_11130 2.704E-04 1.212E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP malaria DOID_12365 2.704E-04 1.202E-03 0.11850323 0.38095106 HELLER_SILENCED_BY_METHYLATION_UP Behcet's disease DOID_13241 2.704E-04 1.231E-03 7.04E-03 0.07152816 HELLER_SILENCED_BY_METHYLATION_UP nephrosis DOID_2527 2.728E-04 1.203E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP bile duct disease DOID_4138 2.728E-04 1.194E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP male reproductive system disease DOID_48 2.728E-04 1.185E-03 0.26751439 0.62899044 HELLER_SILENCED_BY_METHYLATION_UP biliary tract disease DOID_9741 2.872E-04 1.238E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP toxic encephalopathy DOID_3602 2.985E-04 1.277E-03 7.505E-03 0.07237475 HELLER_SILENCED_BY_METHYLATION_UP corneal disease DOID_10124 3.284E-04 1.394E-03 0.12588771 0.39574644 HELLER_SILENCED_BY_METHYLATION_UP syndrome DOID_225 3.338E-04 1.407E-03 0.04265508 0.24270739 HELLER_SILENCED_BY_METHYLATION_UP mixed glioma DOID_5076 3.677E-04 1.538E-03 4.696E-03 0.05808726 HELLER_SILENCED_BY_METHYLATION_UP pleural disease DOID_1532 4.293E-04 1.783E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP bladder disease DOID_365 4.293E-04 1.77E-03 0.13684931 0.40768199 HELLER_SILENCED_BY_METHYLATION_UP bone development disease DOID_0080006 4.842E-04 1.982E-03 5.744E-03 0.06166176 HELLER_SILENCED_BY_METHYLATION_UP hepatitis C DOID_1883 5.065E-04 2.059E-03 0.01057349 0.0970374 HELLER_SILENCED_BY_METHYLATION_UP nephroblastoma DOID_2154 5.065E-04 2.044E-03 5.065E-04 0.01253125 HELLER_SILENCED_BY_METHYLATION_UP periodontal disease DOID_3388 5.065E-04 2.03E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP macular degeneration DOID_4448 5.065E-04 2.016E-03 0.14408106 0.42477783 HELLER_SILENCED_BY_METHYLATION_UP lymphoid leukemia DOID_10747 5.483E-04 2.166E-03 0.14767431 0.4265314 HELLER_SILENCED_BY_METHYLATION_UP transitional cell carcinoma DOID_2671 5.751E-04 2.257E-03 6.514E-03 0.06863315 HELLER_SILENCED_BY_METHYLATION_UP mouth disease DOID_403 7.333E-04 2.858E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP Gilles de la Tourette syndrome DOID_11119 7.694E-04 2.978E-03 7.694E-04 0.01683804 HELLER_SILENCED_BY_METHYLATION_UP phagocyte bactericidal dysfunction DOID_3262 7.694E-04 2.958E-03 7.694E-04 0.01621441 HELLER_SILENCED_BY_METHYLATION_UP chondrosarcoma DOID_3371 7.694E-04 2.938E-03 0.04116237 0.24654093 HELLER_SILENCED_BY_METHYLATION_UP keratitis DOID_4677 7.694E-04 2.919E-03 0.04116237 0.24145761 HELLER_SILENCED_BY_METHYLATION_UP Paget's disease of bone DOID_5408 7.694E-04 2.899E-03 7.694E-04 0.01563533 HELLER_SILENCED_BY_METHYLATION_UP Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.694E-04 2.88E-03 0.04116237 0.23899376 HELLER_SILENCED_BY_METHYLATION_UP Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.694E-04 2.88E-03 0.04116237 0.23899376 HELLER_SILENCED_BY_METHYLATION_UP Hodgkin's granuloma DOID_8651 7.694E-04 2.88E-03 0.04116237 0.23899376 HELLER_SILENCED_BY_METHYLATION_UP Hodgkin's lymphoma, mixed cellularity DOID_8654 7.694E-04 2.88E-03 0.04116237 0.23899376 HELLER_SILENCED_BY_METHYLATION_UP adenoid cystic carcinoma DOID_4866 7.898E-04 2.937E-03 0.01410318 0.12345705 HELLER_SILENCED_BY_METHYLATION_UP lymphatic system disease DOID_75 7.898E-04 2.918E-03 0.01410318 0.12158649 HELLER_SILENCED_BY_METHYLATION_UP salivary gland cancer DOID_8850 9.026E-04 3.314E-03 0.01537786 0.12681164 HELLER_SILENCED_BY_METHYLATION_UP maturity-onset diabetes of the young DOID_0050524 9.378E-04 3.421E-03 9.378E-04 0.01778674 HELLER_SILENCED_BY_METHYLATION_UP trypanosomiasis DOID_10113 9.378E-04 3.399E-03 0.04518483 0.25206046 HELLER_SILENCED_BY_METHYLATION_UP pneumocystosis DOID_11339 9.378E-04 3.377E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP prediabetes syndrome DOID_11716 9.378E-04 3.356E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP common variable immunodeficiency DOID_12177 9.378E-04 3.335E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP bronchiectasis DOID_9563 9.378E-04 3.314E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP diabetic autonomic neuropathy DOID_11503 1.025E-03 3.601E-03 0.17934648 0.48826865 HELLER_SILENCED_BY_METHYLATION_UP autonomic neuropathy DOID_11504 1.025E-03 3.601E-03 0.17934648 0.48826865 HELLER_SILENCED_BY_METHYLATION_UP diabetic polyneuropathy DOID_12785 1.025E-03 3.601E-03 0.17934648 0.48826865 HELLER_SILENCED_BY_METHYLATION_UP gallbladder cancer DOID_3121 1.025E-03 3.579E-03 0.17934648 0.48594356 HELLER_SILENCED_BY_METHYLATION_UP diabetic neuropathy DOID_9743 1.025E-03 3.601E-03 0.17934648 0.48826865 HELLER_SILENCED_BY_METHYLATION_UP tic disorder DOID_2769 1.122E-03 3.894E-03 1.122E-03 0.02059871 HELLER_SILENCED_BY_METHYLATION_UP stomach disease DOID_76 1.122E-03 3.87E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP Hodgkin's lymphoma DOID_8567 1.122E-03 3.847E-03 0.04919052 0.24552109 HELLER_SILENCED_BY_METHYLATION_UP autonomic nervous system disease DOID_11465 1.228E-03 4.183E-03 0.18964176 0.49956557 HELLER_SILENCED_BY_METHYLATION_UP berylliosis DOID_10322 1.323E-03 4.48E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP osteogenesis imperfecta DOID_12347 1.323E-03 4.453E-03 0.05317951 0.25215949 HELLER_SILENCED_BY_METHYLATION_UP lung small cell carcinoma DOID_5409 1.376E-03 4.605E-03 0.19643388 0.50121469 HELLER_SILENCED_BY_METHYLATION_UP movement disease DOID_480 1.454E-03 4.838E-03 1.454E-03 0.02507114 HELLER_SILENCED_BY_METHYLATION_UP viral pneumonia DOID_10533 1.539E-03 5.091E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP atopic dermatitis DOID_3310 1.618E-03 5.323E-03 0.02244756 0.16375205 HELLER_SILENCED_BY_METHYLATION_UP Williams-Beuren syndrome DOID_1928 1.771E-03 5.79E-03 1.771E-03 0.02878656 HELLER_SILENCED_BY_METHYLATION_UP communication disorder DOID_2033 1.771E-03 5.757E-03 0.06110766 0.2695369 HELLER_SILENCED_BY_METHYLATION_UP membranoproliferative glomerulonephritis DOID_2920 1.771E-03 5.725E-03 0.06110766 0.26542183 HELLER_SILENCED_BY_METHYLATION_UP mesenchymal cell neoplasm DOID_3350 1.771E-03 5.692E-03 0.06110766 0.26341106 HELLER_SILENCED_BY_METHYLATION_UP spindle cell sarcoma DOID_4235 1.771E-03 5.692E-03 0.06110766 0.26341106 HELLER_SILENCED_BY_METHYLATION_UP lung oat cell carcinoma DOID_5411 1.771E-03 5.66E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP epithelioid sarcoma DOID_6193 1.771E-03 5.692E-03 0.06110766 0.26341106 HELLER_SILENCED_BY_METHYLATION_UP osteochondrodysplasia DOID_2256 1.886E-03 5.996E-03 0.02478437 0.17410257 HELLER_SILENCED_BY_METHYLATION_UP silicosis DOID_10325 2.018E-03 6.379E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP hemolytic-uremic syndrome DOID_12554 2.018E-03 6.344E-03 0.06504697 0.2762069 HELLER_SILENCED_BY_METHYLATION_UP oral cavity cancer DOID_8618 2.18E-03 6.815E-03 0.02721588 0.18006783 HELLER_SILENCED_BY_METHYLATION_UP hyperostosis DOID_205 2.281E-03 7.092E-03 2.281E-03 0.03415332 HELLER_SILENCED_BY_METHYLATION_UP bronchitis DOID_6132 2.281E-03 7.053E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP urinary system benign neoplasm DOID_731 2.281E-03 7.015E-03 0.06896985 0.28232981 HELLER_SILENCED_BY_METHYLATION_UP leukocyte disease DOID_9500 2.284E-03 6.986E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP eosinophilia DOID_999 2.559E-03 7.786E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP hypothyroidism DOID_1459 2.613E-03 7.91E-03 0.23922436 0.57434034 HELLER_SILENCED_BY_METHYLATION_UP Down syndrome DOID_14250 2.852E-03 8.587E-03 2.852E-03 0.03958226 HELLER_SILENCED_BY_METHYLATION_UP agammaglobulinemia DOID_2583 2.852E-03 8.541E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP hyperglycemia DOID_4195 3.097E-03 9.226E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP brain edema DOID_4724 3.16E-03 9.366E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP blood protein disease DOID_620 3.16E-03 9.317E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP tooth disease DOID_1091 3.226E-03 9.461E-03 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP endocrine organ benign neoplasm DOID_0060089 3.358E-03 9.797E-03 0.03597034 0.22996768 HELLER_SILENCED_BY_METHYLATION_UP autoimmune hepatitis DOID_2048 3.483E-03 0.01011262 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP blood coagulation disease DOID_1247 3.632E-03 0.01048916 0.2644234 0.62430255 HELLER_SILENCED_BY_METHYLATION_UP sinusitis DOID_0050127 4.174E-03 0.01199416 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP paranasal sinus disease DOID_1352 4.174E-03 0.01199416 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP cystic fibrosis DOID_1485 4.375E-03 0.0125089 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP endogenous depression DOID_1595 4.375E-03 0.01244635 0.04265508 0.24515898 HELLER_SILENCED_BY_METHYLATION_UP Goodpasture syndrome DOID_9808 4.541E-03 0.01285391 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP electroclinical syndrome DOID_0050701 4.696E-03 0.01322779 4.696E-03 0.05937809 HELLER_SILENCED_BY_METHYLATION_UP spastic quadriplegia DOID_10970 4.922E-03 0.01379607 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP acute pancreatitis DOID_2913 4.922E-03 0.01372844 0.09976971 0.36390361 HELLER_SILENCED_BY_METHYLATION_UP osteosarcoma DOID_3347 5.318E-03 0.01475937 5.318E-03 0.06303482 HELLER_SILENCED_BY_METHYLATION_UP mental depression DOID_1596 5.56E-03 0.01535768 0.04976237 0.244093 HELLER_SILENCED_BY_METHYLATION_UP cleft lip DOID_9296 5.727E-03 0.01574287 0.10731013 0.37005734 HELLER_SILENCED_BY_METHYLATION_UP diffuse large B-cell lymphoma DOID_0050745 6.588E-03 0.01802306 6.588E-03 0.06815994 HELLER_SILENCED_BY_METHYLATION_UP Sciatic Neuropathy DOID_11446 6.588E-03 0.01793683 0.11478778 0.38195466 HELLER_SILENCED_BY_METHYLATION_UP gestational diabetes DOID_11714 6.588E-03 0.01785141 0.11478778 0.37973399 HELLER_SILENCED_BY_METHYLATION_UP lesion of sciatic nerve DOID_12528 6.588E-03 0.01793683 0.11478778 0.38195466 HELLER_SILENCED_BY_METHYLATION_UP periodontitis DOID_824 6.588E-03 0.01776681 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP mononeuritis of lower limb DOID_9473 6.588E-03 0.01793683 0.11478778 0.38195466 HELLER_SILENCED_BY_METHYLATION_UP amino acid metabolic disorder DOID_9252 6.715E-03 0.01802314 0.05616803 0.25983424 HELLER_SILENCED_BY_METHYLATION_UP nervous system cancer DOID_3093 6.92E-03 0.01848693 0.32099601 0.73647874 HELLER_SILENCED_BY_METHYLATION_UP sarcoma DOID_1115 7.04E-03 0.01871765 0.11850323 0.38311556 HELLER_SILENCED_BY_METHYLATION_UP mononeuritis DOID_1802 7.04E-03 0.01863059 0.11850323 0.37881089 HELLER_SILENCED_BY_METHYLATION_UP coronary stenosis DOID_4248 7.04E-03 0.01854434 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP mononeuropathy DOID_1188 7.505E-03 0.01967793 0.12220319 0.38845593 HELLER_SILENCED_BY_METHYLATION_UP alcohol-related neurodevelopmental disorder DOID_0050667 7.779E-03 0.02030312 0.33234342 0.75945142 HELLER_SILENCED_BY_METHYLATION_UP endometrial carcinoma DOID_2871 7.983E-03 0.02074123 0.12588771 0.39142134 HELLER_SILENCED_BY_METHYLATION_UP spastic cerebral palsy DOID_0050669 8.475E-03 0.02191893 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP age related macular degeneration DOID_10871 8.475E-03 0.02181975 0.12955686 0.40064051 HELLER_SILENCED_BY_METHYLATION_UP degeneration of macula and posterior pole DOID_2007 8.475E-03 0.02181975 0.12955686 0.40064051 HELLER_SILENCED_BY_METHYLATION_UP endometrial cancer DOID_1380 8.98E-03 0.02301598 0.13321071 0.40533098 HELLER_SILENCED_BY_METHYLATION_UP chronic leukemia DOID_1036 9.498E-03 0.02423503 0.13684931 0.41418755 HELLER_SILENCED_BY_METHYLATION_UP chronic lymphocytic leukemia DOID_1040 9.498E-03 0.02423503 0.13684931 0.41418755 HELLER_SILENCED_BY_METHYLATION_UP autonomic nervous system neoplasm DOID_2621 9.498E-03 0.02412684 0.13684931 0.40982769 HELLER_SILENCED_BY_METHYLATION_UP neuroblastoma DOID_769 9.498E-03 0.02412684 0.13684931 0.40982769 HELLER_SILENCED_BY_METHYLATION_UP papilloma DOID_2615 0.01002933 0.02536307 0.14047274 0.41629683 HELLER_SILENCED_BY_METHYLATION_UP calcinosis DOID_182 0.0122823 0.03092313 0.15481592 0.43826001 HELLER_SILENCED_BY_METHYLATION_UP peripheral nervous system neoplasm DOID_1192 0.01287696 0.03227748 0.1583644 0.44388839 HELLER_SILENCED_BY_METHYLATION_UP hepatitis DOID_2237 0.01348395 0.03365074 0.01348395 0.11988077 HELLER_SILENCED_BY_METHYLATION_UP congenital diaphragmatic hernia DOID_3827 0.01348395 0.0335038 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP peptic ulcer DOID_750 0.01348395 0.03335813 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP benign mesothelioma DOID_2645 0.01473452 0.03629412 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP Huntington's disease DOID_12858 0.0160331 0.03932256 0.17588592 0.48582082 HELLER_SILENCED_BY_METHYLATION_UP idiopathic generalized epilepsy DOID_1827 0.0160331 0.03915379 0.17588592 0.48347386 HELLER_SILENCED_BY_METHYLATION_UP thyroid adenoma DOID_2891 0.0187708 0.04564352 0.18964176 0.49726342 HELLER_SILENCED_BY_METHYLATION_UP heart valve disease DOID_4079 0.0187708 0.04544929 0.0187708 0.14433221 HELLER_SILENCED_BY_METHYLATION_UP hemolytic anemia DOID_583 0.01948387 0.04697594 0.19304492 0.5015642 HELLER_SILENCED_BY_METHYLATION_UP normocytic anemia DOID_720 0.01948387 0.04697594 0.19304492 0.5015642 HELLER_SILENCED_BY_METHYLATION_UP integumentary system benign neoplasm DOID_0060121 0.02020819 0.0485167 0.19643388 0.50804943 HELLER_SILENCED_BY_METHYLATION_UP glaucoma DOID_1686 0.02020819 0.04831285 0.19643388 0.50575057 HELLER_SILENCED_BY_METHYLATION_UP skin benign neoplasm DOID_3165 0.02020819 0.0485167 0.19643388 0.50804943 HELLER_SILENCED_BY_METHYLATION_UP calcium metabolism disease DOID_10575 0.02094364 0.04986164 0.19980869 0.50754975 HELLER_SILENCED_BY_METHYLATION_UP hemorrhagic disease DOID_2213 0.02169013 0.05142369 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP orofacial cleft DOID_0050567 0.02244756 0.05299859 0.20651612 0.52225631 HELLER_SILENCED_BY_METHYLATION_UP atrophic muscular disease DOID_913 0.02321581 0.05458592 0.20984885 0.52600879 HELLER_SILENCED_BY_METHYLATION_UP muscular dystrophy DOID_9884 0.02321581 0.05458592 0.20984885 0.52600879 HELLER_SILENCED_BY_METHYLATION_UP integumentary system cancer DOID_0060122 0.02478437 0.05803419 0.21647264 0.53553449 HELLER_SILENCED_BY_METHYLATION_UP skin cancer DOID_4159 0.02478437 0.05803419 0.21647264 0.53553449 HELLER_SILENCED_BY_METHYLATION_UP congenital nervous system abnormality DOID_2490 0.02639502 0.06155233 0.22304125 0.5470279 HELLER_SILENCED_BY_METHYLATION_UP hypertrophic cardiomyopathy DOID_11984 0.02721588 0.06320748 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP melancholia DOID_2848 0.02804695 0.06487282 0.22955514 0.55819178 HELLER_SILENCED_BY_METHYLATION_UP neurotic disorder DOID_4964 0.02888814 0.06654798 0.23279171 0.56365311 HELLER_SILENCED_BY_METHYLATION_UP congenital heart defect DOID_1682 0.03147146 0.07220669 0.03147146 0.20583058 HELLER_SILENCED_BY_METHYLATION_UP mineral metabolism disease DOID_0050032 0.03235216 0.07392922 0.24560341 0.5871779 HELLER_SILENCED_BY_METHYLATION_UP temporal lobe epilepsy DOID_3328 0.03414236 0.07770801 0.25192931 0.5997815 HELLER_SILENCED_BY_METHYLATION_UP DiGeorge syndrome DOID_11198 0.03712307 0.08415549 0.03712307 0.23212119 HELLER_SILENCED_BY_METHYLATION_UP velocardiofacial syndrome DOID_12583 0.03712307 0.08415549 0.03712307 0.23212119 HELLER_SILENCED_BY_METHYLATION_UP gallbladder disease DOID_0000000 0.04116237 0.09294202 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP T cell deficiency DOID_11200 0.04116237 0.09257466 0.04116237 0.25184289 HELLER_SILENCED_BY_METHYLATION_UP facioscapulohumeral muscular dystrophy DOID_11727 0.04116237 0.09221019 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP familial combined hyperlipidemia DOID_13809 0.04116237 0.09184858 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP retinal vascular occlusion DOID_1729 0.04116237 0.0914898 0.04116237 0.24916371 HELLER_SILENCED_BY_METHYLATION_UP transient cerebral ischemia DOID_224 0.04116237 0.09113381 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP progressive muscular atrophy DOID_318 0.04116237 0.09078058 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP labyrinthine disease DOID_4539 0.04116237 0.09043007 0.04116237 0.2439728 HELLER_SILENCED_BY_METHYLATION_UP acute T cell leukemia DOID_5603 0.04116237 0.09008226 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP breast benign neoplasm DOID_0060082 0.04518483 0.09850639 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP thoracic benign neoplasm DOID_0060097 0.04518483 0.09850639 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP nervous system benign neoplasm DOID_0060115 0.04518483 0.09813041 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP dermatomyositis DOID_10223 0.04518483 0.09775729 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP sickle cell anemia DOID_10923 0.04518483 0.097387 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP obsessive-compulsive disorder DOID_10933 0.04518483 0.0970195 0.04518483 0.24961327 HELLER_SILENCED_BY_METHYLATION_UP migraine without aura DOID_12783 0.04518483 0.09665476 0.04518483 0.24721315 HELLER_SILENCED_BY_METHYLATION_UP neuronal ceroid lipofuscinosis DOID_14503 0.04518483 0.09629276 0.04518483 0.24485874 HELLER_SILENCED_BY_METHYLATION_UP benign breast phyllodes tumor DOID_1631 0.04518483 0.09850639 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP craniosynostosis DOID_2340 0.04518483 0.09593346 0.04518483 0.24254875 HELLER_SILENCED_BY_METHYLATION_UP inner ear disease DOID_2952 0.04518483 0.09557683 0.04518483 0.24028194 HELLER_SILENCED_BY_METHYLATION_UP invasive lobular carcinoma DOID_3457 0.04518483 0.09522284 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP chronic monocytic leukemia DOID_8593 0.04518483 0.09487147 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP speech disorder DOID_92 0.04518483 0.09452267 0.04518483 0.2380571 HELLER_SILENCED_BY_METHYLATION_UP retinal detachment DOID_5327 0.04919052 0.09996216 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP ocular hypertension DOID_9282 0.04919052 0.09960642 1.000 1.000 HELLER_SILENCED_BY_METHYLATION_UP borderline glaucoma DOID_9283 0.04919052 0.09960642 1.000 1.000 SCHEIDEREIT_IKK_TARGETS pre-malignant neoplasm DOID_0060071 1.127E-08 6.412E-06 3.089E-04 0.05858214 SCHEIDEREIT_IKK_TARGETS in situ carcinoma DOID_8719 1.127E-08 6.412E-06 3.089E-04 0.05858214 SCHEIDEREIT_IKK_TARGETS lymphoma DOID_0060058 4.737E-08 1.348E-05 6.573E-06 3.74E-03 SCHEIDEREIT_IKK_TARGETS invasive lobular carcinoma DOID_3457 8.02E-06 1.521E-03 1.000 1.000 SCHEIDEREIT_IKK_TARGETS encephalitis DOID_9588 9.622E-06 1.369E-03 9.622E-06 2.737E-03 SCHEIDEREIT_IKK_TARGETS angiosarcoma DOID_0001816 1.748E-05 1.989E-03 1.000 1.000 SCHEIDEREIT_IKK_TARGETS colon carcinoma DOID_1520 2.765E-05 2.622E-03 1.000 1.000 SCHEIDEREIT_IKK_TARGETS sarcoma DOID_1115 6.316E-05 5.134E-03 1.000 1.000 SCHEIDEREIT_IKK_TARGETS papilloma DOID_2615 9.134E-05 6.497E-03 1.000 1.000 SCHEIDEREIT_IKK_TARGETS multiple myeloma DOID_9538 1.13E-04 7.143E-03 0.01571306 0.37253055 SCHEIDEREIT_IKK_TARGETS cervix uteri carcinoma in situ DOID_8991 1.369E-04 7.79E-03 0.01727163 0.36398361 SCHEIDEREIT_IKK_TARGETS myeloma DOID_0070004 1.77E-04 9.158E-03 0.01960516 0.33804052 SCHEIDEREIT_IKK_TARGETS brain cancer DOID_1319 1.77E-04 8.395E-03 0.01960516 0.32809815 SCHEIDEREIT_IKK_TARGETS central nervous system cancer DOID_3620 1.842E-04 8.063E-03 0.01999358 0.32503849 SCHEIDEREIT_IKK_TARGETS integumentary system benign neoplasm DOID_0060121 1.915E-04 7.785E-03 0.02038186 0.32214655 SCHEIDEREIT_IKK_TARGETS skin benign neoplasm DOID_3165 1.915E-04 7.785E-03 0.02038186 0.32214655 SCHEIDEREIT_IKK_TARGETS B-cell lymphocytic neoplasm DOID_707 2.066E-04 7.838E-03 0.02115798 0.31681284 SCHEIDEREIT_IKK_TARGETS bone marrow cancer DOID_4960 2.303E-04 8.19E-03 0.02232108 0.32565881 SCHEIDEREIT_IKK_TARGETS reproductive organ benign neoplasm DOID_0050622 2.385E-04 7.981E-03 0.02270849 0.32302831 SCHEIDEREIT_IKK_TARGETS chronic kidney failure DOID_784 5.118E-04 0.01617966 5.118E-04 0.07280848 SCHEIDEREIT_IKK_TARGETS transitional cell carcinoma DOID_2671 5.735E-04 0.01717618 1.000 1.000 SCHEIDEREIT_IKK_TARGETS nervous system cancer DOID_3093 5.992E-04 0.01704702 0.03579565 0.36370935 SCHEIDEREIT_IKK_TARGETS alcohol-related neurodevelopmental disorder DOID_0050667 6.521E-04 0.01766965 0.03732451 0.35996013 SCHEIDEREIT_IKK_TARGETS hyperparathyroidism DOID_13543 3.95E-03 0.0977212 1.000 1.000 SCHEIDEREIT_IKK_TARGETS teratoma DOID_3307 3.95E-03 0.09364948 1.000 1.000 SCHEIDEREIT_IKK_TARGETS malignant teratoma DOID_5563 3.95E-03 0.09364948 1.000 1.000 SCHEIDEREIT_IKK_TARGETS mature teratoma DOID_5566 3.95E-03 0.09364948 1.000 1.000 SCHEIDEREIT_IKK_TARGETS Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 3.95E-03 0.0899035 3.95E-03 0.37459793 SCHEIDEREIT_IKK_TARGETS Hodgkin's lymphoma, lymphocytic depletion DOID_8628 3.95E-03 0.0899035 3.95E-03 0.37459793 SCHEIDEREIT_IKK_TARGETS Hodgkin's granuloma DOID_8651 3.95E-03 0.0899035 3.95E-03 0.37459793 SCHEIDEREIT_IKK_TARGETS Hodgkin's lymphoma, mixed cellularity DOID_8654 3.95E-03 0.0899035 3.95E-03 0.37459793 SCHEIDEREIT_IKK_TARGETS breast benign neoplasm DOID_0060082 4.344E-03 0.09507269 1.000 1.000 SCHEIDEREIT_IKK_TARGETS thoracic benign neoplasm DOID_0060097 4.344E-03 0.09507269 1.000 1.000 SCHEIDEREIT_IKK_TARGETS benign breast phyllodes tumor DOID_1631 4.344E-03 0.09507269 1.000 1.000 SCHEIDEREIT_IKK_TARGETS Hodgkin's lymphoma DOID_8567 4.738E-03 0.09985591 4.738E-03 0.38515851 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN nutritional deficiency disease DOID_5113 1.326E-05 7.545E-03 5.526E-03 0.62886005 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN autoimmune disease of the nervous system DOID_438 5.476E-05 0.01557965 1.000 1.000 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN pulmonary tuberculosis DOID_2957 1.662E-04 0.03151408 0.01903584 0.49233592 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN sarcoidosis DOID_11335 1.928E-04 0.02742689 0.0204861 0.48569137 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN hypersensitivity reaction type IV disease DOID_2916 2.289E-04 0.02604587 0.02229614 0.48794242 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN tuberculosis DOID_399 3.101E-04 0.02941147 0.0259069 0.50831117 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN metabolic syndrome X DOID_14221 4.135E-04 0.0336128 0.02986442 0.51493508 IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN primary bacterial infectious disease DOID_0050338 4.869E-04 0.03462942 0.03237507 0.49787613 LEE_LIVER_CANCER_CIPROFIBRATE_UP allergic contact dermatitis DOID_3042 2.987E-08 1.7E-05 1.95E-06 2.774E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP metabolic syndrome X DOID_14221 6.658E-08 1.894E-05 3.679E-06 4.186E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP contact dermatitis DOID_2773 6.658E-08 1.263E-05 3.679E-06 3.488E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP diabetic autonomic neuropathy DOID_11503 3.875E-07 5.512E-05 3.875E-07 2.205E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP autonomic neuropathy DOID_11504 3.875E-07 5.512E-05 3.875E-07 2.205E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP diabetic polyneuropathy DOID_12785 3.875E-07 5.512E-05 3.875E-07 2.205E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP diabetic neuropathy DOID_9743 3.875E-07 5.512E-05 3.875E-07 2.205E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP autonomic nervous system disease DOID_11465 4.99E-07 5.678E-05 4.99E-07 1.42E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP carotid artery disease DOID_3407 1.359E-06 1.289E-04 1.359E-06 2.577E-04 LEE_LIVER_CANCER_CIPROFIBRATE_UP cerebral infarction DOID_3526 3.165E-05 2.573E-03 1.706E-03 0.06067136 LEE_LIVER_CANCER_CIPROFIBRATE_UP brain infarction DOID_3454 1.025E-04 7.289E-03 3.689E-03 0.09542287 LEE_LIVER_CANCER_CIPROFIBRATE_UP nephrosis DOID_2527 1.159E-04 7.328E-03 4E-03 0.09484485 LEE_LIVER_CANCER_CIPROFIBRATE_UP carotid stenosis DOID_13001 1.214E-04 6.905E-03 1.214E-04 9.864E-03 LEE_LIVER_CANCER_CIPROFIBRATE_UP diabetic angiopathy DOID_11713 4.256E-04 0.02201522 4.256E-04 0.03027093 LEE_LIVER_CANCER_CIPROFIBRATE_UP gestational diabetes DOID_11714 6.235E-04 0.02956634 6.235E-04 0.03942179 LEE_LIVER_CANCER_CIPROFIBRATE_UP papilloma DOID_2615 9.621E-04 0.04211102 9.621E-04 0.05474433 LEE_LIVER_CANCER_CIPROFIBRATE_UP myocarditis DOID_820 9.621E-04 0.03910309 9.621E-04 0.04976757 LEE_LIVER_CANCER_CIPROFIBRATE_UP hepatitis DOID_2237 1.309E-03 0.04963728 1.309E-03 0.0620466 LEE_LIVER_CANCER_CIPROFIBRATE_UP adenoid cystic carcinoma DOID_4866 1.371E-03 0.0487656 1.371E-03 0.0600192 LEE_LIVER_CANCER_CIPROFIBRATE_UP salivary gland cancer DOID_8850 1.501E-03 0.0502379 1.501E-03 0.06100317 LEE_LIVER_CANCER_CIPROFIBRATE_UP nephrotic syndrome DOID_1184 1.568E-03 0.0495636 1.568E-03 0.05947632 LEE_LIVER_CANCER_CIPROFIBRATE_UP giant cell tumor DOID_200 2.314E-03 0.0693045 2.314E-03 0.07745797 LEE_LIVER_CANCER_CIPROFIBRATE_UP malignant giant cell tumor DOID_2705 2.314E-03 0.0693045 2.314E-03 0.07745797 LEE_LIVER_CANCER_CIPROFIBRATE_UP giant cell glioblastoma DOID_3074 2.314E-03 0.0693045 2.314E-03 0.07745797 LEE_LIVER_CANCER_CIPROFIBRATE_UP atrophic muscular disease DOID_913 2.314E-03 0.06583928 2.314E-03 0.07315475 LEE_LIVER_CANCER_CIPROFIBRATE_UP muscular dystrophy DOID_9884 2.314E-03 0.06583928 2.314E-03 0.07315475 LEE_LIVER_CANCER_CIPROFIBRATE_UP vasculitis DOID_865 2.396E-03 0.06493188 0.06971862 0.47226063 LEE_LIVER_CANCER_CIPROFIBRATE_UP pustulosis of palm and sole DOID_4398 2.48E-03 0.06414233 2.48E-03 0.07427006 LEE_LIVER_CANCER_CIPROFIBRATE_UP glioblastoma DOID_3068 2.739E-03 0.06775921 2.739E-03 0.07792309 LEE_LIVER_CANCER_CIPROFIBRATE_UP oral cavity cancer DOID_8618 2.739E-03 0.06493591 2.739E-03 0.07421247 LEE_LIVER_CANCER_CIPROFIBRATE_UP hyperglycemia DOID_4195 3.489E-03 0.07940279 0.08377783 0.51814769 LEE_LIVER_CANCER_CIPROFIBRATE_UP astrocytoma DOID_3069 3.792E-03 0.08298255 3.792E-03 0.09380636 LEE_LIVER_CANCER_CIPROFIBRATE_UP blood coagulation disease DOID_1247 3.895E-03 0.082094 0.08841784 0.54096507 LEE_LIVER_CANCER_CIPROFIBRATE_UP peripheral vascular disease DOID_341 4.107E-03 0.0834557 4.107E-03 0.09347038 LEE_LIVER_CANCER_CIPROFIBRATE_UP lipid metabolism disorder DOID_3146 4.887E-03 0.09589083 4.887E-03 0.10695515 SANA_TNF_SIGNALING_DN pre-eclampsia DOID_10591 3.495E-07 1.988E-04 1.557E-03 0.17713484 SANA_TNF_SIGNALING_DN pancreatic ductal carcinoma DOID_3587 1.62E-06 4.608E-04 8.571E-05 0.04876879 SANA_TNF_SIGNALING_DN pancreatic carcinoma DOID_4905 1.905E-06 3.612E-04 9.664E-05 0.02749477 SANA_TNF_SIGNALING_DN coronary stenosis DOID_4248 5.793E-06 8.241E-04 0.03425162 0.4236776 SANA_TNF_SIGNALING_DN giant cell tumor DOID_200 3.873E-05 4.407E-03 1.948E-03 0.184752 SANA_TNF_SIGNALING_DN malignant giant cell tumor DOID_2705 3.873E-05 4.407E-03 1.948E-03 0.184752 SANA_TNF_SIGNALING_DN giant cell glioblastoma DOID_3074 3.873E-05 4.407E-03 1.948E-03 0.184752 SANA_TNF_SIGNALING_DN glioblastoma DOID_3068 5.008E-05 4.749E-03 2.307E-03 0.16405251 SANA_TNF_SIGNALING_DN astrocytoma DOID_3069 8.225E-05 6.686E-03 3.196E-03 0.16530146 SANA_TNF_SIGNALING_DN bone resorption disease DOID_0080011 1.084E-04 7.713E-03 3.832E-03 0.1677346 SANA_TNF_SIGNALING_DN osteoporosis DOID_11476 1.084E-04 7.713E-03 3.832E-03 0.1677346 SANA_TNF_SIGNALING_DN contact dermatitis DOID_2773 1.212E-04 7.66E-03 4.122E-03 0.16751666 SANA_TNF_SIGNALING_DN biliary tract cancer DOID_4607 1.348E-04 7.67E-03 4.421E-03 0.15722023 SANA_TNF_SIGNALING_DN renovascular hypertension DOID_1591 1.369E-04 7.082E-03 1.000 1.000 SANA_TNF_SIGNALING_DN hemangioma DOID_255 1.369E-04 6.492E-03 0.01727163 0.3931023 SANA_TNF_SIGNALING_DN mesenchymal cell neoplasm DOID_3350 1.369E-04 5.992E-03 1.000 1.000 SANA_TNF_SIGNALING_DN spindle cell sarcoma DOID_4235 1.369E-04 5.992E-03 1.000 1.000 SANA_TNF_SIGNALING_DN epithelioid sarcoma DOID_6193 1.369E-04 5.992E-03 1.000 1.000 SANA_TNF_SIGNALING_DN ureteral obstruction DOID_5199 1.99E-04 8.09E-03 0.0206908 0.37977637 SANA_TNF_SIGNALING_DN glycogen metabolism disorder DOID_0050728 3.279E-04 0.0124397 0.02636361 0.42859695 SANA_TNF_SIGNALING_DN glycogen storage disease DOID_2747 3.279E-04 0.0124397 0.02636361 0.42859695 SANA_TNF_SIGNALING_DN uremia DOID_4676 3.279E-04 0.01166222 1.000 1.000 SANA_TNF_SIGNALING_DN urinary tract obstruction DOID_5200 3.279E-04 0.0109762 0.02636361 0.41669148 SANA_TNF_SIGNALING_DN pulmonary embolism DOID_9477 3.279E-04 0.01036641 0.02636361 0.40542954 SANA_TNF_SIGNALING_DN diabetic angiopathy DOID_11713 3.575E-04 0.01070571 1.000 1.000 SANA_TNF_SIGNALING_DN ureteral disease DOID_1426 3.575E-04 0.01017043 0.02749431 0.40113492 SANA_TNF_SIGNALING_DN myositis DOID_633 4.536E-04 0.01229099 4.536E-04 0.08603693 SANA_TNF_SIGNALING_DN renal hypertension DOID_1073 5.609E-04 0.01450791 1.000 1.000 SANA_TNF_SIGNALING_DN secondary hypertension DOID_11130 5.609E-04 0.01450791 1.000 1.000 SANA_TNF_SIGNALING_DN sarcoma DOID_1115 5.609E-04 0.01387713 1.000 1.000 SANA_TNF_SIGNALING_DN bronchiolitis obliterans DOID_2799 6.794E-04 0.01610647 1.000 1.000 SANA_TNF_SIGNALING_DN blood platelet disease DOID_2218 1.049E-03 0.02387211 0.04652104 0.50904753 SANA_TNF_SIGNALING_DN pulmonary emphysema DOID_9675 1.207E-03 0.02642255 1.000 1.000 SANA_TNF_SIGNALING_DN autoimmune disease of urogenital tract DOID_0060049 1.263E-03 0.02660777 1.263E-03 0.17960247 SANA_TNF_SIGNALING_DN primary biliary cirrhosis DOID_12236 1.263E-03 0.02660777 1.263E-03 0.17960247 SANA_TNF_SIGNALING_DN hyperinsulinism DOID_2018 1.319E-03 0.026804 0.05204757 0.54842712 SANA_TNF_SIGNALING_DN hemorrhagic disease DOID_2213 1.813E-03 0.03557137 0.06082496 0.55821613 SANA_TNF_SIGNALING_DN bile duct adenocarcinoma DOID_4896 2.018E-03 0.03826588 2.018E-03 0.16399662 SANA_TNF_SIGNALING_DN cholangiocarcinoma DOID_4947 2.018E-03 0.03826588 2.018E-03 0.16399662 SANA_TNF_SIGNALING_DN bile duct cancer DOID_4606 2.307E-03 0.04233613 2.307E-03 0.14582446 SANA_TNF_SIGNALING_DN bile duct carcinoma DOID_4897 2.307E-03 0.04233613 2.307E-03 0.14582446 SANA_TNF_SIGNALING_DN collagen disease DOID_854 2.535E-03 0.04508207 0.07168506 0.61801212 SANA_TNF_SIGNALING_DN pre-malignant neoplasm DOID_0060071 2.694E-03 0.04644488 0.07384231 0.61788637 SANA_TNF_SIGNALING_DN in situ carcinoma DOID_8719 2.694E-03 0.04644488 0.07384231 0.61788637 SANA_TNF_SIGNALING_DN endocrine pancreas disease DOID_1428 2.774E-03 0.04643174 0.07491909 0.61781107 SANA_TNF_SIGNALING_DN allergic contact dermatitis DOID_3042 3.024E-03 0.04915822 3.024E-03 0.17205378 SANA_TNF_SIGNALING_DN blood coagulation disease DOID_1247 3.283E-03 0.0518934 0.08135416 0.6519791 SANA_TNF_SIGNALING_DN male reproductive system disease DOID_48 3.372E-03 0.05185527 1.000 1.000 SANA_TNF_SIGNALING_DN peripheral vascular disease DOID_341 3.462E-03 0.05183585 1.000 1.000 SANA_TNF_SIGNALING_DN diabetic retinopathy DOID_8947 3.553E-03 0.05183367 3.553E-03 0.16845942 SANA_TNF_SIGNALING_DN mixed glioma DOID_5076 3.928E-03 0.05587047 1.000 1.000 SANA_TNF_SIGNALING_DN alcohol abuse DOID_1574 4.421E-03 0.06135424 4.421E-03 0.16770158 SANA_TNF_SIGNALING_DN chronic kidney failure DOID_784 4.421E-03 0.05989342 1.000 1.000 SANA_TNF_SIGNALING_DN bone development disease DOID_0080006 4.523E-03 0.05984945 0.09514709 0.74162595 SANA_TNF_SIGNALING_DN retinal vascular disease DOID_2462 4.626E-03 0.05982151 4.626E-03 0.15483215 SANA_TNF_SIGNALING_DN transitional cell carcinoma DOID_2671 4.941E-03 0.06248212 0.0993502 0.76392251 SANA_TNF_SIGNALING_DN nervous system cancer DOID_3093 5.157E-03 0.06379249 0.1014446 0.76962636 SANA_TNF_SIGNALING_DN carbohydrate metabolic disorder DOID_2978 5.489E-03 0.06645008 0.10457727 0.77278528 SANA_TNF_SIGNALING_DN encephalomyelitis DOID_640 5.489E-03 0.06506571 0.10457727 0.76287778 SANA_TNF_SIGNALING_DN Crohn's disease DOID_8778 5.602E-03 0.06504621 0.10561912 0.76072506 SANA_TNF_SIGNALING_DN hypersensitivity reaction type I disease DOID_1205 5.715E-03 0.06503955 0.10665979 0.75861773 SANA_TNF_SIGNALING_DN ulcerative colitis DOID_8577 6.063E-03 0.06764158 0.10977469 0.77113329 MCLACHLAN_DENTAL_CARIES_DN tuberculosis DOID_399 2.323E-29 1.322E-26 0.26238002 1.000 MCLACHLAN_DENTAL_CARIES_DN hypersensitivity reaction type I disease DOID_1205 2.521E-28 7.171E-26 8.173E-04 0.03875514 MCLACHLAN_DENTAL_CARIES_DN primary bacterial infectious disease DOID_0050338 2.846E-27 5.398E-25 0.31721186 1.000 MCLACHLAN_DENTAL_CARIES_DN aneurysm disease DOID_2403 1.878E-26 2.671E-24 4.776E-03 0.14301473 MCLACHLAN_DENTAL_CARIES_DN contact dermatitis DOID_2773 3.949E-26 4.493E-24 1.568E-15 8.925E-13 MCLACHLAN_DENTAL_CARIES_DN primary immunodeficiency disease DOID_612 3.086E-25 2.926E-23 2.168E-13 4.113E-11 MCLACHLAN_DENTAL_CARIES_DN parasitic infectious disease DOID_1398 7.015E-24 5.702E-22 3.132E-03 0.11137186 MCLACHLAN_DENTAL_CARIES_DN allergic contact dermatitis DOID_3042 1.175E-23 8.359E-22 1.071E-14 3.046E-12 MCLACHLAN_DENTAL_CARIES_DN sarcoidosis DOID_11335 2.081E-23 1.316E-21 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hypersensitivity reaction type IV disease DOID_2916 8.868E-23 5.046E-21 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pulmonary tuberculosis DOID_2957 5.861E-22 3.032E-20 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN parasitic protozoa infectious disease DOID_2789 3.288E-21 1.559E-19 0.0256568 0.33178904 MCLACHLAN_DENTAL_CARIES_DN bacterial pneumonia DOID_874 7.784E-21 3.407E-19 0.29032204 1.000 MCLACHLAN_DENTAL_CARIES_DN brain infarction DOID_3454 7.441E-20 3.024E-18 0.03721203 0.44111757 MCLACHLAN_DENTAL_CARIES_DN collagen disease DOID_854 1.055E-18 4.003E-17 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pleural disease DOID_1532 2.346E-18 8.344E-17 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN aortic aneurysm DOID_3627 5.616E-18 1.88E-16 0.02168639 0.29379902 MCLACHLAN_DENTAL_CARIES_DN encephalomyelitis DOID_640 5.787E-18 1.829E-16 0.0626064 0.54804681 MCLACHLAN_DENTAL_CARIES_DN chronic kidney failure DOID_784 5.496E-17 1.646E-15 0.30538817 1.000 MCLACHLAN_DENTAL_CARIES_DN carotid artery disease DOID_3407 6.641E-17 1.889E-15 1.672E-04 0.01056915 MCLACHLAN_DENTAL_CARIES_DN rheumatic disease DOID_1575 7.206E-17 1.953E-15 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN scleroderma DOID_419 7.206E-17 1.953E-15 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN peripheral vascular disease DOID_341 5.074E-16 1.312E-14 0.04110009 0.47726435 MCLACHLAN_DENTAL_CARIES_DN cystic fibrosis DOID_1485 8.344E-16 2.064E-14 0.04411201 0.48268715 MCLACHLAN_DENTAL_CARIES_DN vasculitis DOID_865 9.573E-16 2.27E-14 1.064E-04 8.647E-03 MCLACHLAN_DENTAL_CARIES_DN urticaria DOID_1555 1.114E-15 2.535E-14 5.514E-03 0.14939707 MCLACHLAN_DENTAL_CARIES_DN systemic scleroderma DOID_418 2.004E-15 4.386E-14 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN B cell deficiency DOID_2115 2.444E-15 5.151E-14 1.933E-09 2.75E-07 MCLACHLAN_DENTAL_CARIES_DN pleurisy DOID_10247 5.027E-15 1.021E-13 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN agammaglobulinemia DOID_2583 6.78E-15 1.33E-13 1.484E-08 1.688E-06 MCLACHLAN_DENTAL_CARIES_DN cerebral infarction DOID_3526 8.716E-15 1.653E-13 0.01799974 0.27680689 MCLACHLAN_DENTAL_CARIES_DN proteinuria DOID_576 1.091E-14 2.003E-13 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN blood protein disease DOID_620 1.126E-14 2.002E-13 1.971E-08 1.869E-06 MCLACHLAN_DENTAL_CARIES_DN abdominal aortic aneurysm DOID_7693 1.34E-14 2.311E-13 0.13183756 0.73544676 MCLACHLAN_DENTAL_CARIES_DN vascular skin disease DOID_9540 1.359E-14 2.274E-13 0.01943947 0.28361689 MCLACHLAN_DENTAL_CARIES_DN ulcerative colitis DOID_8577 1.862E-14 3.027E-13 9.15E-03 0.17952974 MCLACHLAN_DENTAL_CARIES_DN autoimmune disease of gastrointestinal tract DOID_0060031 2.077E-14 3.284E-13 0.02092592 0.29767127 MCLACHLAN_DENTAL_CARIES_DN funisitis DOID_0050698 2.837E-14 4.363E-13 1.111E-04 7.903E-03 MCLACHLAN_DENTAL_CARIES_DN esophageal disease DOID_6050 4.261E-14 6.38E-13 0.14659526 0.75146582 MCLACHLAN_DENTAL_CARIES_DN pancreatitis DOID_4989 4.998E-14 7.291E-13 0.29032204 1.000 MCLACHLAN_DENTAL_CARIES_DN adult respiratory distress syndrome DOID_11394 1.89E-13 2.688E-12 0.16826562 0.81831744 MCLACHLAN_DENTAL_CARIES_DN intracranial arterial disease DOID_13089 1.89E-13 2.623E-12 0.16826562 0.81138254 MCLACHLAN_DENTAL_CARIES_DN cerebral arterial disease DOID_3527 1.89E-13 2.623E-12 0.16826562 0.81138254 MCLACHLAN_DENTAL_CARIES_DN myositis DOID_633 1.935E-13 2.621E-12 0.10922415 0.69053932 MCLACHLAN_DENTAL_CARIES_DN respiratory failure DOID_11162 2.242E-13 2.967E-12 0.24314733 0.96748831 MCLACHLAN_DENTAL_CARIES_DN Human immunodeficiency virus infectious disease DOID_526 2.454E-13 3.173E-12 0.05917699 0.54309208 MCLACHLAN_DENTAL_CARIES_DN middle cerebral artery infarction DOID_3525 2.699E-13 3.412E-12 0.11303329 0.69156928 MCLACHLAN_DENTAL_CARIES_DN endometriosis of uterus DOID_288 2.948E-13 3.647E-12 0.01592975 0.26658905 MCLACHLAN_DENTAL_CARIES_DN uterine disease DOID_345 3.601E-13 4.36E-12 0.03439521 0.41640158 MCLACHLAN_DENTAL_CARIES_DN endometriosis DOID_289 3.652E-13 4.329E-12 0.01660765 0.26999294 MCLACHLAN_DENTAL_CARIES_DN mouth disease DOID_403 3.967E-13 4.607E-12 0.33742398 1.000 MCLACHLAN_DENTAL_CARIES_DN influenza DOID_8469 4.5E-13 5.121E-12 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN prion disease DOID_649 6.983E-13 7.791E-12 0.07420192 0.57836839 MCLACHLAN_DENTAL_CARIES_DN pre-eclampsia DOID_10591 8.185E-13 8.956E-12 0.19285738 0.8506655 MCLACHLAN_DENTAL_CARIES_DN bronchiolitis obliterans DOID_2799 1.184E-12 1.271E-11 8.784E-03 0.17851128 MCLACHLAN_DENTAL_CARIES_DN calcium metabolism disease DOID_10575 1.432E-12 1.509E-11 0.20317421 0.86273229 MCLACHLAN_DENTAL_CARIES_DN metabolic syndrome X DOID_14221 2.518E-12 2.605E-11 0.29638707 1.000 MCLACHLAN_DENTAL_CARIES_DN female reproductive system disease DOID_229 2.852E-12 2.898E-11 0.04930695 0.51954912 MCLACHLAN_DENTAL_CARIES_DN pneumoconiosis DOID_10316 3.245E-12 3.239E-11 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pulmonary sarcoidosis DOID_13406 6.394E-12 6.273E-11 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN calcinosis DOID_182 6.394E-12 6.166E-11 0.15749969 0.79307364 MCLACHLAN_DENTAL_CARIES_DN mineral metabolism disease DOID_0050032 1.313E-11 1.245E-10 0.24961297 0.9728067 MCLACHLAN_DENTAL_CARIES_DN pulmonary emphysema DOID_9675 1.452E-11 1.355E-10 0.1718238 0.80799787 MCLACHLAN_DENTAL_CARIES_DN cholestasis DOID_13580 1.508E-11 1.384E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN periodontitis DOID_824 3.293E-11 2.974E-10 0.11682625 0.69972775 MCLACHLAN_DENTAL_CARIES_DN bile duct disease DOID_4138 3.309E-11 2.942E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN biliary tract disease DOID_9741 3.746E-11 3.28E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN diabetic retinopathy DOID_8947 4.234E-11 3.65E-10 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN malaria DOID_12365 4.279E-11 3.634E-10 7.298E-03 0.15379796 MCLACHLAN_DENTAL_CARIES_DN heart valve disease DOID_4079 4.305E-11 3.602E-10 0.19285738 0.83767824 MCLACHLAN_DENTAL_CARIES_DN giant cell tumor DOID_200 1.115E-10 9.192E-10 0.21335998 0.89266049 MCLACHLAN_DENTAL_CARIES_DN malignant giant cell tumor DOID_2705 1.115E-10 9.192E-10 0.21335998 0.89266049 MCLACHLAN_DENTAL_CARIES_DN giant cell glioblastoma DOID_3074 1.115E-10 9.192E-10 0.21335998 0.89266049 MCLACHLAN_DENTAL_CARIES_DN celiac disease DOID_10608 1.115E-10 9.061E-10 0.13555059 0.74881831 MCLACHLAN_DENTAL_CARIES_DN retinal vascular disease DOID_2462 1.465E-10 1.174E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pustulosis of palm and sole DOID_4398 1.493E-10 1.18E-09 0.22007849 0.90742508 MCLACHLAN_DENTAL_CARIES_DN periodontal disease DOID_3388 2.111E-10 1.645E-09 0.14659526 0.77233987 MCLACHLAN_DENTAL_CARIES_DN glioblastoma DOID_3068 2.269E-10 1.745E-09 0.23004948 0.92181799 MCLACHLAN_DENTAL_CARIES_DN leukocyte disease DOID_9500 2.596E-10 1.97E-09 0.02902832 0.35906768 MCLACHLAN_DENTAL_CARIES_DN autoimmune hepatitis DOID_2048 2.854E-10 2.137E-09 0.08602544 0.62754458 MCLACHLAN_DENTAL_CARIES_DN Crohn's disease DOID_8778 3.583E-10 2.648E-09 0.06376429 0.54972546 MCLACHLAN_DENTAL_CARIES_DN uveitis DOID_13141 4.543E-10 3.314E-09 0.16110363 0.79711275 MCLACHLAN_DENTAL_CARIES_DN peptic ulcer DOID_750 5.432E-10 3.913E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN temporal arteritis DOID_13375 6.06E-10 4.31E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN central nervous system vasculitis DOID_525 6.06E-10 4.31E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hyperglycemia DOID_4195 6.26E-10 4.397E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN astrocytoma DOID_3069 8.864E-10 6.151E-09 0.26553791 1.000 MCLACHLAN_DENTAL_CARIES_DN common cold DOID_10459 1.035E-09 7.097E-09 0.05009694 0.51827559 MCLACHLAN_DENTAL_CARIES_DN encephalitis DOID_9588 1.035E-09 7.012E-09 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN uveal disease DOID_3480 1.062E-09 7.112E-09 0.17889483 0.81432926 MCLACHLAN_DENTAL_CARIES_DN ankylosing spondylitis DOID_7147 1.524E-09 1.009E-08 0.10922415 0.68295098 MCLACHLAN_DENTAL_CARIES_DN intracranial aneurysm DOID_10941 1.933E-09 1.264E-08 0.11303329 0.69908634 MCLACHLAN_DENTAL_CARIES_DN neuritis DOID_1803 1.954E-09 1.264E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN autoimmune disease of the nervous system DOID_438 3.026E-09 1.934E-08 0.12060309 0.70745522 MCLACHLAN_DENTAL_CARIES_DN biliary tract cancer DOID_4607 3.401E-09 2.15E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN autoimmune disease of endocrine system DOID_0060005 3.738E-09 2.338E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN varicose veins DOID_799 3.885E-09 2.403E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN atopic dermatitis DOID_3310 3.9E-09 2.386E-08 1.707E-03 0.0693841 MCLACHLAN_DENTAL_CARIES_DN thyroiditis DOID_7166 5.631E-09 3.408E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN autoimmune thyroiditis DOID_7188 5.631E-09 3.408E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN vein disease DOID_866 5.631E-09 3.373E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN systemic mycosis DOID_0050136 9.717E-09 5.759E-08 0.14292938 0.76723412 MCLACHLAN_DENTAL_CARIES_DN fungal infectious disease DOID_1564 9.717E-09 5.759E-08 0.14292938 0.76723412 MCLACHLAN_DENTAL_CARIES_DN myocarditis DOID_820 9.717E-09 5.7E-08 4.93E-04 0.02805387 MCLACHLAN_DENTAL_CARIES_DN leishmaniasis DOID_9065 1.484E-08 8.614E-08 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN multiple myeloma DOID_9538 1.888E-08 1.085E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN membranous glomerulonephritis DOID_10976 1.971E-08 1.122E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN esophagitis DOID_11963 1.971E-08 1.111E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN tooth disease DOID_1091 2.184E-08 1.218E-07 0.25920864 1.000 MCLACHLAN_DENTAL_CARIES_DN endocrine organ benign neoplasm DOID_0060089 2.414E-08 1.333E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN mitochondrial myopathy DOID_699 2.578E-08 1.411E-07 0.08602544 0.61960098 MCLACHLAN_DENTAL_CARIES_DN nephrosis DOID_2527 3.232E-08 1.751E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN male reproductive system disease DOID_48 3.232E-08 1.735E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hepatitis B DOID_2043 3.325E-08 1.768E-07 0.08993317 0.6396497 MCLACHLAN_DENTAL_CARIES_DN sinusitis DOID_0050127 4.234E-08 2.231E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN paranasal sinus disease DOID_1352 4.234E-08 2.231E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN myasthenia gravis DOID_437 4.234E-08 2.21E-07 0.0938243 0.64320513 MCLACHLAN_DENTAL_CARIES_DN diabetic autonomic neuropathy DOID_11503 5.153E-08 2.665E-07 0.01729769 0.27339955 MCLACHLAN_DENTAL_CARIES_DN autonomic neuropathy DOID_11504 5.153E-08 2.665E-07 0.01729769 0.27339955 MCLACHLAN_DENTAL_CARIES_DN diabetic polyneuropathy DOID_12785 5.153E-08 2.665E-07 0.01729769 0.27339955 MCLACHLAN_DENTAL_CARIES_DN diabetic neuropathy DOID_9743 5.153E-08 2.665E-07 0.01729769 0.27339955 MCLACHLAN_DENTAL_CARIES_DN meningitis DOID_9471 5.33E-08 2.732E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Goodpasture syndrome DOID_9808 5.33E-08 2.708E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Sjogren's syndrome DOID_12894 6.613E-08 3.33E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN phagocyte bactericidal dysfunction DOID_3262 6.613E-08 3.301E-07 0.04192414 0.46774186 MCLACHLAN_DENTAL_CARIES_DN cutaneous leishmaniasis DOID_9111 6.613E-08 3.272E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN toxic shock syndrome DOID_14115 6.639E-08 3.257E-07 0.10155701 0.6798346 MCLACHLAN_DENTAL_CARIES_DN myeloma DOID_0070004 7.545E-08 3.67E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN autonomic nervous system disease DOID_11465 7.545E-08 3.638E-07 0.01943947 0.29108049 MCLACHLAN_DENTAL_CARIES_DN commensal bacterial infectious disease DOID_0050339 8.192E-08 3.917E-07 0.10539874 0.68933201 MCLACHLAN_DENTAL_CARIES_DN bronchiolitis DOID_2942 8.192E-08 3.884E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN cystitis DOID_1679 1.002E-07 4.711E-07 5.938E-03 0.14690732 MCLACHLAN_DENTAL_CARIES_DN neuromuscular junction disease DOID_439 1.002E-07 4.673E-07 0.10922415 0.69829819 MCLACHLAN_DENTAL_CARIES_DN common variable immunodeficiency DOID_12177 1.036E-07 4.791E-07 0.04601924 0.49405557 MCLACHLAN_DENTAL_CARIES_DN bronchiectasis DOID_9563 1.036E-07 4.752E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN vitiligo DOID_12306 1.216E-07 5.533E-07 6.377E-03 0.15119286 MCLACHLAN_DENTAL_CARIES_DN extrinsic allergic alveolitis DOID_841 1.216E-07 5.489E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN transitional cell carcinoma DOID_2671 1.267E-07 5.677E-07 0.32013639 1.000 MCLACHLAN_DENTAL_CARIES_DN Sciatic Neuropathy DOID_11446 1.464E-07 6.507E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lesion of sciatic nerve DOID_12528 1.464E-07 6.507E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN mononeuritis of lower limb DOID_9473 1.464E-07 6.507E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN stomach disease DOID_76 1.548E-07 6.83E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN ocular hypertension DOID_9282 1.548E-07 6.777E-07 0.05009694 0.50009048 MCLACHLAN_DENTAL_CARIES_DN borderline glaucoma DOID_9283 1.548E-07 6.777E-07 0.05009694 0.50009048 MCLACHLAN_DENTAL_CARIES_DN bone marrow cancer DOID_4960 1.681E-07 7.302E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lymphoma DOID_0060058 1.711E-07 7.377E-07 0.06145583 0.55505348 MCLACHLAN_DENTAL_CARIES_DN mononeuritis DOID_1802 1.75E-07 7.488E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lymphoblastic leukemia DOID_1037 1.841E-07 7.816E-07 7.56E-04 0.03910337 MCLACHLAN_DENTAL_CARIES_DN integumentary system cancer DOID_0060122 1.868E-07 7.875E-07 0.0256568 0.33950506 MCLACHLAN_DENTAL_CARIES_DN skin cancer DOID_4159 1.868E-07 7.875E-07 0.0256568 0.33950506 MCLACHLAN_DENTAL_CARIES_DN mononeuropathy DOID_1188 2.08E-07 8.702E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN carotid stenosis DOID_13001 2.229E-07 9.258E-07 1.372E-03 0.06006852 MCLACHLAN_DENTAL_CARIES_DN polyneuropathy DOID_1389 2.229E-07 9.191E-07 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN opportunistic mycosis DOID_2473 2.885E-07 1.181E-06 0.13183756 0.74272841 MCLACHLAN_DENTAL_CARIES_DN allergic rhinitis DOID_4481 3.371E-07 1.37E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN chronic leukemia DOID_1036 3.919E-07 1.582E-06 9.844E-03 0.18670847 MCLACHLAN_DENTAL_CARIES_DN chronic lymphocytic leukemia DOID_1040 3.919E-07 1.582E-06 9.844E-03 0.18670847 MCLACHLAN_DENTAL_CARIES_DN bladder disease DOID_365 3.919E-07 1.57E-06 9.844E-03 0.18068561 MCLACHLAN_DENTAL_CARIES_DN idiopathic pulmonary fibrosis DOID_0050156 4.227E-07 1.682E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN adrenal cortex disease DOID_3952 4.227E-07 1.67E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN oral submucous fibrosis DOID_5773 4.227E-07 1.659E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN spindle cell carcinoma DOID_4015 5.226E-07 2.037E-06 0.14659526 0.76525418 MCLACHLAN_DENTAL_CARIES_DN hemolytic-uremic syndrome DOID_12554 5.617E-07 2.174E-06 0.06623525 0.5625053 MCLACHLAN_DENTAL_CARIES_DN Barrett's esophagus DOID_9206 5.617E-07 2.16E-06 0.06623525 0.5462008 MCLACHLAN_DENTAL_CARIES_DN adrenal gland disease DOID_9553 7.321E-07 2.796E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN respiratory syncytial virus infectious disease DOID_1273 1.002E-06 3.803E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hepatitis DOID_2237 1.002E-06 3.778E-06 0.16469226 0.80784391 MCLACHLAN_DENTAL_CARIES_DN bone resorption disease DOID_0080011 1.192E-06 4.461E-06 0.28727006 1.000 MCLACHLAN_DENTAL_CARIES_DN osteoporosis DOID_11476 1.192E-06 4.461E-06 0.28727006 1.000 MCLACHLAN_DENTAL_CARIES_DN brain edema DOID_4724 1.476E-06 5.488E-06 0.08210104 0.61467752 MCLACHLAN_DENTAL_CARIES_DN nephrotic syndrome DOID_1184 1.593E-06 5.887E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN gallbladder cancer DOID_3121 1.777E-06 6.523E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN thyroid adenoma DOID_2891 2.429E-06 8.86E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN IgA glomerulonephritis DOID_2986 2.67E-06 9.677E-06 0.0938243 0.6510491 MCLACHLAN_DENTAL_CARIES_DN uremia DOID_4676 2.67E-06 9.616E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN sleep disorder DOID_535 2.67E-06 9.555E-06 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hemolytic anemia DOID_583 2.684E-06 9.544E-06 0.19631099 0.84621934 MCLACHLAN_DENTAL_CARIES_DN normocytic anemia DOID_720 2.684E-06 9.544E-06 0.19631099 0.84621934 MCLACHLAN_DENTAL_CARIES_DN integumentary system benign neoplasm DOID_0060121 2.959E-06 1.046E-05 0.02092592 0.290411 MCLACHLAN_DENTAL_CARIES_DN glaucoma DOID_1686 2.959E-06 1.039E-05 0.19974991 0.85456918 MCLACHLAN_DENTAL_CARIES_DN skin benign neoplasm DOID_3165 2.959E-06 1.046E-05 0.02092592 0.290411 MCLACHLAN_DENTAL_CARIES_DN alcohol-related neurodevelopmental disorder DOID_0050667 3.744E-06 1.307E-05 0.33742398 1.000 MCLACHLAN_DENTAL_CARIES_DN acute pancreatitis DOID_2913 3.789E-06 1.315E-05 0.10155701 0.67192954 MCLACHLAN_DENTAL_CARIES_DN portal hypertension DOID_10762 4.463E-06 1.539E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN mitochondrial metabolism disease DOID_700 5.564E-06 1.907E-05 0.22341633 0.90802781 MCLACHLAN_DENTAL_CARIES_DN hypertrophic cardiomyopathy DOID_11984 6.567E-06 2.237E-05 0.23004948 0.92835571 MCLACHLAN_DENTAL_CARIES_DN bile duct cancer DOID_4606 6.567E-06 2.224E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN bile duct carcinoma DOID_4897 6.567E-06 2.224E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hepatic vascular disease DOID_272 8.073E-06 2.718E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN angioedema DOID_1558 8.991E-06 3.009E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pre-malignant neoplasm DOID_0060071 9.696E-06 3.226E-05 0.24638704 0.96685672 MCLACHLAN_DENTAL_CARIES_DN in situ carcinoma DOID_8719 9.696E-06 3.226E-05 0.24638704 0.96685672 MCLACHLAN_DENTAL_CARIES_DN endocrine pancreas disease DOID_1428 1.044E-05 3.454E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN spastic cerebral palsy DOID_0050669 1.193E-05 3.925E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pneumocystosis DOID_11339 1.232E-05 4.03E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN prediabetes syndrome DOID_11716 1.232E-05 4.007E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pancreatic ductal carcinoma DOID_3587 1.591E-05 5.143E-05 0.26868236 1.000 MCLACHLAN_DENTAL_CARIES_DN mitochondrial encephalomyopathy DOID_890 1.638E-05 5.266E-05 0.05009694 0.50902066 MCLACHLAN_DENTAL_CARIES_DN thyroid carcinoma DOID_3963 1.901E-05 6.076E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pancreatic carcinoma DOID_4905 1.937E-05 6.156E-05 0.27803566 1.000 MCLACHLAN_DENTAL_CARIES_DN berylliosis DOID_10322 2.123E-05 6.71E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN larynx cancer DOID_2596 2.123E-05 6.673E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN laryngeal benign neoplasm DOID_2598 2.123E-05 6.673E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN thyroid cancer DOID_1781 2.351E-05 7.352E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN polycystic kidney disease DOID_898 2.693E-05 8.374E-05 0.05820045 0.54288612 MCLACHLAN_DENTAL_CARIES_DN narcolepsy DOID_8986 2.693E-05 8.328E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lipid metabolism disorder DOID_3146 2.802E-05 8.618E-05 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN skeletal system cancer DOID_0060124 3.356E-05 1.027E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN thoracic aortic aneurysm DOID_14004 3.356E-05 1.021E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN bone cancer DOID_184 3.356E-05 1.027E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN intermediate coronary syndrome DOID_8805 3.356E-05 1.016E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hyperhomocysteinemia DOID_9279 3.356E-05 1.01E-04 0.0622264 0.55323157 MCLACHLAN_DENTAL_CARIES_DN cervix uteri carcinoma in situ DOID_8991 3.817E-05 1.143E-04 0.1718238 0.81473118 MCLACHLAN_DENTAL_CARIES_DN silicosis DOID_10325 4.117E-05 1.227E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN tongue cancer DOID_8649 4.117E-05 1.22E-04 0.06623525 0.55423316 MCLACHLAN_DENTAL_CARIES_DN nervous system cancer DOID_3093 4.879E-05 1.439E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN juvenile rheumatoid arthritis DOID_676 4.984E-05 1.462E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN eosinophilia DOID_999 5.962E-05 1.74E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN amyloidosis DOID_9120 8.277E-05 2.403E-04 0.08210104 0.60669469 MCLACHLAN_DENTAL_CARIES_DN hemorrhagic disease DOID_2213 8.602E-05 2.484E-04 0.20658395 0.87071308 MCLACHLAN_DENTAL_CARIES_DN B-cell lymphocytic neoplasm DOID_707 8.602E-05 2.472E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN bile duct adenocarcinoma DOID_4896 1.064E-04 3.042E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN cholangiocarcinoma DOID_4947 1.064E-04 3.042E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN gastric ulcer DOID_10808 1.111E-04 3.161E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN neutropenia DOID_1227 1.111E-04 3.145E-04 3.963E-03 0.13264797 MCLACHLAN_DENTAL_CARIES_DN familial hypercholesterolemia DOID_13810 1.111E-04 3.13E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN familial hyperlipidemia DOID_1168 1.218E-04 3.413E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN agranulocytosis DOID_12987 1.274E-04 3.553E-04 4.328E-03 0.13682645 MCLACHLAN_DENTAL_CARIES_DN pulmonary embolism DOID_9477 1.274E-04 3.536E-04 0.0938243 0.63554793 MCLACHLAN_DENTAL_CARIES_DN hypoglycemia DOID_9993 1.274E-04 3.518E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN oral cavity cancer DOID_8618 1.387E-04 3.812E-04 0.0281696 0.35618889 MCLACHLAN_DENTAL_CARIES_DN diabetic angiopathy DOID_11713 1.451E-04 3.97E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN spastic quadriplegia DOID_10970 1.644E-04 4.476E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN temporal lobe epilepsy DOID_3328 2.237E-04 6.062E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN gestational diabetes DOID_11714 2.579E-04 6.955E-04 0.11682625 0.70717166 MCLACHLAN_DENTAL_CARIES_DN lung adenocarcinoma DOID_3910 2.579E-04 6.922E-04 6.83E-03 0.15546181 MCLACHLAN_DENTAL_CARIES_DN blood coagulation disease DOID_1247 2.78E-04 7.425E-04 0.26868236 1.000 MCLACHLAN_DENTAL_CARIES_DN autoimmune disease of cardiovascular system DOID_0060051 2.857E-04 7.596E-04 7.298E-03 0.15971327 MCLACHLAN_DENTAL_CARIES_DN Behcet's disease DOID_13241 2.857E-04 7.596E-04 7.298E-03 0.15971327 MCLACHLAN_DENTAL_CARIES_DN coronary stenosis DOID_4248 2.857E-04 7.56E-04 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN syndrome DOID_225 3.583E-04 9.439E-04 0.28420505 1.000 MCLACHLAN_DENTAL_CARIES_DN age related macular degeneration DOID_10871 3.803E-04 9.972E-04 0.13183756 0.7501557 MCLACHLAN_DENTAL_CARIES_DN degeneration of macula and posterior pole DOID_2007 3.803E-04 9.972E-04 0.13183756 0.7501557 MCLACHLAN_DENTAL_CARIES_DN mixed glioma DOID_5076 3.947E-04 1.03E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN papilloma DOID_2615 4.93E-04 1.281E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN focal epilepsy DOID_2234 4.97E-04 1.285E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hepatitis C DOID_1883 5.349E-04 1.377E-03 0.14659526 0.779558 MCLACHLAN_DENTAL_CARIES_DN macular degeneration DOID_4448 5.349E-04 1.371E-03 0.14659526 0.75829732 MCLACHLAN_DENTAL_CARIES_DN leukopenia DOID_615 5.349E-04 1.365E-03 0.01095747 0.19483759 MCLACHLAN_DENTAL_CARIES_DN adenoma DOID_657 6.252E-04 1.588E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN amino acid metabolic disorder DOID_9252 6.431E-04 1.626E-03 0.32304847 1.000 MCLACHLAN_DENTAL_CARIES_DN congenital diaphragmatic hernia DOID_3827 7.78E-04 1.959E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hyperparathyroidism DOID_13543 7.985E-04 2.001E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hypolipoproteinemia DOID_1387 7.985E-04 1.993E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN retinal vascular occlusion DOID_1729 7.985E-04 1.984E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN transient cerebral ischemia DOID_224 7.985E-04 1.975E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN insulinoma DOID_3892 7.985E-04 1.967E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN adrenal gland hyperfunction DOID_3947 7.985E-04 1.958E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lymphatic system disease DOID_75 8.337E-04 2.036E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN autoimmune disease of urogenital tract DOID_0060049 9.527E-04 2.317E-03 0.17536685 0.81789947 MCLACHLAN_DENTAL_CARIES_DN primary biliary cirrhosis DOID_12236 9.527E-04 2.317E-03 0.17536685 0.81789947 MCLACHLAN_DENTAL_CARIES_DN familial adenomatous polyposis DOID_0050424 9.732E-04 2.356E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN trypanosomiasis DOID_10113 9.732E-04 2.346E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN dermatomyositis DOID_10223 9.732E-04 2.336E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN sickle cell anemia DOID_10923 9.732E-04 2.327E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN diarrhea DOID_13250 1.165E-03 2.772E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN islet cell tumor DOID_1799 1.165E-03 2.761E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN peritonitis DOID_8283 1.165E-03 2.749E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN brain cancer DOID_1319 1.295E-03 3.046E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN central nervous system cancer DOID_3620 1.372E-03 3.213E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN parathyroid gland disease DOID_11201 1.372E-03 3.2E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN psoriatic arthritis DOID_9008 1.372E-03 3.187E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN viral pneumonia DOID_10533 1.597E-03 3.693E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN aspergillosis DOID_13564 1.597E-03 3.678E-03 0.05820045 0.56128904 MCLACHLAN_DENTAL_CARIES_DN parasitic helminthiasis infectious disease DOID_883 1.597E-03 3.663E-03 0.05820045 0.55193422 MCLACHLAN_DENTAL_CARIES_DN bacterial meningitis DOID_9470 1.597E-03 3.649E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN mesenchymal cell neoplasm DOID_3350 1.837E-03 4.181E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN spindle cell sarcoma DOID_4235 1.837E-03 4.181E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lung oat cell carcinoma DOID_5411 1.837E-03 4.165E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN epithelioid sarcoma DOID_6193 1.837E-03 4.181E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN spastic diplegia DOID_10965 2.094E-03 4.727E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN bronchitis DOID_6132 2.366E-03 5.322E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN melancholia DOID_2848 2.408E-03 5.394E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN neurotic disorder DOID_4964 2.52E-03 5.624E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN glucose intolerance DOID_10603 2.655E-03 5.9E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hypothyroidism DOID_1459 2.755E-03 6.1E-03 0.24314733 0.96076965 MCLACHLAN_DENTAL_CARIES_DN Down syndrome DOID_14250 2.958E-03 6.525E-03 0.07815989 0.60098616 MCLACHLAN_DENTAL_CARIES_DN MHC class II deficiency DOID_5812 2.958E-03 6.5E-03 2.958E-03 0.11222546 MCLACHLAN_DENTAL_CARIES_DN amnestic disorder DOID_10914 3.278E-03 7.174E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pulmonary edema DOID_11396 3.278E-03 7.146E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Kawasaki disease DOID_13378 3.613E-03 7.846E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lymphadenitis DOID_1602 3.613E-03 7.846E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN coronary restenosis DOID_4247 3.613E-03 7.817E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lymph node disease DOID_9942 3.613E-03 7.846E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN acquired immunodeficiency syndrome DOID_635 3.963E-03 8.542E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN urinary tract obstruction DOID_5200 4.328E-03 9.294E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN polyarteritis nodosa DOID_9810 4.328E-03 9.259E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN endogenous depression DOID_1595 4.608E-03 9.821E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Lewy body dementia DOID_12217 4.709E-03 9.997E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN aortic valve disease DOID_62 4.709E-03 9.96E-03 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN severe combined immunodeficiency DOID_627 5.104E-03 0.01075597 5.104E-03 0.14520566 MCLACHLAN_DENTAL_CARIES_DN combined T cell and B cell immunodeficiency DOID_628 5.514E-03 0.01157689 5.514E-03 0.14260629 MCLACHLAN_DENTAL_CARIES_DN mental depression DOID_1596 5.855E-03 0.01224745 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN spinal cord disease DOID_319 6.377E-03 0.01329168 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN perinatal necrotizing enterocolitis DOID_8677 6.83E-03 0.01418447 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN renal hypertension DOID_1073 7.298E-03 0.01510016 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN secondary hypertension DOID_11130 7.298E-03 0.01510016 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN sarcoma DOID_1115 7.298E-03 0.01504545 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN thrombocytopenia DOID_1588 7.298E-03 0.01499114 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN invasive ductal carcinoma DOID_3008 7.298E-03 0.01493721 0.12060309 0.71482455 MCLACHLAN_DENTAL_CARIES_DN toxic encephalopathy DOID_3602 7.78E-03 0.01586579 0.12436387 0.72207187 MCLACHLAN_DENTAL_CARIES_DN focal glomerulosclerosis DOID_3945 7.78E-03 0.01580912 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN carbohydrate metabolic disorder DOID_2978 7.954E-03 0.01610705 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN endometrial carcinoma DOID_2871 8.275E-03 0.01669682 0.12810867 0.73630136 MCLACHLAN_DENTAL_CARIES_DN dilated cardiomyopathy DOID_12930 8.421E-03 0.01693095 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN endometrial cancer DOID_1380 9.307E-03 0.01864762 0.13555059 0.74161814 MCLACHLAN_DENTAL_CARIES_DN germinoma DOID_3304 9.307E-03 0.01858219 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN autonomic nervous system neoplasm DOID_2621 9.844E-03 0.0195848 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN neuroblastoma DOID_769 9.844E-03 0.0195848 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN nephroblastoma DOID_2154 0.01095747 0.02172405 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hyperthyroidism DOID_7998 0.01095747 0.02164862 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lymphoid leukemia DOID_10747 0.01153406 0.02270893 0.01153406 0.19887519 MCLACHLAN_DENTAL_CARIES_DN embryonal cancer DOID_688 0.01272636 0.02497 0.15749969 0.78611685 MCLACHLAN_DENTAL_CARIES_DN peripheral nervous system neoplasm DOID_1192 0.01334183 0.02608764 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN blood platelet disease DOID_2218 0.01334183 0.0259983 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN benign mesothelioma DOID_2645 0.0152641 0.02964257 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Huntington's disease DOID_12858 0.01660765 0.03214202 0.17889483 0.82089643 MCLACHLAN_DENTAL_CARIES_DN hyperinsulinism DOID_2018 0.01660765 0.03203306 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN uterine cancer DOID_363 0.01729769 0.0332513 0.18240781 0.8237305 MCLACHLAN_DENTAL_CARIES_DN learning disability DOID_8927 0.01799974 0.03448436 0.18590585 0.82640961 MCLACHLAN_DENTAL_CARIES_DN leukodystrophy DOID_10579 0.01871371 0.03573188 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN bone marrow disease DOID_4961 0.01943947 0.03699351 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lung small cell carcinoma DOID_5409 0.02092592 0.0396895 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN withdrawal disorder DOID_0060001 0.02245821 0.04245423 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN atrophic muscular disease DOID_913 0.02403546 0.04528536 0.21335998 0.88614472 MCLACHLAN_DENTAL_CARIES_DN muscular dystrophy DOID_9884 0.02403546 0.04528536 0.21335998 0.88614472 MCLACHLAN_DENTAL_CARIES_DN cerebral degeneration DOID_1443 0.03439521 0.06459034 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN leber hereditary optic neuropathy DOID_705 0.03781157 0.07077232 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN gallbladder disease DOID_0000000 0.04192414 0.07821257 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN interstitial nephritis DOID_1063 0.04192414 0.07795698 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN familial combined hyperlipidemia DOID_13809 0.04192414 0.07770304 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN childhood type dermatomyositis DOID_14203 0.04192414 0.07745076 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN bilirubin metabolic disorder DOID_2741 0.04192414 0.07720011 0.04192414 0.47709669 MCLACHLAN_DENTAL_CARIES_DN acute kidney failure DOID_3021 0.04192414 0.07695108 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN progressive muscular atrophy DOID_318 0.04192414 0.07670365 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN teratoma DOID_3307 0.04192414 0.0764578 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN chondrosarcoma DOID_3371 0.04192414 0.07621353 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Hermansky-Pudlak syndrome DOID_3753 0.04192414 0.07597081 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN conjunctival disease DOID_4251 0.04192414 0.07572963 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN keratitis DOID_4677 0.04192414 0.07548998 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN malignant teratoma DOID_5563 0.04192414 0.0764578 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN mature teratoma DOID_5566 0.04192414 0.0764578 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN conjunctivitis DOID_6195 0.04192414 0.07572963 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN polycythemia DOID_8432 0.04192414 0.07525184 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN visceral leishmaniasis DOID_9146 0.04192414 0.0750152 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN alopecia areata DOID_986 0.04192414 0.07478005 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN nervous system benign neoplasm DOID_0060115 0.04601924 0.08182795 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN adrenoleukodystrophy DOID_10588 0.04601924 0.08157304 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN neuronal ceroid lipofuscinosis DOID_14503 0.04601924 0.08131971 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN invasive lobular carcinoma DOID_3457 0.04601924 0.08106794 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN eosinophilic pneumonia DOID_5870 0.04601924 0.08081773 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN pulmonary eosinophilia DOID_9498 0.04601924 0.08081773 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Loeffler syndrome DOID_9503 0.04601924 0.08081773 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN chromosomal disease DOID_0080014 0.04930695 0.08632508 0.29940025 1.000 MCLACHLAN_DENTAL_CARIES_DN otitis media DOID_10754 0.05009694 0.08743913 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN beta thalassemia DOID_12241 0.05009694 0.08717173 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN intracranial arteriosclerosis DOID_13097 0.05009694 0.08690597 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN aortic valve stenosis DOID_1712 0.05009694 0.08664182 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN relapsing-remitting multiple sclerosis DOID_2378 0.05009694 0.08637926 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN epidermolysis bullosa DOID_2730 0.05009694 0.0861183 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN middle ear disease DOID_5100 0.05009694 0.08743913 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN retinal detachment DOID_5327 0.05009694 0.08585891 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN aortic valve insufficiency DOID_57 0.05009694 0.08560107 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN lipodystrophy DOID_811 0.05009694 0.08534478 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN vascular dementia DOID_8725 0.05009694 0.08690597 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN leprosy DOID_1024 0.05415732 0.09198661 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN essential hypertension DOID_10825 0.05415732 0.09171284 0.05415732 0.53130194 MCLACHLAN_DENTAL_CARIES_DN newborn respiratory distress syndrome DOID_12716 0.05415732 0.09144069 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN vesiculobullous skin disease DOID_2731 0.05415732 0.09117016 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN intracranial thrombosis DOID_4193 0.05415732 0.09090122 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN Legionnaires' disease DOID_10457 0.05820045 0.09740016 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN legionellosis DOID_10458 0.05820045 0.09740016 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN open-angle glaucoma DOID_1067 0.05820045 0.09711453 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN tethered spinal cord syndrome DOID_1089 0.05820045 0.09683057 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN hypercalcemia DOID_12678 0.05820045 0.09654826 1.000 1.000 MCLACHLAN_DENTAL_CARIES_DN eyelid disease DOID_530 0.05820045 0.0962676 1.000 1.000 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER pre-malignant neoplasm DOID_0060071 1.888E-09 1.074E-06 1.888E-09 1.074E-06 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER in situ carcinoma DOID_8719 1.888E-09 1.074E-06 1.888E-09 1.074E-06 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER cervix uteri carcinoma in situ DOID_8991 4.229E-08 1.203E-05 4.229E-08 1.203E-05 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER myeloma DOID_0070004 7.151E-08 1.356E-05 8.546E-06 9.725E-04 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER bone marrow cancer DOID_4960 1.222E-07 1.738E-05 1.271E-05 1.205E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER vulva cancer DOID_1245 1.272E-07 1.447E-05 1.272E-07 2.412E-05 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER transitional cell carcinoma DOID_2671 7.762E-07 7.361E-05 5.014E-05 3.17E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER muscle cancer DOID_4045 7.834E-07 6.368E-05 1.516E-04 5.75E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER nephroblastoma DOID_2154 3.412E-06 2.426E-04 3.412E-06 4.853E-04 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER multiple myeloma DOID_9538 4.331E-06 2.738E-04 4.634E-04 0.01255642 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER integumentary system cancer DOID_0060122 1.34E-05 7.623E-04 9.734E-04 0.02051431 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER skin cancer DOID_4159 1.34E-05 7.623E-04 9.734E-04 0.02051431 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER keratitis DOID_4677 2.713E-05 1.404E-03 2.713E-05 2.206E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER mixed glioma DOID_5076 3.525E-05 1.672E-03 3.525E-05 2.507E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER lymphoma DOID_0060058 5.709E-05 2.499E-03 2.529E-03 0.04360518 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER lymphoblastic leukemia DOID_1037 5.892E-05 2.395E-03 5.892E-05 3.353E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER idiopathic pulmonary fibrosis DOID_0050156 6.316E-05 2.396E-03 6.316E-05 3.267E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER basal cell carcinoma DOID_2513 8.172E-05 2.906E-03 8.172E-05 3.875E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER skin carcinoma DOID_3451 9.189E-05 3.076E-03 9.189E-05 4.022E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER testicular cancer DOID_2998 1.027E-04 3.245E-03 1.027E-04 4.172E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER female reproductive organ benign neoplasm DOID_0060086 2.958E-04 8.86E-03 2.958E-04 0.0105211 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER uterine benign neoplasm DOID_0060095 2.958E-04 8.86E-03 2.958E-04 0.0105211 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER corneal disease DOID_10124 2.958E-04 8.417E-03 2.958E-04 9.902E-03 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER uterine fibroid DOID_13223 2.958E-04 8.86E-03 2.958E-04 0.0105211 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER leiomyoma DOID_127 3.544E-04 9.602E-03 3.544E-04 0.01120219 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER bladder disease DOID_365 3.544E-04 9.165E-03 0.02733918 0.2287646 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER lymphoid leukemia DOID_10747 4.181E-04 0.01034297 4.181E-04 0.01252043 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER aplastic anemia DOID_12449 4.181E-04 9.912E-03 0.02964862 0.23430647 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER embryonal cancer DOID_688 4.634E-04 0.01054739 4.634E-04 0.01318424 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER congenital diaphragmatic hernia DOID_3827 5.11E-04 0.0111839 5.11E-04 0.01321733 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER benign mesothelioma DOID_2645 5.609E-04 0.01182126 5.609E-04 0.01387713 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER nephrotic syndrome DOID_1184 6.131E-04 0.01245924 6.131E-04 0.01453578 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER gallbladder cancer DOID_3121 6.4E-04 0.01255809 6.4E-04 0.01456738 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER uterine cancer DOID_363 6.4E-04 0.01213948 0.03654519 0.24755016 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER bone marrow disease DOID_4961 7.242E-04 0.01329321 0.0388335 0.25109388 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER B-cell lymphocytic neoplasm DOID_707 8.444E-04 0.01501382 0.04187641 0.25621157 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER reproductive organ benign neoplasm DOID_0050622 9.734E-04 0.01678443 9.734E-04 0.02130332 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER melancholia DOID_2848 1.111E-03 0.01859974 0.04793431 0.27004577 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER neurotic disorder DOID_4964 1.147E-03 0.01865156 0.04868894 0.27160791 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER carotid artery disease DOID_3407 1.184E-03 0.01870922 1.184E-03 0.02405471 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER pancreatic ductal carcinoma DOID_3587 1.536E-03 0.02362498 1.536E-03 0.03014221 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER nephrosis DOID_2527 1.578E-03 0.02363064 1.578E-03 0.02993215 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER pancreatic carcinoma DOID_4905 1.664E-03 0.02427103 1.664E-03 0.03053453 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER endogenous depression DOID_1595 1.751E-03 0.02491018 0.05993924 0.29917039 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER bacterial pneumonia DOID_874 1.841E-03 0.02554809 0.06142952 0.29874699 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER mental depression DOID_1596 2.075E-03 0.02810659 0.06514526 0.30634422 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER biliary tract cancer DOID_4607 2.075E-03 0.02745295 2.075E-03 0.0368899 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER alcohol-related neurodevelopmental disorder DOID_0050667 2.636E-03 0.03408452 2.636E-03 0.04410939 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER mouth disease DOID_403 2.636E-03 0.03332709 0.07326988 0.32827214 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER familial combined hyperlipidemia DOID_13809 7.886E-03 0.09754743 7.886E-03 0.12820519 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER bilirubin metabolic disorder DOID_2741 7.886E-03 0.09547195 1.000 1.000 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER teratoma DOID_3307 7.886E-03 0.09348295 7.886E-03 0.12464394 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER holoprosencephaly DOID_4621 7.886E-03 0.09157514 7.886E-03 0.12127518 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER malignant teratoma DOID_5563 7.886E-03 0.09348295 7.886E-03 0.12464394 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER mature teratoma DOID_5566 7.886E-03 0.09348295 7.886E-03 0.12464394 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER Hodgkin's lymphoma, lymphocytic-histiocytic predominance DOID_8543 7.886E-03 0.08974363 1.000 1.000 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER Hodgkin's lymphoma, lymphocytic depletion DOID_8628 7.886E-03 0.08974363 1.000 1.000 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER Hodgkin's granuloma DOID_8651 7.886E-03 0.08974363 1.000 1.000 SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER Hodgkin's lymphoma, mixed cellularity DOID_8654 7.886E-03 0.08974363 1.000 1.000